PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Soman, R; Yuan, JJ; Kuhn, A; Dalbey, RE				Soman, Raunak; Yuan, Jijun; Kuhn, Andreas; Dalbey, Ross E.			Polarity and Charge of the Periplasmic Loop Determine the YidC and Sec Translocase Requirement for the M13 Procoat Lep Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							COLI INNER MEMBRANE; F1F0 ATP SYNTHASE; PROTON MOTIVE FORCE; ESCHERICHIA-COLI; SUBUNIT-C; TERMINAL DOMAINS; INSERTION; RESIDUES; BIOGENESIS; SUBSTRATE	During membrane biogenesis, the M13 procoat protein is inserted into the lipid bilayer in a strictly YidC-dependent manner with both the hydrophobic signal sequence and the membrane anchor sequence promoting translocation of the periplasmic loop via a hairpin mechanism. Here, we find that the translocase requirements can be altered for PClep in a predictable manner by changing the polarity and charge of the peptide region that is translocated across the membrane. When the polarity of the translocated peptide region is lowered and the charged residues in this region are removed, translocation of this loop region occurs largely by a YidC- and Sec-independent mechanism. When the polarity is increased to that of the wild-type procoat protein, the YidC insertase is essential for translocation. Further increasing the polarity, by adding charged residues, switches the insertion pathway to a YidC/Sec mechanism. Conversely, we find that increasing the hydrophobicity of the transmembrane segments of PClep can decrease the translocase requirement for translocation of the peptide chain. This study provides a framework to understand why the YidC and Sec machineries exist in parallel and demonstrates that the YidC insertase has a limited capacity to translocate a peptide chain on its own.	[Soman, Raunak; Yuan, Jijun; Dalbey, Ross E.] Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA; [Kuhn, Andreas] Univ Hohenheim, Inst Microbiol & Mol Biol, D-70599 Stuttgart, Germany	University System of Ohio; Ohio State University; University Hohenheim	Dalbey, RE (corresponding author), Ohio State Univ, Dept Chem & Biochem, Columbus, OH 43210 USA.	dalbey@chemistry.ohio-state.edu			National Science Foundation [MCB-1052033]; Deutsche Forschungsgemeinschaft [KU749/6]	National Science Foundation(National Science Foundation (NSF)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by National Science Foundation Grant MCB-1052033 (to R. E. D.) and by Deutsche Forschungsgemeinschaft Grant KU749/6 (to A. K.).	ANDERSSON H, 1993, EMBO J, V12, P683, DOI 10.1002/j.1460-2075.1993.tb05702.x; CAO GQ, 1995, EMBO J, V14, P866, DOI 10.1002/j.1460-2075.1995.tb07068.x; Celebi N, 2006, J MOL BIOL, V357, P1428, DOI 10.1016/j.jmb.2006.01.030; Chen MY, 2005, BIOCHEMISTRY-US, V44, P10741, DOI 10.1021/bi047418k; DALBEY RE, 1986, J BIOL CHEM, V261, P3844; Dalbey RE, 2011, ANNU REV BIOCHEM, V80, P161, DOI 10.1146/annurev-biochem-060409-092524; Deitermann S, 2005, J BIOL CHEM, V280, P39077, DOI 10.1074/jbc.M509647200; Delgado-Partin VM, 1998, J BIOL CHEM, V273, P9927, DOI 10.1074/jbc.273.16.9927; Driessen AJM, 2008, ANNU REV BIOCHEM, V77, P643, DOI 10.1146/annurev.biochem.77.061606.160747; ECONOMOU A, 1994, CELL, V78, P835, DOI 10.1016/S0092-8674(94)90582-7; Facey SJ, 2007, J MOL BIOL, V365, P995, DOI 10.1016/j.jmb.2006.10.083; Facey SJ, 2004, BBA-MOL CELL RES, V1694, P55, DOI 10.1016/j.bbamcr.2004.03.012; Froderberg L, 2003, MOL MICROBIOL, V47, P1015, DOI 10.1046/j.1365-2958.2003.03346.x; GELLER BL, 1985, J BIOL CHEM, V260, P3281; Kim SJ, 1999, J BIOL CHEM, V274, P4715, DOI 10.1074/jbc.274.8.4715; Klenner C, 2012, J BIOL CHEM, V287, P3769, DOI 10.1074/jbc.M111.307223; Kol S, 2009, J MOL BIOL, V390, P893, DOI 10.1016/j.jmb.2009.05.074; Kudva R, 2013, RES MICROBIOL, V164, P505, DOI 10.1016/j.resmic.2013.03.016; KUHN A, 1988, EUR J BIOCHEM, V177, P267, DOI 10.1111/j.1432-1033.1988.tb14372.x; KUHN A, 1990, EMBO J, V9, P2385, DOI 10.1002/j.1460-2075.1990.tb07413.x; KUHN A, 1990, J STRUCT BIOL, V104, P38, DOI 10.1016/1047-8477(90)90055-H; Miller J.H., 1972, EXPT MOL GENETICS; Neugebauer SA, 2012, J MOL BIOL, V417, P375, DOI 10.1016/j.jmb.2012.01.046; OLIVER DB, 1990, P NATL ACAD SCI USA, V87, P8227, DOI 10.1073/pnas.87.21.8227; Robinson PJ, 2013, BBA-MOL CELL RES, V1833, P2781, DOI 10.1016/j.bbamcr.2013.07.003; ROHRER J, 1990, SCIENCE, V250, P1418, DOI 10.1126/science.2124001; Roos T, 2001, J BIOL CHEM, V276, P37909; Samuelson JC, 2000, NATURE, V406, P637, DOI 10.1038/35020586; Schuenemann TA, 1999, J BIOL CHEM, V274, P6855, DOI 10.1074/jbc.274.11.6855; Scotti PA, 2000, EMBO J, V19, P542, DOI 10.1093/emboj/19.4.542; Serek J, 2004, EMBO J, V23, P294, DOI 10.1038/sj.emboj.7600063; Traxler B, 1996, J BIOL CHEM, V271, P12394, DOI 10.1074/jbc.271.21.12394; Tsukazaki T, 2011, NATURE, V474, P235, DOI 10.1038/nature09980; van Bloois E, 2006, J BIOL CHEM, V281, P10002, DOI 10.1074/jbc.M511357200; van Bloois E, 2004, FEBS LETT, V576, P97, DOI 10.1016/j.febslet.2004.08.069; van der Laan M, 2004, J CELL BIOL, V165, P213, DOI 10.1083/jcb.200402100; Welte T, 2012, MOL BIOL CELL, V23, P464, DOI 10.1091/mbc.E11-07-0590; Xie K, 2007, BIOCHEMISTRY-US, V46, P15153, DOI 10.1021/bi701398y; Yi L, 2003, BIOCHEMISTRY-US, V42, P10537, DOI 10.1021/bi034309h; Yi L, 2004, J BIOL CHEM, V279, P39260, DOI 10.1074/jbc.M405490200; Zhu L, 2013, J BIOL CHEM, V288, P7704, DOI 10.1074/jbc.M112.429431; Zhu L, 2012, J MOL BIOL, V424, P354, DOI 10.1016/j.jmb.2012.09.026	42	11	12	0	3	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1023	1032		10.1074/jbc.M113.522250	http://dx.doi.org/10.1074/jbc.M113.522250			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275657	hybrid, Green Published			2022-12-25	WOS:000330541200035
J	Neyrinck, AM; Alligier, M; Memvanga, PB; Nevraumont, E; Larondelle, Y; Preat, V; Cani, PD; Delzenne, NM				Neyrinck, Audrey M.; Alligier, Maud; Memvanga, Patrick B.; Nevraumont, Elodie; Larondelle, Yvan; Preat, Veronique; Cani, Patrice D.; Delzenne, Nathalie M.			Curcuma longa Extract Associated with White Pepper Lessens High Fat Diet-Induced Inflammation in Subcutaneous Adipose Tissue	PLOS ONE			English	Article							GUT-MICROBIOTA; INSULIN-RESISTANCE; OBESITY; TETRAHYDROCURCUMIN; ANGIOGENESIS; POMEGRANATE; POLYPHENOLS; MICROFLORA; MODULATION; PREVENTION	Background Supra-nutritional doses of curcumin, derived from the spice Curcuma longa, have been proposed as a potential treatm related to obesity. The aim of the present study was to test whether Curcuma longa extract rich in curcumin and asso doses compatible with human use, could modulate systemic inflammation in diet-induced obese mice. We questioned t and gut microbiota in the effect of Curcuma-P (R) in obesity. Methodology/Principal Findings Mice were fed either a control diet (CT), a high fat (HF) diet or a HF diet containing Curcuma longa extract (0.1 % of pepper (0.01 %) for four weeks. Curcumin has been usually combined with white pepper, which contain piperine, in or combination did not significantly modify body weight gain, glycemia, insulinemia, serum lipids and intestinal inflammato curcumin accumulated in the subcutaneous adipose tissue. Importantly, the co-supplementation in curcuma extract and pro-inflammatory cytokines expression in the subcutaneous adipose tissue, an effect independent of adiposity, immune of gut bacteria controlling inflammation. Conclusions/Significance These findings support that nutritional doses of Curcuma longa, associated with white pepper, is able to decrease infl tissue and this effect could be rather linked to a direct effect of bioactive metabolites reaching the adipose tissue, than composition.					Delzenne, Nathalie/AAC-4628-2019; Neyrinck, Audrey/AAE-7929-2019; D., Cani Patrice/M-8055-2016	Delzenne, Nathalie/0000-0003-2115-6082; Neyrinck, Audrey/0000-0002-9435-3338; D., Cani Patrice/0000-0003-2040-2448	Longevie SA	Longevie SA	P.D. Cani is Research Associate from the FRS-FNRS (Fonds de la Recherche Scientifique, http://www.f recipient of a grant from the SFD (Societe Francophone du Diabete). This work was supported by Longevie SA. T data collection and analysis, decision to publish, or preparation of the manuscript.	Aggarwal BB, 2006, BIOCHEM PHARMACOL, V71, P1397, DOI 10.1016/j.bcp.2006.02.009; Aggarwal BB, 2010, ANNU REV NUTR, V30, P173, DOI 10.1146/annurev.nutr.012809.104755; Ahn J, 2010, AM J PHYSIOL-CELL PH, V298, pC1510, DOI 10.1152/ajpcell.00369.2009; Alappat L, 2010, NUTR REV, V68, P729, DOI 10.1111/j.1753-4887.2010.00341.x; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Babu PS, 1997, MOL CELL BIOCHEM, V166, P169, DOI 10.1023/A:1006819605211; Basu A, 2009, NUTR REV, V67, P49, DOI 10.1111/j.1753-4887.2008.00133.x; Bhandarkar SS, 2007, ADV EXP MED BIOL, V595, P185; Caesar R, 2010, J INTERN MED, V268, P320, DOI 10.1111/j.1365-2796.2010.02270.x; Cani PD, 2007, DIABETOLOGIA, V50, P2374, DOI 10.1007/s00125-007-0791-0; Cani PD, 2007, DIABETES, V56, P1761, DOI 10.2337/db06-1491; Delzenne NM, 2011, MICROB CELL FACT, V10, DOI 10.1186/1475-2859-10-S1-S10; Delzenne NM, 2013, BRIT J NUTR, V109, pS81, DOI 10.1017/S0007114512004047; Delzenne NM, 2011, ANNU REV NUTR, V31, P15, DOI 10.1146/annurev-nutr-072610-145146; Delzenne NM, 2011, TARGETING GUT MICROB, P639, DOI [10.1038/nrendo.2011.126, DOI 10.1038/NREND0.2011.126]; Dewulf EM, 2011, J NUTR BIOCHEM, V22, P712, DOI 10.1016/j.jnutbio.2010.05.009; Diamant M, 2011, OBES REV, V12, P272, DOI 10.1111/j.1467-789X.2010.00797.x; Ejaz A, 2009, J NUTR, V139, P919, DOI 10.3945/jn.108.100966; El-Moselhy MA, 2011, FOOD CHEM TOXICOL, V49, P1129, DOI 10.1016/j.fct.2011.02.004; Finucane MM, 2011, LANCET, V377, P557, DOI 10.1016/S0140-6736(10)62037-5; FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499; Gonzales AM, 2008, NUTR METAB, V5, DOI 10.1186/1743-7075-5-17; Hassaninasab A, 2011, P NATL ACAD SCI USA, V108, P6615, DOI 10.1073/pnas.1016217108; Jang EM, 2008, METABOLISM, V57, P1576, DOI 10.1016/j.metabol.2008.06.014; Kemperman RA, 2010, MICROBIOL-SGM, V156, P3224, DOI 10.1099/mic.0.042127-0; Lansky EP, 2007, J ETHNOPHARMACOL, V109, P177, DOI 10.1016/j.jep.2006.09.006; Ley RE, 2010, CURR OPIN GASTROEN, V26, P5, DOI 10.1097/MOG.0b013e328333d751; Marczylo TH, 2009, J AGR FOOD CHEM, V57, P797, DOI 10.1021/jf803038f; Memvanga PB, 2013, ORAL MALARIA THERAPY, DOI DOI 10.1016/J.JC0NREL.2013.09.001; Murakami Y, 2008, ANTICANCER RES; Murugan Pidaran, 2006, Journal of Basic and Clinical Physiology and Pharmacology, V17, P231; Neyrinck AM, 2012, J NUTR BIOCHEM, V23, P51, DOI 10.1016/j.jnutbio.2010.10.008; Oner-Iyidogan Y, 2013, J PHYSIOL BIOCHEM, V69, P677, DOI 10.1007/s13105-013-0244-9; Osborn O, 2012, NAT MED, V18, P363, DOI 10.1038/nm.2627; Parkar SG, 2008, INT J FOOD MICROBIOL, V124, P295, DOI 10.1016/j.ijfoodmicro.2008.03.017; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Selma MV, 2009, J AGR FOOD CHEM, V57, P6485, DOI 10.1021/jf902107d; Shao WJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0028784; Sharma RA, 2005, EUR J CANCER, V41, P1955, DOI 10.1016/j.ejca.2005.05.009; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Shehzad A, 2011, EUR J NUTR, V50, P151, DOI 10.1007/s00394-011-0188-1; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Tzounis X, 2008, BRIT J NUTR, V99, P782, DOI 10.1017/S0007114507853384; Weisberg SP, 2008, ENDOCRINOLOGY, V149, P3549, DOI 10.1210/en.2008-0262; Woo HM, 2007, LIFE SCI, V80, P926, DOI 10.1016/j.lfs.2006.11.030; Yoysungnoen P, 2006, CLIN HEMORHEOL MICRO, V34, P109	47	33	36	3	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81252	10.1371/journal.pone.0081252	http://dx.doi.org/10.1371/journal.pone.0081252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260564	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900127
J	Al-Mudaris, ZA; Majid, ASA; Ji, D; Al-Mudarris, BA; Chen, SH; Liang, PH; Osman, H; Din, SKKJ; Majid, AMSA				Al-Mudaris, Zena A.; Majid, Aman S. A.; Ji, Dan; Al-Mudarris, Ban A.; Chen, Shih-Hsun; Liang, Po-Huang; Osman, Hasnah; Din, Shah Kamal Khan Jamal; Majid, Amin M. S. Abdul			Conjugation of Benzylvanillin and Benzimidazole Structure Improves DNA Binding with Enhanced Antileukemic Properties	PLOS ONE			English	Article							MINOR-GROOVE-BINDING; ETHIDIUM-BROMIDE INTERCALATION; TOPOISOMERASE-I; HOECHST 33258; BIOLOGICAL-ACTIVITY; DERIVATIVES; MUTAGENICITY; RECOGNITION; COMPLEXES; INHIBITION	Benzyl-o-vanillin and benzimidazole nucleus serve as important pharmacophore in drug discovery. The benzyl vanillin (2-(benzyloxy)-3-methoxybenzaldehyde) compound shows anti-proliferative activity in HL60 leukemia cancer cells and can effect cell cycle progression at G2/M phase. Its apoptosis activity was due to disruption of mitochondrial functioning. In this study, we have studied a series of compounds consisting of benzyl vanillin and benzimidazole structures. We hypothesize that by fusing these two structures we can produce compounds that have better anticancer activity with improved specificity particularly towards the leukemia cell line. Here we explored the anticancer activity of three compounds namely 2-(2-benzyloxy-3-methoxyphenyl)-1H-benzimidazole, 2MP, N-1-(2-benzyloxy-3-methoxybenzyl)-2-(2-benzyloxy-3-methoxyphenyl)-1H-benzimidazole, 2XP, and (R) and (S)-1-(2-benzyloxy-3-methoxyphenyl)-2, 2, 2-trichloroethyl benzenesulfonate, 3BS and compared their activity to 2-benzyloxy-3-methoxybenzaldehyde, (Bn1), the parent compound. 2XP and 3BS induces cell death of U937 leukemic cell line through DNA fragmentation that lead to the intrinsic caspase 9 activation. DNA binding study primarily by the equilibrium binding titration assay followed by the Viscosity study reveal the DNA binding through groove region with intrinsic binding constant 7.39 mu M/bp and 6.86 mu M/bp for 3BS and 2XP respectively. 2XP and 3BS showed strong DNA binding activity by the UV titration method with the computational drug modeling showed that both 2XP and 3BS failed to form any electrostatic linkages except via hydrophobic interaction through the minor groove region of the nucleic acid. The benzylvanillin alone (Bn1) has weak anticancer activity even after it was combined with the benzimidazole (2MP), but after addition of another benzylvanillin structure (2XP), stronger activity was observed. Also, the combination of benzylvanillin with benzenesulfonate (3BS) significantly improved the anticancer activity of Bn1. The present study provides a new insight of benzyl vanillin derivatives as potential anti-leukemic agent.	[Al-Mudaris, Zena A.; Majid, Amin M. S. Abdul] Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia; [Majid, Aman S. A.; Al-Mudarris, Ban A.] Univ Sains Malaysia, Adv Med & Dent Inst, Bandar Putra Bertam, Penang, Malaysia; [Ji, Dan] Third Mil Med Univ, Southwest Hosp, Southwest Eye Hosp, Key Lab Visual Damage & Regenerat & Restorat Chon, Chongqing, Peoples R China; [Al-Mudarris, Ban A.] Ajman Univ, Coll Dent, Ajman, U Arab Emirates; [Chen, Shih-Hsun] Natl Chiao Tung Univ, Dept Biol Sci & Technol, Hsinchu, Taiwan; [Liang, Po-Huang] Acad Sinica, Inst Biol Chem, Taipei, Taiwan; [Osman, Hasnah] Univ Sains Malaysia, Sch Chem Sci, Minden, Penang, Malaysia; [Din, Shah Kamal Khan Jamal] Hosp Sultanah Bhiyah, OMF Surg, Alor Setar, Kedah, Malaysia	Universiti Sains Malaysia; Universiti Sains Malaysia; Army Medical University; Ajman University; National Yang Ming Chiao Tung University; Academia Sinica - Taiwan; Universiti Sains Malaysia	Majid, AMSA (corresponding author), Univ Sains Malaysia, Sch Pharmaceut Sci, Minden, Penang, Malaysia.	aminmalikshah@gmail.com	Liang, Po-Huang/H-6610-2015; Majid, Aman Shah Abdul/I-3809-2012; Osman, Hasnah/B-4748-2011	Liang, Po-Huang/0000-0003-1207-5256; Majid, Aman Shah Abdul/0000-0001-9679-122X; Osman, Hasnah/0000-0001-8695-470X; Abdul Majid, Amin Malik Shah/0000-0001-7499-2258	Universiti Sains Malaysia [RU: 1001/PFARMASI/811144]	Universiti Sains Malaysia(Universiti Sains Malaysia)	The authors are grateful to Universiti Sains Malaysia and University Fellowship Foundations for financial support. This study was supported by research grants from the Universiti Sains Malaysia (RU: 1001/PFARMASI/811144). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Douh MH, 2007, ACTA CRYSTALLOGR E, V63, pO3233, DOI 10.1107/S1600536807027353; Al-Douh MH, 2006, ACTA CRYSTALLOGR E, V62, pO4768, DOI 10.1107/S1600536806039250; Al-Douh MH, 2006, ACTA CRYSTALLOGR E, V62, pO3954, DOI 10.1107/S160053680603251X; Al-Douh MH, 2009, ACTA CRYSTALLOGR E, V65, pO925, DOI 10.1107/S1600536809011192; Al-Mudaris ZAAH, 2012, ANTICANCER PROPERTIE; Alper Sabiha, 2003, Farmaco (Lausanne), V58, P497, DOI 10.1016/S0014-827X(03)00042-9; Ames B.N, 1971, CHEM MUTAGENS, P267, DOI [10.1007/978-1-4615-8966-2_9, DOI 10.1007/978-1-4615-8966-2_9]; Arjmand F, 2009, EUR J MED CHEM, V44, P834, DOI 10.1016/j.ejmech.2008.05.006; Baba A.I., 2007, PUBLISHING HOUSE ROM, V31, P4967; Baraldi PG, 2004, MED RES REV, V24, P475, DOI 10.1002/med.20000; Blackburn GM, 2006, NUCLEIC ACIDS IN CHEMISTRY AND BIOLOGY, THIRD EDITION, P341; Boddie AW, 1998, BRIT J CANCER, V77, P1395, DOI 10.1038/bjc.1998.232; Bostock-Smith CE, 1999, NUCLEIC ACIDS RES, V27, P1619, DOI 10.1093/nar/27.7.1619; Camden J. B, 2001, U. S. Patent, Patent No. [6,262,093, 6262093]; Camden JB, 2001, United States Patent, Patent No. 6271217; Can-Eke B, 1998, CHEM-BIOL INTERACT, V113, P65, DOI 10.1016/S0009-2797(98)00020-9; Chaires JB, 2004, J MED CHEM, V47, P5729, DOI 10.1021/jm049491e; Clark GR, 1997, NUCLEIC ACIDS RES, V25, P1510, DOI 10.1093/nar/25.8.1510; Coban G, 2009, EUR J MED CHEM, V44, P2280, DOI 10.1016/j.ejmech.2008.06.018; Denny WA, 2000, EXPERT OPIN THER PAT, V10, P459, DOI 10.1517/13543776.10.4.459; Dervan PB, 2001, BIOORGAN MED CHEM, V9, P2215, DOI 10.1016/S0968-0896(01)00262-0; Devereux M, 2007, J INORG BIOCHEM, V101, P881, DOI 10.1016/j.jinorgbio.2007.02.002; Encell L, 1996, CHEM RES TOXICOL, V9, P563, DOI 10.1021/tx9501849; FAIRLEY TA, 1993, J MED CHEM, V36, P1746, DOI 10.1021/jm00064a008; Fitzgerald DJ, 1999, J BIOL CHEM, V274, P27128, DOI 10.1074/jbc.274.38.27128; Guddneppanavar R, 2007, ANTI-CANCER AGENT ME, V7, P125, DOI 10.2174/187152007779313991; Gumus F, 2003, EUR J MED CHEM, V38, P473, DOI 10.1016/S00223-5234(03)00058-8; Gupta A, 2007, PROTEIN PEPTIDE LETT, V14, P632; Harrington Dean J, 2003, Teratog Carcinog Mutagen, VSuppl 2, P31; Hayashi M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm529; Helleday T, 2008, NAT REV CANCER, V8, P193, DOI 10.1038/nrc2342; Hyttinen JMT, 1996, CARCINOGENESIS, V17, P1179, DOI 10.1093/carcin/17.5.1179; Ioannou YA, 1996, NUCLEIC ACIDS RES, V24, P992; Jenkins T C, 1997, Methods Mol Biol, V90, P195; Jin S, 2000, BIOORG MED CHEM LETT, V10, P719, DOI 10.1016/S0960-894X(00)00087-1; Kamal A, 2008, BIOORG MED CHEM LETT, V18, P2594, DOI 10.1016/j.bmcl.2008.03.039; Kasibhatla S, 2006, CSH PROTOC, P4429; Kim JS, 1996, J MED CHEM, V39, P992, DOI 10.1021/jm950412w; KOCH WH, 1994, CARCINOGENESIS, V15, P79, DOI 10.1093/carcin/15.1.79; Kubota Y, 1999, Nucleic Acids Symp Ser, P53; Lin CF, 2005, BIOORGAN MED CHEM, V13, P1537, DOI 10.1016/j.bmc.2004.12.026; Lukhtanov EA, 1997, NUCLEIC ACIDS RES, V25, P5077, DOI 10.1093/nar/25.24.5077; Majid AMSA, 2009, CHEM RES TOXICOL, V22, P146, DOI 10.1021/tx800276h; Neidle S, 2001, NAT PROD REP, V18, P291, DOI 10.1039/a705982e; NOVICK A, 1956, Brookhaven Symp Biol, P201; PFITZNER J, 1976, ANAESTHESIA, V31, P273, DOI 10.1111/j.1365-2044.1976.tb11804.x; Poyraz M, 2008, POLYHEDRON, V27, P2091, DOI 10.1016/j.poly.2008.03.030; PRUTZ WA, 1984, RADIAT ENVIRON BIOPH, V23, P1, DOI 10.1007/BF01326731; Reddy BSP, 1999, PHARMACOL THERAPEUT, V84, P1, DOI 10.1016/S0163-7258(99)00021-2; SEILER JP, 1972, MUTAT RES, V15, P273, DOI 10.1016/0027-5107(72)90074-7; SEILER JP, 1975, BIOCHEM GENET, V13, P635, DOI 10.1007/BF00484921; SEILER JP, 1973, MUTAT RES, V17, P21, DOI 10.1016/0027-5107(73)90249-2; Seitz O, 2003, ANGEW CHEM INT EDIT, V1, P4994, DOI DOI 10.1002/ANIE.200385976; Shaikh SA, 2004, ARCH BIOCHEM BIOPHYS, V429, P81, DOI 10.1016/j.abb.2004.05.019; Sharma SK, 2001, BIOORG MED CHEM LETT, V11, P769, DOI 10.1016/S0960-894X(01)00064-6; Sinha R, 2006, BIOORGAN MED CHEM, V14, P800, DOI 10.1016/j.bmc.2005.09.007; Snyder RD, 2005, ENVIRON MOL MUTAGEN, V45, P100, DOI 10.1002/em.20096; STOKKE T, 1985, J HISTOCHEM CYTOCHEM, V33, P333, DOI 10.1177/33.4.2579998; Suckling CJ, 2004, EXPERT OPIN THER PAT, V14, P1693, DOI 10.1517/13543776.14.12.1693; SZYBALSKI W, 1958, ANN NY ACAD SCI, V76, P475, DOI 10.1111/j.1749-6632.1958.tb57106.x; Varadarajan S, 2003, BIOCHEMISTRY-US, V42, P14318, DOI 10.1021/bi0353272; VERGANI L, 1994, BIOCHEMISTRY-US, V33, P6578, DOI 10.1021/bi00187a027; Woolley DW, 1944, J BIOL CHEM, V152, P225; ZHANG Y, 1993, BIOCHEMISTRY-US, V32, P7954, DOI 10.1021/bi00082a017	64	7	7	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80983	10.1371/journal.pone.0080983	http://dx.doi.org/10.1371/journal.pone.0080983			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260527	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600107
J	Massaro, FC; Brooks, PR; Wallace, HM; Nsengiyumva, V; Narokai, L; Russell, FD				Massaro, Flavia C.; Brooks, Peter R.; Wallace, Helen M.; Nsengiyumva, Vianne; Narokai, Lorraine; Russell, Fraser D.			Effect of Australian Propolis from Stingless Bees (Tetragonula carbonaria) on Pre-Contracted Human and Porcine Isolated Arteries	PLOS ONE			English	Article							ACID PHENETHYL ESTER; BRAZILIAN PROPOLIS; SERUM WITHDRAWAL; APOPTOSIS; ANGIOGENESIS; MECHANISMS; RESIN	Bee propolis is a mixture of plant resins and bee secretions. While bioactivity of honeybee propolis has been reported previously, information is limited on propolis from Australian stingless bees (Tetragonula carbonaria). The aim of this study was to investigate possible vasomodulatory effects of propolis in KCl-precontracted porcine coronary arteries using an ex vivo tissue bath assay. Polar extracts of propolis produced a dose-dependent relaxant response (EC50=44.7 +/- 7.0 mu g/ml), which was unaffected by endothelial denudation, suggesting a direct effect on smooth muscle. Propolis markedly attenuated a contractile response to Ca2+ in vessels that were depolarised with 60 mM KCl, in Ca2+-free Krebs solution. Propolis (160 mu g/ml) reduced vascular tone in KCl pre-contracted vessels to near-baseline levels over 90 min, and this effect was partially reversible with 6h washout. Some loss in membrane integrity, but no loss in mitochondrial function was detected after 90 min exposure of human cultured umbilical vein endothelial cells to 160 mu g/ml propolis. We conclude that Australian stingless bee (T. carbonaria) propolis relaxes porcine coronary artery in an endothelial-independent manner that involves inhibition of voltage-gated Ca2+ channels. This effect is partially and slowly reversible upon washout. Further studies are required to determine the therapeutic potential of Australian stingless bee propolis for conditions in which vascular supply is compromised.	[Massaro, Flavia C.; Brooks, Peter R.; Wallace, Helen M.; Nsengiyumva, Vianne; Narokai, Lorraine; Russell, Fraser D.] Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia	University of the Sunshine Coast	Russell, FD (corresponding author), Univ Sunshine Coast, Fac Sci Hlth Educ & Engn, Maroochydore, Qld, Australia.	Frussell@usc.edu.au	Wallace, Helen/AAB-3162-2019	Wallace, Helen/0000-0002-8801-4401; Brooks, Peter/0000-0003-4915-4986; Russell, Fraser/0000-0001-8396-4558; Massaro, C. Flavia/0000-0003-2558-413X	Comvita New Zealand FRST bursary (New Zealand); University of the Sunshine Coast	Comvita New Zealand FRST bursary (New Zealand); University of the Sunshine Coast	The authors are grateful to the industry partner, Comvita New Zealand, for funding this project through the FRST bursary (New Zealand), and for providing the New Zealand propolis. This study also received financial support from the University of the Sunshine Coast. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Magableh MR, 2011, N-S ARCH PHARMACOL, V383, P403, DOI 10.1007/s00210-011-0608-z; Bankova V., 2007, Pharmacognosy Reviews, V1, P88; Banskota AH, 2001, PHYTOTHER RES, V15, P561, DOI 10.1002/ptr.1029; Barroso Poliana Ribeiro, 2012, Inflammopharmacology, V20, P289, DOI 10.1007/s10787-011-0105-5; Bufalo MC, 2013, J ETHNOPHARMACOL, V149, P84, DOI 10.1016/j.jep.2013.06.004; Chen Y, 2009, CELL DEATH DIFFER, V16, P1040, DOI 10.1038/cdd.2009.49; de Moura SA, 2011, EVID-BASED COMPL ALT, V2011; Deenadayalu VUP, 2001, AM J PHYSIOL-HEART C, V281, pH1720, DOI 10.1152/ajpheart.2001.281.4.H1720; Gogebakan A, 2012, CLIN EXP HYPERTENS, V34, P424, DOI 10.3109/10641963.2012.665542; Izuta H, 2009, BMC COMPLEM ALTERN M, V9, DOI 10.1186/1472-6882-9-45; Khalil Mahmoud Lotfy, 2006, Asian Pac J Cancer Prev, V7, P22; King AR, 2003, LAB INVEST, V83, P1497, DOI 10.1097/01.LAB.0000093096.62765.85; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Leonhardt SD, 2011, AUSTRAL ECOL, V36, P537, DOI 10.1111/j.1442-9993.2010.02184.x; Long Y, 2009, VASC PHARMACOL, V51, P78, DOI 10.1016/j.vph.2009.03.002; Maestre I, 2003, ENDOCRINOLOGY, V144, P335, DOI 10.1210/en.2001-211282; Maruyama H, 2009, BIOL PHARM BULL, V32, P1244, DOI 10.1248/bpb.32.1244; Massaro FC, 2011, NATURWISSENSCHAFTEN, V98, P329, DOI 10.1007/s00114-011-0770-7; McLennan SV, 2008, WOUND REPAIR REGEN, V16, P706, DOI 10.1111/j.1524-475X.2008.00421.x; Nader MA, 2010, ARCH PHARM RES, V33, P637, DOI 10.1007/s12272-010-0420-1; Ohta T, 2008, BIOSCI BIOTECH BIOCH, V72, P2436, DOI 10.1271/bbb.80169; Oner M, 2011, J PEDIATR ORTHOP B, V20, P8, DOI 10.1097/BPB.0b013e32833faca8; Orsolic N, 2005, BIOL PHARM BULL, V28, P694, DOI 10.1248/bpb.28.694; Santos FA, 2002, J ETHNOPHARMACOL, V80, P1, DOI 10.1016/S0378-8741(02)00003-X; Seo KW, 2003, PHYTOTHER RES, V17, P250, DOI 10.1002/ptr.1120; Simone-Finstrom M, 2010, APIDOLOGIE, V41, P295, DOI 10.1051/apido/2010016; Tirapelli CR, 2004, PHARMACOLOGY, V70, P31, DOI 10.1159/000074240; Pessolato AGT, 2011, BURNS, V37, P1192, DOI 10.1016/j.burns.2011.05.016; Wallace HM, 2008, DIVERS DISTRIB, V14, P87, DOI 10.1111/j.1472-4642.2007.00427.x; Webb RC, 2003, ADV PHYSIOL EDUC, V27, P201, DOI 10.1152/advan.00025.2003; Wu J, 2011, CANCER LETT, V308, P43, DOI 10.1016/j.canlet.2011.04.012; Xuan HZ, 2011, EVID-BASED COMPL ALT, V2011, P1, DOI 10.1155/2011/985278; Xuan HZ, 2011, FOOD CHEM TOXICOL, V49, P78, DOI 10.1016/j.fct.2010.09.034	33	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81297	10.1371/journal.pone.0081297	http://dx.doi.org/10.1371/journal.pone.0081297			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260567	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600113
J	Muller-Krebs, S; Weber, L; Tsobaneli, J; Kihm, LP; Reiser, J; Zeier, M; Schwenger, V				Mueller-Krebs, Sandra; Weber, Lena; Tsobaneli, Julia; Kihm, Lars P.; Reiser, Jochen; Zeier, Martin; Schwenger, Vedat			Cellular Effects of Everolimus and Sirolimus on Podocytes	PLOS ONE			English	Article							RENAL-ALLOGRAFT RECIPIENTS; CALCINEURIN INHIBITORS; MYCOPHENOLATE-MOFETIL; TRANSPLANT RECIPIENTS; NEPHROTIC-SYNDROME; KIDNEY PODOCYTES; DE-NOVO; SDZ RAD; CYCLOSPORINE; NEPHRIN	Everolimus (EVL) and Sirolimus (SRL) are potent immunosuppressant agents belonging to the group of mammalian target of rapamycin (mTOR) inhibitors used to prevent transplant rejection. However, some patients develop proteinuria following a switch from a calcineurin inhibitor regimen to mTOR inhibitors. Whether different mTOR inhibitors show similar effects on podocytes is still unknown. To analyze this, human podocytes were incubated with different doses of EVL and SRL. After incubation with EVL or SRL, podocytes revealed a reduced expression of total mTOR. Phosphorylation of p70S6K and Akt was diminished, whereas pAkt expression was more reduced in the SRL group. In both groups actin cytoskeletal reorganization was increased. Synaptopodin and podocin expression was reduced as well as nephrin protein, particularly in the SRL group. NFkB activation and IL-6 levels were lower in EVL and SRL, and even lower in SRL. Apoptosis was more increased in SRL than in the EVL group. Our data suggests that mTOR inhibitors affect podocyte integrity with respect to podocyte proteins, cytoskeleton, inflammation, and apoptosis. Our study is the first to analyze both mTOR inhibitors, EVL and SRL, in parallel in podocytes. Partially, the impact of EVL and SRL on podocytes differs. Nevertheless, it still remains unclear whether these differences are of relevance regarding to proteinuria in transplant patients.	[Mueller-Krebs, Sandra; Weber, Lena; Tsobaneli, Julia; Kihm, Lars P.; Zeier, Martin; Schwenger, Vedat] Heidelberg Univ, Dept Nephrol, Heidelberg, Germany; [Reiser, Jochen] Rush Univ, Dept Med, Med Ctr, Chicago, IL 60612 USA	Ruprecht Karls University Heidelberg; Rush University	Muller-Krebs, S (corresponding author), Heidelberg Univ, Dept Nephrol, Heidelberg, Germany.	sandra.mueller@urz.uni-heidelberg.de			Novartis Pharma AG (Nuremberg, Germany)	Novartis Pharma AG (Nuremberg, Germany)	SMK, MZ, and VS received research grants from Novartis Pharma AG (Nuremberg, Germany). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asanuma K, 2006, NAT CELL BIOL, V8, P485, DOI 10.1038/ncb1400; Asanuma K, 2005, J CLIN INVEST, V115, P1188, DOI 10.1172/JCI200523371; Bohra R, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048063; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Budde K, 2011, LANCET, V377, P837, DOI 10.1016/S0140-6736(10)62318-5; Carvalho C, 2011, CLIN TRANSPLANT, V25, pE401, DOI 10.1111/j.1399-0012.2011.01446.x; Doublier S, 2001, AM J PATHOL, V158, P1723, DOI 10.1016/S0002-9440(10)64128-4; Durrbach A, 2008, TRANSPLANTATION, V85, P486, DOI 10.1097/TP.0b013e318160d3c9; Ekberg H, 2007, NEW ENGL J MED, V357, P2562, DOI 10.1056/NEJMoa067411; Eto N, 2007, KIDNEY INT, V72, P455, DOI 10.1038/sj.ki.5002311; Faul C, 2008, NAT MED, V14, P931, DOI 10.1038/nm.1857; Flechner SM, 2011, AM J TRANSPLANT, V11, P1633, DOI 10.1111/j.1600-6143.2011.03573.x; Gibbons James J, 2009, Semin Oncol, V36 Suppl 3, pS3, DOI 10.1053/j.seminoncol.2009.10.011; Huber TB, 2001, J BIOL CHEM, V276, P41543, DOI 10.1074/jbc.C100452200; Jastrzebski K, 2007, GROWTH FACTORS, V25, P209, DOI 10.1080/08977190701779101; Keller K, 2006, NEPHROL DIAL TRANSPL, V21, P2724, DOI 10.1093/ndt/gfl340; Keogh A, 2004, J HEART LUNG TRANSPL, V23, pS202, DOI 10.1016/j.healun.2004.03.008; Kihm LP, 2011, J AM SOC NEPHROL, V22, P914, DOI 10.1681/ASN.2010070750; Kirchner GI, 2000, BRIT J CLIN PHARMACO, V50, P449, DOI 10.1046/j.1365-2125.2000.00293.x; LANNIGAN R, 1962, Guys Hosp Rep, V111, P378; Lebranchu Y, 2011, AM J TRANSPLANT, V11, P1665, DOI 10.1111/j.1600-6143.2011.03637.x; Letavernier E, 2007, CLIN J AM SOC NEPHRO, V2, P326, DOI 10.2215/CJN.03751106; Letavernier E, 2009, NEPHROL DIAL TRANSPL, V24, P630, DOI 10.1093/ndt/gfn574; Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6; Madhusudhan T, 2012, BLOOD, V119, P874, DOI 10.1182/blood-2011-07-365973; Manito N, 2011, TRANSPL P, V43, P2699, DOI 10.1016/j.transproceed.2011.04.017; Morelon E, 2003, TRANSPLANT P, V35, p52S, DOI 10.1016/S0041-1345(03)00244-6; Muller-Krebs S, 2012, NEPHROL DIAL TRANSPL, V27, P3129, DOI 10.1093/ndt/gfs005; Munivenkatappa R, 2010, HISTOL HISTOPATHOL, V25, P189, DOI 10.14670/HH-25.189; Nashan B, 2002, EXPERT OPIN INV DRUG, V11, P1845, DOI 10.1517/13543784.11.12.1845; Ojo AO, 2003, NEW ENGL J MED, V349, P931, DOI 10.1056/NEJMoa021744; Oroszlan M, 2010, TRANSPL IMMUNOL, V23, P125, DOI 10.1016/j.trim.2010.05.003; Rehm B, 2006, TRANSPL P, V38, P711, DOI 10.1016/j.transproceed.2006.01.052; Reiser J, 2004, J CLIN INVEST, V113, P1390, DOI 10.1172/JCI200420402; Rico M, 2005, AM J PHYSIOL-RENAL, V289, pF431, DOI 10.1152/ajprenal.00389.2004; Rubel JR, 2004, J HEART LUNG TRANSPL, V23, P289, DOI 10.1016/S1053-2498(03)00191-8; Saleem MA, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133630; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Schuler W, 1997, TRANSPLANTATION, V64, P36, DOI 10.1097/00007890-199707150-00008; Shankland SJ, 2006, KIDNEY INT, V69, P2131, DOI 10.1038/sj.ki.5000410; Vollenbroker B, 2009, AM J PHYSIOL-RENAL, V296, pF418, DOI 10.1152/ajprenal.90319.2008; Yanagida-Asanuma E, 2007, AM J PATHOL, V171, P415, DOI 10.2353/ajpath.2007.070075; Zimmerman JJ, 1997, J CLIN PHARMACOL, V37, P405, DOI 10.1002/j.1552-4604.1997.tb04318.x	43	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80340	10.1371/journal.pone.0080340	http://dx.doi.org/10.1371/journal.pone.0080340			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260371	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600057
J	Chaturvedi, D; Mahalakshmi, R				Chaturvedi, Deepti; Mahalakshmi, Radhakrishnan			Methionine Mutations of Outer Membrane Protein X Influence Structural Stability and Beta-Barrel Unfolding	PLOS ONE			English	Article							ESCHERICHIA-COLI; SIDE-CHAIN; YERSINIA-ENTEROCOLITICA; BILAYER MEMBRANES; GLOBULAR-PROTEINS; T4 LYSOZYME; IN-VITRO; OMPX; RESIDUES; NMR	We report the biochemical and biophysical characterization of outer membrane protein X (OmpX), an eight-stranded transmembrane beta-barrel from E. coli, and compare the barrel behavior with a mutant devoid of methionine residues. Transmembrane outer membrane proteins of bacterial origin are known to display high tolerance to sequence rearrangements and mutations. Our studies with the triple mutant of OmpX that is devoid of all internal methionine residues (M18L; M21L; M118L) indicate that Met replacement has no influence on the refolding efficiency and structural characteristics of the protein. Surprisingly, the conserved substitution of Met -> Leu leads to barrel destabilization and causes a lowering of the unfolding free energy by a factor of similar to 8.5 kJ/mol, despite the mutations occurring at the loop regions. We report that the barrel destabilization is accompanied by a loss in cooperativity of unfolding in the presence of chemical denaturants. Furthermore, we are able to detect an unfolding intermediate in the Met-less barrel, whereas the parent protein exhibits a classic two-state unfolding. Thermal denaturation measurements also suggest a greater susceptibility of the OmpX barrel to heat, in the Met-less construct. Our studies reveal that even subtle variations in the extra-membrane region of rigid barrel structures such as OmpX, may bear severe implications on barrel stability. We propose that methionines contribute to efficient barrel structuring and protein-lipid interactions, and are therefore important elements of OmpX stability.	[Chaturvedi, Deepti; Mahalakshmi, Radhakrishnan] Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India	Indian Institute of Science Education & Research (IISER) - Bhopal	Mahalakshmi, R (corresponding author), Indian Inst Sci Educ & Res, Dept Biol Sci, Mol Biophys Lab, Bhopal, Madhya Pradesh, India.	maha@iiserb.ac.in	Chaturvedi, Deepti/AAC-6193-2021; Mahalakshmi, Radhakrishnan/B-3143-2008	Mahalakshmi, Radhakrishnan/0000-0003-1549-7550	Department of Biotechnology (DBT), Govt. of India [BT/HRD/35/02/25/2009, BT/01/IYBA/2009]; IISER Bhopal; DBT, Govt. of India	Department of Biotechnology (DBT), Govt. of India(Department of Biotechnology (DBT) India); IISER Bhopal; DBT, Govt. of India(Department of Biotechnology (DBT) India)	This work is supported by the Department of Biotechnology (DBT), Govt. of India award number BT/HRD/35/02/25/2009 and BT/01/IYBA/2009. DC is supported by a research fellowship from IISER Bhopal. RM is a recipient of the Ramalingaswami Fellowship from DBT, Govt. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGASHE VR, 1995, BIOCHEMISTRY-US, V34, P3286, DOI 10.1021/bi00010a019; Andersen KK, 2012, BIOCHEMISTRY-US, V51, P8371, DOI 10.1021/bi300974y; Arnold T, 2007, J MOL BIOL, V366, P1174, DOI 10.1016/j.jmb.2006.12.029; BONE R, 1989, NATURE, V339, P191, DOI 10.1038/339191a0; Booth PJ, 2009, CURR OPIN STRUC BIOL, V19, P8, DOI 10.1016/j.sbi.2008.12.005; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Braun P, 1999, BIOCHEMISTRY-US, V38, P9778, DOI 10.1021/bi990923a; Burgess NK, 2008, J BIOL CHEM, V283, P26748, DOI 10.1074/jbc.M802754200; Charalambous K, 2012, J AM CHEM SOC, V134, P5746, DOI 10.1021/ja300523q; Choi M, 2009, BIOCHEMISTRY-US, V48, P9174, DOI 10.1021/bi900836h; DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809; Dewald AH, 2011, BIOPHYS J, V100, P2131, DOI 10.1016/j.bpj.2011.03.025; Duquesne K, 2010, METHODS MOL BIOL, V601, P205, DOI 10.1007/978-1-60761-344-2_13; Feng HQ, 2005, P NATL ACAD SCI USA, V102, P5026, DOI 10.1073/pnas.0501372102; Fernandez C, 2001, P NATL ACAD SCI USA, V98, P2358, DOI 10.1073/pnas.051629298; FINNEY JL, 1980, BIOPHYS J, V32, P17, DOI 10.1016/S0006-3495(80)84913-7; Gassner NC, 2003, BIOPHYS CHEM, V100, P325, DOI 10.1016/S0301-4622(02)00290-9; Gassner NC, 1996, P NATL ACAD SCI USA, V93, P12155, DOI 10.1073/pnas.93.22.12155; Gasteiger E., 2005, PROTEOMICS PROTOCOLS, DOI DOI 10.1385/1592598900; Goddard T.D., SPARKY 3; Gupta A., 2012, INT REV BIOPHYSICAL, V3, P147; Gustavsson N, 2001, PROTEIN SCI, V10, P1785, DOI 10.1110/ps.11301; GUY HR, 1985, BIOPHYS J, V47, P61, DOI 10.1016/S0006-3495(85)83877-7; HALTIA T, 1995, BBA-BIOENERGETICS, V1228, P1, DOI 10.1016/0005-2728(94)00161-W; Harris NJ, 2012, BBA-BIOMEMBRANES, V1818, P1055, DOI 10.1016/j.bbamem.2011.11.006; HEFFERNAN EJ, 1994, INFECT IMMUN, V62, P5183, DOI 10.1128/IAI.62.11.5183-5186.1994; Hensen U, 2013, STRUCTURE, DOI [10.1016/j.str.2013.1006.1001, DOI 10.1016/J.STR.2013.1006.1001]; Hong H, 2013, BIOCHEMISTRY-US, V52, P4413, DOI 10.1021/bi400344b; Huysmans GHM, 2010, P NATL ACAD SCI USA, V107, P4099, DOI 10.1073/pnas.0911904107; Jain V, 2006, PROTEIN SCI, V15, P1449, DOI 10.1110/ps.062117006; Kim YH, 2001, PROTEIN ENG, V14, P343, DOI 10.1093/protein/14.5.343; Levine RL, 1996, P NATL ACAD SCI USA, V93, P15036, DOI 10.1073/pnas.93.26.15036; Lin SH, 2009, METHOD ENZYMOL, V463, P619, DOI 10.1016/S0076-6879(09)63035-4; Luo S, 2009, FASEB J, V23, P464, DOI 10.1096/fj.08-118414; Mahalakshmi R, 2008, BIOCHEMISTRY-US, V47, P6531, DOI 10.1021/bi800362b; Mahalakshmi R, 2007, BBA-BIOMEMBRANES, V1768, P3216, DOI 10.1016/j.bbamem.2007.08.008; Maurya SR, 2013, J BIOL CHEM, V288, P25584, DOI 10.1074/jbc.M113.493692; Maurya SR, 2013, SCI REP-UK, V3, DOI 10.1038/srep01989; McClean S, 2012, PROTEIN PEPTIDE LETT, V19, P1013, DOI 10.2174/092986612802762688; MECSAS J, 1995, J BACTERIOL, V177, P799, DOI 10.1128/jb.177.3.799-804.1995; Minetti CASA, 2006, ARCH BIOCHEM BIOPHYS, V453, P32, DOI 10.1016/j.abb.2006.03.023; Moon CP, 2013, P NATL ACAD SCI USA, V110, P4285, DOI 10.1073/pnas.1212527110; Moon CP, 2011, J MOL BIOL, V413, P484, DOI 10.1016/j.jmb.2011.08.041; Moon CP, 2011, P NATL ACAD SCI USA, V108, P10174, DOI 10.1073/pnas.1103979108; Moon CP, 2011, METHOD ENZYMOL, V492, P189, DOI 10.1016/B978-0-12-381268-1.00018-5; Neudecker P, 2012, SCIENCE, V336, P362, DOI 10.1126/science.1214203; Ohmura T, 2001, PROTEIN ENG, V14, P421, DOI 10.1093/protein/14.6.421; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Privalov PL, 2007, BIOPHYS CHEM, V126, P16, DOI 10.1016/j.bpc.2006.05.004; Reed J, 1997, ANAL BIOCHEM, V254, P36, DOI 10.1006/abio.1997.2355; Rice JJ, 2006, PROTEIN SCI, V15, P825, DOI 10.1110/ps.051897806; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schlebach JP, 2013, BIOCHEMISTRY-US, V52, P3229, DOI 10.1021/bi301635f; Schrodinger L., 2020, PYMOL; Seddon AM, 2004, BBA-BIOMEMBRANES, V1666, P105, DOI 10.1016/j.bbamem.2004.04.011; Sillen A, 1998, PHOTOCHEM PHOTOBIOL, V67, P475, DOI 10.1562/0031-8655(1998)067<0475:TCUOFP>2.3.CO;2; Szilagyi A., 2007, HDB NEUROCHEMISTRY M, P303; Tian CL, 2005, METHOD ENZYMOL, V394, P321, DOI 10.1016/S0076-6879(05)94012-3; Vallee-Belisle A, 2012, NAT STRUCT MOL BIOL, V19, P731, DOI 10.1038/nsmb.2322; Valley CC, 2012, J BIOL CHEM, V287, P34979, DOI 10.1074/jbc.M112.374504; Vogt J, 1999, STRUCTURE, V7, P1301, DOI 10.1016/S0969-2126(00)80063-5; von Heijne G, 2006, NAT REV MOL CELL BIO, V7, P909, DOI 10.1038/nrm2063; Wang H, 2013, BBA-PROTEINS PROTEOM, V1834, P127, DOI 10.1016/j.bbapap.2012.09.002; Yang HQ, 2012, APPL ENVIRON MICROB, V78, P7519, DOI 10.1128/AEM.01307-12	64	18	19	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79351	10.1371/journal.pone.0079351	http://dx.doi.org/10.1371/journal.pone.0079351			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265768	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100101
J	Kreibich, A; Stech, O; Hundt, J; Ziller, M; Mettenleiter, TC; Stech, J				Kreibich, Anne; Stech, Olga; Hundt, Jana; Ziller, Mario; Mettenleiter, Thomas C.; Stech, Juergen			Avian Influenza Virus H3 Hemagglutinin May Enable High Fitness of Novel Human Virus Reassortants	PLOS ONE			English	Article							FULL-LENGTH AMPLIFICATION; A VIRUS; RECEPTOR SPECIFICITY; VIRAL POLYMERASE; CLEAVAGE SITE; TRANSMISSION; ORIGIN; BINDING; GENE; ACID	Reassortment of influenza A virus genes enables antigenic shift resulting in the emergence of pandemic viruses with novel hemagglutinins (HA) acquired from avian strains. Here, we investigated whether historic and contemporary avian strains with different replication capacity in human cells can donate their hemagglutinin to a pandemic human virus. We performed double-infections with two avian H3 strains as HA donors and a human acceptor strain, and determined gene compositions and replication of HA reassortants in mammalian cells. To enforce selection for the avian virus HA, we generated a strictly elastase-dependent HA cleavage site mutant from A/Hong Kong/1/68 (H3N2) (Hk68-Ela). This mutant was used for co-infections of human cells with A/Duck/Ukraine/1/63 (H3N8) (DkUkr63) or the more recent A/Mallard/Germany/Wv64-67/05 (H3N2) (MallGer05) in the absence of elastase but presence of trypsin. Among 21 plaques analyzed from each assay, we found 12 HA reassortants with DkUkr63 (4 genotypes) and 14 with MallGer05 (10 genotypes) that replicated in human cells comparable to the parental human virus. Although DkUkr63 replicated in mammalian cells at a reduced level compared to MallGer05 and Hk68, it transmitted its HA to the human virus, indicating that lower replication efficiency of an avian virus in a mammalian host may not constrain the emergence of viable HA reassortants. The finding that HA and HA/NA reassortants replicated efficiently like the human virus suggests that further HA adaptation remains a relevant barrier for emergence of novel HA reassortants.	[Kreibich, Anne; Stech, Olga; Hundt, Jana; Mettenleiter, Thomas C.; Stech, Juergen] Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany; [Ziller, Mario] Friedrich Loeffler Inst, Biomath Working Grp, Greifswald, Germany	Friedrich Loeffler Institute; Friedrich Loeffler Institute	Stech, J (corresponding author), Friedrich Loeffler Inst, Inst Mol Biol, Greifswald, Germany.	juergen.stech@fli.bund.de	Mettenleiter, h. c. Thomas C./U-1016-2019	Stech, Juergen/0000-0002-3187-702X	Forschungssofortprogramm Influenza of the German Government [FSI 2.44]	Forschungssofortprogramm Influenza of the German Government	This work was supported by the Forschungssofortprogramm Influenza of the German Government (FSI 2.44). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexander DJ, 2007, VACCINE, V25, P5637, DOI 10.1016/j.vaccine.2006.10.051; Bogs J, 2011, J VIROL, V85, P10691, DOI 10.1128/JVI.00786-11; Chen LF, 2008, J NANOMATER, V2008, DOI 10.1155/2008/783981; CONNOR RJ, 1994, VIROLOGY, V205, P17, DOI 10.1006/viro.1994.1615; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; de Silva UC, 2012, BIOL OPEN, V1, P385, DOI 10.1242/bio.2012281; FANG RX, 1981, CELL, V25, P315, DOI 10.1016/0092-8674(81)90049-0; Gabriel G, 2005, P NATL ACAD SCI USA, V102, P18590, DOI 10.1073/pnas.0507415102; Gao QS, 2012, J VIROL, V86, P7043, DOI 10.1128/JVI.00662-12; Garten RJ, 2009, SCIENCE, V325, P197, DOI 10.1126/science.1176225; Garten Wolfgang, 2008, V27, P156; Herfst S, 2012, SCIENCE, V336, P1534, DOI 10.1126/science.1213362; Hoffmann E, 2000, P NATL ACAD SCI USA, V97, P6108, DOI 10.1073/pnas.100133697; Hoffmann E, 2001, ARCH VIROL, V146, P2275, DOI 10.1007/s007050170002; Hollander M, 1973, NONPARAMETRIC STAT M, Vxviii; Hothorn T., 2013, EXACTRANKTESTS EXACT; Imai M, 2012, NATURE, V486, P420, DOI 10.1038/nature10831; Kan ND, 2005, J MATH SCI, V127, P1737; KAWAOKA Y, 1989, J VIROL, V63, P4603, DOI 10.1128/JVI.63.11.4603-4608.1989; Kreibich A, 2009, J VIROL METHODS, V159, P308, DOI 10.1016/j.jviromet.2009.04.020; Kumari K, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-42; Kunze S, 2010, THESIS; Labadie K, 2007, VIROLOGY, V362, P271, DOI 10.1016/j.virol.2006.12.027; Li CJ, 2008, J VIROL, V82, P11880, DOI 10.1128/JVI.01445-08; Maines TR, 2006, P NATL ACAD SCI USA, V103, P12121, DOI 10.1073/pnas.0605134103; MARKOFF LJ, 1979, ARCH VIROL, V62, P277, DOI 10.1007/BF01317560; Marsh GA, 2008, J VIROL, V82, P2295, DOI 10.1128/JVI.02267-07; Matrosovich M, 2000, J VIROL, V74, P8502, DOI 10.1128/JVI.74.18.8502-8512.2000; Matrosovich M, 1999, J VIROL, V73, P1146, DOI 10.1128/JVI.73.2.1146-1155.1999; Matrosovich MN, 1997, VIROLOGY, V233, P224, DOI 10.1006/viro.1997.8580; Matrosovich MN, 2001, VIROLOGY, V281, P156, DOI 10.1006/viro.2000.0799; Mecham RP, 1997, J BIOL CHEM, V272, P18071, DOI 10.1074/jbc.272.29.18071; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; NAEVE CW, 1984, J VIROL, V51, P567, DOI 10.1128/JVI.51.2.567-569.1984; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ng AKL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036415; Ostrowsky B, 2012, EMERG INFECT DIS, V18, P1128, DOI 10.3201/eid1807.111913; R Core Team, 2012, R LANG ENV STAT COMP; Rameix-Welti MA, 2009, J VIROL, V83, P1320, DOI 10.1128/JVI.00977-08; Rawlings ND, 2008, NUCLEIC ACIDS RES, V36, pD320, DOI 10.1093/nar/gkm954; Robert C.P., 2004, TECHNOMETRICS, V2nd ed., DOI [10.1007/978-1-4757-4145-2, DOI 10.2307/1270959]; ROGERS GN, 1985, J BIOL CHEM, V260, P7362; ROGERS GN, 1983, VIROLOGY, V127, P361, DOI 10.1016/0042-6822(83)90150-2; Russell CA, 2012, SCIENCE, V336, P1541, DOI 10.1126/science.1222526; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Scholtissek C, 2002, J VIROL, V76, P1781, DOI 10.1128/JVI.76.4.1781-1786.2002; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; SCHOLTISSEK C, 1977, VIROLOGY, V81, P74, DOI 10.1016/0042-6822(77)90059-9; Shinya K, 2006, NATURE, V440, P435, DOI 10.1038/440435a; Stech J, 1999, J VIROL, V73, P1878, DOI 10.1128/JVI.73.3.1878-1884.1999; Stech J, 2005, NAT MED, V11, P683, DOI 10.1038/nm1256; Stech J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn646; SUBBARAO EK, 1993, J VIROL, V67, P1761, DOI 10.1128/JVI.67.4.1761-1764.1993; Tumpey TM, 2007, SCIENCE, V315, P655, DOI 10.1126/science.1136212; Van Hoeven N, 2009, P NATL ACAD SCI USA, V106, P3366, DOI 10.1073/pnas.0813172106; Van Poucke S, 2012, INFLUENZA OTHER RESP; Veits J, 2012, P NATL ACAD SCI USA, V109, P2579, DOI 10.1073/pnas.1109397109; Vines A, 1998, J VIROL, V72, P7626, DOI 10.1128/JVI.72.9.7626-7631.1998; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WEBSTER RG, 1972, B WORLD HEALTH ORGAN, V47, P449; WEBSTER RG, 1982, NATURE, V296, P115, DOI 10.1038/296115a0; WEBSTER RG, 1989, VIROLOGY, V171, P484, DOI 10.1016/0042-6822(89)90618-1; Wright PF, 2007, FIELDS VIROLOGY, V2, P1691; Xu R, 2012, J VIROLOGY; Yamada S, 2006, NATURE, V444, P378, DOI 10.1038/nature05264	65	4	4	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79165	10.1371/journal.pone.0079165	http://dx.doi.org/10.1371/journal.pone.0079165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265752	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100085
J	Van Nuland, ME; Haag, EN; Bryant, JAM; Read, QD; Klein, RN; Douglas, MJ; Gorman, CE; Greenwell, TD; Busby, MW; Collins, J; LeRoy, JT; Schuchmann, G; Schweitzer, JA; Bailey, JK				Van Nuland, Michael E.; Haag, Elliot N.; Bryant, Jessica A. M.; Read, Quentin D.; Klein, Robert N.; Douglas, Morgan J.; Gorman, Courtney E.; Greenwell, Trey D.; Busby, Mark W.; Collins, Jonathan; LeRoy, Joseph T.; Schuchmann, George; Schweitzer, Jennifer A.; Bailey, Joseph K.			Fire Promotes Pollinator Visitation: Implications for Ameliorating Declines of Pollination Services	PLOS ONE			English	Article							RESOURCE CONCENTRATION HYPOTHESIS; PLANT DIVERSITY; PRESCRIBED FIRE; OAK FORESTS; PATCH SIZE; DENSITY; BEES; CONSERVATION; COMMUNITIES; AVAILABILITY	Pollinators serve critical roles for the functioning of terrestrial ecosystems, and have an estimated annual value of over $150 billion for global agriculture. Mounting evidence from agricultural systems reveals that pollinators are declining in many regions of the world, and with a lack of information on whether pollinator communities in natural systems are following similar trends, identifying factors which support pollinator visitation and services are important for ameliorating the effects of the current global pollinator crisis. We investigated how fire affects resource structure and how that variation influences floral pollinator communities by comparing burn versus control treatments in a southeastern USA old-field system. We hypothesized and found a positive relationship between fire and plant density of a native forb, Verbesina alternifolia, as well as a significant difference in floral visitation of V. alternifolia between burn and control treatments. V. alternifolia density was 44% greater and floral visitation was 54% greater in burned treatments relative to control sites. When the density of V. alternifolia was experimentally reduced in the burn sites to equivalent densities observed in control sites, floral visitation in burned sites declined to rates found in control sites. Our results indicate that plant density is a proximal mechanism by which an imposed fire regime can indirectly impact floral visitation, suggesting its usefulness as a tool for management of pollination services. Although concerns surround the negative impacts of management, indirect positive effects may provide an important direction to explore for managing future ecological and conservation issues. Studies examining the interaction among resource concentration, plant apparency, and how fire affects the evolutionary consequences of altered patterns of floral visitation are overdue.	[Van Nuland, Michael E.; Haag, Elliot N.; Bryant, Jessica A. M.; Read, Quentin D.; Douglas, Morgan J.; Gorman, Courtney E.; Greenwell, Trey D.; Busby, Mark W.; Collins, Jonathan; LeRoy, Joseph T.; Schuchmann, George; Schweitzer, Jennifer A.; Bailey, Joseph K.] Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA; [Klein, Robert N.] Great Smoky Mts Natl Pk, Gatlinburg, TN USA	University of Tennessee System; University of Tennessee Knoxville	Van Nuland, ME (corresponding author), Univ Tennessee, Dept Ecol & Evolutionary Biol, Knoxville, TN 37996 USA.	mvannula@utk.edu	Gorman, Courtney/M-5219-2019	Gorman, Courtney/0000-0001-7310-8803	University of Tennessee Department of Ecology and Evolutionary Biology	University of Tennessee Department of Ecology and Evolutionary Biology	This work was supported by the University of Tennessee Department of Ecology and Evolutionary Biology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS MD, 1992, BIOSCIENCE, V42, P346, DOI 10.2307/1311781; Allen-Wardell G, 1998, CONSERV BIOL, V12, P8; Bailey JK, 2003, OIKOS, V101, P127, DOI 10.1034/j.1600-0706.2003.12185.x; Bailey JK, 2002, ECOLOGY, V83, P1701, DOI 10.1890/0012-9658(2002)083[1701:IAFAAE]2.0.CO;2; Barnosky AD, 2011, NATURE, V471, P51, DOI 10.1038/nature09678; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Brockway DG, 1997, FOREST ECOL MANAG, V96, P167, DOI 10.1016/S0378-1127(96)03939-4; Buchmann SL, 1996, FORGOTTEN POLLINATOR; CAMBELL JW, 2007, BIOL CONSERV, V134, P393, DOI DOI 10.1016/J.BI0C0N.2006.08.029; Capitanio R, 2008, FOREST ECOL MANAG, V255, P431, DOI 10.1016/j.foreco.2007.09.010; CARSON WP, 1988, ECOLOGY, V69, P984, DOI 10.2307/1941253; Certini G, 2005, OECOLOGIA, V143, P1, DOI 10.1007/s00442-004-1788-8; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Emery SM, 2011, FOREST ECOL MANAG, V261, P1401, DOI 10.1016/j.foreco.2011.01.024; Endara MJ, 2011, FUNCT ECOL, V25, P389, DOI 10.1111/j.1365-2435.2010.01803.x; Essenberg CJ, 2012, AM NAT, V180, P153, DOI 10.1086/666610; Feeny P., 1976, BIOCHEMICAL INTERACT, V10, P1, DOI [10.1007/978-1-4684-2646-5_1, DOI 10.1007/978-1-4684-2646-5_1]; Gallai N, 2009, ECOL ECON, V68, P810, DOI 10.1016/j.ecolecon.2008.06.014; Genung MA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008711; Goulson D, 2008, ANNU REV ENTOMOL, V53, P191, DOI 10.1146/annurev.ento.53.103106.093454; Goulson D, 2003, ANNU REV ECOL EVOL S, V34, P1, DOI 10.1146/annurev.ecolsys.34.011802.132355; GREZ AA, 1995, OECOLOGIA, V103, P471, DOI 10.1007/BF00328685; Grundel R, 2010, ECOL APPL, V20, P1678, DOI 10.1890/08-1792.1; Hegland SJ, 2006, ECOL ENTOMOL, V31, P532, DOI 10.1111/j.1365-2311.2006.00812.x; HERRERA CM, 1995, ECOLOGY, V76, P1516, DOI 10.2307/1938153; Hessl AE, 2002, J BIOGEOGR, V29, P889, DOI 10.1046/j.1365-2699.2002.00703.x; HOBBS RJ, 1992, CONSERV BIOL, V6, P324, DOI 10.1046/j.1523-1739.1992.06030324.x; Kearns CA, 1998, ANNU REV ECOL SYST, V29, P83, DOI 10.1146/annurev.ecolsys.29.1.83; KEARNS CA, 1993, TECHNIQUES POLLINATI, P335; Keeley JE, 2003, ECOL APPL, V13, P1355, DOI 10.1890/02-5002; Klein AM, 2007, P ROY SOC B-BIOL SCI, V274, P303, DOI 10.1098/rspb.2006.3721; Knight TM, 2005, ECOLOGY, V86, P587, DOI 10.1890/04-1069; Kremen C, 2007, ECOL LETT, V10, P299, DOI 10.1111/j.1461-0248.2007.01018.x; KUNIN WE, 1993, ECOLOGY, V74, P2145, DOI 10.2307/1940859; McEwan RW, 2007, J VEG SCI, V18, P655, DOI 10.1111/j.1654-1103.2007.tb02579.x; MCGINLEY MA, 1993, AM MIDL NAT, V129, P409, DOI 10.2307/2426523; Moreira AG, 2000, J BIOGEOGR, V27, P1021, DOI 10.1046/j.1365-2699.2000.00422.x; Munyuli T, 2011, AFR J ECOL, V49, P501, DOI 10.1111/j.1365-2028.2011.01284.x; Ne'eman G, 2000, PLANT ECOL, V146, P97, DOI 10.1023/A:1009815318590; PIMM SL, 1995, SCIENCE, V269, P347, DOI 10.1126/science.269.5222.347; Potts SG, 2003, OIKOS, V101, P103, DOI 10.1034/j.1600-0706.2003.12186.x; Potts SG, 2003, ECOLOGY, V84, P2628, DOI 10.1890/02-0136; Potts SG, 2010, TRENDS ECOL EVOL, V25, P345, DOI 10.1016/j.tree.2010.01.007; PRICE P., 1984, INSECT ECOLOGY; RASMONT P, 1988, ANN SOC ROY ZOOL BEL, V118, P141; Rasmont P, 2005, SURVEY WILD BEES HYM; Rhainds M, 2003, ECOL ENTOMOL, V28, P348, DOI 10.1046/j.1365-2311.2003.00508.x; RICHARDS KW, 1993, REV SUISSE ZOOL, V100, P807, DOI 10.5962/bhl.part.79885; Ricketts TH, 2008, ECOL LETT, V11, P499, DOI 10.1111/j.1461-0248.2008.01157.x; Ricketts TH, 2004, CONSERV BIOL, V18, P1262, DOI 10.1111/j.1523-1739.2004.00227.x; ROOT RB, 1973, ECOL MONOGR, V43, P95, DOI 10.2307/1942161; Rowe JS, 1983, ROLE FIRE NO CIRCUMP, V18, P135; RUNDEL PW, 1980, AM J BOT, V67, P51, DOI 10.2307/2442536; Safford HD, 2004, ECOLOGY, V85, P539, DOI 10.1890/03-0039; Scharenbroch BC, 2012, GEODERMA, V183, P80, DOI 10.1016/j.geoderma.2012.03.010; Smith AR, 2012, ECOL ENTOMOL, V37, P309, DOI 10.1111/j.1365-2311.2012.01367.x; Steffan-Dewenter I, 1999, OECOLOGIA, V121, P432, DOI 10.1007/s004420050949; Stout JC, 2000, ACTA OECOL, V21, P277, DOI 10.1016/S1146-609X(00)01085-7; Swengel AB, 2001, BIODIVERS CONSERV, V10, P1141, DOI 10.1023/A:1016683807033; THOMSON JD, 1982, OIKOS, V39, P241, DOI 10.2307/3544491; Torres-Diaz C, 2007, REV CHIL HIST NAT, V80, P455, DOI 10.4067/S0716-078X2007000400007; Totland O, 2001, ECOLOGY, V82, P2233, DOI 10.1890/0012-9658(2001)082[2233:EDPLAS]2.0.CO;2; Turner MG, 1997, ECOL MONOGR, V67, P411, DOI 10.1890/0012-9615(1997)067[0411:EOFSAP]2.0.CO;2; USDA NRC, 2009, PLANTS DAT; Vanengelsdorp D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004071; Wall WA, 2012, PLANT ECOL, V213, P1093, DOI 10.1007/s11258-012-0068-7; Winfree R, 2009, ECOLOGY, V90, P2068, DOI 10.1890/08-1245.1	67	34	36	4	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79853	10.1371/journal.pone.0079853	http://dx.doi.org/10.1371/journal.pone.0079853			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265787	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100120
J	Rubbab, Q; Vieru, D; Fetecau, C; Fetecau, C				Rubbab, Qammar; Vieru, Dumitru; Fetecau, Corina; Fetecau, Constantin			Natural Convection Flow near a Vertical Plate that Applies a Shear Stress to a Viscous Fluid	PLOS ONE			English	Article							TRANSIENT FREE-CONVECTION; BOUNDARY-LAYER-FLOW; THERMAL-RADIATION; SURFACE	The unsteady natural convection flow of an incompressible viscous fluid near a vertical plate that applies an arbitrary shear stress to the fluid is studied using the Laplace transform technique. The fluid flow is due to both the shear and the heating of the plate. Closed-form expressions for velocity and temperature are established under the usual Boussinesq approximation. For illustration purposes, two special cases are considered and the influence of pertinent parameters on the fluid motion is graphically underlined. The required time to reach the steady state in the case of oscillating shear stresses on the boundary is also determined.	[Fetecau, Constantin] Tech Univ, Dept Math, Iasi, Romania	GH Asachi Technical University	Fetecau, C (corresponding author), Tech Univ, Dept Math, Iasi, Romania.	c_fetecau@yahoo.com						Bandelli R., 1995, ARCH MECH, V47, P661; Chandran P, 2005, HEAT MASS TRANSFER, V41, P459, DOI 10.1007/s00231-004-0568-7; Das UN, 1999, J HEAT TRANS-T ASME, V121, P1091, DOI 10.1115/1.2826063; Debnath L., 2007, INTEGRAL TRANSFORMS; Fetecau C, 2013, Z NATURFORSCH A, V68, P130, DOI 10.5560/ZNA.2012-0083; Hetnarski RB, 1975, J APPL MATH PHYS, V26, P249; INGHAM DB, 1978, INT J HEAT MASS TRAN, V21, P67, DOI 10.1016/0017-9310(78)90159-X; Khan I, 2012, J PHYS SOC JPN, V81; Khan WA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054024; Lesnic D, 1999, INT J HEAT MASS TRAN, V42, P2621, DOI 10.1016/S0017-9310(98)00251-8; Magyari E, 2011, INT COMMUN HEAT MASS, V38, P554, DOI 10.1016/j.icheatmasstransfer.2011.03.006; MERKIN JH, 1994, INT J HEAT FLUID FL, V15, P392, DOI 10.1016/0142-727X(94)90053-1; MERKIN JH, 1985, J ENG MATH, V19, P189, DOI 10.1007/BF00042533; Narahari M, 2013, ZAMM-Z ANGEW MATH ME, V93, P38, DOI 10.1002/zamm.201200008; Narahari Marneni, 2011, Turkish Journal of Engineering and Environmental Sciences, V35, P187, DOI 10.3906/muh-1101-15; Narahari M., 2011, Journal of Applied Sciences, V11, P1096, DOI 10.3923/jas.2011.1096.1104; Rajesh, 2010, INT J APPL MATH MECH, V6, P1; RENARDY M, 1988, ROCKY MT J MATH, V18, P445, DOI 10.1216/RMJ-1988-18-2-445; Roberts GE, 1968, TABLE LAPLACE TRANSF, P170; Samiulhaq, 2012, Z NATURFORSCH A, V67, P572, DOI 10.5560/ZNA.2012-0070; SINGH AK, 1984, ASTROPHYS SPACE SCI, V98, P245, DOI 10.1007/BF00651403; Soundalgekar VM, 1980, ACTA CIENC INDICA, V3, P138; Toki CJ, 2007, ZAMM-Z ANGEW MATH ME, V87, P4, DOI 10.1002/zamm.200510291; Toki CJ, 2009, J APPL MECH-T ASME, V76, DOI 10.1115/1.2998758; Uddin MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049499; Waters N. D., 1970, Rheologica Acta, V9, P345, DOI 10.1007/BF01975401	26	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e78352	10.1371/journal.pone.0078352	http://dx.doi.org/10.1371/journal.pone.0078352			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278110	Green Submitted, gold, Green Published			2022-12-25	WOS:000327541700004
J	Zana-Taieb, E; Butruille, L; Franco-Montoya, ML; Lopez, E; Vernier, F; Grandvuillemin, I; Evain-Brion, D; Deruelle, P; Baud, O; Delacourt, C; Jarreau, PH				Zana-Taieb, Elodie; Butruille, Laura; Franco-Montoya, Marie-Laure; Lopez, Emmanuel; Vernier, Flore; Grandvuillemin, Isabelle; Evain-Brion, Daniele; Deruelle, Philippe; Baud, Olivier; Delacourt, Christophe; Jarreau, Pierre-Henri			Effect of Two Models of Intrauterine Growth Restriction on Alveolarization in Rat Lungs: Morphometric and Gene Expression Analysis	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHESIS; PROTEIN RESTRICTION; SKELETAL-MUSCLE; BIRTH-WEIGHT; INHIBITION; PREGNANCY; ANGIOGENESIS; PLASTICITY; INJURY; BORN	Intrauterine growth restriction (IUGR) in preterm infants increases the risk of bronchopulmonary dysplasia, characterized by arrested alveolarization. We evaluated the impact of two different rat models (nitric oxide synthase inhibition or protein deprivation) of IUGR on alveolarization, before, during, and at the end of this postnatal process. We studied IUGR rat pups of dams fed either a low protein (LPD) or a normal diet throughout gestation and pups of dams treated by continuous infusion of Nv-nitro-L-arginine methyl ester (L-NAME) or its diluent on the last four days of gestation. Morphometric parameters, alveolar surface (Svap), mean linear intercept (MLI) and radial alveolar count (RAC) and transcriptomic analysis were determined with special focus on genes involved in alveolarization. IUGR pups regained normal weight at day 21 in the two treated groups. In the LPD group, Svap, MLI and RAC were not different from those of controls at day 4, but were significantly decreased at day 21, indicating alveolarization arrest. In the L-NAME group, Svap and RAC were significantly decreased and MLI was increased at day 4 with complete correction at day 21. In the L-NAME model, several factors involved in alveolarization, VEGF, VEGF-R1 and -R2, MMP14, MMP16, FGFR3 and 4, FGF18 and 7, were significantly decreased at day 4 and/or day 10, while the various factors studied were not modified in the LPD group. These results demonstrate that only maternal protein deprivation leads to sustained impairment of alveolarization in rat pups, whereas L-NAME impairs lung development before alveolarization. Known growth factors involved in lung development do not seem to be involved in LPD-induced alveolarization disorders, raising the question of a possible programming of altered alveolarization.	[Zana-Taieb, Elodie; Lopez, Emmanuel; Vernier, Flore; Evain-Brion, Daniele; Jarreau, Pierre-Henri] INSERM U767, Paris, France; [Zana-Taieb, Elodie; Lopez, Emmanuel; Vernier, Flore; Evain-Brion, Daniele; Baud, Olivier; Delacourt, Christophe; Jarreau, Pierre-Henri] PremUp, Paris, France; [Zana-Taieb, Elodie; Lopez, Emmanuel; Jarreau, Pierre-Henri] Assistance Publ Hop Paris, Grp hosp Cochin, Serv Med & Reanimat Neonatales Port Royal, Paris, France; [Butruille, Laura; Deruelle, Philippe] Univ Lille Nord France, Fac Med, Pole Rech, Unite Environm Perinatal & Croissance,EA4489,IFR, Lille, France; [Franco-Montoya, Marie-Laure] Hop Henri Mondor, INSERM, U955 IMRB Equipe 04, F-94010 Creteil, France; [Grandvuillemin, Isabelle] Univ Mediterrane, Fac Pharm, INSERM UMR 1076, Marseille, France; [Baud, Olivier] INSERM U676, Paris, France; [Delacourt, Christophe] Hop Necker Enfants Malad, Assistance Publ Hop Paris, Serv Pneumol Pediat, Paris, France; [Zana-Taieb, Elodie; Evain-Brion, Daniele; Delacourt, Christophe; Jarreau, Pierre-Henri] Univ Paris 05, Paris, France; [Baud, Olivier] Hop Robert Debre, Assistance Publ Hop Paris, Serv Reanimat & Pediat Neonatales, F-75019 Paris, France; [Baud, Olivier] Univ Paris Diderot, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; Universite de Lille - ISITE; Universite de Lille; Assistance Publique Hopitaux Paris (APHP); Universite Paris-Est-Creteil-Val-de-Marne (UPEC); Hopital Universitaire Henri-Mondor - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Aix-Marseille Universite; Assistance Publique-Hopitaux de Marseille; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite	Zana-Taieb, E (corresponding author), INSERM U767, Paris, France.	elodie.zana-taieb@cch.aphp.fr	Deruelle, Philippe/O-3689-2016; Delacourt, Christophe/K-6161-2019	Deruelle, Philippe/0000-0003-4273-6553; BUTRUILLE, Laura/0000-0001-5760-1489	Legs Poix grant of la Chancellerie des Universites de Paris; Air Liquide Foundation	Legs Poix grant of la Chancellerie des Universites de Paris; Air Liquide Foundation	This work has been supported by a Legs Poix grant of la Chancellerie des Universites de Paris, 2006 and by the Air Liquide Foundation, 2011. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcazar MAA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026371; BARKER DJP, 1991, BRIT MED J, V303, P671, DOI 10.1136/bmj.303.6804.671; Bourbon J, 2005, PEDIATR RES, V57, p38R, DOI 10.1203/01.PDR.0000159630.35883.BE; Briana DD, 2012, PAEDIAT RESP REV; Buffat C, 2007, ENDOCRINOLOGY, V148, P5549, DOI 10.1210/en.2007-0765; BURRI PH, 1974, ANAT REC, V178, P711, DOI 10.1002/ar.1091780405; Butruille L, 2013, METABOLISM; Diaz V, 2005, PEDIATR RES, V58, P557, DOI 10.1203/01.PDR.0000179398.62365.43; Doyle LW, 2006, PEDIATR PULM, V41, P570, DOI 10.1002/ppul.20412; Edwards CA, 2003, THORAX, V58, P1061, DOI 10.1136/thorax.58.12.1061; EMERY JL, 1960, ARCH DIS CHILD, V35, P544, DOI 10.1136/adc.35.184.544; Fernandez Celadilla Lina, 2005, Archives of Gynecology and Obstetrics, V271, P243, DOI 10.1007/s00404-004-0633-y; Franco ML, 2002, AM J PHYSIOL-LUNG C, V282, pL491, DOI 10.1152/ajplung.00140.2001; Franco-Montoya ML, 2011, PHYSIOL GENOMICS, V43, P1226, DOI 10.1152/physiolgenomics.00034.2011; Greenough A, 2004, EUR RESPIR J, V24, P731, DOI 10.1183/09031936.04.00060304; Hale SA, 2011, AM J PHYSIOL-HEART C, V301, pH1266, DOI 10.1152/ajpheart.00519.2011; Halliday HL, 2009, BEST PRACT RES CL OB, V23, P871, DOI 10.1016/j.bpobgyn.2009.06.005; Jobe Alan H., 2001, American Journal of Respiratory and Critical Care Medicine, V163, P1723; Maritz GS, 2004, PEDIATR RES, V55, P287, DOI 10.1203/01.PDR.0000106314.99930.65; Maritz GS, 2001, PEDIATR PULM, V32, P201, DOI 10.1002/ppul.1109; Martin-Gronert MS, 2008, AM J PHYSIOL-REG I, V294, pR494, DOI 10.1152/ajpregu.00530.2007; McAdams RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046863; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; Mehats C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003445; Neerhof MG, 2011, HYPERTENS PREGNANCY, V30, P28, DOI 10.3109/10641950903322915; Ozanne SE, 1999, BIOCHEM SOC T, V27, P94, DOI 10.1042/bst0270094; Petry CJ, 1997, CLIN SCI, V93, P147, DOI 10.1042/cs0930147; Rosenberg A, 2008, SEMIN PERINATOL, V32, P219, DOI 10.1053/j.semperi.2007.11.003; Thebaud B, 2005, CIRCULATION, V112, P2477, DOI 10.1161/CIRCULATIONAHA.105.541524; Thomas W, 2011, NEONATOLOGY, V99, P177, DOI 10.1159/000320170; Tiboni GM, 2003, PEDIATR RES, V54, P69, DOI 10.1203/01.PDR.0000069840.78984.76; Toscano AE, 2008, NUTRITION, V24, P270, DOI 10.1016/j.nut.2007.12.004; Vadivel A, 2010, AM J RESP CELL MOL, V43, P152, DOI 10.1165/rcmb.2009-0004OC; Wang JJ, 2008, J NUTR, V138, P60, DOI 10.1093/jn/138.1.60; WEIBEL ER, 1966, HELV PHYSIOL PHARM A, V24, pC56; Weinstein M, 1998, DEVELOPMENT, V125, P3615; YALLAMPALLI C, 1993, AM J OBSTET GYNECOL, V169, P1316, DOI 10.1016/0002-9378(93)90299-X; Zeitlin J, 2010, J PEDIATR-US, V157, P733, DOI 10.1016/j.jpeds.2010.05.002	38	17	19	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e78326	10.1371/journal.pone.0078326	http://dx.doi.org/10.1371/journal.pone.0078326			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278109	Green Published, gold, Green Submitted			2022-12-25	WOS:000327539800003
J	Nie, YZ; Chen, YQ; Mou, YB; Weng, LH; Xu, ZJ; Du, YW; Wang, WM; Hou, YY; Wang, TT				Nie, Yunzhong; Chen, Yueqiu; Mou, Yongbin; Weng, Leihua; Xu, Zhenjun; Du, Youwei; Wang, Wenmei; Hou, Yayi; Wang, Tingting			Low Frequency Magnetic Fields Enhance Antitumor Immune Response against Mouse H22 Hepatocellular Carcinoma	PLOS ONE			English	Article							OCCUPATIONAL-EXPOSURE; TUMOR-GROWTH; CANCER; MICE; MACROPHAGES; CELLS; ANGIOGENESIS; STIMULATION; LYMPHOCYTES; APOPTOSIS	Objective: Many studies have shown that magnetic fields (MF) inhibit tumor growth and influence the function of immune system. However, the effect of MF on mechanism of immunological function in tumor-bearing mice is still unclear. Methods: In this study, tumor-bearing mice were prepared by subcutaneously inoculating Balb/c mice with hepatocarcinoma cell line H22. The mice were then exposed to a low frequency MF (0.4 T, 7.5 Hz) for 30 days. Survival rate, tumor growth and the innate and adaptive immune parameters were measured. Results: MF treatment could prolong survival time (n = 28, p < 0.05) and inhibit tumor growth (n = 9, p < 0.01) in tumor-bearing mice. Moreover, this MF suppressed tumor-induced production of cytokines including interleukin-6 (IL-6), granulocyte colony-stimulating factor (G-CSF) and keratinocyte-derived chemokine (KC) (n = 9-10, p < 0.05 or 0.01). Furthermore, MF exposure was associated with activation of macrophages and dendritic cells, enhanced profiles of CD4(+) T and CD8(+) T lymphocytes, the balance of Th17/Treg and reduced inhibitory function of Treg cells (n = 9-10, p < 0.05 or 0.01) in the mice model. Conclusion: The inhibitory effect of MF on tumor growth was related to the improvement of immune function in the tumor-bearing mice.	[Nie, Yunzhong; Chen, Yueqiu; Weng, Leihua; Xu, Zhenjun; Hou, Yayi; Wang, Tingting] Nanjing Univ, Sch Med, Div Immunol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China; [Mou, Yongbin; Wang, Wenmei] Nanjing Univ, Stomatol Hosp Affiliated Med Sch, Nanjing 210008, Jiangsu, Peoples R China; [Du, Youwei] Nanjing Univ, Natl Lab Solid Microstruct, Nanjing 210008, Jiangsu, Peoples R China; [Hou, Yayi; Wang, Tingting] Nanjing Univ, Jiangsu Key Lab Mol Med, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University; Nanjing University; Nanjing University	Hou, YY (corresponding author), Nanjing Univ, Sch Med, Div Immunol, State Key Lab Pharmaceut Biotechnol, Nanjing 210008, Jiangsu, Peoples R China.	yayihou@nju.edu.cn; wangtt@nju.edu.cn	wang, tingting/AAK-2640-2020; mou, yongbin/AAR-9889-2020	mou, yongbin/0000-0003-0964-2862	National Natural Science Foundation of China [81101552/81070839]; Natural Science Foundation of Jiangsu Province [BK2011571, BK2012744]; Specialized Research Fund for the Doctoral Program of Higher Education [20100091120002]; Ministry of Science and Technology [2012BA/15B03]; Medical Science and Technology Development Foundation, Nanjing Department of Health [ZKX10030]; Jiangsu Province's Outstanding Medical Academic Leader Program [LJ201110]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province(Natural Science Foundation of Jiangsu Province); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Medical Science and Technology Development Foundation, Nanjing Department of Health; Jiangsu Province's Outstanding Medical Academic Leader Program	This work was supported by the National Natural Science Foundation of China (81101552/81070839), the Natural Science Foundation of Jiangsu Province (BK2011571& BK2012744), Specialized Research Fund for the Doctoral Program of Higher Education (20100091120002), the Ministry of Science and Technology "Twelfth Five-Year" national scientific and technological support for major projects (2012BA/15B03), Key Project supported by Medical Science and Technology Development Foundation, Nanjing Department of Health (ZKX10030), and Jiangsu Province's Outstanding Medical Academic Leader Program (No. LJ201110). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bistolfi F, 2007, NEURORADIOL J, V20, P676, DOI 10.1177/197140090702000612; Biswas SK, 2010, NAT IMMUNOL, V11, P889, DOI 10.1038/ni.1937; Cakir DU, 2009, ARCH MED RES, V40, P352, DOI 10.1016/j.arcmed.2009.07.001; Chung MK, 2010, BIOELECTROMAGNETICS, V31, P130, DOI 10.1002/bem.20538; Davanipour Zoreh, 2009, Pathophysiology, V16, P149, DOI 10.1016/j.pathophys.2009.01.005; Fisher PJ, 2008, BLOOD, V112, P5037, DOI 10.1182/blood-2008-04-149526; Frahm J, 2006, J CELL BIOCHEM, V99, P168, DOI 10.1002/jcb.20920; Gobba F, 2009, SCI TOTAL ENVIRON, V407, P1218, DOI 10.1016/j.scitotenv.2008.08.012; Heikkila K, 2008, EUR J CANCER, V44, P937, DOI 10.1016/j.ejca.2008.02.047; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hug K, 2010, AM J EPIDEMIOL, V171, P27, DOI 10.1093/aje/kwp339; Koh EK, 2008, INT J RADIAT BIOL, V84, P945, DOI 10.1080/09553000802460206; Lee HJ, 2010, INT J RADIAT BIOL, V86, P384, DOI 10.3109/09553000903567920; Mannerling AC, 2010, RADIAT ENVIRON BIOPH, V49, P731, DOI 10.1007/s00411-010-0306-0; Mariucci G, 2010, INT J RADIAT BIOL, V86, P701, DOI 10.3109/09553001003789588; Minton K, 2011, NAT REV IMMUNOL, V11, DOI 10.1038/nri2934; Miyakoshi J, 2005, PROG BIOPHYS MOL BIO, V87, P213, DOI 10.1016/j.pbiomolbio.2004.08.008; Novikov VV, 2009, BIOELECTROMAGNETICS, V30, P343, DOI 10.1002/bem.20487; Okazaki T, 2006, INT IMMUNOL, V18, P1, DOI 10.1093/intimm/dxh334; Ostrand-Rosenberg S, 2008, CURR OPIN GENET DEV, V18, P11, DOI 10.1016/j.gde.2007.12.007; Presky DH, 1996, P NATL ACAD SCI USA, V93, P14002, DOI 10.1073/pnas.93.24.14002; Saito T, 2010, J EPIDEMIOL, V20, P54, DOI 10.2188/jea.JE20081017; Salerno S, 2006, INT J RADIAT BIOL, V82, P77, DOI 10.1080/09553000600589131; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Simko M, 2004, J CELL BIOCHEM, V93, P83, DOI 10.1002/jcb.20198; Simko M, 2001, EUR J CELL BIOL, V80, P562, DOI 10.1078/0171-9335-00187; Smyth MJ, 2000, J IMMUNOL, V165, P2665, DOI 10.4049/jimmunol.165.5.2665; Swann JB, 2007, J CLIN INVEST, V117, P1137, DOI 10.1172/JCI31405; Tofani S, 2003, PHARMACOL RES, V48, P83, DOI 10.1016/S1043-6618(03)00062-8; Tofani S, 2001, BIOELECTROMAGNETICS, V22, P419, DOI 10.1002/bem.69; Wang DZ, 2006, J EXP MED, V203, P941, DOI 10.1084/jem.20052124; Wang TT, 2011, BIOELECTROMAGNETICS, V32, P443, DOI 10.1002/bem.20654; Yamaguchi S, 2006, BIOELECTROMAGNETICS, V27, P64, DOI 10.1002/bem.20177; Zou WP, 2005, NAT REV CANCER, V5, P263, DOI 10.1038/nrc1586	34	44	49	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e72411	10.1371/journal.pone.0072411	http://dx.doi.org/10.1371/journal.pone.0072411			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278103	Green Submitted, Green Published, gold			2022-12-25	WOS:000327313100001
J	DeFaveri, J; Merila, J				DeFaveri, Jacquelin; Merila, Juha			Variation in Age and Size in Fennoscandian Three-Spined Sticklebacks (Gasterosteus aculeatus)	PLOS ONE			English	Article							EFFECTIVE POPULATION-SIZE; LIFE-HISTORY VARIATION; BODY SHAPE; THREESPINE; BIOLOGY; GROWTH	Average age and maximum life span of breeding adult three-spined sticklebacks (Gasterosteus aculeatus) were determined in eight Fennoscandian localities with the aid of skeletochronology. The average age varied from 1.8 to 3.6 years, and maximum life span from three to six years depending on the locality. On average, fish from marine populations were significantly older than those from freshwater populations, but variation within habitat types was large. We also found significant differences in mean body size among different habitat types and populations, but only the population differences remained significant after accounting for variation due to age effects. These results show that generation length and longevity in three-spined sticklebacks can vary significantly from one locality to another, and that population differences in mean body size cannot be explained as a simple consequence of differences in population age structure. We also describe a nanistic population from northern Finland exhibiting long life span and small body size.	[DeFaveri, Jacquelin; Merila, Juha] Univ Helsinki, Ecol Genet Res Unit, Dept Biosci, Helsinki, Finland	University of Helsinki	Merila, J (corresponding author), Univ Helsinki, Ecol Genet Res Unit, Dept Biosci, Helsinki, Finland.	juha.merila@helsinki.fi	Merila, Juha/A-4061-2008	Merila, Juha/0000-0001-9614-0072	Academy of Finland [s 200940, 108601, 118673]; LUOVA graduate school; European Community [217246]	Academy of Finland(Academy of Finland); LUOVA graduate school; European Community(European Commission)	This research was supported by the Academy of Finland (grant #s 200940, 108601 and 118673 to JM) and LUOVA graduate school (JD). The research leading to these results has also received funding from the European Community's Seventh Framework Programme (FP/2007-2013) under grant agreement nu217246 made with BONUS, the joint Baltic Sea research and development programme. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANEER G, 1973, ZOOL SCR, V2, P157; Arai T, 2003, ICHTHYOL RES, V50, P90, DOI 10.1007/s102280300014; Baker J, 1994, EVOLUTIONARY BIOL TH; Baker JA, 2008, BEHAVIOUR, V145, P579, DOI 10.1163/156853908792451539; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Charlesworth B., 1994, EVOLUTION AGE STRUCT, DOI [10.1017/CBO9780511525711, DOI 10.1017/CBO9780511525711]; Clavero M, 2009, ECOL FRESHW FISH, V18, P550, DOI 10.1111/j.1600-0633.2009.00369.x; Clutton-Brock TH, 1988, REPROD SUCCESS STUDI; Coad BW, 1973, LE NAT CAN, V100, P437; CRAIG JF, 1985, CAN J ZOOL, V63, P1, DOI 10.1139/z85-001; Cuveliers EL, 2011, MOL ECOL, V20, P3555, DOI 10.1111/j.1365-294X.2011.05196.x; Frankham R., 2002, INTRO CONSERVATION G; Gambling SJ, 2012, CAN J ZOOL, V90, P284, DOI 10.1139/Z11-133; Greenbank J, 1959, FISH B, V59, P537; HILL WG, 1979, GENETICS, V92, P317; JONES JW, 1950, J ANIM ECOL, V19, P59, DOI 10.2307/1571; JORDE PE, 1995, GENETICS, V139, P1077; Leinonen T, 2006, J EVOLUTION BIOL, V19, P1803, DOI 10.1111/j.1420-9101.2006.01182.x; Leinonen T, 2011, J EVOLUTION BIOL, V24, P206, DOI 10.1111/j.1420-9101.2010.02161.x; Luikart G, 2010, CONSERV GENET, V11, P355, DOI 10.1007/s10592-010-0050-7; MacColl ADC, 2013, J ANIM ECOL, V82, P642, DOI 10.1111/1365-2656.12028; MANN RHK, 1971, J ANIM ECOL, V40, P155, DOI 10.2307/3336; Palstra FP, 2008, MOL ECOL, V17, P3428, DOI 10.1111/j.1365-294X.2008.03842.x; Partridge L, 2010, PHILOS T R SOC B, V365, P147, DOI 10.1098/rstb.2009.0222; PENNYCUICK L, 1971, PARASITOLOGY, V63, P407, DOI 10.1017/S0031182000079932; Poizat G, 2002, J FISH BIOL, V60, P1296, DOI 10.1006/jfbi.2002.1944; REIMCHEN TE, 1992, CAN FIELD NAT, V106, P122; Rose M.R., 1991, EVOLUTIONARY BIOL AG; SHIRVELL CS, 1981, J FISH BIOL, V18, P377, DOI 10.1111/j.1095-8649.1981.tb03779.x; SNYDER RJ, 1991, COPEIA, P526; Waples RS, 2010, MOL ECOL RESOUR, V10, P785, DOI 10.1111/j.1755-0998.2010.02876.x; Wootton R. J., 1984, FUNCTIONAL BIOL STIC; Wootton R.J., 1976, BIOL STICKLEBACKS; Wootton RJ, 2000, BEHAVIOUR, V137, P981, DOI 10.1163/156853900502385	34	29	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80866	10.1371/journal.pone.0080866	http://dx.doi.org/10.1371/journal.pone.0080866			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260496	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900102
J	Alnajar, A; Nordhoff, C; Schied, T; Chiquet-Ehrismann, R; Loser, K; Vogl, T; Ludwig, S; Wixler, V				Alnajar, Abdulaleem; Nordhoff, Carolin; Schied, Tanja; Chiquet-Ehrismann, Ruth; Loser, Karin; Vogl, Thomas; Ludwig, Stephan; Wixler, Viktor			The LIM-Only Protein FHL2 Attenuates Lung Inflammation during Bleomycin-Induced Fibrosis	PLOS ONE			English	Article							TENASCIN-C; WOUND REPAIR; MACROPHAGE; EXPRESSION; BETA; DEFICIENCY; MECHANISMS; DISEASE; SKIN; DIFFERENTIATION	Fibrogenesis is usually initiated when regenerative processes have failed and/or chronic inflammation occurs. It is characterised by the activation of tissue fibroblasts and dysregulated synthesis of extracellular matrix proteins. FHL2 (four-and-a-half LIM domain protein 2) is a scaffolding protein that interacts with numerous cellular proteins, regulating signalling cascades and gene transcription. It is involved in tissue remodelling and tumour progression. Recent data suggest that FHL2 might support fibrogenesis by maintaining the transcriptional expression of alpha smooth muscle actin and the excessive synthesis and assembly of matrix proteins in activated fibroblasts. Here, we present evidence that FHL2 does not promote bleomycin-induced lung fibrosis, but rather suppresses this process by attenuating lung inflammation. Loss of FHL2 results in increased expression of the pro-inflammatory matrix protein tenascin C and downregulation of the macrophage activating C-type lectin receptor DC-SIGN. Consequently, FHL2 knockout mice developed a severe and long-lasting lung pathology following bleomycin administration due to enhanced expression of tenascin C and impaired activation of inflammation-resolving macrophages.	[Alnajar, Abdulaleem; Nordhoff, Carolin; Schied, Tanja; Ludwig, Stephan; Wixler, Viktor] Univ Munster, Ctr Mol Biol Inflammat ZMBE, Inst Mol Virol, D-48149 Munster, Germany; [Chiquet-Ehrismann, Ruth] Friedrich Miescher Inst Biomed Res, Basel, Switzerland; [Chiquet-Ehrismann, Ruth] Univ Basel, Fac Sci, Basel, Switzerland; [Loser, Karin] Univ Munster, Dept Dermatol, D-48149 Munster, Germany; [Vogl, Thomas] Univ Munster, Inst Immunol, D-48149 Munster, Germany	University of Munster; Friedrich Miescher Institute for Biomedical Research; University of Basel; University of Munster; University of Munster	Wixler, V (corresponding author), Univ Munster, Ctr Mol Biol Inflammat ZMBE, Inst Mol Virol, D-48149 Munster, Germany.	vwixler@uni-muenster.de		Ludwig, Stephan/0000-0003-4490-3052	Deutsche Forschungsgemeinschaft (DFG) [SFB492A17]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by grant SFB492A17 from the Deutsche Forschungsgemeinschaft (DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ASHCROFT T, 1988, J CLIN PATHOL, V41, P467, DOI 10.1136/jcp.41.4.467; Asparuhova MB, 2011, FASEB J, V25, P3477, DOI 10.1096/fj.11-187310; Bai ST, 2005, J CLIN INVEST, V115, P2742, DOI 10.1172/JCI24921; Brellier F, 2011, FEBS LETT, V585, P913, DOI 10.1016/j.febslet.2011.02.023; Chan JK, 2012, J CLIN INVEST, V122, P2711, DOI 10.1172/JCI62423; Chu PH, 2000, MOL CELL BIOL, V20, P7460, DOI 10.1128/MCB.20.20.7460-7462.2000; Dahan J, 2013, MOL CELL BIOL, V33, P3299, DOI 10.1128/MCB.00105-13; Dean RA, 2008, BLOOD, V112, P3455, DOI 10.1182/blood-2007-12-129080; Degryse AL, 2011, AM J MED SCI, V341, P444, DOI 10.1097/MAJ.0b013e31821aa000; den Dunnen J, 2010, IMMUNOL LETT, V128, P12, DOI 10.1016/j.imlet.2009.09.008; EDWARDS CA, 1980, CLIN CHIM ACTA, V104, P161, DOI 10.1016/0009-8981(80)90192-8; FARJANEL J, 1993, AM REV RESPIR DIS, V147, P1091, DOI 10.1164/ajrccm/147.5.1091; Fernandez Isis E, 2012, Proc Am Thorac Soc, V9, P111, DOI 10.1513/pats.201203-023AW; Foell D, 2004, CLIN CHIM ACTA, V344, P37, DOI 10.1016/j.cccn.2004.02.023; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Gullotti L, 2011, LAB INVEST, V91, P1695, DOI 10.1038/labinvest.2011.109; Gunther T, 2005, EMBO J, V24, P3049, DOI 10.1038/sj.emboj.7600773; Guo Z, 2010, MOL CARCINOGEN, V49, P826, DOI 10.1002/mc.20659; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hamidouche Z, 2008, FASEB J, V22, P3813, DOI 10.1096/fj.08-106302; HAY J, 1991, ARCH TOXICOL, V65, P81, DOI 10.1007/BF02034932; Hesselstrand R, 2013, RESP MED, V107, P1079, DOI 10.1016/j.rmed.2013.03.015; Homer RJ, 2011, ARCH PATHOL LAB MED, V135, P780, DOI 10.1043/2010-0296-RA.1; Huss Sebastian, 2013, BMC Gastroenterol, V13, P8, DOI 10.1186/1471-230X-13-8; Johannessen M, 2006, CELL MOL LIFE SCI, V63, P268, DOI 10.1007/s00018-005-5438-z; Joos H, 2008, MOL MED, V14, P150, DOI 10.2119/2007-00118.Joos; Kerkhoff C, 2012, EXP DERMATOL, V21, P822, DOI 10.1111/j.1600-0625.2012.01571.x; Kirfel J, 2008, EXP CELL RES, V314, P3684, DOI 10.1016/j.yexcr.2008.09.023; Kong YF, 2001, CIRCULATION, V103, P2731; Krieg T, 2007, ARTHRITIS RES THER, V9, DOI 10.1186/ar2188; Lai CF, 2006, J BONE MINER RES, V21, P17, DOI 10.1359/JBMR.050915; Martin B, 2002, J CELL BIOL, V159, P113, DOI 10.1083/jcb.200202075; Mi S, 2011, J IMMUNOL, V187, P3003, DOI 10.4049/jimmunol.1004081; Midwood K, 2009, NAT MED, V15, P774, DOI 10.1038/nm.1987; Midwood KS, 2009, J CELL COMMUN SIGNAL, V3, P287, DOI 10.1007/s12079-009-0075-1; Mori R, 2008, J EXP MED, V205, P43, DOI 10.1084/jem.20071412; Muller JM, 2002, EMBO J, V21, P736, DOI 10.1093/emboj/21.4.736; Nishida M, 2008, NEPHRON EXP NEPHROL, V110, pE31, DOI 10.1159/000151561; Park J, 2008, FASEB J, V22, P2508, DOI 10.1096/fj.07-095521; PARK SJ, 2013, ASIAN WOMEN, V29, P1, DOI DOI 10.4046/TRD.2013.74.1.1.PUBMED:23390446; Philippar U, 2004, MOL CELL, V16, P867, DOI 10.1016/j.molcel.2004.11.039; Purcell NH, 2004, MOL CELL BIOL, V24, P1081, DOI 10.1128/MCB.24.3.1081-1095.2004; Schmidt R, 2004, TOXICOL APPL PHARM, V195, P218, DOI 10.1016/j.taap.2003.11.011; Shaw TJ, 2009, J CELL SCI, V122, P3209, DOI 10.1242/jcs.031187; Stramer BM, 2007, J INVEST DERMATOL, V127, P1009, DOI 10.1038/sj.jid.5700811; Strieter Robert M, 2008, Proc Am Thorac Soc, V5, P305, DOI 10.1513/pats.200710-160DR; Tucker RP, 2009, BBA-MOL CELL RES, V1793, P888, DOI 10.1016/j.bbamcr.2008.12.012; Udalova IA, 2011, CRIT REV IMMUNOL, V31, P115, DOI 10.1615/CritRevImmunol.v31.i2.30; van Amerongen MJ, 2007, AM J PATHOL, V170, P818, DOI 10.2353/ajpath.2007.060547; van den Berg LM, 2012, ANN NY ACAD SCI, V1253, P149, DOI 10.1111/j.1749-6632.2011.06392.x; Verrecchia F, 2007, WORLD J GASTROENTERO, V13, P3056, DOI 10.3748/wjg.v13.i22.3056; Vogl T, 2007, NAT MED, V13, P1042, DOI 10.1038/nm1638; Walters DM, 2008, CURRENT PROTOC PHARM; Wixler V, 2007, J CELL BIOL, V177, P163, DOI 10.1083/jcb.200606043; Wynn TA, 2011, J EXP MED, V208, P1339, DOI 10.1084/jem.20110551; Yoshizaki A, 2008, AM J PATHOL, V172, P1650, DOI 10.2353/ajpath.2008.071049	56	21	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81356	10.1371/journal.pone.0081356	http://dx.doi.org/10.1371/journal.pone.0081356			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260575	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500206
J	Garcia-Orenes, F; Morugan-Coronado, A; Zornoza, R; Scow, K				Garcia-Orenes, Fuensanta; Morugan-Coronado, Alicia; Zornoza, Raul; Scow, Kate			Changes in Soil Microbial Community Structure Influenced by Agricultural Management Practices in a Mediterranean Agro-Ecosystem	PLOS ONE			English	Article							FATTY-ACID PATTERNS; RESIDUE MANAGEMENT; LAND-USE; BIOMASS; TILLAGE; DIVERSITY; BACTERIAL; LITTER; IMPACT; FERTILIZATION	Agricultural practices have proven to be unsuitable in many cases, causing considerable reductions in soil quality. Land management practices can provide solutions to this problem and contribute to get a sustainable agriculture model. The main objective of this work was to assess the effect of different agricultural management practices on soil microbial community structure (evaluated as abundance of phospholipid fatty acids, PLFA). Five different treatments were selected, based on the most common practices used by farmers in the study area (eastern Spain): residual herbicides, tillage, tillage with oats and oats straw mulching; these agricultural practices were evaluated against an abandoned land after farming and an adjacent long term wild forest coverage. The results showed a substantial level of differentiation in the microbial community structure, in terms of management practices, which was highly associated with soil organic matter content. Addition of oats straw led to a microbial community structure closer to wild forest coverage soil, associated with increases in organic carbon, microbial biomass and fungal abundances. The microbial community composition of the abandoned agricultural soil was characterised by increases in both fungal abundances and the metabolic quotient (soil respiration per unit of microbial biomass), suggesting an increase in the stability of organic carbon. The ratio of bacteria: fungi was higher in wild forest coverage and land abandoned systems, as well as in the soil treated with oat straw. The most intensively managed soils showed higher abundances of bacteria and actinobacteria. Thus, the application of organic matter, such as oats straw, appears to be a sustainable management practice that enhances organic carbon, microbial biomass and activity and fungal abundances, thereby changing the microbial community structure to one more similar to those observed in soils under wild forest coverage.	[Garcia-Orenes, Fuensanta] Univ Miguel HernandezElche, Dept Agrochem & Environm, Alicante, Spain; [Morugan-Coronado, Alicia] Univ Valencia, Deparment Geog, Valencia, Spain; [Zornoza, Raul] Univ Politecn Cartagena, Dept Agr Sci & Technol, Murcia, Spain; [Scow, Kate] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA	University of Valencia; Universidad Politecnica de Cartagena; University of California System; University of California Davis	Garcia-Orenes, F (corresponding author), Univ Miguel HernandezElche, Dept Agrochem & Environm, Alicante, Spain.	fuensanta.garcia@umh.es	Scow, Kate/ABE-6730-2020; Zornoza, Raul/M-6939-2013; Morugan-Coronado, Alicia/K-7553-2014	Scow, Kate/0000-0002-2649-1122; Zornoza, Raul/0000-0001-7291-5742; Morugan-Coronado, Alicia/0000-0002-4145-9921	Masia d'Agricultura i Ramaderia Ecologica from El Teularet; Massis del Caroig;  [CGL2008-02879]	Masia d'Agricultura i Ramaderia Ecologica from El Teularet; Massis del Caroig; 	The authors are grateful for the CGL2008-02879 project, the Masia d'Agricultura i Ramaderia Ecologica from El Teularet, and the Massis del Caroig (leader II) for providing financial support. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison VJ, 2005, SOIL SCI SOC AM J, V69, P1412, DOI 10.2136/sssaj2004.0252; [Anonymous], 1995, METHODS APPL SOIL MI; Bailey KL, 2003, SOIL TILL RES, V72, P169, DOI 10.1016/S0167-1987(03)00086-2; Bailey VL, 2002, SOIL BIOL BIOCHEM, V34, P997, DOI 10.1016/S0038-0717(02)00033-0; BARDGETT RD, 1993, AGR ECOSYST ENVIRON, V45, P25, DOI 10.1016/0167-8809(93)90057-V; Benito Rueda E., 1986, Anales de Edafologia y Agrobiologia, V45, P1115; Bonet A, 2004, J ARID ENVIRON, V56, P213, DOI 10.1016/S0140-1963(03)00048-X; Bossio DA, 1998, MICROBIAL ECOL, V36, P1, DOI 10.1007/s002489900087; BRADSHAW AD, 1984, LANDSCAPE PLAN, V11, P35, DOI 10.1016/0304-3924(84)90016-9; Bremner JM, 1982, AGRONOMY, P595, DOI DOI 10.2134/AGRONMONOGR9.2.2ED.C31; Brussaard L, 2007, AGR ECOSYST ENVIRON, V121, P233, DOI 10.1016/j.agee.2006.12.013; CAMBARDELLA CA, 1994, SOIL SCI SOC AM J, V58, P123, DOI 10.2136/sssaj1994.03615995005800010017x; Caravaca F, 2002, SOIL TILL RES, V68, P23, DOI 10.1016/S0167-1987(02)00080-6; Christensen B.T., 1996, EVALUATION SOIL ORGA, V38, P143; DeGrood SH, 2005, SOIL BIOL BIOCHEM, V37, P1427, DOI 10.1016/j.soilbio.2004.12.013; Diez J. A., 1982, Anales de Edafologia y Agrobiologia, V41, P1345; Dilly O, 2001, SOIL BIOL BIOCHEM, V33, P921, DOI 10.1016/S0038-0717(00)00239-X; Doran J. W., 1994, P1; Drijber RA, 2000, SOIL BIOL BIOCHEM, V32, P1419, DOI 10.1016/S0038-0717(00)00060-2; DUAHYENTUMI S, 1986, SOIL BIOL BIOCHEM, V18, P629, DOI 10.1016/0038-0717(86)90086-6; Dunbar J, 2000, APPL ENVIRON MICROB, V66, P2943, DOI 10.1128/AEM.66.7.2943-2950.2000; Elliott LF, 1997, ADV AGRON, V60, P121, DOI 10.1016/S0065-2113(08)60602-1; Enwall K, 2007, SOIL BIOL BIOCHEM, V39, P106, DOI 10.1016/j.soilbio.2006.06.015; Federle T.W., 1986, PERSPECTIVES MICROBI, P493; Fedoroff N., 1987, Scientific basis for soil protection in the European Community, P65; Feng Y, 2003, SOIL BIOL BIOCHEM, V35, P1693, DOI 10.1016/j.soilbio.2003.08.016; Frey SD, 1999, SOIL BIOL BIOCHEM, V31, P573, DOI 10.1016/S0038-0717(98)00161-8; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; Garcia-Orenes F, 2012, SOIL USE MANAGE, V28, P571, DOI 10.1111/j.1475-2743.2012.00451.x; Garcia-Orenes F, 2010, SOIL TILL RES, V109, P110, DOI 10.1016/j.still.2010.05.005; Garcia-Orenes F, 2009, SOIL TILL RES, V106, P117, DOI 10.1016/j.still.2009.06.002; Giller PS, 1996, BIODIVERS CONSERV, V5, P135, DOI 10.1007/BF00055827; Griffith GS, 2000, NEW PHYTOL, V148, P143, DOI 10.1046/j.1469-8137.2000.00747.x; Hackl E, 2005, SOIL BIOL BIOCHEM, V37, P661, DOI 10.1016/j.soilbio.2004.08.023; Hedlund K, 2002, SOIL BIOL BIOCHEM, V34, P1299, DOI 10.1016/S0038-0717(02)00073-1; Helgason B. L., 2007, SOIL SCI SOC AM J, V73, P120; HOLLAND EA, 1987, ECOLOGY, V68, P425, DOI 10.2307/1939274; Jangid K, 2008, SOIL BIOL BIOCHEM, V40, P2843, DOI 10.1016/j.soilbio.2008.07.030; LOVELL RD, 1995, SOIL BIOL BIOCHEM, V27, P969, DOI 10.1016/0038-0717(94)00241-R; Mathew R. P., 2012, Applied and Environmental Soil Science, V2012, P548620; MOORE JC, 1991, AGR ECOSYST ENVIRON, V34, P371, DOI 10.1016/0167-8809(91)90122-E; Nelson D. W., 1996, Methods of soil analysis. Part 3 - chemical methods., P961; NICHOLS P, 1986, ARCH MICROBIOL, V146, P1, DOI 10.1007/BF00690149; OLSSON PA, 1995, MYCOL RES, V99, P623, DOI 10.1016/S0953-7562(09)80723-5; Pampulha ME, 2006, CURR MICROBIOL, V53, P238, DOI 10.1007/s00284-006-0116-4; Pankhurst CE, 2002, BIOL FERT SOILS, V35, P189, DOI 10.1007/s00374-002-0459-3; Perez-Piqueres A, 2006, SOIL BIOL BIOCHEM, V38, P460, DOI 10.1016/j.soilbio.2005.05.025; Rivas-Martinez S, 1987, MEMORIA MAPA SERIES; Roger-Estrade J, 2010, SOIL TILL RES, V111, P33, DOI 10.1016/j.still.2010.08.010; ROLDAN A, 1994, SOIL BIOL BIOCHEM, V26, P1699, DOI 10.1016/0038-0717(94)90323-9; Ruppel S, 2007, BIOL FERT SOILS, V43, P449, DOI 10.1007/s00374-006-0122-5; Smith JL, 2002, SOIL BIOL BIOCHEM, V34, P1749, DOI 10.1016/S0038-0717(02)00162-1; Soil Survey Staff, 2010, KEYS SOIL TAXONOMY, P106; Soupir ML, 2006, WATER AIR SOIL POLL, V169, P125, DOI 10.1007/s11270-006-1808-x; ter Braak C.J.F., 1987, P91; van der Wal A, 2006, SOIL BIOL BIOCHEM, V38, P51, DOI 10.1016/j.soilbio.2005.04.017; VANCE ED, 1987, SOIL BIOL BIOCHEM, V19, P703, DOI 10.1016/0038-0717(87)90052-6; Young IM, 2004, SCIENCE, V304, P1634, DOI 10.1126/science.1097394; Zeller V, 2001, SOIL BIOL BIOCHEM, V33, P639, DOI 10.1016/S0038-0717(00)00208-X; ZELLES L, 1994, SOIL BIOL BIOCHEM, V26, P439, DOI 10.1016/0038-0717(94)90175-9; Zelles L, 1997, CHEMOSPHERE, V35, P275, DOI 10.1016/S0045-6535(97)00155-0; Zelles L, 1999, BIOL FERT SOILS, V29, P111, DOI 10.1007/s003740050533; Zornoza R, 2007, GEODERMA, V142, P334, DOI 10.1016/j.geoderma.2007.09.002; Zornoza R, 2009, APPL SOIL ECOL, V42, P315, DOI 10.1016/j.apsoil.2009.05.011	65	136	144	1	135	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80522	10.1371/journal.pone.0080522	http://dx.doi.org/10.1371/journal.pone.0080522			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260409	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500148
J	Kondoh, M; Ohga, N; Akiyama, K; Hida, Y; Maishi, N; Towfik, AM; Inoue, N; Shindoh, M; Hida, K				Kondoh, Miyako; Ohga, Noritaka; Akiyama, Kosuke; Hida, Yasuhiro; Maishi, Nako; Towfik, Alam Mohammad; Inoue, Nobuo; Shindoh, Masanobu; Hida, Kyoko			Hypoxia-Induced Reactive Oxygen Species Cause Chromosomal Abnormalities in Endothelial Cells in the Tumor Microenvironment	PLOS ONE			English	Article							INDUCED GENETIC INSTABILITY; ANGIOGENIC FACTOR; OXIDATIVE STRESS; BLOOD-VESSELS; MESSENGER-RNA; UP-REGULATION; DNA-DAMAGE; IN-VIVO; EXPRESSION; MECHANISM	There is much evidence that hypoxia in the tumor microenvironment enhances tumor progression. In an earlier study, we reported abnormal phenotypes of tumor-associated endothelial cells such as those resistant to chemotherapy and chromosomal instability. Here we investigated the role of hypoxia in the acquisition of chromosomal abnormalities in endothelial cells. Tumor-associated endothelial cells isolated from human tumor xenografts showed chromosomal abnormalities, > 30% of which were aneuploidy. Aneuploidy of the tumor-associated endothelial cells was also shown by simultaneous in-situ hybridization for chromosome 17 and by immunohistochemistry with anti-CD31 antibody for endothelial staining. The aneuploid cells were surrounded by a pimonidazole-positive area, indicating hypoxia. Human microvascular endothelial cells expressed hypoxia-inducible factor 1 and vascular endothelial growth factor A in response to either hypoxia or hypoxia-reoxygenation, and in these conditions, they acquired aneuploidy in 7 days. Induction of aneuploidy was inhibited by either inhibition of vascular endothelial growth factor signaling with vascular endothelial growth factor receptor 2 inhibitor or by inhibition of reactive oxygen species by N-acetyl-L-cysteine. These results indicate that hypoxia induces chromosomal abnormalities in endothelial cells through the induction of reactive oxygen species and excess signaling of vascular endothelial growth factor in the tumor microenvironment.	[Kondoh, Miyako; Ohga, Noritaka; Akiyama, Kosuke; Maishi, Nako; Towfik, Alam Mohammad; Hida, Kyoko] Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan; [Shindoh, Masanobu] Hokkaido Univ, Dept Oral Pathol & Biol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Inoue, Nobuo] Hokkaido Univ, Dept Gerodontol, Grad Sch Dent Med, Sapporo, Hokkaido, Japan; [Hida, Yasuhiro] Hokkaido Univ, Dept CardioVasc & Thorac Surg, Grad Sch Dent Med, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University; Hokkaido University; Hokkaido University	Hida, K (corresponding author), Hokkaido Univ, Grad Sch Dent Med, Dept Vasc Biol, Sapporo, Hokkaido, Japan.	khida@den.hokudai.ac.jp	Hida, Kyoko/A-8444-2012; Shindoh, Masanobu/A-4799-2012; Maishi, Nako/A-8403-2012; Hida, Yasuhiro/A-7761-2012; Hida, Kyoko/AAE-3183-2020	Shindoh, Masanobu/0000-0002-7782-5823; Hida, Yasuhiro/0000-0003-1759-4215; Hida, Kyoko/0000-0002-7968-6062	Ministry of Education, Science and Culture of Japan [23112501, 21659458]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This article was supported in part by a grant-in-aid for scientific research from the Ministry of Education, Science and Culture of Japan (23112501 and 21659458 to KH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abid MR, 2000, FEBS LETT, V486, P252, DOI 10.1016/S0014-5793(00)02305-X; Akino T, 2009, AM J PATHOL, V175, P2657, DOI 10.2353/ajpath.2009.090202; Akiyama K, 2012, AM J PATHOL, V180, P1283, DOI 10.1016/j.ajpath.2011.11.029; Blouw B, 2003, CANCER CELL, V4, P133, DOI 10.1016/S1535-6108(03)00194-6; Bos R, 2001, JNCI-J NATL CANCER I, V93, P309, DOI 10.1093/jnci/93.4.309; Brahimi-Horn MC, 2009, J CELL SCI, V122, P1055, DOI 10.1242/jcs.035022; BROWN JM, 1979, BRIT J RADIOL, V52, P650, DOI 10.1259/0007-1285-52-620-650; Bussolati B, 2006, J MOL MED-JMM, V84, P852, DOI 10.1007/s00109-006-0075-z; Colavitti R, 2002, J BIOL CHEM, V277, P3101, DOI 10.1074/jbc.M107711200; Corn PG, 2007, CANCER BIOL THER, V6, P1858, DOI 10.4161/cbt.6.12.5330; Ebos JML, 2009, CANCER CELL, V15, P232, DOI 10.1016/j.ccr.2009.01.021; El-Remessy AB, 2007, FASEB J, V21, P2528, DOI 10.1096/fj.06-7854com; Enholm B, 1997, ONCOGENE, V14, P2475, DOI 10.1038/sj.onc.1201090; FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182; Forsythe JA, 1996, MOL CELL BIOL, V16, P4604; Giatromanolaki A, 2001, BRIT J CANCER, V85, P881, DOI 10.1054/bjoc.2001.2018; GUYTON KZ, 1993, BRIT MED BULL, V49, P523, DOI 10.1093/oxfordjournals.bmb.a072628; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Hida K, 2004, CANCER RES, V64, P8249, DOI 10.1158/0008-5472.CAN-04-1567; Hida K, 2013, J BIOCH IN PRESS; Hida K, 2008, CANCER SCI, V99, P459, DOI 10.1111/j.1349-7006.2007.00704.x; Hida K, 2011, PATHOL INT, V61, P630, DOI 10.1111/j.1440-1827.2011.02726.x; Huang LE, 2007, J MOL MED, V85, P139, DOI 10.1007/s00109-006-0133-6; Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097; Kawamoto T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034045; Kimura H, 1996, CANCER RES, V56, P5522; Klaunig JE, 1998, ENVIRON HEALTH PERSP, V106, P289, DOI 10.2307/3433929; KOZLOWSKI JM, 1984, J NATL CANCER I, V72, P913; Kuroki M, 1996, J CLIN INVEST, V98, P1667, DOI 10.1172/JCI118962; Kurosu T, 2011, BRIT J CANCER, V104, P819, DOI 10.1038/bjc.2011.20; Lee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028454; LIU YX, 1995, CIRC RES, V77, P638, DOI 10.1161/01.RES.77.3.638; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lluis JM, 2007, CANCER RES, V67, P7368, DOI 10.1158/0008-5472.CAN-07-0515; Maishi N, 2012, PATHOL INT, V62, P309, DOI 10.1111/j.1440-1827.2012.02792.x; Matsuda K, 2010, BIOCHEM BIOPH RES CO, V394, P947, DOI 10.1016/j.bbrc.2010.03.089; McDonald DM, 2000, CANCER METAST REV, V19, P109, DOI 10.1023/A:1026529222845; Moeller BJ, 2004, CANCER CELL, V5, P429, DOI 10.1016/S1535-6108(04)00115-1; Morikawa S, 2002, AM J PATHOL, V160, P985, DOI 10.1016/S0002-9440(10)64920-6; Muraki C, 2012, INT J CANCER, V130, P59, DOI 10.1002/ijc.25976; Negoro S, 2001, CIRCULATION, V104, P979, DOI 10.1161/hc3401.095947; Ohga N, 2012, AM J PATHOL, V180, P1294, DOI 10.1016/j.ajpath.2011.11.035; Ohga N, 2009, CANCER SCI, V100, P1963, DOI 10.1111/j.1349-7006.2009.01255.x; OHYASHIKI K, 1987, CANCER RES, V47, P3842; Osawa T, 2012, CANCER SCI, V103, P1038, DOI 10.1111/j.1349-7006.2012.02261.x; Taylor SM, 2010, BLOOD, V116, P3108, DOI 10.1182/blood-2010-01-266197; Vafa O, 2002, MOL CELL, V9, P1031, DOI 10.1016/S1097-2765(02)00520-8; Yamamoto K, 2012, BRIT J CANCER, V106, P1214, DOI 10.1038/bjc.2012.59	48	65	69	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80349	10.1371/journal.pone.0080349	http://dx.doi.org/10.1371/journal.pone.0080349			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260373	Green Published, gold			2022-12-25	WOS:000327258600059
J	Kung, N; McLaughlin, A; Taylor, M; Moloney, B; Wright, T; Field, H				Kung, Nina; McLaughlin, Amanda; Taylor, Melanie; Moloney, Barbara; Wright, Therese; Field, Hume			Hendra Virus and Horse Owners - Risk Perception and Management	PLOS ONE			English	Article							PTEROPID BATS; MORBILLIVIRUS; HENIPAVIRUSES; TRANSMISSION; INFECTION; RESERVOIR	Hendra virus is a highly pathogenic novel paramyxovirus causing sporadic fatal infection in horses and humans in Australia. Species of fruit-bats (genus Pteropus), commonly known as flying-foxes, are the natural host of the virus. We undertook a survey of horse owners in the states of Queensland and New South Wales, Australia to assess the level of adoption of recommended risk management strategies and to identify impediments to adoption. Survey questionnaires were completed by 1431 respondents from the target states, and from a spectrum of industry sectors. Hendra virus knowledge varied with sector, but was generally limited, with only 13% of respondents rating their level of knowledge as high or very high. The majority of respondents (63%) had seen their state's Hendra virus information for horse owners, and a similar proportion found the information useful. Fifty-six percent of respondents thought it moderately, very or extremely likely that a Hendra virus case could occur in their area, yet only 37% said they would consider Hendra virus if their horse was sick. Only 13% of respondents stabled their horses overnight, although another 24% said it would be easy or very easy to do so, but hadn't done so. Only 13% and 15% of respondents respectively had horse feed bins and water points under solid cover. Responses varied significantly with state, likely reflecting different Hendra virus history. The survey identified inconsistent awareness and/or adoption of available knowledge, confusion in relation to Hendra virus risk perception, with both over-and under-estimation of true risk, and lag in the uptake of recommended risk minimisation strategies, even when these were readily implementable. However, we also identified frustration and potential alienation by horse owners who found the recommended strategies impractical, onerous and prohibitively expensive. The insights gained from this survey have broader application to other complex risk-management scenarios.	[Kung, Nina; McLaughlin, Amanda; Field, Hume] Biosecur Queensland, Queensland Ctr Emerging Infect Dis, Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia; [Taylor, Melanie] Univ Western Sydney, Sch Med, Ctr Hlth Res, Sydney, NSW, Australia; [Moloney, Barbara; Wright, Therese] Biosecur New South Wales, Dept Primary Ind, Orange, NSW, Australia; [Field, Hume] EcoHlth Alliance, New York, NY USA; [Kung, Nina] Biosecur Queensland, Anim Biosecur & Welf Program, Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia	Queensland Department of Agriculture & Fisheries; Western Sydney University; NSW Department of Primary Industries; EcoHealth Alliance; Queensland Department of Agriculture & Fisheries	Kung, N (corresponding author), Biosecur Queensland, Queensland Ctr Emerging Infect Dis, Dept Agr Fisheries & Forestry, Brisbane, Qld, Australia.	nina.kung@daff.qld.gov.au	Kung, Nina Y/H-1260-2012; Moloney, Barbara Jean/G-2003-2011; Taylor, Melanie R/H-5248-2017	Moloney, Barbara Jean/0000-0002-4416-3579; Taylor, Melanie R/0000-0002-8862-9510	Queensland State Government through the Queensland Centre for Emerging Infectious Diseases	Queensland State Government through the Queensland Centre for Emerging Infectious Diseases	Financial support was provided by the Queensland State Government through the Queensland Centre for Emerging Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, HENDRA VIRUS RES UPD; [Anonymous], 2013, HENDR VIR; [Anonymous], 2013, HENDR VIR INC SUMM; [Anonymous], 2013, GUID VET HANDL POT H; [Anonymous], 2013, HENDR VIR INF QUEENS; Balzer M, 2011, AUST VET J, V89, pN2; Biosecurity Queensland, 2013, HENDR VIR INF HORS O; Field H, 2001, MICROBES INFECT, V3, P307, DOI 10.1016/S1286-4579(01)01384-3; Field H, 2011, CURR OPIN VIROL, V1, P658, DOI 10.1016/j.coviro.2011.10.025; Field H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028678; Field H, 2011, ECOHEALTH, V7, pS143; Field H, 2010, EMERG INFECT DIS, V16, P338, DOI 10.3201/eid1602.090780; Fogarty R, 2008, VIRUS RES, V132, P140, DOI 10.1016/j.virusres.2007.11.010; Hall L.S., 2000, FLYING FOXES FRUIT B; Halpin K, 2000, J GEN VIROL, V81, P1927, DOI 10.1099/0022-1317-81-8-1927; Halpin K, 2011, AM J TROP MED HYG, V85, P946, DOI 10.4269/ajtmh.2011.10-0567; Hanna JN, 2006, MED J AUSTRALIA, V185, P562, DOI 10.5694/j.1326-5377.2006.tb00692.x; MURRAY K, 1995, EMERG INFECT DIS, V1, P31, DOI 10.3201/eid0101.950107; Murray PK, 1996, AUST VET J, V74, P214, DOI 10.1111/j.1751-0813.1996.tb15406.x; Playford EG, 2010, EMERG INFECT DIS, V16, P219, DOI 10.3201/eid1602.090552; SELVEY LA, 1995, MED J AUSTRALIA, V162, P642, DOI 10.5694/j.1326-5377.1995.tb126050.x; Williamson MM, 1998, AUST VET J, V76, P813, DOI 10.1111/j.1751-0813.1998.tb12335.x; Williamson MM, 2000, J COMP PATHOL, V122, P201, DOI 10.1053/jcpa.1999.0364	23	26	26	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80897	10.1371/journal.pone.0080897	http://dx.doi.org/10.1371/journal.pone.0080897			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260503	Green Submitted, Green Published, Green Accepted, gold			2022-12-25	WOS:000327258600093
J	Xu, L; Yu, Z; Fan, W; Wang, XP; Xie, MS; Xu, YT; Hu, LH; Li, YR				Xu, Lei; Yu, Zhen; Fan, Wen; Wang, Xueping; Xie, Mingshui; Xu, Yiting; Hu, Lihua; Li, Yirong			Negative Interference in Serum HBsAg ELISA from Rheumatoid Factors	PLOS ONE			English	Article							CARDIAC TROPONIN-I; SURFACE-ANTIGEN; HEPATITIS-B; ARTHRITIS; IMMUNOASSAYS; QUANTIFICATION	Background: RF(Rheumatoid factor) is usually thought to cause positive interference in immunoassay. Recently, our study showed that high-concentration RFs caused negative interference as well as positive interference in serum HBsAg(Hepatitis B surface antigen) ELISA(Enzyme-linked immunosorbent assay), but it is unclear that RF causing negative interference is an anomaly produced by a certain ELISA kit or a common property of most of HBsAg ELISA kits. Methods: Serum models were made by blending HBsAg-positive sera and high-or moderate-concentration RFs sera at the ratio of 1:9, then one-step and two-step ELISA were adopted to determine HBsAg in serum models. Results: No matter what kind of kit used, one-step ELISA showed that HBsAg S/CO(sample/cut off) values in serum models were significantly lower than original values. Bivariate correlations tests showed decline rates of HBsAg S/CO Values were not associated to serum RF concentrations ranging from 288 to 3560 IU/mL. HBsAg converted to be negative in 69.80% serum models with original-value ranging from 1.00 to 10.00, and in 2.68% serum models with higher original-value. RF causing decline of HBsAg S/CO value provided by one-step ELISA was more obvious than that provided by two-step ELISA. Conclusions: It is concluded that susceptibility of all HBsAg ELISA assays to interference from RF, leading to predominantly lower and in some cases "false-negative" results, and moreover, the lower the original HBsAg S/CO Value, the higher the false-negative rate.	[Xu, Lei; Wang, Xueping; Hu, Lihua; Li, Yirong] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Peoples R China; [Yu, Zhen; Xu, Yiting] Huazhong Univ Sci & Technol, Tongji Med Coll, Dept Lab Med, Wuhan 430074, Peoples R China; [Fan, Wen; Li, Yirong] Jingzhou First Peoples Hosp, Dept Lab Med, Jinzhou, Peoples R China; [Xie, Mingshui] Suizhou Cent Hosp, Dept Lab Med, Suizhou, Peoples R China	Huazhong University of Science & Technology; Huazhong University of Science & Technology	Hu, LH (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Lab Med, Wuhan 430074, Peoples R China.	xhhlh@126.com; liyirong838@163.com			National Natural Science Foundation of China [30970060]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by grants 30970060 from the National Natural Science Foundation of China. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartels EM, 2013, METHODS, V61, P18, DOI 10.1016/j.ymeth.2012.12.015; Berth M, 2006, CLIN CHEM LAB MED, V44, P1137, DOI 10.1515/CCLM.2006.205; BOSCATO LM, 1986, CLIN CHEM, V32, P1491; Chan HLY, 2011, J HEPATOL, V55, P1121, DOI 10.1016/j.jhep.2011.06.006; Churchman SM, 2012, CLIN EXP RHEUMATOL, V30, P534; Fleming SM, 2002, AM J CARDIOL, V89, P1212, DOI 10.1016/S0002-9149(02)02309-3; Ismail AA, 2013, ANN CLIN BIOCHEM, V48, P65; Janssen HLA, 2012, GUT, V61, P641, DOI 10.1136/gutjnl-2011-301096; Kenny PR, 2005, J RHEUMATOL, V32, P1258; Krahn J, 1999, CLIN BIOCHEM, V32, P477, DOI 10.1016/S0009-9120(99)00044-2; Mewar D, 2006, BIOMED PHARMACOTHER, V60, P648, DOI 10.1016/j.biopha.2006.09.002; MOORE TL, 1993, CLIN BIOCHEM, V26, P75, DOI 10.1016/0009-9120(93)90032-2; Norden AGW, 1997, CLIN CHEM, V43, P957; Onuska KD, 2000, CLIN CHEM, V46, P307; Tsavaris N, 2007, ANN RHEUM DIS, V66, P980, DOI 10.1136/ard.2007.070052; Xu L, 2013, CLIN BIOCHEM, V46, P799, DOI 10.1016/j.clinbiochem.2013.03.013	16	7	7	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80620	10.1371/journal.pone.0080620	http://dx.doi.org/10.1371/journal.pone.0080620			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260439	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600075
J	Yin, J; Zhu, DH; Zhang, ZP; Wang, W; Fan, JY; Men, D; Deng, JY; Wei, HP; Zhang, XE; Cui, ZQ				Yin, Juan; Zhu, Duanhao; Zhang, Zhiping; Wang, Wei; Fan, Jinyu; Men, Dong; Deng, Jiaoyu; Wei, Hongping; Zhang, Xian-En; Cui, Zongqiang			Imaging of mRNA-Protein Interactions in Live Cells Using Novel mCherry Trimolecular Fluorescence Complementation Systems	PLOS ONE			English	Article							INFLUENZA-VIRUS; NUCLEAR EXPORT; HUMAN INFECTION; IDENTIFICATION; VISUALIZATION; TRANSPORT; ORIGIN	Live cell imaging of mRNA-protein interactions makes it possible to study posttranscriptional processes of cellular and viral gene expression under physiological conditions. In this study, red color mCherry-based trimolecular fluorescence complementation (TriFC) systems were constructed as new tools for visualizing mRNA-protein interaction in living cells using split mCherry fragments and HIV REV-RRE and TAT-TAR peptide-RNA interaction pairs. The new mCherry TriFC systems were successfully used to image RNA-protein interactions such as that between influenza viral protein NS1 and the 5' UTR of influenza viral mRNAs NS, M, and NP. Upon combination of an mCherry TriFC system with a Venus TriFC system, multiple mRNA-protein interactions could be detected simultaneously in the same cells. Then, the new mCherry TriFC system was used for imaging of interactions between influenza A virus mRNAs and some of adapter proteins in cellular TAP nuclear export pathway in live cells. Adapter proteins Aly and UAP56 were found to associate with three kinds of viral mRNAs. Another adapter protein, splicing factor 9G8, only interacted with intron-containing spliced M2 mRNA. Co-immunoprecipitation assays with influenza A virus-infected cells confirmed these interactions. This study provides long-wavelength-spectrum TriFC systems as new tools for visualizing RNA-protein interactions in live cells and help to understand the nuclear export mechanism of influenza A viral mRNAs.	[Yin, Juan; Zhu, Duanhao; Zhang, Zhiping; Wang, Wei; Fan, Jinyu; Men, Dong; Deng, Jiaoyu; Wei, Hongping; Zhang, Xian-En; Cui, Zongqiang] Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China; [Yin, Juan; Zhu, Duanhao] Chinese Acad Sci, Grad Univ, Beijing, Peoples R China	Chinese Academy of Sciences; Wuhan Institute of Virology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Zhang, XE (corresponding author), Chinese Acad Sci, Wuhan Inst Virol, State Key Lab Virol, Wuhan, Peoples R China.	x.zhang@wh.iov.cn; czq@wh.iov.cn	ZHANG, Xian-En/AAJ-5579-2021		National Nano Project [2011CB933600]; National Natural Science Foundation of China [31070774]; Chinese Academy of Sciences [KSCX2-EW-Q-15]	National Nano Project; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences)	ZC is supported by the National Nano Project (no. 2011CB933600) and the National Natural Science Foundation of China (no. 31070774). The authors are also grateful for support from the Chinese Academy of Sciences (no. KSCX2-EW-Q-15). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bao G, 2009, ANNU REV BIOMED ENG, V11, P25, DOI 10.1146/annurev-bioeng-061008-124920; Bertrand E, 1998, MOL CELL, V2, P437, DOI 10.1016/S1097-2765(00)80143-4; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Chen IHB, 2002, J VIROL, V76, P12877, DOI 10.1128/JVI.76.24.12877-12889.2002; Chen ZY, 2000, TRENDS MICROBIOL, V8, P376, DOI 10.1016/S0966-842X(00)01794-7; Cui ZQ, 2005, NUCLEIC ACIDS RES, V33, P3245, DOI 10.1093/nar/gki629; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Fan JY, 2008, BIOCHEM BIOPH RES CO, V367, P47, DOI 10.1016/j.bbrc.2007.12.101; Frankel AD, 1992, CURR OPIN GENET DEV, V2, P293, DOI 10.1016/S0959-437X(05)80287-4; Gao RB, 2013, NEW ENGL J MED, V368, P1888, DOI 10.1056/NEJMoa1304459; Harada K, 1996, NATURE, V380, P175, DOI 10.1038/380175a0; Hocine S, 2013, NAT METHODS, V10, P119, DOI 10.1038/nmeth.2305; Huang YQ, 2003, MOL CELL, V11, P837, DOI 10.1016/S1097-2765(03)00089-3; Huang YQ, 2001, MOL CELL, V7, P899, DOI 10.1016/S1097-2765(01)00233-7; Huranova M, 2009, RNA, V15, P2063, DOI 10.1261/rna.1678209; KRUG RM, 1989, INFLUENZA VIRUSES, P89; Liu D, 2013, LANCET, V381, P1926, DOI 10.1016/S0140-6736(13)60938-1; Lorenz M, 2009, RNA, V15, P97, DOI 10.1261/rna.1307809; Luo MJ, 2001, NATURE, V413, P644, DOI 10.1038/35098106; MALIM MH, 1989, NATURE, V338, P254, DOI 10.1038/338254a0; Mayer D, 2007, J PROTEOME RES, V6, P672, DOI 10.1021/pr060432u; Milev MP, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-41; Momose F, 2001, J VIROL, V75, P1899, DOI 10.1128/JVI.75.4.1899-1908.2001; Nakielny S, 1999, CELL, V99, P677, DOI 10.1016/S0092-8674(00)81666-9; PARK YW, 1995, J BIOL CHEM, V270, P28433; Peritz T, 2006, NAT PROTOC, V1, P577, DOI 10.1038/nprot.2006.82; Rackham O, 2004, EMBO J, V23, P3346, DOI 10.1038/sj.emboj.7600341; Read EKC, 2010, J GEN VIROL, V91, P1290, DOI 10.1099/vir.0.018564-0; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Schneider J, 2009, VACCINE, V27, P6312, DOI 10.1016/j.vaccine.2009.01.015; Shyu YJ, 2008, TRENDS BIOTECHNOL, V26, P622, DOI 10.1016/j.tibtech.2008.07.006; Stewart M, 2001, FEBS LETT, V498, P145, DOI 10.1016/S0014-5793(01)02489-9; Taura T, 2005, MOL B INT U, P161; Wang W, 2008, NUCLEIC ACIDS RES, V36, P4913, DOI 10.1093/nar/gkn475; Yiu HW, 2011, PHARMACEUTICALS, V4, P494, DOI 10.3390/ph4030494; Zhou ZL, 2000, NATURE, V407, P401, DOI 10.1038/35030160	36	14	15	1	43	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80851	10.1371/journal.pone.0080851	http://dx.doi.org/10.1371/journal.pone.0080851			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260494	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600089
J	Alex, A; Silva, V; Vasconcelos, V; Antunes, A				Alex, Anoop; Silva, Vitor; Vasconcelos, Vitor; Antunes, Agostinho			Evidence of Unique and Generalist Microbes in Distantly Related Sympatric Intertidal Marine Sponges (Porifera: Demospongiae)	PLOS ONE			English	Article							16S RIBOSOMAL-RNA; PHYLOGENETIC DIVERSITY; HYMENIACIDON-PERLEVE; BACTERIAL COMMUNITY; ASSOCIATION; ACTINOBACTERIA; CYANOBACTERIA; TRANSMISSION; VARIABILITY; SYMBIONTS	The diversity and specificity of microbial communities in marine environments is a key aspect of the ecology and evolution of both the eukaryotic hosts and their associated prokaryotes. Marine sponges harbor phylogenetically diverse and complex microbial lineages. Here, we investigated the sponge bacterial community and distribution patterns of microbes in three sympatric intertidal marine demosponges, Hymeniacidon perlevis, Ophlitaspongia papilla and Polymastia penicillus, from the Atlantic coast of Portugal using classical isolation techniques and 16S rRNA gene clone libraries. Microbial composition assessment, with nearly full-length 16S rRNA gene sequences (ca. 1400 bp) from the isolates (n = 31) and partial sequences (ca. 280 bp) from clone libraries (n = 349), revealed diverse bacterial communities and other sponge-associated microbes. The majority of the bacterial isolates were members of the order Vibrionales and other symbiotic bacteria like Pseudovibrio ascidiaceiocola, Roseobacter sp., Hahellaceae sp. and Cobetia sp. Extended analyses using ecological metrics comprising 142 OTUs supported the clear differentiation of bacterial community profiles among the sponge hosts and their ambient seawater. Phylogenetic analyses were insightful in defining clades representing shared bacterial communities, particularly between H. perlevis and the geographically distantly-related H. heliophila, but also among other sponges. Furthermore, we also observed three distinct and unique bacterial groups, Betaproteobactria (similar to 81%), Spirochaetes (similar to 7%) and Chloroflexi (similar to 3%), which are strictly maintained in low-microbial-abundance host species O. papilla and P. penicillus. Our study revealed the largely generalist nature of microbial associations among these co-occurring intertidal marine sponges.	[Alex, Anoop; Silva, Vitor; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, P-4100 Oporto, Portugal; [Alex, Anoop; Vasconcelos, Vitor; Antunes, Agostinho] Univ Porto, Fac Ciencias, Dept Biol, P-4100 Oporto, Portugal	Universidade do Porto; Universidade do Porto	Antunes, A (corresponding author), Univ Porto, Ctr Interdisciplinar Invest Marinha & Ambiental, CIMAR CIIMAR, Rua Campo Alegre 823, P-4100 Oporto, Portugal.	aantunes@ciimar.up.pt	Vasconcelos, Vitor/A-8933-2008	Vasconcelos, Vitor/0000-0003-3585-2417; Antunes, Agostinho/0000-0002-1328-1732; Alex, Anoop/0000-0001-5788-1089	Fundacao para a Ciencia e a Tecnologia (FCT) [SFRH/BD/62356/2009]; European Regional Development Fund (ERDF) through FCT [PEst-C/MAR/LA0015/2013, PTDC/AAC-AMB/104983/2008, FCOMP-01-0124-FEDER-008610, PTDC/AAC-CLI/116122/2009, FCOMP-01-0124-FEDER-014029, PTDC/MAR/099642/2008]	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); European Regional Development Fund (ERDF) through FCT	Anoop Alex was supported by the PhD grant SFRH/BD/62356/2009 from Fundacao para a Ciencia e a Tecnologia (FCT). This work was partially supported by the European Regional Development Fund (ERDF) through the COMPETE - Operational Competitiveness Program and national funds through FCT under the projects PEst-C/MAR/LA0015/2013, PTDC/AAC-AMB/104983/2008 (FCOMP-01-0124-FEDER-008610), PTDC/AAC-CLI/116122/2009 (FCOMP-01-0124-FEDER-014029), and PTDC/MAR/099642/2008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051834; Anderson SA, 2010, FEMS MICROBIOL ECOL, V72, P328, DOI 10.1111/j.1574-6941.2010.00869.x; Ashelford KE, 2006, APPL ENVIRON MICROB, V72, P5734, DOI 10.1128/AEM.00556-06; Baker GC, 2003, J MICROBIOL METH, V55, P541, DOI 10.1016/j.mimet.2003.08.009; Bayer K, 2008, ENVIRON MICROBIOL, V10, P2942, DOI 10.1111/j.1462-2920.2008.01582.x; Bondarev V, 2013, ENVIRON MICROBIOL, V15, P2095, DOI 10.1111/1462-2920.12123; Cabioch L, 1968, CAHIERS BIOL MARINE; Carballeira NM, 2009, CHEM PHYS LIPIDS, V161, P38, DOI 10.1016/j.chemphyslip.2009.06.140; Cole JR, 2009, NUCLEIC ACIDS RES, V37, pD141, DOI 10.1093/nar/gkn879; DeSantis TZ, 2006, NUCLEIC ACIDS RES, V34, pW394, DOI 10.1093/nar/gkl244; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Diaz MC, 1997, MAR ECOL PROG SER, V156, P97, DOI 10.3354/meps156097; Enticknap JJ, 2006, APPL ENVIRON MICROB, V72, P3724, DOI 10.1128/AEM.72.5.3724-3732.2006; Erwin PM, 2012, FEMS MICROBIOL ECOL, V79, P619, DOI 10.1111/j.1574-6941.2011.01243.x; Erwin PM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026806; EXCOFFIER L, 1992, GENETICS, V131, P479; Falgueras J, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-38; Ferreira M, 2011, ENVIRON TOXICOL PHAR, V32, P430, DOI 10.1016/j.etap.2011.08.012; Fukunaga Y, 2006, INT J SYST EVOL MICR, V56, P343, DOI 10.1099/ijs.0.63879-0; Garson MJ, 1998, CELL TISSUE RES, V293, P365, DOI 10.1007/s004410051128; Giles EC, 2013, FEMS MICROBIOL ECOL, V83, P232, DOI 10.1111/j.1574-6941.2012.01467.x; Gomez-Gil B, 2000, AQUACULTURE, V191, P259, DOI 10.1016/S0044-8486(00)00431-2; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Hamady M, 2010, ISME J, V4, P17, DOI 10.1038/ismej.2009.97; Hedlund BP, 2006, ENVIRON MICROBIOL, V8, P178, DOI 10.1111/j.1462-2920.2005.00871.x; Hentschel U, 2003, MAR MOL BIOTECHNOL, P59; Hentschel U, 2002, APPL ENVIRON MICROB, V68, P4431, DOI 10.1128/AEM.68.9.4431-4440.2002; Hill M, 2006, MAR BIOL, V148, P1221, DOI 10.1007/s00227-005-0164-5; Hoffmann F, 2005, GEOMICROBIOL J, V22, P1, DOI 10.1080/01490450590922505; Hoffmann F, 2009, ENVIRON MICROBIOL, V11, P2228, DOI 10.1111/j.1462-2920.2009.01944.x; Hoffmann M, 2013, CLADISTICS, V29, P46, DOI 10.1111/j.1096-0031.2012.00416.x; Howson CM, 1999, J MAR BIOL ASSOC UK, V79, P609, DOI 10.1017/S0025315498000770; Lafi FF, 2009, APPL ENVIRON MICROB, V75, P5695, DOI 10.1128/AEM.00035-09; Lafi FF, 2005, MICROB ECOL, V50, P213, DOI 10.1007/s00248-004-0202-8; Lee EY, 2003, BIOMOL ENG, V20, P299, DOI 10.1016/S1389-0344(03)00034-0; Lee OO, 2011, ISME J, V5, P650, DOI 10.1038/ismej.2010.165; Lemloh Marie-Louise, 2009, BMC Ecology, V9, P4, DOI 10.1186/1472-6785-9-4; Maldonado M, 2005, BIOL BULL-US, V209, P94, DOI 10.2307/3593127; Margassery LM, 2012, LETT APPL MICROBIOL, V55, P2, DOI 10.1111/j.1472-765X.2012.03256.x; Martin AP, 2002, APPL ENVIRON MICROB, V68, P3673, DOI 10.1128/AEM.68.8.3673-3682.2002; Meyer B, 2008, MICROB ECOL, V56, P306, DOI 10.1007/s00248-007-9348-5; Meyer CP, 2005, EVOLUTION, V59, P113, DOI 10.1111/j.0014-3820.2005.tb00899.x; Montalvo NF, 2011, APPL ENVIRON MICROB, V77, P7207, DOI 10.1128/AEM.05285-11; Muscholl-Silberhorn A, 2008, MICROB ECOL, V55, P94, DOI 10.1007/s00248-007-9255-9; Nylander J. A. A., 2004, MRAIC PL PROGRAM DIS; O' Halloran JA, 2011, J APPL MICROBIOL, V110, P1495, DOI 10.1111/j.1365-2672.2011.05008.x; Ondov BD, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-385; SANTAVY DL, 1990, APPL ENVIRON MICROB, V56, P1750, DOI 10.1128/AEM.56.6.1750-1762.1990; Santos OCS, 2010, RES MICROBIOL, V161, P604, DOI 10.1016/j.resmic.2010.05.013; Schloss PD, 2009, APPL ENVIRON MICROB, V75, P7537, DOI 10.1128/AEM.01541-09; Schmitt S, 2012, HYDROBIOLOGIA, V687, P341, DOI 10.1007/s10750-011-0799-9; SHIEH WY, 1994, B MAR SCI, V54, P557; Simister RL, 2012, ENVIRON MICROBIOL, V14, P517, DOI 10.1111/j.1462-2920.2011.02664.x; Singleton DR, 2001, APPL ENVIRON MICROB, V67, P4374, DOI 10.1128/AEM.67.9.4374-4376.2001; Stewart CN, 1996, J EVOLUTION BIOL, V9, P153, DOI 10.1046/j.1420-9101.1996.9020153.x; Taylor MW, 2013, ISME J, V7, P438, DOI 10.1038/ismej.2012.111; Taylor MW, 2004, ENVIRON MICROBIOL, V6, P121, DOI 10.1046/j.1462-2920.2003.00545.x; Thacker RW, 2005, INTEGR COMP BIOL, V45, P369, DOI 10.1093/icb/45.2.369; Thiel V, 2007, MICROB ECOL, V54, P101, DOI 10.1007/s00248-006-9177-y; Thomas TRA, 2010, MAR DRUGS, V8, P1417, DOI 10.3390/md8041417; Turner S, 1999, J EUKARYOT MICROBIOL, V46, P327, DOI 10.1111/j.1550-7408.1999.tb04612.x; Turque AS, 2008, MAR BIOL, V155, P135, DOI 10.1007/s00227-008-1008-x; Turque AS, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015774; Usher KM, 2007, ANNU REV ECOL EVOL S, V38, P255, DOI 10.1146/annurev.ecolsys.38.091206.095641; Usher KM, 2001, HYDROBIOLOGIA, V461, P15; Wang GY, 2009, ISME J, V3, P374, DOI 10.1038/ismej.2008.107; Webster NS, 2010, ENVIRON MICROBIOL, V12, P2070, DOI 10.1111/j.1462-2920.2009.02065.x; WILKINSON CR, 1983, SCIENCE, V219, P410, DOI 10.1126/science.219.4583.410; WILKINSON CR, 1979, NATURE, V279, P527, DOI 10.1038/279527a0; Xin YJ, 2008, ANTON LEEUW INT J G, V94, P533, DOI 10.1007/s10482-008-9270-y; Zan JD, 2011, ISME J, V5, P1505, DOI 10.1038/ismej.2011.31; Zhang HT, 2006, ANTON LEEUW INT J G, V90, P159, DOI 10.1007/s10482-006-9070-1	73	30	30	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80653	10.1371/journal.pone.0080653	http://dx.doi.org/10.1371/journal.pone.0080653			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265835	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100171
J	Canning, P; Rea, D; Morty, RE; Fulop, V				Canning, Peter; Rea, Dean; Morty, Rory E.; Fueloep, Vilmos			Crystal Structures of Trypanosoma brucei Oligopeptidase B Broaden the Paradigm of Catalytic Regulation in Prolyl Oligopeptidase Family Enzymes	PLOS ONE			English	Article							HUMAN AFRICAN TRYPANOSOMIASIS; MOLECULAR-DYNAMICS; ENDOPEPTIDASE INHIBITOR; MODEL; PEPTIDASE; AUTOINDUCTION; PURIFICATION; EXPRESSION; INTERFACE; MECHANISM	Oligopeptidase B cleaves after basic amino acids in peptides up to 30 residues. As a virulence factor in bacteria and trypanosomatid pathogens that is absent in higher eukaryotes, this is a promising drug target. Here we present ligand-free open state and inhibitor-bound closed state crystal structures of oligopeptidase B from Trypanosoma brucei, the causative agent of African sleeping sickness. These (and related) structures show the importance of structural dynamics, governed by a fine enthalpic and entropic balance, in substrate size selectivity and catalysis. Peptides over 30 residues cannot fit the enzyme cavity, preventing the complete domain closure required for a key propeller Asp/Glu to fix the catalytic His and Arg in the catalytically competent conformation. This size exclusion mechanism protects larger peptides and proteins from degradation. Similar bacterial prolyl endopeptidase and archael acylaminoacyl peptidase structures demonstrate this mechanism is conserved among oligopeptidase family enzymes across all three domains of life.	[Canning, Peter; Rea, Dean; Fueloep, Vilmos] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England; [Morty, Rory E.] Max Planck Inst Heart & Lung Res, Dept Lung Dev & Remodelling, Bad Nauheim, Germany	University of Warwick; Max Planck Society	Fulop, V (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	V.Fulop@warwick.ac.uk	Fulop, Vilmos/AAZ-7720-2021	Canning, Peter/0000-0001-9678-4169	BBSRC; EU [223077]	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission)	PC was supported by BBSRC. This work was supported by EU-FP7 HEALTH-Proposal No. 223077 (NEUROPRO) funding. Some equipment used in this research was obtained through the Birmingham-Warwick Science City Translational Medicine: Experimental Medicine Network of Excellence project, with support from Advantage West Midlands (AWM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson AC, 2003, CHEM BIOL, V10, P787, DOI 10.1016/j.chembiol.2003.09.002; ASHALL F, 1990, BIOCHIM BIOPHYS ACTA, V1035, P293, DOI 10.1016/0304-4165(90)90091-A; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bartlam M, 2004, STRUCTURE, V12, P1481, DOI 10.1016/j.str.2004.05.019; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Burleigh BA, 1997, J CELL BIOL, V136, P609, DOI 10.1083/jcb.136.3.609; Caler EV, 1998, EMBO J, V17, P4975, DOI 10.1093/emboj/17.17.4975; Coetzer THT, 2008, BIOCHIMIE, V90, P336, DOI 10.1016/j.biochi.2007.10.011; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Guedes HLD, 2008, ACTA PARASITOL, V53, P197, DOI 10.2478/s11686-008-0026-7; DeLano WL, 2002, PYMOL USERS MANUAL; Duarte JM, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-334; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Fairlamb AH, 2003, TRENDS PARASITOL, V19, P488, DOI 10.1016/j.pt.2003.09.002; Fulop V, 2000, EMBO REP, V1, P277, DOI 10.1093/embo-reports/kvd048; Fulop V, 1998, CELL, V94, P161, DOI 10.1016/S0092-8674(00)81416-6; Fuxreiter M, 2005, PROTEINS, V60, P504, DOI 10.1002/prot.20508; Garcia-Horsman JA, 2007, NEUROPEPTIDES, V41, P1, DOI 10.1016/j.npep.2006.10.004; Haffner CD, 2008, BIOORG MED CHEM LETT, V18, P4360, DOI 10.1016/j.bmcl.2008.06.067; Harmat V, 2011, J BIOL CHEM, V286, P1987, DOI 10.1074/jbc.M110.169862; Ismail NIM, 2010, J BIOCHEM, V147, P201, DOI 10.1093/jb/mvp156; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; KANATANI A, 1991, J BIOCHEM-TOKYO, V110, P315, DOI 10.1093/oxfordjournals.jbchem.a123577; Kangethe RT, 2012, MOL BIOCHEM PARASIT, V182, P7, DOI 10.1016/j.molbiopara.2011.11.007; Kaszuba K, 2009, SAR QSAR ENVIRON RES, V20, P595, DOI 10.1080/10629360903438198; Kaszuba K, 2012, BIOCHIMIE, V94, P1398, DOI 10.1016/j.biochi.2012.03.012; Kennedy PGE, 2008, ANN NEUROL, V64, P116, DOI 10.1002/ana.21429; Kichik N, 2011, CHEMBIOCHEM, V12, P2737, DOI 10.1002/cbic.201100614; Kioy D, 2004, NAT REV MICROBIOL, V2, P186, DOI 10.1038/nrmicro848; Krafsur ES, 2009, INFECT GENET EVOL, V9, P124, DOI 10.1016/j.meegid.2008.09.010; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lee RA, 2003, BIOINFORMATICS, V19, P1290, DOI 10.1093/bioinformatics/btg137; Li M, 2010, J BIOL CHEM, V285, P21487, DOI 10.1074/jbc.M109.092692; Mannisto PT, 2007, DRUG NEWS PERSPECT, V20, P293; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McLuskey K, 2010, J BIOL CHEM, V285, P39249, DOI 10.1074/jbc.M110.156679; Morain P, 2007, NEUROPSYCHOBIOLOGY, V55, P176, DOI 10.1159/000107070; Morty RE, 1999, J BIOL CHEM, V274, P26149, DOI 10.1074/jbc.274.37.26149; Morty RE, 1999, MOL BIOCHEM PARASIT, V102, P145, DOI 10.1016/S0166-6851(99)00097-3; Morty RE, 2000, BIOCHEM PHARMACOL, V60, P1497, DOI 10.1016/S0006-2952(00)00459-7; Morty RE, 2005, J BIOL CHEM, V280, P10925, DOI 10.1074/jbc.M410066200; Motta FN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030431; Munday JC, 2011, MOL BIOCHEM PARASIT, V175, P49, DOI 10.1016/j.molbiopara.2010.09.003; Murshudov GN, 2011, ACTA CRYSTALLOGR D, V67, P355, DOI 10.1107/S0907444911001314; PEPIN J, 1994, ADV PARASIT, V33, P1, DOI 10.1016/S0065-308X(08)60410-8; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Dias JCP, 2006, ANN INTERN MED, V144, P772, DOI 10.7326/0003-4819-144-10-200605160-00012; Polgar L, 1997, PROTEINS, V28, P375; Rasmussen HB, 2003, NAT STRUCT BIOL, V10, P19, DOI 10.1038/nsb882; Rea D, 2006, CELL BIOCHEM BIOPHYS, V44, P349, DOI 10.1385/CBB:44:3:349; Rea D, 2006, ACTA CRYSTALLOGR F, V62, P808, DOI 10.1107/S1744309106027874; Shan L, 2005, P NATL ACAD SCI USA, V102, P3599, DOI 10.1073/pnas.0408286102; Sreenath HK, 2005, PROTEIN EXPRES PURIF, V40, P256, DOI 10.1016/j.pep.2004.12.022; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Szeltner Z, 2004, J MOL BIOL, V340, P627, DOI 10.1016/j.jmb.2004.05.011; Szeltner Z, 2013, BBA-PROTEINS PROTEOM, V1834, P98, DOI 10.1016/j.bbapap.2012.08.012; Tarrago T, 2009, CHEMBIOCHEM, V10, P2736, DOI 10.1002/cbic.200900575; Terwilliger T, 2004, J SYNCHROTRON RADIAT, V11, P49, DOI 10.1107/S0909049503023938; Toide K, 1997, BEHAV BRAIN RES, V83, P147, DOI 10.1016/S0166-4328(97)86059-7; Van der Veken P, 2012, J MED CHEM, V55, P9856, DOI 10.1021/jm301060g	62	25	25	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79349	10.1371/journal.pone.0079349	http://dx.doi.org/10.1371/journal.pone.0079349			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265767	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100100
J	Sheykholeslami, K; Thimmappa, V; Nava, C; Bai, XH; Yu, HP; Zheng, TH; Zhang, ZQ; Li, SL; Liu, SQ; Zheng, QY				Sheykholeslami, Kianoush; Thimmappa, Vikrum; Nava, Casey; Bai, Xiaohui; Yu, Heping; Zheng, Tihua; Zhang, Zhaoqiang; Li, Sheng Li; Liu, Shuqing; Zheng, Qing Yin			A New Mutation of the Atoh1 Gene in Mice with Normal Life Span Allows Analysis of Inner Ear and Cerebellar Phenotype in Aging	PLOS ONE			English	Article							COCHLEAR HAIR-CELLS; IN-VIVO; USH1C GENE; MATH1; MOUSE; EXPRESSION; DIFFERENTIATION; NEURONS; REQUIREMENT; GENERATION	Atoh1 is a transcription factor that regulates neural development in multiple tissues and is conserved among species. Prior mouse models of Atoh1, though effective and important in the evolution of our understanding of the gene, have been limited by perinatal lethality. Here we describe a novel point mutation of Atoh1 (designated Atoh1(trhl)) underlying a phenotype of trembling gait and hearing loss. Histology revealed inner ear hair cell loss and cerebellar atrophy. Auditory Brainstem Response (ABR) and Distortion Product Otoacoustic Emission (DPOAE) showed functional abnormalities in the ear. Normal lifespan and fecundity of Atoh1(trhl) mice provide a complementary model to facilitate elucidation of ATOH1 function in hearing, central nervous system and cancer biology.	[Sheykholeslami, Kianoush; Thimmappa, Vikrum; Nava, Casey; Bai, Xiaohui; Yu, Heping; Zhang, Zhaoqiang; Li, Sheng Li; Zheng, Qing Yin] Case Western Reserve Univ, Dept Otolaryngol HNS, Cleveland, OH 44106 USA; [Zheng, Tihua; Zheng, Qing Yin] Binzhou Med Univ, Transformat Otol & Neurosci Ctr, Yantai, Shandong, Peoples R China; [Yu, Heping; Zheng, Qing Yin] Jackson Lab, Bar Harbor, ME 04609 USA; [Zheng, Tihua; Liu, Shuqing] Dalian Med Univ, Dept Biochem, Dalian, Peoples R China	Case Western Reserve University; Binzhou Medical University; Jackson Laboratory; Dalian Medical University	Zheng, QY (corresponding author), Case Western Reserve Univ, Dept Otolaryngol HNS, Cleveland, OH 44106 USA.	qing.zheng@case.edu	兆强, 张/GRJ-1212-2022; Sheykoleslami Kianoush, FACS/ABF-5857-2020; Zhang, Zhaoqiang/AAE-3664-2019	兆强, 张/0000-0002-9183-7273; Zhang, Zhaoqiang/0000-0002-9183-7273; Bai, Xiaohui/0000-0002-4027-7798	National Institutes of Health; National Institute on Deafness and Other Communication Disorders [R01DC009246, R21DC005846, R01DC007392]; Foundation of Taishan Scholar [tshw20110515, ZR2012HZ004]; National Natural Science Foundation of China [81271085]; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC009246, R01DC007392, R21DC005846] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Foundation of Taishan Scholar; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	This project was supported by the National Institutes of Health, National Institute on Deafness and Other Communication Disorders (R01DC009246, R21DC005846, R01DC009246 and R01DC007392), Foundation of Taishan Scholar (tshw20110515 and ZR2012HZ004) and National Natural Science Foundation of China (81271085). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BenArie N, 1997, NATURE, V390, P169, DOI 10.1038/36579; Bermingham NA, 1999, SCIENCE, V284, P1837, DOI 10.1126/science.284.5421.1837; Bermingham NA, 2001, NEURON, V30, P411, DOI 10.1016/S0896-6273(01)00305-1; Chellappa R, 2008, MOL CELL BIOL, V28, P1905, DOI 10.1128/MCB.01454-07; Flora A, 2009, SCIENCE, V326, P1424, DOI 10.1126/science.1181453; Han F, 2012, PHARMACOGENOMICS J, V12, P30, DOI 10.1038/tpj.2010.60; Johnson KR, 2003, HUM MOL GENET, V12, P3075, DOI 10.1093/hmg/ddg332; Kawamoto K, 2003, J NEUROSCI, V23, P4395; Kawauchi D, 2008, DEV BIOL, V322, P345, DOI 10.1016/j.ydbio.2008.08.005; Kim D, 2011, J NEUROSCI, V31, P2167, DOI 10.1523/JNEUROSCI.5254-10.2011; Klisch TJ, 2011, P NATL ACAD SCI USA, V108, P3288, DOI 10.1073/pnas.1100230108; Lai HC, 2011, J NEUROSCI, V31, P10859, DOI 10.1523/JNEUROSCI.0445-11.2011; Li SG, 2004, J NEUROSCI, V24, P3104, DOI 10.1523/JNEUROSCI.4444-03.2004; Li SG, 2002, DEVELOPMENT, V129, P3523; Lim JH, 2003, DEVELOPMENT, V130, P5965, DOI 10.1242/dev.00818; McEvilly RJ, 1996, NATURE, V384, P574, DOI 10.1038/384574a0; MURRE C, 1989, CELL, V56, P777, DOI 10.1016/0092-8674(89)90682-X; Pan N, 2011, HEARING RES, V275, P66, DOI 10.1016/j.heares.2010.12.002; Rose MF, 2009, NEURON, V64, P341, DOI 10.1016/j.neuron.2009.10.023; Saba R, 2005, DEVELOPMENT, V132, P2147, DOI 10.1242/dev.01781; Shou JY, 2003, MOL CELL NEUROSCI, V23, P169, DOI 10.1016/S1044-7431(03)00066-6; TAYLOR BA, 1994, GENOMICS, V21, P626, DOI 10.1006/geno.1994.1323; Thi VHP, 2012, ONCOL REP, V27, P2045, DOI 10.3892/or.2012.1731; Tian C, 2010, BRAIN RES, V1328, P57, DOI 10.1016/j.brainres.2010.02.079; Yang Q, 2001, SCIENCE, V294, P2155, DOI 10.1126/science.1065718; Zheng JL, 2000, NAT NEUROSCI, V3, P580, DOI 10.1038/75753; Zheng JL, 2000, DEVELOPMENT, V127, P4551; Zheng QY, 1999, HEARING RES, V130, P94, DOI 10.1016/S0378-5955(99)00003-9	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79791	10.1371/journal.pone.0079791	http://dx.doi.org/10.1371/journal.pone.0079791			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265785	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100118
J	Tachezy, R; Smahelova, J; Kaspirkova, J; Salakova, M				Tachezy, Ruth; Smahelova, Jana; Kaspirkova, Jana; Salakova, Martina			Human Papillomavirus Type-Specific Prevalence in the Cervical Cancer Screening Population of Czech Women	PLOS ONE			English	Article							HPV DNA; GLOBAL PROFICIENCY; METAANALYSIS; INFECTIONS; PREVENTION; ANTIBODIES; CYTOLOGY; SPECTRUM	Background: Infection with high-risk human papillomavirus (HPV) types has been recognized as a causal factor for the development of cervical cancer and a number of other malignancies. Today, vaccines against HPV, highly effective in the prevention of persistent infection and precancerous lesions, are available for the routine clinical practice. Objectives: The data on the prevalence and type-specific HPV distribution in the population of each country are crucial for the surveillance of HPV type-specific prevalence at the onset of vaccination against HPV. Methods: Women attending a preventive gynecological examination who had no history of abnormal cytological finding and/or surgery for cervical lesions were enrolled. All samples were tested for the presence of HPV by High-Risk Hybrid Capture 2 (HR HC2) and by a modified PCR-reverse line blot assay with broad spectrum primers (BS-RLB). Results: Cervical smears of 1393 women were analyzed. In 6.5% of women, atypical cytological findings were detected. Altogether, 28.3% (394/1393) of women were positive for any HPV type by BS-RLB, 18.2% (254/1393) by HR HC2, and 22.3% (310/1393) by BS-RLB for HR HPV types. In women with atypical findings the prevalence for HR and any HPV types were significantly higher than in women with normal cytological findings. Overall, 36 different HPV types were detected, with HPV 16 being the most prevalent (4.8%). HPV positivity decreased with age; the highest prevalence was 31.5% in the age group 21-25 years. Conclusions: Our study subjects represent the real screening population. HPV prevalence in this population in the Czech Republic is higher than in other countries of Eastern Europe. Also the spectrum of the most prevalent HPV types differs from those reported by others but HPV 16 is, concordantly, the most prevalent type. Country-specific HPV type-specific prevalences provide baseline information which will enable to measure the impact of HPV vaccination in the future.	[Tachezy, Ruth; Smahelova, Jana; Salakova, Martina] Inst Hematol & Blood Transfus, Dept Expt Virol, CR-12820 Prague, Czech Republic; [Kaspirkova, Jana] Biopt Lab, Plzen, Czech Republic	Institute of Hematology Prague	Tachezy, R (corresponding author), Inst Hematol & Blood Transfus, Dept Expt Virol, CR-12820 Prague, Czech Republic.	rutach@uhkt.cz	Tachezy, Ruth/H-3785-2017; Šmahelová, Jana/N-4284-2017; Salakova, Martina/N-4288-2017	Tachezy, Ruth/0000-0001-7689-9727; Šmahelová, Jana/0000-0002-9164-4279; Salakova, Martina/0000-0003-0827-1211	Ministry of Health of the Czech Republic [NS 10/656-3/2009, NT 12372]	Ministry of Health of the Czech Republic(Ministry of Health, Czech Republic)	This work was supported by grant NS 10/656-3/2009 and by grant NT 12372 from the Ministry of Health of the Czech Republic. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2004, B MINISTRY PUBLIC HL, V7, P7; Arbyn M, 2012, VACCINE, V30, pF88, DOI 10.1016/j.vaccine.2012.06.095; Bardin A, 2008, EUR J CANCER, V44, P557, DOI 10.1016/j.ejca.2007.12.001; Bernard HU, 2010, VIROLOGY, V401, P70, DOI 10.1016/j.virol.2010.02.002; Bruni L, 2010, J INFECT DIS, V202, P1789, DOI 10.1086/657321; Clifford GM, 2005, LANCET, V366, P991, DOI 10.1016/S0140-6736(05)67069-9; de Sanjose S, 2007, LANCET INFECT DIS, V7, P453, DOI 10.1016/S1473-3099(07)70158-5; Eklund C, 2012, J CLIN MICROBIOL, V50, P2289, DOI 10.1128/JCM.00840-12; Eklund C, 2010, J CLIN MICROBIOL, V48, P4147, DOI 10.1128/JCM.00918-10; Gillison ML, 2003, J NATL CANC I MONOGR, V65; Harper DM, 2009, EXPERT REV VACCINES, V8, P1663, DOI [10.1586/erv.09.123, 10.1586/ERV.09.123]; IARC Working Group on the Evaluation of Carcinogenic Risks to Humans, 2007, IARC Monogr Eval Carcinog Risks Hum, V90, P1; Kuhmala SMA, 2007, J MED VIROL, V79, P771, DOI 10.1002/jmv.20839; Munoz N, 2003, NEW ENGL J MED, V348, P518, DOI 10.1056/NEJMoa021641; Rijkaart DC, 2012, BRIT J CANCER, V106, P975, DOI 10.1038/bjc.2011.581; Schmitt M, 2006, J CLIN MICROBIOL, V44, P504, DOI 10.1128/JCM.44.2.504-512.2006; Schmitt M, 2008, J CLIN MICROBIOL, V46, P1050, DOI 10.1128/JCM.02227-07; Schmitt M, 2013, INT J CANCER, V132, P2395, DOI 10.1002/ijc.27891; Solomon D, 2002, JAMA-J AM MED ASSOC, V287, P2114, DOI 10.1001/jama.287.16.2114; Tachezy R, 2006, EUR J CLIN MICROBIOL, V25, P492, DOI 10.1007/s10096-006-0172-5; Tachezy R, 1999, J MED VIROL, V58, P378, DOI 10.1002/(SICI)1096-9071(199908)58:4&lt;378::AID-JMV10&gt;3.0.CO;2-P; Tachezy R, 2008, J MED SCREEN, V15, P207, DOI 10.1258/jms.2008.008057; Tachezy R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021913; Ucakar V, 2012, VACCINE, V30, P116, DOI 10.1016/j.vaccine.2011.10.066; van den Brule AJC, 2002, J CLIN MICROBIOL, V40, P779, DOI 10.1128/JCM.40.3.779-787.2002; Walboomers JMM, 1997, J PATHOL, V181, P253, DOI 10.1002/(SICI)1096-9896(199703)181:3<253::AID-PATH755>3.0.CO;2-0; Wentzensen N, 2009, INT J CANCER, V125, P2151, DOI 10.1002/ijc.24528; zurHausen H, 1996, BBA-REV CANCER, V1288, pF55	28	27	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79156	10.1371/journal.pone.0079156	http://dx.doi.org/10.1371/journal.pone.0079156			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265750	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100083
J	Xiao, S; Ni, GY; Callaway, RM				Xiao, Sa; Ni, Guangyan; Callaway, Ragan M.			Models of Experimentally Derived Competitive Effects Predict Biogeographical Differences in the Abundance of Invasive and Native Plant Species	PLOS ONE			English	Article							ACROPTILON-REPENS L.; RELATIVE IMPORTANCE; FACILITATION; DIVERSITY; COMMUNITY; INTERPLAY; IMPACT; PERFORMANCE; TEMPERATE; NEIGHBORS	Mono-dominance by invasive species provides opportunities to explore determinants of plant distributions and abundance; however, linking mechanistic results from small scale experiments to patterns in nature is difficult. We used experimentally derived competitive effects of an invader in North America, Acroptilon repens, on species with which it co-occurs in its native range of Uzbekistan and on species with which it occurs in its non-native ranges in North America, in individual-based models. We found that competitive effects yielded relative abundances of Acroptilon and other species in models that were qualitatively similar to those observed in the field in the two ranges. In its non-native range, Acroptilon can occur in nearly pure monocultures at local scales, whereas such nearly pure stands of Acroptilon appear to be much less common in its native range. Experimentally derived competitive effects of Acroptilon on other species predicted Acroptilon to be 4-9 times more proportionally abundant than natives in the North American models, but proportionally equal to or less than the abundance of natives in the Eurasian models. Our results suggest a novel way to integrate complex combinations of interactions simultaneously, and that biogeographical differences in the competitive effects of an invader correspond well with biogeographical differences in abundance and impact.	[Xiao, Sa] Lanzhou Univ, Sch Life Sci, Minist Educ, Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Gansu, Peoples R China; [Ni, Guangyan] Chinese Acad Sci, South China Bot Garden, Key Lab Vegetat Restorat & Management Degraded Ec, Guangzhou, Guangdong, Peoples R China; [Callaway, Ragan M.] Univ Montana, Div Biol Sci, Missoula, MT 59812 USA; [Callaway, Ragan M.] Univ Montana, Inst Ecosyst, Missoula, MT 59812 USA	Lanzhou University; Chinese Academy of Sciences; South China Botanical Garden, CAS; University of Montana System; University of Montana; University of Montana System; University of Montana	Xiao, S (corresponding author), Lanzhou Univ, Sch Life Sci, Minist Educ, Key Lab Cell Activ & Stress Adaptat, Lanzhou 730000, Gansu, Peoples R China.	xiaos@lzu.edu.cn			International Programs at The University of Montana; U.S. National Science Foundation [DEB 0614406]; NSF EPSCoR; State Key Program of National Natural Science of China [31230014, 40930533]; National Natural Science Foundation of China [31270472, 31070357, 31000203, 31000178]; Central University special fund basic research and operating expenses of China [lzujbky-2013-101]; Office of Integrative Activities [1443108] Funding Source: National Science Foundation	International Programs at The University of Montana; U.S. National Science Foundation(National Science Foundation (NSF)); NSF EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD)); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Central University special fund basic research and operating expenses of China; Office of Integrative Activities(National Science Foundation (NSF)NSF - Office of the Director (OD))	RMC thanks the International Programs at The University of Montana, the U.S. National Science Foundation DEB 0614406, and NSF EPSCoR for support. SX thanks the State Key Program of National Natural Science of China (31230014, 40930533), the National Natural Science Foundation of China (31270472, 31070357, 31000203 and 31000178), and the Central University special fund basic research and operating expenses of China (lzujbky-2013-101). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armas C, 2004, ECOLOGY, V85, P2682, DOI 10.1890/03-0650; Bazzaz F.A., 1990, PERSPECTIVES PLANT C, P240; BERTNESS MD, 1991, ECOLOGY, V72, P138, DOI 10.2307/1938909; Besaw LM, 2011, J APPL ECOL, V48, P998, DOI 10.1111/j.1365-2664.2011.01988.x; Brooker R, 2005, OIKOS, V109, P63, DOI 10.1111/j.0030-1299.2005.13557.x; Brooker RW, 2009, AM NAT, V174, P919, DOI 10.1086/648058; Busing RT, 2002, FOLIA GEOBOT, V37, P33, DOI 10.1007/BF02803189; Cahill JF, 2003, J ECOL, V91, P532, DOI 10.1046/j.1365-2745.2003.00792.x; Callaway RM, 2012, BIOL INVASIONS, V14, P1143, DOI 10.1007/s10530-011-0145-1; Callaway RM, 2011, ECOLOGY, V92, P2208, DOI 10.1890/11-0518.1; Callaway RM, 2000, SCIENCE, V290, P521, DOI 10.1126/science.290.5491.521; Callaway RM, 1996, ECOLOGY, V77, P2130, DOI 10.2307/2265707; Callaway RM, 2000, AM NAT, V156, P416, DOI 10.1086/303398; Chen SY, 2009, J THEOR BIOL, V258, P266, DOI 10.1016/j.jtbi.2009.01.011; Davis MA, 2001, ECOL LETT, V4, P421, DOI 10.1046/j.1461-0248.2001.00246.x; GRACE JB, 1981, AM NAT, V118, P463, DOI 10.1086/283841; Grant DW, 2003, PLANT ECOL, V166, P157, DOI 10.1023/A:1023221024593; GUREVITCH J, 1986, ECOLOGY, V67, P46, DOI 10.2307/1938502; He WM, 2009, OECOLOGIA, V159, P803, DOI 10.1007/s00442-008-1234-4; Hejda M, 2009, J ECOL, V97, P393, DOI 10.1111/j.1365-2745.2009.01480.x; Inderjit, 2011, ECOLOGY, V92, P316, DOI 10.1890/10-0400.1; Keddy P, 2002, J VEG SCI, V13, P5, DOI 10.1111/j.1654-1103.2002.tb02018.x; Koloren O, 2008, PAK J BOT, V40, P2259; Lamb EG, 2008, ECOLOGY, V89, P216, DOI 10.1890/07-0393.1; Le Bagousse-Pinguet Y, 2012, OIKOS, V121, P95, DOI 10.1111/j.1600-0706.2011.19778.x; Lenth R., 2019, Journal of Statistical Software, V60, P1; MacDougall AS, 2004, J ECOL, V92, P422, DOI 10.1111/j.0022-0477.2004.00886.x; Maron JL, 2008, J ECOL, V96, P1187, DOI 10.1111/j.1365-2745.2008.01440.x; Michalet R, 2011, ECOL LETT, V14, P433, DOI 10.1111/j.1461-0248.2011.01605.x; MILLER TE, 1987, ECOLOGY, V68, P1201, DOI 10.2307/1939204; Ni GY, 2010, BIOL INVASIONS, V12, P3653, DOI 10.1007/s10530-010-9759-y; Pages JP, 2003, J ECOL, V91, P932, DOI 10.1046/j.1365-2745.2003.00825.x; PENNINGS SC, 1992, ECOLOGY, V73, P681, DOI 10.2307/1940774; Reinhart KO, 2003, ECOL LETT, V6, P1046, DOI 10.1046/j.1461-0248.2003.00539.x; SALE PF, 1977, AM NAT, V111, P337, DOI 10.1086/283164; SALE PF, 1979, OECOLOGIA, V42, P159, DOI 10.1007/BF00344855; Schaffner U, 2011, ECOLOGY, V92, P829, DOI 10.1890/10-1230.1; STEVENS KL, 1986, J CHEM ECOL, V12, P1205, DOI 10.1007/BF01012342; Travis JMJ, 2006, J THEOR BIOL, V241, P896, DOI 10.1016/j.jtbi.2006.01.025; Travis JMJ, 2005, BIOL LETT-UK, V1, P5, DOI 10.1098/rsbl.2004.0236; Vasquez E, 2008, INVAS PLANT SCI MANA, V1, P287, DOI 10.1614/IPSM-08-062.1; Vila M, 2004, OIKOS, V105, P229, DOI 10.1111/j.0030-1299.2004.12682.x; WATSON AK, 1980, CAN J PLANT SCI, V60, P993, DOI 10.4141/cjps80-142; Xiao S, 2012, AM NAT, V180, P707, DOI 10.1086/668008; Xiao S, 2010, GLOBAL ECOL BIOGEOGR, V19, P343, DOI 10.1111/j.1466-8238.2009.00511.x; Xiao S, 2009, OIKOS, V118, P1343, DOI 10.1111/j.1600-0706.2009.17588.x; Yamamura N, 2004, J THEOR BIOL, V226, P421, DOI 10.1016/j.jtbi.2003.09.016	47	3	3	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78625	10.1371/journal.pone.0078625	http://dx.doi.org/10.1371/journal.pone.0078625			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265701	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100034
J	Rothwell, SW; Stansfeld, PJ; Bragg, L; Verkhratsky, A; North, RA				Rothwell, Simon W.; Stansfeld, Phillip J.; Bragg, Laricia; Verkhratsky, Alexej; North, R. Alan			Direct Gating of ATP-activated Ion Channels (P2X2 Receptors) by Lipophilic Attachment at the Outer End of the Second Transmembrane Domain	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RAT P2X(2) RECEPTOR; BINDING-SITE; RESIDUES; PORE; IDENTIFICATION; SIMULATIONS; PROTEINS	The ionic pore of the P2X receptor passes through the central axis of six transmembrane (TM) helices, two from each of three subunits. Val(48) and Ile(328) are at the outer end of TM1 and TM2, respectively. Homology models of the open and closed states of P2X2 indicate that pore opening is associated with a large lateral displacement of Ile(328). In addition, molecular dynamics simulations suggest that lipids enter the interstices between the outer ends of the TM domains. The P2X2(I328C) receptor was activated by propyl-methanethiosulfonate (MTS) as effectively as by ATP, but cysteine substitutions elsewhere in TM2 had no such effect. Other lipophilic MTS compounds (methyl, ethyl, and tert-butylethyl) had a similar effect but not polar MTS. The properties of the conducting pathway opened by covalent attachment of propyl-MTS were the same as those opened by ATP, with respect to unitary conductance, rectification, and permeability of N-methyl-D-glucamine. The ATP-binding residue Lys(69) was not required for the action of propyl-MTS, although propyl-MTS did not open P2X2(K308A/I328C) receptors. The propyl-MTS did not open P2X2 receptors in which the Val(48) side chain was removed (P2X2(V48G/I328C)). The results suggest that an interaction between Val(48) and Ile(328) stabilizes the closed channel and that this is broken by covalent attachment of a larger lipophilic moiety at the I328C receptors. Lipid intercalation between the separating TM domains during channel opening would be facilitated in P2X2(I328C) receptors with attached propyl-MTS. The results are consistent with the channel opening mechanism proposed on the basis of closed and open crystal structures and permit the refinement of the position of the TMs within the bilayer.	[Rothwell, Simon W.; Verkhratsky, Alexej; North, R. Alan] Univ Manchester, Fac Life Sci, Manchester M13 9PL, Lancs, England; [Bragg, Laricia; North, R. Alan] Univ Manchester, Fac Med & Human Sci, Manchester M13 9PL, Lancs, England; [Stansfeld, Phillip J.] Univ Oxford, Dept Biochem, Oxford OX1 3QU, England	University of Manchester; University of Manchester; University of Oxford	North, RA (corresponding author), Univ Manchester, Fac Med & Human Sci, Michael Smith Bldg,Oxford Rd, Manchester M13 9PL, Lancs, England.	r.a.north@manchester.ac.uk	Verkhratsky, Alexei/J-4527-2013; North, Richard/GQA-6156-2022; Stansfeld, Phillip James/AAA-9228-2020	Verkhratsky, Alexei/0000-0003-2592-9898; Stansfeld, Phillip James/0000-0001-8800-7669	Astra Zeneca studentship; Wellcome Trust [093140/Z/10/Z]; Biotechnology and Biological Sciences Research Council Grant [BB/I019855/1]; Biotechnology and Biological Sciences Research Council [B19456, BB/I019855/1, BBS/B/16011, BEP17032, BB/H000267/1, BB/L002558/1] Funding Source: researchfish; Engineering and Physical Sciences Research Council [EP/J010421/1] Funding Source: researchfish; BBSRC [BB/I019855/1, BB/L002558/1, BB/H000267/1] Funding Source: UKRI; EPSRC [EP/J010421/1] Funding Source: UKRI	Astra Zeneca studentship; Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council Grant(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	This work was supported by an Astra Zeneca studentship, Wellcome Trust Grant 093140/Z/10/Z, and Biotechnology and Biological Sciences Research Council Grant BB/I019855/1.	Borghese CM, 2014, J NEUROCHEM, V128, P363, DOI 10.1111/jnc.12476; Browne LE, 2010, TRENDS PHARMACOL SCI, V31, P229, DOI 10.1016/j.tips.2010.02.004; Cao LS, 2007, J NEUROSCI, V27, P12916, DOI 10.1523/JNEUROSCI.4036-07.2007; Cao LS, 2009, J NEUROSCI, V29, P14257, DOI 10.1523/JNEUROSCI.4403-09.2009; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; Egan TM, 1998, J NEUROSCI, V18, P2350; Hattori M, 2012, NATURE, V485, P207, DOI 10.1038/nature11010; HAZES B, 1988, PROTEIN ENG, V2, P119, DOI 10.1093/protein/2.2.119; Jiang LH, 2000, J BIOL CHEM, V275, P34190, DOI 10.1074/jbc.M005481200; Jiang LH, 2001, J BIOL CHEM, V276, P14902, DOI 10.1074/jbc.M011327200; Kawate T, 2011, J GEN PHYSIOL, V137, P579, DOI 10.1085/jgp.201010593; Kawate T, 2009, NATURE, V460, P592, DOI 10.1038/nature08198; Khakh BS, 2012, NEURON, V76, P51, DOI 10.1016/j.neuron.2012.09.024; Khakh BS, 1999, NAT NEUROSCI, V2, P322, DOI 10.1038/7233; Kubo Y, 2009, J PHYSIOL-LONDON, V587, P5317, DOI 10.1113/jphysiol.2009.179309; Li MF, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1048; Marquez-Klaka B, 2007, J NEUROSCI, V27, P1456, DOI 10.1523/JNEUROSCI.3105-06.2007; North RA, 2002, PHYSIOL REV, V82, P1013, DOI 10.1152/physrev.00015.2002; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Rassendren F, 1997, EMBO J, V16, P3446, DOI 10.1093/emboj/16.12.3446; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; Samways DSK, 2011, P NATL ACAD SCI USA, V108, P13800, DOI 10.1073/pnas.1017550108; Simpson RJ, 2009, BASIC METHODS PROTEI; Stansfeld PJ, 2013, STRUCTURE, V21, P810, DOI 10.1016/j.str.2013.03.005; Stansfeld PJ, 2011, J CHEM THEORY COMPUT, V7, P1157, DOI 10.1021/ct100569y; Stelmashenko O, 2012, MOL PHARMACOL, V82, P760, DOI 10.1124/mol.112.080903; Valiyaveetil FI, 2002, BIOCHEMISTRY-US, V41, P10771, DOI 10.1021/bi026215y; Virginio C, 1999, NAT NEUROSCI, V2, P315, DOI 10.1038/7225; Weingarth M, 2013, J AM CHEM SOC, V135, P3983, DOI 10.1021/ja3119114; Wilkinson WJ, 2006, MOL PHARMACOL, V70, P1159, DOI 10.1124/mol.106.026658; Yan D, 2013, P NATL ACAD SCI USA, V110, P2228, DOI 10.1073/pnas.1222285110	31	15	15	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					618	626		10.1074/jbc.M113.529099	http://dx.doi.org/10.1074/jbc.M113.529099			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273165	Green Published, hybrid			2022-12-25	WOS:000330541200003
J	Gaviria, D; Paguio, MF; Turnbull, LB; Tan, A; Siriwardana, A; Ghosh, D; Ferdig, MT; Sinai, AP; Roepe, PD				Gaviria, David; Paguio, Michelle F.; Turnbull, Lindsey B.; Tan, Asako; Siriwardana, Amila; Ghosh, Debasish; Ferdig, Michael T.; Sinai, Anthony P.; Roepe, Paul D.			A Process Similar to Autophagy Is Associated with Cytocidal Chloroquine Resistance in Plasmodium falciparum	PLOS ONE			English	Article							TRANSMEMBRANE PROTEIN PFCRT; CELL-DEATH; IN-VITRO; MUTATIONS; QUININE; QUANTIFICATION; SUSCEPTIBILITY; ANTIMALARIALS; PYRIMETHAMINE; EXPRESSION	Resistance to the cytostatic activity of the antimalarial drug chloroquine (CQ) is becoming well understood, however, resistance to cytocidal effects of CQ is largely unexplored. We find that PfCRT mutations that almost fully recapitulate P. falciparum cytostatic CQ resistance (CQR(CS)) as quantified by CQ IC50 shift, account for only 10-20% of cytocidal CQR (CQR(CC)) as quantified by CQ LD50 shift. Quantitative trait loci (QTL) analysis of the progeny of a chloroquine sensitive (CQS; strain HB3) x chloroquine resistant (CQR; strain Dd2) genetic cross identifies distinct genetic architectures for CQR(CS) vs CQR(CC) phenotypes, including identification of novel interacting chromosomal loci that influence CQ LD50. Candidate genes in these loci are consistent with a role for autophagy in CQR(CC), leading us to directly examine the autophagy pathway in intraerythrocytic CQR parasites. Indirect immunofluorescence of RBC infected with synchronized CQS vs CQR trophozoite stage parasites reveals differences in the distribution of the autophagy marker protein PfATG8 coinciding with CQR(CC). Taken together, the data show that an unusual autophagy - like process is either activated or inhibited for intraerythrocytic trophozoite parasites at LD50 doses (but not IC50 doses) of CQ, that the pathway is altered in CQR P. falciparum, and that it may contribute along with mutations in PfCRT to confer the CQR(CC) phenotype.	[Gaviria, David; Paguio, Michelle F.; Siriwardana, Amila; Roepe, Paul D.] Georgetown Univ, Dept Chem, Washington, DC 20057 USA; [Gaviria, David; Paguio, Michelle F.; Siriwardana, Amila; Roepe, Paul D.] Georgetown Univ, Dept Biochem Cellular & Mol Biol, Washington, DC USA; [Turnbull, Lindsey B.; Tan, Asako; Ferdig, Michael T.] Univ Notre Dame, Eck Inst Global Hlth, Dept Biol, Notre Dame, IN 46556 USA; [Ghosh, Debasish; Sinai, Anthony P.] Univ Kentucky, Coll Med, Dept Microbiol Mol Genet & Immunol, Lexington, KY USA	Georgetown University; Georgetown University; University of Notre Dame; University of Kentucky	Roepe, PD (corresponding author), Georgetown Univ, Dept Chem, Washington, DC 20057 USA.	roepep@georgetown.edu	Ferdig, Michael/C-6627-2016	Ghosh, Debasish/0000-0001-9691-1498	National Institutes of Health (NIH) [NIH RO1 AI045957, NIH RO1 AI049367, NIH RO1 AI071121]; Kentucky Science and Education Foundation [KSEF-2624-RDE015]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045957, R01AI049367, R01AI071121] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kentucky Science and Education Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by National Institutes of Health (NIH) grants: NIH RO1 AI045957 (to PDR); NIH RO1 AI049367 (to APS); NIH RO1 AI071121 (to MTF); and Kentucky Science and Education Foundation grant: KSEF-2624-RDE015 (to APS). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoah LE, 2007, BIOCHEMISTRY-US, V46, P6060, DOI 10.1021/bi7002026; Ayala HBR, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-577; Babbitt SE, 2012, P NATL ACAD SCI USA, V109, pE3278, DOI 10.1073/pnas.1209823109; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bakshi Rahul P, 2013, Sci Transl Med, V5, p205ra135, DOI 10.1126/scitranslmed.3006684; Baro NK, 2013, BIOCHEMISTRY-US, V52, P4242, DOI 10.1021/bi400557x; Bennett TN, 2004, ANTIMICROB AGENTS CH, V48, P1807, DOI 10.1128/AAC.48.5.1807-1810.2004; Brennand A, 2011, MOL BIOCHEM PARASIT, V177, P83, DOI 10.1016/j.molbiopara.2011.02.003; Cabrera M, 2009, BIOCHEMISTRY-US, V48, P11152, DOI 10.1021/bi901765v; Ch'ng JH, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.2; Cheeseman IH, 2012, SCIENCE, V336, P79, DOI 10.1126/science.1215966; Cooper RA, 2002, MOL PHARMACOL, V61, P35, DOI 10.1124/mol.61.1.35; DEDUVE C, 1974, BIOCHEM PHARMACOL, V23, P2495, DOI 10.1016/0006-2952(74)90174-9; Dotiwala F, 2013, P NATL ACAD SCI USA, V110, pE41, DOI 10.1073/pnas.1218065109; Ecker A, 2012, TRENDS PARASITOL, V28, P504, DOI 10.1016/j.pt.2012.08.002; Federici E, 1999, ANTIPLASMODIAL ACTIV, V66, P93; Ferdig MT, 2004, MOL MICROBIOL, V52, P985, DOI 10.1111/j.1365-2958.2004.04035.x; Fidock DA, 2000, MOL CELL, V6, P861, DOI 10.1016/S1097-2765(05)00077-8; Ghosh D, 2012, CELL MICROBIOL, V14, P589, DOI 10.1111/j.1462-5822.2011.01745.x; Gligorijevic B, 2008, MOL BIOCHEM PARASIT, V159, P7, DOI 10.1016/j.molbiopara.2007.12.014; Gligorijevic B, 2006, BIOCHEMISTRY-US, V45, P12400, DOI 10.1021/bi061033f; Gonzales JM, 2008, PLOS BIOL, V6, P2016, DOI 10.1371/journal.pbio.0060238; Gorka AP, 2013, J MED CHEM, V56, P5231, DOI 10.1021/jm400282d; Gorka AP, 2013, ANTIMICROB AGENTS CH, V57, P356, DOI 10.1128/AAC.01709-12; Gorka AP, 2013, ANTIMICROB AGENTS CH, V57, P365, DOI 10.1128/AAC.01234-12; Gozuacik D, 2007, CURR TOP DEV BIOL, V78, P217, DOI 10.1016/S0070-2153(06)78006-1; Hodel EM, 2009, J CHROMATOGR B, V877, P867, DOI 10.1016/j.jchromb.2009.02.006; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Istvan ES, 2011, P NATL ACAD SCI USA, V108, P1627, DOI 10.1073/pnas.1011560108; Khalil IF, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-249; Kitamura K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042977; Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001; Lavine MD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042107; Lin M, 2012, NEUROSCIENCE, V210, P308, DOI 10.1016/j.neuroscience.2012.03.004; Liu J, 2006, P NATL ACAD SCI USA, V103, P8840, DOI 10.1073/pnas.0601876103; Maser P, 2012, CURR OPIN PHARMACOL, V12, P562, DOI 10.1016/j.coph.2012.05.001; Matsui A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003245; Meschini S, 2007, TOXICOL IN VITRO, V21, P197, DOI 10.1016/j.tiv.2006.09.007; Meslin B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023867; Notte A, 2011, BIOCHEM PHARMACOL, V82, P427, DOI 10.1016/j.bcp.2011.06.015; Nyakeriga AM, 2006, MICROBES INFECT, V8, P1560, DOI 10.1016/j.micinf.2006.01.016; Paguio MF, 2011, MOL BIOCHEM PARASIT, V178, P1, DOI 10.1016/j.molbiopara.2011.03.003; Patel JJ, 2010, MOL MICROBIOL, V78, P770, DOI 10.1111/j.1365-2958.2010.07366.x; Platini F, 2010, CURR PHARM DESIGN, V16, P101, DOI 10.2174/138161210789941810; Pleeter P, 2010, MOL BIOCHEM PARASIT, V173, P158, DOI 10.1016/j.molbiopara.2010.05.012; Plowe CV, 1997, J INFECT DIS, V176, P1590, DOI 10.1086/514159; Ramanitrahasimbola D, 2001, PHYTOTHER RES, V15, P30, DOI 10.1002/1099-1573(200102)15:1&lt;30::AID-PTR680&gt;3.0.CO;2-T; Reed MB, 2000, NATURE, V403, P906, DOI 10.1038/35002615; RICHARDS WHG, 1979, ANN TROP MED PARASIT, V73, P99, DOI 10.1080/00034983.1979.11687236; Totino PRR, 2008, EXP PARASITOL, V118, P478, DOI 10.1016/j.exppara.2007.10.017; Roberts L, 2008, ANTIMICROB AGENTS CH, V52, P1840, DOI 10.1128/AAC.01478-07; Roepe PD, 2011, BIOCHEMISTRY-US, V50, P163, DOI 10.1021/bi101638n; Sa JM, 2009, P NATL ACAD SCI USA, V106, P18883, DOI 10.1073/pnas.0911317106; SALAKO LA, 1987, B WORLD HEALTH ORGAN, V65, P47; Sanchez CP, 2011, MOL MICROBIOL, V82, P865, DOI 10.1111/j.1365-2958.2011.07855.x; Shpilka T, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-7-226; Sidhu ABS, 2002, SCIENCE, V298, P210, DOI 10.1126/science.1074045; Sinai AP, 2012, TRENDS PARASITOL, V28, P358, DOI 10.1016/j.pt.2012.06.006; Suradji EW, 2011, PARASITOLOGY, V138, P1852, DOI 10.1017/S0031182011001399; Taguchi K, 2012, P NATL ACAD SCI USA, V109, P13561, DOI 10.1073/pnas.1121572109; Tawk L, 2010, EUKARYOT CELL, V9, P1519, DOI 10.1128/EC.00124-10; Vaid A, 2010, BLOOD, V115, P2500, DOI 10.1182/blood-2009-08-238972; Waller KL, 2003, J BIOL CHEM, V278, P33593, DOI 10.1074/jbc.M302215200; Wang P, 1997, MOL MICROBIOL, V23, P979, DOI 10.1046/j.1365-2958.1997.2821646.x; WILSON CM, 1989, SCIENCE, V244, P1184, DOI 10.1126/science.2658061; YOUNG RD, 1993, ANTIMICROB AGENTS CH, V37, P1102, DOI 10.1128/AAC.37.5.1102	66	27	27	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e79059	10.1371/journal.pone.0079059	http://dx.doi.org/10.1371/journal.pone.0079059			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278114	Green Published, gold, Green Submitted			2022-12-25	WOS:000327313100009
J	Han, S; Zhang, XL; Chen, R; Wen, JS; Li, YH; Shu, J; Ling, H; Zhang, FM				Han, Su; Zhang, Xiaoli; Chen, Rui; Wen, Jingshan; Li, Yihong; Shu, Jing; Ling, Hong; Zhang, Fengmin			Trends in Prevalence of Clonorchiasis among Patients in Heilongjiang Province, Northeast China (2009-2012): Implications for Monitoring and Control	PLOS ONE			English	Article							SINENSIS INFECTION; REINFECTION; COMMUNITY	Background: Clonorchiasis is an important zoonotic parasitic disease worldwide. Past estimates showed the prevalence increased based on studies undertaken ten years or more ago. However, control strategies, changing ecology and migration may have resulted to changes in the prevalence of clonorchiasis. The purpose of the present study was to analysis the prevalence and epidemiological characterisation of clonorchiasis in Heilongjiang Province, Northeast China. Methodology/Principal Findings: A total of 4951 clinically suspected outpatients were examined from January 2009 to December 2012. Overall prevalence of clonorchiasis was 25.93% (1284/4951) by the combination strategy of the Kato-Katz technique (KK) and enzyme-linked immunosorbent assay (ELISA), with a significant increase from 22.53% in 2009 to 34.25% in 2012. Apart from Daxinganling city, clonorchiasis was reported throughout Heilongjiang Province and mainly along the Songhua River and Nen River basin, with an increased annual prevalence. The annual prevalence in men increased significantly in 2012 and was higher than that in women over 4 years. A similar pattern was seen for the annual infection rate in rural and urban areas. Farm labourers accounted for the majority of cases (65.93%), with a higher prevalence than in other occupations. Consumption of freshwater fish was considered the strongest risk factor of clonorchiasis. The infection rates in the 40-49 and 50-59 years age groups showed a significant increasing trend in 2012. Cases of re-infection were common. Conclusions/Significance: The present study revealed that clonorchiasis remained widespread and prevalent in Heilongjiang Province. An integrated control programme is urgently needed to reduce the public health impact of clonorchiasis in this endemic area.	[Han, Su; Zhang, Xiaoli; Wen, Jingshan; Li, Yihong; Shu, Jing; Ling, Hong; Zhang, Fengmin] Harbin Med Univ, Heilongjiang Key Lab Immun & Infect, Dept Microbiol & Parasitol, Harbin, Peoples R China; [Chen, Rui] Harbin Med Univ, Affiliated Hosp 2, Dept Spine Surg, Harbin, Peoples R China; [Zhang, Fengmin] Harbin Med Univ, Minist Educ, Key Lab Biopharmaceut, Harbin, Peoples R China	Harbin Medical University; Harbin Medical University; Harbin Medical University	Zhang, FM (corresponding author), Harbin Med Univ, Heilongjiang Key Lab Immun & Infect, Dept Microbiol & Parasitol, Harbin, Peoples R China.	fengminzhang@ems.hrbmu.edu.cn		ling, hong/0000-0002-1886-1242	China, Heilongjiang postdoctoral Fund [LRB08-304]; Heilongjiang Province Education Bureau [12531347]; Heilongjiang postdoctoral scientific research fund [LBH-Q11056]; Heilongjiang Province Ministry Bureau [2012-753]; Heilongjiang Province ordinary colleges and universities Medical Etiology Key Laboratory Open Foundation [BSL3]	China, Heilongjiang postdoctoral Fund; Heilongjiang Province Education Bureau; Heilongjiang postdoctoral scientific research fund; Heilongjiang Province Ministry Bureau; Heilongjiang Province ordinary colleges and universities Medical Etiology Key Laboratory Open Foundation	This work was supported by China, Heilongjiang postdoctoral Fund (Grant LRB08-304), Heilongjiang Province Education Bureau (Grant 12531347), Heilongjiang postdoctoral scientific research fund (Grant LBH-Q11056), Heilongjiang Province Ministry Bureau 2012-753, and Heilongjiang Province ordinary colleges and universities Medical Etiology (BSL3) Key Laboratory Open Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Cam TDT, 2008, T ROY SOC TROP MED H, V102, P1263, DOI 10.1016/j.trstmh.2008.06.002; Chen YD, 2008, BIOMED ENVIRON SCI, V21, P173, DOI 10.1016/S0895-3988(08)60025-2; Choi MH, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000601; Coordinating Office of the National Survey on the Important Human Parasitic Diseases, 2005, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V23, P332; Guoqing L, 2001, Southeast Asian J Trop Med Public Health, V32 Suppl 2, P8; Han S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046977; Hong ST, 2003, DIAGN MICR INFEC DIS, V47, P345, DOI 10.1016/S0732-8893(03)00113-5; Ju Young-Hee, 2005, J Prev Med Public Health, V38, P425; Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614; Kim Bong Jin, 2002, Korean Journal of Parasitology, V40, P191, DOI 10.3347/kjp.2002.40.4.191; Kim HG, 2009, WORLD J GASTROENTERO, V15, P86, DOI 10.3748/wjg.15.86; Lim MK, 2006, AM J TROP MED HYG, V75, P93, DOI 10.4269/ajtmh.2006.75.93; Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6; Niu H., 2001, CHIN J PREVENT MED, V35, P308; Nontasut P., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P269; Peng Zhao-qiong, 2007, Zhonghua Liu Xing Bing Xue Za Zhi, V28, P544; Prichard RK, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001549; Qian MB, 2013, INFECT DIS POVERTY, V2, DOI 10.1186/2049-9957-2-4; Qian MB, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001377; Rim HJ, 2005, J HELMINTHOL, V79, P269, DOI 10.1079/JOH2005300; Sripa B, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000232; UPATHAM ES, 1988, INT J PARASITOL, V18, P643, DOI 10.1016/0020-7519(88)90099-9; Wu W, 2012, PARASITOL RES, V111, P1879, DOI 10.1007/s00436-012-3152-y; Yu SH, 2003, JPN J INFECT DIS, V56, P168; Zhang XL, 2008, PARASITOL RES, V103, P393, DOI 10.1007/s00436-008-0985-5; Zhou P, 2008, TRENDS PARASITOL, V24, P190, DOI 10.1016/j.pt.2008.01.001; Zhou XN, 2005, ACTA TROP, V96, P97, DOI 10.1016/j.actatropica.2005.07.005	28	8	10	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80173	10.1371/journal.pone.0080173	http://dx.doi.org/10.1371/journal.pone.0080173			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260354	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900060
J	Ji, WJ; Ma, YQ; Zhou, X; Zhang, YD; Lu, RY; Guo, ZZ; Sun, HY; Hu, DC; Yang, GH; Li, YM; Wei, LQ				Ji, Wen-Jie; Ma, Yong-Qiang; Zhou, Xin; Zhang, Yi-Dan; Lu, Rui-Yi; Guo, Zhao-Zeng; Sun, Hai-Ying; Hu, Dao-Chuan; Yang, Guo-Hong; Li, Yu-Ming; Wei, Lu-Qing			Spironolactone Attenuates Bleomycin-Induced Pulmonary Injury Partially via Modulating Mononuclear Phagocyte Phenotype Switching in Circulating and Alveolar Compartments	PLOS ONE			English	Article							ANGIOTENSIN-CONVERTING ENZYME-2; INDUCED LUNG INJURY; MACROPHAGE POLARIZATION; MINERALOCORTICOID RECEPTORS; ALTERNATIVE ACTIVATION; NEUTROPHIL EMIGRATION; CELL SUBSETS; MONOCYTES; FIBROSIS; INFLAMMATION	Background: Recent experimental studies provide evidence indicating that manipulation of the mononuclear phagocyte phenotype could be a feasible approach to alter the severity and persistence of pulmonary injury and fibrosis. Mineralocorticoid receptor (MR) has been reported as a target to regulate macrophage polarization. The present work was designed to investigate the therapeutic potential of MR antagonism in bleomycin-induced acute lung injury and fibrosis. Methodology/Principal Findings: We first demonstrated the expression of MR in magnetic bead-purified Ly6G-/CD11b+ circulating monocytes and in alveolar macrophages harvested in bronchoalveolar lavage fluid (BALF) from C57BL/6 mice. Then, a pharmacological intervention study using spironolactone (20mg/kg/day by oral gavage) revealed that MR antagonism led to decreased inflammatory cell infiltration, cytokine production (downregulated monocyte chemoattractant protein-1, transforming growth factor beta 1, and interleukin-1 beta at mRNA and protein levels) and collagen deposition (decreased lung total hydroxyproline content and collagen positive area by Masson' trichrome staining) in bleomycin treated (2.5mg/kg, via oropharyngeal instillation) male C57BL/6 mice. Moreover, serial flow cytometry analysis in blood, BALF and enzymatically digested lung tissue, revealed that spironolactone could partially inhibit bleomycin-induced circulating Ly6C(hi) monocyte expansion, and reduce alternative activation (F4/80+CD11c+CD206+) of mononuclear phagocyte in alveoli, whereas the phenotype of interstitial macrophage (F4/80+CD11c-) remained unaffected by spironolactone during investigation. Conclusions/Significance: The present work provides the experimental evidence that spironolactone could attenuate bleomycin-induced acute pulmonary injury and fibrosis, partially via inhibition of MR-mediated circulating monocyte and alveolar macrophage phenotype switching.	[Ji, Wen-Jie; Ma, Yong-Qiang; Zhang, Yi-Dan; Hu, Dao-Chuan; Wei, Lu-Qing] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Dept Resp & Crit Care Med, Tianjin, Peoples R China; [Ji, Wen-Jie; Zhou, Xin; Lu, Rui-Yi; Guo, Zhao-Zeng; Sun, Hai-Ying; Yang, Guo-Hong; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Inst Cardiovasc Dis, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin, Peoples R China; [Ji, Wen-Jie; Zhou, Xin; Lu, Rui-Yi; Guo, Zhao-Zeng; Sun, Hai-Ying; Yang, Guo-Hong; Li, Yu-Ming] Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Ctr Heart, Tianjin Key Lab Cardiovasc Remodeling & Target Or, Tianjin, Peoples R China		Ji, WJ (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Pingjin Hosp, Dept Resp & Crit Care Med, Tianjin, Peoples R China.	wenjieji@gmail.com; wei_luqing@hotmail.com	JI, WENJIE/H-1274-2015; Zhou, Xin/AAH-7351-2019	Zhou, Xin/0000-0003-1395-7103	National Natural Science Foundation of China [81102088, 81170238, 81070121]; Tianjin Municipal Science and Technology Committee [12JCYBJC16600, 11JCYBJC11800, 11JCYBJC12000]; Logistics University of the Chinese People's Armed Police Forces [WYB201108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Tianjin Municipal Science and Technology Committee; Logistics University of the Chinese People's Armed Police Forces	This work was supported by National Natural Science Foundation of China (81102088, 81170238, 81070121), Tianjin Municipal Science and Technology Committee (12JCYBJC16600, 11JCYBJC11800, 11JCYBJC12000) and intramural research program from Logistics University of the Chinese People's Armed Police Forces (WYB201108). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alber A, 2012, INT J EXP PATHOL, V93, P243, DOI 10.1111/j.1365-2613.2012.00833.x; Bargagli E, 2011, PULM MED, V2011, DOI 10.1155/2011/717130; Bergmann A, 2010, HYPERTENSION, V55, P370, DOI 10.1161/HYPERTENSIONAHA.109.141309; Bessich JL, 2013, J IMMUNOL, V191, P378, DOI 10.4049/jimmunol.1300221; Cat AND, 2012, CURR OPIN NEPHROL HY, V21, P147, DOI 10.1097/MNH.0b013e32834fb25b; Chang YJ, 2011, NAT IMMUNOL, V12, P631, DOI 10.1038/ni.2045; Chawla A, 2011, NAT REV IMMUNOL, V11, P738, DOI 10.1038/nri3071; Dhaliwal K, 2012, AM J RESP CRIT CARE, V186, P514, DOI 10.1164/rccm.201112-2132OC; du Bois RM, 2010, NAT REV DRUG DISCOV, V9, P129, DOI 10.1038/nrd2958; Durante A, 2012, CURR PHARM DESIGN, V18, P981, DOI 10.2174/138161212799436467; Frieler RA, 2012, FRONT BIOSCI-LANDMRK, V17, P1917, DOI 10.2741/4028; Frieler RA, 2011, STROKE, V42, P179, DOI 10.1161/STROKEAHA.110.598441; Fujita T, 2010, HYPERTENSION, V55, P813, DOI 10.1161/HYPERTENSIONAHA.109.149062; Gautier EL, 2012, NAT IMMUNOL, V13, P1118, DOI 10.1038/ni.2419; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Gibbons MA, 2011, AM J RESP CRIT CARE, V184, P569, DOI 10.1164/rccm.201010-1719OC; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; Herold S, 2011, FRONT IMMUNOL, V2, DOI 10.3389/fimmu.2011.00065; Imai Y, 2005, NATURE, V436, P112, DOI 10.1038/nature03712; Ivashkiv LB, 2013, TRENDS IMMUNOL, V34, P216, DOI 10.1016/j.it.2012.11.001; Janssen WJ, 2011, AM J RESP CRIT CARE, V184, P547, DOI 10.1164/rccm.201011-1891OC; Johnston LK, 2012, AM J RESP CELL MOL, V47, P417, DOI 10.1165/rcmb.2012-0090OC; Kikuchi N, 2011, AM J RESP CELL MOL, V45, P600, DOI 10.1165/rcmb.2010-0137OC; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Kreisel D, 2010, P NATL ACAD SCI USA, V107, P18073, DOI 10.1073/pnas.1008737107; Kuba K, 2005, NAT MED, V11, P875, DOI 10.1038/nm1267; Labuzek K, 2013, PHARMACOL REP, V65, P226; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li P, 2010, AM J PATHOL, V177, P1113, DOI 10.2353/ajpath.2010.081127; Li WH, 2003, NATURE, V426, P450, DOI 10.1038/nature02145; LIEBER GB, 2013, EUR J PHARMACOL, DOI DOI 10.1016/J.EJPHAR.2013.08.019.PUBMED:24012780; Liu G, 2013, ARTERIOSCL THROM VAS, V33, P170, DOI 10.1161/ATVBAHA.112.300068; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Mancini GBJ, 2005, CLIN INVEST MED, V28, P118; Maron BA, 2012, CIRCULATION, V126, P963, DOI 10.1161/CIRCULATIONAHA.112.094722; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Maus UA, 2003, J IMMUNOL, V170, P3273, DOI 10.4049/jimmunol.170.6.3273; Maus UA, 2006, AM J RESP CELL MOL, V35, P227, DOI 10.1165/rcmb.2005-0241OC; Misharin AV, 2013, AM J RESP CELL MOL, V49, P503, DOI 10.1165/rcmb.2013-0086MA; Misharin AV, 2011, AM J RESP CRIT CARE, V184, P497, DOI 10.1164/rccm.201107-1343ED; Molina-Molina M, 2006, THORAX, V61, P604, DOI 10.1136/thx.2005.051946; Nalysnyk L, 2012, EUR RESPIR REV, V21, P355, DOI 10.1183/09059180.00002512; Osterholzer JJ, 2013, J IMMUNOL, V190, P3447, DOI 10.4049/jimmunol.1200604; Pechkovsky DV, 2010, CLIN IMMUNOL, V137, P89, DOI 10.1016/j.clim.2010.06.017; Prasse A, 2006, AM J RESP CRIT CARE, V173, P781, DOI 10.1164/rccm.200509-1518OC; Preston IR, 2013, AM J PHYSIOL-LUNG C, V304, pL678, DOI 10.1152/ajplung.00300.2012; Re RN, 2004, NAT CLIN PRACT CARD, V1, P42, DOI 10.1038/ncpcardio0012; Redente EF, 2011, AM J PHYSIOL-LUNG C, V301, pL510, DOI 10.1152/ajplung.00122.2011; Rey-Parra GJ, 2012, J MOL MED, V90, P637, DOI 10.1007/s00109-012-0859-2; Reynolds HY, 2005, AM J RESP CRIT CARE, V171, P98, DOI 10.1164/rccm.200406-788PP; Rickard AJ, 2009, HYPERTENSION, V54, P537, DOI 10.1161/HYPERTENSIONAHA.109.131110; Russo RC, 2009, AM J RESP CELL MOL, V40, P410, DOI 10.1165/rcmb.2007-0364OC; Sewing ACP, 2012, AM J PHYSIOL-LUNG C, V303, pL75, DOI 10.1152/ajplung.00072.2012; Shaykhiev R, 2009, J IMMUNOL, V183, P2867, DOI 10.4049/jimmunol.0900473; Spence S, 2013, IMMUNITY, V38, P66, DOI 10.1016/j.immuni.2012.09.013; SZAPIEL SV, 1979, AM REV RESPIR DIS, V120, P893; Tanaka J, 2013, RESPIR INVESTIG, V51, P76, DOI 10.1016/j.resinv.2012.12.005; Tschernig Thomas, 2009, BMC Pulm Med, V9, P39, DOI 10.1186/1471-2466-9-39; Usher MG, 2010, J CLIN INVEST, V120, P3350, DOI 10.1172/JCI41080; Van Rheen Z, 2011, AM J RESP CELL MOL, V44, P500, DOI 10.1165/rcmb.2010-0065OC; Voltz JW, 2008, AM J RESP CELL MOL, V39, P45, DOI 10.1165/rcmb.2007-0340OC; Vyas SP, 2007, EXPERT OPIN DRUG DEL, V4, P95, DOI 10.1517/17425247.4.2.95; Waseda Y, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-43; Wilson M, 2010, J PETROL, V51, P1, DOI 10.1093/petrology/egp099; Wynn TA, 2013, NATURE, V496, P445, DOI 10.1038/nature12034; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zaynagetdinov R, 2013, AM J RESP CELL MOL, V49, P180, DOI 10.1165/rcmb.2012-0366MA; Zhao Li, 1998, Zhonghua Jiehe He Huxi Zazhi, V21, P300; Zhou X, 2011, AM J PHYSIOL-HEART C, V300, pH1863, DOI 10.1152/ajpheart.00830.2010	69	26	31	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81090	10.1371/journal.pone.0081090	http://dx.doi.org/10.1371/journal.pone.0081090			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260540	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900116
J	Tregoning, JS; Buffa, V; Oszmiana, A; Klein, K; Walters, AA; Shattock, RJ				Tregoning, John S.; Buffa, Viviana; Oszmiana, Anna; Klein, Katja; Walters, Adam A.; Shattock, Robin J.			A "Prime-Pull" Vaccine Strategy Has a Modest Effect on Local and Systemic Antibody Responses to HIV gp140 in Mice	PLOS ONE			English	Article							MUCOSAL IMMUNITY; CHEMOKINE; RESPONSIVENESS; IMMUNIZATION	One potential strategy for the prevention of HIV infection is to induce virus specific mucosal antibody that can act as an immune barrier to prevent transmission. The mucosal application of chemokines after immunisation, termed "prime-pull", has been shown to recruit T cells to mucosal sites. We wished to determine whether this strategy could be used to increase B cells and antibody in the vaginal mucosa following immunisation with an HIV antigen. BALB/c mice were immunised intranasally with trimeric gp140 prior to vaginal application of the chemokine CCL28 or the synthetic TLR4 ligand MPLA, without antigen six days later. There was no increase in vaginal IgA, IgG or B cells following the application of CCL28, however vaginal application of MPLA led to a significant boost in antigen specific vaginal IgA. Follow up studies to investigate the effect of the timing of the "pull" stimulation demonstrated that when given 14 days after the initial immunisation MPLA significantly increased systemic antibody responses. We speculate that this may be due to residual inflammation prior to re-immunisation. Overall we conclude that in contrast to the previously observed effect on T cells, the use of "prime-pull" has only a modest effect on B cells and antibody.	[Tregoning, John S.; Buffa, Viviana; Oszmiana, Anna; Klein, Katja; Walters, Adam A.; Shattock, Robin J.] Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Mucosal Infect & Immun Grp, London, England	Imperial College London	Shattock, RJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Infect Dis Sect, Mucosal Infect & Immun Grp, London, England.	r.shattock@imperial.ac.uk	Oszmiana, Anna/F-6915-2015	Oszmiana, Anna/0000-0003-1501-4184; Tregoning, John/0000-0001-8093-8741	National Institute of Allergy and Infectious Diseases (NIAID); National Institutes of Health (NIH); Division of AIDS (DAIDS); U.S. Department of Health and Human Services (HHS); Center for HIV/AIDS Vaccine Immunology (CHAVI) [U19 AI067854-05]; Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery [UM1-AI100645-01]; Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067854, UM1AI100645] Funding Source: NIH RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Division of AIDS (DAIDS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); U.S. Department of Health and Human Services (HHS); Center for HIV/AIDS Vaccine Immunology (CHAVI); Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery; Dormeur Investment Service Ltd; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	Research in this publication was supported by the National Institute of Allergy and Infectious Diseases (NIAID), National Institutes of Health (NIH), Division of AIDS (DAIDS), U.S. Department of Health and Human Services (HHS), the Center for HIV/AIDS Vaccine Immunology (CHAVI) # U19 AI067854-05 and the Center for HIV/AIDS Vaccine Immunology and Immunogen Discovery, grant number UM1-AI100645-01. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health. The authors gratefully acknowledge an equipment grant from Dormeur Investment Service Ltd that provided funding to purchase of equipment used in these studies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agnello D, 2013, J IMMUNOL, V190, P4836, DOI 10.4049/jimmunol.1202979; Arias MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041144; Belyakov IM, 2012, CURR TOP MICROBIOL, V354, P157, DOI 10.1007/82_2010_119; Bowman EP, 2002, J EXP MED, V195, P269, DOI 10.1084/jem.20010670; Buffa V, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050529; Donnelly L, 2011, VACCINE, V29, P4512, DOI 10.1016/j.vaccine.2011.04.023; Hargreaves DC, 2001, J EXP MED, V194, P45, DOI 10.1084/jem.194.1.45; Hauser AE, 2002, J IMMUNOL, V169, P1277, DOI 10.4049/jimmunol.169.3.1277; Haynes BF, 2012, NEW ENGL J MED, V366, P1275, DOI 10.1056/NEJMoa1113425; Holmgren J, 2005, NAT MED, V11, pS45, DOI 10.1038/nm1213; Hope TJ, 2011, NAT MED, V17, P1195, DOI 10.1038/nm.2528; Hu K, 2013, J IMMUNOL, V191, P1935, DOI 10.4049/jimmunol.1300120; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kunkel EJ, 2002, IMMUNITY, V16, P1, DOI 10.1016/S1074-7613(01)00261-8; Lazarus NH, 2003, J IMMUNOL, V170, P3799, DOI 10.4049/jimmunol.170.7.3799; Loebbermann J, 2013, P NATL ACAD SCI USA, V110, P2987, DOI 10.1073/pnas.1217580110; Mann JFS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067412; Mascola JR, 2010, ANNU REV IMMUNOL, V28, P413, DOI 10.1146/annurev-immunol-030409-101256; Naranbhai V, 2012, J INFECT DIS, V206, P993, DOI 10.1093/infdis/jis465; Okada T, 2002, J EXP MED, V196, P65, DOI 10.1084/jem.20020201; Rainone V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026979; Reed SG, 2009, TRENDS IMMUNOL, V30, P23, DOI 10.1016/j.it.2008.09.006; Shang LM, 2008, GASTROENTEROLOGY, V135, P529, DOI 10.1053/j.gastro.2008.04.020; Shin HN, 2012, NATURE, V491, P463, DOI 10.1038/nature11522; Stein JV, 2005, IMMUNOLOGY, V116, P1, DOI 10.1111/j.1365-2567.2005.02183.x; Su L, 2000, J VIROL, V74, P11367, DOI 10.1128/JVI.74.23.11367-11376.2000; Van Roey GA, 2012, EUR J IMMUNOL, V42, P353, DOI 10.1002/eji.201141787; Wrammert J, 2008, NATURE, V453, P667, DOI 10.1038/nature06890	28	14	15	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80559	10.1371/journal.pone.0080559	http://dx.doi.org/10.1371/journal.pone.0080559			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260419	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900071
J	Sjeklocha, LM; Wong, PYP; Belcher, JD; Vercellotti, GM; Steer, CJ				Sjeklocha, Lucas M.; Wong, Phillip Y. -P.; Belcher, John D.; Vercellotti, Gregory M.; Steer, Clifford J.			beta-Globin Sleeping Beauty Transposon Reduces Red Blood Cell Sickling in a Patient-Derived CD34(+)-Based In Vitro Model	PLOS ONE			English	Article							STABLE GENE-TRANSFER; HEMATOPOIETIC STEM-CELLS; LENTIVIRAL VECTORS; PROGENITOR CELLS; MOUSE MODEL; DISEASE; SYSTEM; THERAPY; EXPRESSION; ANEMIA	The ultimate goal of gene therapy for sickle cell anemia (SCA) is an improved phenotype for the patient. In this study, we utilized bone marrow from a sickle cell patient as a model of disease in an in vitro setting for the hyperactive Sleeping Beauty transposon gene therapy system. We demonstrated that mature sickle red blood cells containing hemoglobin-S and sickling in response to metabisulfite can be generated in vitro from SCA bone marrow. These cells showed the characteristic morphology and kinetics of hemoglobin-S polymerization, which we quantified using video microscopy and imaging cytometry. Using video assessment, we showed that delivery of an IHK-beta(T87Q) antisickling globin gene by Sleeping Beauty via nucleofection improves metrics of sickling, decreasing percent sickled from 53.2 +/- 2.2% to 43.9 +/- 2.0%, increasing the median time to sickling from 8.5 to 9.6 min and decreasing the maximum rate of sickling from 2.3 x 10(-3) sickling cells/total cells/sec in controls to 1.26 x 10(-3) sickling cells/total cells/sec in the IHK-beta(T87Q)-globin group (p < 0.001). Using imaging cytometry, the percentage of elongated sickled cells decreased from 34.8 +/- 4.5% to 29.5 +/- 3.0% in control versus treated (p < 0.05). These results support the potential use of Sleeping Beauty as a clinical gene therapy vector and provide a useful tool for studying sickle red blood cells in vitro.	[Sjeklocha, Lucas M.; Wong, Phillip Y. -P.; Steer, Clifford J.] Univ Minnesota, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Minneapolis, MN 55455 USA; [Belcher, John D.; Vercellotti, Gregory M.] Univ Minnesota, Sch Med, Vasc Biol Ctr, Minneapolis, MN 55455 USA; [Belcher, John D.; Vercellotti, Gregory M.] Univ Minnesota, Sch Med, Dept Med, Div Hematol Oncol & Transplantat, Minneapolis, MN 55455 USA; [Steer, Clifford J.] Univ Minnesota, Dept Genet Cell Biol & Dev, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Steer, CJ (corresponding author), Univ Minnesota, Sch Med, Dept Med, Div Gastroenterol Hepatol & Nutr, Minneapolis, MN 55455 USA.	steer001@umn.edu		Sjeklocha, Lucas/0000-0003-0658-3377	National Institutes of Health (NIH) [R21/33 HL096469-01]; NATIONAL CANCER INSTITUTE [P30CA077598] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL096469] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	These studies were supported by National Institutes of Health (NIH) grant R21/33 HL096469-01. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aronovich EL, 2011, HUM MOL GENET, V20, pR14, DOI 10.1093/hmg/ddr140; Asakura T, 1996, BLOOD CELL MOL DIS, V22, P297, DOI 10.1006/bcmd.1996.0112; Ballas SK, 2002, DRUGS, V62, P1143, DOI 10.2165/00003495-200262080-00003; Cavazzana-Calvo M, 2010, NATURE, V467, P318, DOI 10.1038/nature09328; Ciuffi A, 2006, MOL THER, V13, P366, DOI 10.1016/j.ymthe.2005.10.009; Gassmann M, 2009, ELECTROPHORESIS, V30, P1845, DOI 10.1002/elps.200800720; Geurts AM, 2003, MOL THER, V8, P108, DOI 10.1016/S1525-0016(03)00099-6; Giarratana MC, 2011, BLOOD, V118, P5071, DOI 10.1182/blood-2011-06-362038; Giarratana MC, 2005, NAT BIOTECHNOL, V23, P69, DOI 10.1038/nbt1047; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; HEBBEL RP, 1991, BLOOD, V77, P214; Hollis RP, 2006, EXP HEMATOL, V34, P1333, DOI 10.1016/j.exphem.2006.05.023; Hsieh MM, 2011, BLOOD, V118, P1197, DOI 10.1182/blood-2011-01-332510; Hsieh MM, 2009, NEW ENGL J MED, V361, P2309, DOI 10.1056/NEJMoa0904971; Huang X, 2010, MOL THER, V18, P1803, DOI 10.1038/mt.2010.141; Ivics Z, 2011, HUM GENE THER, V22, P1043, DOI 10.1089/hum.2011.143; Kobari L, 2012, HAEMATOL-HEMATOL J, V97, P1795, DOI 10.3324/haematol.2011.055566; Laufs S, 2004, MOL THER, V10, P874, DOI 10.1016/j.ymthe.2004.08.001; Levasseur DN, 2003, BLOOD, V102, P4312, DOI 10.1182/blood-2003-04-1251; Levasseur DN, 2004, J BIOL CHEM, V279, P27518, DOI 10.1074/jbc.M402578200; Mates L, 2009, NAT GENET, V41, P753, DOI 10.1038/ng.343; MCCUNE SL, 1994, P NATL ACAD SCI USA, V91, P9852, DOI 10.1073/pnas.91.21.9852; Moldt B, 2011, MOL THER, V19, P1499, DOI 10.1038/mt.2011.47; Moreau-Gaudry F, 2001, BLOOD, V98, P2664, DOI 10.1182/blood.V98.9.2664; Obata K, 2006, AM J HEMATOL, V81, P26, DOI 10.1002/ajh.20514; PAULING L, 1949, SCIENCE, V109, P443; Perumbeti A, 2009, BLOOD, V114, P1174, DOI 10.1182/blood-2009-01-201863; Rees DC, 2012, BRIT J HAEMATOL, V156, P433, DOI 10.1111/j.1365-2141.2011.08961.x; Sebastiano V, 2011, STEM CELLS, V29, P1717, DOI 10.1002/stem.718; Sjeklocha LM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029110; Tsiftsoglou AS, 2009, IUBMB LIFE, V61, P800, DOI 10.1002/iub.226; Williams DA, 2008, MOL THER, V16, P1515, DOI 10.1038/mt.2008.169; Xue XK, 2009, BLOOD, V114, P1319, DOI 10.1182/blood-2009-03-210005; Zhu JH, 2007, BIOCHEMISTRY-US, V46, P6844, DOI 10.1021/bi6024484; Zou JZ, 2011, BLOOD, V118, P4599, DOI 10.1182/blood-2011-02-335554	35	13	13	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80403	10.1371/journal.pone.0080403	http://dx.doi.org/10.1371/journal.pone.0080403			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260386	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500134
J	Zylla, MM; Zhang, XM; Reichinnek, S; Draguhn, A; Both, M				Zylla, Maura M.; Zhang, Xiaomin; Reichinnek, Susanne; Draguhn, Andreas; Both, Martin			Cholinergic Plasticity of Oscillating Neuronal Assemblies in Mouse Hippocampal Slices	PLOS ONE			English	Article							LONG-TERM POTENTIATION; HIGH-FREQUENCY OSCILLATIONS; WAVE-RIPPLE COMPLEXES; IN-VITRO; NETWORK OSCILLATIONS; BEHAVING RAT; THETA-RHYTHM; ACETYLCHOLINE-RELEASE; SYNAPTIC PLASTICITY; NOVELTY DETECTION	The mammalian hippocampus expresses several types of network oscillations which entrain neurons into transiently stable assemblies. These groups of co-active neurons are believed to support the formation, consolidation and recall of context-dependent memories. Formation of new assemblies occurs during theta-and gamma-oscillations under conditions of high cholinergic activity. Memory consolidation is linked to sharp wave-ripple oscillations (SPW-R) during decreased cholinergic tone. We hypothesized that increased cholinergic tone supports plastic changes of assemblies while low cholinergic tone favors their stability. Coherent spatiotemporal network patterns were measured during SPW-R activity in mouse hippocampal slices. We compared neuronal activity within the oscillating assemblies before and after a transient phase of carbachol-induced gamma oscillations. Single units maintained their coupling to SPW-R throughout the experiment and could be re-identified after the transient phase of gamma oscillations. However, the frequency of SPW-R-related unit firing was enhanced after muscarinic stimulation. At the network level, these changes resulted in altered patterns of extracellularly recorded SPW-R waveforms. In contrast, recording of ongoing SPW-R activity without intermittent cholinergic stimulation revealed remarkably stable repetitive activation of assemblies. These results show that activation of cholinergic receptors induces plasticity at the level of oscillating hippocampal assemblies, in line with the different role of gamma-and SPW-R network activity for memory formation and -consolidation, respectively.	[Zylla, Maura M.; Zhang, Xiaomin; Reichinnek, Susanne; Draguhn, Andreas; Both, Martin] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany	Ruprecht Karls University Heidelberg	Both, M (corresponding author), Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.	mboth@physiologie.uni-heidelberg.de	Zhang, Xiaomin/GVT-8927-2022	Zhang, Xiaomin/0000-0003-0256-6529	German Research Foundation (DFG); German Ministry of Education and Science (BMBF) [SFB 636]	German Research Foundation (DFG)(German Research Foundation (DFG)); German Ministry of Education and Science (BMBF)(Federal Ministry of Education & Research (BMBF))	Grant sponsor: German Research Foundation (DFG) and German Ministry of Education and Science (BMBF); Grant number SFB 636 and BCCN B3. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahner F, 2011, P NATL ACAD SCI USA, V108, pE607, DOI 10.1073/pnas.1103546108; Bedard C, 2004, BIOPHYS J, V86, P1829, DOI 10.1016/S0006-3495(04)74250-2; Behrens CJ, 2005, NAT NEUROSCI, V8, P1560, DOI 10.1038/nn1571; Blanche TJ, 2006, J NEUROSCI METH, V155, P81, DOI 10.1016/j.jneumeth.2005.12.031; Both M, 2008, HIPPOCAMPUS, V18, P899, DOI 10.1002/hipo.20446; BRAGIN A, 1995, J NEUROSCI, V15, P47; Bukalo O, 2013, P NATL ACAD SCI USA, V110, P5175, DOI 10.1073/pnas.1210735110; Buzsaki G, 1996, CEREB CORTEX, V6, P81, DOI 10.1093/cercor/6.2.81; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; BUZSAKI G, 1985, ELECTROEN CLIN NEURO, V61, P77, DOI 10.1016/0013-4694(85)91075-2; BUZSAKI G, 1989, NEUROSCIENCE, V31, P551, DOI 10.1016/0306-4522(89)90423-5; BUZSAKI G, 1992, SCIENCE, V256, P1025, DOI 10.1126/science.1589772; Buzsaki G, 2010, NEURON, V68, P362, DOI 10.1016/j.neuron.2010.09.023; Carr MF, 2011, NAT NEUROSCI, V14, P147, DOI 10.1038/nn.2732; Chrobak JJ, 1996, J NEUROSCI, V16, P3056; Colgin LL, 2003, P NATL ACAD SCI USA, V100, P2872, DOI 10.1073/pnas.0530289100; Csicsvari J, 2000, NEURON, V28, P585, DOI 10.1016/S0896-6273(00)00135-5; Csicsvari J, 1999, J NEUROSCI, V19, P274, DOI 10.1523/JNEUROSCI.19-01-00274.1999; D'Antuono M, 2007, NEUROPHARMACOLOGY, V52, P1291, DOI 10.1016/j.neuropharm.2007.01.008; Davidson TJ, 2009, NEURON, V63, P497, DOI 10.1016/j.neuron.2009.07.027; Ego-Stengel V, 2010, HIPPOCAMPUS, V20, P1, DOI 10.1002/hipo.20707; Egorov AV, 2003, EUR J NEUROSCI, V18, P3343, DOI 10.1111/j.1460-9568.2003.03050.x; Ellender TJ, 2010, J NEUROSCI, V30, P5979, DOI 10.1523/JNEUROSCI.3962-09.2010; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fisahn A, 1998, NATURE, V394, P186, DOI 10.1038/28179; Foster DJ, 2006, NATURE, V440, P680, DOI 10.1038/nature04587; Frank LM, 2006, HIPPOCAMPUS, V16, P775, DOI 10.1002/hipo.20200; Girardeau G, 2009, NAT NEUROSCI, V12, P1222, DOI 10.1038/nn.2384; Grosmark AD, 2012, NEURON, V75, P1001, DOI 10.1016/j.neuron.2012.08.015; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Harris KD, 2003, NATURE, V424, P552, DOI 10.1038/nature01834; Hasselmo ME, 2006, J MOL NEUROSCI, V30, P133, DOI 10.1385/JMN:30:1:133; Hasselmo ME, 2004, PROG BRAIN RES, V145, P207, DOI 10.1016/S0079-6123(03)45015-2; HASSELMO ME, 1995, J NEUROSCI, V15, P6592; Hazan L, 2006, J NEUROSCI METH, V155, P207, DOI 10.1016/j.jneumeth.2006.01.017; Hebb D. O., 1949, ORG BEHAV NEUROPHYSI; Jadhav SP, 2012, SCIENCE, V336, P1454, DOI 10.1126/science.1217230; Jensen O, 2005, TRENDS NEUROSCI, V28, P67, DOI 10.1016/j.tins.2004.12.001; King C, 1999, J PHYSIOL-LONDON, V521, P159, DOI 10.1111/j.1469-7793.1999.00159.x; Kobayashi K, 2004, NEURON, V41, P445, DOI 10.1016/S0896-6273(03)00873-0; Kohling R, 1998, BRAIN, V121, P1073, DOI 10.1093/brain/121.6.1073; Kubota D, 2003, J NEUROPHYSIOL, V89, P81, DOI 10.1152/jn.00542.2002; Lee AK, 2002, NEURON, V36, P1183, DOI 10.1016/S0896-6273(02)01096-6; Leung LS, 2003, J NEUROSCI, V23, P9297; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb JK, 2005, NEURON, V48, P345, DOI 10.1016/j.neuron.2005.09.007; Linden H, 2011, NEURON, V72, P859, DOI 10.1016/j.neuron.2011.11.006; Lisman JE, 2001, HIPPOCAMPUS, V11, P551; Lisman JE, 1999, NEURON, V22, P233, DOI 10.1016/S0896-6273(00)81085-5; Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209; Maier N, 2003, J PHYSIOL-LONDON, V550, P873, DOI 10.1113/jphysiol.2003.044602; Mann EO, 2007, TRENDS NEUROSCI, V30, P343, DOI 10.1016/j.tins.2007.05.003; Markram Henry, 2011, Front Synaptic Neurosci, V3, P4, DOI 10.3389/fnsyn.2011.00004; MARROSU F, 1995, BRAIN RES, V671, P329, DOI 10.1016/0006-8993(94)01399-3; Memmesheimer RM, 2010, P NATL ACAD SCI USA, V107, P11092, DOI 10.1073/pnas.0909615107; Monmaur P, 1997, BRAIN RES BULL, V42, P141, DOI 10.1016/S0361-9230(96)00200-6; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Oren I, 2010, J PHYSIOL-LONDON, V588, P785, DOI 10.1113/jphysiol.2009.180851; Ovsepian SV, 2004, EUR J NEUROSCI, V20, P1267, DOI 10.1111/j.1460-9568.2004.03582.x; Ovsepian SV, 2006, NEUROSCI LETT, V393, P1, DOI 10.1016/j.neulet.2005.09.035; Patil MM, 1998, J NEUROPHYSIOL, V80, P2467, DOI 10.1152/jn.1998.80.5.2467; Reichinnek S, 2010, J NEUROSCI, V30, P15441, DOI 10.1523/JNEUROSCI.2535-10.2010; Shoham S, 2006, J COMP PHYSIOL A, V192, P777, DOI 10.1007/s00359-006-0117-6; Skaggs WE, 1996, SCIENCE, V271, P1870, DOI 10.1126/science.271.5257.1870; Traub RD, 2004, ANNU REV NEUROSCI, V27, P247, DOI 10.1146/annurev.neuro.27.070203.144303; Traub RD, 2000, EUR J NEUROSCI, V12, P4093, DOI 10.1046/j.1460-9568.2000.00300.x; Traub RD, 2012, EUR J NEUROSCI, V36, P2650, DOI 10.1111/j.1460-9568.2012.08184.x; Vago DR, 2008, BEHAV BRAIN RES, V189, P273, DOI 10.1016/j.bbr.2008.01.002; VANDERWOLF CH, 1969, ELECTROEN CLIN NEURO, V26, P407, DOI 10.1016/0013-4694(69)90092-3; WILSON MA, 1994, SCIENCE, V265, P676, DOI 10.1126/science.8036517; YLINEN A, 1995, J NEUROSCI, V15, P30	71	17	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80718	10.1371/journal.pone.0080718	http://dx.doi.org/10.1371/journal.pone.0080718			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260462	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500169
J	Peille, AL; Brouste, V; Kauffmann, A; Lagarde, P; Le Morvan, V; Coindre, JM; Chibon, F; Bresson-Bepoldin, L				Peille, Anne-Lise; Brouste, Veronique; Kauffmann, Audrey; Lagarde, Pauline; Le Morvan, Valerie; Coindre, Jean-Michel; Chibon, Frederic; Bresson-Bepoldin, Laurence			Prognostic Value of PLAGL1-Specific CpG Site Methylation in Soft-Tissue Sarcomas	PLOS ONE			English	Article							MALIGNANT FIBROUS HISTIOCYTOMAS; DNA METHYLATION; ISLAND METHYLATION; GENE; EXPRESSION; CANCER; CELL; DIFFERENTIATION; ZAC/PLAGL1; SUBGROUP	Soft tissue sarcomas (STS) are rare, complex tumors with a poor prognosis. The identification of new prognostic biomarkers is needed to improve patient management. Our aim was to determine the methylation status of the 118 CpG sites in the PLAGL1 tumor-suppressor gene P1 CpG island promoter and study the potential prognostic impact of PLAGL1 promoter methylation CpG sites in STS. Training cohorts constituted of 28 undifferentiated sarcomas (US) and 35 leiomyosarcomas (LMS) were studied. PLAGL1 mRNA expression was investigated by microarray analysis and validated by RT-qPCR. Pyrosequencing was used to analyze quantitative methylation of the PLAGL1 promoter. Associations between global promoter or specific CpG site methylation and mRNA expression were evaluated using Pearson's product moment correlation coefficient. Cox univariate and multivariate proportional hazard models were used to assess the predictive power of CpG site methylation status. Sixteen CpG sites associated with PLAGL1 mRNA expression were identified in US and 6 in LMS. Statistical analyses revealed an association between CpG107 methylation status and both overall and metastasis-free survival in US, which was confirmed in a validation cohort of 37 US. The exhaustive study of P1 PLAGL1 promoter methylation identified a specific CpG site methylation correlated with mRNA expression, which was predictive for both metastasis-free and overall survival and may constitute the first US-specific biomarker. Such a biomarker may be relevant for identifying patients likely to derive greater benefit from treatment.	[Peille, Anne-Lise; Lagarde, Pauline; Le Morvan, Valerie; Chibon, Frederic; Bresson-Bepoldin, Laurence] Ctr Comprehens Canc, Inst Bergonie, Bordeaux, France; [Peille, Anne-Lise; Lagarde, Pauline; Le Morvan, Valerie; Chibon, Frederic; Bresson-Bepoldin, Laurence] Univ Bordeaux, Bordeaux, France; [Peille, Anne-Lise; Lagarde, Pauline; Le Morvan, Valerie; Chibon, Frederic; Bresson-Bepoldin, Laurence] INSERM U916 VINCO, Bordeaux, France; [Brouste, Veronique] Ctr Comprehens Canc, Inst Bergonie, Clin & Epidemiol Res Unit, Bordeaux, France; [Kauffmann, Audrey] Ctr Comprehens Canc, Inst Bergonie, Dept Bioinformat, Bordeaux, France; [Coindre, Jean-Michel; Chibon, Frederic] Ctr Comprehens Canc, Inst Bergonie, Dept Biopathol, Bordeaux, France	UNICANCER; Centre Eugene Marquis; Institut Bergonie; UDICE-French Research Universities; Universite de Bordeaux; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UNICANCER; Centre Eugene Marquis; Institut Bergonie; UNICANCER; Centre Eugene Marquis; Institut Bergonie; UNICANCER; Centre Eugene Marquis; Institut Bergonie	Bresson-Bepoldin, L (corresponding author), Ctr Comprehens Canc, Inst Bergonie, Bordeaux, France.	laurence.bresson-bepoldin@inserm.fr	chibon, frederic/A-2651-2013	chibon, Frederic/0000-0002-6548-2181; Laurence, Bresson-Bepoldin/0000-0002-8829-9945	Institut national de la sante et de la recherche medicale; University of Bordeaux 2 Victor Segalen	Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); University of Bordeaux 2 Victor Segalen	This work was supported by Institut national de la sante et de la recherche medicale and the University of Bordeaux 2 Victor Segalen. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdollahi A, 2007, J CELL PHYSIOL, V210, P16, DOI 10.1002/jcp.20835; Basyuk E, 2005, MOL CANCER RES, V3, P483, DOI 10.1158/1541-7786.MCR-05-0019; Bohlig L, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/464916; Brinck U, 1995, In Vivo, V9, P475; Casorzo L, 2005, MELANOMA RES, V15, P155, DOI 10.1097/00008390-200506000-00003; Chibon F, 2003, CANCER GENET CYTOGEN, V141, P75, DOI 10.1016/S0165-4608(02)00664-7; Chibon F, 2002, CANCER GENET CYTOGEN, V139, P24, DOI 10.1016/S0165-4608(02)00614-3; Chibon F, 2010, NAT MED, V16, P781, DOI 10.1038/nm.2174; Claus R, 2012, J CLIN ONCOL, V30, P2483, DOI 10.1200/JCO.2011.39.3090; Coindre JM, 2003, MODERN PATHOL, V16, P256, DOI 10.1097/01.MP.0000056983.78547.77; Demicco EG, 2011, SEMIN ONCOL, V38, pS3, DOI 10.1053/j.seminoncol.2011.09.001; Derre J, 2001, LAB INVEST, V81, P211, DOI 10.1038/labinvest.3780229; Ge MH, 2011, HUM PATHOL, V42, P1862, DOI 10.1016/j.humpath.2011.02.003; Graff JR, 1998, CANCER RES, V58, P2063; Heyn H, 2012, NAT REV GENET, V13, P679, DOI 10.1038/nrg3270; Hide T, 2009, CANCER RES, V69, P7953, DOI 10.1158/0008-5472.CAN-09-2006; Idbaih A, 2005, LAB INVEST, V85, P176, DOI 10.1038/labinvest.3700202; Issa JP, 2012, J CLIN ONCOL, V30, P2566, DOI 10.1200/JCO.2012.42.1016; Jiang J, 2012, GYNECOL ONCOL, V124, P534, DOI 10.1016/j.ygyno.2011.11.023; Karayan-Tapon L, 2010, J NEURO-ONCOL, V97, P311, DOI 10.1007/s11060-009-0031-1; Kawaguchi K, 2006, MODERN PATHOL, V19, P106, DOI 10.1038/modpathol.3800502; Kim JI, 2009, HUM PATHOL, V40, P934, DOI 10.1016/j.humpath.2009.01.005; Kulis M, 2010, ADV GENET, V70, P27, DOI [10.1016/S0065-2660(10)70002-X, 10.1016/B978-0-12-380866-0.60002-2]; La Rosa P, 2006, BIOINFORMATICS, V22, P2066, DOI 10.1093/bioinformatics/btl359; Li L, 2010, ANN ANAT, V192, P275, DOI 10.1016/j.aanat.2010.07.010; Lim SP, 2012, EUR J CANCER, V48, P3300, DOI 10.1016/j.ejca.2012.03.023; Markl IDC, 2001, CANCER RES, V61, P5875; Miyajima K, 2003, PATHOL INT, V53, P163, DOI 10.1046/j.1440-1827.2003.01449.x; O'Brien P, 2011, CANCER RES, V71, P7345, DOI 10.1158/0008-5472.CAN-11-1874; Perot G, 2010, AM J PATHOL, V177, P2080, DOI 10.2353/ajpath.2010.100104; Rezvani G, 2012, PEDIATR RES, V71, P32, DOI 10.1038/pr.2011.6; Siddiqi S, 2010, CURR STEM CELL RES T, V5, P63, DOI 10.2174/157488810790442859; Smyth GK., 2005, LIMMA LINEAR MODELS; Sohn BH, 2010, GASTROENTEROLOGY, V138, P1898, DOI 10.1053/j.gastro.2009.12.044; Spengler D, 1997, EMBO J, V16, P2814, DOI 10.1093/emboj/16.10.2814; Taborelli M, 2006, CANCER GENET CYTOGEN, V165, P106, DOI 10.1016/j.cancergencyto.2005.06.025; Valleley EM, 2007, HUM MOL GENET, V16, P972, DOI 10.1093/hmg/ddm041; Valleley EMA, 2010, GENE CHROMOSOME CANC, V49, P480, DOI 10.1002/gcc.20758; Varrault A, 1998, P NATL ACAD SCI USA, V95, P8835, DOI 10.1073/pnas.95.15.8835; Varrault A, 2006, DEV CELL, V11, P711, DOI 10.1016/j.devcel.2006.09.003; Vincent-Salomon A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1666	41	11	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80741	10.1371/journal.pone.0080741	http://dx.doi.org/10.1371/journal.pone.0080741			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260468	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600082
J	Davies, NA; Gramotnev, G; McAlpine, C; Seabrook, L; Baxter, G; Lunney, D; Rhodes, JR; Bradley, A				Davies, Nicole Ashley; Gramotnev, Galina; McAlpine, Clive; Seabrook, Leonie; Baxter, Greg; Lunney, Daniel; Rhodes, Jonathan R.; Bradley, Adrian			Physiological Stress in Koala Populations near the Arid Edge of Their Distribution	PLOS ONE			English	Article							FECAL CORTISOL-LEVELS; PHASCOLARCTOS-CINEREUS POPULATIONS; SOUTH-WEST QUEENSLAND; GLUCOCORTICOID METABOLITES; CORTICOSTEROID LEVELS; ENVIRONMENTAL-STRESS; ADRENAL ACTIVITY; PREDATION RISK; CLIMATE-CHANGE; SNOWSHOE HARE	Recent research has shown that the ecology of stress has hitherto been neglected, but it is in fact an important influence on the distribution and numbers of wild vertebrates. Environmental changes have the potential to cause physiological stress that can affect population dynamics. Detailed information on the influence of environmental variables on glucocorticoid levels (a measure of stress) at the trailing edge of a species' distribution can highlight stressors that potentially threaten species and thereby help explain how environmental challenges, such as climate change, will affect the survival of these populations. Rainfall determines leaf moisture and/or nutritional content, which in turn impacts on cortisol concentrations. We show that higher faecal cortisol metabolite (FCM) levels in koala populations at the trailing arid edge of their range in southwestern Queensland are associated with lower rainfall levels (especially rainfall from the previous two months), indicating an increase in physiological stress when moisture levels are low. These results show that koalas at the semi-arid, inland edge of their geographic range, will fail to cope with increasing aridity from climate change. The results demonstrate the importance of integrating physiological assessments into ecological studies to identify stressors that have the potential to compromise the long-term survival of threatened species. This finding points to the need for research to link these stressors to demographic decline to ensure a more comprehensive understanding of species' responses to climate change.	[Davies, Nicole Ashley; Bradley, Adrian] Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia; [Gramotnev, Galina; McAlpine, Clive; Seabrook, Leonie; Baxter, Greg; Rhodes, Jonathan R.] Univ Queensland, Landscape Ecol & Conservat Grp, Sch Geog Planning & Environm Management, St Lucia, Qld, Australia; [Lunney, Daniel] Off Environm & Heritage New South Wales, Hurstville, NSW, Australia; [Lunney, Daniel] Murdoch Univ, Sch Vet & Life Sci, Perth, WA, Australia	University of Queensland; University of Queensland; Office of Environment & Heritage - New South Wales; Murdoch University	Davies, NA (corresponding author), Univ Queensland, Sch Biomed Sci, St Lucia, Qld, Australia.	n.davies1@uq.edu.au	Seabrook, Leonie M K/D-2992-2009; Rhodes, Jonathan R/C-4841-2008	Seabrook, Leonie M K/0000-0001-5602-5168; Rhodes, Jonathan R/0000-0001-6746-7412; Lunney, Dan/0000-0002-5771-0746; McAlpine, Clive/0000-0003-0457-8144; Gramotnev, Galina/0000-0002-9091-6359	Australian Koala Foundation; Australian Research Council; South West NRM	Australian Koala Foundation; Australian Research Council(Australian Research Council); South West NRM	Funding was provided by The Australian Koala Foundation, Australian Research Council and South West NRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Australian Bureau of Meteorology CSIRO], 2007, CLIM CHANG AUSTR TEC; Australian Soil Resource Information System, 2011, ATL AUSTR SOILS; AXELROD J, 1984, SCIENCE, V224, P452, DOI 10.1126/science.6143403; Badyaev Alexander V., 2005, P277, DOI 10.1016/B978-012088777-4/50015-6; Badyaev AV, 2005, P ROY SOC B-BIOL SCI, V272, P877, DOI 10.1098/rspb.2004.3045; Beehner JC, 2008, PHYSIOL BEHAV, V95, P508, DOI 10.1016/j.physbeh.2008.07.022; Bijlsma R, 2005, J EVOLUTION BIOL, V18, P744, DOI 10.1111/j.1420-9101.2005.00962.x; Boonstra R, 1998, ECOL MONOGR, V68, P371, DOI 10.1890/0012-9615(1998)068[0371:TIOPIS]2.0.CO;2; BOONSTRA R, 1993, GEN COMP ENDOCR, V91, P126, DOI 10.1006/gcen.1993.1113; Boonstra R, 2013, FUNCT ECOL, V27, P7, DOI 10.1111/1365-2435.12048; Boonstra R, 2013, FUNCT ECOL, V27, P11, DOI 10.1111/1365-2435.12008; Busch DS, 2009, BIOL CONSERV, V142, P2844, DOI 10.1016/j.biocon.2009.08.013; Cai W, 2005, CLIMATE CHANGE QUEEN; Cavigelli SA, 1999, ANIM BEHAV, V57, P935, DOI 10.1006/anbe.1998.1054; Cavigellil SA, 2005, J ENDOCRINOL, V184, P153, DOI 10.1677/joe.1.05935; Charbonnel N, 2008, PHYSIOL BIOCHEM ZOOL, V81, P63, DOI 10.1086/523306; Creel S, 2002, CONSERV BIOL, V16, P809, DOI 10.1046/j.1523-1739.2002.00554.x; Creel S, 2009, P NATL ACAD SCI USA, V106, P12388, DOI 10.1073/pnas.0902235106; Crowther MS, ECOGRAPHY IN PRESS; Dallman M.F., 2001, HDB PHYSL 7, VIV, P179; Davenport MD, 2006, GEN COMP ENDOCR, V147, P255, DOI 10.1016/j.ygcen.2006.01.005; DAVENPORT ML, 1993, INT J REMOTE SENS, V14, P2369, DOI 10.1080/01431169308954042; Davies N, 2013, MOV ECOL, V1, DOI 10.1186/2051-3933-1-8; Davies N, 2013, J ENDOCRINOL, V219, P1, DOI 10.1530/JOE-13-0123; DeGabriel JL, 2010, CHEMOECOLOGY, V20, P97, DOI 10.1007/s00049-009-0037-3; DEGABRIELE R, 1979, J COMP PHYSIOL, V134, P293, DOI 10.1007/BF00709996; Department of Environment and Resource Management, 2012, SOILS QUEENSL; DOBSON H, 1995, J REPROD FERTIL, P451; Ellis W., 2010, Australian Zoologist, V35, P369; Foley CAH, 2001, CONSERV BIOL, V15, P1134, DOI 10.1046/j.1523-1739.2001.0150041134.x; Gary JM, 2002, PREDICTING SOIL DIST; GORDON G, 1988, AUST J ECOL, V13, P451, DOI 10.1111/j.1442-9993.1988.tb00993.x; Gordon G., 1990, P85; Goymann W, 1999, GEN COMP ENDOCR, V114, P340, DOI 10.1006/gcen.1999.7268; Goymann W, 2005, ANN NY ACAD SCI, V1046, P35, DOI 10.1196/annals.1343.005; Goymann W, 2001, P ROY SOC B-BIOL SCI, V268, P2453, DOI 10.1098/rspb.2001.1828; Goymann W, 2012, METHODS ECOL EVOL, V3, P757, DOI 10.1111/j.2041-210X.2012.00203.x; Hampe A, 2005, ECOL LETT, V8, P461, DOI 10.1111/j.1461-0248.2005.00739.x; Hanger J, 2009, LISM KOAL CONS C LIS; Harper JM, 2001, GEN COMP ENDOCR, V123, P337, DOI 10.1006/gcen.2001.7682; Harper JM, 2000, PHYSIOL BIOCHEM ZOOL, V73, P12, DOI 10.1086/316721; HENDERSON CR, 1975, BIOMETRICS, V31, P423, DOI 10.2307/2529430; Hoffmann A.A., 1991, EVOLUTIONARY GENETIC; Hoffmann AA, 2000, BIOSCIENCE, V50, P217, DOI 10.1641/0006-3568(2000)050[0217:ESAAEF]2.3.CO;2; Hoffmann AA, 1997, EXTREME ENV CHANGE E; Hogan LA, 2012, GEN COMP ENDOCR, V179, P376, DOI 10.1016/j.ygcen.2012.09.020; Hogan LA, 2011, APPL ANIM BEHAV SCI, V134, P217, DOI 10.1016/j.applanim.2011.07.010; Huber S, 2003, GEN COMP ENDOCR, V130, P48, DOI 10.1016/S0016-6480(02)00535-X; IPCC, 2007, CLIM CHANG 2007 PHYS; Jessop TS, 2013, FUNCT ECOL, V27, P120, DOI 10.1111/j.1365-2435.2012.02057.x; Karabulut Murat, 2003, Turkish Journal of Botany, V27, P93; Kataria N, 2004, J CAMEL PRACT RES, V11, P129; Keay JM, 2006, J ZOO WILDLIFE MED, V37, P234, DOI 10.1638/05-050.1; Kenagy GJ, 2000, GEN COMP ENDOCR, V117, P189, DOI 10.1006/gcen.1999.7397; Klasing KC, 2005, ANN NY ACAD SCI, V1046, P5, DOI 10.1196/annals.1343.003; Koren L, 2002, ANIM BEHAV, V63, P403, DOI 10.1006/anbe.2001.1907; Lane J, 2006, ANIM WELFARE, V15, P331; Lee AK., 1985, EVOL ECOL; LIPTRAP RM, 1993, ANN NY ACAD SCI, V697, P275, DOI 10.1111/j.1749-6632.1993.tb49941.x; Lunney Daniel, 2012, P150; MALO AR, 1990, J ARID ENVIRON, V19, P1; Mateo JM, 2006, HORM BEHAV, V50, P718, DOI 10.1016/j.yhbeh.2006.05.008; Matteri RL, 2000, BIOLOGY OF ANIMAL STRESS, P43, DOI 10.1079/9780851993591.0043; McEwen B. S., 1994, HOSTAGE BRAIN; McEwen BS, 2010, HORM BEHAV, V57, P105, DOI 10.1016/j.yhbeh.2009.09.011; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McKenzie S, 2005, COMP BIOCHEM PHYS A, V140, P81, DOI 10.1016/j.cbpb.2004.11.002; Megahed GA, 2008, REPROD DOMEST ANIM, V43, P672, DOI 10.1111/j.1439-0531.2007.00968.x; Melzer A., 1996, KOALAS RES MANAGEMEN, P17; Millspaugh JJ, 2004, GEN COMP ENDOCR, V138, P189, DOI 10.1016/j.ygcen.2004.07.002; Millspaugh JJ, 2003, GEN COMP ENDOCR, V132, P21, DOI 10.1016/S0016-6480(03)00061-3; Moberg G.P., 1985, ANIMAL STRESS; MOBERG GP, 1987, J AM VET MED ASSOC, V191, P1207; Monfort SL, 1998, J ZOO WILDLIFE MED, V29, P129; Moore BD, 2000, AUST J ZOOL, V48, P317, DOI 10.1071/ZO99034; Mostl E, 2002, VET RES COMMUN, V26, P127, DOI 10.1023/A:1014095618125; Mostl E, 2002, DOMEST ANIM ENDOCRIN, V23, P67, DOI 10.1016/S0739-7240(02)00146-7; MUNCK A, 1984, ENDOCR REV, V5, P25, DOI 10.1210/edrv-5-1-25; Munks SA, 1996, WILDLIFE RES, V23, P185, DOI 10.1071/WR9960185; Nalini Kataria, 2006, Slovenian Veterinary Research, V43, P135; Narayan EJ, 2013, GEN COMP ENDOCR, V187, P39, DOI 10.1016/j.ygcen.2013.03.021; Oates JE, 2007, GEN COMP ENDOCR, V150, P445, DOI 10.1016/j.ygcen.2006.11.004; Palme R, 2005, ANN NY ACAD SCI, V1040, P162, DOI 10.1196/annals.1327.021; Palme R, 2005, ANN NY ACAD SCI, V1046, P75, DOI 10.1196/annals.1343.007; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; PRIDE ER, 2004, BIOL LETT, V1, P60; Rangel-Negrin A, 2009, ANIM CONSERV, V12, P496, DOI 10.1111/j.1469-1795.2009.00280.x; REYNAERT R, 1976, HORM METAB RES, V8, P109, DOI 10.1055/s-0028-1093663; Romero LM, 2004, TRENDS ECOL EVOL, V19, P249, DOI 10.1016/j.tree.2004.03.008; Romero ML, 2007, INT J COMP PSYCHOL, V20, P89; Sapolsky R.M., 2002, BEHAV ENDOCRINOLOGY, V2nd, P409; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Sattler P., 1999, CONSERVATION STATUS; Schultner J, 2013, FUNCT ECOL, V27, P45, DOI 10.1111/j.1365-2435.2012.02058.x; Seabrook L, 2011, WILDLIFE RES, V38, P509, DOI 10.1071/WR11064; SEYLE H, 1936, NATURE, V138, P32; Sheriff MJ, 2011, OECOLOGIA, V166, P869, DOI 10.1007/s00442-011-1943-y; Sheriff MJ, 2010, GEN COMP ENDOCR, V166, P614, DOI 10.1016/j.ygcen.2009.12.017; Sheriff MJ, 2009, J COMP PHYSIOL B, V179, P305, DOI 10.1007/s00360-008-0314-4; Smith AG, 2013, AUSTRAL ECOL, V38, P230, DOI 10.1111/j.1442-9993.2012.02396.x; Smith MS, 2008, RANGELAND J, V30, P15, DOI 10.1071/RJ07052; Spinage CA, 1994, ELEPHANTS; StataCorp, 2011, STAT STAT SOFTW REL, P173; Stead-Richardson E, 2010, GEN COMP ENDOCR, V165, P155, DOI 10.1016/j.ygcen.2009.06.009; Stewart PM, 2003, WILLIAMS TXB ENDOCRI, P491; Strier KB, 1999, HORM BEHAV, V35, P125, DOI 10.1006/hbeh.1998.1505; Sullivan BJ, 2003, WILDLIFE RES, V30, P583, DOI 10.1071/WR02036; Sullivan BJ, 2003, WILDLIFE RES, V30, P331, DOI 10.1071/WR00032; Taylor W, 1971, Vitam Horm, V29, P201; Thackway R., 1995, INTERIM BIOGEOGRAPHI; Thiel D, 2008, J APPL ECOL, V45, P845, DOI 10.1111/j.1365-2664.2008.01465.x; Thomas CD, 2006, TRENDS ECOL EVOL, V21, P415, DOI 10.1016/j.tree.2006.05.012; Touma C, 2005, ANN NY ACAD SCI, V1046, P54, DOI 10.1196/annals.1343.006; Turner C. D., 1976, GEN ENDOCRINOLOGY; Wasser SK, 1997, CONSERV BIOL, V11, P1019, DOI 10.1046/j.1523-1739.1997.96240.x; Weingrill T, 2004, HORM BEHAV, V45, P259, DOI 10.1016/j.yhbeh.2003.12.004; WESTERN D, 1984, AFR J ECOL, V22, P229, DOI 10.1111/j.1365-2028.1984.tb00699.x; Wikelski M, 2006, TRENDS ECOL EVOL, V21, P38, DOI 10.1016/j.tree.2005.10.018; Wilson RJ, 2004, NATURE, V432, P393, DOI 10.1038/nature03031; Wingfield JC, 2005, J MAMMAL, V86, P248, DOI 10.1644/BHE-004.1; Wingfield JC, 2003, ANIM BEHAV, V66, P807, DOI 10.1006/anbe.2003.2298; Wingfield JC, 2002, INTEGR COMP BIOL, V42, P600, DOI 10.1093/icb/42.3.600; Wingfield JC, 1998, AM ZOOL, V38, P191, DOI 10.1093/icb/38.1.191; Wingfield JC, 2013, FUNCT ECOL, V27, P37, DOI 10.1111/1365-2435.12039; Wu Y, 2012, AUSTR ZOOLOGIST, V36, P93; Young IR, 2011, HORMONES REPROD VERT, V5; Young KM, 2004, GEN COMP ENDOCR, V137, P148, DOI 10.1016/j.ygcen.2004.02.016; Zanette LY, 2011, SCIENCE, V334, P1398, DOI 10.1126/science.1210908; ZIEGLER TE, 1995, HORM BEHAV, V29, P407, DOI 10.1006/hbeh.1995.1028; [No title captured]	130	36	37	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79136	10.1371/journal.pone.0079136	http://dx.doi.org/10.1371/journal.pone.0079136			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265749	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100082
J	Mao, CP; Brovarney, MR; Dabbagh, K; Birnbock, HF; Richter, WF; Del Nagro, CJ				Mao, Cheng-Ping; Brovarney, Martin R.; Dabbagh, Karim; Birnboeck, Herbert F.; Richter, Wolfgang F.; Del Nagro, Christopher J.			Subcutaneous versus Intravenous Administration of Rituximab: Pharmacokinetics, CD20 Target Coverage and B-Cell Depletion in Cynomolgus Monkeys	PLOS ONE			English	Article							CHRONIC LYMPHOCYTIC-LEUKEMIA; NON-HODGKINS-LYMPHOMA; MONOCLONAL-ANTIBODY; 1ST-LINE TREATMENT; IGG; ALEMTUZUMAB; MECHANISMS; RECEPTOR; MODEL; FCRN	The CD20-specific monoclonal antibody rituximab (MabThera (R), Rituxan (R)) is widely used as the backbone of treatment for patients with hematologic disorders. Intravenous administration of rituximab is associated with infusion times of 4-6 hours, and can be associated with infusion-related reactions. Subcutaneous administration of rituximab may reduce this and facilitate administration without infusion-related reactions. We sought to determine the feasibility of achieving equivalent efficacy (measured by endogenous B-cell depletion) and long-term durability of CD20 target coverage for subcutaneously administered rituximab compared with intravenous dosing. In these preclinical studies, male cynomolgus monkeys were treated with either intravenous rituximab or novel subcutaneous formulation of rituximab containing human recombinant DNA-derived hyaluronidase enzyme. Peripheral blood samples were analyzed for serum rituximab concentrations, peripheral B-cell depletion, and CD20 target coverage, including subset analysis according to CD21+ status. Distal lymph node B-cell depletion and CD20 target coverage were also measured. Initial peak serum concentrations of rituximab were significantly higher following intravenous administration than subcutaneous. However, the mean serum rituximab trough concentrations were comparable at 2 and 7 days post-first dose and 9 and 14 days post-second dose. Efficacy of B-cell depletion in both peripheral blood and distal lymph nodes was comparable for both methods. In lymph nodes, 9 days after the second dose with subcutaneous and intravenous rituximab, B-cell levels were decreased by 57% and 42% respectively. Similarly, levels of peripheral blood B cells were depleted by >94% for both subcutaneous and intravenous dosing at all time points. Long-term recovery of free unbound surface CD20 levels was similar, and the duration of B-cell depletion was equally sustained over 2 months for both methods. These results demonstrate that, despite initial peak serum drug level differences, subcutaneous rituximab has similar durability, pharmacodynamics, and efficacy compared with intravenous rituximab.	[Mao, Cheng-Ping; Brovarney, Martin R.; Dabbagh, Karim; Del Nagro, Christopher J.] Roche Palo Alto, Discovery Inflammat, Palo Alto, CA USA; [Birnboeck, Herbert F.; Richter, Wolfgang F.] Roche Basel, Drug Metab & Pharmacokinet, Basel, Switzerland; [Del Nagro, Christopher J.] Genentech Inc, Discovery Oncol, San Francisco, CA 94080 USA	Roche Holding; Roche Holding; Roche Holding; Genentech	Del Nagro, CJ (corresponding author), Roche Palo Alto, Discovery Inflammat, Palo Alto, CA USA.	delnagro.christopher@gene.com		Richter, Wolfgang/0000-0002-8094-8605	F. Hoffmann-La Roche	F. Hoffmann-La Roche(Hoffmann-La Roche)	All funding for work was provided by F. Hoffmann-La Roche. While the intended purpose of the study was to evaluate the potential for drug development, the fiscal source had no role in study design, data collection and analysis and preparation of the manuscript which was performed at the independent discretion of the researchers involved. The decision to publish the work was however held until developmental interests were secure.	[Anonymous], 2011, RIT PRESCR INF; Beers SA, 2010, BLOOD, V115, P5191, DOI 10.1182/blood-2010-01-263533; Bleeker WK, 2008, BRIT J HAEMATOL, V140, P303, DOI 10.1111/j.1365-2141.2007.06916.x; Bookbinder LH, 2006, J CONTROL RELEASE, V114, P230, DOI 10.1016/j.jconrel.2006.05.027; Dayde D, 2009, BLOOD, V113, P3765, DOI 10.1182/blood-2008-08-175125; Frost GI, 2007, EXPERT OPIN DRUG DEL, V4, P427, DOI 10.1517/17425247.4.4.427; Garg A, 2007, J PHARMACOKINET PHAR, V34, P687, DOI 10.1007/s10928-007-9065-1; Ghetie V, 1997, IMMUNOL TODAY, V18, P592, DOI 10.1016/S0167-5699(97)01172-9; Ghetie V, 1996, EUR J IMMUNOL, V26, P690, DOI 10.1002/eji.1830260327; Glennie MJ, 2007, MOL IMMUNOL, V44, P3823, DOI 10.1016/j.molimm.2007.06.151; Hagemeister F, 2010, DRUGS, V70, P261, DOI 10.2165/11532180-000000000-00000; Haller MF, PHARM TECHNOL; Hornberger J, 2008, LEUKEMIA LYMPHOMA, V49, P227, DOI 10.1080/10428190701769665; Keating GM, 2010, DRUGS, V70, P1445, DOI 10.2165/11201110-000000000-00000; Kivitz A, 2007, EXPERT REV MED DEVIC, V4, P109, DOI 10.1586/17434440.4.2.109; Lindorfer MA, 2012, ONCOIMMUNOLOGY, V1, P959, DOI 10.4161/onci.20368; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Lundin J, 2002, BLOOD, V100, P768, DOI 10.1182/blood-2002-01-0159; Mo CC, 2013, HAEMATOLOGICA, V98, P1259, DOI 10.3324/haematol.2012.080929; Morcos PN, 2013, INT J CLIN PHARM TH, V51, P537, DOI 10.5414/CP201847; Muchmore Douglas B, 2012, J Diabetes Sci Technol, V6, P764; Ratner M, 2010, NAT BIOTECHNOL, V28, P298, DOI 10.1038/nbt0410-298; Ray JA, 2010, VALUE HEALTH, V13, P346, DOI 10.1111/j.1524-4733.2009.00676.x; Roche Hoffmann-La, 2013, STUD COMP SUBC VERS; Roche Hoffmann-La, 2013, STUD MABTHERA SUBC; Salar A, 2010, BLOOD, V116, P1177; Stilgenbauer S, 2009, J CLIN ONCOL, V27, P3994, DOI 10.1200/JCO.2008.21.1128; Tabrizi MA, 2006, DRUG DISCOV TODAY, V11, P81, DOI 10.1016/S1359-6446(05)03638-X; Vogel WH, 2010, CLIN J ONCOL NURS, V14, P10, DOI DOI 10.1188/10.CJ0N.E10-E21.PUBMED:20350882; Vugmeyster Y, 2003, INT IMMUNOPHARMACOL, V3, P1477, DOI 10.1016/S1567-5769(03)00147-4; Vugmeyster Y, 2003, CYTOM PART A, V52A, P101, DOI 10.1002/cyto.a.10030; Yin A, 2010, J CLIN ONCOL, V28	32	25	27	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80533	10.1371/journal.pone.0080533	http://dx.doi.org/10.1371/journal.pone.0080533			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265828	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100164
J	Robbez-Masson, LJ; Bodor, C; Jones, JL; Hurst, HC; Fitzgibbon, J; Hart, IR; Grose, RP				Robbez-Masson, Luisa J.; Boedoer, Csaba; Jones, J. Louise; Hurst, Helen C.; Fitzgibbon, Jude; Hart, Ian R.; Grose, Richard P.			Functional Analysis of a Breast Cancer-Associated FGFR2 Single Nucleotide Polymorphism Using Zinc Finger Mediated Genome Editing	PLOS ONE			English	Article							ESTROGEN-RECEPTOR BINDING; WIDE ASSOCIATION; GROWTH-FACTOR; CELL-LINES; EXPRESSION; GENE; RESISTANCE; RISK	Genome wide association studies have identified single nucleotide polymorphisms (SNP) within fibroblast growth factor receptor 2 (FGFR2) as one of the highest ranking risk alleles in terms of development of breast cancer. The potential effect of these SNPs, in intron two, was postulated to be due to the differential binding of cis-regulatory elements, such as transcription factors, since all the SNPs in linkage disequilibrium were located in a regulatory DNA region. A Runx2 binding site was reported to be functional only in the minor, disease associated allele of rs2981578, resulting in increased expression of FGFR2 in cancers from patients homozygous for that allele. Moreover, the increased risk conferred by the minor FGFR2 allele associates most strongly in oestrogen receptor alpha positive (ER alpha) breast tumours, suggesting a potential interaction between ER alpha and FGFR signalling. Here, we have developed a human cell line model system to study the effect of the putative functional SNP, rs2981578, on cell behaviour. MCF7 cells, an ER alpha positive breast cancer cell line homozygous for the wild-type allele were edited using a Zinc Finger Nuclease approach. Unexpectedly, the acquisition of a single risk allele in MCF7 clones failed to affect proliferation or cell cycle progression. Binding of Runx2 to the risk allele was not observed. However FOXA1 binding, an important ER alpha partner, appeared decreased at the rs2981578 locus in the risk allele cells. Differences in allele specific expression (ASE) of FGFR2 were not observed in a panel of 72 ER alpha positive breast cancer samples. Thus, the apparent increased risk of developing ER alpha positive breast cancer seems not to be caused by rs2981578 alone. Rather, the observed increased risk of developing breast cancer might be the result of a coordinated effect of multiple SNPs forming a risk haplotype in the second intron of FGFR2.	[Robbez-Masson, Luisa J.; Jones, J. Louise; Hurst, Helen C.; Hart, Ian R.; Grose, Richard P.] Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England; [Boedoer, Csaba; Fitzgibbon, Jude] Queen Mary Univ London, Barts Canc Inst, Ctr Haematooncol, London, England	University of London; Queen Mary University London; University of London; Queen Mary University London	Grose, RP (corresponding author), Queen Mary Univ London, Barts Canc Inst, Ctr Tumour Biol, London, England.	r.p.grose@qmul.ac.uk	; Bodor, Csaba/O-4524-2017	Jones, J Louise/0000-0003-3880-3274; Bodor, Csaba/0000-0002-0729-692X; Robbez-Masson, Luisa/0000-0002-6060-8080; Grose, Richard/0000-0002-4738-0173; Fitzgibbon, Jude/0000-0002-9069-1866	Barts Charity; Breast Cancer Campaign	Barts Charity; Breast Cancer Campaign	The authors thank Barts Charity for funding and Breast Cancer Campaign for funding the Barts Breast Tissue Bank. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen M, 2008, BREAST CANCER RES, V10, P28; Carroll JS, 2005, CELL, V122, P33, DOI 10.1016/j.cell.2005.05.008; Chang CJ, 2012, BLOOD, V120, P3906, DOI 10.1182/blood-2012-03-420703; Conner AJ, 1999, MUTAT RES-GEN TOX EN, V443, P223, DOI 10.1016/S1383-5742(99)00020-4; Dellaire G, 1998, RADIAT RES, V149, P325, DOI 10.2307/3579693; Easton DF, 2007, NATURE, V447, P1087, DOI 10.1038/nature05887; Ensembl, 2010, FGFR2 VAR ENS GEN BR; Genomes, 2011, 1000 GEN PROJ MIN AL; Geurts AM, 2009, SCIENCE, V325, P433, DOI 10.1126/science.1172447; GUDAS JM, 1995, CLIN CANCER RES, V1, P235; Gutschner T., 2012, CANC RES; Hishikawa Y, 2004, ARCH HISTOL CYTOL, V67, P455, DOI 10.1679/aohc.67.455; Huijts PEA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2917; Hunter DJ, 2007, NAT GENET, V39, P870, DOI 10.1038/ng2075; Hurtado A, 2011, NAT GENET, V43, P27, DOI 10.1038/ng.730; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Kim H, 2011, NAT METHODS, V8, P941, DOI [10.1038/NMETH.1733, 10.1038/nmeth.1733]; Kim J, 2000, J STEROID BIOCHEM, V74, P157, DOI 10.1016/S0960-0760(00)00119-9; Meyer KB, 2008, PLOS BIOL, V6, P1098, DOI 10.1371/journal.pbio.0060108; Milani L, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1152; Miller JC, 2007, NAT BIOTECHNOL, V25, P778, DOI 10.1038/nbt1319; Motulsky Arno G, 2006, J Zhejiang Univ Sci B, V7, P167, DOI 10.1631/jzus.2006.B0167; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ng KP, 2012, NAT MED, V18, P521, DOI 10.1038/nm.2713; Perez EE, 2008, NAT BIOTECHNOL, V26, P808, DOI 10.1038/nbt1410; Ramakrishna S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054282; Ross-Innes CS, 2012, NATURE, V481, P389, DOI 10.1038/nature10730; SOULE HD, 1973, J NATL CANCER I, V51, P1409, DOI 10.1093/jnci/51.5.1409; Turner N, 2010, ONCOGENE, V29, P2013, DOI 10.1038/onc.2009.489; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wenger SL, 2004, BIOSCIENCE REP, V24, P631, DOI 10.1007/s10540-005-2797-5; Wilen CB, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002020; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	33	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78839	10.1371/journal.pone.0078839	http://dx.doi.org/10.1371/journal.pone.0078839			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265722	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100055
J	Seo, H; Lee, IS; Park, JE; Park, SG; Lee, DH; Park, BC; Cho, S				Seo, Huiyun; Lee, In-Seon; Park, Jae Eun; Park, Sung Goo; Lee, Do Hee; Park, Byoung Chul; Cho, Sayeon			Role of Protein Tyrosine Phosphatase Non-Receptor Type 7 in the Regulation of TNF-alpha Production in RAW 264.7 Macrophages	PLOS ONE			English	Article							DUAL-SPECIFICITY PHOSPHATASES; SIGNAL-TRANSDUCTION; CATALYTIC DOMAIN; IMMUNE-RESPONSES; KINASE; LPS; EXPRESSION; PATHWAY; HEPTP; MAPK	Protein tyrosine phosphatases play key roles in a diverse range of cellular processes such as differentiation, cell proliferation, apoptosis, immunological signaling, and cytoskeletal function. Protein tyrosine phosphatase non-receptor type 7 (PTPN7), a member of the phosphatase family, specifically inactivates mitogen-activated protein kinases (MAPKs). Here, we report that PTPN7 acts as a regulator of pro-inflammatory TNF-alpha production in RAW 264.7 cells that are stimulated with lipopolysaccharide (LPS) that acts as an endotoxin and elicits strong immune responses in animals. Stimulation of RAW 264.7 cells with LPS leads to a transient decrease in the levels of PTPN7 mRNA and protein. The overexpression of PTPN7 inhibits LPS-stimulated production of TNF-alpha. In addition, small interfering RNA (siRNA) analysis showed that knock-down of PTPN7 in RAW 264.7 cells increased TNF-alpha production. PTPN7 has a negative regulatory function to extracellular signal regulated kinase 1/2 (ERK1/2) and p38 that increase LPS-induced TNF-alpha production in macrophages. Thus, our data presents PTPN7 as a negative regulator of TNF-alpha expression and the inflammatory response in macrophages.	[Seo, Huiyun; Lee, In-Seon; Cho, Sayeon] Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea; [Park, Jae Eun; Park, Sung Goo; Park, Byoung Chul] Korea Res Inst Biosci & Biotechnol, Med Prote Res Ctr, Taejon, South Korea; [Lee, Do Hee] Seoul Womens Univ, Coll Nat Sci, Dept Biotechnol, Seoul, South Korea	Chung Ang University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Seoul Women's University	Cho, S (corresponding author), Chung Ang Univ, Coll Pharm, Seoul 156756, South Korea.	sycho@cau.ac.kr			National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning [NRF-2011-0030029, NRF-2012R1A2A2A01047338]	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea)	This research was supported by the National Research Foundation of Korea (NRF) grant funded by the Ministry of Science, ICT & Future Planning (NRF-2011-0030029 and NRF-2012R1A2A2A01047338). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADACHI M, 1992, BIOCHEM BIOPH RES CO, V186, P1607, DOI 10.1016/S0006-291X(05)81592-X; Chen PL, 2002, J IMMUNOL, V169, P6408, DOI 10.4049/jimmunol.169.11.6408; Cornell TT, 2010, INFECT IMMUN, V78, P2868, DOI 10.1128/IAI.00018-10; Critton DA, 2008, BIOCHEMISTRY-US, V47, P13336, DOI 10.1021/bi801724n; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Dorfman K, 1996, ONCOGENE, V13, P925; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Franklin CC, 1997, J BIOL CHEM, V272, P16917, DOI 10.1074/jbc.272.27.16917; Gronda M, 2001, MOL CELL BIOL, V21, P6851, DOI 10.1128/MCB.21.20.6851-6858.2001; HAN J, 1990, J EXP MED, V172, P391, DOI 10.1084/jem.172.1.391; Jeeves M, 2008, BIOMOL NMR ASSIGN, V2, P101, DOI 10.1007/s12104-008-9095-7; Jeffrey KL, 2007, NAT REV DRUG DISCOV, V6, P391, DOI 10.1038/nrd2289; Keyse SM, 2000, CURR OPIN CELL BIOL, V12, P186, DOI 10.1016/S0955-0674(99)00075-7; Kovanen PE, 2005, INT IMMUNOL, V17, P1009, DOI 10.1093/intimm/dxh283; Lang R, 2006, J IMMUNOL, V177, P7497, DOI 10.4049/jimmunol.177.11.7497; Mustelin T, 2005, J MOL BIOL, V354, P150, DOI 10.1016/j.jmb.2005.09.049; Ono K, 2000, CELL SIGNAL, V12, P1, DOI 10.1016/S0898-6568(99)00071-6; OSTMAN A, 1994, P NATL ACAD SCI USA, V91, P9680, DOI 10.1073/pnas.91.21.9680; ROTHE J, 1993, NATURE, V364, P798, DOI 10.1038/364798a0; Salojin K, 2007, J LEUKOCYTE BIOL, V81, P860, DOI 10.1189/jlb.1006639; Saxena M, 1999, J BIOL CHEM, V274, P11693, DOI 10.1074/jbc.274.17.11693; Saxena M, 1998, J BIOL CHEM, V273, P15340, DOI 10.1074/jbc.273.25.15340; Seo H, 2010, B KOREAN CHEM SOC, V31, P3812, DOI 10.5012/bkcs.2010.31.12.3812; Seo H, 2010, B KOREAN CHEM SOC, V31, P2692, DOI 10.5012/bkcs.2010.31.9.2692; Seo H, 2010, B KOREAN CHEM SOC, V31, P2419, DOI 10.5012/bkcs.2010.31.8.2419; ZANKE B, 1992, EUR J IMMUNOL, V22, P235, DOI 10.1002/eji.1830220134; Zhang YL, 2004, NATURE, V430, P793, DOI 10.1038/nature02764	27	7	7	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78776	10.1371/journal.pone.0078776	http://dx.doi.org/10.1371/journal.pone.0078776			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265715	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100048
J	Tan, RJ; Zhou, LL; Zhou, D; Lin, L; Liu, YH				Tan, Roderick J.; Zhou, Lili; Zhou, Dong; Lin, Lin; Liu, Youhua			Endothelin Receptor A Blockade Is an Ineffective Treatment for Adriamycin Nephropathy	PLOS ONE			English	Article							SERIAL MICROPUNCTURE ANALYSIS; HOMOZYGOUS REN-2 RATS; END-ORGAN DAMAGE; BLOOD-PRESSURE; DIABETIC-NEPHROPATHY; RENIN-ANGIOTENSIN; RENAL FIBROSIS; KIDNEY INJURY; MODEL; HYPERTENSION	Endothelin is a vasoconstricting peptide that plays a key role in vascular homeostasis, exerting its biologic effects via two receptors, the endothelin receptor A (ETA) and endothelin receptor B (ETB). Activation of ETA and ETB has opposing actions, in which hyperactive ETA is generally vasoconstrictive and pathologic. Selective ETA blockade has been shown to be beneficial in renal injuries such as diabetic nephropathy and can improve proteinuria. Atrasentan is a selective pharmacologic ETA blocker that preferentially inhibits ETA activation. In this study, we evaluated the efficacy of ETA blockade by atrasentan in ameliorating proteinuria and kidney injury in murine adriamycin nephropathy, a model of human focal segmental glomerulosclerosis. We found that ETA expression was unaltered during the course of adriamycin nephropathy. Whether initiated prior to injury in a prevention protocol (5 mg/kg/day, i.p.) or after injury onset in a therapeutic protocol (7 mg/kg or 20 mg/kg three times a week, i.p.), atrasentan did not significantly affect the initiation and progression of adriamycin-induced albuminuria (as measured by urinary albumin-to-creatinine ratios). Indices of glomerular damage were also not improved in atrasentan-treated groups, in either the prevention or therapeutic protocols. Atrasentan also failed to improve kidney function as determined by serum creatinine, histologic damage, and mRNA expression of numerous fibrosis-related genes such as collagen-I and TGF-beta 1. Therefore, we conclude that selective blockade of ETA by atrasentan has no effect on preventing or ameliorating proteinuria and kidney injury in adriamycin nephropathy.	[Tan, Roderick J.] Univ Pittsburgh, Sch Med, Dept Med, Pittsburgh, PA 15213 USA; [Zhou, Lili; Zhou, Dong; Lin, Lin; Liu, Youhua] Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Liu, YH (corresponding author), Univ Pittsburgh, Sch Med, Dept Pathol, Pittsburgh, PA 15260 USA.	liuy@upmc.edu	Tan, Roderick/AAQ-7678-2021; zhou, dong/F-8373-2015	Tan, Roderick/0000-0003-1012-1722; zhou, dong/0000-0003-1981-8745; Liu, Youhua/0000-0002-4740-805X	Abbott Laboratories; NIH [DK064005, T32 DK061296]; American Heart Association [13FTF16990086]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [T32DK061296, R01DK091239, R01DK064005] Funding Source: NIH RePORTER	Abbott Laboratories(Abbott Laboratories); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported by a Grant-in-Aid from the Abbott Laboratories and NIH grant DK064005. R.J.T. was supported by a NIH post-doctoral fellowship (T32 DK061296) and American Heart Association Fellow-to-Faculty Transition Grant (13FTF16990086). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amann K, 2001, J AM SOC NEPHROL, V12, P2572, DOI 10.1681/ASN.V12122572; Banfor PN, 2009, J CARDIOVASC PHARM, V53, P173, DOI 10.1097/FJC.0b013e3181993493; Dhaun N, 2006, J AM SOC NEPHROL, V17, P943, DOI 10.1681/ASN.2005121256; Ding H, 2012, J AM SOC NEPHROL, V23, P801, DOI 10.1681/ASN.2011060614; FOGO A, 1988, J CLIN INVEST, V82, P322, DOI 10.1172/JCI113590; Gagliardini E, 2009, AM J PHYSIOL-RENAL, V297, pF1448, DOI 10.1152/ajprenal.00340.2009; He WC, 2011, J AM SOC NEPHROL, V22, P90, DOI 10.1681/ASN.2009121236; Kohan DE, 2011, J AM SOC NEPHROL, V22, P763, DOI 10.1681/ASN.2010080869; Kohan DE, 2011, PHYSIOL REV, V91, P1, DOI 10.1152/physrev.00060.2009; Leask Andrew, 2009, Front Biosci (Elite Ed), V1, P115; Lee VWS, 2011, NEPHROLOGY, V16, P30, DOI 10.1111/j.1440-1797.2010.01383.x; Liu YH, 2011, NAT REV NEPHROL, V7, P684, DOI 10.1038/nrneph.2011.149; Mann JFE, 2010, J AM SOC NEPHROL, V21, P527, DOI 10.1681/ASN.2009060593; Morigi M, 2005, AM J PATHOL, V166, P1309, DOI 10.1016/S0002-9440(10)62350-4; Mulder P, 2000, CIRCULATION, V102, P491; Opgenorth TJ, 1996, J PHARMACOL EXP THER, V276, P473; Opocensky M, 2006, HYPERTENSION, V48, P965, DOI 10.1161/01.HYP.0000245117.57524.d6; Patinha D, 2013, AM J PHYSIOL-RENAL, V304, pF614, DOI 10.1152/ajprenal.00285.2012; Saleh MA, 2011, DIABETOLOGIA, V54, P979, DOI 10.1007/s00125-010-2021-4; Sarafidis PA, 2010, NAT REV NEPHROL, V6, P447, DOI 10.1038/nrneph.2010.86; Vaneckova I, 2005, HYPERTENSION, V46, P969, DOI 10.1161/01.HYP.0000173426.06832.b5; Vaneckova I, 2012, KIDNEY BLOOD PRESS R, V35, P382, DOI 10.1159/000336823; Vignon-Zellweger N, 2012, LIFE SCI, V91, P490, DOI 10.1016/j.lfs.2012.03.026; Wenzel RR, 2009, J AM SOC NEPHROL, V20, P655, DOI 10.1681/ASN.2008050482; Yang KM, 2009, CANCER BIOL THER, V8, P1940, DOI 10.4161/cbt.8.20.9595; YOSHIDA Y, 1988, KIDNEY INT, V33, P855, DOI 10.1038/ki.1988.77; Zhou LL, 2013, J AM SOC NEPHROL, V24, P771, DOI 10.1681/ASN.2012080865; Zoja C, 2011, AM J PHYSIOL-RENAL, V301, pF1114, DOI 10.1152/ajprenal.00122.2011	28	9	9	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79963	10.1371/journal.pone.0079963	http://dx.doi.org/10.1371/journal.pone.0079963			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265790	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000327252100123
J	Lee, J; Taneva, SG; Holland, BW; Tieleman, DP; Cornell, RB				Lee, Jaeyong; Taneva, Svetla G.; Holland, Bryan W.; Tieleman, D. Peter; Cornell, Rosemary B.			Structural Basis for Autoinhibition of CTP: Phosphocholine Cytidylyltransferase (CCT), the Regulatory Enzyme in Phosphatidylcholine Synthesis, by Its Membrane-binding Amphipathic Helix	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Allosteric Regulation; Enzyme Inactivation; Enzyme Structure; Membrane Enzymes; Molecular Dynamics; Phosphatidylcholine; X-ray Crystallography; Amphipathic Helix	AMPHITROPIC ENZYME; DOMAIN; ALPHA; ACTIVATION; RESIDUES; DYNAMICS; CURVATURE; CATALYSIS; FEATURES; MOTIONS	Background: The CCT M-domain contains an autoinhibitory (AI) segment, but its mechanism was obscure. Results: The AI helix partly occludes active site access and engages a mobile loop (L2), impeding the dynamics of key catalytic lysine 122. Conclusion: Loop L2 is a key target of the AI clamp. Significance: This work reveals the nature of a regulatory off-switch in an enzyme regulated by membrane binding. CTP:phosphocholine cytidylyltransferase (CCT) interconverts between an inactive soluble and active membrane-bound form in response to changes in membrane lipid composition. Activation involves disruption of an inhibitory interaction between the E helices at the base of the active site and an autoinhibitory (AI) segment in the regulatory M domain and membrane insertion of the M domain as an amphipathic helix. We show that in the CCT soluble form the AI segment functions to suppress k(cat) and elevate the K-m for CTP. The crystal structure of a CCT dimer composed of the catalytic and AI segments reveals an AI-E interaction as a cluster of four amphipathic helices (two E and two AI helices) at the base of the active sites. This interaction corroborates mutagenesis implicating multiple hydrophobic residues within the AI segment that contribute to its silencing function. The AI-E interaction directs the turn at the C-terminal end of the AI helix into backbone-to-backbone contact with a loop (L2) at the opening to the active site, which houses the key catalytic residue, lysine 122. Molecular dynamics simulations suggest that lysine 122 side-chain orientations are constrained by contacts with the AI helix-turn, which could obstruct its engagement with substrates. This work deciphers how the CCT regulatory amphipathic helix functions as a silencing device.	[Lee, Jaeyong; Taneva, Svetla G.; Cornell, Rosemary B.] Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada; [Cornell, Rosemary B.] Simon Fraser Univ, Dept Chem, Burnaby, BC V5A 1S6, Canada; [Holland, Bryan W.; Tieleman, D. Peter] Univ Calgary, Dept Biol Sci, Calgary, AB T2N 1N4, Canada	Simon Fraser University; Simon Fraser University; University of Calgary	Cornell, RB (corresponding author), Simon Fraser Univ, Dept Mol Biol & Biochem, Burnaby, BC V5A 1S6, Canada.	cornell@sfu.ca	Tieleman, D. Peter/A-4790-2011	Tieleman, D. Peter/0000-0001-5507-0688	Canada Foundation for Innovation; Natural Sciences and Engineering Research Council of Canada; National Research Council Canada; Canadian Institutes of Health Research; Government of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); National Research Council Canada; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Government of Saskatchewan, Western Economic Diversification Canada; University of Saskatchewan	We thank Dr. Mark Paetzel for use of equipment for purification and initial diffraction collection and for helpful advice. We are grateful to Ziwei Ding for construction of many plasmids and to Deidre de Jong-Wong for valuable technical assistance. Simulations used West-Grid/Compute Canada facilities. Diffraction was obtained at Beamlines 081D-1 and 08B1-1 at the Canadian Light Source, which is funded by the Canada Foundation for Innovation, the Natural Sciences and Engineering Research Council of Canada, the National Research Council Canada, the Canadian Institutes of Health Research, the Government of Saskatchewan, Western Economic Diversification Canada, and the University of Saskatchewan.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Arnold RS, 1996, BIOCHEMISTRY-US, V35, P9917, DOI 10.1021/bi960397c; Arsenault DJ, 2013, J BIOL CHEM, V288, P633, DOI 10.1074/jbc.M112.347682; Battye TGG, 2011, ACTA CRYSTALLOGR D, V67, P271, DOI 10.1107/S0907444910048675; Bogan MJ, 2005, J BIOL CHEM, V280, P19613, DOI 10.1074/jbc.M414028200; Bussi G, 2007, J CHEM PHYS, V126, DOI 10.1063/1.2408420; CORNELL RB, 1991, BIOCHEMISTRY-US, V30, P5881, DOI 10.1021/bi00238a011; Cornell RB, 2000, TRENDS BIOCHEM SCI, V25, P441, DOI 10.1016/S0968-0004(00)01625-X; Cornell RB, 2006, CURR PROTEIN PEPT SC, V7, P539, DOI 10.2174/138920306779025675; Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c; Dennis MK, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.201715; Desamero R, 2003, BIOCHEMISTRY-US, V42, P2941, DOI 10.1021/bi026994i; Ding ZW, 2012, J BIOL CHEM, V287, P38980, DOI 10.1074/jbc.M112.402081; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ESSMANN U, 1995, J CHEM PHYS, V103, P8577, DOI 10.1063/1.470117; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; Filippakopoulos P, 2009, CURR OPIN STRUC BIOL, V19, P643, DOI 10.1016/j.sbi.2009.10.001; Friesen JA, 1999, J BIOL CHEM, V274, P13384, DOI 10.1074/jbc.274.19.13384; Fuentes EJ, 2004, J MOL BIOL, V335, P1105, DOI 10.1016/j.jmb.2003.11.010; Gautier R, 2008, BIOINFORMATICS, V24, P2101, DOI 10.1093/bioinformatics/btn392; Helmink BA, 2003, BIOCHEMISTRY-US, V42, P5043, DOI 10.1021/bi027431+; Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.0.CO;2-H; Huang HKH, 2013, J MOL BIOL, V425, P1546, DOI 10.1016/j.jmb.2012.12.003; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; Jacobs RL, 2004, J BIOL CHEM, V279, P47402, DOI 10.1074/jbc.M404027200; Johnson JE, 2003, J BIOL CHEM, V278, P514, DOI 10.1074/jbc.M206072200; Johnson JE, 1998, BIOCHEMISTRY-US, V37, P9509, DOI 10.1021/bi980340l; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kazanietz MG, 2011, STRUCTURE, V19, P144, DOI 10.1016/j.str.2011.01.004; Khajehpour M, 2007, BIOCHEMISTRY-US, V46, P4370, DOI 10.1021/bi602335x; Krahmer N, 2011, CELL METAB, V14, P504, DOI 10.1016/j.cmet.2011.07.013; Lee JY, 2009, J BIOL CHEM, V284, P33535, DOI 10.1074/jbc.M109.053363; Leonard TA, 2011, CURR OPIN STRUC BIOL, V21, P785, DOI 10.1016/j.sbi.2011.07.006; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Malabanan MM, 2010, CURR OPIN STRUC BIOL, V20, P702, DOI 10.1016/j.sbi.2010.09.005; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nashine VC, 2010, CURR OPIN CHEM BIOL, V14, P644, DOI 10.1016/j.cbpa.2010.07.020; Neumann P, 2008, P NATL ACAD SCI USA, V105, P17390, DOI 10.1073/pnas.0805027105; Northrop DB, 1998, J CHEM EDUC, V75, P1153, DOI 10.1021/ed075p1153; PARRINELLO M, 1981, J APPL PHYS, V52, P7182, DOI 10.1063/1.328693; Pattridge KA, 2003, J BIOL CHEM, V278, P51863, DOI 10.1074/jbc.M306174200; Pronk S, 2013, BIOINFORMATICS, V29, P845, DOI 10.1093/bioinformatics/btt055; Sarri E, 2011, J BIOL CHEM, V286, P28632, DOI 10.1074/jbc.M111.267534; SOHAL PS, 1990, J BIOL CHEM, V265, P11746; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; Taneva S, 2003, BIOCHEMISTRY-US, V42, P11768, DOI 10.1021/bi035234k; Taneva S, 2008, J BIOL CHEM, V283, P28137, DOI 10.1074/jbc.M802595200; Taneva SG, 2012, BBA-BIOMEMBRANES, V1818, P1173, DOI 10.1016/j.bbamem.2012.01.006; Tian Y, 2007, MOL CELL BIOL, V27, P975, DOI 10.1128/MCB.01512-06; Vanquelef E, 2011, NUCLEIC ACIDS RES, V39, pW511, DOI 10.1093/nar/gkr288; Veitch DP, 1998, EUR J BIOCHEM, V255, P227, DOI 10.1046/j.1432-1327.1998.2550227.x; Wang JM, 2004, J COMPUT CHEM, V25, P1157, DOI 10.1002/jcc.20035; Weidner A, 2009, J MOL CATAL B-ENZYM, V61, P88, DOI 10.1016/j.molcatb.2009.02.020; Whittier SK, 2013, SCIENCE, V341, P899, DOI 10.1126/science.1241735; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Wu WI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012913; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; YANG W, 1995, J BIOL CHEM, V270, P23951, DOI 10.1074/jbc.270.41.23951	62	31	31	1	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1742	1755		10.1074/jbc.M113.526970	http://dx.doi.org/10.1074/jbc.M113.526970			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24275660	Green Published, hybrid			2022-12-25	WOS:000332401700045
J	Pflieger, A; Jaillet, J; Petit, A; Auge-Gouillou, C; Renault, S				Pflieger, Aude; Jaillet, Jerome; Petit, Agnes; Auge-Gouillou, Corinne; Renault, Sylvaine			Target Capture during Mos1 Transposition	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						DNA-Protein Interaction; Enzyme Mechanisms; Gene Transposable Elements; Genome Structure; Genomic Instability; Target Capture; Transposition	DNA TRANSPOSITION; RETROVIRAL INTEGRATION; SYNAPTIC COMPLEX; MARINER; GENE; MU; MECHANISM; INSERTION; EXCISION; ELEMENT	DNA transposition contributes to genomic plasticity. Target capture is a key step in the transposition process, because it contributes to the selection of new insertion sites. Nothing or little is known about how eukaryotic mariner DNA transposons trigger this step. In the case of Mos1, biochemistry and crystallography have deciphered several inverted terminal repeat-transposase complexes that are intermediates during transposition. However, the target capture complex is still unknown. Here, we show that the preintegration complex (i.e., the excised transposon) is the only complex able to capture a target DNA. Mos1 transposase does not support target commitment, which has been proposed to explain Mos1 random genomic integrations within host genomes. We demonstrate that the TA dinucleotide used as the target is crucial both to target recognition and in the chemistry of the strand transfer reaction. Bent DNA molecules are better targets for the capture when the target DNA is nicked two nucleotides apart from the TA. They improve strand transfer when the target DNA contains a mismatch near the TA dinucleotide.	[Pflieger, Aude; Jaillet, Jerome; Auge-Gouillou, Corinne; Renault, Sylvaine] Univ Tours, UFR Sci & Tech, UFR Pharm, EA Innovat Mol & Therapeut 6306, F-37200 Tours, France; [Petit, Agnes] Univ Tours, Ctr Etud Pathol Resp INSERM UMR 1100, UFR Med, F-37032 Tours 1, France; [Pflieger, Aude] CRIUCPQ, Grp Rech Hypertens Pulm, Quebec City, PQ G1V 4G5, Canada	Universite de Tours; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Tours	Auge-Gouillou, C (corresponding author), Univ Tours, UFR Sci & Tech, UFR Pharm, EA Innovat Mol & Therapeut 6306, 31 Ave Monge, F-37200 Tours, France.	corinne.gouillou@univ-tours.fr; sylvaine.renault@univ-tours.fr	GOUILLOU, Corinne AUGE/T-2346-2018	GOUILLOU, Corinne AUGE/0000-0002-3340-5560; PETIT, AGNES/0000-0003-3214-807X; Renault, Sylvaine/0000-0002-6980-8855	Region Centre (InhDDE Project); University of Tours; Centre National de la Recherche Scientifique	Region Centre (InhDDE Project)(Region Centre-Val de Loire); University of Tours; Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS))	This work was supported by the Region Centre (InhDDE Project), the University of Tours, and the Centre National de la Recherche Scientifique.	Auge-Gouillou C, 2005, MOL CELL BIOL, V25, P2861, DOI 10.1128/MCB.25.7.2861-2870.2005; Babatz TD, 2013, CURR OPIN GENET DEV, V23, P264, DOI 10.1016/j.gde.2013.02.007; BENJAMIN HW, 1989, CELL, V59, P373, DOI 10.1016/0092-8674(89)90298-5; Bouchet N., 2013, NUCL ACIDS RES, DOI 10.1093/nar/gkt874; Bouuaert CC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053690; Bouuaert CC, 2011, MOL CELL BIOL, V31, P317, DOI 10.1128/MCB.01066-10; Bouuaert CC, 2010, GENETICA, V138, P473, DOI 10.1007/s10709-009-9391-x; Bouuaert CC, 2010, NUCLEIC ACIDS RES, V38, P190, DOI 10.1093/nar/gkp891; BRYAN G, 1990, GENETICS, V125, P103; Carpentier G, 2011, J MOL BIOL, V405, P892, DOI 10.1016/j.jmb.2010.11.032; Chalopin Domitille, 2012, Int J Evol Biol, V2012, P724519, DOI 10.1155/2012/724519; Cherepanov P, 2011, CURR OPIN STRUC BIOL, V21, P249, DOI 10.1016/j.sbi.2010.12.005; Cordaux R, 2006, P NATL ACAD SCI USA, V103, P8101, DOI 10.1073/pnas.0601161103; Crenes G, 2010, GENETICA, V138, P509, DOI 10.1007/s10709-009-9387-6; Crenes G, 2009, MOL GENET GENOMICS, V281, P315, DOI 10.1007/s00438-008-0414-6; Cuypers MG, 2013, NUCLEIC ACIDS RES, V41, P2020, DOI 10.1093/nar/gks1295; Dawson A, 2003, MOL CELL, V11, P225, DOI 10.1016/S1097-2765(02)00798-0; Gradman RJ, 2008, MOL MICROBIOL, V67, P528, DOI 10.1111/j.1365-2958.2007.06056.x; Jaillet J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043365; Klenchin VA, 2008, NUCLEIC ACIDS RES, V36, P5855, DOI 10.1093/nar/gkn577; Krishnan L, 2012, J BIOL CHEM, V287, P40858, DOI 10.1074/jbc.R112.397760; Kuduvalli PN, 2001, EMBO J, V20, P924, DOI 10.1093/emboj/20.4.924; Kunarso G, 2010, NAT GENET, V42, P631, DOI 10.1038/ng.600; Lipkow K, 2004, J BIOL CHEM, V279, P48569, DOI 10.1074/jbc.M408759200; Lohe AR, 1997, P NATL ACAD SCI USA, V94, P1293, DOI 10.1073/pnas.94.4.1293; LOHE AR, 1995, MOL BIOL EVOL, V12, P62, DOI 10.1093/oxfordjournals.molbev.a040191; Lohe AR, 2000, GENETICS, V154, P647; Maertens GN, 2010, NATURE, V468, P326, DOI 10.1038/nature09517; Matthews AGW, 2004, EMBO J, V23, P1198, DOI 10.1038/sj.emboj.7600131; Miskey C, 2007, MOL CELL BIOL, V27, P4589, DOI 10.1128/MCB.02027-06; Montano SP, 2012, NATURE, V491, P413, DOI 10.1038/nature11602; Montano SP, 2011, CURR OPIN STRUC BIOL, V21, P370, DOI 10.1016/j.sbi.2011.03.004; MULLER HP, 1994, EMBO J, V13, P4704, DOI 10.1002/j.1460-2075.1994.tb06794.x; Naigamwalla DZ, 1997, EMBO J, V16, P5227, DOI 10.1093/emboj/16.17.5227; Neiditch MB, 2001, MOL CELL BIOL, V21, P4302, DOI 10.1128/MCB.21.13.4302-4310.2001; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Plasterk R.H.A., 2002, MOBILE DNA, P519; Pribil PA, 2004, MOL MICROBIOL, V52, P1173, DOI 10.1111/j.1365-2958.2004.04046.x; Pribil PA, 2003, J MOL BIOL, V330, P247, DOI 10.1016/S0022-2836(03)00588-6; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Sakai J, 1997, CELL, V89, P205, DOI 10.1016/S0092-8674(00)80200-7; Shevchenko Y, 2002, NUCLEIC ACIDS RES, V30, P2469, DOI 10.1093/nar/30.11.2469; Sinzelle L, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-106; Tsai CL, 2003, NUCLEIC ACIDS RES, V31, P6180, DOI 10.1093/nar/gkg819; Vallin E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030482; Wang W, 2000, INSECT MOL BIOL, V9, P145, DOI 10.1046/j.1365-2583.2000.00172.x; Yanagihara K, 2002, P NATL ACAD SCI USA, V99, P11317, DOI 10.1073/pnas.132403399; Zayed H, 2003, NUCLEIC ACIDS RES, V31, P2313, DOI 10.1093/nar/gkg341	48	6	6	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					100	111		10.1074/jbc.M113.523894	http://dx.doi.org/10.1074/jbc.M113.523894			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24269942	Green Published, hybrid			2022-12-25	WOS:000329370900009
J	Bergamo, P; Cocca, E; Palumbo, R; Gogliettino, M; Rossi, M; Palmieri, G				Bergamo, Paolo; Cocca, Ennio; Palumbo, Rosanna; Gogliettino, Marta; Rossi, Mose; Palmieri, Gianna			RedOx Status, Proteasome and APEH: Insights into Anticancer Mechanisms of t10,c12-Conjugated Linoleic Acid Isomer on A375 Melanoma Cells	PLOS ONE			English	Article							OXIDIZED PROTEIN HYDROLASE; OXIDATIVE STRESS; ROS GENERATION; APOPTOSIS; INHIBITOR; GROWTH; GLUTATHIONE; ACTIVATION; OVEREXPRESSION; RESISTANCE	This study describes the investigation of the efficiency of conjugated linoleic acid (CLA) isomers in reducing cancer cells viability exploring the role of the oxidative stress and acylpeptide hydrolase (APEH)/proteasome mediated pathways on pro-apoptotic activity of the isomer trans10,cis12 (t10,c12)-CLA. The basal activity/expression levels of APEH and proteasome (beta-5 subunit) were preliminarily measured in eight cancer cell lines and the functional relationship between these enzymes was clearly demonstrated through their strong positive correlation. t10,c12-CLA efficiently inhibited the activity of APEH and proteasome isoforms in cell-free assays and the negative correlation between cell viability and caspase 3 activity confirmed the pro-apoptotic role of this isomer. Finally, modulatory effects of t10, c12-CLA on cellular redox status (intracellular glutathione, mRNA levels of antioxidant/detoxifying enzymes activated through NF-E2-related factor 2, Nrf2, pathway) and on APEH/beta-5 activity/expression levels, were investigated in A375 melanoma cells. Dose-and time-dependent variations of the considered parameters were established and the resulting pro-apoptotic effects were shown to be associated with an alteration of the redox status and a down-regulation of APEH/proteasome pathway. Therefore, our results support the idea that these events are involved in ROS-dependent apoptosis of t10,c12-CLA-treated A375 cells. The combined inhibition, triggered by t10, c12-CLA, via the modulation of APEH/proteasome and Nrf2 pathway for treating melanoma, is suggested as a subject for further in vivo studies.	[Bergamo, Paolo] Natl Res Council CNR ISA, Inst Food Sci, Avellino, Italy; [Cocca, Ennio; Gogliettino, Marta; Rossi, Mose; Palmieri, Gianna] Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy; [Palumbo, Rosanna] CNR, Inst Biostruct & Bioimaging, I-80125 Naples, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell' Alimentazione (ISA-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biochimica delle Proteine (IBP-CNR); Consiglio Nazionale delle Ricerche (CNR); Istituto di Biostrutture e Bioimmagini (IBB-CNR)	Palmieri, G (corresponding author), Natl Res Council CNR IBP, Inst Prot Biochem, Naples, Italy.	g.palmieri@ibp.cnr.it	Cocca, Ennio/AAY-3817-2020; Palmieri, Gianna/S-4872-2017; Palmieri, Gianna/AAW-6176-2020; Bergamo, Paolo/F-7835-2013	Cocca, Ennio/0000-0003-2432-9663; Palmieri, Gianna/0000-0002-9007-4075; Bergamo, Paolo/0000-0002-1726-7911; PALUMBO, ROSANNA/0000-0002-3858-4529	MERIT grant [RBNE08YFN3_009]; PON grant [PON01_01802]	MERIT grant; PON grant	This research was supported by MERIT grant project no. RBNE08YFN3_009 and PON grant project 2007-2013, PON01_01802. The funders have no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiken CT, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.006924; Ballatori N, 2009, BIOL CHEM, V390, P191, DOI 10.1515/BC.2009.033; Belury MA, 2002, ANNU REV NUTR, V22, P505, DOI 10.1146/annurev.nutr.22.021302.121842; Bergamo P, 2004, CELL PHYSIOL BIOCHEM, V14, P57, DOI 10.1159/000076927; Bergamo P, 2007, FREE RADICAL BIO MED, V43, P71, DOI 10.1016/j.freeradbiomed.2007.03.023; Bergamo P, 2011, MOL NUTR FOOD RES, V55, pS248, DOI 10.1002/mnfr.201100295; Brohem CA, 2012, PIGM CELL MELANOMA R, V25, P354, DOI 10.1111/j.1755-148X.2012.00992.x; Carretero J, 1999, CLIN EXP METASTAS, V17, P567, DOI 10.1023/A:1006725226078; Chandra J, 2009, ANTIOXID REDOX SIGN, V11, P1123, DOI [10.1089/ars.2008.2302, 10.1089/ARS.2008.2302]; Chapple SJ, 2012, INT J BIOCHEM CELL B, V44, P1315, DOI 10.1016/j.biocel.2012.04.021; Ciechanover A, 2012, NEURODEGENER DIS, V10, P7, DOI 10.1159/000334283; Devery R, 2001, BIOCHEM SOC T, V29, P341, DOI 10.1042/BST0290341; Dilzer Allison, 2012, Crit Rev Food Sci Nutr, V52, P488, DOI 10.1080/10408398.2010.501409; Franco R, 2009, MUTAT RES-GEN TOX EN, V674, P3, DOI 10.1016/j.mrgentox.2008.11.012; Fribley A, 2004, MOL CELL BIOL, V24, P9695, DOI 10.1128/MCB.24.22.9695-9704.2004; Fried L, 2008, PIGM CELL MELANOMA R, V21, P117, DOI 10.1111/j.1755-148X.2008.00451.x; Fruehauf JP, 2008, EXPERT REV ANTICANC, V8, P1751, DOI 10.1586/14737140.8.11.1751; Govindarajan B, 2007, J CLIN INVEST, V117, P719, DOI 10.1172/JCI30102; Grune T, 1997, BIOFACTORS, V6, P165, DOI 10.1002/biof.5520060210; Hsu YC, 2011, CELL SIGNAL, V23, P2013, DOI 10.1016/j.cellsig.2011.07.015; Jung JI, 2010, J MED FOOD, V13, P13, DOI 10.1089/jmf.2009.1201; Kelley NS, 2007, J NUTR, V137, P2599, DOI 10.1093/jn/137.12.2599; Kisselev AF, 1999, J BIOL CHEM, V274, P3363, DOI 10.1074/jbc.274.6.3363; LAI GM, 1991, INT J CANCER, V49, P688, DOI 10.1002/ijc.2910490511; Lau DSY, 2010, NUTR CANCER, V62, P116, DOI 10.1080/01635580903191536; Lee KW, 2005, CRIT REV FOOD SCI, V45, P135, DOI 10.1080/10408690490911800; Lee SH, 2006, CARCINOGENESIS, V27, P972, DOI 10.1093/carcin/bgi268; Ling YH, 2003, J BIOL CHEM, V278, P33714, DOI 10.1074/jbc.M302559200; Magesh S, 2012, MED RES REV, V32, P687, DOI 10.1002/med.21257; Ochoa JJ, 2004, CARCINOGENESIS, V25, P1185, DOI 10.1093/carcin/bgh116; Ou LH, 2008, J LIPID RES, V49, P985, DOI 10.1194/jlr.M700465-JLR200; Palmieri G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025888; Perez-Galan P, 2006, BLOOD, V107, P257, DOI 10.1182/blood-2005-05-2091; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qiao SX, 2012, BIOCHEM PHARMACOL, V83, P1229, DOI 10.1016/j.bcp.2012.01.027; Reinheckel T, 1998, BIOCHEM J, V335, P637, DOI 10.1042/bj3350637; Reits E, 2004, IMMUNITY, V20, P495, DOI 10.1016/S1074-7613(04)00074-3; Ren DM, 2011, P NATL ACAD SCI USA, V108, P1433, DOI 10.1073/pnas.1014275108; Schwartz AL, 2009, ANNU REV PHARMACOL, V49, P73, DOI 10.1146/annurev.pharmtox.051208.165340; Shimizu K, 2004, BIOCHEM BIOPH RES CO, V324, P140, DOI 10.1016/j.bbrc.2004.08.231; Shimizu K, 2003, BIOCHEM BIOPH RES CO, V304, P766, DOI 10.1016/S0006-291X(03)00657-0; Trachootham D, 2009, NAT REV DRUG DISCOV, V8, P579, DOI 10.1038/nrd2803; Wu MX, 2009, FREE RADICAL BIO MED, V46, P62, DOI 10.1016/j.freeradbiomed.2008.09.021; Yang JM, 2007, FREE RADICAL BIO MED, V42, P1369, DOI 10.1016/j.freeradbiomed.2007.01.036; Yu CR, 2004, EXP CELL RES, V295, P555, DOI 10.1016/j.yexcr.2004.02.001	45	11	11	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80900	10.1371/journal.pone.0080900	http://dx.doi.org/10.1371/journal.pone.0080900			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260504	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900104
J	Chang, YC; Tsai, MH; Sheu, WHH; Hsieh, SC; Chiang, AN				Chang, Yu-Cheng; Tsai, Ming-Han; Sheu, Wayne Huey-Herng; Hsieh, Shu-Chen; Chiang, An-Na			The Therapeutic Potential and Mechanisms of Action of Quercetin in Relation to Lipopolysaccharide-Induced Sepsis In Vitro and In Vivo	PLOS ONE			English	Article							NF-KAPPA-B; NITRIC-OXIDE SYNTHASE; ADIPOSE-TISSUE; EXPRESSION; PATHWAY; INHIBITION; ACTIVATION; AKT; CYCLOOXYGENASE-2; MACROPHAGES	Sepsis caused by Gram-negative bacterial infection is characterized by extensive inflammatory cytokine production, which leads to multiple organ failure and a high lethality rate. Therefore, compounds that are able to alleviate profound inflammatory responses may have therapeutic potential in relation to sepsis. Quercetin, one of the flavonoids found widely in the human diet, has been reported to have many health benefits, but the mechanisms underlying its biological effects remain obscure. In the present study, our aim was to investigate the molecular mechanisms by which quercetin inhibits lipopolysaccharide (LPS)-induced pro-inflammatory cytokine production and to evaluate the capacity of quercetin to attenuate the mortality rate in a mice model of lethal sepsis. Our results show that quercetin significantly attenuates LPS-induced production of tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta) in RAW264.7 macrophages. The LPS-stimulated phosphorylations of the inhibitors of kappa B kinase (IKKs), Akt, and c-Jun N-terminal kinase (JNK) are also inhibited by quercetin. Quercetin causes a significant reduction in the phosphorylation and degradation of inhibitor of kappa B alpha (I kappa B alpha) and in the nuclear level of nuclear factor-kappa B (NF-kappa B), the latter being associated with decreased NF-kappa B binding activity. Most importantly, acute administration of quercetin reduces the lethality rate and circulating levels of TNF-alpha and IL-1 beta in C57BL/6J mice with endotoxemia induced by LPS, whereas chronic dietary supplementation with quercetin shows no inhibitory effect on serum TNF-alpha and IL-1 beta levels. These findings provide clues that quercetin may be a promising agent for the prevention of systemic inflammatory diseases such as sepsis.	[Chang, Yu-Cheng; Tsai, Ming-Han; Chiang, An-Na] Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan; [Sheu, Wayne Huey-Herng] Taichung Vet Gen Hosp, Dept Internal Med, Taichung, Taiwan; [Hsieh, Shu-Chen] Natl Taiwan Univ, Inst Food Sci & Technol, Taipei 10764, Taiwan	National Yang Ming Chiao Tung University; Taichung Veterans General Hospital; National Taiwan University	Chiang, AN (corresponding author), Natl Yang Ming Univ, Inst Biochem & Mol Biol, Taipei 112, Taiwan.	anchia@ym.edu.tw		HSIEH, SHU-CHEN/0000-0002-0844-7435; Tsai, Ming-Han/0000-0001-5563-3057	Ministry of Education, Aim for the Top University Plan, Taiwan [101 AC-P504]	Ministry of Education, Aim for the Top University Plan, Taiwan(Ministry of Education, Taiwan)	This study was supported by grant from Ministry of Education, Aim for the Top University Plan (101 AC-P504), Taiwan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Bischoff SC, 2008, CURR OPIN CLIN NUTR, V11, P733, DOI 10.1097/MCO.0b013e32831394b8; Boots AW, 2008, EUR J PHARMACOL, V585, P325, DOI 10.1016/j.ejphar.2008.03.008; Bournival J, 2012, OXID MED CELL LONGEV, V2012, DOI 10.1155/2012/921941; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Chen JC, 2005, EUR J PHARMACOL, V521, P9, DOI 10.1016/j.ejphar.2005.08.005; Cho SY, 2003, MOL CELL BIOCHEM, V243, P153, DOI 10.1023/A:1021624520740; Choi BH, 2008, CANCER LETT, V259, P111, DOI 10.1016/j.canlet.2007.10.003; Chong DLW, 2011, CONTRIB MICROBIOL, V17, P86, DOI 10.1159/000324022; Comalada M, 2005, EUR J IMMUNOL, V35, P584, DOI 10.1002/eji.200425778; de Jong HK, 2010, J INNATE IMMUN, V2, P422, DOI 10.1159/000316286; Doi K, 2009, J CLIN INVEST, V119, P2868, DOI 10.1172/JCI39421; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Guha M, 2002, J BIOL CHEM, V277, P32124, DOI 10.1074/jbc.M203298200; Gulati N, 2006, ANTICANCER RES, V26, P1177; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hong KO, 2009, J EXP CLIN CANC RES, V28, DOI 10.1186/1756-9966-28-28; Hsu CC, 2013, BIOCHEM PHARMACOL, V85, P385, DOI 10.1016/j.bcp.2012.11.002; Jiang SJ, 2013, MICROCIRCULATION, V20, P190, DOI 10.1111/micc.12024; Julien S, 2007, ONCOGENE, V26, P7445, DOI 10.1038/sj.onc.1210546; Jung J, 2012, IMMUNOLOGY, V137, P98, DOI 10.1111/j.1365-2567.2012.03618.x; Jung WK, 2008, INT J BIOCHEM CELL B, V40, P2572, DOI 10.1016/j.biocel.2008.05.005; Li XH, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/186710; Lu YC, 2008, CYTOKINE, V42, P145, DOI 10.1016/j.cyto.2008.01.006; Nguyen MTA, 2007, J BIOL CHEM, V282, P35279, DOI 10.1074/jbc.M706762200; Park YM, 2006, BIOL PHARM BULL, V29, P985, DOI 10.1248/bpb.29.985; Peet GW, 1999, J BIOL CHEM, V274, P32655, DOI 10.1074/jbc.274.46.32655; Peluso MR, 2006, EXP BIOL MED, V231, P1287, DOI 10.1177/153537020623100802; Pianetti S, 2001, ONCOGENE, V20, P1287, DOI 10.1038/sj.onc.1204257; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Riedemann NC, 2003, NAT MED, V9, P517, DOI 10.1038/nm0503-517; Tang DL, 2009, AM J RESP CELL MOL, V41, P651, DOI 10.1165/rcmb.2008-0119OC; Yuan Guang-Jin, 2006, Hepatobiliary Pancreat Dis Int, V5, P262; Zhang DY, 2013, J DIABETES, V5, P13, DOI 10.1111/1753-0407.12017	35	38	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80744	10.1371/journal.pone.0080744	http://dx.doi.org/10.1371/journal.pone.0080744			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260470	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900092
J	Gallego-Sanchez, A; Ufano, S; Andres, S; Bueno, A				Gallego-Sanchez, Alfonso; Ufano, Sandra; Andres, Sonia; Bueno, Avelino			Analysis of the Tolerance to DNA Alkylating Damage in MEC1 and RAD53 Checkpoint Mutants of Saccharomyces cerevisiae	PLOS ONE			English	Article							EFFICIENT PCNA UBIQUITINATION; ERROR-FREE; POSTREPLICATION REPAIR; PHYSICALLY INTERACTS; PROTEIN DDC1P; CDC6 PROTEIN; YEAST REV1; CELL-CYCLE; PHOSPHORYLATION; POLYMERASES	Checkpoint response, tolerance and repair are three major pathways that eukaryotic cells evolved independently to maintain genome stability and integrity. Here, we studied the sensitivity to DNA damage in checkpoint-deficient budding yeast cells and found that checkpoint kinases Mec1 and Rad53 may modulate the balance between error-free and error-prone branches of the tolerance pathway. We have consistently observed that mutation of the RAD53 counterbalances error-free and error-prone branches upon exposure of cells to DNA damage induced either by MMS alkylation or by UV-radiation. We have also found that the potential Mec1/Rad53 balance modulation is independent from Rad6/Rad18-mediated PCNA ubiquitylation, as mec1D or rad53D mutants show no defects in the modification of the sliding clamp, therefore, we infer that it is likely exerted by acting on TLS polymerases and/or template switching targets.	[Gallego-Sanchez, Alfonso; Ufano, Sandra; Andres, Sonia; Bueno, Avelino] Univ Salamanca, CSIC, Inst Biol Mol Celular & Canc, Dept Microbiol & Genet, E-37008 Salamanca, Spain	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-USAL - Instituto de Biologia Molecular y Celular del Cancer de Salamanca (IBMCC); University of Salamanca	Bueno, A (corresponding author), Univ Salamanca, CSIC, Inst Biol Mol Celular & Canc, Dept Microbiol & Genet, E-37008 Salamanca, Spain.	abn@usal.es	Bueno, Avelino/A-9505-2016; Andrés, Sonia/AAC-5850-2021	Bueno, Avelino/0000-0002-0362-4391; 	Spanish Science Ministry [BFU2009-06938, BFU2012-30787]; Ministry of Education	Spanish Science Ministry(Spanish Government); Ministry of Education	This work was supported by the Spanish Science Ministry (grants BFU2009-06938 and BFU2012-30787 to AB). A.G-S. was a recipient of an FPU fellowship from the Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barbour L, 2006, GENETICS, V174, P1789, DOI 10.1534/genetics.106.056283; Bi XH, 2006, MOL CELL BIOL, V26, P3527, DOI 10.1128/MCB.26.9.3527-3540.2006; Broomfield S, 1998, P NATL ACAD SCI USA, V95, P5678, DOI 10.1073/pnas.95.10.5678; Calzada A, 2000, J BIOL CHEM, V275, P9734, DOI 10.1074/jbc.275.13.9734; Chang DJ, 2006, J BIOL CHEM, V281, P32081, DOI 10.1074/jbc.M606799200; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Chin JK, 2006, DNA REPAIR, V5, P618, DOI 10.1016/j.dnarep.2006.02.005; Conde F, 2008, GENETICS, V179, P1197, DOI 10.1534/genetics.108.089003; Conde F, 2010, DNA REPAIR, V9, P1038, DOI 10.1016/j.dnarep.2010.07.003; Cordon-Preciado V, 2006, NUCLEIC ACIDS RES, V34, P5852, DOI 10.1093/nar/gkl741; Davies AA, 2008, MOL CELL, V29, P625, DOI 10.1016/j.molcel.2007.12.016; Downs JA, 2000, NATURE, V408, P1001, DOI 10.1038/35050000; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Frederiks F, 2008, NAT STRUCT MOL BIOL, V15, P550, DOI 10.1038/nsmb.1432; Gallego-Sanchez A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002826; Gallego-Sanchez A, 2010, BIOCHEM SOC T, V38, P104, DOI 10.1042/BST0380104; Gangavarapu V, 2011, MBIO, V2, DOI 10.1128/mBio.00079-11; Giannattasio M, 2005, J BIOL CHEM, V280, P9879, DOI 10.1074/jbc.M414453200; Gohler T, 2008, DNA REPAIR, V7, P775, DOI 10.1016/j.dnarep.2008.02.001; Haracska L, 2001, GENE DEV, V15, P945, DOI 10.1101/gad.882301; Hirano Y, 2006, CURR BIOL, V16, P586, DOI 10.1016/j.cub.2006.01.063; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Kai M, 2003, GENE DEV, V17, P64, DOI 10.1101/gad.1043203; Keogh MC, 2006, NATURE, V439, P497, DOI 10.1038/nature04384; Longhese MP, 1997, EMBO J, V16, P5216, DOI 10.1093/emboj/16.17.5216; Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.3.CO;2-L; Moldovan GL, 2007, CELL, V129, P665, DOI 10.1016/j.cell.2007.05.003; Nelson JR, 1996, NATURE, V382, P729, DOI 10.1038/382729a0; Niimi A, 2008, P NATL ACAD SCI USA, V105, P16125, DOI 10.1073/pnas.0802727105; Paciotti V, 1998, EMBO J, V17, P4199, DOI 10.1093/emboj/17.14.4199; Pages V, 2009, GENE DEV, V23, P1438, DOI 10.1101/gad.1793409; Rattray AJ, 2003, ANNU REV GENET, V37, P31, DOI 10.1146/annurev.genet.37.042203.132748; Roberts TM, 2006, MOL BIOL CELL, V17, P539, DOI 10.1091/mbc.E05-08-0785; Rouse J, 2004, EMBO J, V23, P1188, DOI 10.1038/sj.emboj.7600129; Sabbioneda S, 2005, J BIOL CHEM, V280, P38657, DOI 10.1074/jbc.M507638200; Sabbioneda S, 2007, DNA REPAIR, V6, P121, DOI 10.1016/j.dnarep.2006.09.002; Sanchez M, 1999, J BIOL CHEM, V274, P9092, DOI 10.1074/jbc.274.13.9092; Shachar S, 2009, EMBO J, V28, P383, DOI 10.1038/emboj.2008.281; Soria G, 2006, ONCOGENE, V25, P2829, DOI 10.1038/sj.onc.1209315; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Wysocki R, 2005, MOL CELL BIOL, V25, P8430, DOI 10.1128/MCB.25.19.8430-8443.2005; Yang XH, 2008, GENE DEV, V22, P1147, DOI 10.1101/gad.1632808; Zappulla DC, 2006, BMC MOL BIOL, V7, DOI 10.1186/1471-2199-7-40; Zhang HS, 2005, P NATL ACAD SCI USA, V102, P15954, DOI 10.1073/pnas.0504586102	46	4	4	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81108	10.1371/journal.pone.0081108	http://dx.doi.org/10.1371/journal.pone.0081108			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260543	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900119
J	Halary, S; Daubois, L; Terrat, Y; Ellenberger, S; Wostemeyer, J; Hijri, M				Halary, Sebastien; Daubois, Laurence; Terrat, Yves; Ellenberger, Sabrina; Woestemeyer, Johannes; Hijri, Mohamed			Mating Type Gene Homologues and Putative Sex Pheromone-Sensing Pathway in Arbuscular Mycorrhizal Fungi, a Presumably Asexual Plant Root Symbiont	PLOS ONE			English	Article							MITOCHONDRIAL GENOME; MUCOR-MUCEDO; SEQUENCE; MICROSPORIDIA; EVOLUTION; ALIGNMENT; SPORES	The fungal kingdom displays a fascinating diversity of sex-determination systems. Recent advances in genomics provide insights into the molecular mechanisms of sex, mating type determination, and evolution of sexual reproduction in many fungal species in both ancient and modern phylogenetic lineages. All major fungal groups have evolved sexual differentiation and recombination pathways. However, sexuality is unknown in arbuscular mycorrhizal fungi (AMF) of the phylum Glomeromycota, an ecologically vital group of obligate plant root symbionts. AMF are commonly considered an ancient asexual lineage dating back to the Ordovician, approximately 460 M years ago. In this study, we used genomic and transcriptomic surveys of several AMF species to demonstrate the presence of conserved putative sex pheromone-sensing mitogen-activated protein (MAP) kinases, comparable to those described in Ascomycota and Basidiomycota. We also find genes for high mobility group (HMG) transcription factors, homologous to SexM and SexP genes in the Mucorales. The SexM genes show a remarkable sequence diversity among multiple copies in the genome, while only a single SexP sequence was detected in some isolates of Rhizophagus irregularis. In the Mucorales and Microsporidia, the sexM gene is flanked by genes for a triosephosphate transporter (TPT) and a RNA helicase, but we find no evidence for synteny in the vicinity of the Sex locus in AMF. Nonetheless, our results, together with previous observations on meiotic machinery, suggest that AMF could undergo a complete sexual reproduction cycle.	[Halary, Sebastien; Daubois, Laurence; Terrat, Yves; Hijri, Mohamed] Univ Montreal, Dept Sci Biol, IRBV, Montreal, PQ H3C 3J7, Canada; [Ellenberger, Sabrina; Woestemeyer, Johannes] Univ Jena, Inst Gen Microbiol & Microbe Genet, Jena, Germany	Universite de Montreal; Friedrich Schiller University of Jena	Hijri, M (corresponding author), Univ Montreal, Dept Sci Biol, IRBV, CP 6128, Montreal, PQ H3C 3J7, Canada.	mohamed.hijri@umontreal.ca	Hijri, Mohamed/ABC-5969-2021; Hijri, Mohamed/AAL-5737-2021	Hijri, Mohamed/0000-0001-6112-8372; 	Natural Sciences and Engineering Research Council of Canada (NSERC) [328098-2012]; Genome Canada; Genome Quebec funds	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Genome Canada(Genome Canada); Genome Quebec funds	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) to MH (grant number: 328098-2012). SH and YT were supported by Genome Canada and Genome Quebec funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bardwell L, 2005, PEPTIDES, V26, P337, DOI 10.1016/j.peptides.2004.10.001; Berglund AC, 2008, NUCLEIC ACIDS RES, V36, pD263, DOI 10.1093/nar/gkm1020; Chou S, 2006, MOL CELL BIOL, V26, P4794, DOI 10.1128/MCB.02053-05; Corradi N, 2007, APPL ENVIRON MICROB, V73, P366, DOI 10.1128/AEM.01574-06; Czempinski K, 1996, MICROBIOL-SGM, V142, P2647, DOI 10.1099/00221287-142-9-2647; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Ellenberger S, 2013, J THEOR BIOL, V320, P66, DOI 10.1016/j.jtbi.2012.12.009; Gryganskyi AP, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015273; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Halary Sebastien, 2011, Genome Biol Evol, V3, P950, DOI 10.1093/gbe/evr089; Hall T, 1999, NUCL ACIDS S SER, V41, P95, DOI DOI 10.1021/BK-1999-0734.CH008; Heitman J., 2007, SEX FUNGI MOL DETERM; Hibbett DS, 2007, MYCOL RES, V111, P509, DOI 10.1016/j.mycres.2007.03.004; Idnurm A, 2008, NATURE, V451, P193, DOI 10.1038/nature06453; Idnurm A, 2011, EUKARYOT CELL, V10, P1485, DOI 10.1128/EC.05149-11; Ismail Y, 2012, FUNCT PLANT BIOL, V39, P236, DOI 10.1071/FP11218; Ismail Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017990; Jany JL, 2010, AM NAT, V175, P424, DOI 10.1086/650725; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Koestler T, 2011, GENOME BIOL EVOL, V3, P186, DOI 10.1093/gbe/evr009; LACHANCE MA, 1994, YEAST, V10, P895, DOI 10.1002/yea.320100705; Lee J, 2009, NEW PHYTOL, V183, P200, DOI 10.1111/j.1469-8137.2009.02834.x; Lee SC, 2008, CURR BIOL, V18, P1675, DOI 10.1016/j.cub.2008.09.030; Lee SC, 2010, MICROBIOL MOL BIOL R, V74, P298, DOI 10.1128/MMBR.00005-10; Lee SC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010539; LODE T, 2012, HAVE SEX NOT LESSONS; Marleau J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-51; Meirmans S, 2010, J HERED, V101, pS3, DOI 10.1093/jhered/esq021; Nadimi M, 2012, MOL BIOL EVOL, V29, P2199, DOI 10.1093/molbev/mss088; Ni M, 2011, ANNU REV GENET, V45, P405, DOI 10.1146/annurev-genet-110410-132536; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Otto SP, 2009, AM NAT, V174, pS1, DOI 10.1086/599084; Otto SP, 2002, NAT REV GENET, V3, P252, DOI 10.1038/nrg761; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Pelin A, 2012, NEW PHYTOL, V194, P836, DOI 10.1111/j.1469-8137.2012.04072.x; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; Raudaskoski M, 2010, EUKARYOT CELL, V9, P847, DOI 10.1128/EC.00319-09; Redecker D, 2000, SCIENCE, V289, P1920, DOI 10.1126/science.289.5486.1920; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Rispail N, 2009, FUNGAL GENET BIOL, V46, P287, DOI 10.1016/j.fgb.2009.01.002; Schimek C, 2003, MYCOL RES, V107, P736, DOI 10.1017/S0953756203007949; SCHIMEK C, 2006, MYCOTA; Schimek C, 2009, PHYTOCHEMISTRY, V70, P1867, DOI 10.1016/j.phytochem.2009.07.014; Sievers F, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.75; Swanson WJ, 2002, NAT REV GENET, V3, P137, DOI 10.1038/nrg733; Tisserant E, 2012, NEW PHYTOL, V193, P755, DOI 10.1111/j.1469-8137.2011.03948.x; Tollot M, 2009, NEW PHYTOL, V181, P693, DOI 10.1111/j.1469-8137.2008.02696.x; TOMMERUP IC, 1990, MYCOL RES, V94, P897, DOI 10.1016/S0953-7562(09)81303-8; TOMMERUP IC, 1988, ADV PLANT PATHOL, V6, P81, DOI DOI 10.1016/B978-0-12-033706-4.50008-6; Traff KL, 2001, APPL ENVIRON MICROB, V67, P5668, DOI 10.1128/AEM.67.12.5668-5674.2001; Wass MN, 2010, NUCLEIC ACIDS RES, V38, pW469, DOI 10.1093/nar/gkq406; Wetzel J, 2012, MICROBIOL-SGM, V158, P1016, DOI 10.1099/mic.0.054106-0; Wetzel J, 2009, EUKARYOT CELL, V8, P88, DOI 10.1128/EC.00225-08; Williams BAP, 2011, MYCOTA, V14, P25	57	24	24	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80729	10.1371/journal.pone.0080729	http://dx.doi.org/10.1371/journal.pone.0080729			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260466	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900091
J	Ishisaka, A; Kawabata, K; Miki, S; Shiba, Y; Minekawa, S; Nishikawa, T; Mukai, R; Terao, J; Kawai, Y				Ishisaka, Akari; Kawabata, Kyuichi; Miki, Satomi; Shiba, Yuko; Minekawa, Shoko; Nishikawa, Tomomi; Mukai, Rie; Terao, Junji; Kawai, Yoshichika			Mitochondrial Dysfunction Leads to Deconjugation of Quercetin Glucuronides in Inflammatory Macrophages	PLOS ONE			English	Article							POTENTIALLY ANTICARCINOGENIC FLAVONOIDS; CORONARY-HEART-DISEASE; DIETARY FLAVONOIDS; TISSUE DISTRIBUTION; IL-6 PRODUCTION; RAT PLASMA; AUTOPHAGY; RISK; CONSUMPTION; ANTIOXIDANT	Dietary flavonoids, such as quercetin, have long been recognized to protect blood vessels from atherogenic inflammation by yet unknown mechanisms. We have previously discovered the specific localization of quercetin-3-O-glucuronide (Q3GA), a phase II metabolite of quercetin, in macrophage cells in the human atherosclerotic lesions, but the biological significance is poorly understood. We have now demonstrated the molecular basis of the interaction between quercetin glucuronides and macrophages, leading to deconjugation of the glucuronides into the active aglycone. In vitro experiments showed that Q3GA was bound to the cell surface proteins of macrophages through anion binding and was readily deconjugated into the aglycone. It is of interest that the macrophage-mediated deconjugation of Q3GA was significantly enhanced upon inflammatory activation by lipopolysaccharide (LPS). Zymography and immunoblotting analysis revealed that beta-glucuronidase is the major enzyme responsible for the deglucuronidation, whereas the secretion rate was not affected after LPS treatment. We found that extracellular acidification, which is required for the activity of beta-glucuronidase, was significantly induced upon LPS treatment and was due to the increased lactate secretion associated with mitochondrial dysfunction. In addition, the beta-glucuronidase secretion, which is triggered by intracellular calcium ions, was also induced by mitochondria dysfunction characterized using antimycin-A (a mitochondrial inhibitor) and siRNA-knockdown of Atg7 (an essential gene for autophagy). The deconjugated aglycone, quercetin, acts as an anti-inflammatory agent in the stimulated macrophages by inhibiting the c-Jun N-terminal kinase activation, whereas Q3GA acts only in the presence of extracellular beta-glucuronidase activity. Finally, we demonstrated the deconjugation of quercetin glucuronides including the sulfoglucuronides in vivo in the spleen of mice challenged with LPS. These results showed that mitochondrial dysfunction plays a crucial role in the deconjugation of quercetin glucuronides in macrophages. Collectively, this study contributes to clarifying the mechanism responsible for the anti-inflammatory activity of dietary flavonoids within the inflammation sites.	[Ishisaka, Akari] Kurashiki Sakuyo Univ, Dept Nutr, Fac Food Culture, Kurashiki, Okayama, Japan; [Kawabata, Kyuichi] Fukui Prefectural Univ, Fac Biotechnol, Dept Biosci, Fukui, Japan; [Miki, Satomi; Shiba, Yuko; Minekawa, Shoko; Nishikawa, Tomomi; Mukai, Rie; Terao, Junji] Univ Tokushima, Grad Sch Nutr & Biosci, Dept Food Sci, Tokushima 770, Japan; [Kawai, Yoshichika] Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan	Fukui Prefectural University; Tokushima University; Nagoya University	Kawai, Y (corresponding author), Nagoya Univ, Grad Sch Bioagr Sci, Lab Food & Biodynam, Nagoya, Aichi 4648601, Japan.	kawaiy@agr.nagoya-u.ac.jp	Kawai, Yoshichika/G-3231-2011	Mukai, Rie/0000-0003-3906-4848	Ministry of Education, Sciences, Sports, Technology, Japan; Japan Society for the Promotion of Science Research Fellow	Ministry of Education, Sciences, Sports, Technology, Japan; Japan Society for the Promotion of Science Research Fellow(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This work was supported in part by a Grant-in-Aid for Young Scientists (A) (to Y.K.) from the Ministry of Education, Sciences, Sports, Technology, Japan, and by a Grant-in-Aid from the Japan Society for the Promotion of Science Research Fellow (to A. I.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bentsath A, 1936, NATURE, V138, P798, DOI 10.1038/138798a0; Bieger J, 2008, J NUTR, V138, P1417, DOI 10.1093/jn/138.8.1417; CABANTCHIK ZI, 1972, J MEMBRANE BIOL, V10, P311, DOI 10.1007/BF01867863; Choi EM, 2012, J APPL TOXICOL, V32, P118, DOI 10.1002/jat.1642; Day AJ, 2001, FREE RADICAL RES, V35, P941, DOI 10.1080/10715760100301441; de Boer VCJ, 2005, J NUTR, V135, P1718, DOI 10.1093/jn/135.7.1718; Fiorani M, 2010, J NUTR BIOCHEM, V21, P397, DOI 10.1016/j.jnutbio.2009.01.014; Furukawa A, 2003, BIOCHEM PHARMACOL, V66, P1769, DOI 10.1016/S0006-2952(03)00541-0; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harwood M, 2007, FOOD CHEM TOXICOL, V45, P2179, DOI 10.1016/j.fct.2007.05.015; HERTOG MGL, 1994, NUTR CANCER, V22, P175, DOI 10.1080/01635589409514342; HERTOG MGL, 1993, NUTR CANCER, V20, P21, DOI 10.1080/01635589309514267; HERTOG MGL, 1995, ARCH INTERN MED, V155, P381, DOI 10.1001/archinte.155.4.381; HERTOG MGL, 1993, LANCET, V342, P1007, DOI 10.1016/0140-6736(93)92876-U; Hertog MGL, 1996, EUR J CLIN NUTR, V50, P63; HERTOG MGL, 1992, J AGR FOOD CHEM, V40, P2379, DOI 10.1021/jf00024a011; HERTOG MGL, 1993, J AGR FOOD CHEM, V41, P1242, DOI 10.1021/jf00032a015; Ishisaka A, 2011, FREE RADICAL BIO MED, V51, P1329, DOI 10.1016/j.freeradbiomed.2011.06.017; Isshiki M, 2002, J BIOL CHEM, V277, P43389, DOI 10.1074/jbc.M205411200; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kamada C, 2005, FREE RADICAL RES, V39, P185, DOI 10.1080/10715760400019638; Kawai Y, 2008, BIOCHEM BIOPH RES CO, V374, P527, DOI 10.1016/j.bbrc.2008.07.086; Kawai Y, 2008, J BIOL CHEM, V283, P9424, DOI 10.1074/jbc.M706571200; Kawai Y, 2009, BIOSCI BIOTECH BIOCH, V73, P517, DOI 10.1271/bbb.80516; Keli SO, 1996, ARCH INTERN MED, V156, P637, DOI 10.1001/archinte.156.6.637; Kim M, 2005, CARCINOGENESIS, V26, P1553, DOI 10.1093/carcin/bgi104; Kim SB, 2000, NUTR CANCER, V37, P41, DOI 10.1207/S15327914NC3701_5; Komatsu M, 2006, NATURE, V441, P880, DOI 10.1038/nature04723; Komatsu M, 2010, NAT CELL BIOL, V12, P213, DOI 10.1038/ncb2021; Le Marchand L, 2000, JNCI-J NATL CANCER I, V92, P154, DOI 10.1093/jnci/92.2.154; Lindsay J, 2002, AM J EPIDEMIOL, V156, P445, DOI 10.1093/aje/kwf074; Moon JH, 2001, FREE RADICAL BIO MED, V30, P1274, DOI 10.1016/S0891-5849(01)00522-6; Mullen W, 2004, J CHROMATOGR A, V1058, P163, DOI 10.1016/j.chroma.2004.08.117; Myohanen TT, 2010, INT REV NEUROBIOL, V95, P29, DOI [10.1016/B978-0-12-381326-8-00003-X, 10.1016/B978-0-12-381326-8.00003-X]; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Narendra D, 2008, J CELL BIOL, V183, P795, DOI 10.1083/jcb.200809125; Oka T, 2012, NATURE, V485, P251, DOI 10.1038/nature10992; Orgogozo JM, 1997, REV NEUROL-FRANCE, V153, P185; Pietrocola F, 2012, CELL CYCLE, V11, P3851, DOI 10.4161/cc.22027; Rusznyak S, 1936, NATURE, V138, P27, DOI 10.1038/138027a0; Sakano K, 2005, FREE RADICAL BIO MED, V39, P1041, DOI 10.1016/j.freeradbiomed.2005.05.024; Shirai M, 2006, FREE RADICAL RES, V40, P1047, DOI 10.1080/10715760600794287; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Triggiani M, 2001, J IMMUNOL, V166, P4083, DOI 10.4049/jimmunol.166.6.4083; Triggiani M, 2000, J IMMUNOL, V164, P4908, DOI 10.4049/jimmunol.164.9.4908; Williams RJ, 2004, FREE RADICAL BIO MED, V36, P838, DOI 10.1016/j.freeradbiomed.2004.01.001; Williamson G, 2005, FREE RADICAL RES, V39, P457, DOI 10.1080/10715760500053610; Wu JJ, 2009, AGING-US, V1, P425, DOI 10.18632/aging.100038; Yamashita N, 2000, FREE RADICAL RES, V33, P623, DOI 10.1080/10715760000301141; Zhou RB, 2011, NATURE, V469, P221, DOI 10.1038/nature09663	50	76	76	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80843	10.1371/journal.pone.0080843	http://dx.doi.org/10.1371/journal.pone.0080843			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260490	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900099
J	Yuan, K; Farney, JK; Mamedova, LK; Sordillo, LM; Bradford, BJ				Yuan, Kai; Farney, Jaymelynn K.; Mamedova, Laman K.; Sordillo, Lorraine M.; Bradford, Barry J.			TNF alpha Altered Inflammatory Responses, Impaired Health and Productivity, but Did Not Affect Glucose or Lipid Metabolism in Early-Lactation Dairy Cows	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ORGANIC NUTRIENT METABOLISM; FATTY LIVER; INSULIN; TRANSITION; PHOSPHORYLATION; PREVENTION; ETIOLOGY; MASTITIS; STRESS	Inflammation may be a major contributing factor to peripartum metabolic disorders in dairy cattle. We tested whether administering an inflammatory cytokine, recombinant bovine tumor necrosis factor-alpha (rbTNF alpha), affects milk production, metabolism, and health during this period. Thirty-three Holstein cows (9 primiparous and 24 multiparous) were randomly assigned to 1 of 3 treatments at parturition. Treatments were 0 (Control), 1.5, or 3.0 g/kg body weight rbTNF alpha, which were administered once daily by subcutaneous injection for the first 7 days of lactation. Statistical contrasts were used to evaluate the treatment and dose effects of rbTNF alpha administration. Plasma TNF alpha concentrations at 16 h post-administration tended to be increased (P < 0.10) by rbTNF alpha administration, but no dose effect (P > 0.10) was detected; rbTNFa treatments increased (P < 0.01) concentrations of plasma haptoglobin. Most plasma eicosanoids were not affected (P > 0.10) by rbTNF alpha administration, but 6 out of 16 measured eicosanoids changed (P < 0.05) over the first week of lactation, reflecting elevated inflammatory mediators in the days immediately following parturition. Dry matter and water intake, milk yield, and milk fat and protein yields were all decreased (P < 0.05) by rbTNFa treatments by 15 to 18%. Concentrations of plasma glucose, insulin, beta-hydroxybutyrate, non-esterified fatty acids, triglyceride, 3-methylhistidine,and liver triglyceride were unaffected (P < 0.10) by rbTNFa treatment. Glucose turnover rate was unaffected (P = 0.18) by rbTNFa administration. The higher dose of rbTNFa tended to increase the risk of cows developing one or more health disorders (P = 0.08). Taken together, these results indicate that administration of rbTNFa daily for the first 7 days of lactation altered inflammatory responses, impaired milk production and health, but did not significantly affect liver triglyceride accumulation or nutrient metabolism in dairy cows.	[Yuan, Kai; Farney, Jaymelynn K.; Mamedova, Laman K.; Bradford, Barry J.] Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA; [Sordillo, Lorraine M.] Michigan State Univ, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA	Kansas State University; Michigan State University	Bradford, BJ (corresponding author), Kansas State Univ, Dept Anim Sci & Ind, Manhattan, KS 66506 USA.	bbradfor@ksu.edu	Bradford, Barry/B-7870-2010	Bradford, Barry/0000-0002-6775-4961; Sordillo, Lorraine/0000-0001-8873-3134	Elanco Animal Health	Elanco Animal Health	This work was partially funded by Elanco Animal Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ametaj BN, 2005, CAN J ANIM SCI, V85, P165, DOI 10.4141/A04-043; Ballou MA, 2012, J ANIM SCI, V90, P1466, DOI 10.2527/jas.2011-4663; BELL AW, 1995, J ANIM SCI, V73, P2804, DOI 10.2527/1995.7392804x; Bionaz M, 2007, J DAIRY SCI, V90, P1740, DOI 10.3168/jds.2006-445; BLUM JW, 1985, J DAIRY SCI, V68, P2580, DOI 10.3168/jds.S0022-0302(85)81140-1; Bobe G, 2004, J DAIRY SCI, V87, P3105, DOI 10.3168/jds.S0022-0302(04)73446-3; Bradford BJ, 2009, J NUTR, V139, P1451, DOI 10.3945/jn.109.108233; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Duffield TF, 2009, J DAIRY SCI, V92, P571, DOI 10.3168/jds.2008-1507; Farney JK, 2011, J DAIRY SCI, V94, P3504, DOI 10.3168/jds.2010-4082; Farney JK, 2013, AM J PHYSIOL-REG I, V305, pR110, DOI 10.1152/ajpregu.00152.2013; FRONK TJ, 1980, J DAIRY SCI, V63, P1080, DOI 10.3168/jds.S0022-0302(80)83050-5; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Grinberg N, 2008, INFECT IMMUN, V76, P2802, DOI 10.1128/IAI.00051-08; Grummer RR, 2008, VET J, V176, P10, DOI 10.1016/j.tvjl.2007.12.033; GRUMMER RR, 1995, J ANIM SCI, V73, P2820; Hachenberg S, 2007, J ANIM SCI, V85, P1923, DOI 10.2527/jas.2006-480; Hacker H, 2006, SCI STKE, V357, pre13; HOTAMISLIGIL GS, 1995, J CLIN INVEST, V95, P2409, DOI 10.1172/JCI117936; Karin M, 2000, ANNU REV IMMUNOL, V18, P621, DOI 10.1146/annurev.immunol.18.1.621; Kelton DF, 1998, J DAIRY SCI, V81, P2502, DOI 10.3168/jds.S0022-0302(98)70142-0; Kushibiki S, 2000, J ANIM SCI, V78, P2164; Kushibiki S, 2003, J DAIRY SCI, V86, P819, DOI 10.3168/jds.S0022-0302(03)73664-9; Lee SA, 2001, J BIOL CHEM, V276, P11783, DOI 10.1074/jbc.M004517200; Mamedova LK, 2010, J ANIM SCI, V88, P124, DOI 10.2527/jas.2009-2258; Morey SD, 2011, J DAIRY SCI, V94, P5090, DOI 10.3168/jds.2011-4304; NAKAGAWATOSA N, 1995, J VET MED SCI, V57, P219, DOI 10.1292/jvms.57.219; NASEM (National Academies of Science Engineering and Medicine), 2001, NUTR REQ DAIR CATTL, V7th, DOI 10.17226/9825; Neuschwander-Tetri BA, 2010, HEPATOLOGY, V52, P774, DOI 10.1002/hep.23719; Oetzel GR, 2007, PREC SEM 7C DAIR HER, P67; Ohtsuka H, 2001, J VET MED SCI, V63, P1021, DOI 10.1292/jvms.63.1021; Reynolds CK, 2003, J DAIRY SCI, V86, P1201, DOI 10.3168/jds.S0022-0302(03)73704-7; Romanatto T, 2007, PEPTIDES, V28, P1050, DOI 10.1016/j.peptides.2007.03.006; SAKURAI Y, 1993, J CLIN INVEST, V91, P2437, DOI 10.1172/JCI116478; Sakurai Y, 1996, AM J PHYSIOL-ENDOC M, V270, pE864, DOI 10.1152/ajpendo.1996.270.5.E864; Schoenberg KM, 2011, J DAIRY SCI, V94, P5523, DOI 10.3168/jds.2011-4501; SCHULZE E, 1991, COMP BIOCHEM PHYS B, V100, P167, DOI 10.1016/0305-0491(91)90101-I; SHOOK GE, 1993, VET CLIN N AM-FOOD A, V9, P563, DOI 10.1016/S0749-0720(15)30622-8; Sordillo Lorraine M., 2009, Animal Health Research Reviews, V10, P53, DOI 10.1017/S1466252309990016; Starke A, 2010, J ANIM SCI, V88, P2741, DOI 10.2527/jas.2009-2599; Steinhour W. D., 1988, Aspects of digestive physiology in ruminants. Proceedings of a Satellite Symposium of the 30th International Congress of the International Union of Physiological Sciences, July 21-23, 1986. Ithaca, New York, P238; TSERNG KY, 1983, AM J PHYSIOL, V245, pE476, DOI 10.1152/ajpendo.1983.245.5.E476; YOUNG JW, 1977, J DAIRY SCI, V60, P1, DOI 10.3168/jds.S0022-0302(77)83821-6; Zhang HH, 2002, DIABETES, V51, P2929, DOI 10.2337/diabetes.51.10.2929	44	47	48	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80316	10.1371/journal.pone.0080316	http://dx.doi.org/10.1371/journal.pone.0080316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260367	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900063
J	Zhang, T; Niu, XH; Liao, LL; Cho, EA; Yang, HF				Zhang, Ting; Niu, Xiaohua; Liao, Lili; Cho, Eun-Ah; Yang, Haifeng			The Contributions of HIF-Target Genes to Tumor Growth in RCC	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR; FACTOR-BINDING PROTEIN-3; RENAL-CELL CARCINOMA; CANCER; VHL; HYDROXYLATION; INHIBITION; EXPRESSION; RESISTANCE; APOPTOSIS	Somatic mutations or loss of expression of tumor suppressor VHL happen in the vast majority of clear cell Renal Cell Carcinoma, and it's causal for kidney cancer development. Without VHL, constitutively active transcription factor HIF is strongly oncogenic and is essential for tumor growth. However, the contribution of individual HIF-responsive genes to tumor growth is not well understood. In this study we examined the contribution of important HIF-responsive genes such as VEGF, CCND1, ANGPTL4, EGLN3, ENO2, GLUT1 and IGFBP3 to tumor growth in a xenograft model using immune-compromised nude mice. We found that the suppression of VEGF or CCND1 impaired tumor growth, suggesting that they are tumor-promoting genes. We further discovered that the lack of ANGPTL4, EGLN3 or ENO2 expression did not change tumor growth. Surprisingly, depletion of GLUT1 or IGFBP3 significantly increased tumor growth, suggesting that they have tumor-inhibitory functions. Depletion of IGFBP3 did not lead to obvious activation of IGFIR. Unexpectedly, the depletion of IGFIR protein led to significant increase of IGFBP3 at both the protein and mRNA levels. Concomitantly, the tumor growth was greatly impaired, suggesting that IGFBP3 might suppress tumor growth in an IGFIR-independent manner. In summary, although the overall transcriptional activity of HIF is strongly tumor-promoting, the expression of each individual HIF-responsive gene could either enhance, reduce or do nothing to the kidney cancer tumor growth.	[Zhang, Ting] Tianjin Med Univ, Hosp 2, Tianjin Inst Urol, Tianjin, Peoples R China; [Niu, Xiaohua; Liao, Lili; Yang, Haifeng] Cleveland Clin, Dept Canc Biol, Lerner Res Inst, Cleveland, OH 44106 USA; [Cho, Eun-Ah] Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA	Tianjin Medical University; Cleveland Clinic Foundation; Jefferson University	Yang, HF (corresponding author), Thomas Jefferson Univ, Dept Pathol Anat & Cell Biol, Philadelphia, PA 19107 USA.	haifeng.yang@jefferson.edu			National Institute of Health [CA155015]; VHL Family Alliance; Chinese Scholar Council; NATIONAL CANCER INSTITUTE [R01CA155015] Funding Source: NIH RePORTER	National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); VHL Family Alliance; Chinese Scholar Council; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was funded in part by National Institute of Health (CA155015 to HY), VHL Family Alliance (to HY) and Chinese Scholar Council (to TZ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adekola K, 2012, CURR OPIN ONCOL, V24, P650, DOI 10.1097/CCO.0b013e328356da72; Bhatt RS, 2010, MOL CANCER THER, V9, P2793, DOI 10.1158/1535-7163.MCT-10-0477; Boone David N., 2012, Critical Reviews in Oncogenesis, V17, P161; Bukowski RM, 2010, EXPERT REV ANTICANC, V10, P635, DOI [10.1586/era.10.38, 10.1586/ERA.10.38]; Butt AJ, 2000, J BIOL CHEM, V275, P39174, DOI 10.1074/jbc.M908888199; Chan DA, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002394; Covello KL, 2006, GENE DEV, V20, P557, DOI 10.1101/gad.1399906; Epstein ACR, 2001, CELL, V107, P43, DOI 10.1016/S0092-8674(01)00507-4; Escudier B, 2007, NEW ENGL J MED, V356, P125, DOI 10.1056/NEJMoa060655; Gunaratnam L, 2003, J BIOL CHEM, V278, P44966, DOI 10.1074/jbc.M305502200; H-Zadeh AM, 2006, INT J ONCOL, V29, P1279; Huang D, 2010, CANCER RES, V70, P1063, DOI 10.1158/0008-5472.CAN-09-3965; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Jogie-Brahim S, 2009, ENDOCR REV, V30, P417, DOI 10.1210/er.2008-0028; Kaelin WG, 2011, COLD SH Q B, V76, P335, DOI 10.1101/sqb.2011.76.010975; Kaelin WG, 2002, NAT REV CANCER, V2, P673, DOI 10.1038/nrc885; Kondo K, 2003, PLOS BIOL, V1, P439, DOI 10.1371/journal.pbio.0000083; Kondo K, 2002, CANCER CELL, V1, P237, DOI 10.1016/S1535-6108(02)00043-0; Li LJ, 2007, MOL CELL BIOL, V27, P5381, DOI 10.1128/MCB.00282-07; Linehan WM, 2004, CLIN CANCER RES, V10, p6282S, DOI 10.1158/1078-0432.CCR-050013; Maranchie JK, 2002, CANCER CELL, V1, P247, DOI 10.1016/S1535-6108(02)00044-2; Marangoni E, 2007, CLIN CANCER RES, V13, P3989, DOI 10.1158/1078-0432.CCR-07-0078; Motzer RJ, 2007, NEW ENGL J MED, V356, P115, DOI 10.1056/NEJMoa065044; Muller FL, 2012, NATURE, V488, P337, DOI 10.1038/nature11331; Niu X, 2012, ONCOGENE, V31, P776, DOI 10.1038/onc.2011.266; OH Y, 1993, J BIOL CHEM, V268, P26045; OH YM, 1993, J BIOL CHEM, V268, P14964; Pestell RG, 2013, AM J PATHOL, V183, P3, DOI 10.1016/j.ajpath.2013.03.001; Raval RR, 2005, MOL CELL BIOL, V25, P5675, DOI 10.1128/MCB.25.13.5675-5686.2005; Rini BI, 2005, BJU INT, V96, P286, DOI 10.1111/j.1464-410X.2005.05616.x; Rini BI, 2009, LANCET ONCOL, V10, P992, DOI 10.1016/S1470-2045(09)70240-2; Schlisio S, 2009, J CELL MOL MED, V13, P4104, DOI 10.1111/j.1582-4934.2009.00881.x; Sonpavde G, 2008, EXPERT OPIN INV DRUG, V17, P741, DOI [10.1517/13543784.17.5.741, 10.1517/13543784.17.5.741 ]; Su Y, 2010, BRIT J CANCER, V103, P1571, DOI 10.1038/sj.bjc.6605936; Tan MJ, 2012, MOL CANCER RES, V10, P677, DOI 10.1158/1541-7786.MCR-11-0519; Taniguchi CM, 2013, NAT MED, V19, P1325, DOI 10.1038/nm.3294; Tsao CC, 2008, CANCER BIOL THER, V7, P1619, DOI 10.4161/cbt.7.10.6583; Wright TM, 2009, ONCOGENE, V28, P2513, DOI 10.1038/onc.2009.116; Wright TM, 2010, J BIOL CHEM, V285, P12916, DOI 10.1074/jbc.M109.073924; Xie L, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000444; Yan Q, 2007, MOL CELL BIOL, V27, P2092, DOI 10.1128/MCB.01514-06; Yu F, 2001, P NATL ACAD SCI USA, V98, P9630, DOI 10.1073/pnas.181341498; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zimmer M, 2004, MOL CANCER RES, V2, P89	46	42	44	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80544	10.1371/journal.pone.0080544	http://dx.doi.org/10.1371/journal.pone.0080544			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260413	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500151
J	Melkonian, S; Argos, M; Hall, MN; Chen, Y; Parvez, F; Pierce, B; Cao, HY; Aschebrook-Kilfoy, B; Ahmed, A; Islam, T; Slavcovich, V; Gamble, M; Haris, PI; Graziano, JH; Ahsan, H				Melkonian, Stephanie; Argos, Maria; Hall, Megan N.; Chen, Yu; Parvez, Faruque; Pierce, Brandon; Cao, Hongyuan; Aschebrook-Kilfoy, Briseis; Ahmed, Alauddin; Islam, Tariqul; Slavcovich, Vesna; Gamble, Mary; Haris, Parvez I.; Graziano, Joseph H.; Ahsan, Habibul			Urinary and Dietary Analysis of 18,470 Bangladeshis Reveal a Correlation of Rice Consumption with Arsenic Exposure and Toxicity	PLOS ONE			English	Article							PREMALIGNANT SKIN-LESIONS; LONGITUDINAL-STUDY HEALS; DRINKING-WATER; COOKED RICE; RISK; SPECIATION; BIOACCESSIBILITY; BIOAVAILABILITY; POPULATION; IRRIGATION	Background: We utilized data from the Health Effects of Arsenic Longitudinal Study (HEALS) in Araihazar, Bangladesh, to evaluate the association of steamed rice consumption with urinary total arsenic concentration and arsenical skin lesions in the overall study cohort (N=18,470) and in a subset with available urinary arsenic metabolite data (N=4,517). Methods: General linear models with standardized beta coefficients were used to estimate associations between steamed rice consumption and urinary total arsenic concentration and urinary arsenic metabolites. Logistic regression models were used to estimate prevalence odds ratios (ORs) and their 95% confidence intervals (CIs) for the associations between rice intake and prevalent skin lesions at baseline. Discrete time hazard models were used to estimate discrete time (HRs) ratios and their 95% CIs for the associations between rice intake and incident skin lesions. Results: Steamed rice consumption was positively associated with creatinine-adjusted urinary total arsenic (beta=0.041, 95% CI: 0.032-0.051) and urinary total arsenic with statistical adjustment for creatinine in the model (beta=0.043, 95% CI: 0.032-0.053). Additionally, we observed a significant trend in skin lesion prevalence (P-trend=0.007) and a moderate trend in skin lesion incidence (P-trend=0.07) associated with increased intake of steamed rice. Conclusions: This study suggests that rice intake may be a source of arsenic exposure beyond drinking water.	[Melkonian, Stephanie; Argos, Maria; Pierce, Brandon; Cao, Hongyuan; Aschebrook-Kilfoy, Briseis; Ahsan, Habibul] Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA; [Hall, Megan N.; Parvez, Faruque; Graziano, Joseph H.] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY USA; [Slavcovich, Vesna; Gamble, Mary; Graziano, Joseph H.] Columbia Univ, Dept Environm Hlth Sci, Mailman Sch Publ Hlth, New York, NY USA; [Chen, Yu] NYU, Dept Environm Med, New York, NY 10016 USA; [Ahmed, Alauddin; Islam, Tariqul] U Chicago Res Bangladesh Ltd, Dhaka, Bangladesh; [Haris, Parvez I.] De Montfort Univ, Fac Hlth & Life Sci, Leicester LE1 9BH, Leics, England; [Ahsan, Habibul] Univ Chicago, Dept Med, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Ahsan, Habibul] Univ Chicago, Ctr Comprehens Canc, Chicago, IL 60637 USA	University of Chicago; Columbia University; Columbia University; New York University; De Montfort University; University of Chicago; University of Chicago; Robert H. Lurie Comprehensive Cancer Center; University of Chicago	Ahsan, H (corresponding author), Univ Chicago, Dept Hlth Studies, Chicago, IL 60637 USA.	habib@uchicago.edu		Pierce, Brandon/0000-0002-7829-952X; Chen, Yu/0000-0002-1519-4894; Haris, Parvez/0000-0002-4071-3553	Natioanl Institutes of Health [P42 ES010349, RO1 CA107431]; NATIONAL CANCER INSTITUTE [R01CA107431] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010349, R00ES018890] Funding Source: NIH RePORTER	Natioanl Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This research is supported by Natioanl Institutes of Health grants P42 ES010349 and RO1 CA107431. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahsan H, 2006, J EXPO SCI ENV EPID, V16, P191, DOI 10.1038/sj.jea.7500449; Ahsan H, 2000, J OCCUP ENVIRON MED, V42, P1195, DOI 10.1097/00043764-200012000-00016; Ahsan H, 2007, CANCER EPIDEM BIOMAR, V16, P1270, DOI 10.1158/1055-9965.EPI-06-0676; Ahsan H, 2006, AM J EPIDEMIOL, V163, P1138, DOI 10.1093/aje/kwj154; Al Rmalli SW, 2005, SCI TOTAL ENVIRON, V337, P23, DOI 10.1016/j.scitotenv.2004.06.008; Argos M, 2010, EUR J NUTR, V49, P473, DOI 10.1007/s00394-010-0106-y; Bae M, 2002, LANCET, V360, P1839, DOI 10.1016/S0140-6736(02)11738-7; Cascio C, 2011, J ENVIRON MONITOR, V13, P257, DOI 10.1039/c0em00482k; Chen Y, 2004, AM J PUBLIC HEALTH, V94, P741, DOI 10.2105/AJPH.94.5.741; Chen Y, 2004, BRIT J NUTR, V92, P851, DOI 10.1079/BJN20041277; Chen Y, 2007, CANCER EPIDEM BIOMAR, V16, P207, DOI 10.1158/1055-9965.EPI-06-0581; Chizmar JF, 2000, J ECON EDUC, V31, P107, DOI 10.2307/1183183; Davis MA, 2012, ENVIRON HEALTH PERSP, V120, P1418, DOI 10.1289/ehp.1205014; Fattorini D, 2013, ENVIRON SCI-PROC IMP, V15, P773, DOI 10.1039/c3em30819g; Ferreccio C, 2000, EPIDEMIOLOGY, V11, P673, DOI 10.1097/00001648-200011000-00010; Gilbert-Diamond D, 2011, P NATL ACAD SCI USA, V108, P20656, DOI 10.1073/pnas.1109127108; He Y, 2012, J ENVIRON SCI HEAL B, V47, P74, DOI 10.1080/03601234.2012.611431; He Y, 2010, SCI TOTAL ENVIRON, V408, P1430, DOI 10.1016/j.scitotenv.2009.12.043; Heck JE, 2009, ENVIRON HEALTH PERSP, V117, P99, DOI 10.1289/ehp.11589; HopenhaynRich C, 1996, ENVIRON HEALTH PERSP, V104, P620, DOI 10.2307/3433091; Huq SMI, 2006, J HEALTH POPUL NUTR, V24, P305; Juhasz AL, 2006, ENVIRON HEALTH PERSP, V114, P1826, DOI 10.1289/ehp.9322; Kenneth F., 2000, CAMBRIDGE WORLD HIST; Laparra JM, 2005, J AGR FOOD CHEM, V53, P8829, DOI 10.1021/jf051365b; Leufroy A, 2012, ANAL BIOANAL CHEM, V402, P2849, DOI 10.1007/s00216-012-5774-4; Marshall G, 2007, JNCI-J NATL CANCER I, V99, P920, DOI 10.1093/jnci/djm004; Meharg AA, 2004, TRENDS PLANT SCI, V9, P415, DOI 10.1016/j.tplants.2004.07.002; Meharg AA, 2008, J ENVIRON MONITOR, V10, P428, DOI 10.1039/b800981c; Parvez F, 2006, ENVIRON HEALTH PERSP, V114, P355, DOI 10.1289/ehp.7903; Parvez F, 2010, THORAX, V65, P528, DOI 10.1136/thx.2009.119347; Pierce BL, 2011, AM J EPIDEMIOL, V173, P345, DOI 10.1093/aje/kwq366; Rahman F, 2009, ENVIRON GEOCHEM HLTH, V31, P103, DOI 10.1007/s10653-008-9225-2; Rahman MA, 2011, SCI TOTAL ENVIRON, V409, P4645, DOI 10.1016/j.scitotenv.2011.07.068; Sarkar S, 2010, WATER RES, V44, P5813, DOI 10.1016/j.watres.2010.07.072; SLOT C, 1965, SCAND J CLIN LAB INV, V17, P381, DOI 10.3109/00365516509077065; Smith NM, 2006, SCI TOTAL ENVIRON, V370, P294, DOI 10.1016/j.scitotenv.2006.06.010; Sun GX, 2009, ENVIRON INT, V35, P473, DOI 10.1016/j.envint.2008.07.020; Trenary HR, 2012, J EXPO SCI ENV EPID, V22, P369, DOI 10.1038/jes.2012.24; Vahter Marie, 1999, Science Progress, V82, P69; Williams PN, 2007, ENVIRON SCI TECHNOL, V41, P2178, DOI 10.1021/es061489k; Williams PN, 2005, ENVIRON SCI TECHNOL, V39, P5531, DOI 10.1021/es0502324; Xue J, 2012, ENV HLTH PERSPECT, V118, P345	42	44	44	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80691	10.1371/journal.pone.0080691	http://dx.doi.org/10.1371/journal.pone.0080691			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260455	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600078
J	Bu, W; Zhang, X; Dai, H; Huang, S; Li, Y				Bu, Wen; Zhang, Xiang; Dai, Hua; Huang, Shixia; Li, Yi			Mammary Cells with Active Wnt Signaling Resist ErbB2-Induced Tumorigenesis	PLOS ONE			English	Article							WNT/BETA-CATENIN PATHWAY; MIDDLE T-ANTIGEN; STEM-CELLS; BREAST-CANCER; BETA-CATENIN; TRANSGENIC MICE; SELF-RENEWAL; EPITHELIAL-CELLS; PROGENITOR CELLS; EXPRESSION	Aberrant activation of Wnt signaling is frequent in human malignancies. In normal epithelial tissues, including the breast, Wnt signaling is active only in a subset of cells, but it is unknown whether this subset of Wnt signaling-active cells is at increased risk of carcinogenesis. We created transgenic mice (TOP-tva) in which the synthetic Wnt-responsive promoter TOP controlled the gene encoding TVA, which confers susceptibility to infection by the retroviral vector RCAS. Thus, only cells in which Wnt signaling is active will express tva and be targeted by RCAS. Surprisingly, we found that RCAS-mediated delivery of cDNA encoding a constitutively activated version of ErbB2 (HER2/Neu) into the small number of TVA+ mammary epithelial cells in TOP-tva mice failed to induce tumor, while the same virus readily induced mammary tumors after it was delivered into a comparable number of cells in our previously reported mouse line MMTV-tva, whose tva is broadly expressed in mammary epithelium. Furthermore, we could not even detect any early lesions or infected cells in TOP-tva mice at the time of necropsy. Therefore, we conclude that the Wnt pathway-active cell subset in the normal mammary epithelium does not evolve into tumors following ErbB2 activation-rather, they apparently die due to apoptosis, an anticancer "barrier" that we have reported to be erected in some mammary cells followed ErbB2 activation. In accord with these mouse model data, we found that unlike the basal subtype, ErbB2+ human breast cancers rarely involve aberrant activation of Wnt signaling. This is the first report of a defined sub-population of mammalian cells that is "protected" from tumorigenesis by a potent oncogene, and provides direct in vivo evidence that mammary epithelial cells are not equal in their response to oncogene-initiated transformation.	[Bu, Wen; Zhang, Xiang; Dai, Hua; Li, Yi] Baylor Coll Med, Lester & Sue Smith Breast Ctr, Houston, TX 77030 USA; [Bu, Wen; Zhang, Xiang; Huang, Shixia; Li, Yi] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Dai, Hua] Yangzhou Univ, Sch Med, Dept Physiol, Yangzhou, Jiangsu, Peoples R China	Baylor College of Medicine; Baylor College of Medicine; Yangzhou University	Li, Y (corresponding author), Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.	liyi@bcm.edu	Li, Yi/A-7635-2009	Li, Yi/0000-0002-9976-518X	BCM Pathology Core; National Cancer Institute (NCI) [P50-CA058183, P30CA125123]; Cytometry and Cell Sorting Core; National Institutes of Health (NIH) [P30AI036211, NCI P30CA125123]; National Center for Research Resources [S10RR024574]; NIH [R01 CA124820]; Congressionally Directed Medical Research Programs [BC073703, BC085050, U54CA149196]; NATIONAL CANCER INSTITUTE [R01CA124820, U54CA149196, P50CA058183, P30CA125123] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI036211] Funding Source: NIH RePORTER	BCM Pathology Core; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cytometry and Cell Sorting Core; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Congressionally Directed Medical Research Programs(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This project was supported by BCM Pathology Core, which is funded in part by National Cancer Institute (NCI) P50-CA058183 and P30CA125123, and the Cytometry and Cell Sorting Core with funding from the National Institutes of Health (NIH) (http://nih.gov/) (National Institute of Allergy and Infectious Diseases P30AI036211, NCI P30CA125123, and National Center for Research Resources S10RR024574) and the assistance of Joel M. Sederstrom. This work was also supported in part by NIH R01 CA124820 (to YL), Congressionally Directed Medical Research Programs (http://cdmrp.army.mil/default.shtml) BC073703 and BC085050 (to YL), and U54CA149196 (to YL; PI: Stephan Wong). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayyanan A, 2006, P NATL ACAD SCI USA, V103, P3799, DOI 10.1073/pnas.0600065103; Badders NM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006594; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Bu W, 2011, ONCOGENE, V30, P4399, DOI 10.1038/onc.2011.147; Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347; Clevers H, 2012, CELL, V149, P1192, DOI 10.1016/j.cell.2012.05.012; DasGupta R, 1999, DEVELOPMENT, V126, P4557; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Dimeo TA, 2009, CANCER RES, V69, P5364, DOI 10.1158/0008-5472.CAN-08-4135; Dorsky RI, 2002, DEV BIOL, V241, P229, DOI 10.1006/dbio.2001.0515; Du ZJ, 2007, CELL CYCLE, V6, P823, DOI 10.4161/cc.6.7.4074; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Green JL, 2013, P NATL ACAD SCI USA, V110, P6991, DOI 10.1073/pnas.1303671110; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Halazonetis TD, 2008, SCIENCE, V319, P1352, DOI 10.1126/science.1140735; Hallett RM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033976; Henry MD, 2004, ONCOGENE, V23, P6980, DOI 10.1038/sj.onc.1207827; Holland EC, 2000, AM J PATHOL, V157, P1031, DOI 10.1016/S0002-9440(10)64615-9; Huang SX, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r84; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Jeselsohn R, 2010, CANCER CELL, V17, P65, DOI 10.1016/j.ccr.2009.11.024; Khalil S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033421; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kirikoshi H, 2002, INT J ONCOL, V21, P895; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Li Y, 2005, J MAMMARY GLAND BIOL, V10, P17, DOI 10.1007/s10911-005-2537-2; Li Y, 2003, P NATL ACAD SCI USA, V100, P15853, DOI 10.1073/pnas.2136825100; Li Y, 2012, GENETICALLY ENGINEERED MICE FOR CANCER RESEARCH: DESIGN, ANALYSIS, PATHWAYS, VALIDATION AND PRE-CLINICAL TESTING, P83, DOI 10.1007/978-0-387-69805-2_5; Lin SY, 2000, P NATL ACAD SCI USA, V97, P4262, DOI 10.1073/pnas.060025397; Lindvall C, 2007, STEM CELL REV, V3, P157, DOI 10.1007/s12015-007-0025-3; Lindvall C, 2006, J BIOL CHEM, V281, P35081, DOI 10.1074/jbc.M607571200; Lindvall C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005813; Liu CC, 2010, P NATL ACAD SCI USA, V107, P5136, DOI 10.1073/pnas.0911220107; Lowe SW, 2004, NATURE, V432, P307, DOI 10.1038/nature03098; Malanchi I, 2008, NATURE, V452, P650, DOI 10.1038/nature06835; Moody SE, 2002, CANCER CELL, V2, P451, DOI 10.1016/S1535-6108(02)00212-X; Ni M, 2011, CANCER CELL, V20, P119, DOI 10.1016/j.ccr.2011.05.026; Nusse R, 2012, EMBO J, V31, P2670, DOI 10.1038/emboj.2012.146; O'Toole SA, 2013, J CLIN PATHOL, V66, P530, DOI 10.1136/jclinpath-2012-201361; Podsypanina K, 2004, BMC MED, V2, DOI 10.1186/1741-7015-2-24; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Reddy JP, 2010, P NATL ACAD SCI USA, V107, P3728, DOI 10.1073/pnas.0910665107; Reddy JP, 2009, J MAMMARY GLAND BIOL, V14, P405, DOI 10.1007/s10911-009-9157-1; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Schade B, 2013, CANCER RES, V73, P4474, DOI 10.1158/0008-5472.CAN-12-3925; Sircoulomb F, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-539; Smid M, 2008, CANCER RES, V68, P3108, DOI 10.1158/0008-5472.CAN-07-5644; Suzuki H, 2008, BRIT J CANCER, V98, P1147, DOI 10.1038/sj.bjc.6604259; Ursini-Siegel J, 2007, NAT REV CANCER, V7, P389, DOI 10.1038/nrc2127; van Amerongen R, 2012, CELL STEM CELL, V11, P387, DOI 10.1016/j.stem.2012.05.023; vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X; Wang YZ, 2010, SCIENCE, V327, P1650, DOI 10.1126/science.1186624; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yang L, 2011, ONCOGENE, V30, P4437, DOI 10.1038/onc.2011.145; Zeng YA, 2010, CELL STEM CELL, V6, P568, DOI 10.1016/j.stem.2010.03.020; Zhang M, 2010, P NATL ACAD SCI USA, V107, P3522, DOI 10.1073/pnas.0910179107; Zhang XHF, 2009, CANCER CELL, V16, P67, DOI 10.1016/j.ccr.2009.05.017	59	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78720	10.1371/journal.pone.0078720	http://dx.doi.org/10.1371/journal.pone.0078720			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265712	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100045
J	Kishimoto, H; Momiyama, M; Aki, R; Kimura, H; Suetsugu, A; Bouvet, M; Fujiwara, T; Hoffman, RM				Kishimoto, Hiroyuki; Momiyama, Masashi; Aki, Ryoichi; Kimura, Hiroaki; Suetsugu, Atsushi; Bouvet, Michael; Fujiwara, Toshiyoshi; Hoffman, Robert M.			Development of a Clinically-Precise Mouse Model of Rectal Cancer	PLOS ONE			English	Article							IN-VIVO; FLUORESCENT PROTEINS; NUDE-MOUSE; MICE; CARCINOMA; DISCOVERY; CELLS; COLON	Currently-used rodent tumor models, including transgenic tumor models, or subcutaneously growing tumors in mice, do not sufficiently represent clinical cancer. We report here development of methods to obtain a highly clinically-accurate rectal cancer model. This model was established by intrarectal transplantation of mouse rectal cancer cells, stably expressing green fluorescent protein (GFP), followed by disrupting the epithelial cell layer of the rectal mucosa by instilling an acetic acid solution. Early-stage tumor was detected in the rectal mucosa by 6 days after transplantation. The tumor then became invasive into the submucosal tissue. The tumor incidence was 100% and mean volume (+/-SD) was 1232.4 +/- 994.7 mm(3) at 4 weeks after transplantation detected by fluorescence imaging. Spontaneous lymph node metastasis and lung metastasis were also found approximately 4 weeks after transplantation in over 90% of mice. This rectal tumor model precisely mimics the natural history of rectal cancer and can be used to study early tumor development, metastasis, and discovery and evaluation of novel therapeutics for this treatment-resistant disease.	[Kishimoto, Hiroyuki; Momiyama, Masashi; Aki, Ryoichi; Kimura, Hiroaki; Suetsugu, Atsushi; Hoffman, Robert M.] AntiCancer Inc, San Diego, CA USA; [Kishimoto, Hiroyuki; Bouvet, Michael; Hoffman, Robert M.] Univ Calif San Diego, Dept Surg, San Diego, CA 92103 USA; [Kishimoto, Hiroyuki; Fujiwara, Toshiyoshi] Okayama Univ, Grad Sch Med Dent & Pharmaceut Sci, Dept Surg, Div Surg Oncol, Okayama, Japan	Anti Cancer Inc; University of California System; University of California San Diego; Okayama University	Hoffman, RM (corresponding author), AntiCancer Inc, San Diego, CA USA.	all@anticancer.com			Ministry of Education, Culture, Sports, Science and Technology, Japan; Grants-in-Aid for Scientific Research [24790700] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by grants from Young Scientists (B), The Ministry of Education, Culture, Sports, Science and Technology, Japan (H. K.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amoh Y, 2004, P NATL ACAD SCI USA, V101, P13291, DOI 10.1073/pnas.0405250101; Amoh Y, 2005, CANCER RES, V65, P5352, DOI 10.1158/0008-5472.CAN-05-0821; BRATTAIN MG, 1981, CANCER RES, V41, P1751; FU XY, 1991, P NATL ACAD SCI USA, V88, P9345, DOI 10.1073/pnas.88.20.9345; FURUKAWA T, 1993, CANCER RES, V53, P1204; Gespedes MV, 2007, AM J PATHOL, V170, P1077; Gest TR, 2003, ANAT REC PART A, V271A, P192, DOI 10.1002/ar.a.10022; Hamamoto T, 2002, CANCER RES, V62, P5955; Hoffman RA, 2005, METH MOLEC MED, V111, P297; Hoffman RM, 1999, INVEST NEW DRUG, V17, P343, DOI 10.1023/A:1006326203858; Hoffman RM, 2005, NAT REV CANCER, V5, P796, DOI 10.1038/nrc1717; Hoffman RM, 2006, NAT PROTOC, V1, P1429, DOI 10.1038/nprot.2006.223; Hoffman RM, 2006, NAT PROTOC, V1, P775, DOI 10.1038/nprot.2006.109; Hoffman RM, 2006, NAT PROTOC, V1, P928, DOI 10.1038/nprot.2006.119; Kimura H, 2010, J BIOMED OPT, V15, DOI 10.1117/1.3526356; Kishimoto H, 2006, NAT MED, V12, P1213, DOI 10.1038/nm1404; Rosenberg MP, 1998, CANCER METAST REV, V17, P295, DOI 10.1023/A:1006196614142; Tan KK, 2009, J GASTROINTEST SURG, V13, P642, DOI 10.1007/s11605-008-0757-7; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Van den Broeck W, 2006, J IMMUNOL METHODS, V312, P12, DOI 10.1016/j.jim.2006.01.022; WANG M, 1995, J IMMUNOL, V154, P4685; WHITE AC, 1982, CANCER RES, V42, P906; Winn B, 2009, HUM PATHOL, V40, P398, DOI 10.1016/j.humpath.2008.08.014; Yamamoto N, 2003, CLIN EXP METASTAS, V20, P633, DOI 10.1023/A:1027311230474; Yamauchi K, 2006, CANCER RES, V66, P4208, DOI 10.1158/0008-5472.CAN-05-3927	25	10	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79453	10.1371/journal.pone.0079453	http://dx.doi.org/10.1371/journal.pone.0079453			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265772	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100105
J	Li, WQ; Zhang, YX; Gu, RJ; Zhang, P; Liang, F; Gu, JP; Zhang, XM; Zhang, HY; Zhang, HX				Li, Wenqiang; Zhang, Yanxia; Gu, Renjun; Zhang, Ping; Liang, Fei; Gu, Jiapeng; Zhang, Xuemin; Zhang, Hongya; Zhang, Hongxing			DNA Pooling Base Genome-Wide Association Study Identifies Variants at NRXN3 Associated with Delayed Encephalopathy after Acute Carbon Monoxide Poisoning	PLOS ONE			English	Article							POLYMORPHISMS; GENE; SUSCEPTIBILITY; SCHIZOPHRENIA; DEPENDENCE; SEQUELAE; NEUREXIN; SMOKING; LINKAGE	Delayed encephalopathy after acute carbon monoxide poisoning (DEACMP) is more characteristic of anoxic encephalopathy than of other types of anoxia. Those who have the same poisoning degree and are of similar age and gender have a greater risk of getting DEACMP. This has made it clear that there are obvious personal differences. Genetic factors may play a very important role. The authors performed a genome-wide association study involving pooling of DNA obtained from 175 patients and 244 matched acute carbon monoxide poisoning without delayed encephalopathy controls. The Illumina HumanHap 660 Chip array was used for DNA pools. Allele frequencies of all SNPs were compared between delayed encephalopathy after acute carbon monoxide poisoning and control groups and ranked. A total of 123 SNPs gave an OR >1.4. Of these, 46 mapped in or close to known genes. Forty-eight SNPs located in 19 genes were associated with DEACMP after correction for 5% FDR in the genome-wide association of pooled DNA. Two SNPs (rs11845632 and rs2196447) locate in the Neurexin 3 gene were selected for individual genotyping in all samples and another cohort consisted of 234 and 271 controls. There were significant differences in the genotype and allele frequencies of rs11845632 and rs2196447 between the DEACMP group and controls group (all P-values <0.05). This study describes a positive association between Neurexin 3 and controls in the Han Chinese population, and provides genetic evidence to support the susceptibility of DEACMP, which may be the resulting interaction of environmental and genetic factors.	[Li, Wenqiang; Zhang, Yanxia; Gu, Renjun; Zhang, Ping; Gu, Jiapeng; Zhang, Xuemin] Xinxiang Med Univ, Affiliated Hosp 2, Dept Neurol, Xinxiang, Peoples R China; [Li, Wenqiang; Gu, Renjun; Zhang, Hongxing] Xinxiang Med Univ, Henan Key Lab Biol Psychiat, Xinxiang, Peoples R China; [Liang, Fei] Chinese Peoples Liberat Army, Hlth Team, Unit 93123, Dalian, Peoples R China; [Zhang, Hongya] Yang Pu Dist Ctr Dis Control & Prevent, Shanghai, Peoples R China; [Zhang, Yanxia] Tongzhou Hosp Matenal & Child Hlth Care, Beijing, Peoples R China	Xinxiang Medical University; Xinxiang Medical University; Shanghai Center for Disease Control & Prevention	Li, WQ (corresponding author), Xinxiang Med Univ, Affiliated Hosp 2, Dept Neurol, Xinxiang, Peoples R China.	lwq781603@163.com; gurenjun1961@126.com			National Natural Science Foundation of China [81141071, 81201040]; Key Technologies R&D Program of Henan Department of Science and Technology [102102310152]; Natural Science Foundation of Henan [122300410119, 122300413212]; Open Fund of Key Disciplines of Xinxiang Medical University [ZD200996]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Key Technologies R&D Program of Henan Department of Science and Technology; Natural Science Foundation of Henan; Open Fund of Key Disciplines of Xinxiang Medical University	This research was sponsored by the National Natural Science Foundation of China (81141071, 81201040), the Key Technologies R&D Program of Henan Department of Science and Technology (102102310152), the Natural Science Foundation of Henan (122300410119, 122300413212), and the Open Fund of Key Disciplines of Xinxiang Medical University (ZD200996). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baum AE, 2008, MOL PSYCHIATR, V13, P197, DOI 10.1038/sj.mp.4002012; Bille DS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020640; Castro-Giner F, 2009, BMC MED GENET, V10, DOI 10.1186/1471-2350-10-128; Chen Zhi-qiang, 2005, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V23, P438; CHOI IS, 1983, ARCH NEUROL-CHICAGO, V40, P433, DOI 10.1001/archneur.1983.04050070063016; Clay SW, 2008, POSTGRAD MED, V120, pE01; Custodio CM, 2004, ARCH PHYS MED REHAB, V85, P502, DOI 10.1016/S0003-9993(03)00471-4; Diergaarde B, 2010, PANCREATOLOGY, V10, P194, DOI 10.1159/000236023; Docampo E, 2012, GENES BRAIN BEHAV, V11, P704, DOI 10.1111/j.1601-183X.2012.00815.x; Forstbauer LM, 2012, EUR J HUM GENET, V20, P326, DOI 10.1038/ejhg.2011.185; Galvan A, 2010, CARCINOGENESIS, V31, P462, DOI 10.1093/carcin/bgp315; Ginsberg M D, 1979, Adv Neurol, V26, P21; GINSBERG MD, 1985, J TOXICOL-CLIN TOXIC, V23, P281, DOI 10.3109/15563658508990635; Gu R, 2001, J APOPLEXY NERVDUS D, V18, P173; Gu Ren-jun, 2005, Zhonghua Lao Dong Wei Sheng Zhi Ye Bing Za Zhi, V23, P461; Heard-Costa NL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000539; Hishimoto A, 2007, HUM MOL GENET, V16, P2880, DOI 10.1093/hmg/ddm247; Hoogendoorn B, 2000, HUM GENET, V107, P488, DOI 10.1007/s004390000397; Hsiao Cheng-Lung, 2004, Acta Neurol Taiwan, V13, P64; Hu MC, 2006, PROG NEURO-PSYCHOPH, V30, P755, DOI 10.1016/j.pnpbp.2006.01.019; Hu XF, 2013, PROG NEURO-PSYCHOPH, V43, P197, DOI 10.1016/j.pnpbp.2012.12.007; Janicki PK, 2011, ANESTHESIOLOGY, V115, P54, DOI 10.1097/ALN.0b013e31821810c7; Krumbiegel M, 2011, EUR J HUM GENET, V19, P186, DOI 10.1038/ejhg.2010.144; Lachman HM, 2007, HUM MOL GENET, V16, P1327, DOI 10.1093/hmg/ddm081; Li SG, 2012, GENET MOL RES, V11, P4479, DOI 10.4238/2012.December.19.1; Lippi G, 2012, CLIN BIOCHEM, V45, P1278, DOI 10.1016/j.clinbiochem.2012.06.004; Liu LF, 2011, VIRAL IMMUNOL, V24, P397, DOI 10.1089/vim.2011.0027; Mak KK, 2013, J NEUROL NEUROSUR PS, V84, P322, DOI 10.1136/jnnp-2012-303791; Martinez-Mir A, 2013, J ALZHEIMERS DIS, V35, P403, DOI 10.3233/JAD-122257; Novak G, 2009, WORLD J BIOL PSYCHIA, V10, P929, DOI 10.1080/15622970903079499; Panagopoulos VN, 2013, DRUG ALCOHOL DEPEN, V128, P187, DOI 10.1016/j.drugalcdep.2012.11.011; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Schwarzbold Marcelo, 2008, Neuropsychiatr Dis Treat, V4, P797; Shifman S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040028; STARKSTEIN SE, 1987, ARCH NEUROL-CHICAGO, V44, P1069, DOI 10.1001/archneur.1987.00520220065019; Stefanidou ME, 2012, AM J FOREN MED PATH, V33, P128, DOI 10.1097/PAF.0b013e318252eca9; Sun HT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055693; Tapeantong Toungrat, 2009, Journal of the Medical Association of Thailand, V92, P1374; Taskiran D, 2007, HUM EXP TOXICOL, V26, P645, DOI 10.1177/0960327107076882; THORN SR, 1995, ANN EMERG MED, V25, P474, DOI 10.1016/S0196-0644(95)70261-X; Velez JI, 2013, MOL PSYCHIATR, V18, P568, DOI 10.1038/mp.2012.81; Wagner AK, 2012, BRAIN INJURY, V26, P1658, DOI 10.3109/02699052.2012.700089; Wang S, 2013, HUM EXP TOX IN PRESS; Zhen L, 2008, CHINESE J IND HYGIEN, V26, P651; 顾仁骏, 2002, [中华老年医学杂志, Chinese Journal of Geriatrics], V21, P60	45	4	6	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79159	10.1371/journal.pone.0079159	http://dx.doi.org/10.1371/journal.pone.0079159			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265751	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100084
J	Schellong, K; Neumann, U; Rancourt, RC; Plagemann, A				Schellong, Karen; Neumann, Uta; Rancourt, Rebecca C.; Plagemann, Andreas			Increase of Long-Term 'Diabesity' Risk, Hyperphagia, and Altered Hypothalamic Neuropeptide Expression in Neonatally Overnourished 'Small-For-Gestational-Age' (SGA) Rats	PLOS ONE			English	Article							DEPENDENT DIABETES-MELLITUS; BODY-MASS INDEX; CATCH-UP GROWTH; BIRTH-WEIGHT; INSULIN-RESISTANCE; ARCUATE NEURONS; BLOOD-PRESSURE; SYNDROME-X; OBESITY; GLUCOSE	Background: Epidemiological data have shown long-term health adversity in low birth weight subjects, especially concerning the metabolic syndrome and 'diabesity' risk. Alterations in adult food intake have been suggested to be causally involved. Responsible mechanisms remain unclear. Methods and Findings: By rearing in normal (NL) vs. small litters (SL), small-for-gestational-age (SGA) rats were neonatally exposed to either normal (SGA-in-NL) or over-feeding (SGA-in-SL), and followed up into late adult age as compared to normally reared appropriate-for-gestational-age control rats (AGA-in-NL). SGA-in-SL rats displayed rapid neonatal weight gain within one week after birth, while SGA-in-NL growth caught up only at juvenile age (day 60), as compared to AGA-in-NL controls. In adulthood, an increase in lipids, leptin, insulin, insulin/glucose-ratio (all p<0.05), and hyperphagia under normal chow as well as high-energy/high-fat diet, modelling modern 'westernized' lifestyle, were observed only in SGA-inSL as compared to both SGA-in-NL and AGA-in-NL rats (p<0.05). Lasercapture microdissection (LMD)-based neuropeptide expression analyses in single neuron pools of the arcuate hypothalamic nucleus (ARC) revealed a significant shift towards down-regulation of the anorexigenic melanocortinergic system (proopiomelanocortin, Pomc) in SGA-in-SL rats (p<0.05). Neuropeptide expression within the orexigenic system (neuropeptide Y (Npy), agouti-related-peptide (Agrp) and galanin (Gal)) was not significantly altered. In essence, the 'orexigenic index', proposed here as a neuroendocrine 'net-indicator', was increased in SGA-in-SL regarding Npy/Pomc expression (p<0.01), correlated to food intake (p<0.05). Conclusion: Adult SGA rats developed increased 'diabesity' risk only if exposed to neonatal overfeeding. Hypothalamic malprogramming towards decreased anorexigenic activity was involved into the pathophysiology of this neonatally acquired adverse phenotype. Neonatal overfeeding appears to be a critical long-term risk factor in 'small-for-gestational-age babies'.	[Schellong, Karen; Neumann, Uta; Rancourt, Rebecca C.; Plagemann, Andreas] Charite, Clin Obstet, Div Expt Obstet, Campus Virchow Klinikum, D-13353 Berlin, Germany; [Neumann, Uta] Klinikum Ernst von Bergmann, Dept Pediat, Med Ctr Womens & Childrens Hlth, Potsdam, Germany	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Klinikum Ernst von Bergmann	Plagemann, A (corresponding author), Charite, Clin Obstet, Div Expt Obstet, Campus Virchow Klinikum, D-13353 Berlin, Germany.	andreas.plagemann@charite.de		Rancourt, Rebecca/0000-0003-2696-7220	German Research Foundation (DFG) [DFG: 241/3, 241/4, 241/6-1]	German Research Foundation (DFG)(German Research Foundation (DFG))	Aspects of this study were supported by grants of the German Research Foundation (DFG: 241/3, 241/4, 241/6-1). No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALBERTSSONWIKLAND K, 1994, ACTA PAEDIATR, V83, P64, DOI 10.1111/j.1651-2227.1994.tb13292.x; BARKER DJP, 1993, DIABETOLOGIA, V36, P62, DOI 10.1007/BF00399095; Benoit SC, 2002, J NEUROSCI, V22, P9048; Boullu-Ciocca S, 2005, DIABETES, V54, P197, DOI 10.2337/diabetes.54.1.197; Caruso V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025261; Crowther NJ, 1998, DIABETOLOGIA, V41, P1163, DOI 10.1007/s001250051046; Crowther NJ, 2000, DIABETOLOGIA, V43, P978, DOI 10.1007/s001250051479; Darner G, 2008, HUM ONTOGENET, V2, P51; Davidowa H, 2000, NEUROREPORT, V11, P2795, DOI 10.1097/00001756-200008210-00037; Davidowa H, 2007, NEUROREPORT, V18, P521, DOI 10.1097/WNR.0b013e32805dfb93; DORNER G, 1977, DEUT GESUNDHEITSWES, V32, P6; DORNER G, 1994, HORM METAB RES, V26, P213, DOI 10.1055/s-2007-1001668; Fabricius-Bjerre S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020595; Fewtrell MS, 2000, DIABETOLOGIA, V43, P714, DOI 10.1007/s001250051368; FIOROTTO ML, 1991, AM J PHYSIOL, V260, pR1104, DOI 10.1152/ajpregu.1991.260.6.R1104; Flegal KM, 2012, JAMA-J AM MED ASSOC, V307, P491, DOI 10.1001/jama.2012.39; Forsen T, 1999, BRIT MED J, V319, P1403, DOI 10.1136/bmj.319.7222.1403; Franke K, 2005, BRAIN RES, V1031, P276, DOI 10.1016/j.brainres.2004.11.006; Gamborg M, 2007, AM J EPIDEMIOL, V166, P634, DOI 10.1093/aje/kwm042; Gan SK, 2003, OBES RES, V11, P1295, DOI 10.1038/oby.2003.176; Gundlach AL, 2002, EUR J PHARMACOL, V440, P255, DOI 10.1016/S0014-2999(02)01433-4; HALES CN, 1992, DIABETOLOGIA, V35, P595, DOI 10.1007/BF00400248; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; Harder T, 2007, AM J EPIDEMIOL, V165, P849, DOI 10.1093/aje/kwk071; Hofman PL, 2004, NEW ENGL J MED, V351, P2179, DOI 10.1056/NEJMoa042275; HOKKENKOELEGA ACS, 1995, PEDIATR RES, V38, P267, DOI 10.1203/00006450-199508000-00022; Holemans K, 1999, BRIT J NUTR, V81, P73, DOI 10.1017/S0007114599000173; Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177; Hou M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025726; Huxley R, 2002, LANCET, V360, P659, DOI 10.1016/S0140-6736(02)09834-3; Ibanez L, 2006, J CLIN ENDOCR METAB, V91, P2153, DOI 10.1210/jc.2005-2778; Indulekha K, 2011, CLIN BIOCHEM, V44, P281, DOI 10.1016/j.clinbiochem.2010.12.015; Kotronen A, 2011, OBESITY, V19, P23, DOI 10.1038/oby.2010.137; Landmann EM, 2012, NEUROSCI LETT, V515, P87, DOI 10.1016/j.neulet.2012.03.025; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; Leibowitz SF, 1998, ENDOCRINOLOGY, V139, P1771, DOI 10.1210/en.139.4.1771; Levin BE, 2010, FRONT NEUROENDOCRIN, V31, P270, DOI 10.1016/j.yfrne.2010.02.005; LEVIN BE, 1989, AM J PHYSIOL, V256, pR766, DOI 10.1152/ajpregu.1989.256.3.R766; Levy-Marchal C, 2004, PEDIATR DIABETES, V5, P147, DOI 10.1111/j.1399-543X.2004.00057.x; Lopez M, 2005, DIABETOLOGIA, V48, P140, DOI 10.1007/s00125-004-1596-z; Neitzke U, 2011, MICROCIRCULATION, V18, P304, DOI 10.1111/j.1549-8719.2011.00089.x; Ogden CL, 2012, JAMA-J AM MED ASSOC, V307, P483, DOI 10.1001/jama.2012.40; Ong KKL, 2000, BRIT MED J, V320, P967, DOI 10.1136/bmj.320.7240.967; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 1999, J ENDOCRINOL, V162, P313, DOI 10.1677/joe.0.1620313; Perala MM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046139; Petry CJ, 1997, CLIN SCI, V93, P147, DOI 10.1042/cs0930147; Plagemann A, 2005, PHYSIOL BEHAV, V86, P661, DOI 10.1016/j.physbeh.2005.08.065; Plagemann A, 1999, BRAIN RES, V836, P146, DOI 10.1016/S0006-8993(99)01662-5; Plagemann A, 1999, J NEUROENDOCRINOL, V11, P541; Plagemann A, 2005, NEW ENGL J MED, V352, P940; Plagemann A, 2012, J PERINAT MED, V40, P557, DOI 10.1515/jpm-2011-0270; Plagemann A, 2012, BEST PRACT RES CL EN, V26, P641, DOI 10.1016/j.beem.2012.03.008; Plagemann A, 2010, J PERINAT MED, V38, P393, DOI [10.1515/JPM.2010.051, 10.1515/jpm.2010.051]; Plagemann A, 2009, J PHYSIOL-LONDON, V587, P4963, DOI 10.1113/jphysiol.2009.176156; Pruss H, 2008, J CEREBR BLOOD F MET, V28, P526, DOI 10.1038/sj.jcbfm.9600550; Rodrigues AL, 2009, J PHYSIOL-LONDON, V587, P2647, DOI 10.1113/jphysiol.2009.169045; Schellong K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047776; Schmidt I, 2000, PHYSIOL GENOMICS, V3, P113, DOI 10.1152/physiolgenomics.2000.3.2.113; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schwartz MW, 2000, NATURE, V404, P661, DOI 10.1038/35007534; Schwartz MW, 1997, DIABETES, V46, P2119, DOI 10.2337/diabetes.46.12.2119; Scully Tony, 2012, Nature, V485, pS2; Shultis WA, 2005, J EPIDEMIOL COMMUN H, V59, P955, DOI 10.1136/jech.2005.034413; Stettler N, 2002, PEDIATRICS, V109, P194, DOI 10.1542/peds.109.2.194; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Woods SC, 2008, J CLIN ENDOCR METAB, V93, pS37, DOI 10.1210/jc.2008-1630	67	10	11	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78799	10.1371/journal.pone.0078799	http://dx.doi.org/10.1371/journal.pone.0078799			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265718	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100051
J	Jove, M; Moreno-Navarrete, JM; Pamplona, R; Ricart, W; Portero-Otin, M; Fernandez-Real, JM				Jove, Mariona; Maria Moreno-Navarrete, Jose; Pamplona, Reinald; Ricart, Wifredo; Portero-Otin, Manuel; Manuel Fernandez-Real, Jose			Human omental and subcutaneous adipose tissue exhibit specific lipidomic signatures	FASEB JOURNAL			English	Article						insulin resistance; metabolism; systems biology	FATTY-ACID-COMPOSITION; INSULIN SENSITIVITY; HUMAN ADIPOCYTES; GENE-EXPRESSION; IN-VITRO; DIFFERENTIATION; OBESITY; CELLS; BIOSYNTHESIS; CHOLESTEROL	Despite their differential effects on human metabolic pathophysiology, the differences in omental and subcutaneous lipidomes are largely unknown. To explore this field, liquid chromatography coupled with mass spectrometry was used for lipidome analyses of adipose tissue samples (visceral and subcutaneous) selected from a group of obese subjects (n=38). Transcriptomics and in vitro studies in adipocytes were used to confirm the pathways affected by location. The analyses revealed the existence of obesity-related specific lipidome signatures in each of these locations, attributed to selective enrichment of specific triglycerides, glycerophospholipids, and sphingolipids, because these were not observed in adipose tissues from nonobese individuals. The changes were compatible with subcutaneous enrichment in pathways involved in adipogenesis, triacylglyceride synthesis, and lipid droplet formation, as well as increased -oxidation. Marked differences between omental and subcutaneous depots in obese individuals were seen in the association of lipid species with metabolic traits (body mass index and insulin sensitivity). Targeted studies also revealed increased cholesterol (56%) and cholesterol epoxide (34%) concentrations in omental adipose tissue. In view of the effects of cholesterol epoxide, which induced enhanced expression of adipocyte differentiation and -oxidation genes in human omental adipocytes, a novel role for cholesterol epoxide as a signaling molecule for differentiation is proposed. In summary, in obesity, adipose tissue exhibits a location-specific differential lipid profile that may contribute to explaining part of its distinct pathogenic role.Jove, M., Moreno-Navarrete, J. M., Pamplona, R., Ricart, W., Portero-Otin, M., Fernandez-Real, J. M. Human omental and subcutaneous adipose tissue exhibit specific lipidomic signatures.	[Jove, Mariona; Pamplona, Reinald; Portero-Otin, Manuel] Inst Recerca Biomed Lleida IRBLLEIDA UdL, Nutricio Envelliment NUTREN Nutrigen, Cientif Tecnolg Agroalimentari Lleida PCiTAL, Lleida, Spain; [Maria Moreno-Navarrete, Jose; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst dInvestigacio Biomed Girona IdIBGi, Dept Diabet, Centro Investigac Biomed Red Fisiopatologia Obesi, Endocrinol & Nutr, Girona, Spain; [Jove, Mariona; Pamplona, Reinald; Portero-Otin, Manuel] Inst Recerca Biomed Lleida IRBLLEIDA UdL Cient &, Nutr & Envelliment NUTREN Nutrigen, Lleida, Spain; [Maria Moreno-Navarrete, Jose; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Ctr Invest Biomed Red Fisiopatol Obesidad & Nutr, Dept Diabet Endocrinol & Nutr, Inst Invest Biomed Girona IdIBGi, Girona, Spain; [Maria Moreno-Navarrete, Jose; Ricart, Wifredo; Manuel Fernandez-Real, Jose] Inst Salud Carlos III, Girona, Spain	Institut de Recerca Biomedica - IRB Lleida; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Institut de Recerca Biomedica - IRB Lleida; CIBER - Centro de Investigacion Biomedica en Red; CIBEROBN; Universitat de Girona; Girona University Hospital Dr. Josep Trueta; Institut d'Investigacio Biomedica de Girona (IDIBGI); Instituto de Salud Carlos III	Fernandez-Real, JM (corresponding author), Hosp Girona Dr Josep Trueta, Sect Diabet Endocrinol & Nutr, Carretera de Franca S-N, Girona 17007, Spain.	jmfreal@idibgi.org	Fernández-Real, Jose Manuel/AGH-3599-2022; Jové, Mariona/M-9104-2016; Portero-Otin, Manuel/B-7122-2009; Moreno-Navarrete, José María/H-9772-2015; Pamplona, Reinald/A-7359-2010; Moreno-Navarrete, José María/ABG-5548-2021	Fernández-Real, Jose Manuel/0000-0002-7442-9323; Jové, Mariona/0000-0001-5577-6162; Portero-Otin, Manuel/0000-0002-1823-0299; Moreno-Navarrete, José María/0000-0002-2883-511X; Pamplona, Reinald/0000-0003-4337-6107; Moreno-Navarrete, José María/0000-0002-2883-511X; Ricart, Wifredo/0000-0002-3452-9098	Spanish Ministry of Science and Innovation (INNPRONTA Program) [BFU2009-11879/BFI, AGL2006-1243]; Autonomous Government of Catalunya [2009SGR-735]; Autonomous Government of Catalunya (ACC1O program); Spanish Ministry of Health [FIS 08-1843, 11-01532]; COST B-35 Action; Instituto Tomas Pascual para la Nutricion y Salud; Ministerio de Educacion y Ciencia [SAF2011-0214]	Spanish Ministry of Science and Innovation (INNPRONTA Program); Autonomous Government of Catalunya; Autonomous Government of Catalunya (ACC1O program); Spanish Ministry of Health(Instituto de Salud Carlos IIISpanish Government); COST B-35 Action; Instituto Tomas Pascual para la Nutricion y Salud; Ministerio de Educacion y Ciencia(Spanish Government)	Work performed in the Institut de Recerca Biomedica de Lleida-Cientific i Tecnologic Agroalimentari de Lleida (IRBLLEIDA-PCiTAL) was supported by the Spanish Ministry of Science and Innovation (INNPRONTA Program, BFU2009-11879/BFI and AGL2006-1243) the Autonomous Government of Catalunya (2009SGR-735, ACC1O program), and the Spanish Ministry of Health (FIS 08-1843 and 11-01532]. This work was also supported by the COST B-35 Action, Instituto Tomas Pascual para la Nutricion y Salud, and partially supported by research grants from the Ministerio de Educacion y Ciencia (SAF2011-0214). Centro de Investigacion Biomedica en Red-Fisiopatologia de la Obesidad y la Nutricion (CIBERobn) is an initiative from the Instituto de Salud Carlos III (Girona, Spain). M.P.-O. and J.M.F.-R. designed the experiment; M.J. and J.M.M-N. performed research; R.P. and W.R. analyzed data; M.J., M.P.-O., and J.M.F.-R. wrote the paper. The authors declare no conflicts of interest.	Arner P, 2002, DIABETES-METAB RES, V18, pS5, DOI 10.1002/dmrr.254; BAS P, 1992, LIPIDS, V27, P470, DOI 10.1007/BF02536391; Davies JD, 2005, J BIOL CHEM, V280, P3911, DOI 10.1074/jbc.M410075200; Dwyer JR, 2007, J BIOL CHEM, V282, P8959, DOI 10.1074/jbc.M611741200; Fox CS, 2007, CIRCULATION, V116, P39, DOI 10.1161/CIRCULATIONAHA.106.675355; Garcia-Serrano S, 2011, MOL MED, V17, P273, DOI 10.2119/molmed.2010.00078; Gesta S, 2006, P NATL ACAD SCI USA, V103, P6676, DOI 10.1073/pnas.0601752103; Gomez-Ambrosi J, 2004, FASEB J, V18, P215, DOI 10.1096/fj.03-0591fje; Guo L, 2010, J BIOL CHEM, V285, P25438, DOI 10.1074/jbc.M110.119933; Hodson L, 2008, PROG LIPID RES, V47, P348, DOI 10.1016/j.plipres.2008.03.003; Horl G, 2011, J BIOL CHEM, V286, P17338, DOI 10.1074/jbc.M111.234534; Johnson JS, 2011, J CELL BIOCHEM, V112, P1673, DOI 10.1002/jcb.23082; Jung HR, 2011, BBA-MOL CELL BIOL L, V1811, P925, DOI 10.1016/j.bbalip.2011.06.025; Kha HT, 2004, J BONE MINER RES, V19, P830, DOI 10.1359/JBMR.040115; Kim JK, 2009, METHODS MOL BIOL, V560, P221, DOI 10.1007/978-1-59745-448-3_15; Kim WK, 2007, J BONE MINER RES, V22, P1711, DOI 10.1359/JBMR.070710; Kobayashi A, 2006, J LIPID RES, V47, P1791, DOI 10.1194/jlr.M500546-JLR200; Kolak M, 2007, DIABETES, V56, P1960, DOI 10.2337/db07-0111; Laaksonen R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000097; Laffitte BA, 2001, P NATL ACAD SCI USA, V98, P507, DOI 10.1073/pnas.021488798; LAU WF, 1995, EXPERIENTIA, V51, P731, DOI 10.1007/BF01941271; Leemand J, 2012, EXP DIABETES RES, DOI 10.1155/2012/242984; Machann J, 2013, NMR BIOMED, V26, P232, DOI 10.1002/nbm.2849; MacLaren R, 2008, J LIPID RES, V49, P308, DOI 10.1194/jlr.M700199-JLR200; Moreno-Navarrete JM, 2011, DIABETES, V60, P168, DOI 10.2337/db10-0805; Marwarha G, 2012, CELL SIGNAL, V24, P484, DOI 10.1016/j.cellsig.2011.09.029; Meex RCR, 2009, AM J PHYSIOL-REG I, V297, pR913, DOI 10.1152/ajpregu.91053.2008; *NAT I GEN MED SCI, 2010, LIP MET PATHW STRAT; Ortega FJ, 2010, INT J OBESITY, V34, P487, DOI 10.1038/ijo.2009.263; Ortiz A, 2012, NEW ENGL J MED, V366, P668, DOI 10.1056/NEJMc1114201; Otani H, 2011, ANTIOXID REDOX SIGN, V15, P1911, DOI 10.1089/ars.2010.3739; Patti GJ, 2012, NAT REV MOL CELL BIO, V13, P263, DOI 10.1038/nrm3314; Perez-Perez R, 2009, J PROTEOME RES, V8, P1682, DOI 10.1021/pr800942k; Perrini S, 2008, DIABETOLOGIA, V51, P155, DOI 10.1007/s00125-007-0841-7; Perrini S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057892; Quehenberger O, 2011, NEW ENGL J MED, V365, P1812, DOI 10.1056/NEJMra1104901; Roberts LD, 2009, PHYSIOL GENOMICS, V39, P109, DOI 10.1152/physiolgenomics.90365.2008; Samad F, 2006, DIABETES, V55, P2579, DOI 10.2337/db06-0330; Samad F, 2011, ADV EXP MED BIOL, V721, P67, DOI 10.1007/978-1-4614-0650-1_5; Sandra K, 2010, J CHROMATOGR A, V1217, P4087, DOI 10.1016/j.chroma.2010.02.039; Sato D, 2012, METABOLISM, V61, P92, DOI 10.1016/j.metabol.2011.05.012; Ulven SM, 2005, PROSTAG LEUKOTR ESS, V73, P59, DOI 10.1016/j.plefa.2005.04.009; Virtanen KA, 2002, J CLIN ENDOCR METAB, V87, P3902, DOI 10.1210/jc.87.8.3902; WAHLE KWJ, 1991, EUR J CLIN NUTR, V45, P195; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zheng W, 2006, BBA-BIOMEMBRANES, V1758, P1864, DOI 10.1016/j.bbamem.2006.08.009	46	38	39	0	4	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1071	1081		10.1096/fj.13-234419	http://dx.doi.org/10.1096/fj.13-234419			11	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24265485				2022-12-25	WOS:000335324800005
J	Etzerodt, A; Rasmussen, MR; Svendsen, P; Chalaris, A; Schwarz, J; Galea, I; Moller, HJ; Moestrup, SK				Etzerodt, Anders; Rasmussen, Mie Rostved; Svendsen, Pia; Chalaris, Athena; Schwarz, Jeanette; Galea, Ian; Moller, Holger Jon; Moestrup, Soren Kragh			Structural Basis for Inflammation-driven Shedding of CD163 Ectodomain and Tumor Necrosis Factor-alpha in Macrophages	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEMOGLOBIN; HAPTOGLOBIN; DISINTEGRIN; ADAM17; BINDING; METALLOPROTEINASE; IDENTIFICATION; ENDOTOXIN; CLONING	The haptoglobin-hemoglobin receptor CD163 and proTNF-alpha are transmembrane macrophage proteins subjected to cleavage by the inflammation-responsive protease ADAM17. This leads to release of soluble CD163 (sCD163) and bioactive TNF-alpha. Sequence comparison of the juxtamembrane region identified similar palindromic sequences in human CD163 ((1044)Arg-Ser-Ser-Arg) and proTNF-alpha ((78)Arg-Ser-Ser-Ser-Arg). In proTNF-alpha the Arg-Ser-Ser-Ser-Arg sequence is situated next to the previously established ADAM17 cleavage site. Site-directed mutagenesis revealed that the sequences harbor essential information for efficient cleavage of the two proteins upon ADAM17 stimulation. This was further evidenced by analysis of mouse CD163 that, like CD163 in other non-primates, does not contain the palindromic CD163 sequence in the juxtamembrane region. Mouse CD163 resisted endotoxin-and phorbol ester-induced shedding, and ex vivo analysis of knock-in of the Arg-Ser-Ser-Arg sequence in mouse CD163 revealed a receptor shedding comparable with that of human CD163. In conclusion, we have identified an essential substrate motif for ADAM17-mediated CD163 and proTNF-alpha cleavage in macrophages. In addition, the present data indicate that CD163, by incorporation of this motif in late evolution, underwent a modification that allows for an instant down-regulation of surface CD163 expression and inhibition of hemoglobin uptake. This regulatory modality seems to have coincided with the evolution of an enhanced hemoglobin-protecting role of the haptoglobin-CD163 system in primates.	[Etzerodt, Anders; Rasmussen, Mie Rostved; Svendsen, Pia; Moestrup, Soren Kragh] Aarhus Univ, Dept Biomed, DK-8000 Aarhus C, Denmark; [Chalaris, Athena; Schwarz, Jeanette] Univ Kiel, Dept Biochem, D-24118 Kiel, Germany; [Galea, Ian] Univ Southampton, Fac Med, Southampton SO17 1BJ, Hants, England; [Moller, Holger Jon; Moestrup, Soren Kragh] Aarhus Univ Hosp, Dept Clin Biochem, DK-8000 Aarhus C, Denmark	Aarhus University; University of Kiel; University of Southampton; Aarhus University	Moestrup, SK (corresponding author), Aarhus Univ, Dept Biomed, Ole Worms Alle 3, DK-8000 Aarhus C, Denmark.	skm@biokemi.au.dk	Etzerodt, Anders/E-2839-2013; Moestrup, Søren Kragh/A-1403-2014; Galea, Ian/B-7997-2011; Etzerodt, Anders/O-9860-2019; Moestrup, Søren Kragh/AAD-1735-2019	Etzerodt, Anders/0000-0002-6757-2068; Moestrup, Søren Kragh/0000-0003-3862-2107; Galea, Ian/0000-0002-1268-5102; Etzerodt, Anders/0000-0002-6757-2068; Rostved Bechshoft, Mie/0000-0002-6109-5221; Moller, Holger Jon/0000-0001-7687-5995	Danish Medical Research Council; Novo Nordisk Foundation; European Research Council [233312]; Lundbeck Foundation; Lundbeck Foundation [R54-2010-5637] Funding Source: researchfish; Novo Nordisk Fonden [NNF14OC0011537] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); European Research Council(European Research Council (ERC)European Commission); Lundbeck Foundation(Lundbeckfonden); Lundbeck Foundation(Lundbeckfonden); Novo Nordisk Fonden(Novo Nordisk Foundation)	This work was supported by grants from the Danish Medical Research Council, the Novo Nordisk Foundation, the European Research Council (Advanced Grant for the TROJA program, Grant 233312), and the Lundbeck Foundation.	Black RA, 1997, NATURE, V385, P729, DOI 10.1038/385729a0; Caescu CI, 2009, BIOCHEM J, V424, P79, DOI 10.1042/BJ20090549; Chalaris A, 2010, J EXP MED, V207, P1617, DOI 10.1084/jem.20092366; Chiu J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh172; Delanghe J, 2000, CLIN CHIM ACTA, V291, P43, DOI 10.1016/S0009-8981(99)00194-1; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2352, DOI 10.1089/ars.2012.4834; Etzerodt A, 2013, ANTIOXID REDOX SIGN, V18, P2254, DOI 10.1089/ars.2012.4605; Etzerodt A, 2012, J CONTROL RELEASE, V160, P72, DOI 10.1016/j.jconrel.2012.01.034; Etzerodt A, 2010, J LEUKOCYTE BIOL, V88, P1201, DOI 10.1189/jlb.0410235; Garbers C, 2011, J BIOL CHEM, V286, P14804, DOI 10.1074/jbc.M111.229393; Gooz M, 2010, CRIT REV BIOCHEM MOL, V45, P146, DOI 10.3109/10409231003628015; Hogger P, 2001, BIOCHEM BIOPH RES CO, V288, P841, DOI 10.1006/bbrc.2001.5845; Horiuchi K, 2007, J IMMUNOL, V179, P2686, DOI 10.4049/jimmunol.179.5.2686; Kneidl J, 2012, CELL MICROBIOL, V14, P914, DOI 10.1111/j.1462-5822.2012.01766.x; KNYSZYNSKI A, 1971, EXPERIENTIA, V27, P838, DOI 10.1007/BF02136897; Kristiansen M, 2001, NATURE, V409, P198, DOI 10.1038/35051594; Looze C, 2009, BIOCHEM BIOPH RES CO, V378, P433, DOI 10.1016/j.bbrc.2008.11.050; Maniecki MB, 2011, IMMUNOBIOLOGY, V216, P882, DOI 10.1016/j.imbio.2011.02.001; Manzanero S, 2012, METHODS MOL BIOL, V844, P177, DOI 10.1007/978-1-61779-527-5_12; Moller HJ, 2002, SCAND J CLIN LAB INV, V62, P293, DOI 10.1080/003655102760145852; Moller HJ, 2002, BLOOD, V99, P378, DOI 10.1182/blood.V99.1.378; Moller HJ, 2012, SCAND J CLIN LAB INV, V72, P1, DOI 10.3109/00365513.2011.626868; Moller HJ, 2010, IMMUNOBIOLOGY, V215, P406, DOI 10.1016/j.imbio.2009.05.003; Moss ML, 1997, NATURE, V385, P733, DOI 10.1038/385733a0; Nielsen MJ, 2013, J BIOL CHEM, V288, P18834, DOI 10.1074/jbc.M113.471060; Otterbein LE, 2003, TRENDS IMMUNOL, V24, P449, DOI 10.1016/S1471-4906(03)00181-9; Scheller J, 2011, TRENDS IMMUNOL, V32, P380, DOI 10.1016/j.it.2011.05.005; Stawikowska R, 2013, J BIOL CHEM, V288, P22871, DOI 10.1074/jbc.M113.462267; Thomsen JH, 2013, OXID MED CELL LONGEV, V2013, DOI 10.1155/2013/523652; Vanhollebeke B, 2008, SCIENCE, V320, P677, DOI 10.1126/science.1156296; WANG AM, 1985, SCIENCE, V228, P149, DOI 10.1126/science.3856324; Weaver LK, 2006, J LEUKOCYTE BIOL, V80, P26, DOI 10.1189/jlb.1205756; Wurch T, 1998, BIOTECHNOL TECH, V12, P653, DOI 10.1023/A:1008848517221	33	58	58	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					778	788		10.1074/jbc.M113.520213	http://dx.doi.org/10.1074/jbc.M113.520213			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275664	Green Accepted, Green Published, hybrid			2022-12-25	WOS:000330541200016
J	Ronchi, VP; Klein, JM; Edwards, DJ; Haas, AL				Ronchi, Virginia P.; Klein, Jennifer M.; Edwards, Daniel J.; Haas, Arthur L.			The Active Form of E6-associated protein (E6AP)/UBE3A Ubiquitin Ligase Is an Oligomer	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HUMAN-PAPILLOMAVIRUS TYPE-16; ANGELMAN-SYNDROME; E6 ONCOPROTEIN; CHAIN FORMATION; HPV E6; DEGRADATION; BINDING; DOMAIN; E6-AP; UBE3A	Employing I-125-polyubiquitin chain formation as a functional readout of ligase activity, biochemical and biophysical evidence demonstrates that catalytically active E6-associated protein (E6AP)/UBE3A is an oligomer. Based on an extant structure previously discounted as an artifact of crystal packing forces, we propose that the fully active form of E6AP is a trimer, analysis of which reveals a buried surface of 7508 angstrom(2) and radially symmetric interacting residues that are conserved within the Hect (homologous to E6AP C terminus) ligase superfamily. An absolutely conserved interaction between Phe(727) and a hydrophobic pocket present on the adjacent subunit is critical for trimer stabilization because mutation disrupts the oligomer and decreases k(cat) 62-fold but fails to affect E2 similar to ubiquitin binding or subsequent formation of the Hect domain Cys(820) similar to ubiquitin thioester catalytic intermediate. Exogenous N-acetylphenylalanylamide reversibly antagonizes Phe(727)-dependent trimer formation and catalytic activity (K-i = 12 mM), as does a conserved alpha-helical peptide corresponding to residues 474-490 of E6AP isoform 1 (K-i = 22 mu M) reported to bind the hydrophobic pocket of other Hect ligases, presumably blocking Phe(727) intercalation and trimer formation. Conversely, oncogenic human papillomavirus-16/18 E6 protein significantly enhances E6AP catalytic activity by promoting trimer formation (K-activation = 1.5 nM) through the ability of E6 to form homodimers. Recombinant E6 protein additionally rescues the k(cat) defect of the Phe(727) mutation and that of a specific loss-of-function Angelman syndrome mutation that promotes trimer destabilization. The present findings codify otherwise disparate observations regarding the mechanism of E6AP and related Hect ligases in addition to suggesting therapeutic approaches for modulating ligase activity.	[Ronchi, Virginia P.; Klein, Jennifer M.; Edwards, Daniel J.; Haas, Arthur L.] Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, New Orleans, LA 70112 USA; [Haas, Arthur L.] Louisiana State Univ, Stanley S Scott Canc Ctr, Hlth Sci Ctr, New Orleans, LA 70112 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans	Haas, AL (corresponding author), Louisiana State Univ, Dept Biochem & Mol Biol, Hlth Sci Ctr, 1901 Perdido St, New Orleans, LA 70112 USA.	ahaas@lsuhsc.edu			National Institutes of Health [GM034009]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034009] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM034009 (to A. L. H.).	Baboshina OV, 1996, J BIOL CHEM, V271, P2823, DOI 10.1074/jbc.271.5.2823; Baboshina OV, 2001, J BIOL CHEM, V276, P39428, DOI 10.1074/jbc.M106967200; Be XB, 2001, BIOCHEMISTRY-US, V40, P1293, DOI 10.1021/bi0019592; Beaudenon S, 2008, BMC BIOCHEM, V9, DOI 10.1186/1471-2091-9-S1-S4; BeerRomero P, 1997, ONCOGENE, V14, P595, DOI 10.1038/sj.onc.1200872; Chan AL, 2013, BIOCHEMISTRY-US, V52, P3119, DOI 10.1021/bi301710c; Chen JJ, 1998, J BIOL CHEM, V273, P13537, DOI 10.1074/jbc.273.22.13537; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Dagli A, 2011, MOL SYNDROMOL, V2, P100, DOI 10.1159/000328837; Dai BB, 2010, CANCER RES, V70, P2951, DOI 10.1158/0008-5472.CAN-09-3909; Davies SW, 1997, CELL, V90, P537, DOI 10.1016/S0092-8674(00)80513-9; Elston RC, 1998, J GEN VIROL, V79, P371, DOI 10.1099/0022-1317-79-2-371; Fang P, 1999, HUM MOL GENET, V8, P129, DOI 10.1093/hmg/8.1.129; Flashner BM, 2013, NEUROMOL MED, V15, P339, DOI 10.1007/s12017-013-8222-5; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2010, CELL, V140, P704, DOI 10.1016/j.cell.2010.01.026; Gregianin E, 2013, EUR J NEUROL, V20, P1486, DOI 10.1111/ene.12220; HAAS AL, 1982, J BIOL CHEM, V257, P329; HAAS AL, 1988, J BIOL CHEM, V263, P13258; Haas Arthur L., 2005, V301, P23; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Heer A, 2011, BIOCHEMISTRY-US, V50, P1376, DOI 10.1021/bi101941c; Huang HS, 2013, BEHAV BRAIN RES, V243, P79, DOI 10.1016/j.bbr.2012.12.052; Huang L, 1999, SCIENCE, V286, P1321, DOI 10.1126/science.286.5443.1321; Huang YC, 2008, J BIOL CHEM, V283, P32880, DOI 10.1074/jbc.M805484200; HUIBREGTSE JM, 1993, MOL CELL BIOL, V13, P4918, DOI 10.1128/MCB.13.8.4918; HUIBREGTSE JM, 1991, EMBO J, V10, P4129, DOI 10.1002/j.1460-2075.1991.tb04990.x; HUIBREGTSE JM, 1995, P NATL ACAD SCI USA, V92, P2563, DOI 10.1073/pnas.92.7.2563; Jiang YH, 1999, AM J HUM GENET, V65, P1, DOI 10.1086/302473; Kamadurai HB, 2009, MOL CELL, V36, P1095, DOI 10.1016/j.molcel.2009.11.010; Kao WH, 2000, J VIROL, V74, P6408, DOI 10.1128/JVI.74.14.6408-6417.2000; Kentsis A, 2002, P NATL ACAD SCI USA, V99, P15404, DOI 10.1073/pnas.202608799; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kiyono T, 1998, NATURE, V396, P84, DOI 10.1038/23962; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Kuhnle S, 2013, P NATL ACAD SCI USA, V110, P8888, DOI 10.1073/pnas.1302792110; Lagrange M, 2005, J GEN VIROL, V86, P1001, DOI 10.1099/vir.0.80607-0; Lawson JS, 2009, BRIT J CANCER, V101, P1351, DOI 10.1038/sj.bjc.6605328; Levy ED, 2013, PROG MOL BIOL TRANSL, V117, P25, DOI 10.1016/B978-0-12-386931-9.00002-7; Liu YQ, 2009, J MOL BIOL, V386, P1123, DOI 10.1016/j.jmb.2009.01.018; Lossie AC, 2001, J MED GENET, V38, P834, DOI 10.1136/jmg.38.12.834; Mabb AM, 2011, TRENDS NEUROSCI, V34, P293, DOI 10.1016/j.tins.2011.04.001; Margolis SS, 2010, CELL, V143, P442, DOI 10.1016/j.cell.2010.09.038; Marianayagam NJ, 2004, TRENDS BIOCHEM SCI, V29, P618, DOI 10.1016/j.tibs.2004.09.006; Maru Y, 1996, J BIOL CHEM, V271, P15353, DOI 10.1074/jbc.271.26.15353; Maspero E, 2011, EMBO REP, V12, P342, DOI 10.1038/embor.2011.21; Matentzoglu K, 2008, BIOCHEM SOC T, V36, P797, DOI 10.1042/BST0360797; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; MEDCALF EA, 1993, ONCOGENE, V8, P2847; Muench P, 2010, CANCER RES, V70, P6913, DOI 10.1158/0008-5472.CAN-10-1307; Munakata T, 2007, PLOS PATHOG, V3, P1335, DOI 10.1371/journal.ppat.0030139; Nicholls RD, 2001, ANNU REV GENOM HUM G, V2, P153, DOI 10.1146/annurev.genom.2.1.153; Nomine Y, 2003, BIOCHEMISTRY-US, V42, P4909, DOI 10.1021/bi026980c; Ogunjimi AA, 2005, MOL CELL, V19, P297, DOI 10.1016/j.molcel.2005.06.028; Ogunjimi AA, 2010, J BIOL CHEM, V285, P6308, DOI 10.1074/jbc.M109.044537; PAGE MI, 1971, P NATL ACAD SCI USA, V68, P1678, DOI 10.1073/pnas.68.8.1678; Pandya RK, 2010, J BIOL CHEM, V285, P5664, DOI 10.1074/jbc.M109.051805; Perica T, 2012, P NATL ACAD SCI USA, V109, P8127, DOI 10.1073/pnas.1120028109; Philpot BD, 2011, J NEURODEV DISORD, V3, P50, DOI 10.1007/s11689-010-9066-z; Ronchi VP, 2013, J BIOL CHEM, V288, P10349, DOI 10.1074/jbc.M113.458059; Ronchi VP, 2012, METHODS MOL BIOL, V832, P197, DOI 10.1007/978-1-61779-474-2_14; Rotin D, 2009, NAT REV MOL CELL BIO, V10, P398, DOI 10.1038/nrm2690; Samaco RC, 2005, HUM MOL GENET, V14, P483, DOI 10.1093/hmg/ddi045; Sato M, 2010, P NATL ACAD SCI USA, V107, P5611, DOI 10.1073/pnas.1001281107; Schaaf CP, 2011, HUM MOL GENET, V20, P3366, DOI 10.1093/hmg/ddr243; SCHEFFNER M, 1990, CELL, V63, P1129, DOI 10.1016/0092-8674(90)90409-8; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; SCHEFFNER M, 1994, P NATL ACAD SCI USA, V91, P8797, DOI 10.1073/pnas.91.19.8797; Shirakura M, 2007, J VIROL, V81, P1174, DOI 10.1128/JVI.01684-06; Siepmann TJ, 2003, J BIOL CHEM, V278, P9448, DOI 10.1074/jbc.M211240200; Smith SEP, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002627; Spitkovsky D, 1996, ONCOGENE, V13, P1027; Streich FC, 2013, J BIOL CHEM, V288, P8209, DOI 10.1074/jbc.M113.451567; Sun LJ, 2004, MOL CELL, V14, P289, DOI 10.1016/S1097-2765(04)00236-9; Sutcliffe JS, 1997, GENOME RES, V7, P368, DOI 10.1101/gr.7.4.368; Talis AL, 1998, J BIOL CHEM, V273, P6439, DOI 10.1074/jbc.273.11.6439; Thomas M, 2013, VIROLOGY, V435, P357, DOI 10.1016/j.virol.2012.11.004; Tokgoz Z, 2012, J BIOL CHEM, V287, P311, DOI 10.1074/jbc.M111.294975; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Vargo MA, 2004, BIOCHEMISTRY-US, V43, P3327, DOI 10.1021/bi030245z; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Wang M, 2005, EMBO J, V24, P4324, DOI 10.1038/sj.emboj.7600895; Wang M, 2006, EMBO J, V25, P1710, DOI 10.1038/sj.emboj.7601061; Wang XL, 2007, J CELL BIOL, V177, P613, DOI 10.1083/jcb.200611063; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Zanier K, 2005, J MOL BIOL, V349, P401, DOI 10.1016/j.jmb.2005.03.071; Zanier K, 2013, SCIENCE, V339, P694, DOI 10.1126/science.1229934; Zanier K, 2010, J MOL BIOL, V396, P90, DOI 10.1016/j.jmb.2009.11.022	90	43	47	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1033	1048		10.1074/jbc.M113.517805	http://dx.doi.org/10.1074/jbc.M113.517805			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273172	Green Published, hybrid			2022-12-25	WOS:000330541200036
J	Roy, S; Karmakar, M; Pearlman, E				Roy, Sanhita; Karmakar, Mausita; Pearlman, Eric			CD14 Mediates Toll-like Receptor 4 (TLR4) Endocytosis and Spleen Tyrosine Kinase (Syk) and Interferon Regulatory Transcription Factor 3 (IRF3) Activation in Epithelial Cells and Impairs Neutrophil Infiltration and Pseudomonas aeruginosa Killing in Vivo	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CORNEAL INFLAMMATION; LIPOPOLYSACCHARIDE LPS; INDEPENDENT PATHWAYS; TERMINAL KINASE; GENE-EXPRESSION; HOST-DEFENSE; EXOENZYME-S; MICE; INFECTION; KERATITIS	In the current study, we examined the role of CD14 in regulating LPS activation of corneal epithelial cells and Pseudomonas aeruginosa corneal infection. Our findings demonstrate that LPS induces Toll-like receptor 4 (TLR4) internalization in corneal epithelial cells and that blocking with anti-CD14 selectively inhibits TLR4 endocytosis, spleen tyrosine kinase (Syk) and IRF3 phosphorylation, and production of CCL5/RANTES and IFN-beta, but not IL-8. Using a murine model of P. aeruginosa corneal infection, we show that although infected CD14(-/-) corneas produce less CCL5, they exhibit significantly increased CXC chemokine production, neutrophil recruitment to the corneal stroma, and bacterial clearance than C57BL/6 mice. We conclude that CD14 has a critical role in mediating TLR4 signaling through IRF3 in resident corneal epithelial cells and macrophages and thereby modulates TLR4 cell surface activation of the MyD88/NF-kappa B/AP-1 pathway and production of CXC chemokines and neutrophil infiltration to infected tissues.	[Roy, Sanhita; Karmakar, Mausita; Pearlman, Eric] Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, Cleveland, OH 44095 USA	Case Western Reserve University	Pearlman, E (corresponding author), Case Western Reserve Univ, Dept Ophthalmol & Visual Sci, 10900 Euclid Ave, Cleveland, OH 44095 USA.	eric.pearlman@case.edu	Karmakar, Mausita/ABC-6480-2020	Karmakar, Mausita/0000-0002-6952-1731; ROY, SANHITA/0000-0002-0407-8177	National Institutes of Health [R01EY14362, P30EY11373]; Research to Prevent Blindness Foundation; Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE [P30EY011373, R01EY014362] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Research to Prevent Blindness Foundation(Research to Prevent Blindness (RPB)); Ohio Lions Eye Research Foundation; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01EY14362 and P30EY11373 (to E. P.). This work was also supported by the Research to Prevent Blindness Foundation and the Ohio Lions Eye Research Foundation.	Abreu MT, 2002, J BIOL CHEM, V277, P20431, DOI 10.1074/jbc.M110333200; Adhikary G, 2008, J LEUKOCYTE BIOL, V83, P991, DOI 10.1189/jlb.1107783; Benhnia MREI, 2005, J IMMUNOL, V174, P1539, DOI 10.4049/jimmunol.174.3.1539; Berenger BM, 2011, J LEUKOCYTE BIOL, V90, P189, DOI 10.1189/jlb.0510265; Bode JG, 2001, BIOL CHEM, V382, P1447, DOI 10.1515/BC.2001.178; Chinnery HR, 2009, J IMMUNOL, V182, P2738, DOI 10.4049/jimmunol.0803505; Dessing MC, 2007, AM J RESP CRIT CARE, V175, P604, DOI 10.1164/rccm.200606-824OC; Echchannaoui H, 2005, J LEUKOCYTE BIOL, V78, P705, DOI 10.1189/jlb.0205063; Epelman S, 2004, J IMMUNOL, V173, P2031, DOI 10.4049/jimmunol.173.3.2031; Fitzgerald KA, 2003, J EXP MED, V198, P1043, DOI 10.1084/jem.20031023; Haziot A, 2001, J IMMUNOL, V166, P1075, DOI 10.4049/jimmunol.166.2.1075; Haziot A, 1996, IMMUNITY, V4, P407, DOI 10.1016/S1074-7613(00)80254-X; Huang X, 2006, INVEST OPHTH VIS SCI, V47, P4910, DOI 10.1167/iovs.06-0537; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Johnson AC, 2008, J BIOL CHEM, V283, P3988, DOI 10.1074/jbc.M707264200; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kawai T, 2011, IMMUNITY, V34, P637, DOI 10.1016/j.immuni.2011.05.006; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; KUSUNOKI T, 1995, J EXP MED, V182, P1673, DOI 10.1084/jem.182.6.1673; Metkar S, 2007, INFECT IMMUN, V75, P5415, DOI 10.1128/IAI.00601-07; Metkar S, 2012, J LEUKOCYTE BIOL, V92, P389, DOI 10.1189/jlb.0112011; Motshwene PG, 2009, J BIOL CHEM, V284, P25404, DOI 10.1074/jbc.M109.022392; Pearlman E, 2013, INT REV IMMUNOL, V32, P4, DOI 10.3109/08830185.2012.749400; Perera PY, 2001, J IMMUNOL, V166, P574, DOI 10.4049/jimmunol.166.1.574; Perera PY, 1997, J IMMUNOL, V158, P4422; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Robertson DM, 2005, INVEST OPHTH VIS SCI, V46, P470, DOI 10.1167/iovs.04-0528; Roy S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054245; Roy S, 2011, J BIOL CHEM, V286, P23753, DOI 10.1074/jbc.M111.219345; Sun Y, 2012, J IMMUNOL, V188, P1884, DOI 10.4049/jimmunol.1102148; Sun Y, 2010, J IMMUNOL, V185, P4272, DOI 10.4049/jimmunol.1000874; Talreja J, 2005, INFLAMMATION, V29, P170, DOI 10.1007/s10753-006-9014-y; TRINKAUSRANDALL V, 1991, INVEST OPHTH VIS SCI, V32, P603; Visintin A, 2003, J BIOL CHEM, V278, P48313, DOI 10.1074/jbc.M306802200; Wiersinga WJ, 2008, J INFECT DIS, V198, P1388, DOI 10.1086/592220; Wilkinson TS, 2009, AM J PATHOL, V174, P1338, DOI 10.2353/ajpath.2009.080746; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; Zanoni I, 2011, CELL, V147, P868, DOI 10.1016/j.cell.2011.09.051	38	32	35	0	11	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1174	1182		10.1074/jbc.M113.523167	http://dx.doi.org/10.1074/jbc.M113.523167			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275652	Green Published, hybrid			2022-12-25	WOS:000330541200048
J	Toth, TI; Grabowska, M; Schmidt, J; Buschges, A; Daun-Gruhn, S				Toth, Tibor Istvan; Grabowska, Martyna; Schmidt, Joachim; Bueschges, Ansgar; Daun-Gruhn, Silvia			A Neuro-Mechanical Model Explaining the Physiological Role of Fast and Slow Muscle Fibres at Stop and Start of Stepping of an Insect Leg	PLOS ONE			English	Article							COXAL DEPRESSOR MUSCLES; STICK INSECT; INHIBITORY MOTONEURONS; FILTER CHARACTERISTICS; NEUROMECHANICAL MODEL; SEARCHING MOVEMENTS; PATTERN GENERATION; SENSORY CONTROL; WALKING; JOINT	Stop and start of stepping are two basic actions of the musculo-skeletal system of a leg. Although they are basic phenomena, they require the coordinated activities of the leg muscles. However, little is known of the details of how these activities are generated by the interactions between the local neuronal networks controlling the fast and slow muscle fibres at the individual leg joints. In the present work, we aim at uncovering some of those details using a suitable neuromechanical model. It is an extension of the model in the accompanying paper and now includes all three antagonistic muscle pairs of the main joints of an insect leg, together with their dedicated neuronal control, as well as common inhibitory motoneurons and the residual stiffness of the slow muscles. This model enabled us to study putative processes of intra-leg coordination during stop and start of stepping. We also made use of the effects of sensory signals encoding the position and velocity of the leg joints. Where experimental observations are available, the corresponding simulation results are in good agreement with them. Our model makes detailed predictions as to the coordination processes of the individual muscle systems both at stop and start of stepping. In particular, it reveals a possible role of the slow muscle fibres at stop in accelerating the convergence of the leg to its steady-state position. These findings lend our model physiological relevance and can therefore be used to elucidate details of the stop and start of stepping in insects, and perhaps in other animals, too.	[Toth, Tibor Istvan; Grabowska, Martyna; Daun-Gruhn, Silvia] Univ Cologne, Dept Anim Physiol, Emmy Noether Res Grp Computat Biol, D-50931 Cologne, Germany; [Schmidt, Joachim; Bueschges, Ansgar] Univ Cologne, Dept Anim Physiol, D-50931 Cologne, Germany	University of Cologne; University of Cologne	Daun-Gruhn, S (corresponding author), Univ Cologne, Dept Anim Physiol, Emmy Noether Res Grp Computat Biol, D-50931 Cologne, Germany.	sgruhn@uni-koeln.de		Daun, Silvia/0000-0001-7342-1015; Grabowska, Martyna/0000-0002-1727-7714	DFG Emmy-Noether Programme	DFG Emmy-Noether Programme(German Research Foundation (DFG))	This work was supported by DFG Emmy-Noether Programme (http://www.dfg.de/en/research_funding/programmes/individual/emmy_noether/index.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALLANTYNE D, 1981, J COMP PHYSIOL, V143, P111, DOI 10.1007/BF00606074; Bassler D, 1996, J EXP BIOL, V199, P2169; BASSLER U, 1977, BIOL CYBERN, V25, P61, DOI 10.1007/BF00337264; Bassler U, 1996, J EXP BIOL, V199, P2185; Bassler U, 1983, NEURAL BASIS ELEMENT; Borgmann A, 2012, BIOL CYBERN, V422, P473; BRAUNIG P, 1981, CELL TISSUE RES, V216, P57; Bucher D, 2003, J NEUROPHYSIOL, V89, P1245, DOI 10.1152/jn.00637.2002; Buschges A, 2007, ADV INSECT PHYSIOL, V34, P193, DOI 10.1016/S0065-2806(07)34004-6; Buschges A, 2005, J NEUROPHYSIOL, V93, P1127, DOI 10.1152/jn.00615.2004; BUSCHGES A, 1995, J NEUROBIOL, V27, P488, DOI 10.1002/neu.480270405; CRUSE H, 1995, J INSECT PHYSIOL, V41, P761, DOI 10.1016/0022-1910(95)00032-P; DEAN J, 1984, J EXP BIOL, V110, P203; Fischer H, 2001, J NEUROPHYSIOL, V85, P341, DOI 10.1152/jn.2001.85.1.341; Godlewska E, 2012, THESIS U COLOGNE GER; Hooper SL, 2009, J NEUROSCI, V29, P4109, DOI 10.1523/JNEUROSCI.5510-08.2009; HUSTERT R, 1978, CELL TISSUE RES, V194, P337; ILES JF, 1971, J EXP BIOL, V55, P151; Knops S, 2013, J NEUROPHYSIOL, V109, P679, DOI 10.1152/jn.00648.2012; LAURENT G, 1989, J NEUROSCI, V9, P3019; LAURENT G, 1989, J NEUROSCI, V9, P3030; Marder E, 1996, PHYSIOL REV, V76, P687, DOI 10.1152/physrev.1996.76.3.687; Mulloney B, 2007, J NEUROPHYSIOL, V98, P405, DOI 10.1152/jn.00345.2007; PEARSON KG, 1971, J EXP BIOL, V54, P215; Rosenbaum P, 2010, J NEUROPHYSIOL, V104, P1681, DOI 10.1152/jn.00362.2010; SCHMIDT J, 1993, J COMP PHYSIOL A, V172, P447, DOI 10.1007/BF00213526; Schmidt J, 2001, J NEUROPHYSIOL, V85, P354, DOI 10.1152/jn.2001.85.1.354; SCHMITZ J, 1986, BIOL CYBERN, V55, P35, DOI 10.1007/BF00363976; SCHMITZ J, 1986, BIOL CYBERN, V55, P25, DOI 10.1007/BF00363975; Toth TI, 2012, J NEUROPHYSIOL, V107, P3267, DOI 10.1152/jn.01124.2011; Toth TI, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078247; Westmark S, 2009, J NEUROPHYSIOL, V102, P1049, DOI 10.1152/jn.91360.2008; WOLF H, 1990, J EXP BIOL, V152, P281; Zill SN, 2011, J COMP PHYSIOL A, V197, P851, DOI 10.1007/s00359-011-0647-4	34	15	15	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e78246	10.1371/journal.pone.0078246	http://dx.doi.org/10.1371/journal.pone.0078246			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278108	gold, Green Submitted, Green Published			2022-12-25	WOS:000327541700003
J	Jiang, XY; Zeng, T; Zhang, SK; Zhang, YS				Jiang, Xueyuan; Zeng, Tao; Zhang, Shukun; Zhang, Yuanshu			Comparative Proteomic and Bioinformatic Analysis of the Effects of a High-Grain Diet on the Hepatic Metabolism in Lactating Dairy Goats	PLOS ONE			English	Article							CALRETICULIN; PROTEIN; CHAPERONE; BINDING; IDENTIFICATION; ROLES; GENE	To gain insight on the impart of high-grain diets on liver metabolism in ruminants, we employed a comparative proteomic approach to investigate the proteome-wide effects of diet in lactating dairy goats by conducting a proteomic analysis of the liver extracts of 10 lactating goats fed either a control diet or a high-grain diet. More than 500 protein spots were detected per condition by two-dimensional electrophoresis (2-DE). In total, 52 differentially expressed spots (>= 2.0-fold changed) were excised and analyzed using MALDI TOF/TOF. Fifty-one protein spots were successfully identified. Of these, 29 proteins were upregulated, while 22 were downregulated in the high-grain fed vs. control animals. Differential expressions of proteins including alpha enolase, elongation factor 2, calreticulin, cytochrome b5, apolipoprotein A-I, catalase, was verified by mRNA analysis and/or Western blotting. Database searches combined with Gene Ontology (GO) analysis and KEGG pathway analysis revealed that the high-grain diet resulted in altered expression of proteins related to amino acids metabolism. These results suggest new candidate proteins that may contribute to a better understanding of the signaling pathways and mechanisms that mediate liver adaptation to high-grain diet.	[Jiang, Xueyuan; Zhang, Shukun; Zhang, Yuanshu] Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China; [Zeng, Tao] Nanjing Agr Univ, Minist Agr, Key Lab Anim Physiol & Biochem, Nanjing, Jiangsu, Peoples R China	Nanjing Agricultural University; Ministry of Agriculture & Rural Affairs; Nanjing Agricultural University	Zhang, YS (corresponding author), Nanjing Agr Univ, Coll Anim Sci & Technol, Nanjing, Jiangsu, Peoples R China.	zhangyuanshu@njau.edu.cn			China National Basic Research Program Foundation [2011CB100802]; Priority Academic Program Development of Jiangsu Higher Education Institutions; Graduate Students' Innovative Projects of Jiangsu Higher Education Institutions [CXLX13-291]	China National Basic Research Program Foundation(National Basic Research Program of China); Priority Academic Program Development of Jiangsu Higher Education Institutions; Graduate Students' Innovative Projects of Jiangsu Higher Education Institutions	This project was sponsored by grants from the China National Basic Research Program Foundation ((Project No. 2011CB100802); Priority Academic Program Development of Jiangsu Higher Education Institutions; and Graduate Students' Innovative Projects of Jiangsu Higher Education Institutions (Project No. CXLX13-291). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bondzio A, 2011, AM J PHYSIOL-GASTR L, V301, pG260, DOI 10.1152/ajpgi.00304.2010; Chen J, 2012, VET J, V193, P514, DOI 10.1016/j.tvjl.2012.01.034; Chen J, 2010, COMP BIOCHEM PHYS B, V155, P380, DOI 10.1016/j.cbpb.2009.12.005; Durand TC, 2011, J PROTEOMICS, V74, P1396, DOI 10.1016/j.jprot.2011.03.013; El-Aneed A, 2006, ANTICANCER RES, V26, P3293; Emmanuel DGV, 2008, J DAIRY SCI, V91, P606, DOI 10.3168/jds.2007-0256; Endo T, 2000, BIOCHEM BIOPH RES CO, V276, P999, DOI 10.1006/bbrc.2000.3581; Fella K, 2005, PROTEOMICS, V5, P1914, DOI 10.1002/pmic.200401067; Gelebart P, 2005, INT J BIOCHEM CELL B, V37, P260, DOI 10.1016/j.biocel.2004.02.030; Guo GF, 2012, J PROTEOMICS, V75, P1867, DOI 10.1016/j.jprot.2011.12.032; Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720; Huang DW, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r183; Jianzhen H, 2007, J VET MED A, V54, P464, DOI 10.1111/j.1439-0442.2007.00990.x; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; Katayama H, 2001, RAPID COMMUN MASS SP, V15, P1416, DOI 10.1002/rcm.379; LADIAS JAA, 1991, SCIENCE, V251, P561, DOI 10.1126/science.1899293; Laino P, 2010, PROTEOMICS, V10, P2359, DOI 10.1002/pmic.200900803; Michalak M, 1998, BIOCHEM CELL BIOL, V76, P779, DOI 10.1139/bcb-76-5-779; Michalak M, 2009, BIOCHEM J, V417, P651, DOI 10.1042/BJ20081847; NURTEN R, 1980, EUR J BIOCHEM, V103, P551, DOI 10.1111/j.1432-1033.1980.tb05979.x; Obeid M, 2007, IMMUNOL REV, V220, P22, DOI 10.1111/j.1600-065X.2007.00567.x; Orr AL, 2012, J BIOL CHEM, V287, P42921, DOI 10.1074/jbc.M112.397828; Parent R, 2005, J HEPATOL, V43, P177, DOI 10.1016/j.jhep.2005.04.001; Pi JB, 2010, TOXICOL APPL PHARM, V244, P77, DOI 10.1016/j.taap.2009.05.025; Porter TD, 2002, J BIOCHEM MOL TOXIC, V16, P311, DOI 10.1002/jbt.10052; Ryu SY, 2012, CELL SIGNAL, V24, P60, DOI 10.1016/j.cellsig.2011.07.011; Schenkman JB, 2003, PHARMACOL THERAPEUT, V97, P139, DOI 10.1016/S0163-7258(02)00327-3; Segrest JP, 1999, J LIPID RES, V40, P1401; Wang WA, 2012, INT J BIOCHEM CELL B, V44, P842, DOI 10.1016/j.biocel.2012.02.009; Wang ZW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046463; Yan Q, 2011, BIOCHEMISTRY-US, V50, P566, DOI 10.1021/bi101639y; Zeng T, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0076917; Zhang W, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063472	33	16	18	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80698	10.1371/journal.pone.0080698	http://dx.doi.org/10.1371/journal.pone.0080698			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260456	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900087
J	Vitale, N; Kisslinger, A; Paladino, S; Procaccini, C; Matarese, G; Pierantoni, GM; Mancini, FP; Tramontano, D				Vitale, Nicoletta; Kisslinger, Annamaria; Paladino, Simona; Procaccini, Claudio; Matarese, Giuseppe; Pierantoni, Giovanna Maria; Mancini, Francesco Paolo; Tramontano, Donatella			Resveratrol Couples Apoptosis with Autophagy in UVB-Irradiated HaCaT Cells	PLOS ONE			English	Article							ULTRAVIOLET-RADIATION; HUMAN KERATINOCYTES; SIGNALING PATHWAY; KAPPA-B; CANCER; DEATH; CHEMOPREVENTION; ACTIVATION; MECHANISMS; ERK	UVB radiation causes about 90% of non-melanoma skin cancers by damaging DNA either directly or indirectly by increasing levels of reactive oxygen species (ROS). Skin, chronically exposed to both endogenous and environmental pro-oxidant agents, contains a well-organised system of chemical and enzymatic antioxidants. However, increased or prolonged free radical action can overwhelm ROS defence mechanisms, contributing to the development of cutaneous diseases. Thus, new strategies for skin protection comprise the use of food antioxidants to counteract oxidative stress. Resveratrol, a phytoalexin from grape, has gained a great interest for its ability to influence several biological mechanisms like redox balance, cell proliferation, signal transduction pathways, immune and inflammatory response. Therefore, the potential of resveratrol to modify skin cell response to UVB exposure could turn out to be a useful option to protect skin from sunlight-induced degenerative diseases. To investigate into this matter, HaCaT cells, a largely used model for human skin keratinocytes, were treated with 25 or 100 mu M resveratrol for 2 and 24 hours prior to UVB irradiation (10 to 100 mJ/cm(2)). Cell viability and molecular markers of proliferation, oxidative stress, apoptosis, and autophagy were analyzed. In HaCaT cells resveratrol pretreatment: reduces UVB-induced ROS formation, enhances the detrimental effect of UVB on HaCaT cell vitality, increases UVB-induced caspase 8, PARP cleavage, and induces autophagy. These findings suggest that resveratrol could exert photochemopreventive effects by enhancing UVB-induced apoptosis and by inducing autophagy, thus reducing the odds that damaged cells could escape programmed cell death and initiate malignant transformation.	[Vitale, Nicoletta; Paladino, Simona; Pierantoni, Giovanna Maria; Tramontano, Donatella] Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy; [Kisslinger, Annamaria; Procaccini, Claudio] CNR, Inst Oncol & Expt Endocrinol, I-80125 Naples, Italy; [Matarese, Giuseppe] Univ Salerno, Dept Med & Surg, I-84100 Salerno, Italy; [Matarese, Giuseppe] IRCCS MultiMed, Milan, Italy; [Mancini, Francesco Paolo] Univ Sannio, Dept Sci & Technol, Benevento, Italy	University of Naples Federico II; Consiglio Nazionale delle Ricerche (CNR); University of Salerno; IRCCS Multimedica; University of Sannio	Tramontano, D (corresponding author), Univ Naples Federico II, Dept Mol Med & Med Biotechnol, Naples, Italy.	dtramont@unina.it	Tramontano, Donatella/AAS-1740-2020; Paladino, Simona/J-5383-2018; Pierantoni, Giovanna Maria/O-7527-2015; Paladino, Simona/ABH-7826-2020; Matarese, Giuseppe/AAO-4077-2021; Procaccini, Claudio/AAB-3696-2019	Paladino, Simona/0000-0001-5332-6774; Pierantoni, Giovanna Maria/0000-0003-4078-8528; Matarese, Giuseppe/0000-0001-9429-0616; Migliaccio, Antimo/0000-0002-4197-2055; Tramontano, Donatella/0000-0002-9308-034X; PROCACCINI, CLAUDIO/0000-0002-2184-0442; Vitale, Nicoletta/0000-0001-6677-2597	EU Ideas Programme; ERC-Starting Independent Grant "menTORingTregs" [310496]; Telethon-JDRF [GJT08004]; FISM [2012/R/11]; Assessorato alle Attivita' Produttive, Regione Campania, Italy [LR 5/02]; Regione Campania, Italy; POR Campania	EU Ideas Programme; ERC-Starting Independent Grant "menTORingTregs"; Telethon-JDRF(Juvenile Diabetes Research Foundation); FISM(Fondazione Italiana Sclerosi Multipla (FISM)); Assessorato alle Attivita' Produttive, Regione Campania, Italy(Regione Campania); Regione Campania, Italy(Regione Campania); POR Campania(Regione Campania)	G.M. is supported by grants from the EU Ideas Programme, ERC-Starting Independent Grant "menTORingTregs" N. 310496, Telethon-JDRF Grant N. GJT08004, FISM 2012/R/11. Assessorato alle Attivita' Produttive, Regione Campania, Italy, Grant LR 5/02, Regione Campania, Italy, POR Campania FSE 2007-2013, Project CREME, Fondazione GENS Onlus, Naples, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad N, 1999, NUTR REV, V57, P78, DOI 10.1111/j.1753-4887.1999.tb06927.x; [Anonymous], 2011, Annals of the New York Academy of Sciences, V1215, P1, DOI 10.1111/j.1749-6632.2010.05870.x; Assefa Z, 2005, BBA-REV CANCER, V1755, P90, DOI 10.1016/j.bbcan.2005.04.001; Assefa Z, 2000, J BIOL CHEM, V275, P21416, DOI 10.1074/jbc.M002634200; Athar M, 2009, ARCH BIOCHEM BIOPHYS, V486, P95, DOI 10.1016/j.abb.2009.01.018; Aziz MH, 2005, FASEB J, V19, P1193, DOI 10.1096/fj.04-3582fje; Biasutto L, 2012, CHEMBIOCHEM, V13, P1256, DOI 10.1002/cbic.201200193; Bursch W, 2000, ANN NY ACAD SCI, V926, P1, DOI 10.1111/j.1749-6632.2000.tb05594.x; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cao C, 2009, J CELL MOL MED, V13, P3632, DOI 10.1111/j.1582-4934.2008.00453.x; Catalgol B, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00141; Chaturvedi V, 2004, J CELL PHYSIOL, V198, P100, DOI 10.1002/jcp.10392; Cucciolla V, 2007, CELL CYCLE, V6, P2495, DOI 10.4161/cc.6.20.4815; De Amicis F, 2011, FASEB J, V25, P3695, DOI 10.1096/fj.10-178871; Delmas D, 2011, CURR MED CHEM, V18, P1100, DOI 10.2174/092986711795029708; DOLL R, 1981, JNCI-J NATL CANCER I, V66, P1191, DOI 10.1093/jnci/66.6.1192; Fabbrocini G, 2010, EXP DERMATOL, V19, P895, DOI 10.1111/j.1600-0625.2010.01117.x; Faurschou A, 2010, DAN MED BULL, V57; Filippi-Chiela EC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020849; Ghavami S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016523; Haspel J, 2011, AUTOPHAGY, V7, P629, DOI 10.4161/auto.7.6.15100; He H, 2003, J BIOL CHEM, V278, P29278, DOI 10.1074/jbc.M303800200; Ivashkevich A, 2012, CANCER LETT, V327, P123, DOI 10.1016/j.canlet.2011.12.025; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kulms D, 2002, BIOCHEM PHARMACOL, V64, P837, DOI 10.1016/S0006-2952(02)01146-2; LEBEL CP, 1992, CHEM RES TOXICOL, V5, P227, DOI 10.1021/tx00026a012; Lee ER, 2005, J BIOL CHEM, V280, P31498, DOI 10.1074/jbc.M505537200; Lei X, 2010, PHOTOCH PHOTOBIO SCI, V9, P1640, DOI 10.1039/c0pp00244e; Low ICC, 2010, ANTIOXID REDOX SIGN, V13, P807, DOI 10.1089/ars.2009.3050; Manson MM, 2000, TOXICOL LETT, V112, P499, DOI 10.1016/S0378-4274(99)00211-8; Martin P, 2010, FEBS J, V277, P39, DOI 10.1111/j.1742-4658.2009.07369.x; McEwan DG, 2011, TRENDS CELL BIOL, V21, P195, DOI 10.1016/j.tcb.2010.12.006; Miller AB, 2010, INT J CANCER, V126, P1531, DOI 10.1002/ijc.25006; Morselli E, 2009, AGING-US, V1, P961, DOI 10.18632/aging.100110; Mukhtar H, 1999, TOXICOL APPL PHARM, V158, P207, DOI 10.1006/taap.1999.8721; Nakatogawa H, 2009, NAT REV MOL CELL BIO, V10, P458, DOI 10.1038/nrm2708; Namasivayam N, 2011, ANN NY ACAD SCI, V1215, P60, DOI 10.1111/j.1749-6632.2010.05873.x; Narayanan DL, 2010, INT J DERMATOL, V49, P978, DOI 10.1111/j.1365-4632.2010.04474.x; Ogier-Denis E, 2000, J BIOL CHEM, V275, P39090, DOI 10.1074/jbc.M006198200; Pallauf K, 2013, AGEING RES REV, V12, P237, DOI 10.1016/j.arr.2012.03.008; Pani G, 2009, INT J BIOCHEM CELL B, V41, P1002, DOI 10.1016/j.biocel.2008.10.011; Park K, 2008, ONCOL REP, V19, P413; Park SJ, 2012, CELL, V148, P421, DOI 10.1016/j.cell.2012.01.017; Pastore S, 2012, PHOTOCHEM PHOTOBIOL, V88, P1522, DOI 10.1111/j.1751-1097.2012.01195.x; Pattingre S, 2003, J BIOL CHEM, V278, P16667, DOI 10.1074/jbc.M210998200; Pervaiz S, 2009, ANTIOXID REDOX SIGN, V11, P2851, DOI [10.1089/ars.2008.2412, 10.1089/ARS.2008.2412]; Potapovich AI, 2011, TOXICOL APPL PHARM, V255, P138, DOI 10.1016/j.taap.2011.06.007; Roy P, 2009, BIOCHEM BIOPH RES CO, V384, P215, DOI 10.1016/j.bbrc.2009.04.100; Sander CS, 2004, INT J DERMATOL, V43, P326, DOI 10.1111/j.1365-4632.2004.02222.x; Su MF, 2013, J ONCOL, V2013, DOI 10.1155/2013/102735; Takasawa R, 2005, APOPTOSIS, V10, P1121, DOI 10.1007/s10495-005-0901-8; Tamimi RM, 2002, J INTERN MED, V251, P286, DOI 10.1046/j.1365-2796.2002.00969.x; Vinod BS, 2013, ANTIOXID REDOX SIGN, V18, P1307, DOI 10.1089/ars.2012.4573; Wang JR, 2009, J BIOL CHEM, V284, P21412, DOI 10.1074/jbc.M109.026013; Yang ZF, 2010, NAT CELL BIOL, V12, P814, DOI 10.1038/ncb0910-814; Zhang X, 2012, CELL PROLIFERAT, V45, P466, DOI 10.1111/j.1365-2184.2012.00833.x; Zhuang SG, 2006, J PHARMACOL EXP THER, V319, P991, DOI 10.1124/jpet.106.107367; ZIEGLER A, 1994, NATURE, V372, P773, DOI 10.1038/372773a0	59	55	58	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80728	10.1371/journal.pone.0080728	http://dx.doi.org/10.1371/journal.pone.0080728			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260465	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900090
J	Blenkiron, C; Hurley, DG; Fitzgerald, S; Print, CG; Lasham, A				Blenkiron, Cherie; Hurley, Daniel G.; Fitzgerald, Sandra; Print, Cristin G.; Lasham, Annette			Links between the Oncoprotein YB-1 and Small Non-Coding RNAs in Breast Cancer	PLOS ONE			English	Article							SMALL-NUCLEOLAR RNAS; MESSENGER-RNA; STRESS GRANULES; SELF-RENEWAL; NUCLEAR-LOCALIZATION; TARGETING YB-1; CELL-LINES; EXPRESSION; PATHWAY; MICRORNAS	Background: The nucleic acid-binding protein YB-1, a member of the cold-shock domain protein family, has been implicated in the progression of breast cancer and is associated with poor patient survival. YB-1 has sequence similarity to LIN28, another cold-shock protein family member, which has a role in the regulation of small noncoding RNAs (sncRNAs) including microRNAs (miRNAs). Therefore, to investigate whether there is an association between YB-1 and sncRNAs in breast cancer, we investigated whether sncRNAs were bound by YB-1 in two breast cancer cell lines (luminal A-like and basal cell-like), and whether the abundance of sncRNAs and mRNAs changed in response to experimental reduction of YB-1 expression. Results: RNA-immunoprecipitation with an anti-YB-1 antibody showed that several sncRNAs are bound by YB-1. Some of these were bound by YB-1 in both breast cancer cell lines; others were cell-line specific. The small RNAs bound by YB-1 were derived from various sncRNA families including miRNAs such as let-7 and miR-320, transfer RNAs, ribosomal RNAs and small nucleolar RNAs (snoRNA). Reducing YB-1 expression altered the abundance of a number of transcripts encoding miRNA biogenesis and processing proteins but did not alter the abundance of mature or precursor miRNAs. Conclusions: YB-1 binds to specific miRNAs, snoRNAs and tRNA-derived fragments and appears to regulate the expression of miRNA biogenesis and processing machinery. We propose that some of the oncogenic effects of YB-1 in breast cancer may be mediated through its interactions with sncRNAs.	[Blenkiron, Cherie; Hurley, Daniel G.; Fitzgerald, Sandra; Print, Cristin G.; Lasham, Annette] Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand; [Blenkiron, Cherie] Univ Auckland, Dept Surg, Auckland 1, New Zealand; [Hurley, Daniel G.; Print, Cristin G.] Univ Auckland, Bioinformat Inst, Auckland 1, New Zealand	University of Auckland; University of Auckland; University of Auckland	Blenkiron, C (corresponding author), Univ Auckland, Dept Mol Med & Pathol, Auckland 1, New Zealand.	c.blenkiron@auckland.ac.nz	Blenkiron, Cherie/H-8468-2019	Blenkiron, Cherie/0000-0002-0217-3808; Fitzgerald, Sandra/0000-0002-5121-0804; Print, Cristin/0000-0001-8345-7812; Hurley, Daniel Glyn/0000-0003-0171-1982	Genesis Oncology Trust	Genesis Oncology Trust	This work was funded by a research grant from The Genesis Oncology Trust, http://genesisoncology.org.nz/oncology/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bargou RC, 1997, NAT MED, V3, P447, DOI 10.1038/nm0497-447; Basaki Y, 2010, EUR J CANCER, V46, P954, DOI 10.1016/j.ejca.2009.12.024; Belian E, 2010, ANTICANCER RES, V30, P629; Bergmann S, 2005, CANCER RES, V65, P4078, DOI 10.1158/0008-5472.CAN-04-4056; Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Blenkiron C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r214; Bockhorn J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2393; Bockhorn J, 2013, BREAST CANCER RES TR, V137, P373, DOI 10.1007/s10549-012-2346-4; Bratkovic T, 2011, CELL MOL LIFE SCI, V68, P3843, DOI 10.1007/s00018-011-0762-y; Buchan JR, 2009, MOL CELL, V36, P932, DOI 10.1016/j.molcel.2009.11.020; Chambers AF, 2009, CANCER RES, V69, P5292, DOI 10.1158/0008-5472.CAN-09-1528; Cohen SB, 2010, ONCOGENE, V29, P403, DOI 10.1038/onc.2009.321; Dabo S, 2012, VIRUSES-BASEL, V4, P2598, DOI 10.3390/v4112598; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Di Costanzo A, 2012, J BIOL CHEM, V287, P30170, DOI 10.1074/jbc.M112.349951; Dong JJ, 2009, RNA BIOL, V6, P59, DOI 10.4161/rna.6.1.7458; Eliseeva IA, 2011, BIOCHEMISTRY-MOSCOW+, V76, P1402, DOI 10.1134/S0006297911130049; Emara MM, 2010, J BIOL CHEM, V285, P10959, DOI 10.1074/jbc.M109.077560; Evdokimova V, 2006, MOL CELL BIOL, V26, P277, DOI 10.1128/MCB.26.1.277-292.2006; Evdokimova V, 2009, CANCER CELL, V15, P402, DOI 10.1016/j.ccr.2009.03.017; Falaleeva M, 2013, BIOESSAYS, V35, P46, DOI 10.1002/bies.201200117; Feng C, 2012, CELL CYCLE, V11, P2486, DOI 10.4161/cc.20893; Gee HE, 2011, BRIT J CANCER, V104, P1168, DOI 10.1038/sj.bjc.6606076; Gonda K, 2006, J BIOL CHEM, V281, P8153, DOI 10.1074/jbc.M512890200; Guil S, 2006, MOL CELL BIOL, V26, P5744, DOI 10.1128/MCB.00224-06; Guo L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020517; Habibi G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2156; Hafner M, 2013, RNA; Hanina SA, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001163; Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088; Hollestelle A, 2009, CANCER RES, V69, P7893, DOI 10.1158/0008-5472.CAN-09-2396; Hsieh AC, 2012, NATURE, V485, P55, DOI 10.1038/nature10912; Hsieh IS, 2013, CARCINOGENESIS, V34, P530, DOI 10.1093/carcin/bgs371; Huang YM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001107; Hummel R, 2010, EUR J CANCER, V46, P298, DOI 10.1016/j.ejca.2009.10.027; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Ivanov P, 2011, MOL CELL, V43, P613, DOI 10.1016/j.molcel.2011.06.022; Jeon SH, 2012, FEBS LETT, V586, P3477, DOI 10.1016/j.febslet.2012.07.076; Kallen Amanda N., 2012, Frontiers in Genetics, V3, P240, DOI 10.3389/fgene.2012.00240; Kalra J, 2010, ONCOGENE, V29, P6343, DOI 10.1038/onc.2010.366; Kato M, 2010, J BIOL CHEM, V285, P34004, DOI 10.1074/jbc.M110.165027; Kedersha N, 2007, METHOD ENZYMOL, V431, P61, DOI 10.1016/S0076-6879(07)31005-7; Kishore S, 2010, HUM MOL GENET, V19, P1153, DOI 10.1093/hmg/ddp585; Langenberger D, 2010, BIOCOMPUT-PAC SYM, P80; Lasham A, 2013, BIOCHEM J, V449, P11, DOI 10.1042/BJ20121323; Lasham A, 2012, JNCI-J NATL CANCER I, V104, P133, DOI 10.1093/jnci/djr512; Lasham A, 2010, NUCLEIC ACIDS RES, V38, DOI 10.1093/nar/gkp1076; Lee C, 2008, CANCER RES, V68, P8661, DOI 10.1158/0008-5472.CAN-08-1082; Lee K, 2011, RNA, V17, P1076, DOI 10.1261/rna.2701111; Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lui LR, 2013, ESSAYS BIOCHEM, V54, P53, DOI [10.1042/BSE0540053, 10.1042/bse0540053]; Lv KZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040008; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Majumder S, 2011, GENE EXPRESSION, V15, P141, DOI 10.3727/105221611X13176664479287; Mantwill K, 2006, CANCER RES, V66, P7195, DOI 10.1158/0008-5472.CAN-05-2339; Martens-Uzunova E. S., 2013, CANC LETT; Meiri E, 2010, NUCLEIC ACIDS RES, V38, P6234, DOI 10.1093/nar/gkq376; Michel CI, 2011, CELL METAB, V14, P33, DOI 10.1016/j.cmet.2011.04.009; Moore LM, 2013, J PATHOL, V229, P449, DOI 10.1002/path.4109; Moss EG, 2003, DEV BIOL, V258, P432, DOI 10.1016/S0012-1606(03)00126-X; Nordentoft I, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-40; Ono M, 2011, NUCLEIC ACIDS RES, V39, P3879, DOI 10.1093/nar/gkq1355; Peter ME, 2009, CELL CYCLE, V8, P843, DOI 10.4161/cc.8.6.7907; Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798; Rattenbacher B, 2010, MOL CELL BIOL, V30, P3970, DOI 10.1128/MCB.00624-10; Reid Glen, 2009, J RNAi Gene Silencing, V5, P321; Schepeler T, 2008, CANCER RES, V68, P6416, DOI 10.1158/0008-5472.CAN-07-6110; Skabkina OV, 2005, MOL CELL BIOL, V25, P3317, DOI 10.1128/MCB.25.8.3317-3323.2005; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Su H, 2013, ONCOGENE; Sugimura K, 2012, CLIN CANCER RES, V18, P5144, DOI 10.1158/1078-0432.CCR-12-0701; Svitkin YV, 2009, EMBO J, V28, P58, DOI 10.1038/emboj.2008.259; To K, 2010, CANCER RES, V70, P2840, DOI 10.1158/0008-5472.CAN-09-3155; Viswanathan SR, 2010, CELL, V140, P445, DOI 10.1016/j.cell.2010.02.007; Volinia S, 2010, GENOME RES, V20, P589, DOI 10.1101/gr.098046.109; Wei WJ, 2012, NUCLEIC ACIDS RES, V40, P8622, DOI 10.1093/nar/gks579; Wilbert ML, 2012, MOL CELL, V48, P195, DOI 10.1016/j.molcel.2012.08.004; Woolley AG, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020603; Xia J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047863; Yang WH, 2007, RNA, V13, P704, DOI 10.1261/rna.411907; Yu F, 2010, ONCOGENE, V29, P4194, DOI 10.1038/onc.2010.167; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054; Yun JU, 2011, EMBO J, V30, P4500, DOI 10.1038/emboj.2011.312; Zhou JB, 2013, INT J BIOCHEM CELL B, V45, P973, DOI 10.1016/j.biocel.2013.02.006; Zhou M, 2011, FEBS J, V278, P929, DOI 10.1111/j.1742-4658.2011.08008.x; Zhu XL, 2013, ACTA BIOCH BIOPH SIN, V45, P80, DOI 10.1093/abbs/gms099	87	32	33	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80171	10.1371/journal.pone.0080171	http://dx.doi.org/10.1371/journal.pone.0080171			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260353	Green Published, gold			2022-12-25	WOS:000327308500119
J	Delzon, S; Urli, M; Samalens, JC; Lamy, JB; Lischke, H; Sin, F; Zimmermann, NE; Porte, AJ				Delzon, Sylvain; Urli, Morgane; Samalens, Jean-Charles; Lamy, Jean-Baptiste; Lischke, Heike; Sin, Fabrice; Zimmermann, Niklaus E.; Porte, Annabel J.			Field Evidence of Colonisation by Holm Oak, at the Northern Margin of Its Distribution Range, during the Anthropocene Period	PLOS ONE			English	Article							CLIMATE-CHANGE IMPACTS; PLANT MIGRATION RATES; QUERCUS-ILEX; HABITAT FRAGMENTATION; SPECIES DISTRIBUTIONS; MEDITERRANEAN OAKS; POTENTIAL CHANGES; GLOBAL CLIMATE; TREE MIGRATION; SHIFTS	A major unknown in the context of current climate change is the extent to which populations of slowly migrating species, such as trees, will track shifting climates. Niche modelling generally predicts substantial northward shifts of suitable habitats. There is therefore an urgent need for field-based forest observations to corroborate these extensive model simulations. We used forest inventory data providing presence/absence information from just over a century (1880-2010) for a Mediterranean species (Quercus ilex) in forests located at the northern edge of its distribution. The main goals of the study were (i) to investigate whether this species has actually spread into new areas during the Anthropocene period and (ii) to provide a direct estimation of tree migration rate. We show that Q. ilex has colonised substantial new areas over the last century. However, the maximum rate of colonisation by this species (22 to 57 m/year) was much slower than predicted by the models and necessary to follow changes in habitat suitability since 1880. Our results suggest that the rates of tree dispersion and establishment may also be too low to track shifts in bioclimatic envelopes in the future. The inclusion of contemporary, rather than historical, migration rates into models should improve our understanding of the response of species to climate change.	[Delzon, Sylvain; Urli, Morgane; Lamy, Jean-Baptiste; Porte, Annabel J.] INRA, UMR BIOGECO 1202, Cestas, France; [Delzon, Sylvain; Urli, Morgane; Lamy, Jean-Baptiste; Porte, Annabel J.] Univ Bordeaux, UMR BIOGECO 1202, Cestas, France; [Samalens, Jean-Charles] INRA, UR EPHYSE 1263, Villenave Dornon, France; [Lischke, Heike; Zimmermann, Niklaus E.] Swiss Fed Res Inst WSL, Birmensdorf, Switzerland; [Sin, Fabrice] Agence Bordeaux, ONF, Brugge, France	INRAE; UDICE-French Research Universities; Universite de Bordeaux; INRAE; Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research	Delzon, S (corresponding author), INRA, UMR BIOGECO 1202, Cestas, France.	sylvain.delzon@u-bordeaux1.fr	Delzon, Sylvain/R-9538-2018; Lischke, Heike/J-5719-2013; Zimmermann, Niklaus E./A-4276-2008	Delzon, Sylvain/0000-0003-3442-1711; Lischke, Heike/0000-0003-4284-5194; Zimmermann, Niklaus E./0000-0003-3099-9604; Lamy, Jean-Baptiste/0000-0002-6078-0905; Urli, Morgane/0000-0001-8627-1116	European Community [226299, 226544]	European Community(European Commission)	This study was supported by a grant from the Aquitaine region and the BACCARA and MOTIVE projects, which were funded by the European Community's Seventh Framework Programme (FP7/2007-2013) under grant agreements nos. 226299 and 226544, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aitken SN, 2008, EVOL APPL, V1, P95, DOI 10.1111/j.1752-4571.2007.00013.x; Araujo MB, 2006, J BIOGEOGR, V33, P1712, DOI 10.1111/j.1365-2699.2006.01482.x; BARBERO M, 1992, VEGETATIO, V100, P19; Bertin RI, 2008, J TORREY BOT SOC, V135, P126, DOI 10.3159/07-RP-035R.1; BIRKS HJB, 1989, J BIOGEOGR, V16, P503, DOI 10.2307/2845208; Brian Huntley, 1983, ATLAS PRESENT POLLEN; Bush MB, 2004, SCIENCE, V303, P827, DOI 10.1126/science.1090795; Cain ML, 2000, AM J BOT, V87, P1217, DOI 10.2307/2656714; Chauchard S, 2010, FOREST ECOL MANAG, V259, P1406, DOI 10.1016/j.foreco.2010.01.009; Cheaib A, 2012, ECOL LETT, V15, P533, DOI 10.1111/j.1461-0248.2012.01764.x; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Corlett RT, 2013, TRENDS ECOL EVOL, V28, P482, DOI 10.1016/j.tree.2013.04.003; Damesin C, 1998, FUNCT ECOL, V12, P778, DOI 10.1046/j.1365-2435.1998.00259.x; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Espelta JM, 2003, FOREST ECOL MANAG, V179, P401, DOI 10.1016/S0378-1127(02)00541-8; GEAR AJ, 1991, SCIENCE, V251, P544, DOI 10.1126/science.251.4993.544; Gehrig-Fasel J, 2007, J VEG SCI, V18, P571, DOI 10.1111/j.1654-1103.2007.tb02571.x; Gerber S, 2003, ACTES BRG, V4, P349; Gomez JM, 2003, ECOGRAPHY, V26, P573, DOI 10.1034/j.1600-0587.2003.03586.x; Gomez JM, 2008, OECOLOGIA, V155, P529, DOI 10.1007/s00442-007-0928-3; GRABHERR G, 1994, NATURE, V369, P448, DOI 10.1038/369448a0; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Higgins SI, 2003, J ECOL, V91, P341, DOI 10.1046/j.1365-2745.2003.00781.x; Higgins SI, 1999, AM NAT, V153, P464, DOI 10.1086/303193; Higgins SI, 2003, OIKOS, V101, P354, DOI 10.1034/j.1600-0706.2003.12141.x; Honnay O, 2002, ECOL LETT, V5, P525, DOI 10.1046/j.1461-0248.2002.00346.x; Huntley B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001439; Ibanez I, 2009, GLOBAL CHANGE BIOL, V15, P1173, DOI 10.1111/j.1365-2486.2008.01777.x; Iverson LR, 2004, GLOBAL ECOL BIOGEOGR, V13, P209, DOI 10.1111/j.1466-822X.2004.00093.x; Iverson LR, 2001, ECOSYSTEMS, V4, P186, DOI 10.1007/s10021-001-0003-6; Jetz W, 2007, PLOS BIOL, V5, P1211, DOI 10.1371/journal.pbio.0050157; King GA, 1996, FUTURE RAPID ENV CHA, P91; Kullman L, 2002, J ECOL, V90, P68, DOI 10.1046/j.0022-0477.2001.00630.x; LARCHER W, 1969, OECOLOG PLANTAR, V4, P347; Larcher W, 1990, ATTI ACC NAZ LINCEI, V387, P3; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Limousin JM, 2009, GLOBAL CHANGE BIOL, V15, P2163, DOI 10.1111/j.1365-2486.2009.01852.x; Lindner M, 2010, FOREST ECOL MANAG, V259, P698, DOI 10.1016/j.foreco.2009.09.023; Lischke H, 2005, ECOL COMPLEX, V2, P159, DOI 10.1016/j.ecocom.2004.11.009; Lumaret R, 2002, MOL ECOL, V11, P2327, DOI 10.1046/j.1365-294X.2002.01611.x; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Martinez-Vilalta J, 2002, OECOLOGIA, V133, P19, DOI 10.1007/s00442-002-1009-2; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; McLachlan JS, 2004, FOREST ECOL MANAG, V197, P139, DOI 10.1016/j.foreco.2004.05.026; Meier ES, 2012, GLOBAL ECOL BIOGEOGR, V21, P164, DOI 10.1111/j.1466-8238.2011.00669.x; MICHAUD H, 1995, HEREDITY, V74, P590, DOI 10.1038/hdy.1995.83; Moisselin J.M., 2002, METEOROLOGIE, V38, P45, DOI DOI 10.4267/2042/36233; Morin X, 2008, J ECOL, V96, P784, DOI 10.1111/j.1365-2745.2008.01369.x; Morin X, 2007, ECOLOGY, V88, P2280, DOI 10.1890/06-1591.1; Morin X, 2009, ECOLOGY, V90, P1301, DOI 10.1890/08-0134.1; Murphy HT, 2010, ECOL LETT, V13, P1233, DOI 10.1111/j.1461-0248.2010.01526.x; Neilson RP, 2005, BIOSCIENCE, V55, P749, DOI 10.1641/0006-3568(2005)055[0749:FRTGPM]2.0.CO;2; Noss RF, 2001, CONSERV BIOL, V15, P578, DOI 10.1046/j.1523-1739.2001.015003578.x; ONF, 1951, PLAN AM HOURT; ONF, 1936, PLAN AM HOURT; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Petit RJ, 2008, SCIENCE, V320, P1450, DOI 10.1126/science.1155457; SCHWARTZ MW, 1993, BIODIVERS CONSERV, V2, P51, DOI 10.1007/BF00055102; Shafer SL, 2001, ECOSYSTEMS, V4, P200, DOI 10.1007/s10021-001-0004-5; Shiyatov SG, 2007, RUSS J ECOL+, V38, P223, DOI 10.1134/S1067413607040017; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Stewart JR, 2001, TRENDS ECOL EVOL, V16, P608, DOI 10.1016/S0169-5347(01)02338-2; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Thuiller W, 2008, PERSPECT PLANT ECOL, V9, P137, DOI 10.1016/j.ppees.2007.09.004; Tyree MT, 1996, ANN SCI FOREST, V53, P173, DOI 10.1051/forest:19960201; Urli M, 2014, J VEG SCI, V25, P147, DOI 10.1111/jvs.12079; Vitousek PM, 1997, SCIENCE, V277, P494, DOI 10.1126/science.277.5325.494; Walther GR, 2005, P ROY SOC B-BIOL SCI, V272, P1427, DOI 10.1098/rspb.2005.3119; WARDLE P, 1992, NEW ZEAL J BOT, V30, P303, DOI 10.1080/0028825X.1992.10412909; Woodall CW, 2009, FOREST ECOL MANAG, V257, P1434, DOI 10.1016/j.foreco.2008.12.013; Woodward FI, 2004, PHILOS T ROY SOC B, V359, P1465, DOI 10.1098/rstb.2004.1525; Zhu K, 2012, GLOBAL CHANGE BIOL, V18, P1042, DOI 10.1111/j.1365-2486.2011.02571.x	75	38	38	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80443	10.1371/journal.pone.0080443	http://dx.doi.org/10.1371/journal.pone.0080443			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260391	Green Published, gold			2022-12-25	WOS:000327308500139
J	Ehrnthaller, C; Huber-Lang, M; Nilsson, P; Bindl, R; Redeker, S; Recknagel, S; Rapp, A; Mollnes, T; Amling, M; Gebhard, F; Ignatius, A				Ehrnthaller, Christian; Huber-Lang, Markus; Nilsson, Per; Bindl, Ronny; Redeker, Simon; Recknagel, Stefan; Rapp, Anna; Mollnes, Tom; Amling, Michael; Gebhard, Florian; Ignatius, Anita			Complement C3 and C5 Deficiency Affects Fracture Healing	PLOS ONE			English	Article							OSSIFICATION CENTER; BONE; EXPRESSION; C1S; OSTEOCLASTOGENESIS; DIFFERENTIATION; OSTEOBLASTS; ACTIVATION; MECHANISMS; GENERATION	There is increasing evidence that complement may play a role in bone development. Our previous studies demonstrated that the key complement receptor C5aR was strongly expressed in the fracture callus not only by immune cells but also by bone cells and chondroblasts, indicating a function in bone repair. To further elucidate the role of complement in bone healing, this study investigated fracture healing in mice in the absence of the key complement molecules C3 and C5. C3(-/-) and C5(-/-) as well as the corresponding wildtype mice received a standardized femur osteotomy, which was stabilized using an external fixator. Fracture healing was investigated after 7 and 21 days using histological, micro-computed tomography and biomechanical measurements. In the early phase of fracture healing, reduced callus area (C3(-/-): -25%, p=0.02; C5(-/-): -20% p=0.052) and newly formed bone (C3(-/-): -38%, p=0.01; C5(-/-): -52%, p=0.009) was found in both C3- and C5-deficient mice. After 21 days, healing was successful in the absence of C3, whereas in C5-deficient mice fracture repair was significantly reduced, which was confirmed by a reduced bending stiffness (-45%; p=0.029) and a smaller callus volume (-17%; p=0.039). We further demonstrated that C5a was activated in C3(-/-) mice, suggesting cleavage via extrinsic pathways. Our results suggest that the activation of the terminal complement cascade in particular may be crucial for successful fracture healing.	[Ehrnthaller, Christian; Huber-Lang, Markus; Gebhard, Florian] Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany; [Bindl, Ronny; Redeker, Simon; Recknagel, Stefan; Rapp, Anna; Ignatius, Anita] Univ Ulm, Ctr Musculoskeletal Res, Inst Orthoped Res & Biomech, Ulm, Germany; [Amling, Michael] Univ Med Ctr Hamburg Eppendorf, Dept Osteol & Biomech, Hamburg, Germany; [Nilsson, Per; Mollnes, Tom] Univ Oslo, Inst Clin Med, Dept Immunol, Oslo, Norway	Ulm University; Ulm University; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Oslo	Ehrnthaller, C (corresponding author), Univ Ulm, Ctr Surg, Dept Traumatol Hand Plast & Reconstruct Surg, Ulm, Germany.	christian.ehrnthaller@uniklinik-ulm.de	Ignatius, Anita/M-6012-2013; Huber-Lang, Markus/AAJ-2209-2020; Rapp, Anna/L-8807-2016; Mollnes, Tom/ABI-5183-2020	Ignatius, Anita/0000-0002-4782-1979; Rapp, Anna/0000-0001-5122-765X; Nilsson, Per/0000-0002-7192-5794	German Research Foundation [KFO 200, IG18/14-2]	German Research Foundation(German Research Foundation (DFG))	This study was supported by the German Research Foundation (KFO 200, IG18/14-2). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu-Amer Y, 2001, J CLIN INVEST, V107, P1375, DOI 10.1172/JCI10530; Ai-Aql ZS, 2008, J DENT RES, V87, P107, DOI 10.1177/154405910808700215; Andrades JA, 1996, EXP CELL RES, V227, P208, DOI 10.1006/excr.1996.0269; Billiard J, 2003, J CELL BIOCHEM, V89, P389, DOI 10.1002/jcb.10514; Carter Shea, 2011, Curr Osteoporos Rep, V9, P112, DOI 10.1007/s11914-011-0058-z; Circolo A, 1999, IMMUNOPHARMACOLOGY, V42, P135, DOI 10.1016/S0162-3109(99)00021-1; Claes L, 2012, NAT REV RHEUMATOL, V8, P133, DOI 10.1038/nrrheum.2012.1; Czermak BJ, 1999, NAT MED, V5, P788, DOI 10.1038/10512; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Flierl MA, 2008, FASEB J, V22, P3483, DOI 10.1096/fj.08-110595; Gerstenfeld LC, 2003, J BONE MINER RES, V18, P1584, DOI 10.1359/jbmr.2003.18.9.1584; Huber-Lang M, 2002, AM J PATHOL, V161, P1849, DOI 10.1016/S0002-9440(10)64461-6; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Huber-Lang MS, 2002, FASEB J, V16, P1567, DOI 10.1096/fj.02-0209com; Ignatius A, 2011, J TRAUMA, V71, P952, DOI 10.1097/TA.0b013e3181f8aa2d; Ignatius A, 2011, J CELL BIOCHEM, V112, P2594, DOI 10.1002/jcb.23186; Kimura Y, 2003, J IMMUNOL, V170, P2331, DOI 10.4049/jimmunol.170.5.2331; MARDER SR, 1985, J IMMUNOL, V134, P3325; Morgan EF, 2009, BONE, V44, P335, DOI 10.1016/j.bone.2008.10.039; PARFITT AM, 1988, BONE, V9, P67, DOI 10.1016/8756-3282(88)90029-4; Pobanz JM, 2000, J PERIODONTAL RES, V35, P137, DOI 10.1034/j.1600-0765.2000.035003137.x; Recknagel S, 2011, J ORTHOP RES, V29, P734, DOI 10.1002/jor.21299; Rontgen V, 2010, J ORTHOP RES, V28, P1456, DOI 10.1002/jor.21148; Roman-Roman S, 2003, BONE, V32, P474, DOI 10.1016/S8756-3282(03)00052-8; Rutkowski MJ, 2010, INFLAMM RES, V59, P897, DOI 10.1007/s00011-010-0220-6; SAKIYAMA H, 1994, CELL TISSUE RES, V277, P239, DOI 10.1007/s004410050151; Sakiyama H, 1997, CELL TISSUE RES, V288, P557, DOI 10.1007/s004410050841; SATO T, 1993, ENDOCRINOLOGY, V133, P397, DOI 10.1210/en.133.1.397; Schoengraf P, 2013, IMMUNOBIOLOGY, V218, P1, DOI 10.1016/j.imbio.2012.01.020; Schraufstatter IU, 2009, J IMMUNOL, V182, P3827, DOI 10.4049/jimmunol.0803055; Segal LG, 1996, ANN MED INTERNE, V147, P281; Takayanagi H, 2000, NATURE, V408, P600, DOI 10.1038/35046102; Takayanagi H, 2007, NAT REV IMMUNOL, V7, P292, DOI 10.1038/nri2062; Toyoguchi T, 1996, CELL TISSUE RES, V285, P199, DOI 10.1007/s004410050637; Tu Z, 2010, BLOOD, V116, P4456, DOI 10.1182/blood-2010-01-263590; Unnewehr H, 2013, J IMMUNOL, V190, P4215, DOI 10.4049/jimmunol.1200534; WETSEL RA, 1990, J BIOL CHEM, V265, P2435; YAMAGUCHI K, 1994, BBA-PROTEIN STRUCT M, V1205, P133, DOI 10.1016/0167-4838(94)90101-5; Yang X, 2007, BONE, V41, P928, DOI 10.1016/j.bone.2007.07.022	39	37	41	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81341	10.1371/journal.pone.0081341	http://dx.doi.org/10.1371/journal.pone.0081341			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260573	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500204
J	Gicquel, G; Bouffartigues, E; Bains, M; Oxaran, V; Rosay, T; Lesouhaitier, O; Connil, N; Bazire, A; Maillot, O; Benard, M; Cornelis, P; Hancock, REW; Dufour, A; Feuilloley, MGJ; Orange, N; Deziel, E; Chevalier, S				Gicquel, Gwendoline; Bouffartigues, Emeline; Bains, Manjeet; Oxaran, Virginie; Rosay, Thibaut; Lesouhaitier, Olivier; Connil, Nathalie; Bazire, Alexis; Maillot, Olivier; Benard, Magalie; Cornelis, Pierre; Hancock, Robert E. W.; Dufour, Alain; Feuilloley, Marc G. J.; Orange, Nicole; Deziel, Eric; Chevalier, Sylvie			The Extra-Cytoplasmic Function Sigma Factor SigX Modulates Biofilm and Virulence-Related Properties in Pseudomonas aeruginosa	PLOS ONE			English	Article							OUTER-MEMBRANE PROTEIN; CAENORHABDITIS-ELEGANS; DIFFERENTIAL EXPRESSION; REGULATORY NETWORK; SWARMING MOTILITY; EFFLUX SYSTEM; IV PILI; INVOLVEMENT; RESISTANCE; ACTIVATION	SigX, one of the 19 extra-cytoplasmic function sigma factors of P. aeruginosa, was only known to be involved in transcription of the gene encoding the major outer membrane protein OprF. We conducted a comparative transcriptomic study between the wildtype H103 strain and its sigX mutant PAOSX, which revealed a total of 307 differentially expressed genes that differed by more than 2 fold. Most dysregulated genes belonged to six functional classes, including the "chaperones and heat shock proteins", "antibiotic resistance and susceptibility", "energy metabolism", "protein secretion/export apparatus", and "secreted factors", and "motility and attachment" classes. In this latter class, the large majority of the affected genes were down-regulated in the sigX mutant. In agreement with the array data, the sigX mutant was shown to demonstrate substantially reduced motility, attachment to biotic and abiotic surfaces, and biofilm formation. In addition, virulence towards the nematode Caenorhabditis elegans was reduced in the sigX mutant, suggesting that SigX is involved in virulence- related phenotypes.	[Gicquel, Gwendoline; Bouffartigues, Emeline; Oxaran, Virginie; Rosay, Thibaut; Lesouhaitier, Olivier; Connil, Nathalie; Maillot, Olivier; Feuilloley, Marc G. J.; Orange, Nicole; Chevalier, Sylvie] Univ Rouen, Normandie Univ, Lab Microbiol Signaux & Microenvironm, EA 4312, Evreux, France; [Bains, Manjeet; Hancock, Robert E. W.] Univ British Columbia, Ctr Microbal Dis & Immun Res, Vancouver, BC V5Z 1M9, Canada; [Bazire, Alexis; Dufour, Alain] Univ Bretagne Sud UEB, IUEM, Lab Biotechnol & Chim Marines, EA 3884, Lorient, France; [Benard, Magalie] Univ Rouen, Fac Sci, IRIB, Cell Imaging Platform Normandy PRIMACEN, Mont St Aignan, France; [Cornelis, Pierre] Vrije Univ Brussel VIB, Dept Bioengn Sci, Microbiol Res Grp, Dept Biol Struct, B-1050 Brussels, Belgium; [Deziel, Eric] Univ Quebec, Inst Armand Frappier, INRS, Laval, PQ, Canada	Universite de Rouen Normandie; University of British Columbia; Universite de Bretagne Occidentale; Institut Universitaire Europeen de la Mer (IUEM); Universite de Rouen Normandie; Flanders Institute for Biotechnology (VIB); Vrije Universiteit Brussel; University of Quebec; Institut national de la recherche scientifique (INRS)	Chevalier, S (corresponding author), Univ Rouen, Normandie Univ, Lab Microbiol Signaux & Microenvironm, EA 4312, Evreux, France.	sylvie.chevalier@univ-rouen.fr	Déziel, Eric/A-7678-2008; Cornelis, Pierre/H-3058-2019; Bouffartigues, Emeline/CAG-9939-2022; Hancock, Robert E. W./E-1145-2013	Déziel, Eric/0000-0002-4609-0115; Bouffartigues, Emeline/0000-0003-2569-4961; Hancock, Robert E. W./0000-0001-5989-8503; Oxaran, Virginie/0000-0001-6766-6497; CHEVALIER, sylvie/0000-0001-6489-438X; Dufour, Alain/0000-0003-0112-6046; FEUILLOLEY, Marc G.J./0000-0001-6467-4336	French government and Region Haute Normandie, France; Grand Evreux Agglomeration; European FEDER [32789]; Canadian Institutes for Health Research (CIHR); Cystic Fibrosis Canada grant	French government and Region Haute Normandie, France(Region Normandie); Grand Evreux Agglomeration; European FEDER(European Commission); Canadian Institutes for Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); Cystic Fibrosis Canada grant	This work was supported by the French government and Region Haute Normandie, France (part of the doctoral fellowship to G. Gicquel), the Grand Evreux Agglomeration (financial support of O. Maillot), the European FEDER funds number 32789 for the LMSM ( post doctoral fellowships to E. Bouffartigues and V. Oxaran) and by Canadian Institutes for Health Research (CIHR) grants to ED and REWH. REWH was further supported by a Cystic Fibrosis Canada grant. ED holds a tier 2 Canada Research Chair and REWH holds a tier 1 Canada Research Chair. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aires JR, 1999, ANTIMICROB AGENTS CH, V43, P2624, DOI 10.1128/AAC.43.11.2624; ARAI H, 1995, FEBS LETT, V371, P73, DOI 10.1016/0014-5793(95)00885-D; Arai H, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00103; Barken KB, 2008, ENVIRON MICROBIOL, V10, P2331, DOI 10.1111/j.1462-2920.2008.01658.x; Bastiaansen KC, 2012, BACTERIAL REGULATORY NETWORKS, P59; Bernard CS, 2009, J BACTERIOL, V191, P1961, DOI 10.1128/JB.01330-08; BIELECKI P, 2013, ENVIRON MICROBIOL, DOI DOI 10.1111/1462-2920.12024.PUBMED:23145907; Blazejczyk M., 2007, FLEXARRAY STAT DATA; Bloemberg GV, 1997, APPL ENVIRON MICROB, V63, P4543, DOI 10.1128/AEM.63.11.4543-4551.1997; BODEY GP, 1983, REV INFECT DIS, V5, P279; Bouffartigues E., 2011, J BACTERIOL PARASITO, V2, P118, DOI [10.4172/2155-9597.1000118, DOI 10.4172/2155-9597.1000118]; Bouffartigues E, 2012, J BACTERIOL, V194, P4301, DOI 10.1128/JB.00509-12; Brinkman FSL, 1999, J BACTERIOL, V181, P4746, DOI 10.1128/JB.181.16.4746-4754.1999; Burrows LL, 2012, ANNU REV MICROBIOL, V66, P493, DOI 10.1146/annurev-micro-092611-150055; Cao M, 2004, J BACTERIOL, V186, P1136, DOI 10.1128/JB.186.4.1136-1146.2004; CHANTRET I, 1994, J CELL SCI, V107, P213; Cornelis P, 2009, BIOMETALS, V22, P15, DOI 10.1007/s10534-008-9193-0; Crabbe A, 2010, ENVIRON MICROBIOL, V12, P1545, DOI 10.1111/j.1462-2920.2010.02184.x; de Bentzmann S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003052; Deziel E, 2003, MICROBIOL-SGM, V149, P2005, DOI 10.1099/mic.0.26154-0; Dou Y, 2010, FEMS MICROBIOL LETT, V312, P24, DOI 10.1111/j.1574-6968.2010.02093.x; Elias S, 2011, MICROBIOL-SGM, V157, P2172, DOI 10.1099/mic.0.044768-0; ESSAR DW, 1990, J BACTERIOL, V172, P884, DOI 10.1128/jb.172.2.884-900.1990; Fito-Boncompte L, 2011, INFECT IMMUN, V79, P1176, DOI 10.1128/IAI.00850-10; Gaines JM, 2005, MICROBIOL-SGM, V151, P2263, DOI 10.1099/mic.0.27754-0; Giraud C, 2011, ENVIRON MICROBIOL, V13, P666, DOI 10.1111/j.1462-2920.2010.02372.x; Gooderham WJ, 2008, J BACTERIOL, V190, P5624, DOI 10.1128/JB.00594-08; Hahn MY, 2005, J BACTERIOL, V187, P7062, DOI 10.1128/JB.187.20.7062-7071.2005; Hancock REW, 2002, ANNU REV MICROBIOL, V56, P17, DOI 10.1146/annurev.micro.56.012302.160310; HANCOCK REW, 1979, J BACTERIOL, V140, P902, DOI 10.1128/JB.140.3.902-910.1979; Helmann John D., 2006, Science Progress, V89, P243, DOI 10.3184/003685006783238290; Hong HJ, 2002, MOL MICROBIOL, V44, P1199, DOI 10.1046/j.1365-2958.2002.02960.x; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Kawakami T, 2010, ENVIRON MICROBIOL, V12, P1399, DOI 10.1111/j.1462-2920.2009.02109.x; Kindrachuk KN, 2011, ANTIMICROB AGENTS CH, V55, P1874, DOI 10.1128/AAC.00935-10; KING EO, 1954, J LAB CLIN MED, V44, P301; Kojic M, 2002, J BACTERIOL, V184, P2324, DOI 10.1128/JB.184.8.2324-2330.2002; Llamas MA, 2008, MOL MICROBIOL, V67, P458; Llamas MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000572; Mahajan-Miklos S, 1999, CELL, V96, P47, DOI 10.1016/S0092-8674(00)80958-7; Mavrodi DV, 2001, J BACTERIOL, V183, P6454, DOI 10.1128/JB.183.21.6454-6465.2001; Morita Y, 2006, J BACTERIOL, V188, P1847, DOI 10.1128/JB.188.5.1847-1855.2006; Muller C, 2011, ANTIMICROB AGENTS CH, V55, P1211, DOI 10.1128/AAC.01252-10; Ochsner UA, 2000, MICROBIOL-UK, V146, P185, DOI 10.1099/00221287-146-1-185; Paget MSB, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-1-203; Picot L, 2003, MICROB PATHOGENESIS, V35, P95, DOI 10.1016/S0882-4010(03)00092-5; Potvin E, 2008, FEMS MICROBIOL REV, V32, P38, DOI 10.1111/j.1574-6976.2007.00092.x; Ramsey DM, 2005, MOL MICROBIOL, V56, P309, DOI 10.1111/j.1365-2958.2005.04552.x; Ratledge C, 2000, ANNU REV MICROBIOL, V54, P881, DOI 10.1146/annurev.micro.54.1.881; Rawling EG, 1998, J BACTERIOL, V180, P3556, DOI 10.1128/JB.180.14.3556-3562.1998; Ruiz-Diez B, 2003, J THEOR BIOL, V225, P469, DOI 10.1016/S0022-5193(03)00288-1; Schobel S, 2004, MOL MICROBIOL, V52, P1091, DOI 10.1111/j.1365-2958.2004.04031.x; Schreiber K, 2007, J BACTERIOL, V189, P4310, DOI 10.1128/JB.00240-07; SCHWYN B, 1987, ANAL BIOCHEM, V160, P47, DOI 10.1016/0003-2697(87)90612-9; Shaw LN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003844; Tan MW, 1999, P NATL ACAD SCI USA, V96, P2408, DOI 10.1073/pnas.96.5.2408; Tremblay J, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-587; Trunk K, 2010, ENVIRON MICROBIOL, V12, P1719, DOI 10.1111/j.1462-2920.2010.02252.x; Winsor GL, 2011, NUCLEIC ACIDS RES, V39, pD596, DOI 10.1093/nar/gkq869; Wood LF, 2009, MOL MICROBIOL, V72, P183, DOI 10.1111/j.1365-2958.2009.06635.x; WOODRUFF WA, 1989, J BACTERIOL, V171, P3304, DOI 10.1128/jb.171.6.3304-3309.1989; Wu LC, 2005, SCIENCE, V309, P774, DOI 10.1126/science.1112422; Yanamandra SS, 2012, MOL ORAL MICROBIOL, V27, P202, DOI 10.1111/j.2041-1014.2012.00643.x; YE RW, 1995, J BACTERIOL, V177, P3606, DOI 10.1128/jb.177.12.3606-3609.1995	64	34	35	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80407	10.1371/journal.pone.0080407	http://dx.doi.org/10.1371/journal.pone.0080407			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260387	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327308500135
J	Skouras, S; Gray, M; Critchley, H; Koelsch, S				Skouras, Stavros; Gray, Marcus; Critchley, Hugo; Koelsch, Stefan			fMRI Scanner Noise Interaction with Affective Neural Processes	PLOS ONE			English	Article							GRADIENT ACOUSTIC NOISE; AUDITORY-CORTEX; POSITIVE EMOTIONS; BACKGROUND-NOISE; OPTIMIZED EPI; MRI; ATTENTION; ACTIVATION; MOTOR; AMYGDALA	The purpose of the present study was the investigation of interaction effects between functional MRI scanner noise and affective neural processes. Stimuli comprised of psychoacoustically balanced musical pieces, expressing three different emotions (fear, neutral, joy). Participants (N=34, 19 female) were split into two groups, one subjected to continuous scanning and another subjected to sparse temporal scanning that features decreased scanner noise. Tests for interaction effects between scanning group (sparse/quieter vs continuous/noisier) and emotion (fear, neutral, joy) were performed. Results revealed interactions between the affective expression of stimuli and scanning group localized in bilateral auditory cortex, insula and visual cortex (calcarine sulcus). Post-hoc comparisons revealed that during sparse scanning, but not during continuous scanning, BOLD signals were significantly stronger for joy than for fear, as well as stronger for fear than for neutral in bilateral auditory cortex. During continuous scanning, but not during sparse scanning, BOLD signals were significantly stronger for joy than for neutral in the left auditory cortex and for joy than for fear in the calcarine sulcus. To the authors' knowledge, this is the first study to show a statistical interaction effect between scanner noise and affective processes and extends evidence suggesting scanner noise to be an important factor in functional MRI research that can affect and distort affective brain processes.	[Skouras, Stavros; Koelsch, Stefan] Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany; [Gray, Marcus; Critchley, Hugo] Brighton & Sussex Med Sch, Clin Imaging Sci Ctr, Brighton, E Sussex, England; [Skouras, Stavros; Koelsch, Stefan] Univ Sussex, Dept Psychol, Falmer, E Sussex, England; [Gray, Marcus] Univ Queensland, Ctr Adv Imaging, St Lucia, Qld, Australia; [Critchley, Hugo] Univ Sussex, Sackler Ctr Consciousness Sci, Brighton BN1 9RH, E Sussex, England	Free University of Berlin; University of Brighton; University of Sussex; University of Sussex; University of Queensland; University of Sussex	Skouras, S (corresponding author), Free Univ Berlin, Cluster Excellence Languages Emot, Berlin, Germany.	mail@stavros-skouras.com	Koelsch, Stefan/AAV-1556-2020; critchley, hugo d/G-9267-2011; Gray, Marcus/F-6521-2013	critchley, hugo d/0000-0002-2445-9284; Gray, Marcus/0000-0001-8671-6939; Skouras, Stavros/0000-0003-2288-7821	RCUK; Psychology Department of the University of Sussex; Brighton and Sussex Medical School	RCUK(UK Research & Innovation (UKRI)); Psychology Department of the University of Sussex; Brighton and Sussex Medical School	The study was funded by an RCUK fellowship awarded to S. K., the Psychology Department of the University of Sussex, and the Brighton and Sussex Medical School. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achten E, 1999, RADIOLOGY, V210, P529, DOI 10.1148/radiology.210.2.r99ja31529; Amaro E, 2002, J MAGN RESON IMAGING, V16, P497, DOI 10.1002/jmri.10186; Bandettini PA, 1998, MAGNET RESON MED, V39, P410, DOI 10.1002/mrm.1910390311; Beck A.T., 1993, BECK DEPRESSION INVE; BERRY A, 1999, P ACT 99, V99, P73; Bizley JK, 2007, CEREB CORTEX, V17, P2172, DOI 10.1093/cercor/bhl128; Blamire AM, 2008, BRIT J RADIOL, V81, P601, DOI 10.1259/bjr/96872829; BOWTELL RW, 1995, MAGNET RESON MED, V34, P494, DOI 10.1002/mrm.1910340331; Bublak P, 2006, RESTOR NEUROL NEUROS, V24, P287; Cate AD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004645; Chen GK, 1999, IEEE T BIO-MED ENG, V46, P186, DOI 10.1109/10.740881; Chesney MA, 2005, INT J BEHAV MED, V12, P50, DOI 10.1207/s15327558ijbm1202_2; Cho ZH, 1997, MAGN RESON IMAGING, V15, P815, DOI 10.1016/S0730-725X(97)00090-8; Cho ZH, 1998, MAGNET RESON MED, V39, P331, DOI 10.1002/mrm.1910390224; Clark C, 2007, INT J COMP PSYCHOL, V20; Cohen S, 2006, CURR DIR PSYCHOL SCI, V15, P122, DOI 10.1111/j.0963-7214.2006.00420.x; Connan F, 2003, PHYSIOL BEHAV, V79, P13, DOI 10.1016/S0031-9384(03)00101-X; Counter SA, 1997, JMRI-J MAGN RESON IM, V7, P606, DOI 10.1002/jmri.1880070327; Cremillieux Y, 1997, MAGNET RESON MED, V38, P645, DOI 10.1002/mrm.1910380419; de Zwart JA, 2002, NEUROIMAGE, V16, P1151, DOI 10.1006/nimg.2002.1119; Deichmann R, 2002, NEUROIMAGE, V15, P120, DOI 10.1006/nimg.2001.0985; Deichmann R, 2003, NEUROIMAGE, V19, P430, DOI 10.1016/S1053-8119(03)00073-9; Edelstein WA, 2002, MAGN RESON IMAGING, V20, P155, DOI 10.1016/S0730-725X(02)00475-7; Edmister WB, 1999, HUM BRAIN MAPP, V7, P89, DOI 10.1002/(SICI)1097-0193(1999)7:2<89::AID-HBM2>3.3.CO;2-E; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; FOX NA, 1991, AM PSYCHOL, V46, P863, DOI 10.1037/0003-066X.46.8.863; FRAHM J, 1985, J MAGN RESON, V64, P81, DOI 10.1016/0022-2364(85)90033-2; FRISTON KJ, 2007, STAT PARAMETRIC MAPP, P17; Gaab N, 2007, HUM BRAIN MAPP, V28, P703, DOI 10.1002/hbm.20298; Gaab N, 2007, HUM BRAIN MAPP, V28, P721, DOI 10.1002/hbm.20299; Gabrielsson A, 2003, SER AFFECTIVE SCI, P503; GOLDMAN AM, 1989, RADIOLOGY, V173, P549, DOI 10.1148/radiology.173.2.2798889; Goldman RN, 2006, PSYCHOTHER RES, V16, P536, DOI 10.1080/10503300600589456; Hall DA, 1999, HUM BRAIN MAPP, V7, P213, DOI 10.1002/(SICI)1097-0193(1999)7:3<213::AID-HBM5>3.0.CO;2-N; Hennig J., 1993, MAGMA, V1, P39, DOI 10.1007/BF02660372; Hoekert M, 2007, SCHIZOPHR RES, V96, P135, DOI 10.1016/j.schres.2007.07.023; Idiyatullin D, 2006, J MAGN RESON, V181, P342, DOI 10.1016/j.jmr.2006.05.014; Jakob PM, 1998, MAGNET RESON MED, V40, P614, DOI 10.1002/mrm.1910400414; Jancke L, 1999, NEUROSCI LETT, V266, P125, DOI 10.1016/S0304-3940(99)00288-8; Johnstone T, 2006, HUM BRAIN MAPP, V27, P779, DOI 10.1002/hbm.20219; Juslin PN, 2008, BEHAV BRAIN SCI, V31, P559, DOI 10.1017/S0140525X08005293; Kamio S, 2001, SCHIZOPHR RES, V49, P213, DOI 10.1016/S0920-9964(00)00069-4; Kang JI, 2012, J AFFECT DISORDERS, V141, P286, DOI 10.1016/j.jad.2012.04.001; Katsunuma A, 2002, MAGN RESON MATER PHY, V13, P139, DOI 10.1016/S1352-8661(01)00142-9; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koelsch S, 2013, NEUROIMAGE, V81, P49, DOI 10.1016/j.neuroimage.2013.05.008; KRAMER DM, 1984, RADIOL CLIN N AM, V22, P765; Krasnow B, 2003, NEUROIMAGE, V18, P813, DOI 10.1016/S1053-8119(03)00002-8; Kraus KS, 2012, HEARING RES, V288, P34, DOI 10.1016/j.heares.2012.02.009; Lang P.J., 1997, INT AFFECTIVE PICTUR, V1, P3, DOI DOI 10.1027/0269-8803/A000147; Lang PJ, 1998, PSYCHOPHYSIOLOGY, V35, P199, DOI 10.1017/S0048577298001991; Langers DRM, 2005, MAGN RESON MED, V53, P49, DOI 10.1002/mrm.20315; Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00; Lerner Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006230; Loenneker T, 2001, MAGN RESON MATER PHY, V13, P76, DOI 10.1016/S1352-8661(01)00131-4; Lohmann G, 2001, COMPUT MED IMAG GRAP, V25, P449, DOI 10.1016/S0895-6111(01)00008-8; LOHMANN G, 2008, P 1 WORKSH AN FUNCT, P1; LUDWIG U, 1999, P 7 ANN M ISMRM PHIL, P1662; Mannie ZN, 2007, NEUROPSYCHOLOGIA, V45, P2975, DOI 10.1016/j.neuropsychologia.2007.05.016; Mansfield P, 1998, MAGNET RESON MED, V39, P539, DOI 10.1002/mrm.1910390406; MANSFIELD P, 1994, MEAS SCI TECHNOL, V5, P1021, DOI 10.1088/0957-0233/5/8/026; Mathiak K, 2002, HUM BRAIN MAPP, V16, P190, DOI 10.1002/hbm.10041; Mazard A, 2002, J COGNITIVE NEUROSCI, V14, P172, DOI 10.1162/089892902317236821; McJury M, 1997, MAGN RESON IMAGING, V15, P319, DOI 10.1016/S0730-725X(96)00337-2; McJury M, 2000, J MAGN RESON IMAGING, V12, P37, DOI 10.1002/1522-2586(200007)12:1<37::AID-JMRI5>3.0.CO;2-I; Moelker A, 2003, J MAGN RESON IMAGING, V17, P270, DOI 10.1002/jmri.10251; Moelker A, 2003, HUM BRAIN MAPP, V20, P123, DOI 10.1002/hbm.10134; Mueller K, 2011, NEUROIMAGE, V54, P337, DOI 10.1016/j.neuroimage.2010.08.029; Mueller WM, 1996, NEUROSURGERY, V39, P515, DOI 10.1097/00006123-199609000-00015; Novitski N, 2003, NEUROIMAGE, V20, P1320, DOI 10.1016/S1053-8119(03)00390-2; O'Mara S, 2005, J ANAT, V207, P271, DOI 10.1111/j.1469-7580.2005.00446.x; Oesterle C, 2001, MAGN RESON IMAGING, V19, P1333, DOI 10.1016/S0730-725X(01)00458-1; PANKSEPP J, 2005, AFFECTIVE NEUROSCIEN, P41; Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087; Plevier CM, 2001, QUAL LIFE RES, V10, P123, DOI 10.1023/A:1016753531137; Plichta MM, 2011, NEUROIMAGE, V55, P1200, DOI 10.1016/j.neuroimage.2011.01.011; Price DL, 2001, J MAGN RESON IMAGING, V13, P288, DOI 10.1002/1522-2586(200102)13:2<288::AID-JMRI1041>3.3.CO;2-G; Schwarzbauer C, 2006, NEUROIMAGE, V29, P774, DOI 10.1016/j.neuroimage.2005.08.025; Shah NJ, 1999, J MAGN RESON IMAGING, V9, P19, DOI 10.1002/(SICI)1522-2586(199901)9:1<19::AID-JMRI3>3.0.CO;2-K; Smiley JF, 2007, J COMP NEUROL, V502, P894, DOI 10.1002/cne.21325; STANSFELD SA, 1992, PSYCHOL MED, P1, DOI 10.1017/S0033291716002336; Steptoe A, 2005, P NATL ACAD SCI USA, V102, P6508, DOI 10.1073/pnas.0409174102; Sunaert S, 2001, NEUROIMAG CLIN N AM, V11, P221; Talavage TM, 2004, HUM BRAIN MAPP, V22, P216, DOI 10.1002/hbm.20029; TARNOPOLSKY A, 1978, PSYCHOL MED, V8, P219, DOI 10.1017/S0033291700014276; Tomasi D, 2005, NEUROIMAGE, V27, P377, DOI 10.1016/j.neuroimage.2005.04.010; Tosevski DL, 2006, CURR OPIN PSYCHIATR, V19, P184, DOI 10.1097/01.yco.0000214346.44625.57; VOETS N, 2005, IMAGING DECIS MRI, V9, P16, DOI DOI 10.1111/J.1617-0830.2005.00037.X; Vuilleumier P, 2001, NEURON, V30, P829, DOI 10.1016/S0896-6273(01)00328-2; Warner-Schmidt JL, 2006, HIPPOCAMPUS, V16, P239, DOI 10.1002/hipo.20156; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Weiskopf N, 2007, MAGN RESON MATER PHY, V20, P39, DOI 10.1007/s10334-006-0067-6; Weniger G, 2009, J PSYCHIATR NEUROSCI, V34, P383; Zhang NY, 2005, MAGN RESON MED, V54, P258, DOI 10.1002/mrm.20512	94	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80564	10.1371/journal.pone.0080564	http://dx.doi.org/10.1371/journal.pone.0080564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260420	Green Accepted, Green Published, gold			2022-12-25	WOS:000327308500154
J	Arbogast, P; Glosmann, M; Peichl, L				Arbogast, Patrick; Gloesmann, Martin; Peichl, Leo			Retinal Cone Photoreceptors of the Deer Mouse Peromyscus maniculatus: Development, Topography, Opsin Expression and Spectral Tuning	PLOS ONE			English	Article							VISUAL PIGMENTS; COLOR-VISION; DIURNAL RODENT; EVOLUTION; COEXPRESSION; SENSITIVITY; ADAPTATIONS; MORPHOLOGY; MAMMALS; ADULT	A quantitative analysis of photoreceptor properties was performed in the retina of the nocturnal deer mouse, Peromyscus maniculatus, using pigmented (wildtype) and albino animals. The aim was to establish whether the deer mouse is a more suitable model species than the house mouse for photoreceptor studies, and whether oculocutaneous albinism affects its photoreceptor properties. In retinal flatmounts, cone photoreceptors were identified by opsin immunostaining, and their numbers, spectral types, and distributions across the retina were determined. Rod photoreceptors were counted using differential interference contrast microscopy. Pigmented P. maniculatus have a rod-dominated retina with rod densities of about 450.000/mm(2) and cone densities of 3000 - 6500/mm(2). Two cone opsins, shortwave sensitive (S) and middle-to-longwave sensitive (M), are present and expressed in distinct cone types. Partial sequencing of the S opsin gene strongly supports UV sensitivity of the S cone visual pigment. The S cones constitute a 5-15% minority of the cones. Different from house mouse, S and M cone distributions do not have dorsoventral gradients, and coexpression of both opsins in single cones is exceptional (<2% of the cones). In albino P. maniculatus, rod densities are reduced by approximately 40% (270.000/mm(2)). Overall, cone density and the density of cones exclusively expressing S opsin are not significantly different from pigmented P. maniculatus. However, in albino retinas S opsin is coexpressed with M opsin in 60-90% of the cones and therefore the population of cones expressing only M opsin is significantly reduced to 5-25%. In conclusion, deer mouse cone properties largely conform to the general mammalian pattern, hence the deer mouse may be better suited than the house mouse for the study of certain basic cone properties, including the effects of albinism on cone opsin expression.	[Arbogast, Patrick; Gloesmann, Martin; Peichl, Leo] Max Planck Inst Brain Res, Frankfurt, Germany	Max Planck Society	Peichl, L (corresponding author), Max Planck Inst Brain Res, Frankfurt, Germany.	leo.peichl@brain.mpg.de	Glösmann, Martin/F-9349-2019	Glösmann, Martin/0000-0002-2094-3247; Peichl, Leo/0000-0002-8141-0911	Deutsche Forschungsgemeinschaft [PE 38/16]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	Supported by Deutsche Forschungsgemeinschaft grant PE 38/16. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahnelt PK, 2000, PROG RETIN EYE RES, V19, P711, DOI 10.1016/S1350-9462(00)00012-4; Applebury ML, 2000, NEURON, V27, P513, DOI 10.1016/S0896-6273(00)00062-3; Bowmaker JK, 2008, VISION RES, V48, P2022, DOI 10.1016/j.visres.2008.03.025; CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204; Carvalho LD, 2006, CURR BIOL, V16, pR81, DOI 10.1016/j.cub.2006.01.045; Chavez AE, 2003, INVEST OPHTH VIS SCI, V44, P2290, DOI 10.1167/iovs.02-0670; Cowing JA, 2002, BIOCHEM J, V367, P129, DOI 10.1042/BJ20020483; Rocha FAD, 2009, VISUAL NEUROSCI, V26, P167, DOI 10.1017/S095252380808098X; Donatien P, 2002, INVEST OPHTH VIS SCI, V43, P1198; Forrest D, 2012, MOL ENDOCRINOL, V26, P905, DOI 10.1210/me.2012-1010; Glaschke A, 2010, INVEST OPHTH VIS SCI, V51, P1719, DOI 10.1167/iovs.09-3592; Glosmann M, 2008, J VISION, V8, DOI 10.1167/8.4.23; Gresh J, 2003, VISUAL NEUROSCI, V20, P211, DOI 10.1017/S0952523803202108; Gronskov K, 2007, ORPHANET J RARE DIS, V2, DOI 10.1186/1750-1172-2-43; HICKS D, 1986, EXP EYE RES, V42, P55, DOI 10.1016/0014-4835(86)90017-5; Hunt DM, 2007, PHOTOCHEM PHOTOBIOL, V83, P303, DOI 10.1562/2006-06-27-IR-952; Hunt DM, 2009, PHILOS T R SOC B, V364, P2941, DOI 10.1098/rstb.2009.0044; Hunt DM, 2001, CELL MOL LIFE SCI, V58, P1583, DOI 10.1007/PL00000798; Hunt DM, 2013, VIS NEUROSC IN PRESS; Jacobs GH, 2013, VISUAL NEUROSCI, V30, P39, DOI 10.1017/S0952523812000429; Jacobs GH, 2010, OPHTHAL PHYSL OPT, V30, P422, DOI 10.1111/j.1475-1313.2010.00719.x; Jacobs GH, 1998, VISUAL NEUROSCI, V15, P581; Jacobs GH, 2003, J COMP PHYSIOL A, V189, P347, DOI 10.1007/s00359-003-0408-0; JACOBS GH, 1993, BIOL REV, V68, P413, DOI 10.1111/j.1469-185X.1993.tb00738.x; JEFFERY G, 1994, EUR J NEUROSCI, V6, P657, DOI 10.1111/j.1460-9568.1994.tb00311.x; Jeon CJ, 1998, J NEUROSCI, V18, P8936; Joyner Charlotte P., 1998, ILAR J, V39, P322; Lukats A, 2005, HISTOL HISTOPATHOL, V20, P551, DOI 10.14670/HH-20.551; Lukats A, 2002, INVEST OPHTH VIS SCI, V43, P2468; Moritz GL, 2013, EVOL BIOL, V40, P542, DOI 10.1007/s11692-013-9230-y; Ortin-Martinez A, 2010, INVEST OPHTH VIS SCI, V51, P3171, DOI 10.1167/iovs.09-4861; Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262; Peichl L, 2005, J COMP NEUROL, V486, P197, DOI 10.1002/cne.20491; Peichl L, 2004, EUR J NEUROSCI, V19, P1545, DOI 10.1111/j.1460-9568.2004.03263.x; Peichl L, 2000, VISUAL NEUROSCI, V17, P937, DOI 10.1017/S0952523800176138; ROHLICH P, 1994, NEURON, V13, P1159, DOI 10.1016/0896-6273(94)90053-1; Schiviz AN, 2008, J COMP NEUROL, V507, P1336, DOI 10.1002/cne.21626; Schleich CE, 2010, J COMP NEUROL, V518, P4001, DOI 10.1002/cne.22440; Shupe JM, 2006, BRAIN BEHAV EVOLUT, V67, P39, DOI 10.1159/000088857; SZEL A, 1993, J COMP NEUROL, V331, P564, DOI 10.1002/cne.903310411; SZEL A, 1994, NATURE, V370, P336, DOI 10.1038/370336a0; SZEL A, 1992, EXP EYE RES, V55, P47; WANG YS, 1992, NEURON, V9, P429, DOI 10.1016/0896-6273(92)90181-C; Yokoyama S, 2000, PROG RETIN EYE RES, V19, P385, DOI 10.1016/S1350-9462(00)00002-1; Yokoyama S, 1998, FEBS LETT, V423, P155, DOI 10.1016/S0014-5793(98)00086-6	45	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80910	10.1371/journal.pone.0080910	http://dx.doi.org/10.1371/journal.pone.0080910			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260509	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600097
J	Chen, LJ; Zhu, MX; Yang, GP; Huang, XL				Chen, Liang-Jin; Zhu, Mao-Xu; Yang, Gui-Peng; Huang, Xiang-Li			Reductive Reactivity of Iron(III) Oxides in the East China Sea Sediments: Characterization by Selective Extraction and Kinetic Dissolution	PLOS ONE			English	Article							SOLID-PHASE IRON; CONTINENTAL-SHELF; ORGANIC-MATTER; BUFFERING CAPACITY; SULFATE REDUCTION; FE(III) REDUCTION; ASCORBIC-ACID; DIAGENESIS; MANGANESE; SULFIDE	Reactive Fe(III) oxides in gravity-core sediments collected from the East China Sea inner shelf were quantified by using three selective extractions (acidic hydroxylamine, acidic oxalate, bicarbonate-citrate buffered sodium dithionite). Also the reactivity of Fe(III) oxides in the sediments was characterized by kinetic dissolution using ascorbic acid as reductant at pH 3.0 and 7.5 in combination with the reactive continuum model. Three parameters derived from the kinetic method: m(0) (theoretical initial amount of ascorbate-reducible Fe(III) oxides), k' (rate constant) and gamma (heterogeneity of reactivity), enable a quantitative characterization of Fe(III) oxide reactivity in a standardized way. Amorphous Fe(III) oxides quantified by acidic hydroxylamine extraction were quickly consumed in the uppermost layer during early diagenesis but were not depleted over the upper 100 cm depth. The total amounts of amorphous and poorly crystalline Fe(III) oxides are highly available for efficient buffering of dissolved sulfide. As indicated by the m(0), k' and gamma, the surface sediments always have the maximum content, reactivity and heterogeneity of reactive Fe(III) oxides, while the three parameters simultaneously downcore decrease, much more quickly in the upper layer than at depth. Albeit being within a small range (within one order of magnitude) of the initial rates among sediments at different depths, incongruent dissolution could result in huge discrepancies of the later dissolution rates due to differentiating heterogeneity, which cannot be revealed by selective extraction. A strong linear correlation of the m(0) at pH 3.0 with the dithionite-extractable Fe(III) suggests that the m(0) may represent Fe(III) oxide assemblages spanning amorphous and crystalline Fe(III) oxides. Maximum microbially available Fe(III) predicted by the m(0) at pH 7.5 may include both amorphous and a fraction of other less reactive Fe(III) phases.	[Chen, Liang-Jin; Zhu, Mao-Xu; Yang, Gui-Peng; Huang, Xiang-Li] Ocean Univ China, Coll Chem & Chem Engn, Key Lab Marine Chem Theory & Technol, Minist Educ, Qingdao, Peoples R China	Ocean University of China	Zhu, MX (corresponding author), Ocean Univ China, Coll Chem & Chem Engn, Key Lab Marine Chem Theory & Technol, Minist Educ, Qingdao, Peoples R China.	zhumaoxu@ouc.edu.cn	Yang, Gui-Peng/GZG-6468-2022	Yang, Gui-Peng/0000-0002-0107-4568	Natural Science Foundation of China [41076045, 41030858]; Shandong Province Natural Science Foundation [ZR2011DM003]; Taishan Scholars Programme of Shandong Province	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shandong Province Natural Science Foundation(Natural Science Foundation of Shandong Province); Taishan Scholars Programme of Shandong Province	This research was financially supported by the Natural Science Foundation of China (grant No. 41076045, and 41030858), the Shandong Province Natural Science Foundation (grant No. ZR2011DM003), and the Taishan Scholars Programme of Shandong Province. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLER RC, 1986, CONT SHELF RES, V6, P263, DOI 10.1016/0278-4343(86)90064-6; ALLER RC, 1985, CONT SHELF RES, V4, P227, DOI 10.1016/0278-4343(85)90031-7; Bao G.-D., 1989, SCI CHINA SER B, V19, P93; BURDIGE DJ, 1993, EARTH-SCI REV, V35, P249, DOI 10.1016/0012-8252(93)90040-E; CANFIELD DE, 1993, GEOCHIM COSMOCHIM AC, V57, P3867, DOI 10.1016/0016-7037(93)90340-3; CANFIELD DE, 1989, GEOCHIM COSMOCHIM AC, V53, P619, DOI 10.1016/0016-7037(89)90005-7; Canfield DE, 2005, ADV MAR BIOL, V48, P313; CANFIELD DE, 1987, GEOCHIM COSMOCHIM AC, V51, P645, DOI 10.1016/0016-7037(87)90076-7; CANFIELD DE, 1992, AM J SCI, V292, P659, DOI 10.2475/ajs.292.9.659; Couture RM, 2010, GEOCHIM COSMOCHIM AC, V74, P1238, DOI 10.1016/j.gca.2009.11.028; Davranche M, 2013, CHEM GEOL, V335, P24, DOI 10.1016/j.chemgeo.2012.10.040; de Koff JP, 2008, HYDROBIOLOGIA, V604, P111, DOI 10.1007/s10750-008-9322-3; DEMASTER DJ, 1985, CONT SHELF RES, V4, P143, DOI 10.1016/0278-4343(85)90026-3; Dong HL, 2009, AM MINERAL, V94, P1505, DOI 10.2138/am.2009.3246; Giordani G, 2008, HYDROBIOLOGIA, V611, P55, DOI 10.1007/s10750-008-9457-2; Gounou C, 2010, WATER AIR SOIL POLL, V212, P123, DOI 10.1007/s11270-010-0327-y; Haese R.R., 2006, MARINE GEOCHEMISTRY, P207; HUANG KM, 1995, GEOCHEM J, V29, P301, DOI 10.2343/geochemj.29.301; Hyacinthe C, 2006, GEOCHIM COSMOCHIM AC, V70, P4166, DOI 10.1016/j.gca.2006.05.018; Hyacinthe C, 2004, MAR CHEM, V91, P227, DOI 10.1016/j.marchem.2004.04.006; KOSTKA JE, 1994, GEOCHIM COSMOCHIM AC, V58, P1701, DOI 10.1016/0016-7037(94)90531-2; Larsen O, 2001, GEOCHIM COSMOCHIM AC, V65, P1367, DOI 10.1016/S0016-7037(00)00623-2; Larsen O, 2006, GEOCHIM COSMOCHIM AC, V70, P4827, DOI 10.1016/j.gca.2006.03.027; Lehtoranta J, 2009, AMBIO, V38, P303, DOI 10.1579/09-A-656.1; LESLIE BW, 1990, J GEOPHYS RES-SOLID, V95, P4453, DOI 10.1029/JB095iB04p04453; Lin S, 2000, CONT SHELF RES, V20, P619, DOI 10.1016/S0278-4343(99)00088-6; Lin S, 2002, DEEP-SEA RES PT I, V49, P1837, DOI 10.1016/S0967-0637(02)00092-4; Liu JP, 2007, GEOMORPHOLOGY, V85, P208, DOI 10.1016/j.geomorph.2006.03.023; Liu J, 2014, ENVIRON EARTH SCI, V71, P465, DOI 10.1007/s12665-013-2454-4; LORD CJ, 1982, J SEDIMENT PETROL, V52, P664, DOI 10.1306/212F7FF4-2B24-11D7-8648000102C1865D; LOVLEY DR, 1987, APPL ENVIRON MICROB, V53, P1536, DOI 10.1128/AEM.53.7.1536-1540.1987; Lu RY., 2011, GEOCHIMICA, V40, P363; MEHRA O. P., 1960, Proceedings 7th nat. Conf. Clays, V5, P317; Nickel M, 2008, DEEP-SEA RES PT II, V55, P2390, DOI 10.1016/j.dsr2.2008.05.003; Pedersen HD, 2006, GEOCHIM COSMOCHIM AC, V70, P4116, DOI 10.1016/j.gca.2006.06.1370; Pedersen HD, 2005, GEOCHIM COSMOCHIM AC, V69, P3967, DOI 10.1016/j.gca.2005.03.016; POSTMA D, 1993, GEOCHIM COSMOCHIM AC, V57, P5027, DOI 10.1016/S0016-7037(05)80015-8; Postma D, 2010, GEOCHIM COSMOCHIM AC, V74, P3367, DOI 10.1016/j.gca.2010.03.024; Poulton SW, 2005, CHEM GEOL, V214, P209, DOI 10.1016/j.chemgeo.2004.09.003; Poulton SW, 2004, GEOCHIM COSMOCHIM AC, V68, P3703, DOI 10.1016/j.gca.2004.03.012; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; RAISWELL R, 1994, CHEM GEOL, V111, P101, DOI 10.1016/0009-2541(94)90084-1; Raiswell R, 2010, CHEM GEOL, V278, P70, DOI 10.1016/j.chemgeo.2010.09.002; Raiswell R, 2012, GEOCHEM PERSPECT, V1, P1, DOI 10.7185/geochempersp.1.1; Roden EE, 2003, ENVIRON SCI TECHNOL, V37, P1319, DOI 10.1021/es026038o; Roden EE, 2004, GEOCHIM COSMOCHIM AC, V68, P3205, DOI 10.1016/j.gca.2004.03.028; Roden EE, 2002, LIMNOL OCEANOGR, V47, P198, DOI 10.4319/lo.2002.47.1.0198; Roden EE, 1996, ENVIRON SCI TECHNOL, V30, P1618, DOI 10.1021/es9506216; Roden EE, 2006, CR GEOSCI, V338, P456, DOI 10.1016/j.crte.2006.04.009; Rozan TF, 2002, LIMNOL OCEANOGR, V47, P1346, DOI 10.4319/lo.2002.47.5.1346; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Taylor KG, 2011, ELEMENTS, V7, P83, DOI 10.2113/gselements.7.2.83; Thamdrup B, 2000, ADV MICROB ECOL, V16, P41; van der Zee C, 2004, J SEA RES, V52, P73, DOI 10.1016/j.seares.2003.10.005; Wang XC, 2008, J OCEANOGR, V64, P311, DOI 10.1007/s10872-008-0025-1; Wang YF, 1996, GEOCHIM COSMOCHIM AC, V60, P2993, DOI 10.1016/0016-7037(96)00140-8; Weiss JV, 2004, FEMS MICROBIOL ECOL, V48, P89, DOI 10.1016/j.femsec.2003.12.014; Wijsman JWM, 2002, ESTUAR COAST SHELF S, V54, P403, DOI 10.1006/ecss.2000.0655; Xu KH, 2009, CONT SHELF RES, V29, P2240, DOI 10.1016/j.csr.2009.08.017; Zachara JM, 2004, GEOCHIM COSMOCHIM AC, V68, P1791, DOI 10.1016/j.gca.2003.09.022; ZHAO YY, 1995, GEO-MAR LETT, V15, P71, DOI 10.1007/BF01275409; Zhu MX, 2013, CONT SHELF RES, V54, P24, DOI 10.1016/j.csr.2013.01.002; Zhu MX, 2012, MAR ENVIRON RES, V80, P46, DOI 10.1016/j.marenvres.2012.06.010; Zhu MX, 2012, APPL GEOCHEM, V27, P892, DOI 10.1016/j.apgeochem.2012.01.004	64	4	5	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80367	10.1371/journal.pone.0080367	http://dx.doi.org/10.1371/journal.pone.0080367			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260377	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600061
J	Lyall, DM; Royle, NA; Harris, SE; Bastin, ME; Munoz Maniega, S; Murray, C; Lutz, MW; Saunders, AM; Roses, AD; Hernandez, MCD; Starr, JM; Porteous, DJ; Wardlaw, JM; Deary, IJ				Lyall, Donald M.; Royle, Natalie A.; Harris, Sarah E.; Bastin, Mark E.; Munoz Maniega, Susana; Murray, Catherine; Lutz, Michael W.; Saunders, Ann M.; Roses, Allen D.; Hernandez, Maria C. del Valdes; Starr, John M.; Porteous, David. J.; Wardlaw, Joanna M.; Deary, Ian J.			Alzheimer's Disease Susceptibility Genes APOE and TOMM40, and Hippocampal Volumes in the Lothian Birth Cohort 1936	PLOS ONE			English	Article							GRAY-MATTER VOLUME; APOLIPOPROTEIN-E; MITOCHONDRIAL IMPORT; BRAIN; AGE; ONSET; COGNITION; ALLELE; MRI; VARIANTS	The APOE e and TOMM40 rs10524523 ('523') variable length poly-T repeat gene loci have been significantly and independently associated with Alzheimer's disease (AD) related phenotypes such as age of clinical onset. Hippocampal atrophy has been significantly associated with memory impairment, a characteristic of AD. The current study aimed to test for independent effects of APOE e and TOMM40 '523'genotypes on hippocampal volumes as assessed by brain structural MRI in a relatively large sample of community-dwelling older adults. As part of a longitudinal study of cognitive ageing, participants in the Lothian Birth Cohort 1936 underwent genotyping for APOE epsilon 2/epsilon 3/epsilon 4 status and TOMM40 '523' poly-T repeat length, and detailed structural brain MRI at a mean age of 72.7 years (standard deviation = 0.7, N range = 624 to 636). No significant effects of APOE e or TOMM40 523 genotype were found on hippocampal volumes when analysed raw, or when adjusted for either intracranial or total brain tissue volumes. In summary, in a large community-dwelling sample of older adults, we found no effects of APOE epsilon or TOMM40 523 genotypes on hippocampal volumes. This is discrepant with some previous reports of significant association between APOE and left/right hippocampal volumes, and instead echoes other reports that found no association. Previous significant findings may partly reflect type 1 error. Future studies should carefully consider: 1) their specific techniques in adjusting for brain size; 2) assessing more detailed sub-divisions of the hippocampal formation; and 3) testing whether significant APOE-hippocampal associations are independent of generalised brain atrophy.	[Lyall, Donald M.; Royle, Natalie A.; Harris, Sarah E.; Bastin, Mark E.; Munoz Maniega, Susana; Murray, Catherine; Hernandez, Maria C. del Valdes; Starr, John M.; Porteous, David. J.; Wardlaw, Joanna M.; Deary, Ian J.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Lyall, Donald M.; Royle, Natalie A.; Bastin, Mark E.; Munoz Maniega, Susana; Hernandez, Maria C. del Valdes; Wardlaw, Joanna M.] Univ Edinburgh, Div Neuroimaging Sci, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Lyall, Donald M.; Murray, Catherine; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Lyall, Donald M.; Harris, Sarah E.; Porteous, David. J.] Univ Edinburgh, Med Genet Sect, Ctr Genom & Expt Med, Edinburgh, Midlothian, Scotland; [Lyall, Donald M.; Harris, Sarah E.; Porteous, David. J.] Univ Edinburgh, MRC Inst Genet & Mol Med, Edinburgh, Midlothian, Scotland; [Royle, Natalie A.; Bastin, Mark E.; Munoz Maniega, Susana; Hernandez, Maria C. del Valdes; Wardlaw, Joanna M.] Univ Edinburgh, Scottish Imaging Network, Div Neuroimaging Sci, Edinburgh, Midlothian, Scotland; [Lutz, Michael W.; Saunders, Ann M.; Roses, Allen D.] Duke Univ, Med Ctr, Dept Neurol, Joseph & Kathleen Bryan Alzheimers Dis Res Ctr, Durham, NC USA; [Roses, Allen D.] Zinfandel Pharmaceut Inc, Durham, NC USA; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Edinburgh; Duke University; University of Edinburgh	Deary, IJ (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	Ian_Deary@ed.ac.uk	Deary, Ian J/C-6297-2009; Porteous, David/AAA-3446-2021; Maniega, Susana Muñoz/I-8730-2014; Wardlaw, Joanna M/Y-3456-2019; Hernandez, María/GYU-3543-2022	Deary, Ian J/0000-0002-1733-263X; Porteous, David/0000-0003-1249-6106; Maniega, Susana Muñoz/0000-0001-5185-6384; Wardlaw, Joanna M/0000-0002-9812-6642; Lutz, Michael/0000-0001-8809-5574; , Donald/0000-0002-4565-9656; Bastin, Mark/0000-0002-0490-0845	Age United Kingdom; Lifelong Health and Wellbeing Initiative [G0700704/84698]; Biotechnology and Biological Sciences Research Council; Engineering and Physical Sciences Research Council; Economic and Social Research Council; Medical Research Council; Scottish Funding Council as part of the SINAPSE Collaboration; MRC [G0100266, G1001245, G0700704] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G0100266, G1001245, G0700704] Funding Source: researchfish	Age United Kingdom; Lifelong Health and Wellbeing Initiative; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council as part of the SINAPSE Collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	LBC1936 data collection was supported by the Disconnected Mind project (http://disconnectedmind.ed.ac.uk) funded by Age United Kingdom. JMW is part-funded by the Scottish Funding Council as part of the SINAPSE Collaboration (http://www.sinapse.ac.uk).The work was undertaken within the University of Edinburgh Centre for Cognitive Ageing and Cognitive Epidemiology (http://www.ccace.ed.ac.uk), part of the cross council Lifelong Health and Wellbeing Initiative (G0700704/84698).Funding from the Biotechnology and Biological Sciences Research Council, Engineering and Physical Sciences Research Council, Economic and Social Research Council and Medical Research Council is gratefully acknowledged.The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral D., 2006, HIPPOCAMPUS BOOK, VVolume 1, P37, DOI DOI 10.1093/ACPROF:OSO/9780195100273.001.0001; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Bekris LM, 2012, J HUM GENET, V57, P18, DOI 10.1038/jhg.2011.123; BRAAK H, 1995, NEUROBIOL AGING, V16, P271, DOI 10.1016/0197-4580(95)00021-6; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; Bruno D, 2012, PSYCHONEUROENDOCRINO, V37, P366, DOI 10.1016/j.psyneuen.2011.07.006; Bu GJ, 2009, NAT REV NEUROSCI, V10, P333, DOI 10.1038/nrn2620; Caselli RJ, 2012, ALZHEIMERS DEMENT, V8, P490, DOI 10.1016/j.jalz.2011.11.006; Cherbuin N, 2008, J GERONTOL A-BIOL, V63, P501, DOI 10.1093/gerona/63.5.501; Chiang GC, 2010, NEUROLOGY, V75, P1976, DOI 10.1212/WNL.0b013e3181ffe4d1; CORDER EH, 1994, NAT GENET, V7, P180, DOI 10.1038/ng0694-180; *COUNC SCOTT RES E, 1949, TREND SCOTT INT COMP; Cruchaga C, 2011, ARCH NEUROL-CHICAGO, V68, P1013, DOI 10.1001/archneurol.2011.155; de la Torre JC, 2010, AGEING RES REV, V9, P218, DOI 10.1016/j.arr.2010.04.002; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary IJ, 2004, PSYCHOL AGING, V19, P367, DOI 10.1037/0882-7974.19.2.367; Deary IJ, 2007, BMC GERIATR, V7, P1, DOI DOI 10.1186/1471-2318-7-1.PUBMED:17222340; den Heijer T, 2002, NEUROLOGY, V59, P746, DOI 10.1212/WNL.59.5.746; deToledo-Morrell L, 2004, NEUROBIOL AGING, V25, P1197, DOI 10.1016/j.neurobiolaging.2003.12.007; Devanand DP, 2012, NEUROIMAGE, V60, P1622, DOI 10.1016/j.neuroimage.2012.01.075; Devi L, 2006, J NEUROSCI, V26, P9057, DOI 10.1523/JNEUROSCI.1469-06.2006; DUVERNOY HM, 2006, HUMAN HIPPOCAMPUS AT, P39; Eisenberg DTA, 2010, AM J PHYS ANTHROPOL, V143, P100, DOI 10.1002/ajpa.21298; Erkinjuntti Timo, 2007, Cerebrovasc Dis, V24 Suppl 1, P189, DOI 10.1159/000107395; Ferencz B, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00198; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; FREE SL, 1995, AM J NEURORADIOL, V16, P637; Garcia-Berthou E, 2001, J ANIM ECOL, V70, P708, DOI 10.1046/j.1365-2656.2001.00524.x; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; Hedskog L, 2012, J ALZHEIMERS DIS, V31, P527, DOI 10.3233/JAD-2012-120580; HOSTAGE C, 2013, PLOS ONE, V8, DOI DOI 10.1371/J0URNAL.P0NE.0054483; Humphries AD, 2005, J BIOL CHEM, V280, P11535, DOI 10.1074/jbc.M413816200; Jak AJ, 2007, DEMENT GERIATR COGN, V23, P382, DOI 10.1159/000101340; Johnson SC, 2011, ALZHEIMERS DEMENT, V7, P456, DOI 10.1016/j.jalz.2010.11.012; Koehler CM, 1999, TRENDS BIOCHEM SCI, V24, P428, DOI 10.1016/S0968-0004(99)01462-0; Lemaitre H, 2005, NEUROIMAGE, V24, P1205, DOI 10.1016/j.neuroimage.2004.10.016; Lind J, 2006, NEUROSCI LETT, V396, P23, DOI 10.1016/j.neulet.2005.11.070; Linnertz C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030994; Luciano M, 2009, BEHAV GENET, V39, P6, DOI 10.1007/s10519-008-9236-x; Lutz MW, 2010, ALZHEIMERS DEMENT, V6, P125, DOI 10.1016/j.jalz.2010.01.011; MacLullich AMJ, 2002, NEUROLOGY, V59, P169, DOI 10.1212/WNL.59.2.169; Martins IJ, 2006, MOL PSYCHIATR, V11, P721, DOI 10.1038/sj.mp.4001854; NCBI, 2012, TOMM40 INF; *NCBI APOE, 2012, INFORMATION; OHM TG, 1995, NEUROSCIENCE, V66, P583, DOI 10.1016/0306-4522(94)00596-W; Panizzon MS, 2010, NEUROLOGY, V75, P874, DOI 10.1212/WNL.0b013e3181f11deb; Plassman BL, 1997, NEUROLOGY, V48, P985, DOI 10.1212/WNL.48.4.985; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Price JL, 1999, ANN NEUROL, V45, P358, DOI 10.1002/1531-8249(199903)45:3<358::AID-ANA12>3.0.CO;2-X; Raji CA, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.08.010; Richter-Schmidinger T, 2011, J NEURAL TRANSM, V118, P249, DOI 10.1007/s00702-010-0539-8; Ringman JM, 2009, GENETICS OF COGNITIVE NEUROSCIENCE, P221; Roses AD, 2010, PHARMACOGENOMICS J, V10, P375, DOI 10.1038/tpj.2009.69; Rushton JP, 1996, PSYCHON B REV, V3, P21, DOI 10.3758/BF03210739; Schiepers OJG, 2012, MOL PSYCHIATR, V17, P315, DOI 10.1038/mp.2010.137; Shenkin Susan D, 2009, BMC Geriatr, V9, P12, DOI 10.1186/1471-2318-9-12; Simic G, 1997, J COMP NEUROL, V379, P482, DOI 10.1002/(SICI)1096-9861(19970324)379:4<482::AID-CNE2>3.0.CO;2-Z; Stein JL, 2012, NAT GENET, V44, P552, DOI 10.1038/ng.2250; Swerdlow RH, 2004, MED HYPOTHESES, V63, P8, DOI 10.1016/j.mehy.2003.12.045; Takei N, 2009, GENOMICS, V93, P441, DOI 10.1016/j.ygeno.2009.01.003; Tupler LA, 2007, NEUROBIOL AGING, V28, P1644, DOI 10.1016/j.neurobiolaging.2006.07.001; Van Petten C, 2004, NEUROPSYCHOLOGIA, V42, P1394, DOI 10.1016/j.neuropsychologia.2004.04.006; Wardlaw JM, 2011, INT J STROKE, V6, P547, DOI 10.1111/j.1747-4949.2011.00683.x; Wisdom NM, 2011, NEUROBIOL AGING, V32, P63, DOI 10.1016/j.neurobiolaging.2009.02.003	64	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80513	10.1371/journal.pone.0080513	http://dx.doi.org/10.1371/journal.pone.0080513			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260406	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600067
J	Valenzuela, IMPY; Pires-Oliveira, M; Akaaboune, M				Martinez-Pena y Valenzuela, Isabel; Pires-Oliveira, Marcelo; Akaaboune, Mohammed			PKC and PKA Regulate AChR Dynamics at the Neuromuscular Junction of Living Mice	PLOS ONE			English	Article							PROTEIN-KINASE-C; NICOTINIC ACETYLCHOLINE-RECEPTOR; IN-VIVO; SKELETAL-MUSCLE; POSTSYNAPTIC MATURATION; SYNAPTIC PLASTICITY; ALPHA-DYSTROBREVIN; PHORBOL ESTER; PHOSPHORYLATION; CELLS	The steady state of the acetylcholine receptor (AChR) density at the neuromuscular junction (NMJ) is critical for efficient and reliable synaptic transmission. However, little is known about signaling molecules involved in regulating the equilibrium between the removal and insertion of AChRs that establishes a stable postsynaptic receptor density over time. In this work, we tested the effect of activities of two serine/threonine kinases, PKC and PKA, on the removal rate of AChRs from and the re-insertion rate of internalized recycled AChRs into synaptic sites of innervated and denervated NMJs of living mice. Using an in vivo time-lapse imaging approach and various pharmacological agents, we showed that PKC and PKA activities have antagonistic effects on the removal and recycling of AChRs. Inhibition of PKC activity or activation of PKA largely prevents the removal of pre-existing AChRs and promotes the recycling of internalized AChRs into the postsynaptic membrane. In contrast, stimulation of PKC or inactivation of PKA significantly accelerates the removal of postsynaptic AChRs and depresses AChR recycling. These results indicate that a balance between PKA and PKC activities may be critical for the maintenance of the postsynaptic receptor density.	[Martinez-Pena y Valenzuela, Isabel; Pires-Oliveira, Marcelo; Akaaboune, Mohammed] Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA; [Akaaboune, Mohammed] Univ Michigan, Program Neurosci, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Akaaboune, M (corresponding author), Univ Michigan, Dept Mol Cellular & Dev Biol, Ann Arbor, MI 48109 USA.	makaabou@umich.edu	Martinez-Pena y Valenzuela, Isabel/AAI-9845-2020	, Isabel/0000-0002-2196-9297	National Institutes of Health [NS-047332]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047332] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health Grant NS-047332. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akaaboune M, 2002, NEURON, V34, P865, DOI 10.1016/S0896-6273(02)00739-0; Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503; BALICEGORDON RJ, 1993, J NEUROSCI, V13, P834; Blazev R, 2001, J MUSCLE RES CELL M, V22, P277, DOI 10.1023/A:1012289526618; Bruneau E, 2005, J NEUROSCI, V25, P9949, DOI 10.1523/JNEUROSCI.3169-05.2005; Bruneau EG, 2006, DEVELOPMENT, V133, P4485, DOI 10.1242/dev.02619; Bruneau EG, 2010, J NEUROSCI, V30, P614, DOI 10.1523/JNEUROSCI.4595-09.2010; Bruneau EG, 2009, FASEB J, V23, P679, DOI 10.1096/fj.08-107946; BRUNS RF, 1991, BIOCHEM BIOPH RES CO, V176, P288, DOI 10.1016/0006-291X(91)90922-T; BURSZTAJN S, 1988, BIOL CELL, V63, P57, DOI 10.1016/0248-4900(88)90108-6; CHANGEUX JP, 1984, SCIENCE, V225, P1335, DOI 10.1126/science.6382611; Choi KR, 2012, J CELL SCI, V125, P714, DOI 10.1242/jcs.092361; Dong ZH, 2013, AM J PHYSIOL-ENDOC M, V304, pE222, DOI 10.1152/ajpendo.00473.2012; Ehlers MD, 2000, NEURON, V28, P511, DOI 10.1016/S0896-6273(00)00129-X; Grady RM, 2003, J CELL BIOL, V160, P741, DOI 10.1083/jcb.200209045; HUGANIR RL, 1984, P NATL ACAD SCI-BIOL, V81, P6968, DOI 10.1073/pnas.81.22.6968; IIDA T, 1989, J ANTIBIOT, V42, P1475, DOI 10.7164/antibiotics.42.1475; JOHANNES FJ, 1994, J BIOL CHEM, V269, P6140; KOBAYASHI E, 1989, J ANTIBIOT, V42, P1470, DOI 10.7164/antibiotics.42.1470; Lanuza MA, 2000, J NEUROSCI RES, V61, P616, DOI 10.1002/1097-4547(20000915)61:6<616::AID-JNR5>3.0.CO;2-N; Lanuza MA, 2006, J NEUROSCI RES, V83, P1407, DOI 10.1002/jnr.20848; Lanuza MA, 2002, J NEUROSCI RES, V67, P607, DOI 10.1002/jnr.10122; Lanuza MA, 2010, EXP NEUROL, V225, P183, DOI 10.1016/j.expneurol.2010.06.014; Lee TH, 2000, MOL BIOL CELL, V11, P2577, DOI 10.1091/mbc.11.8.2577; Li MX, 2001, NAT NEUROSCI, V4, P871, DOI 10.1038/nn0901-871; LICHTMAN JW, 1987, J NEUROSCI, V7, P1215; Valenzuela IMPY, 2011, J NEUROSCI, V31, P15586, DOI 10.1523/JNEUROSCI.4038-11.2011; Valenzuela IMPY, 2010, J NEUROSCI, V30, P12455, DOI 10.1523/JNEUROSCI.3309-10.2010; Miles K, 2003, J NEUROSCI RES, V71, P188, DOI 10.1002/jnr.10467; MILES K, 1988, MOL NEUROBIOL, V2, P91, DOI 10.1007/BF02935341; NAKANO S, 1992, MUSCLE NERVE, V15, P496, DOI 10.1002/mus.880150414; Nelson PG, 2003, J NEUROCYTOL, V32, P803, DOI 10.1023/B:NEUR.0000020625.70284.a6; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; Nimnual AS, 1998, BIOCHEMISTRY-US, V37, P14823, DOI 10.1021/bi9802824; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; OHNO S, 1991, ADV ENZYME REGUL, V31, P287, DOI 10.1016/0065-2571(91)90018-H; Pacheco MA, 2003, MOL BRAIN RES, V114, P65, DOI 10.1016/S0169-328X(03)00138-4; Perkins GA, 2001, BMC NEUROSCI, V2, DOI 10.1186/1471-2202-2-17; Pires-Oliveira M, 2013, CURR ALZHEIMER RES, V10, P631; Roder IV, 2010, P NATL ACAD SCI USA, V107, P2031, DOI 10.1073/pnas.0914087107; ROSS A, 1988, J CELL BIOL, V107, P1139, DOI 10.1083/jcb.107.3.1139; Schmidt N, 2011, J CELL BIOL, V195, P1171, DOI 10.1083/jcb.201107083; SHYNG SL, 1991, NEURON, V6, P469, DOI 10.1016/0896-6273(91)90254-W; Turney SG, 1996, J NEUROSCI METH, V64, P199, DOI 10.1016/0165-0270(95)00135-2; WALLACE BG, 1988, J CELL BIOL, V107, P267, DOI 10.1083/jcb.107.1.267	45	18	18	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81311	10.1371/journal.pone.0081311	http://dx.doi.org/10.1371/journal.pone.0081311			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260568	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600114
J	Rosenheim, JA; Meisner, MH				Rosenheim, Jay A.; Meisner, Matthew H.			Ecoinformatics Can Reveal Yield Gaps Associated with Crop-Pest Interactions: A Proof-of-Concept	PLOS ONE			English	Article							HESPERUS HETEROPTERA-MIRIDAE; LYGUS-HESPERUS; HEMIPTERA-MIRIDAE; PLANT BUG; ECONOMIC THRESHOLD; GRAZING TOLERANCE; COTTON PRODUCTION; FOOD SECURITY; UNITED-STATES; CALIFORNIA	Farmers and private consultants execute a vast, decentralized data collection effort with each cropping cycle, as they gather pest density data to make real-time pest management decisions. Here we present a proof of concept for an ecoinformatics approach to pest management research, which attempts to harness these data to answer questions about pest-crop interactions. The impact of herbivory by Lygus hesperus on cotton is explored as a case study. Consultant-derived data satisfied a 'positive control' test for data quality by clearly resolving the expected negative relationship between L. hesperus density and retention of flower buds. The enhanced statistical power afforded by the large ecoinformatics dataset revealed an early-season window of crop sensitivity, during which L. hesperus densities as low as 1-2 per sample were associated with yield loss. In contrast, during the mid-season insecticide use by farmers was often unnecessary, as cotton compensated fully for moderate L. hesperus densities. Because the dataset emerged from the commercial production setting, it also revealed the limited degree to which farmers were willing to delay crop harvest to provide opportunities for compensatory fruiting. Observational approaches to pest management research have strengths and weaknesses that complement those of traditional, experimental approaches; combining these methods can contribute to enhanced agricultural productivity.	[Rosenheim, Jay A.; Meisner, Matthew H.] Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA	University of California System; University of California Davis	Rosenheim, JA (corresponding author), Univ Calif Davis, Dept Entomol & Nematol, Davis, CA 95616 USA.	jarosenheim@ucdavis.edu			California State Support Committee of Cotton Incorporated; University of California Statewide IPM Program; USDA-NRICGP [2006-01761]; California Department of Pesticide Regulation	California State Support Committee of Cotton Incorporated; University of California Statewide IPM Program; USDA-NRICGP(United States Department of Agriculture (USDA)); California Department of Pesticide Regulation	This project was supported in part by grants from the California State Support Committee of Cotton Incorporated; the University of California Statewide IPM Program; USDA-NRICGP grant 2006-01761; and a contract from the California Department of Pesticide Regulation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Birch ANE, 2011, J EXP BOT, V62, P3251, DOI 10.1093/jxb/err064; Carriere Y, 2006, ENTOMOL EXP APPL, V118, P203, DOI 10.1111/j.1570-7458.2006.00384.x; Carriere Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039862; Cock J, 2011, AGR SYST, V104, P755, DOI 10.1016/j.agsy.2011.07.001; Cooper WR, 2012, ENVIRON ENTOMOL, V41, P342, DOI 10.1603/EN11236; de Valpine P, 2010, ECOL APPL, V20, P1926, DOI 10.1890/09-0468.1; DYER MI, 1993, ECOL APPL, V3, P10, DOI 10.2307/1941781; Ellsworth PC, 2001, PUBL U ARIZONA, VAZ1224; Ellsworth PC, 2000, PUBL U ARIZONA, VAZ1170; FALCON LA, 1971, J ECON ENTOMOL, V64, P56, DOI 10.1093/jee/64.1.56; FALCON LA, 1968, J ECON ENTOMOL, V61, P633, DOI 10.1093/jee/61.3.633; Forbes AA, 2011, ENTOMOL EXP APPL, V139, P242, DOI 10.1111/j.1570-7458.2011.01125.x; Gao Y, 2008, ENVIRON EXP BOT, V63, P113, DOI 10.1016/j.envexpbot.2007.10.030; Godfray HCJ, 2010, SCIENCE, V327, P812, DOI 10.1126/science.1185383; Goodell P.B., 1998, Proceedings Beltwide Cotton Conferences, V2, P949; Gross K, 2011, ECOL APPL, V21, P2770, DOI 10.1890/11-0118.1; GUTIERREZ AP, 1979, CAN ENTOMOL, V111, P41, DOI 10.4039/Ent11141-1; GUTIERREZ AP, 1977, CAN ENTOMOL, V109, P1375, DOI 10.4039/Ent1091375-10; GUTIERREZ AP, 1975, ENVIRON ENTOMOL, V4, P125, DOI 10.1093/ee/4.1.125; Huhta AP, 2003, PLANT ECOL, V166, P49, DOI 10.1023/A:1023278502972; Jimenez D, 2011, AGR SYST, V104, P258, DOI 10.1016/j.agsy.2010.10.004; Kerby TA, 1996, COTTON PRODUCTION MA, P294; LEIGH TF, 1988, J ECON ENTOMOL, V81, P1328, DOI 10.1093/jee/81.5.1328; Lu YH, 2010, SCIENCE, V328, P1151, DOI 10.1126/science.1187881; MANGEL M, 1985, J ECON ENTOMOL, V78, P1009, DOI 10.1093/jee/78.5.1009; Musser FR, 2009, J ECON ENTOMOL, V102, P2109, DOI 10.1603/029.102.0614; Musser FR, 2009, J ECON ENTOMOL, V102, P1827, DOI 10.1603/029.102.0513; Oerke EC, 2006, J AGR SCI, V144, P31, DOI 10.1017/S0021859605005708; Parsa S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036533; Ragsdale DW, 2007, J ECON ENTOMOL, V100, P1258, DOI 10.1603/0022-0493(2007)100[1258:ETFSAH]2.0.CO;2; Rochester WA, 2002, COMPUT ELECTRON AGR, V35, P139, DOI 10.1016/S0168-1699(02)00015-7; Rosenheim JA, 2006, ENVIRON ENTOMOL, V35, P1141, DOI 10.1603/0046-225X(2006)35[1141:ETIOLH]2.0.CO;2; Rosenheim JA, 2013, J ECON ENTOMOL, V106, P1286, DOI 10.1603/EC12511; Rosenheim JA, 2011, J ECON ENTOMOL, V104, P331, DOI 10.1603/EC10380; SADRAS VO, 1995, FIELD CROP RES, V40, P1, DOI 10.1016/0378-4290(94)00088-T; SEVACHERIAN V, 1972, Environmental Entomology, V1, P704, DOI 10.1093/ee/1.6.704; Steinmann KP, 2011, J ECON ENTOMOL, V104, P1496, DOI 10.1603/EC11168; STERN VERNON M., 1959, HILGARDIA, V29, P81; STEWART SD, 1989, J ECON ENTOMOL, V82, P954, DOI 10.1093/jee/82.3.954; Wilson LJ, 2003, CROP SCI, V43, P2125, DOI 10.2135/cropsci2003.2125; Wood S, 2017, GEN ADDITIVE MODELS, DOI 10.1201/9781315370279; Zeilinger AR, 2011, ENTOMOL EXP APPL, V141, P59, DOI 10.1111/j.1570-7458.2011.01165.x; [No title captured]	43	16	16	1	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80518	10.1371/journal.pone.0080518	http://dx.doi.org/10.1371/journal.pone.0080518			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260408	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600068
J	Stegbauer, J; Friedrich, S; Potthoff, SA; Broekmans, K; Cortese-Krott, MM; Quack, I; Rump, LC; Koesling, D; Mergia, E				Stegbauer, Johannes; Friedrich, Sebastian; Potthoff, Sebastian A.; Broekmans, Kathrin; Cortese-Krott, Miriam M.; Quack, Ivo; Rump, Lars Christian; Koesling, Doris; Mergia, Evanthia			Phosphodiesterase 5 Attenuates the Vasodilatory Response in Renovascular Hypertension	PLOS ONE			English	Article							NITRIC-OXIDE; ONE-CLIP; GUANYLYL CYCLASE; MICE LACKING; IN-VIVO; 2-KIDNEY; CGMP; EXPRESSION; PDE5	NO/cGMP signaling plays an important role in vascular relaxation and regulation of blood pressure. The key enzyme in the cascade, the NO-stimulated cGMP-forming guanylyl cyclase exists in two enzymatically indistinguishable isoforms (NO-GC1, NO-GC2) with NO-GC1 being the major NO-GC in the vasculature. Here, we studied the NO/cGMP pathway in renal resistance arteries of NO-GC1 KO mice and its role in renovascular hypertension induced by the 2-kidney-1-clip-operation (2K1C). In the NO-GC1 KOs, relaxation of renal vasculature as determined in isolated perfused kidneys was reduced in accordance with the marked reduction of cGMP-forming activity (80%). Noteworthy, increased eNOS-catalyzed NO formation was detected in kidneys of NO-GC1 KOs. Upon the 2K1C operation, NO-GC1 KO mice developed hypertension but the increase in blood pressures was not any higher than in WT. Conversely, operated WT mice showed a reduction of cGMP-dependent relaxation of renal vessels, which was not found in the NO-GC1 KOs. The reduced relaxation in operated WT mice was restored by sildenafil indicating that enhanced PDE5-catalyzed cGMP degradation most likely accounts for the attenuated vascular responsiveness. PDE5 activation depends on allosteric binding of cGMP. Because cGMP levels are lower, the 2K1C-induced vascular changes do not occur in the NO-GC1 KOs. In support of a higher PDE5 activity, sildenafil reduced blood pressure more efficiently in operated WT than NO-GC1 KO mice. All together our data suggest that within renovascular hypertension, cGMP-based PDE5 activation terminates NO/cGMP signaling thereby providing a new molecular basis for further pharmacological interventions.	[Stegbauer, Johannes; Friedrich, Sebastian; Potthoff, Sebastian A.; Quack, Ivo; Rump, Lars Christian] Univ Dusseldorf, Univ Klinikum, Klin Nephrol, Dusseldorf, Germany; [Cortese-Krott, Miriam M.] Univ Dusseldorf, Univ Klinikum, Kardiol Klin, Dusseldorf, Germany; [Broekmans, Kathrin; Koesling, Doris; Mergia, Evanthia] Ruhr Univ Bochum, Inst Pharmakol, Bochum, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Ruhr University Bochum	Mergia, E (corresponding author), Ruhr Univ Bochum, Inst Pharmakol, Univ Str 150, Bochum, Germany.	mergia@evanthia.de	Stegbauer, Johannes/L-7461-2013; Cortese-Krott, Miriam/I-7513-2012	Cortese-Krott, Miriam/0000-0002-0593-1192	FoRUM grant of the Ruhr-University, Bochum; German Society of Hypertension; Heinrich-Heine-University Duesseldorf	FoRUM grant of the Ruhr-University, Bochum; German Society of Hypertension; Heinrich-Heine-University Duesseldorf	This work was supported by a FoRUM grant of the Ruhr-University, Bochum. Johannes Stegbauer was supported by a Grant of the German Society of Hypertension and the Heinrich-Heine-University Duesseldorf. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arruda RMP, 2005, HYPERTENSION, V46, P932, DOI 10.1161/01.HYP.0000182154.61862.52; Buys ES, 2012, J CLIN INVEST, V122, P2316, DOI 10.1172/JCI60119; CHAUDHARI A, 1988, AM J PHYSIOL, V254, pF291, DOI 10.1152/ajprenal.1988.254.2.F291; Cortese-Krott MM, 2012, FREE RADICAL BIO MED, V53, P2146, DOI 10.1016/j.freeradbiomed.2012.09.008; Feil R, 2003, CIRC RES, V93, P907, DOI 10.1161/01.RES.0000100390.68771.CC; Friebe A, 2003, CIRC RES, V93, P96, DOI 10.1161/01.RES.0000082524.34487.31; Friebe A, 2007, P NATL ACAD SCI USA, V104, P7699, DOI 10.1073/pnas.0609778104; Giachini FR, 2011, HYPERTENSION, V57, P655, DOI 10.1161/HYPERTENSIONAHA.110.164327; Heitzer T, 1999, KIDNEY INT, V55, P252, DOI 10.1046/j.1523-1755.1999.00229.x; Hiyoshi H, 2005, HYPERTENSION, V45, P967, DOI 10.1161/01.HYP.0000164571.77710.19; HUANG PL, 1995, NATURE, V377, P239, DOI 10.1038/377239a0; Ignarro LJ, 2002, J PHYSIOL PHARMACOL, V53, P503; Jung O, 2004, CIRCULATION, V109, P1795, DOI 10.1161/01.CIR.0000124223.00113.A4; Jung O, 2003, CIRC RES, V93, P622, DOI 10.1161/01.RES.0000092140.81594.A8; Kim D, 2005, J MOL CELL CARDIOL, V38, P175, DOI 10.1016/j.yjmcc.2004.10.013; Kim D, 2001, CIRCULATION, V104, P2338, DOI 10.1161/hc4401.098432; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Mergia E, 2006, J CLIN INVEST, V116, P1731, DOI 10.1172/JCI27657; MONCADA S, 1995, FASEB J, V9, P1319, DOI 10.1096/fasebj.9.13.7557022; Mullershausen F, 2004, MOL BIOL CELL, V15, P4023, DOI 10.1091/mbc.E03-12-0890; Mullershausen F, 2003, J CELL BIOL, V160, P719, DOI 10.1083/jcb.200211041; Russwurm M, 2002, MOL CELL BIOCHEM, V230, P159, DOI 10.1023/A:1014252309493; Rybalkin SD, 2003, CIRC RES, V93, P280, DOI 10.1161/01.RES.0000087541.15600.2B; Rybalkin SD, 2003, EMBO J, V22, P469, DOI 10.1093/emboj/cdg051; Sigmon DH, 1998, HYPERTENSION, V31, P649, DOI 10.1161/01.HYP.31.2.649; Stegbauer J, 2005, J HYPERTENS, V23, P1691, DOI 10.1097/01.hjh.0000179763.02583.8e; Takimoto E, 2005, NAT MED, V11, P214, DOI 10.1038/nm1175; Turkstra E, 2000, J AM SOC NEPHROL, V11, P847, DOI 10.1681/ASN.V115847; WALDMAN SA, 1987, PHARMACOL REV, V39, P163; Wiesel P, 1997, HYPERTENSION, V29, P1025, DOI 10.1161/01.HYP.29.4.1025	30	20	20	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80674	10.1371/journal.pone.0080674	http://dx.doi.org/10.1371/journal.pone.0080674			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260450	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600077
J	Tan, XH; Carretero, J; Chen, Z; Zhang, JS; Wang, YX; Chen, JC; Li, XB; Ye, H; Tang, CH; Cheng, X; Hou, N; Yang, X; Wong, KK				Tan, Xiaohong; Carretero, Julian; Chen, Zhao; Zhang, Jishuai; Wang, Yanxiao; Chen, Jicheng; Li, Xiubin; Ye, Hui; Tang, Chuanhao; Cheng, Xuan; Hou, Ning; Yang, Xiao; Wong, Kwok-Kin			Loss of p53 Attenuates the Contribution of IL-6 Deletion on Suppressed Tumor Progression and Extended Survival in Kras-Driven Murine Lung Cancer	PLOS ONE			English	Article							SERUM-LEVELS; INTERLEUKIN-6 LEVEL; MOUSE MODEL; KAPPA-B; INFLAMMATION; ACTIVATION; RECEPTOR; CYTOKINES; STAT3; PROLIFERATION	Interleukin-6 (IL-6) is involved in lung cancer tumorigenesis, tumor progression, metastasis, and drug resistance. Previous studies show that blockade of IL-6 signaling can inhibit tumor growth and increase drug sensitivity in mouse models. Clinical trials in non-small cell lung cancer (NSCLC) reveal that IL-6 targeted therapy relieves NSCLC-related anemia and cachexia, although other clinical effects require further study. We crossed IL-6(-/-) mice with Kras(G12D) mutant mice, which develop lung tumors after activation of mutant Kras(G12D), to investigate whether IL-6 inhibition contributes to tumor progression and survival time in vivo. Kras(G12D); IL-6(-/-) mice exhibited increased tumorigenesis, but slower tumor growth and longer survival, than Kras(G12D) mice. Further, in order to investigate whether IL-6 deletion contributes to suppression of lung cancer metastasis, we generated Kras(G12D); p53(flox/flox); IL-6(-/-) mice, which developed lung cancer with a trend for reduced metastases and longer survival than Kras(G12D); p53(flox/flox) mice. Tumors from Kras(G12D); IL-6(-/-) mice showed increased expression of TNF alpha and decreased expression of CCL-19, CCL-20 and phosphorylated STAT3 (pSTAT3) than Kras(G12D) mice; however, these changes were not present between tumors from Kras(G12D); p53(flox/flox); IL-6(-/-) and Kras(G12D); p53(flox/flox) mice. Upregulation of pSTAT3 and phosphorylated AKT (pAKT) were observed in Kras(G12D) tumors with p53 deletion. Taken together, these results indicate that IL-6 deletion accelerates tumorigenesis but delays tumor progression and prolongs survival time in a Kras-driven mouse model of lung cancer. However, these effects can be attenuated by p53 deletion.	[Tan, Xiaohong; Zhang, Jishuai; Wang, Yanxiao; Chen, Jicheng; Li, Xiubin; Ye, Hui; Cheng, Xuan; Hou, Ning; Yang, Xiao] Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing, Peoples R China; [Tan, Xiaohong; Carretero, Julian; Chen, Zhao; Wong, Kwok-Kin] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Tan, Xiaohong; Carretero, Julian; Chen, Zhao; Wong, Kwok-Kin] Harvard Univ, Sch Med, Dept Med, Boston, MA USA; [Yang, Xiao] Shanghai Jiao Tong Univ, E Inst Shanghai Univ, Model Organism Div, Shanghai 200030, Peoples R China; [Tang, Chuanhao] Acad Mil Med Sci, Affiliated Hosp, Dept Lung Canc, Beijing, Peoples R China; [Wong, Kwok-Kin] Harvard Univ, Brigham & Womens Hosp, Dept Med, Sch Med, Boston, MA 02115 USA; [Wong, Kwok-Kin] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA USA; [Wong, Kwok-Kin] Dana Farber Canc Inst, Belfer Inst Appl Canc Sci, Boston, MA USA; [Carretero, Julian] Univ Valencia, Fac Med & Odontol, Dept Physiol, Valencia, Spain	Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Shanghai Jiao Tong University; Academy of Military Medical Sciences - China; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; University of Valencia	Yang, X (corresponding author), Inst Biotechnol, Genet Lab Dev & Dis, State Key Lab Prote, Beijing, Peoples R China.	yangx@nic.bmi.ac.cn; kwong1@partners.org	Carretero, Julian/N-5214-2014	Carretero, Julian/0000-0001-7269-8506; wong, kwok kin/0000-0001-6323-235X	NIH [CA122794, CA140594, CA163896, CA166480, CA154303, SPORE P50CA090578]; United against Lung Cancer; American Lung Association; Susan Spooner Research Fund; Chinese National Key Program on Basic Research [2012CB945100, 2011CB504202]; National Natural Science Foundation of China [31030040]; NATIONAL CANCER INSTITUTE [P01CA154303, R01CA163896, R01CA140594, P50CA090578, R01CA166480, R01CA122794] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); United against Lung Cancer; American Lung Association; Susan Spooner Research Fund; Chinese National Key Program on Basic Research; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work is supported by the NIH (CA122794, CA140594, CA163896, CA166480, CA154303, and Lung SPORE P50CA090578), United against Lung Cancer, American Lung Association, Susan Spooner Research Fund (KKW), Chinese National Key Program on Basic Research (2012CB945100, 2011CB504202) and National Natural Science Foundation of China (31030040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amedei A, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/690571; Ancrile B, 2007, GENE DEV, V21, P1714, DOI 10.1101/gad.1549407; Bai L, 2013, MED ONCOL, V30, DOI 10.1007/s12032-012-0414-6; Balkwill F, 2002, CYTOKINE GROWTH F R, V13, P135, DOI 10.1016/S1359-6101(01)00020-X; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Ballaz Santiago, 2003, Clin Lung Cancer, V5, P46, DOI 10.3816/CLC.2003.n.021; Bayliss TJ, 2011, EXPERT OPIN BIOL TH, V11, P1663, DOI 10.1517/14712598.2011.627850; Bollrath J, 2009, EMBO REP, V10, P1314, DOI 10.1038/embor.2009.243; Carpagnano GE, 2002, INT J BIOL MARKER, V17, P141, DOI 10.1177/172460080201700211; Chang CH, 2013, INT J CANCER, V132, P1977, DOI 10.1002/ijc.27892; Chen J, 2013, J CANCER RES CLIN, V139, P231, DOI 10.1007/s00432-012-1314-z; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; De Vita F, 1998, ONCOL REP, V5, P649; Enewold L, 2009, CANCER EPIDEM BIOMAR, V18, P215, DOI 10.1158/1055-9965.EPI-08-0705; Fukuda Koji, 2012, Front Biosci (Schol Ed), V4, P787; Hagemann T, 2008, J EXP MED, V205, P1261, DOI 10.1084/jem.20080108; Heikkila K, 2009, CANCER CAUSE CONTROL, V20, P15, DOI 10.1007/s10552-008-9212-z; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Hsu HS, 2012, LUNG CANCER, V75, P167, DOI 10.1016/j.lungcan.2011.07.001; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; Keller ET, 1996, FRONT BIOSCI, V1, P340, DOI DOI 10.2741/A136; Kim SM, 2012, MOL CANCER THER, V11, P2254, DOI 10.1158/1535-7163.MCT-12-0311; Kita H, 2011, ANN THORAC CARDIOVAS, V17, P454, DOI 10.5761/atcs.oa.10.01627; Kleeff J, 1999, INT J CANCER, V81, P650, DOI 10.1002/(SICI)1097-0215(19990517)81:4<650::AID-IJC23>3.0.CO;2-#; Koh E, 2012, INT J SURG PATHOL, V20, P233, DOI 10.1177/1066896911436274; KOPF M, 1994, NATURE, V368, P339, DOI 10.1038/368339a0; Levina V, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003077; Ma Y, 2012, SEMIN CANCER BIOL, V22, P298, DOI 10.1016/j.semcancer.2012.02.010; Martin F, 1999, CYTOKINE, V11, P80, DOI 10.1006/cyto.1998.0398; Mazieres J, 2005, CANCER LETT, V222, P1, DOI 10.1016/j.canlet.2004.08.040; Meylan E, 2009, NATURE, V462, P104, DOI 10.1038/nature08462; O'Hayer KM, 2009, CARCINOGENESIS, V30, P1841, DOI 10.1093/carcin/bgp198; Ochoa CE, 2011, CANCER PREV RES, V4, P51, DOI 10.1158/1940-6207.CAPR-10-0180; Ott TR, 2004, BIOCHEMISTRY-US, V43, P3670, DOI 10.1021/bi035895h; Seki Y, 2004, INT J ONCOL, V24, P931; Song LX, 2011, MOL CANCER THER, V10, P481, DOI 10.1158/1535-7163.MCT-10-0502; Songur N, 2004, TUMORI J, V90, P196, DOI 10.1177/030089160409000207; Suganuma M, 2002, INT J ONCOL, V20, P131; Szczesny TJ, 2007, EUR J CARDIO-THORAC, V31, P719, DOI 10.1016/j.ejcts.2007.01.027; Takeuchi E, 1996, INTERNAL MED, V35, P212, DOI 10.2169/internalmedicine.35.212; Tas F, 2005, MED ONCOL, V22, P353, DOI 10.1385/MO:22:4:353; Tawara Ken, 2011, Cancer Manag Res, V3, P177, DOI 10.2147/CMR.S18101; Ujiie H, 2012, ANTICANCER RES, V32, P3251; Wojciechowska-Lacka A, 1997, YALE J BIOL MED, V70, P139; Wojcik E, 2010, ANTICANCER RES, V30, P1773; Yamaji H, 2004, CANCER IMMUNOL IMMUN, V53, P786, DOI 10.1007/s00262-004-0533-9; YANAGAWA H, 1995, BRIT J CANCER, V71, P1095, DOI 10.1038/bjc.1995.212; YANAGAWA H, 1992, CLIN EXP IMMUNOL, V88, P207; Yang CL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037960; Yao Z, 2010, P NATL ACAD SCI USA, V107, P15535, DOI 10.1073/pnas.1009472107; Yeh HH, 2006, ONCOGENE, V25, P4300, DOI 10.1038/sj.onc.1209464; Yi H, 2012, INT J ONCOL, V41, P310, DOI 10.3892/ijo.2012.1447	54	17	17	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80885	10.1371/journal.pone.0080885	http://dx.doi.org/10.1371/journal.pone.0080885			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260500	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600091
J	Eisenberger, T; Neuhaus, C; Khan, AO; Decker, C; Preising, MN; Friedburg, C; Bieg, A; Gliem, M; Issa, PC; Holz, FG; Baig, SM; Hellenbroich, Y; Galvez, A; Platzer, K; Wollnik, B; Laddach, N; Ghaffari, SR; Rafati, M; Botzenhart, E; Tinschert, S; Borger, D; Bohring, A; Schreml, J; Kortge-Jung, S; Schell-Apacik, C; Bakur, K; Al-Aama, JY; Neuhann, T; Herkenrath, P; Nurnberg, G; Nurnburg, P; Davis, JS; Gal, A; Bergmann, C; Lorenz, B; Bolz, HJ				Eisenberger, Tobias; Neuhaus, Christine; Khan, Arif O.; Decker, Christian; Preising, Markus N.; Friedburg, Christoph; Bieg, Anika; Gliem, Martin; Issa, Peter Charbel; Holz, Frank G.; Baig, Shahid M.; Hellenbroich, Yorck; Galvez, Alberto; Platzer, Konrad; Wollnik, Bernd; Laddach, Nadja; Ghaffari, Saeed Reza; Rafati, Maryam; Botzenhart, Elke; Tinschert, Sigrid; Boerger, Doris; Bohring, Axel; Schreml, Julia; Koertge-Jung, Stefani; Schell-Apacik, Chayim; Bakur, Khadijah; Al-Aama, Jumana Y.; Neuhann, Teresa; Herkenrath, Peter; Nuernberg, Gudrun; Nuernburg, Peter; Davis, John S.; Gal, Andreas; Bergmann, Carsten; Lorenz, Birgit; Bolz, Hanno J.			Increasing the Yield in Targeted Next-Generation Sequencing by Implicating CNV Analysis, Non-Coding Exons and the Overall Variant Load: The Example of Retinal Dystrophies	PLOS ONE			English	Article							RECESSIVE RETINITIS-PIGMENTOSA; MESSENGER-RNA; RP1 MUTATIONS; GENE ACCOUNT; DISEASE; IDENTIFICATION; ANNOTATION; TOOL; DEGENERATION; PREDICTION	Retinitis pigmentosa (RP) and Leber congenital amaurosis (LCA) are major causes of blindness. They result from mutations in many genes which has long hampered comprehensive genetic analysis. Recently, targeted next-generation sequencing (NGS) has proven useful to overcome this limitation. To uncover "hidden mutations" such as copy number variations (CNVs) and mutations in non-coding regions, we extended the use of NGS data by quantitative readout for the exons of 55 RP and LCA genes in 126 patients, and by including non-coding 59 exons. We detected several causative CNVs which were key to the diagnosis in hitherto unsolved constellations, e. g. hemizygous point mutations in consanguineous families, and CNVs complemented apparently monoallelic recessive alleles. Mutations of non-coding exon 1 of EYS revealed its contribution to disease. In view of the high carrier frequency for retinal disease gene mutations in the general population, we considered the overall variant load in each patient to assess if a mutation was causative or reflected accidental carriership in patients with mutations in several genes or with single recessive alleles. For example, truncating mutations in RP1, a gene implicated in both recessive and dominant RP, were causative in biallelic constellations, unrelated to disease when heterozygous on a biallelic mutation background of another gene, or even non-pathogenic if close to the C-terminus. Patients with mutations in several loci were common, but without evidence for di- or oligogenic inheritance. Although the number of targeted genes was low compared to previous studies, the mutation detection rate was highest (70%) which likely results from completeness and depth of coverage, and quantitative data analysis. CNV analysis should routinely be applied in targeted NGS, and mutations in non-coding exons give reason to systematically include 5'-UTRs in disease gene or exome panels. Consideration of all variants is indispensable because even truncating mutations may be misleading.	[Eisenberger, Tobias; Neuhaus, Christine; Decker, Christian; Bieg, Anika; Bergmann, Carsten; Bolz, Hanno J.] Bioscientia Ctr Human Genet, Ingelheim, Germany; [Khan, Arif O.; Galvez, Alberto] King Khalid Eye Specialist Hosp, Div Pediat Ophthalmol, Riyadh, Saudi Arabia; [Preising, Markus N.; Friedburg, Christoph; Lorenz, Birgit] Univ Giessen, Univ Hosp Giessen & Marburg GmbH, Dept Ophthalmol, D-35390 Giessen, Germany; [Gliem, Martin; Issa, Peter Charbel; Holz, Frank G.] Univ Bonn, Dept Ophthalmol, Bonn, Germany; [Baig, Shahid M.] Natl Inst Biotechnol & Genet Engn, Hlth Biotechnol Div, Human Mol Genet Lab, Faisalabad, Pakistan; [Hellenbroich, Yorck; Platzer, Konrad] Univ Lubeck, Inst Human Genet, Lubeck, Germany; [Wollnik, Bernd; Schreml, Julia; Bolz, Hanno J.] Univ Hosp Cologne, Inst Human Genet, Cologne, Germany; [Wollnik, Bernd; Schreml, Julia; Nuernberg, Gudrun; Nuernburg, Peter] Univ Cologne, Ctr Mol Med Cologne, D-50931 Cologne, Germany; [Wollnik, Bernd] Univ Cologne, Cologne Excellence Cluster Cellular Stress Respon, D-50931 Cologne, Germany; [Laddach, Nadja] MRC Holland, Amsterdam, Netherlands; [Ghaffari, Saeed Reza] Univ Tehran Med Sci, Comprehens Genet Ctr, Tehran, Iran; [Rafati, Maryam] Avicenna Biotechnol Res Inst, Tehran, Iran; [Botzenhart, Elke] Pranatalzentrum Hamburg & Humangenet, Hamburg, Germany; [Tinschert, Sigrid] Tech Univ Dresden, Inst Clin Genet, D-01062 Dresden, Germany; [Tinschert, Sigrid] Med Univ Innsbruck, Div Human Genet, A-6020 Innsbruck, Austria; [Bohring, Axel] Univ Munster, Inst Human Genet, D-48149 Munster, Germany; [Koertge-Jung, Stefani] Praenatal Med & Genet Dusseldorf, Dusseldorf, Germany; [Schell-Apacik, Chayim] Praxis Humangenet DRK Klinikum Westend, Berlin, Germany; [Bakur, Khadijah; Al-Aama, Jumana Y.] King Abdulaziz Univ, Princess Al Jawhara Albrahim Ctr Excellence Res H, Jeddah 21413, Saudi Arabia; [Neuhann, Teresa] Med Genet Zentrum, Munich, Germany; [Herkenrath, Peter] Univ Hosp Cologne, Dept Pediat, Cologne, Germany; [Nuernberg, Gudrun; Nuernburg, Peter] Univ Cologne, Cologne Ctr Genom, D-50931 Cologne, Germany; [Nuernberg, Gudrun; Nuernburg, Peter] Univ Cologne, Ctr Mol Med, D-50931 Cologne, Germany; [Davis, John S.] Zayed Mil Hosp, Dept Ophthalmol, Abu Dhabi, U Arab Emirates; [Gal, Andreas] Univ Med Ctr Hamburg Eppendorf, Inst Human Genet, Hamburg, Germany; [Bergmann, Carsten] Univ Hosp Freiburg, Clin Res Ctr, Freiburg, Germany	King Khaled Eye Specialist Hospital; Justus Liebig University Giessen; University Hospital of Giessen & Marburg; University of Bonn; Pakistan Institute of Engineering & Applied Science; University of Lubeck; University of Cologne; University of Cologne; University of Cologne; Tehran University of Medical Sciences; Technische Universitat Dresden; Medical University of Innsbruck; University of Munster; King Abdulaziz University; University of Cologne; University of Cologne; University of Cologne; University of Hamburg; University Medical Center Hamburg-Eppendorf; University of Freiburg	Bolz, HJ (corresponding author), Bioscientia Ctr Human Genet, Ingelheim, Germany.	hanno.bolz@bioscientia.de	Baig, Shahid Mahmood/I-7309-2015; BAig, Shahid Mahmood/AAS-8365-2020; Al-aama, Jumana/AAA-8653-2021; Issa, Peter Charbel/O-2580-2019; Issa, Peter Charbel/E-8935-2018; Wollnik, Bernd/GRY-6062-2022; Preising, Markus/GQA-9591-2022	Issa, Peter Charbel/0000-0002-0351-6673; Issa, Peter Charbel/0000-0002-0351-6673; Wollnik, Bernd/0000-0003-2589-0364; Rafati, Maryam/0000-0001-7118-3412; Bakur, Khadijah/0000-0002-0668-1762; Platzer, Konrad/0000-0001-6127-6308				Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Astuto LM, 2002, AM J HUM GENET, V71, P262, DOI 10.1086/341558; Audo I, 2012, ORPHANET J RARE DIS, V7, DOI 10.1186/1750-1172-7-8; Botstein D, 2003, NAT GENET, V33, P228, DOI 10.1038/ng1090; Bowne SJ, 2011, INVEST OPHTH VIS SCI, V52, P494, DOI 10.1167/iovs.10-6180; Branham K, 2012, INVEST OPHTH VIS SCI, V53, P8232, DOI 10.1167/iovs.12-11025; BRUNAK S, 1991, J MOL BIOL, V220, P49, DOI 10.1016/0022-2836(91)90380-O; Cartegni L, 2003, NUCLEIC ACIDS RES, V31, P3568, DOI 10.1093/nar/gkg616; Chen LJ, 2010, INVEST OPHTH VIS SCI, V51, P2236, DOI 10.1167/iovs.09-4437; Chen X, 2013, INVEST OPHTH VIS SCI; Cho TJ, 2012, AM J HUM GENET, V91, P343, DOI 10.1016/j.ajhg.2012.06.005; Churchill Jennifer D, 2013, Invest Ophthalmol Vis Sci, V54, P1411, DOI 10.1167/iovs.12-11541; Davuluri RV, 2001, NAT GENET, V29, P412, DOI 10.1038/ng780; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; den Hollander AI, 2006, AM J HUM GENET, V79, P556, DOI 10.1086/507318; den Hollander AI, 2010, J CLIN INVEST, V120, P3042, DOI 10.1172/JCI42258; Ebermann I, 2010, J CLIN INVEST, V120, P1812, DOI 10.1172/JCI39715; Ferrer-Costa C, 2005, BIOINFORMATICS, V21, P3176, DOI 10.1093/bioinformatics/bti486; Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311; Frick KD, 2012, ARCH OPHTHALMOL-CHIC, V130, P629, DOI 10.1001/archophthalmol.2011.2820; Glockle N, 2013, EUR J HUM GENET; Gudbjartsson DF, 2000, NAT GENET, V25, P12, DOI 10.1038/75514; Hartong DT, 2006, LANCET, V368, P1795, DOI 10.1016/S0140-6736(06)69740-7; Hebsgaard SM, 1996, NUCLEIC ACIDS RES, V24, P3439, DOI 10.1093/nar/24.17.3439; Hosono K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031036; Jacobson SG, 2000, INVEST OPHTH VIS SCI, V41, P1898; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Koboldt DC, 2012, GENOME RES, V22, P568, DOI 10.1101/gr.129684.111; Li H, 2009, BIOINFORMATICS, V25, P1094, DOI [10.1093/bioinformatics/btp100, 10.1093/bioinformatics/btp324]; Littink KW, 2010, OPHTHALMOLOGY, V117, P2026, DOI 10.1016/j.ophtha.2010.01.040; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; Louie CM, 2010, NAT GENET, V42, P175, DOI 10.1038/ng.519; Mathe E, 2006, NUCLEIC ACIDS RES, V34, P1317, DOI 10.1093/nar/gkj518; McKenna A, 2010, GENOME RES, V20, P1297, DOI 10.1101/gr.107524.110; Meyer LR, 2013, NUCLEIC ACIDS RES, V41, pD64, DOI 10.1093/nar/gks1048; Neveling K, 2012, HUM MUTAT, V33, P963, DOI 10.1002/humu.22045; Ng PC, 2003, NUCLEIC ACIDS RES, V31, P3812, DOI 10.1093/nar/gkg509; Nishiguchi KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041902; O'Connell JR, 1998, AM J HUM GENET, V63, P259, DOI 10.1086/301904; O'Sullivan J, 2012, J MED GENET, V49, P322, DOI 10.1136/jmedgenet-2012-100847; Pieras JI, 2011, INVEST OPHTH VIS SCI, V52, P5625, DOI 10.1167/iovs.11-7292; Pierce EA, 1999, NAT GENET, V22, P248, DOI 10.1038/10305; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Pruitt KD, 2012, NUCLEIC ACIDS RES, V40, pD130, DOI 10.1093/nar/gkr1079; Reese MG, 2001, COMPUT CHEM, V26, P51, DOI 10.1016/S0097-8485(01)00099-7; Reese MG, 1997, J COMPUT BIOL, V4, P311, DOI 10.1089/cmb.1997.4.311; Riazuddin SA, 2005, INVEST OPHTH VIS SCI, V46, P2264, DOI 10.1167/iovs.04-1280; Rogozin IB, 1997, J MOL EVOL, V45, P50, DOI 10.1007/PL00006200; Ruschendorf F, 2005, BIOINFORMATICS, V21, P2123, DOI 10.1093/bioinformatics/bti264; Schwarz JM, 2010, NAT METHODS, V7, P575, DOI 10.1038/nmeth0810-575; Semler O, 2012, AM J HUM GENET, V91, P349, DOI 10.1016/j.ajhg.2012.06.011; Shanks ME, 2013, EUR J HUM GENET, V21, P274, DOI 10.1038/ejhg.2012.172; Sharon D, 2003, AM J HUM GENET, V73, P1131, DOI 10.1086/379379; Sheffield VC, 2011, NEW ENGL J MED, V364, P1932, DOI 10.1056/NEJMra1012354; Solovyev V, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P294; Stenson Peter D, 2012, Curr Protoc Bioinformatics, VChapter 1, DOI 10.1002/0471250953.bi0113s39; Sullivan LS, 2006, INVEST OPHTH VIS SCI, V47, P4579, DOI 10.1167/iovs.06-0440; Swaroop A, 1999, HUM MOL GENET, V8, P299, DOI 10.1093/hmg/8.2.299; Tavtigian SV, 2006, J MED GENET, V43, P295, DOI 10.1136/jmg.2005.033878; Thiele H, 2005, BIOINFORMATICS, V21, P1730, DOI 10.1093/bioinformatics/bth488; Webb TR, 2012, HUM MOL GENET, V21, P3647, DOI 10.1093/hmg/dds194; Wright AF, 2010, NAT REV GENET, V11, P273, DOI 10.1038/nrg2717; Xu F, 2012, MOL VIS, V18, P3021; Yzer S, 2006, INVEST OPHTH VIS SCI, V47, P1167, DOI 10.1167/iovs.05-0848; Zhang X, 2010, MOL VIS, V16, P1353; Ziviello C, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.031682	68	169	172	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78496	10.1371/journal.pone.0078496	http://dx.doi.org/10.1371/journal.pone.0078496			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265693	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100026
J	Fan, PX; Nie, LL; Jiang, P; Feng, JJ; Lv, SL; Chen, XY; Bao, H; Guo, J; Tai, F; Wang, JH; Jia, WT; Li, YX				Fan, Pengxiang; Nie, Lingling; Jiang, Ping; Feng, Juanjuan; Lv, Sulian; Chen, Xianyang; Bao, Hexigeduleng; Guo, Jie; Tai, Fang; Wang, Jinhui; Jia, Weitao; Li, Yinxin			Transcriptome Analysis of Salicornia europaea under Saline Conditions Revealed the Adaptive Primary Metabolic Pathways as Early Events to Facilitate Salt Adaptation	PLOS ONE			English	Article							PECTIN METHYLESTERASE INHIBITORS; COMPARATIVE PROTEOMIC ANALYSIS; GENE-EXPRESSION; ARABIDOPSIS-THALIANA; NUCLEAR-DNA; CHLOROPLAST DEVELOPMENT; STRESS TOLERANCE; AUXIN RESPONSE; WALL FORMATION; GENOME SIZE	Background: Halophytes such as Salicornia europaea have evolved to exhibit unique mechanisms controlled by complex networks and regulated by numerous genes and interactions to adapt to habitats with high salinity. However, these mechanisms remain unknown. Methods: To investigate the mechanism by which halophytes tolerate salt based on changes in the whole transcriptome, we performed transcriptome sequencing and functional annotation by database search. Using the unigene database, we conducted digital gene expression analysis of S. europaea at various time points after these materials were treated with NaCl. We also quantified ion uptakes. Gene functional enrichment analysis was performed to determine the important pathways involved in this process. Results: A total of 57,151 unigenes with lengths of >300 bp were assembled, in which 57.5% of these unigenes were functionally annotated. Differentially expressed genes indicated that cell wall metabolism and lignin biosynthetic pathways were significantly enriched in S. europaea to promote the development of the xylem under saline conditions. This result is consistent with the increase in sodium uptake as ions pass through the xylem. Given that PSII efficiency remained unaltered, salt treatment activated the expression of electron transfer-related genes encoded by the chloroplast chromosome. Chlorophyll biosynthesis was also inhibited, indicating the energy-efficient state of the electron transfer system of S. europaea. Conclusions: The key function of adjusting important primary metabolic pathways in salt adaption was identified by analyzing the changes in the transcriptome of S. europaea. These pathways could involve unique salt tolerance mechanisms in halophytes. This study also provided information as the basis of future investigations on salt response genes in S. europaea. Ample gene resources were also provided to improve the genes responsible for the salt tolerance ability of crops.	[Fan, Pengxiang; Nie, Lingling; Jiang, Ping; Feng, Juanjuan; Lv, Sulian; Chen, Xianyang; Bao, Hexigeduleng; Guo, Jie; Tai, Fang; Wang, Jinhui; Jia, Weitao; Li, Yinxin] Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Botany, CAS	Li, YX (corresponding author), Chinese Acad Sci, Inst Bot, Key Lab Plant Mol Physiol, Beijing, Peoples R China.	yxli@ibcas.ac.cn	Fan, Pengxiang/M-5173-2019		Chinese Ministry of Agriculture [2013ZX08009-003-002]	Chinese Ministry of Agriculture(Ministry of Agriculture & Rural Affairs)	The research was supported by the research programs from the Chinese Ministry of Agriculture (Grant No 2013ZX08009-003-002). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Sadi AM, 2010, PLANT PATHOL, V59, P112, DOI 10.1111/j.1365-3059.2009.02176.x; Amtmann A, 2009, MOL PLANT, V2, P3, DOI 10.1093/mp/ssn094; Ansorge WJ, 2009, NEW BIOTECHNOL, V25, P195, DOI 10.1016/j.nbt.2008.12.009; Aslam R, 2011, J MED PLANTS RES, V5, P7108, DOI 10.5897/JMPRx11.009; Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986; Bennett MD, 2000, ANN BOT-LONDON, V86, P859, DOI 10.1006/anbo.2000.1253; Bischoff V, 2009, J EXP BOT, V60, P955, DOI 10.1093/jxb/ern344; Bleecker AB, 2000, ANNU REV CELL DEV BI, V16, P1, DOI 10.1146/annurev.cellbio.16.1.1; Bressan RA, 2001, PLANT PHYSIOL, V127, P1354, DOI 10.1104/pp.010752; Brinker M, 2010, PLANT PHYSIOL, V154, P1697, DOI 10.1104/pp.110.164152; Cano-Delgado A, 2003, PLANT J, V34, P351, DOI 10.1046/j.1365-313X.2003.01729.x; Cheng ZJ, 2013, PLANT PHYSIOL, V161, P240, DOI 10.1104/pp.112.203166; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; De Angeli A, 2006, NATURE, V442, P939, DOI 10.1038/nature05013; Diet A, 2006, PLANT CELL, V18, P1630, DOI 10.1105/tpc.105.038653; Dolezel J, 2003, CYTOM PART A, V51A, P127, DOI 10.1002/cyto.a.10013; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Fan PX, 2011, PROTEOMICS, V11, P4346, DOI 10.1002/pmic.201100054; Fitter DW, 2002, PLANT J, V31, P713, DOI 10.1046/j.1365-313X.2002.01390.x; Flowers TJ, 2008, NEW PHYTOL, V179, P945, DOI 10.1111/j.1469-8137.2008.02531.x; FLOWERS TJ, 1977, ANNU REV PLANT PHYS, V28, P89, DOI 10.1146/annurev.pp.28.060177.000513; Geelen D, 2000, PLANT J, V21, P259, DOI 10.1046/j.1365-313x.2000.00680.x; Glenn EP, 1999, CRIT REV PLANT SCI, V18, P227, DOI 10.1016/S0735-2689(99)00388-3; GREENWAY H, 1980, ANNU REV PLANT PHYS, V31, P149, DOI 10.1146/annurev.pp.31.060180.001053; Hao DC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021220; Hasegawa PM, 2000, ANNU REV PLANT PHYS, V51, P463, DOI 10.1146/annurev.arplant.51.1.463; He XJ, 2005, PLANT J, V44, P903, DOI 10.1111/j.1365-313X.2005.02575.x; Hedrich R, 2006, CELL, V125, P1221, DOI 10.1016/j.cell.2006.06.017; Hou YB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006978; Inan G, 2004, PLANT PHYSIOL, V135, P1718, DOI 10.1104/pp.104.041723; Iseli C, 1999, Proc Int Conf Intell Syst Mol Biol, P138; Jiang GQ, 2007, PLANTA, V225, P1405, DOI 10.1007/s00425-006-0449-z; Koce JD, 2008, AQUAT BOT, V89, P385, DOI 10.1016/j.aquabot.2008.04.009; Koh S, 2002, PLANT PHYSIOL, V128, P21, DOI 10.1104/pp.010332; Koussevitzky S, 2007, SCIENCE, V316, P715, DOI 10.1126/science. 1140516; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lee KJD, 2011, MOL PLANT, V4, P212, DOI 10.1093/mp/ssq075; Lee SC, 2010, PLANT MOL BIOL, V73, P409, DOI 10.1007/s11103-010-9629-0; Li EY, 2012, NEW PHYTOL, V194, P102, DOI 10.1111/j.1469-8137.2011.04016.x; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liscum E, 2002, PLANT MOL BIOL, V49, P387, DOI 10.1023/A:1015255030047; Lv SL, 2012, ACTA PHYSIOL PLANT, V34, P503, DOI 10.1007/s11738-011-0847-0; Lv SL, 2012, PLANT PHYSIOL BIOCH, V51, P47, DOI 10.1016/j.plaphy.2011.10.015; Ma JB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065877; Mao CZ, 2007, NEW PHYTOL, V176, P288, DOI 10.1111/j.1469-8137.2007.02177.x; Mar JC, 2011, BIOINFORMATICS, V27, P1094, DOI 10.1093/bioinformatics/btr074; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; Micheli F, 2001, TRENDS PLANT SCI, V6, P414, DOI 10.1016/S1360-1385(01)02045-3; Mockaitis K, 2008, ANNU REV CELL DEV BI, V24, P55, DOI 10.1146/annurev.cellbio.23.090506.123214; Morrissy AS, 2009, GENOME RES, V19, P1825, DOI 10.1101/gr.094482.109; Muller A, 1998, EMBO J, V17, P6903, DOI 10.1093/emboj/17.23.6903; Munns R, 2008, ANNU REV PLANT BIOL, V59, P651, DOI 10.1146/annurev.arplant.59.032607.092911; Nakashima K, 2000, PLANT MOL BIOL, V42, P657, DOI 10.1023/A:1006321900483; Ohashi-Ito K, 2003, PLANT CELL PHYSIOL, V44, P1350, DOI 10.1093/pcp/pcg164; Ooka H, 2003, DNA RES, V10, P239, DOI 10.1093/dnares/10.6.239; Pang QY, 2010, J PROTEOME RES, V9, P2584, DOI 10.1021/pr100034f; Paponov IA, 2005, TRENDS PLANT SCI, V10, P170, DOI 10.1016/j.tplants.2005.02.009; Peng YH, 2004, J EXP BOT, V55, P939, DOI 10.1093/jxb/erh071; Pfalz J, 2006, PLANT CELL, V18, P176, DOI 10.1105/tpc.105.036392; Powell ALT, 2012, SCIENCE, V336, P1711, DOI 10.1126/science.1222218; Raiola A, 2004, FEBS LETT, V557, P199, DOI 10.1016/S0014-5793(03)01491-1; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Rodriguez-Concepcion M, 2004, PLANT CELL, V16, P144, DOI 10.1105/tpc.016204; Rohdich F, 2001, CURR OPIN CHEM BIOL, V5, P535, DOI 10.1016/S1367-5931(00)00240-4; Rotter A, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-10; Ruzicka K, 2007, PLANT CELL, V19, P2197, DOI 10.1105/tpc.107.052126; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Sandhu APS, 2009, MOL PLANT, V2, P840, DOI 10.1093/mp/ssp056; Shabala S, 2008, PHYSIOL PLANTARUM, V133, P651, DOI 10.1111/j.1399-3054.2007.01008.x; Smith AM, 2006, NAT PROTOC, V1, P1342, DOI 10.1038/nprot.2006.232; Sreenivasulu N, 2008, PLANT PHYSIOL, V146, P1738, DOI 10.1104/pp.107.111781; Strader LC, 2010, PLANT J, V64, P874, DOI 10.1111/j.1365-313X.2010.04373.x; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; UNGAR IA, 1987, ECOLOGY, V68, P569, DOI 10.2307/1938462; Usadel B, 2005, PLANT PHYSIOL, V138, P1195, DOI 10.1104/pp.105.060459; Usadel B, 2009, PLANT CELL ENVIRON, V32, P1211, DOI 10.1111/j.1365-3040.2009.01978.x; Ushakova SA, 2006, RUSS J PLANT PHYSL+, V53, P785, DOI 10.1134/S1021443706060094; Wahl MB, 2005, BIOINFORMATICS, V21, P1393, DOI 10.1093/bioinformatics/bti207; Wang DY, 2012, PLANT PHYSIOL BIOCH, V51, P53, DOI 10.1016/j.plaphy.2011.10.009; Wang SM, 2007, PLANT PHYSIOL, V145, P559, DOI 10.1104/pp.107.104315; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XC, 2008, MOL BIOTECHNOL, V38, P57, DOI 10.1007/s12033-007-0073-6; Wang XC, 2009, J PROTEOME RES, V8, P3331, DOI 10.1021/pr801083a; Waters MT, 2009, PLANT CELL, V21, P1109, DOI 10.1105/tpc.108.065250; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Wu HJ, 2012, P NATL ACAD SCI USA, V109, P12219, DOI 10.1073/pnas.1209954109; Xue JA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014233; Yamaguchi T, 2005, P NATL ACAD SCI USA, V102, P16107, DOI 10.1073/pnas.0504437102; Yang CW, 2009, PHOTOSYNTHETICA, V47, P55, DOI 10.1007/s11099-009-0010-y; Yang TB, 2003, TRENDS PLANT SCI, V8, P505, DOI 10.1016/j.tplants.2003.09.004; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW293, DOI 10.1093/nar/gkl031; Zhang JL, 2010, PLANT SOIL, V326, P45, DOI 10.1007/s11104-009-0076-0; Zhao KF, 2002, PLANT SCI, V163, P491, DOI 10.1016/S0168-9452(02)00160-7; Zheng Q, 2008, NUCLEIC ACIDS RES, V36, pW358, DOI 10.1093/nar/gkn276; Zheng YQ, 2008, J PLANT PHYSIOL, V165, P1906, DOI 10.1016/j.jplph.2008.04.008; Zhong RQ, 2008, PLANT CELL, V20, P2763, DOI 10.1105/tpc.108.061325; Zhu JK, 2002, ANNU REV PLANT BIOL, V53, P247, DOI 10.1146/annurev.arplant.53.091401.143329; Zhu JK, 2001, TRENDS PLANT SCI, V6, P66, DOI 10.1016/S1360-1385(00)01838-0	102	29	32	0	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80595	10.1371/journal.pone.0080595	http://dx.doi.org/10.1371/journal.pone.0080595			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265831	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100167
J	Godefroy, N; Foveau, B; Albrecht, S; Goodyer, CG; LeBlanc, AC				Godefroy, Nelly; Foveau, Benedicte; Albrecht, Steffen; Goodyer, Cynthia G.; LeBlanc, Andrea C.			Expression and Activation of Caspase-6 in Human Fetal and Adult Tissues	PLOS ONE			English	Article							AMYLOID PRECURSOR PROTEIN; APOPTOTIC LAMIN KINASE; CANCER CELL APOPTOSIS; INTERMEDIATE-FILAMENTS; ALZHEIMERS-DISEASE; BETA-PEPTIDE; PROMOTES APOPTOSIS; LENS DEVELOPMENT; NEURON CULTURES; CLEAVAGE	Caspase-6 is an effector caspase that has not been investigated thoroughly despite the fact that Caspase-6 is strongly activated in Alzheimer disease brains. To understand the full physiological impact of Caspase-6 in humans, we investigated Caspase-6 expression. We performed western blot analyses to detect the pro-Caspase-6 and its active p20 subunit in fetal and adult lung, kidney, brain, spleen, muscle, stomach, colon, heart, liver, skin, and adrenals tissues. The levels were semi-quantitated by densitometry. The results show a ubiquitous expression of Caspase-6 in most fetal tissues with the lowest levels in the brain and the highest levels in the gastrointestinal system. Caspase-6 active p20 subunits were only detected in fetal stomach. Immunohistochemical analysis of a human fetal embryo showed active Caspase-6 positive apoptotic cells in the dorsal root ganglion, liver, lung, kidney, ovary, skeletal muscle and the intestine. In the adult tissues, the levels of Caspase-6 were lower than in fetal tissues but remained high in the colon, stomach, lung, kidney and liver. Immunohistological analyses revealed that active Caspase-6 was abundant in goblet cells and epithelial cells sloughing off the intestinal lining of the adult colon. These results suggest that Caspase-6 is likely important in most tissues during early development but is less involved in adult tissues. The low levels of Caspase-6 in fetal and adult brain indicate that increased expression as observed in Alzheimer Disease is a pathological condition. Lastly, the high levels of Caspase-6 in the gastrointestinal system indicate a potential specific function of Caspase-6 in these tissues.	[Godefroy, Nelly; LeBlanc, Andrea C.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Godefroy, Nelly; Foveau, Benedicte; LeBlanc, Andrea C.] Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Bloomfield Ctr Res Aging, Montreal, PQ, Canada; [Albrecht, Steffen] McGill Univ, Dept Pathol, Montreal, PQ, Canada; [Goodyer, Cynthia G.] McGill Univ Montreal, Dept Pediat, Quebec City, PQ, Canada	McGill University; Lady Davis Institute; McGill University; McGill University	LeBlanc, AC (corresponding author), McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada.	andrea.leblanc@mcgill.ca	Godefroy, Nelly/AAG-2052-2020		Canadian Institutes of Health Research [15118]; National Institutes of Health [40965]; Valorisation Recherche Quebec; Fonds de Recherche en Sante du Quebec	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Valorisation Recherche Quebec; Fonds de Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec)	This work was supported by Canadian Institutes of Health Research operating grant 15118, National Institutes of Health operating grant Neuroscience/Mental Health 40965, Valorisation Recherche Quebec, and Fonds de Recherche en Sante du Quebec to Andrea LeBlanc. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akpan N, 2011, J NEUROSCI, V31, P8894, DOI 10.1523/JNEUROSCI.0698-11.2011; Albrecht S, 2007, AM J PATHOL, V170, P1200, DOI 10.2353/ajpath.2007.060974; Albrecht S, 2009, J NEUROPATH EXP NEUR, V68, P1282, DOI 10.1097/NEN.0b013e3181c1da10; BEDI A, 1995, CANCER RES, V55, P1811; Buendia B, 1999, J CELL SCI, V112, P1743; Byun Y, 2001, CELL DEATH DIFFER, V8, P443, DOI 10.1038/sj.cdd.4400840; Caulin C, 1997, J CELL BIOL, V138, P1379, DOI 10.1083/jcb.138.6.1379; Cetin E, 2006, SURG RADIOL ANAT, V28, P438, DOI 10.1007/s00276-006-0124-x; Chailler Pierre, 1999, Frontiers in Bioscience, V4, pD87, DOI 10.2741/Chailler; Chan JY, 2008, CANCER BIOL THER, V7, P1305, DOI 10.4161/cbt.7.8.6302; Chen F, 2003, J BIOL CHEM, V278, P6848, DOI 10.1074/jbc.M212021200; Chen YZ, 2000, J BIOL CHEM, V275, P8929, DOI 10.1074/jbc.275.12.8929; Chiarini A, 2002, J BIOL CHEM, V277, P18827, DOI 10.1074/jbc.M111921200; Columbaro M, 2001, FEBS LETT, V509, P423, DOI 10.1016/S0014-5793(01)03203-3; Cross T, 2000, ONCOGENE, V19, P2331, DOI 10.1038/sj.onc.1203555; Dee K, 2002, CELL DEATH DIFFER, V9, P209, DOI 10.1038/sj/cdd/4400930; Doostzadeh-Cizeron J, 2000, J BIOL CHEM, V275, P25336, DOI 10.1074/jbc.M000793200; Eymin B, 1999, ONCOGENE, V18, P4839, DOI 10.1038/sj.onc.1202860; Foley JD, 2004, J BIOL CHEM, V279, P32142, DOI 10.1074/jbc.M313683200; Galande S, 2001, MOL CELL BIOL, V21, P5591, DOI 10.1128/MCB.21.16.5591-5604.2001; Gervais FG, 1999, CELL, V97, P395, DOI 10.1016/S0092-8674(00)80748-5; Giaime E, 2010, CELL DEATH DIFFER, V17, P158, DOI 10.1038/cdd.2009.116; Gotzmann J, 2000, CELL DEATH DIFFER, V7, P425, DOI 10.1038/sj.cdd.4400668; Graham RK, 2011, TRENDS NEUROSCI, V34, P646, DOI 10.1016/j.tins.2011.09.001; Gray DC, 2010, CELL, V142, P637, DOI 10.1016/j.cell.2010.07.014; Grossmann J, 1998, AM J PHYSIOL-GASTR L, V274, pG1117, DOI 10.1152/ajpgi.1998.274.6.G1117; Guo H, 2006, CELL DEATH DIFFER, V13, P285, DOI 10.1038/sj.cdd.4401753; Guo HS, 2004, AM J PATHOL, V165, P523, DOI 10.1016/S0002-9440(10)63317-2; Hirata H, 1998, J EXP MED, V187, P587, DOI 10.1084/jem.187.4.587; Ilkovski B, 2005, NEUROMUSCULAR DISORD, V15, P829, DOI 10.1016/j.nmd.2005.08.004; Jee CD, 2005, INT J ONCOL, V26, P1265; Klaiman G, 2008, MOL CELL PROTEOMICS, V7, P1541, DOI 10.1074/mcp.M800007-MCP200; Klaiman G, 2009, BBA-MOL CELL RES, V1793, P592, DOI 10.1016/j.bbamcr.2008.12.004; Kuida K, 1996, NATURE, V384, P368, DOI 10.1038/384368a0; Lagace TA, 2002, MOL CELL BIOL, V22, P4851, DOI 10.1128/MCB.22.13.4851-4862.2002; LeBlanc A, 1995, J NEUROSCI, V15, P7837; LeBlanc A, 1999, J BIOL CHEM, V274, P23426, DOI 10.1074/jbc.274.33.23426; Lee SC, 2006, PROTEOMICS, V6, P2386, DOI 10.1002/pmic.200500366; Lee SC, 2010, CANCER LETT, V288, P36, DOI 10.1016/j.canlet.2009.06.020; Liu XS, 1999, J BIOL CHEM, V274, P13836, DOI 10.1074/jbc.274.20.13836; MacLachan TK, 2002, P NATL ACAD SCI USA, V99, P9492, DOI 10.1073/pnas.132241599; Morozov V, 2006, DEVELOPMENT, V133, P813, DOI 10.1242/dev.02262; MUNSICK RA, 1984, AM J OBSTET GYNECOL, V149, P883, DOI 10.1016/0002-9378(84)90609-4; Nyormoi O, 2001, MOL CELL BIOL, V21, P4856, DOI 10.1128/MCB.21.15.4856-4867.2001; Olson NE, 2003, J IMMUNOL, V170, P6065, DOI 10.4049/jimmunol.170.12.6065; Pellegrini L, 1999, J BIOL CHEM, V274, P21011, DOI 10.1074/jbc.274.30.21011; Prasad S, 1999, INT J ONCOL, V14, P563; Ramcharitar J, 2013, NEUROBIOL AGING, V34, P1815, DOI 10.1016/j.neurobiolaging.2013.01.007; Rickers A, 1999, EUR J BIOCHEM, V261, P269, DOI 10.1046/j.1432-1327.1999.00273.x; Rouaux C, 2003, EMBO J, V22, P6537, DOI 10.1093/emboj/cdg615; Ruchaud S, 2002, EMBO J, V21, P1967, DOI 10.1093/emboj/21.8.1967; Samejima K, 1999, J BIOL CHEM, V274, P4335, DOI 10.1074/jbc.274.7.4335; Shimizu T, 1998, J BIOL CHEM, V273, P8669, DOI 10.1074/jbc.273.15.8669; Simon DJ, 2012, J NEUROSCI, V32, P17540, DOI 10.1523/JNEUROSCI.3012-12.2012; Sivananthan SN, 2010, CELL DEATH DIS, V1, DOI 10.1038/cddis.2010.74; Slee EA, 2001, J BIOL CHEM, V276, P7320, DOI 10.1074/jbc.M008363200; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Uribe V, 2012, HUM MOL GENET, V21, P1954, DOI 10.1093/hmg/dds005; Van de Craen M, 1997, FEBS LETT, V403, P61, DOI 10.1016/S0014-5793(97)00026-4; Watanabe C, 2008, J IMMUNOL, V181, P6810, DOI 10.4049/jimmunol.181.10.6810; Weidemann A, 1999, J BIOL CHEM, V274, P5823, DOI 10.1074/jbc.274.9.5823; Zandy AJ, 2005, J BIOL CHEM, V280, P30263, DOI 10.1074/jbc.M504007200; Zhang Y, 2000, J NEUROSCI, V20, P8384, DOI 10.1523/JNEUROSCI.20-22-08384.2000	63	24	24	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79313	10.1371/journal.pone.0079313	http://dx.doi.org/10.1371/journal.pone.0079313			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265764	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100097
J	Gonzalez, BA; Samaniego, H; Marin, JC; Estades, CF				Gonzalez, Benito A.; Samaniego, Horacio; Carlos Marin, Juan; Estades, Cristian F.			Unveiling Current Guanaco Distribution in Chile Based upon Niche Structure of Phylogeographic Lineages: Andean Puna to Subpolar Forests	PLOS ONE			English	Article							SPECIES DISTRIBUTION; LAMA-GUANICOE; CONSERVATISM; PREDICTION; ECOLOGY; ARTIODACTYLA; BIOGEOGRAPHY; PERFORMANCE; DIVERGENCE; EVOLUTION	Niche description and differentiation at broad geographic scales have been recent major topics in ecology and evolution. Describing the environmental niche structure of sister taxa with known evolutionary trajectories stands out as a useful exercise in understanding niche requirements. Here we model the environmental niche structure and distribution of the recently resolved phylogeography of guanaco (Lama guanicoe) lineages on the western slope of the southern Andes. Using a maximum entropy framework, field data, and information on climate, topography, human density, and vegetation cover, we identify differences between the two subspecies (L. g. cacsilensis, L. g. guanicoe) and their intermediate-hybrid lineage, that most likely determine the distribution of this species. While aridity seems to be a major factor influencing the distribution at the species-level (annual precipitation <900 mm), we also document important differences in niche specificity for each subspecies, where distribution of Northern lineage is explained mainly by elevation (mean = 3,413 m) and precipitation seasonality (mean = 161 mm), hybrid lineage by annual precipitation (mean = 139 mm), and Southern subspecies by annual precipitation (mean = 553 mm), precipitation seasonality (mean = 21 mm) and grass cover (mean = 8.2%). Among lineages, we detected low levels of niche overlap: I (Similarity Index) = 0.06 and D (Schoener's Similarity Index) = 0.01; and higher levels when comparing Northern and Southern subspecies with hybrids lineage (I = 0.32-0.10 and D = 0.12-0.03, respectively). This suggests that important ecological and/or evolutionary processes are shaping the niche of guanacos in Chile, producing discrepancies when comparing range distribution at the species-level (81,756 km(2)) with lineages-level (65,321 km(2)). The subspecies-specific description of niche structure is provided here based upon detailed spatial distribution of the lineages of guanacos in Chile. Such description provides a scientific tool to further develop large scale plans for habitat conservation and preservation of intraspecific genetic variability for this far ranging South American camelid, which inhabits a diversity of ecoregion types from Andean puna to subpolar forests.	[Gonzalez, Benito A.; Estades, Cristian F.] Univ Chile, Fac Ciencias Forestales & Conservac Nat, Lab Ecol Vida Silvestre, Santiago, Chile; [Samaniego, Horacio] Univ Austral Chile, Inst Conservac Biodiversidad & Terr, Lab Ecoinformat, Valdivia, Chile; [Samaniego, Horacio] Univ Desarrollo, Ctr Invest Complejidad Social, Santiago, Chile; [Samaniego, Horacio] Los Alamos Natl Lab, Ctr Non Linear Studies, Los Alamos, NM USA; [Carlos Marin, Juan] Univ Bio Bio, Fac Ciencias, Dept Ciencias Basicas, Lab Genom & Biodiversidad, Chillan, Chile	Universidad de Chile; Universidad Austral de Chile; Universidad del Desarrollo; United States Department of Energy (DOE); Los Alamos National Laboratory; Universidad del Bio-Bio	Samaniego, H (corresponding author), Univ Austral Chile, Inst Conservac Biodiversidad & Terr, Lab Ecoinformat, Valdivia, Chile.	horacio@ecoinformatica.cl	González, Benito/I-9570-2014; Estades, Cristian F/A-5221-2008; Samaniego, Horacio/O-8820-2015; González, Benito/H-5189-2013	González, Benito/0000-0001-8201-8789; Estades, Cristian F/0000-0002-4479-7774; Samaniego, Horacio/0000-0002-2485-9827; Gonzalez, Benito/0000-0002-0039-5722	CONICYT; US Department of Energy throughout the NANL/LDRD program; FONDEF [D1-I1038]; Proyecto Interfacultades from Universidad del Desarrollo	CONICYT(Comision Nacional de Investigacion Cientifica y Tecnologica (CONICYT)); US Department of Energy throughout the NANL/LDRD program(United States Department of Energy (DOE)); FONDEF; Proyecto Interfacultades from Universidad del Desarrollo	BAG was funded by a Ph.D. fellowship from CONICYT. HS was supported by the US Department of Energy throughout the NANL/LDRD program, FONDEF # D1-I1038, and partially by a Proyecto Interfacultades from Universidad del Desarrollo. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham EM, 2000, Z ANGEW GEOLOGIE SH, V1, P55; Acebes P, 2010, MAMMALIA, V74, P57, DOI 10.1515/MAMM.2009.071; Armesto JJ, 2010, LAND USE POLICY, V27, P148, DOI 10.1016/j.landusepol.2009.07.006; Austin MP, 2002, ECOL MODEL, V157, P101, DOI 10.1016/S0304-3800(02)00205-3; Baldi B, 2008, IUCN 2010 IUCN RED L; BalthoIome E, 2005, INT J REMOTE SENS, V26, P1959, DOI [10.1080/01431160412331291297, DOI 10.1080/01431160412331291297]; Cabeza M, 2004, J APPL ECOL, V41, P252, DOI 10.1111/j.0021-8901.2004.00905.x; Ceballos G, 2002, SCIENCE, V296, P904, DOI 10.1126/science.1069349; Center for International Earth Science Information Network, 2005, GLOB RUR URB MAPP PR; Cunazza C, 1991, GUANACO ESPECIE FAUN, P37; Elith J, 2006, ECOGRAPHY, V29, P129, DOI 10.1111/j.2006.0906-7590.04596.x; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2004, J APPL ECOL, V41, P263, DOI 10.1111/j.0021-8901.2004.00881.x; Franklin J, 2009, MAPPING SPECIES DIST; Franklin W. L., 1982, MAMMALIAN BIOL S AM, P457; Franklin William, 2011, HDB MAMMALS WORLD HO, V2, P206, DOI DOI 10.1002/ZOO.21021; Gonzalez BA, 2006, MAMMAL REV, V36, P157, DOI 10.1111/j.1365-2907.2006.00084.x; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrell FE, 2001, REGRESSION MODELING; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; HOLT RD, 1992, EVOL ECOL, V6, P433, DOI 10.1007/BF02270702; Huete A, 2002, REMOTE SENS ENVIRON, V83, P195, DOI 10.1016/S0034-4257(02)00096-2; Jackson ST, 2009, P NATL ACAD SCI USA, V106, P19685, DOI 10.1073/pnas.0901644106; Jaksic FM, 2001, ECOGRAPHY, V24, P241, DOI 10.1034/j.1600-0587.2001.240301.x; JAYNES ET, 1990, FUND THEOR, V39, P1; JOHNSON DH, 1980, ECOLOGY, V61, P65, DOI 10.2307/1937156; Kearney M, 2009, ECOL LETT, V12, P334, DOI 10.1111/j.1461-0248.2008.01277.x; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; LEVINS RICHARD, 1968; Mandle L, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015297; Marin JC, 2008, J MAMMAL, V89, P269, DOI 10.1644/06-MAMM-A-385R.1; Marin JC, 2013, MOL ECOL, V22, P463, DOI 10.1111/mec.12111; Marino A, 2008, ETHOLOGY, V114, P413, DOI 10.1111/j.1439-0310.2008.01485_1.x; McCormack JE, 2010, EVOLUTION, V64, P1231, DOI 10.1111/j.1558-5646.2009.00900.x; Melgar CM, 2013, QUATERN INT, V301, P60, DOI 10.1016/j.quaint.2012.04.003; Menegaz A.N., 1989, Ameghiniana, V26, P153; Morueta-Holme N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010360; Nakazato T, 2010, AM J BOT, V97, P680, DOI 10.3732/ajb.0900216; Ochsenius C, 1985, REV GEOGR NORTE GD, V47, P35; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Rodriguez JP, 2007, DIVERS DISTRIB, V13, P243, DOI 10.1111/j.1472-4642.2007.00356.x; Pearce J, 2000, ECOL MODEL, V133, P225, DOI 10.1016/S0304-3800(00)00322-7; Pedrana J, 2010, BIODIVERS CONSERV, V19, P3499, DOI 10.1007/s10531-010-9910-1; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Phillips SJ, 2009, ECOL APPL, V19, P181, DOI 10.1890/07-2153.1; Pino M, 2013, QUATERN INT, V299, P3, DOI 10.1016/j.quaint.2012.05.001; Politis GG, 2011, J ARCHAEOL SCI, V38, P1405, DOI 10.1016/j.jas.2011.01.013; Rabus B, 2003, ISPRS J PHOTOGRAMM, V57, P241, DOI 10.1016/S0924-2716(02)00124-7; Samaniego H, 2013, THEOR ECOL-NETH, V6, P419, DOI 10.1007/s12080-013-0177-5; Samaniego H, 2009, REV CHIL HIST NAT, V82, P135, DOI 10.4067/S0716-078X2009000100009; Schulz N, 2011, ERDKUNDE, V65, P169, DOI 10.3112/erdkunde.2011.02.05; Syphard AD, 2009, ECOGRAPHY, V32, P907, DOI 10.1111/j.1600-0587.2009.05883.x; Vidiella PE, 1999, J ARID ENVIRON, V43, P449, DOI 10.1006/jare.1999.0565; Wake DB, 2009, P NATL ACAD SCI USA, V106, P19631, DOI 10.1073/pnas.0911097106; Warren DL, 2008, EVOLUTION, V62, P2868, DOI 10.1111/j.1558-5646.2008.00482.x; Warren DL, 2010, ECOGRAPHY, V33, P607, DOI 10.1111/j.1600-0587.2009.06142.x; Weaver KF, 2006, DIVERS DISTRIB, V12, P756, DOI 10.1111/j.1472-4642.2006.00289.x; Wellenreuther M, 2012, ECOLOGY, V93, P1353; Wiens JJ, 2004, EVOLUTION, V58, P193, DOI 10.1111/j.0014-3820.2004.tb01586.x; Wiens JJ, 2005, ANNU REV ECOL EVOL S, V36, P519, DOI 10.1146/annurev.ecolsys.36.102803.095431	61	8	8	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78894	10.1371/journal.pone.0078894	http://dx.doi.org/10.1371/journal.pone.0078894			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265726	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100059
J	Harren, K; Brandhoff, B; Knodler, M; Tudzynski, B				Harren, Karin; Brandhoff, Beate; Knoedler, Michael; Tudzynski, Bettina			The High-Affinity Phosphodiesterase BcPde2 Has Impact on Growth, Differentiation and Virulence of the Phytopathogenic Ascomycete Botrytis cinerea	PLOS ONE			English	Article							CYCLIC-AMP PHOSPHODIESTERASE; ALPHA SUBUNIT BCG1; GRAY MOLD FUNGUS; CAMP-PHOSPHODIESTERASE; SIGNAL-TRANSDUCTION; GENE-EXPRESSION; PROTEIN; CLONING; GERMINATION; INFECTION	Components of the cAMP signaling pathway, such as the adenylate cyclase Bac and the protein kinase A (PKA) were shown to affect growth, morphogenesis and differentiation as well as virulence of the phytopathogenic fungus Botrytis cinerea. While loss of Bac caused drastically reduced intracellular cAMP levels, deletion of the PKA resulted in extremely increased cAMP concentrations. To regulate the intracellular level of the second messenger cAMP, a balance between its biosynthesis through adenylate cyclase activity and its hydrolysis by phosphodiesterases (PDEs) is crucial. Here, we report the functional characterization of the two PDEs in the ascomycete B. cinerea, BcPde1 and BcPde2. While deletion of bcpde2 resulted in severely affected vegetative growth, conidiation, germination and virulence, the bcpde1 deletion strain displayed a wild-type-like phenotype. However, the double bcpde1/2 deletion mutant exhibited an even stronger phenotype. Localization studies revealed that BcPde2 accumulates at the plasma membrane, but is also localized in the cytoplasm. BcPde1 was shown to be distributed in the cytoplasm as well, but also accumulates in so far unknown mobile vesicles. Overexpression of bcpde1 in the Delta bcpde2 background rescued the deletion phenotype, and in addition an increased transcript level of bcpde1 in the Delta bcpde2 strain was observed, indicating redundant functions of both PDEs and an interdependent gene expression.	[Harren, Karin; Brandhoff, Beate; Knoedler, Michael; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Plants, D-48149 Munster, Germany	University of Munster	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Plants, D-48149 Munster, Germany.	tudzynsb@uni-muenster.de			Deutsche Forschungsgemeinschaft (DFG) [TU101/10-6]	Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	The research was supported by the Deutsche Forschungsgemeinschaft (DFG) grant number TU101/10-6. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beene DL, 2007, CURR OPIN CELL BIOL, V19, P192, DOI 10.1016/j.ceb.2007.02.011; BUTTNER P, 1994, CURR GENET, V25, P445, DOI 10.1007/BF00351784; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Conti M, 2007, ANNU REV BIOCHEM, V76, P481, DOI 10.1146/annurev.biochem.76.060305.150444; Doehlemann G, 2006, MOL MICROBIOL, V59, P821, DOI 10.1111/j.1365-2958.2005.04991.x; Elad Y, 2004, BOTRYTIS: BIOLOGY, PATHOLOGY AND CONTROL, P1; Greenwald CJ, 2010, GENETICS, V186, P1217, DOI 10.1534/genetics.110.121780; Gronover CS, 2004, MOL PLANT MICROBE IN, V17, P537, DOI 10.1094/MPMI.2004.17.5.537; Gronover CS, 2001, MOL PLANT MICROBE IN, V14, P1293, DOI 10.1094/MPMI.2001.14.11.1293; Harren K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041761; Hicks JK, 2005, EUKARYOT CELL, V4, P1971, DOI 10.1128/EC.4.12.1971-1981.2005; Jung WH, 2005, YEAST, V22, P285, DOI 10.1002/yea.1199; Klimpel A, 2002, MOL PLANT PATHOL, V3, P439, DOI 10.1046/j.1364-3703.2002.00137.x; Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000; Leroch M, 2011, APPL ENVIRON MICROB, V77, P2887, DOI 10.1128/AEM.02644-10; Liebmann B, 2004, INFECT IMMUN, V72, P5193, DOI 10.1128/IAI.72.9.5193-5203.2004; Ma PS, 1999, MOL BIOL CELL, V10, P91, DOI 10.1091/mbc.10.1.91; NIKAWA J, 1987, GENE DEV, V1, P931, DOI 10.1101/gad.1.9.931; NIKAWA JI, 1987, MOL CELL BIOL, V7, P3629, DOI 10.1128/MCB.7.10.3629; Park JI, 2005, BIOCHEM BIOPH RES CO, V327, P311, DOI 10.1016/j.bbrc.2004.12.019; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; Portela P, 2006, BIOCHEM J, V396, P117, DOI 10.1042/BJ20051642; Quidde T, 1999, EUR J PLANT PATHOL, V105, P273, DOI 10.1023/A:1008796006051; Ramanujam R, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000897; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SASS P, 1986, P NATL ACAD SCI USA, V83, P9303, DOI 10.1073/pnas.83.24.9303; Schumacher J, 2008, MOL PLANT MICROBE IN, V21, P1443, DOI 10.1094/MPMI-21-11-1443; Schumacher J, 2008, EUKARYOT CELL, V7, P584, DOI 10.1128/EC.00426-07; Schumacher J, 2008, MOL MICROBIOL, V67, P1027, DOI 10.1111/j.1365-2958.2008.06105.x; Schumacher J, 2012, FUNGAL GENET BIOL, V49, P483, DOI 10.1016/j.fgb.2012.03.005; Siewers V, 2004, APPL ENVIRON MICROB, V70, P3868, DOI 10.1128/AEM.70.7.3868-3876.2004; Staben C, 1989, FUNGAL GENET NEWSL, V36, P79, DOI DOI 10.4148/1941-4765.1519; Stangherlin A, 2011, J CARDIOVASC PHARM, V58, P345, DOI 10.1097/FJC.0b013e3182214f2b; SUORANTA K, 1984, J BIOL CHEM, V259, P6964; van Kan JAL, 2006, TRENDS PLANT SCI, V11, P247, DOI 10.1016/j.tplants.2006.03.005; Williamson B, 2007, MOL PLANT PATHOL, V8, P561, DOI 10.1111/J.1364-3703.2007.00417.X; Zaccolo M, 2009, BRIT J PHARMACOL, V158, P50, DOI 10.1111/j.1476-5381.2009.00185.x; Zhang HF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017241	39	15	17	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78525	10.1371/journal.pone.0078525	http://dx.doi.org/10.1371/journal.pone.0078525			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265695	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100028
J	He, SQ; Minton, AZ; Ma, HY; Stankowska, DL; Sun, XL; Krishnamoorthy, RR				He, Shaoqing; Minton, Alena Z.; Ma, Hai-Ying; Stankowska, Dorota L.; Sun, Xiangle; Krishnamoorthy, Raghu R.			Involvement of AP-1 and C/EBP beta in Upregulation of Endothelin B (ETB) Receptor Expression in a Rodent Model of Glaucoma	PLOS ONE			English	Article							BINDING-PROTEIN-BETA; ELEVATED INTRAOCULAR-PRESSURE; NERVE HEAD ASTROCYTES; SMOOTH-MUSCLE-CELLS; OPEN-ANGLE GLAUCOMA; NF-KAPPA-B; TRANSCRIPTION FACTORS; C-JUN; SIGNALING PATHWAYS; GENE-EXPRESSION	Previous studies showed that the endothelin B receptor (ETB) expression was upregulated and played a key role in neurodegeneration in rodent models of glaucoma. However, the mechanisms underlying upregulation of ETB receptor expression remain largely unknown. Using promoter-reporter assays, the 1258 bp upstream the human ETB promoter region was found to be essential for constitutive expression of ETB receptor gene in human non-pigmented ciliary epithelial cells (HNPE). The -300 to -1 bp and -1258 to -600 bp upstream promoter regions of the ETB receptor appeared to be the key binding regions for transcription factors. In addition, the crucial AP-1 binding site located at -615 to -624 bp upstream promoter was confirmed by luciferase assays and CHIP assays which were performed following overexpression of c-Jun in HNPE cells. Overexpression of either c-Jun or C/EBP beta enhanced the ETB receptor promoter activity, which was reflected in increased mRNA and protein levels of ETB receptor. Furthermore, knock-down of either c-Jun or C/EBP beta in HNPE cells was significantly correlated to decreased mRNA levels of both ETB and ETA receptor. These observations suggest that c-Jun and C/EBP beta are important for regulated expression of the ETB receptor in HNPE cells. In separate experiments, intraocular pressure (IOP) was elevated in one eye of Brown Norway rats while the corresponding contralateral eye served as control. Two weeks of IOP elevation produced increased expression of c-Jun and C/EBP beta in the retinal ganglion cell (RGC) layer from IOP-elevated eyes. The mRNA levels of c-Jun, ETA and ETB receptor were upregulated by 2.2-, 3.1-and 4.4-fold in RGC layers obtained by laser capture microdissection from retinas of eyes with elevated IOP, compared to those from contralateral eyes. Taken together, these data suggest that transcription factor AP-1 plays a key role in elevation of ETB receptor in a rodent model of ocular hypertension.	[He, Shaoqing; Minton, Alena Z.; Stankowska, Dorota L.; Krishnamoorthy, Raghu R.] Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX 76107 USA; [Ma, Hai-Ying] Univ N Texas, Hlth Sci Ctr, Dept Pharmacol & Neurosci, Ft Worth, TX USA; [Sun, Xiangle] Univ N Texas, Hlth Sci Ctr, Dept Mol Biol & Immunol, Ft Worth, TX USA	University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center; University of North Texas System; University of North Texas Health Science Center	He, SQ (corresponding author), Univ N Texas, Hlth Sci Ctr, Dept Cell Biol & Anat, Ft Worth, TX 76107 USA.	Shaoqing.He@unthsc.edu			National Eye Institute [EY019952]; NATIONAL EYE INSTITUTE [R01EY019952] Funding Source: NIH RePORTER	National Eye Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	The study was funded by a grant from National Eye Institute (EY019952) to RRK. The study was funded by a grant from National Eye Institute (EY019952) to RRK. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bein K, 2011, AM J RESP CELL MOL, V45, P436, DOI 10.1165/rcmb.2010-0260OC; Cattaruzza M, 2001, J BIOL CHEM, V276, P36999, DOI 10.1074/jbc.M105158200; Chauhan BC, 2008, CAN J OPHTHALMOL, V43, P356, DOI 10.3129/i08-060; Chen SL, 2003, AM J PHYSIOL-CELL PH, V284, pC263, DOI 10.1152/ajpcell.00192.2002; Chintalgattu V, 2004, J PHARMACOL EXP THER, V311, P691, DOI 10.1124/jpet.104.070151; Clark AF, 2003, NAT REV DRUG DISCOV, V2, P448, DOI 10.1038/nrd1106; Fernandes KA, 2012, NEUROBIOL DIS, V46, P393, DOI 10.1016/j.nbd.2012.02.003; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gonsalves C, 2010, J IMMUNOL, V185, P6253, DOI 10.4049/jimmunol.1000660; Grondin B, 2007, MOL CELL BIOL, V27, P2919, DOI 10.1128/MCB.00936-06; Guo Y, 2011, INVEST OPHTH VIS SCI, V52, P1460, DOI 10.1167/iovs.10-5930; Guo Y, 2010, INVEST OPHTH VIS SCI, V51, P3003, DOI 10.1167/iovs.09-4663; Hashimoto K, 2005, BRAIN RES, V1054, P103, DOI 10.1016/j.brainres.2005.06.050; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; Howell GR, 2011, J CLIN INVEST, V121, P1429, DOI 10.1172/JCI44646; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Iwai-Kanai E, 2004, MOL CELL BIOCHEM, V259, P163, DOI 10.1023/B:MCBI.0000021368.80389.b9; Ji Y, 2004, CANCER RES, V64, P370, DOI 10.1158/0008-5472.CAN-03-3029; Johnson PF, 2005, J CELL SCI, V118, P2545, DOI 10.1242/jcs.02459; Krishnamoorthy RR, 2008, CAN J PHYSIOL PHARM, V86, P380, DOI 10.1139/Y08-040; Kuwaki T, 1997, PROG NEUROBIOL, V51, P545, DOI 10.1016/S0301-0082(96)00063-9; Lau J, 2006, EXP EYE RES, V82, P132, DOI 10.1016/j.exer.2005.06.002; Lekstrom-Himes J, 1998, J BIOL CHEM, V273, P28545, DOI 10.1074/jbc.273.44.28545; Levkovitch-Verbin H, 2005, EXP EYE RES, V80, P663, DOI 10.1016/j.exer.2004.11.016; MACCUMBER MW, 1994, ARCH OPHTHALMOL-CHIC, V112, P1231, DOI 10.1001/archopht.1994.01090210119024; MARTINVASALLO P, 1989, J CELL PHYSIOL, V141, P243, DOI 10.1002/jcp.1041410203; Minton AZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043199; Morga E, 2000, J NEUROCHEM, V74, P603, DOI 10.1046/j.1471-4159.2000.740603.x; Morrison JC, 1997, EXP EYE RES, V64, P85, DOI 10.1006/exer.1996.0184; Nerlov C, 2008, CURR OPIN CELL BIOL, V20, P180, DOI 10.1016/j.ceb.2008.02.002; Noske, 1997, GRAEFES ARCH CLIN EX, V235, P551; Orgul S, 1996, INVEST OPHTH VIS SCI, V37, P1860; Prasanna G, 2005, PHARMACOL RES, V51, P41, DOI 10.1016/j.phrs.2004.04.006; Prasanna G, 2003, MOL CELL BIOCHEM, V253, P71, DOI 10.1023/A:1026005418874; Prasanna G, 2002, INVEST OPHTH VIS SCI, V43, P2704; Quigley EN, 1996, OPHTHALMOLOGY, V103, P1680, DOI 10.1016/S0161-6420(96)30447-8; Quigley HA, 1996, BRIT J OPHTHALMOL, V80, P389, DOI 10.1136/bjo.80.5.389; Rahman SM, 2007, HEPATOLOGY, V45, P1108, DOI 10.1002/hep.21614; Schinelli S, 2001, J NEUROSCI, V21, P8842, DOI 10.1523/JNEUROSCI.21-22-08842.2001; Shackleford TJ, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2902; Shaulian E, 2002, NAT CELL BIOL, V4, pE131, DOI 10.1038/ncb0502-e131; Shichiri M, 1998, MOL ENDOCRINOL, V12, P172, DOI 10.1210/me.12.2.172; Stitt AW, 1996, CURR EYE RES, V15, P111, DOI 10.3109/02713689609017618; Sutcliffe AM, 2009, BRIT J PHARMACOL, V157, P436, DOI 10.1111/j.1476-5381.2009.00143.x; Tachibana Keisuke, 2005, Nucl Recept, V3, P3, DOI 10.1186/1478-1336-3-3; Tezel G, 1997, J GLAUCOMA, V6, P83; Tsukada J, 2011, CYTOKINE, V54, P6, DOI 10.1016/j.cyto.2010.12.019; Wagner AH, 2000, MOL PHARMACOL, V58, P1333, DOI 10.1124/mol.58.6.1333; Wang L, 2006, ARCH OPHTHALMOL-CHIC, V124, P717, DOI 10.1001/archopht.124.5.717; Yang ZY, 2007, INVEST OPHTH VIS SCI, V48, P5539, DOI 10.1167/iovs.07-0542; Yorio T, 2002, J GLAUCOMA, V11, P259, DOI 10.1097/00061198-200206000-00016; Zhang XY, 2003, EXP EYE RES, V76, P261, DOI 10.1016/S0014-4835(02)00323-8; Zhou MS, 2010, J CARDIOVASC PHARM T, V15, P78, DOI 10.1177/1074248409354603	53	16	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79183	10.1371/journal.pone.0079183	http://dx.doi.org/10.1371/journal.pone.0079183			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265756	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100089
J	Huang, W; McDowell, WH; Zou, XM; Ruan, HH; Wang, JS; Li, LG				Huang, Wei; McDowell, William H.; Zou, Xiaoming; Ruan, Honghua; Wang, Jiashe; Li, Liguang			Dissolved Organic Carbon in Headwater Streams and Riparian Soil Organic Carbon along an Altitudinal Gradient in the Wuyi Mountains, China	PLOS ONE			English	Article							ELEVATION GRADIENT; DOC; NITROGEN; MATTER; VEGETATION; TRANSPORT; WATER; PEATLAND; RELEASE; EXPORT	Stream water dissolved organic carbon (DOC) correlates positively with soil organic carbon (SOC) in many biomes. Does this relationship hold in a small geographic region when variations of temperature, precipitation and vegetation are driven by a significant altitudinal gradient? We examined the spatial connectivity between concentrations of DOC in headwater stream and contents of riparian SOC and water-soluble soil organic carbon (WSOC), riparian soil C:N ratio, and temperature in four vegetation types along an altitudinal gradient in the Wuyi Mountains, China. Our analyses showed that annual mean concentrations of headwater stream DOC were lower in alpine meadow (AM) than in subtropical evergreen broadleaf forest (EBF), coniferous forest (CF), and subalpine dwarf forest (SDF). Headwater stream DOC concentrations were negatively correlated with riparian SOC as well as WSOC contents, and were unrelated to riparian soil C: N ratio. Our findings suggest that DOC concentrations in headwater streams are affected by different factors at regional and local scales. The dilution effect of higher precipitation and adsorption of soil DOC to higher soil clay plus silt content at higher elevation may play an important role in causing lower DOC concentrations in AM stream of the Wuyi Mountains. Our results suggest that upscaling and downscaling of the drivers of DOC export from forested watersheds when exploring the response of carbon flux to climatic change or other drivers must done with caution.	[Huang, Wei; Zou, Xiaoming; Ruan, Honghua; Li, Liguang] Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China; [McDowell, William H.] Univ New Hampshire, Dept Nat Resources & Environm, Durham, NH 03824 USA; [Zou, Xiaoming] Univ Puerto Rico, Inst Trop Ecosyst Studies, San Juan, PR 00936 USA; [Wang, Jiashe] Adm Bur Wuyishan Natl Nat Reserve, Wuyishan, Fujian, Peoples R China; [Li, Liguang] Univ Florida, Soil & Water Sci Dept, Gainesville, FL USA	Nanjing Forestry University; University System Of New Hampshire; University of New Hampshire; University of Puerto Rico; University of Puerto Rico Rio Piedras; State University System of Florida; University of Florida	Ruan, HH (corresponding author), Nanjing Forestry Univ, Fac Forest Resources & Environm Sci, Nanjing, Jiangsu, Peoples R China.	honghuaruan@gmail.com	Li, Liguang/Q-2916-2019; Zou, Xiaoming/GWV-5608-2022; McDowell, William H/E-9767-2010	Zou, Xiaoming/0000-0001-9023-3067; McDowell, William H/0000-0002-8739-9047	National Science Foundation of China [31170417]; Chinese National Public-Welfare Program [200804006]; Doctorate Fellowship Foundation of Nanjing Forestry University [163010106]; Scientific and Technological Innovation Foundation for Graduate Student of Jiangsu Province [CXZZ_110510]	National Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese National Public-Welfare Program; Doctorate Fellowship Foundation of Nanjing Forestry University; Scientific and Technological Innovation Foundation for Graduate Student of Jiangsu Province	This study was supported by the National Science Foundation of China (No. 31170417), Chinese National Public-Welfare Program (No. 200804006), Doctorate Fellowship Foundation of Nanjing Forestry University (No. 163010106) and Scientific and Technological Innovation Foundation for Graduate Student of Jiangsu Province (No. CXZZ_110510). The funders had role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren AM, 2012, GLOBAL CHANGE BIOL, V18, P1895, DOI 10.1111/j.1365-2486.2012.02666.x; Aitkenhead JA, 2000, GLOBAL BIOGEOCHEM CY, V14, P127, DOI 10.1029/1999GB900083; Aitkenhead JA, 1999, HYDROL PROCESS, V13, P1289, DOI 10.1002/(SICI)1099-1085(19990615)13:8&lt;1289::AID-HYP766&gt;3.0.CO;2-M; Aitkenhead-Peterson JA, 2007, WATER RESOUR RES, V43, DOI 10.1029/2006WR004999; Aitkenhead-Peterson JA, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002438; Amiotte-suchet P, 2007, J HYDROL, V335, P354, DOI 10.1016/j.jhydrol.2006.12.002; Armstrong A, 2012, ECOL ENG, V47, P182, DOI 10.1016/j.ecoleng.2012.06.027; Balcarczyk KL, 2009, BIOGEOCHEMISTRY, V94, P255, DOI 10.1007/s10533-009-9324-x; Billett MF, 2006, J GEOPHYS RES-BIOGEO, V111, DOI 10.1029/2005JG000065; Brooks PD, 1999, WATER RESOUR RES, V35, P1895, DOI 10.1029/1998WR900125; Bu XL, 2010, GEODERMA, V159, P139, DOI 10.1016/j.geoderma.2010.07.005; Clark JM, 2007, J HYDROL, V347, P438, DOI 10.1016/j.jhydrol.2007.09.030; Cole JJ, 2007, ECOSYSTEMS, V10, P171, DOI 10.1007/s10021-006-9013-8; CRONAN CS, 1985, GEOCHIM COSMOCHIM AC, V49, P1697, DOI 10.1016/0016-7037(85)90140-1; Dillon PJ, 2005, J GEOPHYS RES-BIOGEO, V110, DOI 10.1029/2004JG000003; DOSSKEY MG, 1994, BIOGEOCHEMISTRY, V24, P1, DOI 10.1007/BF00001304; Eimers MC, 2008, GLOBAL CHANGE BIOL, V14, P938, DOI 10.1111/j.1365-2486.2007.01530.x; FIEBIG DM, 1991, FRESHWATER BIOL, V26, P45, DOI 10.1111/j.1365-2427.1991.tb00507.x; FIEBIG DM, 1990, J HYDROL, V116, P217, DOI 10.1016/0022-1694(90)90124-G; Findlay SEG, 2005, FRONT ECOL ENVIRON, V3, P133, DOI 10.1890/1540-9295(2005)003[0133:ICTITH]2.0.CO;2; Froberg M, 2011, FOREST ECOL MANAG, V262, P1742, DOI 10.1016/j.foreco.2011.07.033; Harrison AF, 2008, GLOBAL CHANGE BIOL, V14, P687, DOI 10.1111/j.1365-2486.2007.01504.x; He J. Y., 1994, WUYISHAN RES SERIES; He Rong, 2009, Shengtaixue Zazhi, V28, P394; Hope D, 1997, HYDROL PROCESS, V11, P325, DOI 10.1002/(SICI)1099-1085(19970315)11:3&lt;325::AID-HYP476&gt;3.0.CO;2-I; JARDINE PM, 1989, SOIL SCI SOC AM J, V53, P1378, DOI 10.2136/sssaj1989.03615995005300050013x; Jiang PK, 2006, FOREST ECOL MANAG, V236, P30, DOI 10.1016/j.foreco.2006.06.010; Jones DL, 2006, SOIL BIOL BIOCHEM, V38, P991, DOI 10.1016/j.soilbio.2005.08.012; LEE KE, 1991, AUST J SOIL RES, V29, P745, DOI 10.1071/SR9910745; MCDOWELL WH, 1984, SOIL SCI, V137, P23, DOI 10.1097/00010694-198401000-00004; MEYER JL, 1990, LIFE SCI R, V48, P281; Monteith DT, 2007, NATURE, V450, P537, DOI 10.1038/nature06316; Moore TR, 2008, ECOSYSTEMS, V11, P740, DOI 10.1007/s10021-008-9156-x; Moore TR, 2001, SOIL SCI, V166, P38, DOI 10.1097/00010694-200101000-00007; Nakagawa Y, 2008, LIMNOLOGY, V9, P195, DOI 10.1007/s10201-008-0251-7; Neff JC, 2002, GLOBAL CHANGE BIOL, V8, P872, DOI 10.1046/j.1365-2486.2002.00517.x; NELSON PN, 1993, BIOGEOCHEMISTRY, V19, P27; Preston MD, 2011, SCI TOTAL ENVIRON, V409, P1235, DOI 10.1016/j.scitotenv.2010.12.027; Strahler NA, 1957, AM GEOPHYS UNION T, V38, P912; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Turgeon JML, 2008, HYDROL PROCESS, V22, P327, DOI 10.1002/hyp.6613; Wang SJ, 2010, ECOL RES, V25, P1113, DOI 10.1007/s11284-010-0736-9; Weyhenmeyer GA, 2009, LIMNOL OCEANOGR, V54, P2513, DOI 10.4319/lo.2009.54.6_part_2.2513; Xu X., 2010, J RESOURCES ECOLOGY, V1, P368, DOI [10.3969/j.issn.1674-764x.2010.04.010, DOI 10.3969/J.ISSN.1674-764X.2010.04.010]; Yamashita Y, 2011, ECOSYSTEMS, V14, P1110, DOI 10.1007/s10021-011-9469-z	45	15	17	6	77	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78973	10.1371/journal.pone.0078973	http://dx.doi.org/10.1371/journal.pone.0078973			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265737	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100070
J	Ishinabe, N; Fujii, H; Managi, S				Ishinabe, Nagisa; Fujii, Hidemichi; Managi, Shunsuke			The True Cost of Greenhouse Gas Emissions: Analysis of 1,000 Global Companies	PLOS ONE			English	Article								This study elucidated the shadow price of greenhouse gas (GHG) emissions for 1,024 international companies worldwide that were surveyed from 15 industries in 37 major countries. Our results indicate that the shadow price of GHG at the firm level is much higher than indicated in previous studies. The higher shadow price was found in this study as a result of the use of Scope 3 GHG emissions data. The results of this research indicate that a firm would carry a high cost of GHG emissions if Scope 3 GHG emissions were the focus of the discussion of corporate social responsibility. In addition, such shadow prices were determined to differ substantially among countries, among sectors, and within sectors. Although a number of studies have calculated the shadow price of GHG emissions, these studies have employed country-level or industry-level data or a small sample of firm-level data in one country. This new data from a worldwide firm analysis of the shadow price of GHG emissions can play an important role in developing climate policy and promoting sustainable development.	[Ishinabe, Nagisa] Purdue Univ, Dept Agr Econ, W Lafayette, IN 47907 USA; [Fujii, Hidemichi; Managi, Shunsuke] Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 980, Japan; [Managi, Shunsuke] Inst Global Environm Strategies, Hayama, Kanagawa, Japan	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Tohoku University	Managi, S (corresponding author), Tohoku Univ, Grad Sch Environm Studies, Sendai, Miyagi 980, Japan.	managi.s@gmail.com	Fujii, Hidemichi/E-8261-2014; Managi, Shunsuke/G-1740-2013	Fujii, Hidemichi/0000-0002-3043-1122; Managi, Shunsuke/0000-0001-7883-1427	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); Grants-in-Aid for Scientific Research [24651034] Funding Source: KAKEN	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This research was funded by a Grant-in-Aid for Japanese Ministry of the Environment conducted in 2011 and a Grant-in-Aid for Scientific Research from (B) in 2011 from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Fare R, 2005, J ECONOMETRICS, V126, P469, DOI 10.1016/j.jeconom.2004.05.010; Lee JD, 2002, J ENVIRON MANAGE, V64, P365, DOI 10.1006/jema.2001.0480; Lobell DB, 2011, SCIENCE, V333, P616, DOI [10.1126/science.1204531, 10.1126/science.1206376]; Parry M., 2007, CLIMATE CHANGE 2007, P7, DOI DOI 10.2134/JEQ2008.0015BR	4	7	7	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78703	10.1371/journal.pone.0078703	http://dx.doi.org/10.1371/journal.pone.0078703			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265710	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100043
J	Mukhopadhyay, P; Farrell, T; Sharma, G; McGuire, TR; O'Kane, B; Sharp, JG				Mukhopadhyay, Partha; Farrell, Tracy; Sharma, Gayatri; McGuire, Timothy R.; O'Kane, Barbara; Sharp, J. Graham			Heterogeneity of Functional Properties of Clone 66 Murine Breast Cancer Cells Expressing Various Stem Cell Phenotypes	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; ENDOTHELIAL GROWTH-FACTOR; SIDE POPULATION CELLS; IN-VITRO PROPAGATION; MULTIPLE-MYELOMA; GENE-EXPRESSION; NUDE-MICE; ANGIOGENESIS; TUMORIGENESIS; CARCINOMA	Introduction: Breast cancer grows, metastasizes and relapses from rare, therapy resistant cells with a stem cell phenotype (cancer stem cells/CSCs). However, there is a lack of studies comparing the functions of CSCs isolated using different phenotypes in order to determine if CSCs are homogeneous or heterogeneous. Methods: Cells with various stem cell phenotypes were isolated by sorting from Clone 66 murine breast cancer cells that grow orthotopically in immune intact syngeneic mice. These populations were compared by in vitro functional assays for proliferation, growth, sphere and colony formation; and in vivo limiting dilution analysis of tumorigenesis. Results: The proportion of cells expressing CD44(high)CD24(low/neg), side population (SP) cells, ALDH1(+), CD49f(high), CD133(high), and CD34(high) differed, suggesting heterogeneity. Differences in frequency and size of tumor spheres from these populations were observed. Higher rates of proliferation of non-SP, ALDH1(+), CD34(low), and CD49f(high) suggested properties of transit amplifying cells. Colony formation was higher from ALDH1(-) and non-SP cells than ALDH1(+) and SP cells suggesting a progenitor phenotype. The frequency of clonal colonies that grew in agar varied and was differentially altered by the presence of Matrigel (TM). In vivo, fewer cells with a stem cell phenotype were needed for tumor formation than "non-stem" cells. Fewer SP cells were needed to form tumors than ALDH1(+) cells suggesting further heterogeneities of cells with stem phenotypes. Different levels of cytokines/chemokines were produced by Clone 66 with RANTES being the highest. Whether the heterogeneity reflects soluble factor production remains to be determined. Conclusions: These data demonstrate that Clone 66 murine breast cancer cells that express stem cell phenotypes are heterogeneous and exhibit different functional properties, and this may also be the case for human breast cancer stem cells.	[Mukhopadhyay, Partha; Farrell, Tracy; Sharma, Gayatri; Sharp, J. Graham] Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA; [McGuire, Timothy R.] Univ Nebraska Med Ctr, Omaha, NE USA; [O'Kane, Barbara] Creighton Univ Sch Dent, Dept Oral Biol, Omaha, NE USA	University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center; Creighton University	Sharp, JG (corresponding author), Univ Nebraska Med Ctr, Dept Genet Cell Biol & Anat, Omaha, NE 68198 USA.	jsharp@unmc.edu		Mukhopadhyay, Partha/0000-0001-5817-0174	Nebraska Tobacco Settlement Biomedical Research Development Funds	Nebraska Tobacco Settlement Biomedical Research Development Funds	This work was supported by Nebraska Tobacco Settlement Biomedical Research Development Funds awarded to JGS, and sabbatical funding to TM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acharyya S, 2012, CELL, V150, P165, DOI 10.1016/j.cell.2012.04.042; Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Avwioro G., 2011, J PHARM CLIN SCI JPC, V1, P24; Azenshtein E, 2005, CANCER LETT, V217, P73, DOI 10.1016/j.canlet.2004.05.024; Azenshtein E, 2002, CANCER RES, V62, P1093; Badve S, 2012, LANCET ONCOL, V13, pE43, DOI 10.1016/S1470-2045(11)70191-7; Benoy IH, 2005, BREAST CANCER RES, V7, pR210, DOI 10.1186/bcr980; Berezov TT, 2009, B EXP BIOL MED+, V148, P419, DOI 10.1007/s10517-010-0727-4; Bigelow RLH, 2009, BREAST CANCER RES TR, V117, P31, DOI 10.1007/s10549-008-0170-7; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Britton KM, 2012, CANCER LETT, V323, P97, DOI 10.1016/j.canlet.2012.03.041; Cariati M, 2008, INT J CANCER, V122, P298, DOI 10.1002/ijc.23103; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Chiba T, 2006, HEPATOLOGY, V44, P240, DOI 10.1002/hep.21227; Clarke Michael F, 2006, Cancer Res, V66, P9339, DOI 10.1158/0008-5472.CAN-06-3126; DEXTER DL, 1978, CANCER RES, V38, P3174; Dick JE, 2008, BLOOD, V112, P4793, DOI 10.1182/blood-2008-08-077941; Dixit M, 1997, J NATL CANCER I, V89, P365, DOI 10.1093/jnci/89.5.365; Donjacour A A, 1991, Cancer Treat Res, V53, P335; Dontu G, 2005, J MAMMARY GLAND BIOL, V10, P75, DOI 10.1007/s10911-005-2542-5; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Doyle LA, 1998, P NATL ACAD SCI USA, V95, P15665, DOI 10.1073/pnas.95.26.15665; FREEDMAN VH, 1974, CELL, V3, P355, DOI 10.1016/0092-8674(74)90050-6; Gazzaniga S, 2007, J INVEST DERMATOL, V127, P2031, DOI 10.1038/sj.jid.5700827; Gellmini S, 2008, J ENDOCRINOL INVEST, V31, P809, DOI 10.1007/BF03349262; Ginestier C, 2007, CELL STEM CELL, V1, P555, DOI 10.1016/j.stem.2007.08.014; Grimshaw MJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2106; Houghton PJ, 2004, CANCER RES, V64, P2333, DOI 10.1158/0008-5472.CAN-03-3344; Iliopoulos D, 2011, P NATL ACAD SCI USA, V108, P1397, DOI 10.1073/pnas.1018898108; Kakarala M, 2008, J CLIN ONCOL, V26, P2813, DOI 10.1200/JCO.2008.16.3931; Kelly PN, 2007, SCIENCE, V317, P337, DOI 10.1126/science.1142596; Khodarev NN, 2003, J CELL SCI, V116, P1013, DOI 10.1242/jcs.00281; Koga M, 2008, BIOCHEM BIOPH RES CO, V365, P279, DOI 10.1016/j.bbrc.2007.10.182; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kryczek I, 2005, CANCER RES, V65, P465; Kuroda T, 2005, CLIN CANCER RES, V11, P7629, DOI 10.1158/1078-0432.CCR-05-0798; Laoui D, 2011, INT J DEV BIOL, V55, P861, DOI 10.1387/ijdb.113371dl; Lin SS, 2012, CANCER SCI, V103, P904, DOI 10.1111/j.1349-7006.2012.02259.x; Lindeman GJ, 2010, ASIA-PAC J CLIN ONCO, V6, P89, DOI 10.1111/j.1743-7563.2010.01279.x; Ling-Ling Z, 2012, SCIENCE, V338, P1485; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Liu SL, 2011, CANCER RES, V71, P614, DOI 10.1158/0008-5472.CAN-10-0538; Lv DD, 2013, CELL MOL IMMUNOL, V10, P303, DOI 10.1038/cmi.2012.69; Masuda A, 1997, CANCER RES, V57, P4898; Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797; Mukhopadhyay P, 2013, PLOS ONE, V8; Mulligan AM, 2013, CLIN CANCER RES, V19, P336, DOI 10.1158/1078-0432.CCR-11-3314; Murphy BO, 2002, CLIN EXP METASTAS, V19, P561; Nakshatri H, 2009, CURR STEM CELL RES T, V4, P50, DOI 10.2174/157488809787169110; Nguyen LV, 2012, NAT REV CANCER, V12, P133, DOI 10.1038/nrc3184; O'Brien CA, 2007, NATURE, V445, P106, DOI 10.1038/nature05372; Pereira Carla, 2007, V407, P177, DOI 10.1007/978-1-59745-536-7_14; Pichiorri F, 2008, P NATL ACAD SCI USA, V105, P12885, DOI 10.1073/pnas.0806202105; Pierce GB, 1974, DEV ASPECTS CARCINOG, P3; Ponti D, 2005, CANCER RES, V65, P5506, DOI 10.1158/0008-5472.CAN-05-0626; Qin W, 2012, HUMANIZED MOUSE MODE; Raman D, 2007, CANCER LETT, V256, P137, DOI 10.1016/j.canlet.2007.05.013; Ricardo S, 2011, J CLIN PATHOL, V64, P937, DOI 10.1136/jcp.2011.090456; Ricci-Vitiani L, 2007, NATURE, V445, P111, DOI 10.1038/nature05384; Robinson SN, 2005, BONE MARROW TRANSPL, V35, P807, DOI 10.1038/sj.bmt.1704881; Sharp JG., 2008, CURRENT MED PHILADEL, P201; Sheridan C, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1610; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Smalley MJ, 2005, J MAMMARY GLAND BIOL, V10, P37, DOI 10.1007/s10911-005-2539-0; Sun CY, 2013, CARCINOGENESIS, V34, P426, DOI 10.1093/carcin/bgs333; Sun XT, 2005, WORLD J GASTROENTERO, V11, P2283, DOI 10.3748/wjg.v11.i15.2283; Thorup J, 2010, J PEDIATR SURG, V45, P2074, DOI 10.1016/j.jpedsurg.2010.07.030; Vincent A, 2012, BBA-REV CANCER, V1826, P83, DOI 10.1016/j.bbcan.2012.03.009; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Visvader JE, 2009, GENE DEV, V23, P2563, DOI 10.1101/gad.1849509; Wang Y, 2011, CELL STEM CELL, V8, P399, DOI 10.1016/j.stem.2011.02.006; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843; Weber KSC, 1999, ARTERIOSCL THROM VAS, V19, P2085, DOI 10.1161/01.ATV.19.9.2085; Willyard C, 2013, NATURE, V498, pS12, DOI 10.1038/498S12a; Wright MH, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1855; Wu C, 2008, CANCER LETT, V268, P1, DOI 10.1016/j.canlet.2008.03.048; Yaal-Hahoshen N, 2006, CLIN CANCER RES, V12, P4474, DOI 10.1158/1078-0432.CCR-06-0074; Yamada M, 2003, ARTERIOSCL THROM VAS, V23, P1996, DOI 10.1161/01.ATV.0000096208.80992.63	80	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78725	10.1371/journal.pone.0078725	http://dx.doi.org/10.1371/journal.pone.0078725			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265713	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100046
J	Oike, T; Suzuki, Y; Sugawara, K; Shirai, K; Noda, S; Tamaki, T; Nagaishi, M; Yokoo, H; Nakazato, Y; Nakano, T				Oike, Takahiro; Suzuki, Yoshiyuki; Sugawara, Ken-ichi; Shirai, Katsuyuki; Noda, Shin-ei; Tamaki, Tomoaki; Nagaishi, Masaya; Yokoo, Hideaki; Nakazato, Yoichi; Nakano, Takashi			Radiotherapy plus Concomitant Adjuvant Temozolomide for Glioblastoma: Japanese Mono-Institutional Results	PLOS ONE			English	Article							RADIATION-THERAPY; PHASE-II; SURVIVAL; MGMT; IMMUNOHISTOCHEMISTRY; MULTIFORME; EXPRESSION	This study was conducted to investigate the feasibility and survival benefits of combined treatment with radiotherapy and temozolomide (TMZ), which has been covered by the national health insurance in Japanese patients with glioblastoma since September 2006. Between September 2006 and December 2011, 47 patients with newly diagnosed and histologically confirmed glioblastoma received radiotherapy for 60 Gy in 30 fractions. Among them, 45 patients (TMZ group) received concomitant TMZ (75 mg/m(2)/day, every day) and adjuvant TMZ (200 mg/m(2)/day, 5 days during each 28-days). All 36 of the glioblastoma patients receiving radiotherapy between January 1988 and August 2006 were analyzed as historical controls (control group). All patients were followed for at least 1 year or until they died. The median survival was 15.8 months in the TMZ group and 12.0 months in the control group after a median follow-up of 14.0 months. The hazard ratio for death in the TMZ group relative to the control group was 0.52 (P < 0.01); the 2-year survival rate was 27.7% in the TMZ group and 14.6% in the control group. Hematologic toxicity of grade 3 and higher was observed in 20.4% in the TMZ group. Multivariate analysis showed that extent of surgery had the strongest impact on survival (P < 0.01), while the use of TMZ had the second largest impact on survival (P = 0.035). The results indicate that combined treatment with radiotherapy and TMZ has a significant survival benefit for Japanese patients with newly diagnosed glioblastoma with slightly higher toxicities than previously reported.	[Oike, Takahiro; Suzuki, Yoshiyuki; Shirai, Katsuyuki; Noda, Shin-ei; Tamaki, Tomoaki; Nakano, Takashi] Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan; [Sugawara, Ken-ichi] Gunma Univ, Grad Sch Med, Dept Neurosurg, Maebashi, Gunma 371, Japan; [Nagaishi, Masaya; Yokoo, Hideaki; Nakazato, Yoichi] Gunma Univ, Grad Sch Med, Dept Human Pathol, Maebashi, Gunma 371, Japan	Gunma University; Gunma University; Gunma University	Suzuki, Y (corresponding author), Gunma Univ, Grad Sch Med, Dept Radiat Oncol, Maebashi, Gunma 371, Japan.	syoshi@med.gunma-u.ac.jp	Tamaki, Tomoaki/AAU-2699-2020		Grants-in-Aid for Scientific Research [24591834] Funding Source: KAKEN	Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))		Afra D, 2002, LANCET, V359, P1011; Athanassiou H, 2005, J CLIN ONCOL, V23, P2372, DOI 10.1200/JCO.2005.00.331; Brown DC, 2002, HISTOPATHOLOGY, V40, P2, DOI 10.1046/j.1365-2559.2002.01343.x; Chinot OL, 2007, J CLIN ONCOL, V25, P1470, DOI 10.1200/JCO.2006.07.4807; Colleoni M, 2003, BREAST, V12, P538, DOI 10.1016/S0960-9776(03)00163-2; Cunningham JM, 1997, J NEUROSURG, V86, P121, DOI 10.3171/jns.1997.86.1.0121; Gerson SL, 2004, NAT REV CANCER, V4, P296, DOI 10.1038/nrc1319; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Iuchi T, 2006, INT J RADIAT ONCOL, V64, P1317, DOI 10.1016/j.ijrobp.2005.12.005; Lai A, 2011, J CLIN ONCOL, V29, P142, DOI 10.1200/JCO.2010.30.2729; Louis DN, 2007, ACTA NEUROPATHOL, V114, P97, DOI 10.1007/s00401-007-0243-4; Nagaishi M, 2011, NEUROPATHOLOGY, V31, P152, DOI 10.1111/j.1440-1789.2010.01143.x; Prados MD, 2009, J CLIN ONCOL, V27, P579, DOI 10.1200/JCO.2008.18.9639; Preusser M, 2008, BRAIN PATHOL, V18, P520, DOI 10.1111/j.1750-3639.2008.00153.x; Quillien V, 2012, CANCER-AM CANCER SOC, V118, P4201, DOI 10.1002/cncr.27392; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Suzuki Y, 2010, J RADIAT RES, V51, P343, DOI 10.1269/jrr.09109; Tanaka G, 2004, INT CONGR SER, V1259, P15, DOI 10.1016/S0531-5131(03)01668-6; Tang K, 2012, MED ONCOL, V29, P1292, DOI 10.1007/s12032-011-9901-4; Tsien CI, 2012, CLIN CANCER RES, V18, P273, DOI 10.1158/1078-0432.CCR-11-2073; WALKER MD, 1980, NEW ENGL J MED, V303, P1323, DOI 10.1056/NEJM198012043032303; Weller M, 2009, J CLIN ONCOL, V27, P5743, DOI 10.1200/JCO.2009.23.0805	23	62	72	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78943	10.1371/journal.pone.0078943	http://dx.doi.org/10.1371/journal.pone.0078943			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265731	Green Published, gold			2022-12-25	WOS:000327252100064
J	Robinson, TJW; Liu, JC; Vizeacoumar, F; Sun, T; Maclean, N; Egan, SE; Schimmer, AD; Datti, A; Zacksenhaus, E				Robinson, Tyler J. W.; Liu, Jeff C.; Vizeacoumar, Frederick; Sun, Thomas; Maclean, Neil; Egan, Sean E.; Schimmer, Aaron D.; Datti, Alessandro; Zacksenhaus, Eldad			RB1 Status in Triple Negative Breast Cancer Cells Dictates Response to Radiation Treatment and Selective Therapeutic Drugs	PLOS ONE			English	Article							RETINOBLASTOMA TUMOR-SUPPRESSOR; PHASE-II TRIAL; KINASE 4/6 INHIBITOR; BASAL-LIKE; NEOADJUVANT CHEMOTHERAPY; PATHWAY DISRUPTION; CONSERVING SURGERY; ANTITUMOR-ACTIVITY; INITIATING CELLS; PD 0332991	Triple negative breast cancer (TNBC) includes basal-like and claudin-low subtypes for which only chemotherapy and radiation therapy are currently available. The retinoblastoma (RB1) tumor suppressor is frequently lost in human TNBC. Knockdown of RB1 in luminal BC cells was shown to affect response to endocrine, radiation and several antineoplastic drugs. However, the effect of RB1 status on radiation and chemo-sensitivity in TNBC cells and whether RB1 status affects response to divergent or specific treatment are unknown. Using multiple basal-like and claudin-low cell lines, we hereby demonstrate that RB-negative TNBC cell lines are highly sensitive to gamma-irradiation, and moderately more sensitive to doxorubicin and methotrexate compared to RB-positive TNBC cell lines. In contrast, RB1 status did not affect sensitivity of TNBC cells to multiple other drugs including cisplatin (CDDP), 5-fluorouracil, idarubicin, epirubicin, PRIMA-1 met, fludarabine and PD-0332991, some of which are used to treat TNBC patients. Moreover, a non-biased screen of,3400 compounds, including FDA-approved drugs, revealed similar sensitivity of RB-proficient and -deficient TNBC cells. Finally, ESA(+)/CD24 -/ (low)/CD44(+) cancer stem cells from RB-negative TNBC lines were consistently more sensitive to gamma-irradiation than RB-positive lines, whereas the effect of chemotherapy on the cancer stem cell fraction varied irrespective of RB1 expression. Our results suggest that patients carrying RB-deficient TNBCs would benefit from gamma-irradiation as well as doxorubicin and methotrexate therapy, but not necessarily from many other anti-neoplastic drugs.	[Robinson, Tyler J. W.; Zacksenhaus, Eldad] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada; [Liu, Jeff C.; Zacksenhaus, Eldad] Univ Hlth Network, Toronto Gen Res Inst, Div Adv Diagnost, Toronto, ON, Canada; [Vizeacoumar, Frederick; Sun, Thomas; Datti, Alessandro] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, SMART High Throughput Facil, Toronto, ON M5G 1X5, Canada; [Maclean, Neil; Schimmer, Aaron D.] Univ Hlth Network, OCI, Clin Studies Resource Ctr, Toronto, ON, Canada; [Egan, Sean E.] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5G 1X8, Canada; [Datti, Alessandro] Univ Perugia, Dept Expt Med & Biochem Sci, I-06100 Perugia, Italy	University of Toronto; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Perugia	Robinson, TJW (corresponding author), Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada.	tyler.robinson@mail.utoronto.ca; eldad.zacksenhaus@utoronto.ca	Zacksenhaus, Eldad/AAD-3584-2020; Datti, Alessandro/ABA-1108-2021	Datti, Alessandro/0000-0001-6824-7382; Schimmer, Aaron/0000-0003-4023-3899; Vizeacoumar, Frederick/0000-0002-4676-2911	Canadian BC Foundation; Canadian BC Research Alliance; Ontario Institute for Cancer Research; Government of Ontario	Canadian BC Foundation; Canadian BC Research Alliance; Ontario Institute for Cancer Research; Government of Ontario	This study was conducted with support of the Canadian BC Foundation, Canadian BC Research Alliance, Ontario Institute for Cancer Research through funding provided by the Government of Ontario to E. Zacksenhaus, as well as the Terry-Fox Foundation to S. E. Egan and E. Zacksenhaus. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas H, 2011, INT ARCH MED, V4; Allis S, 2012, TUMORI J, V98, P543, DOI 10.1700/1190.13193; Arslan C, 2009, EXPERT OPIN PHARMACO, V10, P2081, DOI 10.1517/14656560903117309; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; BASTHOLT L, 1987, CANCER TREAT REP, V71, P451; Bollet MA, 2012, RADIOTHER ONCOL, V102, P82, DOI 10.1016/j.radonc.2011.08.017; BOOKSTEIN R, 1989, MOL CELL BIOL, V9, P1628, DOI 10.1128/MCB.9.4.1628; Bosco EE, 2007, J CLIN INVEST, V117, P218, DOI 10.1172/JCI28803; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Burkhart DL, 2008, NAT REV CANCER, V8, P671, DOI 10.1038/nrc2399; Byrski T, 2010, J CLIN ONCOL, V28, P375, DOI 10.1200/JCO.2008.20.7019; CHU FCH, 1976, CANCER, V37, P2677, DOI 10.1002/1097-0142(197606)37:6<2677::AID-CNCR2820370616>3.0.CO;2-L; Clark RM, 1996, J NATL CANCER I, V88, P1659, DOI 10.1093/jnci/88.22.1659; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Dent R, 2007, CLIN CANCER RES, V13, P4429, DOI 10.1158/1078-0432.CCR-06-3045; Dent R, 2009, BREAST CANCER RES TR, V115, P423, DOI 10.1007/s10549-008-0086-2; Derenzini M, 2008, CLIN CANCER RES, V14, P2199, DOI 10.1158/1078-0432.CCR-07-2065; Dick JE, 2003, P NATL ACAD SCI USA, V100, P3547, DOI 10.1073/pnas.0830967100; Ertel A, 2010, CELL CYCLE, V9, P4153, DOI 10.4161/cc.9.20.13454; Fillmore CM, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr1982; Finn RS, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2419; Flaherty KT, 2012, CLIN CANCER RES, V18, P568, DOI 10.1158/1078-0432.CCR-11-0509; Fleskens AJHM, 2010, BONE MARROW TRANSPL, V45, P464, DOI 10.1038/bmt.2009.178; Fry DW, 2004, MOL CANCER THER, V3, P1427; Hassett-Sipple B, 1997, EPA452R92007, VV; Hennessy BT, 2009, CANCER RES, V69, P4116, DOI 10.1158/0008-5472.CAN-08-3441; Herschkowitz JI, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2142; Hoeflich KP, 2009, CLIN CANCER RES, V15, P4649, DOI 10.1158/1078-0432.CCR-09-0317; Hollestelle A, 2010, BREAST CANCER RES TR, V121, P53, DOI 10.1007/s10549-009-0460-8; Hong JY, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-122; Hopfinger G, 2013, CANCER; Jiang Z, 2011, CELL CYCLE, V10, P1563, DOI 10.4161/cc.10.10.15703; Jiang Z, 2010, J CLIN INVEST, V120, P3296, DOI 10.1172/JCI41490; Jobsen JJ, 2012, INT J RADIAT ONCOL, V82, pE811, DOI 10.1016/j.ijrobp.2011.11.020; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Lambert JMR, 2009, CANCER CELL, V15, P376, DOI 10.1016/j.ccr.2009.03.003; LEE EYHP, 1988, SCIENCE, V241, P218, DOI 10.1126/science.3388033; Li XX, 2008, JNCI-J NATL CANCER I, V100, P672, DOI 10.1093/jnci/djn123; Liljegren G, 1999, J CLIN ONCOL, V17, P2326, DOI 10.1200/JCO.1999.17.8.2326; LOPEZ M, 1986, INVEST NEW DRUG, V4, P39, DOI 10.1007/BF00172014; Magee JA, 2012, CANCER CELL, V21, P283, DOI 10.1016/j.ccr.2012.03.003; MARTONI A, 1990, ONCOLOGY, V47, P427; McLaughlin B, 2012, INT J HEMATOL, V96, P743, DOI 10.1007/s12185-012-1192-9; MITTELMAN A, 1988, CANCER CHEMOTH PHARM, V22, P63; Moeller TA, 2012, ASSAY DRUG DEV TECHN, V10, P78, DOI 10.1089/adt.2010.0365; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Perou CM, 2011, ONCOLOGIST, V16, P61, DOI 10.1634/theoncologist.2011-S1-61; Phillips TM, 2006, JNCI-J NATL CANCER I, V98, P1777, DOI 10.1093/jnci/djj495; PIERQUIN B, 1976, AM J ROENTGENOL, V127, P645, DOI 10.2214/ajr.127.4.645; Prat A, 2011, MOL ONCOL, V5, P5, DOI 10.1016/j.molonc.2010.11.003; Robinson TJW, 2013, CELL CYCLE IN PRESS; Sage J, 2003, NATURE, V424, P223, DOI 10.1038/nature01764; Shah SP, 2012, NATURE, V486, P395, DOI 10.1038/nature10933; Shahinas D, 2010, J MED CHEM, V53, P3552, DOI 10.1021/jm901796s; Sharma A, 2007, CANCER RES, V67, P6192, DOI 10.1158/0008-5472.CAN-06-4424; Sherr CJ, 1996, SCIENCE, V274, P1672, DOI 10.1126/science.274.5293.1672; Smith KM, 2010, EMBO MOL MED, V2, P371, DOI 10.1002/emmm.201000093; Subhawong AP, 2009, AM J SURG PATHOL, V33, P163, DOI 10.1097/PAS.0b013e31817f9790; TANG A, 1988, SCIENCE, V242, P263, DOI 10.1126/science.3175651; Trere D, 2009, ANN ONCOL, V20, P1818, DOI 10.1093/annonc/mdp209; TRUDEL M, 1992, HUM PATHOL, V23, P1388, DOI 10.1016/0046-8177(92)90059-C; VARLEY JM, 1989, HORM RES, V32, P250, DOI 10.1159/000181357; VARLEY JM, 1989, ONCOGENE, V4, P725; Veronesi U, 2005, ANN SURG, V242, P101, DOI 10.1097/01.sla.0000167927.82353.bc; WANG NP, 1993, ONCOGENE, V8, P279; Witkiewicz AK, 2012, CLIN CANCER RES, V18, P5110, DOI 10.1158/1078-0432.CCR-12-0903	66	49	51	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78641	10.1371/journal.pone.0078641	http://dx.doi.org/10.1371/journal.pone.0078641			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265703	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100036
J	Wen, JX; Yang, MJ; Li, LJ; Sun, GX; Tan, J				Wen, Junxiang; Yang, Mingjie; Li, Lijun; Sun, Guixin; Tan, Jun			Partial Recovery of Respiratory Function and Diaphragm Reinnervation following Unilateral Vagus Nerve to Phrenic Nerve Anastomosis in Rabbits	PLOS ONE			English	Article							SPINAL-CORD-INJURY; HIGH CERVICAL QUADRIPLEGIA; TO-SIDE NEURORRHAPHY; LARYNGEAL NERVE; RECURRENT LARYNGEAL; PERINEURIAL WINDOW; AXONAL CONDUCTION; ACCESSORY NERVE; MOTOR AXONS; VOCAL CORD	Respiratory dysfunction is the leading cause of mortality following upper cervical spinal cord injury (SCI). Reinnervation of the paralyzed diaphragm via an anastomosis between phrenic nerve and a donor nerve is a potential strategy to mitigate ventilatory deficits. In this study, anastomosis of vagus nerve (VN) to phrenic nerve (PN) in rabbits was performed to assess the potential capacity of the VN to compensate for lost PN inputs. At first, we compared spontaneous discharge pattern, nerve thickness and number of motor fibers between these nerves. The PN exhibited a highly rhythmic discharge while the VN exhibited a variable frequency discharge pattern. The rabbit VN had fewer motor axons (105.3+/-12.1 vs. 268.1+/-15.4). Nerve conduction and respiratory function were measured 20 weeks after left PN transection with or without left VN-PN anastomosis. Compared to rabbits subjected to unilateral phrenicotomy without VN-PN anastomosis, diaphragm muscle action potential (AP) amplitude was improved by 292%, distal latency by 695%, peak inspiratory flow (PIF) by 22.6%, peak expiratory flow (PRF) by 36.4%, and tidal volume by 21.8% in the anastomosis group. However, PIF recovery was only 28.0%, PEF 28.2%, and tidal volume 31.2% of Control. Our results suggested that VN-PN anastomosis is a promising therapeutic strategy for partial restoration of diaphragm reinnervation, but further modification and improvements are necessary to realize the full potential of this technique.	[Wen, Junxiang; Yang, Mingjie; Li, Lijun; Tan, Jun] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Orthopaed, Shanghai 200092, Peoples R China; [Sun, Guixin] Tongji Univ, Shanghai East Hosp, Sch Med, Dept Emergency, Shanghai 200092, Peoples R China	Tongji University; Tongji University	Tan, J (corresponding author), Tongji Univ, Shanghai East Hosp, Sch Med, Dept Orthopaed, Shanghai 200092, Peoples R China.	dr.tan@139.com			Health Bureau of Shanghai, China [2009162]	Health Bureau of Shanghai, China	The present work was supported by grants from the Health Bureau of Shanghai, China (2009162) to J. Tan. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BALDISSERA F, 1993, J APPL PHYSIOL, V75, P639, DOI 10.1152/jappl.1993.75.2.639; Berthoud HR, 2000, AUTON NEUROSCI-BASIC, V85, P1, DOI 10.1016/S1566-0702(00)00215-0; BROWN JO, 1951, AM J MED SCI, V222, P613, DOI 10.1097/00000441-195112000-00001; Brown R, 2006, RESP CARE, V51, P853; CALARESU FR, 1965, J PHYSIOL-LONDON, V176, P228, DOI 10.1113/jphysiol.1965.sp007546; Cederna PS, 2012, PLAST RECONSTR SURG, V130, P615, DOI 10.1097/PRS.0b013e31825efdb2; Derrey S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-17; DiMarco AF, 2005, RESP PHYSIOL NEUROBI, V147, P273, DOI 10.1016/j.resp.2005.03.007; DiMarco AF, 2005, ARCH PHYS MED REHAB, V86, P1200, DOI 10.1016/j.apmr.2004.11.027; DiMarco AF, 2011, J PHYSIOL-LONDON, V589, P1383, DOI 10.1113/jphysiol.2010.199679; DiMarco AF, 2010, RESP PHYSIOL NEUROBI, V171, P218, DOI 10.1016/j.resp.2010.03.017; DiMarco AF, 2009, RESP PHYSIOL NEUROBI, V169, P200, DOI 10.1016/j.resp.2009.09.008; DiMarco AF, 2009, J APPL PHYSIOL, V107, P662, DOI 10.1152/japplphysiol.00252.2009; Ducko CT, 2011, INNOVATIONS, V6, P289, DOI 10.1097/IMI.0b013e318237cc97; DUNCAN D, 1952, P SOC EXP BIOL MED, V80, P20; EVANS DHL, 1954, J ANAT, V88, P320; Gauthier P, 2006, NEUROBIOL DIS, V24, P53, DOI 10.1016/j.nbd.2006.05.002; GODING GS, 1991, OTOLARYNG CLIN N AM, V24, P1239; Grosu HB, 2012, CHEST, V142, P1455, DOI 10.1378/chest.11-1638; GUTH L, 1960, EXP NEUROL, V2, P251, DOI 10.1016/0014-4886(60)90012-1; GUTH L, 1959, EXP NEUROL, V1, P1, DOI 10.1016/0014-4886(59)90009-3; Haninec P, 2012, PLAST RECONSTR SURG, V130, P609, DOI 10.1097/PRS.0b013e31825dc20a; Imaizumi T, 1998, J NEUROSCI, V18, P6176; Jiang BG, 2007, EUR NEUROL, V58, P12, DOI 10.1159/000102161; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; Kohama I, 2001, J NEUROSCI, V21, P944, DOI 10.1523/JNEUROSCI.21-03-00944.2001; Krieger LM, 2000, PLAST RECONSTR SURG, V105, P1255, DOI 10.1097/00006534-200004040-00001; Le Pimpec-Barthes F, 2011, J THORAC CARDIOV SUR, V142, P378, DOI 10.1016/j.jtcvs.2011.04.033; Leiter JC, 2004, RESP PHYSIOL NEUROBI, V142, P115, DOI 10.1016/j.resp.2004.06.008; Levine S, 2008, NEW ENGL J MED, V358, P1327, DOI 10.1056/NEJMoa070447; MACEFIELD G, 1986, RESP PHYSIOL, V64, P57, DOI 10.1016/0034-5687(86)90060-5; MANIGLIA AJ, 1989, ANN OTO RHINOL LARYN, V98, P907, DOI 10.1177/000348948909801113; MURAKOSHI T, 1985, BRIT J PHARMACOL, V86, P95, DOI 10.1111/j.1476-5381.1985.tb09439.x; NSISC, 2012, SPIN CORD INJ FACTS; RICHARDS SA, 1969, COMP BIOCHEM PHYSIOL, V29, P955, DOI 10.1016/0010-406X(69)90997-9; Romero FJ, 2012, SPINAL CORD, V50, P895, DOI 10.1038/sc.2012.74; Sharma H, 2012, EXP NEUROL, V235, P18, DOI 10.1016/j.expneurol.2011.12.018; SHEPARD RS, 1964, AM J PHYSIOL, V206, P265, DOI 10.1152/ajplegacy.1964.206.2.265; STEELE AM, 1993, DEV BRAIN RES, V74, P57, DOI 10.1016/0165-3806(93)90083-M; TAKAISHI S, 1990, RESPIRATION, V57, P293; Tomoda C, 2006, WORLD J SURG, V30, P1230, DOI 10.1007/s00268-005-0351-z; Tubbs RS, 2008, CHILD NERV SYST, V24, P1341, DOI 10.1007/s00381-008-0650-4; Wang C, 2012, NEURAL REGEN RES, V7, P703, DOI 10.3969/j.issn.1673-5374.2012.09.011; Wang C, 2011, MED HYPOTHESES, V76, P564, DOI 10.1016/j.mehy.2011.01.001; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Yang ML, 2011, J NEUROSURG-SPINE, V15, P190, DOI 10.3171/2011.3.SPINE10911; Zakaria Hazem M, 2011, Oman Med J, V26, P34, DOI 10.5001/omj.2011.09; Zimmer MB, 2007, J SPINAL CORD MED, V30, P319, DOI 10.1080/10790268.2007.11753947	48	2	3	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79552	10.1371/journal.pone.0079552	http://dx.doi.org/10.1371/journal.pone.0079552			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265777	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100110
J	Guo, LQ; Chen, HX; Li, YS; Zhou, QX; Sui, Y				Guo, Liqiong; Chen, Hongxiang; Li, Yongsheng; Zhou, Qixing; Sui, Yang			An Aquaporin 3-Notch1 Axis in Keratinocyte Differentiation and Inflammation	PLOS ONE			English	Article							HYDROGEN-PEROXIDE UPTAKE; NOTCH SIGNALING PATHWAY; CELL-MIGRATION; GENE DISRUPTION; WATER CHANNELS; RETINOIC ACID; HUMAN SKIN; EPIDERMAL-KERATINOCYTES; MICE; EXPRESSION	Aquaporin 3 (AQP3) is an aquaglyceroporin which transports water, glycerol and small solutes across the plasma membrane. Its functions are not limited to fluid transport but also involve the regulation of cell proliferation, migration, skin hydration, wound healing and tumorigenesis. While AQP3 has been reported to play an important role in keratinocyte proliferation, its role in differentiation remains controversial. Our study demonstrated that the expression of AQP3 was regulated during differentiation and that it participated in keratinocyte differentiation control. We further revealed that AQP3 was a transcriptional target of Notch signaling, a critical pathway regulating keratinocyte differentiation and tumor suppression, and it regulated differentiation through a reciprocal negative feedback loop with Notch1. When the expression level of AQP3 was elevated, impaired barrier integrity and increased pro-inflammatory cytokine production ensued, mimicking the pathological conditions in Notch deficient mice and in atopic dermatitis. Dysregulation of AQP3 and Notch receptors has been reported in several skin diseases, including skin cancer. Our discovery of the novel AQP3-Notch1 axis may provide insight into epidermal homeostasis control and possible translational applications, including its potential use as a biomarker for molecular diagnosis in environmental studies.	[Guo, Liqiong; Zhou, Qixing] Nankai Univ, Key Lab Pollut Proc & Environm Criteria, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China; [Chen, Hongxiang] Huazhong Univ Sci & Technol, Dept Dermatol, Union Hosp, Tongji Med Coll, Wuhan 430074, Hubei, Peoples R China; [Chen, Hongxiang] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Dept Dermatol,Cutaneous Biol Res Ctr, Boston, MA USA; [Li, Yongsheng] Brigham & Womens Hosp, Ctr Expt Therapeut & Reperfus Injury, Harvard Inst Med, Dept Anesthesiol Perioperat & Pain Med, Boston, MA 02115 USA; [Li, Yongsheng] Harvard Univ, Sch Med, Boston, MA USA; [Sui, Yang] Wuhan Univ, Dept Bioinformat, Int Sch Software, Wuhan 430072, Hubei, Peoples R China	Nankai University; Huazhong University of Science & Technology; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Harvard Medical School; Wuhan University	Zhou, QX (corresponding author), Nankai Univ, Key Lab Pollut Proc & Environm Criteria, Coll Environm Sci & Engn, Tianjin 300071, Peoples R China.	zhouqx@nankai.edu.cn; suiyang@iss.whu.edu.cn		guo, liqiong/0000-0002-1141-9646; Li, Yongsheng/0000-0003-2175-9449	China Ministry of Science and Technology [2011CB503802]; National Natural Science Foundation of China [21037002, 81171495, 81271765]	China Ministry of Science and Technology(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by grants from China Ministry of Science and Technology (2011CB503802 to QXZ), National Natural Science Foundation of China as a key project (grant No. 21037002 to QXZ) and National Natural Science Foundation of China Grants (grant No. 81171495 and 81271765 to HXC). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdou AG, 2012, ANN DIAGN PATHOL, V16, P177, DOI 10.1016/j.anndiagpath.2011.09.005; Bellemere G, 2008, J INVEST DERMATOL, V128, P542, DOI 10.1038/sj.jid.5701047; Binder DK, 2006, ACTA NEUROCHIR SUPPL, V96, P389; Blanpain C, 2006, GENE DEV, V20, P3022, DOI 10.1101/gad.1477606; Bollag WB, 2007, J INVEST DERMATOL, V127, P2823, DOI 10.1038/sj.jid.5700921; Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009; Cao C, 2008, J CELL PHYSIOL, V215, P506, DOI 10.1002/jcp.21336; Da T, 2004, INVEST OPHTH VIS SCI, V45, P4477, DOI 10.1167/iovs.04-0940; Demehri S, 2009, CANCER CELL, V16, P55, DOI 10.1016/j.ccr.2009.05.016; Dotto GP, 2008, ONCOGENE, V27, P5115, DOI 10.1038/onc.2008.225; Dumortier A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009258; Hara M, 2002, J BIOL CHEM, V277, P46616, DOI 10.1074/jbc.M209003200; Hara-Chikuma M, 2005, J BIOL CHEM, V280, P15493, DOI 10.1074/jbc.C500028200; Hara-Chikuma M, 2008, J INVEST DERMATOL, V128, P2145, DOI 10.1038/jid.2008.70; Hara-Chikuma M, 2008, J MOL MED-JMM, V86, P221, DOI 10.1007/s00109-007-0272-4; Hara-Chikuma M, 2008, MOL CELL BIOL, V28, P326, DOI 10.1128/MCB.01482-07; Hara-Chikuma M, 2006, J AM SOC NEPHROL, V17, P39, DOI 10.1681/ASN.2005080846; Hara-Chikuma M, 2012, J EXP MED, V209, P1743, DOI 10.1084/jem.20112398; Hara-Chikuma M, 2009, ARCH DERMATOL RES, V301, P245, DOI 10.1007/s00403-009-0927-9; Horie I, 2009, BIOCHEM BIOPH RES CO, V387, P564, DOI 10.1016/j.bbrc.2009.07.077; Iso T, 2003, J CELL PHYSIOL, V194, P237, DOI 10.1002/jcp.10208; Jiang YJ, 2011, EXP DERMATOL, V20, P595, DOI 10.1111/j.1600-0625.2011.01269.x; Kim NH, 2010, J INVEST DERMATOL, V130, P2231, DOI 10.1038/jid.2010.99; Kopan R, 2009, CELL, V137, P216, DOI 10.1016/j.cell.2009.03.045; Lee Y, 2012, ANN DERMATOL, V24, P168, DOI 10.5021/ad.2012.24.2.168; Lee YS, 1998, J INVEST DERMATOL, V111, P762, DOI 10.1046/j.1523-1747.1998.00365.x; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Levin MH, 2006, INVEST OPHTH VIS SCI, V47, P4365, DOI 10.1167/iovs.06-0335; Li J, 2001, J BIOL CHEM, V276, P31233, DOI 10.1074/jbc.M104368200; Ma TH, 1998, J BIOL CHEM, V273, P4296, DOI 10.1074/jbc.273.8.4296; Ma TH, 2002, J BIOL CHEM, V277, P17147, DOI 10.1074/jbc.M200925200; Ma TH, 2000, P NATL ACAD SCI USA, V97, P4386, DOI 10.1073/pnas.080499597; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mhatre AN, 2002, BIOCHEM BIOPH RES CO, V297, P987, DOI 10.1016/S0006-291X(02)02296-9; Miller EW, 2010, P NATL ACAD SCI USA, V107, P15681, DOI 10.1073/pnas.1005776107; Murthy A, 2012, IMMUNITY, V36, P105, DOI 10.1016/j.immuni.2012.01.005; Nakahigashi K, 2011, J INVEST DERMATOL, V131, P865, DOI 10.1038/jid.2010.395; Olsson M, 2006, ALLERGY, V61, P1132, DOI 10.1111/j.1398-9995.2006.01151.x; Onoyama I, 2011, J CLIN INVEST, V121, P342, DOI 10.1172/JCI40725; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; POUMAY Y, 1995, J INVEST DERMATOL, V104, P271, DOI 10.1111/1523-1747.ep12612810; Rangarajan A, 2001, EMBO J, V20, P3427, DOI 10.1093/emboj/20.13.3427; Rizzo P, 2008, ONCOGENE, V27, P5124, DOI 10.1038/onc.2008.226; Roti G, 2013, CANCER CELL, V23, P390, DOI 10.1016/j.ccr.2013.01.015; Ruiz-Ederra J, 2006, INVEST OPHTH VIS SCI, V47, P3960, DOI 10.1167/iovs.06-0229; Saadoun S, 2005, NATURE, V434, P786, DOI 10.1038/nature03460; Schroeder T, 2000, EMBO J, V19, P2558, DOI 10.1093/emboj/19.11.2558; Song XZ, 2008, INT J MOL MED, V22, P229, DOI 10.3892/ijmm_00000013; Sougrat R, 2002, J INVEST DERMATOL, V118, P678, DOI 10.1046/j.1523-1747.2002.01710.x; Thiagarajah JR, 2007, GUT, V56, P1529, DOI 10.1136/gut.2006.104620; Verkman AS, 2012, ANNU REV MED, V63, P303, DOI 10.1146/annurev-med-043010-193843; Voss KE, 2011, ARCH DERMATOL RES, V303, P591, DOI 10.1007/s00403-011-1136-x; Yockey LJ, 2013, J INVEST DERMATOL; Zheng XJ, 2003, BBA-MOL CELL RES, V1643, P25, DOI 10.1016/j.bbamcr.2003.08.006	55	26	27	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80179	10.1371/journal.pone.0080179	http://dx.doi.org/10.1371/journal.pone.0080179			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260356	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200108
J	Palmer, SR; Evans, A; Broughton, H; Huddart, S; Drayton, M; Rankin, J; Draper, ES; Cameron, A; Paranjothy, S				Palmer, Stephen R.; Evans, Annette; Broughton, Hannah; Huddart, Simon; Drayton, Mark; Rankin, Judith; Draper, Elizabeth S.; Cameron, Alan; Paranjothy, Shantini			The Role of Maternal Stress in Early Pregnancy in the Aetiology of Gastroschisis: An Incident Case Control Study	PLOS ONE			English	Article							RESIDENTIAL-MOBILITY; HEALTH BEHAVIORS; SOCIAL SUPPORT; RISK-FACTORS; LIFE EVENTS; DRUG-USE; EPIDEMIOLOGY; PATHOGENESIS; HYPOTHESIS; ESTROGEN	Objective: The incidence of gastroschisis, a congenital anomaly where the infant abdominal wall is defective and intestines protrude from the abdominal cavity, is increasing in many countries. The role of maternal stress in some adverse birth outcomes is now well established. We tested the hypothesis that major stressful life events in the first trimester are risk factors for gastroschisis, and social support protective, in a case-control study in the United Kingdom. Methods: Gastroschisis cases and three controls per case (matched for maternal age) were identified at routine 18-20 week fetal anomaly ultrasound scan, in 2007-2010. Face to face questionnaire interviews were carried out during the antenatal period (median 24 weeks gestation) asking about serious stressful events and social support in the first trimester. Data were analysed using conditional logistic regression. Results: Two or more stressful life events in the first trimester (adjusted OR 4.9; 95% CI 1.2-19.4), and moving address in the first trimester (aOR 4.9; 95% CI 1.7-13.9) were strongly associated with risk of gastroschisis, independent of behavioural risk factors including smoking, alcohol, and poor diet. Perceived availability of social support was not associated with reduced risk of gastroschisis (aOR 0.8; 95% CI 0.2-3.1). Conclusions: Stressful maternal life events in the first trimester of pregnancy including change of address were strongly associated with a substantial increase in the risk of gastroschisis, independent of stress related high risk behaviours such as smoking, alcohol consumption and poor diet. This suggests that stress pathways are involved in the aetiology of gastroschisis.	[Palmer, Stephen R.; Evans, Annette; Broughton, Hannah; Paranjothy, Shantini] Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff, S Glam, Wales; [Huddart, Simon; Drayton, Mark] Cardiff & Vale Univ, Hlth Board, Cardiff, S Glam, Wales; [Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne, Tyne & Wear, England; [Draper, Elizabeth S.] Univ Leicester, Dept Hlth Sci, Leicester, Leics, England; [Cameron, Alan] Univ Glasgow, Glasgow, Lanark, Scotland; [Cameron, Alan] So Gen Hosp, Ian Donald Fetal Med Unit, Glasgow G51 4TF, Lanark, Scotland	Cardiff University; Newcastle University - UK; University of Leicester; University of Glasgow; University of Glasgow	Paranjothy, S (corresponding author), Cardiff Univ, Cochrane Inst Primary Care & Publ Hlth, Sch Med, Cardiff, S Glam, Wales.	ParanjothyS@Cardiff.ac.uk	Draper, Elizabeth/S-6874-2019; Draper, Elizabeth S/I-6304-2018	Draper, Elizabeth/0000-0001-9340-8176; Draper, Elizabeth S/0000-0001-9340-8176; Paranjothy, Shantini/0000-0002-0528-3121	Newlife Foundation for Disabled Children Grant [06/14]	Newlife Foundation for Disabled Children Grant	Funding from the Newlife Foundation for Disabled Children Grant Ref (06/14). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alderdice F, 2012, J PSYCHOSOM OBST GYN, V33, P62, DOI 10.3109/0167482X.2012.673040; American Psychiatric Association, 1987, DIAGN STAT MAN MENT; Bell ML, 2012, J EXPO SCI ENV EPID, V22, P429, DOI 10.1038/jes.2012.42; Bradnock TJ, 2011, BMJ-BRIT MED J, V15, P343, DOI DOI 10.1136/BMJ.D6749.PUBMED:22089731; Carmichael SL, 2000, EPIDEMIOLOGY, V11, P30, DOI 10.1097/00001648-200001000-00008; Carmichael SL, 2007, EPIDEMIOLOGY, V18, P356, DOI 10.1097/01.ede.0000259986.85239.87; Castilla EE, 2008, AM J MED GENET C, V148C, P162, DOI 10.1002/ajmg.c.30181; Christian LM, 2012, NEUROSCI BIOBEHAV R, V36, P350, DOI 10.1016/j.neubiorev.2011.07.005; Draper ES, 2008, AM J EPIDEMIOL, V167, P485, DOI 10.1093/aje/kwm335; Dumas JA, 2012, AM J GERIAT PSYCHIAT, V20, P734, DOI 10.1097/JGP.0b013e31825c0a14; Feldkamp ML, 2008, BMJ-BRIT MED J, V336, P1420, DOI 10.1136/bmj.39567.509074.25; Feldkamp ML, 2007, AM J MED GENET A, V143A, P639, DOI 10.1002/ajmg.a.31578; Fielder HMP, 2000, BRIT MED J, V320, P19, DOI 10.1136/bmj.320.7226.19; Forrester MB, 2006, J TOXICOL ENV HEAL A, V69, P1253, DOI 10.1080/15287390500361750; Hansen D, 2000, LANCET, V356, P875, DOI 10.1016/S0140-6736(00)02676-3; HOLMES TH, 1967, J PSYCHOSOM RES, V11, P213, DOI 10.1016/0022-3999(67)90010-4; Hosmer DW, 2000, APPL LOGISTIC REGRES, DOI 10.1002/0471722146; HOYME HE, 1981, J PEDIATR-US, V98, P228, DOI 10.1016/S0022-3476(81)80640-3; Jones KL, 2009, CLIN GENET, V75, P322, DOI 10.1111/j.1399-0004.2009.01164.x; Keys C, 2008, J PEDIATR SURG, V43, P654, DOI 10.1016/j.jpedsurg.2007.12.005; KOENIG HG, 1993, PSYCHOSOMATICS, V34, P61, DOI 10.1016/S0033-3182(93)71928-3; Laitinen J, 2002, PREV MED, V34, P29, DOI 10.1006/pmed.2001.0948; Loane M, 2011, BIRTH DEFECTS RES A, V91, pS31, DOI 10.1002/bdra.20778; Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242; Lubinsky M, 2012, AM J MED GENET A, V158A, P808, DOI 10.1002/ajmg.a.35203; Morrison JJ, 2005, BJOG-INT J OBSTET GY, V112, P1022, DOI 10.1111/j.1471-0528.2005.00655.x; Mulder EJH, 2002, EARLY HUM DEV, V70, P3, DOI 10.1016/S0378-3782(02)00075-0; Ng DM, 2003, HEALTH PSYCHOL, V22, P638, DOI 10.1037/0278-6133.22.6.638; Obel C, 2005, PSYCHONEUROENDOCRINO, V30, P647, DOI 10.1016/j.psyneuen.2004.11.006; Paranjothy S, 2012, INT J EPIDEMIOL, V41, P1141, DOI 10.1093/ije/dys092; Rasmussen SA, 2008, AM J MED GENET C, V148C, P199, DOI 10.1002/ajmg.c.30175; Root ED, 2009, SOC SCI MED, V68, P1361, DOI 10.1016/j.socscimed.2009.01.034; Rose D., 2005, NS SEC ORIGINS DEV U; Schetter CD, 2011, ANNU REV PSYCHOL, V62, P531, DOI 10.1146/annurev.psych.031809.130727; *STATACORP, 2007, STAT SOFTW REL 10; Suarez L, 2003, EPIDEMIOLOGY, V14, P612, DOI 10.1097/01.ede.0000073270.39780.e9; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; Torfs CP, 2006, BIRTH DEFECTS RES A, V76, P723, DOI 10.1002/bdra.20310; Tunstall H, 2010, SOC SCI MED, V71, P786, DOI 10.1016/j.socscimed.2010.04.013; Werler MM, 2009, AM J MED GENET A, V149A, P1399, DOI 10.1002/ajmg.a.32897	40	19	19	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80103	10.1371/journal.pone.0080103	http://dx.doi.org/10.1371/journal.pone.0080103			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255CG	24260340	Green Published, gold, Green Submitted, Green Accepted			2022-12-25	WOS:000327216200103
J	Kolb, KE; Hein, PP; Landick, R				Kolb, Kellie E.; Hein, Pyae P.; Landick, Robert			Antisense Oligonucleotide-stimulated Transcriptional Pausing Reveals RNA Exit Channel Specificity of RNA Polymerase and Mechanistic Contributions of NusA and RfaH	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							ELONGATION-FACTOR NUSA; OPERON LEADER REGION; N-TERMINAL DOMAIN; ESCHERICHIA-COLI; TRIGGER LOOP; THERMODYNAMIC PARAMETERS; ALLOSTERIC CONTROL; STRUCTURAL BASIS; RNA/DNA HYBRID; HAIRPIN	Transcript elongation by bacterial RNA polymerase (RNAP) is thought to be regulated at pause sites by open versus closed positions of the RNAP clamp domain, pause-suppressing regulators like NusG and RfaH that stabilize the closed-clamp RNAP conformation, and pause-enhancing regulators like NusA and exit channel nascent RNA structures that stabilize the open clamp RNAP conformation. However, the mutual effects of these protein and RNA regulators on RNAP conformation are incompletely understood. For example, it is unknown whether NusA directly interacts with exit channel duplexes and whether formation of exit channel duplexes and RfaH binding compete by favoring the open and closed RNAP conformations. We report new insights into these mechanisms using antisense oligonucleotide mimics of a pause RNA hairpin from the leader region of the his biosynthetic operon of enteric bacteria like Escherichia coli. By systematically varying the structure and length of the oligonucleotide mimic, we determined that full pause stabilization requires an RNA-RNA duplex of at least 8 bp or a DNA-RNA duplex of at least 11 bp; RNA-RNA duplexes were more effective than DNA-RNA. NusA stimulation of pausing was optimal with 10-bp RNA-RNA duplexes and was aided by single-stranded RNA upstream of the duplex but was significantly reduced with DNA-RNA duplexes. Our results favor direct NusA stabilization of exit channel duplexes, which consequently affect RNAP clamp conformation. Effects of RfaH, which suppresses oligo-stabilization of pausing, were competitive with antisense oligonucleotide concentration, suggesting that RfaH and exit channel duplexes compete via opposing effects on RNAP clamp conformation.	[Kolb, Kellie E.; Hein, Pyae P.; Landick, Robert] Univ Wisconsin, Dept Biochem, Madison, WI 53706 USA; [Landick, Robert] Univ Wisconsin, Dept Bacteriol, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Landick, R (corresponding author), Univ Wisconsin, Dept Biochem, 1550 Linden Dr, Madison, WI 53706 USA.	landick@biochem.wisc.edu			National Institutes of Health [GM39660]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grant GM39660 (to R. L.).	Artsimovitch I, 2000, P NATL ACAD SCI USA, V97, P7090, DOI 10.1073/pnas.97.13.7090; Artsimovitch I, 1998, GENE DEV, V12, P3110, DOI 10.1101/gad.12.19.3110; Artsimovitch I, 2003, J BIOL CHEM, V278, P12344, DOI 10.1074/jbc.M211214200; Artsimovitch I, 2002, CELL, V109, P193, DOI 10.1016/S0092-8674(02)00724-9; Belogurov GA, 2007, MOL CELL, V26, P117, DOI 10.1016/j.molcel.2007.02.021; Belogurov GA, 2010, MOL MICROBIOL, V76, P286, DOI 10.1111/j.1365-2958.2010.07056.x; Belogurov GA, 2009, EMBO J, V28, P112, DOI 10.1038/emboj.2008.268; Chakraborty A, 2012, SCIENCE, V337, P591, DOI 10.1126/science.1218716; CHAN CL, 1993, J MOL BIOL, V233, P25, DOI 10.1006/jmbi.1993.1482; Chan CL, 1997, J MOL BIOL, V268, P37, DOI 10.1006/jmbi.1997.0934; Cisse II, 2012, NAT STRUCT MOL BIOL, V19, P623, DOI 10.1038/nsmb.2294; DOCKBREGEON AC, 1989, J MOL BIOL, V209, P459, DOI 10.1016/0022-2836(89)90010-7; FARNHAM PJ, 1982, CELL, V29, P945, DOI 10.1016/0092-8674(82)90457-3; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; Ha KS, 2010, J MOL BIOL, V401, P708, DOI 10.1016/j.jmb.2010.06.036; Hein PP, 2011, BIOCHEMISTRY-US, V50, P7002, DOI 10.1021/bi200437q; Horton NC, 1996, J MOL BIOL, V264, P521, DOI 10.1006/jmbi.1996.0658; KASSAVETIS GA, 1981, J BIOL CHEM, V256, P2777; Kireeva M, 2010, BBA-GENE REGUL MECH, V1799, P389, DOI 10.1016/j.bbagrm.2010.01.007; Klein BJ, 2011, P NATL ACAD SCI USA, V108, P546, DOI 10.1073/pnas.1013828108; Kyzer S, 2007, J BIOL CHEM, V282, P19020, DOI 10.1074/jbc.M701483200; Landick R, 2006, BIOCHEM SOC T, V34, P1062, DOI 10.1042/BST0341062; Landick R, 1996, METHOD ENZYMOL, V274, P334; LANDICK R, 1984, J BIOL CHEM, V259, P1550; LANDICK R, 1985, P NATL ACAD SCI USA, V82, P4663, DOI 10.1073/pnas.82.14.4663; Malinen AM, 2012, NUCLEIC ACIDS RES, V40, P7442, DOI 10.1093/nar/gks383; Martinez-Rucobo FW, 2011, EMBO J, V30, P1302, DOI 10.1038/emboj.2011.64; Mooney RA, 2009, J MOL BIOL, V391, P341, DOI 10.1016/j.jmb.2009.05.078; Nakano S, 1999, NUCLEIC ACIDS RES, V27, P2957, DOI 10.1093/nar/27.14.2957; Nayak D, 2013, MOL CELL, V50, P882, DOI 10.1016/j.molcel.2013.05.015; Neuman KC, 2003, CELL, V115, P437, DOI 10.1016/S0092-8674(03)00845-6; Opalka N, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000483; Owczarzy R, 2004, BIOCHEMISTRY-US, V43, P3537, DOI 10.1021/bi034621r; Owczarzy R, 2008, BIOCHEMISTRY-US, V47, P5336, DOI 10.1021/bi702363u; Pan T, 1999, P NATL ACAD SCI USA, V96, P9545, DOI 10.1073/pnas.96.17.9545; Pan T, 2006, ANNU REV BIOPH BIOM, V35, P161, DOI 10.1146/annurev.biophys.35.040405.102053; Peters JM, 2011, J MOL BIOL, V412, P793, DOI 10.1016/j.jmb.2011.03.036; Proshkin S, 2010, SCIENCE, V328, P504, DOI 10.1126/science.1184939; Shankar S, 2007, MOL CELL, V27, P914, DOI 10.1016/j.molcel.2007.07.025; SUGIMOTO N, 1995, BIOCHEMISTRY-US, V34, P11211, DOI 10.1021/bi00035a029; Svetlov V, 2007, NUCLEIC ACIDS RES, V35, P5694, DOI 10.1093/nar/gkm600; Tagami S, 2010, NATURE, V468, P978, DOI 10.1038/nature09573; Toulokhonov I, 2003, MOL CELL, V12, P1125, DOI 10.1016/S1097-2765(03)00439-8; Toulokhonov I, 2001, SCIENCE, V292, P730, DOI 10.1126/science.1057738; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyeva MN, 2002, ACTA CRYSTALLOGR D, V58, P1497, DOI 10.1107/S0907444902011770; Wang DG, 1997, P NATL ACAD SCI USA, V94, P8433, DOI 10.1073/pnas.94.16.8433; Weixlbaumer A, 2013, CELL, V152, P431, DOI 10.1016/j.cell.2012.12.020; Wickiser JK, 2005, MOL CELL, V18, P49, DOI 10.1016/j.molcel.2005.02.032; Worbs M, 2001, MOL CELL, V7, P1177, DOI 10.1016/S1097-2765(01)00262-3; Xia TB, 1998, BIOCHEMISTRY-US, V37, P14719, DOI 10.1021/bi9809425; Yakhnin AV, 2008, P NATL ACAD SCI USA, V105, P16131, DOI 10.1073/pnas.0808842105; Yang XA, 2010, RNA BIOL, V7, P272, DOI 10.4161/rna.7.3.12021; Yang X, 2009, EMBO REP, V10, P997, DOI 10.1038/embor.2009.155; Zhang JW, 2010, NAT STRUCT MOL BIOL, V17, P99, DOI 10.1038/nsmb.1732; Zhang Jinwei, 2009, P206, DOI 10.1039/9781847559982-00206	56	39	39	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1151	1163		10.1074/jbc.M113.521393	http://dx.doi.org/10.1074/jbc.M113.521393			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275665	Green Published, hybrid			2022-12-25	WOS:000330541200046
J	Aiba, I; Shuttleworth, CW				Aiba, Isamu; Shuttleworth, C. William			Hypoxia Limits Inhibitory Effects of Zn2+ on Spreading Depolarizations	PLOS ONE			English	Article							FOCAL CEREBRAL-ISCHEMIA; REDOX MODULATORY SITE; NMDA-RECEPTOR; ANOXIC DEPOLARIZATION; BRAIN-SLICES; IN-VITRO; PERIINFARCT DEPOLARIZATIONS; ARTERY OCCLUSION; ZINC INHIBITION; DEPRESSION	Spreading depolarizations (SDs) are coordinated depolarizations of brain tissue that have been well-characterized in animal models and more recently implicated in the progression of stroke injury. We previously showed that extracellular Zn2+ accumulation can inhibit the propagation of SD events. In that prior work, Zn2+ was tested in normoxic conditions, where SD was generated by localized KCl pulses in oxygenated tissue. The current study examined the extent to which Zn2+ effects are modified by hypoxia, to assess potential implications for stroke studies. The present studies examined SD generated in brain slices acutely prepared from mice, and recordings were made from the hippocampal CA1 region. SDs were generated by either local potassium injection (K-SD), exposure to the Na+/K+-ATPase inhibitor ouabain (ouabain-SD) or superfusion with modified ACSF with reduced oxygen and glucose concentrations (oxygen glucose deprivation: OGD-SD). Extracellular Zn2+ exposures (100 mu M ZnCl2) effectively decreased SD propagation rates and significantly increased the initiation threshold for K-SD generated in oxygenated ACSF (95% O-2). In contrast, ZnCl2 did not inhibit propagation of OGD-SD or ouabain-SD generated in hypoxic conditions. Zn2+ sensitivity in 0% O-2 was restored by exposure to the protein oxidizer DTNB, suggesting that redox modulation may contribute to resistance to Zn2+ in hypoxic conditions. DTNB pretreatment also significantly potentiated the inhibitory effects of competitive (D-AP5) or allosteric (Ro25-6981) NMDA receptor antagonists on OGD-SD. Finally, Zn2+ inhibition of isolated NMDAR currents was potentiated by DTNB. Together, these results suggest that hypoxia-induced redox modulation can influence the sensitivity of SD to Zn2+ as well as to other NMDAR antagonists. Such a mechanism may limit inhibitory effects of endogenous Zn2+ accumulation in hypoxic regions close to ischemic infarcts.	[Aiba, Isamu; Shuttleworth, C. William] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA	University of New Mexico	Shuttleworth, CW (corresponding author), Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA.	bshuttleworth@salud.unm.edu			National Institutes of Health [NS051288]; AHA [11PRE4870002]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000041] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051288] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); AHA(American Heart Association); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported by National Institutes of Health grant NS051288 (CWS), www.nih.gov; & AHA grant 11PRE4870002 (IA), www.heart.org. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aiba I, 2012, J PHYSL; Aiba I, 2012, J NEUROPHYSIOL, V107, P1032, DOI 10.1152/jn.00453.2011; Calderone A, 2004, J NEUROSCI, V24, P9903, DOI 10.1523/JNEUROSCI.1713-04.2004; Carter RE, 2011, J CEREBR BLOOD F MET, V31, P1073, DOI 10.1038/jcbfm.2010.183; Choi YB, 2001, J NEUROSCI, V21, P392, DOI 10.1523/JNEUROSCI.21-02-00392.2001; Chung RS, 2008, J BIOL CHEM, V283, P15349, DOI 10.1074/jbc.M708446200; Dietz RM, 2008, J NEUROSCI, V28, P8014, DOI 10.1523/JNEUROSCI.0765-08.2008; Dietz RM, 2009, J NEUROCHEM, V109, P145, DOI 10.1111/j.1471-4159.2009.05853.x; Dohmen C, 2008, ANN NEUROL, V63, P720, DOI 10.1002/ana.21390; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; GILL R, 1992, J CEREBR BLOOD F MET, V12, P371, DOI 10.1038/jcbfm.1992.54; Gong LW, 2000, NEUROSCI LETT, V286, P191, DOI 10.1016/S0304-3940(00)01121-6; GOZLAN H, 1994, J NEUROPHYSIOL, V72, P3017, DOI 10.1152/jn.1994.72.6.3017; GRIBKOFF VK, 1992, J NEUROPHYSIOL, V68, P620, DOI 10.1152/jn.1992.68.2.620; Hartings JA, 2003, J NEUROSCI, V23, P11602; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hepp S, 2005, J NEUROPHYSIOL, V94, P1091, DOI 10.1152/jn.00291.2005; Herin GA, 2001, J NEUROCHEM, V78, P1307, DOI 10.1046/j.1471-4159.2001.00517.x; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; IIJIMA T, 1992, J CEREBR BLOOD F MET, V12, P727, DOI 10.1038/jcbfm.1992.103; Jarvis CR, 2001, CEREB CORTEX, V11, P249, DOI 10.1093/cercor/11.3.249; Joshi I, 2001, J NEUROPHYSIOL, V85, P414, DOI 10.1152/jn.2001.85.1.414; Kitamura Y, 2006, BRAIN RES BULL, V69, P622, DOI 10.1016/j.brainresbull.2006.03.004; Koh JY, 1996, SCIENCE, V272, P1013, DOI 10.1126/science.272.5264.1013; LAURITZEN M, 1992, J CEREBR BLOOD F MET, V12, P223, DOI 10.1038/jcbfm.1992.32; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Lindquist BE, 2012, NEUROSCIENCE, V223, P365, DOI 10.1016/j.neuroscience.2012.07.053; Low CM, 2000, P NATL ACAD SCI USA, V97, P11062, DOI 10.1073/pnas.180307497; Murphy TH, 2008, J NEUROSCI, V28, P1756, DOI 10.1523/JNEUROSCI.5128-07.2008; Nakamura H, 2010, BRAIN, V133, P1994, DOI 10.1093/brain/awq117; NEDERGAARD M, 1993, J CEREBR BLOOD F MET, V13, P568, DOI 10.1038/jcbfm.1993.74; Ohta K, 2001, STROKE, V32, P535, DOI 10.1161/01.STR.32.2.535; Paoletti P, 1997, J NEUROSCI, V17, P5711; Paoletti P, 2007, CURR OPIN PHARMACOL, V7, P39, DOI 10.1016/j.coph.2006.08.011; Park MK, 1997, PFLUG ARCH EUR J PHY, V434, P764, DOI 10.1007/s004240050463; Petzold GC, 2005, STROKE, V36, P1270, DOI 10.1161/01.STR.0000166023.51307.e0; Pringle AK, 2000, EUR J NEUROSCI, V12, P3833, DOI 10.1046/j.1460-9568.2000.00272.x; Qian J, 2011, J NEUROSCI, V31, P97, DOI 10.1523/JNEUROSCI.5162-10.2011; Rumschik SM, 2009, J NEUROCHEM, V108, P1300, DOI 10.1111/j.1471-4159.2009.05880.x; Sanchez RM, 2000, J NEUROSCI, V20, P2409; Sensi SL, 2009, NAT REV NEUROSCI, V10, P780, DOI 10.1038/nrn2734; Shuttleworth CW, 2011, TRENDS PHARMACOL SCI, V32, P480, DOI 10.1016/j.tips.2011.04.001; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Takahashi H, 2007, NEURON, V53, P53, DOI 10.1016/j.neuron.2006.11.023; TANG LH, 1993, J PHYSIOL-LONDON, V465, P303, DOI 10.1113/jphysiol.1993.sp019678; Wagner CA, 1996, AM J PHYSIOL-RENAL, V271, pF926, DOI 10.1152/ajprenal.1996.271.4.F926	46	2	2	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e75739	10.1371/journal.pone.0075739	http://dx.doi.org/10.1371/journal.pone.0075739			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278106	Green Submitted, gold, Green Published			2022-12-25	WOS:000327541700002
J	Wessels, JM; Edwards, AK; Khalaj, K; Kridli, RT; Bidarimath, M; Tayade, C				Wessels, Jocelyn M.; Edwards, Andrew K.; Khalaj, Kasra; Kridli, Rami T.; Bidarimath, Mallikarjun; Tayade, Chandrakant			The MicroRNAome of Pregnancy: Deciphering miRNA Networks at the Maternal-Fetal Interface	PLOS ONE			English	Article							GENE-EXPRESSION; MESSENGER-RNA; PORCINE; ENDOMETRIUM; INTEGRATION; VALIDATION; RECEPTORS; TARGETS	MicroRNAs (miRNAs) post-transcriptionally regulate a vast network of genes by inhibiting mRNA translation. Aberrant miRNA expression profiles have been implicated in pathologies and physiological processes including pregnancy and angiogenesis. Using our established model of implantation failure and spontaneous fetal loss in pigs (Sus scrofa), 236 miRNAs were profiled and compared between 1) non-pregnant and pregnant endometrium, 2) maternal and fetal tissues, and 3) viable and growth-arrested conceptus attachment sites by microarray and Real-Time PCR. Many significant differences in miRNA expression were observed between each of the aforementioned comparisons, and several were validated by PCR. Results indicated which miRNAs were important during pregnancy, which were elevated on the maternal or fetal side of the maternal-fetal interface, and they implicated the maternal expression of miR-10a, 27a, 29c, 323, 331-5p, 339-3p, 374b-5p, and 935 in the spontaneous loss observed in pigs. Several putative mRNA targets of the miRNAs (elevated in endometrium associated with arresting conceptuses) were assessed by quantitative Real-Time PCR and were depressed, supporting their regulation by miRNAs. Finally, targets were clustered by function to obtain ranked lists of gene networks that indicated which pathways/physiological processes might be important in non-pregnant (extracellular matrix factors) versus pregnant endometrium (nuclear transcription factor regulation), maternal (blood vessel development) versus fetal (neuronal differentiation) tissue, and healthy (extracellular matrix factors) versus arresting (GRAM domain) conceptus attachment sites. Overall, we demonstrate the presence of miRNAs on both sides of the maternal-fetal interface, implicate them in spontaneous fetal loss, and present a unique glimpse into the vast microRNAome of pregnancy.	[Wessels, Jocelyn M.; Khalaj, Kasra; Kridli, Rami T.; Tayade, Chandrakant] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada; [Edwards, Andrew K.; Bidarimath, Mallikarjun; Tayade, Chandrakant] Queens Univ, DepT Biomed & Mol Sci, Kingston, ON, Canada; [Kridli, Rami T.] Jordan Univ Sci & Technol, Fac Agr, Dept Anim Prod, Irbid, Jordan	University of Guelph; Queens University - Canada; Jordan University of Science & Technology	Tayade, C (corresponding author), Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1, Canada.	tayadec@queensu.ca	Bidarimath, Mallikarjun/L-2874-2017	Bidarimath, Mallikarjun/0000-0002-9080-8737; Khalaj, Kasra/0000-0002-5947-6500	Ontario Pork; Natural Sciences and Engineering Research Council of Canada; Ontario Ministry of Agriculture Food and Rural Affairs	Ontario Pork; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Ontario Ministry of Agriculture Food and Rural Affairs	This research was supported by funding from Ontario Pork, Natural Sciences and Engineering Research Council of Canada and Ontario Ministry of Agriculture Food and Rural Affairs. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aghajanova L, 2011, REPROD SCI, V18, P229, DOI 10.1177/1933719110386241; Altmae S, 2012, REPROD SCI; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; [Anonymous], 2012, MIRBASE REL 19, P19; Chen K, 2006, COLD SPRING HARB SYM, V71, P149, DOI 10.1101/sqb.2006.71.039; Cho JH, 2011, BMC MED GENOMICS, V4, DOI 10.1186/1755-8794-4-8; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Donker RB, 2012, MOL HUM REPROD, V18, P417, DOI 10.1093/molehr/gas013; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Edwards AK, 2011, REPROD BIOL ENDOCRIN, V9, DOI 10.1186/1477-7827-9-5; Fang Y, 2010, P NATL ACAD SCI USA, V107, P13450, DOI 10.1073/pnas.1002120107; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo HL, 2010, NATURE, V466, P835, DOI 10.1038/nature09267; Hu SJ, 2008, J BIOL CHEM, V283, P23473, DOI 10.1074/jbc.M800406200; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Huang ZP, 2011, METHODS MOL BIOL, V709, P197, DOI 10.1007/978-1-61737-982-6_12; Lei B, 2011, MOL BIOL REP, V38, P3725, DOI 10.1007/s11033-010-0487-2; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Liu N, 2013, CANCER LETT, V329, P181, DOI 10.1016/j.canlet.2012.10.032; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Montenegro D, 2009, J PATHOL, V217, P113, DOI 10.1002/path.2463; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nicoli S, 2010, NATURE, V464, P1196, DOI 10.1038/nature08889; Pope WF, 1994, EMBRYONIC MORTALITY, P53; Qian K, 2009, ENDOCRINOLOGY, V150, P4734, DOI 10.1210/en.2008-1629; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Su LJ, 2010, REPROD FERT DEVELOP, V22, P1175, DOI 10.1071/RD10046; Tayade C, 2006, J IMMUNOL, V176, P148, DOI 10.4049/jimmunol.176.1.148; Tayade C, 2007, J LEUKOCYTE BIOL, V82, P877, DOI 10.1189/jlb.0507330; Thum T, 2008, CARDIOVASC RES, V79, P562, DOI 10.1093/cvr/cvn137; Wessels JM, 2007, AM J REPROD IMMUNOL, V58, P470, DOI 10.1111/j.1600-0897.2007.00534.x; Wessels JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028940; Wessels JM, 2011, IMMUNOL CELL BIOL, V89, P304, DOI 10.1038/icb.2010.95; WU MC, 1987, J ANIM SCI, V65, P762, DOI 10.2527/jas1987.653762x; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Yao JQ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015546; Zeng X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046367; Zhao Z, 2012, CLIN CHEM, V58, P896, DOI 10.1373/clinchem.2011.179283; Zudova D, 2003, CYTOGENET GENOME RES, V102, P179, DOI 10.1159/000075745	40	45	45	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e72264	10.1371/journal.pone.0072264	http://dx.doi.org/10.1371/journal.pone.0072264			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278102	Green Published, gold, Green Submitted			2022-12-25	WOS:000327541700001
J	Reece, JS; Noss, RF; Oetting, J; Hoctor, T; Volk, M				Reece, Joshua Steven; Noss, Reed F.; Oetting, Jon; Hoctor, Tom; Volk, Michael			A Vulnerability Assessment of 300 Species in Florida: Threats from Sea Level Rise, Land Use, and Climate Change	PLOS ONE			English	Article							BIODIVERSITY CONSERVATION; ECOSYSTEM SERVICES; TAXONOMIC BIAS; HABITAT LOSS; EXTINCTION; UNCERTAINTY; POPULATIONS; ALLOCATION; RESOURCES; HOTSPOTS	Species face many threats, including accelerated climate change, sea level rise, and conversion and degradation of habitat from human land uses. Vulnerability assessments and prioritization protocols have been proposed to assess these threats, often in combination with information such as species rarity; ecological, evolutionary or economic value; and likelihood of success. Nevertheless, few vulnerability assessments or prioritization protocols simultaneously account for multiple threats or conservation values. We applied a novel vulnerability assessment tool, the Standardized Index of Vulnerability and Value, to assess the conservation priority of 300 species of plants and animals in Florida given projections of climate change, human land-use patterns, and sea level rise by the year 2100. We account for multiple sources of uncertainty and prioritize species under five different systems of value, ranging from a primary emphasis on vulnerability to threats to an emphasis on metrics of conservation value such as phylogenetic distinctiveness. Our results reveal remarkable consistency in the prioritization of species across different conservation value systems. Species of high priority include the Miami blue butterfly (Cyclargus thomasi bethunebakeri), Key tree cactus (Pilosocereus robinii), Florida duskywing butterfly (Ephyriades brunnea floridensis), and Key deer (Odocoileus virginianus clavium). We also identify sources of uncertainty and the types of life history information consistently missing across taxonomic groups. This study characterizes the vulnerabilities to major threats of a broad swath of Florida's biodiversity and provides a system for prioritizing conservation efforts that is quantitative, flexible, and free from hidden value judgments.	[Reece, Joshua Steven] Valdosta State Univ, Dept Biol, Valdosta, GA 31698 USA; [Noss, Reed F.] Univ Cent Florida, Dept Biol, Orlando, FL 32816 USA; [Oetting, Jon] Florida State Univ, Florida Nat Areas Inventory, Tallahassee, FL 32306 USA; [Hoctor, Tom; Volk, Michael] Univ Florida, Ctr Landscape Conservat Planning, Gainesville, FL USA	University System of Georgia; Valdosta State University; State University System of Florida; University of Central Florida; State University System of Florida; Florida State University; State University System of Florida; University of Florida	Reece, JS (corresponding author), Valdosta State Univ, Dept Biol, Valdosta, GA 31698 USA.	jreece@valdosta.edu			Florida Fish and Wildlife Conservation Commission [10289]; Kresge Foundation	Florida Fish and Wildlife Conservation Commission; Kresge Foundation	Funding for this work was provided by the Florida Fish and Wildlife Conservation Commission (Project Number 10289) and the Kresge Foundation (project entitled, "Adaption to Sea Level Rise in Florida: Biological Conservation Priorities"). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arponen A, 2012, BIODIVERS CONSERV, V21, P875, DOI 10.1007/s10531-012-0242-1; Balmford A, 2003, P NATL ACAD SCI USA, V100, P1046, DOI 10.1073/pnas.0236945100; Beier P, 2010, CONSERV BIOL, V24, P701, DOI 10.1111/j.1523-1739.2009.01422.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Black S, 2010, CONSERV BIOL, V24, P1448, DOI 10.1111/j.1523-1739.2010.01562.x; Boettcher PJ, 2010, ANIM GENET, V41, P64, DOI 10.1111/j.1365-2052.2010.02050.x; Bonin A, 2007, CONSERV BIOL, V21, P697, DOI 10.1111/j.1523-1739.2007.00685.x; Bonnet X, 2002, TRENDS ECOL EVOL, V17, P1, DOI 10.1016/S0169-5347(01)02381-3; Brockington D, 2010, ANTIPODE, V42, P469, DOI 10.1111/j.1467-8330.2010.00760.x; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Brooks TM, 2002, CONSERV BIOL, V16, P909, DOI 10.1046/j.1523-1739.2002.00530.x; Burgman MA, 1999, RISK ANAL, V19, P585, DOI 10.1023/A:1007073301150; Caro T. M, 2010, CONSERVATION PROXY I; Charney ND, 2012, ECOL MODEL, V242, P37, DOI 10.1016/j.ecolmodel.2012.05.026; Clark JA, 2002, SCIENCE, V297, P191; Clark JA, 2002, CONSERV BIOL, V16, P1510, DOI 10.1046/j.1523-1739.2002.01376.x; Clevenger AP, 2002, CONSERV BIOL, V16, P503, DOI 10.1046/j.1523-1739.2002.00328.x; Cushman SA, 2006, BIOL CONSERV, V128, P231, DOI 10.1016/j.biocon.2005.09.031; Daily GC, 2009, FRONT ECOL ENVIRON, V7, P21, DOI 10.1890/080025; Dubois N., 2011, INTEGRATING CLIMATE; ESTES JA, 1989, CONSERV BIOL, V3, P252, DOI 10.1111/j.1523-1739.1989.tb00085.x; Faber-Langendoen D., 2009, NATURESERVE CONSERVA; Fisher DO, 2004, TRENDS ECOL EVOL, V19, P391, DOI 10.1016/j.tree.2004.05.004; Fleishman E, 2000, ECOL APPL, V10, P569, DOI 10.1890/1051-0761(2000)010[0569:ANMFSO]2.0.CO;2; Foden WB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065427; Game ET, 2013, CONSERV BIOL, V27, P480, DOI 10.1111/cobi.12051; Gardali T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029507; Gleason H.A., 1926, B TORREY BOT CLUB, V53, P7, DOI DOI 10.2307/2479933; Halpern BS, 2006, CONSERV BIOL, V20, P56, DOI 10.1111/j.1523-1739.2005.00258.x; Herring B, 2004, INVENTORY RARE ENDEM; Hinrichsen D, 1998, COASTAL WATERS WORLD; Hughes L, 2000, TRENDS ECOL EVOL, V15, P56, DOI 10.1016/S0169-5347(99)01764-4; James A, 2001, BIOSCIENCE, V51, P43, DOI 10.1641/0006-3568(2001)051[0043:CWATCB]2.0.CO;2; JAMES C. W., 1961, BRITTONIA, V13, P225, DOI 10.2307/2805339; Johnson CJ, 2004, J APPL ECOL, V41, P1032, DOI 10.1111/j.0021-8901.2004.00975.x; Joseph LN, 2009, CONSERV BIOL, V23, P328, DOI 10.1111/j.1523-1739.2008.01124.x; Klironomos JN, 2002, SCIENCE, V298, P749, DOI 10.1126/science.298.5594.749; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Lawler JJ, 2006, FRONT ECOL ENVIRON, V4, P473, DOI 10.1890/1540-9295(2006)4[473:CSAYRC]2.0.CO;2; Loehle C, 2012, DIVERS DISTRIB, V18, P84, DOI 10.1111/j.1472-4642.2011.00856.x; MACE GM, 1991, CONSERV BIOL, V5, P148, DOI 10.1111/j.1523-1739.1991.tb00119.x; Marsh H, 2007, CONSERV BIOL, V21, P387, DOI 10.1111/j.1523-1739.2006.00589.x; McKelvey KS, 2008, BIOSCIENCE, V58, P549, DOI 10.1641/B580611; McKinney ML, 1999, TRENDS ECOL EVOL, V14, P450, DOI 10.1016/S0169-5347(99)01679-1; MILLSAP BA, 1990, WILDLIFE MONOGR, P1; Mulkey S, 2007, CLIMATE CHANGE LAND; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Nelson E, 2009, FRONT ECOL ENVIRON, V7, P4, DOI 10.1890/080023; Noss RF, 2012, CONSERV BIOL, V26, P1, DOI 10.1111/j.1523-1739.2011.01738.x; O'Neill SJ, 2008, J APPL ECOL, V45, P1649, DOI 10.1111/j.1365-2664.2008.01552.x; Oetting JB, 2006, BIOL CONSERV, V128, P37, DOI 10.1016/j.biocon.2005.09.014; PECK SB, 1989, FLA ENTOMOL, V72, P603, DOI 10.2307/3495034; Pfeffer WT, 2008, SCIENCE, V321, P1340, DOI 10.1126/science.1159099; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Redding DW, 2006, CONSERV BIOL, V20, P1670, DOI 10.1111/j.1523-1739.2006.00555.x; Reece JS, 2013, NAT AREAS J IN PRESS; Rogers HM, 2010, LANDSCAPE URBAN PLAN, V96, P48, DOI 10.1016/j.landurbplan.2010.02.002; Shine R, 2000, TRENDS ECOL EVOL, V15, P221, DOI 10.1016/S0169-5347(00)01853-X; Shoo LP, 2013, CLIMATIC CHANGE, V119, P239, DOI 10.1007/s10584-013-0699-2; Sorrie Bruce A., 2001, Castanea, V66, P50; Soule ME, 2003, CONSERV BIOL, V17, P1238, DOI 10.1046/j.1523-1739.2003.01599.x; Stein BA, 2002, SCIENCE, V297, P1807; Stith BM, 1994, 1 ANN C WILDL SOC AL; Strauss BH, 2012, ENVIRON RES LETT, V7, DOI 10.1088/1748-9326/7/1/014033; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Vermeer M, 2009, P NATL ACAD SCI USA, V106, P21527, DOI 10.1073/pnas.0907765106; Young B. E., 2009, USING NATURESERVE CL; Zhang KQ, 2013, CLIMATIC CHANGE, V118, P487, DOI 10.1007/s10584-012-0645-8; Zwick P.D., 2006, FLORIDA 2060 POPULAT	69	25	27	4	133	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80658	10.1371/journal.pone.0080658	http://dx.doi.org/10.1371/journal.pone.0080658			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260447	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900081
J	Vandame, D; Ulmann, L; Teigell, M; Prieto-Cappellini, M; Vignon, J; Privat, A; Perez-Polo, R; Nesic, O; Hirbec, H				Vandame, Delphine; Ulmann, Lauriane; Teigell, Marisa; Prieto-Cappellini, Monica; Vignon, Jacques; Privat, Alain; Perez-Polo, Regino; Nesic, Olivera; Hirbec, Helene			Development of NMDAR Antagonists with Reduced Neurotoxic Side Effects: a Study on GK11	PLOS ONE			English	Article							D-ASPARTATE RECEPTORS; NEURONAL CELL-DEATH; SPINAL-CORD; NEUROPROTECTIVE AGENT; POSTERIOR CINGULATE; RETROSPLENIAL CORTEX; MOLECULAR-MECHANISMS; SYNAPTIC PLASTICITY; BRAIN-REGIONS; RAT-BRAIN	The NMDAR glutamate receptor subtype mediates various vital physiological neuronal functions. However, its excessive activation contributes to neuronal damage in a large variety of acute and chronic neurological disorders. NMDAR antagonists thus represent promising therapeutic tools that can counteract NMDARs' overactivation. Channel blockers are of special interest since they are use-dependent, thus being more potent at continuously activated NMDARs, as may be the case in pathological conditions. Nevertheless, it has been established that NMDAR antagonists, such as MK801, also have unacceptable neurotoxic effects. Presently only Memantine is considered a safe NMDAR antagonist and is used clinically. It has recently been speculated that antagonists that preferentially target extrasynaptic NMDARs would be less toxic. We previously demonstrated that the phencyclidine derivative GK11 preferentially inhibits extrasynaptic NMDARs. We thus anticipated that this compound would be safer than other known NMDAR antagonists. In this study we used whole-genome profiling of the rat cingulate cortex, a brain area that is particularly sensitive to NMDAR antagonists, to compare the potential adverse effects of GK11 and MK801. Our results showed that in contrast to GK11, the transcriptional profile of MK801 is characterized by a significant upregulation of inflammatory and stress-response genes, consistent with its high neurotoxicity. In addition, behavioural and immunohistochemical analyses confirmed marked inflammatory reactions (including astrogliosis and microglial activation) in MK801-treated, but not GK11-treated rats. Interestingly, we also showed that GK11 elicited less inflammation and neuronal damage, even when compared to Memantine, which like GK11, preferentially inhibits extrasynaptic NMDAR. As a whole, our study suggests that GK11 may be a more attractive therapeutic alternative in the treatment of CNS disorders characterized by the overactivation of glutamate receptors.	[Vandame, Delphine; Vignon, Jacques; Privat, Alain; Hirbec, Helene] INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France; [Ulmann, Lauriane; Hirbec, Helene] CNRS, Inst Genom Fonct, Labex ICST, UMR 5203, Montpellier, France; [Ulmann, Lauriane; Hirbec, Helene] INSERM, U661, Montpellier, France; [Ulmann, Lauriane; Hirbec, Helene] Univ Montpellier I, UMR5203, Montpellier, France; [Ulmann, Lauriane; Hirbec, Helene] Univ Montpellier 2, UMR5203, Montpellier, France; [Teigell, Marisa; Prieto-Cappellini, Monica] CHU St Eloi, Montpellier, France; [Perez-Polo, Regino; Nesic, Olivera] UTMB, Dept Biochem & Mol Biol, Galveston, TX USA; [Nesic, Olivera] Sch Med, Dept Med Educ, El Paso, TX USA	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Universite de Montpellier; CHU de Montpellier; University of Texas System; University of Texas Medical Branch Galveston	Hirbec, H (corresponding author), INSERM, Inst Neurosci Montpellier, U1051, Montpellier, France.	helene.hirbec@igf.cnrs.fr	Hirbec, Helene/ABE-4188-2021; nesic, olivera/C-6456-2012; Ulmann, Lauriane/Q-8156-2018	Hirbec, Helene/0000-0002-5593-5255; Ulmann, Lauriane/0000-0002-2202-6733	INSERM; "Verticale" charity	INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); "Verticale" charity	This study was supported by grants from the INSERM, and the "Verticale" charity. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aracava Y, 2005, J PHARMACOL EXP THER, V312, P1195, DOI 10.1124/jpet.104.077172; Arundine M, 2003, CELL CALCIUM, V34, P325, DOI 10.1016/S0143-4160(03)00141-6; Bengtson CP, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-11; BLASI E, 1990, J NEUROIMMUNOL, V27, P229, DOI 10.1016/0165-5728(90)90073-V; BRESINK I, 1995, NEUROPHARMACOLOGY, V34, P533, DOI 10.1016/0028-3908(95)00017-Z; Bresink I, 1996, BRIT J PHARMACOL, V119, P195, DOI 10.1111/j.1476-5381.1996.tb15971.x; Butte A J, 2001, Pac Symp Biocomput, P6; Conti F, 1997, MOL NEUROBIOL, V14, P1, DOI 10.1007/BF02740618; Creeley C, 2006, J NEUROSCI, V26, P3923, DOI 10.1523/JNEUROSCI.4883-05.2006; de la Monte SM, 2003, LAB INVEST, V83, P287, DOI 10.1097/01.LAB.0000056995.07053.C0; Donnelly DJ, 2009, J NEUROSCI METH, V181, P36, DOI 10.1016/j.jneumeth.2009.04.010; Drian MJ, 1999, J NEUROSCI RES, V57, P927, DOI 10.1002/(SICI)1097-4547(19990915)57:6<927::AID-JNR18>3.0.CO;2-C; EWALD RC, 2009, NMDA RECEPTORS BRAIN; Feldblum S, 2000, J NEUROTRAUM, V17, P1079, DOI 10.1089/neu.2000.17.1079; FIX AS, 1995, BRAIN RES, V696, P194, DOI 10.1016/0006-8993(95)00842-E; GASS P, 1993, NEUROSCIENCE, V53, P749, DOI 10.1016/0306-4522(93)90621-L; Gaviria M, 2000, J NEUROTRAUM, V17, P19, DOI 10.1089/neu.2000.17.19; Gehrmann J, 1996, RES VIROLOGY, V147, P79, DOI 10.1016/0923-2516(96)80220-2; Gouix E, 2009, MOL CELL NEUROSCI, V40, P463, DOI 10.1016/j.mcn.2009.01.002; Hamon J, 1999, EUR J MED CHEM, V34, P125, DOI 10.1016/S0223-5234(99)80046-4; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Hardingham GE, 2010, NAT REV NEUROSCI, V11, P682, DOI 10.1038/nrn2911; Hashimoto K, 1997, EUR J NEUROSCI, V9, P1891, DOI 10.1111/j.1460-9568.1997.tb00756.x; Hirbec H, 2000, EUR J PHARMACOL, V388, P235, DOI 10.1016/S0014-2999(99)00857-2; Hirbec H, 2001, J NEUROCHEM, V77, P190, DOI 10.1046/j.1471-4159.2001.t01-1-00250.x; Hirbec H, 2001, CNS DRUG REV, V7, P172; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Ivanov A, 2006, J PHYSIOL-LONDON, V572, P789, DOI 10.1113/jphysiol.2006.105510; Janelsins MC, 2008, AM J PATHOL, V173, P1768, DOI 10.2353/ajpath.2008.080528; Kaindl AM, 2012, ANN NEUROL, V72, P536, DOI 10.1002/ana.23626; Kalia LV, 2008, LANCET NEUROL, V7, P742, DOI 10.1016/S1474-4422(08)70165-0; KAMENKA JM, 1982, J MED CHEM, V25, P431, DOI 10.1021/jm00346a019; KASHIHARA K, 1990, BRAIN RES, V528, P80, DOI 10.1016/0006-8993(90)90197-J; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kimura R, 2008, J PHYSIOL-LONDON, V586, P3195, DOI 10.1113/jphysiol.2008.151894; Kocaeli H, 2005, SURG NEUROL, V64, P22, DOI 10.1016/j.surneu.2005.07.034; Laurenzi MA, 2001, NEUROCHEM RES, V26, P1209, DOI 10.1023/A:1013911205494; Lepeintre JF, 2004, NEUROCHIRURGIE, V50, P83; Leveille F, 2008, FASEB J, V22, P4258, DOI 10.1096/fj.08-107268; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Low SJ, 2004, INT J CLIN PHARM TH, V42, P1; Manahan-Vaughan D, 2008, HIPPOCAMPUS, V18, P125, DOI 10.1002/hipo.20367; Marvanova M, 2004, NEUROPSYCHOPHARMACOL, V29, P1070, DOI 10.1038/sj.npp.1300398; Marvanova M, 2001, MOL CELL NEUROSCI, V18, P247, DOI 10.1006/mcne.2001.1027; McKeage K, 2009, CNS DRUGS, V23, P881, DOI 10.2165/11201020-000000000-00000; Menet V, 2001, J NEUROSCI, V21, P6147; MICHAUD M, 1994, EUR J MED CHEM, V29, P869, DOI 10.1016/0223-5234(94)90109-0; MODY I, 1995, TRENDS PHARMACOL SCI, V16, P356, DOI 10.1016/S0165-6147(00)89070-7; Mony L, 2009, BRIT J PHARMACOL, V157, P1301, DOI 10.1111/j.1476-5381.2009.00304.x; NAKKI R, 1995, J NEUROSCI, V15, P2097, DOI 10.1523/JNEUROSCI.15-03-02097.1995; Nesic O, 2002, J NEUROSCI RES, V68, P406, DOI 10.1002/jnr.10171; OCALLAGHAN JP, 1995, NEUROCHEM INT, V26, P115, DOI 10.1016/0197-0186(94)00106-5; OLNEY JW, 1991, SCIENCE, V254, P1515, DOI 10.1126/science.1835799; Parsons CG, 1999, NEUROPHARMACOLOGY, V38, P735, DOI 10.1016/S0028-3908(99)00019-2; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Planells-Cases R, 2006, CURR PHARM DESIGN, V12, P3583, DOI 10.2174/138161206778522092; RIEDERER P, 1991, LANCET, V338, P1022, DOI 10.1016/0140-6736(91)91888-2; SHARP FR, 1991, ANN NEUROL, V30, P801, DOI 10.1002/ana.410300609; Storvik M, 2006, EUR NEUROPSYCHOPHARM, V16, P211, DOI 10.1016/j.euroneuro.2005.08.007; Tadie M, 2003, RACHIS, V15, P363; Tomitaka S, 1996, BRAIN RES, V740, P1, DOI 10.1016/S0006-8993(96)00842-6; Toronen P, 2002, NEUROCHEM RES, V27, P1209, DOI 10.1023/A:1020985611667; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vandame D, 2007, J NEUROCHEM, V103, P1682, DOI 10.1111/j.1471-4159.2007.04925.x; Xia P, 2010, J NEUROSCI, V30, P11246, DOI 10.1523/JNEUROSCI.2488-10.2010; Zhang D, 2010, MOL NEUROBIOL, V41, P232, DOI 10.1007/s12035-010-8098-4; Zhang SJ, 2007, NEURON, V53, P549, DOI 10.1016/j.neuron.2007.01.025	69	8	8	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81004	10.1371/journal.pone.0081004	http://dx.doi.org/10.1371/journal.pone.0081004			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260528	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900109
J	Xun, HM; Kang, DM; Huang, T; Qian, YS; Li, XF; Wilson, EC; Yang, S; Jiang, ZX; Gong, CH; Tao, XR; Zhang, XJ; Wang, GY; Song, YP; Xu, ZJ; Marley, G; Huai, PC; Ma, W				Xun, Huanmiao; Kang, Dianmin; Huang, Tao; Qian, Yuesheng; Li, Xiufang; Wilson, Erin C.; Yang, Shan; Jiang, Zhenxia; Gong, Cuihua; Tao, Xiaorun; Zhang, Xijiang; Wang, Guoyong; Song, Yapei; Xu, Zhijian; Marley, Gifty; Huai, Pengcheng; Ma, Wei			Factors Associated with Willingness to Accept Oral Fluid HIV Rapid Testing among Most-at-Risk Populations in China	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEX; SALIVA; PREFERENCES; ANTIBODIES; BARRIERS; CLIENTS; VENUES; IMPACT; MEN	Background: The availability of oral fluid HIV rapid testing provides an approach that may have the potential to expand HIV testing in China, especially among most-a-risk populations. There are few investigations about the acceptability of oral fluid HIV testing among most-at-risk populations in China. Method: A cross-sectional study with men who have sex with men (MSM), female sex workers (FSW) and voluntary counseling and testing (VCT) clients was conducted in three cities of Shandong province, China from 2011 to 2012. Data were collected by face-to-face questionnaire. Results: About 71% of participants were willing to accept the oral fluid HIV rapid testing, and home HIV testing was independently associated with acceptability of the new testing method among MSM, FSW and VCT clients (AOR of 4.46, 3.19 and 5.74, respectively). Independent predictors of oral fluid HIV rapid testing acceptability among MSM were having ever taken an oral fluid HIV rapid test (AOR= 15.25), having ever taken an HIV test (AOR= 2.07), and education level (AOR= 1.74). Engagement in HIV-related risk behaviors (AOR= 1.68) was an independent predictor of acceptability for FSW. Having taken an HIV test (AOR= 2.85) was an independent predictor of acceptability for VCT clients. The primary concern about the oral fluid HIV testing was accuracy. The median price they would pay for the testing ranged from 4.8 to 8.1 U. S. dollars. Conclusion: High acceptability of oral fluid HIV rapid testing was shown among most-at-risk populations. Findings provide support for oral rapid HIV testing as another HIV prevention tool, and provide a backdrop for the implementation of HIV home testing in the near future. Appropriate pricing and increased public education through awareness campaigns that address concerns about the accuracy and safety of the oral fluid HIV rapid testing may help increase acceptability and use among most-at-risk populations in China.	[Xun, Huanmiao; Song, Yapei; Xu, Zhijian; Marley, Gifty; Huai, Pengcheng; Ma, Wei] Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China; [Kang, Dianmin; Huang, Tao; Qian, Yuesheng; Tao, Xiaorun; Wang, Guoyong] Shandong Prov Ctr Dis Control & Prevent, Jinan, Peoples R China; [Li, Xiufang] Qingdao Univ, Coll Med, Affiliated Hosp, Qingdao 266071, Peoples R China; [Wilson, Erin C.] San Francisco Dept Publ Hlth, San Francisco, CA USA; [Yang, Shan] Yantai Municipal Ctr Dis Control & Prevent, Yantai, Peoples R China; [Jiang, Zhenxia; Zhang, Xijiang] Qingdao Municipal Ctr Dis Control & Prevent, Qingdao, Peoples R China; [Gong, Cuihua] Zibo Municipal Ctr Dis Control & Prevent, Zibo, Peoples R China	Shandong University; Qingdao University; San Francisco Department of Public Health	Ma, W (corresponding author), Shandong Univ, Sch Publ Hlth, Jinan 250100, Peoples R China.	weima@sdu.edu.cn	Ma, Wei/C-4748-2019; Ma, Wei/L-2374-2019	Ma, Wei/0000-0002-8092-3280; Ma, Wei/0000-0002-8092-3280; , Guoyong Wang/0000-0003-0445-9807; Marley, Gifty/0000-0002-0025-3062	Shandong Provincial Scientific Research Foundation for Outstanding Young Scientist Award [BS2010YY019]; Ministry of Education, China [10YJCZH109]	Shandong Provincial Scientific Research Foundation for Outstanding Young Scientist Award; Ministry of Education, China(Ministry of Education, China)	The study was supported by Shandong Provincial Scientific Research Foundation for Outstanding Young Scientist Award (BS2010YY019) and Ministry of Education, China (10YJCZH109). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aho J, 2012, HIV MED, V13, P156, DOI 10.1111/j.1468-1293.2011.00951.x; Branson Bernard M, 2004, AIDS Clin Care, V16, P39; Campbell S, 2006, J CLIN MICROBIOL, V44, P3473, DOI 10.1128/JCM.01511-06; Carpenter CCJ, 1997, JAMA-J AM MED ASSOC, V277, P1962, DOI 10.1001/jama.277.24.1962; CHASSANY O, 1994, AIDS, V8, P713, DOI 10.1097/00002030-199405000-00026; China Ministry of Health, 2011, EST HIV AIDS EP CHIN; De Cock KM, 2006, NEW ENGL J MED, V354, P440, DOI 10.1056/NEJMp058327; Gottfried TD, 2006, EXPERT REV MOL DIAGN, V6, P139, DOI 10.1586/14737159.6.2.139; Greenwald Jeffrey L, 2006, Curr Infect Dis Rep, V8, P125, DOI 10.1007/s11908-006-0008-6; Holm-Hansen C, 1993, Clin Diagn Virol, V1, P207, DOI 10.1016/0928-0197(93)90002-M; Holm-Hansen C, 2007, ANN NY ACAD SCI, V1098, P461, DOI 10.1196/annals.1384.036; Hong Y, 2012, AIDS BEHAV, V16, P44, DOI 10.1007/s10461-011-9960-8; Jafa K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000185; Lechuga J, 2013, HEALTH PROMOT PRACT, V14, P433, DOI 10.1177/1524839912460870; Lee S, 2013, AIDS CARE, V25, P1; Li N, 2010, J INT REPROD HLTH FA, V29, P357; Li XF, 2012, SEX TRANSM INFECT, V88, P187, DOI 10.1136/sextrans-2011-050248; Liang TS, 2005, AIDS PATIENT CARE ST, V19, P253, DOI 10.1089/apc.2005.19.253; Lyu SY, 2011, AIDS CARE, V23, P508, DOI 10.1080/09540121.2010.516331; Ng OT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045168; Pai NP, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000367; Pai NP, 2007, EXPERT REV MOL DIAGN, V7, P325, DOI 10.1586/14737159.7.4.325; Pai NP, 2013, PLOS MED, V10, DOI 10.1371/journal.pmed.1001414; Pai NP, 2012, LANCET INFECT DIS, V12, P373, DOI 10.1016/S1473-3099(11)70368-1; Pai NP, 2008, PLOS MED, V5, P768, DOI 10.1371/journal.pmed.0050092; Pant Pai N., 2008, FUTUR HIV THER, V2, P515, DOI [DOI 10.2217/17469600.2.6.515, 10.2217/17469600.2.6.515]; Peralta L, 2001, ARCH PEDIAT ADOL MED, V155, P838, DOI 10.1001/archpedi.155.7.838; Pu Ying, 2012, Modern Preventive Medicine, V39, P160; Rou KM, 2009, JAIDS-J ACQ IMM DEF, V50, P432, DOI 10.1097/QAI.0b013e3181946088; Spielberg F, 2003, JAIDS-J ACQ IMM DEF, V32, P318, DOI 10.1097/00126334-200303010-00012; Spielberg F, 2005, FDA BLOOD PROD ADV C; Sun XH, 2010, INT J EPIDEMIOL, V39, pII4, DOI 10.1093/ije/dyq217; Valdiserri RO, 1997, AIDS EDUC PREV, V9, P2; Wang Y, 2009, AIDS BEHAV, V13, P866, DOI 10.1007/s10461-008-9446-5; Webber LM, 2000, S AFR MED J, V90, P1004; Weller S, 2001, COCHRANE DB SYST REV, pD3255; Wolff B, 2005, HEALTH POLICY PLANN, V20, P109, DOI 10.1093/heapol/czi013; Wright AA, 2006, NEW ENGL J MED, V354, P437, DOI 10.1056/NEJMp058302; Wu ZY, 2007, LANCET, V369, P679, DOI 10.1016/S0140-6736(07)60315-8; Xu YN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064652; Zhang AH, 2012, APPL BIOCHEM BIOTECH, V168, P1718, DOI 10.1007/s12010-012-9891-5; Zhang ZY, 2012, CHINESE J EXTHETIC M, V21, P395	42	30	38	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80594	10.1371/journal.pone.0080594	http://dx.doi.org/10.1371/journal.pone.0080594			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LO	24260432	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900075
J	Yang, L; Ding, GH; Lin, HY; Cheng, HN; Kong, Y; Wei, YK; Fang, X; Liu, RY; Wang, LG; Chen, XY; Yang, CQ				Yang, Lei; Ding, Guohui; Lin, Haiyan; Cheng, Haining; Kong, Yu; Wei, Yukun; Fang, Xin; Liu, Renyi; Wang, Lingiian; Chen, Xiaoya; Yang, Changqing			Transcriptome Analysis of Medicinal Plant Salvia miltiorrhiza and Identification of Genes Related to Tanshinone Biosynthesis	PLOS ONE			English	Article							HAIRY-ROOT CULTURE; ROSMARINIC ACID; CARNOSIC ACID; SAGE; ANTIOXIDANT; EXPRESSION; ENHANCEMENT; ARABIDOPSIS; ARTEMISININ; ANNOTATION	Salvia miltiorrhiza Bunge, a perennial plant of Lamiaceae, accumulates abietane-type diterpenoids of tanshinones in root, which have been used as traditional Chinese medicine to treat neuroasthenic insomnia and cardiovascular diseases. However, to date the biosynthetic pathway of tanshinones is only partially elucidated and the mechanism for their root-specific accumulation remains unknown. To identify enzymes and transcriptional regulators involved in the biosynthesis of tanshinones, we conducted transcriptome profiling of S. miltiorrhiza root and leaf tissues using the 454 GS-FLX pyrosequencing platform, which generated 550,546 and 525,292 reads, respectively. RNA sequencing reads were assembled and clustered into 64,139 unigenes (29,883 isotigs and 34,256 singletons). NCBI non-redundant protein databases (NR) and Swiss-Prot database searches anchored 32,096 unigenes (50%) with functional annotations based on sequence similarities. Further assignments with Gene Ontology (GO) terms and KEGG biochemical pathways identified 168 unigenes referring to the terpenoid backbone biosynthesis (including 144 MEP and MVA pathway genes and 24 terpene synthases). Comparative analysis of the transcriptomes identified 2,863 unigenes that were highly expressed in roots, including those encoding enzymes of early steps of tanshinone biosynthetic pathway, such as copalyl diphosphate synthase (SmCPS), kaurene synthase-like (SmKSL) and CYP76AH1. Other differentially expressed unigenes predicted to be related to tanshinone biosynthesis fall into cytochrome P450 monooxygenases, dehydrogenases and reductases, as well as regulatory factors. In addition, 21 P450 genes were selectively confirmed by real-time PCR. Thus we have generated a large unigene dataset which provides a valuable resource for further investigation of the radix development and biosynthesis of tanshinones.	[Yang, Lei; Cheng, Haining; Kong, Yu; Wei, Yukun; Chen, Xiaoya] Chinese Acad Sci, Shanghai Chenshan Plant Sci Res Ctr, Shanghai Chenshan Bot Garden, Shanghai, Peoples R China; [Yang, Lei; Fang, Xin; Wang, Lingiian; Chen, Xiaoya; Yang, Changqing] Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China; [Yang, Lei; Fang, Xin; Wang, Lingiian; Chen, Xiaoya; Yang, Changqing] Chinese Acad Sci, Natl Ctr Plant Gene Res, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Ding, Guohui] Chinese Acad Sci, Key Lab Syst Biol, Shanghai Inst Biol Sci, Shanghai, Peoples R China; [Lin, Haiyan; Liu, Renyi] Chinese Acad Sci, Shanghai Ctr Plant Stress Biol,Chinese Acad, Shanghai Inst Biol Sci, Shanghai, Peoples R China	Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS	Yang, CQ (corresponding author), Chinese Acad Sci, Natl Key Lab Plant Mol Genet, Shanghai, Peoples R China.	cqyang@sibs.ac.cn	Liu, Renyi/AAA-6449-2020	Chen, Xiaoya/0000-0002-2909-8414; Yang, Changqing/0000-0002-9761-6850	National Natural Science Foundation of China [31200222]; Special Fund for Shanghai Landscaping Administration Bureau Program [F132424, F112418]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Special Fund for Shanghai Landscaping Administration Bureau Program	This work was supported by the National Natural Science Foundation of China (grant No. 31200222), and the Special Fund for Shanghai Landscaping Administration Bureau Program (grant No. F132424 and F112418). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bak S, 2011, ARABIDOPSIS BOOK, V9; Basappa Maheswarappa N, 2013, J SCI FOOD AGR; Baskan S, 2007, FOOD CHEM, V101, P1748, DOI 10.1016/j.foodchem.2006.01.033; Ben Farhat M, 2009, J AGR FOOD CHEM, V57, P10349, DOI 10.1021/jf901877x; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Cui GH, 2011, MOL BIOL REP, V38, P2471, DOI 10.1007/s11033-010-0383-9; Cui HC, 2007, SCIENCE, V316, P421, DOI 10.1126/science.1139531; De Geyter N, 2012, TRENDS PLANT SCI, V17, P349, DOI 10.1016/j.tplants.2012.03.001; Dhondt S, 2010, PLANT PHYSIOL, V154, P1183, DOI 10.1104/pp.110.158857; Dong YZ, 2011, NAT PROD REP, V28, P529, DOI 10.1039/c0np00035c; Gao W, 2009, ORG LETT, V11, P5170, DOI 10.1021/ol902051v; Ge XC, 2005, APPL MICROBIOL BIOT, V68, P183, DOI 10.1007/s00253-004-1873-2; Ge XC, 2005, PLANT SCI, V168, P487, DOI 10.1016/j.plantsci.2004.09.012; Guo J, 2013, P NATL ACAD SCI USA; Guterman I, 2002, PLANT CELL, V14, P2325, DOI 10.1105/tpc.005207; Hua WP, 2011, GENOMICS, V98, P272, DOI 10.1016/j.ygeno.2011.03.012; Huang BB, 2008, MOL BIOL REP, V35, P601, DOI 10.1007/s11033-007-9130-2; Jordan MJ, 2012, J AGR FOOD CHEM, V60, P9603, DOI 10.1021/jf302881t; Kai GY, 2012, ACTA PHYSIOL PLANT, V34, P1421, DOI 10.1007/s11738-012-0940-z; Kai GY, 2010, BIOTECHNOL BIOPROC E, V15, P236, DOI 10.1007/s12257-009-0123-y; Kamatou GPP, 2005, J ETHNOPHARMACOL, V102, P382, DOI 10.1016/j.jep.2005.06.034; Lamien-Meda A, 2010, J AGR FOOD CHEM, V58, P3813, DOI 10.1021/jf903993f; Laule O, 2003, P NATL ACAD SCI USA, V100, P6866, DOI 10.1073/pnas.1031755100; Li Jin Tong, 2008, Fen Zi Xi Bao Sheng Wu Xue Bao, V41, P44; Li MH, 2008, J ETHNOPHARMACOL, V120, P419, DOI 10.1016/j.jep.2008.09.013; Li YI, 2008, LIFE SCI, V83, P557, DOI 10.1016/j.lfs.2008.08.003; Liu TT, 2011, J CHROMATOGR A, V1218, P8480, DOI 10.1016/j.chroma.2011.09.073; Ma YMA, 2012, J EXP BOT, V63, P2809, DOI 10.1093/jxb/err466; Menke FLH, 1999, EMBO J, V18, P4455, DOI 10.1093/emboj/18.16.4455; Moriya Y, 2007, NUCLEIC ACIDS RES, V35, pW182, DOI 10.1093/nar/gkm321; Murata J, 2008, PLANT CELL, V20, P524, DOI 10.1105/tpc.107.056630; Nakajima K, 2002, PLANT CELL, V14, pS265, DOI 10.1105/tpc.010471; Okamoto S, 2011, FEBS J, V278, P2892, DOI 10.1111/j.1742-4658.2011.08211.x; Sanchez C, 2007, TREE PHYSIOL, V27, P1459, DOI 10.1093/treephys/27.10.1459; Santos-Gomes PC, 2003, J PLANT PHYSIOL, V160, P1025, DOI 10.1078/0176-1617-00831; Shi M, 2007, BIOTECHNOL APPL BIOC, V46, P191, DOI 10.1042/BA20060147; Swaminathan S, 2009, PLANT CELL, V21, P3315, DOI 10.1105/tpc.108.063677; Torres-Galea P, 2006, MOL GENET GENOMICS, V276, P13, DOI 10.1007/s00438-006-0123-y; van der Fits L, 2001, PLANT J, V25, P43, DOI 10.1046/j.1365-313x.2001.00932.x; Wang H, 2012, BMC PLANT BIOL, V12, DOI [10.1186/1471-2229-12-194, 10.1186/1471-2229-12-10]; Wang Q, 2012, PLANT PHYSIOL, V158, P1418, DOI 10.1104/pp.111.187518; Wang XH, 2007, MED RES REV, V27, P133, DOI 10.1002/med.20077; Wu YS, 2011, FEBS LETT, V585, P3446, DOI 10.1016/j.febslet.2011.09.038; Xiao Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029713; Xu YH, 2004, PLANT PHYSIOL, V135, P507, DOI 10.1104/pp.104.038612; Yan QO, 2011, BIOTECHNOL LETT, V33, P813, DOI 10.1007/s10529-010-0484-5; Yan YP, 2010, SCI CHINA LIFE SCI, V53, P273, DOI 10.1007/s11427-010-0005-8; Yang CQ, 2012, J INTEGR PLANT BIOL, V54, P703, DOI 10.1111/j.1744-7909.2012.01161.x; Yang YF, 2010, MOL BIOL REP, V37, P507, DOI 10.1007/s11033-009-9703-3; Yesil-Celiktas O, 2010, PLANT FOOD HUM NUTR, V65, P158, DOI 10.1007/s11130-010-0166-4; Yu ZX, 2012, MOL PLANT, V5, P353, DOI 10.1093/mp/ssr087; Zhang CH, 2004, PLANTA MED, V70, P147, DOI 10.1055/s-2004-815492; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200; Zhang Y, 2012, J AGR FOOD CHEM, V60, P9305, DOI 10.1021/jf302179c; Zhou LM, 2005, J CLIN PHARMACOL, V45, P1345, DOI 10.1177/0091270005282630; Zu G, 2012, INT J MOL SCI, V13, P11027, DOI 10.3390/ijms130911027	57	86	105	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80464	10.1371/journal.pone.0080464	http://dx.doi.org/10.1371/journal.pone.0080464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260395	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900067
J	Gonzalez-Juarrero, M; Mima, N; Trunck, LA; Schweizer, HP; Bowen, RA; Dascher, K; Mwangi, W; Eckstein, TM				Gonzalez-Juarrero, Mercedes; Mima, Naoko; Trunck, Lily A.; Schweizer, Herbert P.; Bowen, Richard A.; Dascher, Kyle; Mwangi, Waithaka; Eckstein, Torsten M.			Polar Lipids of Burkholderia pseudomallei Induce Different Host Immune Responses	PLOS ONE			English	Article							ORNITHINE-CONTAINING LIPIDS; T-CELLS; ANTIGEN PRESENTATION; ADAPTIVE IMMUNITY; MELIOIDOSIS; INFECTION; VACCINES; PROTECTION; GAMMA	Melioidosis is a disease in tropical and subtropical regions of the world that is caused by Burkholderia pseudomallei. In endemic regions the disease occurs primarily in humans and goats. In the present study, we used the goat as a model to dissect the polar lipids of B. pseudomallei to identify lipid molecules that could be used for adjuvants/vaccines or as diagnostic tools. We showed that the lipidome of B. pseudomallei and its fractions contain several polar lipids with the capacity to elicit different immune responses in goats, namely rhamnolipids and ornithine lipids which induced IFN-gamma, whereas phospholipids and an undefined polar lipid induced strong IL-10 secretion in CD4(+) T cells. Autologous T cells cocultured with caprine dendritic cells (cDCs) and polar lipids of B. pseudomallei proliferated and up-regulated the expression of CD25 (IL-2 receptor) molecules. Furthermore, we demonstrated that polar lipids were able to up-regulate CD1w2 antigen expression in cDCs derived from peripheral blood monocytes. Interestingly, the same polar lipids had only little effect on the expression of MHC class II DR antigens in the same caprine dendritic cells. Finally, antibody blocking of the CD1w2 molecules on cDCs resulted in decreased expression for IFN-gamma by CD4(+) T cells. Altogether, these results showed that polar lipids of B. pseudomallei are recognized by the caprine immune system and that their recognition is primarily mediated by the CD1 antigen cluster.	[Gonzalez-Juarrero, Mercedes; Mima, Naoko; Trunck, Lily A.; Schweizer, Herbert P.; Dascher, Kyle; Eckstein, Torsten M.] Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA; [Bowen, Richard A.] Colorado State Univ, Dept Biomed Sci, Ft Collins, CO 80523 USA; [Mwangi, Waithaka] Texas A&M Univ, Dept Vet Pathobiol, College Stn, TX USA	Colorado State University; Colorado State University; Texas A&M University System; Texas A&M University College Station	Eckstein, TM (corresponding author), Colorado State Univ, Dept Microbiol Immunol & Pathol, Ft Collins, CO 80523 USA.	eckstein@mail.colostate.edu		gonzalez-juarrero, mercedes/0000-0002-4045-2365	Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; National Institute for Allergies and Infectious Diseases [U54 AI065357]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI065357] Funding Source: NIH RePORTER	Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research; National Institute for Allergies and Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by developmental grants administered by the Rocky Mountain Regional Center of Excellence for Biodefense and Emerging Infectious Diseases Research, which is funded by grant U54 AI065357 from the National Institute for Allergies and Infectious Diseases. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdel-Mawgoud AM, 2010, APPL MICROBIOL BIOT, V86, P1323, DOI 10.1007/s00253-010-2498-2; Adler NRL, 2009, FEMS MICROBIOL REV, V33, P1079, DOI 10.1111/j.1574-6976.2009.00189.x; Andra J, 2006, BIOL CHEM, V387, P301, DOI 10.1515/BC.2006.040; Barnes JL, 2004, CLIN IMMUNOL, V113, P22, DOI 10.1016/j.clim.2004.06.006; BOBO RA, 1968, CAN J MICROBIOL, V14, P503, DOI 10.1139/m68-086; Brandenburg K, 2004, BIOCHEMISTRY-US, V43, P4039, DOI 10.1021/bi0361158; Brandenburg K, 2003, EUR J BIOCHEM, V270, P3271, DOI 10.1046/j.1432-1033.2003.03719.x; Cohen NR, 2009, ADV IMMUNOL, V102, P1, DOI 10.1016/S0065-2776(09)01201-2; DUTIA BM, 1991, VET IMMUNOL IMMUNOP, V27, P189, DOI 10.1016/0165-2427(91)90099-X; Gan YH, 2005, J INFECT DIS, V192, P1845, DOI 10.1086/497382; Goodyear A, 2009, INFECT IMMUN, V77, P1579, DOI 10.1128/IAI.01384-08; Haque A, 2006, J INFECT DIS, V193, P370, DOI 10.1086/498983; Haussler S, 1998, INFECT IMMUN, V66, P1588; Haussler S, 2003, INFECT IMMUN, V71, P2970, DOI 10.1128/IAI.71.5.2970-2975.2003; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P14240, DOI 10.1073/pnas.0403302101; Howe J, 2006, FEBS J, V273, P5101, DOI 10.1111/j.1742-4658.2006.05507.x; Inglis TJJ, 2006, AM J TROP MED HYG, V75, P947, DOI 10.4269/ajtmh.2006.75.947; KAWAI Y, 1991, INFECT IMMUN, V59, P2560, DOI 10.1128/IAI.59.8.2560-2566.1991; KAWAI Y, 1988, EUR J BIOCHEM, V175, P633; Kawai Y, 2002, FEMS IMMUNOL MED MIC, V34, P173, DOI 10.1111/j.1574-695X.2002.tb00621.x; KOKKINOPOULOS D, 1992, J IMMUNOL METHODS, V154, P1, DOI 10.1016/0022-1759(92)90205-8; Lertmemongkolchai G, 2001, J IMMUNOL, V166, P1097, DOI 10.4049/jimmunol.166.2.1097; Limmathurotsakul D, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000327; Lipsitz R., 2012, EMERG INFECT DIS, V18, pe2; Melian A, 2000, J IMMUNOL, V165, P4494, DOI 10.4049/jimmunol.165.8.4494; Morgan AH, 2009, J BIOL CHEM, V284, P21185, DOI 10.1074/jbc.M109.021634; Mwangi W, 2002, J IMMUNOL, V169, P3837, DOI 10.4049/jimmunol.169.7.3837; Nimtz M, 1997, EUR J BIOCHEM, V250, P608, DOI 10.1111/j.1432-1033.1997.0608a.x; Palacios-Chaves L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016030; Panomket Pawana, 2011, Journal of the Medical Association of Thailand, V94, P1410; Patel N, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00198; Peacock SJ, 2012, PLOS NEGLECT TROP D, V6, DOI 10.1371/journal.pntd.0001488; Reckseidler SL, 2001, INFECT IMMUN, V69, P34, DOI 10.1128/IAI.69.1.34-44.2001; Rhind SM, 2000, IMMUNOLOGY, V101, P452, DOI 10.1046/j.1365-2567.2000.00134.x; Rolim DB, 2011, AM J TROP MED HYG, V84, P302, DOI 10.4269/ajtmh.2011.10-0220; Roura-Mir C, 2005, J IMMUNOL, V175, P1758, DOI 10.4049/jimmunol.175.3.1758; Salio M, 2010, CURR OPIN IMMUNOL, V22, P81, DOI 10.1016/j.coi.2009.12.008; Santanirand P, 1999, INFECT IMMUN, V67, P3593, DOI 10.1128/IAI.67.7.3593-3600.1999; Saravu K, 2010, SE ASIAN J TROP MED, V41, P401; Sarkar-Tyson M, 2010, CLIN THER, V32, P1437, DOI 10.1016/j.clinthera.2010.07.020; Sarkar-Tyson M, 2009, VACCINE, V27, P4447, DOI 10.1016/j.vaccine.2009.05.040; Silk JD, 2008, ANNU REV CELL DEV BI, V24, P369, DOI 10.1146/annurev.cellbio.24.110707.175359; Steinmetz I, 2000, ACTA TROP, V74, P211, DOI 10.1016/S0001-706X(99)00072-8; Tippayawat P, 2011, INFECT IMMUN, V79, P305, DOI 10.1128/IAI.00803-10; Vahedi F, 2010, IRAN J IMMUNOL, V7, P210, DOI IJIv7i4A2; VANPHUNG L, 1995, MICROBIOL IMMUNOL, V39, P105, DOI 10.1111/j.1348-0421.1995.tb02176.x; Wiersinga WJ, 2012, NEW ENGL J MED, V367, P1035, DOI 10.1056/NEJMra1204699	47	5	5	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80368	10.1371/journal.pone.0080368	http://dx.doi.org/10.1371/journal.pone.0080368			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260378	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500128
J	Li, H; Zhang, XP; Liu, F				Li, Hao; Zhang, Xiao-Peng; Liu, Feng			Coordination between p21 and DDB2 in the Cellular Response to UV Radiation	PLOS ONE			English	Article							P53 TUMOR-SUPPRESSOR; SINGLE-STRAND BREAKS; DNA-DAMAGE RESPONSE; ATR; CANCER; REPAIR; PTEN; GENE; TRANSCRIPTION; DYNAMICS	The tumor suppressor p53 guides the cellular response to DNA damage mainly by regulating expression of target genes. The cyclin-dependent kinase inhibitor p21, which is induced by p53, can both arrest the cell cycle and inhibit apoptosis. Interestingly, p53-inducible DDB2 (damaged-DNA binding protein 2) promotes apoptosis by mediating p21 degradation after ultraviolet (UV)-induced DNA damage. Here, we developed an integrated model of the p53 network to explore how the UV-irradiated cell makes a decision between survival and death and how the activities of p21 and DDB2 are modulated. By numerical simulations, we found that p53 is activated progressively and the promoter selectivity of p53 depends on its concentration. For minor DNA damage, p53 settles at an intermediate level. p21 is induced by p53 to arrest the cell cycle via inhibiting E2F1 activity, allowing for DNA repair. The proapoptotic genes are expressed at low levels. For severe DNA damage, p53 undergoes a two-phase behavior and accumulates to high levels in the second phase. Consequently, those proapoptotic proteins accumulate remarkably. Bax activates the release of cytochrome c, while DDB2 promotes the degradation of p21, which leads to activation of E2F1 and induction of Apaf-1. Finally, the caspase cascade is activated to trigger apoptosis. We revealed that the downregulation of p21 is necessary for apoptosis induction and PTEN promotes apoptosis by amplifying p53 activation. This work demonstrates that how the dynamics of the p53 network can be finely regulated through feed-forward and feedback loops within the network and emphasizes the importance of p21 regulation in the DNA damage response.	[Zhang, Xiao-Peng] Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210008, Jiangsu, Peoples R China; Nanjing Univ, Dept Phys, Nanjing 210008, Jiangsu, Peoples R China	Nanjing University; Nanjing University	Zhang, XP (corresponding author), Nanjing Univ, Natl Lab Solid State Microstruct, Nanjing 210008, Jiangsu, Peoples R China.	zhangxp@nju.edu.cn; fliu@nju.edu.cn	Zhang, Xiao-Peng/E-1973-2011; Liu, Feng/E-1462-2011	Zhang, Xiao-Peng/0000-0001-8170-1236; 	973 program [2013834104]; National Natural Science Foundation of China [11175084, 11204126]; Priority Academic Program Development of Jiangsu Higher Education Institutions	973 program(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Priority Academic Program Development of Jiangsu Higher Education Institutions	This work was supported by the 973 program (2013834104), National Natural Science Foundation of China (11175084 and 11204126), and the Priority Academic Program Development of Jiangsu Higher Education Institutions. http://www.nsfc.gov.cn; http://www.973.gov.cn/Default_3.aspx. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbas T, 2009, NAT REV CANCER, V9, P400, DOI 10.1038/nrc2657; Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Berger MF, 2012, NATURE, V485, P502, DOI 10.1038/nature11071; Bieging KT, 2012, TRENDS CELL BIOL, V22, P97, DOI 10.1016/j.tcb.2011.10.006; Cadet J, 2005, MUTAT RES-FUND MOL M, V571, P3, DOI 10.1016/j.mrfmmm.2004.09.012; Cimprich KA, 2008, NAT REV MOL CELL BIO, V9, P616, DOI 10.1038/nrm2450; Das S, 2007, CELL, V130, P624, DOI 10.1016/j.cell.2007.06.013; ELDEIRY WS, 1993, CELL, V75, P817, DOI 10.1016/0092-8674(93)90500-P; Fine B, 2009, SCIENCE, V325, P1261, DOI 10.1126/science.1173569; Fitch ME, 2003, J BIOL CHEM, V278, P46906, DOI 10.1074/jbc.M307254200; FORNACE AJ, 1976, P NATL ACAD SCI USA, V73, P39, DOI 10.1073/pnas.73.1.39; Furukawa Y, 2002, J BIOL CHEM, V277, P39760, DOI 10.1074/jbc.M200805200; He GG, 2005, ONCOGENE, V24, P2929, DOI 10.1038/sj.onc.1208474; Janicke RU, 2007, CELL CYCLE, V6, P407; JEFFREY PD, 1995, SCIENCE, V267, P1498, DOI 10.1126/science.7878469; Kholodenko BN, 2006, NAT REV MOL CELL BIO, V7, P165, DOI 10.1038/nrm1838; Kitaura H, 2000, J BIOL CHEM, V275, P10477, DOI 10.1074/jbc.275.14.10477; Lahav G, 2004, NAT GENET, V36, P147, DOI 10.1038/ng1293; Lankinen MH, 1996, MUTAT RES-FUND MOL M, V352, P31, DOI 10.1016/0027-5107(95)00172-7; Latonen L, 2005, BBA-REV CANCER, V1755, P71, DOI 10.1016/j.bbcan.2005.04.003; Lee JJ, 2011, CELL DEATH DIFFER, V18, P666, DOI 10.1038/cdd.2010.139; Liu SZ, 2011, MOL CELL, V43, P192, DOI 10.1016/j.molcel.2011.06.019; Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009; Mayo LD, 2002, TRENDS BIOCHEM SCI, V27, P462, DOI 10.1016/S0968-0004(02)02166-7; Mayo LD, 2001, P NATL ACAD SCI USA, V98, P11598, DOI 10.1073/pnas.181181198; McCubrey JA, 2011, J CELL PHYSIOL, V226, P2762, DOI 10.1002/jcp.22647; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; MIYASHITA T, 1995, CELL, V80, P293; Murray-Zmijewski F, 2008, NAT REV MOL CELL BIO, V9, P702, DOI 10.1038/nrm2451; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Ohtani K, 1995, P NATL ACAD SCI USA, V92, P12146, DOI 10.1073/pnas.92.26.12146; Riedl SJ, 2007, NAT REV MOL CELL BIO, V8, P405, DOI 10.1038/nrm2153; Shinozaki T, 2003, ONCOGENE, V22, P8870, DOI 10.1038/sj.onc.1207176; Shiyanov P, 1999, J BIOL CHEM, V274, P35309, DOI 10.1074/jbc.274.50.35309; Sinha RP, 2002, PHOTOCH PHOTOBIO SCI, V1, P225, DOI 10.1039/b201230h; Sohn D, 2006, CANCER RES, V66, P11254, DOI 10.1158/0008-5472.CAN-06-1569; Song MS, 2012, NAT REV MOL CELL BIO, V13, P283, DOI 10.1038/nrm3330; Speidel D, 2010, TRENDS CELL BIOL, V20, P14, DOI 10.1016/j.tcb.2009.10.002; Stambolic V, 1998, CELL, V95, P29, DOI 10.1016/S0092-8674(00)81780-8; Stambolic V, 2001, MOL CELL, V8, P317, DOI 10.1016/S1097-2765(01)00323-9; Stoyanova T, 2009, P NATL ACAD SCI USA, V106, P10690, DOI 10.1073/pnas.0812254106; Suzuki A, 1998, ONCOGENE, V17, P931, DOI 10.1038/sj.onc.1202021; Tan T, 2002, MOL CELL BIOL, V22, P3247, DOI 10.1128/MCB.22.10.3247-3254.2002; Tibbetts RS, 1999, GENE DEV, V13, P152, DOI 10.1101/gad.13.2.152; Unsal-Kacmaz K, 2002, P NATL ACAD SCI USA, V99, P6673, DOI 10.1073/pnas.102167799; WALDMAN T, 1995, CANCER RES, V55, P5187; Weinberg RL, 2005, J MOL BIOL, V348, P589, DOI 10.1016/j.jmb.2005.03.014; Wood RD, 1997, J BIOL CHEM, V272, P23465, DOI 10.1074/jbc.272.38.23465; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; WU XW, 1993, GENE DEV, V7, P1126, DOI 10.1101/gad.7.7a.1126; Yao G, 2008, NAT CELL BIOL, V10, P476, DOI 10.1038/ncb1711; Zhang TL, 2007, CELL CYCLE, V6, P85, DOI 10.4161/cc.6.1.3705; Zhang XP, 2012, BIOPHYS J, V102, P2251, DOI 10.1016/j.bpj.2012.04.002; Zhang XP, 2011, P NATL ACAD SCI USA, V108, P8990, DOI 10.1073/pnas.1100600108; Zhang XP, 2009, P NATL ACAD SCI USA, V106, P12245, DOI 10.1073/pnas.0813088106; Zou H, 2003, J BIOL CHEM, V278, P8091, DOI 10.1074/jbc.M204783200	56	12	12	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80111	10.1371/journal.pone.0080111	http://dx.doi.org/10.1371/journal.pone.0080111			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260342	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500115
J	Marin-Juez, R; Diaz, M; Morata, J; Planas, JV				Marin-Juez, Ruben; Diaz, Monica; Morata, Jordi; Planas, Josep V.			Mechanisms Regulating GLUT4 Transcription in Skeletal Muscle Cells Are Highly Conserved across Vertebrates	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED RECEPTORS; GLUCOSE-TRANSPORTER GLUT4; PPAR-GAMMA; TRANSGENIC MICE; GENE PROMOTER; RAT GLUT4; ADIPOCYTE DIFFERENTIATION; PHYSIOLOGICAL REGULATION; MEDIATES REPRESSION; ADIPOSE-TISSUE	The glucose transporter 4 (GLUT4) plays a key role in glucose uptake in insulin target tissues. This transporter has been extensively studied in many species in terms of its function, expression and cellular traffic and complex mechanisms are involved in its regulation at many different levels. However, studies investigating the transcription of the GLUT4 gene and its regulation are scarce. In this study, we have identified the GLUT4 gene in a teleost fish, the Fugu (Takifugu rubripes), and have cloned and characterized a functional promoter of this gene for the first time in a non-mammalian vertebrate. In silico analysis of the Fugu GLUT4 promoter identified potential binding sites for transcription factors such as SP1, C/EBP, MEF2, KLF, SREBP-1c and GC-boxes, as well as a CpG island, but failed to identify a TATA box. In vitro analysis revealed three transcription start sites, with the main residing 307 bp upstream of the ATG codon. Deletion analysis determined that the core promoter was located between nucleotides -132/+94. By transfecting a variety of 5'deletion constructs into L6 muscle cells we have determined that Fugu GLUT4 promoter transcription is regulated by insulin, PG-J2, a PPAR gamma agonist, and electrical pulse stimulation. Furthermore, our results suggest the implication of motifs such as PPAR gamma/RXR and HIF-1 alpha in the regulation of Fugu GLUT4 promoter activity by PPAR gamma and contractile activity, respectively. These data suggest that the characteristics and regulation of the GLUT4 promoter have been remarkably conserved during the evolution from fish to mammals, further evidencing the important role of GLUT4 in metabolic regulation in vertebrates.	[Planas, Josep V.] Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain; Univ Barcelona, Inst Biomed, Barcelona, Spain	University of Barcelona; University of Barcelona	Planas, JV (corresponding author), Univ Barcelona, Fac Biol, Dept Fisiol & Immunol, Barcelona, Spain.	jplanas@ub.edu	Marín-Juez, Rubén/F-4401-2014; Marín-Juez, Rubén/AAN-7660-2021; Diaz, Mònica/AAF-8427-2019	Marín-Juez, Rubén/0000-0001-5903-7463; Marín-Juez, Rubén/0000-0001-5903-7463; Diaz, Mònica/0000-0002-4428-4258; Morata, Jordi/0000-0002-6146-4322; Planas, Josep/0000-0002-6525-9617	FPI fellowship from the Spanish government;  [AGL2009-07006];  [CSD2007-0002]	FPI fellowship from the Spanish government; ; 	This study was funded by grants AGL2009-07006 and CSD2007-0002 to JVP. RMJ was supported by a FPI fellowship from the Spanish government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anish R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005103; Antonescu CN, 2008, TRAFFIC, V9, P1173, DOI 10.1111/j.1600-0854.2008.00755.x; Armoni M, 2003, J BIOL CHEM, V278, P30614, DOI 10.1074/jbc.M304654200; Boukouvala E, 2004, LIPIDS, V39, P1085, DOI 10.1007/s11745-004-1334-z; BRANDEIS M, 1994, NATURE, V371, P435, DOI 10.1038/371435a0; Bryant NJ, 2002, NAT REV MOL CELL BIO, V3, P267, DOI 10.1038/nrm782; BUSE JB, 1992, DIABETES, V41, P1436, DOI 10.2337/diabetes.41.11.1436; Capilla E, 2004, AM J PHYSIOL-ENDOC M, V287, pE348, DOI 10.1152/ajpendo.00538.2003; Capilla E, 2002, AM J PHYSIOL-ENDOC M, V283, pE44, DOI 10.1152/ajpendo.00065.2002; Capilla E, 2010, AM J PHYSIOL-ENDOC M, V298, pE329, DOI 10.1152/ajpendo.00547.2009; Cho HK, 2009, GEN COMP ENDOCR, V163, P251, DOI 10.1016/j.ygcen.2009.04.018; Cooke DW, 1999, J BIOL CHEM, V274, P12917, DOI 10.1074/jbc.274.18.12917; Cooke DW, 1998, J BIOL CHEM, V273, P6210, DOI 10.1074/jbc.273.11.6210; Diaz M, 2007, ENDOCRINOLOGY, V148, P5248, DOI 10.1210/en.2007-0265; Diaz M, 2007, J EXP BIOL, V210, P2346, DOI 10.1242/jeb.002857; Diaz M, 2009, AM J PHYSIOL-REG I, V296, pR794, DOI 10.1152/ajpregu.90673.2008; Fajas L, 1997, J BIOL CHEM, V272, P18779, DOI 10.1074/jbc.272.30.18779; Felip O, 2012, BRIT J NUTR, V107, P834, DOI 10.1017/S0007114511003709; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; GERRITS PM, 1993, J BIOL CHEM, V268, P640; Giron MD, 2008, DIABETOLOGIA, V51, P1285, DOI 10.1007/s00125-008-1003-2; Grabe Niels, 2002, In Silico Biology, V2, pS1; Gray S, 2002, J BIOL CHEM, V277, P34322, DOI 10.1074/jbc.M201304200; Hallakou S, 1997, DIABETES, V46, P1393, DOI 10.2337/diabetes.46.9.1393; He S, 2012, COMP BIOCHEM PHYS C, V155, P381, DOI 10.1016/j.cbpc.2011.10.008; Host HH, 1998, J APPL PHYSIOL, V84, P798, DOI 10.1152/jappl.1998.84.3.798; Ibabe A, 2005, TOXICOL IN VITRO, V19, P725, DOI 10.1016/j.tiv.2005.03.019; Ibabe A, 2005, HISTOCHEM CELL BIOL, V123, P75, DOI 10.1007/s00418-004-0737-2; Ishiki M, 2005, ENDOCRINOLOGY, V146, P5071, DOI 10.1210/en.2005-0850; KAESTNER KH, 1990, P NATL ACAD SCI USA, V87, P251, DOI 10.1073/pnas.87.1.251; Kaneko G, 2013, GEN COMP ENDOCR, V184, P51, DOI 10.1016/j.ygcen.2013.01.003; Karnieli E, 2008, AM J PHYSIOL-ENDOC M, V295, pE38, DOI 10.1152/ajpendo.90306.2008; Kawanaka K, 1997, J APPL PHYSIOL, V83, P2043, DOI 10.1152/jappl.1997.83.6.2043; KLIEWER SA, 1995, CELL, V83, P813, DOI 10.1016/0092-8674(95)90194-9; Knight JB, 2003, P NATL ACAD SCI USA, V100, P14725, DOI 10.1073/pnas.2432756100; Kondo H, 2007, GEN COMP ENDOCR, V154, P120, DOI 10.1016/j.ygcen.2007.05.034; Larance M, 2008, MOL ENDOCRINOL, V22, P226, DOI 10.1210/me.2007-0282; Lauritzen HPMM, 2010, AM J PHYSIOL-ENDOC M, V299, pE169, DOI 10.1152/ajpendo.00066.2010; Leaver MJ, 2005, ENDOCRINOLOGY, V146, P3150, DOI 10.1210/en.2004-1638; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lima GA, 2009, AM J PHYSIOL-ENDOC M, V296, pE132, DOI 10.1152/ajpendo.90548.2008; LIU ML, 1994, J BIOL CHEM, V269, P28514; LIU ML, 1992, J BIOL CHEM, V267, P11673; MacLean PS, 2002, BIOCHEM BIOPH RES CO, V292, P409, DOI 10.1006/bbrc.2002.6654; MACLEOD D, 1994, GENE DEV, V8, P2282, DOI 10.1101/gad.8.19.2282; Magnoni LJ, 2013, COMP BIOCHEM PHYS A, V166, P510, DOI 10.1016/j.cbpa.2013.08.005; Magnoni Vraskou Y, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0031219, DOI 10.1371/J0URNAL.P0NE.0031219.PUBMED:22359576]; Marotta M, 2004, BIOTECHNIQUES, V36, P68, DOI 10.2144/04361ST01; Nedachi T, 2008, AM J PHYSIOL-ENDOC M, V295, pE1191, DOI 10.1152/ajpendo.90280.2008; NEUFER PD, 1993, J BIOL CHEM, V268, P13824; Niu WY, 2010, AM J PHYSIOL-ENDOC M, V298, pE1058, DOI 10.1152/ajpendo.00773.2009; Olefsky JM, 2000, TRENDS ENDOCRIN MET, V11, P362, DOI 10.1016/S1043-2760(00)00306-4; OLSON AL, 1995, J BIOL CHEM, V270, P23491, DOI 10.1074/jbc.270.40.23491; Ovcharenko I, 2004, GENOME RES, V14, P472, DOI 10.1101/gr.2129504; Pinney SE, 2010, TRENDS ENDOCRIN MET, V21, P223, DOI 10.1016/j.tem.2009.10.002; Quandt K, 1995, NUCLEIC ACIDS RES, V23, P4878, DOI 10.1093/nar/23.23.4878; REN JM, 1994, J BIOL CHEM, V269, P14396; RICHARDSON JM, 1993, J BIOL CHEM, V268, P21021; Royer C, 2000, BRAIN RES, V856, P119, DOI 10.1016/S0006-8993(99)02365-3; Scheepers A, 2004, JPEN-PARENTER ENTER, V28, P364, DOI 10.1177/0148607104028005364; Schoonjans K, 1997, CURR OPIN LIPIDOL, V8, P159, DOI 10.1097/00041433-199706000-00006; Silva JLT, 2005, MOL CELL ENDOCRINOL, V240, P82, DOI 10.1016/j.mce.2005.05.006; SLENTZ CA, 1992, J APPL PHYSIOL, V73, P486, DOI 10.1152/jappl.1992.73.2.486; Thai MV, 1998, J BIOL CHEM, V273, P14285, DOI 10.1074/jbc.273.23.14285; Wagner PD, 2001, ADV EXP MED BIOL, V502, P21; Watson RT, 2006, TRENDS BIOCHEM SCI, V31, P215, DOI 10.1016/j.tibs.2006.02.007; YAFFE D, 1968, P NATL ACAD SCI USA, V61, P477, DOI 10.1073/pnas.61.2.477; Zhu J, 2008, TRENDS GENET, V24, P481, DOI 10.1016/j.tig.2008.08.004; Zorzano A, 2005, ACTA PHYSIOL SCAND, V183, P43, DOI 10.1111/j.1365-201X.2004.01380.x	69	27	27	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80628	10.1371/journal.pone.0080628	http://dx.doi.org/10.1371/journal.pone.0080628			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260440	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500161
J	Kohler, JB; Jorgensen, MLM; Beinoraite, G; Thorsen, M; Thon, G				Kohler, Julie Bonne; Jorgensen, Maria Louise Monster; Beinoraite, Gabriele; Thorsen, Michael; Thon, Genevieve			Concerted Action of the Ubiquitin-Fusion Degradation Protein 1 (Ufd1) and Sumo-Targeted Ubiquitin Ligases (STUbLs) in the DNA-Damage Response	PLOS ONE			English	Article							FORK PROTECTION COMPLEX; AAA-ATPASE; FISSION YEAST; SCHIZOSACCHAROMYCES-POMBE; POSTREPLICATION REPAIR; SELECTIVE SEGREGASE; GLOBAL ANALYSIS; E3 LIGASE; SUMOYLATION; REPLICATION	In eukaryotes many players in the DNA-damage response (DDR) catalyze protein sumoylation or ubiquitylation. Emphasis has been placed on how these modifications orchestrate the sequential recruitment of repair factors to sites of DNA damage or stalled replication forks. Here, we shed light on a pathway in which sumoylated factors are eliminated through the coupled action of Sumo-targeted ubiquitin ligases (STUbLs) and the ubiquitin-fusion degradation protein 1 (Ufd1). Ufd1 is a subunit of the Cdc48-Ufd1-Npl4 complex implicated in the sorting of ubiquitylated substrates for degradation by the proteasome. We find that in fission yeast, Ufd1 interacts physically and functionally with the Sumo-targeted ubiquitin ligase (STUbL) Rfp1, homologous to human RNF4, and with the Sumo E3 ligase Pli1, homologous to human PIAS1. Deleting a C-terminal domain of Ufd1 that mediates the interaction of Ufd1 with Rfp1, Pli1, and Sumo (ufd1 Delta Ct(213-342)) lead to an accumulation of high-molecular-weight Sumo conjugates and caused severe genomic instabilities. The spectrum of sensitivity of ufd1 Delta Ct(213-342) cells to genotoxins, the epistatic relationships of ufd1 Delta Ct(213-342) with mutations in DNA repair factors, and the localization of the repair factor Rad22 in ufd1 Delta Ct(213-342) cells point to ufd1 Delta Ct(213-342) cells accumulating aberrant structures during replication that require homologous recombination (HR) for their repair. We present evidence that HR is however often not successful in ufd1 Delta Ct(213-342) cells and we identify Rad22 as one of the high-molecular-weight conjugates accumulating in the ufd1 Delta Ct(213-342) mutant consistent with Rad22 being a STUbL/Ufd1 substrate. Suggesting a direct role of Ufd1 in the processing of Sumo-conjugates, Ufd1 formed nuclear foci colocalizing with Sumo during the DDR, and Sumo-conjugates accumulated in foci in the ufd1 Delta Ct(213-342) mutant. Broader functional relationships between Ufd1 and STUbLs conceivably affect numerous cellular processes beyond the DDR.	[Kohler, Julie Bonne; Jorgensen, Maria Louise Monster; Beinoraite, Gabriele; Thorsen, Michael; Thon, Genevieve] Univ Copenhagen, Dept Biol, Copenhagen, Denmark	University of Copenhagen	Thon, G (corresponding author), Univ Copenhagen, Dept Biol, Copenhagen, Denmark.	gen@bio.ku.dk	Jørgensen, Maria/AAI-3488-2021; Thon, Genevieve/L-9497-2014	Jørgensen, Maria/0000-0001-7589-6508; Thon, Genevieve/0000-0001-8550-5945	Danish Research Council [09-064284]; Novo Nordisk Foundation; University of Copenhagen Center of Excellence MolPhysX	Danish Research Council(Det Frie Forskningsrad (DFF)); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); University of Copenhagen Center of Excellence MolPhysX	The authors' research was supported by the Danish Research Council (http://fivu.dk/en/; grant 09-064284 to GT), the Novo Nordisk Foundation (http://www.novonordiskfonden.dk/en) and the University of Copenhagen Center of Excellence MolPhysX (http://www.ku.dk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acs K, 2011, NAT STRUCT MOL BIOL, V18, P1345, DOI 10.1038/nsmb.2188; Alexandru G, 2008, CELL, V134, P804, DOI 10.1016/j.cell.2008.06.048; Altmannova V, 2010, NUCLEIC ACIDS RES, V38, P4708, DOI 10.1093/nar/gkq195; Andrews EA, 2005, MOL CELL BIOL, V25, P185, DOI 10.1128/MCB.25.1.185-196.2005; Asleson EN, 2003, GENETICS, V163, P91; BANNISTER AJ, 1991, ONCOGENE, V6, P1243; Bekker-Jensen S, 2011, FEBS LETT, V585, P2914, DOI 10.1016/j.febslet.2011.05.056; Bergink S, 2013, NAT CELL BIOL, V15, P526, DOI 10.1038/ncb2729; Branzei D, 2006, CELL, V127, P509, DOI 10.1016/j.cell.2006.08.050; Branzei D, 2008, NATURE, V456, P915, DOI 10.1038/nature07587; Brown M, 2002, DNA REPAIR, V1, P869, DOI 10.1016/S1568-7864(02)00111-8; Bruderer RM, 2004, J BIOL CHEM, V279, P49609, DOI 10.1074/jbc.M408695200; Burgess RC, 2007, MOL CELL BIOL, V27, P6153, DOI 10.1128/MCB.00787-07; Cook CE, 2009, CELL CYCLE, V8, P1080, DOI 10.4161/cc.8.7.8123; Cremona CA, 2012, MOL CELL, V45, P422, DOI 10.1016/j.molcel.2011.11.028; Danielsen JR, 2012, J CELL BIOL, V197, P179, DOI 10.1083/jcb.201106152; Dantuma NP, 2012, TRENDS CELL BIOL, V22, P483, DOI 10.1016/j.tcb.2012.06.003; Deichsel A, 2009, CELL CYCLE, V8, P185, DOI 10.4161/cc.8.2.7356; Dou H, 2010, MOL CELL, V39, P333, DOI 10.1016/j.molcel.2010.07.021; Frampton J, 2006, MOL BIOL CELL, V17, P2976, DOI 10.1091/mbc.e05-11-1008; Franz A, 2011, MOL CELL, V44, P85, DOI 10.1016/j.molcel.2011.08.028; Galanty Y, 2012, GENE DEV, V26, P1179, DOI 10.1101/gad.188284.112; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Gareau JR, 2010, NAT REV MOL CELL BIO, V11, P861, DOI 10.1038/nrm3011; Hannich JT, 2005, J BIOL CHEM, V280, P4102, DOI 10.1074/jbc.M413209200; Hardeland U, 2002, EMBO J, V21, P1456, DOI 10.1093/emboj/21.6.1456; Hetzer M, 2001, NAT CELL BIOL, V3, P1086, DOI 10.1038/ncb1201-1086; Ho JCY, 2001, NUCLEIC ACIDS RES, V29, P4179, DOI 10.1093/nar/29.20.4179; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoege C, 2002, NATURE, V419, P135, DOI 10.1038/nature00991; Ii T, 2007, CELL CYCLE, V6, P2800, DOI 10.4161/cc.6.22.4882; James P, 1996, GENETICS, V144, P1425; Kannouche PL, 2004, MOL CELL, V14, P491, DOI 10.1016/S1097-2765(04)00259-X; Kim WJ, 2000, J BIOL CHEM, V275, P35607, DOI 10.1074/jbc.M007060200; Kosoy A, 2007, J BIOL CHEM, V282, P20388, DOI 10.1074/jbc.M702652200; Lyne R, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-27; Mailand N, 2007, CELL, V131, P887, DOI 10.1016/j.cell.2007.09.040; Makhnevych T, 2009, MOL CELL, V33, P124, DOI 10.1016/j.molcel.2008.12.025; Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222; Meerang M, 2011, NAT CELL BIOL, V13, P1376, DOI 10.1038/ncb2367; Meister P, 2005, J CELL BIOL, V168, P537, DOI 10.1083/jcb.200410006; Meyer H, 2012, NAT CELL BIOL, V14, P117, DOI 10.1038/ncb2407; Meyer HH, 2000, EMBO J, V19, P2181, DOI 10.1093/emboj/19.10.2181; MOIR D, 1982, GENETICS, V100, P547; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Mouysset J, 2008, P NATL ACAD SCI USA, V105, P12879, DOI 10.1073/pnas.0805944105; Nagai S, 2008, SCIENCE, V322, P597, DOI 10.1126/science.1162790; Naula N, 2003, CURR GENET, V43, P400, DOI 10.1007/s00294-003-0413-4; Nie MH, 2012, J BIOL CHEM, V287, P29610, DOI 10.1074/jbc.M112.379768; Nielsen IS, 2002, EUKARYOT CELL, V1, P613, DOI 10.1128/EC1.4.613-625.2002; Noguchi C, 2007, GENETICS, V175, P553, DOI 10.1534/genetics.106.065334; Noguchi E, 2004, MOL CELL BIOL, V24, P8342, DOI 10.1128/MCB.24.19.8342-8355.2004; Ohuchi T, 2009, DNA REPAIR, V8, P690, DOI 10.1016/j.dnarep.2009.01.018; Park S, 2005, STRUCTURE, V13, P995, DOI 10.1016/j.str.2005.04.013; Parker JL, 2012, NUCLEIC ACIDS RES, V40, P11380, DOI 10.1093/nar/gks892; Petermann E, 2010, MOL CELL, V37, P492, DOI 10.1016/j.molcel.2010.01.021; Prudden J, 2007, EMBO J, V26, P4089, DOI 10.1038/sj.emboj.7601838; Prudden J, 2011, MOL CELL BIOL, V31, P2299, DOI 10.1128/MCB.05188-11; Psakhye I, 2012, CELL, V151, P807, DOI 10.1016/j.cell.2012.10.021; Ramadan K, 2007, NATURE, V450, P1258, DOI 10.1038/nature06388; Ramadan K, 2012, CELL CYCLE, V11, P1062, DOI 10.4161/cc.11.6.19446; Raman M, 2011, MOL CELL, V44, P72, DOI 10.1016/j.molcel.2011.06.036; Richly H, 2005, CELL, V120, P73, DOI 10.1016/j.cell.2004.11.013; Sacher M, 2006, NAT CELL BIOL, V8, P1284, DOI 10.1038/ncb1488; Saintigny Y, 2001, EMBO J, V20, P3861, DOI 10.1093/emboj/20.14.3861; Saito Y, 2013, SCI REP-UK, V3, DOI 10.1038/srep02022; Sale JE, 2012, J CELL SCI, V125, P1633, DOI 10.1242/jcs.094748; Sato M, 2005, YEAST, V22, P583, DOI 10.1002/yea.1233; Schuberth C, 2008, CELL MOL LIFE SCI, V65, P2360, DOI 10.1007/s00018-008-8072-8; Simon P, 2003, BIOINFORMATICS, V19, P1439, DOI 10.1093/bioinformatics/btg157; Stelter P, 2003, NATURE, V425, P188, DOI 10.1038/nature01965; Stolz A, 2011, TRENDS BIOCHEM SCI, V36, P515, DOI 10.1016/j.tibs.2011.06.001; Sun H, 2007, EMBO J, V26, P4102, DOI 10.1038/sj.emboj.7601839; Tanaka K, 1999, MOL CELL BIOL, V19, P8660; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Thon G, 2002, GENETICS, V161, P611; Ulrich HD, 2012, J CELL SCI, V125, P249, DOI 10.1242/jcs.091801; Uzunova K, 2007, J BIOL CHEM, V282, P34167, DOI 10.1074/jbc.M706505200; Verma R, 2011, MOL CELL, V41, P82, DOI 10.1016/j.molcel.2010.12.017; Vong QP, 2005, SCIENCE, V310, P1499, DOI 10.1126/science.1120160; Wan SH, 1999, YEAST, V15, P821, DOI 10.1002/(SICI)1097-0061(199907)15:10A<821::AID-YEA422>3.3.CO;2-R; Watanabe K, 2004, EMBO J, V23, P3886, DOI 10.1038/sj.emboj.7600383; Watts FZ, 2007, BIOCHEM SOC T, V35, P1379, DOI 10.1042/BST0351379; Wilkinson KA, 2010, BIOCHEM J, V428, P133, DOI 10.1042/BJ20100158; Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200; Wolf DH, 2012, BBA-MOL CELL RES, V1823, P117, DOI 10.1016/j.bbamcr.2011.09.002; Xhemalce B, 2004, EMBO J, V23, P3844, DOI 10.1038/sj.emboj.7600394; Xhemalce B, 2007, P NATL ACAD SCI USA, V104, P893, DOI 10.1073/pnas.0605442104; Xie Y, 2007, J BIOL CHEM, V282, P34176, DOI 10.1074/jbc.M706025200; Ye YH, 2003, J CELL BIOL, V162, P71, DOI 10.1083/jcb.200302169; Yin YL, 2012, GENE DEV, V26, P1196, DOI 10.1101/gad.189274.112; Yuasa T, 2004, GENES CELLS, V9, P1069, DOI 10.1111/j.1365-2443.2004.00790.x; Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200	93	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80442	10.1371/journal.pone.0080442	http://dx.doi.org/10.1371/journal.pone.0080442			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265825	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100161
J	Maj, A; Dziewit, L; Czarnecki, J; Wlodarczyk, M; Baj, J; Skrzypczyk, G; Giersz, D; Bartosik, D				Maj, Anna; Dziewit, Lukasz; Czarnecki, Jakub; Wlodarczyk, Miroslawa; Baj, Jadwiga; Skrzypczyk, Grazyna; Giersz, Dorota; Bartosik, Dariusz			Plasmids of Carotenoid-Producing Paracoccus spp. (Alphaproteobacteria) - Structure, Diversity and Evolution	PLOS ONE			English	Article							RESTRICTION-MODIFICATION SYSTEM; TOXIN-ANTITOXIN SYSTEMS; SP-NOV.; MOLECULAR CHARACTERIZATION; REPLICATOR REGION; THIOBACILLUS-VERSUTUS; NUCLEOTIDE-SEQUENCE; MEGAPLASMID PTAV3; ENTRY EXCLUSION; CRYPTIC PLASMID	Plasmids are components of many bacterial genomes. They enable the spread of a large pool of genetic information via lateral gene transfer. Many bacterial strains contain mega-sized replicons and these are particularly common in Alphaproteobacteria. Considerably less is known about smaller alphaproteobacterial plasmids. We analyzed the genomes of 14 such plasmids residing in 4 multireplicon carotenoid-producing strains of the genus Paracoccus (Alphaproteobacteria): P. aestuarii DSM 19484, P. haeundaensis LG P-21903, P. marcusii DSM 11574 and P. marcusii OS22. Comparative analyses revealed mosaic structures of the plasmids and recombinational shuffling of diverse genetic modules involved in (i) plasmid replication, (ii) stabilization (including toxin-antitoxin systems of the relBE/parDE, tad-ata, higBA, mazEF and toxBA families) and (iii) mobilization for conjugal transfer (encoding relaxases of the Mob(Q), Mob(P) or Mob(V) families). A common feature of the majority of the plasmids is the presence of AT-rich sequence islets (located downstream of exc1-like genes) containing genes, whose homologs are conserved in the chromosomes of many bacteria (encoding e. g. RelA/SpoT, SMC-like proteins and a retron-type reverse transcriptase). The results of this study have provided insight into the diversity and plasticity of plasmids of Paracoccus spp., and of the entire Alphaproteobacteria. Some of the identified plasmids contain replication systems not described previously in this class of bacteria. The composition of the plasmid genomes revealed frequent transfer of chromosomal genes into plasmids, which significantly enriches the pool of mobile DNA that can participate in lateral transfer. Many strains of Paracoccus spp. have great biotechnological potential, and the plasmid vectors constructed in this study will facilitate genetic studies of these bacteria.	[Maj, Anna; Dziewit, Lukasz; Czarnecki, Jakub; Wlodarczyk, Miroslawa; Baj, Jadwiga; Skrzypczyk, Grazyna; Giersz, Dorota; Bartosik, Dariusz] Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland	University of Warsaw	Bartosik, D (corresponding author), Univ Warsaw, Fac Biol, Inst Microbiol, Dept Bacterial Genet, Warsaw, Poland.	bartosik@biol.uw.edu.pl	Dziewit, Lukasz/L-1131-2016	Dziewit, Lukasz/0000-0002-5057-2811; Bartosik, Dariusz/0000-0002-3589-8864; Czarnecki, Jakub/0000-0003-4372-5143	Ministry of Science and Higher Education, Poland [2 P04A 028 29, PBZ-MNiSW-04/I/2007, N N302 224638]	Ministry of Science and Higher Education, Poland(Ministry of Science and Higher Education, Poland)	This work was supported by the Ministry of Science and Higher Education, Poland - grants 2 P04A 028 29 (characterization of pMARC plasmids), PBZ-MNiSW-04/I/2007 (characterization of pAES, pHAE, and pMOS plasmids) and N N302 224638 (construction of vector cassettes and shuttle vectors). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTINGMEES MA, 1989, NUCLEIC ACIDS RES, V17, P9494, DOI 10.1093/nar/17.22.9494; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Bartosik D, 1997, PLASMID, V38, P53, DOI 10.1006/plas.1997.1295; Bartosik D, 2002, MICROBIOL-SGM, V148, P2847, DOI 10.1099/00221287-148-9-2847; Bartosik D, 2002, MICROBIOL-SGM, V148, P871, DOI 10.1099/00221287-148-3-871; Bartosik D, 2001, PLASMID, V45, P222, DOI 10.1006/plas.2000.1505; Bartosik D, 2001, J BACTERIOL, V183, P6234, DOI 10.1128/JB.183.21.6234-6243.2001; BARTOSIK D, 1993, ACTA MICROBIOL POL, V42, P97; Bartosik D, 2008, J BACTERIOL, V190, P3306, DOI 10.1128/JB.01878-07; Bartosik Dariusz, 1997, Acta Microbiologica Polonica, V46, P387; Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; BERINGER JE, 1974, J GEN MICROBIOL, V84, P188; Berry A, 2003, INT J SYST EVOL MICR, V53, P231, DOI 10.1099/ijs.0.02368-0; BIRNBOIM HC, 1979, NUCLEIC ACIDS RES, V7, P1513; Burian J, 2003, BIOCHEMISTRY-US, V42, P10282, DOI 10.1021/bi034341b; Carver T, 2008, BIOINFORMATICS, V24, P2672, DOI 10.1093/bioinformatics/btn529; Cevallos MA, 2008, PLASMID, V60, P19, DOI 10.1016/j.plasmid.2008.03.001; CHAN PT, 1985, J BIOL CHEM, V260, P8925; CHEN WP, 1993, NUCLEIC ACIDS RES, V21, P2260, DOI 10.1093/nar/21.9.2260; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; Daneshvar MI, 2003, J CLIN MICROBIOL, V41, P1289, DOI 10.1128/JCM.41.3.1289-1294.2003; del Solar G, 1998, MICROBIOL MOL BIOL R, V62, P434, DOI 10.1128/MMBR.62.2.434-464.1998; DODD IB, 1990, NUCLEIC ACIDS RES, V18, P5019, DOI 10.1093/nar/18.17.5019; Dolowy P, 2005, PLASMID, V53, P239, DOI 10.1016/j.plasmid.2004.11.005; Doronina N. V., 2000, Mikrobiologiya, V69, P706; Doronina NV, 1998, SYST APPL MICROBIOL, V21, P230, DOI 10.1016/S0723-2020(98)80027-1; Drewniak L, 2008, ENVIRON POLLUT, V156, P1069, DOI 10.1016/j.envpol.2008.04.019; Dziewit L, 2007, J BACTERIOL, V189, P1983, DOI 10.1128/JB.01610-06; Dziewit L, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-59; Dziewit L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032277; Dziewit L, 2011, J MICROBIOL METH, V86, P166, DOI 10.1016/j.mimet.2011.04.016; Dziewit L, 2010, APPL ENVIRON MICROB, V76, P1861, DOI 10.1128/AEM.01926-09; FELSENSTEIN J, 1989, SCIENCE, V246, P941, DOI 10.1126/science.246.4932.941; Francia MV, 2004, FEMS MICROBIOL REV, V28, P79, DOI 10.1016/j.femsre.2003.09.001; Garcillan-Barcia MP, 2008, PLASMID, V60, P1, DOI 10.1016/j.plasmid.2008.03.002; Garcillan-Barcia MP, 2009, FEMS MICROBIOL REV, V33, P657, DOI 10.1111/j.1574-6976.2009.00168.x; Gerdes K, 2000, MOL MICROBIOL, V37, P455, DOI 10.1046/j.1365-2958.2000.01975.x; Harker M, 1998, INT J SYST BACTERIOL, V48, P543, DOI 10.1099/00207713-48-2-543; Harrison PW, 2010, TRENDS MICROBIOL, V18, P141, DOI 10.1016/j.tim.2009.12.010; Ichige A, 2005, J BACTERIOL, V187, P6612, DOI 10.1128/JB.187.19.6612-6621.2005; Inui M, 2003, APPL ENVIRON MICROB, V69, P725, DOI 10.1128/AEM.69.2.725-733.2003; Jordan SL, 1997, ARCH MICROBIOL, V168, P225, DOI 10.1007/s002030050492; KATAYAMA Y, 1995, MICROBIOL-UK, V141, P1469, DOI 10.1099/13500872-141-6-1469; Kim BY, 2006, INT J SYST EVOL MICR, V56, P2387, DOI 10.1099/ijs.0.64275-0; Korkhin Y, 1998, J MOL BIOL, V278, P967, DOI 10.1006/jmbi.1998.1750; Kushner SR, 1978, GENET ENG N Y, P17; La HJ, 2005, INT J SYST EVOL MICR, V55, P1657, DOI 10.1099/ijs.0.63494-0; Lee J, 2004, FORBES, V173, P54; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Liu XY, 2006, INT J SYST EVOL MICR, V56, P2693, DOI 10.1099/ijs.0.64548-0; Liu ZP, 2008, INT J SYST EVOL MICR, V58, P257, DOI 10.1099/ijs.0.65237-0; LUDTKE DN, 1989, J MOL BIOL, V209, P393, DOI 10.1016/0022-2836(89)90005-3; Madl T, 2006, J MOL BIOL, V364, P170, DOI 10.1016/j.jmb.2006.08.082; Makarova KS, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-19; Neely RK, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-48; NOEL KD, 1984, J BACTERIOL, V158, P148, DOI 10.1128/JB.158.1.148-155.1984; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Petersen J, 2012, ENVIRON MICROBIOL, V14, P2661, DOI 10.1111/j.1462-2920.2012.02806.x; Petersen J, 2011, MOL BIOL EVOL, V28, P1229, DOI 10.1093/molbev/msq310; Pukall R, 2003, INT J SYST EVOL MICR, V53, P443, DOI 10.1099/ijs.0.02352-0; REECE KS, 1995, GENE, V165, P141, DOI 10.1016/0378-1119(95)00529-F; Riley MA, 2001, PLASMID, V45, P209, DOI 10.1006/plas.2001.1519; Rocha J, 2010, ACTA CRYSTALLOGR F, V66, P69, DOI 10.1107/S174430910904929X; Roh SW, 2009, INT J SYST EVOL MICR, V59, P790, DOI 10.1099/ijs.0.65759-0; Sambrook J., 2001, MOL CLONING LAB MANU; Sambrook J., 1989, MOL CLONING LAB MANU; Siguier P, 2006, NUCLEIC ACIDS RES, V34, pD32, DOI 10.1093/nar/gkj014; Siller H, 1996, INT J SYST BACTERIOL, V46, P1125, DOI 10.1099/00207713-46-4-1125; Smillie C, 2010, MICROBIOL MOL BIOL R, V74, P434, DOI 10.1128/MMBR.00020-10; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Speck C, 2001, EMBO J, V20, P1469, DOI 10.1093/emboj/20.6.1469; SPRATT BG, 1986, GENE, V41, P337, DOI 10.1016/0378-1119(86)90117-4; Szymanik M, 2006, POL J MICROBIOL, V55, P261; Tatar LD, 2007, MICROBIOL-SGM, V153, P2518, DOI 10.1099/mic.0.2007/006312-0; TAYLOR BF, 1969, J BACTERIOL, V100, P487, DOI 10.1128/JB.100.1.487-497.1969; Tian QB, 1996, BIOCHEM BIOPH RES CO, V220, P280, DOI 10.1006/bbrc.1996.0396; Uga H, 1999, EMBO J, V18, P3856, DOI 10.1093/emboj/18.13.3856; URAKAMI T, 1989, INT J SYST BACTERIOL, V39, P116, DOI 10.1099/00207713-39-2-116; URAKAMI T, 1990, INT J SYST BACTERIOL, V40, P287, DOI 10.1099/00207713-40-3-287; Wong CMVL, 2013, PLASMID, V69, P186, DOI 10.1016/j.plasmid.2012.12.002; Yakushi T, 2010, APPL MICROBIOL BIOT, V86, P1257, DOI 10.1007/s00253-010-2529-z; YAMADA Y, 1995, J BACTERIOL, V177, P6064, DOI 10.1128/jb.177.21.6064-6068.1995; Yu WQ, 2010, J BACTERIOL, V192, P4067, DOI 10.1128/JB.00010-10	85	15	15	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80258	10.1371/journal.pone.0080258	http://dx.doi.org/10.1371/journal.pone.0080258			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260361	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200111
J	Zheng, Y; Peng, X; Liu, GM; Pan, HY; Dorn, S; Chen, MH				Zheng, Yan; Peng, Xiong; Liu, Gaoming; Pan, Hongyan; Dorn, Silvia; Chen, Maohua			High Genetic Diversity and Structured Populations of the Oriental Fruit Moth in Its Range of Origin	PLOS ONE			English	Article							GRAPHOLITA-MOLESTA BUSCK; CYDIA-POMONELLA L.; CODLING MOTH; LEPIDOPTERA; TORTRICIDAE; SOFTWARE; FLOW; DIFFERENTIATION; RAREFACTION; PERFORMANCE	The oriental fruit moth Grapholita (=Cydia) molesta is a key fruit pest globally. Despite its economic importance, little is known about its population genetics in its putative native range that includes China. We used five polymorphic microsatellite loci and two mitochondrial gene sequences to characterize the population genetic diversity and genetic structure of G. molesta from nine sublocations in three regions of a major fruit growing area of China. Larval samples were collected throughout the season from peach, and in late season, after host switch by the moth to pome fruit, also from apple and pear. We found high numbers of microsatellite alleles and mitochondrial DNA haplotypes in all regions, together with a high number of private alleles and of haplotypes at all sublocations, providing strong evidence that the sampled area belongs to the origin of this species. Samples collected from peach at all sublocations were geographically structured, and a significant albeit weak pattern of isolation-by-distance was found among populations, likely reflecting the low flight capacity of this moth. Interestingly, populations sampled from apple and pear in the late season showed a structure differing from that of populations sampled from peach throughout the season, indicating a selective host switch of a certain part of the population only. The recently detected various olfactory genotypes in G. molesta may underly this selective host switch. These genetic data yield, for the first time, an understanding of population dynamics of G. molesta in its native range, and of a selective host switch from peach to pome fruit, which may have a broad applicability to other global fruit production areas for designing suitable pest management strategies.	[Zheng, Yan; Peng, Xiong; Liu, Gaoming; Pan, Hongyan; Chen, Maohua] Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China; [Dorn, Silvia] ETH, Zurich, Switzerland; [Chen, Maohua] Minist Agr, Key Lab Crop Pest Integrated Pest Management Loes, Yangling, Peoples R China	Northwest A&F University - China; Swiss Federal Institutes of Technology Domain; ETH Zurich; Ministry of Agriculture & Rural Affairs	Chen, MH (corresponding author), Northwest A&F Univ, Coll Plant Protect, Yangling, Peoples R China.	maohua.chen@nwsuaf.edu.cn			National Natural Science Foundation of China [31071687, 31272036]; Northwest AF University; ETH Zurich; Talent Recruitment Project of Northwest AF University; National Key Technology R&D Program from the Ministry of Science and Technology [2012BAK11B03]; Doctoral Fund from the Ministry of Education of China [20110204110001]; Scientific Research Foundation for Returned of Ministry of Education of China; International Exchange Project of Northwest AF University	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Northwest AF University; ETH Zurich(ETH Zurich); Talent Recruitment Project of Northwest AF University; National Key Technology R&D Program from the Ministry of Science and Technology(National Key Technology R&D Program); Doctoral Fund from the Ministry of Education of China(Ministry of Education, China); Scientific Research Foundation for Returned of Ministry of Education of China; International Exchange Project of Northwest AF University	This work was supported by grants of the National Natural Science Foundation of China (No. 31071687 and No. 31272036), the Joint Project of Northwest A&F University and ETH Zurich, the Talent Recruitment Project of Northwest A&F University, the National Key Technology R&D Program (No. 2012BAK11B03) from the Ministry of Science and Technology, the Doctoral Fund (No. 20110204110001) from the Ministry of Education of China and the Scientific Research Foundation for Returned of Ministry of Education of China and International Exchange Project of Northwest A&F University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Bonnet E, 2002, J STAT SOFTW, V7, P1, DOI DOI 10.18637/JSS.V007.I10; Bovey A, 1979, DEFENSE PLANTES CULT; Chen MH, 2010, B ENTOMOL RES, V100, P75, DOI 10.1017/S0007485309006786; Dakin EE, 2004, HEREDITY, V93, P504, DOI 10.1038/sj.hdy.6800545; Domingues FA, 2012, J ECON ENTOMOL, V105, P2136, DOI 10.1603/EC12123; Dorn Silvia, 2001, IOBC-WPRS Bulletin, V24, P133; Ellis NH, 2013, ENTOMOL EXP APPL, V146, P232, DOI 10.1111/eea.12015; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Felsenstein J., 1989, CLADISTICS, V5, P164, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Feng MX, 2002, CHINA FRUITS, V4, P30; Fuentes-Contreras E, 2007, J ECON ENTOMOL, V100, P551, DOI 10.1603/0022-0493(2007)100[551:EOARAA]2.0.CO;2; Grapputo A, 2005, MOL ECOL, V14, P4207, DOI 10.1111/j.1365-294X.2005.02740.x; Guillot G, 2005, GENETICS, V170, P1261, DOI 10.1534/genetics.104.033803; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Hughes Hern A, 2004, ENV ENTOMOL, V33, P1155; Hughes J, 2002, ENTOMOL EXP APPL, V103, P171, DOI 10.1023/A:1020351800534; Il'ichev AL, 2007, J APPL ENTOMOL, V131, P368, DOI 10.1111/j.1439-0418.2007.01201.x; Kalinowski ST, 2005, MOL ECOL NOTES, V5, P187, DOI 10.1111/j.1471-8286.2004.00845.x; Karsten M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054281; Kirk H, 2013, EVOL APPL, V6, P842, DOI 10.1111/eva.12071; Kirk H, 2013, BMC ECOL, V13, DOI 10.1186/1472-6785-13-12; Lehrian S, 2010, J N AM BENTHOL SOC, V29, P1100, DOI 10.1899/09-100.1; Li Bo, 2008, Acta Phytophylacica Sinica, V35, P285; Li T, 2010, J SHANXI AGR SCI, V5, P47; Librado P, 2009, BIOINFORMATICS, V25, P1451, DOI 10.1093/bioinformatics/btp187; Loxdale HD, 2011, BIOL J LINN SOC, V104, P838, DOI 10.1111/j.1095-8312.2011.01761.x; Lu PF, 2012, J CHEM ECOL, V38, P1003, DOI 10.1007/s10886-012-0152-4; MANTEL N, 1967, CANCER RES, V27, P209; Mazzi D, 2012, ANN APPL BIOL, V160, P97, DOI 10.1111/j.1744-7348.2012.00533.x; Meglecz E, 2004, MOL ECOL, V13, P1693, DOI 10.1111/j.1365-294X.2004.02163.x; Miller NJ, 2003, HEREDITY, V91, P217, DOI 10.1038/sj.hdy.6800331; Myers CT, 2007, J ECON ENTOMOL, V100, P421, DOI 10.1603/0022-0493(2007)100[421:EOOHPA]2.0.CO;2; Najar-Rodriguez A, 2012, BEHAV GENET, V42, P687, DOI 10.1007/s10519-012-9539-9; Najar-Rodriguez A, 2013, PHYSIOL ENTOMOL, V38, P63, DOI 10.1111/phen.12003; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Pinero JC, 2009, ENTOMOL EXP APPL, V131, P67, DOI 10.1111/j.1570-7458.2009.00832.x; Pollini A., 1993, Informatore Agrario, V49, P19; Pritchard JK, 2000, GENETICS, V155, P945; Puillandre N, 2008, BIOL INVASIONS, V10, P319, DOI 10.1007/s10530-007-9132-y; Rothschild G. H. L., 1991, TORTRICID PESTS THEI, V5, P389; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schneider S, 2000, ARLEQUIN SOFTWARE PO, V2, P2496; Schuelke M, 2000, NAT BIOTECHNOL, V18, P233, DOI 10.1038/72708; Sciarretta A, 2006, J APPL ENTOMOL, V130, P73, DOI 10.1111/j.1439-0418.2006.01034.x; SIMON C, 1994, ANN ENTOMOL SOC AM, V87, P651, DOI 10.1093/aesa/87.6.651; Singh YT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049972; Sword GA, 2005, MOL ECOL, V14, P2197, DOI 10.1111/j.1365-294X.2005.02546.x; SZIRAKI G, 1979, ACTA PHYTOPATHOL HUN, V14, P209; Szpiech ZA, 2008, BIOINFORMATICS, V24, P2498, DOI 10.1093/bioinformatics/btn478; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thaler R, 2008, MOL PHYLOGENET EVOL, V48, P838, DOI 10.1016/j.ympev.2008.05.027; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Timm AE, 2008, ANN ENTOMOL SOC AM, V101, P197, DOI 10.1603/0013-8746(2008)101[197:PGSOGM]2.0.CO;2; Timm AE, 2006, J ECON ENTOMOL, V99, P341, DOI 10.1603/0022-0493-99.2.341; Torriani MVG, 2010, MOL ECOL, V19, P2651, DOI 10.1111/j.1365-294X.2010.04711.x; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Yang X. M, 2012, PLOS ONE, V8	60	39	45	0	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78476	10.1371/journal.pone.0078476	http://dx.doi.org/10.1371/journal.pone.0078476			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24265692	gold, Green Published, Green Submitted			2022-12-25	WOS:000326503400066
J	Rajurkar, M; Huang, H; Cotton, JL; Brooks, JK; Sicklick, J; McMahon, AP; Mao, J				Rajurkar, M.; Huang, H.; Cotton, J. L.; Brooks, J. K.; Sicklick, J.; McMahon, A. P.; Mao, J.			Distinct cellular origin and genetic requirement of Hedgehog-Gli in postnatal rhabdomyosarcoma genesis	ONCOGENE			English	Article						Hedgehog; Gli; progenitor; rhbdomyosarcoma	FOLLICLE STEM-CELLS; SONIC HEDGEHOG; HUMAN HOMOLOG; MOUSE MODEL; EXPRESSION; AMPLIFICATION; PATHWAY; TARGET; CANCER; SOX4	Dysregulation of the Hedgehog (Hh)-Gli signaling pathway is implicated in a variety of human cancers, including basal cell carcinoma (BCC), medulloblastoma (MB) and embryonal rhabdhomyosarcoma (eRMS), three principle tumors associated with human Gorlin syndrome. However, the cells of origin of these tumors, including eRMS, remain poorly understood. In this study, we explore the cell populations that give rise to Hh-related tumors by specifically activating Smoothened (Smo) in both Hhproducing and -responsive cell lineages in postnatal mice. Interestingly, we find that unlike BCC and MB, eRMS originates from the stem/progenitor populations that do not normally receive active Hh signaling. Furthermore, we find that the myogenic lineage in postnatal mice is largely Hh quiescent and that Pax7-expressing muscle satellite cells are not able to give rise to eRMS upon Smo or Gli1/2 overactivation in vivo, suggesting that Hh-induced skeletal muscle eRMS arises from Hh/Gli quiescent non-myogenic cells. In addition, using the Gli1 null allele and a Gli3 repressor allele, we reveal a specific genetic requirement for Gli proteins in Hh-induced eRMS formation and provide molecular evidence for the involvement of Sox4/11 in eRMS cell survival and differentiation.	[Rajurkar, M.; Huang, H.; Cotton, J. L.; Brooks, J. K.; Mao, J.] Univ Massachusetts, Sch Med, Dept Canc Biol, Worcester, MA 01605 USA; [Huang, H.] Cent S Univ, Xiangya Sch Med, Dept Histol & Embryol, Changsha, Hunan, Peoples R China; [Sicklick, J.] Univ Calif San Diego, Moores Canc Ctr, Div Surg Oncol, La Jolla, CA 92093 USA; [McMahon, A. P.] Univ So Calif, WM Keck Sch Med, Broad CIRM Ctr Regenerat Med & Stem Cell Res, Dept Stem Cell Biol & Regenerat Med, Los Angeles, CA USA	University of Massachusetts System; University of Massachusetts Worcester; Central South University; University of California System; University of California San Diego; University of Southern California	Mao, J (corresponding author), Univ Massachusetts, Sch Med, Dept Canc Biol, 364 Plantat St,LRB417, Worcester, MA 01605 USA.	junhao.mao@umassmed.edu	McMahon, Andrew P/ABE-7520-2020; Rajurkar, Mihir/I-6238-2019	Rajurkar, Mihir/0000-0002-0573-1705; Cotton, Jennifer/0000-0003-0106-1801	American Cancer Society [120376-RSG-11-04001-DDC]; Charles H Hood Foundation; Worcester Foundation for Biomedical Research; NIH [NS033642]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS033642, R01NS033642] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); Charles H Hood Foundation; Worcester Foundation for Biomedical Research; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work is supported by grants from American Cancer Society (120376-RSG-11-040-01-DDC), Charles H Hood Foundation and Worcester Foundation for Biomedical Research to JM. APM is supported by a grant from NIH (NS033642). The authors thank Drs Michael Rudnicki (University of Ottawa) and Amy Wagers (Joslin Diabetes Center) for providing cell isolation protocols, Joe Vaughan and Zhiwei Pang for technical support, and members of the Mao lab for helpful discussion.	Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994; Ahn S, 2004, CELL, V118, P505, DOI 10.1016/j.cell.2004.07.023; Asakura A, 2007, P NATL ACAD SCI USA, V104, P16552, DOI 10.1073/pnas.0708145104; Aszterbaum M, 1999, NAT MED, V5, P1285, DOI 10.1038/15242; Bai CB, 2002, DEVELOPMENT, V129, P4753; Barakat MT, 2010, TRENDS MOL MED, V16, P337, DOI 10.1016/j.molmed.2010.05.003; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Breneman JC, 2003, J CLIN ONCOL, V21, P78, DOI 10.1200/JCO.2003.06.129; Brennana DJ, 2009, EUR J CANCER, V45, P1510, DOI 10.1016/j.ejca.2009.01.028; Bridge JA, 2002, GENE CHROMOSOME CANC, V33, P310, DOI 10.1002/gcc.10026; Bridge JA, 2000, GENE CHROMOSOME CANC, V27, P337, DOI 10.1002/(SICI)1098-2264(200004)27:4<337::AID-GCC1>3.0.CO;2-1; Brownell I, 2011, CELL STEM CELL, V8, P552, DOI 10.1016/j.stem.2011.02.021; Gerber AN, 2007, ONCOGENE, V26, P1122, DOI 10.1038/sj.onc.1209891; Gibson P, 2010, NATURE, V468, P1095, DOI 10.1038/nature09587; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; Grachtchouk M, 2000, NAT GENET, V24, P216, DOI 10.1038/73417; Grachtchouk M, 2011, J CLIN INVEST, V121, P1768, DOI 10.1172/JCI46307; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Harfe BD, 2004, CELL, V118, P517, DOI 10.1016/j.cell.2004.07.024; Hatley ME, 2012, CANCER CELL, V22, P536, DOI 10.1016/j.ccr.2012.09.004; Hayashi S, 2002, DEV BIOL, V244, P305, DOI 10.1006/dbio.2002.0597; Hettmer S, 2011, P NATL ACAD SCI USA, V108, P20002, DOI 10.1073/pnas.1111733108; Hettmer S, 2010, NAT MED, V16, P171, DOI 10.1038/nm0210-171; Hirai H, 2010, J CELL BIOL, V191, P347, DOI 10.1083/jcb.201006025; Hooper JE, 2005, NAT REV MOL CELL BIO, V6, P306, DOI 10.1038/nrm1622; Hui CC, 2011, ANNU REV CELL DEV BI, V27, P513, DOI 10.1146/annurev-cellbio-092910-154048; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Kasper M, 2011, P NATL ACAD SCI USA, V108, P4099, DOI 10.1073/pnas.1014489108; Kimura H, 2005, ONCOGENE, V24, P4026, DOI 10.1038/sj.onc.1208567; Koleva M, 2005, CELL MOL LIFE SCI, V62, P1863, DOI 10.1007/s00018-005-5072-9; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lee CJ, 2002, J NEURO-ONCOL, V57, P201, DOI 10.1023/A:1015773818302; Lee J, 1997, DEVELOPMENT, V124, P2537; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Liao YL, 2008, ONCOGENE, V27, P5578, DOI 10.1038/onc.2008.168; Liu PB, 2006, CANCER RES, V66, P4011, DOI 10.1158/0008-5472.CAN-05-3055; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; McMahon AP, 2003, CURR TOP DEV BIOL, V53, P1, DOI 10.1016/S0070-2153(03)53002-2; Medina PP, 2009, HUM MOL GENET, V18, P1343, DOI 10.1093/hmg/ddp034; Merlino G, 1999, ONCOGENE, V18, P5340, DOI 10.1038/sj.onc.1203038; Oliver TG, 2005, DEVELOPMENT, V132, P2425, DOI 10.1242/dev.01793; Oro AE, 1997, SCIENCE, V276, P817, DOI 10.1126/science.276.5313.817; Pappo Alberto S., 1995, Current Opinion in Oncology, V7, P361, DOI 10.1097/00001622-199507000-00012; Ridky TW, 2010, CELL STEM CELL, V6, P292, DOI 10.1016/j.stem.2010.03.009; ROBERTS WM, 1989, CANCER RES, V49, P5407; Rowitch DH, 1999, J NEUROSCI, V19, P8954, DOI 10.1523/JNEUROSCI.19-20-08954.1999; Rubin BP, 2011, CANCER CELL, V19, P177, DOI 10.1016/j.ccr.2010.12.023; Rubin LL, 2006, NAT REV DRUG DISCOV, V5, P1026, DOI 10.1038/nrd2086; Schuller U, 2008, CANCER CELL, P123; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Stecca B, 2010, J MOL CELL BIOL, V2, P84, DOI 10.1093/jmcb/mjp052; Teglund S, 2010, BBA-REV CANCER, V1805, P181, DOI 10.1016/j.bbcan.2010.01.003; Tiffin N, 2003, BRIT J CANCER, V89, P327, DOI 10.1038/sj.bjc.6601040; Tostar U, 2006, J PATHOL, V208, P17, DOI 10.1002/path.1882; Tostar Ulrica, 2010, Genes Cancer, V1, P941, DOI 10.1177/1947601910385449; Vokes SA, 2008, GENE DEV, V22, P2651, DOI 10.1101/gad.1693008; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Wechsler-Reya RJ, 1999, NEURON, V22, P103, DOI 10.1016/S0896-6273(00)80682-0; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; Youssef KK, 2010, NAT CELL BIOL, V12, P299, DOI 10.1038/ncb2031; Zibat A, 2010, ONCOGENE, V29, P6323, DOI 10.1038/onc.2010.368	65	15	15	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5370	5378		10.1038/onc.2013.480	http://dx.doi.org/10.1038/onc.2013.480			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24276242	Green Accepted			2022-12-25	WOS:000345120600007
J	Herrmann, J; Berberich, H; Hartmann, J; Beyer, S; Davies, K; Koch, J				Herrmann, Julia; Berberich, Hannah; Hartmann, Jessica; Beyer, Steffen; Davies, Karen; Koch, Joachim			Homo-oligomerization of the Activating Natural Killer Cell Receptor NKp30 Ectodomain Increases Its Binding Affinity for Cellular Ligands	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							VIRUS-INFECTED CELLS; NK CELLS; CYTOTOXICITY RECEPTOR; T-CELLS; CRYSTAL-STRUCTURE; LEUKEMIA-CELLS; IMMUNOGLOBULIN SUPERFAMILY; HIV-1 INFECTION; NKP46 RECEPTOR; TUMOR	The natural cytotoxicity receptors, comprised of three type I membrane proteins NKp30, NKp44, and NKp46, are a unique set of activating proteins expressed mainly on the surface of natural killer (NK) cells. Among these, NKp30 is a major receptor targeting virus-infected cells, malignantly transformed cells, and immature dendritic cells. To date, only few cellular ligands of NKp30 have been discovered, and the molecular details of ligand recognition by NKp30 are poorly understood. Within the current study, we found that the ectodomain of NKp30 forms functional homo-oligomers that mediate high affinity binding to its corresponding cellular ligand B7-H6. Notably, this homo-oligomerization is strongly promoted by the stalk domain of NKp30. Based on these data, we suggest that homo-oligomerization of NKp30 in the plasma membrane of NK cells, which might be favored by IL-2-dependent up-regulation of NKp30 expression, provides a way to improve recognition and lysis of target cells by NK cells.	[Herrmann, Julia; Berberich, Hannah; Hartmann, Jessica; Beyer, Steffen; Koch, Joachim] Inst Tumor Biol & Expt Therapy, NK Cell Biol, D-60596 Frankfurt, Germany; [Davies, Karen] Max Planck Inst Biophys, Dept Biol Struct, D-60438 Frankfurt, Germany	Max Planck Society	Koch, J (corresponding author), Inst Biomed Res, Georg Speyer Haus,Paul Ehrlich Str 42-44, D-60596 Frankfurt, Germany.	joachim.koch@gsh.uni-frankfurt.de	Hartmann, Jessica/AAL-8849-2021	Hartmann, Jessica/0000-0001-9372-8954; Davies, Karen/0000-0002-3207-9337	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research, and the Arts of the State of Hessen (HMWK)	German Federal Ministry of Health (BMG); Ministry of Higher Education, Research, and the Arts of the State of Hessen (HMWK)	We thank Dr. Roy Mariuzza (University of Maryland, Rockville, MD) for critical reading of the manuscript and helpful discussions. Moreover, we kindly acknowledge Dr. Carsten Watzl (IfADo), Dr. Andreas Diefenbach (University of Freiburg, Germany), Dr. Alexander Steinle (Goethe-University, Frankfurt am Main, Germany), and Dr. Imre Berger (EMBL, Grenoble, France) for providing cells, reagents, and related technical advice. The Georg-Speyer-Haus is supported jointly by the German Federal Ministry of Health (BMG) and the Ministry of Higher Education, Research, and the Arts of the State of Hessen (HMWK).	Ali MH, 2005, BIOORGAN MED CHEM, V13, P5013, DOI 10.1016/j.bmc.2005.05.037; Andersen PS, 2001, J BIOL CHEM, V276, P49125, DOI 10.1074/jbc.M109396200; Arnon TI, 2004, BLOOD, V103, P664, DOI 10.1182/blood-2003-05-1716; Arnon TI, 2001, EUR J IMMUNOL, V31, P2680, DOI 10.1002/1521-4141(200109)31:9<2680::AID-IMMU2680>3.0.CO;2-A; Binici J, 2014, CELL MOL LIFE SCI, V71, P1829, DOI 10.1007/s00018-013-1522-y; Binici J, 2013, J BIOL CHEM, V288, P34295, DOI 10.1074/jbc.M113.483602; Brandt CS, 2009, J EXP MED, V206, P1495, DOI 10.1084/jem.20090681; Brown ACN, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001152; Cantoni C, 2003, STRUCTURE, V11, P725, DOI 10.1016/S0969-2126(03)00095-9; Cantoni C, 1999, J EXP MED, V189, P787, DOI 10.1084/jem.189.5.787; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Correia DV, 2011, BLOOD, V118, P992, DOI 10.1182/blood-2011-02-339135; Farag SS, 2006, BLOOD REV, V20, P123, DOI 10.1016/j.blre.2005.10.001; Fauriat C, 2007, BLOOD, V109, P323, DOI 10.1182/blood-2005-08-027979; Ferlazzo G, 2004, J IMMUNOL, V172, P1455, DOI 10.4049/jimmunol.172.3.1455; Foster CE, 2003, J BIOL CHEM, V278, P46081, DOI 10.1074/jbc.M308491200; Funke J, 2011, AIDS REV, V13, P67; Garcia-Iglesias T, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-186; Garg A, 2006, J IMMUNOL, V177, P6192, DOI 10.4049/jimmunol.177.9.6192; Garrity D, 2005, P NATL ACAD SCI USA, V102, P7641, DOI 10.1073/pnas.0502439102; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Grave L, 2012, PROTEIN EXPRES PURIF, V86, P142, DOI 10.1016/j.pep.2012.09.016; Groth A, 2011, J INNATE IMMUN, V3, P344, DOI 10.1159/000327014; Hartmann J, 2012, J BIOL CHEM, V287, P31527, DOI 10.1074/jbc.M111.304238; Hudspeth K, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00069; Hudspeth K, 2012, BLOOD, V119, P4013, DOI 10.1182/blood-2011-11-390153; Jarahian M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002195; Jarahian M, 2009, J VIROL, V83, P8108, DOI 10.1128/JVI.00211-09; Jaron-Mendelson M, 2012, J IMMUNOL, V188, P6165, DOI 10.4049/jimmunol.1102496; Joyce MG, 2011, P NATL ACAD SCI USA, V108, P6223, DOI 10.1073/pnas.1100622108; Kaifu T, 2011, CELL MOL LIFE SCI, V68, P3531, DOI 10.1007/s00018-011-0802-7; Kajitani K, 2012, BREAST CANCER RES TR, V134, P139, DOI 10.1007/s10549-011-1944-x; Kloess S, 2010, EUR J IMMUNOL, V40, P3255, DOI 10.1002/eji.201040568; Koch J, 2013, TRENDS IMMUNOL, V34, P182, DOI 10.1016/j.it.2013.01.003; Lamken P, 2005, J MOL BIOL, V350, P476, DOI 10.1016/j.jmb.2005.05.008; Lanier LL, 2005, ANNU REV IMMUNOL, V23, P225, DOI 10.1146/annurev.immunol.23.021704.115526; Lanier LL, 1998, ANNU REV IMMUNOL, V16, P359, DOI 10.1146/annurev.immunol.16.1.359; Li PW, 2001, NAT IMMUNOL, V2, P443, DOI 10.1038/87757; Li YL, 2011, J EXP MED, V208, P703, DOI 10.1084/jem.20102548; Lisnic VJ, 2010, CURR OPIN MICROBIOL, V13, P530, DOI 10.1016/j.mib.2010.05.011; Lodoen MB, 2005, NAT REV MICROBIOL, V3, P59, DOI 10.1038/nrmicro1066; Mamessier E, 2011, J CLIN INVEST, V121, P3609, DOI 10.1172/JCI45816; Mandelboim O, 2001, NATURE, V409, P1055, DOI 10.1038/35059110; Mavilio D, 2003, P NATL ACAD SCI USA, V100, P15011, DOI 10.1073/pnas.2336091100; Mavoungou E, 2007, J INFECT DIS, V195, P1521, DOI 10.1086/515579; Moretta A, 2001, ANNU REV IMMUNOL, V19, P197, DOI 10.1146/annurev.immunol.19.1.197; Moretta L, 2006, SEMIN IMMUNOL, V18, P151, DOI 10.1016/j.smim.2006.03.002; Pende D, 1999, J EXP MED, V190, P1505, DOI 10.1084/jem.190.10.1505; Pessino A, 1998, J EXP MED, V188, P953, DOI 10.1084/jem.188.5.953; Pietra G, 2012, CANCER RES, V72, P1407, DOI 10.1158/0008-5472.CAN-11-2544; Rak GD, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001151; Reiners KS, 2013, BLOOD, V121, P3658, DOI 10.1182/blood-2013-01-476606; ROSENBERG SA, 1986, ANNU REV IMMUNOL, V4, P681, DOI 10.1146/annurev.immunol.4.1.681; Seidel E, 2012, CELL MOL LIFE SCI, V69, P3911, DOI 10.1007/s00018-012-1001-x; Simhadri VR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003377; Sivori S, 1997, J EXP MED, V186, P1129, DOI 10.1084/jem.186.7.1129; Snyder GA, 1999, P NATL ACAD SCI USA, V96, P3864, DOI 10.1073/pnas.96.7.3864; Steinle A, 2001, IMMUNOGENETICS, V53, P279, DOI 10.1007/s002510100325; Tang Q, 2008, J IMMUNOL, V181, P4507, DOI 10.4049/jimmunol.181.7.4507; Trowitzsch S, 2010, J STRUCT BIOL, V172, P45, DOI 10.1016/j.jsb.2010.02.010; Vitale M, 1998, J EXP MED, V187, P2065, DOI 10.1084/jem.187.12.2065; Vivier E, 2008, NAT IMMUNOL, V9, P503, DOI 10.1038/ni1582; Vivier E, 2012, NAT REV IMMUNOL, V12, P239, DOI 10.1038/nri3174; Vivier E, 2011, SCIENCE, V331, DOI 10.1126/science.1198687; von Strandmann EP, 2007, IMMUNITY, V27, P965, DOI 10.1016/j.immuni.2007.10.010; Watzl Carsten, 2010, Curr Protoc Immunol, VChapter 11, DOI 10.1002/0471142735.im1109bs90; Wehner R, 2011, J INNATE IMMUN, V3, P258, DOI 10.1159/000323923	67	7	8	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					765	777		10.1074/jbc.M113.514786	http://dx.doi.org/10.1074/jbc.M113.514786			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275655	Green Published, Green Submitted, hybrid			2022-12-25	WOS:000330541200015
J	Snyder, GA; Deredge, D; Waldhuber, A; Fresquez, T; Wilkins, DZ; Smith, PT; Durr, S; Cirl, C; Jiang, JS; Jennings, W; Luchetti, T; Snyder, N; Sundberg, EJ; Wintrode, P; Miethke, T; Xiao, TS				Snyder, Greg A.; Deredge, Daniel; Waldhuber, Anna; Fresquez, Theresa; Wilkins, David Z.; Smith, Patrick T.; Durr, Susi; Cirl, Christine; Jiang, Jiansheng; Jennings, William; Luchetti, Timothy; Snyder, Nathaniel; Sundberg, Eric J.; Wintrode, Patrick; Miethke, Thomas; Xiao, T. Sam			Crystal Structures of the Toll/Interleukin-1 Receptor (TIR) Domains from the Brucella Protein TcpB and Host Adaptor TIRAP Reveal Mechanisms of Molecular Mimicry	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							X-RAY-DIFFRACTION; SUBVERSION; FAMILY; INTERFERENCE; DIMERIZATION; RECRUITMENT; SYSTEM	The Toll/IL-1 receptor (TIR) domains are crucial innate immune signaling modules. Microbial TIR domain-containing proteins inhibit Toll-like receptor (TLR) signaling through molecular mimicry. The TIR domain-containing protein TcpB from Brucella inhibits TLR signaling through interaction with host adaptor proteins TIRAP/Mal and MyD88. To characterize the microbial mimicry of host proteins, we have determined the X-ray crystal structures of the TIR domains from the Brucella protein TcpB and the host adaptor protein TIRAP. We have further characterized homotypic interactions of TcpB using hydrogen/deuterium exchange mass spectrometry and heterotypic TcpB and TIRAP interaction by co-immunoprecipitation and NF-kappa B reporter assays. The crystal structure of the TcpB TIR domain reveals the microtubule-binding site encompassing the BB loop as well as a symmetrical dimer mediated by the DD and EE loops. This dimerization interface is validated by peptide mapping through hydrogen/deuterium exchange mass spectrometry. The human TIRAP TIR domain crystal structure reveals a unique N-terminal TIR domain fold containing a disulfide bond formed by Cys89 and Cys134. A comparison between the TcpB and TIRAP crystal structures reveals substantial conformational differences in the region that encompasses the BB loop. These findings underscore the similarities and differences in the molecular features found in the microbial and host TIR domains, which suggests mechanisms of bacterial mimicry of host signaling adaptor proteins, such as TIRAP.	[Snyder, Greg A.; Fresquez, Theresa; Smith, Patrick T.; Jiang, Jiansheng; Jennings, William; Luchetti, Timothy; Snyder, Nathaniel; Xiao, T. Sam] NIAID, Immunol Lab, NIH, Bethesda, MD 20892 USA; [Deredge, Daniel; Wintrode, Patrick] Univ Maryland Sch Pharm, Dept Pharmaceut Sci, Baltimore, MD 21201 USA; [Waldhuber, Anna; Durr, Susi; Cirl, Christine] Tech Univ Munich, Inst Med Mikrobiol Immunol & Hyg, D-81675 Munich, Germany; [Wilkins, David Z.; Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Med, Inst Human Virol, Baltimore, MD 21201 USA; [Sundberg, Eric J.] Univ Maryland, Sch Med, Dept Microbiol & Immunol, Baltimore, MD 21201 USA; [Miethke, Thomas] Heidelberg Univ, Med Fac Mannheim, Inst Med Microbiol & Hyg, D-68167 Mannheim, Germany	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); University System of Maryland; University of Maryland Baltimore; Technical University of Munich; University System of Maryland; University of Maryland Baltimore; University System of Maryland; University of Maryland Baltimore; Ruprecht Karls University Heidelberg	Snyder, GA (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	Gsnyder@som.umaryland.edu; Thomas.Miethke@medma.uni-heidelberg.de; Xiaot@niaid.nih.gov	Xiao, Tsan Sam/A-8590-2010	Xiao, Tsan Sam/0000-0001-9688-475X; Jiang, Jiansheng/0000-0003-0964-5481; Sundberg, Eric/0000-0003-0478-3033; Snyder, Nathaniel/0000-0001-5643-8747	Division of Intramural Research, NIAID, National Institutes of Health; Deutsche Forschungsgemeinschaft [MI471/6-1]	Division of Intramural Research, NIAID, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported, in whole or in part, by the Division of Intramural Research, NIAID, National Institutes of Health (to T. S. X.).; Supported by Deutsche Forschungsgemeinschaft Grant MI471/6-1.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alaidarous M, 2014, J BIOL CHEM, V289, P654, DOI 10.1074/jbc.M113.523274; Campos MA, 2004, INFECT IMMUN, V72, P176, DOI 10.1128/IAI.72.1.176-186.2004; Chaudhary A, 2012, BIOCHEM BIOPH RES CO, V417, P299, DOI 10.1016/j.bbrc.2011.11.104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cirl C, 2010, INT J MED MICROBIOL, V300, P396, DOI 10.1016/j.ijmm.2010.04.001; DeLano W. L., 2010, PYMOL MOL GRAPHICS S; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kagan JC, 2006, CELL, V125, P943, DOI 10.1016/j.cell.2006.03.047; Kaplan-Turkoz B, 2013, FEBS LETT, V587, P3412, DOI 10.1016/j.febslet.2013.09.007; Kavan D, 2011, INT J MASS SPECTROM, V302, P53, DOI 10.1016/j.ijms.2010.07.030; Kenny EF, 2008, CYTOKINE, V43, P342, DOI 10.1016/j.cyto.2008.07.010; Kissner TL, 2011, J BIOL CHEM, V286, P31385, DOI 10.1074/jbc.M110.204982; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Loiarro M, 2005, J BIOL CHEM, V280, P15809, DOI 10.1074/jbc.C400613200; Loiarro M, 2007, J LEUKOCYTE BIOL, V82, P801, DOI 10.1189/jlb.1206746; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; O'Neill LAJ, 2007, NAT REV IMMUNOL, V7, P353, DOI 10.1038/nri2079; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Potterton L, 2004, ACTA CRYSTALLOGR D, V60, P2288, DOI 10.1107/S0907444904023716; Radhakrishnan GK, 2011, BIOCHEM J, V439, P79, DOI 10.1042/BJ20110577; Radhakrishnan GK, 2010, BIOCHEM BIOPH RES CO, V397, P59, DOI 10.1016/j.bbrc.2010.05.056; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rana RR, 2011, MICROB PATHOGENESIS, V51, P89, DOI 10.1016/j.micpath.2011.05.004; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; Snyder G, 2010, J IMMUNOL, V184; Snyder GA, 2014, CURR PHARM DESIGN, V20, P1244, DOI 10.2174/13816128113199990069; Snyder GA, 2013, P NATL ACAD SCI USA, V110, P6985, DOI 10.1073/pnas.1215770110; Tao X, 2002, BIOCHEM BIOPH RES CO, V299, P216, DOI 10.1016/S0006-291X(02)02581-0; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; Xiao TS, 2010, J CLIN IMMUNOL, V30, P638, DOI 10.1007/s10875-010-9435-0; Yadav M, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001120; Yang HW, 2004, ACTA CRYSTALLOGR D, V60, P1833, DOI 10.1107/S0907444904019419	43	53	60	0	18	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					669	679		10.1074/jbc.M113.523407	http://dx.doi.org/10.1074/jbc.M113.523407			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275656	hybrid, Green Published			2022-12-25	WOS:000330541200007
J	Takahashi, K; Takabayashi, A; Tanaka, A; Tanaka, R				Takahashi, Kaori; Takabayashi, Atsushi; Tanaka, Ayumi; Tanaka, Ryouichi			Functional Analysis of Light-harvesting-like Protein 3 (LIL3) and Its Light-harvesting Chlorophyll-binding Motif in Arabidopsis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CAB-LIKE PROTEINS; SYNECHOCYSTIS-SP PCC-6803; SP PCC 6803; CRYSTAL-STRUCTURE; PHOTOSYSTEM-II; COMPLEX; A/B; FERROCHELATASE; LOCALIZATION; INVOLVEMENT	The light-harvesting complex (LHC) constitutes the major light-harvesting antenna of photosynthetic eukaryotes. LHC contains a characteristic sequence motif, termed LHC motif, consisting of 25-30 mostly hydrophobic amino acids. This motif is shared by a number of transmembrane proteins from oxygenic photoautotrophs that are termed light-harvesting-like (LIL) proteins. To gain insights into the functions of LIL proteins and their LHC motifs, we functionally characterized a plant LIL protein, LIL3. This protein has been shown previously to stabilize geranylgeranyl reductase (GGR), a key enzyme in phytol biosynthesis. It is hypothesized that LIL3 functions to anchor GGR to membranes. First, we conjugated the transmembrane domain of LIL3 or that of ascorbate peroxidase to GGR and expressed these chimeric proteins in an Arabidopsis mutant lacking LIL3 protein. As a result, the transgenic plants restored phytol-synthesizing activity. These results indicate that GGR is active as long as it is anchored to membranes, even in the absence of LIL3. Subsequently, we addressed the question why the LHC motif is conserved in the LIL3 sequences. We modified the transmembrane domain of LIL3, which contains the LHC motif, by substituting its conserved amino acids (Glu-171, Asn-174, and Asp-189) with alanine. As a result, the Arabidopsis transgenic plants partly recovered the phytol-biosynthesizing activity. However, in these transgenic plants, the LIL3-GGR complexes were partially dissociated. Collectively, these results indicate that the LHC motif of LIL3 is involved in the complex formation of LIL3 and GGR, which might contribute to the GGR reaction.	[Takahashi, Kaori; Takabayashi, Atsushi; Tanaka, Ayumi; Tanaka, Ryouichi] Hokkaido Univ, Inst Low Temp Sci, Sapporo, Hokkaido 0600819, Japan; [Takabayashi, Atsushi; Tanaka, Ayumi; Tanaka, Ryouichi] Japan Core Res Evolutionary Sci & Technol, Sapporo, Hokkaido 0600819, Japan	Hokkaido University	Tanaka, R (corresponding author), Hokkaido Univ, Inst Low Temp Sci, Kita Ku, N19W8, Sapporo, Hokkaido 0600819, Japan.	rtanaka@lowtem.hokudai.ac.jp	Tanaka, Ayumi/D-9003-2012; Tanaka, Ryouichi/A-4030-2012; Takabayashi, Atsushi/G-1998-2011; Takabayashi, Atsushi/AAH-6025-2020	Tanaka, Ryouichi/0000-0002-5858-5326; Takabayashi, Atsushi/0000-0003-1100-7462; Takabayashi, Atsushi/0000-0003-1100-7462	Ministry of Education, Culture, Sports, Science and Technology, Japan; Institute of Low Temperature Science, Hokkaido University;  [23570042]	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Institute of Low Temperature Science, Hokkaido University; 	This work was supported by the Ministry of Education, Culture, Sports, Science and Technology, Japan, by Grant-in-Aid for Scientific Research 23570042, and by a leadership research grant from the Institute of Low Temperature Science, Hokkaido University (to R. T.).	Adamska I, 2001, J BIOL CHEM, V276, P8582, DOI 10.1074/jbc.M010447200; Adamska I, 1999, EUR J BIOCHEM, V260, P453, DOI 10.1046/j.1432-1327.1999.00178.x; Barros T, 2009, EMBO J, V28, P298, DOI 10.1038/emboj.2008.276; Earley KW, 2006, PLANT J, V45, P616, DOI 10.1111/j.1365-313X.2005.02617.x; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Engelken J, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-233; Finn RD, 2010, NUCLEIC ACIDS RES, V38, pD211, DOI 10.1093/nar/gkp985; Funk C, 1999, BIOCHEMISTRY-US, V38, P9397, DOI 10.1021/bi990545+; Funk C, 1999, NATO ASI 3 HIGH TECH, V64, P103; GREEN BR, 1995, PHOTOSYNTH RES, V44, P139, DOI 10.1007/BF00018304; GREEN BR, 1991, TRENDS BIOCHEM SCI, V16, P181, DOI 10.1016/0968-0004(91)90072-4; GREEN BR, 1994, PHOTOSYNTH RES, V39, P149, DOI 10.1007/BF00029382; Heddad M, 2000, P NATL ACAD SCI USA, V97, P3741, DOI 10.1073/pnas.050391397; Heddad M, 2006, PLANT PHYSIOL, V142, P75, DOI 10.1104/pp.106.081489; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Hernandez-Prieto MA, 2011, BBA-BIOENERGETICS, V1807, P1143, DOI 10.1016/j.bbabio.2011.05.002; Jansson S, 1999, TRENDS PLANT SCI, V4, P236, DOI 10.1016/S1360-1385(99)01419-3; Jenni S, 2007, SCIENCE, V316, P254, DOI 10.1126/science.1138248; Keller Y, 1998, EUR J BIOCHEM, V251, P413, DOI 10.1046/j.1432-1327.1998.2510413.x; Kufryk G, 2008, PHOTOSYNTH RES, V95, P135, DOI 10.1007/s11120-007-9244-3; Kunugi M, 2013, J BIOL CHEM, V288, P19330, DOI 10.1074/jbc.M113.462663; Liu ZF, 2004, NATURE, V428, P287, DOI 10.1038/nature02373; Martins BM, 2001, J BIOL CHEM, V276, P44108, DOI 10.1074/jbc.M104759200; Neilson JAD, 2010, GENOME, V53, P68, DOI [10.1139/G09-081, 10.1139/g09-081]; Promnares K, 2006, J BIOL CHEM, V281, P32705, DOI 10.1074/jbc.M606360200; Rizza A, 2011, NEW PHYTOL, V190, P896, DOI 10.1111/j.1469-8137.2010.03637.x; Rossini S, 2006, PLANT PHYSIOL, V141, P1264, DOI 10.1104/pp.106.083055; Salvi D, 2011, METHODS MOL BIOL, V775, P189, DOI 10.1007/978-1-61779-237-3_10; Salvi Daniel, 2008, V432, P19, DOI 10.1007/978-1-59745-028-7_2; Sasaki D, 2011, J MOL BIOL, V409, P543, DOI 10.1016/j.jmb.2011.04.002; Sobotka R, 2008, J BACTERIOL, V190, P2086, DOI 10.1128/JB.01678-07; Sobotka R, 2011, PLANT PHYSIOL, V155, P1735, DOI 10.1104/pp.110.167528; Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320; Storm P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055569; Storm P, 2008, PHOTOSYNTH RES, V98, P479, DOI 10.1007/s11120-008-9368-0; Tanaka R, 1999, PLANT PHYSIOL, V120, P695, DOI 10.1104/pp.120.3.695; Tanaka R, 2010, P NATL ACAD SCI USA, V107, P16721, DOI 10.1073/pnas.1004699107; Vavilin D, 2007, J BIOL CHEM, V282, P37660, DOI 10.1074/jbc.M707133200; Wang Q, 2008, PLANT PHYSIOL, V147, P1239, DOI 10.1104/pp.108.121087; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yao D, 2007, J BIOL CHEM, V282, P267, DOI 10.1074/jbc.M605463200; Yoshimura K, 1999, BIOCHEM J, V338, P41, DOI 10.1042/0264-6021:3380041	42	34	37	2	28	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					987	999		10.1074/jbc.M113.525428	http://dx.doi.org/10.1074/jbc.M113.525428			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275650	Green Submitted, Green Published, hybrid			2022-12-25	WOS:000330541200033
J	Dai, HM; Pang, YP; Ramirez-Alvarado, M; Kaufmann, SH				Dai, Haiming; Pang, Yuan-Ping; Ramirez-Alvarado, Marina; Kaufmann, Scott H.			Evaluation of the BH3-only Protein Puma as a Direct Bak Activator	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Apoptosis; Bcl-2 Family Proteins; Cell Death; Mitochondrial Apoptosis; Molecular Cell Biology; Bak; Puma; Oligomerization	OUTER-MEMBRANE PERMEABILIZATION; COLORECTAL-CANCER CELLS; BCL-2 FAMILY-MEMBERS; INDUCED APOPTOSIS; BH3 DOMAINS; DNA-DAMAGE; MITOCHONDRIAL APOPTOSIS; CONFORMATIONAL-CHANGES; CYTOKINE DEPRIVATION; NEURONAL APOPTOSIS	Interactions among Bcl-2 family proteins play critical roles in cellular life and death decisions. Previous studies have established the BH3-only proteins Bim, tBid, and Noxa as direct activators that are able to directly initiate the oligomerization and activation of Bak and/or Bax. Earlier studies of Puma have yielded equivocal results, with some concluding that it also acts as a direct activator and other studies suggesting that it acts solely as a sensitizer BH3-only protein. In the present study we examined the interaction of Puma BH3 domain or full-length protein with Bak by surface plasmon resonance, assessed Bak oligomerization status by cross-linking followed by immunoblotting, evaluated the ability of the Puma BH3 domain to induce Bak-mediated permeabilization of liposomes and mitochondria, and determined the effect of wild type and mutant Puma on cell viability in a variety of cellular contexts. Results of this analysis demonstrate high affinity (K-D = 26 +/- 5 nm) binding of the Puma BH3 domain to purified Bak ex vivo, leading to Bak homo-oligomerization and membrane permeabilization. Mutations in Puma that inhibit (L141E/M144E/L148E) or enhance (M144I/A145G) Puma BH3 binding to Bak also produce corresponding alterations in Bak oligomerization, Bak-mediated membrane permeabilization and, in a cellular context, Bak-mediated killing. Collectively, these results provide strong evidence that Puma, like Bim, Noxa, and tBid, is able to act as a direct Bak activator.	[Dai, Haiming; Kaufmann, Scott H.] Mayo Clin, Div Oncol Res, Rochester, MN 55905 USA; [Pang, Yuan-Ping; Kaufmann, Scott H.] Mayo Clin, Dept Mol Pharmacol & Expt Therapeut, Rochester, MN 55905 USA; [Ramirez-Alvarado, Marina] Mayo Clin, Dept Biochem & Mol Biol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic; Mayo Clinic	Kaufmann, SH (corresponding author), Mayo Clin, Div Oncol Res, Gonda 19-212,200 1st St SW, Rochester, MN 55905 USA.	Kaufmann.scott@mayo.edu		Pang, Yuan-Ping/0000-0003-0838-2560; Dai, Haiming/0000-0002-0484-7407; Kaufmann, Scott/0000-0002-4900-7145; Ramirez-Alvarado, Marina/0000-0003-2325-6773	National Institutes of Health [R01 CA166704]; NATIONAL CANCER INSTITUTE [R01CA166741, P30CA015083] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported, in whole or in part, by National Institutes of Health Grant R01 CA166704.	Abdulghani J, 2010, EXPERT OPIN THER TAR, V14, P1091, DOI 10.1517/14728222.2010.519701; Adjei PN, 1996, J CLIN INVEST, V98, P2588, DOI 10.1172/JCI119078; Afonina IS, 2010, IMMUNOL REV, V235, P105, DOI 10.1111/j.0105-2896.2010.00908.x; Bean GR, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003483; BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118; Bernstein AI, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-2; Chipuk JE, 2008, TRENDS CELL BIOL, V18, P157, DOI 10.1016/j.tcb.2008.01.007; Chipuk JE, 2010, MOL CELL, V37, P299, DOI 10.1016/j.molcel.2010.01.025; Chipuk JE, 2009, CELL CYCLE, V8, P2692, DOI 10.4161/cc.8.17.9412; Clybouw C, 2011, BLOOD, V118, P4120, DOI 10.1182/blood-2011-04-347096; Concannon CG, 2007, ONCOGENE, V26, P1681, DOI 10.1038/sj.onc.1209974; Creagh EM, 2001, BIOCHEM SOC T, V29, P696, DOI 10.1042/0300-5127:0290696; Czabotar PE, 2013, CELL, V152, P519, DOI 10.1016/j.cell.2012.12.031; Dai HM, 2011, J CELL BIOL, V194, P38, DOI 10.1083/jcb.201102027; Dai HM, 2009, J BIOL CHEM, V284, P18311, DOI 10.1074/jbc.M109.004770; DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397; Debatin KM, 2004, ONCOGENE, V23, P2950, DOI 10.1038/sj.onc.1207558; Dewson G, 2008, MOL CELL, V30, P369, DOI 10.1016/j.molcel.2008.04.005; Ding HS, 2011, BLOOD, V118, DOI 10.1182/blood-2011-02-334870; Du H, 2011, J BIOL CHEM, V286, P491, DOI 10.1074/jbc.M110.167148; Earnshaw WC, 1999, ANNU REV BIOCHEM, V68, P383, DOI 10.1146/annurev.biochem.68.1.383; Edwards AL, 2013, CHEM BIOL, V20, P888, DOI 10.1016/j.chembiol.2013.06.007; Ekert PG, 2006, BLOOD, V108, P1461, DOI 10.1182/blood-2006-03-014209; Ekoff M, 2007, BLOOD, V110, P3209, DOI 10.1182/blood-2007-02-073957; Erlacher M, 2005, BLOOD, V106, P4131, DOI 10.1182/blood-2005-04-1595; Erlacher M, 2006, J EXP MED, V203, P2939, DOI 10.1084/jem.20061552; Ewen CL, 2012, CELL DEATH DIFFER, V19, P28, DOI 10.1038/cdd.2011.153; Fadeel B, 1999, FASEB J, V13, P1647, DOI 10.1096/fasebj.13.13.1647; Fischer SF, 2008, P NATL ACAD SCI USA, V105, P3035, DOI 10.1073/pnas.0706913105; Follis AV, 2013, NAT CHEM BIOL, V9, P163, DOI [10.1038/NCHEMBIO.1166, 10.1038/nchembio.1166]; Gallenne T, 2009, J CELL BIOL, V185, P279, DOI 10.1083/jcb.200809153; Garrison SP, 2008, MOL CELL BIOL, V28, P5391, DOI 10.1128/MCB.00907-07; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Ghosh AP, 2009, J NEUROPATH EXP NEUR, V68, P747, DOI 10.1097/NEN.0b013e3181a9d524; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Gray DHD, 2012, IMMUNITY, V37, P451, DOI 10.1016/j.immuni.2012.05.030; Hackbarth JS, 2004, BIOTECHNIQUES, V37, P835; Happo L, 2010, BLOOD, V116, P5256, DOI 10.1182/blood-2010-04-280818; Hornak V, 2006, PROTEINS, V65, P712, DOI 10.1002/prot.21123; Jabbour AM, 2009, CELL DEATH DIFFER, V16, P555, DOI 10.1038/cdd.2008.179; Jabbour AM, 2010, BLOOD, V115, P344, DOI 10.1182/blood-2009-07-230730; Jeffers JR, 2003, CANCER CELL, V4, P321, DOI 10.1016/S1535-6108(03)00244-7; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Johnstone RW, 2008, NAT REV CANCER, V8, P782, DOI 10.1038/nrc2465; Kerr JB, 2012, MOL CELL, V48, P343, DOI 10.1016/j.molcel.2012.08.017; Killian BJ, 2009, J MOL BIOL, V389, P315, DOI 10.1016/j.jmb.2009.04.003; Kim H, 2009, MOL CELL, V36, P487, DOI 10.1016/j.molcel.2009.09.030; Kroemer G, 2005, NAT MED, V11, P725, DOI 10.1038/nm1263; Kuwana T, 2005, MOL CELL, V17, P525, DOI 10.1016/j.molcel.2005.02.003; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Letai A, 2002, CANCER CELL, V2, P183, DOI 10.1016/S1535-6108(02)00127-7; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Meng XW, 2007, J BIOL CHEM, V282, P29831, DOI 10.1074/jbc.M706110200; Merino D, 2009, J CELL BIOL, V186, P355, DOI 10.1083/jcb.200905153; Mesa RA, 2005, BLOOD, V106, P318, DOI 10.1182/blood-2004-09-3523; Michalak EM, 2008, CELL DEATH DIFFER, V15, P1019, DOI 10.1038/cdd.2008.16; Michalak EM, 2009, CELL DEATH DIFFER, V16, P684, DOI 10.1038/cdd.2008.195; Moldoveanu T, 2006, MOL CELL, V24, P677, DOI 10.1016/j.molcel.2006.10.014; Nakano K, 2001, MOL CELL, V7, P683, DOI 10.1016/S1097-2765(01)00214-3; Oh KJ, 2010, J BIOL CHEM, V285, P28924, DOI 10.1074/jbc.M110.135293; Pang YP, 2012, SCI REP-UK, V2, DOI 10.1038/srep00257; Qiu W, 2008, CELL STEM CELL, V2, P576, DOI 10.1016/j.stem.2008.03.009; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Schutze S, 2008, NAT REV MOL CELL BIO, V9, P655, DOI 10.1038/nrm2430; Steckley D, 2007, J NEUROSCI, V27, P12989, DOI 10.1523/JNEUROSCI.3400-07.2007; Strasser A, 2011, EMBO J, V30, P3667, DOI 10.1038/emboj.2011.307; Tait SWG, 2008, ONCOGENE, V27, P6452, DOI 10.1038/onc.2008.311; Tait SWG, 2010, NAT REV MOL CELL BIO, V11, P621, DOI 10.1038/nrm2952; Taylor RC, 2008, NAT REV MOL CELL BIO, V9, P231, DOI 10.1038/nrm2312; THOMPSON CB, 1995, SCIENCE, V267, P1456, DOI 10.1126/science.7878464; Vela L, 2013, J BIOL CHEM, V288, P4935, DOI 10.1074/jbc.M112.422204; Villunger A, 2003, SCIENCE, V302, P1036, DOI 10.1126/science.1090072; Walczak H, 2000, EXP CELL RES, V256, P58, DOI 10.1006/excr.2000.4840; Wickstrom L, 2009, BIOPHYS J, V97, P853, DOI 10.1016/j.bpj.2009.04.063; Wyllie A H, 1980, Int Rev Cytol, V68, P251; Yu H, 2010, BLOOD, V115, P3472, DOI 10.1182/blood-2009-10-248278; Yu J, 2001, MOL CELL, V7, P673, DOI 10.1016/S1097-2765(01)00213-1; Yu J, 2003, P NATL ACAD SCI USA, V100, P1931, DOI 10.1073/pnas.2627984100; Zhang YJ, 2009, MOL BIOL CELL, V20, P3077, DOI 10.1091/mbc.E08-11-1109	79	48	49	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					89	99		10.1074/jbc.M113.505701	http://dx.doi.org/10.1074/jbc.M113.505701			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24265320	hybrid, Green Published			2022-12-25	WOS:000329370900008
J	Gerofotis, CD; Ioannou, CS; Papadopoulos, NT				Gerofotis, Christos D.; Ioannou, Charalampos S.; Papadopoulos, Nikos T.			Aromatized to Find Mates: alpha-Pinene Aroma Boosts the Mating Success of Adult Olive Fruit Flies	PLOS ONE			English	Article							GINGER ROOT OIL; FEMALE SEX-PHEROMONE; DACUS-OLEAE GMELIN; CERATITIS-CAPITATA; STERILE MALES; HOST-PLANT; SPODOPTERA-EXIGUA; FLY DIPTERA; VOLATILES; ATTRACTION	Background: Contrary to other Tephritidae, female but also male olive flies, Bactrocera oleae release pheromones during their sexual communication. Alpha-pinene, a common plant volatile found in high amounts in unripe olive fruit and leaves has been detected as one of the major components of the female pheromone. However, possible effects of alpha-pinene and that of other host volatiles on the mating behavior of the olive fly have not been investigated. Methodology: Using wild olive flies, reared on olive fruit for 3 generations in the laboratory, we explored whether exposure of male and female olive flies to alpha-pinene affects their sexual performance. Results: Exposure of sexually mature adult olive flies to the aroma of alpha-pinene significantly increases the mating performance over non-exposed individuals. Interestingly, exposure to alpha-pinene boosts the mating success of both males and female olive flies. Conclusions: This is the first report of such an effect on the olive fly, and the first time that a single plant volatile has been reported to induce such a phenomenon on both sexes of a single species. We discuss the possible associated mechanism and provide some practical implications.	[Gerofotis, Christos D.; Ioannou, Charalampos S.; Papadopoulos, Nikos T.] Univ Thessaly, Lab Entomol & Agr Zool, Dept Agr Crop Prod & Rural Environm, Volos, Greece	University of Thessaly	Papadopoulos, NT (corresponding author), Univ Thessaly, Lab Entomol & Agr Zool, Dept Agr Crop Prod & Rural Environm, Volos, Greece.	nikopap@uth.gr	Papadopoulos, Nikos/AAJ-1721-2020; Papadopoulos, Nikos T./B-9156-2011	Papadopoulos, Nikos/0000-0003-2480-8189; Papadopoulos, Nikos T./0000-0003-2480-8189; D. Gerofotis, Chris/0000-0002-2455-0088				Baldwin IT, 1999, PLANTA, V208, P137, DOI 10.1007/s004250050543; Benelli G, 2013, ENTOMOL SCI, V16, P47, DOI 10.1111/j.1479-8298.2012.00538.x; Blight MM, 1995, J CHEM ECOL, V21, P1649, DOI 10.1007/BF02033667; BORDEN JH, 1980, CAN J FOREST RES, V10, P290, DOI 10.1139/x80-049; Broad ST, 2008, AGR FOREST ENTOMOL, V10, P157, DOI 10.1111/j.1461-9563.2008.00374.x; BYERS JA, 1981, INSECT BIOCHEM, V11, P563, DOI 10.1016/0020-1790(81)90024-X; BYERS JA, 1985, NATURWISSENSCHAFTEN, V72, P324, DOI 10.1007/BF00454776; Canale A., 2012, IOBC/WPRS Bulletin, V74, P219; Carpita A, 2012, NATURWISSENSCHAFTEN, V99, P77, DOI 10.1007/s00114-011-0868-y; CAUSSE R, 1966, CR ACAD SCI D NAT, V262, P1558; CAVALLORO R, 1971, Redia, V52, P201; De Moraes CM, 2001, NATURE, V410, P577, DOI 10.1038/35069058; Deng JY, 2004, J CHEM ECOL, V30, P2037, DOI 10.1023/B:JOEC.0000045593.62422.73; DICKENS JC, 1989, ENTOMOL EXP APPL, V52, P191, DOI 10.1007/BF00414044; Erbilgin N, 2001, OECOLOGIA, V127, P444, DOI 10.1007/s004420000606; Erbilgin N, 2000, J CHEM ECOL, V26, P2527, DOI 10.1023/A:1005532612117; Estes AM, 2012, J APPL ENTOMOL, V136, P1, DOI 10.1111/j.1439-0418.2011.01620.x; FERON M., 1962, ANN EPIPHYTIES [PARIS], V13, P269; FERON M, 1970, B SOC ENTOMOL FR, V65, P139; FLETCHER BS, 1991, HOST LOCATION OVIPOS; Frati F, 2009, J CHEM ECOL, V35, P201, DOI 10.1007/s10886-008-9572-6; Hilker M, 2010, BIOL REV, V85, P267, DOI 10.1111/j.1469-185X.2009.00100.x; Hong TK, 1998, ENTOMOL EXP APPL, V89, P155, DOI 10.1023/A:1003487611529; JANG EB, 1994, J CHEM ECOL, V20, P9, DOI 10.1007/BF02065987; JANG EB, 1989, ENTOMOL EXP APPL, V50, P7, DOI 10.1007/BF00190122; Juan-Blasco M, 2013, J APPL ENTOMOL, V137, P244, DOI 10.1111/j.1439-0418.2011.01688.x; Katsoyannos BI, 1997, ENTOMOL EXP APPL, V82, P181, DOI 10.1023/A:1002940012328; Kouloussis NA, 2013, J APPL ENTOMOL, V137, P30, DOI 10.1111/j.1439-0418.2010.01535.x; Kumaran N, 2013, ANIM BEHAV, V85, P781, DOI 10.1016/j.anbehav.2013.01.024; Landolt PJ, 1997, ANNU REV ENTOMOL, V42, P371, DOI 10.1146/annurev.ento.42.1.371; Linz J, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.0626; LIQUIDO NJ, 1991, MISCELLANEOUS PUBLIC, P1863; Liscia A, 2013, J INSECT PHYSIOL, V59, P705, DOI 10.1016/j.jinsphys.2013.04.008; MARZO LD, 1978, ENTOMOLOGICA BARI, P203; Mavraganis V.G., 2010, Entomologia Hellenica, V19, P14; MAZOMENOS BE, 1981, J CHEM ECOL, V7, P437, DOI 10.1007/BF00995766; MAZOMENOS BE, 1985, J CHEM ECOL, V11, P397, DOI 10.1007/BF01411425; Meiners T, 2005, ENTOMOL EXP APPL, V115, P171, DOI 10.1111/j.1570-7458.2005.00280.x; Mercier B, 2009, INT J OCCUP MED ENV, V22, P331, DOI 10.2478/v10001-009-0032-5; Nardi F, 2010, MOL PHYLOGENET EVOL, V57, P678, DOI 10.1016/j.ympev.2010.08.008; NISHIDA R, 1988, EXPERIENTIA, V44, P534, DOI 10.1007/BF01958941; Nishida R, 1997, J CHEM ECOL, V23, P2275, DOI 10.1023/B:JOEC.0000006673.27221.2e; NISHIDA R, 1990, J CHEM ECOL, V16, P151, DOI 10.1007/BF01021276; Nishida Ritsuo, 2000, P631; Papadopoulos NT, 2006, J INSECT BEHAV, V19, P403, DOI 10.1007/s10905-006-9031-6; Papadopoulos NT, 2009, PHYSIOL ENTOMOL, V34, P238, DOI 10.1111/j.1365-3032.2009.00680.x; Papadopoulos NT, 2001, ENTOMOL EXP APPL, V99, P253, DOI 10.1023/A:1019288301757; PAYNE TL, 1978, ENVIRON ENTOMOL, V7, P578, DOI 10.1093/ee/7.4.578; Quintana A, 2003, J CHEM ECOL, V29, P639, DOI 10.1023/A:1022868603108; Raghu S, 2004, B ENTOMOL RES, V94, P385, DOI 10.1079/BER2004313; RENWICK JAA, 1976, SCIENCE, V191, P199, DOI 10.1126/science.1246609; RICE RE, 2003, CALIFORNIA AGR, V57; Ryan M.J., 1990, Oxford Surveys in Evolutionary Biology, V7, P157; SACANTANIS K., 1953, Revue de Pathologie Vegetale, V32, P50; SCARPATI ML, 1993, J CHEM ECOL, V19, P881, DOI 10.1007/BF00985017; Schoonhoven L. M., 2005, Insect-plant biology; Seybold SJ, 2003, ANNU REV ENTOMOL, V48, P425, DOI 10.1146/annurev.ento.48.091801.112645; Shelly T, 2004, J INSECT BEHAV, V17, P303, DOI 10.1023/B:JOIR.0000031532.29287.95; Shelly TE, 2004, FLA ENTOMOL, V87, P628, DOI 10.1653/0015-4040(2004)087[0628:SMOTMF]2.0.CO;2; Shelly TE, 2004, J ECON ENTOMOL, V97, P846, DOI 10.1603/0022-0493(2004)097[0846:AITMFF]2.0.CO;2; Shelly TE, 2000, ECOL ENTOMOL, V25, P109, DOI 10.1046/j.1365-2311.2000.00231.x; Shelly TE, 2001, J ECON ENTOMOL, V94, P1413, DOI 10.1603/0022-0493-94.6.1413; Shelly TE, 2001, ANN ENTOMOL SOC AM, V94, P497, DOI 10.1603/0013-8746(2001)094[0497:ETCACC]2.0.CO;2; SHELLY TE, 2006, P 7 INT S FRUIT FLIE, P59; Shelly T, 2007, ENTOMOL EXP APPL, V123, P193, DOI 10.1111/j.1570-7458.2007.00538.x; Shelly T, 2012, ANN ENTOMOL SOC AM, V105, P368, DOI 10.1603/AN11125; Shelly Todd, 2003, Proceedings of the Hawaiian Entomological Society, V36, P1; Shelly TE, 2007, J CHEM ECOL, V33, P2308, DOI 10.1007/s10886-007-9394-y; Showler AT, 2001, J CHEM ECOL, V27, P2013, DOI 10.1023/A:1012238803311; Stensmyr MC, 2001, J COMP PHYSIOL A, V187, P509; Tan KH, 2000, J CHEM ECOL, V26, P533, DOI 10.1023/A:1005477926244; TAN KH, 1996, FRUIT FLY PESTS WORL; Vera MT, 2013, J APPL ENTOMOL, V137, P2, DOI 10.1111/j.1439-0418.2010.01516.x; VET LEM, 1992, ANNU REV ENTOMOL, V37, P141, DOI 10.1146/annurev.en.37.010192.001041; West-Eberhard M.J., 1984, P283; Zygouridis NE, 2009, HEREDITY, V102, P402, DOI 10.1038/hdy.2008.125	81	22	24	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81336	10.1371/journal.pone.0081336	http://dx.doi.org/10.1371/journal.pone.0081336			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260571	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900129
J	Kirk, NL; Ritson-Williams, R; Coffroth, MA; Miller, MW; Fogarty, ND; Santos, SR				Kirk, Nathan L.; Ritson-Williams, Raphael; Coffroth, Mary Alice; Miller, Margaret W.; Fogarty, Nicole D.; Santos, Scott R.			Tracking Transmission of Apicomplexan Symbionts in Diverse Caribbean Corals	PLOS ONE			English	Article							SEXUAL REPRODUCTION; GENUS SYMBIODINIUM; PERKINSUS-MARINUS; ACROPORA-PALMATA; CLONAL STRUCTURE; PLANULA LARVAE; REEF; PARASITE; PATTERNS; HISTORY	Symbionts in each generation are transmitted to new host individuals either vertically (parent to offspring), horizontally (from exogenous sources), or a combination of both. Scleractinian corals make an excellent study system for understanding patterns of symbiont transmission since they harbor diverse symbionts and possess distinct reproductive modes of either internal brooding or external broadcast spawning that generally correlate with vertical or horizontal transmission, respectively. Here, we focused on the under-recognized, but apparently widespread, coral-associated apicomplexans (Protista: Alveolata) to determine if symbiont transmission depends on host reproductive mode. Specifically, a PCR-based assay was utilized towards identifying whether planula larvae and reproductive adults from brooding and broadcast spawning scleractinian coral species in Florida and Belize harbored apicomplexan DNA. Nearly all (85.5%; n = 85/89) examined planulae of five brooding species (Porites astreoides, Agaricia tenuifolia, Agaricia agaricites, Favia fragum, Mycetophyllia ferox) and adults of P. astreoides were positive for apicomplexan DNA. In contrast, no (n = 0/10) apicomplexan DNA was detected from planulae of four broadcast spawning species (Acropora cervicornis, Acropora palmata, Pseudodiploria strigosa, and Orbicella faveolata) and rarely in gametes (8.9%; n = 5/56) of these species sampled from the same geographical range as the brooding species. In contrast, tissue samples from nearly all (92.0%; n = 81/88) adults of the broadcast spawning species A. cervicornis, A. palmata and O. faveolata harbored apicomplexan DNA, including colonies whose gametes and planulae tested negative for these symbionts. Taken together, these data suggest apicomplexans are transmitted vertically in these brooding scleractinian coral species while the broadcast spawning scleractinian species examined here acquire these symbionts horizontally. Notably, these transmission patterns are consistent with those of other scleractinian coral symbionts. While this study furthers knowledge regarding these symbionts, numerous questions remain to be addressed, particularly in regard to the specific interaction(s) between these apicomplexans and their hosts.	[Kirk, Nathan L.; Santos, Scott R.] Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA; [Kirk, Nathan L.; Santos, Scott R.] Auburn Univ, Molette Biol Lab Environm & Climate Change Studie, Auburn, AL 36849 USA; [Ritson-Williams, Raphael] Smithsonian Marine Stn, Ft Pierce, FL USA; [Coffroth, Mary Alice] SUNY Buffalo, Dept Geol, Buffalo, NY 14260 USA; [Miller, Margaret W.] NOAA, Southeast Fisheries Sci Ctr, Miami, FL USA; [Fogarty, Nicole D.] Nova SE Univ, Oceanog Ctr, Dania, FL USA; [Santos, Scott R.] Auburn Univ, Cellular & Mol Biosci Peak Program, Auburn, AL 36849 USA	Auburn University System; Auburn University; Auburn University System; Auburn University; Smithsonian Institution; Smithsonian National Museum of Natural History; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; National Oceanic Atmospheric Admin (NOAA) - USA; Nova Southeastern University; Auburn University System; Auburn University	Kirk, NL (corresponding author), Auburn Univ, Dept Biol Sci, Auburn, AL 36849 USA.	kirknat@gmail.com	Santos, Scott R/A-7472-2009	Kirk, Nathan/0000-0002-7289-3907	PADI Foundation [4005]; National Science Foundation [OCE-09-26822]; NOAA Coral Reef Conservation Program; MOTE protect our reefs grant [POR-2010-29]	PADI Foundation; National Science Foundation(National Science Foundation (NSF)); NOAA Coral Reef Conservation Program(National Oceanic Atmospheric Admin (NOAA) - USA); MOTE protect our reefs grant	This work was funded by grants from the PADI Foundation (http://www.padifoundation.org/ #4005 to NLK), National Science Foundation (http://www.nsf.gov/: OCE-09-26822 to MAC), the NOAA Coral Reef Conservation Program (http://coralreef.noaa.gov/aboutcrcp/workwithus/funding/grants/) and the MOTE protect our reefs grant (http://isurus.mote.org/Keys/reef_plate.phtml: POR-2010-29 to VP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Apprill A, 2009, ISME J, V3, P685, DOI 10.1038/ismej.2009.3; Audemard C, 2004, APPL ENVIRON MICROB, V70, P6611, DOI 10.1128/AEM.70.11.6611-6618.2004; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Baird AH, 2009, ANNU REV ECOL EVOL S, V40, P551, DOI 10.1146/annurev.ecolsys.110308.120220; Bassim KM, 2003, MAR BIOL, V142, P241, DOI 10.1007/S00227-002-0953-z; Baums IB, 2006, ECOL MONOGR, V76, P503, DOI 10.1890/0012-9615(2006)076[0503:GVICSI]2.0.CO;2; Bergeron N, 2000, CAN VET J, V41, P464; Budd AF, 2012, ZOOL J LINN SOC-LOND, V166, P465, DOI 10.1111/j.1096-3642.2012.00855.x; Burreson EM, 2008, DIS AQUAT ORGAN, V80, P81, DOI 10.3354/dao01925; Bush AO, 1997, J PARASITOL, V83, P575, DOI 10.2307/3284227; Bushek D, 2002, DIS AQUAT ORGAN, V51, P217, DOI 10.3354/dao051217; Castro-Sanguino C, 2012, BIOL LETTERS, V8, P282, DOI 10.1098/rsbl.2011.0836; CHORNESKY EA, 1987, BIOL BULL-US, V172, P161, DOI 10.2307/1541790; COFFROTH MA, 1992, MAR BIOL, V114, P317, DOI 10.1007/BF00349534; Coffroth MA, 2006, CURR BIOL, V16, pR985, DOI 10.1016/j.cub.2006.10.049; Correa AMS, 2009, CORAL REEFS, V28, P437, DOI 10.1007/s00338-008-0464-6; Craft JD, 2008, LIMNOL OCEANOGR, V53, P675, DOI 10.4319/lo.2008.53.2.0675; Dirks U, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034709; Douglas AE, 1994, SYMBIOTIC INTERACTIO; Dubey JP, 2008, J EUKARYOT MICROBIOL, V55, P467, DOI 10.1111/j.1550-7408.2008.00345.x; Edmunds PJ, 2005, INVERTEBR BIOL, V124, P185, DOI 10.1111/j.1744-7410.2005.00018.x; Fadlallah Y.H., 1983, Coral Reefs, V2, P129, DOI 10.1007/BF00336720; Fellous S, 2009, J EVOLUTION BIOL, V22, P582, DOI 10.1111/j.1420-9101.2008.01665.x; Folmer O., 1994, Molecular Marine Biology and Biotechnology, V3, P294; FRIEDMAN CS, 1993, J SHELLFISH RES, V12, P201; Fukami H, 2004, EVOLUTION, V58, P324, DOI 10.1111/j.0014-3820.2004.tb01648.x; Gleason DF, 2009, CORAL REEFS, V28, P549, DOI 10.1007/s00338-009-0480-1; GLEASON DF, 1995, MAR BIOL, V123, P693, DOI 10.1007/BF00349112; Goulet TL, 2004, CORAL REEFS, V23, P465, DOI 10.1007/s00338-004-0408-8; Hide G, 2009, PARASITOLOGY, V136, P1877, DOI 10.1017/S0031182009990941; Hill SLL, 2007, PARASITOLOGY, V134, P841, DOI 10.1017/S0031182007002259; JACKSON JBC, 1986, PHILOS T R SOC B, V313, P7, DOI 10.1098/rstb.1986.0022; Janouskovec J, 2013, ISME J, V7, P444, DOI 10.1038/ismej.2012.129; Janouskovec J, 2012, CURR BIOL, V22, pR518, DOI 10.1016/j.cub.2012.04.047; Jokiel P. L, 1985, P 5 INT CORAL REEF C, V4, P307; JOKIEL PL, 1985, MAR BIOL, V88, P167, DOI 10.1007/BF00397164; Kirk NL, 2013, CORAL REEFS IN PRESS; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; KNOWLTON N, 1994, TRENDS ECOL EVOL, V9, P7, DOI 10.1016/0169-5347(94)90224-0; Koh LP, 2004, SCIENCE, V305, P1632, DOI 10.1126/science.1101101; Lake JA, 2009, NATURE, V460, P967, DOI 10.1038/nature08183; Lesser MP, 2004, SCIENCE, V305, P997, DOI 10.1126/science.1099128; Levitan DR, 2011, EVOLUTION, V65, P1254, DOI 10.1111/j.1558-5646.2011.01235.x; Lirman D, 2000, J EXP MAR BIOL ECOL, V251, P41, DOI 10.1016/S0022-0981(00)00205-7; Little AF, 2004, SCIENCE, V304, P1492, DOI 10.1126/science.1095733; Martin B.D., 2012, INT J BIOL, V5, P32, DOI [10.5539/ijb.v5n1p32, DOI 10.5539/ijb.v5n1p32]; Mason BM, 2012, BIOL BULL-US, V222, P88, DOI 10.1086/BBLv222n2p88; McGuire MP, 1998, CORAL REEFS, V17, P369, DOI 10.1007/s003380050141; Morris DJ, 2006, INT J PARASITOL, V36, P371, DOI 10.1016/j.ijpara.2005.10.009; MUSCATINE L, 1981, LIMNOL OCEANOGR, V26, P601, DOI 10.4319/lo.1981.26.4.0601; Nissimov J, 2009, FEMS MICROBIOL LETT, V292, P210, DOI 10.1111/j.1574-6968.2009.01490.x; Padilla-Gamino JL, 2011, CORAL REEFS, V30, P371, DOI 10.1007/s00338-010-0700-8; Park KI, 2010, J INVERTEBR PATHOL, V105, P261, DOI 10.1016/j.jip.2010.07.006; PARKER GM, 1984, BIOL BULL, V167, P159, DOI 10.2307/1541344; PETERS EC, 1984, HELGOLANDER MEERESUN, V37, P113, DOI 10.1007/BF01989298; Plaisance L, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025026; PLUTHERO FG, 1993, NUCLEIC ACIDS RES, V21, P4850, DOI 10.1093/nar/21.20.4850; Porto I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002160; Poulin R, 1996, INT J PARASITOL, V26, P1127, DOI 10.1016/S0020-7519(96)80014-2; Poulin R, 2008, TRENDS PARASITOL, V24, P24, DOI 10.1016/j.pt.2007.10.002; Pratchett MS, 2001, CORAL REEFS, V20, P13, DOI 10.1007/s003380000113; Prensier G, 2008, J EUKARYOT MICROBIOL, V55, P541, DOI 10.1111/j.1550-7408.2008.00361.x; Reshef L, 2006, ENVIRON MICROBIOL, V8, P2068, DOI 10.1111/j.1462-2920.2006.01148.x; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Ritson-Williams R, 2010, CORAL REEFS, V29, P71, DOI 10.1007/s00338-009-0555-z; Rosenberg E, 2011, BIRTH DEFECTS RES C, V93, P56, DOI 10.1002/bdrc.20196; ROWAN R, 1991, MAR ECOL PROG SER, V71, P65, DOI 10.3354/meps071065; Rozsa L, 2000, J PARASITOL, V86, P228, DOI 10.1645/0022-3395(2000)086[0228:QPISOH]2.0.CO;2; Sandstrom JP, 2001, MOL ECOL, V10, P217, DOI 10.1046/j.1365-294X.2001.01189.x; Schwarz JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-97; Sharp KH, 2012, ISME J, V6, P790, DOI 10.1038/ismej.2011.144; Sharp KH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010898; Siboni N, 2010, J EUKARYOT MICROBIOL, V57, P236, DOI 10.1111/j.1550-7408.2010.00469.x; SIMON L, 1993, NATURE, V363, P67, DOI 10.1038/363067a0; Slapeta J, 2013, PLOS ONE IN PRESS; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Stat M, 2006, PERSPECT PLANT ECOL, V8, P23, DOI 10.1016/j.ppees.2006.04.001; STORK NE, 1993, NATURE, V366, P307, DOI 10.1038/366307a0; SZMANT AM, 1986, CORAL REEFS, V5, P43, DOI 10.1007/BF00302170; SZMANTFROELICH A, 1985, B MAR SCI, V37, P880; Toller WW, 2002, CORAL REEFS, V21, P143, DOI 10.1007/s00338-002-0220-2; TUNNICLIFFE V, 1981, P NATL ACAD SCI-BIOL, V78, P2427, DOI 10.1073/pnas.78.4.2427; UPTON SJ, 1986, J INVERTEBR PATHOL, V47, P184, DOI 10.1016/0022-2011(86)90045-5; Vollmer SV, 2007, J HERED, V98, P40, DOI 10.1093/jhered/esl057; Wellington GM, 2003, MAR BIOL, V143, P1185, DOI 10.1007/s00227-003-1150-4; Windsor DA, 1998, INT J PARASITOL, V28, P1939, DOI 10.1016/S0020-7519(98)00153-2	87	9	9	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80618	10.1371/journal.pone.0080618	http://dx.doi.org/10.1371/journal.pone.0080618			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260438	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900079
J	Sanchez-Martin, FJ; Fan, YX; Lindquist, DM; Xia, Y; Puga, A				Sanchez-Martin, Francisco Javier; Fan, Yunxia; Lindquist, Diana M.; Xia, Ying; Puga, Alvaro			Lead Induces Similar Gene Expression Changes in Brains of Gestationally Exposed Adult Mice and in Neurons Differentiated from Mouse Embryonic Stem Cells	PLOS ONE			English	Article							DISEASE; RATS; PROLIFERATION; HIPPOCAMPUS; ASSOCIATION; INDUCTION; BEHAVIOR; MONKEYS; DEATH; RNA	Exposure to environmental toxicants during embryonic life causes changes in the expression of developmental genes that may last for a lifetime and adversely affect the exposed individual. Developmental exposure to lead (Pb), an ubiquitous environmental contaminant, causes deficits in cognitive functions and IQ, behavioral effects, and attention deficit hyperactivity disorder (ADHD). Long-term effects observed after early life exposure to Pb include reduction of gray matter, alteration of myelin structure, and increment of criminal behavior in adults. Despite growing research interest, the molecular mechanisms responsible for the effects of lead in the central nervous system are still largely unknown. To study the molecular changes due to Pb exposure during neurodevelopment, we exposed mice to Pb in utero and examined the expression of neural markers, neurotrophins, transcription factors and glutamate-related genes in hippocampus, cortex, and thalamus at postnatal day 60. We found that hippocampus was the area where gene expression changes due to Pb exposure were more pronounced. To recapitulate gestational Pb exposure in vitro, we differentiated mouse embryonic stem cells (ESC) into neurons and treated ESC-derived neurons with Pb for the length of the differentiation process. These neurons expressed the characteristic neuronal markers Tubb3, Syp, Gap43, Hud, Ngn1, Vglut1 (a marker of glutamatergic neurons), and all the glutamate receptor subunits, but not the glial marker Gafp. Importantly, several of the changes observed in Pb-exposed mouse brains in vivo were also observed in Pb-treated ESC-derived neurons, including those affecting expression of Ngn1, Bdnf exon IV, Grin1, Grin2D, Grik5, Gria4, and Grm6. We conclude that our ESC-derived model of toxicant exposure during neural differentiation promises to be a useful model to analyze mechanisms of neurotoxicity induced by Pb and other environmental agents.	[Sanchez-Martin, Francisco Javier; Fan, Yunxia; Xia, Ying; Puga, Alvaro] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA; [Sanchez-Martin, Francisco Javier; Fan, Yunxia; Xia, Ying; Puga, Alvaro] Univ Cincinnati, Coll Med, Ctr Environm Genet, Cincinnati, OH 45267 USA; [Lindquist, Diana M.] Cincinnati Childrens Hosp Med Ctr, Dept Radiol, Cincinnati, OH 45229 USA	University System of Ohio; University of Cincinnati; University System of Ohio; University of Cincinnati; Cincinnati Children's Hospital Medical Center	Puga, A (corresponding author), Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA.	Alvaro.Puga@uc.edu		Sanchez Martin, Francisco Javier/0000-0002-9599-4380	National Institutes of Health [5 R01 ES010807, R21 ES020048]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES010807, R21ES020048] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by National Institutes of Health grants 5 R01 ES010807 and R21 ES020048. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aid T, 2007, J NEUROSCI RES, V85, P525, DOI 10.1002/jnr.21139; Baranowska-Bosiacka I, 2013, TOXICOLOGY, V303, P187, DOI 10.1016/j.tox.2012.10.027; BARKER DJP, 1989, LANCET, V2, P577; Barker DJP, 1999, ANN MED, V31, P3, DOI 10.1080/07853890.1999.11904392; Basha MR, 2005, J NEUROSCI, V25, P823, DOI 10.1523/JNEUROSCI.4335-04.2005; BELLINGER D, 1994, ENVIRON RES, V66, P12, DOI 10.1006/enrs.1994.1041; Bertrand N, 2002, NAT REV NEUROSCI, V3, P517, DOI 10.1038/nrn874; Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147; Bihaqi SW, 2011, J ALZHEIMERS DIS, V27, P819, DOI 10.3233/JAD-2011-111013; Boulle F, 2012, MOL PSYCHIATR, V17, P584, DOI 10.1038/mp.2011.107; Brubaker CJ, 2010, NEUROTOXICOLOGY, V31, P259, DOI 10.1016/j.neuro.2010.03.004; Brubaker CJ, 2009, NEUROTOXICOLOGY, V30, P867, DOI 10.1016/j.neuro.2009.07.007; Burgess N, 2002, NEURON, V35, P625, DOI 10.1016/S0896-6273(02)00830-9; Callaghan CK, 2013, NEUROBIOL LEARN MEM, V104, P39, DOI 10.1016/j.nlm.2013.04.011; Cattaneo E, 2005, NAT REV NEUROSCI, V6, P919, DOI 10.1038/nrn1806; Cecil KM, 2011, ENVIRON HEALTH PERSP, V119, P403, DOI 10.1289/ehp.1002176; Cecil KM, 2008, PLOS MED, V5, P741, DOI 10.1371/journal.pmed.0050112; Chen AM, 2007, PEDIATRICS, V119, pE650, DOI 10.1542/peds.2006-1973; Chetty CS, 2005, CELL MOL BIOL LETT, V10, P413; Cholvin T, 2013, J NEUROSCI, V33, P8772, DOI 10.1523/JNEUROSCI.0771-13.2013; DEGAWA M, 1995, BIOL PHARM BULL, V18, P1215; Dosunmu R, 2009, J ALZHEIMERS DIS, V18, P211, DOI 10.3233/JAD-2009-1138; Dou CM, 2011, J HAZARD MATER, V194, P277, DOI 10.1016/j.jhazmat.2011.07.106; Flora Gagan, 2012, Interdiscip Toxicol, V5, P47, DOI 10.2478/v10102-012-0009-2; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Froehlich TE, 2009, PEDIATRICS, V124, pE1054, DOI 10.1542/peds.2009-0738; Gertsenstein M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011260; Guilarte TR, 2003, MOL BRAIN RES, V113, P37, DOI 10.1016/S0169-328X(03)00083-4; Hu H, 1998, ENVIRON HEALTH PERSP, V106, P1, DOI 10.2307/3433626; Huang EJ, 2001, DEVELOPMENT, V128, P2421; Huang FN, 2004, NEUROTOXICOLOGY, V25, P1001, DOI 10.1016/j.neuro.2004.03.010; Jones M. W., 2002, Current Molecular Medicine (Hilversum), V2, P639, DOI 10.2174/1566524023361989; Kermani S, 2008, TOXICOL IN VITRO, V22, P995, DOI 10.1016/j.tiv.2008.02.009; Kojima M, 2002, ARCH TOXICOL, V76, P398, DOI 10.1007/s00204-002-0365-3; Kumar BK, 2009, TOXICOL LETT, V184, P56, DOI 10.1016/j.toxlet.2008.10.023; Leasure JL, 2008, ENVIRON HEALTH PERSP, V116, P355, DOI 10.1289/ehp.10862; Liguz-Lecznar M, 2007, ACTA NEUROBIOL EXP, V67, P207; Lu XB, 2013, BIOL TRACE ELEM RES, V151, P75, DOI 10.1007/s12011-012-9531-5; Marchetti C, 2005, NEUROTOX RES, V8, P245, DOI 10.1007/BF03033978; Markowitz M, 2000, Pediatr Rev, V21, P327, DOI 10.1542/pir.21-10-327; NAKANISHI S, 1994, ANNU REV BIOPH BIOM, V23, P319, DOI 10.1146/annurev.bb.23.060194.001535; Neal AP, 2011, NEUROTOXICOLOGY, V32, P281, DOI 10.1016/j.neuro.2010.12.013; Neal AP, 2010, TOXICOL SCI, V116, P249, DOI 10.1093/toxsci/kfq111; Peterson SM, 2013, NEUROTOXICOL TERATOL, V38, P53, DOI 10.1016/j.ntt.2013.04.007; Peterson SM, 2011, ENVIRON HEALTH PERSP, V119, P615, DOI 10.1289/ehp.1002590; Piomelli S, 2002, PEDIATR CLIN N AM, V49, P1285, DOI 10.1016/S0031-3955(02)00097-4; Rastogi SK., 2008, INDIAN J OCCUP ENVIR, V12, DOI 10.4103/0019-5278.44689; Reichard JF, 2007, NUCLEIC ACIDS RES, V35, P7074, DOI 10.1093/nar/gkm638; Ris MD, 2004, J INT NEUROPSYCH SOC, V10, P261, DOI 10.1017/S1355617704102154; Riva MA, 2012, SAF HEALTH WORK, V3, P11, DOI 10.5491/SHAW.2012.3.1.11; SCHWARTZ J, 1995, ARCH ENVIRON HEALTH, V50, P31, DOI 10.1080/00039896.1995.9955010; Smith TC, 1999, J PHYSIOL-LONDON, V517, P51, DOI 10.1111/j.1469-7793.1999.0051z.x; Stansfield KH, 2012, TOXICOL SCI, V127, P277, DOI 10.1093/toxsci/kfs090; Swanson GT, 1996, J PHYSIOL-LONDON, V492, P129, DOI 10.1113/jphysiol.1996.sp021295; Takeuchi Y, 2002, J NEUROCHEM, V83, P67, DOI 10.1046/j.1471-4159.2002.01096.x; Tao X, 1998, NEURON, V20, P709, DOI 10.1016/S0896-6273(00)81010-7; Toscano CD, 2005, BRAIN RES REV, V49, P529, DOI 10.1016/j.brainresrev.2005.02.004; Wang Y, 2010, TOXICOL SCI, V115, P225, DOI 10.1093/toxsci/kfq038; Wright JP, 2008, PLOS MED, V5, P732, DOI 10.1371/journal.pmed.0050101; Wu J, 2008, J NEUROSCI, V28, P3, DOI 10.1523/JNEUROSCI.4405-07.2008; Yuan WH, 2006, PEDIATRICS, V118, P971, DOI 10.1542/peds.2006-0467	61	20	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80558	10.1371/journal.pone.0080558	http://dx.doi.org/10.1371/journal.pone.0080558			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260418	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900070
J	Bindt, C; Guo, N; Bonle, MT; Appiah-Poku, J; Hinz, R; Barthel, D; Schoppen, S; Feldt, T; Barkmann, C; Koffi, M; Loag, W; Nguah, SB; Eberhardt, KA; Tagbor, H; N'Goran, E; Ehrhardt, S				Bindt, Carola; Guo, Nan; Bonle, Marguerite Te; Appiah-Poku, John; Hinz, Rebecca; Barthel, Dana; Schoppen, Stefanie; Feldt, Torsten; Barkmann, Claus; Koffi, Mathurin; Loag, Wibke; Nguah, Samuel Blay; Eberhardt, Kirsten A.; Tagbor, Harry; N'Goran, Eliezer; Ehrhardt, Stephan		Int CDS Study Grp	No Association between Antenatal Common Mental Disorders in Low-Obstetric Risk Women and Adverse Birth Outcomes in Their Offspring: Results from the CDS Study in Ghana and Cote D'Ivoire	PLOS ONE			English	Article							SPONTANEOUS PRETERM BIRTH; MATERNAL STRESS; PERINATAL OUTCOMES; NEONATAL OUTCOMES; ANXIETY SYMPTOMS; GESTATIONAL-AGE; DEPRESSION; PREGNANCY; WEIGHT; POPULATION	Background: Evidence linking common mental disorders (CMD) in pregnant women to adverse birth outcomes is inconsistent, and studies often failed to control for pregnancy complications. This study aimed to explore the association between antenatal depression and anxiety symptoms and birth outcomes in a low-obstetric risk sample of mother/child dyads in Ghana and Cote d'Ivoire. Methods: In 2010-2011, a prospective cohort of 1030 women in their third trimester in Ghana and Cote d'Ivoire was enrolled. Depression and anxiety were assessed in the third trimester using the Patient Health Questionnaire depression module and the 7-item Generalized Anxiety Disorder scale. 719 mother/child dyads were included in the analysis. We constructed multivariate regression models to estimate the association between CMD and low birth weight (LBW), and preterm birth (PTB) to control for potential confounders. Results: The prevalence of depression and anxiety symptoms were 28.9% and 14.2% respectively. The mean birth weight was 3172.1g (SD 440.6) and the prevalence of LBW was 1.7%. The mean gestational age was 39.6 weeks and the proportion of PTB was 4%. Multivariate linear regression revealed no significant association between maternal depression (B=52.2, 95% CI -18.2 122.6, p=0.15) or anxiety (B=17.1, 95% CI -74.6 108.7, p=0.72) and birth weight. Yet, low socio-economic status, female sex of the child, and younger maternal age were associated with lower birth weight. Multivariate logistic regression suggested no significant association between maternal depression (OR: 2.1, 95% CI 0.8 5.6, p=0.15) or anxiety (OR: 1.8, 95% CI 0.6 5.5, p=0.29) with PTB. Conclusions: Our data suggests that depression and/or anxiety in the 3rd trimester of pregnancy are not independent predictors of adverse birth outcomes in low obstetric risk women. The role of pregnancy complications as confounders or effect modifiers in studies of maternal CMD and their impact on birth outcomes should be investigated.	[Bindt, Carola; Barkmann, Claus] Univ Med Ctr Hamburg Eppendorf, Dept Child & Adolescent Psychiat, Hamburg, Germany; [Guo, Nan; Ehrhardt, Stephan] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA; [Bonle, Marguerite Te] Inst Natl Sante Publ, Ctr Guidance Infantile, Abidjan, Cote Ivoire; [Appiah-Poku, John] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Behav Sci, Kumasi, Ghana; [Hinz, Rebecca; Barthel, Dana; Schoppen, Stefanie; Feldt, Torsten; Eberhardt, Kirsten A.; Ehrhardt, Stephan] Bernhard Nocht Inst Trop Med, Clin Res Unit, D-20359 Hamburg, Germany; [Koffi, Mathurin] Jean Lorougnon Guede Univ, Daloa, Cote Ivoire; [Loag, Wibke] Bernhard Nocht Inst Trop Med, D-20359 Hamburg, Germany; [Nguah, Samuel Blay] Komfo Anokye Teaching Hosp, Dept Child Hlth, Kumasi, Ghana; [Tagbor, Harry] Kwame Nkrumah Univ Sci & Technol, Sch Med Sci, Dept Community Hlth, Kumasi, Ghana; [N'Goran, Eliezer] Univ Cocody, Res Unit Parasitol & Parasite Ecol, Abidjan, Cote Ivoire; [N'Goran, Eliezer] Univ Cocody, Unite Format & Rech Biosci, Abidjan, Cote Ivoire	University of Hamburg; University Medical Center Hamburg-Eppendorf; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Kwame Nkrumah University Science & Technology; Bernhard Nocht Institut fur Tropenmedizin; Bernhard Nocht Institut fur Tropenmedizin; Kwame Nkrumah University Science & Technology; Kwame Nkrumah University Science & Technology	Ehrhardt, S (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, Baltimore, MD 21205 USA.	sehrhard@jhsph.edu	Mohammed, Yasmin/AAY-1391-2021; Eberhardt, Kirsten/AAP-8440-2021; Feldt, Torsten/ABF-5894-2021; Tagbor, Harry/B-9312-2018; Ehrhardt, Stephan/D-8957-2017; Nguah, Samuel/AAQ-9725-2020; Hahn, Andreas/AAV-3364-2020	Mohammed, Yasmin/0000-0002-3561-3945; Eberhardt, Kirsten/0000-0002-1002-0326; Tagbor, Harry/0000-0002-9300-665X; Hahn, Andreas/0000-0002-5157-8369; Barthel, Dana/0000-0001-8779-2554	German Research Council (DFG) [EH 384/1-1]; Johns Hopkins Libraries Open Access Promotion Fund	German Research Council (DFG)(German Research Foundation (DFG)); Johns Hopkins Libraries Open Access Promotion Fund	Funding was provided by the German Research Council (DFG; grant EH 384/1-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The authors thank the Johns Hopkins Libraries Open Access Promotion Fund for sponsoring the cost for this publication.	ABIODUN OA, 1993, GEN HOSP PSYCHIAT, V15, P125, DOI 10.1016/0163-8343(93)90109-2; Adams SS, 2011, ACTA OBSTET GYN SCAN, V90, P1267, DOI 10.1111/j.1600-0412.2011.01204.x; Alderliesten ML, 2007, BJOG-INT J OBSTET GY, V114, P1232, DOI 10.1111/j.1471-0528.2007.01438.x; American Psychiatric Association, 1994, DIAGN STAT MAN MENT, V4th ed.; Andersson L, 2004, AM J EPIDEMIOL, V159, P872, DOI 10.1093/aje/kwh122; Ashdown-Lambert JR, 2005, J R SOC PROMO HEALTH, V125, P76, DOI 10.1177/146642400512500211; Berle JO, 2005, ARCH WOMEN MENT HLTH, V8, P181, DOI 10.1007/s00737-005-0090-z; Bindt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048396; Copper RL, 1996, AM J OBSTET GYNECOL, V175, P1286, DOI 10.1016/S0002-9378(96)70042-X; Ferri CP, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-209; Fisher J, 2012, B WORLD HEALTH ORGAN, V90, P139, DOI 10.2471/BLT.11.091850; Goldenberg RL, 2008, LANCET, V371, P75, DOI 10.1016/S0140-6736(08)60074-4; Greenland S, 2001, ANNU REV PUBL HEALTH, V22, P189, DOI 10.1146/annurev.publhealth.22.1.189; Grote NK, 2010, ARCH GEN PSYCHIAT, V67, P1012, DOI 10.1001/archgenpsychiatry.2010.111; Guo N, 2013, AM J EPIDEMIOL, V178, P1394, DOI 10.1093/aje/kwt142; Hanlon C, 2009, TROP MED INT HEALTH, V14, P156, DOI 10.1111/j.1365-3156.2008.02198.x; Johnson RC, 2003, J PSYCHOSOM OBST GYN, V24, P1, DOI 10.3109/01674820309042796; Katon WJ, 2012, GEN HOSP PSYCHIAT, V34, P9, DOI 10.1016/j.genhosppsych.2011.09.018; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Leitner Y, 2007, J CHILD NEUROL, V22, P580, DOI 10.1177/0883073807302605; Leung BMY, 2009, J AM DIET ASSOC, V109, P1566, DOI 10.1016/j.jada.2009.06.368; Littleton HL, 2007, AM J OBSTET GYNECOL, V196, P424, DOI 10.1016/j.ajog.2007.03.042; Lobel M, 2008, HEALTH PSYCHOL, V27, P604, DOI 10.1037/a0013242; Meades R, 2011, J AFFECT DISORDERS, V133, P1, DOI 10.1016/j.jad.2010.10.009; Nasreen HE, 2010, BMC PUBLIC HEALTH, V10, DOI 10.1186/1471-2458-10-515; Nkyekyer K, 2006, Ghana Med J, V40, P93; O'Keane V, 2007, BMJ-BRIT MED J, V334, P1003, DOI 10.1136/bmj.39189.662581.55; Orr ST, 2002, AM J EPIDEMIOL, V156, P797, DOI 10.1093/aje/kwf131; Orr ST, 2007, PSYCHOSOM MED, V69, P566, DOI 10.1097/PSY.0b013e3180cac25d; Owusu-Dabo E, 2009, TOB CONTROL, V18, P206, DOI 10.1136/tc.2009.030601; Patel V, 2006, BRIT J PSYCHIAT, V188, P284, DOI 10.1192/bjp.bp.105.012096; Rahman A, 2007, ACTA PSYCHIAT SCAND, V115, P481, DOI 10.1111/j.1600-0447.2006.00950.x; Ross LE, 2006, J CLIN PSYCHIAT, V67, P1285, DOI 10.4088/JCP.v67n0818; Ruiz RJ, 2003, OBSTET GYNECOL SURV, V58, P415, DOI 10.1097/00006254-200306000-00025; Saigal S, 2008, LANCET, V371, P261, DOI 10.1016/S0140-6736(08)60136-1; Sawyer A, 2010, J AFFECT DISORDERS, V123, P17, DOI 10.1016/j.jad.2009.06.027; Simen-Kapeu A, 2009, CANCER CAUSE CONTROL, V20, P163, DOI 10.1007/s10552-008-9230-x; Simmons LE, 2010, SEMIN PERINATOL, V34, P408, DOI 10.1053/j.semperi.2010.09.005; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; STEER RA, 1992, J CLIN EPIDEMIOL, V45, P1093, DOI 10.1016/0895-4356(92)90149-H; Suri R, 2007, AM J PSYCHIAT, V164, P1206, DOI 10.1176/appi.ajp.2007.06071172; UNICEF, 2004, LOW BIRTHW COUNTR RE; Wadhwa PD, 2011, CLIN PERINATOL, V38, P351, DOI 10.1016/j.clp.2011.06.007; Weobong B, 2009, J AFFECT DISORDERS, V113, P109, DOI 10.1016/j.jad.2008.05.009; Zhu P, 2010, AM J OBSTET GYNECOL, V203, DOI 10.1016/j.ajog.2010.02.023	46	29	30	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80711	10.1371/journal.pone.0080711	http://dx.doi.org/10.1371/journal.pone.0080711			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260460	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500168
J	Brew-Appiah, RAT; Ankrah, N; Liu, WG; Konzak, CF; von Wettstein, D; Rustgi, S				Brew-Appiah, Rhoda A. T.; Ankrah, Nii; Liu, Weiguo; Konzak, Calvin F.; von Wettstein, Diter; Rustgi, Sachin			Generation of Doubled Haploid Transgenic Wheat Lines by Microspore Transformation	PLOS ONE			English	Article							TRITICUM-AESTIVUM L.; GENETIC-TRANSFORMATION; ANTHER CULTURE; BETA-GLUCURONIDASE; BARLEY; DNA; PLANTS; EMBRYOGENESIS; FERTILE; IDENTIFICATION	Microspores can be induced to develop homozygous doubled haploid plants in a single generation. In the present experiments androgenic microspores of wheat have been genetically transformed and developed into mature homozygous transgenic plants. Two different transformation techniques were investigated, one employing electroporation and the other co-cultivation with Agrobacterium tumefaciens. Different tissue culture and transfection conditions were tested on nine different wheat cultivars using four different constructs. A total of 19 fertile transformants in five genotypes from four market classes of common wheat were recovered by the two procedures. PCR followed by DNA sequencing of the products, Southern blot analyses and bio/histo-chemical and histological assays of the recombinant enzymes confirmed the presence of the transgenes in the T-0 transformants and their stable inheritance in homozygous T-1:2 doubled haploid progenies. Several decisive factors determining the transformation and regeneration efficiency with the two procedures were determined: (i) pretreatment of immature spikes with CuSO4 solution (500 mg/L) at 4 degrees C for 10 days; (ii) electroporation of plasmid DNA in enlarged microspores by a single pulse of similar to 375 V; (iii) induction of microspores after transfection at 28 degrees C in NPB-99 medium and regeneration at 26 degrees C in MMS5 medium; (iv) co-cultivation with Agrobacterium AGL-1 cells for transfer of plasmid T-DNA into microspores at day 0 for <24 hours; and (v) elimination of AGL-1 cells after co-cultivation with timentin (200-400 mg/L).	[Brew-Appiah, Rhoda A. T.; Ankrah, Nii; Liu, Weiguo; Konzak, Calvin F.; von Wettstein, Diter; Rustgi, Sachin] Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA; [Liu, Weiguo] Pioneer HiBred Int Inc, Doubled Haploid Lab, Waipahu, HI USA; [von Wettstein, Diter] Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA; [von Wettstein, Diter] Washington State Univ, Ctr Reprod Biol, Pullman, WA 99164 USA	Washington State University; DuPont; Washington State University; Washington State University	von Wettstein, D (corresponding author), Washington State Univ, Dept Crop & Soil Sci, Pullman, WA 99164 USA.	diter@wsu.edu; rustgi@wsu.edu	Rustgi, Sachin/AAF-5590-2020; Brew-Appiah, Rhoda Araba Tawiah/N-9817-2019	Brew-Appiah, Rhoda Araba Tawiah/0000-0003-2123-0828; Rustgi, Sachin/0000-0002-6881-9501	National Institutes of Health Grant [1R01GM080749-01A2]; Life Sciences Discovery Fund Grant [3143956]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080749] Funding Source: NIH RePORTER	National Institutes of Health Grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Life Sciences Discovery Fund Grant; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This project was supported in part by the National Institutes of Health Grant 1R01GM080749-01A2 and the Life Sciences Discovery Fund Grant 3143956. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bahieldin A, 2005, PLANT CELL TISS ORG, V82, P11, DOI 10.1007/s11240-004-5890-8; Barcelo P, 1998, TRANSGENIC PLANT RESEARCH, P35; BARCLAY IR, 1975, NATURE, V256, P410, DOI 10.1038/256410a0; BarnabSSs B., 2003, DOUBLED HAPLOID PROD, P65, DOI 10.1007/978-94-017-1293-4_11; Brisibe EA, 2000, J EXP BOT, V51, P187, DOI 10.1093/jexbot/51.343.187; Chauhan H, 2011, PLANT BIOTECHNOL J, V9, P408, DOI 10.1111/j.1467-7652.2010.00561.x; Cheng M, 1997, PLANT PHYSIOL, V115, P971, DOI 10.1104/pp.115.3.971; Dong JJ, 2001, MOL BREEDING, V7, P187, DOI 10.1023/A:1011357709073; Eudes F, 2003, PLANT CELL TISS ORG, V73, P147, DOI 10.1023/A:1022800512708; FELDMANN KA, 1991, PLANT J, V1, P71, DOI 10.1111/j.1365-313X.1991.00071.x; FENNELL A, 1992, PLANT CELL REP, V11, P567, DOI 10.1007/BF00233094; Folling L, 2001, PLANT CELL REP, V20, P629, DOI 10.1007/s002990100371; Gharanjik Shahrokh, 2008, Iranian Journal of Biotechnology, V6, P207; Haliloglu K., 2002, Ziraat Fakultesi Dergisi, Ataturk Universitesi, V33, P413; Hansen G, 1997, P NATL ACAD SCI USA, V94, P11726, DOI 10.1073/pnas.94.21.11726; Horvath H, 2000, P NATL ACAD SCI USA, V97, P1914, DOI 10.1073/pnas.030527497; Horvath H, 2002, BARLEY SCI RECENT AD, P143; Hu H., 1997, IN VITRO HAPLOID PRO, V4, P73, DOI [10.1111/j.1399-3054.1962.tb08052.x, DOI 10.1111/J.1399-3054.1962.TB08052.X978-94-017-1862-2]; Hu T, 1997, PLANT CELL REP, V16, P520, DOI [10.1007/s002990050271, 10.1007/BF01142316]; Hu TC, 1999, GENOME, V42, P432, DOI 10.1139/gen-42-3-432; Indrianto A, 2001, PLANTA, V212, P163, DOI 10.1007/s004250000375; Irish VF, 1991, CURR OPIN GENET DEV, V1, P169, DOI 10.1016/S0959-437X(05)80065-6; Jacquard C, 2009, PLANTA, V229, P393, DOI 10.1007/s00425-008-0838-6; JARDINAUD MF, 1995, PLANT CELL REP, V15, P55, DOI 10.1007/BF01690253; JOERSBO M, 1990, PLANT CELL TISS ORG, V23, P125, DOI 10.1007/BF00035832; KASHA KJ, 2003, DOUBLED HAPLOID PROD, P77, DOI DOI 10.1007/978-94-017-1293-4_13; KLEINHOFS A, 1993, THEOR APPL GENET, V86, P705, DOI 10.1007/BF00222660; Kohl EA, 2003, THESIS WASHINGTON ST, P36; Kumar M, 2004, THESIS U IDAHO MOSCO; Kumlehn J, 2006, PLANT BIOTECHNOL J, V4, P251, DOI 10.1111/j.1467-7652.2005.00178.x; Kumlehn J, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P295, DOI 10.1007/978-1-4020-8854-4_24; LAURIE DA, 1988, THEOR APPL GENET, V76, P393, DOI 10.1007/BF00265339; LAURIE DA, 1988, PLANT BREEDING, V100, P73, DOI 10.1111/j.1439-0523.1988.tb00220.x; Lee H, 2011, P NATL ACAD SCI USA, V108, P8909, DOI 10.1073/pnas.1105612108; Li BC, 2009, PLANT CELL REP, V28, P373, DOI 10.1007/s00299-008-0640-8; LINDSEY K, 1993, TRANSGENIC RES, V2, P33, DOI 10.1007/BF01977679; LINSMAIER EM, 1965, PHYSIOL PLANTARUM, V18, P100, DOI 10.1111/j.1399-3054.1965.tb06874.x; Liu W, 2002, PLANT CELL REP, V20, P821, DOI 10.1007/s00299-001-0408-x; Liu WG, 2002, CROP SCI, V42, P686, DOI 10.2135/cropsci2002.0686; Maraschin SD, 2005, PLANTA, V220, P531, DOI 10.1007/s00425-004-1371-x; Maraschin SD, 2003, J EXP BOT, V54, P1033, DOI 10.1093/jxb/erg098; Maraschin SF, 2005, J EXP BOT, V56, P1711, DOI 10.1093/jxb/eri190; Massiah A, 2001, MOL BREEDING, V7, P163, DOI 10.1023/A:1011308916226; MCCABE DE, 1988, BIO-TECHNOL, V6, P923, DOI 10.1038/nbt0888-923; Mentewab A, 1999, CEREAL RES COMMUN, V27, P17; NAVARROALVAREZ W, 1994, PLANT BREEDING, V112, P192, DOI 10.1111/j.1439-0523.1994.tb00670.x; Obert B, 2004, MAYDICA, V49, P15; OUYANG JW, 1973, SCI SINICA, V16, P79; Pedersen C, 1997, THEOR APPL GENET, V94, P749, DOI 10.1007/s001220050474; Pellegrineschi A, 2002, GENOME, V45, P421, DOI 10.1139/G01-154; Resch T., 2011, Plant transformation technologies, P83; Sa-Pereira P, 2002, J BIOTECHNOL, V94, P265, DOI 10.1016/S0168-1656(01)00436-9; Sharma AK., 1980, CHROMOSOME TECHNIQUE, Vthird ed.; Simonson R. L., 1997, Journal of Applied Genetics, V38, P381; Sorensen MB, 1996, MOL GEN GENET, V250, P750, DOI 10.1007/BF02172987; Stahl R, 2002, P NATL ACAD SCI USA, V99, P2146, DOI 10.1073/pnas.032645299; Stober A, 1997, PLANT BREEDING, V116, P443, DOI 10.1111/j.1439-0523.1997.tb01028.x; Svitashev S, 2000, THEOR APPL GENET, V100, P872, DOI 10.1007/s001220051364; Torp AM, 2009, ADVANCES IN HAPLOID PRODUCTION IN HIGHER PLANTS, P155, DOI 10.1007/978-1-4020-8854-4_12; Touraev A, 1997, TRENDS PLANT SCI, V2, P297, DOI 10.1016/S1360-1385(97)89951-7; Touraev A, 2001, ADV BOT RES, V35, P53, DOI 10.1016/S0065-2296(01)35004-8; Touraev A, 1996, SEX PLANT REPROD, V9, P209, DOI 10.1007/BF02173100; VASIL V, 1993, BIO-TECHNOL, V11, P1553, DOI 10.1038/nbt1293-1553; VASIL V, 1992, BIO-TECHNOL, V10, P667, DOI 10.1038/nbt0692-667; Zheng MY, 2002, PLANT CELL REP, V20, P802, DOI 10.1007/s00299-001-0411-2; Zheng MY, 2003, DOUBLED HAPLOID PROD, P83; Zhou H, 2003, CROP SCI, V43, P1072, DOI 10.2135/cropsci2003.1072; Zhou H., 1997, Journal of Applied Genetics, V38, P393; Ziemienowicz A, 2012, PLANT PHYSIOL, V158, P1503, DOI 10.1104/pp.111.192856	69	34	35	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80155	10.1371/journal.pone.0080155	http://dx.doi.org/10.1371/journal.pone.0080155			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260351	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500118
J	Gaytan, BD; Loguinov, AV; Penate, X; Lerot, JM; Chavez, S; Denslow, ND; Vulpe, CD				Gaytan, Brandon D.; Loguinov, Alex V.; Penate, Xenia; Lerot, Jan-Michael; Chavez, Sebastian; Denslow, Nancy D.; Vulpe, Chris D.			A Genome-Wide Screen Identifies Yeast Genes Required for Tolerance to Technical Toxaphene, an Organochlorinated Pesticide Mixture	PLOS ONE			English	Article							MESSENGER-RNA EXPORT; ADENOSINE-TRIPHOSPHATASE ACTIVITIES; TRANSCRIPTION-COUPLED REPAIR; SACCHAROMYCES-CEREVISIAE; POLYMERASE-II; IN-VIVO; ELONGATION; COMPLEX; INHIBITION; RESISTANCE	Exposure to toxaphene, an environmentally persistent mixture of chlorinated terpenes previously utilized as an insecticide, has been associated with various cancers and diseases such as amyotrophic lateral sclerosis. Nevertheless, the cellular and molecular mechanisms responsible for these toxic effects have not been established. In this study, we used a functional approach in the model eukaryote Saccharomyces cerevisiae to demonstrate that toxaphene affects yeast mutants defective in (1) processes associated with transcription elongation and (2) nutrient utilization. Synergistic growth defects are observed upon exposure to both toxaphene and the known transcription elongation inhibitor mycophenolic acid (MPA). However, unlike MPA, toxaphene does not deplete nucleotides and additionally has no detectable effect on transcription elongation. Many of the yeast genes identified in this study have human homologs, warranting further investigations into the potentially conserved mechanisms of toxaphene toxicity.	[Gaytan, Brandon D.; Loguinov, Alex V.; Lerot, Jan-Michael; Vulpe, Chris D.] Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA; [Penate, Xenia; Chavez, Sebastian] Univ Seville, Dept Genet, Seville, Spain; [Penate, Xenia; Chavez, Sebastian] Univ Seville, Inst Biomed Sevilla, Hosp Univ Virgen del Rocio, CSIC, Seville, Spain; [Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Gainesville, FL 32610 USA; [Denslow, Nancy D.] Univ Florida, Ctr Environm & Human Toxicol, Gainesville, FL USA	University of California System; University of California Berkeley; University of Sevilla; Consejo Superior de Investigaciones Cientificas (CSIC); University of Sevilla; CSIC-JA-USE - Instituto de Biomedicina de Sevilla (IBIS); Virgen del Rocio University Hospital; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Gaytan, BD (corresponding author), Univ Calif Berkeley, Dept Nutr Sci & Toxicol, Berkeley, CA 94720 USA.	vulpe@berkeley.edu	Chavez, Sebastian S/F-7574-2011; Vulpe, Chris/AAF-9170-2020; Penate, Xenia/F-5692-2016; IBIS, GENICA/O-1906-2015; Chávez, Sebastián/GXF-7069-2022	Chavez, Sebastian S/0000-0002-8064-4839; Vulpe, Chris/0000-0001-5134-8929; Penate, Xenia/0000-0002-4117-888X; 	National Institute of Environmental Health Sciences Superfund Research Program [P42ES004705]; Spanish Ministerio de Ciencia e Innovacion [BFU2010-21975-C03-02]; Junta de Andalucia [P07-CVI02623, P08-CVI-03508]; European Union; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES004705] Funding Source: NIH RePORTER	National Institute of Environmental Health Sciences Superfund Research Program; Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); Junta de Andalucia(Junta de Andalucia); European Union(European Commission); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by the National Institute of Environmental Health Sciences Superfund Research Program (http://www.niehs.nih.gov/) [grant numbers P42ES004705 awarded to Martyn T. Smith, CDV is leader on Project 2], and the Spanish Ministerio de Ciencia e Innovacion (BFU2010-21975-C03-02) and Junta de Andalucia (P07-CVI02623; P08-CVI-03508), involving European Regional Development Fund resources from the European Union, to SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agency for Toxic Substances and Disease Registry (ATSDR), 2010, TOX PROF TOX; Blackman RK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029798; BOYD EM, 1971, TOXICOL APPL PHARM, V18, P158, DOI 10.1016/0041-008X(71)90325-5; Chavez S, 2000, EMBO J, V19, P5824, DOI 10.1093/emboj/19.21.5824; de Geus HJ, 1999, ENVIRON HEALTH PERSP, V107, P115, DOI 10.2307/3434478; DENISDUPHIL M, 1989, BIOCHEM CELL BIOL, V67, P612, DOI 10.1139/o89-094; Desmoucelles C, 2002, J BIOL CHEM, V277, P27036, DOI 10.1074/jbc.M111433200; Ding BJ, 2010, J BIOL CHEM, V285, P5317, DOI 10.1074/jbc.M109.082818; dos Santos SC, 2012, FRONT GENET, V3; ELBEIN AD, 1981, TRENDS BIOCHEM SCI, V6, P219, DOI 10.1016/0968-0004(81)90080-3; EXINGER F, 1992, CURR GENET, V22, P9, DOI 10.1007/BF00351735; Fischer T, 2002, EMBO J, V21, P5843, DOI 10.1093/emboj/cdf590; Gaillard H, 2007, NUCLEIC ACIDS RES, V35, P3893, DOI 10.1093/nar/gkm373; Gaillard H, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000364; Gaytan BD, 2013, TOXICOL SCI, V132, P347, DOI 10.1093/toxsci/kft018; Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935; Hedstrom L, 2009, CHEM REV, V109, P2903, DOI 10.1021/cr900021w; Hyle JW, 2003, J BIOL CHEM, V278, P28470, DOI 10.1074/jbc.M303736200; Jo WJ, 2009, TOXICOL SCI, V111, P424, DOI 10.1093/toxsci/kfp162; Jo WJ, 2009, TOXICOL APPL PHARM, V241, P294, DOI 10.1016/j.taap.2009.08.027; Kamel F, 2012, NEUROTOXICOLOGY, V33, P457, DOI 10.1016/j.neuro.2012.04.001; Kaplan CD, 2013, BBA-GENE REGUL MECH, V1829, P39, DOI 10.1016/j.bbagrm.2012.09.007; Lei EP, 2003, MOL BIOL CELL, V14, P836, DOI 10.1091/mbc.E02-08-0520; Martyniuk CJ, 2009, AQUAT TOXICOL, V95, P1, DOI 10.1016/j.aquatox.2009.06.009; Mason PB, 2005, MOL CELL, V17, P831, DOI 10.1016/j.molcel.2005.02.017; Mills PK, 2005, CANCER CAUSE CONTROL, V16, P823, DOI 10.1007/s10552-005-2703-2; Morillo-Huesca M, 2006, FEBS J, V273, P756, DOI 10.1111/j.1742-4658.2005.05108.x; MOURELLE M, 1985, J APPL TOXICOL, V5, P39, DOI 10.1002/jat.2550050108; National Toxicology Program (NTP), 2011, REP CARC; North M, 2010, INT J MOL SCI, V11, P4796, DOI 10.3390/ijms11124796; Purdue MP, 2007, INT J CANCER, V120, P642, DOI 10.1002/ijc.22258; Robinson MD, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-35; Rodriguez-Gil A, 2010, NUCLEIC ACIDS RES, V38, P4651, DOI 10.1093/nar/gkq215; Saguez C, 2008, MOL CELL, V31, P91, DOI 10.1016/j.molcel.2008.04.030; Sanchez BC, 2011, J APPL TOXICOL, V31, P108, DOI 10.1002/jat.1553; Sanchez BC, 2009, AQUAT TOXICOL, V95, P52, DOI 10.1016/j.aquatox.2009.08.002; Schroeder JC, 2001, EPIDEMIOLOGY, V12, P701, DOI 10.1097/00001648-200111000-00020; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shaw RJ, 2000, MOL CELL BIOL, V20, P7427, DOI 10.1128/MCB.20.20.7427-7437.2000; Skrtic M, 2011, CANCER CELL, V20, P674, DOI 10.1016/j.ccr.2011.10.015; Steinmetz LM, 2002, NAT GENET, V31, P400, DOI 10.1038/ng929; Strasser K, 2002, NATURE, V417, P304, DOI 10.1038/nature746; TROTTMAN CH, 1979, J ENVIRON SCI HEAL B, V14, P393, DOI 10.1080/03601237909372137; TROTTMAN CH, 1985, LIFE SCI, V36, P427, DOI 10.1016/0024-3205(85)90254-1; Woo S, 2011, COMP BIOCHEM PHYS C, V153, P355, DOI 10.1016/j.cbpc.2010.12.006	45	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81253	10.1371/journal.pone.0081253	http://dx.doi.org/10.1371/journal.pone.0081253			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260565	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500203
J	Kwon, I; Hong, SY; Kim, YD; Nam, HS; Kang, S; Yang, SH; Heo, JH				Kwon, Il; Hong, Sung-Yu; Kim, Young Dae; Nam, Hyo Suk; Kang, Sungsoo; Yang, Seung-Hee; Heo, Ji Hoe			Thrombolytic Effects of the Snake Venom Disintegrin Saxatilin Determined by Novel Assessment Methods: A FeCl3-Induced Thrombosis Model in Mice	PLOS ONE			English	Article							TISSUE-PLASMINOGEN ACTIVATOR; ARTERIAL THROMBOSIS; STROKE; INTEGRINS; TIROFIBAN; ABCIXIMAB; ADHESION; BINDING; RECANALIZATION; INTRAARTERIAL	Saxatilin, a novel disintegrin purified and cloned from the venom of the Korean snake Gloydius saxatilis, strongly inhibits activation and aggregation of platelets. Glycoprotein (GP) IIb/IIIa receptor antagonists can resolve thrombus, so saxatilin might also have thrombolytic effects. We investigated the thrombolytic effects of saxatilin in mice using a ferric chloride-induced carotid arterial thrombosis model. Thrombotic occlusion and thrombus resolution were evaluated quantitatively by measuring blood flow in the carotid artery with an ultrasonic flow meter and calculating the degree of flow restoration on a minute-by-minute basis; results were confirmed by histological examination. Saxatilin dissolved thrombi in a dose-dependent manner. Saxatilin at 5 mg/kg restored blood flow to baseline levels. As saxatilin dose increased, time to recanalization decreased. A bolus injection of 10% of a complete dose with continuous infusion of the remaining dose for 60 minutes resulted in effective recanalization without reocclusion. The thrombolytic effect of saxatilin was also demonstrated in vitro using platelet aggregometry by administering saxatilin in preformed thrombi. Bleeding complications were observed in 2 of 71 mice that received saxatilin. Fibrin/fibrinogen zymography and platelet aggregometry studies indicated that saxatilin does not have fibrinolytic activity, but exerted its action on platelets. Integrin-binding assays showed that saxatilin inhibited multiple integrins, specifically alpha(2b)beta(3) (GP IIb/IIIa), alpha(5)beta(1), alpha(v)beta(3), alpha(v)beta(1), and alpha(v)beta(5), which act on platelet adhesion/aggregation. Saxatilin inhibited multiple integrins by acting on platelets, and was safe and effective in resolving thrombi in mice.	[Kwon, Il; Kim, Young Dae; Nam, Hyo Suk; Yang, Seung-Hee; Heo, Ji Hoe] Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea; [Kwon, Il; Hong, Sung-Yu; Kim, Young Dae; Nam, Hyo Suk; Kang, Sungsoo; Yang, Seung-Hee; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Integrat Res Inst Cerebral & Cardiovasc, Seoul, South Korea; [Kwon, Il; Heo, Ji Hoe] Yonsei Univ, Coll Med, Severance Biomed Sci Inst, Seoul, South Korea; [Hong, Sung-Yu; Kang, Sungsoo] Yonsei Univ, Coll Med, Cardiovasc Prod Evaluat Ctr, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Heo, JH (corresponding author), Yonsei Univ, Coll Med, Dept Neurol, Seoul, South Korea.	jhheo@yuhs.ac		Kwon, Il/0000-0001-9449-5646; NAM, HYO SUK/0000-0002-4415-3995; Heo, Ji Hoe/0000-0001-9898-3321; Kim, Young Dae/0000-0001-5750-2616	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea [A085136]	Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea	This work was supported by a grant from the Korea Health 21 R&D Project, Ministry of Health & Welfare, Republic of Korea (A085136). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abou-Chebl A, 2005, STROKE, V36, P2286, DOI 10.1161/01.STR.0000179043.73314.4f; Chen HS, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-88; Chopp M, 1999, ACT NEUR S, V73, P67; Eckert B, 2005, STROKE, V36, P1160, DOI 10.1161/01.STR.0000165918.80812.1e; Eckly A, 2011, J THROMB HAEMOST, V9, P779, DOI 10.1111/j.1538-7836.2011.04218.x; Eliceiri BP, 2002, J CELL BIOL, V157, P149, DOI 10.1083/jcb.200109079; Gruner S, 2003, BLOOD, V102, P4021, DOI 10.1182/blood-2003-05-1391; Hacke W, 2008, NEW ENGL J MED, V359, P1317, DOI 10.1056/NEJMoa0804656; Hacke W, 2009, LANCET NEUROL, V8, P141, DOI 10.1016/S1474-4422(08)70267-9; Heo JH, 2003, NEUROLOGY, V60, P1684, DOI 10.1212/01.WNL.0000063323.23493.98; Heo JH, 1999, J CEREBR BLOOD F MET, V19, P624, DOI 10.1097/00004647-199906000-00005; Hong SY, 2002, THROMB RES, V105, P79, DOI 10.1016/S0049-3848(01)00416-9; Hong SY, 2002, BIOCHEM BIOPH RES CO, V293, P530, DOI 10.1016/S0006-291X(02)00258-9; Jang YJ, 2007, J VASC RES, V44, P129, DOI 10.1159/000098519; Konstantinides S, 2001, CIRCULATION, V103, P576, DOI 10.1161/01.CIR.103.4.576; KORNINGER C, 1981, THROMB HAEMOSTASIS, V46, P561; Kroll MH, 1996, BLOOD, V88, P1525; KURZ KD, 1990, THROMB RES, V60, P269, DOI 10.1016/0049-3848(90)90106-M; Kwon I, 2009, J NEUROSCI RES, V87, P668, DOI 10.1002/jnr.21877; Lee KY, 2001, NEUROLOGY, V56, P1585, DOI 10.1212/WNL.56.11.1585; Lee KY, 2007, STROKE, V38, P192, DOI 10.1161/01.STR.0000251788.03914.00; Lees KR, 2010, LANCET, V375, P1695, DOI 10.1016/S0140-6736(10)60491-6; LILIOM K, 1991, J IMMUNOL METHODS, V143, P119, DOI 10.1016/0022-1759(91)90280-S; Lu X, 2006, CURR PHARM DESIGN, V12, P2749, DOI 10.2174/138161206777947713; Marder VJ, 2010, STROKE, V41, pS45, DOI 10.1161/STROKEAHA.110.595157; Medcalf RL, 2012, INT J STROKE, V7, P419, DOI 10.1111/j.1747-4949.2012.00783.x; Moser M, 2003, J CARDIOVASC PHARM, V41, P586, DOI 10.1097/00005344-200304000-00011; Murray V, 2010, J INTERN MED, V267, P191, DOI 10.1111/j.1365-2796.2009.02205.x; Ni HY, 2003, TRANSFUS APHER SCI, V28, P257, DOI 10.1016/S1473-0502(03)00044-2; Niessen F, 2002, STROKE, V33, P2999, DOI 10.1161/01.STR.0000038096.60932.F4; Orosz F, 2002, J IMMUNOL METHODS, V270, P155, DOI 10.1016/S0022-1759(02)00295-8; PHILLIPS DR, 1988, BLOOD, V71, P831; Podolnikova NP, 2003, J BIOL CHEM, V278, P32251, DOI 10.1074/jbc.M300410200; Rha JH, 2007, STROKE, V38, P967, DOI 10.1161/01.STR.0000258112.14918.24; Seitz RJ, 2004, NEUROLOGY, V62, P2110, DOI 10.1212/01.WNL.0000129480.17345.4A; Seitz RJ, 2003, STROKE, V34, P1932, DOI 10.1161/01.STR.0000080535.61188.A6; Sohn YD, 2008, TOXICON, V51, P406, DOI 10.1016/j.toxicon.2007.10.019; Sugimori T, 1997, KIDNEY INT, V51, P1454, DOI 10.1038/ki.1997.199; Thijs VNS, 2009, STROKE, V40, P3789, DOI 10.1161/STROKEAHA.109.560201; Wang XK, 2005, THROMB RES, V115, P95, DOI 10.1016/j.thromres.2004.07.009; Wang YMF, 1998, NAT MED, V4, P228, DOI 10.1038/nm0298-228; Yee KO, 1998, CIRC RES, V83, P241, DOI 10.1161/01.RES.83.3.241	42	19	22	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81165	10.1371/journal.pone.0081165	http://dx.doi.org/10.1371/journal.pone.0081165			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260554	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500198
J	Mulder, MJ; van Maanen, L				Mulder, Martijn J.; van Maanen, Leendert			Are Accuracy and Reaction Time Affected via Different Processes?	PLOS ONE			English	Article							DIFFUSION-MODEL ANALYSIS; DECISION-MAKING; PRIOR PROBABILITY; NEURAL BASIS; TASK; SPEED; MECHANISMS; ACCOUNT; BRAIN; BIAS	A recent study by van Ede et al. (2012) shows that the accuracy and reaction time in humans of tactile perceptual decisions are affected by an attentional cue via distinct cognitive and neural processes. These results are controversial as they undermine the notion that accuracy and reaction time are influenced by the same latent process that underlie the decision process. Typically, accumulation-to-bound models (like the drift diffusion model) can explain variability in both accuracy and reaction time by a change of a single parameter. To elaborate the findings of van Ede et al., we fitted the drift diffusion model to their behavioral data. Results show that both changes in accuracy and reaction time can be partly explained by an increase in the accumulation of sensory evidence (drift rate). In addition, a change in non-decision time is necessary to account for reaction time changes as well. These results provide a subtle explanation of how the underlying dynamics of the decision process might give rise to differences in both the speed and accuracy of perceptual tactile decisions. Furthermore, our analyses highlight the importance of applying a model-based approach, as the observed changes in the model parameters might be ecologically more valid, since they have an intuitive relationship with the neuronal processes underlying perceptual decision making.	[Mulder, Martijn J.; van Maanen, Leendert] Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands; [Mulder, Martijn J.; van Maanen, Leendert] Univ Amsterdam, Dept Psychol Methods, Amsterdam, Netherlands	University of Amsterdam; University of Amsterdam	Mulder, MJ (corresponding author), Univ Amsterdam, Cognit Sci Ctr Amsterdam, Amsterdam, Netherlands.	m.j.mulder@uva.nl	Van Maanen, Leendert/Z-5637-2019	Van Maanen, Leendert/0000-0001-9120-1075; Mulder, Martijn/0000-0001-9640-4322	Dutch organization for scientific research (NWO)	Dutch organization for scientific research (NWO)(Netherlands Organization for Scientific Research (NWO))	This study was supported by the Dutch organization for scientific research (NWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bogacz R, 2006, PSYCHOL REV, V113, P700, DOI 10.1037/0033-295X.113.4.700; Brown SD, 2008, COGNITIVE PSYCHOL, V57, P153, DOI 10.1016/j.cogpsych.2007.12.002; Diederich A, 2006, PERCEPT PSYCHOPHYS, V68, P194, DOI 10.3758/BF03193669; Forstmann BU, 2011, TRENDS COGN SCI, V15, P272, DOI 10.1016/j.tics.2011.04.002; Gold JI, 2007, ANNU REV NEUROSCI, V30, P535, DOI 10.1146/annurev.neuro.29.051605.113038; Hanks TD, 2011, J NEUROSCI, V31, P6339, DOI 10.1523/JNEUROSCI.5613-10.2011; Heekeren HR, 2008, NAT REV NEUROSCI, V9, P467, DOI 10.1038/nrn2374; Heitz RP, 2012, NEURON, V76, P616, DOI 10.1016/j.neuron.2012.08.030; Hommel B, 1998, J EXP PSYCHOL HUMAN, V24, P1368, DOI 10.1037/0096-1523.24.5.1368; Liu YS, 2008, NEURAL COMPUT, V20, P345, DOI 10.1162/neco.2007.08-06-313; Missenard O, 2011, NEUROSCIENCE, V197, P233, DOI 10.1016/j.neuroscience.2011.09.020; Mulder MJ, 2012, J NEUROSCI, V32, P2335, DOI 10.1523/JNEUROSCI.4156-11.2012; NELDER JA, 1965, COMPUT J, V7, P308, DOI 10.1093/comjnl/7.4.308; Palmer J, 2005, J VISION, V5, P376, DOI 10.1167/5.5.1; PASHLER H, 1994, PSYCHOL BULL, V116, P220, DOI 10.1037/0033-2909.116.2.220; Pouget P, 2011, J NEUROSCI, V31, P12604, DOI 10.1523/JNEUROSCI.1868-11.2011; RATCLIFF R, 1985, PSYCHOL REV, V92, P212, DOI 10.1037/0033-295X.92.2.212; RATCLIFF R, 1978, PSYCHOL REV, V85, P59, DOI 10.1037//0033-295X.85.2.59; Ratcliff R, 2008, NEURAL COMPUT, V20, P873, DOI 10.1162/neco.2008.12-06-420; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sigman M, 2008, J NEUROSCI, V28, P7585, DOI 10.1523/JNEUROSCI.0948-08.2008; Smith PL, 2009, PSYCHOL REV, V116, P283, DOI 10.1037/a0015156; Smith PJ, 2004, SIGHT SOUND, V14, P44; Standage D, 2011, NEURAL NETWORKS, V24, P1062, DOI 10.1016/j.neunet.2011.05.004; van Ede F, 2012, J NEUROSCI, V32, P10408, DOI 10.1523/JNEUROSCI.1337-12.2012; van Maanen L, 2012, FRONT NEUROSCI, V5, P1; van Maanen L, 2012, COGNITIVE SCI, V36, P62, DOI 10.1111/j.1551-6709.2011.01213.x; van Ravenzwaaij D, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00132; Vandekerckhove J, 2008, BEHAV RES METHODS, V40, P61, DOI 10.3758/BRM.40.1.61; Voss A, 2004, MEM COGNITION, V32, P1206, DOI 10.3758/BF03196893; Wagenmakers EJ, 2004, PSYCHON B REV, V11, P192, DOI 10.3758/BF03206482; Wagenmakers EJ, 2008, J MEM LANG, V58, P140, DOI 10.1016/j.jml.2007.04.006; Wagenmakers EJ, 2008, PSYCHON B REV, V15, P1229, DOI 10.3758/PBR.15.6.1229; White CN, 2011, COGNITIVE PSYCHOL, V63, P210, DOI 10.1016/j.cogpsych.2011.08.001; Zylberberg A, 2012, CURR BIOL, V22, P1795, DOI 10.1016/j.cub.2012.07.043	35	22	22	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80222	10.1371/journal.pone.0080222	http://dx.doi.org/10.1371/journal.pone.0080222			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256KH	24260358	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500121
J	Barros, MHM; Hauck, F; Dreyer, JH; Kempkes, B; Niedobitek, G				Barros, Mario Henrique M.; Hauck, Franziska; Dreyer, Johannes H.; Kempkes, Bettina; Niedobitek, Gerald			Macrophage Polarisation: an Immunohistochemical Approach for Identifying M1 and M2 Macrophages	PLOS ONE			English	Article							TUMOR-ASSOCIATED MACROPHAGES; EPSTEIN-BARR-VIRUS; SCAVENGER RECEPTOR; HUMAN MONOCYTES; TRANSCRIPTION FACTOR; GENE-EXPRESSION; CD163; MICROENVIRONMENT; IDENTIFICATION; ACTIVATION	Macrophage polarization is increasingly recognised as an important pathogenetic factor in inflammatory and neoplastic diseases. Proinflammatory M1 macrophages promote T helper (Th) 1 responses and show tumoricidal activity. M2 macrophages contribute to tissue repair and promote Th2 responses. CD68 and CD163 are used to identify macrophages in tissue sections. However, characterisation of polarised macrophages in situ has remained difficult. Macrophage polarisation is regulated by transcription factors, pSTAT1 and RBP-J for M1, and CMAF for M2. We reasoned that double-labelling immunohistochemistry for the detection of macrophage markers together with transcription factors may be suitable to characterise macrophage polarisation in situ. To test this hypothesis, we have studied conditions associated with Th1- and Th2-predominant immune responses: infectious mononucleosis and Crohn's disease for Th1 and allergic nasal polyps, oxyuriasis, wound healing and foreign body granulomas for predominant Th2 response. In all situations, CD163+ cells usually outnumbered CD68+ cells. Moreover, CD163+ cells, usually considered as M2 macrophages, co-expressing pSTAT1 and RBP-J were found in all conditions examined. The numbers of putative M1 macrophages were higher in Th1-than in Th2-associated diseases, while more M2 macrophages were seen in Th2-than in Th1 related disorders. In most Th1-related diseases, the balance of M1 over M2 cells was shifted towards M1 cells, while the reverse was observed for Th2-related conditions. Hierarchical cluster analysis revealed two distinct clusters: cluster I included Th1 diseases together with cases with high numbers of CD163+pSTAT1+, CD68+pSTAT1+, CD163+RBP-J+ and CD68+RBP-J+ macrophages; cluster II comprised Th2 conditions together with cases displaying high numbers of CD163+CMAF+ and CD68+CMAF+ macrophages. These results suggest that the detection of pSTAT1, RBP-J, and CMAF in the context of CD68 or CD163 expression is a suitable tool for the characterisation of macrophage polarisation in situ. Furthermore, CD163 cannot be considered a reliable M2 marker when used on its own.	[Barros, Mario Henrique M.; Dreyer, Johannes H.; Niedobitek, Gerald] Unfallkrankenhaus, Inst Pathol, Berlin, Germany; [Hauck, Franziska] Sana Klinikum Lichtenberg, Inst Pathol, Berlin, Germany; [Kempkes, Bettina] Natl Res Ctr Environm Hlth, Helmholtz Zentrum, Dept Gene Vectors, Munich, Germany	Helmholtz Association; University of Munich	Barros, MHM (corresponding author), Unfallkrankenhaus, Inst Pathol, Berlin, Germany.	mario.barros@ukb.de	Kempkes, Bettina/B-3322-2013; Barros, Mario/G-1842-2014	Niedobitek, Gerald/0000-0003-4474-1882; Barros, Mario/0000-0001-6826-9565	Wilhelm Sander Foundation [2012.029.1]; Alexander von Humboldt Foundation	Wilhelm Sander Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation)	This work was supported by a grant from the Wilhelm Sander Foundation (2012.029.1). MB was supported by the Alexander von Humboldt Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barros MHM, 2012, CLIN CANCER RES, V18, P3762, DOI 10.1158/1078-0432.CCR-12-0129; Bonilla FA, 2010, J ALLERGY CLIN IMMUN, V125, pS33, DOI 10.1016/j.jaci.2009.09.017; Buechler C, 2000, J LEUKOCYTE BIOL, V67, P97, DOI 10.1002/jlb.67.1.97; Cao SJ, 2005, J IMMUNOL, V174, P3484, DOI 10.4049/jimmunol.174.6.3484; Chaplin DD, 2010, J ALLERGY CLIN IMMUN, V125, pS3, DOI 10.1016/j.jaci.2009.12.980; Crawford DH, 2001, PHILOS T R SOC B, V356, P461, DOI 10.1098/rstb.2000.0783; Deonarine K, 2007, J TRANSL MED, V5, DOI 10.1186/1479-5876-5-11; Edin S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047045; Gordon S, 2010, IMMUNITY, V32, P593, DOI 10.1016/j.immuni.2010.05.007; Hardison SE, 2012, J IMMUNOL, V189, P4060, DOI 10.4049/jimmunol.1103455; Herrera M, 2013, CANCER SCI, V104, P437, DOI 10.1111/cas.12096; Heusinkveld M, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-216; Hogger P, 1998, J IMMUNOL, V161, P1883; Ino Y, 2013, BRIT J CANCER, V108, P914, DOI 10.1038/bjc.2013.32; Janeway C., 2001, IMMUNOBIOLOGY, V5th; Kamper P, 2011, HAEMATOL-HEMATOL J, V96, P269, DOI 10.3324/haematol.2010.031542; Kato H, 1996, FEBS LETT, V395, P221, DOI 10.1016/0014-5793(96)01046-0; Katze MG, 2002, NAT REV IMMUNOL, V2, P675, DOI 10.1038/nri888; LAN C, 2012, TECHNOL CANCER RES T, V259, P89476; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lau SK, 2004, AM J CLIN PATHOL, V122, P794, DOI 10.1309/QHD6YFN81KQXUUH6; Lucas T, 2010, J IMMUNOL, V184, P3964, DOI 10.4049/jimmunol.0903356; Maier S, 2005, J VIROL, V79, P8784, DOI 10.1128/JVI.79.14.8784-8792.2005; Mantovani A, 2013, J PATHOL, V229, P176, DOI 10.1002/path.4133; Mantovani A, 2010, CURR OPIN IMMUNOL, V22, P231, DOI 10.1016/j.coi.2010.01.009; Medrek C, 2012, BMC CANCER, V12, DOI 10.1186/1471-2407-12-306; Nguyen TDT, 2005, AM J SURG PATHOL, V29, P617, DOI 10.1097/01.pas.0000157940.80538.ec; Noel W, 2004, TRENDS PARASITOL, V20, P126, DOI 10.1016/j.pt.2004.01.004; Pettersen JS, 2011, J INVEST DERMATOL, V131, P1322, DOI [10.1038/jid.2011.9, 10.103/jid.2011.9]; Reinartz S, 2014, INT J CANCER, V134, P32, DOI 10.1002/ijc.28335; SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420; Sica A, 2012, J CLIN INVEST, V122, P787, DOI 10.1172/JCI59643; Sulahian TH, 2000, CYTOKINE, V12, P1312, DOI 10.1006/cyto.2000.0720; Vakkila J, 2005, PEDIATR DEVEL PATHOL, V8, P43, DOI 10.1007/s10024-004-5045-2; van Steenwijk PJD, 2013, INT J CANCER, V133, P2884, DOI 10.1002/ijc.28309; Verbeke CS, 2000, CLIN EXP IMMUNOL, V120, P294, DOI 10.1046/j.1365-2249.2000.01181.x; Waidmann O, 2013, J HEPATOL, V59, P769, DOI 10.1016/j.jhep.2013.06.008; Walter SD, 1998, STAT MED, V17, P101, DOI 10.1002/(SICI)1097-0258(19980115)17:1<101::AID-SIM727>3.0.CO;2-E; Wang YC, 2010, CANCER RES, V70, P4840, DOI 10.1158/0008-5472.CAN-10-0269; WARREN KS, 1976, ANN NY ACAD SCI, V278, P7, DOI 10.1111/j.1749-6632.1976.tb47011.x; Wynn TA, 2010, SEMIN LIVER DIS, V30, P245, DOI 10.1055/s-0030-1255354; Xu HX, 2012, NAT IMMUNOL, V13, P642, DOI 10.1038/ni.2304; Zaki MAA, 2011, VIRCHOWS ARCH, V459, P361, DOI 10.1007/s00428-011-1140-8	43	354	364	9	85	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80908	10.1371/journal.pone.0080908	http://dx.doi.org/10.1371/journal.pone.0080908			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260507	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600095
J	Inturi, R; Thaduri, S; Punga, T				Inturi, Raviteja; Thaduri, Srinivas; Punga, Tanel			Adenovirus Precursor pVII Protein Stability Is Regulated By Its Propeptide Sequence	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME PATHWAY; TEMPLATE-ACTIVATING FACTOR; DEPENDENT DEGRADATION; CORE PROTEINS; VIRAL-DNA; FACTOR-I; TRANSCRIPTION; VII; GENE; SUBSTRATE	Adenovirus encodes for the pVII protein, which interacts and modulates virus DNA structure in the infected cells. The pVII protein is synthesized as the precursor protein and undergoes proteolytic processing by viral proteinase Avp, leading to release of a propeptide sequence and accumulation of the mature VII protein. Here we elucidate the molecular functions of the propeptide sequence present in the precursor pVII protein. The results show that the propeptide is the destabilizing element targeting the precursor pVII protein for proteasomal degradation. Our data further indicate that the propeptide sequence and the lysine residues K26 and K27 regulate the precursor pVII protein stability in a co-dependent manner. We also provide evidence that the Cullin-3 E3 ubiquitin ligase complex alters the precursor pVII protein stability by association with the propeptide sequence. In addition, we show that inactivation of the Cullin-3 protein activity reduces adenovirus E1A gene expression during early phase of virus infection. Collectively, our results indicate a novel function of the adenovirus propeptide sequence and involvement of Cullin-3 in adenovirus gene expression.	[Inturi, Raviteja; Thaduri, Srinivas; Punga, Tanel] Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden	Uppsala University	Punga, T (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Uppsala, Sweden.	Tanel.Punga@imbim.uu.se	Punga, Tanel/K-9844-2019	Punga, Tanel/0000-0002-0561-367X; Inturi, Raviteja/0000-0003-1344-3962	Swedish Cancer Society [12 0504]; Swedish Research Council [VR-Unga Forskare, K2012-99X-21959-01-3]; Ake Wibergs Foundation; PO Zetterling Foundation; Swedish Society of Medicine; Swedish Research Council through a grant to the Uppsala RNA Research Centre [2006-5038-36531-16]	Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission); Ake Wibergs Foundation; PO Zetterling Foundation; Swedish Society of Medicine; Swedish Research Council through a grant to the Uppsala RNA Research Centre	This work was supported by the Swedish Cancer Society (12 0504); the Swedish Research Council (VR-Unga Forskare, K2012-99X-21959-01-3); Ake Wibergs Foundation; PO Zetterling Foundation; the Swedish Society of Medicine; and the Swedish Research Council through a grant to the Uppsala RNA Research Centre (2006-5038-36531-16). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALESTROM P, 1984, J BIOL CHEM, V259, P3980; Baker A, 2007, J VIROL, V81, P7034, DOI 10.1128/JVI.00029-07; Blackford AN, 2010, P NATL ACAD SCI USA, V107, P12251, DOI 10.1073/pnas.0914605107; Blanchette P, 2009, VIROLOGY, V384, P317, DOI 10.1016/j.virol.2008.10.005; BURG JL, 1983, J VIROL, V46, P749, DOI 10.1128/JVI.46.3.749-755.1983; Carson CT, 2003, EMBO J, V22, P6610, DOI 10.1093/emboj/cdg630; CHATTERJEE PK, 1986, EMBO J, V5, P1633, DOI 10.1002/j.1460-2075.1986.tb04406.x; Chen JN, 2007, VIROLOGY, V369, P411, DOI 10.1016/j.virol.2007.08.012; Cheng CY, 2011, J VIROL, V85, P765, DOI 10.1128/JVI.01890-10; Chondrogianni N, 2012, PROG MOL BIOL TRANSL, V109, P41, DOI 10.1016/B978-0-12-397863-9.00002-X; Dallaire F, 2009, J VIROL, V83, P5329, DOI 10.1128/JVI.00089-09; Gastaldelli M, 2008, TRAFFIC, V9, P2265, DOI 10.1111/j.1600-0854.2008.00835.x; Genschik P, 2013, EMBO J, V32, P2307, DOI 10.1038/emboj.2013.173; Gregory MA, 2000, MOL CELL BIOL, V20, P2423, DOI 10.1128/MCB.20.7.2423-2435.2000; Gupta A, 2013, ONCOGENE, V32, P5017, DOI 10.1038/onc.2012.534; Gyurcsik B, 2006, BIOCHEMISTRY-US, V45, P303, DOI 10.1021/bi051248+; Haruki H, 2006, J VIROL, V80, P794, DOI 10.1128/JVI.80.2.794-801.2006; Hewitt L, 2010, J CELL BIOL, V190, P25, DOI 10.1083/jcb.201002133; Huotari J, 2012, P NATL ACAD SCI USA, V109, P823, DOI 10.1073/pnas.1118744109; Jin JP, 2005, METHOD ENZYMOL, V399, P287, DOI 10.1016/S0076-6879(05)99020-4; Johnson JS, 2004, J VIROL, V78, P6459, DOI 10.1128/JVI.78.12.6459-6468.2004; Kamel W, 2013, NUCLEIC ACIDS RES, V41, P4802, DOI 10.1093/nar/gkt172; Karen KA, 2011, J VIROL, V85, P4135, DOI 10.1128/JVI.02540-10; Komatsu T, 2011, NUCLEIC ACIDS RES, V39, P889, DOI 10.1093/nar/gkq783; Kwon JE, 2006, J BIOL CHEM, V281, P12664, DOI 10.1074/jbc.M600204200; Lee TWR, 2003, J GEN VIROL, V84, P3423, DOI 10.1099/vir.0.19546-0; Marvin SA, 2012, BIOL CELL, V104, P188, DOI 10.1111/boc.201100096; MATSUMOTO K, 1995, J BIOL CHEM, V270, P9645, DOI 10.1074/jbc.270.16.9645; Meier O, 2004, J GENE MED, V6, pS152, DOI 10.1002/jgm.553; Mercer J, 2012, CELL REP, V2, P1036, DOI 10.1016/j.celrep.2012.09.003; NEVINS JR, 1981, CELL, V26, P213, DOI 10.1016/0092-8674(81)90304-4; Okuwaki M, 1998, J BIOL CHEM, V273, P34511, DOI 10.1074/jbc.273.51.34511; Ostberg S, 2012, VIROLOGY, V433, P273, DOI 10.1016/j.virol.2012.08.021; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Querido E, 2001, GENE DEV, V15, P3104, DOI 10.1101/gad.926401; RUSSELL WC, 1982, J GEN VIROL, V63, P69, DOI 10.1099/0022-1317-63-1-69; SADOWSKI I, 1989, NUCLEIC ACIDS RES, V17, P7539, DOI 10.1093/nar/17.18.7539; Schreiner S, 2013, J VIROL, V87, P10412, DOI 10.1128/JVI.00425-13; Schreiner S, 2013, NUCLEIC ACIDS RES, V41, P3532, DOI 10.1093/nar/gkt064; Schreiner S, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002549; Schreiner S, 2010, J VIROL, V84, P7029, DOI 10.1128/JVI.00074-10; Sundqvist A, 2005, CELL METAB, V1, P379, DOI 10.1016/j.cmet.2005.04.010; SUNG MT, 1983, P NATL ACAD SCI-BIOL, V80, P2902, DOI 10.1073/pnas.80.10.2902; VAYDA ME, 1983, NUCLEIC ACIDS RES, V11, P441, DOI 10.1093/nar/11.2.441; WEBER J, 1976, J VIROL, V17, P462, DOI 10.1128/JVI.17.2.462-471.1976; Weber J M, 1995, Curr Top Microbiol Immunol, V199 ( Pt 1), P227; WEBSTER A, 1989, J GEN VIROL, V70, P3225, DOI 10.1099/0022-1317-70-12-3225; Weitzman MD, 2011, FEBS LETT, V585, P2897, DOI 10.1016/j.febslet.2011.04.049; Wodrich H, 2006, J VIROL, V80, P9608, DOI 10.1128/JVI.00850-06; Wodrich H, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000808; Ye YH, 2009, NAT REV MOL CELL BIO, V10, P755, DOI 10.1038/nrm2780; Zhang W, 2005, VIROLOGY, V334, P194, DOI 10.1016/j.virol.2005.01.048; Zhuang M, 2009, MOL CELL, V36, P39, DOI 10.1016/j.molcel.2009.09.022	53	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80617	10.1371/journal.pone.0080617	http://dx.doi.org/10.1371/journal.pone.0080617			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260437	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600074
J	Riva, F; Bisi, MC; Stagni, R				Riva, Federico; Bisi, Maria Cristina; Stagni, Rita			Influence of Input Parameters on Dynamic Orbital Stability of Walking: In-Silico and Experimental Evaluation	PLOS ONE			English	Article							GAIT STABILITY; FALL RISK; SENSITIVITY; VARIABILITY; INSTABILITY; PRECISION; SYSTEM; SPACE	Many measures aiming to assess the stability of human motion have been proposed in the literature, but still there is no commonly accepted way to define or quantify locomotor stability. Among these measures, orbital stability analysis via Floquet multipliers is still under debate. Some of the controversies concerning the use of this technique could lie in the absence of a standard implementation. The aim of this study was to analyse the influence of i) experimental measurement noise, ii) variables selected for the construction of the state space, and iii) number of analysed cycles on the outputs of orbital stability applied to walking. The analysis was performed on a 2-dimensional 5-link walking model and on a sample of 10 subjects performing long over-ground walks. Noise resulting from stereophotogrammetric and accelerometric measurement systems was simulated in the in-silico analysis. Maximum Floquet multipliers resulted to be affected by both number of analysed strides and state space composition. The effect of experimental noise was found to be slightly more potentially critical when analysing stereophotogrammetric data then when dealing with acceleration data. Experimental and model results were comparable in terms of overall trend, but a difference was found in the influence of the number of analysed cycles.	[Riva, Federico; Bisi, Maria Cristina; Stagni, Rita] Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy; [Stagni, Rita] Univ Bologna, HST ICIR, Bologna, Italy	University of Bologna; University of Bologna	Riva, F (corresponding author), Univ Bologna, Dept Elect Elect & Informat Engn Guglielmo Marcon, Bologna, Italy.	f.riva@unibo.it	Stagni, Rita/ABD-8948-2020; Stagni, Rita/I-4070-2014	Stagni, Rita/0000-0002-3352-1406; Stagni, Rita/0000-0002-3352-1406; BISI, MARIA CRISTINA/0000-0002-4645-2534	project "Fall risk estimation and prevention in the elderly using a quantitative multifactorial approach" [2010R277FT]	project "Fall risk estimation and prevention in the elderly using a quantitative multifactorial approach"	This research was funded by the project "Fall risk estimation and prevention in the elderly using a quantitative multifactorial approach" (project ID number 2010R277FT) managed by Italian Ministry of Education, University and Research (Ministero dell'Istruzione, dell'Universita e della Ricerca). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aminian K, 2002, J BIOMECH, V35, P689, DOI 10.1016/S0021-9290(02)00008-8; Bruijn SM, 2011, J BIOMECH, V44, P2401, DOI 10.1016/j.jbiomech.2011.06.031; Bruijn SM, 2010, ANN BIOMED ENG, V38, P2588, DOI 10.1007/s10439-010-0018-2; Bruijn SM, 2009, J NEUROSCI METH, V178, P327, DOI 10.1016/j.jneumeth.2008.12.015; CAMPBELL AJ, 1989, J GERONTOL, V44, pM112, DOI 10.1093/geronj/44.4.m112; CAPPOZZO A, 1995, CLIN BIOMECH, V10, P171, DOI 10.1016/0268-0033(95)91394-T; Della Croce U, 1999, MED BIOL ENG COMPUT, V37, P155, DOI 10.1007/BF02513282; Dingwell JB, 2000, CHAOS, V10, P848, DOI 10.1063/1.1324008; Dingwell JB, 2008, J NEUROENG REHABIL, V5, DOI 10.1186/1743-0003-5-12; Dingwell JB, 2007, J BIOMECH ENG-T ASME, V129, P586, DOI 10.1115/1.2746383; England SA, 2007, GAIT POSTURE, V25, P172, DOI 10.1016/j.gaitpost.2006.03.003; Fuller GF, 2000, AM FAM PHYSICIAN, V61, P2159; Gates DH, 2009, J BIOMECH, V42, P1345, DOI 10.1016/j.jbiomech.2009.03.015; Granata KP, 2008, J ELECTROMYOGR KINES, V18, P172, DOI 10.1016/j.jelekin.2007.06.008; GROOD ES, 1983, J BIOMECH ENG-T ASME, V105, P136, DOI 10.1115/1.3138397; Hamacher D, 2011, J R SOC INTERFACE, V8, P1682, DOI 10.1098/rsif.2011.0416; Hausdorff JM, 2001, ARCH PHYS MED REHAB, V82, P1050, DOI 10.1053/apmr.2001.24893; Heinrich S, 2010, OSTEOPOROSIS INT, V21, P891, DOI 10.1007/s00198-009-1100-1; Hobbelen DGE, 2007, IEEE T ROBOT, V23, P1213, DOI 10.1109/TRO.2007.904908; Hof AL, 2005, J BIOMECH, V38, P1, DOI 10.1016/j.jbiomech.2004.03.025; HOLT KG, 1995, J MOTOR BEHAV, V27, P164, DOI 10.1080/00222895.1995.9941708; Hurmuzlu Y, 1996, J BIOMECH ENG-T ASME, V118, P405, DOI 10.1115/1.2796024; HURMUZLU Y, 1994, J BIOMECH ENG-T ASME, V116, P30, DOI 10.1115/1.2895701; Kang HG, 2009, J BIOMECH, V42, P2231, DOI 10.1016/j.jbiomech.2009.06.038; Kang HG, 2009, GAIT POSTURE, V30, P260, DOI 10.1016/j.gaitpost.2009.05.003; Kantz H., 2004, NONLINEAR TIME SERIE; McAndrew PM, 2011, J BIOMECH, V44, P644, DOI 10.1016/j.jbiomech.2010.11.007; MCGEER T, 1990, INT J ROBOT RES, V9, P62, DOI 10.1177/027836499000900206; Riva F, 2013, GAIT POSTURE, V37, P1, DOI 10.1016/j.gaitpost.2012.06.015; Roos PE, 2011, J BIOMECH, V44, P1514, DOI 10.1016/j.jbiomech.2011.03.003; RUBENSTEIN LZ, 1988, J AM GERIATR SOC, V36, P266, DOI 10.1111/j.1532-5415.1988.tb01811.x; Solomon JH, 2010, ADAPT BEHAV, V18, P492, DOI 10.1177/1059712310389624; Su JLS, 2007, J BIOMECH ENG-T ASME, V129, P802, DOI 10.1115/1.2800760; Takens F, 1981, LECT NOTES MATH, P366, DOI [10.1007/BFb0091924, DOI 10.1007/BFB0091924]; van Schooten KS, 2011, GAIT POSTURE, V33, P656, DOI 10.1016/j.gaitpost.2011.02.017	35	0	0	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80878	10.1371/journal.pone.0080878	http://dx.doi.org/10.1371/journal.pone.0080878			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260498	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600090
J	Shinoy, M; Dennehy, R; Coleman, L; Carberry, S; Schaffer, K; Callaghan, M; Doyle, S; McClean, S				Shinoy, Minu; Dennehy, Ruth; Coleman, Lorraine; Carberry, Stephen; Schaffer, Kirsten; Callaghan, Maire; Doyle, Sean; McClean, Siobhan			Immunoproteomic Analysis of Proteins Expressed by Two Related Pathogens, Burkholderia multivorans and Burkholderia cenocepacia, during Human Infection	PLOS ONE			English	Article							CYSTIC-FIBROSIS PATIENTS; OUTER-MEMBRANE PROTEINS; CEPACIA COMPLEX; PSEUDOMONAS-AERUGINOSA; STREPTOCOCCUS-PNEUMONIAE; IMMUNOREACTIVE PROTEINS; BACILLUS-ANTHRACIS; BINDING-PROTEINS; IDENTIFICATION; SURFACE	Burkholderia cepacia complex (Bcc) is an opportunistic bacterial pathogen that causes chronic infections in people with cystic fibrosis (CF). It is a highly antibiotic resistant organism and Bcc infections are rarely cleared from patients, once they are colonized. The two most clinically relevant species within Bcc are Burkholderia cenocepacia and Burkholderia multivorans. The virulence of these pathogens has not been fully elucidated and the virulence proteins expressed during human infection have not been identified to date. Furthermore, given its antibiotic resistance, prevention of infection with a prophylactic vaccine may represent a better alternative than eradication of an existing infection. We have compared the immunoproteome of two strains each from these two species of Bcc, with the aim of identifying immunogenic proteins which are common to both species. Fourteen immunoreactive proteins were exclusive to both B. cenocepacia strains, while 15 were exclusive to B. multivorans. A total of 15 proteins were immunogenic across both species. DNA-directed RNA polymerase, GroEL, 38kDa porin and elongation factor-Tu were immunoreactive proteins expressed by all four strains examined. Many proteins which were immunoreactive in both species, warrant further investigations in order to aid in the elucidation of the mechanisms of pathogenesis of this difficult organism. In addition, identification of some of these could also allow the development of protective vaccines which may prevent colonisation.	[Shinoy, Minu; Dennehy, Ruth; Coleman, Lorraine; Callaghan, Maire; McClean, Siobhan] ITT Dublin, Ctr Microbial Host Interact, Dublin, Ireland; [Dennehy, Ruth; Coleman, Lorraine; Callaghan, Maire; McClean, Siobhan] ITT Dublin, Ctr Appl Sci Hlth, Dublin, Ireland; [Carberry, Stephen; Doyle, Sean] Natl Univ Ireland, Dept Biol, Maynooth, Kildare, Ireland; [Schaffer, Kirsten] St Vincents Univ Hosp, Dept Microbiol, Dublin 4, Ireland	Technological University Dublin; Technological University Dublin; Maynooth University; University College Dublin; Saint Vincent's University Hospital	McClean, S (corresponding author), ITT Dublin, Ctr Microbial Host Interact, Dublin, Ireland.	Siobhan.mcclean@ittdublin.ie		McClean, Siobhan/0000-0001-6389-2542; Doyle, Sean/0000-0003-1679-3247	Technological Sector Research; Science Foundation Ireland [RFP3307]; Programme for Research in Third Level Institutions Cycle 4; European Union Regional Development Plan; Irish Government National Development Plan	Technological Sector Research; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Programme for Research in Third Level Institutions Cycle 4; European Union Regional Development Plan; Irish Government National Development Plan	This research was funded in part by the Technological Sector Research support for MMT. RD is supported by Science Foundation Ireland (RFP3307). The Centre of Applied Science for Health is funded by the Programme for Research in Third Level Institutions Cycle 4, supported by the European Union Regional Development Plan, the Irish Government National Development Plan 2007-2013 and administered by the Higher Education Authority in Ireland and provided support for LC and SC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altindis E, 2009, VACCINE, V27, P542, DOI 10.1016/j.vaccine.2008.11.020; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baldwin A, 2008, J CLIN MICROBIOL, V46, P290, DOI 10.1128/JCM.01818-07; Baldwin A, 2007, EMERG INFECT DIS, V13, P458, DOI 10.3201/eid1303.060403; Bamford CV, 2010, MOL ORAL MICROBIOL, V25, P369, DOI 10.1111/j.2041-1014.2010.00584.x; Bernhardt SA, 2003, CLIN INFECT DIS, V37, P780, DOI 10.1086/377541; Bertot GM, 2007, INFECT IMMUN, V75, P2740, DOI 10.1128/IAI.01668-06; Bevivino A, 2012, MICROBIOL-SGM, V158, P1325, DOI 10.1099/mic.0.056986-0; Chang CC, 2011, VET MICROBIOL, V149, P147, DOI 10.1016/j.vetmic.2010.09.033; Charity JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000641; Choi CW, 2012, DIAGN MICR INFEC DIS, V72, P318, DOI 10.1016/j.diagmicrobio.2011.12.013; Chung JW, 2007, MICROBIOL-SGM, V153, P206, DOI 10.1099/mic.0.2006/000455-0; Cieri MV, 2002, INFECT IMMUN, V70, P1081, DOI 10.1128/IAI.70.3.1081-1086.2002; DelVecchio VG, 2006, APPL ENVIRON MICROB, V72, P6355, DOI 10.1128/AEM.00455-06; Dennehy R, 2012, CURR PROTEIN PEPT SC, V13, P807, DOI 10.2174/138920312804871184; Drevinek P, 2010, CLIN MICROBIOL INFEC, V16, P821, DOI 10.1111/j.1469-0691.2010.03237.x; Duff C, 2006, MICROB PATHOGENESIS, V41, P183, DOI 10.1016/j.micpath.2006.07.005; Garduno RA, 1998, INFECT IMMUN, V66, P4602; Harding SV, 2007, VACCINE, V25, P2664, DOI 10.1016/j.vaccine.2006.12.006; Henry DA, 1997, J CLIN MICROBIOL, V35, P614, DOI 10.1128/JCM.35.3.614-619.1997; ISLES A, 1984, J PEDIATR-US, V104, P206, DOI 10.1016/S0022-3476(84)80993-2; Itzek A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013826; Jeong HS, 2010, J BIOL CHEM, V285, P9357, DOI 10.1074/jbc.M109.089987; Kariyawasam S, 2006, FEMS MICROBIOL LETT, V262, P193, DOI 10.1111/j.1574-6968.2006.00392.x; Khan MN, 2009, FEMS IMMUNOL MED MIC, V56, P56, DOI 10.1111/j.1574-695X.2009.00548.x; Ko KY, 2012, VET MICROBIOL, V156, P374, DOI 10.1016/j.vetmic.2011.11.011; Kovach Z, 2011, FEMS IMMUNOL MED MIC, V63, P387, DOI 10.1111/j.1574-695X.2011.00864.x; Kunert A, 2007, J IMMUNOL, V179, P2979, DOI 10.4049/jimmunol.179.5.2979; Ling E, 2004, CLIN EXP IMMUNOL, V138, P290, DOI 10.1111/j.1365-2249.2004.02628.x; Mahenthiralingam E, 2000, J CLIN MICROBIOL, V38, P910, DOI 10.1128/JCM.38.2.910-913.2000; Makidon PE, 2010, MED MICROBIOL IMMUN, V199, P81, DOI 10.1007/s00430-009-0137-2; Mariappan V, 2010, VACCINE, V28, P1318, DOI 10.1016/j.vaccine.2009.11.027; Matsui H, 2006, P NATL ACAD SCI USA, V103, P18131, DOI 10.1073/pnas.0606428103; McClean S, 2009, J MED MICROBIOL, V58, P1, DOI 10.1099/jmm.0.47788-0; McDowell A, 2004, J MED MICROBIOL, V53, P663, DOI 10.1099/jmm.0.45557-0; Mendum TA, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005940; Montes CL, 2002, CLIN EXP IMMUNOL, V127, P27, DOI 10.1046/j.1365-2249.2002.01746.x; Nally JE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026046; Nieves W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014361; Olekhnovich IN, 2004, J BACTERIOL, V186, P3249, DOI 10.1128/JB.186.10.3249-3253.2004; Paino A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018929; PAPPIN DJC, 1993, CURR BIOL, V3, P327, DOI 10.1016/0960-9822(93)90195-T; Vidakovics ML, 2007, J PROTEOME RES, V6, P2518, DOI 10.1021/pr060681i; Pirone L, 2008, ENVIRON MICROBIOL, V10, P2773, DOI 10.1111/j.1462-2920.2008.01697.x; POOLE K, 1993, J BACTERIOL, V175, P7363, DOI 10.1128/JB.175.22.7363-7372.1993; Riedel K, 2006, PROTEOMICS, V6, P207, DOI 10.1002/pmic.200500097; Sanchez-Campillo M, 1999, ELECTROPHORESIS, V20, P2269, DOI 10.1002/(SICI)1522-2683(19990801)20:11<2269::AID-ELPS2269>3.0.CO;2-D; Sass AM, 2013, ISME J; Sellman BR, 2005, INFECT IMMUN, V73, P6591, DOI 10.1128/IAI.73.10.6591-6600.2005; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Sinha K, 2010, MOL IMMUNOL, V48, P264, DOI 10.1016/j.molimm.2010.08.001; Subramoni S, 2011, INFECT IMMUN, V79, P2984, DOI 10.1128/IAI.00170-11; Tefon BE, 2011, VACCINE, V29, P3583, DOI 10.1016/j.vaccine.2011.02.086; Toledo A, 2012, INFECT IMMUN, V80, P359, DOI 10.1128/IAI.05836-11; Twine SM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010000; Upritchard HG, 2008, INFECT IMMUN, V76, P4624, DOI 10.1128/IAI.01707-07; Whitlock GC, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00227; YAMAGUCHI H, 1990, J GEN MICROBIOL, V136, P1091, DOI 10.1099/00221287-136-6-1091; Ying TY, 2005, PROTEOMICS, V5, P4777, DOI 10.1002/pmic.200401326; Yu NY, 2010, BIOINFORMATICS, V26, P1608, DOI 10.1093/bioinformatics/btq249; Zhang XH, 2009, MICROB PATHOGENESIS, V47, P267, DOI 10.1016/j.micpath.2009.09.001; Zlosnik JEA, 2010, J INFECT DIS, V202, P770, DOI 10.1086/655663	62	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80796	10.1371/journal.pone.0080796	http://dx.doi.org/10.1371/journal.pone.0080796			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260482	Green Published, Green Accepted, gold, Green Submitted			2022-12-25	WOS:000327258600086
J	Gheldof, N; Witwicki, RM; Migliavacca, E; Leleu, M; Didelot, G; Harewood, L; Rougemont, J; Reymond, A				Gheldof, Nele; Witwicki, Robert M.; Migliavacca, Eugenia; Leleu, Marion; Didelot, Gerard; Harewood, Louise; Rougemont, Jacques; Reymond, Alexandre			Structural Variation-Associated Expression Changes Are Paralleled by Chromatin Architecture Modifications	PLOS ONE			English	Article							COPY NUMBER VARIATION; GENE-EXPRESSION; HISTONE MODIFICATIONS; HI-C; CHROMOSOME; LANDSCAPE; IDENTIFICATION; CONFORMATION; IMPACT; REARRANGEMENTS	Copy number variants (CNVs) influence the expression of genes that map not only within the rearrangement, but also to its flanks. To assess the possible mechanism(s) underlying this "neighboring effect", we compared intrachromosomal interactions and histone modifications in cell lines of patients affected by genomic disorders and control individuals. Using chromosome conformation capture (4C-seq), we observed that a set of genes flanking the Williams-Beuren Syndrome critical region (WBSCR) were often looping together. The newly identified interacting genes include AUTS2, mutations of which are associated with autism and intellectual disabilities. Deletion of the WBSCR disrupts the expression of this group of flanking genes, as well as long-range interactions between them and the rearranged interval. We also pinpointed concomitant changes in histone modifications between samples. We conclude that large genomic rearrangements can lead to chromatin conformation changes that extend far away from the structural variant, thereby possibly modulating expression globally and modifying the phenotype. GEO Series accession number: GSE33784, GSE33867.	[Gheldof, Nele; Witwicki, Robert M.; Migliavacca, Eugenia; Didelot, Gerard; Harewood, Louise; Reymond, Alexandre] Univ Lausanne, Ctr Integrat Gen, Lausanne, Switzerland; [Migliavacca, Eugenia; Leleu, Marion; Rougemont, Jacques] SIB, Lausanne, Switzerland; [Leleu, Marion; Rougemont, Jacques] Ecole Polytech Fed Lausanne, Sch Life Sci, Lausanne, Switzerland	University of Lausanne; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Gheldof, N (corresponding author), Nestle Inst Hlth Sci, Lausanne, Switzerland.	nele.gheldof@rd.nestle.com; alexandre.reymond@unil.ch	Kutalik, Zoltan/HHZ-5697-2022	Kutalik, Zoltan/0000-0001-8285-7523; Gheldof, Nele/0000-0001-8922-7372; Reymond, Alexandre/0000-0003-1030-8327; Harewood, Louise/0000-0002-6398-6714	European Commission anEUploidy Integrated Project [037627]; Swiss National Science Foundation; SNSF Sinergia grant; doctoral school of the Faculty of Biology and Medicine, University of Lausanne	European Commission anEUploidy Integrated Project(European CommissionEuropean Commission Joint Research Centre); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); SNSF Sinergia grant; doctoral school of the Faculty of Biology and Medicine, University of Lausanne	This work was supported by the European Commission anEUploidy Integrated Project (grant 037627), the Swiss National Science Foundation and a SNSF Sinergia grant to AR. RMW was supported by a fellowship from the doctoral school of the Faculty of Biology and Medicine, University of Lausanne. NG is a grantee of the Marie Heim Vogtlin and the Pro-Women programs of the SNSF and the Faculty of Biology and Medicine, University of Lausanne, respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anders S, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-10-r106; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Ben-David E, 2011, HUM MOL GENET, V20, P3632, DOI 10.1093/hmg/ddr283; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Cahan P, 2009, NAT GENET, V41, P430, DOI 10.1038/ng.350; Carvalho CMB, 2010, P NATL ACAD SCI USA, V107, P1765, DOI 10.1073/pnas.0906222107; Chaignat E, 2011, GENOME RES, V21, P106, DOI 10.1101/gr.112748.110; Chambeyron S, 2004, GENE DEV, V18, P1119, DOI 10.1101/gad.292104; Conrad DF, 2010, NATURE, V464, P704, DOI 10.1038/nature08516; Cutler G, 2007, GENOME RES, V17, P1743, DOI 10.1101/gr.6754607; de Wit E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000045; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Dunham I, 2012, NATURE, V489, P57, DOI 10.1038/nature11247; Dutly F, 1996, HUM MOL GENET, V5, P1893, DOI 10.1093/hmg/5.12.1893; Ernst J, 2010, NAT BIOTECHNOL, V28, P817, DOI 10.1038/nbt.1662; Fanciulli M, 2009, CLIN GENET; Gheldof N, 2012, METHODS MOL BIOL, V786, P211, DOI 10.1007/978-1-61779-292-2_13; Graubert TA, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030003; Guryev V, 2008, NAT GENET, V40, P538, DOI 10.1038/ng.141; Harewood L, 2010, GENOME RES, V20, P554, DOI 10.1101/gr.103622.109; Henrichsen CN, 2009, NAT GENET, V41, P424, DOI 10.1038/ng.345; Henrichsen CN, 2009, HUM MOL GENET, V18, pR1, DOI 10.1093/hmg/ddp011; Huang XL, 2010, AM J MED GENET A, V152A, P2112, DOI 10.1002/ajmg.a.33497; Jacquemont S, 2011, NATURE, V478, P97, DOI 10.1038/nature10406; Kalscheuer VM, 2007, HUM GENET, V121, P501, DOI 10.1007/s00439-006-0284-0; Kleinjan DA, 2008, ADV GENET, V61, P339, DOI 10.1016/S0065-2660(07)00013-2; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; Lee C, 2010, EXPERT REV MOL MED, V12, DOI 10.1017/S1462399410001390; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lieberman-Aiden E, 2009, SCIENCE, V326, P289, DOI 10.1126/science.1181369; Lyle R, 2004, GENOME RES, V14, P1268, DOI 10.1101/gr.2090904; McDaniell R, 2010, SCIENCE, V328, P235, DOI 10.1126/science.1184655; Merla G, 2006, AM J HUM GENET, V79, P332, DOI 10.1086/506371; Mills RE, 2011, GENOME RES, V21, P830, DOI 10.1101/gr.115907.110; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; Noordermeer D, 2011, SCIENCE, V334, P222, DOI 10.1126/science.1207194; O'Geen H, 2006, BIOTECHNIQUES, V41, P577, DOI 10.2144/000112268; Orozco LD, 2009, HUM MOL GENET, V18, P4118, DOI 10.1093/hmg/ddp360; Pastinen T, 2010, NAT REV GENET, V11, P533, DOI 10.1038/nrg2815; Pober BR, 2010, NEW ENGL J MED, V362, P239, DOI 10.1056/NEJMra0903074; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Redon R, 2006, NATURE, V444, P444, DOI 10.1038/nature05329; Reymond A, 2007, CURR OPIN GENET DEV, V17, P381, DOI 10.1016/j.gde.2007.08.009; Ricard G, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000543; Roh TY, 2006, P NATL ACAD SCI USA, V103, P15782, DOI 10.1073/pnas.0607617103; Sanyal A, 2012, NATURE, V489, P109, DOI 10.1038/nature11279; Sanyal A, 2011, CURR OPIN CELL BIOL, V23, P325, DOI 10.1016/j.ceb.2011.03.009; She XW, 2008, NAT GENET, V40, P909, DOI 10.1038/ng.172; Shu WJ, 2011, NUCLEIC ACIDS RES, V39, P7428, DOI 10.1093/nar/gkr443; Simonis M, 2007, NAT METHODS, V4, P895, DOI 10.1038/NMETH1114; Simonis M, 2006, NAT GENET, V38, P1348, DOI 10.1038/ng1896; Simonis M, 2009, NAT METHODS, V6, P837, DOI [10.1038/NMETH.1391, 10.1038/nmeth.1391]; Soutoglou E, 2007, CURR OPIN GENET DEV, V17, P435, DOI 10.1016/j.gde.2007.08.004; Splinter E, 2011, GENE DEV, V25, P1371, DOI 10.1101/gad.633311; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Sung MH, 2011, NAT GENET, V43, P1047, DOI 10.1038/ng.984; Thurman RE, 2012, NATURE, V489, P75, DOI 10.1038/nature11232; Tolhuis B, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001343; Wasserman NF, 2010, GENOME RES, V20, P1191, DOI 10.1101/gr.105361.110; Yaffe E, 2011, NAT GENET, V43, P1059, DOI 10.1038/ng.947; Yalcin B, 2011, NATURE, V477, P326, DOI 10.1038/nature10432; Zang CZ, 2009, BIOINFORMATICS, V25, P1952, DOI 10.1093/bioinformatics/btp340; Zhang F, 2009, ANNU REV GENOM HUM G, V10, P451, DOI 10.1146/annurev.genom.9.081307.164217	64	23	25	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79973	10.1371/journal.pone.0079973	http://dx.doi.org/10.1371/journal.pone.0079973			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265791	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100124
J	Medley, TL; Furtado, M; Lam, NT; Idrizi, R; Williams, D; Verma, PJ; Costa, M; Kaye, DM				Medley, Tanya L.; Furtado, Milena; Lam, Nicholas T.; Idrizi, Rejhan; Williams, David; Verma, Paul J.; Costa, Mauro; Kaye, David M.			Effect of Oxygen on Cardiac Differentiation in Mouse iPS Cells: Role of Hypoxia Inducible Factor-1 and Wnt/Beta-Catenin Signaling	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; HEART DEVELOPMENT; UP-REGULATION; MESODERM; FACTOR-1-ALPHA; SPECIFICATION; HIF-1-ALPHA; CHILDHOOD; MORTALITY; SURVIVAL	Background: Disturbances in oxygen levels have been found to impair cardiac organogenesis. It is known that stem cells and differentiating cells may respond variably to hypoxic conditions, whereby hypoxia may enhance stem cell pluripotency, while differentiation of multiple cell types can be restricted or enhanced under hypoxia. Here we examined whether HIF-1alpha modulated Wnt signaling affected differentiation of iPS cells into beating cardiomyocytes. Objective: We investigated whether transient and sustained hypoxia affects differentiation of cardiomyocytes derived from murine induced pluripotent stem (iPS) cells, assessed the involvement of HIF-1alpha (hypoxia-inducible factor-1alpha) and the canonical Wnt pathway in this process. Methods: Embryoid bodies (EBs) derived from iPS cells were differentiated into cardiomyocytes and were exposed either to 24 h normoxia or transient hypoxia followed by a further 13 days of normoxic culture. Results: At 14 days of differentiation, 59 +/- 2% of normoxic EBs were beating, whilst transient hypoxia abolished beating at 14 days and EBs appeared immature. Hypoxia induced a significant increase in Brachyury and islet-1 mRNA expression, together with reduced troponin C expression. Collectively, these data suggest that transient and sustained hypoxia inhibits maturation of differentiating cardiomyocytes. Compared to normoxia, hypoxia increased HIF-1alpha, Wnt target and ligand genes in EBs, as well as accumulation of HIF-1alpha and beta-catenin in nuclear protein extracts, suggesting involvement of the Wnt/beta-catenin pathway. Conclusion: Hypoxia impairs cardiomyocyte differentiation and activates Wnt signaling in undifferentiated iPS cells. Taken together the study suggests that oxygenation levels play a critical role in cardiomyocyte differentiation and suggest that hypoxia may play a role in early cardiogenesis.	[Medley, Tanya L.; Lam, Nicholas T.; Idrizi, Rejhan; Williams, David; Kaye, David M.] Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia; [Furtado, Milena; Costa, Mauro] Monash Univ, Australian Regenerat Med Inst, Melbourne, Vic 3004, Australia; [Verma, Paul J.] Monash Inst Med Res, Ctr Reprod & Dev, Melbourne, Vic, Australia	Baker Heart and Diabetes Institute; Australian Regenerative Medicine Institute; Monash University; Monash University	Kaye, DM (corresponding author), Baker IDI Heart & Diabet Inst, Heart Failure Res Grp, Melbourne, Vic, Australia.	david.kaye@bakeridi.edu.au	Kaye, David/AAF-1202-2021; Verma, Paul/AAQ-4657-2021; Costa, Mauro W/S-9219-2018	Costa, Mauro W/0000-0003-3579-8625; Kaye, David/0000-0003-4058-0372; Lam, Nicholas/0000-0002-9446-7378	National Health and Medical Research Council; Victorian Government OIS Program	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Victorian Government OIS Program	This study was supported by a Program Grant from the National Health and Medical Research Council (to DMK) and in part by the by the Victorian Government OIS Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adelman DM, 2000, GENE DEV, V14, P3191, DOI 10.1101/gad.853700; Bae S, 2003, AM J PHYSIOL-HEART C, V285, pH983, DOI 10.1152/ajpheart.00005.2003; BARKER DJP, 1989, BRIT MED J, V298, P564, DOI 10.1136/bmj.298.6673.564; BARKER DJP, 1986, LANCET, V1, P1077; Bianco C, 2009, AM J PATHOL, V175, P2146, DOI 10.2353/ajpath.2009.090218; Cameron CM, 2008, EXP BIOL MED, V233, P1044, DOI 10.3181/0709-RM-263; Chu WF, 2012, J CELL MOL MED, V16, P2022, DOI 10.1111/j.1582-4934.2011.01497.x; Compernolle V, 2003, CARDIOVASC RES, V60, P569, DOI 10.1016/j.cardiores.2003.07.003; Dunwoodie SL, 2009, DEV CELL, V17, P755, DOI 10.1016/j.devcel.2009.11.008; Eberli D, 2009, METHODS, V47, P98, DOI 10.1016/j.ymeth.2008.10.016; Gessert S, 2010, CIRC RES, V107, P186, DOI 10.1161/CIRCRESAHA.110.221531; Graham RA, 2004, J EXP BIOL, V207, P3189, DOI 10.1242/jeb.01109; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Ji L, 2009, J CELL PHYSIOL, V221, P54, DOI 10.1002/jcp.21826; Krishnan J, 2008, CIRC RES, V103, P1139; Lindsley RC, 2006, DEVELOPMENT, V133, P3787, DOI 10.1242/dev.02551; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mitani T, 2012, J BIOL CHEM, V287, P33594, DOI 10.1074/jbc.M112.388298; Patterson AJ, 2010, CURR MOL MED, V10, P653; Rai M, 2012, STEM CELLS DEV, V21, P54, DOI 10.1089/scd.2011.0326; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Ramirez-Bergeron DL, 2001, STEM CELLS, V19, P279, DOI 10.1634/stemcells.19-4-279; Robador PA, 2011, CARDIOVASC RES, V92, P247, DOI 10.1093/cvr/cvr202; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Semenza GL, 2004, PHYSIOLOGY, V19, P176, DOI 10.1152/physiol.00001.2004; Simon MC, 2008, NAT REV MOL CELL BIO, V9, P285, DOI 10.1038/nrm2354; Springer ML, 2002, CURR PROTOC HUM GENE; Stubbs SL, 2012, STEM CELLS DEV, V21, P1887, DOI 10.1089/scd.2011.0289; Sugishita Y, 2004, DEV BIOL, V273, P285, DOI 10.1016/j.ydbio.2004.05.036; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Wenger Roland H, 2005, Sci STKE, V2005, pre12, DOI 10.1126/stke.3062005re12; Yamaguchi TP, 1999, GENE DEV, V13, P3185, DOI 10.1101/gad.13.24.3185; Yamanaka Shinya, 2006, Tanpakushitsu Kakusan Koso, V51, P2346	34	33	35	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80280	10.1371/journal.pone.0080280	http://dx.doi.org/10.1371/journal.pone.0080280			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265804	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100139
J	Ruiz-Montoya, L; Nunez-Farfan, J				Ruiz-Montoya, Lorena; Nunez-Farfan, Juan			Testing Local Host Adaptation and Phenotypic Plasticity in a Herbivore When Alternative Related Host Plants Occur Sympatrically	PLOS ONE			English	Article							BREVICORYNE-BRASSICAE HOMOPTERA; QUANTITATIVE GENETICS; MYZUS-PERSICAE; NATURAL-SELECTION; EVOLUTION; APHID; PERFORMANCE; SPECIALIZATION; SPECIATION; INSECTS	Host race formation in phytophagous insects can be an early stage of adaptive speciation. However, the evolution of phenotypic plasticity in host use is another possible outcome. Using a reciprocal transplant experiment we tested the hypothesis of local adaptation in the aphid Brevicoryne brassicae. Aphid genotypes derived from two sympatric host plants, Brassica oleracea and B. campestris, were assessed in order to measure the extent of phenotypic plasticity in morphological and life history traits in relation to the host plants. We obtained an index of phenotypic plasticity for each genotype. Morphological variation of aphids was summarized by principal components analysis. Significant effects of recipient host on morphological variation and life history traits (establishment, age at first reproduction, number of nymphs, and intrinsic growth rate) were detected. We did not detected genotype x host plant interaction; in general the genotypes developed better on B. campestris, independent of the host plant species from which they were collected. Therefore, there was no evidence to suggest local adaptation. Regarding plasticity, significant differences among genotypes in the index of plasticity were detected. Furthermore, significant selection on PC1 (general aphid body size) on B. campestris, and on PC1 and PC2 (body length relative to body size) on B. oleracea was detected. The elevation of the reaction norm of PC1 and the slope of the reaction norm for PC2 (i.e., plasticity) were under directional selection. Thus, host plant species constitute distinct selective environments for B. brassicae. Aphid genotypes expressed different phenotypes in response to the host plant with low or nil fitness costs. Phenotypic plasticity and gene flow limits natural selection for host specialization promoting the maintenance of genetic variation in host exploitation.	[Ruiz-Montoya, Lorena] El Colegio Frontera Sur, Dept Conservac Biodiversidad, Grp Ecol Evolutiva & Conservac, San Cristobal De La Casa, Chiapas, Mexico; [Nunez-Farfan, Juan] Univ Nacl Autonoma Mexico, Lab Genet Ecol & Evoluc, Dept Ecol Evolut, Inst Ecol, Mexico City 04510, DF, Mexico	El Colegio de la Frontera Sur (ECOSUR); Universidad Nacional Autonoma de Mexico	Ruiz-Montoya, L (corresponding author), El Colegio Frontera Sur, Dept Conservac Biodiversidad, Grp Ecol Evolutiva & Conservac, San Cristobal De La Casa, Chiapas, Mexico.	lruiz@ecosur.mx	Núñez-Farfán, Juan/D-3379-2018; Ruiz-Montoya, Lorena/I-3523-2013	Ruiz-Montoya, Lorena/0000-0003-1039-7374	CONACYT [31543-B, 990039-DO]; ECOSUR	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); ECOSUR	Financial support was provided by CONACYT grants (31543-B and 990039-DO) and by ECOSUR to LRM. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annan B, 1997, INT J PEST MANAGE, V43, P307; Auld JR, 2010, P ROY SOC B-BIOL SCI, V277, P503, DOI 10.1098/rspb.2009.1355; AYRES MP, 1990, EVOLUTION, V44, P221, DOI [10.2307/2409540, 10.1111/j.1558-5646.1990.tb04295.x]; Baythavong BS, 2010, EVOLUTION, V64, P2904, DOI 10.1111/j.1558-5646.2010.01057.x; Bazzaz F.A., 1987, DIFFERENTIATION PATT, P69; Blackman RL, 2000, APHIDS WORLDS CROPS, V2nd, DOI 10.1016/0261-2194(96)89825-5; Caillaud MC, 2000, AM NAT, V156, P606, DOI 10.1086/316991; Cardoza YJ, 2006, J CHEM ECOL, V32, P1965, DOI 10.1007/s10886-006-9121-0; CHRISTIANSEN FB, 1975, AM NAT, V109, P11, DOI 10.1086/282970; Cole RA, 1997, ENTOMOL EXP APPL, V85, P121, DOI 10.1023/A:1003049105464; Cook LG, 2007, ECOL ENTOMOL, V32, P506, DOI 10.1111/j.1365-2311.2007.00893.x; DEJONG G, 1990, J EVOLUTION BIOL, V3, P447, DOI 10.1046/j.1420-9101.1990.3050447.x; DeWitt T.J., 2004, PHENOTYPIC PLASTICIT; DeWitt TJ, 1998, TRENDS ECOL EVOL, V13, P77, DOI 10.1016/S0169-5347(97)01274-3; Dhuyvetter H, 2007, EVOLUTION, V61, P184, DOI 10.1111/j.1558-5646.2007.00015.x; DIEHL SR, 1984, ANNU REV ENTOMOL, V29, P471, DOI 10.1146/annurev.en.29.010184.002351; Farrell BD, 2004, EVOLUTION, V58, P1984; Fitzpatrick BM, 2012, INT J ECOL, V2012, P1; FRY JD, 1992, EVOLUTION, V46, P540, DOI [10.2307/2409870, 10.1111/j.1558-5646.1992.tb02057.x]; Fry JD, 1996, AM NAT, V148, pS84, DOI 10.1086/285904; GAVRILETS S, 1993, J EVOLUTION BIOL, V6, P31, DOI 10.1046/j.1420-9101.1993.6010031.x; Gorur G, 2005, ECOL ENTOMOL, V30, P657, DOI 10.1111/j.0307-6946.2005.00742.x; HEIE OE, 1987, WORLD CROP PESTS APH, P393; Kawecki TJ, 2004, ECOL LETT, V7, P1225, DOI 10.1111/j.1461-0248.2004.00684.x; Kos M, 2011, ECOL ENTOMOL, V36, P377, DOI 10.1111/j.1365-2311.2011.01282.x; LANDE R, 1983, EVOLUTION, V37, P1210, DOI [10.1111/j.1558-5646.1983.tb00236.x, 10.2307/2408842]; Leal-Aguilar K, 2008, ECOL ENTOMOL, V33, P735, DOI 10.1111/j.1365-2311.2008.01030.x; Loxdale HD, 2011, BIOL J LINN SOC, V103, P1, DOI 10.1111/j.1095-8312.2011.01627.x; Mayr E, 1966, EVOLUTION DIVERSITY; MITTER C, 1991, TRENDS ECOL EVOL, V6, P290, DOI 10.1016/0169-5347(91)90007-K; Miyasaka SC, 2007, CROP PROT, V26, P511, DOI 10.1016/j.cropro.2006.04.023; Nunez-Farfan J, 2005, EVOL ECOL RES, V7, P105; Peppe FB, 2003, GENET MOL BIOL, V26, P189, DOI 10.1590/S1415-47572003000200012; Quinn GP, 2003, EXPT DESIGN DATA ANA; RAUSHER MD, 1984, EVOLUTION, V38, P582, DOI 10.1111/j.1558-5646.1984.tb00324.x; Roff DA, 2011, P ROY SOC B-BIOL SCI, V278, P2724, DOI 10.1098/rspb.2011.0595; ROLLINS CR, 1993, CRUCIFERAE CONTINENT; Ruiz-Montoya L, 2005, ECOL RES, V20, P591, DOI 10.1007/s11284-005-0076-3; Ruiz-Montoya L, 2004, SCI UPDATE, P261; Ruiz-Montoya L, 2003, HEREDITY, V91, P415, DOI 10.1038/sj.hdy.6800338; Ruiz-Montoya L, 2012, ADV ZOOLOGY RES, V4, P179; Ruiz-Montoya L, 2009, FLA ENTOMOL, V92, P635, DOI 10.1653/024.092.0417; SAS, 2003, JMP STAT GRAPH GUID; SCHLICHTING CD, 1986, ANNU REV ECOL SYST, V17, P667, DOI 10.1146/annurev.es.17.110186.003315; Schoonhoven LM, 1999, ENTOMOL EXP APPL, V91, P1, DOI 10.1023/A:1003692602901; SMITH JM, 1966, AM NAT, V100, P637, DOI 10.1086/282457; Spitze K, 1996, AM NAT, V148, pS108, DOI 10.1086/285905; Stowe KA, 1998, EVOLUTION, V52, P703, DOI [10.2307/2411265, 10.1111/j.1558-5646.1998.tb03695.x]; Sultan SE, 2002, AM NAT, V160, P271, DOI 10.1086/341015; Tilmon KJ, 1998, ANN ENTOMOL SOC AM, V91, P397, DOI 10.1093/aesa/91.4.397; Uddin MM, 2009, J APPL BOT FOOD QUAL, V82, P108; Valladares F, 2006, J ECOL, V94, P1103, DOI 10.1111/j.1365-2745.2006.01176.x; Van Buskirk J, 2009, J EVOLUTION BIOL, V22, P852, DOI 10.1111/j.1420-9101.2009.01685.x; VANTIENDEREN PH, 1991, EVOLUTION, V45, P1317, DOI [10.1111/j.1558-5646.1991.tb02638.x, 10.2307/2409882]; vanTienderen PH, 1997, EVOLUTION, V51, P1372, DOI [10.1111/j.1558-5646.1997.tb01460.x, 10.2307/2411189]; Via S, 2001, TRENDS ECOL EVOL, V16, P381, DOI 10.1016/S0169-5347(01)02188-7; VIA S, 1985, EVOLUTION, V39, P505, DOI [10.2307/2408649, 10.1111/j.1558-5646.1985.tb00391.x]; VIA S, 1991, ECOLOGY, V72, P1420, DOI 10.2307/1941114; Via Sara, 1994, P35; Wang H, 2011, GENE, V487, P135, DOI 10.1016/j.gene.2011.07.021; Wayatt J, 1977, J APPL ECOL, V14, P757; WEIS AE, 1992, EVOLUTION, V46, P1674, DOI [10.1111/j.1558-5646.1992.tb01161.x, 10.2307/2410023]	62	8	12	0	56	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79070	10.1371/journal.pone.0079070	http://dx.doi.org/10.1371/journal.pone.0079070			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265743	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100076
J	Salinas, S; Zussy, C; Loustalot, F; Henaff, D; Menendez, G; Morton, PE; Parsons, M; Schiavo, G; Kremer, EJ				Salinas, Sara; Zussy, Charleine; Loustalot, Fabien; Henaff, Daniel; Menendez, Guillermo; Morton, Penny E.; Parsons, Maddy; Schiavo, Giampietro; Kremer, Eric J.			Disruption of the Coxsackievirus and Adenovirus Receptor-Homodimeric Interaction Triggers Lipid Microdomain- and Dynamin-dependent Endocytosis and Lysosomal Targeting	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							AXONAL RETROGRADE TRANSPORT; CELL-ADHESION MOLECULES; CENTRAL-NERVOUS-SYSTEM; MEDIATED ENDOCYTOSIS; CHOLERA-TOXIN; IN-VITRO; VIRUS; INTERNALIZATION; FIBER; CAR	The coxsackievirus and adenovirus receptor (CAR) serves as a docking factor for some adenovirus (AdV) types and group B coxsackieviruses. Its role in AdV internalization is unclear as studies suggest that its intracellular domain is dispensable for some AdV infection. We previously showed that in motor neurons, AdV induced CAR internalization and co-transport in axons, suggesting that CAR was linked to endocytic and long-range transport machineries. Here, we characterized the mechanisms of CAR endocytosis in neurons and neuronal cells. We found that CAR internalization was lipid microdomain-, actin-, and dynamin-dependent, and subsequently followed by CAR degradation in lysosomes. Moreover, ligands that disrupted the homodimeric CAR interactions in its D1 domains triggered an internalization cascade involving sequences in its intracellular tail.	[Salinas, Sara; Zussy, Charleine; Loustalot, Fabien; Henaff, Daniel; Kremer, Eric J.] Univ Montpellier I, CNRS UMR 5535, Inst Genet Mol Montpellier, Montpellier, France; [Salinas, Sara; Zussy, Charleine; Loustalot, Fabien; Henaff, Daniel; Kremer, Eric J.] Univ Montpellier 2, CNRS UMR 5535, Inst Genet Mol Montpellier, Montpellier, France; [Morton, Penny E.; Parsons, Maddy] Kings Coll London, Randall Div Cell & Mol Biophys, London WC2R 2LS, England; [Menendez, Guillermo; Schiavo, Giampietro] Canc Res UK London Res Inst, Mol NeuroPathobiol Lab, London WC2A 3PX, England; [Salinas, Sara; Kremer, Eric J.] INSERM, F-75654 Paris 13, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; University of London; King's College London; Cancer Research UK; Institut National de la Sante et de la Recherche Medicale (Inserm)	Salinas, S (corresponding author), Univ Montpellier I, CNRS UMR 5535, Inst Genet Mol Montpellier, Montpellier, France.	sara.salinas@igmm.cnrs.fr; eric.kremer@igmm.cnrs.fr	Salinas, Sara/O-1150-2019; Parsons, Maddy/B-2203-2013; Salinas, Sara/O-1856-2013; Kremer, Eric J/D-3734-2013; Kremer, EJ/P-9838-2019	Salinas, Sara/0000-0003-4492-2093; Parsons, Maddy/0000-0002-2021-8379; Salinas, Sara/0000-0003-4492-2093; Kremer, EJ/0000-0001-6114-7530; Schiavo, Giampietro/0000-0002-4319-8745	European Community [222992-BrainCAV]; French Agence National de la Recherche; E-Rare; Fondation de France; Association pour la Recherche sur la Sclerose Amyotrophique Laterale (ARSLa); Association Francaise contre les Myopathies; Cancer Research UK; UK Motor Neuron Disease Association; Chemical Biology Center; Imperial College London, UK	European Community(European Commission); French Agence National de la Recherche(French National Research Agency (ANR)); E-Rare; Fondation de France(Fondation de France); Association pour la Recherche sur la Sclerose Amyotrophique Laterale (ARSLa); Association Francaise contre les Myopathies(Association Francaise contre les Myopathies); Cancer Research UK(Cancer Research UK); UK Motor Neuron Disease Association; Chemical Biology Center; Imperial College London, UK	This work was supported in part by European Community 7th Framework Program FP7/2007-2013 Grant 222992-BrainCAV, the French Agence National de la Recherche, E-Rare, the Fondation de France, the Association pour la Recherche sur la Sclerose Amyotrophique Laterale (ARSLa), and the Association Francaise contre les Myopathies.; Supported by Cancer Research UK, Chemical Biology Center, Imperial College London, UK, and the UK Motor Neuron Disease Association.	AKLI S, 1993, NAT GENET, V3, P224, DOI 10.1038/ng0393-224; Boulware MI, 2007, J NEUROSCI, V27, P9941, DOI 10.1523/JNEUROSCI.1647-07.2007; Bru T, 2010, VIRUSES-BASEL, V2, P2134, DOI 10.3390/v2092134; Burckhardt CJ, 2011, CELL HOST MICROBE, V10, P105, DOI 10.1016/j.chom.2011.07.006; Carcea I, 2010, J NEUROSCI, V30, P15317, DOI 10.1523/JNEUROSCI.1821-10.2010; Carvajal-Gonzalez JM, 2012, P NATL ACAD SCI USA, V109, P3820, DOI 10.1073/pnas.1117949109; Castellani V, 2004, MOL CELL NEUROSCI, V26, P89, DOI 10.1016/j.mcn.2004.01.010; Chillon M, 2001, HUM GENE THER, V12, P1815, DOI 10.1089/104303401750476302; Coyne CB, 2006, CELL, V124, P119, DOI 10.1016/j.cell.2005.10.035; DAMKE H, 1994, J CELL BIOL, V127, P915, DOI 10.1083/jcb.127.4.915; de Ory F, 2013, J MED VIROL, V85, P554, DOI 10.1002/jmv.23470; Deinhardt K, 2006, NEURON, V52, P293, DOI 10.1016/j.neuron.2006.08.018; Diaz F, 2009, P NATL ACAD SCI USA, V106, P11143, DOI 10.1073/pnas.0811227106; Drayman N, 2013, CELL HOST MICROBE, V14, P63, DOI 10.1016/j.chom.2013.05.005; Ewers H, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a004721; Excoffon KJDA, 2003, J VIROL, V77, P2559, DOI 10.1128/JVI.77.4.2559-2567.2003; Ezratty EJ, 2009, J CELL BIOL, V187, P733, DOI 10.1083/jcb.200904054; Farmer C, 2009, EXP CELL RES, V315, P2637, DOI 10.1016/j.yexcr.2009.06.008; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; Franker MAM, 2013, J CELL SCI, V126, P2319, DOI 10.1242/jcs.115030; Freimuth P, 2008, CURR TOP MICROBIOL, V323, P67; Gonnord P, 2012, SEMIN CELL DEV BIOL, V23, P154, DOI 10.1016/j.semcdb.2011.11.002; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Gralinski LE, 2009, J VIROL, V83, P9398, DOI 10.1128/JVI.00954-09; Granseth B, 2006, NEURON, V51, P773, DOI 10.1016/j.neuron.2006.08.029; He YN, 2001, NAT STRUCT BIOL, V8, P874, DOI 10.1038/nsb1001-874; Hnasko TS, 2006, P NATL ACAD SCI USA, V103, P8858, DOI 10.1073/pnas.0603081103; Huang KC, 2007, FEBS LETT, V581, P2702, DOI 10.1016/j.febslet.2007.05.019; Huang YC, 2013, J CLIN VIROL, V57, P300, DOI 10.1016/j.jcv.2013.03.017; Ibanez CF, 2007, TRENDS CELL BIOL, V17, P519, DOI 10.1016/j.tcb.2007.09.003; Kamiguchi H, 2001, J NEUROSCI, V21, P9194, DOI 10.1523/JNEUROSCI.21-23-09194.2001; Kosulin K, 2007, J VIROL, V81, P7629, DOI 10.1128/JVI.00355-07; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Kremer EJ, 2000, J VIROL, V74, P505, DOI 10.1128/JVI.74.1.505-512.2000; Lajoie P, 2009, J CELL MOL MED, V13, P3218, DOI 10.1111/j.1582-4934.2009.00732.x; Lang DM, 1998, J NEUROBIOL, V37, P502, DOI 10.1002/(SICI)1097-4695(199812)37:4<502::AID-NEU2>3.0.CO;2-S; LASALLE GL, 1993, SCIENCE, V259, P988, DOI 10.1126/science.8382374; Lingwood D, 2010, SCIENCE, V327, P46, DOI 10.1126/science.1174621; Lobert VH, 2010, DEV CELL, V19, P148, DOI 10.1016/j.devcel.2010.06.010; Lortat-Jacob H, 2001, J BIOL CHEM, V276, P9009, DOI 10.1074/jbc.M009304200; Meier O, 2003, J GENE MED, V5, P451, DOI 10.1002/jgm.409; Mineo C, 1999, J BIOL CHEM, V274, P30636, DOI 10.1074/jbc.274.43.30636; Moore ML, 2003, J VIROL, V77, P10060, DOI 10.1128/JVI.77.18.10060-10070.2003; Mooren OL, 2012, ANNU REV BIOCHEM, V81, P661, DOI 10.1146/annurev-biochem-060910-094416; Ohka S, 2004, J VIROL, V78, P7186, DOI 10.1128/JVI.78.13.7186-7198.2004; Ohka S, 2009, J VIROL, V83, P4995, DOI 10.1128/JVI.02225-08; Olusanya O, 2001, CURR BIOL, V11, P896, DOI 10.1016/S0960-9822(01)00240-8; Orlandi PA, 1998, J CELL BIOL, V141, P905, DOI 10.1083/jcb.141.4.905; Patzke C, 2010, J NEUROSCI, V30, P2897, DOI 10.1523/JNEUROSCI.5725-09.2010; Paxinos G., 2003, MOUSE BRAIN STEREOTA, p[22, 30]; Payne CK, 2007, TRAFFIC, V8, P389, DOI 10.1111/j.1600-0854.2007.00540.x; Pelkmans L, 2002, SCIENCE, V296, P535, DOI 10.1126/science.1069784; Persaud-Sawin DA, 2009, J LIPID RES, V50, P759, DOI 10.1194/jlr.D800037-JLR200; Rajendran L, 2005, J CELL SCI, V118, P1099, DOI 10.1242/jcs.01681; Restani L, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003087; Richart SM, 2003, J VIROL, V77, P3307, DOI 10.1128/JVI.77.5.3307-3311.2003; Sakisaka T, 2005, J CELL SCI, V118, P5407, DOI 10.1242/jcs.02672; Salinas S, 2008, CURR OPIN CELL BIOL, V20, P445, DOI 10.1016/j.ceb.2008.04.002; Salinas S, 2010, NAT REV MICROBIOL, V8, P645, DOI 10.1038/nrmicro2395; Salinas S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000442; Sarnataro D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005829; Schaefer AW, 1999, J BIOL CHEM, V274, P37965, DOI 10.1074/jbc.274.53.37965; Schafer MKE, 2010, FEBS LETT, V584, P4475, DOI 10.1016/j.febslet.2010.10.011; Schneider A, 2008, J NEUROSCI, V28, P2874, DOI 10.1523/JNEUROSCI.5345-07.2008; Schoelm G, 2008, J VIROL, V82, P3192, DOI 10.1128/JVI.02393-07; Seiradake E, 2006, J BIOL CHEM, V281, P33704, DOI 10.1074/jbc.M605316200; Simons K, 2010, NAT REV MOL CELL BIO, V11, P688, DOI 10.1038/nrm2977; Soudais C, 2000, J VIROL, V74, P10639, DOI 10.1128/JVI.74.22.10639-10649.2000; Soudais C, 2001, FASEB J, V15, P2283, DOI 10.1096/fj.01-0321fje; Takahashi T, 2011, BIOCHEM RES INT, V2011, DOI 10.1155/2011/245090; Tamanini A, 2006, J VIROL, V80, P11241, DOI 10.1128/JVI.00721-06; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Taylor Anne M., 2006, V321, P167; van Raaij MJ, 2000, STRUCTURE, V8, P1147, DOI 10.1016/S0969-2126(00)00528-1; Verdino P, 2010, SCIENCE, V329, P1210, DOI 10.1126/science.1187996; Walters RW, 2002, CELL, V110, P789, DOI 10.1016/S0092-8674(02)00912-1; Wang XH, 1999, J VIROL, V73, P2559, DOI 10.1128/JVI.73.3.2559-2562.1999; WICKHAM TJ, 1993, CELL, V73, P309, DOI 10.1016/0092-8674(93)90231-E; Xie JS, 2006, J VIROL, V80, P11833, DOI 10.1128/JVI.00857-06; Zhang YZ, 2000, J NEUROSCI, V20, P5671, DOI 10.1523/JNEUROSCI.20-15-05671.2000	80	36	36	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					680	695		10.1074/jbc.M113.518365	http://dx.doi.org/10.1074/jbc.M113.518365			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273169	Green Published, hybrid			2022-12-25	WOS:000330541200008
J	Kroger, S; Pieper, R; Schwelberger, HG; Wang, J; Tudela, CV; Aschenbach, JR; Van Kessel, AG; Zentek, J				Kroeger, Susan; Pieper, Robert; Schwelberger, Hubert G.; Wang, Jing; Villodre Tudela, Carmen; Aschenbach, Joerg R.; Van Kessel, Andrew G.; Zentek, Juergen			Diets High in Heat-Treated Soybean Meal Reduce the Histamine-Induced Epithelial Response in the Colon of Weaned Piglets and Increase Epithelial Catabolism of Histamine	PLOS ONE			English	Article							ENTEROTOXIGENIC STRAIN; PROTEIN FERMENTATION; CHLORIDE SECRETION; HYDROGEN-SULFIDE; BIOGENIC-AMINES; SMALL-INTESTINE; PORCINE ILEUM; DIARRHEA; PERFORMANCE; TRANSPORT	We examined the influence of dietary fermentable protein (fCP) and fermentable carbohydrates (fCHO) on the colonic epithelial response to histamine in pigs. Thirty-two weaned piglets were fed 4 diets in a 2 x 2 factorial design with low fCP/low fCHO, low fCP/high fCHO, high fCP/low fCHO and high fCP/high fCHO. After 21-23 days, the pigs were killed and tissue from the proximal colon was stimulated with carbachol, histamine, PGE(2) or sodium hydrogen sulphide in Ussing chambers. Changes in short-circuit current and tissue conductance were measured. Diamine oxidase, histamine N-methyltransferase, stem cell growth factor receptor, Fc-epsilon receptor I and cystic fibrosis transmembrane conductance regulator gene expression was determined. Activities of diamine oxidase and histamine N-methyltransferase and numbers of colonic mast cells were measured. The change in the short-circuit current in response to histamine was lower (P = 0.002) and tended to be lower for PGE(2) (P = 0.053) in high fCP groups compared to low fCP groups, irrespective of fCHO. Additionally, the change in tissue conductance after the application of histamine was lower (P = 0.005) in the high fCP groups. The expression of histamine N-methyltransferase mRNA (P = 0.033) and the activities of diamine oxidase (P = 0.001) and histamine N-methyltransferase (P = 0.006) were higher with high fCP in comparison with low fCP. The expression of mast cell markers, stem cell growth factor receptor (P = 0.005) and Fc-epsilon receptor I (P = 0.049) was higher with high fCP diets compared to diets low in fCP, whereas the mast cell count did not differ between groups. The expression of the cystic fibrosis transmembrane conductance regulator was reduced (P = 0.001) with high fCP diets compared to low fCP diets. The lower epithelial response to histamine and PGE(2) and elevated epithelial histamine inactivation suggests an adaptation to high fCP diets.	[Kroeger, Susan; Pieper, Robert; Villodre Tudela, Carmen; Zentek, Juergen] Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Berlin, Germany; [Schwelberger, Hubert G.] Med Univ Innsbruck, Dept Visceral Transplantat & Thorac Surg, Mol Biol Lab, A-6020 Innsbruck, Austria; [Wang, Jing; Van Kessel, Andrew G.] Univ Saskatchewan, Dept Anim & Poultry Sci, Saskatoon, SK S7N 0W0, Canada; [Villodre Tudela, Carmen] Univ Murcia, Dept Anim Prod, Fac Vet Sci, Murcia, Spain; [Aschenbach, Joerg R.] Free Univ Berlin, Inst Vet Physiol, Dept Vet Med, Berlin, Germany	Free University of Berlin; Medical University of Innsbruck; University of Saskatchewan; University of Murcia; Free University of Berlin	Zentek, J (corresponding author), Free Univ Berlin, Inst Anim Nutr, Dept Vet Med, Berlin, Germany.	Juergen.Zentek@fu-berlin.de	Aschenbach, Joerg R/R-7572-2016	Aschenbach, Joerg R/0000-0001-5080-1007; Pieper, Robert/0000-0002-0292-1482	Evonik Industries (Hanau - Wolfgang, Germany); German Research Foundation (DFG) [SFB852/1]; Canadian Swine Research and Development Cluster; Integrated Graduate School 'Biology of Nutrition' of the Collaborative Research Group [SFB852]	Evonik Industries (Hanau - Wolfgang, Germany); German Research Foundation (DFG)(German Research Foundation (DFG)); Canadian Swine Research and Development Cluster; Integrated Graduate School 'Biology of Nutrition' of the Collaborative Research Group	Evonik Industries (Hanau - Wolfgang, Germany; http://www.evonik.de), the German Research Foundation (DFG; http://www.dfg.de/) through grant # SFB852/1 and the Canadian Swine Research and Development Cluster (http://www.swineinnovationporc.ca) provided funding for this study. The Integrated Graduate School 'Biology of Nutrition' of the Collaborative Research Group SFB852 provided a doctoral stipend to J. Wang. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens F, 2003, INFLAMM RES, V52, P79; Akhavein MA, 2012, GASTROENT RES PRACT, DOI [10.1155/2012/950582, DOI 10.1155/2012/950582)]; Aschenbach JR, 2009, INFLAMM RES, V58, P269, DOI 10.1007/s00011-008-8091-9; Aschenbach JR, 2006, SCAND J GASTROENTERO, V41, P712, DOI 10.1080/00365520500419540; Barrett KE, 2000, ANNU REV PHYSIOL, V62, P535, DOI 10.1146/annurev.physiol.62.1.535; BEAVER MH, 1962, BRIT J PHARM CHEMOTH, V19, P385, DOI 10.1111/j.1476-5381.1962.tb01443.x; Blaut M, 2007, J NUTR, V137, p751S, DOI 10.1093/jn/137.3.751S; Blikslager AT, 2002, GUT, V50, P615, DOI 10.1136/gut.50.5.615; Blikslager AT, 1999, AM J PHYSIOL-GASTR L, V276, pG28, DOI 10.1152/ajpgi.1999.276.1.G28; Bock P., 1989, ROMEIS MIKROSKOPISCH; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; de Lange CFM, 2010, LIVEST SCI, V134, P124, DOI 10.1016/j.livsci.2010.06.117; Fairbrother John M., 2005, Animal Health Research Reviews, V6, P17, DOI 10.1079/AHR2005105; Fernandez-No IC, 2010, ELECTROPHORESIS, V31, P1116, DOI 10.1002/elps.200900591; Geypens B, 1997, GUT, V41, P70, DOI 10.1136/gut.41.1.70; HALASZ A, 1994, TRENDS FOOD SCI TECH, V5, P42, DOI 10.1016/0924-2244(94)90070-1; Hennig B, 2009, BRIT J PHARMACOL, V158, P1263, DOI 10.1111/j.1476-5381.2009.00385.x; Heo JM, 2009, J ANIM SCI, V87, P2833, DOI 10.2527/jas.2008-1274; Heo JM, 2008, ARCH ANIM NUTR, V62, P343, DOI 10.1080/17450390802327811; Hill SJ, 1997, PHARMACOL REV, V49, P253; Hughes R, 2000, Curr Issues Intest Microbiol, V1, P51; Ji Y, 2012, AM J PHYSIOL-GASTR L, V302, pG1292, DOI 10.1152/ajpgi.00011.2012; Kim JC, 2011, ANIM FEED SCI TECH, V170, P222, DOI 10.1016/j.anifeedsci.2011.08.012; Kim JC, 2008, BRIT J NUTR, V99, P1217, DOI 10.1017/S0007114507868462; Klaus A, 2003, TRANSPL INT, V16, P572, DOI 10.1007/s00147-003-0589-z; Klocker J, 2005, INFLAMM RES, V54, pS54, DOI 10.1007/s00011-004-0425-7; Liu YH, 2006, POULTRY SCI, V85, P2149, DOI 10.1093/ps/85.12.2149; Lucas ML, 2008, J PHYSIOL BIOCHEM, V64, P69, DOI 10.1007/BF03168236; Maintz L, 2007, AM J CLIN NUTR, V85, P1185, DOI 10.1093/ajcn/85.5.1185; Molist F, 2010, LIVEST SCI, V133, P214, DOI 10.1016/j.livsci.2010.06.067; Molist F, 2011, BRIT J NUTR, V105, P1592, DOI 10.1017/S0007114510004575; Pieper R, 2012, J NUTR, V142, P661, DOI 10.3945/jn.111.156190; RODWELL AW, 1953, J GEN MICROBIOL, V8, P224, DOI 10.1099/00221287-8-2-224; Schicho R, 2006, GASTROENTEROLOGY, V131, P1542, DOI 10.1053/j.gastro.2006.08.035; SCHNEIDER R, 1989, ARCH TIERERNAHR, V39, P1021, DOI 10.1080/17450398909434377; Schwelberger H G, 1995, Inflamm Res, V44 Suppl 1, pS94, DOI 10.1007/BF01674413; Thomas CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031951; TRAYNOR TR, 1993, J PHARMACOL EXP THER, V264, P61; WELSH MJ, 1982, SCIENCE, V218, P1219, DOI 10.1126/science.6293054; YAMANI MI, 1985, INT J FOOD MICROBIOL, V2, P273, DOI 10.1016/0168-1605(85)90040-6; Zhang H, 2007, J PHYSIOL-LONDON, V581, P1221, DOI 10.1113/jphysiol.2007.129262; Zielschot NC, 2012, THESIS TIERARZTLICHE; Zijlstra RT, 1999, J NUTR, V129, P838, DOI 10.1093/jn/129.4.838	43	16	16	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80612	10.1371/journal.pone.0080612	http://dx.doi.org/10.1371/journal.pone.0080612			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260435	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900077
J	Meyer, C; Corten, K; Wesseling, M; Peers, K; Simon, JP; Jonkers, I; Desloovere, K				Meyer, Christophe; Corten, Kristoff; Wesseling, Mariska; Peers, Koen; Simon, Jean-Pierre; Jonkers, Ilse; Desloovere, Kaat			Test-Retest Reliability of Innovated Strength Tests for Hip Muscles	PLOS ONE			English	Article							HAND-HELD DYNAMOMETRY; LOW-BACK-PAIN; KNEE ARTHROPLASTY; BODY-SIZE; OSTEOARTHRITIS; REPRODUCIBILITY; FIXATION; CHILDREN; VALIDITY; CHAIR	The burden of hip muscles weakness and its relation to other impairments has been well documented. It is therefore a pre-requisite to have a reliable method for clinical assessment of hip muscles function allowing the design and implementation of a proper strengthening program. Motor-driven dynamometry has been widely accepted as the gold-standard for lower limb muscle strength assessment but is mainly related to the knee joint. Studies focusing on the hip joint are less exhaustive and somewhat discrepant with regard to optimal participants position, consequently influencing outcome measures. Thus, we aimed to develop a standardized test setup for the assessment of hip muscles strength, i.e. flexors/extensors and abductors/adductors, with improved participant stability and to define its psychometric characteristics. Eighteen participants performed unilateral isokinetic and isometric contractions of the hip muscles in the sagittal and coronal plane at two separate occasions. Peak torque and normalized peak torque were measured for each contraction. Relative and absolute measures of reliability were calculated using the intraclass correlation coefficient and standard error of measurement, respectively. Results from this study revealed higher levels of between-day reliability of isokinetic/isometric hip abduction/flexion peak torque compared to existing literature. The least reliable measures were found for hip extension and adduction, which could be explained by a less efficient stabilization technique. Our study additionally provided a first set of reference normalized data which can be used in future research.	[Meyer, Christophe; Desloovere, Kaat] Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium; [Meyer, Christophe; Corten, Kristoff; Simon, Jean-Pierre] UZ Pellenberg, Dept Orthoped, Univ Hosp Leuven, Pellenberg, Belgium; [Wesseling, Mariska; Jonkers, Ilse] Katholieke Univ Leuven, Dept Human Movement Biomech, Fac Kinesiol & Rehabil Sci, Louvain, Belgium; [Peers, Koen] UZ Pellenberg, Dept Phys Med & Rehabil, Univ Hosp Leuven, Pellenberg, Belgium; [Peers, Koen] Katholieke Univ Leuven, Dept Dev & Regenerat, Fac Med, Louvain, Belgium	KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven; KU Leuven; University Hospital Leuven; KU Leuven	Meyer, C (corresponding author), Katholieke Univ Leuven, Dept Rehabil Sci, Fac Kinesiol & Rehabil Sci, Louvain, Belgium.	christophe.meyer@faber.kuleuven.be	jonkers, ilse/J-9544-2015; Desloovere, Kaat/F-3240-2014	jonkers, ilse/0000-0001-7611-3747; Desloovere, Kaat/0000-0002-8507-5276; Meyer, Christophe, AG/0000-0002-7214-9598; Wesseling, Mariska/0000-0002-3347-2130	Agency of Innovation by Science and Technology of the Flemish Government [100786]	Agency of Innovation by Science and Technology of the Flemish Government	This study has been supported by the Agency of Innovation by Science and Technology of the Flemish Government, by an Applied Biomedical Research grant (Grant number: 100786). http://www.iwt.be/subsidies/tbm The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arokoski MH, 2002, J RHEUMATOL, V29, P2185; Bazett-Jones DM, 2011, ARCH PHYS MED REHAB, V92, P76, DOI 10.1016/j.apmr.2010.08.020; Benard MR, 2010, CLIN BIOMECH, V25, P802, DOI 10.1016/j.clinbiomech.2010.04.010; Bohannon RW, 2001, AM J PHYS MED REHAB, V80, P13, DOI 10.1097/00002060-200101000-00004; Bolgla LA, 2011, INT J SPORTS PHYS TH, V6, P285; Claiborne Tina L, 2009, J Electromyogr Kinesiol, V19, pe345, DOI 10.1016/j.jelekin.2008.07.005; Emery CA, 1999, CLIN J SPORT MED, V9, P79, DOI 10.1097/00042752-199904000-00007; Gagnon D, 2005, ARCH PHYS MED REHAB, V86, P1998, DOI 10.1016/j.apmr.2005.04.013; Hinman RS, 2010, ARTHRIT CARE RES, V62, P1190, DOI 10.1002/acr.20199; Hogrel JY, 2007, ARCH PHYS MED REHAB, V88, P1289, DOI 10.1016/j.apmr.2007.07.011; Jaric S, 2002, SPORTS MED, V32, P615, DOI 10.2165/00007256-200232100-00002; Julia M., 2010, Annals of Physical and Rehabilitation Medicine, V53, P293, DOI 10.1016/j.rehab.2010.05.002; Kamada S, 2011, ARCH ORTHOP TRAUM SU, V131, P1723, DOI 10.1007/s00402-011-1350-1; Koblbauer IFH, 2011, BMC MUSCULOSKEL DIS, V12, DOI 10.1186/1471-2474-12-249; Kolber MJ, PHYSIOTHERAPY THEORY, V23, P119, DOI [10.1080/09593980701213032, DOI 10.1080/09593980701213032.PUBMED:17530541]; Laheru D, 2007, ARCH PHYS MED REHAB, V88, P1147, DOI 10.1016/j.apmr.2007.05.017; Lugade V, 2010, CLIN BIOMECH, V25, P675, DOI 10.1016/j.clinbiomech.2010.05.003; Mahony K, 2009, PHYS OCCUP THER PEDI, V29, P44, DOI 10.1080/01942630802574858; Marshall PWM, 2011, HUM MOVEMENT SCI, V30, P63, DOI 10.1016/j.humov.2010.08.017; Mayr E, 2009, CLIN BIOMECH, V24, P812, DOI 10.1016/j.clinbiomech.2009.07.010; Nadler SF, 2000, CLIN J SPORT MED, V10, P89, DOI 10.1097/00042752-200004000-00002; Nelson-Wong E, 2008, CLIN BIOMECH, V23, P545, DOI 10.1016/j.clinbiomech.2008.01.002; Pincivero DM, 2003, EUR J APPL PHYSIOL, V89, P134, DOI 10.1007/s00421-002-0739-5; Prins MR, 2009, AUST J PHYSIOTHER, V55, P9, DOI 10.1016/S0004-9514(09)70055-8; Rasch A, 2010, ACTA ORTHOP, V81, P183, DOI 10.3109/17453671003793204; Reiman MP, 2009, J SPORT REHABIL, V18, P33, DOI 10.1123/jsr.18.1.33; Saenz A, 2010, EUR J PHYS REHAB MED, V46, P81; Thorborg K, 2010, SCAND J MED SCI SPOR, V20, P493, DOI 10.1111/j.1600-0838.2009.00958.x; Thorborg K, 2013, KNEE SURG SPORT TR A, V21, P550, DOI 10.1007/s00167-012-2115-2; Vincent W.J., 2012, STAT KINESIOLOGY, V4th ed.; WADSWORTH CT, 1987, PHYS THER, V67, P1342, DOI 10.1093/ptj/67.9.1342; Weir JP, 2005, J STRENGTH COND RES, V19, P231, DOI 10.1519/15184.1; Widler KS, 2009, J BONE JOINT SURG AM, V91A, P2666, DOI 10.2106/JBJS.H.01119; WRETENBERG P, 1994, EUR J APPL PHYSIOL, V68, P413, DOI 10.1007/BF00843738	34	29	31	1	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81149	10.1371/journal.pone.0081149	http://dx.doi.org/10.1371/journal.pone.0081149			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260550	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900122
J	Clementi, EA; Wilhelm, KR; Schleucher, J; Morozova-Roche, LA; Hakansson, AP				Clementi, Emily A.; Wilhelm, Kristina R.; Schleucher, Juergen; Morozova-Roche, Ludmilla A.; Hakansson, Anders P.			A Complex of Equine Lysozyme and Oleic Acid with Bactericidal Activity against Streptococcus pneumoniae	PLOS ONE			English	Article							HUMAN ALPHA-LACTALBUMIN; FATTY-ACIDS; RUTHENIUM RED; TUMOR-CELLS; FOLDING VARIANT; HAMLET; PROTEIN; APOPTOSIS; MEMBRANE; MILK	HAMLET and ELOA are complexes consisting of oleic acid and two homologous, yet functionally different, proteins with cytotoxic activities against mammalian cells, with HAMLET showing higher tumor cells specificity, possibly due to the difference in propensity for oleic acid binding, as HAMLET binds 5-8 oleic acid molecules per protein molecule and ELOA binds 11-48 oleic acids. HAMLET has been shown to possess bactericidal activity against a number of bacterial species, particularly those with a respiratory tropism, with Streptococcus pneumoniae displaying the greatest degree of sensitivity. We show here that ELOA also displays bactericidal activity against pneumococci, which at lower concentrations shows mechanistic similarities to HAMLET's bactericidal activity. ELOA binds to S. pneumoniae and causes perturbations of the plasma membrane, including depolarization and subsequent rupture, and activates an influx of calcium into the cells. Selective inhibition of calcium channels and sodium/calcium exchange activity significantly diminished ELOA's bactericidal activity, similar to what we have observed with HAMLET. Finally, ELOA-induced death was also accompanied by DNA fragmentation into high molecular weight fragments - an apoptosis-like morphological phenotype that is seen during HAMLET-induced death. Thus, in contrast to different mechanisms of eukaryote cell death induced by ELOA and HAMLET, these complexes are characterized by rather similar activities towards bacteria. Although the majority of these events could be mimicked using oleic acid alone, the concentrations of oleic acid required were significantly higher than those present in the ELOA complex, and for some assays, the results were not identical between oleic acid alone and the ELOA complex. This indicates that the lipid, as a common denominator in both complexes, is an important component for the complexes' bactericidal activities, while the proteins are required both to solubilize and/or present the lipid at the bacterial membrane and likely to confer other and separate functions during the bacterial death.	[Clementi, Emily A.; Hakansson, Anders P.] SUNY Buffalo, Dept Microbiol & Immunol, Buffalo, NY 14260 USA; [Wilhelm, Kristina R.; Schleucher, Juergen; Morozova-Roche, Ludmilla A.] Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden; [Hakansson, Anders P.] Witebsky Ctr Microbial Pathogenesis & Immunol, Buffalo, NY USA; [Hakansson, Anders P.] SUNY Buffalo, New York Ctr Excellence Bioinformat & Life Sci, Buffalo, NY 14260 USA	State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Umea University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo	Hakansson, AP (corresponding author), Umea Univ, Dept Med Biochem & Biophys, S-90187 Umea, Sweden.	ludmilla.morozova-roche@medchem.umu.se; andersh@buffalo.edu	Morozova-Roche, Ludmilla A./AAU-9044-2021; Hakansson, Anders P/AAX-1225-2020; Morozova-Roche, Ludmilla/AAV-9983-2021; Hakansson, Anders/H-8190-2014	Hakansson, Anders P/0000-0002-2834-6009; Morozova-Roche, Ludmilla/0000-0001-5886-2023; Hakansson, Anders/0000-0002-2834-6009	Bill and Melinda Gates Foundation [53085]; JR Oishei Foundation; American Lung Association [RG-123721-N]; NIH (NIDCD) [F31DC011218]; Swedish Medical Research Council; Insamlingsstiftelsen Umea; Kempe Foundation	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); JR Oishei Foundation; American Lung Association; NIH (NIDCD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Insamlingsstiftelsen Umea; Kempe Foundation	This work was supported by the Bill and Melinda Gates Foundation (Grant 53085), the JR Oishei Foundation, and The American Lung Association (Grant RG-123721-N) to APH, and NIH (NIDCD) fellowship F31DC011218 to EAC. LAM-R acknowledges the support from the Swedish Medical Research Council, Insamlingsstiftelsen Umea and Kempe Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antignani A, 2006, CURR OPIN CELL BIOL, V18, P685, DOI 10.1016/j.ceb.2006.10.004; Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137; Baumann A, 2012, J MOL BIOL, V418, P90, DOI 10.1016/j.jmb.2012.02.006; Bender T, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a011106; BERRY AM, 1989, INFECT IMMUN, V57, P2324, DOI 10.1128/IAI.57.8.2324-2330.1989; BORST P, 1962, BIOCHIM BIOPHYS ACTA, V62, P509, DOI 10.1016/0006-3002(62)90232-9; Brinkmann CR, 2013, FEBS J, V280, P1733, DOI 10.1111/febs.12204; Brinkmann CR, 2011, FEBS J, V278, P1955, DOI 10.1111/j.1742-4658.2011.08112.x; BRODBECK U, 1967, J BIOL CHEM, V242, P1391; CAMPAGNARI AA, 1987, INFECT IMMUN, V55, P882, DOI 10.1128/IAI.55.4.882-887.1987; CARSON DD, 1980, J BACTERIOL, V141, P1122, DOI 10.1128/JB.141.3.1122-1126.1980; CHAMBERLAIN NR, 1991, INFECT IMMUN, V59, P4332, DOI 10.1128/IAI.59.12.4332-4337.1991; Chiti F, 2006, ANNU REV BIOCHEM, V75, P333, DOI 10.1146/annurev.biochem.75.101304.123901; Clementi EA, 2012, J BIOL CHEM, V287, P27168, DOI 10.1074/jbc.M112.371070; COONROD JD, 1991, J INFECT DIS, V164, P527, DOI 10.1093/infdis/164.3.527; COTTAGNOUD P, 1993, J INFECT DIS, V167, P684, DOI 10.1093/infdis/167.3.684; Desbois AP, 2010, APPL MICROBIOL BIOT, V85, P1629, DOI 10.1007/s00253-009-2355-3; Fassel TA, 1999, BIOTECH HISTOCHEM, V74, P194, DOI 10.3109/10520299909047974; Gagnaire V, 2009, J DAIRY SCI, V92, P811, DOI 10.3168/jds.2008-1476; GALBRAITH H, 1971, J APPL BACTERIOL, V34, P803, DOI 10.1111/j.1365-2672.1971.tb01019.x; Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320; HAKANSSON A, 1995, P NATL ACAD SCI USA, V92, P8064, DOI 10.1073/pnas.92.17.8064; Hakansson A, 1999, EXP CELL RES, V246, P451, DOI 10.1006/excr.1998.4265; Hakansson A, 2000, MOL MICROBIOL, V35, P589, DOI 10.1046/j.1365-2958.2000.01728.x; Hakansson AP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017717; Kasai M, 1996, Ion Channels, V4, P303; KERR JFR, 1995, METHOD CELL BIOL, V46, P1; Knyazeva EL, 2008, BIOCHEMISTRY-US, V47, P13127, DOI 10.1021/bi801423s; Kohler C, 2001, EUR J BIOCHEM, V268, P186, DOI 10.1046/j.1432-1327.2001.01870.x; LAGARKOVA MA, 1995, J BIOL CHEM, V270, P20239, DOI 10.1074/jbc.270.35.20239; Lukyanenko V, 2000, BIOPHYS J, V79, P1273, DOI 10.1016/S0006-3495(00)76381-8; Malisauskas M, 2005, J BIOL CHEM, V280, P6269, DOI 10.1074/jbc.M407273200; Marks LR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063158; Marks LR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043514; Morozova-Roche LA, 2007, FEBS LETT, V581, P2587, DOI 10.1016/j.febslet.2007.05.023; Mossberg AK, 2010, FEBS J, V277, P4614, DOI 10.1111/j.1742-4658.2010.07890.x; Mossberg AK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009384; Nielsen SB, 2010, J MOL BIOL, V398, P351, DOI 10.1016/j.jmb.2010.03.012; Permyakov SE, 2011, BIOCHIMIE, V93, P1495, DOI 10.1016/j.biochi.2011.05.002; Permyakovz SE, 2012, BIOL CHEM, V393, P85, DOI 10.1515/BC-2011-230; Pettersson-Kastberg J, 2009, J MOL BIOL, V394, P994, DOI 10.1016/j.jmb.2009.09.026; Pettersson-Kastberg J, 2009, ANN MED, V41, P162, DOI 10.1080/07853890802502614; Rodland I, 2005, BBA-BIOMEMBRANES, V1717, P11, DOI 10.1016/j.bbamem.2005.09.004; SHEU CW, 1972, J BACTERIOL, V111, P516, DOI 10.1128/JB.111.2.516-524.1972; SPEERT DP, 1979, INFECT IMMUN, V26, P1202, DOI 10.1128/IAI.26.3.1202-1210.1979; SPOLAORE B, 2010, BIOCHEMISTRY; Storm P, 2011, ONCOGENE, V30, P4765, DOI 10.1038/onc.2011.196; Svensson M, 2000, P NATL ACAD SCI USA, V97, P4221, DOI 10.1073/pnas.97.8.4221; Svensson M, 1999, J BIOL CHEM, V274, P6388, DOI 10.1074/jbc.274.10.6388; Tolin S, 2010, FEBS J, V277, P163, DOI 10.1111/j.1742-4658.2009.07466.x; Voelker D, 1996, BIOPHYS J, V70, P818, DOI 10.1016/S0006-3495(96)79621-2; Vukojevic V, 2010, LANGMUIR, V26, P14782, DOI 10.1021/la1026416; WATSON EL, 1971, BIOCHIM BIOPHYS ACTA, V249, P606, DOI 10.1016/0005-2736(71)90140-4; Wilhelm K, 2009, FEBS J, V276, P3975, DOI 10.1111/j.1742-4658.2009.07107.x; WILLETT NP, 1966, J BACTERIOL, V91, P2245, DOI 10.1128/JB.91.6.2245-2250.1966; YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9; Zherelova OM, 2009, J BIOENERG BIOMEMBR, V41, P229, DOI 10.1007/s10863-009-9222-x	57	17	17	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80649	10.1371/journal.pone.0080649	http://dx.doi.org/10.1371/journal.pone.0080649			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260444	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500164
J	Dong, BX; Zhang, SS; Gao, W; Su, HC; Chen, J; Jin, FZ; Bhargava, A; Chen, XQ; Jorgensen, L; Alberts, AS; Zhang, JY; Siminovitch, KA				Dong, Baoxia; Zhang, Steven S.; Gao, Wen; Su, Haichun; Chen, Jun; Jin, Fuzi; Bhargava, Ajay; Chen, Xiequn; Jorgensen, Lars; Alberts, Arthur S.; Zhang, Jinyi; Siminovitch, Katherine A.			Mammalian Diaphanous-Related Formin 1 Regulates GSK3 beta-Dependent Microtubule Dynamics Required for T Cell Migratory Polarization	PLOS ONE			English	Article							ADENOMATOUS POLYPOSIS-COLI; LYMPH-NODE; PROTEIN; ACTIVATION; GROWTH; PHOSPHORYLATION; CENTROSOME; GSK-3-BETA; STABILITY; TRACKING	The mammalian diaphanous-related formin (mDia1), a Rho-regulated cytoskeletal modulator, has been shown to promote T lymphocyte chemotaxis and interaction with antigen presenting cells, but the mechanisms underpinning mDia1 roles in these processes have not been defined. Here we show that mDia1(-/-) T cells exhibit impaired lymphocyte function-associated antigen 1 (LFA-1)-mediated T cell adhesion, migration and in vivo trafficking. These defects are associated with impaired microtubule (MT) polarization and stabilization, altered MT dynamics and reduced peripheral clustering of the MT plus-end-protein, adenomatous polyposis coli (APC) in migrating T cells following LFA-1-engagement. Loss of mDia1 also leads to impaired inducible inactivation of the glycogen synthase kinase (GSK) 3 beta as well as hyperphosphorylation and reduced levels of APC in migrating T cells. These findings identify essential roles for the mDia1 formin in modulating GSK3 beta-dependent MT contributions to induction of T-cell polarity, adhesion and motility.	[Dong, Baoxia; Zhang, Steven S.; Gao, Wen; Su, Haichun; Chen, Jun; Jin, Fuzi; Bhargava, Ajay; Jorgensen, Lars; Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Immunol, Toronto, ON M5G 1X5, Canada; [Dong, Baoxia; Zhang, Steven S.; Gao, Wen; Su, Haichun; Chen, Jun; Jin, Fuzi; Bhargava, Ajay; Jorgensen, Lars; Siminovitch, Katherine A.] Univ Toronto, Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Mol Genet, Toronto, ON M5G 1X5, Canada; [Dong, Baoxia; Zhang, Steven S.; Gao, Wen; Su, Haichun; Chen, Jun; Jin, Fuzi; Bhargava, Ajay; Jorgensen, Lars; Siminovitch, Katherine A.] Toronto Gen Res Inst, Toronto, ON, Canada; [Dong, Baoxia; Chen, Xiequn] Xijing Hosp, Dept Hematol, Xian, Shaanxi, Peoples R China; [Alberts, Arthur S.] Van Andel Inst, Cell Struct & Signal Integrat Lab, Grand Rapids, MI USA; [Zhang, Jinyi; Siminovitch, Katherine A.] Univ Toronto, Dept Med, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Toronto General Hospital; Air Force Military Medical University; Van Andel Institute; University of Toronto	Zhang, JY (corresponding author), Univ Toronto, Dept Med, Toronto, ON, Canada.	jinyi@lunenfeld.ca; ksimin@mshri.on.ca	Siminovitch, Katherine/K-1475-2013	Jin, Fuzi/0000-0002-3401-8511	Canadian Institutes for Health Research [MOP 119287, MOP79321]	Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR))	This work is supported by grants from the Canadian Institutes for Health Research (MOP 119287, MOP79321) to K.A.S. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Billadeau DD, 2007, NAT REV IMMUNOL, V7, P131, DOI 10.1038/nri2021; Braun A, 2011, NAT IMMUNOL, V12, P879, DOI 10.1038/ni.2085; Butler B, 2009, CURR BIOL, V19, P1886, DOI 10.1016/j.cub.2009.10.029; Cahalan MD, 2008, ANNU REV IMMUNOL, V26, P585, DOI 10.1146/annurev.immunol.24.021605.090620; Chen S, 2013, DEV CELL, V24, P26, DOI 10.1016/j.devcel.2012.11.014; CROSS DAE, 1995, NATURE, V378, P785, DOI 10.1038/378785a0; Eisenmann KM, 2007, J BIOL CHEM, V282, P25152, DOI 10.1074/jbc.M703243200; Etienne-Manneville S, 2003, NATURE, V421, P753, DOI 10.1038/nature01423; Faix J, 2006, DEV CELL, V10, P693, DOI 10.1016/j.devcel.2006.05.001; Gaillard J, 2011, MOL BIOL CELL, V22, P4575, DOI 10.1091/mbc.E11-07-0616; Gomez TS, 2007, IMMUNITY, V26, P177, DOI 10.1016/j.immuni.2007.01.008; Harris ES, 2010, MOL BIOL CELL, V21, P2611, DOI 10.1091/mbc.E10-03-0235; Hashimoto-Tane A, 2011, IMMUNITY, V34, P919, DOI 10.1016/j.immuni.2011.05.012; Hogg N, 2011, NAT REV IMMUNOL, V11, P416, DOI 10.1038/nri2986; Hur EM, 2011, GENE DEV, V25, P1968, DOI 10.1101/gad.17015911; Jacobelli J, 2009, J IMMUNOL, V182, P2041, DOI 10.4049/jimmunol.0803267; Janke C, 2011, NAT REV MOL CELL BIO, V12, P773, DOI 10.1038/nrm3227; Katakai T, 2013, J IMMUNOL, V191, P1188, DOI 10.4049/jimmunol.1300739; Kinashi T, 2005, NAT REV IMMUNOL, V5, P546, DOI 10.1038/nri1646; Kroboth K, 2007, MOL BIOL CELL, V18, P910, DOI 10.1091/mbc.E06-03-0179; Krummel MF, 2006, NAT IMMUNOL, V7, P1143, DOI 10.1038/ni1404; Kumar P, 2009, J CELL BIOL, V184, P895, DOI 10.1083/jcb.200901042; Matov A, 2010, NAT METHODS, V7, P761, DOI 10.1038/nmeth.1493; Molema G, 1998, CYTOMETRY, V32, P37, DOI 10.1002/(SICI)1097-0320(19980501)32:1<37::AID-CYTO5>3.0.CO;2-C; Mora JR, 2006, TRENDS IMMUNOL, V27, P235, DOI 10.1016/j.it.2006.03.007; Palazzo A, 2003, NATURE, V421, P230, DOI 10.1038/421230a; Park EJ, 2010, BLOOD, V115, P1572, DOI 10.1182/blood-2009-08-237917; Purro SA, 2008, J NEUROSCI, V28, P8644, DOI 10.1523/JNEUROSCI.2320-08.2008; Ratner S, 1997, J IMMUNOL, V159, P1063; RIDLEY AJ, 2010, SMALL GTPASES, V1, P174, DOI DOI 10.4161/SGTP.1.3.14724.PUBMED:21686273; Sakata D, 2007, J EXP MED, V204, P2031, DOI 10.1084/jem.20062647; Sbalzarini IF, 2005, J STRUCT BIOL, V151, P182, DOI 10.1016/j.jsb.2005.06.002; Shi YQ, 2009, J IMMUNOL, V182, P3837, DOI 10.4049/jimmunol.0803838; Shulman Z, 2009, IMMUNITY, V30, P384, DOI 10.1016/j.immuni.2008.12.020; Takesono A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008774; von Andrian UH, 2003, NAT REV IMMUNOL, V3, P867, DOI 10.1038/nri1222; Wang HY, 2009, P NATL ACAD SCI USA, V106, P12436, DOI 10.1073/pnas.0900510106; Watanabe T, 2005, TRENDS CELL BIOL, V15, P76, DOI 10.1016/j.tcb.2004.12.006; Wen YD, 2004, KENYON REV, V26, P1; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zumbrunn J, 2001, CURR BIOL, V11, P44, DOI 10.1016/S0960-9822(01)00002-1	43	12	12	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80500	10.1371/journal.pone.0080500	http://dx.doi.org/10.1371/journal.pone.0080500			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260404	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500145
J	Micucci, M; Aldini, R; Cevenini, M; Colliva, C; Spinozzi, S; Roda, G; Montagnani, M; Camborata, C; Camarda, L; Chiarini, A; Mazzella, G; Budriesi, R				Micucci, Matteo; Aldini, Rita; Cevenini, Monica; Colliva, Carolina; Spinozzi, Silvia; Roda, Giulia; Montagnani, Marco; Camborata, Cecilia; Camarda, Luca; Chiarini, Alberto; Mazzella, Giuseppe; Budriesi, Roberta			Curcuma longa L. as a Therapeutic Agent in Intestinal Motility Disorders. 2: Safety Profile in Mouse	PLOS ONE			English	Article							IRRITABLE-BOWEL-SYNDROME; SALT EXPORT PUMP; INDUCED CHOLESTASIS; INHIBITION; ACTIVATION; SUPPRESSION; METABOLISM; EXPRESSION; SEROTONIN; APOPTOSIS	Background: Curcuma extract exerts a myorelaxant effect on the mouse intestine. In view of a possible use of curcuma extract in motor functional disorders of the gastrointestinal tract, a safety profile study has been carried out in the mouse. Methods: Thirty mice were used to study the in vitro effect of curcuma on gallbladder, bladder, aorta and trachea smooth muscular layers and hearth inotropic and chronotropic activity. The myorelaxant effect on the intestine was also thoroughly investigated. Moreover, curcuma extract (200 mg/Kg/day) was orally administered to twenty mice over 28 days and serum liver and lipids parameters were evaluated. Serum, bile and liver bile acids qualitative and quantitative composition was were also studied. Results: In the intestine, curcuma extract appeared as a not competitive inhibitor through cholinergic, histaminergic and serotoninergic receptors and showed spasmolytic effect on K+ induced contraction at the level of L type calcium channels. No side effect was observed on bladder, aorta, trachea and heart when we used a dose that is effective on the intestine. An increase in gallbladder tone and contraction was observed. Serum liver and lipids parameters were normal, while a slight increase in serum and liver bile acids concentration and a decrease in bile were observed. Conclusions: Although these data are consistent with the safety of curcuma extract as far as its effect on the smooth muscular layers of different organs and on the heart, the mild cholestatic effect observed in absence of alteration of liver function tests must be further evaluated and the effective dose with minimal side effects considered.	[Micucci, Matteo; Aldini, Rita; Camarda, Luca; Chiarini, Alberto; Budriesi, Roberta] Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy; [Cevenini, Monica; Roda, Giulia; Montagnani, Marco; Mazzella, Giuseppe] Univ Bologna, Dipartimento Sci Med & Chirurg, Bologna, Italy; [Colliva, Carolina; Spinozzi, Silvia; Camborata, Cecilia] Univ Bologna, Dipartimento Chim G Ciamician, I-40126 Bologna, Italy	University of Bologna; University of Bologna; University of Bologna	Aldini, R (corresponding author), Univ Bologna, Dipartimento Farm & Biotecnol, Bologna, Italy.	rita.aldini@unibo.it; roberta.budriesi@unibo.it	Roda, Giulia/E-5521-2011; Micucci, Matteo/AAM-6126-2020; mazzella, giuseppe/A-1865-2016	MONTAGNANI, MARCO/0000-0003-0103-0327; MICUCCI, MATTEO/0000-0003-3525-1531; Mazzella, Giuseppe/0000-0001-8656-8112	Fondazione del Monte di Bologna e Ravenna; Alisal [Mazz100136-2010]; MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI [11008/7303/10]	Fondazione del Monte di Bologna e Ravenna(Fondazione del Monte di Bologna e Ravenna); Alisal; MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI	This work was supported by grants from Fondazione del Monte di Bologna e Ravenna and from Alisal (Mazz100136-2010). ALISAL is a project supported by the MINISTERO DELLE POLITICHE AGRICOLE, ALIMENTARI E FORESTALI, with D. M. 11008/7303/10, dated 17/05/2010. The title of the project is: Miglioramento delle proprieta igienico-sanitarie, salutistiche e funzionali di commodity per l'alimentazione dell'uomo e/o degli animali (Improvement of sanitary properties, healthy and functional food commodities for human and/or animals). Prof. GM was supported with materials, reagents, animals. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AHMED T, 2008, PHARM BIOCH BEHAV, V91, P554; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Balestra B, 2012, NEUROGASTROENT MOTIL, V24, P1118, DOI 10.1111/nmo.12000; BHAVANISHANKAR TN, 1980, INDIAN J EXP BIOL, V18, P73; Budriesi R, 2011, J MED CHEM, V54, P3885, DOI 10.1021/jm200199r; Budriesi R, 2010, J MED FOOD, V13, P1104, DOI 10.1089/jmf.2009.0210; Carosati E, 2006, J MED CHEM, V49, P5206, DOI 10.1021/jm0604373; Chainani-Wu N, 2003, J ALTERN COMPLEM MED, V9, P161, DOI 10.1089/107555303321223035; Cremon C, 2011, AM J GASTROENTEROL, V106, P1290, DOI 10.1038/ajg.2011.86; Cuomo J, 2011, J NAT PROD, V74, P664, DOI 10.1021/np1007262; De Ponti F, 2004, GUT, V53, P1520, DOI 10.1136/gut.2003.035568; De Ponti F, 2013, FRONT PHARMACOL, V4, DOI 10.3389/fphar.2013.00007; Deters M, 2003, PLANTA MED, V69, P337, DOI 10.1055/s-2003-38870; Elguero J, 2009, BIOORGAN MED CHEM, V17, P8027, DOI 10.1016/j.bmc.2009.10.006; Ervin CM, 2013, REV RECENT CLIN TRIA, V8, P9, DOI 10.2174/1574887111308010003; Fan X, 2013, CURR PHARM DESIGN, V19, P2011; Gerloff T, 1998, J BIOL CHEM, V273, P10046, DOI 10.1074/jbc.273.16.10046; Gupta SC, 2013, AAPS J, V15, P195, DOI 10.1208/s12248-012-9432-8; Hanai H, 2006, CLIN GASTROENTEROL H, V4, P1502, DOI 10.1016/j.cgh.2006.08.008; HUANG TS, 1991, P NATL ACAD SCI USA, V88, P5292, DOI 10.1073/pnas.88.12.5292; Hurley LL, 2013, BEHAV BRAIN RES, V239, P27, DOI 10.1016/j.bbr.2012.10.049; ITTHIPANICHPONG C, 2003, J MED ASS THAI S2, V86, pS2999; Jitoe-Masuda A, 2013, CURR PHARM DESIGN, V19, P2084; Kaur CD, 2011, J COSMET DERMATOL-US, V10, P260, DOI 10.1111/j.1473-2165.2011.00586.x; Khaw AK, 2013, J CELL BIOCHEM, V114, P1257, DOI 10.1002/jcb.24466; Kim Darrick S H L, 2012, Recent Pat CNS Drug Discov, V7, P184; Kurapati Kesava Rao V., 2012, Journal of Basic and Clinical Physiology and Pharmacology, V23, P139, DOI 10.1515/jbcpp-2012-0021; Lao Christopher D, 2006, BMC Complement Altern Med, V6, P10, DOI 10.1186/1472-6882-6-10; Lee JH, 2012, BIOL PHARM BULL, V35, P777, DOI 10.1248/bpb.35.777; Leray V, 2011, BRIT J NUTR, V106, pS198, DOI 10.1017/S0007114511002492; Liju VB, 2013, FOOD CHEM TOXICOL, V53, P52, DOI 10.1016/j.fct.2012.11.027; Luo CF, 2011, INT J PHARMACEUT, V410, P138, DOI 10.1016/j.ijpharm.2011.02.064; Madkor HR, 2011, BRIT J NUTR, V105, P1210, DOI 10.1017/S0007114510004927; Marzio L, 2003, DIGEST LIVER DIS, V35, pS17, DOI 10.1016/S1590-8658(03)00088-4; Orellana-Paucar AM, 2012, EPILEPSY BEHAV, V24, P14, DOI 10.1016/j.yebeh.2012.02.020; Motulsky H, 2003, PRACTICAL GUIDE CURV; Moynihan R, 2002, BRIT MED J, V325, P592, DOI 10.1136/bmj.325.7364.592; Negi PS, 1999, J AGR FOOD CHEM, V47, P4297, DOI 10.1021/jf990308d; Noorafshan A, 2013, CURR PHARM DESIGN, V19, P2032; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Qin XY, 2012, NEUROSCI BULL, V28, P606, DOI 10.1007/s12264-012-1275-x; Rahimi R, 2012, WORLD J GASTROENTERO, V18, P589, DOI 10.3748/wjg.v18.i7.589; Rasyid A, 1999, ALIMENT PHARM THERAP, V13, P245; Reagan-Shaw S, 2008, FASEB J, V22, P659, DOI 10.1096/fj.07-9574LSF; Reuland DJ, 2013, FREE RADICAL BIO MED, V56, P102, DOI 10.1016/j.freeradbiomed.2012.11.016; RODA A, 1995, J CHROMATOGR B, V665, P281, DOI 10.1016/0378-4347(94)00544-F; Saelee C, 2011, MOLECULES, V16, P3908, DOI 10.3390/molecules16053908; SAHEBKAR A, 2012, BIOFACTORS, V39, DOI DOI 10.1002/BI0F.1062.PUBMED:23239418; Sharma RA, 2007, ADV EXP MED BIOL, V595, P453; Singh AK, 1996, CANCER LETT, V107, P109, DOI 10.1016/0304-3835(96)04357-1; *SOFTW INC, VERS 3 0 GRAPHPAD; STIEGER B, 1992, BIOCHEM J, V284, P67, DOI 10.1042/bj2840067; STIEGER B, 1994, GASTROENTEROLOGY, V107, P1781, DOI 10.1016/0016-5085(94)90821-4; Stieger B, 2000, GASTROENTEROLOGY, V118, P422, DOI 10.1016/S0016-5085(00)70224-1; Su J, 2010, J ETHNOPHARMACOL, V130, P70, DOI 10.1016/j.jep.2010.04.012; Sun XD, 2012, MOL MED REP, V6, P1267, DOI 10.3892/mmr.2012.1103; TALLARIDA RJ, 1987, MANUAL PHARM CALCULA; Trendle MC, 1997, CANCER, V79, P830, DOI 10.1002/(SICI)1097-0142(19970215)79:4<830::AID-CNCR20>3.0.CO;2-#; Tsai YM, 2011, INT J PHARMACEUT, V416, P331, DOI 10.1016/j.ijpharm.2011.06.030; Venneman NG, 2006, BEST PRACT RES CL GA, V20, P1063, DOI 10.1016/j.bpg.2006.03.008; Wortelboer HM, 2003, CHEM RES TOXICOL, V16, P1642, DOI 10.1021/tx034101x; Xia Q, 2012, THROMB RES, V130, P409, DOI 10.1016/j.thromres.2012.04.005; Xu YX, 1997, EXP HEMATOL, V25, P413; Zhao JF, 2012, MOL NUTR FOOD RES, V56, P691, DOI 10.1002/mnfr.201100735	64	6	7	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80925	10.1371/journal.pone.0080925	http://dx.doi.org/10.1371/journal.pone.0080925			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260512	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500183
J	Takeshita, T; Yamamoto-Ibusuki, M; Yamamoto, Y; Omoto, Y; Honda, Y; Iyama, K; Zhang, ZH; Iwase, H				Takeshita, Takashi; Yamamoto-Ibusuki, Mutsuko; Yamamoto, Yutaka; Omoto, Yoko; Honda, Yumi; Iyama, Ken-ichi; Zhang, Zhenhuan; Iwase, Hirotaka			PTIP Associated protein 1, PA1, Is an Independent Prognostic Factor for Lymphnode Negative Breast Cancer	PLOS ONE			English	Article							INTERNATIONAL EXPERT CONSENSUS; ENDOCRINE THERAPY RESISTANCE; ESTROGEN-RECEPTOR; CLINICAL-IMPLICATIONS; MESSENGER-RNA; HIGHLIGHTS; MECHANISMS; EXPRESSION; STRATEGIES; INTERACTS	Pax transactivation domain interacting protein (PTIP) associated protein 1, PA1, was a newly found protein participating in the modulation of transactivity of nuclear receptor super family members such as estrogen receptor (ER), androgen receptor (AR) and glucocorticoid receptor (GR). Breast cancer is one of the most life threatening diseases for women and has tight association with estrogen and ER. This study was performed to understand the function of PA1 in breast cancer. The expression of PA1 had been evaluated in a total of 344 primary invasive breast cancer samples and examined the relationship with clinical output, relapse free survival (RFS), breast cancer-specific survival (BCSS). PA1 expression was observed in both nucleus and cytoplasm, however, appeared mainly in nuclear. PA1 nuclear expression was correlated with postmenopausal (P = 0.0097), smaller tumor size (P = 0.0025), negative Ki67 (P = 0.02), positive AR (P = 0.049) and positive ER beta (P = 0.0020). Kaplan-Meier analysis demonstrated PA1 nuclear positive cases seemed to have a longer survival than negative ones for RFS (P = 0.023) but not for BCSS (P = 0.23). In the Cox hazards model, PA1 nuclear protein expression proved to be a significant prognostic univariate parameter for RFS (P = 0.03), but not for BCSS (P = 0.20). In addition, for those patients without lymphnode metastasis PA1 was found to be an independent prognostic factor for RFS (P = 0.025), which was verified by univariate and multivariate analyses. These investigations suggested PA1 expression could be a potential prognostic indicator for RFS in breast cancer.	[Takeshita, Takashi; Yamamoto-Ibusuki, Mutsuko; Omoto, Yoko; Zhang, Zhenhuan; Iwase, Hirotaka] Kumamoto Univ, Grad Sch Med Sci, Dept Breast & Endocrine Surg, Kumamoto, Japan; [Yamamoto, Yutaka] Kumamoto Univ Hosp, Dept Mol Targeting Therapy Breast Canc, Kumamoto, Japan; [Honda, Yumi; Iyama, Ken-ichi] Kumamoto Univ Hosp, Dept Surg Pathol, Kumamoto, Japan	Kumamoto University; Kumamoto University; Kumamoto University	Zhang, ZH (corresponding author), Univ Florida, Dept Radiat Oncol, Gainesville, FL 32610 USA.	zzhang@ufl.edu; hiwase@kumamoto-u.ac.jp	Takeshita, Takashi/J-1423-2019	Takeshita, Takashi/0000-0002-8559-8181	Ministry of Education, Science and Culture of Japan [2459191000]	Ministry of Education, Science and Culture of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported in part by a grant-in-aid (project numbers 2459191000) for scientific research from the Ministry of Education, Science and Culture of Japan. No additional external funding was received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chang JJ, 2013, ANTI-CANCER AGENT ME, V13, P464; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Clarke M, 1998, LANCET, V351, P1451; Giuliano M, 2011, BREAST, V20, pS42, DOI 10.1016/S0960-9776(11)70293-4; Goldhirsch A, 2007, ANN ONCOL, V18, P1133, DOI 10.1093/annonc/mdm271; Goldhirsch A, 2011, ANN ONCOL, V22, P1736, DOI 10.1093/annonc/mdr304; Goldhirsch A, 2003, J CLIN ONCOL, V21, P3357, DOI 10.1200/JCO.2003.04.576; Goldhirsch A, 2005, ANN ONCOL, V16, P1569, DOI 10.1093/annonc/mdi326; Gong ZH, 2009, J BIOL CHEM, V284, P7284, DOI 10.1074/jbc.M809158200; Hammond MEH, 2010, J CLIN ONCOL, V28, P2784, DOI 10.1200/JCO.2009.25.6529; Hastings PJ, 2009, NAT REV GENET, V10, P551, DOI 10.1038/nrg2593; Johnston SRD, 2003, CLIN CANCER RES, V9, p524S; Lechner MS, 2000, NUCLEIC ACIDS RES, V28, P2741, DOI 10.1093/nar/28.14.2741; Liang J, 2009, EMBO REP, V10, P51, DOI 10.1038/embor.2008.223; Locker GY, 1998, CANCER TREAT REV, V24, P221, DOI 10.1016/S0305-7372(98)90051-2; Ma CL, 2008, GASTROENTEROLOGY, V135, P947, DOI 10.1053/j.gastro.2008.05.046; McShane LM, 2005, J CLIN ONCOL, V23, P9067, DOI 10.1200/JCO.2004.01.0454; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Osborne CK, 2005, CLIN CANCER RES, V11, p865S; Schiff R, 2003, CLIN CANCER RES, V9, p447S; Tarver T, 2012, J CONS HLTH INTERNET, V16, P366, DOI 10.1080/15398285.2012.701177; Yamamoto Y, 2008, BREAST CANCER RES TR, V110, P465, DOI 10.1007/s10549-007-9742-1; Yamashita H, 2011, ANN ONCOL, V22, P1318, DOI 10.1093/annonc/mdq596; Zhang ZH, 2005, BREAST CANCER RES TR, V94, P11, DOI 10.1007/s10549-005-6001-1; Zhang ZH, 2004, CLIN CANCER RES, V10, P6962, DOI 10.1158/1078-0432.CCR-04-0455; Zhang ZH, 2006, CANCER LETT, V237, P123, DOI 10.1016/j.canlet.2005.05.046; Zhang ZH, 2013, J BIOL CHEM, V288, P42, DOI 10.1074/jbc.M112.427740	27	2	3	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80552	10.1371/journal.pone.0080552	http://dx.doi.org/10.1371/journal.pone.0080552			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260416	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500153
J	Ando, H; Ushijima, K; Fujimura, A				Ando, Hitoshi; Ushijima, Kentarou; Fujimura, Akio			Indirect Effects of Glucagon-Like Peptide-1 Receptor Agonist Exendin-4 on the Peripheral Circadian Clocks in Mice	PLOS ONE			English	Article							GLUCOSE-HOMEOSTASIS; METABOLIC SYNDROME; GENE-EXPRESSION; LIVER CLOCK; OBESITY; KINASE; SUSCEPTIBILITY; DEGRADATION; ENTRAINMENT; IMPROVEMENT	Circadian clocks in peripheral tissues are powerfully entrained by feeding. The mechanisms underlying this food entrainment remain unclear, although various humoral and neural factors have been reported to affect peripheral clocks. Because glucagon-like peptide-1 (GLP-1), which is rapidly secreted in response to food ingestion, influences multiple humoral and neural signaling pathways, we suggest that GLP-1 plays a role in the food entrainment of peripheral clocks. To test this, we compared the effects of exendin-4, a GLP-1 receptor agonist, on mRNA expression of the clock genes (Clock, Bmal1, Nr1d1, Per1, Per2, and Cry1) with those of refeeding. In addition, we investigated whether exendin-4 could affect the rhythms of the peripheral clocks. In male C57BL/6J mice, although refeeding rapidly (within 2 h) altered mRNA levels of Per1 and Per2 in the liver and that of Per1 in adipose tissue, a single i.p. injection of exendin-4 did not cause such changes. However, unlike the GLP-1 receptor antagonist exendin-(9-39), exendin-4 significantly influenced Per1 mRNA levels in the liver at 12 h after injection. Moreover, pretreatment with exendin-4 affected the rapid-feeding-induced change in Per1 not only in the liver, but also in adipose tissue, without effect on food intake. Furthermore, during light-phase restricted feeding, repeated dosing of exendin-4 at the beginning of the dark phase profoundly influenced both the food intake and daily rhythms of clock gene expression in peripheral tissues. Thus, these results suggest that exendin-4 modulates peripheral clocks via multiple mechanisms different from those of refeeding.	[Ando, Hitoshi; Ushijima, Kentarou; Fujimura, Akio] Jichi Med Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Shimotsuke, Tochigi, Japan	Jichi Medical University	Ando, H (corresponding author), Jichi Med Univ, Sch Med, Dept Pharmacol, Div Clin Pharmacol, Shimotsuke, Tochigi, Japan.	h-ando@jichi.ac.jp	ANDO, Hitoshi/O-8199-2016; Ushijima, Kentaro/AAF-8690-2021	ANDO, Hitoshi/0000-0001-6179-9993; Ushijima, Kentaro/0000-0003-2637-3916	Japan Society for the Promotion of Science [24590666]; Naito Foundation; Takeda Science Foundation; Ministry of Education, Culture, Sports, Science and Technology of Japan	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Naito Foundation(Naito Memorial Foundation); Takeda Science Foundation(Takeda Science Foundation (TSF)); Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	This work was supported by a Grant-in-Aid for Scientific Research (C) (24590666) from the Japan Society for the Promotion of Science (http://www.jsps.go.jp/), grants from the Naito Foundation (https://www.naito-f.or.jp/), the Takeda Science Foundation (http://www.takeda-sci.or.jp/), and the Program for the Strategic Research Foundation at Private Universities 2011-2015 "Cooperative Basic and Clinical Research on Circadian Medicine" from the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Ando H, 2009, DIABETOLOGIA, V52, P329, DOI 10.1007/s00125-008-1194-6; Ando H, 2011, ENDOCRINOLOGY, V152, P1347, DOI 10.1210/en.2010-1068; Ando H, 2010, CHRONOBIOL INT, V27, P194, DOI 10.3109/07420520903398617; Baggio LL, 2007, GASTROENTEROLOGY, V132, P2131, DOI 10.1053/j.gastro.2007.03.054; Bass J, 2010, SCIENCE, V330, P1349, DOI 10.1126/science.1195027; Ben-Shlomo S, 2011, J HEPATOL, V54, P1214, DOI 10.1016/j.jhep.2010.09.032; Cani PD, 2006, DIABETES, V55, P1484, DOI 10.2337/db05-1360; De Leon DD, 2006, INT J BIOCHEM CELL B, V38, P845, DOI 10.1016/j.biocel.2005.07.011; Englund Ani, 2009, J Circadian Rhythms, V7, P5, DOI 10.1186/1740-3391-7-5; Fan RR, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020443; GOKE R, 1993, J BIOL CHEM, V268, P19650; Gupta NA, 2010, HEPATOLOGY, V51, P1584, DOI 10.1002/hep.23569; HERRMANN C, 1995, DIGESTION, V56, P117, DOI 10.1159/000201231; Himeno T, 2011, DIABETES, V60, P2397, DOI 10.2337/db10-1462; Hirao A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006909; Karnani M, 2011, AM J PHYSIOL-REG I, V300, pR47, DOI 10.1152/ajpregu.00527.2010; Kennaway DJ, 2007, AM J PHYSIOL-REG I, V293, pR1528, DOI 10.1152/ajpregu.00018.2007; Kim W, 2008, PHARMACOL REV, V60, P470, DOI 10.1124/pr.108.000604; Lamia KA, 2008, P NATL ACAD SCI USA, V105, P15172, DOI 10.1073/pnas.0806717105; Lamia KA, 2009, SCIENCE, V326, P437, DOI 10.1126/science.1172156; Lee MY, 2012, AM J TRANSL RES, V4, P1; Liu C, 2007, NATURE, V447, P477, DOI 10.1038/nature05767; Marcheva B, 2010, NATURE, V466, P627, DOI 10.1038/nature09253; Miyamoto L, 2012, J BIOL CHEM, V287, P40441, DOI 10.1074/jbc.M112.384545; Oike H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023709; Panjwani N, 2013, ENDOCRINOLOGY, V154, P127, DOI 10.1210/en.2012-1937; Refinetti R, 2007, BIOL RHYTHM RES, V38, P275, DOI 10.1080/09291010600903692; Schirra J, 1998, J CLIN INVEST, V101, P1421, DOI 10.1172/JCI1349; Scott EM, 2008, INT J OBESITY, V32, P658, DOI 10.1038/sj.ijo.0803778; Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781; Sookoian S, 2008, AM J CLIN NUTR, V87, P1606, DOI 10.1093/ajcn/87.6.1606; Stokkan KA, 2001, SCIENCE, V291, P490, DOI 10.1126/science.291.5503.490; Tahara Y, 2011, J BIOL RHYTHM, V26, P230, DOI 10.1177/0748730411405958; Talsania T, 2005, ENDOCRINOLOGY, V146, P3748, DOI 10.1210/en.2005-0473; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Um JH, 2007, J BIOL CHEM, V282, P20794, DOI 10.1074/jbc.C700070200; Waget A, 2011, ENDOCRINOLOGY, V152, P3018, DOI 10.1210/en.2011-0286; WANG ZL, 1995, J CLIN INVEST, V95, P417, DOI 10.1172/JCI117671; Woon PY, 2007, P NATL ACAD SCI USA, V104, P14412, DOI 10.1073/pnas.0703247104; Wu T, 2008, GENE, V419, P27, DOI 10.1016/j.gene.2008.04.010	41	13	14	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81119	10.1371/journal.pone.0081119	http://dx.doi.org/10.1371/journal.pone.0081119			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260546	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600108
J	Cui, JD; Li, LL; Bian, HJ				Cui, Jian Dong; Li, Lian Lian; Bian, Hong Jie			Immobilization of Cross-Linked Phenylalanine Ammonia Lyase Aggregates in Microporous Silica Gel	PLOS ONE			English	Article							CLEAS; STABILIZATION; BIOCATALYSTS; EFFICIENT; ENZYMES; LIPASES	A separable and highly-stable enzyme system was developed by adsorption of phenylalanine ammonia lyase (PAL) from Rhodotorula glutinis in amino-functionalized macroporous silica gel and subsequent enzyme crosslinking. This resulted in the formation of cross-linked enzyme aggregates (PAL-CLEAs) into macroporous silica gel (MSG-CLEAs). The effect of adsorptive conditions, type of aggregating agent, its concentration as well as that of cross-linking agent was studied. MSG-CLEAs production was most effective using ammonium sulfate (40%-saturation), followed by cross-linking for 1 h with 1.5% (v/v) glutaraldehyde. The resulting MSG-CLEAs extended the optimal temperature and pH range compared to free PAL and PAL-CLEAs. Moreover, MSG-CLEAs exhibited the excellent stability of the enzyme against various deactivating conditions such as temperature and denaturants, and showed higher storage stability compared to the free PAL and the conventional PAL-CLEAs. Such as, after 6 h incubation at 60 degrees C, the MSG-CLEAs still retained more than 47% of the initial activity whereas PAL-CLEAs only retained 7% of the initial activity. Especially, the MSG-CLEAs exhibited good reusability due to its suitable size and active properties. These results indicated that PAL-CLEAs on MSG might be used as a feasible and efficient solution for improving properties of immobilized enzyme in industrial application.	[Cui, Jian Dong; Li, Lian Lian] Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Res Ctr Fermentat Engn Hebei, Shijiazhuang, Peoples R China; [Cui, Jian Dong] Chinese Acad Sci, Inst Proc Engn, Natl Key Lab Biochem Engn, Beijing, Peoples R China; [Cui, Jian Dong] Tianjin Univ Sci & Technol, Minist Educ, Key Lab Ind Microbiol, Tai Da Dev Area, Tianjin, Peoples R China	Hebei University of Science & Technology; Chinese Academy of Sciences; Institute of Process Engineering, CAS; Tianjin University Science & Technology	Cui, JD (corresponding author), Hebei Univ Sci & Technol, Coll Biosci & Bioengn, Res Ctr Fermentat Engn Hebei, Shijiazhuang, Peoples R China.	cjd007cn@163.com		cui, jian dong/0000-0002-2809-530X	National Natural Science Foundation of China (NSFC) [21072041]; National Key Laboratory of Biochemical Engineering [KF2010-12]; Foundation of Tianjin Key Laboratory of Industrial Microbiology (Tianjin University of Science and Technology), P. R. China [2012IM004]; Foundation of Hebei University of Science and technology for Distinguished Young Scientists	National Natural Science Foundation of China (NSFC)(National Natural Science Foundation of China (NSFC)); National Key Laboratory of Biochemical Engineering; Foundation of Tianjin Key Laboratory of Industrial Microbiology (Tianjin University of Science and Technology), P. R. China; Foundation of Hebei University of Science and technology for Distinguished Young Scientists	The authors are grateful for the financial support provided by the National Natural Science Foundation of China (NSFC, Project No. 21072041), Open Funding Project of the National Key Laboratory of Biochemical Engineering (NO. KF2010-12) and the Foundation (NO. 2012IM004) of Tianjin Key Laboratory of Industrial Microbiology (Tianjin University of Science and Technology), P. R. China, and Foundation of Hebei University of Science and technology for Distinguished Young Scientists. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bilkova Z, 2002, J CHROMATOGR B, V770, P177, DOI 10.1016/S1570-0232(02)00037-5; Cabana H, 2009, BIOTECHNOL BIOENG, V102, P1582, DOI 10.1002/bit.22198; Cao LQ, 2000, ORG LETT, V2, P1361, DOI 10.1021/ol005593x; Cowan DA, 2011, ENZYME MICROB TECH, V49, P326, DOI 10.1016/j.enzmictec.2011.06.023; Cui JD, 2013, APPL BIOCHEM BIOTECH, V170, P1827, DOI 10.1007/s12010-013-0317-9; Cui JD, 2012, APPL BIOCHEM BIOTECH, V167, P835, DOI 10.1007/s12010-012-9738-0; EVANS CT, 1987, APPL MICROBIOL BIOT, V25, P399; Garcia-Galan C, 2011, ADV SYNTH CATAL, V353, P2885, DOI 10.1002/adsc.201100534; Hernandez K, 2011, ENZYME MICROB TECH, V48, P510, DOI 10.1016/j.enzmictec.2011.02.005; Jung D, 2009, J MATER SCI, V44, P6747, DOI 10.1007/s10853-009-3917-6; Kim MI, 2007, BIOTECHNOL BIOENG, V96, P210, DOI 10.1002/bit.21107; Palomo JM, 2002, J MOL CATAL B-ENZYM, V19, P279, DOI 10.1016/S1381-1177(02)00178-9; Park JM, 2013, INT J BIOL MACROMOL, V54, P37, DOI 10.1016/j.ijbiomac.2012.11.025; Park JM, 2010, PROCESS BIOCHEM, V45, P259, DOI 10.1016/j.procbio.2009.09.015; Quinn AJ, 2011, BIOTECHNOL PROGR, V27, P1554, DOI 10.1002/btpr.687; Rees DG, 1996, ENZYME MICROB TECH, V19, P282; Reshmi R, 2013, J MOL CATAL B-ENZYM, V85-86, P111, DOI 10.1016/j.molcatb.2012.08.007; Rodrigues RC, 2013, CHEM SOC REV, V42, P6290, DOI 10.1039/c2cs35231a; Sangeetha K, 2008, INT J BIOL MACROMOL, V43, P314, DOI 10.1016/j.ijbiomac.2008.07.001; Schoevaart R, 2004, BIOTECHNOL BIOENG, V87, P754, DOI 10.1002/bit.20184; Sheldon RA, 2007, BIOCHEM SOC T, V35, P1583, DOI 10.1042/BST0351583; Talekar S, 2013, RSC ADV, V3, P12485, DOI 10.1039/c3ra40818c; Talekar S, 2012, BIORESOURCE TECHNOL, V123, P542, DOI 10.1016/j.biortech.2012.07.044; WADDELL TG, 1981, J AM CHEM SOC, V103, P5303, DOI 10.1021/ja00408a005; Wang MF, 2010, BIOCHEM ENG J, V52, P168, DOI 10.1016/j.bej.2010.08.003; Wilson L, 2004, BIOTECHNOL BIOENG, V86, P558, DOI 10.1002/bit.20107; Wilson L, 2006, ENZYME MICROB TECH, V39, P750, DOI 10.1016/j.enzmictec.2005.12.011; Yang XL, 2012, CHINESE J CATAL, V33, P878, DOI 10.3724/SP.J.1088.2012.11139; Zhang BZ, 2010, J AGR FOOD CHEM, V58, P2795, DOI 10.1021/jf9036744	29	26	28	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80581	10.1371/journal.pone.0080581	http://dx.doi.org/10.1371/journal.pone.0080581			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260425	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600071
J	Quraishi, SA; Bittner, EA; Christopher, KB; Camargo, CA				Quraishi, Sadeq A.; Bittner, Edward A.; Christopher, Kenneth B.; Camargo, Carlos A., Jr.			Vitamin D Status and Community-Acquired Pneumonia: Results from the Third National Health and Nutrition Examination Survey	PLOS ONE			English	Article							RESPIRATORY-TRACT INFECTIONS; LOCALLY WEIGHTED REGRESSION; D SUPPLEMENTATION; ANTIMICROBIAL PEPTIDES; CHRONIC RHINOSINUSITIS; DOUBLE-BLIND; D DEFICIENCY; TUBERCULOSIS; RISK; ASSOCIATION	Objective: To investigate the association between serum 25-hydroxyvitamin D [25(OH)D] level and history of community-acquired pneumonia (CAP). Patients and Methods: We identified 16,975 individuals (>= 17 years) from the third National Health and Nutrition Examination Survey (NHANES III) with documented 25(OH)D levels. To investigate the association of 25(OH)D with history of CAP in these participants, we developed a multivariable logistic regression model, adjusting for demographic factors (age, sex, race, poverty-to-income ratio, and geographic location), clinical data (body mass index, smoking status, asthma, chronic obstructive pulmonary disease, congestive heart failure, diabetes mellitus, stroke, chronic kidney disease, neutropenia, and alcohol consumption), and season. Locally weighted scatterplot smoothing (LOWESS) was used to depict the relationship between increasing 25(OH)D levels and the cumulative frequency of CAP in the study cohort. Results: The median [interquartile range (IQR)] serum 25(OH)D level was 24 (IQR 18-32) ng/mL. 2.1% [95% confidence interval (CI): 1.9-2.3] of participants reported experiencing a CAP within one year of their participation in the national survey. After adjusting for demographic factors, clinical data, and season, 25(OH)D levels <30 ng/mL were associated with 56% higher odds of CAP [odds ratio 1.56; 95% confidence interval: 1.17-2.07] compared to levels >= 30 ng/mL. LOWESS analysis revealed a near linear relationship between vitamin D status and the cumulative frequency of CAP up to 25(OH)D levels around 30 ng/mL. Conclusion: Among 16,975 participants in NHANES III, 25(OH)D levels were inversely associated with history of CAP. Randomized controlled trials are warranted to determine the effect of optimizing vitamin D status on the risk of CAP.	[Quraishi, Sadeq A.; Bittner, Edward A.; Christopher, Kenneth B.; Camargo, Carlos A., Jr.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Quraishi, Sadeq A.; Bittner, Edward A.] Massachusetts Gen Hosp, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02114 USA; [Christopher, Kenneth B.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Camargo, Carlos A., Jr.] Massachusetts Gen Hosp, Dept Emergency Med, Boston, MA 02114 USA; [Camargo, Carlos A., Jr.] Harvard Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard T.H. Chan School of Public Health	Quraishi, SA (corresponding author), Harvard Univ, Sch Med, Boston, MA 02115 USA.	squraishi@partners.org	Bittner, Edward/ABB-3519-2021; Christopher, Kenneth/AAD-6801-2021; Camargo, Carlos A./C-2145-2008; Christopher, Kenneth B./C-5243-2012	Christopher, Kenneth/0000-0001-6067-972X; Camargo, Carlos A./0000-0002-5071-7654; Christopher, Kenneth B./0000-0001-6067-972X	National Institutes of Health (NIH) [5T32GM007592-33, UL1 RR025758, R01 AI093723, U01 AI087881]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI087881, R01AI093723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007592] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	SAQ received support from the National Institutes of Health (NIH) 5T32GM007592-33 and UL1 RR025758. CAC received support from NIH R01 AI093723 and U01 AI087881. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JS, 2008, NAT CLIN PRACT ENDOC, V4, P80, DOI 10.1038/ncpendmet0716; Aregbesola A, 2013, J EPIDEMIOL COMMUN H, V67, P533, DOI 10.1136/jech-2012-202027; Belderbos ME, 2011, PEDIATRICS, V127, pE1513, DOI 10.1542/peds.2010-3054; Bergman P, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065835; Berry DJ, 2011, BRIT J NUTR, V106, P1433, DOI 10.1017/S0007114511001991; BHALLA AK, 1986, CELL IMMUNOL, V98, P311, DOI 10.1016/0008-8749(86)90291-1; Burton DC, 2010, AM J PUBLIC HEALTH, V100, P1904, DOI 10.2105/AJPH.2009.181313; Camargo CA, 2012, PEDIATRICS, V130, pE561, DOI 10.1542/peds.2011-3029; Centers for Disease Control and Prevention Fast Stats, 2013, DEATHS MORT, P8; Choudhary N, 2012, INDIAN PEDIATR, V49, P449, DOI 10.1007/s13312-012-0073-x; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282; da Silva FP, 2012, PEPTIDES, V36, P308, DOI 10.1016/j.peptides.2012.05.014; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Fabri M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003045; Feikin DR, 2000, AM J PUBLIC HEALTH, V90, P223, DOI 10.2105/AJPH.90.2.223; File TM, 2010, POSTGRAD MED, V122, P130, DOI 10.3810/pgm.2010.03.2130; Finklea JD, 2011, ADV NUTR, V2, P244, DOI 10.3945/an.111.000398; Ginde AA, 2009, ARCH INTERN MED, V169, P384, DOI 10.1001/archinternmed.2008.560; Herr C, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-31; Holick MF, 2007, NEW ENGL J MED, V357, P266, DOI 10.1056/NEJMra070553; Holick MF, 2011, J CLIN ENDOCR METAB, V96, P1911, DOI 10.1210/jc.2011-0385; Hughes DA, 2009, CLIN EXP IMMUNOL, V158, P20, DOI 10.1111/j.1365-2249.2009.04001.x; KANKOVA M, 1991, IMMUNOLOGY, V73, P466; Laaksi I, 2010, J INFECT DIS, V202, P809, DOI 10.1086/654881; Leow L, 2011, RESPIROLOGY, V16, P611, DOI 10.1111/j.1440-1843.2011.01924.x; Li-Ng M, 2009, EPIDEMIOL INFECT, V137, P1396, DOI 10.1017/S0950268809002404; Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060; Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933; Manaseki-Holland S, 2012, LANCET, V379, P1419, DOI 10.1016/S0140-6736(11)61650-4; Mandell LA, 2007, CLIN INFECT DIS, V44, pS27, DOI 10.1086/511159; Mao S, 2013, SCAND J INFECT DIS, V45, P696, DOI 10.3109/00365548.2013.803293; Martineau AR, 2011, LANCET, V377, P242, DOI 10.1016/S0140-6736(10)61889-2; McNally JD, 2009, PEDIATR PULM, V44, P981, DOI 10.1002/ppul.21089; Mulligan JK, 2011, CLIN EXP IMMUNOL, V164, P312, DOI 10.1111/j.1365-2249.2011.04325.x; Mulligan JK, 2012, OTOLARYNG HEAD NECK, V147, P773, DOI 10.1177/0194599812448852; Murdoch DR, 2012, JAMA-J AM MED ASSOC, V308, P1333, DOI 10.1001/jama.2012.12505; Niederman M, 2009, ANN INTERN MED, V151, P827, DOI 10.7326/0003-4819-151-7-200910060-01004; Platz EA, 2004, CANCER CAUSE CONTROL, V15, P255, DOI 10.1023/B:CACO.0000024245.24880.8a; Quraishi SA, JAMA SURG IN PRESS; Quraishi SA, 2013, AM J CLIN NUTR, V98, P952, DOI 10.3945/ajcn.113.058909; Quraishi SA, 2012, CURR OPIN CLIN NUTR, V15, P625, DOI 10.1097/MCO.0b013e328358fc2b; Ramirez JA, 2011, J ANTIMICROB CHEMOTH, V66, pS3, DOI [10.1093/jac/dkr119, DOI 10.1093/JAC/DKR119.PUBMED:21482567]; Remmelts HHF, 2012, CLIN INFECT DIS, V55, P1488, DOI 10.1093/cid/cis751; Salahuddin N, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-22; Tollin M, 2003, PEPTIDES, V24, P523, DOI 10.1016/S0196-9781(03)00114-1; Watkins RR, 2011, AM FAM PHYSICIAN, V83, P1299; Watt JP, 2010, EPIDEMIOL INFECT, V138, P1146, DOI 10.1017/S0950268809991464; Wejse C, 2009, AM J RESP CRIT CARE, V179, P843, DOI 10.1164/rccm.200804-567OC; Wunderink RG, 2004, INFECT DIS CLIN N AM, V18, P743, DOI 10.1016/j.idc.2004.07.004	50	50	51	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81120	10.1371/journal.pone.0081120	http://dx.doi.org/10.1371/journal.pone.0081120			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260547	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600109
J	Bhargava, R; Altmann, CJ; Andres-Hernando, A; Webb, RG; Okamura, K; Yang, YM; Falk, S; Schmidt, EP; Faubel, S				Bhargava, Rhea; Altmann, Christopher J.; Andres-Hernando, Ana; Webb, Ryan G.; Okamura, Kayo; Yang, Yimu; Falk, Sandor; Schmidt, Eric P.; Faubel, Sarah			Acute Lung Injury and Acute Kidney Injury Are Established by Four Hours in Experimental Sepsis and Are Improved with Pre, but Not Post, Sepsis Administration of TNF-alpha Antibodies	PLOS ONE			English	Article							ACUTE-RENAL-FAILURE; MECHANICAL VENTILATION; UNITED-STATES; SEPTIC SHOCK; MICE; INTERLEUKIN-6; EPIDEMIOLOGY; INFLAMMATION; DYSFUNCTION; CHILDREN	Introduction: Acute kidney injury (AKI) and acute lung injury (ALI) are serious complications of sepsis. AKI is often viewed as a late complication of sepsis. Notably, the onset of AKI relative to ALI is unclear as routine measures of kidney function (BUN and creatinine) are insensitive and increase late. In this study, we hypothesized that AKI and ALI would occur simultaneously due to a shared pathophysiology (i.e., TNF-alpha mediated systemic inflammatory response syndrome [SIRS]), but that sensitive markers of kidney function would be required to identify AKI. Methods: Sepsis was induced in adult male C57B/6 mice with 5 different one time doses of intraperitoneal (IP) endotoxin (LPS) (0.00001, 0.0001, 0.001, 0.01, or 0.25 mg) or cecal ligation and puncture (CLP). SIRS was assessed by serum proinflammatory cytokines (TNF-alpha, IL-1 beta, CXCL1, IL-6), ALI was assessed by lung inflammation (lung myeloperoxidase [MPO] activity), and AKI was assessed by serum creatinine, BUN, and glomerular filtration rate (GFR) (by FITC-labeled inulin clearance) at 4 hours. 20 mu gs of TNF-alpha antibody (Ab) or vehicle were injected IP 2 hours before or 2 hours after IP LPS. Results: Serum cytokines increased with all 5 doses of LPS; AKI and ALI were detected within 4 hours of IP LPS or CLP, using sensitive markers of GFR and lung inflammation, respectively. Notably, creatinine did not increase with any dose; BUN increased with 0.01 and 0.25 mg. Remarkably, GFR was reduced 50% in the 0.001 mg LPS dose, demonstrating that dramatic loss of kidney function can occur in sepsis without a change in BUN or creatinine. Prophylactic TNF-alpha Ab reduced serum cytokines, lung MPO activity, and BUN; however, post-sepsis administration had no effect. Conclusions: ALI and AKI occur together early in the course of sepsis and TNF-alpha plays a role in the early pathogenesis of both.	[Bhargava, Rhea; Altmann, Christopher J.; Andres-Hernando, Ana; Webb, Ryan G.; Okamura, Kayo; Falk, Sandor; Faubel, Sarah] Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO USA; [Yang, Yimu; Schmidt, Eric P.] Div Pulm Sci & Crit Care Med, Program Translat Lung Res, Aurora, CO USA	University of Colorado System; University of Colorado Anschutz Medical Campus	Faubel, S (corresponding author), Univ Colorado, Sch Med, Div Renal Dis & Hypertens, Aurora, CO USA.	sarah.faubel@ucdenver.edu		Schmidt, Eric/0000-0002-7360-0504; Andres-Hernando, Ana/0000-0002-0676-0188	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI) [R01 HL095363-01A2]; NIH/NHLBI [K08-HL105538]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL105538, R01HL095363] Funding Source: NIH RePORTER	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	S. Faubel is currently receiving a grant (R01 HL095363-01A2) from the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI); EPS is currently receiving a grant (K08-HL105538) from the NIH/NHLBI. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andres-Hernando A, 2011, AM J PHYSIOL-RENAL, V301, pF907, DOI 10.1152/ajprenal.00107.2011; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Bagshaw SM, 2010, INTENS CARE MED, V36, P452, DOI 10.1007/s00134-009-1724-9; BONE RC, 1991, ANN INTERN MED, V115, P457, DOI 10.7326/0003-4819-115-6-457; Breyer MD, 2010, KIDNEY INT, V77, P487, DOI 10.1038/ki.2009.544; Carlet J, 2013, CRIT CARE MED, V41, pE56, DOI 10.1097/CCM.0b013e318283cf9d; Cavaillon JM, 2003, SCAND J INFECT DIS, V35, P535, DOI 10.1080/00365540310015935; Chawla LS, 2007, CLIN J AM SOC NEPHRO, V2, P22, DOI 10.2215/CJN.02510706; Cunningham PN, 2004, J IMMUNOL, V172, P2629, DOI 10.4049/jimmunol.172.4.2629; Dennen P, 2010, CRIT CARE, V14, DOI 10.1186/cc9289; Doi K, 2009, J AM SOC NEPHROL, V20, P1217, DOI 10.1681/ASN.2008060617; Eisner C, 2010, KIDNEY INT, V77, P519, DOI 10.1038/ki.2009.501; Faubel S, 2009, Minerva Urol Nefrol, V61, P171; Faubel S, 2008, ADV CHRONIC KIDNEY D, V15, P284, DOI 10.1053/j.ackd.2008.04.008; Faubel S, 2012, CLIN J AM SOC NEPHRO, V7, P861, DOI 10.2215/CJN.12191111; Fisher CJ, 1996, NEW ENGL J MED, V334, P1697, DOI 10.1056/NEJM199606273342603; Haase M, 2011, J AM COLL CARDIOL, V57, P1752, DOI 10.1016/j.jacc.2010.11.051; Hassoun HT, 2007, AM J PHYSIOL-RENAL, V293, pF30, DOI 10.1152/ajprenal.00023.2007; Hoke TS, 2007, J AM SOC NEPHROL, V18, P155, DOI 10.1681/ASN.2006050494; Imai Y, 2003, JAMA-J AM MED ASSOC, V289, P2104, DOI 10.1001/jama.289.16.2104; Iskander KN, 2013, CRIT CARE MED, V41, P159, DOI 10.1097/CCM.0b013e3182676322; Kalakeche R, 2011, J AM SOC NEPHROL, V22, P1505, DOI 10.1681/ASN.2011020203; Kim DH, 2009, KIDNEY INT, V76, P1180, DOI 10.1038/ki.2009.387; Klein CL, 2008, KIDNEY INT; Knotek M, 2001, KIDNEY INT, V59, P2243, DOI 10.1046/j.1523-1755.2001.00740.x; Liu KD, 2009, CRIT CARE, V13, DOI 10.1186/cc7940; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Matthay MA, 2012, J CLIN INVEST, V122, P2731, DOI 10.1172/JCI60331; Mehta RL, 2007, CRIT CARE, V11, DOI 10.1186/cc5713; Mitra A, 2007, NEPHROL DIAL TRANSPL, V22, P2349, DOI 10.1093/ndt/gfm216; Miyazaki H, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-153; Rabb H, 2003, KIDNEY INT, V63, P600, DOI 10.1046/j.1523-1755.2003.00753.x; Remick DG, 2000, SHOCK, V13, P110, DOI 10.1097/00024382-200013020-00004; Schmidt EP, 2012, NAT MED; Singbartl K, 2011, KIDNEY INT, V80, P633, DOI 10.1038/ki.2011.201; Star RA, 1998, KIDNEY INT, V54, P1817, DOI 10.1046/j.1523-1755.1998.00210.x; Tran M, 2011, J CLIN INVEST, V121, P4003, DOI 10.1172/JCI58662; Vincent JL, 2011, CONTRIB NEPHROL, V174, P71, DOI 10.1159/000329238; Vincent JL, 2011, CRIT CARE MED, V39, P1050, DOI 10.1097/CCM.0b013e31820eda29; Wang E, 2012, KIDNEY INT, V81, P112, DOI 10.1038/ki.2011.294; Wang W, 2008, AM J PHYSIOL-RENAL, V294, pF571, DOI 10.1152/ajprenal.00538.2007	41	63	70	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79037	10.1371/journal.pone.0079037	http://dx.doi.org/10.1371/journal.pone.0079037			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265742	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100075
J	Birkbak, NJ; Kochupurakkal, B; Izarzugaza, JMG; Eklund, AC; Li, Y; Liu, J; Szallasi, Z; Matulonis, UA; Richardson, AL; Iglehart, JD; Wang, ZC				Birkbak, Nicolai Juul; Kochupurakkal, Bose; Izarzugaza, Jose M. G.; Eklund, Aron C.; Li, Yang; Liu, Joyce; Szallasi, Zoltan; Matulonis, Ursula A.; Richardson, Andrea L.; Iglehart, J. Dirk; Wang, Zhigang C.			Tumor Mutation Burden Forecasts Outcome in Ovarian Cancer with BRCA1 or BRCA2 Mutations	PLOS ONE			English	Article							HOMOLOGOUS RECOMBINATION; BREAST-CANCER; COPY NUMBERS; DNA-REPAIR; SENSITIVITY; ASSOCIATION; SURVIVAL; ARRAYS; CELLS; WOMEN	Background: Increased number of single nucleotide substitutions is seen in breast and ovarian cancer genomes carrying disease-associated mutations in BRCA1 or BRCA2. The significance of these genome-wide mutations is unknown. We hypothesize genome-wide mutation burden mirrors deficiencies in DNA repair and is associated with treatment outcome in ovarian cancer. Methods and Results: The total number of synonymous and non-synonymous exome mutations (Nmut), and the presence of germline or somatic mutation in BRCA1 or BRCA2 (mBRCA) were extracted from whole-exome sequences of high-grade serous ovarian cancers from The Cancer Genome Atlas (TCGA). Cox regression and Kaplan-Meier methods were used to correlate Nmut with chemotherapy response and outcome. Higher Nmut correlated with a better response to chemotherapy after surgery. In patients with mBRCA-associated cancer, low Nmut was associated with shorter progression-free survival (PFS) and overall survival (OS), independent of other prognostic factors in multivariate analysis. Patients with mBRCA-associated cancers and a high Nmut had remarkably favorable PFS and OS. The association with survival was similar in cancers with either BRCA1 or BRCA2 mutations. In cancers with wild-type BRCA, tumor Nmut was associated with treatment response in patients with no residual disease after surgery. Conclusions: Tumor Nmut was associated with treatment response and with both PFS and OS in patients with high-grade serous ovarian cancer carrying BRCA1 or BRCA2 mutations. In the TCGA cohort, low Nmut predicted resistance to chemotherapy, and for shorter PFS and OS, while high Nmut forecasts a remarkably favorable outcome in mBRCA-associated ovarian cancer. Our observations suggest that the total mutation burden coupled with BRCA1 or BRCA2 mutations in ovarian cancer is a genomic marker of prognosis and predictor of treatment response. This marker may reflect the degree of deficiency in BRCA-mediated pathways, or the extent of compensation for the deficiency by alternative mechanisms.	[Birkbak, Nicolai Juul; Kochupurakkal, Bose; Li, Yang; Iglehart, J. Dirk; Wang, Zhigang C.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Birkbak, Nicolai Juul; Izarzugaza, Jose M. G.; Eklund, Aron C.; Szallasi, Zoltan] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark; [Liu, Joyce; Matulonis, Ursula A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Szallasi, Zoltan] Harvard Univ, Childrens Hosp Informat Program Harvard Massachus, Sch Med, Boston, MA USA; [Richardson, Andrea L.] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Iglehart, J. Dirk; Wang, Zhigang C.] Brigham & Womens Hosp, Dept Surg, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Technical University of Denmark; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital	Iglehart, JD (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.	JIGLEHART@PARTNERS.ORG; zhigang_wang@dfci.harvard.edu	Izarzugaza, Jose/N-4503-2014	Izarzugaza, Jose/0000-0003-1754-5122; Birkbak, Nicolai/0000-0003-1613-9587; Eklund, Aron Charles/0000-0003-0861-1001; Szallasi, Zoltan/0000-0001-5395-7509	Breast Cancer Research Foundation; Villum Kann Rasmussen Foundation	Breast Cancer Research Foundation; Villum Kann Rasmussen Foundation(Villum Fonden)	This work was supported by the funding granted from the Breast Cancer Research Foundation to ALR, JDI, UAM, ZS, and ZCW. NUB was funded by The Villum Kann Rasmussen Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexandrov LB, 2013, NATURE, V500, P415, DOI 10.1038/nature12477; Alsop K, 2012, J CLIN ONCOL, V30, P2654, DOI 10.1200/JCO.2011.39.8545; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Bengtsson H, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-245; Bengtsson H, 2009, BIOINFORMATICS, V25, P2149, DOI 10.1093/bioinformatics/btp371; Birkbak NJ, 2012, CANCER DISCOV, V2, P366, DOI 10.1158/2159-8290.CD-11-0206; Bolton KL, 2012, JAMA-J AM MED ASSOC, V307, P382, DOI 10.1001/jama.2012.20; Bowtell DDL, 2010, NAT REV CANCER, V10, P803, DOI 10.1038/nrc2946; Bunting SF, 2012, MOL CELL, V46, P125, DOI 10.1016/j.molcel.2012.02.015; Bunting SF, 2010, CELL, V141, P243, DOI 10.1016/j.cell.2010.03.012; Dhillon KK, 2011, CANCER SCI, V102, P663, DOI 10.1111/j.1349-7006.2010.01840.x; Farmer H, 2005, NATURE, V434, P917, DOI 10.1038/nature03445; Fung-Kee-Fung M, 2007, Curr Oncol, V14, P195; Higgins MJ, 2011, J CLIN INVEST, V121, P3797, DOI 10.1172/JCI57152; Johnston SRD, 2010, CLIN CANCER RES, V16, P1979, DOI 10.1158/1078-0432.CCR-09-1823; Mukhopadhyay A, 2010, CLIN CANCER RES, V16, P2344, DOI 10.1158/1078-0432.CCR-09-2758; Nik-Zainal S, 2012, CELL, V149, DOI 10.1016/j.cell.2012.04.023; Ortiz-Estevez M, 2012, BIOINFORMATICS, V28, P1793, DOI 10.1093/bioinformatics/bts248; Pathania S, 2011, MOL CELL, V44, P235, DOI 10.1016/j.molcel.2011.09.002; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Silver DP, 2012, CANCER DISCOV, V2, P679, DOI 10.1158/2159-8290.CD-12-0221; Tomasetti C, 2013, P NATL ACAD SCI USA, V110, P1999, DOI 10.1073/pnas.1221068110; Turner N, 2004, NAT REV CANCER, V4, P814, DOI 10.1038/nrc1457; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Venkitaraman AR, 2002, CELL, V108, P171, DOI 10.1016/S0092-8674(02)00615-3; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; Wang ZGC, 2012, CLIN CANCER RES, V18, P5806, DOI 10.1158/1078-0432.CCR-12-0857; Xie J, 2010, ONCOGENE, V29, P2499, DOI 10.1038/onc.2010.18; Yang D, 2011, JAMA-J AM MED ASSOC, V306, P1557, DOI 10.1001/jama.2011.1456	29	108	110	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80023	10.1371/journal.pone.0080023	http://dx.doi.org/10.1371/journal.pone.0080023			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265793	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100126
J	Jebiwott, S; Govindaswamy, K; Mbugua, A; Bhanot, P				Jebiwott, Sylvia; Govindaswamy, Kavitha; Mbugua, Amos; Bhanot, Purnima			Plasmodium berghei Calcium Dependent Protein Kinase 1 Is Not Required for Host Cell Invasion	PLOS ONE			English	Article							MOSQUITO TRANSMISSION; MICRONEME DISCHARGE; TOXOPLASMA-GONDII; MALARIA PARASITE; MOTILITY; EGRESS; ERYTHROCYTES; EXPRESSION; SECRETION	Plasmodium Calcium Dependent Protein Kinase (CDPK1) is required for the development of sexual stages in the mosquito. In addition, it is proposed to play an essential role in the parasite's invasive stages possibly through the regulation of the actinomyosin motor and micronemal secretion. We demonstrate that Plasmodium berghei CDPK1 is dispensable in the parasite's erythrocytic and pre-erythrocytic stages. We successfully disrupted P. berghei CDPK1 (PbCDPK1) by homologous recombination. The recovery of erythrocytic stage parasites lacking PbCDPK1 (PbCDPK1-) demonstrated that PbCDPK1 is not essential for erythrocytic invasion or intra-erythrocytic development. To study PbCDPK1's role in sporozoites and liver stage parasites, we generated a conditional mutant (CDPK1 cKO). Phenotypic characterization of CDPK1 cKO sporozoites demonstrated that CDPK1 is redundant or dispensable for the invasion of mammalian hepatocytes, the egress of parasites from infected hepatocytes and through the subsequent erythrocytic cycle. We conclude that P. berghei CDPK1 plays an essential role only in the mosquito sexual stages.	[Jebiwott, Sylvia; Govindaswamy, Kavitha; Mbugua, Amos; Bhanot, Purnima] Rutgers State Univ, Dept Microbiol & Mol Genet, Rutgers New Jersey Med Sch, Newark, NJ 07102 USA	Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Bhanot, P (corresponding author), Rutgers State Univ, Dept Microbiol & Mol Genet, Rutgers New Jersey Med Sch, Newark, NJ 07102 USA.	bhanotpu@njms.rutgers.edu			National Institutes of Health/National Institute of Allergy and Infectious Diseases [AI094167-02]; National Science Foundation [1146221]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI094167] Funding Source: NIH RePORTER	National Institutes of Health/National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Science Foundation(National Science Foundation (NSF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by awards AI094167-02 from the National Institutes of Health/National Institute of Allergy and Infectious Diseases and 1146221 from the National Science Foundation to PB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agarwal S, 2012, CELL MICROBIOL; Azevedo MF, 2013, BIOCHEM J, V452, P433, DOI 10.1042/BJ20130124; Bansal A, 2013, J BIOL CHEM, V288, P1590, DOI 10.1074/jbc.M112.411934; Billker O, 2004, CELL, V117, P503, DOI 10.1016/S0092-8674(04)00449-0; Billker O, 2009, CELL HOST MICROBE, V5, P612, DOI 10.1016/j.chom.2009.05.017; Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x; Carruthers VB, 1999, BIOCHEM J, V342, P379, DOI 10.1042/0264-6021:3420379; Carruthers VB, 1999, MOL MICROBIOL, V31, P421, DOI 10.1046/j.1365-2958.1999.01174.x; Chen XM, 2004, INFECT IMMUN, V72, P6806, DOI 10.1128/IAI.72.12.6806-6816.2004; Coppi A, 2007, CELL HOST MICROBE, V2, P316, DOI 10.1016/j.chom.2007.10.002; Dvorin JD, 2010, SCIENCE, V328, P910, DOI 10.1126/science.1188191; Falae A, 2010, J BIOL CHEM, V285, P3282, DOI 10.1074/jbc.M109.070367; Garg S, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2725; Garrison E, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003049; Holder AA, 2012, MICROBES INFECT, V14, P825, DOI 10.1016/j.micinf.2012.04.006; Ishino T, 2006, MOL MICROBIOL, V59, P1175, DOI 10.1111/j.1365-2958.2005.05014.x; Kato N, 2008, NAT CHEM BIOL, V4, P347, DOI 10.1038/nchembio.87; Lourido S, 2012, EMBO J, V31, P4524, DOI 10.1038/emboj.2012.299; Mccoy JM, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003066; Panchal D, 2012, MOL BIOCHEM PARASIT, V184, P52, DOI 10.1016/j.molbiopara.2012.03.005; Ridzuan MAM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033845; Sebastian S, 2012, CELL HOST MICROBE, V12, P9, DOI 10.1016/j.chom.2012.05.014; Siden-Kiamos I, 2006, MOL MICROBIOL, V60, P1355, DOI 10.1111/j.1365-2958.2006.05189.x; Singh S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000746; Tewari R, 2010, CELL HOST MICROBE, V8, P377, DOI 10.1016/j.chom.2010.09.006; Thomas DC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035855; Wiersma HI, 2004, INT J PARASITOL, V34, P369, DOI 10.1016/j.ijpara.2003.11.019	27	24	25	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79171	10.1371/journal.pone.0079171	http://dx.doi.org/10.1371/journal.pone.0079171			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265753	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100086
J	Kropski, JA; Pritchett, JM; Mason, WR; Sivarajan, L; Gleaves, LA; Johnson, JE; Lancaster, LH; Lawson, WE; Blackwell, TS; Steele, MP; Loyd, JE; Rickman, OB				Kropski, Jonathan A.; Pritchett, Jason M.; Mason, Wendi R.; Sivarajan, Lakshmi; Gleaves, Linda A.; Johnson, Joyce E.; Lancaster, Lisa H.; Lawson, William E.; Blackwell, Timothy S.; Steele, Mark P.; Loyd, James E.; Rickman, Otis B.			Bronchoscopic Cryobiopsy for the Diagnosis of Diffuse Parenchymal Lung Disease	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; USUAL INTERSTITIAL PNEUMONIA; TRANSBRONCHIAL BIOPSY	Background: Although in some cases clinical and radiographic features may be sufficient to establish a diagnosis of diffuse parenchymal lung disease (DPLD), surgical lung biopsy is frequently required. Recently a new technique for bronchoscopic lung biopsy has been developed using flexible cryo-probes. In this study we describe our clinical experience using bronchoscopic cryobiopsy for diagnosis of diffuse lung disease. Methods: A retrospective study of subjects who had undergone bronchoscopic cryobiopsy for evaluation of DPLD at an academic tertiary care center from January 1, 2012 through January 15, 2013 was performed. The procedure was performed using a flexible bronchoscope to acquire biopsies of lung parenchyma. H&E stained biopsies were reviewed by an expert lung pathologist. Results: Twenty-five eligible subjects were identified. With a mean area of 64.2 mm(2), cryobiopsies were larger than that typically encountered with traditional transbronchial forceps biopsy. In 19 of the 25 subjects, a specific diagnosis was obtained. In one additional subject, biopsies demonstrating normal parenchyma were felt sufficient to exclude diffuse lung disease as a cause of dyspnea. The overall diagnostic yield of bronchoscopic cryobiopsy was 80% (20/25). The most frequent diagnosis was usual interstitial pneumonia (UIP) (n = 7). Three of the 25 subjects ultimately required surgical lung biopsy. There were no significant complications. Conclusion: In patients with suspected diffuse parenchymal lung disease, bronchoscopic cryobiopsy is a promising and minimally invasive approach to obtain lung tissue with high diagnostic yield.	[Kropski, Jonathan A.; Pritchett, Jason M.; Mason, Wendi R.; Sivarajan, Lakshmi; Gleaves, Linda A.; Lancaster, Lisa H.; Lawson, William E.; Blackwell, Timothy S.; Steele, Mark P.; Loyd, James E.; Rickman, Otis B.] Vanderbilt Univ Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37203 USA; [Johnson, Joyce E.] Vanderbilt Univ Sch Med, Dept Pathol Microbiol & Immunol, Nashville, TN USA; [Blackwell, Timothy S.] Vanderbilt Univ Sch Med, Dept Cell & Dev Biol, Nashville, TN USA; [Blackwell, Timothy S.] Vanderbilt Univ Sch Med, Dept Canc Biol, Nashville, TN USA; [Rickman, Otis B.] Vanderbilt Univ Sch Med, Dept Thorac Surg, Nashville, TN USA; [Lawson, William E.; Blackwell, Timothy S.] Dept Vet Affairs Med Ctr, Nashville, TN 37212 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Kropski, JA (corresponding author), Vanderbilt Univ Sch Med, Dept Med, Div Allergy Pulm & Crit Care Med, Nashville, TN 37203 USA.	Jon.Kropski@vanderbilt.edu	Rickman, Otis B/AAH-1474-2020; Rickman, Otis/D-8199-2014	Rickman, Otis B/0000-0001-7222-6840; Rickman, Otis/0000-0001-7222-6840; Loyd, James/0000-0002-5042-7390	National Institutes of Health (NIH) Heart, Lung and Blood Institute [HL92870, HL085317, HL105479, HL094296]; NIH National Center for Research Resources [UL1 RR024975]; Department of Veterans Affairs; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024975] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL092870, T32HL094296, R01HL105479, R01HL085317] Funding Source: NIH RePORTER	National Institutes of Health (NIH) Heart, Lung and Blood Institute; NIH National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Funded by National Institutes of Health (NIH) Heart, Lung and Blood Institute HL92870 (to TSB), HL085317 (to TSB), HL105479 (to WEL), HL094296 (to JAK); NIH National Center for Research Resources UL1 RR024975; and the Department of Veterans Affairs (to WEL and TSB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berbescu EA, 2006, CHEST, V129, P1126, DOI 10.1378/chest.129.5.1126; KRASNA MJ, 1995, ANN THORAC SURG, V59, P348, DOI 10.1016/0003-4975(94)00844-W; Kropski JA, 2013, DIS MODEL MECH, V6, P9, DOI 10.1242/dmm.010736; Noble PW, 2011, LANCET, V377, P1760, DOI 10.1016/S0140-6736(11)60405-4; Pajares V, 2010, ARCH BRONCONEUMOL, V46, P111, DOI 10.1016/j.arbres.2009.09.012; POLETTI V, 1988, Respiration, V54, P66; Pritchett JM, 2013, AM J RESP CRIT CARE, pA5978; Raghu G, 2011, AM J RESP CRIT CARE, V183, P788, DOI 10.1164/rccm.2009-040GL; Richeldi L, 2011, NEW ENGL J MED, V365, P1079, DOI 10.1056/NEJMoa1103690; Rosas IO, 2007, AM J RESP CRIT CARE, V176, P698, DOI 10.1164/rccm.200702-254OC; Shim HS, 2010, PATHOL INT, V60, P373, DOI 10.1111/j.1440-1827.2010.02528.x; Tomassetti S, 2012, RESP RES, V13, DOI 10.1186/1465-9921-13-96; Utz JP, 2001, EUR RESPIR J, V17, P175, DOI 10.1183/09031936.01.17201750; Yarmus L, 2013, CHEST, V143, P621, DOI 10.1378/chest.12-2290	14	113	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78674	10.1371/journal.pone.0078674	http://dx.doi.org/10.1371/journal.pone.0078674			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265706	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100039
J	Zhang, L; Xu, Z; Xu, X; Zhang, B; Wu, H; Wang, M; Zhang, X; Yang, T; Cai, J; Yan, Y; Mao, F; Zhu, W; Shao, Q; Qian, H; Xu, W				Zhang, L.; Xu, Z.; Xu, X.; Zhang, B.; Wu, H.; Wang, M.; Zhang, X.; Yang, T.; Cai, J.; Yan, Y.; Mao, F.; Zhu, W.; Shao, Q.; Qian, H.; Xu, W.			SALL4, a novel marker for human gastric carcinogenesis and metastasis	ONCOGENE			English	Article						SALL4; gastric cancer; metastasis; EMT; stemness	EPITHELIAL-MESENCHYMAL TRANSITION; CANCER STEM-CELLS; EARLY EMBRYONIC-DEVELOPMENT; ACUTE MYELOID-LEUKEMIA; PROSPECTIVE IDENTIFICATION; BREAST-CANCER; GENE; PLURIPOTENCY; EPIDEMIOLOGY; EXPRESSION	SALL4, a zinc-finger transcriptional factor for embryonic stem cell self-renewal and pluripotency, has been suggested to be involved in tumorigenesis. The role of SALL4 in human gastric cancer, however, remains largely unknown. In this study, we demonstrated that SALL4 was aberrantly expressed at both mRNA and protein levels in human gastric cancer tissues, and SALL4 level was highly correlated with lymph node metastasis. Enforced expression of SALL4 enhanced the proliferation and migration of human gastric cancer cells, whereas knockdown of SALL4 by siRNA led to the opposite effects. In addition, SALL4 overexpression promoted the growth and metastasis of gastric xenograft tumor in vivo. SALL4 overexpression induced epithelial-mesenchymal transition (EMT) in gastric cancer cells, with increased expression of Twist1, N-cadherin and decreased expression of E-cadherin. Moreover, SALL4 promoted the acquirement of stemness in gastric cancer cells through the induction of Bmi-1 and Lin28B. Taken together, our findings indicate that SALL4 has oncogenic roles in gastric cancer through the modulation of EMT and cell stemness, suggesting SALL4 as a novel target for human gastric cancer diagnosis and therapy.	[Zhang, L.; Xu, Z.; Xu, X.; Zhang, B.; Wang, M.; Zhang, X.; Yang, T.; Cai, J.; Yan, Y.; Mao, F.; Zhu, W.; Shao, Q.; Qian, H.; Xu, W.] Jiangsu Univ, Sch Med Sci & Lab Med, Zhenjiang 212013, Jiangsu, Peoples R China; [Wu, H.] First Peoples Hosp Lianyungang, Dept Cent Lab, Lianyungang, Peoples R China; [Xu, W.] Jiangsu Univ, Affiliated Hosp, Zhenjiang 212013, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Xu, W (corresponding author), Jiangsu Univ, Sch Med Sci & Lab Med, 301 Xuefu Rd, Zhenjiang 212013, Jiangsu, Peoples R China.	lstmmmlst@163.com; icls@ujs.edu.cn	B, Zhang/R-4316-2019; Zhang, Bin/HCP-1386-2022	B, Zhang/0000-0002-2879-379X; Qian, Hui/0000-0002-0098-3196	Major Research Plan of the National Natural Science Foundation of China [91129718]; National Natural Science Foundation of China [81071421]; Natural Science Foundation of the Jiangsu Province [BK2012709]; Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation [BL2012055]; Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program [LJ201117]; Jiangsu Province Doctoral Innovation Fund [CXLX12_0678]; Doctoral Program Foundation of State Education Ministry [20113227110011]	Major Research Plan of the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of the Jiangsu Province(Natural Science Foundation of Jiangsu Province); Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation; Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program; Jiangsu Province Doctoral Innovation Fund; Doctoral Program Foundation of State Education Ministry	This work was supported by the Major Research Plan of the National Natural Science Foundation of China (Grant no. 91129718), the National Natural Science Foundation of China (Grant no. 81071421), the Natural Science Foundation of the Jiangsu Province (Grant no. BK2012709), Jiangsu Province's Project of Scientific and Technological Innovation and Achievements Transformation (Grant no. BL2012055), Jiangsu Province's Outstanding Medical Academic Leader and Sci-tech Innovation Team Program (Grant no. LJ201117), Jiangsu Province Doctoral Innovation Fund (Grant no. CXLX12_0678) and Doctoral Program Foundation of State Education Ministry (Grant no. 20113227110011).	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Bard JD, 2009, FASEB J, V23, P1405, DOI 10.1096/fj.08-117721; Bjerkvig R, 2005, NAT REV CANCER, V5, P899, DOI 10.1038/nrc1740; Bonnet D, 1997, NAT MED, V3, P730, DOI 10.1038/nm0797-730; Brenner Hermann, 2009, V472, P467, DOI 10.1007/978-1-60327-492-0_23; Cao DF, 2009, CANCER-AM CANCER SOC, V115, P2640, DOI 10.1002/cncr.24308; Chen Z, 2009, J SURG ONCOL, V99, P414, DOI 10.1002/jso.21270; Collins AT, 2005, CANCER RES, V65, P10946, DOI 10.1158/0008-5472.CAN-05-2018; Crew KD, 2006, WORLD J GASTROENTERO, V12, P354, DOI 10.3748/wjg.v12.i3.354; Dalerba P, 2007, ANNU REV MED, V58, P267, DOI 10.1146/annurev.med.58.062105.204854; Desai Anant M, 2004, Gastric Cancer, V7, P196, DOI 10.1007/s10120-004-0289-0; Elling U, 2006, P NATL ACAD SCI USA, V103, P16319, DOI 10.1073/pnas.0607884103; Giraud AS, 2012, EXPERT OPIN THER TAR, V16, P889, DOI 10.1517/14728222.2012.709238; Kanda N, 2004, ONCOGENE, V23, P4921, DOI 10.1038/sj.onc.1207606; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kobayashi D, 2011, INT J ONCOL, V38, P933, DOI 10.3892/ijo.2011.929; Kopper L, 2004, PATHOL ONCOL RES, V10, P69, DOI 10.1007/BF02893458; Lee JM, 2006, J CELL BIOL, V172, P973, DOI 10.1083/jcb.200601018; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Lin T, 2012, MED ONCOL, V29, P878, DOI 10.1007/s12032-011-9860-9; Lu JY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005577; Ma YP, 2006, BLOOD, V108, P2726, DOI 10.1182/blood-2006-02-001594; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Matsuoka J, 2012, J SURG RES, V174, P130, DOI 10.1016/j.jss.2010.11.903; Oikawa T, 2013, HEPATOLOGY, V57, P1469, DOI 10.1002/hep.26159; Palafox M, 2012, CANCER RES, V72, P2879, DOI 10.1158/0008-5472.CAN-12-0044; Szotek PP, 2006, P NATL ACAD SCI USA, V103, P11154, DOI 10.1073/pnas.0603672103; Takaishi S, 2008, J CLIN ONCOL, V26, P2876, DOI 10.1200/JCO.2007.15.2603; Ushiku T, 2010, AM J SURG PATHOL, V34, P533, DOI 10.1097/PAS.0b013e3181d1dcdd; Voon DCC, 2012, STEM CELLS, V30, P2088, DOI 10.1002/stem.1183; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Warren M, 2007, GENESIS, V45, P51, DOI 10.1002/dvg.20264; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Yang JC, 2008, BLOOD, V112, P805, DOI 10.1182/blood-2007-11-126326; Yang JC, 2007, P NATL ACAD SCI USA, V104, P10494, DOI 10.1073/pnas.0704001104; Yang JC, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010766; Yang ZF, 2008, HEPATOLOGY, V47, P919, DOI 10.1002/hep.22082; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang XW, 2010, MOL CANCER, V9, DOI 10.1186/1476-4598-9-40; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	40	81	92	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5491	5500		10.1038/onc.2013.495	http://dx.doi.org/10.1038/onc.2013.495			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24276240				2022-12-25	WOS:000346087900002
J	Lee, KL; Hoey, DA; Spasic, M; Tang, T; Hammond, HK; Jacobs, CR				Lee, Kristen L.; Hoey, David A.; Spasic, Milos; Tang, Tong; Hammond, H. Kirk; Jacobs, Christopher R.			Adenylyl cyclase 6 mediates loading-induced bone adaptation in vivo	FASEB JOURNAL			English	Article						mechanotransduction; mechanical loading; fluid flow	PRIMARY CILIA; OSTEOBLAST DIFFERENTIATION; FLUID-FLOW; INTRACELLULAR CALCIUM; PARATHYROID-HORMONE; PRIMARY OSTEOCYTES; MECHANICAL-STRESS; SIGNALING PATHWAY; INTERMITTENT PTH; MC3T3-E1 CELLS	Primary cilia are single, nonmotile, antenna-like structures extending from the apical membrane of most mammalian cells. They may mediate mechanotransduction, the conversion of external mechanical stimuli into biochemical intracellular signals. Previously we demonstrated that adenylyl cyclase 6 (AC6), a membrane-bound enzyme enriched in primary cilia of MLO-Y4 osteocyte-like cells, may play a role in a primary cilium-dependent mechanism of osteocyte mechanotransduction in vitro. In this study, we determined whether AC6 deletion impairs loading-induced bone formation in vivo. Skeletally mature mice with a global knockout of AC6 exhibited normal bone morphology and responded to osteogenic chemical stimuli similar to wild-type mice. Following ulnar loading over 3 consecutive days, bone formation parameters were assessed using dynamic histomorphometry. Mice lacking AC6 formed significantly less bone than control animals (41% lower bone formation rate). Furthermore, there was an attenuated flow-induced increase in COX-2 mRNA expression levels in primary bone cells isolated from AC6 knockout mice compared to controls (1.3 +/- 0.1- vs. 2.6 +/- 0.2-fold increase). Collectively, these data indicate that AC6 plays a role in loading-induced bone adaptation, and these findings are consistent with our previous studies implicating primary cilia and AC6 in a novel mechanism of osteocyte mechanotransduction.Lee, K. L., Hoey, D. A., Spasic, M., Tang, T., Hammond, H. K., Jacobs, C. R. Adenylyl cyclase 6 mediates loading-induced bone adaptation in vivo.	[Lee, Kristen L.; Hoey, David A.; Spasic, Milos; Jacobs, Christopher R.] Columbia Univ, Dept Biomed Engn, New York, NY 10027 USA; [Hoey, David A.] Royal Coll Surgeons Ireland, Dept Anat, Dublin 2, Ireland; [Hoey, David A.] Univ Limerick, Dept Mech Aeronaut & Biomed Engn, Ctr Appl Biomed Engn Res, Mat & Surface Sci Inst, Limerick, Ireland; [Spasic, Milos] Univ Calif San Diego, Dept Bioengn, San Diego, CA 92103 USA; [Tang, Tong; Hammond, H. Kirk] Univ Calif San Diego, Dept Med, San Diego, CA 92103 USA; [Tang, Tong; Hammond, H. Kirk] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	Columbia University; Royal College of Surgeons - Ireland; University of Limerick; University of California System; University of California San Diego; University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Jacobs, CR (corresponding author), Columbia Univ, 351 Engn Terr,1210 Amsterdam Ave,Mail Code 8904, New York, NY 10027 USA.	crj2111@columbia.edu	Hoey, David/X-9231-2019; Hoey, David/A-7587-2012	Hoey, David/0000-0001-5898-0409	U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health [AR054156, AR062177, 5P01HL066941, HL081741, HL088426]; American Heart Association [11GRNT7610059]; National Science Foundation [GRFP 0707425]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL088426, P01HL066941, R01HL081741] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR054156, R01AR062177] Funding Source: NIH RePORTER	U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health; American Heart Association(American Heart Association); National Science Foundation(National Science Foundation (NSF)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The authors thank J. Christopher Fritton, Alesha B. Castillo, Sara Temiyasathit, and Ron Kwon for valuable discussions; Julia C. Chen and An M. Nguyen for technical assistance and helpful input; and Bin Zhou and Ji Wang for conducting microCT imaging and analyses. This publication was made possible by grants from the U.S. National Institute of Arthritis and Musculoskeletal and Skin Diseases/National Institutes of Health (AR054156 and AR062177, to C.R.J.; 5P01HL066941, HL081741, and HL088426, to H.K.H.), the American Heart Association (grant-in-aid 11GRNT7610059 to T.T.), and the National Science Foundation (GRFP 0707425 to K.L.L.).	Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Cheng SL, 2001, CALCIFIED TISSUE INT, V68, P87, DOI 10.1007/BF02678146; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Delghandi MP, 2005, CELL SIGNAL, V17, P1343, DOI 10.1016/j.cellsig.2005.02.003; Elis S, 2010, J BONE MINER RES, V25, P2051, DOI 10.1002/jbmr.100; Ferrari SL, 2005, ENDOCRINOLOGY, V146, P1854, DOI 10.1210/en.2004-1282; Gu GL, 2006, CELL TISSUE RES, V323, P263, DOI 10.1007/s00441-005-0066-3; Guillou JL, 1999, J BIOL CHEM, V274, P35539, DOI 10.1074/jbc.274.50.35539; Hanoune J, 2001, ANNU REV PHARMACOL, V41, P145, DOI 10.1146/annurev.pharmtox.41.1.145; Husse B, 2010, HEART INT, V5, P10, DOI 10.4081/hi.2010.e3; Ishijima M, 2001, J EXP MED, V193, P399, DOI 10.1084/jem.193.3.399; Jacobs CR, 2010, ANNU REV BIOMED ENG, V12, P369, DOI 10.1146/annurev-bioeng-070909-105302; Jessop HL, 2001, J BONE MINER RES, V16, P1045, DOI 10.1359/jbmr.2001.16.6.1045; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Jilka RL, 2009, BONE, V44, P275, DOI 10.1016/j.bone.2008.10.037; Jin XJ, 2014, CELL MOL LIFE SCI, V71, P2165, DOI 10.1007/s00018-013-1483-1; Kaiser E, 2003, BIOCHEM BIOPH RES CO, V305, P573, DOI 10.1016/S0006-291X(03)00820-9; Klein-Nulend J, 2007, CLIN REV BONE MINER, V5, P195, DOI 10.1007/s12018-008-9014-6; KLEINNULEND J, 1995, FASEB J, V9, P441, DOI 10.1096/fasebj.9.5.7896017; Kotttgen M, 2008, J CELL BIOL, V182, P437, DOI 10.1083/jcb.200805124; Kwon RY, 2010, FASEB J, V24, P2859, DOI 10.1096/fj.09-148007; Lai CF, 2005, J BONE MINER RES, V20, P330, DOI 10.1359/JBMR.041013; Lee KCL, 2002, BONE, V31, P407, DOI 10.1016/S8756-3282(02)00842-6; Lee KL, 2010, CLIN REV BONE MINER, V8, P201, DOI 10.1007/s12018-010-9078-y; Liedert A, 2006, BIOCHEM BIOPH RES CO, V349, P1, DOI 10.1016/j.bbrc.2006.07.214; Litzenberger JB, 2009, CELL MOL BIOENG, V2, P416, DOI 10.1007/s12195-009-0068-4; Malone AMD, 2007, P NATL ACAD SCI USA, V104, P13325, DOI 10.1073/pnas.0700636104; Masi L, 2005, J Endocrinol Invest, V28, P37; Masyuk AI, 2008, AM J PHYSIOL-GASTR L, V295, pG725, DOI 10.1152/ajpgi.90265.2008; Matsubara T, 2008, J BIOL CHEM, V283, P29119, DOI 10.1074/jbc.M801774200; McGlashan SR, 2010, CELL BIOL INT, V34, P441, DOI 10.1042/CBI20090094; Morinobu M, 2003, J BONE MINER RES, V18, P1706, DOI 10.1359/jbmr.2003.18.9.1706; Mullender M, 2004, MED BIOL ENG COMPUT, V42, P14, DOI 10.1007/BF02351006; Ogasawara A, 2001, J BIOL CHEM, V276, P7048, DOI 10.1074/jbc.M008070200; Ogasawara T, 2004, MOL CELL BIOL, V24, P6560, DOI 10.1128/mcb.24.15.6560-6568.2004; Praetorius HA, 2001, J MEMBRANE BIOL, V184, P71, DOI 10.1007/s00232-001-0075-4; Praetorius HA, 2003, J MEMBRANE BIOL, V191, P69, DOI 10.1007/s00232-002-1042-4; Qiu N, 2012, J CELL SCI, V125, P1945, DOI 10.1242/jcs.095893; Sabsovich I, 2008, BONE, V42, P439, DOI 10.1016/j.bone.2007.09.041; Salih E, 1996, J BONE MINER RES, V11, P1461; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Schmidt C, 1997, EUR J CELL BIOL, V72, P191; Stern AR, 2012, BIOTECHNIQUES, V52, P361, DOI 10.2144/0000113876; Su S, 2013, NAT METHODS, V10, P1105, DOI [10.1038/NMETH.2647, 10.1038/nmeth.2647]; Tang T, 2008, CIRCULATION, V117, P61, DOI 10.1161/CIRCULATIONAHA.107.730069; Tatsumi S, 2007, CELL METAB, V5, P464, DOI 10.1016/j.cmet.2007.05.001; Temiyasathit S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033368; Toyosawa S, 2001, J BONE MINER RES, V16, P2017, DOI 10.1359/jbmr.2001.16.11.2017; Tuson M, 2011, DEVELOPMENT, V138, P4921, DOI 10.1242/dev.070805; Wadhwa S, 2002, BIOCHEM BIOPH RES CO, V297, P46, DOI 10.1016/S0006-291X(02)02124-1; Wang YL, 2007, P NATL ACAD SCI USA, V104, P15941, DOI 10.1073/pnas.0707246104; Wann AKT, 2012, FASEB J, V26, P1663, DOI 10.1096/fj.11-193649; Werthmann RC, 2009, J PHYSIOL-LONDON, V587, P4091, DOI 10.1113/jphysiol.2009.172957; Wheatley DN, 1996, CELL BIOL INT, V20, P73, DOI 10.1006/cbir.1996.0011; Willoughby D, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002299; Yang DC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001540; You J, 2001, J BIOL CHEM, V276, P13365, DOI 10.1074/jbc.M009846200; You LD, 2001, J BIOMECH, V34, P1375, DOI 10.1016/S0021-9290(01)00107-5	59	27	30	0	9	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1157	1165		10.1096/fj.13-240432	http://dx.doi.org/10.1096/fj.13-240432			9	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24277577	Green Published			2022-12-25	WOS:000335324800012
J	Srivastav, S; Ball, WB; Gupta, P; Giri, J; Ukil, A; Das, PK				Srivastav, Supriya; Ball, Writoban Basu; Gupta, Purnima; Giri, Jayeeta; Ukil, Anindita; Das, Pijush K.			Leishmania donovani Prevents Oxidative Burst-mediated Apoptosis of Host Macrophages through Selective Induction of Suppressors of Cytokine Signaling (SOCS) Proteins	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							GROWTH-FACTOR-BETA; MICE LACKING SUPPRESSOR; TYROSINE PHOSPHATASES; CELL-DEATH; INFECTION; EGR-1; INACTIVATION; STIMULATION; THIOREDOXIN; LYMPHOCYTES	One of the mechanisms for establishment of infection employed by intra-macrophage pathogen-like Leishmania is inhibition of oxidative burst-mediated macrophage apoptosis to protect their niche for survival and replication. We tried to elucidate the underlying mechanism for this by using H2O2 for induction of apoptosis. Leishmania donovani-infected macrophages were much more resistant to H2O2-mediated apoptosis compared with control. Although infected cells were capable of comparable reactive oxygen species production, there was less activation of the downstream cascade consisting of caspase-3 and -7 and cleaved poly(ADP)-ribose polymerase. Suppressors of cytokine signaling (SOCS) 1 and 3 proteins and reactive oxygen species scavenging enzyme thioredoxin, known to be involved in stabilization of protein-tyrosine phosphatases, were found to be induced during infection. Induction of SOCS proteins may be mediated by Egr1, and silencing of Socs1 and -3 either alone or in combination resulted in reduced thioredoxin levels, enhanced activation of caspases, and increased apoptosis of infected macrophages. The induction of protein-tyrosine phosphatases, thioredoxin, SOCS, and Egr1 in L. donovani-infected macrophages was found to be unaffected by H2O2 treatment. SOCS knocked down cells also displayed decreased parasite survival thus marking reduction in disease progression. Taken together, these results suggest that L. donovani may exploit SOCS for subverting macrophage apoptotic machinery toward establishing its replicative niche inside the host.	[Srivastav, Supriya; Ball, Writoban Basu; Das, Pijush K.] CSIR Indian Inst Chem Biol, Infect Dis & Immunol Div, Kolkata 700032, India; [Gupta, Purnima; Giri, Jayeeta; Ukil, Anindita] Univ Calcutta, Dept Biochem, Kolkata 700019, India	Council of Scientific & Industrial Research (CSIR) - India; CSIR - Indian Institute of Chemical Biology (IICB); University of Calcutta	Das, PK (corresponding author), CSIR Indian Inst Chem Biol, 4 Raja SC Mullick Rd, Kolkata 700032, India.	pijushdas@iicb.res.in	Gupta, Purnima/AAP-8717-2020	GIRI, JAYEETA/0000-0002-2688-7274; Basu Ball, Writoban/0000-0001-7678-126X; Gupta, Purnima/0000-0003-4389-3024	Council of Scientific and Industrial Research [BSC 0206, BSC 0114]; J. C. Bose Fellowship (Department of Science and Technology), Government of India	Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India); J. C. Bose Fellowship (Department of Science and Technology), Government of India(Department of Science & Technology (India))	This work was supported by Network Project Grant BSC 0206 and Supra Institutional Project Grant BSC 0114 from the Council of Scientific and Industrial Research and the J. C. Bose Fellowship (Department of Science and Technology), Government of India.	Ashida H, 2011, J CELL BIOL, V195, P931, DOI 10.1083/jcb.201108081; Barry M, 2002, NAT REV IMMUNOL, V2, P401, DOI 10.1038/nri819; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Campanella M, 2004, J BIOL CHEM, V279, P18440, DOI 10.1074/jbc.M309494200; Carratelli CR, 2002, FEMS MICROBIOL LETT, V215, P69, DOI 10.1016/S0378-1097(02)00910-2; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chowdhury I, 2006, CELL MOL BIOL LETT, V11, P506, DOI 10.2478/s11658-006-0041-3; Denu JM, 1998, BIOCHEMISTRY-US, V37, P5633, DOI 10.1021/bi973035t; Didier C, 2001, FREE RADICAL BIO MED, V31, P585, DOI 10.1016/S0891-5849(01)00617-7; Duval D, 2000, FASEB J, V14, P1577, DOI 10.1096/fj.14.11.1577; Eley A, 2005, HUM REPROD, V20, P2601, DOI 10.1093/humrep/dei082; Fiorentini C, 2003, CELL DEATH DIFFER, V10, P147, DOI 10.1038/sj.cdd.4401151; Fu MG, 2003, BIOCHEM J, V370, P1019, DOI 10.1042/BJ20021503; Gao LY, 2000, TRENDS MICROBIOL, V8, P306, DOI 10.1016/S0966-842X(00)01784-4; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; Hoffmann KMV, 1997, J BIOL CHEM, V272, P27505, DOI 10.1074/jbc.272.44.27505; Horta Maria Fatima, 2012, J Parasitol Res, V2012, P203818, DOI 10.1155/2012/203818; LIND L, 1992, EXP CLIN ENDOCRINOL, V99, P87, DOI 10.1055/s-0029-1211142; Lisi S, 2005, J EUKARYOT MICROBIOL, V52, P211, DOI 10.1111/j.1550-7408.2005.00026.x; Lodge R, 2006, CELL MICROBIOL, V8, P1922, DOI 10.1111/j.1462-5822.2006.00758.x; Madonna S, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2012.69; Maillet A, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.185; Meng TC, 2002, MOL CELL, V9, P387, DOI 10.1016/S1097-2765(02)00445-8; MOORE KJ, 1994, J IMMUNOL, V152, P2930; MURRAY HW, 1981, J EXP MED, V153, P1302, DOI 10.1084/jem.153.5.1302; Naka T, 1998, P NATL ACAD SCI USA, V95, P15577, DOI 10.1073/pnas.95.26.15577; Nash PB, 1998, J IMMUNOL, V160, P1824; Oh J, 2009, ONCOGENE, V28, P3145, DOI 10.1038/onc.2009.169; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Puhr M, 2009, CANCER RES, V69, P7375, DOI 10.1158/0008-5472.CAN-09-0806; Qian YR, 2012, MOL MED REP, V5, P452, DOI 10.3892/mmr.2011.672; Roberts AW, 2001, P NATL ACAD SCI USA, V98, P9324, DOI 10.1073/pnas.161271798; Roulston A, 1999, ANNU REV MICROBIOL, V53, P577, DOI 10.1146/annurev.micro.53.1.577; Ruhland A, 2007, CELL MICROBIOL, V9, P84, DOI 10.1111/j.1462-5822.2006.00769.x; Schaumburg F, 2006, PARASITOLOGY, V132, pS69, DOI 10.1017/S0031182006000874; Shim JH, 2005, GENE DEV, V19, P2668, DOI 10.1101/gad.1360605; Sinai AP, 2004, INT J PARASITOL, V34, P381, DOI 10.1016/j.ijpara.2003.11.009; Somanna A, 2002, J BIOL CHEM, V277, P25305, DOI 10.1074/jbc.M203034200; Srivastav S, 2012, J IMMUNOL, V189, P924, DOI 10.4049/jimmunol.1102845; Starr R, 1998, P NATL ACAD SCI USA, V95, P14395, DOI 10.1073/pnas.95.24.14395; Sukumaran SK, 2004, INFECT IMMUN, V72, P6012, DOI 10.1128/IAI.72.10.6012-6022.2004; van de Sand C, 2005, MOL MICROBIOL, V58, P731, DOI 10.1111/j.1365-2958.2005.04888.x; VAUX DL, 1994, CELL, V76, P777, DOI 10.1016/0092-8674(94)90350-6; Wilson ME, 1998, J IMMUNOL, V161, P6148; Wu Y, 2013, CLIN EXP PHARMACOL P, V40, P626, DOI 10.1111/1440-1681.12141; Xiong H, 2012, MOL CARCINOGEN, V51, P174, DOI 10.1002/mc.20777; Yamamoto K, 2005, CLIN EXP IMMUNOL, V142, P268, DOI 10.1111/j.1365-2249.2005.02922.x; Zimmermann S, 2006, J IMMUNOL, V176, P1840, DOI 10.4049/jimmunol.176.3.1840	48	38	40	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1092	1105		10.1074/jbc.M113.496323	http://dx.doi.org/10.1074/jbc.M113.496323			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275663	Green Published, hybrid			2022-12-25	WOS:000330541200041
J	Kim, C; Kim, W; Lee, H; Ji, E; Choe, YJ; Martindale, JL; Akamatsu, W; Okano, H; Kim, HS; Nam, SW; Gorospe, M; Lee, EK				Kim, Chongtae; Kim, Wook; Lee, Heejin; Ji, Eunbyul; Choe, Yun-Jeong; Martindale, Jennifer L.; Akamatsu, Wado; Okano, Hideyuki; Kim, Ho-Shik; Nam, Suk Woo; Gorospe, Myriam; Lee, Eun Kyung			The RNA-binding Protein HuD Regulates Autophagosome Formation in Pancreatic beta Cells by Promoting Autophagy-related Gene 5 Expression	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Autophagy; RNA-binding Protein; RNA Metabolism; RNA Turnover; RNA-Protein Interaction	GAP-43 MESSENGER-RNA; POSTTRANSCRIPTIONAL REGULATION; NEURITE OUTGROWTH; PC12 CELLS; TRANSLATION; OVEREXPRESSION; LIPIDATION; STARVATION; ROLES; ATG5	Tight regulation of autophagy is critical for the fate of pancreatic beta cells. The autophagy protein ATG5 is essential for the formation of autophagosomes by promoting the lipidation of microtubule-associated protein LC3 (light chain 3). However, little is known about the mechanisms that regulate ATG5 expression levels. In this study, we investigated the regulation of ATG5 expression by HuD. The association of HuD with ATG5 mRNA was analyzed by ribonucleoprotein complex immunoprecipitation and biotin pulldown assays. HuD expression levels in pancreatic beta cells were knocked down via siRNA, elevated by overexpression of a HuD-expressing plasmid. The expression levels of HuD, ATG5, LC3, and -actin were determined by Western blot and quantitative RT-PCR analysis. Autophagosome formation was assessed by fluorescence microscopy in GFP-LC3-expressing cells and in pancreatic tissues from WT and HuD-null mice. We identified ATG5 mRNA as a post-transcriptional target of the mammalian RNA-binding protein HuD in pancreatic beta cells. HuD associated with the 3-UTR of the ATG5 mRNA. Modulating HuD abundance did not alter ATG5 mRNA levels, but HuD silencing decreased ATG5 mRNA translation, and, conversely, HuD overexpression enhanced ATG5 mRNA translation. Through its effect on ATG5, HuD contributed to the lipidation of LC3 and the formation of LC3-positive autophagosomes. In keeping with this regulatory paradigm, HuD-null mice displayed lower ATG5 and LC3 levels in pancreatic beta cells. Our results reveal HuD to be an inducer of ATG5 expression and hence a critical regulator of autophagosome formation in pancreatic beta cells.	[Kim, Chongtae; Lee, Heejin; Ji, Eunbyul; Choe, Yun-Jeong; Kim, Ho-Shik; Lee, Eun Kyung] Catholic Univ Korea, Coll Med, Dept Biochem, Seoul 137701, South Korea; [Nam, Suk Woo] Catholic Univ Korea, Coll Med, Dept Pathol, Seoul 137701, South Korea; [Kim, Wook] Ajou Univ, Dept Mol Sci & Technol, Suwon 443749, South Korea; [Martindale, Jennifer L.; Gorospe, Myriam] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Akamatsu, Wado; Okano, Hideyuki] Keio Univ, Grad Sch Med, Dept Physiol, Shinjuku Ku, Tokyo 1608582, Japan	Catholic University of Korea; Catholic University of Korea; Ajou University; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); Keio University	Lee, EK (corresponding author), Catholic Univ Korea, Coll Med, Dept Biochem, 222 Banpodaero, Seoul 137701, South Korea.	leeek@catholic.ac.kr	Okano, Hideyuki/I-7584-2019; Martindale, Jennifer Luethy/AAD-1963-2022	Martindale, Jennifer Luethy/0000-0002-3234-6861	National Research Foundation of Korea [20110013116, 012M3A9D1054517, 2012R1A1A1041352]; Korean government; Intramural Research Program of NIA, National Institutes of Health; NATIONAL INSTITUTE ON AGING [ZIAAG000511] Funding Source: NIH RePORTER	National Research Foundation of Korea(National Research Foundation of Korea); Korean government(Korean Government); Intramural Research Program of NIA, National Institutes of Health; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by National Research Foundation of Korea Grants 20110013116 and 012M3A9D1054517 (to E. K. L.) and 2012R1A1A1041352 (to W. K.) funded by the Korean government and by funds from the Intramural Research Program of NIA, National Institutes of Health (to J. L. M. and M. G.).	Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102; Anderson KD, 2000, J NEUROCHEM, V75, P1103, DOI 10.1046/j.1471-4159.2000.0751103.x; Anderson KD, 2001, EXP NEUROL, V168, P250, DOI 10.1006/exnr.2000.7599; Antic D, 1999, GENE DEV, V13, P449, DOI 10.1101/gad.13.4.449; Beckel-Mitchener AC, 2002, J BIOL CHEM, V277, P27996, DOI 10.1074/jbc.M201982200; Bolognani F, 2008, J NEUROSCI RES, V86, P481, DOI 10.1002/jnr.21473; Bolognani F, 2007, NEUROBIOL LEARN MEM, V87, P635, DOI 10.1016/j.nlm.2006.11.004; Choe YJ, 2012, ONCOL REP, V28, P2049, DOI 10.3892/or.2012.2034; Chung SM, 1996, J BIOL CHEM, V271, P11518, DOI 10.1074/jbc.271.19.11518; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Deschenes-Furry J, 2003, J BIOL CHEM, V278, P5710, DOI 10.1074/jbc.M209383200; Ebato C, 2008, CELL METAB, V8, P325, DOI 10.1016/j.cmet.2008.08.009; Florey O, 2012, TRENDS CELL BIOL, V22, P374, DOI 10.1016/j.tcb.2012.04.005; Fu LL, 2012, INT J BIOCHEM CELL B, V44, P733, DOI 10.1016/j.biocel.2012.02.004; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; George MD, 2000, MOL BIOL CELL, V11, P969, DOI 10.1091/mbc.11.3.969; Hanada T, 2007, J BIOL CHEM, V282, P37298, DOI 10.1074/jbc.C700195200; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Huang YP, 2012, CELL CYCLE, V11, P1247, DOI 10.4161/cc.11.6.19670; Jager S, 2004, J CELL SCI, V117, P4837, DOI 10.1242/jcs.01370; Jung HS, 2008, CELL METAB, V8, P318, DOI 10.1016/j.cmet.2008.08.013; Kaniuk NA, 2007, DIABETES, V56, P930, DOI 10.2337/db06-1160; Kasashima K, 1999, GENES CELLS, V4, P667, DOI 10.1046/j.1365-2443.1999.00292.x; Keil E, 2013, CELL DEATH DIFFER, V20, P321, DOI 10.1038/cdd.2012.129; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Kullmann M, 2002, GENE DEV, V16, P3087, DOI 10.1101/gad.248902; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Lee EK, 2012, MOL CELL, V45, P826, DOI 10.1016/j.molcel.2012.01.016; Lee EK, 2010, NAT STRUCT MOL BIOL, V17, P732, DOI 10.1038/nsmb.1815; Lee IH, 2009, J BIOL CHEM, V284, P6322, DOI 10.1074/jbc.M807135200; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Levine B, 2011, NATURE, V469, P323, DOI 10.1038/nature09782; Lin NY, 2013, ANN RHEUM DIS, V72, P761, DOI 10.1136/annrheumdis-2012-201671; Luciani A, 2010, NAT CELL BIOL, V12, P863, DOI 10.1038/ncb2090; Masini M, 2009, DIABETOLOGIA, V52, P1083, DOI 10.1007/s00125-009-1347-2; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Noureddine MA, 2005, HUM GENET, V117, P27, DOI 10.1007/s00439-005-1259-2; Perrone-Bizzozero N, 2002, J NEUROSCI RES, V68, P121, DOI 10.1002/jnr.10175; Ratti A, 2008, J BIOL CHEM, V283, P7531, DOI 10.1074/jbc.M706082200; SADOT E, 1995, J CELL SCI, V108, P2857; Sukseree S, 2013, BIOCHEM BIOPH RES CO, V430, P689, DOI 10.1016/j.bbrc.2012.11.090; Tanida I, 2011, MICROBIOL IMMUNOL, V55, P1, DOI 10.1111/j.1348-0421.2010.00271.x; Tekirdag KA, 2013, AUTOPHAGY, V9, P374, DOI 10.4161/auto.23117; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Xu JZ, 2012, AUTOPHAGY, V8, P873, DOI 10.4161/auto.19629	45	30	30	1	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					112	121		10.1074/jbc.M113.474700	http://dx.doi.org/10.1074/jbc.M113.474700			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275661	hybrid, Green Published			2022-12-25	WOS:000329370900010
J	Yang, Q; Wang, B; Zang, W; Wang, XP; Liu, ZF; Li, WJ; Jia, JH				Yang, Qing; Wang, Bo; Zang, Wen; Wang, Xuping; Liu, Zhifang; Li, Wenjuan; Jia, Jihui			Resveratrol Inhibits the Growth of Gastric Cancer by Inducing G1 Phase Arrest and Senescence in a Sirt1-Dependent Manner	PLOS ONE			English	Article							SMALL-MOLECULE ACTIVATORS; CELL-CYCLE ARREST; IN-VITRO; SIRT1; APOPTOSIS; STRESS; HUMANS; P53	Resveratrol, a naturally occurring polyphenolic compound, has been reported to exert anticancer activity by affecting diverse molecular targets. In this study, we examined the effects and the underlying mechanisms of resveratrol on gastric cancer. We found that resveratrol inhibited the proliferation of gastric cancer cells in a dose-dependent manner. At the concentration of 25 and 50 mu M, resveratrol inhibited the cell viability and diminished the clonogenic potential of gastric cancer cells. Resveratrol treatment arrested gastric cancer cells in the G1 phase and led to senescence instead of apoptosis. Regulators of the cell cycle and senescence pathways, including cyclin D1, cyclin-dependent kinase (CDK4 and 6), p21 and p16, were dysregulated by resveratrol treatment. The inhibitory effects of resveratrol on gastric cancer were also verified in vivo using a nude mice xenograft model. Resveratrol (40 mg/kg/d) exerted inhibitory activities on gastric cancer development and significantly decreased the fractions of Ki67-positive cells in the tumor specimens from the nude mice. After resveratrol treatment, the induction of senescence and the changes in the expression of the regulators involved in the cell cycle and senescence pathways were similar to what we observed in vitro. However, the depletion of Sirtuin (Sirt)1 reversed the above-described effects of resveratrol both in vitro and in vivo. Our data suggest that resveratrol inhibits gastric cancer in a Sirt1-dependent manner and provide detailed evidence for the possibility of applying resveratrol in gastric cancer prevention and therapy.	[Yang, Qing; Zang, Wen; Li, Wenjuan; Jia, Jihui] Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan, Shandong, Peoples R China; [Wang, Bo] Shandong Univ, Qilu Hosp, Dept Tradit Chinese Med, Jinan, Shandong, Peoples R China; [Wang, Xuping] Shandong Univ, Qilu Hosp, Key Lab Cardiovasc Remodeling & Funct Res, Chinese Minist Educ, Jinan, Shandong, Peoples R China; [Wang, Xuping] Shandong Univ, Qilu Hosp, Chinese Minist Publ Hlth, Jinan, Shandong, Peoples R China; [Liu, Zhifang] Shandong Univ, Sch Med, Dept Biochem, Jinan, Shandong, Peoples R China	Shandong University; Shandong University; Shandong University; Shandong University; Shandong University	Jia, JH (corresponding author), Shandong Univ, Sch Med, Inst Pathogen Biol, Jinan, Shandong, Peoples R China.	jiajihui@sdu.edu.cn			National Natural Science Foundation of China [81101869, 81100103, 81171536, 81000868]; National Basic Research Program of China (973 Program) [2012CB911202]; Independent Innovation Foundation of Shandong University [2012TS108]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China (973 Program)(National Basic Research Program of China); Independent Innovation Foundation of Shandong University	This work was supported by the National Natural Science Foundation of China (No. 81101869, 81100103, 81171536 and 81000868), the National Basic Research Program of China (973 Program, No. 2012CB911202), and Independent Innovation Foundation of Shandong University (2012TS108).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bai Y, 2010, CANCER SCI, V101, P488, DOI 10.1111/j.1349-7006.2009.01415.x; Bertuccio P, 2009, INT J CANCER, V125, P666, DOI 10.1002/ijc.24290; Bjorklund M, 2011, CANCER CHEMOTH PHARM, V68, P1459, DOI 10.1007/s00280-011-1640-x; Brunet A, 2004, SCIENCE, V303, P2011, DOI 10.1126/science.1094637; Casanova F, 2012, J CELL BIOCHEM, V113, P2586, DOI 10.1002/jcb.24134; Fang YJ, 2012, CANCER SCI, V103, P1090, DOI 10.1111/j.1349-7006.2012.02272.x; Frazzi R, 2013, INT J CANCER, V132, P1013, DOI 10.1002/ijc.27748; Gonzalez-Sarrias A, 2011, J AGR FOOD CHEM, V59, P8632, DOI 10.1021/jf201561e; Green DR, 2009, NATURE, V458, P1127, DOI 10.1038/nature07986; Harikumar Kuzhuvelil B, 2010, Int J Cancer, V127, P257, DOI 10.1002/ijc.25041; Heiss EH, 2007, J BIOL CHEM, V282, P26759, DOI 10.1074/jbc.M703229200; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Im HJ, 2012, J CELL PHYSIOL, V227, P3488, DOI 10.1002/jcp.24049; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kang TW, 2011, NATURE, V479, P547, DOI 10.1038/nature10599; Key TJ, 2011, BRIT J CANCER, V104, P6, DOI 10.1038/sj.bjc.6606032; Kim WY, 2006, CELL, V127, P265, DOI 10.1016/j.cell.2006.10.003; Kita Y, 2012, J BIOMED BIOTECHNOL, DOI 10.1155/2012/672416; Knight CM, 2011, DIABETES, V60, P2691, DOI 10.2337/db10-0987; Kume S, 2007, J BIOL CHEM, V282, P151, DOI 10.1074/jbc.M605904200; Li TY, 2012, CELL, V149, P1269, DOI 10.1016/j.cell.2012.04.026; Massague J, 2004, NATURE, V432, P298, DOI 10.1038/nature03094; Meng XF, 2004, J AGR FOOD CHEM, V52, P935, DOI 10.1021/jf030582e; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Pacholec M, 2010, J BIOL CHEM, V285, P8340, DOI 10.1074/jbc.M109.088682; Papazoglu C, 2007, J PATHOL, V211, P124, DOI 10.1002/path.2086; Patel KR, 2011, ANN NY ACAD SCI, V1215, P161, DOI 10.1111/j.1749-6632.2010.05853.x; Patel KR, 2010, CANCER RES, V70, P7392, DOI 10.1158/0008-5472.CAN-10-2027; Peltz L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037162; Pozo-Guisado E, 2002, BIOCHEM PHARMACOL, V64, P1375, DOI 10.1016/S0006-2952(02)01296-0; Ruggiero P, 2012, CURR OPIN INFECT DIS, V25, P337, DOI 10.1097/QCO.0b013e3283531f7c; Scott E, 2012, MOL NUTR FOOD RES, V56, P7, DOI 10.1002/mnfr.201100400; Sheth S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051655; Tang YH, 2012, J NUTR BIOCHEM, V23, P1410, DOI 10.1016/j.jnutbio.2011.08.008; Thomasset SC, 2007, INT J CANCER, V120, P451, DOI 10.1002/ijc.22419; Ulrich S, 2006, CANCER RES, V66, P7348, DOI 10.1158/0008-5472.CAN-05-2777; van Delft MF, 2006, CELL RES, V16, P203, DOI 10.1038/sj.cr.7310028; Vaquero A, 2004, MOL CELL, V16, P93, DOI 10.1016/j.molcel.2004.08.031; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Wang YM, 2009, CANCER RES, V69, P4093, DOI 10.1158/0008-5472.CAN-09-0309; Wood JG, 2004, NATURE, V430, P686, DOI 10.1038/nature02789; Wu KC, 2009, J GASTROEN HEPATOL, V24, P37, DOI 10.1111/j.1440-1746.2008.05753.x; Yang Q, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022708; Yu J, 2008, ONCOGENE, V27, pS71, DOI 10.1038/onc.2009.45	45	94	100	0	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e70627	10.1371/journal.pone.0070627	http://dx.doi.org/10.1371/journal.pone.0070627			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278101	Green Published, gold, Green Submitted			2022-12-25	WOS:000327539800001
J	Benedetti, M; Andreani, F; Leggio, C; Galantini, L; Di Matteo, A; Pavel, NV; De Lorenzo, G; Cervone, F; Federici, L; Sicilia, F				Benedetti, Manuel; Andreani, Federico; Leggio, Claudia; Galantini, Luciano; Di Matteo, Adele; Pavel, Nicolae Viorel; De Lorenzo, Giulia; Cervone, Felice; Federici, Luca; Sicilia, Francesca			A Single Amino-Acid Substitution Allows Endo-Polygalacturonase of Fusarium verticillioides to Acquire Recognition by PGIP2 from Phaseolus vulgaris	PLOS ONE			English	Article							X-RAY-SCATTERING; SMALL-ANGLE SCATTERING; INHIBITING PROTEIN PGIP; BIOLOGICAL MACROMOLECULES; MOLECULAR-PATTERNS; STRUCTURAL-CHANGES; CRYSTAL-STRUCTURE; FULL VIRULENCE; PLANT DEFENSE; ENDOPOLYGALACTURONASE	Polygalacturonases (PGs) are secreted by phytopathogenic fungi to degrade the plant cell wall homogalacturonan during plant infection. To counteract Pgs, plants have evolved polygalacturonase-inhibiting proteins (PGIPs) that slow down fungal infection and defend cell wall integrity. PGIPs favour the accumulation of oligogalacturonides, which are homogalacturonan fragments that act as endogenous elicitors of plant defence responses. We have previously shown that PGIP2 from Phaseolus vulgaris (PvPGIP2) forms a complex with PG from Fusarium phyllophilum (FpPG), hindering the enzyme active site cleft from substrate. Here we analyse by small angle X-ray scattering (SAXS) the interaction between PvPGIP2 and a PG from Colletotrichum lupini (CluPG1). We show a different shape of the PGPGIP complex, which allows substrate entry and provides a structural explanation for the different inhibition kinetics exhibited by PvPGIP2 towards the two isoenzymes. The analysis of SAXS structures allowed us to investigate the basis of the inability of PG from Fusarium verticilloides (FvPG) to be inhibited by PvPGIP2 or by any other known PGIP. FvPG is 92.5% identical to FpPG, and we show here, by both loss-and gain-of-function mutations, that a single amino acid site acts as a switch for FvPG recognition by PvPGIP2.	[Benedetti, Manuel; Andreani, Federico; De Lorenzo, Giulia; Cervone, Felice; Sicilia, Francesca] Univ Roma La Sapienza, Dipartimento Biol & Biotecnol Charles Darwin, I-00185 Rome, Italy; [Leggio, Claudia; Galantini, Luciano; Pavel, Nicolae Viorel] Univ Roma La Sapienza, Dipartimento Chim, I-00185 Rome, Italy; [Di Matteo, Adele] CNR, Ist Biol & Patol Mol, Rome, Italy; [Federici, Luca] Univ Chieti Pescara G dAnnunzio, Dipartimento Sci Sperimentali & Clin, Chieti, Italy; [Federici, Luca] Univ Chieti Pescara G dAnnunzio, Ctr Sci Invecchiamento, Chieti, Italy	Sapienza University Rome; Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia e Patologia Molecolari (IBPM-CNR); G d'Annunzio University of Chieti-Pescara; G d'Annunzio University of Chieti-Pescara	Federici, L (corresponding author), Univ Chieti Pescara G dAnnunzio, Dipartimento Sci Sperimentali & Clin, Chieti, Italy.	lfederici@unich.it	Benedetti, Manuel/AAN-9565-2021; Cervone, Felice/G-9905-2013; Di Matteo, Adele/AAC-8338-2019; galantini, luciano/T-3041-2017; De Lorenzo, Giulia/F-5475-2013; Pavel, Nicolae Viorel/C-3277-2009	Benedetti, Manuel/0000-0003-0124-4464; Cervone, Felice/0000-0001-8141-5352; Di Matteo, Adele/0000-0002-5921-7365; galantini, luciano/0000-0001-5484-2658; De Lorenzo, Giulia/0000-0002-1707-5418; Pavel, Nicolae Viorel/0000-0002-7637-4821	ERC [ERC_AdG_233083]; Ministero dell'Istruzione, dell'Universita e della Ricerca [PRIN2009WTCJL8, FIRB ERA-PG RBER063SN4]; Istituto Pasteur - Fondazione Cenci-Bolognetti; Sapienza Universita di Roma [C26A10ME4X]; University of Chieti	ERC(European Research Council (ERC)European Commission); Ministero dell'Istruzione, dell'Universita e della Ricerca(Ministry of Education, Universities and Research (MIUR)); Istituto Pasteur - Fondazione Cenci-Bolognetti(Istituto Pasteur Italia Fondazione Cenci Bolognetti); Sapienza Universita di Roma; University of Chieti	This work was supported by the ERC (ERC_AdG_233083 to F. C.), by the Ministero dell'Istruzione, dell'Universita e della Ricerca (PRIN2009WTCJL8 to G. D. L. and to L. F. and FIRB ERA-PG RBER063SN4 to G. D. L.), by the Istituto Pasteur - Fondazione Cenci-Bolognetti, by Sapienza Universita di Roma (Ricerche Universitarie C26A10ME4X to G. D. L.) and by University of Chieti (Fondi di Ateneo to L. F.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antolin-Llovera M, 2012, ANNU REV PHYTOPATHOL, V50, P451, DOI 10.1146/annurev-phyto-081211-173002; Benedetti M, 2011, J PLANT PATHOL, V93, P89; Benedetti M, 2011, PLANT PHYSIOL, V157, P599, DOI 10.1104/pp.111.181057; Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Bonivento D, 2008, PROTEINS, V70, P294, DOI 10.1002/prot.21610; Borras-Hidalgo O, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00268; Brutus A, 2010, P NATL ACAD SCI USA, V107, P9452, DOI 10.1073/pnas.1000675107; Cantu D, 2008, TRENDS PLANT SCI, V13, P610, DOI 10.1016/j.tplants.2008.09.002; Casasoli M, 2009, P NATL ACAD SCI USA, V106, P7666, DOI 10.1073/pnas.0812625106; CERVONE F, 1989, PLANT PHYSIOL, V90, P542, DOI 10.1104/pp.90.2.542; Chacon P, 2000, J MOL BIOL, V299, P1289, DOI 10.1006/jmbi.2000.3784; D'Ovidio R, 2004, BBA-PROTEINS PROTEOM, V1696, P237, DOI 10.1016/j.bbapap.2003.08.012; De Lorenzo G, 2002, CURR OPIN PLANT BIOL, V5, P295, DOI 10.1016/S1369-5266(02)00271-6; De Lorenzo G, 2001, ANNU REV PHYTOPATHOL, V39, P313, DOI 10.1146/annurev.phyto.39.1.313; De Lorenzo G, 2011, FEBS LETT, V585, P1521, DOI 10.1016/j.febslet.2011.04.043; DELORENZO G, 1994, BIOCHEM SOC T, V22, P394, DOI 10.1042/bst0220394; Di Matteo A, 2006, PHYTOCHEMISTRY, V67, P528, DOI 10.1016/j.phytochem.2005.12.025; Di Matteo A, 2003, P NATL ACAD SCI USA, V100, P10124, DOI 10.1073/pnas.1733690100; Federici L, 2006, TRENDS PLANT SCI, V11, P65, DOI 10.1016/j.tplants.2005.12.005; Federici L, 2001, P NATL ACAD SCI USA, V98, P13425, DOI 10.1073/pnas.231473698; Fenton AW, 2010, BIOCHEMISTRY-US, V49, P7202, DOI 10.1021/bi100147w; Ferrari S., 2013, Frontiers in Plant Science, V4, P49; Ferrari S, 2003, PLANT CELL, V15, P93, DOI 10.1105/tpc.005165; Ferrari S, 2006, MOL PLANT MICROBE IN, V19, P931, DOI 10.1094/MPMI-19-0931; Firoz A, 2010, BIOINFORMATION, V5, P55, DOI 10.6026/97320630005055; FREDIANI M, 1993, THEOR APPL GENET, V87, P369, DOI 10.1007/BF01184925; Galantini L, 2010, BIOPHYS CHEM, V147, P111, DOI 10.1016/j.bpc.2010.01.002; Galantini L, 2008, J PHYS CHEM B, V112, P15460, DOI 10.1021/jp806821e; Galletti R, 2009, PLANT SIGNAL BEHAV, V4, P33, DOI 10.4161/psb.4.1.7224; GLATTER O, 1977, J APPL CRYSTALLOGR, V10, P415, DOI 10.1107/S0021889877013879; Glatter O., 1982, SMALL ANGLE X RAY SC; GUINIER A, 1955, SMALL ANGLE XRAYS; Hammel M, 2012, EUR BIOPHYS J BIOPHY, V41, P789, DOI 10.1007/s00249-012-0820-x; Heller WT, 2003, BIOCHEMISTRY-US, V42, P10579, DOI 10.1021/bi0348664; Huang Q, 2000, PHYSIOL MOL PLANT P, V57, P77, DOI 10.1006/pmpp.2000.0283; Jacques DA, 2012, ACTA CRYSTALLOGR D, V68, P620, DOI 10.1107/S0907444912012073; Joubert DA, 2006, TRANSGENIC RES, V15, P687, DOI 10.1007/s11248-006-9019-1; King D, 2002, BIOCHEMISTRY-US, V41, P10225, DOI 10.1021/bi020119f; Koch MHJ, 2003, Q REV BIOPHYS, V36, P147, DOI 10.1017/S0033583503003871; Leckie F, 1999, EMBO J, V18, P2352, DOI 10.1093/emboj/18.9.2352; Leggio C, 2008, PHYS CHEM CHEM PHYS, V10, P6741, DOI 10.1039/b808938h; Leggio C, 2009, J PHYS CHEM B, V113, P12590, DOI 10.1021/jp904330v; Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655; Manfredini C, 2005, PHYSIOL MOL PLANT P, V67, P108, DOI 10.1016/j.pmpp.2005.10.002; Mariotti L, 2009, J PLANT PATHOL, V91, P129; Mariotti Lorenzo, 2008, Mycol Res, V112, P1010; Mertens HDT, 2010, J STRUCT BIOL, V172, P128, DOI 10.1016/j.jsb.2010.06.012; Misas-Villamil JC, 2008, CURR OPIN PLANT BIOL, V11, P380, DOI 10.1016/j.pbi.2008.04.007; Oeser B, 2002, FUNGAL GENET BIOL, V36, P176, DOI 10.1016/S1087-1845(02)00020-8; Orthaber D, 2000, J APPL CRYSTALLOGR, V33, P218, DOI 10.1107/S0021889899015216; Pelikan M, 2009, GEN PHYSIOL BIOPHYS, V28, P174, DOI 10.4149/gpb_2009_02_174; Petoukhov MV, 2013, INT J BIOCHEM CELL B, V45, P429, DOI 10.1016/j.biocel.2012.10.017; Petoukhov MV, 2005, BIOPHYS J, V89, P1237, DOI 10.1529/biophysj.105.064154; Pons C, 2010, J MOL BIOL, V403, P217, DOI 10.1016/j.jmb.2010.08.029; Powell ALT, 2000, MOL PLANT MICROBE IN, V13, P942, DOI 10.1094/MPMI.2000.13.9.942; Raiola A, 2008, FUNGAL GENET BIOL, V45, P776, DOI 10.1016/j.fgb.2007.11.003; Rambo RP, 2011, BIOPOLYMERS, V95, P559, DOI 10.1002/bip.21638; RODRIGUEZPALENZUELA P, 1991, J BACTERIOL, V173, P6547, DOI 10.1128/jb.173.20.6547-6552.1991; Schneidman-Duhovny D, 2012, BMC STRUCT BIOL, V12, DOI 10.1186/1472-6807-12-17; Sella L, 2004, FEMS MICROBIOL LETT, V240, P117, DOI 10.1016/j.femsle.2004.09.019; Sicilia F, 2005, PLANT PHYSIOL, V139, P1380, DOI 10.1104/pp.105.067546; STABINGER H, 1978, MAKROMOL CHEM, V179, P1655; Svergun DI, 1999, BIOPHYS J, V76, P2879, DOI 10.1016/S0006-3495(99)77443-6; Svergun DI, 1998, BIOPHYS J, V75, P2212, DOI 10.1016/S0006-3495(98)77665-9; Tabarani G, 2009, J BIOL CHEM, V284, P21229, DOI 10.1074/jbc.M109.021204; ten Have A, 1998, MOL PLANT MICROBE IN, V11, P1009, DOI 10.1094/MPMI.1998.11.10.1009; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Zuppini A, 2005, MOL PLANT MICROBE IN, V18, P849, DOI 10.1094/MPMI-18-0849	69	20	21	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80610	10.1371/journal.pone.0080610	http://dx.doi.org/10.1371/journal.pone.0080610			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260434	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900076
J	Velasco-Hernandez, MC; Ramirez-Romero, R; Cicero, L; Michel-Rios, C; Desneux, N				Concepcion Velasco-Hernandez, Maria; Ramirez-Romero, Ricardo; Cicero, Lizette; Michel-Rios, Claudia; Desneux, Nicolas			Intraguild Predation on the Whitefly Parasitoid Eretmocerus eremicus by the Generalist Predator Geocoris punctipes: A Behavioral Approach	PLOS ONE			English	Article							BEMISIA-ARGENTIFOLII HOMOPTERA; BIOLOGICAL-CONTROL; NATURAL ENEMIES; MATING-BEHAVIOR; APHIDIUS-ERVI; LIFE-HISTORY; PREY; HYMENOPTERA; IMPACT; TABACI	Intraguild predation (IGP) takes place when natural enemies that use similar resources attack each other. The impact of IGP on biological control can be significant if the survival of natural enemy species is disrupted. In the present study, we assessed whether Geocoris punctipes (Hemiptera: Lygaeidae) engages in IGP on Eretmocerus eremicus (Hymenoptera: Aphelinidae) while developing on whitefly nymphs of Trialeurodes vaporariorum (Hemiptera: Aleyrodidae). In choice and non-choice tests, we exposed G. punctipes to parasitized and non-parasitized whitefly nymphs. We found that G. punctipes does practice IGP on E. eremicus. However, choice tests assessing G. punctipes consumption revealed a significant preference for non-parasitized T. vaporariorum nymphs. Subsequently, we investigated whether E. eremicus females modify their foraging behavior when exposed to conditions involving IGP risk. To assess this, we analyzed wasp foraging behavior under the following treatments: i) whitefly nymphs only (control = C), ii) whitefly nymphs previously exposed to a predator (= PEP) and, iii) whitefly nymphs and presence of a predator (= PP). In non-choice tests we found that E. eremicus did not significantly modify its number of attacks, attack duration, oviposition duration, or behavior sequences. However, E. eremicus oviposited significantly more eggs in the PEP treatment. In the PP treatment, G. punctipes also preyed upon adult E. eremicus wasps, significantly reducing their number of ovipositions and residence time. When the wasps were studied under choice tests, in which they were exposed simultaneously to all three treatments, the number of attacks and frequency of selection were similar under all treatments. These results indicate that under IGP risk, E. eremicus maintains several behavioral traits, but can also increase its number of ovipositions in the presence of IG-predator cues. We discuss these findings in the context of population dynamics and biological control.	[Concepcion Velasco-Hernandez, Maria; Ramirez-Romero, Ricardo; Michel-Rios, Claudia] Univ Guadalajara, Dept Agr Prod, Ctr Univ Ciencias Biol & Agr, Zapopan, Jalisco, Mexico; [Cicero, Lizette] Inst Nacl Invest Forest Agr & Pecuarias, Campo Expt Mococha, Yucatan, Mexico; [Desneux, Nicolas] INRA, French Natl Inst Agr Res, Sophia Antipolis, France	Universidad de Guadalajara; INRAE	Ramirez-Romero, R (corresponding author), Univ Guadalajara, Dept Agr Prod, Ctr Univ Ciencias Biol & Agr, Zapopan, Jalisco, Mexico.	rramirez@cucba.udg.mx	Desneux, Nicolas/J-6262-2013; Cicero, Lizette/A-9848-2016	Cicero, Lizette/0000-0002-8486-5700; Ramirez-Romero, Ricardo/0000-0003-1310-0484	Mexican Council for Science and Technology (CONACyT, Ciencia Basica program) [0157259]; 'KOPPERT Mexico SA de CV'; 'Organismos Beneficos para la Agricultura SA de CV'	Mexican Council for Science and Technology (CONACyT, Ciencia Basica program); 'KOPPERT Mexico SA de CV'; 'Organismos Beneficos para la Agricultura SA de CV'	Financial support is acknowledged to Mexican Council for Science and Technology (CONACyT, Ciencia Basica program, Project ID: 0157259) granted to RR-R. 'KOPPERT Mexico SA de CV' and 'Organismos Beneficos para la Agricultura SA de CV' are acknowledged for partial financial support on the acquisition of wasps and predators. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABRAMS P, 1993, EVOL ECOL, V7, P312, DOI 10.1007/BF01237749; Al-Zyoud F, 2004, J PEST SCI, V77, P197, DOI 10.1007/s10340-004-0054-5; ALTMANN J, 1974, BEHAVIOUR, V49, P227, DOI 10.1163/156853974X00534; Lopez YIA, 2012, J CHEM ECOL, V38, P1376, DOI 10.1007/s10886-012-0201-z; Ardeh MJ, 2005, BIOCONTROL, V50, P449, DOI 10.1007/s10526-004-3071-7; Ardeh MJ, 2004, J INSECT BEHAV, V17, P745, DOI 10.1023/B:JOIR.0000048986.16676.8a; Ardeh MJ, 2004, THESIS WAGENINGEN U; Asplen M.K., 2001, EGGS ERETMOCERUS ERE, P1; Batchelor TP, 2005, BIOL CONTROL, V33, P194, DOI 10.1016/j.biocontrol.2005.02.010; Bellamy DE, 2004, BIOL CONTROL, V29, P227, DOI 10.1016/S1049-9644(03)00150-6; Bilu E, 2007, BIOCONTROL, V52, P753, DOI 10.1007/s10526-007-9071-7; Bilu E, 2006, ECOL ENTOMOL, V31, P331, DOI 10.1111/j.1365-2311.2006.00786.x; BROWN JK, 1992, PLANT DIS, V76, P220, DOI 10.1094/PD-76-0220; BYRNE DN, 1991, ANNU REV ENTOMOL, V36, P431, DOI 10.1146/annurev.en.36.010191.002243; Chailleux A, 2013, J PEST SCI, V86, P533, DOI 10.1007/s10340-013-0498-6; CHAMPLAIN RA, 1967, ANN ENTOMOL SOC AM, V60, P881, DOI 10.1093/aesa/60.5.881; Chen P.S., 1966, ADV INSECT PHYSIOL, V3, P53, DOI DOI 10.1016/S0065-2806(08)60186-1; Choh Y, 2010, OECOLOGIA, V163, P335, DOI 10.1007/s00442-010-1605-5; COHEN AC, 1992, ENTOMOL EXP APPL, V64, P195, DOI 10.1111/j.1570-7458.1992.tb01609.x; COHEN AC, 1985, J ECON ENTOMOL, V78, P1173, DOI 10.1093/jee/78.5.1173; Colfer Ramana G., 2000, Proceedings Beltwide Cotton Conferences, V2, P1151; Colfer RG, 2001, OECOLOGIA, V126, P292, DOI 10.1007/s004420000510; Cortes ME, 2013, MEMORIA CAPACITACION; Crawley MJ., 2007, R BOOK; Dicke M, 2001, ANNU REV ECOL SYST, V32, P1, DOI 10.1146/annurev.ecolsys.32.081501.113951; DUNBAR DM, 1972, ANN ENTOMOL SOC AM, V65, P764, DOI 10.1093/aesa/65.3.764; DUNBAR DM, 1972, ANN ENTOMOL SOC AM, V65, P892, DOI 10.1093/aesa/65.4.892; Finke DL, 2003, ECOL ENTOMOL, V28, P67, DOI 10.1046/j.1365-2311.2003.00475.x; Frechette B, 2007, BIOCONTROL, V52, P175, DOI 10.1007/s10526-006-9028-2; Gagnon AE, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028061; Gelman DB, 2002, J INSECT PHYSIOL, V48, P63, DOI 10.1016/S0022-1910(01)00146-9; Gerling D, 2001, CROP PROT, V20, P779, DOI 10.1016/S0261-2194(01)00111-9; Gould J., 2008, CLASSICAL BIOL CONTR; Hagler JR, 2004, J INSECT SCI, V4, DOI 10.1093/jis/4.1.1; Headrick DH, 1996, BIOL CONTROL, V6, P64, DOI 10.1006/bcon.1996.0009; Heimpel GE, 1997, OECOLOGIA, V110, P346, DOI 10.1007/s004420050168; Herrick NJ, 2008, BIOL CONTROL, V45, P386, DOI 10.1016/j.biocontrol.2008.02.008; HOELMER KA, 1994, ENVIRON ENTOMOL, V23, P136, DOI 10.1093/ee/23.1.136; Holt RD, 1997, AM NAT, V149, P745, DOI 10.1086/286018; HOY MA, 1981, ENTOMOL EXP APPL, V29, P241, DOI 10.1007/BF00294062; Janssen A, 2006, PROG BIOL CONTROL, V3, P21; Joyce AL, 1999, ENVIRON ENTOMOL, V28, P282, DOI 10.1093/ee/28.2.282; Kaneko S, 2007, ECOL RES, V22, P451, DOI 10.1007/s11284-006-0025-9; Kennedy GG, 2003, ANNU REV ENTOMOL, V48, P51, DOI 10.1146/annurev.ento.48.091801.112733; Kim JK, 2001, ENTOMOL EXP APPL, V100, P235, DOI 10.1023/A:1019269210492; LIMA SL, 1990, CAN J ZOOL, V68, P619, DOI 10.1139/z90-092; Lopez A. J. I., 2007, TEORIA APLICACION CO, P90; Lucas E, 2002, J ECON ENTOMOL, V95, P1123, DOI 10.1603/0022-0493-95.6.1123; Lucas E, 2001, BIOL CONTROL, V20, P147, DOI 10.1006/bcon.2000.0890; Lucas E, 2011, BIOL CONTROL, V59, P61, DOI 10.1016/j.biocontrol.2011.05.010; MAGNHAGEN C, 1991, TRENDS ECOL EVOL, V6, P183, DOI 10.1016/0169-5347(91)90210-O; Marques FD, 2000, J CHEM ECOL, V26, P2843, DOI 10.1023/A:1026498028531; Martinou AF, 2010, ECOL ENTOMOL, V35, P183, DOI 10.1111/j.1365-2311.2009.01171.x; Mead FW, 2011, EENY252 U FLOR IFAS; Meisner M, 2011, ENTOMOL EXP APPL, V138, P193, DOI 10.1111/j.1570-7458.2010.01090.x; Meyhofer R, 2002, BIOL CONTROL, V25, P239, DOI 10.1016/S1049-9644(02)00104-4; Nakashima Y, 2004, J CHEM ECOL, V30, P1103, DOI 10.1023/B:JOEC.0000030266.81665.19; Nakashima Y, 2003, ENTOMOL EXP APPL, V109, P163, DOI 10.1046/j.1570-7458.2003.00094.x; Naranjo SE, 2004, BIOL CONTROL, V30, P52, DOI 10.1016/j.biocontrol.2003.09.010; NARANJO SE, 1987, FLA ENTOMOL, V70, P173, DOI 10.2307/3495105; Naranjo SE, 2007, BIOCONTROL SCI TECHN, V17, P605, DOI 10.1080/09583150701408816; Ortega-Arenas LD, 2008, MOSCAS BLANCAS TEMAS; Ottoni EB, 2000, BEHAV RES METH INS C, V32, P446, DOI 10.3758/BF03200814; Parrella M. P., 1992, California Agriculture, V46, P25; Pendleton N.D, 2002, THESIS U TENNESSEE K; POLIS GA, 1992, TRENDS ECOL EVOL, V7, P151, DOI 10.1016/0169-5347(92)90208-S; POLIS GA, 1989, ANNU REV ECOL SYST, V20, P297, DOI 10.1146/annurev.es.20.110189.001501; Ramirez-Romero R, 2012, BIOCONTROL, V57, P427, DOI 10.1007/s10526-011-9413-3; Raymond B, 2000, OECOLOGIA, V124, P367, DOI 10.1007/s004420000396; READIO J., 1982, MISC PUB ENTOMOL SOC, V12, P1; Reznick D, 2001, AM NAT, V157, P126, DOI 10.1086/318627; Roger C, 2000, ENTOMOL EXP APPL, V94, P3, DOI 10.1023/A:1003909804831; Rose M, 1997, P ENTOMOL SOC WASH, V99, P1; Rosenheim JA, 2005, BIOL CONTROL, V32, P172, DOI 10.1016/j.biocontrol.2004.09.007; ROSENHEIM JA, 1995, BIOL CONTROL, V5, P303, DOI 10.1006/bcon.1995.1038; Rosenheim JA, 2006, PROG BIOL CONTROL, V3, P1; Seelmann L, 2007, OIKOS, V116, P807, DOI [10.1111/j.2007.0030-1299.15895.x, 10.1111/j.0030-1299.2007.15895.x]; Snyder WE, 2001, ECOLOGY, V82, P705, DOI 10.1890/0012-9658(2001)082[0705:GPDBCB]2.0.CO;2; Snyder William E., 2008, P71, DOI 10.1002/9780470696200.ch4; Sokal RR, 1995, BIOMETRY; Stansly P.A., 2010, BEMISIA BIONOMICS MA, DOI DOI 10.1007/978-90-481-2460-2; Taylor AJ, 1998, J INSECT BEHAV, V11, P297, DOI 10.1023/A:1021056226037; Team R, 2011, R LANG ENV STAT COMP; Tillman PG, 2003, ENVIRON ENTOMOL, V32, P1399, DOI 10.1603/0046-225X-32.6.1399; van Lenteren JC, 2003, QUALITY CONTROL AND PRODUCTION OF BIOLOGICAL CONTROL AGENTS: THEORY AND TESTING PROCEDURES, P167, DOI 10.1079/9780851996882.0167; Walzer A, 2011, ANIM BEHAV, V81, P177, DOI 10.1016/j.anbehav.2010.09.031; Welch BL, 1938, BIOMETRIKA, V29, P350, DOI 10.1093/biomet/29.3-4.350; WILLIAMSON CE, 1980, LIMNOL OCEANOGR, V25, P903; Wintermantel W. M., 2004, AM PHYTOPATHOLOGICAL, V604, P1; Zar JH, 1999, BIOSTATISTICAL ANAL; Zuur Alain F., 2009, P1	91	25	25	0	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80679	10.1371/journal.pone.0080679	http://dx.doi.org/10.1371/journal.pone.0080679			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260452	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900085
J	Kim, SA; Lee, BH; Bae, JH; Kim, KJ; Steffensen, SC; Ryu, YH; Leem, JW; Yang, CH; Kim, HY				Kim, Seol Ah; Lee, Bong Hyo; Bae, Jong Han; Kim, Kwang Joong; Steffensen, Scott C.; Ryu, Yeon-Hee; Leem, Joong Woo; Yang, Chae Ha; Kim, Hee Young			Peripheral Afferent Mechanisms Underlying Acupuncture Inhibition of Cocaine Behavioral Effects in Rats	PLOS ONE			English	Article							MANUAL ACUPUNCTURE; NUCLEUS-ACCUMBENS; DOPAMINE RELEASE; STIMULATION; NERVE; ELECTROACUPUNCTURE; RESINIFERATOXIN; MODULATION; ACTIVATION; ANALGESIA	Administration of cocaine increases locomotor activity by enhancing dopamine transmission. To explore the peripheral mechanisms underlying acupuncture treatment for drug addiction, we developed a novel mechanical acupuncture instrument (MAI) for objective mechanical stimulation. The aim of this study was to evaluate whether acupuncture inhibition of cocaine-induced locomotor activity is mediated through specific peripheral nerves, the afferents from superficial or deep tissues, or specific groups of nerve fibers. Mechanical stimulation of acupuncture point HT7 with MAI suppressed cocaine-induced locomotor activity in a stimulus time-dependent manner, which was blocked by severing the ulnar nerve or by local anesthesia. Suppression of cocaine-induced locomotor activity was elicited after HT7 stimulation at frequencies of either 50 (for Meissner corpuscles) or 200 (for Pacinian corpuscles) Hz and was not affected by block of C/Ad-fibers in the ulnar nerve with resiniferatoxin, nor generated by direct stimulation of C/Ad-fiber afferents with capsaicin. These findings suggest that HT7 inhibition of cocaine-induced locomotor activity is mediated by A-fiber activation of ulnar nerve that originates in superficial and deep tissue.	[Kim, Seol Ah; Lee, Bong Hyo; Kim, Kwang Joong; Yang, Chae Ha; Kim, Hee Young] Daegu Haany Univ, Coll Korean Med, Taegu, South Korea; [Bae, Jong Han] Yeungnam Univ, Dept Phys, Gyongsan, Gyeongbuk, South Korea; [Steffensen, Scott C.] Brigham Young Univ, Dept Psychol & Neurosci, Provo, UT 84602 USA; [Ryu, Yeon-Hee] Korea Inst Oriental Med, Div Stand Res, Acupuncture Moxibust & Meridian Res Ctr, Taejon, South Korea; [Leem, Joong Woo] Yonsei Univ, Coll Med, Dept Physiol, Seoul, South Korea	Daegu Haany University; Yeungnam University; Brigham Young University; Korea Institute of Oriental Medicine (KIOM); Yonsei University; Yonsei University Health System	Yang, CH (corresponding author), Daegu Haany Univ, Coll Korean Med, Taegu, South Korea.	chyang@dhu.ac.kr; hykim@dhu.ac.kr		Leem, Joong/0000-0002-1605-2230	National Research Foundation of Korea (NRF); Korea government (MEST) [2011-0016038]; Basic Science Research Program through the National Research Foundation of Korea (NRF); Ministry of Education, Science and Technology [2010-0009492]; Korea Institute of Oriental Medicine [K13290]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [R01AA020919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA035958] Funding Source: NIH RePORTER	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST)(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government); Basic Science Research Program through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Korea Institute of Oriental Medicine; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0016038), Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Education, Science and Technology (2010-0009492) and Korea Institute of Oriental Medicine (K13290). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BONNEL F, 1985, J HAND SURG-BRIT EUR, V10B, P165, DOI 10.1016/0266-7681(85)90007-5; Cha SW, 1996, HISTOL HISTOPATHOL, V11, P117; Chae Y, 2010, NEUROL RES, V32, pS27, DOI 10.1179/016164109X12537002793805; Dawidson I, 1997, J ORAL REHABIL, V24, P204; DUNDEE JW, 1991, CLIN PHARMACOL THER, V50, P78, DOI 10.1038/clpt.1991.106; Griffin MJ, 1997, OCCUP ENVIRON MED, V54, P73, DOI 10.1136/oem.54.2.73; GUOWEI L, 1979, SCI SINICA, V22, P680; HARPER AA, 1985, J PHYSIOL-LONDON, V359, P31, DOI 10.1113/jphysiol.1985.sp015573; Harrington GS, 2001, BRAIN RES, V897, P188, DOI 10.1016/S0006-8993(01)02139-4; Kandell E.R., 2000, PRINCIPLES NEURAL SC; Kim HY, 2011, NEUROL RES S1, V32, P10; Kim MR, 2005, NEUROSCI LETT, V387, P17, DOI 10.1016/j.neulet.2005.07.007; Kim PS, 2010, J BRACHIAL PLEX PERI, V5, DOI 10.1186/1749-7221-5-6; Kim SN, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027566; Lee B, 2009, NEUROSCI LETT, V449, P128, DOI 10.1016/j.neulet.2008.10.089; LEEM JW, 1993, J NEUROPHYSIOL, V70, P2411, DOI 10.1152/jn.1993.70.6.2411; LEEM JW, 1993, J NEUROPHYSIOL, V69, P1684, DOI 10.1152/jn.1993.69.5.1684; Li P, 1998, CIRCULATION, V97, P1186, DOI 10.1161/01.CIR.97.12.1186; Mitchell K, 2010, MOL PAIN, V6, DOI 10.1186/1744-8069-6-94; Napadow V, 2005, HUM BRAIN MAPP, V24, P193, DOI 10.1002/hbm.20081; NAPPI G, 1982, ACUPUNCTURE ELECTRO, V7, P93, DOI 10.3727/036012982816952125; Noguchi E, 1996, JPN J PHYSIOL, V46, P53, DOI 10.2170/jjphysiol.46.53; Pan HL, 2003, J NEUROSCI, V23, P2911; Ramsay DJ, 1998, JAMA-J AM MED ASSOC, V280, P1518; SATO A, 1992, NEUROSCI RES, V15, P189, DOI 10.1016/0168-0102(92)90004-V; Soh KS, 2009, J ACUPUNCT MERIDIAN, V2, P93, DOI 10.1016/S2005-2901(09)60041-8; Stux G, 1997, BASICS ACUPUNCTURE; Suter MR, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-53; Tjen-A-Looi SC, 2005, AUTON NEUROSCI-BASIC, V118, P43, DOI 10.1016/j.autneu.2004.12.006; Uchida S, 2000, JPN J PHYSIOL, V50, P495, DOI 10.2170/jjphysiol.50.495; Ulett GA, 1998, BIOL PSYCHIAT, V44, P129, DOI 10.1016/S0006-3223(97)00394-6; Wang SM, 2008, ANESTH ANALG, V106, P602, DOI 10.1213/01.ane.0000277493.42335.7b; Yang CH, 2008, EVID-BASED COMPL ALT, V5, P257, DOI 10.1093/ecam/nem081; Yang CH, 2010, ALCOHOL CLIN EXP RES, V34, P2137, DOI 10.1111/j.1530-0277.2010.01310.x; Yoo SS, 2004, NEUROIMAGE, V22, P932, DOI 10.1016/j.neuroimage.2004.02.017; Yoon SS, 2012, PSYCHOPHARMACOLOGY, V222, P303, DOI 10.1007/s00213-012-2683-3; Yoon SS, 2010, BRAIN RES BULL, V81, P625, DOI 10.1016/j.brainresbull.2009.12.011; Yoon SS, 2004, NEUROSCI LETT, V369, P234, DOI 10.1016/j.neulet.2004.07.095; Zhao ZQ, 2008, PROG NEUROBIOL, V85, P355, DOI 10.1016/j.pneurobio.2008.05.004; Zhou W, 2005, J APPL PHYSIOL, V98, P872, DOI 10.1152/japplphysiol.01079.2004	40	16	17	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81018	10.1371/journal.pone.0081018	http://dx.doi.org/10.1371/journal.pone.0081018			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260531	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500192
J	Zhang, ZL; Liu, Q; Leskov, KS; Wu, XM; Duan, J; Zhang, GL; Hall, M; Rosenbaum, JT				Zhang, Zili; Liu, Qi; Leskov, Konstantin S.; Wu, Xiumei; Duan, Jie; Zhang, Gary L.; Hall, Mark; Rosenbaum, James T.			Roscovitine Suppresses CD4+T Cells and T Cell-Mediated Experimental Uveitis	PLOS ONE			English	Article							CYCLIN-DEPENDENT KINASES; R-ROSCOVITINE; IN-VIVO; AUTOIMMUNE-DISEASE; DOWN-REGULATION; CDK INHIBITOR; ACTIVATION; EXPRESSION; SIGNALS; STIMULATION	Background: T cells are essential for the development of uveitis and other autoimmune diseases. After initial activation, CD4+ lymphocytes express the co-stimulatory molecule OX40 that plays an important role in T cell proliferation. Cyclin dependent kinase 2 (CdK2) plays a pivotal role in the cell cycle transition from G1 to S phase. In addition, recent research has implicated CdK2 in T cell activation. Thus, we sought to test the immunosuppressive effect of roscovitine, a potent CdK2 inhibitor, on CD4+ T cell activation, proliferation, and function. Design and Methods: Mouse CD4+ T cells were activated by anti-CD3 and anti-CD28 antibodies. The expression of OX40, CD44, and CdK2 were analyzed by flow cytometry. In addition, cell cycle progression and apoptosis of control and roscovitine-treated T lymphocytes were measured by BrdU incorporation and annexin V assay, respectively. Furthermore, the immunoregulatory effect of roscovitine was evaluated in both ovalbumin-induced uveitis and experimental autoimmune uveitis (EAU) models. Results: In this study, we found that T cell activation induced OX40 expression. Cell cycle analysis showed that more CD4+ OX40+ cells entered S phase than OX40- T cells. Concurrently, CD4+ OX40+ cells had a higher level of CdK2 expression. Roscovitine treatment blocked activated CD4+ cells from entering S phase. In addition, roscovitine not only reduced the viability of CD4+ lymphocytes but also suppressed T cell activation and cytokine production. Finally, roscovitine significantly attenuated the severity of T cell-dependent, OX40-enhanced uveitis. Conclusion: These results implicate CdK2 in OX40-augmented T cell response and expansion. Furthermore, this study suggests that roscovitine is a novel, promising, therapeutic agent for treating T cell-mediated diseases such as uveitis.	[Zhang, Zili; Liu, Qi; Leskov, Konstantin S.] Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA; [Zhang, Zili; Wu, Xiumei; Duan, Jie; Zhang, Gary L.; Hall, Mark] Oregon Hlth & Sci Univ, Dept Pediat, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Med, Portland, OR 97201 USA; [Rosenbaum, James T.] Oregon Hlth & Sci Univ, Dept Ophthalmol, Portland, OR 97201 USA; [Rosenbaum, James T.] Legacy Hlth Syst, Devers Eye Inst, Portland, OR USA	Case Western Reserve University; Oregon Health & Science University; Oregon Health & Science University; Oregon Health & Science University; Devers Eye Institute; Legacy Health	Zhang, ZL (corresponding author), Case Western Reserve Univ, Dept Pediat, Cleveland, OH 44106 USA.	Zili.Zhang@UHhospitals.org	Leskov, Konstantin S/J-2339-2017	Leskov, Konstantin S/0000-0001-6201-5660	National Institutes of Health [EY022937]; NATIONAL EYE INSTITUTE [R01EY022937] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by the National Institutes of Health (Grant EY022937), http://www.nei.nih.gov/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALDERSON MR, 1995, J EXP MED, V181, P71, DOI 10.1084/jem.181.1.71; Alvi AJ, 2005, BLOOD, V105, P4484, DOI 10.1182/blood-2004-07-2713; Balomenos D, 2000, IMMUNOL TODAY, V21, P551, DOI 10.1016/S0167-5699(00)01748-5; Becker MD, 2001, GRAEF ARCH CLIN EXP, V239, P609, DOI 10.1007/s004170100320; Bird JJ, 1998, IMMUNITY, V9, P229, DOI 10.1016/S1074-7613(00)80605-6; Boussiotis VA, 2001, BLOOD, V97, P565, DOI 10.1182/blood.V97.2.565; Budd RC, 2001, CURR OPIN IMMUNOL, V13, P356, DOI 10.1016/S0952-7915(00)00227-2; CASPI RR, 1988, J IMMUNOL, V140, P1490; Chunder N, 2012, J IMMUNOL, V189, P5659, DOI 10.4049/jimmunol.1202313; Croft M, 2010, ANNU REV IMMUNOL, V28, P57, DOI 10.1146/annurev-immunol-030409-101243; Duffin R, 2009, FEBS LETT, V583, P2540, DOI 10.1016/j.febslet.2009.07.017; Dullforce PA, 2006, CELL IMMUNOL, V239, P49, DOI 10.1016/j.cellimm.2006.03.005; Ekholm SV, 2000, CURR OPIN CELL BIOL, V12, P676, DOI 10.1016/S0955-0674(00)00151-4; Gaspal FM, 2011, J EXP MED, V208, P1579, DOI 10.1084/jem.20101484; Gerard C, 2009, P NATL ACAD SCI USA, V106, P21643, DOI 10.1073/pnas.0903827106; Gett AV, 1998, P NATL ACAD SCI USA, V95, P9488, DOI 10.1073/pnas.95.16.9488; Gough MJ, 2008, CANCER RES, V68, P5206, DOI 10.1158/0008-5472.CAN-07-6484; Gudmundsdottir H, 1999, J IMMUNOL, V162, P5212; Hoffman B, 2009, J CELL PHYSIOL, V218, P26, DOI 10.1002/jcp.21582; Kreslavsky T, 2012, IMMUNITY, V37, P840, DOI 10.1016/j.immuni.2012.08.020; LAZEBNIK YA, 1994, NATURE, V371, P346, DOI 10.1038/371346a0; Leitch AE, 2010, EUR J IMMUNOL, V40, P1127, DOI 10.1002/eji.200939664; Li LQ, 2006, NAT IMMUNOL, V7, P1157, DOI 10.1038/ni1398; Lu BF, 2004, NAT IMMUNOL, V5, P38, DOI 10.1038/ni1020; Luger D, 2008, J EXP MED, V205, P799, DOI 10.1084/jem.20071258; McClue SJ, 2002, INT J CANCER, V102, P463, DOI 10.1002/ijc.10738; Meijer L, 1997, EUR J BIOCHEM, V243, P527, DOI 10.1111/j.1432-1033.1997.t01-2-00527.x; Patsoukis N, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002796; Redmond WL, 2009, CRIT REV IMMUNOL, V29, P187, DOI 10.1615/CritRevImmunol.v29.i3.10; SHERR CJ, 1995, TRENDS BIOCHEM SCI, V20, P187, DOI 10.1016/S0968-0004(00)89005-2; SHERR CJ, 1993, CELL, V73, P1059, DOI 10.1016/0092-8674(93)90636-5; Song JX, 2007, NAT IMMUNOL, V8, P64, DOI 10.1038/ni1413; Song JX, 2005, IMMUNITY, V22, P621, DOI 10.1016/j.immuni.2005.03.012; TEWARI M, 1995, CELL, V81, P801, DOI 10.1016/0092-8674(95)90541-3; Veiga-Fernandes H, 2004, NAT IMMUNOL, V5, P31, DOI 10.1038/ni1015; Vermeulen K, 2003, CELL PROLIFERAT, V36, P131, DOI 10.1046/j.1365-2184.2003.00266.x; Wu XM, 2011, INVEST OPHTH VIS SCI, V52, P8520, DOI 10.1167/iovs.11-7664; Yang JF, 2001, NAT IMMUNOL, V2, P157, DOI 10.1038/84264; Zhang J, 2010, J BIOL CHEM, V285, P14052, DOI 10.1074/jbc.M109.068262; Zhang ZL, 2010, AM J PATHOL, V177, P2912, DOI 10.2353/ajpath.2010.100353	40	7	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81154	10.1371/journal.pone.0081154	http://dx.doi.org/10.1371/journal.pone.0081154			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260551	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500196
J	Zhou, J; Shu, Y; Lu, SH; Li, JJ; Sun, HY; Tang, RY; Duan, CM; Wang, Y; Lin, QX; Mou, YC; Li, X; Wang, CY				Zhou, Jin; Shu, Yao; Lu, Shuang-Hong; Li, Jun-Jie; Sun, Hong-Yu; Tang, Rong-Yu; Duan, Cui-Mi; Wang, Yan; Lin, Qiu-Xia; Mou, Yong-Chao; Li, Xia; Wang, Chang-Yong			The Spatiotemporal Development of Intercalated Disk in Three-Dimensional Engineered Heart Tissues Based on Collagen/Matrigel Matrix	PLOS ONE			English	Article							ADULT-RAT CARDIOMYOCYTES; CARDIAC-MUSCLE CONSTRUCT; INTERCELLULAR-JUNCTIONS; GAP-JUNCTIONS; CELLS; MYOCARDIUM; COSTAMERES; CONNEXIN43; SCAFFOLDS; MYOCYTES	Intercalated disk (ID), which electromechanically couples cardiomyocytes into a functional syncitium, is closely related to normal morphology and function of engineered heart tissues (EHTs), but the development mode of ID in the three-dimensional (3D) EHTs is still unclear. In this study, we focused on the spatiotemporal development of the ID in the EHTs constructed by mixing neonatal rat cardiomyocytes with collagen/Matrigel, and investigated the effect of 3D microenvironment provided by collagen/Matrigel matrix on the formation of ID. By histological and immmunofluorescent staining, the spatiotemporal distribution of ID-related junctions was detected. Furthermore, the ultra-structures of the ID in different developmental stages were observed under transmission electron microscope. In addition, the expression of the related proteins was quantitatively analyzed. The results indicate that accompanying the re-organization of cardiomyocytes in collagen/Matrigel matrix, the proteins of adherens junctions, desmosomes and gap junctions redistributed from diffused distribution to intercellular regions to form an integrated ID. The adherens junction and desmosome which are related with mechanical connection appeared earlier than gap junction which is essential for electrochemical coupling. These findings suggest that the 3D microenvironment based on collagen/Matrigel matrix could support the ordered assembly of the ID in EHTs and have implications for comprehending the ordered and coordinated development of ID during the functional organization of EHTs.	[Zhou, Jin; Shu, Yao; Li, Jun-Jie; Sun, Hong-Yu; Tang, Rong-Yu; Duan, Cui-Mi; Wang, Yan; Lin, Qiu-Xia; Mou, Yong-Chao; Li, Xia; Wang, Chang-Yong] Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing, Peoples R China; [Zhou, Jin; Shu, Yao; Li, Jun-Jie; Sun, Hong-Yu; Tang, Rong-Yu; Duan, Cui-Mi; Wang, Yan; Lin, Qiu-Xia; Mou, Yong-Chao; Li, Xia; Wang, Chang-Yong] Acad Mil Med Sci, Tissue Engn Res Ctr, Beijing, Peoples R China; [Lu, Shuang-Hong] Acad Mil Med Sci, Affiliated Hosp, Lab Oncol, Beijing, Peoples R China	Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China; Academy of Military Medical Sciences - China	Wang, CY (corresponding author), Acad Mil Med Sci, Inst Basic Med Sci, Dept Adv Interdisciplinary Studies, Beijing, Peoples R China.	wangchy@bmi.ac.cn	Mou, Yongchao/J-6091-2019; Li, Junjie/B-7068-2012	Li, Junjie/0000-0003-2152-6952; /0000-0001-9548-4674	Key Program of National Natural Science Foundation of China [31030032]; National Key Basic Research and Development Program of China [2011CB606206]; National Natural Science Funds for Distinguished Young Scholar [31025013]; National High Technology Research and Development Program of China [2012AA020506]; National Natural Science Foundation of China [31100697]	Key Program of National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Key Basic Research and Development Program of China(National Basic Research Program of China); National Natural Science Funds for Distinguished Young Scholar(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); National High Technology Research and Development Program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Key Program of National Natural Science Foundation of China (No. 31030032), National Key Basic Research and Development Program of China (No. 2011CB606206), National Natural Science Funds for Distinguished Young Scholar (No. 31025013), National High Technology Research and Development Program of China (No. 2012AA020506), National Natural Science Foundation of China (No. 31100697). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhyari P, 2008, EUR J CARDIO-THORAC, V34, P229, DOI 10.1016/j.ejcts.2008.03.062; BISHOP SP, 1990, CIRC RES, V66, P84, DOI 10.1161/01.RES.66.1.84; Bouten CVC, 2011, ADV DRUG DELIVER REV, V63, P221, DOI 10.1016/j.addr.2011.01.007; DANOWSKI BA, 1992, J CELL BIOL, V118, P1411, DOI 10.1083/jcb.118.6.1411; Di Mauro D, 2009, FOLIA HISTOCHEM CYTO, V47, P605, DOI 10.2478/v10042-009-0114-z; Engelmayr GC, 2008, NAT MATER, V7, P1003, DOI 10.1038/nmat2316; Franke WW, 2007, EUR J CELL BIOL, V86, P127, DOI 10.1016/j.ejcb.2006.11.003; Geisler SB, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/624719; Guo XM, 2006, CIRCULATION, V113, P2229, DOI 10.1161/CIRCULATIONAHA.105.583039; Kaprielian RR, 1998, CIRCULATION, V97, P651, DOI 10.1161/01.CIR.97.7.651; Kostin S, 1999, CIRC RES, V85, P154, DOI 10.1161/01.RES.85.2.154; Kostin S, 1998, CELL TISSUE RES, V294, P449, DOI 10.1007/s004410051196; Li JF, 2008, J MOL CELL CARDIOL, V44, P597, DOI 10.1016/j.yjmcc.2007.11.013; Lutolf MP, 2005, NAT BIOTECHNOL, V23, P47, DOI 10.1038/nbt1055; Madden LR, 2010, P NATL ACAD SCI USA, V107, P15211, DOI 10.1073/pnas.1006442107; Miyamoto T, 2002, HEART VESSELS, V16, P232, DOI 10.1007/s003800200030; Noorman M, 2009, J MOL CELL CARDIOL, V47, P23, DOI 10.1016/j.yjmcc.2009.03.016; Ohno S, 2001, CURR OPIN CELL BIOL, V13, P641, DOI 10.1016/S0955-0674(00)00264-7; Ott HC, 2008, NAT MED, V14, P213, DOI 10.1038/nm1684; Oxford EM, 2007, CIRC RES, V101, P703, DOI 10.1161/CIRCRESAHA.107.154252; Radisic M, 2004, P NATL ACAD SCI USA, V101, P18129, DOI 10.1073/pnas.0407817101; Saffitz JE, 2004, CIRC RES, V94, P585, DOI 10.1161/01.RES.0000121575.34653.50; Samarel AM, 2005, AM J PHYSIOL-HEART C, V289, pH2291, DOI 10.1152/ajpheart.00749.2005; Sapir Y, 2011, BIOMATERIALS, V32, P1838, DOI 10.1016/j.biomaterials.2010.11.008; Shin K, 2006, ANNU REV CELL DEV BI, V22, P207, DOI 10.1146/annurev.cellbio.22.010305.104219; Zhao YS, 2005, J HEART LUNG TRANSPL, V24, P1091, DOI 10.1016/j.healun.2004.07.010; Zimmermann WH, 2002, CIRC RES, V90, P223, DOI 10.1161/hh0202.103644; Zimmermann WH, 2006, NAT MED, V12, P452, DOI 10.1038/nm1394; Zimmermann WH, 2000, BIOTECHNOL BIOENG, V68, P106	29	9	11	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81420	10.1371/journal.pone.0081420	http://dx.doi.org/10.1371/journal.pone.0081420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260578	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600115
J	Chen, XM; Bai, Y; Zhong, YJ; Xie, XL; Long, HW; Yang, YY; Wu, SG; Jia, Q; Wang, XH				Chen, Xin-mei; Bai, Yang; Zhong, Yu-jian; Xie, Xiao-lin; Long, Han-wu; Yang, Yu-yin; Wu, Shi-gen; Jia, Qiang; Wang, Xiao-hua			Wogonin Has Multiple Anti-Cancer Effects by Regulating c-Myc/SKP2/Fbw7 alpha and HDAC1/HDAC2 Pathways and Inducing Apoptosis in Human Lung Adenocarcinoma Cell Line A549	PLOS ONE			English	Article							C-MYC; CARCINOMA-CELLS; DOWN-REGULATION; DEGRADATION; PROTEIN; SKP2; INACTIVATION; SCUTELLARIA; ACTIVATION; MECHANISMS	Wogonin is a plant monoflavonoid which has been reported to inhibit cell growth and/or induce apoptosis in various tumors. The present study examined the apoptosis-inducing activity and underlying mechanism of action of wogonin in A549 cells. The results showed that wogonin was a potent inhibitor of the viability of A549 cells. Apoptotic protein changes detected after exposure to wogonin included decreased XIAP and Mcl-1 expression, increased cleaved-PARP expression and increased release of AIF and cytotchrome C. Western blot analysis showed that the activity of c-Myc/Skp2 and HDAC1/HDAC2 pathways, which play important roles in tumor progress, was decreased. Quantitative PCR identified increased levels of c-Myc mRNA and decreased levels of its protein. Protein levels of Fbw7 alpha, GSK3 beta and Thr58-Myc, which are involved in c-Myc ubiquitin-dependent degradation, were also analyzed. After exposure to wogonin, Fbw7 alpha and GSK3 beta expression decreased and Thr58-Myc expression increased. However, MG132 was unable to prevent c-Myc degradation. The present results suggest that wogonin has multiple anti-cancer effects associated with degradation of c-Myc, SKP2, HDAC1 and HDAC2. Its ability to induce apoptosis independently of Fbw7 alpha suggests a possible use in drug-resistance cancer related to Fbw7 deficiency. Further studies are needed to determine which pathways are related to c-Myc and Fbw7 alpha reversal and whether Thr58 phosphorylation of c-Myc is dependent on GSK3 beta.	[Chen, Xin-mei; Zhong, Yu-jian; Wang, Xiao-hua] Guangzhou Med Univ, Guangzhou, Guangdong, Peoples R China; [Bai, Yang] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Xie, Xiao-lin; Long, Han-wu; Yang, Yu-yin; Wu, Shi-gen; Jia, Qiang] Guizhou Acad Sci, Inst Biol, Guiyang, Guizhou, Peoples R China; [Jia, Qiang] Guizhou Acad Sci, Fanjingshan Forest Ecosyst Res Stn, Jiangkou, Guizhou, Peoples R China	Guangzhou Medical University; Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS	Jia, Q (corresponding author), Guizhou Acad Sci, Inst Biol, Guiyang, Guizhou, Peoples R China.	ytjq0629_cn@sina.com; xiaoh_wang@126.com			Ministry of Science and Technology of Guizhou Province, China [[2012] 7006, [2011]3072]; Guangzhou Medical College [2012C16]; Foundation for Young Scientists of Guangzhou Educational Committee [2012C118]	Ministry of Science and Technology of Guizhou Province, China; Guangzhou Medical College; Foundation for Young Scientists of Guangzhou Educational Committee	The study was supported by grants from the Ministry of Science and Technology of Guizhou Province, China ([2012] 7006 and NY [2011]3072); Guangzhou Medical College (2012C16); the Foundation for Young Scientists of Guangzhou Educational Committee (2012C118). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akhoondi S, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2788; Amati B, 2004, P NATL ACAD SCI USA, V101, P8843, DOI 10.1073/pnas.0403046101; Carrano AC, 1999, NAT CELL BIOL, V1, P193, DOI 10.1038/12013; Chan CH, 2013, CELL, V154, P556, DOI 10.1016/j.cell.2013.06.048; Chen P, 2011, TOXICOLOGY, V282, P122, DOI 10.1016/j.tox.2011.01.018; Chen YC, 2002, ARCH TOXICOL, V76, P351, DOI 10.1007/s00204-002-0346-6; Chi YS, 2001, BIOCHEM PHARMACOL, V61, P1195, DOI 10.1016/S0006-2952(01)00597-4; Chow SE, 2011, CANCER CHEMOTH PHARM, V68, P835, DOI 10.1007/s00280-010-1552-1; Crocetti E, 2002, LUNG CANCER-J IASLC, V35, P215, DOI 10.1016/S0169-5002(01)00335-X; Dang CV, 1999, EXP CELL RES, V253, P63, DOI 10.1006/excr.1999.4686; De Ruijter AJM, 2003, BIOCHEM J, V370, P737, DOI 10.1042/BJ20021321; Ding J, 2012, J BIOL CHEM, V287, P641, DOI 10.1074/jbc.M111.286526; Flinn EM, 1998, MOL CELL BIOL, V18, P5961, DOI 10.1128/MCB.18.10.5961; Hiramatsu Y, 2006, CANCER RES, V66, P8477, DOI 10.1158/0008-5472.CAN-06-1603; Inuzuka H, 2011, NATURE, V471, P104, DOI 10.1038/nature09732; JONES TR, 1987, MOL CELL BIOL, V7, P4513, DOI 10.1128/MCB.7.12.4513; Juergens Rosalyn, 2007, Curr Oncol Rep, V9, P255, DOI 10.1007/s11912-007-0031-2; Kamura T, 2003, P NATL ACAD SCI USA, V100, P10231, DOI 10.1073/pnas.1831009100; KELLY K, 1983, CELL, V35, P603, DOI 10.1016/0092-8674(83)90092-2; Kim SY, 2003, MOL CELL, V11, P1177, DOI 10.1016/S1097-2765(03)00173-4; Lee E, 2009, ANN NY ACAD SCI, V1171, P132, DOI 10.1111/j.1749-6632.2009.04722.x; Li Q, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008531; Li-Weber M, 2009, CANCER TREAT REV, V35, P57, DOI 10.1016/j.ctrv.2008.09.005; Marks PA, 2009, J CELL BIOCHEM, V107, P600, DOI 10.1002/jcb.22185; Nesbit CE, 1999, ONCOGENE, V18, P3004, DOI 10.1038/sj.onc.1202746; O'Neil J, 2007, ONCOGENE, V26, P6838, DOI 10.1038/sj.onc.1210766; PULVERER BJ, 1994, ONCOGENE, V9, P59; Ruthenburg AJ, 2007, NAT REV MOL CELL BIO, V8, P983, DOI 10.1038/nrm2298; Sancho R, 2010, GASTROENTEROLOGY, V139, P929, DOI 10.1053/j.gastro.2010.05.078; Song XM, 2013, TOXICOL APPL PHARM, V271, P144, DOI 10.1016/j.taap.2013.04.031; Spruck CH, 2002, CANCER RES, V62, P4535; Tedesco D, 2002, GENE DEV, V16, P2946, DOI 10.1101/gad.1011202; Tsai CF, 2012, INT J MOL SCI, V13, P9877, DOI 10.3390/ijms13089877; Wang W, 2006, ANTI-CANCER DRUG, V17, P797, DOI 10.1097/01.cad.0000217431.64118.3f; Wang ZW, 2011, BIOESSAYS, V33, P851, DOI 10.1002/bies.201100101; Welcker M, 2004, CURR BIOL, V14, P1852, DOI 10.1016/j.cub.2004.09.083; Wertz IE, 2011, NATURE, V471, P110, DOI 10.1038/nature09779; Yang L, 2013, APOPTOSIS, V18, P618, DOI 10.1007/s10495-013-0808-8; Yang L, 2009, BIOCHEM CELL BIOL, V87, P933, DOI [10.1139/O09-060, 10.1139/o09-060]; Yu JS, 2011, MOL CELLS, V31, P327, DOI 10.1007/s10059-011-0041-7; Zhang M, 2013, LIFE SCI, V92, P55, DOI 10.1016/j.lfs.2012.10.023; Zhao D, 2010, CANCER RES, V70, P4728, DOI 10.1158/0008-5472.CAN-10-0040	42	22	26	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79201	10.1371/journal.pone.0079201	http://dx.doi.org/10.1371/journal.pone.0079201			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265759	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100092
J	Dong, GH; Lin, X; Hu, YB; Lu, QL				Dong, Guangheng; Lin, Xiao; Hu, Yanbo; Lu, Qilin			Brain Activity in Advantageous and Disadvantageous Situations: Implications for Reward/Punishment Sensitivity in Different Situations	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; DECISION-MAKING; REWARD; EMOTION; GYRUS; FMRI	Objective: This study modeled win and lose trials in a simple gambling task to examine the effect of entire win-lose situations (WIN, LOSS, or TIE) on single win/lose trials and related neural underpinnings. Methods: The behavior responses and brain activities of 17 participants were recorded by an MRI scanner while they performed a gambling task. Different conditions were compared to determine the effect of the task on the behavior and brain activity of the participants. Correlations between brain activity and behavior were calculated to support the imaging results. Results: In win trials, LOSS caused less intense posterior cingulate activity than TIE. In lose trials, LOSS caused more intense activity in the right superior temporal gyrus, bilateral superior frontal gyrus, bilateral anterior cingulate, bilateral insula cortex, and left orbitofrontal cortex than WIN and TIE. Conclusions: The experiences of the participants in win trials showed great similarity among different win-lose situations. However, the brain activity and behavior responses of the participants in lose trials indicated that they experienced stronger negative emotion in LOSS. The participants also showed an increased desire to win in LOSS than in WIN or TIE conditions.	[Dong, Guangheng; Lin, Xiao] Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China; [Hu, Yanbo] Univ Reading, Sch Psychol & Clin Language Sci, CINN, Reading RG6 2AH, Berks, England; [Lu, Qilin] Univ Sci & Technol China, Sch Life Sci, Hefei 230026, Anhui, Peoples R China	Zhejiang Normal University; University of Reading; Chinese Academy of Sciences; University of Science & Technology of China, CAS	Dong, GH (corresponding author), Zhejiang Normal Univ, Dept Psychol, Jinhua, Zhejiang, Peoples R China.	dongguangheng@zjnu.edu.cn		Hu, Yanbo/0000-0002-3189-8736	National Science Fundation of China (NSFC) [31371023]	National Science Fundation of China (NSFC)	This research was supported by National Science Fundation of China (NSFC) (31371023). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Bigler ED, 2007, DEV NEUROPSYCHOL, V31, P217, DOI 10.1080/87565640701190841; Buhle J, 2010, PAIN, V149, P19, DOI 10.1016/j.pain.2009.10.027; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; Critchley HD, 2004, NAT NEUROSCI, V7, P189, DOI 10.1038/nn1176; Dong GH, 2011, J PSYCHIATR RES, V45, P1525, DOI 10.1016/j.jpsychires.2011.06.017; Drevets WC, 1998, COGNITION EMOTION, V12, P353, DOI 10.1080/026999398379646; Gu X, 2012, CEREB CORTEX; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hare TA, 2008, J NEUROSCI, V28, P5623, DOI 10.1523/JNEUROSCI.1309-08.2008; Holroyd CB, 2002, PSYCHOL REV, V109, P679, DOI 10.1037/0033-295X.109.4.679; Kahnt T, 2010, P NATL ACAD SCI USA, V107, P6010, DOI 10.1073/pnas.0912838107; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Krawitz A, 2010, COGN AFFECT BEHAV NE, V10, P392, DOI 10.3758/CABN.10.3.392; Lecrubier Y, 1997, EUR PSYCHIAT, V12, P224, DOI 10.1016/S0924-9338(97)83296-8; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; McClernon FJ, 2005, NEUROPSYCHOPHARMACOL, V30, P1940, DOI 10.1038/sj.npp.1300780; Ogino Y, 2007, CEREB CORTEX, V17, P1139, DOI 10.1093/cercor/bhl023; Pearson JM, 2009, CURR BIOL, V19, P1532, DOI 10.1016/j.cub.2009.07.048; Platt ML, 2008, NAT NEUROSCI, V11, P398, DOI 10.1038/nn2062; Posner MI, 2007, COGN AFFECT BEHAV NE, V7, P391, DOI 10.3758/CABN.7.4.391; Radua J, 2010, NEUROIMAGE, V49, P939, DOI 10.1016/j.neuroimage.2009.08.030; Rolls ET, 2000, CEREB CORTEX, V10, P284, DOI 10.1093/cercor/10.3.284; Salvatore MF, 2012, JOVE-J VIS EXP, DOI 10.3791/4171; Spiro JE, 2001, NAT NEUROSCI, V4, P12, DOI 10.1038/82844; Starcke K, 2012, NEUROSCI BIOBEHAV R, V36, P1228, DOI 10.1016/j.neubiorev.2012.02.003; van Duuren E, 2008, J NEUROSCI, V28, P8590, DOI 10.1523/JNEUROSCI.5549-07.2008; van Veen V, 2004, BRAIN COGNITION, V56, P267, DOI 10.1016/j.bandc.2004.06.007; Wallis JD, 2011, ANN NY ACAD SCI, V1239, P33, DOI 10.1111/j.1749-6632.2011.06277.x	30	6	6	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80232	10.1371/journal.pone.0080232	http://dx.doi.org/10.1371/journal.pone.0080232			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265801	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100136
J	Han, XF; Xu, Y; Yang, YL; Xi, JL; Tian, W; Duggineni, S; Huang, ZW; An, J				Han, Xiaofeng; Xu, Yan; Yang, Yilei; Xi, Jingle; Tian, Wang; Duggineni, Srinivas; Huang, Ziwei; An, Jing			Discovery and Characterization of a Novel Cyclic Peptide That Effectively Inhibits Ephrin Binding to the EphA4 Receptor and Displays Anti-Angiogenesis Activity	PLOS ONE			English	Article							TYROSINE KINASE; NERVOUS-SYSTEM; CANCER; PROLIFERATION; REGENERATION; EXPRESSION	The EphA4 receptor tyrosine kinase regulates a variety of physiological and pathological processes during neural development and the formation of tumor blood vessels; thus, it represents a new and promising therapeutic target. We used a combination of phage peptide display and computer modeling/docking approaches and discovered a novel cyclic nonapeptide, now designated TYY. This peptide selectively inhibits the binding of the ephrinA5 ligand with EphA4 and significantly blocks angiogenesis in a 3D matrigel culture system. Molecular docking reveals that TYY recognizes the same binding pocket on EphA4 that the natural ephrin ligand binds to and that the Tyr3 and Tyr4 side chains of TYY are both critical for the TYY/EphA4 interaction. The discovery of TYY introduces a valuable probe of EphA4 function and a new lead for EphA4-targeted therapeutic development.	[Han, Xiaofeng; Xu, Yan; Yang, Yilei; Xi, Jingle; Tian, Wang; Duggineni, Srinivas; Huang, Ziwei; An, Jing] SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA; [Han, Xiaofeng; Xu, Yan; Yang, Yilei; Xi, Jingle; Tian, Wang; Duggineni, Srinivas; Huang, Ziwei; An, Jing] SUNY Syracuse, SUNY Upstate Canc Res Inst, Dept Pharmacol, Syracuse, NY USA; [Xi, Jingle] Southern Med Univ, Nanfang Hosp, Dept Oncol, Guangzhou, Guangdong, Peoples R China	State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; State University of New York (SUNY) System; Southern Medical University - China	Huang, ZW (corresponding author), SUNY Upstate Med Univ, Dept Pharmacol, Syracuse, NY 13210 USA.	huangz@upstate.edu; anji@upstate.edu			DoD [W81 XWH-07-1-0462]	DoD(United States Department of Defense)	This work was supported by the DoD grant W81 XWH-07-1-0462. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1699, SYBYL X1 3 TRIP INT; Ashida S, 2004, CANCER RES, V64, P5963, DOI 10.1158/0008-5472.CAN-04-0020; Bowden TA, 2009, STRUCTURE, V17, P1386, DOI 10.1016/j.str.2009.07.018; Brantley-Sieders D, 2004, CURR PHARM DESIGN, V10, P3431, DOI 10.2174/1381612043383160; Brantley-Sieders DM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024426; Castano J, 2008, HISTOL HISTOPATHOL, V23, P1011, DOI 10.14670/HH-23.1011; Du J, 2007, CURR PHARM DESIGN, V13, P2507; Fabes J, 2007, EUR J NEUROSCI, V26, P2496, DOI 10.1111/j.1460-9568.2007.05859.x; Fukai J, 2008, MOL CANCER THER, V7, P2768, DOI 10.1158/1535-7163.MCT-07-2263; Goldshmit Y, 2004, J NEUROSCI, V24, P10064, DOI 10.1523/JNEUROSCI.2981-04.2004; Goldshmit Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024636; Horswill AR, 2005, CELL CYCLE, V4, P552, DOI 10.4161/cc.4.4.1585; Iiizumi M, 2006, CANCER SCI, V97, P1211, DOI 10.1111/j.1349-7006.2006.00313.x; Koolpe M, 2005, J BIOL CHEM, V280, P17301, DOI 10.1074/jbc.M500363200; Koolpe M, 2002, J BIOL CHEM, V277, P46974, DOI 10.1074/jbc.M208495200; Li JG, 2012, NEUROSCI LETT, V518, P92, DOI 10.1016/j.neulet.2012.04.060; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Mosch B, 2010, J ONCOL, V2010, DOI 10.1155/2010/135285; Munro KM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037635; Murai KK, 2003, MOL CELL NEUROSCI, V24, P1000, DOI 10.1016/j.mcn.2003.08.006; Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625; Noberini R, 2008, J BIOL CHEM, V283, P29461, DOI 10.1074/jbc.M804103200; Oki M, 2008, WORLD J GASTROENTERO, V14, P5650, DOI 10.3748/wjg.14.5650; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2005, NAT REV MOL CELL BIO, V6, P462, DOI 10.1038/nrm1662; Pasquale EB, 2010, NAT REV CANCER, V10, P165, DOI 10.1038/nrc2806; Sawada T, 2010, GENES CELLS, V15, P297, DOI 10.1111/j.1365-2443.2010.01391.x; van Doorn R, 2004, CANCER RES, V64, P5578, DOI 10.1158/0008-5472.CAN-04-1253; Van Hoecke A, 2012, NAT MED, V18, P1418, DOI 10.1038/nm.2901; Walkenhorst J, 2000, MOL CELL NEUROSCI, V16, P365, DOI 10.1006/mcne.2000.0878; Xi JL, 2013, MOL CANCER RES, V11, P856, DOI 10.1158/1541-7786.MCR-12-0177; Young TS, 2011, P NATL ACAD SCI USA, V108, P11052, DOI 10.1073/pnas.1108045108	32	12	13	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80183	10.1371/journal.pone.0080183	http://dx.doi.org/10.1371/journal.pone.0080183			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265799	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100132
J	Hanemann, ALP; Liborio, AB; Daher, EF; Martins, AMC; Pinheiro, MCC; Sousa, MS; Bezerra, FSM				Hanemann, Ana Lucia P.; Liborio, Alexandre B.; Daher, Elizabeth F.; Martins, Alice Maria C.; Pinheiro, Marta Cristhiany C.; Sousa, Mariana S.; Bezerra, Fernando Schemelzer M.			Monocyte Chemotactic Protein-1 (MCP-1) in Patients with Chronic Schistosomiasis Mansoni: Evidences of Subclinical Renal Inflammation	PLOS ONE			English	Article							CHEMOATTRACTANT PROTEIN-1; EXPRESSION	The aim of this study is to investigate renal markers and the biomarker MCP-1 in patients with schistosomiasis mansoni. This is a cross-sectional study with 85 patients aged 5 to 48 years, with a confirmed diagnosis of schistosomiasis mansoni through the Kato-Katz method. The patients were divided in three groups: control (G-I); infected by S. mansoni before treatment (G-II) and infected by S. mansoni after treatment (G-III). Renal function was evaluated by tubular and glomerular biomarkers and through urinary MCP-1. Patients' mean age was 23.2 +/- 13 years. There was no statistically significant difference between the groups regarding tubular and glomerular function evaluated through the traditional biomarkers. MCP-1 was higher in G-II and G-III, when compared to G-I; p=0.009 and p=0.007, respectively. There was no difference when comparing groups G-II and G-III (p=0.892). Although it was not different among the groups, there was a significant correlation between albuminuria and MCP-1. There was a significant increase in urinary MCP-1 levels in patients with schistosomiasis mansoni, which was associated with albuminuria. This protein has a role in the recruitment of monocytes to injury and inflammation sites. The increase of MCP-1 in the urine evidences that there is silent renal inflammation in these patients and the inflammatory status is not interrupted by specific treatment of the offending agent. Our findings suggest that urinary MCP-1 can be a sensitive marker of renal injury in patients with schistosomiasis mansoni.	[Hanemann, Ana Lucia P.; Sousa, Mariana S.; Bezerra, Fernando Schemelzer M.] Univ Fed Ceara, Dept Pathol & Legal Med, Fortaleza, Ceara, Brazil; [Liborio, Alexandre B.; Daher, Elizabeth F.] Univ Fed Ceara, Dept Clin Med, Fortaleza, Ceara, Brazil; [Martins, Alice Maria C.; Pinheiro, Marta Cristhiany C.; Bezerra, Fernando Schemelzer M.] Univ Fed Ceara, Dept Clin Anal & Toxicol, Fortaleza, Ceara, Brazil; [Pinheiro, Marta Cristhiany C.; Bezerra, Fernando Schemelzer M.] Univ Fed Ceara, Dept Community Hlth, Fortaleza, Ceara, Brazil	Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara; Universidade Federal do Ceara	Bezerra, FSM (corresponding author), Univ Fed Ceara, Dept Pathol & Legal Med, Fortaleza, Ceara, Brazil.	bezerra@ufc.br	Martins, Alice Maria Costa/AAX-3093-2020; Pinheiro, Marta/GLQ-8281-2022; PINHEIRO, MARTA/AAJ-7688-2020; De Francesco Daher, Elizabeth/G-2210-2012; Pinheiro, Marta C. C./B-8409-2013	Pinheiro, Marta/0000-0002-0511-6964; De Francesco Daher, Elizabeth/0000-0003-4189-1738; Pinheiro, Marta C. C./0000-0002-0511-6964; Bezerra, Fernando/0000-0003-4920-7718				Barbado J, 2012, CYTOKINE, V60, P583, DOI 10.1016/j.cyto.2012.07.009; BARSOUM RS, 1993, KIDNEY INT, V44, P1, DOI 10.1038/ki.1993.205; Castro-Sesquen YE, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058480; COCKCROFT DW, 1976, NEPHRON, V16, P31, DOI 10.1159/000180580; Grandaliano G, 1996, J AM SOC NEPHROL, V7, P906; Katz N, 1972, Rev Inst Med Trop Sao Paulo, V14, P397; Martinelli R, 1999, GLOMERULOPATIAS PATO, P206; Mori Kiyoshi, 2012, Nihon Rinsho, V70, P864; Murea M, 2012, BMC NEPHROL, V13, DOI 10.1186/1471-2369-13-148; Murussi M, 2007, DIABETIC MED, V24, P1136, DOI 10.1111/j.1464-5491.2007.02209.x; SCHWARTZ GJ, 1976, PEDIATRICS, V58, P259; Segerer S, 2000, J AM SOC NEPHROL, V11, P2231, DOI 10.1681/ASN.V11122231; Urbschat A, 2011, BIOMARKERS, V16, pS22, DOI 10.3109/1354750X.2011.587129; Yoshimoto K, 2004, NEPHRON CLIN PRACT, V98, pC25, DOI 10.1159/000079924; Zheng D, 2003, J AM SOC NEPHROL, V14, P2588, DOI 10.1097/01.ASN.0000088720.61783.19	15	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80421	10.1371/journal.pone.0080421	http://dx.doi.org/10.1371/journal.pone.0080421			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265821	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100157
J	Nijjar, S; Woodland, HR				Nijjar, Sarbjit; Woodland, Hugh R.			Protein Interactions in Xenopus Germ Plasm RNP Particles	PLOS ONE			English	Article							BINDING PROTEIN; GENE-EXPRESSION; LAEVIS OOCYTES; MESSENGER-RNA; LOCALIZATION; ORGANIZATION; HERMES; MICROTUBULES; CYTOKERATIN; BODY	Hermes is an RNA-binding protein that we have previously reported to be found in the ribonucleoprotein (RNP) particles of Xenopus germ plasm, where it is associated with various RNAs, including that encoding the germ line determinant Nanos1. To further define the composition of these RNPs, we performed a screen for Hermes-binding partners using the yeast two-hybrid system. We have identified and validated four proteins that interact with Hermes in germ plasm: two isoforms of Xvelo1 (a homologue of zebrafish Bucky ball) and Rbm24b and Rbm42b, both RNA-binding proteins containing the RRM motif. GFP-Xvelo fusion proteins and their endogenous counterparts, identified with antisera, were found to localize with Hermes in the germ plasm particles of large oocytes and eggs. Only the larger Xvelo isoform was naturally found in the Balbiani body of previtellogenic oocytes. Bimolecular fluorescence complementation (BiFC) experiments confirmed that Hermes and the Xvelo variants interact in germ plasm, as do Rbm24b and 42b. Depletion of the shorter Xvelo variant with antisense oligonucleotides caused a decrease in the size of germ plasm aggregates and loosening of associated mitochondria from these structures. This suggests that the short Xvelo variant, or less likely its RNA, has a role in organizing and maintaining the integrity of germ plasm in Xenopus oocytes. While GFP fusion proteins for Rbm24b and 42b did not localize into germ plasm as specifically as Hermes or Xvelo, BiFC analysis indicated that both interact with Hermes in germ plasm RNPs. They are very stable in the face of RNA depletion, but additive effects of combinations of antisense oligos suggest they may have a role in germ plasm structure and may influence the ability of Hermes protein to effectively enter RNP particles.	[Nijjar, Sarbjit; Woodland, Hugh R.] Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England	University of Warwick	Woodland, HR (corresponding author), Univ Warwick, Sch Life Sci, Coventry CV4 7AL, W Midlands, England.	h.r.woodland@warwick.ac.uk			Wellcome Trust [WT084169]	Wellcome Trust(Wellcome TrustEuropean Commission)	This work was financially supported by the Wellcome Trust (Project Grant WT084169). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson P, 2006, J CELL BIOL, V172, P803, DOI 10.1083/jcb.200512082; Anyanful A, 2004, J CELL BIOL, V167, P639, DOI 10.1083/jcb.200407085; Berekelya LA, 2007, DIFFERENTIATION, V75, P546, DOI 10.1111/j.1432-0436.2006.00160.x; Bilinski SM, 2004, EXP CELL RES, V299, P171, DOI 10.1016/j.yexcr.2004.05.016; Bontems F, 2009, CURR BIOL, V19, P414, DOI 10.1016/j.cub.2009.01.038; Bowes JB, 2010, NUCLEIC ACIDS RES, V38, pD607, DOI 10.1093/nar/gkp953; Claussen M, 2004, DEV BIOL, V266, P270, DOI 10.1016/j.ydbio.2003.09.043; Fukuda T, 2009, GENES CELLS, V14, P113, DOI 10.1111/j.1365-2443.2008.01256.x; GARD DL, 1991, DEV BIOL, V143, P346, DOI 10.1016/0012-1606(91)90085-H; Gerber WV, 2002, DEV BIOL, V247, P116, DOI 10.1006/dbio.2002.0678; Gerber WV, 1999, MECH DEVELOP, V80, P77, DOI 10.1016/S0925-4773(98)00195-6; Harnes RS, 2008, EXP CELL RES, V314, P574, DOI 10.1016/j.yexcr.2007.10.019; HEASMAN J, 1984, DEV BIOL, V105, P458, DOI 10.1016/0012-1606(84)90303-8; HERTIG AT, 1968, AM J ANAT, V122, P107, DOI 10.1002/aja.1001220107; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Hulstrand AM, 2010, METHODS, V51, P75, DOI 10.1016/j.ymeth.2009.12.015; Jin DH, 2010, GENES CELLS, V15, P1158, DOI 10.1111/j.1365-2443.2010.01446.x; Joung JK, 2000, P NATL ACAD SCI USA, V97, P7382, DOI 10.1073/pnas.110149297; Kerppola TK, 2008, ANNU REV BIOPHYS, V37, P465, DOI 10.1146/annurev.biophys.37.032807.125842; King ML, 1999, BIOESSAYS, V21, P546, DOI 10.1002/(SICI)1521-1878(199907)21:7<546::AID-BIES3>3.0.CO;2-Z; Kloc M, 2001, INT REV CYTOL, V203, P63; Kloc M, 2007, EXP CELL RES, V313, P1639, DOI 10.1016/j.yexcr.2007.02.018; Kosaka K, 2007, MECH DEVELOP, V124, P279, DOI 10.1016/j.mod.2007.01.003; Lai FF, 2012, DEVELOPMENT, V139, P1476, DOI 10.1242/dev.079608; Lai FF, 2011, MECH DEVELOP, V128, P153, DOI 10.1016/j.mod.2010.12.001; Lewis RA, 2007, RIBONUCLEOPROTEIN RE; Li HY, 2010, MECH DEVELOP, V127, P281, DOI 10.1016/j.mod.2010.03.002; Machado RJ, 2005, DEV BIOL, V287, P289, DOI 10.1016/j.ydbio.2005.08.044; Marlow FL, 2008, DEV BIOL, V321, P40, DOI 10.1016/j.ydbio.2008.05.557; Mir Adnan, 2008, V469, P417, DOI 10.1007/978-1-60327-469-2_26; Miyamoto S, 2009, GENES CELLS, V14, P1241, DOI 10.1111/j.1365-2443.2009.01347.x; Morgan GT, 2000, J STRUCT BIOL, V129, P258, DOI 10.1006/jsbi.2000.4231; Nijjar S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0061847; Nizami ZF, 2010, COLD SH Q B, V75, P313, DOI 10.1101/sqb.2010.75.005; Poon KL, 2012, CARDIOVASC RES, V94, P418, DOI 10.1093/cvr/cvs095; Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645; Schneider CA, 2012, NAT METHODS, V9, P671, DOI 10.1038/nmeth.2089; Song HW, 2007, DIFFERENTIATION, V75, P519, DOI 10.1111/j.1432-0436.2006.00155.x; TORPEY NP, 1992, J CELL SCI, V101, P151; Voronina E, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a002774; Yanai I, 2011, DEV CELL, V20, P483, DOI 10.1016/j.devcel.2011.03.015; YISRAELI JK, 1990, DEVELOPMENT, V108, P289; Yost C, 1998, CELL, V93, P1031, DOI 10.1016/S0092-8674(00)81208-8; Zhou Y, 2004, IUBMB LIFE, V56, P19, DOI 10.1080/15216540310001658886	45	22	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80077	10.1371/journal.pone.0080077	http://dx.doi.org/10.1371/journal.pone.0080077			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265795	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100128
J	Ohkuma, T; Fujii, H; Iwase, M; Ogata-Kaizu, S; Ide, H; Kikuchi, Y; Idewaki, Y; Jodai, T; Hirakawa, Y; Nakamura, U; Kitazono, T				Ohkuma, Toshiaki; Fujii, Hiroki; Iwase, Masanori; Ogata-Kaizu, Shinako; Ide, Hitoshi; Kikuchi, Yohei; Idewaki, Yasuhiro; Jodai, Tamaki; Hirakawa, Yoichiro; Nakamura, Udai; Kitazono, Takanari			Association between Sleep Duration and Urinary Albumin Excretion in Patients with Type 2 Diabetes: The Fukuoka Diabetes Registry	PLOS ONE			English	Article							DIET HISTORY QUESTIONNAIRES; RESTLESS LEGS SYNDROME; C-REACTIVE PROTEIN; CARDIOVASCULAR-DISEASE; RISK-FACTOR; MECHANISMS; IMPACT; APNEA; HYPERTENSION; DYSFUNCTION	Objective: Few studies have so far investigated the impact of sleep duration on chronic kidney disease in diabetic patients. The objective of the present study was to examine the relationship between sleep duration and albuminuria in type 2 diabetic patients. Research Design and Methods: A total of 4,870 Japanese type 2 diabetic patients >= 20 years of age were divided into six groups according to self-reported sleep duration: less than 4.5 hours, 4.5-5.4 hours, 5.5-6.4 hours, 6.5-7.4 hours, 7.5-8.4 hours and more than 8.5 hours. The association between sleep duration and urinary albumin-creatinine ratio (UACR) was examined cross-sectionally. Results: Both short and long sleep durations were significantly associated with higher UACR levels and higher proportions of patients with albuminuria (>= 30 mg/g) and macroalbuminuria (>= 300 mg/g) compared with a sleep duration of 6.5-7.4 hours (P for quadratic trend <0.001). A U-shaped association between sleep duration and UACR remained significant even after adjustment for potential confounders, including age, sex, duration of diabetes, current smoking habits, former smoking habits, current drinking habits, regular exercise habits, total energy intake, total protein intake, hypnotic use and estimated glomerular filtration rate. Furthermore, the association remained substantially unchanged after additional adjustment for body mass index, hemoglobin A(1c), systolic blood pressure, renin-angiotensin system inhibitor use and depressive symptoms. Conclusions: Our findings suggest that sleep duration has a U-shaped association with the UACR levels in type 2 diabetic patients, independent of potential confounders.	[Ohkuma, Toshiaki; Fujii, Hiroki; Iwase, Masanori; Ogata-Kaizu, Shinako; Ide, Hitoshi; Kikuchi, Yohei; Idewaki, Yasuhiro; Jodai, Tamaki; Nakamura, Udai; Kitazono, Takanari] Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan; [Hirakawa, Yoichiro] Kyushu Univ, Grad Sch Med Sci, Dept Environm Med, Fukuoka 812, Japan; [Ohkuma, Toshiaki] Fukuoka Dent Coll, Med & Dent Hosp, Dept Internal Med, Fukuoka, Japan; [Iwase, Masanori] Hakujyuji Hosp, Ctr Diabet, Fukuoka, Japan	Kyushu University; Kyushu University; Fukuoka Dental College (FDC)	Iwase, M (corresponding author), Kyushu Univ, Grad Sch Med Sci, Dept Med & Clin Sci, Fukuoka 812, Japan.	iwase@intmed2.med.kyushu-u.ac.jp			JSPS KAKENHI [23249037, 23659353]	JSPS KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported in part by JSPS KAKENHI (grant number 23249037, 23659353) for MI. No additional external funding received for this study. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adeseun GA, 2010, CURR HYPERTENS REP, V12, P378, DOI 10.1007/s11906-010-0135-1; Arima S, 2003, NEPHROL DIAL TRANSPL, V18, P1966, DOI 10.1093/ndt/gfg263; Avogaro A, 2005, CLIN CHIM ACTA, V360, P9, DOI 10.1016/j.cccn.2005.04.020; Ayas NT, 2003, ARCH INTERN MED, V163, P205, DOI 10.1001/archinte.163.2.205; Bakker W, 2009, CELL TISSUE RES, V335, P165, DOI 10.1007/s00441-008-0685-6; Canales MT, 2011, SLEEP BREATH, V15, P137, DOI 10.1007/s11325-010-0339-2; DINGES DF, 1994, J CLIN INVEST, V93, P1930, DOI 10.1172/JCI117184; Faulx MD, 2007, SLEEP, V30, P923, DOI 10.1093/sleep/30.7.923; Fujibayashi K, 2012, J ATHEROSCLER THROMB, V19, P932, DOI 10.5551/jat.12781; Gangwisch JE, 2007, SLEEP, V30, P1667, DOI 10.1093/sleep/30.12.1667; Gerstein HC, 2001, JAMA-J AM MED ASSOC, V286, P421, DOI 10.1001/jama.286.4.421; Gottlieb DJ, 2006, SLEEP, V29, P1009, DOI 10.1093/sleep/29.8.1009; Hall JE, 1999, ANN NY ACAD SCI, V892, P91, DOI 10.1111/j.1749-6632.1999.tb07788.x; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Innes KE, 2012, SLEEP MED REV, V16, P309, DOI 10.1016/j.smrv.2011.04.001; Iseki K, 2003, KIDNEY INT, V63, P1468, DOI 10.1046/j.1523-1755.2003.00868.x; Kabutoya T, 2010, J CLIN HYPERTENS, V12, P345, DOI 10.1111/j.1751-7176.2010.00276.x; Kobayashi S, 2012, J EPIDEMIOL, V22, P151, DOI 10.2188/jea.JE20110075; Kobayashi S, 2011, PUBLIC HEALTH NUTR, V14, P1200, DOI 10.1017/S1368980011000504; Kronholm E, 2008, J SLEEP RES, V17, P54, DOI 10.1111/j.1365-2869.2008.00627.x; Kuzuya T, 2002, DIABETES RES CLIN PR, V55, P65, DOI 10.1016/S0168-8227(01)00365-5; Lauderdale DS, 2008, EPIDEMIOLOGY, V19, P838, DOI 10.1097/EDE.0b013e318187a7b0; Levey AS, 2011, KIDNEY INT, V80, P17, DOI 10.1038/ki.2010.483; Lockley SW, 1999, J SLEEP RES, V8, P175, DOI 10.1046/j.1365-2869.1999.00155.x; Matsuo S, 2009, AM J KIDNEY DIS, V53, P982, DOI 10.1053/j.ajkd.2008.12.034; Meier-Ewert HK, 2004, J AM COLL CARDIOL, V43, P678, DOI 10.1016/j.jacc.2003.07.050; Merlino G, 2007, SLEEP, V30, P866, DOI 10.1093/sleep/30.7.866; Musselman DL, 1998, ARCH GEN PSYCHIAT, V55, P580, DOI 10.1001/archpsyc.55.7.580; Ohkuma T, 2013, DIABETOLOGIA, V56, P70, DOI 10.1007/s00125-012-2746-3; Ohkuma T, 2013, DIABETES CARE, V36, P611, DOI 10.2337/dc12-0904; Pamidi S, 2010, BEST PRACT RES CL EN, V24, P703, DOI 10.1016/j.beem.2010.08.009; Patel SR, 2006, SLEEP, V29, P881, DOI 10.1093/sleep/29.7.881; Patel SR, 2004, SLEEP, V27, P440, DOI 10.1093/sleep/27.3.440; Perkovic V, 2008, PLOS MED, V5, P1486, DOI 10.1371/journal.pmed.0050207; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Ruggenenti P, 2012, J AM SOC NEPHROL, V23, P1717, DOI 10.1681/ASN.2012030252; Shimokawa H, 1998, J Atheroscler Thromb, V4, P118; Taheri S, 2004, PLOS MED, V1, P210, DOI 10.1371/journal.pmed.0010062; Verhave JC, 2004, KIDNEY INT, V66, pS18, DOI 10.1111/j.1523-1755.2004.09205.x; Vgontzas AN, 2004, J CLIN ENDOCR METAB, V89, P2119, DOI 10.1210/jc.2003-031562; Yaggi HK, 2006, DIABETES CARE, V29, P657, DOI 10.2337/diacare.29.03.06.dc05-0879; Yamamoto R, 2012, AM J KIDNEY DIS, V59, P343, DOI 10.1053/j.ajkd.2011.08.032	42	27	27	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78968	10.1371/journal.pone.0078968	http://dx.doi.org/10.1371/journal.pone.0078968			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265736	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100069
J	Palmer, SO; Rangel, EY; Hu, YM; Tran, AT; Bullard, JM				Palmer, Stephanie O.; Rangel, Edna Y.; Hu, Yanmei; Tran, Alexis T.; Bullard, James M.			Two Homologous EF-G Proteins from Pseudomonas aeruginosa Exhibit Distinct Functions	PLOS ONE			English	Article							ELONGATION-FACTOR-G; POLYMERASE-III HOLOENZYME; FUSIDIC ACID; THERMUS-THERMOPHILUS; ESCHERICHIA-COLI; CYSTIC-FIBROSIS; RNA MOVEMENT; RIBOSOME; GTP; IDENTIFICATION	Genes encoding two proteins corresponding to elongation factor G (EF-G) were cloned from Pseudomonas aeruginosa. The proteins encoded by these genes are both members of the EFG I subfamily. The gene encoding one of the forms of EF-G is located in the str operon and the resulting protein is referred to as EF-G1A while the gene encoding the other form of EF-G is located in another part of the genome and the resulting protein is referred to as EF-G1B. These proteins were expressed and purified to 98% homogeneity. Sequence analysis indicated the two proteins are 90/84% similar/identical. In other organisms containing multiple forms of EF-G a lower degree of similarity is seen. When assayed in a poly(U)-directed poly-phenylalanine translation system, EF-G1B was 75-fold more active than EF-G1A. EF-G1A pre-incubate with ribosomes in the presence of the ribosome recycling factor (RRF) decreased polymerization of poly-phenylalanine upon addition of EF-G1B in poly(U)-directed translation suggesting a role for EF-G1A in uncoupling of the ribosome into its constituent subunits. Both forms of P. aeruginosa EF-G were active in ribosome dependent GTPase activity. The kinetic parameters (KM) for the interaction of EF-G1A and EF-G1B with GTP were 85 and 70 mu M, respectively. However, EF-G1B exhibited a 5-fold greater turnover number (observed k(cat)) for the hydrolysis of GTP than EF-G1A; 0.2 s(-1) vs. 0.04 s(-1). These values resulted in specificity constants (k(cat)(obs)/K-M) for EF-G1A and EF-G1B of 0.5 x 10(3) s(-1) M-1 and 3.0 x 10(3) s(-1) M-1, respectively. The antibiotic fusidic acid (FA) completely inhibited poly(U)-dependent protein synthesis containing P. aeruginosa EF-G1B, but the same protein synthesis system containing EF-G1A was not affected. Likewise, the activity of EF-G1B in ribosome dependent GTPase assays was completely inhibited by FA, while the activity of EF-G1A was not affected.	[Palmer, Stephanie O.; Rangel, Edna Y.; Hu, Yanmei; Tran, Alexis T.; Bullard, James M.] Univ Texas Pan Amer, Edinburg, TX 78541 USA	University of Texas System; University of Texas Rio Grande Valley	Bullard, JM (corresponding author), Univ Texas Pan Amer, Edinburg, TX 78541 USA.	bullardj@utpa.edu	Hu, Yanmei/ABA-7872-2020	Bullard, James M/0000-0002-3068-3717; Hu, Yanmei/0000-0003-0525-7342	National Institutes of Health [1SC3GM098173-01A1]; South Texas Border Health Disparities Center (STBHDC) at The University of Texas-Pan American (UTPA); Welch Foundation [BG-0017]; Centers for Disease Control and Prevention [75DP001812]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [H75DP001812] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [SC3GM098173] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); South Texas Border Health Disparities Center (STBHDC) at The University of Texas-Pan American (UTPA); Welch Foundation(The Welch Foundation); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are grateful for the financial support provided by the National Institutes of Health (grant number: 1SC3GM098173-01A1) (http://www.nigms.nih.gov/). Portions of this research were also supported by the South Texas Border Health Disparities Center (STBHDC)(http://portal.utpa.edu/utpa_main/daa_home/stbhdc_home) at The University of Texas-Pan American (UTPA) as well as the Welch Foundation (Grant #BG-0017) (http://www.welch1.org/). STBHDC is funded by a grant from the Centers for Disease Control and Prevention (Grant 75DP001812). The contents of this paper are solely the responsibility of the authors and do not necessarily represent the official views of the funding agencies.	AEVARSSON A, 1994, EMBO J, V13, P3669, DOI 10.1002/j.1460-2075.1994.tb06676.x; ALAKHOV YB, 1981, FEBS LETT, V126, P183, DOI 10.1016/0014-5793(81)80237-2; An DD, 2007, CURR OPIN MICROBIOL, V10, P292, DOI 10.1016/j.mib.2007.05.011; Atkinson GC, 2011, MOL BIOL EVOL, V28, P1281, DOI 10.1093/molbev/msq316; Bhargava K, 2004, PROTEIN EXPRES PURIF, V37, P368, DOI 10.1016/j.pep.2004.06.030; Bielecki P, 2012, CHEMBIOCHEM, V13, P2339, DOI 10.1002/cbic.201200479; BODLEY JW, 1969, BIOCHEM BIOPH RES CO, V37, P437, DOI 10.1016/0006-291X(69)90934-6; BOURNE HR, 1991, NATURE, V349, P117, DOI 10.1038/349117a0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Bullard JM, 2002, J BIOL CHEM, V277, P13401, DOI 10.1074/jbc.M110833200; Chen Y, 2010, FEBS J, V277, P3789, DOI 10.1111/j.1742-4658.2010.07780.x; Connell SR, 2007, MOL CELL, V25, P751, DOI 10.1016/j.molcel.2007.01.027; CONWAY TW, 1964, P NATL ACAD SCI USA, V52, P1462, DOI 10.1073/pnas.52.6.1462; Cull MG, 1995, METHOD ENZYMOL, V262, P22; CZWORKOWSKI J, 1994, EMBO J, V13, P3661, DOI 10.1002/j.1460-2075.1994.tb06675.x; De VE, 1986, J BIOL CHEM, V261, P4445; Frank J, 2007, P NATL ACAD SCI USA, V104, P19671, DOI 10.1073/pnas.0708517104; Gao YG, 2009, SCIENCE, V326, P694, DOI 10.1126/science.1179709; Hammarsund M, 2001, HUM GENET, V109, P542, DOI 10.1007/s00439-001-0610-5; Hansson S, 2005, J MOL BIOL, V348, P939, DOI 10.1016/j.jmb.2005.02.066; HIRASHIM.A, 1973, J BIOL CHEM, V248, P7580; JOHANSON U, 1994, GENE, V143, P55, DOI 10.1016/0378-1119(94)90604-1; JURNAK F, 1994, STRUCTURE, V2, P785, DOI 10.1016/S0969-2126(94)00078-6; Margus T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-15; Margus T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022789; Martemyanov KA, 2001, J BIOL CHEM, V276, P28774, DOI 10.1074/jbc.M102023200; Moreau-Marquis S, 2008, PULM PHARMACOL THER, V21, P595, DOI 10.1016/j.pupt.2007.12.001; MOSTELLER RD, 1968, BIOCHEM BIOPH RES CO, V30, P631, DOI 10.1016/0006-291X(68)90559-7; Nechifor R, 2007, J BIOL CHEM, V282, P36998, DOI 10.1074/jbc.M707179200; NISHIZUKA Y, 1966, P NATL ACAD SCI USA, V55, P212, DOI 10.1073/pnas.55.1.212; Nyfeler B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042657; Palmer SO, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/585748; Ribble W, 2010, ANTIMICROB AGENTS CH, V54, P4648, DOI 10.1128/AAC.00638-10; Rodnina MV, 2011, BIOCHEM SOC T, V39, P658, DOI 10.1042/BST0390658; Rodnina MV, 1997, NATURE, V385, P37, DOI 10.1038/385037a0; Roussel P, 2003, ADV EXP MED BIOL, V535, P17; Seshadri A, 2009, TUBERCULOSIS, V89, P453, DOI 10.1016/j.tube.2009.06.003; Suematsu T, 2010, MOL MICROBIOL, V75, P1445, DOI 10.1111/j.1365-2958.2010.07067.x; TAM MF, 1981, J BIOL CHEM, V256, P6430; Tsuboi M, 2009, MOL CELL, V35, P502, DOI 10.1016/j.molcel.2009.06.028; Zavialov AV, 2005, MOL CELL, V18, P675, DOI 10.1016/j.molcel.2005.05.016	41	12	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80252	10.1371/journal.pone.0080252	http://dx.doi.org/10.1371/journal.pone.0080252			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260360	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200110
J	Karki, S; Surolia, R; Hock, TD; Guroji, P; Zolak, JS; Duggal, R; Ye, T; Thannickal, VJ; Antony, VB				Karki, Suman; Surolia, Ranu; Hock, Thomas David; Guroji, Purusotham; Zolak, Jason S.; Duggal, Ryan; Ye, Tong; Thannickal, Victor J.; Antony, Veena B.			Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis	FASEB JOURNAL			English	Article						mesothelial-to-mesenchymal transition; smooth muscle actin; matrix remodeling	EPITHELIAL-MESENCHYMAL TRANSITION; E-CADHERIN; TRANSCRIPTION FACTORS; GENE-EXPRESSION; LUNG INJURY; TGF-BETA; GROWTH; MIGRATION; INVASION; MORPHOGENESIS	Pleural mesothelial cells (PMCs), which are derived from the mesoderm, exhibit an extraordinary capacity to undergo phenotypic changes during development and disease. PMC transformation and trafficking has a newly defined role in idiopathic pulmonary fibrosis (IPF); however, the contribution of Wilms' tumor 1 (Wt1)-positive PMCs to the generation of pathognomonic myofibroblasts remains unclear. PMCs were obtained from IPF lung explants and healthy donor lungs that were not used for transplantation. Short hairpin Wt1-knockdown PMCs (sh Wt1) were generated with Wt1 shRNA, and morphologic and functional assays were performed in vitro. Loss of Wt1 abrogated the PMC phenotype and showed evidence of mesothelial-to-mesenchymal transition (MMT), with a reduced expression of E-cadherin and an increase in the profibrotic markers -smooth muscle actin (-SMA) and fibronectin, along with increased migration and contractility, compared with that of the control. Migration of PMCs in response to active transforming growth factor (TGF)-1 was assessed by live-cell imaging with 2-photon microscopy and 3D imaging, of Wt1-EGFP transgenic mice. Lineage-tracing experiments to map the fate of Wt1(+) PMCs in mouse lung in response to TGF-1 were also performed by using a Cre-loxP system. Our results, for the first time, demonstrate that Wt1 is necessary for the morphologic integrity of pleural membrane and that loss of Wt1 contributes to IPF via MMT of PMCs into a myofibroblast phenotype.Karki, S., Surolia, R., Hock, T. D., Guroji, P., Zolak, J. S., Duggal, R., Ye, T., Thannickal, V., J., Antony, V. B. Wilms' tumor 1 (Wt1) regulates pleural mesothelial cell plasticity and transition into myofibroblasts in idiopathic pulmonary fibrosis.	[Karki, Suman; Surolia, Ranu; Hock, Thomas David; Guroji, Purusotham; Duggal, Ryan; Thannickal, Victor J.; Antony, Veena B.] Univ Alabama Birmingham, Dept Med, Div Pulm & Crit Care, Birmingham, AL 35294 USA; [Zolak, Jason S.; Ye, Tong] Univ Alabama Birmingham, Dept Neurobiol, Birmingham, AL 35294 USA	University of Alabama System; University of Alabama Birmingham; University of Alabama System; University of Alabama Birmingham	Antony, VB (corresponding author), Univ Alabama Birmingham, Dept Med, Birmingham, AL 35294 USA.	vantony@uab.edu	Ye, Tong/ABG-8560-2021; Ye, Tong/A-8251-2010	Ye, Tong/0000-0003-1017-6969; Ye, Tong/0000-0003-1017-6969; Guroji, Purushotham/0000-0001-9331-5711	U.S. National Insitutes of Health (NIH) [P01 HL114470]; NIH [P30AR048311]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL114470] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [P30AR048311] Funding Source: NIH RePORTER	U.S. National Insitutes of Health (NIH); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by U.S. National Insitutes of Health (NIH) grant P01 HL114470. The authors thank Prof. Lucas Puzzo-Miller for help in the vibratome sectioning and live imaging of mouse lung sections and the University of Alabama School of Medicine Comprehenive Flow Cytometry Core (NIH grant P30AR048311) for help in sorting the transfected cells. The authors declare no conflicts of interest.	Antony VB, 2003, EUR RESPIR J, V21, P539, DOI 10.1183/09031936.03.00403902; ANTONY VB, 1995, AM J RESP CELL MOL, V12, P581, DOI 10.1165/ajrcmb.12.6.7766422; Arlt MJE, 2012, JOVE-J VIS EXP, DOI 10.3791/4162; Bjoraker JA, 1998, AM J RESP CRIT CARE, V157, P199, DOI 10.1164/ajrccm.157.1.9704130; Borok Z, 2009, J CLIN INVEST, V119, P7, DOI 10.1172/JCI38084; Bostrom H, 1996, CELL, V85, P863, DOI 10.1016/S0092-8674(00)81270-2; Burwell EA, 2007, ONCOGENE, V26, P3423, DOI 10.1038/sj.onc.1210127; Chapman Harold A, 2012, Proc Am Thorac Soc, V9, P89, DOI 10.1513/pats.201112-053AW; Chen HY, 1997, J CELL SCI, V110, P345; Chilosi M, 2003, AM J PATHOL, V162, P1495, DOI 10.1016/S0002-9440(10)64282-4; Come C, 2004, J MAMMARY GLAND BIOL, V9, P183, DOI 10.1023/B:JOMG.0000037161.91969.de; Cool CD, 2006, AM J RESP CRIT CARE, V174, P654, DOI 10.1164/rccm.200602-205OC; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Decologne N, 2007, J IMMUNOL, V179, P6043, DOI 10.4049/jimmunol.179.9.6043; Fransvea E, 2008, HEPATOLOGY, V47, P1557, DOI 10.1002/hep.22201; Gauldie J, 2007, BIOCHEM SOC T, V35, P661, DOI 10.1042/BST0350661; Glista-Baker EE, 2012, AM J RESP CELL MOL, V47, P552, DOI 10.1165/rcmb.2012-0023OC; Hinz Boris, 2010, F1000 Biol Rep, V2, P78, DOI 10.3410/B2-78; Hosono S, 2000, J BIOL CHEM, V275, P10943, DOI 10.1074/jbc.275.15.10943; Humphreys BD, 2010, AM J PATHOL, V176, P85, DOI 10.2353/ajpath.2010.090517; Jomgeow T, 2006, CANCER SCI, V97, P259, DOI 10.1111/j.1349-7006.2006.00169.x; Ju WJ, 2006, MOL CELL BIOL, V26, P654, DOI 10.1128/MCB.26.2.654-667.2006; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; Khalil N, 2004, CAN MED ASSOC J, V171, P153, DOI 10.1503/cmaj.1030055; Miller-Hodges E, 2012, J PATHOL, V226, P229, DOI 10.1002/path.2977; Misumi Shigeki, 2006, Proc Am Thorac Soc, V3, P307, DOI 10.1513/pats.200602-018TK; Morita T, 2007, J CELL BIOL, V179, P1027, DOI 10.1083/jcb.200708174; Mubarak KK, 2012, EUR RESPIR J, V39, P133, DOI 10.1183/09031936.00141010; Mutsaers SE, 2002, RESPIROLOGY, V7, P171, DOI 10.1046/j.1440-1843.2002.00404.x; Nakamura Y, 2003, INVEST OPHTH VIS SCI, V44, P4331, DOI 10.1167/iovs.03-0068; Nasreen N, 2009, AM J PHYSIOL-LUNG C, V297, pL115, DOI 10.1152/ajplung.90587.2008; Pace E, 2008, J IMMUNOL, V181, P7292, DOI 10.4049/jimmunol.181.10.7292; Parenti R, 2013, ACTA HISTOCHEM, V115, P70, DOI 10.1016/j.acthis.2012.04.006; Phanish MK, 2006, BIOCHEM J, V393, P601, DOI 10.1042/BJ20051106; Que JW, 2008, P NATL ACAD SCI USA, V105, P16626, DOI 10.1073/pnas.0808649105; Rock JR, 2011, P NATL ACAD SCI USA, V108, pE1475, DOI 10.1073/pnas.1117988108; Sakairi T, 2011, NEPHROL DIAL TRANSPL, V26, P2746, DOI 10.1093/ndt/gfr061; Sally ML, 2011, J CELL MOL MED, V15, P2095, DOI 10.1111/j.1582-4934.2010.01212.x; Sato M, 2003, J CLIN INVEST, V112, P1486, DOI 10.1172/JCI200319270; Scholz H, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00004; Takeichi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057829; Thornton Emily E, 2012, Curr Protoc Cytom, VChapter 12, DOI 10.1002/0471142956.cy1228s60; Thuault S, 2006, J CELL BIOL, V174, P175, DOI 10.1083/jcb.200512110; Walters Dianne M, 2008, Curr Protoc Pharmacol, VChapter 5, DOI 10.1002/0471141755.ph0546s40; Willis Brigham C, 2006, Proc Am Thorac Soc, V3, P377, DOI 10.1513/pats.200601-004TK; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927; Zhou B, 2008, NATURE, V454, P109, DOI 10.1038/nature07060; Zhou B, 2012, CIRC RES, V111, pE276, DOI 10.1161/CIRCRESAHA.112.275784; Zolak JS, 2013, AM J PATHOL, V182, P1239, DOI 10.1016/j.ajpath.2012.12.030	49	65	65	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1122	1131		10.1096/fj.13-236828	http://dx.doi.org/10.1096/fj.13-236828			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24265486	Green Published			2022-12-25	WOS:000335324800009
J	He, Y; Varadarajan, S; Munoz-Planillo, R; Burberry, A; Nakamura, Y; Nunez, G				He, Yuan; Varadarajan, Saranyaraajan; Munoz-Planillo, Raul; Burberry, Aaron; Nakamura, Yuumi; Nunez, Gabriel			3,4-Methylenedioxy-beta-nitrostyrene Inhibits NLRP3 Inflammasome Activation by Blocking Assembly of the Inflammasome	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NALP3 INFLAMMASOME; CASPASE-1 ACTIVATION; NITROSTYRENE DERIVATIVES; P2X7 RECEPTOR; CELL-DEATH; INTERLEUKIN-1-BETA; IL-1-BETA; MECHANISM; CRYSTALS; DEUBIQUITINATION	The NLRP3 inflammasome is a critical component of the innate immune system. NLRP3 activation is induced by diverse stimuli associated with bacterial infection or tissue damage, but its inappropriate activation is involved in the pathogenesis of inherited and acquired inflammatory diseases. However, the mechanism by which NLRP3 is activated remains poorly understood. In this study, we explored the role of kinases in NLRP3 inflammasome activation by screening a kinase inhibitor library and identified 3,4-methylenedioxy-beta-nitrostyrene (MNS) as an inhibitor for NLRP3 inflammasome activation. Notably, MNS did not affect the activation of the NLRC4 or AIM2 (absent in melanoma 2) inflammasome. Mechanistically, MNS specifically prevented NLRP3-mediated ASC speck formation and oligomerization without blocking potassium efflux induced by NLRP3 agonists. Surprisingly, Syk kinase, the reported target of MNS, did not mediate the inhibitory activity of MNS on NLRP3 inflammasome activation. We also found that the nitrovinyl group of MNS is essential for the inhibitory activity of MNS. Immunoprecipitation, mass spectrometry, and mutation studies suggest that both the nucleotide binding oligomerization domain and the leucine-rich repeat domain of NLRP3 were the intracellular targets of MNS. Administration of MNS also inhibited NLRP3 ATPase activity in vitro, suggesting that MNS blocks the NLRP3 inflammasome by directly targeting NLRP3 or NLRP3-associated complexes. These studies identified a novel chemical probe for studying the molecular mechanism of NLRP3 inflammasome activation which may advance the development of novel strategies to treat diseases associated with abnormal activation of NLRP3 inflammasome.	[Nunez, Gabriel] Univ Michigan, Dept Pathol, Sch Med, Ann Arbor, MI 48109 USA; Univ Michigan, Ctr Comprehens Canc, Sch Med, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Nunez, G (corresponding author), Univ Michigan, Dept Pathol, Sch Med, 1500 E Med Ctr Dr,Rm 4215 CC, Ann Arbor, MI 48109 USA.	gabriel.nunez@umich.edu	Nuñez, Gabriel/A-7160-2014; Nakamura, Yuumi/H-8459-2017	Nakamura, Yuumi/0000-0001-6256-8302; Varadarajan, Saranyaraajan/0000-0002-4473-9435	National Institutes of Health [R01AI063331, R01DK091191]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI063331] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK091191] Funding Source: NIH RePORTER; Grants-in-Aid for Scientific Research [26713038] Funding Source: KAKEN	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01AI063331 and R01DK091191.	Bauernfeind FG, 2009, J IMMUNOL, V183, P787, DOI 10.4049/jimmunol.0901363; Cassel SL, 2008, P NATL ACAD SCI USA, V105, P9035, DOI 10.1073/pnas.0803933105; Coll RC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029539; Davis BK, 2011, ANNU REV IMMUNOL, V29, P707, DOI 10.1146/annurev-immunol-031210-101405; Dinarello CA, 2009, ANNU REV IMMUNOL, V27, P519, DOI 10.1146/annurev.immunol.021908.132612; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Feldmann J, 2002, AM J HUM GENET, V71, P198, DOI 10.1086/341357; Fernandes-Alnemri T, 2007, CELL DEATH DIFFER, V14, P1590, DOI 10.1038/sj.cdd.4402194; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Franchi L, 2007, J BIOL CHEM, V282, P18810, DOI 10.1074/jbc.M610762200; Franchi L, 2012, NAT IMMUNOL, V13, P449, DOI 10.1038/ni.2263; Franchi L, 2012, NAT IMMUNOL, V13, P325, DOI 10.1038/ni.2231; Franchi L, 2006, NAT IMMUNOL, V7, P576, DOI 10.1038/ni1346; Franchi L, 2009, J IMMUNOL, V183, P792, DOI 10.4049/jimmunol.0900173; Giubellino A, 2008, J MED CHEM, V51, P7459, DOI 10.1021/jm800523u; Gong YN, 2010, CELL RES, V20, P1289, DOI 10.1038/cr.2010.135; Gross O, 2009, NATURE, V459, P433, DOI 10.1038/nature07965; Halle A, 2008, NAT IMMUNOL, V9, P857, DOI 10.1038/ni.1636; He Y, 2013, EUR J IMMUNOL, V43, P1147, DOI 10.1002/eji.201243187; He Y, 2013, J IMMUNOL, V190, P334, DOI 10.4049/jimmunol.1202737; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Hornung V, 2008, NAT IMMUNOL, V9, P847, DOI 10.1038/ni.1631; Hornung V, 2009, NATURE, V458, P514, DOI 10.1038/nature07725; Juliana C, 2012, J BIOL CHEM, V287, P36617, DOI 10.1074/jbc.M112.407130; Juliana C, 2010, J BIOL CHEM, V285, P9792, DOI 10.1074/jbc.M109.082305; Kaap S, 2003, BIOCHEM PHARMACOL, V65, P603, DOI 10.1016/S0006-2952(02)01618-0; Kahlenberg JM, 2004, AM J PHYSIOL-CELL PH, V286, pC1100, DOI 10.1152/ajpcell.00494.2003; Kim JH, 2003, MOL PHARMACOL, V63, P1117, DOI 10.1124/mol.63.5.1117; Lamkanfi M, 2009, J CELL BIOL, V187, P61, DOI 10.1083/jcb.200903124; Lopez-Castejon G, 2013, J BIOL CHEM, V288, P2721, DOI 10.1074/jbc.M112.422238; Lopez-Castejon G, 2012, EXPERT OPIN INV DRUG, V21, P995, DOI 10.1517/13543784.2012.690032; Lu B, 2012, NATURE, V488, P670, DOI 10.1038/nature11290; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinez FO, 2009, ANNU REV IMMUNOL, V27, P451, DOI 10.1146/annurev.immunol.021908.132532; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Masters SL, 2010, NAT IMMUNOL, V11, P897, DOI 10.1038/ni.1935; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Munoz-Planillo R, 2013, IMMUNITY, V38, P1142, DOI 10.1016/j.immuni.2013.05.016; Petrilli V, 2007, CELL DEATH DIFFER, V14, P1583, DOI 10.1038/sj.cdd.4402195; Py BF, 2013, MOL CELL, V49, P331, DOI 10.1016/j.molcel.2012.11.009; Qu Y, 2012, NATURE, V490, P539, DOI 10.1038/nature11429; Rathinam VAK, 2012, NAT IMMUNOL, V13, P333, DOI 10.1038/ni.2237; Schroder K, 2010, CELL, V140, P821, DOI 10.1016/j.cell.2010.01.040; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wang WY, 2007, BIOCHEM PHARMACOL, V74, P601, DOI 10.1016/j.bcp.2007.06.001; Wang WY, 2006, MOL PHARMACOL, V70, P1380, DOI 10.1124/mol.106.023986	47	161	173	2	31	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1142	1150		10.1074/jbc.M113.515080	http://dx.doi.org/10.1074/jbc.M113.515080			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265316	hybrid, Green Published			2022-12-25	WOS:000330541200045
J	Araujo, CVM; Romero-Romero, S; Lourencato, LF; Moreno-Garrido, I; Blasco, J; Gretz, MR; Moreira-Santos, M; Ribeiro, R				Araujo, Cristiano V. M.; Romero-Romero, Sonia; Lourencato, Lucio F.; Moreno-Garrido, Ignacio; Blasco, Julian; Gretz, Michael R.; Moreira-Santos, Matilde; Ribeiro, Rui			Going with the Flow: Detection of Drift in Response to Hypo-Saline Stress by the Estuarine Benthic Diatom Cylindrotheca closterium	PLOS ONE			English	Article							SEDIMENT TOXICITY TESTS; WATER MARINE HABITATS; VERTICAL MIGRATION; INVERTEBRATE DRIFT; ECOLOGICAL ROLE; SECRET GARDEN; MICROPHYTOBENTHOS; MOTILITY; GROWTH; COPPER	Avoidance response is a well-known mechanism for escaping environmental stress. For organisms with reduced active movement, such as benthic microalgae, drifting could be a specifically selected mean of avoiding less favorable environments. To test this hypothesis, a system was developed to assess if hypo-saline stress triggers drift in the estuarine benthic diatom Cylindrotheca closterium. Concurrently, the effects of salinity on growth inhibition were also investigated in order to compare the sensitivity of this endpoint with the drift response, and to estimate the immediate population decline caused by both drift and population growth responses. It was verified that the salinity value that inhibited the algal population growth by 50% (IGS(50)) was 19, while the salinity value that triggered the drift response by 50% of the population (TDS50) was 15. These results indicate that drift is an identifiable response triggered to escape stressful environments. The combination of the two responses (population growth and drift) showed that population decline based exclusively on the inhibition of population growth may result in an underestimation of the risk, compared with the decline when drifting to avoid stress is also taken into account.	[Araujo, Cristiano V. M.; Lourencato, Lucio F.; Moreira-Santos, Matilde; Ribeiro, Rui] Univ Coimbra, IMAR Inst Mar, Dept Life Sci, Coimbra, Portugal; [Romero-Romero, Sonia; Moreno-Garrido, Ignacio; Blasco, Julian] Inst Ciencias Marinas Andalucia CSIC, Cadiz, Spain; [Gretz, Michael R.] Michigan Technol Univ, Dept Biol Sci, Houghton, MI 49931 USA	Universidade de Coimbra; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Ciencias Marinas de Andalucia (ICMAN); Michigan Technological University	Araujo, CVM (corresponding author), Univ Coimbra, IMAR Inst Mar, Dept Life Sci, Coimbra, Portugal.	cristiano.araujo@icman.csic.es	Moreira-Santos, Matilde/J-2609-2013; Romero Romero, Sonia/GOP-0364-2022; Blasco, Julian/A-5319-2008; Araujo, Cristiano/H-4813-2015; Ribeiro, Rui/C-7788-2012	Moreira-Santos, Matilde/0000-0001-7067-5028; Blasco, Julian/0000-0002-9750-383X; Araujo, Cristiano/0000-0003-1793-2966; Ribeiro, Rui/0000-0002-0883-1939; Moreno-Garrido, Ignacio/0000-0003-2664-8713; Romero, Sonia/0000-0003-4683-8805	"Fundacao para a Ciencia e a Tecnologia" (FCT, Portugal) [SFRH/BPD/74044/2010, PTDC/AAC-CLI/111706/2009]; "Quadro de Referencia Estrategico Nacional" (QREN) through the European Social Fund (ESF); Spanish Ministry of Education and Science (MEC) funds	"Fundacao para a Ciencia e a Tecnologia" (FCT, Portugal)(Portuguese Foundation for Science and Technology); "Quadro de Referencia Estrategico Nacional" (QREN) through the European Social Fund (ESF); Spanish Ministry of Education and Science (MEC) funds(German Research Foundation (DFG))	This study was partially funded by the "Fundacao para a Ciencia e a Tecnologia" (FCT, Portugal) through a postdoctoral fellowship (reference SFRH/BPD/74044/2010) to C.V.M. Araujo, through the SALTFREE project (contract PTDC/AAC-CLI/111706/2009) and through "Ciencia 2007 - Human Potential Operational Program" (POPH) and "Quadro de Referencia Estrategico Nacional" (QREN) through the European Social Fund (ESF) and the Spanish Ministry of Education and Science (MEC) funds. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apoya-Horton MD, 2006, J PHYCOL, V42, P379, DOI 10.1111/j.1529-8817.2006.00194.x; Araujo CVM, 2014, AQUAT TOXICOL, V146, P70, DOI 10.1016/j.aquatox.2013.10.030; Araujo CVM, 2010, ENVIRON INT, V36, P637, DOI 10.1016/j.envint.2010.04.017; Araujo CVM, 2010, SCI TOTAL ENVIRON, V408, P822, DOI 10.1016/j.scitotenv.2009.10.018; Araujo CVM, 2009, ENVIRON INT, V35, P831, DOI 10.1016/j.envint.2009.02.003; Beketov MA, 2008, ARCH ENVIRON CON TOX, V55, P247, DOI 10.1007/s00244-007-9104-3; BRITTAIN JE, 1988, HYDROBIOLOGIA, V166, P77, DOI 10.1007/BF00017485; Cardoso PG, 2008, MAR POLLUT BULL, V56, P483, DOI 10.1016/j.marpolbul.2007.11.006; Clavero E, 2000, J PHYCOL, V36, P1021, DOI 10.1046/j.1529-8817.2000.99177.x; Cohn SA, 2004, DIATOM RES, V19, P167; Cohn SA, 2003, DIATOM RES, V18, P225; Cohn SA, 2000, DIATOM RES, V15, P19; Dickman Chris R., 2006, P1; DRUM RW, 1966, PROTOPLASMA, V62, P1, DOI 10.1007/BF01254629; Du Guo Ying, 2010, Algae, V25, P133, DOI 10.4490/algae.2010.25.3.133; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; FLECKER AS, 1992, ECOLOGY, V73, P438, DOI 10.2307/1940751; GUILLARD RR, 1962, CAN J MICROBIOL, V8, P229, DOI 10.1139/m62-029; Hader DP, 1997, J PHOTOCH PHOTOBIO B, V40, P23, DOI 10.1016/S1011-1344(97)00028-6; Harvey EL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046438; Hose GC, 2002, ECOTOX ENVIRON SAFE, V51, P44, DOI 10.1006/eesa.2001.2127; ISO, 1989, 8692 ISO; Kingston MB, 2002, J PHYCOL, V38, P872, DOI 10.1046/j.1529-8817.2002.t01-1-01197.x; Larras F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044458; Lauridsen RB, 2005, ENVIRON TOXICOL, V20, P513, DOI 10.1002/tox.20140; Liu GX, 2011, J ENVIRON SCI-CHINA, V23, P330, DOI 10.1016/S1001-0742(10)60410-X; Lopes I, 2004, ENVIRON TOXICOL CHEM, V23, P1702, DOI 10.1897/03-231; MacIntyre HL, 1996, ESTUARIES, V19, P186, DOI 10.2307/1352224; Mauffret A, 2010, ECOTOX ENVIRON SAFE, V73, P262, DOI 10.1016/j.ecoenv.2009.12.001; McLachlan DH, 2009, J PHYCOL, V45, P592, DOI 10.1111/j.1529-8817.2009.00681.x; Miller DC, 1996, ESTUARIES, V19, P202, DOI 10.2307/1352225; Moreira-Santos M, 2008, ENVIRON TOXICOL CHEM, V27, P1576, DOI 10.1897/07-094; Moreno-Garrido I, 2003, ECOTOX ENVIRON SAFE, V54, P290, DOI 10.1016/S0147-6513(02)00077-5; Moreno-Garrido I, 2009, OCEANOGRAPHY OCEAN E, P1; Moreno-Garrido I, 2007, ESTUAR COAST SHELF S, V71, P278, DOI 10.1016/j.ecss.2006.08.003; OECD (Organization for Economic Co-operation and Development), 1998, FISH SHORT TERM TOX; Ribeiro R, 2013, ECOTOXICOLOGY, V22, P889, DOI 10.1007/s10646-013-1070-0; Rosa R, 2008, B ENVIRON CONTAM TOX, V81, P464, DOI 10.1007/s00128-008-9538-y; Rosa R, 2012, ENVIRON TOXICOL CHEM, V31, P1301, DOI 10.1002/etc.1813; Sakuma M, 1998, APPL ENTOMOL ZOOL, V33, P339, DOI 10.1303/aez.33.339; Sauer J, 2002, DIATOM RES, V17, P189; STAUBER JL, 1985, AQUAT TOXICOL, V6, P297, DOI 10.1016/0166-445X(85)90025-6; Torres MA, 2008, ECOTOX ENVIRON SAFE, V71, P1, DOI 10.1016/j.ecoenv.2008.05.009; Underwood GJC, 1998, EUR J PHYCOL, V33, P173, DOI 10.1017/S0967026298001565; Underwood GJC, 2000, EUR J PHYCOL, V35, P173, DOI 10.1080/09670260010001735761; USEPA, 2002, EPA600489001	46	7	7	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81073	10.1371/journal.pone.0081073	http://dx.doi.org/10.1371/journal.pone.0081073			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260535	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900112
J	Wang, DY; Zhu, WJ; Li, JM; An, CY; Wang, ZL				Wang, Dongyu; Zhu, Wenjing; Li, Jieming; An, Chongyou; Wang, Zilian			Serum Concentrations of Fibroblast Growth Factors 19 and 21 in Women with Gestational Diabetes Mellitus: Association with Insulin Resistance, Adiponectin, and Polycystic Ovary Syndrome History	PLOS ONE			English	Article							FASTING PLASMA-GLUCOSE; BETA-CELL FUNCTION; METABOLIC SYNDROME; ADIPOSE-TISSUE; RISK; FIBROBLAST-GROWTH-FACTOR-19; FGF19; EXPRESSION; PREDICTOR; PREGNANCY	Background: Fibroblast growth factor 19 (FGF19) and FGF21 are considered to be novel adipokines that improve glucose tolerance and insulin sensitivity. In the current study, we investigated serum FGF19 and FGF21 levels in patients with gestational diabetes mellitus (GDM) and explored their relationships with anthropometric and endocrine parameters. Method: Serum FGF19 and FGF21 levels were determined by enzyme-linked immunosorbent assay (ELISA) in patients with GDM (n = 30) and healthy pregnant controls (n = 60) matched for maternal and gestational age. Serum FGF19 and FGF21 levels were correlated with anthropometric, metabolic, and endocrine parameters. Results: Circulating levels of FGF19 were significantly reduced in patients with GDM relative to healthy pregnant subjects, whereas FGF21 levels were increased in GDM patients. Serum FGF19 levels independently and inversely correlated with insulin resistance (increased homeostasis model assessment of insulin resistance, HOMA-IR) and were positively related to serum adiponectin in both groups. In contrast, serum FGF21 levels independently and positively correlated with insulin resistance and serum triglycerides and were inversely related to serum adiponectin. In addition, in the combined population of both groups, those women with preconception polycystic ovary syndrome (PCOS) history had the lowest levels of FGF19, which were significantly lower than those in GDM patients without PCOS history and those in controls without PCOS history. Conclusions: Circulating FGF19 levels are reduced in GDM patients, in contrast with FGF21 levels. Both serum FGF19 and FGF21 levels are strongly related to insulin resistance and serum levels of adiponectin. Considering the different situation between FGF19 and FGF21, we suggest that reduced serum FGF19 levels could be involved in the pathophysiology of GDM, while increased serum FGF21 levels could be in a compensatory response to this disease.	[Wang, Dongyu; Zhu, Wenjing; Li, Jieming; An, Chongyou; Wang, Zilian] Sun Yat Sen Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China	Sun Yat Sen University	Wang, ZL (corresponding author), Sun Yat Sen Univ, Dept Obstet & Gynecol, Affiliated Hosp 1, Guangzhou 510275, Guangdong, Peoples R China.	wangzilian2013@gmail.com		Wang, Zilian/0000-0002-8902-8215				Adams AC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038438; Angelin B, 2012, CELL METAB, V16, P693, DOI 10.1016/j.cmet.2012.11.001; Barnes-Powell LL, 2007, NEONATAL NETW, V26, P283, DOI 10.1891/0730-0832.26.5.283; Barutcuoglu B, 2011, ANN CLIN LAB SCI, V41, P390; Bellamy L, 2009, LANCET, V373, P1773, DOI 10.1016/S0140-6736(09)60731-5; Bergmann K, 2013, CLIN CHEM LAB MED, V51, P177, DOI 10.1515/cclm-2012-0490; Bo S, 2007, ATHEROSCLEROSIS, V194, pE72, DOI 10.1016/j.atherosclerosis.2006.09.017; Bobbert T, 2013, DIABETES CARE, V36, P145, DOI 10.2337/dc12-0703; Boomsma CM, 2006, HUM REPROD UPDATE, V12, P673, DOI 10.1093/humupd/dml036; CHANG RJ, 1983, J CLIN ENDOCR METAB, V57, P356, DOI 10.1210/jcem-57-2-356; Chen C, 2011, DIABETES CARE, V34, P2113, DOI 10.2337/dc11-0294; Damm P, 2009, INT J GYNECOL OBSTET, V104, pS25, DOI 10.1016/j.ijgo.2008.11.025; Dostalova I, 2008, J CLIN ENDOCR METAB, V93, P3627, DOI 10.1210/jc.2008-0746; Fauser BCJM, 2004, HUM REPROD, V19, P41, DOI 10.1093/humrep/deh098; Fisher FM, 2011, ENDOCRINOLOGY, V152, P2996, DOI 10.1210/en.2011-0281; Fu L, 2004, ENDOCRINOLOGY, V145, P2594, DOI 10.1210/en.2003-1671; Gallego-Escuredo JM, 2012, JAIDS-J ACQ IMM DEF, V61, P527, DOI 10.1097/QAI.0b013e318271c2c7; Kharitonenkov A, 2007, ENDOCRINOLOGY, V148, P774, DOI 10.1210/en.2006-1168; Kir S, 2011, SCIENCE, V331, P1621, DOI 10.1126/science.1198363; Kirwan JP, 2002, DIABETES, V51, P2207, DOI 10.2337/diabetes.51.7.2207; Krzyzanowska K, 2008, DIABETOLOGIA, V51, P1115, DOI 10.1007/s00125-008-1009-9; Lain KY, 2008, CLIN ENDOCRINOL, V69, P407, DOI 10.1111/j.1365-2265.2008.03198.x; Lewandowski KC, 2007, DIABETOLOGIA, V50, P1033, DOI 10.1007/s00125-007-0610-7; Lundasen T, 2006, J INTERN MED, V260, P530, DOI 10.1111/j.1365-2796.2006.01731.x; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Metzger BE, 2009, DIABETES, V58, P453, DOI 10.2337/db08-1112; Mraz M, 2011, PHYSIOL RES, V60, P627, DOI 10.33549/physiolres.932099; Mraz M, 2009, CLIN ENDOCRINOL, V71, P369, DOI 10.1111/j.1365-2265.2008.03502.x; Potthoff MJ, 2012, GENE DEV, V26, P312, DOI 10.1101/gad.184788.111; Qiu CF, 2004, OBSTET GYNECOL, V103, P519, DOI 10.1097/01.AOG.0000113621.53602.7a; Reiche M, 2010, HORM METAB RES, V42, P178, DOI 10.1055/s-0029-1243249; Retnakaran R, 2005, DIABETOLOGIA, V48, P993, DOI 10.1007/s00125-005-1710-x; Schreuder TCMA, 2010, AM J PHYSIOL-GASTR L, V298, pG440, DOI 10.1152/ajpgi.00322.2009; Shin DJ, 2009, J BIOL CHEM, V284, P11110, DOI 10.1074/jbc.M808747200; Stein S, 2010, METABOLISM, V59, P33, DOI 10.1016/j.metabol.2009.07.003; Stejskal D, 2008, SCAND J CLIN LAB INV, V68, P501, DOI 10.1080/00365510701854967; Tomlinson E, 2002, ENDOCRINOLOGY, V143, P1741, DOI 10.1210/en.143.5.1741; Toulis KA, 2009, HUM REPROD UPDATE, V15, P297, DOI 10.1093/humupd/dmp006; Wente W, 2006, DIABETES, V55, P2470, DOI 10.2337/db05-1435; Yang HX, 2012, CHINESE MED J-PEKING, V125, P1212, DOI 10.3760/cma.j.issn.0366-6999.2012.07.004; Zhang X, 2008, DIABETES, V57, P1246, DOI 10.2337/db07-1476; Zhu WW, 2013, DIABETES CARE, V36, P2038, DOI 10.2337/dc12-2465	42	42	50	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81190	10.1371/journal.pone.0081190	http://dx.doi.org/10.1371/journal.pone.0081190			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260557	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900125
J	Zhang, QW; Deng, XX; Sun, X; Xu, JX; Sun, FY				Zhang, Qiu-Wan; Deng, Xu-Xu; Sun, Xiao; Xu, Jin-Xiu; Sun, Feng-Yan			Exercise Promotes Axon Regeneration of Newborn Striatonigral and Corticonigral Projection Neurons in Rats after Ischemic Stroke	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; CEREBRAL-ARTERY OCCLUSION; NEURAL STEM-CELLS; NEUROTROPHIC FACTOR; SUBSTANTIA-NIGRA; INDUCED NEUROGENESIS; NOGO-A; STIMULATES NEUROGENESIS; HIPPOCAMPAL-NEURONS; HUMAN BRAIN	Newborn striatal neurons induced by middle cerebral artery occlusion (MCAO) can form functional projections targeting into the substantia nigra, which should be very important for the recovery of motor function. Exercise training post-stroke improves motor recovery in clinic patients and increases striatal neurogenesis in experimental animals. This study aimed to investigate the effects of exercise on axon regeneration of newborn projection neurons in adult rat brains following ischemic stroke. Rats were subjected to a transient MCAO to induce focal cerebral ischemic injury, followed by 30 minutes of exercise training daily from 5 to 28 days after MCAO. Motor function was tested using the rotarod test. We used fluorogold (FG) nigral injection to trace striatonigral and corticonigral projection neurons, and green fluorescent protein (GFP)targeting retroviral vectors combined with FG double labeling (GFP(+) -FG(+)) to detect newborn projection neurons. The results showed that exercise improved the recovery of motor function of rats after MCAO. Meanwhile, exercise also increased the levels of BDNF and VEGF, and reduced Nogo-A in ischemic brain. On this condition, we further found that exercise significantly increased the number of GFP(+) -FG(+) neurons in the striatum and frontal and parietal cortex ipsilateral to MCAO, suggesting an increase of newborn striatonigral and corticonigral projection neurons by exercise post-stroke. In addition, we found that exercise also increased NeuN(+) and FG(+) cells in the striatum and frontal and parietal cortex, the ischemic territory, and tyrosine hydroxylase (TH) immunopositive staining cells in the substantia nigra, a region remote from the ischemic territory. Our results provide the first evidence that exercise can effectively enhance the capacity for regeneration of newborn projection neurons in ischemic injured mammalian brains while improving motor function. Our results provide a very important cellular mechanism to illustrate the effectiveness of rehabilitative treatment post-stroke in the clinic.	[Zhang, Qiu-Wan; Sun, Xiao; Sun, Feng-Yan] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Sch Basic Med Sci,Dept Neurobiol, Shanghai 200433, Peoples R China; [Zhang, Qiu-Wan; Sun, Xiao; Sun, Feng-Yan] Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Inst Stem Cell & Regenerat Med, Shanghai 200433, Peoples R China; [Zhang, Qiu-Wan; Deng, Xu-Xu; Sun, Xiao; Xu, Jin-Xiu; Sun, Feng-Yan] Fudan Univ, State Key Lab Med Neurobiol, Shanghai 200433, Peoples R China; [Sun, Feng-Yan] Shanghai Key Lab Clin Geriatr Med, Shanghai, Peoples R China	Fudan University; Fudan University; Fudan University	Sun, FY (corresponding author), Fudan Univ, Shanghai Med Coll, Inst Biomed Sci, Sch Basic Med Sci,Dept Neurobiol, Shanghai 200433, Peoples R China.	fysun@fudan.edu.cn			National Nature Science Foundation of China [81030020, 30770660]; National Basic Research Program of China [2006 CB943702]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China)	This work was supported by grants from National Nature Science Foundation of China (81030020 and 30770660), and National Basic Research Program of China (2006 CB943702). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral D.G., 2000, PRINCIPLES NEURAL SC, V4, P317; Arvidsson A, 2002, NAT MED, V8, P963, DOI 10.1038/nm747; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Chen JL, 2001, STROKE, V32, P2682, DOI 10.1161/hs1101.098367; Cho HY, 2012, CLIN REHABIL; Chytrova G, 2008, EUR J NEUROSCI, V27, P1, DOI 10.1111/j.1460-9568.2007.05982.x; Darsalia V, 2005, STROKE, V36, P1790, DOI 10.1161/01.STR.0000173151.36031.be; Ding Q, 2011, NEUROSCIENCE, V192, P773, DOI 10.1016/j.neuroscience.2011.06.032; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; GrandPre T, 2000, NATURE, V403, P439, DOI 10.1038/35000226; Guo JJ, 2012, NEUROSCI BULL, V28, P669, DOI 10.1007/s12264-012-1288-5; Haines DE, 1995, NEUROANATOMY ATLAS S, P134; Hou SW, 2008, STROKE, V39, P2837, DOI 10.1161/STROKEAHA.107.510982; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jin KL, 2006, P NATL ACAD SCI USA, V103, P13198, DOI 10.1073/pnas.0603512103; Kilic E, 2010, J CEREBR BLOOD F MET, V30, P969, DOI 10.1038/jcbfm.2009.268; Kuge A, 2009, NEUROL RES, V31, P969, DOI 10.1179/174313209X383312; Leasure JL, 2010, EXP NEUROL, V226, P58, DOI 10.1016/j.expneurol.2010.08.003; Lichtenwalner RJ, 2006, J CEREBR BLOOD F MET, V26, P1, DOI 10.1038/sj.jcbfm.9600170; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; Luo CX, 2007, J NEUROSCI RES, V85, P1637, DOI 10.1002/jnr.21317; Ma YY, 2009, J NEUROSCI RES, V87, P393, DOI 10.1002/jnr.21859; Macas J, 2006, J NEUROSCI, V26, P13114, DOI 10.1523/JNEUROSCI.4667-06.2006; MacLellan CL, 2011, NEUROREHAB NEURAL RE, V25, P740, DOI 10.1177/1545968311407517; Mallet N, 2006, J NEUROSCI, V26, P3875, DOI 10.1523/JNEUROSCI.4439-05.2006; Martin AB, 2008, NEUROPSYCHOPHARMACOL, V33, P1667, DOI 10.1038/sj.npp.1301558; Metrot J, 2012, NEUROREHABIL NEURAL; Minger SL, 2007, REGEN MED, V2, P69, DOI 10.2217/17460751.2.1.69; Mink J. W., 1999, FUNDAMENTAL NEUROSCI, P951; NAKANE M, 1992, STROKE, V23, P328, DOI 10.1161/01.STR.23.3.328; NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9; Ploughman M, 2009, STROKE, V40, P1490, DOI 10.1161/STROKEAHA.108.531806; Qiu MH, 2003, J NEUROCHEM, V87, P1509, DOI 10.1046/j.1471-4159.2003.02110.x; Schabitz WR, 2007, STROKE, V38, P2165, DOI 10.1161/STROKEAHA.106.477331; Speisman RB, 2012, BRAIN BEHAV IMMUN; Sun FY, 2005, J NEUROSCI RES, V79, P180, DOI 10.1002/jnr.20321; Sun X, 2012, NEUROBIOL DIS, V45, P601, DOI 10.1016/j.nbd.2011.09.018; TAMURA A, 1990, BRAIN RES, V510, P154, DOI 10.1016/0006-8993(90)90744-V; Thompson LH, 2009, EUR J NEUROSCI, V30, P625, DOI 10.1111/j.1460-9568.2009.06878.x; Trushina E, 2004, MOL CELL BIOL, V24, P8195, DOI 10.1128/MCB.24.18.8195-8209.2004; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Wan YQ, 2007, J NEUROSCI RES, V85, P73, DOI 10.1002/jnr.21091; Wang YQ, 2009, NEUROCHEM INT, V55, P629, DOI 10.1016/j.neuint.2009.06.007; Weinmann O, 2006, MOL CELL NEUROSCI, V32, P161, DOI 10.1016/j.mcn.2006.03.007; Wild AR, 2013, NEUROPHARMACOLOGY, V73, P138, DOI 10.1016/j.neuropharm.2013.05.013; Xu JY, 2003, NEUROSCIENCE, V118, P59, DOI 10.1016/S0306-4522(02)00948-X; Yang SZ, 2010, ADULT NEUROGENESIS C, P91; Yang YR, 2003, CAN J NEUROL SCI, V30, P252, DOI 10.1017/S0317167100002687; Yang ZJ, 2002, J NEUROSCI RES, V70, P140, DOI 10.1002/jnr.10380; Zhang F, 2011, NEUROSCIENCE, V177, P170, DOI 10.1016/j.neuroscience.2011.01.018; Zhang R, 2006, NEUROBIOL DIS, V24, P345, DOI 10.1016/j.nbd.2006.07.012; Zhu JM, 2011, J INT MED RES, V39, P488, DOI 10.1177/147323001103900216	52	35	39	2	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80139	10.1371/journal.pone.0080139	http://dx.doi.org/10.1371/journal.pone.0080139			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260348	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900058
J	Ladbury, GAF; Gavana, M; Danis, K; Papa, A; Papamichail, D; Mourelatos, S; Gewehr, S; Theocharopoulos, G; Bonovas, S; Benos, A; Panagiotopoulos, T				Ladbury, Georgia A. F.; Gavana, Magda; Danis, Kostas; Papa, Anna; Papamichail, Dimitris; Mourelatos, Spiros; Gewehr, Sandra; Theocharopoulos, George; Bonovas, Stefanos; Benos, Alexis; Panagiotopoulos, Takis			Population Seroprevalence Study after a West Nile Virus Lineage 2 Epidemic, Greece, 2010	PLOS ONE			English	Article							BLOOD-DONOR; ENCEPHALITIS; ANTIBODIES; STRAINS; HUMANS; FEVER	Introduction: During summer 2010, 262 human cases including 35 deaths from West Nile virus (WNV) infection were reported from Central Macedonia, Greece. Evidence from mosquitoes, birds and blood donors demonstrated that the epidemic was caused by WNV lineage 2, which until recently was considered of low virulence. We conducted a household seroprevalence study to estimate the spread of infection in the population during the epidemic, ascertain the relationship of infection to clinical disease, and identify risk factors for infection. Methods: We used a two-stage cluster design to select a random sample of residents aged >= 18 years in the outbreak epicentre. We collected demographic, medical, and risk factor data using standard questionnaires and environmental checklists, and tested serum samples for presence of WNV IgG and IgM antibodies using ELISA. Results: Overall, 723 individuals participated in the study, and 644 blood samples were available. Weighted seropositivity for IgG antibodies was 5.8% (95% CI: 3.8-8.6; n=41). We estimated that about 1 in 130 (1: 141 to 1: 124) infected individuals developed WNV neuroinvasive disease, and approximately 18% had clinical manifestations attributable to their infection. Risk factors for infection reflected high exposure to mosquitoes; rural residents were particularly at risk (prevalence ratio: 8.2, 95% CI: 1.1-58.7). Discussion: This study adds to the evidence that WNV lineage 2 strains can cause significant illness, demonstrating ratios of infection to clinical disease similar to those found previously for WNV lineage 1.	[Ladbury, Georgia A. F.] European Ctr Dis Prevent & Control ECDC, EPIET, Stockholm, Sweden; [Ladbury, Georgia A. F.] Dutch Natl Inst Publ Hlth & Environm RIVM, Bilthoven, Netherlands; [Gavana, Magda; Papa, Anna; Benos, Alexis] Aristotle Univ Thessaloniki, GR-54006 Thessaloniki, Greece; [Danis, Kostas; Theocharopoulos, George; Bonovas, Stefanos] Hellen Ctr Dis Control & Prevent KEELPNO, Athens, Greece; [Danis, Kostas; Papamichail, Dimitris; Panagiotopoulos, Takis] Natl Sch Publ Hlth, Athens, Greece; [Mourelatos, Spiros; Gewehr, Sandra] Ecodevelopment SA, Thessaloniki, Greece	European Centre for Disease Prevention & Control; Netherlands National Institute for Public Health & the Environment; Aristotle University of Thessaloniki; National & Kapodistrian University of Athens	Danis, K (corresponding author), Hellen Ctr Dis Control & Prevent KEELPNO, Athens, Greece.	daniscostas@gmail.com	Danis, Kostas/ABD-7357-2020; Bonovas, Stefanos/H-5653-2011; Gavana, Magda/ABE-7184-2020; Bonovas, Stefanos/GZG-4609-2022; Benos, Alexis/ABA-5812-2021	Bonovas, Stefanos/0000-0001-6102-6579; Mourelatos, Spiros/0000-0001-9276-0135; Benos, Alexis/0000-0002-5397-9385; Gewehr, Sandra/0000-0001-5236-9537; Ladbury, Georgia/0000-0003-3489-9571	Hellenic Centre for Disease Control and Prevention, Athens, Greece	Hellenic Centre for Disease Control and Prevention, Athens, Greece	This work was financed by the Hellenic Centre for Disease Control and Prevention, Athens, Greece. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman DG, 2003, BMJ-BRIT MED J, V326, P219, DOI 10.1136/bmj.326.7382.219; Antoniadis A., 1990, Archives of Virology, Supplementum, P277; Bakonyi T, 2006, EMERG INFECT DIS, V12, P618; Botha EM, 2008, EMERG INFECT DIS, V14, P222, DOI 10.3201/eid1402.070457; Brault AC, 2007, NAT GENET, V39, P1162, DOI 10.1038/ng2097; Centers for Disease Control and Prevention (CDC), 2001, MMWR Morb Mortal Wkly Rep, V50, P37; Chaintoutis SC, 2013, EMERG INFECT DIS, V19, P827, DOI 10.3201/eid1905.121418; Chaskopoulou A., 2011, EURO SURVEILL, V16; Chowers MY, 2005, EUR J CLIN MICROBIOL, V24, P851, DOI 10.1007/s10096-005-0061-3; Danis K, 2011, EUROSURVEILLANCE, V16; Danis K, 2011, EMERG INFECT DIS, V17, P1868, DOI 10.3201/eid1710.110525; Dimou V, 2013, VECTOR BORN IN PRESS, V13; Hellenic Centre for Disease Control and Prevention, 2012, WEEKLY EPIDEMIO 0928; Lanciotti RS, 2002, VIROLOGY, V298, P96, DOI 10.1006/viro.2002.1449; Mandalakas AM, 2005, EMERG INFECT DIS, V11, P1774, DOI 10.3201/eid1111.040933; Moro ML, 2010, AM J TROP MED HYG, V82, P508, DOI 10.4269/ajtmh.2010.09-0322; Mostashari F, 2001, LANCET, V358, P261, DOI 10.1016/S0140-6736(01)05480-0; National Statistical Service of Greece, 2007, POP HOUS CENS MARCH, VII; National Statistical Service of Greece, 2003, FACT POP GREEC POP H; Papa A, 2013, VECTOR BORN IN PRESS, V13; Papa A, 2013, PARASITOL RES, V112, P1551, DOI 10.1007/s00436-013-3302-x; Papa A, 2012, EMERG INFECT DIS, V18, P688, DOI 10.3201/eid1804.110771; Papa A, 2011, J MED VIROL, V83, P1861, DOI 10.1002/jmv.22180; Papa A, 2011, J MED VIROL, V83, P1857, DOI 10.1002/jmv.22190; Papa A, 2011, EMERG INFECT DIS, V17, P920, DOI 10.3201/eid1705.101759; Papa A, 2010, VECTOR-BORNE ZOONOT, V10, P655, DOI 10.1089/vbz.2010.0042; Pavlidou V, 2008, VECTOR-BORNE ZOONOT, V8, P351, DOI 10.1089/vbz.2007.0215; Petersen LR, 2008, MED CLIN N AM, V92, P1307, DOI 10.1016/j.mcna.2008.07.004; PEZZOTTI P, 2009, EURO SURVEILL, V16; Platonov AE, 2011, ZH MIKROBIOL EPIDEMI, V2, P29; Sirbu A, 2011, EUROSURVEILLANCE, V16, P2; Soliman Atef, 2010, J Infect Public Health, V3, P54, DOI 10.1016/j.jiph.2009.11.002; Tsai TF, 1998, LANCET, V352, P767, DOI 10.1016/S0140-6736(98)03538-7; Valiakos G, 2011, EUROSURVEILLANCE, V16, P5; Venter M, 2010, VECTOR-BORNE ZOONOT, V10, P659, DOI 10.1089/vbz.2009.0230; Z alidis C.G., 1994, INVENTORY GREEK WETL; Zou SMA, 2010, J INFECT DIS, V202, P1354, DOI 10.1086/656602	37	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80432	10.1371/journal.pone.0080432	http://dx.doi.org/10.1371/journal.pone.0080432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260390	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500138
J	Nho, SW; Hikima, J; Park, SB; Jang, HB; Cha, IS; Yasuike, M; Nakamura, Y; Fujiwara, A; Sano, M; Kanai, K; Kondo, H; Hirono, I; Takeyama, H; Aoki, T; Jung, TS				Nho, Seong-Won; Hikima, Jun-ichi; Park, Seong Bin; Jang, Ho Bin; Cha, In Seok; Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atsushi; Sano, Motohiko; Kanai, Kinya; Kondo, Hidehiro; Hirono, Ikuo; Takeyama, Haruko; Aoki, Takashi; Jung, Tae-Sung			Comparative Genomic Characterization of Three Streptococcus parauberis Strains in Fish Pathogen, as Assessed by Wide-Genome Analyses	PLOS ONE			English	Article							PHOSPHOTRANSFERASE SYSTEM; CATABOLITE REPRESSION; METABOLISM; VIRULENCE; LACTOSE; PROTEIN; SEQUENCE; GENE; TRANSPORT; FLOUNDER	Streptococcus parauberis, which is the main causative agent of streptococcosis among olive flounder (Paralichthys olivaceus) in northeast Asia, can be distinctly divided into two groups (type I and type II) by an agglutination test. Here, the whole genome sequences of two Japanese strains (KRS-02083 and KRS-02109) were determined and compared with the previously determined genome of a Korean strain (KCTC 11537). The genomes of S. parauberis are intermediate in size and have lower GC contents than those of other streptococci. We annotated 2,236 and 2,048 genes in KRS-02083 and KRS-02109, respectively. Our results revealed that the three S. parauberis strains contain different genomic insertions and deletions. In particular, the genomes of Korean and Japanese strains encode different factors for sugar utilization; the former encodes the phosphotransferase system (PTS) for sorbose, whereas the latter encodes proteins for lactose hydrolysis, respectively. And the KRS-02109 strain, specifically, was the type II strain found to be able to resist phage infection through the clustered regularly interspaced short palindromic repeats (CRISPR)/Cas system and which might contribute valuably to serologically distribution. Thus, our genome-wide association study shows that polymorphisms can affect pathogen responses, providing insight into biological/biochemical pathways and phylogenetic diversity.	[Nho, Seong-Won; Park, Seong Bin; Jang, Ho Bin; Cha, In Seok; Aoki, Takashi; Jung, Tae-Sung] Gyeongsang Natl Univ, Coll Vet Med, Jinju, Gyeongnam, South Korea; [Hikima, Jun-ichi] Miyazaki Univ, Fac Agr, Dept Biochem & Appl Biosci, Miyazaki 88921, Japan; [Yasuike, Motoshige; Nakamura, Yoji; Fujiwara, Atsushi; Sano, Motohiko] Fisheries Res Agcy, Natl Res Inst Fisheries Sci, Yokohama, Kanagawa, Japan; [Kanai, Kinya] Nagasaki Univ, Fac Fisheries, Nagasaki 852, Japan; [Kondo, Hidehiro; Hirono, Ikuo] Tokyo Univ Marine Sci & Technol, Lab Genome Sci, Minato Ku, Tokyo, Japan; [Takeyama, Haruko] Waseda Univ, Dept Life Sci & Med Biosci, Shinjuku Ku, Tokyo, Japan; [Aoki, Takashi] Waseda Univ, Consolidated Res Inst Adv Sci & Med Care, Shinjuku Ku, Tokyo, Japan	Gyeongsang National University; University of Miyazaki; Japan Fisheries Research & Education Agency (FRA); Nagasaki University; Tokyo University of Marine Science & Technology; Waseda University; Waseda University	Aoki, T (corresponding author), Gyeongsang Natl Univ, Coll Vet Med, Jinju, Gyeongnam, South Korea.	aokitaka@aoni.waseda.jp; jungts@gnu.ac.kr	Hirono, Ikuo/O-1940-2014; Chen, Jianmeng/G-2001-2011; Jung, Tae Sung/G-8245-2017; Hikima, Jun-ichi/AAI-6983-2020; Kondo, Hidehiro/O-1954-2014	Jung, Tae Sung/0000-0001-6028-0946; Hikima, Jun-ichi/0000-0002-4184-7422; Kondo, Hidehiro/0000-0001-5102-6831; Jang, Ho Bin/0000-0003-1316-316X; Hirono, Ikuo/0000-0002-2355-3121	World Class University Program [R32-10253]; Korean Ministry of Education, Science, and Technology (Republic of Korea)	World Class University Program; Korean Ministry of Education, Science, and Technology (Republic of Korea)(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was supported by a grant from the World Class University Program (R32-10253), funded by the Korean Ministry of Education, Science, and Technology (Republic of Korea). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abranches J, 2008, J BACTERIOL, V190, P2340, DOI 10.1128/JB.01237-07; Alikhan NF, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-402; AOKI T, 1990, DIS AQUAT ORGAN, V8, P171, DOI 10.3354/dao008171; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; BRENNAN RG, 1989, J BIOL CHEM, V264, P1903; Brosch R, 2000, INT J MED MICROBIOL, V290, P143; Browngardt CM, 2004, FEMS MICROBIOL LETT, V240, P75, DOI 10.1016/j.femsle.2004.09.012; Chenna R, 2003, NUCLEIC ACIDS RES, V31, P3497, DOI 10.1093/nar/gkg500; CRICHTON PB, 1982, J MED MICROBIOL, V15, P233, DOI 10.1099/00222615-15-2-233; DEUTSCHER J, 1983, P NATL ACAD SCI-BIOL, V80, P6790, DOI 10.1073/pnas.80.22.6790; DEUTSCHER J, 1995, MOL MICROBIOL, V15, P1049, DOI 10.1111/j.1365-2958.1995.tb02280.x; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; DEVOS WM, 1990, J BIOL CHEM, V265, P22554; Dobrindt U, 2001, CURR OPIN MICROBIOL, V4, P550, DOI 10.1016/S1369-5274(00)00250-2; Domenech A, 1996, J FISH DIS, V19, P33, DOI 10.1111/j.1365-2761.1996.tb00117.x; ELDAR A, 1995, INT J SYST BACTERIOL, V45, P840, DOI 10.1099/00207713-45-4-840; Garcia-Vallve S, 2002, TRENDS MICROBIOL, V10, P445, DOI 10.1016/S0966-842X(02)02446-0; Garzetti D, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-467; Ghittino P., 1992, B SOC IT PATOL ITTIC, V8, P4; Gorke B, 2008, NAT REV MICROBIOL, V6, P613, DOI 10.1038/nrmicro1932; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; HAMILTON IR, 1978, J BACTERIOL, V136, P900, DOI 10.1128/JB.136.3.900-908.1978; Harmon-Smith M, 2010, STAND GENOMIC SCI, V2, P220, DOI 10.4056/sigs.811799; Hernandez D, 2008, GENOME RES, V18, P802, DOI 10.1101/gr.072033.107; Holden MTG, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000346; HUECK CJ, 1995, MOL MICROBIOL, V15, P395, DOI 10.1111/j.1365-2958.1995.tb02252.x; Iguchi A, 2008, MICROBIOL-SGM, V154, P559, DOI 10.1099/mic.0.2007/013334-0; Iyer R, 2005, J BACTERIOL, V187, P8340, DOI 10.1128/JB.187.24.8340-8349.2005; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; Kanai K, 2009, FISH PATHOL, V44, P33, DOI 10.3147/jsfp.44.33; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Makarova KS, 2011, NAT REV MICROBIOL, V9, P467, DOI 10.1038/nrmicro2577; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Marion C, 2012, INFECT IMMUN, V80, P1390, DOI 10.1128/IAI.05756-11; Maruyama F, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-358; Nho SW, 2011, J BACTERIOL, V193, P3356, DOI 10.1128/JB.00182-11; Nho SW, 2009, FEMS MICROBIOL LETT, V293, P20, DOI 10.1111/j.1574-6968.2009.01491.x; Ogura Y, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r138; Perera Ramesh P., 1994, Journal of Aquatic Animal Health, V6, P335, DOI 10.1577/1548-8667(1994)006&lt;0335:SIAWMO&gt;2.3.CO;2; Saier MH, 1996, MICROBIOL-UK, V142, P217, DOI 10.1099/13500872-142-2-217; Seidl K, 2006, ANTIMICROB AGENTS CH, V50, P1183, DOI 10.1128/AAC.50.4.1183-1194.2006; Shin GW, 2006, B EUR ASSOC FISH PAT, V26, P68; Thomson NR, 2006, PLOS GENET, V2, P2039, DOI 10.1371/journal.pgen.0020206; Tsai YK, 2006, J APPL MICROBIOL, V100, P446, DOI 10.1111/j.1365-2672.2005.02790.x; Ward PN, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-54; WEHMEIER UF, 1992, J BACTERIOL, V174, P7784, DOI 10.1128/JB.174.23.7784-7790.1992; Wiedenheft B, 2009, STRUCTURE, V17, P904, DOI 10.1016/j.str.2009.03.019; Wren BW, 2000, NAT REV GENET, V1, P30, DOI 10.1038/35049551; Yang MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036987; Yu Y, 2007, APPL ENVIRON MICROB, V73, P1842, DOI 10.1128/AEM.02082-06; Zeng L, 2010, J BACTERIOL, V192, P2434, DOI 10.1128/JB.01624-09	55	10	10	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80395	10.1371/journal.pone.0080395	http://dx.doi.org/10.1371/journal.pone.0080395			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260382	Green Published, gold			2022-12-25	WOS:000327308500130
J	Meyer, L; Patte-Mensah, C; Taleb, O; Mensah-Nyagan, AG				Meyer, Laurence; Patte-Mensah, Christine; Taleb, Omar; Mensah-Nyagan, Ayikoe Guy			Neurosteroid 3 alpha-Androstanediol Efficiently Counteracts Paclitaxel-Induced Peripheral Neuropathy and Painful Symptoms	PLOS ONE			English	Article							5-ALPHA-REDUCED METABOLITES; NEUROGENIC PAIN; GENE-EXPRESSION; TAXOL; CHEMOTHERAPY; CANCER; NERVE; ALLOPREGNANOLONE; NEUROTOXICITY; PROGESTERONE	Painful peripheral neuropathy belongs to major side-effects limiting cancer chemotherapy. Paclitaxel, widely used to treat several cancers, induces neurological symptoms including burning pain, allodynia, hyperalgesia and numbness. Therefore, identification of drugs that may effectively counteract paclitaxel-induced neuropathic symptoms is crucial. Here, we combined histopathological, neurochemical, behavioral and electrophysiological methods to investigate the natural neurosteroid 3 alpha-androstanediol (3 alpha-DIOL) ability to counteract paclitaxel-evoked peripheral nerve tissue damages and neurological symptoms. Prophylactic or corrective 3 alpha-DIOL treatment (4 mg/kg/2days) prevented or suppressed PAC-evoked heat-thermal hyperalgesia, cold-allodynia and mechanical allodynia/hyperalgesia, by reversing to normal, decreased thermal and mechanical pain thresholds of PAC-treated rats. Electrophysiological studies demonstrated that 3 alpha-DIOL restored control values of nerve conduction velocity and action potential peak amplitude significantly altered by PAC-treatment. 3 alpha-DIOL also repaired PAC-induced nerve damages by restoring normal neurofilament-200 level in peripheral axons and control amount of 2',3'-cyclic-nucleotide-3'-phosphodiesterase in myelin sheaths. Decreased density of intraepidermal nerve fibers evoked by PAC-therapy was also counteracted by 3 alpha-DIOL treatment. More importantly, 3 alpha-DIOL beneficial effects were not sedation-dependent but resulted from its neuroprotective ability, nerve tissue repairing capacity and long-term analgesic action. Altogether, our results showing that 3 alpha-DIOL efficiently counteracted PAC-evoked painful symptoms, also offer interesting possibilities to develop neurosteroid-based strategies against chemotherapy-induced peripheral neuropathy. This article shows that the prophylactic or corrective treatment with 3 alpha-androstanediol prevents or suppresses PAC-evoked painful symptoms and peripheral nerve dysfunctions in rats. The data suggest that 3 alpha-androstanediol-based therapy may constitute an efficient strategy to explore in humans for the eradication of chemotherapy-induced peripheral neuropathy.	[Meyer, Laurence; Patte-Mensah, Christine; Taleb, Omar; Mensah-Nyagan, Ayikoe Guy] Univ Strasbourg, Fac Med, INSERM, Federat Med Translat Strasbourg,U1119, Strasbourg, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg	Mensah-Nyagan, AG (corresponding author), Univ Strasbourg, Fac Med, INSERM, Federat Med Translat Strasbourg,U1119, Strasbourg, France.	gmensah@unistra.fr	Taleb, Omar/K-1457-2016; Patte-Mensah, Christine/D-5961-2011; Mensah-Nyagan, Ayikoe G/D-5951-2011; Meyer, Laurence/D-5967-2011	Taleb, Omar/0000-0003-2407-0380; Patte-Mensah, Christine/0000-0002-9970-8214; Mensah-Nyagan, Ayikoe G/0000-0003-4454-511X; Meyer, Laurence/0000-0002-6113-936X	Association Ti'toine (Normandie, France); Universite de Strasbourg (France)	Association Ti'toine (Normandie, France); Universite de Strasbourg (France)	This work was supported by grants from Association Ti'toine (Normandie, France, http://www.titoine-normandie.org/) and Universite de Strasbourg (France). LM was a postdoctoral fellow supported by Association Ti'toine (Normandie, France). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwa Y, 1999, BEHAV BRAIN RES, V106, P119, DOI 10.1016/S0166-4328(99)00101-1; Amato SF, 1998, CANCER RES, V58, P241; Authier N, 2009, NEUROTHERAPEUTICS, V6, P620, DOI 10.1016/j.nurt.2009.07.003; Balayssac D, 2011, EXPERT OPIN DRUG SAF, V10, P407, DOI 10.1517/14740338.2011.543417; BAULIEU EE, 1999, CONT ENDOCRINOLOGY; Belelli D, 2005, NAT REV NEUROSCI, V6, P565, DOI 10.1038/nrn1703; Bitran D, 1996, LIFE SCI, V58, P573, DOI 10.1016/0024-3205(95)02326-7; Boyette-Davis J, 2011, PAIN, V152, P308, DOI 10.1016/j.pain.2010.10.030; Brooks BP, 1998, J NEUROCHEM, V70, P1054; Cai J, 2000, Sarcoma, V4, P37, DOI 10.1155/S1357714X00000074; CAVALETTI G, 1995, EXP NEUROL, V133, P64, DOI 10.1006/exnr.1995.1008; CAVALETTI G, 1995, CANCER, V75, P1141, DOI 10.1002/1097-0142(19950301)75:5<1141::AID-CNCR2820750514>3.0.CO;2-U; Cerghet M, 2006, J NEUROSCI, V26, P1439, DOI 10.1523/JNEUROSCI.2219-05.2006; CHAUDHRY V, 1994, ANN NEUROL, V35, P304, DOI 10.1002/ana.410350310; Ciriza I, 2004, J NEUROENDOCRINOL, V16, P58, DOI 10.1111/j.1365-2826.2004.01121.x; Ciriza I, 2006, J NEUROBIOL, V66, P916, DOI 10.1002/neu.20293; Cliffer KD, 1998, ANN NEUROL, V43, P46, DOI 10.1002/ana.410430111; Croom KF, 2011, DRUGS, V71, P2213, DOI 10.2165/11207720-000000000-00000; Dougherty PM, 2007, J PAIN SYMPTOM MANAG, V33, P166, DOI 10.1016/j.jpainsymman.2006.08.006; Dougherty PM, 2004, PAIN, V109, P132, DOI 10.1016/j.pain.2004.01.021; Durand JP, 2005, ANTI-CANCER DRUG, V16, P587, DOI 10.1097/00001813-200506000-00015; Edinger KL, 2005, PSYCHONEUROENDOCRINO, V30, P418, DOI 10.1016/j.psyneuen.2004.11.001; Edinger KL, 2004, BEHAV NEUROSCI, V118, P1352, DOI 10.1037/0735-7044.118.6.1352; Fazio R, 1999, ACTA NEUROPATHOL, V98, P651, DOI 10.1007/s004010051132; Forsyth PA, 1997, J NEURO-ONCOL, V35, P47, DOI 10.1023/A:1005805907311; Frye CA, 2001, PSYCHONEUROENDOCRINO, V26, P731, DOI 10.1016/S0306-4530(01)00027-0; Frye CA, 1996, BEHAV BRAIN RES, V79, P119, DOI 10.1016/0166-4328(96)00005-8; Frye CA, 2007, PHARMACOL BIOCHEM BE, V86, P415, DOI 10.1016/j.pbb.2006.05.025; Frye CA, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00015; Frye CA, 2009, PHYSIOL BEHAV, V97, P266, DOI 10.1016/j.physbeh.2009.02.022; Gamelin L, 2004, CLIN CANCER RES, V10, P4055, DOI 10.1158/1078-0432.CCR-03-0666; Gordon AN, 1997, J CLIN ONCOL, V15, P1965, DOI 10.1200/JCO.1997.15.5.1965; Griffin LD, 2004, NAT MED, V10, P704, DOI 10.1038/nm1073; HARGREAVES K, 1988, PAIN, V32, P77, DOI 10.1016/0304-3959(88)90026-7; HOFFMAN PN, 1984, J CELL BIOL, V99, P705, DOI 10.1083/jcb.99.2.705; HOFFMAN PN, 1987, P NATL ACAD SCI USA, V84, P3472, DOI 10.1073/pnas.84.10.3472; HOFFMAN PN, 1985, J NEUROSCI, V5, P2920; HOLMES FA, 1991, J NATL CANCER I, V83, P1797, DOI 10.1093/jnci/83.24.1797-a; Hosie AM, 2006, NATURE, V444, P486, DOI 10.1038/nature05324; Kriz J, 2000, BRAIN RES, V885, P32, DOI 10.1016/S0006-8993(00)02899-7; Lang E, 1996, PAIN, V68, P151, DOI 10.1016/S0304-3959(96)03223-X; Lappe-Siefke C, 2003, NAT GENET, V33, P366, DOI 10.1038/ng1095; Lauria G, 2005, J PERIPHER NERV SYST, V10, P202, DOI 10.1111/j.1085-9489.2005.0010210.x; Le XF, 2011, CANCER BIOL THER, V12, P260, DOI 10.4161/cbt.12.4.16430; LEBLANC AC, 1992, MOL BRAIN RES, V15, P40, DOI 10.1016/0169-328X(92)90149-6; Lee MK, 1996, ANNU REV NEUROSCI, V19, P187, DOI 10.1146/annurev.ne.19.030196.001155; Ling B, 2007, PAIN, V128, P225, DOI 10.1016/j.pain.2006.09.016; Marchand F, 2003, PAIN, V103, P229, DOI 10.1016/S0304-3959(03)00168-4; Melcangi RC, 2008, CELL MOL LIFE SCI, V65, P777, DOI 10.1007/s00018-007-7403-5; Mensah-Nyagan AG, 1999, PHARMACOL REV, V51, P63; Meyer L, 2008, NEUROBIOL DIS, V30, P30, DOI 10.1016/j.nbd.2007.12.001; Meyer L, 2011, PAIN, V152, P170, DOI 10.1016/j.pain.2010.10.015; Meyer L, 2010, CELL MOL LIFE SCI, V67, P3017, DOI 10.1007/s00018-010-0372-0; Patte-Mensah C, 2006, J MOL NEUROSCI, V28, P17, DOI 10.1385/JMN:28:1:17; Patte-Mensah C, 2005, P NATL ACAD SCI USA, V102, P9044, DOI 10.1073/pnas.0502968102; Patte-Mensah C, 2004, J COMP NEUROL, V477, P286, DOI 10.1002/cne.20251; Peters CM, 2007, BRAIN RES, V1168, P46, DOI 10.1016/j.brainres.2007.06.066; Polomano RC, 2001, PAIN, V94, P293, DOI 10.1016/S0304-3959(01)00363-3; POSTMA TJ, 1995, ANN ONCOL, V6, P489, DOI 10.1093/oxfordjournals.annonc.a059220; Quasthoff S, 2002, J NEUROL, V249, P9, DOI 10.1007/PL00007853; Reddy DS, 2008, NEUROCHEM INT, V52, P541, DOI 10.1016/j.neuint.2007.05.019; Rhodes ME, 2004, PHARMACOL BIOCHEM BE, V78, P483, DOI 10.1016/j.pbb.2004.04.020; Roglio I, 2009, J PERIPHER NERV SYST, V14, P36, DOI 10.1111/j.1529-8027.2009.00204.x; ROWINSKY EK, 1993, SEMIN ONCOL, V20, P1; SHAW G, 1986, EUR J CELL BIOL, V42, P1; Siau C, 2006, EXP NEUROL, V201, P507, DOI 10.1016/j.expneurol.2006.05.007; Singh S, 2009, CRIT REV THER DRUG, V26, P333, DOI 10.1615/CritRevTherDrugCarrierSyst.v26.i4.10; SPRINKLE TJ, 1989, CRIT REV NEUROBIOL, V4, P235; Tanner KD, 1998, J NEUROSCI, V18, P6480; Uzunova V, 1998, P NATL ACAD SCI USA, V95, P3239, DOI 10.1073/pnas.95.6.3239; vandenBent MJ, 1997, MUSCLE NERVE, V20, P750; Verstappen CCP, 2003, DRUGS, V63, P1549, DOI 10.2165/00003495-200363150-00003; Wang JM, 2010, P NATL ACAD SCI USA, V107, P6498, DOI 10.1073/pnas.1001422107; Wang MS, 2002, ANN NEUROL, V52, P442, DOI 10.1002/ana.10300; Yang JY, 2011, CURR DRUG TARGETS, V12, P1284, DOI 10.2174/138945011796150299; YOSHINO J, 1985, BRAIN RES, V325, P199, DOI 10.1016/0006-8993(85)90316-6; Young M, 2001, PHARMACOECONOMICS, V19, P1227, DOI 10.2165/00019053-200119120-00005; ZIMMERMANN M, 1983, PAIN, V16, P109, DOI 10.1016/0304-3959(83)90201-4	78	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80915	10.1371/journal.pone.0080915	http://dx.doi.org/10.1371/journal.pone.0080915			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260511	Green Published, gold			2022-12-25	WOS:000327258600099
J	Neselius, S; Zetterberg, H; Blennow, K; Marcusson, J; Brisby, H				Neselius, Sanna; Zetterberg, Henrik; Blennow, Kaj; Marcusson, Jan; Brisby, Helena			Increased CSF Levels of Phosphorylated Neurofilament Heavy Protein following Bout in Amateur Boxers	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; AMYLOID PRECURSOR PROTEIN; FLUID APOLIPOPROTEIN-E; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; AXONAL INJURY; CONCUSSION; RISK; BIOMARKER; SPORTS	Introduction: Diagnosis of mild TBI is hampered by the lack of imaging or biochemical measurements for identifying or quantifying mild TBI in a clinical setting. We have previously shown increased biomarker levels of protein reflecting axonal (neurofilament light protein and tau) and glial (GFAP and S-100B) damage in cerebrospinal fluid (CSF) after a boxing bout. The aims of this study were to find other biomarkers of mild TBI, which may help clinicians diagnose and monitor mild TBI, and to calculate the role of APOE epsilon 4 allele genotype which has been associated with poor outcome after TBI. Materials and Methods: Thirty amateur boxers with a minimum of 45 bouts and 25 non-boxing matched controls were included in a prospective cohort study. CSF and blood were collected at one occasion between 1 and 6 days after a bout, and after a rest period for at least 14 days (follow up). The controls were tested once. CSF levels of neurofilament heavy (pNFH), amyloid precursor proteins (sAPP alpha and sAPP beta), ApoE and ApoA1 were analyzed. In blood, plasma levels of A beta 42 and ApoE genotype were analyzed. Results: CSF levels of pNFH were significantly increased between 1 and 6 days after boxing as compared with controls (p<0.001). The concentrations decreased at follow up but were still significantly increased compared to controls (p = 0.018). CSF pNFH concentrations correlated with NFL (r = 0.57 after bout and 0.64 at follow up, p<0.001). No significant change was found in the other biomarkers, as compared to controls. Boxers carrying the APOE epsilon 4 allele had similar biomarker concentrations as non-carriers. Conclusions: pNFH, even without unconsciousness or concussion symptoms. Possession of the APOE epsilon 4 allele was not found to influence biomarker levels after acute TBI.	[Neselius, Sanna; Brisby, Helena] Sahlgrens Univ Hosp, Dept Orthopaed, S-41345 Gothenburg, Sweden; [Neselius, Sanna; Brisby, Helena] Univ Gothenburg, Sahlgrenska Acad, Inst Clin Sci, Gothenburg, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Sahlgrens Univ Hosp, Dept Psychiat & Neurochem, Clin Neurochem Lab, S-41345 Gothenburg, Sweden; [Zetterberg, Henrik; Blennow, Kaj] Univ Gothenburg, Sahlgrenska Acad, Inst Neurosci & Physiol, Gothenburg, Sweden; [Marcusson, Jan] Linkoping Univ Hosp, Geriatr Sect, S-58185 Linkoping, Sweden; [Marcusson, Jan] Linkoping Univ, Inst Clin & Expt Med, Linkoping, Sweden	Sahlgrenska University Hospital; University of Gothenburg; Sahlgrenska University Hospital; University of Gothenburg; Linkoping University; Linkoping University	Neselius, S (corresponding author), Sahlgrens Univ Hosp, Dept Orthopaed, S-41345 Gothenburg, Sweden.	sanna.neselius@vgregion.se			Marianne and Marcus Wallenberg Foundation, SWEDEN; ALF Grants, County Council of Vastra Gotaland, SWEDEN; Sahlgrenska University Hospital, Gothenburg, SWEDEN; Gothenburg Medical Society, SWEDEN; ALF Grants, County Council of Ostergotland, SWEDEN; Swedish Research Council	Marianne and Marcus Wallenberg Foundation, SWEDEN; ALF Grants, County Council of Vastra Gotaland, SWEDEN; Sahlgrenska University Hospital, Gothenburg, SWEDEN; Gothenburg Medical Society, SWEDEN; ALF Grants, County Council of Ostergotland, SWEDEN; Swedish Research Council(Swedish Research CouncilEuropean Commission)	This study has been funded by the Marianne and Marcus Wallenberg Foundation, SWEDEN; ALF Grants, County Council of Vastra Gotaland, SWEDEN; Sahlgrenska University Hospital, Gothenburg, SWEDEN; Gothenburg Medical Society, SWEDEN; ALF Grants, County Council of Ostergotland, SWEDEN and The Swedish Research Council. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	BLENNOW K, 1994, NEUROREPORT, V5, P2534, DOI 10.1097/00001756-199412000-00032; Bramley H, 2012, CLIN PEDIATR, V51, P283, DOI 10.1177/0009922811422434; Constantinescu R, 2009, PARKINSONISM RELAT D, V15, P205, DOI 10.1016/j.parkreldis.2008.05.001; De Strooper B, 2000, J CELL SCI, V113, P1857; Ellenbogen RG, 2010, WORLD NEUROSURG, V74, P560, DOI 10.1016/j.wneu.2010.11.016; Ganesalingam J, 2013, AMYOTROPH LAT SCL FR, V14, P146, DOI 10.3109/21678421.2012.729596; Graham DI, 1996, ACT NEUR S, V66, P96; Horsburgh K, 2000, NEUROBIOL AGING, V21, P245, DOI 10.1016/S0197-4580(00)00097-X; Jordan BD, 1996, AM J SPORT MED, V24, P704, DOI 10.1177/036354659602400526; Jordan BD, 1997, JAMA-J AM MED ASSOC, V278, P136, DOI 10.1001/jama.278.2.136; Kay AD, 2003, J NEUROTRAUM, V20, P943, DOI 10.1089/089771503770195795; Kuhle J, 2011, NEUROLOGY, V76, P1206, DOI 10.1212/WNL.0b013e31821432ff; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MAYEUX R, 1995, NEUROLOGY, V45, P555, DOI 10.1212/WNL.45.3.555; McCrory P, 2009, J SCI MED SPORT, V12, P340, DOI 10.1016/j.jsams.2009.02.004; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Olivecrona Z, 2012, ACTA NEUROCHIR, V154, P675, DOI 10.1007/s00701-012-1292-6; Olsson A, 2004, J NEUROL, V251, P870, DOI 10.1007/s00415-004-0451-y; OMeara ES, 1997, AM J EPIDEMIOL, V146, P373, DOI 10.1093/oxfordjournals.aje.a009290; Piccini A, 2005, J BIOL CHEM, V280, P34186, DOI 10.1074/jbc.M501694200; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Puchades M, 2003, MOL BRAIN RES, V118, P140, DOI 10.1016/j.molbrainres.2003.08.005; Roses AD, 1996, CURR OPIN NEUROL, V9, P265, DOI 10.1097/00019052-199608000-00004; Shaw G, 2005, BIOCHEM BIOPH RES CO, V336, P1268, DOI 10.1016/j.bbrc.2005.08.252; Tang MX, 1996, ANN NY ACAD SCI, V802, P6, DOI 10.1111/j.1749-6632.1996.tb32593.x; Tegner Y, 1991, Br J Sports Med, V25, P87; VANDUIJN CM, 1992, AM J EPIDEMIOL, V135, P775, DOI 10.1093/oxfordjournals.aje.a116364; Xie YY, 2003, J NEUROSCI RES, V73, P557, DOI 10.1002/jnr.10667; Yard EE, 2009, BRAIN INJURY, V23, P888, DOI 10.1080/02699050903283171; Zetterberg H, 2008, ARCH NEUROL-CHICAGO, V65, P1102, DOI 10.1001/archneur.65.8.1102; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zhou WD, 2008, J NEUROTRAUM, V25, P279, DOI 10.1089/neu.2007.0489; Zurek J, 2012, ACTA NEUROCHIR, V154, P93, DOI 10.1007/s00701-011-1175-2	35	42	43	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81249	10.1371/journal.pone.0081249	http://dx.doi.org/10.1371/journal.pone.0081249			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260563	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600111
J	Genard, M; Lescourret, F				Genard, Michel; Lescourret, Francoise			Combining Niche and Dispersal in a Simple Model (NDM) of Species Distribution	PLOS ONE			English	Article							HABITAT SUITABILITY; GEOMETRIC CONSTRAINTS; FOREST FRAGMENTATION; RANGE DYNAMICS; BIRD; LANDSCAPE; PATTERNS; MATRIX; METACOMMUNITIES; PARTRIDGE	Predicting the distribution of species has become a crucial issue in biodiversity research. Two kinds of model address this question: niche models, which are usually based on static approaches linking species distribution to habitat characteristics, and dispersal models, which are usually dynamic and process-based. We propose a model (NDM: niche and dispersal model) that considers the local presence of a species to result from a dynamic balance between extinction (based on the niche concept) and immigration (based on the dispersal concept), at a given moment in time, in a spatially explicit context. We show that NDM correctly predicts observed bird species and community distributions at different scales. NDM helps to reconcile the contrasting paradigms of metacommunity theory. It shows that sorting and mass effects are the factors determining bird species distribution. One of the most interesting features of NDM is its ability to predict well known properties of communities, such as decreasing species richness with decreasing patch size and increasing distance to the mainland, and the mid-domain effect at the regional scale, contrasting with predictions of much smaller effects at the local scale. NDM shows that habitat destruction in the matrix around patches of forest can affect the forest bird community, principally by decreasing the occurrence of typical matrix birds within the forest. This model could be used as the starting point for applied ecological studies on the management of species and community distributions.	[Genard, Michel; Lescourret, Francoise] INRA, PSH, UR1115, Avignon, France	INRAE	Genard, M (corresponding author), INRA, PSH, UR1115, Avignon, France.	michel.genard@avignon.inra.fr		Lescourret, Francoise/0000-0002-6576-8067				Acevedo P, 2007, ACTA OECOL, V31, P174, DOI 10.1016/j.actao.2006.09.003; [Anonymous], 2010, R LANG ENV STAT COMP; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Baiser B, 2013, OIKOS, V122, P492, DOI 10.1111/j.1600-0706.2012.00005.x; Barbet-Massin M, 2012, GLOBAL CHANGE BIOL, V18, P881, DOI 10.1111/j.1365-2486.2011.02552.x; Begon M., 1996, ECOLOGY; BLONDEL J, 1981, STUDIES AVIAN BIOL, V6, P414; Bowman J, 2003, CAN J ZOOL, V81, P195, DOI 10.1139/Z02-237; Brotons L, 2004, ECOGRAPHY, V27, P437, DOI 10.1111/j.0906-7590.2004.03764.x; Brotons L, 2012, ECOGRAPHY, V35, P458, DOI 10.1111/j.1600-0587.2011.06878.x; Cabral JS, 2010, GLOBAL ECOL BIOGEOGR, V19, P85, DOI 10.1111/j.1466-8238.2009.00492.x; Chisholm RA, 2009, ECOL LETT, V12, P1385, DOI 10.1111/j.1461-0248.2009.01389.x; Clobert J, 2012, DISPERSAL ECOLOGY AND EVOLUTION, P1, DOI 10.1093/acprof:oso/9780199608898.001.0001; Colwell RK, 2000, TRENDS ECOL EVOL, V15, P70, DOI 10.1016/S0169-5347(99)01767-X; Debinski DM, 2006, J BIOGEOGR, V33, P1791, DOI 10.1111/j.1365-2699.2006.01596.x; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; Engler R, 2009, DIVERS DISTRIB, V15, P590, DOI 10.1111/j.1472-4642.2009.00566.x; Fukami T, 2004, POPUL ECOL, V46, P137, DOI 10.1007/s10144-004-0182-z; Gaggiotti O.E., 2004, ECOLOGY GENETICS EVO; GENARD M, 1990, Gibier Faune Sauvage, V7, P205; GENARD M, 1990, Gerfaut, V80, P107; GENARD M, 1985, ACTA OECOL-OEC GEN, V6, P209; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Harrison S, 2008, ECOL LETT, V11, P969, DOI 10.1111/j.1461-0248.2008.01210.x; Holzkamper A, 2006, ECOL MODEL, V198, P277, DOI 10.1016/j.ecolmodel.2006.05.001; Hoverman JT, 2011, ECOGRAPHY, V34, P1049, DOI 10.1111/j.1600-0587.2011.06856.x; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Iverson LR, 1999, ECOL MODEL, V115, P77, DOI 10.1016/S0304-3800(98)00200-2; KAMADA T, 1989, INFORM PROCESS LETT, V31, P7, DOI 10.1016/0020-0190(89)90102-6; Keymer JE, 1998, J THEOR BIOL, V194, P79, DOI 10.1006/jtbi.1998.0745; Kupfer JA, 2006, GLOBAL ECOL BIOGEOGR, V15, P8, DOI 10.1111/j.1466-822x.2006.00204.x; Leibold MA, 2004, ECOL LETT, V7, P601, DOI 10.1111/j.1461-0248.2004.00608.x; LESCOURRET F, 1994, J ENVIRON MANAGE, V40, P317, DOI 10.1006/jema.1994.1025; LEVIN SA, 1974, P NATL ACAD SCI USA, V71, P2744, DOI 10.1073/pnas.71.7.2744; LEVINS R, 1969, Bulletin of the Entomological Society of America, V15, P237; Logue JB, 2011, TRENDS ECOL EVOL, V26, P482, DOI 10.1016/j.tree.2011.04.009; MAC ARTHUR ROBERT H., 1967; MACE GM, 1983, AM NAT, V121, P120, DOI 10.1086/284043; Midgley GF, 2010, ECOGRAPHY, V33, P612, DOI 10.1111/j.1600-0587.2009.06000.x; Mouillot D, 2007, J APPL ECOL, V44, P760, DOI 10.1111/j.1365-2664.2007.01330.x; Murphy HT, 2007, OIKOS, V116, P99, DOI 10.1111/j.2006.0030-1299.15050.x; Paradis E, 1998, J ANIM ECOL, V67, P518, DOI 10.1046/j.1365-2656.1998.00215.x; Prevedello JA, 2010, BIODIVERS CONSERV, V19, P1205, DOI 10.1007/s10531-009-9750-z; PRODON R, 1981, OIKOS, V37, P21, DOI 10.2307/3544069; Prodon R, 1994, NOUVEL ATLAS OISEAUX, P520; Randin CF, 2006, J BIOGEOGR, V33, P1689, DOI 10.1111/j.1365-2699.2006.01466.x; Rangel TFLVB, 2005, ECOL LETT, V8, P783, DOI 10.1111/j.1461-0248.2005.00786.x; Schurr FM, 2012, J BIOGEOGR, V39, P2146, DOI 10.1111/j.1365-2699.2012.02737.x; Simberloff DS, 1974, ANNU REV ECOL SYST, V5, P161, DOI 10.1146/annurev.es.05.110174.001113; Smolik MG, 2010, J BIOGEOGR, V37, P411, DOI 10.1111/j.1365-2699.2009.02227.x; Soberon Jorge, 2005, Biodiversity Informatics, V2, P1; Tapia L, 2007, EUR J WILDLIFE RES, V53, P178, DOI 10.1007/s10344-006-0079-6; Thuiller W, 2004, J BIOGEOGR, V31, P353, DOI 10.1046/j.0305-0270.2003.00991.x; VanDerWal J, 2008, ECOGRAPHY, V31, P435, DOI 10.1111/j.0906-7590.2008.05396.x; Voous KH, 1960, ATLAS EUROPEAN BIRDS; Yeatman L., 1976, ATLAS OISEAUX NICHEU; [No title captured]; [No title captured]; [No title captured]; [No title captured]	61	8	8	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79948	10.1371/journal.pone.0079948	http://dx.doi.org/10.1371/journal.pone.0079948			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265788	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100121
J	Kao, CH; Chen, JJJ; Hsu, YM; Bau, DT; Yao, CH; Chen, YS				Kao, Chia-Hong; Chen, Jia-Jin J.; Hsu, Yuan-Man; Bau, Da-Tian; Yao, Chun-Hsu; Chen, Yueh-Sheng			High-Frequency Electrical Stimulation Can Be a Complementary Therapy to Promote Nerve Regeneration in Diabetic Rats	PLOS ONE			English	Article							GENE-RELATED PEPTIDE; PERIPHERAL-NERVE; SKELETAL-MUSCLE; CRUSH INJURY; MICROVASCULAR PERFUSION; NEURITE OUTGROWTH; ACTIVATION	The purpose of this study was to evaluate whether 1 mA of percutaneous electrical stimulation (ES) at 0, 2, 20, or 200 Hz augments regeneration between the proximal and distal nerve stumps in streptozotocin diabetic rats. A10-mm gap was made in the diabetic rat sciatic nerve by suturing the stumps into silicone rubber tubes. Normal animals were used as the controls. Starting 1 week after transection, ES was applied between the cathode placed at the distal stump and the anode at the proximal stump every other day for 3 weeks. At 4 weeks after surgery, the normal controls and the groups receiving ES at 20, and 200 Hz had a higher success percentage of regeneration compared to the ES groups at 0 and 2 Hz. In addition, quantitative histology of the successfully regenerated nerves revealed that the groups receiving ES at a higher frequency, especially at 200 Hz, had a more mature structure with more myelinated fibers compared to those in the lower-frequency ES groups. Similarly, electrophysiology in the ES group at 200 Hz showed significantly shorter latency, larger amplitude, larger area of evoked muscle action potentials and faster conduction velocity compared to other groups. Immunohistochemical staining showed that ES at a higher frequency could significantly promote calcitonin gene-related peptide expression in lamina I-II regions in the dorsal horn and recruit a higher number of macrophages in the diabetic distal sciatic nerve. The macrophages were found that they could stimulate the secretion of nerve growth factor, platelet-derived growth factor, and transforming growth factor-beta in dissected sciatic nerve segments. The ES at a higher frequency could also increase cutaneous blood flow in the ipsilateral hindpaw to the injury. These results indicated that a high-frequency ES could be necessary to heal severed diabetic peripheral nerve with a long gap to be repaired.	[Kao, Chia-Hong; Bau, Da-Tian; Yao, Chun-Hsu; Chen, Yueh-Sheng] China Med Univ, Sch Chinese Med, Lab Biomat, Taichung, Taiwan; [Kao, Chia-Hong] Taipei Med Univ Hosp, Dept Chinese Med, Taipei, Taiwan; [Chen, Jia-Jin J.] Natl Cheng Kung Univ, Dept Biomed Engn, Tainan 70101, Taiwan; [Hsu, Yuan-Man] China Med Univ, Dept Biol Sci & Technol, Taichung, Taiwan; [Bau, Da-Tian] China Med Univ Hosp, Terry Fox Canc Res Lab, Taichung, Taiwan; [Yao, Chun-Hsu; Chen, Yueh-Sheng] China Med Univ, Dept Biomed Imaging & Radiol Sci, Taichung, Taiwan; [Yao, Chun-Hsu; Chen, Yueh-Sheng] Asia Univ, Dept Biomed Informat, Taichung, Taiwan	China Medical University Taiwan; Taipei Medical University; Taipei Medical University Hospital; National Cheng Kung University; China Medical University Taiwan; China Medical University Taiwan; China Medical University Hospital - Taiwan; China Medical University Taiwan; Asia University Taiwan	Chen, YS (corresponding author), China Med Univ, Sch Chinese Med, Lab Biomat, Taichung, Taiwan.	yuehsc@mail.cmu.edu.tw	Hsu, Yuan-Man/K-7074-2015	Hsu, Yuan-Man/0000-0002-4575-7475	National Science Council of the Republic of China, Taiwan [NSC99-2221-E-039-006-MY3]; China Medical University Hospital [DMR-100-183, DMR-102-050]; Taiwan Department of Health Clinical Trial and Research Center of Excellence [DOH102-TD-B-111-004]	National Science Council of the Republic of China, Taiwan(Ministry of Science and Technology, Taiwan); China Medical University Hospital; Taiwan Department of Health Clinical Trial and Research Center of Excellence	The sources of funding includes National Science Council of the Republic of China, Taiwan (NSC99-2221-E-039-006-MY3), China Medical University Hospital (DMR-100-183; DMR-102-050), and Taiwan Department of Health Clinical Trial and Research Center of Excellence (DOH102-TD-B-111-004). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alrashdan MS, 2010, ACTA NEUROL BELG, V110, P168; Baptista AF, 2008, J PERIPHER NERV SYST, V13, P71, DOI 10.1111/j.1529-8027.2008.00160.x; CAMERON NE, 1993, AM J PHYSIOL, V264, pE161, DOI 10.1152/ajpendo.1993.264.2.E161; CAMERON NE, 1989, DIABETOLOGIA, V32, P759, DOI 10.1007/BF00274538; Chang YJ, 2013, BBA-GEN SUBJECTS, V1830, P4130, DOI 10.1016/j.bbagen.2013.04.007; CLEMENTE FR, 1991, PHYS THER, V71, P397, DOI 10.1093/ptj/71.5.397; Clemente FR, 1996, ARCH PHYS MED REHAB, V77, P155, DOI 10.1016/S0003-9993(96)90160-4; CUNHA RA, 1993, PFLUG ARCH EUR J PHY, V424, P503, DOI 10.1007/BF00374914; Foecking EM, 2012, J REHABIL RES DEV, V49, P451, DOI 10.1682/JRRD.2011.03.0033; Gao J, 2010, BRAIN RES, V1313, P53, DOI 10.1016/j.brainres.2009.11.072; Kennedy JM, 2005, J PERIPHER NERV SYST, V10, P144, DOI 10.1111/j.1085-9489.2005.0010205.x; Knoferle J, 2010, NEUROBIOL DIS, V38, P395, DOI 10.1016/j.nbd.2010.02.011; Layec G, 2008, EUR J APPL PHYSIOL, V102, P289, DOI 10.1007/s00421-007-0581-x; Lu MC, 2008, NEUROREHAB NEURAL RE, V22, P367, DOI 10.1177/1545968307313507; Rittenhouse PA, 1996, PEPTIDES, V17, P1017; Rosenberg AF, 2012, J NEUROSCI, V32, P3898, DOI 10.1523/JNEUROSCI.5225-11.2012; Teodori RM, 2011, BRAZ J PHYS THER, V15, P325, DOI 10.1590/S1413-35552011005000008; Terada M, 1998, J NEUROL SCI, V155, P23, DOI 10.1016/S0022-510X(97)00269-4; Toth CC, 2009, J NEUROPATH EXP NEUR, V68, P326, DOI 10.1097/NEN.0b013e31819ac71b; Yamazaki T, 2009, J PERIPHER NERV SYST, V14, P165, DOI 10.1111/j.1529-8027.2009.00228.x; Yao CH, 2012, J TRAUMA ACUTE CARE, V72, P199, DOI 10.1097/TA.0b013e31822d233c; Yasuda H, 2003, PROG NEUROBIOL, V69, P229, DOI 10.1016/S0301-0082(03)00034-0; Ydens E, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-176; Zheng LF, 2008, BRAIN RES, V1187, P20, DOI 10.1016/j.brainres.2007.10.044	24	18	20	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79078	10.1371/journal.pone.0079078	http://dx.doi.org/10.1371/journal.pone.0079078			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265744	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100077
J	Ngubane, NAC; Gresh, L; Ioerger, TR; Sacchettini, JC; Zhang, YJJ; Rubin, EJ; Pym, A; Khati, M				Ngubane, Nqobile A. C.; Gresh, Lionel; Ioerger, Thomas R.; Sacchettini, James C.; Zhang, Yanjia J.; Rubin, Eric J.; Pym, Alexander; Khati, Makobetsa			High-Throughput Sequencing Enhanced Phage Display Identifies Peptides That Bind Mycobacteria	PLOS ONE			English	Article							PULMONARY TUBERCULOSIS; DIAGNOSIS; MICROSCOPY; BIOMARKERS; LIBRARIES; CULTURE	Bacterial cell wall components have been previously used as infection biomarkers detectable by antibodies. However, it is possible that the surface of the Mycobacterium tuberculosis (M. tb), the causative agent of tuberculosis (TB), also possesses molecules which might be non-antigenic. This makes the probing of biomarkers on the surface of M. tb cell wall difficult using antibodies. Here we demonstrate the use of phage display technology to identify peptides that bind to mycobacteria. We identified these clones using both random clone picking and high throughput sequencing. We demonstrate that random clone picking does not necessarily identify highly enriched clones. We further showed that the clone displaying the CPLHARLPC peptide which was identified by Illumina sequencing as the most enriched, binds better to mycobacteria than three clones selected by random picking. Using surface plasmon resonance, we showed that chemically synthesised CPLHARLPC peptide binds to a 15 KDa peptide from M. tb H37Rv whole cell lysates. These observations demonstrate that phage display technology combined with high-throughput sequencing is a powerful tool to identify peptides that can be used for investigating potential non-antigenic biomarkers for TB and other bacterial infections.	[Ngubane, Nqobile A. C.; Gresh, Lionel; Khati, Makobetsa] CSIR, Emerging Hlth Technol Platform, Biosci Unit, ZA-0001 Pretoria, Gauteng, South Africa; [Ngubane, Nqobile A. C.; Pym, Alexander] Univ KwaZulu Natal, Nelson R Mandela Sch Med, KwaZulu Natal Res Inst TB & Human Immunodeficienc, Durban, South Africa; [Ioerger, Thomas R.] Texas A&M Univ, Dept Comp Sci & Engn, College Stn, TX USA; [Sacchettini, James C.] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Zhang, Yanjia J.; Rubin, Eric J.] Harvard Univ, Sch Publ Hlth, Dept Immunol & Infect Dis, Boston, MA 02115 USA; [Khati, Makobetsa] Groote Schuur Hosp, Dept Med, ZA-7925 Cape Town, South Africa; [Khati, Makobetsa] Univ Cape Town, ZA-7925 Cape Town, South Africa	Council for Scientific & Industrial Research (CSIR) - South Africa; University of Kwazulu Natal; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Harvard University; Harvard T.H. Chan School of Public Health; University of Cape Town; University of Cape Town	Khati, M (corresponding author), CSIR, Emerging Hlth Technol Platform, Biosci Unit, ZA-0001 Pretoria, Gauteng, South Africa.	Mkhati@csir.co.za		Gresh, Lionel/0000-0002-2333-1748; Rubin, Eric/0000-0001-5120-962X; Pym, Alexander/0000-0002-6260-8180	South African Department of Science and Technology; Technology Innovation Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007638] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	South African Department of Science and Technology; Technology Innovation Agency; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the South African Department of Science and Technology (www.dst.gov.za) and the Technology Innovation Agency (www.tia.org.za). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adda CG, 2002, COMB CHEM HIGH T SCR, V5, P1; Brennan PJ, 2003, TUBERCULOSIS, V83, P91, DOI 10.1016/S1472-9792(02)00089-6; Chan ED, 2000, AM J RESP CRIT CARE, V161, P1713, DOI 10.1164/ajrccm.161.5.9908125; Chen YCJ, 1996, P NATL ACAD SCI USA, V93, P1997, DOI 10.1073/pnas.93.5.1997; Davis JL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016321; Dias-Neto E, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008338; Fend R, 2006, J CLIN MICROBIOL, V44, P2039, DOI 10.1128/JCM.01591-05; Griffin JE, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002251; Huang J, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/101932; KINGSBURY GA, 1995, NUCLEIC ACIDS RES, V23, P2563, DOI 10.1093/nar/23.13.2563; Kiselar JG, 1999, BIOCHEMISTRY-US, V38, P14185, DOI 10.1021/bi991609j; LEVY H, 1989, CHEST, V95, P1193, DOI 10.1378/chest.95.6.1193; Ling DI, 2011, EUR RESPIR J, V38, P649, DOI 10.1183/09031936.00181610; Ling DI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001536; Lucchese G, 2009, FEMS IMMUNOL MED MIC, V57, P88, DOI 10.1111/j.1574-695X.2009.00582.x; Lunder M, 2008, BIOTECHNIQUES, V44, P893, DOI 10.2144/000112759; Phillips M, 2007, TUBERCULOSIS, V87, P44, DOI 10.1016/j.tube.2006.03.004; Ravn P, 2005, CLIN DIAGN LAB IMMUN, V12, P491, DOI 10.1128/CDLI.12.4.491-496.2005; SADA E, 1992, J CLIN MICROBIOL, V30, P2415, DOI 10.1128/JCM.30.9.2415-2418.1992; Sampson SL, 2004, INFECT IMMUN, V72, P3031, DOI 10.1128/IAI.72.5.3031-3037.2004; Steingart KR, 2006, LANCET INFECT DIS, V6, P664, DOI 10.1016/S1473-3099(06)70602-8; Stratmann J, 2002, J CLIN MICROBIOL, V40, P4244, DOI 10.1128/JCM.40.11.4244-4250.2002; 't Hoen PAC, 2012, ANAL BIOCHEM, V421, P622, DOI 10.1016/j.ab.2011.11.005; Van Deun A, 2002, INT J TUBERC LUNG D, V6, P222; Vodnik M, 2011, MOLECULES, V16, P790, DOI 10.3390/molecules16010790; Wallis RS, 2010, LANCET INFECT DIS, V10, P68, DOI 10.1016/S1473-3099(10)70003-7; Wallis RS, 2001, J INFECT DIS, V183, P1300, DOI 10.1086/319679; WHO, 2012, WHO REPORT 2012 GLOB; Zhong YW, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-542	29	18	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e77844	10.1371/journal.pone.0077844	http://dx.doi.org/10.1371/journal.pone.0077844			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265677	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100010
J	Simoes, HG; Asano, RY; Sales, MM; Browne, RAV; Arsa, G; Motta-Santos, D; Puga, GM; Lima, LCD; Campbell, CSG; Franco, OL				Simoes, Herbert Gustavo; Asano, Ricardo Yukio; Sales, Marcelo Magalhaes; Vieira Browne, Rodrigo Alberto; Arsa, Gisela; Motta-Santos, Daisy; Puga, Guilherme Morais; de Jesus Lima, Laila Candida; Grubert Campbell, Carmen Silvia; Franco, Octavio Luiz			Type 2 Diabetes Elicits Lower Nitric Oxide, Bradykinin Concentration and Kallikrein Activity Together with Higher DesArg(9)-BK and Reduced Post-Exercise Hypotension Compared to Non-Diabetic Condition	PLOS ONE			English	Article							ANAEROBIC THRESHOLD; ENDOTHELIAL DYSFUNCTION; OXIDATIVE STRESS; EXERCISE; GLUCOSE; HYPERTENSION; COAGULATION; ACTIVATION; INCREASE; LACTATE	This study compared the plasma kallikrein activity (PKA), bradykinin concentration (BK), DesArg(9)-BK production, nitric oxide release (NO) and blood pressure (BP) response after moderate-intensity aerobic exercise performed by individuals with and without type 2 diabetes. Ten subjects with type 2 diabetes (T2D) and 10 without type 2 diabetes (ND) underwent three sessions: 1) maximal incremental test on cycle ergometer to determine lactate threshold (LT); 2) 20-min of constant-load exercise on cycle ergometer, at 90% LT and; 3) control session. BP and oxygen uptake were measured at rest and at 15, 30 and 45 min post-exercise. Venous blood samples were collected at 15 and 45 minutes of the recovery period for further analysis of PKA, BK and DesArg(9)-BK. Nitrite plus nitrate (NOx) was analyzed at 15 minutes post exercise. The ND group presented post-exercise hypotension (PEH) of systolic blood pressure and mean arterial pressure on the 90% LT session but T2D group did not. Plasma NOx increased similar to 24.4% for ND and similar to 13.8% for T2D group 15min after the exercise session. Additionally, only ND individuals showed increases in PKA and BK in response to exercise and only T2D group showed increased DesArg(9)-BK production. It was concluded that T2D individuals presented lower PKA, BK and NOx release as well as higher DesArg(9)-BK production and reduced PEH in relation to ND participants after a single exercise session.	[Simoes, Herbert Gustavo; Asano, Ricardo Yukio; Sales, Marcelo Magalhaes; Vieira Browne, Rodrigo Alberto; de Jesus Lima, Laila Candida; Grubert Campbell, Carmen Silvia; Franco, Octavio Luiz] Univ Catolica Brasilia, Programa Posgrad Educ Fis, Brasilia, DF, Brazil; [Arsa, Gisela] Univ Fed Mato Grosso, Programa Posgrad Educ Fis, Cuiaba, Mato Grosso, Brazil; [Motta-Santos, Daisy] Univ Fed Minas Gerais, Inst Ciencias Biol, Dept Fisiol & Biofis, Belo Horizonte, MG, Brazil; [Puga, Guilherme Morais] UNESP, Dept Educ Fis, Rio Claro, SP, Brazil; [Puga, Guilherme Morais] Univ Fed Uberlandia, Dept Educ Fis, Uberlandia, MG, Brazil; [Simoes, Herbert Gustavo; Franco, Octavio Luiz] Univ Catolica Brasilia, Ctr Anal Proteom & Bioquim, Brasilia, DF, Brazil; [Simoes, Herbert Gustavo; Franco, Octavio Luiz] Univ Fed Juiz de Fora, Programa Posgrad Imunol, Juiz De Fora, MG, Brazil; [Simoes, Herbert Gustavo; Franco, Octavio Luiz] Univ Fed Juiz de Fora, DIP Genet & Biotecnol, Juiz De Fora, MG, Brazil	Universidade Catolica de Brasilia; Universidade Federal de Mato Grosso; Universidade Federal de Minas Gerais; Universidade Estadual Paulista; Universidade Federal de Uberlandia; Universidade Catolica de Brasilia; Universidade Federal de Juiz de Fora; Universidade Federal de Juiz de Fora	Simoes, HG (corresponding author), Univ Catolica Brasilia, Programa Posgrad Educ Fis, Brasilia, DF, Brazil.	hgsimoes@gmail.com	Browne, Rodrigo Alberto Vieira/J-8284-2014; Arsa, Gisela/ABG-3856-2021; Santos, Robson A S/C-9336-2011; Franco, Octavio L/T-3020-2017; Puga, Guilherme M/F-4854-2019; Sales, Marcelo M/G-7189-2012; Sales, Marcelo Magalhães/AAM-1045-2020; Motta-Santos, Daisy/A-9191-2010; Campbell, Carmen SG/D-4281-2014	Browne, Rodrigo Alberto Vieira/0000-0003-3005-247X; Arsa, Gisela/0000-0003-3586-3749; Santos, Robson A S/0000-0001-8738-5852; Puga, Guilherme M/0000-0002-9093-6640; Sales, Marcelo M/0000-0003-3814-6964; Sales, Marcelo Magalhães/0000-0003-3814-6964; Motta-Santos, Daisy/0000-0002-3265-7838; Franco, Octavio/0000-0001-9546-0525; Silvia Grubert Campbell, Carmen/0000-0001-5946-7180; Simoes, Herbert/0000-0002-2378-4026	CNPq; CAPES; CAPES/PROCAD	CNPq(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); CAPES(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); CAPES/PROCAD(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES))	The authors are grateful for the students' scholarships at undergraduate (CNPq), masters (CAPES) and PhD (CAPES and CNPq), as well as for the research productivity scholarships (CNPq) and materials for this research (CAPES/PROCAD and CNPq). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, J EXERCISE PHYSL ONL; Augeri A.L., 2009, ATHEROSCLEROSIS, V204, pE28, DOI [10.1016/j.atherosclerosis.2008.12.015, DOI 10.1016/j.atherosclerosis.2008.12.015, DOI 10.1016/J.ATHEROSCLEROSIS.2008.12.015]; Belli T, 2007, DIABETES RES CLIN PR, V76, P18, DOI 10.1016/j.diabres.2006.07.028; Camm AJ, 1996, CIRCULATION, V93, P1043; Carnethon MR, 2003, DIABETES CARE, V26, P3035, DOI 10.2337/diacare.26.11.3035; Chobanian AV., 2003, HYPERTENSION, V42, P1206, DOI [10.1161/01.HYP.0000107251, DOI 10.1161/01.HYP.9.2_PT_2.II36, DOI 10.1161/01.HYP.0000107251.49515.C2]; Cubbon RM, 2010, ARTERIOSCL THROM VAS, V30, P878, DOI 10.1161/ATVBAHA.109.201012; Frontoni S, 2005, NUTR METAB CARDIOVAS, V15, P441, DOI 10.1016/j.numecd.2005.06.010; Granger DL, 1999, METHOD ENZYMOL, V301, P49; Grossman E, 2008, DIABETES CARE, V31, pS185, DOI 10.2337/dc08-s246; Guerci B, 2001, DIABETES METAB, V27, P436; HOWLEY ET, 1995, MED SCI SPORT EXER, V27, P1292; Jaffa AA, 2003, DIABETES, V52, P1215, DOI 10.2337/diabetes.52.5.1215; Jermendy G, 2003, ACTA DIABETOL, V40, pS370, DOI 10.1007/s00592-003-0122-y; Lima LCJ, 2008, DIABETES RES CLIN PR, V81, P216, DOI 10.1016/j.diabres.2008.04.019; LOTTENBERG R, 1981, METHOD ENZYMOL, V80, P341; Meyer T, 2005, AM HEART J, V149, DOI 10.1016/j.ahj.2004.72.006; Miche E, 2006, CLIN RES CARDIOL, V95, P117, DOI 10.1007/s00392-006-1106-z; Moraes MR, 2007, BIOL CHEM, V388, P533, DOI 10.1515/BC.2007.055; Morais PK, 2011, DIABETES METAB, V37, P112, DOI 10.1016/j.diabet.2010.08.008; Moreira SR, 2007, BRAZ J PHYS THER, V11, P289, DOI 10.1590/S1413-35552007000400008; Motta DF, 2010, DIABETES METAB, V36, P363, DOI 10.1016/j.diabet.2010.03.008; Nystrom T, 2006, CLIN SCI, V110, P673, DOI 10.1042/CS20050353; Okada Y, 1999, BIOPOLYMERS, V51, P41, DOI 10.1002/(SICI)1097-0282(1999)51:1<41::AID-BIP5>3.0.CO;2-Y; Pontes FL, 2008, INT IMMUNOPHARMACOL, V8, P261, DOI 10.1016/j.intimp.2007.09.001; RAYMOND P, 1995, J IMMUNOL METHODS, V180, P247, DOI 10.1016/0022-1759(94)00320-V; Resnick HE, 2002, ANNU REV MED, V53, P245, DOI 10.1146/annurev.med.53.082901.103904; Rodrigo R, 2007, HYPERTENS RES, V30, P1159, DOI 10.1291/hypres.30.1159; Rohlfing CL, 2002, DIABETES CARE, V25, P275, DOI 10.2337/diacare.25.2.275; SAKR HF, 2010, AM J BIOCH BIOTECHNO, V6, P103, DOI DOI 10.3844/AJBBSP.2010.103.110; Sales MM, 2011, DIABETOL METAB SYNDR, V3, DOI 10.1186/1758-5996-3-1; Sharma JN, 2012, J DIABETES METAB, V3, DOI 10.4172/2155-6156.S4-004; Simoes HG, 2010, ARQ BRAS CARDIOL, V94, P71, DOI 10.1590/S0066-782X2010000100012; Simoes HG, 2010, PERCEPT MOTOR SKILL, V111, P365, DOI 10.2466/06.13.15.27.PMS.111.5.365-378; Stabler T, 2010, ANN NY ACAD SCI, V1203, P101, DOI 10.1111/j.1749-6632.2010.05599.x; Taguchi T, 2000, METABOLISM, V49, P920, DOI 10.1053/meta.2000.6755; Tentolouris N, 2008, NEUROMOL MED, V10, P169, DOI 10.1007/s12017-008-8022-5; WANAKA K, 1990, THROMB RES, V57, P889, DOI 10.1016/0049-3848(90)90155-6; Zhu WL, 2007, EUR J APPL PHYSIOL, V99, P585, DOI 10.1007/s00421-006-0378-3	39	15	15	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80348	10.1371/journal.pone.0080348	http://dx.doi.org/10.1371/journal.pone.0080348			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265812	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100148
J	Lizak, C; Gerber, S; Zinne, D; Michaud, G; Schubert, M; Chen, F; Bucher, M; Darbre, T; Zenobi, R; Reymond, JL; Locher, KP				Lizak, Christian; Gerber, Sabina; Zinne, Daria; Michaud, Gaelle; Schubert, Mario; Chen, Fan; Bucher, Monika; Darbre, Tamis; Zenobi, Renato; Reymond, Jean-Louis; Locher, Kaspar P.			A Catalytically Essential Motif in External Loop 5 of the Bacterial Oligosaccharyltransferase PglB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LINKED PROTEIN GLYCOSYLATION; X-RAY-STRUCTURE; SUBSTRATE-SPECIFICITY; N-GLYCOSYLATION; CAMPYLOBACTER-JEJUNI; MECHANISM; COMPLEX; STT3; GLYCANS; ROLES	Asparagine-linked glycosylation is a post-translational protein modification that is conserved in all domains of life. The initial transfer of a lipid-linked oligosaccharide (LLO) onto acceptor asparagines is catalyzed by the integral membrane protein oligosaccharyltransferase (OST). The previously reported structure of a single-subunit OST enzyme, the Campylobacter lari protein PglB, revealed a partially disordered external loop (EL5), whose role in catalysis was unclear. We identified a new and functionally important sequence motif in EL5 containing a conserved tyrosine residue (Tyr(293)) whose aromatic side chain is essential for catalysis. A synthetic peptide containing the conserved motif can partially but specifically rescue in vitro activity of mutated PglB lacking Tyr293. Using site-directed disulfide cross-linking, we show that disengagement of the structurally ordered part of EL5 is an essential step of the glycosylation reaction, probably by allowing sequon binding or glyco-product release. Our findings define two distinct mechanistic roles of EL5 in OST-catalyzed glycosylation. These functions, exerted by the two halves of EL5, are independent, because the loop can be cleaved by specific proteolysis with only slight reduction in activity.	[Lizak, Christian; Gerber, Sabina; Zinne, Daria; Schubert, Mario; Bucher, Monika; Locher, Kaspar P.] ETH, Dept Biol, Inst Mol Biol & Biophys, CH-8093 Zurich, Switzerland; [Michaud, Gaelle; Darbre, Tamis; Reymond, Jean-Louis] Univ Bern, Dept Chem & Biochem, CH-3012 Bern, Switzerland; [Chen, Fan; Zenobi, Renato] ETH, Dept Chem & Appl Biosci, CH-8093 Zurich, Switzerland	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Bern; Swiss Federal Institutes of Technology Domain; ETH Zurich	Locher, KP (corresponding author), ETH, Dept Biol, Inst Mol Biol & Biophys, Schafmattstr 20, CH-8093 Zurich, Switzerland.	locher@mol.biol.ethz.ch	Schubert, Mario/B-3972-2008	Schubert, Mario/0000-0003-0278-4091; Reymond, Jean-Louis/0000-0003-2724-2942	NCCR Structural Biology Zurich; Swiss National Science Foundation Grants [SNF 200020-125020, SNF 200020-124663, SNF 31003A-131075/1, SNF 31003A-146191/1]	NCCR Structural Biology Zurich; Swiss National Science Foundation Grants(Swiss National Science Foundation (SNSF))	This work was supported by a grant from NCCR Structural Biology Zurich (to K. P. L.) and Swiss National Science Foundation Grants SNF 200020-125020 (to J. L. R.), SNF 200020-124663 (to R. Z.), and SNF 31003A-131075/1 and SNF 31003A-146191/1 (to K. P. L.).	Abu-Qarn M, 2007, J MOL BIOL, V374, P1224, DOI 10.1016/j.jmb.2007.10.042; Baar C, 2003, P NATL ACAD SCI USA, V100, P11690, DOI 10.1073/pnas.1932838100; Calo D, 2010, GLYCOBIOLOGY, V20, P1065, DOI 10.1093/glycob/cwq055; Chen F, 2013, ANAL CHEM, V85, P3483, DOI 10.1021/ac4000943; Dell Anne, 2010, Int J Microbiol, V2010, P148178, DOI 10.1155/2010/148178; Eichler J, 2013, NAT REV MICROBIOL, V11, P151, DOI 10.1038/nrmicro2957; Feldman MF, 2005, P NATL ACAD SCI USA, V102, P3016, DOI 10.1073/pnas.0500044102; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Hese K, 2009, GLYCOBIOLOGY, V19, P160, DOI 10.1093/glycob/cwn118; Jervis AJ, 2012, J BACTERIOL, V194, P2355, DOI 10.1128/JB.00042-12; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Kowarik M, 2006, SCIENCE, V314, P1148, DOI 10.1126/science.1134351; Lefebre MD, 2002, APPL ENVIRON MICROB, V68, P5956, DOI 10.1128/AEM.68.12.5956-5964.2002; Linton D, 2005, MOL MICROBIOL, V55, P1695, DOI 10.1111/j.1365-2958.2005.04519.x; Lizak C, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3627; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lizak C, 2011, BIOCONJUGATE CHEM, V22, P488, DOI 10.1021/bc100511k; Losfeld ME, 2012, FASEB J, V26, P4210, DOI 10.1096/fj.12-211656; Markley JL, 1998, PURE APPL CHEM, V70, P117, DOI 10.1351/pac199870010117; Matsumoto S, 2013, P NATL ACAD SCI USA, V110, P17868, DOI 10.1073/pnas.1309777110; Mattle D, 2010, J MOL BIOL, V404, P220, DOI 10.1016/j.jmb.2010.09.005; Morales JC, 2008, CHEM-EUR J, V14, P7828, DOI 10.1002/chem.200800335; Nasab FP, 2008, MOL BIOL CELL, V19, P3758, DOI 10.1091/mbc.E08-05-0467; Nilsson I, 2003, J CELL BIOL, V161, P715, DOI 10.1083/jcb.200301043; Nothaft H, 2013, J BIOL CHEM, V288, P6912, DOI 10.1074/jbc.R112.417857; Nothaft H, 2010, NAT REV MICROBIOL, V8, P765, DOI 10.1038/nrmicro2383; Nyirenda J, 2013, STRUCTURE, V21, P32, DOI 10.1016/j.str.2012.10.011; Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264; Schubert M, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002706; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Tai VWF, 2001, BIOORGAN MED CHEM, V9, P1133, DOI 10.1016/S0968-0896(00)00334-5; Tai VWF, 2001, J ORG CHEM, V66, P6217, DOI 10.1021/jo0100345; VARKI A, 1993, GLYCOBIOLOGY, V3, P97, DOI 10.1093/glycob/3.2.97; Wacker M, 2006, P NATL ACAD SCI USA, V103, P7088, DOI 10.1073/pnas.0509207103; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; WEIS W, 1988, NATURE, V333, P426, DOI 10.1038/333426a0; Weis WI, 1996, ANNU REV BIOCHEM, V65, P441, DOI 10.1146/annurev.bi.65.070196.002301; Woo JS, 2012, NAT STRUCT MOL BIOL, V19, P1310, DOI 10.1038/nsmb.2417; WRIGHT CS, 1990, J MOL BIOL, V215, P635, DOI 10.1016/S0022-2836(05)80174-3; WRIGHT CS, 1984, J MOL BIOL, V178, P91, DOI 10.1016/0022-2836(84)90232-8; Yan G, 2002, J BIOL CHEM, V277, P47692, DOI 10.1074/jbc.M208136200	43	21	23	0	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					735	746		10.1074/jbc.M113.524751	http://dx.doi.org/10.1074/jbc.M113.524751			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275651	Green Published, hybrid			2022-12-25	WOS:000330541200013
J	Alsarraj, J; Faraji, F; Geiger, TR; Mattaini, KR; Williams, M; Wu, J; Ha, NH; Merlino, T; Walker, RC; Bosley, AD; Xiao, Z; Andresson, T; Esposito, D; Smithers, N; Lugo, D; Prinjha, R; Day, A; Crawford, NPS; Ozato, K; Gardner, K; Hunter, KW				Alsarraj, Jude; Faraji, Farhoud; Geiger, Thomas R.; Mattaini, Katherine R.; Williams, Mia; Wu, Josephine; Ha, Ngoc-Han; Merlino, Tyler; Walker, Renard C.; Bosley, Allen D.; Xiao, Zhen; Andresson, Thorkell; Esposito, Dominic; Smithers, Nicholas; Lugo, Dave; Prinjha, Rab; Day, Anup; Crawford, Nigel P. S.; Ozato, Keiko; Gardner, Kevin; Hunter, Kent W.			BRD4 Short Isoform Interacts with RRP1B, SIPA1 and Components of the LINC Complex at the Inner Face of the Nuclear Membrane	PLOS ONE			English	Article							BROMODOMAIN PROTEIN BRD4; P-TEFB; C-MYC; CANCER; CHROMATIN; RECRUITMENT; METASTASIS; INHIBITION; GENE; BINDING	Recent studies suggest that BET inhibitors are effective anti-cancer therapeutics. Here we show that BET inhibitors are effective against murine primary mammary tumors, but not pulmonary metastases. BRD4, a target of BET inhibitors, encodes two isoforms with opposite effects on tumor progression. To gain insights into why BET inhibition was ineffective against metastases the pro-metastatic short isoform of BRD4 was characterized using mass spectrometry and cellular fractionation. Our data show that the pro-metastatic short isoform interacts with the LINC complex and the metastasis-associated proteins RRP1B and SIPA1 at the inner face of the nuclear membrane. Furthermore, histone binding arrays revealed that the short isoform has a broader acetylated histone binding pattern relative to the long isoform. These differential biochemical and nuclear localization properties revealed in our study provide novel insights into the opposing roles of BRD4 isoforms in metastatic breast cancer progression.	[Alsarraj, Jude; Faraji, Farhoud; Geiger, Thomas R.; Mattaini, Katherine R.; Williams, Mia; Wu, Josephine; Ha, Ngoc-Han; Merlino, Tyler; Walker, Renard C.; Hunter, Kent W.] NCI, Ctr Canc Res, Lab Canc Biol & Genet, NIH, Bethesda, MD 20892 USA; [Faraji, Farhoud] St Louis Univ, Sch Med, Dept Biochem & Mol Biol, St Louis, MO 63104 USA; [Bosley, Allen D.; Xiao, Zhen; Andresson, Thorkell; Esposito, Dominic] Frederick Natl Lab Canc Res, Lab Prote & Analyt Technol, Frederick, MD USA; [Smithers, Nicholas; Lugo, Dave; Prinjha, Rab] GlaxoSmithKline, Immuno Inflammat Therapeut Area, Epinova DPU & Quantitat Pharmacol, Stevenage, Herts, England; [Day, Anup; Ozato, Keiko] Natl Inst Child Hlth & Human Dev, Lab Mol Growth Regulat, NIH, Bethesda, MD USA; [Crawford, Nigel P. S.] NHGRI, Canc Genet Branch, NIH, Bethesda, MD 20892 USA; [Gardner, Kevin] NCI, Ctr Canc Res, Genet Branch, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Saint Louis University; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); GlaxoSmithKline; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Hunter, KW (corresponding author), Univ Washington, Sch Med, Dept Med, Div Cardiol, Seattle, WA 98195 USA.	hunter@mail.nih.gov	Faraji, Farhoud/AAG-2417-2019	Faraji, Farhoud/0000-0001-5078-813X; Wu, Josephine/0000-0001-8740-7716; Esposito, Dominic/0000-0002-9987-1687	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research;  [ZIA BC 011255]; NATIONAL CANCER INSTITUTE [ZIABC010847, ZIABC011255] Funding Source: NIH RePORTER	Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); ; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Intramural project number/grant number ZIA BC 011255. This research was supported by the Intramural Research Program of the NIH, National Cancer Institute, Center for Cancer Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alsarraj J, 2011, CANCER RES, V71, P3121, DOI 10.1158/0008-5472.CAN-10-4417; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104; Bock I, 2011, BMC BIOCHEM, V12, DOI 10.1186/1471-2091-12-48; Chambliss AB, 2013, SCI REP-UK, V3, DOI 10.1038/srep01087; Chamousset D, 2010, MOL BIOL CELL, V21, P4212, DOI 10.1091/mbc.E10-04-0287; Chen J, 2009, NUCLEIC ACIDS RES, V37, pW305, DOI 10.1093/nar/gkp427; Chi YH, 2007, J BIOL CHEM, V282, P27447, DOI 10.1074/jbc.M703098200; Cole PA, 2008, NAT CHEM BIOL, V4, P590, DOI 10.1038/nchembio.111; Crawford NPS, 2008, CLIN EXP METASTAS, V25, P357, DOI 10.1007/s10585-008-9146-6; Crawford NPS, 2007, PLOS GENET, V3, P2296, DOI 10.1371/journal.pgen.0030214; Crawford NPS, 2008, P NATL ACAD SCI USA, V105, P6380, DOI 10.1073/pnas.0710331105; Crawford NPS, 2009, J BIOL CHEM, V284, P28660, DOI 10.1074/jbc.M109.023457; Crawford NPS, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1389; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Das S, 2010, J PROTEOME RES, V9, P6696, DOI 10.1021/pr100843x; Dawson MA, 2011, NATURE, V478, P529, DOI 10.1038/nature10509; Delmore JE, 2011, CELL, V146, P903, DOI 10.1016/j.cell.2011.08.017; den Bakker MA, 2009, AM J SURG PATHOL, V33, P1253, DOI 10.1097/PAS.0b013e3181abe120; Dey A, 2000, MOL CELL BIOL, V20, P6537, DOI 10.1128/MCB.20.17.6537-6549.2000; Dey A, 2003, P NATL ACAD SCI USA, V100, P8758, DOI 10.1073/pnas.1433065100; Farina A, 2004, MOL CELL BIOL, V24, P9059, DOI 10.1128/MCB.24.20.9059-9069.2004; Filippakopoulos P, 2012, CELL, V149, P214, DOI 10.1016/j.cell.2012.02.013; Filippakopoulos P, 2010, NATURE, V468, P1067, DOI 10.1038/nature09504; French CA, 2008, ONCOGENE, V27, P2237, DOI 10.1038/sj.onc.1210852; French CA, 2012, ANNU REV PATHOL-MECH, V7, P247, DOI 10.1146/annurev-pathol-011811-132438; Harazaki M, 2004, IMMUNOL LETT, V92, P221, DOI 10.1016/j.imlet.2004.01.004; Hodzic DM, 2004, J BIOL CHEM, V279, P25805, DOI 10.1074/jbc.M313157200; Hsieh SM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-331; Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jang MK, 2005, MOL CELL, V19, P523, DOI 10.1016/j.molcel.2005.06.027; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Korfali N, 2010, MOL CELL PROTEOMICS, V9, P2571, DOI 10.1074/mcp.M110.002915; Kubben N, 2010, NUCLEUS-PHILA, V1, P460, DOI 10.4161/nucl.1.6.13513; Kubben N, 2010, NUCLEUS-PHILA, V1, P513, DOI 10.4161/nucl.1.6.13512; Kurachi H, 1997, J BIOL CHEM, V272, P28081, DOI 10.1074/jbc.272.44.28081; Liu H, 2012, NAT CELL BIOL, V14, P567, DOI 10.1038/ncb2491; Liu Y, 2008, BIOCHEMISTRY-US, V47, P6403, DOI 10.1021/bi8001659; Maruyama T, 2002, MOL CELL BIOL, V22, P6509, DOI 10.1128/MCB.22.18.6509-6520.2002; Mendoza A, 2010, J CLIN INVEST, V120, P2979, DOI 10.1172/JCI40252; Mertz JA, 2011, P NATL ACAD SCI USA, V108, P16669, DOI 10.1073/pnas.1108190108; Meuleman W, 2013, GENOME RES, V23, P270, DOI 10.1101/gr.141028.112; Noda Y, 2005, BIOL CELL, V97, P885; Ott CJ, 2012, BLOOD, V120, P2843, DOI 10.1182/blood-2012-02-413021; Paik JC, 2010, J BIOL CHEM, V285, P6348, DOI 10.1074/jbc.M109.072074; Park YG, 2005, NAT GENET, V37, P1055, DOI 10.1038/ng1635; Pei XF, 2004, IN VITRO CELL DEV-AN, V40, P14; Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Uhlen M, 2005, MOL CELL PROTEOMICS, V4, P1920, DOI 10.1074/mcp.M500279-MCP200; van Koningsbruggen S, 2010, MOL BIOL CELL, V21, P3735, DOI 10.1091/mbc.E10-06-0508; Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712; Wang N, 2009, NAT REV MOL CELL BIO, V10, P75, DOI 10.1038/nrm2594; Wu SY, 2013, MOL CELL, V49, P843, DOI 10.1016/j.molcel.2012.12.006; Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029; Zhang L, 2007, BIOCHEM BIOPH RES CO, V361, P611, DOI 10.1016/j.bbrc.2007.07.089; Zuber J, 2011, NATURE, V478, P524, DOI 10.1038/nature10334	58	39	39	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80746	10.1371/journal.pone.0080746	http://dx.doi.org/10.1371/journal.pone.0080746			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260471	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900093
J	Fendler, A; Jung, M; Stephan, C; Erbersdobler, A; Jung, K; Yousef, GM				Fendler, Annika; Jung, Monika; Stephan, Carsten; Erbersdobler, Andreas; Jung, Klaus; Yousef, George M.			The Antiapoptotic Function of miR-96 in Prostate Cancer by Inhibition of FOXO1	PLOS ONE			English	Article							TUMOR-SUPPRESSOR GENE; MICRORNA EXPRESSION; PHOSPHORYLATION; APOPTOSIS; SURVIVAL; MIR-182; FKHR; SIGNATURE; TARGETS; PROFILE	microRNAs (miRNAs) are small molecules that regulate gene expression posttranscriptionally. In a previous study, we identified miR-96 to be upregulated in prostate cancer specimens in comparison to normal adjacent tissue and to be an independent marker of biochemical relapse in a multivariate prediction model. Therefore, we investigated the functional role of miR-96 in prostate carcinogenesis. LNCaP and DU145 prostate cancer cells were transiently transfected with miR-96 precursors and phenotypic changes were analyzed. The miR-96 increased proliferation and impaired apoptosis induced by camptothecine in these cells. In silico target prediction analysis identified FOXO1 as potential pro-apoptotic miR-96 target. miR-96 was able to bind to both bindings sites in the FOXO1 3' UTR in a luciferase reporter gene assay. Overexpression of miR-96 in LNCaP cells resulted in a reduced FOXO1 expression. Overexpression of FOXO1 induced a strong apoptotic phenotype that was partially rescued by coexpression of miR-96. RT-qPCR and immunohistochemistry of 69 prostate cancer specimens revealed a downregulation of FOXO1 and an inverse correlation of miR-96 and FOXO1 protein expression. In conclusion, we show that miR-96 can regulate apoptosis in prostate cancer, by inhibiting the FOXO1 transcription factor.	[Fendler, Annika; Jung, Monika; Stephan, Carsten; Jung, Klaus] Charite, Dept Urol, Berlin, Germany; [Fendler, Annika; Stephan, Carsten; Jung, Klaus] Berlin Inst Urol Res, Berlin, Germany; [Erbersdobler, Andreas] Univ Hosp Rostock, Dept Pathol, Rostock, Germany; [Yousef, George M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Dept Lab Med, Toronto, ON M5B 1W8, Canada; [Yousef, George M.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON M5B 1W8, Canada; [Yousef, George M.] Univ Toronto, Dept Lab Med & Pathobiol, Toronto, ON, Canada	Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Rostock; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Fendler, A (corresponding author), Charite, Dept Urol, Berlin, Germany.	Annika.Schaefer@charite.de	Jung, Klaus/Z-2122-2018	Jung, Klaus/0000-0001-9797-5362; Fendler, Annika/0000-0002-7267-0981; Stephan, Carsten/0000-0002-3270-258X	Foundation for Urologic Research, Berlin; Sonnenfeld Stiftung, Berlin	Foundation for Urologic Research, Berlin; Sonnenfeld Stiftung, Berlin	The work of AF and KJ was funded by the Foundation for Urologic Research, Berlin and the Sonnenfeld Stiftung, Berlin. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Dong XY, 2006, CANCER RES, V66, P6998, DOI 10.1158/0008-5472.CAN-06-0411; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Geback T, 2009, BIOTECHNIQUES, V46, P265, DOI 10.2144/000113083; Gokhale A, 2010, J CANCER RES THER, V6, P521, DOI 10.4103/0973-1482.77072; Gunia S, 2010, PATHOL ONCOL RES, V16, P371, DOI 10.1007/s12253-009-9231-4; Guttilla IK, 2009, J BIOL CHEM, V284, P23204, DOI 10.1074/jbc.M109.031427; Han S, 2011, CURR EYE RES, V36, P71, DOI 10.3109/02713683.2010.510943; Huang HJ, 2006, SCIENCE, V314, P294, DOI 10.1126/science.1130512; Jalvy-Delvaille S, 2012, NUCLEIC ACIDS RES, V40, P1356, DOI 10.1093/nar/gkr843; Jemal A, 2011, CA-CANCER J CLIN, V61, P133, DOI [10.3322/caac.20105, 10.3322/caac.20073]; Kim SJ, 2005, J BIOL CHEM, V280, P22297, DOI 10.1074/jbc.M500540200; Kops GJPL, 2002, MOL CELL BIOL, V22, P2025, DOI 10.1128/MCB.22.7.2025-2036.2002; Lein M, 2006, EUR UROL, V50, P1278, DOI 10.1016/j.eururo.2006.06.023; Li R, 2007, HUM PATHOL, V38, P1501, DOI 10.1016/j.humpath.2007.02.016; Li T, 2009, BIOCHEM BIOPH RES CO, V383, P280, DOI 10.1016/j.bbrc.2009.03.077; Lin HX, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015797; Lin SL, 2008, RNA, V14, P417, DOI 10.1261/rna.874808; Liu P, 2008, ONCOGENE, V27, P4733, DOI 10.1038/onc.2008.104; Loscher CJ, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r248; Machida S, 2003, J CELL PHYSIOL, V196, P523, DOI 10.1002/jcp.10339; Matsuzaki H, 2003, P NATL ACAD SCI USA, V100, P11285, DOI 10.1073/pnas.1934283100; Mihelich BL, 2011, J BIOL CHEM, V286, P44503, DOI 10.1074/jbc.M111.262915; Modur V, 2002, J BIOL CHEM, V277, P47928, DOI 10.1074/jbc.M207509200; Morgan TM, 2009, CURR CANCER DRUG TAR, V9, P237, DOI 10.2174/156800909787580999; Motta MC, 2004, CELL, V116, P551, DOI 10.1016/S0092-8674(04)00126-6; Myatt SS, 2010, CANCER RES, V70, P367, DOI 10.1158/0008-5472.CAN-09-1891; Navon R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008003; Ohl F, 2005, J MOL MED, V83, P1014, DOI 10.1007/s00109-005-0703-z; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Rabien A, 2010, INT J CANCER, V127, P2386, DOI 10.1002/ijc.25435; Rena G, 1999, J BIOL CHEM, V274, P17179, DOI 10.1074/jbc.274.24.17179; Sacheli R, 2009, GENE EXPR PATTERNS, V9, P364, DOI 10.1016/j.gep.2009.01.003; Sarver AL, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-401; Sato F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016435; Schaefer A, 2010, INT J CANCER, V126, P1166, DOI 10.1002/ijc.24827; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Spahn M, 2010, INT J CANCER, V127, P394, DOI 10.1002/ijc.24715; Tong AW, 2009, CANCER GENE THER, V16, P206, DOI 10.1038/cgt.2008.77; VANKUPPEVELD FJM, 1994, APPL ENVIRON MICROB, V60, P149, DOI 10.1128/AEM.60.1.149-152.1994; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang Y, 2012, MOL MED REP, V5, P260, DOI 10.3892/mmr.2011.621; Xie LK, 2012, BLOOD, V119, P3503, DOI 10.1182/blood-2011-09-381905; Xu SB, 2007, J BIOL CHEM, V282, P25053, DOI 10.1074/jbc.M700501200; Yu SN, 2010, CANCER RES, V70, P6015, DOI 10.1158/0008-5472.CAN-09-4531; Zeng FY, 2009, CANCER LETT, V284, P157, DOI 10.1016/j.canlet.2009.04.016	47	59	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80807	10.1371/journal.pone.0080807	http://dx.doi.org/10.1371/journal.pone.0080807			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260486	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900098
J	Katsuki, F; Constantinidis, C				Katsuki, Fumi; Constantinidis, Christos			Time Course of Functional Connectivity in Primate Dorsolateral Prefrontal and Posterior Parietal Cortex during Working Memory	PLOS ONE			English	Article							INFERIOR TEMPORAL CORTEX; LATERAL INTRAPARIETAL AREA; MONKEY AOTUS-TRIVIRGATUS; D1 RECEPTOR ACTIONS; EYE FIELD NEURONS; SHORT-TERM-MEMORY; CEREBRAL-CORTEX; RECURRENT EXCITATION; SPATIAL INFORMATION; PERSISTENT ACTIVITY	The dorsolateral prefrontal and posterior parietal cortex play critical roles in mediating attention, working memory, and executive function. Despite proposed dynamic modulation of connectivity strength within each area according to task demands, scant empirical data exist about the time course of the strength of effective connectivity, particularly in tasks requiring information to be sustained in working memory. We investigated this question by performing time-resolved cross-correlation analysis for pairs of neurons recorded simultaneously at distances of 0.2-1.5 mm apart of each other while monkeys were engaged in working memory tasks. The strength of effective connectivity determined in this manner was higher throughout the trial in the posterior parietal cortex than the dorsolateral prefrontal cortex. Significantly higher levels of parietal effective connectivity were observed specifically during the delay period of the task. These differences could not be accounted for by differences in firing rate, or electrode distance in the samples recorded in the posterior parietal and prefrontal cortex. Differences were present when we restricted our analysis to only neurons with significant delay period activity and overlapping receptive fields. Our results indicate that dynamic changes in connectivity strength are present but area-specific intrinsic organization is the predominant factor that determines the strength of connections between neurons in each of the two areas.	[Katsuki, Fumi; Constantinidis, Christos] Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA	Wake Forest University	Constantinidis, C (corresponding author), Wake Forest Sch Med, Dept Neurobiol & Anat, Winston Salem, NC 27101 USA.	cconstan@wakehealth.edu	Katsuki, Fumi/AAA-7248-2019; Constantinidis, Christos/ABB-5760-2021	Katsuki, Fumi/0000-0002-1411-6317; Constantinidis, Christos/0000-0001-7441-022X	National Eye Institute of the National Institutes of Health [R01 EY016773, R01 EY017077, T32 NS073553]; Tab Williams Family Endowment Fund; NATIONAL EYE INSTITUTE [R01EY016773, R01EY017077] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS073553] Funding Source: NIH RePORTER	National Eye Institute of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Tab Williams Family Endowment Fund; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by the National Eye Institute of the National Institutes of Health under award numbers R01 EY016773, R01 EY017077, and T32 NS073553, and by the Tab Williams Family Endowment Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Armstrong KM, 2009, J NEUROSCI, V29, P15621, DOI 10.1523/JNEUROSCI.4465-09.2009; Arnsten AFT, 2011, INT J DEV NEUROSCI, V29, P215, DOI 10.1016/j.ijdevneu.2011.02.006; Baddeley A, 2003, NAT REV NEUROSCI, V4, P829, DOI 10.1038/nrn1201; Bisley JW, 2010, ANNU REV NEUROSCI, V33, P1, DOI 10.1146/annurev-neuro-060909-152823; Bisley JW, 2003, SCIENCE, V299, P81, DOI 10.1126/science.1077395; Chafee MV, 2005, CEREB CORTEX, V15, P1393, DOI 10.1093/cercor/bhi021; Chafee MV, 1998, J NEUROPHYSIOL, V79, P2919, DOI 10.1152/jn.1998.79.6.2919; Chen GJ, 2004, P NATL ACAD SCI USA, V101, P2596, DOI 10.1073/pnas.0308618100; Cohen JY, 2010, J NEUROSCI, V30, P3227, DOI 10.1523/JNEUROSCI.4600-09.2010; Compte A, 2000, CEREB CORTEX, V10, P910, DOI 10.1093/cercor/10.9.910; Constantinidis C, 1996, J NEUROPHYSIOL, V76, P1352, DOI 10.1152/jn.1996.76.2.1352; Constantinidis C, 2004, NEUROSCIENTIST, V10, P553, DOI 10.1177/1073858404268742; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Constantinidis C, 2002, NAT NEUROSCI, V5, P175, DOI 10.1038/nn799; Constantinidis C, 2001, NAT NEUROSCI, V4, P311, DOI 10.1038/85179; Constantinidis C, 2001, J NEUROSCI, V21, P3646, DOI 10.1523/JNEUROSCI.21-10-03646.2001; Constantinidis C, 2006, REV NEUROSCIENCE, V17, P415; Constantinidis Christos, 2004, Cognitive Affective & Behavioral Neuroscience, V4, P444, DOI 10.3758/CABN.4.4.444; Crowe DA, 2010, J NEUROSCI, V30, P11640, DOI 10.1523/JNEUROSCI.0954-10.2010; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; DIPELLEGRINO G, 1993, SOMATOSENS MOT RES, V10, P245; DOUGLAS RJ, 1995, SCIENCE, V269, P981, DOI 10.1126/science.7638624; Durstewitz D, 2000, J NEUROPHYSIOL, V83, P1733, DOI 10.1152/jn.2000.83.3.1733; Elston GN, 2003, BRAIN BEHAV EVOLUT, V62, P19, DOI 10.1159/000071957; Elston GN, 2003, EUR J NEUROSCI, V17, P1313, DOI 10.1046/j.1460-9568.2003.02552.x; Elston GN, 2000, J NEUROSCI, V20, DOI 10.1523/JNEUROSCI.20-18-j0002.2000; FUNAHASHI S, 1989, J NEUROPHYSIOL, V61, P331, DOI 10.1152/jn.1989.61.2.331; FUSTER JM, 1971, SCIENCE, V173, P652, DOI 10.1126/science.173.3997.652; FUSTER JM, 1985, BRAIN RES, V330, P299, DOI 10.1016/0006-8993(85)90689-4; Gao WJ, 2001, P NATL ACAD SCI USA, V98, P295, DOI 10.1073/pnas.011524298; GNADT JW, 1988, EXP BRAIN RES, V70, P216; Goldman-Rakic PS, 2004, PSYCHOPHARMACOLOGY, V174, P3, DOI 10.1007/s00213-004-1793-y; GOLDMANRAKIC PS, 1995, NEURON, V14, P477, DOI 10.1016/0896-6273(95)90304-6; Gonzalez-Islas C, 2003, J NEUROSCI, V23, P867; Gottlieb JP, 1998, NATURE, V391, P481, DOI 10.1038/35135; Haber SN, 1997, CRIT REV NEUROBIOL, V11, P323, DOI 10.1615/CritRevNeurobiol.v11.i4.40; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; Katsuki F, 2013, CEREB CORTEX; Katsuki F, 2012, NAT NEUROSCI, V15, P1160, DOI 10.1038/nn.3164; Katsuki F, 2012, FRONT INTEGR NEUROSC, V6, DOI 10.3389/fnint.2012.00017; Krimer LS, 2005, J NEUROPHYSIOL, V94, P3009, DOI 10.1152/jn.00156.2005; KRITZER MF, 1995, J COMP NEUROL, V359, P131, DOI 10.1002/cne.903590109; Lee D, 1998, J NEUROSCI, V18, P1161; LEVITT JB, 1993, J COMP NEUROL, V338, P360, DOI 10.1002/cne.903380304; LEVITT P, 1984, J COMP NEUROL, V227, P23, DOI 10.1002/cne.902270105; LEWIS DA, 1988, NEUROSCI LETT, V86, P11, DOI 10.1016/0304-3940(88)90174-7; Lewis DA, 2001, J COMP NEUROL, V432, P119, DOI 10.1002/cne.1092; LIDOW MS, 1991, NEUROSCIENCE, V40, P657, DOI 10.1016/0306-4522(91)90003-7; Meyer T, 2005, J NEUROSCI METH, V142, P27, DOI 10.1016/j.jneumeth.2004.07.009; Meyer T, 2011, J NEUROSCI, V31, P6266, DOI 10.1523/JNEUROSCI.6798-10.2011; Meyers EM, 2008, J NEUROPHYSIOL, V100, P1407, DOI 10.1152/jn.90248.2008; Meyers EM, 2012, P NATL ACAD SCI USA, V109, P4651, DOI 10.1073/pnas.1201022109; MILLER EK, 1993, J NEUROSCI, V13, P1460; Miller EK, 1996, J NEUROSCI, V16, P5154; Nowak LG, 1995, J NEUROPHYSIOL, V74, P2379, DOI 10.1152/jn.1995.74.6.2379; OADES RD, 1987, BRAIN RES REV, V12, P117, DOI 10.1016/0165-0173(87)90011-7; Paspalas CD, 2005, J NEUROSCI, V25, P1260, DOI 10.1523/JNEUROSCI.3436-04.2005; PERKEL DH, 1967, BIOPHYS J, V7, P419, DOI 10.1016/S0006-3495(67)86597-4; Powell KD, 2000, J NEUROPHYSIOL, V84, P301, DOI 10.1152/jn.2000.84.1.301; Qi XL, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00012; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Seamans JK, 2004, PROG NEUROBIOL, V74, P1, DOI 10.1016/j.pneurobio.2004.05.006; Seamans JK, 2001, P NATL ACAD SCI USA, V98, P301, DOI 10.1073/pnas.011518798; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Stokes MG, 2013, NEURON, V78, P364, DOI 10.1016/j.neuron.2013.01.039; Suzuki M, 2013, NAT NEUROSCI, V16, P98, DOI 10.1038/nn.3282; Takeda M, 2005, NEURON, V48, P839, DOI 10.1016/j.neuron.2005.09.028; Tsujimoto S, 2008, CEREB CORTEX, V18, P2748, DOI 10.1093/cercor/bhn033; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; Vijayraghavan S, 2007, NAT NEUROSCI, V10, P376, DOI 10.1038/nn1846; Wang M, 2013, NEURON, V77, P736, DOI 10.1016/j.neuron.2012.12.032; Wang X.-J., 2013, PRINCIPLES FRONTAL L, P226; Wang XJ, 2004, P NATL ACAD SCI USA, V101, P1368, DOI 10.1073/pnas.0305337101; Wang XJ, 2001, TRENDS NEUROSCI, V24, P455, DOI 10.1016/S0166-2236(00)01868-3; Wang XJ, 1999, J NEUROSCI, V19, P9587; WILLIAMS GV, 1995, NATURE, V376, P572, DOI 10.1038/376572a0; Woloszyn L, 2009, J NEUROSCI, V29, P5494, DOI 10.1523/JNEUROSCI.5785-08.2009; Yang CR, 1996, J NEUROSCI, V16, P1922; Zaitsev AV, 2005, CEREB CORTEX, V15, P1178, DOI 10.1093/cercor/bhh218; Zhou X, 2012, J NEUROPHYSIOL, V108, P31, DOI 10.1152/jn.01151.2011	81	9	9	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81601	10.1371/journal.pone.0081601	http://dx.doi.org/10.1371/journal.pone.0081601			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260582	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900133
J	Dresang, LR; Guastafierro, A; Arora, R; Normolle, D; Chang, Y; Moore, PS				Dresang, Lindsay R.; Guastafierro, Anna; Arora, Reety; Normolle, Daniel; Chang, Yuan; Moore, Patrick S.			Response of Merkel Cell Polyomavirus-Positive Merkel Cell Carcinoma Xenografts to a Survivin Inhibitor	PLOS ONE			English	Article							LARGE T-ANTIGEN; SMALL-MOLECULE SUPPRESSOR; PHASE-II; ANTITUMOR-ACTIVITY; YM155; EXPRESSION; GROWTH; COMBINATION	Merkel cell carcinoma (MCC) is a neuroendocrine skin cancer associated with high mortality. Merkel cell polyomavirus (MCV), discovered in 2008, is associated with 80% of MCC. The MCV large tumor (LT) oncoprotein upregulates the cellular oncoprotein survivin through its conserved retinoblastoma protein-binding motif. We confirm here that YM155, a survivin suppressor, is cytotoxic to MCV-positive MCC cells in vitro at nanomolar levels. Mouse survival was significantly improved for NOD-Scid-Gamma mice treated with YM155 in a dose and duration dependent manner for 3 of 4 MCV-positive MCC xenografts. One MCV-positive MCC xenograft (MS-1) failed to significantly respond to YM155, which corresponds with in vitro dose-response activity. Combination treatment of YM155 with other chemotherapeutics resulted in additive but not synergistic cell killing of MCC cell lines in vitro. These results suggest that survivin targeting is a promising therapeutic approach for most but not all MCV-positive MCCs.	[Dresang, Lindsay R.; Guastafierro, Anna; Arora, Reety; Chang, Yuan; Moore, Patrick S.] Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA 15260 USA; [Arora, Reety] Natl Ctr Biol Sci, Inst Stem Cell Biol & Regenerat Med, Bangalore, Karnataka, India; [Normolle, Daniel] Univ Pittsburgh, Inst Canc, Biostat Facil, Pittsburgh, PA USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Department of Biotechnology (DBT) India; Institute for Stem Cell Biology & Regenerative Medicine - inStem; Tata Institute of Fundamental Research (TIFR); National Centre for Biological Sciences (NCBS); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Chang, Y (corresponding author), Univ Pittsburgh, Inst Canc, Canc Virol Program, Pittsburgh, PA 15260 USA.	yc70@pitt.edu; psm9@pitt.edu	Arora, Reety/F-5504-2011; Chang, Yuan/F-4146-2011; Moore, Patrick S./F-3960-2011; Moore, Patrick/GVR-8294-2022	Chang, Yuan/0000-0003-1125-4041; Moore, Patrick S./0000-0002-8132-858X; Arora, Reety/0000-0002-1871-9297; Dresang, Lindsay/0000-0001-6038-1050; Normolle, Daniel/0000-0001-8675-5014	American Cancer Society Research Professorships; NIH [CA136363, T32 AI060525]; UPCI Hillman Cancer Center Animal Facility [P30CA047904]; NATIONAL CANCER INSTITUTE [P30CA047904, R01CA170354, R01CA136363] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI060525] Funding Source: NIH RePORTER	American Cancer Society Research Professorships(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); UPCI Hillman Cancer Center Animal Facility; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by American Cancer Society Research Professorships to Y.C. and P.S.M., and by NIH grant CA136363 to P.S.M. and D.N. L.R.D. was supported by NIH T32 AI060525 (Flynn, PI). This project used the UPCI Hillman Cancer Center Animal Facility, which is supported in part by award P30CA047904. This project used Research Histology Services at the University of Pittsburgh's Thomas E. Starzl Transplantation Institute core facilities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agelli M, 2003, J AM ACAD DERMATOL, V49, P832, DOI 10.1016/S0190-9622(03)02108-X; AHRENS H, 1987, BIOMETR J, V31, P338; Albores-Saavedra J, 2010, J CUTAN PATHOL, V37, P20, DOI 10.1111/j.1600-0560.2009.01370.x; Allen PJ, 2005, J CLIN ONCOL, V23, P2300, DOI 10.1200/JCO.2005.02.329; Aoyama Y, 2012, CANCER CHEMOTH PHARM, V70, P373, DOI 10.1007/s00280-012-1913-z; Arora R, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003713; Chang Y, 2012, ANNU REV PATHOL-MECH, V7, P123, DOI 10.1146/annurev-pathol-011110-130227; Cheng JW, 2013, J VIROL, V87, P6118, DOI 10.1128/JVI.00385-13; Cheson BD, 2012, CANCER-AM CANCER SOC, V118, P3128, DOI 10.1002/cncr.26510; Eng TY, 2007, AM J CLIN ONCOL-CANC, V30, P624, DOI 10.1097/COC.0b013e318142c882; Engels EA, 2002, LANCET, V359, P497, DOI 10.1016/S0140-6736(02)07668-7; Feng HC, 2008, SCIENCE, V319, P1096, DOI 10.1126/science.1152586; Giaccone G, 2009, J CLIN ONCOL, V27, P4481, DOI 10.1200/JCO.2008.21.1862; Guastafierro A, 2013, J VIROL METHODS, V187, P6, DOI 10.1016/j.jviromet.2012.10.001; Harms PW, 2013, J INVEST DERMATOL, V133, P936, DOI 10.1038/jid.2012.445; Heath M, 2008, J AM ACAD DERMATOL, V58, P375, DOI 10.1016/j.jaad.2007.11.020; Hodgson NC, 2005, J SURG ONCOL, V89, P1, DOI 10.1002/jso.20167; Houben R, 2012, INT J CANCER, V130, P847, DOI 10.1002/ijc.26076; Houben R, 2010, J VIROL, V84, P7064, DOI 10.1128/JVI.02400-09; Iwasa T, 2010, BRIT J CANCER, V103, P36, DOI 10.1038/sj.bjc.6605713; Kaae J, 2010, JNCI-J NATL CANCER I, V102, P793, DOI 10.1093/jnci/djq120; Kita A, 2011, LEUKEMIA RES, V35, P787, DOI 10.1016/j.leukres.2010.11.016; Kumar B, 2012, MOL CANCER THER, V11, P1988, DOI 10.1158/1535-7163.MCT-12-0167; Kuwamoto S, 2011, HUM PATHOL, V42, P1063, DOI 10.1016/j.humpath.2011.01.020; Lamers F, 2012, EUR J CANCER, V48, P763, DOI 10.1016/j.ejca.2011.10.012; Lewis KD, 2011, INVEST NEW DRUG, V29, P161, DOI 10.1007/s10637-009-9333-6; Li J, 2013, J VIROL, V87, P9173, DOI 10.1128/JVI.01216-13; MUNOZ IP, 2013, CANC TREAT REV, V39, P75558; Nakahara T, 2007, CANCER RES, V67, P8014, DOI 10.1158/0008-5472.CAN-07-1343; Nakahara T, 2011, ANTI-CANCER DRUG, V22, P454, DOI 10.1097/CAD.0b013e328344ac68; Nakahara T, 2011, CANCER SCI, V102, P614, DOI 10.1111/j.1349-7006.2010.01834.x; Nakamura N, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.013243; Nakamura T, 2010, VIROLOGY, V398, P273, DOI 10.1016/j.virol.2009.12.024; Plummer M., 2003, JAGS PROGRAM ANAL BA, DOI DOI 10.1.1.13.3406; ROSEN ST, 1987, LAB INVEST, V56, P302; *SAS I, 2012, US GUID SURV DAT AN; Satoh T, 2009, CLIN CANCER RES, V15, P3872, DOI 10.1158/1078-0432.CCR-08-1946; Schrama D, 2013, INT J CANCER, V132, P2980, DOI 10.1002/ijc.27962; Schrama D, 2012, CURR OPIN ONCOL, V24, P141, DOI 10.1097/CCO.0b013e32834fc9fe; Shuda M, 2008, P NATL ACAD SCI USA, V105, P16272, DOI 10.1073/pnas.0806526105; Shuda M, 2011, J CLIN INVEST, V121, P3623, DOI 10.1172/JCI46323; Shuda M, 2009, INT J CANCER, V125, P1243, DOI 10.1002/ijc.24510; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Tolcher AW, 2012, ANN ONCOL, V23, P968, DOI 10.1093/annonc/mdr353; Van Gele M, 2002, INT J CANCER, V101, P137, DOI 10.1002/ijc.10591; Veness M, 2010, INT J RADIAT ONCOL, V78, P703, DOI 10.1016/j.ijrobp.2009.08.011; XIE H, 2013, J INVEST DERMATOL, DOI DOI 10.1038/JID.2013.355.PUBMED:23962809; Yamanaka K, 2011, CLIN CANCER RES, V17, P5423, DOI 10.1158/1078-0432.CCR-10-3410; Yamauchi T, 2012, BIOCHEM BIOPH RES CO, V425, P711, DOI 10.1016/j.bbrc.2012.07.103; Zhao LL, 2011, CLIN CANCER RES, V17, P1057, DOI 10.1158/1078-0432.CCR-10-1935	50	31	32	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80543	10.1371/journal.pone.0080543	http://dx.doi.org/10.1371/journal.pone.0080543			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260412	gold, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000327308500150
J	Li, F; Wiegman, C; Seiffert, JM; Zhu, J; Clarke, C; Chang, Y; Bhavsar, P; Adcock, I; Zhang, JF; Zhou, X; Chung, KF				Li, Feng; Wiegman, Cornelis; Seiffert, Joanna M.; Zhu, Jie; Clarke, Colin; Chang, Yan; Bhavsar, Pank; Adcock, Ian; Zhang, Junfeng; Zhou, Xin; Chung, Kian Fan			Effects of N-Acetylcysteine in Ozone-Induced Chronic Obstructive Pulmonary Disease Model	PLOS ONE			English	Article							INDUCED AIRWAY HYPERRESPONSIVENESS; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; INDUCED COPD; EMPHYSEMA; INFLAMMATION; ASTHMA; LUNGS	Introduction: Chronic exposure to high levels of ozone induces emphysema and chronic inflammation in mice. We determined the recovery from ozone-induced injury and whether an antioxidant, N-acetylcysteine (NAC), could prevent or reverse the lung damage. Methods: Mice were exposed to ozone (2.5 ppm, 3 hours/12 exposures, over 6 weeks) and studied 24 hours (24h) or 6 weeks (6W) later. Nac (100 mg/kg, intraperitoneally) was administered either before each exposure (preventive) or after completion of exposure (therapeutic) for 6 weeks. Results: After ozone exposure, there was an increase in functional residual capacity, total lung volume, and lung compliance, and a reduction in the ratio of forced expiratory volume at 25 and 50 milliseconds to forced vital capacity (FEV25/FVC, FEV50/FVC). Mean linear intercept (L-m) and airway hyperresponsiveness (AHR) to acetylcholine increased, and remained unchanged at 6W after cessation of exposure. Preventive NAC reduced the number of BAL macrophages and airway smooth muscle (ASM) mass. Therapeutic NAC reversed AHR, and reduced ASM mass and apoptotic cells. Conclusion: Emphysema and lung function changes were irreversible up to 6W after cessation of ozone exposure, and were not reversed by NAC. The beneficial effects of therapeutic NAC may be restricted to the ASM.	[Li, Feng; Wiegman, Cornelis; Seiffert, Joanna M.; Zhu, Jie; Clarke, Colin; Bhavsar, Pank; Adcock, Ian; Chung, Kian Fan] Univ London Imperial Coll Sci Technol & Med, Expt Studies Unit, Natl Heart & Lung Inst, London, England; [Li, Feng; Zhou, Xin] Shanghai Jiao Tong Univ, Dept Resp Med, Affiliated Peoples Hosp 1, Shanghai 200030, Peoples R China; [Chang, Yan; Zhang, Junfeng] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA	Imperial College London; Shanghai Jiao Tong University; University of Southern California	Chung, KF (corresponding author), Univ London Imperial Coll Sci Technol & Med, Expt Studies Unit, Natl Heart & Lung Inst, London, England.	f.chung@imperial.ac.uk	Chung, Kian Fan/B-1872-2012; Chung, Kian Fan/I-8456-2019; Adcock, Ian/L-3217-2019; Zhang, Junfeng/AAJ-9183-2020	Chung, Kian Fan/0000-0001-7101-1426; Chung, Kian Fan/0000-0001-7101-1426; Zhang, Junfeng/0000-0003-3759-6672; Adcock, Ian/0000-0003-2101-8843; Li, Feng/0000-0002-0646-6560; Wiegman, Coen/0000-0001-9161-0581	Wellcome Trust [083905]; European Respiratory Society Fellowship (LTRF) [4-2011]	Wellcome Trust(Wellcome TrustEuropean Commission); European Respiratory Society Fellowship (LTRF)	This study was supported by Wellcome Trust grant No 083905. Feng Li was supported by a European Respiratory Society Fellowship (LTRF no4-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Braber S, 2010, RESP RES, V11, DOI 10.1186/1465-9921-11-99; Cai S, 2009, RESPIROLOGY, V14, P354, DOI 10.1111/j.1440-1843.2009.01511.x; Chakrabarti S, 2005, EXP LUNG RES, V31, P599, DOI 10.1080/019021490944232; Chung KF, 2008, EUR RESPIR J, V31, P1334, DOI 10.1183/09031936.00018908; Chung KF, 2010, ANN NY ACAD SCI, V1203, P85, DOI 10.1111/j.1749-6632.2010.05600.x; Churg A, 2008, AM J PHYSIOL-LUNG C, V294, pL612, DOI 10.1152/ajplung.00390.2007; Ciencewicki J, 2008, J ALLERGY CLIN IMMUN, V122, P456, DOI 10.1016/j.jaci.2008.08.004; Decramer M, 2012, LANCET, V379, P1341, DOI 10.1016/S0140-6736(11)60968-9; HEILI FS, 2008, CLIN EXP PHARM PHYSL, V35, P1337, DOI DOI 10.1111/J.1440-1681.2008.05026.X; Held HD, 2000, AM J RESP CRIT CARE, V162, P1547, DOI 10.1164/ajrccm.162.4.9912079; Katre A, 2011, INHAL TOXICOL, V23, P486, DOI 10.3109/08958378.2011.584919; Kohansal R, 2009, AM J RESP CRIT CARE, V180, P3, DOI 10.1164/rccm.200901-0047OC; Li F, 2011, EUR RESPIR J, V37, P933, DOI 10.1183/09031936.00021110; Lin JL, 2010, COPD, V7, P291, DOI 10.3109/15412555.2010.496818; March TH, 2006, TOXICOL SCI, V92, P545, DOI 10.1093/toxsci/kfl016; Millea PJ, 2009, AM FAM PHYSICIAN, V80, P265; Miller M, 2011, CHEST, V139, P1380, DOI 10.1378/chest.10-0705; Potts-Kant EN, 2012, FREE RADICAL BIO MED, V52, P705, DOI 10.1016/j.freeradbiomed.2011.11.027; Rahman I, 2012, CURR OPIN PHARMACOL, V12, P256, DOI 10.1016/j.coph.2012.01.015; Rubio ML, 2004, CHEST, V125, P1500, DOI 10.1378/chest.125.4.1500; Schutze N, 2010, AM J RESP CRIT CARE, V181, P1188, DOI 10.1164/rccm.200909-1350OC; Scichilone Nicola, 2006, Int J Chron Obstruct Pulmon Dis, V1, P49, DOI 10.2147/copd.2006.1.1.49; Tighe RM, 2011, J IMMUNOL, V187, P4800, DOI 10.4049/jimmunol.1101312; Triantaphyllopoulos K, 2011, AM J PHYSIOL-LUNG C, V300, pL691, DOI 10.1152/ajplung.00252.2010; Tuder Rubin M, 2006, Proc Am Thorac Soc, V3, P503, DOI 10.1513/pats.200603-054MS; van den Berge M, 2012, EUR RESPIR J, V40, P1098, DOI 10.1183/09031936.00169711; Willemse BWM, 2004, EUR RESPIR J, V24, P391, DOI 10.1183/09031936.04.00117603; Williams AS, 2008, EUR RESPIR J, V32, P571, DOI 10.1183/09031936.00121607; Williams AS, 2007, J APPL PHYSIOL, V103, P1189, DOI 10.1152/japplphysiol.00172.2007	29	39	46	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80782	10.1371/journal.pone.0080782	http://dx.doi.org/10.1371/journal.pone.0080782			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260479	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500175
J	Taylor, MD; McPhan, L; van der Meulen, DE; Gray, CA; Payne, NL				Taylor, Matthew D.; McPhan, Luke; van der Meulen, Dylan E.; Gray, Charles A.; Payne, Nicholas L.			Interactive Drivers of Activity in a Free-Ranging Estuarine Predator	PLOS ONE			English	Article							DIEL VERTICAL MIGRATION; ACANTHOPAGRUS-AUSTRALIS GUNTHER; MULLOWAY ARGYROSOMUS-JAPONICUS; YELLOWFIN BREAM; METABOLIC-RATE; TIDAL RHYTHMS; HABITAT USE; FISH USE; PATTERNS; BEHAVIOR	Animal activity patterns evolve as an optimal balance between energy use, energy acquisition, and predation risk, so understanding how animals partition activity relative to extrinsic environmental fluctuations is central to understanding their ecology, biology and physiology. Here we use accelerometry to examine the degree to which activity patterns of an estuarine teleost predator are driven by a series of rhythmic and arrhythmic environmental fluctuations. We implanted free-ranging bream Acanthopagrus australis with acoustic transmitters that measured bi-axial acceleration and pressure (depth), and simultaneously monitored a series of environmental variables (photosynthetically active radiation, tidal height, temperature, turbidity, and lunar phase) for a period of approximately four months. Linear modeling showed an interaction between fish activity, light level and tidal height; with activity rates also negatively correlated with fish depth. These patterns highlight the relatively-complex trade-offs that are required to persist in highly variable environments. This study demonstrates how novel acoustic sensor tags can reveal interactive links between environmental cycles and animal behavior.	[Taylor, Matthew D.] Fisheries NSW, Port Stephens Fisheries Inst, Taylors Beach, NSW, Australia; [Taylor, Matthew D.; McPhan, Luke; van der Meulen, Dylan E.; Gray, Charles A.; Payne, Nicholas L.] Univ New S Wales, Sch Biol Earth & Environm Sci, Sydney, NSW, Australia; [van der Meulen, Dylan E.] Fisheries NSW, Batemans Bay Fisheries Ctr, Batemans Bay, NSW, Australia	NSW Department of Primary Industries; University of New South Wales Sydney	Taylor, MD (corresponding author), Fisheries NSW, Port Stephens Fisheries Inst, Taylors Beach, NSW, Australia.	matt.taylor@dpi.nsw.gov.au	van der Meulen, Dylan E/A-8449-2017; Taylor, Matthew/C-4833-2008; Payne, Nicholas/E-7811-2013	van der Meulen, Dylan E/0000-0002-9777-7670; 	Australian Research Council [LP100100367]; NSW Recreational Fishing Trust; NSW DPI	Australian Research Council(Australian Research Council); NSW Recreational Fishing Trust; NSW DPI	Financial support was provided to this project through an Australian Research Council Linkage Grant (LP100100367) with the NSW Recreational Fishing Trust and NSW DPI awarded to MDT, CAG and others. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahrens RNM, 2012, FISH FISH, V13, P41, DOI 10.1111/j.1467-2979.2011.00432.x; Aitken L. S., 1991, MULTIPLE REGRESSION; Baktoft H, 2012, ECOL FRESHW FISH, V21, P386, DOI 10.1111/j.1600-0633.2012.00558.x; BARKER D, 2009, GUIDE ACCEPTABLE PRO; Becker A, 2011, J FISH BIOL, V79, P761, DOI 10.1111/j.1095-8649.2011.03057.x; Berger D, 2008, BEHAV ECOL SOCIOBIOL, V62, P1655, DOI 10.1007/s00265-008-0594-4; Boaden E, 2012, CORAL REEFS, V31, P871, DOI 10.1007/s00338-012-0903-2; BOZDOGAN H, 1987, PSYCHOMETRIKA, V52, P345, DOI 10.1007/BF02294361; Brenner M, 2007, J FISH BIOL, V70, P406, DOI 10.1111/j.1095-8649.2007.01313.x; Butcher PA, 2010, ICES J MAR SCI, V67, P1175, DOI 10.1093/icesjms/fsq028; CRONIN TW, 1979, SCIENCE, V205, P1020, DOI 10.1126/science.205.4410.1020; Cummings SM, 2001, CHRONOBIOL INT, V18, P27, DOI 10.1081/CBI-100001173; de Pontual H, 2012, J FISH BIOL, V81, P728, DOI 10.1111/j.1095-8649.2012.03345.x; DeCoursey PJ, 2000, J COMP PHYSIOL A, V186, P169, DOI 10.1007/s003590050017; Driggers WB, 2012, MAR ECOL PROG SER, V465, P185, DOI 10.3354/meps09901; ENRIGHT JT, 1965, SCIENCE, V147, P864, DOI 10.1126/science.147.3660.864; Espinoza M, 2011, FISH RES, V108, P364, DOI 10.1016/j.fishres.2011.01.011; Favreau A, 2009, ANIM BEHAV, V77, P983, DOI 10.1016/j.anbehav.2009.01.004; FORWARD RB, 1980, BIOL BULL, V158, P295, DOI 10.2307/1540856; Gattermann R, 2008, BIOL LETTERS, V4, P253, DOI 10.1098/rsbl.2008.0066; GIBBONS MJ, 1993, MAR BIOL, V116, P257, DOI 10.1007/BF00350016; GIBBS PJ, 2001, MONITORING NATURAL R; GIBSON RN, 1973, MAR BIOL, V22, P379, DOI 10.1007/BF00391398; Griffiths SP, 2001, J APPL ICHTHYOL, V17, P240, DOI 10.1046/j.1439-0426.2001.00288.x; Halle S, 2000, ECOL STU AN, V141, P67; Halsey LG, 2009, PHYSIOL BIOCHEM ZOOL, V82, P396, DOI 10.1086/589815; Harvey ES, 2012, J EXP MAR BIOL ECOL, V426, P78, DOI 10.1016/j.jembe.2012.05.019; HAWORTH R, 2002, WETLANDS, V20, P80; Heupel MR, 2006, MAR FRESHWATER RES, V57, P1, DOI 10.1071/MF05091; Kroon FJ, 2005, MAR ECOL PROG SER, V285, P193, DOI 10.3354/meps285193; Krumme U, 2009, ECOLOGICAL CONNECTIVITY AMONG TROPICAL COASTAL ECOSYSTEMS, P271, DOI 10.1007/978-90-481-2406-0_8; Metcalfe JD, 2006, MAR FRESHW BEHAV PHY, V39, P25, DOI 10.1080/10236240600563404; Meyer CG, 2007, MAR BIOL, V151, P2133, DOI 10.1007/s00227-007-0647-7; Murchie KJ, 2011, J EXP MAR BIOL ECOL, V396, P147, DOI 10.1016/j.jembe.2010.10.019; Ochwada F, 2009, MAR ECOL PROG SER, V380, P161, DOI 10.3354/meps07936; Payne NL, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2363; Payne NL, 2011, J ANIM ECOL, V80, P422, DOI 10.1111/j.1365-2656.2010.01758.x; Payne NL, 2010, MAR ECOL PROG SER, V419, P295, DOI 10.3354/meps08864; Payne NL, 2011, OECOLOGIA, V165, P341, DOI 10.1007/s00442-010-1729-7; Pease B, 1981, 23B BBS STAT POLL CO, V23B; POLLOCK BR, 1982, J FISH BIOL, V20, P245, DOI 10.1111/j.1095-8649.1982.tb04705.x; Qasem L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031187; Raffaelli D., 1999, INTERTIDAL ECOLOGY; REFINETTI R, 1992, PHYSIOL BEHAV, V51, P613, DOI 10.1016/0031-9384(92)90188-8; Sarkar D., 2019, NLME LINEAR NONLINEA; Schabenberger O., 2002, CONT STAT MODELS PLA; Shepard ELC, 2006, MAR ECOL PROG SER, V328, P205, DOI 10.3354/meps328205; Sims DW, 2005, J ANIM ECOL, V74, P755, DOI 10.1111/j.1365-2656.2005.00971.x; Smith CL, 2001, CAN J FISH AQUAT SCI, V58, P736, DOI 10.1139/cjfas-58-4-736; Taylor MD, 2008, MAR FRESHWATER RES, V59, P792, DOI 10.1071/MF07247; Taylor MD, 2006, MAR ECOL PROG SER, V328, P237, DOI 10.3354/meps328237; Taylor MD, 2006, ESTUAR COAST, V29, P785, DOI 10.1007/BF02786529; Taylor MD, 2011, MAR BIOL, V158, P835, DOI 10.1007/s00227-010-1610-6; Thomas BE, 2001, MAR ECOL PROG SER, V209, P275, DOI 10.3354/meps209275; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Walsh CT, 2012, ECOL FRESHW FISH, V21, P145, DOI 10.1111/j.1600-0633.2011.00534.x; Walters C, 2007, ECOL MODEL, V209, P342, DOI 10.1016/j.ecolmodel.2007.06.025; West JM, 2000, ESTUARIES, V23, P699, DOI 10.2307/1352896; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; Yerushalmi S, 2009, ECOL LETT, V12, P970, DOI 10.1111/j.1461-0248.2009.01343.x; ZOUFAL R, 1991, MAR BIOL, V108, P193, DOI 10.1007/BF01344333; Zuur Alain F., 2009, P1	62	19	19	2	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80962	10.1371/journal.pone.0080962	http://dx.doi.org/10.1371/journal.pone.0080962			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260520	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500186
J	Munguia-Rosas, MA; Campos-Navarrete, MJ; Parra-Tabla, V				Munguia-Rosas, Miguel A.; Campos-Navarrete, Maria J.; Parra-Tabla, Victor			The Effect of Pollen Source vs. Flower Type on Progeny Performance and Seed Predation under Contrasting Light Environments in a Cleistogamous Herb	PLOS ONE			English	Article							INBREEDING DEPRESSION; AMPHICARPUM-PURSHII; RESOURCE-ALLOCATION; SELF-FERTILIZATION; FITNESS; PLANTS; MAINTENANCE; RESISTANCE; VIOLACEAE; EVOLUTION	Dimorphic cleistogamy is a specialized form of mixed mating system where a single plant produces both open, potentially outcrossed chasmogamous (CH) and closed, obligately self-pollinated cleistogamous (CL) flowers. Typically, CH flowers and seeds are bigger and energetically more costly than those of CL. Although the effects of inbreeding and floral dimorphism are critical to understanding the evolution and maintenance of cleistogamy, these effects have been repeatedly confounded. In an attempt to separate these effects, we compared the performance of progeny derived from the two floral morphs while controlling for the source of pollen. That is, flower type and pollen source effects were assessed by comparing the performance of progeny derived from selfed CH vs. CL and outcrossed CH vs. selfed CH flowers, respectively. The experiment was carried out with the herb Ruellia nudiflora under two contrasting light environments. Outcrossed progeny generally performed better than selfed progeny. However, inbreeding depression ranges from low (1%) to moderate (36%), with the greatest value detected under shaded conditions when cumulative fitness was used. Although flower type generally had less of an effect on progeny performance than pollen source did, the progeny derived from selfed CH flowers largely outperformed the progeny from CL flowers, but only under shaded conditions and when cumulative fitness was taken into account. On the other hand, the source of pollen and flower type influenced seed predation, with selfed CH progeny the most heavily attacked by predators. Therefore, the effects of pollen source and flower type are environment-dependant and seed predators may increase the genetic differences between progeny derived from CH and CL flowers. Inbreeding depression alone cannot account for the maintenance of a mixed mating system in R. nudiflora and other unidentified mechanisms must thus be involved.	[Munguia-Rosas, Miguel A.] Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ecol Humana, Merida, Yucatan, Mexico; [Campos-Navarrete, Maria J.; Parra-Tabla, Victor] Univ Autonoma Yucatan, Dept Ecol Trop, Merida, Yucatan, Mexico	Instituto Politecnico Nacional - Mexico; Universidad Autonoma de Yucatan	Munguia-Rosas, MA (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Ecol Humana, Merida, Yucatan, Mexico.	munguiarma@mda.cinvestav.mx	Parra-Tabla, Victor/H-7320-2015; Munguia-Rosas, Miguel/H-9364-2019	Parra-Tabla, Victor/0000-0001-5920-0881; Munguia-Rosas, Miguel A./0000-0003-2319-1666	CINVESTAV	CINVESTAV	The study was suported by CINVESTAV, Funds to MAM-R. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdala-Roberts L, 2013, PLANT SPECI IN PRESS; Abdala-Roberts L, 2010, BIOTROPICA, V42, P180, DOI 10.1111/j.1744-7429.2009.00571.x; Armbruster P, 2005, HEREDITY, V95, P235, DOI 10.1038/sj.hdy.6800721; Bello-Bedoy R, 2011, J EVOLUTION BIOL, V24, P518, DOI 10.1111/j.1420-9101.2010.02185.x; Bello-Bedoy R, 2010, ANN BOT-LONDON, V105, P747, DOI 10.1093/aob/mcq038; Berg H, 2003, PLANT BIOLOGY, V5, P194, DOI 10.1055/s-2003-40727; CAMPBELL CS, 1983, ANNU REV ECOL SYST, V14, P411, DOI 10.1146/annurev.es.14.110183.002211; Cervera JC, 2009, PLANT ECOL, V205, P285, DOI 10.1007/s11258-009-9617-0; CHARLESWORTH D, 1987, ANNU REV ECOL SYST, V18, P237, DOI 10.1146/annurev.ecolsys.18.1.237; CHEPLICK GP, 1982, OECOLOGIA, V52, P327, DOI 10.1007/BF00367955; Chico-Ponce de Leon PA, 1999, ATLAS PROCESOS TERRI; CLAY K, 1983, AM J BOT, V70, P835, DOI 10.2307/2442935; CLAY K, 1985, EVOLUTION, V39, P205, DOI 10.1111/j.1558-5646.1985.tb04094.x; COLE CT, 1992, AM J BOT, V79, P567, DOI 10.2307/2444869; Crawley MJ., 2007, R BOOK; Culley TM, 2007, BOT REV, V73, P1, DOI 10.1663/0006-8101(2007)73[1:TCBSAR]2.0.CO;2; Culley TM, 2002, INT J PLANT SCI, V163, P113, DOI 10.1086/324180; Culley TM, 2000, CAN J BOT, V78, P1420, DOI 10.1139/cjb-78-11-1420; Darwin CR, 1876, EFFECTS CROSS SELF F; DUDASH MR, 1990, EVOLUTION, V44, P1129, DOI 10.1111/j.1558-5646.1990.tb05220.x; Eckstein RL, 2005, BASIC APPL ECOL, V6, P339, DOI 10.1016/j.baae.2004.12.002; Flores S, 1994, ETNOFLORA YUCATANENS, P63; GARA B, 1990, AM J BOT, V77, P1, DOI 10.2307/2444786; Goodwillie C, 2005, ANNU REV ECOL EVOL S, V36, P47, DOI 10.1146/annurev.ecolsys.36.091704.175539; LANDE R, 1985, EVOLUTION, V39, P24, DOI [10.2307/2408514, 10.1111/j.1558-5646.1985.tb04077.x]; LORD EM, 1981, BOT REV, V47, P421, DOI 10.1007/BF02860538; Lu YQ, 2002, BIOL J LINN SOC, V75, P543, DOI 10.1046/j.1095-8312.2002.00039.x; MCNAMARA J, 1977, AM J BOT, V64, P17, DOI 10.2307/2441871; Munguia-Rosas MA, 2013, WEED RES, V53, P328, DOI 10.1111/wre.12028; Munguia-Rosas MA, 2013, OECOLOGIA IN PRESS; Munguia-Rosas MA, 2012, ANN BOT-LONDON, V109, P343, DOI 10.1093/aob/mcr284; Muola A, 2011, ANN BOT-LONDON, V108, P547, DOI 10.1093/aob/mcr174; Oakley CG, 2007, ANNU REV ECOL EVOL S, V38, P437, DOI 10.1146/annurev.ecolsys.38.091206.095654; Oakley CG, 2008, INT J PLANT SCI, V169, P523, DOI 10.1086/528752; R Development Core Team, 2011, LANG ENV STAT COMP, DOI 10.1007/978-3-540-74686-7; Ruan CJ, 2012, CRIT REV PLANT SCI, V31, P290, DOI 10.1080/07352689.2011.645442; SCHMITT J, 1990, EVOLUTION, V44, P269, DOI [10.2307/2409406, 10.1111/j.1558-5646.1990.tb05197.x]; SCHOEN DJ, 1984, BIOL J LINN SOC, V23, P303, DOI 10.1111/j.1095-8312.1984.tb00147.x; SMITH JM, 1978, EVOLUTION SEX; STEBBINS GL, 1957, AM NAT, V91, P337, DOI 10.1086/281999; Venables W.N., 2002, MODERN APPL STAT S, V4th ed, DOI DOI 10.1007/978-0-387-21706-2; Winn AA, 2011, EVOLUTION, V65, P3339, DOI 10.1111/j.1558-5646.2011.01462.x; Winn AA, 2009, AM J BOT, V96, P2074, DOI 10.3732/ajb.0900048	43	9	11	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80934	10.1371/journal.pone.0080934	http://dx.doi.org/10.1371/journal.pone.0080934			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260515	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600102
J	Wickramasinghe, M; Kiss, IZ				Wickramasinghe, Mahesh; Kiss, Istvan Z.			Spatially Organized Dynamical States in Chemical Oscillator Networks: Synchronization, Dynamical Differentiation, and Chimera Patterns	PLOS ONE			English	Article							CHAOTIC ELECTROCHEMICAL OSCILLATORS; COMPLEX NETWORKS; PROPAGATION FAILURE; MICRO-OSCILLATORS; LARGE POPULATIONS; ARRAYS; REACTORS; SYSTEMS	Dynamical processes in many engineered and living systems take place on complex networks of discrete dynamical units. We present laboratory experiments with a networked chemical system of nickel electrodissolution in which synchronization patterns are recorded in systems with smooth periodic, relaxation periodic, and chaotic oscillators organized in networks composed of up to twenty dynamical units and 140 connections. The reaction system formed domains of synchronization patterns that are strongly affected by the architecture of the network. Spatially organized partial synchronization could be observed either due to densely connected network nodes or through the 'chimera' symmetry breaking mechanism. Relaxation periodic and chaotic oscillators formed structures by dynamical differentiation. We have identified effects of network structure on pattern selection (through permutation symmetry and coupling directness) and on formation of hierarchical and 'fuzzy' clusters. With chaotic oscillators we provide experimental evidence that critical coupling strengths at which transition to identical synchronization occurs can be interpreted by experiments with a pair of oscillators and analysis of the eigenvalues of the Laplacian connectivity matrix. The experiments thus provide an insight into the extent of the impact of the architecture of a network on self-organized synchronization patterns.	[Wickramasinghe, Mahesh; Kiss, Istvan Z.] St Louis Univ, Dept Chem, St Louis, MO 63103 USA	Saint Louis University; Washington University (WUSTL)	Kiss, IZ (corresponding author), St Louis Univ, Dept Chem, St Louis, MO 63103 USA.	izkiss@slu.edu	Kiss, Istvan Z/C-1801-2008	Kiss, Istvan Z/0000-0003-0993-3184	National Science Foundation [CHE-0955555]; Division Of Chemistry [0955555] Funding Source: National Science Foundation	National Science Foundation(National Science Foundation (NSF)); Division Of Chemistry(National Science Foundation (NSF)NSF - Directorate for Mathematical & Physical Sciences (MPS))	This material is based upon work supported by the National Science Foundation under grant number CHE-0955555. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams DM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.174102; Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Battogtokh D, 2002, NONLIN PHENOM COMPLE, V5, P380; BOOTH V, 1994, J PHYS CHEM-US, V98, P6537, DOI 10.1021/j100077a019; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Chavez M, 2010, PHYS REV LETT, V104, DOI 10.1103/PhysRevLett.104.118701; Dorfler F, 2013, P NATL ACAD SCI USA, V110, P2005, DOI 10.1073/pnas.1212134110; Epstein I.R., 1998, INTRO NONLINEAR CHEM; Hagerstrom AM, 2012, NAT PHYS, V8, P658, DOI [10.1038/nphys2372, 10.1038/NPHYS2372]; HANSEL D, 1993, PHYS REV E, V48, P3470, DOI 10.1103/PhysRevE.48.3470; HAUSER MJB, 1994, J CHEM PHYS, V100, P1058, DOI 10.1063/1.466637; Herzog ED, 2007, NAT REV NEUROSCI, V8, P790, DOI 10.1038/nrn2215; Hohmann W, 1999, J PHYS CHEM A, V103, P5742, DOI 10.1021/jp991224a; Jia YX, 2012, J PHYS CHEM C, V116, P19290, DOI 10.1021/jp3047278; KANEKO K, 1990, PHYSICA D, V41, P137, DOI 10.1016/0167-2789(90)90119-A; Kiss IZ, 2007, SCIENCE, V316, P1886, DOI 10.1126/science.1140858; Kiss IZ, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.248301; Kiss IZ, 2003, AICHE J, V49, P2234, DOI 10.1002/aic.690490902; Kiss IZ, 2002, SCIENCE, V296, P1676, DOI 10.1126/science.1070757; Kiss IZ, 2000, PHYS CHEM CHEM PHYS, V2, P3847, DOI 10.1039/b003812l; Kuramoto Y., 1984, CHEM OSCILLATIONS WA; LAPLANTE JP, 1992, J PHYS CHEM-US, V96, P4931, DOI 10.1021/j100191a038; LAPLANTE JP, 1992, PHYSICA A, V188, P89, DOI 10.1016/0378-4371(92)90256-P; Manrubia SC, 1999, PHYS REV E, V60, P1579, DOI 10.1103/PhysRevE.60.1579; Martens EA, 2013, P NATL ACAD SCI USA, V110, P10563, DOI 10.1073/pnas.1302880110; Nakao H, 2010, NAT PHYS, V6, P544, DOI 10.1038/NPHYS1651; Nevoral V, 1997, J PHYS CHEM A, V101, P4954, DOI 10.1021/jp970672k; Newman MEJ, 2003, SIAM REV, V45, P167, DOI 10.1137/S003614450342480; Nicosia V, 2013, PHYS REV LETT, V110, DOI 10.1103/PhysRevLett.110.174102; Pecora LM, 1998, PHYS REV E, V58, P347, DOI 10.1103/PhysRevE.58.347; Pikovsky A., 2001, SYNCHRONIZATION UNIV; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Taylor AF, 2011, ANGEW CHEM INT EDIT, V50, P10161, DOI 10.1002/anie.201008248; Taylor AF, 2009, SCIENCE, V323, P614, DOI 10.1126/science.1166253; Tinsley MR, 2012, NAT PHYS, V8, P662, DOI [10.1038/nphys2371, 10.1038/NPHYS2371]; Toiya M, 2008, ANGEW CHEM INT EDIT, V47, P7753, DOI 10.1002/anie.200802339; Toiya M, 2010, J PHYS CHEM LETT, V1, P1241, DOI 10.1021/jz100238u; Votrubova V, 1998, J PHYS CHEM A, V102, P1318, DOI 10.1021/jp973041z; Wang W, 2000, CHAOS, V10, P248, DOI 10.1063/1.166470; Wang W, 2001, PHYS REV LETT, V86, P4954, DOI 10.1103/PhysRevLett.86.4954; Wiley DA, 2006, CHAOS, V16, DOI 10.1063/1.2165594; Winfree A. T., 1980, GEOMETRY BIOL TIME, DOI 10.1007/978-1-4757-3484-3; Wolfrum M, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.015201; YOSHIMOTO M, 1993, PHYS REV E, V47, P864, DOI 10.1103/PhysRevE.47.864	46	156	156	0	44	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80586	10.1371/journal.pone.0080586	http://dx.doi.org/10.1371/journal.pone.0080586			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260429	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600072
J	Yanagawa, T; Chao, ZC; Hasegawa, N; Fujii, N				Yanagawa, Toru; Chao, Zenas C.; Hasegawa, Naomi; Fujii, Naotaka			Large-Scale Information Flow in Conscious and Unconscious States: an ECoG Study in Monkeys	PLOS ONE			English	Article							PROPOFOL-INDUCED LOSS; EFFECTIVE CONNECTIVITY; TOP-DOWN; SLOW OSCILLATION; ALPHA-ACTIVITY; SYNCHRONIZATION; CORRELATE; NETWORKS; SLEEP; BAND	Consciousness is an emergent property of the complex brain network. In order to understand how consciousness is constructed, neural interactions within this network must be elucidated. Previous studies have shown that specific neural interactions between the thalamus and frontoparietal cortices; frontal and parietal cortices; and parietal and temporal cortices are correlated with levels of consciousness. However, due to technical limitations, the network underlying consciousness has not been investigated in terms of large-scale interactions with high temporal and spectral resolution. In this study, we recorded neural activity with dense electrocorticogram (ECoG) arrays and used the spectral Granger causality to generate a more comprehensive network that relates to consciousness in monkeys. We found that neural interactions were significantly different between conscious and unconscious states in all combinations of cortical region pairs. Furthermore, the difference in neural interactions between conscious and unconscious states could be represented in 4 frequency-specific large-scale networks with unique interaction patterns: 2 networks were related to consciousness and showed peaks in alpha and beta bands, while the other 2 networks were related to unconsciousness and showed peaks in theta and gamma bands. Moreover, networks in the unconscious state were shared amongst 3 different unconscious conditions, which were induced either by ketamine and medetomidine, propofol, or sleep. Our results provide a novel picture that the difference between conscious and unconscious states is characterized by a switch in frequency-specific modes of large-scale communications across the entire cortex, rather than the cessation of interactions between specific cortical regions.	[Yanagawa, Toru; Chao, Zenas C.; Hasegawa, Naomi; Fujii, Naotaka] RIKEN, Brain Sci Inst, Lab Adapt Intelligence, Saitama, Japan	RIKEN	Fujii, N (corresponding author), RIKEN, Brain Sci Inst, Lab Adapt Intelligence, Saitama, Japan.	na@brain.riken.jp	Yanagawa, Toru/GYU-6448-2022	Yanagawa, Toru/0000-0003-0868-2563	Ministry of Education, Culture, Sports, Science and Technology of Japan; RIKEN	Ministry of Education, Culture, Sports, Science and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); RIKEN	A part of this study is the result of "Brain Machine Interface Development" carried out under the Strategic Research Program for Brain Sciences by the Ministry of Education, Culture, Sports, Science and Technology of Japan (http://www.mext.go.jp/english/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Rest part of the study was supported by RIKEN internal research budget. There is no other research funding source for this study.	Alkire MT, 2008, SCIENCE, V322, P876, DOI 10.1126/science.1149213; Andersson CA, 2000, CHEMOMETR INTELL LAB, V52, P1, DOI 10.1016/S0169-7439(00)00071-X; Arthuis M, 2009, BRAIN, V132, P2091, DOI 10.1093/brain/awp086; Baars BJ, 2002, TRENDS COGN SCI, V6, P47, DOI 10.1016/S1364-6613(00)01819-2; Barrett AB, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0029072; Boly M, 2012, J NEUROSCI, V32, P7082, DOI 10.1523/JNEUROSCI.3769-11.2012; Boly M, 2011, SCIENCE, V332, P858, DOI 10.1126/science.1202043; Boveroux P, 2010, ANESTHESIOLOGY, V113, P1038, DOI 10.1097/ALN.0b013e3181f697f5; Bro R, 2003, J CHEMOMETR, V17, P274, DOI 10.1002/cem.801; Brovelli A, 2004, P NATL ACAD SCI USA, V101, P9849, DOI 10.1073/pnas.0308538101; Buschman TJ, 2007, SCIENCE, V315, P1860, DOI 10.1126/science.1138071; Chao Zenas C, 2010, Front Neuroeng, V3, P3, DOI 10.3389/fneng.2010.00003; Chauvette S, 2011, J NEUROSCI, V31, P14998, DOI 10.1523/JNEUROSCI.2339-11.2011; Chen YH, 2006, J NEUROSCI METH, V150, P228, DOI 10.1016/j.jneumeth.2005.06.011; de Pasquale F, 2012, NEURON, V74, P753, DOI 10.1016/j.neuron.2012.03.031; Delorme A, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/130714; Ding MZ, 2000, BIOL CYBERN, V83, P35, DOI 10.1007/s004229900137; Fan RE, 2008, J MACH LEARN RES, V9, P1871; Fries P, 2009, ANNU REV NEUROSCI, V32, P209, DOI 10.1146/annurev.neuro.051508.135603; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2003, NEUROIMAGE, V19, P1273, DOI 10.1016/S1053-8119(03)00202-7; GEWEKE J, 1982, J AM STAT ASSOC, V77, P304, DOI 10.2307/2287238; Haegens S, 2010, HUM BRAIN MAPP, V31, P26, DOI 10.1002/hbm.20842; Hammond C, 2007, TRENDS NEUROSCI, V30, P357, DOI 10.1016/j.tins.2007.05.004; Handel BF, 2011, J COGNITIVE NEUROSCI, V23, P2494, DOI 10.1162/jocn.2010.21557; Hipp JF, 2012, NAT NEUROSCI, V15, P884, DOI 10.1038/nn.3101; Jensen O, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00186; John ER, 2001, CONSCIOUS COGN, V10, P165, DOI 10.1006/ccog.2001.0507; Jokisch D, 2007, J NEUROSCI, V27, P3244, DOI 10.1523/JNEUROSCI.5399-06.2007; Ku SW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025155; KWIATKOWSKI D, 1992, J ECONOMETRICS, V54, P159, DOI 10.1016/0304-4076(92)90104-Y; Lee U, 2009, CONSCIOUS COGN, V18, P1069, DOI 10.1016/j.concog.2009.04.004; Lewis LD, 2012, P NATL ACAD SCI USA, V109, pE3377, DOI 10.1073/pnas.1210907109; Markowitsch HJ, 2000, EXP BRAIN RES, V133, P94, DOI 10.1007/s002210000404; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Miller KJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002655; Mitra P., 2007, OBSERVED BRAIN DYNAM; Miwakeichi F, 2004, NEUROIMAGE, V22, P1035, DOI 10.1016/j.neuroimage.2004.03.039; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Nagasaka Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022561; Pfurtscheller G, 1996, INT J PSYCHOPHYSIOL, V24, P39, DOI 10.1016/S0167-8760(96)00066-9; Pfurtscheller G, 1996, ELECTROEN CLIN NEURO, V98, P281, DOI 10.1016/0013-4694(95)00258-8; Pogosyan A, 2009, CURR BIOL, V19, P1637, DOI 10.1016/j.cub.2009.07.074; Rihs TA, 2007, EUR J NEUROSCI, V25, P603, DOI 10.1111/j.1460-9568.2007.05278.x; Schrouff J, 2011, NEUROIMAGE, V57, P198, DOI 10.1016/j.neuroimage.2011.04.020; Seth AK, 2008, TRENDS COGN SCI, V12, P314, DOI 10.1016/j.tics.2008.04.008; Seth AK, 2010, J NEUROSCI METH, V186, P262, DOI 10.1016/j.jneumeth.2009.11.020; Tononi G, 1998, SCIENCE, V282, P1846, DOI 10.1126/science.282.5395.1846; Tononi Giulio, 2004, BMC Neurosci, V5, P42, DOI 10.1186/1471-2202-5-42; Valdes-Sosa PA, 2005, PHILOS T R SOC B, V360, P969, DOI 10.1098/rstb.2005.1654; Valdes-Sosa PA, 2011, NEUROIMAGE, V58, P339, DOI 10.1016/j.neuroimage.2011.03.058; von Stein A, 2000, P NATL ACAD SCI USA, V97, P14748, DOI 10.1073/pnas.97.26.14748; White NS, 2003, NEUROIMAGE, V19, P402, DOI 10.1016/S1053-8119(03)00103-4	54	43	43	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80845	10.1371/journal.pone.0080845	http://dx.doi.org/10.1371/journal.pone.0080845			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260491	Green Submitted, gold, Green Published			2022-12-25	WOS:000327258600088
J	Aribisala, BS; Gow, AJ; Bastin, ME; Hernandez, MDV; Murray, C; Royle, NA; Munoz Maniega, S; Starr, JM; Deary, IJ; Wardlaw, JM				Aribisala, Benjamin S.; Gow, Alan J.; Bastin, Mark E.; Hernandez, Maria del Carmen Valdes; Murray, Catherine; Royle, Natalie A.; Munoz Maniega, Susana; Starr, John M.; Deary, Ian J.; Wardlaw, Joanna M.			Associations between Level and Change in Physical Function and Brain Volumes	PLOS ONE			English	Article							OLDER-ADULTS; CARDIORESPIRATORY FITNESS; COGNITIVE FUNCTION; EXERCISE; ATROPHY; DECLINE	Background: Higher levels of fitness or physical function are positively associated with cognitive outcomes but the potential underlying mechanisms via brain structure are still to be elucidated in detail. We examined associations between brain structure and physical function (contemporaneous and change over the previous three years) in community-dwelling older adults. Methodology/Principal Findings: Participants from the Lothian Birth Cohort 1936 (N=694) underwent brain MRI at age 73 years to assess intracranial volume, and the volumes of total brain tissue, ventricles, grey matter, normal-appearing white matter, and white matter lesions. At ages 70 and 73, physical function was assessed by 6-meter walk, grip strength, and forced expiratory volume. A summary 'physical function factor' was derived from the individual measures using principal components analysis. Performance on each individual physical function measure declined across the three year interval (p<0.001). Higher level of physical function at ages 70 and 73 was associated with larger total brain tissue and white matter volumes, and smaller ventricular and white matter lesion volumes (standardized beta ranged in magnitude from 0.07 to 0.17, p<0.001 to 0.034). Decline in physical function from age 70 to 73 was associated with smaller white matter volume (0.08, p<0.01, though not after correction for multiple testing), but not with any other brain volumetric measurements. Conclusions/Significance: Physical function was related to brain volumes in community-dwelling older adults: declining physical function was associated with less white matter tissue. Further study is required to explore the detailed mechanisms through which physical function might influence brain structure, and vice versa.	[Aribisala, Benjamin S.; Bastin, Mark E.; Hernandez, Maria del Carmen Valdes; Royle, Natalie A.; Munoz Maniega, Susana; Wardlaw, Joanna M.] Univ Edinburgh, Sch Clin Sci, Div Neuroimaging Sci, Brain Res Imaging Ctr, Edinburgh, Midlothian, Scotland; [Aribisala, Benjamin S.; Gow, Alan J.; Bastin, Mark E.; Hernandez, Maria del Carmen Valdes; Royle, Natalie A.; Munoz Maniega, Susana; Starr, John M.; Deary, Ian J.; Wardlaw, Joanna M.] Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland; [Aribisala, Benjamin S.; Bastin, Mark E.; Hernandez, Maria del Carmen Valdes; Royle, Natalie A.; Munoz Maniega, Susana; Wardlaw, Joanna M.] SINAPSE Scottish Imaging Network Platform Sci Exc, Edinburgh, Midlothian, Scotland; [Aribisala, Benjamin S.] Lagos State Univ, Fac Sci, Dept Comp Sci, Lagos, Nigeria; [Gow, Alan J.] Heriot Watt Univ, Dept Psychol, Sch Life Sci, Edinburgh, Midlothian, Scotland; [Murray, Catherine; Deary, Ian J.] Univ Edinburgh, Dept Psychol, Edinburgh, Midlothian, Scotland; [Starr, John M.] Univ Edinburgh, Alzheimer Scotland Dementia Res Ctr, Edinburgh, Midlothian, Scotland	University of Edinburgh; University of Edinburgh; Lagos State University; Heriot Watt University; University of Edinburgh; University of Edinburgh	Gow, AJ (corresponding author), Univ Edinburgh, Ctr Cognit Ageing & Cognit Epidemiol, Edinburgh, Midlothian, Scotland.	A.J.Gow@hw.ac.uk	Deary, Ian J/C-6297-2009; Maniega, Susana Muñoz/I-8730-2014; Hernandez, María/GYU-3543-2022; Wardlaw, Joanna M/Y-3456-2019; Gow, Alan J/A-6070-2009	Deary, Ian J/0000-0002-1733-263X; Maniega, Susana Muñoz/0000-0001-5185-6384; Wardlaw, Joanna M/0000-0002-9812-6642; Gow, Alan J/0000-0002-3320-4531; Bastin, Mark/0000-0002-0490-0845	Research Into Ageing programme; Age UK-funded Disconnected Mind project; Medical Research Council; Scottish Funding Council through the SINAPSE Collaboration; MRC [G1001245, G0701120, G0700704] Funding Source: UKRI; Medical Research Council [MR/K026992/1, G1001245, G0701120, G0700704] Funding Source: researchfish	Research Into Ageing programme; Age UK-funded Disconnected Mind project; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Scottish Funding Council through the SINAPSE Collaboration; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by a Research Into Ageing programme grant (to I.J.D. and J.M.S.) and the Age UK-funded Disconnected Mind project (http://www.disconnectedmind.ed.ac.uk; to I.J.D., J.M.S. and J.M.W.), with additional funding from the Medical Research Council (to I.J.D., J.M.S., J.M.W. and M.E.B.). J.M.W. is supported by the Scottish Funding Council through the SINAPSE Collaboration (http://www.sinapse.ac.uk). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burns JM, 2008, NEUROLOGY, V71, P210, DOI 10.1212/01.wnl.0000317094.86209.cb; Callisaya ML, 2013, J AM GERIATR SOC, V61, P1074, DOI 10.1111/jgs.12331; Colcombe S, 2003, PSYCHOL SCI, V14, P125, DOI 10.1111/1467-9280.t01-1-01430; Colcombe SJ, 2006, J GERONTOL A-BIOL, V61, P1166, DOI 10.1093/gerona/61.11.1166; Deary IJ, 2006, NEUROLOGY, V67, P1195, DOI 10.1212/01.wnl.0000238520.06958.6a; Deary IJ, 2012, INT J EPIDEMIOL, V41, P1576, DOI 10.1093/ije/dyr197; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Erickson KI, 2012, AGING RES, V4, P34, DOI DOI 10.4081/AR.2012.E6; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gordon BA, 2008, PSYCHOPHYSIOLOGY, V45, P825, DOI 10.1111/j.1469-8986.2008.00676.x; Gow AJ, 2012, NEUROLOGY, V79, P1802, DOI 10.1212/WNL.0b013e3182703fd2; Gow AJ, 2012, PSYCHOL AGING, V27, P250, DOI 10.1037/a0024144; Hertzog Christopher, 2008, Psychol Sci Public Interest, V9, P1, DOI 10.1111/j.1539-6053.2009.01034.x; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Johnson NF, 2012, NEUROIMAGE, V59, P1514, DOI 10.1016/j.neuroimage.2011.08.032; Kramer AF, 2005, NEUROBIOL AGING, V26, pS124, DOI 10.1016/j.neurobiolaging.2005.09.009; Kramer AF, 2006, J APPL PHYSIOL, V101, P1237, DOI 10.1152/japplphysiol.00500.2006; Lezak M.D., 1995, NEUROPSYCHOLOGICAL A; Makizako H, 2011, ARCH PHYS MED REHAB, V92, P1992, DOI 10.1016/j.apmr.2011.07.195; Moonen HMR, 2008, MENTAL HLTH PHYS ACT, V1, P62, DOI [10.1016/j.mhpa.2008.09.001, DOI 10.1016/J.MHPA.2008.09.001]; Office GR, 1956, CENS 1951 CLASS OCC; Penke L, 2012, NEUROBIOL AGING, V33, P510, DOI 10.1016/j.neurobiolaging.2010.04.032; Peters J, 2009, NEUROSCIENCE, V163, P1102, DOI 10.1016/j.neuroscience.2009.07.030; Rosano C, 2010, NEUROBIOL AGING, V31, P1197, DOI 10.1016/j.neurobiolaging.2008.08.004; SCRE, 1949, TREND SCOTT INT; Sen A, 2012, NEURODEGENER DIS, V10, P1, DOI [10.1159/000338008, DOI 10.1159/000338008]; Starr JM, 2003, J NEUROL NEUROSUR PS, V74, P94, DOI 10.1136/jnnp.74.1.94; Thomas AG, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00086; Hernandez MDV, 2010, EUR RADIOL, V20, P1684, DOI 10.1007/s00330-010-1718-6; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Voss MW, 2013, BRAIN BEHAV IMMUN, V28, P90, DOI 10.1016/j.bbi.2012.10.021; Voss MW, 2010, NEUROPSYCHOLOGIA, V48, P1394, DOI 10.1016/j.neuropsychologia.2010.01.005; Voss MW, 2010, NEUROSCIENC IN PRESS; Wardlaw JM, 2011, INT J STROKE, V6, P547, DOI 10.1111/j.1747-4949.2011.00683.x	34	44	47	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80386	10.1371/journal.pone.0080386	http://dx.doi.org/10.1371/journal.pone.0080386			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265818	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100154
J	Keller, MR; Haynes, LD; Jankowska-Gan, E; Sullivan, JA; Agashe, VV; Burlingham, SR; Burlingham, WJ				Keller, Melissa R.; Haynes, Lynn D.; Jankowska-Gan, Ewa; Sullivan, Jeremy A.; Agashe, Vrushali V.; Burlingham, Scott R.; Burlingham, William J.			Epitope Analysis of the Collagen Type V-Specific T Cell Response in Lung Transplantation Reveals an HLA-DRB1(star)15 Bias in Both Recipient and Donor	PLOS ONE			English	Article							OBLITERATIVE BRONCHIOLITIS; ALLOGRAFT VASCULOPATHY; INTERNATIONAL SOCIETY; ANTIGEN; AUTOIMMUNITY; ARTHRITIS; PEPTIDES; IMMUNITY; MODEL; SUSCEPTIBILITY	Background: IL-17-dependent cellular immune responses to the alpha 1 chain of collagen type V are associated with development of bronchiolitis obliterans syndrome after lung transplantation, and with idiopathic pulmonary fibrosis and coronary artery disease, primary indications for lung or heart transplantation, respectively. Methodology/Principal Findings: We found that 30% of the patients awaiting lung transplantation exhibited a strong cell-mediated immune response to col(V). Of these, 53% expressed HLA-DR15, compared to a 28% HLA-DR15 frequency in col(V) low-responders (p=0.02). After transplantation, patients with HLA-DR1 and -DR17, not DR15, developed anti-col(V) responses most frequently (p=0.04 and 0.01 vs. controls, respectively). However, recipients of a lung from an HLA-DR15(+) donor were at significantly elevated risk of developing anti-col(V) responses (p=0.02) and BOS (p=0.03). To determine the molecular basis of this unusual pattern of DR allele bias, a peptide library comprising the collagenous region of the a1(V) protein was screened for binding to HLA-DR0101, -DR1501, -DR0301 (DR17) or to HLA-DQ2 (DQA1(star)0501: DQB1(star)0201; in linkage disequilibrium with -DR17) and -DQ6 (DQA1(star)0102: DQB1(star)0602; linked to -DR15). Eight 15-mer peptides, six DR-binding and two DQ-binding, were identified. HLA-DR15 binding to two peptides yielded the highest binding scores: 650 (where 100 = positive control) for p799 (GIRGLKGTKGEKGED), and 193 for p1439 (LRGIPGPVGEQGLPG). These peptides, which also bound weakly to HLA-DR1, elicited responses in both HLA-DR1(+) and -DR15(+) col(V) reactive hosts, whereas binding and immunoreactivity of p1049 (KDGPPGLRGFPGDRG) was DR15-specific. Remarkably, a col(V)-reactive HLA-DR1(+) DR15neg lung transplant patient, whose donor was HLA-DR15(+), responded not only to p799 and p1439, but also to p1049. Conclusions/Significance: HLA-DR15 and IPF disease were independently associated with pre-transplant col(V) autoimmunity. The increased risk of de novo immunity to col(V) and BOS, associated with receiving a lung transplant from an HLA-DR15(+) donor, may result from presentation by donor-derived HLA-DR15, of novel self-peptides to recipient T cells.	[Keller, Melissa R.; Haynes, Lynn D.; Jankowska-Gan, Ewa; Sullivan, Jeremy A.; Agashe, Vrushali V.; Burlingham, William J.] Univ Wisconsin, Dept Surg, Madison, WI 53706 USA; [Keller, Melissa R.] Univ Wisconsin, Cellular & Mol Pathol Grad Program, Madison, WI USA; [Agashe, Vrushali V.] Univ Wisconsin, Comparat Biomed Sci Grad Program, Madison, WI USA; [Burlingham, Scott R.] Univ Wisconsin, Dept Chem, Madison, WI 53706 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Burlingham, WJ (corresponding author), Univ Wisconsin, Dept Surg, Madison, WI 53706 USA.	burlingham@surgery.wisc.edu	Agashe, Vrushali/AAG-4768-2020	Agashe, Vrushali/0000-0001-8800-5946	NIH [PO1AI084853]; EU; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI084853] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EU(European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant #PO1AI084853 (MRK, EJG, LDH, VVA, SRB, WJB), and by the EU-sponsored One Study (WJB). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony PA, 2005, J IMMUNOL, V174, P2591, DOI 10.4049/jimmunol.174.5.2591; Behrens M, 2010, J AUTOIMMUN, V35, P1, DOI 10.1016/j.jaut.2009.12.007; Burlingham WJ, 2007, J CLIN INVEST, V117, P3498, DOI 10.1172/JCI28031; Carrodeguas L, 1999, HUM IMMUNOL, V60, P640, DOI 10.1016/S0198-8859(99)00002-6; Christie JD, 2012, J HEART LUNG TRANSPL, V31, P1073, DOI 10.1016/j.healun.2012.08.004; Dart ML, 2010, CIRC RES, V107, P1106, DOI 10.1161/CIRCRESAHA.110.221069; Doyle HA, 2013, AUTOIMMUNITY, V46, P6, DOI 10.3109/08916934.2012.710859; Estenne M, 2002, AM J RESP CRIT CARE, V166, P440, DOI 10.1164/rccm.200201-003PP; Fan L, 2011, AM J TRANSPLANT, V11, P911, DOI 10.1111/j.1600-6143.2011.03482.x; Feitsma AL, 2007, P NATL ACAD SCI USA, V104, P19966, DOI 10.1073/pnas.0710260104; Feitsma AL, 2010, ARTHRITIS RHEUM-US, V62, P117, DOI 10.1002/art.25059; Frasca L, 1998, TRANSPLANTATION, V66, P1238, DOI 10.1097/00007890-199811150-00020; Fukami N, 2009, J IMMUNOL, V182, P309, DOI 10.4049/jimmunol.182.1.309; Getts DR, 2012, NAT BIOTECHNOL, V30, P1217, DOI 10.1038/nbt.2434; Gomez A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036095; Grundtman C, 2011, CURR OPIN LIPIDOL, V22, P327, DOI 10.1097/MOL.0b013e32834aa0c2; Guthrie KA, 2009, ANN RHEUM DIS, V68, P107, DOI 10.1136/ard.2008.092312; Harari S, 2005, ALLERGY, V60, P421, DOI 10.1111/j.1398-9995.2005.00719.x; Herrera OB, 2004, J IMMUNOL, V173, P4828, DOI 10.4049/jimmunol.173.8.4828; Hill JA, 2008, J EXP MED, V205, P967, DOI 10.1084/jem.20072051; Holmdahl R, 2002, AGEING RES REV, V1, P135, DOI 10.1016/S0047-6374(01)00371-2; Hoo ZH, 2012, THORAX, V67, P742, DOI 10.1136/thoraxjnl-2011-200515; Iwata T, 2008, J IMMUNOL, V181, P5738, DOI 10.4049/jimmunol.181.8.5738; Jankowska-Gan E, 2013, JOVE-J VIS EXP, DOI 10.3791/4454; King TE, 2011, LANCET, V378, P1949, DOI 10.1016/S0140-6736(11)60052-4; Liu ZR, 1996, J CLIN INVEST, V98, P1150, DOI 10.1172/JCI118898; McMahon EJ, 2005, NAT MED, V11, P335, DOI 10.1038/nm1202; Mehra MR, 2010, J HEART LUNG TRANSPL, V29, P717, DOI 10.1016/j.healun.2010.05.017; OLERUP O, 1992, TISSUE ANTIGENS, V39, P225, DOI 10.1111/j.1399-0039.1992.tb01940.x; Pajot A, 2004, EUR J IMMUNOL, V34, P3060, DOI 10.1002/eji.200425463; Rahmani M, 2006, CIRC RES, V99, P801, DOI 10.1161/01.RES.0000246086.93555.f3; Rich C, 2004, EUR J IMMUNOL, V34, P1251, DOI 10.1002/eji.200324354; Robertson J, 2005, KIDNEY INT, V68, P1061, DOI 10.1111/j.1523-1755.2005.00498.x; Schmauss D, 2008, CIRCULATION, V117, P2131, DOI 10.1161/CIRCULATIONAHA.107.711911; Sullivan JA, 2013, TRANSPLANTA IN PRESS; TANEJA V, 1992, RHEUMATOL INT, V11, P251, DOI 10.1007/BF00301502; Taneja V, 2008, J IMMUNOL, V181, P2869, DOI 10.4049/jimmunol.181.4.2869; Tiriveedhi V, 2012, CLIN EXP IMMUNOL, V167, P158, DOI 10.1111/j.1365-2249.2011.04486.x; TRENTHAM DE, 1977, J EXP MED, V146, P857, DOI 10.1084/jem.146.3.857; Van Den Steen PE, 2002, FASEB J, V16, DOI 10.1096/fj.01-0688com; Vella JP, 1997, TRANSPLANTATION, V64, P795, DOI 10.1097/00007890-199709270-00001; Verleden GM, 2009, TRANSPL INT, V22, P771, DOI 10.1111/j.1432-2277.2009.00872.x; Vittal R, 2012, AM J PHYSL LUNG CELL; Xu QY, 2009, TRANSPL IMMUNOL, V20, P203, DOI 10.1016/j.trim.2008.12.005; Xue JM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0014715; Yang CX, 2012, J BIOL CHEM, V287, P40598, DOI 10.1074/jbc.M112.406850	46	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79601	10.1371/journal.pone.0079601	http://dx.doi.org/10.1371/journal.pone.0079601			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265781	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100114
J	Myers, EM; Harwell, TI; Yale, EL; Lamb, AM; Frankino, WA				Myers, Erin M.; Harwell, Tiffany I.; Yale, Elizabeth L.; Lamb, Abigail M.; Frankino, W. Anthony			Multifaceted, Cross-Generational Costs of Hybridization in Sibling Drosophila species	PLOS ONE			English	Article							HYBRID MALE-STERILITY; REPRODUCTIVE ISOLATION; SEXUAL SELECTION; NATURAL-SELECTION; CHARACTER DISPLACEMENT; POSTZYGOTIC ISOLATION; GENE EXCHANGE; D-PERSIMILIS; PSEUDOOBSCURA; REINFORCEMENT	Maladaptive hybridization, as determined by the pattern and intensity of selection against hybrid individuals, is an important factor contributing to the evolution of prezygotic reproductive isolation. To identify the consequences of hybridization between Drosophila pseudoobscura and D. persimilis, we estimated multiple fitness components for F1 hybrids and backcross progeny and used these to compare the relative fitness of parental species and their hybrids across two generations. We document many sources of intrinsic (developmental) and extrinsic (ecological) selection that dramatically increase the fitness costs of hybridization beyond the well-documented F1 male sterility in this model system. Our results indicate that the cost of hybridization accrues over multiple generations and reinforcement in this system is driven by selection against hybridization above and beyond the cost of hybrid male sterility; we estimate a fitness loss of >95% relative to the parental species across two generations of hybridization. Our findings demonstrate the importance of estimating hybridization costs using multiple fitness measures from multiple generations in an ecologically relevant context; so doing can reveal intense postzygotic selection against hybridization and thus, an enhanced role for reinforcement in the evolution of populations and diversification of species.	[Myers, Erin M.; Harwell, Tiffany I.; Yale, Elizabeth L.; Lamb, Abigail M.; Frankino, W. Anthony] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA	University of Houston System; University of Houston	Myers, EM (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.	myers.erinm@gmail.com			(National Science Foundation) NSF Bioinformatics Postdoctoral Fellowship; NSF [DEB 0805818, IOS 0920720]; University of Houston GEAR Award	(National Science Foundation) NSF Bioinformatics Postdoctoral Fellowship; NSF(National Science Foundation (NSF)); University of Houston GEAR Award	E.M.M was supported by an (National Science Foundation) NSF Bioinformatics Postdoctoral Fellowship. This research was supported by NSF grants DEB 0805818, IOS 0920720 and a University of Houston GEAR Award to W. A. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold ML, 2010, TRENDS ECOL EVOL, V25, P530, DOI 10.1016/j.tree.2010.06.005; ARNOLD ML, 1995, TRENDS ECOL EVOL, V10, P67, DOI 10.1016/S0169-5347(00)88979-X; ARNTZEN JW, 1990, HOLARCTIC ECOL, V13, P325; ATKINSON WD, 1979, J ANIM ECOL, V48, P91, DOI 10.2307/4102; Bono JM, 2009, J EVOLUTION BIOL, V22, P1387, DOI 10.1111/j.1420-9101.2009.01753.x; BREEUWER JAJ, 1995, EVOLUTION, V49, P705, DOI 10.1111/j.1558-5646.1995.tb02307.x; Burke DT, 2012, GENOME RES, V22, P1549, DOI 10.1101/gr.135582.111; Chang AS, 2010, EVOLUTION, V64, P253, DOI 10.1111/j.1558-5646.2009.00823.x; COYNE JA, 1992, NATURE, V355, P511, DOI 10.1038/355511a0; Coyne JA, 2004, SPECIATION, V37; CROSSLEY SA, 1974, EVOLUTION, V28, P631, DOI 10.1111/j.1558-5646.1974.tb00795.x; da Silva LB, 2005, BEHAV PROCESS, V70, P149, DOI 10.1016/j.beproc.2005.06.004; Dobzhansky T, 1937, AM NAT, V71, P404, DOI 10.1086/280726; Dobzhansky T, 1936, GENETICS, V21, P113; Dobzhansky T, 1940, AM NAT, V74, P312, DOI 10.1086/280899; DOBZHANSKY T, 1976, EVOLUTION, V30, P201, DOI 10.1111/j.1558-5646.1976.tb00904.x; DOBZHANSKY T, 1973, AM NAT, V107, P312, DOI 10.1086/282833; Dobzhansky T, 1981, DOBZHANSKYS GENETICS, pI; Dobzhansky T., 1937; Dudley R., 2000, BIOMECHANICS INSECT; Endler J.A., 1977, Monographs in Population Biology, pi; Gibo DL, 1969, THESIS U CALIFORNIA; Haldane JBS, 1922, J GENET, V12, P101, DOI 10.1007/BF02983075; Hatfield T, 1999, EVOLUTION, V53, P866, DOI 10.1111/j.1558-5646.1999.tb05380.x; Hey J, 2004, GENETICS, V167, P747, DOI 10.1534/genetics.103.024182; Higgie M, 2000, SCIENCE, V290, P519, DOI 10.1126/science.290.5491.519; Hobel G, 2003, EVOLUTION, V57, P894; Hoffmann AA, 2006, EVOL ECOL RES, V8, P813; HOLM S, 1979, SCAND J STAT, V6, P65; Hopkins R, 2013, NEW PHYTOL, V197, P1095, DOI 10.1111/nph.12119; Hopkins R, 2012, SCIENCE, V335, P1090, DOI 10.1126/science.1215198; Howard DJ, 1993, HYBRID ZONES EVOLUTI; Jiggins CD, 2001, NATURE, V411, P302, DOI 10.1038/35077075; Kay KM, 2006, EVOLUTION, V60, P538; Kelly JK, 1996, GENETICS, V143, P1485; Khadem M, 2011, J EVOLUTION BIOL, V24, P1263, DOI 10.1111/j.1420-9101.2011.02263.x; King EG, 2012, GENETICS, V191, P935, DOI 10.1534/genetics.112.138537; Kirkpatrick M, 2002, AM NAT, V159, pS22, DOI 10.1086/338370; Kirkpatrick M, 2000, P ROY SOC B-BIOL SCI, V267, P1649, DOI 10.1098/rspb.2000.1191; KNIGHT GR, 1956, EVOLUTION, V10, P14, DOI 10.2307/2406092; KOOPMAN KF, 1950, EVOLUTION, V4, P135, DOI 10.1111/j.1558-5646.1950.tb00048.x; Laurie CC, 1997, GENETICS, V147, P937; Lemmon EM, 2010, EVOLUTION, V64, P1748, DOI 10.1111/j.1558-5646.2010.00955.x; Lewontin RC, 1981, DOBZHANSKYS GENETICS, pI; LIOU LW, 1994, EVOLUTION, V48, P1451, DOI 10.1111/j.1558-5646.1994.tb02187.x; Lorch PD, 2005, EVOLUTION, V59, P1039; Machado CA, 2007, GENETICS, V175, P1289, DOI 10.1534/genetics.106.064758; Matute DR, 2010, CURR BIOL, V20, P2229, DOI 10.1016/j.cub.2010.11.036; Matute DR, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000341; Myers EM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031759; NOOR MA, 1995, NATURE, V375, P674, DOI 10.1038/375674a0; Noor MAF, 2006, BEHAV GENET, V36, P322, DOI 10.1007/s10519-005-9033-8; Noor MAF, 1998, ANIM BEHAV, V56, P115, DOI 10.1006/anbe.1998.0779; Noor MAF, 2001, P NATL ACAD SCI USA, V98, P12084, DOI 10.1073/pnas.221274498; Noor MAF, 1997, EVOLUTION, V51, P809, DOI [10.2307/2411156, 10.1111/j.1558-5646.1997.tb03663.x]; Noor MAF, 1996, GENET RES, V68, P117, DOI 10.1017/S0016672300034005; Noor MAF, 2001, EVOLUTION, V55, P512, DOI 10.1554/0014-3820(2001)055[0512:TGORIA]2.0.CO;2; NUNNEY L, 1990, ECOLOGY, V71, P1904, DOI 10.2307/1937598; ORR HA, 1987, GENETICS, V116, P555; Ortiz-Barrientos D, 2005, SCIENCE, V310, P1467, DOI 10.1126/science.1121260; Ortiz-Barrientos D, 2004, PLOS BIOL, V2, P2256, DOI 10.1371/journal.pbio.0020416; Otto PA, 2000, GENET MOL BIOL, V23, P835, DOI 10.1590/S1415-47572000000400022; Oxenkrug G, 2010, J NEURAL TRANSM, V117, P23, DOI 10.1007/s00702-009-0341-7; Panhuis TM, 2001, TRENDS ECOL EVOL, V16, P364, DOI 10.1016/S0169-5347(01)02160-7; PATERNIANI E, 1969, EVOLUTION, V23, P534, DOI 10.1111/j.1558-5646.1969.tb03539.x; Pekkala N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024560; Pfennig KS, 2007, SCIENCE, V318, P965, DOI 10.1126/science.1146035; POWELL JR, 1983, P NATL ACAD SCI-BIOL, V80, P492, DOI 10.1073/pnas.80.2.492; Presgraves DC, 2003, GENETICS, V163, P955; Presgraves DC, 2002, EVOLUTION, V56, P1168, DOI 10.1111/j.0014-3820.2002.tb01430.x; Price TD, 2002, EVOLUTION, V56, P2083; Promislow DEL, 2001, J HERED, V92, P30, DOI 10.1093/jhered/92.1.30; Ramsey J, 2003, EVOLUTION, V57, P1520, DOI 10.1111/j.0014-3820.2003.tb00360.x; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Ruane LG, 2008, EVOL ECOL, V22, P229, DOI 10.1007/s10682-007-9174-8; Saetre GP, 1997, NATURE, V387, P589; Servedio MR, 2003, ANNU REV ECOL EVOL S, V34, P339, DOI 10.1146/annurev.ecolsys.34.011802.132412; Shaw KL, 2011, GENETICA, V139, P649, DOI 10.1007/s10709-011-9562-4; Simmons LW, 2008, J EVOLUTION BIOL, V21, P1227, DOI 10.1111/j.1420-9101.2008.01575.x; SINGH BN, 1989, GENET SEL EVOL, V21, P447, DOI 10.1051/gse:19890405; Snow AA, 1998, AM J BOT, V85, P794, DOI 10.2307/2446414; Sokal R. R., 2012, BIOMETRY; Stillwell R.C., 2011, JOVE-J VIS EXP, V56, pe3162; Sturtevant AH, 1920, GENETICS, V5, P488; Svedin N, 2008, P ROY SOC B-BIOL SCI, V275, P735, DOI 10.1098/rspb.2007.0967; Tamura K, 2004, MOL BIOL EVOL, V21, P36, DOI 10.1093/molbev/msg236; Tao Y, 2003, GENETICS, V164, P1383; Tech C, 2006, J EVOL BIOL, V19; van Doorn GS, 2009, SCIENCE, V326, P1704, DOI 10.1126/science.1181661; Weber KE, 1996, GENETICS, V144, P205; Weber KE, 1988, DROSOPHILA INF SERV, V67, P92; WEISBROT DR, 1963, GENETICS, V48, P1121; WILCOXON F, 1946, J ECON ENTOMOL, V39, P269, DOI 10.1093/jee/39.2.269; Wiley C, 2009, EVOLUTION, V63, P1731, DOI 10.1111/j.1558-5646.2009.00674.x; WU CI, 1993, AM NAT, V142, P187, DOI 10.1086/285534	95	2	2	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80331	10.1371/journal.pone.0080331	http://dx.doi.org/10.1371/journal.pone.0080331			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265807	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100143
J	Siener, R; Netzer, L; Hesse, A				Siener, Roswitha; Netzer, Linda; Hesse, Albrecht			Determinants of Brushite Stone Formation: A Case-Control Study	PLOS ONE			English	Article							HPLC-ENZYME-REACTOR; IDIOPATHIC HYPERCALCIURIA; CLINICAL-IMPLICATIONS; CALCIUM-PHOSPHATE; OXALATE; NEPHROLITHIASIS; PATHOGENESIS; FRAGILITY	Purpose: The occurrence of brushite stones has increased during recent years. However, the pathogenic factors driving the development of brushite stones remain unclear. Methods: Twenty-eight brushite stone formers and 28 age-, sex- and BMI-matched healthy individuals were enrolled in this case-control study. Anthropometric, clinical, 24 h urinary parameters and dietary intake from 7-day weighed food records were assessed. Results: Pure brushite stones were present in 46% of patients, while calcium oxalate was the major secondary stone component. Urinary pH and oxalate excretion were significantly higher, whereas urinary citrate was lower in patients as compared to healthy controls. Despite lower dietary intake, urinary calcium excretion was significantly higher in brushite stone patients. Binary logistic regression analysis revealed pH >6.50 (OR 7.296; p = 0.035), calcium >6.40 mmol/24 h (OR 25.213; p = 0.001) and citrate excretion <2.600 mmol/24 h (OR 15.352; p = 0.005) as urinary risk factors for brushite stone formation. A total of 56% of patients exhibited distal renal tubular acidosis (dRTA). Urinary pH, calcium and citrate excretion did not significantly differ between patients with or without dRTA. Conclusions: Hypercalciuria, a diminished citrate excretion and an elevated pH turned out to be the major urinary determinants of brushite stone formation. Interestingly, urinary phosphate was not associated with urolithiasis. The increased urinary oxalate excretion, possibly due to decreased calcium intake, promotes the risk of mixed stone formation with calcium oxalate. Neither dietary factors nor dRTA can account as cause for hypercalciuria, higher urinary pH and diminished citrate excretion. Further research is needed to define the role of dRTA in brushite stone formation and to evaluate the hypothesis of an acquired acidification defect.	[Siener, Roswitha; Netzer, Linda; Hesse, Albrecht] Univ Bonn, Dept Urol, Univ Stone Ctr, Bonn, Germany	University of Bonn	Siener, R (corresponding author), Univ Bonn, Dept Urol, Univ Stone Ctr, Bonn, Germany.	Roswitha.Siener@ukb.uni-bonn.de						Arampatzis S, 2012, UROL RES, V40, P53, DOI 10.1007/s00240-011-0397-3; Borghi L, 2002, NEW ENGL J MED, V346, P77, DOI 10.1056/NEJMoa010369; Bouzidi H, 2011, NEPHROL DIAL TRANSPL, V26, P565, DOI 10.1093/ndt/gfq433; Daudon M, 2010, UROL RES, V38, P459, DOI 10.1007/s00240-010-0320-3; DRETLER SP, 1988, J UROLOGY, V139, P1124, DOI 10.1016/S0022-5347(17)42801-1; Evan AP, 2005, KIDNEY INT, V67, P576, DOI 10.1111/j.1523-1755.2005.67114.x; Hesse A, 1999, WORLD J UROL, V17, P308, DOI 10.1007/s003450050152; Hesse AT, 2009, URINARY STONES DIAGN; Honow R, 2002, FOOD CHEM, V78, P511, DOI 10.1016/S0308-8146(02)00212-1; Honow R, 1997, CLIN CHIM ACTA, V261, P131, DOI 10.1016/S0009-8981(97)06521-2; KLEE LW, 1991, J UROLOGY, V145, P715, DOI 10.1016/S0022-5347(17)38432-X; Knoll T, 2011, J UROLOGY, V185, P1304, DOI 10.1016/j.juro.2010.11.073; Krambeck AE, 2010, J UROLOGY, V184, P1367, DOI 10.1016/j.juro.2010.05.094; Mandel N, 2003, J UROLOGY, V169, P2026, DOI 10.1097/01.ju.0000065592.55499.4e; Pak CYC, 2004, J UROLOGY, V171, P1046, DOI 10.1097/01.ju.0000104860.65987.4a; Parks JH, 2004, KIDNEY INT, V66, P777, DOI 10.1111/j.1523-1755.2004.00803.x; Parks JH, 2009, NEPHROL DIAL TRANSPL, V24, P130, DOI 10.1093/ndt/gfn420; [Schweizerische Gesellschaft fur Ernahrungsforschung Osterreichische Gesellschaft fur Ernahrung Deutsche Gesellschaft fur Ernahrung], 2000, REF NAHRST; Siener R, 2006, J AGR FOOD CHEM, V54, P3008, DOI 10.1021/jf052776v; Siener R, 2006, FOOD CHEM, V98, P220, DOI 10.1016/j.foodchem.2005.05.059; Siener R, 2009, ENCY MOL MECH DIS, V3, P2149; SIMPSON DP, 1983, AM J PHYSIOL, V244, pF223, DOI 10.1152/ajprenal.1983.244.3.F223; Turk C., 2013, GUIDELINES UROLITHIA; Von Unruh GE, 2004, J AM SOC NEPHROL, V15, P1567, DOI 10.1097/01.ASN.0000127864.26968.7F; WERNESS PG, 1985, J UROLOGY, V134, P1242, DOI 10.1016/S0022-5347(17)47703-2; Worcester EM, 2008, SEMIN NEPHROL, V28, P120, DOI 10.1016/j.semnephrol.2008.01.005; Zerwekh JE, 2002, ENDOCRIN METAB CLIN, V31, P869, DOI 10.1016/S0889-8529(02)00028-2; ZHONG P, 1994, J ENDOUROL, V8, P263, DOI 10.1089/end.1994.8.263	28	11	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78996	10.1371/journal.pone.0078996	http://dx.doi.org/10.1371/journal.pone.0078996			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265740	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100073
J	Jones, C; Allsopp, L; Horlick, J; Kulasekara, H; Filloux, A				Jones, Cerith; Allsopp, Luke; Horlick, Jack; Kulasekara, Hemantha; Filloux, Alain			Subinhibitory Concentration of Kanamycin Induces the Pseudomonas aeruginosa type VI Secretion System	PLOS ONE			English	Article							COMPLETE GENOME SEQUENCE; CYCLIC DI-GMP; BIOFILM FORMATION; BACTERIAL 2ND-MESSENGER; PROTEIN SECRETION; VIRULENCE GENES; RETS; RNA; PATHOGENESIS; INFECTION	Pseudomonas aeruginosa is a Gram-negative bacterium found in natural environments including plants, soils and warm moist surfaces. This organism is also in the top ten of nosocomial pathogens, and prevalent in cystic fibrosis (CF) lung infections. The ability of P. aeruginosa to colonize a wide variety of environments in a lasting manner is associated with the formation of a resistant biofilm and the capacity to efficiently outcompete other microorganisms. Here we demonstrate that sub-inhibitory concentration of kanamycin not only induces biofilm formation but also induces expression of the type VI secretion genes in the H1-T6SS cluster. The H1-T6SS is known for its role in toxin production and bacterial competition. We show that the antibiotic induction of the H1-T6SS only occurs when a functional Gac/Rsm pathway is present. These observations may contribute to understand how P. aeruginosa responds to antibiotic producing competitors. It also suggests that improper antibiotic therapy may enhance P. aeruginosa colonization, including in the airways of CF patients.	[Jones, Cerith; Allsopp, Luke; Horlick, Jack; Filloux, Alain] Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect CBMI, London, England; [Kulasekara, Hemantha] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Kulasekara, Hemantha] Univ Washington, Dept Med, Seattle, WA USA; [Kulasekara, Hemantha] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA	Imperial College London; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Filloux, A (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Life Sci, MRC, Ctr Mol Bacteriol & Infect CBMI, London, England.	a.filloux@imperial.ac.uk	Jones, Cerith/AAH-5992-2020; Allsopp, Luke/AAG-2488-2020	Allsopp, Luke/0000-0002-0313-9265; Jones, Cerith/0000-0001-6275-0235	BBSRC; MRC [MR/K001930/1]; Wellcome Trust [WT091939]; Medical Research Council [MR/K001930/1] Funding Source: researchfish; MRC [MR/J006874/1] Funding Source: UKRI	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Cerith Jones is supported by a BBSRC PhD fellowship. The work on T6SS in Alain Filloux's laboratory is supported by the MRC programme grant MR/K001930/1 and the Wellcome Trust grant WT091939. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BARON SS, 1981, ANTIMICROB AGENTS CH, V20, P814, DOI 10.1128/AAC.20.6.814; Basler M, 2013, CELL, V152, P884, DOI 10.1016/j.cell.2013.01.042; Bjarnsholt T, 2007, ANAL BIOANAL CHEM, V387, P409, DOI 10.1007/s00216-006-0774-x; Bleves S, 2005, J BACTERIOL, V187, P3898, DOI 10.1128/JB.187.11.3898-3902.2005; Bordi C, 2010, MOL MICROBIOL, V76, P1427, DOI 10.1111/j.1365-2958.2010.07146.x; Brencic A, 2009, MOL MICROBIOL, V73, P434, DOI 10.1111/j.1365-2958.2009.06782.x; Brencic A, 2009, MOL MICROBIOL, V72, P612, DOI 10.1111/j.1365-2958.2009.06670.x; Brinkman FSL, 2001, INFECT IMMUN, V69, P5207, DOI 10.1128/IAI.69.8.5207-5211.2001; Byrd MS, 2011, INFECT IMMUN, V79, P3087, DOI 10.1128/IAI.00057-11; Casabona MG, 2013, ENVIRON MICROBIOL, V15, P471, DOI 10.1111/j.1462-2920.2012.02816.x; Coggan KA, 2012, CURR ISSUES MOL BIOL, V14, P47; Driscoll JA, 2007, DRUGS, V67, P351, DOI 10.2165/00003495-200767030-00003; FIGURSKI DH, 1979, P NATL ACAD SCI USA, V76, P1648, DOI 10.1073/pnas.76.4.1648; Filloux A, 2008, MICROBIOL-SGM, V154, P1570, DOI 10.1099/mic.0.2008/016840-0; Girard G, 2008, FUTURE MICROBIOL, V3, P97, DOI 10.2217/17460913.3.1.97; Goodman AL, 2004, DEV CELL, V7, P745, DOI 10.1016/j.devcel.2004.08.020; Goodman AL, 2009, GENE DEV, V23, P249, DOI 10.1101/gad.1739009; Gotoh H, 2008, RES MICROBIOL, V159, P294, DOI 10.1016/j.resmic.2008.02.002; Hachani A, 2013, JOVE-J VIS EXP, DOI 10.3791/50103; Hachani A, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.193045; Harmsen M, 2010, FEMS IMMUNOL MED MIC, V59, P253, DOI 10.1111/j.1574-695X.2010.00690.x; Hauser AR, 2009, NAT REV MICROBIOL, V7, P654, DOI 10.1038/nrmicro2199; Heurlier K, 2004, J BACTERIOL, V186, P2936, DOI 10.1128/JB.186.10.2936-2945.2004; Hilbi H, 2007, ENVIRON MICROBIOL, V9, P563, DOI 10.1111/j.1462-2920.2007.01238.x; Hocquet D, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002778; Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912; Hood RD, 2010, CELL HOST MICROBE, V7, P25, DOI 10.1016/j.chom.2009.12.007; Irie Y, 2010, MOL MICROBIOL, V78, P158, DOI 10.1111/j.1365-2958.2010.07320.x; Jimenez PN, 2012, MICROBIOL MOL BIOL R, V76, P46, DOI 10.1128/MMBR.05007-11; Jing X, 2010, PROTEINS, V78, P1631, DOI 10.1002/prot.22679; KANIGA K, 1991, GENE, V109, P137, DOI 10.1016/0378-1119(91)90599-7; Kulasekara HD, 2007, NAT CELL BIOL, V9, P734, DOI 10.1038/ncb0707-734; Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103; Lapouge K, 2008, MOL MICROBIOL, V67, P241, DOI 10.1111/j.1365-2958.2007.06042.x; Laskowski MA, 2006, INFECT IMMUN, V74, P4462, DOI 10.1128/IAI.00575-06; LeRoux M, 2012, P NATL ACAD SCI USA, V109, P19804, DOI 10.1073/pnas.1213963109; Liberati NT, 2006, P NATL ACAD SCI USA, V103, P2833, DOI 10.1073/pnas.0511100103; Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103; Lory Stephen, 2009, Nucleic Acids Symp Ser (Oxf), P51, DOI 10.1093/nass/nrp026; Lossi NS, 2013, J BIOL CHEM, V288, P7536, DOI 10.1074/jbc.M112.439273; Mann EE, 2012, FEMS MICROBIOL REV, V36, P893, DOI 10.1111/j.1574-6976.2011.00322.x; Mikkelsen H, 2010, FEMS MICROBIOL LETT; Mikkelsen H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029113; Mikkelsen H, 2011, ENVIRON MICROBIOL, V13, P1666, DOI 10.1111/j.1462-2920.2011.02495.x; Miller J.H., 1992, SHORT COURSE BACTERI, P150; Mills E, 2011, CELL MICROBIOL, V13, P1122, DOI 10.1111/j.1462-5822.2011.01619.x; Moscoso JA, 2011, ENVIRON MICROBIOL, V13, P3128, DOI 10.1111/j.1462-2920.2011.02595.x; Mougous JD, 2007, NAT CELL BIOL, V9, P797, DOI 10.1038/ncb1605; Mougous JD, 2006, SCIENCE, V312, P1526, DOI 10.1126/science.1128393; Petrova OE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000668; RINGEN LM, 1952, J BACTERIOL, V64, P841, DOI 10.1128/JB.64.6.841-845.1952; Rodrigue A, 2000, TRENDS MICROBIOL, V8, P498, DOI 10.1016/S0966-842X(00)01833-3; Romling U, 2013, MICROBIOL MOL BIOL R, V77, P1, DOI 10.1128/MMBR.00043-12; Roy PH, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008842; Russe AB, 2012, CELL HOST MICROBE, V11, P538, DOI 10.1016/j.chom.2012.04.007; Russell AB, 2011, NATURE, V475, P343, DOI 10.1038/nature10244; Rybtke MT, 2012, APPL ENVIRON MICROB, V78, P5060, DOI 10.1128/AEM.00414-12; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; Strateva T, 2011, J CHEMOTHERAPY, V23, P374, DOI 10.1179/joc.2011.23.6.374; Vasseur P, 2005, MICROBIOL-SGM, V151, P985, DOI 10.1099/mic.0.27410-0; Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103; Vincent F, 2010, ENVIRON MICROBIOL, V12, P1775, DOI 10.1111/j.1462-2920.2010.02264.x; Wolfgang MC, 2003, DEV CELL, V4, P253, DOI 10.1016/S1534-5807(03)00019-4; Zin NZM, 2011, TROP BIOMED, V28, P651	64	27	30	5	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e81132	10.1371/journal.pone.0081132	http://dx.doi.org/10.1371/journal.pone.0081132			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260549	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200117
J	Chen, YQ; Wei, HJ; Liu, F; Guan, JL				Chen, Yongqiang; Wei, Huijun; Liu, Fei; Guan, Jun-Lin			Hyperactivation of Mammalian Target of Rapamycin Complex 1 (mTORC1) Promotes Breast Cancer Progression through Enhancing Glucose Starvation-induced Autophagy and Akt Signaling	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							FOCAL ADHESION KINASE; TUBEROUS SCLEROSIS COMPLEX; CONDITIONAL KNOCKOUT; TUMORIGENESIS; ANGIOGENESIS; SUPPRESSION; SUFFICIENT; METABOLISM; ACTIVATION; MECHANISMS	The mammalian target of rapamycin complex 1 (mTORC1) is a master regulator of cell growth and proliferation. Recent studies have suggested that constitutive activation of mTORC1 in normal cells could lead to malignant tumor development in several tissues. However, the mechanisms of mTORC1 hyperactivation to promote the growth and metastasis of breast or other cancers are still not well characterized. Here, using a new inducible deletion system, we show that deletion of Tsc1 in mouse primary mammary tumor cells, either before or after their transplantation, significantly increased their growth in vivo. The increase in tumor growth was completely rescued by rapamycin treatment, suggesting a major contribution from mTORC1 hyperactivation. Interestingly, glucose starvation-induced autophagy, but not amino acid starvation-induced autophagy, was increased significantly in Tsc1-null tumor cells. Further analysis of these cells also showed an increased Akt activation but no significant changes in Erk signaling. Together, these results provide insights into the mechanism by which hyperactivation of mTORC1 promotes breast cancer progression through increasing autophagy and Akt activation in vivo.	[Chen, Yongqiang; Wei, Huijun; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Mol Med, Dept Internal Med, Ann Arbor, MI 48109 USA; [Chen, Yongqiang; Wei, Huijun; Guan, Jun-Lin] Univ Michigan, Sch Med, Div Genet, Dept Internal Med, Ann Arbor, MI 48109 USA; [Guan, Jun-Lin] Univ Michigan, Sch Med, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA; [Liu, Fei] Univ Michigan, Dept Biol & Mat Sci, Sch Dent, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Guan, JL (corresponding author), Univ Cincinnati, Dept Canc Biol, Coll Med, Cincinnati, OH 45267 USA.	guanjn@ucmail.uc.edu	Chen, Yongqiang/ABF-6081-2021	Chen, Yongqiang/0000-0003-2309-5674; , fei/0000-0002-2646-3009	National Institutes of Health [CA150926, CA163493]; NATIONAL CANCER INSTITUTE [R01CA150926, R01CA163493] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR062030] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This research was supported, in whole or in part, by National Institutes of Health Grants CA150926 and CA163493 (to J. L. G.).	Abbas HA, 2010, CELL STEM CELL, V7, P606, DOI 10.1016/j.stem.2010.09.013; Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Amaravadi RK, 2011, SCIENCE, V334, P1501, DOI 10.1126/science.1216428; Annibaldi A, 2010, CURR OPIN CLIN NUTR, V13, P466, DOI 10.1097/MCO.0b013e32833a5577; Castets P, 2013, CELL METAB, V17, P731, DOI 10.1016/j.cmet.2013.03.015; Chakraborty S, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-163; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chen YQ, 2011, J CELL SCI, V124, P161, DOI 10.1242/jcs.064576; Curtis C, 2012, NATURE, V486, P346, DOI 10.1038/nature10983; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Dowling RJO, 2010, SCIENCE, V328, P1172, DOI 10.1126/science.1187532; Fan HP, 2011, J BIOL CHEM, V286, P18573, DOI 10.1074/jbc.M110.200717; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Hoshii T, 2012, J CLIN INVEST, V122, P2114, DOI 10.1172/JCI62279; Inoki K, 2009, HUM MOL GENET, V18, pR94, DOI 10.1093/hmg/ddp032; Ju XM, 2007, P NATL ACAD SCI USA, V104, P7438, DOI 10.1073/pnas.0605874104; Kladney RD, 2010, CANCER RES, V70, P8937, DOI 10.1158/0008-5472.CAN-10-1646; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Kon M, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3003182; Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x; Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058; Lock R, 2011, MOL BIOL CELL, V22, P165, DOI 10.1091/mbc.E10-06-0500; Lu ZH, 2010, CANCER RES, V70, P3287, DOI 10.1158/0008-5472.CAN-09-3467; Luo M, 2009, CANCER RES, V69, P466, DOI 10.1158/0008-5472.CAN-08-3078; Ma XJM, 2009, NAT REV MOL CELL BIO, V10, P307, DOI 10.1038/nrm2672; Mathew R, 2009, CELL, V137, P1062, DOI 10.1016/j.cell.2009.03.048; Menon S, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002739; Mizushima N, 2011, CELL, V147, P728, DOI 10.1016/j.cell.2011.10.026; Orlova KA, 2010, ANN NY ACAD SCI, V1184, P87, DOI 10.1111/j.1749-6632.2009.05117.x; Radvanyi L, 2005, P NATL ACAD SCI USA, V102, P11005, DOI 10.1073/pnas.0500904102; Richardson AL, 2006, CANCER CELL, V9, P121, DOI 10.1016/j.ccr.2006.01.013; Rubinsztein DC, 2011, CELL, V146, P682, DOI 10.1016/j.cell.2011.07.030; Shaw RJ, 2006, CURR OPIN CELL BIOL, V18, P598, DOI 10.1016/j.ceb.2006.10.005; Shen TL, 2005, J CELL BIOL, V169, P941, DOI 10.1083/jcb.200411155; Takamura A, 2011, GENE DEV, V25, P795, DOI 10.1101/gad.2016211; Uhlmann EJ, 2002, ANN NEUROL, V52, P285, DOI 10.1002/ana.10283; Wei HJ, 2011, GENE DEV, V25, P1510, DOI 10.1101/gad.2051011; White E, 2012, NAT REV CANCER, V12, P401, DOI 10.1038/nrc3262; Yang SH, 2011, GENE DEV, V25, P717, DOI 10.1101/gad.2016111; Yu YH, 2011, SCIENCE, V332, P1322, DOI 10.1126/science.1199484; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	43	29	32	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1164	1173		10.1074/jbc.M113.526335	http://dx.doi.org/10.1074/jbc.M113.526335			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275666	hybrid, Green Published			2022-12-25	WOS:000330541200047
J	Cherniavsky-Lev, M; Golani, O; Karlish, SJD; Garty, H				Cherniavsky-Lev, Marina; Golani, Ofra; Karlish, Steven J. D.; Garty, Haim			Ouabain-induced Internalization and Lysosomal Degradation of the Na+/K+-ATPase	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NA-K-ATPASE; EXOGENOUS CARDIAC-GLYCOSIDES; SIGNAL-TRANSDUCTION; EPITHELIAL-CELLS; FXYD PROTEINS; MUSCLE-CELLS; SODIUM-PUMP; NA,K-ATPASE; ENDOCYTOSIS; NA+,K+-ATPASE	Internalization of the Na+/K+-ATPase (the Na+ pump) has been studied in the human lung carcinoma cell line H1299 that expresses YFP-tagged alpha 1 from its normal genomic localization. Both real-time imaging and surface biotinylation have demonstrated internalization of alpha 1 induced by >= 100 nM ouabain which occurs in a time scale of hours. Unlike previous studies in other systems, the ouabain-induced internalization was insensitive to Src or PI3K inhibitors. Accumulation of alpha 1 in the cells could be augmented by inhibition of lysosomal degradation but not by proteosomal inhibitors. In agreement, the internalized alpha 1 could be colocalized with the lysosomal marker LAMP1 but not with Golgi or nuclear markers. In principle, internalization could be triggered by a conformational change of the ouabain-bound Na+/K+-ATPase molecule or more generally by the disruption of cation homeostasis (Na+, K+, Ca2+) due to the partial inhibition of active Na+ and K+ transport. Overexpression of ouabain-insensitive rat alpha 1 failed to inhibit internalization of human alpha 1 expressed in the same cells. In addition, incubating cells in a K+-free medium did not induce internalization of the pump or affect the response to ouabain. Thus, internalization is not the result of changes in the cellular cation balance but is likely to be triggered by a conformational change of the protein itself. In physiological conditions, internalization may serve to eliminate pumps that have been blocked by endogenous ouabain or other cardiac glycosides. This mechanism may be required due to the very slow dissociation of the ouabain.Na+/K+-ATPase complex.	[Cherniavsky-Lev, Marina; Golani, Ofra; Karlish, Steven J. D.; Garty, Haim] Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Garty, H (corresponding author), Weizmann Inst Sci, Dept Biol Chem, IL-76100 Rehovot, Israel.	h.garty@weizmann.ac.il						Akimova OA, 2008, PFLUG ARCH EUR J PHY, V455, P711, DOI 10.1007/s00424-007-0283-6; Berger G, 2011, AM J PHYSIOL-LUNG C, V301, pL23, DOI 10.1152/ajplung.00010.2010; Blanco G, 1998, AM J PHYSIOL-RENAL, V275, pF633, DOI 10.1152/ajprenal.1998.275.5.F633; Blaustein MP, 1996, KIDNEY INT, V49, P1748, DOI 10.1038/ki.1996.260; CAIN CC, 1989, P NATL ACAD SCI USA, V86, P544, DOI 10.1073/pnas.86.2.544; CASTRO J, 1979, J BIOL CHEM, V254, P2221; Chibalin AV, 1997, AM J PHYSIOL-CELL PH, V273, pC1458, DOI 10.1152/ajpcell.1997.273.5.C1458; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; Cornelius F, 2009, BIOCHEMISTRY-US, V48, P10056, DOI 10.1021/bi901212r; Crambert G, 2000, J BIOL CHEM, V275, P1976, DOI 10.1074/jbc.275.3.1976; Dada LA, 2003, J CLIN INVEST, V111, P1057, DOI 10.1172/JCI200316826; DEVARAJAN P, 1994, P NATL ACAD SCI USA, V91, P2965, DOI 10.1073/pnas.91.8.2965; Feldmann T, 2007, AM J PHYSIOL-CELL PH, V293, pC885, DOI 10.1152/ajpcell.00602.2006; Ferrandi M, 2004, J BIOL CHEM, V279, P33306, DOI 10.1074/jbc.M402187200; Ferrandi M, 1999, AM J PHYSIOL-HEART C, V277, pH1338, DOI 10.1152/ajpheart.1999.277.4.H1338; Garty H, 2006, ANNU REV PHYSIOL, V68, P431, DOI 10.1146/annurev.physiol.68.040104.131852; Gupta S, 2012, HYPERTENSION, V59, P665, DOI 10.1161/HYPERTENSIONAHA.111.176727; Katz A, 2010, J BIOL CHEM, V285, P19582, DOI 10.1074/jbc.M110.119248; Kometiani P, 2005, MOL PHARMACOL, V67, P929, DOI 10.1124/mol.104.007302; Kotova O, 2006, J BIOL CHEM, V281, P20085, DOI 10.1074/jbc.M601577200; Lecuona E, 2009, AM J RESP CELL MOL, V41, P671, DOI 10.1165/rcmb.2008-0365OC; Lifshitz Y, 2007, BIOCHEMISTRY-US, V46, P14937, DOI 10.1021/bi701812c; Lindzen M, 2006, J BIOL CHEM, V281, P5947, DOI 10.1074/jbc.M512063200; Liu J, 2004, KIDNEY INT, V66, P227, DOI 10.1111/j.1523-1755.2004.00723.x; Liu Jiang, 2007, Pathophysiology, V14, P171, DOI 10.1016/j.pathophys.2007.09.008; Liu JA, 2010, BBA-MOL BASIS DIS, V1802, P1237, DOI 10.1016/j.bbadis.2010.01.013; Liu LJ, 2004, AM J PHYSIOL-HEART C, V287, pH2173, DOI 10.1152/ajpheart.00352.2004; Moshitzky S, 2012, J BIOL CHEM, V287, P21130, DOI 10.1074/jbc.M112.347807; Schoner W, 2007, AM J CARDIOVASC DRUG, V7, P173, DOI 10.2165/00129784-200707030-00004; Schoner W, 2007, AM J PHYSIOL-CELL PH, V293, pC509, DOI 10.1152/ajpcell.00098.2007; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Silva E, 2012, INT REV CEL MOL BIO, V294, P99, DOI 10.1016/B978-0-12-394305-7.00002-1; Taguchi T, 2013, J BIOCHEM, V153, P505, DOI 10.1093/jb/mvt034; Torielli L, 2008, AM J PHYSIOL-RENAL, V295, pF478, DOI 10.1152/ajprenal.90226.2008; WALLICK ET, 1988, METHOD ENZYMOL, V156, P201; Welch LC, 2010, FEBS LETT, V584, P3985, DOI 10.1016/j.febslet.2010.08.002; Xie ZJ, 2002, EUR J BIOCHEM, V269, P2434, DOI 10.1046/j.1432-1033.2002.02910.x; Yan YL, 2012, MOL CELL BIOCHEM, V367, P175, DOI 10.1007/s11010-012-1331-x; Zhang LN, 2008, FUND CLIN PHARMACOL, V22, P615, DOI 10.1111/j.1472-8206.2008.00620.x; Zhang YB, 1999, AM J PHYSIOL-RENAL, V276, pF711, DOI 10.1152/ajprenal.1999.276.5.F711	40	24	27	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1049	1059		10.1074/jbc.M113.517003	http://dx.doi.org/10.1074/jbc.M113.517003			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275648	hybrid, Green Published			2022-12-25	WOS:000330541200037
J	Amiable, C; Pochet, S; Padilla, A; Labesse, G; Kaminski, PA				Amiable, Claire; Pochet, Sylvie; Padilla, Andre; Labesse, Gilles; Kaminski, Pierre Alexandre			N-6-Substituted AMPs Inhibit Mammalian Deoxynucleotide N-Hydrolase DNPH1	PLOS ONE			English	Article							BREAST-CANCER CELLS; KINETIN-RIBOSIDE; LACTATE-DEHYDROGENASE; ANTICANCER ACTIVITY; HL-60 CELLS; RCL; APOPTOSIS; GENE; NUCLEOSIDE; ANALOGS	The gene dnph1 (or rcl) encodes a hydrolase that cleaves the 2'-deoxyribonucleoside 5'-monophosphate (dNMP) N-glycosidic bond to yield a free nucleobase and 2-deoxyribose 5-phosphate. Recently, the crystal structure of rat DNPH1, a potential target for anti-cancer therapies, suggested that various analogs of AMP may inhibit this enzyme. From this result, we asked whether N-6-substituted AMPs, and among them, cytotoxic cytokinin riboside 5'-monophosphates, may inhibit DNPH1. Here, we characterized the structural and thermodynamic aspects of the interactions of these various analogs with DNPH1. Our results indicate that DNPH1 is inhibited by cytotoxic cytokinins at concentrations that inhibit cell growth.	[Amiable, Claire; Pochet, Sylvie; Kaminski, Pierre Alexandre] Inst Pasteur, Unite Chim & Biocatalyse, Paris, France; [Amiable, Claire; Pochet, Sylvie; Kaminski, Pierre Alexandre] CNRS, UMR3523, Paris, France; [Amiable, Claire] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Padilla, Andre; Labesse, Gilles] CNRS, Ctr Biochim Structurale, UMR5048, Montpellier, France; [Padilla, Andre; Labesse, Gilles] INSERM, U554, Montpellier, France; [Padilla, Andre; Labesse, Gilles] Univ Montpellier 1 & 2, IFR3, Montpellier, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite de Montpellier; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Montpellier; Universite de Montpellier	Kaminski, PA (corresponding author), Inst Pasteur, Unite Chim & Biocatalyse, Paris, France.	pierre-alexandre.kaminski@pasteur.fr		PADILLA, ANDRE/0000-0001-9702-4612; Labesse, Gilles/0000-0002-6861-3300; Kaminski, Pierre Alexandre/0000-0001-9841-6837	Institut Pasteur; CNRS; Fondation pour la Recherche Medicale [DCM20111223063]; French Infrastructure for Integrated Structural Biology (FRISBI) [ANR-10-INSB-05-01]; French Ministry of Research	Institut Pasteur(European Commission); CNRS(Centre National de la Recherche Scientifique (CNRS)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Infrastructure for Integrated Structural Biology (FRISBI); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	This work was financially supported by the Institut Pasteur, CNRS, Fondation pour la Recherche Medicale (DCM20111223063 to S. Pochet) and by the French Infrastructure for Integrated Structural Biology (FRISBI) ANR-10-INSB-05-01. C. Amiable was recipient of a fellowship from the French Ministry of Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENNETT LL, 1978, BIOCHEM PHARMACOL, V27, P233, DOI 10.1016/0006-2952(78)90306-4; Cabello CM, 2009, BIOCHEM PHARMACOL, V77, P1125, DOI 10.1016/j.bcp.2008.12.002; Cheong J, 2009, MOL BIOSYST, V5, P91, DOI 10.1039/b712807j; Choi BH, 2008, CANCER LETT, V261, P37, DOI 10.1016/j.canlet.2007.11.014; Doddapaneni K, 2009, J MOL BIOL, V394, P423, DOI 10.1016/j.jmb.2009.08.054; Dolezal K, 2007, BIOORGAN MED CHEM, V15, P3737, DOI 10.1016/j.bmc.2007.03.038; Dudzik P, 2011, J CELL BIOCHEM, V112, P2115, DOI 10.1002/jcb.23132; Dupouy C, 2010, J BIOL CHEM, V285, P41806, DOI 10.1074/jbc.M110.181594; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FLEYSHER MH, 1980, J MED CHEM, V23, P1448, DOI 10.1021/jm00186a031; Garrett CR, 2011, INVEST NEW DRUG, V29, P1381, DOI 10.1007/s10637-010-9479-2; Ghiorghi YK, 2007, J BIOL CHEM, V282, P8150, DOI 10.1074/jbc.M610648200; Gorgun G, 2009, P NATL ACAD SCI USA, V106, P6250, DOI 10.1073/pnas.0901166106; Jiang H, 2010, J AM CHEM SOC, V132, P9363, DOI 10.1021/ja101588r; KAPLAN NO, 1974, P NATL ACAD SCI USA, V71, P3450, DOI 10.1073/pnas.71.9.3450; Laezza C, 2010, MOL CARCINOGEN, V49, P892, DOI 10.1002/mc.20666; Laezza C, 2009, INT J CANCER, V124, P1322, DOI 10.1002/ijc.24056; Le A, 2010, P NATL ACAD SCI USA, V107, P2037, DOI 10.1073/pnas.0914433107; Lewis BC, 1997, MOL CELL BIOL, V17, P4967, DOI 10.1128/MCB.17.9.4967; Lewis BC, 2000, CANCER RES, V60, P6178; Lomenick B, 2011, ACS CHEM BIOL, V6, P34, DOI 10.1021/cb100294v; McDermott SP, 2012, BLOOD, V119, P1200, DOI 10.1182/blood-2011-01-330019; Mlejnek P, 2005, TOXICOL IN VITRO, V19, P985, DOI 10.1016/j.tiv.2005.06.023; Mlejnek P, 2001, J CELL BIOCHEM, V83, P678, DOI 10.1002/jcb.1262; Murakami E, 2011, J MED CHEM, V54, P5902, DOI 10.1021/jm200650j; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Olsson TSG, 2011, PROTEIN SCI, V20, P1607, DOI 10.1002/pro.692; Ottria R, 2010, BIOORGAN MED CHEM, V18, P8396, DOI 10.1016/j.bmc.2010.09.030; Padilla A, 2013, ACTA CRYSTALLOGR D, V69, P247, DOI 10.1107/S0907444912045039; Parker WB, 2009, CHEM REV, V109, P2880, DOI 10.1021/cr900028p; PLAGEMANN PGW, 1976, J NATL CANCER I, V57, P1283, DOI 10.1093/jnci/57.6.1283; Rajabi M, 2010, DNA CELL BIOL, V29, P687, DOI 10.1089/dna.2010.1073; Rhodes DR, 2002, CANCER RES, V62, P4427; Sampath D, 2003, ONCOGENE, V22, P9063, DOI 10.1038/sj.onc.1207229; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Shin S, 2008, J CELL BIOCHEM, V105, P866, DOI 10.1002/jcb.21884; Spinola M, 2007, INT J CANCER, V120, P2744, DOI 10.1002/ijc.22601; Tiedemann RE, 2008, J CLIN INVEST, V118, P1750, DOI 10.1172/JCI34149; Vagin A, 2010, ACTA CRYSTALLOGR D, V66, P22, DOI 10.1107/S0907444909042589; Voller J, 2010, PHYTOCHEMISTRY, V71, P1350, DOI 10.1016/j.phytochem.2010.04.018; Yang YS, 2009, J MOL BIOL, V394, P435, DOI 10.1016/j.jmb.2009.10.004	41	13	14	2	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80755	10.1371/journal.pone.0080755	http://dx.doi.org/10.1371/journal.pone.0080755			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260472	Green Submitted, gold, Green Published			2022-12-25	WOS:000327311900094
J	Flexas, A; Rossello, J; Christensen, JF; Nadal, M; La Rosa, AO; Munar, E				Flexas, Albert; Rossello, Jaume; Christensen, Julia F.; Nadal, Marcos; Olivera La Rosa, Antonio; Munar, Enric			Affective Priming Using Facial Expressions Modulates Liking for Abstract Art	PLOS ONE			English	Article							AFFECT MISATTRIBUTION; AWARENESS; JUDGMENT; FACES; MODEL	We examined the influence of affective priming on the appreciation of abstract artworks using an evaluative priming task. Facial primes (showing happiness, disgust or no emotion) were presented under brief (Stimulus Onset Asynchrony, SOA = 20ms) and extended (SOA = 300ms) conditions. Differences in aesthetic liking for abstract paintings depending on the emotion expressed in the preceding primes provided a measure of the priming effect. The results showed that, for the extended SOA, artworks were liked more when preceded by happiness primes and less when preceded by disgust primes. Facial expressions of happiness, though not of disgust, exerted similar effects in the brief SOA condition. Subjective measures and a forced-choice task revealed no evidence of prime awareness in the suboptimal condition. Our results are congruent with findings showing that the affective transfer elicited by priming biases evaluative judgments, extending previous research to the domain of aesthetic appreciation.	[Flexas, Albert; Rossello, Jaume; Christensen, Julia F.; Nadal, Marcos; Olivera La Rosa, Antonio; Munar, Enric] Univ Balearic Isl, Associated Grp IFISC, Human Evolut & Cognit Grp, CSIC, Palma De Mallorca, Balearic Island, Spain; [Flexas, Albert; Rossello, Jaume; Christensen, Julia F.; Olivera La Rosa, Antonio; Munar, Enric] Univ Balearic Isl, Dept Psychol, Palma De Mallorca, Balearic Island, Spain; [Nadal, Marcos] Univ Vienna, Dept Basic Psychol Res & Res Methods, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); Universitat de les Illes Balears; Universitat de les Illes Balears; University of Vienna	Flexas, A (corresponding author), Univ Balearic Isl, Associated Grp IFISC, Human Evolut & Cognit Grp, CSIC, Palma De Mallorca, Balearic Island, Spain.	albert.flexas@uib.eu	Christensen, Julia F./AAK-4477-2021; Nadal, Marcos/A-5817-2009; Flexas, Albert/U-6228-2017; Rosa, Antonio Olivera-La/AAZ-1370-2020; Munar, Enric/C-7397-2011; Munar, Enric/AAK-4175-2021; Rosselló, Jaume/AAA-6333-2020	Christensen, Julia F./0000-0003-0381-5101; Nadal, Marcos/0000-0002-9341-4688; Flexas, Albert/0000-0002-0104-7113; Rosa, Antonio Olivera-La/0000-0001-7637-8518; Munar, Enric/0000-0001-7330-8389; Rosselló, Jaume/0000-0003-4010-7868	Spanish Government Ministerio de Economia y Competitividad [FFI2010-20759]; Ministerio de Educacion (Spanish Government) [AP2008/02284, AP2009-2889]	Spanish Government Ministerio de Economia y Competitividad(Spanish Government); Ministerio de Educacion (Spanish Government)(Spanish Government)	This study was funded by research grant FFI2010-20759 from the Spanish Government Ministerio de Economia y Competitividad (http:// www.mineco.gob.es). Albert Flexas and Julia F. Christensen were supported by the grants AP2008/02284 and AP2009-2889 from Ministerio de Educacion (Spanish Government - http://www.mecd.gob.es), respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beaupre MG, 2005, J CROSS CULT PSYCHOL, V36, P355, DOI 10.1177/0022022104273656; Belke B., 2006, PSYCHOL SCI, V48, P115; Belke B, 2010, PSYCHOL AESTHET CREA, V4, P214, DOI 10.1037/a0019648; Blanchette I, 2010, COGNITION EMOTION, V24, P561, DOI 10.1080/02699930903132496; Bordens K. S., 2010, EMPIR STUD ARTS, V28, P111, DOI [DOI 10.2190/EM.28.1.G, 10.2190/EM.28.1.g]; FAZIO RH, 1986, J PERS SOC PSYCHOL, V50, P229, DOI 10.1037/0022-3514.50.2.229; FORGAS JP, 1995, PSYCHOL BULL, V117, P39, DOI 10.1037/0033-2909.117.1.39; Hermans D, 2001, COGNITION EMOTION, V15, P143, DOI 10.1080/0269993004200033; Hofmann W, 2010, COGNITION EMOTION, V24, P522, DOI 10.1080/02699930902847193; Hsu SM, 2008, COGN AFFECT BEHAV NE, V8, P282, DOI 10.3758/CABN.8.3.282; Klauer KC, 2003, PSYCHOLOGY OF EVALUATION, P7; Leder H, 2004, BRIT J PSYCHOL, V95, P489, DOI 10.1348/0007126042369811; Leder H., 2005, B PSYCHOL ARTS, V5, P11; Lee SY, 2011, ATTEN PERCEPT PSYCHO, V73, P473, DOI 10.3758/s13414-010-0032-3; Li W, 2008, J COGNITIVE NEUROSCI, V20, P95; Maxwell JS, 2004, COGNITION EMOTION, V18, P1009, DOI 10.1080/02699930441000003; Milders M, 2006, EMOTION, V6, P10, DOI 10.1037/1528-3542.6.1.10; MURPHY ST, 1993, J PERS SOC PSYCHOL, V64, P723, DOI 10.1037/0022-3514.64.5.723; Nadal M, 2008, SPATIAL VISION, V21, P379, DOI 10.1163/156856808784532653; Ohman A, 2009, SCAND J PSYCHOL, V50, P543, DOI 10.1111/j.1467-9450.2009.00784.x; Payne BK, 2005, J PERS SOC PSYCHOL, V89, P277, DOI 10.1037/0022-3514.89.3.277; Rotteveel M, 2001, EMOTION, V1, P348, DOI 10.1037//1528-3542.1.4.348; Silvia PJ, 2009, PSYCHOL AESTHET CREA, V3, P48, DOI 10.1037/a0014632; Sweeny TD, 2009, CONSCIOUS COGN, V18, P929, DOI 10.1016/j.concog.2009.07.011; Winkielman P, 2005, PERS SOC PSYCHOL B, V31, P121, DOI 10.1177/0146167204271309; Wong PS, 2003, CONSCIOUS COGN, V12, P147, DOI 10.1016/S1053-8100(03)00007-2	26	25	25	6	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80154	10.1371/journal.pone.0080154	http://dx.doi.org/10.1371/journal.pone.0080154			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256LO	24260350	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900059
J	Imperio, S; Bionda, R; Viterbi, R; Provenzale, A				Imperio, Simona; Bionda, Radames; Viterbi, Ramona; Provenzale, Antonello			Climate Change and Human Disturbance Can Lead to Local Extinction of Alpine Rock Ptarmigan: New Insight from the Western Italian Alps	PLOS ONE			English	Article							ESTIMATING DENSITY-DEPENDENCE; LAGOPUS-MUTUS; POPULATION-DYNAMICS; BEHAVIOR; IMPACTS; WEATHER; SPORTS; BIRDS	Alpine grouses are particularly vulnerable to climate change due to their adaptation to extreme conditions and to their relict distributions in the Alps where global warming has been particularly marked in the last half century. Grouses are also currently threatened by habitat modification and human disturbance, and an assessment of the impact of multiple stressors is needed to predict the fate of Alpine populations of these birds in the next decades. We estimated the effect of climate change and human disturbance on a rock ptarmigan population living in the western Italian Alps by combining an empirical population modelling approach and stochastic simulations of the population dynamics under the a1B climate scenario and two different disturbance scenarios, represented by the development of a ski resort, through 2050. The early appearance of snow-free ground in the previous spring had a favorable effect on the rock ptarmigan population, probably through a higher reproductive success. On the contrary, delayed snowfall in autumn had a negative effect possibly due to a mismatch in time to molt to white winter plumage which increases predation risk. The regional climate model PROTHEUS does not foresee any significant change in snowmelt date in the study area, while the start date of continuous snow cover is expected to be significantly delayed. The net effect in the stochastic projections is a more or less pronounced (depending on the model used) decline in the studied population. The addition of extra-mortality due to collision with ski-lift wires led the population to fatal consequences in most projections. Should these results be confirmed by larger studies the conservation of Alpine populations would deserve more attention. To counterbalance the effects of climate change, the reduction of all causes of death should be pursued, through a strict preservation of the habitats in the present area of occurrence.	[Imperio, Simona; Provenzale, Antonello] CNR, Inst Atmospher Sci & Climate, I-10126 Turin, Italy; [Bionda, Radames] Ente Gestione Aree Protette Ossola, Varzo, Italy; [Viterbi, Ramona] Gran Paradiso Natl Pk, Turin, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto di Scienze dell'Atmosfera e del Clima (ISAC-CNR)	Imperio, S (corresponding author), CNR, Inst Atmospher Sci & Climate, I-10126 Turin, Italy.	simona.imperio@libero.it	Imperio, Simona/M-3201-2019	Imperio, Simona/0000-0002-9982-205X	EU Interreg ALCOTRA Project "Galliformi Alpini"; Italian Ministry of Education, University and Research through the PRIN Project [20108 TZKHC]; Project of Interest "NextData" (PNR)	EU Interreg ALCOTRA Project "Galliformi Alpini"; Italian Ministry of Education, University and Research through the PRIN Project; Project of Interest "NextData" (PNR)	This research was supported by the EU Interreg ALCOTRA Project "Galliformi Alpini" and by the Italian Ministry of Education, University and Research through the PRIN Project 2010-2011 "Climate change and animal populations: predictive models for mammals and birds" (20108 TZKHC) and the Project of Interest "NextData" (PNR 2011-2013). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlettaz R, 2007, P R SOC B, V274, P1219, DOI 10.1098/rspb.2006.0434; Artale V, 2010, CLIM DYNAM, V35, P721, DOI 10.1007/s00382-009-0691-8; BARTMANN RM, 1992, WILDLIFE MONOGR, P1; Bech N, 2012, ANIM BIODIV CONSERV, V35, P95; Beniston M, 1997, CLIMATIC CHANGE, V36, P233, DOI 10.1023/A:1005380714349; Bevanger K., 2004, Animal Biodiversity and Conservation, V27, P67; Bossert A., 1977, Ornithologische Beobachter, V74, P95; Bossert A, 1997, ALETSCHGEBIET WALLIS, V68, P150; Bossert Andreas, 1995, Ornithologische Beobachter, V92, P307; Bradshaw WE, 2008, MOL ECOL, V17, P157, DOI 10.1111/j.1365-294X.2007.03509.x; Brenot JF, 2005, WILDLIFE BIOL, V11, P281, DOI 10.2981/0909-6396(2005)11[281:GVIBMO]2.0.CO;2; Brichetti P, 2004, TETRAONIDAE SCOLOPAC, V2; Burnham K.P., 2002, MODEL SELECTION MULT, V2nd, DOI [DOI 10.1007/B97636, 10.2307/3802723, DOI 10.2307/3802723]; Coppack T, 2002, ARDEA, V90, P369; COTTER RC, 1992, J RAPTOR RES, V26, P146; De Leo GA, 2004, ECOL MODEL, V177, P313, DOI 10.1016/j.ecolmodel.2003.11.017; Dell'Aquila A, 2012, CLIM RES, V52, P135, DOI 10.3354/cr01037; Dennis B, 2006, ECOL MONOGR, V76, P323, DOI 10.1890/0012-9615(2006)76[323:EDDPNA]2.0.CO;2; Fasce P, 2011, IBIS, V153, P581, DOI 10.1111/j.1474-919X.2011.01125.x; Freckleton RP, 2006, J ANIM ECOL, V75, P837, DOI 10.1111/j.1365-2656.2006.01121.x; Harrison Paula A., 2003, Journal for Nature Conservation (Jena), V11, P31, DOI 10.1078/1617-1381-00036; HEWSON R, 1973, J ZOOL, V171, P177; Host P., 1942, Auk, V59, P388; Huntley B, 2006, IBIS, V148, P8, DOI 10.1111/j.1474-919X.2006.00523.x; Kokko H, 2001, WILDLIFE BIOL, V7, P141, DOI 10.2981/wlb.2001.018; Krebs CJ, 2002, PHILOS T ROY SOC B, V357, P1211, DOI 10.1098/rstb.2002.1122; Ladurner Eva, 2001, Avocetta, V25, P221; Lebreton JD, 2013, J WILDLIFE MANAGE, V77, P12, DOI 10.1002/jwmg.425; Leonard P, 1995, B MENSUEL OFFICE NAT, V199, P85; Martin KM, 2001, WILDLIFE-HABITAT RELATIONSHIPS IN OREGON AND WASHINGTON, P239; Montgomerie R, 2001, BEHAV ECOL, V12, P429, DOI 10.1093/beheco/12.4.429; Moss R, 2001, BIOL CONSERV, V101, P255, DOI 10.1016/S0006-3207(01)00066-0; Nakicenovic N., 2000, IPCC SPECIAL REPORT; Nopp-Mayr U, 2008, J ORNITHOL, V149, P135, DOI 10.1007/s10336-007-0231-4; Novoa C, 2008, IBIS, V150, P270, DOI 10.1111/j.1474-919X.2007.00771.x; Novoa C, 2011, STUD AVIAN BIOL, P267; Observatoire des Galliformes; de Montagne, 2006, PERC OIS CABL AER DO; Patthey P, 2008, J APPL ECOL, V45, P1704, DOI 10.1111/j.1365-2664.2008.01547.x; Pedersen HC, 2004, P ROY SOC B-BIOL SCI, V271, P381, DOI 10.1098/rspb.2003.2599; Peronace Valentina, 2012, Avocetta, V36, P11; Post E, 2005, ECOLOGY, V86, P2320, DOI 10.1890/04-0823; R Development Core Team, 2011, R LANG ENV STAT COMP; Ranta E, 1998, OIKOS, V83, P376, DOI 10.2307/3546852; Revermann R, 2012, J ORNITHOL, V153, P891, DOI 10.1007/s10336-012-0819-1; RICH TD, 2004, PARTNERS FLIGHT N AM; Rodenhouse NL, 2008, MITIG ADAPT STRAT GL, V13, P517, DOI 10.1007/s11027-007-9126-1; Scherini GC, 2003, ARDEA, V91, P11; Sinclair ARE, 1996, FRONTIERS OF POPULATION ECOLOGY, P127; Smith A, 1999, J WILDLIFE MANAGE, V63, P722, DOI 10.2307/3802662; Speakman JR, 2010, J ANIM ECOL, V79, P726, DOI 10.1111/j.1365-2656.2010.01689.x; STEEN JB, 1992, ORNIS SCAND, V23, P101, DOI 10.2307/3676433; Storch I, 2007, GROUSE STATUS SURVEY, P2006; Terzago S, 2013, METEOROL ATMOS PHYS, V119, P125, DOI 10.1007/s00703-012-0231-7; Turchin Peter, 2003, Monographs in Population Biology, V35, pi; Walther GR, 2005, MOUNTAIN ECOSYSTEMS: STUDIES IN TREELINE ECOLOGY, P77, DOI 10.1007/3-540-27365-4_3; Wang GM, 2002, CLIM RES, V23, P81, DOI 10.3354/cr023081; Watson A, 2004, BIOL CONSERV, V116, P267, DOI 10.1016/S0006-3207(03)00197-6; Watson A, 1998, ECOLOGY, V79, P1174; WATSON A, 1965, J ANIM ECOL, V34, P135, DOI 10.2307/2373; Watson A, 2000, ECOLOGY, V81, P2126, DOI 10.1890/0012-9658(2000)081[2126:WASIYP]2.0.CO;2; Watson A, 2010, GROUSE; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	62	44	48	3	97	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81598	10.1371/journal.pone.0081598	http://dx.doi.org/10.1371/journal.pone.0081598			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260581	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900132
J	Lionetti, V; Romano, SL; Bianchi, G; Bernini, F; Dushpanova, A; Mascia, G; Nesti, M; Di Gregorio, F; Barbetta, A; Padeletti, L				Lionetti, Vincenzo; Romano, Simone Lorenzo; Bianchi, Giacomo; Bernini, Fabio; Dushpanova, Anar; Mascia, Giuseppe; Nesti, Martina; Di Gregorio, Franco; Barbetta, Alberto; Padeletti, Luigi			Impact of Acute Changes of Left Ventricular Contractility on the Transvalvular Impedance: Validation Study by Pressure-Volume Loop Analysis in Healthy Pigs	PLOS ONE			English	Article							CARDIAC RESYNCHRONIZATION THERAPY; MYOCARDIAL PERFORMANCE INDEX; INTRACARDIAC IMPEDANCE; HEART-FAILURE; LOADING CONDITIONS; DOBUTAMINE STRESS; STROKE VOLUME; SENSOR; OPTIMIZATION; AFTERLOAD	Background: The real-time and continuous assessment of left ventricular (LV) myocardial contractility through an implanted device is a clinically relevant goal. Transvalvular impedance (TVI) is an impedentiometric signal detected in the right cardiac chambers that changes during stroke volume fluctuations in patients. However, the relationship between TVI signals and LV contractility has not been proven. We investigated whether TVI signals predict changes of LV inotropic state during clinically relevant loading and inotropic conditions in swine normal heart. Methods: The assessment of RVTVI signals was performed in anesthetized adult healthy anesthetized pigs (n = 6) instrumented for measurement of aortic and LV pressure, dP/dt(max) and LV volumes. Myocardial contractility was assessed with the slope (Ees) of the LV end systolic pressure-volume relationship. Effective arterial elastance (Ea) and stroke work (SW) were determined from the LV pressure-volume loops. Pigs were studied at rest (baseline), after transient mechanical preload reduction and afterload increase, after 10-min of low dose dobutamine infusion (LDDS, 10 mu g/kg/min, i.v), and esmolol administration (ESMO, bolus of 500 mu g and continuous infusion of 100 mu g kg-1.min-1). Results: We detected a significant relationship between ESTVI and dP/dtmax during LDDS and ESMO administration. In addition, the fluctuations of ESTVI were significantly related to changes of the Ees during afterload increase, LDDS and ESMO infusion. Conclusions: ESTVI signal detected in right cardiac chamber is significantly affected by acute changes in cardiac mechanical activity and is able to predict acute changes of LV inotropic state in normal heart.	[Lionetti, Vincenzo; Romano, Simone Lorenzo; Bianchi, Giacomo; Bernini, Fabio; Dushpanova, Anar] Scuola Super, Inst Life Sci, Lab Med Sci, Pisa, Italy; [Lionetti, Vincenzo; Bianchi, Giacomo] Fdn CNR Reg Toscana G Monasterio, Pisa, Italy; [Mascia, Giuseppe; Nesti, Martina; Padeletti, Luigi] Univ Florence, Dept Med & Surg Crit Care, Florence, Italy; [Di Gregorio, Franco; Barbetta, Alberto] Medico Spa, Clin Res Unit, Padua, Italy	University of Florence	Lionetti, V (corresponding author), Scuola Super, Inst Life Sci, Lab Med Sci, Pisa, Italy.	v.lionetti@sssup.it	Lionetti, Vincenzo/AAN-1994-2020; Mascia, Giuseppe/ADR-2155-2022; Lionetti, Vincenzo/AAH-9503-2020; Dushpanova, Anar/I-7583-2017; Lionetti, Vincenzo/G-9528-2014; Bianchi, Giacomo/AFL-9046-2022	Lionetti, Vincenzo/0000-0002-0640-8651; Mascia, Giuseppe/0000-0002-7069-4015; Dushpanova, Anar/0000-0001-6941-2773; Bianchi, Giacomo/0000-0003-4240-0099	Ministero del Lavoro, Salute e Politiche Sociali - Bando Giovani Ricercatori, Italy [GR-2007-683407]; Scuola Superiore Sant' Anna, Pisa, Italy	Ministero del Lavoro, Salute e Politiche Sociali - Bando Giovani Ricercatori, Italy; Scuola Superiore Sant' Anna, Pisa, Italy	This work was supported in part by Ministero del Lavoro, Salute e Politiche Sociali - Bando Giovani Ricercatori GR-2007-683407, Italy and in part by internal funds of Scuola Superiore Sant' Anna, Pisa, Italy. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altman RK, 2011, AM J CARDIOL, V108, P252, DOI 10.1016/j.amjcard.2011.03.033; BENNETT T, 1992, PACE, V15, P219, DOI 10.1111/j.1540-8159.1992.tb03066.x; Bocchiardo M, 2010, EUROPACE, V12, P1589, DOI 10.1093/europace/euq273; Bocchiardo M, 2010, EUROPACE, V12, P702, DOI 10.1093/europace/euq045; Bombardini T, 2000, PACE, V23, P1381, DOI 10.1111/j.1540-8159.2000.tb00966.x; BOROW KM, 1992, J AM COLL CARDIOL, V20, P787, DOI 10.1016/0735-1097(92)90173-K; Braunschweig F, 2007, HEART FAIL REV, V12, P157, DOI 10.1007/s10741-007-9019-0; Burkhoff D, 2005, AM J PHYSIOL-HEART C, V289, pH501, DOI 10.1152/ajpheart.00138.2005; Cannesson M, 2006, AM J PHYSIOL-HEART C, V290, pH1952, DOI 10.1152/ajpheart.01090.2005; Cheung MMH, 2004, EUR HEART J, V25, P2238, DOI 10.1016/j.ehj.2004.07.034; CHIRIFE R, 1988, PACE, V11, P1545, DOI 10.1111/j.1540-8159.1988.tb06272.x; CHIRIFE R, 1993, PACE, V16, P1673, DOI 10.1111/j.1540-8159.1993.tb01038.x; Clementy J, 2001, EUROPACE, V3, P124, DOI 10.1053/eupc.2001.0152; Delnoy PPHM, 2009, EUR HEART J, V30, P797, DOI 10.1093/eurheartj/ehp011; DiGregorio F, 1996, PACE, V19, P1689; Dongaonkar RM, 2010, CARDIOVASC RES, V87, P331, DOI 10.1093/cvr/cvq145; Dzwonczyk R, 2009, J CLIN MONIT COMPUT, V23, P217, DOI 10.1007/s10877-009-9185-9; FLEISCHHAUER J, 1995, CIRCULATION, V92, P587, DOI 10.1161/01.CIR.92.3.587; Gasparini G, 2005, EUROPACE, V7, P234, DOI 10.1016/j.eupc.2005.02.115; Gemignani V, 2010, PACE, V33, P795, DOI 10.1111/j.1540-8159.2009.02684.x; Ginks MR, 2011, EUROPACE, V13, P984, DOI 10.1093/europace/eur055; KASS DA, 1987, CIRCULATION, V76, P1422, DOI 10.1161/01.CIR.76.6.1422; Lin HY, 2011, J MAGN RESON IMAGING, V34, P203, DOI 10.1002/jmri.22587; Lionetti Vincenzo, 2009, J Card Fail, V15, P920, DOI 10.1016/j.cardfail.2009.06.436; Merchant FM, 2010, CIRC-ARRHYTHMIA ELEC, V3, P657, DOI 10.1161/CIRCEP.110.959502; NOZAWA T, 1988, CIRCULATION, V77, P1116, DOI 10.1161/01.CIR.77.5.1116; Osswald S, 2000, PACE, V23, P1502, DOI 10.1046/j.1460-9592.2000.01502.x; Padeletti L, 2000, PACE, V23, P1618, DOI 10.1046/j.1460-9592.2000.01618.x; Padeletti L, 2012, CIRC-ARRHYTHMIA ELEC, V5, P460, DOI 10.1161/CIRCEP.111.970277; Padeletti L, 2012, HEART FAIL REV, V17, P97, DOI 10.1007/s10741-011-9250-6; PICHLMAIER AM, 1992, PACE, V15, P1787, DOI 10.1111/j.1540-8159.1992.tb02969.x; Pingitore A, 2013, INT J CARDIOL, V166, P475, DOI 10.1016/j.ijcard.2011.11.037; Post H, 2003, J PHYSIOL-LONDON, V552, P233, DOI 10.1113/jphysiol.2003.048769; Ritter P, 2012, EUROPACE, V14, P1324, DOI 10.1093/europace/eus059; SCHALDACH M, 1990, PACE, V13, P1702, DOI 10.1111/j.1540-8159.1990.tb06876.x; Stahl C, 2009, PACE, V32, P1395, DOI 10.1111/j.1540-8159.2009.02477.x; SUGA H, 1990, PHYSIOL REV, V70, P247, DOI 10.1152/physrev.1990.70.2.247; SUNAGAWA K, 1983, AM J PHYSIOL, V245, pH773, DOI 10.1152/ajpheart.1983.245.5.H773; Taborsky M, 2013, BIOMED PAP IN PRESS; Taborsky M, 2010, EUROPACE, V12, P534, DOI 10.1093/europace/euq052; TEITEL DF, 1992, EUR HEART J, V13, P40, DOI 10.1093/eurheartj/13.suppl_E.40; Valzania C, 2009, PACE, V32, P1492, DOI 10.1111/j.1540-8159.2009.02511.x	42	6	6	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80591	10.1371/journal.pone.0080591	http://dx.doi.org/10.1371/journal.pone.0080591			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260431	Green Published, gold			2022-12-25	WOS:000327311900074
J	Perucca, P; Dubeau, F; Gotman, J				Perucca, Piero; Dubeau, Francois; Gotman, Jean			Widespread EEG Changes Precede Focal Seizures	PLOS ONE			English	Article							HIGH-FREQUENCY OSCILLATIONS; TEMPORAL-LOBE EPILEPSY; SLEEP STAGE; ANTICIPATION; PREDICTION; LOCALIZATION; TRANSITION; PATTERNS; SHIFTS; DEPTH	The process by which the brain transitions into an epileptic seizure is unknown. In this study, we investigated whether the transition to seizure is associated with changes in brain dynamics detectable in the wideband EEG, and whether differences exist across underlying pathologies. Depth electrode ictal EEG recordings from 40 consecutive patients with pharmacoresistant lesional focal epilepsy were low-pass filtered at 500 Hz and sampled at 2,000 Hz. Predefined EEG sections were selected immediately before (immediate preictal), and 30 seconds before the earliest EEG sign suggestive of seizure activity (baseline). Spectral analysis, visual inspection and discrete wavelet transform were used to detect standard (delta, theta, alpha, beta and gamma) and high-frequency bands (ripples and fast ripples). At the group level, each EEG frequency band activity increased significantly from baseline to the immediate preictal section, mostly in a progressive manner and independently of any modification in the state of vigilance. Preictal increases in each frequency band activity were widespread, being observed in the seizure-onset zone and lesional tissue, as well as in remote regions. These changes occurred in all the investigated pathologies (mesial temporal atrophy/sclerosis, local/regional cortical atrophy, and malformations of cortical development), but were more pronounced in mesial temporal atrophy/sclerosis. Our findings indicate that a brain state change with distinctive features, in the form of unidirectional changes across the entire EEG bandwidth, occurs immediately prior to seizure onset. We postulate that these changes might reflect a facilitating state of the brain which enables a susceptible region to generate seizures.	[Perucca, Piero; Dubeau, Francois; Gotman, Jean] McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada	McGill University	Perucca, P (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	piero.perucca@libero.it		Perucca, Piero/0000-0002-7855-7066	American Brain Foundation; American Epilepsy Society; Epilepsy Foundation; Canadian Institutes of Health Research [MOP-10189]	American Brain Foundation; American Epilepsy Society; Epilepsy Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by the "Susan S. Spencer clinical research training fellowship in epilepsy" from the American Brain Foundation (http://www.curebraindisease.org/), the American Epilepsy Society (http://www.aesnet.org/), and the Epilepsy Foundation (http://www.epilepsyfoundation.org/); and by the Canadian Institutes of Health Research (grant no. MOP-10189) (http://www.cihr-irsc.gc.ca/e/193.html). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALARCON G, 1994, J NEUROL NEUROSUR PS, V57, P435, DOI 10.1136/jnnp.57.4.435; Badawy R, 2009, BRAIN, V132, P1013, DOI 10.1093/brain/awp017; Bagshaw AP, 2009, EPILEPSIA, V50, P617, DOI 10.1111/j.1528-1167.2008.01784.x; Baumgartner C, 1998, J NUCL MED, V39, P978; Bertram EH, 2013, EXP NEUROL, V244, P67, DOI 10.1016/j.expneurol.2012.01.028; BLANCHET P, 1986, J NERV MENT DIS, V174, P471, DOI 10.1097/00005053-198608000-00005; Cunningham MO, 2012, EPILEPSIA, V53, P1205, DOI 10.1111/j.1528-1167.2012.03530.x; David O, 2008, NEUROIMAGE, V39, P1633, DOI 10.1016/j.neuroimage.2007.11.005; Fisher RS, 2012, ANN NEUROL, V71, P157, DOI 10.1002/ana.22621; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Gadhoumi K, 2012, CLIN NEUROPHYSIOL, V123, P1906, DOI 10.1016/j.clinph.2012.03.001; GOTMAN J, 1985, ANN NEUROL, V17, P597, DOI 10.1002/ana.410170612; Haut SR, 2007, NEUROLOGY, V69, P1905, DOI 10.1212/01.wnl.0000278112.48285.84; Helmy MM, 2011, ANN NEUROL, V69, P493, DOI 10.1002/ana.22223; Huberfeld G, 2011, NAT NEUROSCI, V14, P627, DOI 10.1038/nn.2790; Ikeda A, 1999, BRAIN, V122, P827, DOI 10.1093/brain/122.5.827; Ikeda A, 1996, EPILEPSIA, V37, P662, DOI 10.1111/j.1528-1157.1996.tb00631.x; Jirsch JD, 2006, BRAIN, V129, P1593, DOI 10.1093/brain/awl085; Jiruska P, 2010, J NEUROSCI, V30, P5690, DOI 10.1523/JNEUROSCI.0535-10.2010; KATZ A, 1991, ELECTROEN CLIN NEURO, V79, P153, DOI 10.1016/0013-4694(91)90054-8; Khosravani H, 2009, EPILEPSIA, V50, P605, DOI 10.1111/j.1528-1167.2008.01761.x; Le Van Quyen M, 2000, EUR J NEUROSCI, V12, P2124, DOI 10.1046/j.1460-9568.2000.00088.x; Le Van Quyen M, 2001, LANCET, V357, P183, DOI 10.1016/S0140-6736(00)03591-1; Lee SA, 2000, EPILEPSIA, V41, P297, DOI 10.1111/j.1528-1157.2000.tb00159.x; Litt B, 2002, CURR OPIN NEUROL, V15, P173, DOI 10.1097/00019052-200204000-00008; Malow BA, 2000, SLEEP, V23, P231; Minecan D, 2002, SLEEP, V25, P899; Mormann F, 2007, BRAIN, V130, P314, DOI 10.1093/brain/awl241; Navarro V, 2005, EPILEPSIA, V46, P385, DOI 10.1111/j.0013-9580.2005.15504.x; Navarro V, 2002, BRAIN, V125, P640, DOI 10.1093/brain/awf048; OLIVIER A, 1994, J NEUROSURG, V81, P629, DOI 10.3171/jns.1994.81.4.0629; Ren LK, 2011, ANN NEUROL, V69, P201, DOI 10.1002/ana.22158; Schuchmann S, 2011, EPILEPSIA, V52, P1949, DOI 10.1111/j.1528-1167.2011.03259.x; SIMES RJ, 1986, BIOMETRIKA, V73, P751, DOI 10.2307/2336545; SPENCER SS, 1992, EPILEPSIA, V33, P537, DOI 10.1111/j.1528-1157.1992.tb01706.x; Tolner EA, 2011, EPILEPSIA, V52, P104, DOI 10.1111/j.1528-1167.2010.02731.x; Truccolo W, 2011, NAT NEUROSCI, V14, P635, DOI 10.1038/nn.2782; Yankovsky AE, 2005, NEUROLOGY, V65, P1979, DOI 10.1212/01.wnl.0000188820.17776.cd; Zhang ZJ, 2012, J NEUROSCI, V32, P2499, DOI 10.1523/JNEUROSCI.4247-11.2012; Zijlmans M, 2012, ANN NEUROL, V71, P169, DOI 10.1002/ana.22548; Zijlmans M, 2011, CLIN NEUROPHYSIOL, V122, P664, DOI 10.1016/j.clinph.2010.09.021	41	23	23	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80972	10.1371/journal.pone.0080972	http://dx.doi.org/10.1371/journal.pone.0080972			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260523	Green Published, gold			2022-12-25	WOS:000327311900107
J	Bauer, M; Benard, J; Gaasterland, T; Willert, K; Cappellen, D				Bauer, Matthieu; Benard, Jean; Gaasterland, Terry; Willert, Karl; Cappellen, David			WNT5A Encodes Two Isoforms with Distinct Functions in Cancers	PLOS ONE			English	Article							TYROSINE KINASE ROR2; CELL-PROLIFERATION; DIFFERENTIAL EXPRESSION; WNT-5A PROTEIN; TUMOR; GROWTH; MIGRATION; RECOGNITION; MODULATOR; MELANOMA	WNT5A, a member of the WNT family of secreted lipid-modified glycoproteins, is a critical regulator of a host of developmental processes, including limb formation, lung morphogenesis, intestinal elongation and mammary gland development. Altered WNT5A expression has been associated with a number of cancers. Interestingly, in certain types of cancers, such as hematological malignancies and colorectal carcinoma, WNT5A is inactivated and exerts a tumor suppressive function, while in other cancers, such as melanoma and gastric carcinoma, WNT5A is overexpressed and promotes tumor progression. The mechanism by which WNT5A achieves these distinct activities in cancers is poorly understood. Here, we provide evidence that the WNT5A gene produces two protein isoforms, WNT5A-long (WNT5A-L) and WNT5A-short (WNT5A-S). Amino-terminal sequencing and a WNT5A-L specific antibody demonstrate that the mature and secreted isoforms are distinct, with WNT5A-L carrying an additional 18 N-terminal amino acids. Biochemical analysis indicates that both purified proteins are similar with respect to their stability, hydrophobicity and WNT/beta-catenin signaling activity. Nonetheless, modulation of these two WNT5A isoforms, either through ectopic expression or knockdown, demonstrates that they exert distinct activities in cancer cell lines: while WNT5A-L inhibits proliferation of tumor cell lines, WNT5A-S promotes their growth. Finally, we show that expression of these two WNT5A isoforms is altered in breast and cervix carcinomas, as well as in the most aggressive neuroblastoma tumors. In these cancers, WNT5A-L is frequently down-regulated, whereas WNT5A-S is found overexpressed in a significant fraction of tumors. Altogether, our study provides evidence that the distinct activities of WNT5A in cancer can be attributed to the production of two WNT5A isoforms.	[Bauer, Matthieu; Benard, Jean; Cappellen, David] Univ Paris, Inst Cancerol Gustave Roussy, CNRS, Villejuif, France; [Bauer, Matthieu; Willert, Karl] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Benard, Jean] Inst Cancerol Gustave Roussy, Dept Pathol & Biol Med, Villejuif, France; [Gaasterland, Terry] Univ Calif San Diego, La Jolla, CA 92093 USA; [Gaasterland, Terry] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA; [Cappellen, David] Univ Bordeaux, Ctr Hosp Univ Bordeaux, Bordeaux, France; [Cappellen, David] Univ Bordeaux, Bordeaux, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Cite; UNICANCER; Gustave Roussy; University of California System; University of California San Diego; UNICANCER; Gustave Roussy; University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Institution of Oceanography; CHU Bordeaux; UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Willert, K (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA.	kwillert@ucsd.edu; david.cappellen@u-bordeaux2.fr			Association pour la Recherche sur le Cancer (DC); Institut National du Cancer (JB); Societe Francaise des Cancers de l'Enfant (JB); European Connective Tissue Cancer Network (DC and MB); California Institute for Regenerative Medicine [CIRM, RB1-01406, KW]; Ministere de l'Enseignement Superieur et de la Recherche and from CIRM [TG2-01154]; NATIONAL EYE INSTITUTE [R01EY022306] Funding Source: NIH RePORTER	Association pour la Recherche sur le Cancer (DC)(Fondation ARC pour la Recherche sur le Cancer); Institut National du Cancer (JB); Societe Francaise des Cancers de l'Enfant (JB); European Connective Tissue Cancer Network (DC and MB); California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Ministere de l'Enseignement Superieur et de la Recherche and from CIRM; NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported by grants from the Association pour la Recherche sur le Cancer (DC), the Institut National du Cancer (JB), Societe Francaise des Cancers de l'Enfant (JB), the European Connective Tissue Cancer Network (DC and MB) and by the California Institute for Regenerative Medicine (CIRM, RB1-01406, KW). MB was awarded fellowships from the Ministere de l'Enseignement Superieur et de la Recherche and from CIRM (TG2-01154). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bhanot P, 1996, NATURE, V382, P225, DOI 10.1038/382225a0; Bittner M, 2000, NATURE, V406, P536, DOI 10.1038/35020115; Bunaciu RP, 2008, ONCOL REP, V20, P195; Cappellen D, 2007, EMBO REP, V8, P70, DOI 10.1038/sj.embor.7400849; Cha SW, 2008, DEVELOPMENT, V135, P3719, DOI 10.1242/dev.029025; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Da Forno PD, 2008, CLIN CANCER RES, V14, P5825, DOI 10.1158/1078-0432.CCR-07-5104; Danielson KG, 1995, J BIOL CHEM, V270, P31225, DOI 10.1074/jbc.270.52.31225; Dejmek J, 2005, CANCER RES, V65, P9142, DOI 10.1158/0008-5472.CAN-05-1710; Dejmek J, 2006, MOL CELL BIOL, V26, P6024, DOI 10.1128/MCB.02354-05; Fear MW, 2000, BIOCHEM BIOPH RES CO, V278, P814, DOI 10.1006/bbrc.2000.3852; FERRANDIS E, 1994, CANCER RES, V54, P2256; Firestein R, 2008, NATURE, V455, P547, DOI 10.1038/nature07179; Fuerer C, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009370; GOILLOT E, 1992, CANCER RES, V52, P3194; Gonzalez-Sancho JM, 2004, MOL CELL BIOL, V24, P4757, DOI 10.1128/MCB.24.11.4757-4768.2004; Green JL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058395; He FL, 2008, DEVELOPMENT, V135, P3871, DOI 10.1242/dev.025767; Herr P, 2012, DEV BIOL, V361, P392, DOI 10.1016/j.ydbio.2011.11.003; Janda CY, 2012, SCIENCE, V337, P59, DOI 10.1126/science.1222879; Jonsson M, 2002, CANCER RES, V62, P409; Katula KS, 2012, DNA CELL BIOL, V31, P1585, DOI 10.1089/dna.2012.1698; KEMSHEAD JT, 1982, BRAIN RES, V236, P451, DOI 10.1016/0006-8993(82)90727-2; Klaus A, 2008, NAT REV CANCER, V8, P387, DOI 10.1038/nrc2389; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Kurayoshi M, 2006, CANCER RES, V66, P10439, DOI 10.1158/0008-5472.CAN-06-2359; Liang HL, 2003, CANCER CELL, V4, P349, DOI 10.1016/S1535-6108(03)00268-X; Maris JM, 2007, LANCET, V369, P2106, DOI 10.1016/S0140-6736(07)60983-0; Medrek C, 2009, J BIOL CHEM, V284, P10968, DOI 10.1074/jbc.M804923200; Meier R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001016; Mikels AJ, 2006, PLOS BIOL, V4, P570, DOI 10.1371/journal.pbio.0040115; MOON RT, 1993, DEVELOPMENT, V119, P97; Morris EJ, 2008, NATURE, V455, P552, DOI 10.1038/nature07310; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Nishita M, 2006, J CELL BIOL, V175, P555, DOI 10.1083/jcb.200607127; OCONNELL MP, 2009, ONCOGENE, V29, P34, DOI DOI 10.1038/0NC.2009.305.PUBMED:19802008; Oishi I, 2003, GENES CELLS, V8, P645, DOI 10.1046/j.1365-2443.2003.00662.x; Pinson KI, 2000, NATURE, V407, P535, DOI 10.1038/35035124; Qian D, 2007, DEV BIOL, V306, P121, DOI 10.1016/j.ydbio.2007.03.011; Ripka S, 2007, CARCINOGENESIS, V28, P1178, DOI 10.1093/carcin/bgl255; Schambony A, 2007, DEV CELL, V12, P779, DOI 10.1016/j.devcel.2007.02.016; Takada R, 2006, DEV CELL, V11, P791, DOI 10.1016/j.devcel.2006.10.003; Tamai K, 2000, NATURE, V407, P530, DOI 10.1038/35035117; Teh MT, 2007, J CELL SCI, V120, P330, DOI 10.1242/jcs.03329; Torres MA, 1996, J CELL BIOL, V133, P1123, DOI 10.1083/jcb.133.5.1123; van Amerongen R, 2009, DEVELOPMENT, V136, P3205, DOI 10.1242/dev.033910; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Weeraratna AT, 2002, CANCER CELL, V1, P279, DOI 10.1016/S1535-6108(02)00045-4; Willert K, 1997, EMBO J, V16, P3089, DOI 10.1093/emboj/16.11.3089; Willert K, 2003, NATURE, V423, P448, DOI 10.1038/nature01611; Willert Karl H., 2008, V468, P17, DOI 10.1007/978-1-59745-249-6_2; Yamaguchi TP, 1999, DEVELOPMENT, V126, P1211; YANAGAWA SI, 1995, GENE DEV, V9, P1087, DOI 10.1101/gad.9.9.1087; Ying JM, 2008, CLIN CANCER RES, V14, P55, DOI 10.1158/1078-0432.CCR-07-1644; Ying J, 2007, BLOOD, V110, P4130, DOI 10.1182/blood-2007-06-094870; Yoshikawa S, 2003, NATURE, V422, P583, DOI 10.1038/nature01522	56	35	37	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80526	10.1371/journal.pone.0080526	http://dx.doi.org/10.1371/journal.pone.0080526			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260410	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500149
J	Goossens, D; da Silva, N; Metral, S; Cortes, U; Callebaut, I; Picot, J; Mouro-Chanteloup, I; Cartron, JP				Goossens, Dominique; da Silva, Nelly; Metral, Sylvain; Cortes, Ulrich; Callebaut, Isabelle; Picot, Julien; Mouro-Chanteloup, Isabelle; Cartron, Jean-Pierre			Mice Expressing RHAG and RHD Human Blood Group Genes	PLOS ONE			English	Article							CELL-SURFACE EXPRESSION; ANTI-D; MOLECULAR-BIOLOGY; HEREDITARY SPHEROCYTOSIS; STRUCTURAL ORGANIZATION; MULTIPROTEIN COMPLEX; AMMONIA TRANSPORT; K562 CELLS; HIGH-LEVEL; PROTEINS	Anti-RhD prophylaxis of haemolytic disease of the fetus and newborn (HDFN) is highly effective, but as the suppressive mechanism remains uncertain, a mouse model would be of interest. Here we have generated transgenic mice expressing human RhAG and RhD erythrocyte membrane proteins in the presence and, for human RhAG, in the absence, of mouse Rhag. Human RhAG associates with mouse Rh but not mouse Rhag on red blood cells. In Rhag knockout mice transgenic for human RHAG, the mouse Rh protein is "rescued" (re-expressed), and coimmunoprecipitates with human RhAG, indicating the presence of hetero-complexes which associate mouse and human proteins. RhD antigen was expressed from a human RHD gene on a BAC or from RHD cDNA under control of beta-globin regulatory elements. RhD was never observed alone, strongly indicative that its expression absolutely depends on the presence of transgenic human RhAG. This first expression of RhD in mice is an important step in the creation of a mouse model of RhD allo-immunisation and HDFN, in conjunction with the Rh-Rhag knockout mice we have developed previously.	[Goossens, Dominique; da Silva, Nelly; Metral, Sylvain; Cortes, Ulrich; Picot, Julien; Mouro-Chanteloup, Isabelle; Cartron, Jean-Pierre] Inst Natl Transfus Sanguine, F-75015 Paris, France; [Goossens, Dominique; Picot, Julien; Mouro-Chanteloup, Isabelle] INSERM, UMR S 665, Paris, France; [Goossens, Dominique; Picot, Julien; Mouro-Chanteloup, Isabelle] Univ Paris Diderot, Sorbonne Paris Cite, UMR S665, Paris, France; [Callebaut, Isabelle] Univ Paris 06, CNRS, UMR 7590, Inst Mineral & Phys Milieux Condenses, Paris, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Physics (INP); UDICE-French Research Universities; Sorbonne Universite; Institut de Recherche pour le Developpement (IRD)	Goossens, D (corresponding author), Inst Natl Transfus Sanguine, F-75015 Paris, France.	dominique.goossens@inserm.fr	METRAL, Sylvain/P-5833-2017; Isabelle, Mouro-Chanteloup/M-9750-2018	METRAL, Sylvain/0000-0001-6244-8546; Isabelle, Mouro-Chanteloup/0000-0002-6368-9904	Laboratoire Francais du Fractionnement et des Biotechnologies, France; Association Recherche Transfusion [25-2001, 34-2003]; GIS Maladies Rares	Laboratoire Francais du Fractionnement et des Biotechnologies, France; Association Recherche Transfusion; GIS Maladies Rares	N.d.S. and U.C. were supported by post-doctoral funding from Laboratoire Francais du Fractionnement et des Biotechnologies, France. This work was supported by grants from the Association Recherche Transfusion (Contracts 25-2001 and 34-2003) (http://www.art-hemobiologie.org/) and the GIS Maladies Rares (support for part of the initial analysis of the Rh/Rhag knockout mouse models at the ICS) (http://fondation-maladiesrares.org/). No individuals employed or contracted by the funders (other than the named authors) played any role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGRE P, 1991, BLOOD, V78, P551, DOI 10.1182/blood.V78.3.551.bloodjournal783551; Alami R, 2000, HUM MOL GENET, V9, P631, DOI 10.1093/hmg/9.4.631; Avent Neil D., 2006, Expert Reviews in Molecular Medicine, V8, P1, DOI 10.1017/S1462399406010969; Beckmann R, 1998, BLOOD, V92, P4428, DOI 10.1182/blood.V92.11.4428.423k15_4428_4438; Beckmann R, 2001, BLOOD, V97, P2496, DOI 10.1182/blood.V97.8.2496; Boscher C, 2011, CURR OPIN CELL BIOL, V23, P383, DOI 10.1016/j.ceb.2011.05.001; Brinc Davor, 2009, Hematology Am Soc Hematol Educ Program, P185, DOI 10.1182/asheducation-2009.1.185; Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824; Bruce LJ, 2002, BLOOD, V100, P1878, DOI 10.1182/blood-2002-03-0706; Burton NM, 2011, BIOCHEM CELL BIOL, V89, P200, DOI [10.1139/o10-154, 10.1139/O10-154]; Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001; Cartron JP, 2010, ISBT SCI SER, V5, P27, DOI 10.1111/j.1751-2824.2010.01388.x; Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047; CARTRON JP, 2008, ED PROGR ANN C EUR H, P158; Cope NF, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-3-204; Dennis JW, 2009, CELL, V139, P1229, DOI 10.1016/j.cell.2009.12.008; FRIEND C., 1966, NAT CANCER INST MONOGR, V22, P505; Gane P, 2001, BRIT J HAEMATOL, V113, P680, DOI 10.1046/j.1365-2141.2001.02757.x; Genetet S, 2012, AM J PHYSIOL-CELL PH, V302, pC419, DOI 10.1152/ajpcell.00092.2011; Glozman R, 2009, J CELL BIOL, V184, P847, DOI 10.1083/jcb.200808124; Goossens D, 2010, BRIT J HAEMATOL, V148, P161, DOI 10.1111/j.1365-2141.2009.07928.x; Gruswitz F, 2010, P NATL ACAD SCI USA, V107, P9638, DOI 10.1073/pnas.1003587107; HERMAND P, 1993, BLOOD, V82, P669; Huang CH, 2000, SEMIN HEMATOL, V37, P150, DOI 10.1016/S0037-1963(00)90040-4; Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952; Kumar S, 2005, BRIT MED J, V330, P1255, DOI 10.1136/bmj.330.7502.1255; Kumpel BM, 2008, CLIN EXP IMMUNOL, V154, P1, DOI 10.1111/j.1365-2249.2008.03735.x; Kumpel BM, 2001, TRENDS IMMUNOL, V22, P26, DOI 10.1016/S1471-4906(00)01801-9; Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104; Mankelow TJ, 2012, BLOOD CELL MOL DIS, V49, P1, DOI 10.1016/j.bcmd.2012.03.001; MOLLISON PL, 1993, RH BLOOD GROUP SYSTE, P204; Mouro-Chanteloup I, 2003, BLOOD, V101, P338, DOI 10.1182/blood-2002-04-1285; Mouro-Chanteloup I, 2002, BLOOD, V100, P1038; Mouro-Chanteloup I, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008921; NEEDHAM M, 1992, NUCLEIC ACIDS RES, V20, P997, DOI 10.1093/nar/20.5.997; Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200; Pilgrim H, 2009, HEALTH TECHNOL ASSES, V13, P1, DOI 10.3310/hta13100; Rank G, 2009, BLOOD, V113, P3352, DOI 10.1182/blood-2008-08-172841; RIDGWELL K, 1994, J BIOL CHEM, V269, P6410; Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101; Salomao M, 2008, P NATL ACAD SCI USA, V105, P8026, DOI 10.1073/pnas.0803225105; Salomao M, 2010, BLOOD, V116, P267, DOI 10.1182/blood-2010-02-264127; Satchwell TJ, 2011, BLOOD, V118, P182, DOI 10.1182/blood-2010-10-314187; Scott M, 2002, TRANSFUS CLIN BIOL, V9, P23, DOI 10.1016/S1246-7820(01)00211-7; Smythe JS, 1996, BLOOD, V87, P2968, DOI 10.1182/blood.V87.7.2968.bloodjournal8772968; Subramanian S, 2006, BLOOD CELL MOL DIS, V36, P364, DOI 10.1016/j.bcmd.2006.01.012; TERAJIMA M, 1994, J BIOCHEM-TOKYO, V116, P1105, DOI 10.1093/oxfordjournals.jbchem.a124634; Thorpe SJ, 2003, TRANSFUSION MED, V13, P153, DOI 10.1046/j.1365-3148.2003.00436.x; van den Akker E, 2010, BLOOD CELL MOL DIS, V45, P1, DOI 10.1016/j.bcmd.2010.02.019; Yazdanbakhsh K, 2000, AM J HEMATOL, V63, P114, DOI 10.1002/(SICI)1096-8652(200003)63:3<114::AID-AJH2>3.0.CO;2-Z; Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101	51	8	11	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80460	10.1371/journal.pone.0080460	http://dx.doi.org/10.1371/journal.pone.0080460			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260394	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500140
J	Tai, GP; Ranjzad, P; Marriage, F; Rehman, S; Denley, H; Dixon, J; Mitchell, K; Day, PJR; Woolf, AS				Tai, Guangping; Ranjzad, Parisa; Marriage, Fiona; Rehman, Samrina; Denley, Helen; Dixon, Jill; Mitchell, Karen; Day, Philip J. R.; Woolf, Adrian S.			Cytokeratin 15 Marks Basal Epithelia in Developing Ureters and Is Upregulated in a Subset of Urothelial Cell Carcinomas	PLOS ONE			English	Article							HAIR FOLLICLE BULGE; STEM-CELLS; BLADDER-CANCER; EPIDERMOLYSIS-BULLOSA; GENE-EXPRESSION; BIOLOGY; GROWTH; P63; PROLIFERATION; UROPLAKINS	The mammalian ureter contains a water-tight epithelium surrounded by smooth muscle. Key molecules have been defined which regulate ureteric bud initiation and drive the differentiation of ureteric mesenchyme into peristaltic smooth muscle. Less is known about mechanisms underlying the developmental patterning of the multilayered epithelium characterising the mature ureter. In skin, which also contains a multilayered epithelium, cytokeratin 15 (CK15), an acidic intermediate filament protein, marks cells whose progeny contribute to epidermal regeneration following wounding. Moreover, CK15+ precursor cells in skin can give rise to basal cell carcinomas. In the current study, using transcriptome microarrays of embryonic wild type mouse ureters, Krt15, coding for CK15, was detected. Quantitative polymerase chain reaction analyses confirmed the initial finding and demonstrated that Krt15 levels increased during the fetal period when the ureteric epithelium becomes multilayered. CK15 protein was undetectable in the ureteric bud, the rudiment from which the ureter grows. Nevertheless, later in fetal development, CK15 was immunodetected in a subset of basal urothelial cells in the ureteric stalk. Superficial epithelial cells, including those positive for the differentiation marker uroplakin III, were CK15-. Transformation-related protein 63 (P63) has been implicated in epithelial differentiation in murine fetal urinary bladders. In wild type fetal ureters, CK15+ cells were positive for P63, and p63 homozygous null mutant ureters lacked CK15+ cells. In these mutant ureters, sections of the urothelium were monolayered versus the uniform multilayering found in wild type littermates. Human urothelial cell carcinomas account for considerable morbidity and mortality. CK15 was upregulated in a subset of invasive ureteric and urinary bladder cancers. Thus, in ureter development, the absence of CK15 is associated with a structurally simplified urothelium whereas, postnatally, increased CK15 levels feature in malignant urothelial overgrowth. CK15 may be a novel marker for urinary tract epithelial precursor cells.	[Tai, Guangping; Ranjzad, Parisa; Marriage, Fiona; Day, Philip J. R.; Woolf, Adrian S.] Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England; [Tai, Guangping; Dixon, Jill; Mitchell, Karen] Univ Manchester, Fac Life Sci, Manchester, Lancs, England; [Rehman, Samrina] Univ Manchester, Manchester Ctr Integrat Syst Biol, Manchester, Lancs, England; [Rehman, Samrina] Univ Manchester, Sch Chem Engn & Analyt Sci, Manchester, Lancs, England; [Denley, Helen] Manchester Royal Infirm, Dept Histopathol, Manchester M13 9WL, Lancs, England	University of Manchester; University of Manchester; University of Manchester; University of Manchester; University of Manchester	Woolf, AS (corresponding author), Univ Manchester, Fac Med & Human Sci, Manchester, Lancs, England.	adrian.woolf@manchester.ac.uk	Woolf, Adrian S./AAZ-1075-2020	Woolf, Adrian S./0000-0001-5541-1358; Ranjzad, Parisa/0000-0001-7413-4157; Rehman, Samrina/0000-0003-4754-9247	Manchester Biomedical Research Centre, Kids Kidney Research and the Medical Research Council [MR/L002744/1]; ERASysBio program; BBSRC; Medical Research Council [G0901539]; Medical Research Council [MR/L002744/1] Funding Source: researchfish; MRC [MR/L002744/1] Funding Source: UKRI	Manchester Biomedical Research Centre, Kids Kidney Research and the Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); ERASysBio program; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	GT, PR and ASW acknowledge research funding support from the Manchester Biomedical Research Centre, Kids Kidney Research and the Medical Research Council (MR/L002744/1). SR acknowledges research funding support from the transnational ERASysBio program and its funders BBSRC. JD and KM acknowledge research funding support from the Medical Research Council (G0901539). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bassuk JA, 2003, ADV EXP MED BIOL, V539, P623; Burger M, 2013, EUR UROL, V63, P234, DOI 10.1016/j.eururo.2012.07.033; Burgu B, 2007, J UROLOGY, V177, P1552, DOI 10.1016/j.juro.2006.12.011; Caubit X, 2008, DEVELOPMENT, V135, P3301, DOI 10.1242/dev.022442; Cheng W, 2006, DEVELOPMENT, V133, P4783, DOI 10.1242/dev.02621; Choi W, 2012, PLOS ONE, V7, P453, DOI 10.1371/journal.pone.0030206; Elsamman E, 2006, UROL ONCOL-SEMIN ORI, V24, P109, DOI 10.1016/j.urolonc.2005.07.011; Figueira EC, 2007, INVEST OPHTH VIS SCI, V48, P144, DOI 10.1167/iovs.06-0346; Gabriel U, 2012, MOL CARCINOGEN, V51, P907, DOI 10.1002/mc.20860; Garza LA, 2011, J CLIN INVEST, V121, P613, DOI 10.1172/JCI44478; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glazier DB, 1998, J UROLOGY, V159, P2122, DOI 10.1016/S0022-5347(01)63291-9; Green DA, 2013, J UROLOGY, V189, P1214, DOI 10.1016/j.juro.2012.05.079; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Jenkins D, 2007, KIDNEY INT, V71, P195, DOI 10.1038/sj.ki.5002053; Jenkins D, 2005, J AM SOC NEPHROL, V16, P2141, DOI 10.1681/ASN.2004090776; Karni-Schmidt O, 2011, AM J PATHOL, V178, P1350, DOI 10.1016/j.ajpath.2010.11.061; Keyes WM, 2011, CELL STEM CELL, V8, P164, DOI 10.1016/j.stem.2010.12.009; Kim JJ, 2012, CURR UROL REP, V13, P147, DOI 10.1007/s11934-012-0238-0; Kong XT, 2004, J CELL BIOL, V167, P1195, DOI 10.1083/jcb.200406025; Kouwenhoven EN, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001065; LEUBE RE, 1988, J CELL BIOL, V106, P1249, DOI 10.1083/jcb.106.4.1249; Liu YP, 2003, J INVEST DERMATOL, V121, P963, DOI 10.1046/j.1523-1747.2003.12600.x; Long DA, 2013, KIDNEY INT, V83, P1118, DOI 10.1038/ki.2013.45; Lughezzani G, 2012, EUR UROL, V62, P100, DOI 10.1016/j.eururo.2012.02.030; Lye CM, 2010, J AM SOC NEPHROL, V21, P24, DOI 10.1681/ASN.2008111206; Michos O, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000809; Mills AA, 1999, NATURE, V398, P708, DOI 10.1038/19531; Pearson RD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-211; Peters B, 2001, MOL BIOL CELL, V12, P1775, DOI 10.1091/mbc.12.6.1775; Pignon JC, 2013, P NATL ACAD SCI USA, V110, P8105, DOI 10.1073/pnas.1221216110; Pitera JE, 2012, J AM SOC NEPHROL, V23, P1790, DOI 10.1681/ASN.2012020146; Qiao JZ, 1999, DEVELOPMENT, V126, P547; Signoretti S, 2005, P NATL ACAD SCI USA, V102, P11355, DOI 10.1073/pnas.0500165102; SMEDTS F, 1993, AM J PATHOL, V142, P403; Wang GY, 2011, CANCER CELL, V19, P114, DOI 10.1016/j.ccr.2010.11.007; Waseem A, 1999, J INVEST DERMATOL, V112, P362, DOI 10.1046/j.1523-1747.1999.00535.x; Whitbread LA, 1998, EXP CELL RES, V244, P448, DOI 10.1006/excr.1998.4217; Wilkins S, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003070; Woolf AS, 2013, J AM SOC NEPHROL, V24, P19, DOI 10.1681/ASN.2012020127; Wu XR, 2009, KIDNEY INT, V75, P1153, DOI 10.1038/ki.2009.73; Yang A, 1999, NATURE, V398, P714, DOI 10.1038/19539; Yates DR, 2013, WORLD J UROL, V31, P21, DOI 10.1007/s00345-012-0946-6; Yu J, 2002, DEVELOPMENT, V129, P5301; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	45	14	15	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81167	10.1371/journal.pone.0081167	http://dx.doi.org/10.1371/journal.pone.0081167			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260555	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500199
J	Zhong, HJ; Wang, D; Fang, LR; Zhang, H; Luo, R; Shang, M; Ouyang, C; Ouyang, HP; Chen, HC; Xiao, SB				Zhong, Huijuan; Wang, Dang; Fang, Liurong; Zhang, Huan; Luo, Rui; Shang, Min; Ouyang, Chao; Ouyang, Haiping; Chen, Huanchun; Xiao, Shaobo			Ubiquitin-Specific Proteases 25 Negatively Regulates Virus-Induced Type I Interferon Signaling	PLOS ONE			English	Article							NF-KAPPA-B; RIG-I; TUMOR-SUPPRESSOR; ADAPTER PROTEIN; IFN-BETA; INNATE; ACTIVATION; DEUBIQUITINATION; RECOGNITION; HELICASES	Ubiquitination and deubiquitination have emerged as critical regulatory processes in the virus-triggered type I interferon (IFN) induction pathway. In this study, we carried out a targeted siRNA screen of 54 ubiquitin-specific proteases (USPs) and identified USP25 as a negative regulator of the virus-triggered type I IFN signaling pathway. Overexpression of USP25 inhibited virus-induced activation of IFN-beta, interferon regulation factor 3 (IRF3) and nuclear factor-kappa B (NF-kappa B), as well as the phosphorylation of IRF3 and NF-kappa B subunit p65. Furthermore, Knockdown of USP25 potentiated virus-induced induction of the IFN-beta. In addition, detailed analysis demonstrated that USP25 cleaved lysine 48- and lysine 63-linked polyubiquitin chains in vitro and in vivo, and its deubiquitinating enzyme (DUB) activity, were dependent on a cysteine residue (Cys178) and a histidine residue (His607). USP25 mutants lacking DUB activity lost the ability to block virus-induced type I IFN to some degree. Mechanistically, USP25 deubiquitinated retinoic acid-inducible gene I (RIG-I), tumornecrosis factor (TNF) receptor-associated factor 2 (TRAF2), and TRAF6 to inhibit RIG-I-like receptor-mediated IFN signaling. Our findings suggest that USP25 is a novel DUB negatively regulating virus-induced type I IFN production.	[Zhong, Huijuan; Wang, Dang; Fang, Liurong; Zhang, Huan; Luo, Rui; Shang, Min; Ouyang, Chao; Ouyang, Haiping; Chen, Huanchun; Xiao, Shaobo] Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China	Huazhong Agricultural University	Fang, LR (corresponding author), Huazhong Agr Univ, Coll Vet Med, State Key Lab Agr Microbiol, Wuhan, Peoples R China.	fanglr@mail.hzau.edu.cn		Xiao, Shaobo/0000-0003-0023-9188	National Natural Sciences Foundation of China [31225027, 31121004]; Fundamental Research Funds for the Central Universities [2013PY043]	National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Sciences Foundation of China (31225027, 31121004), and the Fundamental Research Funds for the Central Universities (2013PY043). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari A, 2007, ONCOGENE, V26, P3214, DOI 10.1038/sj.onc.1210413; Beura LK, 2010, J VIROL, V84, P1574, DOI 10.1128/JVI.01326-09; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Blount JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036542; Brummelkamp TR, 2003, NATURE, V424, P797, DOI 10.1038/nature01811; Chen R, 2010, CELL RES, V20, P802, DOI 10.1038/cr.2010.41; Clementz MA, 2010, J VIROL, V84, P4619, DOI 10.1128/JVI.02406-09; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Denuc A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005571; Ehrhardt C, 2004, FEBS LETT, V567, P230, DOI 10.1016/j.febslet.2004.04.069; Enesa K, 2008, J BIOL CHEM, V283, P7036, DOI 10.1074/jbc.M708690200; Fan YH, 2011, CELL DEATH DIFFER, V18, P1547, DOI 10.1038/cdd.2011.11; Friedman CS, 2008, EMBO REP, V9, P930, DOI 10.1038/embor.2008.136; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Hubackova S, 2010, CELL CYCLE, V9, P3085, DOI 10.4161/cc.9.15.12521; Isaacson MK, 2009, CELL HOST MICROBE, V5, P559, DOI 10.1016/j.chom.2009.05.012; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2011, IMMUNOL REV, V243, P91, DOI 10.1111/j.1600-065X.2011.01052.x; Kawai T, 2005, NAT IMMUNOL, V6, P981, DOI 10.1038/ni1243; Kawai T, 2006, NAT IMMUNOL, V7, P131, DOI 10.1038/ni1303; Kayagaki N, 2007, SCIENCE, V318, P1628, DOI 10.1126/science.1145918; Loo YM, 2008, J VIROL, V82, P335, DOI 10.1128/JVI.01080-07; Luo R, 2008, MOL IMMUNOL, V45, P2839, DOI 10.1016/j.molimm.2008.01.028; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Maelfait J, 2012, MICROBIOL MOL BIOL R, V76, P33, DOI 10.1128/MMBR.05012-11; Mao AP, 2010, J BIOL CHEM, V285, P9470, DOI 10.1074/jbc.M109.071043; McCloskey RJ, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003092; Metzig M, 2011, INT J CANCER, V129, P607, DOI 10.1002/ijc.26124; Meylan E, 2005, NATURE, V437, P1167, DOI 10.1038/nature04193; Nijman SMB, 2005, CELL, V123, P773, DOI 10.1016/j.cell.2005.11.007; Nishikawa H, 2004, J BIOL CHEM, V279, P3916, DOI 10.1074/jbc.M308540200; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pickart CM, 2001, ANNU REV BIOCHEM, V70, P503, DOI 10.1146/annurev.biochem.70.1.503; Quesada V, 2004, BIOCHEM BIOPH RES CO, V314, P54, DOI 10.1016/j.bbrc.2003.12.050; Reyes-Turcu FE, 2009, ANNU REV BIOCHEM, V78, P363, DOI 10.1146/annurev.biochem.78.082307.091526; Schmidt M, 2005, BIOL CHEM, V386, P725, DOI 10.1515/BC.2005.085; Schweitzer K, 2007, EMBO J, V26, P1532, DOI 10.1038/sj.emboj.7601600; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Song L, 2008, CURR OPIN CELL BIOL, V20, P156, DOI 10.1016/j.ceb.2008.01.012; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Sun WJ, 2010, CELL SIGNAL, V22, P386, DOI 10.1016/j.cellsig.2009.10.008; Tzimas C, 2006, CELL SIGNAL, V18, P83, DOI 10.1016/j.cellsig.2005.03.017; Weissman AM, 2001, NAT REV MOL CELL BIO, V2, P169, DOI 10.1038/35056563; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; WILKINSON KD, 1995, BIOCHEMISTRY-US, V34, P14535, DOI 10.1021/bi00044a032; Wilkinson KD, 2009, J CELL SCI, V122, P2325, DOI 10.1242/jcs.041046; Xu GF, 2010, J BIOL CHEM, V285, P969, DOI 10.1074/jbc.M109.042689; Xu LG, 2005, MOL CELL, V19, P727, DOI 10.1016/j.molcel.2005.08.014; Yasunaga J, 2011, J VIROL, V85, P6212, DOI 10.1128/JVI.00079-11; Ye JQ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020681; Yoneyama M, 1998, EMBO J, V17, P1087, DOI 10.1093/emboj/17.4.1087; Yoneyama M, 2007, CYTOKINE GROWTH F R, V18, P545, DOI 10.1016/j.cytogfr.2007.06.023; Zhong B, 2013, SCI SIGNAL, V6, DOI 10.1126/scisignal.2003708; Zhong B, 2012, NAT IMMUNOL, V13, P1110, DOI 10.1038/ni.2427	55	46	48	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80976	10.1371/journal.pone.0080976	http://dx.doi.org/10.1371/journal.pone.0080976			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260525	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500188
J	Bibost, AL; Brown, C				Bibost, Anne-Laurence; Brown, Culum			Laterality Influences Schooling Position in Rainbowfish, Melanotaenia spp	PLOS ONE			English	Article							PREDATOR RECOGNITION; FAMILIAR INDIVIDUALS; SHOAL SIZE; BEHAVIOR; RISK; PERFORMANCE; PREFERENCE; ASYMMETRY; MINNOW; COSTS	Cerebral lateralization is a widespread trait among animals, is often manifested as side biases in behaviour (laterality) and has been suggested to provide fitness benefits. Here we examined the influence of laterality on the organisation of fish schools using rainbowfish (Melanotaenia spp) as model species. The pattern and strength of laterality for each individual was determined by examining eye preferences whilst examining their reflection in a mirror. Schools of four fish of known laterality were then created and the preferred position for each fish within the school was repeatedly observed in a flume. Fish which showed right eye preferences in the mirror test preferentially adopted a position on the left side of the school. Conversely, fish that showed left eye preferences in the mirror test or where non-lateralised preferentially adopted a position slightly to the right side of the school. However, this general pattern varied depending on the species and sex of the school. Our results strongly implicate individual laterality in the geometry of school formation.	[Bibost, Anne-Laurence; Brown, Culum] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Macquarie University	Brown, C (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	Culum.Brown@mq.edu.au	Brown, Culum/S-9826-2017	Brown, Culum/0000-0002-0210-1820	Australian Research Council	Australian Research Council(Australian Research Council)	The work was supported by the Australian Research Council. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anfora G, 2010, BEHAV BRAIN RES, V206, P236, DOI 10.1016/j.bbr.2009.09.023; Bibost AL., 2013, BEHAV LATERALIZATION, P9, DOI [10.1007/978-3-642-30203-9_2, DOI 10.1007/978-3-642-30203-9_2]; Bisazza A, 2000, LATERALITY, V5, P269, DOI 10.1080/135765000406111; Bisazza A, 2005, P ROY SOC B-BIOL SCI, V272, P1677, DOI 10.1098/rspb.2005.3145; Bisazza A, 2005, BEHAV BRAIN RES, V156, P165, DOI 10.1016/j.bbr.2004.05.022; Bisazza A., 2011, LATERALIZATION COGNI, P298, DOI [10.1002/9781444342536.ch14, DOI 10.1002/9781444342536.CH14]; Bonati B, 2008, BEHAV PROCESS, V79, P171, DOI 10.1016/j.beproc.2008.07.007; Brown C, 1997, BEHAV ECOL SOCIOBIOL, V41, P61, DOI 10.1007/s002650050364; Brown C, 2005, BEHAV BRAIN SCI, V28, P591, DOI 10.1017/S0140525X05240104; Brown C, 2005, BEHAV ECOL, V16, P482, DOI 10.1093/beheco/ari016; Brown C, 2004, P ROY SOC B-BIOL SCI, V271, pS455, DOI 10.1098/rsbl.2004.0222; Brown C, 2002, J ETHOL, V20, P89, DOI 10.1007/s10164-002-0059-6; Brown C, 2000, BEHAV ECOLOGY PREDAT; Brown C, 2007, BEHAV ECOL SOCIOBIOL, V62, P237, DOI 10.1007/s00265-007-0458-3; Brown C, 2011, BEHAV ECOL, V22, P1201, DOI 10.1093/beheco/arr114; Bumann D, 1997, BEHAVIOUR, V134, P1063, DOI 10.1163/156853997X00403; Colleter M, 2011, ANIM BEHAV, V81, P1231, DOI 10.1016/j.anbehav.2011.03.011; Dadda M, 2006, ANIM BEHAV, V72, P523, DOI 10.1016/j.anbehav.2005.10.019; Dadda M, 2009, P ROY SOC B-BIOL SCI, V276, P4399, DOI 10.1098/rspb.2009.1406; Ferrari MCO, 2008, ETHOLOGY, V114, P238, DOI 10.1111/j.1439-0310.2007.01468.x; Griffiths SW, 2004, P ROY SOC B-BIOL SCI, V271, P695, DOI 10.1098/rspb.2003.2648; Krause J, 1998, J FISH BIOL, V52, P494, DOI 10.1006/jfbi.1997.0595; Krause J, 2000, BIOL REV, V75, P477; Krause J, 2000, FISH FISH, V1, P82, DOI 10.1111/j.1467-2979.2000.tb00001.x; Kydd E, 2009, J FISH BIOL, V74, P2187, DOI 10.1111/j.1095-8649.2009.02240.x; Magat M, 2009, P ROY SOC B-BIOL SCI, V276, P4155, DOI 10.1098/rspb.2009.1397; MAGURRAN AE, 1991, P ROY SOC B-BIOL SCI, V246, P31, DOI 10.1098/rspb.1991.0121; MAGURRAN AE, 1990, ANIM BEHAV, V40, P443, DOI 10.1016/S0003-3472(05)80524-X; MAGURRAN AE, 1987, PROC R SOC SER B-BIO, V229, P439, DOI 10.1098/rspb.1987.0004; MENCH JA, 1986, BEHAV NEURAL BIOL, V46, P107, DOI 10.1016/S0163-1047(86)90570-4; Pike AVL, 1997, BEHAV PROCESS, V39, P241, DOI 10.1016/S0376-6357(96)00758-9; PITCHER TJ, 1973, ANIM BEHAV, V21, P673, DOI 10.1016/S0003-3472(73)80091-0; Pitcher TJ., 2001, ENCY OCEAN SCI, P975, DOI DOI 10.1006/RWOS.2001.0022; POTTS WK, 1984, NATURE, V309, P344, DOI 10.1038/309344a0; Rogers LJ., 2002, COMP VERTEBRATE LATE; Sovrano VA, 2004, BEHAV BRAIN RES, V152, P385, DOI 10.1016/j.bbr.2003.10.022; Svendsen JC, 2003, J FISH BIOL, V62, P834, DOI 10.1046/j.1095-8649.2003.00068.x; Vallortigara G, 1999, BRAIN RES REV, V30, P164, DOI 10.1016/S0165-0173(99)00012-0; Zucca P, 2008, CORTEX, V44, P13, DOI 10.1016/j.cortex.2006.01.002; Zucca P, 2011, BEHAV PROCESS, V88, P63, DOI 10.1016/j.beproc.2011.06.012	40	24	24	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80907	10.1371/journal.pone.0080907	http://dx.doi.org/10.1371/journal.pone.0080907			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260506	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600094
J	Bayliss, AL; Evans, PD				Bayliss, Asha L.; Evans, Peter D.			Characterisation of AmphiAmR11, an Amphioxus (Branchiostoma floridae) D-2-Dopamine-Like G Protein-Coupled Receptor	PLOS ONE			English	Article							DOPAMINE-RECEPTOR; TYRAMINE RECEPTOR; ADENYLYL-CYCLASE; MOLECULAR CHARACTERIZATION; FUNCTIONAL SELECTIVITY; KINASE ACTIVATION; IDENTIFICATION; EVOLUTION; CELLS; STIMULATION	The evolution of the biogenic amine signalling system in vertebrates is unclear. However, insights can be obtained from studying the structures and signalling properties of biogenic amine receptors from the protochordate, amphioxus, which is an invertebrate species that exists at the base of the chordate lineage. Here we describe the signalling properties of AmphiAmR11, an amphioxus (Branchiostoma floridae) G protein-coupled receptor which has structural similarities to vertebrate alpha(2)-adrenergic receptors but which functionally acts as a D-2 dopamine-like receptor when expressed in Chinese hamster ovary -K1 cells. AmphiAmR11 inhibits forskolin-stimulated cyclic AMP levels with tyramine, phenylethylamine and dopamine being the most potent agonists. AmphiAmR11 also increases mitogen-activated protein kinase activity and calcium mobilisation, and in both pathways, dopamine was found to be more potent than tyramine. Thus, differences in the relative effectiveness of various agonists in the different second messenger assay systems suggest that the receptor displays agonist-specific coupling (biased agonism) whereby different agonists stabilize different conformations of the receptor which lead to the enhancement of one signalling pathway over another. The present study provides insights into the evolution of alpha(2)-adrenergic receptor signalling and support the hypothesis that alpha(2)-adrenergic receptors evolved from D-2-dopamine receptors. The AmphiAmR11 receptor may represent a transition state between D-2-dopamine receptors and alpha(2)-adrenergic receptors.	[Bayliss, Asha L.; Evans, Peter D.] Babraham Inst, Signalling Lab, Cambridge, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute	Evans, PD (corresponding author), Babraham Inst, Signalling Lab, Cambridge, England.	peter.evans@babraham.ac.uk			BBSRC through the Babraham Institute; BBSRC; BBSRC [BBS/E/B/0000C194] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000C194] Funding Source: researchfish	BBSRC through the Babraham Institute(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was funded by the BBSRC through the Babraham Institute and by a BBSRC Studentship to ALB. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARTHUR JM, 1993, BIOCHEM PHARMACOL, V45, P2337, DOI 10.1016/0006-2952(93)90208-E; Balmanno K, 1999, ONCOGENE, V18, P3085, DOI 10.1038/sj.onc.1202647; Bayliss A, 2013, INVERTEBR NEUROSCI, V13, P71, DOI 10.1007/s10158-012-0145-6; Bayliss A, 2013, J NEUROCHEM, V125, P37, DOI 10.1111/jnc.12158; BOOTMAN MD, 1992, J PHYSIOL-LONDON, V450, P163, DOI 10.1113/jphysiol.1992.sp019121; BUNN PA, 1990, P NATL ACAD SCI USA, V87, P2162, DOI 10.1073/pnas.87.6.2162; Burman C, 2008, THESIS U CAMBRIDGE; Burman C, 2010, INVERTEBR NEUROSCI, V10, P93, DOI 10.1007/s10158-010-0111-0; Burman C, 2009, J NEUROCHEM, V111, P26, DOI 10.1111/j.1471-4159.2009.06295.x; Burman Chloe, 2007, Invertebrate Neuroscience, V7, P87, DOI 10.1007/s10158-006-0041-z; Cussac D, 1999, MOL PHARMACOL, V56, P1025, DOI 10.1124/mol.56.5.1025; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; EASON MG, 1992, J BIOL CHEM, V267, P15795; FLORDELLIS CS, 1995, J BIOL CHEM, V270, P3491, DOI 10.1074/jbc.270.8.3491; FRYXELL KJ, 1995, J MOL EVOL, V41, P85, DOI 10.1007/BF00174044; Garcia-Fernandez J, 2009, BIOESSAYS, V31, P665, DOI 10.1002/bies.200800110; Gardner B, 1996, BRIT J PHARMACOL, V118, P1544, DOI 10.1111/j.1476-5381.1996.tb15572.x; George SE, 1997, J NEUROCHEM, V69, P1278; Hall DA, 1999, BIOCHEM PHARMACOL, V58, P285, DOI 10.1016/S0006-2952(99)00101-X; Hearn MG, 2002, P NATL ACAD SCI USA, V99, P14554, DOI 10.1073/pnas.202498299; Insel PA, 2003, CELL MOL NEUROBIOL, V23, P305, DOI 10.1023/A:1023684503883; Kenakin T, 2007, MOL PHARMACOL, V72, P1393, DOI 10.1124/mol.107.040352; Kukkonen JP, 1998, J PHARMACOL EXP THER, V287, P667; Maqueira B, 2005, J NEUROCHEM, V94, P547, DOI 10.1111/j.1471-4159.2005.03251.x; Missale C, 1998, PHYSIOL REV, V78, P189, DOI 10.1152/physrev.1998.78.1.189; Moret F, 2004, J COMP NEUROL, V468, P135, DOI 10.1002/cne.10965; Neve KA, 2004, J RECEPT SIG TRANSD, V24, P165, DOI 10.1081/LRST-200029981; Nordstrom KJV, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-9; Obadiah J, 1999, CELL MOL NEUROBIOL, V19, P653, DOI 10.1023/A:1006988603199; Ohta H, 2003, INSECT MOL BIOL, V12, P217, DOI 10.1046/j.1365-2583.2003.00404.x; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Rex E, 2002, J NEUROCHEM, V82, P1352, DOI 10.1046/j.1471-4159.2002.01065.x; ROBB S, 1994, EMBO J, V13, P1325, DOI 10.1002/j.1460-2075.1994.tb06385.x; Rotte C, 2009, NEUROSCIENCE, V162, P1120, DOI 10.1016/j.neuroscience.2009.05.066; Schubert M, 2006, TRENDS ECOL EVOL, V21, P269, DOI 10.1016/j.tree.2006.01.009; Srivastava DP, 2005, J NEUROSCI, V25, P6145, DOI 10.1523/JNEUROSCI.1005-05.2005; Sugiura M, 2005, J NEUROCHEM, V94, P1146, DOI 10.1111/j.1471-4159.2005.03268.x; Suo S, 2003, J NEUROCHEM, V86, P869, DOI 10.1046/j.1471-4159.2003.01896.x; Swatton JE, 2004, EUR J NEUROSCI, V19, P2711, DOI 10.1111/j.0953-816X.2004.03365.x; Urban JD, 2007, J PHARMACOL EXP THER, V320, P1, DOI 10.1124/jpet.106.104463; Vallone D, 2000, NEUROSCI BIOBEHAV R, V24, P125, DOI 10.1016/S0149-7634(99)00063-9; VERNIER P, 1995, TRENDS PHARMACOL SCI, V16, P375, DOI 10.1016/S0165-6147(00)89078-1; Walker S, 2008, BIOTECHNIQUES, V45, P347, DOI 10.2144/000112957; Welsh GI, 1998, J NEUROCHEM, V70, P2139; WEST RE, 1985, J BIOL CHEM, V260, P4428; Xhaard H, 2006, J MED CHEM, V49, P1706, DOI 10.1021/jm0511031; Yamamoto K, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00021	47	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80833	10.1371/journal.pone.0080833	http://dx.doi.org/10.1371/journal.pone.0080833			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265838	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100174
J	Evans, J; McCormick, RF; Morishige, D; Olson, SN; Weers, B; Hilley, J; Klein, P; Rooney, W; Mullet, J				Evans, Joseph; McCormick, Ryan F.; Morishige, Daryl; Olson, Sara N.; Weers, Brock; Hilley, Josie; Klein, Patricia; Rooney, William; Mullet, John			Extensive Variation in the Density and Distribution of DNA Polymorphism in Sorghum Genomes	PLOS ONE			English	Article							GENETIC-VARIATION; WIDE PATTERNS; STAY-GREEN; MAIZE DOMESTICATION; MUTATION-RATE; PLANT HEIGHT; HOT-SPOTS; ASSOCIATION; DIVERSITY; POPULATION	Sorghum genotypes currently used for grain production in the United States were developed from African landraces that were imported starting in the mid-to-late 19th century. Farmers and plant breeders selected genotypes for grain production with reduced plant height, early flowering, increased grain yield, adaptation to drought, and improved resistance to lodging, diseases and pests. DNA polymorphisms that distinguish three historically important grain sorghum genotypes, BTx623, BTx642 and Tx7000, were characterized by genome sequencing, genotyping by sequencing, genetic mapping, and pedigree-based haplotype analysis. The distribution and density of DNA polymorphisms in the sequenced genomes varied widely, in part because the lines were derived through breeding and selection from diverse Kafir, Durra, and Caudatum race accessions. Genomic DNA spanning dw1 (SBI-09) and dw3 (SBI-07) had identical haplotypes due to selection for reduced height. Lower SNP density in genes located in pericentromeric regions compared with genes located in euchromatic regions is consistent with background selection in these regions of low recombination. SNP density was higher in euchromatic DNA and varied >100-fold in contiguous intervals that spanned up to 300 Kbp. The localized variation in DNA polymorphism density occurred throughout euchromatic regions where recombination is elevated, however, polymorphism density was not correlated with gene density or DNA methylation. Overall, sorghum chromosomes contain distal euchromatic regions characterized by extensive, localized variation in DNA polymorphism density, and large pericentromeric regions of low gene density, diversity, and recombination.	[Evans, Joseph; McCormick, Ryan F.; Morishige, Daryl; Olson, Sara N.; Weers, Brock; Hilley, Josie; Mullet, John] Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA; [Klein, Patricia] Texas A&M Univ, Dept Hort, College Stn, TX 77843 USA; [Rooney, William] Texas A&M Univ, Dept Soil & Crop Sci, College Stn, TX 77843 USA	Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station; Texas A&M University System; Texas A&M University College Station	Mullet, J (corresponding author), Texas A&M Univ, Dept Biochem & Biophys, College Stn, TX 77843 USA.	jmullet@neo.tamu.edu		McCormick, Ryan/0000-0002-0753-0384	Pioneer Hi-Bred International	Pioneer Hi-Bred International	All authors have no financial, personal, or professional interests that could be construed to have influenced the paper. Partial funding for genome sequencing was provided by Pioneer Hi-Bred International, however, the authors confirm that this does not alter our adherence to all of the PLOS ONE policies on sharing data and materials as detailed in the PLOS ONE guide to authors. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1974, SORGHUM IMPROVEMENT; Baer CF, 2007, NAT REV GENET, V8, P619, DOI 10.1038/nrg2158; Bennetzen JL, 2005, ANN BOT-LONDON, V95, P127, DOI 10.1093/aob/mci008; Brown PJ, 2008, GENETICS, V180, P629, DOI 10.1534/genetics.108.092239; Casa AM, 2008, CROP SCI, V48, P30, DOI 10.2135/cropsci2007.02.0080; CHARLESWORTH B, 1993, GENETICS, V134, P1289; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Fay JC, 2000, GENETICS, V155, P1405; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Goodstein DM, 2012, NUCLEIC ACIDS RES, V40, pD1178, DOI 10.1093/nar/gkr944; Harris K, 2007, J EXP BOT, V58, P327, DOI 10.1093/jxb/erl225; Horton MW, 2012, NAT GENET, V44, P212, DOI 10.1038/ng.1042; Huang XH, 2010, NAT GENET, V42, P961, DOI 10.1038/ng.695; Huang XH, 2009, GENOME RES, V19, P1068, DOI 10.1101/gr.089516.108; Hufford MB, 2012, NAT GENET, V44, P808, DOI 10.1038/ng.2309; Jackson SA, 2011, NEW PHYTOL, V191, P915, DOI 10.1111/j.1469-8137.2011.03804.x; Jordan DR, 2012, CROP SCI, V52, P1153, DOI 10.2135/cropsci2011.06.0326; Kim JS, 2005, GENETICS, V171, P1963, DOI 10.1534/genetics.105.048215; Kimber C, 2000, SORGHUM ORGIN HIST T; Klein RR, 2008, CROP SCI, V48, pS12, DOI 10.2135/cropsci2007.06.0319tpg; KLEIN RR, 1986, J BIOL CHEM, V261, P1138; Lai JS, 2010, NAT GENET, V42, P1027, DOI 10.1038/ng.684; LANDER E S, 1987, Genomics, V1, P174, DOI 10.1016/0888-7543(87)90010-3; Lercher MJ, 2002, TRENDS GENET, V18, P337, DOI 10.1016/S0168-9525(02)02669-0; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; Ma X, 2012, CELL REP, V1, P36, DOI 10.1016/j.celrep.2011.10.003; Mace ES, 2010, THEOR APPL GENET, V121, P1339, DOI 10.1007/s00122-010-1392-8; Menz MA, 2004, CROP SCI, V44, P1236, DOI 10.2135/cropsci2004.1236; Michaelson JJ, 2012, CELL, V151, P1431, DOI 10.1016/j.cell.2012.11.019; MILLER FR, 1984, GENETIC CONTRIBUTION; Morishige DT, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-448; Morris GP, 2013, P NATL ACAD SCI USA, V110, P453, DOI 10.1073/pnas.1215985110; Multani DS, 2003, SCIENCE, V302, P81, DOI 10.1126/science.1086072; Nei M., 1983, P 5 WORLD C GEN APPL, V21, P405; Nishant KT, 2009, BIOESSAYS, V31, P912, DOI 10.1002/bies.200900017; Palaisa K, 2004, P NATL ACAD SCI USA, V101, P9885, DOI 10.1073/pnas.0307839101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; PEREIRA MG, 1995, THEOR APPL GENET, V90, P380, DOI 10.1007/BF00221980; Price HJ, 2005, ANN BOT-LONDON, V95, P219, DOI 10.1093/aob/mci015; QUINBY JR, 1973, CROP SCI, V13, P243, DOI 10.2135/cropsci1973.0011183X001300020028x; Rooney WL, 2007, BIOFUEL BIOPROD BIOR, V1, P147, DOI 10.1002/bbb.15; Rooney WL, 2004, ADV AGRON, V83, P37, DOI 10.1016/S0065-2113(04)83002-5; Rosenow D.T., 2000, SORGHUM ORIGIN HIST; Rosenow DT, 1995, P 50 ANN CORN SORGH, P82; Sneath P.H.A., 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; TAJIMA F, 1989, GENETICS, V123, P585; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tian F, 2009, P NATL ACAD SCI USA, V106, P9979, DOI 10.1073/pnas.0901122106; Weers BD, 2011, INTEGRATED ANAL PHEN, P1; Xu WW, 2000, GENOME, V43, P461, DOI 10.1139/g00-003; Zheng LY, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-11-r114; Zou GH, 2012, J EXP BOT, V63, P5451, DOI 10.1093/jxb/ers205	55	37	38	0	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79192	10.1371/journal.pone.0079192	http://dx.doi.org/10.1371/journal.pone.0079192			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265758	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100091
J	Falke, JA; Dunham, JB; Jordan, CE; McNyset, KM; Reeves, GH				Falke, Jeffrey A.; Dunham, Jason B.; Jordan, Christopher E.; McNyset, Kristina M.; Reeves, Gordon H.			Spatial Ecological Processes and Local Factors Predict the Distribution and Abundance of Spawning by Steelhead (Oncorhynchus mykiss) across a Complex Riverscape	PLOS ONE			English	Article							ANADROMOUS SALMONIDS; PACIFIC-NORTHWEST; WATER TEMPERATURE; HABITAT QUALITY; CHINOOK SALMON; TROUT; CONNECTIVITY; SCALE; FISH; COMPLEMENTATION	Processes that influence habitat selection in landscapes involve the interaction of habitat composition and configuration and are particularly important for species with complex life cycles. We assessed the relative influence of landscape spatial processes and local habitat characteristics on patterns in the distribution and abundance of spawning steelhead (Oncorhynchus mykiss), a threatened salmonid fish, across,15,000 stream km in the John Day River basin, Oregon, USA. We used hurdle regression and a multi-model information theoretic approach to identify the relative importance of covariates representing key aspects of the steelhead life cycle (e. g., site access, spawning habitat quality, juvenile survival) at two spatial scales: within 2-km long survey reaches (local sites) and ecological neighborhoods (5 km) surrounding the local sites. Based on Akaike's Information Criterion, models that included covariates describing ecological neighborhoods provided the best description of the distribution and abundance of steelhead spawning given the data. Among these covariates, our representation of offspring survival (growing-season-degree-days, degrees C) had the strongest effect size (7x) relative to other predictors. Predictive performances of model-averaged composite and neighborhood-only models were better than a siteonly model based on both occurrence (percentage of sites correctly classified = 0.8060.03 SD, 0.7860.02 vs. 0.6260.05, respectively) and counts (root mean square error = 3.37, 3.93 vs. 5.57, respectively). The importance of both temperature and stream flow for steelhead spawning suggest this species may be highly sensitive to impacts of land and water uses, and to projected climate impacts in the region and that landscape context, complementation, and connectivity will drive how this species responds to future environments.	[Falke, Jeffrey A.; McNyset, Kristina M.] Oregon State Univ, Dept Fisheries & Wildlife, Corvallis, OR 97331 USA; [Dunham, Jason B.] US Geol Survey, Forest & Rangeland Ecosyst Sci Ctr, Corvallis, OR USA; [Jordan, Christopher E.] NOAA, NW Fisheries Sci Ctr, Seattle, WA USA; [Reeves, Gordon H.] US Forest Serv, Pacific NW Res Stn, Corvallis, OR 97331 USA	Oregon State University; United States Department of the Interior; United States Geological Survey; National Oceanic Atmospheric Admin (NOAA) - USA; United States Department of Agriculture (USDA); United States Forest Service	Falke, JA (corresponding author), Univ Alaska Fairbanks, US Geol Survey, Alaska Cooperat Fish & Wildlife Res Unit, Fairbanks, AK 99775 USA.	Jeffrey.Falke@alaska.edu			National Research Council; American Recovery and Reinvestment Act through the USDA Forest Service Pacific Northwest Research Laboratory; U.S. Geological Survey; National Climate Change and Wildlife Science Center; USDA Forest Service	National Research Council; American Recovery and Reinvestment Act through the USDA Forest Service Pacific Northwest Research Laboratory; U.S. Geological Survey(United States Geological Survey); National Climate Change and Wildlife Science Center; USDA Forest Service(United States Department of Agriculture (USDA)United States Forest Service)	J. A. Falke and K. M. McNyset were supported by funds from the National Research Council and the American Recovery and Reinvestment Act through the USDA Forest Service Pacific Northwest Research Laboratory. J. B. Dunham and G. H. Reeves were supported in part by a collaborative research agreement between U.S. Geological Survey, National Climate Change and Wildlife Science Center, and USDA Forest Service. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ADDICOTT JF, 1987, OIKOS, V49, P340, DOI 10.2307/3565770; Andren H, 1997, OIKOS, V80, P193, DOI 10.2307/3546534; Beechie T, 1999, FISHERIES, V24, P6, DOI 10.1577/1548-8446(1999)024<0006:AATRSH>2.0.CO;2; Beechie T, 2008, AM FISH S S, V65, P83; Beechie TJ, 2010, BIOSCIENCE, V60, P209, DOI 10.1525/bio.2010.60.3.7; Belisle M, 2005, ECOLOGY, V86, P1988, DOI 10.1890/04-0923; Bisson PA, 2009, ECOL SOC, V14; Brotons L, 2005, BIOL CONSERV, V124, P407, DOI 10.1016/j.biocon.2005.01.046; Buffington JM, 2004, CAN J FISH AQUAT SCI, V61, P2085, DOI [10.1139/f04-141, 10.1139/F04-141]; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; Cameron AC., 2013, REGRESSION ANAL COUN, V2nd ed, DOI 10.1017/CBO9781139013567; Chang H., 2010, CLIMATE CHANGE FRESH, P69; Cooper SD, 1998, AUST J ECOL, V23, P27, DOI 10.1111/j.1442-9993.1998.tb00703.x; Crawford SS, 2008, REV FISH BIOL FISHER, V18, P313, DOI 10.1007/s11160-007-9079-1; Crossin GT, 2004, J FISH BIOL, V65, P788, DOI 10.1111/j.0022-1112.2004.00486.x; CURY P, 1994, CAN J FISH AQUAT SCI, V51, P1664, DOI 10.1139/f94-167; Dunham JB, 2002, PREDICTING SPECIES OCCURRENCES: ISSUES OF ACCURACY AND SCALE, P327; DUNNING JB, 1992, OIKOS, V65, P169, DOI 10.2307/3544901; Fahrig L, 2003, ANNU REV ECOL EVOL S, V34, P487, DOI 10.1146/annurev.ecolsys.34.011802.132419; Falke JA, 2010, AM FISH S S, V73, P207; Fausch KD, 2002, BIOSCIENCE, V52, P483, DOI 10.1641/0006-3568(2002)052[0483:LTRBTG]2.0.CO;2; Fausch KD, 2001, ECOL APPL, V11, P1438, DOI 10.1890/1051-0761(2001)011[1438:FDRIRT]2.0.CO;2; Fullerton AH, 2010, FRESHWATER BIOL, V55, P2215, DOI 10.1111/j.1365-2427.2010.02448.x; Ganio LM, 2005, FRONT ECOL ENVIRON, V3, P138, DOI 10.1890/1540-9295(2005)003[0138:AGAFDS]2.0.CO;2; Good TP, 2005, NMFSNWFSC66 NOAA US; Hinch SG, 1996, T AM FISH SOC, V125, P253, DOI 10.1577/1548-8659(1996)125<0253:UOETTA>2.3.CO;2; ICTRT (Interior Columbia Technical Recovery Team), 2007, VIAB CRIT APPL INT C; Isaak DJ, 2007, ECOL APPL, V17, P352, DOI 10.1890/05-1949; Jonsson B, 2009, J FISH BIOL, V75, P2381, DOI 10.1111/j.1095-8649.2009.02380.x; Kahler TH, 2001, CAN J FISH AQUAT SCI, V58, P1947, DOI 10.1139/cjfas-58-10-1947; Katz SL, 2007, RESTOR ECOL, V15, P494, DOI 10.1111/j.1526-100X.2007.00245.x; KIM M, 2011, ATLANTIC, V20, P144, DOI DOI 10.1111/J.1600-0633.2010.00471.X; Knowlton JL, 2010, BIOL CONSERV, V143, P1342, DOI 10.1016/j.biocon.2010.03.011; Koizumi I, 2004, FRESHWATER BIOL, V49, P973, DOI 10.1111/j.1365-2427.2004.01240.x; KONDOLF GM, 1993, WATER RESOUR RES, V29, P2275, DOI 10.1029/93WR00402; Le Pichon C, 2006, ENVIRON MANAGE, V37, P322, DOI 10.1007/s00267-005-0027-3; Lima SL, 1996, TRENDS ECOL EVOL, V11, P131, DOI 10.1016/0169-5347(96)81094-9; Matthews W. J., 1998, PATTERNS FRESHWATER; Mccarthy SG, 2009, T AM FISH SOC, V138, P506, DOI 10.1577/T08-053.1; McClure MM, 2003, ECOL APPL, V13, P964, DOI 10.1890/1051-0761(2003)13[964:ALMSAA]2.0.CO;2; McIntosh BA, 2000, ECOL APPL, V10, P1478, DOI 10.2307/2641299; McKean J, 2009, REMOTE SENS-BASEL, V1, P1065, DOI 10.3390/rs1041065; McMillan JR, 2012, ENVIRON BIOL FISH, V93, P343, DOI 10.1007/s10641-011-9921-0; Mills JS, 2012, ENVIRON BIOL FISH, V93, P505, DOI 10.1007/s10641-011-9946-4; Montgomery DR, 1996, CAN J FISH AQUAT SCI, V53, P1061, DOI 10.1139/cjfas-53-5-1061; Montgomery DR, 1997, GEOL SOC AM BULL, V109, P596, DOI 10.1130/0016-7606(1997)109<0596:CRMIMD>2.3.CO;2; Peterson JT, 2010, INLAND FISHERIES MANAGEMENT IN NORTH AMERICA, THIRD EDITION, P81; Pope SE, 2000, ECOLOGY, V81, P2498; Potts JM, 2006, ECOL MODEL, V199, P153, DOI 10.1016/j.ecolmodel.2006.05.025; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; Reeves GH, 1995, AM FISH S S, V17, P334; Reeves GH, 2011, T AM FISH SOC, V140, P537, DOI 10.1080/00028487.2011.572003; Ricketts TH, 2001, AM NAT, V158, P87, DOI 10.1086/320863; Rodriguez MA, 2002, ECOLOGY, V83, P1; SCHIEMER F, 1991, INT VER THEOR ANGEW, V24, P2497; Schlosser IJ, 1995, AM FISH S S, V17, P392; SCHLOSSER IJ, 1995, HYDROBIOLOGIA, V303, P71, DOI 10.1007/BF00034045; Seaber P.R., 1994, HYDROLOGIC UNIT MAPS; Stevens DL, 1999, J AGRIC BIOL ENVIR S, V4, P415; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Susac GL, 1999, F145R08 OR DEP FISH; Tattam IA, 2007, SEASONAL LIFE HIST O; TAYLOR PD, 1993, OIKOS, V68, P571, DOI 10.2307/3544927; ter Braak C.J.F., 2002, CANOCO REFERENCE MAN, P500; Theobald DM, 2006, FUNCTIONAL LINKAGE W; Torgersen CE, 2001, REMOTE SENS ENVIRON, V76, P386, DOI 10.1016/S0034-4257(01)00186-9; Torgersen CE, 1999, ECOL APPL, V9, P301, DOI 10.1890/1051-0761(1999)009[0301:MTRASH]2.0.CO;2; VANNOTE RL, 1980, CAN J FISH AQUAT SCI, V37, P130, DOI 10.1139/f80-017; Wenger SJ, 2011, P NATL ACAD SCI USA, V108, P14175, DOI 10.1073/pnas.1103097108; Wenger SJ, 2010, WATER RESOUR RES, V46, DOI 10.1029/2009WR008839; White SM, 2008, T AM FISH SOC, V137, P881, DOI 10.1577/T06-207.1; WIENS JA, 1995, IBIS, V137, pS97, DOI 10.1111/j.1474-919X.1995.tb08464.x; Zeileis A, 2008, J STAT SOFTW, V27, P1, DOI 10.18637/jss.v027.i08	73	35	37	1	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79232	10.1371/journal.pone.0079232	http://dx.doi.org/10.1371/journal.pone.0079232			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265762	Green Published, gold			2022-12-25	WOS:000327252100095
J	Hoekstra, M; Frodermann, V; van den Aardweg, T; van der Sluis, RJ; Kuiper, J				Hoekstra, Menno; Frodermann, Vanessa; van den Aardweg, Tim; van der Sluis, Ronald J.; Kuiper, Johan			Leukocytosis and Enhanced Susceptibility to Endotoxemia but Not Atherosclerosis in Adrenalectomized APOE Knockout Mice	PLOS ONE			English	Article							APOLIPOPROTEIN-E; GLUCOCORTICOID-RECEPTOR; METABOLIC SYNDROME; HEART-DISEASE; INHIBITION; COUNT; EXPRESSION; REVERSAL; LESIONS; SEX	Hyperlipidemic apolipoprotein E (APOE) knockout mice show an enhanced level of adrenal-derived anti-inflammatory glucocorticoids. Here we determined in APOE knockout mice the impact of total removal of adrenal function through adrenalectomy (ADX) on two inflammation-associated pathologies, endotoxemia and atherosclerosis. ADX mice exhibited 91% decreased corticosterone levels (P<0.001), leukocytosis (WBC count: 10.0 +/- 0.4 x 10E9/L vs 6.5 +/- 0.5 x 10E9/L; P<0.001) and an increased spleen weight (P<0.01). FACS analysis on blood leukocytes revealed increased B-lymphocyte numbers (55 +/- 2% vs 46 +/- 1%; P<0.01). T-cell populations in blood appeared to be more immature (CD62L+: 26 +/- 2% vs 19 +/- 1% for CD4+ T-cells, P<0.001 and 58 +/- 7% vs 47 +/- 4% for CD8+ T-cells, P<0.05), which coincided with immature CD4/CD8 double positive thymocyte enrichment. Exposure to lipopolysaccharide failed to increase corticosterone levels in ADX mice and was associated with a 3-fold higher (P<0.05) TNF-alpha response. In contrast, the development of initial fatty streak lesions and progression to advanced collagen-containing atherosclerotic lesions was unaffected. Plasma cholesterol levels were decreased by 35% (P<0.001) in ADX mice. This could be attributed to a decrease in pro-atherogenic very-low-density lipoproteins (VLDL) as a result of a diminished hepatic VLDL secretion rate (-24%; P<0.05). In conclusion, our studies show that adrenalectomy induces leukocytosis and enhances the susceptibility for endotoxemia in APOE knockout mice. The adrenalectomy-associated rise in white blood cells, however, does not alter atherosclerotic lesion development probably due to the parallel decrease in plasma levels of pro-atherogenic lipoproteins.	[Hoekstra, Menno; Frodermann, Vanessa; van den Aardweg, Tim; van der Sluis, Ronald J.; Kuiper, Johan] Leiden Acad Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands		Hoekstra, M (corresponding author), Leiden Acad Ctr Drug Res, Div Biopharmaceut, Leiden, Netherlands.	hoekstra@lacdr.leidenuniv.nl		Hoekstra, Menno/0000-0001-7463-2893; Frodermann, Vanessa/0000-0001-5566-6692	TIPharma [T2-110]; Dutch Heart Foundation [2008T070, 2009B093]	TIPharma; Dutch Heart Foundation(Netherlands Heart Foundation)	This study was supported by TIPharma (Grant T2-110) and the Dutch Heart Foundation (Grants 2008T070 and 2009B093). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreau K, 1998, IMMUNOPHARMACOLOGY, V40, P67, DOI 10.1016/S0162-3109(98)00034-4; AUPHAN N, 1995, SCIENCE, V270, P286, DOI 10.1126/science.270.5234.286; Baschant U, 2012, NAT REV RHEUMATOL, V8, P645, DOI 10.1038/nrrheum.2012.166; Baschant U, 2010, J STEROID BIOCHEM, V120, P69, DOI 10.1016/j.jsbmb.2010.03.058; Bergthorsdottir R, 2006, J CLIN ENDOCR METAB, V91, P4849, DOI 10.1210/jc.2006-0076; Caligiuri G, 1999, ATHEROSCLEROSIS, V145, P301, DOI 10.1016/S0021-9150(99)00081-7; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1006/abio.1987.9999; Clayton RN, 2011, J CLIN ENDOCR METAB, V96, P632, DOI 10.1210/jc.2010-1942; Davignon J, 2005, ARTERIOSCL THROM VAS, V25, P267, DOI 10.1161/01.ATV.0000154570.50696.2c; de Bont N, 1999, J LIPID RES, V40, P680; ENSRUD K, 1992, AM HEART J, V124, P207, DOI 10.1016/0002-8703(92)90942-O; Goel N, 2010, ENDOCRINOLOGY, V151, P1784, DOI 10.1210/en.2009-1180; Grootendorst J, 2001, NEUROSCIENCE, V108, P237, DOI 10.1016/S0306-4522(01)00412-2; Hermanowski-Vosatka A, 2005, J EXP MED, V202, P517, DOI 10.1084/jem.20050119; Hoekstra M, 2003, J BIOL CHEM, V278, P25448, DOI 10.1074/jbc.M301189200; Ishigami M, 2000, ARTERIOSCL THROM VAS, V20, P1020, DOI 10.1161/01.ATV.20.4.1020; Lammers B, 2009, ATHEROSCLEROSIS, V205, P420, DOI 10.1016/j.atherosclerosis.2009.01.017; Luijten RKMAC, 2013, AUTOIMMUN REV, V12, P617, DOI 10.1016/j.autrev.2012.12.001; Mahley RW, 1990, J LIPID RES, V40, P1; Mills EJ, 2011, QJM-INT J MED, V104, P109, DOI 10.1093/qjmed/hcq165; Nasir K, 2005, ARTERIOSCL THROM VAS, V25, P1966, DOI 10.1161/01.ATV.0000175296.02550.e4; Nuotio-Antar AM, 2007, AM J PHYSIOL-ENDOC M, V293, pE1517, DOI 10.1152/ajpendo.00522.2007; Preusch MR, 2008, ARTERIOSCL THROM VAS, V28, P2158, DOI 10.1161/ATVBAHA.108.174128; Purton JF, 2004, J IMMUNOL, V173, P3816, DOI 10.4049/jimmunol.173.6.3816; Raber J, 2000, J NEUROSCI, V20, P2064; Rasouli M, 2007, CLIN CHIM ACTA, V377, P127, DOI 10.1016/j.cca.2006.09.009; Romeo RD, 2013, PSYCHONEUROENDOCRINO, V38, P592, DOI 10.1016/j.psyneuen.2012.07.019; Roselaar SE, 1998, J LIPID RES, V39, P1740; Sato Y, 2010, BIOCHEM BIOPH RES CO, V403, P253, DOI 10.1016/j.bbrc.2010.11.002; Silvennoinen R, 2012, CIRC RES, V111, P1459, DOI [10.1161/circresaha.112.277962, 10.1161/CIRCRESAHA.112.277962]; SPINEDI E, 1992, ENDOCRINOLOGY, V131, P2430, DOI 10.1210/en.131.5.2430; Stojic-Vukanic Z, 2009, EXP BIOL MED, V234, P1067, DOI 10.3181/0902-RM-63; Sweetnam PM, 1997, AM J EPIDEMIOL, V145, P416; van der Sluis RJ, 2012, ATHEROSCLEROSIS, V221, P76, DOI 10.1016/j.atherosclerosis.2011.12.022; Wheeler JG, 2004, EUR HEART J, V25, P1287, DOI 10.1016/j.ehj.2004.05.002; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543	36	10	10	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80441	10.1371/journal.pone.0080441	http://dx.doi.org/10.1371/journal.pone.0080441			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265824	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100160
J	Tauschmann, M; Prietl, B; Treiber, G; Gorkiewicz, G; Kump, P; Hogenauer, C; Pieber, TR				Tauschmann, Martin; Prietl, Barbara; Treiber, Gerlies; Gorkiewicz, Gregor; Kump, Patrizia; Hoegenauer, Christoph; Pieber, Thomas R.			Distribution of CD4(pos) -, CD8(pos) - and Regulatory T Cells in the Upper and Lower Gastrointestinal Tract in Healthy Young Subjects	PLOS ONE			English	Article							HELICOBACTER-PYLORI INFECTION; GUT MICROBIOTA; SUPPRESSIVE ACTIVITY; ULCERATIVE-COLITIS; COMMENSAL BACTERIA; SELF-TOLERANCE; ANIMAL-MODELS; HOMEOSTASIS; EXPRESSION; CD4(+)	The gastrointestinal immune system is involved in the development of several autoimmune-mediated diseases, including inflammatory bowel disease, multiple sclerosis, and type 1 diabetes mellitus. Alterations in T-cell populations, especially regulatory T cells (Tregs), are often evident in patients suffering from these diseases. To be able to detect changes in T-cell populations in diseased tissue, it is crucial to investigate T-cell populations in healthy individuals, and to characterize their variation among different regions of the gastrointestinal (GI) tract. While limited data exist, quantitative data on biopsies systematically drawn from various regions of the GI tract are lacking, particularly in healthy young humans. In this report, we present the first systematic assessment of how T cells-including Tregs-are distributed in the gastrointestinal mucosa throughout the GI tract of healthy young humans by means of multi-parameter FACS analysis. Gastroduodenoscopy and colonoscopy were performed on 16 healthy volunteers aged between 18 and 32. Biopsies were drawn from seven GI regions, and were used to determine the frequencies of CD8(+)-, CD4(+)- and Tregs in the gastrointestinal mucosa by means of multi-parameter FACS analysis. Our data show that there is significant variation in the baseline T-cell landscape along the healthy human gastrointestinal tract, and that mucosal T-cell analyses from a single region should not be taken as representative of the entire gastrointestinal tract. We show that certain T-cell subsets in the gastrointestinal mucosa vary significantly among regions; most notably, that Tregs are enriched in the appendiceal orifice region and the ascending colon, and that CD8(pos) T cells are enriched in the gastric mucosa.	[Tauschmann, Martin; Prietl, Barbara; Treiber, Gerlies; Pieber, Thomas R.] Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria; [Gorkiewicz, Gregor] Med Univ Graz, Inst Pathol, Graz, Austria; [Kump, Patrizia; Hoegenauer, Christoph] Med Univ Graz, Dept Internal Med, Div Gastroenterol & Hepatol, Graz, Austria	Medical University of Graz; Medical University of Graz; Medical University of Graz	Pieber, TR (corresponding author), Med Univ Graz, Dept Internal Med, Div Endocrinol & Metab, Graz, Austria.	thomas.pieber@medunigraz.at	Gorkiewicz, Gregor/ABF-1602-2021; Tauschmann, Martin/GLN-8103-2022	Gorkiewicz, Gregor/0000-0003-1149-4782; Pieber, Thomas/0000-0003-3554-0405; Hogenauer, Christoph/0000-0003-4566-0806; Prietl, Barbara/0000-0001-6136-2804; Tauschmann, Martin/0000-0002-2305-2490	Medical University of Graz; European Association for the Study of Diabetes; BioPersMed [825329]; Federal Ministry of Transport, Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG)	Medical University of Graz; European Association for the Study of Diabetes; BioPersMed; Federal Ministry of Transport, Innovation and Technology (BMVIT); Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ); Styrian Business Promotion Agency (SFG)	This work was supported by the Medical University of Graz (http://www.medunigraz.at/), the European Association for the Study of Diabetes (EASD.org) and BioPersMed (COMET K-project 825329), which is funded by the Federal Ministry of Transport, Innovation and Technology (BMVIT) and the Federal Ministry of Economics and Labour/the Federal Ministry of Economy, Family and Youth (BMWA/BMWFJ) and the Styrian Business Promotion Agency (SFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ansaloni L, 2009, EUR SURG RES, V43, P67, DOI 10.1159/000219236; Atkinson MA, 2012, DIABETOLOGIA, V55, P2868, DOI 10.1007/s00125-012-2672-4; Badami E, 2011, DIABETES, V60, P2120, DOI 10.2337/db10-1201; Baecher-Allan C, 2001, J IMMUNOL, V167, P1245, DOI 10.4049/jimmunol.167.3.1245; Berer K, 2012, ACTA NEUROPATHOL, V123, P639, DOI 10.1007/s00401-012-0949-9; Bolin TD, 2009, AM J GASTROENTEROL, V104, P2476, DOI 10.1038/ajg.2009.388; Bollinger RR, 2007, J THEOR BIOL, V249, P826, DOI 10.1016/j.jtbi.2007.08.032; Brenner H, 2006, ANN EPIDEMIOL, V16, P516, DOI 10.1016/j.annepidem.2005.09.009; Breuer T, 1996, EUR J GASTROEN HEPAT, V8, P47, DOI 10.1097/00042737-199601000-00009; Buckner JH, 2010, NAT REV IMMUNOL, V10, P849, DOI 10.1038/nri2889; Cheng HH, 2012, WORLD J GASTROENTERO, V18, P34, DOI 10.3748/wjg.v18.i1.34; Cosnes J, 2002, GUT, V51, P803, DOI 10.1136/gut.51.6.803; Gardenbroek TJ, 2012, COLORECTAL DIS, V14, P545, DOI 10.1111/j.1463-1318.2011.02600.x; Hamada H, 2002, J IMMUNOL, V168, P57, DOI 10.4049/jimmunol.168.1.57; Hmida NB, 2012, AM J GASTROENTEROL, V107, P604, DOI 10.1038/ajg.2011.397; Hoffmann KM, 2003, WIEN KLIN WOCHENSCHR, V115, P175, DOI 10.1007/BF03040305; Holmen N, 2006, INFLAMM BOWEL DIS, V12, P447, DOI 10.1097/00054725-200606000-00003; Im GY, 2011, CLIN GASTROENTEROL H, V9, P1072, DOI 10.1016/j.cgh.2011.06.006; Jang TJ, 2010, PATHOL RES PRACT, V206, P34, DOI 10.1016/j.prp.2009.07.019; Kandulski A, 2008, HELICOBACTER, V13, P295, DOI 10.1111/j.1523-5378.2008.00612.x; Kandulski A, 2010, ANTICANCER RES, V30, P1093; Kataoka H, 2005, INT IMMUNOL, V17, P421, DOI 10.1093/intimm/dxh221; Liu WH, 2006, J EXP MED, V203, P1701, DOI 10.1084/jem.20060772; Lundgren A, 2005, INFECT IMMUN, V73, P523, DOI 10.1128/IAI.73.1.523-531.2005; MacDonald TT, 2011, GASTROENTEROLOGY, V140, P1768, DOI 10.1053/j.gastro.2011.02.047; Macpherson AJ, 2002, CELL MOL LIFE SCI, V59, P2088, DOI 10.1007/s000180200009; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Maul J, 2005, GASTROENTEROLOGY, V128, P1868, DOI 10.1053/j.gastro.2005.03.043; Maynard CL, 2012, NATURE, V489, P231, DOI 10.1038/nature11551; Mazmanian SK, 2005, CELL, V122, P107, DOI 10.1016/j.cell.2005.05.007; McLoughlin RM, 2011, J ALLERGY CLIN IMMUN, V127, P1097, DOI 10.1016/j.jaci.2011.02.012; Miyara M, 2009, IMMUNITY, V30, P899, DOI 10.1016/j.immuni.2009.03.019; Mowat AM, 2003, NAT REV IMMUNOL, V3, P331, DOI 10.1038/nri1057; Palestrant D, 2004, ULTRASTRUCT PATHOL, V28, P23, DOI 10.1080/01913120490275196; Raynor J, 2012, CURR OPIN IMMUNOL, V24, P482, DOI 10.1016/j.coi.2012.04.005; ROEDERER M, 2002, CURRENT PROTOC CYTOM, V1; Sakaguchi S, 2006, IMMUNOL REV, V212, P8, DOI 10.1111/j.0105-2896.2006.00427.x; Saruta M, 2007, CLIN IMMUNOL, V125, P281, DOI 10.1016/j.clim.2007.08.003; Seddiki N, 2006, J EXP MED, V203, P1693, DOI 10.1084/jem.20060468; Smith HF, 2009, J EVOLUTION BIOL, V22, P1984, DOI 10.1111/j.1420-9101.2009.01809.x; Sojka DK, 2008, IMMUNOLOGY, V124, P13, DOI 10.1111/j.1365-2567.2008.02813.x; Tlaskalova-Hogenova H, 2011, CELL MOL IMMUNOL, V8, P110, DOI 10.1038/cmi.2010.67; Ukena SN, 2011, EXP HEMATOL, V39, P1152, DOI 10.1016/j.exphem.2011.08.010; Wang Y, 2011, J DIGEST DIS, V12, P286, DOI 10.1111/j.1751-2980.2011.00505.x; Weiner HL, 2011, IMMUNOL REV, V241, P241, DOI 10.1111/j.1600-065X.2011.01017.x; Weitkamp JH, 2013, GUT, V62, P73, DOI 10.1136/gutjnl-2011-301551; Wing K, 2010, NAT IMMUNOL, V11, P7, DOI 10.1038/ni.1818; Wolff MJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041373; Wu HJ, 2012, GUT MICROBES, V3, P4, DOI 10.4161/gmic.19320; Zanzi D, 2011, AM J GASTROENTEROL, V106, P1308, DOI 10.1038/ajg.2011.80; Ziegler SF, 2006, ANNU REV IMMUNOL, V24, P209, DOI 10.1146/annurev.immunol.24.021605.090547	51	12	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80362	10.1371/journal.pone.0080362	http://dx.doi.org/10.1371/journal.pone.0080362			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265815	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100151
J	Ruggles, KV; Garbarino, J; Liu, Y; Moon, J; Schneider, K; Henneberry, A; Billheimer, J; Millar, JS; Marchadier, D; Valasek, MA; Joblin-Mills, A; Gulati, S; Munkacsi, AB; Repa, JJ; Rader, D; Sturley, SL				Ruggles, Kelly V.; Garbarino, Jeanne; Liu, Ying; Moon, James; Schneider, Kerry; Henneberry, Annette; Billheimer, Jeff; Millar, John S.; Marchadier, Dawn; Valasek, Mark A.; Joblin-Mills, Aidan; Gulati, Sonia; Munkacsi, Andrew B.; Repa, Joyce J.; Rader, Dan; Sturley, Stephen L.			A Functional, Genome-wide Evaluation of Liposensitive Yeast Identifies the "ARE2 Required for Viability" (ARV1) Gene Product as a Major Component of Eukaryotic Fatty Acid Resistance	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Fatty Acid; Lipid Droplets; Lipid Metabolism; Lipotoxicity; Triglyceride; Yeast Genetics	PANCREATIC-BETA-CELLS; ENDOPLASMIC-RETICULUM STRESS; INSULIN-RESISTANCE; INDUCED APOPTOSIS; COMPARATIVE TOXICITY; LIPID DROPLETS; LINOLEIC-ACID; HUMAN ISLETS; OLEIC-ACID; ER STRESS	The toxic subcellular accumulation of lipids predisposes several human metabolic syndromes, including obesity, type 2 diabetes, and some forms of neurodegeneration. To identify pathways that prevent lipid-induced cell death, we performed a genome-wide fatty acid sensitivity screen in Saccharomyces cerevisiae. We identified 167 yeast mutants as sensitive to 0.5 mm palmitoleate, 45% of which define pathways that were conserved in humans. 63 lesions also impacted the status of the lipid droplet; however, this was not correlated to the degree of fatty acid sensitivity. The most liposensitive yeast strain arose due to deletion of the ARE2 required for viability (ARV1) gene, encoding an evolutionarily conserved, potential lipid transporter that localizes to the endoplasmic reticulum membrane. Down-regulation of mammalian ARV1 in MIN6 pancreatic -cells or HEK293 cells resulted in decreased neutral lipid synthesis, increased fatty acid sensitivity, and lipoapoptosis. Conversely, elevated expression of human ARV1 in HEK293 cells or mouse liver significantly increased triglyceride mass and lipid droplet number. The ARV1-induced hepatic triglyceride accumulation was accompanied by up-regulation of DGAT1, a triglyceride synthesis gene, and the fatty acid transporter, CD36. Furthermore, ARV1 was identified as a transcriptional of the protein peroxisome proliferator-activated receptor (PPAR), a key regulator of lipid homeostasis whose transcriptional targets include DGAT1 and CD36. These results implicate ARV1 as a protective factor in lipotoxic diseases due to modulation of fatty acid metabolism. In conclusion, a lipotoxicity-based genetic screen in a model microorganism has identified 75 human genes that may play key roles in neutral lipid metabolism and disease.	[Ruggles, Kelly V.; Garbarino, Jeanne; Liu, Ying; Moon, James; Schneider, Kerry; Henneberry, Annette; Gulati, Sonia; Sturley, Stephen L.] Columbia Univ, Med Ctr, Inst Human Nutr, New York, NY 10032 USA; [Sturley, Stephen L.] Columbia Univ, Dept Pediat, Med Ctr, New York, NY 10032 USA; [Moon, James] Columbia Univ, Dept Biol Sci, New York, NY 10027 USA; [Moon, James] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Billheimer, Jeff; Millar, John S.; Marchadier, Dawn; Rader, Dan] Univ Penn, Sch Med, Philadelphia, PA 19104 USA; [Valasek, Mark A.; Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Physiol, Dallas, TX 75390 USA; [Repa, Joyce J.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Joblin-Mills, Aidan; Munkacsi, Andrew B.] Victoria Univ Wellington, Sch Biol Sci, Wellington 6012, New Zealand; [Joblin-Mills, Aidan; Munkacsi, Andrew B.] Victoria Univ Wellington, Ctr Biodiscovery, Wellington 6012, New Zealand	Columbia University; Columbia University; Columbia University; Columbia University; University of Pennsylvania; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Victoria University Wellington; Victoria University Wellington	Sturley, SL (corresponding author), Columbia Univ, Dept Pediat, Med Ctr, 630 W 168th St, New York, NY 10032 USA.	sls37@columbia.edu	; moon, james/F-1031-2014	Repa, Joyce/0000-0001-5740-1954; Munkacsi, Andrew/0000-0003-3033-395X; Valasek, Mark/0000-0003-1721-3451; Ruggles, Kelly/0000-0002-0152-0863; moon, james/0000-0001-8071-1491	National Institutes of Health [DK54320, DK078592, 2 TL1 RR000082, 5 T32 DK007647]; American Diabetes Association; American Heart Association; Ara Parseghian Medical Research Foundation; National Niemann-Pick Disease Foundation; Wellington Medical Research Foundation; Neurological Foundation of New Zealand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK054320, R01DK078592, T32DK007647] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Diabetes Association(American Diabetes Association); American Heart Association(American Heart Association); Ara Parseghian Medical Research Foundation; National Niemann-Pick Disease Foundation; Wellington Medical Research Foundation; Neurological Foundation of New Zealand; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Grants DK54320 (to S. L. S.) and DK078592 (to J. R.). This work was also supported by the American Diabetes Association, the American Heart Association, and the Ara Parseghian Medical Research Foundation.; Supported by National Institutes of Health Training Grants 2 TL1 RR000082 and 5 T32 DK007647. Present address: 227 E30th, 7-59F, New York University Medical Center, New York, NY 10016.; Supported by the National Niemann-Pick Disease Foundation, the Wellington Medical Research Foundation, and the Neurological Foundation of New Zealand.	Adeyo O, 2011, J CELL BIOL, V192, P1043, DOI 10.1083/jcb.201010111; Anderson N, 2008, PHARMACOL REV, V60, P311, DOI 10.1124/pr.108.00001; Chavez JA, 2010, BBA-MOL CELL BIOL L, V1801, P252, DOI 10.1016/j.bbalip.2009.09.015; Athenstaedt K, 2003, J BIOL CHEM, V278, P23317, DOI 10.1074/jbc.M302577200; Ausubel FM, 1998, CURRENT PROTOCOLS MO; Beller M, 2008, PLOS BIOL, V6, P2530, DOI 10.1371/journal.pbio.0060292; Blakemore AIF, 2008, J CLIN ENDOCR METAB, V93, pS51, DOI 10.1210/jc.2008-1676; Borradaile NM, 2006, J LIPID RES, V47, P2726, DOI 10.1194/jlr.M600299-JLR200; Briaud I, 2001, DIABETES, V50, P315, DOI 10.2337/diabetes.50.2.315; Cauchi S, 2008, OBESITY, V16, P476, DOI 10.1038/oby.2007.77; Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Cohen MH, 2002, AM J MED, V113, P91, DOI 10.1016/S0002-9343(02)01169-5; Cury-Boaventura MF, 2006, LIFE SCI, V78, P1448, DOI 10.1016/j.lfs.2005.07.038; Cury-Boaventura MF, 2004, CLIN NUTR, V23, P721, DOI 10.1016/j.clnu.2003.12.004; Cusi K, 2009, CURR DIABETES REP, V9, P200, DOI 10.1007/s11892-009-0033-6; De Gottardi A, 2007, LAB INVEST, V87, P792, DOI 10.1038/labinvest.3700590; Diakogiannaki E, 2008, J ENDOCRINOL, V197, P553, DOI 10.1677/JOE-08-0041; Duval C, 2007, BBA-MOL CELL BIOL L, V1771, P961, DOI 10.1016/j.bbalip.2007.05.003; Fei WH, 2008, EUKARYOT CELL, V7, P401, DOI 10.1128/EC.00386-07; Fei WH, 2008, J CELL BIOL, V180, P473, DOI 10.1083/jcb.200711136; Fei WH, 2009, BIOCHEM J, V424, P61, DOI 10.1042/BJ20090785; Fores O, 2006, BBA-MOL CELL BIOL L, V1761, P725, DOI 10.1016/j.bbalip.2006.03.025; Garbarino J, 2009, J BIOL CHEM, V284, P30994, DOI 10.1074/jbc.M109.050443; Georgiev AG, 2013, TRAFFIC, V14, P912, DOI 10.1111/tra.12082; Goodman JM, 2008, J BIOL CHEM, V283, P28005, DOI 10.1074/jbc.R800042200; Green CD, 2011, AM J PHYSIOL-ENDOC M, V300, pE640, DOI 10.1152/ajpendo.00544.2010; GREENSPAN P, 1985, J CELL BIOL, V100, P965, DOI 10.1083/jcb.100.3.965; Guillam MT, 1997, NAT GENET, V17, P327, DOI 10.1038/ng1197-327; Guo Y, 2008, NATURE, V453, P657, DOI 10.1038/nature06928; Gwiazda KS, 2009, AM J PHYSIOL-ENDOC M, V296, pE690, DOI 10.1152/ajpendo.90525.2008; Hatunic M, 2009, DIABETES RES CLIN PR, V83, P316, DOI 10.1016/j.diabres.2008.12.004; Haus JM, 2009, DIABETES, V58, P337, DOI 10.2337/db08-1228; Holland WL, 2007, CELL METAB, V5, P167, DOI 10.1016/j.cmet.2007.01.002; ISHIHARA H, 1993, DIABETOLOGIA, V36, P1139, DOI 10.1007/BF00401058; Jaye M, 1999, NAT GENET, V21, P424, DOI 10.1038/7766; Kao G, 2007, CELL, V128, P577, DOI 10.1016/j.cell.2006.12.031; Koliwad SK, 2010, J CLIN INVEST, V120, P756, DOI 10.1172/JCI36066; Kurat CF, 2006, J BIOL CHEM, V281, P491, DOI 10.1074/jbc.M508414200; Kurrasch DM, 2004, METHOD ENZYMOL, V389, P3; Kusminski CM, 2009, APOPTOSIS, V14, P1484, DOI 10.1007/s10495-009-0352-8; LEE Y, 1994, P NATL ACAD SCI USA, V91, P10878, DOI 10.1073/pnas.91.23.10878; Lim HY, 2011, FLY, V5, P234, DOI 10.4161/fly.5.3.15708; Listenberger LL, 2001, J BIOL CHEM, V276, P14890, DOI 10.1074/jbc.M010286200; Listenberger LL, 2003, P NATL ACAD SCI USA, V100, P3077, DOI 10.1073/pnas.0630588100; Liu PS, 2004, J BIOL CHEM, V279, P3787, DOI 10.1074/jbc.M311945200; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729; Magre J, 1998, DIABETES, V47, P284, DOI 10.2337/diab.47.2.284; Malhi H, 2007, GUT, V56, P1124, DOI 10.1136/gut.2006.118059; Marchetti P, 2002, DIABETES, V51, P1419, DOI 10.2337/diabetes.51.5.1419; Mei S, 2011, J PHARMACOL EXP THER, V339, P487, DOI 10.1124/jpet.111.184341; Moffitt JH, 2005, DIABETOLOGIA, V48, P1819, DOI 10.1007/s00125-005-1861-9; Morcillo S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021198; ORRWEAVER TL, 1981, P NATL ACAD SCI-BIOL, V78, P6354, DOI 10.1073/pnas.78.10.6354; Park TS, 2008, J LIPID RES, V49, P2101, DOI 10.1194/jlr.M800147-JLR200; Petschnigg J, 2009, J BIOL CHEM, V284, P30981, DOI 10.1074/jbc.M109.024752; Pineau L, 2009, TRAFFIC, V10, P673, DOI 10.1111/j.1600-0854.2009.00903.x; Roden M, 1996, J CLIN INVEST, V97, P2859, DOI 10.1172/JCI118742; Ruggles KV, 2013, ANNU REV NUTR, V33, P413, DOI 10.1146/annurev-nutr-071812-161254; Sargsyan E, 2011, LIPIDS HEALTH DIS, V10, DOI 10.1186/1476-511X-10-115; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Schrauwen P, 2010, BBA-MOL CELL BIOL L, V1801, P266, DOI 10.1016/j.bbalip.2009.09.011; Schwarz S, 2006, APOPTOSIS, V11, P1111, DOI 10.1007/s10495-006-6982-1; Seo T, 2001, BIOCHEMISTRY-US, V40, P4756, DOI 10.1021/bi0022947; Shechtman CF, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.215038; Smith JJ, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb1400157; Summers SA, 2006, PROG LIPID RES, V45, P42, DOI 10.1016/j.plipres.2005.11.002; Swain E, 2002, J BIOL CHEM, V277, P36152, DOI 10.1074/jbc.M206624200; Szymanski KM, 2007, P NATL ACAD SCI USA, V104, P20890, DOI 10.1073/pnas.0704154104; Tinkelenberg AH, 2000, J BIOL CHEM, V275, P40667, DOI 10.1074/jbc.C000710200; Tong FM, 2010, J BIOL CHEM, V285, P33632, DOI 10.1074/jbc.M110.165761; Trauner M, 2010, BBA-MOL CELL BIOL L, V1801, P299, DOI 10.1016/j.bbalip.2009.10.007; Tsukamoto H, 2001, PRENATAL DIAG, V21, P55, DOI 10.1002/1097-0223(200101)21:1<55::AID-PD23>3.0.CO;2-M; Tsukamoto K, 2000, MOL THER, V1, P189, DOI 10.1006/mthe.2000.0028; Tsunoda K, 2001, DIABETOLOGIA, V44, P2092, DOI 10.1007/s001250100015; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Unger RH, 2010, BBA-MOL CELL BIOL L, V1801, P209, DOI 10.1016/j.bbalip.2009.10.006; van Herpen NA, 2008, PHYSIOL BEHAV, V94, P231, DOI 10.1016/j.physbeh.2007.11.049; Villanueva CJ, 2009, HEPATOLOGY, V50, P434, DOI 10.1002/hep.22980; Wang HY, 2005, J CELL SCI, V118, P3905, DOI 10.1242/jcs.02513; Wei YR, 2006, AM J PHYSIOL-ENDOC M, V291, pE275, DOI 10.1152/ajpendo.00644.2005; Wetterau JR, 1998, SCIENCE, V282, P751, DOI 10.1126/science.282.5389.751; Wrede CE, 2002, J BIOL CHEM, V277, P49676, DOI 10.1074/jbc.M208756200; Yang HY, 1996, SCIENCE, V272, P1353, DOI 10.1126/science.272.5266.1353; Zhu Y, 2005, NEUROCHEM INT, V46, P127, DOI 10.1016/j.neuint.2004.08.003	85	27	27	0	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	FEB 14	2014	289	7					4417	4431		10.1074/jbc.M113.515197	http://dx.doi.org/10.1074/jbc.M113.515197			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA9HG	24273168	Green Published, hybrid			2022-12-25	WOS:000331403800052
J	Woodruff, ML; Rajala, A; Fain, GL; Rajala, RVS				Woodruff, Michael L.; Rajala, Ammaji; Fain, Gordon L.; Rajala, Raju V. S.			Modulation of Mouse Rod Photoreceptor Responses by Grb14 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cyclic GMP (cGMP); Cyclic Nucleotides; Neurobiology; Photoreceptors; Receptor-tyrosine Kinase; Retina	RECEPTOR-BOUND PROTEIN-14; SINGLE-PHOTON RESPONSES; CGMP-PHOSPHODIESTERASE; GATED CHANNEL; LIGHT; INSULIN; SENSITIVITY; ACTIVATION; MICE; IDENTIFICATION	Previous experiments have indicated that growth factor receptor-bound protein 14 (Grb14) may modulate rod photoreceptor cGMP-gated channels by decreasing channel affinity for cGMP; however, the function of Grb14 in rod physiology is not known. In this study, we examined the role of Grb14 by recording electrical responses from rods in which the gene for the Grb14 protein had been deleted. Suction-electrode recordings from single mouse rods showed that responses of dark-adapted Grb14(-/-) mice to brief flashes decayed more rapidly than strain-controlled wild type (WT) rods, with decreased values of both integration time and the exponential time course of decay ((REC)). This result is consistent with an increase in channel affinity for cGMP produced by deletion of Grb14. However, Grb14(-/-) mouse rods also showed little change in dark current and a large and significant decrease in the limiting time constant (D), which are not consistent with an effect on channel affinity but seem rather to indicate modulation of the rate of inactivation of cyclic nucleotide phosphodiesterase 6 (PDE6). Grb14 has been reported to translocate from the inner to the outer segment in bright light, but we saw effects on response time course even in dark-adapted rods, although the effects were somewhat greater after rods had been adapted by exposure to bleaching illumination. Our results indicate that the mechanism of Grb14 action may be more complex than previously realized.	[Woodruff, Michael L.; Fain, Gordon L.] Univ Calif Los Angeles, Dept Integrat Biol & Physiol, Los Angeles, CA 90095 USA; [Rajala, Ammaji; Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Ophthalmol, Oklahoma City, OK 73104 USA; [Rajala, Raju V. S.] Univ Oklahoma, Hlth Sci Ctr, Dept Physiol, Oklahoma City, OK 73104 USA; [Fain, Gordon L.] Univ Calif Los Angeles, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Fain, Gordon L.] Univ Calif Los Angeles, Jules Stein Eye Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Rajala, RVS (corresponding author), Univ Oklahoma, Hlth Sci Ctr, 608 Stanton L Young Blvd, Oklahoma City, OK 73104 USA.	raju-rajala@ouhsc.edu		Fain, Gordon/0000-0002-9813-0342	National Institutes of Health/NEI [EY016507, EY00871, EY01844]; NATIONAL EYE INSTITUTE [R01EY001844, R01EY000871, R37EY001844, R01EY016507] Funding Source: NIH RePORTER	National Institutes of Health/NEI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	This work was supported, in whole or in part, by National Institutes of Health/NEI Grants EY016507 and EY00871 (to R. V. S. R.) and EY01844 (to G. L. F.).	Basavarajappa DK, 2011, MOL CELL BIOL, V31, P3975, DOI 10.1128/MCB.05659-11; Cariou B, 2004, FRONT BIOSCI-LANDMRK, V9, P1626, DOI 10.2741/1228; Chen CK, 2010, J PHYSIOL-LONDON, V588, P3231, DOI 10.1113/jphysiol.2010.191221; Chen CK, 2012, J NEUROSCI, V32, P15998, DOI 10.1523/JNEUROSCI.1639-12.2012; Chen CK, 2010, J NEUROSCI, V30, P1213, DOI 10.1523/JNEUROSCI.4353-09.2010; Chen J, 2010, J NEUROSCI, V30, P16232, DOI 10.1523/JNEUROSCI.2868-10.2010; Cooney GJ, 2004, EMBO J, V23, P582, DOI 10.1038/sj.emboj.7600082; Daly RJ, 1998, CELL SIGNAL, V10, P613, DOI 10.1016/S0898-6568(98)00022-9; Desbuquois B, 2013, FEBS J, V280, P794, DOI 10.1111/febs.12080; Fain GL, 2011, MOL NEUROBIOL, V44, P374, DOI 10.1007/s12035-011-8205-1; Field GD, 2002, NEURON, V35, P733, DOI 10.1016/S0896-6273(02)00822-X; Field GD, 2002, NEURON, V34, P773, DOI 10.1016/S0896-6273(02)00700-6; GORDON SE, 1995, J PHYSIOL-LONDON, V486, P533, DOI 10.1113/jphysiol.1995.sp020832; Gross OP, 2012, NEURON, V76, P370, DOI 10.1016/j.neuron.2012.07.029; Gupta VK, 2010, EMBO REP, V11, P861, DOI 10.1038/embor.2010.142; HSU YT, 1993, NATURE, V365, P279, DOI 10.1038/365279c0; KOUTALOS Y, 1995, J GEN PHYSIOL, V106, P891, DOI 10.1085/jgp.106.5.891; Krispel CM, 2006, NEURON, V51, P409, DOI 10.1016/j.neuron.2006.07.010; Li GY, 2007, J NEUROSCI, V27, P203, DOI 10.1523/JNEUROSCI.0445-06.2007; Lin RCY, 2010, ARTERIOSCL THROM VAS, V30, P724, DOI 10.1161/ATVBAHA.109.201988; Martemyanov KA, 2008, P NATL ACAD SCI USA, V105, P20988, DOI 10.1073/pnas.0808941106; NAKATANI K, 1995, J PHYSIOL-LONDON, V484, P69, DOI 10.1113/jphysiol.1995.sp020648; Nymark S, 2012, J PHYSIOL-LONDON, V590, P2353, DOI 10.1113/jphysiol.2012.228627; PEPPERBERG DR, 1992, VISUAL NEUROSCI, V8, P9, DOI 10.1017/S0952523800006441; PUGH EN, 1993, BIOCHIM BIOPHYS ACTA, V1141, P111, DOI 10.1016/0005-2728(93)90038-H; Rajala A, 2009, BIOCHEMISTRY-US, V48, P5563, DOI 10.1021/bi9000062; Rajala R. V., 2013, INVEST OPHTHALMOL VI, V54; Rajala RVS, 2010, J BIOL CHEM, V285, P8894, DOI 10.1074/jbc.M109.070854; Rajala RVS, 2005, BIOCHEMISTRY-US, V44, P7929, DOI 10.1021/bi0500271; Tsang SH, 2006, J NEUROSCI, V26, P4472, DOI 10.1523/JNEUROSCI.4775-05.2006; Woodruff ML, 2008, J NEUROSCI, V28, P2064, DOI 10.1523/JNEUROSCI.2973-07.2008; Woodruff ML, 2004, J PHYSIOL-LONDON, V557, P821, DOI 10.1113/jphysiol.2004.064014	32	10	10	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					358	364		10.1074/jbc.M113.517045	http://dx.doi.org/10.1074/jbc.M113.517045			7	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24273167	Green Published, hybrid			2022-12-25	WOS:000329370900031
J	Kanwar, N; Scott, HM; Norby, B; Loneragan, GH; Vinasco, J; McGowan, M; Cottell, JL; Chengappa, MM; Bai, JF; Boerlin, P				Kanwar, Neena; Scott, H. Morgan; Norby, Bo; Loneragan, Guy H.; Vinasco, Javier; McGowan, Matthew; Cottell, Jennifer L.; Chengappa, Muckatira M.; Bai, Jianfa; Boerlin, Patrick			Effects of Ceftiofur and Chlortetracycline Treatment Strategies on Antimicrobial Susceptibility and on tet(A), tet(B), and bla(CMY-2) Resistance Genes among E-coli Isolated from the Feces of Feedlot Cattle	PLOS ONE			English	Article							TETRACYCLINE RESISTANCE; ANTIBIOTIC-RESISTANCE; MOLECULAR CHARACTERIZATION; UNITED-STATES; FOOD ANIMALS; DAIRY-CATTLE; SALMONELLA; PREVALENCE; STRAINS; PLASMID	A randomized controlled field trial was conducted to evaluate the effects of two sets of treatment strategies on ceftiofur and tetracycline resistance in feedlot cattle. The strategies consisted of ceftiofur crystalline-free acid (CCFA) administered to either one or all of the steers within a pen, followed by feeding or not feeding a therapeutic dose of chlortetracycline (CTC). Eighty-eight steers were randomly allocated to eight pens of 11 steers each. Both treatment regimens were randomly assigned to the pens in a two-way full factorial design. Non-type-specific (NTS) E. coli (n = 1,050) were isolated from fecal samples gathered on Days 0, 4, 12, and 26. Antimicrobial susceptibility profiles were determined using a microbroth dilution technique. PCR was used to detect tet(A), tet(B), and bla(CMY-2) genes within each isolate. Chlortetracycline administration greatly exacerbated the already increased levels of both phenotypic and genotypic ceftiofur resistance conferred by prior CCFA treatment (P < 0.05). The four treatment regimens also influenced the phenotypic multidrug resistance count of NTS E. coli populations. Chlortetracycline treatment alone was associated with an increased probability of selecting isolates that harbored tet(B) versus tet(A) (P < 0.05); meanwhile, there was an inverse association between finding tet(A) versus tet(B) genes for any given regimen (P < 0.05). The presence of a tet(A) gene was associated with an isolate exhibiting reduced phenotypic susceptibility to a higher median number of antimicrobials (n = 289, median = 6; 95% CI = 4-8) compared with the tet(B) gene (n = 208, median = 3; 95% CI = 3-4). Results indicate that CTC can exacerbate ceftiofur resistance following CCFA therapy and therefore should be avoided, especially when considering their use in sequence. Further studies are required to establish the animal-level effects of co-housing antimicrobial-treated and non-treated animals together.	[Kanwar, Neena; Scott, H. Morgan; Vinasco, Javier; McGowan, Matthew; Chengappa, Muckatira M.; Bai, Jianfa] Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA; [Norby, Bo] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Loneragan, Guy H.] Texas Tech Univ, Int Ctr Food Ind Excellence, Dept Anim & Food Sci, Coll Agr & Nat resources, Lubbock, TX 79409 USA; [Cottell, Jennifer L.; Boerlin, Patrick] Univ Guelph, Ontario Vet Coll, Dept Pathobiol, Guelph, ON N1G 2W1, Canada	Kansas State University; Michigan State University; Texas Tech University System; Texas Tech University; University of Guelph	Norby, B (corresponding author), Kansas State Univ, Coll Vet Med, Dept Diagnost Med Pathobiol, Manhattan, KS 66506 USA.	hmscott@vet.k-state.edu	Bai, Jianfa/M-7830-2019	Bai, Jianfa/0000-0002-0021-3036; McGowan, Matthew/0000-0002-0745-8140; Scott, Harvey/0000-0002-0538-5961	Agriculture and Food Research Initiative [2008-35201-30235, 2008-35201-04682]; United States Department of Agriculture, National Institute of Food and Agriculture; National Integrated Food Safety Initiative [2010-51110-21083]	Agriculture and Food Research Initiative; United States Department of Agriculture, National Institute of Food and Agriculture(United States Department of Agriculture (USDA)); National Integrated Food Safety Initiative	The field trial was funded by United States Department of Agriculture, National Institute of Food and Agriculture (http://www.nifa.usda.gov/), Agriculture and Food Research Initiative grant numbers: 2008-35201-30235 and 2008-35201-04682). The subsequent phenotypic and genotypic analysis of E. coli isolates was funded by United States Department of Agriculture, National Institute of Food and Agriculture (http://www.nifa.usda.gov/), National Integrated Food Safety Initiative grant number: 2010-51110-21083. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akwar HT, 2008, CAN J VET RES, V72, P202; Alali WQ, 2009, FOODBORNE PATHOG DIS, V6, P917, DOI 10.1089/fpd.2009.0271; Alcaine SD, 2005, ANTIMICROB AGENTS CH, V49, P4061, DOI 10.1128/AAC.49.10.4061-4067.2005; Angulo FJ, 2004, J VET MED B, V51, P374, DOI 10.1111/j.1439-0450.2004.00789.x; [Anonymous], 2012, CRIT IMP ANT HUM MED; Blake DP, 2003, J APPL MICROBIOL, V94, P1087, DOI 10.1046/j.1365-2672.2003.01937.x; Boyer TC, 2012, FOODBORNE PATHOG DIS, V9, P1022, DOI 10.1089/fpd.2012.1198; Bryan A, 2004, APPL ENVIRON MICROB, V70, P2503, DOI 10.1128/AEM.70.4.2503-2507.2004; Carattoli A, 2002, ANTIMICROB AGENTS CH, V46, P1269, DOI 10.1128/AAC.46.5.1269-1272.2002; Clinical and Laboratory Standards Institute, 2011, M100S21 CLSI; Cottell JL, 2013, ANTIMICROB AGENTS CH, V57, P1096, DOI 10.1128/AAC.01750-12; Cottell JL, 2012, ANTIMICROB AGENTS CH, V56, P4703, DOI 10.1128/AAC.00848-12; Donaldson SC, 2006, APPL ENVIRON MICROB, V72, P3940, DOI 10.1128/AEM.02770-05; Doyle MP, 2013, COMPR REV FOOD SCI F, V12, P234, DOI 10.1111/1541-4337.12008; Fey PD, 2000, NEW ENGL J MED, V342, P1242, DOI 10.1056/NEJM200004273421703; Folster JP, 2012, FOODBORNE PATHOG DIS, V9, P638, DOI 10.1089/fpd.2012.1130; Frye JG, 2007, INT J ANTIMICROB AG, V30, P134, DOI 10.1016/j.ijantimicag.2007.03.013; Gow SP, 2008, APPL ENVIRON MICROB, V74, P3658, DOI 10.1128/AEM.02505-07; Grave K, 2006, PREV VET MED, V75, P123, DOI 10.1016/j.prevetmed.2006.02.003; Harvey R, 2009, AM J VET RES, V70, P198, DOI 10.2460/ajvr.70.2.198; Hesketh SR, 2008, MULTILEVEL LONGITUDI, P331; Hidalgo A, 2009, RES VET SCI, V87, P7, DOI 10.1016/j.rvsc.2008.10.017; Hidalgo A, 2011, ANTIMICROB AGENTS CH, V55, P3330, DOI 10.1128/AAC.01749-10; HOSMER DW, 2000, WILEY PS TX, P1; JONES CS, 1992, MOL CELL PROBE, V6, P313, DOI 10.1016/0890-8508(92)90007-K; Lamb HM, 2002, DRUGS, V62, P1041, DOI 10.2165/00003495-200262070-00005; Levin BR, 1999, SCIENCE, V283, P806, DOI 10.1126/science.283.5403.806; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Lipsitch M, 2000, P NATL ACAD SCI USA, V97, P1938, DOI 10.1073/pnas.97.4.1938; Lowrance TC, 2007, AM J VET RES, V68, P501, DOI 10.2460/ajvr.68.5.501; LYONS RW, 1980, JAMA-J AM MED ASSOC, V243, P546, DOI 10.1001/jama.243.6.546; Mann S, 2011, FOODBORNE PATHOG DIS, V8, P861, DOI 10.1089/fpd.2010.0751; *NAT ANT RES MON S, 2009, NAT ANT RES MON SYST; National Academy of Sciences, 1999, US DRUGS FOOD AN BEN; Ng LK, 2001, MOL CELL PROBE, V15, P209, DOI 10.1006/mcpr.2001.0363; Norby B, 2011, 4 S ANT RES AN ENV T, P31; O'Connor AM, 2002, CAN J VET RES, V66, P145; Odeh R, 2002, CLIN INFECT DIS, V35, P140, DOI 10.1086/340742; Oliver SP, 2011, FOODBORNE PATHOG DIS, V8, P337, DOI 10.1089/fpd.2010.0730; Platt TM, 2008, AM J VET RES, V69, P988, DOI 10.2460/ajvr.69.8.988; Rankin SC, 2002, J CLIN MICROBIOL, V40, P4679, DOI 10.1128/JCM.40.12.4679-4684.2002; Rollo SN, 2010, JAVMA-J AM VET MED A, V236, P201, DOI 10.2460/javma.236.2.201; Schmidt JW, 2013, APPL ENVIRON MICROB, V79, P2273, DOI 10.1128/AEM.03592-12; Sengelov G, 2003, VET MICROBIOL, V95, P91, DOI 10.1016/S0378-1135(03)00123-8; Singer RS, 2008, APPL ENVIRON MICROB, V74, P6956, DOI 10.1128/AEM.01241-08; Stegeman JA, 2006, PREV VET MED, V74, P56, DOI 10.1016/j.prevetmed.2006.01.007; Sun ZZ, 2013, CELL PHYSIOL BIOCHEM, V31, P347, DOI 10.1159/000343372; Tragesser LA, 2006, AM J VET RES, V67, P1696, DOI 10.2460/ajvr.67.10.1696; U. S. Food and drug Administration, 2005, WITHDR APPR NEW AN D; van den Bogaard AE, 1999, DRUGS, V58, P589, DOI 10.2165/00003495-199958040-00002; Wierup M, 2001, MICROB DRUG RESIST, V7, P183, DOI 10.1089/10766290152045066; WILLETT JB, 1993, J CONSULT CLIN PSYCH, V61, P952, DOI 10.1037/0022-006X.61.6.952; Winokur PL, 2000, ANTIMICROB AGENTS CH, V44, P2777, DOI 10.1128/AAC.44.10.2777-2783.2000; World Health Organization, 2001, WHO GLOB STRAT CONT	54	49	48	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80575	10.1371/journal.pone.0080575	http://dx.doi.org/10.1371/journal.pone.0080575			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260423	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900073
J	Wang, QZ; Gao, CL; Wang, HC; Lang, LL; Yue, T; Lin, HL				Wang, Qinzhou; Gao, Cuilian; Wang, Hongchun; Lang, Lingling; Yue, Tao; Lin, Hualiang			Ischemic Stroke Hospital Admission Associated with Ambient Temperature in Jinan, China	PLOS ONE			English	Article							CORONARY-HEART-DISEASE; RED-CELL COUNTS; AIR-POLLUTION; BLOOD-VISCOSITY; COLD WEATHER; MORTALITY; RISK; PRESSURE; CLIMATE; INFARCTION	Background: This study estimated the effects of ambient temperature and relative humidity on hospital admissions for ischemic stroke during 1990-2009 in Jinan, China. Methods: To account for possible delayed effects and harvesting effect, we examined the impact of meteorological factors up to 30 days before each admission using a distributed lag non-linear model; we controlled for season, long-term trend, day of week and public holidays in the analysis. Stratified analyses were also done for summer and winter. Results: A total of 1,908 ischemic stroke hospital admissions were observed between 1990 and 2009. We found a strong non-linear acute effect of daily temperatures on ischemic stroke hospital admission. With the mean temperature 15 degrees C as the reference, the relative risk (RR) was 1.43 (95% confidence interval (CI): 1.10-1.85) for 0 degrees C daily temperature on the same day, and 0.43 (95% CI: 0.31-0.59) for 30 degrees C daily temperature on the same day, respectively. The effect of ambient temperature was similar in summer and winter. No significant association was observed between relative humidity and ischemic stroke hospitalization. Conclusions: Low temperature might be a risk factor for ischemic stroke, and high temperature might be protective factor of ischemic stroke occurrence in Jinan, China.	[Wang, Qinzhou] Shandong Univ, Qilu Hosp, Dept Neurol, Jinan 250100, Peoples R China; [Gao, Cuilian; Wang, Hongchun] Shandong Univ, Qilu Hosp, Jinan 250100, Peoples R China; [Lang, Lingling; Lin, Hualiang] Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China; [Yue, Tao] Zibo Ctr Hosp, Cadre Hlth Care Dept, Zibo, Peoples R China	Shandong University; Shandong University; Chinese Center for Disease Control & Prevention; Guangdong Provincial Center for Disease Control & Prevention	Lin, HL (corresponding author), Guangdong Prov Ctr Dis Control & Prevent, Guangdong Prov Inst Publ Hlth, Guangzhou, Guangdong, Peoples R China.	linhualiang2002@163.com	Lin, Hualiang/E-6622-2010	Lin, Hualiang/0000-0002-2462-5158	National Major Research Program of China [2012CB955500]	National Major Research Program of China	The study was supported by National Major Research Program of China (Ref. No. 2012CB955500). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Analitis A, 2008, AM J EPIDEMIOL, V168, P1397, DOI 10.1093/aje/kwn266; BERGINER VM, 1989, STROKE, V20, P65, DOI 10.1161/01.STR.20.1.65; Chang CL, 2004, J CLIN EPIDEMIOL, V57, P749, DOI 10.1016/j.jclinepi.2003.10.016; CHEN ZY, 1995, STROKE, V26, P569, DOI 10.1161/01.STR.26.4.569; Dawson J, 2008, ACTA NEUROL SCAND, V117, P85, DOI 10.1111/j.1600-0404.2007.00916.x; Donaldson GC, 1997, BRIT MED J, V315, P1055, DOI 10.1136/bmj.315.7115.1055; Ebi KL, 2004, INT J BIOMETEOROL, V49, P48, DOI 10.1007/s00484-004-0207-5; Feigin VL, 2000, EUR J NEUROL, V7, P171, DOI 10.1046/j.1468-1331.2000.00016.x; Field TS, 2002, STROKE, V33, P1751, DOI 10.1161/01.STR.0000020384.92499.59; Gasparrini A, 2010, STAT MED, V29, P2224, DOI 10.1002/sim.3940; Gasparrini A, 2012, OCCUP ENVIRON MED, V69, P56, DOI 10.1136/oem.2010.059782; Gasparrini A, 2011, J STAT SOFTW, V43, P1, DOI 10.18637/jss.v043.i08; Gasparrini A, 2010, ENVIRON RES, V110, P633, DOI 10.1016/j.envres.2010.06.005; Geng L, 2012, CHINESE MED RECORD, V13, P31; Goggins W, 2011, INT J BIOMETEOROL, P1; Goldberg MS, 2011, ENVIRON RES, V111, P853, DOI 10.1016/j.envres.2011.05.022; Guo YM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016511; Ha J, 2012, INT J BIOMETEOROL, P1; Hong YC, 2003, EPIDEMIOLOGY, V14, P473, DOI 10.1097/01.ede.0000078420.82023.e3; Hong YC, 2002, STROKE, V33, P2165, DOI 10.1161/01.STR.0000026865.52610.5B; Hori A, 2012, INT J ENVIRON HEAL R, V22, P416, DOI 10.1080/09603123.2011.650155; Ishigami A, 2008, ENV HLTH, V7, P1; Jia Q, 2010, CLIN EXP PHARMACOL P, V37, P259, DOI 10.1111/j.1440-1681.2009.05290.x; Kalkstein LS, 1997, ENVIRON HEALTH PERSP, V105, P84, DOI 10.1289/ehp.9710584; KEATINGE WR, 1984, BMJ-BRIT MED J, V289, P1405, DOI 10.1136/bmj.289.6456.1405; KEATINGE WR, 1986, AM J MED, V81, P795, DOI 10.1016/0002-9343(86)90348-7; Kyobutungi C, 2005, EUR J EPIDEMIOL, V20, P693, DOI 10.1007/s10654-005-0703-x; Kysely J, 2009, CLIM RES, V38, P105, DOI 10.3354/cr00775; Lavallee P, 2002, STROKE, V33, P513, DOI 10.1161/hs0202.102328; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Lim Y-K, 2012, INT J BIOMETEOROL, P1; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068417; Lin HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065585; Lin HJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0066403, 10.1371/journal.pone.0066661]; Lisabeth LD, 2008, ANN NEUROL, V64, P53, DOI 10.1002/ana.21403; Liu Fang, 2004, Zhonghua Liu Xing Bing Xue Za Zhi, V25, P962; Ma WJ, 2011, EPIDEMIOLOGY, V22, pS17, DOI 10.1097/01.ede.0000391707.80682.21; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; McArthur K, 2010, EXPERT REV NEUROTHER, V10, P243, DOI 10.1586/ERN.09.154; Mechtouff L, 2012, INT J STROKE; Medina-Ramon M, 2006, ENVIRON HEALTH PERSP, V114, P1331, DOI 10.1289/ehp.9074; Nyquist PA, 2001, NEUROLOGY, V56, P190, DOI 10.1212/WNL.56.2.190; PAN WH, 1995, LANCET, V345, P353, DOI 10.1016/S0140-6736(95)90341-0; Peng RD, 2006, J R STAT SOC A STAT, V169, P179, DOI 10.1111/j.1467-985X.2006.00410.x; Tian L, 2013, AM J RESP CRIT CARE; Wang XY, 2009, INT J BIOMETEOROL, V53, P535, DOI 10.1007/s00484-009-0241-4; Widlansky ME, 2007, AM J CARDIOL, V100, P518, DOI 10.1016/j.amjcard.2007.03.055; WOODHOUSE PR, 1993, J HYPERTENS, V11, P1267; World Health Organization, 2004, WORLD HLTH REP 2004; Yang L, 2008, APPL ENERG, V85, P800, DOI 10.1016/j.apenergy.2007.11.002	50	31	31	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80381	10.1371/journal.pone.0080381	http://dx.doi.org/10.1371/journal.pone.0080381			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260379	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900065
J	Xi, D; Roizen, J; Lai, MZ; Gandhi, N; Kublaoui, B				Xi, Dong; Roizen, Jeff; Lai, Meizan; Gandhi, Nilay; Kublaoui, Bassil			Paraventricular Nucleus Sim1 Neuron Ablation Mediated Obesity Is Resistant to High Fat Diet	PLOS ONE			English	Article							HYPOTHALAMIC GALANIN; HYPERPHAGIC OBESITY; MC4 RECEPTOR; BODY-WEIGHT; FOOD-INTAKE	Single minded 1 (SIM1) is a transcription factor involved in brain patterning and control of energy balance. In humans, haploinsufficiency of SIM1 causes early-onset obesity. Mice deficient in the homologous gene, SIM1, also exhibit early onset obesity and increased sensitivity to a high fat diet. SIM1 is expressed in several areas of the brain implicated in control of energy balance including the paraventricular nucleus (PVN), the supraoptic nucleus (SON), the medial amygdala and nucleus of the lateral olfactory tract. We have previously shown that mice with global Sim1 neuron ablation exhibit obesity with hyperphagia as the primary defect. The PVN has a critical role in feeding and in high-fat appetite, thus, we sought to determine the effect of Sim1 neuron ablation limited to the PVN. We achieved PVN-SIM1 limited ablation through stereotactic injection of diphtheria toxin into the PVN of Sim1Cre-iDTR mice. The specificity of this ablation was confirmed by immunohistochemistry and quantitative real time PCR of the PVN, supraoptic nucleus and the amygdala. Mice with PVN Sim1 neuron ablation, similar to mice with global Sim1 neuron ablation, exhibit early onset obesity with hyperphagia as the primary defect. However, PVN-Sim1 neuron ablated mice have a decreased response to fasting-induced hyperphagia. Consistent with this decrement, PVN-Sim1 neuron ablated mice have a decreased hyperphagic response to PVN injection of agouti-related peptide (AgRP). When PVN-Sim1 neuron ablated mice are placed on a high fat diet, surprisingly, their intake decreases and they actually lose weight. When allowed ad lib access to high fat diet and normal chow simultaneously, PVN-Sim1 neuron ablated mice exhibit overall decreased intake. That is, in PVN-Sim1 neuron ablated mice, access to fat suppresses overall appetite.	[Xi, Dong; Roizen, Jeff; Lai, Meizan; Gandhi, Nilay; Kublaoui, Bassil] Univ Penn, Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Perelman Sch Med, Philadelphia, PA 19104 USA	University of Pennsylvania; Pennsylvania Medicine; Childrens Hospital of Philadelphia	Roizen, J (corresponding author), Univ Penn, Childrens Hosp Philadelphia, Div Endocrinol & Diabet, Perelman Sch Med, Philadelphia, PA 19104 USA.	roizenj@chop.edu	Roizen, Jeffrey/J-5050-2012	Roizen, Jeffrey/0000-0002-3384-6200	National Institutes of Health [NIH T32-HD043021]; DRC at the University of Pennsylvania; NIH [DK 19525]; National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health [UL1TR000003]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [T32HD043021] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000003] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K12DK094723, P30DK019525] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DRC at the University of Pennsylvania; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The project described was supported by the National Institutes of Health through NIH T32-HD043021 and a pilot award from the DRC at the University of Pennsylvania from a grant sponsored by NIH DK 19525 as well as the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant UL1TR000003. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929; Atasoy D, 2012, NATURE, V488, P172, DOI 10.1038/nature11270; Balthasar N, 2005, CELL, V123, P493, DOI 10.1016/j.cell.2005.08.035; Boghossian S, 2010, AM J PHYSIOL-REG I, V298, pR385, DOI 10.1152/ajpregu.00591.2009; Chen SS, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0050456, 10.1371/journal.pone.0036784, 10.1371/journal.pone.0049275, 10.1371/journal.pone.0045763]; Clapham JC, 2012, NEUROPHARMACOLOGY, V63, P111, DOI 10.1016/j.neuropharm.2011.10.014; de Backer MWA, 2011, INT J OBESITY, V35, P629, DOI 10.1038/ijo.2010.169; Foster AC, 2003, ANN NY ACAD SCI, V994, P103, DOI 10.1111/j.1749-6632.2003.tb03168.x; Garza JC, 2008, J ENDOCRINOL, V197, P471, DOI 10.1677/JOE-08-0009; Holder JL, 2004, AM J PHYSIOL-ENDOC M, V287, pE105, DOI 10.1152/ajpendo.00446.2003; Jo YH, 2009, AM J PHYSIOL-ENDOC M, V297, pE563, DOI 10.1152/ajpendo.00064.2009; Kublaoui BM, 2008, MOL ENDOCRINOL, V22, P1723, DOI 10.1210/me.2008-0067; Kublaoui BM, 2006, MOL ENDOCRINOL, V20, P2483, DOI 10.1210/me.2005-0483; Kublaoui BM, 2006, ENDOCRINOLOGY, V147, P4542, DOI 10.1210/en.2006-0453; Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456; Leibowitz SF, 2005, NEUROPEPTIDES, V39, P327, DOI 10.1016/j.npep.2004.12.022; Leibowitz SF, 1998, J NEUROSCI, V18, P2709; Lu XY, 2003, J NEUROSCI, V23, P7863; Melnick I, 2007, NEURON, V56, P1103, DOI 10.1016/j.neuron.2007.10.034; Michaud JL, 1998, GENE DEV, V12, P3264, DOI 10.1101/gad.12.20.3264; Michaud JL, 2001, HUM MOL GENET, V10, P1465, DOI 10.1093/hmg/10.14.1465; Olszewski PK, 2001, AM J PHYSIOL-REG I, V281, pR673, DOI 10.1152/ajpregu.2001.281.2.R673; Sanchez E, 2008, ENDOCRINOLOGY, V149, P4329, DOI 10.1210/en.2008-0411; Siljee-Wong JE, 2011, EUR J PHARMACOL, V660, P234, DOI 10.1016/j.ejphar.2010.10.104; SIMS JS, 1986, BEHAV BRAIN RES, V22, P265, DOI 10.1016/0166-4328(86)90071-9; Srisai D, 2011, ENDOCRINOLOGY, V152, P890, DOI 10.1210/en.2010-0716; Sutton GM, 2005, ENDOCRINOLOGY, V146, P3739, DOI 10.1210/en.2005-0562; Tolson KP, 2010, J NEUROSCI, V30, P3803, DOI 10.1523/JNEUROSCI.5444-09.2010; Tung YCL, 2007, ENDOCRINOLOGY, V148, P5331, DOI 10.1210/en.2007-0797; Will MJ, 2003, J NEUROSCI, V23, P2882; Xi D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036453; Xi D, 2011, NEUROPSYCHOPHARMACOL, V36, P1260, DOI 10.1038/npp.2011.12; Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073	33	10	11	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81087	10.1371/journal.pone.0081087	http://dx.doi.org/10.1371/journal.pone.0081087			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260538	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900115
J	Sakamoto, K; Wakabayashi, Y; Yamamura, T; Tanaka, T; Takeuchi, Y; Mori, Y; Okamura, H				Sakamoto, Kohei; Wakabayashi, Yoshihiro; Yamamura, Takashi; Tanaka, Tomomi; Takeuchi, Yukari; Mori, Yuji; Okamura, Hiroaki			A Population of Kisspeptin/Neurokinin B Neurons in the Arcuate Nucleus May Be the Central Target of the Male Effect Phenomenon in Goats	PLOS ONE			English	Article							HORMONE PULSE-GENERATOR; MALE EFFECT PHEROMONE; NEUROKININ B; STRIA TERMINALIS; ELECTROPHYSIOLOGICAL MANIFESTATION; HYPOGONADOTROPIC HYPOGONADISM; DIFFERENTIAL PROJECTIONS; KISSPEPTIN NEURONS; NEUROPEPTIDE-Y; MEDIAL NUCLEUS	Exposure of females to a male pheromone accelerates pulsatile gonadotropin-releasing hormone (GnRH) secretion in goats. Recent evidence has suggested that neurons in the arcuate nucleus (ARC) containing kisspeptin and neurokinin B (NKB) play a pivotal role in the control of GnRH secretion. Therefore, we hypothesized that these neurons may be the central target of the male pheromone. To test this hypothesis, we examined whether NKB signaling is involved in the pheromone action, and whether ARC kisspeptin/NKB neurons receive input from the medial nucleus of the amygdala (MeA)-the nucleus suggested to relay pheromone signals. Ovariectomized goats were implanted with a recording electrode aimed at a population of ARC kisspeptin/NKB neurons, and GnRH pulse generator activity, represented by characteristic increases in multiple-unit activity (MUA) volleys, was measured. Pheromone exposure induced an MUA volley and luteinizing hormone (LH) pulse in control animals, whereas the MUA and LH responses to the pheromone were completely suppressed by the treatment with an NKB receptor antagonist. These results indicate that NKB signaling is a prerequisite for pheromone action. In ovariectomized goats, an anterograde tracer was injected into the MeA, and possible connections between the MeA and ARC kisspeptin/NKB neurons were examined. Histochemical observations demonstrated that a subset of ARC kisspeptin/NKB neurons receive efferent projections from the MeA. These results suggest that the male pheromone signal is conveyed via the MeA to ARC kisspeptin neurons, wherein the signal stimulates GnRH pulse generator activity through an NKB signaling-mediated mechanism in goats.	[Sakamoto, Kohei; Takeuchi, Yukari; Mori, Yuji] Univ Tokyo, Lab Vet Ethol, Tokyo, Japan; [Sakamoto, Kohei; Wakabayashi, Yoshihiro; Yamamura, Takashi; Okamura, Hiroaki] Natl Inst Agrobiol Sci, Neurobiol Lab, Ibaraki, Japan; [Tanaka, Tomomi] Tokyo Univ Agr & Technol, Lab Vet Reprod, Tokyo, Japan	University of Tokyo; National Institute of Agrobiological Sciences - Japan; Tokyo University of Agriculture & Technology	Okamura, H (corresponding author), Natl Inst Agrobiol Sci, Neurobiol Lab, Ibaraki, Japan.	hokamu@affrc.go.jp	Tanaka, Tomomi/H-6397-2013		Japan Society for the Promotion of Science [21228006]	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This study was supported by a Grant-in-Aid for Scientific Research (S) (21228006) from the Japan Society for the Promotion of Science. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Delgadillo JA, 2009, BEHAV BRAIN RES, V200, P304, DOI 10.1016/j.bbr.2009.02.004; Almeida TA, 2004, CURR MED CHEM, V11, P2045, DOI 10.2174/0929867043364748; Amstalden M, 2010, J NEUROENDOCRINOL, V22, P1, DOI 10.1111/j.1365-2826.2009.01930.x; Backholer K, 2010, ENDOCRINOLOGY, V151, P2233, DOI 10.1210/en.2009-1190; BELTRAMINO C, 1978, BRAIN RES, V144, P95, DOI 10.1016/0006-8993(78)90437-7; Billings HJ, 2010, ENDOCRINOLOGY, V151, P3836, DOI 10.1210/en.2010-0174; Brennan PA, 2001, CELL MOL LIFE SCI, V58, P546, DOI 10.1007/PL00000880; CANTERAS NS, 1995, J COMP NEUROL, V360, P213, DOI 10.1002/cne.903600203; CHEMINEAU P, 1987, LIVEST PROD SCI, V17, P135, DOI 10.1016/0301-6226(87)90059-5; CLAUS R, 1990, ANIM REPROD SCI, V22, P27, DOI 10.1016/0378-4320(90)90035-E; De Bond JA, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0057972, DOI 10.1371/J0URNAL.P0NE.0057972.PUBMED:23469121]; de Roux N, 2003, P NATL ACAD SCI USA, V100, P10972, DOI 10.1073/pnas.1834399100; Dong HW, 2006, J COMP NEUROL, V494, P75, DOI 10.1002/cne.20790; Gelez H, 2006, NEUROSCIENCE, V140, P791, DOI 10.1016/j.neuroscience.2006.02.066; Gelez H, 2004, HORM BEHAV, V46, P257, DOI 10.1016/j.yhbeh.2004.05.002; GOMEZ DM, 1992, J COMP NEUROL, V317, P195, DOI 10.1002/cne.903170208; Goodman RL, 2007, ENDOCRINOLOGY, V148, P5752, DOI 10.1210/en.2007-0961; Goodman RL, 2012, ENDOCRINOLOGY, V153, P5918, DOI 10.1210/en.2012-1611; Hamada T, 1996, NEUROENDOCRINOLOGY, V64, P313, DOI 10.1159/000127134; Ichimaru T, 2008, ANIM REPROD SCI, V106, P361, DOI 10.1016/j.anireprosci.2007.05.012; Ichimaru T, 2001, ENDOCRINOLOGY, V142, P2489, DOI 10.1210/en.142.6.2489; Iwata E, 2000, BIOL REPROD, V62, P806, DOI 10.1095/biolreprod62.3.806; Kakuma Y, 2007, J REPROD DEVELOP, V53, P829, DOI 10.1262/jrd.19013; KANO Y, 1977, Experimental Animals (Tokyo), V26, P239; Karsch F.J., 1984, REPROD MAMMALS BOOK, V2nd, P1; KEVERNE EB, 1983, TRENDS NEUROSCI, V6, P381, DOI 10.1016/0166-2236(83)90170-4; Kinsey-Jones JS, 2008, ENDOCRINOLOGY, V149, P1004, DOI 10.1210/en.2007-1505; KNIGHT TW, 1980, ANIM REPROD SCI, V3, P133, DOI 10.1016/0378-4320(80)90040-8; KNOBIL E, 1981, BIOL REPROD, V24, P44, DOI 10.1095/biolreprod24.1.44; Krajewski SJ, 2010, NEUROSCIENCE, V166, P680, DOI 10.1016/j.neuroscience.2009.12.053; Lehman MN, 2010, ENDOCRINOLOGY, V151, P3479, DOI 10.1210/en.2010-0022; LEHMAN MN, 1982, BRAIN RES, V240, P27, DOI 10.1016/0006-8993(82)90641-2; LEHMAN MN, 1980, SCIENCE, V210, P557, DOI 10.1126/science.7423209; LI CS, 1990, NEUROSCIENCE, V36, P773, DOI 10.1016/0306-4522(90)90019-Z; Maeda K, 2010, BRAIN RES, V1364, P103, DOI 10.1016/j.brainres.2010.10.026; MARTIN GB, 1986, LIVEST PROD SCI, V15, P219, DOI 10.1016/0301-6226(86)90031-X; Matsuyama S, 2005, NEUROSCI LETT, V383, P289, DOI 10.1016/j.neulet.2005.04.026; MORI Y, 1991, NEUROENDOCRINOLOGY, V53, P392, DOI 10.1159/000125746; Murata K, 2011, J REPROD DEVELOP, V57, P197, DOI 10.1262/jrd.10-070E; Navarro VM, 2011, AM J PHYSIOL-ENDOC M, V300, pE202, DOI 10.1152/ajpendo.00517.2010; Navarro VM, 2009, J NEUROSCI, V29, P11859, DOI 10.1523/JNEUROSCI.1569-09.2009; NISHIHARA M, 1991, NEUROENDOCRINOLOGY, V54, P321, DOI 10.1159/000125909; Noritake K, 2011, J REPROD DEVELOP, V57, P409, DOI 10.1262/jrd.11-002S; Oakley AE, 2009, ENDOCR REV, V30, P713, DOI 10.1210/er.2009-0005; OBYRNE KT, 1993, NEUROENDOCRINOLOGY, V57, P588, DOI 10.1159/000126411; Ohara H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-233; Ohkura S, 2009, J NEUROENDOCRINOL, V21, P813, DOI 10.1111/j.1365-2826.2009.01909.x; Okamura H, 2010, J NEUROENDOCRINOL, V22, P825, DOI 10.1111/j.1365-2826.2010.02037.x; Pompolo S, 2005, NEUROSCIENCE, V132, P421, DOI 10.1016/j.neuroscience.2004.12.042; Pompolo S, 2001, BRAIN RES, V904, P1, DOI 10.1016/S0006-8993(01)02372-1; Ramaswamy S, 2010, ENDOCRINOLOGY, V151, P4494, DOI 10.1210/en.2010-0223; Rance NE, 2010, BRAIN RES, V1364, P116, DOI 10.1016/j.brainres.2010.08.059; Roseweir AK, 2009, J NEUROSCI, V29, P3920, DOI 10.1523/JNEUROSCI.5740-08.2009; Sakamoto K, 2012, J REPROD DEVELOP, V58, P700, DOI 10.1262/jrd.2011-038; SCALIA F, 1975, J COMP NEUROL, V161, P31, DOI 10.1002/cne.901610105; SCHINCKEL PG, 1954, AUST J AGR RES, V5, P465, DOI 10.1071/AR9540465; Seminara SB, 2003, NEW ENGL J MED, V349, P1614, DOI 10.1056/NEJMoa035322; SIGNORET JP, 1982, RECHERCHE, V13, P512; Smith JT, 2011, ENDOCRINOLOGY, V152, P1001, DOI 10.1210/en.2010-1225; Suganuma C, 2007, ANIM REPROD SCI, V101, P285, DOI 10.1016/j.anireprosci.2006.09.015; Topaloglu AK, 2009, NAT GENET, V41, P354, DOI 10.1038/ng.306; Wakabayashi Y, 2002, CHEM SENSES, V27, P207, DOI 10.1093/chemse/27.3.207; Wakabayashi Y, 42 ANN M SOC NEUR NE; Wakabayashi Y, 2013, J REPROD DEVELOP, V59, P40; Wakabayashi Y, 2010, J NEUROSCI, V30, P3124, DOI 10.1523/JNEUROSCI.5848-09.2010; WALKDENBROWN SW, 1993, ANIM REPROD SCI, V32, P41, DOI 10.1016/0378-4320(93)90056-W; WATSON RE, 1986, PEPTIDES, V7, P155, DOI 10.1016/0196-9781(86)90076-8; ZUCCOLILLI GO, 1995, J VET MED SCI, V57, P459, DOI 10.1292/jvms.57.459	68	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81017	10.1371/journal.pone.0081017	http://dx.doi.org/10.1371/journal.pone.0081017			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260530	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500191
J	Taylor, D; Cawley, G; Hayward, S				Taylor, Daniel; Cawley, Gavin; Hayward, Steven			Classification of Domain Movements in Proteins Using Dynamic Contact Graphs	PLOS ONE			English	Article							CONFORMATIONAL-CHANGE; STRUCTURAL-CHANGE; MOTIONS; DATABASE	A new method for the classification of domain movements in proteins is described and applied to 1822 pairs of structures from the Protein Data Bank that represent a domain movement in two-domain proteins. The method is based on changes in contacts between residues from the two domains in moving from one conformation to the other. We argue that there are five types of elemental contact changes and that these relate to five model domain movements called: "free'', "open-closed'', "anchored'', "sliding-twist'', and "see-saw.'' A directed graph is introduced called the "Dynamic Contact Graph'' which represents the contact changes in a domain movement. In many cases a graph, or part of a graph, provides a clear visual metaphor for the movement it represents and is a motif that can be easily recognised. The Dynamic Contact Graphs are often comprised of disconnected subgraphs indicating independent regions which may play different roles in the domain movement. The Dynamic Contact Graph for each domain movement is decomposed into elemental Dynamic Contact Graphs, those that represent elemental contact changes, allowing us to count the number of instances of each type of elemental contact change in the domain movement. This naturally leads to sixteen classes into which the 1822 domain movements are classified.	[Taylor, Daniel; Cawley, Gavin; Hayward, Steven] Univ E Anglia, Sch Comp Sci, DArcy Thompson Ctr Computat Biol, Norwich NR4 7TJ, Norfolk, England	University of East Anglia	Hayward, S (corresponding author), Univ E Anglia, Sch Comp Sci, DArcy Thompson Ctr Computat Biol, Norwich NR4 7TJ, Norfolk, England.	sjh@cmp.uea.ac.uk		Cawley, Gavin/0000-0002-4118-9095; hayward, steven/0000-0001-6959-2604				Amemiya T, 2012, NUCLEIC ACIDS RES, V40, pD554, DOI 10.1093/nar/gkr966; Amemiya T, 2011, J MOL BIOL, V408, P568, DOI 10.1016/j.jmb.2011.02.058; BENNETT WS, 1984, CRC CR REV BIOCH MOL, V15, P291, DOI 10.3109/10409238409117796; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Brylinski M, 2008, PROTEINS, V70, P363, DOI 10.1002/prot.21510; George RA, 2002, PROTEIN ENG, V15, P871, DOI 10.1093/protein/15.11.871; GERSTEIN M, 1993, J MOL BIOL, V234, P357, DOI 10.1006/jmbi.1993.1592; GERSTEIN M, 1994, BIOCHEMISTRY-US, V33, P6739, DOI 10.1021/bi00188a001; Gerstein M, 1998, NUCLEIC ACIDS RES, V26, P4280, DOI 10.1093/nar/26.18.4280; Gutteridge A, 2005, J MOL BIOL, V346, P21, DOI 10.1016/j.jmb.2004.11.013; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.0.CO;2-N; Hayward S, 1999, PROTEINS, V36, P425, DOI 10.1002/(SICI)1097-0134(19990901)36:4<425::AID-PROT6>3.3.CO;2-J; Hayward S, 2002, J MOL GRAPH MODEL, V21, P181, DOI 10.1016/S1093-3263(02)00140-7; Hayward S, 1997, PROTEINS, V27, P425, DOI 10.1002/(SICI)1097-0134(199703)27:3<425::AID-PROT10>3.0.CO;2-N; Koike R, 2008, J MOL BIOL, V379, P397, DOI 10.1016/j.jmb.2008.04.019; Poornam GP, 2009, PROTEINS, V76, P201, DOI 10.1002/prot.22339; Qi GY, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-13; Qi GY, 2005, BIOINFORMATICS, V21, P2832, DOI 10.1093/bioinformatics/bti420; Schulz GE, 1991, CURR OPIN STRUC BIOL, V1, P883, DOI 10.1016/0959-440X(91)90082-5; Sinha N, 2001, STRUCTURE, V9, P1165, DOI 10.1016/S0969-2126(01)00687-6	20	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81224	10.1371/journal.pone.0081224	http://dx.doi.org/10.1371/journal.pone.0081224			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260562	Green Accepted, Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500202
J	Wang, GR; Yu, X; Liang, Q; Chen, ST; Wilson, S; Huang, HR				Wang, Guirong; Yu, Xia; Liang, Qian; Chen, Suting; Wilson, Stuart; Huang, Hairong			Evaluation of a Simple in-House Test to Presumptively Differentiate Mycobacterium tuberculosis Complex from Nontuberculous Mycobacteria by Detection of p-Nitrobenzoic Acid Metabolites	PLOS ONE			English	Article							TB SYSTEM; IDENTIFICATION; SUSCEPTIBILITY; INFECTIONS; MORPHOLOGY; BOVIS	The timely differentiation of Mycobacterium tuberculosis complex (MTC) and non-tubercular mycobacterium (NTM) species is urgently needed in patient care since the routine laboratory method is time consuming and cumbersome. An easy and cheap method which can successfully distinguish MTC from NTM was established and evaluated. 38 mycobacterial type and reference strains and 65 clinical isolates representing 10 species of mycobacterium were included in this study. Metabolites of p-nitrobenzoic acid (PNB) reduction were identified using liquid chromatography and tandem mass spectrometry (LC/MS/MS). A spectrophotometric method was developed to detect these metabolites, which was evaluated on a number of MTC and NTM species. All of the tested NTM species and strains reduced PNB to p-aminobenzoic acid (PABA), while none of the MTC strains showed a similar activity. Spectrophotometric detection of PABA had 100% sensitivity and specificity for MTC and NTM differentiation among the type strains and the clinical isolates tested. PABA was identified as one of the metabolites of PNB reduction. All the tested NTM species metabolized PNB to PABA whereas the MTC members lacked this activity. A simple, specific and cost-effective method based on PABA production was established in order to discriminate MTC from NTM from cultured organisms.	[Wang, Guirong; Yu, Xia; Liang, Qian; Chen, Suting; Huang, Hairong] Capital Med Univ, Natl Clin Lab TB, Beijing Key Lab Drug Resistant TB Res, Beijing TB & Thorac Tumor Inst,Beijing Chest Hosp, Beijing, Peoples R China; [Wilson, Stuart] Microsens Medtech Ltd, London, England	Capital Medical University	Huang, HR (corresponding author), Capital Med Univ, Natl Clin Lab TB, Beijing Key Lab Drug Resistant TB Res, Beijing TB & Thorac Tumor Inst,Beijing Chest Hosp, Beijing, Peoples R China.	hairong.huangcn@gmail.com			National Natural Science Foundation of China [31070120]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This project was supported by the National Natural Science Foundation of China (Grant No. 31070120). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANSBACHER S., 1941, SCIENCE, V93, P164, DOI 10.1126/science.93.2407.164; Chihota VN, 2010, INT J TUBERC LUNG D, V14, P1024; Chiyoji A, 1999, J CLIN MICROBIOL, V37, P3793; EIDUS L., 1959, ANTIBIOT AND CHEMOTHER, V9, P491; French AL, 1997, MED CLIN N AM, V81, P361, DOI 10.1016/S0025-7125(05)70522-8; Giampaglia CMS, 2007, INT J TUBERC LUNG D, V11, P803; GROSS WM, 1985, J CLIN MICROBIOL, V21, P565, DOI 10.1128/JCM.21.4.565-568.1985; Ismail NA, 2009, INT J TUBERC LUNG D, V13, P1045; Katoch VM, 2004, INDIAN J MED RES, V120, P290; LASZLO A, 1978, CAN J MICROBIOL, V24, P754, DOI 10.1139/m78-124; Monteiro PHT, 2003, BRAZ J MICROBIOL, V34, P171, DOI 10.1590/S1517-83822003000200016; *NAT TOX PROGR, 1994, NAT TOX PROGR TECH R, V442, P1; RAFII F, 1991, APPL ENVIRON MICROB, V57, P962, DOI 10.1128/AEM.57.4.962-968.1991; Rodrigues C, 2009, INDIAN J MED MICROBI, V27, P217, DOI 10.4103/0255-0857.53203; Sharma Babita, 2010, J Lab Physicians, V2, P89, DOI 10.4103/0974-2727.72157; Somoskovi A, 2000, J CLIN MICROBIOL, V38, P2395; TANZIL HOK, 1973, AM REV RESPIR DIS, V108, P147; TSUKAMURA M, 1968, AM REV RESPIR DIS, V98, P505; TSUKAMURA M, 1965, J BACTERIOL, V90, P556, DOI 10.1128/JB.90.2.556-557.1965; TSUKAMURA M, 1964, Tubercle, V45, P64, DOI 10.1016/S0041-3879(64)80091-X; Tu HZ, 2003, ANN CLIN LAB SCI, V33, P179	21	5	5	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80877	10.1371/journal.pone.0080877	http://dx.doi.org/10.1371/journal.pone.0080877			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260497	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500181
J	Ye, F; Zhang, YB; Liu, Y; Yamada, K; Tso, JL; Menjivar, JC; Tian, JY; Yong, WH; Schaue, D; Mischel, PS; Cloughesy, TF; Nelson, SF; Liau, LM; McBride, W; Tso, CL				Ye, Fei; Zhang, Yibei; Liu, Yue; Yamada, Kazunari; Tso, Jonathan L.; Menjivar, Jimmy C.; Tian, Jane Y.; Yong, William H.; Schaue, Doerthe; Mischel, Paul S.; Cloughesy, Timothy F.; Nelson, Stanley F.; Liau, Linda M.; McBride, William; Tso, Cho-Lea			Protective Properties of Radio-Chemoresistant Glioblastoma Stem Cell Clones Are Associated with Metabolic Adaptation to Reduced Glucose Dependence	PLOS ONE			English	Article							DNA-DAMAGE RESPONSE; TUMOR-INITIATING CELLS; BREAST-CANCER CELLS; CALORIC RESTRICTION; LIFE-SPAN; ADAPTIVE RESPONSE; SIRT1; EXPRESSION; HORMESIS; SURVIVAL	Glioblastoma stem cells (GSC) are a significant cell model for explaining brain tumor recurrence. However, mechanisms underlying their radiochemoresistance remain obscure. Here we show that most clonogenic cells in GSC cultures are sensitive to radiation treatment (RT) with or without temozolomide (TMZ). Only a few single cells survive treatment and regain their self-repopulating capacity. Cells re-populated from treatment-resistant GSC clones contain more clonogenic cells compared to those grown from treatment-sensitive GSC clones, and repeated treatment cycles rapidly enriched clonogenic survival. When compared to sensitive clones, resistant clones exhibited slower tumor development in animals. Upregulated genes identified in resistant clones via comparative expression microarray analysis characterized cells under metabolic stress, including blocked glucose uptake, impaired insulin/Akt signaling, enhanced lipid catabolism and oxidative stress, and suppressed growth and inflammation. Moreover, many upregulated genes highlighted maintenance and repair activities, including detoxifying lipid peroxidation products, activating lysosomal autophagy/ubiquitin-proteasome pathways, and enhancing telomere maintenance and DNA repair, closely resembling the anti-aging effects of caloric/glucose restriction (CR/GR), a nutritional intervention that is known to increase lifespan and stress resistance in model organisms. Although treatment-introduced genetic mutations were detected in resistant clones, all resistant and sensitive clones were subclassified to either proneural (PN) or mesenchymal (MES) glioblastoma subtype based on their expression profiles. Functional assays demonstrated the association of treatment resistance with energy stress, including reduced glucose uptake, fatty acid oxidation (FAO)-dependent ATP maintenance, elevated reactive oxygen species (ROS) production and autophagic activity, and increased AMPK activity and NAD(+) levels accompanied by upregulated mRNA levels of SIRT1/PGC-1 alpha axis and DNA repair genes. These data support the view that treatment resistance may arise from quiescent GSC exhibiting a GR-like phenotype, and suggest that targeting stress response pathways of resistant GSC may provide a novel strategy in combination with standard treatment for glioblastoma.	[Ye, Fei; Zhang, Yibei; Liu, Yue; Yamada, Kazunari; Tso, Jonathan L.; Menjivar, Jimmy C.; Tian, Jane Y.; Tso, Cho-Lea] Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg Surg Oncol, Los Angeles, CA 90095 USA; [Ye, Fei] Huazhong Univ Sci & Technol, Tongji Med Coll, Tongji Hosp, Dept Neurosurg, Wuhan 430074, Hubei, Peoples R China; [Zhang, Yibei] Xiamen Univ, Dept Orthoped, Zhongshan Hosp, Xiamen, Fujian, Peoples R China; [Yamada, Kazunari] Kyushu Univ Hosp, Dept Adv Mol & Cell Therapy, Higashi Ku, Fukuoka 812, Japan; [Yong, William H.; Mischel, Paul S.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Schaue, Doerthe; McBride, William] Univ Calif Los Angeles, David Geffen Sch Med, Dept Radiat Oncol, Los Angeles, CA 90095 USA; [Cloughesy, Timothy F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Nelson, Stanley F.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet, Los Angeles, CA 90095 USA; [Liau, Linda M.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurosurg, Los Angeles, CA 90095 USA; [Yong, William H.; Schaue, Doerthe; Mischel, Paul S.; Cloughesy, Timothy F.; Nelson, Stanley F.; Liau, Linda M.; McBride, William; Tso, Cho-Lea] Univ Calif Los Angeles, Jonsson Comprehens Canc Ctr, Los Angeles, CA 90024 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Huazhong University of Science & Technology; Xiamen University; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; UCLA Jonsson Comprehensive Cancer Center; University of California System; University of California Los Angeles	Tso, CL (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Surg Surg Oncol, Los Angeles, CA 90095 USA.	ctso@mednet.ucla.edu	Nelson, Stanley F/D-4771-2009; Cloughesy, Timothy Francis/AGV-1013-2022	Nelson, Stanley F/0000-0002-2082-3114; Liau, Linda/0000-0002-4053-0052; Yamada, Kazunari/0000-0002-3610-1802	American Cancer Society [RSG-07-109-01-CCE]; National Cancer Institute [1 R21 CA140912-01]; National Institute of Health [1DP2OD006444-01]; Bradley Zankel Foundation; NATIONAL CANCER INSTITUTE [R21CA140912, P30CA016042] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI028697] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD006444] Funding Source: NIH RePORTER	American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bradley Zankel Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was supported by grants from the American Cancer Society (RSG-07-109-01-CCE), National Cancer Institute (1 R21 CA140912-01), National Institute of Health (1DP2OD006444-01), and the Bradley Zankel Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Annabi B, 2009, MOL CARCINOGEN, V48, P910, DOI 10.1002/mc.20541; Bao SD, 2006, NATURE, V444, P756, DOI 10.1038/nature05236; Bergamini E, 2007, ANN NY ACAD SCI, V1114, P69, DOI 10.1196/annals.1396.020; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223; Cabelof DC, 2003, DNA REPAIR, V2, P295, DOI 10.1016/S1568-7864(02)00219-7; Calabrese EJ, 2003, NATURE, V421, P691, DOI 10.1038/421691a; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chen D, 2005, SCIENCE, V310, P1641, DOI 10.1126/science.1118357; Chen RH, 2010, CANCER CELL, V17, P362, DOI 10.1016/j.ccr.2009.12.049; Chen ZH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003316; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; CRAWFORD DR, 1994, ENVIRON HEALTH PERSP, V102, P25, DOI 10.2307/3432208; Dimova EG, 2008, GENET MOL BIOL, V31, P396, DOI 10.1590/S1415-47572008000300002; Eramo A, 2006, CELL DEATH DIFFER, V13, P1238, DOI 10.1038/sj.cdd.4401872; Facchino S, 2010, J NEUROSCI, V30, P10096, DOI 10.1523/JNEUROSCI.1634-10.2010; Feinendegen LE, 1999, CR ACAD SCI III-VIE, V322, P245, DOI 10.1016/S0764-4469(99)80051-1; Feinendegen LE, 2005, BRIT J RADIOL, V78, P3, DOI 10.1259/bjr/63353075; Fontana L, 2010, SCIENCE, V328, P321, DOI 10.1126/science.1172539; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; Gilbert CA, 2010, CANCER RES, V70, P6870, DOI 10.1158/0008-5472.CAN-10-1378; Hemmati HD, 2003, P NATL ACAD SCI USA, V100, P15178, DOI 10.1073/pnas.2036535100; Hsieh D, 2010, BIOCHEM BIOPH RES CO, V397, P367, DOI 10.1016/j.bbrc.2010.05.145; Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535; Komurov K, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.25; Lagadec C, 2012, STEM CELLS, V30, P833, DOI 10.1002/stem.1058; Lee CK, 2000, NAT GENET, V25, P294, DOI 10.1038/77046; Lee JE, 2011, EXP GERONTOL, V46, P891, DOI 10.1016/j.exger.2011.07.009; Lewis KN, 2012, GERONTOLOGY, V58, P453, DOI 10.1159/000335966; Li Z, 2009, CANCER CELL, V15, P501, DOI 10.1016/j.ccr.2009.03.018; Liu QH, 2009, J NEURO-ONCOL, V94, P1, DOI 10.1007/s11060-009-9919-z; Liu Y, 2011, MOL CANCER RES, V9, P1668, DOI 10.1158/1541-7786.MCR-10-0563; Lomonaco SL, 2009, INT J CANCER, V125, P717, DOI 10.1002/ijc.24402; Mao P, 2013, P NATL ACAD SCI USA, V110, P8644, DOI 10.1073/pnas.1221478110; Masoro EJ, 1998, EXP GERONTOL, V33, P61, DOI 10.1016/S0531-5565(97)00071-5; McCay CM, 1935, J NUTR, V10, P63, DOI 10.1093/jn/10.1.63; McCord AM, 2009, CLIN CANCER RES, V15, P5145, DOI 10.1158/1078-0432.CCR-09-0263; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nakai E, 2009, CANCER INVEST, V27, P901, DOI 10.3109/07357900801946679; Palacios JA, 2010, J CELL BIOL, V191, P1299, DOI 10.1083/jcb.201005160; Pardo PS, 2011, J BIOL CHEM, V286, P2559, DOI 10.1074/jbc.M110.149153; Piccirillo SGM, 2006, NATURE, V444, P761, DOI 10.1038/nature05349; Rattan SIS, 2004, J GERONTOL A-BIOL, V59, P705; Ristow M, 2010, EXP GERONTOL, V45, P410, DOI 10.1016/j.exger.2010.03.014; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Ropolo M, 2009, MOL CANCER RES, V7, P383, DOI 10.1158/1541-7786.MCR-08-0409; Safdie F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044603; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Swindell WR, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-585; Vellanki S, 2009, NEOPLASIA, V11, P743, DOI 10.1593/neo.09436; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Wang JL, 2010, STEM CELLS, V28, P17, DOI 10.1002/stem.261; Wang RH, 2008, CANCER CELL, V14, P312, DOI 10.1016/j.ccr.2008.09.001; Yuan XP, 2004, ONCOGENE, V23, P9392, DOI 10.1038/sj.onc.1208311	57	43	45	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80397	10.1371/journal.pone.0080397	http://dx.doi.org/10.1371/journal.pone.0080397			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260384	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500132
J	Yin, J; Wang, X; Zheng, L; Shi, YJ; Wang, LM; Shao, AZ; Tang, WF; Ding, GW; Liu, C; Liu, RP; Chen, SC; Gu, HY				Yin, Jun; Wang, Xu; Zheng, Liang; Shi, Yijun; Wang, Liming; Shao, Aizhong; Tang, Weifeng; Ding, Guowen; Liu, Chao; Liu, Ruiping; Chen, Suocheng; Gu, Haiyong			Hsa-miR-34b/c rs4938723 T > C and hsa-miR-423 rs6505162 C > A Polymorphisms Are Associated with the Risk of Esophageal Cancer in a Chinese Population	PLOS ONE			English	Article							MICRORNA-RELATED GENES; COLORECTAL-CANCER; BREAST-CANCER; SUSCEPTIBILITY LOCI; VARIANT; P53; NETWORK; REGION; CELLS	Esophageal cancer is the eighth most common cancer and sixth leading cause of cancer associated death worldwide. Besides environmental risk factors, genetic factors might play an important role in the esophageal cancer carcinogenesis. We conducted a hospital based case-control study to evaluate the genetic susceptibility of functional single nucleotide polymorphisms (SNPs) in the microRNAs on the development of esophageal cancer. A total of 629 esophageal squamous cell carcinoma (ESCC) cases and 686 controls were recruited for this study. The hsa-miR-34b/c rs4938723 T>C, pri-miR-124-1 rs531564 C>G, pre-miR-125a rs12975333 G>T and hsa-miR-423 rs6505162 C>A genotypes were determined using Ligation Detection Reaction (LDR) method. Our results demonstrated that hsa-miR-34b/c rs4938723 CC genotype had a decreased risk of ESCC. The association was evident among patients who never drinking. Hsa-miR-423 rs6505162 C>A might associated with a significantly increased risk of ESCC in patients who smoking. These findings indicated that functional polymorphisms hsa-miR-34b/c rs4938723 T>C and hsa-miR-423 rs6505162 C>A might alter individual susceptibility to ESCC. However, our results were obtained with a limited sample size. Future larger studies with other ethnic populations are required to confirm current findings.	[Yin, Jun; Wang, Xu; Shi, Yijun; Shao, Aizhong; Tang, Weifeng; Ding, Guowen; Liu, Chao; Chen, Suocheng; Gu, Haiyong] Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China; [Zheng, Liang] Suzhou Univ, Affiliated Hosp 3, Peoples Hosp Changzhou 1, Dept Cardiothorac Surg, Changzhou, Peoples R China; [Wang, Liming] Jiangsu Univ, Affiliated Peoples Hosp, Dept Chemotherapy, Inst Canc, Zhenjiang, Jiangsu, Peoples R China; [Liu, Ruiping] Nanjing Med Univ, Changzhou Peoples Hosp 2, Affiliated Hosp, Dept Orthoped, Changzhou, Peoples R China	Jiangsu University; Jiangsu University; Nanjing Medical University	Chen, SC (corresponding author), Jiangsu Univ, Affiliated Peoples Hosp, Dept Cardiothorac Surg, Zhenjiang, Peoples R China.	chensuocheng@sina.com; haiyong_gu@hotmail.com			National Natural Science Foundation of China [81101889, 81000028]; Jiangsu Province Natural Science Foundation [BK2010333, BK2011481]; Social Development Foundation of Zhenjiang [SH2010017]; Changzhou Young Talents and Science-Technology Foundation of Health Bureau [QN201102]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Jiangsu Province Natural Science Foundation(Natural Science Foundation of Jiangsu Province); Social Development Foundation of Zhenjiang; Changzhou Young Talents and Science-Technology Foundation of Health Bureau	This study was supported in part by National Natural Science Foundation of China (81101889, 81000028), Jiangsu Province Natural Science Foundation (BK2010333,BK2011481), Social Development Foundation of Zhenjiang (SH2010017) and Changzhou Young Talents and Science-Technology Foundation of Health Bureau (QN201102). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bensen JT, 2013, CANCER CAUSE CONTROL, V24, P1099, DOI 10.1007/s10552-013-0187-z; Bommer GT, 2007, CURR BIOL, V17, P1298, DOI 10.1016/j.cub.2007.06.068; Chen ZJ, 2011, NAT GENET, V43, P55, DOI 10.1038/ng.732; Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290; Gao LB, 2013, BIOL CHEM, V394, P415, DOI 10.1515/hsz-2012-0297; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gu HY, 2012, MOL BIOL REP, V39, P9105, DOI 10.1007/s11033-012-1782-x; Han YF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058564; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Kim NH, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001744; Kozaki KI, 2008, CANCER RES, V68, P2094, DOI 10.1158/0008-5472.CAN-07-5194; Li LJ, 2013, TUMOR BIOL, V34, P1919, DOI 10.1007/s13277-013-0736-9; Lujambio A, 2007, CANCER RES, V67, P1424, DOI 10.1158/0008-5472.CAN-06-4218; Mathe E, 2012, INT J CANCER, V131, P760, DOI 10.1002/ijc.26403; Nicoloso MS, 2010, CANCER RES, V70, P2789, DOI 10.1158/0008-5472.CAN-09-3541; Peterlongo P, 2011, J MED GENET, V48, P703, DOI 10.1136/jmedgenet-2011-100103; Sand M, 2009, J DERMATOL SCI, V53, P169, DOI 10.1016/j.jdermsci.2008.10.004; Shen HB, 2013, J BIOMED RES, V27, P167, DOI 10.7555/JBR.27.20130040; Smith RA, 2012, CANCER GENOM PROTEOM, V9, P115; Son MS, 2013, GENE, V524, P156, DOI 10.1016/j.gene.2013.04.042; Tazawa H, 2007, P NATL ACAD SCI USA, V104, P15472, DOI 10.1073/pnas.0707351104; Toyota M, 2008, CANCER RES, V68, P4123, DOI 10.1158/0008-5472.CAN-08-0325; Vogt M, 2011, VIRCHOWS ARCH, V458, P313, DOI 10.1007/s00428-010-1030-5; Wei JS, 2013, HUM IMMUNOL, V74, P1199, DOI 10.1016/j.humimm.2013.06.012; Xing JL, 2012, CANCER EPIDEM BIOMAR, V21, P217, DOI 10.1158/1055-9965.EPI-11-0624; Yang HS, 2008, CANCER RES, V68, P2530, DOI 10.1158/0008-5472.CAN-07-5991; Ye YQ, 2008, CANCER PREV RES, V1, P460, DOI 10.1158/1940-6207.CAPR-08-0135	28	26	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80570	10.1371/journal.pone.0080570	http://dx.doi.org/10.1371/journal.pone.0080570			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260422	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500156
J	Corwin, D; Holdsworth, C; Rockne, RC; Trister, AD; Mrugala, MM; Rockhill, JK; Stewart, RD; Phillips, M; Swanson, KR				Corwin, David; Holdsworth, Clay; Rockne, Russell C.; Trister, Andrew D.; Mrugala, Maciej M.; Rockhill, Jason K.; Stewart, Robert D.; Phillips, Mark; Swanson, Kristin R.			Toward Patient-Specific, Biologically Optimized Radiation Therapy Plans for the Treatment of Glioblastoma	PLOS ONE			English	Article							NEWLY-DIAGNOSED GLIOBLASTOMAS; HIGH-GRADE GLIOMAS; CONFORMAL RADIOTHERAPY; MODEL; CLASSIFICATION; SURVIVAL; PATTERNS; GROWTH; BRAIN	Purpose: To demonstrate a method of generating patient-specific, biologically-guided radiotherapy dose plans and compare them to the standard-of-care protocol. Methods and Materials: We integrated a patient-specific biomathematical model of glioma proliferation, invasion and radiotherapy with a multiobjective evolutionary algorithm for intensity-modulated radiation therapy optimization to construct individualized, biologically-guided plans for 11 glioblastoma patients. Patient-individualized, spherically-symmetric simulations of the standard-of-care and optimized plans were compared in terms of several biological metrics. Results: The integrated model generated spatially non-uniform doses that, when compared to the standard-of-care protocol, resulted in a 67% to 93% decrease in equivalent uniform dose to normal tissue, while the therapeutic ratio, the ratio of tumor equivalent uniform dose to that of normal tissue, increased between 50% to 265%. Applying a novel metric of treatment response (Days Gained) to the patient-individualized simulation results predicted that the optimized plans would have a significant impact on delaying tumor progression, with increases from 21% to 105% for 9 of 11 patients. Conclusions: Patient-individualized simulations using the combination of a biomathematical model with an optimization algorithm for radiation therapy generated biologically-guided doses that decreased normal tissue EUD and increased therapeutic ratio with the potential to improve survival outcomes for treatment of glioblastoma.	[Corwin, David; Rockne, Russell C.; Swanson, Kristin R.] Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA; [Holdsworth, Clay; Trister, Andrew D.; Rockhill, Jason K.; Stewart, Robert D.; Phillips, Mark] Univ Washington, Med Ctr, Dept Radiat Oncol, Seattle, WA 98195 USA; [Holdsworth, Clay] Brigham & Womens Hosp, Dept Radiat Oncol, Boston, MA 02115 USA; [Trister, Andrew D.] Sage Bionetworks, Seattle, WA USA; [Mrugala, Maciej M.] Univ Washington, Med Ctr, Dept Neurol, Seattle, WA 98195 USA; [Swanson, Kristin R.] Northwestern Univ, Dept Engn Sci & Appl Math, McCormick Sch Engn, Evanston, IL 60208 USA	Northwestern University; Feinberg School of Medicine; University of Washington; University of Washington Seattle; Harvard University; Brigham & Women's Hospital; University of Washington; University of Washington Seattle; Northwestern University	Swanson, KR (corresponding author), Northwestern Univ, Dept Neurol Surg, Feinberg Sch Med, Chicago, IL 60611 USA.	Kristin.Swanson@northwestern.edu	Stewart, Robert/A-3609-2013; Rockne, Russell/T-1549-2017	Stewart, Robert/0000-0001-5946-0595; Rockne, Russell/0000-0002-1557-159X; Trister, Andrew/0000-0002-7070-0139	National Institutes of Health (NIH) [R01 NS060752, R01 CA16437]; James D. McDonnell Foundation; NATIONAL CANCER INSTITUTE [R01CA216437] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060752] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); James D. McDonnell Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was funded under National Institutes of Health (NIH) R01 NS060752, NIH R01 CA16437 and the James D. McDonnell Foundation with PI: K. R. Swanson (http://grants.nih.gov/grants/oer.htm). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Blinkov SM., 1968, HUMAN BRAIN FIGURES; Chan JL, 2002, J CLIN ONCOL, V20, P1635, DOI 10.1200/JCO.20.6.1635; Emami B, 1991, J NUCL MED, V15, P109, DOI DOI 10.1016/0360-3016(91)90171-Y; Hall EJ, 2006, RADIOBIOLOGY RADIOLO, V6th; Holdsworth CH, 2012, PHYS MED BIOL, V57, DOI 10.1088/0031-9155/57/24/8271; Jena R, 2005, CLIN ONCOL-UK, V17, P581, DOI 10.1016/j.clon.2005.04.012; Kim Y, 2010, ACTA ONCOL, V49, P1374, DOI 10.3109/02841861003767539; Kleihues P, 2002, J NEUROPATH EXP NEUR, V61, P215, DOI 10.1093/jnen/61.3.215; Lawrence YR, 2010, INT J RADIAT ONCOL, V76, pS20, DOI 10.1016/j.ijrobp.2009.02.091; Lee SW, 1999, INT J RADIAT ONCOL, V43, P79, DOI 10.1016/S0360-3016(98)00266-1; Maucort-Boulch D, 2010, CANCER RADIOTHER, V14, P34, DOI 10.1016/j.canrad.2009.08.141; Narayana A, 2007, BRIT J RADIOL, V80, P347, DOI 10.1259/bjr/65349468; Neal ML, 2013, CANCER RES, V73, P2976, DOI 10.1158/0008-5472.CAN-12-3588; Neal ML, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0051951; Rockne R, 2010, PHYS MED BIOL, V55, P3271, DOI 10.1088/0031-9155/55/12/001; Rockne R, 2009, J MATH BIOL, V58, P561, DOI 10.1007/s00285-008-0219-6; Stall B, 2010, RADIAT ONCOL, V5, DOI 10.1186/1748-717X-5-5; Stewart RD, 2007, MED PHYS, V34, P3739, DOI 10.1118/1.2779861; Stewart RD, 2011, IMAG MED DIAGN THER, P105; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Szeto MD, 2009, CANCER RES, V69, P4502, DOI 10.1158/0008-5472.CAN-08-3884; THIBAULT J, 1987, NUMER HEAT TRANSFER, V12, P457, DOI 10.1080/10407788708913597; Tome WA, 2000, INT J RADIAT ONCOL, V48, P593, DOI 10.1016/S0360-3016(00)00666-0; Wang CH, 2009, CANCER RES, V69, P9133, DOI 10.1158/0008-5472.CAN-08-3863; Zaider M, 2011, MED PHYS, V38, P574, DOI 10.1118/1.3521406	25	76	78	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79115	10.1371/journal.pone.0079115	http://dx.doi.org/10.1371/journal.pone.0079115			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265748	gold, Green Published			2022-12-25	WOS:000327252100081
J	Kasetsuwan, N; Satitpitakul, V; Changul, T; Jariyakosol, S				Kasetsuwan, Ngamjit; Satitpitakul, Vannarut; Changul, Theerapa; Jariyakosol, Supharat			Incidence and Pattern of Dry Eye after Cataract Surgery	PLOS ONE			English	Article							RISK-FACTORS; BENZALKONIUM CHLORIDE; OLDER POPULATION; DISEASE; PREVALENCE; PHACOEMULSIFICATION; SENSITIVITY; SENSATION; PATIENT; TIMOLOL	Purpose: To evaluate the incidence and severity pattern of dry eye after phacoemulsification. Setting: King Chulalongkorn Memorial Hospital, Bangkok, Thailand. Design: Prospective descriptive study. Methods: Samples were collected from ninety-two uncomplicated cataract patients who were 18 years old or older. Dry eye incidence and pattern were analyzed at days 0, 7, 30 and 90 after phacoemulsification using (1) Ocular Surface Disease Index (OSDI) questionnaire, (2) tear break up time (TBUT), (3) Oxford ocular surface staining system, and (4) Schirmer I test without anesthesia. Results: Seven days after phacoemulsification, the incidence of dry eye was 9.8% (95% confidence interval; 3.6-16.0%). The severity of dry eye peaked seven days post-phacoemulsification and was measured by OSDI questionnaire and all three clinical tests. Within thirty days and 3 months post-surgery, both the symptoms and signs showed rapid and gradual improvements, respectively. However, dry eye post-phacoemulsification was not significantly associated with sex and systemic hypertension (P = 0.26, 0.17 and 0.73, respectively). Conclusions: The incidence of dry eye after phacoemulsification was 9.8%. Symptoms and signs of dry eye occurred as early as seven days post-phacoemulsification and the severity pattern improved over time. We recommend that ophthalmologists should evaluate patients both before and after phacoemulsification to prevent further damage to the ocular surface and able to manage the patient promptly and effectively so the patient will not have a poor quality of life and vision due to dry eye syndrome.	[Kasetsuwan, Ngamjit; Satitpitakul, Vannarut; Jariyakosol, Supharat] Chulalongkorn Univ, Dept Ophthalmol, Bangkok, Thailand; [Changul, Theerapa] Chainat Hosp, Dept Ophthalmol, Chainat, Thailand	Chulalongkorn University	Kasetsuwan, N (corresponding author), Chulalongkorn Univ, Dept Ophthalmol, Bangkok, Thailand.	ngamjitk@gmail.com						Al-Aqaba MA, 2010, BRIT J OPHTHALMOL, V94, P784, DOI 10.1136/bjo.2009.173799; Belmonte C, 2004, EXP EYE RES, V78, P513, DOI 10.1016/j.exer.2003.09.023; Cho Yang Kyeung, 2009, Korean J Ophthalmol, V23, P65, DOI 10.3341/kjo.2009.23.2.65; De Paiva CS, 2006, AM J OPHTHALMOL, V141, P438, DOI 10.1016/j.ajo.2005.10.006; Foulks GN, 2008, DRUG AGING, V25, P105, DOI 10.2165/00002512-200825020-00003; García-Catalán M.R., 2009, Arch Soc Esp Oftalmol, V84, P451; Gayton JL, 2009, CLIN OPHTHALMOL, V3, P405; Gilbard JP, 2009, GERIATRICS, V64, P22; Guo B, 2010, OPHTHAL EPIDEMIOL, V17, P234, DOI 10.3109/09286586.2010.498659; Han SB, 2011, ARCH OPHTHALMOL-CHIC, V129, P633, DOI 10.1001/archophthalmol.2011.78; Hardten DR, 2008, CORNEA, V27, P855, DOI 10.1097/ICO.0b013e31816f6854; Ishibashi T, 2003, J GLAUCOMA, V12, P486, DOI 10.1097/00061198-200312000-00008; Khanal S, 2008, OPHTHAL PHYSL OPT, V28, P127, DOI 10.1111/j.1475-1313.2008.00539.x; Kohlhaas M, 1998, J CATARACT REFR SURG, V24, P1399, DOI 10.1016/S0886-3350(98)80237-X; Lekhanont K, 2006, CORNEA, V25, P1162, DOI 10.1097/01.ico.0000244875.92879.1a; Lemp MA, 2007, OCUL SURF, V5, P75; Li XM, 2007, CORNEA, V26, pS16, DOI 10.1097/ICO.0b013e31812f67ca; Lin PY, 2003, OPHTHALMOLOGY, V110, P1096, DOI 10.1016/S0161-6420(03)00262-8; Liu Zu-Guo, 2009, Zhonghua Yan Ke Za Zhi, V45, P483; Liu Zuguo, 2002, Zhonghua Yan Ke Za Zhi, V38, P274; Mertzanis P, 2005, INVEST OPHTH VIS SCI, V46, P46, DOI 10.1167/iovs.03-0915; Moss SE, 2008, OPTOMETRY VISION SCI, V85, P668, DOI 10.1097/OPX.0b013e318181a947; Moss SE, 2004, ARCH OPHTHALMOL-CHIC, V122, P369, DOI 10.1001/archopht.122.3.369; Muller LJ, 1997, INVEST OPHTH VIS SCI, V38, P985; Pisella PJ, 2004, INVEST OPHTH VIS SCI, V45, P1360, DOI 10.1167/iovs.03-1067; Ram J, 2002, J CATARACT REFR SURG, V28, P1386, DOI 10.1016/S0886-3350(02)01387-1; Roberts Calvin W, 2007, Insight, V32, P14; Schaumberg DA, 2003, AM J OPHTHALMOL, V136, P318, DOI 10.1016/S0002-9394(03)00218-6; Schaumberg DA, 2009, ARCH OPHTHALMOL-CHIC, V127, P763, DOI 10.1001/archophthalmol.2009.103; Schiffman RM, 2000, ARCH OPHTHALMOL-CHIC, V118, P615, DOI 10.1001/archopht.118.5.615; Shoja MR, 2007, EUR J OPHTHALMOL, V17, P1; Sitompul R, 2008, CORNEA, V27, pS13, DOI 10.1097/ICO.0b013e31817f29d8; Uchino M, 2011, OPHTHALMOLOGY, V118, P2361, DOI 10.1016/j.ophtha.2011.05.029; WILSON WS, 1975, BRIT J OPHTHALMOL, V59, P667, DOI 10.1136/bjo.59.11.667; ZABEL RW, 1989, CAN J OPHTHALMOL, V24, P311	35	126	141	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78657	10.1371/journal.pone.0078657	http://dx.doi.org/10.1371/journal.pone.0078657			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265705	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100038
J	Kim, J; Badaloni, A; Willert, T; Zimber-Strobl, U; Kuhn, R; Wurst, W; Kieslinger, M				Kim, Jeehee; Badaloni, Aurora; Willert, Torsten; Zimber-Strobl, Ursula; Kuehn, Ralf; Wurst, Wolfgang; Kieslinger, Matthias			An RNAi-Based Approach to Down-Regulate a Gene Family In Vivo	PLOS ONE			English	Article							B-CELL DIFFERENTIATION; SMALL INTERFERING RNA; TRANSGENIC MICE; TRANSCRIPTION FACTORS; NEURONAL DEVELOPMENT; MESSENGER-RNAS; POLYMERASE-II; STEM-CELLS; EXPRESSION; MICRORNA	Genetic redundancy poses a major problem to the analysis of gene function. RNA interference allows the down-regulation of several genes simultaneously, offering the possibility to overcome genetic redundancy, something not easily achieved with traditional genetic approaches. Previously we have used a polycistronic miR155-based framework to knockdown expression of three genes of the early B cell factor family in cultured cells. Here we develop the system further by generating transgenic mice expressing the RNAi construct in vivo in an inducible manner. Expression of the transgene from the strong CAG promoter is compatible with a normal function of the basal miRNA/RNAi machinery, and the miR155 framework readily allows inducible expression from the Rosa26 locus as shown by Gfp. However, expression of the transgene in hematopoietic cells does not lead to changes in B cell development and neuronal expression does not affect cerebellar architecture as predicted from genetic deletion studies. Protein as well as mRNA levels generated from Ebf genes in hetero- and homozygous animals are comparable to wild-type levels. A likely explanation for the discrepancy in the effectiveness of the RNAi construct between cultured cells and transgenic animals lies in the efficiency of the sequences used, possibly together with the complexity of the transgene. Since new approaches allow to overcome efficiency problems of RNAi sequences, the data lay the foundation for future work on the simultaneous knockdown of several genes in vivo.	[Kim, Jeehee; Willert, Torsten; Kieslinger, Matthias] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, Munich, Germany; [Badaloni, Aurora] Ist Sci San Raffaele, Div Neurosci, I-20132 Milan, Italy; [Zimber-Strobl, Ursula] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Dept Gene Vectors, Munich, Germany; [Kuehn, Ralf; Wurst, Wolfgang] German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Dev Genet, Munich, Germany	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health	Kieslinger, M (corresponding author), German Res Ctr Environm Hlth, Helmholtz Zentrum Munchen, Inst Clin Mol Biol & Tumor Genet, Munich, Germany.	matthias.kieslinger@helmholtz-muenchen.de	Kühn, Ralf/U-1278-2017; Zimber-Strobl, Ursula/M-4618-2014	Kühn, Ralf/0000-0003-1694-9803; Zimber-Strobl, Ursula/0000-0002-9765-5251; Jeehee, Kim/0000-0003-1145-7893; Wurst, Wolfgang/0000-0003-4422-7410	German Research Foundation (DFG) [TRR54, FOR1586]	German Research Foundation (DFG)(German Research Foundation (DFG))	This work was supported by grants from the German Research Foundation (DFG, TRR54, FOR1586). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alexopoulou AN, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-2; Barbaric Ivana, 2007, Briefings in Functional Genomics & Proteomics, V6, P91, DOI 10.1093/bfgp/elm008; Cai XZ, 2004, RNA, V10, P1957, DOI 10.1261/rna.7135204; Carmell MA, 2003, NAT STRUCT BIOL, V10, P91, DOI 10.1038/nsb896; Casola S, 2010, METHODS MOL BIOL, V667, P145, DOI 10.1007/978-1-60761-811-9_10; Chang HS, 2004, AM J PATHOL, V165, P1535, DOI 10.1016/S0002-9440(10)63411-6; Chiara F, 2012, DEV BIOL, V365, P277, DOI 10.1016/j.ydbio.2012.02.034; Chung KH, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl143; Chung SH, 2008, NEUROSCIENCE, V153, P721, DOI 10.1016/j.neuroscience.2008.01.090; Cooke J, 1997, TRENDS GENET, V13, P360, DOI 10.1016/S0168-9525(97)01233-X; Corradi A, 2003, DEVELOPMENT, V130, P401, DOI 10.1242/dev.00215; Coumoul X, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni100; Croci L, 2011, CELL DEATH DIFFER, V18, P48, DOI 10.1038/cdd.2010.78; Croci L, 2006, DEVELOPMENT, V133, P2719, DOI 10.1242/dev.02437; de Boer J, 2003, EUR J IMMUNOL, V33, P314, DOI 10.1002/immu.200310005; Dickins RA, 2007, NAT GENET, V39, P914, DOI 10.1038/ng2045; Dow LE, 2012, NAT PROTOC, V7, P374, DOI 10.1038/nprot.2011.446; Dubois L, 2001, MECH DEVELOP, V108, P3, DOI 10.1016/S0925-4773(01)00486-5; Fellmann C, 2011, MOL CELL, V41, P733, DOI 10.1016/j.molcel.2011.02.008; Garel S, 1999, DEVELOPMENT, V126, P5285; Garel S, 2002, DEVELOPMENT, V129, P5621, DOI 10.1242/dev.00166; Garel S, 2000, DEVELOPMENT, V127, P5297; Green YS, 2011, NEURAL DEV, V6, DOI 10.1186/1749-8104-6-19; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hasuwa H, 2002, FEBS LETT, V532, P227, DOI 10.1016/S0014-5793(02)03680-3; Hemann MT, 2003, NAT GENET, V33, P396, DOI 10.1038/ng1091; Jin KX, 2010, J NEUROSCI, V30, P11902, DOI 10.1523/JNEUROSCI.2187-10.2010; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; Kieslinger M, 2010, CELL STEM CELL, V7, P496, DOI 10.1016/j.stem.2010.07.015; Kleinhammer A, 2011, METHODS, V53, P430, DOI 10.1016/j.ymeth.2010.12.015; Kunath T, 2003, NAT BIOTECHNOL, V21, P559, DOI 10.1038/nbt813; Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Liberg D, 2002, MOL CELL BIOL, V22, P8389, DOI 10.1128/MCB.22.24.8389-8397.2002; LIN HH, 1995, NATURE, V376, P263, DOI 10.1038/376263a0; Lynch M, 2003, SCIENCE, V302, P1401, DOI 10.1126/science.1089370; McJunkin K, 2011, P NATL ACAD SCI USA, V108, P7113, DOI 10.1073/pnas.1104097108; Medina MFC, 1999, CURR OPIN MOL THER, V1, P580; Mella S, 2004, GENE EXPR PATTERNS, V4, P537, DOI 10.1016/j.modgep.2004.02.005; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Premsrirut PK, 2011, CELL, V145, P145, DOI 10.1016/j.cell.2011.03.012; Putnam NH, 2008, NATURE, V453, P1064, DOI 10.1038/nature06967; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sambrook J, 1989, MOL CLONING LAB MANU, P2; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Tam W, 2006, GENE CHROMOSOME CANC, V45, P211, DOI 10.1002/gcc.20282; Tam W, 1997, MOL CELL BIOL, V17, P1490, DOI 10.1128/MCB.17.3.1490; TAUTZ D, 1992, BIOESSAYS, V14, P263, DOI 10.1002/bies.950140410; THOMAS JH, 1993, TRENDS GENET, V9, P395, DOI 10.1016/0168-9525(93)90140-D; Tiscornia G, 2003, P NATL ACAD SCI USA, V100, P1844, DOI 10.1073/pnas.0437912100; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Ventura A, 2004, P NATL ACAD SCI USA, V101, P10380, DOI 10.1073/pnas.0403954101; Wang SS, 1997, J NEUROSCI, V17, P4149; Wang SS, 2004, DEVELOPMENT, V131, P1377, DOI 10.1242/dev.01009; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zambrowicz BP, 1997, P NATL ACAD SCI USA, V94, P3789, DOI 10.1073/pnas.94.8.3789; Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	63	1	1	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80312	10.1371/journal.pone.0080312	http://dx.doi.org/10.1371/journal.pone.0080312			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265806	Green Submitted, Green Accepted, Green Published, gold			2022-12-25	WOS:000327252100141
J	Tao, YX; Liu, JL; Li, ZH; Lin, JG; Lu, T; Yan, FR				Tao, Yuxi; Liu, Junlin; Li, Zhihui; Lin, Jinguan; Lu, Tao; Yan, Fangrong			Dose-Finding Based on Bivariate Efficacy-Toxicity Outcome Using Archimedean Copula	PLOS ONE			English	Article							CONTINUAL REASSESSMENT METHOD; I/II CLINICAL-TRIALS; DESIGNS; RESPONSES; CANCER; SAFETY	In dose-finding clinical study, it is common that multiple endpoints are of interest. For instance, efficacy and toxicity endpoints are both primary in clinical trials. In this article, we propose a joint model for correlated efficacy-toxicity outcome constructed with Archimedean Copula, and extend the continual reassessment method (CRM) to a bivariate trial design in which the optimal dose for phase III is based on both efficacy and toxicity. Specially, considering numerous cases that continuous and discrete outcomes are observed in drug study, we will extend our joint model to mixed correlated outcomes. We demonstrate through simulations that our algorithm based on Archimedean Copula model has excellent operating characteristics.	[Tao, Yuxi; Liu, Junlin; Li, Zhihui; Lu, Tao; Yan, Fangrong] China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China; [Tao, Yuxi; Liu, Junlin; Li, Zhihui; Lu, Tao; Yan, Fangrong] China Pharmaceut Univ, Res Ctr Biostat & Computat Pharm, Nanjing, Jiangsu, Peoples R China; [Tao, Yuxi; Liu, Junlin; Li, Zhihui; Lu, Tao; Yan, Fangrong] China Pharmaceut Univ, Dept Math, Nanjing, Jiangsu, Peoples R China; [Lin, Jinguan; Yan, Fangrong] Southeast Univ, Dept Math, Nanjing, Jiangsu, Peoples R China	China Pharmaceutical University; China Pharmaceutical University; China Pharmaceutical University; Southeast University - China	Lu, T (corresponding author), China Pharmaceut Univ, State Key Lab Nat Med, Nanjing, Jiangsu, Peoples R China.	lut@163.com; f.r.yan@163.com	WANG, YUE/GWQ-9256-2022; Wang, Yue/AAS-5975-2020		Fundamental Research Funds for the Central Universities [JKPZ2013015]; NSFC [81130068, 11171065]	Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); NSFC(National Natural Science Foundation of China (NSFC))	The work of Fangrong Yan, Tuxi Tao, Junlin Liu, Zhihui Li and Tao Lu was funded by the Fundamental Research Funds for the Central Universities (Program No. JKPZ2013015) and NSFC (Program No. 81130068). Jinguan Lin's work was supported by NSFC (Program No. 11171065). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bekele BN, 2005, BIOMETRICS, V61, P344, DOI 10.1111/j.-1541-0420.2005.00314.x; Bornkamp B, 2007, J BIOPHARM STAT, V17, P965, DOI 10.1080/10543400701643848; Braun TA, 2002, CONTROL CLIN TRIALS, V23, P240, DOI 10.1016/S0197-2456(01)00205-7; Chevret S, 2006, STAT METHODS DOSE FI; Dragalin V, 2006, J STAT PLAN INFER, V136, P1800, DOI 10.1016/j.jspi.2005.08.005; Dragalin V, 2008, STAT MED, V27, P5156, DOI 10.1002/sim.3356; Fedorov V, 2012, STAT MED, V31, P217, DOI 10.1002/sim.4388; Fedorov VV, 2007, J BIOPHARM STAT, V17, P1085, DOI 10.1080/10543400701645132; Frechet M., 1951, ANN U LYON         A, V9, P53; Ishizuka N, 2001, STAT MED, V20, P2661, DOI 10.1002/sim.735; Lee SM, 2011, BIOSTATISTICS, V12, P386, DOI 10.1093/biostatistics/kxq062; Manner H, 2007, TECHNOLOGY ORG; O'Quigley J, 2001, BIOMETRICS, V57, P1018, DOI 10.1111/j.0006-341X.2001.01018.x; O'Quigley J, 2010, STAT SCI, V25, P202, DOI 10.1214/10-STS332; OQUIGLEY J, 1990, BIOMETRICS, V46, P33, DOI 10.2307/2531628; Ruberg S J, 1995, J Biopharm Stat, V5, P1, DOI 10.1080/10543409508835096; Sklar A, 1959, PUBL I STAT U PARIS, V8, P229, DOI DOI 10.1007/BF01544178; TAO A, 2010, DOSE FINDING METHOD; Thall PF, 2004, BIOMETRICS, V60, P684, DOI 10.1111/j.0006-341X.2004.00218.x; Thall PF, 1998, BIOMETRICS, V54, P251, DOI 10.2307/2534012; Ting N., 2006, DOSE FINDING DRUG DE; Yin GS, 2006, BIOMETRICS, V62, P777, DOI 10.1111/j.1541-0420.2006.00534.x; Zhang W, 2006, STAT MED, V25, P2365, DOI 10.1002/sim.2325	23	6	6	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78805	10.1371/journal.pone.0078805	http://dx.doi.org/10.1371/journal.pone.0078805			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265719	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100052
J	Wu, L; de Bruin, A; Wang, H; Simmons, T; Cleghorn, W; Goldenberg, LE; Sites, E; Sandy, A; Trimboli, A; Fernandez, SA; Eng, C; Shapiro, C; Leone, G				Wu, L.; de Bruin, A.; Wang, H.; Simmons, T.; Cleghorn, W.; Goldenberg, L. E.; Sites, E.; Sandy, A.; Trimboli, A.; Fernandez, S. A.; Eng, C.; Shapiro, C.; Leone, G.			Selective roles of E2Fs for ErbB2-and Myc-mediated mammary tumorigenesis	ONCOGENE			English	Article						Myc; ErbB2; E2F; mammary tumorigenesis; oncogene	TRANSCRIPTION FACTOR; RB DEFICIENCY; MOUSE MODEL; OVEREXPRESSION; PROLIFERATION; EXPRESSION; CANCER; INACTIVATION; FAMILY; TARGET	Previous studies have demonstrated that cyclin D1, an upstream regulator of the Rb/E2F pathway, is an essential component of the ErbB2/Ras (but not the Wnt/Myc) oncogenic pathway in the mammary epithelium. However, the role of specific E2fs for ErbB2/Ras-mediated mammary tunnorigenesis remains unknown. Here, we show that in the majority of mouse and human primary mammary carcinomas with ErbB2/HER2 overexpression, E2f3a is up-regulated, raising the possibility that E2F3a is a critical effector of the ErbB2 oncogenic signaling pathway in the mammary gland. We examined the consequence of ablating individual E2fs in mice on ErbB2-triggered mammary tumorigenesis in comparison to a comparable Myc-driven mammary tumor model. We found that loss of E2f1 or E2f3 led to a significant delay in tumor onset in both oncogenic models, whereas loss of E2f2 accelerated mammary tumorigenesis driven by Myc-overexpression. Furthermore, southern blot analysis of final tumors derived from conditionally deleted E2f3(-/loxP) mammary glands revealed that there is a selection against E2f3(-/-) cells from developing mammary carcinomas, and that such selection pressure is higher in the presence of ErbB2 activation than in the presence of Myc activation. Taken together, our data suggest oncogenic activities of E2F1 and E2F3 in ErbB2- or Myc-triggered mammary tumorigenesis, and a tumor suppressor role of E2F2 in Myc-mediated mammary tumorigenesis.	[Wu, L.; de Bruin, A.; Wang, H.; Simmons, T.; Cleghorn, W.; Goldenberg, L. E.; Sites, E.; Sandy, A.; Trimboli, A.; Leone, G.] Ohio State Univ, Dept Mol Genet, Coll Biol Sci, Columbus, OH 43210 USA; [Wu, L.; de Bruin, A.; Wang, H.; Simmons, T.; Cleghorn, W.; Goldenberg, L. E.; Sites, E.; Sandy, A.; Trimboli, A.; Leone, G.] Ohio State Univ, Ctr Comprehens Canc, Human Canc Genet Program, Columbus, OH 43210 USA; [Wu, L.; de Bruin, A.; Wang, H.; Simmons, T.; Cleghorn, W.; Goldenberg, L. E.; Sites, E.; Sandy, A.; Trimboli, A.; Leone, G.] Ohio State Univ, Coll Med, Dept Mol Virol Immunol & Med Genet, Columbus, OH 43210 USA; [Fernandez, S. A.] Ohio State Univ, Ctr Biostat, Columbus, OH 43210 USA; [Eng, C.] Cleveland Clin, Genom Med Inst, Cleveland, OH 44106 USA; [Shapiro, C.] Ohio State Univ, Coll Med, Div Hematol & Oncol, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; Cleveland Clinic Foundation; University System of Ohio; Ohio State University	Wu, L (corresponding author), Rutgers New Jersey Med Sch, Ctr Canc, 205 South Orange Ave, Newark, NJ 07103 USA.	wuli@njms.rutgers.edu	de Bruin, Alain/AAL-9195-2020	de Bruin, Alain/0000-0001-8579-2649	NIH [R01CA85619, R01CA82259, R01HD047470, R01 CA121275, P01CA097189]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047470] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA082259, R01CA121275, R01CA085619, P01CA097189] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank L Rawahneh, J Moffitt and N Lovett for technical assistance with histology. We also thank OSUCCC Shared Resources for microarray and nucleic acid. This work was funded by NIH grants to GL (R01CA85619, R01CA82259, R01HD047470, R01 CA121275; P01CA097189). GL is a Pew Charitable Trust Scholar and a Leukemia and Lymphoma Society Scholar.	Abate-Shen C, 2000, GENE DEV, V14, P2410, DOI 10.1101/gad.819500; Agger K, 2005, ONCOGENE, V24, P780, DOI 10.1038/sj.onc.1208248; Baudino TA, 2003, MOL CELL, V11, P905, DOI 10.1016/S1097-2765(03)00102-3; Bracken AP, 2004, TRENDS BIOCHEM SCI, V29, P409, DOI 10.1016/j.tibs.2004.06.006; Conner EA, 2000, ONCOGENE, V19, P5054, DOI 10.1038/sj.onc.1203885; Cooper CS, 2006, LUNG CANCER, V54, P155, DOI 10.1016/j.lungcan.2006.07.005; DeGregori J, 2004, J CELL SCI, V117, P3411, DOI 10.1242/jcs.01189; DeGregori J, 2006, CURR MOL MED, V6, P739; Denchi EL, 2005, MOL CELL BIOL, V25, P2660, DOI 10.1128/MCB.25.7.2660-2672.2005; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Feber A, 2004, ONCOGENE, V23, P1627, DOI 10.1038/sj.onc.1207274; Foster CS, 2004, ONCOGENE, V23, P5871, DOI 10.1038/sj.onc.1207800; Fujiwara K, 2011, CANCER RES, V71, P1924, DOI 10.1158/0008-5472.CAN-10-2386; Gaubatz S, 2000, MOL CELL, V6, P729, DOI 10.1016/S1097-2765(00)00071-X; Grasemann C, 2005, ONCOGENE, V24, P6441, DOI 10.1038/sj.onc.1208792; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; He YW, 2002, J BIOL CHEM, V277, P23493, DOI 10.1074/jbc.M202629200; Humbert PO, 2000, GENE DEV, V14, P690; Hurst CD, 2008, ONCOGENE, V27, P2716, DOI 10.1038/sj.onc.1210934; Iwamoto M, 2004, CANCER BIOL THER, V3, P395, DOI 10.4161/cbt.3.4.733; Leone G, 1997, NATURE, V387, P422, DOI 10.1038/387422a0; Leone G, 2001, MOL CELL, V8, P105, DOI 10.1016/S1097-2765(01)00275-1; Leone G, 2000, MOL CELL BIOL, V20, P3626, DOI 10.1128/MCB.20.10.3626-3632.2000; Maddison LA, 2004, CANCER RES, V64, P6018, DOI 10.1158/0008-5472.CAN-03-2509; MULLER WJ, 1988, CELL, V54, P105, DOI 10.1016/0092-8674(88)90184-5; Nevins JR, 2001, HUM MOL GENET, V10, P699, DOI 10.1093/hmg/10.7.699; Nevins JR, 1998, CELL GROWTH DIFFER, V9, P585; Oeggerli M, 2004, ONCOGENE, V23, P5616, DOI 10.1038/sj.onc.1207749; Opavsky R, 2007, P NATL ACAD SCI USA, V104, P15400, DOI 10.1073/pnas.0706307104; Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263; Paulson QX, 2006, CELL CYCLE, V5, P184, DOI 10.4161/cc.5.2.2307; Pusapati RV, 2010, MOL CARCINOGEN, V49, P152, DOI 10.1002/mc.20584; Rempel RE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000640; Rounbehler RJ, 2002, CANCER RES, V62, P3276; SANDGREN EP, 1995, CANCER RES, V55, P3915; Scheijen B, 2004, J BIOL CHEM, V279, P10476, DOI 10.1074/jbc.M313682200; Sharma N, 2006, J BIOL CHEM, V281, P36124, DOI 10.1074/jbc.M604152200; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Simin K, 2004, PLOS BIOL, V2, P194, DOI 10.1371/journal.pbio.0020022; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Suzuki T, 1999, INT J CANCER, V81, P535, DOI 10.1002/(SICI)1097-0215(19990517)81:4<535::AID-IJC5>3.0.CO;2-4; Timmers C, 2007, MOL CELL BIOL, V27, P65, DOI 10.1128/MCB.02147-06; Trimarchi JM, 2002, NAT REV MOL CELL BIO, V3, P11, DOI 10.1038/nrm714; Wagner KU, 1997, NUCLEIC ACIDS RES, V25, P4323, DOI 10.1093/nar/25.21.4323; Wu LZ, 2001, NATURE, V414, P457, DOI 10.1038/35106593; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zhou ZX, 2007, CANCER RES, V67, P5683, DOI 10.1158/0008-5472.CAN-07-0768; Zhou ZX, 2006, CANCER RES, V66, P7889, DOI 10.1158/0008-5472.CAN-06-0486; Ziebold U, 2003, MOL CELL BIOL, V23, P6542, DOI 10.1128/MCB.23.18.6542-6552.2003	50	25	26	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	JAN 2	2015	34	1					119	128		10.1038/onc.2013.511	http://dx.doi.org/10.1038/onc.2013.511			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	CB6MC	24276244	Green Accepted			2022-12-25	WOS:000349740100011
J	Kriz, V; Pospichalova, V; Masek, J; Kilander, MBC; Slavik, J; Tanneberger, K; Schulte, G; Machala, M; Kozubik, A; Behrens, J; Bryja, V				Kriz, Vitezslav; Pospichalova, Vendula; Masek, Jan; Kilander, Michaela Brita Christina; Slavik, Josef; Tanneberger, Kristina; Schulte, Gunnar; Machala, Miroslav; Kozubik, Alois; Behrens, Juergen; Bryja, Vitezslav			beta-Arrestin Promotes Wnt-induced Low Density Lipoprotein Receptor-related Protein 6 (Lrp6) Phosphorylation via Increased Membrane Recruitment of Amer1 Protein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							CONVERGENT EXTENSION MOVEMENTS; SIGNALING PATHWAYS; IN-VIVO; CATENIN; ACTIVATION; BETA-ARRESTIN-2; DVL; APC; ENDOCYTOSIS; MECHANISM	beta-Arrestin is a scaffold protein that regulates signal transduction by seven transmembrane-spanning receptors. Among other functions it is also critically required for Wnt/beta-catenin signal transduction. In the present study we provide for the first time a mechanistic basis for the beta-arrestin function in Wnt/beta-catenin signaling. We demonstrate that beta-arrestin is required for efficient Wnt3a-induced Lrp6 phosphorylation, a key event in downstream signaling. beta-Arrestin regulates Lrp6 phosphorylation via a novel interaction with phosphatidylinositol 4,5-bisphosphate (PtdIns(4,5)P-2)-binding protein Amer1/WTX/Fam123b. Amer1 has been shown very recently to bridge Wnt-induced and Dishevelled-associated PtdIns(4,5)P-2 production to the phosphorylation of Lrp6. Using fluorescence recovery after photobleaching we show here that beta-arrestin is required for the Wnt3a-induced Amer1 membrane dynamics and downstream signaling. Finally, we show that beta-arrestin interacts with PtdIns kinases PI4KII alpha and PIP5KI beta. Importantly, cells lacking beta-arrestin showed higher steady-state levels of the relevant PtdInsP and were unable to increase levels of these PtdInsP in response to Wnt3a. In summary, our data show that beta-arrestins regulate Wnt3a-induced Lrp6 phosphorylation by the regulation of the membrane dynamics of Amer1. We propose that beta-arrestins via their scaffolding function facilitate Amer1 interaction with PtdIns(4,5)P-2, which is produced locally upon Wnt3a stimulation by beta-arrestin- and Dishevelled-associated kinases.	[Kriz, Vitezslav; Pospichalova, Vendula; Masek, Jan; Schulte, Gunnar; Kozubik, Alois; Bryja, Vitezslav] Masaryk Univ, Inst Expt Biol, Fac Sci, CS-61137 Brno, Czech Republic; [Kriz, Vitezslav; Kozubik, Alois; Bryja, Vitezslav] Acad Sci Czech Republic, Inst Biophys, Dept Cytokinet, CS-61265 Brno, Czech Republic; [Tanneberger, Kristina; Behrens, Juergen] Univ Erlangen Nurnberg, Nikolaus Fiebiger Ctr, D-91054 Erlangen, Germany; [Kilander, Michaela Brita Christina; Schulte, Gunnar] Karolinska Inst, Dept Physiol & Pharmacol, S-17177 Stockholm, Sweden; [Slavik, Josef; Machala, Miroslav] Vet Res Inst, Dept Toxicol Pharmacol & Immunotherapy, Brno 62100, Czech Republic; [Masek, Jan] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague, Czech Republic	Masaryk University Brno; Czech Academy of Sciences; Institute of Biophysics of the Czech Academy of Sciences; University of Erlangen Nuremberg; Karolinska Institutet; Czech Veterinary Research Institute; Czech Academy of Sciences; Institute of Molecular Genetics of the Czech Academy of Sciences	Bryja, V (corresponding author), Masaryk Univ, Inst Expt Biol, Fac Sci, Kotlarska 2, CS-61137 Brno, Czech Republic.	bryja@sci.muni.cz	Kozubík, Alois/H-1954-2014; Bryja, Vít?zslav/H-1925-2014; Masek, Jan/I-9029-2014; Bryja, Vítězslav/P-4217-2019; Mašek, Jan/N-3169-2019; Pospichalova, Vendula/C-6126-2015; Kriz, Vitezslav/G-6353-2014	Bryja, Vít?zslav/0000-0002-9136-5085; Bryja, Vítězslav/0000-0002-9136-5085; Mašek, Jan/0000-0003-2904-3808; Pospichalova, Vendula/0000-0002-5957-2156; Machala, Miroslav/0000-0001-6870-6542; Schulte, Gunnar/0000-0002-2700-7013; Kilander, Michaela/0000-0001-5166-4614	Czech Science Foundation [204/09/0498, 204/09/J030, GA13-32990S]; European Molecular Biology Organization (EMBO); Ministry of Education Youth and Sport of the Czech Republic [MSM0021622430]; Project KI-MU [CZ.1.07/2.3.00/20.0180]; European Social Fund; state budget of Czech Republic "Postdoc I" [CZ.1.07/2.3.00/30.0009]; Knut and Alice Wallenberg Foundation [KAW2008.0149]; Swedish Research Council [K2008-68P-20810-01-4, K2008-68K-20805-01-4]; Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Deutsche Forschungsgemeinschaft [Be1550/6-1]	Czech Science Foundation(Grant Agency of the Czech Republic); European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); Ministry of Education Youth and Sport of the Czech Republic(Ministry of Education, Youth & Sports - Czech Republic); Project KI-MU; European Social Fund(European Social Fund (ESF)); state budget of Czech Republic "Postdoc I"; Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for International Cooperation in Research and Higher Education (STINT); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by Czech Science Foundation Grants 204/09/0498, 204/09/J030, and GA13-32990S; a European Molecular Biology Organization (EMBO) installation grant; and Ministry of Education Youth and Sport of the Czech Republic Grant MSM0021622430. The collaboration between Masaryk University and Karolinska Institutet is supported by Project KI-MU Grant CZ.1.07/2.3.00/20.0180.; Supported by a project co-financed by the European Social Fund and the state budget of Czech Republic "Postdoc I," Grant CZ.1.07/2.3.00/30.0009.; Supported by Knut and Alice Wallenberg Foundation Grant KAW2008.0149, Swedish Research Council Grants K2008-68P-20810-01-4 and K2008-68K-20805-01-4, and The Swedish Foundation for International Cooperation in Research and Higher Education (STINT).; Supported by Deutsche Forschungsgemeinschaft Grant Be1550/6-1.	Angers S, 2006, NAT CELL BIOL, V8, P348, DOI 10.1038/ncb1381; Balla A, 2002, J BIOL CHEM, V277, P20041, DOI 10.1074/jbc.M111807200; Behrens J, 1998, SCIENCE, V280, P596, DOI 10.1126/science.280.5363.596; Bernatik O, 2011, J BIOL CHEM, V286, P10396, DOI 10.1074/jbc.M110.169870; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Boutet A, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-280; Bryja V, 2004, BBA-MOL CELL RES, V1691, P105, DOI 10.1016/j.bbamcr.2004.01.001; Bryja V, 2007, P NATL ACAD SCI USA, V104, P6690, DOI 10.1073/pnas.0611356104; Bryja V, 2008, EMBO REP, V9, P1244, DOI 10.1038/embor.2008.193; Cervenka I, 2011, MOL CELL BIOL, V31, P179, DOI 10.1128/MCB.00550-10; Chen MY, 2009, J BIOL CHEM, V284, P35040, DOI 10.1074/jbc.M109.047456; Chen W, 2001, P NATL ACAD SCI USA, V98, P14889, DOI 10.1073/pnas.211572798; Chen W, 2003, SCIENCE, V301, P1391, DOI 10.1126/science.1082808; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Davidson G, 2009, DEV CELL, V17, P788, DOI 10.1016/j.devcel.2009.11.006; Grohmann A, 2007, J CELL SCI, V120, P3738, DOI 10.1242/jcs.011320; Kikuchi A, 2009, TRENDS CELL BIOL, V19, P119, DOI 10.1016/j.tcb.2009.01.003; Kim GH, 2008, J CELL BIOL, V182, P1073, DOI 10.1083/jcb.200710188; Kim GH, 2007, EMBO J, V26, P2513, DOI 10.1038/sj.emboj.7601688; Kimelman D, 2006, ONCOGENE, V25, P7482, DOI 10.1038/sj.onc.1210055; Kohout TA, 2001, P NATL ACAD SCI USA, V98, P1601, DOI 10.1073/pnas.041608198; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Krejci P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035826; Lee JS, 1999, J BIOL CHEM, V274, P21464, DOI 10.1074/jbc.274.30.21464; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; MacDonald BT, 2009, DEV CELL, V17, P9, DOI 10.1016/j.devcel.2009.06.016; Major MB, 2007, SCIENCE, V316, P1043, DOI 10.1126/science/1141515; Major MB, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.2000037; Nelson CD, 2008, J BIOL CHEM, V283, P21093, DOI 10.1074/jbc.M800431200; Pan WJ, 2008, SCIENCE, V321, P1350, DOI 10.1126/science.1160741; Pfister AS, 2012, J BIOL CHEM, V287, P1734, DOI 10.1074/jbc.M111.308650; Qin YB, 2009, J BIOL CHEM, V284, P22544, DOI 10.1074/jbc.M109.014399; Schulte G, 2007, TRENDS PHARMACOL SCI, V28, P518, DOI 10.1016/j.tips.2007.09.001; Schulte G, 2010, BRIT J PHARMACOL, V159, P1051, DOI 10.1111/j.1476-5381.2009.00466.x; Schwarz-Romond T, 2005, J CELL SCI, V118, P5269, DOI 10.1242/jcs.02646; Smalley MJ, 2005, J CELL SCI, V118, P5279, DOI 10.1242/jcs.02647; Tamai K, 2004, MOL CELL, V13, P149, DOI 10.1016/S1097-2765(03)00484-2; Tanneberger K, 2011, J BIOL CHEM, V286, P19204, DOI 10.1074/jbc.M111.224881; Tanneberger K, 2011, EMBO J, V30, P1433, DOI 10.1038/emboj.2011.28; Tauriello DVF, 2010, MOL CELL, V37, P607, DOI 10.1016/j.molcel.2010.01.035; Veeman MT, 2003, CURR BIOL, V13, P680, DOI 10.1016/S0960-9822(03)00240-9; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	44	10	10	0	17	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1128	1141		10.1074/jbc.M113.498444	http://dx.doi.org/10.1074/jbc.M113.498444			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265322	Green Published, hybrid			2022-12-25	WOS:000330541200044
J	Law, BMH; Spain, VA; Leinster, VHL; Chia, R; Beilina, A; Cho, HJ; Taymans, JM; Urban, MK; Sancho, RM; Ramirez, MB; Biskup, S; Baekelandt, V; Cai, HB; Cookson, MR; Berwick, DC; Harvey, K				Law, Bernard M. H.; Spain, Victoria A.; Leinster, Veronica H. L.; Chia, Ruth; Beilina, Alexandra; Cho, Hyun J.; Taymans, Jean-Marc; Urban, Mary K.; Sancho, Rosa M.; Ramirez, Marian Blanca; Biskup, Saskia; Baekelandt, Veerle; Cai, Huaibin; Cookson, Mark R.; Berwick, Daniel C.; Harvey, Kirsten			A Direct Interaction between Leucine-rich Repeat Kinase 2 and Specific beta-Tubulin Isoforms Regulates Tubulin Acetylation	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							DISEASE-ASSOCIATED MUTATIONS; PARKINSONS-DISEASE; NEURONAL MIGRATION; 14-3-3 BINDING; ROC DOMAIN; LRRK2; PROTEIN; PHOSPHORYLATION; MICROTUBULES; GENE	Mutations in LRRK2, encoding the multifunctional protein leucine-rich repeat kinase 2 (LRRK2), are a common cause of Parkinson disease. LRRK2 has been suggested to influence the cytoskeleton as LRRK2 mutants reduce neurite outgrowth and cause an accumulation of hyperphosphorylated Tau. This might cause alterations in the dynamic instability of microtubules suggested to contribute to the pathogenesis of Parkinson disease. Here, we describe a direct interaction between LRRK2 and beta-tubulin. This interaction is conferred by the LRRK2 Roc domain and is disrupted by the familial R1441G mutation and artificial Roc domain mutations that mimic autophosphorylation. LRRK2 selectively interacts with three beta-tubulin isoforms: TUBB, TUBB4, and TUBB6, one of which (TUBB4) is mutated in the movement disorder dystonia type 4 (DYT4). Binding specificity is determined by lysine 362 and alanine 364 of beta-tubulin. Molecular modeling was used to map the interaction surface to the luminal face of microtubule protofibrils in close proximity to the lysine 40 acetylation site in beta-tubulin. This location is predicted to be poorly accessible within mature stabilized microtubules, but exposed in dynamic microtubule populations. Consistent with this finding, endogenous LRRK2 displays a preferential localization to dynamic microtubules within growth cones, rather than adjacent axonal microtubule bundles. This interaction is functionally relevant to microtubule dynamics, as mouse embryonic fibroblasts derived from LRRK2 knockout mice display increased microtubule acetylation. Taken together, our data shed light on the nature of the LRRK2-tubulin interaction, and indicate that alterations in microtubule stability caused by changes in LRRK2 might contribute to the pathogenesis of Parkinson disease.	[Law, Bernard M. H.; Spain, Victoria A.; Leinster, Veronica H. L.; Sancho, Rosa M.; Ramirez, Marian Blanca; Berwick, Daniel C.; Harvey, Kirsten] UCL, UCL Sch Pharm, Dept Pharmacol, London WC1N 1AX, England; [Chia, Ruth; Beilina, Alexandra; Urban, Mary K.; Cookson, Mark R.] NIA, Cell Biol & Gene Express Unit, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Cho, Hyun J.; Cai, Huaibin] NIA, Transgen Sect, Neurogenet Lab, NIH, Bethesda, MD 20892 USA; [Taymans, Jean-Marc; Baekelandt, Veerle] Katholieke Univ Leuven, Dept Neurosci, Lab Neurobiol & Gene Therapy, B-3000 Louvain, Belgium; [Taymans, Jean-Marc; Baekelandt, Veerle] Katholieke Univ Leuven, Leuven Res Inst Neurosci & Dis LIND, B-3000 Louvain, Belgium; [Biskup, Saskia] Hertie Inst Clin Brain Res, D-72076 Tubingen, Germany; [Biskup, Saskia] German Ctr Neurodegenerat Dis, D-72076 Tubingen, Germany	University of London; University College London; National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); National Institutes of Health (NIH) - USA; NIH National Institute on Aging (NIA); KU Leuven; KU Leuven; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE)	Harvey, K (corresponding author), UCL, UCL Sch Pharm, Dept Pharmacol, 29-39 Brunswick Sq, London WC1N 1AX, England.	kirsten.harvey@ucl.ac.uk	Berwick, Dan/J-2378-2012; Ramirez, Marian Blanca/AAN-7851-2020; Taymans, Jean-Marc/M-9175-2018; Baekelandt, Veerle/ABB-9736-2020; Cai, Huaibin/H-3359-2013; Chia, Ruth/AAF-4900-2021; Berwick, Dan/AAJ-7779-2021; Law, Bernard M. H./O-5098-2015; Cookson, Mark/AAW-2516-2021	Berwick, Dan/0000-0002-7144-7841; Taymans, Jean-Marc/0000-0001-5503-5524; Baekelandt, Veerle/0000-0001-8966-2921; Cai, Huaibin/0000-0002-8596-6108; Chia, Ruth/0000-0002-4709-7423; Berwick, Dan/0000-0002-7144-7841; Law, Bernard M. H./0000-0001-9571-6893; Cookson, Mark/0000-0002-1058-3831	National Institutes of Health Intramural Research Program of the National Institutes of Health, NIA; Wellcome Trust [WT088145AIA, WT095010MA]; Michael J. Fox Foundation; Vera Down British Medical Association; Ibercaja Obra Social award; Fund Druwe-Eerdekens; NATIONAL INSTITUTE ON AGING [ZIAAG000937, ZIAAG000928] Funding Source: NIH RePORTER	National Institutes of Health Intramural Research Program of the National Institutes of Health, NIA; Wellcome Trust(Wellcome TrustEuropean Commission); Michael J. Fox Foundation; Vera Down British Medical Association; Ibercaja Obra Social award; Fund Druwe-Eerdekens; NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by the National Institutes of Health Intramural Research Program of the National Institutes of Health, NIA (to M. R. C. and H. C.), Wellcome Trust Grants WT088145AIA and WT095010MA (to K. H.), grants from the Michael J. Fox Foundation (to K. H., V. B., and J. M. T.), a Vera Down British Medical Association Research grant (to K. H.), an Ibercaja Obra Social award (to M. B. R.), and the Fund Druwe-Eerdekens managed by the King Baudouin Foundation (to J. M. T.).	Akella JS, 2010, NATURE, V467, P218, DOI 10.1038/nature09324; Berwick DC, 2012, HUM MOL GENET, V21, P4966, DOI 10.1093/hmg/dds342; Berwick DC, 2012, BIOCHEM SOC T, V40, P1123, DOI 10.1042/BST20120122; Berwick DC, 2011, TRENDS CELL BIOL, V21, P257, DOI 10.1016/j.tcb.2011.01.001; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Ciani L, 2007, BMC CELL BIOL, V8, DOI 10.1186/1471-2121-8-27; Civiero L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043472; Cueva JG, 2012, CURR BIOL, V22, P1066, DOI 10.1016/j.cub.2012.05.012; Daniels V, 2011, J NEUROCHEM, V116, P304, DOI 10.1111/j.1471-4159.2010.07105.x; Demer JL, 2010, INVEST OPHTH VIS SCI, V51, P4600, DOI 10.1167/iovs.10-5438; Deng XM, 2011, NAT CHEM BIOL, V7, P203, DOI 10.1038/NCHEMBIO.538; Dunbrack RL, 2002, CURR OPIN STRUC BIOL, V12, P431, DOI 10.1016/S0959-440X(02)00344-5; Dzamko N, 2010, BIOCHEM J, V430, P405, DOI 10.1042/BJ20100784; Edwards TL, 2010, ANN HUM GENET, V74, P97, DOI 10.1111/j.1469-1809.2009.00560.x; Gandhi PN, 2008, J NEUROSCI RES, V86, P1711, DOI 10.1002/jnr.21622; Geraerts M, 2005, J GENE MED, V7, P1299, DOI 10.1002/jgm.778; Gillardon F, 2009, NEUROSCIENCE, V163, P533, DOI 10.1016/j.neuroscience.2009.06.051; Gillardon F, 2009, J NEUROCHEM, V110, P1514, DOI 10.1111/j.1471-4159.2009.06235.x; Gloeckner CJ, 2010, J PROTEOME RES, V9, P1738, DOI 10.1021/pr9008578; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Gloeckner CJ, 2006, HUM MOL GENET, V15, P223, DOI 10.1093/hmg/ddi439; Goldstein AYN, 2008, CURR OPIN NEUROBIOL, V18, P495, DOI 10.1016/j.conb.2008.10.003; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Greggio E, 2009, BIOCHEM BIOPH RES CO, V389, P449, DOI 10.1016/j.bbrc.2009.08.163; Greggio E, 2009, ASN NEURO, V1, DOI 10.1042/AN20090007; Harvey K, 2004, J NEUROSCI, V24, P5816, DOI 10.1523/JNEUROSCI.1184-04.2004; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Hersheson J, 2013, ANN NEUROL, V73, P546, DOI 10.1002/ana.23832; Ho CCY, 2009, J NEUROSCI, V29, P1011, DOI 10.1523/JNEUROSCI.5175-08.2009; Hsu CH, 2010, NEURODEGENER DIS, V7, P68, DOI 10.1159/000285509; Hsu CH, 2010, J NEUROCHEM, V112, P1593, DOI 10.1111/j.1471-4159.2010.06568.x; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Ibrahimi A, 2009, HUM GENE THER, V20, P845, DOI 10.1089/hum.2008.188; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; Kamikawaji S, 2009, BIOCHEMISTRY-US, V48, P10963, DOI 10.1021/bi9011379; Kar S, 2003, EMBO J, V22, P70, DOI 10.1093/emboj/cdg001; Kawakami F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030834; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Kett LR, 2012, HUM MOL GENET, V21, P890, DOI 10.1093/hmg/ddr526; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Kumari U, 2009, FEBS J, V276, P6455, DOI 10.1111/j.1742-4658.2009.07344.x; Lin CH, 2010, J NEUROSCI, V30, P13138, DOI 10.1523/JNEUROSCI.1737-10.2010; Lohmann K, 2013, ANN NEUROL, V73, P537, DOI 10.1002/ana.23829; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; MacLeod D, 2006, NEURON, V52, P587, DOI 10.1016/j.neuron.2006.10.008; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Melrose HL, 2010, NEUROBIOL DIS, V40, P503, DOI 10.1016/j.nbd.2010.07.010; Nichols RJ, 2010, BIOCHEM J, V430, P393, DOI 10.1042/BJ20100483; Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Paisan-Ruiz C, 2004, NEURON, V44, P595, DOI 10.1016/j.neuron.2004.10.023; Parisiadou Loukia, 2010, Commun Integr Biol, V3, P396, DOI 10.4161/cib.3.5.12286; Parisiadou L, 2009, J NEUROSCI, V29, P13971, DOI 10.1523/JNEUROSCI.3799-09.2009; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Plowey ED, 2008, J NEUROCHEM, V105, P1048, DOI 10.1111/j.1471-4159.2008.05217.x; Poirier K, 2010, HUM MOL GENET, V19, P4462, DOI 10.1093/hmg/ddq377; Ross OA, 2006, ANN NEUROL, V59, P388, DOI 10.1002/ana.20731; Sancho RM, 2009, HUM MOL GENET, V18, P3955, DOI 10.1093/hmg/ddp337; Sarraf SA, 2013, NATURE, V496, P372, DOI 10.1038/nature12043; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Shida T, 2010, P NATL ACAD SCI USA, V107, P21517, DOI 10.1073/pnas.1013728107; Simon-Sanchez J, 2009, NAT GENET, V41, P1308, DOI 10.1038/ng.487; Tischfield MA, 2010, CELL, V140, P74, DOI 10.1016/j.cell.2009.12.011; Tong YR, 2009, P NATL ACAD SCI USA, V106, P14622, DOI 10.1073/pnas.0906334106; Wagner SA, 2012, MOL CELL PROTEOMICS, V11, P1578, DOI 10.1074/mcp.M112.017905; West AB, 2007, HUM MOL GENET, V16, P223, DOI 10.1093/hmg/ddl471; Xiong YL, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1000902; Zhang Y, 2003, EMBO J, V22, P1168, DOI 10.1093/emboj/cdg115; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	69	99	101	0	22	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					895	908		10.1074/jbc.M113.507913	http://dx.doi.org/10.1074/jbc.M113.507913			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275654	hybrid, Green Published, Green Submitted, Green Accepted			2022-12-25	WOS:000330541200025
J	Wang, SL; Horimoto, Y; Dee, DR; Yada, RY				Wang, Shenlin; Horimoto, Yasumi; Dee, Derek R.; Yada, Rickey Y.			Understanding the Mechanism of Prosegment-catalyzed Folding by Solution NMR Spectroscopy	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							RESOLUTION CRYSTAL-STRUCTURE; KINETICALLY STABLE PROTEINS; ALPHA-LYTIC PROTEASE; ASPARTIC PROTEINASES; PORCINE PEPSIN; HEAT-CAPACITY; RELAXATION; IDENTIFICATION; DENATURATION; STABILITY	Multidomain protein folding is often more complex than a two-state process, which leads to the spontaneous folding of the native state. Pepsin, a zymogen-derived enzyme, without its prosegment (PS), is irreversibly denatured and folds to a thermodynamically stable, non-native conformation, termed refolded pepsin, which is separated from native pepsin by a large activation barrier. While it is known that PS binds refolded pepsin and catalyzes its conversion to the native form, little structural details are known regarding this conversion. In this study, solution NMR was used to elucidate the PS-catalyzed folding mechanism by examining the key equilibrium states, e. g. native and refolded pepsin, both in the free and PS-bound states, and pepsinogen, the zymogen form of pepsin. Refolded pepsin was found to be partially structured and lacked the correct domain-domain structure and active-site cleft formed in the native state. Analysis of chemical shift data revealed that upon PS binding refolded pepsin folds into a state more similar to that of pepsinogen than to native pepsin. Comparison of pepsin folding by wild-type and mutant PSs, including a double mutant PS, indicated that hydrophobic interactions between residues of prosegment and refolded pepsin lower the folding activation barrier. A mechanism is proposed for the binding of PS to refolded pepsin and how the formation of the native structure is mediated.	[Wang, Shenlin] Univ Guelph, Dept Phys, Guelph, ON N1G 2W1, Canada; [Horimoto, Yasumi; Yada, Rickey Y.] Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada; [Yada, Rickey Y.] Univ Guelph, Biophys Interdept Grp, Guelph, ON N1G 2W1, Canada; [Dee, Derek R.] Univ Alberta, Dept Phys, Edmonton, AB T6G 2E1, Canada	University of Guelph; University of Guelph; University of Guelph; University of Alberta	Yada, RY (corresponding author), Univ Guelph, Dept Food Sci, Guelph, ON N1G 2W1, Canada.	ryada@uoguelph.ca	Dee, Derek/AAK-5892-2020; Yada, Rickey Y/A-8289-2013; wang, shenlin/B-6530-2016	wang, shenlin/0000-0002-0153-0578; Yada, Rickey/0000-0002-8648-2156	Natural Sciences and Engineering Research Council of Canada (NSERC); Canada Research Chairs (CRC) Program; Canadian Institutes of Health Research (CIHR) Fellowship	Natural Sciences and Engineering Research Council of Canada (NSERC)(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canada Research Chairs (CRC) Program(Canada Research Chairs); Canadian Institutes of Health Research (CIHR) Fellowship(Canadian Institutes of Health Research (CIHR))	This work was supported by the Natural Sciences and Engineering Research Council of Canada (NSERC) and the Canada Research Chairs (CRC) Program.; Supported by the Canadian Institutes of Health Research (CIHR) Fellowship.	AHMAD F, 1978, BIOCHEMISTRY-US, V17, P241, DOI 10.1021/bi00595a008; AHMAD F, 1978, INT J PEPT PROT RES, V12, P155; ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baker D, 1993, CURR OPIN CELL BIOL, V5, P966, DOI 10.1016/0955-0674(93)90078-5; Banci L, 2010, P NATL ACAD SCI USA, V107, P20190, DOI 10.1073/pnas.1010095107; Banci L, 2009, NAT STRUCT MOL BIOL, V16, P198, DOI 10.1038/nsmb.1553; Bryan PN, 2002, CHEM REV, V102, P4805, DOI 10.1021/cr010190b; Connelly S, 2010, CURR OPIN STRUC BIOL, V20, P54, DOI 10.1016/j.sbi.2009.12.009; COOPER JB, 1990, J MOL BIOL, V214, P199, DOI 10.1016/0022-2836(90)90156-G; Cooper JB, 2002, CURR DRUG TARGETS, V3, P155, DOI 10.2174/1389450024605382; Dee D. R., 2010, THESIS U GUELPH CANA; Dee D, 2006, BIOCHEMISTRY-US, V45, P13982, DOI 10.1021/bi061270i; Dee DR, 2010, BIOCHEMISTRY-US, V49, P365, DOI 10.1021/bi9014055; Dee DR, 2009, BBA-PROTEINS PROTEOM, V1794, P1795, DOI 10.1016/j.bbapap.2009.08.017; Demarest SJ, 2002, NATURE, V415, P549, DOI 10.1038/415549a; DILL KA, 1990, BIOCHEMISTRY-US, V29, P7133, DOI 10.1021/bi00483a001; Dill KA, 2008, ANNU REV BIOPHYS, V37, P289, DOI 10.1146/annurev.biophys.37.092707.153558; Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s; EDER J, 1995, MOL MICROBIOL, V16, P609, DOI 10.1111/j.1365-2958.1995.tb02423.x; EDER J, 1993, BIOCHEMISTRY-US, V32, P18, DOI 10.1021/bi00052a004; Fuhrmann CN, 2004, J MOL BIOL, V338, P999, DOI 10.1016/j.jmb.2004.03.018; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GOMEZ J, 1995, PROTEINS, V22, P404, DOI 10.1002/prot.340220410; HARTSUCK JA, 1992, PROTEINS, V13, P1, DOI 10.1002/prot.340130102; Horimoto Y, 2014, BIOMOL NMR ASSIGN, V8, P57, DOI 10.1007/s12104-012-9452-4; Horimoto Y, 2009, NEW BIOTECHNOL, V25, P318, DOI 10.1016/j.nbt.2009.03.010; Kamatari YO, 2003, PROTEIN SCI, V12, P717, DOI 10.1110/ps.0219903; Keller R., 2004, COMPUTER AIDED RESON, V1; Konno T, 2000, BIOCHEMISTRY-US, V39, P4182, DOI 10.1021/bi991923d; Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655; Loladze VV, 2001, PROTEIN SCI, V10, P1343, DOI 10.1110/ps.370101; Manning M, 2004, BIOCHEMISTRY-US, V43, P11248, DOI 10.1021/bi0491898; Meinhold DW, 2011, P NATL ACAD SCI USA, V108, P9078, DOI 10.1073/pnas.1105682108; Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104; Nguyen JT, 2008, ARCH PHARM, V341, P523, DOI 10.1002/ardp.200700267; Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Sanchez-Ruiz JM, 2010, BIOPHYS CHEM, V148, P1, DOI 10.1016/j.bpc.2010.02.004; Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i; Shinde U, 2000, SEMIN CELL DEV BIOL, V11, P35, DOI 10.1006/scdb.1999.0349; SIELECKI AR, 1990, J MOL BIOL, V214, P143, DOI 10.1016/0022-2836(90)90153-D; Sohl JL, 1998, NATURE, V395, P817, DOI 10.1038/27470; Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858; Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003; Xia K, 2007, P NATL ACAD SCI USA, V104, P17329, DOI 10.1073/pnas.0705417104; Xia K, 2010, BIOCHEMISTRY-US, V49, P7239, DOI 10.1021/bi1010877	48	5	5	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					697	707		10.1074/jbc.M113.505891	http://dx.doi.org/10.1074/jbc.M113.505891			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265313	hybrid, Green Published			2022-12-25	WOS:000330541200010
J	Chang, SY; Lee, SN; Yang, JY; Kim, DW; Yoon, JH; Ko, HJ; Ogawa, M; Sasakawa, C; Kweon, MN				Chang, Sun-Young; Lee, Se-Na; Yang, Jin-Young; Kim, Dong Wook; Yoon, Joo-Heon; Ko, Hyun-Jeong; Ogawa, Michinaga; Sasakawa, Chihiro; Kweon, Mi-Na			Autophagy Controls an Intrinsic Host Defense to Bacteria by Promoting Epithelial Cell Survival: A Murine Model	PLOS ONE			English	Article							NF-KAPPA-B; INTESTINAL PANETH CELLS; GROUP-A STREPTOCOCCUS; GENE ATG16L1; SHIGELLA; ACTIVATION; INFECTION; DISEASE; TARGETS; DEATH	Cell death is a critical host response to regulate the fate of bacterial infections, innate immune responses, and ultimately, disease outcome. Shigella spp. invade and colonize gut epithelium in human and nonhuman primates but adult mice are naturally resistant to intra-gastric Shigella infection. In this study, however, we found Shigella could invade the terminal ileum of the mouse small intestine by 1 hour after infection and be rapidly cleared within 24 h. These early phase events occurred shortly after oral infection resulting in epithelial shedding, degranulation of Paneth cells, and cell death in the intestine. During this process, autophagy proceeded without any signs of inflammation. In contrast, blocking autophagy in epithelial cells enhanced host cell death, leading to tissue destruction and to inflammation, suggesting that autophagic flow relieves cellular stress associated with host cell death and inflammation. Herein we propose a new concept of "epithelial barrier turnover" as a general intrinsic host defense mechanism that increases survival of host cells and inhibits inflammation against enteric bacterial infections, which is regulated by autophagy.	[Chang, Sun-Young; Lee, Se-Na; Yang, Jin-Young; Ko, Hyun-Jeong; Kweon, Mi-Na] Int Vaccine Inst, Div Sci Lab, Mucosal Immunol Sect, Seoul, South Korea; [Chang, Sun-Young] Ajou Univ, Coll Pharm, Microbiol Lab, Suwon 441749, Kyeonggi Do, South Korea; [Kim, Dong Wook] Hanyang Univ, Coll Pharm, Ansan, Kyeonggi Do, South Korea; [Yoon, Joo-Heon] Yonsei Univ, Coll Med, Dept Otorhinolaryngol, Seoul, South Korea; [Ko, Hyun-Jeong] Kangwon Natl Univ, Coll Pharm, Lab Microbiol & Immunol, Chunchon, Kangwon Do, South Korea; [Ogawa, Michinaga] Natl Inst Infect Dis, Dept Bacteriol 1, Tokyo, Japan; [Sasakawa, Chihiro] Nippon Inst Biol Sci, Tokyo, Japan; [Sasakawa, Chihiro] Chiba Univ, Med Mycol Res Ctr, Chiba, Japan	International Vaccine Institute; Ajou University; Hanyang University; Yonsei University; Yonsei University Health System; Kangwon National University; National Institute of Infectious Diseases (NIID); Chiba University	Kweon, MN (corresponding author), Int Vaccine Inst, Div Sci Lab, Mucosal Immunol Sect, Seoul, South Korea.	mnkweon@ivi.int	Kim, Dong Wook/H-8253-2015; rchnds, rchnds/D-7595-2016; Yoon, Joo-Heon/E-5781-2016	Kim, Dong Wook/0000-0001-5351-7597; Yoon, Joo-Heon/0000-0003-2404-7156	Ajou University; National Research Foundation of Korea (NRF); Ministry of Science, ICT & Future Planning (MSIP) [2007-0056092, 2010-0029133, 2011-0006965]; Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea [HI12C06870000 (A120770)];  [23000012]	Ajou University; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning (MSIP); Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea; 	This work was supported by the new faculty research fund of Ajou University, the National Research Foundation of Korea (NRF) funded by the Ministry of Science, ICT & Future Planning (MSIP) (No. 2007-0056092, 2010-0029133, and 2011-0006965), the Korean Healthcare Technology R&D Project, Ministry for Health, Welfare and Family Affairs, Republic of Korea HI12C06870000 (A120770), and a Grant-in-Aid for Specially Promoted Research (23000012), Japan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashida H, 2011, CURR OPIN IMMUNOL, V23, P448, DOI 10.1016/j.coi.2011.06.001; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cadwell K, 2010, CELL, V141, P1135, DOI 10.1016/j.cell.2010.05.009; Cadwell K, 2009, AUTOPHAGY, V5, P250, DOI 10.4161/auto.5.2.7560; Carneiro LAM, 2009, CELL HOST MICROBE, V5, P123, DOI 10.1016/j.chom.2008.12.011; Clark CS, 2007, INFECT IMMUN, V75, P2531, DOI 10.1128/IAI.01866-06; Dupont N, 2009, CELL HOST MICROBE, V6, P137, DOI 10.1016/j.chom.2009.07.005; Fernandez MI, 2008, J IMMUNOL, V180, P4924, DOI 10.4049/jimmunol.180.7.4924; Fernandez MI, 2003, CELL MICROBIOL, V5, P481, DOI 10.1046/j.1462-5822.2003.00295.x; Fujishima Y, 2011, ARCH BIOCHEM BIOPHYS, V506, P223, DOI 10.1016/j.abb.2010.12.009; Galluzzi L, 2009, CELL HOST MICROBE, V5, P107, DOI 10.1016/j.chom.2009.01.002; Guma M, 2011, J EXP MED, V208, P1889, DOI 10.1084/jem.20110242; Iwai H, 2007, CELL, V130, P611, DOI 10.1016/j.cell.2007.06.043; Kasper CA, 2010, IMMUNITY, V33, P804, DOI 10.1016/j.immuni.2010.10.015; Kim M, 2010, CELL HOST MICROBE, V8, P20, DOI 10.1016/j.chom.2010.06.006; Kim M, 2009, NATURE, V459, P578, DOI 10.1038/nature07952; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mostowy S, 2010, CELL HOST MICROBE, V8, P433, DOI 10.1016/j.chom.2010.10.009; Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966; Nakahira K, 2011, NAT IMMUNOL, V12, P222, DOI 10.1038/ni.1980; Napirei M, 2006, HEPATOLOGY, V43, P297, DOI 10.1002/hep.21034; OBRIEN AD, 1987, MICROBIOL REV, V51, P206, DOI 10.1128/MMBR.51.2.206-220.1987; Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036; Ogawa M, 2006, AUTOPHAGY, V2, P171, DOI 10.4161/auto.2829; Ogawa M, 2011, MICROBIOL IMMUNOL, V55, P459, DOI 10.1111/j.1348-0421.2011.00343.x; Ogawa M, 2011, CELL HOST MICROBE, V9, P376, DOI 10.1016/j.chom.2011.04.010; Ou XM, 2006, P NATL ACAD SCI USA, V103, P10923, DOI 10.1073/pnas.0601515103; Raqib R, 1996, ANN NY ACAD SCI, V797, P299, DOI 10.1111/j.1749-6632.1996.tb52985.x; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sanada T, 2012, NATURE, V483, P623, DOI 10.1038/nature10894; Sansonetti PJ, 2006, PLOS MED, V3, P1465, DOI 10.1371/journal.pmed.0030354; Shim DH, 2007, J IMMUNOL, V178, P2476, DOI 10.4049/jimmunol.178.4.2476; Shim DH, 2010, BIOCHEM BIOPH RES CO, V401, P554, DOI 10.1016/j.bbrc.2010.09.100; Tasdemir Ezgi, 2008, V445, P29, DOI 10.1007/978-1-59745-157-4_3; Travassos LH, 2010, NAT IMMUNOL, V11, P55, DOI 10.1038/ni.1823; Yoshimori T, 2009, CURR TOP MICROBIOL, V335, P217, DOI 10.1007/978-3-642-00302-8_10	37	20	20	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81095	10.1371/journal.pone.0081095	http://dx.doi.org/10.1371/journal.pone.0081095			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260541	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900117
J	Tong, MM; Li, XX; Parfrey, LW; Roth, B; Ippoliti, A; Wei, B; Borneman, J; McGovern, DPB; Frank, DN; Li, E; Horvath, S; Knight, R; Braun, J				Tong, Maomeng; Li, Xiaoxiao; Parfrey, Laura Wegener; Roth, Bennett; Ippoliti, Andrew; Wei, Bo; Borneman, James; McGovern, Dermot P. B.; Frank, Daniel N.; Li, Ellen; Horvath, Steve; Knight, Rob; Braun, Jonathan			A Modular Organization of the Human Intestinal Mucosal Microbiota and Its Association with Inflammatory Bowel Disease	PLOS ONE			English	Article							COMPUTATIONAL CLUSTER VALIDATION; CROHNS-DISEASE; GUT MICROBIOTA; MICROARRAY DATA; GLOBAL-NETWORK; ECOLOGY; PATHOGENESIS; MECHANISMS; GENETICS; EXCHANGE	Abnormalities of the intestinal microbiota are implicated in the pathogenesis of Crohn's disease (CD) and ulcerative colitis (UC), two spectra of inflammatory bowel disease (IBD). However, the high complexity and low inter-individual overlap of intestinal microbial composition are formidable barriers to identifying microbial taxa representing this dysbiosis. These difficulties might be overcome by an ecologic analytic strategy to identify modules of interacting bacteria (rather than individual bacteria) as quantitative reproducible features of microbial composition in normal and IBD mucosa. We sequenced 16S ribosomal RNA genes from 179 endoscopic lavage samples from different intestinal regions in 64 subjects (32 controls, 16 CD and 16 UC patients in clinical remission). CD and UC patients showed a reduction in phylogenetic diversity and shifts in microbial composition, comparable to previous studies using conventional mucosal biopsies. Analysis of weighted co-occurrence network revealed 5 microbial modules. These modules were unprecedented, as they were detectable in all individuals, and their composition and abundance was recapitulated in an independent, biopsy-based mucosal dataset 2 modules were associated with healthy, CD, or UC disease states. Imputed metagenome analysis indicated that these modules displayed distinct metabolic functionality, specifically the enrichment of oxidative response and glycan metabolism pathways relevant to host-pathogen interaction in the disease-associated modules. The highly preserved microbial modules accurately classified IBD status of individual patients during disease quiescence, suggesting that microbial dysbiosis in IBD may be an underlying disorder independent of disease activity. Microbial modules thus provide an integrative view of microbial ecology relevant to IBD.	[Tong, Maomeng; Braun, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA; [Li, Xiaoxiao; Ippoliti, Andrew; McGovern, Dermot P. B.] Cedars Sinai F Widjaja Inflammatory Bowel & Immun, Los Angeles, CA USA; [Parfrey, Laura Wegener; Knight, Rob] Univ Colorado, Dept Chem & Biochem, Boulder, CO 80309 USA; [Roth, Bennett] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Digest Dis, Los Angeles, CA 90095 USA; [Wei, Bo; Braun, Jonathan] Univ Calif Los Angeles, David Geffen Sch Med, Dept Pathol & Lab Med, Los Angeles, CA 90095 USA; [Borneman, James] Univ Calif Riverside, Dept Plant Pathol & Microbiol, Riverside, CA 92521 USA; [Frank, Daniel N.] Univ Colorado, Sch Med, Div Infect Dis, Aurora, CO USA; [Frank, Daniel N.] Univ Colorado, Sch Med, Denver Microbiome Res Consortium MiRC, Union Council, Aurora, CO USA; [Li, Ellen] SUNY Stony Brook, Dept Med, Stony Brook, NY 11794 USA; [Horvath, Steve] Univ Calif Los Angeles, David Geffen Sch Med, Dept Human Genet & Biostat, Los Angeles, CA 90095 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Boulder, CO 80309 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Cedars Sinai Medical Center; University of Colorado System; University of Colorado Boulder; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Riverside; University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado System; University of Colorado Anschutz Medical Campus; State University of New York (SUNY) System; State University of New York (SUNY) Stony Brook; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Braun, J (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Mol & Med Pharmacol, Los Angeles, CA 90095 USA.	JBraun@mednet.ucla.edu	Parfrey, Laura Wegener/AAE-1402-2019; Knight, Rob/D-1299-2010	Parfrey, Laura Wegener/0000-0001-6959-7616; Knight, Rob/0000-0002-0975-9019; Braun, Jonathan/0000-0003-1646-2974	National Institutes of Health [DK46763, AI078885]; National Center for Research Resources; National Center for Advancing Translational Sciences [UL1TR000124, HG005964]; Crohn's and Colitis Foundation of America [156, 3153, DK062413, DK084554]; Ursula Mandel Student Fellowship; University of California Los Angeles Dissertation Year Fellowships; Howard Hughes Medical Institute; Burroughs Wellcome Fund Inter-school Program in Metabolic Diseases Fellowship; United States Public Health Service [PO1DK046763]; Cedars-Sinai F. Widjaja Inflammatory Bowel and Immunobiology Research Institute Research Funds; Helmsley Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000124] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG005964] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI078885] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R21DK084554, P01DK046763, U01DK062413] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); National Center for Advancing Translational Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); Crohn's and Colitis Foundation of America; Ursula Mandel Student Fellowship; University of California Los Angeles Dissertation Year Fellowships; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund Inter-school Program in Metabolic Diseases Fellowship; United States Public Health Service(United States Department of Health & Human ServicesUnited States Public Health Service); Cedars-Sinai F. Widjaja Inflammatory Bowel and Immunobiology Research Institute Research Funds; Helmsley Foundation; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This study was supported by National Institutes of Health DK46763 (JB), AI078885 (JB), National Center for Research Resources and National Center for Advancing Translational Sciences UL1TR000124 (JB), HG005964 (DNF), the Crohn's and Colitis Foundation of America Grants 156 (LG) and 3153 (JB), the Ursula Mandel Student Fellowship and the University of California Los Angeles Dissertation Year Fellowships (XL), the Howard Hughes Medical Institute (RK) and the Burroughs Wellcome Fund Inter-school Program in Metabolic Diseases Fellowship (MT). Cedars-Sinai is supported by United States Public Health Service grant PO1DK046763 and the Cedars-Sinai F. Widjaja Inflammatory Bowel and Immunobiology Research Institute Research Funds, The Helmsley Foundation (DPM) and the Crohn's and Colitis Foundation of America (DPM), DK062413 (DPM), DK084554 (DPM). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham C, 2009, NEW ENGL J MED, V361, P2066, DOI 10.1056/NEJMra0804647; Abubucker S, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002358; Anderson CA, 2011, NAT GENET, V43, P246, DOI 10.1038/ng.764; Arumugam M, 2011, NATURE, V473, P174, DOI 10.1038/nature09944; Balish E, 2002, AM J PATHOL, V160, P2253, DOI 10.1016/S0002-9440(10)61172-8; Barabasi AL, 2011, NAT REV GENET, V12, P56, DOI 10.1038/nrg2918; Beman JM, 2011, ISME J, V5, P1077, DOI 10.1038/ismej.2010.204; Benson AK, 2010, P NATL ACAD SCI USA, V107, P18933, DOI 10.1073/pnas.1007028107; Braun J, 2007, ANNU REV PATHOL-MECH, V2, P401, DOI 10.1146/annurev.pathol.1.110304.100128; Brock G, 2008, J STAT SOFTW, V25, P1, DOI 10.18637/jss.v025.i04; Caporaso JG, 2012, ISME J, V6, P1621, DOI 10.1038/ismej.2012.8; Caporaso JG, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-5-r50; Caporaso JG, 2010, NAT METHODS, V7, P335, DOI 10.1038/nmeth.f.303; Chaffron S, 2010, GENOME RES, V20, P947, DOI 10.1101/gr.104521.109; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Costello EK, 2012, SCIENCE, V336, P1255, DOI 10.1126/science.1224203; Costello EK, 2009, SCIENCE, V326, P1694, DOI 10.1126/science.1177486; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Edgar RC, 2010, BIOINFORMATICS, V26, P2460, DOI 10.1093/bioinformatics/btq461; Elson CO, 2005, IMMUNOL REV, V206, P260, DOI 10.1111/j.0105-2896.2005.00291.x; Faust K, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002606; Foster James A, 2008, Interdiscip Perspect Infect Dis, V2008, P839501, DOI 10.1155/2008/839501; Frank DN, 2007, P NATL ACAD SCI USA, V104, P13780, DOI 10.1073/pnas.0706625104; Frank DN, 2011, TRENDS MICROBIOL, V19, P427, DOI 10.1016/j.tim.2011.06.005; Frank DN, 2011, INFLAMM BOWEL DIS, V17, P179, DOI 10.1002/ibd.21339; Franke A, 2010, NAT GENET, V42, P1118, DOI 10.1038/ng.717; Friedman J, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002687; Fu JX, 2011, J CLIN INVEST, V121, P1657, DOI 10.1172/JCI45538; Fukuda S, 2011, NATURE, V469, P543, DOI 10.1038/nature09646; Garge NR, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S2-S10; Giancarlo R, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-462; Gophna U, 2006, J CLIN MICROBIOL, V44, P4136, DOI 10.1128/JCM.01004-06; Handl J, 2005, BIOINFORMATICS, V21, P3201, DOI 10.1093/bioinformatics/bti517; Horvath S, 2011, WEIGHTED NETWORK ANALYSIS: APPLICATIONS IN GENOMICS AND SYSTEMS BIOLOGY, P1, DOI 10.1007/978-1-4419-8819-5; Horvath S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000117; Huttenhower C, 2012, NATURE, V486, P207, DOI 10.1038/nature11234; Jay JJ, 2012, BMC BIOINFORMATICS, V13, DOI 10.1186/1471-2105-13-S10-S7; Joossens M, 2011, GUT, V60, P631, DOI 10.1136/gut.2010.223263; Kapp AV, 2007, BIOSTATISTICS, V8, P9, DOI 10.1093/biostatistics/kxj029; Kato S, 2008, MICROB ECOL, V56, P403, DOI 10.1007/s00248-007-9357-4; Khor B, 2011, NATURE, V474, P307, DOI 10.1038/nature10209; Konopka A, 2009, ISME J, V3, P1223, DOI 10.1038/ismej.2009.88; Koren O, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002863; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P; Langfelder P, 2008, BIOINFORMATICS, V24, P719, DOI 10.1093/bioinformatics/btm563; Langfelder P, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-559; Langfelder P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001057; Li E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0026284; Li XX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026542; Lozupone C, 2012, GENOME RES, V22, P1974, DOI 10.1101/gr.138198.112; Maloy KJ, 2011, NATURE, V474, P298, DOI 10.1038/nature10208; Manichanh C, 2006, GUT, V55, P205, DOI 10.1136/gut.2005.073817; McGowan I, 2007, JAIDS-J ACQ IMM DEF, V46, P417, DOI 10.1097/QAI.0b013e318156ef16; Morgan XC, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-9-r79; Nagalingam NA, 2012, INFLAMM BOWEL DIS, V18, P968, DOI 10.1002/ibd.21866; Nugent R, 2010, METHODS MOL BIOL, V620, P369, DOI 10.1007/978-1-60761-580-4_12; Parfrey LW, 2011, FRONT MICROBIOL, V2, DOI 10.3389/fmicb.2011.00153; Peterson DA, 2008, CELL HOST MICROBE, V3, P417, DOI 10.1016/j.chom.2008.05.001; Raes J, 2008, NAT REV MICROBIOL, V6, P693, DOI 10.1038/nrmicro1935; Rausch P, 2011, P NATL ACAD SCI USA, V108, P19030, DOI 10.1073/pnas.1106408108; Robinson CJ, 2010, MICROBIOL MOL BIOL R, V74, P453, DOI 10.1128/MMBR.00014-10; Rocke DM, 2009, BIOINFORMATICS, V25, P701, DOI 10.1093/bioinformatics/btp038; Samuel BS, 2008, P NATL ACAD SCI USA, V105, P16767, DOI 10.1073/pnas.0808567105; Sansonetti Philippe J, 2008, J Pediatr Gastroenterol Nutr, V46 Suppl 1, pE6, DOI 10.1097/01.mpg.0000313819.96520.27; SCHEPPACH W, 1994, GUT, V35, pS35, DOI 10.1136/gut.35.1_Suppl.S35; Sepehri S, 2011, INFLAMM BOWEL DIS, V17, P1451, DOI 10.1002/ibd.21509; Smillie CS, 2011, NATURE, V480, P241, DOI 10.1038/nature10571; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Sokol H, 2008, P NATL ACAD SCI USA, V105, P16731, DOI 10.1073/pnas.0804812105; Summers ZM, 2010, SCIENCE, V330, P1413, DOI 10.1126/science.1196526; Tibshirani R, 2002, P NATL ACAD SCI USA, V99, P6567, DOI 10.1073/pnas.082099299; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Uhlig HH, 2009, EUR J IMMUNOL, V39, P2021, DOI 10.1002/eji.200939602; Virgin HW, 2011, CELL, V147, P44, DOI 10.1016/j.cell.2011.09.009; Voineagu I, 2011, NATURE, V474, P380, DOI 10.1038/nature10110; Wang JX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-S3-S10; Willing BP, 2010, GASTROENTEROLOGY, V139, P1844, DOI 10.1053/j.gastro.2010.08.049; Wong JMW, 2006, J CLIN GASTROENTEROL, V40, P235, DOI 10.1097/00004836-200603000-00015; Wu GD, 2011, SCIENCE, V334, P105, DOI 10.1126/science.1208344; Yatsunenko T, 2012, NATURE, V486, P222, DOI 10.1038/nature11053; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128; Zhang TY, 2011, INFLAMM BOWEL DIS, V17, pS80, DOI 10.1097/00054725-201112002-00264	84	114	116	0	50	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80702	10.1371/journal.pone.0080702	http://dx.doi.org/10.1371/journal.pone.0080702			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260458	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900088
J	Dominguez, A; Godoy, P; Castilla, J; Soldevila, N; Toledo, D; Astray, J; Mayoral, JM; Tamames, S; Garcia-Gutierrez, S; Gonzalez-Candelas, F; Martin, V; Diaz, J; Torner, N				Dominguez, Angela; Godoy, Pere; Castilla, Jesus; Soldevila, Nuria; Toledo, Diana; Astray, Jenaro; Maria Mayoral, Jose; Tamames, Sonia; Garcia-Gutierrez, Susana; Gonzalez-Candelas, Fernando; Martin, Vicente; Diaz, Jose; Torner, Nuria		CIBERESP Working Grp Survey	Knowledge of and Attitudes to Influenza Vaccination in Healthy Primary Healthcare Workers in Spain, 2011-2012	PLOS ONE			English	Article							PANDEMIC H1N1; COVERAGE; ACCEPTANCE; PERSONNEL; BELIEFS; INFANTS; IMMUNIZATION; PROGRAM; NURSES	Annual influenza vaccination is recommended for healthcare workers, but many do not follow the recommendation. The objective of this study was to investigate the factors associated with seasonal influenza vaccination in the 2011-2012 season. We carried out an anonymous web survey of Spanish primary healthcare workers in 2012. Information on vaccination, and knowledge and attitudes about the influenza vaccine was collected. Workers with medical conditions that contraindicated vaccination and those with high risk conditions were excluded. Multivariate analysis was performed using unconditional logistic regression. We included 1,749 workers. The overall vaccination coverage was 50.7% and was higher in workers aged >= 55 years (55.7%), males (57.4%) and paediatricians (63.1%). Factors associated with vaccination were concern about infection at work (aOR 4.93; 95% CI 3.72-6.53), considering that vaccination of heathcare workers is important (aOR 2.62; 95% CI 1.83-3.75) and that vaccination is effective in preventing influenza and its complications (aOR 2.40; 95% CI 1.56-3.67). No association was found between vaccination and knowledge of influenza or the vaccine characteristics. Educational programs should aim to remove the misconceptions and attitudes that limit compliance with recommendations about influenza vaccination in primary healthcare workers rather than only increasing knowledge about influenza and the characteristics of the vaccine.	[Dominguez, Angela; Torner, Nuria] Univ Barcelona, Dept Salud Publ, Barcelona, Spain; [Dominguez, Angela; Godoy, Pere; Castilla, Jesus; Soldevila, Nuria; Toledo, Diana; Torner, Nuria] CIBER Epidemiol & Salud Publ CIBERESP, Barcelona, Spain; [Godoy, Pere; Torner, Nuria] Agencia Salud Publ Cataluna, Barcelona, Spain; [Castilla, Jesus] Inst Salud Publ Navarra, Pamplona, Spain; [Toledo, Diana] Agencia Salud Publ Barcelona, Serv Epidemiol, Barcelona, Spain; [Astray, Jenaro] Comunidad Madrid, Area Epidemiol, Madrid, Spain; [Maria Mayoral, Jose] Serv Vigilancia Andalucia, Seville, Spain; [Tamames, Sonia] Junta de Castilla Leon, Direcc Gen Salud Publ Invest Desarrollo & Innovac, Leon, Spain; [Garcia-Gutierrez, Susana] REDISSEC, Hosp Galdakao Usansolo, Unidad Invest, Bizkaia, Spain; [Gonzalez-Candelas, Fernando] Univ Valencia, Ctr Super Invest Salud Publ, Valencia, Spain; [Martin, Vicente] Univ Leon, Inst Biomed, E-24071 Leon, Spain; [Diaz, Jose] Serv Andaluz Salud, Seville, Spain	University of Barcelona; CIBER - Centro de Investigacion Biomedica en Red; CIBERESP; Public Health Institute of Navarra; Public Health Agency of Barcelona; Galdakao Hospital; University of Valencia; Universidad de Leon	Dominguez, A (corresponding author), Univ Barcelona, Dept Salud Publ, Barcelona, Spain.	angela.dominguez@ub.edu	Castilla, Jesus/B-9048-2008; Cenoz, Manuel García/B-5647-2013; Martin, Vicente/A-1597-2008; Martin, Vicente/GRE-8306-2022; , Nuria/AAG-8951-2019; Candelas, Fernando Gonzalez/G-5681-2010; Martin, Vicente/ABF-2276-2021; Garcia-Gutierrez, Susana/W-3998-2018; Martinez-Baz, Ivan/H-4954-2017	Castilla, Jesus/0000-0002-6396-7265; Cenoz, Manuel García/0000-0001-7316-9104; Martin, Vicente/0000-0003-0552-2804; Martin, Vicente/0000-0003-0552-2804; , Nuria/0000-0003-0143-5295; Candelas, Fernando Gonzalez/0000-0002-0879-5798; Quintana, Jose M./0000-0003-2170-7876; Tamames, Sonia/0000-0001-5548-2594; Godoy, Pere/0000-0002-2896-7286; Garcia-Gutierrez, Susana/0000-0002-8474-2479; Cayla, Joan A./0000-0003-3891-111X; Martinez-Baz, Ivan/0000-0002-3405-2277	Ministry of Science and Innovation, Institute of Health Carlos III, Programme of Research on Influenza A/H1N1 [GR09/0030]; Catalan Agency for the Management of Grants for University Research (AGAUR) [2009/ SGR 42]	Ministry of Science and Innovation, Institute of Health Carlos III, Programme of Research on Influenza A/H1N1; Catalan Agency for the Management of Grants for University Research (AGAUR)	This study was supported by the Ministry of Science and Innovation, Institute of Health Carlos III, Programme of Research on Influenza A/H1N1 (Grant GR09/0030), and the Catalan Agency for the Management of Grants for University Research (AGAUR Grant number 2009/ SGR 42). The funders had no role in the study design, data collection, analysis, the decision to publish or the preparation of the manuscript.	Abramson ZH, 2008, VACCINE, V26, P2482, DOI 10.1016/j.vaccine.2008.03.011; Perreten NA, 2012, GAC SANIT, V26, P477, DOI 10.1016/j.gaceta.2011.10.016; [Anonymous], 2012, VACCINES; Arda B, 2011, BMC INFECT DIS, V11, DOI 10.1186/1471-2334-11-87; Bautista D, 2006, INFECT CONT HOSP EP, V27, P73, DOI 10.1086/499148; Beguin C, 1998, Am J Med Qual, V13, P223, DOI 10.1177/106286069801300408; Benowitz I, 2010, CLIN INFECT DIS, V51, P1355, DOI 10.1086/657309; Bertin M, 2007, AM J INFECT CONTROL, V35, P33, DOI 10.1016/j.ajic.2006.10.005; Blank PR, 2008, WIEN MED WOCHENSCHR, V158, P583, DOI 10.1007/s10354-008-0582-3; Blasi F, 2011, CLIN MICROBIOL INFEC, V17, P1223, DOI 10.1111/j.1469-0691.2011.03501.x; Bohmer MM, 2011, VACCINE, V29, P4492, DOI 10.1016/j.vaccine.2011.04.039; Bouadma L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038646; Centers for Disease Control and Prevention, 2013, PREV STRAT SEAS INFL; Centro Nacional de Epidemiologia, 2011, VIG CAS GRAV HOSP CO, P2010; Chor JSY, 2011, VACCINE, V29, P7364, DOI 10.1016/j.vaccine.2011.07.079; Ajenjo MC, 2010, INFECT CONT HOSP EP, V31, P233, DOI 10.1086/650449; de Juanes JR, 2010, VACUNAS, V11, P49, DOI DOI 10.1016/S1576-9887(10)70011-X; Eick AA, 2011, ARCH PEDIAT ADOL MED, V165, P104, DOI 10.1001/archpediatrics.2010.192; Elorza JM, 2002, MED CLIN-BARCELONA, V119, P451; Esposito S, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-422; Galicia-Garcia MD, 2006, ENFERM INFEC MICR CL, V24, P413, DOI 10.1157/13091777; Hofmann F, 2006, INFECTION, V34, P142, DOI 10.1007/s15010-006-5109-5; Hollmeyer HG, 2009, VACCINE, V27, P3935, DOI 10.1016/j.vaccine.2009.03.056; Jimenez-Garcia R, 2006, INFECTION, V34, P135, DOI 10.1007/s15010-006-5627-1; Kaboli F, 2010, INFECT CONT HOSP EP, V31, P1017, DOI 10.1086/655465; Kraut A, 2011, VACCINE, V29, P8357, DOI 10.1016/j.vaccine.2011.08.084; La Torre G, 2011, HUM VACCINES, V7, P728, DOI 10.4161/hv.7.7.15413; LaVela SL, 2004, INFECT CONT HOSP EP, V25, P933, DOI 10.1086/502323; Looijmans-van den Akker I, 2009, J AM GERIATR SOC, V57, P2253, DOI 10.1111/j.1532-5415.2009.02560.x; Loulergue P, 2009, VACCINE, V27, P4240, DOI 10.1016/j.vaccine.2009.03.039; Mak TK, 2008, LANCET INFECT DIS, V8, P44, DOI 10.1016/S1473-3099(07)70311-0; Maltezou HC, 2008, VACCINE, V26, P1408, DOI 10.1016/j.vaccine.2008.01.049; Maltezou HC, 2013, AM J INFECT CONTROL, V41, P66, DOI 10.1016/j.ajic.2012.01.028; Martinez Martinez F, 2011, VACUNAS, V12, P48, DOI [DOI 10.1016/S1576-9887(11)70005-X, 10.1016/S1576-9887(11)70005-X]; Miller BL, 2011, VACCINE, V29, P9398, DOI 10.1016/j.vaccine.2011.09.047; Ministerio de Sanidad Servicios Sociales e Igualdad, 2013, COB VAC DAT EST; Nichol KL, 1997, INFECT CONT HOSP EP, V18, P189; Ofstead CL, 2008, INFECT CONT HOSP EP, V29, P99, DOI 10.1086/526431; Opstelten W, 2010, VACCINE, V28, P6164, DOI 10.1016/j.vaccine.2010.07.031; Arjona MAO, 2011, VACCINE, V29, P6366, DOI 10.1016/j.vaccine.2011.04.117; Picazo J, 2012, VACUNAS, V13, P100, DOI [10.1016/S1576-9887(12)70048-1, DOI 10.1016/S1576-9887(12)70048-1]; Smedley J, 2007, OCCUP ENVIRON MED, V64, P223, DOI 10.1136/oem.2005.023564; Socan M, 2013, EUR J PUBLIC HEALTH, V23, P92, DOI 10.1093/eurpub/cks006; Tanguy M, 2011, VACCINE, V29, P4190, DOI 10.1016/j.vaccine.2011.03.107; Vaux S, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-30; Virseda S, 2010, VACCINE, V28, P4751, DOI 10.1016/j.vaccine.2010.04.101; Zaman K, 2008, NEW ENGL J MED, V359, P1555, DOI 10.1056/NEJMoa0708630; Zimmerman RK, 2003, VACCINE, V21, P1486, DOI 10.1016/S0264-410X(02)00700-4	48	30	31	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81200	10.1371/journal.pone.0081200	http://dx.doi.org/10.1371/journal.pone.0081200			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260560	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500201
J	Jacobson, BA; Thumma, SC; Jay-Dixon, J; Patel, MR; Kroening, KD; Kratzke, MG; Etchison, RG; Konicek, BW; Graff, JR; Kratzke, RA				Jacobson, Blake A.; Thumma, Saritha C.; Jay-Dixon, Joseph; Patel, Manish R.; Kroening, K. Dubear; Kratzke, Marian G.; Etchison, Ryan G.; Konicek, Bruce W.; Graff, Jeremy R.; Kratzke, Robert A.			Targeting Eukaryotic Translation in Mesothelioma Cells with an eIF4E-Specific Antisense Oligonucleotide	PLOS ONE			English	Article							INITIATION-FACTOR 4E; FACTOR EIF4E; FACTOR EIF-4E; TUMOR-GROWTH; CANCER; EXPRESSION; ACTIVATION; APOPTOSIS; RNA; INHIBITION	Background: Aberrant cap-dependent translation is implicated in tumorigenesis in multiple tumor types including mesothelioma. In this study, disabling the eIF4F complex by targeting eIF4E with eIF4E-specific antisense oligonucleotide (4EASO) is assessed as a therapy for mesothelioma. Methods: Mesothelioma cells were transfected with 4EASO, designed to target eIF4E mRNA, or mismatch-ASO control. Cell survival was measured in mesothelioma treated with 4EASO alone or combined with either gemcitabine or pemetrexed. Levels of eIF4E, ODC, Bcl-2 and beta-actin were assessed following treatment. Binding to a synthetic cap-analogue was used to study the strength of eIF4F complex activation following treatment. Results: eIF4E level and the formation of eIF4F cap-complex decreased in response to 4EASO, but not mismatch control ASO, resulting in cleavage of PARP indicating apoptosis. 4EASO treatment resulted in dose dependent decrease in eIF4E levels, which corresponded to cytotoxicity of mesothelioma cells. 4EASO resulted in decreased levels of eIF4E in non-malignant LP9 cells, but this did not correspond to increased cytotoxicity. Proteins thought to be regulated by cap-dependent translation, Bcl-2 and ODC, were decreased upon treatment with 4EASO. Combination therapy of 4EASO with pemetrexed or gemcitabine further reduced cell number. Conclusion: 4EASO is a novel drug that causes apoptosis and selectively reduces eIF4E levels, eIF4F complex formation, and proliferation of mesothelioma cells. eIF4E knockdown results in decreased expression of antiapoptotic and pro-growth proteins and enhances chemosensitivity.	[Jacobson, Blake A.; Thumma, Saritha C.; Jay-Dixon, Joseph; Patel, Manish R.; Etchison, Ryan G.; Kratzke, Robert A.] Univ Minnesota, Dept Med, Minneapolis, MN 55455 USA; [Kroening, K. Dubear] Univ Wisconsin Fox Valley, Dept Biol Sci, Menasha, WI USA; [Kratzke, Marian G.] Minneapolis Vet Affairs Med Ctr, Res Serv, Minneapolis, MN USA; [Konicek, Bruce W.; Graff, Jeremy R.] Eli Lilly & Co, Lilly Res Labs, Indianapolis, IN 46285 USA	University of Minnesota System; University of Minnesota Twin Cities; University of Wisconsin System; US Department of Veterans Affairs; Veterans Health Administration (VHA); Minneapolis VA Health Care System; Eli Lilly	Kratzke, RA (corresponding author), Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA.	kratz003@umn.edu		Patel, Manish/0000-0003-2752-945X	John Skoglund Lung Cancer Research Endowment	John Skoglund Lung Cancer Research Endowment	Funding that supported this work was the John Skoglund Lung Cancer Research Endowment. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avdulov S, 2004, CANCER CELL, V5, P553, DOI 10.1016/j.ccr.2004.05.024; Britton M, 2002, SEMIN ONCOL, V29, P18, DOI 10.1053/sonc.2002.30237; Carbone M, 2007, ONCOGENE, V26, P6959, DOI 10.1038/sj.onc.1210515; Cencic R, 2009, LEUKEMIA RES, V34, P535; Cencic R, 2011, P NATL ACAD SCI USA, V108, P1046, DOI 10.1073/pnas.1011477108; Chen CN, 2004, J SURG ONCOL, V86, P22, DOI 10.1002/jso.20037; Chou TC, 2010, CANCER RES, V70, P440, DOI 10.1158/0008-5472.CAN-09-1947; Coleman LJ, 2009, BRIT J CANCER, V100, P1393, DOI 10.1038/sj.bjc.6605044; Conrad AH, 1998, ANTISENSE NUCLEIC A, V8, P427, DOI 10.1089/oli.1.1998.8.427; De Benedetti A, 2004, ONCOGENE, V23, P3189, DOI 10.1038/sj.onc.1207545; DeFatta RJ, 2000, LARYNGOSCOPE, V110, P928, DOI 10.1097/00005537-200006000-00007; Dong K, 2009, BREAST CANCER RES TR, V113, P443, DOI 10.1007/s10549-008-9956-x; DUNCAN R, 1987, J BIOL CHEM, V262, P380; Graff JR, 2007, J CLIN INVEST, V117, P2638, DOI 10.1172/JCI32044; Graff JR, 2009, CANCER RES, V69, P3866, DOI 10.1158/0008-5472.CAN-08-3472; Graff JR, 2003, CLIN EXP METASTAS, V20, P265, DOI 10.1023/A:1022943419011; Hayman TJ, 2012, CANCER RES, V72, P2362, DOI 10.1158/0008-5472.CAN-12-0329; Herbert TP, 2000, CURR BIOL, V10, P793, DOI 10.1016/S0960-9822(00)00567-4; HIREMATH LS, 1985, J BIOL CHEM, V260, P7843; Hong DS, 2011, CLIN CANCER RES, V17, P6582, DOI 10.1158/1078-0432.CCR-11-0430; Hsieh AC, 2010, CLIN CANCER RES, V16, P4914, DOI 10.1158/1078-0432.CCR-10-0433; Jacobson BA, 2009, BRIT J CANCER, V101, P424, DOI 10.1038/sj.bjc.6605184; Jacobson BA, 2006, CANCER RES, V66, P4256, DOI 10.1158/0008-5472.CAN-05-2879; Jia Y, 2010, EUR J MED CHEM, V45, P1304, DOI 10.1016/j.ejmech.2009.11.054; Ko SY, 2009, CLIN CANCER RES, V15, P4336, DOI 10.1158/1078-0432.CCR-08-2924; Larsson O, 2006, NUCLEIC ACIDS RES, V34, P4375, DOI 10.1093/nar/gkl558; LAZARISKARATZAS A, 1990, NATURE, V345, P544, DOI 10.1038/345544a0; Li S, 2003, J BIOL CHEM, V278, P3015, DOI 10.1074/jbc.M208821200; Li SN, 2004, J BIOL CHEM, V279, P21312, DOI 10.1074/jbc.M312467200; Mamane Y, 2004, ONCOGENE, V23, P3172, DOI 10.1038/sj.onc.1207549; Moerke NJ, 2007, CELL, V128, P257, DOI 10.1016/j.cell.2006.11.046; NESTLE FO, 1994, J INVEST DERMATOL, V103, P569, DOI 10.1111/1523-1747.ep12396876; PASS HI, 1995, ANN THORAC SURG, V59, P835, DOI 10.1016/0003-4975(95)00045-M; Patel MR, 2007, J THORAC ONCOL, V2, P789, DOI 10.1097/JTO.0b013e31811f3aab; Pervin S, 2007, CANCER RES, V67, P289, DOI 10.1158/0008-5472.CAN-05-4623; Polunovsky VA, 1996, MOL CELL BIOL, V16, P6573; Polunovsky Vitaly A, 2006, RNA Biol, V3, P10; Rosenwald IB, 1999, ONCOGENE, V18, P2507, DOI 10.1038/sj.onc.1202563; Ruggero D, 2004, NAT MED, V10, P484, DOI 10.1038/nm1042; Salehi Z, 2007, CELL BIOL INT, V31, P1400, DOI 10.1016/j.cellbi.2007.06.006; Silvera D, 2010, NAT REV CANCER, V10, P254, DOI 10.1038/nrc2824; Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042; Soni A, 2008, MOL CANCER THER, V7, P1782, DOI 10.1158/1535-7163.MCT-07-2357; Thumma SC, 2007, CANCER LETT, V258, P1, DOI 10.1016/j.canlet.2007.08.022; Wang ST, 1999, AM J PATHOL, V155, P247, DOI 10.1016/S0002-9440(10)65118-8; Wendel HG, 2004, NATURE, V428, P332, DOI 10.1038/nature02369	46	23	23	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81669	10.1371/journal.pone.0081669	http://dx.doi.org/10.1371/journal.pone.0081669			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260583	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500208
J	Mercer, DK; Robertson, J; Wright, K; Miller, L; Smith, S; Stewart, CS; O'Neil, DA				Mercer, Derry K.; Robertson, Jennifer; Wright, Kristine; Miller, Lorna; Smith, Shane; Stewart, Colin S.; O'Neil, Deborah A.			A Prodrug Approach to the Use of Coumarins as Potential Therapeutics for Superficial Mycoses	PLOS ONE			English	Article							ANTIMICROBIAL ACTIVITY; BETA-GLUCOSIDASE; DERIVATIVES; ESCULETIN; ESCULIN; DESIGN	Superficial mycoses are fungal infections of the outer layers of the skin, hair and nails that affect 20-25% of the world's population, with increasing incidence. Treatment of superficial mycoses, predominantly caused by dermatophytes, is by topical and/or oral regimens. New therapeutic options with improved efficacy and/or safety profiles are desirable. There is renewed interest in natural product-based antimicrobials as alternatives to conventional treatments, including the treatment of superficial mycoses. We investigated the potential of coumarins as dermatophyte-specific antifungal agents and describe for the first time their potential utility as topical antifungals for superficial mycoses using a prodrug approach. Here we demonstrate that an inactive coumarin glycone, esculin, is hydrolysed to the antifungal coumarin aglycone, esculetin by dermatophytes. Esculin is hydrolysed to esculetin beta-glucosidases. We demonstrate that beta-glucosidases are produced by dermatophytes as well as members of the dermal microbiota, and that this activity is sufficient to hydrolyse esculin to esculetin with concomitant antifungal activity. A beta-glucosidase inhibitor (conduritol B epoxide), inhibited antifungal activity by preventing esculin hydrolysis. Esculin demonstrates good aqueous solubility (<6 g/l) and could be readily formulated and delivered topically as an inactive prodrug in a water-based gel or cream. This work demonstrates proof-of-principle for a therapeutic application of glycosylated coumarins as inactive prodrugs that could be converted to an active antifungal in situ. It is anticipated that this approach will be applicable to other coumarin glycones.	[Mercer, Derry K.; Robertson, Jennifer; Wright, Kristine; Miller, Lorna; Smith, Shane; Stewart, Colin S.; O'Neil, Deborah A.] NovaBiotics Ltd, Bucksburn, Aberdeen, Scotland		Mercer, DK (corresponding author), NovaBiotics Ltd, Bucksburn, Aberdeen, Scotland.	derry@novabiotics.co.uk	ONeil, Deborah/GWN-2741-2022; Mercer, Derry Keith/AAI-3341-2020	Mercer, Derry Keith/0000-0001-8950-0076				Aoyama Takahiko, 2005, Drug Metab Pharmacokinet, V20, P485, DOI 10.2133/dmpk.20.485; Aureli M, 2012, J INHERIT METAB DIS, V35, P1081, DOI 10.1007/s10545-012-9478-x; Breiden B, 2007, EUR J CELL BIOL, V86, P657, DOI 10.1016/j.ejcb.2007.02.006; CHANG F, 1993, COMP BIOCHEM PHYS A, V105, P251; Clinical and Laboratory Standards Institute, 2008, M38A2 CLSI, V3rd; Crawford F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001434.pub2; De Hoog G. S., 2000, ATLAS CLIN FUNGI; Dekic BR, 2010, MOLECULES, V15, P2246, DOI 10.3390/molecules15042246; Duncan SH, 2004, BRIT J NUTR, V91, P749, DOI 10.1079/BJN20041101; FACKLAM RR, 1970, APPL MICROBIOL, V20, P245, DOI 10.1128/AEM.20.2.245-250.1970; Fidalgo Ana, 2004, Dermatitis, V15, P54, DOI 10.2310/6620.2004.20376; Foti C, 2001, Australas J Dermatol, V42, P145, DOI 10.1046/j.1440-0960.2001.00501.x; Ghannoum M, 2011, J CLIN MICROBIOL; Ghannoum MA, 2006, J CLIN MICROBIOL, V44, P4353, DOI 10.1128/JCM.00688-06; Gomez BL, 2003, CURR OPIN INFECT DIS, V16, P91, DOI 10.1097/00001432-200304000-00005; Gonzalez A, 2009, J CLIN MICROBIOL, V47, P48, DOI 10.1128/JCM.01422-08; Grice EA, 2011, NAT REV MICROBIOL, V9, P244, DOI 10.1038/nrmicro2537; Havlickova B, 2008, MYCOSES, V51, P2, DOI 10.1111/j.1439-0507.2008.01606.x; Huttunen KM, 2011, PHARMACOL REV, V63, P750, DOI 10.1124/pr.110.003459; Jana S, 2010, CURR MED CHEM, V17, P3874, DOI 10.2174/092986710793205426; Johann S, 2007, MEM I OSWALDO CRUZ, V102, P681, DOI [10.1590/S0074-02762007005000087, 10.1590/S0074-02762007000600004]; Kumar R, 2012, FITOTERAPIA, V83, P230, DOI 10.1016/j.fitote.2011.11.003; Lee BC, 2007, ARCH PHARM RES, V30, P1293, DOI 10.1007/BF02980270; Lim EK, 2004, BIOTECHNOL BIOENG, V87, P623, DOI 10.1002/bit.20154; Maranhao FCA, 2011, CAN J MICROBIOL, V57, P333, DOI [10.1139/w11-011, 10.1139/W11-011]; Marren K, 2011, PHYSICIAN SPORTSMED, V39, P75, DOI 10.3810/psm.2011.09.1923; Millikan LE, 2010, CLIN DERMATOL, V28, P212, DOI 10.1016/j.clindermatol.2009.12.016; Munoz-Munoz JL, 2007, BIOSCI BIOTECH BIOCH, V71, P390, DOI 10.1271/bbb.60431; Murray P.R., 2003, MANUAL CLIN MICROBIO, V8th; Redoules D, 2005, J INVEST DERMATOL, V125, P270, DOI 10.1111/j.0022-202X.2005.23785.x; Riveiro ME, 2010, CURR MED CHEM, V17, P1325, DOI 10.2174/092986710790936284; Simon C, 2010, J EXP BOT, V61, P3355, DOI 10.1093/jxb/erq157; Sissi C, 2010, CELL MOL LIFE SCI, V67, P2001, DOI 10.1007/s00018-010-0299-5; Smolinske S. C., 1992, CRC HDB FOOD DRUG CO; Wallace SJ, 2010, J PHYS CHEM B, V114, P4836, DOI 10.1021/jp100458x; WORKMAN WE, 1982, APPL ENVIRON MICROB, V44, P1289, DOI 10.1128/AEM.44.6.1289-1295.1982; Wu L, 2009, CURR MED CHEM, V16, P4236, DOI 10.2174/092986709789578187; Yamada K, 2011, PLANT CELL PHYSIOL, V52, P2039, DOI 10.1093/pcp/pcr156; YANG SJ, 1985, BIOCHIM BIOPHYS ACTA, V828, P236; Youngchim S, 2011, MICROBIOL-SGM, V157, P2348, DOI 10.1099/mic.0.047928-0	40	17	18	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80760	10.1371/journal.pone.0080760	http://dx.doi.org/10.1371/journal.pone.0080760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260474	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500172
J	Tay, WT; Soria, MF; Walsh, T; Thomazoni, D; Silvie, P; Behere, GT; Anderson, C; Downes, S				Tay, Wee Tek; Soria, Miguel F.; Walsh, Thomas; Thomazoni, Danielle; Silvie, Pierre; Behere, Gajanan T.; Anderson, Craig; Downes, Sharon			A Brave New World for an Old World Pest: Helicoverpa armigera (Lepidoptera: Noctuidae) in Brazil	PLOS ONE			English	Article							COTTON BOLLWORM; HUBNER LEPIDOPTERA; HELIOTHIS-ZEA; BT COTTON; RESISTANCE; HISTORY; PENTATOMIDAE; HETEROPTERA; PLATASPIDAE; MANAGEMENT	The highly polyphagous Old World cotton bollworm Helicoverpa armigera is a quarantine agricultural pest for the American continents. Historically H. armigera is thought to have colonised the American continents around 1.5 to 2 million years ago, leading to the current H. zea populations on the American continents. The relatively recent species divergence history is evident in mating compatibility between H. zea and H. armigera under laboratory conditions. Despite periodic interceptions of H. armigera into North America, this pest species is not believed to have successfully established significant populations on either continent. In this study, we provide molecular evidence via mitochondrial DNA (mtDNA) cytochrome oxidase I (COI) and cytochrome b (Cyt b) partial gene sequences for the successful recent incursion of H. armigera into the New World, with individuals being detected at two sites (Primavera do Leste, Pedra Preta) within the State of Mato Grosso in Brazil. The mtDNA COI and Cyt b haplotypes detected in the Brazilian H. armigera individuals are common throughout the Old World, thus precluding identification of the founder populations. Combining the two partial mtDNA gene sequences showed that at least two matrilines are present in Brazil, while the inclusion of three nuclear DNA Exon-Primed Intron-Crossing (EPIC) markers identified a further two possible matrilines in our samples. The economic, biosecurity, resistance management, ecological and evolutionary implications of this incursion are discussed in relation to the current agricultural practices in the Americas.	[Tay, Wee Tek; Anderson, Craig] CSIRO Ecosyst Sci, Biosecur Flagship, Canberra, ACT, Australia; [Soria, Miguel F.; Thomazoni, Danielle] Mato Grosso Cotton Inst, Inst Matogrossense Algodao IMAmt, Dept Entomol, Primavera Do Leste, MG, Brazil; [Walsh, Thomas] CSIRO Ecosyst Sci, Sustainable Agr Flagship, Canberra, ACT, Australia; [Silvie, Pierre] CIRAD, Unite Propre Rech Syst Culture Annuels, Montpellier, France; [Silvie, Pierre] IRD, Lab Evolut Genomes & Speciat, Unite Rech 072, Orsay, France; [Behere, Gajanan T.] Indian Council Agr Res, Div Crop Improvement, Shilong, Meghalaya, India; [Downes, Sharon] CSIRO Ecosyst, Sustainable Agr Flagship, Narrabri, NSW, Australia	Commonwealth Scientific & Industrial Research Organisation (CSIRO); Commonwealth Scientific & Industrial Research Organisation (CSIRO); CIRAD; Institut de Recherche pour le Developpement (IRD); Indian Council of Agricultural Research (ICAR); Commonwealth Scientific & Industrial Research Organisation (CSIRO)	Tay, WT (corresponding author), CSIRO Ecosyst Sci, Biosecur Flagship, Canberra, ACT, Australia.	weetek.tay@csiro.au	Behere, Gajanan Tryambak/AAP-5289-2020; Tay, Wee Tek/C-1818-2008; Downes, Sharon Joy/C-1770-2008; Walsh, Thomas K/C-1263-2009; Anderson, Craig/K-2050-2013; Tay, Wee Tek/GPF-6142-2022	Behere, Gajanan Tryambak/0000-0003-0222-7367; Tay, Wee Tek/0000-0002-8451-0811; Downes, Sharon Joy/0000-0002-3729-1732; Walsh, Thomas K/0000-0001-8425-0135; Anderson, Craig/0000-0002-2832-9313; Tay, Wee Tek/0000-0002-8451-0811	Commonwealth Scientific and Industrial Research Organisation - Australia; Mato Grosso Cotton Growers Association (Associacao Mato-Grossense dos Produtores de Algodao/AMPA) - Brazil	Commonwealth Scientific and Industrial Research Organisation - Australia(Commonwealth Scientific & Industrial Research Organisation (CSIRO)); Mato Grosso Cotton Growers Association (Associacao Mato-Grossense dos Produtores de Algodao/AMPA) - Brazil	To conduct this research the authors received financial support from the Commonwealth Scientific and Industrial Research Organisation - Australia and Mato Grosso Cotton Growers Association (Associacao Mato-Grossense dos Produtores de Algodao/AMPA) - Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agropec Consultoria, 2013, PRAG QUAR CONS DAD P; Ascunce MS, 2011, SCIENCE, V331, P1066, DOI 10.1126/science.1198734; Behere GT, 2008, B ENTOMOL RES, V98, P599, DOI 10.1017/S0007485308005956; Behere GT, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-117; Behere GT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053448; Clement M, 2000, MOL ECOL, V9, P1657, DOI 10.1046/j.1365-294x.2000.01020.x; CONAB-Companhia Nacional de Abastecimento, 2013, AC SAFR BRAS GRAOS O; Czepak Cecília, 2013, Pesqui. Agropecu. Trop., V43, P110, DOI 10.1590/S1983-40632013000100015; Degrande P, 1991, BICUDO DO ALGODOEIRO; Degrande PE, 2013, CULTIVAR GRANDES CUL, V15, P32; Downes S, 2010, EVOL APPL, V3, P574, DOI 10.1111/j.1752-4571.2010.00146.x; EASTEAL S, 1981, BIOL J LINN SOC, V16, P93, DOI 10.1111/j.1095-8312.1981.tb01645.x; Eger J.E. Jr., 2010, Insecta Mundi, V0121, P1; EMBRAPA, 2013, NOT TECN RES TRAB IN, DOI 10.13140/RG.2.1.294667685; Fisher MC, 2012, NATURE, V484, P186, DOI 10.1038/nature10947; Fitt GP, 2000, EMERGING TECHNOLOGIES FOR INTEGRATED PEST MANAGEMENT, P108; Gordon K, 2009, MOL BIOL GENETICS LE, P219; Gould F, 1998, ANNU REV ENTOMOL, V43, P701, DOI 10.1146/annurev.ento.43.1.701; Grgurinovic C. A., 2006, Bulletin OEPP, V36, P486; Hardwick D. F., 1965, Mem ent Soc Canada Ottawa, Vno. 40, P1; Head G, 2010, J APPL ECOL, V47, P583, DOI 10.1111/j.1365-2664.2010.01796.x; Hoebeke ER, 2003, P ENTOMOL SOC WASH, V105, P225; KEHAT M, 1980, ENTOMOL EXP APPL, V27, P188, DOI 10.1007/BF00573893; LASTER ML, 1995, J ECON ENTOMOL, V88, P1288, DOI 10.1093/jee/88.5.1288; LASTER ML, 1995, J ECON ENTOMOL, V88, P77, DOI 10.1093/jee/88.1.77; Leskey T. C., 2012, Outlooks on Pest Management, V23, P218, DOI 10.1564/23oct07; Lima LHC, 2006, COMUNICADO TECNICO; Liu SS, 2007, SCIENCE, V318, P1769, DOI 10.1126/science.1149887; Martin T, 2005, AGR ECOSYST ENVIRON, V107, P409, DOI 10.1016/j.agee.2004.11.006; Matthews M., 1999, MONOGRAPHS AUSTR LEP, V7, P105; NAKANO O, 1983, AGROQUIMICA, V21, P10; Nibouche S, 1998, HEREDITY, V80, P438, DOI 10.1046/j.1365-2540.1998.00273.x; Nielsen AL, 2009, ANN ENTOMOL SOC AM, V102, P608, DOI 10.1603/008.102.0405; Oliveira MRV de, 2003, MANDATO QUARENTENA V, V110; PERRING TM, 1993, SCIENCE, V259, P74, DOI 10.1126/science.8418497; Pimentel D, 2005, ECOL ECON, V52, P273, DOI 10.1016/j.ecolecon.2004.10.002; Pogue MG, 2004, ANN ENTOMOL SOC AM, V97, P1222, DOI 10.1603/0013-8746(2004)097[1222:ANSOHZ]2.0.CO;2; Ramalho FS, 2001, HIST IMPACTO PRAGAS, P113; RINDERER TE, 1993, SCI AM, V269, P84, DOI 10.1038/scientificamerican1293-84; Ruberson JR, 2013, APPL ENTOMOL ZOOL, V48, P3, DOI 10.1007/s13355-012-0146-2; SILVIE P. J., 2013, B TECNICO IMAMT, V1; Suiter DR, 2010, J INTEGR PEST MANAG, V1, DOI 10.1603/IPM10009; Tabashnik BE, 2012, J INVERTEBR PATHOL, V110, P301, DOI 10.1016/j.jip.2012.04.008; Tay WT, 2008, B ENTOMOL RES, V98, P509, DOI 10.1017/S000748530800583X; Venette R.C., 2003, MINI RISK ASSESSMENT; Widmer M. W., 1983, HELIOTHIS DISPERSAL; WINSTON ML, 1992, ANNU REV ENTOMOL, V37, P173, DOI 10.1146/annurev.en.37.010192.001133; Yang YH, 2013, J ECON ENTOMOL, V106, P375, DOI 10.1603/EC12286	48	247	265	3	30	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80134	10.1371/journal.pone.0080134	http://dx.doi.org/10.1371/journal.pone.0080134			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260345	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500116
J	Zaborske, JM; Zeitler, B; Culbertson, MR				Zaborske, John M.; Zeitler, Bethany; Culbertson, Michael R.			Multiple Transcripts from a 3 '-UTR Reporter Vary in Sensitivity to Nonsense-Mediated mRNA Decay in Saccharomyces cerevisiae	PLOS ONE			English	Article							UPF PROTEINS; TERMINATION; POLYRIBOSOMES; INTERACTS; TURNOVER; COMPLEX; GENE	Nonsense-mediated mRNA decay (NMD) causes accelerated transcript degradation when a premature translation termination codon disrupts the open reading frame (ORF). Although endogenous transcripts that have uninterrupted ORFs are typically insensitive to NMD, some can nonetheless become prone to NMD when translation terminates at out-of-frame premature stop codons. This occurs when introns containing stop codons fail to be spliced, when translation of an upstream ORF (uORF) terminates in the 5'-untranslated region (5'-UTR) or the coding region, or when the 5'-proximal AUG initiation codon is bypassed and translation initiates at a downstream out-of-frame AUG followed by a stop codon. Some 3'-untranslated regions (3'-UTRs) are also known to trigger NMD, but the mechanism is less well understood. To further study the role of 3'-UTRs in NMD, a reporter system was designed to examine 3'-UTRs from candidate genes known to produce NMD-sensitive transcripts. Out of eight that were tested, the 3'-UTRs from MSH4 and SPO16 caused NMD-dependent mRNA destabilization. Both endogenous genes produce multiple transcripts that differ in length at the 3' end. Detailed studies revealed that the longest of six reporter MSH4-3'-UTR transcripts was NMD-sensitive but five shorter transcripts were insensitive. NMD-dependent degradation of the long transcript required Xrn1, which degrades mRNA from the 5' end. Sensitivity to NMD was not associated with extensive translational read-through past the normal stop codon. To our knowledge, this is the first example where multiple transcripts containing the same ORF are differentially sensitive to NMD in Saccharomyces cerevisiae. The results provide a proof of principle that long 3'-UTRs can trigger NMD, which suggests a potential link between errors in transcription termination or processing and mRNA decay.	[Culbertson, Michael R.] Univ Wisconsin, Genet Lab, Madison, WI 53706 USA; Univ Wisconsin, Lab Cell & Mol Biol, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Culbertson, MR (corresponding author), Univ Wisconsin, Genet Lab, Madison, WI 53706 USA.	mrculber@wisc.edu			National Science Foundation [MCB0744017]; National Institutes of Health [T32 HG002760]; Div Of Molecular and Cellular Bioscience [0744017] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG002760] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	National Science Foundation MCB0744017, National Institutes of Health, T32 HG002760. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo PR, 2012, COMP FUNCT GENOM, DOI 10.1155/2012/475731; Atkin AL, 1997, J BIOL CHEM, V272, P22163, DOI 10.1074/jbc.272.35.22163; ATKIN AL, 1995, MOL BIOL CELL, V6, P611; Beelman CA, 1996, NATURE, V382, P642, DOI 10.1038/382642a0; Brodsky AS, 2000, RNA, V6, P1737, DOI 10.1017/S1355838200001059; Chamieh H, 2008, NAT STRUCT MOL BIOL, V15, P85, DOI 10.1038/nsmb1330; Cosson B, 2002, MOL CELL BIOL, V22, P3301, DOI 10.1128/MCB.22.10.3301-3315.2002; Culbertson MR, 2003, CURR OPIN GENET DEV, V13, P207, DOI 10.1016/S0959-437X(03)00014-5; Czaplinski K, 1998, GENE DEV, V12, P1665, DOI 10.1101/gad.12.11.1665; Gaba A, 2005, MOL CELL, V20, P449, DOI 10.1016/j.molcel.2005.09.019; Guan QN, 2006, PLOS GENET, V2, P1924, DOI 10.1371/journal.pgen.0020203; He F, 1997, MOL CELL BIOL, V17, P1580, DOI 10.1128/MCB.17.3.1580; Hurowitz EH, 2004, GENOME BIOL, V5; Johnson SA, 2011, NAT STRUCT MOL BIOL, V18, P1164, DOI 10.1038/nsmb.2126; Kebaara B, 2003, CURR GENET, V43, P171, DOI 10.1007/s00294-003-0386-3; Keeling KM, 2004, RNA, V10, P691, DOI 10.1261/rna.5147804; LEEDS P, 1991, GENE DEV, V5, P2303, DOI 10.1101/gad.5.12a.2303; LEEDS P, 1992, MOL CELL BIOL, V12, P2165, DOI 10.1128/MCB.12.5.2165; MALAVASIC MJ, 1990, MOL CELL BIOL, V10, P2809, DOI 10.1128/MCB.10.6.2809; Min EE, 2013, RNA, V19, P1105, DOI 10.1261/rna.039396.113; Mitchell P, 2003, MOL CELL, V11, P1405, DOI 10.1016/S1097-2765(03)00190-4; MUHLRAD D, 1994, NATURE, V370, P578, DOI 10.1038/370578a0; Muhlrad D, 1999, RNA, V5, P1299, DOI 10.1017/S1355838299990829; Nishant KT, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001083; Novak JE, 2001, GENETICS, V158, P1013; Pelechano V, 2013, NATURE, V497, P127, DOI 10.1038/nature12121; Rojas-Duran MF, 2012, RNA, V18, P2299, DOI 10.1261/rna.035865.112; Shinohara M, 2008, NAT GENET, V40, P299, DOI 10.1038/ng.83; Sureau A, 2001, EMBO J, V20, P1785, DOI 10.1093/emboj/20.7.1785; Swisher KD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026547; Takahashi S, 2003, EMBO J, V22, P3951, DOI 10.1093/emboj/cdg374; Wang WR, 2001, EMBO J, V20, P880, DOI 10.1093/emboj/20.4.880; Welch EM, 1999, EMBO J, V18, P6134, DOI 10.1093/emboj/18.21.6134; Wilkening S, 2013, NUCLEIC ACIDS RES, V41, DOI 10.1093/nar/gks1249	34	7	7	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80981	10.1371/journal.pone.0080981	http://dx.doi.org/10.1371/journal.pone.0080981			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260526	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500189
J	Chan, VBS; Thiyagarajan, V; Lu, XW; Zhang, T; Shih, KM				Chan, Vera B. S.; Thiyagarajan, Vengatesen; Lu, Xing Wen; Zhang, Tong; Shih, Kaimin			Temperature Dependent Effects of Elevated CO2 on Shell Composition and Mechanical Properties of Hydroides elegans: Insights from a Multiple Stressor Experiment	PLOS ONE			English	Article							AMORPHOUS CALCIUM-CARBONATE; OCEAN ACIDIFICATION; SR/CA RATIOS; HONG-KONG; TUBE ULTRASTRUCTURE; SEAWATER CHEMISTRY; CALCIFICATION; SALINITY; MG/CA; POLYCHAETA	The majority of marine benthic invertebrates protect themselves from predators by producing calcareous tubes or shells that have remarkable mechanical strength. An elevation of CO2 or a decrease in pH in the environment can reduce intracellular pH at the site of calcification and thus interfere with animal's ability to accrete CaCO3. In nature, decreased pH in combination with stressors associated with climate change may result in the animal producing severely damaged and mechanically weak tubes. This study investigated how the interaction of environmental drivers affects production of calcareous tubes by the serpulid tubeworm, Hydroides elegans. In a factorial manipulative experiment, we analyzed the effects of pH (8.1 and 7.8), salinity (34 and 27 parts per thousand), and temperature (23 degrees C and 29 degrees C) on the biomineral composition, ultrastructure and mechanical properties of the tubes. At an elevated temperature of 29 degrees C, the tube calcite/aragonite ratio and Mg/Ca ratio were both increased, the Sr/Ca ratio was decreased, and the amorphous CaCO3 content was reduced. Notably, at elevated temperature with decreased pH and reduced salinity, the constructed tubes had a more compact ultrastructure with enhanced hardness and elasticity compared to decreased pH at ambient temperature. Thus, elevated temperature rescued the decreased pH-induced tube impairments. This indicates that tubeworms are likely to thrive in early subtropical summer climate. In the context of climate change, tubeworms could be resilient to the projected near-future decreased pH or salinity as long as surface seawater temperature rise at least by 4 degrees C.	[Chan, Vera B. S.; Thiyagarajan, Vengatesen] Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China; [Chan, Vera B. S.; Thiyagarajan, Vengatesen] Univ Hong Kong, Sch Biol Sci, Hong Kong, Hong Kong, Peoples R China; [Lu, Xing Wen; Zhang, Tong; Shih, Kaimin] Univ Hong Kong, Dept Civil Engn, Hong Kong, Hong Kong, Peoples R China	University of Hong Kong; University of Hong Kong; University of Hong Kong	Thiyagarajan, V (corresponding author), Univ Hong Kong, Swire Inst Marine Sci, Hong Kong, Hong Kong, Peoples R China.	rajan@hku.hk	Zhang, Tong/HGC-1090-2022; 張彤, Tong Zhang/C-6786-2008; Shih, Kaimin/N-8512-2017	Shih, Kaimin/0000-0002-6461-3207; Zhang, Tong/0000-0003-1148-4322; Thiyagarajan, Vengatesen/0000-0002-2062-4799; Chan, Bin San/0000-0003-3935-2700	Hong Kong RGC [778309M, 780510M, 705511P]	Hong Kong RGC(Hong Kong Research Grants Council)	This study was supported by three grants from the Hong Kong RGC (No. 778309M,780510M and 705511P). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andreasen DH, 2006, GEOCHEM GEOPHY GEOSY, V7, DOI 10.1029/2005GC001124; Balmain J, 1999, J BIOMED MATER RES, V48, P749, DOI 10.1002/(SICI)1097-4636(1999)48:5<749::AID-JBM22>3.0.CO;2-P; Beniash E, 1997, P ROY SOC B-BIOL SCI, V264, P461, DOI 10.1098/rspb.1997.0066; BURTON EA, 1987, GEOLOGY, V15, P111, DOI 10.1130/0091-7613(1987)15<111:RPROAA>2.0.CO;2; Byrne M, 2011, OCEANOGR MAR BIOL, V49, P1; Byrne M, 2009, P ROY SOC B-BIOL SCI, V276, P1883, DOI 10.1098/rspb.2008.1935; Chan VBS, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042718; Cohen AL, 2009, GEOCHEM GEOPHY GEOSY, V10, DOI 10.1029/2009GC002411; Dickinson GH, 2012, J EXP BIOL, V215, P29, DOI 10.1242/jeb.061481; Dissard D, 2010, BIOGEOSCIENCES, V7, P81, DOI 10.5194/bg-7-81-2010; Duarte CM, 2013, ESTUAR COAST, V36, P221, DOI 10.1007/s12237-013-9594-3; Elderfield H, 2000, NATURE, V405, P442, DOI 10.1038/35013033; ELNER RW, 1978, OECOLOGIA, V36, P333, DOI 10.1007/BF00348059; Feng QL, 2000, MAT SCI ENG C-BIO S, V11, P19, DOI 10.1016/S0928-4931(00)00138-7; Findlay HS, 2010, ESTUAR COAST SHELF S, V86, P675, DOI 10.1016/j.ecss.2009.11.036; Gillikin DP, 2005, GEOCHEM GEOPHY GEOSY, V6, DOI 10.1029/2004GC000874; Gong YUT, 2012, P NATL ACAD SCI USA, V109, P6088, DOI 10.1073/pnas.1118085109; Gower LB, 2008, CHEM REV, V108, P4551, DOI 10.1021/cr800443h; HAINES JL, 1980, MAR BIOL, V56, P43, DOI 10.1007/BF00390592; Hofmann GE, 2010, ANNU REV ECOL EVOL S, V41, P127, DOI 10.1146/annurev.ecolsys.110308.120227; Kisakurek B, 2008, EARTH PLANET SC LETT, V273, P260, DOI 10.1016/j.epsl.2008.06.026; Klein RT, 1996, GEOCHIM COSMOCHIM AC, V60, P4207, DOI 10.1016/S0016-7037(96)00232-3; Kunitake ME, 2013, ACTA BIOMATER, V9, P5353, DOI 10.1016/j.actbio.2012.09.030; Lane AC, 2013, MAR BIOL, V160, P1983, DOI 10.1007/s00227-012-2056-9; Larson AC, 1994, MSH805; Lea DW, 1999, GEOCHIM COSMOCHIM AC, V63, P2369, DOI 10.1016/S0016-7037(99)00197-0; Lee SW, 2011, MICRON, V42, P60, DOI 10.1016/j.micron.2010.08.001; Li XD, 2002, MATER CHARACT, V48, P11, DOI 10.1016/S1044-5803(02)00192-4; Lorrain A, 2005, GEOLOGY, V33, P965, DOI 10.1130/G22048.1; LOWENSTAM HA, 1981, SCIENCE, V211, P1126, DOI 10.1126/science.7008198; LOWENSTAM HA, 1954, J GEOL, V62, P284, DOI 10.1086/626163; Marshall DJ, 2008, MAR ENVIRON RES, V66, P422, DOI 10.1016/j.marenvres.2008.07.003; Melzner F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024223; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Mount AS, 2004, SCIENCE, V304, P297, DOI 10.1126/science.1090506; Moureaux C, 2010, J STRUCT BIOL, V170, P41, DOI 10.1016/j.jsb.2010.01.003; Nedved BT, 2009, SPRINGER SER BIOFILM, V4, P203, DOI 10.1007/7142_2008_15; Nienhuis S, 2010, P ROY SOC B-BIOL SCI, V277, P2553, DOI 10.1098/rspb.2010.0206; PALMER AR, 1992, P NATL ACAD SCI USA, V89, P1379, DOI 10.1073/pnas.89.4.1379; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Pechenik JA, 2007, BIOL BULL-US, V212, P151, DOI 10.2307/25066592; Perez-Huerta A, 2007, J R SOC INTERFACE, V4, P33, DOI 10.1098/rsif.2006.0150; Portner HO, 2008, MAR ECOL PROG SER, V373, P203, DOI 10.3354/meps07768; Porter SM, 2007, SCIENCE, V316, P1302, DOI 10.1126/science.1137284; Qian PY, 1999, HYDROBIOLOGIA, V402, P239, DOI 10.1023/A:1003704928668; Qiu JW, 1997, J EXP MAR BIOL ECOL, V217, P47, DOI 10.1016/S0022-0981(97)00037-3; Qiu JW, 1997, MAR ECOL PROG SER, V152, P79, DOI 10.3354/meps152079; Qiu JW, 1998, MAR ECOL PROG SER, V168, P127, DOI 10.3354/meps168127; Raz S, 2003, ADV FUNCT MATER, V13, P480, DOI 10.1002/adfm.200304285; Reynaud S, 2007, GEOCHIM COSMOCHIM AC, V71, P354, DOI 10.1016/j.gca.2006.09.009; Riebesell U., 2010, GUIDE BEST PRACTICES, DOI 10.2777/58454; Ries JB, 2011, J EXP MAR BIOL ECOL, V403, P54, DOI 10.1016/j.jembe.2011.04.006; Romana L, 2013, MATER CHARACT, V76, P55, DOI 10.1016/j.matchar.2012.11.010; Russell AD, 2004, GEOCHIM COSMOCHIM AC, V68, P4347, DOI 10.1016/j.gca.2004.03.013; Schneider AS, 2012, BMC BIOPHYS, V5, DOI 10.1186/2046-1682-5-19; Stanley SM, 2008, CHEM REV, V108, P4483, DOI 10.1021/cr800233u; Stoll HM, 2002, GEOCHIM COSMOCHIM AC, V66, P927, DOI 10.1016/S0016-7037(01)00836-5; Strasser CA, 2008, J EXP MAR BIOL ECOL, V355, P153, DOI 10.1016/j.jembe.2007.12.022; Stumpp M, 2012, P NATL ACAD SCI USA, V109, P18192, DOI 10.1073/pnas.1209174109; Sumitomo T, 2011, J STRUCT BIOL, V174, P31, DOI 10.1016/j.jsb.2011.01.001; Takesue RK, 2004, GEOCHIM COSMOCHIM AC, V68, P3845, DOI 10.1016/j.gca.2004.03.021; Tanur AE, 2010, J STRUCT BIOL, V169, P145, DOI 10.1016/j.jsb.2009.09.008; TAYLOR J D, 1972, Palaeontology (Oxford), V15, P73; Taylor PD, 2008, INVERTEBR BIOL, V127, P87, DOI 10.1111/j.1744-7410.2007.00106.x; Taylor PD, 2010, J STRUCT BIOL, V171, P402, DOI 10.1016/j.jsb.2010.05.010; Veis A, 2008, BIOMINERALIZATION NA, V4, P2; VERMEIJ GJ, 1980, BIOL BULL, V158, P383, DOI 10.2307/1540864; Vinn O, 2008, PALAEONTOLOGY, V51, P295, DOI 10.1111/j.1475-4983.2008.00763.x; Vinn O, 2013, MICROSC RES TECHNIQ, V76, P453, DOI 10.1002/jemt.22186; Vinn O, 2011, CARNETS GEOL, P137, DOI 10.4267/2042/43896; Vinn O, 2011, ZOOMORPHOLOGY, V130, P181, DOI 10.1007/s00435-011-0133-0; Vinn O, 2008, LETHAIA, V41, P417, DOI 10.1111/j.1502-3931.2008.00093.x; Vinn O, 2009, EST J EARTH SCI, V58, P148, DOI 10.3176/earth.2009.2.05; Vinn O, 2008, ZOOL J LINN SOC-LOND, V154, P633, DOI 10.1111/j.1096-3642.2008.00421.x; Waldbusser GG, 2011, ESTUAR COAST, V34, P221, DOI 10.1007/s12237-010-9307-0; Wallace D, 2006, MS EXCEL PROGRAM DEV; Watson SA, 2012, GLOBAL CHANGE BIOL, V18, P3026, DOI 10.1111/j.1365-2486.2012.02755.x; Weiner S, 1997, J MATER CHEM, V7, P689, DOI 10.1039/a604512j; Weiner S, 2011, ANNU REV MATER RES, V41, P21, DOI 10.1146/annurev-matsci-062910-095803; Wilt FH, 2003, DIFFERENTIATION, V71, P237, DOI 10.1046/j.1432-0436.2003.7104501.x; Yuan XC, 2011, BIOGEOSCIENCES, V8, P289, DOI 10.5194/bg-8-289-2011; Yung YK, 2001, MAR POLLUT BULL, V42, P981, DOI 10.1016/S0025-326X(01)00066-2; Zeebe R. E., 2001, CO2 SEAWATER EQUILIB; Zeebe RE, 2008, SCIENCE, V321, P51, DOI 10.1126/science.1159124	84	16	16	2	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78945	10.1371/journal.pone.0078945	http://dx.doi.org/10.1371/journal.pone.0078945			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265732	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100065
J	Voisset, E; Oeztuerk-Winder, F; Ruiz, EJ; Ventura, JJ				Voisset, Edwige; Oeztuerk-Winder, Feride; Ruiz, Edgar-Josue; Ventura, Juan-Jose			p38 alpha Negatively Regulates Survival and Malignant Selection of Transformed Bronchioalveolar Stem Cells	PLOS ONE			English	Article							LUNG-CANCER; K-RAS; IDENTIFICATION; PROGRESSION; SOX9; MICE	Lung cancer is the cause of most cancer-related deaths in the Western world. Non-small cell lung cancer accounts for almost 80% of all lung cancers, and 50% of this type are adenocarcinomas. The cellular and molecular origin of this type of lung cancer remains elusive and the mechanisms are poorly known. It is known that K-Ras mutations appear in 25-30% of lung adenocarcinomas and it is the best known single mutation that can be related to lung cancers. Recently, it has been suggested that a putative population of mouse bronchioalveolar stem cells could be considered as the cell of origin of adenocarcinomas. These cells are expanded in the early stages of lung tumorigenesis. We have isolated a population of mouse bronchioalveolar stem cells and induced their transformation by oncogenic K-RasG12. Different approaches have shown that an intracellular network linking the p38 alpha MAPK and the PI3K-Pdk1 pathways is involved in regulating the survival and malignant progression of the transformed cells. Absence of p38 alpha catalytic activity leads to further Pdk1 activation (independent of Akt and Erk activity), enhancing the survival and proliferation of the more malignant lung cancer cells. This specifically selects high Sca-1/Sox9 cells that harbour a stronger colonizing potential, as they maintain their capacity to produce secondary tumors after serial transplantations.	[Voisset, Edwige; Oeztuerk-Winder, Feride; Ruiz, Edgar-Josue; Ventura, Juan-Jose] CSCR Wellcome Trust Ctr Stem Cell Res, Cambridge, England		Ventura, JJ (corresponding author), CSCR Wellcome Trust Ctr Stem Cell Res, Cambridge, England.	jv282@cscr.cam.ac.uk	Ventura, Juan-Jose/J-7913-2016; Voisset, Edwige/GSE-5113-2022; Voisset, Edwige/AAM-3503-2021	Ventura, Juan-Jose/0000-0002-9252-843X; Voisset, Edwige/0000-0002-0943-4847; Voisset, Edwige/0000-0002-0943-4847	Medical Research Council (MRC) [RG51968/RG57589]; Cancer Research UK [RG52191]; EMBO long term fellowship; Medical Research Council [G0901677, G0800346] Funding Source: researchfish; MRC [G0800346, G0901677] Funding Source: UKRI	Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Cancer Research UK(Cancer Research UK); EMBO long term fellowship(European Molecular Biology Organization (EMBO)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	Grants from the Medical Research Council (MRC) (RG51968/RG57589) and Cancer Research UK (RG52191) funded this work. E-J.R. was supported by an EMBO long term fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Curtis SJ, 2010, CELL STEM CELL, V7, P127, DOI 10.1016/j.stem.2010.05.021; Downward J, 2003, NAT REV CANCER, V3, P11, DOI 10.1038/nrc969; EUHUS DM, 1986, J SURG ONCOL, V31, P229, DOI 10.1002/jso.2930310402; Greenlee RT, 2001, CA-CANCER J CLIN, V51, P15, DOI 10.3322/canjclin.51.1.15; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Herbst RS, 2008, NEW ENGL J MED, V359, P1367, DOI 10.1056/NEJMra0802714; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Jiang SS, 2010, CLIN CANCER RES, V16, P4363, DOI 10.1158/1078-0432.CCR-10-0138; Johnson L, 2001, NATURE, V410, P1111, DOI 10.1038/35074129; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; TOMAYKO MM, 1989, CANCER CHEMOTH PHARM, V24, P148, DOI 10.1007/BF00300234; Ventura JJ, 2007, NAT GENET, V39, P750, DOI 10.1038/ng2037; Zhao P, 2012, ONCOGENE; Zhou CH, 2012, J EXP CLIN CANC RES, V31, DOI 10.1186/1756-9966-31-18	15	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78911	10.1371/journal.pone.0078911	http://dx.doi.org/10.1371/journal.pone.0078911			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265727	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100060
J	Zhang, Y; Hu, J; Lu, HJ; Li, JP; Wang, N; Li, WW; Zhou, YC; Liu, JY; Wang, SJ; Wang, J; Li, X; Ma, WL; Wei, LC; Shi, M				Zhang, Ying; Hu, Jing; Lu, Hong-Jun; Li, Jian-Ping; Wang, Ning; Li, Wei-Wei; Zhou, Yong-Chun; Liu, Jun-Yue; Wang, Sheng-Jun; Wang, Jing; Li, Xia; Ma, Wan-Ling; Wei, Li-Chun; Shi, Mei			Determination of an Optimal Standardized Uptake Value of Fluorodeoxyglucose for Positron Emission Tomography Imaging to Assess Pathological Volumes of Cervical Cancer: A Prospective Study	PLOS ONE			English	Article							CELL LUNG-CANCER; GROSS TUMOR VOLUME; INTEGRATED PET/CT; RADIOTHERAPY; DELINEATION; TARGET; DEFINITION; CT; CARCINOMA; SPECIMEN	Purpose: To determine the optimal standardized uptake value (SUV) of F-18-fluorodeoxyglucose (F-18-FDG) for positron emission tomography (PET) imaging, at which the PET-defined gross tumor volume (GTV(PET)) best matches with the pathological volume (GTV(PATH)) in the cervical cancer. Materials and Methods: Ten patients with the cervical cancer who underwent surgery were enrolled in this study. The excised specimens were processed for whole-mount serial sections and H-E staining. The tumor borders were outlined in sections under a microscope, histopathological images were scanned and the GTV(PATH) calculated. The GTV(PET) was delineated automatically by using various percentages relative to the maximal SUV and absolute SUV. The optimal threshold SUV was further obtained as the value at which the GTV(PET) best matched with the GTV(PATH). Results: An average of 85 +/- 10% shrinkage of tissue was observed after the formalin fixation. The GTV(PATH) was 13.38 +/- 2.80 cm(3) on average. The optimal threshold on percentile SUV and absolute SUV were 40.50%+/- 3.16% and 7.45 +/- 1.10, respectively. The correlation analysis showed that the optimal percentile SUV threshold was inversely correlated with GTV(PATH) (p<0.05) and tumor diameter (p<0.05). The absolute SUV was also positively correlated with SUVmax (p<0.05). Conclusion: The pathological volume could provide the more accurate tumor volume. The optimal SUV of FDG for PET imaging by use of GTV(PATH) as standard for cervical cancer target volume delineation was thus determined in this study, and more cases are being evaluated to substantiate this conclusion.	[Zhang, Ying; Hu, Jing; Lu, Hong-Jun; Li, Jian-Ping; Wang, Ning; Li, Wei-Wei; Zhou, Yong-Chun; Liu, Jun-Yue; Wei, Li-Chun; Shi, Mei] Fourth Mil Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian 710032, Peoples R China; [Wang, Sheng-Jun; Wang, Jing] Fourth Mil Med Univ, Dept Nucl Med, Xijing Hosp, Xian 710032, Peoples R China; [Li, Xia] Fourth Mil Med Univ, Xijing Hosp, Dept Pathol, Xian 710032, Peoples R China; [Ma, Wan-Ling] Fourth Mil Med Univ, Dept Radiol, Xijing Hosp, Xian 710032, Peoples R China	Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University	Wei, LC (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Radiat Oncol, Xian 710032, Peoples R China.	weilichun@fmmu.edu.cn; mshifmmu@yahoo.com		liu, liwen/0000-0001-9838-5727	National High Technology Research and Development Program (863 project) [2007AA02Z437]; National Nature Science Foundation of China [30970862]	National High Technology Research and Development Program (863 project)(National High Technology Research and Development Program of China); National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC))	This study was supported by the National High Technology Research and Development Program (863 project) (2007AA02Z437) and the National Nature Science Foundation of China (No. 30970862). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ashamalla H, 2005, INT J RADIAT ONCOL, V63, P1016, DOI 10.1016/j.ijrobp.2005.04.021; Bayne M, 2010, INT J RADIAT ONCOL, V77, P1151, DOI 10.1016/j.ijrobp.2009.06.032; Biehl KJ, 2006, J NUCL MED, V47, P1808; Black QC, 2004, INT J RADIAT ONCOL, V60, P1272, DOI 10.1016/j.ijrobp.2004.06.254; Burri RJ, 2008, INT J RADIAT ONCOL, V71, P682, DOI 10.1016/j.ijrobp.2007.10.055; Caldwell CB, 2003, INT J RADIAT ONCOL, V55, P1381, DOI 10.1016/S0360-3016(02)04609-6; Chung HH, 2007, GYNECOL ONCOL, V104, P529, DOI 10.1016/j.ygyno.2006.09.009; Chung HH, 2011, GYNECOL ONCOL, V120, P270, DOI 10.1016/j.ygyno.2010.11.002; Ciernik IF, 2003, INT J RADIAT ONCOL, V57, P853, DOI 10.1016/S0360-3016(03)00346-8; Daisne JF, 2004, RADIOLOGY, V233, P93, DOI 10.1148/radiol.2331030660; Erdi YE, 1997, CANCER, V80, P2505, DOI 10.1002/(SICI)1097-0142(19971215)80:12+<2505::AID-CNCR24>3.3.CO;2-B; Ford EC, 2006, MED PHYS, V33, P4280, DOI 10.1118/1.2361076; Giraud P, 2001, INT J RADIAT ONCOL, V49, P1249, DOI 10.1016/S0360-3016(00)01579-0; Grisaru D, 2004, GYNECOL ONCOL, V94, P680, DOI 10.1016/j.ygyno.2004.05.053; Gupta A, 2011, J NUCL MED, V26, P22; Hong R, 2007, INT J RADIAT ONCOL, V67, P720, DOI 10.1016/j.ijrobp.2006.09.039; Kim EE, 2004, INT J GYNECOL CANCER, V14, P12, DOI 10.1111/j.1048-891x.2004.14224.x; Miller TR, 2002, INT J RADIAT ONCOL, V53, P353, DOI 10.1016/S0360-3016(02)02705-0; Mutic S, 2002, INT J RADIAT ONCOL, V52, P1104, DOI 10.1016/S0360-3016(01)02784-5; Nagel CCA, 2006, MED PHYS, V33, P1840, DOI 10.1118/1.2198170; Nestle U, 2005, J NUCL MED, V46, P1342; Nguyen NC, 2011, ACTA ONCOL, V50, P670, DOI 10.3109/0284186X.2010.550933; Tejwani A, 2012, AM J NUCL MED MOLEC, V2, P307; Uto F, 2010, J RADIAT RES, V51, P157, DOI 10.1269/jrr.09063; Vali FS, 2010, INT J RADIAT ONCOL, V78, P1057, DOI 10.1016/j.ijrobp.2009.09.022; Yaremko B, 2005, PHYS MED BIOL, V50, P5969, DOI 10.1088/0031-9155/50/24/014; Yu JM, 2009, INT J RADIAT ONCOL, V75, P1468, DOI 10.1016/j.ijrobp.2009.01.019; Zhong XJ, 2009, INT J RADIAT ONCOL, V73, P136, DOI 10.1016/j.ijrobp.2008.04.015	28	3	3	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e75159	10.1371/journal.pone.0075159	http://dx.doi.org/10.1371/journal.pone.0075159			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265671	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100003
J	Drazic, A; Gebendorfer, KM; Mak, S; Steiner, A; Krause, M; Bepperling, A; Winter, J				Drazic, Adrian; Gebendorfer, Katharina M.; Mak, Stefanie; Steiner, Andrea; Krause, Maike; Bepperling, Alexander; Winter, Jeannette			Tetramers Are the Activation-competent Species of the HOCl-specific Transcription Factor HypT	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							HEAT-SHOCK-PROTEIN; ESCHERICHIA-COLI; REDOX-SWITCH; REGULATED CHAPERONE; FIBRIL FORMATION; PRION PROTEIN; MECHANISM; STABILITY; ARGININE; OLIGOMERIZATION	Hypochlorous acid (HOCl) is an important component of the immune system and is produced by neutrophils to kill invading microorganisms. The transcription factor HypT is specifically activated by HOCl by methionine oxidation and protects Escherichia coli cells from the detrimental effects of HOCl. HypT forms dodecameric ring-like oligomers. Binding of HypT to DNA induces dissociation of the dodecamers into dimers and tetramers, thus forming the DNA-binding species. To dissect HypT dissociation, binding to DNA, and activation, we aimed to dissociate the dodecamers independently of DNA and to analyze HOCl-dependent activation in vitro. We found that HypT dodecamers dissociated into tetramers in the presence of L-arginine and NaCl, which was reversible upon dilution of the additive. Making use of the reversible dissociation, we generated mixed assemblies consisting of wild-type and mutant HypT subunits and determined that mutant subunits with reduced thermal stability were stabilized by wild-type HypT in the mixed assembly. HypT tetramers, as present at high NaCl concentrations, were stabilized against thermal unfolding and aggregation triggered by high HOCl concentrations. Importantly, in vitro activation by HOCl of HypT tetramers was completed within 1 min, whereas activation of dodecamers required 1 h for completion. Furthermore, activation of HypT tetramers required stoichiometric amounts of HOCl instead of an excess of HOCl, as observed for dodecamers. This supports the idea that small HypT oligomers are the activation-competent species, whereas the dodecamers are a storage form. Our study reveals the importance of the dynamic oligomeric state for HypT activation by HOCl.	[Drazic, Adrian; Gebendorfer, Katharina M.; Mak, Stefanie; Steiner, Andrea; Krause, Maike; Bepperling, Alexander; Winter, Jeannette] Tech Univ Munich, Dept Chem, CiPSM, D-85747 Garching, Germany	Technical University of Munich	Winter, J (corresponding author), Tech Univ Munich, Dept Chem, CiPSM, Lichtenbergstr 4, D-85747 Garching, Germany.	jeannette.winter@tum.de	Drazic, Adrian/AAC-6120-2019	Drazic, Adrian/0000-0001-9263-5502; Krause, Maike/0000-0003-4068-8172	Elitenetzwerk Bayern; Deutsche Forschungsgemeinschaft (DFG)	Elitenetzwerk Bayern; Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG))	This work was supported by the Elitenetzwerk Bayern (to A. D. and K. M. G.) and the Emmy-Noether Program of the Deutsche Forschungsgemeinschaft (DFG; to J. W.).	Arakawa T, 2007, BIOPHYS CHEM, V127, P1, DOI 10.1016/j.bpc.2006.12.007; Baldwin RL, 1996, BIOPHYS J, V71, P2056, DOI 10.1016/S0006-3495(96)79404-3; Beauchamp DL, 2012, BIOPHYS CHEM, V161, P29, DOI 10.1016/j.bpc.2011.11.004; Bender RA, 2010, J BACTERIOL, V192, P4801, DOI 10.1128/JB.00266-10; Campioni S, 2012, J MOL BIOL, V424, P132, DOI 10.1016/j.jmb.2012.09.023; Chang DW, 2003, J BIOL CHEM, V278, P16466, DOI 10.1074/jbc.C300089200; Choi HJ, 2001, CELL, V105, P103, DOI 10.1016/S0092-8674(01)00300-2; Cossins BP, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1002066; Davies MJ, 2005, BBA-PROTEINS PROTEOM, V1703, P93, DOI 10.1016/j.bbapap.2004.08.007; Dominy BN, 2002, J MOL BIOL, V319, P541, DOI 10.1016/S0022-2836(02)00259-0; Drazic A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075683; Drazic A, 2013, P NATL ACAD SCI USA, V110, P9493, DOI 10.1073/pnas.1300578110; Ericsson UB, 2006, ANAL BIOCHEM, V357, P289, DOI 10.1016/j.ab.2006.07.027; Franzmann TM, 2005, J MOL BIOL, V350, P1083, DOI 10.1016/j.jmb.2005.05.034; Gebendorfer KM, 2012, J BIOL CHEM, V287, P6892, DOI 10.1074/jbc.M111.287219; Gray MJ, 2013, ANNU REV MICROBIOL, V67, P141, DOI 10.1146/annurev-micro-102912-142520; Gray MJ, 2013, J BIOL CHEM, V288, P13789, DOI 10.1074/jbc.M113.454421; GREENE RF, 1974, J BIOL CHEM, V249, P5388; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Haslbeck M, 1999, EMBO J, V18, P6744, DOI 10.1093/emboj/18.23.6744; Jain S, 2010, BIOCHEMISTRY-US, V49, P7615, DOI 10.1021/bi100745j; Jakob U, 1999, CELL, V96, P341, DOI 10.1016/S0092-8674(00)80547-4; Kirstein J, 2006, EMBO J, V25, P1481, DOI 10.1038/sj.emboj.7601042; Lange C, 2009, CURR PHARM BIOTECHNO, V10, P408, DOI 10.2174/138920109788488851; Lochowska A, 2001, J BIOL CHEM, V276, P2098, DOI 10.1074/jbc.M007192200; Lyutova EM, 2007, BIOTECHNOL PROGR, V23, P1411, DOI 10.1021/bp070209h; Mao Yong-Jin, 2007, BMC Biochemistry, V8, P28, DOI 10.1186/1471-2091-8-28; Nielsen L, 2001, BIOCHEMISTRY-US, V40, P6036, DOI 10.1021/bi002555c; Palm GJ, 2012, NUCLEIC ACIDS RES, V40, P4178, DOI 10.1093/nar/gkr1316; Pattison DI, 2001, CHEM RES TOXICOL, V14, P1453, DOI 10.1021/tx0155451; Peschek J, 2013, P NATL ACAD SCI USA, V110, pE3780, DOI 10.1073/pnas.1308898110; RICHEY B, 1987, J BIOL CHEM, V262, P7157; Richter K, 2010, MOL CELL, V40, P253, DOI 10.1016/j.molcel.2010.10.006; RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4; ROE JH, 1984, J MOL BIOL, V176, P495, DOI 10.1016/0022-2836(84)90174-8; Rosen H, 2009, P NATL ACAD SCI USA, V106, P18686, DOI 10.1073/pnas.0909464106; Rudolph R, 1996, FASEB J, V10, P49, DOI 10.1096/fasebj.10.1.8566547; Sainsbury S, 2009, NUCLEIC ACIDS RES, V37, P4545, DOI 10.1093/nar/gkp445; SCHULTZ SG, 1961, J GEN PHYSIOL, V45, P355, DOI 10.1085/jgp.45.2.355; Shashidharamurthy R, 2005, J BIOL CHEM, V280, P5281, DOI 10.1074/jbc.M407236200; Srinivas V, 2003, PROTEIN SCI, V12, P1262, DOI 10.1110/ps.0302003; Stengel F, 2010, P NATL ACAD SCI USA, V107, P2007, DOI 10.1073/pnas.0910126107; van Eunen K, 2010, FEBS J, V277, P749, DOI 10.1111/j.1742-4658.2009.07524.x; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Winter J, 2008, CELL, V135, P691, DOI 10.1016/j.cell.2008.09.024; Winter J, 2004, CRIT REV BIOCHEM MOL, V39, P297, DOI 10.1080/10409230490900658; Winter J, 2002, ANAL BIOCHEM, V310, P148, DOI 10.1016/S0003-2697(02)00287-7; Winterbourn CC, 2006, J BIOL CHEM, V281, P39860, DOI 10.1074/jbc.M605898200; Wolf SG, 1999, NATURE, V400, P83, DOI 10.1038/21918; Wright DB, 2002, J MOL BIOL, V323, P327, DOI 10.1016/S0022-2836(02)00916-6; Yeh V, 2010, PROTEIN SCI, V19, P47, DOI 10.1002/pro.281; Zhang YJ, 2006, CURR OPIN CHEM BIOL, V10, P658, DOI 10.1016/j.cbpa.2006.09.020	52	16	16	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					977	986		10.1074/jbc.M113.521401	http://dx.doi.org/10.1074/jbc.M113.521401			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275662	Green Published, hybrid			2022-12-25	WOS:000330541200032
J	Suarez-Vega, A; Gutierrez-Gil, B; Cuchillo-Ibanez, I; Saez-Valero, J; Perez, V; Garcia-Gamez, E; Benavides, J; Arranz, JJ				Suarez-Vega, Aroa; Gutierrez-Gil, Beatriz; Cuchillo-Ibanez, Inmaculada; Saez-Valero, Javier; Perez, Valentin; Garcia-Gamez, Elsa; Benavides, Julio; Jose Arranz, Juan			Identification of a 31-bp Deletion in the RELN Gene Causing Lissencephaly with Cerebellar Hypoplasia in Sheep	PLOS ONE			English	Article							NEURONAL MIGRATION; REELIN; MUTATION; RECEPTOR; PROTEIN; MALFORMATIONS; ASSOCIATION; INVOLVEMENT; DEFECTS; BRAIN	Lissencephaly is an inherited developmental disorder in which neuronal migration is impaired. A type of lissencephaly associated with cerebellar hypoplasia (LCH) was diagnosed in a commercial flock of Spanish Churra sheep. The genotyping of 7 affected animals and 33 controls with the OvineSNP50 BeadChip enabled the localization of the causative mutation for ovine LCH to a 4.8-Mb interval on sheep chromosome 4 using genome-wide association and homozygosity mapping. The RELN gene, which is located within this interval, was considered a strong positional and functional candidate because it plays critical roles in neuronal migration and layer formation. By performing a sequencing analysis of this gene's specific mRNA in a control lamb, we obtained the complete CDS of the ovine RELN gene. The cDNA sequence from an LCH-affected lamb revealed a deletion of 31 bp (c.5410_5440del) in predicted exon 36 of RELN, resulting in a premature termination codon. A functional analysis of this mutation revealed decreased levels of RELN mRNA and a lack of reelin protein in the brain cortex and blood of affected lambs. This mutation showed a complete concordance with the Mendelian recessive pattern of inheritance observed for the disease. The identification of the causal mutation of LCH in Churra sheep will facilitate the implementation of gene-assisted selection to detect heterozygous mutants, which will help breeders avoid at-risk matings in their flocks. Moreover, the identification of this naturally occurring RELN mutation provides an opportunity to use Churra sheep as a genetically characterized large animal model for the study of reelin functions in the developing and mature brain.	[Suarez-Vega, Aroa; Gutierrez-Gil, Beatriz; Garcia-Gamez, Elsa; Jose Arranz, Juan] Univ Leon, Dpto Prod Anim, E-24071 Leon, Spain; [Cuchillo-Ibanez, Inmaculada; Saez-Valero, Javier] Univ Miguel Hernandez, CSIC, Inst Neurociencias Alicante, Alicante, Spain; [Cuchillo-Ibanez, Inmaculada; Saez-Valero, Javier] Univ Miguel Hernandez, Ctr Invest Biomed Red Enfermedades Neurodegenerat, Alicante, Spain; [Perez, Valentin] Univ Leon, Dpto Sanidad Anim, E-24071 Leon, Spain; [Perez, Valentin; Benavides, Julio] Univ Leon, CSIC, Inst Ganaderia Montana, E-24071 Leon, Spain	Universidad de Leon; Consejo Superior de Investigaciones Cientificas (CSIC); Universidad Miguel Hernandez de Elche; CSIC-UMH - Instituto de Neurociencias de Alicante (IN); CIBERNED; Universidad Miguel Hernandez de Elche; Universidad de Leon; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC-ULE - Instituto de Ganaderia de Montana (IGM); Universidad de Leon	Arranz, JJ (corresponding author), Univ Leon, Dpto Prod Anim, E-24071 Leon, Spain.	jjarrs@unileon.es	Sáez, Javier/K-5756-2014; Gutierrez, Beatriz/AAU-1711-2021; cuchillo, inmaculada/P-2975-2019; Benavides, Julio/D-5299-2014; Arranz, Juan-Jose/H-1225-2015; Perez, Valentin/A-6281-2015	Sáez, Javier/0000-0001-7480-320X; Benavides, Julio/0000-0001-9706-100X; Arranz, Juan-Jose/0000-0001-9058-131X; Perez, Valentin/0000-0003-0075-1587; Gutierrez-Gil, Beatriz/0000-0001-7990-5723; Suarez Vega, Aroa/0000-0002-7726-4288; /0000-0002-3689-5518	Spanish Ministry of Science [AGL2009-07000]; European Commission; Spanish Ministry of Education	Spanish Ministry of Science(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); European Commission(European CommissionEuropean Commission Joint Research Centre); Spanish Ministry of Education(Spanish Government)	This work was supported by the Spanish Ministry of Science (Project AGL2009-07000) and by the European Commission 3SR Project (Sustainable Solutions for Small Ruminants; http://www.3srbreeding.eu) (to JJA). Fondo de Investigaciones Sanitarias (PS09/00684; PI12/00593), Fundacion Ramon Areces, and CIBERNED, Instituto de Salud Carlos III from Spain (to JSV). Aroa Suarez-Vega is funded by an FPU contract from the Spanish Ministry of Education. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Barkovich AJ, 2012, BRAIN, V135, P1348, DOI 10.1093/brain/aws019; Becker D, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008689; Beffert U, 2005, NEURON, V47, P567, DOI 10.1016/j.neuron.2005.07.007; Botella-Lopez A, 2006, P NATL ACAD SCI USA, V103, P5573, DOI 10.1073/pnas.0601279103; Boycott KM, 2005, AM J HUM GENET, V77, P477, DOI 10.1086/444400; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Charlier C, 2008, NAT GENET, V40, P449, DOI 10.1038/ng.96; D'Arcangelo G, 1998, BIOESSAYS, V20, P235, DOI 10.1002/(SICI)1521-1878(199803)20:3&lt;235::AID-BIES7&gt;3.0.CO;2-Q; DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0; deBergeyck V, 1997, MOL BRAIN RES, V50, P85, DOI 10.1016/S0169-328X(97)00166-6; DeSilva U, 1997, GENOME RES, V7, P157, DOI 10.1101/gr.7.2.157; Folsom TD, 2013, NEUROPHARMACOLOGY, V68, P122, DOI 10.1016/j.neuropharm.2012.08.015; Frotscher M, 2010, TRENDS NEUROSCI, V33, P407, DOI 10.1016/j.tins.2010.06.001; Gleeson JG, 2000, TRENDS NEUROSCI, V23, P352, DOI 10.1016/S0166-2236(00)01607-6; Glowatzki-Mullis ML, 2007, ANIM GENET, V38, P86, DOI 10.1111/j.1365-2052.2006.01550.x; Groc L, 2007, J NEUROSCI, V27, P10165, DOI 10.1523/JNEUROSCI.1772-07.2007; Herrmann A, 2011, TIERAERZTL PRAX K H, V39, P116; Herz J, 2006, NAT REV NEUROSCI, V7, P850, DOI 10.1038/nrn2009; Hong SE, 2000, NAT GENET, V26, P93, DOI 10.1038/79246; Jissendi-Tchofo P, 2009, NEUROLOGY, V72, P410, DOI 10.1212/01.wnl.0000333256.74903.94; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Kumar RA, 2010, HUM MOL GENET, V19, P2817, DOI 10.1093/hmg/ddq182; Lambert de Rouvroit C, 1998, Adv Anat Embryol Cell Biol, V150, P1; Makinen VP, 2005, EUR J HUM GENET, V13, P987, DOI 10.1038/sj.ejhg.5201430; Martinez-Cerdeno V, 2002, CEREB CORTEX, V12, P1298, DOI 10.1093/cercor/12.12.1298; MILLER SA, 1988, NUCLEIC ACIDS RES, V16, P1215, DOI 10.1093/nar/16.3.1215; Momke S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018943; Nakano Y, 2007, J BIOL CHEM, V282, P20544, DOI 10.1074/jbc.M702300200; PASSEMARD S, 2010, NEWBORN BRAIN NEUROS, P55; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Perez V, 2013, BMC VET RES, V9, DOI 10.1186/1746-6148-9-156; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Qiu SF, 2007, J NEUROPHYSIOL, V97, P2312, DOI 10.1152/jn.00869.2006; Ross ME, 2001, NEUROPEDIATRICS, V32, P256, DOI 10.1055/s-2001-19120; Royaux I, 1997, GENOMICS, V42, P479, DOI 10.1006/geno.1997.4772; Rozen S, 2000, Methods Mol Biol, V132, P365; Shariflou MR, 2013, ANIM GENET, V44, P231, DOI 10.1111/j.1365-2052.2012.02392.x; Sohal APS, 2012, PEDIATR NEUROL, V46, P127, DOI 10.1016/j.pediatrneurol.2011.11.017; Summers BA., 1995, VET NEUROPATHOLOGY, P68; Takahara T, 1996, HUM MOL GENET, V5, P989, DOI 10.1093/hmg/5.7.989; Trommsdorff M, 1999, CELL, V97, P689, DOI 10.1016/S0092-8674(00)80782-5; Ventruti A, 2011, NEUROSCIENCE, V189, P32, DOI 10.1016/j.neuroscience.2011.05.050; Walsh CA, 1999, NEURON, V23, P19, DOI 10.1016/S0896-6273(00)80749-7; Yokoi N, 2003, MOL BRAIN RES, V112, P1, DOI 10.1016/S0169-328X(02)00650-2; Zhao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021739	46	7	8	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81072	10.1371/journal.pone.0081072	http://dx.doi.org/10.1371/journal.pone.0081072			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260534	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900111
J	Cook, S; Chung, BYW; Bass, D; Moureau, G; Tang, SY; McAlister, E; Culverwell, CL; Glucksman, E; Wang, H; Brown, TDK; Gould, EA; Harbach, RE; de Lamballerie, X; Firth, AE				Cook, Shelley; Chung, Betty Y. -W.; Bass, David; Moureau, Gregory; Tang, Shuoya; McAlister, Erica; Culverwell, C. Lorna; Gluecksman, Edvard; Wang, Hui; Brown, T. David K.; Gould, Ernest A.; Harbach, Ralph E.; de Lamballerie, Xavier; Firth, Andrew E.			Novel Virus Discovery and Genome Reconstruction from Field RNA Samples Reveals Highly Divergent Viruses in Dipteran Hosts	PLOS ONE			English	Article							NATURAL MOSQUITO POPULATION; FUSING AGENT VIRUS; INSECT FLAVIVIRUS; MOLECULAR CHARACTERIZATION; YUCATAN PENINSULA; SEQUENCES; EVOLUTION; ALIGNMENT; GENUS; BIRNAVIRUS	We investigated whether small RNA (sRNA) sequenced from field-collected mosquitoes and chironomids (Diptera) can be used as a proxy signature of viral prevalence within a range of species and viral groups, using sRNAs sequenced from wild-caught specimens, to inform total RNA deep sequencing of samples of particular interest. Using this strategy, we sequenced from adult Anopheles maculipennis s.l. mosquitoes the apparently nearly complete genome of one previously undescribed virus related to chronic bee paralysis virus, and, from a pool of Ochlerotatus caspius and Oc. detritus mosquitoes, a nearly complete entomobirnavirus genome. We also reconstructed long sequences (1503-6557 nt) related to at least nine other viruses. Crucially, several of the sequences detected were reconstructed from host organisms highly divergent from those in which related viruses have been previously isolated or discovered. It is clear that viral transmission and maintenance cycles in nature are likely to be significantly more complex and taxonomically diverse than previously expected.	[Cook, Shelley; Bass, David; McAlister, Erica; Culverwell, C. Lorna; Harbach, Ralph E.] Nat Hist Museum, Dept Life Sci, London SW7 5BD, England; [Chung, Betty Y. -W.; Tang, Shuoya] Univ Cambridge, Dept Plant Sci, Cambridge, England; [Moureau, Gregory; Gould, Ernest A.; de Lamballerie, Xavier] Aix Marseille Univ, UMR D Emergence Pathol Virales 190, IRD French Inst Res Dev EHESP French Sch Publ Hea, Marseille, France; [Gluecksman, Edvard] Univ Duisburg Essen, Dept Gen Bot, Essen, Germany; [Wang, Hui; Gould, Ernest A.] Ctr Ecol & Hydrol, Wallingford, Oxon, England; [Brown, T. David K.; Firth, Andrew E.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QP, England	Natural History Museum London; University of Cambridge; UDICE-French Research Universities; Aix-Marseille Universite; University of Duisburg Essen; UK Centre for Ecology & Hydrology (UKCEH); University of Cambridge	Cook, S (corresponding author), Nat Hist Museum, Dept Life Sci, Cromwell Rd, London SW7 5BD, England.	s.cook@nhm.ac.uk; aef24@cam.ac.uk	Culverwell, Lorna/N-3520-2014; Wang, Hui/E-6764-2012	Culverwell, Lorna/0000-0003-0755-5079; Firth, Andrew/0000-0002-7986-9520; Glucksman, Edvard/0000-0002-3542-9793	Wellcome Trust [082744, 088789]; U.K. Biotechnology and Biological Research Council (BBSRC) [BB/J007072/1, BB/J015652/1]; EMBO; Sir Henry Wellcome Postdoctoral Fellowship [096082]; Biotechnology and Biological Sciences Research Council [BB/J015652/1, BB/J007072/1] Funding Source: researchfish; Natural Environment Research Council [CEH010021, NE/I000593/1] Funding Source: researchfish; BBSRC [BB/J015652/1, BB/J007072/1] Funding Source: UKRI; NERC [NE/I000593/1] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); U.K. Biotechnology and Biological Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EMBO(European Molecular Biology Organization (EMBO)); Sir Henry Wellcome Postdoctoral Fellowship; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	SC was funded by a Wellcome Trust Sir Henry Wellcome Postdoctoral Fellowship [082744]. See www.wellcome.ac.uk. Work in the AEF lab is funded by grants from the Wellcome Trust [088789] and the U.K. Biotechnology and Biological Research Council (BBSRC) [BB/J007072/1 and BB/J015652/1]. See www.wellcome.ac.uk and www.bbscr.ac.uk respectively. BYWC is funded by an EMBO Long-Term Postdoctoral Fellowship and a Sir Henry Wellcome Postdoctoral Fellowship [096082]. See www.embo.org and www.wellcome.ac.uk respectively. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aliyari R, 2008, CELL HOST MICROBE, V4, P387, DOI 10.1016/j.chom.2008.09.001; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Aranda C, 2009, VECTOR-BORNE ZOONOT, V9, P171, DOI 10.1089/vbz.2008.0073; Armitage P.D., 1995, THE CHIRONOMIDAE; Aswad A, 2012, TRENDS ECOL EVOL, V27, P627, DOI 10.1016/j.tree.2012.07.007; Attoui H, 2005, VIROLOGY, V343, P212, DOI 10.1016/j.virol.2005.08.028; Becker N, 2010, MOSQUITOES AND THEIR CONTROL, SECOND EDITION, P3, DOI 10.1007/978-3-540-92874-4_1; Bolling BG, 2011, AM J TROP MED HYG, V85, P169, DOI 10.4269/ajtmh.2011.10-0474; Brackney DE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000502; BRIERLEY I, 1992, J MOL BIOL, V227, P463, DOI 10.1016/0022-2836(92)90901-U; Cai GH, 2012, ARCH VIROL, V157, P165, DOI 10.1007/s00705-011-1126-5; Calzolari M, 2010, VECTOR-BORNE ZOONOT, V10, P875, DOI 10.1089/vbz.2009.0176; Camacho C, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-421; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Cook S, 2006, J GEN VIROL, V87, P735, DOI 10.1099/vir.0.81475-0; Cook S, 2012, J GEN VIROL, V93, P223, DOI 10.1099/vir.0.036525-0; Cook S, 2009, J GEN VIROL, V90, P2669, DOI 10.1099/vir.0.014183-0; Crabtree MB, 2009, ARCH VIROL, V154, P857, DOI 10.1007/s00705-009-0373-1; Crabtree MB, 2003, ARCH VIROL, V148, P1095, DOI 10.1007/s00705-003-0019-7; Crochu S, 2004, J GEN VIROL, V85, P1971, DOI 10.1099/vir.0.79850-0; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fang Y, 2012, P NATL ACAD SCI USA, V109, pE2920, DOI 10.1073/pnas.1211145109; Farfan-Ale JA, 2010, VECTOR-BORNE ZOONOT, V10, P777, DOI 10.1089/vbz.2009.0196; Farfan-Ale JA, 2009, AM J TROP MED HYG, V80, P85, DOI 10.4269/ajtmh.2009.80.85; Firth AE, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120109; Firth AE, 2012, J GEN VIROL, V93, P1385, DOI 10.1099/vir.0.042499-0; Firth AE, 2011, NUCLEIC ACIDS RES, V39, P6679, DOI 10.1093/nar/gkr224; Firth AE, 2010, VIROLOGY, V399, P153, DOI 10.1016/j.virol.2009.12.033; Fort P, 2012, MOL BIOL EVOL, V29, P381, DOI 10.1093/molbev/msr226; Gregory R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017418; Hong YG, 1999, VIROLOGY, V258, P118, DOI 10.1006/viro.1999.9691; Hoshino K, 2007, VIROLOGY, V359, P405, DOI 10.1016/j.virol.2006.09.039; Hoshino K, 2009, VIROLOGY, V391, P119, DOI 10.1016/j.virol.2009.06.025; Huang Y, 2013, J GEN VIROL, V94, P663, DOI 10.1099/vir.0.048231-0; Huhtamo E, 2009, J VIROL, V83, P9532, DOI 10.1128/JVI.00529-09; Junglen S, 2013, CURR OPIN MICROBIOL, V16, P507, DOI 10.1016/j.mib.2013.06.005; Katzourakis A, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001191; Keene KM, 2004, P NATL ACAD SCI USA, V101, P17240, DOI 10.1073/pnas.0406983101; Kihara Y, 2007, J VIROL METHODS, V146, P372, DOI 10.1016/j.jviromet.2007.07.008; Kim DY, 2009, VIROLOGY, V386, P154, DOI 10.1016/j.virol.2008.12.034; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu HQ, 2010, J VIROL, V84, P11876, DOI 10.1128/JVI.00955-10; Liu SJ, 2011, VIRUSES-BASEL, V3, P1849, DOI 10.3390/v3101849; Marinkovic M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048096; Marklewitz M, 2011, J VIROL, V85, P9227, DOI 10.1128/JVI.00230-11; Marklewitz M, 2012, J GEN VIROL, V93, P2431, DOI 10.1099/vir.0.045435-0; Morales-Betoulle ME, 2008, J MED ENTOMOL, V45, P1187, DOI 10.1603/0022-2585(2008)45[1187:CFIFMI]2.0.CO;2; Moureau G, 2010, VECTOR-BORNE ZOONOT, V10, P195, DOI 10.1089/vbz.2008.0216; Myles KM, 2008, P NATL ACAD SCI USA, V105, P19938, DOI 10.1073/pnas.0803408105; Ng TFF, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020579; Nibert ML, 2009, ARCH VIROL, V154, P1959, DOI 10.1007/s00705-009-0513-7; Olivier V, 2008, VIRUS RES, V132, P59, DOI 10.1016/j.virusres.2007.10.014; Pabbarak K, 2009, J MED ENTOMOL, V46, P640, DOI 10.1603/033.046.0332; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Rastgou M, 2009, J GEN VIROL, V90, P2525, DOI 10.1099/vir.0.013086-0; Ribiere M, 2010, J INVERTEBR PATHOL, V103, pS120, DOI 10.1016/j.jip.2009.06.013; Rodriguez-Cousino N, 1998, J BIOL CHEM, V273, P20363, DOI 10.1074/jbc.273.32.20363; Roiz D, 2009, VIROL J, V6, DOI 10.1186/1743-422X-6-93; Rosario K, 2012, J GEN VIROL, V93, P2668, DOI 10.1099/vir.0.045948-0; Rosario K, 2011, CURR OPIN VIROL, V1, P289, DOI 10.1016/j.coviro.2011.06.004; Ruby JG, 2013, G3-GENES GENOM GENET, V3, P865, DOI 10.1534/g3.113.005967; Runckel C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020656; Sanchez-Seco MP, 2010, VECTOR-BORNE ZOONOT, V10, P203, DOI 10.1089/vbz.2008.0188; Sanchez-Vargas I, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000299; Sang RC, 2003, ARCH VIROL, V148, P1085, DOI 10.1007/s00705-003-0018-8; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Shwed PS, 2002, VIROLOGY, V296, P241, DOI 10.1006/viro.2001.1334; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Spear A, 2010, VIROLOGY, V404, P304, DOI 10.1016/j.virol.2010.05.015; STOLLAR V, 1975, VIROLOGY, V64, P367, DOI 10.1016/0042-6822(75)90113-0; Stuart DI, 2006, CURR TOP MICROBIOL, V309, P221; SWOFFORD DL, 2001, PHYLOGENETIC ANAL US; Talavera G, 2007, SYST BIOL, V56, P564, DOI 10.1080/10635150701472164; Taylor DJ, 2009, BMC BIOL, V7, DOI 10.1186/1741-7007-7-88; Vancini R, 2012, J VIROL, V86, P2390, DOI 10.1128/JVI.06614-11; Walter CT, 2011, J GEN VIROL, V92, P2467, DOI 10.1099/vir.0.035105-0; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	77	100	100	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80720	10.1371/journal.pone.0080720	http://dx.doi.org/10.1371/journal.pone.0080720			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260463	gold, Green Accepted, Green Published, Green Submitted			2022-12-25	WOS:000327308500170
J	Kuhnert, MT; Bialonski, S; Noennig, N; Mai, H; Hinrichs, H; Helmstaedter, C; Lehnertz, K				Kuhnert, Marie-Therese; Bialonski, Stephan; Noennig, Nina; Mai, Heinke; Hinrichs, Hermann; Helmstaedter, Christoph; Lehnertz, Klaus			Incidental and Intentional Learning of Verbal Episodic Material Differentially Modifies Functional Brain Networks	PLOS ONE			English	Article							MEDIAL TEMPORAL-LOBE; GRAPH-THEORETICAL ANALYSIS; PHASE SYNCHRONIZATION; RECOGNITION MEMORY; COMPLEX NETWORKS; EPILEPTIC BRAIN; EEG; ATTENTION; EFFICIENCY; CORTEX	Learning-and memory-related processes are thought to result from dynamic interactions in large-scale brain networks that include lateral and mesial structures of the temporal lobes. We investigate the impact of incidental and intentional learning of verbal episodic material on functional brain networks that we derive from scalp-EEG recorded continuously from 33 subjects during a neuropsychological test schedule. Analyzing the networks' global statistical properties we observe that intentional but not incidental learning leads to a significantly increased clustering coefficient, and the average shortest path length remains unaffected. Moreover, network modifications correlate with subsequent recall performance: the more pronounced the modifications of the clustering coefficient, the higher the recall performance. Our findings provide novel insights into the relationship between topological aspects of functional brain networks and higher cognitive functions.	[Kuhnert, Marie-Therese; Helmstaedter, Christoph; Lehnertz, Klaus] Univ Bonn, Dept Epileptol, Bonn, Germany; [Kuhnert, Marie-Therese; Lehnertz, Klaus] Univ Bonn, Helmholtz Inst Radiat & Nucl Phys, Bonn, Germany; [Kuhnert, Marie-Therese; Lehnertz, Klaus] Univ Bonn, Interdisciplinary Ctr Complex Syst, Bonn, Germany; [Bialonski, Stephan] Max Planck Inst Phys Komplexer Syst, Dresden, Germany; [Noennig, Nina; Mai, Heinke; Hinrichs, Hermann] Univ Magdeburg, Dept Neurol, D-39106 Magdeburg, Germany	University of Bonn; Helmholtz Association; University of Bonn; University of Bonn; Max Planck Society; Otto von Guericke University	Lehnertz, K (corresponding author), Univ Bonn, Dept Epileptol, Bonn, Germany.	klaus.lehnertz@ukb.uni-bonn.de	Bialonski, Stephan/C-8790-2012	Bialonski, Stephan/0000-0003-1150-8080; Lehnertz, Klaus/0000-0002-5529-8559	Deutsche Forschungsgemeinschaft [SFB-TR3, LE660/4-1, LE660/4-2]; Bundesministerium fur Bildung und Forschung [01GQ0702]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Bundesministerium fur Bildung und Forschung(Federal Ministry of Education & Research (BMBF))	This work was supported by the Deutsche Forschungsgemeinschaft (Grant No. SFB-TR3 sub-project A2 to KL and HH; Grant Nos. LE660/4-1 and LE660/4-2 to KL) and by the Bundesministerium fur Bildung und Forschung (Grant No. 01GQ0702 "Bernstein Group Magdeburg'' to HH). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albert R, 2002, REV MOD PHYS, V74, P47, DOI 10.1103/RevModPhys.74.47; ALVAREZ P, 1994, P NATL ACAD SCI USA, V91, P7041, DOI 10.1073/pnas.91.15.7041; Anderson BS, 1999, SOC NETWORKS, V21, P239, DOI 10.1016/S0378-8733(99)00011-8; [Anonymous], 1991, J CLIN NEUROPHYSIOL, V8, P200, DOI 10.1097/00004691-199104000-00007; Ansmann G, 2012, J NEUROSCI METH, V208, P165, DOI 10.1016/j.jneumeth.2012.05.008; Ansmann G, 2011, PHYS REV E, V84, DOI 10.1103/PhysRevE.84.026103; Arenas A, 2008, PHYS REP, V469, P93, DOI 10.1016/j.physrep.2008.09.002; Astolfi L, 2008, IEEE T NEUR SYS REH, V16, P522, DOI 10.1109/TNSRE.2008.2009784; Bassett DS, 2009, P NATL ACAD SCI USA, V106, P11747, DOI 10.1073/pnas.0903641106; Bassett DS., 2010, SHORT COURSE 3 ANAL, P55; Bassettt DS, 2006, P NATL ACAD SCI USA, V103, P19518, DOI 10.1073/pnas.0606005103; Bell B, 2011, NAT REV NEUROL, V7, P154, DOI 10.1038/nrneurol.2011.3; Bialonski S, 2013, CHAOS, V23, DOI 10.1063/1.4821915; Bialonski S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022826; Bialonski S, 2010, CHAOS, V20, DOI 10.1063/1.3360561; Boashash B., 1992, TIME FREQUENCY SIGNA; Boccaletti S, 2006, PHYS REP, V424, P175, DOI 10.1016/j.physrep.2005.10.009; Bressler SL, 2010, TRENDS COGN SCI, V14, P277, DOI 10.1016/j.tics.2010.04.004; Brewer JB, 2002, TRENDS COGN SCI, V6, P217, DOI 10.1016/S1364-6613(02)01881-8; Brown MW, 2001, NAT REV NEUROSCI, V2, P51, DOI 10.1038/35049064; Bruns A, 2004, J NEUROSCI METH, V137, P321, DOI 10.1016/j.jneumeth.2004.03.002; Buckner RL, 2001, NAT REV NEUROSCI, V2, P624, DOI 10.1038/35090048; Bullmore E, 2013, NAT REV NEUROSCI, V13, P336; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Buzsaki G, 2004, SCIENCE, V304, P1926, DOI 10.1126/science.1099745; Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585; Carr VA, 2010, NEURON, V65, P298, DOI 10.1016/j.neuron.2009.12.022; Chun MM, 2007, CURR OPIN NEUROBIOL, V17, P177, DOI 10.1016/j.conb.2007.03.005; Costa LD, 2007, ADV PHYS, V56, P167, DOI 10.1080/00018730601170527; Dehaene S, 2011, NEURON, V70, P200, DOI 10.1016/j.neuron.2011.03.018; Dijkstra E.W, 1959, NUMER MATH, V1, P269, DOI DOI 10.1007/BF01386390; Dimitriadis SI, 2010, J NEUROSCI METH, V193, P145, DOI 10.1016/j.jneumeth.2010.08.027; Douw L, 2011, NEUROSCIENCE, V175, P169, DOI 10.1016/j.neuroscience.2010.11.039; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Elger CE, 1997, NEUROPSYCHOLOGIA, V35, P657, DOI 10.1016/S0028-3932(96)00110-8; Elger CE, 2004, LANCET NEUROL, V3, P663, DOI 10.1016/S1474-4422(04)00906-8; Engel AK, 2005, NAT REV NEUROSCI, V6, P35, DOI 10.1038/nrn1585; Fell J, 2001, NAT NEUROSCI, V4, P1259, DOI 10.1038/nn759; Fell J, 2011, NAT REV NEUROSCI, V12, P105, DOI 10.1038/nrn2979; Fernandez G, 1999, SCIENCE, V285, P1582, DOI 10.1126/science.285.5433.1582; Fortunato S, 2010, PHYS REP, V486, P75, DOI 10.1016/j.physrep.2009.11.002; Frei MG, 2010, EPILEPSY BEHAV, V19, P4, DOI 10.1016/j.yebeh.2010.06.009; Gabor D., 1946, J I ELECT ENG LOND, V93, P429, DOI DOI 10.1049/JI-3-2.1946.0074; Giessing C, 2013, J NEUROSCI, V33, P5903, DOI 10.1523/JNEUROSCI.4854-12.2013; Helmstaedter C, 1990, Schweiz Arch Neurol Psychiatr (1985), V141, P21; Helmstaedter C, 2009, BRAIN, V132, P2822, DOI 10.1093/brain/awp182; Helmstaedter C, 1997, BRAIN COGNITION, V35, P110, DOI 10.1006/brcg.1997.0930; Henke K, 2010, NAT REV NEUROSCI, V11, P523, DOI 10.1038/nrn2850; Hlavackova-Schindler K, 2007, PHYS REP, V441, P1, DOI 10.1016/j.physrep.2006.12.004; Horstmann MT, 2010, CLIN NEUROPHYSIOL, V121, P172, DOI 10.1016/j.clinph.2009.10.013; Ioannides AA, 2007, CURR OPIN NEUROBIOL, V17, P161, DOI 10.1016/j.conb.2007.03.008; Kitzbichler MG, 2011, J NEUROSCI, V31, P8259, DOI 10.1523/JNEUROSCI.0440-11.2011; Kral T, 2002, ZBL NEUROCHIR, V63, P106, DOI 10.1055/s-2002-35826; Lachaux JP, 2012, PROG NEUROBIOL, V98, P279, DOI 10.1016/j.pneurobio.2012.06.008; Langer N, 2012, HUM BRAIN MAPP, V33, P1393, DOI 10.1002/hbm.21297; Lehnertz K., 2011, EPILEPSY INTERSECTIO, P265; Lehnertz K, 2009, J NEUROSCI METH, V183, P42, DOI 10.1016/j.jneumeth.2009.05.015; Micheloyannis S, 2006, SCHIZOPHR RES, V87, P60, DOI 10.1016/j.schres.2006.06.028; Mormann F, 2000, PHYSICA D, V144, P358, DOI 10.1016/S0167-2789(00)00087-7; Mormann F, 2008, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.003.2008; Moussa MN, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00083; Muzzio IA, 2009, J PHYSIOL-LONDON, V587, P2837, DOI 10.1113/jphysiol.2009.172445; Newman MEJ, 2012, NAT PHYS, V8, P25, DOI 10.1038/nphys2162; Norman KA, 2010, HIPPOCAMPUS, V20, P1217, DOI 10.1002/hipo.20855; Osterhage H, 2007, INT J BIFURCAT CHAOS, V17, P3539, DOI 10.1142/S0218127407019330; Palva JM, 2010, P NATL ACAD SCI USA, V107, P7580, DOI 10.1073/pnas.0913113107; Palva S, 2010, NEUROIMAGE, V49, P3257, DOI 10.1016/j.neuroimage.2009.11.031; PANTER P, 1965, MODULATION NOISE SPE; Pereda E, 2005, PROG NEUROBIOL, V77, P1, DOI 10.1016/j.pneurobio.2005.10.003; Pikovsky A., 2001, SYNCHRONIZATION UNIV; POSNER MI, 1990, ANNU REV NEUROSCI, V13, P25, DOI 10.1146/annurev.ne.13.030190.000325; Reijneveld JC, 2007, CLIN NEUROPHYSIOL, V118, P2317, DOI 10.1016/j.clinph.2007.08.010; Robertson LC, 2003, NAT REV NEUROSCI, V4, P93, DOI 10.1038/nrn1030; Rugg MD, 2007, TRENDS COGN SCI, V11, P251, DOI 10.1016/j.tics.2007.04.004; Schack B, 1999, J NEUROSCI METH, V93, P49, DOI 10.1016/S0165-0270(99)00117-X; Schinkel S, 2011, J NEUROSCI METH, V197, P333, DOI 10.1016/j.jneumeth.2011.02.018; Schnitzler A, 2005, NAT REV NEUROSCI, V6, P285, DOI 10.1038/nrn1650; Squire LR, 2007, NAT REV NEUROSCI, V8, P872, DOI 10.1038/nrn2154; SQUIRE LR, 1991, SCIENCE, V253, P1380, DOI 10.1126/science.1896849; Stam CJ, 2007, CEREB CORTEX, V17, P92, DOI 10.1093/cercor/bhj127; Stark CEL, 2003, J NEUROSCI, V23, P6748; Tsirka V, 2011, INT J PSYCHOPHYSIOL, V79, P89, DOI 10.1016/j.ijpsycho.2010.09.006; van den Heuvel MP, 2009, J NEUROSCI, V29, P7619, DOI 10.1523/JNEUROSCI.1443-09.2009; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Varela F, 2001, NAT REV NEUROSCI, V2, P229, DOI 10.1038/35067550; Vlooswijk MCG, 2011, NEUROLOGY, V77, P938, DOI 10.1212/WNL.0b013e31822cfc2f; Wacker M, 2011, IEEE T BIO-MED ENG, V58, P2844, DOI 10.1109/TBME.2011.2160636; Wang H, 2010, PHYS REV E, V82, DOI 10.1103/PhysRevE.82.021924; Weiss S, 2000, COGNITIVE BRAIN RES, V9, P299, DOI 10.1016/S0926-6410(00)00011-2; Weiss S, 2003, BRAIN LANG, V85, P325, DOI 10.1016/S0093-934X(03)00067-1	92	17	17	2	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80273	10.1371/journal.pone.0080273	http://dx.doi.org/10.1371/journal.pone.0080273			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260362	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500123
J	Beijer, A; Rosenberger, A; Bolck, B; Suhr, F; Rittweger, J; Bloch, W				Beijer, Asa; Rosenberger, Andre; Boelck, Birgit; Suhr, Frank; Rittweger, Joern; Bloch, Wilhelm			Whole-Body Vibrations Do Not Elevate the Angiogenic Stimulus when Applied during Resistance Exercise	PLOS ONE			English	Article							COLLAGEN-XVIII; SHEAR-STRESS; NITRIC-OXIDE; ENDOSTATIN; MUSCLE; VEGF; MMP-2; EXPRESSION; INHIBITOR; HYPOXIA	Knowledge about biological factors involved in exercise-induced angiogenesis is to date still scanty. The present study aimed to investigate the angiogenic stimulus of resistance exercise with and without superimposed whole-body vibrations. Responses to the exercise regimen before and after a 6-week training intervention were investigated in twenty-six healthy male subjects. Serum was collected at the initial and final exercise sessions and circulating levels of matrix metalloproteinases (MMP) -2 and -9, Vascular Endothelial Growth Factor (VEGF) and endostatin were determined via ELISA. Furthermore, we studied the proliferative effect of serum-treated human umbilical vein endothelial cells in vitro via BrdU-incorporation assay. It was found that circulating MMP-2, MMP-9, VEGF and endostatin levels were significantly elevated (P < 0.001) from resting levels after both exercise interventions, with higher post-exercise VEGF concentrations in the resistance exercise (RE) group compared to the resistive vibration exercise (RVE) group. Moreover, RE provoked increased endothelial cell proliferation in vitro and higher post-exercise circulating endostatin concentrations after 6 weeks of training. These effects were elusive in the RVE group. The present findings suggest that resistance exercise leads to a transient rise in circulating angiogenic factors and superimposing vibrations to this exercise type might not further trigger a potential signaling of angiogenic stimulation in skeletal muscle.	[Beijer, Asa; Rosenberger, Andre; Rittweger, Joern] Inst Aerosp Med & Space Physiol, German Aerosp Ctr, Cologne, Germany; [Beijer, Asa; Boelck, Birgit; Suhr, Frank; Bloch, Wilhelm] German Sport Univ Cologne, Dept Mol & Cellular Sport Med, Cologne, Germany; [Rosenberger, Andre] German Sport Univ Cologne, Inst Training Sci & Sports Informat, Cologne, Germany; [Rittweger, Joern] Manchester Metropolitan Univ, Inst Biomed Res Human Movement & Hlth, Manchester M15 6BH, Lancs, England	Helmholtz Association; German Aerospace Centre (DLR); German Sport University Cologne; German Sport University Cologne; Manchester Metropolitan University	Beijer, A (corresponding author), Inst Aerosp Med & Space Physiol, German Aerosp Ctr, Cologne, Germany.	asa.beijer@dlr.de	Rittweger, Jörn/A-4308-2009; Suhr, Frank/AAU-5080-2021	Rittweger, Jörn/0000-0002-2223-8963; Suhr, Frank/0000-0002-9013-3944	Helmholtz Space Life Sciences Research School (SpaceLife) scholarship; Helmholtz Association; German Aerospace Center	Helmholtz Space Life Sciences Research School (SpaceLife) scholarship; Helmholtz Association(Helmholtz Association); German Aerospace Center(Helmholtz AssociationGerman Aerospace Centre (DLR))	An author receives a Helmholtz Space Life Sciences Research School (SpaceLife) scholarship. SpaceLife is funded in equal parts by the Helmholtz Association and the German Aerospace Center. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amaral SL, 2001, MICROCIRCULATION, V8, P57, DOI 10.1038/sj.mn.7300142; ANDERSEN P, 1977, J PHYSIOL-LONDON, V270, P677, DOI 10.1113/jphysiol.1977.sp011975; Babaei S, 1998, CIRC RES, V82, P1007, DOI 10.1161/01.RES.82.9.1007; Baechle TR, 2000, ESSENTIALS STRENGTH, P395; Beijer A, 2013, J MUSCULOSK IN PRESS, V13; Belotti D, 2003, CANCER RES, V63, P5224; BIRKEDALHANSEN H, 1995, CURR OPIN CELL BIOL, V7, P728, DOI 10.1016/0955-0674(95)80116-2; Bloch W, 2000, FASEB J, V14, P2373; Chetty C, 2010, INT J CANCER, V127, P1081, DOI 10.1002/ijc.25134; Coppock HA, 2004, BIOL REPROD, V71, P438, DOI 10.1095/biolreprod.103.023101; Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721; Fowlkes John L., 1995, Progress in Growth Factor Research, V6, P255, DOI 10.1016/0955-2235(95)00017-8; Gu Jian-Wei, 2004, BMC Physiol, V4, P2, DOI 10.1186/1472-6793-4-2; Heljasvaara R, 2005, EXP CELL RES, V307, P292, DOI 10.1016/j.yexcr.2005.03.021; HUDLICKA O, 1990, BAILLIERE CLIN ENDOC, V4, P417, DOI 10.1016/S0950-351X(05)80063-1; HUDLICKA O, 1991, J PHYSIOL-LONDON, V444, P1; Kerschan-Schindl K, 2001, CLIN PHYSIOL, V21, P377, DOI 10.1046/j.1365-2281.2001.00335.x; Koskinen SOA, 2001, SCAND J MED SCI SPOR, V11, P9, DOI 10.1034/j.1600-0838.2001.011001009.x; Kraus RM, 2004, J APPL PHYSIOL, V96, P1445, DOI 10.1152/japplphysiol.01031.2003; Mehta VB, 2008, GROWTH FACTORS, V26, P301, DOI 10.1080/08977190802393596; Milkiewicz M, 2001, MICROCIRCULATION, V8, P229, DOI 10.1038/sj.mn.7800074; OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6; Petrova TV, 1999, EXP CELL RES, V253, P117, DOI 10.1006/excr.1999.4707; Rivilis I, 2002, AM J PHYSIOL-HEART C, V283, pH1430, DOI 10.1152/ajpheart.00082.2002; Rullman E, 2007, J APPL PHYSIOL, V102, P2346, DOI 10.1152/japplphysiol.00822.2006; Runge M, 2004, CLIN PHYSIOL FUNCT I, V24, P335, DOI 10.1111/j.1475-097X.2004.00567.x; Schmidt A, 2004, CANCER BIOL THER, V3, P1162, DOI 10.4161/cbt.3.11.1219; Schmidt A, 2004, DEV DYNAM, V230, P468, DOI 10.1002/dvdy.20072; SCHNAPER HW, 1993, J CELL PHYSIOL, V156, P235, DOI 10.1002/jcp.1041560204; SHWEIKI D, 1992, NATURE, V359, P843, DOI 10.1038/359843a0; Suhr F, 2010, SCAND J MED SCI SPOR, V20, P441, DOI 10.1111/j.1600-0838.2009.00960.x; Suhr F, 2007, J APPL PHYSIOL, V103, P474, DOI 10.1152/japplphysiol.01160.2006; TESCH PA, 1984, J APPL PHYSIOL, V56, P35, DOI 10.1152/jappl.1984.56.1.35; Urso ML, 2009, EUR J APPL PHYSIOL, V106, P655, DOI 10.1007/s00421-009-1063-0; Wenzel D, 2006, CIRC RES, V98, P1203, DOI 10.1161/01.RES.0000219899.93384.ed; Yamada E, 2005, CLIN PHYSIOL FUNCT I, V25, P203, DOI 10.1111/j.1475-097X.2005.00614.x; Yeghiazaryan M, 2012, HISTOCHEM CELL BIOL, V138, P75, DOI 10.1007/s00418-012-0940-5; Yue Z, 2007, STUDIES APPL MATH	38	11	13	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80143	10.1371/journal.pone.0080143	http://dx.doi.org/10.1371/journal.pone.0080143			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260349	gold, Green Accepted, Green Published			2022-12-25	WOS:000327258600054
J	D'Alessandra, Y; Carena, MC; Spazzafumo, L; Martinelli, F; Bassetti, B; Devanna, P; Rubino, M; Marenzi, G; Colombo, GI; Achilli, F; Maggiolini, S; Capogrossi, MC; Pompilio, G				D'Alessandra, Yuri; Carena, Maria Cristina; Spazzafumo, Liana; Martinelli, Federico; Bassetti, Beatrice; Devanna, Paolo; Rubino, Mara; Marenzi, Giancarlo; Colombo, Gualtiero I.; Achilli, Felice; Maggiolini, Stefano; Capogrossi, Maurizio C.; Pompilio, Giulio			Diagnostic Potential of Plasmatic MicroRNA Signatures in Stable and Unstable Angina	PLOS ONE			English	Article							CIRCULATING MICRORNAS; MYOCARDIAL-INFARCTION; BIOMARKERS; MANAGEMENT; GUIDELINE	Purpose: We examined circulating miRNA expression profiles in plasma of patients with coronary artery disease (CAD) vs. matched controls, with the aim of identifying novel discriminating biomarkers of Stable (SA) and Unstable (UA) angina. Methods: An exploratory analysis of plasmatic expression profile of 367 miRNAs was conducted in a group of SA and UA patients and control donors, using TaqMan microRNA Arrays. Screening confirmation and expression analysis were performed by qRT-PCR: all miRNAs found dysregulated were examined in the plasma of troponinnegative UA (n=19) and SA (n=34) patients and control subjects (n=20), matched for sex, age, and cardiovascular risk factors. In addition, the expression of 14 known CAD-associated miRNAs was also investigated. Results: Out of 178 miRNAs consistently detected in plasma samples, 3 showed positive modulation by CAD when compared to controls: miR-337-5p, miR-433, and miR-485-3p. Further, miR-1, -122, -126, -133a, -133b, and miR-199a were positively modulated in both UA and SA patients, while miR-337-5p and miR-145 showed a positive modulation only in SA or UA patients, respectively. ROC curve analyses showed a good diagnostic potential (AUC >= 0.85) for miR-1, -126, and -483-5p in SA and for miR-1, -126, and -133a in UA patients vs. controls, respectively. No discriminating AUC values were observed comparing SA vs. UA patients. Hierarchical cluster analysis showed that the combination of miR-1, -133a, and -126 in UA and of miR-1, -126, and -485-3p in SA correctly classified patients vs. controls with an efficiency >= 87%. No combination of miRNAs was able to reliably discriminate patients with UA from patients with SA. Conclusions: This work showed that specific plasmatic miRNA signatures have the potential to accurately discriminate patients with angiographically documented CAD from matched controls. We failed to identify a plasmatic miRNA expression pattern capable to differentiate SA from UA patients.	[D'Alessandra, Yuri; Carena, Maria Cristina; Bassetti, Beatrice; Devanna, Paolo; Pompilio, Giulio] IRCCS, Lab Vasc Biol & Regenerat Med, Ctr Cardiol Monzino, Milan, Italy; [Martinelli, Federico] IRCCS, Dept Vasc Surg, Ctr Cardiol Monzino, Milan, Italy; [Rubino, Mara; Marenzi, Giancarlo] IRCCS, Cardiac Intens Care Unit UTIC, Ctr Cardiol Monzino, Milan, Italy; [Colombo, Gualtiero I.] IRCCS, Lab Immunol & Funct Genom, Ctr Cardiol Monzino, Milan, Italy; [Spazzafumo, Liana] INRCA Natl Inst, Ctr Stat, Ancona, Italy; [Achilli, Felice] San Gerardo Hosp, Dept Cardiol, Monza, Italy; [Maggiolini, Stefano] SL Mandic Hosp, Div Cardiol, Merate, Italy; [Capogrossi, Maurizio C.] IRCCS, Lab Vasc Pathol, IDI, Rome, Italy; [Pompilio, Giulio] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy	IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; IRCCS Centro Cardiologico Monzino; IRCCS INRCA; San Gerardo Hospital; IRCCS Istituto Dermopatico dell'Immacolata (IDI); University of Milan	D'Alessandra, Y (corresponding author), IRCCS, Lab Vasc Biol & Regenerat Med, Ctr Cardiol Monzino, Milan, Italy.	ydalessa@ccfm.it	Rubino, Mara/K-1537-2016; Spazzafumo, Liana/E-5488-2015; Bassetti, Beatrice/F-3966-2018; Achilli, Felice/AAA-6044-2020; Martinelli, Federico/ABC-7791-2020; D'Alessandra, Yuri/K-4098-2016; Pompilio, Giulio/J-6701-2014; Colombo, Gualtiero I./B-4737-2010	Rubino, Mara/0000-0001-7820-9814; Bassetti, Beatrice/0000-0001-5244-9203; Martinelli, Federico/0000-0002-2504-7425; D'Alessandra, Yuri/0000-0002-3440-2353; Pompilio, Giulio/0000-0003-2581-5735; Colombo, Gualtiero I./0000-0002-7348-1939; Marenzi, Giancarlo/0000-0003-4410-4461; Devanna, Paolo/0000-0003-3966-1837; Spazzafumo, Liana/0000-0002-9718-1658	Italian Health Ministry: Centro Cardiologico "Monzino" - Programma Strategico [RFPS-2007-2-634780]; Regione Lombardia: Centro Cardiologico "Monzino", Ospedale di Lecco, Ospedale di Merate - Progetti di Ricerca Indipendente; Fondazione Umberto Veronesi: Yuri D'Alessandra - Young Investigator Programme 2013.	Italian Health Ministry: Centro Cardiologico "Monzino" - Programma Strategico; Regione Lombardia: Centro Cardiologico "Monzino", Ospedale di Lecco, Ospedale di Merate - Progetti di Ricerca Indipendente; Fondazione Umberto Veronesi: Yuri D'Alessandra - Young Investigator Programme 2013.(Fondazione Umberto Veronesi)	The present study was supported by the following grants: from the Italian Health Ministry: Centro Cardiologico "Monzino" - Programma Strategico (ex art. 12 D.Lgs.n.502/92 e s.m.i.), RFPS-2007-2-634780; from Regione Lombardia: Centro Cardiologico "Monzino", Ospedale di Lecco, Ospedale di Merate - Progetti di Ricerca Indipendente 2009; and from Fondazione Umberto Veronesi : Yuri D'Alessandra - Young Investigator Programme 2013. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Boeri M, 2011, P NATL ACAD SCI USA, V108, P3713, DOI 10.1073/pnas.1100048108; Braunwald E, 2002, CIRCULATION, V106, P1893, DOI 10.1161/01.CIR.0000037106.76139.53; Corsten MF, 2010, CIRC-CARDIOVASC GENE, V3, P499, DOI 10.1161/CIRCGENETICS.110.957415; Cortez MA, 2011, NAT REV CLIN ONCOL, V8, P467, DOI 10.1038/nrclinonc.2011.76; D'Alessandra Y, 2012, CURR OPIN CARDIOL, V27, P228, DOI 10.1097/HCO.0b013e3283522052; D'Alessandra Y, 2010, EUR HEART J, V31, P2765, DOI 10.1093/eurheartj/ehq167; Fasanaro P, 2013, CURR VASC PHARMACOL; Fichtlscherer S, 2011, ARTERIOSCL THROM VAS, V31, P2383, DOI 10.1161/ATVBAHA.111.226696; Fichtlscherer S, 2010, CIRC RES, V107, P677, DOI 10.1161/CIRCRESAHA.109.215566; Fihn SD, 2012, J AM COLL CARDIOL, V60, pE44, DOI 10.1016/j.jacc.2012.07.013; Gao W, 2012, LIPIDS HEALTH DIS, V11, DOI 10.1186/1476-511X-11-55; Gidlof O, 2011, CARDIOLOGY, V118, P217, DOI 10.1159/000328869; Henderson RA, 2011, HEART, V97, P1552, DOI 10.1136/heartjnl-2011-300896; Ortega FJ, 2013, CLIN CHEM, V59, P781, DOI 10.1373/clinchem.2012.195776; Kosaka N, 2010, J BIOL CHEM, V285, P17442, DOI 10.1074/jbc.M110.107821; Latsios G, 2013, CURR TOP ME IN PRESS; Lenfant C, 2010, METABOLISM, V59, pS41, DOI 10.1016/j.metabol.2010.07.014; Li SQ, 2011, CIRCULATION, V124, P175, DOI 10.1161/CIRCULATIONAHA.110.012237; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Nikas JB, 2011, AM J TRANSL RES, V3, P180; Olivieri F, 2013, INT J CARDIOL, V167, P531, DOI 10.1016/j.ijcard.2012.01.075; Papageorgiou N, 2012, CURR MED CHEM, V19, P2605, DOI 10.2174/092986712800493048; Pope JH, 2000, NEW ENGL J MED, V342, P1163, DOI 10.1056/NEJM200004203421603; Shruti K, 2001, BIOCHEM BIOPH RES CO, V407, P445; Stepien E, 2012, ARCH MED RES, V43, P31, DOI 10.1016/j.arcmed.2012.01.006; Sun X, 2012, THROMB J, V10, DOI 10.1186/1477-9560-10-16; Tijsen AJ, 2012, AM J PHYSIOL-HEART C, V303, pH1085, DOI 10.1152/ajpheart.00191.2012; Tijsen AJ, 2010, CIRC RES, V106, P1035, DOI 10.1161/CIRCRESAHA.110.218297; van Empel VPM, 2012, CURR HYPERTENS REP, V14, P498, DOI 10.1007/s11906-012-0310-7; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Wang K, 2009, P NATL ACAD SCI USA, V106, P4402, DOI 10.1073/pnas.0813371106; Weber M, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/532915	32	107	107	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80345	10.1371/journal.pone.0080345	http://dx.doi.org/10.1371/journal.pone.0080345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260372	Green Published, gold			2022-12-25	WOS:000327258600058
J	D'Uva, G; Bertoni, S; Lauriola, M; De Carolis, S; Pacilli, A; D'Anello, L; Santini, D; Taffurelli, M; Ceccarelli, C; Yarden, Y; Montanaro, L; Bonafe, M; Storci, G				D'Uva, Gabriele; Bertoni, Sara; Lauriola, Mattia; De Carolis, Sabrina; Pacilli, Annalisa; D'Anello, Laura; Santini, Donatella; Taffurelli, Mario; Ceccarelli, Claudio; Yarden, Yosef; Montanaro, Lorenzo; Bonafe, Massimiliano; Storci, Gianluca			Beta-Catenin/HuR Post-Transcriptional Machinery Governs Cancer Stem Cell Features in Response to Hypoxia	PLOS ONE			English	Article							RNA-BINDING PROTEINS; CYCLOOXYGENASE-2 MESSENGER-RNA; NEGATIVE BREAST-CANCER; CARBONIC-ANHYDRASE IX; INDUCIBLE FACTORS; IN-VITRO; ACTIVATION; EXPRESSION; TUMOR; HUR	Hypoxia has been long-time acknowledged as major cancer-promoting microenvironment. In such an energy-restrictive condition, post-transcriptional mechanisms gain importance over the energy-expensive gene transcription machinery. Here we show that the onset of hypoxia-induced cancer stem cell features requires the beta-catenin-dependent post-transcriptional up-regulation of CA9 and SNAI2 gene expression. In response to hypoxia, beta-catenin moves from the plasma membrane to the cytoplasm where it binds and stabilizes SNAI2 and CA9 mRNAs, in cooperation with the mRNA stabilizing protein HuR. We also provide evidence that the post-transcriptional activity of cytoplasmic beta-catenin operates under normoxia in basal-like/triple-negative breast cancer cells, where the beta-catenin knockdown suppresses the stem cell phenotype in vitro and tumor growth in vivo. In such cells, we unravel the generalized involvement of the beta-catenin-driven machinery in the stabilization of EGF-induced mRNAs, including the cancer stem cell regulator IL6. Our study highlights the crucial role of post-transcriptional mechanisms in the maintenance/acquisition of cancer stem cell features and suggests that the hindrance of cytoplasmic beta-catenin function may represent an unprecedented strategy for targeting breast cancer stem/basal-like cells.	[D'Uva, Gabriele; Bertoni, Sara; De Carolis, Sabrina; Pacilli, Annalisa; D'Anello, Laura; Santini, Donatella; Ceccarelli, Claudio; Montanaro, Lorenzo; Bonafe, Massimiliano; Storci, Gianluca] Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy; [D'Uva, Gabriele; Lauriola, Mattia; Yarden, Yosef] Weizmann Inst Sci, Dept Regulat Biol, IL-76100 Rehovot, Israel; [Bertoni, Sara; D'Anello, Laura; Bonafe, Massimiliano; Storci, Gianluca] Univ Bologna, S Orsola M Malpighi Hosp, CRBA, Bologna, Italy; [Pacilli, Annalisa] Univ Bologna, Ctr Interdipartimentale Ric Canc Giorgio Prodi CI, Bologna, Italy; [Taffurelli, Mario] Univ Bologna, Bologna, Italy	University of Bologna; Weizmann Institute of Science; IRCCS Azienda Ospedaliero-Universitaria di Bologna; University of Bologna; University of Bologna; University of Bologna	D'Uva, G (corresponding author), Univ Bologna, Dept Expt Diagnost & Specialty Med, Bologna, Italy.	gabrielematteo.duva2@unibo.it; massimiliano.bonafe@unibo.it; gianluca.storci@unibo.it	Montanaro, Lorenzo/I-4236-2019; Storci, Gianluca/AED-6195-2022; Santini, Donatella/AAO-1490-2021; D'Uva, Gabriele/A-6252-2015; YARDEN, YOSEF/K-1467-2012; ceccarelli, claudio/AAS-6105-2020; lauriola, mattia/N-6435-2014	Montanaro, Lorenzo/0000-0001-9776-9518; Storci, Gianluca/0000-0001-5145-3091; Santini, Donatella/0000-0002-1692-6348; D'Uva, Gabriele/0000-0001-9622-9288; ceccarelli, claudio/0000-0003-0743-2087; lauriola, mattia/0000-0002-7966-0065; DE CAROLIS, SABRINA/0000-0001-5785-2624	Italian Ministry for Education, Universities and Scientific Research [PRIN 2008KTRN38]; Cassa di Risparmio in Bologna Foundation "Ruolo della regolazione della sintesi proteica nelle cellule staminali del cancro" [135/2010-0102]; RFO; Cornelia; Roberto Pallotti Foundation [2011-110512]; Fondazione Cassa di Risparmio in Bologna; Fondazione Banca del Monte e Ravenna	Italian Ministry for Education, Universities and Scientific Research; Cassa di Risparmio in Bologna Foundation "Ruolo della regolazione della sintesi proteica nelle cellule staminali del cancro"; RFO; Cornelia; Roberto Pallotti Foundation; Fondazione Cassa di Risparmio in Bologna(Fondazione Carisbo); Fondazione Banca del Monte e Ravenna	This work has been supported by: Italian Ministry for Education, Universities and Scientific Research grant PRIN 2008KTRN38 "Clinical, diagnostic and therapeutic implications of studies on breast cancer stem cells" to MT and MB; Cassa di Risparmio in Bologna Foundation "Ruolo della regolazione della sintesi proteica nelle cellule staminali del cancro" (n. 135/2010-0102) to LM and MB. RFO funds ex 60%, Cornelia and Roberto Pallotti Foundation (n. 2011-110512) to MB. The authors thank Fondazione Cassa di Risparmio in Bologna and Fondazione Banca del Monte e Ravenna for supporting the Center for Applied Biomedical Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hajj M, 2003, P NATL ACAD SCI USA, V100, P3983, DOI 10.1073/pnas.0530291100; Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Anderson P, 2010, NAT REV IMMUNOL, V10, P24, DOI 10.1038/nri2685; Axelson H, 2005, SEMIN CELL DEV BIOL, V16, P554, DOI 10.1016/j.semcdb.2005.03.007; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Briata P, 2003, MOL CELL, V12, P1201, DOI 10.1016/S1097-2765(03)00407-6; Carey L, 2010, NAT REV CLIN ONCOL, V7, P683, DOI 10.1038/nrclinonc.2010.154; Cleator S, 2007, LANCET ONCOL, V8, P235, DOI 10.1016/S1470-2045(07)70074-8; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Farina AK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004797; Farnie G, 2007, JNCI-J NATL CANCER I, V99, P616, DOI 10.1093/jnci/djk133; Geyer FC, 2011, MODERN PATHOL, V24, P209, DOI 10.1038/modpathol.2010.205; Ginestier C, 2010, J CLIN INVEST, V120, P485, DOI 10.1172/JCI39397; Gorospe M, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00007; Gruber AR, 2011, NUCLEIC ACIDS RES, V39, pD66, DOI 10.1093/nar/gkq990; Guo WJ, 2012, CELL, V148, P1015, DOI 10.1016/j.cell.2012.02.008; Harris AL, 2002, NAT REV CANCER, V2, P38, DOI 10.1038/nrc704; Heinonen M, 2005, CANCER RES, V65, P2157, DOI 10.1158/0008-5472.CAN-04-3765; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Ji HT, 2009, MOL CELL, V36, P547, DOI 10.1016/j.molcel.2009.09.034; Kaidi A, 2007, NAT CELL BIOL, V9, P210, DOI 10.1038/ncb1534; Kaluz S, 2009, BBA-REV CANCER, V1795, P162, DOI 10.1016/j.bbcan.2009.01.001; Keith B, 2007, CELL, V129, P465, DOI 10.1016/j.cell.2007.04.019; Khramtsov AI, 2010, AM J PATHOL, V176, P2911, DOI 10.2353/ajpath.2010.091125; Kim I, 2012, NUCLEIC ACIDS RES, V40, P6863, DOI 10.1093/nar/gks331; Korkaya H, 2012, MOL CELL, V47, P570, DOI 10.1016/j.molcel.2012.06.014; Korkaya H, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000121; Krishnamachary B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044078; Kusewitt DF, 2009, J INVEST DERMATOL, V129, P491, DOI 10.1038/jid.2008.222; Lebedeva S, 2011, MOL CELL, V43, P340, DOI 10.1016/j.molcel.2011.06.008; Lee HK, 2007, CANCER RES, V67, P9315, DOI 10.1158/0008-5472.CAN-07-1128; Lee HK, 2006, NUCLEIC ACIDS RES, V34, P5705, DOI 10.1093/nar/gkl698; Levy L, 2002, J BIOL CHEM, V277, P42386, DOI 10.1074/jbc.M207418200; Li Y, 2011, BBA-MOL CELL RES, V1813, P159, DOI 10.1016/j.bbamcr.2010.09.018; Lim JH, 2008, CANCER RES, V68, P5177, DOI 10.1158/0008-5472.CAN-07-6234; Lock FE, 2013, ONCOGENE, V32, P5210, DOI 10.1038/onc.2012.550; Lopez-Knowles E, 2010, CANCER EPIDEM BIOMAR, V19, P301, DOI 10.1158/1055-9965.EPI-09-0741; Lu ZM, 2003, CANCER CELL, V4, P499, DOI 10.1016/S1535-6108(03)00304-0; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Masuda K, 2009, J CELL MOL MED, V13, P2759, DOI 10.1111/j.1582-4934.2009.00842.x; Mazumdar J, 2010, NAT CELL BIOL, V12, P1007, DOI 10.1038/ncb2102; Mohyeldin A, 2010, CELL STEM CELL, V7, P150, DOI 10.1016/j.stem.2010.07.007; Mukherjee N, 2011, MOL CELL, V43, P327, DOI 10.1016/j.molcel.2011.06.007; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Pastorekova S, 2008, CURR PHARM DESIGN, V14, P685, DOI 10.2174/138161208783877893; Paulding WR, 2000, ADV EXP MED BIOL, V475, P111; Proia TA, 2011, CELL STEM CELL, V8, P149, DOI 10.1016/j.stem.2010.12.007; Reya T, 2005, NATURE, V434, P843, DOI 10.1038/nature03319; Sansone P, 2007, J CLIN INVEST, V117, P3988, DOI 10.1172/JCI32533; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Semenza GL, 2012, TRENDS PHARMACOL SCI, V33, P207, DOI 10.1016/j.tips.2012.01.005; SHAULIAN E, 1992, MOL CELL BIOL, V12, P5581, DOI 10.1128/MCB.12.12.5581; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Srikantan S, 2011, MOL CELL, V43, P319, DOI 10.1016/j.molcel.2011.07.016; Storci G, 2008, J PATHOL, V214, P25, DOI 10.1002/path.2254; Storci G, 2013, AM J PATHOL; Storci G, 2010, J CELL PHYSIOL, V225, P682, DOI 10.1002/jcp.22264; Tan EY, 2009, BRIT J CANCER, V100, P405, DOI 10.1038/sj.bjc.6604844; Tenenbaum SA, 2002, METHODS, V26, P191, DOI 10.1016/S1046-2023(02)00022-1; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Yarden Y, 2012, NAT REV CANCER, V12, P553, DOI 10.1038/nrc3309; Zatovicova M, 2010, CURR PHARM DESIGN, V16, P3255, DOI 10.2174/138161210793429832; Zeisel A, 2011, MOL SYST BIOL, V7, DOI 10.1038/msb.2011.62	65	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80742	10.1371/journal.pone.0080742	http://dx.doi.org/10.1371/journal.pone.0080742			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260469	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600083
J	Fiene, J; Kalns, L; Nansen, C; Bernal, J; Harris, M; Sword, GA				Fiene, Justin; Kalns, Lauren; Nansen, Christian; Bernal, Julio; Harris, Marvin; Sword, Gregory A.			Foraging on Individual Leaves by an Intracellular Feeding Insect Is Not Associated with Leaf Biomechanical Properties or Leaf Orientation	PLOS ONE			English	Article							PLANT	Nearly all herbivorous arthropods make foraging-decisions on individual leaves, yet systematic investigations of the adaptive significance and ecological factors structuring these decisions are rare with most attention given to chewing herbivores. This study investigated why an intracellular feeding herbivore, Western flower thrips (WFT) Frankliniella occidentalis Pergande, generally avoids feeding on the adaxial leaf surface of cotton cotyledons. WFT showed a significant aversion to adaxial-feeding even when excised-cotyledons were turned up-side (abaxial-side 'up'), suggesting that negative-phototaxis was not a primary cause of thrips foraging patterns. No-choice bioassays in which individual WFT females were confined to either the abaxial or adaxial leaf surface showed that 35% fewer offspring were produced when only adaxial feeding was allowed, which coincided with 32% less plant feeding on that surface. To test the hypothesis that leaf biomechanical properties inhibited thrips feeding on the adaxial surface, we used a penetrometer to measure two variables related to the 'toughness' of each leaf surface. Neither variable negatively co-varied with feeding. Thus, while avoiding the upper leaf surface was an adaptive foraging strategy, the proximate cause remains to be elucidated, but is likely due, in part, to certain leaf properties that inhibit feeding.	[Fiene, Justin; Kalns, Lauren; Bernal, Julio; Harris, Marvin; Sword, Gregory A.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA; [Fiene, Justin] Elmhurst Coll, Dept Biol, Elmhurst, NY USA; [Nansen, Christian] Univ Western Australia, Sch Anim Biol, Crawley, WA, Australia	Texas A&M University System; Texas A&M University College Station; University of Western Australia	Fiene, J (corresponding author), Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA.	Justin.Fiene@net.elmhurst.edu	Bernal, Julio S./N-1290-2013	Bernal, Julio S./0000-0003-4615-2213; Kalns, Lauren/0000-0002-5924-7118	Cotton Incorporated; Texas A&M University Entomology Department	Cotton Incorporated(Cotton R&D Corp); Texas A&M University Entomology Department	This work was funded by Cotton Incorporated and the C. Everette Salyer Fellowship from the Texas A&M University Entomology Department to J.G. Fiene. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BACKUS EA, 1988, J ECON ENTOMOL, V81, P1819, DOI 10.1093/jee/81.6.1819; Childers Carl C., 1997, P505; Dai YJ, 2009, CROP PROT, V28, P327, DOI 10.1016/j.cropro.2008.11.012; FENNAH R. G., 1963, Bulletin of Entomological Research, V53, P681, DOI 10.1017/S0007485300048434; Hood G.M., 2010, POPTOOLS VERSION 3 2; HORTON DR, 1993, ENTOMOL EXP APPL, V69, P263, DOI 10.1007/BF02381998; Kirk William D. J., 1997, P119; Korth KL, 2006, PLANT PHYSIOL, V141, P188, DOI 10.1104/pp.106.076737; Larsson S, 1997, ECOL ENTOMOL, V22, P445, DOI 10.1046/j.1365-2311.1997.00083.x; Lewis T., 1997, THRIPS CROP PESTS, P736; Peeters PJ, 2007, FUNCT ECOL, V21, P246, DOI 10.1111/j.1365-2435.2006.01223.x; R Development Core Team, 2009, R FDN STAT COMP; REAVEY D, 1991, OIKOS, V61, P19, DOI 10.2307/3545403; Sanson G, 2001, AUSTRAL ECOL, V26, P535, DOI 10.1046/j.1442-9993.2001.01154.x; Shroff R, 2008, P NATL ACAD SCI USA, V105, P6196, DOI 10.1073/pnas.0711730105; Wardle RA, 1927, ANN APPL BIOL, V14, P513, DOI 10.1111/j.1744-7348.1927.tb07030.x; Zuur Alain F., 2009, P1; [No title captured]	18	10	12	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80911	10.1371/journal.pone.0080911	http://dx.doi.org/10.1371/journal.pone.0080911			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260510	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600098
J	Mittal, S; Singh, LR				Mittal, Shruti; Singh, Laishram Rajendrakumar			Denatured State Structural Property Determines Protein Stabilization by Macromolecular Crowding: A Thermodynamic and Structural Approach	PLOS ONE			English	Article							GLOBULAR-PROTEINS; ALPHA-LACTALBUMIN; GUANIDINE HYDROCHLORIDE; UNFOLDED STATE; CYTOCHROME-C; STABILITY; CELLS; ENVIRONMENT; CYTOPLASM; KINETICS	Understanding of protein structure and stability gained to date has been acquired through investigations made under dilute conditions where total macromolecular concentration never surpasses 10 g l(-1). However, biological macromolecules are known to evolve and function under crowded intracellular environments that comprises of proteins, nucleic acids, ribosomes and carbohydrates etc. Crowded environment is known to result in altered biological properties including thermodynamic, structural and functional aspect of macromolecules as compared to the macromolecules present in our commonly used experimental dilute buffers (for example, Tris HCl or phosphate buffer). In this study, we have investigated the thermodynamic and structural consequences of synthetic crowding agent (Ficoll 70) on three different proteins (Ribonuclease-A, lysozyme and holo a-lactalbumin) at different pH values. We report here that the effect of crowding is protein dependent in terms of protein thermal stability and structure. We also observed that the structural characteristics of the denatured state determines if crowding will have an effect or not on the protein stability.	[Mittal, Shruti; Singh, Laishram Rajendrakumar] Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India	University of Delhi	Singh, LR (corresponding author), Univ Delhi, Dr BR Ambedkar Ctr Biomed Res, Delhi 110007, India.	lairksingh@gmail.com		Mittal, Shruti/0000-0002-5318-2763	Department of Science and Technology [SR/SO/BB-0003/2011]; Council of Scientific and Industrial Research [09/045(1047)/2011-EMR-1]	Department of Science and Technology(Department of Science & Technology (India)); Council of Scientific and Industrial Research(Council of Scientific & Industrial Research (CSIR) - India)	This work is supported by grant from Department of Science and Technology (Ref No.: SR/SO/BB-0003/2011). LRS and SM acknowledge Council of Scientific and Industrial Research for the financial assistance provided in the form of research fellowship (File No.: 09/045(1047)/2011-EMR-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; Baldwin RL, 1999, TRENDS BIOCHEM SCI, V24, P26, DOI 10.1016/S0968-0004(98)01346-2; Batra J, 2009, PROTEINS, V77, P133, DOI 10.1002/prot.22425; Benton LA, 2012, BIOCHEMISTRY-US, V51, P9773, DOI 10.1021/bi300909q; BIGELOW C C, 1960, C R Trav Lab Carlsberg, V31, P305; Chen E, 2012, BIOCHEMISTRY-US, V51, P9836, DOI 10.1021/bi301324y; Cheung MS, 2005, P NATL ACAD SCI USA, V102, P4753, DOI 10.1073/pnas.0409630102; Dedmon MM, 2002, P NATL ACAD SCI USA, V99, P12681, DOI 10.1073/pnas.202331299; Dhar A, 2010, P NATL ACAD SCI USA, V107, P17586, DOI 10.1073/pnas.1006760107; Ellis RJ, 2001, CURR OPIN STRUC BIOL, V11, P114, DOI 10.1016/S0959-440X(00)00172-X; Flaugh SL, 2001, BIOMACROMOLECULES, V2, P538, DOI 10.1021/bm015502z; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; GOODSELL DS, 1991, TRENDS BIOCHEM SCI, V16, P203, DOI 10.1016/0968-0004(91)90083-8; Greene LH, 1999, PROTEIN ENG, V12, P581, DOI 10.1093/protein/12.7.581; GRIKO YV, 1994, BIOCHEMISTRY-US, V33, P1889, DOI 10.1021/bi00173a036; Hall D, 2003, BBA-PROTEINS PROTEOM, V1649, P127, DOI 10.1016/S1570-9639(03)00167-5; HAMAGUCHI K, 1963, J BIOCHEM-TOKYO, V54, P111; Harada R, 2013, J AM CHEM SOC, V135, P3696, DOI 10.1021/ja3126992; Homouz D, 2008, P NATL ACAD SCI USA, V105, P11754, DOI 10.1073/pnas.0803672105; Huang LQ, 2010, FASEB J, V24, P3536, DOI 10.1096/fj.09-150987; Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839; Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9; Johansen D, 2011, BIOPHYS J, V100, P1120, DOI 10.1016/j.bpj.2011.01.020; Koepf EK, 1999, PROTEIN SCI, V8, P841, DOI 10.1110/ps.8.4.841; Luby-Phelps K, 2000, INT REV CYTOL, V192, P189; LUBYPHELPS K, 1987, P NATL ACAD SCI USA, V84, P4910, DOI 10.1073/pnas.84.14.4910; Malik A, 2012, J PHYS CHEM B, V116, P12895, DOI 10.1021/jp306873v; McNulty BC, 2006, J MOL BIOL, V355, P893, DOI 10.1016/j.jmb.2005.11.033; McPhie P, 2006, J MOL BIOL, V361, P7, DOI 10.1016/j.jmb.2006.05.075; Mikaelsson T, 2013, BIOPHYS J, V104, P694, DOI 10.1016/j.bpj.2012.12.020; Miklos AC, 2011, J AM CHEM SOC, V133, P7116, DOI 10.1021/ja200067p; Miklos AC, 2010, BIOCHEMISTRY-US, V49, P6984, DOI 10.1021/bi100727y; Minton AP, 2000, CURR OPIN STRUC BIOL, V10, P34, DOI 10.1016/S0959-440X(99)00045-7; Minton AP, 2005, BIOPHYS J, V88, P971, DOI 10.1529/biophysj.104.050351; Minton AP, 2000, BIOPHYS J, V78, P101, DOI 10.1016/S0006-3495(00)76576-3; Morar AS, 2001, PROTEIN SCI, V10, P2195, DOI 10.1110/ps.24301; Myers JK, 2001, NAT STRUCT BIOL, V8, P552, DOI 10.1038/88626; Pace C N, 1986, Methods Enzymol, V131, P266; Perham M, 2007, FEBS LETT, V581, P5065, DOI 10.1016/j.febslet.2007.09.049; Privalov P L, 1979, Adv Protein Chem, V33, P167, DOI 10.1016/S0065-3233(08)60460-X; Sasahara K, 2003, J MOL BIOL, V326, P1227, DOI 10.1016/S0022-2836(02)01443-2; Schlesinger AP, 2011, J AM CHEM SOC, V133, P8082, DOI 10.1021/ja201206t; Sinha A, 2000, BIOCHEM J, V345, P711, DOI 10.1042/0264-6021:3450711; Stagg L, 2007, P NATL ACAD SCI USA, V104, P18976, DOI 10.1073/pnas.0705127104; SUGAI S, 1973, BIOCHIM BIOPHYS ACTA, V328, P35, DOI 10.1016/0005-2795(73)90327-9; Szasz C, 2011, BIOCHEMISTRY-US, V50, P5834, DOI [10.1021/bi200365j, 10.1021/bi200365J]; Takaoka Y, 2013, CHEM COMMUN, V49, P2801, DOI 10.1039/c3cc39205h; Tokuriki N, 2004, PROTEIN SCI, V13, P125, DOI 10.1110/ps.03288104; van den Berg B, 1999, EMBO J, V18, P6927, DOI 10.1093/emboj/18.24.6927; Venturoli D, 2005, AM J PHYSIOL-RENAL, V288, pF605, DOI 10.1152/ajprenal.00171.2004; Waegele MM, 2011, J CHEM PHYS, V134, DOI 10.1063/1.3556671; Wang YQ, 2012, J AM CHEM SOC, V134, P16614, DOI 10.1021/ja305300m; Wenner JR, 1999, BIOPHYS J, V77, P3234, DOI 10.1016/S0006-3495(99)77154-7; ZIMMERMAN SB, 1993, ANNU REV BIOPH BIOM, V22, P27, DOI 10.1146/annurev.bb.22.060193.000331	54	45	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78936	10.1371/journal.pone.0078936	http://dx.doi.org/10.1371/journal.pone.0078936			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265729	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100062
J	Myksvoll, MS; Erikstad, KE; Barrett, RT; Sandvik, H; Vikebo, F				Myksvoll, Mari S.; Erikstad, Kjell E.; Barrett, Robert T.; Sandvik, Hanno; Vikebo, Frode			Climate-Driven Ichthyoplankton Drift Model Predicts Growth of Top Predator Young	PLOS ONE			English	Article							COD GADUS-MORHUA; URIA-AALGE; BARENTS SEA; COMMON MURRES; FLUCTUATIONS; TEMPERATURE; FISH; ADVECTION; ECOSYSTEM; SEABIRDS	Climate variability influences seabird population dynamics in several ways including access to prey near colonies during the critical chick-rearing period. This study addresses breeding success in a Barents Sea colony of common guillemots Uria aalge where trophic conditions vary according to changes in the northward transport of warm Atlantic Water. A drift model was used to simulate interannual variations in transport of cod Gadus morhua larvae along the Norwegian coast towards their nursery grounds in the Barents Sea. The results showed that the arrival of cod larvae from southern spawning grounds had a major effect on the size of common guillemot chicks at fledging. Furthermore, the fraction of larvae from the south was positively correlated to the inflow of Atlantic Water into the Barents Sea thus clearly demonstrating the mechanisms by which climate-driven bottom-up processes influence interannual variations in reproductive success in a marine top predator.	[Myksvoll, Mari S.; Vikebo, Frode] Inst Marine Res, N-5024 Bergen, Norway; [Erikstad, Kjell E.] Norwegian Inst Nat Res, FRAM High North Res Ctr Climate & Environm, Tromso, Norway; [Barrett, Robert T.] Tromso Univ Museum, Dept Nat Sci, Tromso, Norway; [Sandvik, Hanno] Norwegian Univ Sci & Technol, Dept Biol, Ctr Conservat Biol, N-7034 Trondheim, Norway	Institute of Marine Research - Norway; Norwegian Institute Nature Research; UiT The Arctic University of Tromso; Norwegian University of Science & Technology (NTNU)	Myksvoll, MS (corresponding author), Inst Marine Res, POB 1870, N-5024 Bergen, Norway.	mari.myksvoll@imr.no	Sandvik, Hanno/B-5118-2008	Sandvik, Hanno/0000-0002-5889-1606	Norwegian Research Council [216547/E40]	Norwegian Research Council(Research Council of NorwayEuropean Commission)	The research was funded by the Norwegian Research Council (No 216547/E40). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Barrett RT, 2013, MAR BIOL, V160, P1239, DOI 10.1007/s00227-013-2175-y; Barrett Robert T., 2010, Ornis Norvegica, V33, P49; Barrett RT, 1997, CAN J ZOOL, V75, P618, DOI 10.1139/z97-077; Barrett RT, 2002, MAR ECOL PROG SER, V230, P275, DOI 10.3354/meps230275; BIRKHEAD TR, 1977, IBIS, V119, P544, DOI 10.1111/j.1474-919X.1977.tb02068.x; BIRKHEAD TR, 1977, J ANIM ECOL, V46, P751, DOI 10.2307/3638; Blindheim J, 1989, RAPPORTS PROCES VERB, V188, P49; Bugge J, 2011, J ORNITHOL, V152, P253, DOI 10.1007/s10336-010-0578-9; Burger J.., 2004, ECOHEALTH, V1, P263, DOI [10.1007/s10393-004-0096-4, DOI 10.1007/S10393-004-0096-4]; Camphuysen K, 2002, ARDEA, V90, P103; Dalpadado P, 2012, ICES J MAR SCI, V69, P1303, DOI 10.1093/icesjms/fss063; Eriksen E, 2012, ICES J MAR SCI, V69, P870, DOI 10.1093/icesjms/fsr210; Erikstad KE, 2013, MAR ECOL PROG SER, V475, P267, DOI 10.3354/meps10084; Folkvord A, 2005, CAN J FISH AQUAT SCI, V62, P1037, DOI 10.1139/F05-008; Frederiksen M, 2006, J ANIM ECOL, V75, P1259, DOI 10.1111/j.1365-2656.2006.01148.x; Garrison LP, 2000, CAN J FISH AQUAT SCI, V57, P2455, DOI 10.1139/cjfas-57-12-2455; Gaston A.J., 1998, AUKS ALCIDAE; Gaston AJ, 1996, IBIS, V138, P742, DOI 10.1111/j.1474-919X.1996.tb08831.x; Hindell MA, 2012, ECOL EVOL, V2, P1563, DOI 10.1002/ece3.281; ICES, 2011, CM2011ACOM05 ICES; Ingvaldsen RB, 2004, CONT SHELF RES, V24, P1015, DOI 10.1016/j.csr.2004.02.011; Kitaysky AS, 2000, MAR ECOL PROG SER, V206, P283, DOI 10.3354/meps206283; Kristiansen T, 2007, CAN J FISH AQUAT SCI, V64, P136, DOI 10.1139/F06-176; Lien VS, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2505; LOENG H, 1991, POLAR RES, V10, P5, DOI 10.1111/j.1751-8369.1991.tb00630.x; Mork KA, 2010, OCEAN SCI, V6, P901, DOI 10.5194/os-6-901-2010; Opdal AF, 2011, MAR ECOL PROG SER, V439, P255, DOI 10.3354/meps09335; Ottersen G, 2000, ICES J MAR SCI, V57, P339, DOI 10.1006/jmsc.1999.0529; Pedersen OP, 2009, FISH RES, V97, P234, DOI 10.1016/j.fishres.2009.02.008; Piatt JF, 2007, MAR ECOL PROG SER, V352, P199, DOI 10.3354/meps07070; Reiertsen TK, 2012, ECOSPHERE, V3, DOI 10.1890/ES12-00031R; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Sando AB, 2010, J GEOPHYS RES-OCEANS, V115, DOI 10.1029/2009JC005884; Sandvik H, 2008, ECOGRAPHY, V31, P73, DOI 10.1111/j.2007.0906-7590.05090.x; Sandvik H, 2012, MAR ECOL PROG SER, V454, P273, DOI 10.3354/meps09558; SAS, 2008, SAS STAT US GUID STA; Satterthwaite WH, 2012, MAR ECOL PROG SER, V454, P221, DOI 10.3354/meps09539; Schauer JHS, 1996, COLON WATERBIRD, V19, P186, DOI 10.2307/1521855; Skagseth O, 2011, J GEOPHYS RES-OCEANS, V116, DOI 10.1029/2011JC006996; Skardhamar J, 2005, CONT SHELF RES, V25, P1541, DOI 10.1016/j.csr.2005.04.007; Sundby S., 1987, Fisken og Havet, V1987, P1; Sundby S, 2000, SARSIA, V85, P277, DOI 10.1080/00364827.2000.10414580; Sundby S, 2008, ICES J MAR SCI, V65, P953, DOI 10.1093/icesjms/fsn085; Thompson PM, 2001, NATURE, V413, P417, DOI 10.1038/35096558; Thygesen UH, 2007, MAR ECOL PROG SER, V347, P145, DOI 10.3354/meps06975; Vikebo FB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027367; Vikebo FB, 2010, ICES J MAR SCI, V67, P1948, DOI 10.1093/icesjms/fsq084	48	11	11	2	40	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79225	10.1371/journal.pone.0079225	http://dx.doi.org/10.1371/journal.pone.0079225			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265761	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100094
J	Nash, K; Schiller, B; Gianotti, LRR; Baumgartner, T; Knoch, D				Nash, Kyle; Schiller, Bastian; Gianotti, Lorena R. R.; Baumgartner, Thomas; Knoch, Daria			Electrophysiological Indices of Response Inhibition in a Go/NoGo Task Predict Self-Control in a Social Context	PLOS ONE			English	Article							DEFICIT HYPERACTIVITY DISORDER; CONTINUOUS PERFORMANCE-TEST; INDIVIDUAL-DIFFERENCES; EXECUTIVE FUNCTIONS; WORKING-MEMORY; BEHAVIOR; NEUROSCIENCE; P300; NOGO; GRATIFICATION	Recent research demonstrates that response inhibition-a core executive function-may subserve self-regulation and self-control. However, it is unclear whether response inhibition also predicts self-control in the multifaceted, high-level phenomena of social decision-making. Here we examined whether electrophysiological indices of response inhibition would predict self-control in a social context. Electroencephalography was recorded as participants completed a widely used Go/NoGo task (the cued Continuous Performance Test). Participants then interacted with a partner in an economic exchange game that requires self-control. Results demonstrated that greater NoGo-Anteriorization and larger NoGo-P300 peak amplitudes-two established electrophysiological indices of response inhibition-both predicted more self-control in this social game. These findings support continued integration of executive function and self-regulation and help extend prior research into social decision-making processes.	[Nash, Kyle; Schiller, Bastian; Gianotti, Lorena R. R.; Baumgartner, Thomas; Knoch, Daria] Univ Basel, Dept Psychol, CH-4003 Basel, Switzerland	University of Basel	Nash, K (corresponding author), Univ Basel, Dept Psychol, CH-4003 Basel, Switzerland.	kyle.nash@unibas.ch	Schiller, Bastian/GQZ-8353-2022; Schiller, Bastian/AAE-8973-2021	Schiller, Bastian/0000-0002-1063-1434; Baumgartner, Thomas/0000-0001-5966-7377	Swiss National Science Foundation [PP00P1-123381]; OPO Foundation; University of Basel (Forschungsfonds); Mens Sana Foundation; Social Sciences and Humanities Research Council of Canada	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); OPO Foundation; University of Basel (Forschungsfonds); Mens Sana Foundation; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This work was supported by a grant from the Swiss National Science Foundation to Daria Knoch (PP00P1-123381). The authors further acknowledge support from the OPO Foundation, from the University of Basel (Forschungsfonds), from the Mens Sana Foundation, and from the Social Sciences and Humanities Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aron AR, 2005, BIOL PSYCHIAT, V57, P1285, DOI 10.1016/j.biopsych.2004.10.026; Aron AR, 2004, TRENDS COGN SCI, V8, P170, DOI 10.1016/j.tics.2004.02.010; Baddeley A., WORKING MEMORY THOUG, DOI [10.1093/acprof:oso/9780198528012.001.0001, DOI 10.1093/ACPROF:OSO/9780198528012.001.0001]; Baumgartner T, 2009, NEURON, V64, P756, DOI 10.1016/j.neuron.2009.11.017; Berkman ET, 2011, PSYCHOL SCI, V22, P498, DOI 10.1177/0956797611400918; Casey BJ, 2011, P NATL ACAD SCI USA, V108, P14998, DOI 10.1073/pnas.1108561108; Cohen J.R., 2010, SELF CONTROL SOC MIN, P141, DOI [10.1093/acprof:oso/9780195391381.003.0008, DOI 10.1093/ACPROF:OSO/9780195391381.003.0008]; Dresler T, 2010, NEUROPSYCHOPHARMACOL, V35, P2193, DOI 10.1038/npp.2010.91; Enriquez-Geppert S, 2010, NEUROIMAGE, V51, P877, DOI 10.1016/j.neuroimage.2010.02.043; Fallgatter AJ, 1997, BRAIN TOPOGR, V9, P295, DOI 10.1007/BF01464484; Fallgatter AJ, 2005, PSYCHIAT RES-NEUROIM, V138, P157, DOI 10.1016/j.pscychresns.2004.12.002; Fallgatter AJ, 2002, J NEURAL TRANSM, V109, P977, DOI 10.1007/s007020200080; Fallgatter AJ, 2001, PSYCHIAT RES-NEUROIM, V107, P19, DOI 10.1016/S0925-4927(01)00092-0; Fallgatter AJ, 2001, NEUROPSYCHOLOGIA, V39, P328, DOI 10.1016/S0028-3932(00)00115-9; Fallgatter AJ, 1999, INT J PSYCHOPHYSIOL, V32, P233, DOI 10.1016/S0167-8760(99)00018-5; Fallgatter AJ, 2006, NEUROPSYCHOPHARMACOL, V31, P2002, DOI 10.1038/sj.npp.1301003; Garavan H, 2002, NEUROIMAGE, V17, P1820, DOI 10.1006/nimg.2002.1326; Heatherton TF, 2011, TRENDS COGN SCI, V15, P132, DOI 10.1016/j.tics.2010.12.005; Heatherton TF, 2011, ANNU REV PSYCHOL, V62, P363, DOI 10.1146/annurev.psych.121208.131616; Heinzel S, 2013, CEREB CORTEX, V23, P1453, DOI 10.1093/cercor/bhs132; Hofmann W, 2008, J PERS SOC PSYCHOL, V95, P962, DOI 10.1037/a0012705; Hofmann W, 2012, TRENDS COGN SCI, V16, P174, DOI 10.1016/j.tics.2012.01.006; Houben K, 2011, APPETITE, V56, P345, DOI 10.1016/j.appet.2010.12.017; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Knoch D, 2007, ANN NY ACAD SCI, V1104, P123, DOI 10.1196/annals.1390.004; Koenig T, 2009, ELECT NEUROIMAGING, P25, DOI DOI 10.1017/CBO9780511596889; Kuhn S, 2009, HUM BRAIN MAPP, V30, P2834, DOI 10.1002/hbm.20711; Lavric A, 2004, EUR J NEUROSCI, V20, P2483, DOI 10.1111/j.1460-9568.2004.03683.x; Liddle PF, 2001, HUM BRAIN MAPP, V12, P100, DOI 10.1002/1097-0193(200102)12:2<100::AID-HBM1007>3.0.CO;2-6; Metcalfe J, 1999, PSYCHOL REV, V106, P3, DOI 10.1037/0033-295X.106.1.3; Michel CM., 2009, ELECT NEUROIMAGING, P111; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Muraven M, 2000, PSYCHOL BULL, V126, P247, DOI 10.1037/0033-2909.126.2.247; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; NUWER MR, 1998, INT FEDERATION CLIN, V106, P259; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P5; PFEFFERBAUM A, 1985, ELECTROEN CLIN NEURO, V60, P423, DOI 10.1016/0013-4694(85)91017-X; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Rand DG, 2012, NATURE, V489, P427, DOI 10.1038/nature11467; Rilling JK, 2011, ANNU REV PSYCHOL, V62, P23, DOI 10.1146/annurev.psych.121208.131647; Robbins TW, 2012, TRENDS COGN SCI, V16, P81, DOI 10.1016/j.tics.2011.11.009; Romanos M, 2010, J PSYCHIATR RES, V44, P768, DOI 10.1016/j.jpsychires.2010.02.001; ROSVOLD HE, 1956, J CONSULT PSYCHOL, V20, P343, DOI 10.1037/h0043220; Schiller B, 2014, CEREB CORTEX, V24, P2430, DOI 10.1093/cercor/bht095; Schmeichel BJ, 2007, J EXP PSYCHOL GEN, V136, P241, DOI 10.1037/0096-3445.136.2.241; Smith JL, 2008, CLIN NEUROPHYSIOL, V119, P704, DOI 10.1016/j.clinph.2007.11.042; Steinbeis N, 2012, NEURON, V73, P1040, DOI 10.1016/j.neuron.2011.12.027; Swick D, 2011, NEUROIMAGE, V56, P1655, DOI 10.1016/j.neuroimage.2011.02.070; Szuromi B, 2011, PSYCHOL MED, V41, P1529, DOI 10.1017/S0033291710001996; THALER RH, 1981, J POLIT ECON, V89, P392, DOI 10.1086/260971	50	22	22	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79462	10.1371/journal.pone.0079462	http://dx.doi.org/10.1371/journal.pone.0079462			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255PK	24265773	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327252100106
J	Osborne, JL; Smith, A; Clark, SJ; Reynolds, DR; Barron, MC; Lim, KS; Reynolds, AM				Osborne, Juliet L.; Smith, Alan; Clark, Suzanne J.; Reynolds, Don R.; Barron, Mandy C.; Lim, Ka S.; Reynolds, Andy M.			The Ontogeny of Bumblebee Flight Trajectories: From Naive Explorers to Experienced Foragers	PLOS ONE			English	Article							SEARCHING BEHAVIOR; MOVEMENT PATTERNS; FLOWER CONSTANCY; SPATIAL MEMORY; HONEY-BEES; NAVIGATION; SCALE; INFORMATION; RANGE; FOOD	Understanding strategies used by animals to explore their landscape is essential to predict how they exploit patchy resources, and consequently how they are likely to respond to changes in resource distribution. Social bees provide a good model for this and, whilst there are published descriptions of their behaviour on initial learning flights close to the colony, it is still unclear how bees find floral resources over hundreds of metres and how these flights become directed foraging trips. We investigated the spatial ecology of exploration by radar tracking bumblebees, and comparing the flight trajectories of bees with differing experience. The bees left the colony within a day or two of eclosion and flew in complex loops of ever-increasing size around the colony, exhibiting Levy-flight characteristics constituting an optimal searching strategy. This mathematical pattern can be used to predict how animals exploring individually might exploit a patchy landscape. The bees' groundspeed, maximum displacement from the nest and total distance travelled on a trip increased significantly with experience. More experienced bees flew direct paths, predominantly flying upwind on their outward trips although forage was available in all directions. The flights differed from those of naive honeybees: they occurred at an earlier age, showed more complex looping, and resulted in earlier returns of pollen to the colony. In summary bumblebees learn to find home and food rapidly, though phases of orientation, learning and searching were not easily separable, suggesting some multi-tasking.	[Osborne, Juliet L.] Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England; [Osborne, Juliet L.; Smith, Alan; Clark, Suzanne J.; Lim, Ka S.; Reynolds, Andy M.] Rothamsted Res, Harpenden, Herts, England; [Reynolds, Don R.] Univ Greenwich, Nat Resources Inst, Chatham, Kent, England; [Barron, Mandy C.] Landcare Res, Lincoln, New Zealand	University of Exeter; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of Greenwich; Landcare Research - New Zealand	Osborne, JL (corresponding author), Univ Exeter, Environm & Sustainabil Inst, Penryn, Cornwall, England.	J.L.Osborne@exeter.ac.uk	Osborne, Juliet L/I-6776-2012; Reynolds, Donald R/C-7361-2013; Lim, Ka Sing/B-4480-2012	Lim, Ka Sing/0000-0002-9166-2928; Reynolds, Donald/0000-0001-8749-7491	Insect Pollinator Initiative [BB/I000097/1]; Biotechnology and Biological Sciences Research Council (BBSRC); Natural Environment Research Council (NERC); Defra; Scottish Government; Wellcome Trust; BBSRC; Biotechnology and Biological Sciences Research Council [BB/J014915/1, BB/I000097/2, BBS/E/C/00005195, BB/I000097/1] Funding Source: researchfish; BBSRC [BBS/E/C/00005195, BB/J014915/1, BB/I000097/2, BB/I000097/1] Funding Source: UKRI	Insect Pollinator Initiative; Biotechnology and Biological Sciences Research Council (BBSRC)(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Defra(Department for Environment, Food & Rural Affairs (DEFRA)); Scottish Government; Wellcome Trust(Wellcome TrustEuropean Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	JLO is partly funded under the Insect Pollinator Initiative (project BB/I000097/1) which is jointly funded by the Biotechnology and Biological Sciences Research Council (BBSRC), the Natural Environment Research Council (NERC), Defra, the Scottish Government and The Wellcome Trust. Rothamsted Research receives grant-aided funding from the BBSRC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baddeley B, 2009, BIOL CYBERN, V101, P169, DOI 10.1007/s00422-009-0327-4; Biesmeijer J, 2005, BEHAV ECOL SOCIOBIOL, V59, P133, DOI 10.1007/s00265-005-0019-6; BULDYREV SV, 1995, PHYS REV E, V51, P5084, DOI 10.1103/PhysRevE.51.5084; Burns JG, 2006, BEHAV ECOL, V17, P48, DOI 10.1093/beheco/arj002; Capaldi EA, 2000, NATURE, V403, P537, DOI 10.1038/35000564; Cheng K, 2000, ANIM LEARN BEHAV, V28, P1, DOI 10.3758/BF03199768; Chittka L, 1999, NATURWISSENSCHAFTEN, V86, P361, DOI 10.1007/s001140050636; Chittka L, 1997, BEHAV ECOL, V8, P239, DOI 10.1093/beheco/8.3.239; Clauset A, 2009, SIAM REV, V51, P661, DOI 10.1137/070710111; Collett TS, 2006, ADV STUD BEHAV, V36, P123, DOI 10.1016/S0065-3454(06)36003-2; Collett TS, 2008, CURR BIOL, V18, pR1058, DOI 10.1016/j.cub.2008.10.006; Collett TS, 1996, CURR DIR PSYCHOL SCI, V5, P149, DOI 10.1111/1467-8721.ep11512352; Collett TS, 1996, J EXP BIOL, V199, P227; Collett TS, 1998, CONNECT SCI, V10, P255, DOI 10.1080/095400998116431; Conradt L, 2001, OIKOS, V95, P416, DOI 10.1034/j.1600-0706.2001.950306.x; de Ibarra NH, 2009, J EXP BIOL, V212, P3193, DOI 10.1242/jeb.029751; Dobson Heidi E.M., 1994, P47; Dornhaus A, 2004, APIDOLOGIE, V35, P183, DOI 10.1051/apido:2004002; Dornhaus A, 1999, NATURE, V401, P38, DOI 10.1038/43372; Dyer FC, 1996, J EXP BIOL, V199, P147; Dyer FC, 1989, INSECT FLIGHT, P205; FOURCASSIE V, 1994, ANIM BEHAV, V48, P69, DOI 10.1006/anbe.1994.1212; FREE J. B., 1955, INSECTES SOCIAUX, V2, P195, DOI 10.1007/BF02224381; Heinrich B., 1979, BUMBLEBEE EC; HOFFMANN G, 1983, BEHAV ECOL SOCIOBIOL, V13, P81, DOI 10.1007/BF00293798; LEHRER M, 1993, J COMP PHYSIOL A, V172, P549, DOI 10.1007/BF00213678; Lihoreau M, 2010, AM NAT, V176, P744, DOI 10.1086/657042; Menzel R, 1997, ISRAEL J PLANT SCI, V45, P141, DOI 10.1080/07929978.1997.10676680; Osborne JL, 1999, J APPL ECOL, V36, P519, DOI 10.1046/j.1365-2664.1999.00428.x; PENG CK, 1993, PHYS REV LETT, V70, P1343, DOI 10.1103/PhysRevLett.70.1343; Philippides A, 2013, J EXP BIOL, V216, P1093, DOI 10.1242/jeb.081455; PYKE GH, 1978, THEOR POPUL BIOL, V13, P72, DOI 10.1016/0040-5809(78)90036-9; Reinhard J, 2009, CONTEMP TOP ENTOMOL, P165; Reynolds AM, 2008, EPL-EUROPHYS LETT, V82, DOI 10.1209/0295-5075/82/20001; Reynolds AM, 2007, J THEOR BIOL, V245, P141, DOI 10.1016/j.jtbi.2006.10.007; Reynolds AM, 2012, ECOLOGY, V93, P1228, DOI 10.1890/11-1815.1; Reynolds AM, 2006, PHYS LETT A, V354, P384, DOI 10.1016/j.physleta.2006.01.086; Reynolds AM, 2007, J EXP BIOL, V210, P3763, DOI 10.1242/jeb.009563; Reynolds AM, 2007, ECOLOGY, V88, P1955, DOI 10.1890/06-1916.1; Riley JR, 1999, NATURE, V400, P126, DOI 10.1038/22029; Riley JR, 2002, COMPUT ELECTRON AGR, V35, P151, DOI 10.1016/S0168-1699(02)00016-9; Riley JR, 1996, NATURE, V379, P29, DOI 10.1038/379029b0; Seeley T., 1995, WISDOM HIVE SOCIAL P; SEELEY TD, 1987, ANIM BEHAV, V35, P1572, DOI 10.1016/S0003-3472(87)80035-0; Srinivasan MV, 2011, PHYSIOL REV, V91, P413, DOI 10.1152/physrev.00005.2010; Viswanathan GM, 1996, NATURE, V381, P413, DOI 10.1038/381413a0; von Frisch K., 1967, DANCE LANGUAGE ORIEN; WASER NM, 1986, AM NAT, V127, P593, DOI 10.1086/284507; WEHNER R, 1981, J COMP PHYSIOL, V142, P315, DOI 10.1007/BF00605445; Wei CA, 2009, ANIM BEHAV, V77, P1165, DOI 10.1016/j.anbehav.2008.12.031	50	46	46	1	92	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78681	10.1371/journal.pone.0078681	http://dx.doi.org/10.1371/journal.pone.0078681			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265707	Green Published, gold, Green Accepted, Green Submitted			2022-12-25	WOS:000327252100040
J	Santini, NS; Hua, Q; Schmitz, N; Lovelock, CE				Santini, Nadia S.; Hua, Quan; Schmitz, Nele; Lovelock, Catherine E.			Radiocarbon Dating and Wood Density Chronologies of Mangrove Trees in Arid Western Australia	PLOS ONE			English	Article							EXMOUTH GULF; TIME-SERIES; GROWTH; RINGS; BIOMASS; SALINITY; ANATOMY; LINK	Mangrove trees tend to be larger and mangrove communities more diverse in tropical latitudes, particularly where there is high rainfall. Variation in the structure, growth and productivity of mangrove forests over climatic gradients suggests they are sensitive to variations in climate, but evidence of changes in the structure and growth of mangrove trees in response to climatic variation is scarce. Bomb-pulse radiocarbon dating provides accurate dates of recent wood formation and tree age of tropical and subtropical tree species. Here, we used radiocarbon techniques combined with X-ray densitometry to develop a wood density chronology for the mangrove Avicennia marina in the Exmouth Gulf, Western Australia (WA). We tested whether wood density chronologies of A. marina were sensitive to variation in the Pacific Decadal Oscillation Index, which reflects temperature fluctuations in the Pacific Ocean and is linked to the instrumental rainfall record in north WA. We also determined growth rates in mangrove trees from the Exmouth Gulf, WA. We found that seaward fringing A. marina trees (similar to 10 cm diameter) were 48 +/- 1 to 89 +/- 23 years old (mean +/- 1 sigma) and that their growth rates ranged from 4.08 +/- 2.36 to 5.30 +/- 3.33 mm/yr (mean +/- 1 sigma). The wood density of our studied mangrove trees decreased with increases in the Pacific Decadal Oscillation Index. Future predicted drying of the region will likely lead to further reductions in wood density and their associated growth rates in mangrove forests in the region.	[Santini, Nadia S.; Lovelock, Catherine E.] Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia; [Hua, Quan] Australian Nucl Sci & Technol Org, Inst Environm Res, Lucas Heights, NSW, Australia; [Schmitz, Nele] Vrije Univ Brussel, Brussels, Belgium	University of Queensland; Australian Nuclear Science & Technology Organisation; Vrije Universiteit Brussel	Santini, NS (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld, Australia.	nadiasilvanasantini@gmail.com	Hua, Quan/F-9593-2014; Lovelock, Catherine E./AAF-7294-2020; Lovelock, Catherine E/G-7370-2012	Hua, Quan/0000-0003-0179-8539; Lovelock, Catherine E./0000-0002-2219-6855; Lovelock, Catherine E/0000-0002-2219-6855; Santini, Nadia/0000-0002-8319-8862	Mexican Council of Science and Technology (CONACYT); Australian Institute of Nuclear Science and Engineering (AINSE) [09047, 11114]; ARC [DP1096749]; School of Biological Sciences at the The University of Queensland (UQ); Research Foundation - Flanders (FWO)	Mexican Council of Science and Technology (CONACYT)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Australian Institute of Nuclear Science and Engineering (AINSE); ARC(Australian Research Council); School of Biological Sciences at the The University of Queensland (UQ); Research Foundation - Flanders (FWO)(FWO)	This work was supported by The Mexican Council of Science and Technology (CONACYT), The Secretary of Public Education (SEP, Mexico), the Australian Institute of Nuclear Science and Engineering (AINSE Grant No. 09047 & 11114), ARC Discovery award DP1096749, The School of Biological Sciences at the The University of Queensland (UQ) and the Research Foundation - Flanders (FWO). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alongi DM, 2002, ENVIRON CONSERV, V29, P331, DOI 10.1017/S0376892902000231; BALL MC, 1984, PLANT PHYSIOL, V74, P1, DOI 10.1104/pp.74.1.1; Bardsley K, 1985, COASTS TIDAL WETLAND, P167; Bowman DMJS, 2011, TREES-STRUCT FUNCT, V25, P925, DOI 10.1007/s00468-011-0567-5; Campelo F., 2012, **DATA OBJECT**; Chave J, 2006, ECOL APPL, V16, P2356, DOI 10.1890/1051-0761(2006)016[2356:RAPVOW]2.0.CO;2; Chave J, 2009, ECOL LETT, V12, P351, DOI 10.1111/j.1461-0248.2009.01285.x; Clarke LJ, 2012, GLOBAL CHANGE BIOL, V18, P301, DOI 10.1111/j.1365-2486.2011.02560.x; Clough BF, 1997, AUST J BOT, V45, P1023, DOI 10.1071/BT96075; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Devoe NN, 1998, FOREST ECOL MANAG, V103, P33, DOI 10.1016/S0378-1127(97)00176-X; Enquist BJ, 1999, NATURE, V401, P907, DOI 10.1038/44819; Feng M, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL019947; Fink D, 2004, NUCL INSTRUM METH B, V223, P109, DOI 10.1016/j.nimb.2004.04.025; Haneca K, 2006, VEG HIST ARCHAEOBOT, V15, P137, DOI 10.1007/s00334-005-0022-x; Hua Q, 2004, NUCL INSTRUM METH B, V223, P489, DOI 10.1016/j.nimb.2004.04.092; Hua Q, 2001, RADIOCARBON, V43, P275; Hua Q, 2004, RADIOCARBON, V46, P1273, DOI 10.1017/S0033822200033142; Hua Q, 2009, QUAT GEOCHRONOL, V4, P378, DOI 10.1016/j.quageo.2009.03.006; King DA, 2006, J ECOL, V94, P670, DOI 10.1111/j.1365-2745.2006.01112.x; Lovelock CE, 2011, FUNCT PLANT BIOL, V38, P514, DOI 10.1071/FP11027; Lovelock CE, 2007, CLIMATE CHANGE GREAT, P237; McCormac FG, 2004, RADIOCARBON, V46, P1087, DOI 10.1017/S0033822200033014; McGowan HA, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL037049; Nock CA, 2009, ANN BOT-LONDON, V104, P297, DOI 10.1093/aob/mcp118; Paling EI, 2008, ESTUAR COAST SHELF S, V77, P603, DOI 10.1016/j.ecss.2007.10.019; Pearson S, 2011, AUST J BOT, V59, P7, DOI 10.1071/BT10164; PENN JW, 1986, AUST J MAR FRESH RES, V37, P491; Peterson WT, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017528; Poorter L, 2010, NEW PHYTOL, V185, P481, DOI 10.1111/j.1469-8137.2009.03092.x; R Core Team, 2022, R LANG ENV STAT COMP; Ramsey CB, 2008, QUATERNARY SCI REV, V27, P42, DOI 10.1016/j.quascirev.2007.01.019; Richardson AJ, 2012, BIOL LETTERS, V8, P907, DOI 10.1098/rsbl.2012.0530; Robert EMR, 2011, TREES-STRUCT FUNCT, V25, P49, DOI 10.1007/s00468-010-0487-9; SAENGER P, 1993, OECOLOGIA, V96, P293, DOI 10.1007/BF00317496; Santini NS, 2013, FUNCT PLANT BIOL, V40, P400, DOI 10.1071/FP12204; Santini NS, 2012, TREES-STRUCT FUNCT, V26, P1555, DOI 10.1007/s00468-012-0729-0; Schmitz N, 2008, ANN BOT-LONDON, V101, P49, DOI 10.1093/aob/mcm280; Schmitz N, 2006, ANN BOT-LONDON, V98, P1321, DOI 10.1093/aob/mcl224; SCHULTZ TP, 1995, HOLZFORSCHUNG, V49, P29, DOI 10.1515/hfsg.1995.49.1.29; SEMENIUK V, 1983, VEGETATIO, V53, P11, DOI 10.1007/BF00039767; Shadbolt P, 1988, SOME ASPECTS NONDEST; Smith T. J, 1992, TROPICAL MANGROVE EC, P101; SMITH TJ, 1987, J BIOGEOGR, V14, P9, DOI 10.2307/2844783; Solomon S, 2009, P NATL ACAD SCI USA, V106, P1704, DOI 10.1073/pnas.0812721106; Steppe K, 2004, J STRUCT BIOL, V148, P11, DOI 10.1016/j.jsb.2004.05.001; Thomas DS, 2007, TREE PHYSIOL, V27, P251, DOI 10.1093/treephys/27.2.251; TWILLEY RR, 1992, WATER AIR SOIL POLL, V64, P265, DOI 10.1007/BF00477106; Verheyden A, 2005, NEW PHYTOL, V167, P425, DOI 10.1111/j.1469-8137.2005.01415.x; WIGLEY TML, 1984, J CLIM APPL METEOROL, V23, P201, DOI 10.1175/1520-0450(1984)023<0201:OTAVOC>2.0.CO;2; Woodcock DW, 2002, TREES-STRUCT FUNCT, V16, P437, DOI 10.1007/s00468-002-0173-7; Worbes Martin, 2002, Dendrochronologia, V20, P217, DOI 10.1078/1125-7865-00018; Yu KF, 2007, NUCL INSTRUM METH B, V255, P399, DOI 10.1016/j.nimb.2006.11.127	54	13	13	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80116	10.1371/journal.pone.0080116	http://dx.doi.org/10.1371/journal.pone.0080116			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265797	Green Published, gold			2022-12-25	WOS:000327252100130
J	Pham, DH; Powell, JA; Gliddon, BL; Moretti, PAB; Tsykin, A; Van der Hoek, M; Kenyon, R; Goodall, GJ; Pitson, SM				Pham, D. H.; Powell, J. A.; Gliddon, B. L.; Moretti, P. A. B.; Tsykin, A.; Van der Hoek, M.; Kenyon, R.; Goodall, G. J.; Pitson, S. M.			Enhanced expression of transferrin receptor 1 contributes to oncogenic signalling by sphingosine kinase 1	ONCOGENE			English	Article						expression profiling; DNA microarray; neoplastic transformation; sphingosine kinase; transferrin receptor	CANCER-CELLS; IN-VITRO; C-MYC; 1-PHOSPHATE; GROWTH; SPHINGOSINE-1-PHOSPHATE; ACTIVATION; CARCINOMA; APOPTOSIS; HEAT-SHOCK-PROTEIN-105	Sphingosine kinase 1 (SK1) is a lipid kinase that catalyses the formation of sphingosine-1-phosphate (S1P). Considerable evidence has implicated elevated cellular SK1 in tumour development, progression and disease severity. In particular, SK1 has been shown to enhance cell survival and proliferation and induce neoplastic transformation. Although S1P has been found to have both cellsurface G-protein-coupled receptors and intracellular targets, the specific downstream pathways mediating oncogenic signalling by SK1 remain poorly defined. Here, using a gene expression array approach, we have demonstrated a novel mechanism whereby SK1 regulates cell survival, proliferation and neoplastic transformation through enhancing expression of transferrin receptor 1 (TFR1). We showed that elevated levels of SK1 enhanced total as well as cell-surface TFR1 expression, resulting in increased transferrin uptake into cells. Notably, we also found that SK1 activation and localization to the plasma membrane, which are critical for its oncogenic effects, are necessary for regulation of TFR1 expression specifically through engagement of the S1P G-protein coupled receptor, S1P(2). Furthermore, we showed that blocking TFR1 function with a neutralizing antibody inhibits SK1-induced cell proliferation, survival and neoplastic transformation of NIH3T3 fibroblasts. Similar effects were observed following antagonism of S1P2. Together these findings suggest that TFR1 has an important role in SK1-mediated oncogenesis.	[Pham, D. H.; Powell, J. A.; Gliddon, B. L.; Moretti, P. A. B.; Tsykin, A.; Goodall, G. J.; Pitson, S. M.] SA Pathol, Ctr Canc Biol, Frome Rd, Adelaide, SA 5000, Australia; [Pham, D. H.; Tsykin, A.; Goodall, G. J.; Pitson, S. M.] Univ Adelaide, Sch Mol & Biomed Sci, Adelaide, SA, Australia; [Van der Hoek, M.; Kenyon, R.] SA Pathol, Adelaide Microarray Facil, Adelaide, SA, Australia; [Goodall, G. J.; Pitson, S. M.] Univ S Australia, Sch Pharm & Med Sci, Adelaide, SA 5001, Australia	Centre for Cancer Biology; SA Pathology; University of Adelaide; SA Pathology; University of South Australia	Pitson, SM (corresponding author), SA Pathol, Ctr Canc Biol, Frome Rd, Adelaide, SA 5000, Australia.	stuart.pitson@health.sa.gov.au	Pitson, Stuart/B-9342-2009; Pham, Duyen/V-6101-2019	Pitson, Stuart/0000-0002-9527-2740; Pham, Duyen/0000-0003-0664-4133; Tsykin, Anna/0000-0001-5965-6803; Goodall, Gregory/0000-0003-1294-0692; Powell, jason/0000-0001-8493-9178; Moretti, Paul/0000-0002-3523-1496; Gliddon, Briony/0000-0003-3928-7478	Fay Fuller Foundation; University of Adelaide Postgraduate Scholarship; National Health and Medical Research Council of Australia [626936];  [508098];  [1042589]	Fay Fuller Foundation; University of Adelaide Postgraduate Scholarship; National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); ; 	This work was supported by the Fay Fuller Foundation, a University of Adelaide Postgraduate Scholarship (to DHP), Senior Research Fellowships (508098 and 1042589) and Project Grant (626936) from the National Health and Medical Research Council of Australia (to SMP). We thank Julia Zebol for technical assistance and Andrew Bert for assistance with Figure preparation.	Ader I, 2008, CANCER RES, V68, P8635, DOI 10.1158/0008-5472.CAN-08-0917; Ader I, 2009, CANCER RES, V69, P3723, DOI 10.1158/0008-5472.CAN-09-0389; Baran Y, 2007, J BIOL CHEM, V282, P10922, DOI 10.1074/jbc.M610157200; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bianchi L, 1999, NUCLEIC ACIDS RES, V27, P4223, DOI 10.1093/nar/27.21.4223; Callens C, 2008, LEUKEMIA, V22, P42, DOI 10.1038/sj.leu.2404958; Cattoretti G, 2009, CANCER RES, V69, P8686, DOI 10.1158/0008-5472.CAN-09-1110; Chan HS, 2013, BBA-MOL CELL BIOL L, V1831, P147, DOI 10.1016/j.bbalip.2012.07.005; Daniels TR, 2006, CLIN IMMUNOL, V121, P144, DOI 10.1016/j.clim.2006.06.010; Das Gupta A, 1990, Hematol Pathol, V4, P37; El-Shewy HM, 2006, J BIOL CHEM, V281, P31399, DOI 10.1074/jbc.M605339200; French KJ, 2003, CANCER RES, V63, P5962; Habashy HO, 2010, BREAST CANCER RES TR, V119, P283, DOI 10.1007/s10549-009-0345-x; HABESHAW JA, 1983, LANCET, V1, P498; Helpman L, 2009, AM J OBSTET GYNECOL, V201, DOI 10.1016/j.ajog.2009.05.013; Heringdorf DMZ, 2001, EUR J PHARMACOL, V414, P145, DOI 10.1016/S0014-2999(01)00789-0; Hosaka S, 2006, CANCER SCI, V97, P623, DOI 10.1111/j.1349-7006.2006.00217.x; Huang WJ, 2009, INT J CANCER, V124, P298, DOI 10.1002/ijc.23906; Jarman KE, 2010, J BIOL CHEM, V285, P483, DOI 10.1074/jbc.M109.068395; Jiang XP, 2010, ANTICANCER RES, V30, P759; Jose-Eneriz ES, 2008, BRIT J HAEMATOL, V142, P571, DOI 10.1111/j.1365-2141.2008.07221.x; Kawamori T, 2006, FASEB J, V20, P386, DOI 10.1096/fj.05-4331fje; Kawamori T, 2009, FASEB J, V23, P405, DOI 10.1096/fj.08-117572; Kohno M, 2006, MOL CELL BIOL, V26, P7211, DOI 10.1128/MCB.02341-05; Le Scolan E, 2005, BLOOD, V106, P1808, DOI 10.1182/blood-2004-12-4832; Li MH, 2009, J UROLOGY, V181, P1347, DOI 10.1016/j.juro.2008.10.140; Long JS, 2010, J BIOL CHEM, V285, P35957, DOI 10.1074/jbc.M110.117945; Loveridge C, 2010, J BIOL CHEM, V285, P38841, DOI 10.1074/jbc.M110.127993; Michaud MD, 2009, ARTERIOSCL THROM VAS, V29, P902, DOI 10.1161/ATVBAHA.109.185280; Muchemwa FC, 2006, BRIT J DERMATOL, V155, P582, DOI 10.1111/j.1365-2133.2006.07362.x; Muchemwa FC, 2008, MELANOMA RES, V18, P166, DOI 10.1097/CMR.0b013e3282fe9a16; O'Donnell KA, 2006, MOL CELL BIOL, V26, P2373, DOI 10.1128/MCB.26.6.2373-2386.2006; Okazaki F, 2010, CANCER RES, V70, P6238, DOI 10.1158/0008-5472.CAN-10-0184; Olivera A, 1999, J CELL BIOL, V147, P545, DOI 10.1083/jcb.147.3.545; Pantopoulos K, 2004, ANN NY ACAD SCI, V1012, P1, DOI 10.1196/annals.1306.001; Park HS, 2009, J CUTAN PATHOL, V36, P511, DOI 10.1111/j.1600-0560.2008.01085.x; Pchejetski D, 2005, CANCER RES, V65, P11667, DOI 10.1158/0008-5472.CAN-05-2702; Persons DA, 1999, BLOOD, V93, P488, DOI 10.1182/blood.V93.2.488.402k17_488_499; Pham DH, 2008, BIOTECHNIQUES, V45, P155, DOI 10.2144/000112896; Pitman MR, 2010, CURR CANCER DRUG TAR, V10, P354, DOI 10.2174/156800910791208599; Pitman Melissa R, 2012, Methods Mol Biol, V874, P21, DOI 10.1007/978-1-61779-800-9_2; Pitman MR, 2011, INT J BIOCHEM CELL B, V43, P342, DOI 10.1016/j.biocel.2010.11.001; Pitson SM, 2000, J BIOL CHEM, V275, P33945, DOI 10.1074/jbc.M006176200; Pitson SM, 2000, BIOCHEM J, V350, P429, DOI 10.1042/0264-6021:3500429; Pitson SM, 2003, EMBO J, V22, P5491, DOI 10.1093/emboj/cdg540; Pitson SM, 2005, J EXP MED, V201, P49, DOI 10.1084/jem.20040559; Pitson SM, 2011, ANTI-CANCER AGENT ME, V11, P799; Pitson SM, 2011, TRENDS BIOCHEM SCI, V36, P97, DOI 10.1016/j.tibs.2010.08.001; Ponnusamy S, 2012, EMBO MOL MED, V4, P761, DOI 10.1002/emmm.201200244; PRIOR R, 1990, VIRCHOWS ARCH A, V416, P491, DOI 10.1007/BF01600299; Pyne NJ, 2010, NAT REV CANCER, V10, P489, DOI 10.1038/nrc2875; Ryschich E, 2004, EUR J CANCER, V40, P1418, DOI 10.1016/j.ejca.2004.01.036; Salas A, 2011, BLOOD, V117, P5941, DOI 10.1182/blood-2010-08-300772; Salomone S, 2011, FRONT PHARMACOL, V2, DOI 10.3389/fphar.2011.00009; Schwock J, 2008, CANCER CHEMOTH PHARM, V61, P669, DOI 10.1007/s00280-007-0522-8; Shen X, 2008, INT IMMUNOPHARMACOL, V8, P1813, DOI 10.1016/j.intimp.2008.08.022; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Smyth GK, 2005, STAT BIOL HEALTH, P397, DOI 10.1007/0-387-29362-0_23; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; Strub GM, 2010, ADV EXP MED BIOL, V688, P141; Sun J, 2010, CANCER BIOTHER RADIO, V25, P155, DOI 10.1089/cbr.2009.0664; Takeshita A, 2000, J BIOL CHEM, V275, P32220, DOI 10.1074/jbc.M002569200; Takuwa N, 2011, AM J CANCER RES, V1, P460; Tran PLCHB, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-276; TROWBRIDGE IS, 1982, P NATL ACAD SCI-BIOL, V79, P1175, DOI 10.1073/pnas.79.4.1175; TROWBRIDGE IS, 1986, BIOCHEM SOC SYMP, P117; van Dam EM, 2002, J BIOL CHEM, V277, P48876, DOI 10.1074/jbc.M206271200; Wirth GJ, 2006, ONCOLOGY-BASEL, V71, P86, DOI 10.1159/000100476; Xia P, 2000, CURR BIOL, V10, P1527, DOI 10.1016/S0960-9822(00)00834-4; Yang Y H, 2001, Brief Bioinform, V2, P341, DOI 10.1093/bib/2.4.341; Young JC, 2003, TRENDS BIOCHEM SCI, V28, P541, DOI 10.1016/j.tibs.2003.08.009; Zhou HJ, 2008, ANTI-CANCER DRUG, V19, P247, DOI 10.1097/CAD.0b013e3282f3f152	72	23	23	0	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5559	5568		10.1038/onc.2013.502	http://dx.doi.org/10.1038/onc.2013.502			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24276247				2022-12-25	WOS:000346087900008
J	Naegeli, A; Neupert, C; Fan, YY; Lin, CW; Poljak, K; Papini, AM; Schwarz, F; Aebi, M				Naegeli, Andreas; Neupert, Christine; Fan, Yao-Yun; Lin, Chia-Wei; Poljak, Kristina; Papini, Anna Maria; Schwarz, Flavio; Aebi, Markus			Molecular Analysis of an Alternative N-Glycosylation Machinery by Functional Transfer from Actinobacillus pleuropneumoniae to Escherichia coli	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Bacteria; Glucose; Glycosylation; Glycosyltransferases; Post-translational Modification; Actinobacillus pleuropneumoniae	INFLUENZAE HMW1 ADHESIN; HAEMOPHILUS-INFLUENZAE; MECHANISM; PROTEINS; GLYCOSYLTRANSFERASE; GLYCOPROTEIN; ANTIBODIES; ANTIGENS; YERSINIA; SEQUENCE	N-Linked protein glycosylation is a frequent post-translational modification that can be found in all three domains of life. In a canonical, highly conserved pathway, an oligosaccharide is transferred by a membrane-bound oligosaccharyltransferase from a lipid donor to asparagines in the sequon NX(S/T) of secreted polypeptides. The -proteobacterium Actinobacillus pleuropneumoniae encodes an unusual pathway for N-linked protein glycosylation. This pathway takes place in the cytoplasm and is mediated by a soluble N-glycosyltransferase (NGT) that uses nucleotide-activated monosaccharides to glycosylate asparagine residues. To characterize the process of cytoplasmic N-glycosylation in more detail, we studied the glycosylation in A. pleuropneumoniae and functionally transferred the glycosylation system to Escherichia coli. N-Linked glucose specific human sera were used for the analysis of the glycosylation process. We identified autotransporter adhesins as the preferred protein substrate of NGT in vivo, and in depth analysis of the modified sites in E. coli revealed a surprisingly relaxed peptide substrate specificity. Although NX(S/T) is the preferred acceptor sequon, we detected glycosylation of alternative sequons, including modification of glutamine and serine residues. We also demonstrate the use of NGT to glycosylate heterologous proteins. Therefore, our study could provide the basis for a novel route for the engineering of N-glycoproteins in bacteria.	[Naegeli, Andreas; Neupert, Christine; Fan, Yao-Yun; Lin, Chia-Wei; Poljak, Kristina; Schwarz, Flavio; Aebi, Markus] Swiss Fed Inst Technol, Inst Microbiol, Swiss Fed Inst Technol, CH-8093 Zurich, Switzerland; [Papini, Anna Maria] Univ Florence, Dipartimento Chim Ugo Schiff, Lab Peptide & Prot Chem & Biol, I-50019 Sesto Fiorentino, Italy	Swiss Federal Institutes of Technology Domain; ETH Zurich; University of Florence	Aebi, M (corresponding author), Swiss Fed Inst Technol, Inst Microbiol, Wolfgang Pauli Str 10, CH-8093 Zurich, Switzerland.	markus.aebi@micro.biol.ethz.ch	Lin, Chia-wei/ABA-6065-2021; Papini, Anna Maria/AAZ-5204-2020; Fan, YaoYun/AAS-5920-2020	Lin, Chia-wei/0000-0003-4777-2916; Naegeli, Andreas/0000-0002-5938-9124; Schwarz, Flavio/0000-0002-1060-1585; Poljak, Kristina/0000-0002-0199-3812; Papini, Anna Maria/0000-0002-2947-7107	Swiss National Science Foundation [CRSII3_12733, 3100170-105541]; ETH Zurich	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); ETH Zurich(ETH Zurich)	The project was supported by Swiss National Science Foundation Grants CRSII3_12733 and 3100170-105541 (to M. A.) and by ETH Zurich. A patent application ("Pasteurellaceae vaccines," PCT/EP2012/065480) covering the use of N-glycosylated Pasteurellaceae autotransporter adhesins as vaccines has been filed by ETH Zurich on behalf of A. N., F. S., and M. A. and was licensed to Malcisbo AG.	Aebi M, 2010, TRENDS BIOCHEM SCI, V35, P74, DOI 10.1016/j.tibs.2009.10.001; Apweiler R, 1999, BBA-GEN SUBJECTS, V1473, P4, DOI 10.1016/S0304-4165(99)00165-8; ARSCOTT P, 1992, J CLIN ENDOCR METAB, V75, P295, DOI 10.1210/jc.75.1.295; Benz I, 2001, MOL MICROBIOL, V40, P1403, DOI 10.1046/j.1365-2958.2001.02487.x; Cantarel BL, 2009, NUCLEIC ACIDS RES, V37, pD233, DOI 10.1093/nar/gkn663; Charbonneau ME, 2012, MOL MICROBIOL, V83, P894, DOI 10.1111/j.1365-2958.2012.07973.x; Charbonneau ME, 2009, J BIOL CHEM, V284, P17340, DOI 10.1074/jbc.M109.010108; Choi KJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0015888; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; DeFrees S, 2006, GLYCOBIOLOGY, V16, P833, DOI 10.1093/glycob/cwl004; Effraimidis G, 2011, CLIN EXP IMMUNOL, V165, P38, DOI 10.1111/j.1365-2249.2011.04399.x; FADEN H, 1995, J INFECT DIS, V172, P132, DOI 10.1093/infdis/172.1.132; Gerber S, 2013, J BIOL CHEM, V288, P8849, DOI 10.1074/jbc.M112.445940; Grass S, 2003, MOL MICROBIOL, V48, P737, DOI 10.1046/j.1365-2958.2003.03450.x; Grass S, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000919; Gross J, 2008, J BIOL CHEM, V283, P26010, DOI 10.1074/jbc.M801819200; Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752; Ishihama Y, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-102; Junker M, 2006, P NATL ACAD SCI USA, V103, P4918, DOI 10.1073/pnas.0507923103; Kaneko Y, 2006, SCIENCE, V313, P670, DOI 10.1126/science.1129594; Kawai F, 2011, J BIOL CHEM, V286, P38546, DOI 10.1074/jbc.M111.237602; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Lindenthal C, 1999, INFECT IMMUN, V67, P4084, DOI 10.1128/IAI.67.8.4084-4091.1999; Lizak C, 2011, NATURE, V474, P350, DOI 10.1038/nature10151; Lolli F, 2005, J NEUROIMMUNOL, V167, P131, DOI 10.1016/j.jneuroim.2005.05.016; Lolli F, 2005, P NATL ACAD SCI USA, V102, P10273, DOI 10.1073/pnas.0503178102; Lomino JV, 2013, BIOORGAN MED CHEM, V21, P2262, DOI 10.1016/j.bmc.2013.02.007; Nita-Lazar M, 2005, GLYCOBIOLOGY, V15, P361, DOI 10.1093/glycob/cwi019; Racaityte K, 2005, J CHROMATOGR A, V1079, P354, DOI 10.1016/j.chroma.2005.03.080; RESETKOVA E, 1994, THYROID, V4, P269, DOI 10.1089/thy.1994.4.269; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Schwarz F, 2011, CURR OPIN STRUC BIOL, V21, P576, DOI 10.1016/j.sbi.2011.08.005; Schwarz F, 2011, J BIOL CHEM, V286, P35267, DOI 10.1074/jbc.M111.277160; Selkrig J, 2012, NAT STRUCT MOL BIOL, V19, P506, DOI 10.1038/nsmb.2261; Sharon N, 1995, ESSAYS BIOCHEM, V30, P59; Sherlock O, 2006, J BACTERIOL, V188, P1798, DOI 10.1128/JB.188.5.1798-1807.2006; Thein M, 2010, J PROTEOME RES, V9, P6135, DOI 10.1021/pr1002438; Wacker M, 2002, SCIENCE, V298, P1790, DOI 10.1126/science.298.5599.1790; Wang YJ, 2010, INT J PHARMACEUT, V386, P156, DOI 10.1016/j.ijpharm.2009.11.016; WENZEL BE, 1988, LANCET, V1, P56; WILCHEK M, 1987, METHOD ENZYMOL, V138, P429; Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/nmeth.1322, 10.1038/NMETH.1322]; Xiao LW, 2012, J BASIC MICROB, V52, P598, DOI 10.1002/jobm.201100365	43	57	60	2	39	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 24	2014	289	4					2170	2179		10.1074/jbc.M113.524462	http://dx.doi.org/10.1074/jbc.M113.524462			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AA5IV	24275653	Green Published, hybrid			2022-12-25	WOS:000331130200025
J	Tomioka, T; Shimazaki, T; Yamauchi, T; Oki, T; Ohgoh, M; Okano, H				Tomioka, Takeyasu; Shimazaki, Takuya; Yamauchi, Toshihiko; Oki, Toru; Ohgoh, Makoto; Okano, Hideyuki			LIM Homeobox 8 (Lhx8) Is a Key Regulator of the Cholinergic Neuronal Function via a Tropomyosin Receptor Kinase A (TrkA)-mediated Positive Feedback Loop	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NERVE GROWTH-FACTOR; SPATIAL MEMORY IMPAIRMENTS; APOPTOTIC CELL-DEATH; EMBRYONIC STEM-CELLS; RAT BASAL FOREBRAIN; ACETYLCHOLINE-RELEASE; NEUROTROPHIC FACTOR; TRANSCRIPTION FACTOR; SEPTAL CELLS; AGED RATS	Basal forebrain cholinergic neurons play an important role in cognitive functions such as learning and memory, and they are affected in several neurodegenerative diseases, including Alzheimer disease and Down syndrome. Despite their functional importance, the molecular mechanisms of functional maturation and maintenance of these cholinergic neurons after the differentiation stage have not been fully elucidated. This study demonstrates that the LIM homeobox 8 (Lhx8) transcription factor regulates cholinergic function in rat septal cholinergic neurons in primary cultures from E18.5 embryos and in the adult brain. Lhx8 expression modulated tropomyosin receptor kinase A (TrkA) expression in septal cholinergic neurons in vitro and in vivo, resulting in regulated acetylcholine release as an index of cholinergic function. In addition, Lhx8 expression and function were regulated by nerve growth factor (NGF), and the effect of NGF was potentiated by Lhx8-induced TrkA expression. Together, our findings suggest that positive feedback regulation between Lhx8, TrkA, and NGF is an important regulatory mechanism for cholinergic functions of the septum.	[Tomioka, Takeyasu; Shimazaki, Takuya; Okano, Hideyuki] Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan; [Tomioka, Takeyasu; Oki, Toru; Ohgoh, Makoto] Eisai & Co Ltd, Dept Biol Pharmacol, Discovery Res, Neurosci Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan; [Yamauchi, Toshihiko] Eisai & Co Ltd, Dept Biol, KAN Prod Creat Unit, Tsukuba, Ibaraki 3002635, Japan	Keio University; Eisai Co Ltd; Eisai Co Ltd	Okano, H (corresponding author), Keio Univ, Dept Physiol, Sch Med, Shinjuku Ku, Tokyo 1608582, Japan.	hidokano@a2.keio.jp	Shimazaki, Takuya/L-1159-2013; Okano, Hideyuki/I-7584-2019	Shimazaki, Takuya/0000-0002-3936-2098; 	Japanese Ministry of Education, Culture, Sports, Science and Technology; Eisai Co., Ltd.	Japanese Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Eisai Co., Ltd.(Eisai Co Ltd)	This work was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology, Funding Program for World-leading Innovative R&D on Science and Technology (to H. O.), and Eisai Co., Ltd.	Asbreuk CHJ, 2002, NEUROSCIENCE, V109, P287, DOI 10.1016/S0306-4522(01)00466-3; Auld DS, 2001, J NEUROSCI, V21, P3375, DOI 10.1523/JNEUROSCI.21-10-03375.2001; Auld DS, 2000, J PHARMACOL EXP THER, V292, P692; Backman C, 1996, J NEUROSCI, V16, P5437; Bridwell JL, 2001, GENE, V277, P239, DOI 10.1016/S0378-1119(01)00704-1; Casarosa S, 1999, DEVELOPMENT, V126, P525; Donello JE, 1996, J VIROL, V70, P4345, DOI 10.1128/JVI.70.7.4345-4351.1996; ElTamer A, 1996, NEUROSCI LETT, V203, P123, DOI 10.1016/0304-3940(95)12283-4; Everitt BJ, 1997, ANNU REV PSYCHOL, V48, P649, DOI 10.1146/annurev.psych.48.1.649; Fagan AM, 1997, J NEUROSCI, V17, P7644; FISCHER W, 1991, EXP NEUROL, V113, P93, DOI 10.1016/0014-4886(91)90167-B; FISCHER W, 1992, NEUROBIOL AGING, V13, P9, DOI 10.1016/0197-4580(92)90003-G; FISCHER W, 1994, P NATL ACAD SCI USA, V91, P8607, DOI 10.1073/pnas.91.18.8607; Fitzsimons HL, 2002, METHODS, V28, P227, DOI 10.1016/S1046-2023(02)00227-X; Fragkouli A, 2005, EUR J NEUROSCI, V21, P2923, DOI 10.1111/j.1460-9568.2005.04141.x; Goto M, 1996, MOL PHARMACOL, V49, P860; Grigoriou M, 1998, DEVELOPMENT, V125, P2063; Gustilo MC, 1999, J COMP NEUROL, V405, P491, DOI 10.1002/(SICI)1096-9861(19990322)405:4<491::AID-CNE4>3.0.CO;2-N; Ha DH, 1999, J COMP NEUROL, V406, P156; Hallonet M, 1999, GENE DEV, V13, P3106, DOI 10.1101/gad.13.23.3106; HEFTI F, 1986, J NEUROSCI, V6, P2155; Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629; Kimura S, 1996, GENE DEV, V10, P60, DOI 10.1101/gad.10.1.60; Kosasa T, 1999, EUR J PHARMACOL, V380, P101, DOI 10.1016/S0014-2999(99)00545-2; Leanza G, 1996, EUR J NEUROSCI, V8, P1535, DOI 10.1111/j.1460-9568.1996.tb01616.x; LEANZA G, 1995, EUR J NEUROSCI, V7, P329, DOI 10.1111/j.1460-9568.1995.tb01068.x; Lopes R, 2012, P NATL ACAD SCI USA, V109, P3119, DOI 10.1073/pnas.1109251109; Ma L, 2000, DEVELOPMENT, V127, P3777; Ma L, 2003, DEVELOPMENT, V130, P3525, DOI 10.1242/dev.00582; Madziar B, 2005, J NEUROCHEM, V92, P767, DOI 10.1111/j.1471-4159.2004.02908.x; Manabe T, 2007, CELL DEATH DIFFER, V14, P1080, DOI 10.1038/sj.cdd.4402106; MartinezSerrano A, 1996, P NATL ACAD SCI USA, V93, P6355, DOI 10.1073/pnas.93.13.6355; MARTINEZSERRANO A, 1995, NEURON, V15, P473, DOI 10.1016/0896-6273(95)90051-9; MOBLEY WC, 1986, MOL BRAIN RES, V1, P53, DOI 10.1016/0169-328X(86)90020-3; Mori T, 2004, EUR J NEUROSCI, V19, P3129, DOI 10.1111/j.0953-816X.2004.03415.x; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Ohgoh M, 1998, EXP NEUROL, V149, P51, DOI 10.1006/exnr.1997.6719; Okada Y, 2004, DEV BIOL, V275, P124, DOI 10.1016/j.ydbio.2004.07.038; Oosawa H, 1999, J NEUROSCI RES, V57, P381, DOI 10.1002/(SICI)1097-4547(19990801)57:3<381::AID-JNR10>3.3.CO;2-3; Pongrac JL, 1996, J NEUROCHEM, V66, P804; Salehi A, 2003, TRENDS NEUROSCI, V26, P73, DOI 10.1016/S0166-2236(02)00038-3; Saragovi HU, 2005, J NEUROCHEM, V95, P1472, DOI 10.1111/j.1471-4159.2005.03479.x; Saucedo-Cardenas O, 1998, P NATL ACAD SCI USA, V95, P4013, DOI 10.1073/pnas.95.7.4013; Sussel L, 1999, DEVELOPMENT, V126, P3359; SUZUKI T, 1994, BRAIN RES, V665, P311, DOI 10.1016/0006-8993(94)91353-6; Takahashi E, 1999, BIOCHEM BIOPH RES CO, V260, P54, DOI 10.1006/bbrc.1999.0857; TAKEI N, 1989, J NEUROCHEM, V53, P1405, DOI 10.1111/j.1471-4159.1989.tb08531.x; Toresson H, 2000, DEVELOPMENT, V127, P4361; Turjanski AG, 2007, ONCOGENE, V26, P3240, DOI 10.1038/sj.onc.1210415; Tuszynski MH, 2005, NAT MED, V11, P551, DOI 10.1038/nm1239; Whitmarsh AJ, 2007, BBA-MOL CELL RES, V1773, P1285, DOI 10.1016/j.bbamcr.2006.11.011; WILCOX BJ, 1995, J COMP NEUROL, V359, P573, DOI 10.1002/cne.903590405; WILLIAMS LR, 1986, P NATL ACAD SCI USA, V83, P9231, DOI 10.1073/pnas.83.23.9231; WINSON J, 1978, SCIENCE, V201, P160, DOI 10.1126/science.663646; Xu BJ, 2000, J NEUROSCI, V20, P6888, DOI 10.1523/JNEUROSCI.20-18-06888.2000; Yun K, 2001, DEVELOPMENT, V128, P193; Zetterstrom RH, 1997, SCIENCE, V276, P248, DOI 10.1126/science.276.5310.248; Zhao YG, 2003, P NATL ACAD SCI USA, V100, P9005, DOI 10.1073/pnas.1537759100; Zolotukhin S, 2002, METHODS, V28, P158, DOI 10.1016/S1046-2023(02)00220-7	59	10	11	0	4	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1000	1010		10.1074/jbc.M113.494385	http://dx.doi.org/10.1074/jbc.M113.494385			11	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265310	Green Published, hybrid			2022-12-25	WOS:000330541200034
J	Rose, AE; Zhao, CG; Turner, EM; Steyer, AM; Schlieker, C				Rose, April E.; Zhao, Chenguang; Turner, Elizabeth M.; Steyer, Anna M.; Schlieker, Christian			Arresting a Torsin ATPase Reshapes the Endoplasmic Reticulum	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Electron Microscopy (EM); Endoplasmic Reticulum(ER); Enzyme Mechanisms; Membrane Structure; AAA plus ATPase; Torsin	NUCLEAR-ENVELOPE; DYT1 DYSTONIA; MEMBRANE-PROTEINS; MUTANT TORSINA; CELLS; DOMAIN; PHOSPHORYLATION; INCLUSIONS; EXPRESSION; ORGANELLES	Torsins are membrane-tethered AAA+ ATPases residing in the nuclear envelope (NE) and endoplasmic reticulum (ER). Here, we show that the induction of a conditional, dominant-negative TorsinB variant provokes a profound reorganization of the endomembrane system into foci containing double membrane structures that are derived from the ER. These double-membrane sinusoidal structures are formed by compressing the ER lumen to a constant width of 15 nm, and are highly enriched in the ATPase activator LULL1. Further, we define an important role for a highly conserved aromatic motif at the C terminus of Torsins. Mutations in this motif perturb LULL1 binding, reduce ATPase activity, and profoundly limit the induction of sinusoidal structures.	[Rose, April E.; Zhao, Chenguang; Turner, Elizabeth M.; Steyer, Anna M.; Schlieker, Christian] Yale Univ, Dept Mol Biophys & Biochem, New Haven, CT 06520 USA	Yale University	Schlieker, C (corresponding author), Yale Univ, Dept Mol Biophys & Biochem, 266 Whitney Ave,POB 208114,Bass 236A, New Haven, CT 06520 USA.	christian.schlieker@yale.edu		Steyer, Anna/0000-0002-4814-7517	National Institutes of Health [DP2 OD008624-01]; Ellison Medical Foundation [AG-NS-0662-10]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007223] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD008624] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded, in whole or in part, by National Institutes of Health Grant DP2 OD008624-01 and Ellison Medical Foundation Grant AG-NS-0662-10.	ANDERSON RGW, 1983, J CELL SCI, V63, P1; Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008; Bragg DC, 2004, MOL CELL NEUROSCI, V27, P417, DOI 10.1016/j.mcn.2004.07.009; Bragg DC, 2004, NEUROSCIENCE, V125, P651, DOI 10.1016/j.neuroscience.2004.01.053; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Ferguson SM, 2012, NAT REV MOL CELL BIO, V13, P75, DOI 10.1038/nrm3266; FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T; Fukuda M, 2001, J BIOL CHEM, V276, P41112, DOI 10.1074/jbc.M106209200; Gonzalez-Alegre P, 2004, J NEUROSCI, V24, P2593, DOI 10.1523/JNEUROSCI.4461-03.2004; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Goodchild RE, 2005, J CELL BIOL, V168, P855, DOI 10.1083/jcb.200411026; Goodchild RE, 2004, P NATL ACAD SCI USA, V101, P847, DOI 10.1073/pnas.0304375101; GORLICH D, 1992, CELL, V71, P489, DOI 10.1016/0092-8674(92)90517-G; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Hewett J, 2000, HUM MOL GENET, V9, P1403, DOI 10.1093/hmg/9.9.1403; Hewett JW, 2004, J NEUROCHEM, V89, P1186, DOI 10.1111/j.1471-4159.2004.02404.x; Heyden ABV, 2011, EMBO J, V30, P3217, DOI 10.1038/emboj.2011.233; Hurley JH, 2010, NAT REV MOL CELL BIO, V11, P556, DOI 10.1038/nrm2937; Jokhi V, 2013, CELL REP, V3, P988, DOI 10.1016/j.celrep.2013.03.015; Jones TR, 1996, P NATL ACAD SCI USA, V93, P11327, DOI 10.1073/pnas.93.21.11327; Jungwirth M, 2010, HUM MOL GENET, V19, P888, DOI 10.1093/hmg/ddp557; Kim CE, 2010, P NATL ACAD SCI USA, V107, P9861, DOI 10.1073/pnas.0912877107; Kustedjo K, 2000, J BIOL CHEM, V275, P27933; Lingwood D, 2009, J BIOL CHEM, V284, P12041, DOI 10.1074/jbc.M900220200; Mullins C., 2005, MOL BIOL INTELLIGENC; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Naismith TV, 2009, J BIOL CHEM, V284, P27866, DOI 10.1074/jbc.M109.020164; Naismith TV, 2004, P NATL ACAD SCI USA, V101, P7612, DOI 10.1073/pnas.0308760101; Nery FC, 2008, J CELL SCI, V121, P3476, DOI 10.1242/jcs.029454; Neuwald AF, 1999, GENOME RES, V9, P27; Ozelius LJ, 1997, NAT GENET, V17, P40, DOI 10.1038/ng0997-40; Shibata Y, 2009, ANNU REV CELL DEV BI, V25, P329, DOI 10.1146/annurev.cellbio.042308.113324; Smith DM, 2011, CELL, V144, P526, DOI 10.1016/j.cell.2011.02.005; Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020; TAKEI K, 1994, NEURON, V12, P327, DOI 10.1016/0896-6273(94)90275-5; Vander Heyden AB, 2009, MOL BIOL CELL, V20, P2661, DOI 10.1091/mbc.E09-01-0094; Voeltz GK, 2007, NAT REV MOL CELL BIO, V8, P258, DOI 10.1038/nrm2119; Yamamoto A, 1996, J CELL SCI, V109, P1727; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110; Zhao G, 2007, P NATL ACAD SCI USA, V104, P8785, DOI 10.1073/pnas.0702966104	40	26	29	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					552	564		10.1074/jbc.M113.515791	http://dx.doi.org/10.1074/jbc.M113.515791			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275647	hybrid, Green Published			2022-12-25	WOS:000329370900047
J	Nie, XB; Li, M; Lu, B; Zhang, YX; Lan, LH; Chen, L; Lu, JX				Nie, Xiaobo; Li, Min; Lu, Bin; Zhang, Yuxin; Lan, Linhua; Chen, Lin; Lu, Jianxin			Down-Regulating Overexpressed Human Lon in Cervical Cancer Suppresses Cell Proliferation and Bioenergetics	PLOS ONE			English	Article							ATP-DEPENDENT PROTEASE; HUMAN PAPILLOMA-VIRUS; PROTEOMIC ANALYSIS; MITOCHONDRIAL LON; EXPRESSION; PREVENTION; SURVIVAL; ROLES; GENE	The human mitochondrial ATP-dependent Lon protease functions in regulating the metabolism and quality control of proteins and mitochondrial DNA (mtDNA). However, the role of Lon in cancer is not well understood. Therefore, this study was undertaken to investigate the importance of Lon in cervical cancer cells from patients and in established cell lines. Microarray analysis from 30 cancer and 10 normal cervical tissues were analyzed by immunohistochemistry for Lon protein levels. The expression of Lon was also examined by immunoblotting 16 fresh cervical cancer tissues and their respective non-tumor cervical tissues. In all cases, Lon expression was significantly elevated in cervical carcinomas as compared to normal tissues. Augmented Lon expression in tissue microarrays did not vary between age, tumor-node-metastasis grades, or lymph node metastasis. Knocking down Lon in HeLa cervical cancer cells by lentivrial transduction resulted in a substantial decrease in both mRNA and protein levels. Such down-regulation of Lon expression significantly blocked HeLa cell proliferation. In addition, knocking down Lon resulted in decreased cellular bioenergetics as determined by measuring aerobic respiration and glycolysis using the Seahorse XF24 extracellular flux analyzer. Together, these data demonstrate that Lon plays a potential role in the oncogenesis of cervical cancer, and may be a useful biomarker and target in the treatment of cervical cancer. Lon; immunohistochemistry; cervical cancer; cell proliferation; cellular bioenergetics.	[Nie, Xiaobo; Lu, Bin; Zhang, Yuxin; Lan, Linhua; Chen, Lin; Lu, Jianxin] Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Sch Lab Med & Life Sci, Key Lab Lab Med,Minist Educ China, Wenzhou, Zhejiang, Peoples R China; [Nie, Xiaobo; Li, Min] Rutgers State Univ, New Jersey Med Sch, Dept Biochem & Mol Biol, Newark, NJ 07102 USA	Ministry of Education, China; Wenzhou Medical University; Rutgers State University Newark; Rutgers State University New Brunswick; Rutgers State University Medical Center	Lu, JX (corresponding author), Wenzhou Med Univ, Zhejiang Prov Key Lab Med Genet, Sch Lab Med & Life Sci, Key Lab Lab Med,Minist Educ China, Wenzhou, Zhejiang, Peoples R China.	jxlu313@163.com	Lu, Jianxin/E-4485-2015; Lu, Bin/GQQ-3590-2022; Nie, Xiaobo/HGC-1041-2022	Nie, Xiaobo/0000-0001-8117-4616; Lan, Linhua/0000-0002-6482-1508	Natural Science Foundation of China [31070710]; National Basic Research Program of China [2013CB531702]; Zhejiang provincial top key discipline of laboratory medicine; second wave of Zhejiang provincial program for the cultivation of high-level innovative health talents; key scientific and technological innovation team of clinical laboratory diagnostics of Zhejiang Province [604091155]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Basic Research Program of China(National Basic Research Program of China); Zhejiang provincial top key discipline of laboratory medicine; second wave of Zhejiang provincial program for the cultivation of high-level innovative health talents; key scientific and technological innovation team of clinical laboratory diagnostics of Zhejiang Province	The research work was supported by the Natural Science Foundation of China (grant number 31070710), National Basic Research Program of China (grant number 2013CB531702), the Zhejiang provincial top key discipline of laboratory medicine, the second wave of Zhejiang provincial program for the cultivation of high-level innovative health talents, and the key scientific and technological innovation team of clinical laboratory diagnostics of Zhejiang Province (604091155). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bansal M, 2012, AM J CLIN PATHOL, V137, P437, DOI 10.1309/AJCP9TO1OMXLDDPI; Bernstein SH, 2012, BLOOD, V119, P3321, DOI 10.1182/blood-2011-02-340075; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; Bota DA, 2005, FREE RADICAL BIO MED, V38, P665, DOI 10.1016/j.freeradbiomed.2004.11.017; Cheng CW, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.204; CHUNG CH, 1981, P NATL ACAD SCI-BIOL, V78, P4931, DOI 10.1073/pnas.78.8.4931; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Erjavec N, 2013, FREE RADICAL BIO MED, V56, P9, DOI 10.1016/j.freeradbiomed.2012.11.019; Fiander AN, 2011, WOMENS HEALTH, V7, P121, DOI 10.2217/WHE.10.74; Fukada K, 2004, MOL CELL PROTEOMICS, V3, P1211, DOI 10.1074/mcp.M400094-MCP200; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Ghittoni R, 2010, VIRUS GENES, V40, P1, DOI 10.1007/s11262-009-0412-8; GOARD CA, 2013, ONCOGENE, P70858; Granot Z, 2007, MOL ENDOCRINOL, V21, P2164, DOI 10.1210/me.2005-0458; Guillon B, 2009, FEBS J, V276, P1036, DOI 10.1111/j.1742-4658.2008.06847.x; Gupta SC, 2012, ANTIOXID REDOX SIGN, V16, P1295, DOI 10.1089/ars.2011.4414; Hori O, 2002, J CELL BIOL, V157, P1151, DOI 10.1083/jcb.200108103; Kikuchi M, 2004, J BIOL CHEM, V279, P421, DOI 10.1074/jbc.M305623200; Kim KK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0019049; Klaes R, 1999, CANCER RES, V59, P6132; Lu B, 2007, J BIOL CHEM, V282, P17363, DOI 10.1074/jbc.M611540200; Luciakova K, 1999, FEBS LETT, V444, P186, DOI 10.1016/S0014-5793(99)00058-7; MARX JL, 1986, SCIENCE, V231, P920, DOI 10.1126/science.3003916; Nakajima A, 2012, APPL ENVIRON MICROB, V78, P6251, DOI 10.1128/AEM.01039-12; Okumoto K, 2011, J BIOL CHEM, V286, P44367, DOI 10.1074/jbc.M111.285197; Park SC, 2006, MOL CELLS, V21, P129; Pinti M, 2011, MITOCHONDRION, V11, P200, DOI 10.1016/j.mito.2010.09.010; Rep M, 1996, SCIENCE, V274, P103, DOI 10.1126/science.274.5284.103; Samarzija I, 2012, BIOCHEM BIOPH RES CO, V425, P64, DOI 10.1016/j.bbrc.2012.07.051; SUZUKI CK, 1994, SCIENCE, V264, P891, DOI 10.1126/science.8178144; Tzenov YR, 2013, MOL CANCER RES, V11, P19, DOI 10.1158/1541-7786.MCR-12-0510; Venkatesh S, 2012, BBA-MOL CELL RES, V1823, P56, DOI 10.1016/j.bbamcr.2011.11.003; Wang HM, 2010, CANCER SCI, V101, P2612, DOI 10.1111/j.1349-7006.2010.01701.x; Wohlever ML, 2013, PROTEIN ENG DES SEL, V26, P299, DOI 10.1093/protein/gzs105; Xue Xia, 2007, Nan Fang Yi Ke Da Xue Xue Bao, V27, P870	36	39	42	2	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81084	10.1371/journal.pone.0081084	http://dx.doi.org/10.1371/journal.pone.0081084			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260536	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900113
J	Poulsen, SS; Jacobsen, NR; Labib, S; Wu, D; Husain, M; Williams, A; Bogelund, JP; Andersen, O; Kobler, C; Molhave, K; Kyjovska, ZO; Saber, AT; Wallin, H; Yauk, CL; Vogel, U; Halappanavar, S				Poulsen, Sarah Sos; Jacobsen, Nicklas R.; Labib, Sarah; Wu, Dongmei; Husain, Mainul; Williams, Andrew; Bogelund, Jesper P.; Andersen, Ole; Kobler, Carsten; Molhave, Kristian; Kyjovska, Zdenka O.; Saber, Anne T.; Wallin, Hakan; Yauk, Carole L.; Vogel, Ulla; Halappanavar, Sabina			Transcriptomic Analysis Reveals Novel Mechanistic Insight into Murine Biological Responses to Multi-Walled Carbon Nanotubes in Lungs and Cultured Lung Epithelial Cells	PLOS ONE			English	Article							IN-VITRO TOXICITY; ALVEOLAR FLUID CLEARANCE; GENE-EXPRESSION; RISK-ASSESSMENT; STATISTICAL DESIGN; MICROARRAY DATA; MOUSE LUNG; PULMONARY; VIVO; EXPOSURE	There is great interest in substituting animal work with in vitro experimentation in human health risk assessment; however, there are only few comparisons of in vitro and in vivo biological responses to engineered nanomaterials. We used high-content genomics tools to compare in vivo pulmonary responses of multiwalled carbon nanotubes (MWCNT) to those in vitro in cultured lung epithelial cells (FE1) at the global transcriptomic level. Primary size, surface area and other properties of MWCNT-XNRI -7 (Mitsui7) were characterized using DLS, SEM and TEM. Mice were exposed via a single intratracheal instillation to 18, 54, or 162 mu g of Mitsui7/mouse. FE1 cells were incubated with 12.5, 25 and 100 mu g/ml of Mitsui7. Tissue and cell samples were collected at 24 hours post-exposure. DNA microarrays were employed to establish mechanistic differences and similarities between the two models. Microarray results were confirmed using gene-specific RT-qPCR. Bronchoalveolar lavage (BAL) fluid was assessed for indications of inflammation in vivo. A strong dose-dependent activation of acute phase and inflammation response was observed in mouse lungs reflective mainly of an inflammatory response as observed in BAL. In vitro, a wide variety of core cellular functions were affected including transcription, cell cycle, and cellular growth and proliferation. Oxidative stress, fibrosis and inflammation processes were altered in both models. Although there were similarities observed between the two models at the pathway-level, the specific genes altered under these pathways were different, suggesting that the underlying mechanisms of responses are different in cells in culture and the lung tissue. Our results suggest that careful consideration should be given in selecting relevant endpoints when substituting animal with in vitro testing.	[Poulsen, Sarah Sos; Jacobsen, Nicklas R.; Kyjovska, Zdenka O.; Saber, Anne T.; Wallin, Hakan] Natl Res Ctr Working Environm, Copenhagen, Denmark; [Labib, Sarah; Wu, Dongmei; Husain, Mainul; Williams, Andrew; Yauk, Carole L.; Halappanavar, Sabina] Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON K1A 0L2, Canada; [Bogelund, Jesper P.] Danish Technol Inst, Taastrup, Denmark; [Poulsen, Sarah Sos; Andersen, Ole] Roskilde Univ, Dept Sci Syst & Models, Roskilde, Denmark; [Kobler, Carsten; Molhave, Kristian; Vogel, Ulla] Tech Univ Denmark, Dept Micro & Nanotechnol, DK-2800 Lyngby, Denmark; [Wallin, Hakan] Univ Copenhagen, Dept Publ Hlth, Copenhagen, Denmark	National Research Centre for the Working Environment; Health Canada; Roskilde University; Technical University of Denmark; University of Copenhagen	Halappanavar, S (corresponding author), Hlth Canada, Environm & Radiat Hlth Sci Directorate, Ottawa, ON K1A 0L2, Canada.	sabina.halappanavar@hc-sc.gc.ca	Vogel, Ulla/ABC-2212-2020; Molhave, Kristian/B-9209-2008; Wallin, Håkan/I-6459-2012; Mølhave, Kristian/AAP-5837-2020; Vogel, Ulla B/I-5048-2012	Vogel, Ulla/0000-0001-6807-1524; Molhave, Kristian/0000-0002-6493-2750; Wallin, Håkan/0000-0001-7716-0166; Mølhave, Kristian/0000-0002-6493-2750; Vogel, Ulla B/0000-0001-6807-1524; Yauk, Carole/0000-0002-6725-3454; Jacobsen, Nicklas Raun/0000-0002-2504-2229; Williams, Andrew/0000-0002-7637-7686; Yauk, Carole/0000-0003-4919-876X	National Research Centre for the Working Environment in Denmark; Danish NanoSafety Center [20110092173-3]; Health Canada; Genomics Research and Development Initiative	National Research Centre for the Working Environment in Denmark; Danish NanoSafety Center; Health Canada; Genomics Research and Development Initiative	The project was supported by grants from the National Research Centre for the Working Environment in Denmark and the Danish NanoSafety Center, grant# 20110092173-3, and Health Canada's Chemical Management Plan-2 Nano research funds and Genomics Research and Development Initiative. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlt VM, 2008, MUTAGENESIS, V23, P483, DOI 10.1093/mutage/gen037; Aschberger K, 2010, CRIT REV TOXICOL, V40, P759, DOI 10.3109/10408444.2010.506638; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Berndt-Weis ML, 2009, TOXICOL IN VITRO, V23, P816, DOI 10.1016/j.tiv.2009.04.008; Bourdon JA, 2012, TOXICOL SCI, V127, P474, DOI 10.1093/toxsci/kfs119; Bourdon JA, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-5; Button B, 2008, RESP PHYSIOL NEUROBI, V163, P189, DOI 10.1016/j.resp.2008.04.020; Choi JY, 2009, ENVIRON SCI TECHNOL, V43, P3030, DOI 10.1021/es802388s; Chou CC, 2008, NANO LETT, V8, P437, DOI 10.1021/nl0723634; Cui XG, 2005, BIOSTATISTICS, V6, P59, DOI 10.1093/biostatistics/kxh018; Davis IC, 2007, AM J RESP CELL MOL, V37, P379, DOI 10.1165/rcmb.2007-0142OC; Davis IC, 2006, AM J RESP CRIT CARE, V173, P673, DOI 10.1164/rccm.200508-1200OC; Dresselhaus MS, 2004, PHILOS T R SOC A, V362, P2065, DOI 10.1098/rsta.2004.1430; Echtay KS, 2002, NATURE, V415, P96, DOI 10.1038/415096a; Echtay KS, 2002, J BIOL CHEM, V277, P47129, DOI 10.1074/jbc.M208262200; GLEICH GJ, 1984, ANNU REV IMMUNOL, V2, P429, DOI 10.1146/annurev.immunol.2.1.429; Goodnight JH, 1978, LEAST SQUARES MEANS; Halappanavar S, 2011, ENVIRON MOL MUTAGEN, V52, P425, DOI 10.1002/em.20639; Han B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017236; Han JH, 2008, INHAL TOXICOL, V20, P741, DOI [10.1080/08958370801942238, 10.1080/08958370801942238 ]; Han XL, 2012, TOXICOLOGY, V297, P1, DOI 10.1016/j.tox.2012.03.006; Horie M, 2011, J OCCUP HEALTH, V53, P64, DOI 10.1539/joh.L10121; Husain M, 2013, TOXICOL APPL PHARM, V269, P250, DOI 10.1016/j.taap.2013.03.018; Jackson P, 2012, NANOTOXICOLOGY, V6, P486, DOI 10.3109/17435390.2011.587902; Jacobsen NR, 2008, MUTAT RES-FUND MOL M, V641, P54, DOI 10.1016/j.mrfmmm.2008.03.001; Jacobsen NR, 2007, ENVIRON MOL MUTAGEN, V48, P451, DOI 10.1002/em.20300; Jacobsen NR, 2011, ENVIRON MOL MUTAGEN, V52, P331, DOI 10.1002/em.20629; Jacobsen NR, 2009, PART FIBRE TOXICOL, V6, DOI 10.1186/1743-8977-6-2; John AE, 2003, FASEB J, V17, P2296, DOI 10.1096/fj.03-0166fje; Johnston HJ, 2010, NANOTOXICOLOGY, V4, P207, DOI 10.3109/17435390903569639; Johnston HJ, 2010, CRIT REV TOXICOL, V40, P328, DOI 10.3109/10408440903453074; Kerr MK, 2007, GENET RES, V89, P509, DOI 10.1017/S0016672308009713; Kerr MK, 2003, BIOMETRICS, V59, P822; Kerr MK, 2001, GENET RES, V77, P123; Ma Q, 2010, PHARMACOL THERAPEUT, V125, P376, DOI 10.1016/j.pharmthera.2009.11.004; Ma-Hock L, 2009, TOXICOL SCI, V112, P468, DOI 10.1093/toxsci/kfp146; Maertens RM, 2013, TOXICOLOGY, V308, P60, DOI 10.1016/j.tox.2013.03.008; Maurer-Jones MA, 2012, J LAW MED ETHICS, V40, P795, DOI 10.1111/j.1748-720X.2012.00707.x; Mercer RR, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-21; Mitchell LA, 2007, TOXICOL SCI, V100, P203, DOI 10.1093/toxsci/kfm196; Nasibulin AG, 2007, NAT NANOTECHNOL, V2, P156, DOI 10.1038/nnano.2007.37; Nel A, 2006, SCIENCE, V311, P622, DOI 10.1126/science.1114397; Park MVDZ, 2009, NANOMEDICINE-UK, V4, P669, DOI 10.2217/nnm.09.40; Pauluhn J, 2010, REGUL TOXICOL PHARM, V57, P78, DOI 10.1016/j.yrtph.2009.12.012; Pauluhn J, 2010, TOXICOL SCI, V113, P226, DOI 10.1093/toxsci/kfp247; Poland CA, 2008, NAT NANOTECHNOL, V3, P423, DOI 10.1038/nnano.2008.111; Porter DW, 2010, TOXICOLOGY, V269, P136, DOI 10.1016/j.tox.2009.10.017; R Development Core Team, 2009, R FDN STAT COMP; Reddy ARN, 2012, ENVIRON TOXICOL, V27, P211, DOI 10.1002/tox.20632; Saber AT, 2012, NANOTOXICOLOGY, V6, P453, DOI 10.3109/17435390.2011.587900; Saber AT, 2012, NANOTOXICOLOGY, V6, P776, DOI 10.3109/17435390.2011.620745; Saber AT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069020; Saber AT, 2012, PART FIBRE TOXICOL, V9, DOI 10.1186/1743-8977-9-4; Sayes CM, 2007, NANO LETT, V7, P2399, DOI 10.1021/nl0710710; Sayes CM, 2007, TOXICOL SCI, V97, P163, DOI 10.1093/toxsci/kfm018; Seagrave J, 2005, EXP TOXICOL PATHOL, V57, P233, DOI 10.1016/j.etp.2005.05.011; SEARLE SR, 1980, AM STAT, V34, P216, DOI 10.2307/2684063; Snyder-Talkington BN, 2012, J TOXICOL ENV HEAL B, V15, P468, DOI 10.1080/10937404.2012.736856; Takagi A, 2008, J TOXICOL SCI, V33, P105, DOI 10.2131/jts.33.105; Takagi A, 2012, CANCER SCI, V103, P1440, DOI 10.1111/j.1349-7006.2012.02318.x; Wang X, 2011, ACS NANO, V5, P9772, DOI 10.1021/nn2033055; Wang XJ, 2011, PART FIBRE TOXICOL, V8, DOI 10.1186/1743-8977-8-24; Warheit DB, 2009, ENVIRON SCI TECHNOL, V43, P7939, DOI 10.1021/es901453p; White PA, 2003, ENVIRON MOL MUTAGEN, V42, P166, DOI 10.1002/em.10185; Wolk KE, 2008, AM J RESP CRIT CARE, V178, P969, DOI 10.1164/rccm.200803-455OC; Wu H., 2003, ANAL GENE EXPRESSION, P313, DOI DOI 10.1007/0-387-21679-0_14; Yamashita K, 2010, INFLAMMATION, V33, P276, DOI 10.1007/s10753-010-9182-7; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yauk CL, 2012, ENVIRON MOL MUTAGEN, V53, P281, DOI 10.1002/em.21689	69	64	65	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80452	10.1371/journal.pone.0080452	http://dx.doi.org/10.1371/journal.pone.0080452			25	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260392	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900066
J	Yang, L; Wang, WB; Hu, L; Yang, XX; Zhong, J; Li, Z; Yang, H; Lei, H; Yu, HJ; Liao, ZK; Zhou, FX; Xie, CH; Zhou, YF				Yang, Lei; Wang, Wenbo; Hu, Liu; Yang, Xiaoxi; Zhong, Juan; Li, Zheng; Yang, Hui; Lei, Han; Yu, Haijun; Liao, ZhengKai; Zhou, Fuxiang; Xie, Conghua; Zhou, Yunfeng			Telomere-Binding Protein TPP1 Modulates Telomere Homeostasis and Confers Radioresistance to Human Colorectal Cancer Cells	PLOS ONE			English	Article							DYSFUNCTION; LENGTH; ATM; RADIATION; SENSITIVITY; EXPRESSION; POT1; RADIOSENSITIZATION; ABNORMALITIES; PROTECTION	Background: Radiotherapy is one of the major therapeutic strategies in cancer treatment. The telomere-binding protein TPP1 is an important component of the shelterin complex at mammalian telomeres. Our previous reports showed that TPP1 expression was elevated in radioresistant cells, but the exact effects and mechanisms of TPP1 on radiosensitivity is unclear. Principal Findings: In this study, we found that elevated TPP1 expression significantly correlated with radioresistance and longer telomere length in human colorectal cancer cell lines. Moreover, TPP1 overexpression showed lengthened telomere length and a significant decrease of radiosensitivity to X-rays. TPP1 mediated radioresistance was correlated with a decreased apoptosis rate after IR exposure. Furthermore, TPP1 overexpression showed prolonged G2/M arrest mediated by ATM/ATR-Chk1 signal pathway after IR exposure. Moreover, TPP1 overexpression accelerated the repair kinetics of total DNA damage and telomere dysfunction induced by ionizing radiation. Conclusions: We demonstrated that elevated expressions of TPP1 in human colorectal cancer cells could protect telomere from DNA damage and confer radioresistance. These results suggested that TPP1 may be a potential target in the radiotherapy of colorectal cancer.	[Yang, Lei; Wang, Wenbo; Hu, Liu; Yang, Xiaoxi; Li, Zheng; Yang, Hui; Lei, Han; Yu, Haijun; Liao, ZhengKai; Zhou, Fuxiang; Xie, Conghua; Zhou, Yunfeng] Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China; [Lei, Han; Yu, Haijun; Liao, ZhengKai; Zhou, Fuxiang; Xie, Conghua; Zhou, Yunfeng] Wuhan Univ, Zhongnan Hosp, Dept Radiat Oncol & Med Oncol, Wuhan 430072, Peoples R China; [Zhong, Juan] Fifth Hosp Wuhan, Dept Oncol, Wuhan, Peoples R China	Wuhan University; Wuhan University	Zhou, YF (corresponding author), Wuhan Univ, Zhongnan Hosp, Hubei Key Lab Tumor Biol Behav, Hubei Canc Clin Study Ctr, Wuhan 430072, Peoples R China.	yfzhouwhu@163.com			National Natural Science Foundation of China [81071825]; Ministry of Education of China [20120141130010]; Fundamental Research Funds for the Central Universities	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Ministry of Education of China(Ministry of Education, China); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the National Natural Science Foundation of China (No. 81071825), the Doctoral Fund of Ministry of Education of China (No. 20120141130010) and the Fundamental Research Funds for the Central Universities. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abreu E, 2010, MOL CELL BIOL, V30, P2971, DOI 10.1128/MCB.00240-10; Alao JP, 2009, RADIAT ONCOL, V4, DOI 10.1186/1748-717X-4-51; Asmis TR, 2008, GASTROENTEROL CLIN N, V37, P287, DOI 10.1016/j.gtc.2007.12.005; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; Borst GR, 2013, INT J RADIAT ONCOL, V85, P1110, DOI 10.1016/j.ijrobp.2012.08.006; Boukamp P, 2005, J INVEST DERM SYMP P, V10, P89, DOI 10.1111/j.1087-0024.2005.200401.x; Cabuy E, 2005, RADIAT RES, V164, P53, DOI 10.1667/RR3376; de Lange T, 2005, GENE DEV, V19, P2100, DOI 10.1101/gad.1346005; de Lange T, 2002, ONCOGENE, V21, P532, DOI 10.1038/sj.onc.1205080; Fujii K, 2008, INT J MOL MED, V21, P599; Genesca A, 2006, BIOESSAYS, V28, P1172, DOI 10.1002/bies.20501; Gilley D, 2005, INT J BIOCHEM CELL B, V37, P1000, DOI 10.1016/j.biocel.2004.09.003; Gomez-Millan J, 2007, INT J RADIAT ONCOL, V67, P897, DOI 10.1016/j.ijrobp.2006.09.038; Guo X, 2007, EMBO J, V26, P4709, DOI 10.1038/sj.emboj.7601893; Hoffe SE, 2010, CANCER CONTROL, V17, P25, DOI 10.1177/107327481001700104; Hurley PJ, 2007, CELL CYCLE, V6, P414, DOI 10.4161/cc.6.4.3886; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kim YM, 2012, INT J RADIAT ONCOL, V83, pE399, DOI 10.1016/j.ijrobp.2012.01.001; Kim YM, 2011, DNA CELL BIOL, V30, P219, DOI 10.1089/dna.2010.1141; Kondo T, 2004, CANCER RES, V64, P523, DOI 10.1158/0008-5472.CAN-03-1196; Liu D, 2004, NAT CELL BIOL, V6, P673, DOI 10.1038/ncb1142; Ma HX, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020466; McIlrath J, 2001, CANCER RES, V61, P912; Nandakumar J, 2012, NATURE, V492, P285, DOI 10.1038/nature11648; Rainey MD, 2008, CANCER RES, V68, P7466, DOI 10.1158/0008-5472.CAN-08-0763; Sfeir A, 2012, SCIENCE, V336, P593, DOI 10.1126/science.1218498; Soler D, 2005, GENE CHROMOSOME CANC, V44, P339, DOI 10.1002/gcc.20244; Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6; Tang T, 2009, ONCOL REP, V21, P1505, DOI 10.3892/or_00000381; Tribius S, 2001, INT J RADIAT ONCOL, V50, P511, DOI 10.1016/S0360-3016(01)01489-4; Wong KK, 2000, NAT GENET, V26, P85, DOI 10.1038/79232; Ye JZS, 2004, GENE DEV, V18, P1649, DOI 10.1101/gad.1215404; Zhang Y, 2013, P NATL ACAD SCI USA, V110, P5457, DOI 10.1073/pnas.1217733110; Zhong YH, 2008, BIOCHEM BIOPH RES CO, V367, P84, DOI 10.1016/j.bbrc.2007.12.078; Zhou FX, 2007, BIOCHEM BIOPH RES CO, V354, P351, DOI 10.1016/j.bbrc.2006.12.180	35	14	15	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81034	10.1371/journal.pone.0081034	http://dx.doi.org/10.1371/journal.pone.0081034			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260532	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900110
J	Miliara, S; Gkouskou, KK; Sharp, TV; Eliopoulos, AG				Miliara, Sophia; Gkouskou, Kalliopi K.; Sharp, Tyson V.; Eliopoulos, Aristides G.			SUMOylation Is Required for Optimal TRAF3 Signaling Capacity	PLOS ONE			English	Article							HERPES-SIMPLEX ENCEPHALITIS; GROWTH-FACTOR RECEPTOR; FACTOR-KAPPA-B; MULTIPLE-MYELOMA; CD40; SUMO; UBIQUITIN; CELLS; LMP1; DEGRADATION	TNF receptor-associated factors (TRAFs) are multifunctional adaptor proteins involved in temporal and spatial coordination of signals necessary for normal immune function. Here, we report that TRAF3, a TRAF family member with a key role in Tolllike and TNF family receptor signaling and suppressor of lymphomagenesis, is post-translationally modified by the small ubiquitin-related modifier (SUMO). Through yeast two-hybrid and co-immunoprecipitation assays we have identified Ubc9, the SUMO conjugating enzyme, as a novel TRAF3-interacting protein. We show that Ubc9-dependent SUMOylation of TRAF3 modulates optimal association with the CD40 receptor, thereby influencing TRAF3 degradation and non-canonical NF-kappa B activation upon CD40 triggering. Collectively, our findings describe a novel post-translational modification of a TRAF family member and reveal a link between SUMOylation and TRAF-mediated signal transduction.	[Miliara, Sophia; Gkouskou, Kalliopi K.; Eliopoulos, Aristides G.] Univ Crete, Sch Med, Mol & Cellular Biol Lab, Iraklion, Greece; [Miliara, Sophia; Gkouskou, Kalliopi K.; Eliopoulos, Aristides G.] Fdn Res & Technol Hellas, Inst Mol Biol & Biotechnol, Canc Biol Lab, Iraklion, Greece; [Sharp, Tyson V.] Queen Mary Univ London, Barts Canc Inst, London, England	University of Crete; Foundation for Research & Technology - Hellas (FORTH); University of London; Queen Mary University London	Eliopoulos, AG (corresponding author), Univ Crete, Sch Med, Mol & Cellular Biol Lab, Iraklion, Greece.	eliopag@imbb.forth.gr	ELIOPOULOS, ARISTIDES/R-9449-2018; ELIOPOULOS, ARISTIDES/ABI-6632-2020; Sharp, Tyson/AAD-6190-2020; Gkouskou, Kalliopi/AAY-4666-2021	ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; ELIOPOULOS, ARISTIDES/0000-0002-6403-6761; Sharp, Tyson/0000-0003-1861-7984; 	EC [037344, 223151, 285948]	EC(European CommissionEuropean Commission Joint Research Centre)	This work was supported by the European Commission FP6 and FP7 programmes Apotherapy (EC contract number 037344), INFLA-CARE (EC contract number 223151) and 'Translational Potential' (TransPOT; EC contract number 285948) to Aristides Eliopoulos. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aizawa S, 1997, J BIOL CHEM, V272, P2042; Akiba H, 1998, J BIOL CHEM, V273, P13353, DOI 10.1074/jbc.273.21.13353; Annunziata CM, 2007, CANCER CELL, V12, P115, DOI 10.1016/j.ccr.2007.07.004; Arch RH, 1998, MOL CELL BIOL, V18, P558, DOI 10.1128/MCB.18.1.558; Brown KD, 2001, J EXP MED, V193, P943, DOI 10.1084/jem.193.8.943; CHENG GH, 1995, SCIENCE, V267, P1494, DOI 10.1126/science.7533327; Coope HJ, 2002, EMBO J, V21, P5375, DOI 10.1093/emboj/cdf542; Davies CC, 2005, MOL CELL BIOL, V25, P9806, DOI 10.1128/MCB.25.22.9806-9819.2005; de Diego RP, 2010, IMMUNITY, V33, P400, DOI 10.1016/j.immuni.2010.08.014; Eliopoulos AG, 2001, SEMIN CANCER BIOL, V11, P435, DOI 10.1006/scbi.2001.0410; Eliopoulos AG, 1996, ONCOGENE, V13, P2243; Gardam S, 2008, IMMUNITY, V28, P391, DOI 10.1016/j.immuni.2008.01.009; Geoffroy MC, 2009, NAT REV MOL CELL BIO, V10, P564, DOI 10.1038/nrm2707; GYURIS J, 1993, CELL, V75, P791, DOI 10.1016/0092-8674(93)90498-F; Hacker H, 2006, NATURE, V439, P204, DOI 10.1038/nature04369; He JQ, 2006, J EXP MED, V203, P2413, DOI 10.1084/jem.20061166; Hong SY, 2000, J BIOL CHEM, V275, P18022, DOI 10.1074/jbc.M001202200; Hostager BS, 2003, J BIOL CHEM, V278, P45382, DOI 10.1074/jbc.M306708200; HU HM, 1994, J BIOL CHEM, V269, P30069; Keats JJ, 2007, CANCER CELL, V12, P131, DOI 10.1016/j.ccr.2007.07.003; Knox PG, 2011, J CELL BIOL, V192, P391, DOI 10.1083/jcb.201003087; Lallemand-Breitenbach V, 2008, NAT CELL BIOL, V10, P547, DOI 10.1038/ncb1717; Liao GX, 2004, J BIOL CHEM, V279, P26243, DOI 10.1074/jbc.M403286200; Lin X, 2003, J BIOL CHEM, V278, P31043, DOI 10.1074/jbc.C300112200; Loskog ASI, 2009, SEMIN IMMUNOL, V21, P301, DOI 10.1016/j.smim.2009.07.001; Matsuzawa A, 2008, SCIENCE, V321, P663, DOI 10.1126/science.1157340; MOSIALOS G, 1995, CELL, V80, P389, DOI 10.1016/0092-8674(95)90489-1; Muller S, 2001, NAT REV MOL CELL BIO, V2, P202, DOI 10.1038/35056591; Praefcke GJK, 2012, TRENDS BIOCHEM SCI, V37, P23, DOI 10.1016/j.tibs.2011.09.002; Sancho-Shimizu V, 2011, J CLIN INVEST, V121, P4889, DOI 10.1172/JCI59259; Schimmel J, 2008, MOL CELL PROTEOMICS, V7, P2107, DOI 10.1074/mcp.M800025-MCP200; STAMENKOVIC I, 1989, EMBO J, V8, P1403, DOI 10.1002/j.1460-2075.1989.tb03521.x; Stewart R, 2007, J IMMUNOL, V179, P2705, DOI 10.4049/jimmunol.179.5.2705; Tatham MH, 2008, NAT CELL BIOL, V10, P538, DOI 10.1038/ncb1716; Tatham MH, 2009, NAT PROTOC, V4, P1363, DOI 10.1038/nprot.2009.128; Ulrich HD, 2008, MOL CELL, V32, P301, DOI 10.1016/j.molcel.2008.10.010; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; van Eyndhoven WG, 1998, MOL IMMUNOL, V35, P1189, DOI 10.1016/S0161-5890(98)00099-6; VanArsdale TL, 1997, P NATL ACAD SCI USA, V94, P2460, DOI 10.1073/pnas.94.6.2460; Widagdo J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049283; Zhu S, 2010, ONCOGENE, V29, P1763, DOI 10.1038/onc.2009.459	41	3	3	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80470	10.1371/journal.pone.0080470	http://dx.doi.org/10.1371/journal.pone.0080470			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260396	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500141
J	Sampson, MG; Gillies, CE; Ju, WJ; Kretzler, M; Kang, HM				Sampson, Matthew G.; Gillies, Christopher E.; Ju, Wenjun; Kretzler, Matthias; Kang, Hyun Min			Gene-level Integrated Metric of negative Selection (GIMS) Prioritizes Candidate Genes for Nephrotic Syndrome	PLOS ONE			English	Article							FOCAL SEGMENTAL GLOMERULOSCLEROSIS; KIDNEY-DISEASE; MUTATIONS; VARIANTS	Nephrotic syndrome (NS) gene discovery efforts are now occurring in small kindreds and cohorts of sporadic cases. Power to identify causal variants in these groups beyond a statistical significance threshold is challenging due to small sample size and/or lack of family information. There is a need to develop novel methods to identify NS-associated variants. One way to determine putative functional relevance of a gene is to measure its strength of negative selection, as variants in genes under strong negative selection are more likely to be deleterious. We created a gene-level, integrated metric of negative selection (GIMS) score for 20,079 genes by combining multiple comparative genomics and population genetics measures. To understand the utility of GIMS for NS gene discovery, we examined this score in a diverse set of NS-relevant gene sets. These included genes known to cause monogenic forms of NS in humans as well as genes expressed in the cells of the glomerulus and, particularly, the podocyte. We found strong negative selection in the following NS-relevant gene sets: (1) autosomal-dominant Mendelian focal segmental glomerulosclerosis (FSGS) genes (p= 0.03 compared to reference), (2) glomerular expressed genes (p = 4x10(-23)), and (3) predicted podocyte genes (p = 3x10(-9)). Eight genes causing autosomal dominant forms of FSGS had a stronger combined score of negative selection and podocyte enrichment as compared to all other genes (p= 1 x 10(-3)). As a whole, recessive FSGS genes were not enriched for negative selection. Thus, we also created a transcript-level, integrated metric of negative selection (TIMS) to quantify negative selection on an isoform level. These revealed transcripts of known autosomal recessive disease-causing genes that were nonetheless under strong selection. We suggest that a filtering strategy that includes measuring negative selection on a gene or isoform level could aid in identifying NS-related genes. Our GIMS and TIMS scores are available at http://glom.sph.umich.edu/GIMS/.	[Sampson, Matthew G.; Gillies, Christopher E.; Ju, Wenjun; Kretzler, Matthias; Kang, Hyun Min] Univ Michigan, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Sampson, MG (corresponding author), Univ Michigan, Ann Arbor, MI 48109 USA.	mgsamps@med.umich.edu; hmkang@umich.edu	; Sampson, Matthew/U-4501-2017	Ju, Wenjun/0000-0002-9136-8454; Sampson, Matthew/0000-0001-9560-076X	NIDDK NIH HHS [P30 DK081943] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK081943] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Adzhubei IA, 2010, NAT METHODS, V7, P248, DOI 10.1038/nmeth0410-248; Akilesh S, 2011, J CLIN INVEST, V121, P4127, DOI 10.1172/JCI46458; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Barua M, 2012, KIDNEY INT; Blekhman R, 2008, CURR BIOL, V18, P883, DOI 10.1016/j.cub.2008.04.074; Bustamante CD, 2001, GENETICS, V159, P1779; D'Agati VD, 2011, NEW ENGL J MED, V365, P2398, DOI 10.1056/NEJMra1106556; Davydov EV, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1001025; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Genovese G, 2010, SCIENCE, V329, P841, DOI 10.1126/science.1193032; Has C, 2012, NEW ENGL J MED, V366, P1508, DOI 10.1056/NEJMoa1110813; Heeringa SF, 2011, J CLIN INVEST, V121, P2013, DOI 10.1172/JCI45693; Hogg R, 2007, PEDIATR NEPHROL, V22, P183, DOI 10.1007/s00467-006-0370-5; Jin WF, 2012, HUM MOL GENET, V21, P1611, DOI 10.1093/hmg/ddr599; Ju WJ, 2013, GENOME RES, V23, P1862, DOI 10.1101/gr.155697.113; Lemley KV, 2009, PEDIATR NEPHROL, V24, P2345, DOI 10.1007/s00467-008-0836-8; Liu XM, 2011, HUM MUTAT, V32, P894, DOI 10.1002/humu.21517; MacArthur DG, 2012, SCIENCE, V335, P823, DOI 10.1126/science.1215040; Machuca E, 2009, KIDNEY INT, V75, P727, DOI 10.1038/ki.2008.650; McCarthy HJ, 2013, CLIN J AM SOC NEPHRO, V8, P637, DOI 10.2215/CJN.07200712; McGrogan A, 2011, NEPHROL DIAL TRANSPL, V26, P414, DOI 10.1093/ndt/gfq665; Mele C, 2011, NEW ENGL J MED, V365, P295, DOI 10.1056/NEJMoa1101273; Ozaltin F, 2011, AM J HUM GENET, V89, P139, DOI 10.1016/j.ajhg.2011.05.026; Pollard KS, 2010, GENOME RES, V20, P110, DOI 10.1101/gr.097857.109; Rood IM, 2012, NEPHROL DIAL TRANSPL, V27, P882, DOI 10.1093/ndt/gfr771; Tennessen JA, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-9-127; Yasuda Yoshinari, 2006, Clin Exp Nephrol, V10, P91, DOI 10.1007/s10157-006-0421-z; Zhao ZM, 2003, GENE, V312, P207, DOI 10.1016/S0378-1119(03)00670-X	28	7	7	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81062	10.1371/journal.pone.0081062	http://dx.doi.org/10.1371/journal.pone.0081062			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260533	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500193
J	Zou, YN; Wu, QS; Huang, YM; Ni, QD; He, XH				Zou, Ying-Ning; Wu, Qiang-Sheng; Huang, Yong-Ming; Ni, Qiu-Dan; He, Xin-Hua			Mycorrhizal-Mediated Lower Proline Accumulation in Poncirus trifoliata under Water Deficit Derives from the Integration of Inhibition of Proline Synthesis with Increase of Proline Degradation	PLOS ONE			English	Article							DROUGHT STRESS; ARBUSCULAR MYCORRHIZA; OSMOTIC ADJUSTMENT; CITRUS; FUNGI; GROWTH; PLANTS; RESPONSES; SEEDLINGS; AMINOTRANSFERASE	Proline accumulation was often correlated with drought tolerance of plants infected by arbuscular mycorrhizal fungi (AMF), whereas lower proline in some AM plants including citrus was also found under drought stress and the relevant mechanisms have not been fully elaborated. In this study proline accumulation and activity of key enzymes relative to proline biosynthesis (Delta(1)-pyrroline-5-carboxylate synthetase, P5CS; ornithine-delta-aminotransferase, OAT) and degradation (proline dehydrogenase, ProDH) were determined in trifoliate orange (Poncirus trifoliata, a widely used citrus rootstock) inoculated with or without Funneliformis mosseae and under well-watered (WW) or water deficit (WD). AMF colonization significantly increased plant height, stem diameter, leaf number, root volume, biomass production of both leaves and roots and leaf relative water content, irrespectively of water status. Water deficit induced more tissue proline accumulation, in company with an increase of P5CS activity, but a decrease of OAT and ProDH activity, no matter whether under AM or no-AM. Compared with no-AM treatment, AM treatment resulted in lower proline concentration and content in leaf, root, and total plant under both WW and WD. The AMF colonization significantly decreased the activity of both P5CS and OAT in leaf, root, and total plant under WW and WD, except for an insignificant difference of root OAT under WD. The AMF inoculation also generally increased tissue ProDH activity under WW and WD. Plant proline content significantly positively correlated with plant P5CS activity, negatively with plant ProDH activity, but not with plant OAT activity. These results suggest that AM plants may suffer less from WD, thereby inducing lower proline accumulation, which derives from the integration of an inhibition of proline synthesis with an enhancement of proline degradation.	[Zou, Ying-Ning; Wu, Qiang-Sheng; Huang, Yong-Ming; Ni, Qiu-Dan] Yangtze Univ, Coll Hort & Gardening, Jinzhou, Peoples R China; [He, Xin-Hua] NSW Dept Primary Ind, West Pennant Hills, NSW, Australia; [He, Xin-Hua] Univ Western Australia, Sch Plant Biol, Crawley, WA, Australia	Yangtze University; NSW Department of Primary Industries; University of Western Australia	Wu, QS (corresponding author), Yangtze Univ, Coll Hort & Gardening, Jinzhou, Peoples R China.	wuqiangsh@163.com; xinhua.he@uwa.edu.au	He, Xinhua/B-8047-2015; Wu, Qiang-Sheng/A-1956-2012	He, Xinhua/0000-0002-5570-3454; Wu, Qiang-Sheng/0000-0002-3405-8409	National Natural Science Foundation of China [31101513, 31372017]; Natural Science Foundation of Hubei Province [2012FFA001]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Hubei Province(Natural Science Foundation of Hubei Province)	This study was supported by the National Natural Science Foundation of China (31101513; 31372017) and the Key Project Program of Natural Science Foundation of Hubei Province (2012FFA001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbaspour H, 2012, J PLANT PHYSIOL, V169, P704, DOI 10.1016/j.jplph.2012.01.014; Auge RM, 2001, MYCORRHIZA, V11, P3, DOI 10.1007/s005720100097; Augu RM., 2005, MYCORRHIZA ROLE APPL, P136; Azcon R, 1996, BIOL FERT SOILS, V22, P156, DOI 10.1007/BF00384448; Bajji M, 2001, PLANT SCI, V160, P669, DOI 10.1016/S0168-9452(00)00443-X; Banuelos J, 2012, J SOIL SCI PLANT NUT, V12, P263, DOI 10.4067/S0718-95162012000200006; BATES LS, 1973, PLANT SOIL, V39, P205, DOI 10.1007/BF00018060; Doubkova P, 2013, PLANT SOIL, V370, P149, DOI 10.1007/s11104-013-1610-7; Fan QJ, 2011, ACTA PHYSIOL PLANT, V33, P1533, DOI 10.1007/s11738-011-0789-6; Farooq M., 2012, PLANT RESPONSES DROU, P1; Fidelibus MW, 2001, MYCORRHIZA, V10, P231, DOI 10.1007/s005720000084; Funck D, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-40; Goicoechea N, 2000, EUR J PLANT PATHOL, V106, P19, DOI 10.1023/A:1008724816041; Hayashi F, 2000, PLANT CELL PHYSIOL, V41, P1096, DOI 10.1093/pcp/pcd036; HAYZER DJ, 1980, J GEN MICROBIOL, V118, P287; KIM HR, 1994, ANAL BIOCHEM, V223, P205, DOI 10.1006/abio.1994.1574; Ku HM, 2011, PLANT PHYSIOL BIOCH, V49, P1147, DOI 10.1016/j.plaphy.2011.07.003; LEVY Y, 1980, NEW PHYTOL, V85, P25, DOI 10.1111/j.1469-8137.1980.tb04444.x; Manoharan PT, 2010, EUR J SOIL BIOL, V46, P151, DOI 10.1016/j.ejsobi.2010.01.001; PHILLIPS JM, 1970, T BRIT MYCOL SOC, V55, P158, DOI 10.1016/S0007-1536(70)80110-3; Porcel R, 2004, PHYSIOL MOL PLANT P, V65, P211, DOI 10.1016/j.pmpp.2005.02.003; Porcel R, 2004, J EXP BOT, V55, P1743, DOI 10.1093/jxb/erh188; Ramanjulu S, 2000, J PLANT PHYSIOL, V157, P81, DOI 10.1016/S0176-1617(00)80139-X; Ruiz-Sanchez M, 2011, J PLANT PHYSIOL, V168, P1031, DOI 10.1016/j.jplph.2010.12.019; Sanchez-Calderon L, 2013, ABIOTIC STRESS - PLANT RESPONSES AND APPLICATIONS IN AGRICULTURE, P135, DOI 10.5772/55043; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Szabados L, 2010, TRENDS PLANT SCI, V15, P89, DOI 10.1016/j.tplants.2009.11.009; Verslues Paul E, 2010, Arabidopsis Book, V8, pe0140, DOI 10.1199/tab.0140; Wu QS, 2007, ACTA PHYSIOL PLANT, V29, P543, DOI 10.1007/s11738-007-0065-y; Wu QS, 2006, J PLANT PHYSIOL, V163, P1101, DOI 10.1016/j.jplph.2005.09.001; Wu QS, 2011, SCI HORTIC-AMSTERDAM, V129, P294, DOI 10.1016/j.scienta.2011.03.051; Wu QiangSheng, 2006, Acta Horticulturae Sinica, V33, P613; Wu QS, 2008, EUR J SOIL BIOL, V44, P122, DOI 10.1016/j.ejsobi.2007.10.001; Wu QS, 2006, J PLANT PHYSIOL, V163, P417, DOI 10.1016/j.jplph.2005.04.024; Yang F, 2009, BIOL PLANTARUM, V53, P511, DOI 10.1007/s10535-009-0092-1; Yooyongwech S, 2013, PLANT GROWTH REGUL, V69, P285, DOI 10.1007/s10725-012-9771-6; Zeze A, 2007, AFR J BIOTECHNOL, V6, P1524; [赵福庚 Zhao Fugeng], 2002, [植物生理与分子生物学学报, Journal of Plant Physiology and Molecular Biology], V28, P117; Zhu XC, 2011, J FOOD AGRIC ENVIRON, V9, P583	39	26	26	1	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80568	10.1371/journal.pone.0080568	http://dx.doi.org/10.1371/journal.pone.0080568			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260421	Green Submitted, gold, Green Published			2022-12-25	WOS:000327308500155
J	Atalah, J; Hopkins, GA; Forrest, BM				Atalah, Javier; Hopkins, Grant A.; Forrest, Barrie M.			Augmentative Biocontrol in Natural Marine Habitats: Persistence, Spread and Non-Target Effects of the Sea Urchin Evechinus chloroticus	PLOS ONE			English	Article							KELP UNDARIA-PINNATIFIDA; BIOLOGICAL-CONTROL; NEW-ZEALAND; CAULERPA-TAXIFOLIA; ECHINODERMATA; BIODIVERSITY; HERBIVORES; MANAGEMENT; ABUNDANCE; PATTERNS	Augmentative biocontrol aims to control established pest populations through enhancement of their indigenous enemies. To our knowledge, this approach has not been applied at an operational scale in natural marine habitats, in part because of the perceived risk of adverse non-target effects on native ecosystems. In this paper, we focus on the persistence, spread and non-target effects of the sea urchin Evechinus chloroticus when used as biocontrol agent to eradicate an invasive kelp from Fiordland, New Zealand. Rocky reef macrobenthic assemblages were monitored over 17 months in areas where the indigenous algal canopy was either removed or left intact prior to the translocation of a large number of urchins (> 50 ind.center dot m(-2)). Urchin densities in treated areas significantly declined similar to 9 months after transplant, and began spreading to adjacent sites. At the end of the 17-month study, densities had declined to similar to 5 ind.center dot m(-2). Compared to controls, treatment sites showed persistent shifts from kelp forest to urchin barrens, which were accompanied by significant reductions in taxa richness. Although these non-target effects were pronounced, they were considered to be localised and reversible, and arguably outweigh the irreversible and more profound ecological impacts associated with the establishment of an invasive species in a region of high conservation value. Augmentative biocontrol, used in conjunction with traditional control methods, represents a promising tool for the integrated management of marine pests.	[Atalah, Javier; Hopkins, Grant A.; Forrest, Barrie M.] Cawthron Inst, Nelson, New Zealand	Cawthron Institute	Atalah, J (corresponding author), Cawthron Inst, Nelson, New Zealand.	javier.atalah@cawthron.org.nz	Atalah, Javier/AAV-9077-2021	Atalah, Javier/0000-0003-0625-3431	National Institute of Water and Atmospheric Research (NIWA) under Coasts and Oceans Research Programme 4 - Marine Biosecurity [2012/13 SCI]	National Institute of Water and Atmospheric Research (NIWA) under Coasts and Oceans Research Programme 4 - Marine Biosecurity	This research was funded by National Institute of Water and Atmospheric Research (NIWA) under Coasts and Oceans Research Programme 4 - Marine Biosecurity (2012/13 SCI). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson LWJ, 2007, BOT MAR, V50, P418, DOI 10.1515/BOT.2007.045; Anderson LWJ, 2005, BIOL INVASIONS, V7, P1003, DOI 10.1007/s10530-004-3123-z; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; ANDREW NL, 1988, NEW ZEAL J MAR FRESH, V22, P415, DOI 10.1080/00288330.1988.9516313; Atalah J, 2011, 7 INT C MAR BIOINV B; AYLING AM, 1981, ECOLOGY, V62, P830, DOI 10.2307/1937749; Babcock RC, 1999, MAR ECOL PROG SER, V189, P125, DOI 10.3354/meps189125; Bax N, 2001, CONSERV BIOL, V15, P1234, DOI 10.1046/j.1523-1739.2001.99487.x; Bulleri F, 2011, MAR ECOL PROG SER, V431, P55, DOI 10.3354/meps09137; Carver CE, 2003, J SHELLFISH RES, V22, P621; CHOAT JH, 1982, J EXP MAR BIOL ECOL, V60, P129, DOI 10.1016/0022-0981(82)90155-1; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coma R, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022017; Conklin EJ, 2005, BIOL INVASIONS, V7, P1029, DOI 10.1007/s10530-004-3125-x; Coquillard P, 2000, ECOL MODEL, V135, P1, DOI 10.1016/S0304-3800(00)00342-2; Coutts ADM, 2007, J EXP MAR BIOL ECOL, V342, P154, DOI 10.1016/j.jembe.2006.10.042; Dijkstra J, 2007, J EXP MAR BIOL ECOL, V342, P169, DOI 10.1016/j.jembe.2006.10.035; DIX T G, 1972, New Zealand Journal of Marine and Freshwater Research, V6, P48; DIX T G, 1970, New Zealand Journal of Marine and Freshwater Research, V4, P267; Ebeling A.W., 1988, Ecological Studies, V65, P169; Edelist D, 2013, DIVERS DISTRIB, V19, P69, DOI 10.1111/ddi.12002; Eilenberg J, 2001, BIOCONTROL, V46, P387, DOI 10.1023/A:1014193329979; ESTES JA, 1995, ECOL MONOGR, V65, P75, DOI 10.2307/2937159; Fiordland Marine Guardians website, 2011, ANN REP YEAR END 30; Gibbs MT, 2000, ESTUAR COAST SHELF S, V51, P683, DOI 10.1006/ecss.2000.0716; Hajek A.E., 2004, NATURAL ENEMIES INTR; Halekoh U, 2006, J STAT SOFTW, V15, P1, DOI 10.18637/jss.v015.i02; Heimpel GE, 2011, BIOCONTROL, V56, P441, DOI 10.1007/s10526-011-9381-7; Hewitt CL, 2005, BIOL INVASIONS, V7, P251, DOI 10.1007/s10530-004-0739-y; Hopkins GA, 2011, J APPL ECOL, V48, P424, DOI 10.1111/j.1365-2664.2010.01941.x; Hopper KR, 2001, PUBLICATIONS USDAARS; Hunt L., 2009, RESULTS ATTEMPT CONT; Kohler KE, 2006, COMPUT GEOSCI-UK, V32, P1259, DOI 10.1016/j.cageo.2005.11.009; Lafferty KD, 1996, ECOLOGY, V77, P1989, DOI 10.2307/2265695; Lamare MD, 1998, MAR ECOL PROG SER, V174, P107, DOI 10.3354/meps174107; Lawrence J.M., 1975, Oceanography mar Biol, V13, P213; LAWRENCE JM, 1975, J EXP MAR BIOL ECOL, V18, P271, DOI 10.1016/0022-0981(75)90111-2; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lodeiros C, 2004, AQUACULTURE, V231, P293, DOI 10.1016/j.aquaculture.2003.10.022; Murdoch WW, 1996, ECOLOGY, V77, P2001, DOI 10.2307/2265696; Nelson WA, 2002, MARINE MACROALGAE FI, P117; Pan W, 2001, BIOMETRICS, V57, P120, DOI 10.1111/j.0006-341X.2001.00120.x; Piola RF, 2010, BIOFOULING, V26, P187, DOI 10.1080/08927010903428029; Piola Richard F., 2009, P205; Poore AGB, 2012, ECOL LETT, V15, P912, DOI 10.1111/j.1461-0248.2012.01804.x; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Ruiz GM, 1999, LIMNOL OCEANOGR, V44, P950, DOI 10.4319/lo.1999.44.3_part_2.0950; Scheibling RE, 1997, MAR ECOL PROG SER, V152, P155, DOI 10.3354/meps152155; SCHIEL DR, 1982, OECOLOGIA, V54, P379, DOI 10.1007/BF00380007; Secord D, 2003, BIOL INVASIONS, V5, P117, DOI 10.1023/A:1024054909052; Shears Nick T., 2007, Science for Conservation (Wellington), V280, P1; Shears NT, 2003, MAR ECOL PROG SER, V246, P1, DOI 10.3354/meps246001; Simberloff D, 1996, ECOLOGY, V77, P1965, DOI 10.2307/2265693; Steneck RS, 2002, ENVIRON CONSERV, V29, P436, DOI 10.1017/S0376892902000322; Strayer DL, 2006, TRENDS ECOL EVOL, V21, P645, DOI 10.1016/j.tree.2006.07.007; Switzer SE, 2011, AQUACULTURE, V318, P145, DOI 10.1016/j.aquaculture.2011.04.044; Tait LW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026986; Thomas MB, 1998, TRENDS ECOL EVOL, V13, P325, DOI 10.1016/S0169-5347(98)01417-7; Valentine JP, 2005, MAR ECOL PROG SER, V285, P43, DOI 10.3354/meps285043; Villouta E, 2000, CONSERVATION ADVISOR, V286; Wernberg T, 2011, J EXP MAR BIOL ECOL, V400, P264, DOI 10.1016/j.jembe.2011.02.017; Wing SR, 2010, BIOL MONITORING FIOR, P94; [No title captured]	63	13	13	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80365	10.1371/journal.pone.0080365	http://dx.doi.org/10.1371/journal.pone.0080365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260376	gold, Green Submitted, Green Published			2022-12-25	WOS:000327258600060
J	Busnelli, M; Manzini, S; Froio, A; Vargiolu, A; Cerrito, MG; Smolenski, RT; Giunti, M; Cinti, A; Zannoni, A; Leone, BE; Forni, M; Bacci, ML; Biasi, GM; Giovannoni, R; Lavitrano, M				Busnelli, Marco; Manzini, Stefano; Froio, Alberto; Vargiolu, Alessia; Cerrito, Maria Grazia; Smolenski, Ryszard T.; Giunti, Massimo; Cinti, Alessandro; Zannoni, Augusta; Leone, Biagio Eugenio; Forni, Monica; Bacci, Maria Laura; Biasi, Giorgio Maria; Giovannoni, Roberto; Lavitrano, Marialuisa			Diet Induced Mild Hypercholesterolemia in Pigs: Local and Systemic Inflammation, Effects on Vascular Injury - Rescue by High-Dose Statin Treatment	PLOS ONE			English	Article							ADIPOSE-TISSUE INFLAMMATION; NITRIC-OXIDE; HEME OXYGENASE-1; MOUSE MODELS; CHOLESTEROL; ATHEROSCLEROSIS; LIVER; INHIBITION; EXPRESSION; DISEASE	Objective: The aim of the present study was to comprehensively evaluate systemic and local inflammation as well as progression of vascular inflammation in normal and mechanically injured vessels in a large animal model of mild hypercholesterolemia. Our aim was also to test the effect of high-dose statin treatment on these processes. Methods: Pigs were kept for 120 days on a standard diet (SD, n=7), high-cholesterol diet (HCD, n=7) or highcholesterol diet with Atorvastatin starting after 50 days (STATIN, n=7). Left carotid artery balloon injury was conducted in all groups after 60 days of diet treatment. Biochemical analysis together with evaluation of blood and tissue markers of vascular injury and inflammation were performed in all groups at the end of experiment. Results: HCD compared to SD induced systemic inflammation demonstrated by increased number of circulating monocytes and lymphocytes. HCD compared to SD induced also local inflammation demonstrated by adipocyte hypertrophy and infiltration of T-lymphocytes in abdominal white adipose tissue, activation of hepatic stellate cells with infiltration of T-and B-lymphocytes and macrophages in the liver and increased macrophage content in lung parenchyma. These changes were accompanied by increased Intima/Media thickness, stenosis, matrix deposition and activated T-cell infiltrates in injured but not in uninjured contralateral carotid artery as we previously reported. The treatment with high-dose statin attenuated all aspects of systemic and local inflammation as well as pathological changes in injured carotid artery. Conclusions: Diet related mild hypercholesterolemia induce systemic and local inflammation in the liver, lung and adipose tissue that coincide with enhanced inflammation of injured vessel but is without deleterious effect on uninjured vessels. High dose statin attenuated systemic and local inflammation and protected injured vessels. However, finding exact role of reduced systemic and remote inflammation in vascular protection requires further studies.	[Busnelli, Marco; Manzini, Stefano; Froio, Alberto; Vargiolu, Alessia; Cerrito, Maria Grazia; Smolenski, Ryszard T.; Cinti, Alessandro; Leone, Biagio Eugenio; Biasi, Giorgio Maria; Giovannoni, Roberto; Lavitrano, Marialuisa] Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, Milan, Italy; [Smolenski, Ryszard T.] Med Univ Gdansk, Dept Biochem, Gdansk, Poland; [Giunti, Massimo; Zannoni, Augusta; Forni, Monica; Bacci, Maria Laura] Univ Bologna, Dept Vet Med Sci, Bologna, Italy	University of Milano-Bicocca; Fahrenheit Universities; Medical University Gdansk; University of Bologna	Lavitrano, M (corresponding author), Univ Milano Bicocca, Dept Surg & Interdisciplinary Med, Milan, Italy.	marialuisa.lavitrano@unimib.it	Cerrito, Maria Grazia/AAA-1190-2019; Busnelli, Marco/AAO-6981-2021; Giovannoni, Roberto/A-1413-2009; Manzini, Stefano/H-7123-2014; LEONE, BIAGIO EUGENIO/J-8803-2018	Cerrito, Maria Grazia/0000-0002-3347-5817; Busnelli, Marco/0000-0003-3245-2872; Giovannoni, Roberto/0000-0002-7706-0672; Manzini, Stefano/0000-0002-1232-2635; Forni, Monica/0000-0003-1310-6202; Bacci, Maria Laura/0000-0001-6702-5868; Lavitrano, Marialuisa/0000-0003-4852-1318; Smolenski, Ryszard/0000-0002-0190-9414; LEONE, BIAGIO EUGENIO/0000-0002-6978-2405	Ministero della Ricerca e dell'Universita [PRIN2004-2004060070, PRIN2004-2004060070_002, FIRB-RBAP06LAHL]; University of Milano-Bicocca	Ministero della Ricerca e dell'Universita(Ministry of Education, Universities and Research (MIUR)); University of Milano-Bicocca	This work was supported by the Ministero della Ricerca e dell'Universita [PRIN2004-2004060070 to ML, PRIN2004-2004060070_002 to GMB., FIRB-RBAP06LAHL to ML]; and the University of Milano-Bicocca [F. A. R. 2007 and 2008 to ML]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Shawwa B, 2006, J ASTHMA, V43, P231, DOI 10.1080/02770900600567056; Ali F, 2009, J BIOL CHEM, V284, P18882, DOI 10.1074/jbc.M109.009886; Busnelli M, 2009, ATHEROSCLEROSIS, V207, P384, DOI 10.1016/j.atherosclerosis.2009.05.022; Cerrito MG, 2011, BIOL PHARM BULL, V34, P1204, DOI 10.1248/bpb.34.1204; Combadiere C, 2008, CIRCULATION, V117, P1649, DOI 10.1161/CIRCULATIONAHA.107.745091; Della-Morte D, 2011, NEUROL RES, V33, P991, DOI 10.1179/1743132811Y.0000000039; Dimitrova Y, 2003, J THROMB HAEMOST, V1, P2290, DOI 10.1046/j.1538-7836.2003.00412.x; Dixon JL, 1999, ARTERIOSCL THROM VAS, V19, P2981, DOI 10.1161/01.ATV.19.12.2981; Drechsler M, 2010, CIRCULATION, V122, P1837, DOI 10.1161/CIRCULATIONAHA.110.961714; Duewell P, 2010, NATURE, V464, P1357, DOI 10.1038/nature08938; Greenwood J, 2006, NAT REV IMMUNOL, V6, P358, DOI 10.1038/nri1839; Gregor MF, 2011, ANNU REV IMMUNOL, V29, P415, DOI 10.1146/annurev-immunol-031210-101322; Han KH, 2005, CIRCULATION, V111, P1439, DOI 10.1161/01.CIR.0000158484.18024.1F; Heeba G, 2009, BRIT J PHARMACOL, V156, P1256, DOI 10.1111/j.1476-5381.2009.00125.x; Hoffman M, 2004, ATHEROSCLEROSIS, V172, P1, DOI 10.1016/S0021-9150(03)00164-3; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Kadoglou NPE, 2010, J VASC SURG, V51, P114, DOI 10.1016/j.jvs.2009.07.119; Kainuma M, 2006, J GASTROENTEROL, V41, P971, DOI 10.1007/s00535-006-1883-1; Kintscher U, 2008, ARTERIOSCL THROM VAS, V28, P1304, DOI 10.1161/ATVBAHA.108.165100; Koruk M, 2003, J CLIN GASTROENTEROL, V37, P177, DOI 10.1097/00004836-200308000-00017; Lanthier N, 2009, CURR OPIN CLIN NUTR, V12, P404, DOI 10.1097/MCO.0b013e32832c7819; Li Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057130; Lohmann C, 2009, ATHEROSCLEROSIS, V207, P360, DOI 10.1016/j.atherosclerosis.2009.05.004; Madjid M, 2004, J AM COLL CARDIOL, V44, P1945, DOI 10.1016/j.jacc.2004.07.056; Mulhaupt F, 2003, CARDIOVASC RES, V59, P755, DOI 10.1016/S0008-6363(03)00515-7; Napoli C, 2006, NITRIC OXIDE-BIOL CH, V15, P265, DOI 10.1016/j.niox.2006.03.011; Naura AS, 2009, LAB INVEST, V89, P1243, DOI 10.1038/labinvest.2009.98; Ohman MK, 2008, CIRCULATION, V117, P798, DOI 10.1161/CIRCULATIONAHA.107.717595; Ouchi N, 2011, NAT REV IMMUNOL, V11, P85, DOI 10.1038/nri2921; SCHOUTEN JA, 1985, LAB ANIM, V19, P98, DOI 10.1258/002367785780942598; Stanton MC, 2011, J INFLAMM-LOND, V8, DOI 10.1186/1476-9255-8-8; Subramanian S, 2008, ARTERIOSCL THROM VAS, V28, P685, DOI 10.1161/ATVBAHA.107.157685; Sultan A, 2009, CIRC RES, V104, P961, DOI 10.1161/CIRCRESAHA.108.190280; Swirski FK, 2007, J CLIN INVEST, V117, P195, DOI 10.1172/JCI29950; Tani S, 2009, AM J CARDIOL, V104, P464, DOI 10.1016/j.amjcard.2009.04.009; Tellez A, 2010, ATHEROSCLEROSIS, V213, P518, DOI 10.1016/j.atherosclerosis.2010.09.021; Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937; Tous M, 2006, BIOCHEM BIOPH RES CO, V340, P1078, DOI 10.1016/j.bbrc.2005.12.109; Wallace K, 2008, BIOCHEM J, V411, P1, DOI 10.1042/BJ20071570; Wouters K, 2008, HEPATOLOGY, V48, P474, DOI 10.1002/hep.22363; Yoon SS, 2010, J ATHEROSCLER THROMB, V17, P1176, DOI 10.5551/jat.5652; Zadelaar S, 2007, ARTERIOSCL THROM VAS, V27, P1706, DOI 10.1161/ATVBAHA.107.142570	42	20	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80588	10.1371/journal.pone.0080588	http://dx.doi.org/10.1371/journal.pone.0080588			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260430	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600073
J	Henriques, ST; Thorstholm, L; Huang, YH; Getz, JA; Daugherty, PS; Craik, DJ				Henriques, Sonia Troeira; Thorstholm, Louise; Huang, Yen-Hua; Getz, Jennifer A.; Daugherty, Patrick S.; Craik, David J.			A Novel Quantitative Kinase Assay Using Bacterial Surface Display and Flow Cytometry	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASES; PROTEIN-KINASES; BCR-ABL; INHIBITORS; DISCOVERY; LESSONS; CHIP	The inhibition of tyrosine kinases is a successful approach for the treatment of cancers and the discovery of kinase inhibitor drugs is the focus of numerous academic and pharmaceutical laboratories. With this goal in mind, several strategies have been developed to measure kinase activity and to screen novel tyrosine kinase inhibitors. Nevertheless, a general nonradioactive and inexpensive approach, easy to implement and adapt to a range of applications, is still missing. Herein, using Bcr-Abl tyrosine kinase, an oncogenic target and a model protein for cancer studies, we describe a novel cost-effective highthroughput screening kinase assay. In this approach, named the BacKin assay, substrates displayed on a Bacterial cell surface are incubated with Kinase and their phosphorylation is examined and quantified by flow cytometry. This approach has several advantages over existing approaches, as using bacteria (i. e. Escherichia coli) to display peptide substrates provides a self renewing solid support that does not require laborious chemical strategies. Here we show that the BacKin approach can be used for kinetic and mechanistic studies, as well as a platform to characterize and identify small-molecule or peptidebased kinase inhibitors with potential applications in drug development.	[Henriques, Sonia Troeira; Thorstholm, Louise; Huang, Yen-Hua; Craik, David J.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia; [Getz, Jennifer A.; Daugherty, Patrick S.] Univ Calif Santa Barbara, Dept Chem Engn, Santa Barbara, CA 93106 USA	University of Queensland; University of California System; University of California Santa Barbara	Henriques, ST (corresponding author), Univ Queensland, Inst Mol Biosci, Brisbane, Qld, Australia.	s.henriques@imb.uq.edu.au	Huang, Yen-Hua/J-9056-2014; Henriques, Sonia Troeira/J-3500-2016; Craik, David/B-1695-2010	Huang, Yen-Hua/0000-0001-6937-2660; Henriques, Sonia Troeira/0000-0001-9564-9651; Craik, David/0000-0003-0007-6796	UQ Early Career Research; Australian Research Council [DE120103152]	UQ Early Career Research; Australian Research Council(Australian Research Council)	This research was supported by an UQ Early Career Research Grant to STH. STH is the recipient of a Discovery Early Career Researcher Award [DE120103152], awarded by the Australian Research Council. DJC is a National Health and Medical Research Council Professorial Fellow [ APP1026501]. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bixby Dale, 2009, Hematology Am Soc Hematol Educ Program, P461, DOI 10.1182/asheducation-2009.1.461; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; Bogoyevitch MA, 2005, BBA-PROTEINS PROTEOM, V1754, P79, DOI 10.1016/j.bbapap.2005.07.025; Buchdunger E, 1996, CANCER RES, V56, P100; Carmi C, 2012, BIOCHEM PHARMACOL, V84, P1388, DOI 10.1016/j.bcp.2012.07.031; Chapelat J, 2012, EUR J MED CHEM, V57, P1, DOI 10.1016/j.ejmech.2012.08.038; Chen H, 2012, J CHROMATOGR B, V897, P17, DOI 10.1016/j.jchromb.2012.04.001; Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Daugherty PS, 2007, CURR OPIN STRUC BIOL, V17, P474, DOI 10.1016/j.sbi.2007.07.004; Druker BJ, 2001, CANCER J, V7, pS14; Druker BJ, 2000, J CLIN INVEST, V105, P3, DOI 10.1172/JCI9083; FAINSTEIN E, 1987, NATURE, V330, P386, DOI 10.1038/330386a0; Fava C, 2012, CURR ONCOL REP, V14, P379, DOI 10.1007/s11912-012-0253-9; Gumireddy K, 2005, P NATL ACAD SCI USA, V102, P1992, DOI 10.1073/pnas.0408283102; Hughes T, 2006, BLOOD REV, V20, P29, DOI 10.1016/j.blre.2005.01.008; Inamori K, 2005, ANAL CHEM, V77, P3979, DOI 10.1021/ac050135t; Jain P, 2013, CURR TREAT OPTION ON, V14, P127, DOI 10.1007/s11864-013-0234-8; Ji LY, 2012, ANAL CHEM, V84, P2284, DOI 10.1021/ac202897u; Jia Yong, 2008, Curr Drug Discov Technol, V5, P59, DOI 10.2174/157016308783769414; Levitzki A, 2006, ANNU REV BIOCHEM, V75, P93, DOI 10.1146/annurev.biochem.75.103004.142657; Li YJ, 2008, ANAL BIOANAL CHEM, V390, P2049, DOI 10.1007/s00216-008-1986-z; Ma HC, 2008, EXPERT OPIN DRUG DIS, V3, P607, DOI 10.1517/17460441.3.6.607; Min DH, 2004, ANGEW CHEM INT EDIT, V43, P5973, DOI 10.1002/anie.200461061; Nagar B, 2002, CANCER RES, V62, P4236; Rice JJ, 2008, PROTEIN ENG DES SEL, V21, P435, DOI 10.1093/protein/gzn020; SONGYANG Z, 1995, NATURE, V373, P536, DOI 10.1038/373536a0; Westin JR, 2012, MOL CANCER THER, V11, P2549, DOI 10.1158/1535-7163.MCT-12-0473; Zhou GC, 2011, ANAL BIOCHEM, V408, P5, DOI 10.1016/j.ab.2010.08.034	29	13	13	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80474	10.1371/journal.pone.0080474	http://dx.doi.org/10.1371/journal.pone.0080474			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260399	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600064
J	Chen, MJ; Gunel, M; Zhao, HY				Chen, Mengjie; Gunel, Murat; Zhao, Hongyu			SomatiCA: Identifying, Characterizing and Quantifying Somatic Copy Number Aberrations from Cancer Genome Sequencing Data	PLOS ONE			English	Article							VARIANTS; IDENTIFICATION	Whole genome sequencing of matched tumor-normal sample pairs is becoming routine in cancer research. However, analysis of somatic copy-number changes from sequencing data is still challenging because of insufficient sequencing coverage, unknown tumor sample purity and subclonal heterogeneity. Here we describe a computational framework, named SomatiCA, which explicitly accounts for tumor purity and subclonality in the analysis of somatic copy-number profiles. Taking read depths (RD) and lesser allele frequencies (LAF) as input, SomatiCA will output 1) admixture rate for each tumor sample, 2) somatic allelic copy-number for each genomic segment, 3) fraction of tumor cells with subclonal change in each somatic copy number aberration (SCNA), and 4) a list of substantial genomic aberration events including gain, loss and LOH. SomatiCA is available as a Bioconductor R package at http://www.bioconductor.org/packages/2.13/bioc/html/SomatiCA.html.	[Chen, Mengjie] Yale Univ, Program Computat Biol & Bioinformat, New Haven, CT USA; [Gunel, Murat; Zhao, Hongyu] Yale Univ, Dept Genet, New Haven, CT 06520 USA; [Gunel, Murat] Yale Univ, Dept Neurosurg, New Haven, CT USA; [Zhao, Hongyu] Yale Univ, Dept Biostat, New Haven, CT USA	Yale University; Yale University; Yale University; Yale University	Zhao, HY (corresponding author), Yale Univ, Dept Genet, New Haven, CT 06520 USA.	hongyu.zhao@yale.edu			NIH [R01 GM59507]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059507] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported by the NIH grant R01 GM59507. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Abyzov A, 2011, GENOME RES, V21, P974, DOI 10.1101/gr.114876.110; Alkan C, 2011, NAT REV GENET, V12, P363, DOI 10.1038/nrg2958; Alkan C, 2009, NAT GENET, V41, P1061, DOI 10.1038/ng.437; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Boeva V, 2012, BIOINFORMATICS, V28, P423, DOI 10.1093/bioinformatics/btr670; Brennan C, 2011, CURR NEUROL NEUROSCI, V11, P291, DOI 10.1007/s11910-011-0198-7; Cai TT, 2012, J R STAT SOC B, V74, P773, DOI 10.1111/j.1467-9868.2012.01028.x; Carter SL, 2012, NAT BIOTECHNOL, V30, P413, DOI 10.1038/nbt.2203; Chiang DY, 2009, NAT METHODS, V6, P99, DOI [10.1038/nmeth.1276, 10.1038/NMETH.1276]; Diskin SJ, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn556; Efron B, 2004, ANN STAT, V32, P407, DOI 10.1214/009053604000000067; Gusnanto A, 2012, BIOINFORMATICS, V28, P40, DOI 10.1093/bioinformatics/btr593; Hormozdiari F, 2009, GENOME RES, V19, P1270, DOI 10.1101/gr.088633.108; Iqbal Z, 2012, NAT GENET, V44, P226, DOI 10.1038/ng.1028; Ivakhno S, 2010, BIOINFORMATICS, V26, P3051, DOI 10.1093/bioinformatics/btq587; Karakoc E, 2012, NAT METHODS, V9, P176, DOI [10.1038/NMETH.1810, 10.1038/nmeth.1810]; Korbel JO, 2007, P NATL ACAD SCI USA, V104, P10110, DOI 10.1073/pnas.0703834104; Larson NB, 2013, BIOINFORMATICS, V29, P1888, DOI 10.1093/bioinformatics/btt293; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Miller CA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016327; Muggeo VMR, 2011, BIOINFORMATICS, V27, P161, DOI 10.1093/bioinformatics/btq647; Nagode M, 2011, COMMUN STAT-THEOR M, V40, P876, DOI 10.1080/03610920903480890; Oesper L, 2013, GENOME BIOL, V14, DOI 10.1186/gb-2013-14-7-r80; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; Sathirapongsasuti JF, 2011, BIOINFORMATICS, V27, P2648, DOI 10.1093/bioinformatics/btr462; Su XP, 2012, BIOINFORMATICS, V28, P2265, DOI 10.1093/bioinformatics/bts365; Teo SM, 2012, BIOINFORMATICS, V28, P2711, DOI 10.1093/bioinformatics/bts535; Van Loo P, 2010, P NATL ACAD SCI USA, V107, P16910, DOI 10.1073/pnas.1009843107; Xi RB, 2011, P NATL ACAD SCI USA, V108, pE1128, DOI 10.1073/pnas.1110574108; Ye K, 2009, BIOINFORMATICS, V25, P2865, DOI 10.1093/bioinformatics/btp394; Yoon ST, 2009, GENOME RES, V19, P1586, DOI 10.1101/gr.092981.109	31	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78143	10.1371/journal.pone.0078143	http://dx.doi.org/10.1371/journal.pone.0078143			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265680	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100013
J	Cheng, N; Wang, YQ; Zhang, YF; Shi, B				Cheng, Ning; Wang, Yuanqin; Zhang, Yufeng; Shi, Bin			The Osteogenic Potential of Mesoporous Bioglasses/Silk and Non-Mesoporous Bioglasses/Silk Scaffolds in Ovariectomized Rats: In vitro and In vivo Evaluation	PLOS ONE			English	Article							BIOACTIVE GLASSES; BONE; SILK; DIFFERENTIATION; CALCIUM; BIOMATERIALS; OSTEOBLASTS; EXPRESSION; DELIVERY; SILICON	Silk-based scaffolds have been introduced to bone tissue regeneration for years, however, their local therapeutic efficency in bone metabolic disease condition has been seldom reported. According to our previous report, mesoporous bioactive glass (MBG)/silk scaffolds exhibits superior in vitro bioactivity and in vivo osteogenic properties compared to non-mesoporous bioactive glass (BG)/silk scaffolds, but no information could be found about their efficiency in osteoporotic (OVX) environment. This study investigated a biomaterial-based approach for improving MSCs behavior in vitro, and accelerating OVX defect healing by using 3D BG/silk and MBG/silk scaffolds, and pure silk scaffolds as control. The results of SEM, CCK-8 assay and quantitative ALP activity showed that MBG/silk scaffolds can improve attachment, proliferation and osteogenic differentiation of both O-MSCs and sham control. In vivo therapeutic efficiency was evaluated by mu CT analysis, hematoxylin and eosin staining, safranin O staining and tartrate-resistant acid phosphatase, indicating accelerated bone formation with compatible scaffold degradation and reduced osteoclastic response of defect healing in OVX rats after 2 and 4 weeks treatment, with a rank order of MBG/silk > BG/silk > silk group. Immunohistochemical markers of COL I, OPN, BSP and OCN also revealed that MBG/silk scaffolds can better induce accelerated collagen and non-collagen matrix production. The findings of this study suggest that MBG/silk scaffolds provide a better environment for cell attachment, proliferation and differentiation, and act as potential substitute for treating local osteoporotic defects.	[Shi, Bin] Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China; Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, Key Lab Oral Biomed, Wuhan 430072, Peoples R China	Wuhan University; Wuhan University	Shi, B (corresponding author), Wuhan Univ, Sch & Hosp Stomatol, Minist Educ, State Key Lab Breeding Base Basic Sci Stomatol Hu, Wuhan 430072, Peoples R China.	shibin_dentist@126.com	/AAW-5542-2020; Zhang, Yufeng/GZL-1973-2022	/0000-0002-1124-9093; 	National Natural Science Foundation of China [30700948, 81170992]; Fundamental Research Fund for the Central Universities [2012304274818]; NATIONAL CANCER INSTITUTE [F99CA223019] Funding Source: NIH RePORTER	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Fund for the Central Universities; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding for this study was provided by research grants from the National Natural Science Foundation of China (30700948) to Yufeng Zhang and (81170992) to Bin Shi, and the Fundamental Research Fund for the Central Universities (2012304274818) to Ning Cheng. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcaide M, 2010, ACTA BIOMATER, V6, P892, DOI 10.1016/j.actbio.2009.09.008; Bhardwaj N, 2012, BIOMATERIALS, V33, P2848, DOI 10.1016/j.biomaterials.2011.12.028; CARLISLE EM, 1970, SCIENCE, V167, P279, DOI 10.1126/science.167.3916.279; Day RM, 2004, BIOMATERIALS, V25, P5857, DOI 10.1016/j.biomaterials.2004.01.043; Ebneter A, 2010, INVEST OPHTH VIS SCI, V51, P6448, DOI 10.1167/iovs.10-5284; Egermann M, 2005, OSTEOPOROSIS INT, V16, pS129, DOI 10.1007/s00198-005-1859-7; Fan J, 2003, ANGEW CHEM INT EDIT, V42, P3146, DOI 10.1002/anie.200351027; Fernandes JC, 2008, MOL THER, V16, P1243, DOI 10.1038/mt.2008.99; He YX, 2011, BONE, V48, P1388, DOI 10.1016/j.bone.2011.03.720; Hench L. L., 1971, J BIOMED MATER RES, V5, P117, DOI DOI 10.1002/JBM.820050611; Hench LL, 2010, J R SOC INTERFACE, V7, pS379, DOI 10.1098/rsif.2010.0151.focus; Hench LL, 1998, BIOMATERIALS, V19, P1419, DOI 10.1016/S0142-9612(98)00133-1; Hench LL, 2004, J BIOMAT SCI-POLYM E, V15, P543, DOI 10.1163/156856204323005352; Hench LL, 2002, SCIENCE, V295, P1014, DOI 10.1126/science.1067404; Hoppe A, 2011, BIOMATERIALS, V32, P2757, DOI 10.1016/j.biomaterials.2011.01.004; Jugdaohsingh R, 2004, J BONE MINER RES, V19, P297, DOI 10.1359/JBMR.0301225; Karageorgiou V, 2005, BIOMATERIALS, V26, P5474, DOI 10.1016/j.biomaterials.2005.02.002; Kaunitz JD, 2008, J CELL BIOCHEM, V105, P655, DOI 10.1002/jcb.21885; KUNDU J, 2012, ACTA BIOMATER, P85428; LARRY LH, 2009, J EUR CERAM SOC, V29, P1257, DOI DOI 10.1016/J.JEURCERAMS0C.2008.08.002; Lopez-Noriega A, 2010, CHEM-EUR J, V16, P10879, DOI 10.1002/chem.201000137; Low KL, 2010, J BIOMED MATER RES B, V94B, P273, DOI 10.1002/jbm.b.31619; MANIATOPOULOS C, 1988, CELL TISSUE RES, V254, P317; Marie PJ, 2010, BONE, V46, P571, DOI 10.1016/j.bone.2009.07.082; Meghji S, 2001, AM J PHYSIOL-ENDOC M, V280, pE112, DOI 10.1152/ajpendo.2001.280.1.E112; Monfoulet L, 2010, CALCIFIED TISSUE INT, V86, P72, DOI 10.1007/s00223-009-9314-y; NIH Consensus Development Panel on Osteoporosis Prevention, 2001, SOUTH MED J, V94, P569, DOI DOI 10.1097/00007611-200106000-00005; Osathanon T, 2008, BIOMATERIALS, V29, P4091, DOI 10.1016/j.biomaterials.2008.06.030; Park SH, 2010, BIOMATERIALS, V31, P6162, DOI 10.1016/j.biomaterials.2010.04.028; Reffitt DM, 2003, BONE, V32, P127, DOI 10.1016/S8756-3282(02)00950-X; Rockwood DN, 2011, NAT PROTOC, V6, P1612, DOI 10.1038/nprot.2011.379; Sawyer AA, 2009, BIOMATERIALS, V30, P2479, DOI 10.1016/j.biomaterials.2008.12.055; Seib FP, 2012, BIOMATERIALS, V33, P1017, DOI 10.1016/j.biomaterials.2011.10.063; Turner A. Simon, 2001, European Cells & Materials, V1, P66; Vallet-Regi M, 2003, EUR J INORG CHEM, P1029; Vepari C, 2007, PROG POLYM SCI, V32, P991, DOI 10.1016/j.progpolymsci.2007.05.013; Wang SD, 2009, BIOMACROMOLECULES, V10, P2240, DOI 10.1021/bm900416b; Wittrant Y, 2009, BIOCHEM BIOPH RES CO, V381, P259, DOI 10.1016/j.bbrc.2009.02.034; Wray LS, 2011, J BIOMED MATER RES B, V99B, P89, DOI 10.1002/jbm.b.31875; Wu CT, 2008, ACTA BIOMATER, V4, P343, DOI 10.1016/j.actbio.2007.08.010; Wu CT, 2011, BIOMATERIALS, V32, P7068, DOI 10.1016/j.biomaterials.2011.06.009; Wu CT, 2011, ACTA BIOMATER, V7, P2229, DOI 10.1016/j.actbio.2010.12.019; Wu CT, 2010, BIOMATERIALS, V31, P3429, DOI 10.1016/j.biomaterials.2010.01.061; Xia W, 2006, J CONTROL RELEASE, V110, P522, DOI 10.1016/j.jconrel.2005.11.002; Xu S, 2008, BIOMATERIALS, V29, P2588, DOI 10.1016/j.biomaterials.2008.03.013; Yan XX, 2006, BIOMATERIALS, V27, P3396, DOI 10.1016/j.biomaterials.2006.01.043; Yan XX, 2004, ANGEW CHEM INT EDIT, V43, P5980, DOI 10.1002/anie.200460598; Zhang YF, 2012, BIOMATERIALS, V33, P6698, DOI 10.1016/j.biomaterials.2012.06.021; Zhang YF, 2010, BIOMATERIALS, V31, P2848, DOI 10.1016/j.biomaterials.2009.12.049	49	32	32	2	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e81014	10.1371/journal.pone.0081014	http://dx.doi.org/10.1371/journal.pone.0081014			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265840	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100176
J	Leveque, Y; Schon, D				Leveque, Yohana; Schoen, Daniele			Listening to the Human Voice Alters Sensorimotor Brain Rhythms	PLOS ONE			English	Article							SPEECH-PERCEPTION; MOTOR CORTEX; EEG EVIDENCE; MU-RHYTHMS; MIRROR; ACTIVATION; MODULATION; RESPONSES; AREAS; EXCITABILITY	While neuronal desynchronization in the mu ((approximate to)10Hz) and beta ((approximate to)20Hz) frequency bands has long been known to be an EEG index of sensorimotor activity, this method has rarely been employed to study auditory perception. In the present study, we measured mu and beta event-related desynchronisation (ERD) while participants were asked to listen to vocal and triangle-wave melodies and to sing them back. Results showed that mu and beta ERD began earlier and were stronger when listening to vocal compared to non-vocal melodies. Interestingly, this humanness effect was stronger for less accurate singers. These results show that voice perception favors an early involvement of motor representations.	[Leveque, Yohana] CNRS, Lab Parole & Langage, Aix En Provence, France; [Leveque, Yohana] Aix Marseille Univ, Aix En Provence, France; [Schoen, Daniele] CNRS, Inst Neurosci Cognit Mediterranee, Marseille, France; [Schoen, Daniele] Aix Marseille Univ, Marseille, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite; UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Aix-Marseille Universite	Leveque, Y (corresponding author), Inst Natl Sante & Rech Med Rhone Alpes, Equipe Dynam Cerebrale & Cognit, Ctr Rech Neurosci, Lyon, France.	yohana.leveque@inserm.fr	Schön, Daniele/B-2484-2013	Schön, Daniele/0000-0003-4472-4150; Leveque, Yohana/0000-0003-2210-2182	French Research Agency [ANR 09 BLAN 0310]	French Research Agency(French National Research Agency (ANR))	This work was supported by the French Research Agency (ANR 09 BLAN 0310 to D.S.). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alegre M, 2003, NEUROREPORT, V14, P381, DOI 10.1097/01.wnr.0000059624.96928.c0; Anderson KL, 2011, NEUROSCIENCE, V180, P165, DOI 10.1016/j.neuroscience.2011.02.004; Behmer LP, 2011, CLIN NEUROPHYSIOL, V122, P1342, DOI 10.1016/j.clinph.2010.12.035; Belin P, 2000, NATURE, V403, P309, DOI 10.1038/35002078; Brown S, 2008, CEREB CORTEX, V18, P837, DOI 10.1093/cercor/bhm131; Brown S, 2007, BRAIN COGNITION, V63, P59, DOI 10.1016/j.bandc.2006.08.006; Buccino G, 2004, J COGNITIVE NEUROSCI, V16, P114, DOI 10.1162/089892904322755601; Caetano G, 2007, P NATL ACAD SCI USA, V104, P9058, DOI 10.1073/pnas.0702453104; Calvo-Merino B, 2005, CEREB CORTEX, V15, P1243, DOI 10.1093/cercor/bhi007; Chang SE, 2009, NEUROIMAGE, V47, P314, DOI 10.1016/j.neuroimage.2009.03.032; Charest I, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-127; Cohen-Seat G., 1954, REV INT FILMOLOGIE, V5, P7; Costa M, 2004, MUSIC PERCEPT, V22, P1, DOI 10.1525/mp.2004.22.1.1; Crawcour S, 2009, NEUROPSYCHOLOGIA, V47, P2558, DOI 10.1016/j.neuropsychologia.2009.05.001; Cuellar M, 2012, INT J PSYCHOPHYSIOL, V85, P242, DOI 10.1016/j.ijpsycho.2012.04.003; De Lucia M, 2010, J NEUROSCI, V30, P11210, DOI 10.1523/JNEUROSCI.2239-10.2010; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Fadiga L, 2002, EUR J NEUROSCI, V15, P399, DOI 10.1046/j.0953-816x.2001.01874.x; Fujioka T, 2012, J NEUROSCI, V32, P1791, DOI 10.1523/JNEUROSCI.4107-11.2012; Galati G, 2008, NEUROIMAGE, V40, P1274, DOI 10.1016/j.neuroimage.2007.12.044; GASTAUT HJ, 1954, ELECTROEN CLIN NEURO, V6, P433, DOI 10.1016/0013-4694(54)90058-9; Gomez-Herrero G, 2007, UTOMATIC ARTIFACT RE; Granot R, 2004, P 8 INT C MUS PERC C; Gunji A, 2007, NEUROIMAGE, V34, P426, DOI 10.1016/j.neuroimage.2006.07.018; Hari R, 1998, P NATL ACAD SCI USA, V95, P15061, DOI 10.1073/pnas.95.25.15061; Hari R, 1997, TRENDS NEUROSCI, V20, P44, DOI 10.1016/S0166-2236(96)10065-5; Hickok G, 2000, TRENDS COGN SCI, V4, P131, DOI 10.1016/S1364-6613(00)01463-7; Hickok G, 2007, NAT REV NEUROSCI, V8, P393, DOI 10.1038/nrn2113; Hickok G, 2011, NEURON, V69, P407, DOI 10.1016/j.neuron.2011.01.019; Hickok G, 2009, J COGNITIVE NEUROSCI, V21, P1229, DOI 10.1162/jocn.2009.21189; Holz EM, 2008, BRAIN TOPOGR, V21, P93, DOI 10.1007/s10548-008-0066-1; Hutchins S, 2012, J EXP PSYCHOL GEN, V141, P76, DOI 10.1037/a0025064; Jones SR, 2010, J NEUROSCI, V30, P13760, DOI 10.1523/JNEUROSCI.2969-10.2010; Kessler K, 2006, NEUROIMAGE, V33, P227, DOI 10.1016/j.neuroimage.2006.06.014; Kilner JM, 2003, CURR BIOL, V13, P522, DOI 10.1016/S0960-9822(03)00165-9; Leveque Y, 2012, J VOICE, V26, P293, DOI 10.1016/j.jvoice.2011.04.001; Levy DA, 2001, NEUROREPORT, V12, P2653, DOI 10.1097/00001756-200108280-00013; LIBERMAN AM, 1985, COGNITION, V21, P1, DOI 10.1016/0010-0277(85)90021-6; Makeig S, 1996, ADV NEUR IN, V8, P145; Margulis EH, 2009, HUM BRAIN MAPP, V30, P267, DOI 10.1002/hbm.20503; McGarry LM, 2012, EXP BRAIN RES, V218, P527, DOI 10.1007/s00221-012-3046-3; Meyer M, 2005, COGNITIVE BRAIN RES, V24, P291, DOI 10.1016/j.cogbrainres.2005.02.008; Nishitani N, 2002, NEURON, V36, P1211, DOI 10.1016/S0896-6273(02)01089-9; Oberman LM, 2005, COGNITIVE BRAIN RES, V24, P190, DOI 10.1016/j.cogbrainres.2005.01.014; Pascual-Marqui RD, 2002, METHOD FIND EXP CLIN, V24, P91; PFURTSCHELLER G, 1989, ELECTROEN CLIN NEURO, V72, P250, DOI 10.1016/0013-4694(89)90250-2; PFURTSCHELLER G, 1979, ELECTROEN CLIN NEURO, V46, P138, DOI 10.1016/0013-4694(79)90063-4; Pineda JA, 2005, BRAIN RES REV, V50, P57, DOI 10.1016/j.brainresrev.2005.04.005; Pulvermuller F, 2006, P NATL ACAD SCI USA, V103, P7865, DOI 10.1073/pnas.0509989103; Pulvermuller F, 2010, NAT REV NEUROSCI, V11, P351, DOI 10.1038/nrn2811; Ritter P, 2009, HUM BRAIN MAPP, V30, P1168, DOI 10.1002/hbm.20585; SALMELIN R, 1994, ELECTROEN CLIN NEURO, V91, P237, DOI 10.1016/0013-4694(94)90187-2; Schon D, 2010, NEUROIMAGE, V51, P450, DOI 10.1016/j.neuroimage.2010.02.023; Stevens JA, 2000, NEUROREPORT, V11, P109, DOI 10.1097/00001756-200001170-00022; Tai YF, 2004, CURR BIOL, V14, P117, DOI 10.1016/j.cub.2004.01.005; Tamura T, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00225; Ulloa ER, 2007, BEHAV BRAIN RES, V183, P188, DOI 10.1016/j.bbr.2007.06.007; van Ede F, 2011, J NEUROSCI, V31, P2016, DOI 10.1523/JNEUROSCI.5630-10.2011; Warren JE, 2006, J NEUROSCI, V26, P13067, DOI 10.1523/JNEUROSCI.3907-06.2006; Watkins K, 2004, J COGNITIVE NEUROSCI, V16, P978, DOI 10.1162/0898929041502616; Watts CR, 2008, LOGOP PHONIATR VOCO, V33, P74, DOI 10.1080/14015430802028434; Wilson SM, 2004, NAT NEUROSCI, V7, P701, DOI 10.1038/nn1263; Wilson SM, 2006, NEUROIMAGE, V33, P316, DOI 10.1016/j.neuroimage.2006.05.032	63	11	11	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80659	10.1371/journal.pone.0080659	http://dx.doi.org/10.1371/journal.pone.0080659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265836	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100172
J	Malik, C; Ghosh, S				Malik, Chetan; Ghosh, Subhendu			S6 Peptide Derived from KvAP Channel Shows Cooperativity in Gating on Bilayer Lipid Membrane	PLOS ONE			English	Article							GAP-JUNCTION CHANNELS; COLLECTIVE BEHAVIOR; ION CHANNELS; K+-CHANNEL; RYANODINE RECEPTORS; POTASSIUM CHANNEL; ACTIVATION; SEGMENT; MODEL; GATE	Collective behavior of S6 peptide channels derived from KvAP (a bacterial potassium channel) incorporated in lipid bilayer membrane, has been investigated at various applied potentials through multi-channel electrophysiological experiments. The current versus time traces at any particular membrane potential show clear steps for sequential opening of the multichannels. The minimum current (representing one-channel current) was found out from the amplitude histograms. Accordingly, the number of open channels corresponding to a particular open state was calculated. It was observed that the above-mentioned one channel current is higher than the corresponding single-channel current at most of the applied membrane potentials. Moreover, the difference between the single and one channel conductances is a nonlinear function of the membrane potential. We conclude that the S6 multi-channels show co-operative gating. Voltage relaxation studies support the above-mentioned conclusion.	[Malik, Chetan; Ghosh, Subhendu] Univ Delhi, Dept Biophys, New Delhi, India	University of Delhi	Ghosh, S (corresponding author), Univ Delhi, Dept Biophys, South Campus, New Delhi, India.	profsubhendu@gmail.com	Ghosh, Subhendu/GSN-2467-2022	Malik, Dr. Chetan/0000-0003-3428-7567	Council for Scientific & Industrial Research, Government of India	Council for Scientific & Industrial Research, Government of India(Council of Scientific & Industrial Research (CSIR) - India)	CM is thankful to Council for Scientific & Industrial Research, Government of India for Financial assistance in the form of Junior Research Fellowship. The funder had no role in study, design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ader C, 2009, EMBO J, V28, P2825, DOI 10.1038/emboj.2009.218; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; Bak P., 1999, NATURE WORKS SCI SEL; Banerjee J, 2006, EUROPHYS LETT, V73, P457, DOI 10.1209/epl/i2005-10418-2; Bezanilla F, 2000, PHYSIOL REV, V80, P555, DOI 10.1152/physrev.2000.80.2.555; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Camazine S., 2001, SELF ORG BIOLOGICAL, DOI DOI 10.1515/9780691212920; Deutsch A, 2005, CELLULAR AUTOMATON M; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Erdem R, 2006, J BIOL PHYS, V32, P523, DOI 10.1007/s10867-007-9034-3; FOX RF, 1994, PHYS REV E, V49, P3421, DOI 10.1103/PhysRevE.49.3421; Ghosh P, 2004, MATH BIOSCI INTERAC, P89; Ghosh P, 2006, BIOELECTROCHEMISTRY, V68, P150, DOI 10.1016/j.bioelechem.2005.05.007; GHOSH S, 1993, J THEOR BIOL, V165, P171, DOI 10.1006/jtbi.1993.1182; GHOSH S, 1993, J THEOR BIOL, V160, P151, DOI 10.1006/jtbi.1993.1009; Hille B, 1984, IONIC CHANNELS EXCIT, P331; Holmgren M, 1998, NEURON, V21, P617, DOI 10.1016/S0896-6273(00)80571-1; Huang M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037629; Keleshian AM, 2000, BIOPHYS J, V78, P1, DOI 10.1016/S0006-3495(00)76568-4; LIU Y, 1993, BIOPHYS J, V64, P26, DOI 10.1016/S0006-3495(93)81337-7; Marx SO, 1998, SCIENCE, V281, P818, DOI 10.1126/science.281.5378.818; Marx SO, 2001, CIRC RES, V88, P1151, DOI 10.1161/hh1101.091268; Molina ML, 2006, J BIOL CHEM, V281, P18837, DOI 10.1074/jbc.M600342200; Naundorf B, 2006, NATURE, V440, P1060, DOI 10.1038/nature04610; SIGWORTH FJ, 1994, Q REV BIOPHYS, V27, P1, DOI 10.1017/S0033583500002894; Sumpter D. J., 2010, COLLECTIVE ANIMAL BE, DOI [10.1515/9781400837106, DOI 10.1515/9781400837106]; Svetina S, 2004, BIOELECTROCHEMISTRY, V62, P107, DOI 10.1016/j.bioelechem.2003.08.002; Tombola F, 2006, ANNU REV CELL DEV BI, V22, P23, DOI 10.1146/annurev.cellbio.21.020404.145837; Valiunas V, 2001, PFLUG ARCH EUR J PHY, V441, P756, DOI 10.1007/s004240000504; Verma MK, 2006, EUROPHYS LETT, V76, P1050, DOI 10.1209/epl/i2006-10413-1; Verma R, 2011, J BIOL CHEM, V286, P24828, DOI 10.1074/jbc.M110.209676; Vijayvergiya V, 2003, EUR BIOPHYS J BIOPHY, V32, P724, DOI 10.1007/s00249-003-0313-z	32	6	6	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78845	10.1371/journal.pone.0078845	http://dx.doi.org/10.1371/journal.pone.0078845			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265723	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100056
J	Ostermaier, V; Christiansen, G; Schanz, F; Kurmayer, R				Ostermaier, Veronika; Christiansen, Guntram; Schanz, Ferdinand; Kurmayer, Rainer			Genetic Variability of Microcystin Biosynthesis Genes in Planktothrix as Elucidated from Samples Preserved by Heat Desiccation during Three Decades	PLOS ONE			English	Article							CYANOBACTERIA; RUBESCENS; TOXICITY; POPULATIONS; DIVERSITY; ABUNDANCE; GENOTYPES; BLOOMS; IDENTIFICATION; AERUGINOSA	Historic samples of phytoplankton can provide information on the abundance of the toxigenic genotypes of cyanobacteria in dependence on increased or decreased eutrophication. The analysis of a time-series from preserved phytoplankton samples by quantitative PCR (qPCR) extends observation periods considerably. The analysis of DNA from heat-desiccated samples by qPCR can be aggravated by point substitutions or the fragmentation of DNA introduced by the high temperature. In this study, we analyzed whether the heat desiccation of the cellular material of the cyanobacterium Planktothrix sp. introduced potential errors to the template DNA that is used for qPCR within (i) 16S rDNA and phycocyanin genes and (ii) the mcyA gene indicative of the incorporation of either dehydrobutyrine (Dhb) or N-methyl-dehydroalanine (Mdha) in position 7, and (ii) the mcyB gene, which is indicative of homotyrosine (Hty) in position 2 of the microcystin (MC) molecule. Due to high temperature desiccation, the deterioration of the DNA template quality was rather due to fragmentation than due to nucleotide substitutions. By using the heat-desiccated samples of Lake Zurich, Switzerland the abundance of the Dhb, Mdha and Hty genotypes was determined during three decades (1977-2008). Despite major changes in the trophic state of the lake resulting in a major increase of the total Planktothrix population density, the proportion of these genotypes encoding the synthesis of different MC congeners showed high stability. Nevertheless, a decline of the most abundant mcyA genotype indicative of the synthesis of Dhb in position 7 of the MC molecule was observed. This decline could be related to the gradual incline in the proportion of a mutant genotype carrying a 1.8kbp deletion of this gene region. The increase of this mcyA (Dhb) gene deletion mutant has been minor so far, however, and likely did not affect the overall toxicity of the population.	[Ostermaier, Veronika; Christiansen, Guntram; Kurmayer, Rainer] Univ Innsbruck, Res Inst Limnol, Mondsee, Austria; [Schanz, Ferdinand] Univ Zurich, Inst Plant Biol, Limnol Stn, Kilchberg, Switzerland	University of Innsbruck; University of Zurich	Kurmayer, R (corresponding author), Univ Innsbruck, Res Inst Limnol, Mondsee, Austria.	rainer.kurmayer@uibk.ac.at	Kurmayer, Rainer/AAF-4625-2022; Kurmayer, Rainer/AFJ-4791-2022	Kurmayer, Rainer/0000-0002-2100-9616; Kurmayer, Rainer/0000-0002-2100-9616	Austrian Science Fund [FWF-P24070]; DOC-fFORTE fellowship of the Austrian Academy of Sciences; Short Term Scientific Mission (STSM) Fellowship through the EU network "European Cooperation in Science and Technology" (COST) Action [ES1105]; Austrian Science Fund (FWF) [P 24070] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); DOC-fFORTE fellowship of the Austrian Academy of Sciences; Short Term Scientific Mission (STSM) Fellowship through the EU network "European Cooperation in Science and Technology" (COST) Action; Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was supported by the Austrian Science Fund (FWF-P24070) to RK (http://www.fwf.ac.at/). VO was supported by a DOC-fFORTE fellowship of the Austrian Academy of Sciences (http://www.oeaw.ac.at/) and by a Short Term Scientific Mission (STSM) Fellowship through the EU network "European Cooperation in Science and Technology" (COST) Action ES1105 'CYANOCOST' (http://www.cost.eu). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Baumann HI, 2008, LIMNOLOGICA, V38, P350, DOI 10.1016/j.limno.2008.05.010; Blom JF, 2005, TOXICON, V46, P465, DOI 10.1016/j.toxicon.2005.06.013; Blom JF, 2001, TOXICON, V39, P1923, DOI 10.1016/S0041-0101(01)00178-7; Briand JF, 2005, MICROB ECOL, V50, P418, DOI 10.1007/s00248-005-0186-z; Bruskov VI, 2002, NUCLEIC ACIDS RES, V30, P1354, DOI 10.1093/nar/30.6.1354; Christiansen G, 2006, APPL ENVIRON MICROB, V72, P117, DOI 10.1128/AEM.72.1.117-123.2006; Christiansen G, 2003, J BACTERIOL, V185, P564, DOI 10.1128/JB.185.2.564-572.2003; Christiansen G, 2008, MOL BIOL EVOL, V25, P1695, DOI 10.1093/molbev/msn120; EIGNER J, 1961, BIOCHIM BIOPHYS ACTA, V51, P165, DOI 10.1016/0006-3002(61)91028-9; Ernst B, 2009, HARMFUL ALGAE, V8, P329, DOI 10.1016/j.hal.2008.07.006; Fastner J, 1999, ARCH HYDROBIOL, V145, P147; Fewer DP, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-183; Fischbach MA, 2008, P NATL ACAD SCI USA, V105, P4601, DOI 10.1073/pnas.0709132105; Hansen AJ, 2001, MOL BIOL EVOL, V18, P262, DOI 10.1093/oxfordjournals.molbev.a003800; Hoeger SJ, 2007, ENVIRON SCI TECHNOL, V41, P2609, DOI 10.1021/es062681p; Humbert JF, 2010, ANAL BIOANAL CHEM, V397, P1723, DOI 10.1007/s00216-010-3642-7; Kaebernick M, 2001, ENVIRON MICROBIOL, V3, P669, DOI 10.1046/j.1462-2920.2001.00241.x; KARRAN P, 1980, BIOCHEMISTRY-US, V19, P6005, DOI 10.1021/bi00567a010; Kurmayer R, 2005, MICROBIOL-SGM, V151, P1525, DOI 10.1099/mic.0.27779-0; Kurmayer R, 2004, ENVIRON MICROBIOL, V6, P831, DOI 10.1111/j.1462-2920.2004.00626.x; Kurmayer R, 2003, APPL ENVIRON MICROB, V69, P787, DOI 10.1128/AEM.69.2.787-795.2003; Kurmayer R, 2002, MICROB ECOL, V43, P107, DOI 10.1007/s00248-001-0039-3; Kurmayer R, 2006, MOL ECOL, V15, P3849, DOI 10.1111/j.1365-294X.2006.03044.x; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Mikalsen B, 2003, J BACTERIOL, V185, P2774, DOI 10.1128/JB.185.9.2774-2785.2003; Miles CO, 2013, ENVIRON SCI TECHNOL, V47, P4080, DOI 10.1021/es305202p; NAMIKOSHI M, 1992, J ORG CHEM, V57, P866, DOI 10.1021/jo00029a016; Ostermaier V, 2012, BMC BIOL, V10, DOI 10.1186/1741-7007-10-100; Ostermaier V, 2010, APPL ENVIRON MICROB, V76, P3495, DOI 10.1128/AEM.02771-09; Ostermaier V, 2009, MICROB ECOL, V58, P323, DOI 10.1007/s00248-009-9484-1; Posch T, 2012, NAT CLIM CHANGE, V2, P809, DOI [10.1038/NCLIMATE1581, 10.1038/nclimate1581]; RIPPKA R, 1988, METHOD ENZYMOL, V167, P3; Rouhiainen L, 2004, APPL ENVIRON MICROB, V70, P686, DOI 10.1128/AEM.70.2.686-692.2004; Sano T, 1998, TETRAHEDRON, V54, P463, DOI 10.1016/S0040-4020(97)10291-5; Schatz D, 2005, ENVIRON MICROBIOL, V7, P798, DOI 10.1111/j.1462-2920.2005.00752.x; Tillett D, 2000, CHEM BIOL, V7, P753, DOI 10.1016/S1074-5521(00)00021-1; Tooming-Klunderud A, 2008, MICROBIOL-SGM, V154, P1886, DOI 10.1099/mic.0.2007/015875-0; Ufelmann H, 2012, TOXICOLOGY, V293, P59, DOI 10.1016/j.tox.2011.12.011	38	3	3	1	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80177	10.1371/journal.pone.0080177	http://dx.doi.org/10.1371/journal.pone.0080177			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265798	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100131
J	Quinn, EM; Corrigan, MA; O'Mullane, J; Murphy, D; Lehane, EA; Leahy-Warren, P; Coffey, A; McCluskey, P; Redmond, HP; Fulton, GJ				Quinn, Edel Marie; Corrigan, Mark A.; O'Mullane, John; Murphy, David; Lehane, Elaine A.; Leahy-Warren, Patricia; Coffey, Alice; McCluskey, Patricia; Redmond, Henry Paul; Fulton, Greg J.			Clinical Unity and Community Empowerment: The Use of Smartphone Technology to Empower Community Management of Chronic Venous Ulcers through the Support of a Tertiary Unit	PLOS ONE			English	Article							LEG ULCERS; WOUND CARE; TELEMEDICINE	Background: Chronic ulcers affect roughly 60,000 Irish people, at a total cost of (sic)600,000,000, or (sic)10,000 per patient annually. By virtue of their chronicity, these ulcers also contribute a significant burden to tertiary outpatient vascular clinics. Objective: We propose utilizing mobile phone technology to decentralise care from tertiary centres to the community, improving efficiency and patient satisfaction, while maintaining patient safety. Methods: Bespoke mobile software was developed for Apples iPhone 4 platform. This allowed for the remote collection of patient images prospectively and their transmission with clinical queries, from the primary healthcare team to the tertiary centre. Training and iPhones were provided to five public health nurses in geographically remote areas of the region. Data were uploaded securely and user end software was developed allowing the review and manipulation of images, along with two way communication between the teams. Establishing reliability, patients were reviewed clinically as well as remotely, and concordance analysed. Qualitative data were collected through focus group discussion. Results: From October to December 2011 eight patients (61-83 yrs, mean 75.3 yrs) with chronic venous ulceration and their five public health nurses were recruited. Data were transmitted using 3 G, Edge, GPRS and WiFi, at a mean speed of 69.03 kps. Concordance was 100% for wound bed assessment, 80% for skin integrity/colour and 60% for exudate assessment. Focus group analysis explored the concept, practicalities and future applications of the system. Conclusions: With an evolving national data network, the secure transmission of clinical images is a safe alternative to regular clinic appointments for patients with chronic venous ulceration. With further development, and packaged as a freely downloadable application, this has the potential to support the community care of chronic wounds.	[Quinn, Edel Marie; Corrigan, Mark A.; McCluskey, Patricia; Redmond, Henry Paul; Fulton, Greg J.] Cork Univ Hosp, Dept Surg, Cork, Ireland; [O'Mullane, John; Murphy, David] Natl Univ Ireland Univ Coll Cork, Dept Comp Sci, Cork, Ireland; [Lehane, Elaine A.; Leahy-Warren, Patricia; Coffey, Alice] Natl Univ Ireland Univ Coll Cork, Sch Nursing & Midwifery, Cork, Ireland	University College Cork; University College Cork; University College Cork	Quinn, EM (corresponding author), Cork Univ Hosp, Dept Surg, Cork, Ireland.	edelquinn@rcsi.ie	Murphy, David/A-4900-2019	Murphy, David/0000-0002-9685-8292; Coffey, Alice/0000-0002-5178-6723; Corrigan, Mark/0000-0002-9615-6450; Lehane, Elaine/0000-0002-0144-7467; Quinn, Edel/0000-0001-8419-2684; Leahy-Warren, Patricia/0000-0002-4443-4471	Health Research Board, Ireland [HIS-05-16]	Health Research Board, Ireland	This study was funded by the Health Research Board, Ireland, grant ID HIS-05-16 www.hrb.ie. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Hadithy N, 2012, INT ORTHOP, V36, P1543, DOI 10.1007/s00264-012-1527-4; American Medical Informatics Association, 2011, FACT INFL SUCC HLTH; Binder B, 2007, ARCH DERMATOL, V143, P1511, DOI 10.1001/archderm.143.12.1511; Box TL, 2010, J GEN INTERN MED, V25, P72, DOI 10.1007/s11606-009-1130-6; Chanussot-Deprez C, 2008, INT WOUND J, V5, P651, DOI 10.1111/j.1742-481X.2008.00478.x; Ellison D A, 2002, J Wound Care, V11, P47; Grace P, 2002, GUIDELINES MANAGEMEN; Hill ML, 2009, J TELEMED TELECARE, V15, P196, DOI 10.1258/jtt.2009.081002; Hofmann-Wellenhof R, 2006, J TELEMED TELECARE, V12, P15, DOI 10.1258/135763306777978407; Khan SK, 2011, J TELEMED TELECARE, V17, P210, DOI 10.1258/jtt.2010.100618; Kiser M, 2012, BURNS IN PRESS; Marston WA, 1999, J VASC SURG, V30, P491, DOI 10.1016/S0741-5214(99)70076-5; Mohamoud S, 2009, AGENCY HEALTHCARE RE; Payne KFB, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-121; Salmhofer W, 2005, DERMATOLOGY, V210, P211, DOI 10.1159/000083512; Takahashi PY, 2009, OSTOMY WOUND MANAG, V55, P32; van Gent WB, 2010, BMJ-BRIT MED J, V341, DOI 10.1136/bmj.c6045; Walker TW, 2001, J TELEMED TELECARE, V17, P133	18	6	6	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78786	10.1371/journal.pone.0078786	http://dx.doi.org/10.1371/journal.pone.0078786			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265716	Green Published, gold			2022-12-25	WOS:000327252100049
J	Liberman, R; Bond, S; Shainheit, MG; Stadecker, MJ; Forgac, M				Liberman, Rachel; Bond, Sarah; Shainheit, Mara G.; Stadecker, Miguel J.; Forgac, Michael			Regulated Assembly of Vacuolar ATPase Is Increased during Cluster Disruption-induced Maturation of Dendritic Cells through a Phosphatidylinositol 3-Kinase/mTOR-dependent Pathway	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ATPases; Dendritic Cells; Proton Pumps; Transport; Vacuolar Acidification; Vacuolar ATPase; Regulated V-ATPase Assembly	H+-ATPASE; E-CADHERIN; V-ATPASE; RECEPTOR; SUBUNIT; EXPRESSION; MOLECULES; ROTATION; IMMATURE; ALDOLASE	Background: The V-ATPase is induced to assemble during TLR-activated maturation of dendritic cells. Results: Cluster disruption of dendritic cells also induces V-ATPase assembly by a PI3K/mTOR-dependent mechanism. Conclusion: Semi-mature dendritic cells show increased V-ATPase assembly. Significance: Dendritic cell maturation associated with immune tolerance involves V-ATPase assembly. The vacuolar (H+)-ATPases (V-ATPases) are ATP-driven proton pumps composed of a peripheral V-1 domain and a membrane-embedded V-0 domain. Regulated assembly of V-1 and V-0 represents an important regulatory mechanism for controlling V-ATPase activity in vivo. Previous work has shown that V-ATPase assembly increases during maturation of bone marrow-derived dendritic cells induced by activation of Toll-like receptors. This increased assembly is essential for antigen processing, which is dependent upon an acidic lysosomal pH. Cluster disruption of dendritic cells induces a semi-mature phenotype associated with immune tolerance. Thus, semi-mature dendritic cells are able to process and present self-peptides to suppress autoimmune responses. We have investigated V-ATPase assembly in bone marrow-derived, murine dendritic cells and observed an increase in assembly following cluster disruption. This increased assembly is not dependent upon new protein synthesis and is associated with an increase in concanamycin A-sensitive proton transport in FITC-loaded lysosomes. Inhibition of phosphatidylinositol 3-kinase with wortmannin or mTORC1 with rapamycin effectively inhibits the increased assembly observed upon cluster disruption. These results suggest that the phosphatidylinositol 3-kinase/mTOR pathway is involved in controlling V-ATPase assembly during dendritic cell maturation.	[Liberman, Rachel; Bond, Sarah; Forgac, Michael] Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, Boston, MA 02111 USA; [Shainheit, Mara G.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Stadecker, Miguel J.] Tufts Univ, Sch Med, Dept Integrat Physiol & Pathobiol, Boston, MA 02111 USA; [Liberman, Rachel; Bond, Sarah; Forgac, Michael] Tufts Univ, Programs Cellular & Mol Physiol, Sackler Sch Grad Biomed Sci, Boston, MA 02111 USA; [Stadecker, Miguel J.] Tufts Univ, Sackler Sch Grad Biomed Sci, Programs Immunol, Boston, MA 02111 USA	Tufts University; Tufts University; Tufts University; Tufts University; Tufts University	Forgac, M (corresponding author), Tufts Univ, Sch Med, Dept Dev Mol & Chem Biol, 136 Harrison Ave, Boston, MA 02111 USA.	michael.forgac@tufts.edu			National Institutes of Health [GM34478]; NIAID [RO1 18919]; Sackler Dean's Fellow award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI018919] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM034478, R37GM034478, K12GM074869] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Sackler Dean's Fellow award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM34478 (to M. F.) and NIAID RO1 18919 (to M. J. S.). This work was also supported by a Sackler Dean's Fellow award (to R. L.).	Akira S, 2004, NAT REV IMMUNOL, V4, P499, DOI 10.1038/nri1391; Banchereau J, 2000, ANNU REV IMMUNOL, V18, P767, DOI 10.1146/annurev.immunol.18.1.767; Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Brown D, 2009, J EXP BIOL, V212, P1762, DOI 10.1242/jeb.028803; Brown J, 2011, J DENT RES, V90, P417, DOI 10.1177/0022034510381264; Delamarre L, 2003, J EXP MED, V198, P111, DOI 10.1084/jem.20021542; DROSE S, 1993, BIOCHEMISTRY-US, V32, P3902, DOI 10.1021/bi00066a008; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; Granucci F, 1999, MICROBES INFECT, V1, P1079, DOI 10.1016/S1286-4579(99)00209-9; Hawiger D, 2001, J EXP MED, V194, P769, DOI 10.1084/jem.194.6.769; Hirata T, 2003, J BIOL CHEM, V278, P23714, DOI 10.1074/jbc.M302756200; Hirschfeld M, 2000, J IMMUNOL, V165, P618, DOI 10.4049/jimmunol.165.2.618; Huang Q, 2001, SCIENCE, V294, P870, DOI 10.1126/science.294.5543.870; Imamizu H, 2003, P NATL ACAD SCI USA, V100, P5461, DOI 10.1073/pnas.0835746100; Jiang A, 2007, IMMUNITY, V27, P610, DOI 10.1016/j.immuni.2007.08.015; KANE PM, 1995, J BIOL CHEM, V270, P17025; Kawasaki-Nishi S, 2001, P NATL ACAD SCI USA, V98, P12397, DOI 10.1073/pnas.221291798; Krawczyk CM, 2010, BLOOD, V115, P4742, DOI 10.1182/blood-2009-10-249540; Leenen PJM, 1998, J IMMUNOL, V160, P2166; Legate KR, 2009, GENE DEV, V23, P397, DOI 10.1101/gad.1758709; Li SC, 2009, BBA-MOL CELL RES, V1793, P650, DOI 10.1016/j.bbamcr.2008.08.003; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Lu M, 2004, J BIOL CHEM, V279, P8732, DOI 10.1074/jbc.M303871200; Lu M, 2001, J BIOL CHEM, V276, P30407, DOI 10.1074/jbc.M008768200; Lugt BV, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020099; Lutz MB, 2002, TRENDS IMMUNOL, V23, P445, DOI 10.1016/S1471-4906(02)02281-0; Marshall FA, 2008, J IMMUNOL, V181, P7562, DOI 10.4049/jimmunol.181.11.7562; Nakamura I, 1997, J CELL PHYSIOL, V172, P230, DOI 10.1002/(SICI)1097-4652(199708)172:2<230::AID-JCP10>3.0.CO;2-D; Ocana-Morgner C, 2013, J IMMUNOL, V190, P5545, DOI 10.4049/jimmunol.1203095; Parra KJ, 1998, MOL CELL BIOL, V18, P7064, DOI 10.1128/MCB.18.12.7064; Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085; Riedl E, 2000, BLOOD, V96, P4276; Rivard N, 2009, FRONT BIOSCI-LANDMRK, V14, P510, DOI 10.2741/3259; SALLUSTO F, 1995, J EXP MED, V182, P389, DOI 10.1084/jem.182.2.389; Sautin YY, 2005, MOL CELL BIOL, V25, P575, DOI 10.1128/MCB.25.2.575-589.2005; Schuler G, 2001, CURR PROTOC IMMUNOL; STEINMAN RM, 1974, J EXP MED, V139, P1431, DOI 10.1084/jem.139.6.1431; Steinman RM, 2002, P NATL ACAD SCI USA, V99, P351, DOI 10.1073/pnas.231606698; Su Y, 2003, J BIOL CHEM, V278, P20013, DOI 10.1074/jbc.M210077200; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Toei M, 2010, BIOCHEMISTRY-US, V49, P4715, DOI 10.1021/bi100397s; Trombetta ES, 2003, SCIENCE, V299, P1400, DOI 10.1126/science.1080106; Watts C, 2010, CURR OPIN IMMUNOL, V22, P124, DOI 10.1016/j.coi.2009.12.005; WEBER K, 1969, J BIOL CHEM, V244, P4406; Xu YQ, 2012, J BIOL CHEM, V287, P26409, DOI 10.1074/jbc.M112.352229; Zahringer U, 2008, IMMUNOBIOLOGY, V213, P205, DOI 10.1016/j.imbio.2008.02.005; Zoncu R, 2011, SCIENCE, V334, P678, DOI 10.1126/science.1207056	48	50	50	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1355	1363		10.1074/jbc.M113.524561	http://dx.doi.org/10.1074/jbc.M113.524561			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24273170	hybrid, Green Published			2022-12-25	WOS:000332401700014
J	Inohara, T; Kohsaka, S; Okamura, T; Watanabe, M; Nakamura, Y; Higashiyama, A; Kadota, A; Okuda, N; Ohkubo, T; Miura, K; Okayama, A; Ueshima, H				Inohara, Taku; Kohsaka, Shun; Okamura, Tomonori; Watanabe, Makoto; Nakamura, Yasuyuki; Higashiyama, Aya; Kadota, Aya; Okuda, Nagako; Ohkubo, Takayoshi; Miura, Katsuyuki; Okayama, Akira; Ueshima, Hirotsugu		NIPPON DATA 80 90 Res Grp	Long-Term Outcome of Healthy Participants with Atrial Premature Complex: A 15-Year Follow-Up of the NIPPON DATA 90 Cohort	PLOS ONE			English	Article							ALL-CAUSE MORTALITY; CARDIOVASCULAR MORTALITY; GENERAL-POPULATION; PROGNOSTIC VALUE; RISK-FACTOR; JAPANESE; FIBRILLATION; DEATH; STROKE; DISEASE	Background: Atrial premature complexes (APC) are among the most frequently encountered electrocardiographic abnormalities. However, their prognostic value among healthy individuals is unclear. This study aimed to clarify the role of APC in predicting cardiovascular events in a large Japanese community cohort using long-term follow-up data. Methods: National Integrated Project for Prospective Observation of Non-communicable Disease And its Trends in the Aged, 1990-2005, (NIPPON DATA 90) was a large cohort study of cardiovascular disease (CVD) in Japan. A total of 7692 otherwise healthy participants with no history of myocardial infarction, stroke, atrial fibrillation, or atrial flutter were enrolled (men, 41.5%; mean age, 52.5 +/- 13.7 years). Results: A total of 64 (0.8%) participants had at least one beat of APC on screening 12-lead electrocardiogram. During the follow-up of 14.0 +/- 2.9 years (total, 107,474 patient-years), 338 deaths occurred due to CVD. The association between APC and CVD outcome was assessed using Cox proportional hazard models. Cox regression analysis revealed that the presence of APC was an independent predictor for CVD deaths (HR: 2.03, 95% CI: 1.12-3.66, P = 0.019). The association of APC on CVD death was more evident in participants with hypertension (P-value for interaction, 0.03). Conclusions: APC recorded during the screening electrocardiogram are significantly associated with an increased risk of CVD deaths in a Japanese community-dwelling population and are a strong prognostic factor for hypertensive participants.	[Inohara, Taku; Kohsaka, Shun] Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan; [Okamura, Tomonori] Keio Univ, Sch Med, Dept Prevent Med & Publ Hlth, Tokyo, Japan; [Watanabe, Makoto] Natl Cerebral & Cardiovasc Ctr, Dept Prevent Cardiol, Suita, Osaka, Japan; [Nakamura, Yasuyuki] Kyoto Womens Univ, Dept Cardiovasc Epidemiol, Kyoto, Japan; [Higashiyama, Aya] Hyogo Coll Med, Dept Environm & Prevent Med, Nishinomiya, Hyogo 6638501, Japan; [Kadota, Aya] Osaka Kyoiku Univ, Dept Sch Nursing & Hlth Educ, Kashiwara, Japan; [Okuda, Nagako] Natl Inst Hlth & Nutr, Dept Nutr Epidemiol, Tokyo 162, Japan; [Ohkubo, Takayoshi] Teikyo Univ, Sch Med, Dept Hyg & Publ Hlth, Tokyo 173, Japan; [Miura, Katsuyuki; Ueshima, Hirotsugu] Dept Hlth Sci, Tokyo, Japan; [Miura, Katsuyuki; Ueshima, Hirotsugu] Ctr Epidemiol Res Asia, Tokyo, Japan; [Okayama, Akira] JATA, Inst Hlth Promot & Hlth Care 1, Tokyo, Japan	Keio University; Keio University; National Cerebral & Cardiovascular Center - Japan; Kyoto Womens University; Hyogo College of Medicine; Osaka University of Education; National Institute of Health & Nutrition - Japan; Teikyo University	Kohsaka, S (corresponding author), Keio Univ, Sch Med, Dept Cardiol, Tokyo, Japan.	kohsaka@cpnet.med.keio.ac.jp	Okamura, Tomonori/L-1693-2013	Okamura, Tomonori/0000-0003-0488-0351; Kita, Yoshikuni/0000-0002-2366-1106; Ohkubo, Takayoshi/0000-0002-3283-8196; Kohsaka, Shun/0000-0003-3779-2972; Okuda, Nagako/0000-0002-6893-0509	Ministry of Health, Labor, and Welfare under Japanese Association for Cerebro-Cardiovascular Disease Control; Ministry of Health, Labor, and Welfare [7A-2]; Health and Labor Sciences Research Grant, Japan (Comprehensive Research on Aging and Health) [H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014]; Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus [H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022]	Ministry of Health, Labor, and Welfare under Japanese Association for Cerebro-Cardiovascular Disease Control; Ministry of Health, Labor, and Welfare(Ministry of Health, Labour and Welfare, Japan); Health and Labor Sciences Research Grant, Japan (Comprehensive Research on Aging and Health); Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus	This study was supported by a grant-in-aid of the Ministry of Health, Labor, and Welfare under the auspices of the Japanese Association for Cerebro-Cardiovascular Disease Control; a Research Grant for Cardiovascular Diseases (7A-2) from the Ministry of Health, Labor, and Welfare; and a Health and Labor Sciences Research Grant, Japan (Comprehensive Research on Aging and Health [H11-Chouju-046, H14-Chouju-003, H17-Chouju-012, H19-Chouju-Ippan-014] and Comprehensive Research on Life Style-Related Diseases Including Cardiovascular Diseases and Diabetes Mellitus [H22-Jyunkankitou-Seisyu-Sitei-017, H25-Jyunkankitou-Seisyu-Sitei-022]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abhayaratna WP, 2006, J AM COLL CARDIOL, V47, P2357, DOI 10.1016/j.jacc.2006.02.048; Berg AO, 2004, ANN INTERN MED, V140, P569, DOI 10.7326/0003-4819-140-7-200404060-00001; Binici Z, 2010, CIRCULATION, V121, P1904, DOI 10.1161/CIRCULATIONAHA.109.874982; Cheriyath P, 2011, AM J CARDIOL, V107, P151, DOI 10.1016/j.amjcard.2010.09.002; Chong BH, 2012, EUROPACE, V14, P942, DOI 10.1093/europace/eur389; Conen D, 2012, CIRCULATION, V126, P2302, DOI 10.1161/CIRCULATIONAHA.112.112300; Diamond JA, 2005, HYPERTENS RES, V28, P191, DOI 10.1291/hypres.28.191; Engstrom G, 2000, STROKE, V31, P2925, DOI 10.1161/01.STR.31.12.2925; Greenland P, 2010, CIRCULATION, V122, pE584, DOI 10.1161/CIR.0b013e3182051b4c; Healey JS, 2012, NEW ENGL J MED, V366, P120, DOI 10.1056/NEJMoa1105575; Higashiyama A, 2010, J EPIDEMIOL, V20, pS537, DOI 10.2188/jea.JE20090222; Higashiyama A, 2009, J ATHEROSCLER THROMB, V16, P40, DOI 10.5551/jat.E606; Horibe H, 2005, J EPIDEMIOL, V15, P125, DOI 10.2188/jea.15.125; Kadota A, 2011, ATHEROSCLEROSIS, V215, P209, DOI 10.1016/j.atherosclerosis.2010.11.033; Kadowaki S, 2008, DIABETOLOGIA, V51, P575, DOI 10.1007/s00125-007-0915-6; Kohsaka S, 2010, AM J CARDIOL, V105, P1698, DOI 10.1016/j.amjcard.2010.01.349; Nakamura K, 2006, HYPERTENS RES, V29, P353, DOI 10.1291/hypres.29.353; Nakamura Y, 2012, CIRCULATION, V125, P1226, DOI 10.1161/CIRCULATIONAHA.111.070045; Ohsawa M, 2007, CIRC J, V71, P814, DOI 10.1253/circj.71.814; Okamura T, 2006, ATHEROSCLEROSIS, V184, P143, DOI 10.1016/j.atherosclerosis.2005.03.042; Okamura T, 2004, AM HEART J, V147, P1024, DOI 10.1016/j.ahj.2003.12.020; Okamura T, 2007, ATHEROSCLEROSIS, V190, P216, DOI 10.1016/j.atherosclerosis.2006.01.024; Okayama A, 2006, J HYPERTENS, V24, P459, DOI 10.1097/01.hjh.0000209981.43983.cf; Redfield MM, 2003, JAMA-J AM MED ASSOC, V289, P194, DOI 10.1001/jama.289.2.194; Rumana N, 2011, AM J CARDIOL, V107, P1718, DOI 10.1016/j.amjcard.2011.02.335; Santos-Gallego CG, 2012, NAT REV CARDIOL, V9, P10, DOI 10.1038/nrcardio.2011.170; Ueshima H, 2004, STROKE, V35, P1836, DOI 10.1161/01.STR.0000131747.84423.74; Ueshima H, 2008, CIRCULATION, V118, P2702, DOI 10.1161/CIRCULATIONAHA.108.790048; Wallmann D, 2003, HEART, V89, P1247, DOI 10.1136/heart.89.10.1247; Wallmann D, 2007, STROKE, V38, P2292, DOI 10.1161/STROKEAHA.107.485110; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; World Health Organization, 2008, GLOB BURD DIS 2004 U	32	27	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80853	10.1371/journal.pone.0080853	http://dx.doi.org/10.1371/journal.pone.0080853			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260495	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900101
J	Chen, TZ; Lv, YD; Zhao, TM; Li, N; Yang, YW; Yu, WG; He, X; Liu, TL; Zhang, BL				Chen, Tianzi; Lv, Yuanda; Zhao, Tongming; Li, Nan; Yang, Yuwen; Yu, Wengui; He, Xin; Liu, Tingli; Zhang, Baolong			Comparative Transcriptome Profiling of a Resistant vs. Susceptible Tomato (Solanum lycopersicum) Cultivar in Response to Infection by Tomato Yellow Leaf Curl Virus	PLOS ONE			English	Article							PLANT-DISEASE RESISTANCE; RNA-SEQ EXPERIMENTS; PROTEIN-KINASE; EXPRESSION ANALYSIS; GENE-EXPRESSION; DEFENSE; ARABIDOPSIS; PATHOGEN; FAMILY; FRUIT	Tomato yellow leaf curl virus (TYLCV) threatens tomato production worldwide by causing leaf yellowing, leaf curling, plant stunting and flower abscission. The current understanding of the host plant defense response to this virus is very limited. Using whole transcriptome sequencing, we analyzed the differential gene expression in response to TYLCV infection in the TYLCV-resistant tomato breeding line CLN2777A (R) and TYLCV-susceptible tomato breeding line TMXA48-4-0 (S). The mixed inoculated samples from 3, 5 and 7 day post inoculation (dpi) were compared to non-inoculated samples at 0 dpi. Of the total of 34831 mapped transcripts, 209 and 809 genes were differentially expressed in the R and S tomato line, respectively. The proportion of up-regulated differentially expressed genes (DEGs) in the R tomato line (58.37%) was higher than that in the S line (9.17%). Gene ontology (GO) analyses revealed that similar GO terms existed in both DEGs of R and S lines; however, some sets of defense related genes and their expression levels were not similar between the two tomato lines. Genes encoding for WRKY transcriptional factors, R genes, protein kinases and receptor (-like) kinases which were identified as down-regulated DEGs in the S line were up-regulated or not differentially expressed in the R line. The up-regulated DEGs in the R tomato line revealed the defense response of tomato to TYLCV infection was characterized by the induction and regulation of a series of genes involved in cell wall reorganization, transcriptional regulation, defense response, ubiquitination, metabolite synthesis and so on. The present study provides insights into various reactions underlining the successful establishment of resistance to TYLCV in the R tomato line, and helps in the identification of important defense-related genes in tomato for TYLCV disease management.	[Chen, Tianzi; Lv, Yuanda; Zhao, Tongming; Li, Nan; Yang, Yuwen; Yu, Wengui; He, Xin; Liu, Tingli; Zhang, Baolong] Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China	Jiangsu Academy of Agricultural Sciences	Zhang, BL (corresponding author), Jiangsu Acad Agr Sci, Prov Key Lab Agrobiol, Nanjing, Jiangsu, Peoples R China.	zhbl2248@hotmail.com		LV, Yuanda/0000-0001-6576-7999; Lv, Yuanda/0000-0002-6640-5989; Chen, Tianzi/0000-0003-2634-6694	Natural Science Foundation of China [30971830]; Natural Science Foundation of Jiangsu Province, China [BK20130720]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of Jiangsu Province, China(Natural Science Foundation of Jiangsu Province)	This work was supported by grants from the Natural Science Foundation of China (No. 30971830) (http://www.nsfc.gov.cn/Portal0/default166.htm) and the Natural Science Foundation of Jiangsu Province, China (BK20130720) (http://www.jskjjh.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adhikari BN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034954; Adi M, 2012, METABOLOMICS S, V16, P2153; Alba R, 2005, PLANT CELL, V17, P2954, DOI 10.1105/tpc.105.036053; Anbinder I, 2009, THEOR APPL GENET, V119, P519, DOI 10.1007/s00122-009-1060-z; Bagnaresi P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0051609; Bu QY, 2008, CELL RES, V18, P756, DOI 10.1038/cr.2008.53; Campos-Soriano L, 2012, MOL PLANT PATHOL, V13, P579, DOI 10.1111/j.1364-3703.2011.00773.x; Cantu D, 2009, PLANT PHYSIOL, V150, P1434, DOI 10.1104/pp.109.138701; Cheng H, 2010, MOL BREEDING, V25, P13, DOI 10.1007/s11032-009-9305-8; Coker JS, 2003, BIOTECHNIQUES, V35, P740, DOI 10.2144/03354st04; CORBIN DR, 1987, MOL CELL BIOL, V7, P4337, DOI 10.1128/MCB.7.12.4337; Czosnek H, 2013, VIRUSES-BASEL, V5, P998, DOI 10.3390/v5030998; Edwards R, 2000, TRENDS PLANT SCI, V5, P193, DOI 10.1016/S1360-1385(00)01601-0; Egesten A, 1997, BBA-MOL CELL RES, V1358, P255, DOI 10.1016/S0167-4889(97)00081-5; Espinoza C, 2007, FUNCT INTEGR GENOMIC, V7, P95, DOI 10.1007/s10142-006-0031-6; Eybishtz A, 2010, PLANTA, V231, P537, DOI 10.1007/s00425-009-1072-6; Eybishtz A, 2009, PLANT MOL BIOL, V71, P157, DOI 10.1007/s11103-009-9515-9; Faino L, 2012, PLANT SIGNAL BEHAV, V7, P1065, DOI 10.4161/psb.21014; Furlan G, 2012, FRONT PLANT SCI, V3, DOI 10.3389/fpls.2012.00238; Gamas P, 1998, MOL PLANT MICROBE IN, V11, P393, DOI 10.1094/MPMI.1998.11.5.393; Gilbert BM, 2013, MOL PLANT MICROBE IN, V26, P903, DOI 10.1094/MPMI-01-13-0014-R; Glick Efrat, 2009, Plant Protection Science, V45, P81; Gorovits R, 2007, MOL PLANT MICROBE IN, V20, P1376, DOI 10.1094/MPMI-20-11-1376; Gorovits R, 2013, VIRUS RES, V171, P33, DOI 10.1016/j.virusres.2012.09.017; Gupta S, 2013, J EXP BOT, V64, P695, DOI 10.1093/jxb/ers365; Gururani MA, 2012, PHYSIOL MOL PLANT P, V78, P51, DOI 10.1016/j.pmpp.2012.01.002; Hanson P, 2006, REP TOMATO GENET COO, V56, P17; Hanssen IM, 2010, MOL PLANT MICROBE IN, V23, P539, DOI 10.1094/MPMI-23-5-0539; Hematy K, 2009, CURR OPIN PLANT BIOL, V12, P406, DOI 10.1016/j.pbi.2009.06.007; Ishihama N, 2012, CURR OPIN PLANT BIOL, V15, P431, DOI 10.1016/j.pbi.2012.02.003; Ji Y, 2007, MOL BREEDING, V20, P271, DOI 10.1007/s11032-007-9089-7; Ji YF, 2009, J AM SOC HORTIC SCI, V134, P281, DOI 10.21273/JASHS.134.2.281; Julian O, 2013, EUPHYTICA, P1; Kang JH, 2006, PLANT CELL, V18, P3303, DOI 10.1105/tpc.106.041103; Kawahara Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049423; Kruger J, 2002, SCIENCE, V296, P744, DOI 10.1126/science.1069288; Langenbach C, 2013, NEW PHYTOL, V198, P536, DOI 10.1111/nph.12155; Lefeuvre P, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001164; Liao PC, 2011, GENETICA, V139, P1229, DOI 10.1007/s10709-011-9624-7; Lionetti V, 2007, PLANT PHYSIOL, V143, P1871, DOI 10.1104/pp.106.090803; Liu YL, 2002, PLANT J, V31, P777, DOI 10.1046/j.1365-313X.2002.01394.x; Lorenc-Kukula K, 2009, J AGR FOOD CHEM, V57, P6698, DOI 10.1021/jf900833k; Marino D, 2012, PLANT PHYSIOL, V160, P15, DOI 10.1104/pp.112.199281; MARTIN GB, 1993, SCIENCE, V262, P1432, DOI 10.1126/science.7902614; MARTINEAU B, 1991, MOL GEN GENET, V228, P281, DOI 10.1007/BF00282477; Mase K, 2013, MOL PLANT MICROBE IN, V26, P868, DOI 10.1094/MPMI-10-12-0253-R; McCarthy DJ, 2012, NUCLEIC ACIDS RES, V40, P4288, DOI 10.1093/nar/gks042; Monteiro S, 2003, PHYTOPATHOLOGY, V93, P1505, DOI 10.1094/PHYTO.2003.93.12.1505; Moriones E, 2000, VIRUS RES, V71, P123, DOI 10.1016/S0168-1702(00)00193-3; PAUTOT V, 1993, P NATL ACAD SCI USA, V90, P9906, DOI 10.1073/pnas.90.21.9906; Pei DL, 2011, PLANT MOL BIOL REP, V29, P972, DOI 10.1007/s11105-011-0331-4; Petre B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044408; Puranik S, 2012, TRENDS PLANT SCI, V17, P369, DOI 10.1016/j.tplants.2012.02.004; Ramirez V, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003445; Ravichandran S, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-107; Rohrmann J, 2011, PLANT J, V68, P999, DOI 10.1111/j.1365-313X.2011.04750.x; Rowland O, 2005, PLANT CELL, V17, P295, DOI 10.1105/tpc.104.026013; Sade D, 2012, PLANT MOL BIOL, V80, P273, DOI 10.1007/s11103-012-9946-6; Sahu PP, 2012, PROTOPLASMA, V249, P1017, DOI 10.1007/s00709-012-0421-7; Sato S, 2012, NATURE, V485, P635, DOI 10.1038/nature11119; Schaff JE, 2007, PLANT PHYSIOL, V144, P1079, DOI 10.1104/pp.106.090241; Schenk PM, 2012, TRENDS BIOTECHNOL, V30, P177, DOI 10.1016/j.tibtech.2011.11.002; Scholthof KBG, 2011, MOL PLANT PATHOL, V12, P938, DOI [10.1111/j.1364-3703.2011.00752.x, 10.1111/J.1364-3703.2011.00752.X]; Selth LA, 2005, PLANT CELL, V17, P311, DOI 10.1105/tpc.104.027235; Sharma N., 2011, Asian Journal of Biochemistry, V6, P29, DOI 10.3923/ajb.2011.29.37; Shi XL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055090; Silva Y, 2013, PHYSIOL MOL PLANT P, V84, P99, DOI 10.1016/j.pmpp.2013.08.001; Son GH, 2012, MOL PLANT MICROBE IN, V25, P48, DOI 10.1094/MPMI-06-11-0165; SONG WY, 1995, SCIENCE, V270, P1804, DOI 10.1126/science.270.5243.1804; Tang DZ, 2005, PLANT PHYSIOL, V138, P1018, DOI 10.1104/pp.105.060400; Todd J, 1999, PLANT J, V17, P119, DOI 10.1046/j.1365-313X.1999.00352.x; Tornero P, 1997, J BIOL CHEM, V272, P14412, DOI 10.1074/jbc.272.22.14412; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Van Verk MC, 2013, TRENDS PLANT SCI, V18, P175, DOI 10.1016/j.tplants.2013.02.001; Verlaan MG, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003399; Verlaan MG, 2011, PLANT J, V68, P1093, DOI 10.1111/j.1365-313X.2011.04762.x; von Roepenack-Lahaye E, 2003, J BIOL CHEM, V278, P43373, DOI 10.1074/jbc.M305084200; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Westermann AJ, 2012, NAT REV MICROBIOL, V10, P618, DOI 10.1038/nrmicro2852; Whitham SA, 2000, PLANT CELL, V12, P569, DOI 10.1105/tpc.12.4.569; Yang KY, 2001, P NATL ACAD SCI USA, V98, P741, DOI 10.1073/pnas.98.2.741; ZAMIR D, 1994, THEOR APPL GENET, V88, P141, DOI 10.1007/BF00225889; Zhang FJ, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-303; Zhang H, 2009, VIRUS GENES, V39, P249, DOI 10.1007/s11262-009-0384-8; Zheng ZY, 2009, PLANT J, V57, P1040, DOI 10.1111/j.1365-313X.2008.03747.x	85	110	118	5	89	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80816	10.1371/journal.pone.0080816	http://dx.doi.org/10.1371/journal.pone.0080816			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260487	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500178
J	Dunn, SJ; Nathke, IS; Osborne, JM				Dunn, Sara-Jane; Naethke, Inke S.; Osborne, James M.			Computational Models Reveal a Passive Mechanism for Cell Migration in the Crypt	PLOS ONE			English	Article							INTESTINAL CRYPT; STEM-CELLS; ADENOMATOUS-POLYPOSIS; MONOCLONAL CONVERSION; BETA-CATENIN; PROLIFERATION; DIFFERENTIATION; RENEWAL; CANCER; ORGANIZATION	Cell migration in the intestinal crypt is essential for the regular renewal of the epithelium, and the continued upward movement of cells is a key characteristic of healthy crypt dynamics. However, the driving force behind this migration is unknown. Possibilities include mitotic pressure, active movement driven by motility cues, or negative pressure arising from cell loss at the crypt collar. It is possible that a combination of factors together coordinate migration. Here, three different computational models are used to provide insight into the mechanisms that underpin cell movement in the crypt, by examining the consequence of eliminating cell division on cell movement. Computational simulations agree with existing experimental results, confirming that migration can continue in the absence of mitosis. Importantly, however, simulations allow us to infer mechanisms that are sufficient to generate cell movement, which is not possible through experimental observation alone. The results produced by the three models agree and suggest that cell loss due to apoptosis and extrusion at the crypt collar relieves cell compression below, allowing cells to expand and move upwards. This finding suggests that future experiments should focus on the role of apoptosis and cell extrusion in controlling cell migration in the crypt.	[Dunn, Sara-Jane; Osborne, James M.] Microsoft Res Ltd, Sci Computat Lab, Cambridge, England; [Naethke, Inke S.] Univ Dundee, Div Cell & Dev Biol, Dundee, Scotland; [Osborne, James M.] Univ Oxford, Dept Comp Sci, Oxford, England	Microsoft; University of Dundee; University of Oxford	Dunn, SJ (corresponding author), Microsoft Res Ltd, Sci Computat Lab, Cambridge, England.	sara-jane.dunn@microsoft.com	Osborne, James/B-4214-2017	Osborne, James/0000-0002-5622-0104; Nathke, Inke/0000-0003-2420-4385	Cancer Research UK [C430/A11243]; Systems Approaches to Biomedical Science Industrial Doctorate Centres [EP/E501605/1, EP/G50029/1, EP/G037280/1]; Microsoft Research through the 2020 Science Project; EPSRC through the Life Sciences Interface, the Systems Biology; Cancer Research UK [11243] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Systems Approaches to Biomedical Science Industrial Doctorate Centres; Microsoft Research through the 2020 Science Project(Microsoft); EPSRC through the Life Sciences Interface, the Systems Biology(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Cancer Research UK(Cancer Research UK)	This work was supported by funding from Cancer Research UK to ISN, grant number C430/A11243. JMO is supported by the EPSRC through the Life Sciences Interface, the Systems Biology, and the Systems Approaches to Biomedical Science Industrial Doctorate Centres (EP/E501605/1, EP/G50029/1 and EP/G037280/1 respectively) and Microsoft Research through the 2020 Science Project. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alberts B, 2002, MOL BIOL CELL; Barker N, 2009, NATURE, V457, P608, DOI 10.1038/nature07602; Batlle E, 2002, CELL, V111, P251, DOI 10.1016/S0092-8674(02)01015-2; Boman BM, 2004, AM J PATHOL, V165, P1489, DOI 10.1016/S0002-9440(10)63407-4; Buske P, 2012, FEBS J, V279, P3475, DOI 10.1111/j.1742-4658.2012.08646.x; Buske P, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001045; CHENG H, 1974, AM J ANAT, V141, P461, DOI 10.1002/aja.1001410403; Crosnier C, 2006, NAT REV GENET, V7, P349, DOI 10.1038/nrg1840; Drasdo D, 2001, NONLINEAR ANAL-THEOR, V47, P245, DOI 10.1016/S0362-546X(01)00173-0; Dunn SJ, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002515; Dunn SJ, 2012, J THEOR BIOL, V298, P82, DOI 10.1016/j.jtbi.2011.12.013; Eisenhoffer GT, 2012, NATURE, V484, P546, DOI 10.1038/nature10999; FENN R, 2001, GEOMETRY; FINNEY KJ, 1989, VIRCHOWS ARCH B, V56, P397; Fletcher AG, 2012, J THEOR BIOL, V300, P118, DOI 10.1016/j.jtbi.2012.01.021; Fodde R, 2007, CURR OPIN CELL BIOL, V19, P150, DOI 10.1016/j.ceb.2007.02.007; Fodde R, 2010, J PATHOL, V221, P239, DOI 10.1002/path.2718; FRISCH SM, 1994, J CELL BIOL, V124, P619, DOI 10.1083/jcb.124.4.619; Galle J, 2005, BIOPHYS J, V88, P62, DOI 10.1529/biophysj.104.041459; Gaspar C, 2004, INT J DEV BIOL, V48, P377, DOI 10.1387/ijdb.041807cg; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Haramis APG, 2004, SCIENCE, V303, P1684, DOI 10.1126/science.1093587; Heath JP, 1996, CELL BIOL INT, V20, P139, DOI 10.1006/cbir.1996.0018; Humphries A, 2008, NAT REV CANCER, V8, P415, DOI 10.1038/nrc2392; KAUR P, 1986, CELL TISSUE KINET, V19, P601, DOI 10.1111/j.1365-2184.1986.tb00761.x; KAUR P, 1986, CELL TISSUE KINET, V19, P591, DOI 10.1111/j.1365-2184.1986.tb00760.x; KAUR P, 1986, CELL TISSUE KINET, V19, P611, DOI 10.1111/j.1365-2184.1986.tb00762.x; LOEFFLER M, 1988, CELL TISSUE KINET, V21, P247, DOI 10.1111/j.1365-2184.1988.tb00784.x; LOEFFLER M, 1986, CELL TISSUE KINET, V19, P627, DOI 10.1111/j.1365-2184.1986.tb00763.x; Mahmoud NN, 1997, CANCER RES, V57, P5045; Meineke FA, 2001, CELL PROLIFERAT, V34, P253, DOI 10.1046/j.0960-7722.2001.00216.x; MEINZER HP, 1992, CELL PROLIFERAT, V25, P125, DOI 10.1111/j.1365-2184.1992.tb01486.x; Mirams GR, 2013, PLOS COMPUT BIOL, V9, DOI 10.1371/journal.pcbi.1002970; Mirams GR, 2012, J THEOR BIOL, V312, P143, DOI 10.1016/j.jtbi.2012.08.002; Nathke I, 2006, NAT REV CANCER, V6, P967, DOI 10.1038/nrc2010; Nathke IS, 2004, ANNU REV CELL DEV BI, V20, P337, DOI 10.1146/annurev.cellbio.20.012103.094541; NATHKE IS, 2013, UNPUB; NEAL JV, 1981, GUT, V22, P19, DOI 10.1136/gut.22.1.19; Nelson SA, 2012, DIS MODEL MECH, V5, P940, DOI 10.1242/dmm.008607; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; O'Rourke J, 1998, COMPUTATIONAL GEOMET; Osborne JM, 2010, PHILOS T R SOC A, V368, P5013, DOI 10.1098/rsta.2010.0173; PAULUS U, 1992, CELL PROLIFERAT, V25, P559, DOI 10.1111/j.1365-2184.1992.tb01460.x; POTTEN CS, 1990, INT J RADIAT BIOL, V57, P185, DOI 10.1080/09553009014550431; Ramis-Conde I, 2008, BIOPHYS J, V95, P155, DOI 10.1529/biophysj.107.114678; Sancho E, 2003, CURR OPIN CELL BIOL, V15, P763, DOI 10.1016/j.ceb.2003.10.012; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Smallwood R, 2009, WIRES SYST BIOL MED, V1, P191, DOI 10.1002/wsbm.18; TOTAFURNO J, 1987, BIOPHYS J, V52, P279, DOI 10.1016/S0006-3495(87)83215-0; van der Flier LG, 2009, ANNU REV PHYSIOL, V71, P241, DOI 10.1146/annurev.physiol.010908.163145; van Leeuwen IMM, 2009, CELL PROLIFERAT, V42, P617, DOI 10.1111/j.1365-2184.2009.00627.x; Windham TC, 2002, ONCOGENE, V21, P7797, DOI 10.1038/sj.onc.1205989; Wong SY, 2010, J R SOC INTERFACE, V7, pS351, DOI 10.1098/rsif.2010.0018.focus; Wright N, 1984, BIOL EPITHELIAL CELL	54	37	37	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80516	10.1371/journal.pone.0080516	http://dx.doi.org/10.1371/journal.pone.0080516			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260407	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500147
J	Kunda, S; Cheriyan, J; Hur, M; Balsara, RD; Castellino, FJ				Kunda, Shailaja; Cheriyan, John; Hur, Michael; Balsara, Rashna D.; Castellino, Francis J.			Antagonist Properties of Conus parius Peptides on N-Methyl-D-Aspartate Receptors and Their Effects on CREB Signaling	PLOS ONE			English	Article							CONANTOKIN-G; GAMMA-CARBOXYGLUTAMATE; BINDING PROPERTIES; IN-VITRO; CALCIUM-CHANNEL; NMDA; SUBUNIT; VENOM; EXPRESSION; SUBTYPE	Three members of a family of small neurotoxic peptides from the venom of Conus parius, conantokins (Con) Pr1, Pr2, and Pr3, function as antagonists of N-methyl-D-aspartate receptors (NMDAR). We report structural characterizations of these synthetic peptides, and also demonstrate their antagonistic properties toward ion flow through NMDAR ion channels in primary neurons. ConPr1 and ConPr2 displayed moderate increases in alpha-helicity after addition of Mg2+. Native apo-ConPr3 possessed an a-helical conformation, and the helicity increased only slightly on addition of Mg2+. Additionally, these peptides diminished NMDA/Gly-mediated currents and intracellular Ca2+ (iCa(2+)) influx in mature rat primary hippocampal neurons. Electrophysiological data showed that these peptides displayed slower antagonistic properties toward the NMDAR than conantokins from other species of cone snails, e. g., ConT and ConG. Furthermore, to demonstrate selectivity of the C. parius-derived conantokins towards specific NMDAR subunits, cortical neurons from GluN2A(-/-) and GluN2B(-/-) mice were utilized. Robust inhibition of NMDAR-mediated stimulation in GluN2A(-/-)-derived mouse neurons, as compared to those isolated from GluN2B(-/-)-mouse brains, was observed, suggesting a greater selectivity of these antagonists towards the GluN2B subunit. These C. parius conantokins mildly inhibited NMDAR-induced phosphorylation of CREB at Ser(133), suggesting that the peptides modulated iCa(2+) entry and, thereby, activation of CREB, a transcription factor that is required for maintaining long-term synaptic activity. Our data mechanistically show that while these peptides effectively antagonize NMDAR-directed current and iCa(2+) influx, receptor-coupled CREB signaling is maintained. The consequence of sustained CREB signaling is improved neuronal plasticity and survival during neuropathologies.	[Castellino, Francis J.] Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA; Univ Notre Dame, Dept Chem & Biochem, Notre Dame, IN 46556 USA	University of Notre Dame; University of Notre Dame	Castellino, FJ (corresponding author), Univ Notre Dame, WM Keck Ctr Transgene Res, Notre Dame, IN 46556 USA.	fcastell@nd.edu			National Institutes of Health [HL019982]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL019982] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported by National Institutes of Health grant HL019982. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alex AB, 2006, J NEUROPHYSIOL, V96, P1084, DOI 10.1152/jn.01325.2005; Arundine M, 2004, J NEUROSCI, V24, P8106, DOI 10.1523/JNEUROSCI.1362-04.2004; Arzberger T, 1997, J NEUROPATH EXP NEUR, V56, P440, DOI 10.1097/00005072-199704000-00013; Auberson YP, 2002, BIOORG MED CHEM LETT, V12, P1099, DOI 10.1016/S0960-894X(02)00074-4; BADING H, 1991, SCIENCE, V253, P912, DOI 10.1126/science.1715095; Balsara R, 2012, NEUROPHARMACOLOGY, V62, P2227, DOI 10.1016/j.neuropharm.2012.01.018; BANKER GA, 1977, BRAIN RES, V126, P397, DOI 10.1016/0006-8993(77)90594-7; Blandl T, 1997, BIOCHEM J, V328, P777, DOI 10.1042/bj3280777; BLISS TVP, 1973, J PHYSIOL-LONDON, V232, P331, DOI 10.1113/jphysiol.1973.sp010273; BURNASHEV N, 1992, SCIENCE, V257, P1415, DOI 10.1126/science.1382314; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; Chen ZG, 1998, J BIOL CHEM, V273, P16248, DOI 10.1074/jbc.273.26.16248; Cnudde SE, 2007, J AM CHEM SOC, V129, P1586, DOI 10.1021/ja065722q; COLPITTS TL, 1994, BIOCHEMISTRY-US, V33, P3501, DOI 10.1021/bi00178a006; Cull-Candy S, 2001, CURR OPIN NEUROBIOL, V11, P327, DOI 10.1016/S0959-4388(00)00215-4; Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16; Dai QY, 2007, J BIOL CHEM, V282, P12641, DOI 10.1074/jbc.M609087200; El Gaamouch F, 2012, J NEUROSCI, V32, P10767, DOI 10.1523/JNEUROSCI.5622-11.2012; Furukawa H, 2005, NATURE, V438, P185, DOI 10.1038/nature04089; Gowd KH, 2012, BIOCHEMISTRY-US, V51, P4685, DOI 10.1021/bi300055n; HAACK JA, 1990, J BIOL CHEM, V265, P6025; Hardingham GE, 2002, BBA-PROTEINS PROTEOM, V1600, P148, DOI 10.1016/S1570-9639(02)00455-7; Huang LX, 2010, MOL CELL NEUROSCI, V45, P163, DOI 10.1016/j.mcn.2010.06.007; Kemp JA, 2002, NAT NEUROSCI, V5, P1039, DOI 10.1038/nn936; Klein RC, 2001, NEUROPHARMACOLOGY, V41, P801, DOI 10.1016/S0028-3908(01)00119-8; Klein RC, 2001, J NEUROCHEM, V76, P1663, DOI 10.1046/j.1471-4159.2001.00170.x; Kutsuwada T, 1996, NEURON, V16, P333, DOI 10.1016/S0896-6273(00)80051-3; LIPTON SA, 1994, DEV NEUROSCI-BASEL, V16, P145, DOI 10.1159/000112101; Mallon AP, 2005, EXP BRAIN RES, V162, P374, DOI 10.1007/s00221-004-2193-6; Malmberg AB, 2003, PAIN, V101, P109, DOI 10.1016/S0304-3959(02)00303-2; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Martel MA, 2009, NEUROSCIENCE, V158, P334, DOI 10.1016/j.neuroscience.2008.01.080; Martel MA, 2012, NEURON, V74, P543, DOI 10.1016/j.neuron.2012.03.021; MCINTOSH JM, 1984, J BIOL CHEM, V259, P4343; Miao YY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042318; Moddel G, 2005, BRAIN RES, V1046, P10, DOI 10.1016/j.brainres.2005.03.042; Platt RJ, 2012, J BIOL CHEM, V287, P20727, DOI 10.1074/jbc.M112.350462; Prorok M, 1996, BIOCHEMISTRY-US, V35, P16528, DOI 10.1021/bi9621122; Prorok M, 2001, CURR DRUG TARGETS, V2, P313, DOI 10.2174/1389450013348542; Prorok M, 1996, INT J PEPT PROT RES, V48, P281; SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0; Sheng ZY, 2007, NEUROPHARMACOLOGY, V53, P145, DOI 10.1016/j.neuropharm.2007.04.016; Skjaerbaek N, 1997, J BIOL CHEM, V272, P2291; Teichert RW, 2007, J BIOL CHEM, V282, P36905, DOI 10.1074/jbc.M706611200; Terlau H, 2004, PHYSIOL REV, V84, P41, DOI 10.1152/physrev.00020.2003; Warder SE, 1998, J BIOL CHEM, V273, P7512, DOI 10.1074/jbc.273.13.7512; Warder SE, 1997, FEBS LETT, V411, P19, DOI 10.1016/S0014-5793(97)00573-5; Wei JJ, 2006, NEUROSCI LETT, V405, P137, DOI 10.1016/j.neulet.2006.06.040; White HS, 2000, J PHARMACOL EXP THER, V292, P425; Williams AJ, 2003, EXP BRAIN RES, V153, P16, DOI 10.1007/s00221-003-1566-6; Williams AJ, 2000, J PHARMACOL EXP THER, V294, P378; Xiao C, 2008, NEUROPEPTIDES, V42, P601, DOI 10.1016/j.npep.2008.09.003	52	6	6	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81405	10.1371/journal.pone.0081405	http://dx.doi.org/10.1371/journal.pone.0081405			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260577	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500207
J	Norman, AJ; Street, NR; Spong, G				Norman, Anita J.; Street, Nathaniel R.; Spong, Goran			De Novo SNP Discovery in the Scandinavian Brown Bear (Ursus arctos)	PLOS ONE			English	Article							NUCLEOTIDE POLYMORPHISM DISCOVERY; MULTILOCUS GENOTYPE DATA; EXTRA-PAIR PATERNITY; PRUDHOE BAY-REGION; POPULATION-STRUCTURE; MITOCHONDRIAL-DNA; GENETIC-VARIATION; GRIZZLY BEARS; RELATEDNESS; INFERENCE	Information about relatedness between individuals in wild populations is advantageous when studying evolutionary, behavioural and ecological processes. Genomic data can be used to determine relatedness between individuals either when no prior knowledge exists or to confirm suspected relatedness. Here we present a set of 96 SNPs suitable for inferring relatedness for brown bears (Ursus arctos) within Scandinavia. We sequenced reduced representation libraries from nine individuals throughout the geographic range. With consensus reads containing putative SNPs, we applied strict filtering criteria with the aim of finding only high-quality, highly-informative SNPs. We tested 150 putative SNPs of which 96% were validated on a panel of 68 individuals. Ninety-six of the validated SNPs with the highest minor allele frequency were selected. The final SNP panel includes four mitochondrial markers, two monomorphic Y-chromosome sex-determination markers, three X-chromosome SNPs and 87 autosomal SNPs. From our validation sample panel, we identified two previously known parent-offspring dyads with reasonable accuracy. This panel of SNPs is a promising tool for inferring relatedness in the brown bear population in Scandinavia.	[Norman, Anita J.; Spong, Goran] Swedish Univ Agr Sci, Mol Ecol Res Grp, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden; [Street, Nathaniel R.] Umea Univ, Dept Plant Physiol, Umea Plant Sci Ctr, S-90187 Umea, Sweden	Swedish University of Agricultural Sciences; Umea University	Norman, AJ (corresponding author), Swedish Univ Agr Sci, Mol Ecol Res Grp, Dept Wildlife Fish & Environm Studies, S-90183 Umea, Sweden.	Anita.Norman@slu.se	Norman, Anita/H-3341-2019; Street, Nathaniel Robert/B-3920-2008	Norman, Anita/0000-0002-9499-758X; Street, Nathaniel Robert/0000-0001-6031-005X; Spong, Goran/0000-0002-1246-5046	Mauritz Carlgren Foundation; Fortlopande Miljoanalys (FOMA)	Mauritz Carlgren Foundation; Fortlopande Miljoanalys (FOMA)	Mauritz Carlgren Foundation, Fortlopande Miljoanalys (FOMA): Genetic Monitoring. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abecasis GR, 2001, BIOINFORMATICS, V17, P742, DOI 10.1093/bioinformatics/17.8.742; Altshuler D, 2000, NATURE, V407, P513, DOI 10.1038/35035083; Baird NA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003376; Barrowclough GF, 2005, MOL ECOL, V14, P1109, DOI 10.1111/j.1365-294X.2005.02465.x; BIRKHEAD TR, 1995, ANIM BEHAV, V49, P843, DOI 10.1016/0003-3472(95)80217-7; Bohling JH, 2011, MOL ECOL, V20, P2142, DOI 10.1111/j.1365-294X.2011.05084.x; Broquet T, 2009, ANNU REV ECOL EVOL S, V40, P193, DOI 10.1146/annurev.ecolsys.110308.120324; Catchen JM, 2011, G3-GENES GENOM GENET, V1, P171, DOI 10.1534/g3.111.000240; Creel S, 2003, MOL ECOL, V12, P2003, DOI 10.1046/j.1365-294X.2003.01868.x; Cronin M, 1999, J HERED, V90, P622, DOI 10.1093/jhered/90.6.622; Cronin MA, 2005, URSUS, V16, P70, DOI 10.2192/1537-6176(2005)016[0070:GVARIG]2.0.CO;2; Cronin MA, 2009, J HERED, V100, P681, DOI 10.1093/jhered/esp061; Csillery K, 2006, GENETICS, V173, P2091, DOI 10.1534/genetics.106.057331; Falush D, 2003, GENETICS, V164, P1567; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; Foulkes A. S., 2009, APPL STAT GENETICS R, P1; Fung WK, 2002, INT J LEGAL MED, V116, P64, DOI 10.1007/s004140100210; Glaubitz JC, 2003, MOL ECOL, V12, P1039, DOI 10.1046/j.1365-294X.2003.01790.x; Griffith SC, 2002, MOL ECOL, V11, P2195, DOI 10.1046/j.1365-294X.2002.01613.x; Hellborg L, 2004, MOL BIOL EVOL, V21, P158, DOI 10.1093/molbev/msh008; Hellborg L, 2003, MOL ECOL, V12, P283, DOI 10.1046/j.1365-294X.2003.01702.x; Houston DD, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-724; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jones JC, 2013, MOL ECOL, V22, P2986, DOI 10.1111/mec.12269; Keller L, 2002, CONSERV BIOL, V17, P19, DOI DOI 10.1016/S0169-5347(02)02489-8; Kindberg J, 2011, WILDLIFE BIOL, V17, P114, DOI 10.2981/10-100; Kraus RHS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-150; Krawczak M, 1999, ELECTROPHORESIS, V20, P1676, DOI 10.1002/(SICI)1522-2683(19990101)20:8<1676::AID-ELPS1676>3.3.CO;2-4; Langmead B, 2012, NAT METHODS, V9, P357, DOI [10.1038/nmeth.1923, 10.1038/NMETH.1923]; Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338; Luikart G, 2003, NAT REV GENET, V4, P981, DOI 10.1038/nrg1226; Lynch M, 1999, GENETICS, V152, P1753; Mardis ER, 2011, NATURE, V470, P198, DOI 10.1038/nature09796; Martin M., 2011, EMBNET J, V17, P10, DOI 10.14806/ej.17.1.200; Miller W, 2012, P NATL ACAD SCI USA, V109; Nelson JC, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-352; Onorato DP, 2004, CAN J ZOOL, V82, P1201, DOI 10.1139/Z04-097; Pritchard JK, 2000, GENETICS, V155, P945; R Development Core Team, 2013, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Rosenberg NA, 2003, AM J HUM GENET, V73, P1402, DOI 10.1086/380416; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Senn H, 2013, MOL ECOL, V22, P3141, DOI 10.1111/mec.12242; Shin J-H., 2006, J STAT SOFTW, V16, P1, DOI [10.18637/jss.v016.c03, DOI 10.18637/JSS.V016.C03]; Spong GF, 2008, MOL ECOL, V17, P2287, DOI 10.1111/j.1365-294X.2008.03734.x; SWENSON JE, 1994, BIOL CONSERV, V70, P9, DOI 10.1016/0006-3207(94)90293-3; TABERLET P, 1994, P ROY SOC B-BIOL SCI, V255, P195, DOI 10.1098/rspb.1994.0028; Vandepitte K, 2013, MOL ECOL RESOUR, V13, P269, DOI 10.1111/1755-0998.12039; Vignal A, 2002, GENET SEL EVOL, V34, P275, DOI [10.1186/1297-9686-34-3-275, 10.1051/gse:2002009]; Vinogradov AE, 1998, CYTOMETRY, V31, P100, DOI 10.1002/(SICI)1097-0320(19980201)31:2<100::AID-CYTO5>3.0.CO;2-Q; Wang JL, 2011, MOL ECOL RESOUR, V11, P141, DOI 10.1111/j.1755-0998.2010.02885.x	52	22	22	0	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81012	10.1371/journal.pone.0081012	http://dx.doi.org/10.1371/journal.pone.0081012			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260529	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500190
J	Roy-Dufresne, E; Logan, T; Simon, JA; Chmura, GL; Millien, V				Roy-Dufresne, Emilie; Logan, Travis; Simon, Julie A.; Chmura, Gail L.; Millien, Virginie			Poleward Expansion of the White-Footed Mouse (Peromyscus leucopus) under Climate Change: Implications for the Spread of Lyme Disease	PLOS ONE			English	Article							SPECIES DISTRIBUTION MODELS; IXODES-SCAPULARIS TICKS; BORRELIA-BURGDORFERI; PASSIVE SURVEILLANCE; FOREST FRAGMENTATION; RANGE EXPANSION; MICE; PREDICTION; EMERGENCE; RESPONSES	The white-footed mouse (Peromyscus leucopus) is an important reservoir host for Borrelia burgdorferi, the pathogen responsible for Lyme disease, and its distribution is expanding northward. We used an Ecological Niche Factor Analysis to identify the climatic factors associated with the distribution shift of the white-footed mouse over the last 30 years at the northern edge of its range, and modeled its current and potential future (2050) distributions using the platform BIOMOD. A mild and shorter winter is favouring the northern expansion of the white-footed mouse in Quebec. With more favorable winter conditions projected by 2050, the distribution range of the white-footed mouse is expected to expand further northward by 3 degrees latitude. We also show that today in southern Quebec, the occurrence of B. burgdorferi is associated with high probability of presence of the white-footed mouse. Changes in the distribution of the white-footed mouse will likely alter the geographical range of B. burgdorferi and impact the public health in northern regions that have yet to be exposed to Lyme disease.	[Roy-Dufresne, Emilie; Chmura, Gail L.] McGill Univ, Dept Geog, Montreal, PQ, Canada; [Roy-Dufresne, Emilie; Simon, Julie A.; Millien, Virginie] McGill Univ, Redpath Museum, Montreal, PQ H3A 2K6, Canada; [Logan, Travis] Ouranos Consortium, Montreal, PQ, Canada	McGill University; McGill University; Ouranos Consortium	Millien, V (corresponding author), McGill Univ, Redpath Museum, 859 Sherbrooke St W, Montreal, PQ H3A 2K6, Canada.	virginie.millien@mcgill.ca	Millien, Virginie/D-6457-2013; DeHaas, Keith/I-4957-2017	Millien, Virginie/0000-0002-1390-766X; Roy-Dufresne, Emilie/0000-0001-5151-5483; Chmura, Gail/0000-0001-7163-3903	Ouranos Consortium (Fonds vert, PACC 26 - Ouranos); Quebec Centre for Biodiversity Science (QCBS); Global Environmental and Climate Change Center (GEC3); NSERC	Ouranos Consortium (Fonds vert, PACC 26 - Ouranos); Quebec Centre for Biodiversity Science (QCBS); Global Environmental and Climate Change Center (GEC3); NSERC(Natural Sciences and Engineering Research Council of Canada (NSERC))	This work was supported by a grant from the Ouranos Consortium (Fonds vert, PACC 26 - Ouranos) to VM, awards from the Quebec Centre for Biodiversity Science (QCBS) and the Global Environmental and Climate Change Center (GEC3) to ERD, and a NSERC Discovery grant to GC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan BF, 2003, CONSERV BIOL, V17, P267, DOI 10.1046/j.1523-1739.2003.01260.x; Allouche O, 2006, J APPL ECOL, V43, P1223, DOI 10.1111/j.1365-2664.2006.01214.x; ANDREWARTHA HG, 1954, DISTRIBUTION ABUNDAN; [Anonymous], 2000, SPECIAL REPORT EMISS; Araujo MB, 2012, ECOLOGY, V93, P1527, DOI 10.1890/11-1930.1; Barbet-Massin M, 2012, METHODS ECOL EVOL, V3, P327, DOI 10.1111/j.2041-210X.2011.00172.x; Bennie J, 2013, ECOL LETT, V16, P921, DOI 10.1111/ele.12129; Bouchard C, 2011, TICKS TICK-BORNE DIS, V2, P183, DOI 10.1016/j.ttbdis.2011.03.005; Bradshaw WE, 2001, P NATL ACAD SCI USA, V98, P14509, DOI 10.1073/pnas.241391498; Buteau P., 1996, MB9619, P44; Calenge C, 2006, ECOL MODEL, V197, P516, DOI 10.1016/j.ecolmodel.2006.03.017; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clotfelter ED, 2007, OECOLOGIA, V154, P493, DOI 10.1007/s00442-007-0859-z; DARK J, 1983, BIOL REPROD, V28, P213, DOI 10.1095/biolreprod28.1.213; Davis MB, 2001, SCIENCE, V292, P673, DOI 10.1126/science.292.5517.673; Desrosier N, 2002, ATLAS MICROMAMMIFERE; DONAHUE JG, 1987, AM J TROP MED HYG, V36, P92, DOI 10.4269/ajtmh.1987.36.92; Elith J, 2009, ANNU REV ECOL EVOL S, V40, P677, DOI 10.1146/annurev.ecolsys.110308.120159; ESRI, 2013, ARCGIS DESKT REL 10; FALCO RC, 1992, EXP APPL ACAROL, V14, P165, DOI 10.1007/BF01219108; Field Museum of natural History, 2008, COLL MAMM DAT; Fielding AH, 1997, ENVIRON CONSERV, V24, P38, DOI 10.1017/S0376892997000088; Guisan A, 2005, ECOL LETT, V8, P993, DOI 10.1111/j.1461-0248.2005.00792.x; Hernandez PA, 2006, ECOGRAPHY, V29, P773, DOI 10.1111/j.0906-7590.2006.04700.x; Hirzel AH, 2002, ECOLOGY, V83, P2027, DOI 10.1890/0012-9658(2002)083[2027:ENFAHT]2.0.CO;2; HOWARD WE, 1951, J MAMMAL, V32, P300, DOI 10.2307/1375662; Huot M., 2012, PLAN GESTION CERF VI; Illoldi-Rangel P, 2012, J TROP MED-US, V2012, DOI 10.1155/2012/959101; Jones KE, 2008, NATURE, V451, P990, DOI 10.1038/nature06536; KEANE B, 1990, ANIM BEHAV, V40, P143, DOI 10.1016/S0003-3472(05)80674-8; Koffi JK, 2012, J MED ENTOMOL, V49, P400, DOI 10.1603/ME11210; La Sorte FA, 2012, J ANIM ECOL, V81, P914, DOI 10.1111/j.1365-2656.2012.01958.x; Linzey A. V, 2008, IUCN RED LIST THREAT, DOI 10.2305/IUCN.UK.2008.RLTS.T6682A12795176.en; Lobo JM, 2011, J NAT CONSERV, V19, P1, DOI 10.1016/j.jnc.2010.03.002; Lobo JM, 2010, ECOGRAPHY, V33, P103, DOI 10.1111/j.1600-0587.2009.06039.x; LONG C A, 1973, Southwestern Naturalist, V18, P11, DOI 10.2307/3669906; Long CA, 1996, CAN FIELD NAT, V110, P271; MacArthur R.H., 1972, pvii; MacMillen R.E., 1989, P143; Marmion M, 2009, DIVERS DISTRIB, V15, P59, DOI 10.1111/j.1472-4642.2008.00491.x; MARTENS WJM, 1995, GLOBAL ENVIRON CHANG, V5, P195, DOI 10.1016/0959-3780(95)00051-O; McKenney DW, 2006, AGR FOREST METEOROL, V138, P69, DOI 10.1016/j.agrformet.2006.03.012; Meehl GA, 2007, B AM METEOROL SOC, V88, P1383, DOI 10.1175/BAMS-88-9-1383; Music B, 2007, J HYDROMETEOROL, V8, P969, DOI 10.1175/JHM627.1; Myers Philip, 2005, University of California Publications in Zoology, V133, P101; Myers P, 2009, GLOBAL CHANGE BIOL, V15, P1434, DOI 10.1111/j.1365-2486.2009.01846.x; Ogden NH, 2011, APPL ENVIRON MICROB, V77, P3244, DOI 10.1128/AEM.02636-10; Ogden NH, 2006, INT J PARASITOL, V36, P63, DOI 10.1016/j.ijpara.2005.08.016; Ogden NH, 2010, ENVIRON HEALTH PERSP, V118, P909, DOI 10.1289/ehp.0901766; Ogden NH, 2008, INT J HEALTH GEOGR, V7, DOI 10.1186/1476-072X-7-24; Ostfeld R. S., 2011, LYME DIS ECOLOGY COM; Ostfeld RS, 2005, TRENDS ECOL EVOL, V20, P328, DOI 10.1016/j.tree.2005.03.009; Pachauri R.K, 2007, CLIMATE CHANGE 2007, P104; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2001, FINGERPRINTS OF CLIMATE CHANGE, P57; Penuelas J, 2001, SCIENCE, V294, P793, DOI 10.1126/science.1066860; Peterson AT, 2008, NATURWISSENSCHAFTEN, V95, P483, DOI 10.1007/s00114-008-0352-5; R Development Core Team, 2012, R LANG ENV STAT COMP; Reino L, 2013, DIVERS DISTRIB, V19, P423, DOI 10.1111/ddi.12019; Rizkalla CE, 2007, BIOL CONSERV, V140, P339, DOI 10.1016/j.biocon.2007.08.019; Rogic A, 2013, ECOL EVOL, V3, P2075, DOI 10.1002/ece3.620; Root TL, 2003, NATURE, V421, P57, DOI 10.1038/nature01333; Schwanz LE, 2011, VECTOR-BORNE ZOONOT, V11, P117, DOI 10.1089/vbz.2009.0215; Shoo LP, 2006, AUSTRAL ECOL, V31, P22, DOI 10.1111/j.1442-9993.2006.01539.x; Thuiller W, 2003, GLOBAL CHANGE BIOL, V9, P1353, DOI 10.1046/j.1365-2486.2003.00666.x; Thuiller W, 2009, ECOGRAPHY, V32, P369, DOI 10.1111/j.1600-0587.2008.05742.x; Walther GR, 2009, TRENDS ECOL EVOL, V24, P686, DOI 10.1016/j.tree.2009.06.008; Wilder SM, 2005, AM MIDL NAT, V153, P71, DOI 10.1674/0003-0031(2005)153[0071:TEOFFO]2.0.CO;2; Xu C, 2014, GLOBAL ECOL BIOGEOGR, V23, P436, DOI 10.1111/geb.12108	69	55	58	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80724	10.1371/journal.pone.0080724	http://dx.doi.org/10.1371/journal.pone.0080724			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260464	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500171
J	Seijsing, J; Lindborg, M; Lofblom, J; Uhlen, M; Graslund, T				Seijsing, Johan; Lindborg, Malin; Lofblom, John; Uhlen, Mathias; Graslund, Torbjorn			Robust Expression of the Human Neonatal Fc Receptor in a Truncated Soluble Form and as a Full-Length Membrane-Bound Protein in Fusion with eGFP	PLOS ONE			English	Article							I-RELATED RECEPTOR; PH-DEPENDENT BINDING; IMMUNOGLOBULIN-G; CRYSTAL-STRUCTURE; FUNCTIONAL EXPRESSION; IGG; COMPLEX; CELLS; GENERATION; ANTIBODIES	Studies on the neonatal Fc receptor (FcRn) have revealed a multitude of important functions in mammals, including protection of IgG and serum albumin (SA) from lysosomal degradation. The pharmacokinetic behavior of therapeutic antibodies, IgG-Fc- and SA-containing drugs is therefore influenced by their interaction with FcRn. Pre-clinical development of such drugs is facilitated if their interaction with FcRn can be studied in vitro. For this reason we have developed a robust system for production of the soluble extracellular domain of human FcRn as well as the full-length receptor as fusion to green fluorescent protein, taking advantage of a lentivirus-based gene delivery system where stable over-expressing cells are easily and rapidly generated. Production of the extracellular domain in multiple-layered culture flasks, followed by affinity purification using immobilized IgG, resulted in capture of milligram amounts of soluble receptor per liter cell culture with retained IgG binding. The receptor was further characterized by SDS-PAGE, western blotting, circular dichroism spectroscopy, ELISA, surface plasmon resonance and a temperature stability assay showing a functional and stable protein of high purity. The full-length receptor was found to be successfully over-expressed in a membrane-bound form with retained pH-dependent IgG- and SA-binding.	[Seijsing, Johan; Lofblom, John; Uhlen, Mathias; Graslund, Torbjorn] KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden; [Lindborg, Malin] Affibody AB, Solna, Sweden	Royal Institute of Technology	Graslund, T (corresponding author), KTH Royal Inst Technol, Sch Biotechnol, Stockholm, Sweden.	torbjorn@biotech.kth.se	Uhlen, Mathias/B-3262-2016; Uhlen, Mathias/AAV-8746-2021	Uhlen, Mathias/0000-0002-4858-8056; Lofblom, John/0000-0001-9423-0541; Seijsing, Johan/0000-0002-5157-8764	Knut and Alice Wallenberg Foundation	Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation)	Funding provided by the Knut and Alice Wallenberg Foundation (http://www.wallenberg.com/kaw/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agoston D, 2006, J NEUROSCI RES, V67, P58; Akilesh S, 2007, J IMMUNOL, V179, P4580, DOI 10.4049/jimmunol.179.7.4580; Andersen JT, 2008, J IMMUNOL METHODS, V331, P39, DOI 10.1016/j.jim.2007.11.003; Andersen JT, 2006, EUR J IMMUNOL, V36, P3044, DOI 10.1002/eji.200636556; Andersen JT, 2010, J BIOL CHEM, V285, P4826, DOI 10.1074/jbc.M109.081828; Andersen JT, 2009, DRUG METAB PHARMACOK, V24, P318, DOI 10.2133/dmpk.24.318; Berntzen G, 2005, J IMMUNOL METHODS, V298, P93, DOI 10.1016/j.jim.2005.01.002; Bitonti AJ, 2004, P NATL ACAD SCI USA, V101, P9763, DOI 10.1073/pnas.0403235101; Borvak J, 1998, INT IMMUNOL, V10, P1289, DOI 10.1093/intimm/10.9.1289; BURMEISTER WP, 1994, NATURE, V372, P379, DOI 10.1038/372379a0; Charrier S, 2011, GENE THER, V18, P479, DOI 10.1038/gt.2010.163; Chaudhury C, 2006, BIOCHEMISTRY-US, V45, P4983, DOI 10.1021/bi052628y; Dall'Acqua WF, 2006, J BIOL CHEM, V281, P23514, DOI 10.1074/jbc.M604292200; Feng Y, 2011, PROTEIN EXPRES PURIF, V79, P66, DOI 10.1016/j.pep.2011.03.012; Gurbaxani B, 2006, MOL IMMUNOL, V43, P1462, DOI 10.1016/j.molimm.2005.07.032; Jakobsson J, 2003, J NEUROSCI RES, V73, P876, DOI 10.1002/jnr.10719; KIM JK, 1994, EUR J IMMUNOL, V24, P2429, DOI 10.1002/eji.1830241025; Kuo TT, 2009, J BIOL CHEM, V284, P8292, DOI 10.1074/jbc.M805877200; Larsson K, 2011, J IMMUNOL METHODS, V370, P14, DOI 10.1016/j.jim.2011.05.001; Leach JL, 1996, J IMMUNOL, V157, P3317; Lee CH, 2010, PROTEIN EXPRES PURIF, V71, P42, DOI 10.1016/j.pep.2009.12.004; Magistrelli G, 2012, J IMMUNOL METHODS, V375, P20, DOI 10.1016/j.jim.2011.09.002; Martin WL, 2001, MOL CELL, V7, P867, DOI 10.1016/S1097-2765(01)00230-1; Montoyo HP, 2009, P NATL ACAD SCI USA, V106, P2788, DOI 10.1073/pnas.0810796106; Ober RJ, 2001, INT IMMUNOL, V13, P1551, DOI 10.1093/intimm/13.12.1551; Ober RJ, 2004, J IMMUNOL, V172, P2021, DOI 10.4049/jimmunol.172.4.2021; RAGHAVAN M, 1995, BIOCHEMISTRY-US, V34, P14649, DOI 10.1021/bi00045a005; RAGHAVAN M, 1993, BIOCHEMISTRY-US, V32, P8654, DOI 10.1021/bi00084a037; Roopenian DC, 2007, NAT REV IMMUNOL, V7, P715, DOI 10.1038/nri2155; SIMISTER NE, 1989, NATURE, V337, P184, DOI 10.1038/337184a0; Spiekermann GM, 2002, J EXP MED, V196, P303, DOI 10.1084/jem.20020400; Suter DM, 2006, STEM CELLS, V24, P615, DOI 10.1634/stemcells.2005-0226; Tai K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046269; Weng ZP, 1998, J MOL BIOL, V282, P217, DOI 10.1006/jmbi.1998.2020; West AP, 2000, BIOCHEMISTRY-US, V39, P9698, DOI 10.1021/bi000749m; Yeung YA, 2009, J IMMUNOL, V182, P7663, DOI 10.4049/jimmunol.0804182; Zhou JC, 2003, J MOL BIOL, V332, P901, DOI 10.1016/S0022-2836(03)00952-5; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	38	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81350	10.1371/journal.pone.0081350	http://dx.doi.org/10.1371/journal.pone.0081350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260574	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500205
J	Westley, PAH; Stanley, R; Fleming, IA				Westley, Peter A. H.; Stanley, Ryan; Fleming, Ian A.			Experimental Tests for Heritable Morphological Color Plasticity in Non-Native Brown Trout (Salmo trutta) Populations	PLOS ONE			English	Article							ADAPTIVE PHENOTYPIC PLASTICITY; FRESH-WATER SCULPIN; COUNTERGRADIENT VARIATION; SEXUAL COLORATION; ATLANTIC SALMON; LIFE-HISTORY; LOCAL ADAPTATION; SOCKEYE-SALMON; REACTION NORMS; FISH	The success of invasive species is frequently attributed to phenotypic plasticity, which facilitates persistence in novel environments. Here we report on experimental tests to determine whether the intensity of cryptic coloration patterns in a global invader (brown trout, Salmo trutta) was primarily the result of plasticity or heritable variation. Juvenile F-1 offspring were created through experimental crosses of wild-caught parents and reared for 30 days in the laboratory in a split-brood design on either light or dark-colored gravel substrate. Skin and fin coloration quantified with digital photography and image analysis indicated strong plastic effects in response to substrate color; individuals reared on dark substrate had both darker melanin-based skin color and carotenoid-based fin colors than other members of their population reared on light substrate. Slopes of skin and fin color reaction norms were parallel between environments, which is not consistent with heritable population-level plasticity to substrate color. Similarly, we observed weak differences in population-level color within an environment, again suggesting little genetic control on the intensity of skin and fin colors. Taken as whole, our results are consistent with the hypothesis that phenotypic plasticity may have facilitated the success of brown trout invasions and suggests that plasticity is the most likely explanation for the variation in color intensity observed among these populations in nature.	Mem Univ Newfoundland, Dept Ocean Sci, St John, NF, Canada; Mem Univ Newfoundland, Dept Biol, St John, NF, Canada	Memorial University Newfoundland; Memorial University Newfoundland	Westley, PAH (corresponding author), Univ Washington, Sch Aquat & Fishery Sci, Seattle, WA 98195 USA.	resolute@uw.edu	Fleming, Ian/I-7217-2012		Natural Sciences and Engineering Research Council of Canada; Canada Foundation of Innovation; Institute of Biodiversity, Ecosystem Science and Sustainability, Memorial University of Newfoundland; Atlantic Salmon Federation; NSERC graduate student fellowship	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation of Innovation(Canada Foundation for Innovation); Institute of Biodiversity, Ecosystem Science and Sustainability, Memorial University of Newfoundland; Atlantic Salmon Federation; NSERC graduate student fellowship	This work was supported through the Natural Sciences and Engineering Research Council of Canada (www.nserc.ca), the major federal government granting agency for natural sciences in Canada. Infrastructure was funded by the Canada Foundation of Innovation. PAHW was funded by the Institute of Biodiversity, Ecosystem Science and Sustainability, Memorial University of Newfoundland, and the Atlantic Salmon Federation. RS was supported by an NSERC graduate student fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson DR., 2002, PRACTICAL INFORM THE, DOI DOI 10.1007/B97636; Aparicio E, 2005, J FISH BIOL, V67, P931, DOI 10.1111/j.1095-8649.2005.00794.x; Bergstrom CA, 2012, J EVOLUTION BIOL, V25, P2526, DOI 10.1111/j.1420-9101.2012.02624.x; BLANC JM, 1994, AQUAT LIVING RESOUR, V7, P133, DOI 10.1051/alr:1994016; Boersma M, 1998, AM NAT, V152, P237, DOI 10.1086/286164; Boulding EG, 2008, HEREDITY, V101, P381, DOI 10.1038/hdy.2008.67; Carlson SM, 2008, EVOL APPL, V1, P222, DOI 10.1111/j.1752-4571.2008.00025.x; Chapman LJ, 2000, ECOL LETT, V3, P387, DOI 10.1046/j.1461-0248.2000.00160.x; Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Chevin LM, 2011, J EVOLUTION BIOL, V24, P1462, DOI 10.1111/j.1420-9101.2011.02279.x; Craig JK, 2005, BIOL J LINN SOC, V84, P287, DOI 10.1111/j.1095-8312.2005.00430.x; Davidson AM, 2011, ECOL LETT, V14, P419, DOI 10.1111/j.1461-0248.2011.01596.x; Deere KA, 2012, P ROY SOC B-BIOL SCI, V279, P1684, DOI 10.1098/rspb.2011.2132; DONNELLY W A, 1991, North American Journal of Fisheries Management, V11, P206, DOI 10.1577/1548-8675(1991)011<0206:BCAOBT>2.3.CO;2; Donnelly W.A., 1993, Canadian Special Publication of Fisheries and Aquatic Sciences, V118, P25; DONNELLY WA, 1984, J FISH BIOL, V25, P183, DOI 10.1111/j.1095-8649.1984.tb04865.x; Donnelly WA, 1985, THESIS S FRASER U; Einum S, 1999, P ROY SOC B-BIOL SCI, V266, P2095, DOI 10.1098/rspb.1999.0893; Elliott J.M., 1994, QUANTITATIVE ECOLOGY; Garcia de Leaniz C, 2007, BIOL REV, V82, P173, DOI 10.1111/j.1469-185X.2006.00004.x; Ghalambor CK, 2007, FUNCT ECOL, V21, P394, DOI 10.1111/j.1365-2435.2007.01283.x; Grether GF, 2005, EVOLUTION, V59, P175, DOI 10.1111/j.0014-3820.2005.tb00904.x; Grether GF, 1999, P ROY SOC B-BIOL SCI, V266, P1317, DOI 10.1098/rspb.1999.0781; Grether GF, 2014, BIOL J LINN SOC, V112, P276, DOI 10.1111/bij.12064; Hoekstra HE, 2006, SCIENCE, V313, P101, DOI 10.1126/science.1126121; Houde A.E., 1997, SEX COLOR MATE CHOIC; Hulme PE, 2008, FUNCT ECOL, V22, P3, DOI 10.1111/j.1365-2435.2007.01369.x; Husby A, 2010, EVOLUTION, V64, P2221, DOI 10.1111/j.1558-5646.2010.00991.x; Hutchings JA, 2011, HEREDITY, V106, P421, DOI 10.1038/hdy.2010.166; Jonsson B, 2011, FISH FISH SER, V33, P517, DOI 10.1007/978-94-007-1189-1_10; Keeley ER, 2007, J EVOLUTION BIOL, V20, P725, DOI 10.1111/j.1420-9101.2006.01240.x; Klemetsen A, 2003, ECOL FRESHW FISH, V12, P1, DOI 10.1034/j.1600-0633.2003.00010.x; Kolar CS, 2001, TRENDS ECOL EVOL, V16, P199, DOI 10.1016/S0169-5347(01)02101-2; Magellan K, 2013, FRESHWATER BIOL, V58, P793, DOI 10.1111/fwb.12086; MILINSKI M, 1990, NATURE, V344, P330, DOI 10.1038/344330a0; Morris MRJ, 2011, EVOL APPL, V4, P444, DOI 10.1111/j.1752-4571.2010.00159.x; NELIS HJCF, 1988, J LIPID RES, V29, P491; Oke KB, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2013.1047; Olden JD, 2006, ECOL MONOGR, V76, P25, DOI 10.1890/05-0330; Pakkasmaa S, 2000, EVOL ECOL, V14, P721, DOI 10.1023/A:1011691810801; Pakkasmaa S, 2001, BIOL J LINN SOC, V72, P231, DOI 10.1111/j.1095-8312.2001.tb01313.x; Purchase CF, 2012, ECOL EVOL, V2, P2562, DOI 10.1002/ece3.364; Quinn T. P, 2018, BEHAV ECOLOGY PACIFI; R Core Development Team, 2009, R LANG ENV STAT COMP; Rajasingh H, 2007, CAN J FISH AQUAT SCI, V64, P1614, DOI 10.1139/F07-119; Ramstad KM, 2010, EVOL ECOL, V24, P391, DOI 10.1007/s10682-009-9313-5; Richards CL, 2006, ECOL LETT, V9, P981, DOI 10.1111/j.1461-0248.2006.00950.x; Ruesink JL, 2005, CONSERV BIOL, V19, P1883, DOI 10.1111/j.1523-1739.2005.00267.x-i1; Schaefer HM, 2006, P R SOC B, V273, P2427, DOI 10.1098/rspb.2006.3615; Stegen JC, 2004, CAN J ZOOL, V82, P889, DOI 10.1139/Z04-068; STEVEN DM, 1948, J EXP BIOL, V25, P369; STEVEN DM, 1947, NATURE, V160, P540, DOI 10.1038/160540a0; STEVEN DM, 1949, J EXP BIOL, V26, P295; Stevens M, 2007, BIOL J LINN SOC, V90, P211, DOI 10.1111/j.1095-8312.2007.00725.x; Stevens M, 2006, P R SOC B, V273, P2433, DOI 10.1098/rspb.2006.3614; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; Sugimoto M, 2002, MICROSC RES TECHNIQ, V58, P496, DOI 10.1002/jemt.10168; TAYLOR EB, 1991, AQUACULTURE, V98, P185, DOI 10.1016/0044-8486(91)90383-I; TAYLOR EB, 1990, J FISH BIOL, V37, P1, DOI 10.1111/j.1095-8649.1990.tb05922.x; Wedekind C, 2008, P ROY SOC B-BIOL SCI, V275, P1737, DOI 10.1098/rspb.2008.0072; West-Eberhard Mary Jane, 2003, pi; Westley PAH, 2012, THESIS MEMORIAL U NE; Westley PAH, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2327; Westley PAH, 2012, EVOL ECOL RES, V14, P147; Westley PAH, 2011, DIVERS DISTRIB, V17, P566, DOI 10.1111/j.1472-4642.2011.00751.x; Whiteley AR, 2011, ECOL FRESHW FISH, V20, P80, DOI 10.1111/j.1600-0633.2010.00461.x; Whiteley AR, 2009, EVOLUTION, V63, P1519, DOI 10.1111/j.1558-5646.2009.00627.x; Yeh PJ, 2004, AM NAT, V164, P531, DOI 10.1086/423825	68	14	14	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80401	10.1371/journal.pone.0080401	http://dx.doi.org/10.1371/journal.pone.0080401			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260385	Green Accepted, gold, Green Published			2022-12-25	WOS:000327308500133
J	Banerjee, P; Ghosh, S; Dutta, M; Subramani, E; Khalpada, J; RoyChoudhury, S; Chakravarty, B; Chaudhury, K				Banerjee, Priyanka; Ghosh, Sanghamitra; Dutta, Mainak; Subramani, Elavarasan; Khalpada, Jaydeep; RoyChoudhury, Sourav; Chakravarty, Baidyanath; Chaudhury, Koel			Identification of Key Contributory Factors Responsible for Vascular Dysfunction in Idiopathic Recurrent Spontaneous Miscarriage	PLOS ONE			English	Article							NITRIC-OXIDE SYNTHASE; ENDOTHELIAL GROWTH-FACTOR; PREGNANCY LOSS; WOMEN; ENDOMETRIAL; BLOOD; EXPRESSION; ABORTION	Poor endometrial perfusion during implantation window is reported to be one of the possible causes of idiopathic recurrent spontaneous miscarriage (IRSM). We have tested the hypothesis that certain angiogenic and vasoactive factors are associated with vascular dysfunction during implantation window in IRSM and, therefore, could play a contributory role in making the endometrium unreceptive in these women. This is a prospective case-controlled study carried out on 66 women with IRSM and age and BMI matched 50 fertile women serving as controls. Endometrial expression of pro-inflammatory (IL-1 beta, TNF-alpha, IFN-gamma, TGF-beta 1), anti-inflammatory (IL-4, -10), angiogenesis-associated cytokines (IL-2, -6, -8), angiogenic and vasoactive factors including prostaglandin E2 (PGE2), vascular endothelial growth factor (VEGF), endothelial nitric oxide synthase (eNOS), nitric oxide (NO) and adrenomedullin (ADM) were measured during implantation window by ELISA. Subendometrial blood flow (SEBF) was assessed by color Doppler ultrasonography. Multivariate analysis was used to identify the significant factor(s) responsible for vascular dysfunction in IRSM women during window of implantation and further correlated with vascular dysfunction. Endometrial expression of pro-inflammatory cytokines and PGE2 were up-regulated and anti-inflammatory and angiogenesis-associated cytokines down-regulated in IRSM women as compared with controls. Further, the angiogenic and vasoactive factors including VEGF, eNOS, NO and ADM were found to be down-regulated and SEBF grossly affected in these women. Multivariate analysis identified IL-10, followed by VEGF and eNOS as the major factors contributing towards vascular dysfunction in IRSM women. Moreover, these factors strongly correlated with blood flow impairment. This study provides an understanding that IL-10, VEGF and eNOS are the principal key components having a contributory role in endometrial vascular dysfunction in women with IRSM. Down-regulation of these factors is also associated with impaired endometrial perfusion which possibly makes the endometrium unreceptive that may eventually cause early pregnancy loss.	[Banerjee, Priyanka; Dutta, Mainak; Subramani, Elavarasan; Khalpada, Jaydeep; RoyChoudhury, Sourav; Chaudhury, Koel] Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India; [Ghosh, Sanghamitra; Chakravarty, Baidyanath] Inst Reprod Med, Kolkata, India	Indian Institute of Technology System (IIT System); Indian Institute of Technology (IIT) - Kharagpur	Chaudhury, K (corresponding author), Indian Inst Technol, Sch Med Sci & Technol, Kharagpur 721302, W Bengal, India.	koel@smst.iitkgp.ernet.in	Subramani, Elavarasan/G-3133-2010; Dutta, Mainak/X-6269-2018	Subramani, Elavarasan/0000-0003-2610-744X; Dutta, Mainak/0000-0003-0887-2893; RoyChoudhury, Sourav/0000-0001-7914-2842; Chaudhury, Koel/0000-0002-9390-1179				Banerjee P, 2013, FERTIL STERIL, V99, P179, DOI 10.1016/j.fertnstert.2012.08.034; Bates MD, 2002, HUM REPROD, V17, P2439, DOI 10.1093/humrep/17.9.2439; Bates SM, 2010, HEMATOL-AM SOC HEMAT, P166, DOI 10.1182/asheducation-2010.1.166; Chwalisz K, 2000, HUM REPROD, V15, P96, DOI 10.1093/humrep/15.suppl_3.96; Didion SP, 2009, HYPERTENSION, V54, P619, DOI 10.1161/HYPERTENSIONAHA.109.137158; GREEN LC, 1982, ANAL BIOCHEM, V126, P131, DOI 10.1016/0003-2697(82)90118-X; Habara T, 2002, HUM REPROD, V17, P190, DOI 10.1093/humrep/17.1.190; Hoeben A, 2004, PHARMACOL REV, V56, P549, DOI 10.1124/pr.56.4.3; Khorram Omid, 2002, Rev Endocr Metab Disord, V3, P145, DOI 10.1023/A:1015459029397; Li MY, 2008, BIOL REPROD, V79, P1169, DOI 10.1095/biolreprod.108.069336; Li TC, 2002, HUM REPROD UPDATE, V8, P43, DOI 10.1093/humupd/8.1.43; Licht P, 2003, FERTIL STERIL, V80, P1228, DOI 10.1016/S0015-0282(03)02165-4; Malamitsi-Puchner A, 2004, FERTIL STERIL, V81, P1322, DOI 10.1016/j.fertnstert.2003.10.025; Najafi T, 2012, REPROD BIOMED ONLINE, V25, P408, DOI 10.1016/j.rbmo.2012.07.004; Ng EHY, 2004, HUM REPROD, V19, P2385, DOI 10.1093/humrep/deh384; Plevyak M, 2002, AM J REPROD IMMUNOL, V47, P242, DOI 10.1034/j.1600-0897.2002.01060.x; Raghupathy R, 1999, CELL IMMUNOL, V196, P122, DOI 10.1006/cimm.1999.1532; Sher G, 2000, HUM REPROD, V15, P806, DOI 10.1093/humrep/15.4.806; Su MT, 2011, HUM REPROD UPDATE, V17, P803, DOI 10.1093/humupd/dmr027; Suryanarayana Venkata, 2006, Archives of Gynecology and Obstetrics, V274, P119, DOI 10.1007/s00404-005-0107-x; Tempfer C, 2001, HUM REPROD, V16, P1644, DOI 10.1093/humrep/16.8.1644; Toth B, 2010, J REPROD IMMUNOL, V85, P25, DOI 10.1016/j.jri.2009.12.006; Wang LN, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-122; Yurdakan G, 2008, ACTA OBSTET GYN SCAN, V87, P775, DOI 10.1080/00016340802177412	24	52	53	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80940	10.1371/journal.pone.0080940	http://dx.doi.org/10.1371/journal.pone.0080940			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260517	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600103
J	Kim, H; Gao, W; Ho, M				Kim, Heungnam; Gao, Wei; Ho, Mitchell			Novel Immunocytokine IL12-SS1 (Fv) Inhibits Mesothelioma Tumor Growth in Nude Mice	PLOS ONE			English	Article							HUMAN MONOCLONAL-ANTIBODY; POTENT ANTITUMOR-ACTIVITY; PHASE-I TRIAL; HIGH-AFFINITY; RECOMBINANT IMMUNOTOXIN; INTERFERON-GAMMA; FUSION PROTEIN; INTERLEUKIN-12; CANCER; OVARIAN	Mesothelin is a glycosylphosphatidylinositol-anchored glycoprotein that is highly expressed on the cell surface of malignant mesothelioma. Monoclonal antibodies against mesothelin are being evaluated for the treatment of mesothelioma. Immunocytokines represent a novel class of armed antibodies. To provide an alternative approach to current mesothelin-targeted antibody therapies, we have developed a novel immunocytokine based on interleukin-12 (IL12) and the SS1 Fv specific for mesothelin. IL12 possesses potent anti-tumor activity in a wide variety of solid tumors. The newly-developed recombinant immunocytokine, IL12-SS1 (Fv), was produced in insect cells using a baculovirus-insect cell expression system. The SS1 single-chain Fv was fused to the C terminus of the p35 subunit of IL12 through a short linker (GSADGG). The single-chain IL12-SS1 (Fv) immunocytokine bound native mesothelin proteins on malignant mesothelioma (NCI-H226) and ovarian (OVCAR-3) cells as well as recombinant mesothelin on A431/H9 cells. The immunocytokine retained sufficient bioactivity of IL12 and significantly inhibited human malignant mesothelioma (NCI-H226) grown in the peritoneal cavity of nude mice and showed comparable anti-tumor activity to that of the SS1P immunotoxin. IL12-SS1 (Fv) is the first reported immunocytokine to mesothelin-positive tumors and may be an attractive addition to mesothelin-targeted cancer therapies.	[Kim, Heungnam; Gao, Wei; Ho, Mitchell] NCI, Antibody Therapy Sect, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Ho, M (corresponding author), NCI, Antibody Therapy Sect, Mol Biol Lab, Ctr Canc Res,NIH, Bethesda, MD 20892 USA.	homi@mail.nih.gov	Ho, Mitchell/F-5059-2015	Ho, Mitchell/0000-0002-9152-5405	National Institutes of Health, National Cancer Institute; Center for Cancer Research; Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE [ZIABC010891] Funding Source: NIH RePORTER	National Institutes of Health, National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Mesothelioma Applied Research Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This research was supported by the Intramural Research Program of the National Institutes of Health, National Cancer Institute, and Center for Cancer Research. This work was also possible because of a Mesothelioma Applied Research Foundation Craig Kozicki Memorial Grant to MH. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amsen D, 2009, CURR OPIN IMMUNOL, V21, P153, DOI 10.1016/j.coi.2009.03.010; Argani P, 2001, CLIN CANCER RES, V7, P3862; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Caminschi I, 1998, AM J RESP CELL MOL, V19, P738, DOI 10.1165/ajrcmb.19.5.3257m; Car BD, 1999, TOXICOL PATHOL, V27, P58, DOI 10.1177/019262339902700112; CHANG K, 1992, INT J CANCER, V50, P373, DOI 10.1002/ijc.2910500308; Chang K, 1996, P NATL ACAD SCI USA, V93, P136, DOI 10.1073/pnas.93.1.136; Chowdhury PS, 1999, NAT BIOTECHNOL, V17, P568, DOI 10.1038/9872; Chowdhury PS, 1998, P NATL ACAD SCI USA, V95, P669, DOI 10.1073/pnas.95.2.669; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Eggermont AMM, 1996, J CLIN ONCOL, V14, P2653, DOI 10.1200/JCO.1996.14.10.2653; Feng MQ, 2011, J CANCER, V2, P123, DOI 10.7150/jca.2.123; Feng Y, 2009, MOL CANCER THER, V8, P1113, DOI 10.1158/1535-7163.MCT-08-0945; FYFE G, 1995, J CLIN ONCOL, V13, P688, DOI 10.1200/JCO.1995.13.3.688; Gafner V, 2006, INT J CANCER, V119, P2205, DOI 10.1002/ijc.22101; GATELY MK, 1992, CELL IMMUNOL, V143, P127, DOI 10.1016/0008-8749(92)90011-D; Geldhof AB, 1998, BLOOD, V91, P196, DOI 10.1182/blood.V91.1.196.196_196_206; Halin C, 2003, CANCER RES, V63, P3202; Hassan R, 2005, APPL IMMUNOHISTO M M, V13, P243, DOI 10.1097/01.pai.00000141545.36485.d6; Hassan R, 2008, EUR J CANCER, V44, P46, DOI 10.1016/j.ejca.2007.08.028; Hassan R, 2007, CLIN CANCER RES, V13, P5144, DOI 10.1158/1078-0432.CCR-07-0869; Helguera G, 2006, MOL CANCER THER, V5, P1029, DOI 10.1158/1535-7163.MCT-05-0488; Heuser C, 2003, INT J CANCER, V106, P545, DOI 10.1002/ijc.11279; Ho M, 2005, CLIN CANCER RES, V11, P3814, DOI 10.1158/1078-0432.CCR-04-2304; Ho M, 2007, CLIN CANCER RES, V13, P1571, DOI 10.1158/1078-0432.CCR-06-2161; Ho M, 2011, INT J CANCER, V128, P2020, DOI 10.1002/ijc.25557; Kreitman RJ, 2009, CLIN CANCER RES, V15, P5274, DOI 10.1158/1078-0432.CCR-09-0062; Leonard JP, 1997, BLOOD, V90, P2541; LING P, 1995, J IMMUNOL, V154, P116; Lo KM, 2007, CANCER IMMUNOL IMMUN, V56, P447, DOI 10.1007/s00262-006-0203-1; MANETTI R, 1993, J EXP MED, V177, P1199, DOI 10.1084/jem.177.4.1199; NASTALA CL, 1994, J IMMUNOL, V153, P1697; Ordonez NG, 2003, MODERN PATHOL, V16, P192, DOI 10.1097/01.MP.0000056981.16578.C3; Pasche N, 2012, CLIN CANCER RES, V18, P4092, DOI 10.1158/1078-0432.CCR-12-0282; Pastan I, 2006, NAT REV CANCER, V6, P559, DOI 10.1038/nrc1891; Rodolfo M, 1999, METHODS, V19, P114, DOI 10.1006/meth.1999.0836; Siddiqui F, 2007, MOL CANCER THER, V6, P380, DOI 10.1158/1535-7163.MCT-06-0342; Sommavilla R, 2010, PROTEIN ENG DES SEL, V23, P653, DOI 10.1093/protein/gzq038; Tagawa M, 2000, CURR PHARM DESIGN, V6, P681, DOI 10.2174/1381612003400597; Tang ZW, 2013, MOL CANCER THER, V12, P416, DOI 10.1158/1535-7163.MCT-12-0731; Tchou J, 2012, BREAST CANCER RES TR, V133, P799, DOI 10.1007/s10549-012-2018-4; Trinchieri G, 1997, Curr Opin Hematol, V4, P59; Tsung K, 1997, J IMMUNOL, V158, P3359; Yoon C, 2000, EMBO J, V19, P3530, DOI 10.1093/emboj/19.14.3530; Yu LP, 2010, J CANCER, V1, P141	45	17	17	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81919	10.1371/journal.pone.0081919	http://dx.doi.org/10.1371/journal.pone.0081919			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260587	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600119
J	Chang, HR; Hsieh, JC; Hsu, BG; Wang, LY; Chen, MYC; Wang, JH				Chang, Huai-Ren; Hsieh, Jen-Che; Hsu, Bang-Gee; Wang, Ling-Yi; Chen, Michael Yu-Chih; Wang, Ji-Hung			Inverse Association of N-Terminal Pro-B-Type Natriuretic Peptide with Metabolic Syndrome in Patients with Congestive Heart Failure	PLOS ONE			English	Article							AMBULATORY INDIVIDUALS; HUMAN ADIPOCYTES; ADIPOSE-TISSUE; OBESE-PATIENTS; RISK-FACTORS; DIAGNOSIS; BNP; IMPACT; HYPERTENSION; DEFINITION	Background: Metabolic syndrome has been shown to be associated with lower levels of plasma N-terminal pro-B-type natriuretic peptide (Nt-proBNP) in the general population. We sought to elucidate the relationship between Nt-proBNP and components of metabolic syndrome in patients with congestive heart failure (CHF). Methods: Fasting blood samples were obtained from 93 patients in our institution. Plasma levels of Nt-proBNP and other biochemical data were measured. The New York Heart Association (NYHA) classification system (I-IV) was used to define the functional capacity of CHF. Metabolic syndrome and its components were defined using diagnostic criteria from the International Diabetes Federation. Results: Forty-nine patients (52.7%) had CHF. There was a positive correlation between plasma Nt-proBNP levels and NYHA functional capacity in CHF patients. Plasma Nt-proBNP levels increased significantly with each increasing NYHA class of the disease. The prevalence of metabolic syndrome in CHF patients was higher than that in patients without CHF. Most importantly, we found that plasma Nt-proBNP levels were lower in CHF patients with metabolic syndrome attributable to inverse relationships between plasma Nt-proBNP and body mass index (beta = -0.297), plasma triglyceride (beta = -0.286) and homeostasis model assessment of insulin resistance (HOMA-IR; beta = -0.346). Fasting glucose to insulin ratio (FGIR, an insulin sensitivity index) was positively associated with plasma Nt-proBNP levels (beta = 0.491), and was the independent predictor of plasma Nt-proBNP levels in CHF patients. Conclusions: Plasma Nt-proBNP levels are inversely associated with metabolic syndrome in CHF patients. Reduced plasma Nt-proBNP levels in CHF patients may lead to impaired lipolysis and metabolic function, and may contribute to the development of metabolic syndrome in CHF patients.	[Chang, Huai-Ren; Hsieh, Jen-Che; Chen, Michael Yu-Chih; Wang, Ji-Hung] Buddhist Tzu Chi Gen Hosp, Div Cardiol, Dept Internal Med, Hualien, Taiwan; [Hsu, Bang-Gee] Buddhist Tzu Chi Gen Hosp, Div Nephrol, Dept Internal Med, Hualien, Taiwan; [Chang, Huai-Ren; Chen, Michael Yu-Chih] Tzu Chi Univ, Inst Med Sci, Hualien, Taiwan; [Hsu, Bang-Gee; Wang, Ji-Hung] Tzu Chi Univ, Sch Med, Hualien, Taiwan; [Wang, Ling-Yi] Natl Taiwan Univ, Coll Pulb Hlth, Inst Epidemiol & Prevent Med, Taipei 10764, Taiwan	Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Buddhist Tzu Chi General Hospital; Hualien Tzu Chi Hospital; Tzu Chi University; Tzu Chi University; National Taiwan University	Wang, JH (corresponding author), Buddhist Tzu Chi Gen Hosp, Div Cardiol, Dept Internal Med, Hualien, Taiwan.	8311016@gmail.com	Hsu, Bang-Gee/AAV-5287-2020		Tzu Chi General Hospital, Hualien, Taiwan [TCRD100-53-3, TCRD 100-53-3(2/2)]	Tzu Chi General Hospital, Hualien, Taiwan	This work was supported in part by Grants TCRD100-53-3 and TCRD 100-53-3(2/2) from the Tzu Chi General Hospital, Hualien, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Addisu A, 2008, EXP BIOL MED, V233, P475, DOI 10.3181/0708-RM-216; Alberti KGMM, 2006, DIABETIC MED, V23, P469, DOI 10.1111/j.1464-5491.2006.01858.x; Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Allanore Y, 2003, ARTHRITIS RHEUM-US, V48, P3503, DOI 10.1002/art.11345; Bao YY, 2011, ARCH MED SCI, V7, P247, DOI 10.5114/aoms.2011.22075; Beleigoli AMR, 2009, OBES REV, V10, P617, DOI 10.1111/j.1467-789X.2009.00624.x; Bertoni AG, 2012, OBESITY, V20, P1511, DOI 10.1038/oby.2011.296; Bionda C, 2006, ANN CLIN LAB SCI, V36, P299; Boerrigter G, 2004, EXPERT OPIN INV DRUG, V13, P643, DOI 10.1517/13543784.13.6.643; Cheng S, 2011, AM J CARDIOL, V108, P979, DOI 10.1016/j.amjcard.2011.05.033; Costello-Boerrigter LC, 2009, J AM COLL CARDIOL, V53, P2078, DOI 10.1016/j.jacc.2009.02.037; Dessi-Fulgheri P, 1997, J HYPERTENS, V15, P1695, DOI 10.1097/00004872-199715120-00074; Eckel RH, 2005, LANCET, V365, P1415, DOI 10.1016/S0140-6736(05)66378-7; Garbers DL, 2006, TRENDS ENDOCRIN MET, V17, P251, DOI 10.1016/j.tem.2006.06.006; Grundy SM, 2005, CIRCULATION, V112, P2735, DOI 10.1161/CIRCULATIONAHA.105.169404; Hobbs FDR, 2002, BMJ-BRIT MED J, V324, P1498, DOI 10.1136/bmj.324.7352.1498; Hunt SA, 2009, CIRCULATION, V119, pE391, DOI 10.1161/CIRCULATIONAHA.109.192065; Karabulut A, 2005, ACTA CARDIOL, V60, P631, DOI 10.2143/AC.60.6.2004936; Koizumi M, 2012, HEART VESSELS, V27, P287, DOI 10.1007/s00380-011-0143-3; Lazo M, 2013, DIABETES; Legro RS, 1998, J CLIN ENDOCR METAB, V83, P2694, DOI 10.1210/jc.83.8.2694; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Miura Y, 2010, CIRC J, V74, P2612, DOI 10.1253/circj.CJ-10-0677; Olsen MH, 2005, HYPERTENSION, V46, P660, DOI 10.1161/01.HYP.0000179575.13739.72; Raizada V, 2001, MOL CELL BIOCHEM, V216, P137, DOI 10.1023/A:1011027231702; Remme WJ, 2001, EUR HEART J, V22, P1527, DOI 10.1053/euhj.2001.2783; Sakhuja R., 2004, US CARDIOLOGY, V1, P1; Sengenes C, 2003, J BIOL CHEM, V278, P48617, DOI 10.1074/jbc.M303713200; Sengenes C, 2002, AM J PHYSIOL-REG I, V283, pR257, DOI 10.1152/ajpregu.00453.2001; Sengenes C, 2000, FASEB J, V14, P1345, DOI 10.1096/fj.14.10.1345; St Peter JV, 2006, CLIN CHEM, V52, P680, DOI 10.1373/clinchem.2005.062562; Taylor JA, 2006, AM HEART J, V152, P1071, DOI 10.1016/j.ahj.2006.07.010; Wang TJ, 2007, CIRCULATION, V115, P1345, DOI 10.1161/CIRCULATIONAHA.106.655142; Wang TJ, 2004, CIRCULATION, V109, P594, DOI 10.1161/01.CIR.0000112582.16683.EA; Yeo KTJ, 2003, CLIN CHIM ACTA, V338, P107, DOI 10.1016/j.cccn.2003.08.016	35	10	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79096	10.1371/journal.pone.0079096	http://dx.doi.org/10.1371/journal.pone.0079096			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265747	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100080
J	Ducancelle, A; Abgueguen, P; Birguel, J; Mansour, W; Pivert, A; Le Guillou-Guillemette, H; Sobnangou, JJ; Rameau, A; Huraux, JM; Lunel-Fabiani, F				Ducancelle, Alexandra; Abgueguen, Pierre; Birguel, Jacques; Mansour, Wael; Pivert, Adeline; Le Guillou-Guillemette, Helene; Sobnangou, Jean-Jacques; Rameau, Amelie; Huraux, Jean-Marie; Lunel-Fabiani, Francoise			High Endemicity and Low Molecular Diversity of Hepatitis B Virus Infections in Pregnant Women in a Rural District of North Cameroon	PLOS ONE			English	Article							BLOOD-DONORS; DELTA-VIRUS; GENOTYPE-E; PHYLOGENETIC ANALYSIS; GENETIC DIVERSITY; NATURAL-HISTORY; HBV GENOTYPES; PREVALENCE; EPIDEMIOLOGY; TRANSMISSION	Background: A program, supported by the GEMHEP (Groupe d'etude Moleculaire des Hepatites), was established in 2007 in the sanitary district of Tokombere, to prevent perinatal transmission of hepatitis B virus (HBV). It comprises screening for HBV surface antigen (HBsAg) in all pregnant women and vaccinating the newborn if tests are positive. Methods/Principal Findings: 1276 women were enrolled in the study after providing informed consent. Demographic data and blood samples were available for 1267 of the enrolled patients. HBsAg was determined locally using a rapid test (Vikia HBsAg, Biomerieux). Tests for HBV and HDV virological markers (HBeAg, anti-HDV antibodies (Ab), HBV-DNA, HDV-RNA, HBV and HDV genotypes) were performed on the confirmed HBsAg-positive samples in the virology unit of the Angers University Hospital (France). HBsAg was found in 259 of the 1267 pregnant women (20.4%) between January 2009 and April 2010, of whom 59 were HBeAg-positive (22.7%) with high levels of HBV-DNA. Anti-HDV Ab were found in 19 (7.3%) of the HBsAg-positive women. The prevalence rates of HBsAg and HDV were not age-dependent whereas HBeAg carriers were statistically younger than non carriers. Basal core promoter (BCP) and precore (PC) mutations and genotypes were determined by sequencing. Of 120 amplified sequences, 119 belonged to HBV genotype E (HBV/E) and the 9 HDV strains belonged to HDV clade 1. In the PC region, 83/228 patients (36.4%) harbored a G1896A mutant or mixed phenotype virus. In the BCP region, the double mutation A1762T/G1764A and the G1757A substitution were detected respectively in 26/228 patients (11.4%) and 189/228 patients (82.8%). Conclusions: Our results confirm the high prevalence and low molecular diversity of HBV in Far Northern Cameroon; more than 20% of the infected women were highly viremic, suggesting a high rate of HBV perinatal transmission and supporting the WHO recommendation to vaccinate at birth against hepatitis B.	[Ducancelle, Alexandra; Mansour, Wael; Pivert, Adeline; Le Guillou-Guillemette, Helene; Rameau, Amelie; Lunel-Fabiani, Francoise] Angers Univ Hosp, Dept Bacteriol & Virol, Angers 9, France; [Ducancelle, Alexandra; Mansour, Wael; Pivert, Adeline; Le Guillou-Guillemette, Helene; Rameau, Amelie; Lunel-Fabiani, Francoise] SFR 4208, UPRES 3859, HIFIH Lab, Angers 9, France; [Abgueguen, Pierre] Angers Univ Hosp, Dept Infect Dis & Internal Med, Angers 9, France; [Birguel, Jacques] Catholic Hosp Tokombere, Maroua, Cameroon; [Sobnangou, Jean-Jacques] Publ Hlth Dist Tokombere, Mora, Cameroon; [Huraux, Jean-Marie] Univ Paris 06, Hosp AP HP Pitie Salpetriere, Virol Lab, DETIV ER1, F-75252 Paris 05, France	Universite d'Angers; Centre Hospitalier Universitaire d'Angers; Universite d'Angers; Centre Hospitalier Universitaire d'Angers; UDICE-French Research Universities; Sorbonne Universite	Ducancelle, A (corresponding author), Angers Univ Hosp, Dept Bacteriol & Virol, Angers 9, France.	alducancelle@chu-angers.fr	françoise, lunel/B-7273-2015; Ducancelle, Alexandra/D-6393-2014	françoise, lunel/0000-0002-1856-0300; Ducancelle, Alexandra/0000-0003-3173-8000	GEMHEP (Groupe d'etude moleculaire sur les virus des hepatites virales) [CA 20.02.2007]	GEMHEP (Groupe d'etude moleculaire sur les virus des hepatites virales)	This study was initiated by the Angers University Hospital with grants from the GEMHEP (Groupe d'etude moleculaire sur les virus des hepatites virales). Number : CA 20.02.2007. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acquaye J K, 1994, West Afr J Med, V13, P134; Ampofo W, 2002, J CLIN MICROBIOL, V40, P3523, DOI 10.1128/JCM.40.9.3523-3525.2002; Bekondi C, 2007, J CLIN VIROL, V40, P31, DOI 10.1016/j.jcv.2007.05.009; Birguel J, 2011, Med Trop (Mars), V71, P201; Bottero J, 2013, J HEPATOL, V58, P473, DOI 10.1016/j.jhep.2012.11.016; Buseri FI, 2009, BLOOD TRANSFUS-ITALY, V7, P293, DOI 10.2450/2009.0071-08; Candotti D, 2007, J GEN VIROL, V88, P2686, DOI 10.1099/vir.0.83102-0; Chekaraou MA, 2010, J GEN VIROL, V91, P1609, DOI 10.1099/vir.0.018127-0; Echevarria JM, 2006, J MED VIROL, V78, pS36, DOI 10.1002/jmv.20605; EDMUNDS WJ, 1993, P ROY SOC B-BIOL SCI, V253, P197, DOI 10.1098/rspb.1993.0102; Emechebe GO, 2009, NIGERIAN MED J, V50, P18; Fattovich G, 2008, J HEPATOL, V48, P335, DOI 10.1016/j.jhep.2007.11.011; Foupouapouognigni Y, 2011, J CLIN MICROBIOL, V49, P1162, DOI 10.1128/JCM.01822-10; Franco E, 2012, WORLD J HEPATOL, V4, P74, DOI 10.4254/wjh.v4.i3.74; Friedt M, 1999, HEPATOLOGY, V29, P1252, DOI 10.1002/hep.510290418; Fujiwara K, 2005, WORLD J GASTROENTERO, V11, P6410, DOI 10.3748/wjg.v11.i41.6410; Garmiri P, 2009, J GEN VIROL, V90, P2442, DOI 10.1099/vir.0.012013-0; Hennig BJ, 2012, SCI TOTAL ENVIRON, V423, P202, DOI 10.1016/j.scitotenv.2010.09.036; Hsieh TH, 2006, J FORMOS MED ASSOC, V105, P869, DOI 10.1016/S0929-6646(09)60172-8; Hughes SA, 2011, LANCET, V378, P73, DOI 10.1016/S0140-6736(10)61931-9; HYAMS KC, 1995, CLIN INFECT DIS, V20, P992, DOI 10.1093/clinids/20.4.992; Ivaniushina V, 2001, J GEN VIROL, V82, P2709, DOI 10.1099/0022-1317-82-11-2709; Kfutwah AKW, 2012, VIROL J, V9, DOI 10.1186/1743-422X-9-62; Kim BK, 2011, ANTIVIR THER, V16, P1169, DOI 10.3851/IMP1982; Kramvis A, 2005, VACCINE, V23, P2409, DOI 10.1016/j.vaccine.2004.10.045; Kramvis A, 2007, HEPATOL RES, V37, pS9, DOI 10.1111/j.1872-034X.2007.00098.x; Kurbanov F, 2005, J GEN VIROL, V86, P2047, DOI 10.1099/vir.0.80922-0; Kurbanov F, 2010, HEPATOL RES, V40, P14, DOI 10.1111/j.1872-034X.2009.00601.x; Kwon So Young, 2011, Korean J Hepatol, V17, P87, DOI 10.3350/kjhep.2011.17.2.87; Le Gal F, 2006, EMERG INFECT DIS, V12, P1447, DOI 10.3201/eid1209.060112; Lee CF, 2006, BMJ-BRIT MED J, V332, P328, DOI 10.1136/bmj.38719.435833.7C; Liang TJ, 2009, HEPATOLOGY, V49, pS13, DOI 10.1002/hep.22881; Liu CX, 2011, MOL BIOL REP, V38, P1929, DOI 10.1007/s11033-010-0313-x; Lok ASF, 2009, HEPATOLOGY, V50, P661, DOI 10.1002/hep.23190; Makuwa M, 2008, J CLIN MICROBIOL, V46, P754, DOI 10.1128/JCM.02142-07; Mansour W, 2012, J CLIN VIROL, V55, P12, DOI 10.1016/j.jcv.2012.05.011; Mansour W, 2012, J MED VIROL, V84, P1186, DOI 10.1002/jmv.23336; Mbanya DN, 2003, TRANSFUSION MED, V13, P267, DOI 10.1046/j.1365-3148.2003.00453.x; Modi AA, 2007, AIDS REV, V9, P25; Olinger CM, 2006, J GEN VIROL, V87, P1163, DOI 10.1099/vir.0.81614-0; Ott JJ, 2012, VACCINE, V30, P2212, DOI 10.1016/j.vaccine.2011.12.116; Ott JJ, 2012, BMC INFECT DIS, V12, DOI 10.1186/1471-2334-12-131; Poustchi H, 2008, J VIRAL HEPATITIS, V15, P753, DOI 10.1111/j.1365-2893.2008.00998.x; Radjef N, 2004, J VIROL, V78, P2537, DOI 10.1128/JVI.78.5.2537-2544.2004; Ragheb M, 2012, J MED VIROL, V84, P587, DOI 10.1002/jmv.23234; Toure-Fall AO, 2009, TRANSFUS CLIN BIOL, V16, P439, DOI 10.1016/j.tracli.2009.09.005; Villeneuve JP, 2003, J HEPATOL, V39, P1085, DOI 10.1016/j.jhep.2003.09.022; Yeh CT, 2012, J HEPATOL, V57, P484, DOI 10.1016/j.jhep.2012.06.003	48	31	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80346	10.1371/journal.pone.0080346	http://dx.doi.org/10.1371/journal.pone.0080346			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265811	Green Published, gold			2022-12-25	WOS:000327252100147
J	Oldham, P; Hall, S; Forero, O				Oldham, Paul; Hall, Stephen; Forero, Oscar			Biological Diversity in the Patent System	PLOS ONE			English	Article							RESEARCH-AND-DEVELOPMENT; NEGLECTED TROPICAL DISEASES; SOURCE DRUG DISCOVERY; INTELLECTUAL PROPERTY PROTECTION; GREEN-LIPPED MUSSEL; STEM-CELL PATENTS; SYNTHETIC BIOLOGY; NAGOYA PROTOCOL; DEVELOPMENT SPILLOVERS; GENETIC-RESOURCES	Biological diversity in the patent system is an enduring focus of controversy but empirical analysis of the presence of biodiversity in the patent system has been limited. To address this problem we text mined 11 million patent documents for 6 million Latin species names from the Global Names Index (GNI) established by the Global Biodiversity Information Facility (GBIF) and Encyclopedia of Life (EOL). We identified 76,274 full Latin species names from 23,882 genera in 767,955 patent documents. 25,595 species appeared in the claims section of 136,880 patent documents. This reveals that human innovative activity involving biodiversity in the patent system focuses on approximately 4% of taxonomically described species and between 0.8-1% of predicted global species. In this article we identify the major features of the patent landscape for biological diversity by focusing on key areas including pharmaceuticals, neglected diseases, traditional medicines, genetic engineering, foods, biocides, marine genetic resources and Antarctica. We conclude that the narrow focus of human innovative activity and ownership of genetic resources is unlikely to be in the long term interest of humanity. We argue that a broader spectrum of biodiversity needs to be opened up to research and development based on the principles of equitable benefit-sharing, respect for the objectives of the Convention on Biological Diversity, human rights and ethics. Finally, we argue that alternative models of innovation, such as open source and commons models, are required to open up biodiversity for research that addresses actual and neglected areas of human need. The research aims to inform the implementation of the 2010 Nagoya Protocol on Access to Genetic Resources and the Equitable Sharing of Benefits Arising from their Utilization and international debates directed to the governance of genetic resources. Our research also aims to inform debates under the Intergovernmental Committee on Intellectual Property and Genetic Resources, Traditional Knowledge and Folklore at the World Intellectual Property Organization.	[Oldham, Paul; Hall, Stephen; Forero, Oscar] Univ Lancaster, ESRC Ctr Econ & Social Aspects Genom Cesagen, Lancaster, England; [Oldham, Paul] United Nations Univ, Inst Adv Studies, Yokohama, Kanagawa, Japan; [Hall, Stephen] One World Analyt, Lancaster, England; [Forero, Oscar] Univ London, Ctr Dev Environm & Policy, SOAS, London, England	Lancaster University; UK Research & Innovation (UKRI); Economic & Social Research Council (ESRC); United Nations University; University of London; University of London School Oriental & African Studies (SOAS)	Oldham, P (corresponding author), Univ Lancaster, ESRC Ctr Econ & Social Aspects Genom Cesagen, Lancaster, England.	poldham@mac.com		FORERO, OSCAR/0000-0001-5679-4864; Oldham, Paul/0000-0002-1013-4390	Economic and Social Research Council (ESRC), UK; Economic and Social Research Council [ES/F04173X/1] Funding Source: researchfish; ESRC [ES/F04173X/1] Funding Source: UKRI	Economic and Social Research Council (ESRC), UK(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); ESRC(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC))	The support of the Economic and Social Research Council (ESRC), UK, is gratefully acknowledged. The research formed part of the programme of the ESRC Genomics Network at Cesagen (ESRC Centre for Economic and Social Aspects of Genomics). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott A, 2011, NATURE, V471, P280, DOI 10.1038/471280a; AlAzzawi S, 2012, J INT TRADE ECON DEV, V21, P615, DOI 10.1080/09638199.2010.513056; Ang JB, 2013, ECON INQ, V51, P1523, DOI 10.1111/j.1465-7295.2012.00488.x; [Anonymous], 1999, CULTURAL SPIRITUAL V; Arbour L, 2006, COMMUNITY GENET, V9, P153, DOI 10.1159/000092651; Arico S., 2005, BIOPROSPECTING GENET; Arnaud-Haond S, 2011, SCIENCE, V331, P1521, DOI 10.1126/science.1200783; Arora A, 2008, INT J IND ORGAN, V26, P1153, DOI 10.1016/j.ijindorg.2007.11.004; Arrieta JM, 2010, P NATL ACAD SCI USA, V107, P18318, DOI 10.1073/pnas.0911897107; Athreye S, 2011, WIPO EC RES WORKING; Azoulay P, 2009, J IND ECON, V57, P637, DOI 10.1111/j.1467-6451.2009.00395.x; Barton JH, 2002, B WORLD HEALTH ORGAN, V80, P121; Beall R, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001154; Benkler Y, 2004, SCIENCE, V305, P1110, DOI 10.1126/science.1100526; Beuzekom BV., 2006, OECD BIOTECHNOLOGY S; Bhardwaj A, 2011, TUBERCULOSIS, V91, P479, DOI 10.1016/j.tube.2011.06.004; BISBY FA, 2011, SPECIES 2000 ITIS CA; Blakeney M, 2011, FOOD POLICY, V36, pS109, DOI 10.1016/j.foodpol.2010.10.011; Blunt JW, 2012, NAT PROD REP, V29, P144, DOI 10.1039/c2np00090c; Boyle James, 2003, LAW CONTEMP PROBL, V66, P33, DOI DOI 10.2139/SSRN.470983; Branstetter L, 2000, NBER E A EC, V9, P113; Brien S, 2008, QJM-INT J MED, V101, P167, DOI 10.1093/qjmed/hcm108; Briggs K, 2013, INT REV ECON FINANC, V25, P35, DOI 10.1016/j.iref.2012.05.004; Buck M., 2011, REV EUR COMP INT ENV, V20, P47, DOI [10.1111/j.1467-9388.2011.00703.x, DOI 10.1111/J.1467-9388.2011.00703.X]; Calvert J, 2012, BIOSOCIETIES, V7, P169, DOI 10.1057/biosoc.2012.3; Calvert J, 2008, BIOSOCIETIES, V3, P383, DOI 10.1017/S1745855208006303; Canadian Institutes of Health Research Natural Sciences and Engineering Research Council of Canada Social Sciences and Humanities Research Council of Canada, 2010, TRIC POL STAT ETH CO; Chander A, 2004, CALIF LAW REV, V92, P1331, DOI 10.2307/3481419; Chandrasekharan S, 2009, GENOME MED, V1, DOI 10.1186/gm92; CHAPMAN AD, 2009, NUMBERS LIVING SPECI; Chesbrough H, 2012, RES TECHNOL MANAGE, V55, P20, DOI 10.5437/08956308X5504085; Chiarolla C, 2011, INTELLECTUAL PROPERTY, AGRICULTURE AND GLOBAL FOOD SECURITY: THE PRIVATIZATION OF CROP DIVERSITY, P1; Coe DT, 2009, EUR ECON REV, V53, P723, DOI 10.1016/j.euroecorev.2009.02.005; Coe DT, 1997, ECON J, V107, P134, DOI 10.1111/1468-0297.00146; Cohen J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010610; Conley J.M., 2003, J PAT TRADEMARK OFF, V85, P371; Cook-Deegan R, 2007, J TECHNOL TRANSFER, V32, P133, DOI 10.1007/s10961-006-9016-9; Cook-Deegan R, 2012, SCIENCE, V338, P745, DOI 10.1126/science.1229854; Cook-Deegan R, 2010, ANNU REV GENOM HUM G, V11, P383, DOI 10.1146/annurev-genom-082509-141811; Cook-Deegan R, 2010, GENET MED, V12, pS15, DOI 10.1097/GIM.0b013e3181d5a67b; Coombe Rosemary J., 2005, FLORIDA J INT LAW, V17, P115; Cooper H.D., 2002, REV EUROPEAN COMMUNI, V11, P1, DOI [https://doi.org/10.1111/1467-9388.00298, DOI 10.1111/1467-9388.00298]; Correa C.M., 2007, TRADE RELATED ASPECT; Cressey D, 2013, NATURE, V496, P408, DOI 10.1038/496408a; Cullet P, 2007, HUM RIGHTS QUART, V29, P403, DOI 10.1353/hrq.2007.0014; DAM KW, 1994, J LEGAL STUD, V23, P247, DOI 10.1086/467923; Davis Aaron P., 2001, Adansonia (Paris), V23, P137; de Magalhaes JL, 2012, REV SOC BRAS MED TRO, V45, P415, DOI 10.1590/S0037-86822012000300030; de Swaaf ME, 2003, APPL MICROBIOL BIOT, V61, P40, DOI 10.1007/s00253-002-1118-1; Denicolo V, 2003, INT REV LAW ECON, V23, P365, DOI 10.1016/j.irle.2003.07.002; Dicks L, 2013, NATURE, V494, P283, DOI 10.1038/494283a; Dutfield G, 2000, BIOFUTUR, P42, DOI 10.1016/S0294-3506(00)80169-6; Dutfield G, 2000, SCI COMMUN, V21, P274, DOI 10.1177/1075547000021003004; Dutfield G., 2020, INTELLECTUAL PROPERT, P172; Dutfield Graham., 2004, INTELLECTUAL PROPERT; Eisenberg RS, 2003, ADV GENET, V50, P209, DOI 10.1016/S0065-2660(03)50010-4; Eisenberg RS, 1996, TRENDS BIOTECHNOL, V14, P302, DOI 10.1016/0167-7799(96)10040-8; Ellis R., 2004, SCI PUBL POLICY, V31, P95, DOI DOI 10.3152/147154304781780055; Esquinas-Alcazar J, 2005, NAT REV GENET, V6, P946, DOI 10.1038/nrg1729; ETC Group, 2013, GEN GIANTS SEEK PHIL; Fahal AH, 2004, T ROY SOC TROP MED H, V98, P3, DOI 10.1016/S0035-9203(03)00009-9; Falcon WP, 2002, FOOD POLICY, V27, P197, DOI 10.1016/S0306-9192(02)00013-1; Falkowski Paul, 2012, Nature, V483, pS21, DOI 10.1038/483S21a; FAO, 1999, DEV FOOD INS VULN MA; FAO, 2004, AGR BIOT M NEEDS POO; Fidler DP, 2010, PLOS MED, V7, DOI 10.1371/journal.pmed.1000247; Fleisher BM, 2013, ASIA-PAC J ACCOUNT E, V20, P4, DOI 10.1080/16081625.2013.760435; Food and Agriculture Organization, 2011, ABDC10 FAO UN; Francesconi F, 2012, CLIN MICROBIOL REV, V25, P79, DOI 10.1128/CMR.00010-11; Fry JC, 2012, J FOOD SCI, V77, pS362, DOI 10.1111/j.1750-3841.2012.02885.x; Gerber GS, 2004, BJU INT, V94, P338, DOI 10.1111/j.1464-410X.2004.04962.x; Gilbert P, 2003, CLIN MICROBIOL REV, V16, P189, DOI 10.1128/CMR.16.2.189-208.2003; Golden JM, 2010, J LAW MED ETHICS, V38, P314, DOI 10.1111/j.1748-720X.2010.00491.x; Grover A, 2012, J LAW MED ETHICS, V40, P234, DOI 10.1111/j.1748-720X.2012.00661.x; Gupta RK, 2004, NAT BIOTECHNOL, V22, P653, DOI 10.1038/nbt0604-653; Halewood M, 2012, CROP GENETIC RESOURC; Hall BH, 2007, OXFORD REV ECON POL, V23, P568, DOI 10.1093/icb/grm037; Hall BH, 2012, ANNU REV ECON, V4, P541, DOI 10.1146/annurev-economics-080511-111008; Hamilton C, 2006, DEV WORLD BIOETH, V6, P158, DOI 10.1111/j.1471-8847.2006.00168.x; Hamilton CJ, 2007, THESIS U LONDON; Hammer K, 2001, GENET RESOUR CROP EV, V48, P3, DOI 10.1023/A:1011253924058; HARTLINE HK, 1969, SCIENCE, V164, P270, DOI 10.1126/science.164.3877.270; Heckler S., 2009, LANDSCAPE PROCESS PO; Helfer L., 2004, YJIL, V29, P1, DOI DOI 10.2139/ssrn.459740; Heller MA, 1998, SCIENCE, V280, P698, DOI 10.1126/science.280.5364.698; Heller M, 2013, MOD LAW REV, V76, P6, DOI 10.1111/1468-2230.12000; Hellerstein R, 2012, ECON LETT, V116, P108, DOI 10.1016/j.econlet.2011.12.114; HELPMAN E, 1993, ECONOMETRICA, V61, P1247, DOI 10.2307/2951642; Hemment D, 2011, LEONARDO, V44, P62, DOI 10.1162/LEON_a_00096; Herber BP, 2006, POLAR REC, V42, P139, DOI 10.1017/S0032247406005158; Hilgartner S, 2012, BIOSOCIETIES, V7, P188, DOI 10.1057/biosoc.2012.5; Holman C, 2006, CELL, V125, P629, DOI 10.1016/j.cell.2006.05.009; Hope J., 2009, BIOBAZAAR OPEN SOURC; Hotez PJ, 2008, J CLIN INVEST, V118, P1311, DOI 10.1172/JCI34261; Howard Philip H., 2009, Sustainability, V1, P1266, DOI 10.3390/su1041266; Huang KG, 2009, ACAD MANAGE J, V52, P1193, DOI 10.5465/AMJ.2009.47084665; Jack BK, 2008, P NATL ACAD SCI USA, V105, P9465, DOI 10.1073/pnas.0705503104; Jensen K, 2005, SCIENCE, V310, P239, DOI 10.1126/science.1120014; Juma C., 1989, GENE HUNTERS BIOTECH; Kamiyama S, 2006, 20065 STI ORG EC COO; Kean S, 2011, SCIENCE, V331, P530, DOI 10.1126/science.331.6017.530; Kennedy D, 2001, SCIENCE, V294, P2249, DOI 10.1126/science.294.5550.2249; Kettler HE, 2001, B WORLD HEALTH ORGAN, V79, P742; Kobets T, 2012, CURR MED CHEM, V19, P1443, DOI 10.2174/092986712799828300; Konski AF, 2009, NAT BIOTECHNOL, V27, P722, DOI 10.1038/nbt0809-722; KRUMLAUF R, 1994, CELL, V78, P191, DOI 10.1016/0092-8674(94)90290-9; Kuhn R, 2012, NAT MED, V18, P1168, DOI 10.1038/nm0812-1168; Kursar TA, 2011, BIOSCIENCE, V61, P256, DOI 10.1525/bio.2011.61.4.2; Laird S, 2008, ACCESS BENEFIT SHARI; Laird S.A, 2002, BIODIVERSITY TRADITI; Leary D, 2009, MAR POLICY, V33, P183, DOI 10.1016/j.marpol.2008.05.010; Ledford H, 2013, NATURE, V498, P281, DOI 10.1038/498281a; Lee JY, 1996, REV ECON STAT, V78, P181, DOI 10.2307/2109919; Lemley MA, 2005, TEX LAW REV, V83, P1031; Lerner J, 2005, J ECON PERSPECT, V19, P99, DOI 10.1257/0895330054048678; Lerner J, 2002, J IND ECON, V50, P197, DOI 10.1111/1467-6451.00174; Lindoso JAL, 2009, REV INST MED TROP SP, V51, P247, DOI 10.1590/S0036-46652009000500003; Lobo DA, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001222; LOHAN D, 2003, INT REGIME BIOPROSPE; Lorence A, 2004, PHYTOCHEMISTRY, V65, P2735, DOI 10.1016/j.phytochem.2004.09.001; Malvy D, 2011, CLIN MICROBIOL INFEC, V17, P986, DOI 10.1111/j.1469-0691.2011.03536.x; Marshall E, 1998, SCIENCE, V280, P1687; Marshall E, 2012, SCIENCE, V337, P277, DOI 10.1126/science.337.6092.277; Maurer SM, 2006, W12148 NBER; Mayes S, 2012, J EXP BOT, V63, P1075, DOI 10.1093/jxb/err396; McCalman P, 2001, J INT ECON, V55, P161, DOI 10.1016/S0022-1996(01)00091-5; MEA, 2005, EC HUM WELL BEING SY, DOI DOI 10.1119/1.2344558; Moeller N. I., 2013, IDENTIFYING BENEFIT; Moon S, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001218; Mora C, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001127; Moran N, 2012, NAT BIOTECHNOL, V30, P377, DOI 10.1038/nbt0512-377; Moser P, 2013, J ECON PERSPECT, V27, P23, DOI 10.1257/jep.27.1.23; Nelson R.R., 1997, INTELLECTUAL PROPERT; Newman DJ, 2012, J NAT PROD, V75, P311, DOI 10.1021/np200906s; Nijar GS, 2011, RES PAPERS S CTR; Norman FF, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000762; O'Malley MA, 2005, NAT REV GENET, V6, P502, DOI 10.1038/nrg1613; OECD, 2012, OECD SCI TECHN IND O, DOI DOI 10.1787/STI_OUTLOOK-2012-14-EN; Oldham P., 2006, GLOBAL STATUS TRENDS, V3, P1; Oldham P, 2010, UNEPCBDCOP10INF44; Oldham P, 2004, UNEPCBDWGABS3INF4; Oldham P, 2009, INITIATIVE PREVENTIO, V4; Oldham P, 2006, GENOMICS SOC POLICY, V2, P62; Oliva MJ, 2011, PLANTA MED, V77, P1221, DOI 10.1055/s-0031-1279978; Oren Aharon, 2005, Saline Syst, V1, P2, DOI 10.1186/1746-1448-1-2; Orti L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000418; Overwalle GV, 2009, GENE PATENTS COLLABO; Palmer MJ, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2648; Park WG, 2012, REV WORLD ECON, V148, P151, DOI 10.1007/s10290-011-0113-y; Patterson DJ, 2010, TRENDS ECOL EVOL, V25, P686, DOI 10.1016/j.tree.2010.09.004; Pineyro-Nelson A, 2009, MOL ECOL, V18, P750, DOI 10.1111/j.1365-294X.2008.03993.x; Posey D.A., 1996, INTELLECTUAL PROPERT; Rai AK, 2002, ACAD MED, V77, P1368, DOI 10.1097/00001888-200212001-00007; Rai A, 2007, PLOS BIOL, V5, P389, DOI 10.1371/journal.pbio.0050058; Reardon J, 2005, IN-FORMATION, P1; Reichman, 2005, INT PUBLIC GOODS TRA; Relyea R.A., 2009, OECOLOGIA, V159, P363, DOI DOI 10.1007/s00442-008-1213-9; Rezaie R, 2012, HEALTH RES POLICY SY, V10, DOI 10.1186/1478-4505-10-18; Robinson D., 2010, CONFRONTING BIOPIRAC, P105; Safrin S, 2004, AM J INT LAW, V98, P641, DOI 10.2307/3216691; Sarmah AK, 2006, CHEMOSPHERE, V65, P725, DOI 10.1016/j.chemosphere.2006.03.026; Schrijver NJ, 1997, SOVEREIGNTY NATURAL; scotchmer s, 2004, INNOVATION INCENTIVE; Secretariat of the Convention on Biological Diversity, 2011, TKAR RI COD ETH COND; Secretariat of the World Trade Organization, 2006, IPCW368 SECR WORLD T; Sheridan C, 2005, NAT BIOTECHNOL, V23, P511, DOI 10.1038/nbt0505-511; SHIMOMURA O, 1962, J CELL COMPAR PHYSL, V59, P223, DOI 10.1002/jcp.1030590302; Shiva Vandana, 1997, BIOPIRACY PLUNDER NA; Snaddon J, 2013, BIOL LETTERS, V9, DOI 10.1098/rsbl.2012.1029; Soares J, 2011, ACS CHEM BIOL, V6, P289, DOI [10.1021/cb200089w, 10.1021/CEN022211145306]; Sugumaran G, 2012, CURR SCI INDIA, V102, P1637; Sukumaran S, 2010, ANN ONCOL, V21, P1089, DOI 10.1093/annonc/mdp420; 't Hoen E, 2013, CURR OPIN HIV AIDS, V8, P70, DOI 10.1097/COH.0b013e32835b6e5a; Tanne JH, 2012, BRIT MED J, V344, P2; Tansey Geoff, 2008, FUTURE CONTROL FOOD; TAUBES G, 1995, SCIENCE, V270, P1112, DOI 10.1126/science.270.5239.1112; Taubman A., 2020, HDB WTO TRIPS AGREEM, P85; Ten Kate K, 1999, COMMERCIAL USE BIODI; The Royal Society, 2003, KEEP SCI OP EFF INT; Triggle DJ, 2004, DRUG DEVELOP RES, V63, P139, DOI 10.1002/ddr.10404; Tvedt MW, 2011, POLAR REC, V47, P46, DOI 10.1017/S0032247410000045; United Nations, 2011, UN DECL RIGHTS IND P; van de Velde F, 2005, BIOPOLYMERS ONLINE, DOI [10.1002/3527600035.bpol6009, DOI 10.1002/3527600035.BP0L6009]; VLEGGAAR R, 1992, J CHEM SOC PERK T 1, P3095, DOI 10.1039/p19920003095; Wang LD, 2009, TROP MED INT HEALTH, V14, P1475, DOI 10.1111/j.1365-3156.2009.02403.x; WARD WW, 1975, P NATL ACAD SCI USA, V72, P2530, DOI 10.1073/pnas.72.7.2530; Warren R, 2013, NAT CLIM CHANGE, V3, P678, DOI [10.1038/nclimate1887, 10.1038/NCLIMATE1887]; WILLIAMS JGK, 1990, NUCLEIC ACIDS RES, V18, P6531, DOI 10.1093/nar/18.22.6531; Wilson J, 2007, J AGR ENVIRON ETHIC, V20, P261, DOI 10.1007/s10806-007-9032-2; Woodley E, 2012, BIOCULTURAL DIVERSIT; World Trade Organization, 2011, TNCW59 WORLD TRAD OR; Yacoub S, 2011, PHILOS T R SOC A, V369, P1719, DOI 10.1098/rsta.2011.0013; Yanagisawa T, 2009, 20099 STI ORG EC COO; Zainol ZA, 2011, AFR J BIOTECHNOL, V10, P12395	194	41	45	0	75	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78737	10.1371/journal.pone.0078737	http://dx.doi.org/10.1371/journal.pone.0078737			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255PK	24265714	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100047
J	Reis, FP; Barbas, A; Klauer-King, AA; Tsanova, B; Schaeffer, D; Lopez-Vinas, E; Gomez-Puertas, P; van Hoof, A; Arraiano, CM				Reis, Filipa P.; Barbas, Ana; Klauer-King, A. A.; Tsanova, Borislava; Schaeffer, Daneen; Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino; van Hoof, Ambro; Arraiano, Cecilia M.			Modulating the RNA Processing and Decay by the Exosome: Altering Rrp44/Dis3 Activity and End-Product	PLOS ONE			English	Article							HUMAN PM-SCL; YEAST EXOSOME; RIBOSOMAL-RNA; SWISS-MODEL; PERLMAN SYNDROME; RIBONUCLEASE-II; CORE EXOSOME; DEGRADATION; SUBUNIT; EXORIBONUCLEASE	In eukaryotes, the exosome plays a central role in RNA maturation, turnover, and quality control. In Saccharomyces cerevisiae, the core exosome is composed of nine catalytically inactive subunits constituting a ring structure and the active nuclease Rrp44, also known as Dis3. Rrp44 is a member of the ribonuclease II superfamily of exoribonucleases which include RNase R, Dis3L1 and Dis3L2. In this work we have functionally characterized three residues located in the highly conserved RNB catalytic domain of Rrp44: Y595, Q892 and G895. To address their precise role in Rrp44 activity, we have constructed Rrp44 mutants and compared their activity to the wild-type Rrp44. When we mutated residue Q892 and tested its activity in vitro, the enzyme became slightly more active. We also showed that when we mutated Y595, the final degradation product of Rrp44 changed from 4 to 5 nucleotides. This result confirms that this residue is responsible for the stacking of the RNA substrate in the catalytic cavity, as was predicted from the structure of Rrp44. Furthermore, we also show that a strain with a mutation in this residue has a growth defect and affects RNA processing and degradation. These results lead us to hypothesize that this residue has an important biological role. Molecular dynamics modeling of these Rrp44 mutants and the wild-type enzyme showed changes that extended beyond the mutated residues and helped to explain these results.	[Reis, Filipa P.; Barbas, Ana; Arraiano, Cecilia M.] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal; [Klauer-King, A. A.; Tsanova, Borislava; Schaeffer, Daneen; van Hoof, Ambro] Univ Texas Hlth Sci Ctr Houston, Dept Microbiol & Mol Genet, Houston, TX 77030 USA; [Klauer-King, A. A.; Tsanova, Borislava; Schaeffer, Daneen; van Hoof, Ambro] Univ Texas Hlth Sci Ctr Houston, Univ Texas Grad Sch Biomed Sci, Houston, TX 77030 USA; [Lopez-Vinas, Eduardo; Gomez-Puertas, Paulino] Ctr Biol Mol Severo Ochoa CSIC UAM, Madrid, Spain; [Lopez-Vinas, Eduardo] Biomol Informat SL, Madrid, Spain	Universidade Nova de Lisboa; University of Texas System; University of Texas Health Science Center Houston; University of Texas System; University of Texas Health Science Center Houston; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Centro de Biologia Molecular Severo Ochoa (CBM)	Arraiano, CM (corresponding author), Univ Nova Lisboa, Inst Tecnol Quim & Biol, Oeiras, Portugal.	cecilia@itqb.unl.pt	López-Viñas, Eduardo/AAT-1124-2021; Gomez-Puertas, Paulino/G-8821-2014	Gomez-Puertas, Paulino/0000-0003-3131-729X; van Hoof, Ambro/0000-0002-7800-9764; Arraiano, Cecilia/0000-0003-1934-9301; Barbas, Ana/0000-0002-6245-8549	Fundacao para a Ciencia e a Tecnologia (FCT); FCT; FCT, Portugal [PEst-OE/EQB/LA0004/2011]; European Commission [FP7-KBBE-2011-1-289326]; National Institutes of Health [R01GM099790]; Welch foundation [AU-1773]; EMBO; Spanish Ministerio de Ciencia e Innovacion [SAF2007-61926, IPT2011-0964-900000, SAF2011-13156-E]; European Commission (EU) [FP7 HEALTH-F3-2009-223431, FP7 HEALTH-2011-278603]; Fundacion Ramon Areces; European Social Fund; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM099790] Funding Source: NIH RePORTER	Fundacao para a Ciencia e a Tecnologia (FCT)(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT(Portuguese Foundation for Science and TechnologyEuropean Commission); FCT, Portugal(Portuguese Foundation for Science and TechnologyEuropean Commission); European Commission(European CommissionEuropean Commission Joint Research Centre); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Welch foundation(The Welch Foundation); EMBO(European Molecular Biology Organization (EMBO)); Spanish Ministerio de Ciencia e Innovacion(Ministry of Science and Innovation, Spain (MICINN)Instituto de Salud Carlos IIISpanish Government); European Commission (EU)(European CommissionEuropean Commission Joint Research Centre); Fundacion Ramon Areces; European Social Fund(European Social Fund (ESF)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	F.P.R. was a recipient of a Fundacao para a Ciencia e a Tecnologia (FCT) Ph.D. fellowship and A. B. was a recipient of a FCT PostDoc. fellowship. This work was supported by grants from FCT, Portugal (including grant PEst-OE/EQB/LA0004/2011) and by grant FP7-KBBE-2011-1-289326 from European Commission. Work in the A. v. H. laboratory was funded by grants from National Institutes of Health [R01GM099790], the Welch foundation [AU-1773] and an EMBO short term fellowship to [D. S.]. Work at the P. G-P. laboratory was supported by: the Spanish Ministerio de Ciencia e Innovacion [grants SAF2007-61926, IPT2011-0964-900000 and SAF2011-13156-E] and the European Commission [grants FP7 HEALTH-F3-2009-223431 (EU project "Divinocell'') and FP7 HEALTH-2011-278603 (EU project "Dorian'')]. Support from the "Fundacion Ramon Areces'' and the Centro de Computacion Cientifica CCC-UAM'' for computational support is also acknowledged. Work at Biomol-Informatics was partially financed by the European Social Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allmang C, 1999, GENE DEV, V13, P2148, DOI 10.1101/gad.13.16.2148; Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Astuti D, 2012, NAT GENET, V44, P277, DOI 10.1038/ng.1071; Barbas A, 2008, J BIOL CHEM, V283, P13070, DOI 10.1074/jbc.M709989200; Barbas A, 2009, J BIOL CHEM, V284, P20486, DOI 10.1074/jbc.M109.020693; Bollenbach TJ, 2005, NUCLEIC ACIDS RES, V33, P2751, DOI 10.1093/nar/gki576; Bonneau F, 2009, CELL, V139, P547, DOI 10.1016/j.cell.2009.08.042; Briggs MW, 1998, J BIOL CHEM, V273, P13255, DOI 10.1074/jbc.273.21.13255; Cairrao F, 2005, DEV DYNAM, V232, P733, DOI 10.1002/dvdy.20269; Case D.A., 2022, AMBER 2020; Chang HM, 2013, NATURE, V497, P244, DOI 10.1038/nature12119; Chapman MA, 2011, NATURE, V471, P467, DOI 10.1038/nature09837; de la Cruz J, 1998, EMBO J, V17, P1128, DOI 10.1093/emboj/17.4.1128; Dziembowski A, 2007, NAT STRUCT MOL BIOL, V14, P15, DOI 10.1038/nsmb1184; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Frischmeyer PA, 2002, SCIENCE, V295, P2258, DOI 10.1126/science.1067338; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964; Kiefer Florian, 2009, Nucleic Acids Res, V37, pD387, DOI 10.1093/nar/gkn750; Lebreton A, 2008, NATURE, V456, P993, DOI 10.1038/nature07480; Lindorff-Larsen K, 2010, PROTEINS, V78, P1950, DOI 10.1002/prot.22711; Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037; Lorentzen E, 2008, MOL CELL, V29, P717, DOI 10.1016/j.molcel.2008.02.018; Lubas M, 2013, EMBO J, V32, P1855, DOI 10.1038/emboj.2013.135; Lykke-Andersen S, 2009, J CELL SCI, V122, P1487, DOI 10.1242/jcs.047399; Makino DL, 2013, NATURE, V495, P70, DOI 10.1038/nature11870; Malecki M, 2013, EMBO J, V32, P1842, DOI 10.1038/emboj.2013.63; Matos RG, 2009, BIOCHEM J, V423, P291, DOI 10.1042/BJ20090839; Mian IS, 1997, NUCLEIC ACIDS RES, V25, P3187, DOI 10.1093/nar/25.16.3187; Mitchell P, 1997, CELL, V91, P457, DOI 10.1016/S0092-8674(00)80432-8; NIYOGI SK, 1975, J BIOL CHEM, V250, P7307; PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658; Reis FP, 2013, WIRES RNA, V4, P607, DOI 10.1002/wrna.1180; Schaeffer D, 2012, NUCLEIC ACIDS RES, V40, P9298, DOI 10.1093/nar/gks693; Schaeffer D, 2011, P NATL ACAD SCI USA, V108, P2366, DOI 10.1073/pnas.1013180108; Schaeffer D, 2009, NAT STRUCT MOL BIOL, V16, P56, DOI 10.1038/nsmb.1528; Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006; Schneider C, 2009, NUCLEIC ACIDS RES, V37, P1127, DOI 10.1093/nar/gkn1020; Staals RHJ, 2010, EMBO J, V29, P2358, DOI 10.1038/emboj.2010.122; Tomecki R, 2010, EMBO J, V29, P2342, DOI 10.1038/emboj.2010.121; van Hoof A, 2002, SCIENCE, V295, P2262, DOI 10.1126/science.1067272; Wang JM, 2000, J COMPUT CHEM, V21, P1049, DOI 10.1002/1096-987X(200009)21:12<1049::AID-JCC3>3.0.CO;2-F; YU D, 1995, J BACTERIOL, V177, P4137, DOI 10.1128/jb.177.14.4137-4139.1995	44	12	13	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e76504	10.1371/journal.pone.0076504	http://dx.doi.org/10.1371/journal.pone.0076504			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265673	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100005
J	Walzer, A; Schausberger, P				Walzer, Andreas; Schausberger, Peter			Intra- and Trans-Generational Costs of Reduced Female Body Size Caused by Food Limitation Early in Life in Mites	PLOS ONE			English	Article							PERSIMILIS ATHIAS-HENRIOT; EGG SIZE; REPRODUCTIVE SUCCESS; DEVELOPMENTAL STRESS; PREDACIOUS MITES; PREDATORY MITES; GROWTH-RATES; MATE CHOICE; SEX-RATIO; NUMBER	Background: Food limitation early in life may be compensated for by developmental plasticity resulting in accelerated development enhancing survival at the expense of small adult body size. However and especially for females in non-matching maternal and offspring environments, being smaller than the standard may incur considerable intra-and transgenerational costs. Methodology/Principal Findings: Here, we evaluated the costs of small female body size induced by food limitation early in life in the sexually size-dimorphic predatory mite Phytoseiulus persimilis. Females are larger than males. These predators are adapted to exploit ephemeral spider mite prey patches. The intra- and trans-generational effects of small maternal body size manifested in lower maternal survival probabilities, decreased attractiveness for males, and a reduced number and size of eggs compared to standard-sized females. The trans-generational effects of small maternal body size were sex-specific with small mothers producing small daughters but standard-sized sons. Conclusions/Significance: Small female body size apparently intensified the well-known costs of sexual activity because mortality of small but not standard-sized females mainly occurred shortly after mating. The disadvantages of small females in mating and egg production may be generally explained by size-associated morphological and physiological constraints. Additionally, size-assortative mate preferences of standard-sized mates may have rendered small females disproportionally unattractive mating partners. We argue that the sex-specific trans-generational effects were due to sexual size dimorphism females are the larger sex and thus more strongly affected by maternal stress than the smaller males - and to sexually selected lower plasticity of male body size.	[Walzer, Andreas; Schausberger, Peter] Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, Grp Arthropod Ecol & Behav, Vienna, Austria	University of Natural Resources & Life Sciences, Vienna	Walzer, A (corresponding author), Univ Nat Resources & Life Sci, Dept Crop Sci, Div Plant Protect, Grp Arthropod Ecol & Behav, Vienna, Austria.	andreas.walzer@boku.ac.at		Schausberger, Peter/0000-0002-1529-3198	Austrian Science Fund [P19824-B17, PP23504-B17]; Austrian Science Fund (FWF) [P 23504] Funding Source: researchfish	Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	This study was funded by the Austrian Science Fund (www.fwf.ac.at, P19824-B17 and PP23504-B17). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams PA, 1996, AM NAT, V147, P381, DOI 10.1086/285857; AMANO H, 1978, CAN J ZOOL, V56, P1593, DOI 10.1139/z78-221; AMANO H, 1979, ACAROLOGIA, V20, P196; AMANO H, 1977, CAN J ZOOL, V55, P1978, DOI 10.1139/z77-255; Andersson Malte, 1994; Bauerfeind SS, 2007, EVOLUTION, V61, P2374, DOI 10.1111/j.1558-5646.2007.00197.x; BERGER A, 1989, ENTOMOL EXP APPL, V50, P199, DOI 10.1007/BF00341168; Bergstrom J, 2002, ANIM BEHAV, V64, P49, DOI 10.1006/anbe.2002.3032; BERVEN KA, 1981, EVOLUTION, V35, P707, DOI 10.1111/j.1558-5646.1981.tb04931.x; Blanckenhorn WU, 1999, EVOL ECOL, V13, P395, DOI 10.1023/A:1006741222586; Bonduriansky R, 2007, J EVOLUTION BIOL, V20, P2379, DOI 10.1111/j.1420-9101.2007.01419.x; Bonduriansky R, 2009, ANNU REV ECOL EVOL S, V40, P103, DOI 10.1146/annurev.ecolsys.39.110707.173441; Buhl A., 2008, SPSS 16 EINFUHRUNG M; CARRIERE Y, 1995, OECOLOGIA, V102, P389, DOI 10.1007/BF00329806; CRESPI BJ, 1989, ANIM BEHAV, V38, P980, DOI 10.1016/S0003-3472(89)80138-1; Croft BA, 1999, EXP APPL ACAROL, V23, P599, DOI 10.1023/A:1006236310613; DEAN JM, 1981, OECOLOGIA, V48, P385, DOI 10.1007/BF00346499; DELESALLE VA, 1986, BEHAV PROCESS, V12, P1, DOI 10.1016/0376-6357(86)90066-5; FITT GP, 1990, ENTOMOL EXP APPL, V55, P11, DOI 10.1007/BF00188223; Fox CW, 2000, ANNU REV ENTOMOL, V45, P341, DOI 10.1146/annurev.ento.45.1.341; Gage MJG, 1998, BEHAV ECOL, V9, P592, DOI 10.1093/beheco/9.6.592; Herenyi M, 2012, OECOLOGIA, V170, P935, DOI 10.1007/s00442-012-2362-4; HUCK UW, 1987, BIOL REPROD, V37, P612, DOI 10.1095/biolreprod37.3.612; Krantz G., 2009, MANUAL ACAROLOGY; Macke E, 2011, P ROY SOC B-BIOL SCI, V278, P1054, DOI 10.1098/rspb.2010.1706; Malmqvist B, 2004, J VECTOR ECOL, V29, P248; Martins TLF, 2004, BEHAV ECOL, V15, P174, DOI 10.1093/beheco/arg094; McMurtry JA, 1997, ANNU REV ENTOMOL, V42, P291, DOI 10.1146/annurev.ento.42.1.291; Metcalfe NB, 2001, TRENDS ECOL EVOL, V16, P254, DOI 10.1016/S0169-5347(01)02124-3; MOLLER H, 1990, FUNCT ECOL, V4, P489, DOI 10.2307/2389316; Naguib M, 2005, BIOL LETT-UK, V1, P95, DOI 10.1098/rsbl.2004.0277; Naguib M, 2006, P ROY SOC B-BIOL SCI, V273, P1901, DOI 10.1098/rspb.2006.3526; NEWMAN RA, 1994, ECOLOGY, V75, P1085, DOI 10.2307/1939432; Nylin S, 1998, ANNU REV ENTOMOL, V43, P63, DOI 10.1146/annurev.ento.43.1.63; Partridge L., 1986, P45; Rauter CM, 2010, ETHOLOGY, V116, P120, DOI 10.1111/j.1439-0310.2009.01720.x; Robbins AM, 2011, AM J PHYS ANTHROPOL, V146, P582, DOI 10.1002/ajpa.21605; Roff Derek A., 1992; Sabelis M.W., 1985, P141; Sabelis MW, 2002, SEX RATIOS: CONCEPTS AND RESEARCH METHODS, P235, DOI 10.1017/CBO9780511542053.012; SABELIS MW, 1988, EXP APPL ACAROL, V4, P301, DOI 10.1007/BF01196192; Schausberger P, 1997, EXP APPL ACAROL, V21, P131, DOI 10.1023/A:1018478418010; Schausberger P, 2008, J ANIM ECOL, V77, P1109, DOI 10.1111/j.1365-2656.2008.01440.x; Schulten G.G.M., 1985, P55; Snell-Rood EC, 2013, ANIM BEHAV, V85, P1004, DOI 10.1016/j.anbehav.2012.12.031; Stearns S.C., 1992, pi; Stephens PA, 2009, ECOLOGY, V90, P2057, DOI 10.1890/08-1369.1; Strodl MA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043590; Valtonen TM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0031611; Vanas V, 2006, EXP APPL ACAROL, V39, P1, DOI 10.1007/s10493-006-0024-0; VERRELL PA, 1989, ANIM BEHAV, V38, P1086, DOI 10.1016/S0003-3472(89)80150-2; Vijendravarma RK, 2010, BIOL LETTERS, V6, P238, DOI 10.1098/rsbl.2009.0754; Walzer A, 2012, 7 S EUR ASS AC AC CH, P71; Walzer A, 2006, J INSECT BEHAV, V19, P305, DOI 10.1007/s10905-006-9025-4; Walzer A, 2011, BIOL J LINN SOC, V102, P650, DOI 10.1111/j.1095-8312.2010.01593.x; Walzer A, 2011, ANIM BEHAV, V81, P177, DOI 10.1016/j.anbehav.2010.09.031; Wherry T, 2009, J ZOOL, V279, P57, DOI 10.1111/j.1469-7998.2009.00590.x; Zann RA., 1996, ZEBRA FINCH SYNTHESI	58	17	17	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79089	10.1371/journal.pone.0079089	http://dx.doi.org/10.1371/journal.pone.0079089			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265745	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100078
J	Yu, SN; Qiu, JG; Zhang, JG; Pan, L; Xing, SJ; Zhang, LJ				Yu, Shengnan; Qiu, Jianguo; Zhang, Jinggang; Pan, Liang; Xing, Shijun; Zhang, Lijun			Detection of Intratumoral Susceptibility Signals Using T2*-Weighted Gradient Echo MRI in Patients with Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							HEPATOCELLULAR-CARCINOMA; TUMOR ANGIOGENESIS; NUCLEAR GRADE; GLIOMAS; STAGE	Objective: To retrospectively evaluate whether T2*-weighted imaging can be used to grade clear cell renal cell carcinomas (ccRCC) based on intratumoral susceptibility signals (ISSs). Materials and Methods: MR imaging from 37 patients with pathologically-proven ccRCCs was evaluated. ISSs on T2*WI were classified as linear or conglomerated linear structures (type I) and dot-like or patchy foci (type II). Two radiologists assessed the likelihood of the presence of ISS, dominant structure of ISS and ratio of ISS area to tumor area. Results were analyzed by nonparametric Mann-Whitney test. Results: ISSs were seen in all patients except for four patients with low-grade ccRCCs and two patients with high-grade ccRCCs. There was no significant difference of the likelihood of the presence of ISS between low-and high-grade ccRCCs. More type I ISSs and less type II ISSs were predictive of low-grade tumors, whereas more conspicuity type II ISSs correlated with higher occurrence of high-grade tumors (P<0.05). The ratio of ISS area to tumor area was also significantly higher for the high-grade group (1.27+/-0.79) than that for the low-grade group (0.81+/-0.40) (P<0.05). Conclusion: ISSs on T2*-weighted gradient-echo MR images can help grade ccRCCs before operations.	[Yu, Shengnan; Qiu, Jianguo; Zhang, Jinggang; Pan, Liang; Xing, Shijun; Zhang, Lijun] First Peoples Hosp Changzhou, Dept Radiol, Changzhou, Jiangsu, Peoples R China		Qiu, JG (corresponding author), First Peoples Hosp Changzhou, Dept Radiol, Changzhou, Jiangsu, Peoples R China.	step9999@sina.com						ARONEN HJ, 1994, RADIOLOGY, V191, P41, DOI 10.1148/radiology.191.1.8134596; Bagley LJ, 1997, RADIOLOGY, V202, P511, DOI 10.1148/radiology.202.2.9015082; Chavhan GB, 2009, RADIOGRAPHICS, V29, P1433, DOI 10.1148/rg.295095034; Chiu Y, 2012, INT J SURG ONCOL, V2012, DOI 10.1155/2012/123596; Choi JS, 2010, CLIN RADIOL, V65, P916, DOI 10.1016/j.crad.2010.07.003; Chow WH, 2010, NAT REV UROL, V7, P245, DOI 10.1038/nrurol.2010.46; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Goyal A, 2012, ACTA RADIOL, V53, P349, DOI 10.1258/ar.2011.110415; Gudbjartsson T, 2005, EUR UROL, V48, P593, DOI 10.1016/j.eururo.2005.04.016; Hardie AD, 2011, EUR J RADIOL, V80, pE249, DOI 10.1016/j.ejrad.2010.10.027; Hori M, 2010, MAGN RESON IMAGING, V28, P594, DOI 10.1016/j.mri.2010.01.002; Hsu RM, 2004, AM J ROENTGENOL, V182, P551, DOI 10.2214/ajr.182.3.1820551; Jewett MAS, 2011, EUR UROL, V60, P39, DOI 10.1016/j.eururo.2011.03.030; Kato M, 2004, J UROLOGY, V172, P863, DOI 10.1097/01.ju.0000136315.80057.99; Kinouchi T, 2003, UROLOGY, V62, P765, DOI 10.1016/S0090-4295(03)00512-0; Kitagawa Y, 2011, JPN J CLIN ONCOL, V41, P637, DOI 10.1093/jjco/hyr007; Li RK, 2012, J MAGN RESON IMAGING, V36, P900, DOI 10.1002/jmri.23734; Nativ O, 1998, UROLOGY, V51, P693, DOI 10.1016/S0090-4295(98)00019-3; Oda T, 2001, INT J UROL, V8, P473, DOI 10.1046/j.1442-2042.2001.00353.x; Park MJ, 2009, AM J NEURORADIOL, V30, P1402, DOI 10.3174/ajnr.A1593; RECHT L, 1990, J NEUROSURG, V72, P941, DOI 10.3171/jns.1990.72.6.0941; Remzi M, 2006, J UROLOGY, V176, P896, DOI 10.1016/j.juro.2006.04.047; Sabo E, 2001, CLIN CANCER RES, V7, P533; Suzuki K, 2012, JPN J CLIN ONCOL; Tsivian M, 2011, BJU INT, V107, P735, DOI 10.1111/j.1464-410X.2010.09629.x; Tynninen O, 1999, INVEST RADIOL, V34, P427, DOI 10.1097/00004424-199906000-00007; Uno Masahiro, 2004, Int J Clin Oncol, V9, P510, DOI 10.1007/s10147-004-0441-1	27	0	1	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79597	10.1371/journal.pone.0079597	http://dx.doi.org/10.1371/journal.pone.0079597			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265780	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100113
J	Chen, PW; Cescon, M; Megighian, A; Bonaldo, P				Chen, Peiwen; Cescon, Matilde; Megighian, Aram; Bonaldo, Paolo			Collagen VI regulates peripheral nerve myelination and function	FASEB JOURNAL			English	Article						extracellular matrix; peripheral nervous system; Schwann cells	SCHWANN-CELL DIFFERENTIATION; NEGATIVE REGULATOR; SIGNALING PATHWAY; DEFICIENCY; MICE; MECHANISMS; EXPRESSION; NEUROPATHY; MUTATIONS; KINASE	Collagen VI is an extracellular matrix protein with broad distribution in several tissues. Although Col6a1 is expressed by Schwann cells, the role of collagen VI in the peripheral nervous system (PNS) is yet unknown. Here we show that Schwann cells, but not axons, contribute to collagen VI deposition in peripheral nerves. By using Col6a1-null mice, in which collagen VI deposition is compromised, we demonstrate that lack of collagen VI leads to increased myelin thickness (P<0.001) along with 60-130% up-regulation in myelin-associated proteins and disorganized C fibers in the PNS. The hypermyelination of PNS in Col6a1(-/-) mice is supported by alterations of signaling pathways involved in myelination, including increase of P-FAK, P-AKT, P-ERK1, P-ERK2, and P-p38 (4.15, 1.67, 2.47, 3.34, and 2.60-fold, respectively) and reduction of vimentin (0.49-fold), P-JNK (0.74-fold), and P-c-Jun (0.50-fold). Pathologically, Col6a1(-/-) mice display an impairment of nerve conduction velocity and motor coordination (P<0.05), as well as a delayed response to acute pain stimuli (P<0.001), indicating that lack of collagen VI causes functional defects of peripheral nerves. Altogether, these results indicate that collagen VI is a critical component of PNS contributing to the structural integrity and proper function of peripheral nerves.Chen, P., Cescon, M., Megighian, A., Bonaldo, P. Collagen VI regulates peripheral nerve myelination and function.	[Chen, Peiwen; Cescon, Matilde; Bonaldo, Paolo] Univ Padua, Dept Mol Med, I-35131 Padua, Italy; [Megighian, Aram] Univ Padua, Dept Biomed Sci, I-35131 Padua, Italy	University of Padua; University of Padua	Bonaldo, P (corresponding author), Univ Padua, Dept Mol Med, Via Ugo Bassi 58-B, I-35131 Padua, Italy.	bonaldo@bio.unipd.it	Cescon, Matilde/Y-3116-2019; Megighian, Aram/G-6478-2014; MEGIGHIAN, ARAM/I-8146-2019	Cescon, Matilde/0000-0001-7138-1857; Megighian, Aram/0000-0002-7971-5310; MEGIGHIAN, ARAM/0000-0002-7971-5310; Chen, Peiwen/0000-0002-8129-9328; Bonaldo, Paolo/0000-0002-9571-8140	Telethon Foundation [GGP10225, GGP11082]; Italian Ministry of Education, University, and Research [RBAP11Z3YA_003, 2008PB5S89_001, 2009YHX85_002]; University of Padova Strategic Projects; Cariparo Foundation	Telethon Foundation(Fondazione Telethon); Italian Ministry of Education, University, and Research(Ministry of Education, Universities and Research (MIUR)); University of Padova Strategic Projects; Cariparo Foundation(Fondazione Cariparo)	The authors are grateful to C. Colombelli, L. Nobbio, G. Vitale, and M. Filaferro for help with immunofluorescence and functional studies and M. L. Feltri for critical comments on the manuscript. The authors thank Alfonso Colombatti (Centro di Riferimento Oncologico di Aviano, Aviano, Italy), Elior Peles (Weizmann Institute of Science, Rehovot, Israel), James S. Trimmer (University of California, Davis, CA, USA), and Raimund Wagener (Universitat zu Koln, Cologne, Germany) for providing antibodies; P. Giusti and F. Papaleo for providing rotarod and hotplate equipment; and W. Giuriati for technical assistance. This work was supported by grants from the Telethon Foundation (GGP10225, GGP11082), Italian Ministry of Education, University, and Research (RBAP11Z3YA_003, 2008PB5S89_001, 2009YHX85_002), and University of Padova Strategic Projects. P.C. is supported by a fellowship from the Cariparo Foundation.	Allen JM, 2009, J BIOL CHEM, V284, P12020, DOI 10.1074/jbc.M806968200; Bolino A, 2004, J CELL BIOL, V167, P711, DOI 10.1083/jcb.200407010; Bonaldo P, 1998, HUM MOL GENET, V7, P2135, DOI 10.1093/hmg/7.13.2135; Bonnemann Carsten G, 2011, Handb Clin Neurol, V101, P81, DOI 10.1016/B978-0-08-045031-5.00005-0; Bradley JL, 2000, ACTA NEUROPATHOL, V99, P539, DOI 10.1007/s004010051158; BROCKES JP, 1979, BRAIN RES, V165, P105, DOI 10.1016/0006-8993(79)90048-9; Bunge R P, 1993, Curr Opin Neurobiol, V3, P805, DOI 10.1016/0959-4388(93)90157-T; Chance PF, 1999, ANN NY ACAD SCI, V883, P14, DOI 10.1111/j.1749-6632.1999.tb08562.x; Chen ZL, 2003, J CELL BIOL, V163, P889, DOI 10.1083/jcb.200307068; Cheng IH, 2011, NEUROSCIENCE, V183, P178, DOI 10.1016/j.neuroscience.2011.03.057; Cheng JS, 2009, NAT NEUROSCI, V12, P119, DOI 10.1038/nn.2240; Chernousov MA, 2006, J NEUROSCI, V26, P508, DOI 10.1523/JNEUROSCI.2544-05.2006; Chomiak T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007754; COLOMBATTI A, 1995, J BIOL CHEM, V270, P13105, DOI 10.1074/jbc.270.22.13105; D'Mello R, 2008, BRIT J ANAESTH, V101, P8, DOI 10.1093/bja/aen088; Deodato F, 2002, NEUROMUSCULAR DISORD, V12, P392, DOI 10.1016/S0960-8966(01)00312-1; Doran B, 2006, P NATL ACAD SCI USA, V103, P7471, DOI 10.1073/pnas.0602057103; ELDRIDGE CF, 1989, J NEUROSCI, V9, P625; Feltri ML, 2002, J CELL BIOL, V156, P199, DOI 10.1083/jcb.200109021; Fragoso G, 2003, EXP NEUROL, V183, P34, DOI 10.1016/S0014-4886(03)00101-8; Gara SK, 2011, MATRIX BIOL, V30, P248, DOI 10.1016/j.matbio.2011.03.006; Gess B, 2011, J NEUROSCI, V31, P17180, DOI 10.1523/JNEUROSCI.3457-11.2011; Grove M, 2007, J CELL BIOL, V176, P277, DOI 10.1083/jcb.200609021; Haines JD, 2008, J MOL NEUROSCI, V35, P23, DOI 10.1007/s12031-007-9011-0; Harrisingh MC, 2004, EMBO J, V23, P3061, DOI 10.1038/sj.emboj.7600309; Hill R, 2009, J ANAT, V214, P219, DOI 10.1111/j.1469-7580.2008.01026.x; Hossain S, 2010, EXP NEUROL, V226, P47, DOI 10.1016/j.expneurol.2010.08.002; Irwin WA, 2003, NAT GENET, V35, P367, DOI 10.1038/ng1270; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; Karkheiran S, 2013, HUM GENET, V132, P275, DOI 10.1007/s00439-012-1248-1; KEENE DR, 1988, J CELL BIOL, V107, P1995, DOI 10.1083/jcb.107.5.1995; Kuo HJ, 1997, J BIOL CHEM, V272, P26522, DOI 10.1074/jbc.272.42.26522; La Marca R, 2011, NAT NEUROSCI, V14, P857, DOI 10.1038/nn.2849; Lee HJ, 2009, EXP NEUROL, V216, P365, DOI 10.1016/j.expneurol.2008.12.009; Mirsky R, 1999, BRAIN PATHOL, V9, P293; Napoli I, 2012, NEURON, V73, P729, DOI 10.1016/j.neuron.2011.11.031; Newbern JM, 2011, NEURON, V69, P91, DOI 10.1016/j.neuron.2010.12.003; Nobbio L, 2009, J BIOL CHEM, V284, P23146, DOI 10.1074/jbc.M109.027128; Novak N, 2011, J CELL BIOL, V192, P243, DOI 10.1083/jcb.201010013; Ogata T, 2004, J NEUROSCI, V24, P6724, DOI 10.1523/JNEUROSCI.5520-03.2004; Parkinson DB, 2008, J CELL BIOL, V181, P625, DOI 10.1083/jcb.200803013; PELTONEN J, 1990, ANN NY ACAD SCI, V580, P501, DOI 10.1111/j.1749-6632.1990.tb17972.x; PELTONEN J, 1989, ANAL BIOCHEM, V178, P184, DOI 10.1016/0003-2697(89)90377-1; Pujol A, 2002, HUM MOL GENET, V11, P499, DOI 10.1093/hmg/11.5.499; Rasi K, 2010, J NEUROSCI, V30, P14490, DOI 10.1523/JNEUROSCI.2644-10.2010; Sander S, 1998, MUSCLE NERVE, V21, P217, DOI 10.1002/(SICI)1097-4598(199802)21:2<217::AID-MUS9>3.0.CO;2-E; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Triolo D, 2012, DEVELOPMENT, V139, P1359, DOI 10.1242/dev.072371; Vitale P, 2001, MECH DEVELOP, V102, P145, DOI 10.1016/S0925-4773(01)00303-3; Wallquist W, 2005, J NEUROSCI, V25, P3692, DOI 10.1523/JNEUROSCI.5225-04.2005; Warner LE, 1996, NEURON, V17, P451, DOI 10.1016/S0896-6273(00)80177-4; WAXMAN SG, 1980, MUSCLE NERVE, V3, P141, DOI 10.1002/mus.880030207; Webster H. D., 1993, PERIPHERAL NEUROPATH, P243; Wu LMN, 2012, CURR BIOL, V22, P1957, DOI 10.1016/j.cub.2012.08.025; Yang DP, 2012, J NEUROSCI, V32, P7158, DOI 10.1523/JNEUROSCI.5812-11.2012; Yang DR, 2005, J CELL BIOL, V168, P655, DOI 10.1083/jcb.200411158	56	46	48	2	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1145	1156		10.1096/fj.13-239533	http://dx.doi.org/10.1096/fj.13-239533			12	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24277578				2022-12-25	WOS:000335324800011
J	LaBarge, S; McDonald, M; Smith-Powell, L; Auwerx, J; Huss, JM				LaBarge, Samuel; McDonald, Marisa; Smith-Powell, Leslie; Auwerx, Johan; Huss, Janice M.			Estrogen-related receptor-alpha ( ERR alpha) deficiency in skeletal muscle impairs regeneration in response to injury	FASEB JOURNAL			English	Article						nuclear receptors; mitochondria; myogenic differentiation; gene expression; AMP-activated protein kinase	ACTIVATED PROTEIN-KINASE; MITOCHONDRIAL BIOGENESIS; GENE-EXPRESSION; MYOBLAST DIFFERENTIATION; TRANSCRIPTIONAL CONTROL; AMPK; GAMMA; METABOLISM; PGC-1-ALPHA; PHOSPHORYLATION	The estrogen-related receptor- (ERR) regulates mitochondrial biogenesis and glucose and fatty acid oxidation during differentiation in skeletal myocytes. However, whether ERR controls metabolic remodeling during skeletal muscle regeneration in vivo is unknown. We characterized the time course of skeletal muscle regeneration in wild-type (M-ERRWT) and muscle-specific ERR-/- (M-ERR-/-) mice after injury by intramuscular cardiotoxin injection. M-ERR-/- mice exhibited impaired regeneration characterized by smaller myofibers with increased centrally localized nuclei and reduced mitochondrial density and cytochrome oxidase and citrate synthase activities relative to M-ERRWT. Transcript levels of mitochondrial transcription factor A, nuclear respiratory factor-2a, and peroxisome proliferator-activated receptor (PPAR)- coactivator (PGC)-1, were downregulated in the M-ERR-/- muscles at the onset of myogenesis. Furthermore, coincident with delayed myofiber recovery, we observed reduced muscle ATP content (-45% vs.M-ERRWT) and enhanced AMP-activated protein kinase (AMPK) activation in M-ERR-/- muscle. We subsequently demonstrated that pharmacologic postinjury AMPK activation was sufficient to delay muscle regeneration in WT mice. AMPK activation induced ERR transcript expression in M-ERRWT muscle and in C2C12 myotubes through induction of the Esrra promoter, indicating that ERR may control gene regulation downstream of the AMPK pathway. Collectively, these results suggest that ERR deficiency during muscle regeneration impairs recovery of mitochondrial energetic capacity and perturbs AMPK activity, resulting in delayed myofiber repair.LaBarge, S., McDonald, M., Smith-Powell, L., Auwerx, J., Huss, J. M. Estrogen-related receptor- (ERR) deficiency in skeletal muscle impairs regeneration in response to injury.	[LaBarge, Samuel; McDonald, Marisa; Huss, Janice M.] City Hope Natl Med Ctr, Beckman Res Inst, Dept Diabet & Metab Dis Res, Duarte, CA 91010 USA; [LaBarge, Samuel; Huss, Janice M.] City Hope Natl Med Ctr, Beckman Res Inst, Irell & Manella Grad Sch Biol Sci, Duarte, CA 91010 USA; [Smith-Powell, Leslie] City Hope Natl Med Ctr, Beckman Res Inst, Dept Mol Pharmacol, Duarte, CA 91010 USA; [Auwerx, Johan] Ecole Polytech Fed Lausanne, Lab Integrat & Syst Physiol, Lausanne, Switzerland	City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; City of Hope; Beckman Research Institute of City of Hope; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Huss, JM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Diabet & Metab Dis Res, Leslie & Susan Gonda Goldschmied Bldg,Room 2132E3, Duarte, CA 91010 USA.	jhuss@coh.org	Auwerx, Johan/ABE-9307-2021	Auwerx, Johan/0000-0002-5065-5393	TEM-Office of Naval Research (ONR) [N00014-02-10958]; Public Health Service grant from the National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health (NIH; Bethesda MD, USA) [R01 DK074700]; Beckman Research Institute (City of Hope); Morgan and Helen Chu Graduate Student Fellowship; Ecole Polytechnique Federale de Lausanne; EU Ideas program [AdG-231138]; Swiss National Science Foundation [31003A-140780]; NIH [R01AG043930]; National Institute of Child Health and Human Development (NICHD), NIH; National Cancer Institute, NIH [P30CA33572]; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG043930] Funding Source: NIH RePORTER	TEM-Office of Naval Research (ONR); Public Health Service grant from the National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health (NIH; Bethesda MD, USA); Beckman Research Institute (City of Hope); Morgan and Helen Chu Graduate Student Fellowship; Ecole Polytechnique Federale de Lausanne; EU Ideas program; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Child Health and Human Development (NICHD), NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The authors thank Dr. Brian Armstrong and Mariko Lee (Microscopy Core, City of Hope), Dr. Marcia Miller, Dr. Zhou Li, and Ricardo Zerda (Electron Microscopy Core, City of Hope; TEM-Office of Naval Research (ONR) grant N00014-02-10958), and the Animal Resources Center (Department of Comparative Medicine, City of Hope) for assistance; and Dr. Timothy Synold for his contribution to the HPLC assay methodology. This work was supported by Public Health Service grant R01 DK074700 (to J.H.) from the National Institute of Diabetes and Digestive and Kidney Diseases, U.S. National Institutes of Health (NIH; Bethesda MD, USA) and by the Beckman Research Institute (City of Hope) and the Morgan and Helen Chu Graduate Student Fellowship (to S.L.). J.A. is the Nestle Chair in Energy Metabolism, and his laboratory is supported by grants from the Ecole Polytechnique Federale de Lausanne, the EU Ideas program (AdG-231138), the Swiss National Science Foundation (31003A-140780), and NIH (R01AG043930). The Developmental Studies Hybridoma Bank was established under the auspices of the National Institute of Child Health and Human Development (NICHD), NIH, and is maintained by The University of Iowa Department of Biology (Iowa City, IA, USA). The Analytical Pharmacology Core is supported by grant P30CA33572 from the National Cancer Institute, NIH.	Bancroft JD, 2002, THEORY PRACTICE HIST, V5th; Bentzinger CF, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a008342; Bergeron R, 2001, AM J PHYSIOL-ENDOC M, V281, pE1340, DOI 10.1152/ajpendo.2001.281.6.E1340; Bolster DR, 2002, J BIOL CHEM, V277, P23977, DOI 10.1074/jbc.C200171200; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Chan AYM, 2004, J BIOL CHEM, V279, P32771, DOI 10.1074/jbc.M403528200; Ciciliot S, 2010, CURR PHARM DESIGN, V16, P906, DOI 10.2174/138161210790883453; Dufour CR, 2007, CELL METAB, V5, P345, DOI 10.1016/j.cmet.2007.03.007; Duguez S, 2002, AM J PHYSIOL-ENDOC M, V282, pE802, DOI 10.1152/ajpendo.00343.2001; Durante PE, 2002, AM J PHYSIOL-ENDOC M, V283, pE178, DOI 10.1152/ajpendo.00404.2001; Figarola JL, 2013, INT J MOL MED, V31, P1166, DOI 10.3892/ijmm.2013.1313; Fulco M, 2008, DEV CELL, V14, P661, DOI 10.1016/j.devcel.2008.02.004; Galvagni F, 2001, J MOL BIOL, V306, P985, DOI 10.1006/jmbi.2000.4335; Giguere V, 2008, ENDOCR REV, V29, P677, DOI 10.1210/er.2008-0017; Hamai N, 1997, CELL STRUCT FUNCT, V22, P421, DOI 10.1247/csf.22.421; Hu XL, 2011, HYPERTENSION, V58, P696, DOI 10.1161/HYPERTENSIONAHA.111.174128; Huss JM, 2007, CELL METAB, V6, P25, DOI 10.1016/j.cmet.2007.06.005; Huss JM, 2004, MOL CELL BIOL, V24, P9079, DOI 10.1128/MCB.24.20.9079-9091.2004; Huss JM, 2002, J BIOL CHEM, V277, P40265, DOI 10.1074/jbc.M206324200; Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104; Liu DX, 2003, ENDOCRINOLOGY, V144, P4894, DOI 10.1210/en.2003-0432; Lowenstein JM, 1969, METHOD ENZYMOL, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; Luo JM, 2003, MOL CELL BIOL, V23, P7947, DOI 10.1128/MCB.23.22.7947-7956.2003; Lyons CN, 2004, BIOCHEM CELL BIOL, V82, P391, DOI 10.1139/O04-040; Mahlapuu M, 2004, AM J PHYSIOL-ENDOC M, V286, pE194, DOI 10.1152/ajpendo.00147.2003; Mascorro Jose A, 2007, Methods Mol Biol, V369, P19; Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101; Mounier R, 2009, FASEB J, V23, P2264, DOI 10.1096/fj.08-119057; Murray J, 2013, FASEB J, V27, P135, DOI 10.1096/fj.12-212290; Murray J, 2011, AM J PHYSIOL-CELL PH, V301, pC630, DOI 10.1152/ajpcell.00033.2011; Naya FJ, 2000, J BIOL CHEM, V275, P4545, DOI 10.1074/jbc.275.7.4545; Niesler CU, 2007, EXP PHYSIOL, V92, P207, DOI 10.1113/expphysiol.2006.034736; Raney MA, 2008, J APPL PHYSIOL, V104, P1366, DOI 10.1152/japplphysiol.01282.2007; Rangwala SM, 2007, BIOCHEM BIOPH RES CO, V357, P231, DOI 10.1016/j.bbrc.2007.03.126; Remels AHV, 2010, MOL CELL ENDOCRINOL, V315, P113, DOI 10.1016/j.mce.2009.09.029; Scarpulla RC, 2012, BBA-GENE REGUL MECH, V1819, P1088, DOI 10.1016/j.bbagrm.2011.10.011; Schreiber SN, 2004, P NATL ACAD SCI USA, V101, P6472, DOI 10.1073/pnas.0308686101; Schreiber SN, 2003, J BIOL CHEM, V278, P9013, DOI 10.1074/jbc.M212923200; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shao D, 2010, MITOCHONDRION, V10, P516, DOI 10.1016/j.mito.2010.05.012; Sonoda J, 2007, GENE DEV, V21, P1909, DOI 10.1101/gad.1553007; Vettor R, 2009, AM J PHYSIOL-ENDOC M, V297, pE987, DOI 10.1152/ajpendo.00229.2009; Vignaud A, 2005, TOXICON, V45, P789, DOI 10.1016/j.toxicon.2005.02.001; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wagatsuma A, 2011, MOL CELL BIOCHEM, V349, P139, DOI 10.1007/s11010-010-0668-2; Wallace GQ, 2009, ANNU REV PHYSIOL, V71, P37, DOI 10.1146/annurev.physiol.010908.163216; Wang SCM, 2010, MOL CELL ENDOCRINOL, V315, P146, DOI 10.1016/j.mce.2009.07.012; Wende AR, 2005, MOL CELL BIOL, V25, P10684, DOI 10.1128/MCB.25.24.10684-10694.2005; Williamson DL, 2009, AM J PHYSIOL-ENDOC M, V297, pE304, DOI 10.1152/ajpendo.91007.2008; Witczak CA, 2008, CELL MOL LIFE SCI, V65, P3737, DOI 10.1007/s00018-008-8244-6; Yamamoto H, 2011, CELL, V147, P827, DOI 10.1016/j.cell.2011.10.017	51	43	45	0	14	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1082	1097		10.1096/fj.13-229211	http://dx.doi.org/10.1096/fj.13-229211			16	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24277576	Green Published			2022-12-25	WOS:000335324800006
J	Alaidarous, M; Ve, T; Casey, LW; Valkov, E; Ericsson, DJ; Ullah, MO; Schembri, MA; Mansell, A; Sweet, MJ; Kobe, B				Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Schembri, Mark A.; Mansell, Ashley; Sweet, Matthew J.; Kobe, Bostjan			Mechanism of Bacterial Interference with TLR4 Signaling by Brucella Toll/Interleukin-1 Receptor Domain-containing Protein TcpB	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							TIR-LIKE PROTEIN; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SCATTERING; ADAPTER; FAMILY; MYD88; SUBVERSION; REVEALS; SYSTEM	Upon activation of Toll-like receptors (TLRs), cytoplasmic Toll/interleukin-1 receptor (TIR) domains of the receptors undergo homo-or heterodimerization. This in turn leads to the recruitment of adaptor proteins, activation of transcription factors, and the secretion of pro-inflammatory cytokines. Recent studies have described the TIR domain-containing protein from Brucella melitensis, TcpB (BtpA/Btp1), to be involved in virulence and suppression of host innate immune responses. TcpB interferes with TLR4 and TLR2 signaling pathways by a mechanism that remains controversial. In this study, we show using co-immunoprecipitation analyses that TcpB interacts with MAL, MyD88, and TLR4 but interferes only with the MAL-TLR4 interaction. We present the crystal structure of the TcpB TIR domain, which reveals significant structural differences in the loop regions compared with other TIR domain structures. We demonstrate that TcpB forms a dimer in solution, and the crystal structure reveals the dimerization interface, which we validate by mutagenesis and biophysical studies. Our study advances the understanding of the molecular mechanisms of host immunosuppression by bacterial pathogens.	[Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Schembri, Mark A.; Kobe, Bostjan] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia; [Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Sweet, Matthew J.; Kobe, Bostjan] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Alaidarous, Mohammed; Ve, Thomas; Casey, Lachlan W.; Valkov, Eugene; Ericsson, Daniel J.; Ullah, M. Obayed; Schembri, Mark A.; Sweet, Matthew J.; Kobe, Bostjan] Univ Queensland, Australian Infect Dis Res Ctr, Brisbane, Qld 4072, Australia; [Mansell, Ashley] Monash Univ, Monash Inst Med Res, Ctr Innate Immun & Infect Dis, Melbourne, Vic 3168, Australia; [Valkov, Eugene] Med Res Council Lab Mol Biol, Cambridge CB2 0QH, England	University of Queensland; University of Queensland; University of Queensland; Monash University; MRC Laboratory Molecular Biology; UK Research & Innovation (UKRI); Medical Research Council UK (MRC)	Kobe, B (corresponding author), Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia.	b.kobe@uq.edu.au	Valkov, Eugene/AAA-1735-2020; Sweet, Matthew J/F-2229-2011; Schembri, Mark A/C-7262-2009; Ericsson, Daniel/F-7458-2011; Kobe, Bostjan/D-1292-2009; alaidarous, mohammed/ABE-9105-2020; Mansell, Ashley/B-9553-2008; Casey, Lachlan/N-3396-2015; Alaidarous, Eman/D-9316-2012; Ve, Thomas/AEK-1006-2022; Ullah, M Obayed/AAR-7211-2020	Valkov, Eugene/0000-0002-3721-1739; Sweet, Matthew J/0000-0002-0406-8139; Schembri, Mark A/0000-0003-4863-9260; Ericsson, Daniel/0000-0001-5101-9244; Kobe, Bostjan/0000-0001-9413-9166; alaidarous, mohammed/0000-0002-6161-3834; Mansell, Ashley/0000-0002-6540-1281; Casey, Lachlan/0000-0002-4458-0137; Ve, Thomas/0000-0002-0113-1905; Ullah, M Obayed/0000-0002-1175-3636	National Health and Medical Research Council Grant [APP1003326]; Ministry of Higher Education of Saudi Arabia; Majmaah University (Al Majmaah, Saudi Arabia); Australian Research Council [FT100100662, FT100100657]; National Health and Medical Research Council [APP1003470, APP1003325]	National Health and Medical Research Council Grant(National Health and Medical Research Council (NHMRC) of Australia); Ministry of Higher Education of Saudi Arabia; Majmaah University (Al Majmaah, Saudi Arabia); Australian Research Council(Australian Research Council); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia)	This work was supported in part by National Health and Medical Research Council Grant APP1003326 (to B. K. and A. M.).; Supported by a Ph.D. scholarship from the Ministry of Higher Education of Saudi Arabia and the Majmaah University (Al Majmaah, Saudi Arabia).; Australian Research Council Future Fellow under Grant FT100100662.; Australian Research Council Future Fellow under Grant FT100100657 and Honorary National Health and Medical Research Council Research Fellow under Grant APP1003470.; National Health and Medical Research Council Senior Research Fellow under Grant APP1003325.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Alaidarous M, 2013, ACTA CRYSTALLOGR F, V69, P1167, DOI 10.1107/S1744309113024408; Atluri VL, 2011, ANNU REV MICROBIOL, V65, P523, DOI 10.1146/annurev-micro-090110-102905; Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Bernoux M, 2011, CELL HOST MICROBE, V9, P200, DOI 10.1016/j.chom.2011.02.009; Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427; Burns K, 1998, J BIOL CHEM, V273, P12203, DOI 10.1074/jbc.273.20.12203; Chan SL, 2010, PROTEIN SCI, V19, P155, DOI 10.1002/pro.275; Chan SL, 2009, J BIOL CHEM, V284, P21386, DOI 10.1074/jbc.C109.007591; Chang TH, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003563; Chaudhary A, 2012, BIOCHEM BIOPH RES CO, V417, P299, DOI 10.1016/j.bbrc.2011.11.104; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Choi YJ, 2013, FASEB J, V27, P243, DOI 10.1096/fj.12-217596; Cirl C, 2008, NAT MED, V14, P399, DOI 10.1038/nm1734; Cirl C, 2010, INT J MED MICROBIOL, V300, P396, DOI 10.1016/j.ijmm.2010.04.001; Dunne A, 2003, J BIOL CHEM, V278, P41443, DOI 10.1074/jbc.M301742200; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Elde NC, 2009, NAT REV MICROBIOL, V7, P787, DOI 10.1038/nrmicro2222; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Eschenfeldt William H., 2009, V498, P105, DOI 10.1007/978-1-59745-196-3_7; Fekonja O, 2012, J BIOL CHEM, V287, P30993, DOI 10.1074/jbc.M112.376186; Fischer H, 2010, J APPL CRYSTALLOGR, V43, P101, DOI 10.1107/S0021889809043076; Fitzgerald KA, 2001, NATURE, V413, P78, DOI 10.1038/35092578; Folta-Stogniew E, 1999, J Biomol Tech, V10, P51; Franke D, 2009, J APPL CRYSTALLOGR, V42, P342, DOI 10.1107/S0021889809000338; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kaplan-Turkoz B, 2013, FEBS LETT, V587, P3412, DOI 10.1016/j.febslet.2013.09.007; Kawai T, 2010, NAT IMMUNOL, V11, P373, DOI 10.1038/ni.1863; Kelley LA, 2009, NAT PROTOC, V4, P363, DOI 10.1038/nprot.2009.2; Khan JA, 2004, J BIOL CHEM, V279, P31664, DOI 10.1074/jbc.M403434200; Konarev PV, 2006, J APPL CRYSTALLOGR, V39, P277, DOI 10.1107/S0021889806004699; Konarev PV, 2003, J APPL CRYSTALLOGR, V36, P1277, DOI 10.1107/S0021889803012779; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lin ZJ, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0034202, 10.1371/journal.pone.0040262]; Low LY, 2007, BIOCHEM BIOPH RES CO, V356, P481, DOI 10.1016/j.bbrc.2007.03.003; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; McPhillips TM, 2002, J SYNCHROTRON RADIAT, V9, P401, DOI 10.1107/S0909049502015170; Muzio M, 1997, SCIENCE, V278, P1612, DOI 10.1126/science.278.5343.1612; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Ohnishi H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038423; Ohnishi H, 2009, P NATL ACAD SCI USA, V106, P10260, DOI 10.1073/pnas.0812956106; Pappas G, 2006, LANCET INFECT DIS, V6, P91, DOI 10.1016/S1473-3099(06)70382-6; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; Radhakrishnan GK, 2009, J BIOL CHEM, V284, P9892, DOI 10.1074/jbc.M805458200; Rana RR, 2013, MED MICROBIOL IMMUN, V202, P1, DOI 10.1007/s00430-012-0253-2; Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021; Salcedo SP, 2013, FRONT CELL INFECT MI, V3, DOI 10.3389/fcimb.2013.00028; Sengupta D, 2010, J IMMUNOL, V184, P956, DOI 10.4049/jimmunol.0902008; Smart OS, 2012, ACTA CRYSTALLOGR D, V68, P368, DOI 10.1107/S0907444911056058; Snyder GA, 2013, P NATL ACAD SCI USA, V110, P6985, DOI 10.1073/pnas.1215770110; Stack J, 2005, J EXP MED, V201, P1007, DOI 10.1084/jem.20041442; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Valkov E, 2011, P NATL ACAD SCI USA, V108, P14879, DOI 10.1073/pnas.1104780108; van Dijk JAPP, 2000, J CHROMATOGR A, V867, P105, DOI 10.1016/S0021-9673(99)01161-9; Ve T, 2012, CURR DRUG TARGETS, V13, P1360, DOI 10.2174/138945012803530260; Volkov VV, 2003, J APPL CRYSTALLOGR, V36, P860, DOI 10.1107/S0021889803000268; Xu YW, 2000, NATURE, V408, P111, DOI 10.1038/35040600; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	61	53	56	1	13	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					654	668		10.1074/jbc.M113.523274	http://dx.doi.org/10.1074/jbc.M113.523274			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265315	Green Published, hybrid			2022-12-25	WOS:000330541200006
J	Hong, IH; Lewis, K; Iakova, P; Jin, JL; Sullivan, E; Jawanmardi, N; Timchenko, L; Timchenko, N				Hong, Il-Hwa; Lewis, Kyle; Iakova, Polina; Jin, Jingling; Sullivan, Emily; Jawanmardi, Nicole; Timchenko, Lubov; Timchenko, Nikolai			Age-associated Change of C/EBP Family Proteins Causes Severe Liver Injury and Acceleration of Liver Proliferation after CCl4 Treatments	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							EPIGENETIC REGULATION; MICE; INHIBITION; EXPRESSION; HEPATOCYTES; ALPHA; YOUNG; LEADS; RATS; BETA	The aged liver is more sensitive to the drug treatments and has a high probability of developing liver disorders such as fibrosis, cirrhosis, and cancer. Here we present mechanisms underlying age-associated severe liver injury and acceleration of liver proliferation after CCl4 treatments. We have examined liver response to CCl4 treatments using old WT mice and young C/EBP alpha-S193D knockin mice, which express an aged-like isoform of C/EBP alpha. Both animal models have altered chromatin structure as well as increased liver injury and proliferation after acute CCl4 treatments. We found that these age-related changes are associated with the repression of key regulators of liver biology: C/EBP alpha, Farnesoid X Receptor (FXR) and telomere reverse transcriptase (TERT). In quiescent livers of old WT and young S193D mice, the inhibition of TERT is mediated by HDAC1-C/EBP alpha complexes. After CCl4 treatments, TERT, C/EBP alpha and FXR are repressed by different mechanisms. These mechanisms include the increase of a dominant negative isoform, C/EBP beta-LIP, and subsequent repression of C/EBP alpha, FXR, and TERT promoters. C/EBP beta-LIP also disrupts Rb-E2F1 complexes in C/EBP alpha-S193D mice after CCl4 treatments. To examine if these alterations are involved in drug-mediated liver diseases, we performed chronic treatments of mice with CCl4. We found that C/EBP alpha-S193D mice developed fibrosis much more rapidly than WT mice. Thus, our data show that the age-associated alterations of C/EBP proteins create favorable conditions for the increased liver proliferation after CCl4 treatments and for development of drug-mediated liver diseases.	[Hong, Il-Hwa; Lewis, Kyle; Iakova, Polina; Jin, Jingling; Sullivan, Emily; Jawanmardi, Nicole; Timchenko, Nikolai] Baylor Coll Med, Huffington Ctr Aging, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Pathol & Immunol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Mol Physiol, Houston, TX 77030 USA; [Timchenko, Lubov] Baylor Coll Med, Dept Biophys, Houston, TX 77030 USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine	Timchenko, N (corresponding author), Baylor Coll Med, Dept Pathol & Immunol, One Baylor Plaza, Houston, TX 77030 USA.	nikolait@bcm.tmc.edu		Jin, Jingling/0000-0002-4365-1837	National Institutes of Health [GM551888, AG039885, AG028865, CA159942, R01AR044387, R01AR052791]; NATIONAL CANCER INSTITUTE [R01CA159942] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052791, R01AR044387] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028865, R21AG039885, T32AG000183] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported, in whole or in part, by National Institutes of Health Grants GM551888, AG039885, AG028865, and CA159942 (to N. T.) and R01AR044387 and R01AR052791 (to L. T.).	Akiyama TE, 2003, BBA-GEN SUBJECTS, V1619, P223, DOI 10.1016/S0304-4165(02)00480-4; Aroor AR, 2010, ALCOHOL CLIN EXP RES, V34, P1543, DOI 10.1111/j.1530-0277.2010.01239.x; Cairo S, 2012, J HEPATOL, V57, P910, DOI 10.1016/j.jhep.2012.05.017; Fujii T, 2010, BMC GASTROENTEROL, V10, DOI 10.1186/1471-230X-10-79; Greenbaum LE, 1998, J CLIN INVEST, V102, P996, DOI 10.1172/JCI3135; Iakova P, 2011, SEMIN CANCER BIOL, V21, P28, DOI 10.1016/j.semcancer.2010.09.001; Ibrahim ZS, 2008, JPN J VET RES, V56, P119; Jin JL, 2013, CELL REP, V3, P831, DOI 10.1016/j.celrep.2013.02.009; Jin JL, 2011, HEPATOLOGY, V54, P989, DOI 10.1002/hep.24471; Jin JL, 2010, AGING CELL, V9, P895, DOI 10.1111/j.1474-9726.2010.00617.x; Jones K, 2012, AGEING RES REV, V11, P442, DOI 10.1016/j.arr.2012.02.007; Komatsu Y, 2012, BMC MED GENOMICS, V5, DOI 10.1186/1755-8794-5-5; Lee CG, 2012, GASTROENTEROLOGY, V142, P1206, DOI 10.1053/j.gastro.2012.01.007; Lopez-Diazguerrero NE, 2005, LIFE SCI, V77, P2840, DOI 10.1016/j.lfs.2005.05.034; Mandrekar P, 2011, WORLD J GASTROENTERO, V17, P2456, DOI 10.3748/wjg.v17.i20.2456; Meng FY, 2012, AM J PATHOL, V181, P804, DOI 10.1016/j.ajpath.2012.06.010; Meng ZP, 2010, MOL ENDOCRINOL, V24, P886, DOI 10.1210/me.2009-0286; Murali B, 2004, MECH AGEING DEV, V125, P421, DOI 10.1016/j.mad.2004.03.005; Orellana D, 2010, J BIOL CHEM, V285, P23442, DOI 10.1074/jbc.M110.129825; Park PH, 2005, AM J PHYSIOL-GASTR L, V289, pG1124, DOI 10.1152/ajpgi.00091.2005; Rudolph KL, 2000, SCIENCE, V287, P1253, DOI 10.1126/science.287.5456.1253; Schwabe RF, 2011, CANCER CELL, V20, P698, DOI 10.1016/j.ccr.2011.11.021; Sirma H, 2011, GASTROENTEROLOGY, V141, P326, DOI 10.1053/j.gastro.2011.03.047; Timchenko NA, 2011, MOL PATHOL LIB, V5, P279, DOI 10.1007/978-1-4419-7107-4_19; Timchenko NA, 2009, TRENDS ENDOCRIN MET, V20, P171, DOI 10.1016/j.tem.2009.01.005; Wang GL, 2008, J BIOL CHEM, V283, P26169, DOI 10.1074/jbc.M803544200; Wang GL, 2008, J BIOL CHEM, V283, P26179, DOI 10.1074/jbc.M803545200; Wang GL, 2010, J CLIN INVEST, V120, P2549, DOI 10.1172/JCI41933; Wege H., 2007, COMP HEPATOLOGY, V6, P1037; Welm AL, 2000, J BIOL CHEM, V275, P27406; Zangar RC, 2000, CHEM-BIOL INTERACT, V125, P233, DOI 10.1016/S0009-2797(00)00149-6	31	21	22	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1106	1118		10.1074/jbc.M113.526780	http://dx.doi.org/10.1074/jbc.M113.526780			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24273171	hybrid, Green Published			2022-12-25	WOS:000330541200042
J	Daleno, C; Piralla, A; Scala, A; Senatore, L; Principi, N; Esposito, S				Daleno, Cristina; Piralla, Antonio; Scala, Alessia; Senatore, Laura; Principi, Nicola; Esposito, Susanna			Phylogenetic Analysis of Human Rhinovirus Isolates Collected from Otherwise Healthy Children with Community-Acquired Pneumonia during Five Successive Years	PLOS ONE			English	Article							RESPIRATORY-INFECTIONS; HOSPITALIZED CHILDREN; C INFECTIONS; RECOMBINATION; EPIDEMIOLOGY; STRAINS; VIRUSES	In order to evaluate the circulation of the different human rhinovirus (HRV) species and genotypes in Italian children with radiographically confirmed community-acquired pneumonia (CAP), a nasopharyngeal swab was obtained from 643 children admitted to hospital because of CAP during five consecutive winter and early spring seasons (2007-2012). Real-time reverse transcriptase polymerase chain reaction (RT-PCR) was used to identify HRV, and the HRV-positive samples were used for sequencing analysis and to reconstruct the phylogenetic tree. HRV was identified in 198 samples (42.2%), and the VP4/VP2 region was successfully amplified in 151 (76.3%). HRV-A was identified in 78 samples (51.6%), HRV-B in 14 (9.3%) and HRV-C in 59 (39.1%). Forty-seven (31.1%) of the children with HRV infection were aged <1 year, 71 (47.0%) were aged 1-3 years, and 33 (21.9%) were aged >= 4 years. Blast and phylogenetic analyses showed that the HRV strains were closely related to a total of 66 reference genotypes, corresponding to 29 HRV-A, 9 HRV-B and 28 HRV-C strains. Nucleotide variability was 37% between HRV-A and HRV-B, 37.3% between HRV-A and HRV-C, and 39.9% between HRV-B and HRV-C. A number of sequences clustered with known serotypes and, within these clusters, there were strains circulating during several seasons. The most frequently detected genotypes were HRV-A78 (n=17), HRV-A12 (n=9) and HRV-C2 (n=5). This study shows that, although it is mainly associated with HRV-A, pediatric CAP can also be diagnosed in subjects infected by HRV-C and, more rarely, by HRV-B. Moreover, a large number of genotypes may be involved in causing pediatric CAP and can be different from year to year. Although the prolonged circulation of the same genotypes can sometimes be associated with a number of CAP episodes in different years.	[Daleno, Cristina; Scala, Alessia; Senatore, Laura; Principi, Nicola; Esposito, Susanna] Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy; [Piralla, Antonio] Fdn IRCCS Policlin Sa Matte, Virolog Uni, Pavi, Italy	IRCCS Ca Granda Ospedale Maggiore Policlinico; University of Milan	Esposito, S (corresponding author), Univ Milan, Fdn IRCCS Ca Granda Osped Maggiore Policlin, Dept Pathophysiol & Transplantat, Pediat Highly Intens Care Unit, Milan, Italy.	susanna.esposito@unimi.it	Piralla, Antonio/K-4756-2018; Esposito, Susanna/K-3475-2016	Piralla, Antonio/0000-0002-6062-2579; Esposito, Susanna/0000-0003-4103-2837	Italian Ministry of Health (Bando Giovani Ricercatori)	Italian Ministry of Health (Bando Giovani Ricercatori)(Ministry of Health, Italy)	This review was supported by a grant from the Italian Ministry of Health (Bando Giovani Ricercatori 2009). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2013, GenBank FJ615683.1, Patent No. 615683; [Anonymous], GenBank JN855894.1, Patent No. 855894; Arakawa M, 2012, J MED MICROBIOL, V61, P410, DOI 10.1099/jmm.0.035006-0; Brownlee JW, 2008, CURR OPIN PEDIATR, V20, P67, DOI 10.1097/MOP.0b013e3282f41cb6; Calvo C, 2010, ACTA PAEDIATR, V99, P883, DOI 10.1111/j.1651-2227.2010.01714.x; Calvo C, 2010, PEDIATR INFECT DIS J, V29, P717, DOI 10.1097/INF.0b013e3181d7a708; Cheuk DKL, 2007, PEDIATR INFECT DIS J, V26, P995, DOI 10.1097/INF.0b013e3181586b63; Esposito S, 2013, EUR J CLIN MICROBIOL; Esposito S, 2012, EUR J CLIN MICROBIOL, V31, P1637, DOI 10.1007/s10096-011-1487-4; Esposito S, 2013, INFLUENZA OTHER RESP, V7, P18, DOI 10.1111/j.1750-2659.2012.00340.x; Fry AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017780; Garcia-Garcia ML, 2010, PEDIATR PULM, V45, P585, DOI 10.1002/ppul.21225; Hayden FG, 2004, REV MED VIROL, V14, P17, DOI 10.1002/rmv.406; Henquell C, 2012, J CLIN VIROL, V53, P280, DOI 10.1016/j.jcv.2011.10.009; Huang T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006355; Kennedy JL, 2012, CURR OPIN VIROL, V2, P287, DOI 10.1016/j.coviro.2012.03.008; Lee SL, 2011, EUR J PEDIATR, V170, P1317, DOI 10.1007/s00431-011-1446-1; Linsuwanon P, 2009, J INFECTION, V59, P115, DOI 10.1016/j.jinf.2009.05.009; Mahony JB, 2011, CRIT REV CL LAB SCI, V48, P217, DOI 10.3109/10408363.2011.640976; McIntyre CL, 2013, J GEN VIROL, V94, P1791, DOI 10.1099/vir.0.053686-0; Mermond S, 2012, CLIN INFECT DIS, V54, pS180, DOI 10.1093/cid/cir1070; Pierangeli A, 2013, MED MICROBIOL IMMUNO; Piralla A, 2009, J CLIN VIROL, V45, P311, DOI 10.1016/j.jcv.2009.04.016; Piralla A, 2011, J CLIN MICROBIOL, V49, P373, DOI 10.1128/JCM.01814-10; Sansone M, 2013, EUR J CLIN MICROBIOL, V32, P947, DOI 10.1007/s10096-013-1832-x; Savolainen C, 2002, VIRUS RES, V85, P41, DOI 10.1016/S0168-1702(02)00016-3; Savolainen C, 2002, J GEN VIROL, V83, P333, DOI 10.1099/0022-1317-83-2-333; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; TURNER RB, 1987, J PEDIATR-US, V111, P194; van Benten I, 2003, PEDIAT ALLERG IMM-UK, V14, P363, DOI 10.1034/j.1399-3038.2003.00064.x; van Piggelen RO, 2010, PEDIATR INFECT DIS J, V29, P364, DOI 10.1097/INF.0b013e3181c6e60f; Wisdom A, 2009, J CLIN MICROBIOL, V47, P3958, DOI 10.1128/JCM.00993-09; Wisdom A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008518; World Health Organization. Pneumonia Vaccine Trial Investigators' Group, 2001, WHOVB0135 PNEUM VACC; Wright PF, 2007, J CLIN MICROBIOL, V45, P2126, DOI 10.1128/JCM.02553-06; Xiang ZC, 2010, J CLIN VIROL, V49, P94, DOI 10.1016/j.jcv.2010.07.013	36	15	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80614	10.1371/journal.pone.0080614	http://dx.doi.org/10.1371/journal.pone.0080614			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260436	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900078
J	Kosasih, H; Alisjahbana, B; Widjaja, S; Nurhayati; de Mast, Q; Parwati, I; Blair, PJ; Burgess, TH; van der Ven, A; Williams, M				Kosasih, Herman; Alisjahbana, Bachti; Widjaja, Susana; Nurhayati; de Mast, Quirijn; Parwati, Ida; Blair, Patrick J.; Burgess, Timothy H.; van der Ven, Andre; Williams, Maya			The Diagnostic and Prognostic Value of Dengue Non-Structural 1 Antigen Detection in a Hyper-Endemic Region in Indonesia	PLOS ONE			English	Article							LINKED IMMUNOSORBENT ASSAYS; PROTEIN NS1; RAPID TESTS; VIRUS; INFECTION; VIREMIA; SPECIFICITY; SENSITIVITY; ACCURACY; DISEASE	As dengue fever is undifferentiated from other febrile illnesses in the tropics and the clinical course is unpredictable, early diagnosis is important. Several commercial assays to detect dengue NS1 antigen have been developed; however, their performances vary and data is lacking from hyper-endemic areas where all four serotypes of dengue are equally represented. To assess the sensitivity of the Bio-Rad platelia Dengue NS1 antigen assay according to virus serotype, immune status, gender, and parameters of severe disease, acute sera from 220 individuals with confirmed dengue and 55 individuals with a non-dengue febrile illness were tested using the Bio-Rad platelia Dengue NS1 antigen assay. The overall sensitivity of the NS1 ELISA was 46.8% and the specificity was 100%. The sensitivity in primary infections was significantly higher than in secondary infections (100% vs. 35.7%). In secondary infections, the sensitivity of NS1 detection was highest in DENV-3 (47.1%), followed by DENV-1 (40.9%), DENV-2 (30%) and DENV-4 (27%) infections. NS1 was less frequently detected in sera with high titers of HI antibodies or in acute samples from patients whose pre-illness sera showed neutralizing antibodies to more than one serotype. The detection of NS1 was higher in females, severe cases, and individuals with lower platelet counts (<100,000/mm(3)). While the overall sensitivity of this NS1 ELISA is poor, our data suggest that in secondary infections, detection may be predictive of a more severe illness.	[Kosasih, Herman; Alisjahbana, Bachti] Padjadjaran State Univ, Fac Med, Hlth Res Unit, Bandung, Indonesia; [Alisjahbana, Bachti] Hasan Sadikin Hosp, Dept Internal Med, Bandung, Indonesia; [Kosasih, Herman; Widjaja, Susana; Nurhayati; Blair, Patrick J.; Burgess, Timothy H.; Williams, Maya] US Naval Med Res Unit 2, Viral Dis Program, Jakarta, Indonesia; [de Mast, Quirijn; van der Ven, Andre] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6525 ED Nijmegen, Netherlands; [Parwati, Ida] Padjadjaran State Univ, Fac Med, Hasan Sadikin Hosp, Dept Clin Pathol, Bandung, Indonesia	Universitas Padjadjaran; Dr Hasan Sadikin General Hospital; Naval Medical Research Center (NMRC); US Naval Medical Research Unit-2 (NAMRU-2); Radboud University Nijmegen; Dr Hasan Sadikin General Hospital; Universitas Padjadjaran	Williams, M (corresponding author), US Naval Med Res Unit 2, Viral Dis Program, Jakarta, Indonesia.	Maya.williams@med.navy.mil	van der Ven, A.J.A.M./H-8102-2014; de Mast, Quirijn/H-3427-2015	van der Ven, A.J.A.M./0000-0003-1833-3391; Parwati, Ida/0000-0002-9700-589X; de Mast, Quirijn/0000-0001-6056-157X	Military Infectious Disease Research Program [6000.RAD1.S.B0302]; Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center [800000.82000.25GB.B0016]	Military Infectious Disease Research Program; Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center	This work was supported by the Military Infectious Disease Research Program Work Unit Number: 6000.RAD1.S.B0302, and the Global Emerging Infections Surveillance and Response System, a Division of the Armed Forces Health Surveillance Center, Work Unit Number: 800000.82000.25GB.B0016. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alcon S, 2002, J CLIN MICROBIOL, V40, P376, DOI 10.1128/JCM.40.02.376-381.2002; Beckett CG, 2005, AM J TROP MED HYG, V72, P777, DOI 10.4269/ajtmh.2005.72.777; Bessoff K, 2008, CLIN VACCINE IMMUNOL, V15, P1513, DOI 10.1128/CVI.00140-08; Blacksell SD, 2008, DIAGN MICR INFEC DIS, V60, P43, DOI 10.1016/j.diagmicrobio.2007.07.011; Chaterji S, 2011, AM J TROP MED HYG, V84, P224, DOI 10.4269/ajtmh.2011.10-0316; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; de Souza VAUF, 2004, J CLIN MICROBIOL, V42, P1782, DOI 10.1128/JCM.42.4.1782-1784.2004; Duong V, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001244; Dussart P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000280; Duyen HTL, 2011, J INFECT DIS, V203, P1292, DOI 10.1093/infdis/jir014; Falconar AKI, 1997, ARCH VIROL, V142, P897, DOI 10.1007/s007050050127; Farrar Jeremy, 2008, V5, P171; Guzman MG, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000811; Hang VT, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000360; Koraka P, 2003, J CLIN MICROBIOL, V41, P4154, DOI 10.1128/JCM.41.9.4154-4159.2003; Kosasih H., 2006, Dengue Bulletin, V30, P87; Kosasih H, 2011, VECTOR-BORNE ZOONOT, V11, P709, DOI 10.1089/vbz.2010.0093; Kumarasamy V, 2007, J VIROL METHODS, V140, P75, DOI 10.1016/j.jviromet.2006.11.001; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lapphra K, 2008, DIAGN MICR INFEC DIS, V60, P387, DOI 10.1016/j.diagmicrobio.2007.11.010; Libraty DH, 2002, J INFECT DIS, V186, P1165, DOI 10.1086/343813; Martina BEE, 2009, CLIN MICROBIOL REV, V22, P564, DOI 10.1128/CMR.00035-09; MORENS DM, 1985, J CLIN MICROBIOL, V22, P250, DOI 10.1128/JCM.22.2.250-254.1985; MYERS RM, 1971, INDIAN J MED RES, V59, P1231; Najioullah F, 2011, DIAGN MICR INFEC DIS, V69, P172, DOI 10.1016/j.diagmicrobio.2010.09.021; Osorio L, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-361; Lima MDQ, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000738; Shu PY, 2009, CLIN VACCINE IMMUNOL, V16, P589, DOI 10.1128/CVI.00475-08; Thomas L, 2010, AM J TROP MED HYG, V83, P696, DOI 10.4269/ajtmh.2010.10-0138; Tricou V, 2010, BMC INFECT DIS, V10, DOI 10.1186/1471-2334-10-142; WHO, 2009, DENGUE DENGUE HEMORR; WINKLER G, 1989, VIROLOGY, V171, P302, DOI 10.1016/0042-6822(89)90544-8; World Health Organization, 1999, PREV CONTR DENG DENG	34	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80891	10.1371/journal.pone.0080891	http://dx.doi.org/10.1371/journal.pone.0080891			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260501	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900103
J	Antoine, E; Buchanan, C; Fezzaa, K; Lee, WK; Rylander, MN; Vlachos, P				Antoine, Elizabeth; Buchanan, Cara; Fezzaa, Kamel; Lee, Wah-Keat; Rylander, M. Nichole; Vlachos, Pavlos			Flow Measurements in a Blood-Perfused Collagen Vessel Using X-Ray Micro-Particle Image Velocimetry	PLOS ONE			English	Article							MICROFLUIDIC CULTURE MODELS; MICRO-PIV MEASUREMENTS; SHEAR-STRESS; CELL; CANCER; MICROCHANNEL; BIOLOGY	Blood-perfused tissue models are joining the emerging field of tumor engineering because they provide new avenues for modulation of the tumor microenvironment and preclinical evaluation of the therapeutic potential of new treatments. The characterization of fluid flow parameters in such in-vitro perfused tissue models is a critical step towards better understanding and manipulating the tumor microenvironment. However, traditional optical flow measurement methods are inapplicable because of the opacity of blood and the thickness of the tissue sample. In order to overcome the limitations of optical method we demonstrate the feasibility of using phase-contrast x-ray imaging to perform microscale particle image velocimetry (PIV) measurements of flow in blood perfused hydrated tissue-representative microvessels. However, phase contrast x-ray images significantly depart from the traditional PIV image paradigm, as they have high intensity background, very low signal-to-noise ratio, and volume integration effects. Hence, in order to achieve accurate measurements special attention must be paid to the image processing and PIV cross-correlation methodologies. Therefore we develop and demonstrate a methodology that incorporates image preprocessing as well as advanced PIV cross-correlation methods to result in measured velocities within experimental uncertainty.	[Antoine, Elizabeth; Rylander, M. Nichole] Virginia Tech, Dept Mech Engn, Blacksburg, VA USA; [Buchanan, Cara; Rylander, M. Nichole] Virginia Tech, VT WFU Sch Biomed Engn & Sci, Blacksburg, VA USA; [Fezzaa, Kamel; Lee, Wah-Keat] Argonne Natl Lab, Adv Photon Source, Argonne, IL 60439 USA; [Vlachos, Pavlos] Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA	Virginia Polytechnic Institute & State University; Virginia Polytechnic Institute & State University; United States Department of Energy (DOE); Argonne National Laboratory; Purdue University System; Purdue University; Purdue University West Lafayette Campus	Vlachos, P (corresponding author), Purdue Univ, Sch Mech Engn, W Lafayette, IN 47907 USA.	pvlachos@purdue.edu	Lee, Wah-Keat/GRR-9734-2022; Rylander, Marissa Nichole/F-2455-2014; Vlachos, Pavlos P/G-3779-2010	Antoine, Elizabeth/0000-0001-8116-9585; Vlachos, Pavlos P/0000-0002-8040-9257	Clare Boothe Luce Graduate Fellowship; Virginia Space Grant Consortium Graduate STEM Research Fellowship; MBEDS (Multiscale Bio-Engineered Devices and Systems) Center of the Virginia Tech Institute of Critical Technologies and Applied Sciences (ICTAS); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences [DE-AC02-06CH11357]	Clare Boothe Luce Graduate Fellowship; Virginia Space Grant Consortium Graduate STEM Research Fellowship; MBEDS (Multiscale Bio-Engineered Devices and Systems) Center of the Virginia Tech Institute of Critical Technologies and Applied Sciences (ICTAS); U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE))	Funding for this project was provided by a Clare Boothe Luce Graduate Fellowship, and Virginia Space Grant Consortium Graduate STEM Research Fellowship. The authors gratefully acknowledge support provided by the MBEDS (Multiscale Bio-Engineered Devices and Systems) Center of the Virginia Tech Institute of Critical Technologies and Applied Sciences (ICTAS). Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Science, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abraham LC, 2008, J BIOMED MATER RES B, V87B, P264, DOI 10.1002/jbm.b.31078; Adrian R.J., 2011, PARTICLE IMAGE VELOC; Adrian RJ, 2005, EXP FLUIDS, V39, P159, DOI 10.1007/s00348-005-0991-7; [Anonymous], 1998, PHYSICS; Bark DL, 2012, BIOTECHNOL BIOENG, V109, P2642, DOI 10.1002/bit.24537; Bosart LW, 1928, IND ENG CHEM, V20, P1377, DOI 10.1021/ie50228a032; Brown JM, 1998, CANCER RES, V58, P1408; Buchanan C, 2013, BIOTECHNOL BIOENG, V110, P2063, DOI 10.1002/bit.24944; Buchanan CF, 2013, TISSUE ENG C; Chrobak KM, 2006, MICROVASC RES, V71, P185, DOI 10.1016/j.mvr.2006.02.005; Delnoij E, 1999, CHEM ENG SCI, V54, P5159, DOI 10.1016/S0009-2509(99)00233-X; Dubsky S, 2012, EXP FLUIDS, V52, P543, DOI 10.1007/s00348-010-1006-x; Dubsky S, 2010, APPL PHYS LETT, V96, DOI 10.1063/1.3285173; Dusting J, 2006, BIOTECHNOL BIOENG, V94, P1196, DOI 10.1002/bit.20960; Eckstein A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/5/055401; Eckstein A, 2009, MEAS SCI TECHNOL, V20, DOI 10.1088/0957-0233/20/7/075402; Eckstein AC, 2008, EXP FLUIDS, V45, P485, DOI 10.1007/s00348-008-0492-6; Fouras A, 2009, J APPL PHYS, V105, DOI 10.1063/1.3115643; Fouras A, 2007, J APPL PHYS, V102, DOI 10.1063/1.2783978; Ghajar CM, 2010, TISSUE ENG PT A, V16, P2153, DOI 10.1089/ten.TEA.2010.0135; Ingram M, 2010, BIOTECH HISTOCHEM, V85, P213, DOI 10.3109/10520295.2010.483655; Irvine SC, 2008, APPL PHYS LETT, V93, DOI 10.1063/1.3001592; Irvine SC, 2010, OPT EXPRESS, V18, P2368, DOI 10.1364/OE.18.002368; Jamison RA, 2011, ANN BIOMED ENG, V39, P1643, DOI 10.1007/s10439-011-0260-2; KAIBARA M, 1983, BIORHEOLOGY, V20, P583; Kim GB, 2006, EXP FLUIDS, V41, P195, DOI 10.1007/s00348-006-0147-4; Kim GB, 2009, J BIOMECH, V42, P449, DOI 10.1016/j.jbiomech.2008.11.037; KUMAR BVKV, 1990, APPL OPTICS, V29, P2997, DOI 10.1364/AO.29.002997; Leble V, 2011, BIOMICROFLUIDICS, V5, DOI 10.1063/1.3672689; Lee SJ, 2005, J APPL PHYS, V97, DOI 10.1063/1.1851596; Lee SJ, 2003, J APPL PHYS, V94, P3620, DOI 10.1063/1.1599981; Lima R, 2008, BIOMED MICRODEVICES, V10, P153, DOI 10.1007/s10544-007-9121-z; Lima R, 2007, J BIOMECH, V40, P2752, DOI 10.1016/j.jbiomech.2007.01.012; Lima R, 2006, MEAS SCI TECHNOL, V17, P797, DOI 10.1088/0957-0233/17/4/026; Lima R, 2009, ANN BIOMED ENG, V37, P1546, DOI 10.1007/s10439-009-9732-z; Lo BPL, 2001, PROCEEDINGS OF 2001 INTERNATIONAL SYMPOSIUM ON INTELLIGENT MULTIMEDIA, VIDEO AND SPEECH PROCESSING, P158, DOI 10.1109/ISIMP.2001.925356; Mayo SC, 2012, MATERIALS, V5, P937, DOI 10.3390/ma5050937; Meinhart CD, 2000, MEAS SCI TECHNOL, V11, P809, DOI 10.1088/0957-0233/11/6/326; Meinhart CD, 2000, J FLUID ENG-T ASME, V122, P285, DOI 10.1115/1.483256; Minchinton AI, 2006, NAT REV CANCER, V6, P583, DOI 10.1038/nrc1893; Piccardi M, 2004, IEEE SYS MAN CYBERN, P3099, DOI 10.1109/ICSMC.2004.1400815; Poelma C, 2008, EXP FLUIDS, V45, P703, DOI 10.1007/s00348-008-0476-6; Polacheck WJ, 2013, CELL MOL LIFE SCI, V70, P1335, DOI 10.1007/s00018-012-1115-1; Rae PJ, 2011, EXP MECH, V51, P467, DOI 10.1007/s11340-010-9444-1; Rossi M, 2006, 13 INT S APPL LAS TE; Salieb-Beugelaar GB, 2010, ANAL CHEM, V82, P4848, DOI 10.1021/ac1009707; Shin Y, 2012, NAT PROTOC, V7, P1247, DOI 10.1038/nprot.2012.051; Smalley KSM, 2006, IN VITRO CELL DEV-AN, V42, P242; Stroock AD, 2010, TISSUE ENG PT A, V16, P2143, DOI [10.1089/ten.tea.2009.0689, 10.1089/ten.TEA.2009.0689]; Tibbitt MW, 2009, BIOTECHNOL BIOENG, V103, P655, DOI 10.1002/bit.22361; Verbridge SS, 2010, TISSUE ENG PT A, V16, P2147, DOI [10.1089/ten.tea.2009.0668, 10.1089/ten.TEA.2009.0668]; Voigt E., 2012, CARDIOVASCULAR ENG T, V3, P101, DOI DOI 10.1007/S13239-011-0076-0); Westerweel J, 1997, MEAS SCI TECHNOL, V8, P1379, DOI 10.1088/0957-0233/8/12/002; Westerweel J, 2005, EXP FLUIDS, V39, P1096, DOI 10.1007/s00348-005-0016-6; Whatcott CJ., 2012, DESMOPLASIA CHEMORES; Yamada KM, 2007, CELL, V130, P601, DOI 10.1016/j.cell.2007.08.006; Youssef K, 2012, BIOTECHNOL BIOENG, V109, P1844, DOI 10.1002/bit.24440	57	13	13	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81198	10.1371/journal.pone.0081198	http://dx.doi.org/10.1371/journal.pone.0081198			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260559	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500200
J	Riccioni, G; Stagioni, M; Landi, M; Ferrara, G; Barbujani, G; Tinti, F				Riccioni, Giulia; Stagioni, Marco; Landi, Monica; Ferrara, Giorgia; Barbujani, Guido; Tinti, Fausto			Genetic Structure of Bluefin Tuna in the Mediterranean Sea Correlates with Environmental Variables	PLOS ONE			English	Article							GULF-OF-MEXICO; POPULATION-STRUCTURE; THUNNUS-THYNNUS; POSIDONIA-OCEANICA; MITOCHONDRIAL-DNA; F-STATISTICS; LIFE-HISTORY; WESTERN; EASTERN; PACKAGE	Background: Atlantic Bluefin Tuna (ABFT) shows complex demography and ecological variation in the Mediterranean Sea. Genetic surveys have detected significant, although weak, signals of population structuring; catch series analyses and tagging programs identified complex ABFT spatial dynamics and migration patterns. Here, we tested the hypothesis that the genetic structure of the ABFT in the Mediterranean is correlated with mean surface temperature and salinity. Methodology: We used six samples collected from Western and Central Mediterranean integrated with a new sample collected from the recently identified easternmost reproductive area of Levantine Sea. To assess population structure in the Mediterranean we used a multidisciplinary framework combining classical population genetics, spatial and Bayesian clustering methods and a multivariate approach based on factor analysis. Conclusions: F-ST analysis and Bayesian clustering methods detected several subpopulations in the Mediterranean, a result also supported by multivariate analyses. In addition, we identified significant correlations of genetic diversity with mean salinity and surface temperature values revealing that ABFT is genetically structured along two environmental gradients. These results suggest that a preference for some spawning habitat conditions could contribute to shape ABFT genetic structuring in the Mediterranean. However, further studies should be performed to assess to what extent ABFT spawning behaviour in the Mediterranean Sea can be affected by environmental variation.	[Riccioni, Giulia; Stagioni, Marco; Tinti, Fausto] Univ Bologna, Dept Biol Geol & Environm Sci, Marine Biol & Fisheries Lab, Fano, PU, Italy; [Landi, Monica; Ferrara, Giorgia; Tinti, Fausto] Univ Bologna, Dept Biol Geol & Environm Sci, Lab Genet & Genom Marine Resources & Environm, Ravenna, Italy; [Barbujani, Guido] Univ Ferrara, Dept Life Sci & Biotechnol, I-44100 Ferrara, Italy	University of Bologna; University of Bologna; University of Ferrara	Tinti, F (corresponding author), Univ Bologna, Dept Biol Geol & Environm Sci, Marine Biol & Fisheries Lab, Fano, PU, Italy.	fausto.tinti@unibo.it	Barbujani, Guido/ABE-9998-2020; Landi, Monica/J-3611-2012; Tinti, Fausto/D-4847-2012; Stagioni, Marco/ABE-4925-2020	Barbujani, Guido/0000-0001-7854-6669; Landi, Monica/0000-0003-2180-5062; Tinti, Fausto/0000-0002-8649-5387; Stagioni, Marco/0000-0002-8819-0413; Riccioni, Giulia/0000-0003-3934-8840	Italian Ministry of University and Scientific Research; University of Bologna	Italian Ministry of University and Scientific Research(Ministry of Education, Universities and Research (MIUR)); University of Bologna	This research was granted to FT by the Italian Ministry of University and Scientific Research (PRIN 2005 and 2008 grants) under competitive calls and co-financed by the University of Bologna. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alemany F, 2010, PROG OCEANOGR, V86, P21, DOI 10.1016/j.pocean.2010.04.014; Balding DJ, 2003, THEOR POPUL BIOL, V63, P221, DOI 10.1016/S0040-5809(03)00007-8; Bekkevold D, 2005, EVOLUTION, V59, P2656; Bergamasco A., 2010, ADV OCEANOGR LIMNOL, V1, P11, DOI [10.1080/19475721.2010.491656, DOI 10.1080/19475721.2010.491656]; Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Boustany AM, 2008, MAR BIOL, V156, P13, DOI 10.1007/s00227-008-1058-0; Bremer JRA, 2005, MOL PHYLOGENET EVOL, V36, P169, DOI 10.1016/j.ympev.2004.12.011; Carlsson J, 2004, MOL ECOL, V13, P3345, DOI 10.1111/j.1365-294X.2004.02336.x; Carlsson J, 2007, J HERED, V98, P23, DOI 10.1093/jhered/esl046; CAVALLIS.LL, 1966, PROC R SOC SER B-BIO, V164, P362, DOI 10.1098/rspb.1966.0038; Cimmaruta R, 2005, MOL ECOL, V14, P2577, DOI 10.1111/j.1365-294X.2005.02595.x; Corander J, 2003, GENETICS, V163, P367; Corander J, 2008, COMPUTATION STAT, V23, P111, DOI 10.1007/s00180-007-0072-x; Corander J, 2006, MOL ECOL, V15, P2833, DOI 10.1111/j.1365-294X.2006.02994.x; de Metrio G., 2005, International Commission for the Conservation of Atlantic Tunas Collective Volume of Scientific Papers, V58, P1337; Dray S, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i04; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; Excoffier L, 2005, EVOL BIOINFORM, V1, P47, DOI 10.1177/117693430500100003; Falush D, 2003, GENETICS, V164, P1567; Francois O, 2006, GENETICS, V174, P805, DOI 10.1534/genetics.106.059923; Francois O, 2010, MOL ECOL RESOUR, V10, P773, DOI 10.1111/j.1755-0998.2010.02868.x; Fromentin JM, 2009, FISH FISH, V10, P197, DOI 10.1111/j.1467-2979.2008.00311.x; Fromentin JM, 2005, FISH FISH, V6, P281, DOI 10.1111/j.1467-2979.2005.00197.x; Funk DJ, 2006, P NATL ACAD SCI USA, V103, P3209, DOI 10.1073/pnas.0508653103; Galarza JA, 2009, P NATL ACAD SCI USA, V106, P1473, DOI 10.1073/pnas.0806804106; Garcia A, 2013, FISH OCEANOGR, V22, P273, DOI 10.1111/fog.12021; Gerlach G, 2007, P NATL ACAD SCI USA, V104, P858, DOI 10.1073/pnas.0606777104; Goudet J, 1995, J HERED, V86, P485, DOI 10.1093/oxfordjournals.jhered.a111627; Greenacre M, 1966, THEORY APPL CORRES A; Guillot G, 2005, MOL ECOL NOTES, V5, P712, DOI 10.1111/j.1471-8286.2005.01031.x; Guillot G, 2008, BIOINFORMATICS, V24, P1406, DOI 10.1093/bioinformatics/btn136; Hubisz MJ, 2009, MOL ECOL RESOUR, V9, P1322, DOI 10.1111/j.1755-0998.2009.02591.x; Jakobsson M, 2007, BIOINFORMATICS, V23, P1801, DOI 10.1093/bioinformatics/btm233; JOHNSON FM, 1969, BIOCHEM GENET, V3, P429, DOI 10.1007/BF00485604; Jombart T, 2009, HEREDITY, V102, P330, DOI 10.1038/hdy.2008.130; Jombart T, 2008, BIOINFORMATICS, V24, P1403, DOI 10.1093/bioinformatics/btn129; Kaoueche M, 2011, AFR J MAR SCI, V33, P79, DOI 10.2989/1814232X.2011.572342; Karakulak S, 2004, J APPL ICHTHYOL, V20, P318, DOI 10.1111/j.1439-0426.2004.00561.x; Knutsen H, 2004, P ROY SOC B-BIOL SCI, V271, P1337, DOI 10.1098/rspb.2004.2721; Koched W, 2013, MEDITERR MAR SCI, V14, P5, DOI 10.12681/mms.314; Latch EK, 2006, CONSERV GENET, V7, P295, DOI 10.1007/s10592-005-9098-1; Legendre P., 1998, NUMERICAL ECOLOGY, V24; Manel S, 2007, MOL ECOL, V16, P2031, DOI 10.1111/j.1365-294X.2007.03293.x; Manel S, 2005, TRENDS ECOL EVOL, V20, P136, DOI 10.1016/j.tree.2004.12.004; MANTEL N, 1967, CANCER RES, V27, P209; Mariani P, 2010, PROG OCEANOGR, V86, P45, DOI 10.1016/j.pocean.2010.04.027; Mejri R, 2009, MOL PHYLOGENET EVOL, V53, P596, DOI 10.1016/j.ympev.2009.04.018; Millot C, 1999, J MARINE SYST, V20, P423, DOI 10.1016/S0924-7963(98)00078-5; Muhling BA, 2013, MAR ECOL PROG SER, V486, P257, DOI 10.3354/meps10397; Oksanen J., 2013, VEGAN COMMUNITY ECOL; Patarnello T, 2007, MOL ECOL, V16, P4426, DOI 10.1111/j.1365-294X.2007.03477.x; Poulain PM, 2012, J PHYS OCEANOGR, V42, P973, DOI 10.1175/JPO-D-11-0159.1; Pritchard JK, 2000, GENETICS, V155, P945; Procaccini G, 2002, B MAR SCI, V71, P1291; R Core Team, 2021, R LANG ENV STAT COMP; RAYMOND M, 1995, J HERED, V86, P248, DOI 10.1093/oxfordjournals.jhered.a111573; Reeb CA, 2010, P NATL ACAD SCI USA, V107, P2377, DOI 10.1073/pnas.0914639107; Reglero P, 2012, MAR ECOL PROG SER, V463, P273, DOI 10.3354/meps09800; Riccioni G, 2010, P NATL ACAD SCI USA, V107, P2102, DOI 10.1073/pnas.0908281107; RICE WR, 1989, EVOLUTION, V43, P223, DOI 10.1111/j.1558-5646.1989.tb04220.x; Robinson A.R., 2001, OCEAN CURRENTS MEDIT, DOI [10.1006/rwos.2001.0376, DOI 10.1006/RWOS.2001.0376]; Rooker JR, 2007, REV FISH SCI, V15, P265, DOI 10.1080/10641260701484135; Rosenberg NA, 2004, MOL ECOL NOTES, V4, P137, DOI 10.1046/j.1471-8286.2003.00566.x; Rousset F, 1997, GENETICS, V145, P1219; Selkoe KA, 2008, FISH FISH, V9, P363, DOI 10.1111/j.1467-2979.2008.00300.x; Sella M, 1929, R COMITATO TALASSOGR, V16, P3; Sella M, 1932, NOTE I ITALO GERMANI, V3, P3; Serra IA, 2010, MOL ECOL, V19, P557, DOI 10.1111/j.1365-294X.2009.04462.x; SMOUSE PE, 1982, AM NAT, V119, P445, DOI 10.1086/283925; SMOUSE PE, 1986, SYST ZOOL, V35, P627, DOI 10.2307/2413122; Teo SLH, 2007, MAR BIOL, V152, P1105, DOI 10.1007/s00227-007-0758-1; Vinas J, 2004, MOL PHYLOGENET EVOL, V33, P32, DOI 10.1016/j.ympev.2004.04.009; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]	73	26	26	1	51	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80105	10.1371/journal.pone.0080105	http://dx.doi.org/10.1371/journal.pone.0080105			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260341	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500114
J	Rohde, M; Wold, A; Karnath, HO; Ernst, MO				Rohde, Marieke; Wold, Andrew; Karnath, Hans-Otto; Ernst, Marc O.			The Human Touch: Skin Temperature during the Rubber Hand Illusion in Manual and Automated Stroking Procedures	PLOS ONE			English	Article							BODY EXPERIENCES; OWNERSHIP; FEEL; OBJECTS	A difference in skin temperature between the hands has been identified as a physiological correlate of the rubber hand illusion (RHI). The RHI is an illusion of body ownership, where participants perceive body ownership over a rubber hand if they see it being stroked in synchrony with their own occluded hand. The current study set out to replicate this result, i.e., psychologically induced cooling of the stimulated hand using an automated stroking paradigm, where stimulation was delivered by a robot arm (PHANToM (TM) force-feedback device). After we found no evidence for hand cooling in two experiments using this automated procedure, we reverted to a manual stroking paradigm, which is closer to the one employed in the study that first produced this effect. With this procedure, we observed a relative cooling of the stimulated hand in both the experimental and the control condition. The subjective experience of ownership, as rated by the participants, by contrast, was strictly linked to synchronous stroking in all three experiments. This implies that hand-cooling is not a strict correlate of the subjective feeling of hand ownership in the RHI. Factors associated with the differences between the two designs (differences in pressure of tactile stimulation, presence of another person) that were thus far considered irrelevant to the RHI appear to play a role in bringing about this temperature effect.	[Rohde, Marieke; Ernst, Marc O.] Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany; [Rohde, Marieke; Ernst, Marc O.] Univ Bielefeld, Cognit Interact Technol Ctr Excellence, D-33615 Bielefeld, Germany; [Rohde, Marieke; Wold, Andrew; Ernst, Marc O.] Max Planck Inst Biol Cybernet, Multisensory Percept & Act Grp, D-72076 Tubingen, Germany; [Wold, Andrew; Karnath, Hans-Otto] Hertie Inst Clin Brain Res, Div Neuropsychol, Tubingen, Germany; [Wold, Andrew] Charite, Res Div Mind & Brain, D-13353 Berlin, Germany	University of Bielefeld; University of Bielefeld; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Rohde, M (corresponding author), Univ Bielefeld, Dept Cognit Neurosci, D-33615 Bielefeld, Germany.	marieke.rohde@uni-bielefeld.de		Rohde, Marieke/0000-0002-8354-8850; Ernst, Marc/0000-0003-4197-8569	HFSP; Max Planck Society; DFG; Deutsche Forschungsgemeinschaft (DFG); Bielefeld University Library	HFSP(Human Frontier Science Program); Max Planck Society(Max Planck SocietyFoundation CELLEX); DFG(German Research Foundation (DFG)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Bielefeld University Library	This research was supported by the the HFSP Research Grant (2006) on "Mechanisms of associative learning in human perception", by the Max Planck Society, and by the DFG grant ELAPS: Embodied Latency Adaptation and the Perception of Simultaneity. The authors acknowledge support for the Article Processing Charge by the Deutsche Forschungsgemeinschaft (DFG) and the Open Access Publication Funds of Bielefeld University Library. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Armel KC, 2003, P ROY SOC B-BIOL SCI, V270, P1499, DOI 10.1098/rspb.2003.2364; Asai T, 2011, CONSCIOUS COGN, V20, P1744, DOI 10.1016/j.concog.2011.02.005; Barnsley N, 2011, CURR BIOL, V21, pR945, DOI 10.1016/j.cub.2011.10.039; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Durgin FH, 2007, PSYCHOL SCI, V18, P152, DOI 10.1111/j.1467-9280.2007.01865.x; Ehrsson HH, 2007, P NATL ACAD SCI USA, V104, P9828, DOI 10.1073/pnas.0610011104; Ehrsson HH, 2004, SCIENCE, V305, P875, DOI 10.1126/science.1097011; Folegatti A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006920; Gallace A, 2010, NEUROSCI BIOBEHAV R, V34, P246, DOI 10.1016/j.neubiorev.2008.10.004; Hohwy J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009416; Holmes NP, 2006, PERCEPT PSYCHOPHYS, V68, P685, DOI 10.3758/BF03208768; Kammers MPM, 2011, NEUROPSYCHOLOGIA, V49, P1316, DOI 10.1016/j.neuropsychologia.2011.02.039; Longo MR, 2008, COGNITION, V107, P978, DOI 10.1016/j.cognition.2007.12.004; Marasco PD, 2011, BRAIN, V134, P747, DOI 10.1093/brain/awq361; Moseley GL, 2008, P NATL ACAD SCI USA, V105, P13169, DOI 10.1073/pnas.0803768105; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pavani F, 2000, PSYCHOL SCI, V11, P353, DOI 10.1111/1467-9280.00270; Rohde M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021659; Salomon R, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00065; SCHURGER A, 2005, 2 WAY REPEATED MEASU; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2007, CEREB CORTEX, V17, P2235, DOI 10.1093/cercor/bhl131; Tsakiris M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004040	23	54	54	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80688	10.1371/journal.pone.0080688	http://dx.doi.org/10.1371/journal.pone.0080688			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256KH	24260454	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500166
J	Caberlotto, L; Lauria, M; Nguyen, TP; Scotti, M				Caberlotto, Laura; Lauria, Mario; Nguyen, Thanh-Phuong; Scotti, Marco			The Central Role of AMP-Kinase and Energy Homeostasis Impairment in Alzheimer's Disease: A Multifactor Network Analysis	PLOS ONE			English	Article							CANDIDATE GENES; EXPRESSION; METABOLISM; DISCOVERY; PATHWAYS; GENETICS; LINKAGE; CORTEX; TOOL	Alzheimer's disease is the most common cause of dementia worldwide, affecting the elderly population. It is characterized by the hallmark pathology of amyloid-beta deposition, neurofibrillary tangle formation, and extensive neuronal degeneration in the brain. Wealth of data related to Alzheimer's disease has been generated to date, nevertheless, the molecular mechanism underlying the etiology and pathophysiology of the disease is still unknown. Here we described a method for the combined analysis of multiple types of genome-wide data aimed at revealing convergent evidence interest that would not be captured by a standard molecular approach. Lists of Alzheimer-related genes ( seed genes) were obtained from different sets of data on gene expression, SNPs, and molecular targets of drugs. Network analysis was applied for identifying the regions of the human protein-protein interaction network showing a significant enrichment in seed genes, and ultimately, in genes associated to Alzheimer's disease, due to the cumulative effect of different combinations of the starting data sets. The functional properties of these enriched modules were characterized, effectively considering the role of both Alzheimer-related seed genes and genes that closely interact with them. This approach allowed us to present evidence in favor of one of the competing theories about AD underlying processes, specifically evidence supporting a predominant role of metabolism-associated biological process terms, including autophagy, insulin and fatty acid metabolic processes in Alzheimer, with a focus on AMP-activated protein kinase. This central regulator of cellular energy homeostasis regulates a series of brain functions altered in Alzheimer's disease and could link genetic perturbation with neuronal transmission and energy regulation, representing a potential candidate to be targeted by therapy.	[Caberlotto, Laura; Lauria, Mario; Nguyen, Thanh-Phuong; Scotti, Marco] Microsoft Res Univ Trento, Ctr Computat Syst Biol, Rovereto, Italy		Caberlotto, L (corresponding author), Microsoft Res Univ Trento, Ctr Computat Syst Biol, Rovereto, Italy.	caberlotto@cosbi.eu	Scotti, Marco/B-2487-2010; Lauria, Mario/G-6796-2012	Scotti, Marco/0000-0002-0775-6148; Lauria, Mario/0000-0001-5983-7292				Ackermann M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-47; Ahmad W, 2013, MOL NEUROBIOL, V47, P399, DOI 10.1007/s12035-012-8352-z; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bertram L, 2008, NAT REV NEUROSCI, V9, P768, DOI 10.1038/nrn2494; Bertram L, 2007, NAT GENET, V39, P17, DOI 10.1038/ng1934; Bertram L, 2010, NEURON, V68, P270, DOI 10.1016/j.neuron.2010.10.013; Bossers K, 2010, BRAIN, V133, P3699, DOI 10.1093/brain/awq258; Butler AW, 2009, NEUROBIOL AGING, V30, P1037, DOI 10.1016/j.neurobiolaging.2009.03.013; Cai H, 2012, CURR ALZHEIMER RES, V9, P5, DOI 10.2174/156720512799015064; Cai ZY, 2012, NEUROMOL MED, V14, P1, DOI 10.1007/s12017-012-8173-2; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chen JX, 2006, PROCEEDINGS OF THE 2006 IEEE INTERNATIONAL CONFERENCE ON VEHICULAR ELECTRONICS AND SAFETY, P367; Citron M, 2010, NAT REV DRUG DISCOV, V9, P387, DOI 10.1038/nrd2896; Csardi N., 2006, INT J COMP SYST, V1695, P1; Dittrich MT, 2008, BIOINFORMATICS, V24, pI223, DOI 10.1093/bioinformatics/btn161; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Emilsson L, 2006, NEUROBIOL DIS, V21, P618, DOI 10.1016/j.nbd.2005.09.004; Greco SJ, 2009, BIOCHEM BIOPH RES CO, V380, P98, DOI 10.1016/j.bbrc.2009.01.041; Guttula Satya Vani, 2012, Int J Alzheimers Dis, V2012, P649456, DOI 10.1155/2012/649456; Hamosh A, 2005, NUCLEIC ACIDS RES, V33, pD514; Hawrylycz MJ, 2012, NATURE, V489, P391, DOI 10.1038/nature11405; Huang YD, 2012, CELL, V148, P1204, DOI 10.1016/j.cell.2012.02.040; Jiang QG, 2008, CNS DRUGS, V22, P1, DOI 10.2165/00023210-200822010-00001; Johnson JM, 2003, SCIENCE, V302, P2141, DOI 10.1126/science.1090100; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Komurov K, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-282; Krauthammer M, 2004, P NATL ACAD SCI USA, V101, P15148, DOI 10.1073/pnas.0404315101; Lauria M, 2013, SYSTEMS BIO IN PRESS; Liang WS, 2008, P NATL ACAD SCI USA, V105, P4441, DOI 10.1073/pnas.0709259105; Lin A, 2010, GENOME RES, V20, P1122, DOI 10.1101/gr.104216.109; Liu B, 2006, BIOCHEM BIOPH RES CO, V349, P1308, DOI 10.1016/j.bbrc.2006.08.168; Mairet-Coello G, 2013, NEURON, V78, P94, DOI 10.1016/j.neuron.2013.02.003; Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440; Minoshima S, 1997, ANN NEUROL, V42, P85, DOI 10.1002/ana.410420114; Mizuno S, 2012, BMC SYST BIOL, V6, DOI 10.1186/1752-0509-6-52; Moreira PI, 2010, EXPERT REV NEUROTHER, V10, P1209, DOI [10.1586/ern.10.84, 10.1586/ERN.10.84]; Murdoch DJ, 2008, AM STAT, V62, P242, DOI 10.1198/000313008X332421; Nelson PT, 2012, J NEUROPATH EXP NEUR, V71, P362, DOI 10.1097/NEN.0b013e31825018f7; Newman MEJ, 2004, PHYS REV E, V69, DOI [10.1103/PhysRevE.69.026113, 10.1103/PhysRevE.70.056131]; Piaceri I, 2012, J NEUROL SCI, V322, P31, DOI 10.1016/j.jns.2012.05.033; Potter WB, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008996; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Reichardt J, 2006, PHYS REV E, V74, DOI 10.1103/PhysRevE.74.016110; Rice J R, 1995, MATH STAT DATA ANAL, P594; Salminen A, 2012, AGEING RES REV, V11, P230, DOI 10.1016/j.arr.2011.12.005; Searcy JL, 2012, J ALZHEIMERS DIS, V30, P943, DOI 10.3233/JAD-2012-111661; Soler-Lopez M, 2011, GENOME RES, V21, P364, DOI 10.1101/gr.114280.110; Sturges HA, 1926, J AM STAT ASSOC, V21, P65, DOI 10.1080/01621459.1926.10502161; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun JY, 2012, J ALZHEIMERS DIS, V28, P389, DOI 10.3233/JAD-2011-111313; Supek F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021800; Tarca AL, 2013, BIOINFORMATICS; Valentin F, 2010, BRIEF BIOINFORM, V11, P375, DOI 10.1093/bib/bbp065; VANSOMEREN EJW, 1993, BEHAV BRAIN RES, V57, P235, DOI 10.1016/0166-4328(93)90140-L; Wang X, 2011, BIOINFORMATICS, V27, P879, DOI 10.1093/bioinformatics/btr028	55	31	32	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78919	10.1371/journal.pone.0078919	http://dx.doi.org/10.1371/journal.pone.0078919			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265728	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100061
J	Merrigan, MM; Venugopal, A; Roxas, JL; Anwar, F; Mallozzi, MJ; Roxas, BAP; Gerding, DN; Viswanathan, VK; Vedantam, G				Merrigan, Michelle M.; Venugopal, Anilrudh; Roxas, Jennifer L.; Anwar, Farhan; Mallozzi, Michael J.; Roxas, Bryan A. P.; Gerding, Dale N.; Viswanathan, V. K.; Vedantam, Gayatri			Surface-Layer Protein A (SlpA) Is a Major Contributor to Host-Cell Adherence of Clostridium difficile	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; S-LAYER; INCREASED SPORULATION; INFECTION; COLONIZATION; EPIDEMIC; OUTBREAK; ADHESION; STRAINS	Clostridium difficile is a leading cause of antibiotic-associated diarrhea, and a significant etiologic agent of healthcare-associated infections. The mechanisms of attachment and host colonization of C. difficile are not well defined. We hypothesize that non-toxin bacterial factors, especially those facilitating the interaction of C. difficile with the host gut, contribute to the initiation of C. difficile infection. In this work, we optimized a completely anaerobic, quantitative, epithelial-cell adherence assay for vegetative C. difficile cells, determined adherence proficiency under multiple conditions, and investigated C. difficile surface protein variation via immunological and DNA sequencing approaches focused on Surface-Layer Protein A (SlpA). In total, thirty-six epidemic-associated and non-epidemic associated C. difficile clinical isolates were tested in this study, and displayed intra-and inter-clade differences in attachment that were unrelated to toxin production. SlpA was a major contributor to bacterial adherence, and individual subunits of the protein (varying in sequence between strains) mediated host-cell attachment to different extents. Pre-treatment of host cells with crude or purified SlpA subunits, or incubation of vegetative bacteria with anti-SlpA antisera significantly reduced C. difficile attachment. SlpA-mediated adherence-interference correlated with the attachment efficiency of the strain from which the protein was derived, with maximal blockage observed when SlpA was derived from highly adherent strains. In addition, SlpA-containing preparations from a non-toxigenic strain effectively blocked adherence of a phylogenetically distant, epidemic-associated strain, and vice-versa. Taken together, these results suggest that SlpA plays a major role in C. difficile infection, and that it may represent an attractive target for interventions aimed at abrogating gut colonization by this pathogen.	[Merrigan, Michelle M.] Loyola Univ, Ctr Med, Dept Microbiol & Immunol, Maywood, IL 60153 USA; [Venugopal, Anilrudh] Wayne State Univ, St Johns Hosp, Sch Med, Detroit, MI USA; [Venugopal, Anilrudh] Wayne State Univ, Med Ctr, Sch Med, Detroit, MI 48202 USA; [Gerding, Dale N.] Hines VA Hosp, Hines, IL USA; [Gerding, Dale N.] Loyola Univ, Chicago Stritch Sch Med, Div Infect Dis, Maywood, IL USA; [Viswanathan, V. K.; Vedantam, Gayatri] Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA; [Roxas, Jennifer L.; Anwar, Farhan; Mallozzi, Michael J.; Roxas, Bryan A. P.; Viswanathan, V. K.; Vedantam, Gayatri] Univ Arizona, Dept Immunobiol, Tucson, AZ USA; [Viswanathan, V. K.; Vedantam, Gayatri] Univ Arizona, Bio Inst Collaborat Res 5, Tucson, AZ USA; [Vedantam, Gayatri] Southern Arizona VA Healthcare Syst, Tucson, AZ USA	Loyola University Chicago; Wayne State University; Detroit Medical Center; Wayne State University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Loyola University Chicago; University of Arizona; University of Arizona; University of Arizona; US Department of Veterans Affairs; Veterans Health Administration (VHA); Southern Arizona Veterans Affairs Health Care System	Vedantam, G (corresponding author), Univ Arizona, Sch Anim & Comparat Biomed Sci, Tucson, AZ 85721 USA.	gayatri@email.arizona.edu		Viswanathan, VK/0000-0002-9258-9865	US Dept. of Veterans Affairs [BX1I01BX001183, BX000515-04]; USDA [ARZT-570410-A-02-139]; College of Agriculture and Life Sciences, University of Arizona; National Institutes of Health [NIAID1R01AI081742]; Veterans Affairs [I01BX001183] Funding Source: NIH RePORTER	US Dept. of Veterans Affairs; USDA(United States Department of Agriculture (USDA)); College of Agriculture and Life Sciences, University of Arizona; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Veterans Affairs(US Department of Veterans Affairs)	This research project was supported by the US Dept. of Veterans Affairs (BX1I01BX001183 to GV, and BX000515-04 to DNG), USDA (CSREES Hatch Program; ARZT-570410-A-02-139 to GV), and the College of Agriculture and Life Sciences, University of Arizona (to GV and VKV). Work in the Viswanathan laboratory is also supported by the National Institutes of Health (NIAID1R01AI081742 to VKV). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akerlund T, 2008, J CLIN MICROBIOL, V46, P1530, DOI 10.1128/JCM.01964-07; Antikainen J, 2002, MOL MICROBIOL, V46, P381, DOI 10.1046/j.1365-2958.2002.03180.x; Ausiello CM, 2006, MICROBES INFECT, V8, P2640, DOI 10.1016/j.micinf.2006.07.009; Barketi-Klai A, 2011, J MED MICROBIOL, V60, P1155, DOI 10.1099/jmm.0.029553-0; Burns DA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024894; Calabi E, 2002, J BACTERIOL, V184, P3886, DOI 10.1128/JB.184.14.3886-3897.2002; Calabi E, 2002, INFECT IMMUN, V70, P5770, DOI 10.1128/IAI.70.10.5770-5778.2002; Calabi E, 2001, MOL MICROBIOL, V40, P1187, DOI 10.1046/j.1365-2958.2001.02461.x; Cerquetti M, 2000, MICROB PATHOGENESIS, V28, P363, DOI 10.1006/mpat.2000.0356; Dang THT, 2012, BIOORGAN MED CHEM, V20, P614, DOI 10.1016/j.bmc.2011.06.042; Dingle KE, 2013, J INFECT DIS, V207, P675, DOI 10.1093/infdis/jis734; Eggertson L, 2004, CAN MED ASSOC J, V171, P19, DOI 10.1503/cmaj.1040979; Fagan RP, 2011, J MED MICROBIOL, V60, P1225, DOI 10.1099/jmm.0.028472-0; Fagan RP, 2009, MOL MICROBIOL, V71, P1308, DOI 10.1111/j.1365-2958.2009.06603.x; Figueroa I, 2012, CLIN INFECT DIS, V55, pS104, DOI 10.1093/cid/cis357; Hamm EE, 2007, FUTURE MICROBIOL, V2, P85, DOI 10.2217/17460913.2.1.85; Hennequin C, 2003, MICROBIOL-SGM, V149, P2779, DOI 10.1099/mic.0.26145-0; Jandu N, 2009, MICROBIOL-SGM, V155, P531, DOI 10.1099/mic.0.021931-0; Jhung MA, 2008, EMERG INFECT DIS, V14, P1039, DOI 10.3201/eid1407.071641; Karjalainen T, 2001, INFECT IMMUN, V69, P3442, DOI 10.1128/IAI.69.5.3442-3446.2001; Kirby JM, 2009, J BIOL CHEM, V284, P34666, DOI 10.1074/jbc.M109.051177; Kuehne SA, 2011, GUT MICROBES, V2, P252, DOI 10.4161/gmic.2.4.16109; Kyne L, 2001, GASTROENTEROL CLIN N, V30, P753, DOI 10.1016/S0889-8553(05)70209-0; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lyras D, 2009, NATURE, V458, P1176, DOI 10.1038/nature07822; Marsh JW, 2006, J CLIN MICROBIOL, V44, P2558, DOI 10.1128/JCM.02364-05; McDonald LC, 2005, NEW ENGL J MED, V353, P2433, DOI 10.1056/NEJMoa051590; Merrigan M, 2010, J BACTERIOL, V192, P4904, DOI 10.1128/JB.00445-10; Merrigan MM, 2009, INT J ANTIMICROB AG, V33, pS46, DOI 10.1016/S0924-8579(09)70017-2; Ni Eidhin D, 2006, J MED MICROBIOL, V55, P69, DOI 10.1099/jmm.0.46204-0; O'Connor J, 2009, GEOJOURNAL LIB, V98, P1, DOI 10.1007/978-1-4020-9949-6_1; Pechine S, 2007, VACCINE, V25, P3946, DOI 10.1016/j.vaccine.2007.02.055; Petrella LA, 2012, CLIN INFECT DIS, V55, P351, DOI 10.1093/cid/cis430; Sambol SP, 2002, J INFECT DIS, V186, P1781, DOI 10.1086/345676; Sambol SP, 2001, J INFECT DIS, V183, P1760, DOI 10.1086/320736; Samore M, 1997, J INFECT DIS, V176, P1233, DOI 10.1086/514117; Sara M, 2000, J BACTERIOL, V182, P859, DOI 10.1128/JB.182.4.859-868.2000; SCHNEITZ C, 1993, J APPL BACTERIOL, V74, P290, DOI 10.1111/j.1365-2672.1993.tb03028.x; Selma MV, 2012, J AGR FOOD CHEM, V60, P7367, DOI 10.1021/jf203967u; Spigaglia P, 2013, J MED MICROBIOL, V62, P1386, DOI 10.1099/jmm.0.056556-0; Stabler RA, 2006, J BACTERIOL, V188, P7297, DOI 10.1128/JB.00664-06; TAKEOKA A, 1991, J GEN MICROBIOL, V137, P261, DOI 10.1099/00221287-137-2-261; Tasteyre A, 2001, INFECT IMMUN, V69, P7937, DOI 10.1128/IAI.69.12.7937-7940.2001; Ternan NG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042410; Vedantam G, 2012, GUT MICROBES, V3, P121, DOI 10.4161/gmic.19399; Viswanathan VK, 2010, GUT MICROBES, V1, P234, DOI 10.4161/gmic.1.4.12706; Vohra P, 2011, MICROBIOL-SGM, V157, P1343, DOI 10.1099/mic.0.046243-0; Waligora AJ, 2001, INFECT IMMUN, V69, P2144, DOI 10.1128/IAI.69.4.2144-2153.2001; Walker AS, 2013, CLIN INFECT DIS, V56, P1589, DOI 10.1093/cid/cit127	49	82	85	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78404	10.1371/journal.pone.0078404	http://dx.doi.org/10.1371/journal.pone.0078404			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265687	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100021
J	Yan, R; Adinolfi, S; Iannuzzi, C; Kelly, G; Oregioni, A; Martin, S; Pastore, A				Yan, Robert; Adinolfi, Salvatore; Iannuzzi, Clara; Kelly, Geoff; Oregioni, Alain; Martin, Stephen; Pastore, Annalisa			Cluster and Fold Stability of E. coli ISC-Type Ferredoxin	PLOS ONE			English	Article							PROTEIN SECONDARY STRUCTURE; BACKBONE DYNAMICS; 2FE-2S FERREDOXIN; BACTERIAL FRATAXIN; DNA-BINDING; DOMAIN; ADRENODOXIN; BIOGENESIS; DESULFURASE; ASSIGNMENT	Iron-sulfur clusters are essential protein prosthetic groups that provide their redox potential to several different metabolic pathways. Formation of iron-sulfur clusters is assisted by a specialised machine that comprises, among other proteins, a ferredoxin. As a first step to elucidate the precise role of this protein in cluster assembly, we have studied the factors governing the stability and the dynamic properties of E. coli ferredoxin using different spectroscopic techniques. The cluster-loaded protein is monomeric and well structured with a flexible C-terminus but is highly oxygen sensitive so that it readily loses the cluster leading to an irreversible unfolding under aerobic conditions. This process is slowed down by reducing conditions and high ionic strengths. NMR relaxation experiments on the cluster-loaded protein also show that, once the cluster is in place, the protein forms a globular and relatively rigid domain. These data indicate that the presence of the iron-sulfur cluster is the switch between a functional and a non-functional state.	[Yan, Robert; Adinolfi, Salvatore; Iannuzzi, Clara; Kelly, Geoff; Oregioni, Alain; Martin, Stephen; Pastore, Annalisa] MRC, Natl Inst Med Res, Div Mol Struct, London, England	MRC National Institute for Medical Research	Pastore, A (corresponding author), MRC, Natl Inst Med Res, Div Mol Struct, London, England.	apastor@nimr.mrc.ac.uk	Yan, Robert/GYU-0395-2022	IANNUZZI, Clara/0000-0003-0092-5997; ADINOLFI, Salvatore/0000-0003-1319-5516; Oregioni, Alain/0000-0003-2462-3870	Medical Research Council; European Union EFACTS consortium; MRC [MC_PC_13054, MC_U117584256] Funding Source: UKRI; Medical Research Council [MC_U117584256, MC_PC_13054] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union EFACTS consortium; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	The work was supported by the Medical Research Council and the European Union EFACTS consortium. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adinolfi S, 2004, EUR J BIOCHEM, V271, P2093, DOI 10.1111/j.1432-1033.2004.04112.x; Adinolfi S, 2009, NAT STRUCT MOL BIOL, V16, P390, DOI 10.1038/nsmb.1579; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Beilke D, 2002, BIOCHEMISTRY-US, V41, P7969, DOI 10.1021/bi0160361; Chandramouli K, 2007, BIOCHEMISTRY-US, V46, P6804, DOI 10.1021/bi6026659; Eliezer D, 2009, CURR OPIN STRUC BIOL, V19, P23, DOI 10.1016/j.sbi.2008.12.004; Ewen KM, 2012, IUBMB LIFE, V64, P506, DOI 10.1002/iub.1029; Ewen KM, 2011, BBA-PROTEINS PROTEOM, V1814, P111, DOI 10.1016/j.bbapap.2010.06.003; FARROW NA, 1994, BIOCHEMISTRY-US, V33, P5984, DOI 10.1021/bi00185a040; HOWARD JB, 1989, J BIOL CHEM, V264, P11270; Iametti S, 1996, EUR J BIOCHEM, V239, P818, DOI 10.1111/j.1432-1033.1996.0818u.x; JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Jung YS, 1999, J INORG BIOCHEM, V74, P184; Kakuta Y, 2001, BIOCHEMISTRY-US, V40, P11007, DOI 10.1021/bi010544t; KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003; Kelly AE, 2002, J AM CHEM SOC, V124, P12013, DOI 10.1021/ja026121b; Kim JH, 2013, J AM CHEM SOC, V135, P8117, DOI 10.1021/ja401950a; Lewis TE, 2013, NUCLEIC ACIDS RES, V41, pD499, DOI 10.1093/nar/gks1266; Lill R, 2012, BBA-MOL CELL RES, V1823, P1491, DOI 10.1016/j.bbamcr.2012.05.009; Maciejewski MW, 2000, J MOL BIOL, V296, P229, DOI 10.1006/jmbi.1999.3455; MANDEL AM, 1995, J MOL BIOL, V246, P144, DOI 10.1006/jmbi.1994.0073; Marchant J, 2008, BIOMOL NMR ASSIGN, V2, P119, DOI 10.1007/s12104-008-9100-1; Morleo A, 2010, BIOCHEMISTRY-US, V49, P6627, DOI 10.1021/bi100630t; Ollagnier-de-Choudens S, 2001, J BIOL CHEM, V276, P22604, DOI 10.1074/jbc.M102902200; PAGANI S, 1986, BIOCHIM BIOPHYS ACTA, V870, P538, DOI 10.1016/0167-4838(86)90263-3; PALMER AG, 1991, J AM CHEM SOC, V113, P4371, DOI 10.1021/ja00012a001; Pochapsky TC, 1999, BIOCHEMISTRY-US, V38, P4681, DOI 10.1021/bi983030b; Politou AS, 1995, BIOPHYS J, V69, P2601, DOI 10.1016/S0006-3495(95)80131-1; Prischi F, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1097; Qi WB, 2013, DALTON T, V42, P3088, DOI 10.1039/c2dt32018e; Roche B, 2013, BBA-BIOENERGETICS, V1827, P455, DOI 10.1016/j.bbabio.2012.12.010; Sainz G, 2006, J BIOL INORG CHEM, V11, P235, DOI 10.1007/s00775-005-0069-2; Salzmann M, 1999, J AM CHEM SOC, V121, P844, DOI 10.1021/ja9834226; Sattler M, 1999, PROG NUCL MAG RES SP, V34, P93, DOI 10.1016/S0079-6565(98)00025-9; Sheftel AD, 2010, P NATL ACAD SCI USA, V107, P11775, DOI 10.1073/pnas.1004250107; Shi Y, 2012, INT J INF TECH DECIS, V11, P1, DOI 10.1142/S0219622012010018; Sousounis K, 2012, HUM GENOMICS, V6; Sreerama N, 2000, ANAL BIOCHEM, V287, P252, DOI 10.1006/abio.2000.4880; TA DT, 1992, J BIOL CHEM, V267, P11120; Tokumoto U, 2002, J BIOCHEM, V131, P713, DOI 10.1093/oxfordjournals.jbchem.a003156; Tompa P, 2012, TRENDS BIOCHEM SCI, V37, P509, DOI 10.1016/j.tibs.2012.08.004; Tsai CL, 2010, BIOCHEMISTRY-US, V49, P9132, DOI 10.1021/bi1013062; UHLMANN H, 1995, ENDOCR RES, V21, P307, DOI 10.3109/07435809509030447; Wilkins MR, 1999, METH MOL B, V112, P531; WISHART DS, 1994, J BIOMOL NMR, V4, P171; Wittung-Stafshede P, 2002, ACCOUNTS CHEM RES, V35, P201, DOI 10.1021/ar010106e; Yan R, 2013, J BIOL CHEM, V288, P24777, DOI 10.1074/jbc.M113.480327	49	7	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78948	10.1371/journal.pone.0078948	http://dx.doi.org/10.1371/journal.pone.0078948			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265733	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100066
J	Yun, SM; Yoon, K; Lee, S; Kim, E; Kong, SH; Choe, J; Kang, JM; Han, TS; Kim, P; Choi, Y; Jho, S; Yoo, H; Bhak, J; Yang, HK; Kim, SJ				Yun, S. M.; Yoon, K.; Lee, S.; Kim, E.; Kong, S-H; Choe, J.; Kang, J. M.; Han, T-S; Kim, P.; Choi, Y.; Jho, S.; Yoo, H.; Bhak, J.; Yang, H-K; Kim, S-J			PPP1R1B-STARD3 chimeric fusion transcript in human gastric cancer promotes tumorigenesis through activation of PI3K/AKT signaling	ONCOGENE			English	Article						fusion transcript; gastric cancer; transcriptome sequencing	GENE FUSIONS; PROSTATE-CANCER; DARPP-32; PATHWAY; RNAS; REARRANGEMENTS; EXPRESSION; MUTATIONS; DOPAMINE; RECEPTOR	Fusion genes act as potent oncogenes, resulting from chromosomal rearrangements or abnormal transcription in many human cancers. Although multiple gastric cancer genomes have been sequenced, the driving recurrent gene fusions have not been well characterized. Here, we used paired-end transcriptome sequencing to identify novel gene fusions in 18 human gastric cancer cell lines and 18 pairs of primary human gastric cancer tissues and their adjacent normal tissues. Multiple samples revealed expression of PPP1R1B-STARD3 fusion transcript. The presence of PPP1R1B-STARD3 correlated with elevated levels of PPP1R1B mRNA. PPP1R1B-STARD3 fusion transcript was detected in 21.3% of primary human gastric cancers but not in adjacent matched normal gastric tissues. Based on reverse transcription PCR analysis of DNA, unlike other fusions described in gastric cancer, the PPP1R1B-STARD3 appears to be generated by RNA processing without chromosomal rearrangement. Overexpression of PPP1R1B-STARD3 in MKN-28 significantly increased cell proliferation and colony formation. This increased proliferation was mediated by activation of phosphatidylinositol-3-kinase (PI3K)/AKT signaling. Furthermore, expression of PPP1R1B-STARD3 fusion transcript enhanced the tumor growth of MKN-28 cells in athymic nude mice. These findings show that PPP1R1B-STARD3 fusion transcript has a key role in subsets of gastric cancers through the activation of PI3K/AKT signaling.	[Yun, S. M.; Yoon, K.; Kim, E.; Choe, J.; Kang, J. M.; Kim, P.; Choi, Y.; Yoo, H.; Kim, S-J] CHA Univ, CHA Canc Inst, Seoul 135081, South Korea; [Yun, S. M.; Kim, S-J] CHA Univ, Dept Biomed Sci, Coll Life Sci, Seoul 135081, South Korea; [Lee, S.; Jho, S.; Bhak, J.] Genome Res Fdn, Personal Genom Inst, Suwon, South Korea; [Lee, S.; Bhak, J.] TheragenEtex Inc, TheragenEtex Bio Inst, Suwon, South Korea; [Kong, S-H; Han, T-S; Yang, H-K] Seoul Natl Univ, Canc Res Inst, Seoul, South Korea; [Kong, S-H; Yang, H-K] Seoul Natl Univ, Coll Med, Dept Surg, Seoul, South Korea	Pochon Cha University; Pochon Cha University; Seoul National University (SNU); Seoul National University (SNU)	Kim, SJ (corresponding author), CHA Univ, CHA Canc Inst, 605 Yeoksam 1 Dong, Seoul 135081, South Korea.	kimsj@cha.ac.kr		Lee, Sunghoon/0000-0002-8916-2035; Lee, Sunghoon/0000-0002-6682-119X; Kang, Jin Muk/0000-0002-7949-9160	National Research Foundation of Korea (NRF) [2009-0081756, 2012M3A9C4048736]; TheragenEtex; Industrial Strategic Technology Development Program - Ministry of Knowledge Economy (MKE, Korea) [10040231]; Genome Research Foundation	National Research Foundation of Korea (NRF)(National Research Foundation of Korea); TheragenEtex; Industrial Strategic Technology Development Program - Ministry of Knowledge Economy (MKE, Korea); Genome Research Foundation	This work was supported in part by the National Research Foundation of Korea (NRF) grants (2009-0081756 and 2012M3A9C4048736 to S-JK). JB and SL were supported by TheragenEtex and Genome Research Foundation internal funds. JB was supported by the Industrial Strategic Technology Development Program (10040231) funded by the Ministry of Knowledge Economy (MKE, Korea).	Akiva P, 2006, GENOME RES, V16, P30, DOI 10.1101/gr.4137606; Beckler A, 2003, CANCER, V98, P1547, DOI 10.1002/cncr.11654; Belkhiri A, 2005, CANCER RES, V65, P6583, DOI 10.1158/0008-5472.CAN-05-1433; BRENE S, 1994, J NEUROSCI, V14, P985, DOI 10.1523/JNEUROSCI.14-03-00985.1994; Courtney KD, 2010, J CLIN ONCOL, V28, P1075, DOI 10.1200/JCO.2009.25.3641; Deng NT, 2012, GUT, V61, P673, DOI 10.1136/gutjnl-2011-301839; El-Rifai W, 2002, CANCER RES, V62, P4061; Fienberg AA, 1998, SCIENCE, V281, P838, DOI 10.1126/science.281.5378.838; Greengard P, 1999, NEURON, V23, P435, DOI 10.1016/S0896-6273(00)80798-9; Guggenheim DE, 2013, J SURG ONCOL, V107, P230, DOI 10.1002/jso.23262; Guilford P, 1998, NATURE, V392, P402, DOI 10.1038/32918; Hennessy BT, 2005, NAT REV DRUG DISCOV, V4, P988, DOI 10.1038/nrd1902; Hold GL, 2007, GASTROENTEROLOGY, V132, P905, DOI 10.1053/j.gastro.2006.12.026; Ito Kosei, 2012, Seikagaku, V84, P278; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kannan K, 2011, P NATL ACAD SCI USA, V108, P9172, DOI 10.1073/pnas.1100489108; Katoh M, 2004, INT J ONCOL, V24, P757; Li H, 2008, SCIENCE, V321, P1357, DOI 10.1126/science.1156725; McPherson A, 2011, PLOS COMPUT BIOL, V7, DOI 10.1371/journal.pcbi.1001138; Mitelman F, 2007, NAT REV CANCER, V7, P233, DOI 10.1038/nrc2091; Mukherjee K, 2010, SURGERY, V148, P354, DOI 10.1016/j.surg.2010.05.011; Palanisamy N, 2010, NAT MED, V16, P793, DOI 10.1038/nm.2166; Persson M, 2009, P NATL ACAD SCI USA, V106, P18740, DOI 10.1073/pnas.0909114106; Poulin F, 2003, J BIOL CHEM, V278, P52290, DOI 10.1074/jbc.M310761200; Prensner JR, 2009, CURR OPIN GENET DEV, V19, P82, DOI 10.1016/j.gde.2008.11.008; Robinson DR, 2011, NAT MED, V17, P1646, DOI 10.1038/nm.2580; Tao J, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3001423; Trapnell C, 2010, NAT BIOTECHNOL, V28, P511, DOI 10.1038/nbt.1621; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang K, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-348; Wang XS, 2009, NAT BIOTECHNOL, V27, P1005, DOI 10.1038/nbt.1584; Wei JX, 2012, P NATL ACAD SCI USA, V109, pE2543, DOI 10.1073/pnas.1205664109; Yoon K, 2013, GENOME RES, V23, P1109, DOI 10.1101/gr.145706.112; Zayed A, 2007, LEUKEMIA LYMPHOMA, V48, P489, DOI 10.1080/10428190601136163; Zhu SM, 2011, GASTROENTEROLOGY, V141, P1738, DOI 10.1053/j.gastro.2011.06.070	35	26	26	0	13	SPRINGERNATURE	LONDON	CAMPUS, 4 CRINAN ST, LONDON, N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 13	2014	33	46					5341	5347		10.1038/onc.2013.472	http://dx.doi.org/10.1038/onc.2013.472			7	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AT7MF	24276243				2022-12-25	WOS:000345120600004
J	Li, H; Huang, F; Fan, L; Jiang, Y; Wang, X; Li, J; Wang, Q; Pan, H; Sun, J; Cao, X; Wang, X				Li, H.; Huang, F.; Fan, L.; Jiang, Y.; Wang, X.; Li, J.; Wang, Q.; Pan, H.; Sun, J.; Cao, X.; Wang, X.			Phosphatidylethanolamine-binding protein 4 is associated with breast cancer metastasis through Src-mediated Akt tyrosine phosphorylation	ONCOGENE			English	Article						breast cancer metastasis; hPEBP4; Akt; Src	KINASE INHIBITOR PROTEIN; TRAIL-INDUCED APOPTOSIS; ALPHA-INDUCED APOPTOSIS; RAF KINASE; MESENCHYMAL TRANSITION; PATHWAY ACTIVATION; CELLS; EXPRESSION; PROSTATE; RESISTANCE	Metastasis is responsible for more than 90% of the mortality observed among patients with breast cancer. Human phosphatidylethanolamine-binding protein 4 (hPEBP4) is a novel member of the PEBP family and functions as an anti-apoptotic molecule. Here, we found that the metastatic MDA-MB-231 breast cancer cells expressed much higher levels of hPEBP4 than the nonmetastatic MCF-7 breast cancer cells and that the expression levels of hPEBP4 were positively correlated with the metastasis of clinical breast cancer. The hPEBP4 overexpression in the MDA-MB-231 cells significantly promoted cell invasion in vitro and increased the development of lymph node metastasis in vivo. Conversely, the silencing of hPEBP4 suppressed the cell-invasive ability both in vitro and in vivo. Further investigation showed that hPEBP4 promoted the expression or activity of the metastasis-related proteinases MMP (matrix metalloproteinase) 2, MMP9 and MMP13. This hPEBP4-potentiated cell invasion and MMP expression is due to an increase in Akt activation. Knockdown of Akt restored hPEBP4-induced breast tumor metastasis in the hPEBP4-MDA-MB-231 xenograft mouse model. Moreover, we found that hPEBP4 functioned as a scaffolding molecule and enhanced the association of Akt with Src to promote Akt tyrosine phosphorylation, a prerequisite for the full activation of Akt, in a phosphatidylethanolamine-binding domain-dependent manner. Given the present information about human breast cancer, these functional data from cell culture and animal studies suggest that, in human breast cancer hPEBP4 is a novel and clinically relevant metastasis accelerator gene and may be a new diagnostic marker and therapeutic target for breast cancer metastasis.	[Li, H.; Huang, F.; Fan, L.; Jiang, Y.; Wang, X.; Wang, Q.; Cao, X.; Wang, X.] Zhejiang Univ, Inst Immunol, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China; [Li, J.; Pan, H.; Sun, J.] Zhejiang Univ, Sch Med, Hangzhou 310058, Zhejiang, Peoples R China	Zhejiang University; Zhejiang University	Wang, X (corresponding author), Zhejiang Univ, Inst Immunol, 388 Yuhang Tang Rd,Med Res Bldg B819, Hangzhou 310058, Zhejiang, Peoples R China.	wangxiaojian@cad.zju.edu.cn			National Basic Research Program of China (973) [2014CB542101, 2013CB530502]; National Natural Science Foundation of China [81282353, 81072437, 81000302]; Doctoral Fund of Ministry of Education of China [20120101110022]; Zhejiang Major Science and Technology Special Project [2009C13018, 2009C14015]; Research Fund of Science Base [J1103603]; Qianjiang Talent Program of Zhejiang Province [2012R10027]; Scientific Research Foundation of the Health Bureau of Zhejiang Province [WKJ2012-2-030]	National Basic Research Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Doctoral Fund of Ministry of Education of China(Ministry of Education, China); Zhejiang Major Science and Technology Special Project; Research Fund of Science Base; Qianjiang Talent Program of Zhejiang Province; Scientific Research Foundation of the Health Bureau of Zhejiang Province	This work was supported by grants from the National Basic Research Program of China (973) (2014CB542101, 2013CB530502), the National Natural Science Foundation of China (81282353, 81072437, 81000302), the Doctoral Fund of Ministry of Education of China (20120101110022), Zhejiang Major Science and Technology Special Project (2009C13018, 2009C14015), the Research Fund of Science Base (J1103603), Qianjiang Talent Program of Zhejiang Province (2012R10027) and Scientific Research Foundation of the Health Bureau of Zhejiang Province (WKJ2012-2-030).	Al Saleh S, 2011, INT J ONCOL, V38, P1197, DOI 10.3892/ijo.2011.942; Baritaki S, 2007, J IMMUNOL, V179, P5441, DOI 10.4049/jimmunol.179.8.5441; Cantley LC, 2002, SCIENCE, V296, P1655, DOI 10.1126/science.296.5573.1655; Castaneda CA, 2010, CANCER METAST REV, V29, P751, DOI 10.1007/s10555-010-9261-0; Chatterjee D, 2004, J BIOL CHEM, V279, P17515, DOI 10.1074/jbc.M313816200; Chen RY, 2001, J BIOL CHEM, V276, P31858, DOI 10.1074/jbc.C100271200; Cheung LWT, 2006, CANCER RES, V66, P10902, DOI 10.1158/0008-5472.CAN-06-2217; Dangi-Garimella S, 2009, EMBO J, V28, P347, DOI 10.1038/emboj.2008.294; Fu Z, 2003, J NATL CANCER I, V95, P878, DOI 10.1093/jnci/95.12.878; Garcia R, 2009, EMBO REP, V10, P278, DOI 10.1038/embor.2009.4; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hagan S, 2005, CLIN CANCER RES, V11, P7392, DOI 10.1158/1078-0432.CCR-05-0283; Jiang TY, 2003, J BIOL CHEM, V278, P15789, DOI 10.1074/jbc.M212525200; Kohn AD, 1996, J BIOL CHEM, V271, P21920, DOI 10.1074/jbc.271.36.21920; Li HZ, 2007, J BIOL CHEM, V282, P4943, DOI 10.1074/jbc.M609494200; Li P, 2006, INT J MOL MED, V18, P505; Liu HB, 2010, J BIOL CHEM, V285, P21934, DOI 10.1074/jbc.M110.109876; Liu HY, 2012, TUMOR BIOL, V33, P267, DOI 10.1007/s13277-011-0279-x; Lopez-Knowles E, 2010, INT J CANCER, V126, P1121, DOI 10.1002/ijc.24831; Luan B, 2009, NATURE, V457, P1146, DOI 10.1038/nature07617; Ma L, 2007, NATURE, V449, P682, DOI 10.1038/nature06174; Min CY, 2008, J CELL BIOCHEM, V104, P733, DOI 10.1002/jcb.21695; Odabaei G, 2004, ADV CANCER RES, V91, P169, DOI 10.1016/S0065-230X(04)91005-6; Prasad S, 2010, MOL CELL BIOCHEM, V336, P25, DOI 10.1007/s11010-009-0267-2; Qiao M, 2008, CELL CYCLE, V7, P2991, DOI 10.4161/cc.7.19.6784; Roskoski R, 2004, BIOCHEM BIOPH RES CO, V324, P1155, DOI 10.1016/j.bbrc.2004.09.171; Wang XJ, 2005, CLIN CANCER RES, V11, P7545, DOI 10.1158/1078-0432.CCR-05-0879; Wang XJ, 2004, J BIOL CHEM, V279, P45855, DOI 10.1074/jbc.M405147200; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Weigelt B, 2005, NAT REV CANCER, V5, P591, DOI 10.1038/nrc1670; Yang WL, 2010, CELL CYCLE, V9, P486, DOI 10.4161/cc.9.3.10508; Yang WL, 2009, SCIENCE, V325, P1134, DOI 10.1126/science.1175065; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366; Yu GP, 2012, TUMOR BIOL, V33, P223, DOI 10.1007/s13277-011-0265-3; Yu GP, 2011, TUMOR BIOL, V32, P1257, DOI 10.1007/s13277-011-0230-1; Yu GP, 2013, TUMOR BIOL, V34, P91, DOI 10.1007/s13277-012-0514-0; Zhang YY, 2007, INT J MOL MED, V19, P55; Zheng Y, 2010, MOL CELL BIOL, V30, P4280, DOI 10.1128/MCB.00024-10; Zhu QS, 2011, ONCOGENE, V30, P457, DOI 10.1038/onc.2010.421	39	26	30	1	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	SEP 11	2014	33	37					4589	4598		10.1038/onc.2013.408	http://dx.doi.org/10.1038/onc.2013.408			10	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AP3UZ	24276246				2022-12-25	WOS:000342004800006
J	Hahn, SM; Kim, S; Park, KI; Han, SJ; Koh, H				Hahn, Seung Min; Kim, Seung; Park, Kook In; Han, Seok Joo; Koh, Hong			Clinical Benefit of Liver Stiffness Measurement at 3 Months after Kasai Hepatoportoenterostomy to Predict the Liver Related Events in Biliary Atresia	PLOS ONE			English	Article							CHRONIC HEPATITIS-C; TRANSIENT ELASTOGRAPHY; RATIO INDEX; FIBROSIS; CHILDREN; CIRRHOSIS; MANAGEMENT; FIBROTEST; SURVIVAL; VARICES	Background: The progression of hepatic fibrosis may result in decompensated hepatic failure with cirrhosis, liver related events (LRE) such as ascites, variceal bleeding, and death after successful and timely Kasai hepatoportoenterostomy (HPE) in biliary atresia. The aim of this study is to suggest clinical benefit of the liver stiffness measurement (LSM) using transient elastography at 3 months after the Kasai operation to predict LRE. Methods: Between January 2007 and December 2011, 69 eligible biliary atresia patients who underwent Kasai HPE and performed transient elastography before and 3 months after HPE were included. The occurrences of LRE were analyzed for all patients. All patients were divided into 2 groups (with and without LRE) for comparison. Multivariate analysis was used to detect the independent risk factors of LRE. The area under the receiver operation characteristics curve (AUROC) was used to establish the LSM optimal cutoff value of 3 months after Kasai operation in predicting LRE. Results: LSM value, aminotransferase, albumin, bilirubin, and PT-INR significantly differed among the two groups. Multivariate analysis demonstrated LSM value as the most powerful independent factor of the development of LRE. The cutoff value of 19.9 kPa was calculated to be optimal for predicting LRE development with total sensitivity and specificity of 1.804. AUROC resulted in 0.943, with sensitivity of 85.3% and specificity of 95.2%. Conclusions: The LSM value of 3 months after Kasai HPE can be a useful predictor of LRE development.	[Hahn, Seung Min; Kim, Seung; Park, Kook In; Koh, Hong] Yonsei Univ, Coll Med, Dept Pediat, Severance Pediat Liver Dis Res Grp,Severance Chil, Seoul, South Korea; [Han, Seok Joo] Yonsei Univ, Coll Med, Dept Pediat Surg, Severance Pediat Liver Dis Res Grp,Severance Chil, Seoul, South Korea	Yonsei University; Yonsei University Health System; Yonsei University; Yonsei University Health System	Koh, H (corresponding author), Yonsei Univ, Coll Med, Dept Pediat, Severance Pediat Liver Dis Res Grp,Severance Chil, Seoul, South Korea.	khong@yuhs.ac		Han, Seok Joo/0000-0001-5224-1437; Koh, Hong/0000-0002-3660-7483; Kim, Seung/0000-0003-4373-9828; Hahn, Seung Min/0000-0001-9832-6380				Alisi A, 2011, BEST PRACT RES CL GA, V25, P259, DOI 10.1016/j.bpg.2011.02.008; Breton E, 2009, ARCH PEDIATRIE, V16, P1005, DOI 10.1016/j.arcped.2009.03.021; Castera L, 2005, GASTROENTEROLOGY, V128, P343, DOI 10.1053/j.gastro.2004.11.018; Castera L, 2008, J HEPATOL, V48, P835, DOI 10.1016/j.jhep.2008.02.008; Chang HK, 2009, J PEDIATR GASTR NUTR, V49, P323, DOI 10.1097/MPG.0b013e31819de7ba; Chongsrisawat V, 2011, BMC GASTROENTEROL, V11, DOI 10.1186/1471-230X-11-41; de Ledinghen V, 2007, J PEDIATR GASTR NUTR, V45, P443, DOI 10.1097/MPG.0b013e31812e56ff; Fraquelli M, 2007, GUT, V56, P968, DOI 10.1136/gut.2006.111302; Goldschmidt I, 2013, J PEDIATR GASTR NUTR, V57, P109, DOI 10.1097/MPG.0b013e31829206a0; Hadzic N, 2003, J PEDIATR GASTR NUTR, V37, P430; Hartley JL, 2009, LANCET, V374, P1704, DOI 10.1016/S0140-6736(09)60946-6; Honsawek S, 2011, EUR J PEDIATR SURG, V21, P250, DOI 10.1055/s-0031-1273776; Honsawek S, 2010, WORLD J GASTROENTERO, V16, P5467, DOI 10.3748/wjg.v16.i43.5467; Hung PY, 2006, J PEDIATR GASTR NUTR, V42, P190, DOI 10.1097/01.mpg.0000189339.92891.64; Jung KS, 2012, CLIN MOL HEPATOL, V18, P163, DOI 10.3350/cmh.2012.18.2.163; Jung KS, 2011, HEPATOLOGY, V53, P885, DOI 10.1002/hep.24121; Kim SY, 2010, J PEDIATR GASTR NUTR, V51, P198, DOI 10.1097/MPG.0b013e3181da1d98; Kim SU, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036676; Lucidarme D, 2009, HEPATOLOGY, V49, P1083, DOI 10.1002/hep.22748; Millonig G, 2008, HEPATOLOGY, V48, P1718, DOI 10.1002/hep.22577; Moore KP, 2006, GUT, V55, P1, DOI 10.1136/gut.2006.099580; Narkewicz MR, 2001, CURR OPIN PEDIATR, V13, P435, DOI 10.1097/00008480-200110000-00009; Patch D, 2001, WORLD J GASTROENTERO, V7, P466; Sandrin L, 2003, ULTRASOUND MED BIOL, V29, P1705, DOI 10.1016/j.ultrasmedbio.2003.07.001; Sarin SK, 2009, HEPATOL INT, V3, P269, DOI 10.1007/s12072-008-9106-x; Shneider BL, 2006, J PEDIATR-US, V148, P467, DOI 10.1016/j.jpeds.2005.12.054; Superina R, 2011, ANN SURG, V254, P577, DOI 10.1097/SLA.0b013e3182300950; Vizzutti F, 2007, HEPATOLOGY, V45, P1290, DOI 10.1002/hep.21665; Wong VWS, 2010, J GASTROEN HEPATOL, V25, P1726, DOI 10.1111/j.1440-1746.2010.06437.x	29	23	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80652	10.1371/journal.pone.0080652	http://dx.doi.org/10.1371/journal.pone.0080652			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260445	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500165
J	Noss, C; Dabrunz, A; Rosenfeldt, RR; Lorke, A; Schulz, R				Noss, Christian; Dabrunz, Andre; Rosenfeldt, Ricki R.; Lorke, Andreas; Schulz, Ralf			Three-Dimensional Analysis of the Swimming Behavior of Daphnia magna Exposed to Nanosized Titanium Dioxide	PLOS ONE			English	Article							ENGINEERED NANOPARTICLES; FULLERENE C-60; RESPONSES; TOXICITY; TIO2; FOOD; ECOTOXICOLOGY; REPRODUCTION; COMBINATION; ORGANISMS	Due to their surface characteristics, nanosized titanium dioxide particles (nTiO(2)) tend to adhere to biological surfaces and we thus hypothesize that they may alter the swimming performance and behavior of motile aquatic organisms. However, no suitable approaches to address these impairments in swimming behavior as a result of nanoparticle exposure are available. Water fleas Daphnia magna exposed to 5 and 20 mg/L nTiO(2) (61 nm; polydispersity index: 0.157 in 17.46 mg/L stock suspension) for 96 h showed a significantly (p<0.05) reduced growth rate compared to a 1-mg/L treatment and the control. Using three-dimensional video observations of swimming trajectories, we observed a treatment-dependent swarming of D. magna in the center of the test vessels during the initial phase of the exposure period. Ensemble mean swimming velocities increased with increasing body length of D. magna, but were significantly reduced in comparison to the control in all treatments after 96 h of exposure. Spectral analysis of swimming velocities revealed that high-frequency variance, which we consider as a measure of swimming activity, was significantly reduced in the 5- and 20-mg/L treatments. The results highlight the potential of detailed swimming analysis of D. magna for the evaluation of sub-lethal mechanical stress mechanisms resulting from biological surface coating and thus for evaluating the effects of nanoparticles in the aquatic environment.	[Noss, Christian; Dabrunz, Andre; Rosenfeldt, Ricki R.; Lorke, Andreas; Schulz, Ralf] Univ Koblenz Landau, Inst Environm Sci, Landau, Germany	University of Koblenz & Landau	Noss, C (corresponding author), Univ Koblenz Landau, Inst Environm Sci, Landau, Germany.	noss@uni-landau.de	Schulz, Ralf/G-3674-2011; Schulz, Ralf/ABI-4526-2020; Lorke, Andreas/B-9195-2008	Schulz, Ralf/0000-0002-6348-6971; Schulz, Ralf/0000-0002-6348-6971; Lorke, Andreas/0000-0001-5533-1817				ASTM, 2007, STAND GUID COND AC T; Baillieul M, 1998, WATER RES, V32, P1027, DOI 10.1016/S0043-1354(97)00321-7; Baillieul M, 1999, AQUAT TOXICOL, V44, P245, DOI 10.1016/S0166-445X(98)00080-0; Baun A, 2008, ECOTOXICOLOGY, V17, P387, DOI 10.1007/s10646-008-0208-y; Billoir E, 2007, ECOL MODEL, V203, P204, DOI 10.1016/j.ecolmodel.2006.11.021; Bundschuh M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048956; Bundschuh M, 2011, CHEMOSPHERE, V85, P1563, DOI 10.1016/j.chemosphere.2011.07.060; Campos B, 2013, AQUAT TOXICOL, V130, P174, DOI 10.1016/j.aquatox.2013.01.005; Dabrunz A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020112; DODSON SI, 1995, ENVIRON TOXICOL CHEM, V14, P43, DOI 10.1002/etc.5620140106; Dodson SI, 1997, J PLANKTON RES, V19, P969, DOI 10.1093/plankt/19.8.969; Duquesne S, 2010, ECOTOX ENVIRON SAFE, V73, P353, DOI 10.1016/j.ecoenv.2009.11.008; Emery W.J., 2001, DATA ANAL METHODS PH, P159, DOI DOI 10.1016/C2010-0-66362-0; Geller W., 1975, Archiv Hydrobiol, V48, P47; GLIWICZ ZM, 1990, NATURE, V343, P638, DOI 10.1038/343638a0; Gottschalk F, 2011, J ENVIRON MONITOR, V13, P1145, DOI 10.1039/c0em00547a; Han BP, 2001, J THEOR BIOL, V210, P305, DOI 10.1006/jtbi.2001.2307; Handy RD, 2008, ECOTOXICOLOGY, V17, P287, DOI 10.1007/s10646-008-0199-8; Heinlaan M, 2008, CHEMOSPHERE, V71, P1308, DOI 10.1016/j.chemosphere.2007.11.047; HORTON PA, 1979, CAN J ZOOL, V57, P206, DOI 10.1139/z79-019; Kaegi R, 2008, ENVIRON POLLUT, V156, P233, DOI 10.1016/j.envpol.2008.08.004; Lampert W, 2011, DAPHNIA DEV MODEL OR; Lazorchak JM, 2009, ENVIRON TOXICOL CHEM, V28, P1028, DOI 10.1897/08-296.1; Lead JR, 2006, ENVIRON CHEM, V3, P159, DOI 10.1071/EN06025; Lechelt M, 2000, ENVIRON TOXICOL, V15, P390, DOI 10.1002/1522-7278(2000)15:5<390::AID-TOX6>3.0.CO;2-H; Lovern SB, 2007, ENVIRON SCI TECHNOL, V41, P4465, DOI 10.1021/es062146p; Lovern SB, 2006, ENVIRON TOXICOL CHEM, V25, P1132, DOI 10.1897/05-278R.1; Noss C, 2013, LIMNOL OCEANOGR-METH, V11, P139, DOI 10.4319/lom.2013.11.139; Oberdorster E, 2006, CARBON, V44, P1112, DOI 10.1016/j.carbon.2005.11.008; RINGELBERG J, 1995, HYDROBIOLOGIA, V307, P161, DOI 10.1007/BF00032008; Roozen F, 2001, J PLANKTON RES, V23, P797, DOI 10.1093/plankt/23.8.797; Scheringer M, 2008, NAT NANOTECHNOL, V3, P322, DOI 10.1038/nnano.2008.145; Scown TM, 2010, CRIT REV TOXICOL, V40, P653, DOI 10.3109/10408444.2010.494174; Seitz F, 2013, AQUAT TOXICOL, V126, P163, DOI 10.1016/j.aquatox.2012.10.015; Szulkin M, 2006, ANIM BEHAV, V71, P1013, DOI 10.1016/j.anbehav.2005.05.027; Taylor G, 1998, ENVIRON TOXICOL CHEM, V17, P412, DOI 10.1002/etc.5620170310; Untersteiner H, 2005, ZOOL STUD, V44, P71; van Gool E, 1997, J PLANKTON RES, V19, P2041, DOI 10.1093/plankt/19.12.2041; Vanni M, 2002, ADV COLLOID INTERFAC, V97, P151, DOI 10.1016/S0001-8686(01)00050-1; Wiench K, 2009, CHEMOSPHERE, V76, P1356, DOI 10.1016/j.chemosphere.2009.06.025; Zhu XS, 2010, CHEMOSPHERE, V78, P209, DOI 10.1016/j.chemosphere.2009.11.013	41	34	35	0	65	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80960	10.1371/journal.pone.0080960	http://dx.doi.org/10.1371/journal.pone.0080960			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260519	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500185
J	Forsbach-Birk, V; Foddis, C; Simnacher, U; Wilkat, M; Longbottom, D; Walder, G; Benesch, C; Ganter, M; Sachse, K; Essig, A				Forsbach-Birk, Vera; Foddis, Corinna; Simnacher, Ulrike; Wilkat, Max; Longbottom, David; Walder, Gernot; Benesch, Christiane; Ganter, Martin; Sachse, Konrad; Essig, Andreas			Profiling Antibody Responses to Infections by Chlamydia abortus Enables Identification of Potential Virulence Factors and Candidates for Serodiagnosis	PLOS ONE			English	Article							OUTER-MEMBRANE-PROTEIN; CHLAMYDOPHILA-ABORTUS; DEVELOPMENTAL CYCLE; PSITTACI SEROTYPE-1; TRACHOMATIS; PNEUMONIAE; EXPRESSION; PMPD; AUTOTRANSPORTER; LOCALIZATION	Enzootic abortion of ewes (EAE) due to infection with the obligate intracellular pathogen Chlamydia (C.) abortus is an important zoonosis leading to considerable economic loss to agriculture worldwide. The pathogen can be transmitted to humans and may lead to serious infection in pregnant women. Knowledge about epidemiology, clinical course and transmission to humans is hampered by the lack of reliable diagnostic tools. Immunoreactive proteins, which are expressed in infected animals and humans, may serve as novel candidates for diagnostic marker proteins and represent putative virulence factors. In order to broaden the spectrum of immunogenic C. abortus proteins we applied 2D immunoblot analysis and screening of an expression library using human and animal sera. We have identified 48 immunoreactive proteins representing potential diagnostic markers and also putative virulence factors, such as CAB080 (homologue of the "macrophage infectivity potentiator", MIP), CAB167 (homologue of the "translocated actin recruitment protein", TARP), CAB712 (homologue of the "chlamydial protease-like activity factor", CPAF), CAB776 (homologue of the "Polymorphic membrane protein D", PmpD), and the "hypothetical proteins"CAB063, CAB408 and CAB821, which are predicted to be type III secreted. We selected two putative virulence factors for further characterization, i. e. CAB080 (cMIP) and CAB063, and studied their expression profiles at transcript and protein levels. Analysis of the subcellular localization of both proteins throughout the developmental cycle revealed CAB063 being the first C. abortus protein shown to be translocated to the host cell nucleus.	[Forsbach-Birk, Vera; Foddis, Corinna; Simnacher, Ulrike; Wilkat, Max; Essig, Andreas] Univ Hosp, Inst Med Microbiol & Hyg, Ulm, Germany; [Longbottom, David] Moredun Res Inst, Edinburgh EH17 7JH, Midlothian, Scotland; [Walder, Gernot] Med Univ Innsbruck, Dept Hyg & Social Med, A-6020 Innsbruck, Austria; [Benesch, Christiane] Tierseuchenkasse Baden Wurttemberg, Stuttgart, Germany; [Ganter, Martin] Univ Vet Med Hannover, Klin Kleine Klauentiere, Hannover, Germany; [Sachse, Konrad] Fed Res Inst Anim Hlth, Friedrich Loeffler Inst, Jena, Germany	Ulm University; Moredun Research Institute; Medical University of Innsbruck; University of Veterinary Medicine Hannover, Foundation; Friedrich Loeffler Institute	Forsbach-Birk, V (corresponding author), Univ Hosp, Inst Med Microbiol & Hyg, Ulm, Germany.	vera.forsbach-birk@uniklinik-ulm.de	Sachse, Konrad/GWC-4999-2022; Longbottom, David/GWZ-8448-2022	Sachse, Konrad/0000-0003-1230-1786; Longbottom, David/0000-0003-0086-8443	German Ministry for Education and Research ( BMBF) [01 KI 0723]; BBSRC [BB/E018939/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E018939/1] Funding Source: researchfish	German Ministry for Education and Research ( BMBF)(Federal Ministry of Education & Research (BMBF)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was supported by the German Ministry for Education and Research ( BMBF), "Zoonotic chlamydiae - Models of chronic and persistent infections in humans and animals"Grant # 01 KI 0723. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arnold R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000376; Baud D, 2008, CURR OPIN INFECT DIS, V21, P70, DOI 10.1097/QCO.0b013e3282f3e6a5; Bunk S, 2008, J IMMUNOL, V180, P5490, DOI 10.4049/jimmunol.180.8.5490; CALDWELL HD, 1981, INFECT IMMUN, V31, P1161, DOI 10.1128/IAI.31.3.1161-1176.1981; Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101; Demine R, 2005, J BIOL CHEM, V280, P17573, DOI 10.1074/jbc.M501233200; Dinkel H, 2012, NUCLEIC ACIDS RES, V40, pD242, DOI 10.1093/nar/gkr1064; Dong F, 2004, INFECT IMMUN, V72, P3869, DOI 10.1128/IAI.72.7.3869-3875.2004; Essig A, 1999, CLIN DIAGN LAB IMMUN, V6, P819, DOI 10.1128/CDLI.6.6.819-825.1999; Forsbach-Birk V, 2010, CLIN MICROBIOL INFEC, V16, P1237, DOI 10.1111/j.1469-0691.2009.03041.x; Herrmann M, 2006, RES MICROBIOL, V157, P513, DOI 10.1016/j.resmic.2005.12.005; Hobolt-Pedersen AS, 2009, FEMS IMMUNOL MED MIC, V57, P46, DOI 10.1111/j.1574-695X.2009.00581.x; HOBOLTPEDERSEN A, 2006, 11 INT S HUM CHLAM I, P237; Jewett TJ, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000997; Kiselev AO, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000568; Kiselev AO, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005191; Lenzko H, 2011, BMC VET RES, V7, DOI 10.1186/1746-6148-7-29; Livingstone M, 2005, CLIN DIAGN LAB IMMUN, V12, P770, DOI 10.1128/CDLI.12.6.770-777.2005; Longbottom D, 2003, J COMP PATHOL, V128, P217, DOI 10.1053/jcpa.2002.0629; Marques PX, 2010, CLIN VACCINE IMMUNOL, V17, P1274, DOI 10.1128/CVI.00163-10; Muschiol S, 2011, INFECT IMMUN, V79, P571, DOI 10.1128/IAI.00825-10; Neff L, 2007, J BACTERIOL, V189, P4739, DOI 10.1128/JB.01889-06; Pennini ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000995; Sachse K, 2009, VET MICROBIOL, V135, P2, DOI 10.1016/j.vetmic.2008.09.040; SaltiMontesanto V, 1997, AM J VET RES, V58, P228; Swanson KA, 2009, INFECT IMMUN, V77, P508, DOI 10.1128/IAI.01173-08; Tan C, 2009, INFECT IMMUN, V77, P3218, DOI 10.1128/IAI.01566-08; Thomson NR, 2005, GENOME RES, V15, P629, DOI 10.1101/gr.3684805; Vretou E, 2001, INFECT IMMUN, V69, P607, DOI 10.1128/IAI.69.1.607-612.2001; Walder G, 2005, OBSTET GYNECOL, V106, P1215, DOI 10.1097/01.AOG.0000161060.69470.9c; Wehrl W, 2004, MOL MICROBIOL, V51, P319, DOI 10.1046/j.1365-2958.2003.03838.x; Wheelhouse N, 2009, VET RES, V40, DOI 10.1051/vetres/2009030; Zhong GM, 2001, J EXP MED, V193, P935, DOI 10.1084/jem.193.8.935	33	17	20	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80310	10.1371/journal.pone.0080310	http://dx.doi.org/10.1371/journal.pone.0080310			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260366	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600055
J	Prevel, N; Allenbach, Y; Klatzmann, D; Salomon, B; Benveniste, O				Prevel, Nicolas; Allenbach, Yves; Klatzmann, David; Salomon, Benoit; Benveniste, Olivier			Beneficial Role of Rapamycin in Experimental Autoimmune Myositis	PLOS ONE			English	Article							REGULATORY T-CELLS; PERIPHERAL-TISSUES; TOLERANCE; FOXP3; DERMATOMYOSITIS; TRANSPLANTATION; POLYMYOSITIS; MYOPATHIES; MIGRATION; ARTHRITIS	Introduction: We developed an experimental autoimmune myositis (EAM) mouse model of polymyositis where we outlined the role of regulatory T (Treg) cells. Rapamycin, this immunosuppressant drug used to prevent rejection in organ transplantation, is known to spare Treg. Our aim was to test the efficacy of rapamycin in vivo in this EAM model and to investigate the effects of the drug on different immune cell sub-populations. Methods: EAM is induced by 3 injections of myosin emulsified in CFA. Mice received rapamycin during 25 days starting one day before myosin immunization (preventive treatment), or during 10 days following the last myosin immunization (curative treatment). Results: Under preventive or curative treatment, an increase of muscle strength was observed with a parallel decrease of muscle inflammation, both being well correlated (R-2 = -0.645, p<0.0001). Rapamycin induced a general decrease in muscle of CD4 and CD8 T cells in lymphoid tissues, but spared B cells. Among T cells, the frequency of Treg was increased in rapamycin treated mice in draining lymph nodes (16.9 +/- 2.2% vs. 9.3 +/- 1.4%, p<0.001), which were mostly activated regulatory T cells (CD62L(low)CD44(high): 58.1 +/- 5.78% vs. 33.1 +/- 7%, treated vs. untreated, p<0.001). In rapamycin treated mice, inhibition of proliferation (Ki-67(+)) is more important in effector T cells compared to Tregs cells (p<0.05). Furthermore, during preventive treatment, rapamycin increased the levels of KLF2 transcript in CD44(low) CD62L(high) naive T cell and in CD62L(low) CD44(high) activated T cell. Conclusions: Rapamycin showed efficacy both as curative and preventive treatment in our murine model of experimental myositis, in which it induced an increase of muscle strength with a parallel decrease in muscle inflammation. Rapamycin administration was also associated with a decrease in the frequency of effector T cells, an increase in Tregs, and, when administered as preventive treatment, an upregulation of KFL2 in naive and activated T cells.	[Prevel, Nicolas; Klatzmann, David; Salomon, Benoit] Univ Paris 06, UPMC, UMR 7211, Immunol Immunopathol Immunotherapy I3, F-75005 Paris, France; [Klatzmann, David] CNRS, UMR 7211, Immunol Immunopathol Immunotherapy I3, Paris, France; [Klatzmann, David; Salomon, Benoit] INSERM, UMR S 959, Immunol Immunopathol Immunotherapy I3, F-75005 Paris, France; [Allenbach, Yves; Klatzmann, David; Benveniste, Olivier] Hop La Pitie Salpetriere, AP HP, Biotherapy CIC BTi, F-75651 Paris, France; [Allenbach, Yves; Klatzmann, David; Benveniste, Olivier] Inflammat Immunopathol Biotherapy Dept I2B, F-75651 Paris, France	UDICE-French Research Universities; Sorbonne Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite	Prevel, N (corresponding author), Univ Paris 06, UPMC, UMR 7211, Immunol Immunopathol Immunotherapy I3, F-75005 Paris, France.	nicolasprevel@gmail.com	Salomon, Benoit/AAP-5209-2021; Salomon, Benoit L/M-2421-2017	Salomon, Benoit/0000-0001-9673-5578; Salomon, Benoit L/0000-0001-9673-5578; Klatzmann, David/0000-0002-0054-3422; Allenbach, Yves/0000-0002-3185-7993	Association Francaise contre les Myopathies	Association Francaise contre les Myopathies(Association Francaise contre les Myopathies)	This project was sponsored by the grants from the Association Francaise contre les Myopathies to A. F. M. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allenbach Y, 2009, AM J PATHOL, V174, P989, DOI 10.2353/ajpath.2009.080422; Banica L, 2009, AUTOIMMUNITY, V42, P41, DOI 10.1080/08916930802282651; BANKER BQ, 1975, J NEUROPATH EXP NEUR, V34, P46, DOI 10.1097/00005072-197501000-00005; Battaglia M, 2006, DIABETES, V55, P1571, DOI 10.2337/db05-1576; Bromley SK, 2005, NAT IMMUNOL, V6, P895, DOI 10.1038/ni1240; Cejka D, 2010, ARTHRITIS RHEUM-US, V62, P2294, DOI 10.1002/art.27504; Chi H, 2012, NAT REV IMMUNOL, V12, P325, DOI 10.1038/nri3198; Contet C, 2001, BEHAV BRAIN RES, V124, P33, DOI 10.1016/S0166-4328(01)00231-5; Dalakas MC, 2012, AUTOIMMUN REV, V11, P203, DOI 10.1016/j.autrev.2011.05.013; Darasse-Jeze G, 2006, IMMUNOL LETT, V102, P106, DOI 10.1016/j.imlet.2005.07.002; Debes GF, 2005, NAT IMMUNOL, V6, P889, DOI 10.1038/ni1238; Donia M, 2009, J AUTOIMMUN, V33, P135, DOI 10.1016/j.jaut.2009.06.003; Esposito M, 2010, J NEUROIMMUNOL, V220, P52, DOI 10.1016/j.jneuroim.2010.01.001; Fontenot JD, 2017, J IMMUNOL, V198, P986, DOI 10.1038/ni904; Frey O, 2005, ARTHRITIS RES THER, V7, pR291, DOI 10.1186/ar1484; Gambineri E, 2003, CURR OPIN RHEUMATOL, V15, P430, DOI 10.1097/00002281-200307000-00010; Hori S, 2003, SCIENCE, V299, P1057, DOI 10.1126/science.1079490; Hsu WT, 2006, CLIN EXP IMMUNOL, V145, P513, DOI 10.1111/j.1365-2249.2006.03173.x; Kaposztas Z, 2008, TRANSPL P, V40, P1744, DOI [10.1016/j.transproceed.2007.11.072, 10.1016/j.transproceed.2008.10.019]; Kojima T, 1997, J NEUROL SCI, V151, P141, DOI 10.1016/S0022-510X(97)00148-2; Kurobe H, 2006, IMMUNITY, V24, P165, DOI 10.1016/j.immuni.2005.12.011; Lisi L, 2012, J NEUROIMMUNOL, V243, P43, DOI 10.1016/j.jneuroim.2011.12.018; Nadiminti U, 2005, J AM ACAD DERMATOL, V52, pS17, DOI 10.1016/j.jaad.2004.05.044; Roncarolo MG, 2011, IMMUNOL REV, V241, P145, DOI 10.1111/j.1600-065X.2011.01010.x; Saunders RN, 2001, KIDNEY INT, V59, P3, DOI 10.1046/j.1523-1755.2001.00460.x; Scalapino KJ, 2006, J IMMUNOL, V177, P1451, DOI 10.4049/jimmunol.177.3.1451; Sebzda E, 2008, NAT IMMUNOL, V9, P292, DOI 10.1038/ni1565; Sinclair LV, 2008, NAT IMMUNOL, V9, P513, DOI 10.1038/ni.1603; Terrada C, 2006, J IMMUNOL, V176, P7171, DOI 10.4049/jimmunol.176.12.7171; Thomson AW, 2009, NAT REV IMMUNOL, V9, P324, DOI 10.1038/nri2546; Troyanov Y, 2005, MEDICINE, V84, P231, DOI 10.1097/01.md.0000173991.74008.b0; van der Meulen MFG, 2003, NEUROLOGY, V61, P316, DOI 10.1212/WNL.61.3.316; Viola A, 2008, FRONT BIOSCI, V13, P6341, DOI 10.2741/3158; Weinreich MA, 2009, IMMUNITY, V31, P122, DOI 10.1016/j.immuni.2009.05.011	35	22	24	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e74450	10.1371/journal.pone.0074450	http://dx.doi.org/10.1371/journal.pone.0074450			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265670	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100002
J	Zarrinpashneh, E; Poggioli, T; Sarathchandra, P; Lexow, J; Monassier, L; Terracciano, C; Lang, F; Damilano, F; Zhou, JQ; Rosenzweig, A; Rosenthal, N; Santini, MP				Zarrinpashneh, Elham; Poggioli, Tommaso; Sarathchandra, Padmini; Lexow, Jonas; Monassier, Laurent; Terracciano, Cesare; Lang, Florian; Damilano, Federico; Zhou, Jessica Q.; Rosenzweig, Anthony; Rosenthal, Nadia; Santini, Maria Paola			Ablation of SGK1 Impairs Endothelial Cell Migration and Tube Formation Leading to Decreased Neo-Angiogenesis Following Myocardial Infarction	PLOS ONE			English	Article							KAPPA-B ACTIVATION; BRUTONS TYROSINE KINASE; SERUM; FAMILY; GROWTH; CANCER; METASTASIS; MECHANISMS; EXPRESSION; LETHALITY	Serum and glucocorticoid inducible kinase 1 (SGK1) plays a pivotal role in early angiogenesis during embryonic development. In this study, we sought to define the SGK1 downstream signalling pathways in the adult heart and to elucidate their role in cardiac neo-angiogenesis and wound healing after myocardial ischemia. To this end, we employed a viable SGK1 knockout mouse model generated in a 129/SvJ background. Ablation of SGK1 in these mice caused a significant decrease in phosphorylation of SGK1 target protein NDRG1, which correlated with alterations in NF-kappa B signalling and expression of its downstream target protein, VEGF-A. Disruption of these signalling pathways was accompanied by smaller heart and body size. Moreover, the lack of SGK1 led to defective endothelial cell (ECs) migration and tube formation in vitro, and increased scarring with decreased angiogenesis in vivo after myocardial infarct. This study underscores the importance of SGK1 signalling in cardiac neo-angiogenesis and wound healing after an ischemic insult in vivo.	[Zarrinpashneh, Elham; Poggioli, Tommaso; Sarathchandra, Padmini; Lexow, Jonas; Terracciano, Cesare; Rosenthal, Nadia; Santini, Maria Paola] Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, Harefield, Middx, England; [Monassier, Laurent] Lab Neurobiol & Pharmacol Cardiovasc, Strasbourg, France; [Lang, Florian] Univ Tubingen, Inst Physiol, Tubingen, Germany; [Damilano, Federico; Zhou, Jessica Q.; Rosenzweig, Anthony] Beth Israel Deaconess Med Ctr, Div Cardiovasc, Boston, MA 02215 USA; [Damilano, Federico; Zhou, Jessica Q.; Rosenzweig, Anthony] Harvard Univ, Sch Med, Boston, MA USA; [Rosenthal, Nadia] Monash Univ, Australian Regenerat Med Inst, European Mol Biol Lab Australia, Melbourne, Vic 3004, Australia	Imperial College London; Eberhard Karls University of Tubingen; Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; Australian Regenerative Medicine Institute; European Molecular Biology Laboratory (EMBL); Monash University	Zarrinpashneh, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, Natl Heart & Lung Inst, Heart Sci Ctr, Harefield, Middx, England.	e.zarrinpashneh@imperial.ac.uk; m.santini@imperial.ac.uk	Santini, Maria Paola/AGU-9223-2022; Rosenthal, Nadia/O-7009-2015; Rosenzweig, Anthony/AAD-7893-2019	Santini, Maria Paola/0000-0002-9404-2185; Rosenthal, Nadia/0000-0002-7599-7365	Imperial College London; British Heart Foundation [PG/08/111, PG/09/10]; BHF; MYI; British Heart Foundation [PG/08/111/26226] Funding Source: researchfish	Imperial College London(General Electric); British Heart Foundation(British Heart Foundation); BHF(British Heart Foundation); MYI; British Heart Foundation(British Heart Foundation)	This study was supported by Principal Investigator Funding, Imperial College London (NR), British Heart Foundation Project Grants PG/08/111 supporting EZ and NR and PG/09/10 supporting MPS and TP. TP is a BHF Centre of Research Excellence, fellow. NR is a NHMRC Australia Fellow. MPS is spported by BHF and MYI. (As required by the Journal, the acronym MYI in the financial disclosure means Magdi Yacoub Institute.) The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2005, CIRCULATION, V111, P1652, DOI 10.1161/01.CIR.0000160352.58142.06; Bandyopadhyay S, 2003, CANCER RES, V63, P1731; Bonizzi G, 2004, TRENDS IMMUNOL, V25, P280, DOI 10.1016/j.it.2004.03.008; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Carmeliet P, 2011, NATURE, V473, P298, DOI 10.1038/nature10144; Catela C, 2010, DEV DYNAM, V239, P2149, DOI 10.1002/dvdy.22345; Dordevic G, 2008, CROAT MED J, V49, P608, DOI 10.3325/cmj.2008.5.608; Doyle SL, 2005, J BIOL CHEM, V280, P23496, DOI 10.1074/jbc.C500053200; Feucht M, 1997, AM J PATHOL, V151, P1407; Fu JY, 2007, MOL CANCER RES, V5, P1, DOI 10.1158/1541-7786.MCR-06-0208; Hosoi F, 2009, CANCER RES, V69, P4983, DOI 10.1158/0008-5472.CAN-08-4882; Ibrahim M, 2010, FASEB J, V24, P3321, DOI 10.1096/fj.10-156638; Kanda S, 2004, J BIOL CHEM, V279, P4007, DOI 10.1074/jbc.M307569200; Karam H, 1996, AM J HYPERTENS, V9, P991, DOI 10.1016/0895-7061(96)00119-7; Kovacevic Z, 2006, CARCINOGENESIS, V27, P2355, DOI 10.1093/carcin/bgl146; Lara-Pezzi E, 2007, J CELL BIOL, V179, P1205, DOI 10.1083/jcb.200704179; Lolli G, 2004, STRUCTURE, V12, P2067, DOI 10.1016/j.str.2004.08.013; Miquerol L, 2000, DEVELOPMENT, V127, P3941; Murakami Y, 2010, BIOCHEM BIOPH RES CO, V396, P376, DOI 10.1016/j.bbrc.2010.04.100; Murray JT, 2004, BIOCHEM J, V384, P477, DOI 10.1042/BJ20041057; Nowak DG, 2010, J BIOL CHEM, V285, P5532, DOI 10.1074/jbc.M109.074930; Park J, 1999, EMBO J, V18, P3024, DOI 10.1093/emboj/18.11.3024; Peterson QP, 2009, J MOL BIOL, V388, P144, DOI 10.1016/j.jmb.2009.03.003; ROHAN PJ, 1993, SCIENCE, V259, P1763, DOI 10.1126/science.7681221; Sakamoto K, 2006, AM J PHYSIOL-ENDOC M, V290, pE780, DOI 10.1152/ajpendo.00443.2005; Santini MP, 2007, CIRC RES, V100, P1732, DOI 10.1161/CIRCRESAHA.107.148791; Schmidt EM, 2012, FEBS J, V279, P1231, DOI 10.1111/j.1742-4658.2012.08515.x; Shinners NP, 2007, J IMMUNOL, V179, P3872, DOI 10.4049/jimmunol.179.6.3872; Siedlecka U, 2008, AM J PHYSIOL-HEART C, V295, pH1917, DOI 10.1152/ajpheart.00258.2008; Tessier M, 2006, J CELL BIOCHEM, V98, P1391, DOI 10.1002/jcb.20894; Vallon V, 2006, J MOL MED, V84, P396, DOI 10.1007/s00109-005-0027-z; WEBSTER MK, 1993, MOL CELL BIOL, V13, P2031, DOI 10.1128/MCB.13.4.2031; Wulff P, 2002, J CLIN INVEST, V110, P1263, DOI 10.1172/JCI200215696; Yang M, 2012, ARTERIOSCLER THROMB; Zimmerman D, 2012, CLIN SCI, V123, P333, DOI 10.1042/CS20120111	36	28	28	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80268	10.1371/journal.pone.0080268	http://dx.doi.org/10.1371/journal.pone.0080268			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265802	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100137
J	Ferrara, TL; Boughton, P; Slavich, E; Wroe, S				Ferrara, Toni L.; Boughton, Philip; Slavich, Eve; Wroe, Stephen			A Novel Method for Single Sample Multi-Axial Nanoindentation of Hydrated Heterogeneous Tissues Based on Testing Great White Shark Jaws	PLOS ONE			English	Article							SOFT BIOLOGICAL TISSUES; MECHANICAL-PROPERTIES; VISCOELASTIC PROPERTIES; VERTEBRAL CARTILAGE; ARTICULAR-CARTILAGE; ELASTIC-MODULI; BONE; INDENTATION; BEHAVIOR; ELASMOBRANCH	Nanomechanical testing methods that are suitable for a range of hydrated tissues are crucial for understanding biological systems. Nanoindentation of tissues can provide valuable insights into biology, tissue engineering and biomimetic design. However, testing hydrated biological samples still remains a significant challenge. Shark jaw cartilage is an ideal substrate for developing a method to test hydrated tissues because it is a unique heterogeneous composite of both mineralized (hard) and non-mineralized (soft) layers and possesses a jaw geometry that is challenging to test mechanically. The aim of this study is to develop a novel method for obtaining multidirectional nanomechanical properties for both layers of jaw cartilage from a single sample, taken from the great white shark (Carcharodon carcharias). A method for obtaining multidirectional data from a single sample is necessary for examining tissue mechanics in this shark because it is a protected species and hence samples may be difficult to obtain. Results show that this method maintains hydration of samples that would otherwise rapidly dehydrate. Our study is the first analysis of nanomechanical properties of great white shark jaw cartilage. Variation in nanomechanical properties were detected in different orthogonal directions for both layers of jaw cartilage in this species. The data further suggest that the mineralized layer of shark jaw cartilage is less stiff than previously posited. Our method allows multidirectional nanomechanical properties to be obtained from a single, small, hydrated heterogeneous sample. Our technique is therefore suitable for use when specimens are rare, valuable or limited in quantity, such as samples obtained from endangered species or pathological tissues. We also outline a method for tip-to-optic calibration that facilitates nanoindentation of soft biological tissues. Our technique may help address the critical need for a nanomechanical testing method that is applicable to a variety of hydrated biological materials whether soft or hard.	[Ferrara, Toni L.; Slavich, Eve] Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia; [Boughton, Philip] Univ Sydney, AMME Sch, Sydney, NSW 2006, Australia; [Boughton, Philip] Univ New S Wales, Dept Orthopaed Surg, St George Clin Sch, Kogarah, NSW, Australia; [Wroe, Stephen] Univ New England, Div Zool, Sch Environm & Rural Sci, Armidale, NSW, Australia	University of New South Wales Sydney; University of Sydney; University of New South Wales Sydney; University of New England	Ferrara, TL (corresponding author), Univ New S Wales, Sch Biol Earth & Environm Sci, Evolut & Ecol Res Ctr, Sydney, NSW, Australia.	t.ferrara@unsw.edu.au	Boughton, Philip C/N-8359-2016	Boughton, Philip C/0000-0003-4318-8966; Wroe, Stephen/0000-0002-6365-5915	Australia and Pacific Science Foundation; Australian Research Council [DP0666374, DP0987985]; University of New South Wales Internal Strategic Initiatives Grants	Australia and Pacific Science Foundation; Australian Research Council(Australian Research Council); University of New South Wales Internal Strategic Initiatives Grants	This work was funded by the Australia and Pacific Science Foundation, Australian Research Council (DP0666374 and DP0987985), and the University of New South Wales Internal Strategic Initiatives Grants to S. W. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Angker L, 2005, J BIOMECH, V38, P1535, DOI 10.1016/j.jbiomech.2004.07.012; Balooch M, 1998, J BIOMED MATER RES, V40, P539, DOI 10.1002/(SICI)1097-4636(19980615)40:4<539::AID-JBM4>3.3.CO;2-O; Basser PJ, 1998, ARCH BIOCHEM BIOPHYS, V351, P207, DOI 10.1006/abbi.1997.0507; Bembey AK, 2006, PHILOS MAG, V86, P5691, DOI 10.1080/14786430600660864; Bembey AK, 2006, J MATER RES, V21, P1962, DOI 10.1557/JMR.2006.0237; Bushby AJ, 2004, J MATER RES, V19, P249, DOI 10.1557/jmr.2004.19.1.249; Chapman DD, 2003, CONSERV GENET, V4, P415, DOI 10.1023/A:1024771215616; Chen PY, 2008, J MECH BEHAV BIOMED, V1, P208, DOI 10.1016/j.jmbbm.2008.02.003; Cheng L, 2005, MECH MATER, V37, P213, DOI 10.1016/j.mechmat.2004.03.002; Cleasby IR, 2011, BEHAV ECOL SOCIOBIOL, V65, P2361, DOI 10.1007/s00265-011-1254-7; Currey JD, 2010, J MECH BEHAV BIOMED, V3, P357, DOI 10.1016/j.jmbbm.2010.03.002; Dean MN, 2010, J APPL ICHTHYOL, V26, P263, DOI 10.1111/j.1439-0426.2010.01417.x; Dean MN, 2006, ZOOLOGY, V109, P164, DOI 10.1016/j.zool.2006.03.002; Dean MN, 2008, MICROS TODAY, V16, P48; Ebenstein DM, 2004, J BIOMED MATER RES A, V69A, P222, DOI 10.1002/jbm.a.20096; Ebenstein DM, 2004, J MATER RES, V19, P273, DOI 10.1557/jmr.2004.19.1.273; Ebenstein DM, 2006, NANO TODAY, V1, P26, DOI 10.1016/S1748-0132(06)70077-9; Fahle SR, 2008, J FISH BIOL, V72, P1553, DOI 10.1111/j.1095-8649.2008.01826.x; Ferrara TL, 2011, J BIOMECH, V44, P430, DOI 10.1016/j.jbiomech.2010.09.028; FORSTER RP, 1972, COMP BIOCHEM PHYSIOL, V42, P3, DOI 10.1016/0300-9629(72)90359-3; Franke O, 2007, ACTA BIOMATER, V3, P873, DOI 10.1016/j.actbio.2007.04.005; Franke O, 2008, JOM-US, V60, P49, DOI 10.1007/s11837-008-0071-6; Han L, 2011, ANNU REV MATER RES, V41, P133, DOI 10.1146/annurev-matsci-062910-100431; Hengsberger S, 2002, BONE, V30, P178, DOI 10.1016/S8756-3282(01)00624-X; Hoffler CE, 2005, J BIOMECH ENG-T ASME, V127, P1046, DOI 10.1115/1.2073671; Hoffler CE, 2000, BONE, V26, P603, DOI 10.1016/S8756-3282(00)00268-4; Kaufman JD, 2009, J MECH BEHAV BIOMED, V2, P312, DOI 10.1016/j.jmbbm.2008.08.004; LYYRA T, 1995, MED ENG PHYS, V17, P395, DOI 10.1016/1350-4533(95)97322-G; Mann AB, 1996, LANGMUIR, V12, P4583, DOI 10.1021/la950901z; Mattice JM, 2006, J MATER RES, V21, P2003, DOI 10.1557/JMR.2006.0243; McKee CT, 2011, TISSUE ENG PART B-RE, V17, P155, DOI 10.1089/ten.teb.2010.0520; Mow V, 2002, ANNU REV BIOMED ENG, V4, P175, DOI 10.1146/annurev.bioeng.4.110701.120309; Olesiak SE, 2010, PALAEOGEOGR PALAEOCL, V289, P25, DOI 10.1016/j.palaeo.2010.02.006; OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564; Oyen ML, 2008, J MATER RES, V23, P1307, DOI 10.1557/JMR.2008.0156; Oyen ML, 2008, MRS BULL, V33, P49, DOI 10.1557/mrs2008.14; Oyen ML, 2011, EXPT TECHNIQUES, P1; Pinheiro J., 2011, NLME LINEAR NONLINEA; Porter ME, 2007, J EXP BIOL, V210, P3319, DOI 10.1242/jeb.006189; Porter ME, 2006, J EXP BIOL, V209, P2920, DOI 10.1242/jeb.02325; Porter ME, 2010, J MORPHOL, V271, P366, DOI [10.1002/jmor.0803, 10.1002/jmor.10803]; R Development Core Team, 2013, R: A Language and Environment for Statistical Computing; Rho JY, 1999, J MATER SCI-MATER M, V10, P485, DOI 10.1023/A:1008901109705; Summers AP, 2006, FISH PHYSIOL, V23, P141, DOI 10.1016/S1546-5098(05)23005-4; Swadener JG, 2001, J BIOMED MATER RES, V57, P108, DOI 10.1002/1097-4636(200110)57:1<108::AID-JBM1148>3.0.CO;2-6; Wroe S, 2008, J ZOOL, V276, P336, DOI 10.1111/j.1469-7998.2008.00494.x	47	8	8	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81196	10.1371/journal.pone.0081196	http://dx.doi.org/10.1371/journal.pone.0081196			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260558	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900126
J	Webster, MT; Fan, CM				Webster, Micah T.; Fan, Chen-Ming			c-MET Regulates Myoblast Motility and Myocyte Fusion during Adult Skeletal Muscle Regeneration	PLOS ONE			English	Article							SATELLITE CELLS; N-WASP; MIGRATION; ACTIVATION; PROLIFERATION; EXPRESSION; MYOGENESIS; RECEPTOR; PATHWAY	Adult muscle stem cells, satellite cells (SCs), endow skeletal muscle with tremendous regenerative capacity. Upon injury, SCs activate, proliferate, and migrate as myoblasts to the injury site where they become myocytes that fuse to form new muscle. How migration is regulated, though, remains largely unknown. Additionally, how migration and fusion, which both require dynamic rearrangement of the cytoskeleton, might be related is not well understood. c-MET, a receptor tyrosine kinase, is required for myogenic precursor cell migration into the limb for muscle development during embryogenesis. Using a genetic system to eliminate c-MET function specifically in adult mouse SCs, we found that c-MET was required for muscle regeneration in response to acute muscle injury. c-MET mutant myoblasts were defective in lamellipodia formation, had shorter ranges of migration, and migrated slower compared to control myoblasts. Surprisingly, c-MET was also required for efficient myocyte fusion, implicating c-MET in dual functions of regulating myoblast migration and myocyte fusion.	[Webster, Micah T.; Fan, Chen-Ming] Carnegie Inst Sci, Dept Embryol, Baltimore, MD 21210 USA	Carnegie Institution for Science	Fan, CM (corresponding author), Carnegie Inst Sci, Dept Embryol, 115 W Univ Pkwy, Baltimore, MD 21210 USA.	fan@ciwemb.edu			Carnegie Institution; National Institutes of Health [AR060042, AR059685, AR060636, 1F32AR065366-01]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR065366, R01AR059685, R01AR060042, R01AR060636] Funding Source: NIH RePORTER	Carnegie Institution; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	The Carnegie Institution and National Institutes of Health (AR060042, AR059685, AR060636, 1F32AR065366-01) provided funding for this work. The funding sources had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN RE, 1995, J CELL PHYSIOL, V165, P307, DOI 10.1002/jcp.1041650211; Anastasi S, 1997, J CELL BIOL, V137, P1057, DOI 10.1083/jcb.137.5.1057; Anderson J, 2002, NITRIC OXIDE-BIOL CH, V7, P36, DOI 10.1016/S1089-8603(02)00011-3; Birchmeier C, 2003, NAT REV MOL CELL BIO, V4, P915, DOI 10.1038/nrm1261; BISCHOFF R, 1986, DEV BIOL, V115, P129, DOI 10.1016/0012-1606(86)90234-4; Bischoff R, 1997, DEV DYNAM, V208, P505, DOI 10.1002/(SICI)1097-0177(199704)208:4<505::AID-AJA6>3.0.CO;2-M; BLADT F, 1995, NATURE, V376, P768, DOI 10.1038/376768a0; Bondesen BA, 2007, FASEB J, V21, P3338, DOI 10.1096/fj.06-7070com; Borowiak M, 2004, P NATL ACAD SCI USA, V101, P10608, DOI 10.1073/pnas.0403412101; Chen EH, 2004, TRENDS CELL BIOL, V14, P452, DOI 10.1016/j.tcb.2004.07.008; Chmielowiec J, 2007, J CELL BIOL, V177, P151, DOI 10.1083/jcb.200701086; Cornelison DDW, 1997, DEV BIOL, V191, P270, DOI 10.1006/dbio.1997.8721; Crawley S, 1997, EXP CELL RES, V235, P274, DOI 10.1006/excr.1997.3671; Dietrich S, 1999, DEVELOPMENT, V126, P1621; DOWRICK PG, 1991, CYTOKINE, V3, P299, DOI 10.1016/1043-4666(91)90498-3; Floss T, 1997, GENE DEV, V11, P2040, DOI 10.1101/gad.11.16.2040; Gal-Levi R, 1998, BBA-MOL CELL RES, V1402, P39, DOI 10.1016/S0167-4889(97)00124-9; Gruenbaum-Cohen Y, 2012, P NATL ACAD SCI USA, V109, P11211, DOI 10.1073/pnas.1116065109; Huh CG, 2004, P NATL ACAD SCI USA, V101, P4477, DOI 10.1073/pnas.0306068101; Jansen Katie M., 2008, V475, P115, DOI 10.1007/978-1-59745-250-2_7; JOHNSON SE, 1993, J CELL PHYSIOL, V154, P39, DOI 10.1002/jcp.1041540106; Kastner S, 2000, J HISTOCHEM CYTOCHEM, V48, P1079, DOI 10.1177/002215540004800805; Kawamura K, 2004, J BIOL CHEM, V279, P54862, DOI 10.1074/jbc.M408057200; Lepper C, 2009, NATURE, V460, P627, DOI 10.1038/nature08209; Leshem Y, 2002, J CELL PHYSIOL, V191, P173, DOI 10.1002/jcp.10089; Maina F, 1996, CELL, V87, P531, DOI 10.1016/S0092-8674(00)81372-0; Miller KJ, 2000, AM J PHYSIOL-CELL PH, V278, pC174, DOI 10.1152/ajpcell.2000.278.1.C174; Mourikis P, 2012, STEM CELLS, V30, P243, DOI 10.1002/stem.775; Murphy MM, 2011, DEVELOPMENT, V138, P3625, DOI 10.1242/dev.064162; Mylona E, 2006, J CELL PHYSIOL, V209, P314, DOI 10.1002/jcp.20724; Organ Shawna Leslie, 2011, Ther Adv Med Oncol, V3, pS7, DOI 10.1177/1758834011422556; Peters S, 2012, NAT REV CLIN ONCOL, V9, P314, DOI 10.1038/nrclinonc.2012.71; POWELL JA, 1973, EXP CELL RES, V80, P251, DOI 10.1016/0014-4827(73)90295-4; RIDLEY AJ, 1995, MOL CELL BIOL, V15, P1110; Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7; Shen XY, 2012, P NATL ACAD SCI USA, V109, P14464, DOI 10.1073/pnas.1211877109; Sisson TH, 2009, BLOOD, V114, P5052, DOI 10.1182/blood-2008-12-196212; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Srinivas S, 2001, BMC Dev Biol, V1, P4, DOI 10.1186/1471-213X-1-4; Tatsumi R, 1998, DEV BIOL, V194, P114, DOI 10.1006/dbio.1997.8803; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Vicente-Manzanares M, 2009, J CELL SCI, V122, P1473, DOI 10.1242/jcs.052894; Wang J, 1996, SCIENCE, V273, P359, DOI 10.1126/science.273.5273.359; Wozniak AC, 2007, DEV DYNAM, V236, P240, DOI 10.1002/dvdy.21012; YABLONKAREUVENI Z, 1994, DEV BIOL, V164, P588, DOI 10.1006/dbio.1994.1226; Zammit PS, 2004, J CELL BIOL, V166, P347, DOI 10.1083/jcb.200312007	46	47	48	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81757	10.1371/journal.pone.0081757	http://dx.doi.org/10.1371/journal.pone.0081757			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260586	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900134
J	Abuelmaali, SA; Elaagip, AH; Basheer, MA; Frah, EA; Ahmed, FTA; Elhaj, HFA; Seidahmed, OME; Weetman, D; Hamid, MMA				Abuelmaali, Sara A.; Elaagip, Arwa H.; Basheer, Mohammed A.; Frah, Ehab A.; Ahmed, Fayez T. A.; Elhaj, Hassabelrasoul F. A.; Seidahmed, Osama M. E.; Weetman, David; Hamid, Muzamil Mahdi Abdel			Impacts of Agricultural Practices on Insecticide Resistance in the Malaria Vector Anopheles arabiensis in Khartoum State, Sudan	PLOS ONE			English	Article							KDR MUTATION; GAMBIAE COMPLEX; NATURAL-POPULATIONS; DIPTERA-CULICIDAE; DDT RESISTANCE; BURKINA-FASO; URBAN; PERMETHRIN; SUSCEPTIBILITY; IDENTIFICATION	Background: Agricultural pesticides may play a profound role in selection of resistance in field populations of mosquito vectors. The objective of this study is to investigate possible links between agricultural pesticide use and development of resistance to insecticides by the major malaria vector Anopheles arabiensis in northern Sudan. Methodology/Principal Findings: Entomological surveys were conducted during two agricultural seasons in six urban and peri-urban sites in Khartoum state. Agro-sociological data were collected from 240 farmers subjected to semi-structured questionnaires based on knowledge attitude and practice (KAP) surveys. Susceptibility status of An. arabiensis (n=6000) was assessed in all sites and during each season using WHO bioassay tests to DDT, deltamethrin, permethrin, Malathion and bendiocarb. KAP analysis revealed that pesticide application was common practice among both urban and peri-urban farmers, with organophosphates and carbamates most commonly used. Selection for resistance is likely to be greater in peri-urban sites where farmers apply pesticide more frequently and are less likely to dispose of surpluses correctly. Though variable among insecticides and seasons, broad-spectrum mortality was slightly, but significantly higher in urban than peri-urban sites and most marked for bendiocarb, to which susceptibility was lowest. Anopheles arabiensis from all sites showed evidence of resistance or suspected resistance, especially pyrethroids. However, low-moderate frequencies of the L1014F kdr allele in all sites, which was very strongly associated with DDT, permethrin and deltamethrin survivorship (OR=6.14-14.67) suggests that resistance could increase rapidly. Conclusions: Ubiquitous multiple-resistance coupled with presence of a clear mechanism for DDT and pyrethroids (kdr L1014F) in populations of An. arabiensis from Khartoum-Sudan suggests careful insecticide management is essential to prolong efficacy. Our findings are consistent with agricultural insecticide use as a source of selection for resistance and argue for coordination between the integrated vector control program and the Ministry of Agriculture to permit successful implementation of rational resistance management strategies.	[Abuelmaali, Sara A.; Ahmed, Fayez T. A.; Elhaj, Hassabelrasoul F. A.; Seidahmed, Osama M. E.] Fed Minist Hlth, Dept Med Entomol, Natl Publ Hlth Lab, Khartoum, Sudan; [Elaagip, Arwa H.] Univ Khartoum, Fac Med Lab Sci, Dept Parasitol & Med Entomol, Khartoum, Sudan; [Basheer, Mohammed A.; Frah, Ehab A.] Natl Res Ctr, Res Inst Trop Med, Khartoum, Sudan; [Weetman, David] Univ Liverpool, Liverpool Sch Trop Med, Dept Vector Biol, Liverpool L3 5QA, Merseyside, England; [Hamid, Muzamil Mahdi Abdel] Univ Khartoum, Inst Endem Dis, Dept Mol Biol, Khartoum, Sudan	University of Khartoum; Liverpool School of Tropical Medicine; University of Liverpool; University of Khartoum	Abuelmaali, SA (corresponding author), Fed Minist Hlth, Dept Med Entomol, Natl Publ Hlth Lab, Khartoum, Sudan.	profsara83@gmail.com	Frah, Ehab Ahmed/D-5078-2013; Weetman, David/M-1261-2014; Abdel Hamid, Muzamil Mahdi/E-7234-2019	Frah, Ehab Ahmed/0000-0002-4947-7374; Weetman, David/0000-0002-5820-1388; Abdel Hamid, Muzamil Mahdi/0000-0002-6157-4388	WHO TDR/EMRO [SGS 10/46]	WHO TDR/EMRO(World Health Organization)	This work received financial support from WHO TDR/EMRO small grants (ID No. SGS 10/46). The funders had no role in study design, data collection and analyses, decision to publish, or preparation of the manuscript.	Abdalla H, 2008, T ROY SOC TROP MED H, V102, P263, DOI 10.1016/j.trstmh.2007.10.008; Akogbeto MC, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-204; Antonio-Nkondjio C, 2011, MALARIA J, V10, DOI 10.1186/1475-2875-10-154; Balkew M, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-40; Chandre F, 1999, B WORLD HEALTH ORGAN, V77, P230; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Diabate A, 2004, TROP MED INT HEALTH, V9, P1267, DOI 10.1111/j.1365-3156.2004.01336.x; Diabate A, 2004, J AM MOSQUITO CONTR, V20, P195; Diabate A, 2002, AM J TROP MED HYG, V67, P617, DOI 10.4269/ajtmh.2002.67.617; Donnelly MJ, 2009, TRENDS PARASITOL, V25, P213, DOI 10.1016/j.pt.2009.02.007; Elkhalifa S. M., 2008, Eastern Mediterranean Health Journal, V14, P206; Fanello C, 2003, MED VET ENTOMOL, V17, P333, DOI 10.1046/j.1365-2915.2003.00450.x; Gillies MT, 1987, PUBLICATIONS S AFRIC, P55; Guillet P, 2001, MED VET ENTOMOL, V15, P105, DOI 10.1046/j.1365-2915.2001.00288.x; HEMINGWAY J, 1983, T ROY SOC TROP MED H, V77, P477, DOI 10.1016/0035-9203(83)90118-9; Himeidan YE, 2007, AM J TROP MED HYG, V77, P1066, DOI 10.4269/ajtmh.2007.77.1066; Himeidan YE, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-154; Kulkarni MA, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-56; Malik E M, 2003, East Mediterr Health J, V9, P559; Martinez-Torres D, 1998, INSECT MOL BIOL, V7, P179, DOI 10.1046/j.1365-2583.1998.72062.x; Matambo TS, 2007, MED VET ENTOMOL, V21, P97, DOI 10.1111/j.1365-2915.2007.00671.x; Matowo J, 2010, MALARIA J, V9, P1475; Muller P, 2008, MOL ECOL, V17, P1145, DOI 10.1111/j.1365-294X.2007.03617.x; Nourein AB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016948; Onwujekwe O, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-29; Petrarca V, 2000, MED VET ENTOMOL, V14, P149, DOI 10.1046/j.1365-2915.2000.00231.x; Ranson H, 2000, INSECT MOL BIOL, V9, P491, DOI 10.1046/j.1365-2583.2000.00209.x; Ranson H, 2011, TRENDS PARASITOL, V27, P91, DOI 10.1016/j.pt.2010.08.004; Ranson H, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-299; Reimer L, 2008, J MED ENTOMOL, V45, P260, DOI 10.1603/0022-2585(2008)45[260:RBKMAR]2.0.CO;2; Santolamazza F, 2008, AFRICA MALAR J, V7, P1475; SCOTT JA, 1993, AM J TROP MED HYG, V49, P520, DOI 10.4269/ajtmh.1993.49.520; Seidahmed O. M. E., 2012, Eastern Mediterranean Health Journal, V18, P769; [USAID] U.S. Agency for International Development, 2010, 4 USAID; WHO, 2012, WORLD MALARIA REPORT 2012, P1; WHO, 2010, WORLD MALARIA REPORT 2010, P1; WHO, 2013, TEST PROC INREMO, P18; Yadouleton AW, 2010, MALARIA J, V9, DOI 10.1186/1475-2875-9-83; Yadouleton AWM, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-103; Yewhalaw D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016066; Yewhalaw D, 2010, AM J TROP MED HYG, V83, P122, DOI 10.4269/ajtmh.2010.09-0738	41	32	34	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80549	10.1371/journal.pone.0080549	http://dx.doi.org/10.1371/journal.pone.0080549			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260414	Green Accepted, Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500152
J	Choi, JY; Gwon, YD; Kim, JK; Cho, YD; Heo, YK; Cho, HS; Choi, TJ; Poo, HR; Oh, YK; Kim, YB				Choi, Jae-Yoo; Gwon, Yong-Dae; Kim, Jeong-Ki; Cho, Yeon-Dong; Heo, Yoon-Ki; Cho, Han-Sam; Choi, Tae-Jin; Poo, Ha-Ryoung; Oh, Yu-Kyoung; Kim, Young Bong			Protective Efficacy of a Human Endogenous Retrovirus Envelope-Coated, Nonreplicable, Baculovirus-Based Hemagglutin Vaccine against Pandemic Influenza H1N1 2009	PLOS ONE			English	Article							DNA VACCINE; VIRUS HEMAGGLUTININ; A VIRUS; INSECT; GENE; EXPRESSION; CELLS; CHALLENGE; VECTOR; MICE	Despite the advantages of DNA vaccines, overcoming their lower efficacy relative to that of conventional vaccines remains a challenge. Here, we constructed a human endogenous retrovirus (HERV) envelope-coated, nonreplicable, baculovirus-based HA vaccine against swine influenza A/California/04/2009(H1N1) hemagglutin (HA) (AcHERV-sH1N1-HA) as an alternative to conventional vaccines and evaluated its efficacy in two strains of mice, BALB/c and C57BL/6. A commercially available, killed virus vaccine was used as a positive control. Mice were intramuscularly administered AcHERV-sH1N1-HA or the commercial vaccine and subsequently given two booster injections. Compared with the commercial vaccine, AcHERV-sH1N1-HA induced significantly higher levels of cellular immune responses in both BALB/c and C57BL/6 mice. Unlike cellular immune responses, humoral immune responses depended on the strain of mice. Following immunization with AcHERV-sH1N1-HA, C57BL/6 mice showed HA-specific IgG titers 10- to 100-fold lower than those of BALB/c mice. In line with the different levels of humoral immune responses, the survival of immunized mice after intranasal challenge with sH1N1 virus (A/California/04/2009) depended on the strain. After challenge with 10-times the median lethal dose (MLD50) of sH1N1 virus, 100% of BALB/c mice immunized with the commercial vaccine or AcHERV-sH1N1-HA survived. In contrast, C57BL/6 mice immunized with AcHERV-sH1N1-HA or the commercial vaccine showed 60% and 70% survival respectively, after challenge with sH1N1 virus. In all mice, virus titers and results of histological analyses of lung tissues were consistent with the survival data. Our results indicate the importance of humoral immune response as a major defense system against influenza viral infection. Moreover, the complete survival of BALB/c mice immunized with AcHERV-sH1N1-HA after challenge with sH1N1 virus suggests the potential of baculoviral vector-based vaccines to achieve an efficacy comparable to that of killed virus vaccines.	[Choi, Jae-Yoo; Gwon, Yong-Dae; Cho, Yeon-Dong; Heo, Yoon-Ki; Cho, Han-Sam; Kim, Young Bong] Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea; [Kim, Jeong-Ki; Poo, Ha-Ryoung] KRIBB, Syst Prote Res Ctr, Taejon, South Korea; [Choi, Tae-Jin] Pukyong Natl Univ, Dept Microbiol, Pusan, South Korea; [Oh, Yu-Kyoung] Seoul Natl Univ, Coll Pharm, Seoul, South Korea	Konkuk University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Pukyong National University; Seoul National University (SNU)	Kim, YB (corresponding author), Konkuk Univ, Dept Anim Biotechnol, Seoul, South Korea.	kimera@konkuk.ac.kr	Oh, Yu Kyoung/G-8754-2013	Oh, Yu-Kyoung/0000-0002-0969-3339; Gwon, Yong-Dae/0000-0002-0703-4188	Korea Research Council of Fundamental Science Technology; KRIBB Initiative program [NTM1311322]; iPET from Ministry of Agriculture, Food and Rural Affairs [112157-03-1-SB020, 112138-03-1-SB030, 110082-03-2-SD010]; Konkuk University (Center for Glocal Disease Control)	Korea Research Council of Fundamental Science Technology; KRIBB Initiative program; iPET from Ministry of Agriculture, Food and Rural Affairs; Konkuk University (Center for Glocal Disease Control)	This research was supported by Top Brand Project grant from Korea Research Council of Fundamental Science & Technology and KRIBB Initiative program (NTM1311322), by iPET from Ministry of Agriculture, Food and Rural Affairs (112157-03-1-SB020, 112138-03-1-SB030, and 110082-03-2-SD010), by Konkuk University (Center for Glocal Disease Control). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arias CF, 2009, ARCH MED RES, V40, P643, DOI 10.1016/j.arcmed.2009.10.007; Audsley JM, 2008, DRUGS, V68, P1483, DOI 10.2165/00003495-200868110-00002; Bouvier NM, 2010, VIRUSES-BASEL, V2, P1530, DOI 10.3390/v20801530; Chang HY, 2010, VIROL J, V7, DOI 10.1186/1743-422X-7-197; Chen CY, 2011, BIOTECHNOL ADV, V29, P618, DOI 10.1016/j.biotechadv.2011.04.004; Cho HJ, 2012, PHARM RES-DORDR, V29, P585, DOI 10.1007/s11095-011-0598-z; DePolo NJ, 2000, MOL THER, V2, P218, DOI 10.1006/mthe.2000.0116; Du LY, 2010, MICROBES INFECT, V12, P280, DOI 10.1016/j.micinf.2010.01.001; Ehrhardt C, 2010, MICROBES INFECT, V12, P81, DOI 10.1016/j.micinf.2009.09.007; Fouchier RAM, 2005, J VIROL, V79, P2814, DOI 10.1128/JVI.79.5.2814-2822.2005; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Gao H, 2007, J BIOTECHNOL, V131, P138, DOI 10.1016/j.jbiotec.2007.06.002; Ghosh S, 2002, MOL THER, V6, P5, DOI 10.1006/mthe.2000.0643; Glenting J, 2005, MICROB CELL FACT, V4, DOI 10.1186/1475-2859-4-26; HOFMANN C, 1995, P NATL ACAD SCI USA, V92, P10099, DOI 10.1073/pnas.92.22.10099; Huang CY, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033657; Jiang Y, 2007, ANTIVIR RES, V75, P234, DOI 10.1016/j.antiviral.2007.03.009; Khurana S, 2011, J VIROL, V85, P10945, DOI 10.1128/JVI.05406-11; Kost TA, 2005, NAT BIOTECHNOL, V23, P567, DOI 10.1038/nbt1095; Lee HJ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050296; Lee HJ, 2010, VACCINE, V28, P1613, DOI 10.1016/j.vaccine.2009.11.044; Liu FX, 2012, RES VET SCI, V93, P553, DOI 10.1016/j.rvsc.2011.10.018; Liu MA, 2011, IMMUNOL REV, V239, P62, DOI 10.1111/j.1600-065X.2010.00980.x; Liu T, 2002, INFECT IMMUN, V70, P6638, DOI 10.1128/IAI.70.12.6638-6645.2002; Matos I, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0067453; McPherson CE, 2008, BIOLOGICALS, V36, P350, DOI 10.1016/j.biologicals.2008.08.001; Musthaq SS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026428; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ory DS, 1996, P NATL ACAD SCI USA, V93, P11400, DOI 10.1073/pnas.93.21.11400; Pulendran B, 1999, P NATL ACAD SCI USA, V96, P1036, DOI 10.1073/pnas.96.3.1036; Smagghe G, 2009, IN VITRO CELL DEV-AN, V45, P93, DOI 10.1007/s11626-009-9181-x; Tong SX, 2012, P NATL ACAD SCI USA, V109, P4269, DOI 10.1073/pnas.1116200109; Wu QF, 2009, MOL IMMUNOL, V46, P2210, DOI 10.1016/j.molimm.2009.04.017	33	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80762	10.1371/journal.pone.0080762	http://dx.doi.org/10.1371/journal.pone.0080762			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260476	gold, Green Published, Green Submitted			2022-12-25	WOS:000327308500173
J	Gurney, GG; Melbourne-Thomas, J; Geronimo, RC; Alino, PM; Johnson, CR				Gurney, Georgina G.; Melbourne-Thomas, Jessica; Geronimo, Rollan C.; Alino, Perry M.; Johnson, Craig R.			Modelling Coral Reef Futures to Inform Management: Can Reducing Local-Scale Stressors Conserve Reefs under Climate Change?	PLOS ONE			English	Article							GREAT-BARRIER-REEF; INTEGRATED COASTAL MANAGEMENT; LIMITED GROWTH; HUMAN IMPACTS; GLOVERS REEF; RESILIENCE; SIMULATION; COMMUNITY; PHOSPHORUS; INTENSITY	Climate change has emerged as a principal threat to coral reefs, and is expected to exacerbate coral reef degradation caused by more localised stressors. Management of local stressors is widely advocated to bolster coral reef resilience, but the extent to which management of local stressors might affect future trajectories of reef state remains unclear. This is in part because of limited understanding of the cumulative impact of multiple stressors. Models are ideal tools to aid understanding of future reef state under alternative management and climatic scenarios, but to date few have been sufficiently developed to be useful as decision support tools for local management of coral reefs subject to multiple stressors. We used a simulation model of coral reefs to investigate the extent to which the management of local stressors (namely poor water quality and fishing) might influence future reef state under varying climatic scenarios relating to coral bleaching. We parameterised the model for Bolinao, the Philippines, and explored how simulation modelling can be used to provide decision support for local management. We found that management of water quality, and to a lesser extent fishing, can have a significant impact on future reef state, including coral recovery following bleaching-induced mortality. The stressors we examined interacted antagonistically to affect reef state, highlighting the importance of considering the combined impact of multiple stressors rather than considering them individually. Further, by providing explicit guidance for management of Bolinao's reef system, such as which course of management action will most likely to be effective over what time scales and at which sites, we demonstrated the utility of simulation models for supporting management. Aside from providing explicit guidance for management of Bolinao's reef system, our study offers insights which could inform reef management more broadly, as well as general understanding of reef systems.	[Gurney, Georgina G.] James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia; [Gurney, Georgina G.] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Melbourne-Thomas, Jessica] Dept Sustainabil Environm Water Populat & Communi, Australian Antarctic Div, Kingston, Tas, Australia; [Melbourne-Thomas, Jessica] Univ Tasmania, Antarctic Climate & Ecosyst Cooperat Res Ctr, Hobart, Tas, Australia; [Geronimo, Rollan C.] Conservat Int Philippines, Quezon City, Philippines; [Alino, Perry M.] Univ Philippines, Inst Marine Sci, Quezon City 1101, Philippines; [Johnson, Craig R.] Univ Tasmania, Inst Marine & Antarctic Studies, Hobart, Tas, Australia	James Cook University; University of Tasmania; Australian Antarctic Division; Antarctic Climate & Ecosystems Cooperative Research Centre (ACE CRC); University of Tasmania; University of the Philippines System; University of the Philippines Diliman; University of Tasmania	Gurney, GG (corresponding author), James Cook Univ, Australian Res Council Ctr Excellence Coral Reef, Townsville, Qld 4811, Australia.	georgina.gurney@gmail.com	Johnson, Craig R/E-1788-2013; Gurney, Georgina/X-9336-2019; Melbourne-Thomas, Jess/N-2437-2019; Gurney, Georgina/E-1782-2017	Johnson, Craig R/0000-0002-9511-905X; Gurney, Georgina/0000-0002-4884-7468; Melbourne-Thomas, Jess/0000-0001-6585-876X; 	Modelling and Decision (MDS) working group of the Coral Reef Targeted Research and Capacity Building for Management Program (CRTR-CBMP)	Modelling and Decision (MDS) working group of the Coral Reef Targeted Research and Capacity Building for Management Program (CRTR-CBMP)	This work was supported by the Modelling and Decision (MDS) working group of the Coral Reef Targeted Research and Capacity Building for Management Program (CRTR-CBMP). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adjeroud M, 2009, CORAL REEFS, V28, P775, DOI 10.1007/s00338-009-0515-7; Alino P, 1993, ICLARM C P; Anderson M.J., 2008, PERMANOVA PRIMER GUI; Anderson MJ, 2006, BIOMETRICS, V62, P245, DOI 10.1111/j.1541-0420.2005.00440.x; Anthony KRN, 2008, P NATL ACAD SCI USA, V105, P17442, DOI 10.1073/pnas.0804478105; Arceo HO, 2001, B MAR SCI, V69, P579; Ascough JC, 2008, ECOL MODEL, V219, P383, DOI 10.1016/j.ecolmodel.2008.07.015; Babcock R., 2000, P 9 INT COR REEF S; Baker AC, 2004, NATURE, V430, P741, DOI 10.1038/430741a; Baker AC, 2008, ESTUAR COAST SHELF S, V80, P435, DOI 10.1016/j.ecss.2008.09.003; Ball I. R., 2009, SPATIAL CONSERVATION, P185, DOI DOI 10.1111/EVA.12631; Bell PRF, 2007, AMBIO, V36, P416, DOI 10.1579/0044-7447(2007)36[416:ROESFT]2.0.CO;2; Bellwood DR, 2004, NATURE, V429, P827, DOI 10.1038/nature02691; Birrell CL, 2005, MAR POLLUT BULL, V51, P408, DOI 10.1016/j.marpolbul.2004.10.022; Blackwood JC, 2011, ECOL APPL, V21, P2722, DOI 10.1890/10-2195.1; Breitburg D., 2005, MARINE CONSERVATION, P416; Burke L, 2012, REEFS RISK REVISITED; Burke L., 2011, REEFS RISK REVISITED; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Carilli JE, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006324; Carpenter SR, 2002, ECOLOGY, V83, P2069, DOI 10.2307/3072038; Castillo D, 2005, ECOL ECON, V55, P420, DOI 10.1016/j.ecolecon.2004.12.014; Cesar H., 2001, CORAL BLEACHING CAUS; CLARKE KR, 1993, AUST J ECOL, V18, P117, DOI 10.1111/j.1442-9993.1993.tb00438.x; Coreau A, 2009, ECOL LETT, V12, P1277, DOI 10.1111/j.1461-0248.2009.01392.x; CORTES J, 1985, B MAR SCI, V36, P339; Crain CM, 2009, ANN NY ACAD SCI, V1162, P39, DOI 10.1111/j.1749-6632.2009.04496.x; Crain CM, 2008, ECOL LETT, V11, P1304, DOI 10.1111/j.1461-0248.2008.01253.x; Cruz-Trinidad A, 2011, OCEAN COAST MANAGE, V54, P696, DOI 10.1016/j.ocecoaman.2011.07.002; Cruz-Trinidad A, 2009, OCEAN COAST MANAGE, V52, P173, DOI 10.1016/j.ocecoaman.2008.12.002; Darling ES, 2008, ECOL LETT, V11, P1278, DOI 10.1111/j.1461-0248.2008.01243.x; Darling ES, 2010, CONSERV LETT, V3, P122, DOI 10.1111/j.1755-263X.2009.00089.x; David CPC, 2008, ENVIRON GEOL, V58, P447; De'ath G, 2012, P NATL ACAD SCI USA, V109, P17995, DOI 10.1073/pnas.1208909109; Deocadez M, 2003, LINGAYEN GULF NW PHI; Didham RK, 2007, TRENDS ECOL EVOL, V22, P489, DOI 10.1016/j.tree.2007.07.001; DODGE RE, 1974, NATURE, V247, P574, DOI 10.1038/247574a0; Donner SD, 2005, GLOBAL CHANGE BIOL, V11, P2251, DOI 10.1111/j.1365-2486.2005.01073.x; Donner SD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005712; Dunne RP, 2010, CORAL REEFS, V29, P145, DOI 10.1007/s00338-009-0569-6; Edinger EN, 2000, MAR POLLUT BULL, V40, P404, DOI 10.1016/S0025-326X(99)00237-4; Edwards HJ, 2011, GLOBAL CHANGE BIOL, V17, P2033, DOI 10.1111/j.1365-2486.2010.02366.x; Elsner JB, 2008, NATURE, V455, P92, DOI 10.1038/nature07234; Feary DA, 2007, OECOLOGIA, V153, P727, DOI 10.1007/s00442-007-0773-4; Fisheries Resource Management Project (FRMP), 2006, SUST PHIL FISH AG, V1; Folt CL, 1999, LIMNOL OCEANOGR, V44, P864, DOI 10.4319/lo.1999.44.3_part_2.0864; Fung T. C., 2009, THESIS U COLL LONDON; Fung T, 2013, AM NAT, V182, P208, DOI 10.1086/670930; Fung T, 2011, ECOLOGY, V92, P967, DOI 10.1890/10-0378.1; Geronimo RC, 2009, THESIS U PHILIPPINES; Golbuu Y, 2007, CORAL REEFS, V26, P319, DOI 10.1007/s00338-007-0200-7; Gruner DS, 2008, ECOL LETT, V11, P740, DOI 10.1111/j.1461-0248.2008.01192.x; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hilomen VV, 2001, FISHERIES LINGAYEN G; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Holbrook SJ, 2008, MAR ECOL PROG SER, V371, P263, DOI 10.3354/meps07690; Holmer M, 2002, MAR POLLUT BULL, V44, P685, DOI 10.1016/S0025-326X(02)00048-6; Holmes KE, 2000, MAR POLLUT BULL, V40, P606, DOI 10.1016/S0025-326X(00)00067-9; Horigue V, 2012, OCEAN COAST MANAGE, V64, P15, DOI 10.1016/j.ocecoaman.2012.04.012; Hughes TP, 2007, CURR BIOL, V17, P360, DOI 10.1016/j.cub.2006.12.049; Hughes TP, 2003, SCIENCE, V301, P929, DOI 10.1126/science.1085046; Hughes TP, 1999, LIMNOL OCEANOGR, V44, P932, DOI 10.4319/lo.1999.44.3_part_2.0932; Jones A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010437; Keller BD, 2009, ENVIRON MANAGE, V44, P1069, DOI 10.1007/s00267-009-9346-0; Knowlton N, 2001, P NATL ACAD SCI USA, V98, P5419, DOI 10.1073/pnas.091092998; Knowlton N, 2008, PLOS BIOL, V6, P215, DOI 10.1371/journal.pbio.0060054; Kubicek A, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002791; Langmead O, 2004, ECOL MODEL, V175, P271, DOI 10.1016/j.ecolmodel.2003.10.019; LAPOINTE BE, 1989, ESTUAR COAST SHELF S, V28, P347, DOI 10.1016/0272-7714(89)90084-X; Larned ST, 1996, MAR ECOL PROG SER, V145, P95, DOI 10.3354/meps145095; Larned ST, 1998, MAR BIOL, V132, P409, DOI 10.1007/s002270050407; Lenth R., 2019, Journal of Statistical Software, V60, P1; Licuanan WY, 2006, PHILIPP AGRIC SCI, V89, P34; Lirman D, 2003, ECOL MODEL, V161, P169, DOI 10.1016/S0304-3800(02)00346-0; Little LR, 2007, ECOL MODEL, V205, P381, DOI 10.1016/j.ecolmodel.2007.03.005; Marshall PA, 2000, CORAL REEFS, V19, P155, DOI 10.1007/s003380000086; McClanahan TR, 2008, OECOLOGIA, V155, P169, DOI 10.1007/s00442-007-0890-0; McClanahan TR, 2007, MAR POLLUT BULL, V54, P1947, DOI 10.1016/j.marpolbul.2007.09.023; MCCLANAHAN TR, 1995, ECOL MODEL, V80, P1, DOI 10.1016/0304-3800(94)00042-G; McClanahan TR, 2005, MAR POLLUT BULL, V50, P566, DOI 10.1016/j.marpolbul.2005.01.005; McManus J, 1992, STUDIES REV, V22; Melbourne-Thomas J, 2011, ECOL MODEL, V222, P1756, DOI 10.1016/j.ecolmodel.2011.03.008; Melbourne-Thomas J, 2011, ENVIRON MODELL SOFTW, V26, P66, DOI 10.1016/j.envsoft.2010.03.033; Melbourne-Thomas J, 2011, ECOL APPL, V21, P1380, DOI 10.1890/09-1564.1; Miller MW, 1999, LIMNOL OCEANOGR, V44, P1847, DOI 10.4319/lo.1999.44.8.1847; Mora C, 2007, P ROY SOC B-BIOL SCI, V274, P1023, DOI 10.1098/rspb.2006.0338; Mumby PJ, 2006, ECOL MODEL, V196, P131, DOI 10.1016/j.ecolmodel.2005.11.035; Mumby PJ, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008657; Nugues MM, 2003, CORAL REEFS, V22, P507, DOI 10.1007/s00338-003-0338-x; Pandolfi JM, 2011, SCIENCE, V333, P418, DOI 10.1126/science.1204794; Peterson GD, 2003, CONSERV BIOL, V17, P358, DOI 10.1046/j.1523-1739.2003.01491.x; PhilReefs, 2008, REEFS TIM 2008 IN ST; Reichert P, 2005, ENVIRON MODELL SOFTW, V20, P991, DOI 10.1016/j.envsoft.2004.10.005; Roberts CM, 2002, SCIENCE, V295, P1280, DOI 10.1126/science.1067728; Schaffelke B, 1998, MAR ECOL PROG SER, V164, P199, DOI 10.3354/meps164199; Selkoe KA, 2009, CORAL REEFS, V28, P635, DOI 10.1007/s00338-009-0490-z; Sumagaysay-Chavoso NS, 2003, AQUACULTURE, V219, P413, DOI 10.1016/S0044-8486(02)00576-8; Sumalde Z., 2003, EC ENV SELECTED READ; Suzuki A, 2003, CORAL REEFS, V22, P357, DOI 10.1007/s00338-003-0323-4; Travers H, 2011, ECOL ECON, V71, P151, DOI 10.1016/j.ecolecon.2011.08.020; Tu JY, 2009, J CLIMATE, V22, P3617, DOI 10.1175/2009JCLI2411.1; Van Kouwen F, 2008, COAST MANAGE, V36, P19, DOI 10.1080/08920750701682007; van Woesik R, 1999, MAR FRESHWATER RES, V50, P427, DOI 10.1071/MF97046; Vergara M.W.B., 2009, THESIS U PHILIPPINES; Veron JEN, 2009, MAR POLLUT BULL, V58, P1428, DOI 10.1016/j.marpolbul.2009.09.009; Villanueva RD, 2006, MAR ECOL PROG SER, V316, P165, DOI 10.3354/meps316165; Villanueva RD, 2005, MAR POLLUT BULL, V51, P580, DOI 10.1016/j.marpolbul.2005.04.033; Volk S, 2012, J ECON BEHAV ORGAN, V81, P664, DOI 10.1016/j.jebo.2011.10.006; Wernberg T, 2012, GLOBAL CHANGE BIOL, V18, P1491, DOI 10.1111/j.1365-2486.2012.02656.x; Westmacott S, 2001, J ENVIRON MANAGE, V62, P55, DOI 10.1006/jema.2001.0420; White A, 2006, COAST MANAGE, V34, P287, DOI 10.1080/08920750600686687; Wilkinson C, 2008, STATUS CORAL REEFS W; Wolanski E, 2004, J MARINE SYST, V46, P133, DOI 10.1016/j.jmarsys.2003.11.018	113	45	45	2	90	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80137	10.1371/journal.pone.0080137	http://dx.doi.org/10.1371/journal.pone.0080137			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260347	Green Published, gold, Green Accepted			2022-12-25	WOS:000327308500117
J	Kraiselburd, I; Daurelio, LD; Tondo, ML; Merelo, P; Cortadi, AA; Talon, M; Tadeo, FR; Orellano, EG				Kraiselburd, Ivana; Daurelio, Lucas D.; Laura Tondo, Maria; Merelo, Paz; Cortadi, Adriana A.; Talon, Manuel; Tadeo, Francisco R.; Orellano, Elena G.			The LOV Protein of Xanthomonas citri subsp citri Plays a Significant Role in the Counteraction of Plant Immune Responses during Citrus Canker	PLOS ONE			English	Article							AXONOPODIS PV. CITRI; CHLOROPHYLL FLUORESCENCE; TRANSGENIC TOBACCO; DISEASE RESISTANCE; P-SYRINGAE; DEFENSE; LIGHT; GENE; PHOTOSYNTHESIS; METABOLISM	Pathogens interaction with a host plant starts a set of immune responses that result in complex changes in gene expression and plant physiology. Light is an important modulator of plant defense response and recent studies have evidenced the novel influence of this environmental stimulus in the virulence of several bacterial pathogens. Xanthomonas citri subsp. citri is the bacterium responsible for citrus canker disease, which affects most citrus cultivars. The ability of this bacterium to colonize host plants is influenced by bacterial blue-light sensing through a LOV-domain protein and disease symptoms are considerably altered upon deletion of this protein. In this work we aimed to unravel the role of this photoreceptor during the bacterial counteraction of plant immune responses leading to citrus canker development. We performed a transcriptomic analysis in Citrus sinensis leaves inoculated with the wild type X. citri subsp. citri and with a mutant strain lacking the LOV protein by a cDNA microarray and evaluated the differentially regulated genes corresponding to specific biological processes. A down-regulation of photosynthesis-related genes (together with a corresponding decrease in photosynthesis rates) was observed upon bacterial infection, this effect being more pronounced in plants infected with the lov-mutant bacterial strain. Infection with this strain was also accompanied with the up-regulation of several secondary metabolism-and defense response-related genes. Moreover, we found that relevant plant physiological alterations triggered by pathogen attack such as cell wall fortification and tissue disruption were amplified during the lov-mutant strain infection. These results suggest the participation of the LOV-domain protein from X. citri subsp. citri in the bacterial counteraction of host plant defense response, contributing in this way to disease development.	[Kraiselburd, Ivana; Daurelio, Lucas D.; Laura Tondo, Maria; Orellano, Elena G.] Fac Ciencias Bioquim & Farmaceut FBIOYF UNR, Inst Biol Mol & Celular Rosario IBR CONICET, Rosario, Santa Fe, Argentina; [Merelo, Paz; Talon, Manuel; Tadeo, Francisco R.] IVIA, Ctr Genom, Moncada, Valencia, Spain; [Cortadi, Adriana A.] Univ Nacl Rosario, Fac Ciencias Bioquim & Farmaceut, Area Biol Vegetal, RA-2000 Rosario, Argentina	Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET); National University of Rosario	Orellano, EG (corresponding author), Fac Ciencias Bioquim & Farmaceut FBIOYF UNR, Inst Biol Mol & Celular Rosario IBR CONICET, Rosario, Santa Fe, Argentina.	orellano@ibr-conicet.gov.ar	Kraiselburd, Ivana/AAI-8743-2020; Cremades, Paz Merelo/B-8001-2019; Talon, Manuel/C-8540-2014; Tadeo, Francisco R/C-8977-2014; Daurelio, Lucas/AAT-6969-2020	Kraiselburd, Ivana/0000-0002-9677-6094; Cremades, Paz Merelo/0000-0002-1301-7835; Talon, Manuel/0000-0003-4291-9333; Tadeo, Francisco R/0000-0002-5839-4255; Daurelio, Lucas Damian/0000-0002-1156-2266; Tondo, Maria Laura/0000-0002-0160-1882	Agencia Nacional de Promocion Cientifica y Tecnologica [ANPCyT PICT 2010-1762]; Programa de Cooperacion Argentina-Espana (Ministerio de Ciencia, Tecnologia e Innovacion. Productiva of Argentina, Ministerio de Ciencia e Innovacion of Spain) [ES/09/10]; Subprograma de Acciones Integradas - Ministerio de Ciencia e Innovacion of Espana [AR2009-0023]	Agencia Nacional de Promocion Cientifica y Tecnologica(ANPCyT); Programa de Cooperacion Argentina-Espana (Ministerio de Ciencia, Tecnologia e Innovacion. Productiva of Argentina, Ministerio de Ciencia e Innovacion of Spain); Subprograma de Acciones Integradas - Ministerio de Ciencia e Innovacion of Espana	This work was supported by the Agencia Nacional de Promocion Cientifica y Tecnologica (ANPCyT PICT 2010-1762 to EGO) and by the Programa de Cooperacion Argentina-Espana (ES/09/10, Ministerio de Ciencia, Tecnologia e Innovacion. Productiva of Argentina, Ministerio de Ciencia e Innovacion of Spain) to EGO and from the Subprograma de Acciones Integradas - Ministerio de Ciencia e Innovacion (AR2009-0023) of Espana to FRT. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. EGO and LDD are staff members and IK and MLT are Fellows of the Consejo Nacional de Investigaciones Cientificas y Tecnicas (CONICET, Argentina). MT and FT are staff member and PM is a Fellow of the Centre de Genomica, Institut Valencia d'Investigacions Agraries, Spain. AAC is a Professor at the Area de Biologia Vegetal of the Facultad de Ciencias Bioquimicas y Farmaceuticas de la Universidad Nacional de Rosario. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Albrecht U, 2012, PLANT SCI, V185, P118, DOI 10.1016/j.plantsci.2011.09.008; Angelova S, 2010, MOL PLANT, V3, P927, DOI 10.1093/mp/ssq043; Avila-Perez M, 2006, J BACTERIOL, V188, P6411, DOI 10.1128/JB.00716-06; Baker NR, 2008, ANNU REV PLANT BIOL, V59, P89, DOI 10.1146/annurev.arplant.59.032607.092759; BELL JN, 1986, MOL CELL BIOL, V6, P1615, DOI 10.1128/MCB.6.5.1615; Berger S, 2007, J EXP BOT, V58, P797, DOI 10.1093/jxb/erl208; Bolton MD, 2008, MOL MICROBIOL, V69, P119, DOI 10.1111/j.1365-2958.2008.06270.x; Bolton MD, 2009, MOL PLANT MICROBE IN, V22, P487, DOI 10.1094/MPMI-22-5-0487; Bonfig KB, 2006, PLANTA, V225, P1, DOI 10.1007/s00425-006-0303-3; Brunings AM, 2003, MOL PLANT PATHOL, V4, P141, DOI 10.1046/j.1364-3703.2003.00163.x; Chisholm ST, 2006, CELL, V124, P803, DOI 10.1016/j.cell.2006.02.008; D'ambrogio de Argueso A., 1986, MANUAL TECNICAS HIST; da Silva ACR, 2002, NATURE, V417, P459, DOI 10.1038/417459a; Daurelio LD, 2013, J PLANT PHYSIOL, V170, P934, DOI 10.1016/j.jplph.2013.01.011; Daurelio Lucas D., 2009, P187; Dixon RA, 2002, MOL PLANT PATHOL, V3, P371, DOI 10.1046/j.1364-3703.2002.00131.x; Du Z, 2010, NUCLEIC ACIDS RES, V38, pW64, DOI 10.1093/nar/gkq310; ESNAULT R, 1987, PHYSIOL MOL PLANT P, V30, P293, DOI 10.1016/0885-5765(87)90042-7; Essmann J, 2008, PLANT SIGNAL BEHAV, V3, P885, DOI 10.4161/psb.3.10.6501; Forment J, 2005, PLANT MOL BIOL, V57, P375, DOI 10.1007/s11103-004-7926-1; Fotopoulos V, 2003, PLANT PHYSIOL, V132, P821, DOI 10.1104/pp.103.021428; Gomelsky M, 2011, TRENDS MICROBIOL, V19, P441, DOI 10.1016/j.tim.2011.05.002; Gottig N, 2008, P NATL ACAD SCI USA, V105, P18631, DOI 10.1073/pnas.0810107105; Graham JH, 2004, MOL PLANT PATHOL, V5, P1, DOI 10.1046/j.1364-3703.2004.00197.x; Guidetti-Gonzalez S, 2007, GENET MOL BIOL, V30, P943, DOI 10.1590/S1415-47572007000500022; Heath MC, 2000, PLANT MOL BIOL, V44, P321, DOI 10.1023/A:1026592509060; Kangasjarvi S, 2012, J EXP BOT, V63, P1619, DOI 10.1093/jxb/err402; Karsai A, 2002, BIOTECHNIQUES, V32, P790, DOI 10.2144/02324st05; Kerchev PI, 2012, PLANT CELL ENVIRON, V35, P441, DOI 10.1111/j.1365-3040.2011.02399.x; Khalaf A, 2007, PHYSIOL MOL PLANT P, V71, P240, DOI 10.1016/j.pmpp.2008.03.001; Kraiselburd I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038226; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Krauss U, 2009, J BACTERIOL, V191, P7234, DOI 10.1128/JB.00923-09; Lauvergeat V, 2001, PHYTOCHEMISTRY, V57, P1187, DOI 10.1016/S0031-9422(01)00053-X; Lawrence CB, 2000, PHYSIOL MOL PLANT P, V57, P211, DOI 10.1006/pmpp.2000.0298; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Losi A, 2011, PHOTOCHEM PHOTOBIOL, V87, P491, DOI 10.1111/j.1751-1097.2011.00913.x; Major IT, 2010, PHOTOSYNTH RES, V104, P41, DOI 10.1007/s11120-009-9507-2; Martinez-Godoy MA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-318; Moglich A, 2009, STRUCTURE, V17, P1282, DOI 10.1016/j.str.2009.08.011; Mussi MA, 2010, J BACTERIOL, V192, P6336, DOI 10.1128/JB.00917-10; Mysore KS, 2004, TRENDS PLANT SCI, V9, P97, DOI 10.1016/j.tplants.2003.12.005; NIELSEN KK, 1993, MOL PLANT MICROBE IN, V6, P495, DOI 10.1094/MPMI-6-495; PALIYATH G, 1992, PLANT PHYSIOL BIOCH, V30, P789; Porra RJ, 2002, PHOTOSYNTH RES, V73, P149, DOI 10.1023/A:1020470224740; Purcell EB, 2007, P NATL ACAD SCI USA, V104, P18241, DOI 10.1073/pnas.0705887104; Roberts MR, 2006, NEW PHYTOL, V170, P677, DOI 10.1111/j.1469-8137.2006.01707.x; Rozen S, 2000, Methods Mol Biol, V132, P365; Sambrook J., 1989, MOL CLONING LAB MANU, V2; Scharte J, 2009, P NATL ACAD SCI USA, V106, DOI 10.1073/pnas.0812902106; Shadle GL, 2003, PHYTOCHEMISTRY, V64, P153, DOI 10.1016/S0031-9422(03)00151-1; Swartz TE, 2007, SCIENCE, V317, P1090, DOI 10.1126/science.1144306; Tao Y, 2003, PLANT J, V25, P315; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Van der Horst MA, 2004, ACCOUNTS CHEM RES, V37, P13, DOI 10.1021/ar020219d; van Loon LC, 2006, ANNU REV PHYTOPATHOL, V44, P135, DOI 10.1146/annurev.phyto.44.070505.143425; Wang XM, 1999, PLANT PHYSIOL, V120, P645, DOI 10.1104/pp.120.3.645; Word Health Organisation (WHO), 2011, QUAL CONTR METH HERB; Xu L, 2011, J EXP BOT, V62, P5607, DOI 10.1093/jxb/err245; Yamaguchi T, 2005, PLANT CELL PHYSIOL, V46, P579, DOI 10.1093/pcp/pci065; Yan M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049197; Young ND, 1996, ANNU REV PHYTOPATHOL, V34, P479, DOI 10.1146/annurev.phyto.34.1.479	62	15	16	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80930	10.1371/journal.pone.0080930	http://dx.doi.org/10.1371/journal.pone.0080930			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260514	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600101
J	Bittoni, A; Scartozzi, M; Giampieri, R; Faloppi, L; Bianconi, M; Mandolesi, A; Del Prete, M; Pistelli, M; Cecchini, L; Bearzi, I; Cascinu, S				Bittoni, Alessandro; Scartozzi, Mario; Giampieri, Riccardo; Faloppi, Luca; Bianconi, Maristella; Mandolesi, Alessandra; Del Prete, Michela; Pistelli, Mirco; Cecchini, Luca; Bearzi, Italo; Cascinu, Stefano			Clinical Evidence for Three Distinct Gastric Cancer Subtypes: Time for a New Approach	PLOS ONE			English	Article							CLASSIFICATION; PROGNOSIS; DISEASE	Background: Recently, a new classification for gastric cancer (GC) has been proposed, based on Lauren's histology and on anatomic tumour location, identifying three subtypes of disease: type 1 (proximal non diffuse GC), type 2 (diffuse GC) and type 3 (distal non diffuse GC). Aim of our analysis was to compare clinical outcome according to different GC subtypes (1,2,3) in metastatic GC patients receiving first-line chemotherapy. Patients and Methods: Advanced GC pts treated with a first-line combination chemotherapy were included in our analysis. Pts were divided in three subgroups (type 1, type 2 and type 3) as previously defined. Results: A total of 248 advanced GC pts were included: 45.2% belonged to type 2, 43.6% to type 3 and 11.2% to type 1. Patients received a fluoropyrimidine-based chemotherapy doublet or three drugs regimens including a platinum derivate and a fluoropyrimidine with the addition of an anthracycline, a taxane or mytomicin C. RR was higher in type 1 pts (RR = 46.1%) and type 3 (34,3%) compared to type 2 (20,4%), (p = 0.015). Type 2 presented a shorter PFS, median PFS = 4.2 months, compared to type 1, mPFS = 7.2 months, and type 3, mPFS = 5.9 months (p = 0.011) and also a shorter OS (p = 0.022). Conclusions: Our analysis suggests that GC subtypes may be important predictors of benefit from chemotherapy in advanced GC patients. Future clinical trials should take in account these differences for a better stratification of patients.	[Bittoni, Alessandro; Scartozzi, Mario; Giampieri, Riccardo; Pistelli, Mirco; Cecchini, Luca; Cascinu, Stefano] Univ Politecn Marche, AOU Osped Riuniti, Clin Oncol Med, Ancona, Italy; [Faloppi, Luca; Bianconi, Maristella; Del Prete, Michela] Univ Politecn Marche, Scuola Specializzaz Oncol Med, Ancona, Italy; [Mandolesi, Alessandra; Bearzi, Italo] Univ Politecn Marche, AOU Osped Riuniti, Ancona, Italy	Marche Polytechnic University; Marche Polytechnic University; Marche Polytechnic University	Scartozzi, M (corresponding author), Univ Politecn Marche, AOU Osped Riuniti, Clin Oncol Med, Ancona, Italy.	marioscartozzi@gmail.com	Cascinu, Stefano/G-2399-2017; Cascinu, Stefano/AAN-1923-2020; Faloppi, Luca/K-1030-2016	Cascinu, Stefano/0000-0003-2215-0731; Faloppi, Luca/0000-0003-3689-3085; Bianconi, Maristella/0000-0003-3475-2529; Pistelli, Mirco/0000-0002-9289-8537; SCARTOZZI, MARIO/0000-0001-5977-5546				Ajani JA, 2009, J CLIN ONCOL, V27; Bajetta E, 2012, TUMORI S, V13, pS1; Bang YJ, 2010, LANCET, V376, P1302; Carneiro F, 2004, J PATHOL, V203, P681, DOI 10.1002/path.1564; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Kamoshida S, 2005, ONCOL REP, V14, P1223; Kattan MW, 2003, J CLIN ONCOL, V21, P3647, DOI 10.1200/JCO.2003.01.240; Liu L, 2013, ANTI-CANCER AGENT ME, V13, P227, DOI 10.2174/1871520611313020007; Marrelli D, 2002, WORLD J SURG, V26, P1160, DOI 10.1007/s00268-002-6344-2; Ohtsu A, 2011, J CLIN ONCOL, V29, P3968, DOI 10.1200/JCO.2011.36.2236; Peek RM, 2002, NAT REV CANCER, V2, P28, DOI 10.1038/nrc703; Sakaguchi T, 1998, J AM COLL SURGEONS, V187, P352, DOI 10.1016/S1072-7515(98)00191-4; Scartozzi M, 2009, CANCER TREAT REV, V35, P451, DOI 10.1016/j.ctrv.2009.04.008; Shah MA, 2011, CLIN CANCER RES, V17, P2693, DOI 10.1158/1078-0432.CCR-10-2203; Shah MA, 2011, J CLIN ONCOL, V29, P868, DOI 10.1200/JCO.2010.32.0770; Shah MA, 2010, J NATL COMPR CANC NE, V8, P437, DOI 10.6004/jnccn.2010.0033; Smalley SR, 2012, J CLIN ONCOL, V30, P2327, DOI 10.1200/JCO.2011.36.7136; Tanner M, 2005, ANN ONCOL, V16, P273, DOI 10.1093/annonc/mdi064; YOU WC, 1993, CANCER RES, V53, P1317	19	12	13	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78544	10.1371/journal.pone.0078544	http://dx.doi.org/10.1371/journal.pone.0078544			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265697	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100030
J	Goiko, M; Dierolf, J; Gleberzon, JS; Liao, YY; Grohe, B; Goldberg, HA; de Bruyn, JR; Hunter, GK				Goiko, Maria; Dierolf, Joshua; Gleberzon, Jared S.; Liao, Yinyin; Grohe, Bernd; Goldberg, Harvey A.; de Bruyn, John R.; Hunter, Graeme K.			Peptides of Matrix Gla Protein Inhibit Nucleation and Growth of Hydroxyapatite and Calcium Oxalate Monohydrate Crystals	PLOS ONE			English	Article							GAMMA-CARBOXYGLUTAMIC ACID; GENE-EXPRESSION; CALCIFICATION; OSTEOPONTIN; OSTEOCALCIN; HEART; IDENTIFICATION; POLYMORPHISM; ADSORPTION; ARTERIES	Matrix Gla protein (MGP) is a phosphorylated and gamma-carboxylated protein that has been shown to prevent the deposition of hydroxyapatite crystals in the walls of blood vessels. MGP is also expressed in kidney and may inhibit the formation of kidney stones, which mainly consist of another crystalline phase, calcium oxalate monohydrate. To determine the mechanism by which MGP prevents soft-tissue calcification, we have synthesized peptides corresponding to the phosphorylated and gamma-carboxylated sequences of human MGP in both post-translationally modified and non-modified forms. The effects of these peptides on hydroxyapatite formation and calcium oxalate crystallization were quantified using dynamic light scattering and scanning electron microscopy, respectively. Peptides YGlapS (MGP1-14: Y gamma EpSHEpSMEpSYELNP), YEpS (YEpSHEpSMEpSYELNP), YGlaS (Y gamma ESHESMESYELNP) and SK-Gla (MGP43-56: SKPVH gamma ELNR gamma EACDD) inhibited formation of hydroxyapatite in order of potency YGlapS > YEpS > YGlaS > SK-Gla. The effects of YGlapS, YEpS and YGlaS on hydroxyapatite formation were on both crystal nucleation and growth; the effect of SK-Gla was on nucleation. YGlapS and YEpS significantly inhibited the growth of calcium oxalate monohydrate crystals, while simultaneously promoting the formation of calcium oxalate dihydrate. The effects of these phosphopeptides on calcium oxalate monohydrate formation were on growth of crystals rather than nucleation. We have shown that the use of dynamic light scattering allows inhibitors of hydroxyapatite nucleation and growth to be distinguished. We have also demonstrated for the first time that MGP peptides inhibit the formation of calcium oxalate monohydrate. Based on the latter finding, we propose that MGP function not only to prevent blood-vessel calcification but also to inhibit stone formation in kidney.	[Goiko, Maria; de Bruyn, John R.] Univ Western Ontario, Dept Phys & Astron, London, ON, Canada; [Dierolf, Joshua; Liao, Yinyin; Grohe, Bernd; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Sch Dent, London, ON, Canada; [Gleberzon, Jared S.; Goldberg, Harvey A.; Hunter, Graeme K.] Univ Western Ontario, Dept Biochem, London, ON, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario)	Hunter, GK (corresponding author), Univ Western Ontario, Sch Dent, London, ON, Canada.	graeme.hunter@schulich.uwo.ca	Goldberg, Harvey/B-5742-2015		Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR)	This work was supported by the Canadian Institutes of Health Research and the Natural Sciences and Engineering Research Council of Canada. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BERNE B. J., 1976, DYNAMIC LIGHT SCATTE; Canfield AE, 2002, J PATHOL, V196, P228, DOI 10.1002/path.1020; Chan BPH, 2012, COLLOID SURFACE B, V96, P22, DOI 10.1016/j.colsurfb.2012.03.015; de Bruyn JR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056764; Dowd TL, 2003, BIOCHEMISTRY-US, V42, P7769, DOI 10.1021/bi034470s; Estepa L, 1997, BIOSPECTROSCOPY, V3, P347, DOI 10.1002/(SICI)1520-6343(1997)3:5<347::AID-BSPY3>3.0.CO;2-#; FRASER JD, 1988, J BIOL CHEM, V263, P11033; Frisken BJ, 2001, APPL OPTICS, V40, P4087, DOI 10.1364/AO.40.004087; Gao B, 2007, J UROLOGY, V177, P2361, DOI 10.1016/j.juro.2007.01.118; Gavaia PJ, 2006, GENE EXPR PATTERNS, V6, P637, DOI 10.1016/j.modgep.2005.11.010; Grohe B, 2007, J AM CHEM SOC, V129, P14946, DOI 10.1021/ja0745613; Grohe B, 2011, UROL RES, V39, P327, DOI 10.1007/s00240-010-0360-8; Grohe B, 2009, LANGMUIR, V25, P11635, DOI 10.1021/la901145d; Hackeng TM, 2001, PROTEIN SCI, V10, P864, DOI 10.1110/ps.44701; HAUSCHKA PV, 1982, BIOCHEMISTRY-US, V21, P2538, DOI 10.1021/bi00539a038; Hoang QQ, 2003, NATURE, V425, P977, DOI 10.1038/nature02079; HOPP TP, 1981, P NATL ACAD SCI-BIOL, V78, P3824, DOI 10.1073/pnas.78.6.3824; Hunter GK, 2010, LANGMUIR, V26, P18639, DOI 10.1021/la100401r; Kalmar L, 2012, BONE, V51, P528, DOI 10.1016/j.bone.2012.05.009; Konigsberger E, 2001, PURE APPL CHEM, V73, P785, DOI 10.1351/pac200173050785; Lu XL, 2012, GENE, V511, P127, DOI 10.1016/j.gene.2012.09.112; Luo GB, 1997, NATURE, V386, P78, DOI 10.1038/386078a0; O'Young J, 2011, J AM CHEM SOC, V133, P18406, DOI 10.1021/ja207628k; Oh J, 2004, PROTEOMICS, V4, P3485, DOI 10.1002/pmic.200401018; PRICE PA, 1976, P NATL ACAD SCI USA, V73, P3374, DOI 10.1073/pnas.73.10.3374; Price PA, 1998, ARTERIOSCL THROM VAS, V18, P1400, DOI 10.1161/01.ATV.18.9.1400; PRICE PA, 1994, PROTEIN SCI, V3, P822; PRICE PA, 1985, J BIOL CHEM, V260, P4971; PRICE PA, 1983, BIOCHEM BIOPH RES CO, V117, P765, DOI 10.1016/0006-291X(83)91663-7; Roberto VP, 2009, AQUACULTURE, V294, P202, DOI 10.1016/j.aquaculture.2009.06.020; Schurgers LJ, 2007, J THROMB HAEMOST, V5, P2503, DOI 10.1111/j.1538-7836.2007.02758.x; Taller A, 2007, BIOPHYS J, V93, P1768, DOI 10.1529/biophysj.106.101881; TOMSON MB, 1978, SCIENCE, V200, P1059, DOI 10.1126/science.200.4345.1059; Tyan YC, 2006, ANAL CHIM ACTA, V579, P158, DOI 10.1016/j.aca.2006.07.033; Ueland T, 2010, J INTERN MED, V268, P483, DOI 10.1111/j.1365-2796.2010.02264.x; Uvarov V, 2011, ENVIRON GEOCHEM HLTH, V33, P613, DOI 10.1007/s10653-011-9374-6; Villines TC, 2009, CALCIFIED TISSUE INT, V85, P494, DOI 10.1007/s00223-009-9300-4; Wang L, 2000, KIDNEY INT, V58, P528, DOI 10.1046/j.1523-1755.2000.00199.x; Yasui T, 1999, UROL RES, V27, P255, DOI 10.1007/s002400050119	39	24	25	3	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80344	10.1371/journal.pone.0080344	http://dx.doi.org/10.1371/journal.pone.0080344			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265810	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100146
J	Segond, N; Degrelle, SA; Berndt, S; Clouqueur, E; Rouault, C; Saubamea, B; Dessen, P; Fong, KSK; Csiszar, K; Badet, J; Evain-Brion, D; Fournier, T				Segond, Nadine; Degrelle, Severine A.; Berndt, Sarah; Clouqueur, Elodie; Rouault, Christine; Saubamea, Bruno; Dessen, Philippe; Fong, Keith S. K.; Csiszar, Katalin; Badet, Josette; Evain-Brion, Daniele; Fournier, Thierry			Transcriptome Analysis of PPAR gamma Target Genes Reveals the Involvement of Lysyl Oxidase in Human Placental Cytotrophoblast Invasion	PLOS ONE			English	Article							PROLIFERATOR-ACTIVATED-RECEPTOR; HUMAN TROPHOBLAST MIGRATION; DIPEPTIDYL-PEPTIDASE-IV; CELL-MIGRATION; IN-VITRO; CONNEXIN EXPRESSION; MUC1 EXPRESSION; PROTEIN-KINASE; HIGH-AFFINITY; BLOOD-FLOW	Human placental development is characterized by invasion of extravillous cytotrophoblasts (EVCTs) into the uterine wall during the first trimester of pregnancy. Peroxisome proliferator-activated receptor gamma (PPAR gamma) plays a major role in placental development, and activation of PPAR gamma by its agonists results in inhibition of EVCT invasion in vitro. To identify PPAR gamma target genes, microarray analysis was performed using GeneChip technology on EVCT primary cultures obtained from first-trimester human placentas. Gene expression was compared in EVCTs treated with the PPAR gamma agonist rosiglitazone versus control. A total of 139 differentially regulated genes were identified, and changes in the expression of the following 8 genes were confirmed by reverse transcription-quantitative polymerase chain reaction: a disintegrin and metalloproteinase domain12 (ADAM12), connexin 43 (CX43), deleted in liver cancer 1 (DLC1), dipeptidyl peptidase 4 (DPP4), heme oxygenase 1 (HMOX-1), lysyl oxidase (LOX), plasminogen activator inhibitor 1 (PAI-1) and PPAR gamma. Among the upregulated genes, lysyl oxidase (LOX) was further analyzed. In the LOX family, only LOX, LOXL1 and LOXL2 mRNA expression was significantly upregulated in rosiglitazone-treated EVCTs. RNA and protein expression of the subfamily members LOX, LOXL1 and LOXL2 were analyzed by absolute RT-qPCR and western blotting, and localized by immunohistochemistry and immunofluorescence-confocal microscopy. LOX protein was immunodetected in the EVCT cytoplasm, while LOXL1 was found in the nucleus and nucleolus. No signal was detected for LOXL2 protein. Specific inhibition of LOX activity by beta-aminopropionitrile in cell invasion assays led to an increase in EVCT invasiveness. These results suggest that LOX, LOXL1 and LOXL2 are downstream PPAR gamma targets and that LOX activity is a negative regulator of trophoblastic cell invasion.	[Segond, Nadine; Degrelle, Severine A.; Berndt, Sarah; Clouqueur, Elodie; Badet, Josette; Evain-Brion, Daniele; Fournier, Thierry] INSERM, UMR S767, Paris, France; [Segond, Nadine; Degrelle, Severine A.; Berndt, Sarah; Clouqueur, Elodie; Saubamea, Bruno; Badet, Josette; Evain-Brion, Daniele; Fournier, Thierry] Univ Paris 05, Sorbonne Paris Cite, Paris, France; [Segond, Nadine; Degrelle, Severine A.; Berndt, Sarah; Clouqueur, Elodie; Evain-Brion, Daniele; Fournier, Thierry] PremUP Fdn, Paris, France; [Rouault, Christine] INSERM, UMR 872, Equipe 7, Paris, France; [Rouault, Christine] Univ Paris 06, Paris, France; [Saubamea, Bruno] INSERM, U705, Paris, France; [Saubamea, Bruno] CNRS, UMR 8206, Paris, France; [Dessen, Philippe] Inst Gustave Roussy, INSERM, UMR 985, F-94805 Villejuif, France; [Fong, Keith S. K.; Csiszar, Katalin] Univ Hawaii, John A Burns Sch Med, Honolulu, HI 96822 USA	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Institut National de la Sante et de la Recherche Medicale (Inserm); Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; University of Hawaii System	Fournier, T (corresponding author), INSERM, UMR S767, Paris, France.	thierry.fournier@parisdescartes.fr	Fournier, Thierry C/E-5836-2016; Degrelle, Severine/AAC-1726-2020; saubamea, bruno/H-6882-2017	Degrelle, Severine/0000-0001-6263-4875; saubamea, bruno/0000-0002-6218-0460; Fournier, Thierry/0000-0002-7515-339X	National Institute of Health and Medical Research (INSERM); PremUp foundation; National Institute on Minority Health and Health Disparities [U54MD007584] Funding Source: NIH RePORTER	National Institute of Health and Medical Research (INSERM)(Institut National de la Sante et de la Recherche Medicale (Inserm)); PremUp foundation; National Institute on Minority Health and Health Disparities(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Minority Health & Health Disparities (NIMHD))	This work was supported by the National Institute of Health and Medical Research (INSERM). Severine A. Degrelle and Sarah Berndt were supported by postdoctoral fellowships from the PremUp foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Lamki RS, 1999, HUM REPROD, V14, P496, DOI 10.1093/humrep/14.2.496; Aman A, 2010, DEV BIOL, V341, P20, DOI 10.1016/j.ydbio.2009.11.014; APLIN JD, 1991, J CELL SCI, V99, P681; Askari B, 2007, DIABETES, V56, P1143, DOI 10.2337/db06-0267; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bauer S, 2004, J CLIN ENDOCR METAB, V89, P812, DOI 10.1210/jc.2003-031351; Bearfield C, 2005, EUR J ENDOCRINOL, V152, P909, DOI 10.1530/eje.1.01928; Bilban M, 2010, PLACENTA, V31, P989, DOI 10.1016/j.placenta.2010.08.011; Bilban M, 2009, ENDOCRINOLOGY, V150, P1000, DOI 10.1210/en.2008-0456; Bischof P, 2000, PLACENTA, V21, pS55, DOI 10.1053/plac.2000.0521; Bren-Mattison Y, 2005, ONCOGENE, V24, P1412, DOI 10.1038/sj.onc.1208333; Burton GJ, 1999, AM J OBSTET GYNECOL, V181, P718, DOI 10.1016/S0002-9378(99)70518-1; Burton GJ, 2002, J CLIN ENDOCR METAB, V87, P2954, DOI 10.1210/jc.87.6.2954; Burton GJ, 2010, INT J DEV BIOL, V54, P303, DOI 10.1387/ijdb.082764gb; Cervar M, 1999, CELL TISSUE RES, V295, P297, DOI 10.1007/s004410051236; Chakraborty C, 2002, CAN J PHYSIOL PHARM, V80, P116, DOI 10.1139/Y02-016; Chen JG, 2006, BIOCHEM BIOPH RES CO, V347, P821, DOI 10.1016/j.bbrc.2006.06.170; Cohen M, 2007, GYNECOL OBSTET INVES, V64, P126, DOI 10.1159/000101734; Condeelis J, 2003, NAT REV CANCER, V3, P921, DOI 10.1038/nrc1231; Cronier L, 2002, MOL HUM REPROD, V8, P1005, DOI 10.1093/molehr/8.11.1005; Csiszar K, 2001, PROG NUCLEIC ACID RE, V70, P1, DOI 10.1016/S0079-6603(01)70012-8; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Desvergne B, 1999, ENDOCR REV, V20, P649, DOI 10.1210/er.20.5.649; Duan SZ, 2007, J CLIN INVEST, V117, P812, DOI 10.1172/JCI28859; Durkin ME, 2005, FEBS LETT, V579, P1191, DOI 10.1016/j.febslet.2004.12.090; Erler JT, 2006, NATURE, V440, P1222, DOI 10.1038/nature04695; Fogelgren B, 2005, J BIOL CHEM, V280, P24690, DOI 10.1074/jbc.M412979200; Fong SFT, 2009, LOX LYSYL OXIDASE; Fong SFT, 2007, GENE CHROMOSOME CANC, V46, P644, DOI 10.1002/gcc.20444; Fournier T, 2007, PLACENTA, V28, pS76, DOI 10.1016/j.placenta.2006.12.006; Fournier T, 2007, PLACENTA, V28, P65, DOI 10.1016/j.placenta.2006.04.009; Fournier T, 2008, CURR MED CHEM, V15, P3011, DOI 10.2174/092986708786848677; Frendo JL, 2003, J CELL SCI, V116, P3413, DOI 10.1242/jcs.00648; Fryer LGD, 2002, J BIOL CHEM, V277, P25226, DOI 10.1074/jbc.M202489200; Fujiwara H, 2007, PLACENTA, V28, pS70, DOI 10.1016/j.placenta.2007.01.005; Gauster M, 2013, HISTOL HISTOPATHOL; GENBACEV O, 1993, PLACENTA, V14, P463, DOI 10.1016/S0143-4004(05)80466-7; Giampuzzi M, 2003, BBA-PROTEINS PROTEOM, V1647, P245, DOI 10.1016/S1570-9639(03)00059-1; Gleeson LM, 2001, J CLIN ENDOCR METAB, V86, P2484, DOI 10.1210/jc.86.6.2484; Handschuh K, 2007, PLACENTA, V28, P175, DOI 10.1016/j.placenta.2006.01.019; Hayashi K, 2004, J MOL HISTOL, V35, P845, DOI 10.1007/s10735-004-2340-1; Hein S, 2001, PLACENTA, V22, P49, DOI 10.1053/plac.2000.0580; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Jansen MK, 2007, MATRIX BIOL, V26, P136, DOI 10.1016/j.matbio.2006.09.004; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; Ji L, 2013, MOL ASPECTS MED, V34, P981, DOI 10.1016/j.mam.2012.12.008; Kabir-Salmani M, 2003, ENDOCRINOLOGY, V144, P1620, DOI 10.1210/en.2002-220886; Kibschull M, 2008, PLACENTA, V29, P848, DOI 10.1016/j.placenta.2008.07.013; Kliman HJ, 2000, AM J PATHOL, V157, P1759, DOI 10.1016/S0002-9440(10)64813-4; Knofler M, 2012, PLACENTA, V33, pS55, DOI 10.1016/j.placenta.2011.09.019; Knofler M, 2010, INT J DEV BIOL, V54, P269, DOI 10.1387/ijdb.082769mk; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Kveiborg M, 2008, INT J BIOCHEM CELL B, V40, P1685, DOI 10.1016/j.biocel.2008.01.025; Le Bouteiller P, 1999, IMMUNOL REV, V167, P233; Leach RE, 2004, DEV BIOL, V266, P223, DOI 10.1016/j.ydbio.2003.09.026; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li ZY, 2008, CLIN EXP METASTAS, V25, P893, DOI 10.1007/s10585-008-9208-9; Lucero HA, 2006, CELL MOL LIFE SCI, V63, P2304, DOI 10.1007/s00018-006-6149-9; Malassine A, 2005, BBA-BIOMEMBRANES, V1719, P117, DOI 10.1016/j.bbamem.2005.09.019; McCracken SA, 1999, BIOL REPROD, V60, P790, DOI 10.1095/biolreprod60.4.790; Mello MLS, 2011, MICRON, V42, P8, DOI 10.1016/j.micron.2010.09.001; MUHLHAUSER J, 1993, J HISTOCHEM CYTOCHEM, V41, P165, DOI 10.1177/41.2.8093455; MUHLHAUSER J, 1995, J HISTOCHEM CYTOCHEM, V43, P579, DOI 10.1177/43.6.7539466; Nadra K, 2010, ENDOCRINOLOGY, V151, P4969, DOI 10.1210/en.2010-0131; NARAYANAN AS, 1972, BIOCHEM BIOPH RES CO, V46, P745; Nishikawa M, 2005, HORM METAB RES, V37, P408, DOI 10.1055/s-2005-870229; Palamakumbura AH, 2004, J BIOL CHEM, V279, P40593, DOI 10.1074/jbc.M406639200; Payne SL, 2005, CANCER RES, V65, P11429, DOI 10.1158/0008-5472.CAN-05-1274; Payne SL, 2007, J CELL BIOCHEM, V101, P1338, DOI 10.1002/jcb.21371; Pidoux G, 2007, J CELL PHYSIOL, V212, P26, DOI 10.1002/jcp.20995; Postovit LM, 2008, J CELL BIOCHEM, V103, P1369, DOI 10.1002/jcb.21517; Ridley AJ, 2001, J CELL SCI, V114, P2713; Ridley AJ, 2003, SCIENCE, V302, P1704, DOI 10.1126/science.1092053; Rival Y, 2004, J PHARMACOL EXP THER, V311, P467, DOI 10.1124/jpet.104.068254; Roberts JM, 2001, LANCET, V357, P53, DOI 10.1016/S0140-6736(00)03577-7; Roth I, 1999, DEV BIOL, V205, P194, DOI 10.1006/dbio.1998.9122; Sato Y, 2002, J CLIN ENDOCR METAB, V87, P4287, DOI 10.1210/jc.2002-020038; Schaiff WT, 2000, J CLIN ENDOCR METAB, V85, P3874, DOI 10.1210/jc.85.10.3874; Schaiff WT, 2006, MOL CELL ENDOCRINOL, V249, P10, DOI 10.1016/j.mce.2006.02.009; Schaiff WT, 2005, J CLIN ENDOCR METAB, V90, P4267, DOI 10.1210/jc.2004-2265; Shalom-Barak T, 2004, MOL CELL BIOL, V24, P10661, DOI 10.1128/MCB.24.24.10661-10669.2004; Shalom-Barak T, 2012, DEV BIOL, V372, P143, DOI 10.1016/j.ydbio.2012.08.021; Shyu MK, 2008, BIOL REPROD, V79, P233, DOI 10.1095/biolreprod.108.067629; Shyu MK, 2011, J CLIN ENDOCR METAB, V96, P3759, DOI 10.1210/jc.2011-1368; Tarrade A, 2001, J CLIN ENDOCR METAB, V86, P5017, DOI 10.1210/jc.86.10.5017; Tarrade A, 2001, LAB INVEST, V81, P1199, DOI 10.1038/labinvest.3780334; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uzel MI, 2001, J BIOL CHEM, V276, P22537, DOI 10.1074/jbc.M102352200; Varley CL, 2004, J CELL SCI, V117, P2029, DOI 10.1242/jcs.01042; Waite LL, 2000, J CLIN ENDOCR METAB, V85, P3808, DOI 10.1210/jc.85.10.3808; Wang J, 2009, J ENDOCRINOL, V202, P337, DOI 10.1677/JOE-09-0136; Wang MH, 1999, DIABETES, V48, P254, DOI 10.2337/diabetes.48.2.254; Winn VD, 2009, ENDOCRINOLOGY, V150, P452, DOI 10.1210/en.2008-0990; Winterhager E, 1999, PLACENTA, V20, P627, DOI 10.1053/plac.1999.0434; Wu M, 2007, CANCER RES, V67, P6278, DOI 10.1158/0008-5472.CAN-07-0776; Xiong YL, 2013, J CELL PHYSIOL, V228, P362, DOI 10.1002/jcp.24139; Xu Y, 2007, J PHARM SCI-US, V96, P2582, DOI 10.1002/jps.20973; Yan XL, 2010, J CLIN ENDOCR METAB, V95, P1412, DOI 10.1210/jc.2009-2277; Yoon JC, 2000, MOL CELL BIOL, V20, P5343, DOI 10.1128/MCB.20.14.5343-5349.2000; Zhang T, 2009, CANCER LETT, V283, P59, DOI 10.1016/j.canlet.2009.03.025	100	20	20	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79413	10.1371/journal.pone.0079413	http://dx.doi.org/10.1371/journal.pone.0079413			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265769	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100102
J	Sonnleitner, M; Weis, B; Flatscher, R; Garcia, PE; Suda, J; Krejcikova, J; Schneeweiss, GM; Winkler, M; Schonswetter, P; Hulber, K				Sonnleitner, Michaela; Weis, Birgit; Flatscher, Ruth; Garcia, Pedro Escobar; Suda, Jan; Krejcikova, Jana; Schneeweiss, Gerald M.; Winkler, Manuela; Schoenswetter, Peter; Huelber, Karl			Parental Ploidy Strongly Affects Offspring Fitness in Heteroploid Crosses among Three Cytotypes of Autopolyploid Jacobaea carniolica (Asteraceae)	PLOS ONE			English	Article							CHAMERION-ANGUSTIFOLIUM ONAGRACEAE; DACTYLIS-GLOMERATA L; REPRODUCTIVE ISOLATION; SENECIO-CARNIOLICUS; CONTACT ZONE; TETRAPLOID ESTABLISHMENT; NICHE DIFFERENTIATION; ENDOSPERM DEVELOPMENT; DISTRIBUTION PATTERNS; HEXAPLOID CYTOTYPES	Reproductive interactions among cytotypes in their contact zones determine whether these cytotypes can co-exist and form stable contact zones or not. In autopolyploids, heteroploid cross-compatibilities might depend on parental ploidy, but tests of this hypothesis in autopolyploid systems with more than two ploidies are lacking. Here, we study Jacobaea carniolica, which comprises diploid, tetraploid, and hexaploid individuals regularly forming contact zones. Seeds obtained from in situ cross-pollinations within and among cytotypes were subjected to DNA flow cytometry and greenhouse germination experiments. Hybrid fitness and parental effects on hybrid fitness were tested with regression models comparing fitness parameters of early life stages. Irrespective of the direction of crosses, seed viability and seedling survival in diploid-polyploid crosses were substantially lower than in tetraploid-hexaploid crosses. In contrast, seedling growth traits indicated neither transgressive character expression nor any selection against hybrid offspring. Congruent with a model of genome dosage effects, these traits differed between reciprocal crosses, especially of diploids and tetraploids, where trait values resembled those of the maternal parent. The strong effect of parental ploidy on offspring fitness in heteroploid crosses may cause contact zones involving exclusively polyploid cytotypes to be less stable over longer terms than those involving diploids and polyploids.	[Sonnleitner, Michaela; Weis, Birgit; Flatscher, Ruth; Garcia, Pedro Escobar; Schneeweiss, Gerald M.; Winkler, Manuela] Univ Vienna, Dept Systemat & Evolutionary Bot, Vienna, Austria; [Flatscher, Ruth; Schoenswetter, Peter] Univ Innsbruck, Inst Bot, A-6020 Innsbruck, Austria; [Suda, Jan; Krejcikova, Jana] Charles Univ Prague, Fac Sci, Dept Bot, Prague, Czech Republic; [Suda, Jan; Krejcikova, Jana] Acad Sci Czech Republic, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Sonnleitner, Michaela; Huelber, Karl] Univ Vienna, Dept Conservat Biol Vegetat Ecol & Landscape Ecol, Vienna, Austria; [Huelber, Karl] Vienna Inst Nat Conservat & Anal, Vienna, Austria	University of Vienna; University of Innsbruck; Charles University Prague; Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; University of Vienna	Hulber, K (corresponding author), Univ Vienna, Dept Conservat Biol Vegetat Ecol & Landscape Ecol, Vienna, Austria.	karl.huelber@univie.ac.at	Winkler, Manuela/K-5434-2012; Schönswetter, Peter/T-8241-2017; Hülber, Karl/H-7822-2019; Schneeweiss, Gerald M./B-4344-2013; Sonnleitner, Michaela/N-3325-2019; Suda, Jan/D-3369-2013	Winkler, Manuela/0000-0002-8655-9555; Schönswetter, Peter/0000-0001-9225-4566; Hülber, Karl/0000-0001-9274-1647; Schneeweiss, Gerald M./0000-0003-2811-3317; Suda, Jan/0000-0001-8964-9153	Austrian Science Fund [P20736-B16]; Academy of Sciences of the Czech Republic [RVO 67985939]	Austrian Science Fund(Austrian Science Fund (FWF)); Academy of Sciences of the Czech Republic(Czech Academy of Sciences)	Funding for fieldwork, greenhouse experiments, and personnel costs was received from the Austrian Science Fund (P20736-B16 to PS followed by GMS; http://www.fwf.ac.at/). Flow cytometric analyses were supported by long-term research development project no. RVO 67985939 (Academy of Sciences of the Czech Republic; http://www.cas.cz/) and institutional resources of the Ministry of Education, Youth and Sports of the Czech Republic (http://www.msmt.cz/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott RJ, 2004, BIOL J LINN SOC, V82, P467, DOI 10.1111/j.1095-8312.2004.00333.x; ALAM MT, 1973, AM MIDL NAT, V90, P449, DOI 10.2307/2424467; ALLEN GA, 1983, BRITTONIA, V35, P353, DOI 10.2307/2805983; Baack EJ, 2005, EVOLUTION, V59, P1936; Baldwin SJ, 2011, P ROY SOC B-BIOL SCI, V278, P2011, DOI 10.1098/rspb.2010.2208; BARTON NH, 1985, ANNU REV ECOL SYST, V16, P113, DOI 10.1146/annurev.es.16.110185.000553; Bates D., 2008, LME4 LINEAR MIXED EF; BIRCHLER JA, 1993, ANNU REV GENET, V27, P181, DOI 10.1146/annurev.ge.27.120193.001145; Bretagnolle F. A., 1995, NEW PHYTOL, V1, P1; BRINK RA, 1947, BOT REV, V13, P423, DOI 10.1007/BF02861548; Buggs RJA, 2006, CURR BIOL, V16, P996, DOI 10.1016/j.cub.2006.03.093; Burton TL, 2000, EVOLUTION, V54, P1182, DOI 10.1111/j.0014-3820.2000.tb00553.x; Burton TL, 2001, HEREDITY, V87, P573, DOI 10.1046/j.1365-2540.2001.00955.x; Castro S, 2012, ANN BOT-LONDON, V110, P1047, DOI 10.1093/aob/mcs177; Castro S, 2011, EVOL ECOL, V25, P795, DOI 10.1007/s10682-010-9439-5; Chen ZJ, 2007, ANNU REV PLANT BIOL, V58, P377, DOI 10.1146/annurev.arplant.58.032806.103835; Comes HP, 1998, TRENDS PLANT SCI, V3, P432, DOI 10.1016/S1360-1385(98)01327-2; Dasmahapatra KK, 2002, EVOLUTION, V56, P741, DOI 10.1111/j.0014-3820.2002.tb01385.x; DEHAAN A, 1992, ANN BOT-LONDON, V69, P345; Dolezel J, 2007, NAT PROTOC, V2, P2233, DOI 10.1038/nprot.2007.310; Etterson JR, 2007, EVOLUTION, V61, P2671, DOI 10.1111/j.1558-5646.2007.00234.x; Felber F, 1997, BIOL J LINN SOC, V60, P95, DOI 10.1006/bijl.1996.0090; FelberGirard M, 1996, NEW PHYTOL, V133, P531, DOI 10.1111/j.1469-8137.1996.tb01921.x; Ferriol M, 2012, PLANT BIOSYST, V146, P86, DOI 10.1080/11263504.2012.727878; Flatscher R., 2010, THESIS U VIENNA VIEN; Garcia PE, 2012, MOL ECOL, V21, P1255, DOI 10.1111/j.1365-294X.2012.05456.x; Greiner R, 2012, FLORA, V207, P629, DOI 10.1016/j.flora.2012.07.001; HAIG D, 1991, PHILOS T ROY SOC B, V333, P1, DOI 10.1098/rstb.1991.0057; Hardy OJ, 2001, HEREDITY, V87, P136, DOI 10.1046/j.1365-2540.2001.00862.x; Hardy OJ, 2000, NEW PHYTOL, V146, P281, DOI 10.1046/j.1469-8137.2000.00631.x; Hauser TP, 2003, AM J BOT, V90, P571, DOI 10.3732/ajb.90.4.571; Hersch-Green EI, 2012, AM J BOT, V99, P1680, DOI 10.3732/ajb.1200253; Hopkins R, 2013, NEW PHYTOL, V197, P1095, DOI 10.1111/nph.12119; Hulber K, 2009, PRESLIA, V81, P309; Husband BC, 2004, NEW PHYTOL, V161, P703, DOI 10.1046/j.1469-8137.2004.00998.x; Husband BC, 1998, AM J BOT, V85, P1688, DOI 10.2307/2446502; Husband BC, 2002, P ROY SOC B-BIOL SCI, V269, P2565, DOI 10.1098/rspb.2002.2196; Husband BC, 2000, J ECOL, V88, P689, DOI 10.1046/j.1365-2745.2000.00481.x; JOHNSTON SA, 1980, THEOR APPL GENET, V57, P5, DOI 10.1007/BF00276002; Kennedy BF, 2006, OECOLOGIA, V150, P398, DOI 10.1007/s00442-006-0536-7; Kinoshita T, 2007, GENES GENET SYST, V82, P177, DOI 10.1266/ggs.82.177; Kohler C, 2010, TRENDS GENET, V26, P142, DOI 10.1016/j.tig.2009.12.006; Kolar F, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039988; Kolar F, 2009, ANN BOT-LONDON, V103, P963, DOI 10.1093/aob/mcp016; Koutecky P, 2012, PRESLIA, V84, P1; Koutecky P, 2011, BIOL J LINN SOC, V104, P93, DOI 10.1111/j.1095-8312.2011.01707.x; Krahulcova A, 1999, FOLIA GEOBOT, V34, P373, DOI 10.1007/BF02912821; Krahulcova Anna, 2000, Fragmenta Floristica et Geobotanica, V45, P239; Levin D. A., 1975, Taxon, V24, P35, DOI 10.2307/1218997; MACEIRA NO, 1992, ANN BOT-LONDON, V69, P335, DOI 10.1093/oxfordjournals.aob.a088350; Mandakova T, 2006, ANN BOT-LONDON, V98, P845, DOI 10.1093/aob/mcl165; MARKS GE, 1966, EVOLUTION, V20, P552, DOI [10.1111/j.1558-5646.1966.tb03385.x, 10.2307/2406589]; Martin NH, 2007, EVOLUTION, V61, P68, DOI 10.1111/j.1558-5646.2007.00006.x; NISHIYAMA I, 1966, JPN J GENET, V41, P27, DOI 10.1266/jjg.41.27; Olesen JM, 2002, ECOLOGY, V83, P2416, DOI 10.2307/3071803; Ortiz MA, 2006, AM J BOT, V93, P234, DOI 10.3732/ajb.93.2.234; Osborn TC, 2003, TRENDS GENET, V19, P141, DOI 10.1016/S0168-9525(03)00015-5; Otto SP, 2000, ANNU REV GENET, V34, P401, DOI 10.1146/annurev.genet.34.1.401; Parisod C, 2007, MOL ECOL, V16, P2755, DOI 10.1111/j.1365-294X.2007.03315.x; Peckert T, 2006, FOLIA GEOBOT, V41, P323, DOI 10.1007/BF02904945; Pellegrino G, 2010, SEX PLANT REPROD, V23, P281, DOI 10.1007/s00497-010-0138-8; Petit C, 1999, TRENDS ECOL EVOL, V14, P306, DOI 10.1016/S0169-5347(99)01608-0; Petit RJ, 2003, SCIENCE, V300, P1563, DOI 10.1126/science.1083264; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Raabova J, 2008, OECOLOGIA, V158, P463, DOI 10.1007/s00442-008-1156-1; Ramsey J, 1998, ANNU REV ECOL SYST, V29, P467, DOI 10.1146/annurev.ecolsys.29.1.467; Ramsey J, 2007, HEREDITY, V98, P143, DOI 10.1038/sj.hdy.6800912; Ramsey M, 2011, AUST J BOT, V59, P238, DOI 10.1071/BT10272; Richards A.J, 1997, PLANT BREEDING SYSTE; ROACH DA, 1987, ANNU REV ECOL SYST, V18, P209, DOI 10.1146/annurev.ecolsys.18.1.209; Scott RJ, 1998, DEVELOPMENT, V125, P3329; Segraves KA, 1999, EVOLUTION, V53, P1114, DOI 10.1111/j.1558-5646.1999.tb04526.x; Sonnleitner M, 2010, ANN BOT-LONDON, V106, P967, DOI 10.1093/aob/mcq192; Spaniel S, 2008, FOLIA GEOBOT, V43, P131, DOI 10.1007/s12224-008-9008-7; Stahlberg D, 2009, EVOL ECOL, V23, P295, DOI 10.1007/s10682-007-9228-y; Stoute AI, 2012, PLANT J, V71, P503, DOI 10.1111/j.1365-313X.2012.05015.x; Suda J, 2007, AM J BOT, V94, P1391, DOI 10.3732/ajb.94.8.1391; Sweigart AL, 2008, MOL ECOL, V17, P2089, DOI 10.1111/j.1365-294X.2008.03707.x; THOMPSON JD, 1992, TRENDS ECOL EVOL, V7, P302, DOI 10.1016/0169-5347(92)90228-4; VANDIJK P, 1990, HEREDITY, V65, P349, DOI 10.1038/hdy.1990.104; VANDIJK P, 1992, BIOL J LINN SOC, V46, P315, DOI 10.1111/j.1095-8312.1992.tb00867.x; Welch JJ, 2004, EVOLUTION, V58, P1145; Williams JH, 1999, P NATL ACAD SCI USA, V96, P9201, DOI 10.1073/pnas.96.16.9201; Wood TE, 2009, P NATL ACAD SCI USA, V106, P13875, DOI 10.1073/pnas.0811575106	84	32	32	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78959	10.1371/journal.pone.0078959	http://dx.doi.org/10.1371/journal.pone.0078959			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265735	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100068
J	Laha, KT; Ghosh, B; Czajkowski, C				Laha, Kurt T.; Ghosh, Borna; Czajkowski, Cynthia			Macroscopic Kinetics of Pentameric Ligand Gated Ion Channels: Comparisons between Two Prokaryotic Channels and One Eukaryotic Channel	PLOS ONE			English	Article							X-RAY-STRUCTURE; GABA(A) RECEPTORS; ACETYLCHOLINE-RECEPTOR; HIPPOCAMPAL-NEURONS; PORE DOMAIN; OPEN STATE; DESENSITIZATION; CONFORMATION; DETERMINANTS; MUTATIONS	Electrochemical signaling in the brain depends on pentameric ligand-gated ion channels (pLGICs). Recently, crystal structures of prokaryotic pLGIC homologues from Erwinia chrysanthemi (ELIC) and Gloeobacter violaceus (GLIC) in presumed closed and open channel states have been solved, which provide insight into the structural mechanisms underlying channel activation. Although structural studies involving both ELIC and GLIC have become numerous, thorough functional characterizations of these channels are still needed to establish a reliable foundation for comparing kinetic properties. Here, we examined the kinetics of ELIC and GLIC current activation, desensitization, and deactivation and compared them to the GABA(A) receptor, a prototypic eukaryotic pLGIC. Outside-out patch-clamp recordings were performed with HEK-293T cells expressing ELIC, GLIC, or alpha(1)beta(2)gamma(2L) GABA(A) receptors, and ultra-fast ligand application was used. In response to saturating agonist concentrations, we found both ELIC and GLIC current activation were two to three orders of magnitude slower than GABAA receptor current activation. The prokaryotic channels also had slower current desensitization on a timescale of seconds. ELIC and GLIC current deactivation following 25 s pulses of agonist (cysteamine and pH 4.0 buffer, respectively) were relatively fast with time constants of 24.9 +/- 5.1 ms and 1.2 +/- 0.2 ms, respectively. Surprisingly, ELIC currents evoked by GABA activated very slowly with a time constant of 1.3 +/- 0.3 s and deactivated even slower with a time constant of 4.6 +/- 1.2 s. We conclude that the prokaryotic pLGICs undergo similar agonist-mediated gating transitions to open and desensitized states as eukaryotic pLGICs, supporting their use as experimental models. Their uncharacteristic slow activation, slow desensitization and rapid deactivation time courses are likely due to differences in specific structural elements, whose future identification may help uncover mechanisms underlying pLGIC gating transitions.	[Laha, Kurt T.] Univ Wisconsin, Dept Anesthesiol, Madison, WI USA; [Ghosh, Borna; Czajkowski, Cynthia] Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA; [Ghosh, Borna; Czajkowski, Cynthia] Univ Wisconsin, Biophys Training Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Czajkowski, C (corresponding author), Univ Wisconsin, Dept Neurosci, Madison, WI 53706 USA.	cmczajko@wisc.edu		Ghosh, Borna/0000-0003-1952-6523	National Institutes of Health (NIH) [NS34727]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS034727, R01NS034727] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This research was supported by National Institutes of Health (NIH) Grant NS34727 awarded to CC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alqazzaz M, 2011, BIOPHYS J, V101, P2912, DOI 10.1016/j.bpj.2011.10.055; Bianchi MT, 2001, J NEUROSCI, V21, P1127; Bocquet N, 2007, NATURE, V445, P116, DOI 10.1038/nature05371; Bocquet N, 2009, NATURE, V457, P111, DOI 10.1038/nature07462; Colon-Saez JO, 2011, J PHYSIOL-LONDON, V589, P3163, DOI 10.1113/jphysiol.2011.209494; Dellisanti CD, 2011, J BIOL CHEM, V286, P3658, DOI 10.1074/jbc.M110.156851; Gonzalez-Gutierrez G, 2012, P NATL ACAD SCI USA, V109, P6331, DOI 10.1073/pnas.1119268109; Gonzalez-Gutierrez G, 2010, J MOL BIOL, V403, P693, DOI 10.1016/j.jmb.2010.09.026; Grutter T, 2005, P NATL ACAD SCI USA, V102, P18207, DOI 10.1073/pnas.0509024102; Gunthorpe NJ, 2001, PFLUG ARCH EUR J PHY, V442, P668; Hilf RJC, 2008, NATURE, V452, P375, DOI 10.1038/nature06717; Hilf RJC, 2009, NATURE, V457, P115, DOI 10.1038/nature07461; Howard RJ, 2011, P NATL ACAD SCI USA, V108, P12149, DOI 10.1073/pnas.1104480108; JONES MV, 1995, NEURON, V15, P181, DOI 10.1016/0896-6273(95)90075-6; Lewis TM, 2003, J PHYSIOL-LONDON, V549, P361, DOI 10.1113/jphysiol.2002.037796; Mott DD, 2001, J PHYSIOL-LONDON, V535, P427, DOI 10.1111/j.1469-7793.2001.00427.x; Mozrzymas JW, 2003, J NEUROPHYSIOL, V89, P871, DOI 10.1152/jn.00951.2002; NODA M, 1983, NATURE, V305, P818, DOI 10.1038/305818a0; Parikh RB, 2011, J BIOL CHEM, V286, P14098, DOI 10.1074/jbc.M111.221895; Petrini EM, 2003, J BIOL CHEM, V278, P16271, DOI 10.1074/jbc.M213081200; Scheller M, 2002, J NEUROSCI, V22, P8411; Shu HJ, 2004, J NEUROSCI, V24, P6667, DOI 10.1523/JNEUROSCI.1399-04.2004; Solt K, 2007, J NEUROSCI, V27, P13151, DOI 10.1523/JNEUROSCI.3772-07.2007; Spurny R, 2012, P NATL ACAD SCI USA, V109, pE3028, DOI 10.1073/pnas.1208208109; Tasneem A, 2005, GENOME BIOL, V6; Thompson AJ, 2012, NEUROPHARMACOLOGY, V63, P761, DOI 10.1016/j.neuropharm.2012.05.027; Velisetty P, 2012, J BIOL CHEM, V287, P18467, DOI 10.1074/jbc.M112.348045; Venkatachalan SP, 2007, PFLUG ARCH EUR J PHY, V454, P155, DOI 10.1007/s00424-006-0183-1; Weng Y, 2010, ANESTH ANALG, V110, P59, DOI 10.1213/ANE.0b013e3181c4bc69; Zimmermann I, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001429; Zimmermann I, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001101	31	14	14	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80322	10.1371/journal.pone.0080322	http://dx.doi.org/10.1371/journal.pone.0080322			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260369	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900064
J	Bardi, G; Nunes, A; Gherardini, L; Bates, K; Al-Jamal, KT; Gaillard, C; Prato, M; Bianco, A; Pizzorusso, T; Kostarelos, K				Bardi, Giuseppe; Nunes, Antonio; Gherardini, Lisa; Bates, Katie; Al-Jamal, Khuloud T.; Gaillard, Claire; Prato, Maurizio; Bianco, Alberto; Pizzorusso, Tommaso; Kostarelos, Kostas			Functionalized Carbon Nanotubes in the Brain: Cellular Internalization and Neuroinflammatory Responses	PLOS ONE			English	Article							HUNTINGTONS-DISEASE; NEURONAL GROWTH; GENE DELIVERY; MAST-CELLS; IN-VITRO; STIMULATION; PERSPECTIVES; ACTIVATION; RISKS; MODEL	The potential use of functionalized carbon nanotubes (f-CNTs) for drug and gene delivery to the central nervous system (CNS) and as neural substrates makes the understanding of their in vivo interactions with the neural tissue essential. The aim of this study was to investigate the interactions between chemically functionalized multi-walled carbon nanotubes (f-MWNTs) and the neural tissue following cortical stereotactic administration. Two different f-MWNT constructs were used in these studies: shortened (by oxidation) amino-functionalized MWNT (oxMWNT-NH3+) and amino-functionalized MWNT (MWNT-NH3+). Parenchymal distribution of the stereotactically injected f-MWNTs was assessed by histological examination. Both f-MWNT were uptaken by different types of neural tissue cells (microglia, astrocytes and neurons), however different patterns of cellular internalization were observed between the nanotubes. Furthermore, immunohistochemical staining for specific markers of glial cell activation (GFAP and CD11b) was performed and secretion of inflammatory cytokines was investigated using real-time PCR (qRT-PCR). Injections of both f-MWNT constructs led to a local and transient induction of inflammatory cytokines at early time points. Oxidation of nanotubes seemed to induce significant levels of GFAP and CD11b over-expression in areas peripheral to the f-MWNT injection site. These results highlight the importance of nanotube functionalization on their interaction with brain tissue that is deemed critical for the development nanotube-based vector systems for CNS applications.	[Bardi, Giuseppe; Gherardini, Lisa; Pizzorusso, Tommaso] CNR, Neurosci Inst, Pisa Area Recerca, I-56100 Pisa, Italy; [Bardi, Giuseppe; Gherardini, Lisa; Pizzorusso, Tommaso] IIT SSSA, Ctr MicroBioRobot, Pisa, Italy; [Nunes, Antonio; Bates, Katie; Al-Jamal, Khuloud T.; Kostarelos, Kostas] UCL, UCL Sch Pharm, Nanomed Lab, London, England; [Gaillard, Claire; Bianco, Alberto] CNRS, Inst Biol Mol & Cellulaire, UPR Immunol & Chim Therapeut 9021, F-67084 Strasbourg, France; [Prato, Maurizio] Univ Trieste, Dept Chem & Pharmaceut Sci, Trieste, Italy; [Pizzorusso, Tommaso] Univ Florence, Dept Psychol, Area San Salvi, Florence, Italy	Consiglio Nazionale delle Ricerche (CNR); Istituto Italiano di Tecnologia - IIT; University of London; University College London; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Trieste; University of Florence	Pizzorusso, T (corresponding author), CNR, Neurosci Inst, Pisa Area Recerca, I-56100 Pisa, Italy.	tommaso@in.cnr.it; k.kostarelos@ucl.ac.uk	Prato, Maurizio/G-7067-2012; Al-Jamal, Khuloud/ABD-5668-2021; Bardi, Giuseppe/B-6452-2013; Kostarelos, Kostas/AAP-6879-2021; Bardi, Giuseppe/K-7057-2019; Pizzorusso, Tommaso/D-1399-2013	Prato, Maurizio/0000-0002-8869-8612; Bardi, Giuseppe/0000-0001-9662-3007; Kostarelos, Kostas/0000-0002-2224-6672; Bardi, Giuseppe/0000-0001-9662-3007; gherardini, lisa/0000-0002-7003-4295; AL-JAMAL, KHULOUD/0000-0001-5165-2699; Gaillard, Claire/0000-0002-0630-510X; Nunes, Antonio/0000-0002-9014-9030; Pizzorusso, Tommaso/0000-0001-5614-0668	European Union [NMP4-CT-2006-033378, ERC-2008-AdG-227135]; Regione Toscana Project CANESTRO; University of Trieste; Italian Ministry of Education MIUR [2010N3T9M4]; "Centre National de la Recherche Scientifique"	European Union(European Commission); Regione Toscana Project CANESTRO; University of Trieste; Italian Ministry of Education MIUR(Ministry of Education, Universities and Research (MIUR)); "Centre National de la Recherche Scientifique"(Centre National de la Recherche Scientifique (CNRS))	Financial support is acknowledged by the European Union FP6 NINIVE (NMP4-CT-2006-033378) and Regione Toscana Project CANESTRO. This work was partly financed by the European Union FP7 ERC Advanced Grant Carbonanobridge (ERC-2008-AdG-227135), the University of Trieste, the Italian Ministry of Education MIUR (Cofin Prot. 2010N3T9M4) and by the "Centre National de la Recherche Scientifique". The authors wish to thank Dr. Shouping Li for the preparation of amidated MWNTs and acknowledge the Electron Microscope Unit at UCL Institute of Neurology, Queen Square, London, UK for the collaboration. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Jamal KT, 2012, ANGEW CHEM INT EDIT, V51, P6389, DOI 10.1002/anie.201201991; Al-Jamal KT, 2011, P NATL ACAD SCI USA, V108, P10952, DOI 10.1073/pnas.1100930108; Al-Jamal KT, 2011, NANOSCALE, V3, P2627, DOI 10.1039/c1nr10080g; Banati RB, 2003, BRIT MED BULL, V65, P121, DOI 10.1093/bmb/65.1.121; Bardi G, 2009, NANOMED-NANOTECHNOL, V5, P96, DOI 10.1016/j.nano.2008.06.008; Bjartmarz H, 2007, STEREOT FUNCT NEUROS, V85, P235, DOI 10.1159/000103262; Cellot G, 2010, SMALL, V6, P2630, DOI 10.1002/smll.201000906; Cellot G, 2009, NAT NANOTECHNOL, V4, P126, DOI [10.1038/NNANO.2008.374, 10.1038/nnano.2008.374]; Fasano A, 2012, LANCET NEUROL, V11, P429, DOI 10.1016/S1474-4422(12)70049-2; Gaillard C, 2009, ADV MATER, V21, P2903, DOI 10.1002/adma.200900050; Gallina P, 2008, STEREOT FUNCT NEUROS, V86, P308, DOI 10.1159/000155233; Georgakilas V, 2002, J AM CHEM SOC, V124, P760, DOI 10.1021/ja016954m; Hu H, 2004, NANO LETT, V4, P507, DOI 10.1021/nl035193d; Kang GA, 2011, J NEUROL NEUROSUR PS, V82, P272, DOI 10.1136/jnnp.2009.202903; Kateb B, 2007, NEUROIMAGE, V37, pS9, DOI 10.1016/j.neuroimage.2007.03.078; Khalil IA, 2006, PHARMACOL REV, V58, P32, DOI 10.1124/pr.58.1.8; Kostarelos K, 2007, NAT NANOTECHNOL, V2, P108, DOI 10.1038/nnano.2006.209; Lacerda L, 2012, BIOMATERIALS, V33, P3334, DOI 10.1016/j.biomaterials.2012.01.024; Lee HJ, 2011, NAT NANOTECHNOL, V6, P120, DOI 10.1038/nnano.2010.281; Malarkey EB, 2007, NEURODEGENER DIS, V4, P292, DOI 10.1159/000101885; Matsumoto K, 2007, J BIOSCI BIOENG, V103, P216, DOI 10.1263/jbb.103.216; Mattson MP, 2000, J MOL NEUROSCI, V14, P175, DOI 10.1385/JMN:14:3:175; Metcalfe DD, 1997, PHYSIOL REV, V77, P1033, DOI 10.1152/physrev.1997.77.4.1033; Mu QX, 2009, NANO LETT, V9, P4370, DOI 10.1021/nl902647x; Murphy FA, 2011, AM J PATHOL, V178, P2587, DOI 10.1016/j.ajpath.2011.02.040; Nunes A, 2012, ARCH TOXICOL, V86, P1009, DOI 10.1007/s00204-012-0860-0; Nunes A, 2012, NANOMEDICINE-UK, V7, P1485, DOI [10.2217/NNM.12.33, 10.2217/nnm.12.33]; Perez-Martinez FC, 2011, PHARM RES-DORDR, V28, P1843, DOI 10.1007/s11095-010-0364-7; Podesta JE, 2009, SMALL, V5, P1176, DOI 10.1002/smll.200801572; PURCELL WM, 1995, NEUROCHEM RES, V20, P521, DOI 10.1007/BF01694534; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; Roman JA, 2011, J NEUROTRAUM, V28, P2349, DOI 10.1089/neu.2010.1409; Roy A, 2006, J BIOL CHEM, V281, P14971, DOI 10.1074/jbc.M600236200; Sayes CM, 2006, TOXICOL LETT, V161, P135, DOI 10.1016/j.toxlet.2005.08.011; Shih AY, 2006, J NEUROSCI, V26, P3887, DOI 10.1523/JNEUROSCI.0936-06.2006; Streit WJ, 1999, PROG NEUROBIOL, V57, P563, DOI 10.1016/S0301-0082(98)00069-0; Zhao DC, 2011, CLIN CANCER RES, V17, P771, DOI 10.1158/1078-0432.CCR-10-2444	37	68	70	0	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80964	10.1371/journal.pone.0080964	http://dx.doi.org/10.1371/journal.pone.0080964			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260521	Green Published, gold			2022-12-25	WOS:000327308500187
J	Comim, FV; Hardy, K; Franks, S				Comim, Fabio V.; Hardy, Kate; Franks, Stephen			Adiponectin and Its Receptors in the Ovary: Further Evidence for a Link between Obesity and Hyperandrogenism in Polycystic Ovary Syndrome	PLOS ONE			English	Article							THECAL CELL STEROIDOGENESIS; RANDOMIZED CONTROLLED-TRIALS; ANDROGEN PRODUCTION; SURFACE EPITHELIUM; WOMEN; INSULIN; LEPTIN; EXPRESSION; PROTEIN; GENE	Polycystic ovary syndrome (PCOS), characterized by ovarian androgen excess, is the commonest endocrine disorder in women. Obesity increases androgen synthesis, a phenomenon attributed to the accompanying hyperinsulinemia. Our hypothesis was that adipokines, fat cell-derived hormones, play a direct role in modulating ovarian androgen secretion. Therefore, the aims of this study were to explore the effects of adipokines (in particular, adiponectin) on ovarian steroidogenesis and compare the expression of adiponectin receptors in ovaries from women with and without PCO. Sections of archived human ovaries (nine from women with normal ovaries and 16 with PCOS, classified histologically, with reference to menstrual history and ultrasound) were analysed by quantitative morphometry and the proportion of positive-labelling cells compared. In addition, studies of androgen production in relation to adipokine function in primary bovine theca cell culture were also performed. A significantly lower proportion of theca cells expressed adiponectin receptors 1 and 2 (AdipoR1, AdipoR2) in polycystic ovaries than in normal ovaries. In cultured theca cells, adiponectin suppressed androstenedione production and gene expression of LH receptor and key enzymes in the androgen synthesis pathway. Moreover, knockdown of genes for AdipoR1 and AdipoR2 was associated with increased androstenedione secretion by bovine theca cells. These results provide evidence for a direct link between fat cell metabolism and ovarian steroidogenesis, suggesting that disruption of adiponectin and/or its receptors plays a key role in pathogenesis of hyperandrogenism in PCOS.	[Comim, Fabio V.; Hardy, Kate; Franks, Stephen] Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England; [Comim, Fabio V.] Univ Fed Santa Maria, Santa Maria, RS, Brazil	Imperial College London; Universidade Federal de Santa Maria (UFSM)	Franks, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Reprod & Dev Biol, London, England.	s.franks@imperial.ac.uk	Comim, Fabio Vasconcellos/L-1298-2015	Comim, Fabio Vasconcellos/0000-0002-2726-233X	Medical Research Council (MRC) UK [G0802782]; Capes Foundation (Brazilian Ministry of Education), Brazil; MRC [G0802782] Funding Source: UKRI; Medical Research Council [G0802782, 1241993] Funding Source: researchfish	Medical Research Council (MRC) UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Capes Foundation (Brazilian Ministry of Education), Brazil; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Medical Research Council (MRC) UK (Programme grant ref G0802782); FVC was supported by Capes Foundation (Brazilian Ministry of Education), Brazil. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barber TM, 2006, CLIN ENDOCRINOL, V65, P137, DOI 10.1111/j.1365-2265.2006.02587.x; Barber TM, 2008, J CLIN ENDOCR METAB, V93, P2859, DOI 10.1210/jc.2007-2759; Brzechffa PR, 1996, J CLIN ENDOCR METAB, V81, P4166, DOI 10.1210/jc.81.11.4166; Carmina E, 2009, FERTIL STERIL, V91, P1332, DOI 10.1016/j.fertnstert.2008.03.007; Chabrolle C, 2009, FERTIL STERIL, V92, P1988, DOI 10.1016/j.fertnstert.2008.09.008; Cosma M, 2008, J CLIN ENDOCR METAB, V93, P1135, DOI 10.1210/jc.2007-2429; Dharia S, 2004, BIOL REPROD, V71, P83, DOI 10.1095/biolreprod.103.026732; Diamanti-Kandarakis E, 1999, J CLIN ENDOCR METAB, V84, P4006, DOI 10.1210/jc.84.11.4006; FRANKS S, 1995, NEW ENGL J MED, V333, P853, DOI 10.1056/NEJM199509283331307; Franks S, 2006, REPROD BIOMED ONLINE, V12, P526, DOI 10.1016/S1472-6483(10)61177-7; GillingSmith C, 1997, CLIN ENDOCRINOL, V47, P93, DOI 10.1046/j.1365-2265.1997.2321049.x; Glister C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049553; Hall N, 2009, J ENDOCRINOL INVEST, V32, P279, DOI 10.1007/BF03346467; Lagaly DV, 2008, MOL CELL ENDOCRINOL, V284, P38, DOI 10.1016/j.mce.2008.01.007; Li SS, 2009, JAMA-J AM MED ASSOC, V302, P179, DOI 10.1001/jama.2009.976; Maillard V, 2010, REPROD BIOL ENDOCRIN, V8, DOI 10.1186/1477-7827-8-23; Nelson VL, 1999, MOL ENDOCRINOL, V13, P946, DOI 10.1210/me.13.6.946; Nelson-Degrave VL, 2005, MOL ENDOCRINOL, V19, P379, DOI 10.1210/me.2004-0178; Panidis D, 2008, EUR J INTERN MED, V19, P406, DOI 10.1016/j.ejim.2007.05.014; Papacleovoulou G, 2009, MOL HUM REPROD, V15, P379, DOI 10.1093/molehr/gap022; Papacleovoulou G, 2009, MOL CELL ENDOCRINOL, V301, P65, DOI 10.1016/j.mce.2008.08.010; Phelan N, 2011, AM J CLIN NUTR, V93, P652, DOI 10.3945/ajcn.110.005538; Pusalkar M, 2010, GYNECOL ENDOCRINOL, V26, P874, DOI 10.3109/09513590.2010.487586; Rainey WE, 1996, J CLIN ENDOCR METAB, V81, P257, DOI 10.1210/jc.81.1.257; Raucci R, 2013, CYTOKINE, V61, P1, DOI 10.1016/j.cyto.2012.08.036; Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group, 2004, HUM REPROD, V81, P19, DOI DOI 10.1093/HUMREP/DEH098.PUBMED:14688154; Seow KM, 2009, REPROD BIOMED ONLINE, V19, P577, DOI 10.1016/j.rbmo.2009.05.003; Spicer LJ, 1998, BIOL REPROD, V58, P207, DOI 10.1095/biolreprod58.1.207; Spritzer PM, 2005, HORM METAB RES, V37, P94, DOI 10.1055/s-2005-861173; Stewart RE, 1995, J ANIM SCI, V73, P3719; Stubbs SA, 2005, J CLIN ENDOCR METAB, V90, P5536, DOI 10.1210/jc.2005-0907; Stubbs SA, 2007, J CLIN ENDOCR METAB, V92, P4418, DOI 10.1210/jc.2007-0729; Swiglo BA, 2008, J CLIN ENDOCR METAB, V93, P1153, DOI 10.1210/jc.2007-2430; Tan BK, 2006, DIABETOLOGIA, V49, P2723, DOI 10.1007/s00125-006-0419-9; Wickenheisser JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048963; Yildizhan R, 2011, FERTIL STERIL, V96, P246, DOI 10.1016/j.fertnstert.2011.04.073; Zhang N, 2008, EUR J ENDOCRINOL, V158, P255, DOI 10.1530/EJE-07-0576	37	64	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80416	10.1371/journal.pone.0080416	http://dx.doi.org/10.1371/journal.pone.0080416			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260388	gold, Green Submitted, Green Published			2022-12-25	WOS:000327308500136
J	Hohman, TJ; Koran, ME; Thornton-Wells, T				Hohman, Timothy J.; Koran, Mary Ellen; Thornton-Wells, Tricia		Alzheimer's Neuroimaging Initiativ	Epistatic Genetic Effects among Alzheimer's Candidate Genes	PLOS ONE			English	Article							WHOLE-GENOME ASSOCIATION; DIAGNOSTIC GUIDELINES; QUANTITATIVE TRAIT; NATIONAL INSTITUTE; WIDE ASSOCIATION; PICALM; DISEASE; CR-1; CLU; RECOMMENDATIONS	Background: Novel risk variants for late-onset Alzheimer's disease (AD) have been identified and replicated in genome-wide association studies. Recent work has begun to address the relationship between these risk variants and biomarkers of AD, though results have been mixed. The aim of the current study was to characterize single marker and epistatic genetic effects between the top candidate Single Nucleotide Polymorphisms (SNPs) in relation to amyloid deposition. Methods: We used a combined dataset across ADNI-1 and ADNI-2, and looked within each dataset separately to validate identified genetic effects. Amyloid was quantified using data acquired by Positron Emission Tomography (PET) with 18F-AV-45. Results: Two SNP-SNP interactions reached significance when correcting for multiple comparisons, BIN1 (rs7561528, rs744373) x PICALM (rs7851179). Carrying the minor allele in BIN1 was related to higher levels of amyloid deposition, however only in non-carriers of the protective PICALM minor allele. Conclusions: Our results support previous research suggesting these candidate SNPs do not show single marker associations with amyloid pathology. However, we provide evidence for a novel interaction between PICALM and BIN1 in relation to amyloid deposition. Risk related to the BIN1 minor allele appears to be mitigated in the presence of the PICALM protective variant. In that way, variance in amyloid plaque burden can be better classified within the context of a complex genetic background. Efforts to model cumulative risk for AD should explicitly account for this epistatic effect, and future studies should explicitly test for such effects whenever statistically feasible.	[Hohman, Timothy J.; Koran, Mary Ellen; Thornton-Wells, Tricia; Alzheimer's Neuroimaging Initiativ] Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet & Res, Nashville, TN 37212 USA	Vanderbilt University	Hohman, TJ (corresponding author), Vanderbilt Univ, Sch Med, Dept Mol Physiol & Biophys, Ctr Human Genet & Res, Nashville, TN 37212 USA.	Timothyjhohman@gmail.com	Hohman, Timothy/AFN-9053-2022	Hohman, Timothy/0000-0002-3377-7014	Vanderbilt National Institute of Mental Health Neurogenomics Training grant [T32 MH65215]; Vanderbilt Medical Scientist Training Program [T32 GM07347]; Recruitment for Genetic Aging Research [P30 AG036445]; Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health) [U01 AG024904]; National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering; Foundation or the National Institutes of Health; National Institutes of Health [P30 AG010129, K01 AG030514]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007347] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [T32MH065215] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K01AG030514, P30AG036445, U01AG024904, P30AG010129] Funding Source: NIH RePORTER	Vanderbilt National Institute of Mental Health Neurogenomics Training grant; Vanderbilt Medical Scientist Training Program; Recruitment for Genetic Aging Research; Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics; Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); Foundation or the National Institutes of Health; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was supported in part by the Vanderbilt National Institute of Mental Health Neurogenomics Training grant (T32 MH65215), the Vanderbilt Medical Scientist Training Program (T32 GM07347), the Recruitment for Genetic Aging Research (P30 AG036445), and the Pharmaceutical Research and Manufacturers of America Foundation Fellowship in Translational Medicine and Therapeutics. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. Data collection and sharing for this project was funded by Alzheimer's Disease Neuroimaging Initiative (ADNI) (National Institutes of Health Grant U01 AG024904). ADNI is funded by the National Institute on Aging, the National Institute of Biomedical Imaging and Bioengineering, and through generous contributions from the following: Abbott; Alzheimer's Association; Alzheimer's Drug Discovery Foundation; Amorfix Life Sciences Ltd; AstraZeneca; Bayer HealthCare; BioClinica, Inc; Biogen Idec Inc; Bristol-Myers Squibb Company; Eisai Inc; Elan Pharmaceuticals Inc; Eli Lilly and Company; F. Hoffmann-La Roche Ltd and its affiliated company Genentech, Inc; GE Healthcare; Innogenetics, N. V.; IXICO Ltd; Janssen Alzheimer Immunotherapy Research & Development, LLC.; Johnson & Johnson Pharmaceutical Research & Development LLC.; Medpace, Inc; Merck & Co, Inc; Meso Scale Diagnostics, LLC.; Novartis Pharmaceuticals Corporation; Pfizer Inc; Servier; Synarc Inc; and Takeda Pharmaceutical Company. The Canadian Institutes of Health Research is providing funds to support ADNI clinical sites in Canada. Private sector contributions are facilitated by the Foundation or the National Institutes of Health (www.fnih.org). The grantee organization is the Northern California Institute for Research and Education, and the study is coordinated by the Alzheimer's Disease Cooperative Study at the University of California, San Diego. ADNI data are disseminated by the Laboratory for NeuroImaging at the University of California, Los Angeles. This research was also supported by National Institutes of Health grants P30 AG010129 and K01 AG030514.	Albert MS, 2011, ALZHEIMERS DEMENT, V7, P270, DOI 10.1016/j.jalz.2011.03.008; Baig S, 2010, J NEUROPATH EXP NEUR, V69, P1071, DOI 10.1097/NEN.0b013e3181f52e01; Boehm C, 2012, ALZHEIMERS DEMENT, V8, pP652, DOI [10.1016/j.jalz.2012.05.2175, DOI 10.1016/J.JALZ.2012.05.2175]; Carrasquillo MM, 2010, ARCH NEUROL-CHICAGO, V67, P961, DOI 10.1001/archneurol.2010.147; Carter Chris, 2011, Int J Alzheimers Dis, V2011, P501862, DOI 10.4061/2011/501862; Chibnik LB, 2011, ANN NEUROL, V69, P560, DOI 10.1002/ana.22277; Driscoll I, 2012, ACTA NEUROPATHOL, P1; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hu XD, 2011, J COMB OPTIM, V21, P1, DOI 10.1007/s10878-010-9361-3; Jagust WJ, 2009, NEUROLOGY, V73, P1193, DOI 10.1212/WNL.0b013e3181bc010c; Jun G, 2010, ARCH NEUROL-CHICAGO, V67, P1473, DOI 10.1001/archneurol.2010.201; Kauwe JSK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015918; Kingwell Katie, 2013, Nat Rev Neurol, V9, P184, DOI 10.1038/nrneurol.2013.34; Landau S, 2011, FLORBETAPIR PROCESSI; Neale BM, 2004, AM J HUM GENET, V75, P353, DOI 10.1086/423901; Pontecorvo MJ, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt70; Potkin SG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006501; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Shen L, 2010, NEUROIMAGE, V53, P1051, DOI 10.1016/j.neuroimage.2010.01.042; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; Thambisetty M, 2013, BIOL PSYCHIAT, V73, P422, DOI 10.1016/j.biopsych.2012.08.015; Thambisetty M, 2012, NEUROIMAGE, V59, P212, DOI 10.1016/j.neuroimage.2011.07.056; Xiao QL, 2012, J BIOL CHEM, V287, P21279, DOI 10.1074/jbc.M111.338376	24	20	20	1	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80839	10.1371/journal.pone.0080839	http://dx.doi.org/10.1371/journal.pone.0080839			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260488	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500179
J	Saint-Cyr, MJ; Perrin-Guyomard, A; Houee, P; Rolland, JG; Laurentie, M				Saint-Cyr, Manuel J.; Perrin-Guyomard, Agnes; Houee, Pamela; Rolland, Jean-Guy; Laurentie, Michel			Evaluation of an Oral Subchronic Exposure of Deoxynivalenol on the Composition of Human Gut Microbiota in a Model of Human Microbiota-Associated Rats	PLOS ONE			English	Article							FUSARIUM TOXIN DEOXYNIVALENOL; LACTIC-ACID BACTERIA; REAL-TIME PCR; TRICHOTHECENE MYCOTOXINS; FECAL MICROBIOTA; IN-VITRO; URINARY DEOXYNIVALENOL; FUMONISIN B-1; HEALTH; WHEAT	Background: Deoxynivalenol (DON), a mycotoxin produced by Fusarium species, is one of the most prevalent mycotoxins present in cereal crops worldwide. Due to its toxic properties, high stability and prevalence, the presence of DON in the food chain represents a health risk for both humans and animals. The gastrointestinal microbiota represents potentially the first target for these food contaminants. Thus, the effects of mycotoxins on the human gut microbiota is clearly an issue that needs to be addressed in further detail. Using a human microbiota-associated rat model, the aim of the present study was to evaluate the impact of a chronic exposure of DON on the composition of human gut microbiota. Methodology/Principal Findings: Four groups of 5 germ free male rats each, housed in 4 sterile isolators, were inoculated with a different fresh human fecal flora. Rats were then fed daily by gavage with a solution of DON at 100 mu g/kg bw for 4 weeks. Fecal samples were collected at day 0 before the beginning of the treatment; days 7, 16, 21, and 27 during the treatment; and 10 days after the end of the treatment at day 37. DON effect was assessed by real-time PCR quantification of dominant and subdominant bacterial groups in feces. Despite a different intestinal microbiota in each isolator, similar trends were generally observed. During oral DON exposure, a significant increase of 0.5 log10 was observed for the Bacteroides/Prevotella group during the first 3 weeks of administration. Concentration levels for Escherichia coli decreased at day 27. This significant decrease (0.9 log10 CFU/g) remained stable until the end of the experiment. Conclusions/Significance: We have demonstrated an impact of oral DON exposure on the human gut microbiota composition. These findings can serve as a template for risk assessment studies of food contaminants on the human gut microbiota.	[Saint-Cyr, Manuel J.; Perrin-Guyomard, Agnes; Houee, Pamela] Anses, Fougeres Lab, Antibiot Biocides Residues & Resistance Unit, Fougeres, France; [Rolland, Jean-Guy; Laurentie, Michel] Anses, Fougeres Lab, Sci Support Unit, Fougeres, France	Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres; Agence Nationale de Securite Sanitaire de l'Alimentation, de l'Environnement du Travail (ANSES); Laboratoire de Fougeres	Saint-Cyr, MJ (corresponding author), Anses, Fougeres Lab, Antibiot Biocides Residues & Resistance Unit, Fougeres, France.	manuel.saint-cyr@anses.fr		Perrin, Agnes/0000-0002-4078-188X; Michel, Laurentie/0000-0002-3677-5401	French agency for food, environmental and occupational health and safety (Anses)	French agency for food, environmental and occupational health and safety (Anses)(French National Research Agency (ANR))	This work was funded by the French agency for food, environmental and occupational health and safety (Anses). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amuzie CJ, 2008, TOXICOLOGY, V248, P39, DOI 10.1016/j.tox.2008.03.005; ATKINSON HAC, 1984, TOXICOL LETT, V23, P215, DOI 10.1016/0378-4274(84)90129-2; Awad WA, 2006, POULTRY SCI, V85, P974, DOI 10.1093/ps/85.6.974; Becker B, 1997, WORLD J MICROB BIOT, V13, P539, DOI 10.1023/A:1018513308847; Bernbom N, 2006, J MICROBIOL METH, V66, P87, DOI 10.1016/j.mimet.2005.10.014; BHAT RV, 1989, LANCET, V1, P35; Burel C, 2013, TOXINS, V5, P841, DOI 10.3390/toxins5040841; Canady C.R., 2001, WHO FOOD ADDITIVES S, P419; CAST, 2003, MYCOTOXINS RISKS PLA; Clemente JC, 2012, CELL, V148, P1258, DOI 10.1016/j.cell.2012.01.035; Dicksved J, 2008, ISME J, V2, P716, DOI 10.1038/ismej.2008.37; DUCLUZEAU R, 1984, ANN INST PASTEUR MIC, VA135, P303, DOI 10.1016/S0769-2609(84)80013-7; El-Nezami HS, 2002, FOOD ADDIT CONTAM, V19, P680, DOI 10.1080/02652030210134236; Fraher MH, 2012, NAT REV GASTROENTERO; Franco TS, 2011, J APPL MICROBIOL, V111, P739, DOI 10.1111/j.1365-2672.2011.05074.x; Frese SA, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1001314; Furet JP, 2009, FEMS MICROBIOL ECOL, V68, P351, DOI 10.1111/j.1574-6941.2009.00671.x; Goyarts T, 2006, TOXICOL LETT, V163, P171, DOI 10.1016/j.toxlet.2005.10.007; Gratz SW, 2013, APPL ENVIRON MICROB, V79, P1821, DOI 10.1128/AEM.02987-12; Guan S, 2009, AQUACULTURE, V290, P290, DOI 10.1016/j.aquaculture.2009.02.037; HE P, 1992, APPL ENVIRON MICROB, V58, P3857, DOI 10.1128/AEM.58.12.3857-3863.1992; HIRAYAMA K, 1991, Microbial Ecology in Health and Disease, V4, P95; Huijsdens XW, 2002, J CLIN MICROBIOL, V40, P4423, DOI 10.1128/JCM.40.12.4423-4427.2002; Islam MR, 2013, TOXICOL LETT, V221, P152, DOI 10.1016/j.toxlet.2013.05.656; Islam R, 2012, WORLD J MICROB BIOT, V28, P7, DOI 10.1007/s11274-011-0785-4; Ito M, 2012, APPL MICROBIOL BIOT, P1; Ito M, 2013, APPL ENVIRON MICROB, V79, P1619, DOI 10.1128/AEM.03227-12; Iverson F, 1995, TERATOGEN CARCIN MUT, V15, P283, DOI 10.1002/tcm.1770150606; Johnson GL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0040022; Kollarczik Birgit, 1994, Natural Toxins, V2, P105, DOI 10.1002/nt.2620020303; Le Bail M, 2005, REGUL TOXICOL PHARM, V42, P253, DOI 10.1016/j.yrtph.2005.04.001; Leblanc JC, 2002, REGUL TOXICOL PHARM, V36, P149, DOI 10.1006/rtph.2002.1584; LUO XY, 1988, ISSUES FOOD SAFETY, P56; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Nadal I, 2007, J MED MICROBIOL, V56, P1669, DOI 10.1099/jmm.0.47410-0; Nagl V, 2012, TOXICOL LETT, V213, P367, DOI 10.1016/j.toxlet.2012.07.024; Niderkorn V, 2006, J APPL MICROBIOL, V101, P849, DOI 10.1111/j.1365-2672.2006.02958.x; Oswald IP, 2003, APPL ENVIRON MICROB, V69, P5870, DOI 10.1128/AEM.69.10.5870-5874.2003; Perrin-Guyomard A, 2006, REGUL TOXICOL PHARM, V45, P66, DOI 10.1016/j.yrtph.2006.02.002; Pestka JJ, 2007, ANIM FEED SCI TECH, V137, P283, DOI 10.1016/j.anifeedsci.2007.06.006; Pestka JJ, 2010, ARCH TOXICOL, V84, P663, DOI 10.1007/s00204-010-0579-8; RAMAKRISHNA Y, 1989, APPL ENVIRON MICROB, V55, P2619, DOI 10.1128/AEM.55.10.2619-2620.1989; Rinttila T, 2004, J APPL MICROBIOL, V97, P1166, DOI 10.1111/j.1365-2672.2004.02409.x; Rotter BA, 1996, J TOXICOL ENV HEALTH, V48, P1, DOI 10.1080/009841096161447; Sato I, 2012, FEMS MICROBIOL LETT, V327, P110, DOI 10.1111/j.1574-6968.2011.02461.x; Schothorst RC, 2004, TOXICOL LETT, V153, P133, DOI 10.1016/j.toxlet.2004.04.045; Sirot V, 2013, FOOD CHEM TOXICOL, V52, P1, DOI 10.1016/j.fct.2012.10.036; Sorensen LK, 2005, J CHROMATOGR B, V820, P183, DOI 10.1016/j.jchromb.2005.03.020; TENK I, 1982, ZBL BAKT-INT J MED M, V252, P384; Turner PC, 2008, FOOD CHEM TOXICOL, V46, P2118, DOI 10.1016/j.fct.2008.02.004; Turner PC, 2008, FOOD ADDIT CONTAM A, V25, P864, DOI 10.1080/02652030801895040; Turner PC, 2008, ENVIRON HEALTH PERSP, V116, P21, DOI 10.1289/ehp.10663; Turner PC, 2011, FOOD CHEM TOXICOL, V49, P132, DOI 10.1016/j.fct.2010.10.007; Turner PC, 2010, J AGR FOOD CHEM, V58, P5206, DOI 10.1021/jf100892v; Wache YJ, 2009, INT J MOL SCI, V10, P1, DOI 10.3390/ijms10010001; Warth B, 2012, TOXICOL LETT, V211, P85, DOI 10.1016/j.toxlet.2012.02.023; Wos-Oxley ML, 2012, GUT MICROBES, V3, P234, DOI 10.4161/gmic.19934; Yi P, 2011, VET MICROBIOLOGY; Young JC, 2007, FOOD CHEM TOXICOL, V45, P136, DOI 10.1016/j.fct.2006.07.028; Yu H, 2010, BMC MICROBIOL, V10, DOI 10.1186/1471-2180-10-182; Zhou T, 2008, WORLD MYCOTOXIN J, V1, P23, DOI 10.3920/WMJ2008.x003; Zou ZY, 2012, FOOD SCI BIOTECHNOL, V21, P1677, DOI 10.1007/s10068-012-0223-x	62	43	44	1	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80578	10.1371/journal.pone.0080578	http://dx.doi.org/10.1371/journal.pone.0080578			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260424	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500157
J	Honarnejad, K; Daschner, A; Giese, A; Zall, A; Schmidt, B; Szybinska, A; Kuznicki, J; Herms, J				Honarnejad, Kamran; Daschner, Alexander; Giese, Armin; Zall, Andrea; Schmidt, Boris; Szybinska, Aleksandra; Kuznicki, Jacek; Herms, Jochen			Development and Implementation of a High-Throughput Compound Screening Assay for Targeting Disrupted ER Calcium Homeostasis in Alzheimer's Disease	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM; GAMMA-SECRETASE; BETA; CA2+; PRESENILINS; MUTATIONS; CELLS; DEATH; TAU	Disrupted intracellular calcium homeostasis is believed to occur early in the cascade of events leading to Alzheimer's disease (AD) pathology. Particularly familial AD mutations linked to Presenilins result in exaggerated agonist-evoked calcium release from endoplasmic reticulum (ER). Here we report the development of a fully automated high-throughput calcium imaging assay utilizing a genetically-encoded FRET-based calcium indicator at single cell resolution for compound screening. The established high-throughput screening assay offers several advantages over conventional high-throughput calcium imaging technologies. We employed this assay for drug discovery in AD by screening compound libraries consisting of over 20,000 small molecules followed by structure-activity-relationship analysis. This led to the identification of Bepridil, a calcium channel antagonist drug in addition to four further lead structures capable of normalizing the potentiated FAD-PS1-induced calcium release from ER. Interestingly, it has recently been reported that Bepridil can reduce A beta production by lowering BACE1 activity. Indeed, we also detected lowered A beta, increased sAPP alpha and decreased sAPP beta fragment levels upon Bepridil treatment. The latter findings suggest that Bepridil may provide a multifactorial therapeutic modality for AD by simultaneously addressing multiple aspects of the disease.	[Honarnejad, Kamran; Daschner, Alexander; Herms, Jochen] DZNE German Ctr Neurodegenerat Dis, Dept Translat Brain Res, Munich, Germany; [Honarnejad, Kamran; Daschner, Alexander; Giese, Armin; Herms, Jochen] Univ Munich, Ctr Neuropathol & Prion Res, Munich, Germany; [Honarnejad, Kamran] Univ Munich, Grad Sch Syst Neurosci, Munich, Germany; [Zall, Andrea; Schmidt, Boris] Tech Univ Darmstadt, Clemens Schopf Inst Chem & Biochem, Darmstadt, Germany; [Szybinska, Aleksandra; Kuznicki, Jacek] Int Inst Mol & Cell Biol, Lab Neurodegenerat, Warsaw, Poland; [Herms, Jochen] Munich Cluster Syst Neurol SyNergy, Munich, Germany	Helmholtz Association; German Center for Neurodegenerative Diseases (DZNE); University of Munich; University of Munich; Technical University of Darmstadt; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Munich	Herms, J (corresponding author), DZNE German Ctr Neurodegenerat Dis, Dept Translat Brain Res, Munich, Germany.	Jochen.Herms@med.uni-muenchen.de	Kuznicki, Jacek/AAW-9239-2020; Schmidt, Boris/M-7886-2019; Schmidt, Boris/D-3293-2009; Giese, Armin/F-3271-2010	Kuznicki, Jacek/0000-0001-6486-0657; Schmidt, Boris/0000-0003-1662-2392; Schmidt, Boris/0000-0003-1662-2392; Giese, Armin/0000-0002-8238-4102	German Federal Ministry for Education and Research Council [BMBF - 01GZ0713]; Polish Ministry of Science and Higher Education [S001/P-N/2007/01]	German Federal Ministry for Education and Research Council; Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	This work was supported the German-Polish grants from the German Federal Ministry for Education and Research Council (BMBF - 01GZ0713) to JH and from the Polish Ministry of Science and Higher Education to JK (#S001/P-N/2007/01). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Bullock R, 2006, ALZ DIS ASSOC DIS, V20, P23, DOI 10.1097/01.wad.0000201847.29836.a5; Camandola S, 2011, BBA-MOL CELL RES, V1813, P965, DOI 10.1016/j.bbamcr.2010.10.005; CARMICHAEL J, 1987, CANCER RES, V47, P936; Chadwick W, 2012, CURR ALZHEIMER RES, V9, P110, DOI 10.2174/156720512799015055; Cheung KH, 2008, NEURON, V58, P871, DOI 10.1016/j.neuron.2008.04.015; Cheung KH, 2010, SCI SIGNAL, V3, DOI 10.1126/scisignal.2000818; Coleman PD, 2003, NEUROBIOL AGING, V24, P1023, DOI 10.1016/j.neurobiolaging.2003.09.001; GomezIsla T, 1996, J NEUROSCI, V16, P4491; Green KN, 2008, NEURON, V59, P190, DOI 10.1016/j.neuron.2008.07.013; Green KN, 2009, J CELL MOL MED, V13, P2787, DOI 10.1111/j.1582-4934.2009.00861.x; Guo Q, 1996, NEUROREPORT, V8, P379, DOI 10.1097/00001756-199612200-00074; Hayley M, 2009, BBA-BIOMEMBRANES, V1788, P1933, DOI 10.1016/j.bbamem.2009.05.015; Herrup K, 2010, J NEUROSCI, V30, P16755, DOI 10.1523/JNEUROSCI.4521-10.2010; Ho A, 2011, TRENDS MOL MED, V17, P617, DOI 10.1016/j.molmed.2011.06.002; Ho M., 2011, INT J ALZHEIMERS DIS, V2011; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Honarnejad K, 2013, J CELL MOL MED, V17, P293, DOI 10.1111/jcmm.12008; Honarnejad K, 2012, INT J BIOCHEM CELL B, V44, P1983, DOI 10.1016/j.biocel.2012.07.019; Jaworska A, 2013, BIOCH BIOPHYS ACTA; Kelliher M, 1999, NEUROSCIENCE, V92, P499, DOI 10.1016/S0306-4522(99)00042-1; LANDFIELD PW, 1992, J NEUROBIOL, V23, P1247, DOI 10.1002/neu.480230914; Li DX, 2006, AM J HUM GENET, V79, P1030, DOI 10.1086/509900; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Mangialasche F, 2010, LANCET NEUROL, V9, P702, DOI 10.1016/S1474-4422(10)70119-8; MATTSON MP, 1991, MOL CHEM NEUROPATHOL, V15, P117, DOI 10.1007/BF03159951; Mitterreiter S, 2010, J NEUROSCI, V30, P8974, DOI 10.1523/JNEUROSCI.1199-10.2010; Monteith GR, 2005, TRENDS PHARMACOL SCI, V26, P218, DOI 10.1016/j.tips.2005.02.002; Nagai T, 2004, P NATL ACAD SCI USA, V101, P10554, DOI 10.1073/pnas.0400417101; Nelson O, 2010, J ALZHEIMERS DIS, V21, P781, DOI 10.3233/JAD-2010-100159; Oules B, 2012, J NEUROSCI, V32, P11820, DOI 10.1523/JNEUROSCI.0875-12.2012; Page RM, 2008, J BIOL CHEM, V283, P677, DOI 10.1074/jbc.M708754200; Patzke H, 2002, J BIOL CHEM, V277, P8054, DOI 10.1074/jbc.M109645200; Pierrot N, 2006, J BIOL CHEM, V281, P39907, DOI 10.1074/jbc.M606015200; Ripova D, 2004, PHYSIOL RES, V53, P449; Scheff SW, 2006, NEUROBIOL AGING, V27, P1372, DOI 10.1016/j.neurobiolaging.2005.09.012; Stutzmann GE, 2007, NEUROSCIENTIST, V13, P546, DOI 10.1177/1073858407299730; Stutzmann GE, 2006, J NEUROSCI, V26, P5180, DOI 10.1523/JNEUROSCI.0739-06.2006; Stutzmann GE, 2011, PHARMACOL REV, V63, P700, DOI 10.1124/pr.110.003814; Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x; Toescu EC, 2007, AGING CELL, V6, P267, DOI 10.1111/j.1474-9726.2007.00296.x; Tu HP, 2006, CELL, V126, P981, DOI 10.1016/j.cell.2006.06.059; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206	43	13	14	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80645	10.1371/journal.pone.0080645	http://dx.doi.org/10.1371/journal.pone.0080645			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260442	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600076
J	Zhou, WH; Yue, CF; Deng, JY; Hu, RH; Xu, J; Feng, L; Lan, QY; Zhang, WF; Ji, DX; Wu, JB; Liu, QT; Liu, AW				Zhou, Weihua; Yue, Caifeng; Deng, Jinyun; Hu, Ronghuan; Xu, Jie; Feng, Long; Lan, Qiongyu; Zhang, Wenfeng; Ji, Dexiang; Wu, Jianbing; Liu, Quentin; Liu, Anwen			Autophagic Protein Beclin 1 Serves as an Independent Positive Prognostic Biomarker for Non-Small Cell Lung Cancer	PLOS ONE			English	Article							DECREASED EXPRESSION; POOR-PROGNOSIS; TUMOR; TUMORIGENESIS; GENE; PROGRESSION; DISEASE	Beclin 1, a key regulator of autophagy, has been found to be aberrantly expressed in a variety of human malignancies. Herein, we employed immunohistochemistry (IHC) to detect the protein expression of Beclin 1 in nonsmall cell lung cancer (NSCLC) and paired normal adjacent lung tissues, and analyzed its clinicopathological/ prognostic significance in NSCLC. Receiver operating characteristic (ROC) curve analysis was utilized to determine a cutoff point (> 2 VS. <= 2) for Beclin 1 expression in a training set (n = 105). For validation, the ROC-derived cutoff value was subjected to analysis of the association of Beclin 1 with patients' clinical characteristics and outcome in a testing set (n = 111) and the overall patient cohort (n = 216). Our data showed that Beclin 1 was significantly lower in NSCLC tissues compared with the adjacent normal tissues, negatively associating with tumor recurrence rate (65.8% VS 32.3%; p < 0.001). In the testing set and the overall patient cohort, low expression of Beclin 1 showed significantly inferior overall survival (OS) (p < 0.001) and progression-free survival (PFS) (p < 0.001) compared to high expression of Beclin 1. In the testing set and the overall patient cohort, the median duration of OS for patients with high and low expression of Beclin 1 was 108 VS. 24.5 months (p < 0.001) and 108 VS. 28 months (p < 0.001), respectively. Furthermore, low expression of Beclin 1 was also a poor prognostic factor within each stage of NSCLC patients. Multivariate analysis identified that Beclin 1 was an independent prognostic factor for NSCLC. Our findings in the present study provided evidence that Beclin 1 may thus emerge as an independent prognostic biomarker in this tumor entity in the future.	[Zhou, Weihua; Hu, Ronghuan; Xu, Jie; Feng, Long; Lan, Qiongyu; Wu, Jianbing; Liu, Anwen] Nanchang Univ, Affiliated Hosp 2, Dept Oncol, Nanchang, Peoples R China; [Zhou, Weihua; Yue, Caifeng; Xu, Jie; Liu, Quentin] Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China; [Deng, Jinyun] Jiangxi Prov Canc Hosp, Dept Internal Med 6, Nanchang, Peoples R China; [Zhang, Wenfeng] Nanchang Univ, Dept Infect Dis, Affiliated Hosp 1, Nanchang, Peoples R China; [Ji, Dexiang] Nanchang Univ, Dept Hematol, Affiliated Hosp 1, Nanchang, Peoples R China	Nanchang University; State Key Lab Oncology South China; Sun Yat Sen University; Nanchang University; Nanchang University	Liu, QT (corresponding author), Sun Yat Sen Univ, State Key Lab Oncol South China, Ctr Canc, Guangzhou 510275, Guangdong, Peoples R China.	liuq9@mail.sysu.edu.cn; awliu666@163.com	CF, Yue/AAT-9821-2021		National Nature Science Foundation of China [81160305, 81160306]; National Science Fund for Distinguished Young Scholars [30888003]; State Key Program of National Natural Science of China [81130040]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Science Fund for Distinguished Young Scholars(National Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars); State Key Program of National Natural Science of China(National Natural Science Foundation of China (NSFC))	The work was supported by the National Nature Science Foundation of China (Grant No. 81160305 and Grant No. 81160306), a National Science Fund for Distinguished Young Scholars (Grant No. 30888003), and the State Key Program of National Natural Science of China (Grant No. 81130040). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrahamsen H, 2012, FEBS LETT, V586, P1584, DOI 10.1016/j.febslet.2012.04.046; Aita VM, 1999, GENOMICS, V59, P59, DOI 10.1006/geno.1999.5851; Doria A, 2013, NEW ENGL J MED, V368, P1845, DOI [10.1056/NEJMc1303158, 10.1056/NEJMra1205406]; Han WD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018691; HANLEY JA, 1989, CRIT REV DIAGN IMAG, V29, P307; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jiang ZF, 2012, MOL BIOL REP, V39, P259, DOI 10.1007/s11033-011-0734-1; Kamangar F, 2006, J CLIN ONCOL, V24, P2137, DOI 10.1200/JCO.2005.05.2308; Karantza-Wadsworth V, 2007, AUTOPHAGY, V3, P610, DOI 10.4161/auto.4867; Kimmelman AC, 2011, GENE DEV, V25, P1999, DOI 10.1101/gad.17558811; Kroemer G, 2005, NAT REV CANCER, V5, P886, DOI 10.1038/nrc1738; Liang XH, 1999, NATURE, V402, P672, DOI 10.1038/45257; Lind PA, 2006, INT J RADIAT ONCOL, V64, P765, DOI 10.1016/j.ijrobp.2005.08.011; Lokk K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039813; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Mathew R, 2007, NAT REV CANCER, V7, P961, DOI 10.1038/nrc2254; Mathew R, 2007, GENE DEV, V21, P1367, DOI 10.1101/gad.1545107; Miracco C, 2007, INT J ONCOL, V30, P429; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Oberstein A, 2007, J BIOL CHEM, V282, P13123, DOI 10.1074/jbc.M700492200; Pan XH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056679; Pattingre S, 2005, CELL, V122, P927, DOI 10.1016/j.cell.2005.07.002; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Risch A, 2008, INT J CANCER, V123, P1, DOI 10.1002/ijc.23605; Roberts PJ, 2013, J CLIN ONCOL, V31, P1112, DOI 10.1200/JCO.2012.43.0454; Rosenfeldt MT, 2011, CARCINOGENESIS, V32, P955, DOI 10.1093/carcin/bgr031; Scrima M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030427; Shen Y, 2008, AUTOPHAGY, V4, P1067, DOI 10.4161/auto.6827; Shi YH, 2009, AUTOPHAGY, V5, P380, DOI 10.4161/auto.5.3.7658; Sobin LH, 1997, CANCER, V80, P1803, DOI 10.1002/(SICI)1097-0142(19971101)80:9<1803::AID-CNCR16>3.0.CO;2-9; Wan XB, 2010, AUTOPHAGY, V6, P395, DOI 10.4161/auto.6.3.11303; Wang RC, 2012, SCIENCE, V338, P956, DOI 10.1126/science.1225967; Won KY, 2012, HUM PATHOL, V43, P62, DOI 10.1016/j.humpath.2011.04.007; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zhang B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028882; Zhang LQ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054970; Zhou WH, 2012, AUTOPHAGY, V8, P389, DOI 10.4161/auto.18641; Zhou WH, 2011, BMC CANCER, V11, DOI 10.1186/1471-2407-11-397; Zlobec I, 2007, J CLIN PATHOL, V60, P1112, DOI 10.1136/jcp.2006.044537	39	20	22	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80338	10.1371/journal.pone.0080338	http://dx.doi.org/10.1371/journal.pone.0080338			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260370	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600056
J	Alam, MM; Khurshid, A; Shaukat, S; Rana, MS; Sharif, S; Angez, M; Nisar, N; Naeem, M; Zaidi, SSZ				Alam, Muhammad Masroor; Khurshid, Adnan; Shaukat, Shahzad; Rana, Muhammad Suleman; Sharif, Salmaan; Angez, Mehar; Nisar, Nadia; Naeem, Muhammad; Zaidi, Syed Sohail Zahoor			Human Parechovirus Genotypes-10,-13 and-15 in Pakistani Children with Acute Dehydrating Gastroenteritis	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; CLINICAL STOOL SAMPLES; CELL-CULTURE; MOLECULAR-DETECTION; RT-PCR; ROTAVIRUS GASTROENTERITIS; HPEV GENOTYPES; ENTEROVIRUSES; INFECTION; VIRUS	Human parechoviruses are known to cause asymptomatic to severe clinical illness predominantly respiratory and gastroenetric infections. Despite their global prevalence, epidemiological studies have not been performed in Pakistan. In this study, we retrospectively analyzed 110 fecal specimen and found 26 (24%) positive for viral RNA with HPeV-10 (n = 3, 23%), HPeV-13 (n = 4, 31%) and HPeV-15 (n = 6, 46%) genotypes. Clinical features of patients with different HPeV genotypes were compared. All HPeV positive children were aged <= 4 years (mean 13.92 months). The male-to-female ratio was 1:1.17 (46.2 vs 53.8%) with significant association (p=.031) to HPeV infectivity. HPeV-10 and -13 were found during summer while HPeV-15 was only detected during late winter season. Disease symptoms were more severe in children infected with HPeV-10 and -13 as compared to HPeV-15. Fever and vomiting were observed in 100% cases of HPeV-10 and -13 while only 17% patients of HPeV-15 had these complaints. Phylogenetic analyses showed that HPeV-10, -13 and -15 strains found in this study have 9-13%, 16.8% and 21.8% nucleotide divergence respectively from the prototype strains and were clustered to distinct genetic lineages. This is the first report of HPeV-15 infection in humans although first identified in rhesus macaques. The arginine-glycine-aspartic acid (RGD) motif present at the C-terminal of VP1 responsible for the viral attachment to cellular integrins was not found in all of these strains. In conclusion, these findings enhance our knowledge related to the epidemiology and genetic diversity of the HPeV in Pakistan and support the need for continued laboratory based surveillance programs especially in infants and neonatal clinical settings. Further, the parechovirus pathogenesis, cross-species transmission and disease reservoirs must be ascertained to adopt better prevention measures.	[Alam, Muhammad Masroor; Naeem, Muhammad] Quaid I Azam Univ, Dept Biotechnol, Islamabad, Pakistan; [Khurshid, Adnan; Shaukat, Shahzad; Rana, Muhammad Suleman; Sharif, Salmaan; Angez, Mehar; Nisar, Nadia; Zaidi, Syed Sohail Zahoor] Natl Inst Hlth, Dept Virol, Islamabad, Pakistan	Quaid I Azam University	Zaidi, SSZ (corresponding author), Natl Inst Hlth, Dept Virol, Islamabad, Pakistan.	zaidis@pak.emro.who.int	Naeem, Muhammad/F-4869-2011; Zaidi, Syed Sohail Zahoor/F-7432-2015; Shaukat, Shahzad/HHZ-1088-2022; Angez, Mehar/J-3792-2015; Rana, Dr. Muhammad Suleman/HCH-1540-2022	Naeem, Muhammad/0000-0002-3894-3085; 				Abbaszadegan M, 1999, APPL ENVIRON MICROB, V65, P444; Abed Y, 2007, J CLIN MICROBIOL, V45, P2037, DOI 10.1128/JCM.02432-06; Abed Y, 2006, EMERG INFECT DIS, V12, P969, DOI 10.3201/eid1206.051675; Al-Sunaidi M, 2007, J VIROL, V81, P1013, DOI 10.1128/JVI.00584-06; Alam MM, 2012, J CLIN VIROL, V55, P339, DOI 10.1016/j.jcv.2012.08.008; Alam MM, 2009, VIRUS RES, V144, P280, DOI 10.1016/j.virusres.2009.03.015; Alho A, 2003, J CLIN MICROBIOL, V41, P2294, DOI 10.1128/JCM.41.6.2294-2299.2003; Balows A HW, 1988, LAB DIAGNOSIS INFECT, P692; Baumgarte S, 2008, J CLIN MICROBIOL, V46, P242, DOI 10.1128/JCM.01468-07; Benschop K, 2008, J CLIN MICROBIOL, V46, P3965, DOI 10.1128/JCM.01379-08; Benschop K, 2008, J CLIN VIROL, V41, P69, DOI 10.1016/j.jcv.2007.10.004; Benschop K, 2010, DIAGN MICR INFEC DIS, V68, P166, DOI 10.1016/j.diagmicrobio.2010.05.016; Benschop KSM, 2006, EMERG INFECT DIS, V12, P1572, DOI 10.3201/eid1210.051647; Benschop KSM, 2006, CLIN INFECT DIS, V42, P204, DOI 10.1086/498905; Boivin G, 2005, EMERG INFECT DIS, V11, P103, DOI 10.3201/eid1101.040606; Boonyakiat Y, 2001, J VIROL, V75, P10000, DOI 10.1128/JVI.75.20.10000-10004.2001; Bosch A, 1998, Int Microbiol, V1, P191; CHANG KH, 1989, J GEN VIROL, V70, P3269, DOI 10.1099/0022-1317-70-12-3269; CHANG KH, 1992, J GEN VIROL, V73, P621, DOI 10.1099/0022-1317-73-3-621; Chapron CD, 2000, APPL ENVIRON MICROB, V66, P2520, DOI 10.1128/AEM.66.6.2520-2525.2000; Chhabra P, 2013, J INFECT DIS; Corless CE, 2002, J MED VIROL, V67, P555, DOI 10.1002/jmv.10138; Drexler JF, 2009, EMERG INFECT DIS, V15, P310, DOI 10.3201/eid1502.081028; Ehrnst A, 1996, SCAND J INFECT DIS, V28, P205, DOI 10.3109/00365549609049079; EHRNST A, 1993, SCAND J INFECT DIS, V25, P275, DOI 10.3109/00365549309008499; Eyssette-Guerreau S, 2013, ARCH PEDIATRIE, V20, P772, DOI 10.1016/j.arcped.2013.04.020; FIGUEROA JP, 1989, J MED VIROL, V29, P315, DOI 10.1002/jmv.1890290418; FOX G, 1989, J GEN VIROL, V70, P625, DOI 10.1099/0022-1317-70-3-625; Ghazi F, 2012, INT J INFECT DIS, V16, pE673, DOI 10.1016/j.ijid.2012.05.1020; Grist N R, 1978, Prog Med Virol, V24, P114; GRIST NR, 1970, LANCET, V1, P1395; Harvala H, 2008, J CLIN MICROBIOL, V46, P3446, DOI 10.1128/JCM.01207-08; Harvala H, 2009, J INFECT DIS, V199, P1753, DOI 10.1086/599094; Harvala H, 2009, J CLIN VIROL, V45, P1, DOI 10.1016/j.jcv.2009.03.009; Harvala H, 2010, CURR OPIN INFECT DIS, V23, P224, DOI 10.1097/QCO.0b013e32833890ca; HYYPIA T, 1992, P NATL ACAD SCI USA, V89, P8847, DOI 10.1073/pnas.89.18.8847; Hyypia T, 1997, J GEN VIROL, V78, P1; HYYPIA T, 1993, ADV VIRUS RES, V42, P343, DOI 10.1016/S0065-3527(08)60089-5; Ito M, 2004, J GEN VIROL, V85, P391, DOI 10.1099/vir.0.19456-0; Ito M, 2010, J CLIN MICROBIOL, V48, P2683, DOI 10.1128/JCM.00086-10; Iturriza-Gomara M, 2006, J MED VIROL, V78, P243, DOI 10.1002/jmv.20533; Jokela P, 2005, J CLIN MICROBIOL, V43, P1239, DOI 10.1128/JCM.43.3.1239-1245.2005; Joki-Korpela P, 2000, J GEN VIROL, V81, P1709, DOI 10.1099/0022-1317-81-7-1709; Kawai K, 2012, VACCINE, V30, P1244, DOI 10.1016/j.vaccine.2011.12.092; Khetsuriani Nino, 2006, Morbidity and Mortality Weekly Report, V55, P18; KOSKINIEMI M, 1989, SCAND J INFECT DIS, V21, P463, DOI 10.3109/00365548909167453; Landry ML, 2010, CLIN INFECT DIS, V50, P362, DOI 10.1086/649864; Legay V, 2002, J CLIN VIROL, V25, P193, DOI 10.1016/S1386-6532(02)00009-4; Li LL, 2011, CURR OPIN VIROL, V1, P282, DOI 10.1016/j.coviro.2011.07.006; Li LL, 2009, EMERG INFECT DIS, V15, P288, DOI 10.3201/eid1502.080341; MALLER HM, 1967, J PEDIATR-US, V71, P204, DOI 10.1016/S0022-3476(67)80073-8; Mantke OD, 2007, J VIROL METHODS, V141, P71, DOI 10.1016/j.jviromet.2006.11.029; Ngan TKP, 2011, J CLIN MICROBIOL, V49, P364, DOI 10.1128/JCM.02151-10; Ngan TKP, 2011, J MED VIROL, V83, P331, DOI 10.1002/jmv.21740; Nix WA, 2008, J CLIN MICROBIOL, V46, P2519, DOI 10.1128/JCM.00277-08; Nix WA, 2010, J CLIN VIROL, V48, P202, DOI 10.1016/j.jcv.2010.04.007; Nix WA, 2013, J GEN VIROL; Noordhoek GT, 2008, J CLIN VIROL, V41, P75, DOI 10.1016/j.jcv.2007.09.011; Oberste MS, 2013, J VIROL, V87, P558, DOI 10.1128/JVI.00837-12; Oberste MS, 1999, J MED VIROL, V58, P178, DOI 10.1002/(SICI)1096-9071(199906)58:2&lt;178::AID-JMV13&gt;3.0.CO;2-Q; OREGAN S, 1980, CLIN PEDIATR, V19, P125, DOI 10.1177/000992288001900207; Pham NTK, 2010, J CLIN MICROBIOL, V48, P115, DOI 10.1128/JCM.01015-09; Pham NTK, 2010, EMERG INFECT DIS, V16, P130, DOI 10.3201/eid1601.091105; Pianetti A, 2000, EPIDEMIOL INFECT, V125, P455, DOI 10.1017/S0950268899004604; PUIG M, 1994, APPL ENVIRON MICROB, V60, P2963, DOI 10.1128/AEM.60.8.2963-2970.1994; Qazi R, 2009, VACCINE, V27, pF25, DOI 10.1016/j.vaccine.2009.08.064; Reuter G, 2012, J VIROL, V86, P13295, DOI 10.1128/JVI.01142-12; Romero Jose R, 2011, Adv Pediatr, V58, P65, DOI 10.1016/j.yapd.2011.03.008; RUOSLAHTI E, 1987, SCIENCE, V238, P491, DOI 10.1126/science.2821619; Schvoerer E, 2001, RES MICROBIOL, V152, P179, DOI 10.1016/S0923-2508(01)01190-1; Sedmak G, 2010, CLIN INFECT DIS, V50, P357, DOI 10.1086/649863; Shan TL, 2010, EMERG INFECT DIS, V16, P1168, DOI [10.3201/eid1607.091103, 10.3201/1607.091103]; Shoja ZO, 2007, J CLIN LAB ANAL, V21, P232, DOI 10.1002/jcla.20171; Shoja ZO, 2007, J VIROL METHODS, V142, P95, DOI 10.1016/j.jviromet.2007.01.010; Stanway G, 1999, J VIROL, V73, P5249, DOI 10.1128/JVI.73.7.5249-5254.1999; Stanway G, 2000, REV MED VIROL, V10, P57, DOI 10.1002/(SICI)1099-1654(200001/02)10:1&lt;57::AID-RMV266&gt;3.0.CO;2-H; STANWAY G, 1994, J VIROL, V68, P8232, DOI 10.1128/JVI.68.12.8232-8238.1994; Takao S, 2001, JPN J INFECT DIS, V54, P85; Tamim S, 2013, INFECT GENET EVOL, V14, P161, DOI 10.1016/j.meegid.2012.10.009; Tapia G, 2008, J MED VIROL, V80, P1835, DOI 10.1002/jmv.21283; Tauriainen S, 2007, J MED VIROL, V79, P457, DOI 10.1002/jmv.20831; Terietskaia-Ladwig E, 2008, J MED MICROBIOL, V57, P1000, DOI 10.1099/jmm.0.47799-0; Tolf C, 2009, J GEN VIROL, V90, P843, DOI 10.1099/vir.0.007948-0; van der Sanden S, 2008, J CLIN MICROBIOL, V46, P2884, DOI 10.1128/JCM.00168-08; van Doornum GJJ, 2007, J MED VIROL, V79, P1868, DOI 10.1002/jmv.21031; Verboon-Maciolek MA, 2008, PEDIATR INFECT DIS J, V27, P241, DOI 10.1097/INF.0b013e31815c1b07; Watanabe K, 2007, EMERG INFECT DIS, V13, P889, DOI 10.3201/eid1306.060896; WIGAND REINHARD, 1961, ARCH GES VIRUSFORSCH, V11, P224, DOI 10.1007/BF01241688; Wildenbeest JG, 2010, EXPERT REV ANTI-INFE, V8, P1417, DOI [10.1586/eri.10.130, 10.1586/ERI.10.130]; Zhang DL, 2011, CLIN MICROBIOL INFEC, V17, P1563, DOI 10.1111/j.1469-0691.2010.03390.x; Zhang Dong-liang, 2009, Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi, V23, P112; Zimmermann H, 1996, VIRUS GENES, V12, P149, DOI 10.1007/BF00572953	92	12	12	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78377	10.1371/journal.pone.0078377	http://dx.doi.org/10.1371/journal.pone.0078377			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265685	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100019
J	Crispo, M; Van Maele, L; Tabareau, J; Cayet, D; Errea, A; Ferreira, AM; Rumbo, M; Sirard, JC				Crispo, Martina; Van Maele, Laurye; Tabareau, Julien; Cayet, Delphine; Errea, Agustina; Ferreira, Ana Maria; Rumbo, Martin; Sirard, Jean Claude			Transgenic Mouse Model Harboring the Transcriptional Fusion Ccl20-Luciferase as a Novel Reporter of Pro-Inflammatory Response	PLOS ONE			English	Article							NF-KAPPA-B; REGULATED CHEMOKINE LARC; GENE-EXPRESSION; INTESTINAL EPITHELIUM; BACTERIAL FLAGELLIN; IMMUNE-RESPONSES; RECEPTOR; LIVER; ACTIVATION; INNATE	The chemokine CCL20, the unique ligand of CCR6 functions as an attractant of immune cells. Expression of CCL20 is induced by Toll-like Receptor (TLR) signaling or proinflammatory cytokine stimulation. However CCL20 is also constitutively produced at specific epithelial sites of mucosa. This expression profile is achieved by transcriptional regulation. In the present work we characterized regulatory features of mouse Ccl20 gene. Transcriptional fusions between the mouse Ccl20 promoter and the firefly luciferase (luc) encoding gene were constructed and assessed in in vitro and in vivo assays. We found that liver CCL20 expression and luciferase activity were upregulated by systemic administration of the TLR5 agonist flagellin. Using shRNA and dominant negative form specific for mouse TLR5, we showed that this expression was controlled by TLR5. To address in situ the regulation of gene activity, a transgenic mouse line harboring a functional Ccl20-luc fusion was generated. The luciferase expression was highly concordant with Ccl20 expression in different tissues. Our data indicate that the transgenic mouse model can be used to monitor activation of innate response in vivo.	[Crispo, Martina] Inst Pasteur, Unidad Anim Transgen & Expt, Montevideo, Uruguay; [Van Maele, Laurye; Tabareau, Julien; Cayet, Delphine; Sirard, Jean Claude] Inst Pasteur, Ctr Infect & Immun Lille, F-59000 Lille, Region Nord Pas, France; [Van Maele, Laurye; Tabareau, Julien; Cayet, Delphine; Sirard, Jean Claude] Inst Natl Sante & Rech Med, U1019, F-59000 Lille, Region Nord Pas, France; [Van Maele, Laurye; Tabareau, Julien; Cayet, Delphine; Sirard, Jean Claude] Ctr Natl Rech Sci, UMR 8204, F-59000 Lille, Region Nord Pas, France; [Van Maele, Laurye; Tabareau, Julien; Cayet, Delphine; Sirard, Jean Claude] Univ Lille Nord De France, F-59000 Lille, Region Nord Pas, France; [Errea, Agustina; Rumbo, Martin] Natl Univ La Plata, Lab Invest Sistema Inmune LISIN, La Plata, Buenos Aires, Argentina; [Ferreira, Ana Maria] Univ Republica, Fac Quim, Fac Ciencias, Catedra Inmunol, Montevideo, Uruguay	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur de Montevideo; Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille; Universite de Lille - ISITE; Universite de Lille; National University of La Plata; Universidad de la Republica, Uruguay	Sirard, JC (corresponding author), Inst Pasteur, Ctr Infect & Immun Lille, F-59000 Lille, Region Nord Pas, France.	jean-claude.sirard@inserm.fr	Van Maele, Laurye/ABD-3375-2020; Van Maele, Laurye/P-2882-2017; Crispo, Martina/R-2591-2019; Sirard, Jean-Claude/B-5932-2011	Van Maele, Laurye/0000-0001-9495-5403; Van Maele, Laurye/0000-0001-9495-5403; Sirard, Jean-Claude/0000-0001-9854-4652; CAYET, Delphine/0000-0003-1720-0845; Crispo, Martina/0000-0002-9852-5563	Institut national de la sante et de la recherche medicale; Institut Pasteur de Lille; Region Nord Pas de Calais; University Lille Nord de France; European Community (STREP "SavinMucoPath'') [INCO-CT-2006-032296]; Institut Clinique de la Souris [IM1340]	Institut national de la sante et de la recherche medicale(Institut National de la Sante et de la Recherche Medicale (Inserm)); Institut Pasteur de Lille; Region Nord Pas de Calais(Region Hauts-de-France); University Lille Nord de France; European Community (STREP "SavinMucoPath''); Institut Clinique de la Souris	LVM, DC, JT and JCS were funded by Institut national de la sante et de la recherche medicale, Institut Pasteur de Lille, Region Nord Pas de Calais (Ph.D. fellowship), University Lille Nord de France, the European Community (STREP "SavinMucoPath'' INCO-CT-2006-032296), and the Institut Clinique de la Souris (Projet IM1340). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderle P, 2005, GASTROENTEROLOGY, V129, P321, DOI 10.1053/j.gastro.2005.03.044; Ansel KM, 2001, CURR OPIN IMMUNOL, V13, P172, DOI 10.1016/S0952-7915(00)00201-6; Baba M, 1997, J BIOL CHEM, V272, P14893, DOI 10.1074/jbc.272.23.14893; Battaglia F, 2008, J LEUKOCYTE BIOL, V83, P648, DOI 10.1189/jlb.0607349; Boldrick JC, 2002, P NATL ACAD SCI USA, V99, P972, DOI 10.1073/pnas.231625398; Burdelya LG, 2013, P NATL ACAD SCI USA, V110, pE1857, DOI 10.1073/pnas.1222805110; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Carlsen H, 2004, MUTAT RES-FUND MOL M, V551, P199, DOI 10.1016/j.mrfmmm.2004.02.024; Chieppa M, 2006, J EXP MED, V203, P2841, DOI 10.1084/jem.20061884; Della Corte C, 2012, MINERVA PEDIATR, V64, P595; Didierlaurent A, 2004, J IMMUNOL, V172, P6922, DOI 10.4049/jimmunol.172.11.6922; Doyle TC, 2004, CELL MICROBIOL, V6, P303, DOI 10.1111/j.1462-5822.2004.00378.x; Fujiie S, 2001, INT IMMUNOL, V13, P1255, DOI 10.1093/intimm/13.10.1255; Gewirtz AT, 2001, J IMMUNOL, V167, P1882, DOI 10.4049/jimmunol.167.4.1882; Harant H, 2001, FEBS LETT, V509, P439, DOI 10.1016/S0014-5793(01)03138-6; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hieshima K, 1997, J BIOL CHEM, V272, P5846, DOI 10.1074/jbc.272.9.5846; Imaizumi Y, 2002, INT IMMUNOL, V14, P147, DOI 10.1093/intimm/14.2.147; Iwamoto S, 2013, CLIN IMMUNOL, V146, P15, DOI 10.1016/j.clim.2012.10.008; Izadpanah A, 2001, AM J PHYSIOL-GASTR L, V280, pG710, DOI 10.1152/ajpgi.2001.280.4.G710; Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126; Kamiyama T, 2012, J DERMATOL, V39, P838, DOI 10.1111/j.1346-8138.2012.01544.x; Kelkar M, 2012, CURR OPIN PHARMACOL, V12, P592, DOI 10.1016/j.coph.2012.07.014; Kitamura K, 2010, J IMMUNOL, V185, P3295, DOI 10.4049/jimmunol.1001156; Kubes P, 2012, GASTROENTEROLOGY, V143, P1158, DOI 10.1053/j.gastro.2012.09.008; Kwon JH, 2003, J BIOL CHEM, V278, P875, DOI 10.1074/jbc.M208241200; Larrain S, 2012, CLIN LIVER DIS, V16, P525, DOI 10.1016/j.cld.2012.05.009; Le Borgne M, 2006, IMMUNITY, V24, P191, DOI 10.1016/j.immuni.2006.01.005; Le YY, 2004, CELL MOL IMMUNOL, V1, P95; Lewis DL, 2002, NAT GENET, V32, P107, DOI 10.1038/ng944; Mortier A, 2012, IMMUNOL LETT, V145, P2, DOI 10.1016/j.imlet.2012.04.015; Nempont C, 2008, J IMMUNOL, V181, P2036, DOI 10.4049/jimmunol.181.3.2036; Reinhardt RL, 2006, J IMMUNOL, V177, P1618, DOI 10.4049/jimmunol.177.3.1618; Roberts R, 2008, VACCINE, V26, P4639, DOI 10.1016/j.vaccine.2008.07.004; Romanin D, 2010, INT J FOOD MICROBIOL, V140, P102, DOI 10.1016/j.ijfoodmicro.2010.04.014; Rumbo M, 2004, GASTROENTEROLOGY, V127, P213, DOI 10.1053/j.gastro.2004.04.018; Rumbo M, 2006, FEBS LETT, V580, P2976, DOI 10.1016/j.febslet.2006.04.036; Saitoh T, 2003, J BIOL CHEM, V1, P1; Sanders CJ, 2008, J IMMUNOL, V180, P7184, DOI 10.4049/jimmunol.180.11.7184; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Sierro F, 2001, P NATL ACAD SCI USA, V98, P13722, DOI 10.1073/pnas.241308598; Sirard JC, 2009, BBA-GENE REGUL MECH, V1789, P386, DOI 10.1016/j.bbagrm.2009.03.001; Sugita S, 2002, J IMMUNOL, V168, P5621, DOI 10.4049/jimmunol.168.11.5621; Tanaka Y, 1999, EUR J IMMUNOL, V29, P633, DOI 10.1002/(SICI)1521-4141(199902)29:02<633::AID-IMMU633>3.0.CO;2-I; van Golen RF, 2012, CYTOKINE GROWTH F R, V23, P69, DOI 10.1016/j.cytogfr.2012.04.006; Yoon SI, 2012, SCIENCE, V335, P859, DOI 10.1126/science.1215584	47	10	10	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78447	10.1371/journal.pone.0078447	http://dx.doi.org/10.1371/journal.pone.0078447			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265691	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100025
J	Eyre, DW; Griffiths, D; Vaughan, A; Golubchik, T; Acharya, M; O'Connor, L; Crook, DW; Walker, AS; Peto, TEA				Eyre, David W.; Griffiths, David; Vaughan, Alison; Golubchik, Tanya; Acharya, Milind; O'Connor, Lily; Crook, Derrick W.; Walker, A. Sarah; Peto, Tim E. A.			Asymptomatic Clostridium difficile Colonisation and Onward Transmission	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; INFECTION-CONTROL; DISEASE; ACQUISITION; PREVENTION; GUIDELINES; ADMISSIONS; COMMUNITY; DIARRHEA; CARRIERS	Introduction: Combined genotyping/whole genome sequencing and epidemiological data suggest that in endemic settings only a minority of Clostridium difficile infection, CDI, is acquired from other cases. Asymptomatic patients are a potential source for many unexplained cases. Methods: We prospectively screened a cohort of medical inpatients in a UK teaching hospital for asymptomatic C. difficile carriage using stool culture. Electronic and questionnaire data were used to determine risk factors for asymptomatic carriage by logistic regression. Carriage isolates were compared with all hospital/community CDI cases from the same geographic region, from 12 months before the study to 3 months after, using whole genome sequencing and hospital admission data, assessing particularly for evidence of onward transmission from asymptomatic cases. Results: Of 227 participants recruited, 132 provided >= 1 stool samples for testing. 18 participants were culture-positive for C. difficile, 14/132(11%) on their first sample. Independent risk factors for asymptomatic carriage were patient reported loose/frequent stool (but not meeting CDI criteria of >= 3 unformed stools in 24 hours), previous overnight hospital stay within 6 months, and steroid/immunosuppressant medication in the last 6 months (all p <= 0.02). Surprisingly antibiotic exposure in the last 6 months was independently associated with decreased risk of carriage (p = 0.005). The same risk factors were identified excluding participants reporting frequent/loose stool. 13/18(72%) asymptomatically colonised patients carried toxigenic strains from common disease-causing lineages found in cases. Several plausible transmission events to asymptomatic carriers were identified, but in this relatively small study no clear evidence of onward transmission from an asymptomatic case was seen. Conclusions: Transmission events from any one asymptomatic carrier are likely to be relatively rare, but as asymptomatic carriage is common, it may still be an important source of CDI, which could be quantified in larger studies. Risk factors established for asymptomatic carriage may help identify patients for inclusion in such studies.	[Eyre, David W.; Griffiths, David; Vaughan, Alison; Golubchik, Tanya; Acharya, Milind; Crook, Derrick W.; Walker, A. Sarah; Peto, Tim E. A.] Univ Oxford, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, Oxon, England; [O'Connor, Lily; Crook, Derrick W.; Peto, Tim E. A.] Univ Oxford, Hosp NHS Trust, Oxford, Oxon, England	University of Oxford; Oxford University Hospitals NHS Foundation Trust; University of Oxford	Eyre, DW (corresponding author), Univ Oxford, Oxford Biomed Res Ctr, Natl Inst Hlth Res, Oxford, Oxon, England.	david.eyre@ndm.ox.ac.uk	Walker, Sarah/HDM-8717-2022; Golubchik, Tanya/B-4226-2018; Eyre, David W/P-6887-2016	Golubchik, Tanya/0000-0003-2765-9828; Eyre, David W/0000-0001-5095-6367; peto, tim/0000-0003-3477-8307	NIHR Oxford Biomedical Research Centre; UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council; Biotechnology and Biological Sciences Research Council; National Institute for Health Research on behalf of the Department of Health [G0800778]; Wellcome Trust [087646/Z/08/Z, 090532/Z/09/Z]; MRC [G0800778] Funding Source: UKRI; Medical Research Council [G0800778] Funding Source: researchfish; National Institute for Health Research [DRF-2010-03-40, NF-SI-0512-10047, NF-SI-0508-10279] Funding Source: researchfish	NIHR Oxford Biomedical Research Centre(National Institute for Health Research (NIHR)); UKCRC Modernising Medical Microbiology Consortium; UKCRC Translational Infection Research Initiative; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); National Institute for Health Research on behalf of the Department of Health; Wellcome Trust(Wellcome Trust); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))	This work was supported by the NIHR Oxford Biomedical Research Centre and the UKCRC Modernising Medical Microbiology Consortium, the latter funded under the UKCRC Translational Infection Research Initiative supported by Medical Research Council, Biotechnology and Biological Sciences Research Council and the National Institute for Health Research on behalf of the Department of Health (Grant G0800778) and the Wellcome Trust (Grant 087646/Z/08/Z). The authors acknowledge the support of Wellcome Trust core funding (Grant 090532/Z/09/Z). TEAP and DWC are NIHR Senior Investigators. DWE is a NIHR Doctoral Research Fellow. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arvand M, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030183; Barbut F, 2001, CLIN MICROBIOL INFEC, V7, P405, DOI 10.1046/j.1198-743x.2001.00289.x; Bartsch SM, 2012, EUR J CLIN MICROBIOL, V31, P3163, DOI 10.1007/s10096-012-1681-z; Burnham K.P., 2002, MODEL SELECTION MULT, DOI 10.1007/b97636; CLABOTS CR, 1992, J INFECT DIS, V166, P561, DOI 10.1093/infdis/166.3.561; CLABOTS CR, 1989, J CLIN MICROBIOL, V27, P2386, DOI 10.1128/JCM.27.10.2386-2387.1989; Cohen SH, 2010, INFECT CONT HOSP EP, V31, P431, DOI 10.1086/651706; DELMEE M, 1987, EUR J CLIN MICROBIOL, V6, P623, DOI 10.1007/BF02013056; Enoch DA, 2011, J INFECTION, V63, P105, DOI 10.1016/j.jinf.2011.05.016; Eyre DW, 2013, NEW ENGL J MED, V369, P1195, DOI 10.1056/NEJMoa1216064; Flahault A, 2005, J CLIN EPIDEMIOL, V58, P859, DOI 10.1016/j.jclinepi.2004.12.009; Freeman J, 2010, CLIN MICROBIOL REV, V23, P529, DOI 10.1128/CMR.00082-09; Griffiths D, 2010, J CLIN MICROBIOL, V48, P770, DOI 10.1128/JCM.01796-09; Haustein T, 2011, LANCET INFECT DIS, V11, P471, DOI 10.1016/S1473-3099(10)70315-7; Hensgens MPM, 2012, CLIN MICROBIOL INFEC, V18, P635, DOI 10.1111/j.1469-0691.2012.03853.x; JOHNSON S, 1990, LANCET, V336, P97, DOI 10.1016/0140-6736(90)91605-A; JOHNSON S, 1992, ANN INTERN MED, V117, P297, DOI 10.7326/0003-4819-117-4-297; Kato H, 2001, J MED MICROBIOL, V50, P720, DOI 10.1099/0022-1317-50-8-720; KIM KH, 1981, J INFECT DIS, V143, P42, DOI 10.1093/infdis/143.1.42; Leekha S, 2013, AM J INFECT CONTROL, V41, P390, DOI 10.1016/j.ajic.2012.09.023; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Loo VG, 2011, NEW ENGL J MED, V365, P1693, DOI 10.1056/NEJMoa1012413; Lunter G, 2011, GENOME RES, V21, P936, DOI 10.1101/gr.111120.110; McDonald LC, 2007, INFECT CONT HOSP EP, V28, P140, DOI 10.1086/511798; MCFARLAND LV, 1989, NEW ENGL J MED, V320, P204, DOI 10.1056/NEJM198901263200402; Nelson RL, 2011, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004610.pub4, 10.1002/14651858, DOI 10.1002/14651858.CD004610.pub4]; Noren T, 2004, J CLIN MICROBIOL, V42, P3635, DOI [10.1128/JCM.42.8.3635-3643.2004, 10.1128/jcm.42.8.3635-3643.2004]; Ozaki E, 2004, J MED MICROBIOL, V53, P167, DOI 10.1099/jmm.0.05376-0; Planche TD, 2013, LANCET INFECT DIS, V13, P936, DOI 10.1016/S1473-3099(13)70200-7; Riggs MM, 2007, CLIN INFECT DIS, V45, P992, DOI 10.1086/521854; Ryan J, 2009, IRISH J MED SCI, V179, P245, DOI [10.1007/s11845-009-0361-1, DOI 10.1007/S11845-009-0361-1]; Samore MH, 1996, AM J MED, V100, P32, DOI 10.1016/S0002-9343(96)90008-X; Sebaihia M, 2006, NAT GENET, V38, P779, DOI 10.1038/ng1830; Shim JK, 1998, LANCET, V351, P633, DOI 10.1016/S0140-6736(97)08062-8; Simor AE, 2002, INFECT CONT HOSP EP, V23, P696, DOI 10.1086/501997; Surawicz CM, 2013, AM J GASTROENTEROL, V108, P478, DOI 10.1038/ajg.2013.4; Vonberg RP, 2008, CLIN MICROBIOL INFEC, V14, P2, DOI 10.1111/j.1469-0691.2008.01992.x; Walker AS, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001172; Walker AS, 2008, BRIT MED J, V337, P1385; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	40	91	92	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78445	10.1371/journal.pone.0078445	http://dx.doi.org/10.1371/journal.pone.0078445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265690	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100024
J	Genschaft, M; Huebner, T; Plessow, F; Ikonomidou, VN; Abolmaali, N; Krone, F; Hoffmann, A; Holfeld, E; Vorwerk, P; Kramm, C; Gruhn, B; Koustenis, E; Hernaiz-Driever, P; Mandal, R; Suttorp, M; Hummel, T; Ikonomidou, C; Kirschbaum, C; Smolka, MN				Genschaft, Marina; Huebner, Thomas; Plessow, Franziska; Ikonomidou, Vasiliki N.; Abolmaali, Nasreddin; Krone, Franziska; Hoffmann, Andre; Holfeld, Elisabeth; Vorwerk, Peter; Kramm, Christof; Gruhn, Bernd; Koustenis, Elisabeth; Hernaiz-Driever, Pablo; Mandal, Rakesh; Suttorp, Meinolf; Hummel, Thomas; Ikonomidou, Chrysanthy; Kirschbaum, Clemens; Smolka, Michael N.			Impact of Chemotherapy for Childhood Leukemia on Brain Morphology and Function	PLOS ONE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; VOXEL-BASED MORPHOMETRY; LONG-TERM SURVIVORS; ACUTE LYMPHOCYTIC-LEUKEMIA; NEUROPSYCHOLOGICAL PERFORMANCE; CRANIAL IRRADIATION; WHITE-MATTER; THERAPY; MEMORY; ABNORMALITIES	Objective: Using multidisciplinary treatment modalities the majority of children with cancer can be cured but we are increasingly faced with therapy-related toxicities. We studied brain morphology and neurocognitive functions in adolescent and young adult survivors of childhood acute, low and standard risk lymphoblastic leukemia (ALL), which was successfully treated with chemotherapy. We expected that intravenous and intrathecal chemotherapy administered in childhood will affect grey matter structures, including hippocampus and olfactory bulbs, areas where postnatal neurogenesis is ongoing. Methods: We examined 27 ALL-survivors and 27 age-matched healthy controls, ages 15-22 years. ALL-survivors developed disease prior to their 11th birthday without central nervous system involvement, were treated with intrathecal and systemic chemotherapy and received no radiation. Volumes of grey, white matter and olfactory bulbs were measured on T1 and T2 magnetic resonance images manually, using FIRST (FMRIB's integrated Registration and Segmentation Tool) and voxel-based morphometry (VBM). Memory, executive functions, attention, intelligence and olfaction were assessed. Results: Mean volumes of left hippocampus, amygdala, thalamus and nucleus accumbens were smaller in the ALL group. VBM analysis revealed significantly smaller volumes of the left calcarine gyrus, both lingual gyri and the left precuneus. DTI data analysis provided no evidence for white matter pathology. Lower scores in hippocampus-dependent memory were measured in ALL-subjects, while lower figural memory correlated with smaller hippocampal volumes. Interpretation: Findings demonstrate that childhood ALL, treated with chemotherapy, is associated with smaller grey matter volumes of neocortical and subcortical grey matter and lower hippocampal memory performance in adolescence and adulthood.	[Genschaft, Marina; Suttorp, Meinolf] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Kinder & Jugendmed, D-01062 Dresden, Germany; [Huebner, Thomas; Smolka, Michael N.] Tech Univ Dresden, Dept Psychiat, D-01062 Dresden, Germany; [Huebner, Thomas; Smolka, Michael N.] Tech Univ Dresden, Neuroimaging Ctr, D-01062 Dresden, Germany; [Plessow, Franziska; Kirschbaum, Clemens] Tech Univ Dresden, Dept Psychol, D-01062 Dresden, Germany; [Ikonomidou, Vasiliki N.; Hummel, Thomas] George Mason Univ, Volgenau Sch Engn, Dept Bioengn, Fairfax, VA 22030 USA; [Abolmaali, Nasreddin] Tech Univ Dresden, Univ Klinikum Carl Gustav Carus, Klin & Poliklin Diagnost Radiol, D-01062 Dresden, Germany; [Krone, Franziska] Tech Univ Dresden, Interdisciplinary Ctr Smell & Taste, Dept ORL, D-01062 Dresden, Germany; [Hoffmann, Andre] Klinikum Chemnitz GmbH, Klin Kinder & Jugendmed, Chemnitz, Germany; [Holfeld, Elisabeth] Carl Thieme Klinikum Cottbus, Klin Kinder & Jugendmed, Cottbus, Germany; [Vorwerk, Peter] Univ Magdeburg, Dept Pediat, D-39106 Magdeburg, Germany; [Kramm, Christof] Univ Med Ctr Halle, Univ Childrens Hosp, Halle, Germany; [Gruhn, Bernd] Univ Jena, Dept Pediat, Jena, Germany; [Koustenis, Elisabeth; Hernaiz-Driever, Pablo] Charite, Dept Pediat Oncol & Hematol, Pediat Neurooncol Program, D-13353 Berlin, Germany; [Mandal, Rakesh] Univ Wisconsin, Dept Pathol, Madison, WI 53706 USA; [Ikonomidou, Chrysanthy] Univ Wisconsin, Dept Neurol, Madison, WI 53706 USA	Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Technische Universitat Dresden; Technische Universitat Dresden; George Mason University; Technische Universitat Dresden; Carl Gustav Carus University Hospital; Technische Universitat Dresden; Chemnitz Clinic; Otto von Guericke University; Martin Luther University Halle Wittenberg; University of Hamburg; University Medical Center Hamburg-Eppendorf; Friedrich Schiller University of Jena; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Ikonomidou, VN (corresponding author), George Mason Univ, Volgenau Sch Engn, Dept Bioengn, Fairfax, VA 22030 USA.	ikonomidou@neurology.wisc.edu	Plessow, Franziska/AAE-8754-2019; Smolka, Michael/B-4865-2011; Abolmaali, Nasreddin/AAG-7655-2022; Kirschbaum, Clemens/AAB-1752-2020; Abolmaali, Nasreddin/AFL-7713-2022	Smolka, Michael/0000-0001-5398-5569; Hernaiz Driever, Pablo/0000-0003-3135-3872	University of Technology Dresden; Foerderkreis Sonnenstrahl e.V., Dresden	University of Technology Dresden; Foerderkreis Sonnenstrahl e.V., Dresden	This study was supported in part by research grants from the University of Technology Dresden. Travel expenses of the patients and controls were compensated by an unrestricted grant from Foerderkreis Sonnenstrahl e.V., Dresden. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abolmaali ND, 2002, AM J NEURORADIOL, V23, P157; Andersson JLR, 2007, TR07JA1 FMRIB; Andersson JLR, TR07JA2 FMRIB; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Baumler G, 2011, J CANC, V2, P292; Buizer AI, 2005, PEDIATR BLOOD CANCER, V45, P281, DOI 10.1002/pbc.20397; Campbell LK, 2009, J PEDIATR PSYCHOL, V34, P317, DOI 10.1093/jpepsy/jsn080; Carey ME, 2008, AM J NEURORADIOL, V29, P792, DOI 10.3174/ajnr.A0904; Clarke M, 2003, J CLIN ONCOL, V21, P1798, DOI 10.1200/JCO.2003.08.047; de Laat P, 2011, ANN ONCOL, V22, P472, DOI 10.1093/annonc/mdq382; Dellani PR, 2008, J MAGN RESON IMAGING, V27, P1250, DOI 10.1002/jmri.21364; Diller L, 2011, NEW ENGL J MED, V365, P1417, DOI 10.1056/NEJMcp1103645; Dorfel D, 2009, EUR J NEUROSCI, V30, P1947, DOI 10.1111/j.1460-9568.2009.06973.x; Good CD, 2001, NEUROIMAGE, V14, P21, DOI 10.1006/nimg.2001.0786; Hertzberg H, 1997, MED PEDIATR ONCOL, V28, P387, DOI 10.1002/(SICI)1096-911X(199706)28:6<387::AID-MPO1>3.0.CO;2-C; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Jansen NCAJ, 2008, J CLIN ONCOL, V26, P3025, DOI 10.1200/JCO.2007.12.4149; Kadan-Lottick NS, 2009, J CLIN ONCOL, V27, P5986, DOI 10.1200/JCO.2009.23.5408; Kiesel A, 2010, PSYCHOL BULL, V136, P849, DOI 10.1037/a0019842; Kingma A, 2001, J PEDIATR-US, V139, P413, DOI 10.1067/mpd.2001.117066; Knye M, 1996, KINDERDIAGNOSTISCHES; Krappmann P, 2007, PEDIATR HEMAT ONCOL, V24, P101, DOI 10.1080/08880010601123281; Kurtz BP, 2010, CHILD ADOL PSYCH CL, V19, P401, DOI 10.1016/j.chc.2010.01.009; Langer T, 2002, MED PEDIATR ONCOL, V38, P320, DOI 10.1002/mpo.10055; Moore I M, 2000, Semin Oncol Nurs, V16, P279; Patenaude B, 2008, HUM BRAIN MAPP C; Patenaude B., 2007, THESIS U OXFORD; Patenaude B., 2007, HUM BRAIN MAPP C; Peterson CC, 2008, PEDIATR BLOOD CANCER, V51, P99, DOI 10.1002/pbc.21544; Porto L, 2008, EUR RADIOL, V18, P2691, DOI 10.1007/s00330-008-1038-2; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Reddick WE, 2009, AM J NEURORADIOL, V30, P1947, DOI 10.3174/ajnr.A1733; Reddick WE, 2007, NEURORADIOLOGY, V49, P889, DOI 10.1007/s00234-007-0262-9; Robinson KE, 2010, PEDIATR BLOOD CANCER, V54, P585, DOI 10.1002/pbc.22362; Rodgers J, 2003, ARCH DIS CHILD, V88, P147, DOI 10.1136/adc.88.2.147; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Rzeski W, 2004, ANN NEUROL, V56, P351, DOI 10.1002/ana.20185; Sanai N, 2011, NATURE, V478, P382, DOI 10.1038/nature10487; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Weiss RH., 2006, GRUNDINTELLIGENZTEST; Woolrich MW, 2009, NEUROIMAGE, V45, pS173, DOI 10.1016/j.neuroimage.2008.10.055; Yang ZG, 2011, CELL STEM CELL, V9, P385, DOI 10.1016/j.stem.2011.10.007; Zhang Y, 2008, NEUROIMAGE, V42, P218, DOI 10.1016/j.neuroimage.2008.04.181	44	53	55	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78599	10.1371/journal.pone.0078599	http://dx.doi.org/10.1371/journal.pone.0078599			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265700	gold, Green Submitted, Green Published			2022-12-25	WOS:000327252100033
J	Kim, E; Yang, KS; Weissleder, R				Kim, Eunha; Yang, Katherine S.; Weissleder, Ralph			Bioorthogonal Small Molecule Imaging Agents Allow Single-Cell Imaging of MET	PLOS ONE			English	Article							HEPATOCYTE GROWTH-FACTOR; C-MET; MET/HGF RECEPTOR; TYROSINE KINASE; IN-VIVO; EXPRESSION; INHIBITORS; DISCOVERY; ONCOGENE	The hepatocyte growth factor receptor (MET) is a receptor tyrosine kinase (RTK) that has emerged as an important cancer target. Consequently, a number of different inhibitors varying in specificity are currently in clinical development. However, to date, it has been difficult to visualize MET expression, intracellular drug distribution and small molecule MET inhibition. Using a bioorthogonal approach, we have developed two companion imaging drugs based on both mono- and polypharmacological MET inhibitors. We show exquisite drug and target co-localization that can be visualized at single-cell resolution. The developed agents may be useful chemical biology tools to investigate single-cell pharmacokinetics and pharmacodynamics of MET inhibitors.	[Kim, Eunha; Yang, Katherine S.; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Weissleder, Ralph] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Weissleder, R (corresponding author), Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA.	rweissleder@mgh.harvard.edu	Kim, Eunha/ABC-9281-2020; Kim, Eunha/G-1242-2013	Kim, Eunha/0000-0002-0766-696X; Kim, Eunha/0000-0002-0766-696X; /0000-0003-0828-4143	National Institutes of Health/National Cancer Institute [P50 CA086355, R01 CA164448, T32 CA79443]; NATIONAL CANCER INSTITUTE [R01CA164448, T32CA079443, P50CA086355] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR026360] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	This work was supported by grants P50 CA086355, R01 CA164448, T32 CA79443 from the National Institutes of Health/National Cancer Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117; BEHRENS BC, 1987, CANC RES; Comoglio PM, 2008, NAT REV DRUG DISCOV, V7, P504, DOI 10.1038/nrd2530; Davis MI, 2011, NAT BIOTECHNOL, V29, P1046, DOI 10.1038/nbt.1990; Devaraj NK, 2010, ANGEW CHEM INT EDIT, V49, P2869, DOI 10.1002/anie.200906120; Devaraj NK, 2009, ANGEW CHEM INT EDIT, V48, P7013, DOI 10.1002/anie.200903233; Ding SL, 2003, BLOOD, V101, P4816, DOI 10.1182/blood-2002-06-1731; DIRENZO MF, 1995, CLIN CANCER RES, V1, P147; Fabian MA, 2005, NAT BIOTECHNOL, V23, P329, DOI 10.1038/nbt1068; Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a; Ghoussoub RAD, 1998, CANCER, V82, P1513, DOI 10.1002/(SICI)1097-0142(19980415)82:8<1513::AID-CNCR13>3.0.CO;2-7; Hendricks JA, 2012, ANGEW CHEM INT EDIT, V51, P4603, DOI 10.1002/anie.201107957; Hopkins AL, 2008, NAT CHEM BIOL, V4, P682, DOI 10.1038/nchembio.118; Ichimura E, 1996, JPN J CANCER RES, V87, P1063, DOI 10.1111/j.1349-7006.1996.tb03111.x; Jalencas X, 2013, MEDCHEMCOMM, V4, P80, DOI 10.1039/c2md20242e; Kammula US, 2007, CANCER LETT, V248, P219, DOI 10.1016/j.canlet.2006.07.007; KARLAN BY, 1988, GYNECOLOGIC; Kim EM, 2009, BIOCONJUGATE CHEM, V20, P1299, DOI 10.1021/bc8005539; Laird AD, 2003, EXPERT OPIN INV DRUG, V12, P51, DOI 10.1517/eoid.12.1.51.21253; LEMMON MA, 2010, CELL; Liu HS, 2010, CARCINOGENESIS, V31, P1456, DOI 10.1093/carcin/bgq100; Lui VWY, 2011, ONCOGENE, V30, P1127, DOI 10.1038/onc.2010.490; Lukinavicius G, 2013, NAT CHEM, V5, P132, DOI [10.1038/nchem.1546, 10.1038/NCHEM.1546]; Overington JP, 2006, NAT REV DRUG DISCOV, V5, P993, DOI 10.1038/nrd2199; Ponzo MG, 2009, P NATL ACAD SCI USA, V106, P12903, DOI 10.1073/pnas.0810402106; Qian F, 2009, CANCER RES, V69, P8009, DOI 10.1158/0008-5472.CAN-08-4889; Tam NNC, 2000, CARCINOGENESIS, V21, P2183, DOI 10.1093/carcin/21.12.2183; Thurber GM, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2506; Tiedt R, 2011, CANCER RES, V71, P5255, DOI 10.1158/0008-5472.CAN-10-4433; Trusolino L, 2010, NAT REV MOL CELL BIO, V11, P834, DOI 10.1038/nrm3012; Underiner TL, 2010, ANTI-CANCER AGENT ME, V10, P7, DOI 10.2174/1871520611009010007; Yang KS, 2012, ANGEW CHEM INT EDIT, V51, P6598, DOI 10.1002/anie.201200994; Zou HY, 2012, MOL CANCER THER, V11, P1036, DOI 10.1158/1535-7163.MCT-11-0839	33	7	7	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e81275	10.1371/journal.pone.0081275	http://dx.doi.org/10.1371/journal.pone.0081275			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265843	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100179
J	Martinez-Martinez, E; Miana, M; Jurado-Lopez, R; Rousseau, E; Rossignol, P; Zannad, F; Cachofeiro, V; Lopez-Andres, N				Martinez-Martinez, Ernesto; Miana, Maria; Jurado-Lopez, Raquel; Rousseau, Elodie; Rossignol, Patrick; Zannad, Faiez; Cachofeiro, Victoria; Lopez-Andres, Natalia			A Role for Soluble ST2 in Vascular Remodeling Associated with Obesity in Rats	PLOS ONE			English	Article							ARTERIAL STIFFNESS; INTERLEUKIN-1 RECEPTOR; IL-33; PROTEIN; FIBROSIS; HYPERTENSION; INFLAMMATION; MECHANISMS; FAILURE; MUSCLE	Background: The function of the Interleukin-33 (IL-33)/ST2 system has been mainly investigated on immunological aspects, but recent data suggest that this pathway plays also an important role in cardiovascular system and adipose tissue. Whereas IL-33 has been demonstrated to exert anti-inflammatory and protective effects, circulating soluble ST2 (sST2) has emerged as a prognostic biomarker in patients with myocardial infarction and heart failure. Furthermore, sST2 is increased in severe obesity, although its role in the pathogenesis of vascular remodeling associated with obesity is still not well defined. Methodology/Principal Findings: Male Wistar rats fed standard diet (Control) or high fat diet (HFD) for 6 weeks. Aortic tunica media from diet-induced obese animals showed hypertrophy and fibrosis. The IL-33/ST2 system was spontaneously expressed in the aorta from Wistar rats. Administration of HFD in animals did not modify IL-33 expression at the transcriptional level. By contrast, HFD group showed an increase in aortic soluble sST2 and a decrease in the transmembrane isoform (ST2L) levels, resulting in decreased protective pathway activity. Aortic sST2 mRNA levels were associated with parameters showing vascular hypertrophy and fibrosis. In vitro experiments showed that primary cultured vascular smooth muscle cells (VSMCs) spontaneously expressed the IL-33/ST2 system. VSMCs stimulated with sST2 showed an increase in collagen type I, fibronectin and profibrotic factors. Conclusions: This is the first study demonstrating a deleterious role for sST2 in the vascular remodeling associated with obesity. In addition, we demonstrated that sST2 may act not only as a decoy receptor by binding IL-33 and preventing ST2L, but also modulating ECM remodeling and turnover. Thus, sST2 could be a new therapeutic target to reduce vascular remodeling in the context of obesity.	[Martinez-Martinez, Ernesto; Miana, Maria; Jurado-Lopez, Raquel; Cachofeiro, Victoria] Univ Complutense, Sch Med, Dept Physiol, Inst Invest Sanitaria Gregorio Maranon IiSGM, E-28040 Madrid, Spain; [Rousseau, Elodie; Rossignol, Patrick; Zannad, Faiez; Lopez-Andres, Natalia] Univ Lorraine, INSERM, Ctr Invest Clin 9501, UMR 1116, Vandoeuvre Les Nancy, France; [Rousseau, Elodie; Rossignol, Patrick; Zannad, Faiez; Lopez-Andres, Natalia] CHU Nancy, Vandoeuvre Les Nancy, France; [Lopez-Andres, Natalia] NavarraBiomed Fdn Miguel Servet, Cardiovasc Translat Res, Pamplona, Spain	Complutense University of Madrid; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lorraine; CHU de Nancy; Navarrabiomed	Lopez-Andres, N (corresponding author), Univ Lorraine, INSERM, Ctr Invest Clin 9501, UMR 1116, Vandoeuvre Les Nancy, France.	natalia.lopez.andres@navarra.es	Zannad, Faiez/K-4649-2019; Lopez-Andres, Natalia/B-1276-2017; Martinez-Martinez, Ernesto/M-1376-2017	Lopez-Andres, Natalia/0000-0003-3728-2606; Martinez-Martinez, Ernesto/0000-0002-3011-2041; Miana, Maria/0000-0002-0801-8024; Jurado Lopez, Raquel/0000-0002-9149-1073; Cachofeiro, Victoria/0000-0001-6959-6293	Fondo de Investigaciones Sanitarias [P12/01729]; INSERM; Programme National de Recherche Cardiovasculaire societe francaise d'hypertension arterielle; Region Lorraine; U [LSHM-CT-2006-037093, 261409]	Fondo de Investigaciones Sanitarias(Instituto de Salud Carlos III); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); Programme National de Recherche Cardiovasculaire societe francaise d'hypertension arterielle; Region Lorraine(Region Grand-Est); U	This study was supported by grants from Fondo de Investigaciones Sanitarias (P12/01729), INSERM, Programme National de Recherche Cardiovasculaire societe francaise d'hypertension arterielle, Region Lorraine, The 6th EU-FP Network of Excellence Ingenious HyperCare (contract number LSHM-CT-2006-037093), the 7th EU-FP MEDIA project (261409), the 7th EU-FP FIBRO-TARGETS project. E. Martinez-Martinez, M. Miana, R. Jurado-Lopez and V. Cachofeiro are members of the Red de Investigacion Cardiovascular (RD12/0042/0033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bartunek J, 2008, J AM COLL CARDIOL, V52, P2166, DOI 10.1016/j.jacc.2008.09.027; Calvier L, 2013, ARTERIOSCL THROM VAS, V33, P67, DOI 10.1161/ATVBAHA.112.300569; Ciccia F, 2013, ANN RHEUM DIS, V72, P258, DOI 10.1136/annrheumdis-2012-201309; Coglianese EE, 2012, CLIN CHEM, V58, P1673, DOI 10.1373/clinchem.2012.192153; de las HN, 2007, J HYPERTENS, V25, P629; Demyanets S, 2013, J MOL CELL IN PRESS; Folli F, 1997, J CLIN INVEST, V100, P2158, DOI 10.1172/JCI119752; Grassi G, 2010, OBESITY, V18, P92, DOI 10.1038/oby.2009.195; Intengan HD, 2001, HYPERTENSION, V38, P581, DOI 10.1161/hy09t1.096249; Korner J, 2003, J CLIN INVEST, V111, P565, DOI [10.1172/JCI200317953, 10.1172/JCI17953]; Ky B, 2011, CIRC-HEART FAIL, V4, P180, DOI 10.1161/CIRCHEARTFAILURE.110.958223; Laurent S, 2005, HYPERTENSION, V45, P1050, DOI 10.1161/01.HYP.0000164580.39991.3d; Li HJ, 2000, GENOMICS, V67, P284, DOI 10.1006/geno.2000.6269; Maeso R, 1998, J HYPERTENS, V16, P665, DOI 10.1097/00004872-199816050-00014; McLaren JE, 2010, J IMMUNOL, V185, P1222, DOI 10.4049/jimmunol.1000520; Mildner M, 2010, CARDIOVASC RES, V87, P769, DOI 10.1093/cvr/cvq104; Miller AM, 2008, J EXP MED, V205, P339, DOI 10.1084/jem.20071868; Miller AM, 2011, PHARMACOL THERAPEUT, V131, P179, DOI 10.1016/j.pharmthera.2011.02.005; Mokdad AH, 1999, JAMA-J AM MED ASSOC, V282, P1519, DOI 10.1001/jama.282.16.1519; Palmer G, 2008, CYTOKINE, V42, P358, DOI 10.1016/j.cyto.2008.03.008; Redon J, 2009, J HYPERTENS, V27, P441, DOI 10.1097/HJH.0b013e32831e13e5; Ruiz-Ortega M, 2007, CARDIOVASC RES, V74, P196, DOI 10.1016/j.cardiores.2007.02.008; Sanada S, 2007, J CLIN INVEST, V117, P1538, DOI 10.1172/JCI30634; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Shimpo M, 2004, CIRCULATION, V109, P2186, DOI 10.1161/01.CIR.0000127958.21003.5A; Sutton-Tyrrell K, 2001, HYPERTENSION, V38, P429, DOI 10.1161/01.HYP.38.3.429; Tago K, 2001, BIOCHEM BIOPH RES CO, V285, P1377, DOI 10.1006/bbrc.2001.5306; TOMINAGA S, 1989, FEBS LETT, V258, P301, DOI 10.1016/0014-5793(89)81679-5; van Greevenbroek MMJ, 2013, NETH J MED, V71, P174; Wallis MG, 2002, DIABETES, V51, P3492, DOI 10.2337/diabetes.51.12.3492; Weinberg EO, 2003, CIRCULATION, V107, P721, DOI 10.1161/01.CIR.0000047274.66749.FE; WERENSKIOLD AK, 1989, MOL CELL BIOL, V9, P5207, DOI 10.1128/MCB.9.11.5207; Zebekakis PE, 2005, J HYPERTENS, V23, P1839, DOI 10.1097/01.hjh.0000179511.93889.e9; Zeyda M, 2012, INT J OBES IN PRESS; Zieman SJ, 2005, ARTERIOSCL THROM VAS, V25, P932, DOI 10.1161/01.ATV.0000160548.78317.29	35	36	38	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79176	10.1371/journal.pone.0079176	http://dx.doi.org/10.1371/journal.pone.0079176			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265755	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100088
J	Phanuphak, N; Teeratakulpisarn, N; Keelawat, S; Pankam, T; Barisri, J; Triratanachat, S; Deesua, A; Rodbamrung, P; Wongsabut, J; Tantbirojn, P; Numto, S; Ruangvejvorachai, P; Phanuphak, P; Palefsky, JM; Ananworanich, J; Kerr, SJ				Phanuphak, Nittaya; Teeratakulpisarn, Nipat; Keelawat, Somboon; Pankam, Tippawan; Barisri, Jiranuwat; Triratanachat, Surang; Deesua, Amornrat; Rodbamrung, Piyanee; Wongsabut, Jiratchaya; Tantbirojn, Patou; Numto, Saranya; Ruangvejvorachai, Preecha; Phanuphak, Praphan; Palefsky, Joel M.; Ananworanich, Jintanat; Kerr, Stephen J.			Use of Human Papillomavirus DNA, E6/E7 mRNA, and p16 Immunocytochemistry to Detect and Predict anal High-Grade Squamous Intraepithelial Lesions in HIV-Positive and HIV-Negative Men Who Have Sex with Men	PLOS ONE			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; NEOPLASIA; CANCER; CYTOLOGY; PROGRESSION; DYSPLASIA	Background: Men who have sex with men (MSM) are at high risk of having anal cancer. Anal high-grade squamous intraepithelial lesion (HSIL) is the precursor of anal cancer. We explored the use of different biomarkers associated with human papillomavirus (HPV) infection and HPV-mediated cell transformation to detect and predict HSIL among HIV-positive and HIV-negative MSM. Methodology/Principal Findings: A total of 123 HIV-positive and 123 HIV-negative MSM were enrolled and followed for 12 months. High-resolution anoscopy (HRA) with biopsies were performed at every visit along with anal sample collection for cytology, high-risk HPV DNA genotyping, HPV E6/E7 mRNA, and p16 immunocytochemistry. Performance characteristics and area under the receiver operator characteristics curve were calculated for these biomarkers at baseline, and Cox regression compared the usefulness of these biomarkers in predicting incident HSIL. High-risk HPV DNA, E6/E7 mRNA, and p16 immunocytochemistry each identified 43-46% of MSM whose baseline test positivity would trigger HRA referral. E6/E7 mRNA had the highest sensitivity (64.7%) and correctly classified the highest number of prevalent HSIL cases. With the exception of p16 immunochemistry, most tests showed significant increases in sensitivity but decreases specificity versus anal cytology, while the overall number of correctly classified cases was not significantly different. Baseline or persistent type 16 and/or 18 HPV DNA was the only test significantly predicting incident histologic HSIL within 12 months in models adjusted for HIV status and low-grade squamous intraepithelial lesions at baseline. Conclusions/Significance: Countries with a high HIV prevalence among MSM and limited HRA resources may consider using biomarkers to identify individuals at high risk of HSIL. E6/E7 mRNA had the highest sensitivity for prevalent HSIL detection regardless of HIV status, whereas type 16 and/or 18 HPV DNA performed best in predicting development of incident HSIL within 12 months.	[Phanuphak, Nittaya; Teeratakulpisarn, Nipat; Pankam, Tippawan; Barisri, Jiranuwat; Deesua, Amornrat; Rodbamrung, Piyanee; Phanuphak, Praphan; Ananworanich, Jintanat] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Phanuphak, Nittaya; Phanuphak, Praphan; Ananworanich, Jintanat] SEARCH, Bangkok, Thailand; [Keelawat, Somboon; Ruangvejvorachai, Preecha] Chulalongkorn Univ, Fac Med, Dept Pathol, Bangkok 10330, Thailand; [Triratanachat, Surang; Tantbirojn, Patou; Numto, Saranya] Chulalongkorn Univ, Fac Med, Dept Obstet & Gynecol, Bangkok 10330, Thailand; [Wongsabut, Jiratchaya; Phanuphak, Praphan; Ananworanich, Jintanat; Kerr, Stephen J.] HIV NAT, Bangkok, Thailand; [Phanuphak, Praphan; Ananworanich, Jintanat] Chulalongkorn Univ, Fac Med, Dept Med, Bangkok 10330, Thailand; [Palefsky, Joel M.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Kerr, Stephen J.] Univ New S Wales, Kirby Inst Infect & Immun Soc, Sydney, NSW, Australia	Thai Red Cross Society; Chulalongkorn University; Chulalongkorn University; Chulalongkorn University; University of California System; University of California San Francisco; University of New South Wales Sydney; Kirby Institute	Phanuphak, N (corresponding author), Thai Red Cross AIDS Res Ctr, Bangkok, Thailand.	nittaya.p@trcarc.org	Keelawat, Somboon/AAH-8616-2020; Ananworanich, Jintanat/AAC-6348-2021; Kerr, Stephen/J-6126-2012; Phanuphak, Nittaya/AAA-8579-2019	Ananworanich, Jintanat/0000-0003-1369-3224; Kerr, Stephen/0000-0002-1919-4525; Keelawat, Somboon/0000-0002-4180-7914	amfAR, The Foundation for AIDS Research (IeDEA) National Institute of Allergy and Infectious Diseases (NIAID) [U01AI069907]; Eunice Kennedy Shriver National Institute Of Child Health and Human Development (NICHD); National Cancer Institute (NCI); NIH [R25 TW009345]; Fogarty International Center; National Institute of Mental Health; NIH Office of the Director; Office of Women's Health; Office of AIDS Research; FOGARTY INTERNATIONAL CENTER [R25TW009345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069907, P30AI027763] Funding Source: NIH RePORTER	amfAR, The Foundation for AIDS Research (IeDEA) National Institute of Allergy and Infectious Diseases (NIAID); Eunice Kennedy Shriver National Institute Of Child Health and Human Development (NICHD)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fogarty International Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIH Office of the Director(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Office of Women's Health; Office of AIDS Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	The project was supported through a grant from amfAR, The Foundation for AIDS Research, to the International Epidemiologic Databases to Evaluate AIDS (IeDEA; U01AI069907): National Institute of Allergy and Infectious Diseases (NIAID), Eunice Kennedy Shriver National Institute Of Child Health and Human Development (NICHD), and National Cancer Institute (NCI). The project was also supported by NIH Research Training Grant #R25 TW009345 funded by the Fogarty International Center, the National Institute of Mental Health, the NIH Office of the Director, the Office of Women's Health and the Office of AIDS Research. The content of this presentation is solely the responsibility of the authors and does not necessarily represent the official views of any of the institutions mentioned above. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berry JM, 2009, DIS COLON RECTUM, V52, P239, DOI 10.1007/DCR.0b013e31819793d9; Chiao EY, 2006, CLIN INFECT DIS, V43, P223, DOI 10.1086/505219; Chin-Hong PV, 2008, ANN INTERN MED, V149, P300, DOI 10.7326/0003-4819-149-5-200809020-00004; CRITCHLOW CW, 1995, AIDS, V9, P1255, DOI 10.1097/00002030-199511000-00007; D'Souza G, 2008, JAIDS-J ACQ IMM DEF, V48, P491, DOI 10.1097/QAI.0b013e31817aebfe; Daling JR, 2004, CANCER-AM CANCER SOC, V101, P270, DOI 10.1002/cncr.20365; de Pokomandy A, 2011, CLIN INFECT DIS, V52, P1174, DOI 10.1093/cid/cir064; Devaraj B, 2006, DIS COLON RECTUM, V49, P36, DOI 10.1007/s10350-005-0229-z; Dray M, 2005, PATHOLOGY, V37, P112, DOI 10.1080/00313020500058607; Frisch M, 1999, CANCER RES, V59, P753; Goldstone SE, 2012, INT J CANCER, V131, P1641, DOI 10.1002/ijc.27431; Indinnimeo M, 2011, INT J INFECT DIS, V15, pE232, DOI 10.1016/j.ijid.2010.11.012; Kreuter A, 2005, J AM ACAD DERMATOL, V52, P603, DOI 10.1016/j.jaad.2004.11.026; Nayar R., 2004, BETHESDA SYSTEM REPO; Palefsky JM, 2005, AIDS, V19, P1407, DOI 10.1097/01.aids.0000181012.62385.4a; Palefsky JM, 1998, AIDS, V12, P495, DOI 10.1097/00002030-199805000-00011; PALEFSKY JM, 1991, CANCER RES, V51, P1014; Phanuphak N, 2013, AIDS, V27, P1753, DOI 10.1097/QAD.0b013e328360a509; Pirog EC, 2010, AM J SURG PATHOL, V34, P1449, DOI 10.1097/PAS.0b013e3181f0f52a; Roka F, 2008, DIS COLON RECTUM, V51, P62, DOI 10.1007/s10350-007-9082-6; Salit IE, 2009, CANCER EPIDEM BIOMAR, V18, P1986, DOI 10.1158/1055-9965.EPI-08-1141; Scholefield JH, 2005, BRIT J SURG, V92, P1133, DOI 10.1002/bjs.4994; Silling S, 2012, J CLIN VIROL, V53, P325, DOI 10.1016/j.jcv.2011.12.029; Silvera R, 2013, 20 C RETR OPP INF; Tamhane A, 2008, CLIN INFECT DIS, V46, P474, DOI 10.1086/524893; Valari O, 2011, GYNECOL ONCOL, V122, P505, DOI 10.1016/j.ygyno.2011.05.033; van der Snoek EM, 2012, SEX TRANSM DIS, V39, P495, DOI 10.1097/OLQ.0b013e31825aa764; Watson AJM, 2006, ANZ J SURG, V76, P715, DOI 10.1111/j.1445-2197.2006.03837.x; Wentzensen N, 2012, AIDS, V26, P2185, DOI 10.1097/QAD.0b013e328359f255	29	27	29	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78291	10.1371/journal.pone.0078291	http://dx.doi.org/10.1371/journal.pone.0078291			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265682	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100016
J	Rong, K; Yang, H; Ma, JZ; Zong, C; Cai, TJ				Rong, Ke; Yang, Hui; Ma, Jianzhang; Zong, Cheng; Cai, Tijiu			Food Availability and Animal Space Use Both Determine Cache Density of Eurasian Red Squirrels	PLOS ONE			English	Article							HOARDING BEHAVIOR; HABITAT SELECTION; SCIURUS-VULGARIS; KANGAROO RATS; EVOLUTION; PILFERAGE; MODEL; COMPETITION; DISPERSAL; RODENTS	Scatter hoarders are not able to defend their caches. A longer hoarding distance combined with lower cache density can reduce cache losses but increase the costs of hoarding and retrieving. Scatter hoarders arrange their cache density to achieve an optimal balance between hoarding costs and main cache losses. We conducted systematic cache sampling investigations to estimate the effects of food availability on cache patterns of Eurasian red squirrels (Sciurus vulgaris). This study was conducted over a five-year period at two sample plots in a Korean pine (Pinus koraiensis)-dominated forest with contrasting seed production patterns. During these investigations, the locations of nest trees were treated as indicators of squirrel space use to explore how space use affected cache pattern. The squirrels selectively hoarded heavier pine seeds farther away from seed-bearing trees. The heaviest seeds were placed in caches around nest trees regardless of the nest tree location, and this placement was not in response to decreased food availability. The cache density declined with the hoarding distance. Cache density was lower at sites with lower seed production and during poor seed years. During seed mast years, the cache density around nest trees was higher and invariant. The pine seeds were dispersed over a larger distance when seed availability was lower. Our results suggest that 1) animal space use is an important factor that affects food hoarding distance and associated cache densities, 2) animals employ different hoarding strategies based on food availability, and 3) seed dispersal outside the original stand is stimulated in poor seed years.	[Rong, Ke; Yang, Hui; Ma, Jianzhang; Zong, Cheng] Northeast Forestry Univ, Coll Wildlife Resource, Harbin, Peoples R China; [Cai, Tijiu] Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China	Northeast Forestry University - China; Northeast Forestry University - China	Cai, TJ (corresponding author), Northeast Forestry Univ, Sch Forestry, Harbin, Peoples R China.	Caitj@nefu.edu.cn	zong, cheng/HGU-3136-2022		Forestry Industry Research Special Funds for Public Welfare Projects of China [200904012]; National Natural Science Funds of china [31172100, 30970372]	Forestry Industry Research Special Funds for Public Welfare Projects of China; National Natural Science Funds of china(National Natural Science Foundation of China (NSFC))	This work was funded by Forestry Industry Research Special Funds for Public Welfare Projects of China (200904012) and the National Natural Science Funds of china (31172100, 30970372). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ANDERSSON M, 1978, ANIM BEHAV, V26, P707, DOI 10.1016/0003-3472(78)90137-9; BRODIN A, 1994, NATURE, V372, P510, DOI 10.1038/372510a0; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; CLARKE MF, 1994, ANIM BEHAV, V48, P299, DOI 10.1006/anbe.1994.1243; CLARKSON K, 1986, J ANIM ECOL, V55, P111, DOI 10.2307/4696; Dally JM, 2006, ANIM BEHAV, V72, P13, DOI 10.1016/j.anbehav.2005.08.020; DALY M, 1992, BEHAV ECOL, V3, P102, DOI 10.1093/beheco/3.2.102; Donald JL, 2011, J MAMMAL, V92, P1013, DOI 10.1644/10-MAMM-A-340.1; Galvez D, 2009, ANIM BEHAV, V78, P1327, DOI 10.1016/j.anbehav.2009.08.015; Gannon WL, 2007, J MAMMAL, V88, P809, DOI 10.1644/06-MAMM-F-185R1.1; Gerhardt F, 2005, J MAMMAL, V86, P108, DOI 10.1644/1545-1542(2005)086&lt;0108:FPILRS&gt;2.0.CO;2; Hopewell LJ, 2008, BEHAV ECOL, V19, P1143, DOI 10.1093/beheco/arn095; Horne JS, 2008, ECOL MODEL, V214, P338, DOI 10.1016/j.ecolmodel.2008.02.042; Huang ZY, 2011, ANIM BEHAV, V81, P831, DOI 10.1016/j.anbehav.2011.01.018; Hurly TA, 1997, J MAMMAL, V78, P529, DOI 10.2307/1382904; Jansen PA, 2004, ECOL MONOGR, V74, P569, DOI 10.1890/03-4042; JENKINS SH, 1995, ECOLOGY, V76, P2470, DOI 10.2307/2265821; Moore JE, 2007, ECOLOGY, V88, P2529, DOI 10.1890/07-0247.1; Rong Ke, 2009, Acta Theriologica Sinica, V29, P142; Rong Ke, 2009, Acta Theriologica Sinica, V29, P32; SAS Institute, 2010, JMP VERS 9 0 2; SMITH CC, 1984, ANNU REV ECOL SYST, V15, P329, DOI 10.1146/annurev.es.15.110184.001553; STAPANIAN MA, 1978, ECOLOGY, V59, P884, DOI 10.2307/1938541; STAPANIAN MA, 1984, ECOLOGY, V65, P1387, DOI 10.2307/1939119; Tsurim I, 2004, J MAMMAL, V85, P67, DOI 10.1644/1545-1542(2004)085<0067:TEOTCO>2.0.CO;2; Vander Wall SB, 2003, BEHAV ECOL, V14, P656, DOI 10.1093/beheco/arg064; Vander Wall SB, 2002, ECOLOGY, V83, P3508, DOI 10.2307/3072099; Vander Wall SB., 1990, FOOD HOARDING ANIMAL; Vander Wall SB, 2006, ANIM BEHAV, V72, P189, DOI 10.1016/j.anbehav.2006.01.004; VANDERWALL SB, 1995, AM MIDL NAT, V133, P312; Wauters LA, 1995, P ROY SOC B-BIOL SCI, V262, P277, DOI 10.1098/rspb.1995.0206; Wauters LA, 2002, BEHAV ECOL SOCIOBIOL, V51, P360, DOI 10.1007/s00265-001-0446-y; Wauters LA, 2001, ECOGRAPHY, V24, P525, DOI 10.1034/j.1600-0587.2001.d01-208.x; Xiao ZS, 2005, PLANT ECOL, V177, P249, DOI 10.1007/s11258-005-2321-9; Zong C, 2010, FOREST ECOL MANAG, V260, P587, DOI 10.1016/j.foreco.2010.05.014; Zong Cheng, 2009, Acta Ecologica Sinica, V29, P362; Zong Cheng, 2007, Acta Theriologica Sinica, V27, P105; Zuur A.F., 2007, ANAL ECOLOGICAL DATA	38	6	7	2	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80632	10.1371/journal.pone.0080632	http://dx.doi.org/10.1371/journal.pone.0080632			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265833	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100169
J	Scarduzio, M; Panichi, R; Pettorossi, VE; Grassi, S				Scarduzio, Mariangela; Panichi, Roberto; Pettorossi, Vito Enrico; Grassi, Silvarosa			Synaptic Long-Term Potentiation and Depression in the Rat Medial Vestibular Nuclei Depend on Neural Activation of Estrogenic and Androgenic Signals	PLOS ONE			English	Article							BIDIRECTIONAL PLASTICITY; RECEPTOR-BETA; GUINEA-PIG; BRAIN; 17-BETA-ESTRADIOL; ESTRADIOL; AROMATASE; NEUROSTEROIDS; TESTOSTERONE; HIPPOCAMPUS	Estrogenic and androgenic steroids can be synthesised in the brain and rapidly modulate synaptic transmission and plasticity through direct interaction with membrane receptors for estrogens (ERs) and androgens (ARs). We used whole cell patch clamp recordings in brainstem slices of male rats to explore the influence of ER and AR activation and local synthesis of 17 beta-estradiol (E2) and 5 alpha-dihydrotestosterone (DHT) on the long-term synaptic changes induced in the neurons of the medial vestibular nucleus (MVN). Long-term depression (LTD) and long-term potentiation (LTP) caused by different patterns of high frequency stimulation (HFS) of the primary vestibular afferents were assayed under the blockade of ARs and ERs or in the presence of inhibitors for enzymes synthesizing DHT (5 alpha-reductase) and E2 (P450-aromatase) from testosterone (T). We found that LTD is mediated by interaction of locally produced androgens with ARs and LTP by interaction of locally synthesized E2 with ERs. In fact, the AR block with flutamide prevented LTD while did not affect LTP, and the blockade of ERs with ICI 182,780 abolished LTP without influencing LTD. Moreover, the block of P450-aromatase with letrozole not only prevented the LTP induction, but inverted LTP into LTD. This LTD is likely due to the local activation of androgens, since it was abolished under blockade of ARs. Conversely, LTD was still induced in the presence of finasteride the inhibitor of 5 alpha-reductase demonstrating that T is able to activate ARs and induce LTD even when DHT is not synthesized. This study demonstrates a key and opposite role of sex neurosteroids in the long-term synaptic changes of the MVN with a specific role of T-DHT for LTD and of E2 for LTP. Moreover, it suggests that different stimulation patterns can lead to LTD or LTP by specifically activating the enzymes involved in the synthesis of androgenic or estrogenic neurosteroids.	[Scarduzio, Mariangela; Panichi, Roberto; Pettorossi, Vito Enrico; Grassi, Silvarosa] Univ Perugia, Fac Med & Chirurg, Sez Fisiol Umana, Dipartimento Med Interna, I-06100 Perugia, Italy	University of Perugia	Grassi, S (corresponding author), Univ Perugia, Fac Med & Chirurg, Sez Fisiol Umana, Dipartimento Med Interna, I-06100 Perugia, Italy.	silvarosa.grassi@unipg.it	Pettorossi, Vito/K-9695-2019	Scarduzio, Mariangela/0000-0002-6371-8568	COMPAGNIA di San Paolo (Torino) [2008.2176]; Fondazione Cassa di Risparmio di Perugia [2009.020.0036]	COMPAGNIA di San Paolo (Torino)(Compagnia di San Paolo); Fondazione Cassa di Risparmio di Perugia(Fondazione Cassa Risparmio Perugia)	This work has been supported by COMPAGNIA di San Paolo (Torino): Progetti Programma Neuroscienze to S. G (Grant 2008.2176) and Fondazione Cassa di Risparmio di Perugia to V. E. P. (Grant 2009.020.0036. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmadiani A, 2003, EPILEPSIA, V44, P629, DOI 10.1046/j.1528-1157.2003.36402.x; Babalian A, 1997, NEUROSCIENCE, V81, P405, DOI 10.1016/S0306-4522(97)00069-9; Balthazart J, 2006, ENDOCRINOLOGY, V147, P359, DOI 10.1210/en.2005-0845; Baulieu EE, 1997, RECENT PROG HORM RES, V52, P1; Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Bi RF, 2000, P NATL ACAD SCI USA, V97, P3602, DOI 10.1073/pnas.060034497; Compagnone NA, 2000, FRONT NEUROENDOCRIN, V21, P1, DOI 10.1006/frne.1999.0188; Fang H, 2003, CHEM RES TOXICOL, V16, P1338, DOI 10.1021/tx030011g; Foradori CD, 2008, FRONT NEUROENDOCRIN, V29, P169, DOI 10.1016/j.yfrne.2007.10.005; Foy MR, 1999, J NEUROPHYSIOL, V81, P925, DOI 10.1152/jn.1999.81.2.925; Garcia-Segura LM, 2008, J NEUROENDOCRINOL, V20, P705, DOI 10.1111/j.1365-2826.2008.01713.x; Gittis AH, 2006, CURR OPIN NEUROBIOL, V16, P385, DOI 10.1016/j.conb.2006.06.012; Grassi S, 2011, NEUROSCIENCE, V192, P67, DOI 10.1016/j.neuroscience.2011.06.078; Grassi S, 2010, NEUROSCIENCE, V171, P666, DOI 10.1016/j.neuroscience.2010.09.035; Grassi S, 2010, NEUROSCIENCE, V165, P1100, DOI 10.1016/j.neuroscience.2009.11.039; Grassi S, 2013, BRAIN RES BULL, V97, P1, DOI 10.1016/j.brainresbull.2013.05.006; Grassi S, 2012, BRAIN RES BULL, V87, P319, DOI 10.1016/j.brainresbull.2011.11.008; Grassi S, 2009, J NEUROSCI, V29, P10779, DOI 10.1523/JNEUROSCI.1697-09.2009; Hajszan T, 2008, HORM BEHAV, V53, P638, DOI 10.1016/j.yhbeh.2007.12.007; Handa RJ, 2008, HORM BEHAV, V53, P741, DOI 10.1016/j.yhbeh.2007.09.012; Hojo Y, 2004, P NATL ACAD SCI USA, V101, P865, DOI 10.1073/pnas.2630225100; Hojo Y, 2008, MOL CELL ENDOCRINOL, V290, P31, DOI 10.1016/j.mce.2008.04.017; Hojo Y, 2009, ENDOCRINOLOGY, V150, P5106, DOI 10.1210/en.2009-0305; Isgor C, 2003, J NEUROBIOL, V55, P179, DOI 10.1002/neu.10200; JOHNSTON AR, 1994, J PHYSIOL-LONDON, V481, P61, DOI 10.1113/jphysiol.1994.sp020419; Kimoto T, 2001, ENDOCRINOLOGY, V142, P3578, DOI 10.1210/en.142.8.3578; LEPHART ED, 1993, MOL CELL NEUROSCI, V4, P473, DOI 10.1006/mcne.1993.1059; Levin ER, 2009, TRENDS ENDOCRIN MET, V20, P477, DOI 10.1016/j.tem.2009.06.009; MacLusky NJ, 2006, NEUROSCIENCE, V138, P957, DOI 10.1016/j.neuroscience.2005.12.054; McElvain LE, 2010, NEURON, V68, P763, DOI 10.1016/j.neuron.2010.09.025; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; Micevych PE, 2008, MOL NEUROBIOL, V38, P66, DOI 10.1007/s12035-008-8034-z; Morissette M, 2008, J STEROID BIOCHEM, V108, P327, DOI 10.1016/j.jsbmb.2007.09.011; Mukai H, 2006, NEUROSCIENCE, V138, P757, DOI 10.1016/j.neuroscience.2005.09.010; Naftolin F, 1975, Adv Biosci, V15, P105; Ooishi Y, 2012, J STEROID BIOCHEM, V131, P37, DOI 10.1016/j.jsbmb.2011.10.004; Pedram A, 2006, MOL ENDOCRINOL, V20, P1996, DOI 10.1210/me.2005-0525; Pettorossi VE, 2003, ACTA OTO-LARYNGOL, V123, P182, DOI 10.1080/0036554021000028093; Pettorossi VE, 2011, ACTA OTO-LARYNGOL, V131, P434, DOI 10.3109/00016489.2010.536992; Pouliot WA, 1996, SYNAPSE, V23, P10, DOI 10.1002/(SICI)1098-2396(199605)23:1<10::AID-SYN2>3.3.CO;2-Z; Raz L, 2008, NEUROSIGNALS, V16, P140, DOI 10.1159/000111559; Reddy DS, 2004, NEUROREPORT, V15, P515, DOI 10.1097/00001756-200403010-00026; Scarduzio M, 2012, NEUROSCIENCE, V223, P1, DOI 10.1016/j.neuroscience.2012.07.039; SELMANOFF MK, 1977, ENDOCRINOLOGY, V101, P841, DOI 10.1210/endo-101-3-841; SERAFIN M, 1991, EXP BRAIN RES, V84, P417, DOI 10.1007/BF00231464; SIMPSON ER, 1994, ENDOCR REV, V15, P342, DOI 10.1210/er.15.3.342; Smith CC, 2006, J NEUROSCI, V26, P8517, DOI 10.1523/JNEUROSCI.5279-05.2006; Tabori NE, 2005, NEUROSCIENCE, V130, P151, DOI 10.1016/j.neuroscience.2004.08.048; Wade CB, 2001, ENDOCRINOLOGY, V142, P2336, DOI 10.1210/en.142.6.2336; Wong M, 1996, CRIT REV NEUROBIOL, V10, P189, DOI 10.1615/CritRevNeurobiol.v10.i2.30; ZHOU ZX, 1995, MOL ENDOCRINOL, V9, P208, DOI 10.1210/me.9.2.208	51	16	16	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80792	10.1371/journal.pone.0080792	http://dx.doi.org/10.1371/journal.pone.0080792			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265837	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100173
J	Weidner, C; Wowro, SJ; Rousseau, M; Freiwald, A; Kodelja, V; Abdel-Aziz, H; Kelber, O; Sauer, S				Weidner, Christopher; Wowro, Sylvia J.; Rousseau, Morten; Freiwald, Anja; Kodelja, Vitam; Abdel-Aziz, Heba; Kelber, Olaf; Sauer, Sascha			Antidiabetic Effects of Chamomile Flowers Extract in Obese Mice through Transcriptional Stimulation of Nutrient Sensors of the Peroxisome Proliferator-Activated Receptor (PPAR) Family	PLOS ONE			English	Article							NATURAL-PRODUCTS; GAMMA; INFLAMMATION; MECHANISMS; DISCOVERY; POTENT; L.; IBEROGAST(R); MODULATORS; COMPONENTS	Given the significant increases in the incidence of metabolic diseases, efficient strategies for preventing and treating of these common disorders are urgently needed. This includes the development of phytopharmaceutical products or functional foods to prevent or cure metabolic diseases. Plant extracts from edible biomaterial provide a potential resource of structurally diverse molecules that can synergistically interfere with complex disorders. In this study we describe the safe application of ethanolic chamomile (Matricaria recutita) flowers extract (CFE) for the treatment and prevention of type 2 diabetes and associated disorders. We show in vitro that this extract activates in particular nuclear receptor peroxisome proliferator-activated receptor gamma (PPAR gamma) and its isotypes. In a cellular context, in human primary adipocytes CFE administration (300 mu g/ml) led to specific expression of target genes of PPAR gamma, whereas in human hepatocytes CFE-induced we detected expression changes of genes that were regulated by PPAR alpha. In vivo treatment of insulin-resistant high-fat diet (HFD)-fed C57BL/6 mice with CFE (200 mg/kg/d) for 6 weeks considerably reduced insulin resistance, glucose intolerance, plasma triacylglycerol, non-esterified fatty acids (NEFA) and LDL/VLDL cholesterol. Co-feeding of lean C57BL/6 mice a HFD with 200 mg/kg/d CFE for 20 weeks showed effective prevention of fatty liver formation and hepatic inflammation, indicating additionally hepatoprotective effects of the extract. Moreover, CFE treatment did not reveal side effects, which have otherwise been associated with strong synthetic PPAR-targeting molecules, such as weight gain, liver disorders, hemodilution or bone cell turnover. Taken together, modulation of PPARs and other factors by chamomile flowers extract has the potential to prevent or treat type 2 diabetes and related disorders.	[Weidner, Christopher; Wowro, Sylvia J.; Rousseau, Morten; Freiwald, Anja; Kodelja, Vitam; Sauer, Sascha] Max Planck Inst Mol Genet, Otto Warburg Lab, D-14195 Berlin, Germany; [Weidner, Christopher] Free Univ Berlin, Dept Biol Chem & Pharm, Berlin, Germany; [Abdel-Aziz, Heba; Kelber, Olaf] Steigerwald Arzneimittelwerk GmbH, Dept Sci, Darmstadt, Germany	Max Planck Society; Free University of Berlin; Bayer AG; Steigerwald Pharmaceutical Factory GmbH	Sauer, S (corresponding author), Max Planck Inst Mol Genet, Otto Warburg Lab, Ihnestr 73, D-14195 Berlin, Germany.	sauer@molgen.mpg.de	Kelber, Olaf/AAH-4819-2021	Kelber, Olaf/0000-0003-3334-5833; Abdel-Aziz, Heba/0000-0002-4808-5926; Wowro, Sylvia/0000-0003-1728-9210	German Ministry for Education and Research (BMBF) [0315082]; European Union [262055]; Max Planck Society	German Ministry for Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); European Union(European Commission); Max Planck Society(Max Planck SocietyFoundation CELLEX)	The authors' work is supported by the German Ministry for Education and Research (BMBF, grant number 0315082), the European Union (FP7/2007-2013, under grant agreement number no 262055 (ESGI)), and the Max Planck Society. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2010, NAT REV DRUG DISCOV, V9, P828; Argmann CA, 2005, EUR J CLIN INVEST, V35, P82, DOI 10.1111/j.1365-2362.2005.01456.x; Berger J, 2002, ANNU REV MED, V53, P409, DOI 10.1146/annurev.med.53.082901.104018; Cemek M, 2008, J NAT MED-TOKYO, V62, P284, DOI 10.1007/s11418-008-0228-1; Cho N, 2008, CURR TOP MED CHEM, V8, P1483, DOI 10.2174/156802608786413474; Christensen KB, 2010, PHYTOTHER RES, V24, pS129, DOI 10.1002/ptr.3005; Chuang CC, 2011, ANNU REV NUTR, V31, P155, DOI 10.1146/annurev-nutr-072610-145149; Cock TA, 2004, EMBO REP, V5, P142, DOI 10.1038/sj.embor.7400082; Doshi LS, 2010, EXPERT OPIN INV DRUG, V19, P489, DOI 10.1517/13543781003640169; Eddouks M, 2005, DIABETES RES CLIN PR, V67, P189, DOI 10.1016/j.diabres.2004.07.015; Evans RM, 2004, NAT MED, V10, P355, DOI 10.1038/nm1025; Ganesan A, 2004, CURR OPIN BIOTECH, V15, P584, DOI 10.1016/j.copbio.2004.09.002; Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551; Gupta AK, 2006, AM J PHARM TOXICOL, V1, P17, DOI [DOI 10.3844/AJPTSP.2006.17.20, 10.3844/ajptsp.2006.17.20]; Harbourne N, 2009, FOOD CHEM, V115, P15, DOI 10.1016/j.foodchem.2008.11.044; Heikkinen S, 2007, CURR PROTOC MOL BIOL, DOI DOI 10.1002/0471142727.MB29B03S77; Heinle H, 2006, PHYTOMEDICINE, V13, P75, DOI 10.1016/j.phymed.2006.03.013; Hohenester B, 2004, NEUROGASTROENT MOTIL, V16, P765, DOI 10.1111/j.1365-2982.2004.00548.x; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; Kato A, 2008, J AGR FOOD CHEM, V56, P8206, DOI 10.1021/jf8014365; Kliewer SA, 2001, RECENT PROG HORM RES, V56, P239, DOI 10.1210/rp.56.1.239; Kroll U, 2006, PHYTOMEDICINE, V13, P12, DOI 10.1016/j.phymed.2006.03.016; Lalloyer F, 2010, ARTERIOSCL THROM VAS, V30, P894, DOI 10.1161/ATVBAHA.108.179689; Lehrke M, 2005, CELL, V123, P993, DOI 10.1016/j.cell.2005.11.026; Li JWH, 2009, SCIENCE, V325, P161, DOI 10.1126/science.1168243; Liang YC, 2001, FEBS LETT, V496, P12, DOI 10.1016/S0014-5793(01)02393-6; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; McCarty MF, 2005, MED HYPOTHESES, V64, P151, DOI 10.1016/j.mehy.2004.03.036; Medjakovic S, 2010, NUTRIENTS, V2, P241, DOI 10.3390/nu2030241; Meierhofer D, 2013, MOL CELL PROTEOMICS, V12, P1965, DOI 10.1074/mcp.M112.025031; Michalik L, 2006, PHARMACOL REV, V58, P726, DOI 10.1124/pr.58.4.5; Moreno M, 2010, PPAR RES, V2010, DOI 10.1155/2010/435689; Mueller M, 2008, J AGR FOOD CHEM, V56, P11621, DOI 10.1021/jf802298w; Muller M, 2003, NAT REV GENET, V4, P315, DOI 10.1038/nrg1047; Portincasa P, 2006, CURR MED CHEM, V13, P2889, DOI 10.2174/092986706778521878; Pourcet Benoit, 2006, Expert Opin Emerg Drugs, V11, P379, DOI 10.1517/14728214.11.3.379; Puhl AC, 2012, MOL PHARMACOL, V81, P788, DOI 10.1124/mol.111.076216; Rosen CJ, 2010, NEW ENGL J MED, V363, P803, DOI 10.1056/NEJMp1008233; Singh Ompal, 2011, Pharmacogn Rev, V5, P82, DOI 10.4103/0973-7847.79103; Smyth S, 2006, NAT MED, V12, P75, DOI 10.1038/nm0106-75; SPIEGELMAN BM, 1983, J BIOL CHEM, V258, P83; Spiegelman BM, 1998, DIABETES, V47, P507, DOI 10.2337/diabetes.47.4.507; Wegener T, 2006, PHYTOMEDICINE, V13, P20, DOI 10.1016/j.phymed.2006.07.001; Weidner C, 2013, DIABETOLOGIA; Weidner C, 2012, P NATL ACAD SCI USA, V109, P7257, DOI 10.1073/pnas.1116971109; *WHO, 2003, OB OV FACT SHEET; Wilkinson AS, 2008, J AGR FOOD CHEM, V56, P3037, DOI 10.1021/jf800046n; Yang XY, 2006, CELL, V126, P801, DOI 10.1016/j.cell.2006.06.050	50	31	32	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80335	10.1371/journal.pone.0080335	http://dx.doi.org/10.1371/journal.pone.0080335			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265809	Green Accepted, gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100145
J	McKinley, ET; Liu, HL; McDonald, WH; Luo, WF; Zhao, P; Coffey, RJ; Hanks, SK; Manning, HC				McKinley, Eliot T.; Liu, Huiling; McDonald, W. Hayes; Luo, Weifeng; Zhao, Ping; Coffey, Robert J.; Hanks, Steven K.; Manning, H. Charles			Global Phosphotyrosine Proteomics Identifies PKC delta as a Marker of Responsiveness to Src Inhibition in Colorectal Cancer	PLOS ONE			English	Article							DOMAIN-CONTAINING PROTEIN-1; TYROSINE-PHOSPHATASE-ALPHA; CHRONIC MYELOID-LEUKEMIA; GROWTH-FACTOR RECEPTOR; HUMAN-COLON CARCINOMA; FAMILY KINASES; LUNG-CANCER; PHOSPHORYLATION; ACTIVATION; PP60C-SRC	Sensitive and specific biomarkers of protein kinase inhibition can be leveraged to accelerate drug development studies in oncology by associating early molecular responses with target inhibition. In this study, we utilized unbiased shotgun phosphotyrosine (pY) proteomics to discover novel biomarkers of response to dasatinib, a small molecule Src-selective inhibitor, in preclinical models of colorectal cancer (CRC). We performed unbiased mass spectrometry shotgun pY proteomics to reveal the pY proteome of cultured HCT-116 colonic carcinoma cells, and then extended this analysis to HCT-116 xenograft tumors to identify pY biomarkers of dasatinib-responsiveness in vivo. Major dasatinib-responsive pY sites in xenograft tumors included sites on delta-type protein kinase C (PKC delta), CUB-domain-containing protein 1 (CDCP1), Type-II SH2-domain-containing inositol 5-phosphatase (SHIP2), and receptor protein-tyrosine phosphatase alpha (RPTP alpha). The pY313 site PKC delta was further supported as a relevant biomarker of dasatinib-mediated Src inhibition in HCT-116 xenografts by immunohistochemistry and immunoblotting with a phosphospecific antibody. Reduction of PKC delta pY313 was further correlated with dasatinib-mediated inhibition of Src and diminished growth as spheroids of a panel of human CRC cell lines. These studies reveal PKCd pY313 as a promising readout of Src inhibition in CRC and potentially other solid tumors and may reflect responsiveness to dasatinib in a subset of colorectal cancers.	[McKinley, Eliot T.; Zhao, Ping; Manning, H. Charles] Vanderbilt Univ, Vanderbilt Univ Inst Imaging Sci, Nashville, TN 37235 USA; [McKinley, Eliot T.; Manning, H. Charles] Vanderbilt Univ, Dept Biomed Engn, Nashville, TN 37235 USA; [Liu, Huiling; Luo, Weifeng; Coffey, Robert J.; Hanks, Steven K.] Vanderbilt Univ, Sch Med, Dept Cell & Dev Biol, Nashville, TN 37212 USA; [McDonald, W. Hayes] Vanderbilt Univ, Dept Biochem, Nashville, TN 37232 USA; [Coffey, Robert J.] Vanderbilt Univ, Sch Med, Dept Med, Nashville, TN 37212 USA; [Coffey, Robert J.; Hanks, Steven K.; Manning, H. Charles] Vanderbilt Univ, Med Ctr, Vanderbilt Ingram Canc Ctr, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Sch Med, Program Chem & Phys Biol, Nashville, TN 37212 USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Neurosurg, Nashville, TN USA; [Manning, H. Charles] Vanderbilt Univ, Med Ctr, Dept Radiol & Radiol Sci, Nashville, TN 37232 USA	Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University; Vanderbilt University	Manning, HC (corresponding author), Vanderbilt Univ, Vanderbilt Univ Inst Imaging Sci, 221 Kirkland Hall, Nashville, TN 37235 USA.	henry.c.manning@vanderbilt.edu	McDonald, W. Hayes/B-4109-2016	McDonald, W. Hayes/0000-0002-3510-426X	National Cancer Institute [R25 CA136440, P50-951903, R01-CA140628, K25-CA127349, RC1-CA145138, R01-CA46413]; Kleberg Foundation; NATIONAL CANCER INSTITUTE [R25CA092043, R01CA140628, RC1CA145138, K25CA127349, R01CA046413, R25CA136440] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Kleberg Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	These studies were supported by grants from the National Cancer Institute: R25 CA136440, P50-951903; R01-CA140628; K25-CA127349; RC1-CA145138; R01-CA46413; and the Kleberg Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allgayer H, 2002, CANCER, V94, P344, DOI 10.1002/cncr.10221; Alvarez RH, 2006, CANCER-AM CANCER SOC, V107, P1918, DOI 10.1002/cncr.22215; Araujo J, 2010, CANCER TREAT REV, V36, P492, DOI 10.1016/j.ctrv.2010.02.015; Benes CH, 2005, CELL, V121, P271, DOI 10.1016/j.cell.2005.02.019; Bhatt AS, 2005, ONCOGENE, V24, P5333, DOI 10.1038/sj.onc.1208582; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Blume-Jensen P, 2001, NATURE, V411, P355, DOI 10.1038/35077225; BOLEN JB, 1987, P NATL ACAD SCI USA, V84, P2251, DOI 10.1073/pnas.84.8.2251; BRATTAIN MG, 1981, CANCER RES, V41, P1751; Bromann PA, 2004, ONCOGENE, V23, P7957, DOI 10.1038/sj.onc.1208079; Brown TA, 2004, J BIOL CHEM, V279, P14772, DOI 10.1074/jbc.M309678200; CARTWRIGHT CA, 1989, J CLIN INVEST, V83, P2025, DOI 10.1172/JCI114113; Chapman PB, 2011, NEW ENGL J MED, V364, P2507, DOI 10.1056/NEJMoa1103782; Chen M, 2006, J BIOL CHEM, V281, P11972, DOI 10.1074/jbc.M600561200; Ciardiello F, 2001, CLIN CANCER RES, V7, P2958; CORTES HJ, 1987, J HIGH RES CHROMATOG, V10, P446, DOI 10.1002/jhrc.1240100805; Dancey J, 2003, NAT REV DRUG DISCOV, V2, P296, DOI 10.1038/nrd1066; DENHERTOG J, 1994, EMBO J, V13, P3020, DOI 10.1002/j.1460-2075.1994.tb06601.x; Druker BJ, 2001, NEW ENGL J MED, V344, P1031, DOI 10.1056/NEJM200104053441401; Druker BJ, 2008, BLOOD, V112, P4808, DOI 10.1182/blood-2008-07-077958; Du JY, 2009, NAT BIOTECHNOL, V27, P77, DOI 10.1038/nbt.1513; Flaherty KT, 2010, NEW ENGL J MED, V363, P809, DOI 10.1056/NEJMoa1002011; Frame MC, 2004, J CELL SCI, V117, P989, DOI 10.1242/jcs.01111; Huang F, 2007, CANCER RES, V67, P2226, DOI 10.1158/0008-5472.CAN-06-3633; Hunter T, 2009, CURR OPIN CELL BIOL, V21, P140, DOI 10.1016/j.ceb.2009.01.028; Janne PA, 2005, J CLIN ONCOL, V23, P3227, DOI 10.1200/JCO.2005.09.985; Kantarjian H, 2010, NEW ENGL J MED, V362, P2260, DOI 10.1056/NEJMoa1002315; Kim LC, 2009, NAT REV CLIN ONCOL, V6, P587, DOI 10.1038/nrclinonc.2009.129; Krause DS, 2005, NEW ENGL J MED, V353, P172, DOI 10.1056/NEJMra044389; Luo W, 2008, J PROTEOME RES, V7, P3447, DOI 10.1021/pr800187n; Perry SE, 2007, FEBS LETT, V581, P1137, DOI 10.1016/j.febslet.2007.02.025; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; SARIS CJM, 1986, CELL, V46, P201, DOI 10.1016/0092-8674(86)90737-3; Scherl-Mostageer M, 2001, ONCOGENE, V20, P4402, DOI 10.1038/sj.onc.1204566; Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104; SHIRASAWA S, 1993, SCIENCE, V260, P85, DOI 10.1126/science.8465203; Snead JL, 2009, BLOOD, V114, P3459, DOI 10.1182/blood-2007-10-113969; STOVER DR, 1995, J BIOL CHEM, V270, P15591, DOI 10.1074/jbc.270.26.15591; Summy JM, 2006, CLIN CANCER RES, V12, P1398, DOI 10.1158/1078-0432.CCR-05-2692; Summy JM, 2003, CANCER METAST REV, V22, P337, DOI 10.1023/A:1023772912750; TALAMONTI MS, 1993, J CLIN INVEST, V91, P53, DOI 10.1172/JCI116200; Uekita T, 2008, AM J PATHOL, V172, P1729, DOI 10.2353/ajpath.2008.070981; Uekita T, 2007, MOL CELL BIOL, V27, P7649, DOI 10.1128/MCB.01246-07; Wang R, 1996, P NATL ACAD SCI USA, V93, P8425, DOI 10.1073/pnas.93.16.8425; WHITEHEAD RH, 1985, JNCI-J NATL CANCER I, V74, P759; Yeatman TJ, 2004, NAT REV CANCER, V4, P470, DOI 10.1038/nrc1366	47	13	13	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80207	10.1371/journal.pone.0080207	http://dx.doi.org/10.1371/journal.pone.0080207			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260357	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200109
J	Loo, TW; Clarke, DM				Loo, Tip W.; Clarke, David M.			Locking Intracellular Helices 2 and 3 Together Inactivates Human P-glycoprotein	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						ABC Transporter; Drug Resistance; Membrane Proteins; Protein Folding; Protein Misfolding; P-glycoprotein	DRUG-BINDING POCKET; NUCLEOTIDE-BINDING; TRANSMEMBRANE SEGMENT-11; MULTIDRUG TRANSPORTER; PROMOTE MATURATION; ABC TRANSPORTERS; ATPASE ACTIVITY; MUTANTS; SITES; RESISTANCE	The P-glycoprotein (P-gp) drug pump (ABCB1) has two transmembrane domains and two nucleotide-binding domains (NBDs). Coupling of the drug-binding sites in the transmembrane domains to the NBDs occurs through interaction of the intracellular helices (IHs) with residues in the NBDs (IH1/IH4/NBD1 and IH2/IH3/NBD2). We showed previously that cross-linking of cysteines in IH3 and IH1 with a short cross-linker mimicked drug binding as it activated P-gp ATPase activity. Here we show that residue A259C(IH2) could be directly cross-linked to W803C(IH3). Cross-linking was inhibited by the presence of ATP and adenosine 5-(,-imino)triphosphate but not by ADP. Cross-linking of mutant A259C/W803C inhibited its verapamil-stimulated ATPase activity mutant, but activity was restored after addition of dithiothreitol. Because these residues are close to the ball-and-socket joint A266C(IH2)/Phe(1086)(NBD2), we mutated the adjacent Tyr(1087)(NBD2) close to IH3. Mutants Y1087A and Y1087L, but not Y1087F, were misprocessed, and all inhibited ATPase activity. Mutation of hydrophobic residues (F793A, L797A, L814A, and L818A) flanking IH3 also inhibited maturation. The results suggest that these residues, together with Trp(803) and Phe(804), form a large hydrophobic pocket. The results show that there is an important hydrophobic network at the IH2/IH3/NBD2 transmission interface that is critical for folding and activity of P-gp.	[Clarke, David M.] Univ Toronto, Dept Med, Toronto, ON M5S 1A8, Canada; Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada	University of Toronto; University of Toronto	Clarke, DM (corresponding author), Univ Toronto, Dept Med, 1 Kings Coll Circle,Rm 7342,Med Sci Bldg, Toronto, ON M5S 1A8, Canada.	david.clarke@utoronto.ca	Clarke, David M./A-1112-2008	Clarke, David M./0000-0003-4335-7184; Loo, Tip W/0000-0003-2108-0188	Canadian Institutes of Health Research	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))	This work was supported by a grant from the Canadian Institutes of Health Research (to D. M. C.).	Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; CHEN CJ, 1986, CELL, V47, P381, DOI 10.1016/0092-8674(86)90595-7; CHIFFLET S, 1988, ANAL BIOCHEM, V168, P1, DOI 10.1016/0003-2697(88)90002-4; Cui LY, 2007, J MOL BIOL, V365, P981, DOI 10.1016/j.jmb.2006.10.086; Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155; Delannoy S, 2005, BIOCHEMISTRY-US, V44, P14010, DOI 10.1021/bi0512445; Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594; Eckford PDW, 2009, CHEM REV, V109, P2989, DOI 10.1021/cr9000226; Globisch C, 2008, CHEMMEDCHEM, V3, P280, DOI 10.1002/cmdc.200700249; Gutmann DAP, 2010, TRENDS BIOCHEM SCI, V35, P36, DOI 10.1016/j.tibs.2009.07.009; Jin MS, 2012, NATURE, V490, P566, DOI 10.1038/nature11448; JULIANO RL, 1976, BIOCHIM BIOPHYS ACTA, V455, P152, DOI 10.1016/0005-2736(76)90160-7; Kapoor K, 2013, J BIOL CHEM, V288, P32622, DOI 10.1074/jbc.M113.498980; Khare D, 2009, MOL CELL, V33, P528, DOI 10.1016/j.molcel.2009.01.035; Loo TW, 2008, J BIOL CHEM, V283, P24860, DOI 10.1074/jbc.M803351200; Loo TW, 2007, J BIOL CHEM, V282, P32043, DOI 10.1074/jbc.M706175200; Loo TW, 2006, BIOCHEM J, V399, P351, DOI 10.1042/BJ20060715; Loo TW, 2006, BIOCHEM J, V396, P537, DOI 10.1042/BJ20060012; Loo TW, 2013, BIOCHEMISTRY-US, V52, P7167, DOI 10.1021/bi401269m; Loo TW, 2013, BIOCHEMISTRY-US, V52, P3194, DOI 10.1021/bi400425k; Loo TW, 2013, J BIOL CHEM, V288, P20326, DOI 10.1074/jbc.M113.484550; Loo TW, 2012, J BIOL CHEM, V287, P26806, DOI 10.1074/jbc.M112.376202; Loo TW, 2012, BIOCHEM PHARMACOL, V83, P345, DOI 10.1016/j.bcp.2011.11.014; Loo TW, 2010, BIOCHEM BIOPH RES CO, V395, P436, DOI 10.1016/j.bbrc.2010.04.057; Loo TW, 2009, J BIOL CHEM, V284, P24074, DOI 10.1074/jbc.M109.023267; Loo TW, 1997, J BIOL CHEM, V272, P709, DOI 10.1074/jbc.272.2.709; Loo TW, 2003, J BIOL CHEM, V278, P13603, DOI 10.1074/jbc.C300073200; Loo TW, 2004, J BIOL CHEM, V279, P18232, DOI 10.1074/jbc.M400229200; Loo TW, 2004, J BIOL CHEM, V279, P7692, DOI 10.1074/jbc.M311825200; Loo TW, 2003, J BIOL CHEM, V278, P50136, DOI 10.1074/jbc.M310448200; Loo TW, 1999, J BIOL CHEM, V274, P24759, DOI 10.1074/jbc.274.35.24759; LOO TW, 1995, J BIOL CHEM, V270, P843, DOI 10.1074/jbc.270.2.843; LOO TW, 1994, J BIOL CHEM, V269, P7243; Loo TW, 1999, BIOCHEMISTRY-US, V38, P5124, DOI 10.1021/bi982525y; LOO TW, 1995, J BIOL CHEM, V270, P21449, DOI 10.1074/jbc.270.37.21449; LOO TW, 1995, J BIOL CHEM, V270, P21839, DOI 10.1074/jbc.270.37.21839; LOO TW, 1995, J BIOL CHEM, V270, P22957, DOI 10.1074/jbc.270.39.22957; Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326; Mourez M, 1997, EMBO J, V16, P3066, DOI 10.1093/emboj/16.11.3066; Oldham ML, 2008, CURR OPIN STRUC BIOL, V18, P726, DOI 10.1016/j.sbi.2008.09.007; Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200; Pajeva IK, 2013, CHEMMEDCHEM, V8, P748, DOI 10.1002/cmdc.201200491; Ravna AW, 2007, THEOR BIOL MED MODEL, V4, DOI 10.1186/1742-4682-4-33; Rees DC, 2009, NAT REV MOL CELL BIO, V10, P218, DOI 10.1038/nrm2646; Sauna ZE, 2007, BIOCHEMISTRY-US, V46, P13787, DOI 10.1021/bi701385t; Siarheyeva A, 2010, J BIOL CHEM, V285, P7575, DOI 10.1074/jbc.M109.047290; URBATSCH IL, 1995, J BIOL CHEM, V270, P19383, DOI 10.1074/jbc.270.33.19383; Wang Y, 2007, MOL PHARMACOL, V71, P751, DOI 10.1124/mol.106.029926; Wise JG, 2012, BIOCHEMISTRY-US, V51, P5125, DOI 10.1021/bi300299z	49	16	16	1	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					229	236		10.1074/jbc.M113.527804	http://dx.doi.org/10.1074/jbc.M113.527804			8	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275649	Green Published, hybrid			2022-12-25	WOS:000329370900020
J	Thakur, HC; Singh, M; Nagel-Steger, L; Kremer, J; Prumbaum, D; Fansa, EK; Ezzahoini, H; Nouri, K; Gremer, L; Abts, A; Schmitt, L; Raunser, S; Ahmadian, MR; Piekorz, RP				Thakur, Harish C.; Singh, Madhurendra; Nagel-Steger, Luitgard; Kremer, Jana; Prumbaum, Daniel; Fansa, Eyad Kalawy; Ezzahoini, Hakima; Nouri, Kazem; Gremer, Lothar; Abts, Andre; Schmitt, Lutz; Raunser, Stefan; Ahmadian, Mohammad R.; Piekorz, Roland P.			The Centrosomal Adaptor TACC3 and the Microtubule Polymerase chTOG Interact via Defined C-terminal Subdomains in an Aurora-A Kinase-independent Manner	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Centrosome; Microtubules; Mitosis; Mitotic Spindle; Protein Domains; Aurora-A; Coiled-Coil; Protein Interaction; TACC3; chTOG	INTERKINETIC NUCLEAR MIGRATION; SPINDLE POLE ORGANIZATION; COILED-COIL; PROTEIN COMPLEXES; LOCALIZATION; CANCER; PHOSPHORYLATION; AMPLIFICATION; DYNAMICS; FAMILY	The cancer-associated, centrosomal adaptor protein TACC3 (transforming acidic coiled-coil 3) and its direct effector, the microtubule polymerase chTOG (colonic and hepatic tumor overexpressed gene), play a crucial function in centrosome-driven mitotic spindle assembly. It is unclear how TACC3 interacts with chTOG. Here, we show that the C-terminal TACC domain of TACC3 and a C-terminal fragment adjacent to the TOG domains of chTOG mediate the interaction between these two proteins. Interestingly, the TACC domain consists of two functionally distinct subdomains, CC1 (amino acids (aa) 414-530) and CC2 (aa 530-630). Whereas CC1 is responsible for the interaction with chTOG, CC2 performs an intradomain interaction with the central repeat region of TACC3, thereby masking the TACC domain before effector binding. Contrary to previous findings, our data clearly demonstrate that Aurora-A kinase does not regulate TACC3-chTOG complex formation, indicating that Aurora-A solely functions as a recruitment factor for the TACC3-chTOG complex to centrosomes and proximal mitotic spindles. We identified with CC1 and CC2, two functionally diverse modules within the TACC domain of TACC3 that modulate and mediate, respectively, TACC3 interaction with chTOG required for spindle assembly and microtubule dynamics during mitotic cell division.	[Thakur, Harish C.; Singh, Madhurendra; Kremer, Jana; Fansa, Eyad Kalawy; Ezzahoini, Hakima; Nouri, Kazem; Ahmadian, Mohammad R.; Piekorz, Roland P.] Univ Dusseldorf, Fak Med, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard; Gremer, Lothar] Univ Dusseldorf, Inst Phys Biol, D-40225 Dusseldorf, Germany; [Nagel-Steger, Luitgard; Gremer, Lothar] Forschungszentrum Julich, ICS 6, D-52425 Julich, Germany; [Abts, Andre; Schmitt, Lutz] Univ Dusseldorf, Inst Biochem, D-40225 Dusseldorf, Germany; [Prumbaum, Daniel; Raunser, Stefan] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany	Heinrich Heine University Dusseldorf; Heinrich Heine University Dusseldorf; Helmholtz Association; Research Center Julich; Heinrich Heine University Dusseldorf; Max Planck Society	Piekorz, RP (corresponding author), Univ Dusseldorf, Univ Klinikum, Inst Biochem & Mol Biol 2, D-40225 Dusseldorf, Germany.	Roland.Piekorz@uni-duesseldorf.de	Gremer, Lothar/H-9128-2013; Raunser, Stefan/AHE-1573-2022; Nagel-Steger, Luitgard/H-6415-2013	Gremer, Lothar/0000-0001-7065-5027; Nagel-Steger, Luitgard/0000-0001-5232-2149; Singh, Madhurendra/0000-0001-9935-5706; Thakur, Harish/0000-0001-6996-2046; Nouri, Kazem/0000-0001-7787-1304; Raunser, Stefan/0000-0001-9373-3016	NRW (North Rhine-Westphalia) graduate school "BioStruct; Biological Structures in Molecular Medicine and Biotechnology"; Deutsche Forschungsgemeinschaft [SFB 728/TP A5]; research commission of the medical faculty of the Heinrich-Heine-University; strategic research fund of the Heinrich-Heine-University; International Graduate School of Protein Science and Technology (iGRASP); Bundesministerium fur Bildung und Forschung (NGFNplus program) [01GS08100]	NRW (North Rhine-Westphalia) graduate school "BioStruct; Biological Structures in Molecular Medicine and Biotechnology"; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); research commission of the medical faculty of the Heinrich-Heine-University; strategic research fund of the Heinrich-Heine-University; International Graduate School of Protein Science and Technology (iGRASP); Bundesministerium fur Bildung und Forschung (NGFNplus program)(Federal Ministry of Education & Research (BMBF))	This work was supported by a fellowship of the NRW (North Rhine-Westphalia) graduate school "BioStruct; Biological Structures in Molecular Medicine and Biotechnology" (to H. C. T.), the Deutsche Forschungsgemeinschaft (SFB 728/TP A5;to R. P. P.), the research commission of the medical faculty of the Heinrich-Heine-University (grants to R. P. P. and M. R. A.), the strategic research fund of the Heinrich-Heine-University (grants to R. P. P. and M. R. A.), and the International Graduate School of Protein Science and Technology (iGRASP; to K. N. and M. R. A.).; Supported by Bundesministerium fur Bildung und Forschung (NGFNplus program Grant 01GS08100).	Albee AJ, 2008, MOL BIOL CELL, V19, P3347, DOI 10.1091/mbc.E07-11-1204; Albee AJ, 2006, J BIOL CHEM, V281, P38293, DOI 10.1074/jbc.M607203200; Anderhub SJ, 2012, CANCER LETT, V322, P8, DOI 10.1016/j.canlet.2012.02.006; Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166; Angrisano T, 2006, NUCLEIC ACIDS RES, V34, P364, DOI 10.1093/nar/gkj400; Barros TP, 2005, J CELL BIOL, V170, P1039, DOI 10.1083/jcb.200504097; Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039; Bettencourt-Dias M, 2011, TRENDS GENET, V27, P307, DOI 10.1016/j.tig.2011.05.004; Booth DG, 2011, EMBO J, V30, P906, DOI 10.1038/emboj.2011.15; Bornens M, 2012, SCIENCE, V335, P422, DOI 10.1126/science.1209037; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; Cassimeris L, 2004, MOL BIOL CELL, V15, P1580, DOI 10.1091/mbc.E03-07-0544; Chan JY, 2011, INT J BIOL SCI, V7, P1122, DOI 10.7150/ijbs.7.1122; Compton DA, 2000, ANNU REV BIOCHEM, V69, P95, DOI 10.1146/annurev.biochem.69.1.95; Cunha-Ferreira I, 2009, TRAFFIC, V10, P482, DOI 10.1111/j.1600-0854.2009.00905.x; Delgehyr N, 2005, J CELL SCI, V118, P1565, DOI 10.1242/jcs.02302; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Eberth A, 2009, BIOCHEM J, V417, P371, DOI 10.1042/BJ20081535; Fielding AB, 2011, ONCOGENE, V30, P521, DOI 10.1038/onc.2010.431; Fu WX, 2013, P NATL ACAD SCI USA, V110, P15295, DOI 10.1073/pnas.1312382110; Fu WX, 2011, CELL RES, V21, P1655, DOI 10.1038/cr.2011.106; Garriga-Canut M, 2004, J BIOL CHEM, V279, P23597, DOI 10.1074/jbc.M313987200; Gergely F, 2003, GENE DEV, V17, P336, DOI 10.1101/gad.245603; Gergely F, 2002, BIOESSAYS, V24, P915, DOI 10.1002/bies.10162; Gergely F, 2000, P NATL ACAD SCI USA, V97, P14352, DOI 10.1073/pnas.97.26.14352; Gomez-Baldo L, 2010, CELL CYCLE, V9, P1143, DOI 10.4161/cc.9.6.11018; Guo YR, 2013, ACS CHEM BIOL, V8, P626, DOI 10.1021/cb300604u; Hao ZL, 2002, MOL REPROD DEV, V63, P291, DOI 10.1002/mrd.90012; Hodis E, 2012, CELL, V150, P251, DOI 10.1016/j.cell.2012.06.024; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Hood FE, 2013, J CELL BIOL, V202, P463, DOI 10.1083/jcb.201211127; Hood Fiona E, 2011, Bioarchitecture, V1, P105; Hutchins JRA, 2010, SCIENCE, V328, P593, DOI 10.1126/science.1181348; Jakobsen L, 2011, EMBO J, V30, P1520, DOI 10.1038/emboj.2011.63; Jeng JC, 2009, CELL CYCLE, V8, P3537, DOI 10.4161/cc.8.21.9935; Kinoshita K, 2005, J CELL BIOL, V170, P1047, DOI 10.1083/jcb.200503023; Kramer A, 2011, MOL ONCOL, V5, P324, DOI 10.1016/j.molonc.2011.05.003; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Lauffart B, 2002, BIOCHEM J, V363, P195, DOI 10.1042/0264-6021:3630195; Lauffart Brenda, 2005, BMC Womens Health, V5, P8, DOI 10.1186/1472-6874-5-8; LeRoy PJ, 2007, CANCER RES, V67, P5362, DOI 10.1158/0008-5472.CAN-07-0122; Lioutas A, 2013, EMBO REP, V14, P829, DOI 10.1038/embor.2013.109; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mardin BR, 2012, J CELL BIOL, V197, P11, DOI 10.1083/jcb.201108006; Marthiens V, 2012, J CELL SCI, V125, P3281, DOI 10.1242/jcs.094797; Mattison C., 2006, CENTROSOME CYCLE CEL, P925; Meraldi P, 2002, FEBS LETT, V521, P9, DOI 10.1016/S0014-5793(02)02865-X; Muller H, 2010, EMBO J, V29, P3344, DOI 10.1038/emboj.2010.210; Neumann B, 2010, NATURE, V464, P721, DOI 10.1038/nature08869; NIGG EA, 2004, CENTROSOMES DEV DIS; Nigg EA, 2011, NAT CELL BIOL, V13, P1154, DOI 10.1038/ncb2345; Partch CL, 2011, P NATL ACAD SCI USA, V108, P7739, DOI 10.1073/pnas.1101357108; Peset I, 2005, J CELL BIOL, V170, P1057, DOI 10.1083/jcb.200504037; Peset I, 2008, TRENDS CELL BIOL, V18, P379, DOI 10.1016/j.tcb.2008.06.005; Piekorz RP, 2002, EMBO J, V21, P653, DOI 10.1093/emboj/21.4.653; Popov AV, 2001, EMBO J, V20, P397, DOI 10.1093/emboj/20.3.397; Raab MS, 2012, CANCER RES, V72, P5374, DOI 10.1158/0008-5472.CAN-12-2026; Raff JW, 2002, TRENDS CELL BIOL, V12, P222, DOI 10.1016/S0962-8924(02)02268-7; Risse SL, 2013, BIOL CHEM, V394, P421, DOI 10.1515/hsz-2012-0246; Royle SJ, 2012, J CELL SCI, V125, P19, DOI 10.1242/jcs.094607; Sadek CM, 2003, GENE EXPR PATTERNS, V3, P203, DOI 10.1016/S1567-133X(02)00066-2; Sardon T, 2010, EMBO REP, V11, P977, DOI 10.1038/embor.2010.171; Sato M, 2004, MOL BIOL CELL, V15, P1609, DOI 10.1091/mbc.e03-11-0837; Schmidt S, 2010, ONCOGENE, V29, P6184, DOI 10.1038/onc.2010.354; Schmidt S, 2010, CELL CYCLE, V9, P4469, DOI 10.4161/cc.9.22.13684; Schneider L, 2008, ONCOGENE, V27, P116, DOI 10.1038/sj.onc.1210628; Schneider L, 2007, J BIOL CHEM, V282, P29273, DOI 10.1074/jbc.M704151200; Schuendeln MM, 2004, MOL CELL BIOL, V24, P6403, DOI 10.1128/MCB.24.14.6403-6409.2004; Shi YH, 2012, PROTEIN SCI, V21, P1197, DOI 10.1002/pro.2107; Simpson RJY, 2004, J BIOL CHEM, V279, P39789, DOI 10.1074/jbc.M404130200; Singh D, 2012, SCIENCE, V337, P1231, DOI 10.1126/science.1220834; Still IH, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-16; Thakur H.C., 2012, THESIS H HEINE U DUS; Thakur HC, 2013, BIOL CHEM, V394, P1411, DOI 10.1515/hsz-2013-0184; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vitre BD, 2012, CURR OPIN CELL BIOL, V24, P809, DOI 10.1016/j.ceb.2012.10.006; Williams SV, 2013, HUM MOL GENET, V22, P795, DOI 10.1093/hmg/dds486; Wurdak H, 2010, P NATL ACAD SCI USA, V107, P16542, DOI 10.1073/pnas.1010300107; Xie ZG, 2007, NEURON, V56, P79, DOI 10.1016/j.neuron.2007.08.026; Yang YT, 2012, NAT NEUROSCI, V15, P1201, DOI 10.1038/nn.3171; Yao R, 2012, ONCOGENE, V31, P135, DOI 10.1038/onc.2011.235; Yao R., 2013, ONCOGENE, DOI 10.1038/onc.2013.382; Yao R, 2007, CANCER SCI, V98, P555, DOI 10.1111/j.1349-7006.2007.00433.x; Zyss D, 2009, TRENDS CELL BIOL, V19, P334, DOI 10.1016/j.tcb.2009.04.001	84	33	34	0	9	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					74	88		10.1074/jbc.M113.532333	http://dx.doi.org/10.1074/jbc.M113.532333			15	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24273164	hybrid, Green Published			2022-12-25	WOS:000329370900007
J	Gan, HC; Wang, GB; Hao, Q; Wang, QJ; Tang, H				Gan, Huachen; Wang, Guibo; Hao, Qin; Wang, Q. Jane; Tang, Hua			Protein Kinase D Promotes Airway Epithelial Barrier Dysfunction and Permeability through Down-regulation of Claudin-1	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cell Junctions; Epithelial Cell; Permeability; Protein Kinase D (PKD); Tight Junctions; Claudin-1	APICAL JUNCTIONAL COMPLEX; TIGHT JUNCTIONS; INTRACELLULAR REDISTRIBUTION; ALTERED EXPRESSION; OCCLUDIN; GROWTH; PHOSPHORYLATION; DIFFERENTIATION; ACTIVATION; VEGF	At the interface between host and external environment, the airway epithelium serves as a major protective barrier. In the present study we show that protein kinase D (PKD) plays an important role in the formation and integrity of the airway epithelial barrier. Either inhibition of PKD activity or silencing of PKD increased transepithelial electrical resistance (TEER), resulting in a tighter epithelial barrier. Among the three PKD isoforms, PKD3 knockdown was the most efficient one to increase TEER in polarized airway epithelial monolayers. In contrast, overexpression of PKD3 wild type, but not PKD3 kinase-inactive mutant, disrupted the formation of apical intercellular junctions and their reassembly, impaired the development of TEER, and increased paracellular permeability to sodium fluorescein in airway epithelial monolayers. We further found that overexpression of PKD, in particular PKD3, markedly suppressed the mRNA and protein levels of claudin-1 but had only minor effects on the expression of other tight junctional proteins (claudin-3, claudin-4, claudin-5, occludin, and ZO-1) and adherent junctional proteins (E-cadherin and -catenin). Immunofluorescence study revealed that claudin-1 level was markedly reduced and almost disappeared from intercellular contacts in PKD3-overexpressed epithelial monolayers and that claudin-4 was also restricted from intercellular contacts and tended to accumulate in the cell cytosolic compartments. Last, we found that claudin-1 knockdown prevented TEER elevation by PKD inhibition or silencing in airway epithelial monolayers. These novel findings indicate that PKD negatively regulates human airway epithelial barrier formation and integrity through down-regulation of claudin-1, which is a key component of tight junctions.	[Gan, Huachen; Wang, Guibo; Hao, Qin; Tang, Hua] Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, Tyler, TX 75708 USA; [Wang, Q. Jane] Univ Pittsburgh, Dept Pharmacol & Chem Biol, Pittsburgh, PA 15261 USA	University of Texas System; University of Texas-Health Sciences Center at Tyler (UTHSCT); Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Tang, H (corresponding author), Univ Texas Hlth Ctr Tyler, Dept Cellular & Mol Biol, 11937 US Highway 271, Tyler, TX 75708 USA.	hua.tang@uthct.edu	Wang, Qiming Jane/B-6064-2012; Gan, Huachen/AAE-5925-2021	Wang, Qiming Jane/0000-0002-9502-4851; 	NHLBI, National Institutes of Health [R21-HL097216]; NATIONAL CANCER INSTITUTE [R01CA142580] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R21HL097216] Funding Source: NIH RePORTER	NHLBI, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	work was supported, in whole or in part, by NHLBI, National Institutes of Health Grant R21-HL097216 (to H. T.).	Auer A, 2005, MOL BIOL CELL, V16, P4375, DOI 10.1091/mbc.E05-03-0251; Banan A, 2005, J PHARMACOL EXP THER, V313, P962, DOI 10.1124/jpet.104.083428; Bastea LI, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030459; Bhat AA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037174; Chen J, 2005, MOL PHARMACOL, V67, P152, DOI 10.1124/mol.104.004200; Cording J, 2013, J CELL SCI, V126, P554, DOI 10.1242/jcs.114306; COZENS AL, 1994, AM J RESP CELL MOL, V10, P38, DOI 10.1165/ajrcmb.10.1.7507342; Cummins PM, 2012, MOL CELL BIOL, V32, P242, DOI 10.1128/MCB.06029-11; de Boer WI, 2008, CAN J PHYSIOL PHARM, V86, P105, DOI [10.1139/Y08-004, 10.1139/y08-004]; Deissler HL, 2013, EXP EYE RES, V115, P162, DOI 10.1016/j.exer.2013.07.018; Doppler H, 2005, J BIOL CHEM, V280, P15013, DOI 10.1074/jbc.C400575200; Fu Y, 2011, EMBO REP, V12, P785, DOI 10.1038/embor.2011.139; Furuse M, 1998, J CELL BIOL, V141, P1539, DOI 10.1083/jcb.141.7.1539; Furuse M, 2002, J CELL BIOL, V156, P1099, DOI 10.1083/jcb.200110122; Gonzalez-Mariscal L, 2003, PROG BIOPHYS MOL BIO, V81, P1, DOI 10.1016/S0079-6107(02)00037-8; Gschwendt M, 1996, FEBS LETT, V392, P77, DOI 10.1016/0014-5793(96)00785-5; Ha CH, 2008, ARTERIOSCL THROM VAS, V28, P1782, DOI 10.1161/ATVBAHA.108.172528; Hackett NR, 2011, PLOS ONE, V6; Hao Q, 2013, ANTICANCER RES, V33, P393; Hao Q, 2009, AM J PHYSIOL-CELL PH, V296, pC821, DOI 10.1152/ajpcell.00504.2008; Hao Q, 2009, J BIOL CHEM, V284, P799, DOI 10.1074/jbc.M807546200; Harten SK, 2009, MOL BIOL CELL, V20, P1089, DOI 10.1091/mbc.E08-06-0566; Hirota JA, 2012, CURR OPIN IMMUNOL, V24, P740, DOI 10.1016/j.coi.2012.08.012; Inai T, 1999, EUR J CELL BIOL, V78, P849, DOI 10.1016/S0171-9335(99)80086-7; Kluger MS, 2013, ARTERIOSCL THROM VAS, V33, P489, DOI 10.1161/ATVBAHA.112.300893; Komiya S, 2005, GENES CELLS, V10, P1065, DOI 10.1111/j.1365-2443.2005.00899.x; Koval M, 2009, AM J PHYSIOL-LUNG C, V297, pL217, DOI 10.1152/ajplung.00196.2009; Lambrecht BN, 2012, NAT MED, V18, P684, DOI 10.1038/nm.2737; LaValle Courtney R., 2010, BMC Chemical Biology, V10, P5, DOI 10.1186/1472-6769-10-5; Martinez-Estrada OM, 2006, BIOCHEM J, V394, P449, DOI 10.1042/BJ20050591; Milatz S, 2010, BBA-BIOMEMBRANES, V1798, P2048, DOI 10.1016/j.bbamem.2010.07.014; Mitchell LA, 2011, AM J PHYSIOL-LUNG C, V301, pL40, DOI 10.1152/ajplung.00299.2010; Miwa D, 2013, ANGIOGENESIS, V16, P675, DOI 10.1007/s10456-013-9345-x; Ngok SP, 2012, J CELL BIOL, V199, P1103, DOI 10.1083/jcb.201207009; Ogasawara N, 2010, PHARMACOL RES, V61, P489, DOI 10.1016/j.phrs.2010.03.002; Ohta H, 2012, AM J PHYSIOL-LUNG C, V302, pL193, DOI 10.1152/ajplung.00349.2010; Olayioye MA, 2013, CELL SIGNAL, V25, P1739, DOI 10.1016/j.cellsig.2013.04.010; Park JE, 2008, J IMMUNOL, V181, P2044, DOI 10.4049/jimmunol.181.3.2044; PAUSE A, 1994, NATURE, V371, P762, DOI 10.1038/371762a0; Proud D, 2011, IMMUNOL REV, V242, P186, DOI 10.1111/j.1600-065X.2011.01033.x; Rey O, 2003, J BIOL CHEM, V278, P23773, DOI 10.1074/jbc.M300226200; Rey O, 2003, BIOCHEM BIOPH RES CO, V302, P817, DOI 10.1016/S0006-291X(03)00269-9; Rezaee F, 2013, J VIROL, V87, P11088, DOI 10.1128/JVI.01573-13; Rezaee F, 2011, J ALLERGY CLIN IMMUN, V128, P1216, DOI 10.1016/j.jaci.2011.08.035; Rozengurt E, 2005, J BIOL CHEM, V280, P13205, DOI 10.1074/jbc.R500002200; Saitou M, 2000, MOL BIOL CELL, V11, P4131, DOI 10.1091/mbc.11.12.4131; Schulzke JD, 2012, ANN NY ACAD SCI, V1257, P1, DOI 10.1111/j.1749-6632.2012.06485.x; Shaykhiev R, 2011, CELL MOL LIFE SCI, V68, P877, DOI 10.1007/s00018-010-0500-x; Sheth B, 2000, MECH DEVELOP, V97, P93, DOI 10.1016/S0925-4773(00)00416-0; Soini Y, 2011, RESP RES, V12, DOI 10.1186/1465-9921-12-70; Storz P, 2004, MOL CELL BIOL, V24, P2614, DOI 10.1128/MCB.24.7.2614-2626.2004; Sturany S, 2001, J BIOL CHEM, V276, P3310, DOI 10.1074/jbc.M008719200; Takahashi S, 2009, J CELL SCI, V122, P985, DOI 10.1242/jcs.040055; Tang H, 2000, J BIOL CHEM, V275, P8389, DOI 10.1074/jbc.275.12.8389; Tinsley JH, 2004, AM J PHYSIOL-CELL PH, V286, pC105, DOI 10.1152/ajpcell.00340.2003; Tobey NA, 2004, AM J PHYSIOL-GASTR L, V286, pG1042, DOI 10.1152/ajpgi.00387.2003; Van Itallie CM, 2006, ANNU REV PHYSIOL, V68, P403, DOI 10.1146/annurev.physiol.68.040104.131404; Wan R, 2013, J CELL PHYSIOL, V228, P1295, DOI 10.1002/jcp.24286; Xiao C, 2011, J ALLERGY CLIN IMMUN, V128, P549, DOI 10.1016/j.jaci.2011.05.038	59	24	24	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	DEC 27	2013	288	52					37343	37354		10.1074/jbc.M113.511527	http://dx.doi.org/10.1074/jbc.M113.511527			12	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	282RH	24265314	Green Published, hybrid			2022-12-25	WOS:000329189700050
J	Janssen, BD; Garza-Sanchez, F; Hayes, CS				Janssen, Brian D.; Garza-Sanchez, Fernando; Hayes, Christopher S.			A-Site mRNA Cleavage Is Not Required for tmRNA-Mediated ssrA-Peptide Tagging	PLOS ONE			English	Article							AMINO-ACID STARVATION; SMALL PROTEIN-B; ESCHERICHIA-COLI; RIBOSOME-RESCUE; NASCENT-PEPTIDE; POLYNUCLEOTIDE PHOSPHORYLASE; RIBONUCLEASE-II; RARE CODONS; EF-P; TRANSLATION	In Escherichia coli, prolonged translational arrest allows mRNA degradation into the A site of stalled ribosomes. The enzyme that cleaves the A-site codon is not known, but its activity requires RNase II to degrade mRNA downstream of the ribosome. This A-site mRNA cleavage process is thought to function in translation quality control because stalled ribosomes are recycled from A-site truncated transcripts by the tmRNA-SmpB "ribosome rescue" system. During rescue, the tmRNA-encoded ssrA peptide is added to the nascent chain, thereby targeting the tagged protein for degradation after release from the ribosome. Here, we examine the influence of A-site mRNA cleavage upon tmRNA-SmpB activity. Using a model transcript that undergoes stop-codon cleavage in response to inefficient translation termination, we quantify ssrA-peptide tagging of the encoded protein in cells that contain (rnb(+)) or lack (Delta rnb) RNase II. A-site mRNA cleavage is reduced approximately three-fold in Delta rnb backgrounds, but the efficiency of ssrA-tagging is identical to that of rnb(+) cells. Additionally, pulse-chase analysis demonstrates that paused ribosomes recycle from the test transcripts at similar rates in rnb(+) and Delta rnb cells. Together, these results indicate that A-site truncated transcripts are not required for tmRNA-SmpB-mediated ribosome rescue and suggest that A-site mRNA cleavage process may play a role in other recycling pathways.	[Janssen, Brian D.; Garza-Sanchez, Fernando; Hayes, Christopher S.] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Hayes, Christopher S.] Univ Calif Santa Barbara, Biomol Sci & Engn Program, Santa Barbara, CA 93106 USA	University of California System; University of California Santa Barbara; University of California System; University of California Santa Barbara	Hayes, CS (corresponding author), Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA.	chayes@lifesci.ucsb.edu			National Institutes of Health [R01 GM078634]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078634] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the National Institutes of Health through grant R01 GM078634 (to C. S. H.). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrade JM, 2009, PROG MOL BIOL TRANSL, V85, P187, DOI 10.1016/S0079-6603(08)00805-2; Atkins JF, 1996, NATURE, V379, P769, DOI 10.1038/379769a0; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Bjornsson A, 1996, EMBO J, V15, P1696, DOI 10.1002/j.1460-2075.1996.tb00515.x; Chadani Y, 2012, MOL MICROBIOL, V86, P37, DOI 10.1111/j.1365-2958.2012.08190.x; Chadani Y, 2011, GENES GENET SYST, V86, P151; Chadani Y, 2011, MOL MICROBIOL, V80, P772, DOI 10.1111/j.1365-2958.2011.07607.x; Chadani Y, 2010, MOL MICROBIOL, V78, P796, DOI 10.1111/j.1365-2958.2010.07375.x; Cheng ZF, 2005, MOL CELL, V17, P313, DOI 10.1016/j.molcel.2004.11.048; Cheng ZF, 1998, J BIOL CHEM, V273, P14077, DOI 10.1074/jbc.273.23.14077; Choy JS, 2007, J BACTERIOL, V189, P6564, DOI 10.1128/JB.00860-07; Collier J, 2004, J BIOL CHEM, V279, P54193, DOI 10.1074/jbc.M314012200; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Doerfel LK, 2013, SCIENCE, V339, P85, DOI 10.1126/science.1229017; DONOVAN WP, 1986, P NATL ACAD SCI USA, V83, P120, DOI 10.1073/pnas.83.1.120; Felden B, 2011, RNA BIOL, V8, P440, DOI 10.4161/rna.8.3.15387; Frazao C, 2006, NATURE, V443, P110, DOI 10.1038/nature05080; Garza-Sanchez F, 2008, J MOL BIOL, V378, P505, DOI 10.1016/j.jmb.2008.02.065; Garza-Sanchez F, 2006, J BIOL CHEM, V281, P34258, DOI 10.1074/jbc.M608052200; Garza-Sanchez F, 2011, MOL MICROBIOL, V80, P1204, DOI 10.1111/j.1365-2958.2011.07638.x; Garza-Sanchez F, 2009, MOL MICROBIOL, V73, P882, DOI 10.1111/j.1365-2958.2009.06813.x; Ge ZY, 2010, MOL MICROBIOL, V78, P1159, DOI 10.1111/j.1365-2958.2010.07396.x; Gottesman S, 1998, GENE DEV, V12, P1338, DOI 10.1101/gad.12.9.1338; Handa Y, 2010, NUCL ACIDS RES; Hayes CS, 2010, FEBS LETT, V584, P413, DOI 10.1016/j.febslet.2009.11.023; Hayes CS, 2003, MOL CELL, V12, P903, DOI 10.1016/S1097-2765(03)00385-X; Hayes CS, 2002, J BIOL CHEM, V277, P33825, DOI 10.1074/jbc.M205405200; Hayes CS, 2002, P NATL ACAD SCI USA, V99, P3440, DOI 10.1073/pnas.052707199; Herman C, 1998, GENE DEV, V12, P1348, DOI 10.1101/gad.12.9.1348; Hersch SJ, 2013, MBIO, V4, DOI 10.1128/mBio.00180-13; Ivanova N, 2004, J MOL BIOL, V338, P33, DOI 10.1016/j.jmb.2004.02.043; Jacob Y, 2005, J BIOL CHEM, V280, P5503, DOI 10.1074/jbc.M409277200; Janssen Brian D, 2012, Methods Mol Biol, V905, P291, DOI 10.1007/978-1-61779-949-5_19; Janssen BD, 2012, ADV PROTEIN CHEM STR, V86, P151, DOI 10.1016/B978-0-12-386497-0.00005-0; Janssen BD, 2009, J MOL BIOL, V394, P251, DOI 10.1016/j.jmb.2009.09.020; Jarrige AC, 2001, EMBO J, V20, P6845, DOI 10.1093/emboj/20.23.6845; Karzai AW, 1999, EMBO J, V18, P3793, DOI 10.1093/emboj/18.13.3793; Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990; KOMINE Y, 1994, P NATL ACAD SCI USA, V91, P9223, DOI 10.1073/pnas.91.20.9223; Kuroha K, 2009, GENES CELLS, V14, P739, DOI 10.1111/j.1365-2443.2009.01304.x; Li X, 2006, RNA, V12, P248, DOI 10.1261/rna.2212606; Li X, 2008, MOL MICROBIOL, V68, P462, DOI 10.1111/j.1365-2958.2008.06167.x; Linder P, 2011, NAT REV MOL CELL BIO, V12, P505, DOI 10.1038/nrm3154; Moore SD, 2011, METHODS MOL BIOL, V765, P155, DOI 10.1007/978-1-61779-197-0_10; MOTTAGUITABAR S, 1994, EMBO J, V13, P249, DOI 10.1002/j.1460-2075.1994.tb06255.x; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Neubauer C, 2012, SCIENCE, V335, P1366, DOI 10.1126/science.1217039; Nonin-Lecomte S, 2009, EMBO REP, V10, P160, DOI 10.1038/embor.2008.243; Py B, 1996, NATURE, V381, P169, DOI 10.1038/381169a0; Ramadoss NS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057537; Richards J, 2006, MOL MICROBIOL, V62, P1700, DOI 10.1111/j.1365-2958.2006.05472.x; Roche ED, 1999, EMBO J, V18, P4579, DOI 10.1093/emboj/18.16.4579; Shimizu Y, 2012, J MOL BIOL, V423, P624, DOI 10.1016/j.jmb.2012.08.007; Shoji S, 2010, BIOCHIMIE, V92, P157, DOI 10.1016/j.biochi.2009.11.002; Spickler C, 2000, J BACTERIOL, V182, P2422, DOI 10.1128/JB.182.9.2422-2427.2000; Sundermeier TR, 2005, P NATL ACAD SCI USA, V102, P2316, DOI 10.1073/pnas.0409694102; Sunohara T, 2004, J BIOL CHEM, V279, P15368, DOI 10.1074/jbc.M312805200; Sunohara T, 2004, RNA, V10, P378, DOI 10.1261/rna.5169404; Ude S, 2013, SCIENCE, V339, P82, DOI 10.1126/science.1228985; Vanzo NF, 1998, GENE DEV, V12, P2770, DOI 10.1101/gad.12.17.2770; Watts T, 2009, J MOL BIOL, V391, P275, DOI 10.1016/j.jmb.2009.06.037; Williams KP, 1999, EMBO J, V18, P5423, DOI 10.1093/emboj/18.19.5423; Woolstenhulme CJ, 2013, P NATL ACAD SCI USA, V110, pE878, DOI 10.1073/pnas.1219536110; Yamamoto Y, 2003, RNA, V9, P408, DOI 10.1261/rna.2174803; Zhang YL, 2009, J BIOL CHEM, V284, P25522, DOI 10.1074/jbc.M109.036624; Zuo YH, 2006, MOL CELL, V24, P149, DOI 10.1016/j.molcel.2006.09.004	66	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81319	10.1371/journal.pone.0081319	http://dx.doi.org/10.1371/journal.pone.0081319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260569	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900128
J	Couch, RD; Navarro, K; Sikaroodi, M; Gillevet, P; Forsyth, CB; Mutlu, E; Engen, PA; Keshavarzian, A				Couch, Robin D.; Navarro, Karl; Sikaroodi, Masoumeh; Gillevet, Pat; Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip A.; Keshavarzian, Ali			The Approach to Sample Acquisition and Its Impact on the Derived Human Fecal Microbiome and VOC Metabolome	PLOS ONE			English	Article							SOLID-PHASE MICROEXTRACTION; VOLATILE ORGANIC-COMPOUNDS; IDENTIFICATION; FIBERS; COLON	Recent studies have illustrated the importance of the microbiota in maintaining a healthy state, as well as promoting disease states. The intestinal microbiota exerts its effects primarily through its metabolites, and metabolomics investigations have begun to evaluate the diagnostic and health implications of volatile organic compounds (VOCs) isolated from human feces, enabled by specialized sampling methods such as headspace solid-phase microextraction (hSPME). The approach to stool sample collection is an important consideration that could potentially introduce bias and affect the outcome of a fecal metagenomic and metabolomic investigation. To address this concern, a comparison of endoscopically collected (in vivo) and home collected (ex vivo) fecal samples was performed, revealing slight variability in the derived microbiomes. In contrast, the VOC metabolomes differ widely between the home collected and endoscopy collected samples. Additionally, as the VOC extraction profile is hyperbolic, with short extraction durations more vulnerable to variation than extractions continued to equilibrium, a second goal of our investigation was to ascertain if hSPME-based fecal metabolomics studies might be biased by the extraction duration employed. As anticipated, prolonged extraction (18 hours) results in the identification of considerably more metabolites than short (20 minute) extractions. A comparison of the metabolomes reveals several analytes deemed unique to a cohort with the 20 minute extraction, but found common to both cohorts when the VOC extraction was performed for 18 hours. Moreover, numerous analytes perceived to have significant fold change with a 20 minute extraction were found insignificant in fold change with the prolonged extraction, underscoring the potential for bias associated with a 20 minute hSPME.	[Couch, Robin D.; Navarro, Karl] George Mason Univ, Dept Chem & Biochem, Manassas, VA USA; [Sikaroodi, Masoumeh; Gillevet, Pat] George Mason Univ, Dept Environm Sci & Policy, Manassas, VA USA; [Sikaroodi, Masoumeh; Gillevet, Pat] George Mason Univ, Microbiome Anal Ctr, Manassas, VA USA; [Forsyth, Christopher B.; Mutlu, Ece; Engen, Phillip A.; Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Med, Div Digest Dis & Nutr, Chicago, IL 60612 USA; Rush Univ, Med Ctr, Dept Biochem, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Pharmacol, Chicago, IL 60612 USA; [Keshavarzian, Ali] Rush Univ, Med Ctr, Dept Physiol & Mol Biophys, Chicago, IL 60612 USA; [Keshavarzian, Ali] Univ Utrecht, Div Pharmacol, Utrecht Inst Pharmaceut Sci, Fac Sci, Utrecht, Netherlands	George Mason University; George Mason University; George Mason University; Rush University; Rush University; Rush University; Rush University; Utrecht University	Couch, RD (corresponding author), George Mason Univ, Dept Chem & Biochem, Manassas, VA USA.	rcouch@gmu.edu			NIH [1RC2AA019405]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [RC2AA019405] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))	This study was supported by NIH grant 1RC2AA019405. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alpendurada MD, 2000, J CHROMATOGR A, V889, P3; ARTHUR CL, 1990, ANAL CHEM, V62, P2145, DOI 10.1021/ac00218a019; Boland W, 1984, NALYSIS VOLATILES, P371; Costello BDL, 2008, J BREATH RES, V2, DOI 10.1088/1752-7155/2/3/037023; COX CD, 1979, J CLIN MICROBIOL, V9, P479; Dickschat JS, 2005, CHEM BIODIVERS, V2, P837, DOI 10.1002/cbdv.200590062; Dixon E, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018471; ECONOMOU D, 1991, PLANTA MED, V57, P347, DOI 10.1055/s-2006-960115; Garner CE, 2009, T ROY SOC TROP MED H, V103, P1171, DOI 10.1016/j.trstmh.2009.02.004; Garner CE, 2007, FASEB J, V21, P1675, DOI 10.1096/fj.06-6927com; Garner CE, 2009, J PEDIATR GASTR NUTR, V49, P559, DOI 10.1097/MPG.0b013e3181a3bfbc; GEORGILOPOULOS DN, 1987, Z LEBENSM UNTERS FOR, V184, P374, DOI 10.1007/BF01126660; Gillevet P, 2010, CHEM BIODIVERS, V7, P1065, DOI 10.1002/cbdv.200900322; Gomez E, 1997, J SCI FOOD AGR, V74, P541, DOI [10.1002/(SICI)1097-0010(199708)74:4<541::AID-JSFA851>3.3.CO;2-4, 10.1002/(SICI)1097-0010(199708)74:4&lt;541::AID-JSFA851&gt;3.0.CO;2-D]; Hashim L, 1997, FOOD RES INT, V30, P163, DOI 10.1016/S0963-9969(97)00039-2; Huo X, 2008, SHENGWU JISHU, V18, P47; Ivanov II, 2012, CELL HOST MICROBE, V12, P496, DOI 10.1016/j.chom.2012.09.009; Kawamura Y, 2004, ACS SYM SER, V875, P262; Koziel J, 2000, ANAL CHEM, V72, P5178, DOI 10.1021/ac000518l; Li RW, 2012, INFECT IMMUN, V80, P2150, DOI 10.1128/IAI.00141-12; Lou F, 2011, ANHUI NONGYE KEXUE, V39, P3934; MANN S, 1967, ARCH MIKROBIOL, V56, P324, DOI 10.1007/BF00425207; Moyler D., 1998, Perfumer & Flavorist, V23, P37; PAWLISZYN J, 1999, QUANTITATIVE ASPECTS; Ratel J, 2009, J CHROMATOGR A, V1216, P7889, DOI 10.1016/j.chroma.2009.09.012; ROEDIGER WEW, 1980, AUST NZ J SURG, V50, P73, DOI 10.1111/j.1445-2197.1980.tb04500.x; Russell SL, 2012, CURR OPIN GASTROEN, V28, P563, DOI 10.1097/MOG.0b013e3283573017; Schulz S, 2004, TETRAHEDRON, V60, P3863, DOI 10.1016/j.tet.2004.03.005; Tremaroli V, 2012, NATURE, V489, P242, DOI 10.1038/nature11552; Vedantam G, 2003, CURR OPIN MICROBIOL, V6, P457, DOI 10.1016/j.mib.2003.09.006; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xing S, 2010, SHIPIN KEXUE BEIJING, V31, P154	32	30	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81163	10.1371/journal.pone.0081163	http://dx.doi.org/10.1371/journal.pone.0081163			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260553	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500197
J	Durkee, CA; Sarlls, JE; Hommer, DW; Momenan, R				Durkee, Caitlin A.; Sarlls, Joelle E.; Hommer, Daniel W.; Momenan, Reza			White Matter Microstructure Alterations: A Study of Alcoholics with and without Post-Traumatic Stress Disorder	PLOS ONE			English	Article							ANTERIOR CINGULATE; HIPPOCAMPAL VOLUME; PREFRONTAL CORTEX; CORPUS-CALLOSUM; INTEGRITY; MEMORY; DISRUPTION; ACTIVATION; GRAY; MRI	Many brain imaging studies have demonstrated reductions in gray and white matter volumes in alcoholism, with fewer investigators using diffusion tensor imaging (DTI) to examine the integrity of white matter pathways. Among various medical conditions, alcoholism and post-traumatic stress disorder (PTSD) are two comorbid diseases that have similar degenerative effects on the white matter integrity. Therefore, understanding and differentiating these effects would be very important in characterizing alcoholism and PTSD. Alcoholics are known to have neurocognitive deficits in decision-making, particularly in decisions related to emotionally-motivated behavior, while individuals with PTSD have deficits in emotional regulation and enhanced fear response. It is widely believed that these types of abnormalities in both alcoholism and PTSD are related to fronto-limbic dysfunction. In addition, previous studies have shown cortico-limbic fiber degradation through fiber tracking in alcoholism. DTI was used to measure white matter fractional anisotropy (FA), which provides information about tissue microstructure, possibly indicating white matter integrity. We quantitatively investigated the microstructure of white matter through whole brain DTI analysis in healthy volunteers (HV) and alcohol dependent subjects without PTSD (ALC) and with PTSD (ALC+PTSD). These data show significant differences in FA between alcoholics and non-alcoholic HVs, with no significant differences in FA between ALC and ALC+PTSD in any white matter structure. We performed a post-hoc region of interest analysis that allowed us to incorporate multiple covariates into the analysis and found similar results. HV had higher FA in several areas implicated in the reward circuit, emotion, and executive functioning, suggesting that there may be microstructural abnormalities in white matter pathways that contribute to neurocognitive and executive functioning deficits observed in alcoholics. Furthermore, our data do not reveal any differences between ALC and ALC+PTSD, suggesting that the effect of alcohol on white matter microstructure may be more significant than any effect caused by PTSD.	[Durkee, Caitlin A.; Hommer, Daniel W.; Momenan, Reza] NIAAA, Sect Brain Electrophysiol & Imaging, Lab Clin & Translat Studies, NIH, Bethesda, MD 20892 USA; [Sarlls, Joelle E.] NINDS, NIH MRI Res Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute on Alcohol Abuse & Alcoholism (NIAAA); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Momenan, R (corresponding author), NIAAA, Sect Brain Electrophysiol & Imaging, Lab Clin & Translat Studies, NIH, Bethesda, MD 20892 USA.	rezam@mail.nih.gov	Momenan, Reza/P-2266-2019					Abe O, 2006, PSYCHIAT RES-NEUROIM, V146, P231, DOI 10.1016/j.pscychresns.2006.01.004; Agartz I, 2003, PSYCHIAT RES-NEUROIM, V122, P21, DOI 10.1016/S0925-4927(02)00084-7; AGGLETON JP, 1995, J NEUROSCI, V15, P7270; Alhassoon OM, 2012, ALCOHOL CLIN EXP RES, V36, P1922, DOI 10.1111/j.1530-0277.2012.01808.x; Baler RD, 2006, TRENDS MOL MED, V12, P559, DOI 10.1016/j.molmed.2006.10.005; Bar M, 2006, P NATL ACAD SCI USA, V103, P449, DOI 10.1073/pnas.0507062103; Bath KG, 2013, NEUROSCIENCE, V239, P149, DOI 10.1016/j.neuroscience.2013.01.074; Bjork JM, 2008, DRUG ALCOHOL DEPEN, V95, P115, DOI 10.1016/j.drugalcdep.2007.12.014; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bonne O, 2001, AM J PSYCHIAT, V158, P1248, DOI 10.1176/appi.ajp.158.8.1248; Bouzyk-Szutkiewicz Joanna, 2012, Pol Merkur Lekarski, V33, P176; Chanraud S, 2007, NEUROPSYCHOPHARMACOL, V32, P429, DOI 10.1038/sj.npp.1301219; Chanraud S, 2009, NEUROPSYCHOPHARMACOL, V34, P1223, DOI 10.1038/npp.2008.101; Duncan JR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044790; Enoch MA, 2011, PSYCHOPHARMACOLOGY, V214, P17, DOI 10.1007/s00213-010-1916-6; Fein G, 2002, ALCOHOL CLIN EXP RES, V26, P558, DOI 10.1111/j.1530-0277.2002.tb02574.x; First MB, 2002, USERS GUIDE STRUCTUR; Fitzpatrick LE, 2008, NEUROSCI BIOBEHAV R, V32, P466, DOI 10.1016/j.neubiorev.2007.08.004; Gilman JM, 2010, ALCOHOL CLIN EXP RES, V34, P331, DOI 10.1111/j.1530-0277.2009.01095.x; Grusser SM, 2004, PSYCHOPHARMACOLOGY, V175, P296, DOI 10.1007/s00213-004-1828-4; Hamner M B, 1999, Depress Anxiety, V9, P1; Harris GJ, 2008, ALCOHOL CLIN EXP RES, V32, P1001, DOI 10.1111/j.1530-0277.2008.00661.x; Heimer L, 2006, NEUROSCI BIOBEHAV R, V30, P126, DOI 10.1016/j.neubiorev.2005.06.006; Hommer D, 1996, ARCH NEUROL-CHICAGO, V53, P359, DOI 10.1001/archneur.1996.00550040099019; Hommer DW, 2011, ANN NY ACAD SCI, V1216, P50, DOI 10.1111/j.1749-6632.2010.05898.x; Hommer DW, 2001, AM J PSYCHIAT, V158, P198, DOI 10.1176/appi.ajp.158.2.198; HOYUMPA AM, 1980, AM J CLIN NUTR, V33, P2750, DOI 10.1093/ajcn/33.12.2750; ITO Y, 1993, J NEUROPSYCH CLIN N, V5, P401; Jacobus J, 2009, NEUROTOXICOL TERATOL, V31, P349, DOI 10.1016/j.ntt.2009.07.006; Jacobus J, 2013, PSYCHOL ADDICT BEHAV, V27, P431, DOI 10.1037/a0028235; JERNIGAN TL, 1991, ALCOHOL CLIN EXP RES, V15, P418, DOI 10.1111/j.1530-0277.1991.tb00540.x; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Kim SJ, 2006, NEUROPSYCHOBIOLOGY, V54, P120, DOI 10.1159/000098262; Langlais PJ, 1997, ALCOHOL CLIN EXP RES, V21, P434; Lanius RA, 2001, AM J PSYCHIAT, V158, P1920, DOI 10.1176/appi.ajp.158.11.1920; LAUDER JM, 1983, PSYCHONEUROENDOCRINO, V8, P121, DOI 10.1016/0306-4530(83)90053-7; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; LENT R, 1993, PROG NEUROBIOL, V40, P249, DOI 10.1016/0301-0082(93)90024-M; Letizia B, 2008, J PSYCHIATR RES, V42, P752, DOI 10.1016/j.jpsychires.2007.08.004; Lindauer RJL, 2004, BIOL PSYCHIAT, V56, P356, DOI 10.1016/j.biopsych.2004.05.021; LOVALLO WR, 2012, INT J PSYCHOPHYSIOL, P85387; McQueeny T, 2009, ALCOHOL CLIN EXP RES, V33, P1278, DOI 10.1111/j.1530-0277.2009.00953.x; Myrick H, 2004, NEUROPSYCHOPHARMACOL, V29, P393, DOI 10.1038/sj.npp.1300295; Pfefferbaum A, 2000, ALCOHOL CLIN EXP RES, V24, P1214, DOI 10.1097/00000374-200008000-00012; Pfefferbaum A, 2005, NEUROPSYCHOPHARMACOL, V30, P423, DOI 10.1038/sj.npp.1300623; PFEFFERBAUM A, 1992, ALCOHOL CLIN EXP RES, V16, P1078, DOI 10.1111/j.1530-0277.1992.tb00702.x; Pfefferbaum A, 2002, NEUROIMAGE, V15, P708, DOI 10.1006/nimg.2001.1018; Pfefferbaum A, 2010, ALCOHOL CLIN EXP RES, V34, P1201, DOI 10.1111/j.1530-0277.2010.01197.x; Pfefferbaum A, 2009, BIOL PSYCHIAT, V65, P680, DOI 10.1016/j.biopsych.2008.10.039; Rauch SL, 2000, BIOL PSYCHIAT, V47, P769, DOI 10.1016/S0006-3223(00)00828-3; REGIER DA, 1990, JAMA-J AM MED ASSOC, V264, P2511; Rosenbloom MJ, 2008, BRAIN IMAGING BEHAV, V2, P74, DOI 10.1007/s11682-007-9017-9; Salloum JB, 2007, ALCOHOL CLIN EXP RES, V31, P1490, DOI 10.1111/j.1530-0277.2007.00447.x; Saxena K, 2012, J CHILD ADOL PSYCHOP, V22, P112, DOI 10.1089/cap.2011.0063; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Schulte T, 2005, CEREB CORTEX, V15, P1384, DOI 10.1093/cercor/bhi020; Schulte Tilman, 2010, Dialogues Clin Neurosci, V12, P554; Shin LM, 2010, NEUROPSYCHOPHARMACOL, V35, P169, DOI 10.1038/npp.2009.83; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Stavro K, 2013, ADDICT BIOL, V18, P203, DOI 10.1111/j.1369-1600.2011.00418.x; Sziklas V, 1998, PROG NEUROBIOL, V54, P55, DOI 10.1016/S0301-0082(97)00064-6; Teicher MH, 2002, PSYCHIAT CLIN N AM, V25, P397, DOI 10.1016/S0193-953X(01)00003-X; Thiebaut de Schotten M, 2012, CORTEX, V48, P82, DOI 10.1016/j.cortex.2011.10.001; Thomaes K, 2010, J CLIN PSYCHIAT, V71, P1636, DOI 10.4088/JCP.08m04754blu; Tomita H, 1999, NATURE, V401, P699, DOI 10.1038/44372; Vann SD, 2004, NAT REV NEUROSCI, V5, P35, DOI 10.1038/nrn1299; Wechsler D., 1999, WECHSLER ABBREVIATED; Wechsler D., 1981, WECHSLER ADULT INTEL; Wu M., 2010, ISMRM 18 ANN M; Yeh PH, 2009, PSYCHIAT RES-NEUROIM, V173, P22, DOI 10.1016/j.pscychresns.2008.07.012; Zhang L, 2011, J AFFECT DISORDERS, V133, P294, DOI 10.1016/j.jad.2011.03.040	74	20	20	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80952	10.1371/journal.pone.0080952	http://dx.doi.org/10.1371/journal.pone.0080952			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260518	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500184
J	Shu, CC; Ato, M; Wang, JT; Jou, R; Wang, JY; Kobayashi, K; Lai, HC; Yu, CJ; Lee, LN; Luh, KT				Shu, Chin-Chung; Ato, Manabu; Wang, Jann-Tay; Jou, Ruwen; Wang, Jann-Yuan; Kobayashi, Kazuo; Lai, Hsin-Chih; Yu, Chong-Jen; Lee, Li-Na; Luh, Kwen-Tay			Sero-Diagnosis of Mycobacterium avium Complex Lung Disease Using Serum Immunoglobulin A Antibody against Glycopeptidolipid Antigen in Taiwan	PLOS ONE			English	Article							NONTUBERCULOUS MYCOBACTERIA; PULMONARY-DISEASE; CLINICAL-SIGNIFICANCE; ENZYME-IMMUNOASSAY; SERODIAGNOSIS; TUBERCULOSIS; PROGNOSIS	Background: Lung disease (LD) due to non-tuberculous mycobacteria is an important clinical concern. Mycobacterium avium complex (MAC) is one of the most common causative agents but the diagnosis of MAC-LD remains challenging. Detection of serum IgA antibody against MAC glycopeptidolipid (GPL) has recently been shown to improve the diagnosis of MAC-LD, but has yet to be validated worldwide. Methods: This prospective study was conducted in a tertiary referral center in northern Taiwan and enrolled patients with MAC-LD, MAC contamination, other lung diseases, and control subjects. Serum immunoglobulin A (IgA) antibody against MAC-GPL was detected in the participants and its specificity and sensitivity was assessed. Results: There were 56 patients with MAC-LD, 11 with MAC contamination, 13 M. kansasii-LD, 26 LD due to rapidly growing mycobacteria (RGM), 48 pulmonary tuberculosis, and 42 household contacts of patients with TB. Patients with MAC-LD were older and 32% of them had an underlying co-morbidity. By logistic regression, serum MAC-GPL IgA level was an independent predictor of MAC-LD among the study subjects and those with culture-positive specimens for MAC. By the receiver operating characteristic curve, serum MAC-GPL IgA had a good power to discriminate MAC-LD from MAC contamination. Under the optimal cut-off value of 0.73 U/mL, its sensitivity and specificity were 60% and 91%, respectively. Among MAC-LD patients, presence of co-morbidity was associated with MAC-GPL <0.73 U/ml in logistic regression analysis. Conclusions: Measurement of serum anti-MAC-GPL IgA level is useful for the diagnosis of MAC-LD. However, its implement in clinical practice for immuno-compromised hosts needs careful consideration.	[Shu, Chin-Chung] Natl Taiwan Univ, Coll Med, Grad Inst Clin Med, Taipei 10764, Taiwan; [Shu, Chin-Chung] Natl Taiwan Univ Hosp, Dept Traumatol, Taipei, Taiwan; [Shu, Chin-Chung; Wang, Jann-Tay; Kobayashi, Kazuo; Yu, Chong-Jen; Lee, Li-Na; Luh, Kwen-Tay] Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan; [Ato, Manabu] Natl Infect Dis, Dept Immunol, Tokyo, Japan; [Jou, Ruwen] Ctr Dis Control, Ctr Res Diagnost & Vaccine Dev, Taipei, Taiwan; [Kobayashi, Kazuo] Asoka Hosp, Dept Med, Tokyo, Japan; [Lai, Hsin-Chih] Chang Gung Univ, Dept Med Biotechnol & Lab Sci, Tao Yuan, Taiwan; [Lee, Li-Na; Luh, Kwen-Tay] Natl Taiwan Univ Hosp, Dept Lab Med, Taipei, Taiwan	National Taiwan University; National Taiwan University; National Taiwan University Hospital; National Taiwan University; National Taiwan University Hospital; National Institute of Infectious Diseases (NIID); Centers For Disease Control - Taiwan; Chang Gung University; National Taiwan University; National Taiwan University Hospital	Wang, JY (corresponding author), Natl Taiwan Univ Hosp, Dept Internal Med, Taipei 100, Taiwan.	jywang@ntu.edu.tw; kobayak@asokakai.or.jp	Ato, Manabu/K-6452-2019	LEE, LI-NA/0000-0002-7654-2450; Yu, Chong-Jen/0000-0001-5664-9392; WANG, JANN-YUAN/0000-0003-3406-366X; Ato, Manabu/0000-0002-3178-2645; SHU, CHIN-CHUNG/0000-0003-0311-5148; WANG, JANN-TAY/0000-0002-0924-3469; LAI, HSIN-CHIH/0000-0002-0605-5040	National Science Council of Taiwan [NSC 102-2325-B-002-066, NSC 101-2325B- 002-077]; Ministry of Health, Labor, and Welfare of Japan	National Science Council of Taiwan(Ministry of Science and Technology, Taiwan); Ministry of Health, Labor, and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan)	The study was supported in part by grants from the National Science Council of Taiwan (NSC 102-2325-B-002-066 and NSC 101-2325B- 002-077) and from the Ministry of Health, Labor, and Welfare of Japan (grants for Research on Emerging and Re-Emerging Infectious Diseases). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chatterjee D, 2001, CELL MOL LIFE SCI, V58, P2018, DOI 10.1007/PL00000834; Field SK, 2006, CHEST, V129, P1653, DOI 10.1378/chest.129.6.1653; Griffith DE, 2007, AM J RESP CRIT CARE, V175, P367, DOI 10.1164/rccm.200604-571ST; Khan K, 2007, AM J RESP CRIT CARE, V176, P306, DOI 10.1164/rccm.200702-201OC; Kitada S, 2002, CLIN INFECT DIS, V35, P1328, DOI 10.1086/344277; Kitada S, 2008, AM J RESP CRIT CARE, V177, P793, DOI 10.1164/rccm.200705-771OC; Kitada S, 2013, EUR RESPIR J, V42, P454, DOI 10.1183/09031936.00098212; Koh WJ, 2006, CHEST, V129, P341, DOI 10.1378/chest.129.2.341; Lai CC, 2010, EMERG INFECT DIS, V16, P294, DOI 10.3201/eid1602.090675; Lin JW, 2009, DIABETES CARE, V32, P2294, DOI 10.2337/dc09-0694; Ripoll F, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-114; Schorey JS, 2008, GLYCOBIOLOGY, V18, P832, DOI 10.1093/glycob/cwn076; Shu CC, 2011, INT J TUBERC LUNG D, V15, P1415, DOI 10.5588/ijtld.10.0786; Shu CC, 2011, LUNG, V189, P467, DOI 10.1007/s00408-011-9321-4; Tanaka E, 1999, AM J RESP CRIT CARE, V160, P866, DOI 10.1164/ajrccm.160.3.9811086; van Ingen J, 2009, THORAX, V64, P502, DOI 10.1136/thx.2008.110957; Wang JY, 2006, THORAX, V61, P903, DOI 10.1136/thx.2005.056887; Wang JY, 2012, J INFECTION, V64, P291, DOI 10.1016/j.jinf.2011.11.028	19	22	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80473	10.1371/journal.pone.0080473	http://dx.doi.org/10.1371/journal.pone.0080473			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260398	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500142
J	Vinader, V; Haji-Abdullahi, MH; Patterson, LH; Afarinkia, K				Vinader, Victoria; Haji-Abdullahi, Mohamed H.; Patterson, L. H.; Afarinkia, Kamyar			Synthesis of a Pseudo-Disaccharide Library and Its Application to the Characterisation of the Heparanase Catalytic Site	PLOS ONE			English	Article							DIELS-ALDER CYCLOADDITIONS; MEDICINAL CHEMISTRY; INHIBITORS; SULFATE; PSEUDODISACCHARIDES; PROTEOGLYCANS; GLYCOSIDASES; METASTASIS; EXPRESSION; BINDING	A novel methodology is described for the efficient and divergent synthesis of pseudodisaccharides, molecules comprising of amino carbasugar analogues linked to natural sugars. The methodology is general and enables the introduction of diversity both at the carbasugar and the natural sugar components of the pseudodisaccharides. Using this approach, a series of pseudodisaccharides are synthesised that mimic the repeating backbone unit of heparan sulfate, and are tested for inhibition of heparanase, a disease-relevant enzyme that hydrolyses heparan sulfate. A new homology model of human heparanase is described based on a family 79 beta-glucuronidase. This model is used to postulate a computational rationale for the observed activity of the different pseudodisaccharides and provide valuable information that informs the design of potential inhibitors of this enzyme.	[Vinader, Victoria; Haji-Abdullahi, Mohamed H.; Patterson, L. H.; Afarinkia, Kamyar] Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England	University of Bradford	Afarinkia, K (corresponding author), Univ Bradford, Inst Canc Therapeut, Bradford BD7 1DP, W Yorkshire, England.	k.afarinkia@bradford.ac.uk	Afarinkia, Kamyar/B-7965-2010	Afarinkia, Kamyar/0000-0003-2819-4364; Vinader, Victoria/0000-0002-7706-8586	Yorkshire Cancer Research programme [B209]	Yorkshire Cancer Research programme	Funding body: Yorkshire Cancer Research programme grant B209 (http://yorkshirecancerresearch.org.uk/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Afarinkia K, 2005, J ORG CHEM, V70, P9529, DOI 10.1021/jo051646i; Afarinkia K, 2005, J ORG CHEM, V70, P1122, DOI 10.1021/jo048213k; Afarinkia K, 2005, TETRAHEDRON-ASYMMETR, V16, P1239, DOI 10.1016/j.tetasy.2005.02.020; Afarinkia K, 1997, TETRAHEDRON LETT, V38, P2369, DOI 10.1016/S0040-4039(97)00352-3; Afarinkia K, 1999, TETRAHEDRON, V55, P3129, DOI 10.1016/S0040-4020(99)00071-X; Afarinkia K, 2000, TETRAHEDRON LETT, V41, P4955, DOI 10.1016/S0040-4039(00)00744-9; Afarinkia K, 2007, SYNLETT, P1375, DOI 10.1055/s-2007-980359; Afarinkia K, 2007, SYNLETT, P1940, DOI 10.1055/s-2007-984540; Afarinkia K, 2010, ORG LETT, V12, P5564, DOI 10.1021/ol102358s; Afarinkia K, 2009, ORG LETT, V11, P5182, DOI 10.1021/ol901960y; Barash U, 2010, FEBS J, V277, P3890, DOI 10.1111/j.1742-4658.2010.07799.x; Breidenbach M, 2006, CANCER LETT, V240, P114, DOI 10.1016/j.canlet.2005.09.007; Carvalho I, 1999, J CHEM SOC PERK T 1, P1795, DOI 10.1039/a902826i; Cipolla L, 2011, MINI-REV MED CHEM, V11, P39, DOI 10.2174/138955711793564060; Cipolla L, 2010, FUTURE MED CHEM, V2, P587, DOI 10.4155/FMC.10.8; Courtney SM, 2005, BIOORG MED CHEM LETT, V15, P2295, DOI 10.1016/j.bmcl.2005.03.014; Diaz L, 2010, CURR MED CHEM, V17, P2393, DOI 10.2174/092986710791698512; Gloster TM, 2012, BIOCHEM SOC T, V40, P913, DOI 10.1042/BST20120201; Gohji K, 2001, INT J CANCER, V95, P295, DOI 10.1002/1097-0215(20010920)95:5<295::AID-IJC1051>3.0.CO;2-A; Gu GF, 2004, CARBOHYD RES, V339, P1155, DOI 10.1016/j.carres.2004.01.020; Haji-Abdullahi MH, SYNTHESIS BIOL UNPUB; Hekking KFW, 2003, TETRAHEDRON, V59, P6751, DOI 10.1016/S0040-4020(03)00819-6; Hulett MD, 2000, BIOCHEMISTRY-US, V39, P15659, DOI 10.1021/bi002080p; Iozzo RV, 2011, J CELL MOL MED, V15, P1013, DOI 10.1111/j.1582-4934.2010.01236.x; Jeon HB, 2009, TETRAHEDRON, V65, P1235, DOI 10.1016/j.tet.2008.12.034; Kajimoto T, 2009, CURR TOP MED CHEM, V9, P13, DOI 10.2174/156802609787354333; Kreuger J, 2006, J CELL BIOL, V174, P323, DOI 10.1083/jcb.200604035; Kuntz DA, 2008, BIOCHEMISTRY-US, V47, P10058, DOI 10.1021/bi8010785; MARKO IE, 1994, TETRAHEDRON, V50, P4557, DOI 10.1016/S0040-4020(01)89387-X; Maxhimer JB, 2002, SURGERY, V132, P326, DOI 10.1067/msy.2002.125719; Michikawa M, 2012, J BIOL CHEM, V287, P14069, DOI 10.1074/jbc.M112.346288; Mosulen S, 2011, BIOPOLYMERS, V95, P151, DOI 10.1002/bip.21549; Ogawa S, 1996, LIEBIGS ANN, P673; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Okada Y, 2002, J BIOL CHEM, V277, P42488, DOI 10.1074/jbc.M206510200; Pinsetta FR, 2013, CARBOHYD RES, V373, P97, DOI 10.1016/j.carres.2013.03.019; Rempel BP, 2008, GLYCOBIOLOGY, V18, P570, DOI 10.1093/glycob/cwn041; Sapay N, 2012, BIOPOLYMERS, V97, P21, DOI 10.1002/bip.21696; Schutzbach John, 2009, V534, P359, DOI 10.1007/978-1-59745-022-5_25; Suzuki K, 2009, CURR TOP MED CHEM, V9, P34, DOI 10.2174/156802609787354315; Vinader MV, 2013, CURR MED CHEM, V20, P3797, DOI 10.2174/09298673113209990180; Wei XD, 2007, J ORG CHEM, V72, P4250, DOI 10.1021/jo062548f; Yamagishi T, 1995, CHEM-EUR J, V1, P634, DOI 10.1002/chem.19950010911; Yang Y, 2005, BLOOD, V105, P1303, DOI 10.1182/blood-200406-2141; Zhou Z, 2006, PROTEINS, V65, P580, DOI 10.1002/prot.21065	45	14	14	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e82111	10.1371/journal.pone.0082111	http://dx.doi.org/10.1371/journal.pone.0082111			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260588	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500209
J	Wang, H; Xue, L; Yan, R; Zhou, Y; Wang, MS; Cheng, MJ; Huang, HJ				Wang, Hong; Xue, Li; Yan, Rong; Zhou, Yin; Wang, Ming-Shan; Cheng, Mei-Juan; Huang, Hai-Jun			Comparison of Histologic Characteristics of Chinese Chronic Hepatitis B Patients with Persistently Normal or Mildly Elevated ALT	PLOS ONE			English	Article							ALANINE AMINOTRANSFERASE; VIRUS INFECTION; FIBROSIS; MANAGEMENT; STATEMENT; CIRRHOSIS; BIOPSY; INDEX; RISK	Liver disease can develop in chronic hepatitis B (CHB) patients with normal or mildly elevated alanine aminotransferase (ALT) who seldom undergo liver biopsy. We aimed to determine histologic characteristics of a large cohort of Chinese CHB patients undergoing liver biopsy and to evaluate the utility of ALT and HBV DNA values at the time of biopsy in predicting liver disease in this population. This prospective study enrolled 230 treatment-naive patients with persistently normal or mildly elevated ALT. All patients had a liver biopsy. ALT, aspartate aminotransferase (AST), and HBV DNA levels were some of the other parameters measured. Using Scheuer's classification, significant histology was defined as stage >= 2 fibrosis and/or stage 1 fibrosis plus >= grade 2 inflammation. Liver disease was observed in 34.4% and 61.8% of patients with normal ALT and mildly elevated ALT, respectively. Patients with mildly elevated ALT levels had significantly more events, including liver disease, elevated AST, and moderate to severe inflammation and liver fibrosis, than patients with normal ALT (all P <= 0.005). A total of 107 patients (46.5%) had liver disease and 123 (53.5%) did not. PLT and ALT were significantly associated with liver disease (both P<0.001). Patients with elevated ALT, lower platelet count and HBV DNA < 7 log(10)copies/mL may have histologically significant changes associated with liver disease. Multivariate analysis showed that PLT and HBV DNA levels were significantly associated with liver disease in patients with normal ALT while gender and HBV DNA levels were significantly associated with liver disease in patients with mildly elevated ALT. Assessing liver damage via biopsy in patients with normal or mildly elevated ALT may help to identify those who would benefit from antiviral therapy.	[Wang, Hong; Yan, Rong; Zhou, Yin; Wang, Ming-Shan; Cheng, Mei-Juan; Huang, Hai-Jun] Zhejiang Prov Peoples Hosp, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China; [Xue, Li] Zhejiang Prov Peoples Hosp, Dept Pathol, Hangzhou, Zhejiang, Peoples R China	Zhejiang Provincial People's Hospital; Zhejiang Provincial People's Hospital	Wang, H (corresponding author), Zhejiang Prov Peoples Hosp, Dept Infect Dis, Hangzhou, Zhejiang, Peoples R China.	hongwang71@yahoo.com						Adinolfi LE, 2001, BRIT J HAEMATOL, V113, P590, DOI 10.1046/j.1365-2141.2001.02824.x; Chen CJ, 2006, JAMA-J AM MED ASSOC, V295, P65, DOI 10.1001/jama.295.1.65; Chen EQ, 2010, DIGEST DIS SCI, V55, P432, DOI 10.1007/s10620-009-0724-5; Chotiyaputta W, 2011, J VIRAL HEPATITIS, V18, P792, DOI 10.1111/j.1365-2893.2010.01364.x; Chu CJ, 2002, GASTROENTEROLOGY, V122, P1756, DOI 10.1053/gast.2002.33588; Gobel T, 2011, J MED VIROL, V83, P968, DOI 10.1002/jmv.22048; Gui HL, 2010, J VIRAL HEPATITIS, V17, P44, DOI 10.1111/j.1365-2893.2010.01270.x; Kawasaki T, 1999, AM J GASTROENTEROL, V94, P1918; Keeffe EB, 2006, CLIN GASTROENTEROL H, V4, P936, DOI 10.1016/j.cgh.2006.05.016; Kim HC, 2004, BMJ-BRIT MED J, V328, P983, DOI 10.1136/bmj.38050.593634.63; Kumar M, 2008, GASTROENTEROLOGY, V134, P1376, DOI 10.1053/j.gastro.2008.02.075; Lai M, 2007, J HEPATOL, V47, P760, DOI 10.1016/j.jhep.2007.07.022; Liaw YF, 2008, HEPATOL INT, V2, P263, DOI 10.1007/s12072-008-9080-3; Lin CL, 2007, HEPATOLOGY, V45, P1193, DOI 10.1002/hep.21585; LOK AS, 2010, AASLD PRACTICE GUIDE; Lok ASF, 2002, NEW ENGL J MED, V346, P1682, DOI 10.1056/NEJM200205303462202; Mallet V, 2009, ALIMENT PHARM THER, V29, P409, DOI 10.1111/j.1365-2036.2008.03895.x; Papatheodoridis GV, 2012, J HEPATOL, V57, P196, DOI 10.1016/j.jhep.2011.11.030; Prati D, 2002, ANN INTERN MED, V137, P1, DOI 10.7326/0003-4819-137-1-200207020-00006; Puoti C, 2013, EUR J INTERN MED, V24, P100, DOI 10.1016/j.ejim.2012.10.013; Rehermann B, 2005, NAT REV IMMUNOL, V5, P215, DOI 10.1038/nri1573; Seto WK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032622; Sorrell MF, 2009, ANN INTERN MED, V150, P104, DOI 10.7326/0003-4819-150-2-200901200-00100; Tanwar Sudeep, 2012, Curr Gastroenterol Rep, V14, P37, DOI 10.1007/s11894-011-0233-5; Wai CT, 2003, HEPATOLOGY, V38, P518, DOI 10.1053/jhep.2003.50346; Wang CC, 2008, J CLIN GASTROENTEROL, V42, P820, DOI 10.1097/MCG.0b013e318156feef; Wong GLH, 2009, CLIN GASTROENTEROL H, V7, P227, DOI 10.1016/j.cgh.2008.10.023; Wu IC, 2010, HEPATOLOGY, V51, P1185, DOI 10.1002/hep.23424; Yuen MF, 2005, GUT, V54, P1610, DOI 10.1136/gut.2005.065136	29	25	31	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80585	10.1371/journal.pone.0080585	http://dx.doi.org/10.1371/journal.pone.0080585			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260428	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500160
J	Liang, TM; Liu, C; Ye, ZC				Liang, Tingming; Liu, Chang; Ye, Zhenchao			Deep Sequencing of Small RNA Repertoires in Mice Reveals Metabolic Disorders-Associated Hepatic miRNAs	PLOS ONE			English	Article							CDNA LIBRARIES; MICRORNA; EXPRESSION; CONSTRUCTION; ORGANIZATION; MIR-33A/B; MIRBASE; TARGETS; OBESITY	Obesity and associated metabolic disorders contribute importantly to the metabolic syndrome. On the other hand, microRNAs (miRNAs) are a class of small non-coding RNAs that repress target gene expression by inducing mRNA degradation and/or translation repression. Dysregulation of specific miRNAs in obesity may influence energy metabolism and cause insulin resistance, which leads to dyslipidemia, steatosis hepatis and type 2 diabetes. In the present study, we comprehensively analyzed and validated dysregulated miRNAs in ob/ob mouse liver, as well as miRNA groups based on miRNA gene cluster and gene family by using deep sequencing miRNA datasets. We found that over 13.8% of the total analyzed miRNAs were dysregulated, of which 37 miRNA species showed significantly differential expression. Further RT-qPCR analysis in some selected miRNAs validated the similar expression patterns observed in deep sequencing. Interestingly, we found that miRNA gene cluster and family always showed consistent dysregulation patterns in ob/ob mouse liver, although they had various enrichment levels. Functional enrichment analysis revealed the versatile physiological roles (over six signal pathways and five human diseases) of these miRNAs. Biological studies indicated that overexpression of miR-126 or inhibition of miR-24 in AML-12 cells attenuated free fatty acids-induced fat accumulation. Taken together, our data strongly suggest that obesity and metabolic disturbance are tightly associated with functional miRNAs. We also identified hepatic miRNA candidates serving as potential biomarkers for the diagnose of the metabolic syndrome.	[Liang, Tingming; Liu, Chang; Ye, Zhenchao] Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China	Nanjing Normal University	Liang, TM (corresponding author), Nanjing Normal Univ, Coll Life Sci, Jiangsu Key Lab Mol & Med Biotechnol, Nanjing, Jiangsu, Peoples R China.	tmliang@njnu.edu.cn	Liang, Tingming/ACL-6141-2022		National Basic Research Program of China (973 Program) [2012CB947600, 2013CB911600]; Program for New Century Excellent Talents in University by the Chinese Ministry of Education [NCET-11-0990]; National Natural Science Foundation of China [31171137, 31271261]; Chinese Ministry of Education [211062]; Research Fund for the Doctoral Program of Higher Education of China [20103207110007]; Fok Ying Tong Education Foundation [121022]; Natural Science Foundation of the Jiangsu Higher Education Institutions of China [12KJB360001]; Natural Science Foundation of China for Talents Training in Basic Science [J1103507]; Priority Academic Program Development of Jiangsu Higher Education Institutions [164320H106]; Collaborative Innovation Center For Cardiovascular Disease Translational Medicine of Jiangsu Higher Education Institutions	National Basic Research Program of China (973 Program)(National Basic Research Program of China); Program for New Century Excellent Talents in University by the Chinese Ministry of Education; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Ministry of Education(Ministry of Education, China); Research Fund for the Doctoral Program of Higher Education of China(Research Fund for the Doctoral Program of Higher Education of China (RFDP)Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP)); Fok Ying Tong Education Foundation(Fok Ying Tung Education Foundation); Natural Science Foundation of the Jiangsu Higher Education Institutions of China(National Natural Science Foundation of China (NSFC)); Natural Science Foundation of China for Talents Training in Basic Science; Priority Academic Program Development of Jiangsu Higher Education Institutions; Collaborative Innovation Center For Cardiovascular Disease Translational Medicine of Jiangsu Higher Education Institutions	This work was supported by grants from the National Basic Research Program of China (973 Program) (2012CB947600, 2013CB911600), the Program for New Century Excellent Talents in University by the Chinese Ministry of Education (NCET-11-0990), the National Natural Science Foundation of China (31171137,31271261), the Key Project of Chinese Ministry of Education (211062), the Research Fund for the Doctoral Program of Higher Education of China (20103207110007), the Fok Ying Tong Education Foundation (121022), the Natural Science Foundation of the Jiangsu Higher Education Institutions of China (12KJB360001), Natural Science Foundation of China for Talents Training in Basic Science (J1103507), the Priority Academic Program Development of Jiangsu Higher Education Institutions (164320H106) and Collaborative Innovation Center For Cardiovascular Disease Translational Medicine of Jiangsu Higher Education Institutions. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bala S, 2011, J BIOL CHEM, V286, P1436, DOI 10.1074/jbc.M110.145870; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Cai ZJ, 1999, WHO TECH REP SER, V887, P1; Castro R. E., 2012, J HEPATOL; Cohen B, 1996, SCIENCE, V274, P1185, DOI 10.1126/science.274.5290.1185; Croucher NJ, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp811; Davalos A, 2011, P NATL ACAD SCI USA, V108, P9232, DOI 10.1073/pnas.1102281108; Esau C, 2006, CELL METAB, V3, P87, DOI 10.1016/j.cmet.2006.01.005; Farazi TA, 2011, CANCER RES, V71, P4443, DOI 10.1158/0008-5472.CAN-11-0608; Foley P, 2010, BBA-MOL CELL BIOL L, V1801, P750, DOI 10.1016/j.bbalip.2010.05.004; Fornari F, 2009, CANCER RES, V69, P5761, DOI 10.1158/0008-5472.CAN-08-4797; Friedlander MR, 2008, NAT BIOTECHNOL, V26, P407, DOI 10.1038/nbt1394; Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Guo L, 2010, COMPUT BIOL CHEM, V34, P165, DOI 10.1016/j.compbiolchem.2010.06.001; Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352; Heneghan HM, 2010, OBES REV, V11, P354, DOI 10.1111/j.1467-789X.2009.00659.x; Hsu SD, 2011, NUCLEIC ACIDS RES, V39, pD163, DOI 10.1093/nar/gkq1107; Hwang HW, 2006, BRIT J CANCER, V94, P776, DOI 10.1038/sj.bjc.6603023; Iliopoulos D, 2010, J LIPID RES, V51, P1513, DOI 10.1194/jlr.M004812; Jordan SD, 2011, NAT CELL BIOL, V13, P434, DOI 10.1038/ncb2211; Kim J, 2012, EXP NEUROL, V235, P476, DOI 10.1016/j.expneurol.2011.11.010; Kozomara A, 2011, NUCLEIC ACIDS RES, V39, pD152, DOI 10.1093/nar/gkq1027; Krutzfeldt J, 2006, CELL METAB, V4, P9, DOI 10.1016/j.cmet.2006.05.009; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; Liang XM, 2011, ANTIOXID REDOX SIGN, V15, P425, DOI 10.1089/ars.2010.3780; Lu C, 2011, METHODS MOL BIOL, V729, P141, DOI 10.1007/978-1-61779-065-2_9; Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399; Megraw M, 2007, NUCLEIC ACIDS RES, V35, pD149, DOI 10.1093/nar/gkl904; Morin RD, 2008, GENOME RES, V18, P610, DOI 10.1101/gr.7179508; Otsubo T, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016617; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rayner KJ, 2011, NATURE, V478, P404, DOI 10.1038/nature10486; Roberts APE, 2011, NUCLEIC ACIDS RES, V39, P7716, DOI 10.1093/nar/gkr426; Rottiers V, 2012, NAT REV MOL CELL BIO, V13, P239, DOI 10.1038/nrm3313; Shen Z, 2009, AM J PHYSIOL-GASTR L, V296, pG1047, DOI 10.1152/ajpgi.00016.2009; Thomas MF, 2010, METHODS MOL BIOL, V667, P93, DOI 10.1007/978-1-60761-811-9_7; Trajkovski M, 2011, NATURE, V474, P649, DOI 10.1038/nature10112; Vergoulis T, 2012, NUCLEIC ACIDS RES, V40, pD222, DOI 10.1093/nar/gkr1161; Vickers K.C., 2012, HEPATOLOGY; Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Xiao FF, 2009, NUCLEIC ACIDS RES, V37, pD105, DOI 10.1093/nar/gkn851; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yin HQ, 2012, J BIOL CHEM, V287, P9817, DOI 10.1074/jbc.M111.333534	47	23	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80774	10.1371/journal.pone.0080774	http://dx.doi.org/10.1371/journal.pone.0080774			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260478	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600084
J	Brichacek, B; Lagenaur, LA; Lee, PP; Venzon, D; Hamer, DH				Brichacek, Beda; Lagenaur, Laurel A.; Lee, Peter P.; Venzon, David; Hamer, Dean H.			In Vivo Evaluation of Safety and Toxicity of a Lactobacillus jensenii Producing Modified Cyanovirin-N in a Rhesus Macaque Vaginal Challenge Model	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; SEXUALLY-TRANSMITTED-DISEASES; GENITAL-TRACT INFLAMMATION; BACTERIAL VAGINOSIS; HIV-INFECTION; COITAL-ACT; ACQUISITION; EXPRESSION; STRAINS; FLORA	Sexual transmission of human immunodeficiency virus type 1 (HIV-1) across the cervicovaginal mucosa in women is influenced by many factors including the microbiota and the presence of underlying inflammation. It is important that potential HIV preventative agents do not alter the mucosal environment in a way that enhances HIV acquisition. We examined the impact of a "live'' microbicide on the vaginal mucosal environment in a rhesus macaque repeated vaginal simian-HIV (SHIVSF162P3) challenge model. The microbicide contained a human vaginal Lactobacillus jensenii expressing the HIV-1 entry inhibitor, modified Cyanovirin-N (mCV-N), and henceforth called LB-mCV-N. Macaques were colonized vaginally each week with LB-mCV-N and sampled six days after colonization for culturable bacteria, pH and cervical-vaginal cytokines during the duration of the six-week study. We show that macaques that retained the engineered LB-mCV-N strain in their vaginal microbiota, during SHIV challenge, had lower pH, when colonization levels were higher, and had no evidence of inflammatory cytokines. Indeed, Interleukin-13, a mediator of inflammation, was detected less often in LB-mCV-N colonized macaques than in controls and we found higher levels of Interleukin 1 receptor antagonist (IL-1RA) in LB-mCV-N colonized macaques during the SHIV challenge period. We noted an inverse correlation between levels of mucosal IL-1RA and peak plasma viral load, thus higher IL-1RA correlated with lower viral load in LB-mCV-N treated macaques. These data support the use of LB-mCV-N as a safe "live'' microbicide and suggest that lactobacilli themselves may positively impact the mucosal environment.	[Brichacek, Beda; Lagenaur, Laurel A.; Hamer, Dean H.] NCI, Vaccine Branch, NIH, Bethesda, MD 20892 USA; [Lagenaur, Laurel A.; Lee, Peter P.] Osel Inc, Mountain View, CA USA; [Venzon, David] NCI, Biostat & Data Management Sect, NIH, Rockville, MD USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Lagenaur, LA (corresponding author), Osel Inc, Mountain View, CA USA.	llagenaur@mail.nih.gov		Lee, Peter P./0000-0002-2660-4377	NIH's Intramural AIDS Targeted Antiviral Program (IATAP); NIH [5R33AI071978-05, 3R33AI071978-04S1]; NATIONAL CANCER INSTITUTE [ZIDSC007202] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R33AI071978] Funding Source: NIH RePORTER	NIH's Intramural AIDS Targeted Antiviral Program (IATAP)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	NIH's Intramural AIDS Targeted Antiviral Program (IATAP) provided funding for the challenge study. This work was also supported by NIH grants 5R33AI071978-05 and 3R33AI071978-04S1. Funders had no role in study design, data collection, analysis, decision to publish or preparation of this manuscript.	Atashili J, 2008, AIDS, V22, P1493, DOI 10.1097/QAD.0b013e3283021a37; Cohen Myron S, 2004, Top HIV Med, V12, P104; de Jong MAWP, 2009, J INTERN MED, V265, P18, DOI 10.1111/j.1365-2796.2008.02046.x; Dezzutti CS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023136; DOYLE L, 1991, J MED PRIMATOL, V20, P409; Fichorova RN, 1999, BIOL REPROD, V60, P508, DOI 10.1095/biolreprod60.2.508; Fichorova RN, 2004, JAIDS-J ACQ IMM DEF, V37, pS184, DOI 10.1097/00126334-200410013-00010; Fichorova RN, 2004, BIOL REPROD, V71, P761, DOI 10.1095/biolreprod.104.029603; Fichorova RN, 1997, BIOL REPROD, V57, P847, DOI 10.1095/biolreprod57.4.847; Fichorova RN, 2001, J INFECT DIS, V184, P418, DOI 10.1086/322047; Galvin SR, 2004, NAT REV MICROBIOL, V2, P33, DOI 10.1038/nrmicro794; Ghadimi D, 2010, INT IMMUNOPHARMACOL, V10, P694, DOI 10.1016/j.intimp.2010.03.014; Gravett MG, 2012, J MED PRIMATOL, V41, P183, DOI 10.1111/j.1600-0684.2012.00537.x; Gray RH, 2001, LANCET, V357, P1149, DOI 10.1016/S0140-6736(00)04331-2; Hawes SE, 1996, J INFECT DIS, V174, P1058, DOI 10.1093/infdis/174.5.1058; Hillier SL, 1998, AIDS RES HUM RETROV, V14, pS17; Hillier SL, 2005, JAIDS-J ACQ IMM DEF, V39, P1, DOI 10.1097/01.qai.0000159671.25950.74; Hladik Florian, 2009, Curr HIV/AIDS Rep, V6, P20, DOI 10.1007/s11904-009-0004-1; Hughes JP, 2012, J INFECT DIS, V205, P358, DOI 10.1093/infdis/jir747; Huskens D, 2008, INT J BIOCHEM CELL B, V40, P2802, DOI 10.1016/j.biocel.2008.05.023; Inamine A, 2012, CLIN IMMUNOL, V143, P170, DOI 10.1016/j.clim.2012.01.008; Karim QA, 2010, CLIN INFECT DIS, V50, pS122, DOI 10.1086/651483; Karim SS, 2012, MICROBICIDES 2012; Lagenaur L, 2011, MUCOSAL IMMUNOL; Liu XW, 2006, ANTIMICROB AGENTS CH, V50, P3250, DOI 10.1128/AAC.00493-06; Liu YY, 2010, AM J PHYSIOL-GASTR L, V299, pG1087, DOI 10.1152/ajpgi.00124.2010; Martin HL, 1999, J INFECT DIS, V180, P1863, DOI 10.1086/315127; Mayer KH, 2011, AM J REPROD IMMUNOL, V65, P308, DOI 10.1111/j.1600-0897.2010.00942.x; Mesquita PMM, 2009, J INFECT DIS, V200, P599, DOI 10.1086/600867; Mirmonsef P, 2011, AIDS RES HUM RETROV; Perrier S, 2006, FEBS LETT, V580, P6289, DOI 10.1016/j.febslet.2006.10.061; POLI G, 1994, P NATL ACAD SCI USA, V91, P108, DOI 10.1073/pnas.91.1.108; Ravel J, 2012, MBIO, V3, DOI 10.1128/mBio.00370-12; Roberts L, 2012, J INFECT DIS, V205, P194, DOI 10.1093/infdis/jir715; Scott ME, 2011, CYTOKINE, V56, P430, DOI 10.1016/j.cyto.2011.06.011; Snel J, 2011, CLIN EXP ALLERGY, V41, P232, DOI 10.1111/j.1365-2222.2010.03650.x; Spear GT, 2010, AIDS RES HUM RETROV, V26, P193, DOI 10.1089/aid.2009.0166; Su HI, 2011, CONTRACEPTION, V84, P525, DOI 10.1016/j.contraception.2011.02.010; Taha TE, 1998, AIDS, V12, P1699, DOI 10.1097/00002030-199813000-00019; Thurman AR, 2011, AM J REPROD IMMUNOL, V65, P89, DOI 10.1111/j.1600-0897.2010.00902.x; Trifonova RT, 2007, BIOMARKERS, V12, P608, DOI 10.1080/13547500701600670; Van Damme L, 2008, NEW ENGL J MED, V359, P463, DOI 10.1056/NEJMoa0707957; Vishwanathan SA, 2011, JAIDS-J ACQ IMM DEF, V57, P261, DOI 10.1097/QAI.0b013e318220ebd3; Vissers YM, 2011, FEMS IMMUNOL MED MIC, V61, P28, DOI 10.1111/j.1574-695X.2010.00741.x; Yamamoto HS, 2013, BMC MICROBIOL, V13, DOI 10.1186/1471-2180-13-4; Yu RR, 2009, J MED PRIMATOL, V38, P125, DOI 10.1111/j.1600-0684.2008.00316.x	46	21	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78817	10.1371/journal.pone.0078817	http://dx.doi.org/10.1371/journal.pone.0078817			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265721	gold, Green Published			2022-12-25	WOS:000327252100054
J	Chauhan, H; Khurana, N; Agarwal, P; Khurana, JP; Khurana, P				Chauhan, Harsh; Khurana, Neetika; Agarwal, Preeti; Khurana, Jitendra P.; Khurana, Paramjit			A Seed Preferential Heat Shock Transcription Factor from Wheat Provides Abiotic Stress Tolerance and Yield Enhancement in Transgenic Arabidopsis under Heat Stress Environment	PLOS ONE			English	Article							EXPRESSION ANALYSIS; RESPONSIVE GENES; RICE; HSFA2; THERMOTOLERANCE; PROTEINS; IDENTIFICATION; SYNTHASE; BINDING; CONFERS	Reduction in crop yield and quality due to various abiotic stresses is a worldwide phenomenon. In the present investigation, a heat shock factor (HSF) gene expressing preferentially in developing seed tissues of wheat grown under high temperatures was cloned. This newly identified heat shock factor possesses the characteristic domains of class A type plant HSFs and shows high similarity to rice OsHsfA2d, hence named as TaHsfA2d. The transcription factor activity of TaHsfA2d was confirmed through transactivation assay in yeast. Transgenic Arabidopsis plants overexpressing TaHsfA2d not only possess higher tolerance towards high temperature but also showed considerable tolerance to salinity and drought stresses, they also showed higher yield and biomass accumulation under constant heat stress conditions. Analysis of putative target genes of AtHSFA2 through quantitative RT-PCR showed higher and constitutive expression of several abiotic stress responsive genes in transgenic Arabidopsis plants over-expressing TaHsfA2d. Under stress conditions, TaHsfA2d can also functionally complement the T-DNA insertion mutants of AtHsfA2, although partially. These observations suggest that TaHsfA2d may be useful in molecular breeding of crop plants, especially wheat, to improve yield under abiotic stress conditions.	[Chauhan, Harsh; Khurana, Neetika; Agarwal, Preeti; Khurana, Jitendra P.; Khurana, Paramjit] Univ Delhi, Dept Plant Mol Biol, New Delhi, India	University of Delhi	Khurana, P (corresponding author), Univ Delhi, Dept Plant Mol Biol, South Campus, New Delhi, India.	param@genomeindia.org	Chauhan, Harsh/U-8270-2019; Agarwal, Preeti/ABA-6669-2020; Chauhan, Harsh/AAB-2751-2021	Chauhan, Harsh/0000-0002-1396-5464	Department of biotechnology, Gov. of India	Department of biotechnology, Gov. of India	Financially work was supported by Department of biotechnology, Gov. of India. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baniwal SK, 2004, J BIOSCIENCES, V29, P471, DOI 10.1007/BF02712120; Banti V, 2010, PLANT PHYSIOL, V152, P1471, DOI 10.1104/pp.109.149815; Bharti K, 2004, PLANT CELL, V16, P1521, DOI 10.1105/tpc.019927; Busch W, 2005, PLANT J, V41, P1, DOI 10.1111/j.1365-313X.2004.02272.x; Charng YY, 2007, PLANT PHYSIOL, V143, P251, DOI 10.1104/pp.106.091322; Chauhan H, 2012, PLANT CELL ENVIRON, V35, P1912, DOI 10.1111/j.1365-3040.2012.02525.x; Chauhan H, 2011, MOL GENET GENOMICS, V286, P171, DOI 10.1007/s00438-011-0638-8; Chauhan H, 2011, PLANT MOL BIOL, V75, P35, DOI 10.1007/s11103-010-9702-8; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cohen-Peer R, 2010, PLANT MOL BIOL, V74, P33, DOI 10.1007/s11103-010-9652-1; Dastidar KG, 2006, PLANT PHYSIOL, V140, P1279, DOI 10.1104/pp.105.075150; Davletova S, 2005, PLANT CELL, V17, P268, DOI 10.1105/tpc.104.026971; Guo JK, 2008, J GENET GENOMICS, V35, P105, DOI 10.1016/S1673-8527(08)60016-8; Guo LH, 2008, PLANT CELL PHYSIOL, V49, P1306, DOI 10.1093/pcp/pcn105; HISCOX JD, 1979, CAN J BOT, V57, P1332, DOI 10.1139/b79-163; Khurana N, 2012, PLANT CELL REP, V31, P237, DOI 10.1007/s00299-011-1160-5; Kotak S, 2004, PLANT J, V39, P98, DOI 10.1111/j.1365-313X.2004.02111.x; Kotak S, 2007, PLANT CELL, V19, P182, DOI 10.1105/tpc.106.048165; KRAUSE GH, 1991, ANNU REV PLANT PHYS, V42, P313, DOI 10.1146/annurev.pp.42.060191.001525; Kumar M, 2009, MOL PLANT, V2, P152, DOI 10.1093/mp/ssn095; Kurek I, 2007, PLANT CELL, V19, P3230, DOI 10.1105/tpc.107.054171; LEE JH, 1995, PLANT J, V8, P603, DOI 10.1046/j.1365-313X.1995.8040603.x; Li CG, 2005, SCI CHINA SER C, V48, P540, DOI 10.1360/062005-119; Liu AL, 2010, J PLANT BIOL, V53, P142, DOI 10.1007/s12374-010-9099-6; Liu H, 2011, PLANT CELL ENVIRON, P34738; Miller G, 2006, ANN BOT-LONDON, V98, P279, DOI 10.1093/aob/mcl107; Mishra SK, 2002, GENE DEV, V16, P1555, DOI 10.1101/gad.228802; Mittal D, 2011, FEBS J, V278, P3076, DOI 10.1111/j.1742-4658.2011.08229.x; Mittal D, 2009, PLANT PHYSIOL BIOCH, V47, P785, DOI 10.1016/j.plaphy.2009.05.003; Nakai A, 1999, CELL STRESS CHAPERON, V4, P86, DOI 10.1379/1466-1268(1999)004<0086:NAITVH>2.3.CO;2; Never L, 1996, CELL STRESS CHAPERON, V1, P215, DOI 10.1379/1466-1268(1996)001<0215:THWCAP>2.3.CO;2; Nishizawa A, 2006, PLANT J, V48, P535, DOI 10.1111/j.1365-313X.2006.02889.x; Nishizawa-Yokoi A, 2011, PLANT CELL PHYSIOL, V52, P933, DOI 10.1093/pcp/pcr045; Nover L, 2001, CELL STRESS CHAPERON, V6, P177, DOI 10.1379/1466-1268(2001)006<0177:AATHST>2.0.CO;2; Ogawa D, 2007, J EXP BOT, V58, P3373, DOI 10.1093/jxb/erm184; Prandl R, 1998, MOL GEN GENET, V258, P269, DOI 10.1007/s004380050731; Prieto-Dapena P, 2008, PLANT J, V54, P1004, DOI 10.1111/j.1365-313X.2008.03465.x; Raychaudhuri A, 1996, PLANT CELL ENVIRON, V19, P1437, DOI 10.1111/j.1365-3040.1996.tb00023.x; Scharf KD, 1998, MOL CELL BIOL, V18, P2240, DOI 10.1128/MCB.18.4.2240; Scharf KD, 2012, BBA-GENE REGUL MECH, V1819, P104, DOI 10.1016/j.bbagrm.2011.10.002; Schoffl F, 1998, PLANT PHYSIOL, V117, P1135, DOI 10.1104/pp.117.4.1135; Schramm F, 2006, PLANT MOL BIOL, V60, P759, DOI 10.1007/s11103-005-5750-x; Shim D, 2009, PLANT CELL, V21, P4031, DOI 10.1105/tpc.109.066902; Singh A, 2012, CELL STRESS CHAPERON, V17, P243, DOI 10.1007/s12192-011-0303-5; Singh G, 2003, PLANT MOL BIOL REP, V21, p93a; Sun WN, 2001, PLANT J, V27, P407, DOI 10.1046/j.1365-313X.2001.01107.x; Swindell WR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-125; Taji T, 2002, PLANT J, V29, P417, DOI 10.1046/j.0960-7412.2001.01227.x; TAYLOR ICA, 1991, GENE DEV, V5, P1285, DOI 10.1101/gad.5.7.1285; Wehmeyer N, 2000, PLANT PHYSIOL, V122, P1099, DOI 10.1104/pp.122.4.1099; Yamanouchi U, 2002, P NATL ACAD SCI USA, V99, P7530, DOI 10.1073/pnas.112209199; Yokotani N, 2008, PLANTA, V227, P957, DOI 10.1007/s00425-007-0670-4; Yoshida T, 2011, MOL GENET GENOMICS, V286, P321, DOI 10.1007/s00438-011-0647-7	54	53	65	2	146	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79577	10.1371/journal.pone.0079577	http://dx.doi.org/10.1371/journal.pone.0079577			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265778	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100111
J	Liu, Y; Zhang, YX; Lin, LZ; Lin, FF; Li, T; Du, HW; Chen, RH; Zheng, W; Liu, N				Liu, Yong; Zhang, Yixian; Lin, Longzai; Lin, Feifei; Li, Tin; Du, Houwei; Chen, Ronghua; Zheng, Wei; Liu, Nan			Effects of Bone Marrow-Derived Mesenchymal Stem Cells on the Axonal Outgrowth through Activation of PI3K/AKT Signaling in Primary Cortical Neurons Followed Oxygen-Glucose Deprivation Injury	PLOS ONE			English	Article							STROMAL CELLS; CEREBRAL-ISCHEMIA; GAP-43 NEUROMODULIN; EXPERIMENTAL STROKE; NEURITE OUTGROWTH; GROWTH-FACTOR; IN-VITRO; RATS; TRANSPLANTATION; EXPRESSION	Background: Transplantation with bone marrow-derived mesenchymal stem cells (BMSCs) improves the survival of neurons and axonal outgrowth after stroke remains undetermined. Here, we investigated whether PI3K/AKT signaling pathway is involved in these therapeutic effects of BMSCs. Methodology/Principal Findings: (1) BMSCs and cortical neurons were derived from Sprague-Dawley rats. The injured neurons were induced by Oxygen-Glucose Deprivation (OGD), and then were respectively co-cultured for 48 hours with BMSCs at different densities (5610 3, 5x10(5)/ml) in transwell co-culture system. The average length of axon and expression of GAP-43 were examined to assess the effect of BMSCs on axonal outgrowth after the damage of neurons induced by OGD. (2) The injured neurons were cultured with a conditioned medium (CM) of BMSCs cultured for 24 hours in neurobasal medium. During the process, we further identified whether PI3K/AKT signaling pathway is involved through the adjunction of LY294002 (a specific phosphatidylinositide-3-kinase (PI3K) inhibitor). Two hours later, the expression of pAKT (phosphorylated AKT) and AKT were analyzed by Western blotting. The length of axons, the expression of GAP-43 and the survival of neurons were measured at 48 hours. Results: Both BMSCs and CM from BMSCs inreased the axonal length and GAP-43 expression in OGD-injured cortical neurons. There was no difference between the effects of BMSCs of 5x10(5)/ml and of 5x10(3) /ml on axonal outgrowth. Expression of pAKT enhanced significantly at 2 hours and the neuron survival increased at 48 hours after the injured neurons cultured with the CM, respectively. These effects of CM were prevented by inhibitor LY294002. Conclusions/Significance: BMSCs promote axonal outgrowth and the survival of neurons against the damage from OGD in vitro by the paracrine effects through PI3K/AKT signaling pathway.	[Liu, Yong; Lin, Longzai; Lin, Feifei; Li, Tin; Du, Houwei; Chen, Ronghua; Zheng, Wei; Liu, Nan] Fujian Med Univ, Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China; [Liu, Yong; Zhang, Yixian; Lin, Longzai; Lin, Feifei; Li, Tin; Du, Houwei; Chen, Ronghua; Zheng, Wei; Liu, Nan] Inst Cerebral Vasc Dis Fujian Prov, Fuzhou, Fujian, Peoples R China; [Zhang, Yixian; Liu, Nan] Fujian Med Univ, Union Hosp, Dept Rehabil, Fuzhou, Fujian, Peoples R China	Fujian Medical University; Fujian Medical University	Liu, N (corresponding author), Fujian Med Univ, Union Hosp, Dept Neurol, Fuzhou, Fujian, Peoples R China.	xieheliunan1984@sina.com			National Natural Science Foundation of China [81171867]; Fujian Provincial Department Science and Technology [2011Y0027]; Medical Innovation Foundation; Fujian Provincial Department of Health [2011-CX-5]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fujian Provincial Department Science and Technology; Medical Innovation Foundation; Fujian Provincial Department of Health	This research was supported by National Natural Science Foundation of China (No. 81171867), Key Research Program provided by Fujian Provincial Department Science and Technology (No. 2011Y0027), Medical Innovation Foundation Grant provided by Fujian Provincial Department of Health (2011-CX-5). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Avwenagha O, 2003, J NEUROCYTOL, V32, P1077, DOI 10.1023/B:NEUR.0000021903.24849.6c; Bao XJ, 2011, BRAIN RES, V1367, P103, DOI 10.1016/j.brainres.2010.10.063; Cantrell DA, 2001, J CELL SCI, V114, P1439; Chakravarthy B, 2008, BIOCHEM BIOPH RES CO, V371, P679, DOI 10.1016/j.bbrc.2008.04.119; Choi DH, 2012, BIOCHEM BIOPH RES CO, V422, P274, DOI 10.1016/j.bbrc.2012.04.147; Choi IY, 2009, ARCH PHARM RES, V32, P1599, DOI 10.1007/s12272-009-2113-1; Crigler L, 2006, EXP NEUROL, V198, P54, DOI 10.1016/j.expneurol.2005.10.029; Dent EW, 1998, J NEUROBIOL, V35, P287, DOI 10.1002/(SICI)1097-4695(19980605)35:3<287::AID-NEU6>3.0.CO;2-V; Dharmasaroja P, 2009, J CLIN NEUROSCI, V16, P12, DOI 10.1016/j.jocn.2008.05.006; Gu, 2012, NEUROLOGICAL RES; Gutierrez-Fernandez M, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt159; Isele NB, 2007, NEUROCHEM INT, V50, P243, DOI 10.1016/j.neuint.2006.08.007; Kocsis JD, 2012, PROG BRAIN RES, V201, P79, DOI 10.1016/B978-0-444-59544-7.00005-6; Krampera M, 2005, BLOOD, V106, P59, DOI 10.1182/blood-2004-09-3645; Laurino L, 2005, J CELL SCI, V118, P3653, DOI 10.1242/jcs.02490; Liu N, 2011, NEUROSCIENCE, V194, P349, DOI 10.1016/j.neuroscience.2011.07.037; Liu N, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-105; Liu Weidong, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P441, DOI 10.3969/j.issn.1672-7347.2012.05.002; Liu Z, 2012, CELL MOL NEUROBIOL, V32, P191, DOI 10.1007/s10571-011-9746-6; Liu ZW, 2010, J CEREBR BLOOD F MET, V30, P1288, DOI 10.1038/jcbfm.2010.8; Ma J, 2013, NEUROCHEM INT, V62, P84, DOI 10.1016/j.neuint.2012.11.010; Marklund N, 2007, J NEUROSURG, V107, P844, DOI 10.3171/JNS-07/10/0844; Montzka K, 2010, CYTOTHERAPY, V12, P870, DOI 10.3109/14653249.2010.501789; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Ramos-Cabrer P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012779; Scheibe F, 2012, CELL MOL NEUROBIOL; Scheibe F, 2012, CELL MOL NEUROBIOL, V32, P567, DOI 10.1007/s10571-012-9798-2; Shen YP, 2013, INT J DEV NEUROSCI, V31, P11, DOI 10.1016/j.ijdevneu.2012.10.006; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Song M, 2012, CELL TRANSPLANT; Tedeschi A, 2009, CELL DEATH DIFFER, V16, P543, DOI 10.1038/cdd.2008.175; Ueno Y, 2012, STROKE, V43, P2221, DOI 10.1161/STROKEAHA.111.646224; Uzun Guven, 2010, J Vasc Interv Neurol, V3, P3; Virdee K, 1999, BRAIN RES, V837, P127, DOI 10.1016/S0006-8993(99)01643-1; Wagner WG, 2007, STEM CELLS, V25, P2638, DOI 10.1634/stemcells.2007-0280; Wei L, 2012, NEUROBIOL DIS, V46, P635, DOI 10.1016/j.nbd.2012.03.002; Wetzel M, 2008, CELL DEATH DIFFER, V15, P143, DOI 10.1038/sj.cdd.4402246; Wilkins A, 2009, STEM CELL RES; Wu X, 2012, MOL BIOTECHNOL	39	20	21	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78514	10.1371/journal.pone.0078514	http://dx.doi.org/10.1371/journal.pone.0078514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265694	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100027
J	Minozzi, G; Nicolazzi, EL; Stella, A; Biffani, S; Negrini, R; Lazzari, B; Ajmone-Marsan, P; Williams, JL				Minozzi, Giulietta; Nicolazzi, Ezequiel L.; Stella, Alessandra; Biffani, Stefano; Negrini, Riccardo; Lazzari, Barbara; Ajmone-Marsan, Paolo; Williams, John L.			Genome Wide Analysis of Fertility and Production Traits in Italian Holstein Cattle	PLOS ONE			English	Article							ANTI-MULLERIAN HORMONE; GENETIC-PARAMETERS; FEMALE FERTILITY; MILK-PRODUCTION; DAIRY-CATTLE; ASSOCIATION; EXPRESSION; REGRESSION; LACTATION; PREGNANCY	A genome wide scan was performed on a total of 2093 Italian Holstein proven bulls genotyped with 50K single nucleotide polymorphisms (SNPs), with the objective of identifying loci associated with fertility related traits and to test their effects on milk production traits. The analysis was carried out using estimated breeding values for the aggregate fertility index and for each trait contributing to the index: angularity, calving interval, non-return rate at 56 days, days to first service, and 305 day first parity lactation. In addition, two production traits not included in the aggregate fertility index were analysed: fat yield and protein yield. Analyses were carried out using all SNPs treated separately, further the most significant marker on BTA14 associated to milk quality located in the DGAT1 region was treated as fixed effect. Genome wide association analysis identified 61 significant SNPs and 75 significant marker-trait associations. Eight additional SNP associations were detected when SNP located near DGAT1 was included as a fixed effect. As there were no obvious common SNPs between the traits analyzed independently in this study, a network analysis was carried out to identify unforeseen relationships that may link production and fertility traits.	[Minozzi, Giulietta; Nicolazzi, Ezequiel L.; Stella, Alessandra; Lazzari, Barbara; Williams, John L.] Parco Tecnol Padano, Lodi, Italy; [Nicolazzi, Ezequiel L.; Negrini, Riccardo; Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Inst Zootech, Piacenza, Italy; [Stella, Alessandra; Biffani, Stefano] CNR, Ist Biol & Biotecnol Agr, Lodi, Italy; [Biffani, Stefano] Assoc Nazl Allevatori Frisona Italiana, Cremona, Italy; [Negrini, Riccardo] Assoc Italiana Allevatori, Rome, Italy; [Ajmone-Marsan, Paolo] Univ Cattolica Sacro Cuore, Nutrigenom Res Ctr, Piacenza, Italy	Catholic University of the Sacred Heart; Consiglio Nazionale delle Ricerche (CNR); Catholic University of the Sacred Heart	Minozzi, G (corresponding author), Parco Tecnol Padano, Lodi, Italy.	giulietta.minozzi@tecnoparco.org	stella, Alessandra/ABB-1952-2021; stella, Alessandra/AAG-6401-2021; Minozzi, Giulietta/K-8126-2017; Stella, Alessandra/AAY-7322-2020; Biffani, Stefano/X-8264-2019; AJMONE MARSAN, Paolo/M-2466-2018	stella, Alessandra/0000-0003-2850-3964; stella, Alessandra/0000-0003-2850-3964; Minozzi, Giulietta/0000-0002-0020-8798; Biffani, Stefano/0000-0001-5559-3630; NEGRINI, Riccardo/0000-0002-8735-0286; AJMONE MARSAN, Paolo/0000-0003-3165-4579; Williams, John/0000-0001-5188-7957	MiPAAF, Ministero delle Politiche Agricole, Alimentari e Fortestali; Regione Lombardia-DG Agricoltura ,Fondazione Cariplo, Fondazione Banca Popolare di Lodi	MiPAAF, Ministero delle Politiche Agricole, Alimentari e Fortestali; Regione Lombardia-DG Agricoltura ,Fondazione Cariplo, Fondazione Banca Popolare di Lodi	This work was partly funded by the "SelMol" project (MiPAAF, Ministero delle Politiche Agricole, Alimentari e Fortestali) and by the "ProZoo" project (Regione Lombardia-DG Agricoltura ,Fondazione Cariplo, Fondazione Banca Popolare di Lodi). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amin N, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001274; Aulchenko YS, 2007, GENETICS, V177, P577, DOI 10.1534/genetics.107.075614; Aulchenko YS, 2007, BIOINFORMATICS, V23, P1294, DOI 10.1093/bioinformatics/btm108; Barbat A, 2010, J REPROD DEVELOP, V56, pS15, DOI 10.1262/jrd.1056S15; Berry DP, 2012, ANIMAL, V6, P1206, DOI 10.1017/S1751731112000067; Biffani S., 2005, INTERBULL B, V33, P63; Catteau-Jonard S, 2008, J CLIN ENDOCR METAB, V93, P4456, DOI 10.1210/jc.2008-1231; Cerri RLA, 2012, J DAIRY SCI, V95, P5657, DOI 10.3168/jds.2011-5114; Cole JB, 2009, J DAIRY SCI, V92, P2931, DOI 10.3168/jds.2008-1762; Djordjevic B, 2013, MODERN PATHOL, V26, P1401, DOI 10.1038/modpathol.2013.67; Garcia MD, 2006, ANIM GENET, V37, P304, DOI 10.1111/j.1365-2052.2006.01443.x; Guillaume F, 2007, ANIM GENET, V38, P72, DOI 10.1111/j.1365-2052.2006.01542.x; Guo JZ, 2012, BMC GENET, V13, DOI 10.1186/1471-2156-13-82; Hoglund JK, 2009, J DAIRY SCI, V92, P5712, DOI 10.3168/jds.2008-1964; Jamrozik J, 2005, J DAIRY SCI, V88, P2199, DOI 10.3168/jds.S0022-0302(05)72895-2; Knight PG, 2006, REPRODUCTION, V132, P191, DOI 10.1530/rep.1.01074; Muir BL, 2007, J DAIRY SCI, V90, P1564, DOI 10.3168/jds.S0022-0302(07)71642-9; Nicolini P, 2013, ACTA VET SCAND, V14, P11; Pimentel ECG, 2011, ANIM GENET, V42, P251, DOI 10.1111/j.1365-2052.2010.02148.x; Pryce JE, 2010, J DAIRY SCI, V93, P3331, DOI 10.3168/jds.2009-2893; Sahana G, 2011, J DAIRY SCI, V94, P479, DOI 10.3168/jds.2010-3381; Schulman NF, 2011, ANIM GENET, V42, P263, DOI 10.1111/j.1365-2052.2010.02149.x; Stubbs SA, 2005, J CLIN ENDOCR METAB, V90, P5536, DOI 10.1210/jc.2005-0907; Thaller G, 2003, J ANIM SCI, V81, P1911; Wickramasinghe S, 2011, J DAIRY SCI, V94, P1552, DOI 10.3168/jds.2010-3237	25	54	57	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80219	10.1371/journal.pone.0080219	http://dx.doi.org/10.1371/journal.pone.0080219			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265800	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100134
J	Zhang, CW; Hong, ZH; Ma, WC; Ma, D; Qian, YC; Xie, W; Tie, F; Fang, M				Zhang, Chengwan; Hong, Zehui; Ma, Wencui; Ma, Da; Qian, Yuchen; Xie, Wei; Tie, Feng; Fang, Ming			Drosophila UTX Coordinates with p53 to Regulate ku80 Expression in Response to DNA Damage	PLOS ONE			English	Article							LYSINE-4 METHYLTRANSFERASE COMPLEX; HISTONE DEMETHYLASE UTX; H3K27 DEMETHYLASES; GENE-EXPRESSION; UP-REGULATION; PATHWAYS; REPAIR; JMJD3; MUTATIONS; CANCER	UTX is known as a general factor that activates gene transcription during development. Here, we demonstrate an additional essential role of UTX in the DNA damage response, in which it upregulates the expression of ku80 in Drosophila, both in cultured cells and in third instar larvae. We further showed that UTX mediates the expression of ku80 by the demethylation of H3K27me3 at the ku80 promoter upon exposure to ionizing radiation (IR) in a p53-dependent manner. UTX interacts physically with p53, and both UTX and p53 are recruited to the ku80 promoter following IR exposure in an interdependent manner. In contrast, the loss of utx has little impact on the expression of ku70, mre11, hid and reaper, suggesting the specific regulation of ku80 expression by UTX. Thus, our findings further elucidate the molecular function of UTX.	[Zhang, Chengwan; Ma, Wencui; Ma, Da; Qian, Yuchen; Xie, Wei; Fang, Ming] Southeast Univ, State Minist Educ, Key Lab Dev Genes & Human Dis, Inst Life Sci, Nanjing, Jiangsu, Peoples R China; [Hong, Zehui] Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China; [Tie, Feng] Case Western Reserve Univ, Dept Genet & Genome Sci, Cleveland, OH 44106 USA	Southeast University - China; Southeast University - China; Case Western Reserve University	Hong, ZH (corresponding author), Southeast Univ, Sch Med, Dept Genet & Dev Biol, Nanjing, Jiangsu, Peoples R China.	hongzehui@seu.edu.cn; mfang@seu.edu.cn	Fang, Ming/A-9099-2013	Fang, Ming/0000-0002-7239-7604; Zhang, Chengwan/0000-0001-7405-9644	Natural Science Foundation of China [90919007, 30900812, 30771068, 31271321]; New-Century Training Program Foundation for Talent of the State Education Commission; Youth Foundation of Southeast University; National Basic Research Program of China [2012CB517904]	Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); New-Century Training Program Foundation for Talent of the State Education Commission; Youth Foundation of Southeast University; National Basic Research Program of China(National Basic Research Program of China)	This work was supported in part by grants from the Natural Science Foundation of China (90919007 and 30900812), the New-Century Training Program Foundation for Talent of the State Education Commission and the Youth Foundation of Southeast University to Z.H. and grants from the National Basic Research Program of China (2012CB517904) and the Natural Science Foundation of China (30771068 and 31271321) to M. F. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agger K, 2007, NATURE, V449, P731, DOI 10.1038/nature06145; Baron Y, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002470; Brodsky MH, 2004, MOL CELL BIOL, V24, P1219, DOI 10.1128/MCB.24.3.1219-1231.2004; Brown KD, 2000, J BIOL CHEM, V275, P6651, DOI 10.1074/jbc.275.9.6651; Cho YW, 2007, J BIOL CHEM, V282, P20395, DOI 10.1074/jbc.M701574200; Ciccia A, 2010, MOL CELL, V40, P179, DOI 10.1016/j.molcel.2010.09.019; Copur O, 2013, DEVELOPMENT, V140, P3478, DOI 10.1242/dev.097204; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Fang M, 2009, DEVELOPMENT, V136, P1929, DOI 10.1242/dev.026559; Gasch AP, 2001, MOL BIOL CELL, V12, P2987, DOI 10.1091/mbc.12.10.2987; Greenfield A, 1998, HUM MOL GENET, V7, P737, DOI 10.1093/hmg/7.4.737; Gui YT, 2011, NAT GENET, V43, P875, DOI 10.1038/ng.907; Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015; Herz HM, 2012, GENE DEV, V26, P2604, DOI 10.1101/gad.201327.112; Herz HM, 2010, MOL CELL BIOL, V30, P2485, DOI 10.1128/MCB.01633-09; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hong SH, 2007, P NATL ACAD SCI USA, V104, P18439, DOI 10.1073/pnas.0707292104; Huang MX, 1998, CELL, V94, P595, DOI 10.1016/S0092-8674(00)81601-3; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Jackson SP, 2009, NATURE, V461, P1071, DOI 10.1038/nature08467; Jelinsky SA, 2000, MOL CELL BIOL, V20, P8157, DOI 10.1128/MCB.20.21.8157-8167.2000; Lahn BT, 1997, SCIENCE, V278, P675, DOI 10.1126/science.278.5338.675; Lan F, 2007, NATURE, V449, P689, DOI 10.1038/nature06192; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Lee S, 2012, DEV CELL, V22, P25, DOI 10.1016/j.devcel.2011.11.009; Lord CJ, 2012, NATURE, V481, P287, DOI 10.1038/nature10760; Luo ZJ, 2012, NAT REV MOL CELL BIO, V13, P543, DOI 10.1038/nrm3417; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mar BG, 2012, LEUKEMIA, V26, P1881, DOI 10.1038/leu.2012.56; Meek DW, 2009, NAT REV CANCER, V9, P714, DOI 10.1038/nrc2716; Miller SA, 2010, MOL CELL, V40, P594, DOI 10.1016/j.molcel.2010.10.028; Mohan M, 2011, MOL CELL BIOL, V31, P4310, DOI 10.1128/MCB.06092-11; Patel SR, 2007, DEV CELL, V13, P580, DOI 10.1016/j.devcel.2007.09.004; Shaw T, 2009, EMBO REP, V10, P881, DOI 10.1038/embor.2009.102; Shpargel KB, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002964; Smith E, 2011, GENE DEV, V25, P661, DOI 10.1101/gad.2015411; Swigut T, 2007, CELL, V131, P29, DOI 10.1016/j.cell.2007.09.026; Tie F, 2012, MOL CELL BIOL, V32, P2323, DOI 10.1128/MCB.06392-11; van Bergeijk P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0036539; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Varela I, 2011, NATURE, V469, P539, DOI 10.1038/nature09639; Wang CC, 2012, P NATL ACAD SCI USA, V109, P15324, DOI 10.1073/pnas.1204166109; Wang JK, 2010, GENE DEV, V24, P327, DOI 10.1101/gad.1882610; Workman CT, 2006, SCIENCE, V312, P1054, DOI 10.1126/science.1122088; Yang L, 2013, DEVELOPMENT, V140, P413, DOI 10.1242/dev.082578	45	15	15	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78652	10.1371/journal.pone.0078652	http://dx.doi.org/10.1371/journal.pone.0078652			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265704	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100037
J	Kantorovich, S; Astary, GW; King, MA; Mareci, TH; Sarntinoranont, M; Carney, PR				Kantorovich, Svetlana; Astary, Garrett W.; King, Michael A.; Mareci, Thomas H.; Sarntinoranont, Malisa; Carney, Paul R.			Influence of Neuropathology on Convection-Enhanced Delivery in the Rat Hippocampus	PLOS ONE			English	Article							TEMPORAL-LOBE EPILEPSY; EXTRACELLULAR-SPACE VOLUME; METHYL-D-ASPARTATE; STATUS EPILEPTICUS; ELECTRICAL-STIMULATION; DIRECT INFUSION; ANIMAL-MODEL; SPINAL-CORD; BRAIN; DIFFUSION	Local drug delivery techniques, such as convention-enhanced delivery (CED), are promising novel strategies for delivering therapeutic agents otherwise limited by systemic toxicity and blood-brain-barrier restrictions. CED uses positive pressure to deliver infusate homogeneously into interstitial space, but its distribution is dependent upon appropriate tissue targeting and underlying neuroarchitecture. To investigate effects of local tissue pathology and associated edema on infusate distribution, CED was applied to the hippocampi of rats that underwent electrically-induced, self-sustaining status epilepticus (SE), a prolonged seizure. Infusion occurred 24 hours post-SE, using a macromolecular tracer, the magnetic resonance (MR) contrast agent gadolinium chelated with diethylene triamine penta-acetic acid and covalently attached to albumin (Gd-albumin). High-resolution T1- and T2-relaxation-weighted MR images were acquired at 11.1 Tesla in vivo prior to infusion to generate baseline contrast enhancement images and visualize morphological changes, respectively. T1-weighted imaging was repeated post-infusion to visualize final contrast-agent distribution profiles. Histological analysis was performed following imaging to characterize injury. Infusions of Gd-albumin into injured hippocampi resulted in larger distribution volumes that correlated with increased injury severity, as measured by hyperintense regions seen in T2-weighted images and corresponding histological assessments of neuronal degeneration, myelin degradation, astrocytosis, and microglial activation. Edematous regions included the CA3 hippocampal subfield, ventral subiculum, piriform and entorhinal cortex, amygdalar nuclei, middle and laterodorsal/lateroposterior thalamic nuclei. This study demonstrates MR-visualized injury processes are reflective of cellular alterations that influence local distribution volume, and provides a quantitative basis for the planning of local therapeutic delivery strategies in pathological brain regions.	[Kantorovich, Svetlana; Carney, Paul R.] Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA; [Kantorovich, Svetlana; Carney, Paul R.] Univ Florida, Wilder Ctr Excellence Epilepsy Res, Gainesville, FL 32610 USA; [Kantorovich, Svetlana; Carney, Paul R.] Univ Florida, Dept Pediat, Div Pediat Neurol, Gainesville, FL 32610 USA; [Astary, Garrett W.; Carney, Paul R.] Univ Florida, J Crayton Pruitt Family Dept Biomed Engn, Gainesville, FL 32610 USA; [King, Michael A.] Univ Florida, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [King, Michael A.] Univ Florida, Malcom Randall Vet Affairs Med Ctr, Gainesville, FL 32610 USA; [Mareci, Thomas H.] Univ Florida, Dept Biochem & Mol Biol, Gainesville, FL 32610 USA; [Sarntinoranont, Malisa] Univ Florida, Dept Mech & Aerosp Engn, Gainesville, FL 32610 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida	Carney, PR (corresponding author), Univ Florida, Dept Neurosci, Gainesville, FL 32610 USA.	carnepr@peds.ufl.edu	Mareci, Thomas Harold/D-7745-2011	Mareci, Thomas Harold/0000-0003-4700-2364	National Institute of Neurological Disorders and Stroke [R01NS063360]; University of Florida Graduate Alumni Fellowship; Children's Miracle Network; Wilder Center of Excellence for Epilepsy Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS063360] Funding Source: NIH RePORTER	National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); University of Florida Graduate Alumni Fellowship(University of Florida); Children's Miracle Network; Wilder Center of Excellence for Epilepsy Research; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by funding from the National Institute of Neurological Disorders and Stroke award R01NS063360, University of Florida Graduate Alumni Fellowship, Children's Miracle Network, and the Wilder Center of Excellence for Epilepsy Research. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. (http://www.ninds.nih.gov/, http://cmnwi.org/, http://www.uff.ufl.edu/scholarships/ScholarshipInfo.asp? ScholarshipFund=006367, https://www.uff.ufl.edu/Research_Program_Support/EndowedFundInfo.asp? eFund=011701). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Astary GW, 2010, J NEUROSCI METH, V187, P129, DOI 10.1016/j.jneumeth.2010.01.002; Bernasconi N, 2004, NEUROIMAGE, V23, P717, DOI 10.1016/j.neuroimage.2004.06.015; BERTRAM EH, 1990, ANN NEUROL, V27, P43, DOI 10.1002/ana.410270108; Bertram EH, 1997, EPILEPSIA, V38, P95, DOI 10.1111/j.1528-1157.1997.tb01083.x; BERTRAM EH, 1994, BRAIN RES, V661, P157, DOI 10.1016/0006-8993(94)91192-4; Bland M., 1995, INTRO MED STAT, P205; BOBO RH, 1994, P NATL ACAD SCI USA, V91, P2076, DOI 10.1073/pnas.91.6.2076; Borowicz KK, 2003, EPILEPSIA, V44, P640, DOI 10.1046/j.1528-1157.2003.45202.x; Brandt C, 2003, NEUROSCIENCE, V118, P727, DOI 10.1016/S0306-4522(03)00027-7; Brown W., 1987, SURGICAL TREATMENT E, P511; Bruton C, 1988, I PSYCHIAT MAUDSLEY, V31; Chen MY, 1999, J NEUROSURG, V90, P315, DOI 10.3171/jns.1999.90.2.0315; Fabene PF, 2003, NEUROIMAGE, V18, P375, DOI 10.1016/S1053-8119(02)00025-3; Fielden J.D.G., 1993, J PHYSIOL-LONDON, V91, DOI [10.1113/JPHYSIOL.1993.SP019851, DOI 10.1113/JPHYSIOL.1993.SP019851]; Gorter JA, 2003, EPILEPSIA, V44, P647, DOI 10.1046/j.1528-1157.2003.53902.x; Groothuis DR, 2007, J CEREBR BLOOD F MET, V27, P43, DOI 10.1038/sj.jcbfm.9600315; Guarnieri M, 2005, J NEUROSCI METH, V144, P147, DOI 10.1016/j.jneumeth.2004.10.019; Haar PJ, 2010, PHYSIOL MEAS, V31, P1075, DOI 10.1088/0967-3334/31/9/001; HANDFORTH A, 1994, EPILEPSY RES, V19, P15, DOI 10.1016/0920-1211(94)90084-1; Heiss JD, 2005, J NEUROSURG, V103, P1035, DOI 10.3171/jns.2005.103.6.1035; Ivanchenko O, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004286; Kim JA, 2001, AM J NEURORADIOL, V22, P1149; Kim JH, 2012, J NEUROSCI METH, V209, P62, DOI 10.1016/j.jneumeth.2012.05.024; Kim JH, 2010, MED BIOL ENG COMPUT, V48, P203, DOI 10.1007/s11517-009-0564-7; Krauze MT, 2006, PHARM RES, V23, P2493, DOI 10.1007/s11095-006-9103-5; KRUSKAL WH, 1958, J AM STAT ASSOC, V53, P814, DOI 10.2307/2281954; Ksendzovsky A, 2012, J NEUROSURG, V117, P197, DOI 10.3171/2012.4.JNS111528; KUZNIECKY R, 1987, ANN NEUROL, V22, P341, DOI 10.1002/ana.410220310; Lam MF, 2011, J CLIN NEUROSCI, V18, P1163, DOI 10.1016/j.jocn.2011.01.012; Lee SJ, 2011, J BIOMED MATER RES B, V97B, P84, DOI 10.1002/jbm.b.31789; Lonser RR, 2007, NEUROLOGY, V68, P254, DOI 10.1212/01.wnl.0000247744.10990.e6; LOTHMAN E, 1990, NEUROLOGY, V40, P13; LOTHMAN EW, 1989, EPILEPSY RES, V3, P107, DOI 10.1016/0920-1211(89)90038-7; Mardor Y, 2009, J PHARMACOL EXP THER, V330, P520, DOI 10.1124/jpet.109.154401; Mathern GW, 1997, NEUROSCIENCE, V77, P1003, DOI 10.1016/S0306-4522(96)00516-7; Mazel T, 1998, NEUROREPORT, V9, P1299; Meierkord H, 1997, ACTA NEUROL SCAND, V96, P127; Morrison PF, 1999, AM J PHYSIOL-REG I, V277, pR1218, DOI 10.1152/ajpregu.1999.277.4.R1218; Nair SP, 2009, EXP NEUROL, V216, P115, DOI 10.1016/j.expneurol.2008.11.009; Nairismagi J, 2006, EPILEPSIA, V47, P479, DOI 10.1111/j.1528-1167.2006.00455.x; NAKASU Y, 1995, AM J NEURORADIOL, V16, P1185; Neuwelt EA, 2004, NEUROSURGERY, V54, P131, DOI 10.1227/01.NEU.0000097715.11966.8E; Newman D, 1939, BIOMETRIKA, V31, P20, DOI 10.1093/biomet/31.1-2.20; Nicoletti JN, 2008, NEUROSCIENCE, V151, P232, DOI 10.1016/j.neuroscience.2007.09.083; Parekh MB, 2010, EXP NEUROL, V224, P258, DOI 10.1016/j.expneurol.2010.03.031; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; RACINE RJ, 1972, ELECTROEN CLIN NEURO, V32, P281, DOI 10.1016/0013-4694(72)90177-0; Raghavan Raghu, 2006, Neurosurg Focus, V20, pE12, DOI 10.3171/foc.2006.20.4.7; Rogawski MA, 2009, NEUROTHERAPEUTICS, V6, P344, DOI 10.1016/j.nurt.2009.01.017; Sampson JH, 2010, J NEUROSURG, V113, P301, DOI 10.3171/2009.11.JNS091052; Sanchez JC, 2006, EXP NEUROL, V198, P31, DOI 10.1016/j.expneurol.2005.10.031; Sanchez JC, 2006, IEEE T NEUR SYS REH, V14, P217, DOI 10.1109/TNSRE.2006.875581; Sarntinoranont M, 2006, ANN BIOMED ENG, V34, P1304, DOI 10.1007/s10439-006-9135-3; Schmued L, 2008, BRAIN RES, V1229, P210, DOI 10.1016/j.brainres.2008.06.129; Schmued LC, 2005, BRAIN RES, V1035, P24, DOI 10.1016/j.brainres.2004.11.054; Simonotto Jennifer D, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P1154; Song DK, 2008, J CHILD NEUROL, V23, P1231, DOI 10.1177/0883073808321064; Spearman C, 1904, AM J PSYCHOL, V15, P72, DOI 10.2307/1412159; Sykova E, 1998, EXP GERONTOL, V33, P837, DOI 10.1016/S0531-5565(98)00038-2; SYKOVA E, 1994, J CEREBR BLOOD F MET, V14, P301, DOI 10.1038/jcbfm.1994.37; Sykova E, 1997, NEUROSCIENTIST, V3, P28, DOI 10.1177/107385849700300113; SYKOVA E, 1983, PROG BIOPHYS MOL BIO, V42, P135, DOI 10.1016/0079-6107(83)90006-8; Sykova E, 1999, NEUROSCIENCE, V91, P783, DOI 10.1016/S0306-4522(98)00603-4; Sykova E, 2008, PHYSIOL REV, V88, P1277, DOI 10.1152/physrev.00027.2007; Talathi SS, 2009, NEUROSCI LETT, V455, P145, DOI 10.1016/j.neulet.2009.03.057; van Vliet EA, 2007, BRAIN, V130, P521, DOI 10.1093/brain/awl318; Vogelbaum MA, 2007, J NEURO-ONCOL, V83, P97, DOI 10.1007/s11060-006-9308-9; Vorisek I, 2002, MAGNET RESON MED, V48, P994, DOI 10.1002/mrm.10305; Vorisek I, 1997, J NEUROPHYSIOL, V78, P912, DOI 10.1152/jn.1997.78.2.912; Wall CJ, 2000, AM J NEURORADIOL, V21, P1841; White E, 2011, J NEUROSCI METH, V199, P87, DOI 10.1016/j.jneumeth.2011.04.027; Wieshmann UC, 1999, MAGN RESON IMAGING, V17, P29, DOI 10.1016/S0730-725X(98)00153-2; Yushkevich PA, 2006, NEUROIMAGE, V31, P1116, DOI 10.1016/j.neuroimage.2006.01.015; Zafar R, 2012, NEUROSCI LETT, V509, P87, DOI 10.1016/j.neulet.2011.12.035; Zhou JB, 2012, CANCER J, V18, P89, DOI 10.1097/PPO.0b013e318244d8ae	75	2	2	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80606	10.1371/journal.pone.0080606	http://dx.doi.org/10.1371/journal.pone.0080606			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260433	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200115
J	Joshi, A; Lee, RTC; Mohl, J; Sedano, M; Khong, WX; Ng, OT; Maurer-Stroh, S; Garg, H				Joshi, Anjali; Lee, Raphael T. C.; Mohl, Jonathan; Sedano, Melina; Khong, Wei Xin; Ng, Oon Tek; Maurer-Stroh, Sebastian; Garg, Himanshu			Genetic Signatures of HIV-1 Envelope-mediated Bystander Apoptosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						AIDS; Apoptosis; Genetics; HIV; Infectious Diseases; Retrovirus; Virology	IMMUNODEFICIENCY-VIRUS TYPE-1; BLOOD MONONUCLEAR-CELLS; T-CELLS; CORECEPTOR USAGE; ANTIBODY NEUTRALIZATION; INFECTED INDIVIDUALS; GLYCOSYLATION SITES; MACROPHAGE TROPISM; ENV CLONES; SUBTYPE	Background: Determinants of HIV-1 Env-mediated apoptosis remain poorly understood. Results: We studied the bystander apoptosis-inducing activity of a panel of primary HIV Envs. Conclusion: Residues Arg-476 and Asn-425 are associated with differences in HIV-1 Env-mediated bystander apoptosis induction. Significance: We identified specific genetic signatures within the HIV-1 Env that are associated with the bystander apoptosis-inducing phenotype. The envelope (Env) glycoprotein of HIV is an important determinant of viral pathogenesis. Several lines of evidence support the role of HIV-1 Env in inducing bystander apoptosis that may be a contributing factor in CD4(+) T cell loss. However, most of the studies testing this phenomenon have been conducted with laboratory-adapted HIV-1 isolates. This raises the question of whether primary Envs derived from HIV-infected patients are capable of inducing bystander apoptosis and whether specific Env signatures are associated with this phenomenon. We developed a high throughput assay to determine the bystander apoptosis inducing activity of a panel of primary Envs. We tested 38 different Envs for bystander apoptosis, virion infectivity, neutralizing antibody sensitivity, and putative N-linked glycosylation sites along with a comprehensive sequence analysis to determine if specific sequence signatures within the viral Env are associated with bystander apoptosis. Our studies show that primary Envs vary considerably in their bystander apoptosis-inducing potential, a phenomenon that correlates inversely with putative N-linked glycosylation sites and positively with virion infectivity. By use of a novel phylogenetic analysis that avoids subtype bias coupled with structural considerations, we found specific residues like Arg-476 and Asn-425 that were associated with differences in bystander apoptosis induction. A specific role of these residues was also confirmed experimentally. These data demonstrate for the first time the potential of primary R5 Envs to mediate bystander apoptosis in CD4(+) T cells. Furthermore, we identify specific genetic signatures within the Env that may be associated with the bystander apoptosis-inducing phenotype.	[Joshi, Anjali; Mohl, Jonathan; Sedano, Melina; Garg, Himanshu] Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, Ctr Excellence Infect Dis, El Paso, TX 79905 USA; [Lee, Raphael T. C.; Maurer-Stroh, Sebastian] Agcy Sci Technol & Res, Bioinformat Inst, Singapore 138671, Singapore; [Lee, Raphael T. C.; Khong, Wei Xin; Ng, Oon Tek] Tan Tock Seng Hosp, Dept Infect Dis, Singapore 308433, Singapore; [Maurer-Stroh, Sebastian] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore	Texas Tech University System; Texas Tech University; Agency for Science Technology & Research (A*STAR); A*STAR - Bioinformatics Institute (BII); Tan Tock Seng Hospital; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University	Garg, H (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Dept Biomed Sci, 5001 El Paso Dr, El Paso, TX 79905 USA.	himanshu.garg@ttuhsc.edu	Maurer-Stroh, Sebastian/Q-9476-2019; Mohl, Jonathon/ABA-7868-2021; Lee, Raphael Tze Chuen/GYU-4585-2022	Maurer-Stroh, Sebastian/0000-0003-0813-9640; Lee, Raphael Tze Chuen/0000-0001-5634-9154; Mohl, Jonathon/0000-0003-4440-4608				Ahr Barbara, 2004, Retrovirology, V1, P12, DOI 10.1186/1742-4690-1-12; Biard-Piechaczyk M, 2000, VIROLOGY, V268, P329, DOI 10.1006/viro.1999.0151; Bjorndal A, 1999, AIDS RES HUM RETROV, V15, P647, DOI 10.1089/088922299310944; Blanco J, 2003, VIROLOGY, V305, P318, DOI 10.1006/viro.2002.1764; Borggren M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020135; Bunnik EM, 2010, VIROLOGY, V397, P224, DOI 10.1016/j.virol.2009.11.009; Castedo M, 2003, ANN NY ACAD SCI, V1010, P19, DOI 10.1196/annals.1299.004; Cayabyab M, 1999, J VIROL, V73, P976, DOI 10.1128/JVI.73.2.976-984.1999; Curlin ME, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1001228; de Mendoza C, 2008, JAIDS-J ACQ IMM DEF, V48, P241, DOI 10.1097/QAI.0b013e3181734f0e; Denizot M, 2008, AUTOPHAGY, V4, P998, DOI 10.4161/auto.6880; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Douek Daniel, 2007, Top HIV Med, V15, P114; Edo-Matas D, 2012, VIROLOGY, V422, P70, DOI 10.1016/j.virol.2011.10.005; Edo-Matas D, 2011, VIROLOGY, V412, P269, DOI 10.1016/j.virol.2011.01.010; Esbjornsson J, 2010, RETROVIROLOGY, V7, DOI 10.1186/1742-4690-7-23; Espert L, 2007, AUTOPHAGY, V3, P32, DOI 10.4161/auto.3275; Eswar Narayanan, 2008, V426, P145, DOI 10.1007/978-1-60327-058-8_8; Etemad-Moghadam B, 2000, J VIROL, V74, P4433, DOI 10.1128/JVI.74.9.4433-4440.2000; Etemad-Moghadam B, 2001, J VIROL, V75, P5646, DOI 10.1128/JVI.75.12.5646-5655.2001; FINKEL TH, 1994, CURR OPIN IMMUNOL, V6, P605, DOI 10.1016/0952-7915(94)90149-X; FINKEL TH, 1995, NAT MED, V1, P129, DOI 10.1038/nm0295-129; Gandhi RT, 1998, J EXP MED, V187, P1113, DOI 10.1084/jem.187.7.1113; Garg H, 2008, CELL MOL LIFE SCI, V65, P3134, DOI 10.1007/s00018-008-8147-6; Garg H, 2007, J BIOL CHEM, V282, P16899, DOI 10.1074/jbc.M701701200; Garg H, 2012, VIRUSES-BASEL, V4, P3020, DOI 10.3390/v4113020; Garg H, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-34; Garg H, 2009, AIDS RES HUM RETROV, V25, P811, DOI 10.1089/aid.2009.0010; Garg H, 2006, J LEUKOCYTE BIOL, V79, P351, DOI 10.1189/jlb.0805430; Gnanakaran S, 2010, PLOS COMPUT BIOL, V6, DOI 10.1371/journal.pcbi.1000955; Gordon SN, 2008, J VIROL, V82, P3725, DOI 10.1128/JVI.02408-07; GOUGEON ML, 1993, AIDS RES HUM RETROV, V9, P287, DOI 10.1089/aid.1993.9.287; GOUGEON ML, 1993, SCIENCE, V260, P1269, DOI 10.1126/science.8098552; Gray L, 2005, VIROLOGY, V337, P384, DOI 10.1016/j.virol.2005.04.034; Gray L, 2009, J VIROL, V83, P5430, DOI 10.1128/JVI.02648-08; HAHN BH, 1985, P NATL ACAD SCI USA, V82, P4813, DOI 10.1073/pnas.82.14.4813; Holm GH, 2004, J VIROL, V78, P4541, DOI 10.1128/JVI.78.9.4541-4551.2004; Holman AG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049538; Holman AG, 2010, AIDS RES THER, V7, DOI 10.1186/1742-6405-7-43; Huang CC, 2005, SCIENCE, V310, P1025, DOI 10.1126/science.1118398; Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373; Hunt PW, 2013, BLOOD, V121, P4635, DOI 10.1182/blood-2012-06-436345; Jansson M, 1999, J HUMAN VIROL, V2, P325; Joshi A, 2011, J BIOL CHEM, V286, P36404, DOI 10.1074/jbc.M111.281659; KANESHIMA H, 1994, J VIROL, V68, P8188, DOI 10.1128/JVI.68.12.8188-8192.1994; Karlsson GB, 1998, J EXP MED, V188, P1159, DOI 10.1084/jem.188.6.1159; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Koot M, 1996, J INFECT DIS, V173, P349, DOI 10.1093/infdis/173.2.349; Krieger E, 2002, PROTEINS, V47, P393, DOI 10.1002/prot.10104; Kulkarni SS, 2009, VIROLOGY, V385, P505, DOI 10.1016/j.virol.2008.12.032; Labonte JA, 2000, J VIROL, V74, P10690, DOI 10.1128/JVI.74.22.10690-10698.2000; LAURENTCRAWFORD AG, 1995, RES VIROLOGY, V146, P5, DOI 10.1016/0923-2516(96)80585-1; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Li M, 2005, J VIROL, V79, P10108, DOI 10.1128/JVI.79.16.10108-10125.2005; Li S, 1999, J VIROL, V73, P9741, DOI 10.1128/JVI.73.12.9741-9755.1999; McDermott AB, 2012, AIDS, V26, P1281, DOI 10.1097/QAD.0b013e328353bcaf; McLellan JS, 2011, NATURE, V480, P336, DOI 10.1038/nature10696; Meissner EG, 2005, VIROLOGY, V336, P184, DOI 10.1016/j.virol.2005.03.032; Meissner EG, 2004, VIROLOGY, V328, P74, DOI 10.1016/j.virol.2004.07.019; Meissner EG, 2006, J VIROL, V80, P11019, DOI 10.1128/JVI.01382-06; Meythaler M, 2008, J MED PRIMATOL, V37, P33, DOI 10.1111/j.1600-0684.2008.00323.x; Meythaler M, 2009, J VIROL, V83, P572, DOI 10.1128/JVI.01715-08; Mosier D. E., 2005, Current Drug Targets - Infectious Disorders, V5, P171, DOI 10.2174/1568005054201553; Navis M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002422; Olivieri K, 2007, VIROLOGY, V358, P23, DOI 10.1016/j.virol.2006.08.027; OYAIZU N, 1995, ADV EXP MED BIOL, V374, P101; OYAIZU N, 1993, BLOOD, V82, P3392; Perfettini JL, 2005, CELL DEATH DIFFER, V12, P916, DOI 10.1038/sj.cdd.4401584; Pirovano W, 2006, NUCLEIC ACIDS RES, V34, P6540, DOI 10.1093/nar/gkl901; Platt EJ, 1998, J VIROL, V72, P2855, DOI 10.1128/JVI.72.4.2855-2864.1998; Rong R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000594; Sagar M, 2006, J VIROL, V80, P9586, DOI 10.1128/JVI.00141-06; SCHUITEMAKER H, 1992, J VIROL, V66, P1354, DOI 10.1128/JVI.66.3.1354-1360.1992; Schuitemaker H, 2011, J TRANSL MED, V9, DOI 10.1186/1479-5876-9-S1-S5; Shankarappa R, 1998, VIROLOGY, V241, P251, DOI 10.1006/viro.1997.8996; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; Spijkerman I, 1998, J INFECT DIS, V178, P397, DOI 10.1086/515627; Sterjovski J, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-89; Sterjovski J, 2011, VIROLOGY, V410, P418, DOI 10.1016/j.virol.2010.12.010; Streeck H, 2010, J INFECT DIS, V202, pS302, DOI 10.1086/655652; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Thomas ER, 2007, VIROLOGY, V360, P105, DOI 10.1016/j.virol.2006.09.036; van Gils MJ, 2011, J VIROL, V85, P8443, DOI 10.1128/JVI.05214-11; van Gils MJ, 2011, J VIROL, V85, P6986, DOI 10.1128/JVI.00268-11; van Rij RP, 2000, J CLIN INVEST, V106, P1569, DOI 10.1172/JCI7953C1; Varbanov M, 2006, AIDS REV, V8, P221; Wade J, 2010, VIROLOGY, V396, P246, DOI 10.1016/j.virol.2009.10.029; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Wei XP, 2002, ANTIMICROB AGENTS CH, V46, P1896, DOI 10.1128/AAC.46.6.1896-1905.2002; Williamson C, 2003, AIDS RES HUM RETROV, V19, P133, DOI 10.1089/088922203762688649; Xu SG, 2007, J MICROBIOL, V45, P441	91	15	15	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	ROCKVILLE	11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES	0021-9258	1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 31	2014	289	5					2497	2514		10.1074/jbc.M113.514018	http://dx.doi.org/10.1074/jbc.M113.514018			18	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AD6WW	24265318	hybrid, Green Published			2022-12-25	WOS:000333403000003
J	Du, F; Qi, Y; Li, XS; Zhang, K				Du, Feng; Qi, Yue; Li, Xingshan; Zhang, Kan			Dual Processes of Oculomotor Capture by Abrupt Onset: Rapid Involuntary Capture and Sluggish Voluntary Prioritization	PLOS ONE			English	Article							CONTINGENT ATTENTIONAL CAPTURE; REAL-WORLD SCENES; STIMULUS-DRIVEN; VISUAL ONSETS; SELECTIVE ATTENTION; OBJECTS; LUMINANCE; MOTION; CANNOT	The present study showed that there are two distinctive processes underlying oculomotor capture by abrupt onset. When a visual mask between the cue and the target eliminates the unique luminance transient of an onset, the onset still attracts attention in a top-down fashion. This memory-based prioritization of onset is voluntarily controlled by the knowledge of target location. But when there is no visual mask between the cue and the target, the onset captures attention mainly in a bottom-up manner. This transient-driven capture of onset is involuntary because it occurs even when the onset is completely irrelevant to the target location. In addition, the present study demonstrated distinctive temporal characteristics for these two processes. The involuntary capture driven by luminance transients is rapid and brief, whereas the memory-based voluntary prioritization of onset is more sluggish and long-lived.	[Du, Feng; Qi, Yue; Li, Xingshan; Zhang, Kan] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Qi, Yue] Univ Chinese Acad Sci, Beijing, Peoples R China	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS	Du, F (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	duf@psych.ac.cn	Li, Xingshan/HHM-6328-2022	Qi, Yue/0000-0002-7546-0613; Du, Feng/0000-0002-5900-8002	National Natural Science Foundation of China [31200766]; key project of Chinese Academy of Sciences [KSZD-EW-Z-008-4]; Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences [Y1CX212005]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); key project of Chinese Academy of Sciences(Chinese Academy of Sciences); Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences(Chinese Academy of Sciences)	This study was supported by grants from the National Natural Science Foundation of China (Grant No. 31200766), the key project of Chinese Academy of Sciences (KSZD-EW-Z-008-4), and the Scientific Foundation of Institute of Psychology, Chinese Academy of Sciences (Grant No. Y1CX212005). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abrams RA, 2005, PERCEPT PSYCHOPHYS, V67, P219, DOI 10.3758/BF03206486; Abrams RA, 2003, PSYCHOL SCI, V14, P427, DOI 10.1111/1467-9280.01458; Brockmole JR, 2008, VIS COGN, V16, P375, DOI 10.1080/13506280701453623; Brockmole JR, 2005, PSYCHON B REV, V12, P1061, DOI 10.3758/BF03206444; Brockmole JR, 2005, J EXP PSYCHOL HUMAN, V31, P857, DOI 10.1037/0096-1523.31.5.857; Christ SE, 2006, PSYCHON B REV, V13, P875, DOI 10.3758/BF03194012; Christ SE, 2006, PERCEPT PSYCHOPHYS, V68, P301, DOI 10.3758/BF03193677; Davoli CC, 2007, PSYCHON B REV, V14, P338, DOI 10.3758/BF03194074; Du F, PSYCHONOMIC IN PRESS; Du F, 2008, PERCEPT PSYCHOPHYS, V70, P1489, DOI 10.3758/PP.70.8.1489; Du F, 2012, COGNITION, V124, P361, DOI 10.1016/j.cognition.2012.05.013; Du F, 2010, EXP BRAIN RES, V205, P115, DOI 10.1007/s00221-010-2345-9; Du F, 2010, BRAIN COGNITION, V72, P310, DOI 10.1016/j.bandc.2009.10.006; Du F, 2009, PSYCHON B REV, V16, P537, DOI 10.3758/PBR.16.3.537; Enns JT, 2001, J EXP PSYCHOL HUMAN, V27, P1287, DOI 10.1037/0096-1523.27.6.1287; FOLK CL, 1994, J EXP PSYCHOL HUMAN, V20, P317, DOI 10.1037/0096-1523.20.2.317; Folk CL, 2002, PERCEPT PSYCHOPHYS, V64, P741, DOI 10.3758/BF03194741; FOLK CL, 1992, J EXP PSYCHOL HUMAN, V18, P1030, DOI 10.1037/0096-1523.18.4.1030; Franconeri SL, 2005, PSYCHOL SCI, V16, P275, DOI 10.1111/j.0956-7976.2005.01528.x; Gibson BS, 1998, J EXP PSYCHOL HUMAN, V24, P699, DOI 10.1037/0096-1523.24.3.699; Henderson JM, 2008, VISION RES, V48, P16, DOI 10.1016/j.visres.2007.10.008; Hollingworth A, 2010, ATTEN PERCEPT PSYCHO, V72, P1298, DOI 10.3758/APP.72.5.1298; Irwin DE, 2010, VISUAL RES, V40, P1443; Ludwig CJH, 2008, J VISION, V8, DOI 10.1167/8.14.11; Ludwig CJH, 2003, PERCEPT PSYCHOPHYS, V65, P1243, DOI 10.3758/BF03194849; Ludwig CJH, 2002, J EXP PSYCHOL HUMAN, V28, P902, DOI 10.1037//0096-1523.28.4.902; Matsukura M, 2011, VISION RES, V51, P546, DOI 10.1016/j.visres.2011.01.014; Matsukura M, 2009, VIS COGN, V17, P835, DOI 10.1080/13506280902868660; Theeuwes J, 2004, PSYCHON B REV, V11, P65, DOI 10.3758/BF03206462; Theeuwes J, 1998, PSYCHOL SCI, V9, P379, DOI 10.1111/1467-9280.00071; THEEUWES J, 1991, PERCEPT PSYCHOPHYS, V49, P83, DOI 10.3758/BF03211619; Theeuwes J, 1999, J EXP PSYCHOL HUMAN, V25, P1595, DOI 10.1037/0096-1523.25.6.1595; YANTIS S, 1994, J EXP PSYCHOL HUMAN, V20, P95, DOI 10.1037/0096-1523.20.1.95; YANTIS S, 1990, J EXP PSYCHOL HUMAN, V16, P121, DOI 10.1037/0096-1523.16.1.121; YANTIS S, 1984, J EXP PSYCHOL HUMAN, V10, P601, DOI 10.1037/0096-1523.10.5.601; Yantis S, 1996, J EXP PSYCHOL HUMAN, V22, P1505, DOI 10.1037/0096-1523.22.6.1505; Yantis S., 1993, CURR DIR PSYCHOL SCI, V2, P156, DOI [DOI 10.1111/1467-8721.EP10768973, 10.1111/1467, DOI 10.1111/1467]	37	0	0	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80678	10.1371/journal.pone.0080678	http://dx.doi.org/10.1371/journal.pone.0080678			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260451	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900084
J	Johnstone, JT; Morton, PD; Jayakumar, AR; Johnstone, AL; Gao, H; Bracchi-Ricard, V; Pearse, DD; Norenberg, MD; Bethea, JR				Johnstone, Joshua T.; Morton, Paul D.; Jayakumar, Arumugam R.; Johnstone, Andrea L.; Gao, Han; Bracchi-Ricard, Valerie; Pearse, Damien D.; Norenberg, Michael D.; Bethea, John R.			Inhibition of NADPH Oxidase Activation in Oligodendrocytes Reduces Cytotoxicity Following Trauma	PLOS ONE			English	Article							SPINAL-CORD-INJURY; FUNCTIONAL RECOVERY; IN-VITRO; RECEPTOR; DEATH; CELLS; MODULATION; MECHANISMS; ASTROCYTES; EXPRESSION	Spinal cord injury is a debilitating neurological disorder that initiates a cascade of cellular events that result in a period of secondary damage that can last for months after the initial trauma. The ensuing outcome of these prolonged cellular perturbations is the induction of neuronal and glial cell death through excitotoxic mechanisms and subsequent free radical production. We have previously shown that astrocytes can directly induce oligodendrocyte death following trauma, but the mechanisms regulating this process within the oligodendrocyte remain unclear. Here we provide evidence demonstrating that astrocytes directly regulate oligodendrocyte death after trauma by inducing activation of NADPH oxidase within oligodendrocytes. Spinal cord injury resulted in a significant increase in oxidative damage which correlated with elevated expression of the gp91 phox subunit of the NADPH oxidase enzyme. Immunohistochemical analysis confirmed the presence of gp91 phox in oligodendrocytes in vitro and at 1 week following spinal cord injury. Exposure of oligodendrocytes to media from injured astrocytes resulted in an increase in oligodendrocyte NADPH oxidase activity. Inhibition of NADPH oxidase activation was sufficient to attenuate oligodendrocyte death in vitro and at 1 week following spinal cord injury, suggesting that excitotoxicity of oligodendrocytes after trauma is dependent on the intrinsic activation of the NADPH oxidase enzyme. Acute administration of the NADPH oxidase inhibitor apocynin and the alpha-amino-3-hydroxy-5-methylisoxazole-4-propionate channel blocker 2,3-dihydroxy-6-nitro-7-sulfamoyl-benzo[f]quinoxaline-2,3-dione significantly improved locomotor behavior and preserved descending axon fibers following spinal cord injury. These studies lead to a better understanding of oligodendrocyte death after trauma and identify potential therapeutic targets in disorders involving demyelination and oligodendrocyte death.	[Johnstone, Joshua T.; Morton, Paul D.; Johnstone, Andrea L.; Gao, Han; Bracchi-Ricard, Valerie; Pearse, Damien D.; Bethea, John R.] Univ Miami, Miami Project Cure Paralysis, Miami, FL 33152 USA; [Jayakumar, Arumugam R.; Norenberg, Michael D.] Univ Miami, Miller Sch Med, Dept Pathol, Miami, FL 33136 USA; [Pearse, Damien D.; Bethea, John R.] Univ Miami, Miller Sch Med, Dept Neurosurg, Miami, FL 33136 USA; [Norenberg, Michael D.] Univ Miami, Dept Biochem & Mol Biol, Miami, FL 33101 USA; [Norenberg, Michael D.] South Florida Fdn Res & Educ Inc, Vet Affairs Med Ctr, Miami, FL USA; [Bethea, John R.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Miami, FL 33136 USA	University of Miami; University of Miami; University of Miami; University of Miami; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Miami	Bethea, JR (corresponding author), Univ Miami, Miami Project Cure Paralysis, Miami, FL 33152 USA.	jbethea@med.miami.edu	Rajadas, Jayakumar/AHC-0630-2022; Pearse, Damien D/D-3176-2011	Pearse, Damien D/0000-0003-1783-221X	National Institutes of Health [R01-NS051709]; Lois Pope LIFE Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051709] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Lois Pope LIFE Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported by National Institutes of Health grant R01-NS051709 (JRB) and the Lois Pope LIFE Fellowship (JTJ). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Antony JM, 2004, NAT NEUROSCI, V7, P1088, DOI 10.1038/nn1319; BARBEAU H, 1991, BRAIN RES, V546, P250, DOI 10.1016/0006-8993(91)91489-N; Basso DM, 2006, J NEUROTRAUM, V23, P635, DOI 10.1089/neu.2006.23.635; Bracchi-Ricard V, 2008, J NEUROCHEM, V104, P611, DOI 10.1111/j.1471-4159.2007.04993.x; Brambilla R, 2005, J EXP MED, V202, P145, DOI 10.1084/jem.20041918; Brambilla R, 2009, J NEUROCHEM, V110, P765, DOI 10.1111/j.1471-4159.2009.06190.x; BRAUGHLER JM, 1986, J BIOL CHEM, V261, P282; Brennan AM, 2009, NAT NEUROSCI, V12, P857, DOI 10.1038/nn.2334; CAVALIERE F, 2012, DROSOPHILA INF SERV, V3, pE268; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; Chen H, 2009, J CEREBR BLOOD F MET, V29, P1262, DOI 10.1038/jcbfm.2009.47; Cohen RI, 2003, J NEUROCHEM, V85, P1262, DOI 10.1046/j.1471-4159.2003.01722.x; DUCIS I, 1990, BRAIN RES, V531, P318, DOI 10.1016/0006-8993(90)90793-B; Griendling KK, 2000, ARTERIOSCL THROM VAS, V20, P2175, DOI 10.1161/01.ATV.20.10.2175; Griendling KK, 2000, CIRC RES, V86, P494, DOI 10.1161/01.RES.86.5.494; Gwak YS, 2007, J NEUROSCI RES, V85, P2352, DOI 10.1002/jnr.21379; Harraz MM, 2008, J CLIN INVEST, V118, P659, DOI 10.1172/JCI34060; Impellizzeri D, 2011, FREE RADICAL RES, V45, P221, DOI 10.3109/10715762.2010.526604; Jaimes EA, 2004, ARTERIOSCL THROM VAS, V24, P1031, DOI 10.1161/01.ATV.0000127083.88549.58; Jayakumar AR, 2008, J NEUROPATH EXP NEUR, V67, P417, DOI 10.1097/NEN.0b013e31816fc9d4; Johnstone JT, 2013, J NEUROSCI RES, V91, P828, DOI 10.1002/jnr.23208; JUURLINK BHJ, 1985, DEV NEUROSCI-BASEL, V7, P263, DOI 10.1159/000112295; Juurlink BHJ, 1997, NEUROSCI BIOBEHAV R, V21, P151, DOI 10.1016/S0149-7634(96)00005-X; LIPTON SA, 1994, NEW ENGL J MED, V330, P613; Liu XZ, 1997, J NEUROSCI, V17, P5395; Lo W, 2007, NEUROSCI LETT, V414, P228, DOI 10.1016/j.neulet.2006.12.055; Matute C, 2001, TRENDS NEUROSCI, V24, P224, DOI 10.1016/S0166-2236(00)01746-X; Matute C, 1997, P NATL ACAD SCI USA, V94, P8830, DOI 10.1073/pnas.94.16.8830; McDonald JW, 1998, NEUROREPORT, V9, P2757, DOI 10.1097/00001756-199808240-00014; McDonald JW, 1998, NAT MED, V4, P291, DOI 10.1038/nm0398-291; McEwen ML, 2005, J HISTOCHEM CYTOCHEM, V53, P809, DOI 10.1369/jhc.4A6467.2005; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Morton PD, 2012, GLIA, V60, P639, DOI 10.1002/glia.22297; Mu XJ, 2002, J NEUROTRAUM, V19, P917, DOI 10.1089/089771502320317078; *NAT CTR BIOT INF, 2011, GENE EXPRESSION OMNI; Park E, 2004, J NEUROTRAUM, V21, P754, DOI 10.1089/0897715041269641; Pearse DD, 2004, NAT MED, V10, P610, DOI 10.1038/nm1056; PERRIN FE, 2011, DROSOPHILA INF SERV, V13, pE218; Pitt D, 2010, BRAIN RES, V1309, P146, DOI 10.1016/j.brainres.2009.10.066; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Stefanska J, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/106507; SULLIVAN HG, 1976, J NEUROSURG, V45, P520, DOI 10.3171/jns.1976.45.5.0520; Tang XN, 2008, NEUROSCIENCE, V154, P556, DOI 10.1016/j.neuroscience.2008.03.090; Tekkok SB, 2007, J CEREBR BLOOD F MET, V27, P1540, DOI 10.1038/sj.jcbfm.9600455; Tekkok SB, 2001, J NEUROSCI, V21, P4237, DOI 10.1523/JNEUROSCI.21-12-04237.2001; Thorburne SK, 1996, J NEUROCHEM, V67, P1014; Trotti D, 1998, TRENDS PHARMACOL SCI, V19, P328, DOI 10.1016/S0165-6147(98)01230-9; Usui S, 2009, J NEUROCHEM, V110, P1028, DOI 10.1111/j.1471-4159.2009.06195.x; Van Buul JD, 2005, ANTIOXID REDOX SIGN, V7, P308, DOI 10.1089/ars.2005.7.308; Werzowa J, 2011, J INVEST DERMATOL, V131, P495, DOI 10.1038/jid.2010.327; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x; Yoo M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057415	53	20	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80975	10.1371/journal.pone.0080975	http://dx.doi.org/10.1371/journal.pone.0080975			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260524	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900108
J	Marullo, R; Werner, E; Degtyareva, N; Moore, B; Altavilla, G; Ramalingam, SS; Doetsch, PW				Marullo, Rossella; Werner, Erica; Degtyareva, Natalya; Moore, Bryn; Altavilla, Giuseppe; Ramalingam, Suresh S.; Doetsch, Paul W.			Cisplatin Induces a Mitochondrial-ROS Response That Contributes to Cytotoxicity Depending on Mitochondrial Redox Status and Bioenergetic Functions	PLOS ONE			English	Article							NUCLEOTIDE EXCISION-REPAIR; ALPHA-LIPOIC ACID; OXIDATIVE STRESS; REACTIVE OXYGEN; INDUCED NEPHROTOXICITY; ENERGETIC METABOLISM; CROSS-LINKING; INDUCED APOPTOSIS; RANDOMIZED-TRIAL; GENE-EXPRESSION	Cisplatin is one of the most effective and widely used anticancer agents for the treatment of several types of tumors. The cytotoxic effect of cisplatin is thought to be mediated primarily by the generation of nuclear DNA adducts, which, if not repaired, cause cell death as a consequence of DNA replication and transcription blockage. However, the ability of cisplatin to induce nuclear DNA (nDNA) damage per se is not sufficient to explain its high degree of effectiveness nor the toxic effects exerted on normal, post-mitotic tissues. Oxidative damage has been observed in vivo following exposure to cisplatin in several tissues, suggesting a role for oxidative stress in the pathogenesis of cisplatin-induced dose-limiting toxicities. However, the mechanism of cisplatin-induced generation of ROS and their contribution to cisplatin cytotoxicity in normal and cancer cells is still poorly understood. By employing a panel of normal and cancer cell lines and the budding yeast Saccharomyces cerevisiae as model system, we show that exposure to cisplatin induces a mitochondrial-dependent ROS response that significantly enhances the cytotoxic effect caused by nDNA damage. ROS generation is independent of the amount of cisplatin-induced nDNA damage and occurs in mitochondria as a consequence of protein synthesis impairment. The contribution of cisplatin-induced mitochondrial dysfunction in determining its cytotoxic effect varies among cells and depends on mitochondrial redox status, mitochondrial DNA integrity and bioenergetic function. Thus, by manipulating these cellular parameters, we were able to enhance cisplatin cytotoxicity in cancer cells. This study provides a new mechanistic insight into cisplatin-induced cell killing and may lead to the design of novel therapeutic strategies to improve anticancer drug efficacy.	[Marullo, Rossella; Ramalingam, Suresh S.; Doetsch, Paul W.] Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA; [Marullo, Rossella; Altavilla, Giuseppe] Univ Messina, Dept Med Oncol, Messina, Italy; [Werner, Erica; Degtyareva, Natalya; Moore, Bryn; Doetsch, Paul W.] Emory Univ, Dept Biochem, Atlanta, GA 30322 USA; [Moore, Bryn; Doetsch, Paul W.] Geisinger Med Ctr, Danville, PA 17822 USA; [Doetsch, Paul W.] Emory Univ, Dept Radiat Oncol, Atlanta, GA 30322 USA	Emory University; University of Messina; Emory University; Geisinger Medical Center; Emory University	Doetsch, PW (corresponding author), Emory Univ, Dept Hematol & Med Oncol, Atlanta, GA 30322 USA.	medpwd@emory.edu	Degtyareva, Natalya/AAI-5500-2021; Ramalingam, Suresh/AAV-7478-2020	Degtyareva, Natalya/0000-0002-7141-6308; Werner, Erica/0000-0002-8183-1601; ALTAVILLA, Giuseppe/0000-0003-3129-7030; Moore, Bryn/0000-0002-8758-7611; Marullo, Rossella/0000-0002-1803-2700	NIEHS [ES011163]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P01ES011163] Funding Source: NIH RePORTER	NIEHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIEHS grant ES011163. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Achanta G, 2005, EMBO J, V24, P3482, DOI 10.1038/sj.emboj.7600819; ALAZARD R, 1982, MUTAT RES, V93, P327, DOI 10.1016/0027-5107(82)90148-8; Arbiser JL, 2002, P NATL ACAD SCI USA, V99, P715, DOI 10.1073/pnas.022630199; Azzoli CG, 2009, J CLIN ONCOL, V27, P6251, DOI 10.1200/JCO.2009.23.5622; BAJORIN DF, 1993, J CLIN ONCOL, V11, P598, DOI 10.1200/JCO.1993.11.4.598; Beljanski V, 2004, MOL PHARMACOL, V65, P1496, DOI 10.1124/mol.65.6.1496; Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020; BRADY HR, 1990, AM J PHYSIOL, V258, pF1181, DOI 10.1152/ajprenal.1990.258.5.F1181; Brown DPG, 2009, CANCER CHEMOTH PHARM, V63, P723, DOI 10.1007/s00280-008-0791-x; Campbell KCM, 1996, HEARING RES, V102, P90, DOI 10.1016/S0378-5955(96)00152-9; CICCARELLI RB, 1985, BIOCHEMISTRY-US, V24, P7533, DOI 10.1021/bi00347a005; Damia G, 1996, INT J CANCER, V66, P779, DOI 10.1002/(SICI)1097-0215(19960611)66:6<779::AID-IJC12>3.0.CO;2-Z; Dehne N, 2001, TOXICOL APPL PHARM, V174, P27, DOI 10.1006/taap.2001.9171; DEKONING P, 1987, TOXICOL APPL PHARM, V89, P81, DOI 10.1016/0041-008X(87)90178-5; Doudican NA, 2005, MOL CELL BIOL, V25, P5196, DOI 10.1128/MCB.25.12.5196-5204.2005; El-Beshbishy HA, 2011, EUR J PHARMACOL, V668, P278, DOI 10.1016/j.ejphar.2011.06.051; Emerling BM, 2009, FREE RADICAL BIO MED, V46, P1386, DOI 10.1016/j.freeradbiomed.2009.02.019; FICHTINGERSCHEPMAN AMJ, 1985, BIOCHEMISTRY-US, V24, P707, DOI 10.1021/bi00324a025; Go RS, 1999, J CLIN ONCOL, V17, P409, DOI 10.1200/JCO.1999.17.1.409; GORDON JA, 1986, AM J PHYSIOL, V250, pF991, DOI 10.1152/ajprenal.1986.250.6.F991; Gotoh Y, 1998, J BIOL CHEM, V273, P17477, DOI 10.1074/jbc.273.28.17477; Hansson A, 2004, P NATL ACAD SCI USA, V101, P3136, DOI 10.1073/pnas.0308710100; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hitosugi T, 2011, MOL CELL, V44, P864, DOI 10.1016/j.molcel.2011.10.015; Horwich A, 1997, J CLIN ONCOL, V15, P1844, DOI 10.1200/JCO.1997.15.5.1844; Hour TC, 2010, BIOCHEM PHARMACOL, V80, P325, DOI 10.1016/j.bcp.2010.04.007; Jiang YL, 2008, CANCER RES, V68, P6425, DOI 10.1158/0008-5472.CAN-08-1173; KANG MA, 2012, DROSOPHILA INF SERV, V3, pE249; Kanki T, 2004, MOL CELL BIOL, V24, P9823, DOI 10.1128/MCB.24.22.9823-9834.2004; LEE KB, 1993, CARCINOGENESIS, V14, P2177, DOI 10.1093/carcin/14.10.2177; Li CH, 2010, TOXICOL SCI, V116, P140, DOI 10.1093/toxsci/kfq085; Liang BC, 1998, CELL DEATH DIFFER, V5, P694, DOI 10.1038/sj.cdd.4400401; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Madesh M, 2001, J CELL BIOL, V155, P1003, DOI 10.1083/jcb.200105057; Marroquin LD, 2007, TOXICOL SCI, V97, P539, DOI 10.1093/toxsci/kfm052; Martins NM, 2008, J APPL TOXICOL, V28, P337, DOI 10.1002/jat.1284; Melli G, 2008, EXP NEUROL, V214, P276, DOI 10.1016/j.expneurol.2008.08.013; MELLO JA, 1995, BIOCHEMISTRY-US, V34, P14783, DOI 10.1021/bi00045a020; Meyer JN, 2013, TOXICOL SCI, V134, P1, DOI 10.1093/toxsci/kft102; Mukhopadhyay P, 2007, NAT PROTOC, V2, P2295, DOI 10.1038/nprot.2007.327; Mukhopadhyay P, 2012, FREE RADICAL BIO MED, V52, P497, DOI 10.1016/j.freeradbiomed.2011.11.001; Olivero OA, 1997, MUTAT RES-GEN TOX EN, V391, P79, DOI 10.1016/S0165-1218(97)00037-2; ORMEROD MG, 1994, BRIT J CANCER, V69, P93, DOI 10.1038/bjc.1994.14; PASCOE JM, 1974, BIOCHEM PHARMACOL, V23, P1345, DOI 10.1016/0006-2952(74)90354-2; PINTO AL, 1985, P NATL ACAD SCI USA, V82, P4616, DOI 10.1073/pnas.82.14.4616; Podratz JL, 2011, NEUROBIOL DIS, V41, P661, DOI 10.1016/j.nbd.2010.11.017; Qian W, 2005, AM J PHYSIOL-CELL PH, V289, pC1466, DOI 10.1152/ajpcell.00265.2005; Raimundo N, 2012, CELL, V148, P716, DOI 10.1016/j.cell.2011.12.027; Rodriguez AM, 2000, FREE RADICAL BIO MED, V29, P801, DOI 10.1016/S0891-5849(00)00362-2; Rodriguez-Enriquez S, 2001, EUR J BIOCHEM, V268, P2512, DOI 10.1046/j.1432-1327.2001.02140.x; Rowe LA, 2008, FREE RADICAL BIO MED, V45, P1167, DOI 10.1016/j.freeradbiomed.2008.07.018; Santandreu FM, 2010, FREE RADICAL BIO MED, V49, P658, DOI 10.1016/j.freeradbiomed.2010.05.031; Santos NAG, 2008, CANCER CHEMOTH PHARM, V61, P145, DOI 10.1007/s00280-007-0459-y; Santos NAG, 2007, ARCH TOXICOL, V81, P495, DOI 10.1007/s00204-006-0173-2; Shen HM, 2006, FREE RADICAL BIO MED, V40, P928, DOI 10.1016/j.freeradbiomed.2005.10.056; STADNICKI SW, 1975, CANCER CHEMOTH REP 1, V59, P467; STEWART DJ, 1982, CANCER CHEMOTH PHARM, V10, P51; Stockwin LH, 2010, INT J CANCER, V127, P2510, DOI 10.1002/ijc.25499; Swanson RL, 1999, MOL CELL BIOL, V19, P2929; WARD JM, 1976, TOXICOL APPL PHARM, V38, P535, DOI 10.1016/0041-008X(76)90185-X; Woo DK, 2012, AM J PATHOL, V180, P24, DOI 10.1016/j.ajpath.2011.10.003; Xiong P, 2011, PROTEIN J, V30, P499, DOI 10.1007/s10930-011-9354-9; Yang ZJ, 2006, CLIN CANCER RES, V12, P5817, DOI 10.1158/1078-0432.CCR-06-1037; Yen HC, 2005, ANN NY ACAD SCI, V1042, P516, DOI 10.1196/annals.1338.047; Zsengeller ZK, 2012, J HISTOCHEM CYTOCHEM, V60, P521, DOI 10.1369/0022155412446227	65	447	456	7	87	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81162	10.1371/journal.pone.0081162	http://dx.doi.org/10.1371/journal.pone.0081162			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260552	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900123
J	Milstead, WB; Hollister, JW; Moore, RB; Walker, HA				Milstead, W. Bryan; Hollister, Jeffrey W.; Moore, Richard B.; Walker, Henry A.			Estimating Summer Nutrient Concentrations in Northeastern Lakes from SPARROW Load Predictions and Modeled Lake Depth and Volume	PLOS ONE			English	Article							NITROGEN-RETENTION; WATER-QUALITY; HUMAN HEALTH; FRESH-WATER; EUTROPHICATION; IMPACTS; COSTS; CYCLE	Global nutrient cycles have been altered by the use of fossil fuels and fertilizers resulting in increases in nutrient loads to aquatic systems. In the United States, excess nutrients have been repeatedly reported as the primary cause of lake water quality impairments. Setting nutrient criteria that are protective of a lakes ecological condition is one common solution; however, the data required to do this are not always easily available. A useful solution for this is to combine available field data (i.e., The United States Environmental Protection Agency (USEPA) National Lake Assessment (NLA)) with average annual nutrient load models (i.e., USGS SPARROW model) to estimate summer concentrations across a large number of lakes. In this paper we use this combined approach and compare the observed total nitrogen (TN) and total phosphorus (TN) concentrations in Northeastern lakes from the 2007 National Lake Assessment to those predicted by the Northeast SPARROW model. We successfully adjusted the SPARROW predictions to the NLA observations with the use of Vollenweider equations, simple input-output models that predict nutrient concentrations in lakes based on nutrient loads and hydraulic residence time. This allows us to better predict summer concentrations of TN and TP in Northeastern lakes and ponds. On average we improved our predicted concentrations of TN and TP with Vollenweider models by 18.7% for nitrogen and 19.0% for phosphorus. These improved predictions are being used in other studies to model ecosystem services (e. g., aesthetics) and dis-services (e. g. cyanobacterial blooms) for similar to 18,000 lakes in the Northeastern United States.	[Milstead, W. Bryan; Hollister, Jeffrey W.; Walker, Henry A.] US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Atlantic Ecol Div, Narragansett, RI 02882 USA; [Moore, Richard B.] US Geol Survey, Pembroke, NH USA	United States Environmental Protection Agency; United States Department of the Interior; United States Geological Survey	Milstead, WB (corresponding author), US EPA, Off Res & Dev, Natl Hlth & Environm Effects Res Lab, Atlantic Ecol Div, Narragansett, RI 02882 USA.	milstead.bryan@epa.gov	Hollister, Jeffrey/J-9920-2013	Hollister, Jeffrey/0000-0002-9254-9740				Alexander RB, 2007, J AM WATER RESOUR AS, V43, P41, DOI 10.1111/j.1752-1688.2007.00005.x; Alexander RB, 2009, BIOGEOCHEMISTRY, V93, P91, DOI 10.1007/s10533-008-9274-8; Bachmann RW, 1980, EPA440581010 REP, p[320, 324]; Booth NL, 2011, J AM WATER RESOUR AS, V47, P1136, DOI 10.1111/j.1752-1688.2011.00573.x; Brett MT, 2008, FRESHWATER BIOL, V53, P194, DOI 10.1111/j.1365-2427.2007.01862.x; Cordell D, 2009, GLOBAL ENVIRON CHANG, V19, P292, DOI 10.1016/j.gloenvcha.2008.10.009; Dodds WK, 2009, ENVIRON SCI TECHNOL, V43, P12, DOI 10.1021/es801217q; Falkowski P, 2000, SCIENCE, V290, P291, DOI 10.1126/science.290.5490.291; Galloway JN, 2008, SCIENCE, V320, P889, DOI 10.1126/science.1136674; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Galloway JN, 2003, BIOSCIENCE, V53, P341, DOI 10.1641/0006-3568(2003)053[0341:TNC]2.0.CO;2; Gesch D, 2009, NAT MAP EL US GEOL S; Harrison JA, 2009, BIOGEOCHEMISTRY, V93, P143, DOI 10.1007/s10533-008-9272-x; HASLER AD, 1969, J BIOSCIENCE, V19, P425, DOI DOI 10.2307/1294478; HEJZLAR J, 2006, INTERACTIONS SEDIMEN, P123; Hollister J, 2010, LAKE RESERV MANAGE, V26, P194, DOI 10.1080/07438141.2010.504321; Hollister JW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025764; Hudnell HK, 2008, ADV EXP MED BIOL, V619, P17, DOI 10.1007/978-0-387-75865-7_2; Hudnell HK, 2010, TOXICON, V55, P1024, DOI 10.1016/j.toxicon.2009.07.021; Kincaid T.M., 2012, SPSURVEY SPATIAL SUR; Lamon EC, 2008, J AM WATER RESOUR AS, V44, P771, DOI 10.1111/j.1752-1688.2008.00205.x; Liu Y, 2008, J IND ECOL, V12, P229, DOI 10.1111/j.1530-9290.2008.00025.x; Moomaw WR, 2005, SCI CHINA SER C, V48, P678, DOI 10.1360/062005-262; Moore RB, 2011, J AM WATER RESOUR AS, V47, P965, DOI 10.1111/j.1752-1688.2011.00582.x; National Research Council, 2001, ASS TMDL APPR WAT QU; PRESTON S.D., 2019, SPARROW MODELING ENH, DOI [10.3133/fs20093019, DOI 10.3133/FS20093019]; Pretty JN, 2003, ENVIRON SCI TECHNOL, V37, P201, DOI 10.1021/es020793k; R Development Core Team, 2012, R LANG ENV STAT COMP; Reckhow KH, 2005, ENVIRON SCI TECHNOL, V39, P2913, DOI 10.1021/es048584i; RECKHOW KH, 1988, WATER RESOUR BULL, V24, P723; Rousseeuw P., 2012, ROBUSTBASE BASIC ROB; Saunders DL, 2001, HYDROBIOLOGIA, V443, P205, DOI 10.1023/A:1017506914063; Schindler DW, 2008, ALGAL BOWL OVERFERTI; Schwarz G., 2006, SPARROW SURFACE WATE, DOI [10.3133/tm6B3, DOI 10.3133/TM6B3]; Seitzinger SP, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002606; Smith VH, 1999, ENVIRON POLLUT, V100, P179, DOI 10.1016/S0269-7491(99)00091-3; Townsend AR, 2003, FRONT ECOL ENVIRON, V1, P240, DOI 10.2307/3868011; Turner RE, 2003, BIOSCIENCE, V53, P563, DOI 10.1641/0006-3568(2003)053[0563:LLAWQI]2.0.CO;2; U. S. Environmental Protection Agency (USEPA), 2009, NAT LAK ASS COLL SUR; USEPA, 2009, EPA NEEDS ACC AD NUM; USEPA, 2002, NAT WAT QUAL INV REP; USEPA, 2007, NAT LAK ASS DAT; USEPA, 2000, NAT WAT QUAL INV 200; USEPA, 1998, NAT WAT QUAL INV 199; USEPA (U. S. Environmental Protection Agency), 1996, NAT WAT QUAL INV 199; [USEPA] U.S. Environmental Protection Agency, 1994, NAT WAT QUAL INV 199; USEPA (US ENVIRONMENTAL PROTECTION AGENCY), 1998, EPA8221R98002 OFF WA; USEPA USGS, 2006, NAT HYDR DAT PLUS VE; USEPA USGS, 2010, NHDPLUS VERS 1 NHDPL; USGS, 2012, SPARROW DEC SUPP SYS; VOLLENWEIDER R A, 1975, Schweizerische Zeitschrift fuer Hydrologie, V37, P53, DOI 10.1007/BF02505178; Windolf J, 1996, BIOGEOCHEMISTRY, V33, P25, DOI 10.1007/BF00000968; Wolfe AH, 2002, AMBIO, V31, P120, DOI 10.1639/0044-7447(2002)031[0120:RNAHHA]2.0.CO;2	53	10	12	1	52	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81457	10.1371/journal.pone.0081457	http://dx.doi.org/10.1371/journal.pone.0081457			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260579	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900131
J	Li, G; Warden, C; Zou, ZX; Neman, J; Krueger, JS; Jain, A; Jandial, R; Chen, M				Li, Gang; Warden, Charles; Zou, Zhaoxia; Neman, Josh; Krueger, Joseph S.; Jain, Alisha; Jandial, Rahul; Chen, Mike			Altered Expression of Polycomb Group Genes in Glioblastoma Multiforme	PLOS ONE			English	Article							CHROMOBOX PROTEIN CBX7; MALIGNANT GLIOMAS; STEM-CELLS; CANCER; COMPLEXES; FAMILY; PRC2; EZH2; BMI1; PROGRESSION	The Polycomb group (PcG) proteins play a critical role in histone mediated epigenetics which has been implicated in the malignant evolution of glioblastoma multiforme (GBM). By systematically interrogating The Cancer Genome Atlas (TCGA), we discovered widespread aberrant expression of the PcG members in GBM samples compared to normal brain. The most striking differences were upregulation of EZH2, PHF19, CBX8 and PHC2 and downregulation of CBX7, CBX6, EZH1 and RYBP. Interestingly, changes in EZH2, PHF19, CBX7, CBX6 and EZH1 occurred progressively as astrocytoma grade increased. We validated the aberrant expression of CBX6, CBX7, CBX8 and EZH2 in GBM cell lines by Western blotting and qRT-PCR, and further the aberrant expression of CBX6 in GBM tissue samples by immunohistochemical staining. To determine if there was functional significance to the diminished CBX6 levels in GBM, CBX6 was overexpressed in GBM cells resulting in decreased proliferative capacity. In conclusion, aberrant expression of PcG proteins in GBMs may play a role in the development or maintenance of the malignancy.	[Li, Gang; Zou, Zhaoxia; Neman, Josh; Jain, Alisha; Jandial, Rahul; Chen, Mike] City Hope Natl Med Ctr, Dept Surg, Div Neurosurg, Duarte, CA 91010 USA; [Warden, Charles] City Hope Natl Med Ctr, Dept Mol Med, Bioinformat Core, Duarte, CA 91010 USA; [Krueger, Joseph S.] Flagship Biosci, Boulder, CO USA	City of Hope; City of Hope	Chen, M (corresponding author), City Hope Natl Med Ctr, Dept Surg, Div Neurosurg, 1500 E Duarte Rd, Duarte, CA 91010 USA.	mchen@coh.org	LI, GANG/O-1409-2016	LI, GANG/0000-0003-3203-8567; Warden, Charles/0000-0002-1827-4486	Margaret E. Early Medical Research Trust Award; NATIONAL CANCER INSTITUTE [P30CA033572] Funding Source: NIH RePORTER	Margaret E. Early Medical Research Trust Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by Margaret E. Early Medical Research Trust Award 2012 (to MC). The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abdouh M, 2009, J NEUROSCI, V29, P8884, DOI 10.1523/JNEUROSCI.0968-09.2009; Barretina J, 2012, NATURE, V483, P603, DOI 10.1038/nature11003; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bonavia R, 2011, CANCER RES, V71, P4055, DOI 10.1158/0008-5472.CAN-11-0153; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2003, EMBO J, V22, P5323, DOI 10.1093/emboj/cdg542; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Dietrich N, 2007, EMBO J, V26, P1637, DOI 10.1038/sj.emboj.7601632; Dunn GP, 2012, GENE DEV, V26, P756, DOI 10.1101/gad.187922.112; Federico A, 2009, CANCER RES, V69, P7079, DOI 10.1158/0008-5472.CAN-09-1542; Freije WA, 2004, CANCER RES, V64, P6503, DOI 10.1158/0008-5472.CAN-04-0452; Gao ZH, 2012, MOL CELL, V45, P344, DOI 10.1016/j.molcel.2012.01.002; Gil J, 2004, NAT CELL BIOL, V6, P67, DOI 10.1038/ncb1077; Gould A, 1997, CURR OPIN GENET DEV, V7, P488, DOI 10.1016/S0959-437X(97)80075-5; Gravendeel LAM, 2009, CANCER RES, V69, P9065, DOI 10.1158/0008-5472.CAN-09-2307; Hinz S, 2008, TUMOR BIOL, V29, P323, DOI 10.1159/000170879; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Karamitopoulou E, 2010, EUR J CANCER, V46, P1438, DOI 10.1016/j.ejca.2010.01.033; Lee Y, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-52; Margueron R, 2011, NATURE, V469, P343, DOI 10.1038/nature09784; Martinez R, 2007, EPIGENETICS, V2, P147, DOI 10.4161/epi.2.3.5049; Morey L, 2012, CELL STEM CELL, V10, P47, DOI 10.1016/j.stem.2011.12.006; Murat A, 2008, J CLIN ONCOL, V26, P3015, DOI 10.1200/JCO.2007.15.7164; Nagarajan RP, 2009, SEMIN CANCER BIOL, V19, P188, DOI 10.1016/j.semcancer.2009.02.005; Noushmehr H, 2010, CANCER CELL, V17, P510, DOI 10.1016/j.ccr.2010.03.017; Orzan F, 2011, NEUROPATH APPL NEURO, V37, P381, DOI 10.1111/j.1365-2990.2010.01132.x; Pallante P, 2008, CANCER RES, V68, P6770, DOI 10.1158/0008-5472.CAN-08-0695; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Phillips HS, 2006, CANCER CELL, V9, P157, DOI 10.1016/j.ccr.2006.02.019; Piunti A, 2011, FUTURE ONCOL, V7, P57, DOI 10.2217/FON.10.157; Sauvageau M, 2010, CELL STEM CELL, V7, P299, DOI 10.1016/j.stem.2010.08.002; Schoeftner S, 2006, EMBO J, V25, P3110, DOI 10.1038/sj.emboj.7601187; Schuettengruber B, 2009, DEVELOPMENT, V136, P3531, DOI 10.1242/dev.033902; Scott CL, 2007, P NATL ACAD SCI USA, V104, P5389, DOI 10.1073/pnas.0608721104; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Sun LX, 2006, CANCER CELL, V9, P287, DOI 10.1016/j.ccr.2006.03.003; Suva ML, 2009, CANCER RES, V69, P9211, DOI 10.1158/0008-5472.CAN-09-1622; Tavares L, 2012, CELL, V148, P664, DOI 10.1016/j.cell.2011.12.029; Trojer P, 2011, MOL CELL, V42, P438, DOI 10.1016/j.molcel.2011.04.004; Vandamme J, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M110.002642; Varambally S, 2002, NATURE, V419, P624, DOI 10.1038/nature01075; Verhaak RGW, 2010, CANCER CELL, V17, P98, DOI 10.1016/j.ccr.2009.12.020; Vincenz C, 2008, P NATL ACAD SCI USA, V105, P16572, DOI 10.1073/pnas.0805317105; Vitucci M, 2011, BRIT J CANCER, V104, P545, DOI 10.1038/sj.bjc.6606031; Zhang XW, 2010, J EXP CLIN CANC RES, V29, DOI 10.1186/1756-9966-29-114	47	68	73	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80970	10.1371/journal.pone.0080970	http://dx.doi.org/10.1371/journal.pone.0080970			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260522	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600106
J	Mazzoni, V; Anfora, G; Virant-Doberlet, M				Mazzoni, Valerio; Anfora, Gianfranco; Virant-Doberlet, Meta			Substrate Vibrations during Courtship in Three Drosophila species	PLOS ONE			English	Article							VIBRATORY COMMUNICATION; SOUND PRODUCTION; HOST PLANTS; MELANOGASTER; EVOLUTION; ORGANS; SIGNALS; SONGS; SENSITIVITY; PLANITIBIA	While a plethora of studies have focused on the role of visual, chemical and near-field airborne signals in courtship of Drosophila fruit flies, the existence of substrate-borne vibrational signals has been almost completely overlooked. Here we describe substrate vibrations generated during courtship in three species of the D. melanogaster group, from the allegedly mute species D. suzukii, its sister species D. biarmipes, and from D. melanogaster. In all species, we recorded several types of substrate vibrations which were generated by locomotion, abdominal vibrations and most likely through the activity of thoracic wing muscles. In D. melanogaster and D. suzukii, all substrate vibrations described in intact males were also recorded in males with amputated wings. Evidence suggests that vibrational signalling may be widespread among Drosophila species, and fruit flies may provide an ideal model to study various aspects of this widespread form of animal communication.	[Mazzoni, Valerio; Anfora, Gianfranco] Fdn Edmund, Res & Innovat Ctr, Mach, San Michele All, Italy; [Virant-Doberlet, Meta] Natl Inst Biol, Dept Entomol, Ljubljana, Slovenia	Fondazione Edmund Mach; National Institute of Biology - Slovenia	Anfora, G (corresponding author), Fdn Edmund, Res & Innovat Ctr, Mach, San Michele All, Italy.	gianfranco.anfora@fmach.it	Mazzoni, Valerio/ABE-4661-2021; Virant-Doberlet, Meta/G-9251-2019	Mazzoni, Valerio/0000-0003-4036-5322; Virant-Doberlet, Meta/0000-0001-7510-2392; ANFORA, Gianfranco/0000-0003-2545-1409	Autonomous Province of Trento [P1-0255]; Slovenian Research Agency [V4-0525]	Autonomous Province of Trento(Autonomous Province of Trento); Slovenian Research Agency(Slovenian Research Agency - Slovenia)	This research was supported by the Autonomous Province of Trento (Accordo di Programma 2012), Funding Research Programme P1-0255 and Research Project V4-0525 by Slovenian Research Agency. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bennet-Clark HC, 1998, PHILOS T ROY SOC B, V353, P407, DOI 10.1098/rstb.1998.0219; Benton R, 2007, TRENDS NEUROSCI, V30, P512, DOI 10.1016/j.tins.2007.07.004; Billeter JC, 2013, CURR OPIN NEUROBIOL, V23, P17, DOI 10.1016/j.conb.2012.08.009; Boake CRB, 1997, ANIM BEHAV, V54, P699, DOI 10.1006/anbe.1997.0474; Cini A, 2012, B INSECTOL, V65, P149; Cocroft RB, 2005, BIOSCIENCE, V55, P323, DOI 10.1641/0006-3568(2005)055[0323:TBEOIV]2.0.CO;2; Cokl A, 2005, J EXP BIOL, V208, P1481, DOI 10.1242/jeb.01557; Cokl A, 2003, ANNU REV ENTOMOL, V48, P29, DOI 10.1146/annurev.ento.48.091801.112605; Cokl A, 2008, J INSECT PHYSIOL, V54, P1113, DOI 10.1016/j.jinsphys.2008.06.004; Cokl A, 2006, CONT T ENT, P71; Colegrave N, 2000, J EVOLUTION BIOL, V13, P143, DOI 10.1046/j.1420-9101.2000.00148.x; Dahanukar A, 2011, FLY, V5, P58, DOI 10.4161/fly.5.1.13794; Devetak D, 1997, J INSECT PHYSIOL, V43, P433, DOI 10.1016/S0022-1910(96)00121-7; Dickson BJ, 2008, SCIENCE, V322, P904, DOI 10.1126/science.1159276; Ejima A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003246; Eriksson A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032954; Fabre CCG, 2012, CURR BIOL, V22, P2180, DOI 10.1016/j.cub.2012.09.042; FUYAMA Y, 1979, EXPERIENTIA, V35, P1327, DOI 10.1007/BF01963987; Gleason JM, 2012, ANIM BEHAV, V83, P217, DOI 10.1016/j.anbehav.2011.10.029; Greenspan RJ, 2000, ANNU REV GENET, V34, P205, DOI 10.1146/annurev.genet.34.1.205; HANRAHAN SA, 1994, ETHOLOGY, V97, P26, DOI 10.1111/j.1439-0310.1994.tb01026.x; Hill PSM, 1997, NATURWISSENSCHAFTEN, V84, P460, DOI 10.1007/s001140050429; HOIKKALA A, 1993, P NATL ACAD SCI USA, V90, P5813, DOI 10.1073/pnas.90.12.5813; HOIKKALA A, 1989, ANIM BEHAV, V37, P927, DOI 10.1016/0003-3472(89)90137-1; Hoikkala A, 2000, MICROSC RES TECHNIQ, V50, P161, DOI 10.1002/1097-0029(20000715)50:2<161::AID-JEMT8>3.0.CO;2-#; HOIKKALA A, 1994, ANIM BEHAV, V47, P1363, DOI 10.1006/anbe.1994.1184; Hoikkala A, 2006, CONT T ENT, P167; HOY RR, 1988, SCIENCE, V240, P217, DOI 10.1126/science.3127882; Joyce AL, 2010, ENTOMOL EXP APPL, V137, P153, DOI 10.1111/j.1570-7458.2010.01048.x; Joyce AL, 2008, ENTOMOL EXP APPL, V127, P39, DOI 10.1111/j.1570-7458.2008.00670.x; Kanmiya K, 2006, INSECT SOUNDS COMMUN; Kopp A, 2002, EVOL DEV, V4, P278, DOI 10.1046/j.1525-142X.2002.02017.x; Lai Y, 2009, J ACOUST SOC AM, V125, P2710, DOI [10.1121/1.4784390, DOI 10.1121/1.4784389]; Lasbleiz C, 2006, ANIM BEHAV, V72, P1001, DOI 10.1016/j.anbehav.2006.01.027; Markow TA, 2005, ANNU REV GENET, V39, P263, DOI 10.1146/annurev.genet.39.073003.112454; MCROBERT SP, 1989, J CHEM ECOL, V15, P1423, DOI 10.1007/BF01012374; MOOK JH, 1968, ENTOMOL EXP APPL, V11, P397, DOI 10.1111/j.1570-7458.1968.tb02069.x; Murthy M, 2010, CURR OPIN NEUROBIOL, V20, P281, DOI 10.1016/j.conb.2010.02.016; Ometto L, 2013, GENOME BIOL EVOL, V5, P745, DOI 10.1093/gbe/evt034; Prud'homme B, 2006, NATURE, V440, P1050, DOI 10.1038/nature04597; RITCHIE MG, 1995, J EVOLUTION BIOL, V8, P463, DOI 10.1046/j.1420-9101.1995.8040463.x; Rota-Stabelli O, 2013, CURR BIOL, V23, pR8, DOI 10.1016/j.cub.2012.11.021; SCHILCHER FV, 1976, ANIM BEHAV, V24, P18; SHANBHAG SR, 1992, INT J INSECT MORPHOL, V21, P311, DOI 10.1016/0020-7322(92)90026-J; SHAW SR, 1994, J NEUROBIOL, V25, P1167, DOI 10.1002/neu.480250911; SHOREY HH, 1962, SCIENCE, V137, P677, DOI 10.1126/science.137.3531.677; Sokal R. R., 2012, BIOMETRY; Stolting Heiko, 2002, J Insect Sci, V2, P2; Tauber E, 2003, BEHAV PROCESS, V64, P197, DOI 10.1016/S0376-6357(03)00135-9; Todi SV, 2004, MICROSC RES TECHNIQ, V63, P388, DOI 10.1002/jemt.20053; Tomaru M., 2011, LOW TEMP SCI, V69, P61; Virant-Doberlet M, 2004, NEOTROP ENTOMOL, V33, P121, DOI 10.1590/S1519-566X2004000200001; WALDRON I, 1964, SCIENCE, V144, P191, DOI 10.1126/science.144.3615.191; Wen S-Y., 2011, LOW TEMP SCI, V69, P87; Yang Y, 2012, MOL PHYLOGENET EVOL, V62, P214, DOI [10.1016/j.ympev.2011.09.018, 10.1016/j.ympev.2011.04.008]; Yeh S-D, 2009, THESIS STONY BROOK U	56	42	40	1	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80708	10.1371/journal.pone.0080708	http://dx.doi.org/10.1371/journal.pone.0080708			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260459	Green Published, gold			2022-12-25	WOS:000327258600079
J	Akrami, R; Jacobsen, A; Hoell, J; Schultz, N; Sander, C; Larsson, E				Akrami, Rozita; Jacobsen, Anders; Hoell, Jessica; Schultz, Nikolaus; Sander, Chris; Larsson, Erik			Comprehensive Analysis of Long Non-Coding RNAs in Ovarian Cancer Reveals Global Patterns and Targeted DNA Amplification	PLOS ONE			English	Article							GENE; CARCINOMA; EXPRESSION; TRANSCRIPTOME; CHROMOSOME; LANDSCAPE; GENOME; CELLS; IDENTIFICATION; METASTASIS	Long non-coding RNAs (lncRNAs) are emerging as potent regulators of cell physiology, and recent studies highlight their role in tumor development. However, while established protein-coding oncogenes and tumor suppressors often display striking patterns of focal DNA copy-number alteration in tumors, similar evidence is largely lacking for lncRNAs. Here, we report on a genomic analysis of GENCODE lncRNAs in high-grade serous ovarian adenocarcinoma, based on The Cancer Genome Atlas (TCGA) molecular profiles. Using genomic copy-number data and deep coverage transcriptome sequencing, we derived dual copy-number and expression data for 10,419 lncRNAs across 407 primary tumors. We describe global correlations between lncRNA copy-number and expression, and associate established expression subtypes with distinct lncRNA signatures. By examining regions of focal copy-number change that lack protein-coding targets, we identified an intergenic lncRNA on chromosome 1, OVAL, that shows narrow focal genomic amplification in a subset of tumors. While weakly expressed in most tumors, focal amplification coincided with strong OVAL transcriptional activation. Screening of 16 other cancer types revealed similar patterns in serous endometrial carcinomas. This shows that intergenic lncRNAs can be specifically targeted by somatic copy-number amplification, suggestive of functional involvement in tumor initiation or progression. Our analysis provides testable hypotheses and paves the way for further study of lncRNAs based on TCGA and other large-scale cancer genomics datasets.	[Akrami, Rozita; Larsson, Erik] Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden; [Jacobsen, Anders; Schultz, Nikolaus; Sander, Chris] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA; [Hoell, Jessica] Univ Dusseldorf, Fac Med, Dept Pediat Oncol Hematol & Clin Immunol, Dusseldorf, Germany	University of Gothenburg; Memorial Sloan Kettering Cancer Center; Heinrich Heine University Dusseldorf	Larsson, E (corresponding author), Univ Gothenburg, Sahlgrenska Acad, Inst Biomed, Dept Med Biochem & Cell Biol, Gothenburg, Sweden.	erik.larsson@gu.se	Skanderup, Anders Jacobsen/K-1081-2013; Hoell, Jessica/J-8136-2016; Larsson Lekholm, Erik/AHE-0932-2022; Schultz, Nikolaus/ABE-6347-2020; Larsson Lekholm, Erik/HDM-8032-2022	Skanderup, Anders Jacobsen/0000-0001-6847-4980; Hoell, Jessica/0000-0002-5532-9845; Larsson Lekholm, Erik/0000-0003-1400-0119; Larsson Lekholm, Erik/0000-0003-1400-0119; Schultz, Nikolaus/0000-0002-0131-4904	Swedish Medical Research Council; Swedish Cancer Society; Swedish Foundation for Strategic Research; Assar Gabrielsson Foundation; Magnus Bergvall Foundation; Ake Wiberg foundation; Lars Hierta Memorial Foundation; US National Cancer Institute as part of the TCGA Genome Data Analysis Center grant [NCI-U24CA143840, NCI-R21CA135870]; Stand Up To Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation [SU2C-AACR-DT0209]; Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) [b2012108]; NATIONAL CANCER INSTITUTE [R21CA135870, U24CA143840] Funding Source: NIH RePORTER	Swedish Medical Research Council(Swedish Medical Research Council (SMRC)); Swedish Cancer Society(Swedish Cancer Society); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Assar Gabrielsson Foundation; Magnus Bergvall Foundation; Ake Wiberg foundation; Lars Hierta Memorial Foundation; US National Cancer Institute as part of the TCGA Genome Data Analysis Center grant; Stand Up To Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation; Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported by grants from the Swedish Medical Research Council; the Swedish Cancer Society; The Swedish Foundation for Strategic Research; the Assar Gabrielsson Foundation; the Magnus Bergvall Foundation; the Ake Wiberg foundation; and the Lars Hierta Memorial Foundation. Funding for A.J., N.S., and C. S. was provided by the US National Cancer Institute as part of the TCGA Genome Data Analysis Center grant (NCI-U24CA143840 and NCI-R21CA135870) and by a Stand Up To Cancer Dream Team Translational Research Grant, a Program of the Entertainment Industry Foundation (SU2C-AACR-DT0209). The computations were in part performed on high-performance computing resources provided by Swedish National Infrastructure for Computing (SNIC) through Uppsala Multidisciplinary Center for Advanced Computational Science (UPPMAX) under project b2012108. The results published here are in whole or part based upon data generated by The Cancer Genome Atlas pilot project established by the National Cancer Institute and National Human Genome Research Institute (NHGRI). Information about TCGA and the investigators and institutions who constitute the TCGA research network can be found at "http://cancergenome.nih.gov". The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Banfai B, 2012, GENOME RES, V22, P1646, DOI 10.1101/gr.134767.111; Beck-Engeser GB, 2008, RETROVIROLOGY, V5, DOI 10.1186/1742-4690-5-4; Bell D, 2011, NATURE, V474, P609, DOI 10.1038/nature10166; Beroukhim R, 2010, NATURE, V463, P899, DOI 10.1038/nature08822; BRANNAN CI, 1990, MOL CELL BIOL, V10, P28, DOI 10.1128/MCB.10.1.28; BROWN CJ, 1991, NATURE, V349, P38, DOI 10.1038/349038a0; Brunner AL, 2012, GENOME BIOL, V13, DOI 10.1186/gb-2012-13-8-r75; Burge SW, 2013, NUCLEIC ACIDS RES, V41, pD226, DOI 10.1093/nar/gks1005; Cabili MN, 2011, GENE DEV, V25, P1915, DOI 10.1101/gad.17446611; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Cerami E, 2012, CANC DISCOV IN PRESS; Cesana M, 2011, CELL, V147, P358, DOI 10.1016/j.cell.2011.09.028; Clemson CM, 2009, MOL CELL, V33, P717, DOI 10.1016/j.molcel.2009.01.026; Derrien T, 2012, GENOME RES, V22, P1775, DOI 10.1101/gr.132159.111; Djebali S, 2012, NATURE, V489, P101, DOI 10.1038/nature11233; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Franco-Zorrilla JM, 2007, NAT GENET, V39, P1033, DOI 10.1038/ng2079; Getz G, 2013, NATURE, V497, P67, DOI 10.1038/nature12113; Gibb EA, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025915; Gong CG, 2011, NATURE, V470, P284, DOI 10.1038/nature09701; Guan YH, 2007, CLIN CANCER RES, V13, P5745, DOI 10.1158/1078-0432.CCR-06-2882; Gupta RA, 2010, NATURE, V464, P1071, DOI 10.1038/nature08975; Guttman M, 2010, NAT BIOTECHNOL, V28, P503, DOI 10.1038/nbt.1633; Harrow J, 2012, GENOME RES, V22, P1760, DOI 10.1101/gr.135350.111; HENDRICKSON M, 1982, AM J SURG PATHOL, V6, P93, DOI 10.1097/00000478-198203000-00002; Huppi K, 2008, MOL CANCER RES, V6, P212, DOI 10.1158/1541-7786.MCR-07-0105; Jeggari A, 2012, BIOINFORMATICS, V28, P2062, DOI 10.1093/bioinformatics/bts344; Ji P, 2003, ONCOGENE, V22, P8031, DOI 10.1038/sj.onc.1206928; Kim YS, 2010, BMC CANCER, V10, DOI 10.1186/1471-2407-10-576; Kong L, 2007, NUCLEIC ACIDS RES, V35, pW345, DOI 10.1093/nar/gkm391; Langyel E, 2010, AM J PATHOL, V177, P1053, DOI 10.2353/ajpath.2010.100105; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Li H, 2009, BIOINFORMATICS, V25, P1754, DOI 10.1093/bioinformatics/btp324; Lin MF, 2011, BIOINFORMATICS, V27, pI275, DOI 10.1093/bioinformatics/btr209; Mizuno H, 2012, BMC PLANT BIOL, V12, DOI 10.1186/1471-2229-12-121; Mohamed JS, 2010, RNA, V16, P324, DOI 10.1261/rna.1441510; Molenaar JJ, 2012, NATURE, V483, P589, DOI 10.1038/nature10910; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Muzny DM, 2012, NATURE, V487, P330, DOI 10.1038/nature11252; Myers RM, 2011, PLOS BIOL, V9, DOI 10.1371/journal.pbio.1001046; NOWELL PC, 1976, SCIENCE, V194, P23, DOI 10.1126/science.959840; Pasic I, 2010, CANCER RES, V70, P160, DOI 10.1158/0008-5472.CAN-09-1902; Prensner JR, 2011, CANCER DISCOV, V1, P391, DOI 10.1158/2159-8290.CD-11-0209; Prensner JR, 2011, NAT BIOTECHNOL, V29, P742, DOI 10.1038/nbt.1914; Quinlan AR, 2010, BIOINFORMATICS, V26, P841, DOI 10.1093/bioinformatics/btq033; Shahrouki Puja, 2012, Frontiers in Genetics, V3, P170, DOI 10.3389/fgene.2012.00170; SHTIVELMAN E, 1989, MOL CELL BIOL, V9, P1148, DOI 10.1128/MCB.9.3.1148; Solyom S, 2012, GENOME RES, V22, P2328, DOI 10.1101/gr.145235.112; Sousa JF, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013510; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Tarailo-Graovac M., 2009, CURR PROTOC BIOINFOR, V25, p4.10.11, DOI 10.1002/0471250953.bi0410s25; Tothill RW, 2008, CLIN CANCER RES, V14, P5198, DOI 10.1158/1078-0432.CCR-08-0196; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Wang F, 2008, FEBS LETT, V582, P1919, DOI 10.1016/j.febslet.2008.05.012; Wang JY, 2010, NUCLEIC ACIDS RES, V38, P5366, DOI 10.1093/nar/gkq285; Yoon JH, 2012, MOL CELL, V47, P648, DOI 10.1016/j.molcel.2012.06.027; Zhou AX, 2011, INT J CANCER, V128, P839, DOI 10.1002/ijc.25417	57	67	73	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80306	10.1371/journal.pone.0080306	http://dx.doi.org/10.1371/journal.pone.0080306			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265805	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100140
J	Chang, Q; Wei, FL; Zhang, L; Ju, XW; Zhu, LG; Huang, CL; Huang, T; Zuo, XC; Gao, CF				Chang, Qi; Wei, Fuling; Zhang, Li; Ju, Xiaowei; Zhu, Lvgang; Huang, Changlin; Huang, Tao; Zuo, Xincheng; Gao, Chunfang			Effects of Vibration in Forced Posture on Biochemical Bone Metabolism Indices, and Morphometric and Mechanical Properties of the Lumbar Vertebra	PLOS ONE			English	Article							WHOLE-BODY VIBRATION; RESISTANT ACID-PHOSPHATASE; LOW-BACK-PAIN; OSTEOPOROSIS; EXPRESSION; TURNOVER; DISEASE; MARKERS; CELLS; RISK	Epidemiological studies have shown a relatively strong association between occupational lower back pain (LBP) and long-term exposure to vibration. However, there is limited knowledge of the impact of vibration and sedentariness on bone metabolism of the lumbar vertebra and the mechanism of bone-derived LBP. The aim of this study was to investigate the effects of vibration in forced posture (a seated posture) on biochemical bone metabolism indices, and morphometric and mechanical properties of the lumbar vertebra, and provide a scientific theoretical basis for the mechanism of bone-derived LBP, serum levels of Ca2+, (HPO4)(2-), tartrate-resistant acid phosphatase (TRAP), bone-specific alkaline phosphatase (BALP), and bone gla protein (BGP), the pathological changes and biomechanics of lumbar vertebra of New Zealand white rabbits were studied. The results demonstrate that both forced posture and vibration can cause pathological changes to the lumbar vertebra, which can result in bone-derived LBP, and vibration combined with a seated posture could cause further damage to bone metabolism. Serological changes can be used as early markers for clinical diagnosis of bone-derived LBP.	[Chang, Qi; Zhang, Li; Ju, Xiaowei; Zhu, Lvgang; Huang, Changlin; Huang, Tao; Zuo, Xincheng] PLA, Hosp 150, Inst Mil Training Related Med Sci, Luoyang, Henan, Peoples R China; [Wei, Fuling] PLA, Hosp 309, Dept Cardiosurg, Luoyang, Henan, Peoples R China; [Gao, Chunfang] PLA, Hosp 150, Inst Anus & Intesine, Luoyang, Henan, Peoples R China		Gao, CF (corresponding author), PLA, Hosp 150, Inst Anus & Intesine, Luoyang, Henan, Peoples R China.	chunfanggaohn@163.com			General program of the General Logistics Department of PLA [13BJZ10]; Scientific Research Plan of the Logistics Department of Jinan Military Region [JN11L035]	General program of the General Logistics Department of PLA; Scientific Research Plan of the Logistics Department of Jinan Military Region	This research was funded by the General program of the General Logistics Department of PLA (grant number: 13BJZ10) and the Scientific Research Plan of the Logistics Department of Jinan Military Region (grant number: JN11L035). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2003, VET CLIN PATH, V32, P101, DOI 10.1111/j.1939-165X.2003.tb00323.x; Balague F, 2012, LANCET, V379, P482, DOI 10.1016/S0140-6736(11)60610-7; Calvo MS, 1996, ENDOCR REV, V17, P333, DOI 10.1210/er.17.4.333; DEFTOS LJ, 1991, HORM METAB RES, V23, P559, DOI 10.1055/s-2007-1003752; Frymoyer J W, 1992, Instr Course Lect, V41, P217; Gomez-Cabello A, 2012, SPORTS MED, V42, P301, DOI 10.2165/11597670-000000000-00000; Gomez-Cabello A., 2013, J SCI MED SPORT; Gunther T, 2011, MAGNESIUM RES, V24, P223, DOI 10.1684/mrh.2011.0297; Hadjidakis DJ, 2006, ANN NY ACAD SCI, V1092, P385, DOI 10.1196/annals.1365.035; Hollberg K, 2005, J BONE MINER METAB, V23, P441, DOI 10.1007/s00774-005-0626-3; KASAI R, 1994, BONE MINER, V25, P167, DOI 10.1016/S0169-6009(08)80237-1; Liang HD, 2013, MOL BIOL REP, V40, P757, DOI 10.1007/s11033-012-2065-2; Magora A, 1970, IMS Ind Med Surg, V39, P504; Milosavljevic S, 2012, ANN OCCUP HYG, V56, P10, DOI 10.1093/annhyg/mer068; Murgia N, 2012, G Ital Med Lav Ergon, V34, P310; Murtezani Ardiana, 2011, Folia Med (Plovdiv), V53, P68; Oddie GW, 2000, BONE, V27, P575, DOI 10.1016/S8756-3282(00)00368-9; Okunribido OO, 2008, ERGONOMICS, V51, P308, DOI 10.1080/00140130701637262; Palmer KT, 2012, SCANDINAVIAN J WORK; Shelerud Randy A, 2006, Clin Occup Environ Med, V5, P501; Teschke K., 1999, OCCUPATIONAL HYGIENE, V6, p1Z3; Verborgt O, 2000, J BONE MINER RES, V15, P60, DOI 10.1359/jbmr.2000.15.1.60; Videman T, 1999, SPINE, V24, P1164, DOI 10.1097/00007632-199906010-00020; Wang Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0053158; Wang Yu-Han, 2013, Shengli Xuebao, V65, P165; Waters T, 2008, ERGONOMICS, V51, P602, DOI 10.1080/00140130701779197; Williford AL, 2008, NEONATAL NETW, V27, P57, DOI 10.1891/0730-0832.27.1.57; Yi HL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030807; You L, 2011, J INT MED RES, V39, P302, DOI 10.1177/147323001103900133	29	3	4	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78640	10.1371/journal.pone.0078640	http://dx.doi.org/10.1371/journal.pone.0078640			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265702	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100035
J	Ellis, LC; Norton, E; Dang, X; Koralnik, IJ				Ellis, Laura C.; Norton, Elizabeth; Dang, Xin; Koralnik, Igor J.			Agnogene Deletion in a Novel Pathogenic JC Virus Isolate Impairs VP1 Expression and Virion Production	PLOS ONE			English	Article							PROGRESSIVE MULTIFOCAL LEUKOENCEPHALOPATHY; GRANULE CELL NEURONOPATHY; POLYOMAVIRUS JC; REGULATORY AGNOPROTEIN; INFECTION; REPLICATION; PROTEIN; DNA; TRANSCRIPTION; MUTANTS	Infection of glial cells by the human polyomavirus JC (JCV) causes progressive multifocal leukoencephalopathy (PML). JCV Encephalopathy (JCVE) is a newly identified disease characterized by JCV infection of cortical pyramidal neurons. The virus JCV(CPN) associated with JCVE contains a unique 143 base pair deletion in the agnogene. Contrary to most JCV brain isolates, JCV(CPN) has an archetype-like regulatory region (RR) usually found in kidney strains. This provided us with the unique opportunity to determine for the first time how each of these regions contributed to the phenotype of JCV(CPN). We characterized the replication of JCV(CPN) compared to the prototype virus JCV(Mad-1) in kidney, glial and neuronal cell lines. We found that JCV(CPN) is capable of replicating viral DNA in all cell lines tested, but is unable to establish persistent infection seen with JCV(Mad-1). JCV(CPN) does not have an increased ability to replicate in the neuronal cell line tested. To determine whether this phenotype results from the archetype-like RR or the agnogene deletion, we generated chimeric viruses between JCV(CPN) of JCV(Mad-1). We found that the deletion in the agnogene is the predominant cause of the inability of the virus to maintain a persistent infection, with the introduction of a full length agnogene, either with or without agnoprotein expression, rescues the replication of JCV(CPN). Studying this naturally occurring pathogenic variant of JCV provides a valuable tool for understanding the functions of the agnogene and RR form in JCV replication.	[Ellis, Laura C.; Norton, Elizabeth; Dang, Xin; Koralnik, Igor J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Neurovirol,Dept Neurol, Boston, MA 02215 USA; [Ellis, Laura C.; Norton, Elizabeth; Dang, Xin; Koralnik, Igor J.] Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Ctr Virol & Vaccine Res,Dept Med, Boston, MA 02215 USA; [Ellis, Laura C.] Harvard Univ, Sch Med, Harvard Program Virol, Boston, MA 02215 USA	Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School; Harvard University; Harvard Medical School	Koralnik, IJ (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Div Neurovirol,Dept Neurol, Boston, MA 02215 USA.	ikoralni@bidmc.harvard.edu			NIH [R01 NS 074995, 047029, K24 NS 060950]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K24NS060950, R01NS074995] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This study was supported in part by NIH grants R01 NS 074995 and 047029 and K24 NS 060950 to IJK; grants.nih.gov. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akan I, 2006, VIROLOGY, V349, P66, DOI 10.1016/j.virol.2006.01.025; Ault GS, 1997, J GEN VIROL, V78, P163, DOI 10.1099/0022-1317-78-1-163; BERGER JR, 1987, ANN INTERN MED, V107, P78, DOI 10.7326/0003-4819-107-1-78; Dang X, 2006, J GEN VIROL, V87, P2533, DOI 10.1099/vir.0.81945-0; Dang X, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035793; Dang X, 2012, J GEN VIROL, V93, P175, DOI 10.1099/vir.0.037440-0; Du Pasquier RA, 2003, NEUROLOGY, V61, P775, DOI 10.1212/01.WNL.0000081306.86961.33; Ferenczy MW, 2012, CLIN MICROBIOL REV, V25, P471, DOI 10.1128/CMR.05031-11; FRISQUE RJ, 1984, J VIROL, V51, P458, DOI 10.1128/JVI.51.2.458-469.1984; Gheuens S, 2013, ANNU REV PATHOL-MECH, V8, P189, DOI 10.1146/annurev-pathol-020712-164018; GLUZMAN Y, 1981, CELL, V23, P175, DOI 10.1016/0092-8674(81)90282-8; Hecht JH, 2007, PEDIATR NEUROL, V36, P186, DOI 10.1016/j.pediatrneurol.2006.10.007; Jensen PN, 2001, J NEUROVIROL, V7, P280; Khalili K, 2005, J CELL PHYSIOL, V204, P1, DOI 10.1002/jcp.20266; Knowles WA, 2003, J MED VIROL, V71, P115, DOI 10.1002/jmv.10450; Koralnik IJ, 2005, ANN NEUROL, V57, P576, DOI 10.1002/ana.20431; MAJOR EO, 1985, P NATL ACAD SCI USA, V82, P1257, DOI 10.1073/pnas.82.4.1257; Molloy ES, 2009, ARTHRITIS RHEUM-US, V60, P3761, DOI 10.1002/art.24966; Safak M, 2001, J VIROL, V75, P1476, DOI 10.1128/JVI.75.3.1476-1486.2001; Safak M, 2002, J VIROL, V76, P3828, DOI 10.1128/JVI.76.8.3828-3838.2002; Saribas AS, 2013, VIROLOGY, V443, P161, DOI 10.1016/j.virol.2013.05.003; Saribas AS, 2012, VIROLOGY, V433, P12, DOI 10.1016/j.virol.2012.06.017; Saribas AS, 2011, VIROLOGY, V420, P51, DOI 10.1016/j.virol.2011.08.015; Sariyer IK, 2006, J VIROL, V80, P3893, DOI 10.1128/JVI.80.8.3893-3903.2006; Sariyer IK, 2008, VIROLOGY, V375, P464, DOI 10.1016/j.virol.2008.02.020; Sariyer IK, 2011, VIROL J, V8, DOI 10.1186/1743-422X-8-255; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Shimizu N, 1999, INTERNAL MED, V38, P932, DOI 10.2169/internalmedicine.38.932; Suzuki T, 2012, MICROBIOL IMMUNOL, V56, P639, DOI 10.1111/j.1348-0421.2012.00484.x; Suzuki T, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000801; Tan CS, 2010, J VIROL, V84, P9200, DOI 10.1128/JVI.00609-10; Tan CS, 2010, LANCET NEUROL, V9, P425, DOI 10.1016/S1474-4422(10)70040-5; TUMILOWICZ JJ, 1970, CANCER RES, V30, P2110; Weber T, 1997, J INFECT DIS, V176, P250, DOI 10.1086/514032; Wuthrich C, 2012, J NEUROPATH EXP NEUR, V71, P54, DOI 10.1097/NEN.0b013e31823ede59; Wuthrich C, 2009, ANN NEUROL, V65, P742, DOI 10.1002/ana.21619; Wuethrich C, 2009, J NEUROPATH EXP NEUR, V68, P15, DOI 10.1097/NEN.0b013e3181912570	37	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80840	10.1371/journal.pone.0080840	http://dx.doi.org/10.1371/journal.pone.0080840			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265839	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100175
J	Hwang, JA; Kim, Y; Hong, SH; Lee, J; Cho, YG; Han, JY; Kim, YH; Han, J; Shim, YM; Lee, YS; Kim, DH				Hwang, Jung-Ah; Kim, Yujin; Hong, Seung-Hyun; Lee, Jieun; Cho, Yong Gu; Han, Ji-Youn; Kim, Young-Ho; Han, Joungho; Shim, Young Mog; Lee, Yeon-Su; Kim, Duk-Hwan			Epigenetic Inactivation of Heparan Sulfate (Glucosamine) 3-O-Sulfotransferase 2 in Lung Cancer and Its Role in Tumorigenesis	PLOS ONE			English	Article							GROWTH-FACTOR; ABERRANT METHYLATION; DNA METHYLATION; PROMOTER METHYLATION; COLORECTAL-CANCER; GENES; BIOSYNTHESIS; P16(INK4A); COOPERATE; DIVERSITY	Background: This study was aimed at investigating the functional significance of heparan sulfate (glucosamine) 3-O-sulfotransferase 2 (HS3ST2) hypermethylation in non-small cell lung cancer (NSCLC). Methodology/Principal Findings : HS3ST2 hypermethylation was characterized in six lung cancer cell lines, and its clinical significance was analyzed using 298 formalin-fixed paraffin-embedded tissues and 26 fresh-frozen tissues from 324 NSCLC patients. MS-HRM (methylation-specific high-resolution melting) and EpiTYPER(TM) assays showed substantial hypermethylation of CpG island at the promoter region of HS3ST2 in six lung cancer cell lines. The silenced gene was demethylated and re-expressed by treatment with 5-aza-2'-deoxycytidine (5-Aza-dC). A promoter assay also showed the core promoter activity of HS3ST2 was regulated by methylation. Exogenous expression of HS3ST2 in lung cancer cells H460 and H23 inhibited cell migration, invasion, cell proliferation and whereas knockdown of HS3ST2 in NHBE cells induced cell migration, invasion, and cell proliferation in vitro. A negative correlation was observed between mRNA and methylation levels of HS3ST2 in 26 fresh-frozen tumors tissues (rho = -0.51, P = 0.009; Spearman's rank correlation). HS3ST2 hypermethylation was found in 95 (32%) of 298 primary NSCLCs. Patients with HS3ST2 hypermethylation in 193 node-negative stage I-II NSCLCs with a median follow-up period of 5.8 years had poor overall survival (hazard ratio = 2.12, 95% confidence interval = 1.25-3.58, P = 0.005) compared to those without HS3ST2 hypermethylation, after adjusting for age, sex, tumor size, adjuvant therapy, recurrence, and differentiation. Conclusions/Significance: The present study suggests that HS3ST2 hypermethylation may be an independent prognostic indicator for overall survival in node-negative stage I-II NSCLC.	[Hwang, Jung-Ah; Hong, Seung-Hyun; Lee, Jieun; Cho, Yong Gu; Lee, Yeon-Su] Natl Canc Ctr, Res Inst, Canc Genom Branch, Goyang Si, South Korea; [Kim, Yujin; Kim, Duk-Hwan] Sungkyunkwan Univ, Sch Med, Samsung Biomed Res Inst, Dept Mol Cell Biol, Suwon, South Korea; [Han, Ji-Youn] Natl Canc Ctr, Ctr Lung Canc, Goyang Si, South Korea; [Kim, Young-Ho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Internal Med, Seoul, South Korea; [Han, Joungho] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Pathol, Seoul, South Korea; [Shim, Young Mog] Sungkyunkwan Univ, Sch Med, Samsung Med Ctr, Dept Thorac & Cardiovasc Surg, Seoul, South Korea	National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); National Cancer Center - Korea (NCC); Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center; Sungkyunkwan University (SKKU); Samsung Medical Center	Lee, YS (corresponding author), Natl Canc Ctr, Res Inst, Canc Genom Branch, Goyang Si, South Korea.	yslee2@ncc.re.kr; dukhwan.kim@samsung.com			National Cancer Center [NCC 1110140-1, 1110100-2]; Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea [A084947AA202308N100010A]; National Research Foundation of Korea (NRF); Korea government (MEST), Republic of Korea [2011-0029138]	National Cancer Center; Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea; National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korea government (MEST), Republic of Korea(Ministry of Education, Science & Technology (MEST), Republic of KoreaKorean Government)	This work was supported by grants from the National Cancer Center (NCC 1110140-1 and 1110100-2), the Korea Healthcare technology R&D Project, Ministry for Health, Welfare & Family Affairs, Republic of Korea. (A084947AA202308N100010A), and the National Research Foundation of Korea (NRF) grant funded by the Korea government (MEST) (No. 2011-0029138), Republic of Korea. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	American Joint Committee on Cancer, 2010, AJCC CANC STAGING MA, P253; Belinsky SA, 2002, CANCER RES, V62, P2370; Belinsky SA, 1996, P NATL ACAD SCI USA, V93, P4045, DOI 10.1073/pnas.93.9.4045; Bernal C, 2008, CLIN CANCER RES, V14, P6264, DOI 10.1158/1078-0432.CCR-07-4522; Carlsson P, 2008, J BIOL CHEM, V283, P20008, DOI 10.1074/jbc.M801652200; Dietrich D, 2009, J HISTOCHEM CYTOCHEM, V57, P477, DOI 10.1369/jhc.2009.953026; Esko JD, 2001, J CLIN INVEST, V108, P169, DOI 10.1172/JCI200113530; Fatemi M, 2002, EUR J BIOCHEM, V269, P4981, DOI 10.1046/j.1432-1033.2002.03198.x; Gonzalo V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008777; Hagner-McWhirter A, 2004, J BIOL CHEM, V279, P14631, DOI 10.1074/jbc.M313760200; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kim DH, 2001, CANCER RES, V61, P3419; Kim JS, 2006, CANCER RES, V66, P4049, DOI 10.1158/0008-5472.CAN-05-3813; Kim JS, 2005, CANCER, V104, P1825, DOI 10.1002/cncr.21409; Lim EH, 2010, GYNECOL ONCOL, V119, P225, DOI 10.1016/j.ygyno.2010.07.028; Lindahl U, 1998, J BIOL CHEM, V273, P24979, DOI 10.1074/jbc.273.39.24979; LYON M, 1994, J BIOL CHEM, V269, P11216; Mahapatra S, 2012, CLIN CANCER RES, V18, P2882, DOI 10.1158/1078-0432.CCR-11-2090; Martin-Subero JI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006986; Miyamoto K, 2003, ONCOGENE, V22, P274, DOI 10.1038/sj.onc.1206146; Ostrovsky O, 2002, J BIOL CHEM, V277, P2444, DOI 10.1074/jbc.M108540200; Pellegrini L, 2001, CURR OPIN STRUC BIOL, V11, P629, DOI 10.1016/S0959-440X(00)00258-X; Rhee I, 2002, NATURE, V416, P552, DOI 10.1038/416552a; Robinson CJ, 2001, J CELL SCI, V114, P853; Shivapurkar N, 2007, GYNECOL ONCOL, V107, P549, DOI 10.1016/j.ygyno.2007.08.057; Shworak NW, 1999, J BIOL CHEM, V274, P5170, DOI 10.1074/jbc.274.8.5170; Swafford DS, 1997, MOL CELL BIOL, V17, P1366, DOI 10.1128/MCB.17.3.1366; Tokuyama Y, 2010, ANTICANCER RES, V30, P4811; Weisenberger DJ, 2005, NUCLEIC ACIDS RES, V33, P6823, DOI 10.1093/nar/gki987	29	35	35	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79634	10.1371/journal.pone.0079634	http://dx.doi.org/10.1371/journal.pone.0079634			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265783	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100116
J	Liu, MB; Xu, SR; He, Y; Deng, GH; Sheng, HF; Huang, XM; Ouyang, CY; Zhou, HW				Liu, Mu-Biao; Xu, Su-Rong; He, Yan; Deng, Guan-Hua; Sheng, Hua-Fang; Huang, Xue-Mei; Ouyang, Cai-Yan; Zhou, Hong-Wei			Diverse Vaginal Microbiomes in Reproductive-Age Women with Vulvovaginal Candidiasis	PLOS ONE			English	Article							GRAM STAIN; FLORA	Vulvovaginal candidiasis (VVC) is one of the most prevalent vaginal infectious diseases, and there are controversial reports regarding the diversity of the associated vaginal microbiota. We determined the vaginal microbial community in patients with VVC, bacterial vaginosis (BV), and mixed infection of VVC and BV using Illumina sequencing of 16S rRNA tags. Our results revealed for the first time the highly variable patterns of the vaginal microbiome from VVC patients. In general, the alpha-diversity results of species richness and evenness showed the following order: normal control, VVC only, mixed BV and VVC infection, BV only. The beta-diversity comparison of community structures also showed an intermediate composition of VVC between the control and BV samples. A detailed comparison showed that, although the control and BV communities had typical patterns, the vaginal microbiota of VVC is complex. The mixed BV and VVC infection group showed a unique pattern, with a relatively higher abundance of Lactobacillus than the BV group and higher abundance of Prevotella, Gardnerella, and Atopobium than the normal control. In contrast, the VVC-only group could not be described by any single profile, ranging from a community structure similar to the normal control (predominated with Lactobacillus) to BV-like community structures (abundant with Gardnerella and Atopobium). Treatment of VVC resulted in inconsistent changes of the vaginal microbiota, with four BV/VVC samples recovering to a higher Lactobacillus level, whereas many VVC-only patients did not. These results will be useful for future studies on the role of vaginal microbiota in VVC and related infectious diseases.	[Liu, Mu-Biao; Xu, Su-Rong; Huang, Xue-Mei; Ouyang, Cai-Yan] Southern Med Univ, Zhujiang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China; [He, Yan; Deng, Guan-Hua; Sheng, Hua-Fang; Zhou, Hong-Wei] Southern Med Univ, Sch Publ Hlth & Trop Med, Dept Environm Hlth, Microbial Ecol Lab, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China; Southern Medical University - China	Liu, MB (corresponding author), Southern Med Univ, Zhujiang Hosp, Dept Obstet & Gynecol, Guangzhou, Guangdong, Peoples R China.	lmbdhj@gmail.com; biodegradation@gmail.com	Zhou, Hongwei/B-4193-2008	He, Yan/0000-0002-6611-2959	National Natural Science Foundation of China [NSFC 31270152, 31322003]; Program for New Century Excellent Talents in University [NCET-11-0921]; Guangdong Natural Science Foundation [S2011010004136]; Educational Commission of Guangdong Province, China [2012KJCX0031]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province); Educational Commission of Guangdong Province, China	This work was supported by National Natural Science Foundation of China (NSFC 31270152, 31322003), Program for New Century Excellent Talents in University (NCET-11-0921), Guangdong Natural Science Foundation (S2011010004136), and Educational Commission of Guangdong Province, China (2012KJCX0031). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AMSEL R, 1983, AM J MED, V74, P14, DOI 10.1016/0002-9343(83)91112-9; Bradford LL, 2013, CURRENT FUNGAL INFEC, P1; Edgar RC, 2011, BIOINFORMATICS, V27, P2194, DOI 10.1093/bioinformatics/btr381; Fettweis JM, 2012, CHEM BIODIVERS, V9, P965, DOI 10.1002/cbdv.201100359; Gajer P, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003605; HILLIER SL, 1992, AM J OBSTET GYNECOL, V166, P938, DOI 10.1016/0002-9378(92)91368-K; Huse SM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000255; Hyman RW, 2005, P NATL ACAD SCI USA, V102, P7952, DOI 10.1073/pnas.0503236102; Ilkit M, 2011, CRIT REV MICROBIOL, V37, P250, DOI 10.3109/1040841X.2011.576332; Jiang XT, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030230; Lamont RF, 2011, BJOG-INT J OBSTET GY, V118, P533, DOI 10.1111/j.1471-0528.2010.02840.x; Ling ZX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-488; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Ma B, 2012, ANNU REV MICROBIOL, V66, P371, DOI 10.1146/annurev-micro-092611-150157; McClelland RS, 2009, J INFECT DIS, V199, P1883, DOI 10.1086/599213; NUGENT RP, 1991, J CLIN MICROBIOL, V29, P297, DOI 10.1128/JCM.29.2.297-301.1991; Pepin J, 2012, PLOS ONE, V6; Pirotta MV, 2003, MED J AUSTRALIA, V179, P43, DOI 10.5694/j.1326-5377.2003.tb05418.x; Ravel J, 2011, P NATL ACAD SCI USA, V108, P4680, DOI 10.1073/pnas.1002611107; Segata N, 2011, GENOME BIOL, V12, DOI 10.1186/gb-2011-12-6-r60; Shipitsyna E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060670; SIEGLER SL, 1946, AM J OBSTET GYNECOL, V52, P1; Sobel JD, 2007, LANCET, V369, P1961, DOI 10.1016/S0140-6736(07)60917-9; Sobel JD, 1996, J CLIN MICROBIOL, V34, P2497, DOI 10.1128/JCM.34.10.2497-2499.1996; Srinivasan S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037818; Swidsinski A, 2010, ANAEROBE, V16, P478, DOI 10.1016/j.anaerobe.2010.06.011; White BA, 2011, TRENDS ENDOCRIN MET, V22, P389, DOI 10.1016/j.tem.2011.06.001; Wilson BA, 2011, METAGENOMICS OF THE HUMAN BODY, P91; Zhou HW, 2011, ISME J, V5, P741, DOI 10.1038/ismej.2010.160; Zhou X, 2009, INFECT IMMUN, V77, P4130, DOI 10.1128/IAI.00436-09	30	86	99	1	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79812	10.1371/journal.pone.0079812	http://dx.doi.org/10.1371/journal.pone.0079812			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265786	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100119
J	Naumann, J; Salomo, K; Der, JP; Wafula, EK; Bolin, JF; Maass, E; Frenzke, L; Samain, MS; Neinhuis, C; dePamphilis, CW; Wanke, S				Naumann, Julia; Salomo, Karsten; Der, Joshua P.; Wafula, Eric K.; Bolin, Jay F.; Maass, Erika; Frenzke, Lena; Samain, Marie-Stephanie; Neinhuis, Christoph; dePamphilis, Claude W.; Wanke, Stefan			Single-Copy Nuclear Genes Place Haustorial Hydnoraceae within Piperales and Reveal a Cretaceous Origin of Multiple Parasitic Angiosperm Lineages	PLOS ONE			English	Article							FLOWERING PLANTS; PHYLOGENETIC INFERENCE; PLASTID GENOME; EVOLUTION; CLASSIFICATION; BIOGEOGRAPHY; CYNOMORIUM; LIKELIHOOD; INTERFACE; RADIATION	Extreme haustorial parasites have long captured the interest of naturalists and scientists with their greatly reduced and highly specialized morphology. Along with the reduction or loss of photosynthesis, the plastid genome often decays as photosynthetic genes are released from selective constraint. This makes it challenging to use traditional plastid genes for parasitic plant phylogenetics, and has driven the search for alternative phylogenetic and molecular evolutionary markers. Thus, evolutionary studies, such as molecular clock-based age estimates, are not yet available for all parasitic lineages. In the present study, we extracted 14 nuclear single copy genes (nSCG) from Illumina transcriptome data from one of the "strangest plants in the world", Hydnora visseri (Hydnoraceae). A,15,000 character molecular dataset, based on all three genomic compartments, shows the utility of nSCG for reconstructing phylogenetic relationships in parasitic lineages. A relaxed molecular clock approach with the same multi-locus dataset, revealed an ancient age of similar to 91 MYA for Hydnoraceae. We then estimated the stem ages of all independently originated parasitic angiosperm lineages using a published dataset, which also revealed a Cretaceous origin for Balanophoraceae, Cynomoriaceae and Apodanthaceae. With the exception of Santalales, older parasite lineages tend to be more specialized with respect to trophic level and have lower species diversity. We thus propose the "temporal specialization hypothesis" (TSH) implementing multiple independent specialization processes over time during parasitic angiosperm evolution.	[Naumann, Julia; Salomo, Karsten; Frenzke, Lena; Neinhuis, Christoph; Wanke, Stefan] Tech Univ Dresden, Inst Bot, D-01062 Dresden, Germany; [Der, Joshua P.; Wafula, Eric K.; dePamphilis, Claude W.] Penn State Univ, Dept Biol, University Pk, PA 16802 USA; [Der, Joshua P.; Wafula, Eric K.; dePamphilis, Claude W.] Penn State Univ, Inst Mol Evolutionary Genet, University Pk, PA 16802 USA; [Bolin, Jay F.] Catawba Coll, Dept Biol, Salisbury, NC USA; [Maass, Erika] Univ Namibia, Dept Biol Sci, Windhoek, Namibia; [Samain, Marie-Stephanie] Ctr Reg Bajio, AC, Inst Ecol, Patzcuaro, Michoacan, Mexico	Technische Universitat Dresden; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Pennsylvania State University - University Park; University of Namibia; Instituto de Ecologia - Mexico	Naumann, J (corresponding author), Tech Univ Dresden, Inst Bot, D-01062 Dresden, Germany.	julia.naumann@tu-dresden.de; stefan.wanke@tu-dresden.de	dePamphilis, Claude W/P-6652-2016; Wanke, Stefan/G-5860-2011; Der, Joshua P/F-9551-2012; Neinhuis, Christoph/AAT-9137-2020; Samain, Marie-Stephanie/A-2316-2015	Der, Joshua P/0000-0001-9668-2525; Neinhuis, Christoph/0000-0001-9965-4394; Samain, Marie-Stephanie/0000-0002-7530-9024; Wanke, Stefan/0000-0001-5405-5216	DAAD (German Academic Exchange Service); Parasitic Plant Genome Project Grant [0701748]; TU Dresden as a "starting grant"; DFG [NE 681/11-1]; Direct For Biological Sciences [0829868] Funding Source: National Science Foundation	DAAD (German Academic Exchange Service)(Deutscher Akademischer Austausch Dienst (DAAD)); Parasitic Plant Genome Project Grant; TU Dresden as a "starting grant"; DFG(German Research Foundation (DFG)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	This study received financial support by the DAAD (German Academic Exchange Service) for a postdoctoral scholarship to SW, as well as the Parasitic Plant Genome Project Grant (P. P. G. P., U. S. N.S. F IOS #0701748) to Jim Westwood, CWD, Mike Timko, and John Yoder, additional funding was provided by the TU Dresden as a "starting grant" to SW and by the DFG Piperales project to SW, CN and Nick Rowe (NE 681/11-1). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ayres DL, 2012, SYST BIOL, V61, P170, DOI [10.1093/sysbio/syr100, 10.1093/sysbio/sys029]; Barkman TJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-248; Bendiksby M, 2010, MOL PHYLOGENET EVOL, V57, P620, DOI 10.1016/j.ympev.2010.08.005; Bolin JF, 2011, SYST BOT, V36, P255, DOI 10.1600/036364411X569453; Bolin JF, 2009, INT J PLANT SCI, V170, P157, DOI 10.1086/593047; Bremer K, 2004, SYST BIOL, V53, P496, DOI 10.1080/10635150490445913; Bromham L, 2013, BMC EVOL BIOL, V13, DOI 10.1186/1471-2148-13-126; Clarke JT, 2011, NEW PHYTOL, V192, P266, DOI 10.1111/j.1469-8137.2011.03794.x; COHEN LI, 1954, AM J BOT, V41, P840, DOI 10.2307/2438552; Colles A, 2009, ECOL LETT, V12, P849, DOI 10.1111/j.1461-0248.2009.01336.x; Davis CC, 2005, AM NAT, V165, pE36, DOI 10.1086/428296; Davis CC, 2007, SCIENCE, V315, P1812, DOI 10.1126/science.1135260; DEPAMPHILIS CW, 1990, NATURE, V348, P337, DOI 10.1038/348337a0; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Duarte JM, 2010, BMC EVOL BIOL, V10, DOI 10.1186/1471-2148-10-61; Friis E. M., 2011, EARLY FLOWERS ANGIOS; Friis EM, 2004, P NATL ACAD SCI USA, V101, P16565, DOI 10.1073/pnas.0407174101; Gamerro JC, 2008, BOT J LINN SOC, V158, P41, DOI 10.1111/j.1095-8339.2008.00860.x; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Granados Mendoza C, 2013, MOL PHYLOGENET EVOL, V66, P233, DOI 10.1016/j.ympev.2012.09.029; Hardy NB, 2012, AM NAT, V180, P438, DOI 10.1086/667588; Haston E, 2009, BOT J LINN SOC, V161, P128, DOI 10.1111/j.1095-8339.2009.00996.x; Honaas LA, 2013, BMC PLANT BIOL, V13, DOI 10.1186/1471-2229-13-9; Jian SG, 2008, SYST BIOL, V57, P38, DOI 10.1080/10635150801888871; Jiao YN, 2011, NATURE, V473, P97, DOI 10.1038/nature09916; KUIJT J., 1969, The biology of parasitic flowering plants. University of California Press, Berkeley.; Lemaire B, 2011, J PLANT RES, V124, P561, DOI 10.1007/s10265-010-0395-5; Linder HP, 2005, MOL PHYLOGENET EVOL, V35, P569, DOI 10.1016/j.ympev.2004.12.006; Maddison WP, 2009, MESQUITE MODULAR SYS; McNeal JR, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-55; McNeal JR, 2013, AM J BOT, V100, P971, DOI 10.3732/ajb.1200448; Mohr BAR, 2004, INT J PLANT SCI, V165, P1121, DOI 10.1086/423879; MULLER J, 1981, BOT REV, V47, P1, DOI 10.1007/BF02860537; Muller J., 2006, PHYDE PHYLOGENETIC D; Muller K, 2004, PLANT BIOLOGY, V6, P477, DOI 10.1055/s-2004-817909; Muller Kai, 2005, Appl Bioinformatics, V4, P65; MUSSELMAN L J, 1989, Aliso, V12, P317; Naumann J, 2011, BMC EVOL BIOL, V11, DOI 10.1186/1471-2148-11-357; Neinhuis C, 2005, PLANT SYST EVOL, V250, P7, DOI 10.1007/s00606-004-0217-0; Nickrent DL, 2010, TAXON, V59, P538, DOI 10.1002/tax.592019; Nickrent DL, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-38; NICKRENT DL, 1994, J MOL EVOL, V39, P62; Nickrent DL, 2004, BMC EVOL BIOL, V4, DOI 10.1186/1471-2148-4-40; Nickrent DL, 2002, AM J BOT, V89, P1809, DOI 10.3732/ajb.89.11.1809; Nickrent DL, 1997, PLANT MOL BIOL, V34, P717, DOI 10.1023/A:1005860632601; Posada D, 2008, MOL BIOL EVOL, V25, P1253, DOI 10.1093/molbev/msn083; Rambaut A., 2007, TRACER V1 5; Richardson JE, 2004, PHILOS T R SOC B, V359, P1495, DOI 10.1098/rstb.2004.1537; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Salazar J, 2008, BOT REV, V74, P103, DOI 10.1007/s12229-008-9002-z; Samain MS, 2008, TAXON, V57, P583, DOI 10.2307/25066024; Schneeweiss GM, 2007, J EVOLUTION BIOL, V20, P471, DOI 10.1111/j.1420-9101.2006.01273.x; Stadler T, 2009, J THEOR BIOL, V261, P58, DOI 10.1016/j.jtbi.2009.07.018; Stamatakis A, 2006, BIOINFORMATICS, V22, P2688, DOI 10.1093/bioinformatics/btl446; STEVENS PF, 2001, ANGIOSPERM PHYLOGENY; Stover BC, 2010, BMC BIOINFORMATICS, V11, DOI 10.1186/1471-2105-11-7; STRATHMANN RR, 1983, PALEOBIOLOGY, V9, P97, DOI 10.1017/S009483730000748X; Swofford D. L., 2003, PAUP PHYLOGENETIC AN; Tennakoon KU, 2007, AM J BOT, V94, P1439, DOI 10.3732/ajb.94.9.1439; Thompson JN, 1994, COEVOLUTIONARY PROCE; Vidal-Russell R, 2008, MOL PHYLOGENET EVOL, V47, P523, DOI 10.1016/j.ympev.2008.01.016; Vidal-Russell R, 2007, SYST BOT, V32, P560, DOI 10.1600/036364407782250643; Visser JH, 1986, VELD FLORA, V71, P109; Wagner ST, 2012, AM J BOT, V99, P1609, DOI 10.3732/ajb.1200244; Wall PK, 2008, NUCLEIC ACIDS RES, V36, pD970, DOI 10.1093/nar/gkm972; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Wanke S, 2007, ANN BOT-LONDON, V99, P1231, DOI 10.1093/aob/mcm063; Wanke S, 2007, MOL PHYLOGENET EVOL, V42, P477, DOI 10.1016/j.ympev.2006.07.007; Westwood JH, 2010, TRENDS PLANT SCI, V15, P227, DOI 10.1016/j.tplants.2010.01.004; Wicke S., 2013, PARASITIC OROBANCHAC, P267, DOI DOI 10.1007/978-3-642-38146-1_15; Wicke S, 2011, PLANT MOL BIOL, V76, P273, DOI 10.1007/s11103-011-9762-4; Wikstrom N, 2001, P ROY SOC B-BIOL SCI, V268, P2211, DOI 10.1098/rspb.2001.1782; Wolfe AD, 2005, FOLIA GEOBOT, V40, P115, DOI 10.1007/BF02803229; Yang Y, 2012, MOL PHYLOGENET EVOL, V62, P214, DOI [10.1016/j.ympev.2011.09.018, 10.1016/j.ympev.2011.04.008]; ZAVADA MS, 1987, AM J BOT, V74, P1590, DOI 10.2307/2444053; Zhang N, 2012, NEW PHYTOL, V195, P923, DOI 10.1111/j.1469-8137.2012.04212.x; Zhang ZH, 2009, J SYST EVOL, V47, P297, DOI 10.1111/j.1759-6831.2009.00035.x	77	72	73	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79204	10.1371/journal.pone.0079204	http://dx.doi.org/10.1371/journal.pone.0079204			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265760	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100093
J	Paraskevis, D; Nikolopoulos, G; Fotiou, A; Tsiara, C; Paraskeva, D; Sypsa, V; Lazanas, M; Gargalianos, P; Psichogiou, M; Skoutelis, A; Wiessing, L; Friedman, SR; des Jarlais, DC; Terzidou, M; Kremastinou, J; Malliori, M; Hatzakis, A				Paraskevis, Dimitrios; Nikolopoulos, Georgios; Fotiou, Anastasios; Tsiara, Chrissa; Paraskeva, Dimitra; Sypsa, Vana; Lazanas, Marios; Gargalianos, Panagiotis; Psichogiou, Mina; Skoutelis, Athanasios; Wiessing, Lucas; Friedman, Samuel R.; des Jarlais, Don C.; Terzidou, Manina; Kremastinou, Jenny; Malliori, Meni; Hatzakis, Angelos			Economic Recession and Emergence of an HIV-1 Outbreak among Drug Injectors in Athens Metropolitan Area: A Longitudinal Study	PLOS ONE			English	Article							EPIDEMIC; PEOPLE; GREECE; PREVALENCE; COVERAGE; CRISIS; HEALTH; USERS	Background: During 2011, a dramatic increase (1600%) of reported HIV-1 infections among injecting drug users (IDUs) was noted in Athens, Greece. We herein assess the potential causal pathways associated with this outbreak. Methods: Our study employed high resolution HIV-1 phylogenetic and phylogeographic analyses. We examined also longitudinal data of ecological variables such as the annual growth of gross domestic product (GDP) of Greece in association with HIV-1 and HCV sentinel prevalence in IDUs, unemployment and homelessness rates and HIV transmission networks in Athens IDUs before and during economic recession (2008-2012). Results: IDU isolates sampled in 2011 and 2012 suggested transmission networks in 94.6% and 92.7% of the cases in striking contrast with the sporadic networking (5%) during 1998-2009. The geographic origin of most HIV-1 isolates was consistent with the recently documented migratory waves in Greece. The decline in GDP was inversely correlated with annual prevalence rates of HIV and HCV and with unemployment and homelessness rates in IDUs (all p<0.001). The slope of anti-HCV prevalence in the sentinel populations of IDUs and in "new'' drug injectors was found 120 and 1.9-fold (p = 0.007, p = 0.08 respectively) higher in 2008-2012 (economic recession) compared with 2002-2006. The median (25th, 75th) size of transmission networks were 34 (12, 58) and 2 (2, 2) (p = 0.057) in 2008-2012 and 1998-2007, respectively. The coverage of harm reduction services was low throughout the study period. Conclusions: Scaling-up harm reduction services and addressing social and structural factors related to the current economic crisis should be urgently considered in environments where HIV-1 outbreaks may occur.	[Paraskevis, Dimitrios; Sypsa, Vana; Psichogiou, Mina; Hatzakis, Angelos] Univ Athens, Sch Med, Natl Retrovirus Reference Ctr, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece; [Nikolopoulos, Georgios; Tsiara, Chrissa; Paraskeva, Dimitra; Kremastinou, Jenny] Hellen Ctr Dis Control & Prevent, Athens, Greece; [Fotiou, Anastasios] UMHRI, EMCDDA, Greek REITOX Focal Point, Athens, Greece; [Lazanas, Marios] Hellen Red Cross Hosp, Dept Internal Med 3, Athens, Greece; [Gargalianos, Panagiotis] Athens Gen Hosp G Gennimatas, Dept Internal Med 1, Athens, Greece; [Psichogiou, Mina] Univ Athens, Sch Med, Laiko Hosp, Dept Propaedeut Med 1, GR-11527 Athens, Greece; [Skoutelis, Athanasios] Evangelismos Gen Hosp, Dept Med & Infect Dis 5, Athens, Greece; [Wiessing, Lucas] EMCDDA, Lisbon, Portugal; [Nikolopoulos, Georgios; Friedman, Samuel R.] NDRI, New York, NY USA; [des Jarlais, Don C.] Beth Israel Deaconess Med Ctr, New York, NY 10003 USA; [Malliori, Meni] Org Against Drugs OKANA, Athens, Greece	Athens Medical School; National & Kapodistrian University of Athens; Athens Medical School; Laiko General Hospital; National & Kapodistrian University of Athens; Evangelismos Hospital; Harvard University; Beth Israel Deaconess Medical Center	Hatzakis, A (corresponding author), Univ Athens, Sch Med, Natl Retrovirus Reference Ctr, Dept Hyg Epidemiol & Med Stat, GR-11527 Athens, Greece.	ahatzak@med.uoa.gr	Fotiou, Anastasios/X-2091-2019; Paraskevis, Dimitrios/H-5835-2019; Nikolopoulos, Georgios/H-5698-2011	Fotiou, Anastasios/0000-0001-7905-3241; Paraskevis, Dimitrios/0000-0001-6167-7152; Nikolopoulos, Georgios/0000-0002-3307-0246; Kremastinou-Kourea, Konstantina/0000-0002-0098-181X; Friedman, Sam/0000-0003-2083-1226; SYPSA, VANA/0000-0002-9430-7614				Bonovas S, 2012, J Prev Med Hyg, V53, P169; Fotiou A., 2012, HIV OUTBREAK INJECTI; Freudenberg N, 2006, AM J PUBLIC HEALTH, V96, P424, DOI 10.2105/AJPH.2005.063511; Friedman SR, 2009, INT J DRUG POLICY, V20, P283, DOI 10.1016/j.drugpo.2008.10.006; Glass TA, 2006, SOC SCI MED, V62, P1650, DOI 10.1016/j.socscimed.2005.08.044; Hagan H, 2011, J INFECT DIS, V204, P74, DOI 10.1093/infdis/jir196; Hatzakis AP, 2011, EUROSURVEILLANCE, V16, P19987; Jarlais DC CH, 2012, CURR OPIN HIV AIDS; Kentikelenis A, 2011, LANCET, V378, P1457, DOI 10.1016/S0140-6736(11)61556-0; Likatavicius G, 2011, EUROSURVEILLANCE B E, V16; Malliori M., 2011, HIV AIDS IDUS GREECE; Mathers BM, 2008, LANCET, V372, P1733, DOI 10.1016/S0140-6736(08)61311-2; Mathers BM, 2010, LANCET, V375, P1014, DOI 10.1016/S0140-6736(10)60232-2; Nikolopoulos G, 2008, FUTURE MICROBIOL, V3, P507, DOI 10.2217/17460913.3.5.507; Nikolopoulos G, 2005, EUR J PUBLIC HEALTH, V15, P296, DOI 10.1093/eurpub/cki064; Organization for Economic Co-operation and Development, 2011, ORG EC COOP DEV COUN; Organization for Economic Co-operation and Development, 2013, INT MIGR OUTL 2013, DOI [10.1787/migr_outlook-2013-en, DOI 10.1787/MIGR_]; Paraskevis D, 2011, EUROSURVEILLANCE B E, V16; Paraskevis D, 2007, J INFECT DIS, V196, P1167, DOI 10.1086/521677; Paraskevis DM, 2010, MOL TYPING HIV 1 NET; Pearl J., 2009, MODELS REASONING INF; Pharris A, 2011, EURO SURVEILLANCE, V16; Rothman KJ., 2008, MODERN EPIDEMIOLOGY, V3rd ed; Salminen M, 2011, EUROSURVEILLANCE, V16; Sanders-Buell E, 2007, AIDS RES HUM RETROV, V23, P834, DOI 10.1089/aid.2006.0299; SCHWARTZ S, 1994, AM J PUBLIC HEALTH, V84, P819, DOI 10.2105/AJPH.84.5.819; Strathdee SA, 2010, LANCET, V376, P268, DOI 10.1016/S0140-6736(10)60743-X; Suhrcke M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020724; Sypsa VP, 2012, RESULTS ARISTOTLE ST; Tempalski B, 2008, INT J DRUG POLICY, V19, pS47, DOI 10.1016/j.drugpo.2007.11.011; Vickerman P, 2010, ADDICTION, V105, P311, DOI 10.1111/j.1360-0443.2009.02759.x; Wiessing L, 2011, EUROSURVEILLANCE B E, V16; Wilson DP, 2012, PLOS MED, V9, DOI 10.1371/journal.pmed.1001231	33	92	93	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78941	10.1371/journal.pone.0078941	http://dx.doi.org/10.1371/journal.pone.0078941			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265730	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100063
J	Su, CL; Chen, WC; Lee, AY; Chen, CY; Chang, YCA; Chao, YT; Shih, MC				Su, Chun-lin; Chen, Wan-Chieh; Lee, Ann-Ying; Chen, Chun-Yi; Chang, Yao-Chien Alex; Chao, Ya-Ting; Shih, Ming-Che			A Modified ABCDE Model of Flowering in Orchids Based on Gene Expression Profiling Studies of the Moth Orchid Phalaenopsis aphrodite	PLOS ONE			English	Article							MADS-BOX GENES; FLORAL ORGAN IDENTITY; ARABIDOPSIS FLOWER; ECTOPIC EXPRESSION; EVOLUTION; MERISTEM; FAMILY; ROLES; IDENTIFICATION; GYNOSTEMIUM	Previously we developed genomic resources for orchids, including transcriptomic analyses using next-generation sequencing techniques and construction of a web-based orchid genomic database. Here, we report a modified molecular model of flower development in the Orchidaceae based on functional analysis of gene expression profiles in Phalaenopsis aphrodite (a moth orchid) that revealed novel roles for the transcription factors involved in floral organ pattern formation. Phalaenopsis orchid floral organ-specific genes were identified by microarray analysis. Several critical transcription factors including AP3, PI, AP1 and AGL6, displayed distinct spatial distribution patterns. Phylogenetic analysis of orchid MADS box genes was conducted to infer the evolutionary relationship among floral organ-specific genes. The results suggest that gene duplication MADS box genes in orchid may have resulted in their gaining novel functions during evolution. Based on these analyses, a modified model of orchid flowering was proposed. Comparison of the expression profiles of flowers of a peloric mutant and wild-type Phalaenopsis orchid further identified genes associated with lip morphology and peloric effects. Large scale investigation of gene expression profiles revealed that homeotic genes from the ABCDE model of flower development classes A and B in the Phalaenopsis orchid have novel functions due to evolutionary diversification, and display differential expression patterns.	[Su, Chun-lin; Chen, Wan-Chieh; Lee, Ann-Ying; Chen, Chun-Yi; Chao, Ya-Ting; Shih, Ming-Che] Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan; [Chang, Yao-Chien Alex] Natl Taiwan Univ, Dept Hort & Landscape Architecture, Taipei 10764, Taiwan	Academia Sinica - Taiwan; National Taiwan University	Shih, MC (corresponding author), Acad Sinica, Agr Biotechnol Res Ctr, Taipei 115, Taiwan.	mcshih@gate.sinica.edu.tw	Shih, Ming-Che/V-1816-2019	Chao, Ya-Ting/0000-0002-4917-2183; CHANG, YAO-CHIEN Alex/0000-0003-4102-0174	Academia Sinica, Taiwan [102S0030008]	Academia Sinica, Taiwan(Academia Sinica - Taiwan)	This work was supported by funding from Academia Sinica (http://www.sinica.edu.tw), Taiwan, under the Development Program of Industrialization for Agricultural Biotechnology, project No. 102S0030008. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aceto S, 2011, CURR GENOMICS, V12, P342, DOI 10.2174/138920211796429754; Adamczyk BJ, 2009, PLANT PHYSIOL, V149, P1713, DOI 10.1104/pp.109.135806; Boisvert FM, 2007, NAT REV MOL CELL BIO, V8, P574, DOI 10.1038/nrm2184; Box MS, 2012, J EXP BOT, V63, P4811, DOI 10.1093/jxb/ers152; Broholm SK, 2008, P NATL ACAD SCI USA, V105, P9117, DOI 10.1073/pnas.0801359105; Causier B, 2003, PLANT MOL BIOL, V52, P1051, DOI 10.1023/A:1025426016267; Causier B, 2010, SEMIN CELL DEV BIOL, V21, P73, DOI 10.1016/j.semcdb.2009.10.005; Chang YY, 2011, PLANT CELL PHYSIOL, V52, P1532, DOI 10.1093/pcp/pcr101; Chang YY, 2010, PLANT PHYSIOL, V152, P837, DOI 10.1104/pp.109.147116; Chang YY, 2009, PLANT CELL PHYSIOL, V50, P1425, DOI 10.1093/pcp/pcp087; Chen YH, 2005, CELL RES, V15, P639, DOI 10.1038/sj.cr.7290334; Chen YY, 2012, PLANT CELL PHYSIOL, V53, P1053, DOI 10.1093/pcp/pcs048; COEN ES, 1991, NATURE, V353, P31, DOI 10.1038/353031a0; Corley SB, 2005, P NATL ACAD SCI USA, V102, P5068, DOI 10.1073/pnas.0501340102; Cubas P, 2004, BIOESSAYS, V26, P1175, DOI 10.1002/bies.20119; Ditta G, 2004, CURR BIOL, V14, P1935, DOI 10.1016/j.cub.2004.10.028; Endress PK, 1999, INT J PLANT SCI, V160, pS3, DOI 10.1086/314211; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Galliot C, 2006, CURR OPIN PLANT BIOL, V9, P78, DOI 10.1016/j.pbi.2005.11.003; GOTO K, 1994, GENE DEV, V8, P1548, DOI 10.1101/gad.8.13.1548; Heijmans K, 2012, PLANT CELL, V24, P2305, DOI 10.1105/tpc.112.097030; Hsu HF, 2003, PLANT CELL PHYSIOL, V44, P783, DOI 10.1093/pcp/pcg099; Immink RGH, 2003, MOL GENET GENOMICS, V268, P598, DOI 10.1007/s00438-002-0781-3; IRISH VF, 1990, PLANT CELL, V2, P741, DOI 10.1105/tpc.2.8.741; Irish VF, 2010, PLANT J, V61, P1014, DOI 10.1111/j.1365-313X.2009.04065.x; JACK T, 1994, CELL, V76, P703, DOI 10.1016/0092-8674(94)90509-6; JOFUKU KD, 1994, PLANT CELL, V6, P1211, DOI 10.1105/tpc.6.9.1211; Kater MM, 2006, J EXP BOT, V57, P3433, DOI 10.1093/jxb/erl097; Kramer EM, 2009, ANNU REV PLANT BIOL, V60, P261, DOI 10.1146/annurev.arplant.043008.092051; Krizek BA, 2005, NAT REV GENET, V6, P688, DOI 10.1038/nrg1675; Lamond AI, 2011, COLD SPRING HARB PER, V3; LINCOLN C, 1994, PLANT CELL, V6, P1859, DOI 10.1105/tpc.6.12.1859; MA H, 1991, GENE DEV, V5, P484, DOI 10.1101/gad.5.3.484; Maes T, 2001, PLANT CELL, V13, P229, DOI 10.1105/tpc.13.2.229; McLachlan GJ., 2005, ANAL MICROARRAY GENE; Mondragon-Palomino M, 2008, TRENDS PLANT SCI, V13, P51, DOI 10.1016/j.tplants.2007.11.007; Parenicova L, 2003, PLANT CELL, V15, P1538, DOI 10.1105/tpc.011544; Peakall R, 2007, MOL ECOL, V16, P2834, DOI 10.1111/j.1365-294X.2007.03311.x; Puzey JR, 2012, P ROY SOC B-BIOL SCI, V279, P1640, DOI 10.1098/rspb.2011.1873; Reinheimer R, 2009, PLANT CELL, V21, P2591, DOI 10.1105/tpc.109.068239; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rudall PJ, 2002, BIOL REV, V77, P403, DOI 10.1017/S1464793102005936; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Salemme M, 2011, DEV GENES EVOL, V221, P241, DOI 10.1007/s00427-011-0372-6; Schwarz-Sommer Z, 2003, NAT REV GENET, V4, P657, DOI 10.1038/nrg1127; SMYTH DR, 1990, PLANT CELL, V2, P755, DOI 10.1105/tpc.2.8.755; Su CL, 2013, PLANT CELL PHYSIOL, V54, pE11, DOI 10.1093/pcp/pct004; Su CL, 2011, PLANT CELL PHYSIOL, V52, P1501, DOI 10.1093/pcp/pcr097; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Theissen G, 2001, CURR OPIN PLANT BIOL, V4, P75, DOI 10.1016/S1369-5266(00)00139-4; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tsai WC, 2004, PLANT CELL PHYSIOL, V45, P831, DOI 10.1093/pcp/pch095; Tsai WC, 2008, ADV BOT RES, V47, P99, DOI 10.1016/S0065-2296(08)00003-7; Tsai WC, 2006, THESCIENTIFICWORLDJO, V6, P1933, DOI 10.1100/tsw.2006.321; WEIGEL D, 1992, CELL, V69, P843, DOI 10.1016/0092-8674(92)90295-N; Xiao SJ, 2010, BIOINFORMATICS, V26, P1273, DOI 10.1093/bioinformatics/btq109; YANOFSKY MF, 1990, NATURE, V346, P35, DOI 10.1038/346035a0; Yu H, 2000, PLANT PHYSIOL, V123, P1325, DOI 10.1104/pp.123.4.1325; Zhu QH, 2011, J EXP BOT, V62, P487, DOI 10.1093/jxb/erq295	59	38	43	3	60	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80462	10.1371/journal.pone.0080462	http://dx.doi.org/10.1371/journal.pone.0080462			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265826	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100162
J	Taira, K; Fujioka, K; Aoyama, Y				Taira, Kumiko; Fujioka, Kazutoshi; Aoyama, Yoshiko			Qualitative Profiling and Quantification of Neonicotinoid Metabolites in Human Urine by Liquid Chromatography Coupled with Mass Spectrometry	PLOS ONE			English	Article							ORGANOPHOSPHORUS PESTICIDE EXPOSURE; INSECTICIDES; MICE; IDENTIFICATION; CHILDREN; LC/MS	Neonicotinoid pesticides have been widely applied for the production of fruits and vegetables, and occasionally detected in conventionally grown produce. Thus oral exposure to neonicotinoid pesticides may exist in the general population; however, neonicotinoid metabolites in human body fluids have not been investigated comprehensively. The purpose of this study is the qualitative profiling and quantitative analysis of neonicotinoid metabolites in the human spot urine by liquid chromatography coupled with mass spectrometry (LC/MS). Human urine samples were collected from three patients suspected of subacute exposure to neonicotinoid pesticides. A qualitative profiling of urinary metabolites was performed using liquid chromatography/time-of-flight mass spectrometry (LC/TOFMS) with a database of nominal molecular weights of 57 known metabolites of three neonicotinoid pesticides (acetamiprid, Imidacloprid, and clothianidin), as well as the parent compounds. Then a quantitative analysis of selected urinary metabolites was performed using liquid chromatography/tandem mass spectrometry (LC/MS/MS) with a standard pesticide and metabolite, which were detected by the qualitative profiling. The result of qualitative profiling showed that seven metabolites, i.e. an acetamiprid metabolite, N-desmethyl-acetamiprid; three Imidacloprid metabolites, 5-hydroxy-Imidacloprid, 4,5-dihydroxy-imidacloprid, 4,5-dehydro-Imidacloprid; a common metabolite of acetamiprid and Imidacloprid, N-(6-chloronicotinoyl)-glycine; and two clothianidin metabolites, N-desmethyl-clothianidin, N-(2-(methylsulfanyl)thiazole-5-carboxyl)-glycine, as well as acetamiprid, were detected in the urine of three cases. The result of the quantitative analysis showed N-desmethyl-acetamiprid was determined in the urine of one case, which had been collected on the first visit, at a concentration of 3.2 ng/mL. This is the first report on the qualitative and quantitative detection of N-desmethyl-acetamiprid in the human urine. The results suggest that the one case with detection of N-desmethyl-acetamiprid was exposed to acetamiprid through the consumption of contaminated foods. Urinary N-desmethyl-acetamiprid, as well as 5-hydroxy-Imidacloprid and N-desmethyl-clothianidin, may be a good biomarker for neonicotinoid exposure in humans and warrants further investigation.	[Taira, Kumiko] Tokyo Womens Med Univ, Med Ctr East, Dept Anesthesiol, Tokyo, Japan; [Fujioka, Kazutoshi] Hawaii Inst Mol Educ, Aiea, HI USA; [Aoyama, Yoshiko] Aoyama Allergy Clin, Maebashi, Gunma, Japan	Tokyo Women's Medical University	Taira, K (corresponding author), Tokyo Womens Med Univ, Med Ctr East, Dept Anesthesiol, Tokyo, Japan.	VFG03077@nifty.com			Japan Endocrine-disruptor Preventive Action	Japan Endocrine-disruptor Preventive Action	This study is partially supported by Japan Endocrine-disruptor Preventive Action. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding received for this study.	Casida JE, 2011, J AGR FOOD CHEM, V59, P2923, DOI 10.1021/jf102438c; Colborn T, 2006, ENVIRON HEALTH PERSP, V114, P10, DOI 10.1289/ehp.7940; Curl CL, 2003, ENVIRON HEALTH PERSP, V111, P377, DOI 10.1289/ehp.5754; Elbert A, 2008, PEST MANAG SCI, V64, P1099, DOI 10.1002/ps.1616; European Food Safety Authority, 2011, EFSA J; Food Safety Commission of Japan, 2005, PEST RISK ASS, P28; Food Safety Commission of Japan, 2008, PEST RISK ASS, P16; Food Safety Commission of Japan, 2008, PEST RISK ASS, P13; Food Safety Commission of Japan, 2008, PEST RISK ASS, P17; Food Safety Commission of Japan, 2010, PEST RISK ASS, P28; Ford KA, 2008, J AGR FOOD CHEM, V56, P10168, DOI 10.1021/jf8020909; Ford KA, 2006, CHEM RES TOXICOL, V19, P1549, DOI 10.1021/tx0601859; Ford KA, 2006, CHEM RES TOXICOL, V19, P944, DOI 10.1021/tx0600696; Huang NC, 2006, AM J EMERG MED, V24, P883, DOI 10.1016/j.ajem.2006.03.008; Imamura T, 2010, CLIN TOXICOL, V48, P851, DOI 10.3109/15563650.2010.517207; Iyyadurai R, 2010, J MED TOXICOL, V6, P77, DOI 10.1007/s13181-010-0041-6; Kimata Akiko, 2009, Environmental Health and Preventive Medicine, V14, P173, DOI 10.1007/s12199-009-0077-x; Kimura-Kuroda J, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032432; Lu CS, 2008, ENVIRON HEALTH PERSP, V116, P537, DOI 10.1289/ehp.10912; Marin A, 2004, J CHROMATOGR B, V804, P269, DOI 10.1016/j.jchromb.2004.01.022; National Research Council, 2011, GUIDE CARE USE LAB A; Pelander A, 2003, ANAL CHEM, V75, P5710, DOI 10.1021/ac030162o; Phua DH, 2009, CLIN TOXICOL, V47, P336, DOI 10.1080/15563650802644533; Plant Japan Protection Association, 2011, HDB PEST, P65; Proenca P, 2005, FORENSIC SCI INT, V153, P75, DOI 10.1016/j.forsciint.2005.04.015; Schadnia SS, 2008, AM J EMERG MED, V26; Swenson TL, 2013, TOXICOL SCI, V133, P22, DOI 10.1093/toxsci/kft066; Taira Kumiko, 2011, Chudoku Kenkyu, V24, P222; Tamura Mitsuyo, 2002, Chudoku Kenkyu, V15, P309; Todani Masaki, 2008, Chudoku Kenkyu, V21, P387; Yeh IJ, 2010, AM J EMERG MED, V28; Zhang NY, 2000, ANAL CHEM, V72, P800, DOI 10.1021/ac9911701	32	52	54	10	111	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80332	10.1371/journal.pone.0080332	http://dx.doi.org/10.1371/journal.pone.0080332			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265808	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100144
J	Zhang, C; Zheng, YY; Chen, LH; Chen, M; Liang, SX; Lin, MS; Luo, DL				Zhang, Chao; Zheng, Yuanyuan; Chen, Lihong; Chen, Min; Liang, Shenxuan; Lin, Mosi; Luo, Dali			Regulation of Basal Lateral Membrane Mobility and Permeability to Divalent Cations by Membrane Associated-Protein Kinase C	PLOS ONE			English	Article							VASCULAR SMOOTH-MUSCLE; ARACHIDONIC-ACID; DOWN-REGULATION; CA2+ ENTRY; ALPHA; PKC; ACTIVATION; CELLS; FLUIDITY; IDENTIFICATION	Biological membrane stabilization is essential for maintenance of cellular homeostasis, functionality and appropriate response to various stimuli. Previous studies have showed that accumulation of PKCs in the cell membrane significantly downregulates the membrane fluidity and Ca2+ influxes through the membranes in activated cells. In addition, membrane-inserted form of PKCs has been found in a variety of resting mammalian cells and tissues. This study is aimed to investigate possible role of the endogenous membrane-associated PKCs in the modulation of basal membrane fluidity. Here, we showed that interfering PKC expression by chronic activation of PKC with phorbol myristate acetate (PMA) or shRNA targeting at PKCa lowered the levels of PKCa in cytosol, peripheral membrane and integral membrane pools, while short-term activation of PKC with PMA induced accumulation of PKCa in the membrane pool accompanied by a dramatic decrease in the cytosol fraction. The lateral membrane mobility increased or decreased in accordance with the abundance alterations in the membrane-associated PKCa by these treatments. In addition, membrane permeability to divalent cations including Ca2+, Mn2+ and Ba2+ were also potentiated or abrogated along with the changes in PKC expression on the plasma membrane. Membrane stabilizer ursodeoxycholate abolished both of the enhanced lateral membrane mobility and permeability to divalent cations due to PKCa deficiency, whereas Go6983, a PKC antagonist, or Gd3+ and 2-aminoethyoxydipheyl borne, two Ca2+ channels blockers, showed no effect, suggesting that this PKC-related regulation is independent of PKC activation or a modulation of specific divalent cation channel. Thus, these data demonstrate that the native membrane-associated PKCa is involved in the maintenance of basal membrane stabilization in resting cells.	[Zhang, Chao; Zheng, Yuanyuan; Chen, Lihong; Chen, Min; Liang, Shenxuan; Lin, Mosi; Luo, Dali] Capital Med Univ, Dept Pharmacol, Sch Chem Biol & Pharmaceut Sci, Beijing, Peoples R China	Capital Medical University	Luo, DL (corresponding author), Capital Med Univ, Dept Pharmacol, Sch Chem Biol & Pharmaceut Sci, Beijing, Peoples R China.	luodl@ccmu.edu.cn			Beijing Natural Science Foundation [5122006]; National Natural Science Foundation [30973537]; project for academic human resources development in institutions of high learning under the jurisdiction of Beijing municipality [PHR201007111]	Beijing Natural Science Foundation(Beijing Natural Science Foundation); National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); project for academic human resources development in institutions of high learning under the jurisdiction of Beijing municipality	This study was supported by grants from Beijing Natural Science Foundation (5122006), National Natural Science Foundation (30973537), and project for academic human resources development in institutions of high learning under the jurisdiction of Beijing municipality (PHR201007111). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amadio M, 2006, PHARMACOL RES, V54, P317, DOI 10.1016/j.phrs.2006.08.002; BAZZI MD, 1992, J BIOL CHEM, V267, P22891; Beck R, 1998, CIRC RES, V83, P923; Berrier AL, 2000, J CELL BIOL, V151, P1549, DOI 10.1083/jcb.151.7.1549; Chakraborty P, 2000, J BIOCHEM-TOKYO, V127, P185, DOI 10.1093/oxfordjournals.jbchem.a022593; CHAKRAVARTHY BR, 1994, BIOCHEM J, V304, P809, DOI 10.1042/bj3040809; Chen LH, 2012, CELL SIGNAL, V24, P1565, DOI 10.1016/j.cellsig.2012.03.016; Chen LH, 2011, CELL SIGNAL, V23, P497, DOI 10.1016/j.cellsig.2010.11.005; Cheng Y, 1998, J INORG BIOCHEM, V69, P1, DOI 10.1016/S0162-0134(97)10002-2; Detjen KM, 2000, J CELL SCI, V113, P3025; Escriba PV, 2003, HYPERTENSION, V41, P176, DOI 10.1161/01.HYP.0000047647.72162.A8; Fukaya T, 2007, NEUROBIOL AGING, V28, P1179, DOI 10.1016/j.neurobiolaging.2006.05.023; Gao T, 2008, J BIOL CHEM, V283, P6300, DOI 10.1074/jbc.M707319200; Goldman A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023835; Hansra G, 1999, BIOCHEM J, V342, P337, DOI 10.1042/0264-6021:3420337; Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002; Jao HC, 2001, SHOCK, V15, P130, DOI 10.1097/00024382-200115020-00009; JENNINGS ML, 1989, ANNU REV BIOCHEM, V58, P999; Katz A. M., 1992, PHYSL HEART; Kolena J, 1999, BBA-BIOMEMBRANES, V1416, P208, DOI 10.1016/S0005-2736(98)00223-5; Kramer HK, 1999, J NEUROCHEM, V72, P594, DOI 10.1046/j.1471-4159.1999.0720594.x; KWAN CY, 1990, J BIOL CHEM, V265, P678; Laroche C, 2001, APPL MICROBIOL BIOT, V56, P249, DOI 10.1007/s002530000583; Leontieva OV, 2004, J BIOL CHEM, V279, P5788, DOI 10.1074/jbc.M308375200; Liu J, 2006, BRAIN RES, V1123, P68, DOI 10.1016/j.brainres.2006.09.058; Luo D, 2001, J BIOL CHEM, V276, P5613, DOI 10.1074/jbc.M007524200; Luo DL, 2008, CELL CALCIUM, V43, P165, DOI 10.1016/j.ceca.2007.04.017; Luo DL, 2005, PROSTAG OTH LIPID M, V75, P141, DOI 10.1016/j.prostaglandins.2004.11.004; Moneer Z, 2002, BIOCHEM J, V362, P13, DOI 10.1042/0264-6021:3620013; Newton AC, 2010, AM J PHYSIOL-ENDOC M, V298, pE395, DOI 10.1152/ajpendo.00477.2009; Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003; OKAMOTO T, 1999, CURRENT PROTOCOLS CE; Rodrigues CMP, 1998, J CLIN INVEST, V101, P2790, DOI 10.1172/JCI1325; Schachter JB, 1996, BBA-GEN SUBJECTS, V1291, P167, DOI 10.1016/0304-4165(96)00063-3; Sergent O, 2005, J PHARMACOL EXP THER, V313, P104, DOI 10.1124/jpet.104.078634; SINGER SJ, 1972, SCIENCE, V175, P720, DOI 10.1126/science.175.4023.720; Sponne I, 2003, J BIOL CHEM, V278, P3437, DOI 10.1074/jbc.M206745200; Steinberg SF, 2008, PHYSIOL REV, V88, P1341, DOI 10.1152/physrev.00034.2007; Stockando JD, 2000, J BIOL CHEM, V275, P25760, DOI 10.1074/jbc.M003615200; Sun XG, 1999, CELL GROWTH DIFFER, V10, P343; Tsvetkova NM, 2002, P NATL ACAD SCI USA, V99, P13504, DOI 10.1073/pnas.192468399; Van der Zee EA, 2004, HIPPOCAMPUS, V14, P849, DOI 10.1002/hipo.20000; Wang XQ, 2007, CANCER RES, V67, P9986, DOI 10.1158/0008-5472.CAN-07-1300; Zhu YM, 2005, CELL SIGNAL, V17, P1125, DOI 10.1016/j.cellsig.2004.12.004	44	1	1	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80291	10.1371/journal.pone.0080291	http://dx.doi.org/10.1371/journal.pone.0080291			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260363	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200112
J	Pisanti, S; Picardi, P; Ciaglia, E; Margarucci, L; Ronca, R; Giacomini, A; Malfitano, AM; Casapullo, A; Laezza, C; Gazzerro, P; Bifulco, M				Pisanti, Simona; Picardi, Paola; Ciaglia, Elena; Margarucci, Luigi; Ronca, Roberto; Giacomini, Arianna; Malfitano, Anna Maria; Casapullo, Agostino; Laezza, Chiara; Gazzerro, Patrizia; Bifulco, Maurizio			Antiangiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end product, mediated by AMPK activation	FASEB JOURNAL			English	Article						mevalonate pathway; cancer progression; endothelial cells; AMP-mimetic	CANCER CELL-GROWTH; PROTEIN-KINASE; ENDOTHELIAL-CELLS; APOPTOSIS; PROLIFERATION; ANGIOGENESIS; EXPRESSION; N-6-ISOPENTENYLADENOSINE; INHIBITION; METFORMIN	N6-isopentenyladenosine (iPA), an end product of the mevalonate pathway with an isopentenyl chain, is already known to exert a suppressor effect against various tumors. In this work, we investigated whether iPA also directly interferes with the angiogenic process, which is fundamental to tumor growth and progression. To this end, using human umbilical vein endothelial cells (HUVECs) as a suitable in vitro model of angiogenesis, we evaluated their viability, proliferation, migration, invasion, tube formation in response to iPA, and molecular mechanisms involved. Data were corroborated in mice by using a gel plug assay. iPA dose- and time-dependently inhibited all the neoangiogenesis stages, with an IC50 of 0.98 M. We demonstrated for the first time, by liquid chromatography-coupled tandem mass spectrometry (LC-MS/MS), that iPA was monophosphorylated into 5-iPA-monophosphate (iPAMP) by the adenosine kinase (ADK) inside the cells. iPAMP is the active form that inhibits angiogenesis through the direct activation of AMP-kinase (AMPK). Indeed, all effects were completely reversed by pretreatment with 5-iodotubercidin (5-Itu), an ADK inhibitor. The isoprenoid intermediate isopentenyl pyrophosphate (IPP), which shares the isopentenyl moiety with iPA, was ineffective in the inhibition of angiogenesis, thus showing that the iPA structure is specific for the observed effects. In conclusion, iPA is a novel AMPK activator and could represent a useful tool for the treatment of diseases where excessive neoangiogenesis is the underlying pathology. Pisanti, S., Picardi, P., Ciaglia, E., Margarucci, L., Ronca, R., Giacomini, A., Malfitano, A. M., Casapullo, A., Laezza, C., Gazzerro, P., Bifulco, M. Anti-angiogenic effects of N6-isopentenyladenosine, an endogenous isoprenoid end-product, mediated by AMPK activation.	[Pisanti, Simona; Picardi, Paola; Ciaglia, Elena; Malfitano, Anna Maria; Bifulco, Maurizio] Univ Salerno, Dept Med & Surg, I-84084 Salerno, Italy; [Pisanti, Simona; Picardi, Paola; Ciaglia, Elena; Margarucci, Luigi; Malfitano, Anna Maria; Casapullo, Agostino; Gazzerro, Patrizia; Bifulco, Maurizio] Univ Salerno, Dept Pharm, I-84084 Salerno, Italy; [Ronca, Roberto; Giacomini, Arianna] Univ Brescia, Dept Mol & Translat Med, Brescia, Italy; [Laezza, Chiara] CNR, Inst Endocrinol & Expt Oncol IEOS, I-80125 Naples, Italy	University of Salerno; University of Salerno; University of Brescia; Consiglio Nazionale delle Ricerche (CNR); Istituto per Endocrinologia e Oncologia "Gaetano Salvatore" (IEOS-CNR)	Pisanti, S (corresponding author), Univ Salerno, Via Giovanni Paolo 2, I-84084 Salerno, Italy.	spisanti@unisa.it; maubiful@unisa.it	Giacomini, Arianna/K-4437-2016; Ronca, Roberto/AAC-6470-2022; laez, chi/AAW-4437-2020; Pisanti, Simona/J-3521-2012; Ciaglia, E/AAA-7924-2019; Giacomini, Arianna/U-6854-2019; CASAPULLO, Agostino/B-4236-2011	Giacomini, Arianna/0000-0002-9984-9033; Ronca, Roberto/0000-0001-8979-7068; Pisanti, Simona/0000-0003-1383-7929; Ciaglia, E/0000-0002-8035-4583; Bifulco, Maurizio/0000-0002-1771-4531; CASAPULLO, Agostino/0000-0002-2310-9426; Malfitano, Anna Maria/0000-0002-6193-2835	Associazione Educazione e Ricerca Medica Salernitana (ERMES); Associazione Italiana per la Ricerca sul Cancro [AIRC-IG 13312]; Fondazione Italiana per la Ricerca sul Cancro (FIRC)	Associazione Educazione e Ricerca Medica Salernitana (ERMES); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); Fondazione Italiana per la Ricerca sul Cancro (FIRC)(Fondazione AIRC per la ricerca sul cancro)	This work was supported by Associazione Educazione e Ricerca Medica Salernitana (ERMES) and by Associazione Italiana per la Ricerca sul Cancro (AIRC-IG 13312 to M.B.). E.C. and A.G. were supported by a fellowship from Fondazione Italiana per la Ricerca sul Cancro (FIRC). The authors declare no conflicts of interest.	Auchampach JA, 2007, CIRC RES, V101, P1075, DOI 10.1161/CIRCRESAHA.107.165761; Bifulco M, 2008, ANTI-CANCER AGENT ME, V8, P200, DOI 10.2174/187152008783497028; Bucci M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057801; BURNS DM, 1976, CANCER BIOCHEM BIOPH, V1, P269; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chen MB, 2011, J CELL PHYSIOL, V226, P1915, DOI 10.1002/jcp.22522; Chen MB, 2011, CELL BIOCHEM BIOPHYS, V60, P311, DOI 10.1007/s12013-011-9153-0; Ciaglia E, 2013, J LEUKOCYTE BIOL, V94, P1207, DOI 10.1189/jlb.0413190; Coltrini D, 2013, ANGIOGENESIS, V16, P469, DOI 10.1007/s10456-012-9324-7; CORTON JM, 1995, EUR J BIOCHEM, V229, P558, DOI 10.1111/j.1432-1033.1995.0558k.x; DIVEKAR AY, 1974, MOL PHARMACOL, V10, P529; Esfahanian N, 2012, MOL MED REP, V5, P1068, DOI 10.3892/mmr.2012.753; Ewart MA, 2008, ARTERIOSCL THROM VAS, V28, P2255, DOI 10.1161/ATVBAHA.108.175919; FAUST JR, 1991, J BIOL CHEM, V266, P9961; Folkman J, 2006, ANNU REV MED, V57, P1, DOI 10.1146/annurev.med.57.121304.131306; Gaskin FS, 2009, MICROCIRCULATION, V16, P167, DOI 10.1080/10739680802355897; Goransson O, 2007, J BIOL CHEM, V282, P32549, DOI 10.1074/jbc.M706536200; Golovko A, 2000, GENE, V258, P85, DOI 10.1016/S0378-1119(00)00421-2; Hardie DG, 2006, J PHYSIOL-LONDON, V574, P7, DOI 10.1113/jphysiol.2006.108944; Kanellis J, 2006, IMMUNOL CELL BIOL, V84, P6, DOI 10.1111/j.1440-1711.2005.01388.x; Laezza C, 1997, EXP CELL RES, V234, P178, DOI 10.1006/excr.1997.3610; Laezza C, 2006, FASEB J, V20, P412, DOI 10.1096/fj.05-4044lsf; Laezza C, 2010, MOL CARCINOGEN, V49, P892, DOI 10.1002/mc.20666; Laezza C, 2009, INT J CANCER, V124, P1322, DOI 10.1002/ijc.24056; Laezza C, 2008, ENDOCR-RELAT CANCER, V15, P965, DOI 10.1677/ERC-08-0030; Laezza C, 2008, J MOL MED, V86, P1341, DOI 10.1007/s00109-008-0396-1; Laezza C, 2006, FEBS LETT, V580, P6076, DOI 10.1016/j.febslet.2006.09.074; Landman GWD, 2010, DIABETES CARE, V33, P322, DOI 10.2337/dc09-1380; Laplante M, 2012, CELL, V149, P274, DOI 10.1016/j.cell.2012.03.017; Lee CW, 2012, CANCER RES, V72, P4394, DOI 10.1158/0008-5472.CAN-12-0429; Lee DH, 2012, CELL SIGNAL, V24, P2216, DOI 10.1016/j.cellsig.2012.07.019; Liu XM, 2011, AM J PHYSIOL-HEART C, V300, pH84, DOI 10.1152/ajpheart.00749.2010; Meisse D, 2002, FEBS LETT, V526, P38, DOI 10.1016/S0014-5793(02)03110-1; Mok DWS, 2001, ANNU REV PLANT PHYS, V52, P89, DOI 10.1146/annurev.arplant.52.1.89; Morizane Y, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.199398; Morrow VA, 2003, J BIOL CHEM, V278, P31629, DOI 10.1074/jbc.M212831200; Nagata D, 2003, J BIOL CHEM, V278, P31000, DOI 10.1074/jbc.M300643200; Ouchi N, 2004, J BIOL CHEM, V279, P1304, DOI 10.1074/jbc.M310389200; Peyton KJ, 2012, J PHARMACOL EXP THER, V342, P827, DOI 10.1124/jpet.112.194712; Pisanti S, 2011, BLOOD, V117, P5541, DOI 10.1182/blood-2010-09-307355; Potente M, 2011, CELL, V146, P873, DOI 10.1016/j.cell.2011.08.039; Reihill JA, 2011, VASC CELL, V3, DOI 10.1186/2045-824X-3-9; Ronca R, 2013, J PATHOL, V230, P228, DOI 10.1002/path.4181; Ruscica M, 2011, J ENDOCRINOL INVEST, V34, pE362, DOI 10.3275/7803; Sanli T., 2013, CANCER BIOL THER, DOI [10.4161/cbt.26726, DOI 10.4161/CBT. 26726]; Santoro A, 2009, INT J CANCER, V125, P996, DOI 10.1002/ijc.24483; Simo R, 2006, CURR DIABETES REV, V2, P71, DOI 10.2174/157339906775473671; Sinclair CJD, 2001, BRIT J PHARMACOL, V134, P1037, DOI 10.1038/sj.bjp.0704349; Spinola M, 2007, INT J CANCER, V120, P2744, DOI 10.1002/ijc.22601; Stahmann N, 2010, J BIOL CHEM, V285, P10638, DOI 10.1074/jbc.M110.108688; Su KH, 2012, J CELL PHYSIOL, V227, P3053, DOI 10.1002/jcp.23052; Theodoropoulou S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0052852; Theodoropoulou S, 2010, FASEB J, V24, P2620, DOI 10.1096/fj.09-152546; Vakana E, 2011, BLOOD, V118, P6399, DOI 10.1182/blood-2011-01-332783; Yung MMH, 2013, BMC CANCER, V13, DOI 10.1186/1471-2407-13-327; Zheng QY, 2012, BIOCHEM BIOPH RES CO, V419, P741, DOI 10.1016/j.bbrc.2012.02.093; Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505; Zou MH, 2008, CLIN EXP PHARMACOL P, V35, P535, DOI 10.1111/j.1440-1681.2007.04851.x	58	29	29	0	6	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	MAR	2014	28	3					1132	1144		10.1096/fj.13-238238	http://dx.doi.org/10.1096/fj.13-238238			13	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AG3MY	24265487				2022-12-25	WOS:000335324800010
J	Stumpp, C; Hose, GC				Stumpp, Christine; Hose, Grant C.			The Impact of Water Table Drawdown and Drying on Subterranean Aquatic Fauna in In-Vitro Experiments	PLOS ONE			English	Article							GROUNDWATER-DEPENDENT ECOSYSTEMS; EASTERN AUSTRALIA; FRESH-WATER; BIODIVERSITY; BIODEGRADATION; STYGOFAUNA; AQUIFERS; ECOLOGY	The abstraction of groundwater is a global phenomenon that directly threatens groundwater ecosystems. Despite the global significance of this issue, the impact of groundwater abstraction and the lowering of groundwater tables on biota is poorly known. The aim of this study is to determine the impacts of groundwater drawdown in unconfined aquifers on the distribution of fauna close to the water table, and the tolerance of groundwater fauna to sediment drying once water levels have declined. A series of column experiments were conducted to investigate the depth distribution of different stygofauna (Syncarida and Copepoda) under saturated conditions and after fast and slow water table declines. Further, the survival of stygofauna under conditions of reduced sediment water content was tested. The distribution and response of stygofauna to water drawdown was taxon specific, but with the common response of some fauna being stranded by water level decline. So too, the survival of stygofauna under different levels of sediment saturation was variable. Syncarida were better able to tolerate drying conditions than the Copepoda, but mortality of all groups increased with decreasing sediment water content. The results of this work provide new understanding of the response of fauna to water table drawdown. Such improved understanding is necessary for sustainable use of groundwater, and allows for targeted strategies to better manage groundwater abstraction and maintain groundwater biodiversity.	[Stumpp, Christine] Helmholtz Zentrum Munchen, Inst Groundwater Ecol, Neuherberg, Germany; [Hose, Grant C.] Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia	Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Macquarie University	Hose, GC (corresponding author), Macquarie Univ, Dept Biol Sci, Sydney, NSW 2109, Australia.	grant.hose@mq.edu.au	Stumpp, Christine/AGG-8290-2022; Stumpp, Christine/K-6934-2012	Stumpp, Christine/0000-0001-9041-2735; Hose, Grant/0000-0003-2106-5543	German Research Foundation [STU 539/2-1]; Australian Research Council [DP1095200]	German Research Foundation(German Research Foundation (DFG)); Australian Research Council(Australian Research Council)	The work was funded by the German Research Foundation (www.dfg.de) project STU 539/2-1 and the Australian Research Council (www.arc.gov.au) project DP1095200. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asmyhr MG, 2014, FRESHWATER BIOL, V59, P1, DOI 10.1111/fwb.12239; Asmyhr MG, 2012, INVERTEBR SYST, V26, P583, DOI 10.1071/IS12032; Bailey J, 2010, GROUNDWATER DEPTH BI; Boulton AJ, 2005, AQUAT CONSERV, V15, P319, DOI 10.1002/aqc.712; Boulton AJ, 2008, INVERTEBR SYST, V22, P103, DOI 10.1071/IS07024; Cartes JE, 2010, DEEP-SEA RES PT I, V57, P1485, DOI 10.1016/j.dsr.2010.08.001; Danielopol DL, 2000, TRENDS ECOL EVOL, V15, P223, DOI 10.1016/S0169-5347(00)01868-1; Datry T, 2005, J N AM BENTHOL SOC, V24, P461, DOI 10.1899/04-140.1; Dobson R, 2007, J CONTAM HYDROL, V94, P235, DOI 10.1016/j.jconhyd.2007.07.007; Eamus D, 2006, AUST J BOT, V54, P91, DOI 10.1071/BT06029; Fryirs K, GEOMORPHIC CHARACTER; GIBERT J, 1990, ECOLOGY MANAGEMENT A, P199, DOI DOI 10.1017/CBO9780511753381; Griebler C, 2009, FRESHWATER BIOL, V54, P649, DOI 10.1111/j.1365-2427.2008.02013.x; Hancock PJ, 2008, INVERTEBR SYST, V22, P117, DOI 10.1071/IS07023; Hancock PJ, 2009, ALLUVIAL AQUIFER FAU; Humphreys WF, 2009, HYDROGEOL J, V17, P5, DOI 10.1007/s10040-008-0349-3; Humphreys WF, 2006, AUST J BOT, V54, P115, DOI 10.1071/BT04151; Korbel KL, 2013, J ENVIRON QUAL, V42, P380, DOI 10.2134/jeq2012.0018; Korbel KL, 2011, HYDROBIOLOGIA, V661, P329, DOI 10.1007/s10750-010-0541-z; Krause S, 2011, ECOHYDROLOGY, V4, P481, DOI 10.1002/eco.176; Larned ST, 2012, FRESHWATER BIOL, V57, P885, DOI 10.1111/j.1365-2427.2012.02769.x; Miller SW, 2007, FRESHWATER BIOL, V52, P2494, DOI 10.1111/j.1365-2427.2007.01850.x; Nielsen OK, 2004, WEED TECHNOL, V18, P30, DOI 10.1614/WT-03-070R1; Notenboom J., 1994, P477; Pilloni G., 2011, DISTRIBUTION DYNAMIC; Poznanska M, 2013, HYDROBIOLOGIA, V700, P47, DOI 10.1007/s10750-012-1218-6; R Core Team, 2012, LANG ENV STAT COMP; RAINWATER K, 1993, WATER ENVIRON RES, V65, P717, DOI 10.2175/WER.65.6.3; Reddi LN, 1998, J ENVIRON ENG-ASCE, V124, P1171, DOI 10.1061/(ASCE)0733-9372(1998)124:12(1171); Ritz C, 2005, J STAT SOFTW, V12, P1; Schonthal M, 1987, BEDEUTUNG METAZOENBE; Stein H, 2012, STYGOREGIONS PROMISI, V2; Stein H, 2010, J ENVIRON MONITOR, V12, P242, DOI [10.1039/b913484k, 10.1039/B913484K]; Tomlinson M, 2008, FRAMEWORK DETERMININ; Wada Y, 2010, GEOPHYS RES LETT, V37, DOI 10.1029/2010GL044571; Wilson GDF, 2008, HYDROBIOLOGIA, V595, P231, DOI 10.1007/s10750-007-9019-z	36	24	24	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 20	2013	8	11							e78502	10.1371/journal.pone.0078502	http://dx.doi.org/10.1371/journal.pone.0078502			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LY	24278111	gold, Green Published, Green Submitted			2022-12-25	WOS:000327313100006
J	Coppede, F; Ricciardi, R; Denaro, M; De Rosa, A; Provenzano, C; Bartoccioni, E; Baggiani, A; Lucchi, M; Mussi, A; Migliore, L				Coppede, Fabio; Ricciardi, Roberta; Denaro, Maria; De Rosa, Anna; Provenzano, Carlo; Bartoccioni, Emanuela; Baggiani, Angelo; Lucchi, Marco; Mussi, Alfredo; Migliore, Lucia			Association of the DNMT3B-579G > T Polymorphism with Risk of Thymomas in Patients with Myasthenia Gravis	PLOS ONE			English	Article							DNA METHYLTRANSFERASE 3B; DNMT3B PROMOTER POLYMORPHISMS; THYMIC EPITHELIAL TUMORS; SQUAMOUS-CELL CARCINOMA; LUNG-CANCER; METHYLATION; GENE; EPIGENETICS; AUTOIMMUNITY; DISEASE	Increasing evidence suggests a contribution of epigenetic processes in promoting cancer and autoimmunity. Myasthenia gravis (MG) is an autoimmune disease mediated, in approximately 80% of the patients, by antibodies against the nicotinic acetylcholine receptor (AChR+). Moreover, epithelial tumours (thymomas) are present in about 10-20% of the patients, and there is indication that changes in DNA methylation might contribute to the risk and progression of thymomas. However, the role of epigenetics in MG is still not completely clarified. In the present study we investigated if a common polymorphism (-579G>T: rs1569686) in the promoter of the DNMT3B gene coding for the DNA methyltransferase 3B, an enzyme that mediates DNA methylation, increases the risk to develop MG or MG-associated thymomas. The study polymorphism was selected based on recent reports and a literature meta-analysis suggesting association with increased risk of various types of cancer. We screened 324 AChR+ MG patients (140 males and 184 females, mean age 56.0 +/- 16.5 years) and 735 healthy matched controls (294 males and 441 females, mean age 57.3 +/- 15.6 years). 94 of the total MG patients had a thymoma. While there was no association with the whole cohort of MG patients, we found a statistically significant association of the DNMT3B -579T allele (OR = 1.51; 95% CI=1.1-2.1, P = 0.01) and the TT homozygous genotype (OR = 2.59; 95% CI=1.4-4.9, P = 0.006) with the risk of thymoma. No association was observed in MG patients without thymoma, even after stratification into clinical subtypes. Present results suggest that the DNMT3B -579T allele might contribute to the risk of developing thymoma in MG patients, particularly in homozygous TT subjects.	[Coppede, Fabio; Denaro, Maria; Baggiani, Angelo; Migliore, Lucia] Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy; [Ricciardi, Roberta; De Rosa, Anna] Univ Pisa, Dept Neurosci, Div Neurol, Pisa, Italy; [Ricciardi, Roberta; Lucchi, Marco; Mussi, Alfredo] Univ Pisa, Cardiac & Thorac Dept, Div Thorac Surg, Pisa, Italy; [Provenzano, Carlo; Bartoccioni, Emanuela] Univ Cattolica Sacro Cuore, Inst Gen Pathol, Rome, Italy	University of Pisa; University of Pisa; University of Pisa; Catholic University of the Sacred Heart; IRCCS Policlinico Gemelli	Coppede, F (corresponding author), Univ Pisa, Dept Translat Res & New Technol Med & Surg, Pisa, Italy.	fabio.coppede@med.unipi.it	Coppedè, Fabio/X-6085-2019; Provenzano, Carlo/D-4573-2012; Lucchi, Marco/K-2140-2019; Baggiani, Angelo/AAC-4596-2022	Provenzano, Carlo/0000-0001-5476-5517; Baggiani, Angelo/0000-0003-2615-7308; Coppede, Fabio/0000-0002-3081-6647; LUCCHI, MARCO/0000-0001-9909-6820				APPEL SH, 1975, NEW ENGL J MED, V293, P760, DOI 10.1056/NEJM197510092931508; Arakawa Y, 2012, CLIN EXP IMMUNOL, V170, P194, DOI 10.1111/j.1365-2249.2012.04646.x; Bao Q, 2011, INT J COLORECTAL DIS, V26, P1107, DOI 10.1007/s00384-011-1199-3; Chang KP, 2008, ONCOL REP, V19, P217; Chen C, 2011, CANCER LETT, V301, P7, DOI 10.1016/j.canlet.2010.10.017; Chen C, 2009, CANCER INVEST, V27, P582, DOI 10.1080/07357900802620869; Chen MF, 2012, CANCER-AM CANCER SOC, V118, P4074, DOI 10.1002/cncr.26736; Coppede F, 2013, HUM REPROD, V28, P545, DOI 10.1093/humrep/des376; Coppede F, 2012, CURR ALZHEIMER RES, V9, P550, DOI 10.2174/156720512800618062; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Fan H, 2008, WORLD J GASTROENTERO, V14, P2230, DOI 10.3748/wjg.14.2230; Fonseca-Silva T, 2012, PATHOBIOLOGY, V79, P18, DOI 10.1159/000330171; Guo XQ, 2010, MOL BIOL REP, V37, P219, DOI 10.1007/s11033-009-9626-z; Hirose Y, 2009, LUNG CANCER, V64, P155, DOI 10.1016/j.lungcan.2008.07.015; Hong YS, 2007, BIOCHEM GENET, V45, P155, DOI 10.1007/s10528-006-9047-9; Hu JB, 2010, DIGEST DIS SCI, V55, P1011, DOI 10.1007/s10620-009-0831-3; Huidobro C, 2013, CELL MOL LIFE SCI, V70, P1543, DOI 10.1007/s00018-013-1296-2; Jiang YQ, 2013, BBA-REV CANCER, V1835, P155, DOI 10.1016/j.bbcan.2012.12.003; Jones PA, 2012, NAT REV GENET, V13, P484, DOI 10.1038/nrg3230; Lee SJ, 2005, CARCINOGENESIS, V26, P403, DOI 10.1093/carcin/bgh307; Leite MI, 2007, AM J PATHOL, V171, P893, DOI 10.2353/ajpath.2007.070240; Liu H, 2012, EXP THER MED, V3, P525, DOI 10.3892/etm.2011.420; Liu ZS, 2008, CANCER LETT, V268, P158, DOI 10.1016/j.canlet.2008.03.034; Martin-Subero Jose Ignacio, 2011, Pediatr Endocrinol Rev, V9 Suppl 1, P506; Marx A, 2013, AUTOIMMUN REV, V12, P875, DOI 10.1016/j.autrev.2013.03.007; Meda F, 2011, CELL MOL IMMUNOL, V8, P226, DOI 10.1038/cmi.2010.78; Murphy TM, 2013, GENES BRAIN BEHAV, V12, P125, DOI 10.1111/j.1601-183X.2012.00865.x; Nam EJ, 2010, RHEUMATOL INT, V30, P1299, DOI 10.1007/s00296-009-1141-y; Ngalamika O, 2012, J AUTOIMMUN, V39, P451, DOI 10.1016/j.jaut.2012.09.002; QUINTERORONDERO.P, 2012, AUTOIMMUNE DIS, V2012, DOI DOI 10.1155/2012/593720; Renaudineau Yves, 2011, Keio Journal of Medicine, V60, P10; Zhang Chen, 2010, Zhonghua Yixue Yichuanxue Zazhi, V27, P697, DOI 10.3760/cma.j.issn.1003-9406.2010.06.022; Zhang P, 2012, J EUR ACAD DERMATOL, V26, P399, DOI 10.1111/j.1468-3083.2011.04261.x; Zhu SM, 2012, MOL BIOL REP, V39, P4429, DOI 10.1007/s11033-011-1231-2	34	9	10	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80846	10.1371/journal.pone.0080846	http://dx.doi.org/10.1371/journal.pone.0080846			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260492	gold, Green Published			2022-12-25	WOS:000327311900100
J	Iwabuchi, S; Koh, JY; Wang, K; Ho, KWD; Harata, NC				Iwabuchi, Sadahiro; Koh, Jin-Young; Wang, Kai; Ho, K. W. David; Harata, N. Charles			Minimal Change in the Cytoplasmic Calcium Dynamics in Striatal GABAergic Neurons of a DYT1 Dystonia Knock-In Mouse Model	PLOS ONE			English	Article							MEDIUM SPINY NEURONS; PRIMARY TORSION DYSTONIA; HIPPOCAMPAL-NEURONS; SYNAPTIC VESICLES; PROTEIN TORSINA; BASAL GANGLIA; CHOLINERGIC INTERNEURONS; MOVEMENT-DISORDERS; TRANSGENIC MICE; PRIMARY CULTURE	DYT1 dystonia is the most common hereditary form of primary torsion dystonia. This autosomal-dominant disorder is characterized by involuntary muscle contractions that cause sustained twisting and repetitive movements. It is caused by an in-frame deletion in the TOR1A gene, leading to the deletion of a glutamic acid residue in the torsinA protein. Heterozygous knock-in mice, which reproduce the genetic mutation in human patients, have abnormalities in synaptic transmission at the principal GABAergic neurons in the striatum, a brain structure that is involved in the execution and modulation of motor activity. However, whether this mutation affects the excitability of striatal GABAergic neurons has not been investigated in this animal model. Here, we examined the excitability of cultured striatal neurons obtained from heterozygous knock-in mice, using calcium imaging as indirect readout. Immunofluorescence revealed that more than 97% of these neurons are positive for a marker of GABAergic neurons, and that more than 92% are also positive for a marker of medium spiny neurons, indicating that these are mixed cultures of mostly medium spiny neurons and a few (similar to 5%) GABAergic interneurons. When these neurons were depolarized by field stimulation, the calcium concentration in the dendrites increased rapidly and then decayed slowly. The amplitudes of calcium transients were larger in heterozygous neurons than in wild-type neurons, resulting in similar to 15% increase in cumulative calcium transients during a train of stimuli. However, there was no change in other parameters of calcium dynamics. Given that calcium dynamics reflect neuronal excitability, these results suggest that the mutation only slightly increases the excitability of striatal GABAergic neurons in DYT1 dystonia.	[Iwabuchi, Sadahiro; Koh, Jin-Young; Ho, K. W. David; Harata, N. Charles] Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Wang, Kai] Univ Iowa, Coll Publ Hlth, Dept Biostat, Iowa City, IA USA; [Ho, K. W. David; Harata, N. Charles] Univ Iowa, Carver Coll Med, Med Scientist Training Program, Iowa City, IA USA	University of Iowa; University of Iowa; University of Iowa	Harata, NC (corresponding author), Univ Iowa, Carver Coll Med, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	charles-harata@uiowa.edu	Iwabuchi, Sadahiro/AAD-4455-2022; Ho, Kwo Wei David/I-9751-2019	Ho, Kwo Wei David/0000-0003-2085-2107; Koh, Jin-Young/0000-0002-6785-0515; Harata, N. Charles/0000-0003-3287-4549	American Heart Association; Dystonia Medical Research Foundation; Edward Mallinckrodt, Jr. Foundation; National Science Foundation [0817608]; Whitehall Foundation [2008-08-24]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES005605] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007337] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); Dystonia Medical Research Foundation; Edward Mallinckrodt, Jr. Foundation; National Science Foundation(National Science Foundation (NSF)); Whitehall Foundation; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	American Heart Association (NCH), http://www.heart.org/HEARTORG/; Dystonia Medical Research Foundation (NCH), http://www.dystonia-foundation.org/; Edward Mallinckrodt, Jr. Foundation (NCH), URL is not available; National Science Foundation (0817608, NCH), http://www.nsf.gov/; Whitehall Foundation (2008-08-24, NCH), http://www.whitehall.org/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akopian G, 2008, J NEUROSCI, V28, P9585, DOI 10.1523/JNEUROSCI.5698-07.2008; Berridge MJ, 2003, NAT REV MOL CELL BIO, V4, P517, DOI 10.1038/nrm1155; Chen X, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-81; Chen YC, 2008, J NEUROSCI METH, V171, P239, DOI 10.1016/j.jneumeth.2008.03.013; Dang MT, 2012, BEHAV BRAIN RES, V226, P465, DOI 10.1016/j.bbr.2011.10.002; Dang MT, 2005, EXP NEUROL, V196, P452, DOI 10.1016/j.expneurol.2005.08.025; Falk T, 2006, J COMP NEUROL, V494, P275, DOI 10.1002/cne.20819; Fernagut PO, 2002, NEUROSCIENCE, V114, P1005, DOI 10.1016/S0306-4522(02)00205-1; FOX AP, 1987, J PHYSIOL-LONDON, V394, P149, DOI 10.1113/jphysiol.1987.sp016864; Garcia-Junco-Clemente P, 2010, J NEUROSCI, V30, P7377, DOI 10.1523/JNEUROSCI.0924-10.2010; Gerfen CR, 2010, HBK BEHAV NEUROSCI, V20, P3; Gilmor ML, 1996, J NEUROSCI, V16, P2179; Gittis AH, 2012, TRENDS NEUROSCI, V35, P557, DOI 10.1016/j.tins.2012.06.008; Goodchild RE, 2005, NEURON, V48, P923, DOI 10.1016/j.neuron.2005.11.010; Greene JG, 1998, NEUROSCIENCE, V84, P503, DOI 10.1016/S0306-4522(97)00389-8; Grundmann K, 2012, NEUROBIOL DIS, V47, P61, DOI 10.1016/j.nbd.2012.03.024; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Harata N, 1999, NEUROSCIENCE, V89, P109, DOI 10.1016/S0306-4522(98)00308-X; Harata N, 2001, P NATL ACAD SCI USA, V98, P12748, DOI 10.1073/pnas.171442798; Harata N, 1996, BRAIN RES, V711, P223, DOI 10.1016/0006-8993(95)01406-3; Hedreen J C, 1988, Adv Neurol, V50, P123; Hewett J, 2010, J NEUROCHEM, V113, P228, DOI 10.1111/j.1471-4159.2010.06590.x; Higley MJ, 2010, NAT NEUROSCI, V13, P958, DOI 10.1038/nn.2592; Huber D, 2012, NATURE, V484, P473, DOI 10.1038/nature11039; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Iwabuchi S, 2013, NEUROSCI LETT, V548, P61, DOI 10.1016/j.neulet.2013.05.047; Johnson I., 2010, MOL PROBES HDB; Kakazu Y, 2012, SYNAPSE, V66, P807, DOI 10.1002/syn.21571; Kakazu Y, 2012, SYNAPSE, V66, P453, DOI 10.1002/syn.21534; Kira T, 1998, NEUROSCIENCE, V85, P383, DOI 10.1016/S0306-4522(97)00637-4; Koizumi S, 1999, NEURON, V22, P125, DOI 10.1016/S0896-6273(00)80684-4; Koos T, 1999, NAT NEUROSCI, V2, P467, DOI 10.1038/8138; Kozorovitskiy Y, 2012, NATURE, V485, P646, DOI 10.1038/nature11052; Kravitz AV, 2010, NATURE, V466, P622, DOI 10.1038/nature09159; Marchi B, 2000, CELL CALCIUM, V28, P225, DOI 10.1054/ceca.2000.0155; Martella G, 2009, BRAIN, V132, P2336, DOI 10.1093/brain/awp194; McNaught KS, 2004, ANN NEUROL, V56, P540, DOI 10.1002/ana.20225; Napolitano F, 2010, NEUROBIOL DIS, V38, P434, DOI 10.1016/j.nbd.2010.03.003; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Oorschot DE, 2010, HBK BEHAV NEUROSCI, V20, P63; Ouimet CC, 1998, BRAIN RES, V808, P8, DOI 10.1016/S0006-8993(98)00724-0; Ozelius LJ, 2011, NEUROBIOL DIS, V42, P127, DOI 10.1016/j.nbd.2010.12.012; Page ME, 2010, NEUROBIOL DIS, V39, P318, DOI 10.1016/j.nbd.2010.04.016; PHELPS PE, 1985, J COMP NEUROL, V238, P286, DOI 10.1002/cne.902380305; Pisani A, 2006, NEUROBIOL DIS, V24, P318, DOI 10.1016/j.nbd.2006.07.006; Pisani A, 2007, TRENDS NEUROSCI, V30, P545, DOI 10.1016/j.tins.2007.07.008; RANDALL A, 1995, J NEUROSCI, V15, P2995; Rostasy K, 2003, NEUROBIOL DIS, V12, P11, DOI 10.1016/S0969-9961(02)00010-4; Scheffe H, 1959, ANAL VARIANCE; Sciamanna G, 2012, J NEUROSCI, V32, P11991, DOI 10.1523/JNEUROSCI.0041-12.2012; Sciamanna G, 2012, NEUROBIOL DIS, V47, P416, DOI 10.1016/j.nbd.2012.04.015; Sciamanna G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024261; Sciamanna G, 2009, NEUROBIOL DIS, V34, P133, DOI 10.1016/j.nbd.2009.01.001; Shuen JA, 2008, J NEUROSCI, V28, P2681, DOI 10.1523/JNEUROSCI.5492-07.2008; Song CH, 2013, NEUROBIOL DIS, V54, P362, DOI 10.1016/j.nbd.2013.01.008; Song CH, 2012, NEUROBIOL DIS, V48, P66, DOI 10.1016/j.nbd.2012.05.009; Standaert DG, 2011, NEUROBIOL DIS, V42, P148, DOI 10.1016/j.nbd.2011.01.012; Tang TS, 2004, EUR J NEUROSCI, V20, P1779, DOI 10.1111/j.1460-9568.2004.03633.x; Tepper JM, 2010, FRONT NEUROANAT, V4, DOI 10.3389/fnana.2010.00150; Tepper JM, 2004, TRENDS NEUROSCI, V27, P662, DOI 10.1016/j.tins.2004.08.007; Tian XY, 2010, MOL CELL NEUROSCI, V44, P94, DOI 10.1016/j.mcn.2010.01.012; Walker RH, 2001, BRAIN RES, V900, P348, DOI 10.1016/S0006-8993(01)02302-2; Zenisek D, 2002, NEURON, V35, P1085, DOI 10.1016/S0896-6273(02)00896-6; Zhao CG, 2013, P NATL ACAD SCI USA, V110, pE1545, DOI 10.1073/pnas.1300676110	64	10	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80793	10.1371/journal.pone.0080793	http://dx.doi.org/10.1371/journal.pone.0080793			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260480	gold, Green Published, Green Submitted			2022-12-25	WOS:000327311900097
J	Kegel, JU; John, U; Valentin, K; Frickenhaus, S				Kegel, Jessica U.; John, Uwe; Valentin, Klaus; Frickenhaus, Stephan			Genome Variations Associated with Viral Susceptibility and Calcification in Emiliania huxleyi	PLOS ONE			English	Article							LIFE-CYCLE STAGES; ACTIVATED PROTEIN-KINASE; BAX INHIBITOR-1; GENE-EXPRESSION; CELL-DEATH; VIRUS ENTRY; ALGAL VIRUS; PAN-GENOME; COCCOLITHOPHORE; HYBRIDIZATION	Emiliania huxleyi, a key player in the global carbon cycle is one of the best studied coccolithophores with respect to biogeochemical cycles, climatology, and host-virus interactions. Strains of E. huxleyi show phenotypic plasticity regarding growth behaviour, light-response, calcification, acidification, and virus susceptibility. This phenomenon is likely a consequence of genomic differences, or transcriptomic responses, to environmental conditions or threats such as viral infections. We used an E. huxleyi genome microarray based on the sequenced strain CCMP1516 (reference strain) to perform comparative genomic hybridizations (CGH) of 16 E. huxleyi strains of different geographic origin. We investigated the genomic diversity and plasticity and focused on the identification of genes related to virus susceptibility and coccolith production (calcification). Among the tested 31940 gene models a core genome of 14628 genes was identified by hybridization among 16 E. huxleyi strains. 224 probes were characterized as specific for the reference strain CCMP1516. Compared to the sequenced E. huxleyi strain CCMP1516 variation in gene content of up to 30 percent among strains was observed. Comparison of core and non-core transcripts sets in terms of annotated functions reveals a broad, almost equal functional coverage over all KOG-categories of both transcript sets within the whole annotated genome. Within the variable (non-core) genome we identified genes associated with virus susceptibility and calcification. Genes associated with virus susceptibility include a Bax inhibitor-1 protein, three LRR receptor-like protein kinases, and mitogen-activated protein kinase. Our list of transcripts associated with coccolith production will stimulate further research, e. g. by genetic manipulation. In particular, the V-type proton ATPase 16 kDa proteolipid subunit is proposed to be a plausible target gene for further calcification studies.	[Kegel, Jessica U.; John, Uwe; Valentin, Klaus; Frickenhaus, Stephan] Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany; [Frickenhaus, Stephan] Hsch Bremerhaven, Bremerhaven, Germany	Helmholtz Association; Alfred Wegener Institute, Helmholtz Centre for Polar & Marine Research	Frickenhaus, S (corresponding author), Alfred Wegener Inst Polar & Marine Res, Bremerhaven, Germany.	Stephan.Frickenhaus@awi.de	Kegel, Jessica U./L-1726-2014; john, uwe/S-3009-2016; Valentin, Klaus/G-5862-2014	Kegel, Jessica U./0000-0002-4740-9554; john, uwe/0000-0002-1297-4086; Valentin, Klaus/0000-0001-7401-9423; Frickenhaus, Stephan/0000-0002-0356-9791	PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; Marine Genomics Europe (EU) [505403]	PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment; Marine Genomics Europe (EU)(European Commission)	Financial support was partly provided by the PACES research program of the Alfred Wegener Institute, within the Helmholtz Foundation Initiative in Earth and Environment, and by Marine Genomics Europe (EU Contract no 505403). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen MJ, 2007, ENVIRON MICROBIOL, V9, P971, DOI 10.1111/j.1462-2920.2006.01219.x; Allen MJ, 2006, ARCH VIROL, V151, P525, DOI 10.1007/s00705-005-0647-1; Allen MJ, 2006, MOL BIOL EVOL, V23, P86, DOI 10.1093/molbev/msj010; Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andrade AA, 2004, BIOCHEM J, V381, P437, DOI 10.1042/BJ20031375; Araki Y, 1998, J PHYCOL, V34, P79, DOI 10.1046/j.1529-8817.1998.340079.x; BALCH WM, 1991, LIMNOL OCEANOGR, V36, P629, DOI 10.4319/lo.1991.36.4.0629; BALCH WM, 1992, CONT SHELF RES, V12, P1353, DOI 10.1016/0278-4343(92)90059-S; Baranowski E, 2001, SCIENCE, V292, P1102, DOI 10.1126/science.1058613; Bateman A, 2002, NUCLEIC ACIDS RES, V30, P276, DOI 10.1093/nar/30.1.276; Bidle KD, 2007, P NATL ACAD SCI USA, V104, P6049, DOI 10.1073/pnas.0701240104; Bidle KD, 2012, J PHYCOL, V48, P1079, DOI 10.1111/j.1529-8817.2012.01209.x; Bidle KD, 2011, CURR OPIN MICROBIOL, V14, P449, DOI 10.1016/j.mib.2011.07.013; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; BRATBAK G, 1993, MAR ECOL PROG SER, V93, P39, DOI 10.3354/meps093039; BROWN CW, 1993, J PLANKTON RES, V15, P1429, DOI 10.1093/plankt/15.12.1429; Cacas JL, 2010, PLANT CELL ENVIRON, V33, P1453, DOI 10.1111/j.1365-3040.2010.02117.x; Castberg T, 2002, J PHYCOL, V38, P767, DOI 10.1046/j.1529-8817.2002.02015.x; Compton T, 2004, TRENDS CELL BIOL, V14, P5, DOI 10.1016/j.tcb.2003.10.009; Cook SS, 2011, J PHYCOL, V47, P615, DOI 10.1111/j.1529-8817.2011.00992.x; Corstjens PLAM, 2001, J PHYCOL, V37, P71, DOI 10.1046/j.1529-8817.1999.014012071.x; Corstjens PLAM, 1998, J PHYCOL, V34, P622, DOI 10.1046/j.1529-8817.1998.340622.x; Dittami SM, 2011, BMC MOL BIOL, V12, DOI 10.1186/1471-2199-12-2; Dyhrman ST, 2006, APPL ENVIRON MICROB, V72, P252, DOI 10.1128/AEM.72.1.252-260.2006; Eichmann R, 2010, MOL PLANT MICROBE IN, V23, P1217, DOI 10.1094/MPMI-23-9-1217; Ejrnaes M, 2006, J EXP MED; Ellis J, 2000, CURR OPIN PLANT BIOL, V3, P278, DOI 10.1016/S1369-5266(00)00080-7; Erbar S, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-142; Evans C, 2007, LIMNOL OCEANOGR, V52, P1036, DOI 10.4319/lo.2007.52.3.1036; Evans C, 2006, J PHYCOL, V42, P1040, DOI 10.1111/j.1529-8817.2006.00256.x; Farquhar MJ, 2008, J VIROL, V82, P8797, DOI 10.1128/JVI.00592-08; Fukiya S, 2004, J BACTERIOL, V186, P3911, DOI 10.1128/JB.186.12.3911-3921.2004; Hagino K, 2011, J PHYCOL, V47, P1164, DOI 10.1111/j.1529-8817.2011.01053.x; HOLLIGAN PM, 1983, NATURE, V304, P339, DOI 10.1038/304339a0; HOLLIGAN PM, 1993, GLOBAL BIOGEOCHEM CY, V7, P879, DOI 10.1029/93GB01731; Hoppe CJM, 2011, J EXP MAR BIOL ECOL, V406, P54, DOI 10.1016/j.jembe.2011.06.008; Huckelhoven R, 2004, APOPTOSIS, V9, P299, DOI 10.1023/B:APPT.0000025806.71000.1c; Huckelhoven R, 2003, P NATL ACAD SCI USA, V100, P5555, DOI 10.1073/pnas.0931464100; Iglesias-Rodriguez MD, 2002, MOL ECOL NOTES, V2, P495, DOI 10.1046/j.1471-8286.2002.00289.x; Jacquet S, 2002, AQUAT MICROB ECOL, V27, P111, DOI 10.3354/ame027111; Jones DA, 1997, ADV BOT RES, V24, P89; Keymer DP, 2007, APPL ENVIRON MICROB, V73, P3705, DOI 10.1128/AEM.02736-06; Kim CC, 2002, GENOME BIOL, V3; Lakeman MB, 2009, HARMFUL ALGAE, V8, P746, DOI 10.1016/j.hal.2008.11.011; Langer G, 2009, BIOGEOSCIENCES, V6, P2637, DOI 10.5194/bg-6-2637-2009; Lefebure T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r71; Mackinder L, 2010, GEOMICROBIOL J, V27, P585, DOI 10.1080/01490451003703014; MALIN G, 1994, HAPTOPHYTE ALGAE, P303; Marchant D, 2010, J VIROL, V84, P11359, DOI 10.1128/JVI.00804-10; Marsh Mary E., 2007, P211, DOI 10.1002/9783527619443.ch12; Marsh ME, 2003, COMP BIOCHEM PHYS B, V136, P743, DOI 10.1016/S1096-4959(03)00180-5; Martinez JM, 2007, APPL ENVIRON MICROB, V73, P554, DOI 10.1128/AEM.00864-06; Medini D, 2005, CURR OPIN GENET DEV, V15, P589, DOI 10.1016/j.gde.2005.09.006; Medlin LK, 1996, J MARINE SYST, V9, P13, DOI 10.1016/0924-7963(96)00013-9; Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002; Monick MM, 2001, J IMMUNOL, V166, P2681, DOI 10.4049/jimmunol.166.4.2681; Mudhakir D, 2009, AAPS J, V11, P65, DOI 10.1208/s12248-009-9080-9; Nguyen B, 2005, APPL ENVIRON MICROB, V71, P2564, DOI 10.1128/AEM.71.5.2564-2575.2005; NORKIN LC, 1995, CLIN MICROBIOL REV, V8, P293, DOI 10.1128/CMR.8.2.293; Ozaki N, 2007, BIOCHEM BIOPH RES CO, V357, P1172, DOI 10.1016/j.bbrc.2007.04.078; Paasche E, 2001, PHYCOLOGIA, V40, P503, DOI 10.2216/i0031-8884-40-6-503.1; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Pearson BM, 2003, FEBS LETT, V554, P224, DOI 10.1016/S0014-5793(03)01164-5; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; PLAM Corstjens, 1996, PLANT PHYSIOL, V111, P652; Quinn P, 2006, APPL ENVIRON MICROB, V72, P5512, DOI 10.1128/AEM.00343-06; Rasmussen TB, 2008, APPL ENVIRON MICROB, V74, P4703, DOI 10.1128/AEM.00132-08; Read BA, 2013, NATURE, V499, P209, DOI 10.1038/nature12221; Read Betsy A., 2007, P227, DOI 10.1002/9783527619443.ch13; REN R, 1990, CELL, V63, P353, DOI 10.1016/0092-8674(90)90168-E; Reno ML, 2009, P NATL ACAD SCI USA, V106, P8605, DOI 10.1073/pnas.0808945106; Richier S, 2009, APPL ENVIRON MICROB, V75, P3366, DOI 10.1128/AEM.02737-08; Riley M, 2000, ANNU REV MICROBIOL, V54, P341, DOI 10.1146/annurev.micro.54.1.341; Rokitta SD, 2012, LIMNOL OCEANOGR, V57, P607, DOI 10.4319/lo.2012.57.2.0607; Rokitta SD, 2011, J PHYCOL, V47, P829, DOI 10.1111/j.1529-8817.2011.01014.x; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Schroeder DC, 2003, APPL ENVIRON MICROB, V69, P2484, DOI 10.1128/AEM.69.5.2484-2490.2003; Schroeder DC, 2002, ARCH VIROL, V147, P1685, DOI 10.1007/s00705-002-0841-3; Sotoj AR, 2006, APPL ENVIRON MICROB, V72, P5500, DOI 10.1128/AEM.00237-06; Sukhanova I. N., 1998, OCEANOLOGY, V38, P502; Taylor AR, 2007, EUR J PHYCOL, V42, P125, DOI 10.1080/09670260601159346; Team TRDC, 2009, R LANG ENV STAT COMP; Tettelin H, 2005, P NATL ACAD SCI USA, V102, P13950, DOI 10.1073/pnas.0506758102; THIERSTEIN HR, 1977, GEOLOGY, V5, P400, DOI 10.1130/0091-7613(1977)5<400:GSOLQC>2.0.CO;2; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thyrhaug R, 2002, J PHYCOL, V38, P338, DOI 10.1046/j.1529-8817.2002.01154.x; Vardi A, 2009, SCIENCE, V326, P861, DOI 10.1126/science.1177322; Wahlund TM, 2004, MAR BIOTECHNOL, V6, P278, DOI 10.1007/s10126-003-0035-3; Watanabe T, 2004, YEAST, V21, P351, DOI 10.1002/yea.1103; WESTBROEK P, 1993, GLOBAL PLANET CHANGE, V8, P27, DOI 10.1016/0921-8181(93)90061-R; Westbroek Peter, 1994, Systematics Association Special Volume Series, V51, P321; Wilson WH, 2002, J MAR BIOL ASSOC UK, V82, P369, DOI 10.1017/S002531540200560X; Winter Amos, 1994, P161; Young Jeremy R., 1994, P63	95	24	24	0	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80684	10.1371/journal.pone.0080684	http://dx.doi.org/10.1371/journal.pone.0080684			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260453	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900086
J	Aponte-Gonzalez, J; Fajardo-Bernal, L; Diaz, J; Eslava-Schmalbach, J; Gamboa, O; Hay, JW				Aponte-Gonzalez, Johanna; Fajardo-Bernal, Luisa; Diaz, Jorge; Eslava-Schmalbach, Javier; Gamboa, Oscar; Hay, Joel W.			Cost-Effectiveness Analysis of the Bivalent and Quadrivalent Human Papillomavirus Vaccines from a Societal Perspective in Colombia	PLOS ONE			English	Article							CERVICAL-CANCER; PARTICLE VACCINE; ECONOMIC-EVALUATION; SUSTAINED EFFICACY; NATURAL-HISTORY; DOUBLE-BLIND; YOUNG-WOMEN; HPV VACCINE; FOLLOW-UP; INFECTION	Objective: To compare costs and effectiveness of three strategies used against cervical cancer (CC) and genital warts: (i) Screening for CC; (ii) Bivalent Human Papillomavirus (HPV) 16/18 vaccine added to screening; (iii) Quadrivalent HPV 6/11/16/18 vaccine added to screening. Methods: A Markov model was designed in order to simulate the natural history of the disease from 12 years of age (vaccination) until death. Transition probabilities were selected or adjusted to match the HPV infection profile in Colombia. A systematic review was undertaken in order to derive efficacy values for the two vaccines as well as for the operational characteristics of the cytology test. The societal perspective was used. Effectiveness was measured in number of averted Disability Adjusted Life Years (DALYS). Results: At commercial prices reported for 2010 the two vaccines were shown to be non-cost-effective alternatives when compared with the existing screening strategy. Sensitivity analyses showed that results are affected by the cost of vaccines and their efficacy values, making it difficult to determine with certainty which of the two vaccines has the best cost-effectiveness profile. To be 'cost-effective' vaccines should cost between 141 and 147 USD (Unite States Dollars) per vaccinated girl at the most. But at lower prices such as those recommended by WHO or the price of other vaccines in Colombia, HPV vaccination could be considered very cost-effective. Conclusions: HPV vaccination could be a convenient alternative for the prevention of CC in Colombia. However, the price of the vaccine should be lower for this vaccination strategy to be cost-effective. It is also important to take into consideration the willingness to pay, budgetary impact, and program implications, in order to determine the relevance of a vaccination program in this country, as well as which vaccine should be selected for use in the program.	[Aponte-Gonzalez, Johanna; Fajardo-Bernal, Luisa; Eslava-Schmalbach, Javier] Univ Nacl Colombia, Dept Clin Epidemiol, Sch Med, Clin Res Inst, Bogota, Colombia; [Diaz, Jorge] Univ Nacl Colombia, Dept Pharmacol, Sch Pharm, Bogota, Colombia; [Gamboa, Oscar] Inst Nacl Cancerol Colombia, Subdirecc Invest, Res Dept, Bogota, Colombia; [Hay, Joel W.] Univ So Calif, Sch Pharm, Titus Family Dept Clin Pharm & Pharmaceut Econ &, Los Angeles, CA USA	Universidad Nacional de Colombia; Universidad Nacional de Colombia; University of Southern California	Aponte-Gonzalez, J (corresponding author), Univ Nacl Colombia, Dept Clin Epidemiol, Sch Med, Clin Res Inst, Bogota, Colombia.	jaaponteg@unal.edu.co	Eslava-Schmalbach, Javier/O-3954-2019	Eslava-Schmalbach, Javier/0000-0003-1502-2918	Univesidad Nacional de Colombia - Direccion de Investigacion Sede Bogota; Vicedecanatura de Investigacion Facultad de Medicina	Univesidad Nacional de Colombia - Direccion de Investigacion Sede Bogota; Vicedecanatura de Investigacion Facultad de Medicina	This project was funded by Univesidad Nacional de Colombia - Direccion de Investigacion Sede Bogota and Vicedecanatura de Investigacion Facultad de Medicina, http://www.dib.unal.edu.co/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvis N, 2011, REV PANAM SALUD PUBL, V30, P209, DOI 10.1590/S1020-49892011000900004; Andres-Gamboa O, 2008, SALUD PUBLICA MEXICO, V50, P276, DOI 10.1590/s0036-36342008000400005; [Anonymous], 2008, Biomed., V28, P457; Aponte-González Johanna, 2011, Rev Colomb Obstet Ginecol, V62, P177; Arbyn M, 2008, OBSTET GYNECOL, V111, P167, DOI 10.1097/01.AOG.0000296488.85807.b3; Bloom DE, 2011, ADV EXP MED BIOL, V697, P1, DOI 10.1007/978-1-4419-7185-2_1; Bosch FX, 2002, J CLIN PATHOL, V55, P244, DOI 10.1136/jcp.55.4.244; Brisson M, 2007, VACCINE, V25, P5399, DOI 10.1016/j.vaccine.2007.04.086; Brown DR, 2009, J INFECT DIS, V199, P926, DOI 10.1086/597307; Castaneda-Orjuela C, 2012, VACCINE, V30, P1936, DOI 10.1016/j.vaccine.2012.01.031; Castaneda-Orjuela C, 2011, VACCINE, V29, P7644, DOI 10.1016/j.vaccine.2011.08.006; Cendales R, 2010, BIOMEDICA, V30, P107, DOI 10.7705/biomedica.v30i1.158; Chesson HW, 2008, EMERG INFECT DIS, V14, P244, DOI 10.3201/eid1402.070499; Colantonio L, 2009, VACCINE, V27, P5519, DOI 10.1016/j.vaccine.2009.06.097; De Carvalho N, 2010, VACCINE, V28, P6247, DOI 10.1016/j.vaccine.2010.07.007; de la Hoz-Restrepo Fernando, 2009, Rev. salud pública, V11, P454; Debicki D, 2008, VACCINE, V26, pF16, DOI 10.1016/j.vaccine.2008.02.040; Dee A, 2010, EUR J PUBLIC HEALTH, V20, P213, DOI 10.1093/eurpub/ckp141; *DEP ADM NAC EST, 2011, INGR LAB PROM SEX RA; Elbasha EH, 2007, EMERG INFECT DIS, V13, P28, DOI 10.3201/eid1301.060438; GARCIA E, 2006, REV CHIL OBSTET GINE, V71, P5; GOLD M, 1996, COST EFFECTINENESS H; Goldie SJ, 2004, JNCI-J NATL CANCER I, V96, P604, DOI 10.1093/jnci/djh104; Goldie SJ, 2008, VACCINE, V26, pL59, DOI 10.1016/j.vaccine.2008.05.063; Goldie SJ, 2007, VACCINE, V25, P6257, DOI 10.1016/j.vaccine.2007.05.058; Heard I, 2009, CURR OPIN HIV AIDS, V4, P68, DOI 10.1097/COH.0b013e328319bcbe; Hoppenot C, 2012, OBSTET GYNECOL SURV, V67, P658, DOI 10.1097/OGX.0b013e3182732375; Insinga RP, 2009, BMC INFECT DIS, V9, DOI 10.1186/1471-2334-9-119; *INST NAC CANC, 2009, TABL DISTR CAS NUEV; Jit M, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a769; Jit M, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5775; Lee VJ, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-203; Leon SCSD, 2009, CLIN MICROBIOL INFEC, V15, P100, DOI 10.1111/j.1469-0691.2008.02120.x; MARTINHIRSCH PP, 2010, COCHRANE DB SYST REV; Mennini FS, 2009, GYNECOL ONCOL, V112, P370, DOI 10.1016/j.ygyno.2008.09.031; *MIN DE SAL, GEN PROM PREV DIR NO; *MIN PROT SOC CONS, 2006, REG PAG COMP CUOT MO; *MIN PROT SOC REP, 2010, GUIA MET EL GUIAS AT; *MIN PROT SOC REP, PERF EP VIH SIDA COL; Molano M, 2003, AM J EPIDEMIOL, V158, P486, DOI 10.1093/aje/kwg171; MOLANO M, 2012, HPV INFECT CAUSALITY; MUENNIG P, 2002, DESIGNING CONDUCTING; *MUND SAL ORG, VAC VIR PAP HUM; Munoz N, 2004, J INFECT DIS, V190, P2077, DOI 10.1086/425907; Munoz N, 2009, LANCET, V373, P1949, DOI 10.1016/S0140-6736(09)60691-7; Myers ER, 2000, AM J EPIDEMIOL, V151, P1158, DOI 10.1093/oxfordjournals.aje.a010166; *NAC DEM SAL ENC, 2010, DET TEMPR CACNC CUEL; Nanda K, 2000, ANN INTERN MED, V132, P810, DOI 10.7326/0003-4819-132-10-200005160-00009; Nuovo J, 2000, INT J GYNECOL OBSTET, V68, P25, DOI 10.1016/S0020-7292(99)00162-9; Paavonen J, 2007, LANCET, V369, P2161, DOI 10.1016/S0140-6736(07)60946-5; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Pardo C, 2009, BIOMEDICA, V29, P437, DOI 10.7705/biomedica.v29i3.2; Romanowski B, 2009, LANCET, V374, P1975, DOI 10.1016/S0140-6736(09)61567-1; Sanders GD, 2003, EMERG INFECT DIS, V9, P37; TANTORRES T, 2003, MAKING CHOISES HLTH; Villa LL, 2005, LANCET ONCOL, V6, P271, DOI 10.1016/S1470-2045(05)70101-7; *WHO CHOICE, CHOOSING INT COST EF; *WHO WEBS, METR DIS AJD LIF YEA; Wiesner Carolina, 2010, Rev. salud pública, V12, P1; *WORLD BANK, 2010, POPULATION; *WORLD DEV IND WOR, 2006, WORLD BANK WEBS TOT	61	12	16	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80639	10.1371/journal.pone.0080639	http://dx.doi.org/10.1371/journal.pone.0080639			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256KH	24260441	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500162
J	Ma, H; Zhao, XL; Wang, XY; Xie, XW; Han, JC; Guan, WL; Wang, Q; Zhu, L; Pan, XB; Wei, L				Ma, Hui; Zhao, Xing-Liang; Wang, Xue-Yan; Xie, Xing-Wang; Han, Jin-Chao; Guan, Wen-Li; Wang, Qin; Zhu, Lin; Pan, Xiao-Ben; Wei, Lai			2 ',3 '-Cyclic Nucleotide 3 '-Phosphodiesterases Inhibit Hepatitis B Virus Replication	PLOS ONE			English	Article							N-TERMINAL DOMAIN; MEMBRANE ANCHOR; GENE-EXPRESSION; TRANSGENIC MICE; C VIRUS; INTERFERON; PROTEIN; SIGNAL; CELLS; IDENTIFICATION	2',3'-cyclic nucleotide 3'-phosphodiesterase (CNP) is a member of the interferon-stimulated genes, which includes isoforms CNP1 and CNP2. CNP1 is locally expressed in the myelin sheath but CNP2 is additionally expressed at low levels outside the nervous system. CNPs regulate multiple cellular functions and suppress protein production by association with polyadenylation of mRNA. Polyadenylation of Hepatitis B virus (HBV) RNAs is crucial for HBV replication. Whether CNPs interact with polyadenylation signal of HBV RNAs and interfere HBV replication is unknown. In this study, we evaluated expressions of CNP isoforms in hepatoma cell lines and their effects on HBV replication. We found that CNP2 is moderately expressed and gently responded to interferon treatment in HepG2, but not in Huh7 cells. The CNP1 and CNP2 potently inhibited HBV production by blocking viral proteins synthesis and reducing viral RNAs, respectively. In chronic hepatitis B patients, CNP was expressed in most of HBV-infected hepatocytes of liver specimens. Knockdown of CNP expression moderately improved viral production in the HepG2.2.15 cells treated with IFN-alpha. In conclusion, CNP might be a mediator of interferon-induced response against HBV.	[Ma, Hui; Zhao, Xing-Liang; Wang, Xue-Yan; Xie, Xing-Wang; Han, Jin-Chao; Guan, Wen-Li; Wang, Qin; Zhu, Lin; Pan, Xiao-Ben; Wei, Lai] Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Beijing 100871, Peoples R China	Peking University	Pan, XB (corresponding author), Peking Univ, Peoples Hosp, Inst Hepatol, Beijing Key Lab Hepatitis & Immunotherapy Liver D, Beijing 100871, Peoples R China.	panxiaoben@pkuph.edu.cn		Pan, Xiao-Ben/0000-0002-7795-8159	National Natural Science Foundation of China [30972605]; Program for New Century Excellent Talents in University [NCET-11-0011]; Beijing Science and Technology Commission [D121100003912003]; National Science and Technology Major Project for Infectious Diseases Control [2012ZX10002003]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET)); Beijing Science and Technology Commission; National Science and Technology Major Project for Infectious Diseases Control	This study was funded by a grant from National Natural Science Foundation of China (Grand number 30972605), Program for New Century Excellent Talents in University (NCET-11-0011), The Key Project of Beijing Science and Technology Commission (No. D121100003912003) and The National Science and Technology Major Project for Infectious Diseases Control during the 12th Five-Year Plan Period (No. 2012ZX10002003). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bifulco M, 2002, P NATL ACAD SCI USA, V99, P1807, DOI 10.1073/pnas.042678799; Calvin K, 2008, CELL MOL LIFE SCI, V65, P1176, DOI 10.1007/s00018-008-7393-y; Chen JL, 2013, HEPATOLOGY, V57, P470, DOI 10.1002/hep.26064; DREILING CE, 1981, BIOCHIM BIOPHYS ACTA, V640, P114, DOI 10.1016/0005-2736(81)90537-X; EDWARDS AM, 1988, DEV NEUROSCI-BASEL, V10, P75, DOI 10.1159/000111958; Esposito C, 2008, BIOCHEMISTRY-US, V47, P308, DOI 10.1021/bi701474t; Feng Y, 2001, BIOL CHEM, V382, P655, DOI 10.1515/BC.2001.077; Ganem D, 2004, NEW ENGL J MED, V350, P1118, DOI 10.1056/NEJMra031087; Gao B, 2009, HEPATOLOGY, V50, P424, DOI 10.1002/hep.23011; Gordien E, 2001, J VIROL, V75, P2684, DOI 10.1128/JVI.75.6.2684-2691.2001; Gravel M, 2009, J NEUROSCI RES, V87, P1069, DOI 10.1002/jnr.21939; Isogawa M, 2005, J VIROL, V79, P7269, DOI 10.1128/JVI.79.11.7269-7272.2005; Jiang D, 2008, J VIROL, V82, P1665, DOI 10.1128/JVI.02113-07; Kozlov G, 2003, J BIOL CHEM, V278, P46021, DOI 10.1074/jbc.M305176200; Lau DTY, 2008, HEPATOLOGY, V47, P799, DOI 10.1002/hep.22076; Lee J, 2006, MOL CELL NEUROSCI, V31, P446, DOI 10.1016/j.mcn.2005.10.017; Lee J, 2001, J BIOL CHEM, V276, P14804, DOI 10.1074/jbc.M009434200; Li N, 2012, HEPATOLOGY, V56, P803, DOI 10.1002/hep.25608; Mao RC, 2011, J VIROL, V85, P1048, DOI 10.1128/JVI.01998-10; McFerran BW, 1997, J CELL SCI, V110, P2979; Myllykoski M, 2012, J NEUROCHEM, V123, P515, DOI 10.1111/jnc.12000; Nguyen DH, 2008, J VIROL, V82, P6852, DOI 10.1128/JVI.00465-08; Nguyen DH, 2007, J VIROL, V81, P4465, DOI 10.1128/JVI.02510-06; Pan XB, 2007, ARCH VIROL, V152, P1159, DOI 10.1007/s00705-006-0927-4; Pan XB, 2008, J MED VIROL, V80, P47, DOI 10.1002/jmv.21042; Park IH, 2011, MOL CELLS, V32, P167, DOI 10.1007/s10059-011-1059-6; PERFUMO S, 1992, J VIROL, V66, P6819, DOI 10.1128/JVI.66.11.6819-6823.1992; Perrillo R, 2009, HEPATOLOGY, V49, pS103, DOI 10.1002/hep.22956; Radtke C, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/608496; Rubinson DA, 2003, NAT GENET, V33, P401, DOI 10.1038/ng1117; Sakamoto Y, 2005, J MOL BIOL, V346, P789, DOI 10.1016/j.jmb.2004.12.024; Seeger C, 2000, MICROBIOL MOL BIOL R, V64, P51, DOI 10.1128/MMBR.64.1.51-68.2000; SPRINKLE TJ, 1987, BRAIN RES, V426, P349, DOI 10.1016/0006-8993(87)90888-2; Stingo S, 2007, CHEM BIOL DRUG DES, V70, P502, DOI 10.1111/j.1747-0285.2007.00592.x; Wang Y, 2005, WORLD J GASTROENTERO, V11, P649, DOI 10.3748/wjg.v11.i5.649; Wilson SJ, 2012, CELL HOST MICROBE, V12, P585, DOI 10.1016/j.chom.2012.08.012	36	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80769	10.1371/journal.pone.0080769	http://dx.doi.org/10.1371/journal.pone.0080769			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260477	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500174
J	Soderstrom, M; Wittebolle, K				Soderstrom, Melanie; Wittebolle, Kelsey			When Do Caregivers Talk? The Influences of Activity and Time of Day on Caregiver Speech and Child Vocalizations in Two Childcare Environments	PLOS ONE			English	Article							LOW-INCOME FAMILIES; LANGUAGE-DEVELOPMENT; LITERACY; FATHERS; MOTHERS; INPUT	The importance of the language environment in influencing language outcomes is well known, but few studies have addressed the contextual factors that influence the amount of speech heard and vocalizations produced by a young child under naturalistic conditions. We analyze effects of type of activity engaged in by the child and time of day on quantitative measures of the language environment. We found effects of both activity and time of day. Structured activities generated the highest levels of adult language, but not necessarily the most child vocalizations. Home and daycare environments looked overall very similar on these measures, however there were important differences across the two environments with respect to the specific effects of activity and time of day.	[Soderstrom, Melanie; Wittebolle, Kelsey] Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada	University of Manitoba	Soderstrom, M (corresponding author), Univ Manitoba, Dept Psychol, Winnipeg, MB R3T 2N2, Canada.	M_Soderstrom@umanitoba.ca		Soderstrom, Melanie/0000-0003-3212-5775	University of Manitoba; Social Sciences and Humanities Research Council of Canada [37679]	University of Manitoba; Social Sciences and Humanities Research Council of Canada(Social Sciences and Humanities Research Council of Canada (SSHRC))	This research was funded by internal funding from the University of Manitoba, and from a Social Sciences and Humanities Research Council of Canada Insight Development grant to the first author, project #37679. The funders had no role in study design, data collection and analysis, decision to publish or preparation of the manuscript.	Ackerman-Ross S, 1989, EARLY CHILDHOOD RES, V4, P97; Belsky J, 2007, CHILD DEV, V78, P681, DOI 10.1111/j.1467-8624.2007.01021.x; Bouchard C, 2010, EARLY CHILD EDUC J, V37, P371, DOI 10.1007/s10643-009-0355-7; Bushnik T, 2006, STAT CANADA CHILDREN, V3; CRAINTHORESON C, 1992, DEV PSYCHOL, V28, P421, DOI 10.1037/0012-1649.28.3.421; Dickinson D., 2001, BEGINNING LITERACY L; ECCRN N, 2000, CHILD DEV, V71, P960; Girolametto L, 2000, J SPEECH LANG HEAR R, V43, P1101, DOI 10.1044/jslhr.4305.1101; Greenwood CR, 2011, COMM DISORD Q, V32, P83, DOI 10.1177/1525740110367826; HART B, 1992, DEV PSYCHOL, V28, P1096, DOI 10.1037/0012-1649.28.6.1096; Hart B., 1995, MEANINGFUL DIFFERENC; Hoff E, 2003, CHILD DEV, V74, P1368, DOI 10.1111/1467-8624.00612; Hoff E., 2010, FIRST LANG, V30, P461, DOI [10.1177/0142723710370525, DOI 10.1177/0142723710370525]; HOFFGINSBERG E, 1991, CHILD DEV, V62, P782, DOI 10.1111/j.1467-8624.1991.tb01569.x; Huttenlocher J, 2002, COGNITIVE PSYCHOL, V45, P337, DOI 10.1016/S0010-0285(02)00500-5; Huttenlocher J, 2007, DEV PSYCHOL, V43, P1062, DOI 10.1037/0012-1649.43.5.1062; Lee Y.-J., 1997, EARLY CHILD DEV CARE, V139, P49; Marcos H, 2004, APPRENDRE PARLER INF; Marinac JV, 2000, CHILD LANG TEACH THE, V16, P181, DOI DOI 10.1177/026565900001600205; MCCARTNEY K, 1984, DEV PSYCHOL, V20, P244, DOI 10.1037/0012-1649.20.2.244; Meltzoff AN, 2009, SCIENCE, V325, P284, DOI 10.1126/science.1175626; Murray AD, 2006, EARLY CHILD EDUC J, V34, P233, DOI 10.1007/s10643-006-0138-3; Newman RS, 2005, DEV PSYCHOL, V41, P352, DOI 10.1037/0012-1649.41.2.352; Newport E., 1977, TALKING CHILDREN LAN, P109; Oller DK, 2010, P NATL ACAD SCI USA, V107, P13354, DOI 10.1073/pnas.1003882107; OSHIMATAKANE Y, 2003, 1 LANGUAGE, V0023; Pan BA, 2005, CHILD DEV, V76, P763, DOI 10.1111/j.1467-8624.2005.00876.x; PAYNE AC, 1994, EARLY CHILD RES Q, V9, P427, DOI 10.1016/0885-2006(94)90018-3; PELLEGRINO MLM, 1990, J CHILD LANG, V17, P101; RONDAL JA, 1980, J CHILD LANG, V7, P353, DOI 10.1017/S0305000900002671; SCHAFFER HR, 1984, BRIT J DEV PSYCHOL, V2, P33, DOI 10.1111/j.2044-835X.1984.tb00532.x; Society CP, 2008, PAEDIAT CHILD HLTH, V13, P863; WALKER K, 1995, CHILD CARE HLTH DEV, V21, P161, DOI 10.1111/j.1365-2214.1995.tb00747.x; Xu D., 2009, RELIABILITY LENA TM; Yont KM, 2003, J PRAGMATICS, V35, P435, DOI 10.1016/S0378-2166(02)00144-3; Zimmerman FJ, 2009, PEDIATRICS, V124, P342, DOI 10.1542/peds.2008-2267	36	89	90	2	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80646	10.1371/journal.pone.0080646	http://dx.doi.org/10.1371/journal.pone.0080646			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	256KH	24260443	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500163
J	Breitbart, A; Scharf, GM; Duncker, D; Widera, C; Gottlieb, J; Vogel, A; Schmidt, S; Brandes, G; Heuft, HG; Lichtinghagen, R; Kempf, T; Wollert, KC; Bauersachs, J; Heineke, J				Breitbart, Astrid; Scharf, Gesine M.; Duncker, David; Widera, Christian; Gottlieb, Jens; Vogel, Arndt; Schmidt, Sebastian; Brandes, Gudrun; Heuft, Hans-Gert; Lichtinghagen, Ralf; Kempf, Tibor; Wollert, Kai C.; Bauersachs, Johann; Heineke, Joerg			Highly Specific Detection of Myostatin Prodomain by an Immunoradiometric Sandwich Assay in Serum of Healthy Individuals and Patients	PLOS ONE			English	Article							CHRONIC HEART-FAILURE; SKELETAL-MUSCLE; PLASMA MYOSTATIN; CANCER CACHEXIA; EXPRESSION; IDENTIFICATION; MEN; INTERVENTION; FOLLISTATIN; MYOCARDIUM	Background: Myostatin is a muscle derived factor that functions as a negative regulator of skeletal muscle growth. Induction of myostatin expression was observed in rodent models of muscle wasting and in cachectic patients with cancer or pulmonary disease. Therefore, there is an increasing interest to use serum myostatin as a biomarker. Methods: We established an immunoradiometric sandwich assay (IRMA), which uses a commercially available chicken polyclonal, affinity purified antibody directed against human myostatin prodomain. We determined the serum concentrations of myostatin prodomain in 249 healthy individuals as well as 169 patients with heart failure, 53 patients with cancer and 44 patients with chronic pulmonary disease. Results: The IRMA had a detection limit of 0.7ng/ml, an intraassay imprecision of <= 14.1% and an interassay imprecision of <= 18.9%. The specificity of our assay was demonstrated by size exclusion chromatography, detection of myostatin by Western-blotting and a SMAD-dependent transcriptional-reporter assay in the signal-rich serum fractions, as well as lack of interference by unspecific substances like albumin, hemoglobin or lipids. Myostatin prodomain was stable at room temperature and resistant to freeze-thaw cycles. Apparently healthy individuals over the age of 55 had a median myostatin prodomain serum concentration of 3.9ng/ml (25th-75th percentiles, 2-7ng/ml) and we could not detect increased levels in patients with stable chronic heart failure or cancer related weight loss. In contrast, we found strongly elevated concentrations of myostatin prodomain (median 26.9ng/ml, 25th-75th percentiles, 7-100ng/ml) in the serum of underweight patients with chronic pulmonary disease. Conclusions: We established a highly specific IRMA for the quantification of myostatin prodomain concentration in human serum. Our assay could be useful to study myostatin as a biomarker for example in patients with chronic pulmonary disease, as we detected highly elevated myostatin prodomain serum levels in underweight individuals of this group.	[Breitbart, Astrid; Scharf, Gesine M.; Duncker, David; Widera, Christian; Kempf, Tibor; Wollert, Kai C.; Bauersachs, Johann; Heineke, Joerg] Hannover Med Sch, Klin Kardiol & Angiol, D-30623 Hannover, Germany; [Vogel, Arndt; Schmidt, Sebastian] Hannover Med Sch, Klin Gastroenterol Hepatol & Endokrinol, D-30623 Hannover, Germany; [Gottlieb, Jens] Hannover Med Sch, Klin Pneumol, D-30623 Hannover, Germany; [Brandes, Gudrun] Hannover Med Sch, Inst Zellbiol, Zentrum Anat, D-30623 Hannover, Germany; [Heuft, Hans-Gert] Hannover Med Sch, Inst Transfus Med, D-30623 Hannover, Germany; [Lichtinghagen, Ralf] Hannover Med Sch, Inst Klin Chem, D-30623 Hannover, Germany	Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School; Hannover Medical School	Heineke, J (corresponding author), Hannover Med Sch, Klin Kardiol & Angiol, D-30623 Hannover, Germany.	Heineke.Joerg@Mh-Hannover.de	Vogel, Arndt/A-8437-2012; Kempf, Tibor/ABA-3167-2021	Kempf, Tibor/0000-0001-6901-8442; Gottlieb, Prof. Jens/0000-0002-9540-9022; Dittrich, Gesine/0000-0002-9053-078X; Vogel, Arndt/0000-0003-0560-5538	German Heart Foundation/German Foundation of Heart Research [F/40/10]; Deutsche Forschungsgemeinschaft through the Excellence Cluster Rebirth [EXC 62/1]; clinical research unit 136 [HE 3658/3-1]; Heisenberg Program [HE 3658/6-1, HE 3658/5-1]	German Heart Foundation/German Foundation of Heart Research; Deutsche Forschungsgemeinschaft through the Excellence Cluster Rebirth; clinical research unit 136; Heisenberg Program(German Research Foundation (DFG))	This study was supported by the German Heart Foundation/German Foundation of Heart Research (F/40/10). JH was also supported by the Deutsche Forschungsgemeinschaft through the Excellence Cluster Rebirth (EXC 62/1), the clinical research unit 136 (HE 3658/3-1), the Heisenberg Program (HE 3658/6-1) and (HE 3658/5-1).The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anker SD, 2003, LANCET, V361, P1077, DOI 10.1016/S0140-6736(03)12892-9; Anker SD, 1997, LANCET, V349, P1050, DOI 10.1016/S0140-6736(96)07015-8; Aversa Z, 2012, ANN SURG ONCOL, V19, P1350, DOI 10.1245/s10434-011-1720-5; Benny Klimek, 2009, BIOCHEM BIOPH RES CO, V391, P1548; Brandt C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037236; Breitbart A, 2011, AM J PHYSIOL-HEART C, V300, pH1973, DOI 10.1152/ajpheart.00200.2011; Chien YH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071900; Christensen HM, 2013, ENDOCRINE, V43, P626, DOI 10.1007/s12020-012-9836-3; Clerico A, 2012, HEART FAIL REV, V17, P81, DOI 10.1007/s10741-011-9249-z; Cook SA, 2002, J BIOL CHEM, V277, P22528, DOI 10.1074/jbc.M201462200; Ehehalt S, 2011, EXP CLIN ENDOCR DIAB, V119, P238, DOI 10.1055/s-0030-1267964; George I, 2010, EUR J HEART FAIL, V12, P444, DOI 10.1093/eurjhf/hfq039; Gielen S, 2012, CIRCULATION, V125, P2716, DOI 10.1161/CIRCULATIONAHA.111.047381; Gonzalez-Cadavid NF, 1998, P NATL ACAD SCI USA, V95, P14938, DOI 10.1073/pnas.95.25.14938; Gruson D, 2011, EUR J HEART FAIL, V13, P734, DOI 10.1093/eurjhf/hfr024; Guiraud S, 2012, NEUROMUSCULAR DISORD, V22, P1057, DOI 10.1016/j.nmd.2012.07.002; Hayot M, 2011, MOL CELL ENDOCRINOL, V332, P38, DOI 10.1016/j.mce.2010.09.008; Heineke J, 2010, NAT MED, V16, P872, DOI 10.1038/nm.2181; Heineke J, 2010, CIRCULATION, V121, P419, DOI 10.1161/CIRCULATIONAHA.109.882068; Hill JJ, 2002, J BIOL CHEM, V277, P40735, DOI 10.1074/jbc.M206379200; Hosoyama T, 2006, J REPROD DEVELOP, V52, P469, DOI 10.1262/jrd.18009; Jiang MS, 2004, BIOCHEM BIOPH RES CO, V315, P525, DOI 10.1016/j.bbrc.2004.01.085; Ju CR, 2012, RESP MED, V106, P102, DOI 10.1016/j.rmed.2011.07.016; Kim JS, 2007, J APPL PHYSIOL, V103, P1488, DOI 10.1152/japplphysiol.01194.2006; Kung Thomas, 2010, Expert Opin Investig Drugs, V19, P579, DOI 10.1517/13543781003724690; Lakshman KM, 2009, MOL CELL ENDOCRINOL, V302, P26, DOI 10.1016/j.mce.2008.12.019; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Lee SJ, 2004, ANNU REV CELL DEV BI, V20, P61, DOI 10.1146/annurev.cellbio.20.012103.135836; Lenk K, 2009, EUR J HEART FAIL, V11, P342, DOI 10.1093/eurjhf/hfp020; Lokireddy S, 2012, BIOCHEM J, V446, P23, DOI 10.1042/BJ20112024; Moretti M, 2011, CLIN CHIM ACTA, V412, P1143, DOI 10.1016/j.cca.2011.03.002; Plant PJ, 2010, AM J RESP CELL MOL, V42, P461, DOI 10.1165/rcmb.2008-0382OC; Ratkevicius A, 2011, J GERONTOL A-BIOL, V66, P620, DOI 10.1093/gerona/glr025; SEEVERS RH, 1982, CHEM REV, V82, P575, DOI 10.1021/cr00052a002; Sharma R, 2001, THORAX, V56, P746, DOI 10.1136/thorax.56.10.746; Shyu KG, 2006, EUR J CLIN INVEST, V36, P713, DOI 10.1111/j.1365-2362.2006.01718.x; Souza TA, 2008, MOL ENDOCRINOL, V22, P2689, DOI 10.1210/me.2008-0290; Spencer CA, 1996, CLIN CHEM, V42, P140; Stephens Nathan A, 2008, Curr Opin Support Palliat Care, V2, P267, DOI 10.1097/SPC.0b013e3283186be2; Szulc P, 2012, EUR J ENDOCRINOL, V167, P873, DOI 10.1530/EJE-12-0512; Szulc P, 2012, J CLIN ENDOCR METAB, V97, P3700, DOI 10.1210/jc.2012-1273; Tholen DW, 2004, EP05A2 CLSI, P1; Vamvini MT, 2011, J CLIN ENDOCR METAB, V96, P3416, DOI 10.1210/jc.2011-1665; von Haehling S, 2007, CARDIOVASC RES, V73, P298, DOI 10.1016/j.cardiores.2006.08.018; Walker KS, 2004, MED SCI SPORT EXER, V36, P787, DOI 10.1249/01.MSS.0000126384.04778.29; Wang F, 2012, J HUAZHONG U SCI-MED, V32, P534, DOI 10.1007/s11596-012-0092-9; Wintgens KF, 2012, CLIN CHIM ACTA, V413, P1288, DOI 10.1016/j.cca.2012.04.023; Zachwieja J J, 1999, J Gravit Physiol, V6, P11; Zamora E, 2010, REV ESP CARDIOL, V63, P992, DOI 10.1016/S0300-8932(10)70212-8; Zhou XL, 2010, CELL, V142, P531, DOI 10.1016/j.cell.2010.07.011; Zimmers TA, 2002, SCIENCE, V296, P1486, DOI 10.1126/science.1069525	51	24	35	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80454	10.1371/journal.pone.0080454	http://dx.doi.org/10.1371/journal.pone.0080454			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260393	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600063
J	Wagner, D; Wiemann, P; Huss, K; Brandt, U; Fleissner, A; Tudzynski, B				Wagner, Dominik; Wiemann, Philipp; Huss, Kathleen; Brandt, Ulrike; Fleissner, Andre; Tudzynski, Bettina			A Sensing Role of the Glutamine Synthetase in the Nitrogen Regulation Network in Fusarium fujikuroi	PLOS ONE			English	Article							NEUROSPORA-CRASSA; METABOLITE REPRESSION; GIBBERELLA-FUJIKUROI; STREPTOMYCES-COELICOLOR; CRYSTAL-STRUCTURE; TRANSCRIPTIONAL CONTROL; NITRATE ASSIMILATION; SECONDARY METABOLISM; ACTIVATORS GLN3; GENE-EXPRESSION	In the plant pathogenic ascomycete Fusarium fujikuroi the synthesis of several economically important secondary metabolites (SM) depends on the nitrogen status of the cells. Of these SMs, gibberellin and bikaverin synthesis is subject to nitrogen catabolite repression (NCR) and is therefore only executed under nitrogen starvation conditions. How the signal of available nitrogen quantity and quality is sensed and transmitted to transcription factors is largely unknown. Earlier work revealed an essential regulatory role of the glutamine synthetase (GS) in the nitrogen regulation network and secondary metabolism as its deletion resulted in total loss of SM gene expression. Here we present extensive gene regulation studies of the wild type, the Delta gln1 mutant and complementation strains of the gln1 deletion mutant expressing heterologous GS-encoding genes of prokaryotic and eukaryotic origin or 14 different F. fujikuroi gln1 copies with site-directed mutations. All strains were grown under different nitrogen conditions and characterized regarding growth, expression of NCR-responsive genes and biosynthesis of SM. We provide evidence for distinct roles of the GS in sensing and transducing the signals to NCR-responsive genes. Three site directed mutations partially restored secondary metabolism and GS-dependent gene expression, but not glutamine formation, demonstrating for the first time that the catalytic and regulatory roles of GS can be separated. The distinct mutant phenotypes show that the GS (1) participates in NH4+-sensing and transducing the signal towards NCR-responsive transcription factors and their subsequent target genes; (2) affects carbon catabolism and (3) activates the expression of a distinct set of non-NCR GS-dependent genes. These novel insights into the regulatory role of the GS provide fascinating perspectives for elucidating regulatory roles of GS proteins of different organism in general.	[Wagner, Dominik; Wiemann, Philipp; Huss, Kathleen; Tudzynski, Bettina] Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany; [Brandt, Ulrike; Fleissner, Andre] Tech Univ Carolo Wilhelmina Braunschweig, Inst Genet, Braunschweig, Germany	University of Munster; Braunschweig University of Technology	Tudzynski, B (corresponding author), Univ Munster, Inst Biol & Biotechnol Pflanzen, D-48149 Munster, Germany.	tudzynsb@uni-muenster.de		Wiemann, Philipp/0000-0002-7983-2218	German Research Foundation [TU101/12-2]	German Research Foundation(German Research Foundation (DFG))	Funding provided by German Research Foundation project TU101/12-2. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALTMANN F, 1992, ANAL BIOCHEM, V204, P215, DOI 10.1016/0003-2697(92)90164-3; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andrianopoulos A, 1998, J BACTERIOL, V180, P1973, DOI 10.1128/JB.180.7.1973-1977.1998; BARENDSE GWM, 1980, J CHROMATOGR, V198, P449, DOI 10.1016/S0021-9673(00)80514-2; Bauer B, 2010, MYCOSES, V53, P296, DOI 10.1111/j.1439-0507.2009.01718.x; Berger H, 2008, MOL MICROBIOL, V69, P1385, DOI 10.1111/j.1365-2958.2008.06359.x; Bohmer M, 2007, PROTEOMICS, V7, P675, DOI 10.1002/pmic.200600900; Bomke C, 2009, PHYTOCHEMISTRY, V70, P1876, DOI 10.1016/j.phytochem.2009.05.020; Brown DW, 2012, FUNGAL GENET BIOL, V49, P521, DOI 10.1016/j.fgb.2012.05.010; CADDICK MX, 1994, ANTON LEEUW INT J G, V65, P169, DOI 10.1007/BF00871943; CALDERON J, 1985, J BACTERIOL, V161, P807; CALDERON J, 1989, J GEN MICROBIOL, V135, P2699; CALDERON J, 1993, BIOCHEM GENET, V31, P425, DOI 10.1007/BF02396227; Camargo A, 2007, PLANT CELL, V19, P3491, DOI 10.1105/tpc.106.045922; CENIS JL, 1992, NUCLEIC ACIDS RES, V20, P2380, DOI 10.1093/nar/20.9.2380; CHURCH GM, 1984, P NATL ACAD SCI-BIOL, V81, P1991, DOI 10.1073/pnas.81.7.1991; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Commichau FM, 2008, MOL MICROBIOL, V67, P692, DOI 10.1111/j.1365-2958.2007.06071.x; Crespo JL, 2002, P NATL ACAD SCI USA, V99, P6784, DOI 10.1073/pnas.102687599; DARKEN MA, 1959, APPL MICROBIOL, V7, P301, DOI 10.1128/AEM.7.5.301-303.1959; DAVILA G, 1978, J BACTERIOL, V134, P693; DAVILA G, 1983, J BACTERIOL, V156, P993; DAVILA G, 1980, BIOCHEM BIOPH RES CO, V92, P134, DOI 10.1016/0006-291X(80)91530-2; Diaz-Sanchez V, 2012, APPL ENVIRON MICROB, V78, P7258, DOI 10.1128/AEM.01552-12; Doyle J.J., 1990, FOCUS, V12, P13, DOI DOI 10.2307/2419362; DUNNCOLEMAN NS, 1981, MOL GEN GENET, V182, P234, DOI 10.1007/BF00269663; DUNNCOLEMAN NS, 1980, MOL GEN GENET, V179, P25, DOI 10.1007/BF00268442; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; ESPIN G, 1979, J GEN MICROBIOL, V115, P59, DOI 10.1099/00221287-115-1-59; Fink D, 1999, MICROBIOL-UK, V145, P2313, DOI 10.1099/00221287-145-9-2313; Fleissner A, 2009, GENETICS, V181, P497, DOI 10.1534/genetics.108.096149; FLORESSAMANIEGO B, 1993, J BACTERIOL, V175, P7705, DOI 10.1128/JB.175.23.7705-7706.1993; Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554; GEISSMAN TA, 1966, PHYTOCHEMISTRY, V5, P933, DOI 10.1016/S0031-9422(00)82790-9; Georis I, 2011, J BIOL CHEM, V286, P44897, DOI 10.1074/jbc.M111.290577; Gill HS, 2001, BIOCHEMISTRY-US, V40, P1903, DOI 10.1021/bi002438h; Gunka K, 2012, MOL MICROBIOL, V85, P213, DOI 10.1111/j.1365-2958.2012.08105.x; He YX, 2009, PROTEINS, V76, P249, DOI 10.1002/prot.22403; HERNANDEZ G, 1986, J GEN MICROBIOL, V132, P3315; Kinoshita S, 2009, MAR GENOM, V2, P103, DOI 10.1016/j.margen.2009.06.003; Kleigrewe K, 2012, J AGR FOOD CHEM, V60, P8350, DOI 10.1021/jf302534x; Krajewski WW, 2008, J MOL BIOL, V375, P217, DOI 10.1016/j.jmb.2007.10.029; KUMADA Y, 1990, J BACTERIOL, V172, P5343, DOI 10.1128/jb.172.9.5343-5351.1990; LARA M, 1982, J BACTERIOL, V150, P105, DOI 10.1128/JB.150.1.105-112.1982; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P675, DOI 10.1021/bi00169a007; LIAW SH, 1994, BIOCHEMISTRY-US, V33, P11184, DOI 10.1021/bi00203a014; Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9; Malonek S, 2004, J BIOL CHEM, V279, P25075, DOI 10.1074/jbc.M308517200; Margelis S, 2001, J BACTERIOL, V183, P5826, DOI 10.1128/JB.183.20.5826-5833.2001; Mathis R, 2000, J MOL EVOL, V50, P116, DOI 10.1007/s002399910013; Meti R.S., 2011, RECENT RES SCI TECHN, V2, P28; Mihlan M, 2003, MOL MICROBIOL, V47, P975, DOI 10.1046/j.1365-2958.2003.03326.x; Montanini B, 2003, BIOCHEM J, V373, P357, DOI 10.1042/BJ20030152; MORA J, 1990, MICROBIOL REV, V54, P293, DOI 10.1128/MMBR.54.3.293-304.1990; Platt A, 1996, EMBO J, V15, P2791, DOI 10.1002/j.1460-2075.1996.tb00639.x; PONTECORVO G, 1953, ADV GENET, V5, P141, DOI 10.1016/S0065-2660(08)60408-3; PREMAKUMAR R, 1979, J BACTERIOL, V137, P1119, DOI 10.1128/JB.137.3.1119-1126.1979; PREMAKUMAR R, 1980, J BACTERIOL, V144, P542, DOI 10.1128/JB.144.2.542-551.1980; Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469; Robertson DL, 2006, MOL BIOL EVOL, V23, P1048, DOI 10.1093/molbev/msj110; Robertson DL, 2001, J PHYCOL, V37, P793, DOI 10.1046/j.1529-8817.2001.01057.x; Rodriguez-Garcia A, 2009, NUCLEIC ACIDS RES, V37, P3230, DOI 10.1093/nar/gkp162; Rutherford JC, 2008, MOL BIOL CELL, V19, P3028, DOI 10.1091/mbc.E08-01-0033; Sambrook J., 1989, MOL CLONING LAB MANU, V2; SANCHEZ F, 1980, J BIOL CHEM, V255, P2231; Schinko T, 2010, MOL MICROBIOL, V78, P720, DOI 10.1111/j.1365-2958.2010.07363.x; Schonig B, 2008, EUKARYOT CELL, V7, P1831, DOI 10.1128/EC.00130-08; Schonig B, 2009, FUNGAL GENET BIOL, V46, P898, DOI 10.1016/j.fgb.2009.08.003; Studt L, 2012, FUNGAL GENET BIOL, V49, P567, DOI 10.1016/j.fgb.2012.05.005; Studt L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058185; Studt L, 2012, APPL ENVIRON MICROB, V78, P4468, DOI 10.1128/AEM.00823-12; Teichert S, 2004, MOL MICROBIOL, V53, P1661, DOI 10.1111/j.1365-2958.2004.04243.x; Teichert S, 2008, EUKARYOT CELL, V7, P187, DOI 10.1128/EC.00351-07; Todd RB, 2005, EUKARYOT CELL, V4, P1646, DOI 10.1128/EC.4.10.1646-1653.2005; Tudzynski B, 1996, MICROBIOL-SGM, V142, P533, DOI 10.1099/13500872-142-3-533; Tudzynski B, 1999, MOL GEN GENET, V261, P106, DOI 10.1007/s004380050950; Unno H, 2006, J BIOL CHEM, V281, P29287, DOI 10.1074/jbc.M601497200; van Rooyen JM, 2011, STRUCTURE, V19, P471, DOI 10.1016/j.str.2011.02.001; Vogel H.J., 1956, MICROB GENET B, V13, P42; Wagner D, 2010, EUKARYOT CELL, V9, P1588, DOI 10.1128/EC.00146-10; WEDLER FC, 1976, J BIOL CHEM, V251, P7530; WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X; Wiemann P, 2013, FUSARIUM GENOMICS MO, P7; Wiemann P, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003475; Wiemann P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037519; Wiemann P, 2010, MOL MICROBIOL, V77, P972, DOI 10.1111/j.1365-2958.2010.07263.x; Wiemann P, 2009, MOL MICROBIOL, V72, P931, DOI 10.1111/j.1365-2958.2009.06695.x; Wong KH, 2007, MOL MICROBIOL, V66, P534, DOI 10.1111/j.1365-2958.2007.05940.x; Wray LV, 2010, J BACTERIOL, V192, P5018, DOI 10.1128/JB.00509-10; Wray LV, 2001, CELL, V107, P427, DOI 10.1016/S0092-8674(01)00572-4; Wyatt K, 2006, STRUCTURE, V14, P1823, DOI 10.1016/j.str.2006.10.008; XIAO XD, 1995, BIOCHEMISTRY-US, V34, P8861, DOI 10.1021/bi00027a038; YAMASHITA MM, 1989, J BIOL CHEM, V264, P17681	93	24	24	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80740	10.1371/journal.pone.0080740	http://dx.doi.org/10.1371/journal.pone.0080740			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260467	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600081
J	Dostalek, T; Pankova, H; Munzbergova, Z; Rydlova, J				Dostalek, Tomas; Pankova, Hana; Muenzbergova, Zuzana; Rydlova, Jana			The Effect of AMF Suppression on Plant Species Composition in a Nutrient-Poor Dry Grassland	PLOS ONE			English	Article							ARBUSCULAR MYCORRHIZAL FUNGI; COMMUNITY STRUCTURE; DIVERSITY; BENOMYL; PRODUCTIVITY; PHOSPHORUS; SOIL; GROWTH; ESTABLISHMENT; COLONIZATION	Arbuscular mycorrhizal fungi (AMF) are expected to be one of the key drivers determining the diversity of natural plant communities, especially in nutrient-poor and dry habitats. Several previous studies have explored the importance of AMF for the composition of plant communities in various types of habitats. Surprisingly, studies of the role of AMF in nutrient-poor dry grassland communities dominated by less mycotrophic plant species are still relatively rare. We present the results of a 3-year study in which a plant community in a species-rich dry grassland was subjected to the fungicide carbendazim to suppress AMF colonization. We tested the effect of the fungicide on the following parameters: the plant species composition; the number of plant species; the cover of the rare, highly mycorrhiza-dependent species Aster amellus; the cover of the dominant, less mycorrhiza-dependent species Brachypodium pinnatum; and the cover of graminoids and perennial forbs. In addition, we examined the mycorrhizal inoculation potential of the soil. We found that the suppression of AMF with fungicide resulted in substantial changes in plant species composition and significant decrease in species richness, the cover of A. amellus and the cover of perennial forbs. In contrast the species increasing their cover after fungicide application were graminoids-the C3 grasses B. pinnatum and Bromus erectus and the sedge Carex flacca. These species appear to be less mycorrhiza dependent. Moreover, due to their clonal growth and efficient nutrient usage, they are, most likely, better competitors than perennial forbs under fungicide application. Our results thus suggest that AMF are an essential part of the soil communities supporting a high diversity of plant species in species-rich dry grasslands in nutrient-poor habitats. The AMF are especially important for the maintenance of the populations of perennial forbs, many of which are rare and endangered in the area.	[Dostalek, Tomas; Pankova, Hana; Muenzbergova, Zuzana; Rydlova, Jana] Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic; [Dostalek, Tomas; Pankova, Hana; Muenzbergova, Zuzana] Charles Univ Prague, Dept Bot, Fac Sci, Prague, Czech Republic	Czech Academy of Sciences; Institute of Botany of the Czech Academy of Sciences; Charles University Prague	Dostalek, T (corresponding author), Acad Sci Czech Republ, Inst Bot, CS-25243 Pruhonice, Czech Republic.	tomas.dostalek@ibot.cas.cz	Münzbergová, Zuzana/F-6321-2013; Dostálek, Tomáš/A-1260-2011; Pánková, Hana/H-1617-2014; Rydlová, Jana/G-3094-2014	Münzbergová, Zuzana/0000-0002-4026-6220; Dostálek, Tomáš/0000-0002-3681-5223; Pánková, Hana/0000-0001-6012-541X; 	GACR [P504/10/1486]; RVO [67985939]	GACR(Grant Agency of the Czech Republic); RVO	GACR P504/10/1486 (www.gacr.cz), long-term research development project no. RVO 67985939 (www.cas.cz). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allison VJ, 2007, PLANT ECOL, V190, P53, DOI 10.1007/s11258-006-9190-8; Blanke V, 2011, PLANT SOIL, V343, P379, DOI 10.1007/s11104-011-0727-9; BOBBINK R, 1991, J APPL ECOL, V28, P28, DOI 10.2307/2404111; Bolliger J, 2011, CONSERV BIOL, V25, P567, DOI 10.1111/j.1523-1739.2010.01630.x; BURROWS LA, 2000, EFFECTS FUNGICIDE CA, V1, P365; Castro S, 2012, ANN BOT-LONDON, V110, P1047, DOI 10.1093/aob/mcs177; Chen SK, 2001, SOIL BIOL BIOCHEM, V33, P1981, DOI 10.1016/S0038-0717(01)00132-8; Chylova T, 2008, PRESLIA, V80, P183; Crawley M. J., 2009, PLANT ECOLOGY; Dhillion SS, 2004, CAN J BOT, V82, P104, DOI [10.1139/b03-139, 10.1139/B03-139]; Doubkova P, 2011, PLANT SOIL, V345, P325, DOI 10.1007/s11104-011-0785-z; Ehrenberger F., 1973, METHODEN ORG ELEMENT; Ellenberg H., 1988, Vegetation ecology of Central Europe.; Environmental Protection Agency, 2001, BEN CANC ORD; FITTER AH, 1986, NEW PHYTOL, V103, P767, DOI 10.1111/j.1469-8137.1986.tb00851.x; FITTER AH, 1988, NEW PHYTOL, V110, P201, DOI 10.1111/j.1469-8137.1988.tb00253.x; FRANCIS R, 1994, PLANT SOIL, V159, P11, DOI 10.1007/BF00000091; GANGE AC, 1990, NEW PHYTOL, V115, P85, DOI 10.1111/j.1469-8137.1990.tb00925.x; GANGE AC, 1993, FUNCT ECOL, V7, P616, DOI 10.2307/2390139; GIOVANNETTI M, 1980, NEW PHYTOL, V84, P489, DOI 10.1111/j.1469-8137.1980.tb04556.x; GRIME JP, 1987, NATURE, V328, P420, DOI 10.1038/328420a0; Grime JP, 1988, COMP PLANT ECOLOGY F, P742, DOI DOI 10.1016/0169-5347(89)90130-4; HARLEY J L, 1987, New Phytologist, V105, P1, DOI 10.1111/j.1469-8137.1987.tb00674.x; Hartnett DC, 1999, ECOLOGY, V80, P1187, DOI 10.1890/0012-9658(1999)080[1187:MIPCSA]2.0.CO;2; HARTNETT DC, 1993, J ECOL, V81, P787, DOI 10.2307/2261676; Helgason T, 2007, J ECOL, V95, P623, DOI 10.1111/j.1365-2745.2007.01239.x; Helweg A, 1973, STATENS FORSOGS PLAN, P232; HETRICK BAD, 1994, CAN J BOT, V72, P168, DOI 10.1139/b94-023; Jones MD, 2004, CAN J BOT, V82, P1089, DOI [10.1139/B04-110, 10.1139/b04-110]; Jordan N, 2008, RENEW AGR FOOD SYST, V23, P108, DOI 10.1017/S1742170508002226; Kahiluoto H, 2000, MYCORRHIZA, V9, P259, DOI 10.1007/PL00009990; Karanika ED, 2008, PLANT ECOL, V199, P225, DOI 10.1007/s11258-008-9427-9; Knappova J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065879; Knappova J, 2012, LANDSCAPE ECOL, V27, P97, DOI 10.1007/s10980-011-9680-5; Koide RT, 1988, FUNCT ECOL, V2, P335, DOI 10.2307/2389406; Koorem K, 2012, BASIC APPL ECOL, V13, P663, DOI 10.1016/j.baae.2012.09.008; KOSKE RE, 1989, MYCOL RES, V92, P486, DOI 10.1016/S0953-7562(89)80195-9; Leps J, 2003, MULTIVARIATE ANAL EC; Mazur AR, 1977, SOIL MICROORGANISMS; McCain KNS, 2011, PLANT ECOL, V212, P1675, DOI 10.1007/s11258-011-9940-0; Munzbergova Z, 2004, J ECOL, V92, P854, DOI 10.1111/j.0022-0477.2004.00919.x; Muthukumar T, 2004, MYCORRHIZA, V14, P65, DOI 10.1007/s00572-004-0296-3; NEWSHAM KK, 1994, J ECOL, V82, P805, DOI 10.2307/2261445; NEWSHAM KK, 1995, FUNCT ECOL, V9, P442, DOI 10.2307/2390007; O'Connor P, 2009, CAN J MICROBIOL, V55, P901, DOI [10.1139/W09-035, 10.1139/w09-035]; O'Connor PJ, 2002, NEW PHYTOL, V154, P209, DOI 10.1046/j.1469-8137.2002.00364.x; Pankova H, 2008, OECOLOGIA, V157, P211, DOI 10.1007/s00442-008-1064-4; Pankova H, 2011, AM J BOT, V98, P850, DOI 10.3732/ajb.0900350; Pedersen CT, 1997, BIOL FERT SOILS, V25, P163, DOI 10.1007/s003740050298; Pendleton RL, 2004, US FOR SERV RMRS-P, V31, P64; Raabova J, 2007, BIOL CONSERV, V139, P348, DOI 10.1016/j.biocon.2007.07.007; Schweiger PF, 2001, SOIL BIOL BIOCHEM, V33, P1231, DOI 10.1016/S0038-0717(01)00028-1; Smilauer P, 2000, FOLIA GEOBOT, V35, P13, DOI 10.1007/BF02803084; Smith MD, 1999, OECOLOGIA, V121, P574, DOI 10.1007/s004420050964; Smith S.E., 2008, MYCORRHIZAL SYMBIOSI, V3rd ed; Studnicka M, 1972, THESIS CHARLES U; Sudova R, 2010, AM J BOT, V97, P1798, DOI 10.3732/ajb.1000114; TANG CS, 1992, ARCH ENVIRON CON TOX, V23, P270, DOI 10.1007/BF00212286; Ter Braak C. J. F., 2012, CANOCO REFERENCE MAN; Tremlova K, 2007, ECOLOGY, V88, P965, DOI 10.1890/06-0924; Turnau K, 1998, ACTA SOC BOT POL, V67, P105, DOI 10.5586/asbp.1998.014; van der Heijden MGA, 2004, ECOL LETT, V7, P293, DOI 10.1111/j.1461-0248.2004.00577.x; van der Heijden MGA, 1998, NATURE, V396, P69, DOI 10.1038/23932; van der Heijden MGA, 1998, ECOLOGY, V79, P2082, DOI 10.1890/0012-9658(1998)079[2082:DAMFSA]2.0.CO;2; Westhoff V., 1973, CLASSIFICATION PLANT, V5, P617, DOI [10.1007/978-94-010-2701-4_20, DOI 10.1007/978-94-009-9183-5_9]; Wilson GWT, 1997, AM J BOT, V84, P478, DOI 10.2307/2446024; Wilson GWT, 1998, AM J BOT, V85, P1732, DOI 10.2307/2446507; Wilson GWT, 2001, AM J BOT, V88, P1452, DOI 10.2307/3558453; WILSON JM, 1983, AUST J SOIL RES, V21, P73, DOI 10.1071/SR9830073; Zobel M, 1999, ACTA OECOL, V20, P29, DOI 10.1016/S1146-609X(99)80013-7	70	24	24	8	125	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80535	10.1371/journal.pone.0080535	http://dx.doi.org/10.1371/journal.pone.0080535			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265829	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100165
J	Duan, Y; Wu, YQ; Luo, LZ; Miao, J; Gong, ZJ; Jiang, YL; Li, T				Duan, Yun; Wu, Yu-qing; Luo, Li-zhi; Miao, Jin; Gong, Zhong-jun; Jiang, Yue-li; Li, Tong			Genetic Diversity and Population Structure of Sitodiplosis mosellana in Northern China	PLOS ONE			English	Article							GEHIN DIPTERA; WHEAT MIDGE; SOFTWARE; DNA; CECIDOMYIIDAE; MIGRATION; DISTANCE; NUMBER	The wheat midge, Sitodiplosis mosellana, is an important pest in Northern China. We tested the hypothesis that the population structure of this species arises during a range expansion over the past 30 years. This study used microsatellite and mitochondrial loci to conduct population genetic analysis of S. mosellana across its distribution range in China. We found strong genetic structure among the 16 studied populations, including two genetically distinct groups (the eastern and western groups), broadly consistent with the geography and habitat fragmentation. These results underline the importance of natural barriers in impeding dispersal and gene flow of S. mosellana populations. Low to moderate genetic diversity among the populations and moderate genetic differentiation (F-ST = 0.117) between the two groups were also found. The populations in the western group had lower genetic diversity, higher genetic differentiation and lower gene flow (F-ST = 0.116, Nm = 1.89) than those in the eastern group (F-ST = 0.049, Nm = 4.91). Genetic distance between populations was positively and significantly correlated with geographic distance (r = 0.56, P<0.001). The population history of this species provided no evidence for population expansion or bottlenecks in any of these populations. Our data suggest that the distribution of genetic diversity, genetic differentiation and population structure of S. mosellana have resulted from a historical event, reflecting its adaptation to diverse habitats and forming two different gene pools. These results may be the outcome of a combination of restricted gene flow due to geographical and environmental factors, population history, random processes of genetic drift and individual dispersal patterns. Given the current risk status of this species in China, this study can offer useful information for forecasting outbreaks and designing effective pest management programs.	[Duan, Yun; Wu, Yu-qing; Miao, Jin; Gong, Zhong-jun; Jiang, Yue-li; Li, Tong] Henan Acad Agr Sci, Inst Plant Protect, Key Lab Crop Integrated Pest Management Southern, Key Lab Crop Pest Control Henan Prov,Minist Agr, Zhengzhou, Peoples R China; [Duan, Yun; Luo, Li-zhi] Chinese Acad Agr Sci, Inst Plant Protect, State Key Lab Biol Plant Dis & Insect Pests, Beijing 100193, Peoples R China	Henan Academy of Agricultural Sciences; Ministry of Agriculture & Rural Affairs; Chinese Academy of Agricultural Sciences; Institute of Plant Protection, CAAS	Wu, YQ (corresponding author), Henan Acad Agr Sci, Inst Plant Protect, Key Lab Crop Integrated Pest Management Southern, Key Lab Crop Pest Control Henan Prov,Minist Agr, Zhengzhou, Peoples R China.	yuqingwu36@hotmail.com; lzluo@ippcaas.cn	Gong, Zhongjun/AAZ-4442-2020	Li, Tong/0000-0001-6269-5117	China Agricultural Research System [CARS-03]	China Agricultural Research System	This work was sponsored by the China Agricultural Research System (CARS-03). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose L, 2012, MOL ECOL, V21, P4327, DOI 10.1111/j.1365-294X.2012.05690.x; Amos W, 1998, PHILOS T ROY SOC B, V353, P177, DOI 10.1098/rstb.1998.0200; Annan Z, 2007, P NATL ACAD SCI USA, V104, P7987, DOI 10.1073/pnas.0702715104; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Berzonsky WA, 2002, PL BRED RE, V22, P221; Chapuis MP, 2008, MOL ECOL, V17, P3640, DOI 10.1111/j.1365-294X.2008.03869.x; COLLINS FH, 1987, AM J TROP MED HYG, V37, P37, DOI 10.4269/ajtmh.1987.37.37; Cornuet JM, 1996, GENETICS, V144, P2001; Crawford NG, 2010, MOL ECOL RESOUR, V10, P556, DOI 10.1111/j.1755-0998.2009.02801.x; Doane JF, 2008, CROP PROT, V27, P951, DOI 10.1016/j.cropro.2007.11.016; Duan Yun, 2011, Acta Entomologica Sinica, V54, P1147; Dyer NA, 2008, MOL PHYLOGENET EVOL, V49, P227, DOI 10.1016/j.ympev.2008.07.011; Evanno G, 2005, MOL ECOL, V14, P2611, DOI 10.1111/j.1365-294X.2005.02553.x; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2010, MOL ECOL RESOUR, V10, P564, DOI 10.1111/j.1755-0998.2010.02847.x; Fairley TL, 2000, J MED ENTOMOL, V37, P754, DOI 10.1603/0022-2585-37.5.754; Fu YX, 1997, GENETICS, V147, P915; Goudet J, 2002, FSTAT PROGRAM ESTIMA, DOI DOI 10.1093/OXFORDJOURNALS.JHERED.A111627; He CG, 2001, ENTOMOTAXONOMIA, V2, P124; He CG, 2003, ACTA ENTOMOL SINICA, V2, P124; He Chun-gui, 2001, Entomologia Sinica, V8, P73; He H, 2004, ENTOMOTAXONOMIA, V2, P124; He H, 2006, J KANSAS ENTOMOL SOC, V79, P211, DOI 10.2317/0504.28.1; Hu Mu-Lin, 1995, Entomological Knowledge, V32, P13; Jost L, 2008, MOL ECOL, V17, P4015, DOI 10.1111/j.1365-294X.2008.03887.x; Kumar S, 2008, BRIEF BIOINFORM, V9, P299, DOI 10.1093/bib/bbn017; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Luikart G, 1998, J HERED, V89, P238, DOI 10.1093/jhered/89.3.238; MANTEL N, 1967, CANCER RES, V27, P209; Miao J, 2013, J INSECT BEHAV, V26, P120, DOI 10.1007/s10905-012-9346-4; Nater A, 2013, J HERED, V104, P2, DOI 10.1093/jhered/ess065; NEI M, 1978, GENETICS, V89, P583; Nei M., 1987, MOL EVOLUTIONARY GEN; Paetkau D, 2004, MOL ECOL, V13, P55, DOI 10.1046/j.1365-294X.2004.02008.x; Pauls SU, 2013, MOL ECOL, V22, P925, DOI 10.1111/mec.12152; Piry S, 2004, J HERED, V95, P536, DOI 10.1093/jhered/esh074; Piry S, 1999, J HERED, V90, P502, DOI 10.1093/jhered/90.4.502; Prugh LR, 2008, P NATL ACAD SCI USA, V105, P20770, DOI 10.1073/pnas.0806080105; Rannala B, 1997, P NATL ACAD SCI USA, V94, P9197, DOI 10.1073/pnas.94.17.9197; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Rousset F, 2008, MOL ECOL RESOUR, V8, P103, DOI 10.1111/j.1471-8286.2007.01931.x; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; TAJIMA F, 1989, GENETICS, V123, P585; Takezaki N, 2010, MOL BIOL EVOL, V27, P747, DOI 10.1093/molbev/msp312; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Wellenreuther M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020440; Wu YQ, 2011, RES CONTROL ORANGE W; Wu Yuqing, 2009, Acta Phytophylacica Sinica, V36, P381; Yeh F.C., 1999, MICROSOFT WINDOWS BA; Yuan F., 2004, WHEAT BLOSSOM MIDGES; Yuan JH, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034955	51	15	17	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78415	10.1371/journal.pone.0078415	http://dx.doi.org/10.1371/journal.pone.0078415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265688	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100022
J	Helaouet, P; Beaugrand, G; Edwards, M				Helaouet, Pierre; Beaugrand, Gregory; Edwards, Martin			Understanding Long-Term Changes in Species Abundance Using a Niche-Based Approach	PLOS ONE			English	Article							NORTH-ATLANTIC OSCILLATION; CALANUS-FINMARCHICUS; CLIMATE-CHANGE; C-HELGOLANDICUS; REGIME SHIFTS; SEA; TEMPERATURE; DEMOGRAPHY; COPEPOD; IMPACT	One of the major challenges to understanding population changes in ecology for assessment purposes is the difficulty in evaluating the suitability of an area for a given species. Here we used a new simple approach able to faithfully predict through time the abundance of two key zooplanktonic species by focusing on the relationship between the species' environmental preferences and their observed abundances. The approach is applied to the marine copepods Calanus finmarchicus and C. helgolandicus as a case study characterising the multidecadal dynamics of the North Sea ecosystem. We removed all North Sea data from the Continuous Plankton Recorder (CPR) dataset and described for both species a simplified ecological niche using Sea Surface Temperature (SST) and CPR Phytoplankton Colour Index (PCI). We then modelled the dynamics of each species by associating the North Sea's environmental parameters to the species' ecological niches, thus creating a method to assess the suitability of this area. By using both C. finmarchicus and C. helgolandicus as indicators, the procedure reproduces the documented switches from cold to warm temperate states observed in the North Sea.	[Helaouet, Pierre; Edwards, Martin] Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England; [Beaugrand, Gregory] Univ Sci & Technol Lille Lille Wimereux, Stn Marine, Lab Oceanol & Geosci UMR LOG CNRS 8187, CNRS, Lille, France	Centre National de la Recherche Scientifique (CNRS); Universite de Lille - ISITE; Universite de Lille	Helaouet, P (corresponding author), Sir Alister Hardy Fdn Ocean Sci, Plymouth, Devon, England.	pihe@sahfos.ac.uk		BEAUGRAND, GREGORY/0000-0002-0712-5223; Helaouet, Pierre/0000-0001-6102-7379	UK DEFRA; UK NERC	UK DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); UK NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	A funding consortium made up of governmental agencies from Canada, Norway, the United Kingdom and the USA financially supports the CPR survey. Main support for this work was provided by UK DEFRA and UK NERC. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AEBISCHER NJ, 1990, NATURE, V347, P753, DOI 10.1038/347753a0; Araujo MB, 2006, J BIOGEOGR, V33, P1677, DOI 10.1111/j.1365-2699.2006.01584.x; Bairlein F, 2001, ARDEA, V89, P7; Batten SD, 2003, PROG OCEANOGR, V58, P193, DOI 10.1016/j.pocean.2003.08.004; Beare DJ, 1999, MAR ECOL PROG SER, V190, P241, DOI 10.3354/meps190241; Beaugrand G, 2003, FISH OCEANOGR, V12, P270, DOI 10.1046/j.1365-2419.2003.00248.x; Beaugrand G, 2001, MAR ECOL PROG SER, V219, P189, DOI 10.3354/meps219189; Beaugrand G, 2008, ECOL LETT, V11, P1157, DOI 10.1111/j.1461-0248.2008.01218.x; Beaugrand G, 2012, MAR ECOL PROG SER, V445, P293, DOI 10.3354/meps09493; Beaugrand G, 2010, P NATL ACAD SCI USA, V107, P10120, DOI 10.1073/pnas.0913855107; Bigg GR, 2008, P ROY SOC B-BIOL SCI, V275, P163, DOI 10.1098/rspb.2007.1153; Bonnet D, 2005, PROG OCEANOGR, V65, P1, DOI 10.1016/j.pocean.2005.02.002; Brown JH, 2004, ECOLOGY, V85, P1771, DOI 10.1890/03-9000; Cheung WWL, 2008, MAR ECOL PROG SER, V365, P187, DOI 10.3354/meps07414; Cook KB, 2007, J PLANKTON RES, V29, P757, DOI 10.1093/plankt/fbm056; Edwards M, 2004, NATURE, V430, P881, DOI 10.1038/nature02808; Fromentin JM, 1996, MAR ECOL PROG SER, V134, P111, DOI 10.3354/meps134111; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Halsband-Lenk C, 2002, J EXP MAR BIOL ECOL, V271, P121, DOI 10.1016/S0022-0981(02)00025-4; HAYS GC, 1995, NATURE, V376, P650, DOI 10.1038/376650a0; Heath MR, 2008, PROG OCEANOGR, V76, P39, DOI 10.1016/j.pocean.2007.10.001; Heath Michael R., 1999, Fisheries Oceanography, V8, P163, DOI 10.1046/j.1365-2419.1999.00008.x; Heath MR, 2005, ICES J MAR SCI, V62, P847, DOI 10.1016/j.icesjms.2005.01.023; Heath MR, 2000, ICES J MAR SCI, V57, P1562, DOI 10.1006/jmsc.2000.0950; Helaouet P, 2007, MAR ECOL PROG SER, V345, P147, DOI 10.3354/meps06775; Helaouet P, 2011, PROG OCEANOGR, V91, P217, DOI 10.1016/j.pocean.2010.11.003; Helaouet P, 2009, ECOSYSTEMS, V12, P1235, DOI 10.1007/s10021-009-9261-5; Hirche HJ, 1996, OPHELIA, V44, P129, DOI 10.1080/00785326.1995.10429843; HIRCHE HJ, 1987, MAR BIOL, V94, P347, DOI 10.1007/BF00428240; Hutchinson G. E., 1957, TREATISE LIMNOLOGY, VI; Jonasdottir SH, 2011, J PLANKTON RES, V33, P85, DOI 10.1093/plankt/fbq085; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Kimmel DG, 2008, MAR ECOL PROG SER, V366, P111, DOI 10.3354/meps07523; Kirby RR, 2009, P ROY SOC B-BIOL SCI, V276, P4095, DOI 10.1098/rspb.2009.1320; Kirby RR, 2009, ECOSYSTEMS, V12, P548, DOI 10.1007/s10021-009-9241-9; Lenoir S, 2011, GLOBAL CHANGE BIOL, V17, P115, DOI 10.1111/j.1365-2486.2010.02229.x; LINDLEY JA, 1995, MAR ECOL PROG SER, V119, P299, DOI 10.3354/meps119299; Lindley JA, 2002, MAR BIOL, V141, P153, DOI 10.1007/s00227-002-0803-z; Longhurst, 2006, ECOLOGICAL GEOGRAPHY; Luczak C, 2011, BIOL LETTERS, V7, P702, DOI 10.1098/rsbl.2011.0225; Perry AL, 2005, SCIENCE, V308, P1912, DOI 10.1126/science.1111322; Planque B, 1998, J MAR BIOL ASSOC UK, V78, P1015, DOI 10.1017/S0025315400044969; Raitsos DE, 2010, LIMNOL OCEANOGR, V55, P1478, DOI 10.4319/lo.2010.55.4.1478; Reid PC, 2003, FISH OCEANOGR, V12, P260, DOI 10.1046/j.1365-2419.2003.00252.x; Reid PC, 2012, J MAR BIOL ASSOC UK, V92, P1435, DOI 10.1017/S0025315412000549; Reygondeau G, 2011, GLOBAL CHANGE BIOL, V17, P756, DOI 10.1111/j.1365-2486.2010.02310.x; Scheffer M, 2003, TRENDS ECOL EVOL, V18, P648, DOI 10.1016/j.tree.2003.09.002; Schmidt-Nielsen K., 1990, ANIMAL PHYSL ADAPTAT; Speirs DC, 2005, FISH OCEANOGR, V14, P333, DOI 10.1111/j.1365-2419.2005.00339.x; vanderHave TM, 1996, J THEOR BIOL, V183, P329, DOI 10.1006/jtbi.1996.0224; Walther GR, 2002, NATURE, V416, P389, DOI 10.1038/416389a; Weijerman M, 2005, MAR ECOL PROG SER, V298, P21, DOI 10.3354/meps298021	52	12	12	1	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79186	10.1371/journal.pone.0079186	http://dx.doi.org/10.1371/journal.pone.0079186			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265757	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100090
J	Mead, O; Thynne, E; Winterberg, B; Solomon, PS				Mead, Oliver; Thynne, Eli; Winterberg, Britta; Solomon, Peter S.			Characterising the Role of GABA and Its Metabolism in the Wheat Pathogen Stagonospora nodorum	PLOS ONE			English	Article							GAMMA-AMINOBUTYRIC-ACID; SPORULATION; SIGNAL; PLANTS; EXPRESSION; INFECTION; MANNITOL; GENOMICS; HOMOLOG; GENE	A reverse genetics approach was used to investigate the role of c-aminobutyric acid metabolism in the wheat pathogenic fungus Stagonospora nodorum. The creation of mutants lacking Sdh1, the gene encoding succinic semialdehyde dehydrogenase, resulted in strains that grew poorly on c-aminobutyric acid as a nitrogen source. The sdh1 mutants were more susceptible to reactive oxygen stress but were less affected by increased growth temperatures. Pathogenicity assays revealed that the metabolism of c-aminobutyric acid is required for complete pathogenicity. Growth assays of the wild-type and mutant strains showed that the inclusion of c-aminobutyric acid as a supplement in minimal media (i.e., not as a nitrogen or carbon source) resulted in restricted growth but increased sporulation. The addition of glutamate, the precursor to GABA, had no effect on either growth or sporulation. The c-aminobutyric acid effect on sporulation was found to be dose dependent and not restricted to Stagonospora nodorum with a similar effect observed in the dothideomycete Botryosphaeria sp. The positive effect on sporulation was assayed using isomers of c-aminobutyric acid and other metabolites known to influence asexual development in Stagonospora nodorum but no effect was observed. These data demonstrate that c-aminobutyric acid plays an important role in Stagonospora nodorum in responding to environmental stresses while also having a positive effect on asexual development.	[Mead, Oliver; Thynne, Eli; Winterberg, Britta; Solomon, Peter S.] Australian Natl Univ, Res Sch Biol, Plant Sci Div, Canberra, ACT, Australia	Australian National University	Solomon, PS (corresponding author), Australian Natl Univ, Res Sch Biol, Plant Sci Div, Canberra, ACT, Australia.	peter.solomon@anu.edu.au	Solomon, Peter/C-9301-2009	Solomon, Peter/0000-0002-5130-7307; Mead, Oliver/0000-0001-7919-9515	Australian Research Council; Grains Research and Development Corporation	Australian Research Council(Australian Research Council); Grains Research and Development Corporation(Grains R&D Corp)	The work was supported by Australian Research Council and Grains Research and Development Corporation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allan WL, 2003, CAN J PLANT SCI, V83, P951; Baker CJ, 2005, BIOCHEM BIOPH RES CO, V328, P130, DOI 10.1016/j.bbrc.2004.12.153; Rodriguez-Urra AB, 2012, ACS CHEM BIOL, V7, P599, DOI 10.1021/cb200455u; Borneman AR, 2000, MOL MICROBIOL, V38, P1034, DOI 10.1046/j.1365-2958.2000.02202.x; Bouche N, 2004, TRENDS PLANT SCI, V9, P110, DOI 10.1016/j.tplants.2004.01.006; Bouche N, 2003, TRENDS CELL BIOL, V13, P607, DOI 10.1016/j.tcb.2003.10.001; Chevrot R, 2006, P NATL ACAD SCI USA, V103, P7460, DOI 10.1073/pnas.0600313103; Coleman ST, 2001, J BIOL CHEM, V276, P244, DOI 10.1074/jbc.M007103200; FUQUA WC, 1994, J BACTERIOL, V176, P269, DOI 10.1128/JB.176.2.269-275.1994; Guo M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001302; Hane JK, 2007, PLANT CELL, V19, P3347, DOI 10.1105/tpc.107.052829; Kumar S, 1997, MYCOL RES, V101, P403, DOI 10.1017/S0953756296002742; LEE BN, 1994, GENE DEV, V8, P641, DOI 10.1101/gad.8.6.641; Lowe RGT, 2009, FUNGAL GENET BIOL, V46, P381, DOI 10.1016/j.fgb.2009.02.002; Ludewig F, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003383; Miller MB, 2001, ANNU REV MICROBIOL, V55, P165, DOI 10.1146/annurev.micro.55.1.165; Oliver RP, 2012, ANNU REV PHYTOPATHOL, V50, P23, DOI 10.1146/annurev-phyto-081211-173019; Oliver RP, 2010, CURR OPIN PLANT BIOL, V13, P415, DOI 10.1016/j.pbi.2010.05.003; Oliver RP, 2004, TRENDS PLANT SCI, V9, P472, DOI 10.1016/j.tplants.2004.08.006; Qazi S, 2006, INFECT IMMUN, V74, P910, DOI 10.1128/IAI.74.2.910-919.2006; Shelp BJ, 2006, PLANT PHYSIOL, V142, P1350, DOI 10.1104/pp.106.088955; Solomon P. S., 2008, FUNGAL GENETICS REPO, V55, P5, DOI [10.4148/1941-4765.1082, DOI 10.4148/1941-4765.1082]; Solomon PS, 2007, TRENDS MICROBIOL, V15, P257, DOI 10.1016/j.tim.2007.04.002; Solomon PS, 2006, BIOCHEM J, V399, P231, DOI 10.1042/BJ20060891; Solomon PS, 2006, MOL MICROBIOL, V62, P367, DOI 10.1111/j.1365-2958.2006.05380.x; Solomon PS, 2006, MOL PLANT PATHOL, V7, P147, DOI [10.1111/j.1364-3703.2006.00326.x, 10.1111/J.1364-3703.2006.00326.X]; Solomon PS, 2005, CURR GENET, V48, P60, DOI 10.1007/s00294-005-0588-y; Solomon PS, 2003, PHYSIOL MOL PLANT P, V63, P191, DOI 10.1016/j.pmpp.2003.12.003; Solomon PS, 2004, MOL PLANT MICROBE IN, V17, P456, DOI 10.1094/MPMI.2004.17.5.456; Solomon PS, 2005, MOL PLANT MICROBE IN, V18, P110, DOI 10.1094/MPMI-18-0110; Solomon PS, 2002, PLANTA, V214, P414, DOI 10.1007/s004250100632; Solomon PS, 2001, PLANTA, V213, P241, DOI 10.1007/s004250000500; Tan KC, 2008, EUKARYOT CELL, V7, P1916, DOI 10.1128/EC.00237-08; Tan KC, 2009, METABOLOMICS, V5, P330, DOI 10.1007/s11306-009-0158-2; TILLAKARATNE NJK, 1995, COMP BIOCHEM PHYS A, V112, P247, DOI 10.1016/0300-9629(95)00099-2; Vincent D, 2012, MOL PLANT PATHOL, V13, P467, DOI 10.1111/j.1364-3703.2011.00763.x	36	31	32	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78368	10.1371/journal.pone.0078368	http://dx.doi.org/10.1371/journal.pone.0078368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265684	Green Published, gold			2022-12-25	WOS:000327252100018
J	Serrano, J; Romo, E; Bermudez, M; Narayanan, AS; Zeichner-David, M; Santos, L; Arzate, H				Serrano, Janeth; Romo, Enrique; Bermudez, Mercedes; Narayanan, A. Sampath; Zeichner-David, Margarita; Santos, Leticia; Arzate, Higinio			Bone Regeneration in Rat Cranium Critical-Size Defects Induced by Cementum Protein 1 (CEMP1)	PLOS ONE			English	Article							PERIODONTAL-LIGAMENT CELLS; MESENCHYMAL STEM-CELLS; OCTACALCIUM PHOSPHATE; MORPHOGENETIC PROTEIN-2; GENE-THERAPY; DELIVERY; GELATIN; EXPRESSION; DIFFERENTIATION; RELEASE	Gene therapy approaches to bone and periodontal tissue engineering are being widely explored. While localized delivery of osteogenic factors like BMPs is attractive for promotion of bone regeneration; method of delivery, dosage and side effects could limit this approach. A novel protein, Cementum Protein 1 (CEMP1), has recently been shown to promote regeneration of periodontal tissues. In order to address the possibility that CEMP1 can be used to regenerate other types of bone, experiments were designed to test the effect of hrCEMP1 in the repair/regeneration of a rat calvaria critical-size defect. Histological and microcomputed tomography (mu CT) analyses of the calvaria defect sites treated with CEMP1 showed that after 16 weeks, hrCEMP1 is able to induce 97% regeneration of the defect. Furthermore, the density and characteristics of the new mineralized tissues were normal for bone. This study demonstrates that hrCEMP1 stimulates bone formation and regeneration and has therapeutic potential for the treatment of bone defects and regeneration of mineralized tissues.	[Serrano, Janeth; Romo, Enrique; Bermudez, Mercedes; Arzate, Higinio] Univ Nacl Autonoma Mexico, Fac Odontol, Lab Biol Periodontal, Mexico City 04510, DF, Mexico; [Narayanan, A. Sampath] Univ Washington, Sch Med, Dept Pathol, Seattle, WA 98195 USA; [Zeichner-David, Margarita] Univ So Calif, Ostrow Sch Dent, Los Angeles, CA USA; [Santos, Leticia] Inst Nacl Invest Nucl, Mexico City 11801, DF, Mexico	Universidad Nacional Autonoma de Mexico; University of Washington; University of Washington Seattle; University of Southern California	Arzate, H (corresponding author), Univ Nacl Autonoma Mexico, Fac Odontol, Lab Biol Periodontal, Mexico City 04510, DF, Mexico.	harzate@unam.mx	Serrano, Janeth/AAR-4493-2021; CUEVAS, CLARA LETICIA SANTOS/A-2968-2015; Arzate, Higinio/K-1934-2019	CUEVAS, CLARA LETICIA SANTOS/0000-0001-5903-1598; 	DGAPA-UNAM [IN216711]; CONACyT [130950]	DGAPA-UNAM(Universidad Nacional Autonoma de Mexico); CONACyT(Consejo Nacional de Ciencia y Tecnologia (CONACyT))	This project was partially supported by DGAPA-UNAM IN216711, and CONACyT 130950. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alvarez-Perez MA, 2006, BONE, V38, P409, DOI 10.1016/j.bone.2005.09.009; Anada T, 2008, TISSUE ENG PT A, V14, P965, DOI [10.1089/ten.tea.2007.0339, 10.1089/tea.2007.0339]; Arzate H, 2002, J DENT RES, V81, P541, DOI 10.1177/154405910208100808; Arzate H, 1998, J PERIODONTAL RES, V33, P249, DOI 10.1111/j.1600-0765.1998.tb02197.x; Bessa PC, 2008, J TISSUE ENG REGEN M, V2, P1, DOI 10.1002/term.63; BROWN WE, 1962, NATURE, V196, P1050, DOI 10.1038/1961050a0; Carmona-Rodriguez B, 2007, BIOCHEM BIOPH RES CO, V358, P763, DOI 10.1016/j.bbrc.2007.04.204; Carofino BC, 2008, J BONE JOINT SURG AM, V90A, P99, DOI 10.2106/JBJS.G.01546; Choi SH, 2002, J PERIODONTOL, V73, P63, DOI 10.1902/jop.2002.73.1.63; Cochran DI, 2000, J PERIODONTOL, V71, P1241, DOI 10.1902/jop.2000.71.8.1241; CUISINIER FJG, 1991, ULTRAMICROSCOPY, V36, P297, DOI 10.1016/0304-3991(91)90122-M; DAMIEN CJ, 1991, J APPL BIOMATER, V2, P187, DOI 10.1002/jab.770020307; Franceschi RT, 2005, J DENT RES, V84, P1093, DOI 10.1177/154405910508401204; Paula-Silva FWG, 2010, CALCIFIED TISSUE INT, V87, P144, DOI 10.1007/s00223-010-9368-x; Garcia-Ruiz JM, 2003, METHOD ENZYMOL, V368, P130, DOI 10.1016/S0076-6879(03)68008-0; Gautschi OP, 2007, ANZ J SURG, V77, P626, DOI 10.1111/j.1445-2197.2007.04175.x; Geesink RGT, 1999, J BONE JOINT SURG BR, V81B, P710, DOI 10.1302/0301-620X.81B4.9311; Giannobile WV, 1998, J PERIODONTOL, V69, P129, DOI 10.1902/jop.1998.69.2.129; Haidar ZS, 2009, BIOTECHNOL LETT, V31, P1817, DOI 10.1007/s10529-009-0099-x; Hamalainen KM, 1998, J CONTROL RELEASE, V56, P273, DOI 10.1016/S0168-3659(98)00094-7; Hogan BLM, 1996, GENE DEV, V10, P1580, DOI 10.1101/gad.10.13.1580; Honda Y, 2009, TISSUE ENG PT A, V15, P1965, DOI 10.1089/ten.tea.2008.0300; Hoz L, 2012, CELL BIOL INT, V36, P129, DOI 10.1042/CBI20110168; Huang YC, 2005, GENE THER, V12, P418, DOI 10.1038/sj.gt.3302439; Huang ZM, 2001, J BIOL CHEM, V276, P21351, DOI 10.1074/jbc.M010921200; HUNTER GK, 1993, P NATL ACAD SCI USA, V90, P8562, DOI 10.1073/pnas.90.18.8562; Jansen JA, 2005, J CONTROL RELEASE, V101, P127, DOI 10.1016/j.jconrel.2004.07.005; Kikawa T, 2009, ACTA BIOMATER, V5, P1756, DOI 10.1016/j.actbio.2008.12.008; King GN, 1997, J DENT RES, V76, P1460, DOI 10.1177/00220345970760080801; King GN, 1998, J PERIODONTAL RES, V33, P226, DOI 10.1111/j.1600-0765.1998.tb02194.x; Kirker-Head CA, 2000, ADV DRUG DELIVER REV, V43, P65, DOI 10.1016/S0169-409X(00)00078-8; Kohara H, 2011, BIOMATERIALS, V32, P5726, DOI 10.1016/j.biomaterials.2011.04.035; Krebsbach PH, 2000, HUM GENE THER, V11, P1201, DOI 10.1089/10430340050015248; Kwon Brian, 2005, Spine J, V5, p224S, DOI 10.1016/j.spinee.2005.02.007; Liening DA, 1997, OTOLARYNG HEAD NECK, V116, P454, DOI 10.1016/S0194-5998(97)70294-8; Liu Y, 2007, BIOMATERIALS, V28, P1393, DOI 10.1016/j.biomaterials.2006.11.019; Nunez J, 2010, J PERIODONTAL RES, V45, P809, DOI 10.1111/j.1600-0765.2010.01291.x; Pang EK, 2004, J PERIODONTOL, V75, P1364, DOI 10.1902/jop.2004.75.10.1364; Perez MAA, 2003, J STRUCT BIOL, V143, P1, DOI 10.1016/S1047-8477(03)00116-3; Ponticiello MS, 2000, J BIOMED MATER RES, V52, P246, DOI 10.1002/1097-4636(200011)52:2<246::AID-JBM2>3.0.CO;2-W; Rohanizadeh R, 2008, J MATER SCI-MATER M, V19, P1173, DOI 10.1007/s10856-007-3154-y; Seeherman H, 2005, CYTOKINE GROWTH F R, V16, P329, DOI 10.1016/j.cytogfr.2005.05.001; SELA M, 1960, BIOCHEM J, V75, P91, DOI 10.1042/bj0750091; Shelton RM, 2006, BIOMATERIALS, V27, P2874, DOI 10.1016/j.biomaterials.2005.12.031; Silverman L, 2004, CALCIFIED TISSUE INT, V75, P494, DOI 10.1007/s00223-004-0019-y; Stanton JS, 1995, J MATER SCI-MATER M, V6, P739; Suzuki O, 2006, BIOMATERIALS, V27, P2671, DOI 10.1016/j.biomaterials.2005.12.004; Suzuki O, 2010, ACTA BIOMATER, V6, P3379, DOI 10.1016/j.actbio.2010.04.002; SUZUKI O, 1991, TOHOKU J EXP MED, V164, P37, DOI 10.1620/tjem.164.37; Takahashi Y, 2005, BIOMATERIALS, V26, P4856, DOI 10.1016/j.biomaterials.2005.01.012; Takahashi Y, 2005, BIOMATERIALS, V26, P3587, DOI 10.1016/j.biomaterials.2004.09.046; Virk MS, 2011, MOL THER, V19, P960, DOI 10.1038/mt.2011.2; Whang K, 1998, J BIOMED MATER RES, V42, P491, DOI 10.1002/(SICI)1097-4636(19981215)42:4<491::AID-JBM3>3.0.CO;2-F; Wozney JM, 1998, CLIN ORTHOP RELAT R, P26	55	16	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78807	10.1371/journal.pone.0078807	http://dx.doi.org/10.1371/journal.pone.0078807			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265720	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100053
J	Breece, MW; Oliver, MJ; Cimino, MA; Fox, DA				Breece, Matthew W.; Oliver, Matthew J.; Cimino, Megan A.; Fox, Dewayne A.			Shifting Distributions of Adult Atlantic Sturgeon Amidst Post-Industrialization and Future Impacts in the Delaware River: a Maximum Entropy Approach	PLOS ONE			English	Article							ACIPENSER-OXYRINCHUS; BIOLOGY	Atlantic sturgeon (Acipenser oxyrinchus oxyrinchus) experienced severe declines due to habitat destruction and overfishing beginning in the late 19th century. Subsequent to the boom and bust period of exploitation, there has been minimal fishing pressure and improving habitats. However, lack of recovery led to the 2012 listing of Atlantic sturgeon under the Endangered Species Act. Although habitats may be improving, the availability of high quality spawning habitat, essential for the survival and development of eggs and larvae may still be a limiting factor in the recovery of Atlantic sturgeon. To estimate adult Atlantic sturgeon spatial distributions during riverine occupancy in the Delaware River, we utilized a maximum entropy (MaxEnt) approach along with passive biotelemetry during the likely spawning season. We found that substrate composition and distance from the salt front significantly influenced the locations of adult Atlantic sturgeon in the Delaware River. To broaden the scope of this study we projected our model onto four scenarios depicting varying locations of the salt front in the Delaware River: the contemporary location of the salt front during the likely spawning season, the location of the salt front during the historic fishery in the late 19th century, an estimated shift in the salt front by the year 2100 due to climate change, and an extreme drought scenario, similar to that which occurred in the 1960's. The movement of the salt front upstream as a result of dredging and climate change likely eliminated historic spawning habitats and currently threatens areas where Atlantic sturgeon spawning may be taking place. Identifying where suitable spawning substrate and water chemistry intersect with the likely occurrence of adult Atlantic sturgeon in the Delaware River highlights essential spawning habitats, enhancing recovery prospects for this imperiled species.	[Breece, Matthew W.; Oliver, Matthew J.; Cimino, Megan A.] Univ Delaware, Lewes, DE 19958 USA; [Fox, Dewayne A.] Delaware State Univ, Dover, DE USA	University of Delaware; Delaware State University	Breece, MW (corresponding author), Univ Delaware, Lewes, DE 19958 USA.	mwbreece@udel.edu			NOAA NMFS Anadromous Fish Conservation Act (NOAA Award) [NA08NMF4050611]; NOAA NMFS Species Recovery Grants to States (NOAA Award) [NA10NMF4720030]; DuPont Clear into the Future Fellowship Program	NOAA NMFS Anadromous Fish Conservation Act (NOAA Award); NOAA NMFS Species Recovery Grants to States (NOAA Award); DuPont Clear into the Future Fellowship Program	Funding was provided by the following: NOAA NMFS Anadromous Fish Conservation Act (NOAA Award NA08NMF4050611; http://www.nmfs.noaa.gov/sfa/state_federal/State-Federal-WEB/afca.htm), NOAA NMFS Species Recovery Grants to States (NOAA Award NA10NMF4720030; http://www.nmfs.noaa.gov/pr/conservation/states/grant.htm), and DuPont Clear into the Future Fellowship Program (http://clearintothefuture.com/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bain MB, 2000, I ESPANOL OCEANOGRFI, V16, P43; Balazik MT, 2012, N AM J FISH MANAGE, V32, P1062, DOI 10.1080/02755947.2012.716016; Bemis WE, 1997, ENVIRON BIOL FISH, V48, P167, DOI 10.1023/A:1007312524792; Billard R, 2001, REV FISH BIOL FISHER, V10, P355; Borodin N., 1925, T AM FISH SOC, V55, P184, DOI [10.1577/1548-8659(1925)55[184:BOOTAS]2.0.CO;2, DOI 10.1577/1548-8659(1925)55[184:BOOTAS]2.0.CO;2, DOI 10.1577/1548-8659(1925)55[]; Cobb JN, 1900, REP COMMISSIONER FIS, V25, P369; Cook TL, 2007, ESTUAR COAST SHELF S, V72, P235, DOI 10.1016/j.ecss.2006.10.014; DiLorenzo JL, 1993, EFFECTS HIST D UNPUB, P124; Economic League of; Greater Philadelphia, 2008, MAR COMM GREAT PHIL, P78; Elith J, 2011, DIVERS DISTRIB, V17, P43, DOI 10.1111/j.1472-4642.2010.00725.x; Fisher M. A, 2011, STATE DELAWARE ANN C, P19; Fox DA, 2000, T AM FISH SOC, V129, P811, DOI 10.1577/1548-8659(2000)129<0811:GSSMAH>2.3.CO;2; Gilbert CR, 1989, US DEP INTERIOR BIOL, V82, P28; Hatin D, 2002, J APPL ICHTHYOL, V18, P586, DOI 10.1046/j.1439-0426.2002.00395.x; Hull CHJ, 1986, GREENHOUSE EFFECT SE, P36; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; LARNTZ K, 1978, J AM STAT ASSOC, V73, P253, DOI 10.2307/2286650; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Redon M., 2010, 6 SAPT AN GEOM INT C, P42; Rodrigue J.P., 2010, FACTORS IMPACTING N, P64; Ryder J. A., 1890, US FISH COMMISSION B, V8, P231; Secor DH, 1999, AM FISH S S, V23, P203; Simpson P. C., 2009, CONT UNDERSTANDING D, V69, P1; Simpson PC, 2008, THESIS, P141; SMITH TIJ, 1985, ENVIRON BIOL FISH, V14, P61, DOI 10.1007/BF00001577; Sommerfield C. K., 2003, SEDIMENTOLOGICAL GEO; Sturgeon Atlantic Status Review Team, 2007, STAT REV ATL STURG A, P175; U.S. Office of the Federal Register, 2012, FED REGISTER, V77, P5880; United States Army Corp of Engineers, 2009, DEL RIV MAIN CHANN D, P131; VanEenennaam JP, 1996, ESTUARIES, V19, P769, DOI 10.2307/1352296; Walsh DR, 2004, THESIS, P85	31	10	10	1	46	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e81321	10.1371/journal.pone.0081321	http://dx.doi.org/10.1371/journal.pone.0081321			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260570	gold, Green Submitted, Green Published			2022-12-25	WOS:000327216200120
J	Rosenfeldt, MT; Bell, LA; Long, JS; O'Prey, J; Nixon, C; Roberts, F; Dufes, C; Ryan, KM				Rosenfeldt, M. T.; Bell, L. A.; Long, J. S.; O'Prey, J.; Nixon, C.; Roberts, F.; Dufes, C.; Ryan, K. M.			E2F1 drives chemotherapeutic drug resistance via ABCG2	ONCOGENE			English	Article						E2F1; ABCG2; cancer; drug sensitivity; multidrug transporters	MULTIDRUG-RESISTANCE; PROTEIN; CANCER; EXPRESSION; DEATH; TRANSCRIPTION; PHEOPHORBIDE; INHIBITION; APOPTOSIS; AUTOPHAGY	Multidrug resistance is a major barrier against successful chemotherapy, and this has been shown in vitro to be often caused by ATP-binding cassette (ABC) transporters. These transporters are frequently overexpressed in human cancers and confer an adverse prognosis in many common malignancies. The genetic factors, however, that initiate their expression in cancer are largely unknown. Here we report that the major multidrug transporter ABCG2 (BCRP/MXR) is directly and specifically activated by the transcription factor E2F1-a factor perturbed in the majority of human cancers. E2F1 regulates ABCG2 expression in multiple cell systems, and, importantly, we have identified a significant correlation between elevated E2F1 and ABCG2 expression in human lung cancers. We show that E2F1 causes chemotherapeutic drug efflux both in vitro and in vivo via ABCG2. Furthermore, the E2F1-ABCG2 axis suppresses chemotherapy-induced cell death that can be restored by the inhibition of ABCG2. These findings therefore identify a new axis in multidrug resistance and highlight a radical new function of E2F1 that is relevant to tumor therapy.	[Rosenfeldt, M. T.; Bell, L. A.; Long, J. S.; O'Prey, J.; Nixon, C.; Ryan, K. M.] Canc Res UK Beatson Inst, Tumour Cell Death Lab, Glasgow, Lanark, Scotland; [Roberts, F.] Univ Glasgow, Western Infirm, Dept Pathol, Glasgow G11 6NT, Lanark, Scotland; [Dufes, C.] Univ Strathclyde, Strathclyde Inst Pharm & Biomed Sci, Glasgow, Lanark, Scotland	Beatson Institute; University of Glasgow; University of Strathclyde	Ryan, KM (corresponding author), Canc Res UK Beatson Inst Canc Res, Tumour Cell Death Lab, Garscube Estate,Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	k.ryan@beatson.gla.ac.uk	Rosenfeldt, Mathias/ABE-4736-2022; Dufès, Christine/AAQ-1604-2021	Rosenfeldt, Mathias/0000-0001-7650-8458; Dufès, Christine/0000-0002-7963-6364; Ryan, Kevin M./0000-0002-1059-9681	Association for International Cancer Research and Cancer Research UK; Wellcome trust [ME0442]; Cancer Research UK [15816] Funding Source: researchfish; Worldwide Cancer Research [12-1262] Funding Source: researchfish	Association for International Cancer Research and Cancer Research UK; Wellcome trust(Wellcome TrustEuropean Commission); Cancer Research UK(Cancer Research UK); Worldwide Cancer Research	This work was supported by Association for International Cancer Research and Cancer Research UK, and by a Wellcome trust equipment grant (ME0442) to CD. We thank Doron Ginsberg, Kristian Helin, Douglas Ross and Karen Vousden for reagents.	Alla V, 2012, CELL CYCLE, V11, P3067, DOI 10.4161/cc.21476; Allen JD, 2002, MOL CANCER THER, V1, P417; Bailey-Dell KJ, 2001, BBA-GENE STRUCT EXPR, V1520, P234, DOI 10.1016/S0167-4781(01)00270-6; Bell HS, 2007, J CLIN INVEST, V117, P1008, DOI 10.1172/JCI28920; Bell LA, 2006, ONCOGENE, V25, P5656, DOI 10.1038/sj.onc.1209580; Bui-Xuan NH, 2010, J ETHNOPHARMACOL, V131, P95, DOI 10.1016/j.jep.2010.06.007; Chen HZ, 2009, NAT REV CANCER, V9, P785, DOI 10.1038/nrc2696; Diestra JE, 2002, J PATHOL, V198, P213, DOI 10.1002/path.1203; Dimova DK, 2005, ONCOGENE, V24, P2810, DOI 10.1038/sj.onc.1208612; Engelmann D, 2012, CANCER RES, V72, P571, DOI 10.1158/0008-5472.CAN-11-2575; Eymin B, 2001, ONCOGENE, V20, P1678, DOI 10.1038/sj.onc.1204242; Gorgoulis VG, 2002, J PATHOL, V198, P142, DOI 10.1002/path.1121; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; Helgason GV, 2010, CANCER RES, V70, P4074, DOI 10.1158/0008-5472.CAN-09-2876; Iaquinta PJ, 2007, CURR OPIN CELL BIOL, V19, P649, DOI 10.1016/j.ceb.2007.10.006; Lundberg AS, 1998, MOL CELL BIOL, V18, P753, DOI 10.1128/MCB.18.2.753; Natarajan K, 2012, BIOCHEM PHARMACOL, V83, P1084, DOI 10.1016/j.bcp.2012.01.002; Polager S, 2008, ONCOGENE, V27, P4860, DOI 10.1038/onc.2008.117; Polager S, 2008, TRENDS CELL BIOL, V18, P528, DOI 10.1016/j.tcb.2008.08.003; Robey RW, 2009, ADV DRUG DELIVER REV, V61, P3, DOI 10.1016/j.addr.2008.11.003; Robey RW, 2004, CANCER RES, V64, P1242, DOI 10.1158/0008-5472.CAN-03-3298; Robey RW, 2001, BBA-BIOMEMBRANES, V1512, P171, DOI 10.1016/S0005-2736(01)00308-X; Stewart DJ, 2010, CRIT REV ONCOL HEMAT, V75, P173, DOI 10.1016/j.critrevonc.2009.11.006; Wu ZL, 2009, INT J BIOCHEM CELL B, V41, P2389, DOI 10.1016/j.biocel.2009.06.004; Zhang W, 2009, DRUG METAB DISPOS, V37, P737, DOI 10.1124/dmd.108.023309; Zhang YM, 2007, CANCER RES, V67, P9389, DOI 10.1158/0008-5472.CAN-07-0944; Zhang YM, 2009, CANCER RES, V69, P5867, DOI 10.1158/0008-5472.CAN-08-4866	27	28	30	0	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	AUG 7	2014	33	32					4164	4172		10.1038/onc.2013.470	http://dx.doi.org/10.1038/onc.2013.470			9	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AN4YK	24276245	hybrid, Green Accepted			2022-12-25	WOS:000340595700007
J	Zhuang, XL; Semenova, E; Maric, D; Craigie, R				Zhuang, Xiaolei; Semenova, Elena; Maric, Dragan; Craigie, Robert			Dephosphorylation of Barrier-to-autointegration Factor by Protein Phosphatase 4 and Its Role in Cell Mitosis	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							NUCLEAR-ENVELOPE; STRUCTURAL BASIS; RETROVIRAL DNA; IN-VITRO; BAF; EMERIN; COMPLEX; LOCALIZATION; CHROMATIN; BINDING	Barrier-to-autointegration factor (BAF or BANF1) is highly conserved in multicellular eukaryotes and was first identified for its role in retroviral DNA integration. Homozygous BAF mutants are lethal and depletion of BAF results in defects in chromatin segregation during mitosis and subsequent nuclear envelope assembly. BAF exists both in phosphorylated and unphosphorylated forms with phosphorylation sites Thr-2, Thr-3, and Ser-4, near the N terminus. Vaccinia-related kinase 1 is the major kinase responsible for phosphorylation of BAF. We have identified the major phosphatase responsible for dephosphorylation of Ser-4 to be protein phosphatase 4 catalytic subunit. By examining the cellular distribution of phosphorylated BAF (pBAF) and total BAF (tBAF) through the cell cycle, we found that pBAF is associated with the core region of telophase chromosomes. Depletion of BAF or perturbing its phosphorylation state results not only in nuclear envelope defects, including mislocalization of LEM domain proteins and extensive invaginations into the nuclear interior, but also impaired cell cycle progression. This phenotype is strikingly similar to that seen in cells from patients with progeroid syndrome resulting from a point mutation in BAF.	[Zhuang, Xiaolei; Semenova, Elena; Craigie, Robert] NIDDK, Mol Biol Lab, Bethesda, MD 20892 USA; [Maric, Dragan] NINDS, Flow Cytometry Core Facil, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); National Institutes of Health (NIH) - USA; NIH National Institute of Neurological Disorders & Stroke (NINDS)	Craigie, R (corresponding author), NIDDK, NIH, Bldg 5,Rm 301, Bethesda, MD 20892 USA.	bobc@helix.nih.gov			National Institutes of Health [DK036171]; NIDDK, National Institutes of Health; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK036171] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDDK, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work was supported, in whole or in part, by National Institutes of Health Intramural Project DK036171. This work was supported by the Intramural Research Program of NIDDK, National Institutes of Health.	Asencio C, 2012, CELL, V150, P122, DOI 10.1016/j.cell.2012.04.043; Barford D, 1998, ANNU REV BIOPH BIOM, V27, P133, DOI 10.1146/annurev.biophys.27.1.133; Bengtsson L, 2006, MOL BIOL CELL, V17, P1154, DOI 10.1091/mbc.E05-04-0356; Bollen M, 2009, TRENDS CELL BIOL, V19, P531, DOI 10.1016/j.tcb.2009.06.005; Bradley CM, 2005, NAT STRUCT MOL BIOL, V12, P935, DOI 10.1038/nsmb989; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Cai M, 1998, NAT STRUCT BIOL, V5, P903, DOI 10.1038/2345; Cai ML, 2007, J BIOL CHEM, V282, P14525, DOI 10.1074/jbc.M700576200; Carnegie GK, 2003, J CELL SCI, V116, P1905, DOI 10.1242/jcs.00409; Chowdhury D, 2008, MOL CELL, V31, P33, DOI 10.1016/j.molcel.2008.05.016; Cohen PT, 2005, FEBS J, V272, P303; Cohen PTW, 2005, FEBS LETT, V579, P3278, DOI 10.1016/j.febslet.2005.04.070; COZZONE AJ, 1988, ANNU REV MICROBIOL, V42, P97, DOI 10.1146/annurev.mi.42.100188.000525; de Oca RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007050; Dechat T, 2004, J CELL SCI, V117, P6117, DOI 10.1242/jcs.01529; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Furukawa K, 1999, J CELL SCI, V112, P2485; Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101; Gorjanacz M, 2007, EMBO J, V26, P132, DOI 10.1038/sj.emboj.7601470; Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550; Gupton SL, 2006, PLANT PHYSIOL BIOCH, V44, P95, DOI 10.1016/j.plaphy.2006.03.003; Haraguchi T, 2000, J CELL SCI, V113, P779; Haraguchi T, 2008, J CELL SCI, V121, P2540, DOI 10.1242/jcs.033597; Haraguchi T, 2007, J CELL SCI, V120, P1967, DOI 10.1242/jcs.03461; Honkanen RE, 2002, CURR MED CHEM, V9, P2055, DOI 10.2174/0929867023368836; Huang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025123; Lee KK, 2001, J CELL SCI, V114, P4567; Lee MS, 1998, P NATL ACAD SCI USA, V95, P1528, DOI 10.1073/pnas.95.4.1528; Mansharamani M, 2005, J BIOL CHEM, V280, P13863, DOI 10.1074/jbc.M413020200; Margalit A, 2005, P NATL ACAD SCI USA, V102, P3290, DOI 10.1073/pnas.0408364102; Nakada S, 2008, EMBO REP, V9, P1019, DOI 10.1038/embor.2008.162; Nichols RJ, 2006, MOL BIOL CELL, V17, P2451, DOI 10.1091/mbc.E05-12-1179; Puente XS, 2011, AM J HUM GENET, V88, P650, DOI 10.1016/j.ajhg.2011.04.010; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shumaker DK, 2001, EMBO J, V20, P1754, DOI 10.1093/emboj/20.7.1754; Skoko D, 2009, P NATL ACAD SCI USA, V106, P16610, DOI 10.1073/pnas.0909077106; Umland TC, 2000, BIOCHEMISTRY-US, V39, P9130, DOI 10.1021/bi000572w; Virshup DM, 2009, MOL CELL, V33, P537, DOI 10.1016/j.molcel.2009.02.015; Zheng RL, 2000, P NATL ACAD SCI USA, V97, P8997, DOI 10.1073/pnas.150240197	39	35	35	0	5	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1119	1127		10.1074/jbc.M113.492777	http://dx.doi.org/10.1074/jbc.M113.492777			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265311	Green Published, hybrid			2022-12-25	WOS:000330541200043
J	Li, Q; Hakimi, P; Liu, X; Yu, WM; Ye, F; Fujioka, H; Raza, S; Shankar, E; Tang, FQ; Dunwoodie, SL; Danielpour, D; Hoppel, CL; Ramirez-Bergeron, DL; Qu, CK; Hanson, RW; Yang, YC				Li, Qiang; Hakimi, Parvin; Liu, Xia; Yu, Wen-Mei; Ye, Fang; Fujioka, Hisashi; Raza, Syed; Shankar, Eswar; Tang, Fangqiang; Dunwoodie, Sally L.; Danielpour, David; Hoppel, Charles L.; Ramirez-Bergeron, Diana L.; Qu, Cheng-Kui; Hanson, Richard W.; Yang, Yu-Chung			Cited2, a Transcriptional Modulator Protein, Regulates Metabolism in Murine Embryonic Stem Cells	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						CBP; Differentiation; Embryonic Stem Cell; Glucose Metabolism; Glycolysis	ACTIVATED RECEPTOR-GAMMA; PARTIALLY RESCUES; BINDING-PROTEIN; GENE-EXPRESSION; DIFFERENTIATION; HIF-1-ALPHA; MOUSE; GLYCOLYSIS; PLURIPOTENCY; DEFECTS	CREB-binding protein (CBP)/p300 interacting transactivator with glutamic acid (Glu) and aspartic acid (Asp)-tail 2 (Cited2) was recently shown to be essential for gluconeogenesis in the adult mouse. The metabolic function of Cited2 in mouse embryonic stem cells (mESCs) remains elusive. In the current study, the metabolism of glucose was investigated in mESCs, which contained a deletion in the gene for Cited2 (Cited2(/-)). Compared with its parental wild type counterpart, Cited2(/-) ESCs have enhanced glycolysis, alternations in mitochondria morphology, reduced glucose oxidation, and decreased ATP content. Cited2 is recruited to the hexokinase 1 (HK1) gene promoter to regulate transcription of HK1, which coordinates glucose metabolism in wild type ESCs. Reduced glucose oxidation and enhanced glycolytic activity in Cited2(/-) ESCs correlates with defective differentiation during hypoxia, which is reflected in an increased expression of pluripotency marker (Oct4) and epiblast marker (Fgf5) and decreased expression of lineage specification markers (T, Gata-6, and Cdx2). Knockdown of hypoxia inducible factor-1 in Cited2(/-) ESCs re-initiates the expression of differentiation markers T and Gata-6. Taken together, a deletion of Cited2 in mESCs results in abnormal mitochondrial morphology and impaired glucose metabolism, which correlates with a defective cell fate decision.	[Li, Qiang; Hakimi, Parvin; Raza, Syed; Tang, Fangqiang; Hanson, Richard W.; Yang, Yu-Chung] Case Western Reserve Univ, Dept Biochem, Cleveland, OH 44106 USA; [Liu, Xia; Yu, Wen-Mei; Hoppel, Charles L.; Qu, Cheng-Kui] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Ye, Fang; Fujioka, Hisashi; Shankar, Eswar; Danielpour, David] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA; [Ramirez-Bergeron, Diana L.] Case Western Reserve Univ, Dept Cardiovasc Med, Cleveland, OH 44106 USA; [Danielpour, David; Ramirez-Bergeron, Diana L.; Qu, Cheng-Kui; Yang, Yu-Chung] Case Western Reserve Univ, Ctr Canc, Cleveland, OH 44106 USA; [Ye, Fang; Hoppel, Charles L.] Case Western Reserve Univ, Ctr Mitochondrial Dis, Cleveland, OH 44106 USA; [Dunwoodie, Sally L.] Victor Chang Cardiac Res Inst, Dev & Stem Cell Biol Div, Darlinghurst, NSW 2010, Australia; [Dunwoodie, Sally L.] Univ New S Wales, St Vincents Clin Sch, Kensington, NSW 2010, Australia; [Dunwoodie, Sally L.] Univ New S Wales, Sch Biotechnol & Biomol Sci, Kensington, NSW 2010, Australia	Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; Victor Chang Cardiac Research Institute; University of New South Wales Sydney; University of New South Wales Sydney	Yang, YC (corresponding author), Case Western Reserve Univ, Sch Med, Dept Biochem, 10900 Euclid Ave,W444, Cleveland, OH 44106 USA.	yu-chung.yang@case.edu	Dunwoodie, Sally L/M-4019-2018; Hakimi, Parvin/AAB-1643-2021; Li, Qiang/O-8055-2014; Shankar, Eswar/E-5139-2015	Dunwoodie, Sally L/0000-0002-2069-7349; Li, Qiang/0000-0002-1779-0737; Shankar, Eswar/0000-0001-8968-838X	National Institutes of Health [R01HL091896, R01HL096597]; Ellison Medical Foundation [AG-SS 2420-10]; National Health and Medical Research Council (NHMRC) [1042002]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096597, R01HL091896] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ellison Medical Foundation(Lawrence Ellison Foundation); National Health and Medical Research Council (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This work was supported, in whole or in part, by National Institutes of Health Grants R01HL091896 (to Y-C. Y) and R01HL096597 (to D. R. B.), Grant AG-SS 2420-10 from the Ellison Medical Foundation (to R. W. H.), and National Health and Medical Research Council (NHMRC) Senior Research Fellowship 1042002 (to S. L. D).	AKUNDI RS, 2012, NEURODEGENE IN PRESS; Asmann YW, 2006, DIABETES, V55, P3309, DOI 10.2337/db05-1230; Bakker WJ, 2007, MOL CELL, V28, P941, DOI 10.1016/j.molcel.2007.10.035; BALLARD FJ, 1969, BIOCHEM J, V112, P195, DOI 10.1042/bj1120195; Bamforth SD, 2001, NAT GENET, V29, P469, DOI 10.1038/ng768; Bhattacharya S, 1999, GENE DEV, V13, P64, DOI 10.1101/gad.13.1.64; Chavez JC, 2006, J NEUROSCI, V26, P9471, DOI 10.1523/JNEUROSCI.2838-06.2006; Chen Y, 2008, DEVELOPMENT, V135, P2939, DOI 10.1242/dev.021097; Cheung KF, 2013, CANCER-AM CANCER SOC, V119, P1217, DOI 10.1002/cncr.27865; Chung Susan, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS60, DOI 10.1038/ncpcardio0766; Coletta DK, 2008, AM J PHYSIOL-ENDOC M, V294, pE910, DOI 10.1152/ajpendo.00607.2007; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; Du JW, 2012, BLOOD, V119, P2789, DOI 10.1182/blood-2011-10-387902; Duggirala R, 2001, AM J HUM GENET, V68, P1149, DOI 10.1086/320100; Fan YJ, 2010, J BIOL CHEM, V285, P7324, DOI 10.1074/jbc.M109.035584; Folmes CDL, 2013, J CARDIOVASC TRANSL, V6, P10, DOI 10.1007/s12265-012-9431-2; Folmes CDL, 2012, CELL STEM CELL, V11, P596, DOI 10.1016/j.stem.2012.10.002; Folmes CDL, 2011, CELL METAB, V14, P264, DOI 10.1016/j.cmet.2011.06.011; GNAIGER E, 2000, MITOCHONDRIA COLD; Han Y, 2010, STEM CELLS, V28, P799, DOI 10.1002/stem.316; Hohorst H. J., 1965, METHODS ENZYMATIC AN, V2nd; Huang TQ, 2012, MOL VIS, V18, P1260; Ito K, 2012, NAT MED, V18, P1350, DOI 10.1038/nm.2882; Johnson MT, 2003, J BIOL CHEM, V278, P31457, DOI 10.1074/jbc.R300002200; JOMAIN M, 1969, J LIPID RES, V10, P674; Kang JS, 2009, TRENDS BIOCHEM SCI, V34, P491, DOI 10.1016/j.tibs.2009.06.003; Khatri S, 2010, J BIOL CHEM, V285, P15960, DOI 10.1074/jbc.M110.121871; Kondoh H, 2007, ANTIOXID REDOX SIGN, V9, P293, DOI 10.1089/ars.2006.1467; Kranc KR, 2009, CELL STEM CELL, V5, P659, DOI 10.1016/j.stem.2009.11.001; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Li Q, 2012, J BIOL CHEM, V287, P29088, DOI 10.1074/jbc.M112.378034; Luo FM, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-26; Mandal S, 2011, STEM CELLS, V29, P486, DOI 10.1002/stem.590; McCleland ML, 2012, CANCER RES, V72, P5812, DOI 10.1158/0008-5472.CAN-12-1098; Nekanti U, 2010, INT J BIOL SCI, V6, P499; Nemetski SM, 2007, J BIOL CHEM, V282, P240, DOI 10.1074/jbc.M607275200; Ou XA, 2011, BLOOD, V117, P440, DOI 10.1182/blood-2010-03-273011; Papanicolaou KN, 2012, CIRC RES, V111, P1012, DOI 10.1161/CIRCRESAHA.112.274142; Peng TI, 2004, ANN NY ACAD SCI, V1011, P112, DOI 10.1196/annals.1293.012; Qu X, 2007, EMBO J, V26, P4445, DOI 10.1038/sj.emboj.7601883; Ramirez-Bergeron DL, 2004, DEVELOPMENT, V131, P4623, DOI 10.1242/dev.01310; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Ryan HE, 1998, EMBO J, V17, P3005, DOI 10.1093/emboj/17.11.3005; Sakai M, 2012, NAT MED, V18, P612, DOI 10.1038/nm.2691; Sengupta A, 2011, J BIOL CHEM, V286, P7468, DOI 10.1074/jbc.M110.179242; Shen JH, 2011, MOL CELL BIOL, V31, P4902, DOI 10.1128/MCB.05629-11; Simsek T, 2010, CELL STEM CELL, V7, P380, DOI 10.1016/j.stem.2010.07.011; SLEIN MW, 1965, METHODS ENZYMATIC AN; Song J, 2012, MOL CELL PROTEOMICS, V11, P1036, DOI 10.1074/mcp.M111.011114; Sun QA, 2011, P NATL ACAD SCI USA, V108, P4129, DOI 10.1073/pnas.1014769108; Tamai S, 2008, J CELL SCI, V121, P2588, DOI 10.1242/jcs.026625; Wang J, 2009, SCIENCE, V325, P435, DOI 10.1126/science.1173288; Weninger WJ, 2005, DEVELOPMENT, V132, P1337, DOI 10.1242/dev.01696; Wilkerson DC, 2011, INT J BIOCHEM CELL B, V43, P1252, DOI 10.1016/j.biocel.2011.05.005; Xu B, 2007, DEV BIOL, V301, P130, DOI 10.1016/j.ydbio.2006.08.072; Yang SH, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003112; Ye F, 2011, J BIOL CHEM, V286, P40013, DOI 10.1074/jbc.M111.292029; Yin Z, 2002, P NATL ACAD SCI USA, V99, P10488, DOI 10.1073/pnas.162371799; Zha XJ, 2011, CANCER RES, V71, P13, DOI 10.1158/0008-5472.CAN-10-1668; Zhang J, 2011, EMBO J, V30, P4860, DOI 10.1038/emboj.2011.401; Zhong L, 2010, CELL, V140, P280, DOI 10.1016/j.cell.2009.12.041; Zhong XM, 2009, J BIOL CHEM, V284, P9168, DOI 10.1074/jbc.M805562200; ZHOU J, 2013, J CLIN INVE IN PRESS; Zhou WY, 2012, EMBO J, V31, P2103, DOI 10.1038/emboj.2012.71; Zhu H, 2011, CELL, V147, P81, DOI 10.1016/j.cell.2011.08.033	65	16	17	1	14	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					251	263		10.1074/jbc.M113.497594	http://dx.doi.org/10.1074/jbc.M113.497594			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24265312	Green Published, hybrid			2022-12-25	WOS:000329370900022
J	Schmid, S; Sachs, D; tenOever, BR				Schmid, Sonja; Sachs, David; tenOever, Benjamin R.			Mitogen-activated Protein Kinase-mediated Licensing of Interferon Regulatory Factor 3/7 Reinforces the Cell Response to Virus	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Cellular Immune Response; MAP Kinases (MAPKs); Protein Phosphorylation; Transcriptomics; Virus; Dimer Formation; IRF3; IRF7; PML Nuclear Bodies; SP100	PROMYELOCYTIC LEUKEMIA PROTEIN; NF-KAPPA-B; FACTOR-I IRF-1; CRYSTAL-STRUCTURE; TRANSCRIPTION FACTORS; DNA-BINDING; RIG-I; GENE-EXPRESSION; BETA-INTERFERON; NUCLEAR-BODIES	The induction of the intrinsic antiviral defense in mammals relies on the accumulation of foreign genetic material. As such, complete engagement of this response is limited to replication-competent viruses. Interferon regulatory factors (IRFs) are mediators of this defense with shared enhancer elements but display a spectrum of transcriptional potential. Here we describe a mechanism designed to enhance this response should a pathogen not be successfully inhibited. We find that activation of IRF7 results in the induction of MAP3K8 and restructuring of the antiviral transcriptome. MAP3K8 mediates the phosphorylation and repression of IRF3 homodimers to promote greater transcriptional activity through utilization of IRF3:IRF7 heterodimers. Among the genes influenced by the MAP3K8/IRF7 signaling axis are members of the SP100 gene family that serve as general transcriptional enhancers of the antiviral defense. We propose that this feed forward loop serves to reinforce the cellular response and is reserved for imminent threats to the host.	[Schmid, Sonja; tenOever, Benjamin R.] Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA; [Sachs, David] Icahn Sch Med Mt Sinai, Dept Genom, New York, NY 10029 USA	Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	tenOever, BR (corresponding author), Icahn Sch Med Mt Sinai, Dept Microbiol, New York, NY 10029 USA.	benjamin.tenoever@mssm.edu		Schmid, Sonja/0000-0002-1946-5970; tenOever, Benjamin/0000-0003-0324-3078; Sachs, David/0000-0002-4445-2055	National Institutes of Health from NIAID [A1080624]	National Institutes of Health from NIAID(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported, in whole or in part, by National Institutes of Health Grant A1080624 from the NIAID.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Au WC, 2001, VIROLOGY, V280, P273, DOI 10.1006/viro.2000.0782; Barnes BJ, 2004, J BIOL CHEM, V279, P45194, DOI 10.1074/jbc.M400726200; Baum A, 2010, P NATL ACAD SCI USA, V107, P16303, DOI 10.1073/pnas.1005077107; Beinke S, 2003, MOL CELL BIOL, V23, P4739, DOI 10.1128/MCB.23.14.4739-4752.2003; Blondel D, 2010, J VIROL, V84, P10719, DOI 10.1128/JVI.01286-10; Bonilla WV, 2002, J VIROL, V76, P3810, DOI 10.1128/JVI.76.8.3810-3818.2002; Borden KLB, 2008, BBA-MOL CELL RES, V1783, P2145, DOI 10.1016/j.bbamcr.2008.06.005; Chattopadhyay S, 2013, J VIROL, V87, P16, DOI 10.1128/JVI.01853-12; Chelbi-Alix MK, 1998, J VIROL, V72, P1043, DOI 10.1128/JVI.72.2.1043-1051.1998; Chen W, 2008, NAT STRUCT MOL BIOL, V15, P1213, DOI 10.1038/nsmb.1496; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; DARNELL JE, 1994, SCIENCE, V264, P1415, DOI 10.1126/science.8197455; Das S, 2005, J BIOL CHEM, V280, P23748, DOI 10.1074/jbc.M412837200; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; Doody GM, 2010, NUCLEIC ACIDS RES, V38, P5336, DOI 10.1093/nar/gkq268; Dumitru CD, 2000, CELL, V103, P1071, DOI 10.1016/S0092-8674(00)00210-5; Eliopoulos AG, 2003, EMBO J, V22, P3855, DOI 10.1093/emboj/cdg386; Eliopoulos AG, 2002, EMBO J, V21, P4831, DOI 10.1093/emboj/cdf478; Escalante CR, 2007, MOL CELL, V26, P703, DOI 10.1016/j.molcel.2007.04.022; Farlik M, 2012, MOL CELL BIOL, V32, P1032, DOI 10.1128/MCB.06021-11; Feng D, 2010, J IMMUNOL, V185, P6003, DOI 10.4049/jimmunol.1000482; Fensterl V, 2009, BIOFACTORS, V35, P14, DOI 10.1002/biof.6; Fitzgerald KA, 2003, NAT IMMUNOL, V4, P491, DOI 10.1038/ni921; Fujii Y, 1999, EMBO J, V18, P5028, DOI 10.1093/emboj/18.18.5028; Genin P, 2009, MOL CELL BIOL, V29, P3435, DOI 10.1128/MCB.01805-08; Geoffroy MC, 2011, J INTERF CYTOK RES, V31, P145, DOI 10.1089/jir.2010.0111; Grandvaux N, 2002, J VIROL, V76, P5532, DOI 10.1128/JVI.76.11.5532-5539.2002; Grotzinger T, 1996, J BIOL CHEM, V271, P25253, DOI 10.1074/jbc.271.41.25253; HARADA H, 1994, MOL CELL BIOL, V14, P1500, DOI 10.1128/MCB.14.2.1500; Hayakawa F, 2004, CANCER CELL, V5, P389, DOI 10.1016/S1535-6108(04)00082-0; Honda K, 2005, NATURE, V434, P772, DOI 10.1038/nature03464; Iki S, 2005, VIROLOGY, V343, P106, DOI 10.1016/j.virol.2005.08.010; Ireton RC, 2011, VIRUSES-BASEL, V3, P906, DOI 10.3390/v3060906; Kaiser F, 2009, J EXP MED, V206, P1863, DOI 10.1084/jem.20091059; Kumar P, 2007, NAT CELL BIOL, V9, P45, DOI 10.1038/ncb1516; Lallemand-Breitenbach V., 2010, COLD SPRING HARB PER, V2; Langlois RA, 2012, P NATL ACAD SCI USA, V109, P12117, DOI 10.1073/pnas.1206039109; Lazear HM, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003118; Levy DE, 2011, CURR OPIN VIROL, V1, P476, DOI 10.1016/j.coviro.2011.11.001; LEVY DE, 1988, GENE DEV, V2, P383, DOI 10.1101/gad.2.4.383; Li J., 2013, MBIO, V4; Lin RT, 2000, J BIOL CHEM, V275, P34320, DOI 10.1074/jbc.M002814200; Lin RT, 2000, MOL CELL BIOL, V20, P6342, DOI 10.1128/MCB.20.17.6342-6353.2000; Mamane Y, 1999, GENE, V237, P1, DOI 10.1016/S0378-1119(99)00262-0; Maniatis T, 1998, COLD SPRING HARB SYM, V63, P609, DOI 10.1101/sqb.1998.63.609; Marie I, 1998, EMBO J, V17, P6660, DOI 10.1093/emboj/17.22.6660; Meylan E, 2006, NATURE, V442, P39, DOI 10.1038/nature04946; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Mielke LA, 2009, J IMMUNOL, V183, P7984, DOI 10.4049/jimmunol.0901336; Moltedo B, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002345; Morin P, 2002, J MOL BIOL, V316, P1009, DOI 10.1006/jmbi.2001.5401; Newhart A, 2013, MOL BIOL CELL, V24, P1454, DOI 10.1091/mbc.E12-09-0669; NIWA H, 1991, GENE, V108, P193, DOI 10.1016/0378-1119(91)90434-D; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Perez JT, 2010, P NATL ACAD SCI USA, V107, P11525, DOI 10.1073/pnas.1001984107; Qin BY, 2003, NAT STRUCT BIOL, V10, P913, DOI 10.1038/nsb1002; Rand U, 2012, MOL SYST BIOL, V8, DOI 10.1038/msb.2012.17; Rehwinkel J, 2010, CELL, V140, P397, DOI 10.1016/j.cell.2010.01.020; Sadler AJ, 2008, NAT REV IMMUNOL, V8, P559, DOI 10.1038/nri2314; Salmeron A, 1996, EMBO J, V15, P817, DOI 10.1002/j.1460-2075.1996.tb00417.x; Sato M, 2000, IMMUNITY, V13, P539, DOI 10.1016/S1074-7613(00)00053-4; Schmid S, 2010, J BIOL CHEM, V285, P42013, DOI 10.1074/jbc.M110.165936; Schoggins JW, 2011, NATURE, V472, P481, DOI 10.1038/nature09907; Servant MJ, 2003, J BIOL CHEM, V278, P9441, DOI 10.1074/jbc.M209851200; Seth RB, 2005, CELL, V122, P669, DOI 10.1016/j.cell.2005.08.012; Sharma S, 2003, SCIENCE, V300, P1148, DOI 10.1126/science.1081315; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; Takahasi K, 2003, NAT STRUCT BIOL, V10, P922, DOI 10.1038/nsb1001; TANAKA N, 1993, MOL CELL BIOL, V13, P4531, DOI 10.1128/MCB.13.8.4531; Taniguchi T, 2001, ANNU REV IMMUNOL, V19, P623, DOI 10.1146/annurev.immunol.19.1.623; Tavalai N, 2008, BBA-MOL CELL RES, V1783, P2207, DOI 10.1016/j.bbamcr.2008.08.004; Tenoever BR, 2007, SCIENCE, V315, P1274, DOI 10.1126/science.1136567; Thakar J, 2013, J INTERF CYTOK RES, V33, P700, DOI 10.1089/jir.2012.0113; Tsatsanis C, 1998, P NATL ACAD SCI USA, V95, P3827, DOI 10.1073/pnas.95.7.3827; Ulbricht T, 2012, J CELL BIOL, V199, P49, DOI 10.1083/jcb.201112015; Varble A, 2013, CELL HOST MICROBE, V14, P346, DOI 10.1016/j.chom.2013.08.007; VEALS SA, 1993, MOL CELL BIOL, V13, P196, DOI 10.1128/MCB.13.1.196; VEALS SA, 1992, MOL CELL BIOL, V12, P3315, DOI 10.1128/MCB.12.8.3315; Vougioukalaki M, 2011, CANCER LETT, V304, P80, DOI 10.1016/j.canlet.2011.02.004; Wang J, 2004, J CELL BIOL, V164, P515, DOI 10.1083/jcb.200305142; Wang JT, 2009, J VIROL, V83, P1856, DOI 10.1128/JVI.01099-08; Waterfield MR, 2003, MOL CELL, V11, P685, DOI 10.1016/S1097-2765(03)00070-4; Watford WT, 2008, J EXP MED, V205, P2803, DOI 10.1084/jem.20081461; Wathelet MG, 1998, MOL CELL, V1, P507, DOI 10.1016/S1097-2765(00)80051-9; Xiao NM, 2009, J IMMUNOL, V183, P7975, DOI 10.4049/jimmunol.0902718; Xu J, 2013, P NATL ACAD SCI USA, V110, P15025, DOI 10.1073/pnas.1303193110; Yang HM, 2002, EUR J BIOCHEM, V269, P6142, DOI 10.1046/j.1432-1033.2002.03330.x; Yang HT, 2011, J IMMUNOL, V186, P1989, DOI 10.4049/jimmunol.1001003; Yoshimura A, 2007, NAT REV IMMUNOL, V7, P454, DOI 10.1038/nri2093	91	20	23	0	2	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					299	311		10.1074/jbc.M113.519934	http://dx.doi.org/10.1074/jbc.M113.519934			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24275658	Green Published, hybrid			2022-12-25	WOS:000329370900026
J	Hansen, MJ; Chen, H; Jones, JE; Langenbach, SY; Vlahos, R; Gualano, RC; Morris, MJ; Anderson, GP				Hansen, Michelle J.; Chen, Hui; Jones, Jessica E.; Langenbach, Shenna Y.; Vlahos, Ross; Gualano, Rosa C.; Morris, Margaret J.; Anderson, Gary P.			The Lung Inflammation and Skeletal Muscle Wasting Induced by Subchronic Cigarette Smoke Exposure Are Not Altered by a High-Fat Diet in Mice	PLOS ONE			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; HYPOTHALAMIC NEUROPEPTIDE-Y; FOXO TRANSCRIPTION FACTORS; UBIQUITIN LIGASES; GENE-EXPRESSION; MOUSE MODEL; WEIGHT-LOSS; OBESE MICE; ATROPHY; PROTEIN	Obesity and cigarette smoking independently constitute major preventable causes of morbidity and mortality and obesity is known to worsen lung inflammation in asthma. Paradoxically, higher body mass index (BMI) is associated with reduced mortality in smoking induced COPD whereas low BMI increases mortality risk. To date, no study has investigated the effect of a dietary-induced obesity and cigarette smoke exposure on the lung inflammation and loss of skeletal muscle mass in mice. Male BALB/c mice were exposed to 4 cigarettes/day, 6 days/week for 7 weeks, or sham handled. Mice consumed either standard laboratory chow (3.5 kcal/g, 12% fat) or a high fat diet (HFD, 4.3 kcal/g, 32% fat). Mice exposed to cigarette smoke for 7 weeks had significantly more inflammatory cells in the BALF (P < 0.05) and the mRNA expression of proinflammatory cytokines and chemokines was significantly increased (P < 0.05); HFD had no effect on these parameters. Sham-and smoke-exposed mice consuming the HFD were significantly heavier than chow fed animals (12 and 13%, respectively; P < 0.05). Conversely, chow and HFD fed mice exposed to cigarette smoke weighed 16 and 15% less, respectively, compared to sham animals (P < 0.05). The skeletal muscles (soleus, tibialis anterior and gastrocnemius) of cigarette smoke-exposed mice weighed significantly less than sham-exposed mice (P < 0.05) and the HFD had no protective effect. For the first time we report that cigarette smoke exposure significantly decreased insulin-like growth factor-1 (IGF-1) mRNA expression in the gastrocnemius and tibialis anterior and IGF-1 protein in the gastrocnemius (P < 0.05). We have also shown that cigarette smoke exposure reduced circulating IGF-1 levels. IL-6 mRNA expression was significantly elevated in all three skeletal muscles of chow fed smoke-exposed mice (P < 0.05). In conclusion, these findings suggest that a down-regulation in local IGF-1 may be responsible for the loss of skeletal muscle mass following cigarette smoke exposure in mice.	[Hansen, Michelle J.; Jones, Jessica E.; Langenbach, Shenna Y.; Vlahos, Ross; Gualano, Rosa C.; Anderson, Gary P.] Univ Melbourne, Lung Hlth Res Ctr, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia; [Morris, Margaret J.] Univ New S Wales, Dept Pharmacol, Sch Med Sci, Sydney, NSW, Australia; [Chen, Hui] Univ Technol Sydney, Fac Sci, Sch Med & Mol Biosci, Sydney, NSW 2007, Australia	University of Melbourne; University of New South Wales Sydney; University of Technology Sydney	Hansen, MJ (corresponding author), Univ Melbourne, Lung Hlth Res Ctr, Dept Pharmacol & Therapeut, Melbourne, Vic 3010, Australia.	mjhansen@unimelb.edu.au	Morris, Margaret J/J-4285-2013; Chen, Hui/R-6137-2019; Chen, Hui/D-2005-2014; Vlahos, Ross/AAM-3837-2020	Chen, Hui/0000-0001-6883-3752; Chen, Hui/0000-0001-6883-3752; Vlahos, Ross/0000-0001-8443-7071; Hansen, Michelle/0000-0002-2607-461X; Anderson, Gary/0000-0001-6580-3398; Morris, Margaret/0000-0003-2285-5117	National Health and Medical Research Council of Australia [628492]	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia)	This work was funded by the National Health and Medical Research Council of Australia (project grant number 628492). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2008, WORLD HLTH REP GLOB; Ardite E, 2006, RESP MED, V100, P1186, DOI 10.1016/j.rmed.2005.10.023; Barnes PJ, 2003, EUR RESPIR J, V22, P672, DOI 10.1183/09031936.03.00040703; Barton ER, 2010, J APPL PHYSIOL, V108, P1069, DOI 10.1152/japplphysiol.01308.2009; Beckett EL, 2013, J ALLERGY CLIN IMMUN, V131, P752, DOI 10.1016/j.jaci.2012.11.053; Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874; Botelho FM, 2010, AM J RESP CELL MOL, V42, P394, DOI 10.1165/rcmb.2008-0301OC; Broekhuizen R, 2006, THORAX, V61, P17, DOI 10.1136/thx.2005.041996; Canoy D, 2005, OBES RES, V13, P1466, DOI 10.1038/oby.2005.177; Chakravarthy MV, 2000, J APPL PHYSIOL, V89, P1365, DOI 10.1152/jappl.2000.89.4.1365; Chen H, 2007, AM J PHYSL ENDOCRINO; Chen H, 2008, BRAIN RES, V1228, P81, DOI 10.1016/j.brainres.2008.06.067; Chen H, 2006, AM J RESP CRIT CARE, V173, P1248, DOI 10.1164/rccm.200506-977OC; Crul T, 2007, EUR J CLIN INVEST, V37, P897, DOI 10.1111/j.1365-2362.2007.01867.x; de Oca MM, 2008, CHEST, V133, P13, DOI 10.1378/chest.07-1592; De Paepe B, 2008, ACTA NEUROPATHOL, V115, P675, DOI 10.1007/s00401-008-0348-4; Dixon Anne E, 2010, Proc Am Thorac Soc, V7, P325, DOI 10.1513/pats.200903-013ST; FONG Y, 1989, AM J PHYSIOL, V256, pR659, DOI 10.1152/ajpregu.1989.256.3.R659; Gan WQ, 2004, THORAX, V59, P574, DOI 10.1136/thx.2003.019588; GOODMAN MN, 1994, P SOC EXP BIOL MED, V205, P182; Gosker HR, 2009, AM J RESP CELL MOL, V40, P710, DOI 10.1165/rcmb.2008-0312OC; Gualano RC, 2008, RESP RES, V9, DOI 10.1186/1465-9921-9-53; Guerassimov A, 2004, AM J RESP CRIT CARE, V170, P974, DOI 10.1164/rccm.200309-1270oc; Guttridge DC, 2000, SCIENCE, V289, P2363, DOI 10.1126/science.289.5488.2363; Haddad F, 2004, J APPL PHYSL; Hansen MJ, 2005, BRAIN RES, V1039, P137, DOI 10.1016/j.brainres.2005.01.063; Hansen MJ, 2004, J NEUROCHEM, V88, P909, DOI 10.1046/j.1471-4159.2003.02217.x; Hansen MJ, 2001, BRAIN RES, V892, P130, DOI 10.1016/S0006-8993(00)03246-7; Hoffman EP, 2004, NAT MED, V10, P584, DOI 10.1038/nm0604-584; Johnston RA, 2008, J APPL PHYSIOL, V104, P1727, DOI 10.1152/japplphysiol.00075.2008; Johnston RA, 2007, AM J RESP CRIT CARE, V176, P650, DOI 10.1164/rccm.200702-323OC; Lainscak M, 2011, J CACHEXIA SARCOPENI, V2, P81, DOI 10.1007/s13539-011-0023-9; Landbo C, 1999, AM J RESP CRIT CARE, V160, P1856, DOI 10.1164/ajrccm.160.6.9902115; Langen RCJ, 2004, FASEB J, V18, P227, DOI 10.1096/fj.03-0251com; Langen RCJ, 2002, AM J PHYSIOL-CELL PH, V283, pC714, DOI 10.1152/ajpcell.00418.2001; Lecker SH, 2004, FASEB J, V18, P39, DOI 10.1096/fj.03-0610com; Llovera M, 1997, BIOCHEM BIOPH RES CO, V230, P238, DOI 10.1006/bbrc.1996.5827; McDuffie Eric, 2006, J Inflamm (Lond), V3, P15, DOI 10.1186/1476-9255-3-15; Michelson PH, 2009, ANN ALLERG ASTHMA IM, V103, P381, DOI 10.1016/S1081-1206(10)60356-0; Petersen AMW, 2007, AM J PHYSIOL-ENDOC M, V293, pE843, DOI 10.1152/ajpendo.00301.2007; Pinto-Plata VM, 2006, THORAX, V61, P23, DOI 10.1136/thx.2005.042200; Poitou C, 2005, DIABETOLOGIA, V48, P519, DOI 10.1007/s00125-004-1654-6; Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3; Scheja L, 2008, EXP DIABETES RES, DOI 10.1155/2008/230837; Schols AMWJ, 1998, AM J RESP CRIT CARE, V157, P1791, DOI 10.1164/ajrccm.157.6.9705017; Schols AMWJ, 1996, THORAX, V51, P819, DOI 10.1136/thx.51.8.819; Serrano AL, 2008, CELL METAB, V7, P33, DOI 10.1016/j.cmet.2007.11.011; Sideleva O, 2012, AM J RESP CRIT CARE, V186, P598, DOI 10.1164/rccm.201203-0573OC; Smith AG, 2007, J NUTR, V137, P1236, DOI 10.1093/jn/137.5.1236; Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4; Tang K, 2010, J CELL PHYSIOL, V222, P320, DOI 10.1002/jcp.21955; van den Borst B, 2013, AM J RESP CRIT CARE, V187, P8, DOI 10.1164/rccm.201208-1441OE; Vlahos R, 2006, AM J PHYSIOL-LUNG C, V290, pL931, DOI 10.1152/ajplung.00201.2005; World Health Organisation, 2013, OB FACT SHEET OB OV; Wust RCI, 2008, EUR J APPL PHYSIOL, V104, P103, DOI 10.1007/s00421-008-0792-9; Yanbaeva DG, 2007, CHEST, V131, P1557, DOI 10.1378/chest.06-2179; Yende S, 2006, THORAX, V61, P10, DOI 10.1136/thx.2004.034181	57	16	17	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80471	10.1371/journal.pone.0080471	http://dx.doi.org/10.1371/journal.pone.0080471			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260397	gold, Green Published			2022-12-25	WOS:000327311900068
J	Dong, ZQ; Peng, ZS; Chang, Q; Lu, F				Dong, Ziqing; Peng, Zhangsong; Chang, Qiang; Lu, Feng			The Survival Condition and Immunoregulatory Function of Adipose Stromal Vascular Fraction (SVF) in the Early Stage of Nonvascularized Adipose Transplantation	PLOS ONE			English	Article							STEM-CELLS; AUTOLOGOUS FAT; TISSUE; MACROPHAGE; INFLAMMATION; RECRUITMENT; ACTIVATION	Introduction: Adipose tissue transplantation is one of the standard procedures for soft-tissue augmentation, reconstruction, and rejuvenation. However, it is unknown as to how the graft survives after transplantation. We thus seek out to investigate the roles of different cellular components in the survival of graft. Materials & Methods: The ratios of stromal vascular fraction (SVF) cellular components from human adipose tissue were evaluated using flow cytometry. Human liposuction aspirates that were either mixed with marked SVF cells or PBS were transplanted into nude mice. The graft was harvested and stained on days 1,4,7 and 14. The inflammation level of both SVF group and Fat-only group were also evaluated. Results: Flow cytometric analysis showed SVF cells mainly contained blood-derived cells, adipose-derived stromal cells (ASCs), and endothelial cells. Our study revealed that most cells are susceptible to death after transplantation, although CD34+ ASCs can remain viable for 14 days. Notably, we found that ASCs migrated to the peripheral edge of the graft. Moreover, the RT-PCR and the immuno-fluorescence examination revealed that although the SVF did not reduce the number of infiltrating immune cells (macrophages) in the transplant, it does have an immunoregulatory function of up-regulating the expression of CD163 and CD206 and down-regulating that of IL-1 beta, IL-6. Conclusions: Our study suggests that the survival of adipose tissue after nonvascularized adipose transplantation may be due to the ASCs in SVF cells. Additionally, the immunoregulatory function of SVF cells may be indirectly contributing to the remolding of adipose transplant, which may lead to SVF-enriched adipose transplantation.	[Dong, Ziqing; Peng, Zhangsong; Chang, Qiang; Lu, Feng] Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Guangdong, Peoples R China	Southern Medical University - China	Lu, F (corresponding author), Southern Med Univ, Nanfang Hosp, Dept Plast & Cosmet Surg, Guangzhou, Guangdong, Peoples R China.	doctorlufeng@hotmail.com			National Nature Science Foundation of China [81171834]; Guangdong Natural Science Foundation [S2011010003058]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangdong Natural Science Foundation(National Natural Science Foundation of Guangdong Province)	This work was financially supported by the National Nature Science Foundation of China (81171834), and the Guangdong Natural Science Foundation (S2011010003058). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aguena M, 2012, STEM CELLS INT, V2012, DOI 10.1155/2012/303610; Badylak SF, 2008, TISSUE ENG PT A, V14, P1835, DOI 10.1089/ten.tea.2007.0264; BILLINGS E, 1989, PLAST RECONSTR SURG, V83, P368, DOI 10.1097/00006534-198902000-00033; BIRCOLL M, 1987, PLAST RECONSTR SURG, V79, P267, DOI 10.1097/00006534-198702000-00022; Cervelli V, 2009, AESTHET PLAST SURG, V33, P22, DOI 10.1007/s00266-008-9223-x; Debels H, 2013, TISSUE ENG A; Donizetti-Oliveira C, 2012, CELL TRANSPLANT, V21, P1727, DOI 10.3727/096368911X623925; Eto H, 2012, PLAST RECONSTR SURG, V129, P1081, DOI 10.1097/PRS.0b013e31824a2b19; Eto H, 2011, AM J PATHOL, V178, P2322, DOI 10.1016/j.ajpath.2011.01.032; Eto H, 2009, PLAST RECONSTR SURG, V124, P1087, DOI 10.1097/PRS.0b013e3181b5a3f1; Fisher C, 2013, PLAST RECONSTR SURG, V132, P351, DOI 10.1097/PRS.0b013e3182958796; Gomez-Mauricio RG, 2013, EUR J PHARM BIOPHARM, V84, P29, DOI 10.1016/j.ejpb.2012.11.028; Harford KA, 2011, P NUTR SOC, V70, P408, DOI 10.1017/S0029665111000565; Hollenbeck ST, 2012, WOUND REPAIR REGEN, V20, P872, DOI 10.1111/j.1524-475X.2012.00854.x; Hung MJ, 2013, J FORMOS MED ASS; Kaufman MR, 2007, PLAST RECONSTR SURG, V119, P2287, DOI 10.1097/01.prs.0000260712.44089.e7; Kawanishi N, 2010, EXERC IMMUNOL REV, V16, P105; Kim YM, 2008, INT J BIOCHEM CELL B, V40, P2482, DOI 10.1016/j.biocel.2008.04.016; Koh YJ, 2011, ARTERIOSCL THROM VAS, V31, P1141, DOI 10.1161/ATVBAHA.110.218206; Li PP, 2010, J BIOL CHEM, V285, P15333, DOI 10.1074/jbc.M110.100263; Lilja HE, 2013, STEM CELLS DEV, V22, P1602, DOI 10.1089/scd.2012.0451; Lin G, 2008, STEM CELLS DEV, V17, P1053, DOI 10.1089/scd.2008.0117; Linde N, 2012, J PATHOL, V227, P17, DOI 10.1002/path.3989; MACKAY DR, 1993, ANN PLAS SURG, V31, P42; Maumus M, 2011, INT J OBESITY, V35, P1141, DOI 10.1038/ijo.2010.269; Mizuno H, 2012, STEM CELLS, V30, P804, DOI 10.1002/stem.1076; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Nishimura S, 2009, NAT MED, V15, P914, DOI 10.1038/nm.1964; Planat-Benard V, 2004, CIRCULATION, V109, P656, DOI 10.1161/01.CIR.0000114522.38265.61; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Premaratne GU, 2011, J CARDIOTHORAC SURG, V6, DOI 10.1186/1749-8090-6-43; Rada T, 2013, CURR STEM CELL RES T, V8, P357, DOI 10.2174/1574888X113089990049; Rehman J, 2004, CIRCULATION, V109, P1292, DOI 10.1161/01.CIR.0000121425.42966.F1; Sheng LL, 2011, TOHOKU J EXP MED, V224, P229, DOI 10.1620/tjem.224.229; Squadrito ML, 2011, MOL ASPECTS MED, V32, P123, DOI 10.1016/j.mam.2011.04.005; Suga H, 2009, STEM CELLS DEV, V18, P1201, DOI 10.1089/scd.2009.0003; van Dijk A, 2011, STEM CELL RES, V7, P219, DOI 10.1016/j.scr.2011.06.003; Yoshimura K, 2008, DERMATOL SURG, V34, P1178, DOI 10.1111/j.1524-4725.2008.34256.x; Zimmerlin L, 2010, CYTOM PART A, V77A, P22, DOI 10.1002/cyto.a.20813	39	36	41	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80364	10.1371/journal.pone.0080364	http://dx.doi.org/10.1371/journal.pone.0080364			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260375	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500127
J	Koch, SI; Groh, K; Vogel, H; Hannson, BS; Kleineidam, CJ; Grosse-Wilde, E				Koch, Sarah I.; Groh, Katrin; Vogel, Heiko; Hannson, Bill S.; Kleineidam, Christoph J.; Grosse-Wilde, Ewald			Caste-Specific Expression Patterns of Immune Response and Chemosensory Related Genes in the Leaf-Cutting Ant, Atta vollenweideri	PLOS ONE			English	Article							OLFACTORY RECEPTOR NEURONS; ODORANT-BINDING; PHENOTYPIC PLASTICITY; CARBON-DIOXIDE; ANTENNAL LOBE; SEX-PHEROMONE; HONEY-BEE; CHEMORECEPTOR SUPERFAMILY; ANTHERAEA-POLYPHEMUS; APIS-MELLIFERA	Leaf-cutting ants are evolutionary derived social insects with elaborated division of labor and tremendous colony sizes with millions of workers. Their social organization is mainly based on olfactory communication using different pheromones and is promoted by a pronounced size-polymorphism of workers that perform different tasks within the colony. The size polymorphism and associated behaviors are correlated to distinct antennal lobe (AL) phenotypes. Two worker phenotypes differ in number of olfactory glomeruli in the AL and the presence or absence of an extremely large glomerulus (macroglomerulus), involved in trail-pheromone reception. The males' AL contains three macroglomeruli which are presumably involved in detection of sex-pheromone components. We investigated the antennal transcriptome data of all major castes (males, queens and workers) and two worker subcastes (large and tiny workers). In order to identify putative odorant receptor genes involved in pheromone detection, we identified differentially expressed odorant receptor genes (OR-genes) using custom microarrays. In total, we found 185 OR-gene fragments that are clearly related to ORs and we identified orthologs for 70 OR-genes. Among them one OR-gene differs in relative expression between the two worker subcastes by a factor of >3 and thus is a very promising candidate gene for the trail-pheromone receptor. Using the relative expression of OR-genes in males versus queens, we identified 2 candidates for sex-pheromone receptor genes in males. In addition, we identified genes from all other chemosensory related gene families (13 chemosensory protein genes, 8 odorant binding protein genes, 2 sensory-neuron membrane protein genes, 7 ionotropic receptor genes, 2 gustatory receptor genes), and we found ant-specific expansions in the chemosensory protein gene family. In addition, a large number of genes involved in immune defense exhibited differential expression across the three different castes, and some genes even between the two worker subcastes.	[Koch, Sarah I.; Kleineidam, Christoph J.] Univ Konstanz, Dept Biol, Constance, Germany; [Koch, Sarah I.; Groh, Katrin; Vogel, Heiko; Hannson, Bill S.; Grosse-Wilde, Ewald] Max Planck Inst Chem Ecol, Dept Evolutionary Neuroethol, Jena, Germany	University of Konstanz; Max Planck Society	Kleineidam, CJ (corresponding author), Univ Konstanz, Dept Biol, Constance, Germany.	Christoph.Kleineidam@uni-konstanz.de; grosse-wilde@ice.mpg.de	Hansson, Bill S/G-2774-2013; Kleineidam, Christoph J/A-6529-2009; Große-Wilde, Ewald/G-5584-2013	Hansson, Bill S/0000-0002-4811-1223; Kleineidam, Christoph J/0000-0003-0671-1455; Große-Wilde, Ewald/0000-0002-3760-9835	Max Planck Society; SPP Integrative Analysis of Olfaction of the Deutsche Forschungsgesellschaft (DFG) [SPP KI 1327/2-1DFG]; DFG [SFB 554, SFB 554/A6]	Max Planck Society(Max Planck SocietyFoundation CELLEX); SPP Integrative Analysis of Olfaction of the Deutsche Forschungsgesellschaft (DFG)(German Research Foundation (DFG)); DFG(German Research Foundation (DFG))	SIK participates in the International Max-Planck Research School for Organismal Biology. This work was supported by the Max Planck Society. The work was funded by the SPP Integrative Analysis of Olfaction of the Deutsche Forschungsgesellschaft (DFG) (SPP KI 1327/2-1DFG) and the SFB 554: "Mechanism and Evolution of Arthropod Behavior" (SFB 554/A6; DFG). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abuin L, 2011, NEURON, V69, P44, DOI 10.1016/j.neuron.2010.11.042; Armitage SAO, 2010, J INSECT PHYSIOL, V56, P780, DOI 10.1016/j.jinsphys.2010.01.009; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bento JMS, 2007, PHYSIOL ENTOMOL, V32, P283, DOI 10.1111/j.1365-3032.2007.00570.x; Benton R, 2006, PLOS BIOL, V4, P240, DOI 10.1371/journal.pbio.0040020; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Benton R, 2009, CELL, V136, P149, DOI 10.1016/j.cell.2008.12.001; Bocher A, 2007, J EVOLUTION BIOL, V20, P2228, DOI 10.1111/j.1420-9101.2007.01424.x; Bolton Barry, 2003, Memoirs of the American Entomological Institute (Gainesville), V71, P1; Bonasio R, 2010, SCIENCE, V329, P1068, DOI 10.1126/science.1192428; BUSCHINGER A, 1972, NATURWISSENSCHAFTEN, V59, P313, DOI 10.1007/BF00593362; CASTEELS P, 1993, J BIOL CHEM, V268, P7044; CASTEELSJOSSON K, 1994, J BIOL CHEM, V269, P28569; Cerenius L, 2004, IMMUNOL REV, V198, P116, DOI 10.1111/j.0105-2896.2004.00116.x; Colgan TJ, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-623; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Couto A, 2005, CURR BIOL, V15, P1535, DOI 10.1016/j.cub.2005.07.034; Cremer S, 2007, CURR BIOL, V17, pR693, DOI 10.1016/j.cub.2007.06.008; Croset V, 2010, PLOS GENET, V6, DOI 10.1371/journal.pgen.1001064; ESSLEN J, 1976, ZOOMORPHOLOGIE, V83, P227, DOI 10.1007/BF00993511; Fishilevich E, 2005, CURR BIOL, V15, P1548, DOI 10.1016/j.cub.2005.07.066; Foret S, 2007, INSECT BIOCHEM MOLEC, V37, P19, DOI 10.1016/j.ibmb.2006.09.009; Foret S, 2006, GENOME RES, V16, P1404, DOI 10.1101/gr.5075706; Forstner M, 2008, CHEM SENSES, V33, P291, DOI 10.1093/chemse/bjm087; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gotzek D, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016289; Graff J, 2007, MOL ECOL, V16, P675, DOI 10.1111/j.1365-294X.2007.03162.x; Grosse-Wilde E, 2006, CHEM SENSES, V31, P547, DOI 10.1093/chemse/bjj059; Grosse-Wilde E, 2011, P NATL ACAD SCI USA, V108, P7449, DOI 10.1073/pnas.1017963108; Hansson BS, 2011, NEURON, V72, P698, DOI 10.1016/j.neuron.2011.11.003; Hekmat-Scafe DS, 2002, GENOME RES, V12, P1357, DOI 10.1101/gr.239402; Hernandez JV, 1999, J CHEM ECOL, V25, P2433, DOI 10.1023/A:1020813905989; Hill CA, 2002, SCIENCE, V298, P176, DOI 10.1126/science.1076196; Holldobler B., 1990, pi; Hu┬lldobler B., 2010, LEAFCUTTER ANTS CIVI; JONES DT, 1994, FEBS LETT, V339, P269, DOI 10.1016/0014-5793(94)80429-X; Jones WD, 2007, NATURE, V445, P86, DOI 10.1038/nature05466; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Kelber C, 2006, J COMP NEUROL, V496, P395, DOI 10.1002/cne.20930; Kelber C, 2010, DEV NEUROBIOL, V70, P222, DOI 10.1002/dneu.20782; Kelber C, 2009, BRAIN BEHAV EVOLUT, V73, P273, DOI 10.1159/000230672; Kent LB, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-41; Kleineidam C, 2000, ARTHROPOD STRUCT DEV, V29, P43, DOI 10.1016/S1467-8039(00)00012-8; Kleineidam C, 1996, NATURWISSENSCHAFTEN, V83, P566; Kleineidam CJ, 2007, J INSECT PHYSIOL, V53, P1233, DOI 10.1016/j.jinsphys.2007.06.015; Krieger J, 2004, P NATL ACAD SCI USA, V101, P11845, DOI 10.1073/pnas.0403052101; Kuebler LS, 2010, J COMP NEUROL, V518, P352, DOI 10.1002/cne.22217; Kwon JY, 2007, P NATL ACAD SCI USA, V104, P3574, DOI 10.1073/pnas.0700079104; Legeai F, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-86; Letunic I, 2011, NUCLEIC ACIDS RES, V39, pW475, DOI [10.1093/nar/gkr201, 10.1093/nar/gkr931]; Moser JC, 2004, J ZOOL, V264, P69, DOI 10.1017/S0952836904005527; Nakagawa T, 2005, SCIENCE, V307, P1638, DOI 10.1126/science.1106267; Nakagawa T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032372; Niehuis O, 2013, NATURE, V494, P345, DOI 10.1038/nature11838; Okonechnikov K, 2012, BIOINFORMATICS, V28, P1166, DOI 10.1093/bioinformatics/bts091; Pophof B, 2004, CHEM SENSES, V29, P117, DOI 10.1093/chemse/bjh012; Price MN, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009490; Price MN, 2009, MOL BIOL EVOL, V26, P1641, DOI 10.1093/molbev/msp077; R. D. C. Team, 2012, R LANG ENV STAT COMP; REDER E, 1995, HELV CHIM ACTA, V78, P73, DOI 10.1002/hlca.19950780107; Robertson HM, 2010, INSECT MOL BIOL, V19, P121, DOI 10.1111/j.1365-2583.2009.00979.x; Robertson HM, 2003, P NATL ACAD SCI USA, V100, P14537, DOI 10.1073/pnas.2335847100; Robertson HM, 2006, GENOME RES, V16, P1395, DOI 10.1101/gr.5057506; Robertson HM, 2009, J INSECT SCI, V9, DOI 10.1673/031.009.1901; Rogers ME, 1997, J BIOL CHEM, V272, P14792, DOI 10.1074/jbc.272.23.14792; Roschard J, 2003, INSECT SOC, V50, P237, DOI 10.1007/s00040-003-0663-7; Sakurai T, 2004, P NATL ACAD SCI USA, V101, P16653, DOI 10.1073/pnas.0407596101; Sato K, 2008, NATURE, V452, P1002, DOI 10.1038/nature06850; Schmid-Hempel P, 2005, ANNU REV ENTOMOL, V50, P529, DOI 10.1146/annurev.ento.50.071803.130420; Scott K, 2001, CELL, V104, P661, DOI 10.1016/S0092-8674(02)02052-4; Silbering AF, 2011, J NEUROSCI, V31, P13357, DOI 10.1523/JNEUROSCI.2360-11.2011; Smith CR, 2011, P NATL ACAD SCI USA, V108, P5667, DOI 10.1073/pnas.1007901108; Smith CD, 2011, P NATL ACAD SCI USA, V108, P5673, DOI 10.1073/pnas.1008617108; Sonnhammer E L, 1998, Proc Int Conf Intell Syst Mol Biol, V6, P175; Staab M, 2014, MYRMECOL NEWS, V19, P93; Streinzer M, 2013, J COMP NEUROL, V521, P2742, DOI 10.1002/cne.23312; Suen G, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002007; Sumner S, 2006, P ROY SOC B-BIOL SCI, V273, P19, DOI 10.1098/rspb.2005.3291; TUMLINSON JH, 1971, NATURE, V234, P348, DOI 10.1038/234348b0; Vieira FG, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r235; Vieira FG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043034; Vieira FG, 2011, GENOME BIOL EVOL, V3, P476, DOI 10.1093/gbe/evr033; Vogt RG, 2009, INSECT BIOCHEM MOLEC, V39, P448, DOI 10.1016/j.ibmb.2009.03.007; Vosshall LB, 2011, CHEM SENSES, V36, P497, DOI 10.1093/chemse/bjr022; Werren JH, 2010, SCIENCE, V327, P343, DOI 10.1126/science.1178028; Whitehouse MEA, 1996, ANIM BEHAV, V51, P1207, DOI 10.1006/anbe.1996.0126; Wicher D, 2008, NATURE, V452, P1007, DOI 10.1038/nature06861; WILSON EO, 1980, BEHAV ECOL SOCIOBIOL, V7, P143, DOI 10.1007/BF00299520; Zhou XF, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002930	89	23	28	1	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81518	10.1371/journal.pone.0081518	http://dx.doi.org/10.1371/journal.pone.0081518			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260580	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600116
J	Andresen, K; Jimenez-Useche, I; Howell, SC; Yuan, CL; Qiu, XY				Andresen, Kurt; Jimenez-Useche, Isabel; Howell, Steven C.; Yuan, Chongli; Qiu, Xiangyun			Solution Scattering and FRET Studies on Nucleosomes Reveal DNA Unwrapping Effects of H3 and H4 Tail Removal	PLOS ONE			English	Article							HISTONE TAILS; CORE PARTICLE; CHROMATIN COMPACTION; ACETYLATION; STABILITY; CONFORMATION; ACCESSIBILITY; METHYLATION; INCREASES; DYNAMICS	Using a combination of small-angle X-ray scattering (SAXS) and fluorescence resonance energy transfer (FRET) measurements we have determined the role of the H3 and H4 histone tails, independently, in stabilizing the nucleosome DNA terminal ends from unwrapping from the nucleosome core. We have performed solution scattering experiments on recombinant wild-type, H3 and H4 tail-removed mutants and fit all scattering data with predictions from PDB models and compared these experiments to complementary DNA-end FRET experiments. Based on these combined SAXS and FRET studies, we find that while all nucleosomes exhibited DNA unwrapping, the extent of this unwrapping is increased for nucleosomes with the H3 tails removed but, surprisingly, decreased in nucleosomes with the H4 tails removed. Studies of salt concentration effects show a minimum amount of DNA unwrapping for all complexes around 50-100mM of monovalent ions. These data exhibit opposite roles for the positively-charged nucleosome tails, with the ability to decrease access (in the case of the H3 histone) or increase access (in the case of the H4 histone) to the DNA surrounding the nucleosome. In the range of salt concentrations studied (0-200mM KCl), the data point to the H4 tail-removed mutant at physiological (50-100mM) monovalent salt concentration as the mononucleosome with the least amount of DNA unwrapping.	[Andresen, Kurt] Gettysburg Coll, Dept Phys, Gettysburg, PA 17325 USA; [Jimenez-Useche, Isabel; Yuan, Chongli] Purdue Univ, Sch Chem Engn, W Lafayette, IN 47907 USA; [Howell, Steven C.; Qiu, Xiangyun] George Washington Univ, Dept Phys, Washington, DC 20052 USA	Gettysburg College; Purdue University System; Purdue University; Purdue University West Lafayette Campus; George Washington University	Andresen, K (corresponding author), Gettysburg Coll, Dept Phys, Gettysburg, PA 17325 USA.	kandrese@gettysburg.edu		Andresen, Kurt/0000-0002-7773-6716	Research Corporation for Science Advancement (RCSA) [20132]	Research Corporation for Science Advancement (RCSA)(Research Corporation for Science Advancement)	This research was supported by the Research Corporation for Science Advancement (RCSA Award 20132) (http://www.rescorp.org/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andrews AJ, 2011, ANNU REV BIOPHYS, V40, P99, DOI 10.1146/annurev-biophys-042910-155329; Bertin A, 2004, BIOCHEMISTRY-US, V43, P4773, DOI 10.1021/bi036210g; Bertin A, 2007, BIOPHYS J, V92, P2633, DOI 10.1529/biophysj.106.093815; Bohm V, 2011, NUCLEIC ACIDS RES, V39, P3093, DOI 10.1093/nar/gkq1279; Bowman GD, 2010, CURR OPIN STRUC BIOL, V20, P73, DOI 10.1016/j.sbi.2009.12.002; Brower-Toland B, 2005, J MOL BIOL, V346, P135, DOI 10.1016/j.jmb.2004.11.056; Buning R, 2010, BIOCHIMIE, V92, P1729, DOI 10.1016/j.biochi.2010.08.010; Choy JS, 2010, J AM CHEM SOC, V132, P1782, DOI 10.1021/ja910264z; Davey CA, 2002, J MOL BIOL, V319, P1097, DOI 10.1016/S0022-2836(02)00386-8; Dyer PN, 2004, METHOD ENZYMOL, V375, P23; Ferreira H, 2007, MOL CELL BIOL, V27, P4037, DOI 10.1128/MCB.02229-06; Gansen A, 2009, J PHYS CHEM B, V113, P2604, DOI 10.1021/jp7114737; GODDE JS, 1995, J BIOL CHEM, V270, P27399, DOI 10.1074/jbc.270.46.27399; Hall MA, 2009, NAT STRUCT MOL BIOL, V16, P124, DOI 10.1038/nsmb.1526; Howell SC, 2013, BIOPHYS J, V105, P194, DOI [10.1016/j.bpj.2013.05.021, 10.1016/j.bpj.2013.05.02]; Jimenez-Useche I, 2012, BIOPHYS J, V103, P2502, DOI 10.1016/j.bpj.2012.11.012; Kelbauskas L, 2008, BIOPHYS J, V94, P147, DOI 10.1529/biophysj.107.111906; Kelbauskas L, 2009, BIOCHEM CELL BIOL, V87, P323, DOI 10.1139/O08-126; Koopmans WJA, 2009, BIOPHYS J, V97, P195, DOI 10.1016/j.bpj.2009.04.030; Li G, 2004, NAT STRUCT MOL BIOL, V11, P763, DOI 10.1038/nsmb801; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Li GH, 2011, CURR OPIN GENET DEV, V21, P175, DOI 10.1016/j.gde.2011.01.022; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Mangenot S, 2002, BIOPHYS J, V82, P345, DOI 10.1016/S0006-3495(02)75399-X; Nielsen SS, 2009, J APPL CRYSTALLOGR, V42, P959, DOI 10.1107/S0021889809023863; Nurse NP, 2013, BIOPHYS J, V104, P1081, DOI 10.1016/j.bpj.2013.01.019; Park YJ, 2004, J BIOL CHEM, V279, P24274, DOI 10.1074/jbc.M313152200; Petoukhov MV, 2012, J APPL CRYSTALLOGR, V45, P342, DOI 10.1107/S0021889812007662; RICHMOND TJ, 1984, NATURE, V311, P532, DOI 10.1038/311532a0; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schlick T, 2012, J BIOL CHEM, V287, P5183, DOI 10.1074/jbc.R111.305763; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; Simon M, 2011, P NATL ACAD SCI USA, V108, P12711, DOI 10.1073/pnas.1106264108; Svergun D, 1995, J APPL CRYSTALLOGR, V28, P768, DOI 10.1107/S0021889895007047; Tan S, 2011, CURR OPIN STRUC BIOL, V21, P128, DOI 10.1016/j.sbi.2010.11.006; Toth K, 2006, BIOCHEMISTRY-US, V45, P1591, DOI 10.1021/bi052110u; Voltz K, 2012, BIOPHYS J, V102, P849, DOI 10.1016/j.bpj.2011.11.4028; Wang XY, 2000, J BIOL CHEM, V275, P35013, DOI 10.1074/jbc.M004998200; Widlund HR, 2000, BIOCHEMISTRY-US, V39, P3835, DOI 10.1021/bi991957l; WOLFFE A, 1992, CHROMATIN STRUCTURE; Yang CH, 2011, NUCLEIC ACIDS RES, V39, P4122, DOI 10.1093/nar/gkr005; Zheng CY, 2003, BIOPOLYMERS, V68, P539, DOI 10.1002/bip.10303; Zhou JS, 2007, NAT STRUCT MOL BIOL, V14, P1070, DOI 10.1038/nsmb1323	44	33	33	1	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78587	10.1371/journal.pone.0078587	http://dx.doi.org/10.1371/journal.pone.0078587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265699	Green Published, gold			2022-12-25	WOS:000327252100032
J	Wang, YS; Yang, ZY; Zhou, SR; Soininen, J; Ai, D; Li, YL; Chu, CJ				Wang, Youshi; Yang, Zhiyong; Zhou, Shurong; Soininen, Janne; Ai, Dexiecuo; Li, Yali; Chu, Chengjin			The Effect of Positive Interactions on Temporal Turnover of Community Composition along an Environmental Gradient	PLOS ONE			English	Article							PLANT-PLANT INTERACTIONS; SPECIES RICHNESS; ABIOTIC STRESS; INTERACTIONS INCREASE; BETA DIVERSITY; FACILITATION; COMPETITION; INSIGHTS; SHRUB; ASSEMBLAGES	It has been demonstrated that the interplay between negative and positive interactions simultaneously shapes community structure and composition. However, few studies have attempted to examine the effect of facilitation on compositional changes in communities through time. Additionally, due to the difficulties in collecting the long-term data, it would be useful to indicate the rate of temporal turnover using a readily obtainable metric. Using an individual-based model incorporating plant strategies, we examined the role of facilitation on the temporal turnover of communities located at different positions along an environmental gradient for three model scenarios: CM without facilitation; CFM-U, a unimodal relationship between facilitation and environmental severity; and CFM-L, a positively linear relationship between facilitation and environmental severity. Our results demonstrated that facilitation could increase, decrease or have no remarkable effect on temporal turnover. The specific outcome depended on the location of the focal community across the environmental gradient and the model employed. Compared with CM, the inclusion of positive interactions (i.e. CFM-U and CFM-L), at intermediate environmental stress levels (such as S = 0.7 and 0.8) resulted in lower Bray-Curtis similarity values; at other severity levels, facilitation slowed down (such as S = 0.3 and 0.4 at low to medium stress levels, and S = 0.9 at high stress levels) or had only a subtle effect (such as at S = 0.1) on temporal turnover. We also found that the coefficient of variation (CV) in species abundances and the rate of temporal variability showed a significant quadratic relationship. Our theoretical analysis contributes to the understanding of factors driving temporal turnover in biotic communities, and presents a potential metric (i.e. CV in species abundances) assessing the consequences of ongoing environmental change on community structure.	[Wang, Youshi] Lanzhou Univ, Minist Educ, Key Lab Western Chinas Environm Syst, Res Sch Arid Environm & Climate Change, Lanzhou 730000, Peoples R China; [Yang, Zhiyong; Ai, Dexiecuo; Chu, Chengjin] Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China; [Zhou, Shurong] Fudan Univ, Sch Life Sci, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China; [Soininen, Janne] Univ Helsinki, Dept Geosci & Geog, Helsinki, Finland; [Li, Yali] Xikehe Sire Breeding Farm Euler Sheep Maqu Cty Ga, Maqu, Peoples R China	Lanzhou University; Lanzhou University; Fudan University; University of Helsinki	Chu, CJ (corresponding author), Lanzhou Univ, Sch Life Sci, State Key Lab Grassland & Agroecosyst, Lanzhou 730000, Peoples R China.	cjchu@lzu.edu.cn	Soininen, Janne/A-4205-2008; Chu, Chu/T-6038-2019	Zhou, Shurong/0000-0002-7093-1703; Soininen, Janne/0000-0002-8583-3137; Chu, Chengjin/0000-0002-0606-449X	National Natural Science Foundation of China [31000199, 41201050]; Fundamental Research Funds for the Central Universities [lzujbky-2012-133, lzujbky-2013-k15]; Program for New Century Excellent Talents in University [NCET-12-0248]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities); Program for New Century Excellent Talents in University(Program for New Century Excellent Talents in University (NCET))	This research was financially supported by the National Natural Science Foundation of China (31000199, 41201050), and the Fundamental Research Funds for the Central Universities (lzujbky-2012-133, lzujbky-2013-k15). CC was also supported by the Program for New Century Excellent Talents in University (NCET-12-0248). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adler PB, 2005, ECOLOGY, V86, P2032, DOI 10.1890/05-0067; Adler PB, 2004, ECOLOGY, V85, P1265, DOI 10.1890/03-0602; Ai D, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046164; Allouche O, 2009, J THEOR BIOL, V258, P274, DOI 10.1016/j.jtbi.2008.12.024; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Brooker RW, 1998, OIKOS, V81, P196, DOI 10.2307/3546481; Callaway R. M., 2007, POSITIVE INTERACTION; Callaway RM, 2002, NATURE, V417, P844, DOI 10.1038/nature00812; Cavieres LA, 2009, J ECOL, V97, P1181, DOI 10.1111/j.1365-2745.2009.01579.x; Chu CJ, 2008, ECOL LETT, V11, P1189, DOI 10.1111/j.1461-0248.2008.01228.x; Chu CJ, 2010, ANN BOT-LONDON, V106, P647, DOI 10.1093/aob/mcq145; Chu CJ, 2009, J ECOL, V97, P1401, DOI 10.1111/j.1365-2745.2009.01562.x; Clark JS, 1999, ECOLOGY, V80, P1475, DOI 10.2307/176541; Dornelas M, 2012, P ROYAL SOC LONDON B; Dvorsky M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053514; Evans KL, 2005, P ROY SOC B-BIOL SCI, V272, P2155, DOI 10.1098/rspb.2005.3209; Gilman SE, 2010, TRENDS ECOL IN PRESS; Gross N, 2010, PERSPECT PLANT ECOL, V12, P9, DOI 10.1016/j.ppees.2009.09.001; He Q, 2013, ECOL LETT, V16, P695, DOI 10.1111/ele.12080; Hurlbert AH, 2004, ECOL LETT, V7, P714, DOI 10.1111/j.1461-0248.2004.00630.x; Huxham M, 2010, PHILOS T R SOC B, V365, P2127, DOI 10.1098/rstb.2010.0094; Jia X, 2011, OIKOS, V120, P472, DOI 10.1111/j.1600-0706.2010.18674.x; Keddy P, 2005, ANN BOT-LONDON, V96, P177, DOI 10.1093/aob/mci166; Koleff P, 2003, GLOBAL ECOL BIOGEOGR, V12, P483, DOI 10.1046/j.1466-822X.2003.00056.x; Korhonen JJ, 2010, ECOLOGY, V91, P508, DOI 10.1890/09-0392.1; Legendre P, 2005, ECOL MONOGR, V75, P435, DOI 10.1890/05-0549; Lenth R., 2019, Journal of Statistical Software, V60, P1; Leslie HM, 2005, ECOLOGY, V86, P2716, DOI 10.1890/04-1767; Liancourt P, 2005, ECOLOGY, V86, P1611, DOI 10.1890/04-1398; Maestre FT, 2009, J ECOL, V97, P199, DOI 10.1111/j.1365-2745.2008.01476.x; Maestre FT, 2005, J ECOL, V93, P748, DOI 10.1111/j.1365-2745.2005.01017.x; Maestre FT, 2004, P ROY SOC B-BIOL SCI, V271, pS331, DOI 10.1098/rsbl.2004.0181; Maestre FT, 2003, ECOLOGY, V84, P3186, DOI 10.1890/02-0635; MAGURRAN A. E., 2004, MEASURING BIOLOGICAL; Magurran AE, 2007, ECOL LETT, V10, P347, DOI 10.1111/j.1461-0248.2007.01024.x; Magurran AE, 2010, PHILOS T R SOC B, V365, P3611, DOI 10.1098/rstb.2010.0285; Malkinson D, 2007, ECOGRAPHY, V30, P339, DOI 10.1111/j.2007.0906-7590.04983.x; Maltez-Mouro S, 2010, ACTA OECOL, V36, P80, DOI 10.1016/j.actao.2009.10.003; McGill BJ, 2005, P NATL ACAD SCI USA, V102, P16701, DOI 10.1073/pnas.0504225102; McGlynn TP, 2010, BIOL LETTERS, V6, P490, DOI 10.1098/rsbl.2010.0103; Michalet R, 2006, ECOL LETT, V9, P767, DOI 10.1111/j.1461-0248.2006.00935.x; Mulder CPH, 2001, P NATL ACAD SCI USA, V98, P6704, DOI 10.1073/pnas.111055298; Lopez RP, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058518; Pugnaire FI, 2010, POSITIVE PLANT INTERACTIONS AND COMMUNITY DYNAMICS, P1, DOI 10.1201/9781439824955; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; R Development Core Team, 2012, R LANG ENV STAT COMP; Schiel DR, 2004, ECOLOGY, V85, P1833, DOI 10.1890/03-3107; Soliveres S, 2011, PERSPECT PLANT ECOL, V13, P247, DOI 10.1016/j.ppees.2011.06.001; Southwood R., 2000, ECOLOGICAL METHODS; Srivastava DS, 1998, AM NAT, V152, P510, DOI 10.1086/286187; Swenson NG, 2012, ECOLOGY, V93, P490, DOI 10.1890/11-1180.1; Vavrek MJ, 2011, PALAEONTOL ELECTRON, V14; Wang YS, 2008, ACTA OECOL, V33, P108, DOI 10.1016/j.actao.2007.10.002; Wang YS, 2012, J PLANT ECOL, V5, P417, DOI 10.1093/jpe/rts005; White EP, 2006, OIKOS, V112, P185; White EP, 2010, PHILOS T R SOC B, V365, P3633, DOI 10.1098/rstb.2010.0280; Wilensky U, 1999, NETLOGO; Xiao S, 2009, OIKOS, V118, P1343, DOI 10.1111/j.1600-0706.2009.17588.x; Xu J, 2010, PLANT BIOLOGY, V12, P780, DOI 10.1111/j.1438-8677.2009.00271.x; Zhang WP, 2013, OIKOS, V122, P1147, DOI 10.1111/j.1600-0706.2012.20877.x	60	2	2	2	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78698	10.1371/journal.pone.0078698	http://dx.doi.org/10.1371/journal.pone.0078698			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265708	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100041
J	Loiselle, AE; Lloyd, SAJ; Paul, EM; Lewis, GS; Donahue, HJ				Loiselle, Alayna E.; Lloyd, Shane A. J.; Paul, Emmanuel M.; Lewis, Gregory S.; Donahue, Henry J.			Inhibition of GSK-3 beta Rescues the Impairments in Bone Formation and Mechanical Properties Associated with Fracture Healing in Osteoblast Selective Connexin 43 Deficient Mice	PLOS ONE			English	Article							WNT SIGNALING PATHWAY; GAP-JUNCTIONS; CORTICAL BONE; EXPRESSION; CELLS; DIFFERENTIATION; GENE; SURVIVAL; MODULATION; DELETION	Connexin 43 (Cx43) is the most abundant gap junction protein in bone and is required for osteoblastic differentiation and bone homeostasis. During fracture healing, Cx43 is abundantly expressed in osteoblasts and osteocytes, while Cx43 deficiency impairs bone formation and healing. In the present study we selectively deleted Cx43 in the osteoblastic lineage from immature osteoblasts through osteocytes and tested the hypothesis that Cx43 deficiency results in delayed osteoblastic differentiation and impaired restoration of biomechanical properties due to attenuated beta-catenin expression relative to wild type littermates. Here we show that Cx43 deficiency results in alterations in the mineralization and remodeling phases of healing. In Cx43 deficient fractures the mineralization phase is marked by delayed expression of osteogenic genes. Additionally, the decrease in the RankL/Opg ratio, osteoclast number and osteoclast size suggest decreased osteoclast bone resorption and remodeling. These changes in healing result in functional deficits as shown by a decrease in ultimate torque at failure. Consistent with these impairments in healing, beta-catenin expression is attenuated in Cx43 deficient fractures at 14 and 21 days, while Sclerostin (Sost) expression, a negative regulator of bone formation is increased in Cx43cKO fractures at 21 days, as is GSK-3 beta, a key component of the beta-catenin proteasomal degradation complex. Furthermore, we show that alterations in healing in Cx43 deficient fractures can be rescued by inhibiting GSK-3 beta activity using Lithium Chloride (LiCl). Treatment of Cx43 deficient mice with LiCl restores both normal bone formation and mechanical properties relative to LiCl treated WT fractures. This study suggests that Cx43 is a potential therapeutic target to enhance fracture healing and identifies a previously unknown role for Cx43 in regulating beta-catenin expression and thus bone formation during fracture repair.	[Loiselle, Alayna E.; Lloyd, Shane A. J.; Paul, Emmanuel M.; Lewis, Gregory S.; Donahue, Henry J.] Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Donahue, HJ (corresponding author), Penn State Coll Med, Dept Orthopaed & Rehabil, Div Musculoskeletal Sci, Hershey, PA 17033 USA.	hdonahue@hmc.psu.edu		Lewis, Gregory/0000-0002-3673-0182	NIH [R01 AG13087-15]; Michael and Myrtle Baker Orthopaedic Research Endowment; NIH; Penn State Clinical and Translational Science Institute;  [5KL2TR000126-03]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000127, KL2TR000126] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013087] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Michael and Myrtle Baker Orthopaedic Research Endowment; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Penn State Clinical and Translational Science Institute; ; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by NIH R01 AG13087-15 (HJD) and the Michael and Myrtle Baker Orthopaedic Research Endowment. GSL.'s contribution was supported by award No. 5KL2TR000126-03 funded by the NIH and Penn State Clinical and Translational Science Institute. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anand RJ, 2008, J IMMUNOL, V181, P8534, DOI 10.4049/jimmunol.181.12.8534; Behrens J, 2000, J CELL SCI, V113, P911; Bivi N, 2013, J ORTHOP RES, V31, P1075, DOI 10.1002/jor.22341; Bivi N, 2012, J BONE MINER RES, V27, P374, DOI 10.1002/jbmr.548; BONNARENS F, 1984, Journal of Orthopaedic Research, V2, P97, DOI 10.1002/jor.1100020115; Castro CHM, 2003, CELL COMMUN ADHES, V10, P445, DOI 10.1080/15419060390267700; Chaible LM, 2011, TOXICOL PATHOL, V39, P1046, DOI 10.1177/0192623311422075; Chen Y, 2007, PLOS MED, V4, P1216, DOI 10.1371/journal.pmed.0040249; Chung DJ, 2006, J CELL SCI, V119, P4187, DOI 10.1242/jcs.03162; Dacquin R, 2002, DEV DYNAM, V224, P245, DOI 10.1002/dvdy.10100; Dempster DW, 2013, J BONE MINER RES, V28, P1, DOI 10.1002/jbmr.1805; Donahue HJ, 2000, BONE, V26, P417, DOI 10.1016/S8756-3282(00)00245-3; Eastman Q, 1999, CURR OPIN CELL BIOL, V11, P233, DOI 10.1016/S0955-0674(99)80031-3; Erlebacher A, 1996, J CELL BIOL, V132, P195, DOI 10.1083/jcb.132.1.195; Ewart JL, 1997, DEVELOPMENT, V124, P1281; Gerstenfeld LC, 2003, J CELL BIOCHEM, V88, P873, DOI 10.1002/jcb.10435; Gluhak-Heinrich J, 2006, CELL COMMUN ADHES, V13, P115, DOI 10.1080/15419060600634619; Gramsch B, 2001, EXP CELL RES, V264, P397, DOI 10.1006/excr.2000.5145; Grimes CA, 2001, PROG NEUROBIOL, V65, P391, DOI 10.1016/S0301-0082(01)00011-9; Grimston SK, 2008, J BONE MINER RES, V23, P879, DOI [10.1359/jbmr.080222, 10.1359/JBMR.080222]; Grimston SK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044222; Grimston SK, 2011, J BONE MINER RES, V26, P2151, DOI 10.1002/jbmr.425; Ikeda S, 1998, EMBO J, V17, P1371, DOI 10.1093/emboj/17.5.1371; INOSE H, 2009, P NATL ACAD SCI US; Karl S, 2008, CELL COMMUNICATION S; Lecanda F, 1998, MOL BIOL CELL, V9, P2249, DOI 10.1091/mbc.9.8.2249; Lecanda F, 2000, J CELL BIOL, V151, P931, DOI 10.1083/jcb.151.4.931; Li ZY, 2006, AM J PHYSIOL-CELL PH, V290, pC1248, DOI 10.1152/ajpcell.00428.2005; Liu F, 2004, INT J DEV BIOL, V48, P645, DOI 10.1387/ijdb.041816fl; Lloyd SA, 2013, BONE, V57, P76, DOI 10.1016/j.bone.2013.07.022; Lloyd SA, 2012, J BONE MINER RES, V27, P2359, DOI 10.1002/jbmr.1687; Loiselle AE, 2013, J ORTHOP RES, V31, P147, DOI 10.1002/jor.22178; Machtaler S, 2011, J CELL SCI, V124, P2611, DOI 10.1242/jcs.089532; Plotkin LI, 2002, J BIOL CHEM, V277, P8648, DOI 10.1074/jbc.M108625200; REAUME AG, 1995, SCIENCE, V267, P1831, DOI 10.1126/science.7892609; Saunders MM, 2003, BONE, V32, P350, DOI 10.1016/S8756-3282(03)00025-5; Saunders MM, 2001, AM J PHYSIOL-CELL PH, V281, pC1917, DOI 10.1152/ajpcell.2001.281.6.C1917; Schindeler A, 2008, SEMIN CELL DEV BIOL, V19, P459, DOI 10.1016/j.semcdb.2008.07.004; Taylor AF, 2007, AM J PHYSIOL-CELL PH, V292, pC545, DOI 10.1152/ajpcell.00611.2005; Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176; Watkins M, 2011, MOL BIOL CELL, V22, P1240, DOI 10.1091/mbc.E10-07-0571; Yellowley CE, 2000, J BONE MINER RES, V15, P209, DOI 10.1359/jbmr.2000.15.2.209; Zhang Y, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023516	43	34	39	1	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e81399	10.1371/journal.pone.0081399	http://dx.doi.org/10.1371/journal.pone.0081399			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260576	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200121
J	Elsum, IA; Yates, LL; Pearson, HB; Phesse, TJ; Long, F; O'Donoghue, R; Ernst, M; Cullinane, C; Humbert, PO				Elsum, I. A.; Yates, L. L.; Pearson, H. B.; Phesse, T. J.; Long, F.; O'Donoghue, R.; Ernst, M.; Cullinane, C.; Humbert, P. O.			Scrib heterozygosity predisposes to lung cancer and cooperates with KRas hyperactivation to accelerate lung cancer progression in vivo	ONCOGENE			English	Article						polarity; scrib; ras; lung; cancer	CELL POLARITY; K-RAS; ACTIVATION; EXPRESSION; PATHWAY; GROWTH; TUMORIGENESIS; DEREGULATION; INFLAMMATION; MACROPHAGES	Lung cancer is the leading cause of cancer deaths worldwide with non small-cell lung cancer (NSCLC) accounting for 80% of all lung cancers. Although activating mutations in genes of the RAS-MAPK pathway occur in up to 30% of all NSCLC, the cooperating genetic lesions that are required for lung cancer initiation and progression remain poorly understood. Here we identify a role for the cell polarity regulator Scribble (Scrib) in NSCLC. A survey of genomic databases reveals deregulation of SCRIB in human lung cancer and we show that Scrib(-/-) mutant mice develop lung cancer by 540 days with a penetrance of 43%. To model NSCLC development in vivo, we used the extensively characterized LSL-KRas(G12D) murine model of NSCLC. We show that loss of Scrib and activated oncogenic KRas cooperate in vivo, resulting in more aggressive lung tumors, likely due to a synergistic elevation in RAS-MAPK signaling. Finally, we provide data consistent with immune infiltration having an important role in the acceleration of tumorigenesis in KRas(G12D) lung tumors following Scrib loss.	[Elsum, I. A.; Yates, L. L.; Pearson, H. B.; Long, F.; Humbert, P. O.] Peter MacCallum Canc Ctr, Div Res, Melbourne, Vic 3002, Australia; [Pearson, H. B.; Cullinane, C.; Humbert, P. O.] Sir Peter MacCallum Dept Oncol, Melbourne, Vic, Australia; [Phesse, T. J.; O'Donoghue, R.; Ernst, M.] Royal Melbourne Hosp, Walter & Eliza Hall Inst Med Res, Cell Signaling & Cell Death Div, Parkville, Vic 3050, Australia; [Cullinane, C.] Peter MacCallum Canc Ctr, Translat Res Lab, Canc Therapeut Program, Melbourne, Vic 3002, Australia; [Humbert, P. O.] Univ Melbourne, Dept Pathol, Parkville, Vic 3052, Australia; [Humbert, P. O.] Univ Melbourne, Dept Mol Biol & Biochem, Parkville, Vic 3052, Australia	Peter Maccallum Cancer Center; Peter Maccallum Cancer Center; Royal Melbourne Hospital; Walter & Eliza Hall Institute; Peter Maccallum Cancer Center; University of Melbourne; University of Melbourne	Humbert, PO (corresponding author), Peter MacCallum Canc Ctr, St Andrews Pl, Melbourne, Vic 3002, Australia.	Patrick.Humbert@petermac.org	Humbert, Patrick O/L-4264-2016; Ernst, Matthias/D-5111-2012	Humbert, Patrick O/0000-0002-1366-6691; Ernst, Matthias/0000-0002-6399-1177; Yates, Laura/0000-0002-1620-1603; Pearson, Helen/0000-0002-3284-0843; Elsum, Imogen/0000-0003-4525-0727; Phesse, Toby/0000-0001-9568-4916; Cullinane, Carleen/0000-0001-5833-6605	NHMRC of Australia [1025239, 1004434]; Movember/PCFA; Richard Pratt Foundation; Cancer Council Victoria Postgraduate Research Scholarship; Biomedical Career Development Award from the NHMRC of Australia	NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia); Movember/PCFA; Richard Pratt Foundation; Cancer Council Victoria Postgraduate Research Scholarship(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); Biomedical Career Development Award from the NHMRC of Australia(National Health and Medical Research Council (NHMRC) of Australia)	We thank Dr Jason Li, Dr David Bimms, Sam Williams, Olivia Cakebread, Tanja Kinwel and the microscopy and histology core at the Peter MacCallum Cancer Centre. We also thank Dr Alison Dooley and Prof Roderick Bronson from the Massachusetts Institute of Technology for their technical advice and to Drs Helena Richardson and Sarah Russell for critical reading of the manuscript. This study was supported by grants from the NHMRC of Australia (no. 1025239 for TJP and RJO; no. 1004434 for IAE and LLY), Movember/PCFA and Richard Pratt Foundation (for HBP). IAE was supported by a Cancer Council Victoria Postgraduate Research Scholarship and POH was supported by a Biomedical Career Development Award from the NHMRC of Australia.	Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Borrello MG, 2008, CANCER LETT, V267, P262, DOI 10.1016/j.canlet.2008.03.060; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; Bryant PJ, 2000, NAT CELL BIOL, V2, pE141, DOI 10.1038/35019616; Cabrita MA, 2008, ANGIOGENESIS, V11, P53, DOI 10.1007/s10456-008-9089-1; Chatterjee S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034343; Cullinane C, 2011, J NUCL MED, V52, P1261, DOI 10.2967/jnumed.110.086967; Dhillon AS, 2007, ONCOGENE, V26, P3279, DOI 10.1038/sj.onc.1210421; Dow LE, 2008, ONCOGENE, V27, P5988, DOI 10.1038/onc.2008.219; DuPage M, 2009, NAT PROTOC, V4, P1064, DOI 10.1038/nprot.2009.95; Elsum I, 2012, ESSAYS BIOCHEM, V53, P141, DOI [10.1042/bse0530141, 10.1042/BSE0530141]; Elsum IA, 2013, J CELL SCI, V126, P3990, DOI 10.1242/jcs.129387; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Fulda S, 2009, INT J CANCER, V124, P511, DOI 10.1002/ijc.24064; Funaba M, 2002, J BIOL CHEM, V277, P41361, DOI 10.1074/jbc.M204597200; Gardiol D, 2006, INT J CANCER, V119, P1285, DOI 10.1002/ijc.21982; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Hao NB, 2012, CLIN DEV IMMUNOL, DOI 10.1155/2012/948098; Huang L, 2010, CURR OPIN GENET DEV, V20, P41, DOI 10.1016/j.gde.2009.12.001; Humbert PO, 2008, ONCOGENE, V27, P6888, DOI 10.1038/onc.2008.341; Jackson EL, 2005, CANCER RES, V65, P10280, DOI 10.1158/0008-5472.CAN-05-2193; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Ji H, 2006, ONCOGENE, V25, P2105, DOI 10.1038/sj.onc.1209237; Ji HB, 2007, NATURE, V448, P807, DOI 10.1038/nature06030; Kamei Y, 2007, HUM PATHOL, V38, P1273, DOI 10.1016/j.humpath.2007.01.026; Karreth FA, 2009, CURR OPIN GENET DEV, V19, P4, DOI 10.1016/j.gde.2008.12.006; Kass DJ, 2012, AM J PATHOL, V180, P1963, DOI 10.1016/j.ajpath.2012.01.010; Kim CFB, 2005, CELL, V121, P823, DOI 10.1016/j.cell.2005.03.032; Kissil JL, 2007, CANCER RES, V67, P8089, DOI 10.1158/0008-5472.CAN-07-2300; Lewis CE, 2006, CANCER RES, V66, P605, DOI 10.1158/0008-5472.CAN-05-4005; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Martin-Belmonte F, 2012, NAT REV CANCER, V12, P23, DOI 10.1038/nrc3169; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; McCubrey JA, 2007, BBA-MOL CELL RES, V1773, P1263, DOI 10.1016/j.bbamcr.2006.10.001; Muthuswamy SK, 2012, ANNU REV CELL DEV BI, V28, P599, DOI 10.1146/annurev-cellbio-092910-154244; Nagasaka K, 2010, ONCOGENE, V29, P5311, DOI 10.1038/onc.2010.265; Navarro C, 2005, ONCOGENE, V24, P4330, DOI 10.1038/sj.onc.1208632; Onder TT, 2008, CANCER RES, V68, P3645, DOI 10.1158/0008-5472.CAN-07-2938; Pages F, 2010, ONCOGENE, V29, P1093, DOI 10.1038/onc.2009.416; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pearson HB, 2011, J CLIN INVEST, V121, P4257, DOI 10.1172/JCI58509; Ramakrishna GT, 2000, MOL CARCINOGEN, V28, P156, DOI 10.1002/1098-2744(200007)28:3<156::AID-MC4>3.0.CO;2-M; Roberts PJ, 2007, ONCOGENE, V26, P3291, DOI 10.1038/sj.onc.1210422; Shaw AT, 2007, GENE DEV, V21, P694, DOI 10.1101/gad.1526207; Sica A, 2008, CANCER LETT, V267, P204, DOI 10.1016/j.canlet.2008.03.028; Sparmann A, 2004, CANCER CELL, V6, P447, DOI 10.1016/j.ccr.2004.09.028; Travis WD, 2002, CLIN CHEST MED, V23, P65, DOI 10.1016/S0272-5231(03)00061-3; Vaira V, 2011, AM J PATHOL, V178, P2478, DOI 10.1016/j.ajpath.2011.02.028; Yusoff P, 2002, J BIOL CHEM, V277, P3195, DOI 10.1074/jbc.M108368200; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045; Zhou YH, 2010, NAT BIOTECHNOL, V28, P71, DOI 10.1038/nbt.1595; Zhuo OY, 2010, ONCOL RES, V18, P593, DOI 10.3727/096504010X12767359114045	52	38	39	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5523	5533		10.1038/onc.2013.498	http://dx.doi.org/10.1038/onc.2013.498			11	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24276238				2022-12-25	WOS:000346087900005
J	Marivin, A; Berthelet, J; Cartier, J; Paul, C; Gemble, S; Morizot, A; Boireau, W; Saleh, M; Bertoglio, J; Solary, E; Dubrez, L				Marivin, A.; Berthelet, J.; Cartier, J.; Paul, C.; Gemble, S.; Morizot, A.; Boireau, W.; Saleh, M.; Bertoglio, J.; Solary, E.; Dubrez, L.			cIAP1 regulates TNF-mediated cdc42 activation and filopodia formation	ONCOGENE			English	Article						IAPs; TNF; RhoGTPases; cdc42; metastasis; Ras	NF-KAPPA-B; INDUCED ACTIN REORGANIZATION; ALPHA-DEPENDENT APOPTOSIS; SIGNALING PATHWAY; CELL-SURVIVAL; CANCER-CELLS; RHO GTPASES; E3 LIGASE; MIGRATION; IAPS	Tumour necrosis factor-alpha (TNF) is a cytokine endowed with multiple functions, depending on the cellular and environmental context. TNF receptor engagement induces the formation of a multimolecular complex including the TNFR-associated factor TRAF2, the receptor-interaction protein kinase RIP1 and the cellular inhibitor of apoptosis cIAP1, the latter being essential for NF-kappa B activation. Here, we show that cIAP1 also regulates TNF-induced actin cytoskeleton reorganization through a cdc42-dependent, NF-kappa B-independent pathway. Deletion of cIAP1 prevents TNF-induced filopodia and cdc42 activation. The expression of cIAP1 or its E3-ubiquitin ligase-defective mutant restores the ability of cIAP1(-/-) MEFs to produce filopodia, whereas a cIAP1 mutant unable to bind TRAF2 does not. Accordingly, the silencing of TRAF2 inhibits TNF-mediated filopodia formation, whereas silencing of RIP1 does not. cIAP1 directly binds cdc42 and promotes its RhoGDI alpha-mediated stabilization. TNF decreases cIAP1-cdc42 interaction, suggesting that TNF-induced recruitment of cIAP1/TRAF2 to the receptor releases cdc42, which in turn triggers actin remodeling. cIAP1 also regulates cdc42 activation in response to EGF and HRas-V12 expression. A downregulation of cIAP1 altered the cell polarization, the cell adhesion to endothelial cells and cell intercalation, which are cdc42-dependent processes. Finally, we demonstrated that the deletion of cIAP1 regulated the HRas-V12-mediated transformation process, including anchorage-dependent cell growth, tumour growth in a xenograft model and the development of experimental metastasis in the lung.	[Marivin, A.; Berthelet, J.; Cartier, J.; Gemble, S.; Dubrez, L.] Fac Med, INSERM, UMR866, 7 Blvd Jeanne Arc, F-21079 Dijon, France; [Marivin, A.; Berthelet, J.; Cartier, J.; Paul, C.; Gemble, S.; Dubrez, L.] Univ Bourgogne, IFR 100, Dijon, France; [Paul, C.] EPHE, Dijon, France; [Morizot, A.; Saleh, M.] McGill Univ, Dept Med, Montreal, PQ, Canada; [Boireau, W.] Univ Franche Comte, Inst FEMTO ST, CLIPP, F-25030 Besancon, France; [Bertoglio, J.] IFR 54, Inserm UMR749, Villejuif, France; [Bertoglio, J.; Solary, E.] IFR 54, Inst Gustave Roussy, Villejuif, France; [Solary, E.] IFR 54, UMR1009, Villejuif, France	Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bourgogne; Universite de Bourgogne; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); McGill University; Universite de Franche-Comte; Institut National de la Sante et de la Recherche Medicale (Inserm); UNICANCER; Gustave Roussy; UDICE-French Research Universities; Universite Paris Saclay	Dubrez, L (corresponding author), Fac Med, INSERM, UMR866, 7 Blvd Jeanne Arc, F-21079 Dijon, France.	ldubrez@u-bourgogne.fr	Laurence, Dubrez/P-9472-2019; Dubrez, Laurence/I-4971-2016	Laurence, Dubrez/0000-0002-7030-2181; Dubrez, Laurence/0000-0002-7030-2181; Paul, Catherine/0000-0002-7657-5535; Solary, Eric/0000-0002-8629-1341; CARTIER, Jessy/0000-0002-0366-8546; Berthelet, Jean/0000-0003-2562-0575	Comite de Cote d'Or of the Ligue Contre le Cancer; 'Association pour la Recherche sur le Cancer' (ARC); Association 'Cent pour sang la Vie'; European Union; Conseil Regional de Bourgogne'; French National Research Agency under the program [ANR-11-LABX-0021]; 'Ministere de l'Enseignement Superieur et de la Recherche' of France; Societe Francaise d'Hematologie	Comite de Cote d'Or of the Ligue Contre le Cancer; 'Association pour la Recherche sur le Cancer' (ARC)(Fondation ARC pour la Recherche sur le Cancer); Association 'Cent pour sang la Vie'; European Union(European Commission); Conseil Regional de Bourgogne'(Region Bourgogne-Franche-Comte); French National Research Agency under the program(French National Research Agency (ANR)); 'Ministere de l'Enseignement Superieur et de la Recherche' of France; Societe Francaise d'Hematologie	We thank Dr J Silke, Dr E Lemichez, Dr S Gasman, Dr CL Day, Dr S Ansieu, Dr R Weil and S Monier for kindly providing plasmids and cell lines. We are grateful to Lydie Desoche, Aziza Aznague, Cedric Seignez and Benoit Simon (FEMTO-ST, CLIPP platform) for their technical assistance. We thank A Bouchot and B Gasquet (CellImaP Imagery Facility), A Hammann (Cytometry platform), V Saint-Giorgio (Animal Facility), A Oudot and B Collin (Precilinal imagery platform, Georges-Francois Leclerc Center) for the use of the imagery, cytometry and animal facilities. We thank P Meier, K Rajalingam, J Breard, M David and S Ansieu for helpful discussions. This work was supported by grants from the 'Comite de Cote d'Or of the Ligue Contre le Cancer' (LD), the 'Association pour la Recherche sur le Cancer' (ARC to LD), the Association 'Cent pour sang la Vie' (LD), the European Union and the 'Conseil Regional de Bourgogne', a French Government grant managed by the French National Research Agency under the program 'Investissements d'Avenir with reference ANR-11-LABX-0021', and fellowships from the 'Ministere de l'Enseignement Superieur et de la Recherche' of France (to AM, JB, JC), ARC (JC) and the 'Societe Francaise d'Hematologie' (AM).	Allen WE, 1997, J CELL SCI, V110, P707; Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boulter E, 2012, FASEB J, V26, P469, DOI 10.1096/fj.11-192252; Boulter E, 2010, NAT CELL BIOL, V12, P477, DOI 10.1038/ncb2049; Cartier J, 2011, J BIOL CHEM, V286, P26406, DOI 10.1074/jbc.M110.191239; Cheng CM, 2011, MOL CELL BIOL, V31, P983, DOI 10.1128/MCB.00137-10; Dogan T, 2008, NAT CELL BIOL, V10, P1447, DOI 10.1038/ncb1804; Dynek JN, 2010, EMBO J, V29, P4198, DOI 10.1038/emboj.2010.300; Etienne-Manneville S, 2004, J CELL SCI, V117, P1291, DOI 10.1242/jcs.01115; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Fortin SP, 2012, MOL CANCER RES, V10, P958, DOI 10.1158/1541-7786.MCR-11-0616; Gadea G, 2004, J CELL SCI, V117, P6355, DOI 10.1242/jcs.01566; Garcia-Mata R, 2011, NAT REV MOL CELL BIO, V12, P493, DOI 10.1038/nrm3153; Geisbrecht ER, 2004, CELL, V118, P111, DOI 10.1016/j.cell.2004.06.020; Grandclement C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020444; Gyrd-Hansen M, 2008, NAT CELL BIOL, V10, P1309, DOI 10.1038/ncb1789; Gyrd-Hansen M, 2010, NAT REV CANCER, V10, P561, DOI 10.1038/nrc2889; Haas TL, 2009, MOL CELL, V36, P831, DOI 10.1016/j.molcel.2009.10.013; Haubert D, 2007, EMBO J, V26, P3308, DOI 10.1038/sj.emboj.7601778; Hehnly H, 2010, TRAFFIC, V11, P1067, DOI 10.1111/j.1600-0854.2010.01082.x; Iden S, 2008, NAT REV MOL CELL BIO, V9, P846, DOI 10.1038/nrm2521; Kant S, 2011, GENE DEV, V25, P2069, DOI 10.1101/gad.17224711; Liu JY, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.176982; Lopez J, 2011, MOL CELL, V42, P569, DOI 10.1016/j.molcel.2011.04.008; Mace PD, 2010, J MOL BIOL, V400, P8, DOI 10.1016/j.jmb.2010.04.055; Makrodouli E, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-118; Mathew SJ, 2009, J CELL SCI, V122, P1939, DOI 10.1242/jcs.044487; Mckenzie JAG, 2007, J CELL PHYSIOL, V213, P221, DOI 10.1002/jcp.21114; Micheau O, 2003, CELL, V114, P181, DOI 10.1016/S0092-8674(03)00521-X; Oberoi TK, 2012, EMBO J, V31, P14, DOI 10.1038/emboj.2011.423; Parameswaran N, 2010, CRIT REV EUKAR GENE, V20, P87, DOI 10.1615/CritRevEukarGeneExpr.v20.i2.10; Peppelenbosch M, 1999, J IMMUNOL, V162, P837; Puls A, 1999, J CELL SCI, V112, P2983; Qiu RG, 1997, MOL CELL BIOL, V17, P3449, DOI 10.1128/MCB.17.6.3449; Reymond N, 2012, J CELL BIOL, V199, P653, DOI 10.1083/jcb.201205169; Silke J, 2011, CURR OPIN IMMUNOL, V23, P620, DOI 10.1016/j.coi.2011.08.002; Stengel K, 2011, CELL SIGNAL, V23, P1415, DOI 10.1016/j.cellsig.2011.04.001; Stengel KR, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037317; Vallabhapurapu S, 2008, NAT IMMUNOL, V9, P1364, DOI 10.1038/ni.1678; Van Troys M, 2008, EUR J CELL BIOL, V87, P649, DOI 10.1016/j.ejcb.2008.04.001; Vanlangenakker N, 2011, CELL DEATH DIFFER, V18, P656, DOI 10.1038/cdd.2010.138; Varfolomeev E, 2008, J BIOL CHEM, V283, P24295, DOI 10.1074/jbc.C800128200; Varfolomeev E, 2007, CELL, V131, P669, DOI 10.1016/j.cell.2007.10.030; Vince JE, 2007, CELL, V131, P682, DOI 10.1016/j.cell.2007.10.037; Wang L, 2008, CELL, V133, P693, DOI 10.1016/j.cell.2008.03.036; Xu L, 2007, MOL CELL, V28, P914, DOI 10.1016/j.molcel.2007.10.027; Yang L, 2006, MOL BIOL CELL, V17, P4675, DOI 10.1091/mbc.E06-05-0466; Zarnegar BJ, 2008, NAT IMMUNOL, V9, P1371, DOI 10.1038/ni.1676; Zhuang M, 2013, MOL CELL, V49, P273, DOI 10.1016/j.molcel.2012.10.022	49	16	16	0	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5534	5545		10.1038/onc.2013.499	http://dx.doi.org/10.1038/onc.2013.499			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24276241				2022-12-25	WOS:000346087900006
J	Koenig, A; Buskiewicz, IA; Fortner, KA; Russell, JQ; Asaoka, T; He, YW; Hakem, R; Eriksson, JE; Budd, RC				Koenig, Andreas; Buskiewicz, Iwona A.; Fortner, Karen A.; Russell, Jennifer Q.; Asaoka, Tomoko; He, You-Wen; Hakem, Razqallah; Eriksson, John E.; Budd, Ralph C.			The c-FLIPL Cleavage Product p43FLIP Promotes Activation of Extracellular Signal-regulated Kinase (ERK), Nuclear Factor kappa B (NF-kappa B), and Caspase-8 and T Cell Survival	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							LONG FORM; INHIBITORY PROTEIN; DEATH; FAS; APOPTOSIS; COMPLEX; RECEPTORS; RIPOPTOSOME; LYMPHOCYTES; IMMUNITY	Caspase-8 is now appreciated to govern both apoptosis following death receptor ligation and cell survival and growth via inhibition of the Ripoptosome. Cells must therefore carefully regulate the high level of caspase-8 activity during apoptosis versus the modest levels observed during cell growth. The caspase-8 paralogue c-FLIP is a good candidate for a molecular rheostat of caspase-8 activity. c-FLIP can inhibit death receptor-mediated apoptosis by competing with caspase-8 for recruitment to FADD. However, full-length c-FLIPL can also heterodimerize with caspase-8 independent of death receptor ligation and activate caspase-8 via an activation loop in the C terminus of c-FLIPL. This triggers cleavage of c-FLIPL at Asp-376 by caspase-8 to produce p43FLIP. The continued function of p43FLIP has, however, not been determined. We demonstrate that acute deletion of endogenous c-FLIP in murine effector T cells results in loss of caspase-8 activity and cell death. The lethality and caspase-8 activity can both be rescued by the transgenic expression of p43FLIP. Furthermore, p43FLIP associates with Raf1, TRAF2, and RIPK1, which augments ERK and NF-kappa B activation, IL-2 production, and T cell proliferation. Thus, not only is c-FLIP the initiator of caspase-8 activity during T cell activation, it is also an initial caspase-8 substrate, with cleaved p43FLIP serving to both stabilize caspase-8 activity and promote activation of pathways involved with T cell growth.	[Koenig, Andreas; Buskiewicz, Iwona A.; Fortner, Karen A.; Russell, Jennifer Q.; Budd, Ralph C.] Univ Vermont, Coll Med, Vermont Ctr Immunol & Infect Dis, Burlington, VT 05405 USA; [Koenig, Andreas; Fortner, Karen A.; Russell, Jennifer Q.; Budd, Ralph C.] Univ Vermont, Coll Med, Dept Med, Burlington, VT 05405 USA; [Buskiewicz, Iwona A.] Univ Vermont, Coll Med, Dept Pathol, Burlington, VT 05405 USA; [Asaoka, Tomoko; Eriksson, John E.] Univ Turku, Turku Ctr Biotechnol, FIN-20521 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Abo Akad Univ, BioCity, FIN-20521 Turku, Finland; [Asaoka, Tomoko; Eriksson, John E.] Abo Akad Univ, Dept Biol Sci, BioCity, FIN-20520 Turku, Finland; [He, You-Wen] Duke Univ, Dept Immunol, Med Ctr, Durham, NC 27710 USA; [Hakem, Razqallah] Univ Toronto, Ontario Canc Inst, Dept Med Biophys, Toronto, ON M5G 2C1, Canada	University of Vermont; University of Vermont; University of Vermont; University of Turku; Abo Akademi University; Abo Akademi University; Duke University; University of Toronto; University Toronto Affiliates; University Health Network Toronto	Koenig, A (corresponding author), Univ Vermont, Coll Med, Immunobiol Program, Given Med Bldg,C-344,89 Beaumont Ave, Burlington, VT 05405 USA.	akoenig@uvm.edu		Hakem, Razqallah/0000-0001-5948-7931; Asaoka, Tomoko/0000-0001-5141-2353	National Institutes of Health [GM103496, AI36333, AI45666]; NATIONAL CANCER INSTITUTE [P30CA014236] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036333, P01AI045666] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103496] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported, in whole or in part, by National Institutes of Health Grants GM103496, AI36333, and AI45666.	AGGARWAL BB, 1995, FEBS LETT, V364, P5, DOI 10.1016/0014-5793(95)00339-B; Beisner DR, 2005, J IMMUNOL, V175, P3469, DOI 10.4049/jimmunol.175.6.3469; Boatright KM, 2004, BIOCHEM J, V382, P651, DOI 10.1042/BJ20040809; Chau H, 2005, J EXP MED, V202, P405, DOI 10.1084/jem.20050118; Chun HJ, 2002, NATURE, V419, P395, DOI 10.1038/nature01063; Collins C, 2005, J IMMUNOL, V175, P5656, DOI 10.4049/jimmunol.175.9.5656; Desbarats J, 2000, NAT MED, V6, P920, DOI 10.1038/78688; Desbarats J, 2003, NAT CELL BIOL, V5, P118, DOI 10.1038/ncb916; Dillon CP, 2012, CELL REPORTS, V1, P401, DOI 10.1016/j.celrep.2012.03.010; Dohrman A, 2005, J IMMUNOL, V175, P311, DOI 10.4049/jimmunol.175.1.311; Dohrman A, 2005, J IMMUNOL, V174, P5270, DOI 10.4049/jimmunol.174.9.5270; Feoktistova M, 2011, MOL CELL, V43, P449, DOI 10.1016/j.molcel.2011.06.011; Hinshaw-Makepeace J, 2008, EUR J IMMUNOL, V38, P54, DOI 10.1002/eji.200636956; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; JU ST, 1995, NATURE, V373, P444, DOI 10.1038/373444a0; Kaiser WJ, 2011, NATURE, V471, P368, DOI 10.1038/nature09857; Kataoka T, 2004, MOL CELL BIOL, V24, P2627, DOI 10.1128/MCB.24.7.2627-2636.2004; Kataoka T, 2000, CURR BIOL, V10, P640, DOI 10.1016/S0960-9822(00)00512-1; Lemmers B, 2007, J BIOL CHEM, V282, P7416, DOI 10.1074/jbc.M606721200; LENARDO MJ, 1991, NATURE, V353, P858, DOI 10.1038/353858a0; Micheau O, 2002, J BIOL CHEM, V277, P45162, DOI 10.1074/jbc.M206882200; MIZUSHIMA S, 1990, NUCLEIC ACIDS RES, V18, P5322, DOI 10.1093/nar/18.17.5322; Oberst A, 2011, NATURE, V471, P363, DOI 10.1038/nature09852; OWENSCHAUB LB, 1994, CANCER RES, V54, P1580; Perlman H, 2001, ARTHRITIS RHEUM, V44, P21, DOI 10.1002/1529-0131(200101)44:1<21::AID-ANR4>3.0.CO;2-8; Pop C, 2011, BIOCHEM J, V433, P447, DOI 10.1042/BJ20101738; Rajput A, 2011, IMMUNITY, V34, P340, DOI 10.1016/j.immuni.2010.12.018; Rincon M, 1997, MOL CELL BIOL, V17, P1522, DOI 10.1128/MCB.17.3.1522; Salmena L, 2005, J EXP MED, V202, P727, DOI 10.1084/jem.20050683; Salmena L, 2003, GENE DEV, V17, P883, DOI 10.1101/gad.1063703; Schleich K, 2012, MOL CELL, V47, P306, DOI 10.1016/j.molcel.2012.05.006; Shu HB, 1997, IMMUNITY, V6, P751, DOI 10.1016/S1074-7613(00)80450-1; Sun LM, 2012, CELL, V148, P213, DOI 10.1016/j.cell.2011.11.031; Tenev T, 2011, MOL CELL, V43, P432, DOI 10.1016/j.molcel.2011.06.006; Thome M, 1997, NATURE, V386, P517, DOI 10.1038/386517a0; Tschopp J, 1998, CURR OPIN IMMUNOL, V10, P552, DOI 10.1016/S0952-7915(98)80223-9; Varfolomeev EE, 1998, IMMUNITY, V9, P267, DOI 10.1016/S1074-7613(00)80609-3; Yeh WC, 2000, IMMUNITY, V12, P633, DOI 10.1016/S1074-7613(00)80214-9; Zhang HB, 2011, NATURE, V471, P373, DOI 10.1038/nature09878; Zhang N, 2005, J EXP MED, V202, P395, DOI 10.1084/jem.20050117	40	33	38	0	6	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1183	1191		10.1074/jbc.M113.506428	http://dx.doi.org/10.1074/jbc.M113.506428			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24275659	hybrid, Green Published			2022-12-25	WOS:000330541200049
J	Feldman, D; Ziv, C; Gorovits, R; Efrat, M; Yarden, O				Feldman, Daria; Ziv, Carmit; Gorovits, Rena; Efrat, Michal; Yarden, Oded			Neurospora crassa Protein Arginine Methyl Transferases Are Involved in Growth and Development and Interact with the NDR Kinase COT1	PLOS ONE			English	Article							FISSION YEAST; METHYLTRANSFERASE; TRANSCRIPTION; HOMOLOG; NUCLEI; HUMANS; DOMAIN	The protein arginine methyltransferaseas (PRMTs) family is conserved from yeast to human, and regulates stability, localization and activity of proteins. We have characterized deletion strains corresponding to genes encoding for PRMT1/3/5 (designated amt-1, amt-3 and skb-1, respectively) in Neurospora crassa. Deletion of PRMT-encoding genes conferred altered Arg-methylated protein profiles, as determined immunologically. Delta amt-1 exhibited reduced hyphal elongation rates (70% of wild type) and increased susceptibility to the ergosterol biosynthesis inhibitor voriconazole. In namt-3, distances between branches were significantly longer than the wild type, suggesting this gene is required for proper regulation of hyphal branching. Deletion of skb-1 resulted in hyper conidiation (2-fold of the wild type) and increased tolerance to the chitin synthase inhibitor polyoxin D. Inactivation of two Type I PRMTs (amt-1 and amt-3) conferred changes in both asymmetric as well as symmetric protein methylation profiles, suggesting either common substrates and/or cross-regulation of different PRMTs. The PRMTs in N. crassa apparently share cellular pathways which were previously reported to be regulated by the NDR (Nuclear DBF2-related) kinase COT1. Using co-immunprecipitation experiments (with MYC-tagged proteins), we have shown that SKB1 and COT1 physically interacted and the abundance of the 75 kDa MYC:: COT1 isoform was increased in a Delta skb-1 background. On the basis of immunological detection, we propose the possible involvement of PRMTs in Arg-methylation of COT1.	[Feldman, Daria; Ziv, Carmit; Gorovits, Rena; Efrat, Michal; Yarden, Oded] Hebrew Univ Jerusalem, RH Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel	Hebrew University of Jerusalem	Yarden, O (corresponding author), Hebrew Univ Jerusalem, RH Smith Fac Agr Food & Environm, Dept Plant Pathol & Microbiol, IL-76100 Rehovot, Israel.	Oded.Yarden@mail.huji.ac.il	Yarden, Oded/J-5988-2012	Ziv, Carmit/0000-0002-2724-3032; Feldman, Daria/0000-0003-0325-2732; , Oded/0000-0002-4722-535X	DFG [SE1054/3-2]; Israel Science Foundation; German-Israel Fund	DFG(German Research Foundation (DFG)); Israel Science Foundation(Israel Science Foundation); German-Israel Fund	This research project was supported by DFG research grant SE1054/3-2, by The Israel Science Foundation and by the German-Israel Fund. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bachand F, 2007, EUKARYOT CELL, V6, P889, DOI 10.1128/EC.00099-07; Bauer I, 2010, FUNGAL GENET BIOL, V47, P551, DOI 10.1016/j.fgb.2010.03.006; Bedford MT, 2009, MOL CELL, V33, P1, DOI 10.1016/j.molcel.2008.12.013; Colot HV, 2006, P NATL ACAD SCI USA, V103, P10352, DOI 10.1073/pnas.0601456103; Davis R.H., 2000, NEUROSPORA CONTRIBUT; Freitag M, 2004, FUNGAL GENET BIOL, V41, P897, DOI 10.1016/j.fgb.2004.06.008; Gary JD, 1996, J BIOL CHEM, V271, P12585, DOI 10.1074/jbc.271.21.12585; Gilbreth M, 1998, P NATL ACAD SCI USA, V95, P14781, DOI 10.1073/pnas.95.25.14781; Gorovits R, 1999, FUNGAL GENET BIOL, V27, P264, DOI 10.1006/fgbi.1999.1152; Gorovits R, 2003, EUKARYOT CELL, V2, P699, DOI 10.1128/EC.2.4.699-707.2003; Henry MF, 1996, MOL CELL BIOL, V16, P3668; Hergovich A, 2006, NAT REV MOL CELL BIO, V7, P253, DOI 10.1038/nrm1891; Herrmann F, 2009, J CELL SCI, V122, P667, DOI 10.1242/jcs.039933; Jansen JM, 2006, J CELL BIOL, V175, P755, DOI 10.1083/jcb.200604107; Lauter FR, 1998, FUNGAL GENET BIOL, V23, P300, DOI 10.1006/fgbi.1998.1038; Leach MD, 2012, EUKARYOT CELL, V11, P98, DOI 10.1128/EC.05238-11; Lee JH, 2000, BIOCHEM BIOPH RES CO, V274, P105, DOI 10.1006/bbrc.2000.3049; Maerz S, 2012, MOL CELL BIOL, V32, P2083, DOI 10.1128/MCB.06263-11; Maerz S, 2009, MOL MICROBIOL, V74, P707, DOI 10.1111/j.1365-2958.2009.06896.x; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Nakazawa T, 2010, CURR GENET, V56, P361, DOI 10.1007/s00294-010-0307-1; PAIK WK, 1967, BIOCHEM BIOPH RES CO, V29, P14, DOI 10.1016/0006-291X(67)90533-5; Riquelme M, 2011, FUNGAL BIOL-UK, V115, P446, DOI 10.1016/j.funbio.2011.02.008; Sambrook J., 2002, MOL CLONING LAB MANU; Sayegh J, 2007, J BIOL CHEM, V282, P36444, DOI 10.1074/jbc.M704650200; Seiler S, 2006, MOL BIOL CELL, V17, P4080, DOI 10.1091/mbc.E06-01-0072; SPRINGER ML, 1993, BIOESSAYS, V15, P365, DOI 10.1002/bies.950150602; Wang G, 2012, PLOS ONE, V7; Watters MK, 2001, APPL ENVIRON MICROB, V67, P1788, DOI 10.1128/AEM.67.4.1788-1792.2001; Wiley DJ, 2003, J BIOL CHEM, V278, P25256, DOI 10.1074/jbc.M209703200; YARDEN O, 1992, EMBO J, V11, P2159, DOI 10.1002/j.1460-2075.1992.tb05275.x; Ziv C, 2013, MOL MICROBIOL, V90, P383, DOI 10.1111/mmi.12371; Ziv C, 2009, MOL MICROBIOL, V74, P974, DOI 10.1111/j.1365-2958.2009.06911.x	33	8	9	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80756	10.1371/journal.pone.0080756	http://dx.doi.org/10.1371/journal.pone.0080756			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260473	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900095
J	Feng, DQ; Wu, J; Tian, Y; Zhou, H; Zhou, Y; Hu, WP; Zhao, WD; Wei, HM; Ling, B; Ma, CH				Feng, Dingqing; Wu, Jiao; Tian, Yuan; Zhou, Hu; Zhou, Ying; Hu, Weiping; Zhao, Weidong; Wei, Haiming; Ling, Bin; Ma, Chunhong			Targeting of Histone Deacetylases to Reactivate Tumour Suppressor Genes and Its Therapeutic Potential in a Human Cervical Cancer Xenograft Model	PLOS ONE			English	Article							TRANS-RETINOIC ACID; VALPROIC ACID; PHASE-I; E-CADHERIN; EXPRESSION; DIFFERENTIATION; COMBINATION; INHIBITOR; MECHANISMS; RAR-BETA-2	Aberrant histone acetylation plays an essential role in the neoplastic process via the epigenetic silencing of tumour suppressor genes (TSGs); therefore, the inhibition of histone deacetylases (HDAC) has become a promising target in cancer therapeutics. To investigate the correlation of histone acetylation with clinicopathological features and TSG expression, we examined the expression of acetylated H3 (AcH3), RAR beta 2, E-cadherin, and beta-catenin by immunohistochemistry in 65 cervical squamous cell carcinoma patients. The results revealed that the absence of AcH3 was directly associated with poor histological differentiation and nodal metastasis as well as reduced/negative expression of RAR beta 2, E-cadherin, and beta-catenin in clinical tumour samples. We further demonstrated that the clinically available HDAC inhibitors valproic acid (VPA) and suberoylanilide hydroxamic acid (SAHA), in combination with all-trans retinoic acid (ATRA), can overcome the epigenetic barriers to transcription of RAR beta 2 in human cervical cancer cells. Chromatin immunoprecipitation analysis showed that the combination treatment increased the enrichment of acetylated histone in the RAR beta 2-RARE promoter region. In view of these findings, we evaluated the antitumor effects induced by combined VPA and ATRA treatment in a xenograft model implanted with poorly differentiated human squamous cell carcinoma. Notably, VPA restored RAR beta 2 expression via epigenetic modulation. Additive antitumour effects were produced in tumour xenografts by combining VPA with ATRA treatment. Mechanistically, the combination treatment reactivated the expression of TSGs RAR beta 2, E-cadherin, P21(CIP1), and P53 and reduced the level of p-Stat3. Sequentially, upregulation of involucrin and loricrin, which indicate terminal differentiation, strongly contributed to tumour growth inhibition along with partial apoptosis. In conclusion, targeted therapy with HDAC inhibitors and RAR beta 2 agonists may represent a novel therapeutic approach for patients with cervical squamous cell carcinoma.	[Feng, Dingqing; Ma, Chunhong] Shandong Univ Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China; [Feng, Dingqing; Wu, Jiao; Tian, Yuan; Zhou, Hu; Zhou, Ying; Ling, Bin] Anhui Med Univ, Anhui Prov Hosp, Anhui Prov Key Lab Mol Med, Hefei, Anhui, Peoples R China; [Zhou, Ying; Hu, Weiping; Zhao, Weidong; Ling, Bin] Anhui Med Univ, Anhui Prov Hosp, Dept Obstet & Gynecol, Hefei, Anhui, Peoples R China; [Wei, Haiming] Univ Sci & Technol China, Hefei Natl Lab Phys Sci Microscale, Inst Immunol, Hefei, Anhui, Peoples R China; [Wei, Haiming] Univ Sci & Technol China, Sch Life Sci, Hefei, Anhui, Peoples R China; [Ling, Bin] China Japan Friendship Hosp, Dept Obstet & Gynecol, Beijing, Peoples R China	Shandong University; Anhui Medical University; Anhui Medical University; Chinese Academy of Sciences; University of Science & Technology of China, CAS; Chinese Academy of Sciences; University of Science & Technology of China, CAS; China-Japan Friendship Hospital	Ma, CH (corresponding author), Shandong Univ Sch Med, Minist Educ, Key Lab Expt Teratol, Jinan, Shandong, Peoples R China.	machunhong@sdu.edu.cn	ma, chunhong/C-6043-2008	ma, chunhong/0000-0002-8121-4718	National Natural Science Foundation of China [30901606, 81001168, 81072127, 81372779, 81372777]; Anhui Provincial Natural Science Foundation [110406M176, 110406M178]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Anhui Provincial Natural Science Foundation(Natural Science Foundation of Anhui Province)	This work was supported by the National Natural Science Foundation of China (30901606, 81001168,81072127, 81372779 and 81372777) and the Anhui Provincial Natural Science Foundation (110406M176 and 110406M178). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abu J, 2005, LANCET ONCOL, V6, P712, DOI 10.1016/S1470-2045(05)70319-3; Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200; Chavez-Blanco A, 2005, MOL CANCER, V4, DOI 10.1186/1476-4598-4-22; Cheng Y, 2012, HUM PATHOL, V43, P1213, DOI 10.1016/j.humpath.2011.08.025; Chui X, 1996, BRIT J CANCER, V73, P1233, DOI 10.1038/bjc.1996.236; Cimino G, 2006, CANCER RES, V66, P8903, DOI 10.1158/0008-5472.CAN-05-2726; Mora-Garcia MD, 2006, J TRANSL MED, V4, DOI 10.1186/1479-5876-4-55; Dutta A, 2009, J ONCOL, V2009, DOI 10.1155/2009/627840; Fandy TE, 2010, EPIGENOMICS-UK, V2, P221, DOI 10.2217/EPI.10.1; Fazi F, 2005, ONCOGENE, V24, P1820, DOI 10.1038/sj.onc.1208286; Feng D, 2012, CURR MOL MED, V12, P342, DOI 10.2174/156652412799218949; Finazzi G, 2013, BRIT J HAEMATOL, V161, P688, DOI 10.1111/bjh.12332; Fleskens SAJHM, 2011, MODERN PATHOL, V24, P892, DOI 10.1038/modpathol.2011.50; Hahn CK, 2008, P NATL ACAD SCI USA, V105, P9751, DOI 10.1073/pnas.0710413105; Hakim SG, 2011, CLIN ORAL INVEST, V15, P321, DOI 10.1007/s00784-010-0388-8; Holt SV, 2012, BRIT J CANCER, V106, P858, DOI 10.1038/bjc.2012.8; Hua SJ, 2009, CELL, V137, P1259, DOI 10.1016/j.cell.2009.04.043; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Ibragimova I, 2010, CANCER PREV RES, V3, P1084, DOI 10.1158/1940-6207.CAPR-10-0039; Kawagoe R, 2002, LEUKEMIA RES, V26, P495, DOI 10.1016/S0145-2126(01)00151-5; Kim NH, 2010, J INVEST DERMATOL, V130, P2231, DOI 10.1038/jid.2010.99; Kumar P, 2010, J BIOL CHEM, V285, P37521, DOI 10.1074/jbc.M110.132795; Laurenzana A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058267; Leiva M, 2012, LEUKEMIA, V26, P1630, DOI 10.1038/leu.2012.39; Li C, 1998, CANCER LETT, V124, P205, DOI 10.1016/S0304-3835(97)00475-8; Li P, 2012, DEV BIOL, V361, P116, DOI 10.1016/j.ydbio.2011.10.018; Lin RJ, 1998, NATURE, V391, P811, DOI 10.1038/35895; Liu LK, 2010, MODERN PATHOL, V23, P213, DOI 10.1038/modpathol.2009.160; Milon BC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049692; Mongan NP, 2005, MOL CANCER THER, V4, P477; Ou JN, 2007, BIOCHEM PHARMACOL, V73, P1297, DOI 10.1016/j.bcp.2006.12.032; Pasqualucci L, 2011, NATURE, V471, P189, DOI 10.1038/nature09730; Pili R, 2012, BRIT J CANCER, V106, P77, DOI 10.1038/bjc.2011.527; Qiu TZ, 2013, FUTURE ONCOL, V9, P255, DOI [10.2217/fon.12.173, 10.2217/FON.12.173]; Raeder MB, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0054873; Rayess H, 2012, INT J CANCER, V130, P1715, DOI 10.1002/ijc.27316; Ryan KR, 2012, J CELL SCI, V125, P3202, DOI 10.1242/jcs.101931; Sandor V, 2002, CLIN CANCER RES, V8, P718; Sarshad A, 2013, PLOS GENET, V9, DOI 10.1371/journal.pgen.1003397; Schug TT, 2007, CELL, V129, P723, DOI 10.1016/j.cell.2007.02.050; Segura-Pacheco B, 2003, CLIN CANCER RES, V9, P1596; Siddiqui H, 2003, MOL CELL BIOL, V23, P7719, DOI 10.1128/MCB.23.21.7719-7731.2003; Tan S, 2012, CURR CANCER DRUG TAR, V12, P170, DOI 10.2174/156800912799095135; Tao MH, 2011, NUTR CANCER, V63, P1143, DOI 10.1080/01635581.2011.605982; Tatebe H, 2009, CANCER LETT, V285, P210, DOI 10.1016/j.canlet.2009.05.019; Tian XR, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/567305; TOKITA H, 1980, CANCER RES, V40, P4287; Touma SE, 2005, CLIN CANCER RES, V11, P3558, DOI 10.1158/1078-0432.CCR-04-1155; Valdes-Mora F, 2012, GENOME RES, V22, P307, DOI 10.1101/gr.118919.110; Venugopal B, 2013, CLIN CANCER RES, V19, P4262, DOI 10.1158/1078-0432.CCR-13-0312; Wilting RH, 2012, DRUG RESIST UPDATE, V15, P21, DOI 10.1016/j.drup.2012.01.008; Xu WS, 2007, ONCOGENE, V26, P5541, DOI 10.1038/sj.onc.1210620	52	25	29	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80657	10.1371/journal.pone.0080657	http://dx.doi.org/10.1371/journal.pone.0080657			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260446	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900080
J	Kou, ZF; Gattu, R; Kobeissy, F; Welch, RD; O'Neil, BJ; Woodard, JL; Ayaz, SI; Kulek, A; Kas-Shamoun, R; Mika, V; Zuk, C; Tomasello, F; Mondello, S				Kou, Zhifeng; Gattu, Ramtilak; Kobeissy, Firas; Welch, Robert D.; O'Neil, Brian J.; Woodard, John L.; Ayaz, Syed Imran; Kulek, Andrew; Kas-Shamoun, Robert; Mika, Valerie; Zuk, Conor; Tomasello, Francesco; Mondello, Stefania			Combining Biochemical and Imaging Markers to Improve Diagnosis and Characterization of Mild Traumatic Brain Injury in the Acute Setting: Results from a Pilot Study	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; C-TERMINAL HYDROLASE; WHITE-MATTER INJURY; DIFFUSE AXONAL INJURY; INTRACEREBRAL HEMORRHAGE; INTRACRANIAL LESIONS; BREAKDOWN PRODUCTS; SERUM-LEVELS; BIOMARKERS; CONCUSSION	Background: Mild traumatic brain injury (mTBI) is a significant healthcare burden and its diagnosis remains a challenge in the emergency department. Serum biomarkers and advanced magnetic resonance imaging (MRI) techniques have already demonstrated their potential to improve the detection of brain injury even in patients with negative computed tomography (CT) findings. The objective of this study was to determine the clinical value of a combinational use of both blood biomarkers and MRI in mTBI detection and their characterization in the acute setting (within 24 hours after injury). Methods: Nine patients with mTBI were prospectively recruited from the emergency department. Serum samples were collected at the time of hospital admission and every 6 hours up to 24 hours post injury. Neuronal (Ubiquitin C-terminal Hydrolase-L1 [UCH-L1]) and glial (glial fibrillary acidic protein [GFAP]) biomarker levels were analyzed. Advanced MRI data were acquired at 9 +/- 6.91 hours after injury. Patients' neurocognitive status was assessed by using the Standard Assessment of Concussion (SAC) instrument. Results: The median serum levels of UCH-L1 and GFAP on admission were increased 4.9 folds and 10.6 folds, respectively, compared to reference values. Three patients were found to have intracranial hemorrhages on SWI, all of whom had very high GFAP levels. Total volume of brain white matter (WM) with abnormal fractional anisotropy (FA) measures of diffusion tensor imaging (DTI) were negatively correlated with patients' SAC scores, including delayed recall. Both increased and decreased DTI-FA values were observed in the same subjects. Serum biomarker level was not correlated with patients' DTI data nor SAC score. Conclusions: Blood biomarkers and advanced MRI may correlate or complement each other in different aspects of mTBI detection and characterization. GFAP might have potential to serve as a clinical screening tool for intracranial bleeding. UCH-L1 complements MRI in injury detection. Impairment at WM tracts may account for the patients' neurocognitive symptoms.	[Kou, Zhifeng] Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA; [Kou, Zhifeng; Gattu, Ramtilak; Zuk, Conor] Wayne State Univ, Sch Med, Dept Radiol, Detroit, MI USA; [Kobeissy, Firas] Univ Florida, McKnight Brain Inst, Dept Psychiat, Ctr Neuroprote & Biomarkers Res, Gainesville, FL USA; [Welch, Robert D.; O'Neil, Brian J.; Ayaz, Syed Imran; Kulek, Andrew; Kas-Shamoun, Robert; Mika, Valerie] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit, MI USA; [Welch, Robert D.; O'Neil, Brian J.] Wayne State Univ, Sch Med, Cardiovasc Res Inst, Detroit, MI USA; [Woodard, John L.] Wayne State Univ, Dept Psychol, Detroit, MI 48202 USA; [Tomasello, Francesco; Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy	Wayne State University; Wayne State University; State University System of Florida; University of Florida; Wayne State University; Wayne State University; Wayne State University; University of Messina	Kou, ZF (corresponding author), Wayne State Univ, Dept Biomed Engn, Detroit, MI 48202 USA.	zhifeng_kou@wayne.edu	Mondello, Stefania/A-1813-2012; Mika, Valerie H./AAO-2816-2020; Kobeissy, Firas/E-7042-2017	Mondello, Stefania/0000-0002-8587-3614; Kobeissy, Firas/0000-0002-5008-6944; Woodard, John/0000-0001-9196-3336	International Society for Magnetic Resonance in Medicine; Department of Defense; Banyan Biomarkers, Inc.	International Society for Magnetic Resonance in Medicine; Department of Defense(United States Department of Defense); Banyan Biomarkers, Inc.	This work was supported by a Seed Grant from the International Society for Magnetic Resonance in Medicine (PI: Zhifeng Kou) and a research grant from the Department of Defense. Drs. Mondello and Kobeissy were employees and received salaries from Banyan Biomarkers, Inc. Dr. Welch is a site PI of a clinical trial from Banyan Biomarkers, Inc., supported by the Department of Defense. Dr. O'Neil is a site PI for BrainScope Technologies. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alves W, 1993, J HEAD TRAUMA REHAB, V8, P48, DOI DOI 10.1097/00001199-199309000-00007; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Bazarian JJ, 2005, EMERG MED J, V22, P473, DOI 10.1136/emj.2004.019273; Belanger HG, 2007, J NEUROPSYCH CLIN N, V19, P5, DOI 10.1176/appi.neuropsych.19.1.5; Benson RR, 2007, J NEUROTRAUM, V24, P446, DOI 10.1089/neu.2006.0153; Brophy GM, 2009, J NEUROTRAUM, V26, P471, DOI 10.1089/neu.2008.0657; CDC,, 2003, REP C MILD TRAUM BRA; Conturo TE, 1996, MAGNET RESON MED, V35, P399, DOI 10.1002/mrm.1910350319; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; ENG LF, 1971, BRAIN RES, V28, P351, DOI 10.1016/0006-8993(71)90668-8; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2012, BIOMARKERS TRAUMATIC; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; JACKSON P, 1981, J NEUROL SCI, V49, P429, DOI 10.1016/0022-510X(81)90032-0; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kay T, 1993, J HEAD TRAUMA REHAB, V8, P74, DOI 10.1097/00001199-199309000-00009; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [DOI 10.1097/00001199-199309000-00010, 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00009]; Kochanek PM, 2008, CURR OPIN CRIT CARE, V14, P135, DOI 10.1097/MCC.0b013e3282f57564; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kou Z, 2010, CLIN MR NEUROIMAGING; Kou Z, 2008, REGION INTEREST ANAL; Kou Z, 2007, JOINT ANN M ISMRM ES; Kou ZF, 2012, RSC DRUG DISCOV, V24, P19, DOI 10.1039/9781849734745-00019; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Lincoln S, 1999, NEUROREPORT, V10, P427, DOI 10.1097/00001756-199902050-00040; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrea M., 2000, STANDARDIZED ASSESSM; Missler U, 1999, CLIN CHEM, V45, P138; Mondello S, 2012, NEUROSURGERY; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mondello S, 2011, EXPERT REV MOL DIAGN, V11, P65, DOI 10.1586/ERM.10.104; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; National Academy of Neuropsychology, 2002, MILD TRAUM BRAIN INJ; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; Papa L, ANN EMER MED    1108; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2012, J TRAUMA ACUTE CARE, V72, P1335, DOI 10.1097/TA.0b013e3182491e3d; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Ptak T, 2003, AM J ROENTGENOL, V181, P1401, DOI 10.2214/ajr.181.5.1811401; Ragnarsson KT, 1999, JAMA-J AM MED ASSOC, V282, P974; Reichenbach JR, 1997, RADIOLOGY, V204, P272, DOI 10.1148/radiology.204.1.9205259; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Rutgers DR, 2008, AM J NEURORADIOL, V29, P1730, DOI 10.3174/ajnr.A1213; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Saigoh K, 1999, NAT GENET, V23, P47, DOI 10.1038/12647; Shimony JS, 1999, RADIOLOGY, V212, P770, DOI 10.1148/radiology.212.3.r99au51770; Unden J, 2009, J NEUROL, V256, P72, DOI 10.1007/s00415-009-0054-8; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; WILLIAMS DH, 1990, NEUROSURGERY, V27, P422, DOI 10.1227/00006123-199009000-00014; Woods RP, 1998, J COMPUT ASSIST TOMO, V22, P139, DOI 10.1097/00004728-199801000-00027; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	77	57	66	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80296	10.1371/journal.pone.0080296	http://dx.doi.org/10.1371/journal.pone.0080296			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260364	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900061
J	Ning, DG; Liu, SB; Xu, WD; Zhuang, Q; Wen, CW; Tang, XX				Ning, Degang; Liu, Shuibing; Xu, Weidong; Zhuang, Qiang; Wen, Chongwei; Tang, Xiaoxia			Transcriptional and Proteolytic Regulation of the Toxin-Antitoxin Locus vapBC10 (ssr2962/slr1767) on the Chromosome of Synechocystis sp PCC 6803	PLOS ONE			English	Article							DEPENDENT CLP PROTEASE; ESCHERICHIA-COLI; CELL-DEATH; TRANSLATION; GROWTH; GENE; EXPRESSION; SYSTEMS; FAMILY; INHIBITION	VapBC toxin-antitoxin (TA) systems are defined by the association of a PIN-domain toxin with a DNA-binding antitoxin, and are thought to play important physiological roles in bacteria and archaea. Recently, the PIN-associated gene pair PIN-COG2442 was proposed to encode VapBC-family TA system and found to be abundant in cyanobacteria. However, the features of these predicted TA loci remain under investigation. We here report characterization of the PIN-COG2442 locus vapBC10 (ssr2962/slr1767) on the chromosome of Synechocystis sp. PCC 6803. RT-PCR analysis revealed that the vapBC10 genes were co-transcribed under normal growth conditions. Ectopic expression of the PIN-domain protein VapC10 caused growth arrest of Escherichia coli that does not possess vapBC TA locus. Coincidentally, this growth-inhibition effect could be neutralized by either simultaneous or subsequent production of the COG2442-domain protein VapB10 through formation of the TA complex VapBC10 in vivo. In contrast to the transcription repression activity of the well-studied antitoxins, VapB10 positively auto-regulated the transcription of its own operon via specific binding to the promoter region. Furthermore, in vivo experiments in E. coli demonstrated that the Synechocystis protease ClpXP2s, rather than Lons, could cleave VapB10 and proteolytically activate the VapC10 toxicity. Our results show that the PIN-COG2442 locus vapBC10 encodes a functional VapBC TA system with an alternative mechanism for the transcriptional auto-regulation of its own operon.	[Ning, Degang; Liu, Shuibing; Zhuang, Qiang; Tang, Xiaoxia] Jiangsu Univ, Sch Environm, Dept Environm Sci, Zhenjiang, Jiangsu, Peoples R China; [Xu, Weidong; Wen, Chongwei] Jiangsu Univ, Sch Pharm, Dept Pharmaceut Engn, Zhenjiang, Jiangsu, Peoples R China	Jiangsu University; Jiangsu University	Ning, DG (corresponding author), Jiangsu Univ, Sch Environm, Dept Environm Sci, Zhenjiang, Jiangsu, Peoples R China.	306502@ujs.edu.cn			National Natural Science Foundation of China [30771176]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by a grant from the National Natural Science Foundation of China (grant no. 30771176). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Amitai S, 2004, J BACTERIOL, V186, P8295, DOI 10.1128/JB.186.24.8295-8300.2004; Anantharaman V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-12-r81; Arcus VL, 2011, PROTEIN ENG DES SEL, V24, P33, DOI 10.1093/protein/gzq081; Bates PA, 2001, PROTEINS, P39; CAI YP, 1990, J BACTERIOL, V172, P3138, DOI 10.1128/jb.172.6.3138-3145.1990; Cherny I, 2004, J BIOL CHEM, V279, P8252, DOI 10.1074/jbc.M308263200; Christensen SK, 2003, J MOL BIOL, V332, P809, DOI 10.1016/S0022-2836(03)00922-7; Christensen SK, 2001, P NATL ACAD SCI USA, V98, P14328, DOI 10.1073/pnas.251327898; Christensen-Dalsgaard M, 2006, MOL MICROBIOL, V62, P397, DOI 10.1111/j.1365-2958.2006.05385.x; Clarke AK, 1996, PLANT MOL BIOL, V31, P721, DOI 10.1007/BF00019460; Clarke AK, 1998, PLANT MOL BIOL, V37, P791, DOI 10.1023/A:1006016302074; Cline SD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032199; Donegan NP, 2010, J BACTERIOL, V192, P1416, DOI 10.1128/JB.00233-09; Florek P, 2008, FEMS MICROBIOL LETT, V278, P177, DOI 10.1111/j.1574-6968.2007.00984.x; Gao Hong, 2007, Acta Hydrobiologica Sinica, V31, P240; Gerdes K, 2005, NAT REV MICROBIOL, V3, P371, DOI 10.1038/nrmicro1147; Hilliard JJ, 1998, J BIOL CHEM, V273, P524, DOI 10.1074/jbc.273.1.524; Holm L, 2010, NUCLEIC ACIDS RES, V38, pW545, DOI 10.1093/nar/gkq366; JAFFE A, 1985, J BACTERIOL, V163, P841; Jorgensen MG, 2009, J BACTERIOL, V191, P1191, DOI 10.1128/JB.01013-08; Kaneko T, 1996, DNA Res, V3, P109; Leplae R, 2011, NUCLEIC ACIDS RES, V39, P5513, DOI 10.1093/nar/gkr131; Magnuson RD, 2007, J BACTERIOL, V189, P6089, DOI 10.1128/JB.00958-07; Makarova K.S., 2009, BIOL DIRECT, V4, DOI [10.1186/1745-6150-1184-1119, DOI 10.1186/1745-6150-1184-1119]; McKenzie JL, 2012, RNA, V18, P1267, DOI 10.1261/rna.031229.111; Miller JH., 1972, EXPT MOL GENETICS; Mitschke J, 2011, P NATL ACAD SCI USA, V108, P2124, DOI 10.1073/pnas.1015154108; Nariya H, 2008, CELL, V132, P55, DOI 10.1016/j.cell.2007.11.044; Ning DG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056035; Ning DG, 2011, CURR MICROBIOL, V63, P496, DOI 10.1007/s00284-011-0011-5; Ning DG, 2004, MICROBIOL-SGM, V150, P447, DOI 10.1099/mic.0.26747-0; Pandey DP, 2005, NUCLEIC ACIDS RES, V33, P966, DOI 10.1093/nar/gki201; Pedersen K, 2002, MOL MICROBIOL, V45, P501, DOI 10.1046/j.1365-2958.2002.03027.x; Pedersen K, 2003, CELL, V112, P131, DOI 10.1016/S0092-8674(02)01248-5; Porankiewicz J, 1998, MOL MICROBIOL, V29, P275, DOI 10.1046/j.1365-2958.1998.00928.x; Prysak MH, 2009, MOL MICROBIOL, V71, P1071, DOI 10.1111/j.1365-2958.2008.06572.x; ROBERTS RC, 1994, J MOL BIOL, V237, P35, DOI 10.1006/jmbi.1994.1207; Schelin J, 2002, MICROBIOL-SGM, V148, P2255, DOI 10.1099/00221287-148-7-2255; Schuster CF, 2013, FEMS MICROBIOL LETT, V340, P73, DOI 10.1111/1574-6968.12074; Sharp JD, 2012, J BIOL CHEM, V287, P12835, DOI 10.1074/jbc.M112.340109; Syed MA, 2011, J BACTERIOL, V193, P1122, DOI 10.1128/JB.01114-10; Van Melderen L, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000437; Williams JJ, 2012, TRENDS MICROBIOL, V20, P291, DOI 10.1016/j.tim.2012.02.005; Winther KS, 2011, P NATL ACAD SCI USA, V108, P7403, DOI 10.1073/pnas.1019587108; Yamaguchi Y, 2011, NAT REV MICROBIOL, V9, P779, DOI 10.1038/nrmicro2651; Yamaguchi Y, 2009, J BIOL CHEM, V284, P28746, DOI 10.1074/jbc.M109.032904; Zhao LX, 2008, FEBS LETT, V582, P710, DOI 10.1016/j.febslet.2008.01.045	47	6	7	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80716	10.1371/journal.pone.0080716	http://dx.doi.org/10.1371/journal.pone.0080716			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260461	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900089
J	van der Woerd, WL; van Haaften-Visser, DY; van de Graaf, SFJ; Ferec, C; Masson, E; Stapelbroek, JM; Bugert, P; Witt, H; Houwen, RHJ				van der Woerd, Wendy L.; van Haaften-Visser, Desiree Y.; van de Graaf, Stan F. J.; Ferec, Claude; Masson, Emmanuelle; Stapelbroek, Janneke M.; Bugert, Peter; Witt, Heiko; Houwen, Roderick H. J.			Mutational Analysis of ATP8B1 in Patients with Chronic Pancreatitis	PLOS ONE			English	Article							FAMILIAL INTRAHEPATIC CHOLESTASIS; HEREDITARY PANCREATITIS; GENE; PREGNANCY; VARIANTS; FIC1; CTRC	Background: Mutations in genes encoding cationic trypsinogen (PRSS1), pancreatic secretory trypsin inhibitor (SPINK1) and chymotrypsinogen C (CTRC) are associated with chronic pancreatitis. However, in many patients with a familial chronic pancreatitis pattern suggesting a genetic cause, no mutations in either of these genes can be found, indicating that other, still unknown, associated genes exist. In this respect ATP8B1 is an interesting candidate due to its strong expression in the pancreas, its supposed general function in membrane organization and the higher incidence of pancreatitis in patients with ATP8B1 deficiency. Methods: We analyzed all 27 ATP8B1 coding exons and adjacent non-coding sequences of 507 chronic pancreatitis patients by direct sequencing. Exons that harbored possible relevant variations were subsequently sequenced in 1,027 healthy controls. Results: In the exonic regions, 5 novel non-synonymous alterations were detected as well as 14 previously described alterations of which some were associated with ATP8B1 deficiency. However, allele frequencies for any of these variations did not significantly differ between patients and controls. Furthermore, several non-synonymous variants were exclusively detected in control subjects and multiple variants in the non-coding sequence were identified with similar frequencies in both groups. Conclusions: We did not find an association between heterozygous ATP8B1 variants and chronic pancreatitis in our cohort of patients with hereditary and idiopathic chronic pancreatitis.	[van der Woerd, Wendy L.; van Haaften-Visser, Desiree Y.; Stapelbroek, Janneke M.; Houwen, Roderick H. J.] Univ Med Ctr Utrecht, Dept Pediat Gastroenterol, Wilhelmina Childrens Hosp, Utrecht, Netherlands; [van der Woerd, Wendy L.; van de Graaf, Stan F. J.] Univ Med Ctr Utrecht, Dept Metab Dis, Utrecht, Netherlands; [Ferec, Claude; Masson, Emmanuelle] Ctr Hosp Reg Univ CHRU Brest, Lab Genet Mol & Histocompatibilite, Brest, France; [Ferec, Claude; Masson, Emmanuelle] INSERM, U1078, Brest, France; [Bugert, Peter] Heidelberg Univ, Inst Transfus Med & Immunol, Med Fac Mannheim, German Red Cross Blood Serv Baden Wurttemberg Hes, Mannheim, Germany; [Witt, Heiko] Tech Univ Munich, Dept Pediat, D-80290 Munich, Germany; [Witt, Heiko] Tech Univ Munich, Else Kroner Fresenius Zentrum Ernahrungsmed EKFZ, Freising Weihenstephan, Germany; [Witt, Heiko] Tech Univ Munich, Zent Inst Ernahrungs & Lebensmittelforsch, Freising Weihenstephan, Germany	Utrecht University; Utrecht University Medical Center; Wilhelmina Kinderziekenhuis; Utrecht University; Utrecht University Medical Center; CHU Brest; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Bretagne Occidentale; Ruprecht Karls University Heidelberg; Technical University of Munich; Technical University of Munich; Technical University of Munich	van der Woerd, WL (corresponding author), Univ Med Ctr Utrecht, Dept Pediat Gastroenterol, Wilhelmina Childrens Hosp, Utrecht, Netherlands.	wwoerd@umcutrecht.nl	Ferec, Claude/ABG-9699-2020	Ferec, Claude/0000-0002-2325-0710; MASSON, Emmanuelle/0000-0001-9777-523X; van de Graaf, Stan/0000-0003-4238-4359	Wilhelmina Children's Hospital Foundation	Wilhelmina Children's Hospital Foundation	This work was supported by a grant from the Wilhelmina Children's Hospital Foundation. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bull LN, 1998, NAT GENET, V18, P219, DOI 10.1038/ng0398-219; Davit-Spraul A, 2010, HEPATOLOGY, V51, P1645, DOI 10.1002/hep.23539; Klomp LWJ, 2004, HEPATOLOGY, V40, P27, DOI 10.1002/hep.20285; Le Marechal C, 2006, NAT GENET, V38, P1372, DOI 10.1038/ng1904; Masson E, 2008, CLIN GASTROENTEROL H, V6, P82, DOI 10.1016/j.cgh.2007.10.004; Mullenbach R, 2005, GUT, V54, P829, DOI 10.1136/gut.2004.058115; Painter JN, 2005, EUR J HUM GENET, V13, P435, DOI 10.1038/sj.ejhg.5201355; Pawlikowska L, 2010, J HEPATOL, V53, P170, DOI 10.1016/j.jhep.2010.01.034; Rosendahl J, 2008, NAT GENET, V40, P78, DOI 10.1038/ng.2007.44; Rosendahl J, 2013, GUT, V62, P582, DOI 10.1136/gutjnl-2011-300645; Stapelbroek JM, 2009, P NATL ACAD SCI USA, V106, P9709, DOI 10.1073/pnas.0807919106; Tygstrup N, 1999, HEPATOLOGY, V29, P506, DOI 10.1002/hep.510290214; van der Woerd WL, 2010, BEST PRACT RES CL GA, V24, P541, DOI 10.1016/j.bpg.2010.07.010; Van Mil SWC, 2004, PEDIATR RES, V56, P981, DOI 10.1203/01.PDR.0000145564.06791.D1; Whitcomb DC, 1996, NAT GENET, V14, P141, DOI 10.1038/ng1096-141; Witt H, 2000, NAT GENET, V25, P213, DOI 10.1038/76088; Witt H, 2010, DIGEST DIS, V28, P702, DOI 10.1159/000324276	17	7	25	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80553	10.1371/journal.pone.0080553	http://dx.doi.org/10.1371/journal.pone.0080553			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260417	gold, Green Submitted, Green Published			2022-12-25	WOS:000327311900069
J	Camacho-Concha, N; Olivos-Ortiz, A; Nunez-Rivera, A; Pedroza-Saavedra, A; Gutierrez-Xicotencatl, L; Rosenstein, Y; Pedraza-Alva, G				Camacho-Concha, Nohemi; Olivos-Ortiz, Amiel; Nunez-Rivera, Alfredo; Pedroza-Saavedra, Adolfo; Gutierrez-Xicotencatl, Lourdes; Rosenstein, Yvonne; Pedraza-Alva, Gustavo			CD43 Promotes Cells Transformation by Preventing Merlin-Mediated Contact Inhibition of Growth	PLOS ONE			English	Article							NF2 TUMOR-SUPPRESSOR; FACTOR RECEPTOR; AKT PHOSPHORYLATION; MESOTHELIOMA CELLS; CYCLE PROGRESSION; BETA-CATENIN; CANCER; EXPRESSION; PROTEIN; MOLECULE	In normal tissues, strict control of tissue size is achieved by regulating cell numbers. The mechanism that controls total cell number is known as contact inhibition of growth and it depends on the NF2/Merlin pathway. Negative regulation of this pathway by deleterious mutations or by oncogenes results in cell transformation and tumor progression. Here we provide evidence that the CD43 sialomucin cooperates with oncogenic signals to promote cell transformation by abrogating the contact inhibition of growth through a molecular mechanism that involves AKT-dependent Merlin phosphorylation and degradation. Accordingly, inhibition of endogenous CD43 expression by RNA interference in lung, cervix and colon human cancer cells impaired tumor growth in vivo. These data underscore a previously unidentified role for CD43 in non-hematopoietic tumor progression.	[Camacho-Concha, Nohemi; Olivos-Ortiz, Amiel; Nunez-Rivera, Alfredo; Rosenstein, Yvonne; Pedraza-Alva, Gustavo] Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico; [Pedroza-Saavedra, Adolfo; Gutierrez-Xicotencatl, Lourdes] Inst Nacl Salud Publ, Ctr Invest Enfermedades Infecciosas, Cuernavaca, Morelos, Mexico	Universidad Nacional Autonoma de Mexico; Instituto Nacional de Salud Publica	Pedraza-Alva, G (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Med Mol & Bioproc, Cuernavaca 62191, Morelos, Mexico.	gustavo@ibt.unam.mx	Gutierrez-Xicotencatl, Lourdes/AFN-8663-2022	Gutierrez-Xicotencatl, Lourdes/0000-0003-1828-0007	CONACYT [42605, 199937, 5118-M, 100275]; DGAPA/UNAM [IN227510, IN206913]	CONACYT(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); DGAPA/UNAM(Universidad Nacional Autonoma de Mexico)	This work was supported by CONACYT Scholarships 42605 to NCC and 199937 to AOO and by grants from CONACYT (5118-M) and DGAPA/UNAM (IN227510) to GPA as well as grants from CONACYT (100275) and DGAPA/UNAM (IN206913) to YR. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson CX, 2005, BIOCHEM J, V387, P377, DOI 10.1042/BJ20041387; Andersson CX, 2004, BIOCHEM BIOPH RES CO, V316, P12, DOI 10.1016/j.bbrc.2004.02.011; BAECKSTROM D, 1991, J BIOL CHEM, V266, P21537; Balikova A, 2012, INT J ONCOL, V41, P299, DOI 10.3892/ijo.2012.1440; Basu S, 2003, MOL CELL, V11, P11, DOI 10.1016/S1097-2765(02)00776-1; Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999; Curto M, 2008, BRIT J CANCER, V98, P256, DOI 10.1038/sj.bjc.6604002; De Laurentiis A, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.007898; Eckstein N, 2008, J BIOL CHEM, V283, P739, DOI 10.1074/jbc.M706287200; Escalante-Alcalde D, 2000, CELL GROWTH DIFFER, V11, P527; Fang XJ, 2000, P NATL ACAD SCI USA, V97, P11960, DOI 10.1073/pnas.220413597; Fernandez-Rodriguez J, 2001, GLYCOCONJUGATE J, V18, P925, DOI 10.1023/A:1022208727512; Fernandez-Rodriguez J, 2002, TUMOR BIOL, V23, P193, DOI 10.1159/000067252; Fu QW, 2013, INT J CANCER, V132, P1761, DOI 10.1002/ijc.27873; Hanahan D, 2011, CELL, V144, P646, DOI 10.1016/j.cell.2011.02.013; Kadaja L, 2004, ONCOGENE, V23, P2523, DOI 10.1038/sj.onc.1207359; Kadaja-Saarepuu L, 2008, ONCOGENE, V27, P1705, DOI 10.1038/sj.onc.1210802; Kley N, 1995, CANCER SURV, V25, P207; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; LOSY J, 1989, J NEUROCYTOL, V18, P71, DOI 10.1007/BF01188425; Mitrovic Z, 2009, CLIN LYMPHOMA MYELOM, V9, P133, DOI 10.3816/CLM.2009.n.033; Moody CA, 2010, NAT REV CANCER, V10, P550, DOI 10.1038/nrc2886; Okada M, 2009, CANCER RES, V69, P4043, DOI 10.1158/0008-5472.CAN-08-3931; Ou WB, 2011, NEOPLASIA, V13, P12, DOI 10.1593/neo.101156; PARK JK, 1991, NATURE, V350, P706, DOI 10.1038/350706a0; Pedraza-Alva G, 1998, J BIOL CHEM, V273, P14218, DOI 10.1074/jbc.273.23.14218; Pedraza-Alva G, 2001, J BIOL CHEM, V276, P729, DOI 10.1074/jbc.M008494200; Pedraza-Alva G., 2007, SIGNAL TRANSDUCT, V7, P372, DOI DOI 10.1002/SITA.200700140; Pedroza-Saavedra A, 2010, VIROLOGY, V400, P44, DOI 10.1016/j.virol.2010.01.009; PEREZ L, 1995, VIROLOGY, V208, P26, DOI 10.1006/viro.1995.1126; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; REMOLDODONNELL E, 1984, J EXP MED, V159, P1705, DOI 10.1084/jem.159.6.1705; Rong R, 2004, ONCOGENE, V23, P8447, DOI 10.1038/sj.onc.1207794; Rossig L, 2001, MOL CELL BIOL, V21, P5644, DOI 10.1128/MCB.21.16.5644-5657.2001; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Saucedo LJ, 2007, NAT REV MOL CELL BIO, V8, P613, DOI 10.1038/nrm2221; Segditsas S, 2006, ONCOGENE, V25, P7531, DOI 10.1038/sj.onc.1210059; Sekido Yoshitaka, 2008, Environmental Health and Preventive Medicine, V13, P65, DOI 10.1007/s12199-007-0015-8; Sekido Y, 2011, PATHOL INT, V61, P331, DOI 10.1111/j.1440-1827.2011.02666.x; Shim C, 1998, CLIN CANCER RES, V4, P3045; Sikut R, 1999, INT J CANCER, V82, P52, DOI 10.1002/(SICI)1097-0215(19990702)82:1<52::AID-IJC10>3.0.CO;2-C; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Thaxton C, 2008, ONCOGENE, V27, P2705, DOI 10.1038/sj.onc.1210923; VELU TJ, 1989, J CELL BIOCHEM, V39, P153, DOI 10.1002/jcb.240390207; Xiao GH, 2005, MOL CELL BIOL, V25, P2384, DOI 10.1128/MCB.25.6.2384-2394.2005; Zhao B, 2007, GENE DEV, V21, P2747, DOI 10.1101/gad.1602907; Zhao B, 2010, GENE DEV, V24, P72, DOI 10.1101/gad.1843810; Zimmer S, 2009, J CANCER RES CLIN, V135, P723, DOI 10.1007/s00432-008-0509-9; Ziprin P, 2004, BIOL CHEM, V385, P755, DOI 10.1515/BC.2004.092	49	12	12	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80806	10.1371/journal.pone.0080806	http://dx.doi.org/10.1371/journal.pone.0080806			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260485	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500177
J	Griewank, KG; Murali, R; Schilling, B; Schimming, T; Moller, I; Moll, I; Schwamborn, M; Sucker, A; Zimmer, L; Schadendorf, D; Hillen, U				Griewank, Klaus G.; Murali, Rajmohan; Schilling, Bastian; Schimming, Tobias; Moeller, Inga; Moll, Iris; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Schadendorf, Dirk; Hillen, Uwe			TERT Promoter Mutations Are Frequent in Cutaneous Basal Cell Carcinoma and Squamous Cell Carcinoma	PLOS ONE			English	Article							NONMELANOMA SKIN-CANCER; HUMAN HOMOLOG; NEVUS SYNDROME; P53 GENE; MELANOMA; SUNLIGHT; EPIDEMIOLOGY; TELOMERES	Activating mutations in the TERT promoter were recently identified in up to 71% of cutaneous melanoma. Subsequent studies found TERT promoter mutations in a wide array of other major human cancers. TERT promoter mutations lead to increased expression of telomerase, which maintains telomere length and genomic stability, thereby allowing cancer cells to continuously divide, avoiding senescence or apoptosis. TERT promoter mutations in cutaneous melanoma often show UV signatures. Non-melanoma skin cancer, including basal cell carcinoma and squamous cell carcinoma, are very frequent malignancies in individuals of European descent. We investigated the presence of TERT promoter mutations in 32 basal cell carcinomas and 34 cutaneous squamous cell carcinomas using conventional Sanger sequencing. TERT promoter mutations were identified in 18 (56%) basal cell carcinomas and in 17 (50%) cutaneous squamous cell carcinomas. The recurrent mutations identified in our cohort were identical to those previously described in cutaneous melanoma, and showed a UV signature (C>T or CC>TT) in line with a causative role for UV exposure in these common cutaneous malignancies. Our study shows that TERT promoter mutations with UV-signatures are frequent in non-melanoma skin cancer, being present in around 50% of basal and squamous cell carcinomas and suggests that increased expression of telomerase plays an important role in the pathogenesis of these tumors.	[Griewank, Klaus G.; Schilling, Bastian; Schimming, Tobias; Moeller, Inga; Moll, Iris; Schwamborn, Marion; Sucker, Antje; Zimmer, Lisa; Schadendorf, Dirk; Hillen, Uwe] Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany; [Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10021 USA; [Murali, Rajmohan] Mem Sloan Kettering Canc Ctr, Human Oncol & Pathogenesis Program, New York, NY 10021 USA	University of Duisburg Essen; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Griewank, KG (corresponding author), Univ Duisburg Essen, Univ Hosp, Dept Dermatol, Essen, Germany.	klaus.griewank@uk-essen.de	Schadendorf, Dirk/AAE-8206-2019; Griewank, Klaus G/A-9097-2017; Schilling, Bastian/AAY-8646-2020; Zimmer, Lisa/AAP-8495-2021; Murali, Rajmohan/A-7960-2008	Griewank, Klaus G/0000-0003-3899-9449; Schilling, Bastian/0000-0001-8859-4103; Zimmer, Lisa/0000-0002-3680-3521; Murali, Rajmohan/0000-0001-6988-4295	Mercur-Stiftung [AN-2012-0040]	Mercur-Stiftung	The presented study was supported by a grant from the Mercur-Stiftung (Grant number AN-2012-0040). http://www.stiftung-mercator.de/en/centres/science-and-humanities/mercator-research-center-ruhr-mercur.html. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam M, 2001, NEW ENGL J MED, V344, P975, DOI 10.1056/NEJM200103293441306; Altshuler DM, 2012, NATURE, V491, P56, DOI 10.1038/nature11632; Aszterbaum M, 1998, J INVEST DERMATOL, V110, P885, DOI 10.1046/j.1523-1747.1998.00222.x; Blackburn EH, 2005, FEBS LETT, V579, P859, DOI 10.1016/j.febslet.2004.11.036; BRASH DE, 1991, P NATL ACAD SCI USA, V88, P10124, DOI 10.1073/pnas.88.22.10124; de Vries E, 2006, WHO CLASSIFICATION T, P52; Epstein EH, 2008, NAT REV CANCER, V8, P743, DOI 10.1038/nrc2503; Gailani MR, 1996, NAT GENET, V14, P78, DOI 10.1038/ng0996-78; Griewank KG, 2013, BRIT J CANCER, V109, P497, DOI 10.1038/bjc.2013.312; Griewank KG, 2013, MOD PATHOL; Gunes C, 2013, CELL, V152, P390, DOI 10.1016/j.cell.2013.01.010; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; Horn S, 2013, SCIENCE, V339, P959, DOI 10.1126/science.1230062; Huang FW, 2013, SCIENCE, V339, P957, DOI 10.1126/science.1229259; Johnson RL, 1996, SCIENCE, V272, P1668, DOI 10.1126/science.272.5268.1668; Killela PJ, 2013, P NATL ACAD SCI US; Kossard S, 2006, WHO CLASSIFICATION T, P13; Landa I, 2013, J CLIN ENDOCRINOL ME; Leiter U, 2008, ADV EXP MED BIOL, V624, P89, DOI 10.1007/978-0-387-77574-6_8; Ling G, 2001, ONCOGENE, V20, P7770, DOI 10.1038/sj.onc.1204946; MILLER DL, 1994, J AM ACAD DERMATOL, V30, P774, DOI 10.1016/S0190-9622(08)81509-5; PIERCEALL WE, 1991, MOL CARCINOGEN, V4, P196, DOI 10.1002/mc.2940040306; Pleasance ED, 2010, NATURE, V463, P191, DOI 10.1038/nature08658; Ratushny V, 2012, J CLIN INVEST, V122, P464, DOI 10.1172/JCI57415; Rubin AI, 2005, NEW ENGL J MED, V353, P2262, DOI 10.1056/NEJMra044151; Scott GA, 2013, MOD PATHOL; Sekulic A, 2012, NEW ENGL J MED, V366, P2171, DOI 10.1056/NEJMoa1113713; Ulrich C, 2004, DERMATOL SURG, V30, P622, DOI 10.1111/j.1524-4725.2004.30147.x; Vinagre J, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms3185; Wang NJ, 2011, P NATL ACAD SCI USA, V108, P17761, DOI 10.1073/pnas.1114669108; Weedon D., 2006, WHO CLASSIFICATION T, P20; Xie JW, 1998, NATURE, V391, P90, DOI 10.1038/34201; ZIEGLER A, 1993, P NATL ACAD SCI USA, V90, P4216, DOI 10.1073/pnas.90.9.4216	33	66	66	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80354	10.1371/journal.pone.0080354	http://dx.doi.org/10.1371/journal.pone.0080354			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260374	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500126
J	Haeberlein, S; Fischer, D; Thomas, SM; Schleicher, U; Beierkuhnlein, C; Bogdan, C				Haeberlein, Simone; Fischer, Dominik; Thomas, Stephanie Margarete; Schleicher, Ulrike; Beierkuhnlein, Carl; Bogdan, Christian			First Assessment for the Presence of Phlebotomine Vectors in Bavaria, Southern Germany, by Combined Distribution Modeling and Field Surveys	PLOS ONE			English	Article							TRANSPHLEBOTOMUS MASCITTII GRASSI; ECOLOGICAL NICHE MODELS; VISCERAL LEISHMANIASIS; CANINE LEISHMANIASIS; CLIMATE-CHANGE; BIOLOGY; SANDFLIES; PSYCHODIDAE; DISPERSAL; DIPTERA	Leishmaniasis is caused by protozoa of the genus Leishmania and transmitted by sand flies from mammalian reservoirs to humans. In recent years, a northward spread of L. infantum from highly endemic Mediterranean countries into previously non-endemic Central European areas has been suspected based on presumed sporadic cases of autochthonous leishmaniasis. Here, we investigated whether sand flies are prevalent in Bavaria in Southern Germany, a federal state in which autochthonous cases have previously been reported. Considering the present and future climatic conditions, we determined whether Bavaria is suitable for five sand fly species with assumed spreading tendencies towards Central Europe: Phlebotomus ariasi, P. neglectus, P. perfiliewi and P. perniciosus that are known vectors for Leishmania in Europe, and P. mascittii, a suspected but not proven vector. Within Bavaria we defined sampling regions based on their climatic suitability and their spatial distance to the sites of the autochthonous cases and/or to areas of reported sand fly detection in states adjacent to Bavaria. At 155 locations in 7 sampling regions, CDC light traps were placed during 38 nights in the summers of 2009 and 2010, resulting in 202 trap-nights. All traps were negative for sand flies. The results suggest that Bavaria is not yet endemic for sand flies, but do not exclude the possibility of sporadic cases of autochthonous human or zoonotic Leishmania infections. This study, which combined methodological approaches from different disciplines, serves as reference for future surveys and risk analyses of sand flies and leishmaniasis in so far non-endemic areas of Europe.	[Haeberlein, Simone; Schleicher, Ulrike; Bogdan, Christian] Univ Erlangen Nurnberg, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany; [Haeberlein, Simone; Schleicher, Ulrike; Bogdan, Christian] Univ Klinikum Erlangen, Erlangen, Germany; [Fischer, Dominik; Thomas, Stephanie Margarete; Beierkuhnlein, Carl] Univ Bayreuth, Dept Biogeog, Bayreuth, Germany	University of Erlangen Nuremberg; University of Erlangen Nuremberg; University of Bayreuth	Bogdan, C (corresponding author), Univ Erlangen Nurnberg, Mikrobiol Inst Klin Mikrobiol Immunol & Hyg, D-91054 Erlangen, Germany.	christian.bogdan@uk-erlangen.de	Beierkuhnlein, Carl/ABF-8797-2021; Haeberlein, Simone/AAM-2685-2020; Beierkuhnlein, Carl/ABF-9693-2021	Beierkuhnlein, Carl/0000-0002-6456-4628; Bogdan, Christian/0000-0002-2300-0631; Thomas, Stephanie Margarete/0000-0003-0507-2006	Bavarian State Ministry of the Environment and Public Health	Bavarian State Ministry of the Environment and Public Health	This study was supported by grants to C. Bogdan (project 6), DF, SMT and C. Beierkuhnlein (project 7) from the 'Bavarian State Ministry of the Environment and Public Health' (website http://www.stmug.bayern.de) within the research consortium "Vector-borne infectious diseases in climate change investigations (VICCI)" coordinated by the 'Bavarian Health and Food Safety Authority', No 08/18. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aspock H, 2007, STARTCLIM2006; Aspock Horst, 2008, Wien Klin Wochenschr, V120, P24, DOI 10.1007/s00508-008-1072-8; Bogdan C, 2001, CLIN INFECT DIS, V32, P302, DOI 10.1086/318476; Boggiatto PM, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001019; Chamaille L, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-31; Dantas-Torres F, 2011, PARASITE VECTOR, V4, DOI 10.1186/1756-3305-4-56; Farkas R, 2011, VECTOR-BORNE ZOONOT, V11, P823, DOI 10.1089/vbz.2010.0186; Fischer D, 2011, PROCEDIA ENVIRON SCI, V7, P164, DOI 10.1016/j.proenv.2011.07.029; Fischer D, 2011, PLOS NEGLECT TROP D, V5, DOI 10.1371/journal.pntd.0001407; Fischer D, 2010, GEOSPATIAL HEALTH, V5, P59, DOI 10.4081/gh.2010.187; Franco AO, 2011, PARASITOLOGY, V138, P1878, DOI 10.1017/S003118201100148X; Galvez R, 2011, VECTOR-BORNE ZOONOT, V11, P799, DOI 10.1089/vbz.2010.0109; Gonzalez C, 2010, PLOS NEGLECT TROP D, V4, DOI 10.1371/journal.pntd.0000585; GOTHE R, 1991, KLEINTIERPRAXIS, V36, P69; GRIMM F, 1993, MED VET ENTOMOL, V7, P170, DOI 10.1111/j.1365-2915.1993.tb00671.x; Harms-Zwingenberger G, 2007, DTSCH ARZTEBL, V104, P3113; Hartemink N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0020817; Killick-Kendrick R, 1999, CLIN DERMATOL, V17, P279, DOI 10.1016/S0738-081X(99)00046-2; Killick-Kendrick R., 1987, Parassitologia (Rome), V29, P181; KILLICKKENDRICK R, 1990, MED VET ENTOMOL, V4, P1, DOI 10.1111/j.1365-2915.1990.tb00255.x; Koehler K, 2002, VET PARASITOL, V109, P9, DOI 10.1016/S0304-4017(02)00246-7; Lozan J, 2008, WARNSIGNAL KLIMA GES, P211; Menn B, 2010, PARASITE VECTOR, V3, DOI 10.1186/1756-3305-3-34; Meyer- Konig U, 2009, NAT S ZOON RES; Naucke TJ, 2008, PARASITOL RES, V103, pS65, DOI 10.1007/s00436-008-1052-y; Naucke TJ, 2000, PARASITOL RES, V86, P335, DOI 10.1007/s004360050053; Naucke TJ, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-67; Naucke TJ, 2011, PARASITOL RES, V109, P1161, DOI 10.1007/s00436-011-2361-0; Peterson AT, 2003, INT J PARASITOL, V33, P919, DOI 10.1016/S0020-7519(03)00094-8; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Ready PD, 2010, EUROSURVEILLANCE, V15, P29; Ready PD, 2013, ANNU REV ENTOMOL, V58, P227, DOI 10.1146/annurev-ento-120811-153557; Rockel B, 2008, METEOROL Z, V17, P347, DOI 10.1127/0941-2948/2008/0309; Solano-Gallego L, 2012, PARASITE VECTOR, V5, DOI 10.1186/1756-3305-5-98; Tanczos B, 2012, VECTOR-BORNE ZOONOT, V12, P588, DOI 10.1089/vbz.2011.0906; Weitzel T, 2005, EUR J CLIN MICROBIOL, V24, P471, DOI 10.1007/s10096-005-1363-1	36	11	11	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e81088	10.1371/journal.pone.0081088	http://dx.doi.org/10.1371/journal.pone.0081088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260539	Green Published, gold			2022-12-25	WOS:000327308500195
J	Ushio, M; Miki, T; Balser, TC				Ushio, Masayuki; Miki, Takeshi; Balser, Teri C.			A Coexisting Fungal-Bacterial Community Stabilizes Soil Decomposition Activity in a Microcosm Experiment	PLOS ONE			English	Article							MICROBIAL COMMUNITY; CLIMATE-CHANGE; ECOSYSTEM PRODUCTIVITY; PLANT DIVERSITY; BIODIVERSITY; NITROGEN; GRASSLAND; FEEDBACK	How diversity influences the stability of a community function is a major question in ecology. However, only limited empirical investigations of the diversity-stability relationship in soil microbial communities have been undertaken, despite the fundamental role of microbial communities in driving carbon and nutrient cycling in terrestrial ecosystems. In this study, we conducted a microcosm experiment to investigate the relationship between microbial diversity and stability of soil decomposition activities against changes in decomposition substrate quality by manipulating microbial community using selective biocides. We found that soil respiration rates and degradation enzyme activities by a coexisting fungal and bacterial community (a taxonomically diverse community) are more stable against changes in substrate quality (plant leaf materials) than those of a fungi-dominated or a bacteria-dominated community (less diverse community). Flexible changes in the microbial community composition and/or physiological state in the coexisting community against changes in substrate quality, as inferred by the soil lipid profile, may be the mechanism underlying this positive diversity-stability relationship. Our experiment demonstrated that the previously found positive diversity-stability relationship could also be valid in the soil microbial community. Our results also imply that the functional/taxonomic diversity and community ecology of soil microbes should be incorporated into the context of climate-ecosystem feedbacks. Changes in substrate quality, which could be induced by climate change, have impacts on decomposition process and carbon dioxide emission from soils, but such impacts may be attenuated by the functional diversity of soil microbial communities.	[Ushio, Masayuki] Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan; [Ushio, Masayuki; Balser, Teri C.] Univ Wisconsin, Dept Soil Sci, Madison, WI 53706 USA; [Miki, Takeshi] Natl Taiwan Univ, Inst Oceanog, Taipei 10764, Taiwan; [Balser, Teri C.] Univ Florida IFAS, Dept Soil & Water Sci, Gainesville, FL USA	Kyoto University; University of Wisconsin System; University of Wisconsin Madison; National Taiwan University; State University System of Florida; University of Florida	Ushio, M (corresponding author), Kyoto Univ, Ctr Ecol Res, Otsu, Shiga, Japan.	ushima@ecology.kyoto-u.ac.jp	Ushio, Masayuki/F-8667-2010; Miki, Takeshi/F-8189-2010	Ushio, Masayuki/0000-0003-4831-7181; Miki, Takeshi/0000-0002-2452-8681	Japan Society for the Promotion of Science (JSPS) [21-1526, 23-586]; Excellent Young Researcher Overseas Visit Program by JSPS	Japan Society for the Promotion of Science (JSPS)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Excellent Young Researcher Overseas Visit Program by JSPS	This study is financially supported by Japan Society for the Promotion of Science (JSPS; grant number 21-1526, 23-586) and the Excellent Young Researcher Overseas Visit Program by JSPS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Agren GI, 2010, NAT GEOSCI, V3, P303, DOI 10.1038/ngeo857; Allison SD, 2011, FUNGAL ECOL, V4, P362, DOI 10.1016/j.funeco.2011.01.003; Allison VJ, 2007, SOIL BIOL BIOCHEM, V39, P1770, DOI 10.1016/j.soilbio.2007.02.006; ANDERSON JM, 1991, ECOL APPL, V1, P326, DOI 10.2307/1941761; Baath E, 2003, SOIL BIOL BIOCHEM, V35, P955, DOI 10.1016/S0038-0717(03)00154-8; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Boyle SA, 2008, SOIL BIOL BIOCHEM, V40, P443, DOI 10.1016/j.soilbio.2007.09.007; DeForest JL, 2009, SOIL BIOL BIOCHEM, V41, P1180, DOI 10.1016/j.soilbio.2009.02.029; Fierer N, 2009, ECOL LETT, V12, P1238, DOI 10.1111/j.1461-0248.2009.01360.x; FROSTEGARD A, 1993, SOIL BIOL BIOCHEM, V25, P723, DOI 10.1016/0038-0717(93)90113-P; Frostegard A, 2011, SOIL BIOL BIOCHEM, V43, P1621, DOI 10.1016/j.soilbio.2010.11.021; German DP, 2011, SOIL BIOL BIOCHEM, V43, P1387, DOI 10.1016/j.soilbio.2011.03.017; Goslee SC, 2007, J STAT SOFTW, V22, P1, DOI 10.18637/jss.v022.i07; Hector A, 1999, SCIENCE, V286, P1123, DOI 10.1126/science.286.5442.1123; Heemsbergen DA, 2004, SCIENCE, V306, P1019, DOI 10.1126/science.1101865; Hol WHG, 2010, ECOL LETT, V13, P292, DOI 10.1111/j.1461-0248.2009.01424.x; Loreau M., 2010, POPULATIONS ECOSYSTE; Manzoni S, 2008, SCIENCE, V321, P684, DOI 10.1126/science.1159792; McGradySteed J, 1997, NATURE, V390, P162, DOI 10.1038/36561; MELILLO JM, 1982, ECOLOGY, V63, P621, DOI 10.2307/1936780; Mentzer JL, 2006, PLANT SOIL, V284, P85, DOI 10.1007/s11104-006-0032-1; Miki T, 2012, ECOL RES, V27, P509, DOI 10.1007/s11284-012-0937-5; Miki T, 2010, P NATL ACAD SCI USA, V107, P14251, DOI 10.1073/pnas.0914281107; Naeem S, 2000, NATURE, V403, P762, DOI 10.1038/35001568; Oksanen J., 2008, VEGAN COMMUNITY ECOL; R DEVELOPMENT CORE TEAM, 2011, R LANG ENV STAT COMP; Ratledge C., 1988, MICROBIAL LIPIDS, V1; Rousk J, 2008, FEMS MICROBIOL ECOL, V63, P350, DOI 10.1111/j.1574-6941.2008.00440.x; Saiya-Cork KR, 2002, SOIL BIOL BIOCHEM, V34, P1309, DOI 10.1016/S0038-0717(02)00074-3; Schimel JP, 2004, ECOLOGY, V85, P591, DOI 10.1890/03-8002; Strickland MS, 2009, ECOLOGY, V90, P441, DOI 10.1890/08-0296.1; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; TILMAN D, 1994, NATURE, V367, P363, DOI 10.1038/367363a0; Tilman D, 2006, NATURE, V441, P629, DOI 10.1038/nature04742; TORSVIK V, 1990, APPL ENVIRON MICROB, V56, P782, DOI 10.1128/AEM.56.3.782-787.1990; Ushio M, 2010, SOIL BIOL BIOCHEM, V42, P1588, DOI 10.1016/j.soilbio.2010.05.035; Wardle DA, 2004, SCIENCE, V304, P1629, DOI 10.1126/science.1094875; Wood SN, 2004, J AM STAT ASSOC, V99, P673, DOI 10.1198/016214504000000980; Yachi S, 1999, P NATL ACAD SCI USA, V96, P1463, DOI 10.1073/pnas.96.4.1463; Yao H, 2000, MICROB ECOL, V40, P223; ZELLES L, 1995, PLANT SOIL, V170, P115, DOI 10.1007/BF02183059	42	14	15	2	63	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80320	10.1371/journal.pone.0080320	http://dx.doi.org/10.1371/journal.pone.0080320			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260368	Green Submitted, Green Published, gold			2022-12-25	WOS:000327308500125
J	Coquerelle, M; Prados-Frutos, JC; Rojo, R; Mitteroecker, P; Bastir, M				Coquerelle, Michael; Carlos Prados-Frutos, Juan; Rojo, Rosa; Mitteroecker, Philipp; Bastir, Markus			Short Faces, Big Tongues: Developmental Origin of the Human Chin	PLOS ONE			English	Article							INFANT GROWTH-PATTERNS; MORPHOLOGY; FETAL; LARYNX; HOMOLOGY; ORIENTATION; INTEGRATION; MODULARITY; ATAPUERCA; EVOLUTION	During the course of human evolution, the retraction of the face underneath the braincase, and closer to the cervical column, has reduced the horizontal dimension of the vocal tract. By contrast, the relative size of the tongue has not been reduced, implying a rearrangement of the space at the back of the vocal tract to allow breathing and swallowing. This may have left a morphological signature such as a chin (mental prominence) that can potentially be interpreted in Homo. Long considered an autopomorphic trait of Homo sapiens, various extinct hominins show different forms of mental prominence. These features may be the evolutionary by-product of equivalent developmental constraints correlated with an enlarged tongue. In order to investigate developmental mechanisms related to this hypothesis, we compare modern 34 human infants against 8 chimpanzee fetuses, whom development of the mandibular symphysis passes through similar stages. The study sets out to test that the shared ontogenetic shape changes of the symphysis observed in both species are driven by the same factor - the space restriction at the back of the vocal tract and the associated arrangement of the tongue and hyoid bone. We apply geometric morphometric methods to extensive three-dimensional anatomical landmarks and semilandmarks configuration, capturing the geometry of the cervico-craniofacial complex including the hyoid bone, tongue muscle and the mandible. We demonstrate that in both species, the forward displacement of the mental region derives from the arrangement of the tongue and hyoid bone, in order to cope with the relative horizontal narrowing of the oral cavity. Because humans and chimpanzees share this pattern of developmental integration, the different forms of mental prominence seen in some extinct hominids likely originate from equivalent ontogenetic constraints. Variations in this process could account for similar morphologies.	[Coquerelle, Michael; Bastir, Markus] CSIC, Museo Nacl Ciencias Nat, Paleoanthropol Grp, E-28006 Madrid, Spain; [Coquerelle, Michael; Carlos Prados-Frutos, Juan; Rojo, Rosa] Univ Rey Juan Carlos, Dept Stomatol, Alcorcon, Spain; [Mitteroecker, Philipp] Univ Vienna, Dept Theoret Biol, Vienna, Austria	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Museo Nacional de Ciencias Naturales (MNCN); Universidad Rey Juan Carlos; University of Vienna	Coquerelle, M (corresponding author), CSIC, Museo Nacl Ciencias Nat, Paleoanthropol Grp, E-28006 Madrid, Spain.	michael.coquerelle@mncn.csic.es	Rojo, Rosa/AAG-9652-2019; Prados-Frutos, Juan-Carlos/J-5193-2019; Mitteroecker, Philipp/A-1591-2012; Rojo, Rosa/Q-2074-2017; Bastir, Markus/G-8987-2013	Rojo, Rosa/0000-0002-7400-902X; Prados-Frutos, Juan-Carlos/0000-0003-1464-0968; Mitteroecker, Philipp/0000-0002-5308-3837; Rojo, Rosa/0000-0002-7400-902X; Coquerelle, Michael/0000-0001-5183-3297; Bastir, Markus/0000-0002-3141-3401	Fyssen-foundation; Catedra Dental Implants and Biomaterials SA; Spanish Ministry of Economy and Competition [CGL-2012-37279]	Fyssen-foundation; Catedra Dental Implants and Biomaterials SA; Spanish Ministry of Economy and Competition(Spanish Government)	Funding provided by Fyssen-foundation http://www.fondationfyssen.fr); Catedra Dental Implants and Biomaterials SA; and the CGL-2012-37279 (Spanish Ministry of Economy and Competition). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ackermann RR, 2005, J HUM EVOL, V48, P175, DOI 10.1016/j.jhevol.2004.11.001; Ackermann RR, 2002, J HUM EVOL, V43, P167, DOI 10.1006/jhev.2002.0569; Aiello L, 1990, INTRO HUMAN EVOLUTIO; ASCENZI A, 1971, ATTI ACCAD NAZ LIN, V50, P763; ASCENZI A, 1971, NATURE, V233, P280, DOI 10.1038/233280a0; Bastir M, 2004, J HUM EVOL, V47, P359, DOI 10.1016/j.jhevol.2004.08.009; Bastir M, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1593; Bookstein F L, 1997, Med Image Anal, V1, P225; Bookstein F. L., 1997, MORPHOMETRIC TOOLS L; Carlsoo S., 1960, T ROY SCH DENT STOCK, V5, P13; Clegg M, 2012, MUSIC LANGUAGE HUMAN, P58, DOI DOI 10.1093/ACPROF:OSOBL/9780199227341.003.0003; Coquerelle M, 2013, J ANAT, V222, P178, DOI 10.1111/joa.12008; Coquerelle M, 2011, AM J PHYS ANTHROPOL, V145, P192, DOI 10.1002/ajpa.21485; Coquerelle M, 2010, J ANAT, V217, P507, DOI 10.1111/j.1469-7580.2010.01287.x; DeBeer, 1958, EMBRYOS ANCESTORS; DuBrul LE, 1954, ADAPTIVE CHIN; DUENHOELTER JH, 1976, AM J OBSTET GYNECOL, V125, P306, DOI 10.1016/0002-9378(76)90564-0; Enlow D. H., 1990, FACIAL GROWTH; FALK D, 1975, AM J PHYS ANTHROPOL, V43, P123, DOI 10.1002/ajpa.1330430116; FRAYER DW, 1993, AM ANTHROPOL, V95, P14, DOI 10.1525/aa.1993.95.1.02a00020; Good P, 2000, PERMUTATION TESTS PR; Goodyear MDE, 2007, BRIT MED J, V335, P624, DOI 10.1136/bmj.39339.610000.BE; Gould S. J., 1977, ONTOGENY PHYLOGENY; Groning F, 2011, AM J PHYS ANTHROPOL, V144, P593, DOI 10.1002/ajpa.21447; Gunz P, 2005, DEV PRIMATOL-PROG PR, P73, DOI 10.1007/0-387-27614-9_3; HOHL TH, 1983, J MAXILLOFAC SURG, V11, P149, DOI 10.1016/S0301-0503(83)80038-1; Hublin J.J., 1981, ASPECTS HUMAN EVOLUT, P167; KURIHARA S, 1980, ANGLE ORTHOD, V50, P98; Lam YM, 1996, AM J PHYS ANTHROPOL, V100, P545; Laubichler MD, 2000, AM ZOOL, V40, P777, DOI 10.1668/0003-1569(2000)040[0777:HIDATD]2.0.CO;2; Le Cabec A, 2012, J HUM EVOL, V63, P667, DOI 10.1016/j.jhevol.2012.07.003; Lieberman DE, 1999, EVOL ANTHROPOL, V7, P142, DOI 10.1002/(SICI)1520-6505(1999)7:4<142::AID-EVAN4>3.0.CO;2-E; Lieberman DE, 2001, ARCH ORAL BIOL, V46, P117, DOI 10.1016/S0003-9969(00)00108-4; LIEBERMAN DE, 1995, CURR ANTHROPOL, V36, P159, DOI 10.1086/204348; Lieberman DE, 2011, EVOLUTION HUMAN HEAD; Lierberman P, 1984, BIOL EVOLUTION LANGU; Mallegni F, 1997, J HUM EVOL, V33, P651, DOI 10.1006/jhev.1997.0159; McCarthy RC, 2001, ANAT REC, V264, P247, DOI 10.1002/ar.1167; Miller JL, 2003, EARLY HUM DEV, V71, P61, DOI 10.1016/S0378-3782(02)00110-X; Milton K, 1999, EVOL ANTHROPOL, V8, P11, DOI 10.1002/(SICI)1520-6505(1999)8:1<11::AID-EVAN6>3.3.CO;2-D; Mitteroecker P, 2004, J HUM EVOL, V46, P679, DOI 10.1016/j.jhevol.2004.03.006; Mitteroecker P, 2008, EVOLUTION, V62, P943, DOI 10.1111/j.1558-5646.2008.00321.x; Mitteroecker P, 2007, SYST BIOL, V56, P818, DOI 10.1080/10635150701648029; Mitteroecker P, 2012, EVOL BIOL, V39, P536, DOI 10.1007/s11692-012-9178-3; Moss M L, 1968, Dent Pract Dent Rec, V19, P65; NEGUS V. E., 1949, COMP ANATOMY PHYSL L; Nishimura T, 2006, COGNITIVE DEVELOPMENT IN CHIMPANZEES, P75, DOI 10.1007/4-431-30248-4_5; PRITCHARD JA, 1966, OBSTET GYNECOL, V28, P606; ROCHE AF, 1965, ANN OTO RHINOL LARYN, V74, P645, DOI 10.1177/000348946507400307; ROHLF FJ, 1990, SYST ZOOL, V39, P40, DOI 10.2307/2992207; Rosas A, 2004, ANAT REC PART A, V278A, P551, DOI 10.1002/ar.a.20049; ROSAS A, 1995, J HUM EVOL, V28, P533, DOI 10.1006/jhev.1995.1041; Schwartz JH, 2000, J HUM EVOL, V38, P367, DOI 10.1006/jhev.1999.0339; SIEBERT JR, 1985, ARCH ORAL BIOL, V30, P433, DOI 10.1016/0003-9969(85)90072-X; Smith F.H., 1984, P137; Stringer C.B., 1984, P51; Tanner JM, 1977, ED PHYS GROWTH; vanSpronsen PH, 1997, EUR J ORTHODONT, V19, P313, DOI 10.1093/ejo/19.3.313; WAGNER GP, 1989, ANNU REV ECOL SYST, V20, P51, DOI 10.1146/annurev.es.20.110189.000411; WESTHORPE RN, 1987, ANAESTH INTENS CARE, V15, P384, DOI 10.1177/0310057X8701500405; Wolpoff M. H, 1980, PALEOANTHROPOLOGY; WOLPOFF MH, 1981, AM J PHYS ANTHROPOL, V54, P499, DOI 10.1002/ajpa.1330540407; Wrangham R, 2010, EVOL ANTHROPOL, V19, P187, DOI 10.1002/evan.20275; Wrangham RW, 1999, CURR ANTHROPOL, V40, P567, DOI 10.1086/300083	64	12	12	0	41	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81287	10.1371/journal.pone.0081287	http://dx.doi.org/10.1371/journal.pone.0081287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260566	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600112
J	Fontana, K; Campos, GER; Staron, RS; da Cruz-Hofling, MA				Fontana, Karina; Campos, Gerson E. R.; Staron, Robert S.; da Cruz-Hoefling, Maria Alice			Effects of Anabolic Steroids and High-Intensity Aerobic Exercise on Skeletal Muscle of Transgenic Mice	PLOS ONE			English	Article							NANDROLONE DECANOATE; ANDROGENIC STEROIDS; MYOSIN ISOFORMS; TESTOSTERONE; FIBERS; EXPRESSION; MORPHOLOGY; ENDURANCE; STRENGTH; HORMONE	In an attempt to shorten recovery time and improve performance, strength and endurance athletes occasionally turn to the illicit use of anabolic-androgenic steroids (AAS). This study evaluated the effects of AAS treatment on the muscle mass and phenotypic characteristics of transgenic mice subjected to a high-intensity, aerobic training program (5d/wk for 6 weeks). The transgenic mice (CETP+/-LDLr-/+) were engineered to exhibit a lipid profile closer to humans. Animals were divided into groups of sedentary (Sed) and/or training (Ex) mice (each treated orally with AAS or gum arabic/vehicle: Sed-C, Sed-M, ex-C, ex-M). The effects of AAS (mesterolone: M) on specific phenotypic adaptations (muscle wet weight, cross-sectional area, and fiber type composition) in three hindlimb muscles (soleus: SOL, tibialis anterior: TA and gastrocnemius: GAS) were assessed. In order to detect subtle changes in fiber type profile, the entire range of fiber types (I, IC, IIAC, IIA, IIAD, IID, IIDB, IIB) was delineated using mATPase histochemistry. Body weight gain occurred throughout the study for all groups. However, the body weight gain was significantly minimized with exercise. This effect was blunted with mesterolone treatment. Both AAS treatment (Sed-M) and high-intensity, aerobic training (ex-C) increased the wet weights of all three muscles and induced differential hypertrophy of pure and hybrid fibers. Combination of AAS and training (ex-M) resulted in enhanced hypertrophy. In the SOL, mesterolone treatment (Sed-M and ex-M) caused dramatic increases in the percentages of fiber types IC, IIAC, IIAD, IID, with concomitant decrease in IIA, but had minimal impact on fiber type percentages in the predominantly fast muscles. Overall, the AAS-induced differential adaptive changes amounted to significant fiber type transformations in the fast-to-slow direction in SOL. AAS treatment had a significant effect on muscle weights and fiber type composition in SOL, TA and GAS which was even maximized in animals subjected to metabolically high-intensity aerobic exercise.	[Fontana, Karina] Univ Estadual Campinas, Fac Med Sci, Dept Pharmacol, Campinas, Brazil; [Fontana, Karina; da Cruz-Hoefling, Maria Alice] Univ Estadual Campinas, Inst Biol, Dept Histol & Embryol, Campinas, Brazil; [Campos, Gerson E. R.] Univ Estadual Campinas, Inst Biol, Dept Biol Estrutural & Func, Campinas, Brazil; [Staron, Robert S.] Ohio Univ, Dept Biomed Sci, Heritage Coll Osteopath Med, Athens, OH 45701 USA	Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; Universidade de Sao Paulo; Universidade Estadual de Campinas; University System of Ohio; Ohio University	da Cruz-Hofling, MA (corresponding author), Univ Estadual Campinas, Inst Biol, Dept Histol & Embryol, Campinas, Brazil.	hofling@unicamp.br			Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [Proc. 04/13767-9]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico [Proc. 522131/95-6]; FAPESP at the Departamento de Farmacologia, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas [04/13768-5]	Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); FAPESP at the Departamento de Farmacologia, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas	This work was supported by grants from Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (Proc. 04/13767-9) and Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Proc. 522131/95-6). KF was a PhD student granted with a scholarship from FAPESP (Proc. 04/13768-5) at the Departamento de Farmacologia, Faculdade de Ciencias Medicas, Universidade Estadual de Campinas. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Always SE, 1994, J STRENGTH COND RES, V8, P161, DOI [10.1519/00124278-199408000-00007, DOI 10.1519/00124278-199408000-00007]; Bahrke MS, 2004, CURR OPIN PHARMACOL, V4, P614, DOI 10.1016/j.coph.2004.05.006; Basaria S, 2001, J CLIN ENDOCR METAB, V86, P5108, DOI 10.1210/jc.86.11.5108; Berti JA, 2001, THYROID HORMONE INCR; Bhasin S, 1996, NEW ENGL J MED, V335, P1, DOI 10.1056/nejm199607043350101; Bisschop A, 1997, J APPL PHYSIOL, V82, P1112, DOI 10.1152/jappl.1997.82.4.1112; BROOKE MH, 1970, J HISTOCHEM CYTOCHEM, V18, P670, DOI 10.1177/18.9.670; Casquero AC, 2006, J LIPID RES, V47, P1526, DOI 10.1194/jlr.M600135-JLR200; Codipilly CN, 2006, J AM COLL NUTR, V25, P307, DOI 10.1080/07315724.2006.10719540; Cunha TS, 2006, ENDOCRINOL METAB, V50, P532; DANHAIVE PA, 1986, J STEROID BIOCHEM, V24, P481, DOI 10.1016/0022-4731(86)90109-3; DIMAURO J, 1992, EUR J APPL PHYSIOL O, V64, P204, DOI 10.1007/BF00626282; EGGINTON S, 1987, PFLUG ARCH EUR J PHY, V410, P349, DOI 10.1007/BF00586510; Eriksson A, 2005, HISTOCHEM CELL BIOL, V124, P167, DOI 10.1007/s00418-005-0029-5; Fontana K, 2008, HISTOL HISTOPATHOL, V23, P1367, DOI 10.14670/HH-23.1367; Fontana K, 2008, INT J EXP PATHOL, V89, P358, DOI 10.1111/j.1365-2613.2008.00601.x; Fontana K, 2010, J ELECTRON MICROSC, V59, P153, DOI 10.1093/jmicro/dfp053; Gentile MA, 2010, J MOL ENDOCRINOL, V44, P55, DOI 10.1677/JME-09-0048; Gondim FJ, 2005, CAN J VET RES, V69, P46; GRIGGS RC, 1989, J APPL PHYSIOL, V66, P498, DOI 10.1152/jappl.1989.66.1.498; Gustafsson J A, 1984, Prog Clin Biol Res, V142, P261; GUTH L, 1970, EXP NEUROL, V28, P365, DOI 10.1016/0014-4886(70)90244-X; Hartgens F, 2004, SPORTS MED, V34, P513, DOI 10.2165/00007256-200434080-00003; Hartgens F, 2002, EUR J APPL PHYSIOL, V86, P233, DOI 10.1007/s00421-001-0535-7; HAUPT HA, 1984, AM J SPORT MED, V12, P469, DOI 10.1177/036354658401200613; Hikim IS, 2002, AM J PHYSIOL-ENDOC M, V283, pE154, DOI 10.1152/ajpendo.00502.2001; HOLMANG A, 1990, AM J PHYSIOL, V259, pE555, DOI 10.1152/ajpendo.1990.259.4.E555; Isayama Ricardo Noboro, 2006, Brazilian Journal of Morphological Sciences, V23, P247; Joumaa WH, 2002, ACTA PHYSIOL SCAND, V175, P189, DOI 10.1046/j.1365-201X.2002.00988.x; Joumaa WH, 2001, MED SCI SPORT EXER, V33, P397, DOI 10.1097/00005768-200103000-00011; Kadi F, 1999, MED SCI SPORT EXER, V31, P1528, DOI 10.1097/00005768-199911000-00006; Kadi F, 2000, Acta Physiol Scand Suppl, V646, P1; KUHN FE, 1985, J APPL PHYSIOL, V59, P24, DOI 10.1152/jappl.1985.59.1.24; KUNG AWC, 1995, CLIN CHEM, V41, P226; Maravelias C, 2005, TOXICOL LETT, V158, P167, DOI 10.1016/j.toxlet.2005.06.005; Noirez P, 2000, EUR J APPL PHYSIOL O, V81, P155, DOI 10.1007/PL00013789; Pette D, 2000, MICROSC RES TECHNIQ, V50, P500, DOI 10.1002/1097-0029(20000915)50:6<500::AID-JEMT7>3.0.CO;2-7; Pette D, 1990, Rev Physiol Biochem Pharmacol, V116, P1; PREZANT DJ, 1993, J APPL PHYSIOL, V75, P1140, DOI 10.1152/jappl.1993.75.3.1140; ROGOZKIN V, 1979, MED SCI SPORT EXER, V11, P160; SALMONS S, 1992, MUSCLE NERVE, V15, P806, DOI 10.1002/mus.880150709; SCHIAFFINO S, 1994, J APPL PHYSIOL, V77, P493, DOI 10.1152/jappl.1994.77.2.493; Sheffield-Moore M, 2000, ANN MED, V32, P181, DOI 10.3109/07853890008998825; Sinha-Hikim I, 2003, AM J PHYSIOL-ENDOC M, V285, pE197, DOI 10.1152/ajpendo.00370.2002; Smolka MB, 2000, AM J PHYSIOL-REG I, V279, pR1539, DOI 10.1152/ajpregu.2000.279.5.R1539; STARON RS, 1992, J HISTOCHEM CYTOCHEM, V40, P563, DOI 10.1177/40.4.1552189; STARON RS, 1993, HISTOCHEMISTRY, V100, P149, DOI 10.1007/BF00572901; VANZYL CG, 1995, MED SCI SPORT EXER, V27, P1385; WILSON JD, 1988, ENDOCR REV, V9, P181, DOI 10.1210/edrv-9-2-181	49	9	9	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80909	10.1371/journal.pone.0080909	http://dx.doi.org/10.1371/journal.pone.0080909			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260508	gold, Green Published, Green Submitted			2022-12-25	WOS:000327258600096
J	Campolongo, P; Ratano, P; Ciotti, MT; Florenzano, F; Nori, SL; Marolda, R; Palmery, M; Rinaldi, AM; Zona, C; Possenti, R; Calissano, P; Severini, C				Campolongo, Patrizia; Ratano, Patrizia; Ciotti, Maria Teresa; Florenzano, Fulvio; Nori, Stefania Lucia; Marolda, Roberta; Palmery, Maura; Rinaldi, Anna Maria; Zona, Cristina; Possenti, Roberta; Calissano, Pietro; Severini, Cinzia			Systemic Administration of Substance P Recovers Beta Amyloid-Induced Cognitive Deficits in Rat: Involvement of Kv Potassium Channels	PLOS ONE			English	Article							EPISODIC-LIKE MEMORY; ALZHEIMERS-DISEASE; CEREBELLAR GRANULE; IN-VIVO; NEURAL MECHANISMS; MAZE PERFORMANCE; MESSENGER-RNA; WATER MAZE; PEPTIDE; PRECURSOR	Reduced levels of Substance P (SP), an endogenous neuropeptide endowed with neuroprotective and anti-apoptotic properties, have been found in brain and spinal fluid of Alzheimer's disease (AD) patients. Potassium (K+) channel dysfunction is implicated in AD development and the amyloid-beta (A beta)-induced up-regulation of voltage-gated potassium channel subunits could be considered a significant step in A beta brain toxicity. The aim of this study was to evaluate whether SP could reduce, in vivo, A beta-induced overexpression of Kv subunits. Rats were intracerebroventricularly infused with amyloid-beta 25-35 (A beta(25-35), 20 mu g) peptide. SP (50 mu g/Kg, i.p.) was daily administered, for 7 days starting from the day of the surgery. Here we demonstrate that the A beta infused rats showed impairment in cognitive performances in the Morris water maze task 4 weeks after A beta(25-35) infusion and that this impairing effect was prevented by SP administration. Kv1.4, Kv2.1 and Kv4.2 subunit levels were quantified in hippocampus and in cerebral cortex by Western blot analysis and immunofluorescence. Interestingly, SP reduced Kv1.4 levels overexpressed by A beta, both in hippocampus and cerebral cortex. Our findings provide in vivo evidence for a neuroprotective activity of systemic administration of SP in a rat model of AD and suggest a possible mechanism underlying this effect.	[Campolongo, Patrizia; Ratano, Patrizia; Palmery, Maura] Sapienza Univ Rome, Dept Physiol & Pharmacol, Rome, Italy; [Ciotti, Maria Teresa; Florenzano, Fulvio; Marolda, Roberta; Severini, Cinzia] CNR, Inst Cell Biol & Neurobiol, Rome, Italy; [Florenzano, Fulvio; Calissano, Pietro] European Brain Res Inst, Rome, Italy; [Nori, Stefania Lucia] Univ Salerno Med Campus, Dept Med & Surg, Baronissi, SA, Italy; [Rinaldi, Anna Maria; Zona, Cristina; Possenti, Roberta] Univ Roma Tor Vergata, Dept Neurosci, Rome, Italy; [Zona, Cristina] IRCCS Fdn Santa Lucia, Rome, Italy	Sapienza University Rome; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biologia Cellulare e Neurobiologia (IBCN-CNR); University of Rome Tor Vergata; IRCCS Santa Lucia	Severini, C (corresponding author), CNR, Inst Cell Biol & Neurobiol, Rome, Italy.	c.severini@inmm.cnr.it	Severini, Cinzia/AAX-3569-2020; Zona, Cristina/K-5079-2014; Campolongo, Patrizia/D-4628-2009	Severini, Cinzia/0000-0002-6932-704X; Campolongo, Patrizia/0000-0002-2827-8755; Ratano, Patrizia/0000-0002-2714-0447	Italian Ministry of Higher Education and Scientific Research, IT (FIRB Fututo in Ricerca) [RBFR10XKHS_003, RBAP10L8TY_004]; PNR-CNR Aging Program; Fondazione Roma	Italian Ministry of Higher Education and Scientific Research, IT (FIRB Fututo in Ricerca); PNR-CNR Aging Program; Fondazione Roma(Fondazione RomaEuropean Commission)	This work was supported by a grant from the Italian Ministry of Higher Education and Scientific Research, IT (FIRB Fututo in Ricerca 2010-2012, RBFR10XKHS_003, and RBAP10L8TY_004), from PNR-CNR Aging Program 2012-2014 and from Fondazione Roma. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alkon DL, 1999, J NEUROSCI RES, V58, P24; Amadoro G, 2007, NEUROPHARMACOLOGY, V52, P1366, DOI 10.1016/j.neuropharm.2007.01.020; Blunck R, 2012, FRONT PHARMACOL, V3, DOI 10.3389/fphar.2012.00166; Campolongo P, 2009, P NATL ACAD SCI USA, V106, P8027, DOI 10.1073/pnas.0903038106; Chappa AK, 2006, PHARM RES-DORDR, V23, P1201, DOI 10.1007/s11095-006-0068-1; Choi E, 2007, MOL PHARMACOL, V72, P499, DOI 10.1124/mol.107.039206; Culmsee C, 2002, NEUROSCIENCE, V115, P1089, DOI 10.1016/S0306-4522(02)00539-0; D'Hooge R, 2001, BRAIN RES REV, V36, P60, DOI 10.1016/S0165-0173(01)00067-4; de Silva HA, 1998, LANCET, V352, P1590, DOI 10.1016/S0140-6736(98)03200-0; Delobette S, 1997, EUR J PHARMACOL, V319, P1, DOI 10.1016/S0014-2999(96)00922-3; Espinosa A, 2013, J ALZHEIMERS DIS, V34, P769, DOI 10.3233/JAD-122002; ETCHEBERRIGARAY R, 1993, P NATL ACAD SCI USA, V90, P8209, DOI 10.1073/pnas.90.17.8209; Furukawa K, 1996, NATURE, V379, P74, DOI 10.1038/379074a0; Gruden MA, 2007, J NEUROIMMUNOL, V186, P181, DOI 10.1016/j.jneuroim.2007.03.023; HARDY JA, 1992, SCIENCE, V256, P184, DOI 10.1126/science.1566067; HASENOHRL RU, 1990, PSYCHOPHARMACOLOGY, V101, P23, DOI 10.1007/BF02253712; HASENOHRL RU, 1994, BEHAV NEURAL BIOL, V62, P110, DOI 10.1016/S0163-1047(05)80032-9; Hasenohrl RU, 2000, NEUROPEPTIDES, V34, P272, DOI 10.1054/npep.2000.0824; HUSTON JP, 1989, NEUROSCI BIOBEHAV R, V13, P171, DOI 10.1016/S0149-7634(89)80027-2; IKEDA M, 1991, BRAIN RES, V567, P51, DOI 10.1016/0006-8993(91)91434-3; Jimenez-Corral C, 2006, REV NEUROLOGIA, V42, P354, DOI 10.33588/rn.4206.2005222; Kaneko I, 2001, NEUROSCIENCE, V104, P1003, DOI 10.1016/S0306-4522(01)00155-5; Kawas Claudia H., 2006, Current Alzheimer Research, V3, P411, DOI 10.2174/156720506779025233; Kertes E, 2009, BEHAV BRAIN RES, V198, P397, DOI 10.1016/j.bbr.2008.11.021; Koistinaho M, 2001, P NATL ACAD SCI USA, V98, P14675, DOI 10.1073/pnas.261562998; Kourrich S, 2001, BEHAV BRAIN RES, V120, P35, DOI 10.1016/S0166-4328(00)00356-9; KOWALL NW, 1991, P NATL ACAD SCI USA, V88, P7247, DOI 10.1073/pnas.88.16.7247; Kubo T, 2002, J NEUROSCI RES, V70, P474, DOI 10.1002/jnr.10391; Lallemend F, 2003, J NEUROCHEM, V87, P508, DOI 10.1046/j.1471-4159.2003.02014.x; Liu XM, 2011, NEUROCHEM RES, V36, P1896, DOI 10.1007/s11064-011-0511-5; Marolda R, 2012, NEUROPHARMACOLOGY, V62, P1954, DOI 10.1016/j.neuropharm.2011.12.025; Maurice T, 1996, BRAIN RES, V731, P249, DOI 10.1016/S0006-8993(96)00710-X; Meiri N, 1997, P NATL ACAD SCI USA, V94, P4430, DOI 10.1073/pnas.94.9.4430; Morris RGM, 2001, PHILOS T R SOC B, V356, P1453, DOI 10.1098/rstb.2001.0945; Nistico R, 2012, MOL NEUROBIOL, V46, P572, DOI 10.1007/s12035-012-8324-3; Pan YP, 2004, J NEUROSCI RES, V77, P94, DOI 10.1002/jnr.20134; Pannaccione A, 2007, MOL PHARMACOL, V72, P665, DOI 10.1124/mol.107.034868; Pannaccione A, 2005, J NEUROCHEM, V94, P572, DOI 10.1111/j.1471-4159.2005.03075.x; Pieri M, 2010, NEUROPHARMACOLOGY, V58, P268, DOI 10.1016/j.neuropharm.2009.06.029; PIKE CJ, 1995, J NEUROCHEM, V64, P253, DOI 10.1046/j.1471-4159.1995.64010253.x; PIKE CJ, 1993, J NEUROSCI, V13, P1676; Plant LD, 2006, NEUROBIOL AGING, V27, P1673, DOI 10.1016/j.neurobiolaging.2005.09.038; Poulopoulou C, 2010, NEUROBIOL DIS, V37, P339, DOI 10.1016/j.nbd.2009.10.012; QUIGLEY BJ, 1991, NEUROSCIENCE, V41, P41, DOI 10.1016/0306-4522(91)90199-X; Raffa RB, 1998, NEUROSCI BIOBEHAV R, V22, P789, DOI 10.1016/S0149-7634(97)00070-5; Ramsden M, 2001, J NEUROCHEM, V79, P699, DOI 10.1046/j.1471-4159.2001.00618.x; Richardson JC, 2003, NEUROSCIENCE, V122, P213, DOI 10.1016/S0306-4522(03)00389-0; Roozendaal B, 2003, P NATL ACAD SCI USA, V100, P1328, DOI 10.1073/pnas.0337480100; Salthun-Lassalle B, 2005, MOL PHARMACOL, V68, P1214, DOI 10.1124/mol.105.015453; Savonenko A, 2005, NEUROBIOL DIS, V18, P602, DOI 10.1016/j.nbd.2004.10.022; SELKOE DJ, 1989, CELL, V58, P611, DOI 10.1016/0092-8674(89)90093-7; Severini C, 2002, PHARMACOL REV, V54, P285, DOI 10.1124/pr.54.2.285; Severini C, 2006, CEREBELLUM, V5, P232, DOI 10.1080/14734220600673295; Sexton CE, 2010, PSYCHIAT RES-NEUROIM, V184, P57, DOI 10.1016/j.pscychresns.2010.07.005; Sprick U, 1996, PEPTIDES, V17, P275, DOI 10.1016/0196-9781(95)02105-1; Waters SM, 1997, ANN NY ACAD SCI, V814, P30, DOI 10.1111/j.1749-6632.1997.tb46142.x; Watson C, 2006, RAT BRAIN STEREOTAXI; Yu SP, 1997, SCIENCE, V278, P114, DOI 10.1126/science.278.5335.114; Yu SP, 2003, PROG NEUROBIOL, V70, P363, DOI 10.1016/S0301-0082(03)00090-X; Zhang W, 2012, FREE RADICAL BIO MED, V52, P1443, DOI 10.1016/j.freeradbiomed.2012.01.023; Zhou MF, 2004, BRAIN RES, V999, P142, DOI 10.1016/j.brainres.2003.10.068; Zussy C, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053117; Zussy C, 2011, AM J PATHOL, V179, P315, DOI 10.1016/j.ajpath.2011.03.021	63	23	23	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78036	10.1371/journal.pone.0078036	http://dx.doi.org/10.1371/journal.pone.0078036			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265678	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100011
J	Hawley, CA; Watson, CA; Orth, K; Krachler, AM				Hawley, Catherine Alice; Watson, Charlie Anne; Orth, Kim; Krachler, Anne Marie			A MAM7 Peptide-Based Inhibitor of Staphylococcus aureus Adhesion Does Not Interfere with In Vitro Host Cell Function	PLOS ONE			English	Article							STREPTOCOCCUS-PYOGENES; MOLECULE 7; FIBRONECTIN; F1; BINDING; MATRIX; PROTEIN	Adhesion inhibitors that block the attachment of pathogens to host tissues may be used synergistically with or as an alternative to antibiotics. The wide-spread bacterial adhesin Multivalent Adhesion Molecule (MAM) 7 has recently emerged as a candidate molecule for a broad-spectrum adhesion inhibitor which may be used to prevent bacterial colonization of wounds. Here we have tested if the antibacterial properties of a MAM-based inhibitor could be used to competitively inhibit adhesion of methicillin-resistant Staphylococcus aureus (MRSA) to host cells. Additionally, we analyzed its effect on host cellular functions linked to the host receptor fibronectin, such as migration, adhesion and matrix formation in vitro, to evaluate potential side effects prior to advancing our studies to in vivo infection models. As controls, we used inhibitors based on well-characterized bacterial adhesin-derived peptides from F1 and FnBPA, which are known to affect host cellular functions. Inhibitors based on F1 or FnBPA blocked MRSA attachment but at the same time abrogated important cellular functions. A MAM7-based inhibitor did not interfere with host cell function while showing good efficacy against MRSA adhesion in a tissue culture model. These observations provide a possible candidate for a bacterial adhesion inhibitor that does not cause adverse effects on host cells while preventing bacterial infection.	[Hawley, Catherine Alice; Watson, Charlie Anne; Krachler, Anne Marie] Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England; [Orth, Kim] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, Dallas, TX 75390 USA	University of Birmingham; University of Texas System; University of Texas Southwestern Medical Center Dallas	Krachler, AM (corresponding author), Univ Birmingham, Inst Microbiol & Infect, Birmingham, W Midlands, England.	a.krachler@bham.ac.uk	Krachler, Anne-Marie/C-8645-2014; Orth, Kim/AAV-4421-2021	Orth, Kim/0000-0002-0678-7620; Krachler, Anne Marie/0000-0002-0936-0016	Birmingham Fellowship; European Molecular Biology Organization (EMBO) [ALTF 938-2011]; NIH-Allergy and Infectious Disease [R01-AI056404, R01-AI087808, R21-AI096133]; Welch Foundation [I-1561]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI096133, R01AI087808, R01AI056404] Funding Source: NIH RePORTER	Birmingham Fellowship; European Molecular Biology Organization (EMBO)(European Molecular Biology Organization (EMBO)); NIH-Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Welch Foundation(The Welch Foundation); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	C.A.H., C.W. and A.M.K. are supported by a Birmingham Fellowship (http://www.birmingham.ac.uk/staff/excellence/fellows/about/index.aspx) and A.M.K. is supported by a European Molecular Biology Organization (EMBO) Fellowship (ALTF 938-2011, http://www.embo.org/). K.O. is supported by grants from NIH-Allergy and Infectious Disease (R01-AI056404, R01-AI087808 and R21-AI096133, http://www.nih.gov/) and the Welch Foundation (I-1561, http://www.welch1.org/). K.O. is a Burroughs Wellcome Investigator in Pathogenesis of Infectious Disease (http://www.bwfund.org/) and a W.W. Caruth Jr. Biomedical Scholar. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Bingham RJ, 2008, P NATL ACAD SCI USA, V105, P12254, DOI 10.1073/pnas.0803556105; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; Chiang HY, 2009, ARTERIOSCL THROM VAS, V29, P1074, DOI 10.1161/ATVBAHA.108.181081; Dryden M, 2008, SURG INFECT, V9, pS3, DOI 10.1089/sur.2008.066.supp; Edwards AM, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018899; Edwards AM, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000964; Ensenberger MG, 2001, J BIOL CHEM, V276, P35606, DOI 10.1074/jbc.M105417200; Fry DE, 2013, AM SURGEON, V79, P1; GRINNELL F, 1984, J CELL BIOCHEM, V26, P107, DOI 10.1002/jcb.240260206; Hanski E, 1996, ADV EXP MED BIOL, V408, P141; Harrison P., 1998, ANTIMICROBIAL RESIST; Hospenthal DR, 2011, J TRAUMA, V71, pS52, DOI 10.1097/TA.0b013e31822118fb; HOTCHIN NA, 1995, J CELL BIOL, V128, P1209, DOI 10.1083/jcb.128.6.1209; Jadoun J, 1998, J INFECT DIS, V178, P147, DOI 10.1086/515589; Krachler AM, 2012, VIRULENCE, V3, P389, DOI 10.4161/viru.20816; Krachler AM, 2012, VIRULENCE, V3, P68, DOI 10.4161/viru.3.1.18172; Krachler AM, 2011, J BIOL CHEM, V286, P38939, DOI 10.1074/jbc.M111.291377; Krachler AM, 2011, P NATL ACAD SCI USA, V108, P11614, DOI 10.1073/pnas.1102360108; Meenan NAG, 2007, J BIOL CHEM, V282, P25893, DOI 10.1074/jbc.M703063200; MENZIES BE, 2002, J INFECTION, DOI DOI 10.1086/339484.PUBMED:11920318; Pankov R, 2002, J CELL SCI, V115, P3861, DOI 10.1242/jcs.00059; Pereira M, 2002, J CELL SCI, V115, P609; RAJA RH, 1990, INFECT IMMUN, V58, P2593, DOI 10.1128/IAI.58.8.2593-2598.1990; Rasko DA, 2010, NAT REV DRUG DISCOV, V9, P117, DOI 10.1038/nrd3013; Sasaki T, 1996, J CELL SCI, V109, P2895; Shi F, 2010, AM J PHYSIOL-CELL PH, V298, pC1265, DOI 10.1152/ajpcell.00341.2009; Singh P, 2010, ANNU REV CELL DEV BI, V26, P397, DOI 10.1146/annurev-cellbio-100109-104020; Tomasini-Johansson BR, 2012, MATRIX BIOL, V31, P360, DOI 10.1016/j.matbio.2012.07.003; Tomasini-Johansson BR, 2001, J BIOL CHEM, V276, P23430, DOI 10.1074/jbc.M103467200	29	16	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e81216	10.1371/journal.pone.0081216	http://dx.doi.org/10.1371/journal.pone.0081216			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265842	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100178
J	Li, S; Dong, GY; Moschidis, A; Ortiz, J; Benakanakere, MR; Kinane, DF; Graves, DT				Li, Shuai; Dong, Guangyu; Moschidis, Anastasios; Ortiz, Javier; Benakanakere, Manjunatha R.; Kinane, Denis F.; Graves, Dana T.			P-gingivalis Modulates Keratinocytes through FOXO Transcription Factors	PLOS ONE			English	Article							EPITHELIAL-CELLS; IN-VITRO; FIBROBLAST APOPTOSIS; EXPRESSION; GINGIPAIN; BACTERIA; DEGRADATION; MECHANISM; INFECTION; PROTEINS	P. gingivalis is a prominent periodontal pathogen that has potent effects on host cells. In this study we challenged gingival epithelial cells with P. gingivalis with the aim of assessing how mRNA levels of key target genes were modulated by P. gingivalis via the transcription factors FOXO1 and FOXO3. Primary mono- and multi-layer cultures of gingival epithelial cells were challenged and barrier function was examined by fluorescent dextran and apoptosis was measured by cytoplasmic histone associated DNA. Gene expression levels were measured by real-time PCR with and without FOXO1 and FOXO3 siRNA compared to scrambled siRNA. P. gingivalis induced a loss of barrier function and stimulated gingival epithelial cell apoptosis in multilayer cultures that was in part gingipain dependent. P. gingivalis stimulated an increase in FOXO1 and FOXO3 mRNA, enhanced mRNA levels of genes associated with differentiated keratinocyte function (keratin-1, -10, -14, and involucrin), increased mRNA levels of apoptotic genes (BID and TRADD), reduced mRNA levels of genes that regulate inflammation (TLR-2 and -4) and reduced those associated with barrier function (integrin beta-1, -3 and -6). The ability of P. gingivalis to modulate these genes was predominantly FOXO1 and FOXO3 dependent. The results indicate that P. gingivalis has pronounced effects on gingival keratinocytes and modulates mRNA levels of genes that affect host response, differentiation, apoptosis and barrier function. Moreover, this modulation is dependent upon the transcription factors FOXO1 or FOXO3. In addition, a new function for FOXO1 was identified, that of suppressing TLR-2 and TLR-4 and maintaining integrin beta -1, beta -3 and beta -6 basal mRNA levels in keratinocytes.	[Li, Shuai] Peking Univ, Dept Implant Dent, Sch & Hosp Stomatol, Beijing 100871, Peoples R China; [Li, Shuai; Dong, Guangyu; Benakanakere, Manjunatha R.; Kinane, Denis F.; Graves, Dana T.] Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA; [Li, Shuai; Dong, Guangyu; Benakanakere, Manjunatha R.; Kinane, Denis F.; Graves, Dana T.] Univ Penn, Sch Dent Med, Dept Periodont, Philadelphia, PA 19104 USA; [Moschidis, Anastasios; Ortiz, Javier] Boston Univ, Sch Dent Med, Dept Periodontol & Oral Biol, Boston, MA 02215 USA	Peking University; University of Pennsylvania; University of Pennsylvania; Boston University	Graves, DT (corresponding author), Univ Penn, Sch Dent Med, Dept Pathol, Philadelphia, PA 19104 USA.	dtgraves@dental.upenn.edu			NIDCR [DE018307, DE019108]; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE018307] Funding Source: NIH RePORTER	NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	This work was supported by funding from the NIDCR DE018307 and DE019108. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alikhani M, 2005, J BIOL CHEM, V280, P12096, DOI 10.1074/jbc.M412171200; Andrian E, 2004, INFECT IMMUN, V72, P4689, DOI 10.1128/IAI.72.8.4689-4698.2004; Bayounis AMA, 2011, J CLIN PERIODONTOL, V38, P754, DOI 10.1111/j.1600-051X.2011.01735.x; Benakanakere MR, 2009, J BIOL CHEM, V284, P23107, DOI 10.1074/jbc.M109.013862; Bragulla HH, 2009, J ANAT, V214, P516, DOI 10.1111/j.1469-7580.2009.01066.x; Brozovic S, 2006, MICROBIOL-SGM, V152, P797, DOI 10.1099/mic.0.28472-0; Darveau RP, 1998, INFECT IMMUN, V66, P1660, DOI 10.1128/IAI.66.4.1660-1665.1998; Dejean AS, 2011, ANTIOXID REDOX SIGN, V14, P663, DOI 10.1089/ars.2010.3414; Desta T, 2007, CELL MICROBIOL, V9, P2667, DOI 10.1111/j.1462-5822.2007.00987.x; Dickinson BC, 2011, MOL ORAL MICROBIOL, V26, P210, DOI 10.1111/j.2041-1014.2011.00609.x; DZINK JL, 1988, J CLIN PERIODONTOL, V15, P316, DOI 10.1111/j.1600-051X.1988.tb01590.x; Graves DT, 2011, J DENT RES, V90, P143, DOI 10.1177/0022034510385236; Groeger S, 2010, EUR J ORAL SCI, V118, P582, DOI 10.1111/j.1600-0722.2010.00782.x; Guo YH, 2010, PERIODONTOL 2000, V54, P15, DOI 10.1111/j.1600-0757.2010.00377.x; Hansson A, 2003, EUR J ORAL SCI, V111, P34, DOI 10.1034/j.1600-0722.2003.00010.x; Houle MA, 2003, FEMS MICROBIOL LETT, V221, P181, DOI 10.1016/S0378-1097(03)00178-2; Katz J, 2000, INFECT IMMUN, V68, P1441, DOI 10.1128/IAI.68.3.1441-1449.2000; Kikkert R, 2007, ORAL MICROBIOL IMMUN, V22, P145, DOI 10.1111/j.1399-302X.2007.00335.x; Kinane DF, 2008, FRONT BIOSCI-LANDMRK, V13, P966, DOI 10.2741/2736; Kuboniwa M, 2008, MICROBES INFECT, V10, P122, DOI 10.1016/j.micinf.2007.10.011; LAMONT RJ, 1995, INFECT IMMUN, V63, P3878, DOI 10.1128/IAI.63.10.3878-3885.1995; Larjava H, 2011, J DENT RES, V90, P1367, DOI 10.1177/0022034511402207; Liu AY, 2002, J INVEST DERMATOL, V118, P275, DOI 10.1046/j.0022-202x.2001.01651.x; Maiese K, 2009, ADV EXP MED BIOL, V665, P242; Nakhjiri SF, 2001, FEMS MICROBIOL LETT, V200, P145, DOI 10.1111/j.1574-6968.2001.tb10706.x; Nobbs AH, 2009, MICROBIOL MOL BIOL R, V73, P407, DOI 10.1128/MMBR.00014-09; ODA D, 1990, IN VITRO CELL DEV B, V26, P589; PAN YM, 1995, J PERIODONTAL RES, V30, P97, DOI 10.1111/j.1600-0765.1995.tb01258.x; Papaioannou W, 1999, J PERIODONTOL, V70, P668, DOI 10.1902/jop.1999.70.6.668; Ponugoti B, 2012, EXP DIABETES RES, DOI 10.1155/2012/939751; Presland Richard B, 2002, J Dent Educ, V66, P564; Rouabhia M, 2002, BIOCHEM CELL BIOL, V80, P189, DOI 10.1139/O01-237; SANDROS J, 1994, J PERIODONTAL RES, V29, P62, DOI 10.1111/j.1600-0765.1994.tb01092.x; Stathopoulou PG, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-107; van der Vos KE, 2008, ONCOGENE, V27, P2289, DOI 10.1038/onc.2008.22; Yu SL, 2012, ARTHRITIS RES THER, V14, DOI 10.1186/ar3803	36	24	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78541	10.1371/journal.pone.0078541	http://dx.doi.org/10.1371/journal.pone.0078541			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265696	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100029
J	Maaroufi, H; Tanguay, RM				Maaroufi, Halim; Tanguay, Robert M.			Analysis and Phylogeny of Small Heat Shock Proteins from Marine Viruses and Their Cyanobacteria Host	PLOS ONE			English	Article							EVOLUTION; SYNECHOCOCCUS; DOMAIN; CORE; T4	Small heat shock proteins (sHSPs) are oligomeric stress proteins characterized by an a-crystallin domain (ACD) surrounded by a N-terminal arm and C-terminal extension. Publications on sHSPs have reported that they exist in prokaryotes and eukaryotes but, to our knowledge, not in viruses. Here we show that sHSPs are present in some cyanophages that infect the marine unicellular cyanobacteria, Synechococcus and Prochlorococcus. These phage sHSPs contain a conserved ACD flanked by a relatively conserved N-terminal arm and a short C-terminal extension with or without the conserved C-terminal anchoring module (CAM) L-X-I/V, suggested to be implicated in the oligomerization. In addition, cyanophage sHSPs have the signature pattern, P-P-[YF]-N-[ILV]-[IV]-x(9)-[EQ], in the predicted beta 2 and beta 3 strands of the ACD. Phylogenetically, cyanophage sHSPs form a monophyletic clade closer to bacterial class A sHSPs than to cyanobacterial sHSPs. Furthermore, three sHSPs from their cellular host, Synechococcus, are phylogenetically close to plants sHSPs. Implications of evolutionary relationships between the sHSPs of cyanophages, bacterial class A, cyanobacteria, and plants are discussed.	[Maaroufi, Halim] Univ Laval, Plateforme Bioinformat, Quebec City, PQ G1K 7P4, Canada; [Maaroufi, Halim] Univ Laval, Inst Biol Integrat & Syst, Quebec City, PQ G1K 7P4, Canada; [Tanguay, Robert M.] Univ Laval, Dept Mol Biol Med Biochem & Pathol, Lab Cellular & Dev Genet, IBIS, Quebec City, PQ G1K 7P4, Canada; [Tanguay, Robert M.] Univ Laval, PROTEO, Quebec City, PQ G1K 7P4, Canada	Laval University; Laval University; Laval University; Laval University	Maaroufi, H (corresponding author), Univ Laval, Plateforme Bioinformat, Quebec City, PQ G1K 7P4, Canada.	halim.maaroufi@ibis.ulaval.ca		Maaroufi, Halim/0000-0002-3026-5339	NSERC (RMT) [3526-2011]	NSERC (RMT)	This work was partly funded by a grant from NSERC (RMT, 3526-2011). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Basha E, 2012, TRENDS BIOCHEM SCI, V37, P106, DOI 10.1016/j.tibs.2011.11.005; Fu XM, 2006, BIOCHEMISTRY-MOSCOW+, V71, pS83, DOI 10.1134/S0006297906130141; Fu XM, 2006, J MOL EVOL, V62, P257, DOI 10.1007/s00239-005-0076-5; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; Guindon S, 2010, SYST BIOL, V59, P307, DOI 10.1093/sysbio/syq010; Hambly E, 2001, P NATL ACAD SCI USA, V98, P11411, DOI 10.1073/pnas.191174498; Haslbeck M, 2005, NAT STRUCT MOL BIOL, V12, P842, DOI 10.1038/nsmb993; Ignacio-Espinoza JC, 2012, ENVIRON MICROBIOL, V14, P2113, DOI 10.1111/j.1462-2920.2012.02704.x; Jaya N, 2009, P NATL ACAD SCI USA, V106, P15604, DOI 10.1073/pnas.0902177106; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Kappe Guido, 2002, Prog Mol Subcell Biol, V28, P1; Kawabata T, 2003, NUCLEIC ACIDS RES, V31, P3367, DOI 10.1093/nar/gkg581; Kriehuber T, 2010, FASEB J, V24, P3633, DOI 10.1096/fj.10-156992; Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460; Lindell D, 2004, P NATL ACAD SCI USA, V101, P11013, DOI 10.1073/pnas.0401526101; Mann NH, 2005, J BACTERIOL, V187, P3188, DOI 10.1128/JB.187.9.3188-3200.2005; Millard AD, 2006, J MAR BIOL ASSOC UK, V86, P507, DOI 10.1017/S0025315406013415; OREJUELA D, 2007, CELL STRESS PROTEINS, P143; Poulain P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009990; Roy A, 2010, NAT PROTOC, V5, P725, DOI 10.1038/nprot.2010.5; Schopf JW, 2006, PHILOS T R SOC B, V361, P869, DOI 10.1098/rstb.2006.1834; Stamler R, 2005, J MOL BIOL, V353, P68, DOI 10.1016/j.jmb.2005.08.025; Sullivan MB, 2010, ENVIRON MICROBIOL, V12, P3035, DOI 10.1111/j.1462-2920.2010.02280.x; Sullivan MB, 2005, PLOS BIOL, V3, P790, DOI 10.1371/journal.pbio.0030144; Sullivan MB, 2003, NATURE, V424, P1047, DOI 10.1038/nature01929; Sun Y, 2005, FEBS J, V272, P2613, DOI 10.1111/j.1742-4658.2005.04708.x; Suttle CA, 2007, NAT REV MICROBIOL, V5, P801, DOI 10.1038/nrmicro1750; Takeda K, 2011, J STRUCT BIOL, V174, P92, DOI 10.1016/j.jsb.2010.12.006; van Montfort RLM, 2001, NAT STRUCT BIOL, V8, P1025, DOI 10.1038/nsb722; Waters ER, 1996, J EXP BOT, V47, P325, DOI 10.1093/jxb/47.3.325; Wommack KE, 2000, MICROBIOL MOL BIOL R, V64, P69, DOI 10.1128/MMBR.64.1.69-114.2000; Zwirglmaier K, 2008, ENVIRON MICROBIOL, V10, P147, DOI 10.1111/j.1462-2920.2007.01440.x	32	39	42	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e81207	10.1371/journal.pone.0081207	http://dx.doi.org/10.1371/journal.pone.0081207			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265841	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100177
J	Ambrose, C; DeBono, A; Wasteneys, G				Ambrose, Chris; DeBono, Allan; Wasteneys, Geoffrey			Cell Geometry Guides the Dynamic Targeting of Apoplastic GPI-Linked Lipid Transfer Protein to Cell Wall Elements and Cell Borders in Arabidopsis thaliana	PLOS ONE			English	Article							CORTICAL MICROTUBULES; EPIDERMAL-CELLS; MORPHOGENESIS; GROWTH; COMPENSATION; ORGANIZATION; SEPARATION; VECTOR; EXPORT; ACTIN	During cellular morphogenesis, changes in cell shape and cell junction topology are fundamental to normal tissue and organ development. Here we show that apoplastic Glycophosphatidylinositol (GPI)-anchored Lipid Transfer Protein (LTPG) is excluded from cell junctions and flat wall regions, and passively accumulates around their borders in the epidermal cells of Arabidopsis thaliana. Beginning with intense accumulation beneath highly curved cell junction borders, this enrichment is gradually lost as cells become more bulbous during their differentiation. In fully mature epidermal cells, YFP-LTPG often shows a fibrous cellulose microfibril-like pattern within the bulging outer faces. Physical contact between a flat glass surface and bulbous cell surface induces rapid and reversible evacuation from contact sites and accumulation to the curved wall regions surrounding the contact borders. Thus, LTPG distribution is dynamic, responding to changes in cell shape and wall curvature during cell growth and differentiation. We hypothesize that this geometry-based mechanism guides wax-carrying LTPG to functional sites, where it may act to "seal" the vulnerable border surrounding cell-cell junctions and assist in cell wall fortification and cuticular wax deposition.	[Ambrose, Chris; DeBono, Allan; Wasteneys, Geoffrey] Univ British Columbia, Dept Bot, Vancouver, BC, Canada; [DeBono, Allan] Univ British Columbia, Beaty Biodivers Res Ctr, Vancouver, BC, Canada	University of British Columbia; University of British Columbia	Wasteneys, G (corresponding author), Univ British Columbia, Dept Bot, Vancouver, BC, Canada.	geoffrey.wasteneys@ubc.ca	Wasteneys, Geoffrey/AGQ-5388-2022	Wasteneys, Geoffrey/0000-0002-8746-7994; debono, allan/0000-0003-1460-1037; Chris, Ambrose/0000-0003-2234-7075	Natural Sciences and Engineering Research Council [298264-2009]; Canadian Institutes of Health Research; Canada Foundation for Innovation; University of British Columbia Bioimaging Facility;  [MOP-86675]	Natural Sciences and Engineering Research Council(Natural Sciences and Engineering Research Council of Canada (NSERC)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); University of British Columbia Bioimaging Facility; 	Funding for this work was obtained through Natural Sciences and Engineering Research Council Discovery grant 298264-2009, Canadian Institutes of Health Research. Operating grant MOP-86675 and the Canada Foundation for Innovation to GW and through the University of British Columbia Bioimaging Facility. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ambrose C, 2011, NAT COMMUN, V2, DOI 10.1038/ncomms1444; Ambrose JC, 2007, PLANT CELL, V19, P2763, DOI 10.1105/tpc.107.053777; Avery GS, 1933, AM J BOT, V20, P565, DOI 10.2307/2436259; Basu D, 2005, PLANT CELL, V17, P502, DOI 10.1105/tpc.104.027987; CLARK CA, 1976, PHYTOPATHOLOGY, V66, P1279, DOI 10.1094/Phyto-66-1279; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cosgrove DJ, 2005, NAT REV MOL CELL BIO, V6, P850, DOI 10.1038/nrm1746; Crowell EF, 2011, PLANT CELL, V23, P2592, DOI 10.1105/tpc.111.087338; Curtis MD, 2003, PLANT PHYSIOL, V133, P462, DOI 10.1104/pp.103.027979; DeBono A, 2009, PLANT CELL, V21, P1230, DOI 10.1105/tpc.108.064451; Edstam MM, 2011, MOL PLANT, V4, P947, DOI 10.1093/mp/ssr019; Esau K., 1977, ANATOMY SEED PLANTS; Espinosa HD, 2009, PROG MATER SCI, V54, P1059, DOI 10.1016/j.pmatsci.2009.05.001; Estevez JM, 2006, PLANT PHYSIOL, V142, P458, DOI 10.1104/pp.106.084244; Fujita M, 2011, PLANT J, V66, P915, DOI 10.1111/j.1365-313X.2011.04552.x; Galatis B, 2004, NEW PHYTOL, V161, P613, DOI 10.1046/j.1469-8137.2003.00986.x; Gumaste KS, 2007, MATER STRUCT, V40, P241, DOI 10.1617/s11527-006-9141-9; Hellens RP, 2000, PLANT MOL BIOL, V42, P819, DOI 10.1023/A:1006496308160; Jarvis MC, 1998, PLANT CELL ENVIRON, V21, P1307, DOI 10.1046/j.1365-3040.1998.00363.x; JEFFREE CE, 1986, PROTOPLASMA, V132, P90, DOI 10.1007/BF01275795; Kervrann C, 2004, J MICROSC-OXFORD, V214, P297, DOI 10.1111/j.0022-2720.2004.01333.x; Kim H, 2012, PLANT CELL PHYSIOL, V53, P1391, DOI 10.1093/pcp/pcs083; Kirik V, 2007, J CELL SCI, V120, P4416, DOI 10.1242/jcs.024950; KNOX JP, 1992, PLANT J, V2, P137, DOI 10.1111/j.1365-313X.1992.00137.x; Kotzer AM, 2006, CAN J BOT, V84, P594, DOI 10.1139/B06-023; Lee SB, 2009, PLANT PHYSIOL, V150, P42, DOI 10.1104/pp.109.137745; Panteris E, 2005, NEW PHYTOL, V167, P721, DOI 10.1111/j.1469-8137.2005.01464.x; PREECE TF, 1967, PLANT PATHOL, V16, P117, DOI 10.1111/j.1365-3059.1967.tb00383.x; Rahman A, 2007, PLANT J, V50, P514, DOI 10.1111/j.1365-313X.2007.03068.x; Schneider K, 1997, DEVELOPMENT, V124, P1789; SIFTON HB, 1945, BOT REV, V11, P108, DOI 10.1007/BF02861138; Watson R. W., 1942, NEW PHYTOL, V41, P223, DOI 10.1111/j.1469-8137.1942.tb07075.x; Whittington AT, 2001, NATURE, V411, P610, DOI 10.1038/35079128; Wu HX, 2005, J MICROSC-OXFORD, V220, P9, DOI 10.1111/j.1365-2818.2005.01508.x	34	25	26	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e81215	10.1371/journal.pone.0081215	http://dx.doi.org/10.1371/journal.pone.0081215			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260561	Green Published, Green Submitted, gold			2022-12-25	WOS:000327216200118
J	Dockal, M; Hartmann, R; Fries, M; Thomassen, MCLGD; Heinzmann, A; Ehrlich, H; Rosing, J; Osterkamp, F; Polakowski, T; Reineke, U; Griessner, A; Brandstetter, H; Scheiflinger, F				Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Thomassen, M. Christella L. G. D.; Heinzmann, Alexandra; Ehrlich, Hartmut; Rosing, Jan; Osterkamp, Frank; Polakowski, Thomas; Reineke, Ulrich; Griessner, Andreas; Brandstetter, Hans; Scheiflinger, Friedrich			Small Peptides Blocking Inhibition of Factor Xa and Tissue Factor-Factor VIIa by Tissue Factor Pathway Inhibitor (TFPI)	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Coagulation Factors; Crystal Structure; Enzyme Inhibitors; Hemostasis; Peptide Interactions; Peptides; Protein Domains	PROTEIN-S; COAGULATION INHIBITOR; MACROMOLECULAR STRUCTURES; THROMBIN GENERATION; KUNITZ DOMAIN; HEMOPHILIA-A; PLASMA; MAINTENANCE; REFINEMENT; DISORDERS	Background: Tissue factor pathway inhibitor (TFPI) inhibits coagulation factors Xa and VIIa. Results: A de novo synthesized 20-mer peptide that binds to TFPI was structurally and functionally characterized. Conclusion: The peptide binds to the Kunitz domain 1 of TFPI and blocks inhibition of factor Xa and factor VIIa by TFPI. Significance: The peptide can potentially prevent bleeding in hemophilia patients. Tissue factor pathway inhibitor (TFPI) is a Kunitz-type protease inhibitor that inhibits activated factor X (FXa) via a slow-tight binding mechanism and tissue factor-activated FVII (TF-FVIIa) via formation of a quaternary FXa-TFPI-TF-FVIIa complex. Inhibition of TFPI enhances coagulation in hemophilia models. Using a library approach, we selected and subsequently optimized peptides that bind TFPI and block its anticoagulant activity. One peptide (termed compound 3), bound with high affinity to the Kunitz-1 (K1) domain of TFPI (K-d approximate to 1 nm). We solved the crystal structure of this peptide in complex with the K1 of TFPI at 2.55- resolution. The structure of compound 3 can be segmented into a N-terminal anchor; an -shaped loop; an intermediate segment; a tight glycine-loop; and a C-terminal -helix that is anchored to K1 at its reactive center loop and two-stranded -sheet. The contact surface has an overall hydrophobic character with some charged hot spots. In a model system, compound 3 blocked FXa inhibition by TFPI (EC50 = 11 nm) and inhibition of TF-FVIIa-catalyzed FX activation by TFPI (EC50 = 2 nm). The peptide prevented transition from the loose to the tight FXa-TFPI complex, but did not affect formation of the loose FXa-TFPI complex. The K1 domain of TFPI binds and inhibits FVIIa and the K2 domain similarly inhibits FXa. Because compound 3 binds to K1, our data show that K1 is not only important for FVIIa inhibition but also for FXa inhibition, i.e. for the transition of the loose to the tight FXa-TFPI complex. This mode of action translates into normalization of coagulation of hemophilia plasmas. Compound 3 thus bears potential to prevent bleeding in hemophilia patients.	[Dockal, Michael; Hartmann, Rudolf; Fries, Markus; Ehrlich, Hartmut; Scheiflinger, Friedrich] Baxter Innovat GmbH, A-2304 Orth, Austria; [Thomassen, M. Christella L. G. D.; Heinzmann, Alexandra; Rosing, Jan] Maastricht Univ, Dept Biochem, Cardiovasc Res Inst Maastricht, NL-6229 ER Maastricht, Netherlands; [Osterkamp, Frank; Polakowski, Thomas; Reineke, Ulrich] 3B Pharmaceut GmbH, D-12489 Berlin, Germany; [Griessner, Andreas; Brandstetter, Hans] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria	Baxter International Inc; Baxter Innovations GmbH; Maastricht University; Salzburg University	Dockal, M (corresponding author), Baxter Innovat GmbH, Uferstr 15, A-2304 Orth, Austria.	Michael_dockal@baxter.com	Scheiflinger, Friedrich/AAO-6307-2020; Brandstetter, Hans/E-6754-2011	Brandstetter, Hans/0000-0002-6089-3045; Thomassen, Stella/0000-0002-9686-6364				Andrejasic M, 2008, ACTA CRYSTALLOGR D, V64, P1093, DOI 10.1107/S0907444908027388; Ariens RAS, 1999, THROMB HAEMOSTASIS, V81, P203; BROZE GJ, 1988, BLOOD, V71, P335; Brunger AT, 2007, NAT PROTOC, V2, P2728, DOI 10.1038/nprot.2007.406; Burgering MJM, 1997, J MOL BIOL, V269, P395, DOI 10.1006/jmbi.1997.1029; Chan WC, 2000, FMOC SOLID PHASE PEP; Dahm A, 2003, BLOOD, V101, P4387, DOI 10.1182/blood-2002-10-3188; Duckers C, 2008, BLOOD, V112, P3615, DOI 10.1182/blood-2008-06-162453; Emsley P, 2010, ACTA CRYSTALLOGR D, V66, P486, DOI 10.1107/S0907444910007493; ERHARDTSEN E, 1995, BLOOD COAGUL FIBRIN, V6, P388, DOI 10.1097/00001721-199507000-00004; Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693; GIRARD TJ, 1993, METHOD ENZYMOL, V222, P195; GIRARD TJ, 1989, NATURE, V338, P518, DOI 10.1038/338518a0; Hackeng TM, 2006, P NATL ACAD SCI USA, V103, P3106, DOI 10.1073/pnas.0504240103; Hedner U, 2008, ANNU REV MED, V59, P29, DOI 10.1146/annurev.med.59.061606.095605; Hemker HC, 2003, PATHOPHYSIOL HAEMO T, V33, P4, DOI 10.1159/000071636; HIGUCHI DA, 1992, BLOOD, V79, P1712; Hilden I, 2012, BLOOD, V119, P5871, DOI 10.1182/blood-2012-01-401620; HUANG ZF, 1993, J BIOL CHEM, V268, P26950; JESTY J, 1973, BIOCHEM J, V131, P791, DOI 10.1042/bj1310791; Knappe S, 2013, THROMB HAEMOSTASIS, V109, P450, DOI 10.1160/TH12-07-0529; Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107; LINDHOUT T, 1994, BIOCHEM J, V297, P131, DOI 10.1042/bj2970131; Liu TY, 2006, THROMB HAEMOSTASIS, V95, P68, DOI 10.1160/TH05-05-0361; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Mine S, 2002, BIOCHEMISTRY-US, V41, P78, DOI 10.1021/bi011299g; MORRISON JF, 1988, ADV ENZYMOL RAMB, V61, P201; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Ndonwi M, 2008, J THROMB HAEMOST, V6, P1044, DOI 10.1111/j.1538-7836.2008.02980.x; Ndonwi M, 2010, BLOOD, V116, P1344, DOI 10.1182/blood-2009-10-246686; Palige M, 2010, BLOOD, V116, P4417; Peraramelli S, 2012, THROMB HAEMOSTASIS, V108, P266, DOI 10.1160/TH11-12-0902; Petersen LC, 1996, EUR J BIOCHEM, V235, P310, DOI 10.1111/j.1432-1033.1996.0310f.x; Prasad S, 2008, BLOOD, V111, P672, DOI 10.1182/blood-2007-07-098913; Sere KM, 2004, BLOOD, V104, P3624, DOI 10.1182/blood-2004-03-1146; Sichler K, 2002, FEBS LETT, V530, P220, DOI 10.1016/S0014-5793(02)03495-6; VALENTIN S, 1993, BLOOD COAGUL FIBRIN, V4, P713, DOI 10.1097/00001721-199304050-00007; Waters EK, 2013, J THROMB HAEMOST, V11, P1137, DOI 10.1111/jth.12201; Waters EK, 2011, BLOOD, V117, P5514, DOI 10.1182/blood-2010-10-311936; WESSELSCHMIDT R, 1992, BLOOD, V79, P2004; WUN TC, 1988, J BIOL CHEM, V263, P6001; Zhang Z., 2013, THROMB HAEMOST, DOI 10.1160/TH13-08-0635; Zogg T, 2011, PROG MOL BIOL TRANSL, V99, P51, DOI 10.1016/B978-0-12-385504-6.00002-6	43	37	43	0	8	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 17	2014	289	3					1732	1741		10.1074/jbc.M113.533836	http://dx.doi.org/10.1074/jbc.M113.533836			10	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	AC3FS	24275667	Green Published, hybrid			2022-12-25	WOS:000332401700044
J	Lee, JM; Gang, GT; Kim, DK; Kim, YD; Koo, SH; Lee, CH; Choi, HS				Lee, Ji-Min; Gang, Gil-Tae; Kim, Don-Kyu; Kim, Yong Deuk; Koo, Seung-Hoi; Lee, Chul-Ho; Choi, Hueng-Sik			Ursodeoxycholic Acid Inhibits Liver X Receptor alpha-mediated Hepatic Lipogenesis via Induction of the Nuclear Corepressor SMILE	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							BILE-ACIDS; LXR-ALPHA; CHENODEOXYCHOLIC ACID; BINDING PROTEIN; ACTIVATION; TRANSCRIPTION; HETERODIMER; INTERACTS; PATHWAY; ELEMENT	Small heterodimer partner interacting leucine zipper protein (SMILE) has been identified as a nuclear corepressor of the nuclear receptor (NRs) family. Here, we examined the role of SMILE in the regulation of nuclear receptor liver X receptor (LXR alpha)-mediated sterol regulatory element binding protein-1c (SREBP-1c) gene expression. We found that SMILE inhibited T0901317 (T7)-induced transcriptional activity of LXR alpha, which functions as a major regulator of lipid metabolism by inducing SREBP-1c, fatty acid synthase (FAS), and acetyl-CoA carboxylase (ACC) gene expression. Moreover, we demonstrated that SMILE physically interacts with LXR alpha and represses T7-induced LXR alpha transcriptional activity by competing with coactivator SRC-1. Adenoviral overexpression of SMILE (Ad-SMILE) attenuated fat accumulation and lipogenic gene induction in the liver of T7 administered or of high fat diet (HFD)-fed mice. Furthermore, we investigated the mechanism by which ursodeoxycholic acid (UDCA) inhibits LXR alpha-induced lipogenic gene expression. Interestingly, UDCA treatment significantly increased SMILE promoter activity and gene expression in an adenosine monophosphate-activated kinase-dependent manner. Furthermore, UDCA treatment repressed T7-induced SREBP-1c, FAS, and ACC protein levels, whereas knockdown of endogenous SMILE gene expression by adenovirus SMILE shRNA (Ad-shSMILE) significantly reversed UDCA-mediated repression of SREBP-1c, FAS, and ACC protein levels. Collectively, these results demonstrate that UDCA activates SMILE gene expression through adenosine monophosphate-activated kinase phosphorylation, which leads to repression of LXR alpha-mediated hepatic lipogenic enzyme gene expression.	[Lee, Ji-Min; Kim, Don-Kyu; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Natl Creat Res Initiat Ctr Nucl Receptor Signals, Kwangju 500757, South Korea; [Lee, Ji-Min; Kim, Don-Kyu; Kim, Yong Deuk; Choi, Hueng-Sik] Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea; [Gang, Gil-Tae; Lee, Chul-Ho] Korea Res Inst Biosci & Biotechnol, Taejon 305806, South Korea; [Koo, Seung-Hoi] Korea Univ, Div Life Sci, Coll Life Sci & Biotechnol, Seoul 136713, South Korea; [Choi, Hueng-Sik] Chonnam Natl Univ, Res Inst Med Sci, Dept Biomed Sci, Sch Med, Kwangju 501746, South Korea	Chonnam National University; Chonnam National University; Korea Research Institute of Bioscience & Biotechnology (KRIBB); Korea University; Chonnam National University	Choi, HS (corresponding author), Chonnam Natl Univ, Hormone Res Ctr, Sch Biol Sci & Technol, Kwangju 500757, South Korea.	hsc@chonnam.ac.kr	Koo, Seung-Hoi/E-2763-2015	Koo, Seung-Hoi/0000-0001-8769-2879	National Creative Research Initiatives through the National Research Foundation of Korea (NRF) [20110018305]; Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF) [20100019512]; Korean government (Ministry of Science, ICT & Future Planning); National Research Foundation of Korea [NRF-2012M3A9B6055345, NRF-2010-0019513]; Ministry of Science, ICT & Future Planning, Republic of Korea	National Creative Research Initiatives through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Future-based Technology Development Program (BIO Fields) through the National Research Foundation of Korea (NRF)(National Research Foundation of Korea); Korean government (Ministry of Science, ICT & Future Planning)(Ministry of Science, ICT & Future Planning, Republic of Korea); National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Science, ICT & Future Planning, Republic of Korea(Ministry of Science, ICT & Future Planning, Republic of Korea)	This work was supported in part by National Creative Research Initiatives Grant 20110018305 and Future-based Technology Development Program (BIO Fields) Grant 20100019512 through the National Research Foundation of Korea (NRF) funded by the Korean government (Ministry of Science, ICT & Future Planning).; Supported by National Research Foundation of Korea Grants NRF-2012M3A9B6055345 and NRF-2010-0019513 and the Ministry of Science, ICT & Future Planning, Republic of Korea.	Angulo Paul, 2002, Curr Gastroenterol Rep, V4, P37, DOI 10.1007/s11894-002-0036-9; Arisawa S, 2009, BIOCHEM PHARMACOL, V77, P858, DOI 10.1016/j.bcp.2008.11.012; Auboeuf D, 1997, DIABETES, V46, P1319, DOI 10.2337/diabetes.46.8.1319; Beuers U, 1998, HEPATOLOGY, V28, P1449, DOI 10.1002/hep.510280601; Brendel C, 2002, MOL ENDOCRINOL, V16, P2065, DOI 10.1210/me.2001-0194; Copaci Ionel, 2005, Rom J Gastroenterol, V14, P259; Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018; Gbaguidi GF, 2004, NUCLEIC ACIDS RES, V32, P1113, DOI 10.1093/nar/gkh260; Grefhorst A, 2002, J BIOL CHEM, V277, P34182, DOI 10.1074/jbc.M204887200; Heery DM, 2001, J BIOL CHEM, V276, P6695, DOI 10.1074/jbc.M009404200; Heitzer MD, 2007, REV ENDOCR METAB DIS, V8, P321, DOI 10.1007/s11154-007-9059-8; Hogan MR, 2006, FEBS LETT, V580, P58, DOI 10.1016/j.febslet.2005.11.046; Huuskonen J, 2004, ARTERIOSCL THROM VAS, V24, P703, DOI 10.1161/01.ATV.0000121202.72593.da; Janowski BA, 1999, P NATL ACAD SCI USA, V96, P266, DOI 10.1073/pnas.96.1.266; Kay HY, 2011, ANTIOXID REDOX SIGN, V15, P2135, DOI 10.1089/ars.2010.3834; Lee JH, 2012, MOL CELL BIOCHEM, V368, P147, DOI 10.1007/s11010-012-1353-4; Lepage G, 1997, J PEDIATR-US, V130, P52, DOI 10.1016/S0022-3476(97)70310-X; Li X, 2007, MOL CELL, V28, P91, DOI 10.1016/j.molcel.2007.07.032; Li Y, 2002, MOL ENDOCRINOL, V16, P506, DOI 10.1210/me.16.3.506; Lopez-Mateo I, 2012, CELL CYCLE, V11, P3887, DOI 10.4161/cc.22133; Lu R, 2000, NUCLEIC ACIDS RES, V28, P2446, DOI 10.1093/nar/28.12.2446; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; Misra J, 2011, J BIOL CHEM, V286, P41972, DOI 10.1074/jbc.M111.274514; Nedumaran B, 2010, J BIOL CHEM, V285, P9221, DOI 10.1074/jbc.M109.073650; Ozcan U, 2006, SCIENCE, V313, P1137, DOI 10.1126/science.1128294; Omata M, 2007, GUT, V56, P1747, DOI 10.1136/gut.2007.120956; POUPON R, 1995, PHARMACOL THERAPEUT, V66, P1, DOI 10.1016/0163-7258(94)00073-C; Ratziu V, 2011, J HEPATOL, V54, P1011, DOI 10.1016/j.jhep.2010.08.030; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Schoemaker MH, 2004, HEPATOLOGY, V39, P1563, DOI 10.1002/hep.20246; SCHOENFIELD LJ, 1981, ANN INTERN MED, V95, P257, DOI 10.7326/0003-4819-95-3-257; Schultz JR, 2000, GENE DEV, V14, P2831, DOI 10.1101/gad.850400; Talukdar S, 2007, J LIPID RES, V48, P2647, DOI 10.1194/jlr.M700189-JLR200; TEBOUL M, 1995, P NATL ACAD SCI USA, V92, P2096, DOI 10.1073/pnas.92.6.2096; Timsit YE, 2007, STEROIDS, V72, P231, DOI 10.1016/j.steroids.2006.12.006; Trauner M, 2010, DIGEST DIS, V28, P220, DOI 10.1159/000282091; Uzun MA, 2009, HEPATOL RES, V39, P814, DOI 10.1111/j.1872-034X.2009.00511.x; Watanabe M, 2004, J CLIN INVEST, V113, P1408, DOI 10.1172/JCI200421025; Watt AJ, 2003, HEPATOLOGY, V37, P1249, DOI 10.1053/jhep.2003.50273; WILLY PJ, 1995, GENE DEV, V9, P1033, DOI 10.1101/gad.9.9.1033; Xie YB, 2009, J BIOL CHEM, V284, P28762, DOI 10.1074/jbc.M109.034165; Xie YB, 2009, NUCLEIC ACIDS RES, V37, P4100, DOI 10.1093/nar/gkp333; Xie YB, 2008, BIOCHEM J, V416, P463, DOI 10.1042/BJ20080782	43	35	36	0	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					1079	1091		10.1074/jbc.M113.491522	http://dx.doi.org/10.1074/jbc.M113.491522			13	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265317	Green Published, hybrid			2022-12-25	WOS:000330541200040
J	Dzinic, SH; Kaplun, A; Li, XH; Bernardo, M; Meng, YH; Dean, I; Krass, D; Stemmer, P; Shin, NH; Lonardo, F; Sheng, SJ				Dzinic, Sijana H.; Kaplun, Alexander; Li, Xiaohua; Bernardo, Margarida; Meng, Yonghong; Dean, Ivory; Krass, David; Stemmer, Paul; Shin, Namhee; Lonardo, Fulvio; Sheng, Shijie			Identification of an Intrinsic Determinant Critical for Maspin Subcellular Localization and Function	PLOS ONE			English	Article							TUMOR-SUPPRESSOR MASPIN; PLASMINOGEN-ACTIVATOR SYSTEM; GREEN-FLUORESCENT PROTEIN; HISTONE DEACETYLASE; CRYSTAL-STRUCTURE; CANCER-CELLS; NUCLEAR-LOCALIZATION; LEPTOMYCIN-B; INHIBITION; EXPRESSION	Maspin, a multifaceted tumor suppressor, belongs to the serine protease inhibitor superfamily, but only inhibits serine protease-like enzymes such as histone deacetylase 1 (HDAC1). Maspin is specifically expressed in epithelial cells and it is differentially regulated during tumor progression. A new emerging consensus suggests that a shift in maspin subcellular localization from the nucleus to the cytoplasm stratifies with poor cancer prognosis. In the current study, we employed a rational mutagenesis approach and showed that maspin reactive center loop (RCL) and its neighboring sequence are critical for maspin stability. Further, when expressed in multiple tumor cell lines, single point mutation of Aspartate(346) (D-346) to Glutamate (E-346), maspin(D346E), was predominantly nuclear, whereas wild type maspin (maspin(WT)) was both cytoplasmic and nuclear. Evidence from cellular fractionation followed by immunological and proteomic protein identification, combined with the evidence from fluorescent imaging of endogenous proteins, fluorescent protein fusion constructs, as well as bimolecular fluorescence complementation (BiFC) showed that the increased nuclear enrichment of maspin(D346E) was, at least in part, due to its increased affinity to HDAC1. Maspin(D346E) was also more potent than maspin(WT) as an HDAC inhibitor. Taken together, our evidence demonstrates that D-346 is a critical cis-element in maspin sequence that determines the molecular context and subcellular localization of maspin. A mechanistic model derived from our evidence suggests a new window of opportunity for the development of maspin-based biologically competent HDAC inhibitors for cancer treatment.	[Dzinic, Sijana H.; Kaplun, Alexander; Li, Xiaohua; Bernardo, Margarida; Meng, Yonghong; Dean, Ivory; Krass, David; Lonardo, Fulvio; Sheng, Shijie] Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA; [Dzinic, Sijana H.; Kaplun, Alexander; Li, Xiaohua; Bernardo, Margarida; Dean, Ivory; Krass, David; Sheng, Shijie] Barbara Ann Karmanos Canc Inst, Tumor & Microenvironm Program, Detroit, MI USA; [Stemmer, Paul; Shin, Namhee; Lonardo, Fulvio] Wayne State Univ, Inst Environm Hlth Sci, Prote Core Facil, Detroit, MI USA	Wayne State University; Barbara Ann Karmanos Cancer Institute; Wayne State University	Sheng, SJ (corresponding author), Wayne State Univ, Sch Med, Dept Pathol, Detroit, MI 48201 USA.	ssheng@med.wayne.edu	Li, Xiaohua/AAW-4713-2021; Kaplun, Alexander/AAH-5033-2020	Li, Xiaohua/0000-0003-3490-916X; Stemmer, Paul/0000-0003-3315-9846	NIH [R01CA127735, R01CA84176, R21CA154319]; NIH Center grant [P30CA22453, P30 ES06639, P30 CA22453, P60 DK020572]; Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University; NATIONAL CANCER INSTITUTE [R21CA154319, R01CA127735, R01CA084176, P30CA022453] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P30ES006639] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH Center grant(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	This work was supported by NIH grants R01CA127735, R01CA84176, R21CA154319 (to Dr. Shijie Sheng). The Microscopy, Imaging and Cytometry Resources Core is supported, in part, by NIH Center grant P30CA22453 to The Karmanos Cancer Institute, Wayne State University and the Perinatology Research Branch of the National Institutes of Child Health and Development, Wayne State University. The Wayne State University Proteomics Core Facility is supported by the NIH Center Grants P30 ES06639, P30 CA22453 and P60 DK020572. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Al-Ayyoubi M, 2004, J BIOL CHEM, V279, P55540, DOI 10.1074/jbc.M409957200; Balasubramanian S, 2009, CANCER LETT, V280, P211, DOI 10.1016/j.canlet.2009.02.013; Belfi CA, 1999, BIOCHEM BIOPH RES CO, V257, P361, DOI 10.1006/bbrc.1999.0472; Bernardo M Margarida, 2011, Genes Cancer, V2, P1009, DOI 10.1177/1947601912440170; Biliran H, 2001, CANCER RES, V61, P8676; Bodenstine TM, 2012, CANCER METAST REV, V31, P529, DOI 10.1007/s10555-012-9361-0; Cher ML, 2003, P NATL ACAD SCI USA, V100, P7847, DOI 10.1073/pnas.1331360100; Delcuve GP, 2013, EXPERT OPIN THER TAR, V17, P29, DOI 10.1517/14728222.2013.729042; Delpino A, 1998, MOL MEMBR BIOL, V15, P21, DOI 10.3109/09687689809027514; Endsley MP, 2011, J BIOL CHEM, V286, P24599, DOI 10.1074/jbc.M111.235788; FELDHERR CM, 1994, INT REV CYTOL, V151, P183, DOI 10.1016/S0074-7696(08)62633-9; Finnin MS, 1999, NATURE, V401, P188, DOI 10.1038/43710; Frey A, 2009, HISTOPATHOLOGY, V54, P590, DOI 10.1111/j.1365-2559.2009.03260.x; Gao F, 2004, DEVELOPMENT, V131, P1479, DOI 10.1242/dev.01048; Goulet B, 2011, BIOCH CELL BIOL; Goulet B, 2012, BIOCHEM CELL BIOL, V90, P109; Grebenok RJ, 1997, PLANT J, V11, P573, DOI 10.1046/j.1365-313X.1997.11030573.x; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Jang HL, 2008, INT J MOL MED, V22, P333, DOI 10.3892/ijmm_00000027; Kaplun A, 2012, CRIT REV EUKAR GENE, V22, P249, DOI 10.1615/CritRevEukarGeneExpr.v22.i3.80; Kato T, 2009, CANCER RES, V69, P3597, DOI 10.1158/0008-5472.CAN-08-4368; Kerppola TK, 2006, NAT PROTOC, V1, P1278, DOI 10.1038/nprot.2006.201; Kim JY, 2010, NAT NEUROSCI, V13, P180, DOI 10.1038/nn.2471; Lagger G, 2002, EMBO J, V21, P2672, DOI 10.1093/emboj/21.11.2672; Law RHP, 2005, J BIOL CHEM, V280, P22356, DOI 10.1074/jbc.M412043200; Lee SJ, 2012, INT J MOL MED, V29, P225, DOI 10.3892/ijmm.2011.833; Li XH, 2006, CANCER RES, V66, P9323, DOI 10.1158/0008-5472.CAN-06-1578; Li XH, 2011, MOL CANCER RES, V9, P733, DOI 10.1158/1541-7786.MCR-10-0505; Lockett J, 2006, J CELL BIOCHEM, V97, P651, DOI 10.1002/jcb.20721; Lonardo F, 2006, LUNG CANCER, V51, P31, DOI 10.1016/j.lungcan.2005.07.011; Lonardo F, 2010, CURR PHARM DESIGN, V16, P1877, DOI 10.2174/138161210791208974; McGowen R, 2000, CANCER RES, V60, P4771; Min JR, 2001, CELL, V105, P269, DOI 10.1016/S0092-8674(01)00317-8; Mohsin SK, 2003, J PATHOL, V199, P432, DOI 10.1002/path.1319; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; MUNRO S, 1987, CELL, V48, P899, DOI 10.1016/0092-8674(87)90086-9; Ni M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006868; NISHI K, 1994, J BIOL CHEM, V269, P6320; Nishioka C, 2008, LEUKEMIA RES, V32, P1382, DOI 10.1016/j.leukres.2008.02.018; OGAWA H, 1995, P NATL ACAD SCI USA, V92, P11899, DOI 10.1073/pnas.92.25.11899; OssarehNazari B, 1997, SCIENCE, V278, P141, DOI 10.1126/science.278.5335.141; PELHAM HRB, 1988, EMBO J, V7, P913, DOI 10.1002/j.1460-2075.1988.tb02896.x; PEMBERTON PA, 1995, J BIOL CHEM, V270, P15832, DOI 10.1074/jbc.270.26.15832; Pierson CR, 2002, PROSTATE, V53, P255, DOI 10.1002/pros.10107; Ravenhill L, 2010, J BIOL CHEM, V285, P36285, DOI 10.1074/jbc.M110.177253; SHENG SJ, 1994, J BIOL CHEM, V269, P30988; Sheng SJ, 1998, P NATL ACAD SCI USA, V95, P499, DOI 10.1073/pnas.95.2.499; Shin BK, 2003, J BIOL CHEM, V278, P7607, DOI 10.1074/jbc.M210455200; Silverman GA, 2001, J BIOL CHEM, V276, P33293, DOI 10.1074/jbc.R100016200; Solomon LA, 2006, GYNECOL ONCOL, V101, P385, DOI 10.1016/j.ygyno.2005.11.049; Somoza JR, 2004, STRUCTURE, V12, P1325, DOI 10.1016/j.str.2004.04.012; Song Y, 2011, HISTOPATHOLOGY, V58, P773, DOI 10.1111/j.1365-2559.2011.03797.x; Sood AK, 2002, CLIN CANCER RES, V8, P2924; Spiegel S, 2012, ONCOGENE, V31, P537, DOI 10.1038/onc.2011.267; Teoh SSY, 2010, J BIOL CHEM, V285, P10862, DOI 10.1074/jbc.M109.073171; Wolff B, 1997, CHEM BIOL, V4, P139, DOI 10.1016/S1074-5521(97)90257-X; Xie Ling, 2003, Ai Zheng, V22, P463; Yin SP, 2005, J BIOL CHEM, V280, P34985, DOI 10.1074/jbc.M503522200; Yoshida M, 2001, CANCER CHEMOTH PHARM, V48, pS20, DOI 10.1007/s002800100300; Zhang M, 1997, P NATL ACAD SCI USA, V94, P5673, DOI 10.1073/pnas.94.11.5673; ZOU ZQ, 1994, SCIENCE, V263, P526, DOI 10.1126/science.8290962	61	18	18	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 21	2013	8	11							e74502	10.1371/journal.pone.0074502	http://dx.doi.org/10.1371/journal.pone.0074502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259PW	24278104	Green Submitted, gold, Green Published			2022-12-25	WOS:000327539800002
J	Ali, N; Allam, H; Bader, T; May, R; Basalingappa, KM; Berry, WL; Chandrakesan, P; Qu, DF; Weygant, N; Bronze, MS; Umar, S; Janknecht, R; Sureban, SM; Huycke, M; Houchen, CW				Ali, Naushad; Allam, Heba; Bader, Ted; May, Randal; Basalingappa, Kanthesh M.; Berry, William L.; Chandrakesan, Parthasarathy; Qu, Dongfeng; Weygant, Nathaniel; Bronze, Michael S.; Umar, Shahid; Janknecht, Ralf; Sureban, Sripathi M.; Huycke, Mark; Houchen, Courtney W.			Fluvastatin Interferes with Hepatitis C Virus Replication via Microtubule Bundling and a Doublecortin-like Kinase-Mediated Mechanism	PLOS ONE			English	Article							RNA REPLICATION; HCV REPLICATION; GENOTYPE 1B; STATINS; TUMOR; RIBAVIRIN; THERAPY; LIVER; COMBINATION; INHIBITION	Hepatitis C virus (HCV)-induced alterations in lipid metabolism and cellular protein expression contribute to viral pathogenesis. The mechanism of pleiotropic actions of cholesterol-lowering drugs, statins, against HCV and multiple cancers are not well understood. We investigated effects of fluvastatin (FLV) on microtubule-associated and cancer stem cell marker (CSC), doublecortin-like kinase 1 (DCLK1) during HCV-induced hepatocarcinogenesis. HCV replication models, cancer cell lines and normal human hepatocytes were used to investigate the antiviral and antitumor effects of statins. FLV treatment resulted in induction of microtubule bundling, cell-cycle arrest and alterations in cellular DCLK1 distribution in HCV-expressing hepatoma cells. These events adversely affected the survival of liver-derived tumor cells without affecting normal human hepatocytes. FLV downregulated HCV replication in cell culture where the ATP pool and cell viability were not compromised. Pravastatin did not exhibit these effects on HCV replication, microtubules and cancer cells. The levels of miR-122 that regulates liver homeostasis and provides HCV genomic stability remained at steady state whereas DCLK1 mRNA levels were considerably reduced during FLV treatment. We further demonstrated that HCV replication was increased with DCLK1 overexpression. In conclusion, unique effects of FLV on microtubules and their binding partner DCLK1 are likely to contribute to its anti-HCV and antitumor activities in addition to its known inhibitory effects on 3-hydroxy-3-methylglutary-CoA reductase (HMGCR).	[Ali, Naushad; Allam, Heba; Bader, Ted; May, Randal; Basalingappa, Kanthesh M.; Chandrakesan, Parthasarathy; Qu, Dongfeng; Weygant, Nathaniel; Bronze, Michael S.; Sureban, Sripathi M.; Huycke, Mark; Houchen, Courtney W.] Univ Oklahoma, Dept Med, Sect Digest Dis & Nutr, Oklahoma City, OK 73190 USA; [Berry, William L.; Janknecht, Ralf] Univ Oklahoma, Dept Cell Biol, Oklahoma City, OK USA; [Ali, Naushad; Janknecht, Ralf; Sureban, Sripathi M.; Huycke, Mark; Houchen, Courtney W.] Univ Oklahoma, Univ Oklahoma Hlth Sci Ctr, Peggy & Charles Stephenson Canc Ctr, Oklahoma City, OK USA; [Ali, Naushad; Bader, Ted; May, Randal; Sureban, Sripathi M.; Huycke, Mark; Houchen, Courtney W.] Univ Oklahoma, Dept Vet Affairs Med Ctr, Oklahoma City, OK USA; [Umar, Shahid] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol & Med, Kansas City, KS 66103 USA; [Allam, Heba] Menoufia Univ, Dept Microbiol & Immunol, Menoufia, Egypt	University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Oklahoma System; University of Oklahoma Health Sciences Center; University of Kansas; University of Kansas Medical Center; Egyptian Knowledge Bank (EKB); Menofia University	Ali, N (corresponding author), Univ Oklahoma, Dept Med, Sect Digest Dis & Nutr, Oklahoma City, OK 73190 USA.	Naushad-ali@ouhsc.edu; Courtney-houchen@ouhsc.edu	Allam, Heba/AAC-9226-2019; Sureban, Sripathi/Q-8232-2019; Chandrakesan, Parthasarathy/AAB-9136-2020; BM, Kanthesh/AAX-8650-2020; Huycke, Mark M./AAG-9384-2020	Allam, Heba/0000-0003-3053-8066; BM, Kanthesh/0000-0002-6970-4546; Chandrakesan, Parthasarathy/0000-0002-7587-9553; Berry, William/0000-0002-1661-5443; Ali, Naushad/0000-0002-0058-7396; Sureban, Sripathi/0000-0001-5476-9593; Weygant, Nathaniel/0000-0001-7861-6532; Janknecht, Ralf/0000-0003-1741-1562	Veterans Affairs Merit Award; Oklahoma Center for the Advancement of Science and Technology [AR101-030]; Frances and Malcolm Robinson Endowed Chair; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH [1P20GM103639NIH]; Egyptian Government; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM010363, P20GM103639] Funding Source: NIH RePORTER	Veterans Affairs Merit Award(US Department of Veterans Affairs); Oklahoma Center for the Advancement of Science and Technology; Frances and Malcolm Robinson Endowed Chair; Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH; Egyptian Government; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was partially supported by Veterans Affairs Merit Award, grant from Oklahoma Center for the Advancement of Science and Technology (AR101-030) and the Frances and Malcolm Robinson Endowed Chair to CWH. NA is partially supported by an Institutional Development Award (IDeA) from the National Institute of General Medical Sciences of the NIH under grant number 1P20GM103639NIH. HA was supported by a fellowship from Egyptian Government. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ali N, 2002, J VIROL, V76, P12001, DOI 10.1128/JVI.76.23.12001-12007.2002; Ali N, 2011, J VIROL, V85, P12292, DOI 10.1128/JVI.05920-11; Atsukawa M, 2013, J GASTROEN HEPATOL, V28, P51, DOI 10.1111/j.1440-1746.2012.07267.x; Bader T HL, 2013, J VIRAL HEP IN PRESS; Bader T, 2008, AM J GASTROENTEROL, V103, P1383, DOI 10.1111/j.1572-0241.2008.01876.x; Bartenschlager R, 2011, TRENDS MICROBIOL, V19, P95, DOI 10.1016/j.tim.2010.11.005; Checchi PM, 2003, TRENDS PHARMACOL SCI, V24, P361, DOI 10.1016/S0165-6147(03)00161-5; Clendening JW, 2012, ONCOGENE, V31, P4967, DOI 10.1038/onc.2012.6; da Costa RF, 2012, PHYS CHEM CHEM PHYS, V14, P1389, DOI 10.1039/c1cp22824b; Delang L, 2009, HEPATOLOGY, V50, P6, DOI 10.1002/hep.22916; Demierre MF, 2005, NAT REV CANCER, V5, P930, DOI 10.1038/nrc1751; El-Serag HB, 2012, GASTROENTEROLOGY, V142, P1264, DOI 10.1053/j.gastro.2011.12.061; Gane EJ, 2013, NEW ENGL J MED, V368, P34, DOI 10.1056/NEJMoa1208953; Guo JT, 2001, J VIROL, V75, P8516, DOI 10.1128/JVI.75.18.8516-8523.2001; Harrison SA, 2010, HEPATOLOGY, V52, P864, DOI 10.1002/hep.23787; Henderson LM, 2010, DIGEST DIS SCI, V55, P190, DOI 10.1007/s10620-009-0959-1; Hsu SH, 2012, J CLIN INVEST, V122, P2871, DOI 10.1172/JCI63539; Ikeda M, 2006, HEPATOLOGY, V44, P117, DOI 10.1002/hep.21232; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kapadia SB, 2005, P NATL ACAD SCI USA, V102, P2561, DOI 10.1073/pnas.0409834102; Kavallaris M, 2010, NAT REV CANCER, V10, P194, DOI 10.1038/nrc2803; Lai CK, 2008, J VIROL, V82, P8838, DOI 10.1128/JVI.00398-08; Lawitz EJ, 2012, J HEPATOL, V57, P24, DOI 10.1016/j.jhep.2011.12.029; Lin PT, 2000, J NEUROSCI, V20, P9152; Milazzo L, 2009, J VIRAL HEPATITIS, V16, P479, DOI 10.1111/j.1365-2893.2009.01104.x; Moradpour D, 2007, NAT REV MICROBIOL, V5, P453, DOI 10.1038/nrmicro1645; Nakanishi Y, 2013, NAT GENET, V45, P98, DOI 10.1038/ng.2481; Nelson HB, 2006, J VIROL, V80, P1181, DOI 10.1128/JVI.80.3.1181-1190.2006; Poordad F, 2011, NEW ENGL J MED, V364, P1195, DOI 10.1056/NEJMoa1010494; Prokunina-Olsson L, 2013, NAT GENET, V45, P164, DOI 10.1038/ng.2521; Qu L, 2010, SEMIN LIVER DIS, V30, P319, DOI 10.1055/s-0030-1267534; Sezaki H, 2009, INTERVIROLOGY, V52, P43, DOI 10.1159/000213504; Shimakami T, 2012, P NATL ACAD SCI USA, V109, P941, DOI 10.1073/pnas.1112263109; Sureban SM, 2011, CANCER RES, V71, P2328, DOI 10.1158/0008-5472.CAN-10-2738; Sureban SM, 2009, GASTROENTEROLOGY, V137, P649, DOI 10.1053/j.gastro.2009.05.004; Syed GH, 2011, HEPATOLOGY, V54, P1936, DOI 10.1002/hep.24619; Syed GH, 2010, TRENDS ENDOCRIN MET, V21, P33, DOI 10.1016/j.tem.2009.07.005; Tsai WC, 2012, J CLIN INVEST, V122, P2884, DOI 10.1172/JCI63455; Vaughan CJ, 2004, CIRCULATION, V110, P886, DOI 10.1161/01.CIR.0000139312.10076.BA; Vermehren J, 2011, CLIN MICROBIOL INFEC, V17, P122, DOI 10.1111/j.1469-0691.2010.03430.x; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang CF, 2005, MOL CELL, V18, P425, DOI 10.1016/j.molcel.2005.04.004; Wen J, 2012, J CLIN INVEST, V122, P2773, DOI 10.1172/JCI63966; Wolk B, 2008, J VIROL, V82, P10519, DOI 10.1128/JVI.00640-08; Wu XF, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002617	45	27	29	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80304	10.1371/journal.pone.0080304	http://dx.doi.org/10.1371/journal.pone.0080304			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260365	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900062
J	Giovinazzo, F; Schimmack, S; Svejda, B; Alaimo, D; Pfragner, R; Modlin, I; Kidd, M				Giovinazzo, Francesco; Schimmack, Simon; Svejda, Bernhard; Alaimo, Daniele; Pfragner, Roswitha; Modlin, Irvin; Kidd, Mark			Chromogranin A and Its Fragments as Regulators of Small Intestinal Neuroendocrine Neoplasm Proliferation	PLOS ONE			English	Article							REAL-TIME PCR; CELL-LINES; PROHORMONE CONVERTASE-1; PROTEOLYTIC CLEAVAGE; CHROMAFFIN GRANULES; PROGNOSTIC-FACTORS; TUMOR DISEASE; GENE-TRANSFER; KRJ-I; VASOSTATIN	Introduction: Chromogranin A is a neuroendocrine secretory product and its loss is a feature of malignant NEN dedifferentiation. We hypothesized that chromogranin A fragments were differentially expressed during NEN metastasis and played a role in the regulation of NEN proliferation. Methods: Chromogranin A mRNA (PCR) and protein (ELISA/western blot) were studied in 10 normal human mucosa, 5 enterochromaffin cell preparations, 26 small intestinal NEN primaries and 9 liver metastases. Cell viability (WST-1 assay), proliferation (bromodeoxyuridine ELISA) and expression of AKT/AKT-P (CASE ELISA/western blot) in response to chromogranin A silencing, inhibition of prohormone convertase and mTOR inhibition (RAD001/AKT antisense) as well as different chromogranin A fragments were examined in 4 SI-NEN cell lines. Results: Chromogranin A mRNA and protein levels were increased (37-340 fold, p<0.0001) in small intestinal NENs compared to normal enterochromaffin cells. Western blot identified chromogranin A-associated processing bands including vasostatin in small intestinal NENs as well as up-regulated expression of prohormone convertase in metastases. Proliferation in small intestinal NEN cell lines was decreased by silencing chromogranin A as well as by inhibition of prohormone convertase (p<0.05). This inhibition also decreased secretion of chromogranin A (p<0.05) and 5-HT (p<0.05) as well as expression of vasostatin. Metastatic small intestinal NEN cell lines were stimulated (50-80%, p<0.05) and AKT phosphorylated (Ser473: p<0.05) by vasostatin I, which was completely reversed by RAD001 (p<0.01) and AKT antisense (p<0.05) while chromostatin inhibited proliferation (similar to 50%, p<0.05). Conclusion: Chromogranin A was differentially regulated in primary and metastatic small intestinal NENs and cell lines. Chromogranin A fragments regulated metastatic small intestinal NEN proliferation via the AKT pathway indicating that CgA plays a far more complex role in the biology of these tumors than previously considered.	[Giovinazzo, Francesco; Schimmack, Simon; Svejda, Bernhard; Alaimo, Daniele; Modlin, Irvin; Kidd, Mark] Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA; [Giovinazzo, Francesco] Univ Verona, Lab Translat Surg LURM, I-37100 Verona, Italy; [Schimmack, Simon] Univ Hosp Gen Visceral & Transplantat Surg Heidel, Heidelberg, Germany; [Svejda, Bernhard; Pfragner, Roswitha] Graz Univ, Dept Pathophysiol & Immunol, Graz, Austria	Yale University; University of Verona; University of Graz	Kidd, M (corresponding author), Yale Univ, Sch Med, Dept Surg, New Haven, CT 06520 USA.	mark.kidd@yale.edu	Giovinazzo, Francesco/P-3608-2019; giovinazzo, francesco/G-2028-2011	Giovinazzo, Francesco/0000-0002-3392-9292; giovinazzo, francesco/0000-0002-3392-9292				Arnold R, 2008, CLIN GASTROENTEROL H, V6, P820, DOI 10.1016/j.cgh.2008.02.052; Biswas N, 2008, ENDOCRINOLOGY, V149, P749, DOI 10.1210/en.2007-0838; Bosman F., 2010, WHO CLASSIFICATION T, V4th; Chin A, 2012, AM J PHYSIOL-GASTR L, V302, pG397, DOI 10.1152/ajpgi.00087.2011; DALESSIO A, 2009, BREAST CANC RES TREA; Dondossola E, 2012, CANCER RES, V72, P449, DOI 10.1158/0008-5472.CAN-11-2944; Drozdov I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022457; Drozdov I, 2009, CANCER-AM CANCER SOC, V115, P1638, DOI 10.1002/cncr.24180; Fasciotto B, 2004, CELL BIOL CHROMAFFIN; Feldman SA, 2003, ENDOCR PATHOL, V14, P3, DOI 10.1385/EP:14:1:3; Ferrero E, 2004, FASEB J, V18, P554, DOI 10.1096/fj.03-0922fje; Ghia JE, 2004, REGUL PEPTIDES, V121, P31, DOI 10.1016/j.regpep.2004.04.003; Helle KB, 2007, CELL MOL LIFE SCI, V64, P2863, DOI 10.1007/s00018-007-7254-0; Helle KB, 2010, CARDIOVASC RES, V85, P9, DOI 10.1093/cvr/cvp266; Hwang SR, 2007, J NEUROCHEM, V100, P1340, DOI 10.1111/j.1471-4159.2006.04325.x; Janson ET, 1997, ANN ONCOL, V8, P685, DOI 10.1023/A:1008215730767; Jiang QJ, 2001, J BIOL CHEM, V276, P25022, DOI 10.1074/jbc.M101545200; Kidd M, 2006, ANN SURG, V243, P273, DOI 10.1097/01.sla.0000197734.28551.0f; Kidd M, 2008, CANCER-AM CANCER SOC, V113, P690, DOI 10.1002/cncr.23700; Kidd M, 2008, CANCER-AM CANCER SOC, V112, P1404, DOI 10.1002/cncr.23303; Kidd M, 2007, PHYSIOL GENOMICS, V30, P363, DOI 10.1152/physiolgenomics.00251.2006; Kidd M, 2007, J MOL ENDOCRINOL, V38, P181, DOI 10.1677/jme.1.02037; KONECKI DS, 1987, J BIOL CHEM, V262, P17026; Lee JC, 2009, BIOCHEMISTRY-US, V48, P5254, DOI 10.1021/bi9002953; Li L, 2006, GUT, V55, P259, DOI 10.1136/gut.2005.064980; Liu MH, 2005, NEUROENDOCRINOLOGY, V82, P1, DOI 10.1159/000089749; LLOYD RV, 1988, AM J PATHOL, V130, P296; Ma LX, 2007, J HEPATOL, V46, P98, DOI 10.1016/j.jhep.2006.07.031; Mahata SK, 2002, ANN NY ACAD SCI, V971, P27, DOI 10.1111/j.1749-6632.2002.tb04429.x; Modlin IM, 2008, LANCET ONCOL, V9, P61, DOI 10.1016/S1470-2045(07)70410-2; Modlin IM, 2006, J CLIN ENDOCR METAB, V91, P2340, DOI 10.1210/jc.2006-0110; Modlin IM, 2010, ANN SURG ONCOL, V17, P2427, DOI 10.1245/s10434-010-1006-3; Montero-Hadjadje M, 2008, ACTA PHYSIOL, V192, P309, DOI 10.1111/j.1748-1716.2007.01806.x; Nehar D, 2004, CLIN ENDOCRINOL, V60, P644, DOI 10.1111/j.1365-2265.2004.02030.x; Nejjari M, 2004, AM J PATHOL, V164, P1925, DOI 10.1016/S0002-9440(10)63753-4; Ngamwongsatit P, 2008, J MICROBIOL METH, V73, P211, DOI 10.1016/j.mimet.2008.03.002; Pfragner R, 1996, INT J ONCOL, V8, P513; Pfragner R, 2009, ANTICANCER RES, V29, P1951; Schimmack S, 2012, CANCER-AM CANCER SOC, V118, P2763, DOI 10.1002/cncr.26592; Schimmack S, 2011, LANGENBECK ARCH SURG, V396, P273, DOI 10.1007/s00423-011-0739-1; Seidah NG, 1999, BRAIN RES, V848, P45, DOI 10.1016/S0006-8993(99)01909-5; Svejda B, 2011, CANCER-AM CANCER SOC, V117, P4141, DOI 10.1002/cncr.26011; Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405; Udupi V, 1998, BIOCHEM BIOPH RES CO, V246, P463, DOI 10.1006/bbrc.1998.8643; Udupi V, 1999, REGUL PEPTIDES, V83, P123, DOI 10.1016/S0167-0115(99)00061-0; WASCHEK JA, 1987, ANN NY ACAD SCI, V493, P308, DOI 10.1111/j.1749-6632.1987.tb27215.x; Yao JC, 2008, J CLIN ONCOL, V26, P3063, DOI 10.1200/JCO.2007.15.4377; Yao JC, 2011, J CLIN ENDOCR METAB, V96, P3741, DOI 10.1210/jc.2011-0666; Yoon H, 2009, J CELL BIOCHEM, V108, P832, DOI 10.1002/jcb.22311; Yuan Joshua S., 2008, Biotechnology Journal, V3, P112, DOI 10.1002/biot.200700169	50	20	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81111	10.1371/journal.pone.0081111	http://dx.doi.org/10.1371/journal.pone.0081111			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260544	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900120
J	Nevo, O; Lee, DK; Caniggia, I				Nevo, Ori; Lee, Dennis K.; Caniggia, Isabella			Attenuation of VEGFR-2 Expression by sFlt-1 and Low Oxygen in Human Placenta	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL-DEATH; HYPOXIA; KDR; HETERODIMERIZATION; IDENTIFICATION; PREGNANCIES; REQUIRES; FLT-1; GENE	Vascular endothelial growth factor receptor 2 (VEGFR-2), the primary receptor for VEGF, is crucial for normal endothelial function. sFlt-1, a truncated and soluble form of VEGFR-1 which binds and inhibits VEGF, is increased in preeclampsia and is positively regulated by low oxygen. Here, we investigated the effects of sFlt-1 and hypoxia on VEGFR-2 expression and signaling in the human placenta. VEGFR-2 transcript and protein levels were significantly decreased in preeclamptic placentae compared to controls (1.82 and 1.85 fold, respectively). An inverse correlation was observed for VEGFR-2 and sFlt-1 levels in both singleton and twin placentae from patients with preeclampsia. Immunofluorescence analyses revealed colocalization of VEGFR-2 and sFlt-1 in placental vasculature and co-immunoprecipitation analyses confirmed VEGFR-2 and sFlt-1 interaction only in preeclamptic placentae compared to age-matched controls. VEGFR-2 transcript and protein levels from explants cultured in 3% O-2 were significantly decreased compared to those incubated at 20% O-2 (5.9 and 12.47 fold, respectively). Also, VEGFR-2 transcript levels were significantly decreased in early first trimester placentae (low oxygen environment) compared to late first trimester placentae (2.05 fold). We next explored whether sFlt-1 directly affects VEGFR-2 expression. Treatment of first trimester placental explants with sFlt-1 resulted in significantly decreased levels of VEGFR-2 (2.03 fold) and downstream signaling proteins phospho-ERK (1.60 fold) and phospho-Akt (1.64 fold). Our findings show a novel hypoxia-induced and PE-related down-regulation of VEGFR-2 in the human placenta. sFlt-1, which is known to be increased in hypoxic conditions and PE, directly attenuates VEGFR-2 expression and signaling. A direct interaction between sFlt-1 and VEGFR-2 may represent an important mechanism in VEGFR-2 regulation, inhibition of VEGFR-2-mediated processes in placentation and a novel platform to examine the onset of preeclampsia.	[Nevo, Ori; Lee, Dennis K.] Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Obstet & Gynecol, Toronto, ON, Canada; [Caniggia, Isabella] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Dept Obstet & Gynecol, Toronto, ON M5G 1X5, Canada; [Caniggia, Isabella] Univ Toronto, Dept Physiol, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto	Nevo, O (corresponding author), Univ Toronto, Sunnybrook Hlth Sci Ctr, Dept Obstet & Gynecol, Toronto, ON, Canada.	ori.nevo@sunnybrook.ca	Caniggia, Isabella/G-6466-2013	Caniggia, Isabella/0000-0001-7340-2359	University of Toronto, Faculty of Medicine; Sunnybrook Health Sciences Centre, Department of Obstetrics and Gynecology	University of Toronto, Faculty of Medicine(University of Toronto); Sunnybrook Health Sciences Centre, Department of Obstetrics and Gynecology	Support provided by University of Toronto, Faculty of Medicine, Dean's Fund; Sunnybrook Health Sciences Centre, Department of Obstetrics and Gynecology. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2002, OBSTET GYNECOL, V99, P159; Autiero M, 2003, NAT MED, V9, P936, DOI 10.1038/nm884; Cudmore MJ, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1977; Gerber HP, 1997, J BIOL CHEM, V272, P23659, DOI 10.1074/jbc.272.38.23659; Helske S, 2001, MOL HUM REPROD, V7, P205, DOI 10.1093/molehr/7.2.205; Heydarian M, 2009, PLACENTA, V30, P250, DOI 10.1016/j.placenta.2008.12.010; Huang K, 2001, INT J BIOCHEM CELL B, V33, P315, DOI 10.1016/S1357-2725(01)00019-X; Jauniaux E, 2000, AM J PATHOL, V157, P2111, DOI 10.1016/S0002-9440(10)64849-3; KATOH O, 1995, CANCER RES, V55, P5687; Kendall RL, 1996, BIOCHEM BIOPH RES CO, V226, P324, DOI 10.1006/bbrc.1996.1355; MacPhee DJ, 2001, LAB INVEST, V81, P1469, DOI 10.1038/labinvest.3780362; Marini M, 2007, REPROD FERT DEVELOP, V19, P641, DOI 10.1071/RD06131; Maynard SE, 2003, J CLIN INVEST, V111, P649, DOI 10.1172/JCI200317189; Neagoe PE, 2005, J BIOL CHEM, V280, P9904, DOI 10.1074/jbc.M412017200; Nevo O, 2008, J CLIN ENDOCR METAB, V93, P285, DOI 10.1210/jc.2007-1042; Nevo O, 2006, AM J PHYSIOL-REG I, V291, pR1085, DOI 10.1152/ajpregu.00794.2005; Olszewska-Pazdrak B, 2009, AM J PHYSIOL-CELL PH, V296, pC1162, DOI 10.1152/ajpcell.00533.2008; Ray JE, 2010, CELL DEATH DIFFER, V17, P846, DOI 10.1038/cdd.2009.167; Schiessl B, 2009, PLACENTA, V30, P79, DOI 10.1016/j.placenta.2008.10.004; Sela S, 2008, CIRC RES, V102, P1566, DOI 10.1161/CIRCRESAHA.108.171504; Soleymanlou N, 2005, CELL DEATH DIFFER, V12, P441, DOI 10.1038/sj.cdd.4401593; Takagi H, 1996, INVEST OPHTH VIS SCI, V37, P1311; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; TERMAN BI, 1991, ONCOGENE, V6, P1677; Ulyatt C, 2011, BIOCHEM BIOPH RES CO, V404, P774, DOI 10.1016/j.bbrc.2010.12.057; Waltenberger J, 1996, CIRCULATION, V94, P1647, DOI 10.1161/01.CIR.94.7.1647; Zhang Z, 2010, CELL DEATH DIFFER, V17, P499, DOI 10.1038/cdd.2009.152; Zhou Y, 2002, AM J PATHOL, V160, P1405, DOI 10.1016/S0002-9440(10)62567-9	28	21	22	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e81176	10.1371/journal.pone.0081176	http://dx.doi.org/10.1371/journal.pone.0081176			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260556	Green Published, gold, Green Submitted			2022-12-25	WOS:000327311900124
J	Schmitz, T; Pourcelot, AG; Moutafoff, C; Biran, V; Sibony, O; Oury, JF				Schmitz, Thomas; Pourcelot, Anne-Gaelle; Moutafoff, Constance; Biran, Valerie; Sibony, Olivier; Oury, Jean-Francois			Cervical Ripening with Low-Dose Prostaglandins in Planned Vaginal Birth after Cesarean	PLOS ONE			English	Article							UTERINE RUPTURE; WOMEN; LABOR; SECTION; RISK; TRIAL; INDUCTION; MISOPROSTOL; PREGNANCY; CHILDHOOD	Objectives: To compare uterine rupture, maternal and perinatal morbidity rates in women with one single previous cesarean after spontaneous onset of labor or low-dose prostaglandin-induced cervical ripening for unfavourable cervix. Study Design: This was a retrospective cohort study of 4,137 women with one single previous cesarean over a 22-year period. Inpatient prostaglandin administration consisted in single daily local applications. Results: Vaginal delivery was planned for 3,544 (85.7%) patients, 2,704 (76.3%) of whom delivered vaginally (vaginal birth after Cesarean (VBAC) rate = 65.4%). Among women receiving prostaglandins (n=515), 323 (62.7%) delivered vaginally. Uterine rupture (0.7% compared with 0.8%, OR 1.1, 95% CI 0.4-3.4, p=0.88), maternal (0.9% compared with 1.2%, OR 1.3, 95% CI 0.5-3.2, p=0.63) and perinatal (0.3% compared with 0.8%, OR 2.4, 95% CI 0.7-8.5, p=0.18) morbidity rates did not differ significantly between patients with spontaneous onset of labor and those receiving prostaglandins, nor did these rates differ according to the planned mode of delivery. Conclusion: In comparison with patients with spontaneous labor, inducing cervical ripening with low-dose prostaglandins in case of unfavourable cervix is not associated with appreciable increase in uterine rupture, maternal or perinatal morbidity.	[Schmitz, Thomas; Pourcelot, Anne-Gaelle; Moutafoff, Constance; Sibony, Olivier; Oury, Jean-Francois] Hop Robert Debre, AP HP, Serv Gynecol Obstet, F-75019 Paris, France; [Schmitz, Thomas; Pourcelot, Anne-Gaelle; Moutafoff, Constance; Biran, Valerie; Sibony, Olivier; Oury, Jean-Francois] Univ Paris Diderot, Paris, France; [Biran, Valerie] Hop Robert Debre, AP HP, Serv Neonatol, F-75019 Paris, France	Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Robert-Debre - APHP; UDICE-French Research Universities; Universite Paris Cite	Schmitz, T (corresponding author), Hop Robert Debre, AP HP, Serv Gynecol Obstet, F-75019 Paris, France.	thomas.schmitz@rdb.aphp.fr	Biran, Valerie/GQY-8192-2022					[Anonymous], AHRQ PUBLICATION; Blondel B., 2003, ENQUETE PERINATALE 2; Boice JD, 1999, TERATOLOGY, V59, P227, DOI 10.1002/(SICI)1096-9926(199904)59:4<227::AID-TERA7>3.0.CO;2-E; D'ercole C, 2000, J Gynecol Obstet Biol Reprod (Paris), V29, P51; Dekker GA, 2010, BJOG-INT J OBSTET GY, V117, P1358, DOI 10.1111/j.1471-0528.2010.02688.x; Elkousy MA, 2003, AM J OBSTET GYNECOL, V188, P824, DOI 10.1067/mob.2003.186; GROBMAN WA, 2009, AM J OBSTET GYNECOL, V200, P22401; Grobman WA, 2007, OBSTET GYNECOL, V110, P1249, DOI 10.1097/01.AOG.0000292082.80566.cd; Grobman WA, 2007, OBSTET GYNECOL, V109, P262, DOI 10.1097/01.AOG.0000254169.49346.e9; HARPER LM, 2013, AM J OBSTET GYNECOL, V208, pE1; Kwee A, 2007, EUR J OBSTET GYN R B, V132, P171, DOI 10.1016/j.ejogrb.2006.07.017; Landon MB, 2006, OBSTET GYNECOL, V108, P12, DOI 10.1097/01.AOG.0000224694.32531.f3; Lydon-Rochelle M, 2001, NEW ENGL J MED, V345, P3, DOI 10.1056/NEJM200107053450101; Macones GA, 2005, AM J OBSTET GYNECOL, V193, P1656, DOI 10.1016/j.ajog.2005.04.002; Mankuta DD, 2003, AM J OBSTET GYNECOL, V189, P714, DOI 10.1067/S0002-9378(03)00833-0; Martel MJ, 2005, J OBSTET GYNAECOL CA, V27, P164; McMahon MJ, 1996, NEW ENGL J MED, V335, P689, DOI 10.1056/NEJM199609053351001; NORMAN M, 1992, ACTA OBSTET GYN SCAN, V71, P351, DOI 10.3109/00016349209021072; Ouzounian JG, 2011, AM J PERINAT, V28, P593, DOI 10.1055/s-0031-1275386; Pare E, 2006, BJOG-INT J OBSTET GY, V113, P75, DOI 10.1111/j.1471-0528.2005.00793.x; Plaut MM, 1999, AM J OBSTET GYNECOL, V180, P1535, DOI 10.1016/S0002-9378(99)70049-9; Rajaraman P, 2011, BRIT MED J, V342, DOI 10.1136/bmj.d472; Ravasia DJ, 2000, AM J OBSTET GYNECOL, V183, P1176, DOI 10.1067/mob.2000.109037; Rouse DJ, 2006, OBSTET GYNECOL, V108, P891, DOI 10.1097/01.AOG.0000236547.35234.8c; Sibony O, 2006, J PERINAT MED, V34, P212, DOI 10.1515/JPM.2006.037; Silver RM, 2006, OBSTET GYNECOL, V107, P1226, DOI 10.1097/01.AOG.0000219750.79480.84; WILLIAMS MA, 1995, GYNECOL OBSTET INVES, V40, P89, DOI 10.1159/000292312; Wing DA, 1998, OBSTET GYNECOL, V91, P828, DOI 10.1016/S0029-7844(97)00553-X; Zelop CM, 1999, AM J OBSTET GYNECOL, V181, P882, DOI 10.1016/S0002-9378(99)70319-4; 2010, OBSTET GYNECOL, V116, P450	30	9	13	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80903	10.1371/journal.pone.0080903	http://dx.doi.org/10.1371/journal.pone.0080903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260505	Green Published, Green Submitted, gold			2022-12-25	WOS:000327311900105
J	Nischalke, HD; Berger, C; Lutz, P; Langhans, B; Wolter, F; Eisenhardt, M; Kramer, B; Kokordelis, P; Glassner, A; Muller, T; Rosendahl, J; Fischer, J; Berg, T; Grunhage, F; Leifeld, L; Soyka, M; Nattermann, J; Sauerbruch, T; Stickel, F; Spengler, U				Nischalke, Hans Dieter; Berger, Cordula; Lutz, Philipp; Langhans, Bettina; Wolter, Franziska; Eisenhardt, Marianne; Kraemer, Benjamin; Kokordelis, Pavlos; Glaessner, Andreas; Mueller, Tobias; Rosendahl, Jonas; Fischer, Janett; Berg, Thomas; Gruenhage, Frank; Leifeld, Ludger; Soyka, Michael; Nattermann, Jacob; Sauerbruch, Tilman; Stickel, Felix; Spengler, Ulrich			Influence of the CXCL1 rs4074 A Allele on Alcohol Induced Cirrhosis and HCC in Patients of European Descent	PLOS ONE			English	Article							HEPATIC STELLATE CELLS; INDUCED LIVER-INJURY; GENE-EXPRESSION; KC CHEMOKINE; FIBROSIS; DISEASE; INFLAMMATION; MODULATION; MECHANISM	Background and Aims: CXCL1 (CXC chemokine-ligand-1) is a ligand for CXC chemokine receptor 2 expressed on hepatic stellate cells (HSC). Thus, CXCL1 might contribute to HSC activation and fibrogenesis. In the present study, we investigated the influence of the CXCL1 rs4074 polymorphism on the occurrence of alcohol induced liver cirrhosis and hepatocellular carcinoma (HCC). Methods: The study involved 458 patients with alcoholic cirrhosis (170 with HCC), 115 alcoholics without liver disease and 342 healthy controls. All subjects were genotyped for the CXCL1 rs4074 polymorphism and CXCL1 serum levels of 132 patients were measured. In vitro CXCL1 secretion in TLR-transfected cell lines were studied by ELISA. Results: Distribution of the CXCL1 genotypes (GG/GA/AA) was 159/219/80 in patients with alcoholic cirrhosis, 52/44/19 in alcoholic controls and 158/140/44 in healthy controls. Patients with alcohol-induced cirrhosis were significantly more often carriers of the CXCL1 rs4074 A allele (65.3%) than alcoholics without liver disease (54.8%, OR=1.55; 95% CI=1.025-2.350; p=0.04) and healthy controls (53.8%, OR=1.62; 95% CI=1.212-2.151; p=0.001). Accordingly, the frequency of the CXCL1 rs4074 A allele was significantly higher in the cirrhotic patients than in the subjects without cirrhosis (41.4% vs. 33.9%, OR=1.38, 95% CI: 1.14-1.66, p=0.001). Furthermore cirrhotic carriers of the CXCL1 rs4074 A allele had significantly higher CXCL1 serum levels than carriers of the GG genotype. In contrast to sera from healthy controls, sera from patients with alcoholic cirrhosis induced CXCL1 secretion in TLR2-(p=0.016) and TLR4-(p=0.008) transfected HEK293 cells. This finding indicates that sera from patients with alcoholic cirrhosis contain soluble ligands that can induce CXCL1 production via stimulation of TLRs. Conclusion: The enhanced CXCL1 serum levels in carriers of the rs4074 A allele together with their increased frequency in patients with alcohol induced cirrhosis suggest the CXCL1 rs4074 A allele as a genetic risk factor for alcoholic cirrhosis.	[Nischalke, Hans Dieter; Berger, Cordula; Lutz, Philipp; Langhans, Bettina; Wolter, Franziska; Eisenhardt, Marianne; Kraemer, Benjamin; Kokordelis, Pavlos; Glaessner, Andreas; Nattermann, Jacob; Sauerbruch, Tilman; Spengler, Ulrich] Univ Bonn, Dept Internal Med 1, Bonn, Germany; [Mueller, Tobias] Med Univ Charite Campus, Med Clin Hepatol & Gastroenterol, Virchow Klinikum Berlin, Berlin, Germany; [Mueller, Tobias; Rosendahl, Jonas; Fischer, Janett; Berg, Thomas] Univ Hosp Leipzig, Dept Gastroenterol, Leipzig, Germany; [Gruenhage, Frank] Saarland Univ Hosp, Dept Med 2, Homburg, Germany; [Leifeld, Ludger] Evangel Krankenhaus Kalk, Cologne, Germany; [Soyka, Michael] Psychiat Hosp Meiringen, Meiringen, Switzerland; [Soyka, Michael] Univ Munich, Munich, Germany; [Stickel, Felix] Univ Bern, Inselspital, Dept Visceral Surg & Med, CH-3010 Bern, Switzerland	University of Bonn; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin; Leipzig University; Universitatsklinikum des Saarlandes; University of Munich; University of Bern; University Hospital of Bern	Nischalke, HD (corresponding author), Univ Bonn, Dept Internal Med 1, Bonn, Germany.	ulrich.spengler@ukb.uni-bonn.de	Krämer, Benjamin/AAC-9618-2019	Krämer, Benjamin/0000-0002-1385-9709; Berg, Thomas/0000-0003-0003-6241; Nischalke, Hans Dieter/0000-0002-3457-0023; Lutz, Philipp/0000-0002-4921-200X; Mueller, Tobias/0000-0003-3426-5421	Deutsche Krebshilfe [107865]; German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft [SFB TRR57 TP12]; H. W. & J. Hector Foundation [M42]	Deutsche Krebshilfe(Deutsche Krebshilfe); German Centre for Infection Research (DZIF); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); H. W. & J. Hector Foundation	This study was funded by the Deutsche Krebshilfe (107865) to HDN and US (http://www.krebshilfe.de/metanavigation/english.html), the German Centre for Infection Research (DZIF) to PL and US (http://www.dzif.de/), the SFB TRR57 (TP12) of the Deutsche Forschungsgemeinschaft to JN and US (http://www.dfg.de/en/index.jsp) and the H. W. & J. Hector Foundation M42 to JN (http://www.hector-stiftung.de/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Aoyama T, 2010, GASTROENT RES PRACT, V2010, DOI 10.1155/2010/192543; BODE C, 1987, J HEPATOL, V4, P8, DOI 10.1016/S0168-8278(87)80003-X; Clement S, 2010, J HEPATOL, V52, P635, DOI 10.1016/j.jhep.2009.10.035; Dominguez M, 2009, GASTROENTEROLOGY, V136, P1639, DOI 10.1053/j.gastro.2009.01.056; Galli R, 2010, J IMMUNOL, V184, P6658, DOI 10.4049/jimmunol.0902401; Hillian AD, 2008, GENES IMMUN, V9, P501, DOI 10.1038/gene.2008.42; Kato N, 2005, HEPATOLOGY, V42, P846, DOI 10.1002/hep.20860; Li M, 2001, J IMMUNOL, V166, P7128, DOI 10.4049/jimmunol.166.12.7128; Lin CS, 2010, BIOCHEM BIOPH RES CO, V397, P283, DOI 10.1016/j.bbrc.2010.05.101; Liu Z, 2011, J SURG RES, V166, P241, DOI 10.1016/j.jss.2009.07.014; Marques PE, 2012, HEPATOLOGY, V56, P1971, DOI 10.1002/hep.25801; Murphy PM, 1997, SEMIN HEMATOL, V34, P311; Nannuru Kalyan C, 2011, J Carcinog, V10, P40, DOI 10.4103/1477-3163.92308; Nguyen-Khac E, 2008, ALIMENT PHARM THER, V28, P1188, DOI 10.1111/j.1365-2036.2008.03831.x; Nischalke HD, 2012, J HEPATOL, V56, P758, DOI 10.1016/j.jhep.2011.10.019; Nischalke HD, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027087; Oak S, 2006, J IMMUNOL, V176, P7628, DOI 10.4049/jimmunol.176.12.7628; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Purohit V, 2008, ALCOHOL, V42, P349, DOI 10.1016/j.alcohol.2008.03.131; Sahin H, 2010, NAT REV GASTRO HEPAT, V7, P682, DOI 10.1038/nrgastro.2010.168; Stefanovic L, 2005, EXP BIOL MED, V230, P573, DOI 10.1177/153537020523000809; Stefanovic L, 2006, J INTERF CYTOK RES, V26, P760, DOI 10.1089/jir.2006.26.760; Stickel F, 2008, ALCOHOL CLIN EXP RES, V32, P959, DOI 10.1111/j.1530-0277.2008.00654.x; Stickel F, 2011, HEPATOLOGY, V53, P86, DOI 10.1002/hep.24017; Strieter RM, 2006, EUR J CANCER, V42, P768, DOI 10.1016/j.ejca.2006.01.006; Suh YG, 2011, WORLD J GASTROENTERO, V17, P2543, DOI 10.3748/wjg.v17.i20.2543; Uesugi T, 2001, HEPATOLOGY, V34, P101, DOI 10.1053/jhep.2001.25350; Varney ML, 2011, CANCER LETT, V300, P180, DOI 10.1016/j.canlet.2010.10.004; Wang L, 2008, BIOCHEM BIOPH RES CO, V366, P852, DOI 10.1016/j.bbrc.2007.12.030; Wasmuth HE, 2010, Z GASTROENTEROL, V48, P38, DOI 10.1055/s-0028-1109933; Wu FX, 2009, CANCER LETT, V279, P163, DOI 10.1016/j.canlet.2009.01.034; Yin M, 2001, J IMMUNOL, V166, P4737, DOI 10.4049/jimmunol.166.7.4737; Zimmermann HW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021381	33	16	16	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80848	10.1371/journal.pone.0080848	http://dx.doi.org/10.1371/journal.pone.0080848			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260493	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500180
J	Perumalsamy, H; Kim, JR; Oh, SM; Jung, JW; Ahn, YJ; Kwon, HW				Perumalsamy, Haribalan; Kim, Jun-Ran; Oh, Sang Mi; Jung, Je Won; Ahn, Young-Joon; Kwon, Hyung Wook			Novel Histopathological and Molecular Effects of Natural Compound Pellitorine on Larval Midgut Epithelium and Anal Gills of Aedes aegypti	PLOS ONE			English	Article							CULEX-PIPIENS-PALLENS; LARVICIDAL ACTIVITY; CARBONIC-ANHYDRASE; TANNIC-ACID; MOSQUITO; EXPRESSION; QUINQUEFASCIATUS; CONSTITUENTS; AZADIRACHTIN; PAPILLAE	The yellow fever mosquito, Aedes aegypti, is a vector for transmitting dengue fever and yellow fever. In this study, we assessed the histopathological and molecular effects of pellitorine, an isobutylamide alkaloid, on the third instar of Ae. aegypti larvae. At 5 mg/l concentration of pellitorine, the whole body of the treated larvae became dark in color, particularly damaged thorax and abdominal regions. Pellitorine was targeted mainly on midgut epithelium and anal gills, indicating variably dramatic degenerative responses of the midgut through a sequential epithelial disorganization. The anterior and posterior midgut was entirely necrosed, bearing only gut lumen residues inside the peritrophic membranes. Pellitorine caused comprehensive damage of anal gill cells and branches of tracheole and debris was found in hemolymph of the anal gills. RT-PCR analysis indicates that the compound inhibited gene expression encoding V-type H+-ATPase and aquaporine 4 after treatment with 2.21 mg/l pellitorine. These results verify that pellitorine merits further study as a potential larvicide with a specific target site and a lead molecule for the control of mosquito populations.	[Perumalsamy, Haribalan; Kim, Jun-Ran] Seoul Natl Univ, Res Inst Agr & Life Sci, Seoul, South Korea; [Perumalsamy, Haribalan; Kim, Jun-Ran; Oh, Sang Mi; Jung, Je Won; Ahn, Young-Joon; Kwon, Hyung Wook] Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea	Seoul National University (SNU); Seoul National University (SNU)	Ahn, YJ (corresponding author), Seoul Natl Univ, Dept Agr Biotechnol, WCU Biomodulat Major, Seoul, South Korea.	yjahn@snu.ac.kr; biomodeling@snu.ac.kr			WCU (World Class University) Program through the National Research Foundation of Korea [R31-10056]; Ministry of Education, Science and Technology	WCU (World Class University) Program through the National Research Foundation of Korea(National Research Foundation of Korea); Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea)	This work was carried out with the support of WCU (World Class University) Program (R31-10056) through the National Research Foundation of Korea funded by the Ministry of Education, Science and Technology to YJA and HWK. The funding agency had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahn YJ, 2006, ADV PHYTOMED, V3, P269; Almehmadi R. M., 2011, Journal of Entomology, V8, P63, DOI 10.3923/je.2011.63.72; BERNAYS EA, 1980, ENTOMOL EXP APPL, V28, P158, DOI 10.1007/BF00287124; Bradley Timothy J., 1994, P303; CDC, 2011, CDC ENT DENG ENT EC; Clements A. N., 1992, BIOL MOSQUITOES, V1; Corena MD, 2002, J EXP BIOL, V205, P591; DAVIDSON EW, 1988, J MED ENTOMOL, V25, P151, DOI 10.1093/jmedent/25.3.151; Donini A, 2005, J EXP BIOL, V208, P603, DOI 10.1242/jeb.01422; Duca OD, 2011, J EXP BIOL, V214, P3992; Edwards HA, 1983, TISSUE CELL, V25, P875; Enan E, 2001, COMP BIOCHEM PHYS C, V130, P325, DOI 10.1016/S1532-0456(01)00255-1; Filippova M, 1998, INSECT MOL BIOL, V7, P223, DOI 10.1111/j.1365-2583.1998.00069.x; GONZALEZ MS, 1992, J INVERTEBR PATHOL, V60, P201, DOI 10.1016/0022-2011(92)90098-O; Halstead SB, 2007, LANCET, V370, P1644, DOI 10.1016/S0140-6736(07)61687-0; Isman MB, 2006, ANNU REV ENTOMOL, V51, P45, DOI 10.1146/annurev.ento.51.110104.151146; Kiernan J.A, 1990, HISTOLOGICAL HISTOCH; Kim KW, 2007, MICRON, V38, P626, DOI 10.1016/j.micron.2006.09.006; Kostyukovsky M, 2002, PEST MANAG SCI, V58, P1101, DOI 10.1002/ps.548; Kwon HW, 2006, P NATL ACAD SCI USA, V103, P13526, DOI 10.1073/pnas.0601107103; Marusalin J, 2012, J COMP PHYSIOL B, V182, P1047, DOI 10.1007/s00360-012-0679-2; NASIRUDDIN M, 1993, TISSUE CELL, V25, P875, DOI 10.1016/0040-8166(93)90036-K; Nishiura JT, 2007, J INSECT PHYSIOL, V53, P47, DOI 10.1016/j.jinsphys.2006.09.014; Park JH, 2012, PESTIC BIOCHEM PHYS, V104, P118, DOI 10.1016/j.pestbp.2012.07.006; Patrick ML, 2006, J EXP BIOL, V209, P4638, DOI 10.1242/jeb.02551; Perumalsamy H, 2010, J AGR FOOD CHEM, V58, P10001, DOI 10.1021/jf102193k; Priestley CM, 2003, BRIT J PHARMACOL, V140, P1363, DOI 10.1038/sj.bjp.0705542; Rey D, 1999, J INVERTEBR PATHOL, V73, P173, DOI 10.1006/jipa.1998.4810; Rey D, 1998, ENTOMOL EXP APPL, V88, P255, DOI 10.1023/A:1003440012880; REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208; Seron TJ, 2004, J EXP BIOL, V207, P4559, DOI 10.1242/jeb.01287; Spielman A, 2001, STORY MANKINDS DEADL; STEINLY BA, 1985, ENTOMOL EXP APPL, V39, P3, DOI 10.1007/BF00338517; STOBBART RH, 1965, J EXP BIOL, V42, P29; The Database of Arthropods Resistance to Pesticides, DAT ARTHR RES PEST; TREHERNE JE, 1954, J EXP BIOL, V31, P386; VOLKMANN A, 1989, TISSUE CELL, V21, P253, DOI 10.1016/0040-8166(89)90070-0; WALLIS MA, 1973, J CLIN PATHOL, V26, P77, DOI 10.1136/jcp.26.1.77; Wang ZQ, 2012, PEST MANAG SCI, V68, P1041, DOI 10.1002/ps.3265; Wigglesworth VB, 1933, J EXP BIOL, V10, P16; Wigglesworth VB, 1942, J EXP BIOL, V19, P56; Wink M, 2006, ADV PHYTOMED, V3, P251; Yang YoungCheol, 2004, Journal of Asia-Pacific Entomology, V7, P227, DOI 10.1016/S1226-8615(08)60220-4	43	24	26	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80226	10.1371/journal.pone.0080226	http://dx.doi.org/10.1371/journal.pone.0080226			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260359	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500122
J	Kim, JK; Kim, JY; Kim, HJ; Park, KG; Harris, RA; Cho, WJ; Lee, JT; Lee, IK				Kim, Jeong-Kook; Kim, Joon-Young; Kim, Han-Jong; Park, Keun-Gyu; Harris, Robert A.; Cho, Won-Jea; Lee, Jae-Tae; Lee, In-Kyu			Scoparone Exerts Anti-Tumor Activity against DU145 Prostate Cancer Cells via Inhibition of STAT3 Activity	PLOS ONE			English	Article							EPIDERMAL-GROWTH-FACTOR; CONSTITUTIVE ACTIVATION; NATURAL-PRODUCTS; SIGNAL TRANSDUCER; FACTOR RECEPTOR; BETA-CATENIN; APOPTOSIS; TRANSCRIPTION; PROGRESSION; EXPRESSION	Scoparone, a natural compound isolated from Artemisia capillaris, has been used in Chinese herbal medicine to treat neonatal jaundice. Signal transducer and activator of transcription 3 (STAT3) contributes to the growth and survival of many human tumors. This study was undertaken to investigate the anti-tumor activity of scoparone against DU145 prostate cancer cells and to determine whether its effects are mediated by inhibition of STAT3 activity. Scoparone inhibited proliferation of DU145 cells via cell cycle arrest in G(1) phase. Transient transfection assays showed that scoparone repressed both constitutive and IL-6-induced transcriptional activity of STAT3. Western blot and quantitative real-time PCR analyses demonstrated that scoparone suppressed the transcription of STAT3 target genes such as cyclin D-1, c-Myc, survivin, Bcl-2, and Socs3. Consistent with this, scoparone decreased phosphorylation and nuclear accumulation of STAT3, but did not reduce phosphorylation of janus kinase 2 (JAK2) or Src, the major upstream kinases responsible for STAT3 activation. Moreover, transcriptional activity of a constitutively active mutant of STAT3 (STAT3C) was inhibited by scoparone, but not by AG490, a JAK2 inhibitor. Furthermore, scoparone treatment suppressed anchorage-independent growth in soft agar and tumor growth of DU145 xenografts in nude mice, concomitant with a reduction in STAT3 phosphorylation. Computational modeling suggested that scoparone might bind the SH2 domain of STAT3. Our findings suggest that scoparone elicits an antitumor effect against DU145 prostate cancer cells in part through inhibition of STAT3 activity.	[Kim, Jeong-Kook] Kyungpook Natl Univ, Dept Biomed Sci, Grad Sch, Taegu, South Korea; [Kim, Joon-Young; Kim, Han-Jong; Park, Keun-Gyu; Lee, In-Kyu] Kyungpook Natl Univ, Sch Med, Dept Internal Med, Res Inst Aging & Metab,World Class Univ Program, Taegu, South Korea; [Kim, Joon-Young] Gwangju Inst Sci & Technol, GIST Coll, Kwangju, South Korea; [Kim, Han-Jong] Chonnam Natl Univ, Res Inst Clin Med, Hwasun Hosp, Jeollanam Do, South Korea; [Harris, Robert A.] Indiana Univ Sch Med, Dept Biochem & Mol Biol, Indianapolis, IN 46202 USA; [Cho, Won-Jea] Chonnam Natl Univ, Coll Pharm, Kwangju, South Korea; [Cho, Won-Jea] Chonnam Natl Univ, Res Inst Drug Dev, Kwangju, South Korea; [Lee, Jae-Tae] Kyungpook Natl Univ, Dept Nucl Med, Sch Med, Taegu, South Korea	Kyungpook National University; Kyungpook National University; Gwangju Institute of Science & Technology (GIST); Chonnam National University; Indiana University System; Indiana University Bloomington; Chonnam National University; Chonnam National University; Kyungpook National University	Lee, IK (corresponding author), Kyungpook Natl Univ, Sch Med, Dept Internal Med, Res Inst Aging & Metab,World Class Univ Program, Taegu, South Korea.	leei@knu.ac.kr	Lee, In-Kyu/AAR-6374-2021; Lee, Jaetae/AAR-3317-2021; Lee, Jaetae/ABF-3980-2020		National Research Foundation [2012R1A2A2A01043867, 2012R1A2A1A03670452, 2012-0001350]; Ministry of Science, ICT & Future Planning; Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea [A111345]	National Research Foundation; Ministry of Science, ICT & Future Planning(Ministry of Science, ICT & Future Planning, Republic of Korea); Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea	his work was supported by grants from National Research Foundation [2012R1A2A2A01043867, 2012R1A2A1A03670452, and Basic Science Research Program, (2012-0001350)] funded by the Ministry of Science, ICT & Future Planning and a grant of the Korea Health technology R&D Project, Ministry of Health & Welfare, Republic of Korea (A111345). The funders had no role in study design, data collection and analysis, decision publish, or preparation of the manuscript.	Abdulghani J, 2008, AM J PATHOL, V172, P1717, DOI 10.2353/ajpath.2008.071054; Becker S, 1998, NATURE, V394, P145, DOI 10.1038/28101; Bromberg J, 2000, ONCOGENE, V19, P2468, DOI 10.1038/sj.onc.1203476; Bromberg J, 2002, J CLIN INVEST, V109, P1139, DOI 10.1172/JCI200215617; Bromberg JF, 1999, CELL, V98, P295, DOI 10.1016/S0092-8674(00)81959-5; Bromberg JF, 1998, MOL CELL BIOL, V18, P2553, DOI 10.1128/MCB.18.5.2553; Catlett-Falcone R, 1999, IMMUNITY, V10, P105, DOI 10.1016/S1074-7613(00)80011-4; Corcoran NM, 2003, BJU INT, V91, P545, DOI 10.1046/j.1464-410X.2003.04025.x; Darnell JE, 1997, SCIENCE, V277, P1630, DOI 10.1126/science.277.5332.1630; Decker T, 2000, ONCOGENE, V19, P2628, DOI 10.1038/sj.onc.1203481; Di Lorenzo G, 2002, CLIN CANCER RES, V8, P3438; Epling-Burnette PK, 2001, J CLIN INVEST, V107, P351, DOI 10.1172/JCI9940; Fletcher S, 2008, CHEMMEDCHEM, V3, P1159, DOI 10.1002/cmdc.200800123; Fok T F, 2001, J Perinatol, V21 Suppl 1, pS98; Garcia R, 2001, ONCOGENE, V20, P2499, DOI 10.1038/sj.onc.1204349; Gordaliza M, 2007, CLIN TRANSL ONCOL, V9, P767, DOI 10.1007/s12094-007-0138-9; Grandis JR, 2000, P NATL ACAD SCI USA, V97, P4227, DOI 10.1073/pnas.97.8.4227; Haftchenary S, 2011, ANTI-CANCER DRUG, V22, P115, DOI 10.1097/CAD.0b013e328341185b; Hoult JRS, 1996, GEN PHARMACOL-VASC S, V27, P713, DOI 10.1016/0306-3623(95)02112-4; HUANG HC, 1993, BRIT J PHARMACOL, V110, P1508, DOI 10.1111/j.1476-5381.1993.tb13993.x; HUANG HC, 1991, EUR J PHARMACOL, V198, P211; Huang WD, 2004, J CLIN INVEST, V113, P137, DOI 10.1172/JCI200418385; Jang SI, 2006, LIFE SCI, V78, P2937, DOI 10.1016/j.lfs.2005.11.020; Jemal A, 2011, CA-CANCER J CLIN, V61, P134, DOI [10.3322/caac.20115, 10.3322/caac.20107]; Karikas GA, 2010, J BUON, V15, P627; Kennell JA, 2003, MOL CELL BIOL, V23, P5366, DOI 10.1128/MCB.23.15.5366-5375.2003; Kim HJ, 2009, ARTERIOSCL THROM VAS, V29, P1558, DOI 10.1161/ATVBAHA.109.190058; Lee YM, 2003, J BIOMED SCI, V10, P518, DOI [10.1159/000072379, 10.1007/BF02256113]; Mora LB, 2002, CANCER RES, V62, P6659; Nakashima J, 2000, CLIN CANCER RES, V6, P2702; Newman DJ, 2007, J NAT PROD, V70, P461, DOI 10.1021/np068054v; Powell CMH, 2000, EMBO J, V19, P4665, DOI 10.1093/emboj/19.17.4665; Qin HR, 2008, CANCER RES, V68, P7736, DOI 10.1158/0008-5472.CAN-08-1125; Sartor AO, 2011, J HEMATOL ONCOL, V4, DOI 10.1186/1756-8722-4-18; Sartor CI, 1997, CANCER RES, V57, P978; Shin DS, 2009, CANCER RES, V69, P193, DOI 10.1158/0008-5472.CAN-08-2575; Siddiquee K, 2007, P NATL ACAD SCI USA, V104, P7391, DOI 10.1073/pnas.0609757104; Siddiquee KAZ, 2008, CELL RES, V18, P254, DOI 10.1038/cr.2008.18; Song H, 2005, P NATL ACAD SCI USA, V102, P4700, DOI 10.1073/pnas.0409894102; Sternberg CN, 2011, EUR J CANCER, V47, pS195, DOI 10.1016/S0959-8049(11)70165-4; Tetsu O, 1999, NATURE, V398, P422, DOI 10.1038/18884; Turkson J, 1998, MOL CELL BIOL, V18, P2545, DOI 10.1128/MCB.18.5.2545; WEN ZL, 1995, CELL, V82, P241, DOI 10.1016/0092-8674(95)90311-9; Yang SH, 2011, BIOORGAN MED CHEM, V19, P968, DOI 10.1016/j.bmc.2010.11.057; Yu H, 2004, NAT REV CANCER, V4, P97, DOI 10.1038/nrc1275; Yuan ZL, 2005, SCIENCE, V307, P269, DOI 10.1126/science.1105166; Zhao M, 2011, CURR MED CHEM, V18, P4012, DOI 10.2174/092986711796957284; ZHONG Z, 1994, SCIENCE, V264, P95, DOI 10.1126/science.8140422	48	44	45	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80391	10.1371/journal.pone.0080391	http://dx.doi.org/10.1371/journal.pone.0080391			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260381	Green Published, gold, Green Submitted			2022-12-25	WOS:000327258600062
J	Sosa-Calvo, J; Schultz, TR; Brandao, CRF; Klingenberg, C; Feitosa, RM; Rabeling, C; Bacci, M; Lopes, CT; Vasconcelos, HL				Sosa-Calvo, Jeffrey; Schultz, Ted R.; Brandao, Carlos R. F.; Klingenberg, Christiana; Feitosa, Rodrigo M.; Rabeling, Christian; Bacci, Mauricio, Jr.; Lopes, Caue T.; Vasconcelos, Heraldo L.			Cyatta abscondita: Taxonomy, Evolution, and Natural History of a New Fungus-Farming Ant Genus from Brazil	PLOS ONE			English	Article							LEAF-CUTTING ANTS; MYCOCEPURUS-SMITHII HYMENOPTERA; GROWING ANT; THELYTOCOUS PARTHENOGENESIS; PHYLOGENETIC ANALYSIS; ATTINI HYMENOPTERA; INSECT ORDER; FORMICIDAE; COEVOLUTION; DIVERSITY	Cyatta abscondita, a new genus and species of fungus-farming ant from Brazil, is described based on morphological study of more than 20 workers, two dealate gynes, one male, and two larvae. Ecological field data are summarized, including natural history, nest architecture, and foraging behavior. Phylogenetic analyses of DNA sequence data from four nuclear genes indicate that Cyatta abscondita is the distant sister taxon of the genus Kalathomyrmex, and that together they comprise the sister group of the remaining neoattine ants, an informal clade that includes the conspicuous and well-known leaf-cutter ants. Morphologically, Cyatta abscondita shares very few obvious character states with Kalathomyrmex. It does, however, possess a number of striking morphological features unique within the fungus-farming tribe Attini. It also shares morphological character states with taxa that span the ancestral node of the Attini. The morphology, behavior, and other biological characters of Cyatta abscondita are potentially informative about plesiomorphic character states within the fungus-farming ants and about the early evolution of ant agriculture.	[Sosa-Calvo, Jeffrey] Univ Maryland, Dept Entomol, Maryland Ctr Systemat Entomol, College Pk, MD 20742 USA; [Sosa-Calvo, Jeffrey; Schultz, Ted R.] Smithsonian Inst, Dept Entomol, Natl Museum Nat Hist, Washington, DC 20560 USA; [Brandao, Carlos R. F.] Univ Sao Paulo, Museu Zool, Sao Paulo, Brazil; [Klingenberg, Christiana] Staatl Museum Nat Kunde, Abt Entomol, Karlsruhe, Germany; [Feitosa, Rodrigo M.] Univ Fed Parana, Dept Zool, BR-80060000 Curitiba, Parana, Brazil; [Rabeling, Christian] Harvard Univ, Museum Comparat Zool, Cambridge, MA 02138 USA; [Bacci, Mauricio, Jr.] Univ Estadual Paulista, Ctr Estudos Insetos Sociais, Sao Paulo, Brazil; [Lopes, Caue T.; Vasconcelos, Heraldo L.] Univ Fed Uberlandia, Inst Biol, BR-38400 Uberlandia, MG, Brazil	University System of Maryland; University of Maryland College Park; Smithsonian Institution; Smithsonian National Museum of Natural History; Universidade de Sao Paulo; Universidade Federal do Parana; Harvard University; Universidade Estadual Paulista; Universidade Federal de Uberlandia	Sosa-Calvo, J (corresponding author), Univ Maryland, Dept Entomol, Maryland Ctr Systemat Entomol, College Pk, MD 20742 USA.	sossajef@si.edu; schultzt@si.edu	Vasconcelos, Heraldo L/C-3353-2013; Fapesp, Biota/F-8655-2017; Feitosa, Rodrigo Machado/D-2171-2012; Brandão, Carlos Roberto F/D-2047-2012; Bacci, Mauricio/C-4960-2013	Vasconcelos, Heraldo L/0000-0001-6969-7131; Fapesp, Biota/0000-0002-9887-8449; Feitosa, Rodrigo Machado/0000-0001-9042-0129; Brandão, Carlos Roberto F/0000-0002-4689-5845; Bacci, Mauricio/0000-0002-5619-1411	United States National Science Foundation [DEB 0949689]; Smithsonian Institution Scholarly Studies Program; Smithsonian National Museum of Natural History (NMNH) Small Grants Program; Harvard Society of Fellows; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2006/00185-7]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq) [476250/2008-0, 310826/2006-3]; Max and Vera Britton Environmental Science Award (Cosmos Club Foundation); Peter Buck Pre-doctoral Fellowship (NMNH-SI); FAPESP [2011/24160-1]; Division Of Environmental Biology [0949689] Funding Source: National Science Foundation	United States National Science Foundation(National Science Foundation (NSF)); Smithsonian Institution Scholarly Studies Program; Smithsonian National Museum of Natural History (NMNH) Small Grants Program; Harvard Society of Fellows; Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Max and Vera Britton Environmental Science Award (Cosmos Club Foundation); Peter Buck Pre-doctoral Fellowship (NMNH-SI); FAPESP(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	The authors gratefully acknowledge their funding sources: TRS was supported by United States National Science Foundation grant DEB 0949689 and by the Smithsonian Institution Scholarly Studies Program. TRS and JSC were supported by the Smithsonian National Museum of Natural History (NMNH) Small Grants Program. CR was supported by the Harvard Society of Fellows. MB was supported by the Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) (2006/00185-7) and the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)(476250/2008-0 and 310826/2006-3). JSC was supported by a Max and Vera Britton Environmental Science Award (Cosmos Club Foundation) and a Peter Buck Pre-doctoral Fellowship (NMNH-SI). RMF was supported by FAPESP (2011/24160-1). CRFB was supported by FAPESP and CNPq. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Araujo Fd, 2005, ANALISE VARIACOES BI, P91; Archibald SB, 2011, P ROY SOC B-BIOL SCI, V278, P3679, DOI 10.1098/rspb.2011.0729; Arillo A, 2006, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2006)3539[1:RCIBAN]2.0.CO;2; Autuori M., 1942, ARQ INST BIOL [SAO PAULO], V13, P137; AUTUORI M., 1941, ARQ INST BIOL [SAO PAULO], V12, P197; Barden P, 2013, ZOOTAXA, V3681, P405, DOI 10.11646/zootaxa.3681.4.5; Barke Joerg, 2011, Communicative & Integrative Biology, V4, P41, DOI 10.4161/cib.4.1.13552; Bebber DP, 2007, P R SOC B, V274, P1651, DOI 10.1098/rspb.2007.0464; Belt T., 1874, NATURALIST NICARAGUA; BLANTON CM, 1985, ECOLOGY, V66, P861, DOI 10.2307/1940548; Bolton B, 2013, ANTCAT ONLINE CATALO; Bolton B, 2008, ZOOTAXA, P1; Bolton Barry, 2012, Zootaxa, V3283, P1; Bramorski J, 2012, REV BRAS CIENC SOLO, V36, P1291, DOI 10.1590/S0100-06832012000400023; Brandao CRF, 2001, SOCIOBIOLOGY, V38, P639; Branstetter MG, 2009, ZOOTAXA, P41, DOI 10.11646/zootaxa.2221.1.3; Cafaro MJ, 2005, CAN J MICROBIOL, V51, P441, DOI 10.1139/W05-023; Caldera EJ, 2009, ENVIRON ENTOMOL, V38, P78, DOI 10.1603/022.038.0110; Cameron SL, 2006, MOL PHYLOGENET EVOL, V38, P274, DOI 10.1016/j.ympev.2005.09.020; CHAPELA IH, 1994, SCIENCE, V266, P1691, DOI 10.1126/science.266.5191.1691; CHERRETT JM, 1976, ANN APPL BIOL, V84, P124, DOI 10.1111/j.1744-7348.1976.tb01741.x; Coutinho L.M., 1978, REV BRASILEIRA BOT, V7, P17; Cover S, 2007, MEMOIRS AM ENTOMOLOG, P89; Currie CR, 2001, ANNU REV MICROBIOL, V55, P357, DOI 10.1146/annurev.micro.55.1.357; Currie CR, 2003, SCIENCE, V299, P386, DOI 10.1126/science.1078155; Currie CR, 2003, OIKOS, V101, P91, DOI 10.1034/j.1600-0706.2003.12036.x; Currie CR, 1999, P NATL ACAD SCI USA, V96, P7998, DOI 10.1073/pnas.96.14.7998; Delabie Jacques H.C., 1998, Agrotropica, V9, P49; Dlussky GM, 2004, INSECT SYST EVOL, V35, P1, DOI 10.1163/187631204788964727; Drummond AJ, 2005, MOL BIOL EVOL, V22, P1185, DOI [10.1093/molbev/msi103, 10.1093/molbev/mss075]; Dubovikov D. A., 2004, Entomologicheskoe Obozrenie, V83, P487; Dubovikov DA, 2004, P RUSSIAN ENTOMOLOGI, V75, P219; Eiten G., 1983, CLASSIFICACAO VEGETA, P305; Engel MS, 2005, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2005)485[0001:PNAICA]2.0.CO;2; Farji-Brener AG, 2001, OIKOS, V92, P169, DOI 10.1034/j.1600-0706.2001.920120.x; Felfili JM, 2000, J TROP ECOL, V16, P579, DOI 10.1017/S0266467400001589; Fernandez C. Fernando, 2003, Zootaxa, V341, P1; Fernandez F, 2004, SOCIOBIOLOGY, V44, P325; Fernandez F, 2009, ZOOTAXA, P55, DOI 10.11646/zootaxa.2204.1.5; Fernandez-Marin H, 2005, J NAT HIST, V39, P1735, DOI 10.1080/00222930400027462; Brandao CR, 2008, REV BRAS ENTOMOL, V52, P349, DOI 10.1590/S0085-56262008000300006; Fisher Brian L., 2006, Myrmecologische Nachrichten, V8, P111; Fisher BL, 2009, ZOOTAXA, P37, DOI 10.11646/zootaxa.2118.1.3; FOWLER HG, 1991, ANT - PLANT INTERACTIONS, P51; FOWLER HG, 1979, INFORM CIENT, V2, P30; Gauld I. D., 1988, HYMENOPTERA; Gerardo NM, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-88; Gerardo NM, 2006, PLOS BIOL, V4, P1358, DOI 10.1371/journal.pbio.0040235; Gottsberger G., 2006, LIFE CERRADO ORIGIN; Green AM, 2002, MOL ECOL, V11, P191, DOI 10.1046/j.1365-294X.2002.01433.x; Guenard B, 2012, P NATL ACAD SCI USA, V109, P7368, DOI 10.1073/pnas.1113867109; Heath TA, 2008, J SYST EVOL, V46, P239, DOI 10.3724/SP.J.1002.2008.08016; HINKLE G, 1994, SCIENCE, V266, P1695, DOI 10.1126/science.7992052; HOLLDOBLER B, 1986, J INSECT PHYSIOL, V32, P143, DOI 10.1016/0022-1910(86)90133-2; Holldobler B., 1990, pi; Hu┬lldobler B., 2010, LEAFCUTTER ANTS CIVI; IISE, 2011, STAT OBS SPEC; International Commission on Zoological Nomenclature (ICZN), 1999, INT CODE ZOOLOGICAL, P306, DOI DOI 10.5962/BHL.TITLE.50608; Klass KD, 2002, SCIENCE, V296, P1456, DOI 10.1126/science.1069397; Klass Klaus-Dieter, 2003, Entomologische Abhandlungen (Dresden), V61, P3; Klingenberg C, 2009, ZOOTAXA, P1; Lapolla JS, 2012, SYST ENTOMOL, V37, P200, DOI 10.1111/j.1365-3113.2011.00605.x; Lopes Benedito C., 2005, Rev. Bras. Zool., V22, P372, DOI 10.1590/S0101-81752005000200011; Lopes SF., 2012, INT J FORESTRY RES, V2012, P1, DOI [DOI 10.1155/2012/537269, 10.1155/2012/537269]; Maddison D.R., 2003, MACCLADE V4 06; Marshall DC, 2006, SYST BIOL, V55, P993, DOI 10.1080/10635150601087641; Marshall DC, 2010, SYST BIOL, V59, P108, DOI 10.1093/sysbio/syp080; Mehdiabadi NJ, 2010, MYRMECOL NEWS, V13, P37; Mehdiabadi NJ, 2006, BEHAV ECOL, V17, P291, DOI 10.1093/beheco/arj028; Mikheyev AS, 2007, MOL ECOL, V16, P209, DOI 10.1111/j.1365-294X.2006.03134.x; Mikheyev AS, 2006, P NATL ACAD SCI USA, V103, P10702, DOI 10.1073/pnas.0601441103; Mueller UG, 2001, Q REV BIOL, V76, P169, DOI 10.1086/393867; Mueller UG, 1998, SCIENCE, V281, P2034, DOI 10.1126/science.281.5385.2034; Mueller UG, 2002, P NATL ACAD SCI USA, V99, P15247, DOI 10.1073/pnas.242594799; Mueller UG, 2002, AM NAT, V160, pS67, DOI 10.1086/342084; Mueller UG, 2004, BEHAV ECOL, V15, P357, DOI 10.1093/beheco/arh020; Munkacsi AB, 2004, P ROY SOC B-BIOL SCI, V271, P1777, DOI 10.1098/rspb.2004.2759; Myers N, 2000, NATURE, V403, P853, DOI 10.1038/35002501; Necchi Jr O, 2012, FAUNA FLORA FRAGMENT, P15; Oliveira-Filho A., 2002, CERRADOS BRAZIL, P91, DOI [10.1590/1519-6984.02016, DOI 10.7312/OLIV12042-007]; Penick CA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041595; Picker MD, 2002, SCIENCE, V297, P1475; Rabeling C, 2007, J INSECT SCI, V7, DOI 10.1673/031.007.4001; Rabeling C, 2008, P NATL ACAD SCI USA, V105, P14913, DOI 10.1073/pnas.0806187105; Rabeling C, 2007, ZOOTAXA, P1; Rabeling C, 2013, ANNU REV ENTOMOL, V58, P273, DOI 10.1146/annurev-ento-120811-153710; Rabeling C, 2011, P NATL ACAD SCI USA, V108, P12366, DOI 10.1073/pnas.1105467108; Rabeling C, 2010, SYST ENTOMOL, V35, P379, DOI 10.1111/j.1365-3113.2010.00533.x; Rabeling C, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006781; Rambaut A., 2007, TRACER V1 4; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schultz Ted R., 2005, P149; Schultz TR, 2008, P NATL ACAD SCI USA, V105, P5435, DOI 10.1073/pnas.0711024105; Schultz TR, 1995, SYST ENTOMOL, V20, P337, DOI 10.1111/j.1365-3113.1995.tb00100.x; Serna F, 2010, J INSECT SCI, V10, DOI 10.1673/031.010.11101; Silva JMC, 2004, BIODIVERSIDADE CAATI; Silva RR, 2009, ZOOTAXA, P32, DOI 10.11646/zootaxa.2052.1.2; Soares AER, 2012, BIOINFORM BIOL INSIG, V6, P129, DOI 10.4137/BBI.S9677; Solomon SE, 2011, J INSECT SCI, V11, DOI 10.1673/031.011.0112; Sosa-Calvo J, 2010, ANN ENTOMOL SOC AM, V103, P181, DOI 10.1603/AN09108; Stutz B, 2009, FINDING NEW SPECIES; Taerum SJ, 2007, P ROY SOC B-BIOL SCI, V274, P1971, DOI 10.1098/rspb.2007.0431; Tannus, 2006, BIOTA NEOTROP, V6, P1, DOI DOI 10.1590/S1676-06032006000300008; Terayama Mamoru, 2009, Research Bulletin of Kanto Gakuen University Liberal Arts, V17, P81; Varon EH, 2007, AGR FOREST ENTOMOL, V9, P47, DOI 10.1111/j.1461-9563.2006.00320.x; Villesen P, 2004, EVOLUTION, V58, P2252; Ward Philip S., 2007, Zootaxa, V1668, P549; Ward PS, 2010, ANT ECOLOGY, P3; Ward PS, 2010, SYST BIOL, V59, P342, DOI 10.1093/sysbio/syq012; WEBER NA, 1966, SCIENCE, V153, P587, DOI 10.1126/science.153.3736.587; Weber NA, 1958, P 10 INT C ENT, V2, P459; Weber Neal A., 1945, REV ENT [RIO DE JANEIRO], V16, P1; Westwood J. O, 1833, MAGAZINE NATURAL HIS, V6, P116; Wheeler G.C., 1976, ANT LARVAE REV SYNTH; Wheeler WM, 1907, B AM MUS NAT HIST, V23, P669; Wild AL, 2006, ZOOTAXA, P57, DOI 10.11646/zootaxa.1142.1.5; Wirth R, 2003, HERBIVORY LEAF CUTTI; Wirth R, 2007, J TROP ECOL, V23, P501, DOI 10.1017/S0266467407004221; Yamane Seiki, 2008, Zootaxa, V1767, P55; Yek SzeHuei, 2012, Psyche: A Journal of Entomology, V2012, P239392; Zompro Oliver, 2001, Mitteilungen aus dem Geologisch-Palaeontologischen Institut der Universitaet Hamburg, V85, P229	121	27	28	1	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80498	10.1371/journal.pone.0080498	http://dx.doi.org/10.1371/journal.pone.0080498			20	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260403	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600066
J	Tanaka, K; Iwatani, H; Takahashi, Y; Sakaguchi, A; Yoshimura, K; Onda, Y				Tanaka, Kazuya; Iwatani, Hokuto; Takahashi, Yoshio; Sakaguchi, Aya; Yoshimura, Kazuya; Onda, Yuichi			Investigation of Spatial Distribution of Radiocesium in a Paddy Field as a Potential Sink	PLOS ONE			English	Article							NUCLEAR-POWER-PLANT; ACCIDENT; CS-137; SOILS; FALLOUT; I-131; PROFILES; U-236	Surface soils, under various land uses, were contaminated by radionuclides that were released by the Fukushima Daiichi Nuclear Power Plant accident. Because paddy fields are one of the main land uses in Japan, we investigated the spatial distribution of radiocesium and the influence of irrigation water in a paddy field during cultivation. Soil core samples collected at a paddy field in Fukushima showed that plowing had disturbed the original depth distribution of radiocesium. The horizontal distribution of radiocesium did not show any evidence for significant influence of radiocesium from irrigation water, and its accumulation within the paddy field, since the original amount of radiocesium was much larger than was added into the paddy field by irrigation water. However, it is possible that rainfall significantly increases the loading of radiocesium.	[Tanaka, Kazuya] Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan; [Iwatani, Hokuto; Takahashi, Yoshio; Sakaguchi, Aya] Hiroshima Univ, Grad Sch Sci, Dept Earth & Planetary Syst Sci, Higashihiroshima 724, Japan; [Yoshimura, Kazuya; Onda, Yuichi] Univ Tsukuba, Ctr Res Isotopes & Environm Dynam, Tsukuba, Ibaraki, Japan	Hiroshima University; Hiroshima University; University of Tsukuba	Tanaka, K (corresponding author), Hiroshima Univ, Inst Sustainable Sci & Dev, Higashihiroshima 724, Japan.	kt0830@hiroshima-u.ac.jp	Takahashi, Yoshio/F-6733-2011; Onda, Yuichi/N-6527-2014; Yoshimura, Kazuya/N-9508-2015; Sakaguchi, Aya/E-8134-2015	Takahashi, Yoshio/0000-0001-7860-2341; Onda, Yuichi/0000-0001-8753-0378; Yoshimura, Kazuya/0000-0001-5256-2679; Sakaguchi, Aya/0000-0003-3870-644X; Iwatani, Hokuto/0000-0001-6823-6528	Ministry of Education, Culture, Sports, Science & Technology, Japan [24110008]; Grants-in-Aid for Scientific Research [22224011] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science & Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	This study was supported by a Grant-in-Aid of Ministry of Education, Culture, Sports, Science & Technology, Japan (No. 24110008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Chino M, 2011, J NUCL SCI TECHNOL, V48, P1129, DOI 10.3327/jnst.48.1129; He Q, 1996, J ENVIRON RADIOACTIV, V30, P117, DOI 10.1016/0265-931X(96)89275-7; Kato H, 2012, J ENVIRON RADIOACTIV, V111, P59, DOI 10.1016/j.jenvrad.2011.10.003; Matsunaga T, 2013, SCI TOTAL ENVIRON, V447, P301, DOI 10.1016/j.scitotenv.2012.12.087; MEXT, 2013, EXT SIT DISTR MAP RA; Ohno T, 2012, GEOCHEM J, V46, P287, DOI 10.2343/geochemj.2.0204; Phillips JM, 2000, HYDROL PROCESS, V14, P2589, DOI [10.1002/1099-1085(20001015)14:14<2589::AID-HYP94>3.0.CO;2-D, 10.1002/1099-1085(20001015)14:14&lt;2589::AID-HYP94&gt;3.0.CO;2-D]; Sakaguchi A, 2010, SCI TOTAL ENVIRON, V408, P5392, DOI 10.1016/j.scitotenv.2010.07.073; Sakaguchi A, 2009, SCI TOTAL ENVIRON, V407, P4238, DOI 10.1016/j.scitotenv.2009.01.058; Sakaguchi A, 2012, GEOCHEM J, V46, P355, DOI 10.2343/geochemj.2.0216; Sasada Y, 2004, HEALTH, V3, P49; Tanaka K, 2013, J RADIOANAL NUCL CH, V295, P1927, DOI 10.1007/s10967-012-2160-9; Tanaka K, 2012, GEOCHEM J, V46, P73, DOI 10.2343/geochemj.1.0137; Tsukada H, 2008, J ENVIRON RADIOACTIV, V99, P875, DOI 10.1016/j.jenvrad.2007.11.014; YAMAMOTO M, 1983, J RADIAT RES, V24, P237, DOI 10.1269/jrr.24.237	15	20	21	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80794	10.1371/journal.pone.0080794	http://dx.doi.org/10.1371/journal.pone.0080794			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260481	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600085
J	Li, L; Hu, YZ; Ylivinkka, I; Li, HN; Chen, P; Keski-Oja, J; Hyytiainen, M				Li, Li; Hu, Yizhou; Ylivinkka, Irene; Li, Huini; Chen, Ping; Keski-Oja, Jorma; Hyytiainen, Marko			NETRIN-4 Protects Glioblastoma Cells FROM Temozolomide Induced Senescence	PLOS ONE			English	Article							METHYLTRANSFERASE MGMT; ADJUVANT TEMOZOLOMIDE; GENE-EXPRESSION; GLIOMA-CELLS; DNA-REPAIR; PHASE-II; RESISTANCE; AKT; INHIBITION; ACTIVATION	Glioblastoma multiforme is the most common primary tumor of the central nervous system. The drug temozolomide (TMZ) prolongs lifespan in many glioblastoma patients. The sensitivity of glioblastoma cells to TMZ is interfered by many factors, such as the expression of O-6-methylguanine-DNA methyltransferase (MGMT) and activation of AKT signaling. We have recently identified the interaction between netrin-4 (NTN4) and integrin beta-4 (ITGB4), which promotes glioblastoma cell proliferation via activating AKT-mTOR signaling pathway. In the current work we have explored the effect of NTN4/ITGB4 interaction on TMZ induced glioblastoma cell senescence. We report here that the suppression of either ITGB4 or NTN4 in glioblastoma cell lines significantly enhances cellular senescence. The sensitivity of GBM cells to TMZ was primarily determined by the expression of MGMT. To omit the effect of MGMT, we concentrated on the cell lines devoid of expression of MGMT. NTN4 partially inhibited TMZ induced cell senescence and rescued AKT from dephosphorylation in U251MG cells, a cell line bearing decent levels of ITGB4. However, addition of exogenous NTN4 displayed no significant effect on TMZ induced senescence rescue or AKT activation in U87MG cells, which expressed ITGB4 at low levels. Furthermore, overexpression of ITGB4 combined with exogenous NTN4 significantly attenuated U87MG cell senescence induced by TMZ. These data suggest that NTN4 protects glioblastoma cells from TMZ induced senescence, probably via rescuing TMZ triggered ITGB4 dependent AKT dephosphorylation. This suggests that interfering the interaction between NTN4 and ITGB4 or concomitant use of the inhibitors of the AKT pathway may improve the therapeutic efficiency of TMZ.	[Li, Li; Hu, Yizhou; Ylivinkka, Irene; Li, Huini; Keski-Oja, Jorma; Hyytiainen, Marko] Univ Helsinki, Dept Virol, Fac Med, Helsinki, Finland; [Li, Li; Hu, Yizhou; Ylivinkka, Irene; Li, Huini; Keski-Oja, Jorma; Hyytiainen, Marko] Univ Helsinki, Dept Pathol, Fac Med, Helsinki, Finland; [Li, Li; Hu, Yizhou; Ylivinkka, Irene; Li, Huini; Keski-Oja, Jorma; Hyytiainen, Marko] Univ Helsinki, Haartman Inst, Translat Canc Biol Res Program, Helsinki, Finland; [Li, Li; Hu, Yizhou; Ylivinkka, Irene; Li, Huini; Keski-Oja, Jorma; Hyytiainen, Marko] Univ Helsinki, Helsinki Univ Hosp, Helsinki, Finland; [Li, Li] Harbin Med Univ, Clin Coll 2, Dept Oncol, Harbin, Peoples R China; [Chen, Ping] Univ Helsinki, Res Programs Unit, Helsinki, Finland; [Chen, Ping] Univ Helsinki, Inst Biomed, Helsinki, Finland	University of Helsinki; University of Helsinki; University of Helsinki; University of Helsinki; Helsinki University Central Hospital; Harbin Medical University; University of Helsinki; University of Helsinki	Hyytiainen, M (corresponding author), Univ Helsinki, Dept Virol, Fac Med, Helsinki, Finland.	marko.hyytiainen@helsinki.fi	Hu, Yizhou/AAP-4047-2020; Chen, Ping/AAL-8264-2020	Hu, Yizhou/0000-0002-2635-0258; Chen, Ping/0000-0002-8068-1891; Li, Huini/0000-0002-7884-9624; Ylivinkka, Irene/0000-0001-5035-0445	Finnish Cultural Foundation; Academy of Finland [139236]; Finnish Cancer Foundation; Sigrid Juselius Foundation; Finska Lakaresallskapet; Finnish Society of Sciences and Letters; Biocentrum Helsinki; Helsinki University Hospital Fund; University of Helsinki; Helsinki Biomedical Graduate Program	Finnish Cultural Foundation(Finnish Cultural FoundationFinnish IT center for science); Academy of Finland(Academy of Finland); Finnish Cancer Foundation; Sigrid Juselius Foundation(Sigrid Juselius Foundation); Finska Lakaresallskapet; Finnish Society of Sciences and Letters; Biocentrum Helsinki; Helsinki University Hospital Fund; University of Helsinki; Helsinki Biomedical Graduate Program	This research was supported by grants from the Finnish Cultural Foundation; the Academy of Finland (grant number 139236); the Finnish Cancer Foundation; the Sigrid Juselius Foundation; Finska Lakaresallskapet; the Finnish Society of Sciences and Letters; Biocentrum Helsinki; Helsinki University Hospital Fund and the University of Helsinki; Helsinki Biomedical Graduate Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alonso MM, 2007, CANCER RES, V67, P11499, DOI 10.1158/0008-5472.CAN-07-5312; Bleau AM, 2009, CELL STEM CELL, V4, P226, DOI 10.1016/j.stem.2009.01.007; Bobustuc GC, 2010, NEURO-ONCOLOGY, V12, P917, DOI 10.1093/neuonc/noq044; Brock CS, 1998, CANCER RES, V58, P4363; Clark AS, 2002, MOL CANCER THER, V1, P707; Coloff JL, 2011, CANCER RES, V71, P5204, DOI 10.1158/0008-5472.CAN-10-4531; DeAngelis LM, 2005, NEW ENGL J MED, V352, P1036, DOI 10.1056/NEJMe058010; Debacq-Chainiaux F, 2009, NAT PROTOC, V4, P1798, DOI 10.1038/nprot.2009.191; Fenton TR, 2012, P NATL ACAD SCI USA, V109, P14164, DOI 10.1073/pnas.1211962109; Gaspar N, 2010, CANCER RES, V70, P9243, DOI 10.1158/0008-5472.CAN-10-1250; Grombacher T, 1998, ONCOGENE, V17, P845, DOI 10.1038/sj.onc.1202000; Gunther W, 2003, BRIT J CANCER, V88, P463, DOI 10.1038/sj.bjc.6600711; Hegi ME, 2005, NEW ENGL J MED, V352, P997, DOI 10.1056/NEJMoa043331; Hegi ME, 2008, J CLIN ONCOL, V26, P4189, DOI 10.1200/JCO.2007.11.5964; Hemmings BA, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a011189; Hirose Y, 2005, CANCER RES, V65, P4861, DOI 10.1158/0008-5472.CAN-04-2633; Hoang S, 2009, J CEREBR BLOOD F MET, V29, P385, DOI 10.1038/jcbfm.2008.128; Hoelzinger DB, 2005, NEOPLASIA, V7, P7, DOI 10.1593/neo.04535; Hu YZ, 2012, NEOPLASIA, V14, P219, DOI 10.1593/neo.111396; Ishii N, 1999, ONCOGENE, V18, P5870, DOI 10.1038/sj.onc.1203241; Johnson DR, 2012, J NEURO-ONCOL, V107, P359, DOI 10.1007/s11060-011-0749-4; Kanzawa T, 2003, J NEUROSURG, V99, P1047, DOI 10.3171/jns.2003.99.6.1047; KARRAN P, 1982, NATURE, V296, P868, DOI 10.1038/296868a0; Koch M, 2000, J CELL BIOL, V151, P221, DOI 10.1083/jcb.151.2.221; Larrieu-Lahargue F, 2010, BLOOD, V115, P5418, DOI 10.1182/blood-2009-11-252338; Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395; Lejmi E, 2008, P NATL ACAD SCI USA, V105, P12491, DOI 10.1073/pnas.0804008105; Louis DN, 2006, ANNU REV PATHOL-MECH, V1, P97, DOI 10.1146/annurev.pathol.1.110304.100043; Momota H, 2005, CANCER RES, V65, P7429, DOI 10.1158/0008-5472.CAN-05-1042; Parsa AT, 2004, TRENDS MOL MED, V10, P607, DOI 10.1016/j.molmed.2004.10.009; Prasad G, 2011, NEURO-ONCOLOGY, V13, P384, DOI 10.1093/neuonc/noq193; Schneiders FI, 2007, J BIOL CHEM, V282, P23750, DOI 10.1074/jbc.M703137200; Sinnberg T, 2009, J INVEST DERMATOL, V129, P1500, DOI 10.1038/jid.2008.379; Sos ML, 2009, CANCER RES, V69, P3256, DOI 10.1158/0008-5472.CAN-08-4055; Staquicinia FI, 2009, P NATL ACAD SCI USA, V106, P2903, DOI 10.1073/pnas.0813286106; Stupp R, 2005, NEW ENGL J MED, V352, P987, DOI 10.1056/NEJMoa043330; Stupp R, 2009, LANCET ONCOL, V10, P459, DOI 10.1016/S1470-2045(09)70025-7; Sun CH, 2010, J CELL PHYSIOL, V225, P673, DOI 10.1002/jcp.22262; Sun CH, 2009, J CELL BIOCHEM, V108, P519, DOI 10.1002/jcb.22282; Tolcher AW, 2003, BRIT J CANCER, V88, P1004, DOI 10.1038/sj.bjc.6600827; van den Bent MJ, 2009, J CLIN ONCOL, V27, P5881, DOI 10.1200/JCO.2009.24.1034; Venkatesh HS, 2012, NEURO-ONCOLOGY, V14, P315, DOI 10.1093/neuonc/nor209; Vivanco I, 2002, NAT REV CANCER, V2, P489, DOI 10.1038/nrc839; Wagner L, 2013, ONCOGENE, V32, P988, DOI 10.1038/onc.2012.108; Wang L, 2012, J CELL PHYSIOL, V227, P474, DOI 10.1002/jcp.22769; Wechsler-Reya R, 2001, ANNU REV NEUROSCI, V24, P385, DOI 10.1146/annurev.neuro.24.1.385; Wilson BD, 2006, SCIENCE, V313, P640, DOI 10.1126/science.1124704; Wong ET, 1999, J CLIN ONCOL, V17, P2572, DOI 10.1200/JCO.1999.17.8.2572; Yin Y, 2000, MECH DEVELOP, V96, P115, DOI 10.1016/S0925-4773(00)00369-5; Ylivinkka I, 2013, J CELL SCI, V126, P2459, DOI 10.1242/jcs.120022; Yung WKA, 2000, BRIT J CANCER, V83, P588, DOI 10.1054/bjoc.2000.1316; Zoncu R, 2011, NAT REV MOL CELL BIO, V12, P21, DOI 10.1038/nrm3025	52	17	18	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80363	10.1371/journal.pone.0080363	http://dx.doi.org/10.1371/journal.pone.0080363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265816	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100152
J	Liu, LY; Liu, WH; Cao, YK; Zhang, L; Wang, PH; Tang, LJ				Liu, Li-ye; Liu, Wei-hui; Cao, Yong-kuan; Zhang, Lin; Wang, Pei-hong; Tang, Li-jun			Urinary Function following Laparoscopic Lymphadenectomy for Male Rectal Cancer	PLOS ONE			English	Article							TOTAL MESORECTAL EXCISION; AUTONOMIC NERVE PRESERVATION; MALE UROGENITAL FUNCTION; NODE DISSECTION; RESECTION; SURGERY; IMPACT	Objectives: Urinary function can be protected following open lateral node dissection (LND) with pelvic autonomic nerve preservation (PANP) for advanced rectal cancer. However data regarding urinary function after laparoscopic LND with PANP have not been reported. The goal of this study was to determine the effects of laparoscopic LND with PANP on urinary function in male patients with rectal cancer. Methods: Urine flowmetry was performed using an Urodyn flowmeter. Patients were also asked to complete the standardized International Prostate Symptom Score (IPSS) questionnaire before surgery and 6 months after. In total, this study consisted of 60 males with advanced rectal cancer. Results: No significant differences were seen in maximal urinary flow rate, voided volume or residual volume before and after surgery. The total IPSS score increased significantly after surgery and at least 41 patients (68.3%) reported there was no change in one of the seven IPSS questions. Conclusions: Laparoscopic LND with PANP was relatively safe in preserving urinary function.	[Liu, Li-ye; Liu, Wei-hui; Cao, Yong-kuan; Zhang, Lin; Wang, Pei-hong; Tang, Li-jun] Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Sichuan Provinc, Peoples R China		Tang, LJ (corresponding author), Chengdu Mil Gen Hosp, Dept Gen Surg, Chengdu, Sichuan Provinc, Peoples R China.	whjtlj1251@163.com						Akasu T, 2008, ANN SURG ONCOL, V15, P2668, DOI 10.1245/s10434-008-0047-3; Akasu T, 2009, ANN SURG ONCOL, V16, P2779, DOI 10.1245/s10434-009-0546-x; Akiyoshi T, 2012, J GASTROINTEST SURG, V16, P2341, DOI 10.1007/s11605-012-1955-x; BARRY MJ, 1992, J UROLOGY, V148, P1549, DOI 10.1016/S0022-5347(17)36966-5; Bhangu A, 2013, ANN SURG; Bilchik AJ, 2007, ANN SURG, V246, P568, DOI 10.1097/SLA.0b013e318155a9c7; Breukink S, 2008, INT J COLORECTAL DIS, V23, P1199, DOI 10.1007/s00384-008-0547-4; Chang AJBA, 2008, J SURG EDUC, V65, P67, DOI 10.1016/j.jsurg.2007.11.002; [杜晓辉 Du Xiaohui], 2012, [中华外科杂志, Chinese Journal of Surgery], V50, P219; Heald B, 2008, Acta Chir Iugosl, V55, P11; Jackson KS, 2006, INT J GYNECOL CANCER, V16, P354, DOI 10.1111/j.1525-1438.2006.00347.x; Jakob C, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027402; Kasparek MS, 2012, DIS COLON RECTUM, V55, P147, DOI 10.1097/DCR.0b013e31823d2606; Kellokumpu IH, 2012, DIS COLON RECTUM, V55, P854, DOI 10.1097/DCR.0b013e31825b9052; Kim TH, 2008, ANN SURG ONCOL, V15, P729, DOI 10.1245/s10434-007-9696-x; Kneist W, 2007, WORLD J SURG, V31, P1321, DOI 10.1007/s00268-007-9008-4; Konishi T, 2011, SURG ENDOSC, V7, P2358; Kusters M, 2009, ANN SURG ONCOL, V16, P289, DOI 10.1245/s10434-008-0223-5; Kyo K, 2006, WORLD J SURG, V30, P1014, DOI 10.1007/s00268-005-0050-9; Liang JT, 2007, ANN SURG ONCOL, V14, P1285, DOI 10.1245/s10434-006-9052-6; Lujan J, 2013, SURG ENDOSC, V27, P295, DOI 10.1007/s00464-012-2444-8; Moriya Yoshihiro, 2006, Int J Clin Oncol, V11, P339, DOI 10.1007/s10147-006-0608-z; Obara Shinsaku, 2012, Gan To Kagaku Ryoho, V39, P2173; Pocard M, 2002, SURGERY, V131, P368, DOI 10.1067/msy.2002.122371; SAUER I, 1951, AM J SURG, V81, P111, DOI 10.1016/0002-9610(51)90196-1; Sautter-Bihl ML, 2013, STRAHLENTHER ONKOL, V189, P105, DOI 10.1007/s00066-012-0299-5; Siani LM, 2012, G CHIR, V33, P404; Vaughan-Shaw PG, 2012, TECH COLOPROCTOL, V5, P355; Wu Xiao-Jian, 2009, Zhonghua Wei Chang Wai Ke Za Zhi, V12, P229	29	7	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78701	10.1371/journal.pone.0078701	http://dx.doi.org/10.1371/journal.pone.0078701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265709	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100042
J	McGowan, LD; Alaama, RA; Striedter, GF				McGowan, Luke D.; Alaama, Roula A.; Striedter, Georg F.			FGF2 Delays Tectal Neurogenesis, Increases Tectal Cell Numbers, and Alters Tectal Lamination in Embryonic Chicks	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; BRAIN EVOLUTION; OPTIC TECTUM; CYCLE EXIT; DIFFERENTIATION; PROGENITORS; PRECURSORS; EXPANSION; NEURONS; RETINA	Intraventricular injections of the fibroblast growth factor 2 (FGF2) are known to increase the size of the optic tectum in embryonic chicks. Here we show that this increase in tectum size is due to a delay in tectal neurogenesis, which by definition extends the proliferation of tectal progenitors. Specifically, we use cumulative labeling with the thymidine analog EdU to demonstrate that FGF2 treatment on embryonic day 4 (ED4) reduces the proportion and absolute number of unlabeled cells in the rostroventral tectum when EdU infusions are begun on ED5, as one would expect if FGF2 retards tectal neurogenesis. We also examined FGF29s effect on neurogenesis in the caudodorsal tectum, which is born 2-3 days after the rostroventral tectum, by combining FGF2 treatment on ED4 with EDU infusions beginning on ED8. Again, FGF2 treatment reduced the proportion and number of EdU-negative (i.e., unlabeled) cells, consistent with a delay in neurogenesis. Collectively, these data indicate FGF2 in embryonic chicks delays neurogenesis throughout much of the tectum and continues to do so for several days after the FGF2 injection. One effect of this delay in neurogenesis is that tectal cell numbers more than double. In addition, tectal laminae that are born early in development become abnormally thin and cell-sparse after FGF2 treatment, whereas late-born layers remain unaffected. Combined with the results of prior work, these data indicate that FGF2 delays tectal neurogenesis and, thereby, triggers a cascade of changes in tectum size and morphology.	[McGowan, Luke D.; Alaama, Roula A.; Striedter, Georg F.] Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92717 USA	University of California System; University of California Irvine	McGowan, LD (corresponding author), Univ Calif Irvine, Ctr Neurobiol Learning & Memory, Dept Neurobiol & Behav, Irvine, CA 92717 USA.	lukemcgowan1@yahoo.com			National Science Foundation [IOS-1025434]	National Science Foundation(National Science Foundation (NSF))	This work was supported by National Science Foundation Grant IOS-1025434. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BOUVIER MM, 1995, J NEUROSCI, V15, P7141; Charvet CJ, 2011, BRAIN BEHAV EVOLUT, V78, P248, DOI 10.1159/000329851; Chenn A, 2002, SCIENCE, V297, P365, DOI 10.1126/science.1074192; DELOULME JC, 1991, NEUROSCIENCE, V42, P561, DOI 10.1016/0306-4522(91)90398-8; Desai AR, 2000, DEVELOPMENT, V127, P2863; Finlay BL, 2008, BRAIN RES, V1192, P5, DOI 10.1016/j.brainres.2007.07.005; Finlay BL, 2001, BEHAV BRAIN SCI, V24, P263, DOI 10.1017/S0140525X01003958; FUJITA S, 1964, J COMP NEUROL, V122, P311, DOI 10.1002/cne.901220303; Lahti L, 2011, DEV BIOL, V349, P270, DOI 10.1016/j.ydbio.2010.11.008; LAVAIL JH, 1971, BRAIN RES, V28, P421; Martin C, 2006, DEV BIOL, V297, P402, DOI 10.1016/j.ydbio.2006.05.010; McGowan LD, 2012, P NATL ACAD SCI USA, V109, P10640, DOI 10.1073/pnas.1201875109; Nishita J, 2011, DEV DYNAM, V240, P1537, DOI 10.1002/dvdy.22616; Rapaport DH, 1996, PERSPECT DEV NEUROBI, V3, P147; Rash BG, 2013, J NEUROSCI, V33, P10802, DOI 10.1523/JNEUROSCI.3621-12.2013; Rash BG, 2011, J NEUROSCI, V31, P15604, DOI 10.1523/JNEUROSCI.4439-11.2011; Tarui T, 2005, CEREB CORTEX, V15, P1343, DOI 10.1093/cercor/bhi017; Thomson RE, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-4; Vaccarino FM, 1999, NAT NEUROSCI, V2, P246, DOI 10.1038/6350; VESCOVI AL, 1993, NEURON, V11, P951, DOI 10.1016/0896-6273(93)90124-A; Walshe J, 2000, MECH DEVELOP, V90, P103, DOI 10.1016/S0925-4773(99)00225-7; Warren M, 2009, DEV DYNAM, V238, P944, DOI 10.1002/dvdy.21895; Yoon KJ, 2004, J NEUROSCI, V24, P9497, DOI 10.1523/JNEUROSCI.0993-04.2004; Zhang LX, 2008, DEVELOPMENT, V135, P2065, DOI 10.1242/dev.022673	24	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79949	10.1371/journal.pone.0079949	http://dx.doi.org/10.1371/journal.pone.0079949			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265789	Green Published, gold			2022-12-25	WOS:000327252100122
J	Zhang, M; Luo, WT; Huang, B; Liu, ZH; Sun, LM; Zhang, QF; Qiu, XS; Xu, K; Wang, EH				Zhang, Min; Luo, Wenting; Huang, Bo; Liu, Zihui; Sun, Limei; Zhang, Qingfu; Qiu, Xueshan; Xu, Ke; Wang, Enhua			Overexpression of JAM-A in Non-Small Cell Lung Cancer Correlates with Tumor Progression	PLOS ONE			English	Article							JUNCTIONAL-ADHESION-MOLECULE; IMMUNOGLOBULIN SUPERFAMILY; MONOCLONAL-ANTIBODY; ENDOTHELIAL-CELLS; F11 RECEPTOR; EXPRESSION; MIGRATION; MEMBER; PROLIFERATION; INVOLVEMENT	The objective of the current study was to determine the clinical significance of junctional adhesion molecule A (JAM-A) in patients with non-small cell lung cancer (NSCLC) and the biological function of JAM-A in NSCLC cell lines. We showed that JAM-A is predominantly expressed in cell membranes and high expression of JAM-A occurred in 37% of lung tumor specimens compared to corresponding normal tissues. High expression of JAM-A was significantly correlated with TNM stage (P = 0.021), lymph node metastasis (P = 0.007), and decreased overall survival (P = 0.02), In addition, we observed that silencing JAM-A by small interfering RNA inhibited tumor cell proliferation and induced cell cycle arrest at the G1/S boundary. Western blotting analysis revealed that knockdown of JAM-A decreased the protein levels of cyclin D1, CDK4, 6, and P-Rb. Thus, JAM-A plays an important role in NSCLC progression.	[Zhang, Min; Luo, Wenting; Liu, Zihui; Sun, Limei; Zhang, Qingfu; Qiu, Xueshan; Wang, Enhua] China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China; [Zhang, Min; Luo, Wenting; Liu, Zihui; Sun, Limei; Zhang, Qingfu; Qiu, Xueshan; Wang, Enhua] China Med Univ, Coll Basic Med Sci, Shenyang, Peoples R China; [Zhang, Min] Shenyang Med Coll, Coll Basic Med Sci, Dept Pathol, Shenyang, Peoples R China; [Huang, Bo] Liaoning Canc Hosp, Dept Pathol, Shenyang, Peoples R China; [Xu, Ke] China Med Univ, Affiliated Hosp 1, Dept Radiol, Shenyang, Peoples R China	China Medical University; China Medical University; Shenyang Medical College; China Medical University	Qiu, XS (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Pathol, Shenyang, Peoples R China.	xueshanqiucmu@gmail.com			National Natural Science Foundation of China [30972967]; Research Fund for the Doctoral Program of the Higher Education of China [20092104110018]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Research Fund for the Doctoral Program of the Higher Education of China	This work was supported by grants from National Natural Science Foundation of China (No. 30972967) and Research Fund for the Doctoral Program of the Higher Education of China (No. 20092104110018). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barton ES, 2001, CELL, V104, P441, DOI 10.1016/S0092-8674(01)00231-8; Bazzoni G, 2000, J BIOL CHEM, V275, P20520, DOI 10.1074/jbc.M905251199; Bradfield PF, 2007, ARTERIOSCL THROM VAS, V27, P2104, DOI 10.1161/ATVBAHA.107.147694; Brennan K, 2013, ONCOGENE, V32, P2799, DOI 10.1038/onc.2012.276; Del MA, 1999, J EXP MED, V190, P1351; Ebnet K, 2000, J BIOL CHEM, V275, P27979; Ebnet K, 2001, EMBO J, V20, P3738, DOI 10.1093/emboj/20.14.3738; Fong D, 2012, ANN SURG ONCOL, V19, P4330, DOI 10.1245/s10434-012-2381-8; Giacinti C, 2006, ONCOGENE, V25, P5220, DOI 10.1038/sj.onc.1209615; Goetsch L, 2013, INT J CANCER, V132, P1463, DOI 10.1002/ijc.27772; Gotte M, 2010, ONCOGENE, V29, P6569, DOI 10.1038/onc.2010.386; Gupta SK, 2000, IUBMB LIFE, V50, P51; Harbour JW, 2000, GENE DEV, V14, P2393, DOI 10.1101/gad.813200; Khidr L, 2006, ONCOGENE, V25, P5210, DOI 10.1038/sj.onc.1209612; KORNECKI E, 1990, J BIOL CHEM, V265, P10042; Koshiba H, 2009, INT J GYNECOL CANCER, V19, P208, DOI 10.1111/IGC.0b013e31819bc6e9; Liang TW, 2000, AM J PHYSIOL-CELL PH, V279, pC1733, DOI 10.1152/ajpcell.2000.279.6.C1733; Liu Y, 2000, J CELL SCI, V113, P2363; Malergue F, 1998, MOL IMMUNOL, V35, P1111, DOI 10.1016/S0161-5890(98)00102-3; Mandell KJ, 2004, J BIOL CHEM, V279, P16254, DOI 10.1074/jbc.M309483200; Martin-Padura I, 1998, J CELL BIOL, V142, P117, DOI 10.1083/jcb.142.1.117; McSherry EA, 2011, BREAST CANCER RES, V13, DOI 10.1186/bcr2853; McSherry EA, 2009, INT J CANCER, V125, P1343, DOI 10.1002/ijc.24498; Murakami M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021242; Naik MU, 2008, CANCER RES, V68, P2194, DOI 10.1158/0008-5472.CAN-07-3057; Naik MU, 2003, BLOOD, V102, P2108, DOI 10.1182/blood-2003-04-1114; Nava P, 2011, EMBO REP, V12, P314, DOI 10.1038/embor.2011.16; Severson EA, 2008, MOL BIOL CELL, V19, P1862, DOI 10.1091/mbc.E07-09-0869; Severson EA, 2009, MOL BIOL CELL, V20, P1916, DOI 10.1091/mbc.E08-10-1014; Sobocka MB, 2000, BLOOD, V95, P2600	30	48	49	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79173	10.1371/journal.pone.0079173	http://dx.doi.org/10.1371/journal.pone.0079173			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265754	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100087
J	Staab, JF; Datta, K; Rhee, P				Staab, Janet F.; Datta, Kausik; Rhee, Peter			Niche-Specific Requirement for Hyphal Wall protein 1 in Virulence of Candida albicans	PLOS ONE			English	Article							SECRETED ASPARTYL PROTEINASES; TRANSGLUTAMINASE TYPE-II; SELECTABLE MARKER URA3; GENE DISRUPTION; GASTRIC CANDIDIASIS; BIOFILM FORMATION; CROSS-LINKING; MOUSE MODEL; EXPRESSION; HWP1	Specialized Candida albicans cell surface proteins called adhesins mediate binding of the fungus to host cells. The mammalian transglutaminase (TG) substrate and adhesin, Hyphal wall protein 1 (Hwp1), is expressed on the hyphal form of C. albicans where it mediates fungal adhesion to epithelial cells. Hwp1 is also required for biofilm formation and mating thus the protein functions in both fungal-host and self-interactions. Hwp1 is required for full virulence of C. albicans in murine models of disseminated candidiasis and of esophageal candidiasis. Previous studies correlated TG activity on the surface of oral epithelial cells, produced by epithelial TG (TG1), with tight binding of C. albicans via Hwp1 to the host cell surfaces. However, the contribution of other Tgs, specifically tissue TG (TG2), to disseminated candidiasis mediated by Hwp1 was not known. A newly created hwp1 null strain in the wild type SC5314 background was as virulent as the parental strain in C57BL/6 mice, and virulence was retained in C57BL/6 mice deleted for Tgm2 (TG2). Further, the hwp1 null strains displayed modestly reduced virulence in BALB/c mice as did strain DD27-U1, an independently created hwp1 Delta/Delta in CAI4 corrected for its ura3 Delta defect at the URA3 locus. Hwp1 was still needed to produce wild type biofilms, and persist on murine tongues in an oral model of oropharyngeal candidiasis consistent with previous studies by us and others. Finally, lack of Hwp1 affected the translocation of C. albicans from the mouse intestine into the bloodstream of mice. Together, Hwp1 appears to have a minor role in disseminated candidiasis, independent of tissue TG, but a key function in host-and self-association to the surface of oral mucosa.	[Staab, Janet F.; Datta, Kausik; Rhee, Peter] Johns Hopkins Univ, Johns Hopkins Sch Med, Baltimore, MD 21218 USA	Johns Hopkins University; Johns Hopkins Medicine	Staab, JF (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Med, Baltimore, MD 21218 USA.	janetstb@gmail.com	Datta, Kausik/A-2879-2016	Datta, Kausik/0000-0001-8666-143X	National Institute of Dental & Craniofacial Research [DE021972]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R21DE021972] Funding Source: NIH RePORTER	National Institute of Dental & Craniofacial Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	The study was funded by a grant from the National Institute of Dental & Craniofacial Research, DE021972, to JFS. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Ahmad A, 2008, YEAST, V25, P433, DOI 10.1002/yea.1597; Arbour M, 2009, FEMS YEAST RES, V9, P1070, DOI 10.1111/j.1567-1364.2009.00563.x; ASHMAN RB, 1987, IMMUNOL CELL BIOL, V65, P163, DOI 10.1038/icb.1987.18; Ashman RB, 1996, INFECT IMMUN, V64, P1866, DOI 10.1128/IAI.64.5.1866-1869.1996; Balish E, 2009, J MED MICROBIOL, V58, P290, DOI 10.1099/jmm.0.004846-0; Barelle CJ, 2006, CELL MICROBIOL, V8, P961, DOI 10.1111/j.1462-5822.2005.00676.x; Brand A, 2004, EUKARYOT CELL, V3, P900, DOI 10.1128/EC.3.4.900-909.2004; Braun BR, 2000, GENETICS, V156, P31; Braun BR, 2000, GENETICS, V155, P57; Carvalho A, 2012, CELL MOL IMMUNOL, V9, P276, DOI 10.1038/cmi.2012.1; Chen X, 2004, MOL MICROBIOL, V51, P551, DOI 10.1046/j.1365-2958.2003.03852.x; Cheng SJ, 2003, INFECT IMMUN, V71, P6101, DOI 10.1128/IAI.71.10.6101-6103.2003; Chibana H, 2005, MICROBIOL IMMUNOL, V49, P937, DOI 10.1111/j.1348-0421.2005.tb03686.x; Cleary IA, 2011, MICROBIOL-SGM, V157, P1806, DOI 10.1099/mic.0.046326-0; Coleman DA, 2009, J MICROBIOL METH, V78, P71, DOI 10.1016/j.mimet.2009.05.002; Correia A, 2010, INFECT IMMUN, V78, P4839, DOI 10.1128/IAI.00248-10; Costa AC, 2013, VIRULENCE, V4; De Laurenzi V, 2001, MOL CELL BIOL, V21, P148, DOI 10.1128/MCB.21.1.148-155.2001; Ene IV, 2009, EUKARYOT CELL, V8, P1909, DOI 10.1128/EC.00245-09; Falasca L, 2005, J IMMUNOL, V174, P7330, DOI 10.4049/jimmunol.174.11.7330; Falasca L, 2008, J IMMUNOL, V180, P2616, DOI 10.4049/jimmunol.180.4.2616; Fanning S, 2012, EUKARYOT CELL, V11, P896, DOI 10.1128/EC.00103-12; FONZI WA, 1993, GENETICS, V134, P717; Fu Y, 1998, INFECT IMMUN, V66, P1783, DOI 10.1128/IAI.66.4.1783-1786.1998; Ganguly S, 2011, CURR OPIN MICROBIOL, V14, P380, DOI 10.1016/j.mib.2011.06.001; GILLUM AM, 1984, MOL GEN GENET, V198, P179, DOI 10.1007/BF00328721; HECTOR RF, 1982, INFECT IMMUN, V38, P1020, DOI 10.1128/IAI.38.3.1020-1028.1982; Hube B, 2001, MICROBIOL-SGM, V147, P879, DOI 10.1099/00221287-147-4-879; Itoh M, 2011, J HISTOCHEM CYTOCHEM, V59, P180, DOI 10.1369/jhc.2010.957225; Jackson BE, 2007, INVEST OPHTH VIS SCI, V48, P3559, DOI 10.1167/iovs.07-0114; Kamai Y, 2001, ANTIMICROB AGENTS CH, V45, P3195, DOI 10.1128/AAC.45.11.3195-3197.2001; Kim SY, 2006, FRONT BIOSCI-LANDMRK, V11, P3026, DOI 10.2741/2030; Koh AY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040035; Lane S, 2001, J BIOL CHEM, V276, P48988, DOI 10.1074/jbc.M104484200; Lay J, 1998, INFECT IMMUN, V66, P5301, DOI 10.1128/IAI.66.11.5301-5306.1998; LORAND L, 1984, MOL CELL BIOCHEM, V58, P9, DOI 10.1007/BF00240602; Lorand L, 2003, NAT REV MOL CELL BIO, V4, P140, DOI 10.1038/nrm1014; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; MacCallum DM, 2005, MYCOSES, V48, P151, DOI 10.1111/j.1439-0507.2005.01121.x; Maccallum Donna M, 2012, Int J Microbiol, V2012, P363764, DOI 10.1155/2012/363764; Martin R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058613; Matsuki M, 1998, P NATL ACAD SCI USA, V95, P1044, DOI 10.1073/pnas.95.3.1044; Mattiuzzi G, 2010, CONT HEMATOLOGY MANA; Mohan K, 2003, J IMMUNOL, V171, P3179, DOI 10.4049/jimmunol.171.6.3179; Morschhauser J, 1999, MOL MICROBIOL, V32, P547, DOI 10.1046/j.1365-2958.1999.01393.x; Mosci P, 2013, MYCOPATHOLOGIA, V175, P1, DOI 10.1007/s11046-012-9589-9; Naglik JR, 2003, J INFECT DIS, V188, P469, DOI 10.1086/376536; Naglik JR, 2008, FEMS MICROBIOL LETT, V283, P129, DOI 10.1111/j.1574-6968.2008.01160.x; Naglik JR, 2006, J MED MICROBIOL, V55, P1323, DOI 10.1099/jmm.0.46737-0; Naglik JR, 2008, MICROBIOL-SGM, V154, P3266, DOI 10.1099/mic.0.2008/022293-0; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Nobile CJ, 2008, CURR BIOL, V18, P1017, DOI 10.1016/j.cub.2008.06.034; Nobile CJ, 2006, EUKARYOT CELL, V5, P1604, DOI 10.1128/EC.00194-06; Nobile CJ, 2006, PLOS PATHOG, V2, P636, DOI 10.1371/journal.ppat.0020063; Oh SH, 2005, MICROBIOL-SGM, V151, P673, DOI 10.1099/mic.0.27680-0; Padovan ACB, 2009, MED MYCOL, V47, P824, DOI 10.3109/13693780802669574; Park Kang-Seo, 2011, Front Biosci (Elite Ed), V3, P341, DOI 10.2741/e249; Park YN, 2013, EUKARYOT CELL, V12, P1120, DOI 10.1128/EC.00112-13; Ponniah G, 2007, J ORAL PATHOL MED, V36, P456, DOI 10.1111/j.1600-0714.2007.00565.x; Radovanovic I, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018957; Ramage G, 2002, APPL ENVIRON MICROB, V68, P5459, DOI 10.1128/AEM.68.11.5459-5463.2002; Reuss O, 2004, GENE, V341, P119, DOI 10.1016/j.gene.2004.06.021; ROMANI L, 2001, CURRENT PROTOCOLS IM; Rose M, 1990, METHOD YEAST GENETIC; Rosenbach A, 2010, EUKARYOT CELL, V9, P1075, DOI 10.1128/EC.00034-10; Samaranayake YH, 2006, APMIS, V114, P857, DOI 10.1111/j.1600-0463.2006.apm_479.x; Schaller M, 2000, J INVEST DERMATOL, V114, P712, DOI 10.1046/j.1523-1747.2000.00935.x; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; Schofield DA, 2005, J MED MICROBIOL, V54, P87, DOI 10.1099/jmm.0.45755-0; Schofield DA, 2003, J INFECT DIS, V188, P591, DOI 10.1086/377182; Selmecki A, 2005, MOL MICROBIOL, V55, P1553, DOI 10.1111/j.1365-2958.2005.04492.x; Sharkey LL, 2005, MICROBIOL-SGM, V151, P1061, DOI 10.1099/mic.0.27487-0; Solis NV, 2012, NAT PROTOC, V7, P637, DOI 10.1038/nprot.2012.011; Spellberg B, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040038; Staab JF, 1998, YEAST, V14, P681, DOI 10.1002/(SICI)1097-0061(199805)14:7&lt;681::AID-YEA256&gt;3.0.CO;2-8; Staab JF, 2004, J BIOL CHEM, V279, P40737, DOI 10.1074/jbc.M406005200; Staab JF, 2003, TRENDS MICROBIOL, V11, P69, DOI 10.1016/S0966-842X(02)00029-X; Staab JF, 1999, SCIENCE, V283, P1535, DOI 10.1126/science.283.5407.1535; Staib P, 2000, P NATL ACAD SCI USA, V97, P6102, DOI 10.1073/pnas.110031497; Steinert PM, 1996, BIOCHEM BIOPH RES CO, V221, P101, DOI 10.1006/bbrc.1996.0552; Sundstrom P, 2002, INFECT IMMUN, V70, P3281, DOI 10.1128/IAI.70.6.3281-3283.2002; Sundstrom P, 2002, J INFECT DIS, V185, P521, DOI 10.1086/338836; Wellington M, 2009, INFECT IMMUN, V77, P405, DOI 10.1128/IAI.00860-08; White SJ, 2007, PLOS PATHOG, V3, P1866, DOI 10.1371/journal.ppat.0030184; Wilson RB, 1999, J BACTERIOL, V181, P1868, DOI 10.1128/JB.181.6.1868-1874.1999; Zhao XM, 2004, MICROBIOL-SGM, V150, P2415, DOI 10.1099/mic.0.26943-0; Zou YL, 2012, MOL VIS, V18, P1215	87	26	28	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80842	10.1371/journal.pone.0080842	http://dx.doi.org/10.1371/journal.pone.0080842			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260489	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200116
J	Mukherjee, M; Ge, G; Zhang, N; Edwards, DG; Sumazin, P; Sharan, S; Rao, PH; Medina, D; Pati, D				Mukherjee, M.; Ge, G.; Zhang, N.; Edwards, D. G.; Sumazin, P.; Sharan, S. K.; Rao, P. H.; Medina, D.; Pati, D.			MMTV-Espl1 transgenic mice develop aneuploid, estrogen receptor alpha (ER alpha)-positive mammary adenocarcinomas	ONCOGENE			English	Article						Separase; Espl1; aneuploidy; p53; cohesin; mammary tumor animal model	HUMAN BREAST-CANCER; CHROMOSOMAL INSTABILITY; MOLECULAR CHARACTERIZATION; CLONAL EVOLUTION; GENE-EXPRESSION; TUMORS; TUMORIGENESIS; SEPARASE; CELLS; PROTEIN	Separase, a protease encoded by the ESPL1 gene, cleaves the chromosomal cohesin during mitosis. Separase protein and transcripts are overexpressed in a wide range of human cancers. To investigate the physiological consequence of Separase overexpression in animals, we have generated a transgenic MMTV-Espl1 mouse model that overexpresses Separase protein in the mammary glands. MMTV-Espl1 mice in a C57BL/6 genetic background develop aggressive, highly aneuploid and estrogen receptor alpha-positive (ER alpha-) mammary adenocarcinomas with an 80% penetrance. The mammary tumors caused by overexpression of Separase, alone or combined with p53 heterozygosity, in mammary epithelium mimic several aspects of the most aggressive forms of human breast cancer, including high levels of genetic instability, cell cycle defects, poor differentiation, distant metastasis and metaplasia. Histopathologically, MMTV-Espl1 tumors are highly heterogeneous showing features of both luminal as well as basal subtypes of breast cancers, with aggressive disease phenotype. In addition to aneuploidy, Separase overexpression results in chromosomal instability (CIN) including premature chromatid separation (PCS), lagging chromosomes, anaphase bridges, micronuclei, centrosome amplification, multinucleated cells, gradual accumulation of DNA damage and progressive loss of tumor suppressors p53 and cadherin gene loci. These results suggest that Separase-overexpressing mammary cells are not only susceptible to chromosomal missegregation-induced aneuploidy but also other genetic instabilities including DNA damage and loss of key tumor suppressor gene loci, which in combination can initiate tumorigenesis and disease progression.	[Mukherjee, M.; Ge, G.; Zhang, N.; Sumazin, P.; Rao, P. H.; Pati, D.] Texas Childrens Canc Ctr, Dep Pediat Hematol Oncol, Houston, TX USA; [Edwards, D. G.; Medina, D.; Pati, D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA; [Sharan, S. K.] NCI, Mouse Canc Genet Program, Ctr Canc Res, Frederick, MD 21701 USA	Texas Children's Cancer Center; Baylor College of Medicine; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Pati, D (corresponding author), Baylor Coll Med, Dept Pediat, 6621 Fannin St,MC3-3320 1102 Bates St, Houston, TX 77030 USA.	pati@bcm.edu	Sumazin, Pavel/AAE-6607-2020	Sumazin, Pavel/0000-0002-1215-4977	National Cancer Institute [1RO1 CA109330, 1RO1 CA109478]; NATIONAL CANCER INSTITUTE [R01CA109478, R01CA109330, ZIABC010387] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by the grants from the National Cancer Institute (1RO1 CA109330 and 1RO1 CA109478) to D. Pati.	Arnold A, 2005, J CLIN ONCOL, V23, P4215, DOI 10.1200/JCO.2005.05.064; Berman J, 2010, NATURE, V468, P183, DOI 10.1038/468183a; Blackburn AC, 2004, CANCER RES, V64, P5140, DOI 10.1158/0008-5472.CAN-03-3435; Cardiff RD, 2010, J MAMMARY GLAND BIOL, V15, P225, DOI 10.1007/s10911-010-9184-y; Cariou S, 2000, P NATL ACAD SCI USA, V97, P9042, DOI 10.1073/pnas.160016897; Creighton CJ, 2009, P NATL ACAD SCI USA, V106, P13820, DOI 10.1073/pnas.0905718106; Duesberg P, 1998, P NATL ACAD SCI USA, V95, P13692, DOI 10.1073/pnas.95.23.13692; Fantozzi A, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1530; Ganmore I, 2009, HUM MOL GENET, V18, pR84, DOI 10.1093/hmg/ddp084; Gao CF, 2007, P NATL ACAD SCI USA, V104, P8995, DOI 10.1073/pnas.0700631104; Han S, 1999, BREAST CANCER RES TR, V55, P161; Heilig CE, 2010, J CELL MOL MED, V14, P895, DOI 10.1111/j.1582-4934.2009.00905.x; Herschkowitz JI, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-5-r76; Holland AJ, 2012, EMBO REP, V13, P501, DOI 10.1038/embor.2012.55; Holland AJ, 2009, NAT REV MOL CELL BIO, V10, P478, DOI 10.1038/nrm2718; Janssen A, 2011, SCIENCE, V333, P1895, DOI 10.1126/science.1210214; KALLIONIEMI A, 1992, SCIENCE, V258, P818, DOI 10.1126/science.1359641; Koboldt DC, 2012, NATURE, V490, P61, DOI 10.1038/nature11412; Kuukasjarvi T, 1997, CANCER RES, V57, P1597; Lacroix M, 2004, MOL CELL ENDOCRINOL, V219, P1, DOI 10.1016/j.mce.2004.02.021; Lacroix M, 2004, ENDOCR-RELAT CANCER, V11, P497, DOI 10.1677/erc.1.00758; Lu XD, 2011, MOL CANCER RES, V9, P430, DOI 10.1158/1541-7786.MCR-10-0277; McClelland SE, 2009, CELL CYCLE, V8, P3262, DOI 10.4161/cc.8.20.9690; McGranahan N, 2012, EMBO REP, V13, P528, DOI 10.1038/embor.2012.61; MEDINA D, 2000, METHODS MAMMARY GLAN, P137; Meyer R, 2009, CLIN CANCER RES, V15, P2703, DOI 10.1158/1078-0432.CCR-08-2454; Miller TE, 2008, J BIOL CHEM, V283, P29897, DOI 10.1074/jbc.M804612200; Mukherjee M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022167; Musgrove EA, 2009, NAT REV CANCER, V9, P631, DOI 10.1038/nrc2713; Nasmyth K, 2009, ANNU REV GENET, V43, P525, DOI 10.1146/annurev-genet-102108-134233; ORNITZ DM, 1991, P NATL ACAD SCI USA, V88, P698, DOI 10.1073/pnas.88.3.698; Panigrahi AK, 2009, CRIT REV ONCOL HEMAT, V72, P181, DOI 10.1016/j.critrevonc.2008.12.002; Pariente N, 2012, EMBO REP, V13, P472, DOI 10.1038/embor.2012.66; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Pati D, 2004, CANCER RES, V64, P5608, DOI 10.1158/0008-5472.CAN-03-0629; Pavelka N, 2010, NATURE, V468, P321, DOI 10.1038/nature09529; Prat A, 2013, ONCOLOGIST, V18, P123, DOI 10.1634/theoncologist.2012-0397; Prat A, 2010, BREAST CANCER RES, V12, DOI 10.1186/bcr2635; Radaelli E, 2009, FUTURE ONCOL, V5, P1113, DOI [10.2217/fon.09.93, 10.2217/FON.09.93]; Sheltzer JM, 2011, TRENDS GENET, V27, P446, DOI 10.1016/j.tig.2011.07.003; Shepard JL, 2007, GENE DEV, V21, P55, DOI 10.1101/gad.1470407; Solomon DA, 2011, SCIENCE, V333, P1039, DOI 10.1126/science.1203619; SONNENBERG A, 1987, EMBO J, V6, P121, DOI 10.1002/j.1460-2075.1987.tb04728.x; Stefansson OA, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2334; Stegmeier F, 2002, CELL, V108, P207, DOI 10.1016/S0092-8674(02)00618-9; Swanton C, 2009, P NATL ACAD SCI USA, V106, P8671, DOI 10.1073/pnas.0811835106; Torres EM, 2007, SCIENCE, V317, P916, DOI 10.1126/science.1142210; Williams BR, 2008, SCIENCE, V322, P703, DOI 10.1126/science.1160058; YAMAMOTO KR, 1985, ANNU REV GENET, V19, P209, DOI 10.1146/annurev.genet.19.1.209; Zhang NG, 2008, P NATL ACAD SCI USA, V105, P13033, DOI 10.1073/pnas.0801610105	50	40	40	2	11	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0950-9232	1476-5594		ONCOGENE	Oncogene	NOV 27	2014	33	48					5511	5522		10.1038/onc.2013.493	http://dx.doi.org/10.1038/onc.2013.493			12	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Oncology; Cell Biology; Genetics & Heredity	AW1ZO	24276237	Green Accepted			2022-12-25	WOS:000346087900004
J	Wu, T; Vander Kooi, C; Shah, P; Charnigo, R; Huang, C; Smyth, SS; Morris, AJ				Wu, Tao; Vander Kooi, Craig; Shah, Pritom; Charnigo, Richard; Huang, Cai; Smyth, Susan S.; Morris, Andrew J.			Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration	FASEB JOURNAL			English	Article						lysophospholipase; lysophosphatidic acid; cell motility; cell adhesion	ACID LPA RECEPTORS; LYSOPHOSPHATIDIC ACID; LYSOPHOSPHOLIPASE-D; CRYSTAL-STRUCTURE; METASTASIS; ACTIVATION; EXPRESSION; INHIBITOR; DYNAMICS; MOTILITY	Autotaxin (ATX) is a secreted lysophospholipase D (lysoPLD) that binds to integrin adhesion receptors. We dissected the roles of integrin binding and lysoPLD activity in stimulation of human breast cancer and mouse aortic vascular smooth muscle cell migration by ATX. We compared effects of wild-type human ATX, catalytically inactive ATX, an integrin binding-defective ATX variant with wild-type lysoPLD activity, the isolated ATX integrin binding N-terminal domain, and a potent ATX selective lysoPLD inhibitor on cell migration using transwell and single-cell tracking assays. Stimulation of transwell migration was reduced (18 or 27% of control, respectively) but not ablated by inactivation of integrin binding or inhibition of lysoPLD activity. The N-terminal domain increased transwell migration (30% of control). ATX lysoPLD activity and integrin binding were necessary for a 3.8-fold increase in the fraction of migrating breast cancer cell step velocities >0.7 m/min. ATX increased the persistent directionality of single-cell migration 2-fold. This effect was lysoPLD activity independent and recapitulated by the integrin binding N-terminal domain. Integrin binding enables uptake and intracellular sequestration of ATX, which redistributes to the front of migrating cells. ATX binding to integrins and lysoPLD activity therefore cooperate to promote rapid persistent directional cell migration.Wu, T., Kooi, C. V., Shah, P., Charnigo, R., Huang, C., Smyth, S. S., Morris, A. J. Integrin-mediated cell surface recruitment of autotaxin promotes persistent directional cell migration.	[Wu, Tao; Smyth, Susan S.; Morris, Andrew J.] Univ Kentucky, Gill Heart Inst, Div Cardiovasc Med, Lexington, KY 40536 USA; [Vander Kooi, Craig] Univ Kentucky, Dept Mol & Cellular Biochem, Lexington, KY 40536 USA; [Huang, Cai] Univ Kentucky, Coll Med, Dept Mol & Biomed Pharmacol, Lexington, KY 40536 USA; [Charnigo, Richard] Univ Kentucky, Coll Publ Hlth, Dept Biostat, Lexington, KY 40536 USA; [Shah, Pritom] UCL, Wolfson Inst Biomed Res, Canc Res Technol Discovery Labs, London, England; [Smyth, Susan S.; Morris, Andrew J.] Dept Vet Affairs Med Ctr, Lexington, KY USA	University of Kentucky; University of Kentucky; University of Kentucky; University of Kentucky; University of London; University College London; US Department of Veterans Affairs; Veterans Health Administration (VHA); Lexington VA Medical Center	Smyth, SS (corresponding author), Univ Kentucky, 741 South Limestone St, Lexington, KY 40536 USA.	a.j.morris@uky.edu; susansmyth@uky.edu			U.S. National Institutes of Health; U.S. Department of Veterans Affairs; American Heart Association; NATIONAL CANCER INSTITUTE [P30CA177558] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR024598, S10RR026884] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL078663] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM094155, P20GM103527, R01GM050388] Funding Source: NIH RePORTER; Veterans Affairs [I01BX001014, I01BX001984] Funding Source: NIH RePORTER	U.S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); U.S. Department of Veterans Affairs(US Department of Veterans Affairs); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Veterans Affairs(US Department of Veterans Affairs)	This work was supported by grants from the U.S. National Institutes of Health and the U.S. Department of Veterans Affairs to A.J.M. and S. S. S. T. W. was the recipient of an American Heart Association postdoctoral fellowship. This material is also based on work supported in part by resources at the Lexington Veterans Affairs Medical Center. The authors are grateful to Manjula Sunkara, Fanmuyi Yang, and Frederick Onono for their contributions to the project.	Albers HMHG, 2012, CHEM REV, V112, P2593, DOI 10.1021/cr2003213; Albers HMHG, 2010, P NATL ACAD SCI USA, V107, P7257, DOI 10.1073/pnas.1001529107; Alemayehu M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056174; Bai ZB, 2013, J IMMUNOL, V190, P2036, DOI 10.4049/jimmunol.1202025; Bridgewater RE, 2012, J CELL SCI, V125, P3695, DOI 10.1242/jcs.095810; David M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0009741; Delorme-Walker VD, 2011, J CELL BIOL, V193, P1289, DOI 10.1083/jcb.201010059; Desgrosellier JS, 2010, NAT REV CANCER, V10, P9, DOI 10.1038/nrc2748; Felding-Habermann B, 2001, P NATL ACAD SCI USA, V98, P1853, DOI 10.1073/pnas.98.4.1853; Fulkerson Z, 2011, J BIOL CHEM, V286, P34654, DOI 10.1074/jbc.M111.276725; Gierse J, 2010, J PHARMACOL EXP THER, V334, P310, DOI 10.1124/jpet.110.165845; Goodman SL, 2012, TRENDS PHARMACOL SCI, V33, P405, DOI 10.1016/j.tips.2012.04.002; Hausmann J, 2011, NAT STRUCT MOL BIOL, V18, P198, DOI 10.1038/nsmb.1980; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Houben AJS, 2011, CANCER METAST REV, V30, P557, DOI 10.1007/s10555-011-9319-7; Huttenlocher A, 2005, NAT CELL BIOL, V7, P336, DOI 10.1038/ncb0405-336; Kanda H, 2008, NAT IMMUNOL, V9, P415, DOI 10.1038/ni1573; Kato K, 2012, P NATL ACAD SCI USA, V109, P16876, DOI 10.1073/pnas.1208017109; Li X, 2013, J CELL SCI, V126, P2617, DOI 10.1242/jcs.117044; Lin ME, 2010, PROSTAG OTH LIPID M, V91, P130, DOI 10.1016/j.prostaglandins.2009.02.002; Liu SY, 2009, CANCER CELL, V15, P539, DOI 10.1016/j.ccr.2009.03.027; Moolenaar WH, 2011, NAT REV MOL CELL BIO, V12, P674, DOI 10.1038/nrm3188; Morris AJ, 2013, J LIPID RES, V54, P1153, DOI 10.1194/jlr.E037887; Muller A, 2001, NATURE, V410, P50, DOI 10.1038/35065016; Nishimasu H, 2011, NAT STRUCT MOL BIOL, V18, P205, DOI 10.1038/nsmb.1998; Pamuklar Z, 2009, J BIOL CHEM, V284, P7385, DOI 10.1074/jbc.M807820200; Panchatcharam M, 2013, ARTERIOSCL THROM VAS, V33, P52, DOI 10.1161/ATVBAHA.112.300527; Price JT, 1999, CANCER RES, V59, P5475; Salous AK, 2013, J LIPID RES, V54, P2775, DOI 10.1194/jlr.M039685; STRACKE ML, 1992, J BIOL CHEM, V267, P2524; Umezu-Goto M, 2002, J CELL BIOL, V158, P227, DOI 10.1083/jcb.200204026; van Meeteren LA, 2007, PROG LIPID RES, V46, P145, DOI 10.1016/j.plipres.2007.02.001; van Meeteren LA, 2006, MOL CELL BIOL, V26, P5015, DOI 10.1128/MCB.02419-05; Wu Z. Y., 2011, PLOS ONE, V6; Yuelling LM, 2008, BBA-MOL CELL BIOL L, V1781, P525, DOI 10.1016/j.bbalip.2008.04.009; Yukiura H, 2011, J BIOL CHEM, V286, P43972, DOI 10.1074/jbc.M111.301093	36	31	31	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	FEB	2014	28	2					861	870		10.1096/fj.13-232868	http://dx.doi.org/10.1096/fj.13-232868			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	AA4NG	24277575	Green Published			2022-12-25	WOS:000331072200031
J	Wang, L; Uhlig, PC; Eikenberry, EF; Robenek, H; Bruckner, P; Hansen, U				Wang, Lei; Uhlig, Philipp C.; Eikenberry, Eric F.; Robenek, Horst; Bruckner, Peter; Hansen, Uwe			Lateral Growth Limitation of Corneal Fibrils and Their Lamellar Stacking Depend on Covalent Collagen Cross-linking by Transglutaminase-2 and Lysyl Oxidases, Respectively	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article							POLYACRYLAMIDE-GELS; SKIN FRAGILITY; FILM DETECTION; STROMA; DECORIN; FIBRILLOGENESIS; ULTRASTRUCTURE; ORGANIZATION; FIBROBLASTS; EXPRESSION	Corneal stroma contains an extracellular matrix of orthogonal lamellae formed by parallel and equidistant fibrils with a homogeneous diameter of similar to 35 nm. This is indispensable for corneal transparency and mechanical functions. However, the mechanisms controlling corneal fibrillogenesis are incompletely understood and the conditions required for lamellar stacking are essentially unknown. Under appropriate conditions, chick embryo corneal fibroblasts can produce an extracellular matrix in vitro resembling primary corneal stroma during embryonic development. Among other requirements, cross-links between fibrillar collagens, introduced by tissue transglutaminase-2, are necessary for the self-assembly of uniform, small diameter fibrils but not their lamellar stacking. By contrast, the subsequent lamellar organization into plywood-like stacks depends on lysyl aldehyde-derived cross-links introduced by lysyl oxidase activity, which, in turn, only weakly influences fibril diameters. These cross-links are introduced at early stages of fibrillogenesis. The enzymes are likely to be important for a correct matrix deposition also during repair of the cornea.	[Wang, Lei; Uhlig, Philipp C.; Bruckner, Peter; Hansen, Uwe] Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, D-48149 Munster, Germany; [Robenek, Horst] Leibniz Inst Arteriosclerosis Res, D-48149 Munster, Germany	University of Munster	Hansen, U (corresponding author), Univ Hosp Munster, Inst Physiol Chem & Pathobiochem, Waldeyerstr 15, D-48149 Munster, Germany.	peter.bruckner@uni-muenster.de	Bruckner, Peter/F-4817-2019	Bruckner, Peter/0000-0002-5566-5611	Deutsche Forschungsgemeinschaft [SFB 492]	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported in part by Deutsche Forschungsgemeinschaft Grant SFB 492 and Projects A2 and B3.	BARD JBL, 1993, J CELL SCI, V105, P1045; BARD JBL, 1977, J CELL BIOL, V74, P816, DOI 10.1083/jcb.74.3.816; Birk DE, 2011, BIOL EXTRACELL MATR, P77, DOI 10.1007/978-3-642-16555-9_3; BIRK DE, 1988, J CELL BIOL, V106, P999, DOI 10.1083/jcb.106.3.999; BIRK DE, 1984, J CELL BIOL, V99, P2024, DOI 10.1083/jcb.99.6.2024; Blaschke UK, 2000, J BIOL CHEM, V275, P10370, DOI 10.1074/jbc.275.14.10370; BONNER WM, 1974, EUR J BIOCHEM, V46, P83, DOI 10.1111/j.1432-1033.1974.tb03599.x; BRUNS RR, 1987, INVEST OPHTH VIS SCI, V28, P1939; Chakravarti S, 2003, INVEST OPHTH VIS SCI, V44, P2422, DOI 10.1167/iovs.02-0783; Chakravarti S, 1998, J CELL BIOL, V141, P1277, DOI 10.1083/jcb.141.5.1277; Chen SJ, 2010, DEV DYNAM, V239, P844, DOI 10.1002/dvdy.22216; CRAIG AS, 1981, J ULTRA MOL STRUCT R, V74, P232, DOI 10.1016/S0022-5320(81)80081-0; Danielson KG, 1997, J CELL BIOL, V136, P729, DOI 10.1083/jcb.136.3.729; GELMAN RA, 1979, J BIOL CHEM, V254, P180; Guo XQ, 2007, INVEST OPHTH VIS SCI, V48, P4050, DOI 10.1167/iovs.06-1216; Hansen U, 2006, MATRIX BIOL, V25, P252, DOI 10.1016/j.matbio.2006.01.005; Hassell JR, 2010, EXP EYE RES, V91, P326, DOI 10.1016/j.exer.2010.06.021; Hay E D, 1969, Monogr Dev Biol, V1, P1; HUNZIKER EB, 1984, J CELL BIOL, V98, P267, DOI 10.1083/jcb.98.1.267; KEENE DR, 1987, J CELL BIOL, V105, P2393, DOI 10.1083/jcb.105.5.2393; Koch M, 2003, J BIOL CHEM, V278, P43236, DOI 10.1074/jbc.M302112200; KOMAI Y, 1991, INVEST OPHTH VIS SCI, V32, P2244; LASKEY RA, 1975, EUR J BIOCHEM, V56, P335, DOI 10.1111/j.1432-1033.1975.tb02238.x; Linsenmayer TF, 1998, PROG RETIN EYE RES, V17, P231; LINSENMAYER TF, 1983, J CELL BIOL, V96, P124, DOI 10.1083/jcb.96.1.124; Meek KM, 2001, MICRON, V32, P261, DOI 10.1016/S0968-4328(00)00041-X; MENDLER M, 1989, J CELL BIOL, V108, P191, DOI 10.1083/jcb.108.1.191; Muszbek L, 2011, PHYSIOL REV, V91, P931, DOI 10.1152/physrev.00016.2010; PROCKOP DJ, 1982, METHOD ENZYMOL, V82, P305; Raghunath M, 1999, INVEST OPHTH VIS SCI, V40, P2780; Ruberti JW, 2008, PROG RETIN EYE RES, V27, P549, DOI 10.1016/j.preteyeres.2008.08.001; SCOTT JE, 1991, BIOCHEM SOC T, V19, P877, DOI 10.1042/bst0190877; Tsukahara N, 2010, J VET MED SCI, V72, P1137, DOI 10.1292/jvms.09-0470; Villone D, 2008, J BIOL CHEM, V283, P24506, DOI 10.1074/jbc.M802415200; Yamauchi M, 1996, BIOCHEM BIOPH RES CO, V219, P311, DOI 10.1006/bbrc.1996.0229; Zhang GY, 2006, J CELL BIOCHEM, V98, P1436, DOI 10.1002/jcb.20776; Zhang G, 2009, J BIOL CHEM, V284, P8888, DOI 10.1074/jbc.M806590200; Zhang W, 2004, CURR EYE RES, V28, P37, DOI 10.1076/ceyr.28.1.37.23493	38	13	13	1	15	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 10	2014	289	2					921	929		10.1074/jbc.M113.496364	http://dx.doi.org/10.1074/jbc.M113.496364			9	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	301OH	24265319	Green Published, hybrid			2022-12-25	WOS:000330541200027
J	Gjersoe, NL; Hood, B				Gjersoe, Nathalia L.; Hood, Bruce			Changing Children's Understanding of the Brain: A Longitudinal Study of the Royal Institution Christmas Lectures as a Measure of Public Engagement	PLOS ONE			English	Article							MEMORIES	Demonstrating the impact of public engagement is an increasingly important activity for today's academics and researchers. The difficulty is that many areas of interest do not lend themselves well to evaluation because the impact of each single intervention can be hard to trace and take time to become manifest. With this in mind, we evaluated a lecture based around the 2011 Royal Institution Christmas Lectures, "Meet Your Brain," delivered to school children from low performing schools. We compared knowledge about four neuroscience facts one week before, one week after and six weeks after the lecture. Analysis revealed significant knowledge transfer one week after the lecture that was retained five weeks later. We conclude that public engagement through tailored lectures can have significant impact in the moderate term with the potential to leave a lasting impression over a longer period.	[Gjersoe, Nathalia L.] Open Univ, Childhood & Youth Study Ctr, Milton Keynes MK7 6AA, Bucks, England; [Hood, Bruce] Univ Bristol, Bristol Cognit Dev Ctr, Bristol, Avon, England	Open University - UK; University of Bristol	Hood, B (corresponding author), Univ Bristol, Bristol Cognit Dev Ctr, Bristol, Avon, England.	bruce.hood@bristol.ac.uk		hood, bruce/0000-0001-7258-981X	University of Bristol; Royal Institution of Great Britain	University of Bristol; Royal Institution of Great Britain	This research was funded by the University of Bristol and the Royal Institution of Great Britain. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 2012, ENGAGING IMPACT DO W; British Science Association, 2010, PUBL ENG TRIANGL SCI; BROWN R, 1977, COGNITION, V5, P73, DOI 10.1016/0010-0277(77)90018-X; Chundler EH, 2009, NEUROSCIENCE KIDS WE; Della Salla S, 2007, TALL TALES MIND BRAI; Facer K., 2012, KNOWLEDGE BASE U PUB; Gjersoe NL, 2013, BRAINBANK ONLINE TEA; HEBB DO, 1955, AM J PSYCHIAT, V111, P826, DOI 10.1176/ajp.111.11.826; HEFCE, 2011, DEC ASS RES IMP; Herculano-Houzel S, 2002, NEUROSCIENTIST, V8, P98, DOI 10.1177/107385840200800206; Higbee KL, 1998, J PSYCHOL, V132, P469, DOI 10.1080/00223989809599280; Higher Education Funding Council for England (HEFCE), 2011, ASS FRAM GUID SUBM; Higher Education Funding Council for England (HEFCE), 2012, PAN CRIT WORK METH; Loftus EF, 2003, AM PSYCHOL, V58, P867, DOI 10.1037/0003-066X.58.11.867; Ovseiko PV, 2012, BMC HEALTH SERV RES, V12, DOI 10.1186/1472-6963-12-478; Roediger HL, 2000, CURR DIR PSYCHOL SCI, V9, P123, DOI 10.1111/1467-8721.00075; Rowe G, 2004, SCI TECHNOL HUM VAL, V29, P512, DOI 10.1177/0162243903259197; SEMB GB, 1994, REV EDUC RES, V64, P253, DOI 10.3102/00346543064002253; Trench B, 2008, COMMUNICATING SCIENCE IN SOCIAL CONTEXTS: NEW MODELS, NEW PRACTICES, P119, DOI 10.1007/978-1-4020-8598-7_7	19	6	6	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80928	10.1371/journal.pone.0080928	http://dx.doi.org/10.1371/journal.pone.0080928			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255RX	24260513	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327258600100
J	Arndt, S; Unger, P; Wacker, E; Shimizu, T; Heinlin, J; Li, YF; Thomas, HM; Morfill, GE; Zimmermann, JL; Bosserhoff, AK; Karrer, S				Arndt, Stephanie; Unger, Petra; Wacker, Eva; Shimizu, Tetsuji; Heinlin, Julia; Li, Yang-Fang; Thomas, Hubertus M.; Morfill, Gregor E.; Zimmermann, Julia L.; Bosserhoff, Anja-Katrin; Karrer, Sigrid			Cold Atmospheric Plasma (CAP) Changes Gene Expression of Key Molecules of the Wound Healing Machinery and Improves Wound Healing In Vitro and In Vivo	PLOS ONE			English	Article							ARGON PLASMA; REPAIR; CELLS	Cold atmospheric plasma (CAP) has the potential to interact with tissue or cells leading to fast, painless and efficient disinfection and furthermore has positive effects on wound healing and tissue regeneration. For clinical implementation it is necessary to examine how CAP improves wound healing and which molecular changes occur after the CAP treatment. In the present study we used the second generation MicroPlaSter beta (R) in analogy to the current clinical standard (2 min treatment time) in order to determine molecular changes induced by CAP using in vitro cell culture studies with human fibroblasts and an in vivo mouse skin wound healing model. Our in vitro analysis revealed that the CAP treatment induces the expression of important key genes crucial for the wound healing response like IL-6, IL-8, MCP-1, TGF-beta 1, TGF-beta 2, and promotes the production of collagen type I and alpha-SMA. Scratch wound healing assays showed improved cell migration, whereas cell proliferation analyzed by XTT method, and the apoptotic machinery analyzed by protein array technology, was not altered by CAP in dermal fibroblasts. An in vivo wound healing model confirmed that the CAP treatment affects above mentioned genes involved in wound healing, tissue injury and repair. Additionally, we observed that the CAP treatment improves wound healing in mice, no relevant side effects were detected. We suggest that improved wound healing might be due to the activation of a specified panel of cytokines and growth factors by CAP. In summary, our in vitro human and in vivo animal data suggest that the 2 min treatment with the MicroPlaSter beta (R) is an effective technique for activating wound healing relevant molecules in dermal fibroblasts leading to improved wound healing, whereas the mechanisms which contribute to these observed effects have to be further investigated.	[Arndt, Stephanie; Wacker, Eva; Bosserhoff, Anja-Katrin] Univ Regensburg, Inst Pathol, D-93053 Regensburg, Germany; [Unger, Petra; Heinlin, Julia; Karrer, Sigrid] Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany; [Shimizu, Tetsuji; Li, Yang-Fang; Thomas, Hubertus M.; Morfill, Gregor E.; Zimmermann, Julia L.] Max Planck Inst Extraterr Phys, D-85748 Garching, Germany	University of Regensburg; University of Regensburg; Max Planck Society	Karrer, S (corresponding author), Univ Hosp Regensburg, Dept Dermatol, Regensburg, Germany.	sigrid.karrer@klinik.uni-regensburg.de	Bosserhoff, Anja/GNH-4801-2022; Shimizu, Tetsuji/L-1478-2018	Shimizu, Tetsuji/0000-0001-9432-1152; Bosserhoff, Anja/0000-0001-8147-394X; Thomas, Hubertus/0000-0001-8358-2023; Li, Yangfang/0000-0002-5346-3741				Ahn HJ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028154; AMENTO EP, 1991, CIBA F SYMP, V157, P115; Arndt S, 2011, AM J PATHOL, V178, P2622, DOI 10.1016/j.ajpath.2011.02.009; Arndt S, 2010, GASTROENTEROLOGY, V138, P372, DOI 10.1053/j.gastro.2009.09.048; Canady J, 2013, J INVEST DERMATOL, V133, P647, DOI 10.1038/jid.2012.389; Chatzigeorgiou A, 2009, BIOFACTORS, V35, P474, DOI 10.1002/biof.62; Gabele E, 2009, BIOCHEM BIOPH RES CO, V378, P348, DOI 10.1016/j.bbrc.2008.10.155; GharaeeKermani M, 1996, J BIOL CHEM, V271, P17779, DOI 10.1074/jbc.271.30.17779; Gillitzer R, 2001, J LEUKOCYTE BIOL, V69, P513; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Heinlin J, 2013, WOUND REPAI IN PRESS; Heinlin J, 2010, J DTSCH DERMATOL GES, V8, P968, DOI 10.1111/j.1610-0387.2010.07495.x; Isbary G, 2012, BRIT J DERMATOL, V167, P404, DOI 10.1111/j.1365-2133.2012.10923.x; Isbary G, 2010, BRIT J DERMATOL, V163, P78, DOI 10.1111/j.1365-2133.2010.09744.x; Kalghatgi S, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016270; KAPPELMANN M, 2012, ONCOGENE; Kolar M, 2012, BIOL CELL, V104, P738, DOI 10.1111/boc.201200018; Lupu Andreea-Roxana, 2010, Roum Arch Microbiol Immunol, V69, P67; Lupu Andreea-Roxana, 2009, Roum Arch Microbiol Immunol, V68, P136; Metelmann HR, 2012, AM J COSMET SURG, V29, P52, DOI DOI 10.5992/AJCS-D-11-00042.1; Nosenko T, 2009, NEW J PHYS, V11, DOI 10.1088/1367-2630/11/11/115013; Paquet P, 1996, INT ARCH ALLERGY IMM, V109, P308, DOI 10.1159/000237257; Penn JW, 2012, INT J BURNS TRAUMA, V2, P18; Profyris C, 2012, J AM ACAD DERMATOL, V66, P11; Profyris C, 2012, J AM ACAD DERMATOL, V66, P1, DOI 10.1016/j.jaad.2011.05.055; Qi L, 2008, J INVEST DERMATOL, V128, P749, DOI 10.1038/sj.jid.5701068; Reinke JM, 2012, EUR SURG RES, V49, P35, DOI 10.1159/000339613; Sensenig R, 2011, ANN BIOMED ENG, V39, P674, DOI 10.1007/s10439-010-0197-x; Shimizu T, 2008, PLASMA PROCESS POLYM, V5, P577, DOI 10.1002/ppap.200800021; Tipa RS, 2011, PLASMA STIMULATED WO, V39, P2978; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Witte MB, 2002, AM J SURG, V183, P406, DOI 10.1016/S0002-9610(02)00815-2; Yu Y, 2011, J HUAZHONG U SCI-MED, V31, P390, DOI 10.1007/s11596-011-0387-2	33	209	216	2	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79325	10.1371/journal.pone.0079325	http://dx.doi.org/10.1371/journal.pone.0079325			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265766	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100099
J	Cai, XX; Fan, J; Jiang, ZX; Basso, B; Sala, F; Spada, A; Grassi, F; Lu, BR				Cai, Xingxing; Fan, Jing; Jiang, Zhuxi; Basso, Barbara; Sala, Francesco; Spada, Alberto; Grassi, Fabrizio; Lu, Bao-Rong			The Puzzle of Italian Rice Origin and Evolution: Determining Genetic Divergence and Affinity of Rice Germplasm from Italy and Asia	PLOS ONE			English	Article							DIVERSITY; YUNNAN; TRENDS	The characterization of genetic divergence and relationships of a set of germplasm is essential for its efficient applications in crop breeding and understanding of the origin/evolution of crop varieties from a given geographical region. As the largest rice producing country in Europe, Italy holds rice germplasm with abundant genetic diversity. Although Italian rice varieties and the traditional ones in particular have played important roles in rice production and breeding, knowledge concerning the origin and evolution of Italian traditional varieties is still limited. To solve the puzzle of Italian rice origin, we characterized genetic divergence and relationships of 348 rice varieties from Italy and Asia based on the polymorphisms of microsatellite fingerprints. We also included common wild rice O. rufipogon as a reference in the characterization. Results indicated relatively rich genetic diversity (H-e = 0.63-0.65) in Italian rice varieties. Further analyses revealed a close genetic relationship of the Italian traditional varieties with those from northern China, which provides strong genetic evidence for tracing the possible origin of early established rice varieties in Italy. These findings have significant implications for the rice breeding programs, in which appropriate germplasm can be selected from a given region and utilized for transferring unique genetic traits based on its genetic diversity and evolutionary relationships.	[Cai, Xingxing; Fan, Jing; Jiang, Zhuxi; Lu, Bao-Rong] Fudan Univ, Dept Ecol & Evolutionary Biol, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China; [Basso, Barbara] Natl Res Council CNR, Inst Biophys, Milan, Italy; [Sala, Francesco; Spada, Alberto; Grassi, Fabrizio] Univ Milan, Dept Biosci, Milan, Italy	Fudan University; Consiglio Nazionale delle Ricerche (CNR); Istituto di Biofisica (IBF-CNR); University of Milan	Lu, BR (corresponding author), Fudan Univ, Dept Ecol & Evolutionary Biol, Key Lab Biodivers Sci & Ecol Engn, Minist Educ, Shanghai 200433, Peoples R China.	brlu@fudan.edu.cn	Lu, Bao-Rong/C-3130-2009; spada, alberto/I-9005-2017	Lu, Bao-Rong/0000-0002-0214-2390; grassi, fabrizio/0000-0003-3606-6469; spada, alberto/0000-0001-7665-0446	"973" program of the Ministry of Science and Technology [2011CB100401]; Natural Science Foundation of China [31271683, 30730066]; Italian Ministry of Environment	"973" program of the Ministry of Science and Technology(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Italian Ministry of Environment	This work was funded by the "973" program of the Ministry of Science and Technology (2011CB100401), the Natural Science Foundation of China (31271683, 30730066), and the Italian Ministry of Environment, Project "Sustainable research and development in biotechnology applied to the protection of the environment, in collaboration with the People's Republic of China," Sub-project 2: "Analysis and protection of biodiversity of wild rice and wild grapevines striving near their cultivated counterpart." The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Asano K, 2007, BREEDING SCI, V57, P53, DOI 10.1270/jsbbs.57.53; Costantini L, 2004, ALIMENTAZIONE ITALIA; Erlich R, 2004, ASIA PAC J CLIN NUTR, V13, P125; Faivre-Rampant O, 2011, MOL BREEDING, V27, P233, DOI 10.1007/s11032-010-9426-0; Ferrero A, 2010, RICE ORIGIN ANTIQUIT, P241; Khush GS, 2005, PLANT MOL BIOL, V59, P1, DOI 10.1007/s11103-005-2159-5; Khush GS, 2001, NAT REV GENET, V2, P815, DOI 10.1038/35093585; Lu BR, 2009, PROG NAT SCI-MATER, V19, P1241, DOI 10.1016/j.pnsc.2009.01.011; Lu Y. G. (Lu Y. K.), 1979, Acta Genetica Sinica, V6, P311; Lupotto E, 2006, CHICCODORO RISO NUTR, P59; Mantegazza R, 2008, CROP SCI, V48, P1832, DOI 10.2135/cropsci2007.09.0532; NEI M, 1978, GENETICS, V89, P583; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Rohlf F. J., 1998, NTSYSPC NUMERICAL TA; SAGHAIMAROOF MA, 1984, P NATL ACAD SCI-BIOL, V81, P8014, DOI 10.1073/pnas.81.24.8014; Spada A, 2004, PLANT BREEDING, V123, P105, DOI 10.1046/j.1439-0523.2003.00950.x; Sthapit B, 2008, INT J AGR SUSTAIN, V6, P148, DOI 10.3763/ijas.2007.0291; Swofford D.L., 2002, PAUP PHYLOGENETIC AN; Tinarelli A, 2006, CHICCODORO RISO NUTR, P17; Tu M, 2007, BIOCHEM GENET, V45, P789, DOI 10.1007/s10528-007-9118-6; Vaughan DA, 2008, PLANT SCI, V174, P394, DOI 10.1016/j.plantsci.2008.01.016; Wang X.K., 1997, CHINESE SCI BULL, V42, P2596; Xiong ZY, 2011, CROP SCI, V51, P1050, DOI 10.2135/cropsci2010.07.0431; Zhu MY, 2004, ACTA BOT SIN, V46, P1458; Zong Y, 2007, NATURE, V449, P459, DOI 10.1038/nature06135	25	10	10	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80351	10.1371/journal.pone.0080351	http://dx.doi.org/10.1371/journal.pone.0080351			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Arts &amp; Humanities Citation Index (A&amp;HCI)	Science & Technology - Other Topics	255PK	24265814	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100150
J	Huang, ZL; Zhao, P; Medina, J; Meilan, R; Woeste, K				Huang, Zhonglian; Zhao, Peng; Medina, Jose; Meilan, Richard; Woeste, Keith			Roles of JnRAP2.6-like from the Transition Zone of Black Walnut in Hormone Signaling	PLOS ONE			English	Article							DNA-BINDING PROTEINS; ERF GENE FAMILY; GCC-BOX; HEARTWOOD FORMATION; ETHYLENE RESPONSE; DISEASE RESISTANCE; PROFILING REVEALS; DEFENSE RESPONSES; ABSCISSION ZONE; OSMOTIC-STRESS	An EST sequence, designated JnRAP2-like, was isolated from tissue at the heartwood/sapwood transition zone (TZ) in black walnut (Juglans nigra L). The deduced amino acid sequence of JnRAP2-like protein consists of a single AP2-containing domain with significant similarity to conserved AP2/ERF DNA-binding domains in other species. Based on multiple sequence alignment, JnRAP2-like appears to be an ortholog of RAP2.6L (At5g13330), which encodes an ethylene response element binding protein in Arabidopsis thaliana. Real-time PCR revealed that the JnRAP2-like was expressed most abundantly in TZ of trees harvested in fall when compared with other xylem tissues harvested in the fall or summer. Independent transgenic lines over-expressing JnRAP2-like in Arabidopsis developed dramatic ethylene-related phenotypes when treated with 50 mu M methyl jasmonate (MeJA). Taken together, these results indicated that JnRAP2-like may participate in the integration of ethylene and jasmonate signals in the xylem and other tissues. Given the role of ethylene in heartwood formation, it is possible JnRAP2-like expression in the transition zone is part of the signal transduction pathway leading to heartwood formation in black walnut.	[Huang, Zhonglian; Meilan, Richard] Purdue Univ, Dept Forestry & Nat Resources, Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA; [Zhao, Peng] Northwest Agr & Forestry Univ, Coll Forestry, Yangling, Shaanxi, Peoples R China; [Medina, Jose] Zamorano Univ, Tegucigalpa, Honduras; [Woeste, Keith] Purdue Univ, USDA Forest Serv, Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; Northwest A&F University - China; Purdue University System; Purdue University; Purdue University West Lafayette Campus; United States Department of Agriculture (USDA); United States Forest Service	Woeste, K (corresponding author), Purdue Univ, USDA Forest Serv, Hardwood Tree Improvement & Regenerat Ctr, W Lafayette, IN 47907 USA.	woeste@purdue.edu	Meilan, Richard/T-9269-2017	Meilan, Richard/0000-0002-8680-1110	NSF I/UCRC grant; United States Department of Agriculture Forest Service; Department of Forestry and Natural Resources at Purdue University	NSF I/UCRC grant; United States Department of Agriculture Forest Service(United States Department of Agriculture (USDA)United States Forest Service); Department of Forestry and Natural Resources at Purdue University	Funds for this research were provided by an NSF I/UCRC grant, the United States Department of Agriculture Forest Service, and the Department of Forestry and Natural Resources at Purdue University. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ABELES FB, 1989, PLANT PHYSIOL, V91, P1609, DOI 10.1104/pp.91.4.1609; Agusti J, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-127; Asahina M, 2011, P NATL ACAD SCI USA, V108, P16128, DOI 10.1073/pnas.1110443108; Balazadeh S, 2008, PLANT BIOLOGY, V10, P63, DOI 10.1111/j.1438-8677.2008.00088.x; Bari R, 2009, PLANT MOL BIOL, V69, P473, DOI 10.1007/s11103-008-9435-0; Beckman CH, 2000, PHYSIOL MOL PLANT P, V57, P101, DOI 10.1006/pmpp.2000.0287; Beritognolo I, 2002, TREE PHYSIOL, V22, P291, DOI 10.1093/treephys/22.5.291; Berthier S, 2001, ANN BOT-LONDON, V87, P19, DOI 10.1006/anbo.2000.1290; BOSSHARD HH, 1965, HOLZFORSCHUNG, V19, P65, DOI 10.1515/hfsg.1965.19.3.65; Brenner WG, 2005, PLANT J, V44, P314, DOI 10.1111/j.1365-313X.2005.02530.x; Brown RL, 2003, PLANT PHYSIOL, V132, P1020, DOI 10.1104/pp.102.017814; Cai SQ, 2008, PLANT PHYSIOL, V146, P1305, DOI 10.1104/pp.107.110908; CHAPPLE CCS, 1992, PLANT CELL, V4, P1413, DOI 10.1105/tpc.4.11.1413; Che P, 2006, PLANT PHYSIOL, V141, P620, DOI 10.1104/pp.106.081240; Cheong YH, 2002, PLANT PHYSIOL, V129, P661, DOI 10.1104/pp.002857; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dehon L, 2001, ACTA HORTIC, P339, DOI 10.17660/ActaHortic.2001.544.45; FREY-WYSSLING A., 1959, HOLZFORSCHUNG, V13, P129, DOI 10.1515/hfsg.1959.13.5.129; Fujimoto SY, 2000, PLANT CELL, V12, P393, DOI 10.1105/tpc.12.3.393; Guo HW, 2004, CURR OPIN PLANT BIOL, V7, P40, DOI 10.1016/j.pbi.2003.11.011; Hao DY, 1998, J BIOL CHEM, V273, P26857, DOI 10.1074/jbc.273.41.26857; Hauch S, 1998, PLANTA, V207, P266, DOI 10.1007/s004250050482; HILLIS WE, 1975, PHYTOCHEMISTRY, V14, P2559, DOI 10.1016/0031-9422(75)85224-1; Huang ZL, 2009, PLANT CELL REP, V28, P1717, DOI 10.1007/s00299-009-0771-6; Huang ZJ, 2004, FEBS LETT, V573, P110, DOI 10.1016/j.febslet.2004.07.064; Hudgins JW, 2004, PLANT PHYSIOL, V135, P2134, DOI 10.1104/pp.103.037929; Huibers RP, 2008, GENETIC ANAL SUSCEPT; Kato M, 2000, PLANT CELL PHYSIOL, V41, P440, DOI 10.1093/pcp/41.4.440; Kihara T, 2006, BIOSCI BIOTECH BIOCH, V70, P1780, DOI 10.1271/bbb.50687; Kim BR, 2003, BIOTECHNOL LETT, V25, P1869, DOI 10.1023/A:1026298032009; Kolosova N, 2004, BIOTECHNIQUES, V36, P821, DOI 10.2144/04365ST06; Koornneef M, 2002, CURR OPIN PLANT BIOL, V5, P33, DOI 10.1016/S1369-5266(01)00219-9; Koyama T, 2003, J EXP BOT, V54, P1175, DOI 10.1093/jxb/erg136; Krishnaswamy S, 2011, PLANT MOL BIOL, V75, P107, DOI 10.1007/s11103-010-9711-7; Lawrence G. H. M., 1951, TAXONOMY VASCULAR PL; Li YC, 2007, PLANT CELL REP, V26, P1999, DOI 10.1007/s00299-007-0394-8; Liang HX, 2008, J EXP BOT, V59, P3111, DOI 10.1093/jxb/ern165; Lopez-Molina L, 2003, GENE DEV, V17, P410, DOI 10.1101/gad.1055803; Lorenzo O, 2003, PLANT CELL, V15, P165, DOI 10.1105/tpc.007468; Magel EA, 2000, EXPTL BIOL REV, P363; McGrath KC, 2005, PLANT PHYSIOL, V139, P949, DOI 10.1104/pp.105.068544; Memelink J, 2001, TRENDS PLANT SCI, V6, P212, DOI 10.1016/S1360-1385(01)01924-0; MILLER AR, 1985, J EXP BOT, V36, P110, DOI 10.1093/jxb/36.1.110; MURASHIGE T, 1962, PHYSIOL PLANTARUM, V15, P473, DOI 10.1111/j.1399-3054.1962.tb08052.x; Nakaba S, 2008, TREES-STRUCT FUNCT, V22, P623, DOI 10.1007/s00468-008-0220-0; Nakano T, 2006, PLANT PHYSIOL, V140, P411, DOI 10.1104/pp.105.073783; Nakano T, 2006, J PLANT RES, V119, P407, DOI 10.1007/s10265-006-0287-x; NELSON ND, 1978, CAN J BOT, V56, P626, DOI 10.1139/b78-070; Nilsson M, 2002, TREE PHYSIOL, V22, P331, DOI 10.1093/treephys/22.5.331; Obayashi T, 2010, J PLANT RES, V123, P311, DOI 10.1007/s10265-010-0333-6; OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173; Okamuro JK, 1997, P NATL ACAD SCI USA, V94, P7076, DOI 10.1073/pnas.94.13.7076; Papadopoulos JS, 2007, BIOINFORMATICS, V23, P1073, DOI 10.1093/bioinformatics/btm076; Park JM, 2001, PLANT CELL, V13, P1035, DOI 10.1105/tpc.13.5.1035; Penninckx IAMA, 1996, PLANT CELL, V8, P2309, DOI 10.1105/tpc.8.12.2309; Pitts RJ, 1998, PLANT J, V16, P553, DOI 10.1046/j.1365-313x.1998.00321.x; Plomion C, 2001, PLANT PHYSIOL, V127, P1513, DOI 10.1104/pp.010816; Pre M, 2008, PLANT PHYSIOL, V147, P1347, DOI 10.1104/pp.108.117523; Riechmann JL, 1998, BIOL CHEM, V379, P633; Rohde A, 2007, J EXP BOT, V58, P4047, DOI 10.1093/jxb/erm261; SHAIN L, 1973, CAN J BOT, V51, P737, DOI 10.1139/b73-092; SHIGO AL, 1984, ANNU REV PHYTOPATHOL, V22, P189, DOI 10.1146/annurev.py.22.090184.001201; Shinshi H, 2008, PLANT SCI, V175, P18, DOI 10.1016/j.plantsci.2008.03.017; Spicer R, 2007, PLANT CELL ENVIRON, V30, P934, DOI 10.1111/j.1365-3040.2007.01677.x; Spicer Rachel, 2005, P457, DOI 10.1016/B978-012088457-5/50024-1; STASWICK PE, 1992, P NATL ACAD SCI USA, V89, P6837, DOI 10.1073/pnas.89.15.6837; Sun KL, 2005, PLANTA, V222, P632, DOI 10.1007/s00425-005-0010-5; Taiz L, 2006, ESSAY 23 1 HETEROPHY; Taylor AM, 2002, WOOD FIBER SCI, V34, P587; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Tournier B, 2003, FEBS LETT, V550, P149, DOI 10.1016/S0014-5793(03)00757-9; Van Hoewyk D, 2008, PHYSIOL PLANTARUM, V132, P236, DOI 10.1111/j.1399-3054.2007.01002.x; Wilkins O, 2009, PLANT PHYSIOL, V149, P981, DOI 10.1104/pp.108.132795; Winter D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000718; Yang JM, 2003, PLANT MOL BIOL, V52, P935, DOI 10.1023/A:1025445427284; Zhang GY, 2008, J EXP BOT, V59, P4095, DOI 10.1093/jxb/ern248; Zhang HW, 2004, PLANTA, V220, P262, DOI 10.1007/s00425-004-1347-x; Zhang JZ, 2003, CURR OPIN PLANT BIOL, V6, P430, DOI 10.1016/S1369-5266(03)00081-5; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	79	1	1	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e75857	10.1371/journal.pone.0075857	http://dx.doi.org/10.1371/journal.pone.0075857			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265672	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100004
J	Wong, ESW; Nicol, S; Warren, WC; Belov, K				Wong, Emily S. W.; Nicol, Stewart; Warren, Wesley C.; Belov, Katherine			Echidna Venom Gland Transcriptome Provides Insights into the Evolution of Monotreme Venom	PLOS ONE			English	Article							PLATYPUS; GENES; BUTYRYLCHOLINESTERASE; GENERATION; DISCOVERY; PEPTIDES; DEFENSIN	Monotremes (echidna and platypus) are egg-laying mammals. One of their most unique characteristic is that males have venom/crural glands that are seasonally active. Male platypuses produce venom during the breeding season, delivered via spurs, to aid in competition against other males. Echidnas are not able to erect their spurs, but a milky secretion is produced by the gland during the breeding season. The function and molecular composition of echidna venom is as yet unknown. Hence, we compared the deeply sequenced transcriptome of an in-season echidna crural gland to that of a platypus and searched for putative venom genes to provide clues into the function of echidna venom and the evolutionary history of monotreme venom. We found that the echidna venom gland transcriptome was markedly different from the platypus with no correlation between the top 50 most highly expressed genes. Four peptides found in the venom of the platypus were detected in the echidna transcriptome. However, these genes were not highly expressed in echidna, suggesting that they are the remnants of the evolutionary history of the ancestral venom gland. Gene ontology terms associated with the top 100 most highly expressed genes in echidna, showed functional terms associated with steroidal and fatty acid production, suggesting that echidna "venom" may play a role in scent communication during the breeding season. The loss of the ability to erect the spur and other unknown evolutionary forces acting in the echidna lineage resulted in the gradual decay of venom components and the evolution of a new role for the crural gland.	[Wong, Emily S. W.] Univ Queensland, Inst Mol Biosci, Brisbane, Qld 4072, Australia; [Nicol, Stewart] Univ Tasmania, Sch Zool, Hobart, Tas 7001, Australia; [Warren, Wesley C.] Washington Univ, Sch Med, Genome Inst, St Louis, MO USA; [Belov, Katherine] Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia	University of Queensland; University of Tasmania; Washington University (WUSTL); University of Sydney	Belov, K (corresponding author), Univ Sydney, Fac Vet Sci, Sydney, NSW 2006, Australia.	kathy.belov@sydney.edu.au	Wong, Emily/C-2302-2018	Wong, Emily/0000-0003-0315-2942; Belov, Katherine/0000-0002-9762-5554	University of Queensland; ARC	University of Queensland(University of Queensland); ARC(Australian Research Council)	EW is supported by a University of Queensland Postdoctoral Fellowship. KB is supported by an ARC Future Fellowship. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Augee M, 1996, ECHIDNA EXTRAORDINAR; Bauer S, 2008, BIOINFORMATICS, V24, P1650, DOI 10.1093/bioinformatics/btn250; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Chen DS, 1997, BIOCHEM J, V325, P685, DOI 10.1042/bj3250685; Chilukuri N, 2009, MOL PHARMACOL, V76, P612, DOI 10.1124/mol.109.055665; de Plater GM, 1998, COMP BIOCHEM PHYS C, V120, P99, DOI 10.1016/S0742-8413(98)00030-9; Griffiths M., 1968, ECHIDNAS; Griffiths M., 1978, BIOL MONOTREMES; Harris RL, 2012, CHEM SENSES; Hurum JH, 2006, ACTA PALAEONTOL POL, V51, P1; Jungo F, 2012, TOXICON, V60, P551, DOI 10.1016/j.toxicon.2012.03.010; Kita M, 2009, J AM CHEM SOC, V131, P18038, DOI 10.1021/ja908148z; Krause WJ, 2010, CELLS TISSUES ORGANS, V191, P336, DOI 10.1159/000252802; Langmead B, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-3-r25; MACKENZIE WC, 1919, GLANDULAR SYSTEM MON; Masson P, 2010, ARCH BIOCHEM BIOPHYS, V494, P107, DOI 10.1016/j.abb.2009.12.005; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rowe T, 2008, P NATL ACAD SCI USA, V105, P1238, DOI 10.1073/pnas.0706385105; Schulz MH, 2012, OASES ROBUST DE NOVO; SCHWEITZ H, 1995, J BIOL CHEM, V270, P25121, DOI 10.1074/jbc.270.42.25121; Surget-Groba Y, 2010, GENOME RES, V20, P1432, DOI 10.1101/gr.103846.109; Torres AM, 2000, BIOCHEM J, V348, P649, DOI 10.1042/0264-6021:3480649; TSAI IH, 1995, BIOCHEM J, V311, P895, DOI 10.1042/bj3110895; Whittington CM, 2008, TOXICON, V52, P559, DOI 10.1016/j.toxicon.2008.07.002; Whittington CM, 2008, GENOME RES, V18, P986, DOI 10.1101/gr.7149808; Whittington CM, 2010, GENOME BIOL, V11, DOI 10.1186/gb-2010-11-9-r95; Wong ESW, 2012, MOL CELL PROTEOMICS, V11, P1354, DOI 10.1074/mcp.M112.017491; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhou X, 2008, BIOPHYS J, V95, P3366, DOI 10.1529/biophysj.107.117747	31	14	15	1	62	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79092	10.1371/journal.pone.0079092	http://dx.doi.org/10.1371/journal.pone.0079092			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265746	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100079
J	Yan, HD; Kolkin, J; Zhao, B; Li, ZF; Jiang, SC; Wang, W; Xia, Z; Fan, CY				Yan, Hede; Kolkin, Jon; Zhao, Bin; Li, Zhefeng; Jiang, Shichao; Wang, Wei; Xia, Zhen; Fan, Cunyi			The Effect of Hemodynamic Remodeling on the Survival of Arterialized Venous Flaps	PLOS ONE			English	Article							HAND RECONSTRUCTION; DELAY PROCEDURES; DIGITAL DEFECTS; FOREARM FLAPS; ISLAND FLAPS; BLOOD-FLOW; MICROCIRCULATION; LACTATE; GLUCOSE; RABBITS	Objective: To evaluate the effect of hemodynamic remodeling on the survival status of the arterialized venous flaps (AVFs) and investigate the mechanism of this procedure. Materials and Methods: Two 7 x 9 cm skin flaps in each rabbit (n=36) were designed symmetrically in the abdomen. The thoracoepigastric pedicle and one femoral artery were used as vascular sources. Four groups were included: Composite skin grafts group and arterial perfusion group were designed in one rabbit; AVF group and hemodynamic remodeling group by ligation of the thoracoepigastric vein in the middle were outlined in another rabbit. Flap viability, status of vascular perfusion and microvasculature, levels of epidermal metabolite and water content in each group were assessed. Results: Highly congested veins and simple trunk veins were found using angiography in the AVF group; while a fairly uniform staining and plenty of small vessels were observed in the hemodynamic remodeling group. The metabolite levels of the remodeling group are comparable with those in the arterial perfusion group. There was no statistically significant difference in the percentage of flap survival between the arterial perfusion group and hemodynamic remodeling group; however, significant difference was seen between the AVF group and the hemodynamic remodeling group. Conclusions: Under the integrated perfusion mode, the AVFs are in an over-perfusion and non-physiological hemodynamic state, resulting in unreliability and unpredictability in flap survival; under the separated perfusion mode produced by remodeling, a physiological-like circulation will be created and therefore, better flap survival can be expected.	[Yan, Hede; Jiang, Shichao; Wang, Wei; Xia, Zhen; Fan, Cunyi] Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200030, Peoples R China; [Yan, Hede; Zhao, Bin; Li, Zhefeng] Wenzhou Med Coll, Affiliated Hosp 2, Dept Orthopaed, Div Plast & Hand Surg, Wenzhou, Peoples R China; [Kolkin, Jon] Duke Raleigh Hosp, Dept Plast & Hand Surg, Raleigh, NC USA	Shanghai Jiao Tong University; Wenzhou Medical University	Fan, CY (corresponding author), Shanghai Jiao Tong Univ, Affiliated Peoples Hosp 6, Dept Orthoped, Shanghai 200030, Peoples R China.	fancunyi888@hotmail.com	fan, cunyi/ABI-7199-2020	fan, cunyi/0000-0002-7854-5233	Natural Science Foundation of Zhejiang province [LY12H06003]; Clinical Research Foundation of Zhejiang Province Medical Association [2010ZYC-B04]; Department of Education of Zhejiang Province [20051185]	Natural Science Foundation of Zhejiang province(Natural Science Foundation of Zhejiang Province); Clinical Research Foundation of Zhejiang Province Medical Association; Department of Education of Zhejiang Province	This study was supported by the Natural Science Foundation of Zhejiang province (Grant No. LY12H06003), Clinical Research Foundation of Zhejiang Province Medical Association (Grant No. 2010ZYC-B04), and funding from the Department of Education of Zhejiang Province (20051185). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akdemir O, 2011, J PLAST RECONSTR AES, V64, P921, DOI 10.1016/j.bjps.2010.12.007; BAEK SM, 1985, PLAST RECONSTR SURG, V75, P88, DOI 10.1097/00006534-198501000-00020; Brooks D, 2002, ANN PLAS SURG, V48, P189, DOI 10.1097/00000637-200202000-00013; BYUN JS, 1995, PLAST RECONSTR SURG, V96, P1650, DOI 10.1097/00006534-199512000-00019; CHAVOIN JP, 1987, BRIT J PLAST SURG, V40, P149, DOI 10.1016/0007-1226(87)90187-1; CHEN HC, 1991, J TRAUMA, V31, P1286, DOI 10.1097/00005373-199109000-00014; Cho BC, 1999, PLAST RECONSTR SURG, V104, P2138, DOI 10.1097/00006534-199912000-00030; Cho BC, 1998, PLAST RECONSTR SURG, V102, P1134, DOI 10.1097/00006534-199809040-00033; GENCOSMANOGLU R, 1993, ANN PLAS SURG, V30, P60, DOI 10.1097/00000637-199301000-00009; Hyza P, 2005, ANN PLAS SURG, V55, P679, DOI 10.1097/01.sap.0000178806.37967.9f; INOUE G, 1991, J RECONSTR MICROSURG, V7, P339, DOI 10.1055/s-2007-1006794; INOUE G, 1988, Journal of Reconstructive Microsurgery, V4, P259, DOI 10.1055/s-2007-1006929; Kong BS, 2008, J HAND SURG-AM, V33A, P1802, DOI 10.1016/j.jhsa.2008.08.001; Kovacs AF, 1998, J CRANIO MAXILL SURG, V26, P249, DOI 10.1016/S1010-5182(98)80021-8; Lam WL, 2013, J HAND SURG-EUR VOL, V38E, P352, DOI 10.1177/1753193412468632; LENOBLE E, 1993, BRIT J PLAST SURG, V46, P378, DOI 10.1016/0007-1226(93)90043-B; Lin YT, 2010, J TRAUMA, V69, P399, DOI 10.1097/TA.0b013e3181bee6ad; Lubiatowski P, 2002, PLAST RECONSTR SURG, V109, P1986, DOI 10.1097/00006534-200205000-00031; MATSUSHITA K, 1993, PLAST RECONSTR SURG, V91, P127, DOI 10.1097/00006534-199301000-00019; Moshammer HET, 2003, MICROSURG, V23, P130, DOI 10.1002/micr.10108; Mutaf M, 1998, BRIT J PLAST SURG, V51, P393, DOI 10.1054/bjps.1997.0151; NAKAYAMA Y, 1981, PLAST RECONSTR SURG, V67, P328, DOI 10.1097/00006534-198103000-00009; Setala L, 2013, J RECONSTR MICROSURG, V29, P505, DOI 10.1055/s-0033-1348039; Setala LP, 2004, MICROSURG, V24, P223, DOI 10.1002/micr.20045; SU CT, 1982, PLAST RECONSTR SURG, V70, P202, DOI 10.1097/00006534-198208000-00014; SUZUKI Y, 1994, BRIT J PLAST SURG, V47, P554, DOI 10.1016/0007-1226(94)90139-2; Tan BK, 2004, ANN ACAD MED SINGAP, V33, P662; Tang YB, 2000, SCAND J PLAST RECONS, V34, P207; Tao YL, 2011, SURG RADIOL ANAT, V33, P789, DOI 10.1007/s00276-011-0809-7; TSAI T-M, 1987, Journal of Reconstructive Microsurgery, V3, P113, DOI 10.1055/s-2007-1006973; Wong MS, 2004, PLAST RECONSTR SURG, V113, P2030, DOI 10.1097/01.prs.0000122217.16985.52; Woo SH, 2007, PLAST RECONSTR SURG, V119, P1823, DOI 10.1097/01.prs.0000259094.68803.3d; Woo SH, 1998, PLAST RECONSTR SURG, V101, P1280, DOI 10.1097/00006534-199804050-00019; XIU ZF, 1995, ANN PLAS SURG, V34, P518, DOI 10.1097/00000637-199505000-00011; Yan HD, 2012, J PLAST RECONSTR AES, V65, P1220, DOI 10.1016/j.bjps.2012.03.036; Yan HD, 2010, MICROSURG, V30, P472, DOI 10.1002/micr.20769; Yan H, 2011, ARCH ORTHOP TRAUM SU, V131, P65, DOI 10.1007/s00402-010-1107-2; Yan HD, 2010, J RECONSTR MICROSURG, V26, P193, DOI 10.1055/s-0030-1247715; Yilmaz M, 1996, BRIT J PLAST SURG, V49, P396, DOI 10.1016/S0007-1226(96)90009-0; Yuan RY, 1998, J RECONSTR MICROSURG, V14, P147, DOI 10.1055/s-2007-1000158	40	10	10	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79608	10.1371/journal.pone.0079608	http://dx.doi.org/10.1371/journal.pone.0079608			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265782	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100115
J	Zhang, LB; Jia, HB; Yin, YT; Wu, G; Xia, H; Wang, XD; Fu, CH; Li, MT; Wu, JS				Zhang, Libin; Jia, Haibo; Yin, Yongtai; Wu, Gang; Xia, Heng; Wang, Xiaodong; Fu, Chunhua; Li, Maoteng; Wu, Jiangsheng			Transcriptome Analysis of Leaf Tissue of Raphanus sativus by RNA Sequencing	PLOS ONE			English	Article							SSR MARKERS; ROOT TRANSCRIPTOME; GENE-EXPRESSION; SEQ DATA; NOVO; IDENTIFICATION; GENERATION; POLYMORPHISM; TOOL	Raphanus sativus is not only a popular edible vegetable but also an important source of medicinal compounds. However, the paucity of knowledge about the transcriptome of R. sativus greatly impedes better understanding of the functional genomics and medicinal potential of R. sativus. In this study, the transcriptome sequencing of leaf tissues in R. sativus was performed for the first time. Approximately 22 million clean reads were generated and used for transcriptome assembly. The generated unigenes were subsequently annotated against gene ontology (GO) database. KEGG analysis further revealed two important pathways in the bolting stage of R. sativus including spliceosome assembly and alkaloid synthesis. In addition, a total of 6,295 simple sequence repeats (SSRs) with various motifs were identified in the unigene library of R. sativus. Finally, four unigenes of R. sativus were selected for alignment with their homologs from other plants, and phylogenetic trees for each of the genes were constructed. Taken together, this study will provide a platform to facilitate gene discovery and advance functional genomic research of R. sativus.	[Zhang, Libin; Jia, Haibo; Yin, Yongtai; Wu, Gang; Xia, Heng; Wang, Xiaodong; Fu, Chunhua; Li, Maoteng] Huazhong Univ Sci & Technol, Sch Life Sci & Techonol, Wuhan 430074, Hubei, Peoples R China; [Zhang, Libin] Wuhan Univ Sci & Technol, Inst Biol & Med, Wuhan, Hubei, Peoples R China; [Wu, Jiangsheng] Huazhong Agr Univ, Natl Key Lab Crop Genet Improvement, Wuhan, Peoples R China	Huazhong University of Science & Technology; Wuhan University of Science & Technology; Huazhong Agricultural University	Li, MT (corresponding author), Huazhong Univ Sci & Technol, Sch Life Sci & Techonol, Wuhan 430074, Hubei, Peoples R China.	limaoteng426@hust.edu.cn			National Natural Science Foundation of China [31071447]; Natural Science Funds for Distinguished Young Scholars of Hubei Province of China [2010CDA097]; New Century Talents Support Program by the Ministry of Education of China [NCET110172]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Natural Science Funds for Distinguished Young Scholars of Hubei Province of China; New Century Talents Support Program by the Ministry of Education of China	This work was supported by 1) the National Natural Science Foundation of China (31071447) (http://www.nsfc.gov.cn/Portal0/default152.htm), 2) the Natural Science Funds for Distinguished Young Scholars of Hubei Province of China (2010CDA097) (http://www.most.gov.cn/), 3) the New Century Talents Support Program by the Ministry of Education of China (NCET110172)(http://www.moe.gov.cn/). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Barrero RA, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-600; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; Feng C, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-19; Gongora-Castillo E, 2013, NAT PROD REP, V30, P490, DOI 10.1039/c3np20099j; Grabherr MG, 2011, NAT BIOTECHNOL, V29, P644, DOI 10.1038/nbt.1883; Kamei A, 2010, THEOR APPL GENET, V120, P1021, DOI 10.1007/s00122-009-1230-z; Knowles DG, 2009, GENOME RES, V19, P1752, DOI 10.1101/gr.095026.109; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Li RQ, 2010, GENOME RES, V20, P265, DOI 10.1101/gr.097261.109; Miller HC, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-439; Morin RD, 2008, BIOTECHNIQUES, V45, P81, DOI 10.2144/000112900; Nakatsuji R, 2011, BREEDING SCI, V61, P413, DOI 10.1270/jsbbs.61.413; Ness RW, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-298; Ogata H, 1999, NUCLEIC ACIDS RES, V27, P29, DOI 10.1093/nar/27.1.29; Ohsako T, 2010, BREEDING SCI, V60, P195, DOI 10.1270/jsbbs.60.195; Sadamoto H, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042546; Sawa M, 2011, P NATL ACAD SCI USA, V108, P11698, DOI 10.1073/pnas.1106771108; Schulz MH, 2012, BIOINFORMATICS, V28, P1086, DOI 10.1093/bioinformatics/bts094; Schuster SC, 2008, NAT METHODS, V5, P16, DOI 10.1038/NMETH1156; Sharopova N, 2002, PLANT MOL BIOL, V48, P463, DOI 10.1023/A:1014868625533; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shi CY, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-131; Simpson JT, 2009, GENOME RES, V19, P1117, DOI 10.1101/gr.089532.108; Sun XD, 2012, PLANT CELL REP, V31, P1823, DOI 10.1007/s00299-012-1295-z; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tang Q, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-343; Van Belleghem SM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0042605; Vera JC, 2008, MOL ECOL, V17, P1636, DOI 10.1111/j.1365-294X.2008.03666.x; Wang LS, 2002, J AGR FOOD CHEM, V50, P868, DOI 10.1021/jf011130+; Wang XW, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-400; Wang XW, 2011, NAT GENET, V43, P1035, DOI 10.1038/ng.919; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066539; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Watt J. M., 1962, The medicinal and poisonous plants of southern and eastern Africa: being an account of their medicinal and other uses, chemical composition, pharmacological effects aod toricotogy in man and annimal.; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Xiang LX, 2010, BMC GENOMICS, V11, DOI 10.1186/1471-2164-11-472; Xu DL, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-133; Xu L, 2013, PLANT SCI, V201, P108, DOI 10.1016/j.plantsci.2012.11.010; Xu P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0015952; Yamane K, 2009, BREEDING SCI, V59, P55, DOI 10.1270/jsbbs.59.55; Yang SS, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-199; Yu Y, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-15; ZAMORE PD, 1989, P NATL ACAD SCI USA, V86, P9243, DOI 10.1073/pnas.86.23.9243; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107; Zhang JA, 2012, BMC GENOMICS, V13, DOI 10.1186/1471-2164-13-90; Zhao QY, 2011, BMC BIOINFORMATICS, V12, DOI 10.1186/1471-2105-12-S14-S2	47	23	28	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80350	10.1371/journal.pone.0080350	http://dx.doi.org/10.1371/journal.pone.0080350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265813	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100149
J	Boucard, AA; Maxeiner, S; Sudhof, TC				Boucard, Antony A.; Maxeiner, Stephan; Suedhof, Thomas C.			Latrophilins Function as Heterophilic Cell-adhesion Molecules by Binding to Teneurins REGULATION BY ALTERNATIVE SPLICING	JOURNAL OF BIOLOGICAL CHEMISTRY			English	Article						Alternative Splicing; Cell Adhesion; G Protein-coupled Receptors (GPCR); Ligand-binding Protein; Neurons; FLRT3; Neurexin; -Latrotoxin; Synapse Formation; Teneurin	ALPHA-LATROTOXIN RECEPTOR; CSP-ALPHA; CONSERVED DOMAIN; PROTEIN; FAMILY; FLRT3; PAIR; IDENTIFICATION; NEUREXINS; 10-M/ODZ	Latrophilin-1, -2, and -3 are adhesion-type G protein-coupled receptors that are auxiliary -latrotoxin receptors, suggesting that they may have a synaptic function. Using pulldowns, we here identify teneurins, type II transmembrane proteins that are also candidate synaptic cell-adhesion molecules, as interactors for the lectin-like domain of latrophilins. We show that teneurin binds to latrophilins with nanomolar affinity and that this binding mediates cell adhesion, consistent with a role of teneurin binding to latrophilins in trans-synaptic interactions. All latrophilins are subject to alternative splicing at an N-terminal site; in latrophilin-1, this alternative splicing modulates teneurin binding but has no effect on binding of latrophilin-1 to another ligand, FLRT3. Addition to cultured neurons of soluble teneurin-binding fragments of latrophilin-1 decreased synapse density, suggesting that latrophilin binding to teneurin may directly or indirectly influence synapse formation and/or maintenance. These observations are potentially intriguing in view of the proposed role for Drosophila teneurins in determining synapse specificity. However, teneurins in Drosophila were suggested to act as homophilic cell-adhesion molecules, whereas our findings suggest a heterophilic interaction mechanism. Thus, we tested whether mammalian teneurins also are homophilic cell-adhesion molecules, in addition to binding to latrophilins as heterophilic cell-adhesion molecules. Strikingly, we find that although teneurins bind to each other in solution, homophilic teneurin-teneurin binding is unable to support stable cell adhesion, different from heterophilic teneurin-latrophilin binding. Thus, mammalian teneurins act as heterophilic cell-adhesion molecules that may be involved in trans-neuronal interaction processes such as synapse formation or maintenance.	[Boucard, Antony A.; Maxeiner, Stephan; Suedhof, Thomas C.] Stanford Univ, Howard Hughes Med Inst, Sch Med, Dept Mol & Cellular Physiol, Palo Alto, CA 94305 USA	Howard Hughes Medical Institute; Stanford University	Boucard, AA (corresponding author), Inst Politecn Nacl, Ctr Invest & Estudios Avanzados, Dept Biol Celular, Apartado Postal 14-740, Mexico City 07000, DF, Mexico.	antonyboucardjr@gmail.com; tcs1@stanford.edu	Boucard, Antony/ABA-9769-2020; Boucard, Antony/CAJ-3093-2022; Maxeiner, Stephan/Y-7692-2019	Maxeiner, Stephan/0000-0002-4472-695X; BOUCARD, Antony Jr/0000-0002-5538-0464	National Institutes of Health [MH052804, NS077906]; NATIONAL INSTITUTE OF MENTAL HEALTH [R37MH052804] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS077906] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	This work was supported, in whole or in part, by National Institutes of Health Grants MH052804 and NS077906.	Aoto J, 2013, CELL, V154, P75, DOI 10.1016/j.cell.2013.05.060; Arac D, 2012, EMBO J, V31, P1364, DOI 10.1038/emboj.2012.26; Beckmann J, 2013, NANO LETT, V13, P2937, DOI 10.1021/nl4013248; Benson DL, 2012, CURR OPIN NEUROBIOL, V22, P397, DOI 10.1016/j.conb.2011.09.011; Bolliger MF, 2011, P NATL ACAD SCI USA, V108, P2534, DOI 10.1073/pnas.1019577108; Bottcher RT, 2004, NAT CELL BIOL, V6, P38, DOI 10.1038/ncb1082; Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026; Boucard AA, 2012, J BIOL CHEM, V287, P9399, DOI 10.1074/jbc.M111.318659; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Dharmaratne N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043083; Dobosy JR, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-80; Feng K, 2002, J BIOL CHEM, V277, P26128, DOI 10.1074/jbc.M203722200; Fernandez-Chacon R, 2004, NEURON, V42, P237, DOI 10.1016/S0896-6273(04)00190-4; Hong WZ, 2012, NATURE, V484, P201, DOI 10.1038/nature10926; Ko J, 2011, J CELL BIOL, V194, P323, DOI 10.1083/jcb.201101072; Krasnoperov VG, 1997, NEURON, V18, P925, DOI 10.1016/S0896-6273(00)80332-3; Lacy SE, 1999, GENOMICS, V62, P417, DOI 10.1006/geno.1999.6033; Langenhan T, 2009, DEV CELL, V17, P494, DOI 10.1016/j.devcel.2009.08.008; Lelianova VG, 1997, J BIOL CHEM, V272, P21504, DOI 10.1074/jbc.272.34.21504; LEVINE A, 1994, CELL, V77, P587, DOI 10.1016/0092-8674(94)90220-8; Maretto S, 2008, DEV BIOL, V318, P184, DOI 10.1016/j.ydbio.2008.03.021; Merlin S, 2013, CEREB CORTEX, V23, P763, DOI 10.1093/cercor/bhs030; Minet AD, 1999, J CELL SCI, V112, P2019; Missler M., 2012, COLD SPRING HARBOR P, V4; Mosca TJ, 2012, NATURE, V484, P237, DOI 10.1038/nature10923; Muller PS, 2011, DEVELOPMENT, V138, P1297, DOI 10.1242/dev.059386; Nguyen T, 1997, J BIOL CHEM, V272, P26032, DOI 10.1074/jbc.272.41.26032; Nguyen T, 2009, J NEUROSCI, V29, P630, DOI 10.1523/JNEUROSCI.5204-08.2009; O'Sullivan ML, 2012, NEURON, V73, P903, DOI 10.1016/j.neuron.2012.01.018; Oohashi T, 1999, J CELL BIOL, V145, P563, DOI 10.1083/jcb.145.3.563; Promel S, 2012, CELL REP, V2, P321, DOI 10.1016/j.celrep.2012.06.015; REBAY I, 1991, CELL, V67, P687, DOI 10.1016/0092-8674(91)90064-6; Robinson M, 2004, MOL CELL NEUROSCI, V27, P202, DOI 10.1016/j.mcn.2004.06.008; Schmitz F, 2006, P NATL ACAD SCI USA, V103, P2926, DOI 10.1073/pnas.0510060103; Sharma M, 2012, EMBO J, V31, P829, DOI 10.1038/emboj.2011.467; Silva JP, 2011, P NATL ACAD SCI USA, V108, P12113, DOI 10.1073/pnas.1019434108; Sollner C, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r99; Sugita S, 1998, J BIOL CHEM, V273, P32715, DOI 10.1074/jbc.273.49.32715; Suzuki N, 2012, J NEUROSCI, V32, P11586, DOI 10.1523/JNEUROSCI.2045-11.2012; Tanabe K, 2003, J NEUROSCI, V23, P9675; Tobaben S, 2002, J BIOL CHEM, V277, P6359, DOI 10.1074/jbc.M111231200; Tsuji L, 2004, BIOCHEM BIOPH RES CO, V313, P1086, DOI 10.1016/j.bbrc.2003.12.047; USHKARYOV YA, 1994, J BIOL CHEM, V269, P11987; Yamagishi S, 2011, EMBO J, V30, P2920, DOI 10.1038/emboj.2011.189; Yin XH, 1998, J NEUROSCI, V18, P1953, DOI 10.1523/jneurosci.18-06-01953.1998; Zhang YQ, 2012, NEURON, V74, P136, DOI 10.1016/j.neuron.2012.01.029; Zheng L, 2011, PLOS ONE, V6	47	125	127	0	10	AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA		1083-351X		J BIOL CHEM	J. Biol. Chem.	JAN 3	2014	289	1					387	402		10.1074/jbc.M113.504779	http://dx.doi.org/10.1074/jbc.M113.504779			16	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	285CN	24273166	hybrid, Green Published			2022-12-25	WOS:000329370900034
J	Chen, YQ; Chen, MJ; Wu, ZH; Zhao, SP				Chen, Yaqin; Chen, Mingjie; Wu, Zhihong; Zhao, Shuiping			Ox-LDL Induces ER Stress and Promotes the adipokines Secretion in 3T3-L1 Adipocytes	PLOS ONE			English	Article							ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; CIRCULATING OXIDIZED LDL; LOW-DENSITY-LIPOPROTEIN; ADIPOSE-TISSUE; OBESITY; VISFATIN; GLUCOSE; STORAGE; FAT	Adipocytes behave as a rich source of adipokines, which may be the link between obesity and its complications. Endoplasmic reticulum (ER) stress in adipocytes can modulate adipokines secretion. The aim of this study is to evaluate the effect of oxidized low density lipoprotein square ox-LDL square treatment on ER stress and adipokines secretion in differentiated adipocytes. 3T3-L1 pre-adipocytes were cultured and differentiated into mature adipocytes in vitro. Differentiated adipocytes were incubated with various concentrations of ox-LDL (0-100 mu g/ml) for 48 hours; 50 mu g/ml ox-LDL for various times (0-48 hours) with or without tauroursodeoxycholic acid (TUDCA) (0-400 mu M) pre-treatment. The protein expressions of ER stress markers, glucose regulated protein 78(GRP78) and CCAAT/enhancer binding protein [C/EBP] homologous protein (CHOP) in adipocytes were detected by Western blot. The mRNA expressions of visfatin and resistin were measured by real-time PCR and the protein release of visfatin and resistin in supernatant were determined by ELISA. Treatment with ox-LDL could increase the cholesterol concentration in adipocytes. Ox-LDL induced the expressions of GRP78 and CHOP protein in adipocytes and promoted visfatin and resistin secretion in culture medium in dose and time-dependent manner. TUDCA could attenuate the effect of ox-LDL on GRP78 and CHOP expressions and reduce visfatin and resistin at mRNA and protein level in dose-dependent manner. In conclusion, ox-LDL promoted the expression and secretion of visfatin and resistin through its activation of ER stress, which may be related to the increase of cholesterol load in adipocytes.	[Chen, Yaqin; Chen, Mingjie; Wu, Zhihong; Zhao, Shuiping] Cent South Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China	Central South University	Wu, ZH (corresponding author), Cent South Univ, Xiangya Hosp 2, Dept Cardiol, Changsha, Hunan, Peoples R China.	wuzh915@hotmail.com; zhaosp@medmail.com.cn			National Natural Science Foundation of China [30900624, 81170262]; National Program on Key Basic Research Project of China (973 Program) [2012CB517504]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); National Program on Key Basic Research Project of China (973 Program)(National Basic Research Program of China)	This work was supported by the National Natural Science Foundation of China (Project 30900624 and 81170262) and National Program on Key Basic Research Project of China (973 Program) (No. 2012CB517504). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Berg AH, 2002, TRENDS ENDOCRIN MET, V13, P84, DOI 10.1016/S1043-2760(01)00524-0; Boden G, 2011, METHOD ENZYMOL, V489, P67, DOI 10.1016/B978-0-12-385116-1.00004-2; Holvoet P, 2001, ARTERIOSCL THROM VAS, V21, P844, DOI 10.1161/01.ATV.21.5.844; Hosogai N, 2007, DIABETES, V56, P901, DOI 10.2337/db06-0911; Hotamisligil GS, 2010, CELL, V140, P900, DOI 10.1016/j.cell.2010.02.034; Hug C, 2005, SCIENCE, V307, P366, DOI 10.1126/science.1106933; Ishigaki Y, 2009, CURR OPIN LIPIDOL, V20, P363, DOI 10.1097/MOL.0b013e32832fa58d; Kaufman RJ, 1999, GENE DEV, V13, P1211, DOI 10.1101/gad.13.10.1211; KOVANEN PT, 1975, J LIPID RES, V16, P211; Kuniyasu A, 2002, BIOCHEM BIOPH RES CO, V295, P319, DOI 10.1016/S0006-291X(02)00666-6; Lefterova MI, 2009, DIABETES, V58, P1879, DOI 10.2337/db08-1706; Li YK, 2005, J BIOL CHEM, V280, P21763, DOI 10.1074/jbc.M501759200; Matsuzawa Y, 1999, ANN NY ACAD SCI, V892, P146, DOI 10.1111/j.1749-6632.1999.tb07793.x; Maury E, 2007, AM J PHYSIOL-ENDOC M, V293, pE656, DOI 10.1152/ajpendo.00127.2007; Moore KA, 2012, ANNU REV GENET, V46, P165, DOI 10.1146/annurev-genet-110711-155644; Nakatani Y, 2005, J BIOL CHEM, V280, P847, DOI 10.1074/jbc.M411860200; Ortegren U, 2007, TRENDS ENDOCRIN MET, V18, P344, DOI 10.1016/j.tem.2007.08.007; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Sanson M, 2009, CIRC RES, V104, P328, DOI 10.1161/CIRCRESAHA.108.183749; Shimomura I, 1996, NAT MED, V2, P800, DOI 10.1038/nm0796-800; Tabas I, 2002, J CLIN INVEST, V110, P905, DOI 10.1172/JCI200216452; Treiman M, 2002, TRENDS CARDIOVAS MED, V12, P57, DOI 10.1016/S1050-1738(01)00147-5; Wang P, 2009, CARDIOVASC RES, V81, P370, DOI 10.1093/cvr/cvn288; Wu ZH, 2013, BIOCHEM BIOPH RES CO, V432, P365, DOI 10.1016/j.bbrc.2013.01.094; Xu L, 2010, HORM METAB RES, V42, P643, DOI 10.1055/s-0030-1255034; Yamawaki H, 2009, BIOCHEM BIOPH RES CO, V383, P503, DOI 10.1016/j.bbrc.2009.04.074; Yoshida H, 2007, FEBS J, V274, P630, DOI 10.1111/j.1742-4658.2007.05639.x; Zhao SP, 2004, ATHEROSCLEROSIS, V177, P255, DOI 10.1016/j.atherosclerosis.2004.07.015; Zhao SP, 2004, CLIN CHIM ACTA, V339, P189, DOI 10.1016/j.cccn.2003.10.007; Zhou LJ, 2010, AUTOPHAGY, V6, P1196, DOI 10.4161/auto.6.8.13478	30	21	22	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 22	2013	8	11							e81379	10.1371/journal.pone.0081379	http://dx.doi.org/10.1371/journal.pone.0081379			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	259QP	24278099	Green Published, gold, Green Submitted			2022-12-25	WOS:000327541700060
J	Bornelov, S; Saaf, A; Melen, E; Bergstrom, A; Moghadam, BT; Pulkkinen, V; Acevedo, N; Pietras, CO; Ege, M; Braun-Fahrlander, C; Riedler, J; Doekes, G; Kabesch, M; van Hage, M; Kere, J; Scheynius, A; Soderhall, C; Pershagen, G; Komorowski, J				Bornelov, Susanne; Saaf, Annika; Melen, Erik; Bergstrom, Anna; Moghadam, Behrooz Torabi; Pulkkinen, Ville; Acevedo, Nathalie; Pietras, Christina Orsmark; Ege, Markus; Braun-Fahrlaender, Charlotte; Riedler, Josef; Doekes, Gert; Kabesch, Michael; van Hage, Marianne; Kere, Juha; Scheynius, Annika; Soderhall, Cilla; Pershagen, Goran; Komorowski, Jan			Rule-Based Models of the Interplay between Genetic and Environmental Factors in Childhood Allergy	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; ATOPIC SENSITIZATION; FEATURE-SELECTION; LARGE-SCALE; ASTHMA; CHILDREN; EXPOSURE; ECZEMA; RISK; LIFE	Both genetic and environmental factors are important for the development of allergic diseases. However, a detailed understanding of how such factors act together is lacking. To elucidate the interplay between genetic and environmental factors in allergic diseases, we used a novel bioinformatics approach that combines feature selection and machine learning. In two materials, PARSIFAL (a European cross-sectional study of 3113 children) and BAMSE (a Swedish birth-cohort including 2033 children), genetic variants as well as environmental and lifestyle factors were evaluated for their contribution to allergic phenotypes. Monte Carlo feature selection and rule based models were used to identify and rank rules describing how combinations of genetic and environmental factors affect the risk of allergic diseases. Novel interactions between genes were suggested and replicated, such as between ORMDL3 and RORA, where certain genotype combinations gave odds ratios for current asthma of 2.1 (95% CI 1.2-3.6) and 3.2 (95% CI 2.0-5.0) in the BAMSE and PARSIFAL children, respectively. Several combinations of environmental factors appeared to be important for the development of allergic disease in children. For example, use of baby formula and antibiotics early in life was associated with an odds ratio of 7.4 (95% CI 4.5-12.0) of developing asthma. Furthermore, genetic variants together with environmental factors seemed to play a role for allergic diseases, such as the use of antibiotics early in life and COL29A1 variants for asthma, and farm living and NPSR1 variants for allergic eczema. Overall, combinations of environmental and life style factors appeared more frequently in the models than combinations solely involving genes. In conclusion, a new bioinformatics approach is described for analyzing complex data, including extensive genetic and environmental information. Interactions identified with this approach could provide useful hints for further in-depth studies of etiological mechanisms and may also strengthen the basis for risk assessment and prevention.	[Bornelov, Susanne; Moghadam, Behrooz Torabi; Komorowski, Jan] Uppsala Univ, Dept Cell & Mol Biol, Sci Life Lab, Uppsala, Sweden; [Saaf, Annika; Melen, Erik; Bergstrom, Anna; Pershagen, Goran] Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden; [Melen, Erik] South Gen Hosp, Sachs Childrens Hosp, Stockholm, Sweden; [Pulkkinen, Ville; Kere, Juha] Univ Helsinki, Biomedicum, Res Programs Unit, Helsinki, Finland; [Pulkkinen, Ville; Kere, Juha] Folkhalsan Inst Genet, Helsinki, Finland; [Acevedo, Nathalie; Pietras, Christina Orsmark; Kere, Juha; Soderhall, Cilla] Karolinska Inst, Dept Biosci & Nutr, S-10401 Stockholm, Sweden; [Acevedo, Nathalie; Scheynius, Annika] Karolinska Inst, Translat Immunol Unit, Dept Med Solna, S-10401 Stockholm, Sweden; [Acevedo, Nathalie; van Hage, Marianne; Scheynius, Annika] Univ Hosp, Stockholm, Sweden; [Ege, Markus] Univ Munich, Dr von Hauner Childrens Hosp, Munich, Germany; [Braun-Fahrlaender, Charlotte] Swiss Trop & Publ Hlth Inst, Dept Epidemiol & Publ Hlth, Basel, Switzerland; [Braun-Fahrlaender, Charlotte] Univ Basel, Dept Publ Hlth, Basel, Switzerland; [Riedler, Josef] Kardinal Schwarzenberg Hosp, Dept Children & Young Adults Med, Schwarzach, Austria; [Doekes, Gert] Univ Utrecht, Inst Risk Assessment Sci, Utrecht, Netherlands; [Kabesch, Michael] Hannover Med Sch, Dept Pediat Pneumol Allergy & Neonatol, Hannover, Germany; [van Hage, Marianne] Karolinska Inst, Dept Med Solna, Clin Immunol & Allergy Unit, S-10401 Stockholm, Sweden; [Kere, Juha] Karolinska Inst, Sci Life Lab, S-10401 Stockholm, Sweden; [Komorowski, Jan] Univ Warsaw, Interdisciplinary Ctr Math & Computat Modelling, Warsaw, Poland	Uppsala University; Karolinska Institutet; University of Helsinki; Karolinska Institutet; Karolinska Institutet; University of Munich; University of Basel; Swiss Tropical & Public Health Institute; University of Basel; Utrecht University; Hannover Medical School; Karolinska Institutet; Karolinska Institutet; University of Warsaw; Interdisciplinary Centre for Mathematical & Computational Modelling	Pershagen, G (corresponding author), Karolinska Inst, Inst Environm Med, S-10401 Stockholm, Sweden.	goran.pershagen@ki.se	Komorowski, Jan/M-2667-2013; Kere, Juha/AAX-9117-2021; van Hage, Marianne/A-9678-2017; Bornelöv, Susanne/I-8225-2019; riedler, josef/AAQ-4666-2020; Ege, Markus/C-1962-2012; Komorowski, Jan/AAP-1685-2020; Kabesch, Michael/GZM-1583-2022; Söderhäll, Cilla/E-3940-2012; Kabesch, Michael/AAB-5701-2020; Kere, Juha/A-9179-2008; Komorowski, Jan/A-9175-2010	Komorowski, Jan/0000-0002-0766-8789; Kere, Juha/0000-0003-1974-0271; van Hage, Marianne/0000-0003-3091-1596; Bornelöv, Susanne/0000-0001-9276-9981; Ege, Markus/0000-0001-6643-3923; Komorowski, Jan/0000-0002-0766-8789; Söderhäll, Cilla/0000-0002-8397-3080; Kere, Juha/0000-0003-1974-0271; Orsmark-Pietras, Christina/0000-0002-6533-0305; Acevedo, Nathalie/0000-0002-5154-2964; Pershagen, Goran/0000-0002-9701-1130	Swedish Research Council; Stockholm County Council; Centre for Allergy Research; Karolinska Institutet; Swedish Heart Lung Foundation; Swedish Foundation for Strategic Research; European Union; Polish Ministry of Science and Higher Education [N301 239536]	Swedish Research Council(Swedish Research CouncilEuropean Commission); Stockholm County Council(Stockholm County Council); Centre for Allergy Research; Karolinska Institutet(Karolinska Institutet); Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); European Union(European Commission); Polish Ministry of Science and Higher Education(Ministry of Science and Higher Education, Poland)	The study was supported by the Swedish Research Council, the Stockholm County Council, the Centre for Allergy Research, Karolinska Institutet, the Swedish Heart Lung Foundation, Swedish Foundation for Strategic Research, and the European Union. Jan Komorowski was partially supported by the Polish Ministry of Science and Higher Education, grant number N301 239536. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acevedo Nathalie, 2013, PLoS One, V8, pe60111, DOI 10.1371/journal.pone.0060111; Alfven T, 2006, ALLERGY, V61, P414, DOI 10.1111/j.1398-9995.2005.00939.x; Alm JS, 1999, LANCET, V353, P1485, DOI 10.1016/S0140-6736(98)09344-1; Asher MI, 2006, LANCET, V368, P733, DOI 10.1016/S0140-6736(06)69283-0; Bieli C, 2007, J ALLERGY CLIN IMMUN, V120, P1308, DOI 10.1016/j.jaci.2007.07.034; Breslow DK, 2010, NATURE, V463, P1048, DOI 10.1038/nature08787; Bruce S, 2009, J MED GENET, V46, P159, DOI 10.1136/jmg.2007.055137; DOLD S, 1992, ARCH DIS CHILD, V67, P1018, DOI 10.1136/adc.67.8.1018; Draminski M, 2008, BIOINFORMATICS, V24, P110, DOI 10.1093/bioinformatics/btm486; Eder W, 2004, J ALLERGY CLIN IMMUN, V113, P482, DOI 10.1016/j.jaci.2003.12.374; Ege MJ, 2011, NEW ENGL J MED, V364, P701, DOI 10.1056/NEJMoa1007302; Ege MJ, 2011, J ALLERGY CLIN IMMUN, V127, P138, DOI 10.1016/j.jaci.2010.09.041; Ege MJ, 2007, J ALLERGY CLIN IMMUN, V119, P1140, DOI 10.1016/j.jaci.2007.01.037; Ege MJ, 2008, J ALLERGY CLIN IMMUN, V122, P407, DOI 10.1016/j.jaci.2008.06.011; Ege MJ, 2006, J ALLERGY CLIN IMMUN, V117, P817, DOI 10.1016/j.jaci.2005.12.1307; Ekelund E, 2009, ACTA DERM-VENEREOL, V89, P115, DOI 10.2340/00015555-0549; Esparza-Gordillo J, 2009, NAT GENET, V41, P596, DOI 10.1038/ng.347; Floistrup H, 2006, J ALLERGY CLIN IMMUN, V117, P59, DOI 10.1016/j.jaci.2005.09.039; Illi S, 2012, J ALLERGY CLIN IMMUN, V129, P1470, DOI 10.1016/j.jaci.2012.03.013; Jetten Anton M, 2009, Nucl Recept Signal, V7, pe003, DOI 10.1621/nrs.07003; Karadag B, 2007, ALLERGY, V62, P1387, DOI 10.1111/j.1398-9995.2007.01505.x; Komorowski J, 2002, HDB DATA MINING KNOW; Kull I, 2010, J ALLERGY CLIN IMMUN, V125, P1013, DOI 10.1016/j.jaci.2010.01.051; Lotvall J, 2011, J ALLERGY CLIN IMMUN, V127, P355, DOI 10.1016/j.jaci.2010.11.037; Melen E, 2005, AM J RESP CRIT CARE, V171, P1089, DOI 10.1164/rccm.200410-1317OC; Melen E, 2012, J INTERN MED, V272, P108, DOI 10.1111/j.1365-2796.2012.02555.x; Melen E, 2008, ENVIRON HEALTH PERSP, V116, P1077, DOI 10.1289/ehp.11117; Melen E, 2010, J ALLERGY CLIN IMMUN, V126, P631, DOI 10.1016/j.jaci.2010.06.030; Mitchell EA, 2012, THORAX, V67, P941, DOI 10.1136/thoraxjnl-2011-200901; Moffatt MF, 2010, NEW ENGL J MED, V363, P1211, DOI 10.1056/NEJMoa0906312; Moore JH, 2010, BIOINFORMATICS, V26, P445, DOI 10.1093/bioinformatics/btp713; Muh HC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005861; Naumann A, 2011, J ALLERGY CLIN IMMUN, V127, P1187, DOI 10.1016/j.jaci.2010.12.1123; Paternoster L, 2012, NAT GENET, V44, P187, DOI 10.1038/ng.1017; PAWLAK Z, 1982, INT J COMPUT INF SCI, V11, P341, DOI 10.1007/BF01001956; Riedler J, 2001, LANCET, V358, P1129, DOI 10.1016/S0140-6736(01)06252-3; Saeys Y, 2007, BIOINFORMATICS, V23, P2507, DOI 10.1093/bioinformatics/btm344; Simpson A, 2010, AM J RESP CRIT CARE, V181, P1200, DOI 10.1164/rccm.200907-1101OC; Soderhall C, 2007, PLOS BIOL, V5, P1952, DOI 10.1371/journal.pbio.0050242; Soeria-Atmadja D, 2007, J ALLERGY CLIN IMMUN, V120, P1433, DOI 10.1016/j.jaci.2007.07.021; Torgerson DG, 2011, NAT GENET, V43, P887, DOI 10.1038/ng.888; Ungvari I, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033573; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Von Ehrenstein OS, 2000, CLIN EXP ALLERGY, V30, P187, DOI 10.1046/j.1365-2222.2000.00801.x; von Hertzen LC, 2004, ALLERGY, V59, P124, DOI 10.1046/j.1398-9995.2003.00433.x; von Mutius E, 2010, NAT REV IMMUNOL, V10, P861, DOI 10.1038/nri2871; Wickman M, 2002, PEDIATR ALLERGY IMMU, V13, P11, DOI 10.1034/j.1399-3038.13.s.15.10.x; Xu MS, 2011, BMC MED GENET, V12, DOI 10.1186/1471-2350-12-90	48	12	12	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80080	10.1371/journal.pone.0080080	http://dx.doi.org/10.1371/journal.pone.0080080			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260339	Green Published, Green Accepted, Green Submitted, gold			2022-12-25	WOS:000327311900057
J	Colucci, JK; Ortlund, EA				Colucci, Jennifer K.; Ortlund, Eric A.			X-Ray Crystal Structure of the Ancestral 3-Ketosteroid Receptor-Progesterone-Mifepristone Complex Shows Mifepristone Bound at the Coactivator Binding Interface	PLOS ONE			English	Article							AMINO-ACID SUBSTITUTION; STRUCTURE VALIDATION; ESTROGEN-RECEPTOR; ANDROGEN; PROTEIN; DOMAIN; DETERMINANTS; ACTIVATION; MECHANISMS; MOLPROBITY	Steroid receptors are a subfamily of nuclear receptors found throughout all metazoans. They are highly important in the regulation of development, inflammation, and reproduction and their misregulation has been implicated in hormone insensitivity syndromes and cancer. Steroid binding to SRs drives a conformational change in the ligand binding domain that promotes nuclear localization and subsequent interaction with coregulator proteins to affect gene regulation. SRs are important pharmaceutical targets, yet most SR-targeting drugs have off-target pharmacology leading to unwanted side effects. A better understanding of the structural mechanisms dictating ligand specificity and the evolution of the forces that created the SR-hormone pairs will enable the design of better pharmaceutical ligands. In order to investigate this relationship, we attempted to crystallize the ancestral 3-ketosteroid receptor (ancSR2) with mifepristone, a SR antagonist. Here, we present the x-ray crystal structure of the ancestral 3-keto steroid receptor (ancSR2)-progesterone complex at a resolution of 2.05 angstrom. This improves upon our previously reported structure of the ancSR2-progesterone complex, permitting unambiguous assignment of the ligand conformation within the binding pocket. Surprisingly, we find mifepristone, fortuitously docked at the protein surface, poised to interfere with coregulator binding. Recent attention has been given to generating pharmaceuticals that block the coregulator binding site in order to obstruct coregulator binding and achieve tissue-specific SR regulation independent of hormone binding. Mifepristone's interaction with the coactivator cleft of this SR suggests that it may be a useful molecular scaffold for further coactivator binding inhibitor development.	[Ortlund, Eric A.] Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA; Emory Univ, Sch Med, Winship Canc Inst, Atlanta, GA 30322 USA	Emory University; Emory University	Ortlund, EA (corresponding author), Emory Univ, Sch Med, Dept Biochem, Atlanta, GA 30322 USA.	eortlun@emory.edu	Ortlund, Eric Anthony/F-4672-2014; Ortlund, Eric Anthony/P-3121-2019	Ortlund, Eric Anthony/0000-0001-8855-3029; Ortlund, Eric Anthony/0000-0001-8855-3029	Emory University; JKC's American Heart Association pre-doctoral fellowship [10PRE3530007]; United States Department of Energy, Office of Science, Office of Basic Energy Sciences [W-31-109-Eng-38];  [R01 GM081592]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081592] Funding Source: NIH RePORTER	Emory University; JKC's American Heart Association pre-doctoral fellowship(American Heart Association); United States Department of Energy, Office of Science, Office of Basic Energy Sciences(United States Department of Energy (DOE)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research is supported by R01 GM081592 (Joseph Thornton PI, EAO coPI), start-up funds from Emory University (EAO), and JKC's American Heart Association pre-doctoral fellowship (10PRE3530007). Use of the Advanced Photon Source was supported by the United States Department of Energy, Office of Science, Office of Basic Energy Sciences, under contract number W-31-109-Eng-38. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams PD, 2010, ACTA CRYSTALLOGR D, V66, P213, DOI 10.1107/S0907444909052925; Bledsoe RK, 2005, J BIOL CHEM, V280, P31283, DOI 10.1074/jbc.M504098200; BOEHM MF, 1994, J MED CHEM, V37, P408, DOI 10.1021/jm00029a013; Bridgham JT, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000497; Bridgham JT, 2009, NATURE, V461, P515, DOI 10.1038/nature08249; Cadepond F, 1997, ANNU REV MED, V48, P129; Carroll SM, 2011, PLOS GENET, V7, DOI 10.1371/journal.pgen.1002117; Chen VB, 2010, ACTA CRYSTALLOGR D, V66, P12, DOI 10.1107/S0907444909042073; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; De Jesus-Tran KP, 2006, PROTEIN SCI, V15, P987, DOI 10.1110/ps.051905906; Eick GN, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003072; Harms MJ, 2010, CURR OPIN STRUC BIOL, V20, P360, DOI 10.1016/j.sbi.2010.03.005; Harms MJ, 2013, P NATL ACAD SCI USA; Heikinheimo O, 2003, CONTRACEPTION, V68, P421, DOI 10.1016/S0010-7824(03)00077-5; Hodgson MC, 2005, J BIOL CHEM, V280, P6511, DOI 10.1074/jbc.M408972200; IMASAKI K, 1994, EUR J ENDOCRINOL, V130, P569, DOI 10.1530/eje.0.1300569; Kohn JA, 2012, J BIOL CHEM, V287, P16267, DOI 10.1074/jbc.M112.346411; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; McKenna NJ, 2002, ENDOCRINOLOGY, V143, P2461, DOI 10.1210/endo.143.7.8892; McKenna NJ, 2002, CELL, V108, P465, DOI 10.1016/S0092-8674(02)00641-4; NAGPAL S, 1992, CELL, V70, P1007, DOI 10.1016/0092-8674(92)90250-G; Nagy L, 2004, TRENDS BIOCHEM SCI, V29, P317, DOI 10.1016/j.tibs.2004.04.006; NAKAO R, 1992, J CLIN ENDOCR METAB, V74, P1152, DOI 10.1210/jc.74.5.1152; NIEMAN LK, 1985, J CLIN ENDOCR METAB, V61, P536, DOI 10.1210/jcem-61-3-536; OMALLEY BW, 1992, BIOL REPROD, V46, P163, DOI 10.1095/biolreprod46.2.163; Ortlund EA, 2007, SCIENCE, V317, P1544, DOI 10.1126/science.1142819; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Patch JA, 2003, J AM CHEM SOC, V125, P12092, DOI 10.1021/ja037320d; Pratt WB, 1997, ENDOCR REV, V18, P306, DOI 10.1210/er.18.3.306; QUIGLEY CA, 1995, ENDOCR REV, V16, P271, DOI 10.1210/er.16.3.271; Rodriguez AL, 2004, J MED CHEM, V47, P600, DOI 10.1021/jm030404c; Song LN, 2004, MOL ENDOCRINOL, V18, P70, DOI 10.1210/me.2003-0189; Thornton JW, 2004, NAT REV GENET, V5, P366, DOI 10.1038/nrg1324; Wang Y, 2006, P NATL ACAD SCI USA, V103, P9908, DOI 10.1073/pnas.0510596103; Watkins RE, 2001, SCIENCE, V292, P2329, DOI 10.1126/science.1060762; Williams SP, 1998, NATURE, V393, P392, DOI 10.1038/30775; Zhang SM, 2007, STEROIDS, V72, P600, DOI 10.1016/j.steroids.2007.03.012	37	8	8	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 19	2013	8	11							e80761	10.1371/journal.pone.0080761	http://dx.doi.org/10.1371/journal.pone.0080761			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256LO	24260475	Green Submitted, Green Published, gold			2022-12-25	WOS:000327311900096
J	Chandrasekhar, A; Abu Osman, NA; Tham, LK; Lim, KS; Abas, WAW				Chandrasekhar, Annapoorna; Abu Osman, Noor Azuan; Tham, Lai Kuan; Lim, Kheng Seang; Abas, Wan Abu Bakar Wan			Influence of Age on Patellar Tendon Reflex Response	PLOS ONE			English	Article							DEEP TENDON; LEVEL; YOUNG	Background: A clinical parameter commonly used to assess the neurological status of an individual is the tendon reflex response. However, the clinical method of evaluation often leads to subjective conclusions that may differ between examiners. Moreover, attempts to quantify the reflex response, especially in older age groups, have produced inconsistent results. This study aims to examine the influence of age on the magnitude of the patellar tendon reflex response. Methodology/Principal Findings: This study was conducted using the motion analysis technique with the reflex responses measured in terms of knee angles. Forty healthy subjects were selected and categorized into three different age groups. Patellar reflexes were elicited from both the left and right patellar tendons of each subject at three different tapping angles and using the Jendrassik maneuver. The findings suggested that age has a significant effect on the magnitude of the reflex response. An angle of 45 degrees may be the ideal tapping angle at which the reflex can be elicited to detect age-related differences in reflex response. The reflex responses were also not influenced by gender and were observed to be fairly symmetrical. Conclusions/Significance: Neurologically normal individuals will experience an age-dependent decline in patellar reflex response.	[Chandrasekhar, Annapoorna; Abu Osman, Noor Azuan; Tham, Lai Kuan; Abas, Wan Abu Bakar Wan] Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia; [Lim, Kheng Seang] Univ Malaya, Fac Med, Div Neurol, Kuala Lumpur, Malaysia	Universiti Malaya; Universiti Malaya	Abu Osman, NA (corresponding author), Univ Malaya, Fac Engn, Dept Biomed Engn, Kuala Lumpur, Malaysia.	azuan@um.edu.my	ABU OSMAN, NOOR AZUAN/B-9265-2010; LIM, KHENG SEANG/B-8863-2010	ABU OSMAN, NOOR AZUAN/0000-0002-2853-4421; LIM, KHENG SEANG/0000-0002-2787-2365	Malaysia UM/MOHE/HIR grant [D000010-16001]	Malaysia UM/MOHE/HIR grant	This study was supported by the Malaysia UM/MOHE/HIR grant (Project number: D000010-16001). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Burke JR, 1996, ARCH PHYS MED REHAB, V77, P600, DOI 10.1016/S0003-9993(96)90302-0; Busch AC, 2009, COMPUT METH PROG BIO, V94, P15, DOI 10.1016/j.cmpb.2008.08.008; CAREL RS, 1979, AM J MED SCI, V278, P57, DOI 10.1097/00000441-197907000-00007; Chung SG, 2005, ARCH PHYS MED REHAB, V86, P318, DOI 10.1016/j.apmr.2004.04.048; CLARKSON PM, 1978, J GERONTOL, V33, P650, DOI 10.1093/geronj/33.5.650; Dafkin C, 2013, MUSCLE NERVE, V47, P81, DOI 10.1002/mus.23487; DEVRIES HA, 1985, AM J PHYS MED REHAB, V64, P71; Dick JPR, 2003, J NEUROL NEUROSUR PS, V74, P150, DOI 10.1136/jnnp.74.2.150; Dixon J, 2005, BMC MUSCULOSKEL DIS, V6, DOI 10.1186/1471-2474-6-46; HART BA, 1986, J GERONTOL, V41, P361, DOI 10.1093/geronj/41.3.361; Kallio J, 2010, J ELECTROMYOGR KINES, V20, P590, DOI 10.1016/j.jelekin.2009.12.005; KAMEN G, 1989, NEUROBIOL AGING, V10, P311, DOI 10.1016/0197-4580(89)90041-9; Khanal S, 2007, Nepal Med Coll J, V9, P278; Kim S, 2010, INT J IND ERGONOM, V40, P315, DOI 10.1016/j.ergon.2009.11.003; KOCEJA DM, 1993, MED SCI SPORT EXER, V25, P245; Kossioni AE, 1998, AGE AGEING, V27, P689, DOI 10.1093/ageing/27.6.689; Lebiedowska MK, 2011, J NEUROSCI METH, V198, P255, DOI 10.1016/j.jneumeth.2011.04.018; Lemoyne R, 2008, J MECH MED BIOL, V8, P75, DOI 10.1142/S0219519408002462; Lim KS, 2009, NEUROL ASIA, V14, P21; Mamizuka N, 2007, J BIOMECH, V40, P2107, DOI 10.1016/j.jbiomech.2006.10.003; Moore BD, 2002, J ELECTROMYOGR KINES, V12, P351, DOI 10.1016/S1050-6411(02)00032-9; Obata H, 2010, J ELECTROMYOGR KINES, V20, P55, DOI 10.1016/j.jelekin.2009.01.009; Pereon Y, 2004, NEUROPHYSIOL CLIN, V34, P131, DOI 10.1016/j.neucli.2004.04.005; SABBAHI MA, 1982, J GERONTOL, V37, P24, DOI 10.1093/geronj/37.1.24; Scaglioni G, 2003, J PHYSIOL-LONDON, V548, P649, DOI 10.1113/jphysiol.2002.032763; STAM J, 1989, J NEUROL, V236, P231, DOI 10.1007/BF00314505; STAM J, 1987, ELECTROEN CLIN NEURO, V67, P463, DOI 10.1016/0013-4694(87)90010-1; Tham LK, 2011, MED ENG PHYS, V33, P407, DOI 10.1016/j.medengphy.2010.11.002; Tham LK, 2013, PLOS ONE, V8; Vickery HSF, 2012, J ELECTROMYOGRAPHY K; Waterhouse J, 2011, ANAEST INTENS CARE M, V12, P214, DOI 10.1016/j.mpaic.2011.02.009; Zhang LQ, 2000, ARCH PHYS MED REHAB, V81, P901, DOI 10.1053/apmr.2000.5582	32	11	11	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80799	10.1371/journal.pone.0080799	http://dx.doi.org/10.1371/journal.pone.0080799			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260483	Green Published, gold, Green Submitted			2022-12-25	WOS:000327308500176
J	Li, LF; Wang, HY; Zhang, C; Wang, XF; Shi, FX; Chen, WN; Ge, XJ				Li, Lin-Feng; Wang, Hua-Ying; Zhang, Cui; Wang, Xin-Feng; Shi, Feng-Xue; Chen, Wen-Na; Ge, Xue-Jun			Origins and Domestication of Cultivated Banana Inferred from Chloroplast and Nuclear Genes	PLOS ONE			English	Article							PCR-RFLP; NUCLEOTIDE POLYMORPHISM; SECTIONAL RELATIONSHIPS; RIBOSOMAL DNA; ADH1 LOCUS; WILD-RICE; A-GENOME; MUSA; DIVERSITY; PLANT	Background: Cultivated bananas are large, vegetatively-propagated members of the genus Musa. More than 1,000 cultivarsare grown worldwide and they are major economic and food resources in numerous developing countries. It has been suggested that cultivated bananas originated from the islands of Southeast Asia (ISEA) and have been developed through complex geodomestication pathways. However, the maternal and parental donors of most cultivars are unknown, and the pattern of nucleotide diversity in domesticated banana has not been fully resolved. Methodology/Principal Findings: We studied the genetics of 16 cultivated and 18 wild Musa accessions using two singlecopy nuclear (granule-bound starch synthase I, GBSS I, also known as Waxy, and alcohol dehydrogenase 1, Adh1) and two chloroplast (maturase K, matK, and the trnL-F gene cluster) genes. The results of phylogenetic analyses showed that all Agenome haplotypes of cultivated bananas were grouped together with those of ISEA subspecies of M. acuminata (Agenome). Similarly, the B-and S-genome haplotypes of cultivated bananas clustered with the wild species M. balbisiana (Bgenome) and M. schizocarpa (S-genome), respectively. Notably, it has been shown that distinct haplotypes of each cultivar (A-genome group) were nested together to different ISEA subspecies M. acuminata. Analyses of nucleotide polymorphism in the Waxy and Adh1 genes revealed that, in comparison to the wild relatives, cultivated banana exhibited slightly lower nucleotide diversity both across all sites and specifically at silent sites. However, dramatically reduced nucleotide diversity was found at nonsynonymous sites for cultivated bananas. Conclusions/Significance: Our study not only confirmed the origin of cultivated banana as arising from multiple intra-and inter-specific hybridization events, but also showed that cultivated banana may have not suffered a severe genetic bottleneck during the domestication process. Importantly, our findings suggested that multiple maternal origins and a reduction in nucleotide diversity at nonsynonymous sites are general attributes of cultivated bananas.	[Li, Lin-Feng; Wang, Hua-Ying; Zhang, Cui; Wang, Xin-Feng; Shi, Feng-Xue] NE Normal Univ, Minist Educ, Key Lab Mol Epigenet, Changchun, Peoples R China; [Li, Lin-Feng; Chen, Wen-Na; Ge, Xue-Jun] Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China	Northeast Normal University - China; Chinese Academy of Sciences; South China Botanical Garden, CAS	Ge, XJ (corresponding author), Chinese Acad Sci, South China Bot Garden, Key Lab Plant Resources Conservat & Sustainable U, Guangzhou, Guangdong, Peoples R China.	xjge@scbg.ac.cn	Ge, Xue-Jun/AAP-5967-2020	Ge, Xue-Jun/0000-0002-5008-9475	Program for Introducing Talents to Universities [B07017]; National Natural Science Foundation of China [31261140366, 30970205, 31100157]	Program for Introducing Talents to Universities; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Program for Introducing Talents to Universities (B07017) and National Natural Science Foundation of China (31261140366, 30970205 and 31100157). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1966, BANANAS; ARGENT G C G, 1976, Notes from the Royal Botanic Garden Edinburgh, V35, P77; Bartos J, 2005, CYTOGENET GENOME RES, V109, P50, DOI 10.1159/000082381; CARREEL F, 1994, GENET SEL EVOL, V26, pS125, DOI 10.1051/gse:19940709; Champion J, 1967, NOTES DOCUMENTS BANA; CHEESMAN E. E., 1947, Kew Bulletin, P106, DOI 10.2307/4109207; D'Hont A, 2000, THEOR APPL GENET, V100, P177, DOI 10.1007/s001220050024; DE LANGHE E., 1960, Bull. Jard. bot. Etat Brux., V30, P375; De Langhe E, 2007, RETHINKING AGR ARCHA, P361; Dufour D, 2009, J AGR FOOD CHEM, V57, P7870, DOI 10.1021/jf900235a; Feldman M., 2001, WORLD WHEAT BOOK HIS; Feuillet C, 2008, TRENDS GENET, V24, P24, DOI 10.1016/j.tig.2007.11.001; FU YX, 1993, GENETICS, V133, P693; Galili S, 2000, MOL GEN GENET, V263, P674, DOI 10.1007/s004380051216; GAUT BS, 1993, GENETICS, V135, P1091; Ge S, 1999, P NATL ACAD SCI USA, V96, P14400, DOI 10.1073/pnas.96.25.14400; Guzman C, 2012, ANN BOT-LONDON, V110, P1161, DOI 10.1093/aob/mcs201; Hall T.A., 1999, NUCL ACIDS S SERIES, V41, P95, DOI [DOI 10.1021/BK-1999-0734.CH008, citeulike-article-id:691774, 10.12691/ajmr-6-4-3]; Hancock JF, 2005, ANN BOT-LONDON, V96, P953, DOI 10.1093/aob/mci259; Heslop-Harrison JS, 2007, ANN BOT-LONDON, V100, P1073, DOI 10.1093/aob/mcm191; Hippolyte I, 2012, ANN BOT-LONDON, V109, P937, DOI 10.1093/aob/mcs010; HORRY JP, 1988, PHYTOCHEMISTRY, V27, P2667, DOI 10.1016/0031-9422(88)87040-7; JARRET RL, 1986, EUPHYTICA, V35, P539, DOI 10.1007/BF00021863; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; KRIKORIAN AD, 1993, ANN BOT-LONDON, V71, P519, DOI 10.1006/anbo.1993.1068; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; LANAUD C, 1992, HEREDITY, V68, P147, DOI 10.1038/hdy.1992.23; Londo JP, 2006, P NATL ACAD SCI USA, V103, P9578, DOI 10.1073/pnas.0603152103; Mandel J, 2011, THEOR APPL GENET, V123, P693, DOI 10.1007/s00122-011-1619-3; Matsuoka Y, 2002, THEOR APPL GENET, V104, P436, DOI 10.1007/s001220100694; Ning SP, 2007, SCI HORTIC-AMSTERDAM, V114, P281, DOI 10.1016/j.scienta.2007.07.002; Nwakanma DC, 2003, THEOR APPL GENET, V108, P154, DOI 10.1007/s00122-003-1402-1; Nwakanma DC, 2003, THEOR APPL GENET, V107, P850, DOI 10.1007/s00122-003-1340-y; Olsen KM, 1999, P NATL ACAD SCI USA, V96, P5586, DOI 10.1073/pnas.96.10.5586; Ortiz R, 1997, GENETIC RESOURCES CR, V44, P449; Perrier X, 2011, P NATL ACAD SCI USA, V108, P11311, DOI 10.1073/pnas.1102001108; Ploetz R.C., 2007, SPECIES PROFILES PAC; Preiss J, 1991, OXFORD SURVEYS PLANT, V7, P59; Purugganan MD, 2009, NATURE, V457, P843, DOI 10.1038/nature07895; Raboin LM, 2005, MOL BREEDING, V16, P333, DOI 10.1007/s11032-005-2452-7; Ross-Ibarra J, 2007, P NATL ACAD SCI USA, V104, P8641, DOI 10.1073/pnas.0700643104; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Shepherd K., 1988, P INT WORKSH HELD LO, P158; SIMMONDS N. W., 1962, The Evolution of the Bananas.; SIMMONDS N. W., 1955, JOUR LINNEAN SOC BOT, V55, P302; SIMMONDS N. W., 1960, Kew Bulletin, V14, P198, DOI 10.2307/4114778; SIMMONDS NW, 1990, NEW PHYTOL, V115, P567, DOI 10.1111/j.1469-8137.1990.tb00485.x; Strommer J, 2011, PLANT J, V66, P128, DOI 10.1111/j.1365-313X.2010.04458.x; Szymkowiak EJ, 1996, ANNU REV PLANT PHYS, V47, P351, DOI 10.1146/annurev.arplant.47.1.351; TABERLET P, 1991, PLANT MOL BIOL, V17, P1105, DOI 10.1007/BF00037152; TAJIMA F, 1989, GENETICS, V123, P585; TAJIMA F, 1983, GENETICS, V105, P437; Tamura K, 2011, MOL BIOL EVOL, V28, P2731, DOI 10.1093/molbev/msr121; Tanksley SD, 1997, SCIENCE, V277, P1063, DOI 10.1126/science.277.5329.1063; Teo CH, 2005, J PLANT BIOL, V48, P96, DOI 10.1007/BF03030568; Tezenas du Montcel H, 1988, IDENTIFICATION GENET, P211; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Triplett JK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0038702; Ude G, 2003, THEOR APPL GENET, V107, P248, DOI 10.1007/s00122-003-1246-8; Ude G, 2002, THEOR APPL GENET, V104, P1239, DOI 10.1007/s00122-001-0802-3; Warmuth V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0018194; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wilson LM, 2004, PLANT CELL, V16, P2719, DOI 10.1105/tpc.104.025700; Yoshida K, 2004, THEOR APPL GENET, V109, P1406, DOI 10.1007/s00122-004-1752-3; Yue XP, 2011, PLOS ONE, V8; Zhu QH, 2005, NEW PHYTOL, V167, P249, DOI 10.1111/j.1469-8137.2005.01406.x; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	70	17	19	1	53	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 18	2013	8	11							e80502	10.1371/journal.pone.0080502	http://dx.doi.org/10.1371/journal.pone.0080502			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	256KH	24260405	Green Published, Green Submitted, gold			2022-12-25	WOS:000327308500146
J	Dun, BY; Sharma, A; Teng, Y; Liu, HT; Purohit, S; Xu, H; Zeng, LW; She, JX				Dun, Boying; Sharma, Ashok; Teng, Yong; Liu, Haitao; Purohit, Sharad; Xu, Heng; Zeng, Lingwen; She, Jin-Xiong			Mycophenolic Acid Inhibits Migration and Invasion of Gastric Cancer Cells via Multiple Molecular Pathways	PLOS ONE			English	Article							IMP DEHYDROGENASE; MOFETIL; ROLES; MECHANISMS; PROMOTES; GROWTH; PROLIFERATION; FIBROBLAST; EXPRESSION; APOPTOSIS	Mycophenolic acid (MPA) is the metabolized product and active element of mycophenolate mofetil (MMF) that has been widely used for the prevention of acute graft rejection. MPA potently inhibits inosine monophosphate dehydrogenase (IMPDH) that is up-regulated in many tumors and MPA is known to inhibit cancer cell proliferation as well as fibroblast and endothelial cell migration. In this study, we demonstrated for the first time MPA's antimigratory and anti-invasion abilities of MPA-sensitive AGS (gastric cancer) cells. Genome-wide expression analyses using Illumina whole genome microarrays identified 50 genes with >= 2 fold changes and 15 genes with > 4 fold alterations and multiple molecular pathways implicated in cell migration. Real-time RT-PCR analyses of selected genes also confirmed the expression differences. Furthermore, targeted proteomic analyses identified several proteins altered by MPA treatment. Our results indicate that MPA modulates gastric cancer cell migration through down-regulation of a large number of genes (PRKCA, DOCK1, INF2, HSPA5, LRP8 and PDGFRA) and proteins (PRKCA, AKT, SRC, CD147 and MMP1) with promigratory functions as well as up-regulation of a number of genes with antimigratory functions (ATF3, SMAD3, CITED2 and CEAMCAM1). However, a few genes that may promote migration (CYR61 and NOS3) were up-regulated. Therefore, MPA's overall antimigratory role on cancer cells reflects a balance between promigratory and antimigratory signals influenced by MPA treatment.	[Dun, Boying; Zeng, Lingwen] Chinese Acad Sci, Guangzhou Inst Biomed & Hlth, Guangzhou 510530, Guangdong, Peoples R China; [Dun, Boying; Xu, Heng; She, Jin-Xiong] Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing 210009, Jiangsu, Peoples R China; [Dun, Boying; Sharma, Ashok; Liu, Haitao; Purohit, Sharad; Xu, Heng; She, Jin-Xiong] Georgia Regents Univ, Med Coll Georgia, Ctr Biotechnol & Genom Med, Augusta, GA USA; [Teng, Yong; She, Jin-Xiong] Georgia Regents Univ, Ctr Canc, Augusta, GA USA	Chinese Academy of Sciences; Guangzhou Institute of Biomedicine & Health, CAS; Nanjing Tech University; University System of Georgia; Augusta University; University System of Georgia; Augusta University	She, JX (corresponding author), Nanjing Univ Technol, Sch Pharmaceut Sci, Inst Translat Med, Nanjing 210009, Jiangsu, Peoples R China.	jshe@gru.edu	Purohit, Sharad/ABA-8054-2021; Teng, Yong/AAK-4160-2020	Teng, Yong/0000-0002-1856-7289; Sharma, Ashok/0000-0001-9597-4374; Purohit, Sharad/0000-0003-0385-3829	Georgia Regents University; Georgia Research Alliance	Georgia Regents University; Georgia Research Alliance	The study was supported by funds from the Georgia Regents University. JXS is partially supported by the Georgia Research Alliance as an eminent scholar. The funder had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akkiprik M, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-103; Allison AC, 2005, TRANSPLANTATION, V80, pS181, DOI 10.1097/01.tp.0000186390.10150.66; Allison AC, 2000, IMMUNOPHARMACOLOGY, V47, P85, DOI 10.1016/S0162-3109(00)00188-0; Andres-Delgado L, 2012, J CELL BIOL, V198, P1025, DOI 10.1083/jcb.201202137; Arora S, 2011, INT J CANCER, V129, P2621, DOI 10.1002/ijc.25939; Bendeck MP, 1996, CIRC RES, V78, P38, DOI 10.1161/01.RES.78.1.38; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Combes AN, 2010, INT J DEV BIOL, V54, P683, DOI 10.1387/ijdb.092920ac; Deryugina EI, 2002, J BIOL CHEM, V277, P9749, DOI 10.1074/jbc.M110269200; Domhan S, 2008, MOL CANCER THER, V7, P1656, DOI 10.1158/1535-7163.MCT-08-0193; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Fellenberg J, 2007, MODERN PATHOL, V20, P1085, DOI 10.1038/modpathol.3800937; Fellenberg J, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012179; Franceschini A, 2013, NUCLEIC ACIDS RES, V41, pD808, DOI 10.1093/nar/gks1094; Gortz A, 1997, CELL DEATH DIFFER, V4, P787, DOI 10.1038/sj.cdd.4400300; Hack I, 2007, DEVELOPMENT, V134, P3883, DOI 10.1242/dev.005447; Huang YF, 2005, INT IMMUNOPHARMACOL, V5, P1029, DOI 10.1016/j.intimp.2005.01.015; Irie HY, 2005, J CELL BIOL, V171, P1023, DOI 10.1083/jcb.200505087; JACKSON RC, 1975, NATURE, V256, P331, DOI 10.1038/256331a0; Jadeski LC, 2003, INT J CANCER, V106, P496, DOI 10.1002/ijc.11268; Kajita M, 2001, J CELL BIOL, V153, P893, DOI 10.1083/jcb.153.5.893; Kim J. I., 2010, MOL CANCER RES, V8, P569, DOI DOI 10.1158/1541-7786.MCR-09-0511.PUBMED:20353998; Klaile E, 2005, J CELL SCI, V118, P5513, DOI 10.1242/jcs.02660; Krishnan Harini, 2012, Genes Cancer, V3, P426, DOI 10.1177/1947601912458583; Laurin M, 2013, P NATL ACAD SCI USA, V110, P7434, DOI 10.1073/pnas.1213050110; Lundgren K, 2011, J MOL DIAGN, V13, P340, DOI 10.1016/j.jmoldx.2011.01.009; MacDonald TJ, 2001, NAT GENET, V29, P143, DOI 10.1038/ng731; Millan O, 2000, CLIN CHEM, V46, P1376; Morath C, 2008, AM J TRANSPLANT, V8, P1786, DOI 10.1111/j.1600-6143.2008.02322.x; Morath C, 2006, CLIN TRANSPLANT, V20, P25, DOI 10.1111/j.1399-0012.2006.00597.x; Muller MM, 2005, BLOOD, V105, P3925, DOI 10.1182/blood-2004-09-3618; Onishi K, 2007, GENES CELLS, V12, P535, DOI 10.1111/j.1365-2443.2007.01071.x; Schmitz P, 2013, INT J CLIN PHARM TH, V51, P47, DOI 10.5414/CPP51047; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sharma A, 2009, BIOINFORMATICS, V25, P1152, DOI 10.1093/bioinformatics/btp123; Silva SL, 2004, TRANSPL P, V36, P1004, DOI 10.1016/j.transproceed.2004.03.057; Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI DOI 10.2202/1544-6115.1027; Stewart JD, 2012, P NATL ACAD SCI USA, V109, P8155, DOI 10.1073/pnas.1117654109; Takebe N, 2006, MOL CANCER THER, V5, P457, DOI 10.1158/1535-7163.MCT-05-0340; Tarca AL, 2009, BIOINFORMATICS, V25, P75, DOI 10.1093/bioinformatics/btn577; Teng Y, 2010, BRIT J CANCER, V103, P1066, DOI 10.1038/sj.bjc.6605850; TRESSLER RJ, 1994, INT J CANCER, V57, P568, DOI 10.1002/ijc.2910570421; Ungefroren H, 2011, MOL CANCER, V10, DOI 10.1186/1476-4598-10-67; Vegso G, 2007, LEUKEMIA RES, V31, P1003, DOI 10.1016/j.leukres.2006.12.019; Wells A, 2013, TRENDS PHARMACOL SCI, V34, P283, DOI 10.1016/j.tips.2013.03.001; Yan L, 2005, THROMB HAEMOSTASIS, V93, P199, DOI 10.1160/TH04-08-0536; Yasuoka H, 2009, AM J RESP CELL MOL, V41, P179, DOI 10.1165/rcmb.2008-0211OC; Yuan XL, 2013, CANCER RES, V73, P3625, DOI 10.1158/0008-5472.CAN-12-3879	48	33	33	0	19	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e81702	10.1371/journal.pone.0081702	http://dx.doi.org/10.1371/journal.pone.0081702			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	24260584	Green Submitted, Green Published, gold			2022-12-25	WOS:000327258600117
J	Menezes, AMB; Murray, J; Laszlo, M; Wehrmeister, FC; Hallal, PC; Goncalves, H; Assuncao, MCF; Menezes, CB; Barros, FC				Baptista Menezes, Ana Maria; Murray, Joseph; Laszlo, Mitzi; Wehrmeister, Fernando C.; Hallal, Pedro C.; Goncalves, Helen; Assuncao, Maria Cecilia F.; Menezes, Carolina Baptista; Barros, Fernando C.			Happiness and Depression in Adolescence after Maternal Smoking during Pregnancy: Birth Cohort Study	PLOS ONE			English	Article							PSYCHIATRIC SCREENING QUESTIONNAIRE; SUBJECTIVE HAPPINESS; BEHAVIORAL-PROBLEMS; SUBSTANCE USE; DSM-IV; EXPOSURE; CHILD; INTERVIEW; VALIDITY; OUTCOMES	Background: Prenatal cigarette smoke exposure may have adverse psychological effects on offspring. The objective was to assess the association between parental smoking during pregnancy and offspring happiness at age 18, as well as depression. Methodology: Participants were part of a birth cohort study in Pelotas, Brazil ( 5,249 participants). Happiness was measured by the Subjective Happiness Scale, a Likert-like scale with four questions generating a score from 1 to 7, with >= 6 indicating "happiness". Depression was measured using the Mini International Psychiatric Interview. Results: About one third of mothers reported having smoked during pregnancy and 4.6% reported smoking 20 or more cigarettes a day. The prevalence of happiness was 32.2% ( 95% CI 30.8; 33.7), depression 6.8% ( 95% CI 6.1; 7.6), and simultaneous happiness and depression less than 1%. The prevalence of offspring happiness decreased as smoking in pregnancy increased, even after control for confounding variables, showing an OR = 0.79 [95% CI 0.55; 1.13]. The opposite happened to depression; the prevalence of offspring depression increased as smoking in pregnancy increased (<20 cigarettes/day OR = 1.38 [95% CI 1.03; 1.84] and >= 20 cigarettes/day OR = 2.11[95% CI 1.31; 3.40]. Smoking by the partner was associated with decreased offspring happiness after adjustment for confounders, but did no show association with offspring depression. Conclusions: Offspring were less likely to be happy and more likely to be depressed if their mother smoked during pregnancy, and less likely to be happy if their father smoked during mother's pregnancy. Although we can not affirm that this is a "causal pathway", public policies to reduce smoking in pregnancy could improve the health of the offspring in the short and long term.	[Baptista Menezes, Ana Maria; Laszlo, Mitzi; Wehrmeister, Fernando C.; Hallal, Pedro C.; Goncalves, Helen; Assuncao, Maria Cecilia F.; Barros, Fernando C.] Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil; [Murray, Joseph] Univ Cambridge, Dept Psychiat, Cambridge, England; [Menezes, Carolina Baptista] Univ Fed Pelotas, Dept Psychol, Pelotas, RS, Brazil; [Barros, Fernando C.] Univ Catolica Pelotas, Postgrad Program Hlth & Behav, Pelotas, RS, Brazil	Universidade Federal de Pelotas; University of Cambridge; Universidade Federal de Pelotas; Universidade Catolica de Pelotas; Universidade Federal de Pelotas	Menezes, AMB (corresponding author), Univ Fed Pelotas, Postgrad Program Epidemiol, Pelotas, RS, Brazil.	anamene@terra.com.br	Gonçalves, Helen/M-1603-2017; Gonçalves, Helen/P-2381-2018; Hallal, Pedro C/A-3249-2011; Menezes, Ana MB/G-7266-2012; Murray, Joseph/Z-6274-2019; Barros, Fernando C/D-4857-2013; Wehrmeister, Fernando/A-3006-2014	Gonçalves, Helen/0000-0001-6470-3352; Hallal, Pedro C/0000-0003-1470-6461; Menezes, Ana MB/0000-0002-2996-9427; Murray, Joseph/0000-0002-5511-3454; Wehrmeister, Fernando/0000-0001-7137-1747; Laszlo, Mitzi/0000-0001-9542-0419; Barros, Fernando/0000-0001-5973-1746	Wellcome Trust [086974/Z/08/Z]; European Union; National Program for Centers of Excellence (Brazil); National Research Council (Brazil); Ministry of Health (Brazil)	Wellcome Trust(Wellcome TrustEuropean Commission); European Union(European Commission); National Program for Centers of Excellence (Brazil); National Research Council (Brazil)(Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ)); Ministry of Health (Brazil)	This work was supported by the Wellcome Trust initiative: 'Major Awards for Latin America on Health Consequences of Population Change' [grant number 086974/Z/08/Z]. Earlier phases of the 1993 cohort study were funded by the European Union, the National Program for Centers of Excellence (Brazil), the National Research Council (Brazil) and the Ministry of Health (Brazil). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abbott LC, 2012, CRIT REV TOXICOL, V42, P279, DOI 10.3109/10408444.2012.658506; Amorim Patricia, 2000, Revista Brasileira de Psiquiatria, V22, P106; Ansari RW, 2012, TOXICOL LETT, V211, P1, DOI 10.1016/j.toxlet.2012.02.012; Anselmi L, 2010, SOC PSYCH PSYCH EPID, V45, P135, DOI 10.1007/s00127-009-0052-2; Batstra L, 2003, EARLY HUM DEV, V75, P21, DOI 10.1016/j.earlhumdev.2003.09.001; Brion MJ, 2010, PEDIATRICS, V126, pE57, DOI 10.1542/peds.2009-2754; Bulloch A, 2013, DEPRESS ANXIETY; Carter S, 2008, EARLY HUM DEV, V84, P59, DOI 10.1016/j.earlhumdev.2007.03.009; Cornelius MD, 2012, NEUROTOXICOL TERATOL, V34, P554, DOI 10.1016/j.ntt.2012.09.003; Cornelius MD, 2012, MATERN CHILD HLTH J, V16, P694, DOI 10.1007/s10995-011-0766-0; Cornelius MD, 2011, NEUROTOXICOL TERATOL, V33, P137, DOI 10.1016/j.ntt.2010.08.006; D'Onofrio BM, 2008, DEV PSYCHOPATHOL, V20, P139, DOI 10.1017/S0954579408000072; D'Onofrio BM, 2013, AM J PUBLIC HEALTH, V103, P46, DOI 10.2105/AJPH.2013.301252; Daniel RM, 2011, STATA J, V11, P479, DOI 10.1177/1536867X1101100401; Faden VB, 2000, J SUBST ABUSE, V12, P329, DOI 10.1016/S0899-3289(01)00052-9; Fleitlich-Bilyk B, 2004, J AM ACAD CHILD PSY, V43, P727, DOI 10.1097/01.chi.0000120021.14101.ca; Goncalves DM, 2008, CAD SAUDE PUBLICA, V24, P380, DOI 10.1590/S0102-311X2008000200017; Goodman R, 1997, J CHILD PSYCHOL PSYC, V38, P581, DOI 10.1111/j.1469-7610.1997.tb01545.x; Huppert FA, 2009, APPL PSYCHOL-HLTH WE, V1, P137, DOI 10.1111/j.1758-0854.2009.01008.x; Knopik VS, 2009, DEV NEUROPSYCHOL, V34, P1, DOI 10.1080/87565640802564366; Koivumaa-Honkanen H, 2000, AM J EPIDEMIOL, V152, P983, DOI 10.1093/aje/152.10.983; Liu TL, 2011, J PSYCHIATR RES, V45, P1648, DOI 10.1016/j.jpsychires.2011.08.007; Lyubomirsky S, 1999, SOC INDIC RES, V46, P137, DOI 10.1023/A:1006824100041; MARI JD, 1986, BRIT J PSYCHIAT, V148, P23, DOI 10.1192/bjp.148.1.23; Mattei D, 2004, PSYCHOL REP, V94, P288; McGorry Patrick, 2013, Br J Psychiatry Suppl, V54, ps3, DOI 10.1192/bjp.bp.112.119222; Miller MW, 2006, BRAIN DEV NORMAL PRO; Monshouwer K, 2011, EUR ADDICT RES, V17, P342, DOI 10.1159/000334507; Montgomery SA, 2013, J CLIN PSYCHIAT, V74, P363, DOI 10.4088/JCP.12m08141; Muneoka K, 1997, DEV BRAIN RES, V102, P117, DOI 10.1016/S0165-3806(97)00092-8; Piqueras JA, 2011, BMC PUBLIC HEALTH, V11, DOI 10.1186/1471-2458-11-443; Rice F, 2010, PSYCHOL MED, V40, P335, DOI 10.1017/S0033291709005911; Robinson M, 2008, J CHILD PSYCHOL PSYC, V49, P1118, DOI 10.1111/j.1469-7610.2008.01955.x; Rutter M, 2006, J CHILD PSYCHOL PSYC, V47, P226, DOI 10.1111/j.1469-7610.2005.01557.x; Santos Élem Guimarães dos, 2010, J. bras. psiquiatr., V59, P238, DOI 10.1590/S0047-20852010000300011; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P34, DOI 10.4088/JCP.09m05305whi; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Steptoe A, 2012, PSYCHOSOM MED, V74, P501, DOI 10.1097/PSY.0b013e31824f82c8; Stroud LR, 2009, PEDIATRICS, V123, pE842, DOI 10.1542/peds.2008-2084; Vaglenova J, 2004, BEHAV BRAIN RES, V150, P159, DOI 10.1016/j.bbr.2003.07.005; Ventegodt S, 2005, THESCIENTIFICWORLDJO, V5, P933, DOI 10.1100/tsw.2005.112; Wakschlag LS, 2002, AM J PUBLIC HEALTH, V92, P966, DOI 10.2105/AJPH.92.6.966; Xu Z, 2001, BRAIN RES, V914, P166, DOI 10.1016/S0006-8993(01)02797-4; Zisook S, 2007, AM J PSYCHIAT, V164, P1539, DOI 10.1176/appi.ajp.2007.06101757	44	30	30	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80370	10.1371/journal.pone.0080370	http://dx.doi.org/10.1371/journal.pone.0080370			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255PK	24265817	Green Submitted, gold, Green Published			2022-12-25	WOS:000327252100153
J	Dharap, A; Pokrzywa, C; Murali, S; Pandi, G; Vemuganti, R				Dharap, Ashutosh; Pokrzywa, Courtney; Murali, Shruthi; Pandi, Gopal; Vemuganti, Raghu			MicroRNA miR-324-3p Induces Promoter-Mediated Expression of RelA Gene	PLOS ONE			English	Article							NF-KAPPA-B; CEREBRAL-ISCHEMIA; MAMMALIAN-CELLS; FOCAL ISCHEMIA; SMALL RNAS; ACTIVATION; OVERLAPS	MicroRNAs (miRNAs) are known to repress translation by binding to the 3'UTRs of mRNAs. Using bioinformatics, we recently reported that several miRNAs also have target sites in DNA particularly in the promoters of the protein-coding genes. To understand the functional significance of this phenomenon, we tested the effects of miR-324-3p binding to RelA promoter. In PC12 cells, co-transfection with premiR-324-3p induced a RelA promoter plasmid in a dose-dependent manner and this effect was lost when the miR-324-3p binding site in the promoter was mutated. PremiR-324-3p transfection also significantly induced the endogenous RelA mRNA and protein expression in PC12 cells. Furthermore, transfection with premiR-324-3p increased the levels of cleaved caspase-3 which is a marker of apoptosis. Importantly, the miR-324-3p effects were Ago2 mediated as Ago2 knockdown prevented RelA expression and cleavage of caspase-3. Thus, our studies show that miRNA-mediated transcriptional activation can be seen in PC12 cells which are neural in origin.	[Dharap, Ashutosh; Pokrzywa, Courtney; Murali, Shruthi; Pandi, Gopal; Vemuganti, Raghu] Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA; [Dharap, Ashutosh; Vemuganti, Raghu] Univ Wisconsin, Neurosci Training Program, Madison, WI USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison	Vemuganti, R (corresponding author), Univ Wisconsin, Dept Neurol Surg, Madison, WI 53706 USA.	vemuganti@neurosurgery.wisc.edu	Pandi, Gopal/M-2465-2019; Dharap, Ashutosh/H-7466-2013	Pandi, Gopal/0000-0002-2186-2473; Dharap, Ashutosh/0000-0001-5223-3197	American Heart Association [09PRE2300220]; US NIH [NS061071, NS074444, NS067274]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS074444, R03NS067274, R21NS061071] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); US NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	American Heart Association grant 09PRE2300220 and US NIH grants NS061071, NS074444 and NS067274. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Esteller M, 2011, NAT REV GENET, V12, P861, DOI 10.1038/nrg3074; Henriquez B, 2013, MOL CELL NEUROSCI; Huang V, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008848; Inta I, 2006, J NEUROSCI, V26, P12896, DOI 10.1523/JNEUROSCI.3670-06.2006; Janowski BA, 2007, NAT CHEM BIOL, V3, P166, DOI 10.1038/nchembio860; Kuhn CD, 2013, TRENDS BIOCHEM SCI, V38, P263, DOI 10.1016/j.tibs.2013.02.008; LeTonqueze O, 2012, RNA BIOL, V9, P871, DOI 10.4161/rna.20806; Li LC, 2006, P NATL ACAD SCI USA, V103, P17337, DOI 10.1073/pnas.0607015103; Matsui M, 2013, ACS CHEM BIOL, V8, P122, DOI 10.1021/cb300490j; Matsui M, 2010, CHEM BIOL, V17, P1344, DOI 10.1016/j.chembiol.2010.10.009; Mousavi K, 2012, MOL CELL, V45, P255, DOI 10.1016/j.molcel.2011.11.019; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Pizzi M, 2002, J BIOL CHEM, V277, P20717, DOI 10.1074/jbc.M201014200; Ridder DA, 2009, NEUROSCIENCE, V158, P995, DOI 10.1016/j.neuroscience.2008.07.007; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schwaninger M, 2006, BIOCHEM SOC T, V34, P1291, DOI 10.1042/BST0341291; Schwartz JC, 2008, NAT STRUCT MOL BIOL, V15, P842, DOI 10.1038/nsmb.1444; Truesdell SS, 2012, SCI REP-UK, V2, DOI 10.1038/srep00842; Tureyen K, 2011, J NEUROCHEM, V116, P499, DOI 10.1111/j.1471-4159.2010.07127.x; Turunen MP, 2009, CIRC RES, V105, P604, DOI 10.1161/CIRCRESAHA.109.200774; Wang J, 2010, CANCER RES, V70, P10182, DOI 10.1158/0008-5472.CAN-10-2414; Yan BX, 2012, CELL MOL LIFE SCI, V69, P2833, DOI 10.1007/s00018-012-0953-1; Yates LA, 2013, CELL, V153, P516, DOI 10.1016/j.cell.2013.04.003; Younger ST, 2009, CHEMBIOCHEM, V10, P1135, DOI 10.1002/cbic.200900015	25	58	58	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79467	10.1371/journal.pone.0079467	http://dx.doi.org/10.1371/journal.pone.0079467			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265774	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100107
J	Geoffroy, MC; Hertzman, C; Li, L; Power, C				Geoffroy, Marie-Claude; Hertzman, Clyde; Li, Leah; Power, Chris			Prospective Association of Morning Salivary Cortisol with Depressive Symptoms in Mid-Life: A Life-Course Study	PLOS ONE			English	Article							MAJOR DEPRESSION; RISK; DISORDER; ONSET; SYMPTOMATOLOGY; PREDICTOR; ADVERSITY; PATTERNS; STRESS; 5-ITEM	Objective: Associations of cortisol and depression vary at different life-stages, yet population-based, prospective studies are scarce. We aimed to assess associations of morning cortisol with depressive symptoms in mid-life taking account of lifetime psychological health. Methods: Participants were 5,403 men and women from the 1958 British Birth Cohort whose salivary cortisol was assessed at 45y (45min after waking (T-1) and 3h later (T-2)) and who completed the 5-item Mental-Health Index (MHI-5) about depressive symptoms at age 50y. Lifetime psychological health was identified from child and adult measures. Results: For women, higher T-2 cortisol at 45y predicted depression (MHI-5 scores <= 52) at 50y (odds ratio [OR]=1.17; 95% confidence intervals [CI] 1.05,1.30 per standard deviation increase in T-2 cortisol), attenuating when adjusted for current (45y) and previous (7-42y) psychological health (OR=1.11; 95% CI 0.98, 1.24). Similarly, an association in women of flatter cortisol delta (T-2-T-1) with depressive symptoms at 50y weakened after adjustment for current (45y) and previous (7-42y) psychological health. For men, lower T-2 cortisol at 45y predicted greater depressive symptoms at 50y and the association strengthened when adjusted for lifetime psychological health. Likewise, lower cortisol AUC predicted higher risk of depression for men after adjusting for prior psychological health (OR=0.85; CI 0.72, 1.00). Associations were largely unaltered by control for covariates. Conclusions: In women, higher cortisol in late morning at 45y is prospectively associated with depressive symptoms at 50y through a link with lifetime psychological health. In men, lower cortisol predicts subsequent symptoms, independent of depressive history.	[Geoffroy, Marie-Claude; Li, Leah; Power, Chris] UCL, MRC, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth,Ctr Epidemiol Child Hlth, London WC1E 6BT, England; [Geoffroy, Marie-Claude] McGill Univ, McGill Grp Suicide Studies, Douglas Mental Hlth Univ Inst, Montreal, PQ, Canada; [Hertzman, Clyde] Univ British Columbia, Sch Populat & Publ Hlth, Vancouver, BC V5Z 1M9, Canada	University of London; University College London; McGill University; University of British Columbia	Power, C (corresponding author), UCL, MRC, Ctr Paediat Epidemiol & Biostat, Inst Child Hlth,Ctr Epidemiol Child Hlth, London WC1E 6BT, England.	christine.power@ucl.ac.uk	Geoffroy, Marie-Claude/AAO-5496-2021	Geoffroy, Marie-Claude/0000-0002-8587-8378	Canadian Institutes of Health Research [202119]; MRC [G0601941]; Medical Research Council [G0000934]; Department of Health's NIHR Biomedical Research Centre; Centre for Paediatric Epidemiology and Biostatistics; Medical Research Council; Canada Research Chairs Program [950-205448]; MRC [G0000934] Funding Source: UKRI; Medical Research Council [G0601941] Funding Source: researchfish	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Department of Health's NIHR Biomedical Research Centre(National Institute for Health Research (NIHR)); Centre for Paediatric Epidemiology and Biostatistics; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Canada Research Chairs Program(Canada Research Chairs); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Marie-Claude Geoffroy was supported by a fellowship from the Canadian Institutes of Health Research (grant no 202119); Leah Li was supported by an MRC Career Development Award in Biostatistics (grant no G0601941); data collection at 45 years was funded by the Medical Research Council, (grant no G0000934), including measurement of cortisol levels under the direction of Professor Kirschbaum (Biological Psychology, Department of Psychology, University of Dresden, Germany); the GOSH/UCL Institute of Child Health was supported in part by the Department of Health's NIHR Biomedical Research Centre; the Centre for Paediatric Epidemiology and Biostatistics was supported in part by the Medical Research Council in its capacity as the MRC Centre of Epidemiology for Child Health; Clyde Hertzman was supported by the Canada Research Chairs Program (grant no 950-205448). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adam EK, 2010, PSYCHONEUROENDOCRINO, V35, P921, DOI 10.1016/j.psyneuen.2009.12.007; Atherton K, 2008, J EPIDEMIOL COMMUN H, V62, P216, DOI 10.1136/jech.2006.058966; Bockting CLH, 2012, PSYCHIAT RES, V200, P281, DOI 10.1016/j.psychres.2012.03.044; Bremmer MA, 2007, BIOL PSYCHIAT, V62, P479, DOI 10.1016/j.biopsych.2006.11.033; Cuijpers P, 2012, JAMA-J AM MED ASSOC, V307, P1033, DOI 10.1001/jama.2012.271; Cuijpers P, 2009, PSYCHIAT RES, V168, P250, DOI 10.1016/j.psychres.2008.05.012; Elander J, 1996, INT J METHOD PSYCH, V6, P63, DOI 10.1002/(SICI)1234-988X(199607)6:2<63::AID-MPR151>3.3.CO;2-M; Ellenbogen MA, 2011, J AFFECT DISORDERS, V132, P265, DOI 10.1016/j.jad.2011.01.007; Geoffroy MC, 2012, PSYCHOL MED, V42, P1763, DOI 10.1017/S0033291711002704; Goodyer IM, 2009, BRIT J PSYCHIAT, V195, P39, DOI 10.1192/bjp.bp.108.054775; Goodyer IM, 2000, BRIT J PSYCHIAT, V177, P499, DOI 10.1192/bjp.177.6.499; Halligan SL, 2007, BIOL PSYCHIAT, V62, P40, DOI 10.1016/j.biopsych.2006.09.011; Harris TO, 2000, BRIT J PSYCHIAT, V177, P505, DOI 10.1192/bjp.177.6.505; Herbert J, 2012, BRIT J PSYCHIAT, V201, P313, DOI 10.1192/bjp.bp.111.107037; Holmes WC, 1998, MED CARE, V36, P237, DOI 10.1097/00005650-199802000-00012; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Knight JM, 2010, PSYCHOSOM MED, V72, P855, DOI 10.1097/PSY.0b013e3181f4ab87; Korten NCM, 2012, J AFFECT DISORDERS, V138, P259, DOI 10.1016/j.jad.2012.01.042; LEWIS G, 1992, PSYCHOL MED, V22, P465, DOI 10.1017/S0033291700030415; Lok A, 2012, PSYCHONEUROENDOCRINO, V37, P892, DOI 10.1016/j.psyneuen.2011.10.005; Lupien SJ, 2009, NAT REV NEUROSCI, V10, P434, DOI 10.1038/nrn2639; Messerli-Burgy N, 2012, PSYCHOL MED, V42, P1815, DOI 10.1017/S0033291711002959; Miller GE, 2007, PSYCHOL BULL, V133, P25, DOI 10.1037/0033-2909.133.1.25; Pan A, 2011, ARCH GEN PSYCHIAT, V68, P42, DOI 10.1001/archgenpsychiatry.2010.176; Power C, 2006, INT J EPIDEMIOL, V35, P34, DOI 10.1093/ije/dyi183; Power C, 2008, PSYCHONEUROENDOCRINO, V33, P530, DOI 10.1016/j.psyneuen.2008.01.017; Power C, 2006, J CLIN ENDOCR METAB, V91, P4264, DOI 10.1210/jc.2006-0625; Power C, 2012, BRIT J PSYCHIAT, V201, P199, DOI 10.1192/bjp.bp.111.096032; Power C, 2011, PSYCHONEUROENDOCRINO, V36, P87, DOI 10.1016/j.psyneuen.2010.06.010; Rao U, 2010, J AM ACAD CHILD PSY, V49, P141, DOI 10.1016/j.jaac.2009.09.008; Rodgers B, 1999, SOC PSYCH PSYCH EPID, V34, P333, DOI 10.1007/s001270050153; Rosenman S, 2004, SOC PSYCH PSYCH EPID, V39, P695, DOI 10.1007/s00127-004-0802-0; Ruttle PL, 2011, HORM BEHAV, V59, P123, DOI 10.1016/j.yhbeh.2010.10.015; Shirtcliff EA, 2008, DEV PSYCHOBIOL, V50, P690, DOI 10.1002/dev.20336; Solomon DA, 2000, AM J PSYCHIAT, V157, P229, DOI 10.1176/appi.ajp.157.2.229; Stetler C, 2011, PSYCHOSOM MED, V73, P114, DOI 10.1097/PSY.0b013e31820ad12b; Stott D. H., 1969, SOCIAL ADJUSTMENT CH; Trickett PK, 2010, DEV PSYCHOPATHOL, V22, P165, DOI 10.1017/S0954579409990332; Vrshek-Schallhorn S, 2013, PSYCHOL MED, V43, P483, DOI 10.1017/S0033291712001213; Wardenaar KJ, 2011, BIOL PSYCHIAT, V69, P366, DOI 10.1016/j.biopsych.2010.09.005; WARE JE, 1992, MED CARE, V30, P473, DOI 10.1097/00005650-199206000-00002; Wolkowitz OM, 2009, ANN NY ACAD SCI, V1179, P19, DOI 10.1111/j.1749-6632.2009.04980.x; Young E, 2010, MOL PSYCHIATR, V15, P23, DOI 10.1038/mp.2009.94; Zobel AW, 2001, J PSYCHIAT RES, V35, P83, DOI 10.1016/S0022-3956(01)00013-9	44	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e77603	10.1371/journal.pone.0077603	http://dx.doi.org/10.1371/journal.pone.0077603			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265676	Green Submitted, Green Published, gold			2022-12-25	WOS:000327252100009
J	Myers, SA; Nield, A; Chew, GS; Myers, MA				Myers, Stephen A.; Nield, Alex; Chew, Guat-Siew; Myers, Mark A.			The Zinc Transporter, Slc39a7 (Zip7) Is Implicated in Glycaemic Control in Skeletal Muscle Cells	PLOS ONE			English	Article							GENE-EXPRESSION; NUCLEAR RECEPTOR; LIV-1 SUBFAMILY; GLUCOSE; IDENTIFICATION; HOMEOSTASIS; METABOLISM; INHIBITION; COMPLEXES; PATHWAYS	Dysfunctional zinc signaling is implicated in disease processes including cardiovascular disease, Alzheimer's disease and diabetes. Of the twenty-four mammalian zinc transporters, ZIP7 has been identified as an important mediator of the 'zinc wave' and in cellular signaling. Utilizing siRNA targeting Zip7 mRNA we have identified that Zip7 regulates glucose metabolism in skeletal muscle cells. An siRNA targeting Zip7 mRNA down regulated Zip7 mRNA 4.6-fold (p = 0.0006) when compared to a scramble control. This was concomitant with a reduction in the expression of genes involved in glucose metabolism including Agl, Dlst, Galm, Gbe1, Idh3g, Pck2, Pgam2, Pgm2, Phkb, Pygm, Tpi1, Gusb and Glut4. Glut4 protein expression was also reduced and insulin-stimulated glycogen synthesis was decreased. This was associated with a reduction in the mRNA expression of Insr, Irs1 and Irs2, and the phosphorylation of Akt. These studies provide a novel role for Zip7 in glucose metabolism in skeletal muscle and highlight the importance of this transporter in contributing to glycaemic control in this tissue.	[Myers, Stephen A.; Nield, Alex; Myers, Mark A.] Univ Ballarat, Collaborat Res Network, Ballarat, Vic 3353, Australia; [Myers, Stephen A.; Nield, Alex; Chew, Guat-Siew; Myers, Mark A.] Univ Ballarat, Sch Hlth Sci, Ballarat, Vic 3353, Australia	Federation University Australia; Federation University Australia	Myers, SA (corresponding author), Univ Ballarat, Collaborat Res Network, Mt Helen Campus, Ballarat, Vic 3353, Australia.	s.myers@ballarat.edu.au	Myers, Mark/H-8599-2016	Myers, Mark/0000-0003-1156-4795; Myers, Stephen/0000-0003-4793-3820	School of Health Sciences Seeding Grant, University of Ballarat, Victoria Australia	School of Health Sciences Seeding Grant, University of Ballarat, Victoria Australia	This study was funded by a School of Health Sciences Seeding Grant, University of Ballarat, Victoria Australia. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ARMSTRONG RB, 1984, AM J ANAT, V171, P259, DOI 10.1002/aja.1001710303; Bajaj M, 2003, J NUCL CARDIOL, V10, P311, DOI 10.1016/S1071-3581(03)00520-8; Basaki M, 2012, BIOL TRACE ELEM RES, V148, P161, DOI 10.1007/s12011-012-9360-6; Biddinger SB, 2011, METABOLIC BASIS OF OBESITY, P175, DOI 10.1007/978-1-4419-1607-5_10; Bin BH, 2011, J BIOL CHEM, V286, P40255, DOI 10.1074/jbc.M111.256784; Bookout Angie L, 2003, Nucl Recept Signal, V1, pe012; BRAUTIGAN DL, 1981, J BIOL CHEM, V256, P6519; Chistiakov DA, 2009, BIOFACTORS, V35, P356, DOI 10.1002/biof.49; COULSTON L, 1980, DIABETES, V29, P665, DOI 10.2337/diabetes.29.8.665; Cousins RJ, 2006, J BIOL CHEM, V281, P24085, DOI 10.1074/jbc.R600011200; Crowther LM, 2011, PHYSIOL GENOMICS, V43, P213, DOI 10.1152/physiolgenomics.00195.2010; Delli AJ, 2012, DIABETES, V61, P2556, DOI 10.2337/db11-1659; Dressel U, 2003, MOL ENDOCRINOL, V17, P2477, DOI 10.1210/me.2003-0151; Ferdousi S, 2012, Mymensingh Med J, V21, P475; Foster M, 2010, ANTIOXID REDOX SIGN, V13, P1549, DOI 10.1089/ars.2010.3111; Fukada T, 2011, J BIOL INORG CHEM, V16, P1123, DOI 10.1007/s00775-011-0797-4; Gaither LA, 2001, BIOMETALS, V14, P251, DOI 10.1023/A:1012988914300; Hogstrand C, 2009, TRENDS MOL MED, V15, P101, DOI 10.1016/j.molmed.2009.01.004; Huang L, 2012, J BIOL CHEM, V282, P37053; Huang LP, 2005, J BIOL CHEM, V280, P15456, DOI 10.1074/jbc.M412188200; Ilouz R, 2002, BIOCHEM BIOPH RES CO, V295, P102, DOI 10.1016/S0006-291X(02)00636-8; Jayaraman AK, 2011, J NUTR BIOCHEM, V22, P79, DOI 10.1016/j.jnutbio.2009.12.001; Jensen J, 2006, AM J PHYSIOL-ENDOC M, V290, pE154, DOI 10.1152/ajpendo.00330.2005; Kambe T, 2008, AM J PHYSIOL-REG I, V294, pR1474, DOI 10.1152/ajpregu.00130.2008; Kawasaki E, 2011, CLIN IMMUNOL, V138, P146, DOI 10.1016/j.clim.2010.10.007; Lau P, 2004, J BIOL CHEM, V279, P36828, DOI 10.1074/jbc.M404927200; Lichten LA, 2009, ANNU REV NUTR, V29, P153, DOI 10.1146/annurev-nutr-033009-083312; Liuzzi JP, 2004, ANNU REV NUTR, V24, P151, DOI 10.1146/annurev.nutr.24.012003.132402; Ma YM, 2011, MOL CELL BIOCHEM, V357, P65, DOI 10.1007/s11010-011-0876-4; Maret W, 1999, P NATL ACAD SCI USA, V96, P1936, DOI 10.1073/pnas.96.5.1936; Maxwell MA, 2005, J BIOL CHEM, V280, P12573, DOI 10.1074/jbc.M409580200; Moniz T, 2011, J INORG BIOCHEM, V105, P1675, DOI 10.1016/j.jinorgbio.2011.09.005; MUSCAT GEO, 1995, NUCLEIC ACIDS RES, V23, P1311, DOI 10.1093/nar/23.8.1311; Muscat GEO, 2002, J BIOL CHEM, V277, P40722, DOI 10.1074/jbc.M206681200; Myers SA, 2006, J BIOL CHEM, V281, P24149, DOI 10.1074/jbc.M601941200; Myers SA, 2012, J NUTR METAB, V2012, DOI 10.1155/2012/173712; Patrushev N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033211; Peppa M, 2010, J BIOMED BIOTECHNOL, DOI 10.1155/2010/527850; Petersen KF, 2007, P NATL ACAD SCI USA, V104, P12587, DOI 10.1073/pnas.0705408104; Raichur S, 2010, NUCLEIC ACIDS RES, V38, P4296, DOI 10.1093/nar/gkq180; Ruchi S, 2011, RES J CHEM ENVIRON, V15, P75; Shimokawa T, 1998, BIOCHEM BIOPH RES CO, V246, P287, DOI 10.1006/bbrc.1998.8600; Simon SF, 2001, EXP BIOL MED, V226, P43, DOI 10.1177/153537020122600107; Smidt K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005684; Spandidos A, 2010, NUCLEIC ACIDS RES, V38, pD792, DOI 10.1093/nar/gkp1005; Spandidos A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-633; Stadler N, 2012, ATHEROSCLEROSIS, V222, P512, DOI 10.1016/j.atherosclerosis.2012.03.015; Tanaka T, 2003, P NATL ACAD SCI USA, V100, P15924, DOI 10.1073/pnas.0306981100; Tang XH, 2001, J NUTR, V131, P1414, DOI 10.1093/jn/131.5.1414; Taniguchi M, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058022; Taylor KM, 2008, ENDOCRINOLOGY, V149, P4912, DOI 10.1210/en.2008-0351; Taylor KM, 2007, MOL MED, V13, P396, DOI 10.2119/2007-00040.Taylor; Taylor KM, 2012, SCI SIGNAL, V5, DOI 10.1126/scisignal.2002585; Taylor KM, 2004, BIOCHEM J, V377, P131, DOI 10.1042/BJ20031183; Wang SCM, 2012, BIOCHEM J, V444, P323, DOI 10.1042/BJ20112033; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Wijesekara N, 2009, DIABETES OBES METAB, V11, P202, DOI 10.1111/j.1463-1326.2009.01110.x; Yamasaki S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039654; Yoshikawa Y, 2004, LIFE SCI, V75, P741, DOI 10.1016/j.lfs.2004.02.006; Zhao YG, 2012, J NUTR BIOCHEM, V23, P1018, DOI 10.1016/j.jnutbio.2011.05.011; Zhu C, 2011, CELL BIOCHEM BIOPHYS, V60, P259, DOI 10.1007/s12013-010-9148-2	62	51	54	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79316	10.1371/journal.pone.0079316	http://dx.doi.org/10.1371/journal.pone.0079316			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265765	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100098
J	Pal, GK; Adithan, C; Ananthanarayanan, PH; Pal, P; Nanda, N; Durgadevi, T; Lalitha, V; Syamsunder, AN; Dutta, TK				Pal, Gopal Krushna; Adithan, Chandrasekaran; Ananthanarayanan, Palghat Hariharan; Pal, Pravati; Nanda, Nivedita; Durgadevi, Thiyagarajan; Lalitha, Venugopal; Syamsunder, Avupati Naga; Dutta, Tarun Kumar			Sympathovagal Imbalance Contributes to Prehypertension Status and Cardiovascular Risks Attributed by Insulin Resistance, Inflammation, Dyslipidemia and Oxidative Stress in First Degree Relatives of Type 2 Diabetics	PLOS ONE			English	Article							HEART-RATE-VARIABILITY; 1ST-DEGREE RELATIVES; DISEASE; PREVALENCE; MELLITUS; GLUCOSE	Background: Though cardiovascular (CV) risks are reported in first-degree relatives (FDR) of type 2 diabetics, the pathophysiological mechanisms contributing to these risks are not known. We investigated the association of sympathovagal imbalance (SVI) with CV risks in these subjects. Subjects and Methods: Body mass index (BMI), basal heart rate (BHR), blood pressure (BP), rate-pressure product (RPP), spectral indices of heart rate variability (HRV), autonomic function tests, insulin resistance (HOMA-IR), lipid profile, inflammatory markers, oxidative stress (OS) marker, rennin, thyroid profile and serum electrolytes were measured and analyzed in subjects of study group (FDR of type 2 diabetics, n = 72) and control group (subjects with no family history of diabetes, n = 104). Results: BMI, BP, BHR, HOMA-IR, lipid profile, inflammatory and OS markers, renin, LF-HF (ratio of low-frequency to high-frequency power of HRV, a sensitive marker of SVI) were significantly increased (p<0.0001) in study group compared to the control group. SVI in study group was due to concomitant sympathetic activation and vagal inhibition. There was significant correlation and independent contribution of markers of insulin resistance, dyslipidemia, inflammation and OS to LF-HF ratio. Multiple-regression analysis demonstrated an independent contribution of LF-HF ratio to prehypertension status (standardized beta 0.415, p<0.001) and bivariate logistic-regression showed significant prediction (OR 2.40, CI 1.128-5.326, p = 0.002) of LF-HF ratio of HRV to increased RPP, the marker of CV risk, in study group. Conclusion: SVI in FDR of type 2 diabetics occurs due to sympathetic activation and vagal withdrawal. The SVI contributes to prehypertension status and CV risks caused by insulin resistance, dyslipidemia, inflammation and oxidative stress in FDR of type 2 diabetics.	[Pal, Gopal Krushna; Pal, Pravati; Lalitha, Venugopal; Syamsunder, Avupati Naga] JIPMER, Dept Physiol, Pondicherry, India; [Adithan, Chandrasekaran] JIPMER, Dept Pharmacol, Pondicherry, India; [Ananthanarayanan, Palghat Hariharan; Durgadevi, Thiyagarajan] JIPMER, Dept Biochem, Pondicherry, India; [Nanda, Nivedita] Pondicherry Inst Med Sci, Dept Biochem, Pondicherry, India; [Dutta, Tarun Kumar] JIPMER, Dept Med, Pondicherry, India	Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Jawaharlal Institute of Postgraduate Medical Education & Research; Pondicherry Institute of Medical Sciences; Jawaharlal Institute of Postgraduate Medical Education & Research	Pal, GK (corresponding author), JIPMER, Dept Physiol, Pondicherry, India.	drgkpal@gmail.com	Nanda, Nivedita/P-6453-2014; C, Adithan/L-9834-2019	Nanda, Nivedita/0000-0002-8887-8357; 				Altinli S, 2007, J PEDIATR ENDOCR MET, V20, P431; Amini M, 2010, ANN NUTR METAB, V56, P267, DOI 10.1159/000294752; Anselmino M, 2009, CURR OPIN CARDIOL, V24, P461, DOI 10.1097/HCO.0b013e32832ec3c5; Camm AJ, 1996, CIRCULATION, V93, P1043; Danson Edward J F, 2006, J Cardiovasc Electrophysiol, V17 Suppl 1, pS104, DOI 10.1111/j.1540-8167.2006.00391.x; Fiorentini A, 2005, CARDIOVASC DIABETOL, V4, DOI 10.1186/1475-2840-4-15; Fleischer Jesper, 2012, J Diabetes Sci Technol, V6, P1207; Ginter Emil, 2012, Adv Exp Med Biol, V771, P35; Graham Ian M, 2006, Eur J Gen Pract, V12, P148, DOI 10.1080/13814780600976282; Hegde SV, 2011, DIABETES CARE, V34, P2208, DOI 10.2337/dc10-2430; International Monetary Fund, 2009, DEFL EC GROWTH BOP C, P1; Jensen MT, 2013, HEART, V99, P882, DOI 10.1136/heartjnl-2012-303375; Jirkovska A, 1991, Vnitr Lek, V37, P671; Johansen NB, 2012, BMC PUBLIC HEALTH, V12, DOI 10.1186/1471-2458-12-1078; Joshi SR, 2012, CLIN LAB MED, V32, P207, DOI 10.1016/j.cll.2012.04.012; Karaman A, 2012, BRATISL MED J, V113, P361, DOI 10.4149/BLL_2012_082; Kiviniemi AM, 2007, ANN MED, V39, P54, DOI 10.1080/07853890600990375; Laitio T, 2007, ANESTH ANALG, V105, P1548, DOI 10.1213/01.ane.0000287654.49358.3a; Lambert E, 2013, AM J HYPERTENS, V26, P250, DOI 10.1093/ajh/hps016; Laslett LJ, 2012, J AM COLL CARDIOL, V60, pS1, DOI 10.1016/j.jacc.2012.11.002; Lehnen AM, 2013, AUTON NEUROSCI-BASIC, V176, P64, DOI 10.1016/j.autneu.2013.02.011; Lieb DC, 2012, EXP DIABETES RES, DOI 10.1155/2012/878760; Lindmark S, 2005, OBES RES, V13, P717, DOI 10.1038/oby.2005.81; Lupachyk S, 2012, FREE RADICAL BIO MED, V52, P1255, DOI 10.1016/j.freeradbiomed.2012.01.029; Malliani Alberto, 2005, Eur J Intern Med, V16, P12, DOI 10.1016/j.ejim.2004.06.016; May AL, 2012, PEDIATRICS, V129, P1035, DOI 10.1542/peds.2011-1082; *NAT HEART LUNG BL, 7 NAT HEART LUNG BLO; Neves FJ, 2008, DIABETIC MED, V25, P355, DOI 10.1111/j.1464-5491.2007.02364.x; Pal GK, 2010, TXB PRACTICAL PHYSL, P282; Pal GK, 2004, INDIAN J MED RES, V3, P154; Pal GK, 2013, FUTUR CARDIOL, V9, P53, DOI [10.2217/fca.12.80, 10.2217/FCA.12.80]; Popa Calin D, 2012, Mediators Inflamm, V2012, P785946; Pradeepa R, 2012, DIABETES TECHNOL THE, V14, pS59, DOI 10.1089/dia.2012.0065; Ruotsalainen E, 2008, ATHEROSCLEROSIS, V197, P271, DOI 10.1016/j.atherosclerosis.2007.04.021; Ruskovska T, 2013, J PROTEOMICS, V92, P323, DOI 10.1016/j.jprot.2013.04.002; Salamin G, 2013, OBESITY, V21, P1578, DOI 10.1002/oby.20089; Thayer JF, 2010, INT J CARDIOL, V141, P122, DOI 10.1016/j.ijcard.2009.09.543; Vinik Aaron I, 2012, Front Endocrinol (Lausanne), V3, P71, DOI 10.3389/fendo.2012.00071; White WB, 1999, AM J HYPERTENS, V12, p50S, DOI 10.1016/S0895-7061(98)00280-5	39	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78072	10.1371/journal.pone.0078072	http://dx.doi.org/10.1371/journal.pone.0078072			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265679	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100012
J	Pechal, JL; Crippen, TL; Tarone, AM; Lewis, AJ; Tomberlin, JK; Benbow, ME				Pechal, Jennifer L.; Crippen, Tawni L.; Tarone, Aaron M.; Lewis, Andrew J.; Tomberlin, Jeffery K.; Benbow, M. Eric			Microbial Community Functional Change during Vertebrate Carrion Decomposition	PLOS ONE			English	Article							BACTERIAL COMMUNITY; SPECIES COMPOSITION; INSECT SUCCESSION; OVIS-ARIES; SOIL; DIVERSITY; RESPONSES; BIODIVERSITY; DISTURBANCE; COMPETITION	Microorganisms play a critical role in the decomposition of organic matter, which contributes to energy and nutrient transformation in every ecosystem. Yet, little is known about the functional activity of epinecrotic microbial communities associated with carrion. The objective of this study was to provide a description of the carrion associated microbial community functional activity using differential carbon source use throughout decomposition over seasons, between years and when microbial communities were isolated from eukaryotic colonizers (e. g., necrophagous insects). Additionally, microbial communities were identified at the phyletic level using high throughput sequencing during a single study. We hypothesized that carrion microbial community functional profiles would change over the duration of decomposition, and that this change would depend on season, year and presence of necrophagous insect colonization. Biolog EcoPlates (TM) were used to measure the variation in epinecrotic microbial community function by the differential use of 29 carbon sources throughout vertebrate carrion decomposition. Pyrosequencing was used to describe the bacterial community composition in one experiment to identify key phyla associated with community functional changes. Overall, microbial functional activity increased throughout decomposition in spring, summer and winter while it decreased in autumn. Additionally, microbial functional activity was higher in 2011 when necrophagous arthropod colonizer effects were tested. There were inconsistent trends in the microbial function of communities isolated from remains colonized by necrophagous insects between 2010 and 2011, suggesting a greater need for a mechanistic understanding of the process. These data indicate that functional analyses can be implemented in carrion studies and will be important in understanding the influence of microbial communities on an essential ecosystem process, carrion decomposition.	[Pechal, Jennifer L.; Lewis, Andrew J.; Benbow, M. Eric] Univ Dayton, Dept Biol, Dayton, OH 45469 USA; [Crippen, Tawni L.] USDA ARS, Southern Plains Agr Res Ctr, College Stn, TX USA; [Pechal, Jennifer L.; Tarone, Aaron M.; Tomberlin, Jeffery K.] Texas A&M Univ, Dept Entomol, College Stn, TX 77843 USA	University of Dayton; United States Department of Agriculture (USDA); Texas A&M University System; Texas A&M University College Station	Pechal, JL (corresponding author), Univ Dayton, Dept Biol, Dayton, OH 45469 USA.	jenpechal18@gmail.com; eric.benbow@gmail.com	Benbow, Mark/V-5895-2019	Pechal, Jennifer/0000-0002-2588-2519; Crippen, Tawni/0000-0001-5129-2371; Tarone, Aaron/0000-0003-0965-7634	University of Dayton Research Council; Department of Biology; Department of Entomology; Whole Systems Genomics Initiative for Improved Human, Animal, and Environmental Wellbeing at Texas A M University; Department of Entomology at Texas A M University; Texas A&M University AgriLife Research; National Institute of Justice, Office of Justice Programs, United States Department of Justice [2010-DN-BX-K243]	University of Dayton Research Council; Department of Biology; Department of Entomology; Whole Systems Genomics Initiative for Improved Human, Animal, and Environmental Wellbeing at Texas A M University; Department of Entomology at Texas A M University; Texas A&M University AgriLife Research; National Institute of Justice, Office of Justice Programs, United States Department of Justice	The authors (AJL and MEB) would like to thank the University of Dayton Research Council and the Department of Biology for financial support of this project. JLP was funded by the Department of Entomology and the Whole Systems Genomics Initiative for Improved Human, Animal, and Environmental Wellbeing at Texas A & M University. JKT and AMT are funded by the Department of Entomology at Texas A & M University and Texas A&M University AgriLife Research. This project was also funded (TLC, AMT, JKT and MEB), in part, by the National Institute of Justice, Office of Justice Programs, United States Department of Justice through Grant 2010-DN-BX-K243. Points of view in this document are those of the authors and do not necessarily represent the official position or policies of the United States Department of Justice. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Alam MJ, 2004, APPL ENVIRON MICROB, V70, P7578, DOI 10.1128/AEM.70.12.7578-7580.2004; Anderson GS, 1996, J FORENSIC SCI, V41, P617; Anderson MJ, 2001, AUSTRAL ECOL, V26, P32, DOI 10.1046/j.1442-9993.2001.01070.x; [Anonymous], 2010, R LANG ENV STAT COMP; Barton PS, 2013, OECOLOGIA, V171, P761, DOI 10.1007/s00442-012-2460-3; Barton PS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053961; Benbow ME, 2013, J MED ENTOMOL, V50, P440, DOI 10.1603/ME12194; Brock T.D., 1978, THERMOPHILIC MICROOR; Bucher AE, 2005, APPL SOIL ECOL, V29, P59, DOI 10.1016/j.apsoil.2004.09.007; Burkepile DE, 2006, ECOLOGY, V87, P2821, DOI 10.1890/0012-9658(2006)87[2821:CMCBMA]2.0.CO;2; Calbrix R, 2005, EUR J SOIL BIOL, V41, P11, DOI 10.1016/j.ejsobi.2005.02.004; Campbell N.A., 2008, BIOLOGY-BASEL, V8th; Carter DO, 2006, SOIL BIOL BIOCHEM, V38, P1139, DOI 10.1016/j.soilbio.2005.09.014; Castro HF, 2010, APPL ENVIRON MICROB, V76, P999, DOI 10.1128/AEM.02874-09; Chaloner DT, 2002, FRESHWATER BIOL, V47, P263, DOI 10.1046/j.1365-2427.2002.00804.x; Curran AM, 2005, J CHEM ECOL, V31, P1607, DOI 10.1007/s10886-005-5801-4; Daviss B, 2005, SCIENTIST, V19, P25; Dekeirsschieter J, 2013, J FORENSIC SCI; Dickson GC, 2011, FORENSIC SCI INT, V209, P1, DOI 10.1016/j.forsciint.2010.10.016; Dowd SE, 2008, FOODBORNE PATHOG DIS, V5, P205, DOI 10.1089/fpd.2007.0062; Dowd SE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-43; Ellis-Evans JC, 1998, ARCH HYDROBIOL, V141, P209; Fiehn O, 2002, PLANT MOL BIOL, V48, P155, DOI 10.1023/A:1013713905833; Frederickx C, 2012, FORENSIC SCI INT, V219, DOI 10.1016/j.forsciint.2012.01.007; Frederickx C, 2012, J FORENSIC SCI, V57, P386, DOI 10.1111/j.1556-4029.2011.02010.x; Velasco AGV, 2009, GEODERMA, V153, P186, DOI 10.1016/j.geoderma.2009.08.005; GARLAND JL, 1991, APPL ENVIRON MICROB, V57, P2351, DOI 10.1128/AEM.57.8.2351-2359.1991; Garland JL, 1997, FEMS MICROBIOL ECOL, V24, P289, DOI 10.1016/S0168-6496(97)00061-5; GARRITY GM, 2004, BERGEYS MANUAL SYSTE; Gill C O, 1978, Meat Sci, V2, P207, DOI 10.1016/0309-1740(78)90006-2; GREENBERG B, 1972, AM J CLIN NUTR, V25, P1459; Haslam TCF, 2009, J FORENSIC SCI, V54, P900, DOI 10.1111/j.1556-4029.2009.01070.x; Hattenschwiler S, 2005, ANNU REV ECOL EVOL S, V36, P191, DOI 10.1146/annurev.ecolsys.36.112904.151932; Hocking MD, 2009, ECOL RES, V24, P1091, DOI 10.1007/s11284-009-0586-5; Ibekwe AM, 2002, FEMS MICROBIOL ECOL, V39, P183, DOI 10.1111/j.1574-6941.2002.tb00921.x; Insam H., 2004, MOL MICROBIAL ECOLOG, P853; Insam H, 2004, MOL MICRO ECOL MAN, V5.3.2, P1; Janaway R, 1996, STUDIES CRIME INTRO, P58; Janetski DJ, 2009, OECOLOGIA, V159, P583, DOI 10.1007/s00442-008-1249-x; JANZEN DH, 1977, AM NAT, V111, P691, DOI 10.1086/283200; Jenkinson D.S., 1977, NZ SOIL NEWS, V25, P213; JIRON LF, 1981, J NEW YORK ENTOMOL S, V89, P158; Jones SE, 2009, ENVIRON MICROBIOL, V11, P905, DOI 10.1111/j.1462-2920.2008.01814.x; Kirk JL, 2004, J MICROBIOL METH, V58, P169, DOI 10.1016/j.mimet.2004.04.006; Kneitel JM, 2006, COMMUNITY ECOL, V7, P245, DOI 10.1556/ComEc.7.2006.2.11; Kneitel JM, 2004, ECOLOGY, V85, P2088, DOI 10.1890/03-3172; Kominoski JS, 2011, ECOLOGY, V92, P151, DOI 10.1890/10-0028.1; Kuske CR, 2002, APPL ENVIRON MICROB, V68, P1854, DOI 10.1128/AEM.68.4.1854-1863.2002; Langenheder S, 2011, ISME J, V5, P1086, DOI 10.1038/ismej.2010.207; Lauber CL, 2009, APPL ENVIRON MICROB, V75, P5111, DOI 10.1128/AEM.00335-09; LeBlanc HN, 2010, CURRENT CONCEPTS IN FORENSIC ENTOMOLOGY, P205, DOI 10.1007/978-1-4020-9684-6_11; LeBlanc HN, 2008, OLFACTORY STIMULI AS; Lewis AJ, 2011, J MED ENTOMOL, V48, P1112, DOI 10.1603/ME11093; Ma Q, 2012, ISME J, V6, P1356, DOI 10.1038/ismej.2011.210; Mardis ER, 2008, ANNU REV GENOM HUM G, V9, P387, DOI 10.1146/annurev.genom.9.081307.164359; McCune B., 2002, ANAL ECOLOGICAL COMM, DOI 10.1016/S0022-0981(03)00091-1; McGradySteed J, 1996, OIKOS, V76, P93, DOI 10.2307/3545751; Megyesi MS, 2005, J FORENSIC SCI, V50, P618; Miller CD, 2007, J APPL MICROBIOL, V102, P1612, DOI 10.1111/j.1365-2672.2006.03202.x; Moore JC, 2004, ECOL LETT, V7, P584, DOI 10.1111/j.1461-0248.2004.00606.x; Mumcuoglu KY, 2001, J MED ENTOMOL, V38, P161, DOI 10.1603/0022-2585-38.2.161; Nayduch D, 2002, MED VET ENTOMOL, V16, P193, DOI 10.1046/j.1365-2915.2002.00363.x; Papatheodorou EM, 2008, EUR J SOIL BIOL, V44, P429, DOI 10.1016/j.ejsobi.2008.06.002; Parmenter RR, 2009, ECOL MONOGR, V79, P637, DOI 10.1890/08-0972.1; PAYNE JA, 1965, ECOLOGY, V46, P592, DOI 10.2307/1934999; Pechal JL, 2013, INT J LEGAL MED; Preston-Mafham J, 2002, FEMS MICROBIOL ECOL, V42, P1, DOI 10.1111/j.1574-6941.2002.tb00990.x; PUTMAN RJ, 1978, OIKOS, V31, P58, DOI 10.2307/3543384; Ramette A, 2007, P NATL ACAD SCI USA, V104, P2761, DOI 10.1073/pnas.0610671104; Richardson NF, 2008, HYDROBIOLOGIA, V596, P269, DOI 10.1007/s10750-007-9102-5; Ros M, 2008, J MICROBIOL METH, V72, P221, DOI 10.1016/j.mimet.2008.01.003; Rozen DE, 2008, P NATL ACAD SCI USA, V105, P17890, DOI 10.1073/pnas.0805403105; Sala MM, 2006, AQUAT MICROB ECOL, V42, P1, DOI 10.3354/ame042001; SALT GW, 1979, AM NAT, V113, P145, DOI 10.1086/283370; Schimel JP, 1999, SOIL BIOL BIOCHEM, V31, P831, DOI 10.1016/S0038-0717(98)00182-5; Schoenly KG, 2007, J MED ENTOMOL, V44, P881, DOI 10.1603/0022-2585(2007)44[881:CPACOF]2.0.CO;2; Setala H, 2004, OECOLOGIA, V139, P98, DOI 10.1007/s00442-003-1478-y; Sherman RA, 2000, ANNU REV ENTOMOL, V45, P55, DOI 10.1146/annurev.ento.45.1.55; Skirnisdottir S, 2000, APPL ENVIRON MICROB, V66, P2835, DOI 10.1128/AEM.66.7.2835-2841.2000; Statheropoulos M, 2005, FORENSIC SCI INT, V153, P147, DOI 10.1016/j.forsciint.2004.08.015; Stefanowicz A, 2006, POL J ENVIRON STUD, V15, P669; Swift M.J., 1979, DECOMPOSITION TERRES, V5; Thottathil SD, 2008, ESTUAR COAST SHELF S, V78, P665, DOI 10.1016/j.ecss.2008.02.002; Tomberlin JK, 2011, ANNU REV ENTOMOL, V56, P401, DOI 10.1146/annurev-ento-051710-103143; Tomberlin JK, 2012, ANIM BEHAV, V84, P1449, DOI 10.1016/j.anbehav.2012.09.013; Tomberlin JK, 2011, TRENDS ECOL EVOL, V26, P53, DOI 10.1016/j.tree.2010.12.001; Trienens M, 2010, OIKOS, V119, P1765, DOI 10.1111/j.1600-0706.2010.18088.x; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; Ward DM, 1998, MICROBIOL MOL BIOL R, V62, P1353, DOI 10.1128/MMBR.62.4.1353-1370.1998; Weber KP, 2010, METHODS MOL BIOL, V599, P263, DOI 10.1007/978-1-60761-439-5_16; Wilson M., 2005, MICROBIAL INHABITANT; Yang LH, 2004, SCIENCE, V306, P1565, DOI 10.1126/science.1103114; Yang LH, 2008, ECOLOGY, V89, P621, DOI 10.1890/07-0175.1; Yang LH, 2010, ECOL MONOGR, V80, P125, DOI 10.1890/08-1996.1	95	94	95	1	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79035	10.1371/journal.pone.0079035	http://dx.doi.org/10.1371/journal.pone.0079035			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265741	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100074
J	Schlecht, R; Scholz, SR; Dahmen, H; Wegener, A; Sirrenberg, C; Musil, D; Bomke, J; Eggenweiler, HM; Mayer, MP; Bukau, B				Schlecht, Rainer; Scholz, Sebastian R.; Dahmen, Heike; Wegener, Ansgar; Sirrenberg, Christian; Musil, Djordje; Bomke, Joerg; Eggenweiler, Hans-Michael; Mayer, Matthias P.; Bukau, Bernd			Functional Analysis of Hsp70 Inhibitors	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; HEAT-SHOCK-PROTEIN; CHAPERONE ACTIVITY; SUBSTRATE-BINDING; ATPASE ACTIVITY; HSC70; HEAT-SHOCK-PROTEIN-70; MECHANISM; STRESS; DNAK	The molecular chaperones of the Hsp70 family have been recognized as targets for anti-cancer therapy. Since several paralogs of Hsp70 proteins exist in cytosol, endoplasmic reticulum and mitochondria, we investigated which isoform needs to be down-regulated for reducing viability of cancer cells. For two recently identified small molecule inhibitors, VER-155008 and 2-phenylethynesulfonamide (PES), which are proposed to target different sites in Hsp70s, we analyzed the molecular mode of action in vitro. We found that for significant reduction of viability of cancer cells simultaneous knockdown of heat-inducible Hsp70 (HSPA1) and constitutive Hsc70 (HSPA8) is necessary. The compound VER-155008, which binds to the nucleotide binding site of Hsp70, arrests the nucleotide binding domain (NBD) in a half-open conformation and thereby acts as ATP-competitive inhibitor that prevents allosteric control between NBD and substrate binding domain (SBD). Compound PES interacts with the SBD of Hsp70 in an unspecific, detergent-like fashion, under the conditions tested. None of the two inhibitors investigated was isoform-specific.	[Schlecht, Rainer; Scholz, Sebastian R.; Mayer, Matthias P.; Bukau, Bernd] Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany; [Bukau, Bernd] Deutsch Krebsforschungszentrum DKFZ, Heidelberg, Germany; [Dahmen, Heike; Wegener, Ansgar; Sirrenberg, Christian; Musil, Djordje; Bomke, Joerg; Eggenweiler, Hans-Michael] Merck Serono, Global Res & Dev, Darmstadt, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg; Helmholtz Association; German Cancer Research Center (DKFZ); Merck KGaA; EMD Serono Inc.	Mayer, MP (corresponding author), Univ Heidelberg ZMBH, DKFZ ZMBH Alliance, Zentrum Mol Biol, Heidelberg, Germany.	M.Mayer@zmbh.uni-heidelberg.de; bukau@zmbh.uni-heidelberg.de	Mayer, Matthias P./B-9340-2013	Mayer, Matthias P./0000-0002-7859-3112; Bukau, Bernd/0000-0003-0521-7199	Bundesministerium fur Bildung und Forschung (BioRN Spitzencluster); Deutsche Forschungsgemeinschaft [MA 1278/4-1, BU 617/19-1]	Bundesministerium fur Bildung und Forschung (BioRN Spitzencluster); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	This work was supported by: Bundesministerium fur Bildung und Forschung (BioRN Spitzencluster), http://www.biorn.org/de/; Deutsche Forschungsgemeinschaft (MA 1278/4-1 to M. P. M. and BU 617/19-1 to B. B.), http://www.dfg.de/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anckar J, 2011, ANNU REV BIOCHEM, V80, P1089, DOI 10.1146/annurev-biochem-060809-095203; Andreasson C, 2008, J BIOL CHEM, V283, P8877, DOI 10.1074/jbc.M710063200; Balaburski GM, 2013, MOL CANCER RES, V11, P219, DOI 10.1158/1541-7786.MCR-12-0547-T; Beere HM, 2001, TRENDS CELL BIOL, V11, P6, DOI 10.1016/S0962-8924(00)01874-2; Brehmer D, 2001, NAT STRUCT BIOL, V8, P427, DOI 10.1038/87588; Broadley SA, 2009, FEBS LETT, V583, P2647, DOI 10.1016/j.febslet.2009.04.029; Brodsky JL, 1999, BIOCHEM PHARMACOL, V57, P877, DOI 10.1016/S0006-2952(98)00376-1; Chang L, 2008, ANAL BIOCHEM, V372, P167, DOI 10.1016/j.ab.2007.08.020; Clarke PA, 2000, ONCOGENE, V19, P4125, DOI 10.1038/sj.onc.1203753; DHINGRA K, 1994, INVEST NEW DRUG, V12, P235, DOI 10.1007/BF00873965; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fewell SW, 2004, J BIOL CHEM, V279, P51131, DOI 10.1074/jbc.M404857200; Fewell SW, 2001, J BIOL CHEM, V276, P910, DOI 10.1074/jbc.M008535200; Gassler CS, 2001, J BIOL CHEM, V276, P32538, DOI 10.1074/jbc.M105328200; Guisbert E, 2008, MICROBIOL MOL BIOL R, V72, P545, DOI 10.1128/MMBR.00007-08; Halgren TA, 2009, J CHEM INF MODEL, V49, P377, DOI 10.1021/ci800324m; Hartl FU, 2011, NATURE, V475, P324, DOI 10.1038/nature10317; Haslberger T, 2008, NAT STRUCT MOL BIOL, V15, P641, DOI 10.1038/nsmb.1425; Henrich B, 2009, NUCL INSTRUM METH A, V607, P247, DOI 10.1016/j.nima.2009.03.200; Jackson SE, 2013, TOP CURR CHEM, V328, P99, DOI 10.1007/128_2012_323; Kabsch W, 2010, ACTA CRYSTALLOGR D, V66, P125, DOI 10.1107/S0907444909047337; Kampinga HH, 2010, NAT REV MOL CELL BIO, V11, P579, DOI 10.1038/nrm2941; Kityk R, 2012, MOL CELL, V48, P863, DOI 10.1016/j.molcel.2012.09.023; Laufen T, 1999, P NATL ACAD SCI USA, V96, P5452, DOI 10.1073/pnas.96.10.5452; Leu JIJ, 2011, MOL CANCER RES, V9, P936, DOI 10.1158/1541-7786.MCR-11-0019; Leu JIJ, 2009, MOL CELL, V36, P15, DOI 10.1016/j.molcel.2009.09.023; Liebscher M, 2009, J BACTERIOL, V191, P1456, DOI 10.1128/JB.01131-08; Malakhov Michael P., 2004, Journal of Structural and Functional Genomics, V5, P75, DOI 10.1023/B:JSFG.0000029237.70316.52; Massey AJ, 2010, CANCER CHEMOTH PHARM, V66, P535, DOI 10.1007/s00280-009-1194-3; Mayer MP, 2000, NAT STRUCT BIOL, V7, P586; Mayer MP, 2005, CELL MOL LIFE SCI, V62, P670, DOI 10.1007/s00018-004-4464-6; Mosser DD, 2004, ONCOGENE, V23, P2907, DOI 10.1038/sj.onc.1207529; NADEAU K, 1994, BIOCHEMISTRY-US, V33, P2561, DOI 10.1021/bi00175a027; Nadler SG, 1998, BIOCHEM BIOPH RES CO, V253, P176, DOI 10.1006/bbrc.1998.9775; Nylandsted J, 2000, ANN NY ACAD SCI, V926, P122; Nylandsted J, 2000, P NATL ACAD SCI USA, V97, P7871, DOI 10.1073/pnas.97.14.7871; OBrien MC, 1996, J BIOL CHEM, V271, P15874, DOI 10.1074/jbc.271.27.15874; Otvos L, 2005, J MED CHEM, V48, P5349, DOI 10.1021/jm050347i; Otvos L, 2000, BIOCHEMISTRY-US, V39, P14150, DOI 10.1021/bi0012843; Pearl LH, 2006, ANNU REV BIOCHEM, V75, P271, DOI 10.1146/annurev.biochem.75.103004.142738; Pierpaoli EV, 1998, BIOCHEMISTRY-US, V37, P16741, DOI 10.1021/bi981762y; PLOWMAN J, 1987, CANCER RES, V47, P685; Powers MV, 2008, CANCER CELL, V14, P250, DOI 10.1016/j.ccr.2008.08.002; Powers MV, 2010, CELL CYCLE, V9, P1542, DOI 10.4161/cc.9.8.11204; Qi RF, 2013, NAT STRUCT MOL BIOL, V20, P900, DOI 10.1038/nsmb.2583; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Schlecht R, 2011, NAT STRUCT MOL BIOL, V18, P345, DOI 10.1038/nsmb.2006; SCHMID D, 1994, SCIENCE, V263, P971, DOI 10.1126/science.8310296; Scieglinska D, 2011, HISTOCHEM CELL BIOL, V135, P337, DOI 10.1007/s00418-011-0791-5; Sondermann H, 2001, SCIENCE, V291, P1553, DOI 10.1126/science.1057268; Strom E, 2006, NAT CHEM BIOL, V2, P474, DOI 10.1038/nchembio809; SZABO A, 1994, P NATL ACAD SCI USA, V91, P10345, DOI 10.1073/pnas.91.22.10345; Theyssen H, 1996, J MOL BIOL, V263, P657, DOI 10.1006/jmbi.1996.0606; Vogel M, 2006, MOL CELL, V21, P359, DOI 10.1016/j.molcel.2005.12.017; Williamson DS, 2009, J MED CHEM, V52, P1510, DOI 10.1021/jm801627a; Winn MD, 2011, ACTA CRYSTALLOGR D, V67, P235, DOI 10.1107/S0907444910045749; Zhu XT, 1996, SCIENCE, V272, P1606, DOI 10.1126/science.272.5268.1606; Zhuravleva A, 2012, CELL, V151, P1296, DOI 10.1016/j.cell.2012.11.002	58	146	148	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e78443	10.1371/journal.pone.0078443	http://dx.doi.org/10.1371/journal.pone.0078443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265689	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100023
J	Tsai, YK; Liou, CH; Fung, CP; Lin, JC; Siu, LK				Tsai, Yu-Kuo; Liou, Ci-Hong; Fung, Chang-Phone; Lin, Jung-Chung; Siu, L. Kristopher			Single or in Combination Antimicrobial Resistance Mechanisms of Klebsiella pneumoniae Contribute to Varied Susceptibility to Different Carbapenems	PLOS ONE			English	Article							SPECTRUM BETA-LACTAMASES; ERTAPENEM RESISTANCE; ESCHERICHIA-COLI; ENTEROBACTER SPP.; EXPRESSION; DHA-1; SEQUENCE; PATIENT	Resistance to carbapenems has been documented by the production of carbapenemase or the loss of porins combined with extended-spectrum beta-lactamases or AmpC beta-lactamases. However, no complete comparisons have been made regarding the contributions of each resistance mechanism towards carbapenem resistance. In this study, we genetically engineered mutants of Klebsiella pneumoniae with individual and combined resistance mechanisms, and then compared each resistance mechanism in response to ertapenem, imipenem, meropenem, doripenem and other antibiotics. Among the four studied carbapenems, ertapenem was the least active against the loss of porins, cephalosporinases and carbapenemases. In addition to the production of KPC-2 or NDM-1 alone, resistance to all four carbapenems could also be conferred by the loss of two major porins, OmpK35 and OmpK36, combined with CTX-M-15 or DHA-1 with its regulator AmpR. Because the loss of OmpK35/36 alone or the loss of a single porin combined with bla(CTX-M-15) or bla(DHA-1)-ampR expression was only sufficient for ertapenem resistance, our results suggest that carbapenems other than ertapenem should still be effective against these strains and laboratory testing for non-susceptibility to other carbapenems should improve the accurate identification of these isolates.	[Tsai, Yu-Kuo; Siu, L. Kristopher] Natl Hlth Res Inst, Natl Inst Infect Dis & Vaccinol, Miaoli, Taiwan; [Liou, Ci-Hong; Lin, Jung-Chung] Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan; [Fung, Chang-Phone] Taipei Vet Gen Hosp, Dept Med, Infect Dis Sect, Taipei, Taiwan; [Fung, Chang-Phone] Natl Yang Ming Univ, Taipei 112, Taiwan; [Siu, L. Kristopher] China Med Univ, Grad Inst Basic Med Sci, Taichung, Taiwan	National Health Research Institutes - Taiwan; National Defense Medical Center; Tri-Service General Hospital; Taipei Veterans General Hospital; National Yang Ming Chiao Tung University; China Medical University Taiwan	Lin, JC (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Internal Med, Div Infect Dis & Trop Med, Taipei, Taiwan.	linjungchung1@yahoo.com.tw	Siu, Leung-Kei/C-1368-2010		National Science Council [NSC 101-2314-B-016-022-MY3]; Tri-Service General Hospital; National Defense Medical Center [TSGH-C101-117, MAB101-1, C03-02]; Centers for Disease Control [DOH100-DC-1025, DOH101-DC-1204]; National Health Research Institutes, Taiwan	National Science Council(Ministry of Science and Technology, Taiwan); Tri-Service General Hospital; National Defense Medical Center; Centers for Disease Control(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); National Health Research Institutes, Taiwan(National Health Research Institutes - Taiwan)	his work was supported by grants from National Science Council (NSC 101-2314-B-016-022-MY3), Tri-Service General Hospital, National Defense Medical Center (TSGH-C101-117, MAB101-1 and C03-02), Centers for Disease Control (DOH100-DC-1025 and DOH101-DC-1204), and National Health Research Institutes, Taiwan. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Anderson KF, 2007, J CLIN MICROBIOL, V45, P2723, DOI 10.1128/JCM.00015-07; Barnaud G, 1998, ANTIMICROB AGENTS CH, V42, P2352, DOI 10.1128/AAC.42.9.2352; Chong Y, 2011, INFECT GENET EVOL, V11, P1499, DOI 10.1016/j.meegid.2011.06.001; Chudackova E, 2010, FEMS MICROBIOL LETT, V309, P62, DOI 10.1111/j.1574-6968.2010.02016.x; CLSI, 2013, PERFORMANCE STANDARD; Doumith M, 2009, J ANTIMICROB CHEMOTH, V63, P659, DOI 10.1093/jac/dkp029; Elliott E, 2006, CLIN INFECT DIS, V42, pE95, DOI 10.1086/503264; Girlich D, 2008, J ANTIMICROB CHEMOTH, V62, P1155, DOI 10.1093/jac/dkn317; Girlich D, 2009, ANTIMICROB AGENTS CH, V53, P832, DOI 10.1128/AAC.01007-08; Hanson ND, 1999, CURR PHARM DESIGN, V5, P881; Ho PL, 2005, J ANTIMICROB CHEMOTH, V55, P326, DOI 10.1093/jac/dki010; Jacobs C, 1997, CELL, V88, P823, DOI 10.1016/S0092-8674(00)81928-5; JACOBS C, 1994, EMBO J, V13, P4684, DOI 10.1002/j.1460-2075.1994.tb06792.x; Jacoby GA, 2009, CLIN MICROBIOL REV, V22, P161, DOI 10.1128/CMR.00036-08; LINDBERG F, 1985, P NATL ACAD SCI USA, V82, P4620, DOI 10.1073/pnas.82.14.4620; Livermore DM, 2012, KOREAN J INTERN MED, V27, P128, DOI 10.3904/kjim.2012.27.2.128; Nordmann P, 2011, EMERG INFECT DIS, V17, P1791, DOI 10.3201/eid1710.110655; Ohtomo R., 2003, MICROBES ENVIRON, V18, P138, DOI [10.1264/jsme2.18.138, DOI 10.1264/JSME2.18.138]; Shin SY, 2012, J MED MICROBIOL, V61, P239, DOI 10.1099/jmm.0.037036-0; Siu LK, 2012, MICROB DRUG RESIST, V18, P380, DOI 10.1089/mdr.2011.0241; Tsai YK, 2011, ANTIMICROB AGENTS CH, V55, P1485, DOI 10.1128/AAC.01275-10; Vading M, 2011, CLIN MICROBIOL INFEC, V17, P668, DOI 10.1111/j.1469-0691.2010.03299.x; Wang XD, 2009, J MED MICROBIOL, V58, P1196, DOI 10.1099/jmm.0.008094-0; Wikler M.A., 2012, CLIN LAB STANDARDS I, V26, pM07; Woodford N, 2007, INT J ANTIMICROB AG, V29, P456, DOI 10.1016/j.ijantimicag.2006.11.020; Wu HS, 2010, J CHIN MED ASSOC, V73, P596, DOI 10.1016/S1726-4901(10)70129-5; Yan JJ, 2006, ANTIMICROB AGENTS CH, V50, P1861, DOI 10.1128/AAC.50.5.1861-1864.2006; Yi H, 2012, J BACTERIOL, V194, P3742, DOI 10.1128/JB.00641-12	28	40	45	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79640	10.1371/journal.pone.0079640	http://dx.doi.org/10.1371/journal.pone.0079640			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265784	Green Published, gold, Green Submitted			2022-12-25	WOS:000327252100117
J	Wang, LL; Miao, JN; Li, LY; Wu, D; Zhang, Y; Peng, ZH; Zhang, LJ; Yuan, ZW; Sun, KL				Wang, Lili; Miao, Jianing; Li, Lianyong; Wu, Di; Zhang, Yi; Peng, Zhaohong; Zhang, Lijun; Yuan, Zhengwei; Sun, Kailai			Identification of an FHL1 Protein Complex Containing Gamma-Actin and Non-Muscle Myosin IIB by Analysis of Protein-Protein Interactions	PLOS ONE			English	Article							MUSCLE LIM PROTEIN-1; TALIPES EQUINOVARUS; BETA-ACTIN; EXPRESSION; GENE; MUTATION; GROWTH; MORPHOLOGY; MYOBLASTS; LOCATION	FHL1 is multifunctional and serves as a modular protein binding interface to mediate protein-protein interactions. In skeletal muscle, FHL1 is involved in sarcomere assembly, differentiation, growth, and biomechanical stress. Muscle abnormalities may play a major role in congenital clubfoot (CCF) deformity during fetal development. Thus, identifying the interactions of FHL1 could provide important new insights into its functional role in both skeletal muscle development and CCF pathogenesis. Using proteins derived from rat L6GNR4 myoblastocytes, we detected FHL1 interacting proteins by immunoprecipitation. Samples were analyzed by liquid chromatography mass spectrometry (LC-MS). Dynamic gene expression of FHL1 was studied. Additionally, the expression of the possible interacting proteins gamma-actin and nonmuscle myosin IIB, which were isolated from the lower limbs of E14, E15, E17, E18, E20 rat embryos or from adult skeletal muscle was analyzed. Potential interacting proteins isolated from E17 lower limbs were verified by immunoprecipitation, and co-localization in adult gastrocnemius muscle was visualized by fluorescence microscopy. FHL1 expression was associated with skeletal muscle differentiation. E17 was found to be the critical time-point for skeletal muscle differentiation in the lower limbs of rat embryos. We also identified gamma-actin and non-muscle myosin IIB as potential binding partners of FHL1, and both were expressed in adult skeletal muscle. We then demonstrated that FHL1 exists as part of a complex, which binds gamma-actin and non-muscle myosin IIB.	[Wang, Lili; Miao, Jianing; Wu, Di; Zhang, Yi; Peng, Zhaohong; Yuan, Zhengwei] China Med Univ, Shengjing Hosp, Key Lab Hlth Minist Congenital Malformat, Shenyang, Peoples R China; [Li, Lianyong; Zhang, Lijun] China Med Univ, Shengjing Hosp, Dept Pediat Surg, Shenyang, Peoples R China; [Sun, Kailai] China Med Univ, Dept Med Genet, Shenyang, Peoples R China	China Medical University; China Medical University; China Medical University	Wang, LL (corresponding author), China Med Univ, Shengjing Hosp, Key Lab Hlth Minist Congenital Malformat, Shenyang, Peoples R China.	wll_1977_21@163.com	wang, lili/HDL-7210-2022		National Key Research Project of China [2001CB510301]; National Natural Science Foundation of China [30973140, 81100434]; Specialized Research Fund for the Doctoral Program of Higher Education [20102104120014]	National Key Research Project of China; National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Specialized Research Fund for the Doctoral Program of Higher Education(Specialized Research Fund for the Doctoral Program of Higher Education (SRFDP))	This work was supported by the National Key Research Project of China (No. 2001CB510301), the National Natural Science Foundation of China (30973140, 81100434) and the Specialized Research Fund for the Doctoral Program of Higher Education (20102104120014). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Betapudi V, 2011, J MOL BIOL, V407, P673, DOI 10.1016/j.jmb.2011.02.010; Brown S, 1999, J BIOL CHEM, V274, P27083, DOI 10.1074/jbc.274.38.27083; Bunnell TM, 2010, CYTOSKELETON, V67, P564, DOI 10.1002/cm.20467; Cardy A, 2007, BMC MUSCULOSKEL DIS, V8, DOI 10.1186/1471-2474-8-62; Conti MA, 2008, J CELL SCI, V121, P11, DOI 10.1242/jcs.007112; Cowling BS, 2008, J CELL BIOL, V183, P1033, DOI 10.1083/jcb.200804077; Cramer LP, 1999, BIOCHEM SOC SYMP, V65, P173; Ding LH, 2011, J CELL MOL MED, V15, P72, DOI 10.1111/j.1582-4934.2009.00938.x; Ding LH, 2009, J CLIN INVEST, V119, P349, DOI 10.1172/JCI35930; Drexler HCA, 2012, MOL CELL PROTEOMICS, V11, DOI 10.1074/mcp.M111.010801; ERBA HP, 1988, MOL CELL BIOL, V8, P1775, DOI 10.1128/MCB.8.4.1775; Even-Ram S, 2007, NAT CELL BIOL, V9, P299, DOI 10.1038/ncb1540; Franklin-Tong VE, 2008, BIOCHEM J, V413, P389, DOI 10.1042/BJ20080320; Gaussin V, 2003, CIRCULATION, V108, P2926, DOI 10.1161/01.CIR.0000101922.18151.7B; GOSZTONYI G, 1989, PATHOL RES PRACT, V185, P790, DOI 10.1016/S0344-0338(89)80241-9; Greene WK, 1999, GENE, V232, P203, DOI 10.1016/S0378-1119(99)00125-0; Gueneau L, 2009, AM J HUM GENET, V85, P338, DOI 10.1016/j.ajhg.2009.07.015; Gupta P, 2007, J PEDIATR ORTHOP B, V16, P106, DOI 10.1097/01.bpb.0000228385.09313.37; Herceg MB, 2006, J PEDIATR ORTHOPED, V26, P91, DOI 10.1097/01.bpo.0000188994.90931.e8; Ivanov AI, 2005, MOL BIOL CELL, V16, P2636, DOI 10.1091/mbc.E05-01-0043; Kim JH, 2012, J BIOL CHEM, V287, P27345, DOI 10.1074/jbc.M111.304824; Knoll R, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/569628; Lee SMY, 1998, GENE, V216, P163, DOI 10.1016/S0378-1119(98)00302-3; Lin J, 2009, INT J BIOCHEM CELL B, V41, P1613, DOI 10.1016/j.biocel.2009.02.007; Lloyd CM, 2004, EXP CELL RES, V297, P82, DOI 10.1016/j.yexcr.2004.02.012; Lu SJ, 2008, CELL MOTIL CYTOSKEL, V65, P747, DOI 10.1002/cm.20299; Ma XF, 2012, P NATL ACAD SCI USA, V109, P4509, DOI 10.1073/pnas.1116268109; McGrath MJ, 2006, J BIOL CHEM, V281, P7666, DOI 10.1074/jbc.M512552200; McGrath MJ, 2003, AM J PHYSIOL-CELL PH, V285, pC1513, DOI 10.1152/ajpcell.00207.2003; MCHUGH KM, 1991, DEV BIOL, V148, P442, DOI 10.1016/0012-1606(91)90263-3; MURAKAMI N, 1993, DEV BIOL, V157, P19, DOI 10.1006/dbio.1993.1108; Nakata T, 2001, BIOCHEM BIOPH RES CO, V286, P156, DOI 10.1006/bbrc.2001.5353; Okeyo KO, 2009, J BIOMECH, V42, P2540, DOI 10.1016/j.jbiomech.2009.07.002; Omerolgu S, 2004, J PEDIATR ORTHOP B, V13, P263, DOI 10.1097/01.bpb.00000111041.46580.b3; Quinzi CM, 2008, AM J HUM GENET, V82, P208, DOI 10.1016/j.ajhg.2007.09.013; Rambani Rohit, 2006, Acta Orthop Belg, V72, P644; Robinson PA, 2003, AM J PHYSIOL-CELL PH, V284, pC681, DOI 10.1152/ajpcell.00370.2002; Ryu JB, 2006, NEURON, V49, P175, DOI 10.1016/j.neuron.2005.12.017; SCHEVZOV G, 1992, J CELL BIOL, V117, P775, DOI 10.1083/jcb.117.4.775; Schoser B, 2009, NEUROLOGY, V73, P543, DOI 10.1212/WNL.0b013e3181b2a4b3; Shalaby S, 2008, NEUROMUSCULAR DISORD, V18, P959, DOI 10.1016/j.nmd.2008.09.012; Sharma P, 2011, MOL BIOSYST, V7, P1185, DOI 10.1039/c0mb00235f; Shathasivam T, 2010, J CELL MOL MED, V14, P2702, DOI 10.1111/j.1582-4934.2010.01176.x; Sheikh F, 2008, J CLIN INVEST, V118, P3870, DOI 10.1172/JCI34472; Sonnemann KJ, 2006, DEV CELL, V11, P387, DOI 10.1016/j.devcel.2006.07.001; Swailes NT, 2006, J CELL SCI, V119, P3561, DOI 10.1242/jcs.03096; Takeda K, 2000, CELL MOTIL CYTOSKEL, V46, P59, DOI 10.1002/(SICI)1097-0169(200005)46:1<59::AID-CM6>3.0.CO;2-Q; Takeda K, 2003, CIRC RES, V93, P330, DOI 10.1161/01.RES.0000089256.00309.CB; Turney SG, 2005, NAT NEUROSCI, V8, P717, DOI 10.1038/nn1466; Wang LL, 2010, STEROIDS, V75, P368, DOI 10.1016/j.steroids.2010.01.021; Weymouth KS, 2011, AM J MED GENET A, V155A, P2170, DOI 10.1002/ajmg.a.34167; Windisch G, 2006, EUR J PEDIATR SURG, V16, P294, DOI 10.1055/s-2006-924372; Windpassinger C, 2008, AM J HUM GENET, V82, P88, DOI 10.1016/j.ajhg.2007.09.004	53	1	1	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e79551	10.1371/journal.pone.0079551	http://dx.doi.org/10.1371/journal.pone.0079551			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265776	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100109
J	Werner, CR; Egetemeyr, DP; Lauer, UM; Nadalin, S; Konigsrainer, A; Malek, NP; Berg, CP				Werner, Christoph R.; Egetemeyr, Daniel P.; Lauer, Ulrich M.; Nadalin, Silvio; Koenigsrainer, Alfred; Malek, Nisar P.; Berg, Christoph P.			Feasibility of Telaprevir-Based Triple Therapy in Liver Transplant Patients with Hepatitis C Virus: SVR 24 Results	PLOS ONE			English	Article							SUSTAINED VIROLOGICAL RESPONSE; ANTIVIRAL THERAPY; INFECTION; COMBINATION; BOCEPREVIR; SOFOSBUVIR; RIBAVIRIN	Management of recurrent Hepatitis C virus (HCV) infection following liver transplantation remains a major challenge. In non-transplanted HCV genotype 1 patients, the introduction of protease inhibitor-based regimens has significantly increased the rate of sustained virological response. In this follow-up study, on the first published cohort of post-liver transplant patients treated with telaprevir-based triple therapy, we investigated both efficacy and safety data in follow-up to 24 weeks (SVR 24) after end of treatment (EOT). SVR 24 efficacy and safety data from 9 liver transplant HCV patients being treated with telaprevir, pegylated interferon, and ribavirin, showed 5 of the transplanted patients accomplished the full duration of the 48 week triple therapy. Notable were the 4 patients found to be HCV RNA-negative at week 4, and 8 patients at week 12. Upon EOT, at week 48, 6 patients were HCV RNA-negative. Importantly, at follow-up (24 weeks after EOT), a favorable sustained virological response rate was observed in 5 of these patients with HCV RNA remaining negative, including in one patient who discontinued treatment prematurely. Due to side effects, 2 patients discontinued, 2 suffered from virological breakthrough after the telaprevir treatment phase, and 1 patient had a relapse after EOT. Two thirds of patients exhibited hematological side effects requiring ribavirin dose reductions, administration of erythropoetin, or even blood transfusions. This retrospective analysis provides evidence that - with respect to SVR 24 - liver transplant patients suffering from HCV genotype 1 recurrence may benefit from a telaprevir-based triple therapy as this new regimen showed acceptable antiviral efficacy in this small cohort of mostly pre-treated patients. Management of drug-drug interactions is challenging, but feasible. In part severe side effects are frequent during treatment and require therapeutic interventions.	[Werner, Christoph R.; Egetemeyr, Daniel P.; Lauer, Ulrich M.; Malek, Nisar P.; Berg, Christoph P.] Univ Hosp Tuebingen, Dept Gastroenterol Hepatol & Infectiol, Med Clin, Tubingen, Germany; [Nadalin, Silvio; Koenigsrainer, Alfred] Univ Hosp Tuebingen, Dept Gen Visceral & Transplant Surg, Tubingen, Germany	Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital	Berg, CP (corresponding author), Univ Hosp Tuebingen, Dept Gastroenterol Hepatol & Infectiol, Med Clin, Tubingen, Germany.	christoph.berg@med.uni-tuebingen.de		Werner, Christoph R./0000-0001-8557-473X	Merck; Roche; Janssen-Cilag	Merck(Merck & Company); Roche(Roche Holding); Janssen-Cilag(Johnson & JohnsonJohnson & Johnson USAJanssen Biotech Inc)	The authors have read the journal's policy and declare the following conflicts concerning Peg-Interferon alpha-2a (Roche), Peg-Interferon alpha-2b (Merck), Ribavirin (Roche, Merck), Telaprevir (Janssen-Cilag): CRW received travel grants from Merck, Roche, and Janssen-Cilag, and lecture fees from Roche, DPE received travel grants from Merck, and Roche, and lecture fees from Roche, UML received travel grants from Merck, and Roche, SN declares no conflict, AK declares no conflict, NPM declares no conflict, CPB received travel grants from Merck, Roche and Janssen-Cilag, and lecture fees from Merck, Roche, and Janssen-Cilag. This does not alter the authors' adherence to all the PLOS ONE policies on sharing data and materials.	Berenguer M, 2008, AM J TRANSPLANT, V8, P679, DOI 10.1111/j.1600-6143.2007.02126.x; Berenguer M, 2008, J HEPATOL, V49, P274, DOI 10.1016/j.jhep.2008.05.002; Coilly A, 2013, J HEPATOL, V58, pS572, DOI 10.1016/S0168-8278(13)61421-X; Crespo G, 2012, GASTROENTEROLOGY, V142, P1373, DOI 10.1053/j.gastro.2012.02.011; Fontana RJ, 2013, AM J TRANSPLANT, V13, P1601, DOI 10.1111/ajt.12209; Garg V, 2011, HEPATOLOGY, V54, P20, DOI 10.1002/hep.24443; Ghany MG, 2011, HEPATOLOGY, V54, P1433, DOI 10.1002/hep.24641; Jacobson IM, 2011, NEW ENGL J MED, V364, P2405, DOI 10.1056/NEJMoa1012912; Picciotto FP, 2007, J HEPATOL, V46, P459, DOI 10.1016/j.jhep.2006.10.017; Pungpapong S, 2013, LIVER TRANSPLANT, V19, P690, DOI 10.1002/lt.23669; Sarrazin C, 2012, Z GASTROENTEROL, V50, P57, DOI 10.1055/s-0031-1282015; Sherman KE, 2011, NEW ENGL J MED, V365, P1014, DOI 10.1056/NEJMoa1014463; Sulkowski MS, 2013, J HEPATOL, V58, pS570, DOI 10.1016/S0168-8278(13)61416-6; Verna EC, 2013, J HEPATOL, V58, pS10, DOI 10.1016/S0168-8278(13)60025-2; Werner CR, 2012, LIVER TRANSPLANT, V18, P1464, DOI 10.1002/lt.23542; Zeuzem S, 2011, NEW ENGL J MED, V364, P2417, DOI 10.1056/NEJMoa1013086	16	13	13	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80528	10.1371/journal.pone.0080528	http://dx.doi.org/10.1371/journal.pone.0080528			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265827	gold, Green Published, Green Submitted			2022-12-25	WOS:000327252100163
J	Zhang, YC; Zhang, QY				Zhang, Yunchun; Zhang, Qiaoying			Clonal Integration of Fragaria orientalis in Reciprocal and Coincident Patchiness Resources: Cost-Benefit Analysis	PLOS ONE			English	Article							DIVISION-OF-LABOR; HERB GLECHOMA-HEDERACEA; PHYSIOLOGICAL INTEGRATION; PHENOTYPIC PLASTICITY; SPATIOTEMPORAL DYNAMICS; NUTRIENT HETEROGENEITY; WATER TRANSLOCATION; PLANT; RAMETS; GROWTH	Clonal growth allows plants to spread horizontally and to experience different levels of resources. If ramets remain physiologically integrated, clonal plants can reciprocally translocate resources between ramets in heterogeneous environments. But little is known about the interaction between benefits of clonal integration and patterns of resource heterogeneity in different patches, i.e., coincident patchiness or reciprocal patchiness. We hypothesized that clonal integration will show different effects on ramets in different patches and more benefit to ramets under reciprocal patchiness than to those under coincident patchiness, as well as that the benefit from clonal integration is affected by the position of proximal and distal ramets under reciprocal or coincident patchiness. A pot experiment was conducted with clonal fragments consisting of two interconnected ramets (proximal and distal ramet) of Fragaria orientalis. In the experiment, proximal and distal ramets were grown in high or low availability of resources, i.e., light and water. Resource limitation was applied either simultaneously to both ramets of a clonal fragment (coincident resource limitation) or separately to different ramets of the same clonal fragment (reciprocal resource limitation). Half of the clonal fragments were connected while the other half were severed. From the experiment, clonal fragments growing under coincident resource limitation accumulated more biomass than those under reciprocal resource limitation. Based on a cost-benefit analysis, the support from proximal ramets to distal ramets was stronger than that from distal ramets to proximal ramets. Through division of labour, clonal fragments of F. orientalis benefited more in reciprocal patchiness than in coincident patchiness. While considering biomass accumulation and ramets production, coincident patchiness were more favourable to clonal plant F. orientalis.	[Zhang, Yunchun] Estonian Univ Life Sci, Inst Agr & Environm Sci, Dept Bot, Tartu, Estonia; [Zhang, Yunchun; Zhang, Qiaoying] Qilu Univ Technol, Jinan, Shandong, Peoples R China; [Zhang, Qiaoying] Univ Tartu, Inst Ecol & Earth Sci, Dept Bot, EE-50090 Tartu, Estonia	Estonian University of Life Sciences; Qilu University of Technology; University of Tartu; Tartu University Institute of Ecology & Earth Sciences	Zhang, YC (corresponding author), Estonian Univ Life Sci, Inst Agr & Environm Sci, Dept Bot, Tartu, Estonia.	yunchunzhang@163.com		Zhang, Yunchun/0000-0001-8259-5850	ERMOS [ERMOS 11]	ERMOS	This research was financially supported by ERMOS Postdoctoral Research Grants (ERMOS 11). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALPERT P, 1991, ECOLOGY, V72, P69, DOI 10.2307/1938903; ALPERT P, 1986, OECOLOGIA, V70, P227, DOI 10.1007/BF00379244; Alpert P, 1999, PLANT ECOL, V141, P99, DOI 10.1023/A:1009823015170; Alpert P, 1999, OECOLOGIA, V120, P69, DOI 10.1007/s004420050834; Alpert P, 1996, J ECOL, V84, P395, DOI 10.2307/2261201; BRADSHAW A. D., 1965, ADVANCE GENET, V13, P115, DOI 10.1016/S0065-2660(08)60048-6; Brezina S, 2006, FLORA, V201, P461, DOI 10.1016/j.flora.2005.10.003; Caldwell M.M., 1994, EXPLOITATION ENV HET; Clark JS, 2010, ECOL MONOGR, V80, P569, DOI 10.1890/09-1541.1; Cutler NA, 2008, J ECOL, V96, P231, DOI 10.1111/j.1365-2745.2007.01344.x; D'Hertefeldt T, 1999, J ECOL, V87, P258, DOI 10.1046/j.1365-2745.1999.00345.x; Day KJ, 2003, J ECOL, V91, P305, DOI 10.1046/j.1365-2745.2003.00763.x; de Kroon H, 1998, OECOLOGIA, V116, P38, DOI 10.1007/s004420050561; De Kroon H, 2009, PLANT CELL ENVIRON, V32, P704, DOI 10.1111/j.1365-3040.2009.01936.x; deKroon H, 1996, OECOLOGIA, V106, P73, DOI 10.1007/BF00334409; DONG M, 1993, NEW PHYTOL, V124, P291, DOI 10.1111/j.1469-8137.1993.tb03819.x; Dorken ME, 2004, J ECOL, V92, P32, DOI 10.1111/j.1365-2745.2004.00857.x; Dyer AR, 2010, EVOL APPL, V3, P179, DOI 10.1111/j.1752-4571.2010.00118.x; ERIKSSON O, 1986, OIKOS, V46, P82, DOI 10.2307/3565383; EVANS RC, 1988, NEW PHYTOL, V109, P369, DOI 10.1111/j.1469-8137.1988.tb04207.x; FRANKLAND JC, 1963, J ECOL, V51, P97, DOI 10.2307/2257508; FRIEDMAN D, 1991, OECOLOGIA, V86, P76, DOI 10.1007/BF00317392; Garcia-Palacios P, 2011, J ECOL, V99, P551, DOI 10.1111/j.1365-2745.2010.01765.x; Getzin S, 2008, J ECOL, V96, P807, DOI 10.1111/j.1365-2745.2008.01377.x; Guan WB, 2004, P 5 NAT S CONS SUST, P288; Hampe A, 2008, J ECOL, V96, P668, DOI 10.1111/j.1365-2745.2008.01364.x; HARTNETT DC, 1983, ECOLOGY, V64, P779, DOI 10.2307/1937201; He WM, 2011, J ECOL, V99, P1202, DOI 10.1111/j.1365-2745.2011.01848.x; Hutchings M, 1994, ORAGING PLANTS ROLE, P159; Hutchings MJ, 2008, EVOL ECOL, V22, P313, DOI 10.1007/s10682-007-9178-4; Hutchings Michael J., 1993, Plant Species Biology, V8, P95, DOI 10.1111/j.1442-1984.1993.tb00061.x; Hutchings MJ, 1997, TRENDS ECOL EVOL, V12, P390, DOI 10.1016/S0169-5347(97)87382-X; JACKSON RB, 1993, ECOLOGY, V74, P612, DOI 10.2307/1939320; Janecek S, 2008, EVOL ECOL, V22, P325, DOI 10.1007/s10682-007-9203-7; JONSDOTTIR IS, 1989, OIKOS, V54, P211, DOI 10.2307/3565269; LEVIN SA, 1992, ECOLOGY, V73, P1943, DOI 10.2307/1941447; Li CL, 2003, FLORA CHINA, P337; Mao SY, 2009, PHYSIOL PLANTARUM, V137, P225, DOI 10.1111/j.1399-3054.2009.01275.x; Marshall C., 1990, CLONAL GROWTH PLANTS, P23; ONG CK, 1979, ANN BOT-LONDON, V43, P147, DOI 10.1093/oxfordjournals.aob.a085619; Pennings SC, 2000, ECOLOGY, V81, P709; Pitelka L.F., 1985, POPULATION BIOL EVOL, P399; PRICE EAC, 1992, J ECOL, V80, P39, DOI 10.2307/2261061; PRICE EAC, 1992, J ECOL, V80, P25, DOI 10.2307/2261060; PRICE EAC, 1992, OIKOS, V63, P376, DOI 10.2307/3544963; Puijalon S, 2008, NEW PHYTOL, V177, P907, DOI 10.1111/j.1469-8137.2007.02314.x; Roiloa SR, 2007, J ECOL, V95, P397, DOI 10.1111/j.1365-2745.2007.01216.x; Roiloa SR, 2012, ECOL RES, V27, P95, DOI 10.1007/s11284-011-0876-6; Saitoh T, 2002, J ECOL, V90, P78, DOI 10.1046/j.0022-0477.2001.00631.x; SALZMAN AG, 1985, SCIENCE, V228, P603, DOI 10.1126/science.3983647; SALZMAN AG, 1985, OECOLOGIA, V65, P273, DOI 10.1007/BF00379229; SHORROCKS B, 1990, LIVING PATCHY ENV; SLADE AJ, 1987, OECOLOGIA, V73, P425, DOI 10.1007/BF00385260; Song YB, 2013, OECOLOGIA, V171, P317, DOI 10.1007/s00442-012-2430-9; Strand JA, 2004, NEW PHYTOL, V163, P449, DOI 10.1111/j.1469-8137.2004.01144.x; Stuefer JF, 1996, VEGETATIO, V127, P55, DOI 10.1007/BF00054847; Stuefer JF, 1996, FUNCT ECOL, V10, P328, DOI 10.2307/2390280; Stuefer Josef F., 1998, Perspectives in Plant Ecology Evolution and Systematics, V1, P47, DOI 10.1078/1433-8319-00051; Wang JC, 2011, J ARID LAND, V3, P34, DOI 10.3724/SP.J.1227.2011.00034; Wang ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025401; WIENS JA, 1976, ANNU REV ECOL SYST, V7, P81, DOI 10.1146/annurev.es.07.110176.000501; Wolfer SR, 2012, HYDROBIOLOGIA, V684, P261, DOI 10.1007/s10750-011-0991-y; Yu FH, 2001, EVOL ECOL, V15, P303, DOI 10.1023/A:1016032831038; Zhang C.Y., 2001, ACTA ECOL SIN, V21, P1986; Zhang YC, 2001, J SICHUAN TEACHERS C, V22, P338; Zhang YC, 2008, BOT STUD, V49, P373; Zhang YC, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0044221; Zhang YC, 2009, ECOL RES, V24, P617, DOI 10.1007/s11284-008-0533-x; Zhou J, 2012, ANN BOT-LONDON, V109, P813, DOI 10.1093/aob/mcr314; [No title captured]	70	12	14	5	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80623	10.1371/journal.pone.0080623	http://dx.doi.org/10.1371/journal.pone.0080623			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255PK	24265832	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100168
J	Qabazard, B; Ahmed, S; Li, L; Arlt, VM; Moore, PK; Stuerzenbaum, SR				Qabazard, Bedoor; Ahmed, Samanza; Li, Ling; Arlt, Volker M.; Moore, Philip K.; Stuerzenbaum, Stephen R.			C. elegans Aging Is Modulated by Hydrogen Sulfide and the sulfhydrylase/cysteine Synthase cysl-2	PLOS ONE			English	Article							CYSTATHIONINE BETA-SYNTHASE; CAENORHABDITIS-ELEGANS; LIFE-SPAN; GENE-EXPRESSION; HOMOCYSTEINE; APOPTOSIS; STRESS; H2S; ACTIVATION; MEDIATOR	Exogenous hydrogen sulfide (H2S) administration and endogenous H2S metabolism were explored in the nematode C. elegans. Chronic treatment with a slow-releasing H2S donor, GYY4137, extended median survival by 17-23% and increased tolerance towards oxidative and endoplasmic reticulum (ER) stress. Also, cysl-2, a sulfhydrylase/cysteine synthase in C. elegans, was transcriptionally upregulated by GYY4137 treatment and the deletion of cysl-2 resulted in a significant reduction in lifespan which was partially recovered by the supplementation of GYY4137. Likewise, a mammalian cell culture system, GYY4137 was able to protect bovine aortic endothelial cells (BAECs) from oxidative stress and (H2O2)-induced cell death. Taken together, this provides further support that H2S exerts a protective function which is consistent with the longevity dividend theory. Overall, this study underlines the therapeutic potential of a slow-releasing H2S donor as regulators of the aging and cellular stress pathways.	[Qabazard, Bedoor; Ahmed, Samanza; Li, Ling; Arlt, Volker M.; Stuerzenbaum, Stephen R.] Kings Coll London, Sch Biomed Sci, London, England; [Moore, Philip K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Neurobiol Grp, Inst Life Sci, Singapore 117595, Singapore; [Moore, Philip K.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Pharmacol, Singapore 117595, Singapore	University of London; King's College London; National University of Singapore; National University of Singapore	Stuerzenbaum, SR (corresponding author), Kings Coll London, Sch Biomed Sci, London, England.	stephen.sturzenbaum@kcl.ac.uk		Arlt, Volker Manfred/0000-0003-4314-9318	King's College London; Ministry of Education, Singapore [MOE2012-T2-2-003]; State of Kuwait; Cancer Research UK; Cancer Research UK [14329] Funding Source: researchfish	King's College London; Ministry of Education, Singapore(Ministry of Education, Singapore); State of Kuwait; Cancer Research UK(Cancer Research UK); Cancer Research UK(Cancer Research UK)	This work was part-funded by King's College London (SRS) and the Ministry of Education, Singapore (grant MOE2012-T2-2-003) (PKM). BQ was supported by a State of Kuwait funded studentship. VMA is supported by Cancer Research UK. The funders had no role in study design, data collection.	Adhikari S, 2008, J CELL MOL MED, V12, P1374, DOI 10.1111/j.1582-4934.2008.00318.x; Arum O, 2007, J GERONTOL A-BIOL, V62, P951, DOI 10.1093/gerona/62.9.951; Baskar R, 2007, FASEB J, V21, P247, DOI 10.1096/fj.06-6255com; Baumbach GL, 2002, CIRC RES, V91, P931, DOI 10.1161/01.RES.0000041408.64867.1D; Bearden SE, 2010, AM J PHYSIOL-HEART C, V299, pH1568, DOI 10.1152/ajpheart.00555.2010; Beyer K, 2004, CURR ALZHEIMER RES, V1, P127, DOI 10.2174/1567205043332243; Brancaleone V, 2008, BRIT J PHARMACOL, V155, P673, DOI 10.1038/bjp.2008.296; C elegans Sequencing Consortium, 1998, SCIENCE, V282, P2012, DOI 10.1126/science.282.5396.2012; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Carson RJ, 2010, EXPERT REV OBSTET GY, V5, P203, DOI [DOI 10.1586/E0G.10.5, 10.1586/eog.10.5]; Chiku T, 2009, J BIOL CHEM, V284, P11601, DOI 10.1074/jbc.M808026200; Cutler RG, 2001, MECH AGEING DEV, V122, P895, DOI 10.1016/S0047-6374(01)00246-9; Distrutti E, 2008, HEPATOLOGY, V47, P659, DOI 10.1002/hep.22037; Fisher CD, 2007, DRUG METAB DISPOS, V35, P995, DOI 10.1124/dmd.106.014340; Fox B, 2012, J CELL MOL MED, V16, P896, DOI 10.1111/j.1582-4934.2011.01357.x; Gems D, 2000, J GERONTOL A-BIOL, V55, pB215, DOI 10.1093/gerona/55.5.B215; Geng B, 2004, BIOCHEM BIOPH RES CO, V318, P756, DOI 10.1016/j.bbrc.2004.04.094; Guzman MA, 2006, HUM MOL GENET, V15, P3168, DOI 10.1093/hmg/ddl393; Harada H, 2007, ECOTOX ENVIRON SAFE, V66, P378, DOI 10.1016/j.ecoenv.2006.02.017; He Xingxuan, 2012, Zhong Nan Da Xue Xue Bao Yi Xue Ban, V37, P109, DOI 10.3969/j.issn.1672-7347.2012.02.001; Jansen WTM, 2002, INFECT IMMUN, V70, P5202, DOI 10.1128/IAI.70.9.5202-5207.2002; Jensen KK, 2011, EUR J PHARMACOL, V650, P86, DOI 10.1016/j.ejphar.2010.09.080; Kabil H, 2011, P NATL ACAD SCI USA, V108, P16831, DOI 10.1073/pnas.1102008108; Kabil O, 2010, J BIOL CHEM, V285, P21903, DOI 10.1074/jbc.R110.128363; Kimura Y, 2004, FASEB J, V18, P1165, DOI 10.1096/fj.04-1815fje; LARSEN PL, 1993, P NATL ACAD SCI USA, V90, P8905, DOI 10.1073/pnas.90.19.8905; Lee ZW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021077; Li L, 2006, CURR OPIN PHARMACOL, V6, P125, DOI 10.1016/j.coph.2005.10.007; Li L, 2012, BIOMETALS, V25, P617, DOI 10.1007/s10534-012-9551-9; Li L, 2008, CIRCULATION, V117, P2351, DOI 10.1161/CIRCULATIONAHA.107.753467; Liang R, 2007, REPROD TOXICOL, V24, P89, DOI 10.1016/j.reprotox.2007.04.002; LITHGOW GJ, 1995, P NATL ACAD SCI USA, V92, P7540, DOI 10.1073/pnas.92.16.7540; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Miller DL, 2007, P NATL ACAD SCI USA, V104, P20618, DOI 10.1073/pnas.0710191104; Miller DL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025476; Murakami S, 1996, GENETICS, V143, P1207; Nuno-Ayala M, 2012, PHYSIOL GENOMICS, V44, P702, DOI 10.1152/physiolgenomics.00189.2010; Oliveira RP, 2009, AGING CELL, V8, P524, DOI 10.1111/j.1474-9726.2009.00501.x; Olshansky SJ, 2006, SCIENTIST, V20, P28; Perry MM, 2011, AM J RESP CELL MOL, V45, P746, DOI 10.1165/rcmb.2010-0304OC; PETERSEN LC, 1977, CAN J BIOCHEM CELL B, V55, P706, DOI 10.1139/o77-102; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Qu K, 2006, STROKE, V37, P889, DOI 10.1161/01.STR.0000204184.34946.41; Saul N, 2011, J NAT PROD, V74, P1713, DOI 10.1021/np200011a; Shen C, 2006, GENETICS, V174, P1205, DOI 10.1534/genetics.106.063594; Singh S, 2009, J BIOL CHEM, V284, P22457, DOI 10.1074/jbc.M109.010868; Smith JV, 2003, J ALZHEIMERS DIS, V5, P287, DOI 10.3233/JAD-2003-5404; Srilatha B, 2009, J SEX MED, V6, P1875, DOI 10.1111/j.1743-6109.2009.01291.x; STIPANUK MH, 1982, BIOCHEM J, V206, P267, DOI 10.1042/bj2060267; Stocker R, 2004, PHYSIOL REV, V84, P1381, DOI 10.1152/physrev.00047.2003; Vozdek R, 2012, BIOCHEM J, V443, P535, DOI 10.1042/BJ20111478; Wang H, 2003, BLOOD, V101, P3901, DOI 10.1182/blood-2002-08-2606; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Whiteman M, 2011, CLIN SCI, V121, P459, DOI 10.1042/CS20110267; Whiteman M, 2010, ANTIOXID REDOX SIGN, V12, P1147, DOI 10.1089/ars.2009.2899; Yan SK, 2006, BIOCHEM BIOPH RES CO, V351, P485, DOI 10.1016/j.bbrc.2006.10.058; Yang GD, 2004, FASEB J, V18, P1782, DOI 10.1096/fj.04-2279fje; Yang GD, 2007, J BIOL CHEM, V282, P16567, DOI 10.1074/jbc.M700605200; Yu Fang, 2010, Beijing Da Xue Xue Bao Yi Xue Ban, V42, P493; Zhang JH, 2010, J PERIODONTAL RES, V45, P71, DOI 10.1111/j.1600-0765.2009.01202.x	60	30	32	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80135	10.1371/journal.pone.0080135	http://dx.doi.org/10.1371/journal.pone.0080135			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260346	Green Published, gold, Green Submitted			2022-12-25	WOS:000327216200106
J	Wernberg, T; Thomsen, MS; Connell, SD; Russell, BD; Waters, JM; Zuccarello, GC; Kraft, GT; Sanderson, C; West, JA; Gurgel, CFD				Wernberg, Thomas; Thomsen, Mads S.; Connell, Sean D.; Russell, Bayden D.; Waters, Jonathan M.; Zuccarello, Giuseppe C.; Kraft, Gerald T.; Sanderson, Craig; West, John A.; Gurgel, Carlos F. D.			The Footprint of Continental-Scale Ocean Currents on the Biogeography of Seaweeds	PLOS ONE			English	Article							EAST AUSTRALIAN CURRENT; LATITUDINAL GRADIENT; BETA DIVERSITY; INTERTIDAL INVERTEBRATES; SPECIES RICHNESS; SUBTIDAL HABITAT; VASCULAR PLANTS; MARINE; PATTERNS; TEMPERATURE	Explaining spatial patterns of biological organisation remains a central challenge for biogeographic studies. In marine systems, large-scale ocean currents can modify broad-scale biological patterns by simultaneously connecting environmental (e.g. temperature, salinity and nutrients) and biological (e.g. amounts and types of dispersed propagules) properties of adjacent and distant regions. For example, steep environmental gradients and highly variable, disrupted flow should lead to heterogeneity in regional communities and high species turnover. In this study, we investigated the possible imprint of the Leeuwin (LC) and East Australia (EAC) Currents on seaweed communities across similar to 7,000 km of coastline in temperate Australia. These currents flow poleward along the west and east coasts of Australia, respectively, but have markedly different characteristics. We tested the hypothesis that, regional seaweed communities show serial change in the direction of current flow and that, because the LC is characterised by a weaker temperature gradient and more un-interrupted along-shore flow compared to the EAC, then coasts influenced by the LC have less variable seaweed communities and lower species turnover across regions than the EAC. This hypothesis was supported. We suggest that this pattern is likely caused by a combination of seaweed temperature tolerances and current-driven dispersal. In conclusion, our findings support the idea that the characteristics of continental-scale currents can influence regional community organisation, and that the coupling of ocean currents and marine biological structure is a general feature that transcends taxa and spatial scales.	[Wernberg, Thomas; Thomsen, Mads S.] Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia; [Wernberg, Thomas; Thomsen, Mads S.] Univ Western Australia, Sch Plant Biol, Perth, WA 6009, Australia; [Thomsen, Mads S.] Univ Canterbury, Sch Biol Sci, Marine Ecol Res Grp, Christchurch 1, New Zealand; [Connell, Sean D.; Russell, Bayden D.; Gurgel, Carlos F. D.] Univ Adelaide, Inst Environm, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Connell, Sean D.; Russell, Bayden D.; Gurgel, Carlos F. D.] Univ Adelaide, Southern Seas Ecol Labs, Sch Earth & Environm Sci, Adelaide, SA, Australia; [Waters, Jonathan M.] Univ Otago, Dept Zool, Dunedin, New Zealand; [Zuccarello, Giuseppe C.] Victoria Univ Wellington, Sch Biol Sci, Wellington, New Zealand; [Kraft, Gerald T.; West, John A.] Univ Melbourne, Sch Bot, Melbourne, Vic, Australia; [Sanderson, Craig] Univ Tasmania, Sch Zool, Hobart, Tas, Australia; [Gurgel, Carlos F. D.] South Australian State Herbarium, Sci Resource Ctr, Dept Environm & Nat Resources, Adelaide, SA, Australia; [Gurgel, Carlos F. D.] South Australian Res & Dev Inst, Adelaide, SA, Australia	University of Western Australia; University of Western Australia; University of Canterbury; University of Adelaide; University of Adelaide; University of Otago; Victoria University Wellington; University of Melbourne; University of Tasmania; South Australian Research & Development Institute (SARDI)	Wernberg, T (corresponding author), Univ Western Australia, UWA Oceans Inst, Perth, WA 6009, Australia.	thomas.wernberg@uwa.edu.au	Wernberg, Thomas/B-4172-2010; Russell, Bayden D./A-9942-2008; Waters, Jon/B-4983-2009; Zuccarello, Giuseppe C./D-8323-2015; Russell, Bayden D./R-9325-2019; Gurgel, Carlos Frederico Deluqui/E-6897-2014; Connell, Sean/A-8874-2008	Wernberg, Thomas/0000-0003-1185-9745; Russell, Bayden D./0000-0003-1282-9978; Waters, Jon/0000-0002-1514-7916; Zuccarello, Giuseppe C./0000-0003-0028-7227; Russell, Bayden D./0000-0003-1282-9978; Gurgel, Carlos Frederico Deluqui/0000-0002-7321-6115; Connell, Sean/0000-0002-5350-6852	Australian Research Council; New Zealand Vegetation Function Network, The Environment Institute of the University of Adelaide	Australian Research Council(Australian Research Council); New Zealand Vegetation Function Network, The Environment Institute of the University of Adelaide	This work was supported by the Australian Research Council and New Zealand Vegetation Function Network, The Environment Institute of the University of Adelaide, and the Australian Research Council linkage, discovery and future fellows grants to TW, SDC, BDR and CFDG. Australian Research Council: http://www.arc.gov.au/. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adey WH, 2001, J PHYCOL, V37, P677, DOI 10.1046/j.1529-8817.2001.00176.x; Airoldi L, 2007, OCEANOGR MAR BIOL, V45, P345; Anderson MJ, 2008, PERMANOVA PRIMER GUI, P214; Ayers KL, 2005, MAR BIOL, V147, P1045, DOI 10.1007/s00227-005-1632-7; Banks SC, 2007, ECOLOGY, V88, P3055, DOI 10.1890/07-0091.1; Belanger CL, 2012, P NATL ACAD SCI USA, V109, P14046, DOI 10.1073/pnas.1212381109; BREEMAN AM, 1988, HELGOLANDER MEERESUN, V42, P199, DOI 10.1007/BF02366043; Broitman BR, 2005, LIMNOL OCEANOGR, V50, P1473, DOI 10.4319/lo.2005.50.5.1473; Buchanan J, 2012, J PHYCOL, V48, P518, DOI 10.1111/j.1529-8817.2012.01167.x; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; CLARKE A, 1993, PALEOBIOLOGY, V19, P499, DOI 10.1017/S0094837300014111; Clarke A, 2000, J ANIM ECOL, V69, P799, DOI 10.1046/j.1365-2656.2000.00440.x; Clarke K, 2006, PRIMER V6 USER MANUA, P190; Coleman MA, 2011, J ECOL, V99, P1026, DOI 10.1111/j.1365-2745.2011.01822.x; Commonwealth of Australia, 2005, NAT MAR BIOR AUSTR; Condie SA, 2011, DEEP-SEA RES PT II, V58, P606, DOI 10.1016/j.dsr2.2010.06.003; Condie SA, 2005, ENVIRON MODELL SOFTW, V20, P1149, DOI 10.1016/j.envsoft.2004.07.005; Connell SD, 2010, P ROYAL SOC B; Connell SD, 2008, J BIOGEOGR, V35, P1608, DOI 10.1111/j.1365-2699.2008.01903.x; Connell SD, 2008, MAR ECOL PROG SER, V360, P63, DOI 10.3354/meps07526; Connolly SR, 2001, ECOLOGY, V82, P1799, DOI 10.1890/0012-9658(2001)082[1799:ALGIRO]2.0.CO;2; Fraser CI, 2011, P ROY SOC B-BIOL SCI, V278, P649, DOI 10.1098/rspb.2010.1117; Fraser CI, 2009, MOL ECOL, V2009; Gaylord B, 2000, AM NAT, V155, P769, DOI 10.1086/303357; Gorman D, 2009, ECOL APPL, V19, P1114, DOI 10.1890/08-0831.1; GUIRY MD, 2013, ALGAEBASE WORLD WIDE; HEDGEPETH JW, 1957, MEMOIRES GEOLOGICAL, P359; HUBBS CL, 1948, J MAR RES, V7, P459; KENDRICK GA, 1991, MAR ECOL PROG SER, V79, P133, DOI 10.3354/meps079133; Luning K, 1990, SEAWEEDS THEIR ENV B, P600; Menge BA, 2003, P NATL ACAD SCI USA, V100, P12229, DOI 10.1073/pnas.1534875100; Nekola JC, 1999, J BIOGEOGR, V26, P867, DOI 10.1046/j.1365-2699.1999.00305.x; Nikula R, 2010, MAR ECOL PROG SER, V405, P221, DOI 10.3354/meps08523; NORTON TA, 1992, BRIT PHYCOL J, V27, P293, DOI 10.1080/00071619200650271; NORTON TA, 1980, BRIT PHYCOL J, V15, P197; O'Hara T, 2000, PATTERNS TEMPERATE M; O'Hara TD, 2000, J BIOGEOGR, V27, P1321, DOI 10.1046/j.1365-2699.2000.00499.x; Phillips JA, 2001, BIODIVERS CONSERV, V10, P1555, DOI 10.1023/A:1011813627613; Phillips JA, 2011, CONSERV BIOL, V25, P913, DOI 10.1111/j.1523-1739.2011.01727.x; PIELOU EC, 1977, J BIOGEOGR, V4, P299, DOI 10.2307/3038189; PIELOU EC, 1978, J BIOGEOGR, V5, P227, DOI 10.2307/3038038; Qian H, 2007, ECOL LETT, V10, P737, DOI 10.1111/j.1461-0248.2007.01066.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P327, DOI 10.1111/j.1466-8238.2009.00450.x; Qian H, 2009, GLOBAL ECOL BIOGEOGR, V18, P111, DOI 10.1111/j.1466-8238.2008.00415.x; Ridgway KR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001921; Ridgway KR, 2003, PROG OCEANOGR, V56, P189, DOI 10.1016/S0079-6611(03)00004-1; Roughan M, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2003JC001833; Roy K, 1998, P NATL ACAD SCI USA, V95, P3699, DOI 10.1073/pnas.95.7.3699; Russell BD, 2009, GLOBAL CHANGE BIOL, V15, P2153, DOI 10.1111/j.1365-2486.2009.01886.x; Schils T, 2006, J PHYCOL, V42, P749, DOI 10.1111/j.1529-8817.2006.00242.x; Shaffer HB, 1998, TRENDS ECOL EVOL, V13, P27, DOI 10.1016/S0169-5347(97)01177-4; Smale DA, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2829; Smale DA, 2010, J EXP MAR BIOL ECOL, V384, P76, DOI 10.1016/j.jembe.2009.11.013; Staehr PA, 2009, J PHYCOL, V45, P91, DOI 10.1111/j.1529-8817.2008.00635.x; Suthers Iain M., 2007, P199; Tittensor DP, 2010, NATURE, V466, P1098, DOI 10.1038/nature09329; VANDENHOEK C, 1987, HELGOLANDER MEERESUN, V41, P261; VANDENHOEK C, 1982, HELGOLANDER MEERESUN, V35, P153; Virola T, 2001, FRESHWATER BIOL, V46, P1471, DOI 10.1046/j.1365-2427.2001.00767.x; von Humboldt A., 1805, ESSAI GEOGRAPHIE PLA; Wallace AR, 1876, GEORGRAPHICAL DISTRI; Waters JM, 2008, DIVERS DISTRIB, V14, P692, DOI 10.1111/j.1472-4642.2008.00481.x; Waters JM, 2010, AUSTRAL ECOL, V35, P988, DOI 10.1111/j.1442-9993.2010.02114.x; Watson JR, 2011, ECOLOGY, V92, P1193, DOI 10.1890/10-1436.1; Wernberg T., 2011, J EXP MAR BIOL ECOL, V400; Wernberg T, 2011, CURR BIOL, V21, P1828, DOI 10.1016/j.cub.2011.09.028; Wernberg T, 2010, ECOL LETT, V13, P685, DOI 10.1111/j.1461-0248.2010.01466.x; Womersley H.B.S., 1990, P367	68	27	27	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 8	2013	8	11							e80168	10.1371/journal.pone.0080168	http://dx.doi.org/10.1371/journal.pone.0080168			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255CG	24260352	Green Published, gold			2022-12-25	WOS:000327216200107
J	Li, YJ; Kakinami, C; Li, Q; Yang, BJ; Li, HW				Li, Yujia; Kakinami, Cherie; Li, Qi; Yang, Baojun; Li, Hongwei			Human Apolipoprotein A-I Is Associated with Dengue Virus and Enhances Virus Infection through SR-BI	PLOS ONE			English	Article							HEPATITIS-C VIRUS; HIGH-DENSITY-LIPOPROTEINS; ACUTE-PHASE RESPONSE; HEMORRHAGIC-FEVER; CHOLESTEROL EFFLUX; ENTRY; RECEPTOR; CELLS; PROTEIN; SERUM	Diseases caused by dengue virus (DV) infection vary in severity, with symptoms ranging from mild fever to life threatening dengue hemorrhage fever (DHF) and dengue shock syndrome (DSS). Clinical studies have shown that significant decrease in the level of lipoproteins is correlated with severe illness in DHF/DSS patients. Available evidence also indicates that lipoproteins including high-density lipoprotein (HDL) and low-density lipoprotein (LDL) are able to facilitate cell entry of HCV or other flaviviruses via corresponding lipoprotein receptors. In this study, we found that pre-incubation of DV with human serum leads to an enhanced DV infectivity in various types of cells. Such enhancement could be due to interactions between serum components and DV particles. Through co-immunoprecipitation we revealed that apolipoprotein A-I (ApoAI), the major protein component in HDL, is associated with DV particles and is able to promote DV infection. Based on that observation, we further found that siRNA knockdown of the scavenger receptor class B type I (SR-BI), the cell receptor of ApoA-I, abolished the activity of ApoA-I in enhancement of DV infection. This suggests that ApoA-I bridges DV particles and cell receptor SR-BI and facilitates entry of DV into cells. FACS analysis of cell surface dengue antigen after virus absorption further confirmed that ApoA-I enhances DV infection via promoting initial attachment of the virus to cells. These findings illustrate a novel entry route of DV into cells, which may provide insights into the functional importance of lipoproteins in dengue pathogenesis.	[Li, Yujia; Kakinami, Cherie; Li, Qi; Yang, Baojun; Li, Hongwei] Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA	University of Hawaii System; University of Hawaii Manoa	Li, HW (corresponding author), Univ Hawaii Manoa, Dept Microbiol, Honolulu, HI 96822 USA.	hli@hawaii.edu			National Institute of General Medical Sciences of the National Institutes of Health [P20GM103516]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P20GM103516] Funding Source: NIH RePORTER	National Institute of General Medical Sciences of the National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This research was supported in part by grant number P20GM103516 from the National Institute of General Medical Sciences of the National Institutes of Health. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. No additional external funding was received for this study.	Agnello V, 1999, P NATL ACAD SCI USA, V96, P12766, DOI 10.1073/pnas.96.22.12766; Albuquerque LM, 2009, J PROTEOME RES, V8, P5431, DOI 10.1021/pr900236f; Andre P, 2002, J VIROL, V76, P6919, DOI 10.1128/JVI.76.14.6919-6928.2002; Andreo U, 2007, CELL MICROBIOL, V9, P2445, DOI 10.1111/j.1462-5822.2007.00972.x; Burger Danielle, 2002, Autoimmunity Reviews, V1, P111, DOI 10.1016/S1568-9972(01)00018-0; Cabana VG, 1997, PEDIATR RES, V42, P651, DOI 10.1203/00006450-199711000-00017; COETZEE GA, 1986, J BIOL CHEM, V261, P9644; Dreux M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000310; Frank PG, 2000, J LIPID RES, V41, P853; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; Guzman MG, 2010, NAT REV MICROBIOL, pS7, DOI 10.1038/nrmicro2460; HASE T, 1989, ARCH VIROL, V104, P129, DOI 10.1007/BF01313814; Hidari Kazuya I P J, 2011, Trop Med Health, V39, P37, DOI 10.2149/tmh.2011-S03; Kelley JF, 2012, VIROLOGY, V422, P326, DOI 10.1016/j.virol.2011.10.030; Kisilevsky R, 2012, AMYLOID, V19, P5, DOI 10.3109/13506129.2011.654294; Kiss RS, 2005, J LIPID RES, V46, P1877, DOI 10.1194/jlr.M400482-JLR200; Krieger M, 1999, ANNU REV BIOCHEM, V68, P523, DOI 10.1146/annurev.biochem.68.1.523; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Kuadkitkan A, 2010, VIROLOGY, V406, P149, DOI 10.1016/j.virol.2010.07.015; Lim HY, 1999, ARCH VIROL, V144, P989, DOI 10.1007/s007050050561; Liu SF, 2012, HEPATOLOGY, V56, P484, DOI 10.1002/hep.25665; Lund-Katz S, 2010, SUBCELL BIOCHEM, V51, P183, DOI 10.1007/978-90-481-8622-8_7; Maillard P, 2006, FASEB J, V20, P735, DOI 10.1096/fj.05-4728fje; Marcel YL, 2003, CURR OPIN LIPIDOL, V14, P151, DOI 10.1097/00041433-200304000-00006; Nielsen SU, 2006, J VIROL, V80, P2418, DOI 10.1128/JVI.80.5.2418-2428.2006; Pagler TA, 2006, J BIOL CHEM, V281, P11193, DOI 10.1074/jbc.M510261200; Rhainds D, 2004, INT J BIOCHEM CELL B, V36, P39, DOI 10.1016/S1357-2725(03)00173-0; Rothblat GH, 2010, CURR OPIN LIPIDOL, V21, P229, DOI 10.1097/MOL.0b013e328338472d; Salas-Benito J, 2007, AM J TROP MED HYG, V77, P283, DOI 10.4269/ajtmh.2007.77.283; Schmitz J, 2011, VACCINE, V29, P7276, DOI 10.1016/j.vaccine.2011.07.017; Se-Thoe SY, 2000, J MED VIROL, V62, P364, DOI 10.1002/1096-9071(200011)62:3&lt;364::AID-JMV9&gt;3.0.CO;2-S; Singh IP, 1999, ANTIVIR RES, V42, P211, DOI 10.1016/S0166-3542(99)00032-7; van Gorp ECM, 2002, CLIN INFECT DIS, V34, P1150, DOI 10.1086/339539; Van Lenten BJ, 2006, ARTERIOSCL THROM VAS, V26, P1687, DOI 10.1161/01.ATV.0000232522.47018.a6; Voisset C, 2005, J BIOL CHEM, V280, P7793, DOI 10.1074/jbc.M411600200; Voisset C, 2006, J GEN VIROL, V87, P2577, DOI 10.1099/vir.0.81932-0; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Zhu XW, 2012, ANNU REV NUTR, V32, P161, DOI 10.1146/annurev-nutr-071811-150709	38	423	429	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 24	2013	8	7							e70390	10.1371/journal.pone.0070390	http://dx.doi.org/10.1371/journal.pone.0070390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	188BY	24260400	gold, Green Submitted, Green Published			2022-12-25	WOS:000322167900123
J	Zheng, YC; Lu, YL; Wang, JF; Yang, LF; Pan, CY; Huang, Y				Zheng, Yongchen; Lu, Yingli; Wang, Jinfeng; Yang, Longfei; Pan, Chenyu; Huang, Ying			Probiotic Properties of Lactobacillus Strains Isolated from Tibetan Kefir Grains	PLOS ONE			English	Article							BILE-SALT HYDROLASE; LACTIC-ACID BACTERIA; IN-VITRO; DAIRY-PRODUCTS; CACO-2 CELLS; MILK-KEFIR; RATS; PLANTARUM; ACIDOPHILUS; ADHESION	The objective of this study was to evaluate the functional properties of lactic acid bacteria (LAB) isolated from Tibetan kefir grains. Three Lactobacillus isolates identified as Lactobacillus acidophilus LA15, Lactobacillus plantarum B23 and Lactobacillus kefiri D17 that showed resistance to acid and bile salts were selected for further evaluation of their probiotic properties. The 3 selected strains expressed high in vitro adherence to Caco-2 cells. They were sensitive to gentamicin, erythromycin and chloramphenicol and resistant to vancomycin with MIC values of 26 mg/ml. All 3 strains showed potential bile salt hydrolase (BSH) activity, cholesterol assimilation and cholesterol co-precipitation ability. Additionally, the potential effect of these strains on plasma cholesterol levels was evaluated in Sprague-Dawley (SD) rats. Rats in 4 treatment groups were fed the following experimental diets for 4 weeks: a high-cholesterol diet, a high-cholesterol diet plus LA15, a high-cholesterol diet plus B23 or a high-cholesterol diet plus D17. The total cholesterol, triglyceride and low-density lipoprotein cholesterol levels in the serum were significantly (P<0.05) decreased in the LAB-treated rats compared with rats fed a high-cholesterol diet without LAB supplementation. The high-density lipoprotein cholesterol levels in groups B23 and D17 were significantly (P<0.05) higher than those in the control and LA15 groups. Additionally, both fecal cholesterol and bile acid levels were significantly (P<0.05) increased after LAB administration. Fecal lactobacilli counts were significantly (P<0.05) higher in the LAB treatment groups than in the control groups. Furthermore, the 3 strains were detected in the rat small intestine, colon and feces during the feeding trial. The bacteria levels remained high even after the LAB administration had been stopped for 2 weeks. These results suggest that these strains may be used in the future as probiotic starter cultures for manufacturing novel fermented foods.	[Zheng, Yongchen; Lu, Yingli; Wang, Jinfeng; Yang, Longfei; Pan, Chenyu; Huang, Ying] Jilin Univ, Hosp 2, Cent Res Lab, Changchun 130023, Peoples R China	Jilin University	Huang, Y (corresponding author), Jilin Univ, Hosp 2, Cent Res Lab, Changchun 130023, Peoples R China.	yinghuang@jlu.edu.cn	Yang, Longfei/B-4223-2018	Yang, Longfei/0000-0003-4153-9670; Ma, Aiguo/0000-0001-9507-8844	National Natural Science Foundation of China [31100022]; Program of Science and Technology Development Plan of Jilin Province [20110737]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Program of Science and Technology Development Plan of Jilin Province	This work was supported by the National Natural Science Foundation of China (No. 31100022) and the Program of Science and Technology Development Plan of Jilin Province (No. 20110737). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	AGERBAEK M, 1995, EUR J CLIN NUTR, V49, P346; Alander M, 1999, APPL ENVIRON MICROB, V65, P351; ANGULO L, 1993, J DAIRY RES, V60, P263, DOI 10.1017/S002202990002759X; Bao Y, 2010, FOOD CONTROL, V21, P695, DOI 10.1016/j.foodcont.2009.10.010; Begley M, 2006, APPL ENVIRON MICROB, V72, P1729, DOI 10.1128/AEM.72.3.1729-1738.2006; BernetCamard MF, 1997, APPL ENVIRON MICROB, V63, P2747, DOI 10.1128/AEM.63.7.2747-2753.1997; Bories G, 2008, EFSA J, V6, DOI 10.2903/j.efsa.2008.732; Charteris WP, 1998, J APPL MICROBIOL, V84, P759; Chen YP, 2012, J DAIRY SCI, V95, P63, DOI 10.3168/jds.2011-4696; COCONNIER MH, 1993, FEMS MICROBIOL LETT, V110, P299, DOI [10.1111/j.1574-6968.1993.tb06339.x, 10.1016/0378-1097(93)90119-M]; CROCIANI J, 1995, LETT APPL MICROBIOL, V21, P146, DOI 10.1111/j.1472-765X.1995.tb01027.x; DASHKEVICZ MP, 1989, APPL ENVIRON MICROB, V55, P11, DOI 10.1128/AEM.55.1.11-16.1989; Diniz RO, 2003, PHARMACOL RES, V47, P49, DOI 10.1016/S1043-6618(02)00240-2; DOWELL VR, 1998, MEDIA ISOLATION CHAR; Dunne C, 2001, AM J CLIN NUTR, V73, p386S, DOI 10.1093/ajcn/73.2.386s; Eckburg PB, 2005, SCIENCE, V308, P1635, DOI 10.1126/science.1110591; EFSA-FEEDAP Panel,, 2005, EFSA J, V3, P1, DOI [10.2903/j.efsa.2005.223, DOI 10.2903/J.EFSA.2005.223]; EZAKI T, 1989, INT J SYST BACTERIOL, V39, P224, DOI 10.1099/00207713-39-3-224; FOLCH J, 1957, J BIOL CHEM, V226, P497; Garrote GL, 2001, J DAIRY RES, V68, P639, DOI 10.1017/S0022029901005210; Gevers D, 2003, APPL ENVIRON MICROB, V69, P1270, DOI 10.1128/AEM.69.2.1270-1275.2003; GILLILAND SE, 1990, J DAIRY SCI, V73, P905, DOI 10.3168/jds.S0022-0302(90)78747-4; Hamon E, 2011, BMC MICROBIOL, V11, DOI 10.1186/1471-2180-11-63; Hashimoto Hideo, 1999, Animal Science Journal, V70, P90; Huang Y, 2013, J DAIRY SCI, V96, P2816, DOI 10.3168/jds.2012-6371; Jacobsen CN, 1999, APPL ENVIRON MICROB, V65, P4949; Klein G, 2000, J APPL MICROBIOL, V89, P815, DOI 10.1046/j.1365-2672.2000.01187.x; Klein G, 1998, INT J FOOD MICROBIOL, V41, P103, DOI 10.1016/S0168-1605(98)00049-X; Kratz M, 2002, EUR J LIPID SCI TECH, V104, P300, DOI 10.1002/1438-9312(200205)104:5<300::AID-EJLT300>3.0.CO;2-2; Kumar R, 2011, BRIT J NUTR, V105, P561, DOI 10.1017/S0007114510003740; Lambert JM, 2008, APPL ENVIRON MICROB, V74, P4719, DOI 10.1128/AEM.00137-08; Lardizabal JA, 2011, CARDIOL CLIN, V29, P87, DOI 10.1016/j.ccl.2010.10.002; Liong MT, 2006, J DAIRY SCI, V89, P1390, DOI 10.3168/jds.S0022-0302(06)72207-X; Liu JR, 2006, BRIT J NUTR, V95, P939, DOI 10.1079/BJN20061752; Maietti L, 2007, SYST APPL MICROBIOL, V30, P509, DOI 10.1016/j.syapm.2007.05.002; Mathara JM, 2008, INT J FOOD MICROBIOL, V126, P57, DOI 10.1016/j.ijfoodmicro.2008.04.027; Minelli EB, 2004, INT DAIRY J, V14, P723, DOI 10.1016/j.idairyj.2004.01.007; Ouwehand AC, 2001, INT J FOOD MICROBIOL, V64, P119, DOI 10.1016/S0168-1605(00)00440-2; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Rossetti L, 2009, INT J FOOD MICROBIOL, V130, P70, DOI 10.1016/j.ijfoodmicro.2009.01.003; Sarkar S., 2003, Nutrition & Food Science, V33, P273, DOI 10.1108/00346650310507109; SCHIFFRIN EJ, 1995, J DAIRY SCI, V78, P491, DOI 10.3168/jds.S0022-0302(95)76659-0; Silva KR, 2009, APPL BIOCHEM BIOTECH, V152, P316, DOI 10.1007/s12010-008-8303-3; Tabuchi M, 2004, MILCHWISSENSCHAFT, V59, P249; Taranto MP, 1998, J DAIRY SCI, V81, P2336, DOI 10.3168/jds.S0022-0302(98)70123-7; Urdaneta E, 2007, NUTR RES, V27, P653, DOI 10.1016/j.nutres.2007.08.002; Vinderola CG, 2005, J DAIRY RES, V72, P195, DOI 10.1017/S0022029905000828; Wang J, 2012, J DAIRY SCI, V95, P1645, DOI 10.3168/jds.2011-4768; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Zavaglia AG, 1998, J FOOD PROTECT, V61, P865, DOI 10.4315/0362-028X-61.7.865; Zhou JZ, 2009, FOOD MICROBIOL, V26, P770, DOI 10.1016/j.fm.2009.04.009	51	125	139	2	84	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69868	10.1371/journal.pone.0069868	http://dx.doi.org/10.1371/journal.pone.0069868			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23894554	Green Published, gold, Green Submitted			2022-12-25	WOS:000322132100083
J	Moreira, GF; Batista, ESD; Campos, HBN; Lemos, RE; Ferreira, MD				Moreira, Grazielle Furtado; de Paula Batista, Elder Simoes; Neves Campos, Henrique Borges; Lemos, Raphael Emilio; Ferreira, Marcelo da Costa			Spray Nozzles, Pressures, Additives and Stirring Time on Viability and Pathogenicity of Entomopathogenic Nematodes (Nematoda: Rhabditida) for Greenhouses	PLOS ONE			English	Article							STEINERNEMA-FELTIAE; HETERORHABDITIDAE; INFECTIVITY; LARVAE	The objective of this study was to evaluate different strategies for the application of entomopathogenic nematodes (EPN). Three different models of spray nozzles with air induction (AI 11003, TTI 11003 and AD-IA 11004), three spray pressures (207, 413 and 720 kPa), four different additives for tank mixtures (cane molasses, mineral oil, vegetable oil and glycerin) and the influence of tank mixture stirring time were all evaluated for their effect on EPN (Steinernema feltiae) viability and pathogenicity. The different nozzles, at pressures of up to 620 kPa, were found to be compatible with S. feltiae. Vegetable oil, mineral oil and molasses were found to be compatible adjuvants for S. feltiae, and stirring in a motorized backpack sprayer for 30 minutes did not impact the viability or pathogenicity of this nematode. Appropriate techniques for the application of nematodes with backpack sprayers are discussed.	[Moreira, Grazielle Furtado; de Paula Batista, Elder Simoes; Neves Campos, Henrique Borges; Lemos, Raphael Emilio; Ferreira, Marcelo da Costa] Univ Estadual Paulista UNESP, Dept Fitossanidade, Sao Paulo, Brazil	Universidade Estadual Paulista	Moreira, GF (corresponding author), Univ Estadual Paulista UNESP, Dept Fitossanidade, Jaboticabal Campus, Sao Paulo, Brazil.	grabiologia@yahoo.com.br	C, Ferreira M/C-6165-2012; Batista, Elder/D-3077-2014; McBride, Alan/D-4106-2012	C, Ferreira M/0000-0002-0159-7422; Batista, Elder/0000-0003-2794-0468; McBride, Alan/0000-0001-9682-540X				Adams Byron J., 2002, P1, DOI 10.1079/9780851995670.0001; Andalo V., 2009, Nematologia Mediterranea, V37, P11; Cunha J.P.A.R., 2003, Planta daninha, V21, P325, DOI 10.1590/S0100-83582003000200019; Cunha JPAR, 2010, PLANTA DANINHA, V28, P1153, DOI 10.1590/S0100-83582010000500023; Da Camara FT, 2008, ENG AGR-JABOTICABAL, V28, P740, DOI 10.1590/S0100-69162008000400014; DUTKY SR, 1964, J INSECT PATHOL, V6, P417; Fernandes Ana P., 2007, Eng. Agríc., V27, P728, DOI 10.1590/S0100-69162007000400016; Ferraz L.C.C.B, 2008, CONTROLE MICROBIANO, V14, P171; Ferraz LCCB, 1998, CONTROLE MICROBIANO, P541; Fife JP, 2007, APPL ENG AGRIC, V23, P405; Fife JP, 2005, T ASAE, V48, P45, DOI 10.13031/2013.17939; Fife JP, 2004, BIOTECHNOL BIOENG, V86, P96, DOI 10.1002/bit.10879; Fife JP, 2003, BIOL CONTROL, V27, P65, DOI 10.1016/S1049-9644(02)00183-4; Garcia Luiz C., 2005, Eng. Agríc., V25, P783; Garcia LC, 2008, NEOTROP ENTOMOL, V37, P305, DOI 10.1590/S1519-566X2008000300010; Gaugler R., 2002, Entomopathogenic nematology, P289, DOI 10.1079/9780851995670.0289; Grewal P. S., 2002, Entomopathogenic nematology, P265, DOI 10.1079/9780851995670.0265; Lara JC, 2008, SCI AGR, V65, P433, DOI 10.1590/S0103-90162008000400017; Mahmoud M. F., 2007, Nematologia Mediterranea, V35, P221; Matthews G. A., 2000, PESTICIDE APPL METHO, V3; Miller P.C.H., 2008, 22 ILASS EUROPE; Molina Acevedo Juan Pablo, 2001, Revista Colombiana de Entomologia, V27, P73; Nilsson U, 1999, CROP PROT, V18, P53, DOI 10.1016/S0261-2194(98)00095-7; Parra JRP, 1998, CONTROLE MICROBIANO, P1015; Queiroz AA, 2008, BIOSCI J, V24, P8; Scheepmaker JWA, 1998, BIOCONTROL, V43, P201, DOI 10.1023/A:1009954401065; Susurluk IA, 2011, TURK J AGRIC FOR, V35, P413, DOI 10.3906/tar-1002-715; WHITE G. F., 1927, SCIENCE, V66, P302, DOI 10.1126/science.66.1709.302-a	28	13	16	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUN 6	2013	8	6							e65759	10.1371/journal.pone.0065759	http://dx.doi.org/10.1371/journal.pone.0065759			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	173SK	24260572	Green Submitted, gold, Green Published			2022-12-25	WOS:000321099000103
J	Chen, YX; Zhu, LQ; Chen, Z				Chen, Yongxiang; Zhu, Liqi; Chen, Zhe			Family Income Affects Children's Altruistic Behavior in the Dictator Game	PLOS ONE			English	Article							PROSOCIAL BEHAVIOR; CATEGORIZATION; EVOLUTION	This study aimed to examine how family income and social distance influence young rural Chinese children's altruistic behavior in the dictator game (DG). A total of 469 four-year-old children from eight rural areas in China, including many children left behind by parents who had migrated to urban areas for work, played the DG. Stickers comprised the resource, while recipients in the game were assumed to be either their friends or strangers, with the social distance (i.e., strangers compared to friends) as a between-subjects variable. Children donated significantly more stickers to their friends than to strangers. Moreover, children from lower income families donated more stickers than children from higher income families. However, no gender and parental migrant status differences in children's prosocial behaviors were evident in this sample. Findings of this study suggest that children's altruistic behaviours to peers are influenced by family characteristics since preschool age. The probable influence of local socialization practices on development and the possible adaptive significance were discussed.	[Chen, Yongxiang; Zhu, Liqi] Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China; [Chen, Yongxiang] Univ Chinese Acad Sci, Beijing, Peoples R China; [Chen, Zhe] Univ Calif Davis, Dept Human & Community Dev, Davis, CA 95616 USA	Chinese Academy of Sciences; Institute of Psychology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; University of California System; University of California Davis	Zhu, LQ (corresponding author), Chinese Acad Sci, Inst Psychol, Key Lab Behav Sci, Beijing 100101, Peoples R China.	zhulq@psych.ac.cn		Liu, Zhi hao/0000-0002-1583-5057; Migliaccio, Antimo/0000-0002-4197-2055; mo, zengnan/0000-0002-3047-3138	Chinese Academy of Sciences [KJZD-EW-L04, Y1CX012Y01]; 973 program [2010CB8339004]; National Science Foundation of China [30970911]	Chinese Academy of Sciences(Chinese Academy of Sciences); 973 program(National Basic Research Program of China); National Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was supported by Chinese Academy of Sciences (KJZD-EW-L04 and Y1CX012Y01), the 973 program(2010CB8339004) and National Science Foundation of China (30970911). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	ALLEN VL, 1975, J PERS SOC PSYCHOL, V32, P971, DOI 10.1037/0022-3514.32.6.971; Andreoni J, 2001, Q J ECON, V116, P293, DOI 10.1162/003355301556419; Asis, 2006, ASIAN POPULATION STU, V2, P45, DOI [10.1080/17441730600700556, DOI 10.1080/17441730600700556]; Ben-Ner A, 2009, J ECON BEHAV ORGAN, V72, P153, DOI 10.1016/j.jebo.2009.05.007; Benenson JF, 2007, EVOL HUM BEHAV, V28, P168, DOI 10.1016/j.evolhumbehav.2006.10.003; Blake PR, 2010, EVOL HUM BEHAV, V31, P210, DOI 10.1016/j.evolhumbehav.2009.06.012; Chu SM, 2012, PERS INDIV DIFFER, V52, P691, DOI 10.1016/j.paid.2011.12.029; De Dreu CKW, 2010, SCIENCE, V328, P1408, DOI 10.1126/science.1189047; Efferson C, 2008, SCIENCE, V321, P1844, DOI 10.1126/science.1155805; ENGEL C, 2010, WORKING PAPER SERIES, P1; *FED CWS, 2008, NAT SURV LEFT BEH CH; Fehr E, 2008, NATURE, V454, P1079, DOI 10.1038/nature07155; Friesen J, 2012, J ECON PSYCHOL, V33, P1156, DOI 10.1016/j.joep.2012.08.003; Froiland JM, 2013, SCHOOL PSYCHOL INT, V34, P33, DOI 10.1177/0143034312454361; Fujisawa KK, 2008, INT J BEHAV DEV, V32, P89, DOI 10.1177/0165025407084055; Gueguen N, 2012, SWISS J PSYCHOL, V71, P157, DOI 10.1024/1421-0185/a000083; Gummerum M, 2010, J ECON PSYCHOL, V31, P25, DOI 10.1016/j.joep.2009.09.002; Harbaugh WT, 2007, J ECON PSYCHOL, V28, P127, DOI 10.1016/j.joep.2006.03.005; Henrich J, 2005, BEHAV BRAIN SCI, V28, P795, DOI 10.1017/S0140525X05000142; Henrich J, 2006, SCIENCE, V312, P1767, DOI 10.1126/science.1127333; Hesketh T, 2011, SOC PSYCH PSYCH EPID, V46, P733, DOI 10.1007/s00127-010-0240-0; HOFFMAN ML, 1975, J PERS SOC PSYCHOL, V31, P937, DOI 10.1037/h0076825; JIAO SL, 1986, CHILD DEV, V57, P357, DOI 10.2307/1130591; Knafo A, 2011, DEV PSYCHOPATHOL, V23, P53, DOI 10.1017/S0954579410000647; Kwan YK, 2009, CHILD INDIC RES, V2, P375, DOI 10.1007/s12187-009-9041-y; LI JL, 1995, POPUL DEV REV, V21, P563, DOI 10.2307/2137750; Milonoff M, 2012, ANN ZOOL FENN, V49, P378, DOI 10.5735/086.049.0512; Ng R, 2011, DEV PSYCHOL, V47, P1230, DOI 10.1037/a0024923; Okasha S, 2010, NATURE, V467, P653, DOI 10.1038/467653a; Rachlin H, 2008, BEHAV PROCESS, V79, P120, DOI 10.1016/j.beproc.2008.06.002; Rao LL, 2011, EVOL HUM BEHAV, V32, P63, DOI 10.1016/j.evolhumbehav.2010.07.002; Rochat P, 2009, J CROSS CULT PSYCHOL, V40, P416, DOI 10.1177/0022022109332844; Rutte C, 2009, CURR SCI INDIA, V97, P1573; Shen JP, 1999, J PSYCHOL, V133, P115, DOI 10.1080/00223989909599726; TAJFEL H, 1971, EUR J SOC PSYCHOL, V1, P149, DOI 10.1002/ejsp.2420010202; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Wang Y, 2009, J AM ACAD CHILD PSY, V48, P1137, DOI 10.1097/CHI.0b013e3181bc72f8; Wen M, 2012, CHILD DEV, V83, P120, DOI 10.1111/j.1467-8624.2011.01698.x; YU J, 2010, DEV CHILDRENS FAIR B; Zheng HM, 2010, NEUROPSYCHOLOGIA, V48, P3198, DOI 10.1016/j.neuropsychologia.2010.06.031; Zhou F., 2006, POPULATION J, V3, P60	41	92	96	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 12	2013	8	11							e80419	10.1371/journal.pone.0080419	http://dx.doi.org/10.1371/journal.pone.0080419			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	255PK	24260499	Green Published, Green Submitted, gold			2022-12-25	WOS:000327252100156
J	Chen, Y; Xin, XX; Li, J; Xu, JF; Yu, XX; Li, TY; Mo, ZN; Hu, YL				Chen, Yang; Xin, Xianxiang; Li, Jie; Xu, Jianfeng; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan; Hu, Yanling			RTK/ERK Pathway under Natural Selection Associated with Prostate Cancer	PLOS ONE			English	Article							FOCAL ADHESION KINASE; POSITIVE SELECTION; ACQUIRED-RESISTANCE; CELL-MIGRATION; GENOME; STATISTICS; PROTEIN; MUTATIONS; GENES; EGFR	Prostate cancer (PCa) is a global disease causing large numbers of deaths every year. Recent studies have indicated the RTK/ERK pathway might be a key pathway in the development of PCa. However, the exact association and evolution-based mechanism remain unclear. This study was conducted by combining genotypic and phenotypic data from the Chinese Consortium for Prostate Cancer Genetics (ChinaPCa) with related databases such as the HapMap Project and Genevar. In this analysis, expression of quantitative trait loci (eQTLs) analysis, natural selection and gene-based pathway analysis were involved. The pathway analysis confirmed the positive relationship between PCa risk and several key genes. In addition, combined with the natural selection, it seems that 4 genes (EGFR, ERBB2, PTK2, and RAF1) with five SNPs (rs11238349, rs17172438, rs984654, rs11773818, and rs17172432) especially rs17172432, might be pivotal factors in the development of PCa. The results indicate that the RTK/ERK pathway under natural selection is a key link in PCa risk. The joint effect of the genes and loci with positive selection might be one reason for the development of PCa. Dealing with all the factors simultaneously might give insight into prevention and aid in predicting the success of potential therapies for PCa.	[Chen, Yang; Xin, Xianxiang; Li, Jie; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan; Hu, Yanling] Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China; [Xin, Xianxiang; Hu, Yanling] Guangxi Med Univ, Med Res Ctr, Nanning, Guangxi, Peoples R China; [Chen, Yang; Yu, Xiaoxiang; Li, Tianyu; Mo, Zengnan] Guangxi Med Univ, Affiliated Hosp 1, Dept Urol & Nephrol, Nanning, Peoples R China; [Yu, Xiaoxiang] 303rd Hosp Chinese Peoples Liberat Army, Dept Urol, Nanning, Guangxi Zhuang, Peoples R China; [Li, Jie] Guangxi Med Univ, Affiliated Hosp 1, Res Ctr Guangxi Reprod Med, Nanning, Guangxi Zhuang, Peoples R China; [Xu, Jianfeng] Fudan Univ, Huashan Hosp, Fudan Inst Urol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, Fudan Ctr Genet Epidemiol, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Fudan Univ, Sch Life Sci, State Key Lab Genet Engn, Shanghai 200433, Peoples R China; [Xu, Jianfeng] Wake Forest Univ, Bowman Gray Sch Med, Ctr Canc Genom, Winston Salem, NC USA	Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Guangxi Medical University; Fudan University; Fudan University; Fudan University; Wake Forest University; Wake Forest Baptist Medical Center	Mo, ZN (corresponding author), Guangxi Med Univ, Ctr Genom & Personalized Med, Nanning, Guangxi Zhuang, Peoples R China.	zengnanmo@hotmail.com; ylhupost@163.com		Liu, Zhi hao/0000-0002-1583-5057; Migliaccio, Antimo/0000-0002-4197-2055; mo, zengnan/0000-0002-3047-3138	National Program on Key Basic Research Project (973 Program) [2012CB518303]; National Natural Science Foundation of China [81060213, 81272853]; Guangxi Natural Science Foundation [2011GXNSFB018100]; Postdoctoral Sustentation Fund of China [2012M511886]	National Program on Key Basic Research Project (973 Program)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Guangxi Natural Science Foundation(National Natural Science Foundation of Guangxi Province); Postdoctoral Sustentation Fund of China	This study was supported by grants from National Program on Key Basic Research Project (973 Program) (2012CB518303), the National Natural Science Foundation of China (81060213, 81272853), Guangxi Natural Science Foundation (2011GXNSFB018100) and Postdoctoral Sustentation Fund of China (2012M511886). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Acuna-Alonzo V, 2010, HUM MOL GENET, V19, P2877, DOI 10.1093/hmg/ddq173; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arteaga CL, 2002, SEMIN ONCOL, V29, P4, DOI 10.1053/sonc.2002.34047; Burris HA, 2013, CANCER CHEMOTH PHARM, V71, P829, DOI 10.1007/s00280-012-2043-3; Caraglia M, 2007, J CELL PHYSIOL, V211, P533, DOI 10.1002/jcp.20960; Chen LQ, 2011, CLIN CANCER RES, V17, P6218, DOI 10.1158/1078-0432.CCR-11-1548; Choi BK, 2012, CANCER MED-US, V1, P28, DOI 10.1002/cam4.10; Dong LM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004895; Dudbridge F, 2003, GENET EPIDEMIOL, V25, P360, DOI 10.1002/gepi.10264; Emuss V, 2005, CANCER RES, V65, P9719, DOI 10.1158/0008-5472.CAN-05-1683; Escara-Wilke J, 2012, CANCER METAST REV, V31, P615, DOI 10.1007/s10555-012-9365-9; Ferlay J, 2010, EUR J CANCER, V46, P765, DOI 10.1016/j.ejca.2009.12.014; Forbes SA, 2011, NUCLEIC ACIDS RES, V39, pD945, DOI 10.1093/nar/gkq929; Hong YS, 2009, CANCER EPIDEM BIOMAR, V18, P680, DOI 10.1158/1055-9965.EPI-08-0961; Howe LR, 2011, CANCER PREV RES, V4, P1149, DOI 10.1158/1940-6207.CAPR-11-0334; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; Jung HY, 2012, CANCER RES TREAT, V44, P251, DOI 10.4143/crt.2012.44.4.251; Keller Evan T, 2011, For Immunopathol Dis Therap, V2, P89; Kelley JL, 2009, HUM MOL GENET, V18, P779, DOI 10.1093/hmg/ddn399; Kim HJ, 2004, NAT REV MOL CELL BIO, V5, P441, DOI 10.1038/nrm1400; Lacoste J, 2005, MOL CELL ENDOCRINOL, V235, P51, DOI 10.1016/j.mce.2004.06.014; Lamy E, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053240; Malumbres M, 2003, NAT REV CANCER, V3, P459, DOI 10.1038/nrc1097; McKay MM, 2007, ONCOGENE, V26, P3113, DOI 10.1038/sj.onc.1210394; Metspalu M, 2011, AM J HUM GENET, V89, P731, DOI 10.1016/j.ajhg.2011.11.010; Milone MR, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.165; Nash D, 2005, P ROY SOC B-BIOL SCI, V272, P1153, DOI 10.1098/rspb.2004.3026; Ning QY, 2011, GENET MOL RES, V10, P3855, DOI 10.4238/2011.December.14.10; Orton RJ, 2005, BIOCHEM J, V392, P249, DOI 10.1042/BJ20050908; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; PAWSON T, 1995, NATURE, V373, P573, DOI 10.1038/373573a0; Peng L, 2013, CURR MOL MED, V13, P333; Pignon JC, 2009, CANCER RES, V69, P2941, DOI 10.1158/0008-5472.CAN-08-3760; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Raj T, 2012, AM J HUM GENET, V90, P720, DOI 10.1016/j.ajhg.2012.02.022; Ren GP, 2012, GENE CHROMOSOME CANC, V51, P1014, DOI 10.1002/gcc.21984; Rezaiemanesh Alireza, 2010, Human Antibodies, V19, P63, DOI 10.3233/HAB-2010-0229; Sabeti PC, 2002, NATURE, V419, P832, DOI 10.1038/nature01140; Seshacharyulu P, 2012, EXPERT OPIN THER TAR, V16, P15, DOI 10.1517/14728222.2011.648617; Shih MC, 2012, ONCOGENE, V31, P2389, DOI 10.1038/onc.2011.419; Siegel R, 2013, CA-CANCER J CLIN, V63, P11, DOI 10.3322/caac.21166; Siegel R, 2012, CA-CANCER J CLIN, V62, P10, DOI 10.3322/caac.20138; Stephens M, 2005, AM J HUM GENET, V76, P449, DOI 10.1086/428594; STORM SM, 1993, TOXICOL LETT, V67, P201, DOI 10.1016/0378-4274(93)90056-4; Sumitomo M, 2000, J CLIN INVEST, V106, P1399, DOI 10.1172/JCI10536; Tan M, 2007, ADV EXP MED BIOL, V608, P119; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Wang GH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055298; Xu JF, 2012, NAT GENET, V44, P1231, DOI 10.1038/ng.2424; Yu K, 2009, GENET EPIDEMIOL, V33, P700, DOI 10.1002/gepi.20422; Zhao GY, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053906	52	92	96	3	88	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2013	8	11							e78254	10.1371/journal.pone.0078254	http://dx.doi.org/10.1371/journal.pone.0078254			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	245ZC	24260499	Green Published, gold, Green Submitted			2022-12-25	WOS:000326503400044
J	Williams, O; Gbadero, D; Edowhorhu, G; Brearley, A; Slusher, T; Lund, TC				Williams, Olatundun; Gbadero, Daniel; Edowhorhu, Grace; Brearley, Ann; Slusher, Tina; Lund, Troy C.			Glucose-6-Phosphate Dehydrogenase Deficiency in Nigerian Children	PLOS ONE			English	Article							ANEMIA	Glucose-6-phosphate dehydrogenase (G6PD) deficiency is the most common human enzymopathy and in Sub-Saharan Africa, is a significant cause of infection-and drug-induced hemolysis and neonatal jaundice. Our goals were to determine the prevalence of G6PD deficiency among Nigerian children of different ethnic backgrounds and to identify predictors of G6PD deficiency by analyzing vital signs and hematocrit and by asking screening questions about symptoms of hemolysis. We studied 1,122 children (561 males and 561 females) aged 1 month to 15 years. The mean age was 7.4 +/- 3.2 years. Children of Yoruba ethnicity made up the largest group (77.5%) followed by those Igbo descent (10.6%) and those of Igede (10.2%) and Tiv (1.8%) ethnicity. G6PD status was determined using the fluorescent spot method. We found that the overall prevalence of G6PD deficiency was 15.3% (24.1% in males, 6.6% in females). Yoruba children had a higher prevalence (16.9%) than Igede (10.5%), Igbo (10.1%) and Tiv (5.0%) children. The odds of G6PD deficiency were 0.38 times as high in Igbo children compared to Yoruba children (p = 0.0500). The odds for Igede and Tiv children were not significantly different from Yoruba children (p = 0.7528 and 0.9789 respectively). Mean oxygen saturation, heart rate and hematocrit were not significantly different in G6PD deficient and G6PD sufficient children. The odds of being G6PD deficient were 2.1 times higher in children with scleral icterus than those without (p = 0.0351). In conclusion, we determined the prevalence of G6PD deficiency in Nigerian sub-populations. The odds of G6PD deficiency were decreased in Igbo children compared to Yoruba children. There was no association between vital parameters or hematocrit and G6PD deficiency. We found that a history of scleral icterus may increase the odds of G6PD deficiency, but we did not exclude other common causes of icterus such as sickle cell disease or malarial infection.	[Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA; [Williams, Olatundun; Slusher, Tina; Lund, Troy C.] Univ Minnesota, Div Global Hlth, Minneapolis, MN USA; [Gbadero, Daniel] Bowen Univ, Teaching Hosp, Dept Pediat, Ogbomosho, Nigeria; [Edowhorhu, Grace] Bowen Univ, Teaching Hosp, Dept Lab Med, Ogbomosho, Nigeria; [Brearley, Ann] Univ Minnesota, Biostat Design & Anal Ctr, Clin & Translat Sci Inst, Minneapolis, MN USA; [Lund, Troy C.] Univ Minnesota, Div Blood & Marrow Transplant, Minneapolis, MN USA	University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities; University of Minnesota System; University of Minnesota Twin Cities	Lund, TC (corresponding author), Univ Minnesota, Dept Pediat, Minneapolis, MN 55455 USA.	lundx072@umn.edu			National Center for Research Resources [UL1TR000114]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000114] Funding Source: NIH RePORTER	National Center for Research Resources(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS))	Biostatistics was made available through grant UL1TR000114 from the National Center for Research Resources. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	[Anonymous], 1989, B WORLD HEALTH ORGAN, V67, P601; BEUTLER E, 1968, BLOOD, V32, P816, DOI 10.1182/blood.V32.5.816.816; BIENZLE U, 1975, BLOOD, V46, P591, DOI 10.1182/blood.V46.4.591.591; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Kaplan M, 2011, SEMIN PERINATOL, V35, P155, DOI 10.1053/j.semperi.2011.02.010; May J, 2000, TROP MED INT HEALTH, V5, P119, DOI 10.1046/j.1365-3156.2000.00529.x; Orimadegun AE, 2011, J INFECT DEV COUNTR, V5, P792, DOI 10.3855/jidc.1837; Peters AL, 2009, J HISTOCHEM CYTOCHEM, V57, P1003, DOI 10.1369/jhc.2009.953828; STEINBERG MH, 1988, BLOOD, V71, P748	10	39	43	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 12	2013	8	7							e68800	10.1371/journal.pone.0068800	http://dx.doi.org/10.1371/journal.pone.0068800			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	182CS	24349006	Green Submitted, Green Published, gold			2022-12-25	WOS:000321718700041
J	Wang, FQ; Wang, L; Xu, ZY; Liang, GL				Wang, Fuqiang; Wang, Ling; Xu, Zhiyang; Liang, Gaolin			Identification and Analysis of Multi-Protein Complexes in Placenta	PLOS ONE			English	Article							INTRAUTERINE GROWTH RESTRICTION; NATIVE GEL-ELECTROPHORESIS; PLASMA-MEMBRANE; PROTEOMIC ANALYSIS; PROTEASOME; UBIQUITINATION; DEGRADATION; PREECLAMPSIA; HOMEOSTASIS; EXPRESSION	Placental malfunction induces pregnancy disorders which contribute to life-threatening complications for both the mother and the fetus. Identification and characterization of placental multi-protein complexes is an important step to integratedly understand the protein-protein interaction networks in placenta which determine placental function. In this study, blue native/sodium dodecyl sulfate polyacrylamide gel electrophoresis (BN/SDS-PAGE) and Liquid chromatography-tandem mass spectrometry (LC-MS/MS) were used to screen the multi-protein complexes in placenta. 733 unique proteins and 34 known and novel heterooligomeric multi-protein complexes including mitochondrial respiratory chain complexes, integrin complexes, proteasome complexes, histone complex, and heat shock protein complexes were identified. A novel protein complex, which involves clathrin and small conductance calcium-activated potassium (SK) channel protein 2, was identified and validated by antibody based gel shift assay, co-immunoprecipitation and immunouorescence staining. These results suggest that BN/SDS-PAGE, when integrated with LC-MS/MS, is a very powerful and versatile tool for the investigation of placental protein complexes. This work paves the way for deeper functional characterization of the placental protein complexes associated with pregnancy disorders.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Xu, Zhiyang] Nanjing Med Univ, Anal Ctr, State Key Lab Reprod Med, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei 230026, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Abell AN, 2011, CELL STEM CELL, V8, P525, DOI 10.1016/j.stem.2011.03.008; Alberts B, 1998, CELL, V92, P291, DOI 10.1016/S0092-8674(00)80922-8; CARVER W, 1995, J CELL PHYSIOL, V165, P425, DOI 10.1002/jcp.1041650224; Chenette EJ, 2012, NAT CELL BIOL, V14, P566; Cox B, 2011, MOL CELL PROTEOMICS, V10, DOI 10.1074/mcp.M111.012526; CRAIG EA, 1993, MICROBIOL REV, V57, P402, DOI 10.1128/MMBR.57.2.402-414.1993; DAMSKY CH, 1994, DEVELOPMENT, V120, P3657; Ekambaram P, 2011, INDIAN J BIOCHEM BIO, V48, P243; Eubel H, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-11; Feikova S, 2000, NEOPLASMA, V47, P212; Garnica AD, 1996, J AM COLL NUTR, V15, P206; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hayes MJ, 2004, TRAFFIC, V5, P571, DOI 10.1111/j.1600-0854.2004.00210.x; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Ito T, 2000, P NATL ACAD SCI USA, V97, P1143, DOI 10.1073/pnas.97.3.1143; Johnstone ED, 2011, PROTEOMICS, V11, P4077, DOI 10.1002/pmic.201000505; Katz A, 2007, MOL CELL PROTEOMICS, V6, P1459, DOI 10.1074/mcp.M700002-MCP200; Lafond J, 2006, INT REV CYTOL, V250, P109, DOI 10.1016/S0074-7696(06)50004-X; Lemarie A, 2011, ONCOGENE, V30, P3985, DOI 10.1038/onc.2011.167; LEWIS PN, 1976, CAN J BIOCHEM CELL B, V54, P641, DOI 10.1139/o76-093; Li XW, 2009, J PROTEOME RES, V8, P3475, DOI 10.1021/pr900101d; Lipkowitz S, 2003, BREAST CANCER RES, V5, P8, DOI 10.1186/bcr541; Liu K, 2009, MOL CELL PROTEOMICS, V8, P495, DOI 10.1074/mcp.M800250-MCP200; Mari G, 2007, CLIN OBSTET GYNECOL, V50, P497, DOI 10.1097/GRF.0b013e31804c96a9; Marin R, 2008, PLACENTA, V29, P671, DOI 10.1016/j.placenta.2008.06.003; Pedarzani P, 2008, CELL MOL LIFE SCI, V65, P3196, DOI 10.1007/s00018-008-8216-x; Powe CE, 2011, CIRCULATION, V123, P2856, DOI 10.1161/CIRCULATIONAHA.109.853127; Reisinger Veronika, 2007, Proteomics, V7 Suppl 1, P6, DOI 10.1002/pmic.200700205; Robinson JM, 2008, PLACENTA, V29, P135, DOI 10.1016/j.placenta.2007.12.005; SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A; Schmitt HP, 2006, MED HYPOTHESES, V67, P311, DOI 10.1016/j.mehy.2006.02.023; Smart EJ, 2004, P NATL ACAD SCI USA, V101, P3450, DOI 10.1073/pnas.0400441101; Soltys BJ, 1996, EXP CELL RES, V222, P16, DOI 10.1006/excr.1996.0003; Streicher WW, 2009, BIOCHEMISTRY-US, V48, P2788, DOI 10.1021/bi8019959; Thorn SR, 2011, SEMIN REPROD MED, V29, P225, DOI 10.1055/s-0031-1275516; Ueki H, 2012, SCI REP-UK, V2, DOI 10.1038/srep00827; Van Blerkom J, 2009, SEMIN CELL DEV BIOL, V20, P354, DOI 10.1016/j.semcdb.2008.12.005; Wang HX, 2006, J CELL PHYSIOL, V206, P616, DOI 10.1002/jcp.20508; Williamson R, 2002, J NEUROSCI, V22, P10, DOI 10.1523/JNEUROSCI.22-01-00010.2002; Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62; Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3; Zhang HJ, 2012, DEVELOPMENT, V139, P2071, DOI 10.1242/dev.077347; Zhang Q, 2010, PROTEOM CLIN APPL, V4, P538, DOI 10.1002/prca.200900048; Zhang Y, 2008, PROTEOMICS, V8, P4344, DOI 10.1002/pmic.200800294	46	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2013	8	4							e62988	10.1371/journal.pone.0062988	http://dx.doi.org/10.1371/journal.pone.0062988			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	181JC	23638173	Green Published, gold, Green Submitted			2022-12-25	WOS:000321662800072
J	Wang, F; Song, XX; Li, XJ; Xin, J; Wang, SX; Yang, WD; Wang, J; Wu, KC; Chen, XY; Liang, JM; Tian, J; Cao, F				Wang, Fu; Song, Xinxing; Li, Xiujuan; Xin, Jing; Wang, Shenxu; Yang, Weidong; Wang, Jing; Wu, Kaichun; Chen, Xiaoyuan; Liang, Jimin; Tian, Jie; Cao, Feng			Noninvasive Visualization of MicroRNA-16 in the Chemoresistance of Gastric Cancer Using a Dual Reporter Gene Imaging System	PLOS ONE			English	Article							DRUG-RESISTANCE; MAPK PATHWAYS; CELLS; CHEMOTHERAPY; ACTIVATION	MicroRNAs (miRNAs) have been implicated to play a central role in the development of drug resistance in a variety of malignancies. However, many studies were conducted at the in vitro level and could not provide the in vivo information on the functions of miRNAs in the anticancer drug resistance. Here, we introduced a dual reporter gene imaging system for noninvasively monitoring the kinetic expression of miRNA-16 during chemoresistance in gastric cancer both in vitro and in vivo. Human sodium iodide symporter (hNIS) and firefly luciferase (Fluc) genes were linked to form hNIS/Fluc double fusion reporter gene and then generate human gastric cancer cell line NF-3xmir16 and its multidrug resistance cell line NF-3xmir16/VCR. Radioiodide uptake and Fluc luminescence signals in vitro correlated well with viable cell numbers. The luciferase activities and radioiodide uptake in NF-3xmir16 cells were remarkably repressed by exogenous or endogenous miRNA-16. The NF-3xmir16/VCR cells showed a significant increase of I-131 uptake and luminescence intensity compared to NF-3xmir16 cells. The radioactivity from in vivo Tc-99m-pertechnetate imaging and the intensity from bioluminescence imaging were also increased in NF-3xmir16/VCR compared with that in NF-3xmir16 tumor xenografts. Furthermore, using this reporter gene system, we found that etoposide (VP-16) and 5-fluorouracil (5-FU) activated miRNA-16 expression in vitro and in vivo, and the upregulation of miRNA-16 is p38MAPK dependent but NF-kappa B independent. This dual imaging reporter gene may be served as a novel tool for in vivo imaging of microRNAs in the chemoresistance of cancers, as well as for early detection and diagnosis in clinic.	[Wang, Fu; Xin, Jing; Liang, Jimin] Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Dept Cardiol, Xian 710032, Shaanxi, Peoples R China; [Wang, Fu; Song, Xinxing; Li, Xiujuan; Wang, Shenxu; Cao, Feng] Fourth Mil Med Univ, Xijing Hosp, Xian 710032, Shaanxi, Peoples R China; [Yang, Weidong; Wang, Jing] Fourth Mil Med Univ, Xijing Hosp, Dept Nucl Med, Xian 710032, Shaanxi, Peoples R China; [Wu, Kaichun] Fourth Mil Med Univ, Xijing Hosp, Dept Digest Dis, Xian 710032, Shaanxi, Peoples R China; [Chen, Xiaoyuan] Natl Inst Biomed Imaging & Bioengn, Lab Mol Imaging & Nanomed, NIH, Bethesda, MD USA; [Tian, Jie] Chinese Acad Sci, Inst Automat, Beijing, Peoples R China	Xidian University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; Air Force Military Medical University; National Institutes of Health (NIH) - USA; NIH National Institute of Biomedical Imaging & Bioengineering (NIBIB); Chinese Academy of Sciences; Institute of Automation, CAS	Liang, JM (corresponding author), Xidian Univ, Sch Life Sci & Technol, Xian, Shaanxi, Peoples R China.	jimleung@mail.xidian.edu.cn; tian@ieee.org; wind8828@gmail.com	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	Program of the National Basic Research and Development Program of China (973) [2012CB518101, 2011CB707702]; National Natural Science Foundation of China [81090272, 81090274, 81227901]; China Department of Education [2010CXTD01]; 863 Program of China [2012AA02A603]; National Key Technology Support Program [2012BAI23B06]	Program of the National Basic Research and Development Program of China (973)(National Basic Research Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); China Department of Education; 863 Program of China(National High Technology Research and Development Program of China); National Key Technology Support Program(National Key Technology R&D Program)	This work was supported by the Program of the National Basic Research and Development Program of China (973) under Grant No. 2012CB518101, 2011CB707702, the National Natural Science Foundation of China under Grant Nos. 81090272, 81090274, 81227901, Innovation Team Development Grant by China Department of Education (2010CXTD01), 863 Program of China (2012AA02A603) and the National Key Technology Support Program under Grant No. 2012BAI23B06. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Allen KE, 2010, MOL CANCER THER, V9, P3126, DOI 10.1158/1535-7163.MCT-10-0397; Baguley BC, 2010, MOL BIOTECHNOL, V46, P308, DOI 10.1007/s12033-010-9321-2; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Blasberg RG, 2002, J CELL BIOCHEM, P172, DOI 10.1002/jcb.10433; Boldt S, 2002, CARCINOGENESIS, V23, P1831, DOI 10.1093/carcin/23.11.1831; Broxterman HJ, 2009, DRUG RESIST UPDATE, V12, P114, DOI 10.1016/j.drup.2009.07.001; Chung JK, 2002, J NUCL MED, V43, P1188; Cunningham D, 2006, NEW ENGL J MED, V355, P11, DOI 10.1056/NEJMoa055531; Fang JY, 2005, LANCET ONCOL, V6, P322, DOI 10.1016/S1470-2045(05)70168-6; Ferlay J, 2010, INT J CANCER, V127, P2893, DOI 10.1002/ijc.25516; Jo MH, 2012, BIOMATERIALS, V33, P6456, DOI 10.1016/j.biomaterials.2012.05.057; Kang JH, 2008, J NUCL MED, V49, p164S, DOI 10.2967/jnumed.107.045955; Kang WJ, 2012, BIOMATERIALS, V33, P6430, DOI 10.1016/j.biomaterials.2012.05.056; Kim JK, 2012, BIOMATERIALS, V33, P207, DOI 10.1016/j.biomaterials.2011.09.023; Li F, 2010, BBA-REV CANCER, V1805, P167, DOI 10.1016/j.bbcan.2010.01.002; Ma J, 2010, CANCER GENE THER, V17, P523, DOI 10.1038/cgt.2010.18; Mansouri A, 2003, J BIOL CHEM, V278, P19245, DOI 10.1074/jbc.M208134200; Massoud TF, 2003, GENE DEV, V17, P545, DOI 10.1101/gad.1047403; Rivera F, 2007, CANCER TREAT REV, V33, P315, DOI 10.1016/j.ctrv.2007.01.004; Sarkar FH, 2010, DRUG RESIST UPDATE, V13, P57, DOI 10.1016/j.drup.2010.02.001; TROPPMAIR J, 1994, J BIOL CHEM, V269, P7030; Wang F, 2011, EUR J NUCL MED MOL I, V38, P1572, DOI 10.1007/s00259-011-1786-0; Xia L, 2008, INT J CANCER, V123, P372, DOI 10.1002/ijc.23501; Yang SY, 2011, INT J ONCOL, V38, P1695, DOI 10.3892/ijo.2011.982; Zheng TS, 2010, INT J CANCER, V126, P2, DOI 10.1002/ijc.24782	25	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 17	2013	8	4							e61792	10.1371/journal.pone.0061792	http://dx.doi.org/10.1371/journal.pone.0061792			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	130IK	23638173	gold, Green Submitted, Green Published			2022-12-25	WOS:000317907200086
J	Wang, F; Hu, CM; Hua, XT; Song, L; Xia, QY				Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou			Translationally Controlled Tumor Protein, a Dual Functional Protein Involved in the Immune Response of the Silkworm, Bombyx mori	PLOS ONE			English	Article							HISTAMINE-RELEASING FACTOR; DROSOPHILA-MELANOGASTER; PATHOGEN RECOGNITION; CELL-PROLIFERATION; SCAVENGER RECEPTOR; INNATE IMMUNITY; PHAGE DISPLAY; TCTP; IDENTIFICATION; INFECTION	Insect gut immunity is the first line of defense against oral infection. Although a few immune-related molecules in insect intestine has been identified by genomics or proteomics approach with comparison to well-studied tissues, such as hemolymph or fat body, our knowledge about the molecular mechanism underlying the gut immunity which would involve a variety of unidentified molecules is still limited. To uncover additional molecules that might take part in pathogen recognition, signal transduction or immune regulation in insect intestine, a T7 phage display cDNA library of the silkworm midgut is constructed. By use of different ligands for biopanning, Translationally Controlled Tumor Protein (TCTP) has been selected. BmTCTP is produced in intestinal epithelial cells and released into the gut lumen. The protein level of BmTCTP increases at the early time points during oral microbial infection and declines afterwards. In vitro binding assay confirms its activity as a multi-ligand binding molecule and it can further function as an opsonin that promotes the phagocytosis of microorganisms. Moreover, it can induce the production of anti-microbial peptide via a signaling pathway in which ERK is required and a dynamic tyrosine phosphorylation of certain cytoplasmic membrane protein. Taken together, our results characterize BmTCTP as a dual-functional protein involved in both the cellular and the humoral immune response of the silkworm, Bombyx mori.	[Wang, Fei; Hu, Cuimei; Hua, Xiaoting; Song, Liang; Xia, Qingyou] Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China	Southwest University - China	Xia, QY (corresponding author), Southwest Univ, State Key Lab Silkworm Genome Biol, Chongqing, Peoples R China.	xiaqy@swu.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Basic Research Program of China [2012CB114600]; Natural Science Foundation of China [31201854]; Fundamental Research Funds for the Central Universities [XDJK2009B033]	National Basic Research Program of China(National Basic Research Program of China); Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Fundamental Research Funds for the Central Universities(Fundamental Research Funds for the Central Universities)	This work was supported by the grant of "National Basic Research Program of China'' (http://www.973.gov.cn/Default_3.aspx) (2012CB114600), "Natural Science Foundation of China'' (http://www.nsfc.gov.cn/Portal0/default152.htm) (31201854) and "Fundamental Research Funds for the Central Universities'' (XDJK2009B033). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Amson R, 2012, NAT MED, V18, P91, DOI 10.1038/nm.2546; Amzallag N, 2004, J BIOL CHEM, V279, P46104, DOI 10.1074/jbc.M404850200; Aoun RB, 2011, J INNATE IMMUN, V3, P52, DOI 10.1159/000321554; Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188; Chen TS, 2011, BMC BIOTECHNOL, V11, DOI 10.1186/1472-6750-11-16; Chung YSA, 2011, J BIOL CHEM, V286, P26524, DOI 10.1074/jbc.M110.214007; Cronin SJF, 2009, SCIENCE, V325, P340, DOI 10.1126/science.1173164; Davis MM, 2012, J INNATE IMMUN, V4, P273, DOI 10.1159/000332947; Dong YM, 2006, PLOS BIOL, V4, P1137, DOI 10.1371/journal.pbio.0040229; Govind S, 2008, INSECT SCI, V15, P29, DOI 10.1111/j.1744-7917.2008.00185.x; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; He NH, 2005, ANTIVIR RES, V66, P39, DOI 10.1016/j.antiviral.2004.12.010; Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528; Hu XL, 2012, MOL BIOL REP, V39, P3427, DOI 10.1007/s11033-011-1114-6; Huang JX, 2012, ANTIMICROB AGENTS CH, V56, P4569, DOI 10.1128/AAC.00567-12; Huang LL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0008098; Janeway CA, 2002, ANNU REV IMMUNOL, V20, P197, DOI 10.1146/annurev.immunol.20.083001.084359; Jung J, 2004, J BIOL CHEM, V279, P49868, DOI 10.1074/jbc.M400895200; Kashiwakura JI, 2012, J CLIN INVEST, V122, P218, DOI 10.1172/JCI59072; Kim CH, 2010, J BIOL CHEM, V285, P25243, DOI 10.1074/jbc.M110.134940; Kocks C, 2005, CELL, V123, P335, DOI 10.1016/j.cell.2005.08.034; Lee JM, 2004, COMP BIOCHEM PHYS B, V139, P35, DOI 10.1016/j.cbpc.2004.06.004; MACDONALD SM, 1995, SCIENCE, V269, P688, DOI 10.1126/science.7542803; Meyvis Y, 2009, INT J PARASITOL, V39, P1205, DOI 10.1016/j.ijpara.2009.02.017; Nayak S, 2010, FISH SHELLFISH IMMUN, V29, P544, DOI 10.1016/j.fsi.2010.05.010; Nehme NT, 2007, PLOS PATHOG, V3, P1694, DOI 10.1371/journal.ppat.0030173; Nie ZM, 2010, MOL BIOL REP, V37, P2621, DOI 10.1007/s11033-009-9787-9; Niikura M, 2004, POULTRY SCI, V83, P1117, DOI 10.1093/ps/83.7.1117; Nupan B, 2011, DEV COMP IMMUNOL, V35, P469, DOI 10.1016/j.dci.2010.11.016; Ochiai M, 2000, J BIOL CHEM, V275, P4995, DOI 10.1074/jbc.275.7.4995; Oliveira GD, 2012, SCIENCE, V335, P856, DOI 10.1126/science.1209678; Pan MH, 2010, TISSUE CELL, V42, P42, DOI 10.1016/j.tice.2009.07.002; Panrat T, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033291; Pauchet Y, 2009, J BIOL CHEM, V284, P2214, DOI 10.1074/jbc.M806204200; Pauchet Y, 2008, J PROTEOME RES, V7, P1629, DOI 10.1021/pr7006208; PEARSON A, 1995, P NATL ACAD SCI USA, V92, P4056, DOI 10.1073/pnas.92.9.4056; Ponnuvel KM, 2003, J VIROL, V77, P10725, DOI 10.1128/JVI.77.19.10725-10729.2003; Popova-Butler A, 2009, J INSECT PHYSIOL, V55, P264, DOI 10.1016/j.jinsphys.2008.12.008; Povelones M, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1002023; Rinnerthaler M, 2006, BBA-BIOENERGETICS, V1757, P631, DOI 10.1016/j.bbabio.2006.05.022; Shitomi Y, 2006, J BIOCHEM, V139, P223, DOI 10.1093/jb/mvj024; Song KH, 2008, J INSECT PHYSIOL, V54, P1271, DOI 10.1016/j.jinsphys.2008.06.010; Sunagar SG, 2011, J INSECT PHYSIOL, V57, P1707, DOI 10.1016/j.jinsphys.2011.09.009; Thaw P, 2001, NAT STRUCT BIOL, V8, P701, DOI 10.1038/90415; Tonganunt M, 2008, FISH SHELLFISH IMMUN, V25, P633, DOI 10.1016/j.fsi.2008.08.006; Venugopal T, 2005, COMP BIOCHEM PHYS B, V142, P8, DOI 10.1016/j.cbpc.2005.04.011; Vonakis BM, 2008, BLOOD, V111, P1789, DOI 10.1182/blood-2007-07-104364; Wang F, 2009, EUR J IMMUNOL, V39, P254, DOI 10.1002/eji.200838472; Wang LH, 2006, IMMUNOBIOLOGY, V211, P251, DOI 10.1016/j.imbio.2006.01.001; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Wu S, 2010, DEV COMP IMMUNOL, V34, P1191, DOI 10.1016/j.dci.2010.06.013; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Zhang J, 2012, P NATL ACAD SCI USA, V109, pE926, DOI 10.1073/pnas.1106300109; Zhang S, 2011, COMP FUNCT GENOM, DOI 10.1155/2011/876064	55	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 22	2013	8	7							e69284	10.1371/journal.pone.0069284	http://dx.doi.org/10.1371/journal.pone.0069284			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	187PW	23638173	Green Submitted, Green Published, gold			2022-12-25	WOS:000322132100052
J	Wang, FQ; Wang, L; Shi, ZH; Liang, GL				Wang, Fuqiang; Wang, Ling; Shi, Zhonghua; Liang, Gaolin			Comparative N-Glycoproteomic and Phosphoproteomic Profiling of Human Placental Plasma Membrane between Normal and Preeclampsia Pregnancies with High-Resolution Mass Spectrometry	PLOS ONE			English	Article							PROTEIN-COUPLED RECEPTOR; LATE-ONSET PREECLAMPSIA; UTERINE ARTERY DOPPLER; METASTASIS SUPPRESSOR; SIGNALING NETWORKS; QUANTITATIVE PROTEOMICS; TROPHOBLAST INVASION; IN-VITRO; EXPRESSION; KISS-1	Preeclampsia is a serious complication of pregnancy, which affects 2-8% of all pregnancies and is one of the leading causes of maternal and perinatal mortality and morbidity worldwide. To better understand the molecular mechanisms involved in pathological development of placenta in preeclampsia, we used high-resolution LC-MS/MS technologies to construct a comparative N-glycoproteomic and phosphoproteomic profiling of human placental plasma membrane in normal and preeclamptic pregnancies. A total of 1027 N-glyco-and 2094 phospho-sites were detected in human placental plasma membrane, and 5 N-glyco-and 38 phospho-proteins, respectively, with differentially expression were definitively identified between control and preeclamptic placental plasma membrane. Further bioinformatics analysis indicated that these differentially expressed proteins correlate with several specific cellular processes occurring during pathological changes of preeclamptic placental plasma membrane.	[Wang, Fuqiang; Liang, Gaolin] Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China; [Wang, Fuqiang; Wang, Ling; Shi, Zhonghua] Nanjing Med Univ, State Key Lab Reprod Med, Anal Ctr, Nanjing, Jiangsu, Peoples R China	Chinese Academy of Sciences; University of Science & Technology of China, CAS; Nanjing Medical University	Liang, GL (corresponding author), Univ Sci & Technol China, Dept Chem, CAS Key Lab Soft Matter Chem, Hefei, Anhui, Peoples R China.	gliang@ustc.edu.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Natural Science Foundation of China [21175122, 91127036]; Technology Development Key Project Fund of Nanjing Medical University [2011NJMU269, 2011NJMU270]	National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Technology Development Key Project Fund of Nanjing Medical University	This work was supported by the National Natural Science Foundation of China (Grants 21175122 and 91127036) and Technology Development Key Project Fund of Nanjing Medical University (Grants 2011NJMU269 and 2011NJMU270). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Beck BH, 2010, EUR J CANCER, V46, P1283, DOI 10.1016/j.ejca.2010.02.023; Bilban M, 2004, J CELL SCI, V117, P1319, DOI 10.1242/jcs.00971; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Boersema PJ, 2009, NAT PROTOC, V4, P484, DOI 10.1038/nprot.2009.21; Cartwright JE, 2012, J ENDOCRINOL, V214, P79, DOI 10.1530/JOE-12-0091; Crispi F, 2008, ULTRASOUND OBST GYN, V31, P303, DOI 10.1002/uog.5184; Danussi C, 2012, CANCER PREV RES, V5, P1131, DOI 10.1158/1940-6207.CAPR-12-0076-T; Danussi C, 2011, J CELL BIOL, V195, P131, DOI 10.1083/jcb.201008013; Duley L, 2009, SEMIN PERINATOL, V33, P130, DOI 10.1053/j.semperi.2009.02.010; Eastabrook G, 2011, BEST PRACT RES CL OB, V25, P435, DOI 10.1016/j.bpobgyn.2011.01.005; Fleischer S, 1974, Methods Enzymol, V31, P6; Hiden U, 2007, REV ENDOCR METAB DIS, V8, P31, DOI 10.1007/s11154-007-9030-8; Huppertz B, 2008, HYPERTENSION, V51, P970, DOI 10.1161/HYPERTENSIONAHA.107.107607; Ilic D, 2001, AM J PATHOL, V159, P93, DOI 10.1016/S0002-9440(10)61677-X; Janneau JL, 2002, J CLIN ENDOCR METAB, V87, P5336, DOI 10.1210/jc.2002-021093; Kotani M, 2001, J BIOL CHEM, V276, P34631, DOI 10.1074/jbc.M104847200; Kratchmarova I, 2005, SCIENCE, V308, P1472, DOI 10.1126/science.1107627; Li CF, 2012, PLACENTA, V33, P47, DOI 10.1016/j.placenta.2011.10.008; Mead EJ, 2007, BRIT J PHARMACOL, V151, P1143, DOI 10.1038/sj.bjp.0707295; MEEKINS JW, 1994, BRIT J OBSTET GYNAEC, V101, P669, DOI 10.1111/j.1471-0528.1994.tb13182.x; Ohtaki T, 2001, NATURE, V411, P613, DOI 10.1038/35079135; Oudejans CBM, 2007, HUM GENET, V120, P607, DOI 10.1007/s00439-006-0259-1; Park DW, 2012, AM J REPROD IMMUNOL, V67, P132, DOI 10.1111/j.1600-0897.2011.01073.x; Ping C, 2007, SCI CHINA SER C, V50, P731, DOI 10.1007/s11427-007-0103-4; Plasencia W, 2008, ULTRASOUND OBST GYN, V32, P138, DOI 10.1002/uog.5402; Qiao Chong, 2005, Zhonghua Fu Chan Ke Za Zhi, V40, P585; [乔宠 Qiao Chong], 2003, [中国实用妇科与产科杂志, Chineses Journal of Practical Gynecology and Obstetrics], V19, P289; Qin HQ, 2013, CHEM COMMUN, V49, P5162, DOI 10.1039/c3cc41479e; Raymond D, 2011, OBSTET GYNECOL SURV, V66, P497, DOI 10.1097/OGX.0b013e3182331028; Roseweir AK, 2012, PLACENTA, V33, P408, DOI 10.1016/j.placenta.2012.02.001; Sibai B, 2005, LANCET, V365, P785, DOI 10.1016/S0140-6736(05)71003-5; Staun-Ram Elsebeth, 2004, Reprod Biol Endocrinol, V2, P59, DOI 10.1186/1477-7827-2-59; Takino T, 2003, ONCOGENE, V22, P4617, DOI 10.1038/sj.onc.1206542; Tena-Sempere M, 2008, NAT MED, V14, P1196, DOI 10.1038/nm1108-1196; Thelemann A, 2005, MOL CELL PROTEOMICS, V4, P356, DOI 10.1074/mcp.M400118-MCP200; Vazquez-Alaniz F, 2011, EUR J OBSTET GYN R B, V159, P67, DOI 10.1016/j.ejogrb.2011.07.019; von Dadelszen P, 2003, HYPERTENS PREGNANCY, V22, P143, DOI 10.1081/PRG-120021060; Walker JJ, 2000, LANCET, V356, P1260, DOI 10.1016/S0140-6736(00)02800-2; Wolf-Yadlin A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100094; Xu B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016046; Xu P, 2001, BIOL REPROD, V65, P240, DOI 10.1095/biolreprod65.1.240; Yan CH, 2001, J BIOL CHEM, V276, P1164, DOI 10.1074/jbc.M008681200; Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200	43	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 15	2013	8	11							e80480	10.1371/journal.pone.0080480	http://dx.doi.org/10.1371/journal.pone.0080480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	255RX	23638173	Green Published, Green Submitted, gold			2022-12-25	WOS:000327258600065
J	Wang, FP; Li, L; Li, J; Wang, JY; Wang, LY; Jiang, W				Wang, Fu-ping; Li, Lei; Li, Jing; Wang, Ji-yao; Wang, Ling-yan; Jiang, Wei			RETRACTED: High Mobility Group Box-1 Promotes the Proliferation and Migration of Hepatic Stellate Cells via TLR4-Dependent Signal Pathways of PI3K/Akt and JNK (Retracted article. See vol. 14, 2019)	PLOS ONE			English	Article; Retracted Publication							GLYCATION END-PRODUCTS; RECEPTOR 4; LIVER FIBROSIS; KAPPA-B; HMGB1; PROTEIN; RAT; EXPRESSION; APOPTOSIS; INFLAMMATION	Background: The migration of hepatic stellate cells (HSCs) is essential to the hepatic fibrotic response, and recently High-mobility group box 1 (HMGB1) has been shown up-regulated during liver fibrosis. Nevertheless, whether HMGB1 can modulate the proliferation and migration of HSCs is poorly understood, as well as the involved intracellular signaling. In this study, we examined the effect of HMGB1 on proliferation, migration, pro-fibrotic function of HSCs and investigated whether toll-like family of receptor 4 (TLR4) dependent signal pathway is involved in the intracellular signaling regulation. Methodology/Principal Findings: Modified transwell chamber system to mimic the space of Disse was used to evaluate the migration of human primary HSCs, and the protein expressions of related signal factors were evaluated by western blot. Cell proliferation was analyzed by MTT assay, the pro-fibrotic functions of HSCs by qRT-PCR and ELISA respectively. Recombinant human HMGB1 could significantly promote migration of HSCs under both haptotactic and chemotactic stimulation, especially the latter. Human TLR4 neutralizing antibody could markedly inhibit HMGB1-induced migration of HSCs. HMGB1 could enhance the phosphorylation of JNK and PI3K/Akt, and TLR4 neutralizing antibody inhibited HMGB1-enhanced phosphorylation of JNK and PI3K/Akt and activation of NF-kappa B. JNK inhibitor (SP600125) and PI3K inhibitor (LY 294002) significantly inhibited HMGB1-induced proliferation and migration of HSCs, and also reduced HMGB1-enhanced related collagen expressions and pro-fibrotic cytokines production. Conclusions/Significance: HMGB1 could significantly enhance migration of HSCs in vitro, and TLR4-dependent JNK and PI3K/Akt signal pathways are involved in the HMGB1-induced proliferation, migration and pro-fibrotic effects of HSCs, which indicates HMGB1 might be an effective target to treat liver fibrosis.	[Wang, Fu-ping; Li, Lei; Wang, Ji-yao; Jiang, Wei] Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China; [Li, Jing] Tongji Univ, Tongji Hosp, Dept Gastroenterol, Shanghai 200092, Peoples R China; [Wang, Ling-yan] Fudan Univ, Zhongshan Hosp, Biomed Res Ctr, Shanghai 200433, Peoples R China	Fudan University; Tongji University; Fudan University	Jiang, W (corresponding author), Fudan Univ, Zhongshan Hosp, Dept Gastroenterol, Shanghai 200433, Peoples R China.	jiang.wei@zs-hospital.sh.cn	Wang, Jing/G-5261-2018; Liang, Gaolin/F-1786-2010; Tian, Jie/H-1190-2011; Liang, Jimin/B-5394-2014; Wang, Fu/S-7955-2017; li, xiu/GXV-1745-2022; Chen, Xiaoyuan/D-1860-2014; Life, MC/M-9554-2013	Liang, Gaolin/0000-0002-6159-9999; Tian, Jie/0000-0003-0498-0432; Liang, Jimin/0000-0003-1428-5804; Wang, Fu/0000-0001-9222-0833; Chen, Xiaoyuan/0000-0002-9622-0870; Xia, Qingyou/0000-0002-9263-2886; Wang, Fuqiang/0000-0002-7777-3541; Song, Xinxing/0000-0001-8649-4096	National Nature Science Foundation of China [30300151, 81070341]; Shanghai Nature Science Foundation [09ZR1406000]	National Nature Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai Nature Science Foundation	This study is supported by grants from the National Nature Science Foundation of China (No. 30300151 &81070341, http://www.nsfc.gov.cn) and Shanghai Nature Science Foundation (No. 09ZR1406000, http://www.stcsm.gov.cn). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Andersson U, 2011, ANNU REV IMMUNOL, V29, P139, DOI 10.1146/annurev-immunol-030409-101323; Bai D, 2009, INT J CANCER, V125, P2863, DOI 10.1002/ijc.24748; Beaulieu JM, 2007, TRENDS PHARMACOL SCI, V28, P166, DOI 10.1016/j.tips.2007.02.006; Brenner DA, 2000, J HEPATOL, V32, P32, DOI 10.1016/S0168-8278(00)80413-4; Chen GQ, 2004, J INTERF CYTOK RES, V24, P329, DOI 10.1089/107999004323142187; Chen XL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050668; Dolcet X, 2005, VIRCHOWS ARCH, V446, P475, DOI 10.1007/s00428-005-1264-9; Fehrenbach H, 2001, HEPATOLOGY, V34, P943, DOI 10.1053/jhep.2001.28788; Friedman SL, 2008, GASTROENTEROLOGY, V134, P1655, DOI 10.1053/j.gastro.2008.03.003; Hamada N, 2008, AM J RESP CELL MOL, V39, P440, DOI 10.1165/rcmb.2007-0330OC; He ZY, 2009, J RECEPT SIG TRANSD, V29, P119, DOI 10.1080/10799890902845690; Ilmakunnas M, 2008, LIVER TRANSPLANT, V14, P1517, DOI 10.1002/lt.21573; Inoue R, 2005, BRIT J PHARMACOL, V146, P633, DOI 10.1038/sj.bjp.0706373; Iredale JP, 2007, J CLIN INVEST, V117, P539, DOI 10.1172/JCI30542; Ito I, 2007, J BIOL CHEM, V282, P16336, DOI 10.1074/jbc.M608467200; Kao YH, 2008, TRANSPL P, V40, P2704, DOI 10.1016/j.transproceed.2008.07.055; Kim CH, 2010, INT J ONCOL, V36, P117, DOI 10.3892/ijo_00000482; Kim DE, 2012, BIOCHEM BIOPH RES CO, V421, P436, DOI 10.1016/j.bbrc.2012.03.131; Kim SY, 2012, BIOCHEM BIOPH RES CO, V419, P466, DOI 10.1016/j.bbrc.2012.02.015; Lang A, 2000, J HEPATOL, V33, P49, DOI 10.1016/S0168-8278(00)80159-2; Lange SS, 2008, P NATL ACAD SCI USA, V105, P10320, DOI 10.1073/pnas.0803181105; Li L, 2012, LIVER INT, V32, P1093, DOI 10.1111/j.1478-3231.2012.02809.x; Lin YL, 2009, J GASTROEN HEPATOL, V24, P453, DOI 10.1111/j.1440-1746.2008.05573.x; Lohwasser C, 2009, WORLD J GASTROENTERO, V15, P5789, DOI 10.3748/wjg.15.5789; Ma JJ, 2009, LIVER INT, V29, P567, DOI 10.1111/j.1478-3231.2009.01981.x; Mitola S, 2006, J IMMUNOL, V176, P12, DOI 10.4049/jimmunol.176.1.12; Nogueira-Machado JA, 2011, EXPERT OPIN THER TAR, V15, P1023, DOI 10.1517/14728222.2011.575360; Novo E, 2012, J PATHOL, V226, P588, DOI 10.1002/path.3005; Paik YH, 2003, HEPATOLOGY, V37, P1043, DOI 10.1053/jhep.2003.50182; Pradere JP, 2010, SEMIN LIVER DIS, V30, P232, DOI 10.1055/s-0030-1255353; Rauvala H, 2010, BBA-GENE REGUL MECH, V1799, P164, DOI 10.1016/j.bbagrm.2009.11.012; Reif S, 2003, J BIOL CHEM, V278, P8083, DOI 10.1074/jbc.M212927200; Reyes-Gordillo K, 2011, AM J PATHOL, V178, P2100, DOI 10.1016/j.ajpath.2011.01.025; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Schnabl B, 2008, BIOCHEM BIOPH RES CO, V375, P210, DOI 10.1016/j.bbrc.2008.07.150; Seki E, 2007, NAT MED, V13, P1324, DOI 10.1038/nm1663; Sims GP, 2010, ANNU REV IMMUNOL, V28, P367, DOI 10.1146/annurev.immunol.021908.132603; Son G, 2009, HEPATOLOGY, V50, P1512, DOI 10.1002/hep.23186; Tang XM, 2009, BIOL PHARM BULL, V32, P963, DOI 10.1248/bpb.32.963; Tsung A, 2007, J EXP MED, V204, P2913, DOI 10.1084/jem.20070247; Uyama N, 2012, LAB INVEST, V92, P57, DOI 10.1038/labinvest.2011.150; Vinas O, 2003, HEPATOLOGY, V38, P919, DOI 10.1053/jhep.2003.50392; Wang X, 2011, J HEPATOL, V55, P379, DOI 10.1016/j.jhep.2010.10.040; Xia JR, 2008, INT J MOL SCI, V9, P638, DOI 10.3390/ijms9040638; Yamada S, 2007, CLIN CHIM ACTA, V375, P36, DOI 10.1016/j.cca.2006.07.019; Yang CQ, 2003, GASTROENTEROLOGY, V124, P147, DOI 10.1053/gast.2003.50012; Yang J, 2012, MOL BIOL REP, V39, P3361, DOI 10.1007/s11033-011-1106-6; Yang LC, 2012, LEUKEMIA LYMPHOMA, V53, P315, DOI 10.3109/10428194.2011.616962	48	311	332	16	131	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 16	2013	8	5							e64373	10.1371/journal.pone.0064373	http://dx.doi.org/10.1371/journal.pone.0064373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	146HW	23638173	Green Published, gold			2022-12-25	WOS:000319081900089
